PT	AU	BA	BE	GP	AF	BF	CA	TI	SO	SE	BS	LA	DT	CT	CY	CL	SP	HO	DE	ID	AB	C1	C3	RP	EM	RI	OI	FU	FX	CR	NR	TC	Z9	U1	U2	PU	PI	PA	SN	EI	BN	J9	JI	PD	PY	VL	IS	PN	SU	SI	MA	BP	EP	AR	DI	D2	EA	PG	WC	WE	SC	GA	UT	PM	OA	HC	HP	DA	WOS
J	Ruchholtz, S; Waydhas, C; Muller, A; Lewan, UM; Nast-Kolb, D; Euler, E; Pfeiffer, KJ; Schweiberer, L				Ruchholtz, S; Waydhas, C; Muller, A; Lewan, UM; Nast-Kolb, D; Euler, E; Pfeiffer, KJ; Schweiberer, L			Percutaneous computed tomographic-controlled ventriculostomy in severe traumatic brain injury	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	11th Annual Meeting of the Eastern-Association-for-the-Surgery-of-Trauma	JAN 14-17, 1998	SANIBEL, FLORIDA	E Assoc Surg Trauma		percutaneous computed tomographic-controlled; ventriculostomy; intracranial pressure monitoring; severe traumatic brain injury	SEVERE HEAD-INJURIES; INTRACRANIAL-PRESSURE; NEEDLE TREPHINATION; FIBEROPTIC DEVICE; TISSUE PRESSURE; EXPERIENCE	Objective: Percutaneous computed tomographic (CT)-controlled ventriculostomy (PCV) was introduced for the monitoring of intracranial pressure in patients with severe traumatic brain injury who did not require simultaneous decompressive trepanation, Methods: PCV (n = 14) was compared with conventional burr hole ventriculostomy (n = 13) based on prospectively collected data. Results: PCV proved to be a successful technique in all cases and also when a burr hole ventriculostomy was impossible previously. There were no complications. In burr hole ventriculostomy, there were one unsuccessful insertion and one catheter contamination, The main advantage of PCV over burr hole ventriculostomy was a significant (p < 0.05) reduction in the time required to perform the procedure, In ventriculostomy directly after the initial evaluation in the emergency department, the operation time was reduced from 45 +/- 11 to 22 +/- 14 minutes. The interval between cranial computed tomography and start of operation was reduced from 78 +/- 38 to 33 +/- 12 minutes, and between initial cranial computed tomography and intensive care unit admittance, from 138 +/- 37 to 73 +/- 28 minutes. For patients requiring ventriculostomy while being treated in the intensive care unit, the duration of the procedure (i.e., absence from the intensive care unit) was able to be reduced from 111 +/- 24 to 81 +/- 21 minutes. Conclusion: Distinct time savings are the major advantages of PCV, allowing exact catheter positioning even with very narrow ventricles.	Univ Munich, Klinikum Innenstadt, Dept Surg, D-8000 Munich, Germany; Univ Munich, Klinikum Innenstadt, Dept Radiol, D-8000 Munich, Germany; Univ Munich, Klinikum Grosshadern, Dept Neurosurg, D-8000 Munich, Germany		Ruchholtz, S (corresponding author), Klinikum Univ Essen, Dept Traumatol, Hufelandstr 55, D-45147 Essen, Germany.						BARDENHEUE M, 1994, UNFALLCHIRURG, V97, P230; BECKER DP, 1977, J NEUROSURG, V47, P492; Bullock Ross, 1996, Journal of Neurotrauma, V13, P639; Burton C, 1965, J Trauma, V5, P643, DOI 10.1097/00005373-196509000-00008; CHAMBERS IR, 1993, NEUROSURGERY, V33, P866; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; GAHJAR JB, 1993, ADV NEUROSURG, V21, P173; GAMBARDELLA G, 1992, NEUROSURGERY, V31, P918, DOI 10.1227/00006123-199211000-00014; GILSBACH J, 1988, NEUROCHIRURGIA, V31, P114; GLISBACH J, 1979, NEUROCHIRURGIA, V21, P128; GOPINATH SP, 1995, NEUROSURGERY, V36, P1137, DOI 10.1227/00006123-199506000-00011; HALLOWAY KL, 1996, J NEUROSURG, V85, P419; JENNETT B, 1977, J NEUROL NEUROSUR PS, V40, P291, DOI 10.1136/jnnp.40.3.291; KANTER RK, 1985, CRIT CARE MED, V13, P837, DOI 10.1097/00003246-198510000-00012; MAHONEY BD, 1981, NEUROSURGERY, V8, P551, DOI 10.1227/00006123-198105000-00006; MARMAROU A, 1991, J NEUROSURG, V75, P159; MARSHALL LF, 1979, J NEUROSURG, V50, P20, DOI 10.3171/jns.1979.50.1.0020; MARSHALL LF, 1991, J NEUROSURG S, V75, P28; MAYALL CG, 1984, NEW ENGL J MED, V310, P553; MEYER B, 1994, ACTA NEUROCHIR, V127, P232, DOI 10.1007/BF01808772; MORLINGANE JR, 1980, ACTA NEUROCHIR WIEN, V54, P181; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; NEGRON RA, 1975, J NEUROSURG, V42, P609, DOI 10.3171/jns.1975.42.5.0609; NORTH B, 1986, NEUROSURGERY, V18, P730, DOI 10.1227/00006123-198606000-00009; OSTRUP RC, 1987, J NEUROSURG, V67, P206, DOI 10.3171/jns.1987.67.2.0206; PARAMORE CG, 1994, ACTA NEUROCHIR, V127, P79, DOI 10.1007/BF01808552; PIEK J, 1990, INTENS CARE MED, V16, P184, DOI 10.1007/BF01724800; ROSNER MJ, 1990, J TRAUMA, V30, P933, DOI 10.1097/00005373-199008000-00001; SAUL TG, 1982, J NEUROSURG, V56, P798; SMITH RW, 1976, J NEUROSURG, V44, P567, DOI 10.3171/jns.1976.44.5.0567; Sundbarg G, 1988, Br J Neurosurg, V2, P485, DOI 10.3109/02688698809029603; ZENTNER J, 1995, NEUROSURG REV, V18, P31, DOI 10.1007/BF00416475	32	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	1998	45	3					505	511		10.1097/00005373-199809000-00013			7	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	120ZG	WOS:000075987300019	9751541				2022-02-06	
J	Vogelbaum, MA; Kaufman, BA; Park, TS; Winthrop, AL				Vogelbaum, MA; Kaufman, BA; Park, TS; Winthrop, AL			Management of uncomplicated skull fractures in children: Is hospital admission necessary?	PEDIATRIC NEUROSURGERY			English	Article						skull fracture; admission; epidural hematoma; computed tomography	TRAUMATIC INTRACRANIAL HEMATOMA; HEAD-INJURY; REQUIRE HOSPITALIZATION; SUBDURAL-HEMATOMA; INFANTS; ABUSE; CT; SCAN	Objective: This study was undertaken to determine the necessity for routine hospital admission of children with skull fractures, a normal neurological exam, a normal head CT, and no other injuries ('uncomplicated skull fracture'). Methods: A prospective study of closed-head injuries in children was done over a 2-year period at St. Louis Children's Hospital. All patients with closed head injuries underwent skull radiographs and a head CT scan. From this cohort, children with uncomplicated skull fractures were identified and studied. For comparison, a retrospective analysis was also performed of the hospital admission records of children admitted over a 5-year period (1990-1994) with the diagnosis of epidural hematoma (EDH) to identify the typical time intervals between injury and documentation of the lesion in these cases. Results: Forty-four patients with uncomplicated skull fractures were identified; all had been admitted for observation. Mean age was 1.8 years. Average time between injury and hospital admission was 6.35 h with half of this time being spent in the emergency room. Average LOS was 35 h, but 50% of patients were hospitalized less than 24 h. No patient in this study group suffered a complication related to their inury. Twenty-three patients with EDH had been admitted during the fi-year review period. Slightly more than one-half of patients had their EDH detected within 6 h of injury. The others were diagnosed more than 6 h after injury due to a delay in medical evaluation or a delay in obtaining a computed tomographic (CT) scan after an initial medical evaluation. Conclusions: Patients with uncomplicated skull fractures, in the absence of recurrent emesis and/or evidence of child abuse, can be considered for discharge home. The definition of an uncomplicated skull fracture requires that a head CT be performed on these patients.	Washington Univ, Sch Med, St Louis Childrens Hosp, Dept Neurol Surg, St Louis, MO USA; Washington Univ, Sch Med, St Louis Childrens Hosp, Dept Surg,Div Pediat Surg, St Louis, MO USA		Kaufman, BA (corresponding author), St Louis Childrens Hosp, Dept Neurosurg, 1 Childrens Pl, St Louis, MO 63110 USA.						BELL RS, 1971, NEW ENGL J MED, V284, P236, DOI 10.1056/NEJM197102042840504; BILLMIRE ME, 1985, PEDIATRICS, V75, P340; BONADIO WA, 1989, AM J DIS CHILD, V143, P194, DOI 10.1001/archpedi.1989.02150140084025; BOULIS ZF, 1978, BRIT J RADIOL, V51, P851, DOI 10.1259/0007-1285-51-611-851; BROWN FD, 1978, J NEUROSURG, V48, P1019, DOI 10.3171/jns.1978.48.6.1019; CHAN KH, 1990, CHILD NERV SYST, V6, P27, DOI 10.1007/BF00262262; DAVIS RL, 1994, ANN EMERG MED, V24, P640, DOI 10.1016/S0196-0644(94)70273-X; DEITCH D, 1989, NEUROLOGY, V39, P985, DOI 10.1212/WNL.39.7.985; DESMET AA, 1979, AM J ROENTGENOL, V132, P95, DOI 10.2214/ajr.132.1.95; GALBRAITH S, 1976, LANCET, V1, P501; GODANO U, 1992, CHILD NERV SYST, V8, P136, DOI 10.1007/BF00298269; Greenes DS, 1997, ANN EMERG MED, V30, P253, DOI 10.1016/S0196-0644(97)70158-6; HELFER RE, 1977, PEDIATRICS, V60, P533; HUGENHOLTZ H, 1987, CHILD NERV SYST, V3, P266, DOI 10.1007/BF00271820; HYDEN PW, 1992, PEDIATR CLIN N AM, V39, P1053; KADISH HA, 1995, ANN EMERG MED, V26, P37, DOI 10.1016/S0196-0644(95)70235-0; KNUCKEY NW, 1989, J NEUROSURG, V70, P392, DOI 10.3171/jns.1989.70.3.0392; KRAVITZ H, 1969, PEDIATRICS, V44, P869; MANN KS, 1986, CHILD NERV SYST, V2, P258; MERTEN DF, 1984, PEDIATR RADIOL, V14, P272, DOI 10.1007/BF01601874; NELSON EL, 1984, NEUROSURGERY, V15, P318, DOI 10.1227/00006123-198409000-00005; PHILLIPS LA, 1979, JACEP-J AM COLL EMER, V8, P106, DOI 10.1016/S0361-1124(79)80152-5; POON WS, 1992, NEUROSURGERY, V30, P681; READ HS, 1995, INJURY, V26, P333, DOI 10.1016/0020-1383(95)00020-A; ROBERTS F, 1972, AM J ROENTGENOL, V114, P230, DOI 10.2214/ajr.114.2.230; ROS SP, 1992, PEDIATR EMERG CARE, V8, P328, DOI 10.1097/00006565-199212000-00005; ROSENTHAL BW, 1989, J PEDIATR-US, V115, P346, DOI 10.1016/S0022-3476(89)80830-3; SHANON A, 1994, PEDIATR EMERG CARE, V10, P322, DOI 10.1097/00006565-199412000-00004; SNOEY ER, 1994, ANN EMERG MED, V23, P1127, DOI 10.1016/S0196-0644(94)70115-6; STEIN SC, 1992, J TRAUMA, V33, P11, DOI 10.1097/00005373-199207000-00003; TEASDALE GM, 1990, BRIT MED J, V300, P363, DOI 10.1136/bmj.300.6721.363	31	16	16	0	0	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1016-2291			PEDIATR NEUROSURG	Pediatr. Neurosurg.	AUG	1998	29	2					96	101		10.1159/000028697			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	138CZ	WOS:000076955000009	9792964				2022-02-06	
J	Palmer, DT; Horn, LJ; Harmon, RL				Palmer, DT; Horn, LJ; Harmon, RL			Botulinum toxin treatment of lumbrical spasticity - A brief report	AMERICAN JOURNAL OF PHYSICAL MEDICINE & REHABILITATION			English	Article						botulinum toxin A; lumbricals; spasticity	INJECTIONS; HAND	Botulinum toxin A has been used to treat wrist and finger spasticity mainly through injection of the forearm flexor muscles. This case study describes its first reported use in managing spastic lumbricals of the hand. A 19-year-old male had significant flexion deformity and hypertonicity of the left wrist and hand, particularly the second through fifth metacarpophalangeal joints, after traumatic brain injury. By using the 0-4 Ashworth scale, spasticity of the lumbricals across the second to fourth metacarpophalangeal joints was rated 2, with persistent clonus of the finger flexors as confirmed by electromyography to the middle and ring fingers, even after botulinum toxin A injection of the flexor digitorum sublimis and profundus muscles. By using the electromyography-guided technique, botulinum toxin A was injected into the first lumbrical of the index finger (12 units), second and third lumbricals of the middle and ring fingers, respectively (15 units each), and fourth lumbrical of the little finger (10 units). At follow-up, clinical and electromyographic examination revealed a significant reduction in tone and clonus of the injected lumbricals. Ashworth scores of the lumbricals from the index to little finger improved to 1. Botulinum toxin A injection of the lumbricals can be beneficial in managing spasticity of these muscles. It is well tolerated and effective at doses of 10 to 15 units. Lumbrical injection of botulinum toxin A is a useful adjunct in our percutaneous armamentarium for managing the spastic hand.	Med Coll Ohio, Dept Phys Med & Rehabil, Toledo, OH 43614 USA		Palmer, DT (corresponding author), Med Coll Ohio, Dept Phys Med & Rehabil, Dowling Hall,3065 Arlington Ave, Toledo, OH 43614 USA.						ASHWORTH B, 1964, PRACTITIONER, V192, P540; COHEN LG, 1989, J NEUROL NEUROSUR PS, V52, P355, DOI 10.1136/jnnp.52.3.355; DAS TK, 1989, POSTGRAD MED J, V65, P208, DOI 10.1136/pgmj.65.762.208; DELAGI EF, 1980, ANATOMIC GUIDE ELECT, P16; GRAZKO MA, 1995, NEUROLOGY, V45, P712, DOI 10.1212/WNL.45.4.712; JANKOVIC J, 1991, NEW ENGL J MED, V324, P1186, DOI 10.1056/nejm199104253241707; KARP BI, 1994, NEUROLOGY, V44, P70, DOI 10.1212/WNL.44.1.70; RIVEST J, 1991, MOVEMENT DISORD, V6, P55, DOI 10.1002/mds.870060110; SIMPSON LL, 1981, PHARMACOL REV, V33, P155; SNOW BJ, 1990, ANN NEUROL, V28, P512, DOI 10.1002/ana.410280407; VANERMENGEM E, 1979, REV INFECT DIS, V1, P701	11	16	16	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0894-9115	1537-7385		AM J PHYS MED REHAB	Am. J. Phys. Med. Rehabil.	JUL-AUG	1998	77	4					348	350		10.1097/00002060-199807000-00020			3	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	109VQ	WOS:000075344900014	9715926				2022-02-06	
J	Brown, JIM; Moulton, RJ; Konasiewicz, SJ; Baker, AJ				Brown, JIM; Moulton, RJ; Konasiewicz, SJ; Baker, AJ			Cerebral oxidative metabolism and evoked potential deterioration after severe brain injury: New evidence of early posttraumatic ischemia	NEUROSURGERY			English	Article						brain injury; cerebral ischemia; somatosensory evoked potentials	SEVERE HEAD-INJURY; BLOOD-FLOW; INTRACRANIAL HYPERTENSION; COMATOSE PATIENTS; MECHANISMS; COMMON	BACKGROUND: We commonly observe progressive deterioration in somatosensory evoked potentials (SSEPs) after severe head injury. We had previously been unable to relate this deterioration to raised intracranial pressure but had noted a relationship with decreasing transcranial oxygen extraction (arteriovenous oxygen difference [AVDO(2)]). The purpose of this study was twofold: to prove the hypothesis that deterioration in SSEP values is associated with decreasing AVDO(2) and to test the subsidiary hypotheses that deteriorating SSEPs were the result of either ischemia/reperfusion injury or failure of oxygen extraction/utilization. METHODS: Monitoring of 97 patients with severe traumatic brain injury (Glasgow Coma Scale scores of less than or equal to 8 after resuscitation) included twice daily AVDO(2) measurement and hourly SSEP recording for an average of 5 days. The last 51 patients also underwent 12-hourly measurement of cerebral blood flow (CBF), with calculation of the cerebral metabolic rate of oxygen. Cluster analysis was used to classify patients based on initial AVDO(2) values and subsequent SSEP trends. The time courses of CBF, SSEPs, AVDO(2), and cerebral metabolic rate of oxygen were examined in the groups defined by the cluster analysis. The clinical outcomes considered were survival or nonsurvival and the Glasgow Outcome Scale scores obtained at 3 months or more after injury. RESULTS: Cluster analysis confirmed the association between high initial AVDO(2) values and subsequent SSEP deterioration. Patients in this category initially had significantly higher AVDO(2), lower CBF, and higher cerebral metabolic rates of oxygen but recovered to adequate levels within 24 to 36 hours after injury. SSEP values were initially identical in the patients with normal AVDO(2) values and those with elevated AVDO(2) but differed significantly at 60 hours after injury and beyond. CONCLUSION: The findings of increased oxygen utilization and lowered CBF in the patients with deteriorating SSEPs strongly imply that early ischemia rather than failure of O-2 extraction or utilization is responsible for the associated SSEP deterioration. This issue of defining thresholds for ischemia based on AVDO(2) is confounded by the dependency of CBF and AVDO(2) values on the time after injury.	Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON M5B 1W8, Canada; Univ Toronto, St Michaels Hosp, Dept Anesthesia, Toronto, ON M5B 1W8, Canada		Brown, JIM (corresponding author), 38 Shuter St, Toronto, ON M5A 1A6, Canada.						BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1992, J NEUROTRAUM, V9, pS333; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; GRAHAM DI, 1989, J NEUROL NEUROSUR PS, V52, P346, DOI 10.1136/jnnp.52.3.346; HOSSMANN KA, 1993, RESUSCITATION, V26, P225, DOI 10.1016/0300-9572(93)90143-E; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KETY SS, 1945, AM J PHYSIOL, V143, P53, DOI 10.1152/ajplegacy.1945.143.1.53; KETY SS, 1948, J CLIN INVEST, V27, P476, DOI 10.1172/JCI101994; KONASIEWICZ SJ, 1994, CAN J NEUROL SCI, V21, P219, DOI 10.1017/S0317167100041196; KRAUSE GS, 1986, AM HEART J, V111, P768, DOI 10.1016/0002-8703(86)90114-6; MARION DW, 1991, J NEUROSURG, V74, P407, DOI 10.3171/jns.1991.74.3.0407; MOULTON R, 1991, J TRAUMA, V31, P676, DOI 10.1097/00005373-199105000-00012; MOULTON RJ, 1994, CLIN INVEST MED, V17, P187; MOULTON RJ, 1994, CAN J NEUROL SCI, V21, pS17, DOI 10.1017/S0084255900007567; MUIZELAAR JP, 1985, CENTRAL NERVOUS SYST, P123; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; SAKAS DE, 1995, J NEUROSURG, V83, P277, DOI 10.3171/jns.1995.83.2.0277; *SAS I INC, 1987, SAS STAT GUIDE PERSO, P283; Schroder ML, 1996, J NEUROTRAUM, V13, P17, DOI 10.1089/neu.1996.13.17	21	16	20	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106 USA	0148-396X			NEUROSURGERY	Neurosurgery	MAY	1998	42	5					1057	1063		10.1097/00006123-199805000-00060			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	ZK454	WOS:000073322500053	9588550				2022-02-06	
J	Lannoo, E; Colardyn, F; De Deyne, C; Vandekerckhove, T; Jannes, C; De Soete, G				Lannoo, E; Colardyn, F; De Deyne, C; Vandekerckhove, T; Jannes, C; De Soete, G			Cerebral perfusion pressure and intracranial pressure in relation to neuropsychological outcome	INTENSIVE CARE MEDICINE			English	Article						cerebral perfusion pressure; closed head injury; intracranial pressure; mean arterial pressure; neuropsychological outcome	SEVERE HEAD-INJURY	Objective: The study attempted to examine the relationship between neuropsychological functioning and reduced cerebral perfusion pressure (CPP), raised intracranial pressure (ICP), and reduced mean arterial pressure (MAP), monitored during intensive care treatment. Design: This prospective follow-up study included consecutive patients and evaluated outcome at 6 months postinjury by the administration of a neuropsychological test battery. Setting: The study was conducted at the University Hospital of Gent, Belgium. Patients and participants: Over a 30-month period, 43 patients were included. Inclusion criteria were the following: hospital admission following closed head injury, ICP monitoring, no medical history of central nervous system disease or mental retardation, survival for at least 6 months, and informed consent for participation. Interventions: All patients received the hospital's standard treatment for head injury, which remained unchanged during the study period. Measurements and results: Reduced CPP was analyzed using the number of observed values below 70 mmHg, raised ICP using the number of values above 20 mmHg, and MAP using the number of values below 80 mmHg. The neuropsychological test battery included 11 measures of attention, information processing, motor reaction time, memory, learning, visuoconstruction, verbal fluency, and mental flexibility. No linear relationships were found between overall neuropsychological impairment and episodes of reduced CPP, raised ICP, or reduced MAP. Conclusions: Although reduced CPP and raised ICP are frequent, often fatal, complications of head injury, in survivors they do not seem to be related to later neuropsychological functioning.	State Univ Ghent Hosp 4K3, Dept Neuropsychol, B-9000 Ghent, Belgium; State Univ Ghent Hosp, Dept Intens Care, B-9000 Ghent, Belgium; State Univ Ghent Hosp, Dept Neurosurg, B-9000 Ghent, Belgium; State Univ Ghent Hosp 4K3, Dept Psychiat, B-9000 Ghent, Belgium; State Univ Gent, Dept Data Anal, Gent, Belgium		Lannoo, E (corresponding author), State Univ Ghent Hosp 4K3, Dept Neuropsychol, De Pintelaan 185, B-9000 Ghent, Belgium.	Engelien.Lannoo@rug.ac.be					ANGGARD E, 1994, LANCET, V343, P1199, DOI 10.1016/S0140-6736(94)92405-8; CHAN KH, 1992, J NEUROSURG ANESTH, V4, P188, DOI 10.1097/00008506-199207000-00007; CHANGARIS DG, 1987, J TRAUMA, V27, P1007, DOI 10.1097/00005373-198709000-00009; CORTBUS F, 1994, ACTA NEUROCHIR, V130, P117, DOI 10.1007/BF01405511; DIKMEN S, 1995, J HEAD TRAUMA REHAB, V10, P74, DOI 10.1097/00001199-199502000-00008; FEARNSIDE MR, 1993, BRIT J NEUROSURG, V7, P67; FEPSY, 1995, NORMATIVE DATA, V3; FEPSY, 1995, NORMATIVE DATA, V2; Heaton PDRK., 1993, WISCONSIN CARD SORTI; JENNETT B, 1975, LANCET, V1, P480; JONES PA, 1994, J NEUROSURG ANESTH, V6, P4; KAWAHARA N, 1989, ACTA NEUROCHIR, V100, P142, DOI 10.1007/BF01403602; Lannoo E, 1997, PSYCHOL BELG, V37, P141; LEVIN HS, 1990, J NEUROSURG, V73, P699, DOI 10.3171/jns.1990.73.5.0699; LEVIN HS, 1991, NEUROSURGERY, V28, P196, DOI 10.1227/00006123-199102000-00004; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; Mannarou A, 1991, J NEUROSURG S, V75, P21; MARMAROU A, 1992, J NEUROTRAUM, V9, pS327; Marmarou A, 1991, J NEUROSURG, V75, pS159; MILLER JD, 1977, J NEUROSURG, V47, P508; ROSNER MJ, 1986, J NEUROSURG, V65, P636, DOI 10.3171/jns.1986.65.5.0636; ROSNER MJ, 1987, NEUROSURGERY, V21, P147, DOI 10.1227/00006123-198708000-00003; ROSNER MJ, 1995, J NEUROSURG, V83, P949, DOI 10.3171/jns.1995.83.6.0949; Spreen O, 1991, COMPENDIUM NEUROPSYC; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630	25	16	16	0	0	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010 USA	0342-4642			INTENS CARE MED	Intensive Care Med.	MAR	1998	24	3					236	241		10.1007/s001340050556			6	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	ZG445	WOS:000073003000007	9565805				2022-02-06	
J	Hall, KM; Wallbom, AS; Englander, J				Hall, KM; Wallbom, AS; Englander, J			Premorbid history and traumatic brain injury	NEUROREHABILITATION			English	Article						premorbid history; traumatic brain injury; outcome; prediction	DISABILITY RATING-SCALE; SEVERE HEAD-INJURY; SUBSTANCE-ABUSE; REHABILITATION; RELIABILITY; PREVALENCE; RECOVERY; CHILDREN; OUTCOMES; RETURN	The literature is replete with studies investigating predictors of outcomes in traumatic brain injury. Few, however, have addressed the premorbid life events and behaviors that may significantly impact the physical, behavioral, cognitive, and/or psychosocial and vocational status of individuals after a traumatic brain injury (TBI). Findings of studies on premorbid history are reviewed and data are presented on a sample of 82 cases on which premorbid psychosocial information, severity of initial injury and outcome status were obtained. Cases were dichotomized into groups at high risk and at low risk for TBI, based on premorbid history. High risk and low risk groups were comparable in the severity of initial injury. Outcomes were defined by the Functional Independence Measure and the Disability Rating Scale scores at 1 year after injury. No differences were found in FIMTM Or DRS scores between those with and without premorbid learning disability, psychiatric history, incarcerations, arrests, academic difficulties, or substance abuse. Explanations for the lack of significant differences are discussed. Based on experience in completing this study, a screening tool incorporating documentation of a number of premorbid factors that might impact status at outcome is presented. (C) 1998 Elsevier Science Ireland Ltd.	Santa Clara Valley Med Ctr, Dept Phys Med & Rehabil, Santa Clara, CA USA; Univ Michigan, Med Ctr, Dept Phys Med & Rehabil, Ann Arbor, MI 48109 USA		Hall, KM (corresponding author), 950 So Bascom Ave,Suite 2011, San Jose, CA 95128 USA.	khallvmc@aol.com					*AM PSYCH ASS, 1994, DIAGN STAT MAN, V4; Asikainen I, 1996, BRAIN INJURY, V10, P883, DOI 10.1080/026990596123864; BRINK JD, 1970, DEV MED CHILD NEUROL, V12, P565; Brooks N, 1989, Brain Inj, V3, P235, DOI 10.3109/02699058909029638; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; BURKE W H, 1990, Brain Injury, V4, P371, DOI 10.3109/02699059009026190; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; DICKER BG, 1989, J HEAD TRAUMA REHAB, V4, P73; DIKMEN S, 1995, J HEAD TRAUMA REHAB, V10, P74, DOI 10.1097/00001199-199502000-00008; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; EWING JA, 1984, JAMA-J AM MED ASSOC, V252, P1905, DOI 10.1001/jama.252.14.1905; FLEMING JM, 1994, ARCH PHYS MED REHAB, V75, P156; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Greenspan AI, 1996, BRAIN INJURY, V10, P207, DOI 10.1080/026990596124520; GURNEY JG, 1992, J TRAUMA, V33, P709, DOI 10.1097/00005373-199211000-00020; HAAS JF, 1987, J NEUROL NEUROSUR PS, V50, P52, DOI 10.1136/jnnp.50.1.52; Hall KM, 1996, J HEAD TRAUMA REHAB, V11, P27, DOI 10.1097/00001199-199610000-00004; HALL KM, 1994, ARCH PHYS MED REHAB, V75, P876, DOI 10.1016/0003-9993(94)90112-0; HALL KM, 1994, ARCH PHYSICAL MED RE, V75, P10; HarrisonFelix C, 1996, J HEAD TRAUMA REHAB, V11, P1, DOI 10.1097/00001199-199610000-00002; Heinemann Allen W, 1994, Top Stroke Rehabil, V1, P1; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; IP RY, 1995, BRAIN INJURY, V9, P517, DOI 10.3109/02699059509008211; KAPLAN C P, 1992, Brain Injury, V6, P337, DOI 10.3109/02699059209034948; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Kelly MP, 1997, BRAIN INJURY, V11, P391, DOI 10.1080/026990597123386; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; KREUTZER J S, 1991, Brain Injury, V5, P177, DOI 10.3109/02699059109008088; KREUTZER JS, 1995, BRAIN INJURY, V9, P757, DOI 10.3109/02699059509008232; Levin HS., 1982, NEUROBEHAVIORAL CONS; Marmarou A., 1990, J HEAD TRAUMA REHAB, V5, P21, DOI [10.1097/00001199-199009000-00006, DOI 10.1097/00001199-199009000-00006]; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; NOVACK TA, 1991, J HEAD TRAUMA REHAB, V6, P69, DOI DOI 10.1097/00001199-199112000-00014; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Parmelee D X, 1989, Brain Inj, V3, P295, DOI 10.3109/02699058909029642; PELCO L, 1992, Brain Injury, V6, P29, DOI 10.3109/02699059209008119; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Ruff RM, 1996, NEUROREHABILITATION, V7, P39, DOI 10.3233/NRE-1996-7105; Sparadeo F. R., 1989, J HEAD TRAUMA REHAB, V4, P75, DOI DOI 10.1097/00001199-198903000-00010; Sparadeo F. R., 1990, J HEAD TRAUMA REHAB, V5, P1, DOI DOI 10.1097/00001199-199009000-00004; *STAT U NEW YORK B, 1996, GUID UN DAT SET MED; Thomsen I V, 1987, Brain Inj, V1, P131, DOI 10.3109/02699058709034452; Vogenthaler D R, 1989, Brain Inj, V3, P355, DOI 10.3109/02699058909004560	45	16	16	0	4	ELSEVIER SCI IRELAND LTD	CLARE	CUSTOMER RELATIONS MANAGER, BAY 15, SHANNON INDUSTRIAL ESTATE CO, CLARE, IRELAND	1053-8135			NEUROREHABILITATION	Neurorehabilitation	JAN	1998	10	1					3	12		10.1016/S1053-8135(97)00040-1			10	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YV946	WOS:000071880300002	24525812				2022-02-06	
J	Leon-Carrion, J; Alarcon, JC; Revuelta, M; Murrillo-Cabezas, F; Dominguez-Roldan, JM; Dominguez-Morales, MR; Machuca-Murga, F; Forastero, P				Leon-Carrion, J; Alarcon, JC; Revuelta, M; Murrillo-Cabezas, F; Dominguez-Roldan, JM; Dominguez-Morales, MR; Machuca-Murga, F; Forastero, P			Executive functioning as outcome in patients after traumatic brain injury	INTERNATIONAL JOURNAL OF NEUROSCIENCE			English	Article; Proceedings Paper	International Conference on Recent Advances in Neurotraumatology	SEP 08-11, 1996	RIMINI, ITALY	World Federat Neurosurg Soc		executive functions; neurosurgery; Glasgow Outcome Scale; traumatic brain injury; neuropsychological assessment; Tower of Hanoi/Sevilla	SEVERE HEAD-INJURY; COMA; TALK; DETERIORATE; SCALE	The present study was designed to determine how traumatic brain injury affects executive Functioning, to know whether different treatments in the acute phase improve this functioning, and to check whether the severity of the neurocognitive impairment is detected by the Glasgow Outcome Scale (GOS). Ability for problem solving and executive functioning within 2 years after Traumatic Brain Injury (TBI) was examined in 35 conscious survivors. Two groups were formed. One group consisted of 13 patients who needed neurosurgery. The other group was made up of 22 patients without neurosurgical treatment. All were treated in the Neurosurgical Intensive Care Unit and in the Rehabilitation Service. The following variables were registered: Secondary Lesions, Glasgow Coma Scale (GCS), CT, subacute CT. and Glasgow Outcome Scale. Neuropsychological tests administered were Wisconsin Card Sorting Test (WCST) and the Tower of Hanoi/Sevilla. Comparing both groups' test performance (Man Whitney U) we found that a severe traumatic brain injury, whatever the treatment applied in the acute phase, impairs the executive functioning of the patients; this impairment is related to acute pathophysiological events. The neurosurgical intervention does not improve the executive functioning. The Glasgow Outcome Scale does not detect more than 25% of the patients with severe impairment. It is suggested that the Tower of Hanoi/Sevilla could be a good tool to evaluate the executive functioning routinely in TBI patients as outcome. It is also suggested that mild TBI patients must be referred for a complete neuropsychological examination.	Ctr Brain Injury Rehabil, CRE CER R, Sevilla 40108, Spain; Univ Seville, Human Cognit Neuropsychol Lab, Seville, Spain; Univ Seville, Traumatol Hosp Virgen del Rocio, Seville, Spain		Leon-Carrion, J (corresponding author), Ctr Brain Injury Rehabil, CRE CER R, Avda Luis Montoto 113 Edif Cristal Portal B,Mod 1, Sevilla 40108, Spain.		Leon Carrion, Jose/D-5638-2012; Dominguez-Roldan, Jose-Maria/M-1728-2016	Dominguez-Roldan, Jose-Maria/0000-0003-1933-1478			ANZAI Y, 1979, PSYCHOL REV, V86, P124, DOI 10.1037/0033-295X.86.2.124; Berg EA, 1948, J GEN PSYCHOL, V39, P15, DOI 10.1080/00221309.1948.9918159; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; DACEY RG, 1986, J NEUROSURG, V65, P203, DOI 10.3171/jns.1986.65.2.0203; DAIGNEAULT S, 1988, J CLIN EXPT NEUROPSY, P10; GOTT PS, 1991, ARCH NEUROL-CHICAGO, V48, P1267, DOI 10.1001/archneur.1991.00530240071024; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Gronwall D., 1989, ASSESSMENT BEHAV CON, P19; Hecaen H., 1975, PSYCHIAT ASPECTS NEU; HORN S, 1992, Brain Injury, V6, P321, DOI 10.3109/02699059209034946; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; KARAT J, 1982, COGNITIVE PSYCHOL, V14, P538, DOI 10.1016/0010-0285(82)90018-4; KIDO DK, 1992, RADIOLOGY, V182, P777, DOI 10.1148/radiology.182.3.1535893; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; LeonCarrion J, 1996, INT J NEUROSCI, V85, P231, DOI 10.3109/00207459608986685; LEONCARRION J, 1991, PERCEPT MOTOR SKILL, V73, P63, DOI 10.2466/pms.1991.73.1.63; LEONCARRION J, IN PRESS SEVILLE COM; LEONCARRION J, 1995, HDB HUMAN NEUROPSYCH; LEONCARRION J, 1997, NEUROPSYCHOLOGICAL R; LEONCARRION J, 1993, WISCONSIN CARD SORTI; LEVIN HS, 1996, CATASTROPHIC BRAIN I; Lezak M., 1989, ASSESSMENT BEHAV CON; LEZAK MD, 1995, NEUROPSYCHOLOGICAL A; LOBATO RD, 1991, J NEUROSURG, V75, P256, DOI 10.3171/jns.1991.75.2.0256; Luria A. R, 1962, HIGHER CORTICAL FUNC; LURIA AR, 1973, PSYCHOL FRONTAL LOBE; MARSHALL LF, 1983, J NEUROSURG, V59, P285, DOI 10.3171/jns.1983.59.2.0285; MARSHALL LF, 1991, J NEUROSURG, V75, P814; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; RAEGRANT AD, 1991, ELECTROEN CLIN NEURO, V79, P349, DOI 10.1016/0013-4694(91)90199-E; REILLY PL, 1975, LANCET, V2, P375; ROBINSON AL, 1980, J CONSULT CLIN PSYCH, V48, P605, DOI 10.1037/0022-006X.48.5.605; TORNER JC, 1992, CURR OPIN NEUROL NEU, V5, P831; UZZELL BP, 1986, J NEUROSURG, V65, P630, DOI 10.3171/jns.1986.65.5.0630	34	16	17	1	11	GORDON BREACH SCI PUBL LTD	READING	C/O STBS LTD, PO BOX 90, READING RG1 8JL, BERKS, ENGLAND	0020-7454			INT J NEUROSCI	Int. J. Neurosci.		1998	94	1-2					75	83		10.3109/00207459808986440			9	Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ZW103	WOS:000074374300006	9622801				2022-02-06	
S	Reichlin, S		McCann, SM; Lipton, JM; Sternberg, EM; Chrousos, GP; Gold, PW; Smith, CC		Reichlin, S			Alternative pathways of neural control of the immune process	NEUROIMMUNOMODULATION: MOLECULAR ASPECTS, INTEGRATIVE SYSTEMS, AND CLINICAL ADVANCES	ANNALS OF THE NEW YORK ACADEMY OF SCIENCES		English	Article; Proceedings Paper	3rd Congress of the International-Society-of-Neuroimmunomodulation on Neuroimmunomodulation - Molecular Aspects, Integrative Systems, and Clinical Advances	NOV 13-15, 1996	BETHESDA, MARYLAND	Int Soc Neuroimmunomodulat, NIH, NCI, Natl Inst Aging, NIAID, Natl Inst Arthritis & Muskuloskeletal & Skin Dis, NICHHD, NIDR, NIMH, Natl Inst Nursing Res, NIH, Off Alternat Med, NIH, Off Behav & Social Sci Res, NIH, Off Rare Dis Res, NIH, Off Res Womens Hlth, Glaxowellcome Inc, TIG Instrumenten Gesell Ag, Vector Lab			TUMOR-NECROSIS-FACTOR; CENTRAL-NERVOUS-SYSTEM; CORTICOTROPIN-RELEASING HORMONE; BLOOD-BRAIN-BARRIER; MESSENGER-RNA; FACTOR-ALPHA; PROINFLAMMATORY CYTOKINES; INTERLEUKIN-6 PRODUCTION; IMMOBILIZATION STRESS; PLASMA INTERLEUKIN-6	Less well established alternative neuromodulatory pathways are neuropeptide-mediated axon reflexes of sensory neurons, gut immunotrafficing, gut transmucosal transport of endogenous bacterial toxin, and the direct secretion of immunoregulatory cytokines by the brain. TNF-alpha and IL-1ra enter peripheral blood after their intracerebroventricular (i.c.v.) injection. Closed head injury or stroke increases blood IL-6 and the acute phase response; neuroblastomas immunosuppress by secreting TGF-beta. The IL-6 that appears in the blood after i.c.v. IL-1 in the rat is partly derived by secretion from the brain into the superior sagital sinus (Romero et al.; 1996. Am. J. Physiol. 270: R518) and is not dependent on peripheral sympathetic activation. Central endothelium and choroid plexus are potential sources of sagital sinus IL-6. TNF-alpha, which appears in blood after i.c.v. LPS, but not IL-1 beta, is due largely to toxin leaving the brain compartment and activating peripheral immunoreactive tissues. Antigens and cytokine immunoregulators drain into cervical lymph. Changes in glial milieu induced by intrinsic neuronal activity could by secretion from brain to blood modulate peripheral immunoreactivity.	Univ Arizona, Hlth Sci Ctr, Dept Internal Med, Neuroendocrine Lab, Tucson, AZ 85724 USA		Reichlin, S (corresponding author), Univ Arizona, Hlth Sci Ctr, Dept Internal Med, Neuroendocrine Lab, 1501 N Campbell Ave, Tucson, AZ 85724 USA.	reichlin@u.arizona.edu					ADER R, 1991, PSYCHONEUROIMMUNOLOG, V2, P611; ANDERSSON PB, 1992, J EXP MED, V176, P255, DOI 10.1084/jem.176.1.255; Banks WA, 1995, NEUROIMMUNOMODULAT, V2, P241, DOI 10.1159/000097202; BENVENISTE EN, 1994, RES P ARNMD, V72, P71; BODMER S, 1991, J NEUROIMMUNOL, V34, P33, DOI 10.1016/0165-5728(91)90096-P; BODNAR RJ, 1989, CANCER RES, V49, P6280; BREDER CD, 1993, J COMP NEUROL, V337, P543, DOI 10.1002/cne.903370403; CHAO CC, 1995, DEV NEUROSCI-BASEL, V17, P97, DOI 10.1159/000111278; CHEN GJ, 1991, J LEUKOCYTE BIOL, V50, P349, DOI 10.1002/jlb.50.4.349; CHROUSOS GP, 1995, NEW ENGL J MED, V332, P135; Cole SW, 1996, PSYCHOSOM MED, V58, P219, DOI 10.1097/00006842-199605000-00005; Cousins, 1979, ANATOMY ILLNESS PERC; CSERR HF, 1992, IMMUNOL TODAY, V13, P507, DOI 10.1016/0167-5699(92)90027-5; DERIJK RH, 1994, PSYCHONEUROENDOCRINO, V19, P155, DOI 10.1016/0306-4530(94)90005-1; DESIMONI MG, 1995, ENDOCRINOLOGY, V136, P897, DOI 10.1210/en.136.3.897; DESIMONI MG, 1993, AM J PHYSIOL, V265, pR739, DOI 10.1152/ajpregu.1993.265.4.R739; DESIMONI MG, 1990, J EXP MED, V171, P1773, DOI 10.1084/jem.171.5.1773; DUNN AJ, 1991, J NEUROCHEM, V57, P1615, DOI 10.1111/j.1471-4159.1991.tb06359.x; ERICSSON A, 1995, J COMP NEUROL, V361, P681, DOI 10.1002/cne.903610410; FAGGIONI R, 1995, NEUROIMMUNOMODULAT, V2, P2, DOI 10.1159/000096828; Fiebich BL, 1996, J NEUROCHEM, V66, P1426; GOODMAN JC, 1990, J NEUROIMMUNOL, V30, P213; GOTTSCHALL PE, 1992, NEUROENDOCRINOLOGY, V56, P935, DOI 10.1159/000126328; GOTTSCHALL PE, 1994, BRAIN RES, V637, P197, DOI 10.1016/0006-8993(94)91233-5; HOPKINS SJ, 1995, TRENDS NEUROSCI, V18, P83; HUANG OH, 1995, AM J PHYSL 2, V273, pR731; IRWIN M, 1988, AM J PHYSIOL, V255, pR744, DOI 10.1152/ajpregu.1988.255.5.R744; IRWIN M, 1994, ADV NEUROIMMUNOL, V4, P29, DOI 10.1016/S0960-5428(06)80188-9; IRWIN M, 1994, ANN NY ACAD SCI, V741, P203; KAKUCSKA I, 1993, ENDOCRINOLOGY, V133, P815, DOI 10.1210/en.133.2.815; KIECOLTGLASER JK, 1991, PSYCHONEUROIMMUNOLOG, V2, P849; KOSSMANN T, 1995, SHOCK, V4, P311, DOI 10.1097/00024382-199511000-00001; KRUGER MJ, 1995, NEUROIMMUNOMODULAT, V2, P216; LECHAN RM, 1990, BRAIN RES, V514, P135, DOI 10.1016/0006-8993(90)90445-H; LEE SC, 1993, J IMMUNOL, V150, P2659; Lewis CE, 1994, PSYCHOIMMUNOLOGY CAN; LOCKE SE, 1983, MIND IMMUNITY; MADDEN KS, 1995, ANNU REV PHARMACOL, V35, P417, DOI 10.1146/annurev.pa.35.040195.002221; McGeer PL, 1995, BRAIN RES REV, V21, P195, DOI 10.1016/0165-0173(95)00011-9; MINAMI M, 1991, NEUROSCI LETT, V123, P254, DOI 10.1016/0304-3940(91)90944-O; NATHANSON JA, 1989, P NATL ACAD SCI USA, V86, P1684, DOI 10.1073/pnas.86.5.1684; NILSSON C, 1992, BRAIN RES REV, V17, P109, DOI 10.1016/0165-0173(92)90011-A; REICHLIN S, 1995, ENDOCRINOLOGY, P2964; Ringheim GE, 1995, J NEUROIMMUNOL, V63, P113, DOI 10.1016/0165-5728(95)00134-4; ROMERO LI, 1996, AM J PHYSIOL, V270, pRK18; ROSZMAN TL, 1985, J NEUROIMMUNOL, V10, P59, DOI 10.1016/0165-5728(85)90034-7; SCHETTINI G, 1994, PHARMACOL RES, V30, P13, DOI 10.1016/1043-6618(94)80083-9; SUNDAR SK, 1990, J NEUROSCI, V10, P3701; Takaki Atsushi, 1994, Neuroimmunomodulation, V1, P335, DOI 10.1159/000097185; TARKOWSKI E, 1995, STROKE, V26, P1393, DOI 10.1161/01.STR.26.8.1393; TARLOW MJ, 1993, NEUROPATH APPL NEURO, V19, P324, DOI 10.1111/j.1365-2990.1993.tb00447.x; Urbaschek B, 1985, MICROBIOLOGY 1985, P39; VanDam AM, 1996, FASEB J, V10, P351, DOI 10.1096/fasebj.10.2.8641570; VREDEVOE DL, 1995, NEUROIMMUNOMODULAT, V2, P16, DOI 10.1159/000096830; WEISS JM, 1994, ANN NY ACAD SCI, V741, P338, DOI 10.1111/j.1749-6632.1994.tb39676.x; WEISS JM, 1989, NEUROIMMUNE NETWORKS, P193; [No title captured]; [No title captured]	58	16	16	0	3	NEW YORK ACAD SCIENCES	NEW YORK	2 EAST 63RD ST, NEW YORK, NY 10021 USA	0077-8923		1-57331-072-7	ANN NY ACAD SCI	Ann.NY Acad.Sci.		1998	840						301	316		10.1111/j.1749-6632.1998.tb09570.x			16	Endocrinology & Metabolism; Immunology; Multidisciplinary Sciences; Neurosciences	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Science & Technology - Other Topics; Neurosciences & Neurology	BL14S	WOS:000074444500028	9629258				2022-02-06	
J	DeWitt, DS; Prough, DS; Uchida, T; Deal, DD; Vines, SM				DeWitt, DS; Prough, DS; Uchida, T; Deal, DD; Vines, SM			Effects of nalmefene, CG3703, tirilazad, or dopamine on cerebral blood flow, oxygen delivery, and electroencephalographic activity after traumatic brain injury and hemorrhage	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; electroencephalography; free radicals; head injury; hemorrhagic hypotension; opiates; peptides	THYROTROPIN-RELEASING-HORMONE; 7.5-PERCENT SODIUM-CHLORIDE; FLUID PERCUSSION INJURY; HEAD-INJURY; 21-AMINOSTEROID U74006F; ENDOGENOUS OPIOIDS; HYPERTONIC SALINE; MILD HEMORRHAGE; CATS; ISCHEMIA	Hemorrhage after traumatic brain injury (TBI) in cats produces significant decreases in cerebral oxygen delivery (DcereO2) and electroencephalographic (EEG) activity. To determine whether effective treatments for the separate insults of TBI and hemorrhagic shock would also prove effective after the clinically relevant combination of the two, we measured the effects of a K-opiate antagonist (nalmefene), an inhibitor of lipid peroxidation (tirilazad), a thyrotropin-releasing hormone analog (CG3703), a clinically useful presser agent (dopamine) or a saline placebo on cerebral blood flow (CBF), and EEG activity after TBI and mild hemorrhagic hypotension. Cats (n = 40, 8 per group) were anesthetized with 1.6% isoflurane in N2O:O-2 (70:30) and prepared for fluid-percussion TBI and microsphere measurements of CBF. Cats were randomized to receive nalmefene (1 mg/kg), tirilazad (5 mg/kg), CG3703 (2 mg/kg), dopamine (20 mu g.kg(-1) min(-1)) or a saline placebo (2 mi, 0.9% NaCl). Animals were injured (2.2 atm), hemorrhaged to 70% of preinjury blood volume, treated as just described and resuscitated with a volume of 10% hydroxyethyl starch equal to shed blood. CBF was determined and EEG activity recorded before injury, after hemorrhage, and 0, 60, and 120 min after resuscitation (RO, R60, and R120). CBF increased significantly after resuscitation (RO) in the nalmefene-and CG3703-treated groups. CBF did not differ significantly from baseline in any group at R60 or R120. DcereO2 was significantly less than baseline in the saline-, dopamine-, and tirilazad-treated groups at R60 and in the dopamine-, tirilazad-, and CG3703-treated groups at R120. EEG activity remained unchanged in the nalmefene-treated group but deteriorated significantly at R60 or R120 compared to baseline in the other groups. Nalmefene and CG3703 preserved the hyperemic response to hemodilution (otherwise antagonized by TBI), and nalmefene prevented the deterioration in DcereO2 and EEG activity that occurs after TBI and hemorrhage.	Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA; Univ Texas, Med Branch, Dept Prevent Med & Community Hlth, Galveston, TX 77555 USA; Wake Forest Univ, Bowman Gray Sch Med, Dept Anesthesia, Winston Salem, NC 27157 USA		DeWitt, DS (corresponding author), Univ Texas, Med Branch, Dept Anesthesiol, Galveston, TX 77555 USA.		Prough, Donald S/G-5793-2013	Prough, Donald S/0000-0001-7994-532X	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS019355] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS19355] Funding Source: Medline		ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; ARMSTEAD WM, 1991, CIRC RES, V68, P922, DOI 10.1161/01.RES.68.4.922; BRAUGHLER JM, 1987, J BIOL CHEM, V262, P10438; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; DeWitt DS, 1988, J NEUROTRAUM, V5, P303, DOI 10.1089/neu.1988.5.303; DEWITT DS, 1992, J NEUROSURG, V76, P812, DOI 10.3171/jns.1992.76.5.0812; DEWITT DS, 1992, AM J PHYSIOL, V263, pH1276, DOI 10.1152/ajpheart.1992.263.4.H1276; DeWitt DS, 1996, CRIT CARE MED, V24, P109, DOI 10.1097/00003246-199601000-00019; EKSTROMJODAL B, 1982, CRIT CARE MED, V10, P375, DOI 10.1097/00003246-198206000-00008; ELLIS E F, 1989, Journal of Neurotrauma, V6, P31, DOI 10.1089/neu.1989.6.31; ELLIS EF, 1981, J NEUROCHEM, V37, P892, DOI 10.1111/j.1471-4159.1981.tb04476.x; ELLIS EF, 1991, J NEUROSURG, V75, P774, DOI 10.3171/jns.1991.75.5.0774; FABIAN RH, 1995, J CEREBR BLOOD F MET, V15, P242, DOI 10.1038/jcbfm.1995.30; FADEN AI, 1992, TRENDS PHARMACOL SCI, V13, P29, DOI 10.1016/0165-6147(92)90013-V; FADEN AI, 1984, JAMA-J AM MED ASSOC, V252, P1452, DOI 10.1001/jama.252.11.1452; FADEN AI, 1993, J NEUROTRAUM, V10, P101, DOI 10.1089/neu.1993.10.101; GURLL NJ, 1987, CRIT CARE MED, V15, P574, DOI 10.1097/00003246-198706000-00006; HALL E, 1987, BRAIN RES, V435, P170; HALL ED, 1988, J NEUROSURG, V68, P462, DOI 10.3171/jns.1988.68.3.0462; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HAYES RL, 1983, J NEUROSURG, V58, P720, DOI 10.3171/jns.1983.58.5.0720; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; HOFFBRAND BI, 1969, CARDIOVASC RES, V3, P426, DOI 10.1093/cvr/3.4.426; HOLADAY JW, 1981, SCIENCE, V213, P216, DOI 10.1126/science.6787704; ISHIGE N, 1988, J NEUROSURG, V68, P129, DOI 10.3171/jns.1988.68.1.0129; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LEWELT W, 1980, J NEUROSURG, V53, P500, DOI 10.3171/jns.1980.53.4.0500; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; MATTSON MP, 1994, J NEUROTRAUM, V11, P3, DOI 10.1089/neu.1994.11.3; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; MCINTOSH TK, 1993, J NEUROTRAUM, V10, P373, DOI 10.1089/neu.1993.10.373; MCINTOSH TK, 1994, CEREBROVAS BRAIN MET, V6, P109; MILLER JD, 1985, BRIT J ANAESTH, V57, P120, DOI 10.1093/bja/57.1.120; PRIOR PF, 1978, BRIT J ANAESTH, V50, P993, DOI 10.1093/bja/50.10.993; RUDOLPH AM, 1967, CIRC RES, V21, P163, DOI 10.1161/01.RES.21.2.163; SANADA T, 1993, J NEUROTRAUM, V10, P65, DOI 10.1089/neu.1993.10.65; TANAKA K, 1992, REGUL PEPTIDES, V38, P129, DOI 10.1016/0167-0115(92)90051-U; TODD MM, 1985, J NEUROSURG, V63, P944, DOI 10.3171/jns.1985.63.6.0944; TRAYSTMAN RJ, 1991, J APPL PHYSIOL, V71, P1185, DOI 10.1152/jappl.1991.71.4.1185; VASSAR MJ, 1991, ARCH SURG-CHICAGO, V126, P1065; VASSAR MJ, 1993, ARCH SURG-CHICAGO, V128, P1003; VINK R, 1991, AM J PHYSIOL, V261, pR1527, DOI 10.1152/ajpregu.1991.261.6.R1527; VINK R, 1988, BRAIN RES, V460, P184, DOI 10.1016/0006-8993(88)91221-8; VINK R, 1990, J NEUROSCI, V10, P3524; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; WEI EP, 1981, CIRC RES, V48, P95, DOI 10.1161/01.RES.48.1.95	50	16	17	0	3	MARY ANN LIEBERT INC PUBL	LARCHMONT	2 MADISON AVENUE, LARCHMONT, NY 10538 USA	0897-7151			J NEUROTRAUM	J. Neurotrauma	DEC	1997	14	12					931	941		10.1089/neu.1997.14.931			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	YU127	WOS:000071685000005	9475374				2022-02-06	
J	Jacobs, HE				Jacobs, HE			The Clubhouse: Addressing work-related behavioral challenges through a supportive social community	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						behavior; Clubhouse; community; service delivery systems; vocational	TRAUMATIC BRAIN INJURY; EMPLOYMENT; RETURN	Behavioral challenges in the workplace are not always the sole dominion of the person with disability after brain injury. These challenges may also emanate from the work site or the vocational services that are used to help people return to work. Although present-day vocational services have helped numerous persons with disabilities after brain injury return to work, most remain unemployed. Other approaches may bene some of these people and address some of the longstanding limitations of existing vocational programming. One such approach is the Clubhouse, a member-directed, community-based program of supports that is gaining increasing attention in supportive programming. This article discusses salient factors that affect can work tenure after brain injury, the origins and design of the Clubhouse model, and examples of its application in helping people with presumed behavioral challenges sustain employment.									ANDERSON S, 1994, MENTAL ILLNESS NORMA; Beard J., 1982, PSYCHOSOC REHABIL J, V5, P47; BEARD JH, 1978, SCHIZOPHRENIA BULL, V4, P622, DOI 10.1093/schbul/4.4.622; BILBY R, 1993, CLUBH PAP SEL PAP 7; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; CATALANO R, 1981, J HEALTH SOC BEHAV, V22, P284, DOI 10.2307/2136522; CORTHELL DW, 1993, EMPLOYMENT OUTCOMES; DEMELLO C, 1994, TBI CHALLENGE, V2, P54; DOOLEY D, 1980, PSYCHOL BULL, V87, P450, DOI 10.1037/0033-2909.87.3.450; HAFFEY WJ, 1991, J HEAD TRAUMA REHAB, V6, P24; Jacobs H. E., 1996, J VOCATIONAL REHABIL, V7, P169, DOI DOI 10.1016/1052-2263(96)00219-X; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JACOBS HE, 1995, TBI CHALLENGE, V3, P26; JACOBS HE, 1995, TBI CHALLENGE, V3, P46; JACOBS HE, 1994, TBI CHALLENGE, V2, P46; JELLINEK HM, 1982, ARCH PHYS MED REHAB, V63, P87; KAPLAN SP, 1993, REHABIL COUNS BULL, V36, P151; KAPLAN SP, 1990, REHABIL COUNS BULL, V34, P16; KAY T, 1993, COMMUNITY BASED EMPL; Millis S R, 1994, Int J Neurosci, V79, P165; NAGELE DA, 1993, KEEPING PERSONS HEAD; Thomas DF, 1996, J VOCATIONAL REHABIL, V7, P243; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; ULICNY GR, 1993, COMMUNITY BASED EMPL; WEHMAN P, 1989, ARCH PHYS MED REHAB, V70, P109; Wehman P., 1988, J HEAD TRAUMA REHAB, V3, P82, DOI DOI 10.1097/00001199-198812000-00012; WEHMAN PH, 1990, ARCH PHYS MED REHAB, V71, P1047	27	16	16	0	1	ASPEN PUBL INC	FREDERICK	7201 MCKINNEY CIRCLE, FREDERICK, MD 21704	0885-9701			J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	OCT	1997	12	5					14	27		10.1097/00001199-199710000-00003			14	Clinical Neurology; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	YA515	WOS:A1997YA51500003					2022-02-06	
J	Lees, AJ				Lees, AJ			Trauma and Parkinson's disease	REVUE NEUROLOGIQUE			English	Article							HEAD TRAUMA; PERIPHERAL TRAUMA; AFTERMATH; DYSTONIA; MIDBRAIN; TREMOR; INJURY	The relationship between physical trauma and Parkinson's disease is reviewed. Post-traumatic Parkinson's syndrome may occur following cumulative head trauma in contact sports and exceptionally rarely after a single severe closed head injury. It remains uncertain, however, whether physical injury should be considered one aetiological factor in the pathogenesis of Parkinson's disease.	UCL HOSP, LONDON, ENGLAND				Lees, Andrew J/A-6605-2009	Lees, Andrew J/0000-0002-2476-4385			BHATIA KP, 1994, BRAIN, V117, P859, DOI 10.1093/brain/117.4.859; BIARY N, 1989, NEUROLOGY, V39, P1103; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Bruetsch WL, 1935, J NERV MENT DIS, V81, P531, DOI 10.1097/00005053-193505000-00004; CARDOSO F, 1995, ARCH NEUROL-CHICAGO, V52, P263, DOI 10.1001/archneur.1995.00540270055019; CARROLL E, 1936, AM J MED SCI, V191, P7066; CLINTON J, 1991, NEUROPATH APPL NEURO, V17, P69, DOI 10.1111/j.1365-2990.1991.tb00695.x; Constantinidis J, 1967, Schweiz Arch Neurol Neurochir Psychiatr, V100, P117; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714, DOI 10.1192/bjp.105.440.714; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; CROUZON O, 1929, PRESSE MED, V37, P1325; DAVIE CA, 1995, J NEUROL NEUROSUR PS, V58, P688, DOI 10.1136/jnnp.58.6.688; DAVIE CA, 1995, ANN NEUROL, V37, P204, DOI 10.1002/ana.410370211; DE MORSIER G., 1960, PSYCHIAT ET NEUROL, V139, P60; FACTOR SA, 1991, MOVEMENT DISORD, V6, P225, DOI 10.1002/mds.870060306; FACTOR SA, 1988, MOVEMENT DISORD, V3, P30, DOI 10.1002/mds.870030105; FRIEDMAN JH, 1989, SOUTHERN MED J, V82, P543, DOI 10.1097/00007611-198905000-00002; GODWINAUSTEN R, 1982, J NEUROL NEUROSUR PS, V44, P577; GOETZ CG, 1991, ANN NEUROL, V29, P191, DOI 10.1002/ana.410290213; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Grimberg L, 1934, J NERV MENT DIS, V79, P14, DOI 10.1097/00005053-193401000-00002; HARVEY PKP, 1974, LANCET, V2, P928; HAUSER T, 1991, M ALI BIOGRAPHY; Heyde W, 1932, ARCH PSYCHIAT NERVEN, V97, P600, DOI 10.1007/BF01815563; Holmes G, 1904, BRAIN, V27, P327, DOI 10.1093/brain/27.3.327; Huhn B, 1970, Nervenarzt, V41, P326; JANKOVIC J, 1988, J NEUROL NEUROSUR PS, V51, P1512, DOI 10.1136/jnnp.51.12.1512; KOLLER WC, 1989, MOVEMENT DISORD, V4, P20, DOI 10.1002/mds.870040106; KOTHBAUER P, 1977, NERVE ENTWICKLUNGEN, P23; KREMER M, 1947, J NEUROL NEUROSUR PS, V10, P49, DOI 10.1136/jnnp.10.2.49; LANG AE, 1995, ARCH NEUROL-CHICAGO, V52, P802, DOI 10.1001/archneur.1995.00540320078015; LINDENBERG R, 1964, Dtsch Z Nervenheilkd, V185, P637; Martland HS, 1928, J AMER MED ASSOC, V91, P1103, DOI 10.1001/jama.1928.02700150029009; MAWDSLEY C, 1963, LANCET, V2, P795; NAYERNOURI T, 1985, SURG NEUROL, V24, P263, DOI 10.1016/0090-3019(85)90035-7; Parkinson J, 1817, ESSAY SHAKING PALSY; Roberts AH, 1969, BRAIN DAMAGE BOXERS; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; RONDOT P, 1994, J NEUROL NEUROSUR PS, V57, P658, DOI 10.1136/jnnp.57.5.658; RUDELLI R, 1990, ARCH NEUROL-CHICAGO, V39, P570; SAMIE MR, 1990, NEUROLOGY, V40, P62, DOI 10.1212/WNL.40.1.62; SANDYK R, 1983, J NEUROSURG, V58, P298, DOI 10.3171/jns.1983.58.2.0298; SCHOTT GD, 1986, LANCET, V2, P712; SCHOTT GD, 1985, J NEUROL NEUROSUR PS, V48, P698, DOI 10.1136/jnnp.48.7.698; SCHWAB RS, 1968, HDB CLIN NEUROLOGY, V6, P230; SLEVIN JT, 1987, NEUROLOGY, V37, P322, DOI 10.1212/WNL.37.2.322; SNYDER AM, 1985, ANN NEUROL, V18, P544, DOI 10.1002/ana.410180506; STERN MB, 1991, MOVEMENT DISORD, V6, P95, DOI 10.1002/mds.870060202; WILLIAMS DB, 1991, NEUROLOGY, V41, P1554, DOI 10.1212/WNL.41.10.1554; [No title captured]	51	16	17	0	6	MASSON EDITEUR	MOULINEAUX CEDEX 9	21 STREET CAMILLE DESMOULINS, ISSY, 92789 MOULINEAUX CEDEX 9, FRANCE	0035-3787			REV NEUROL-FRANCE	Rev. Neurol.	OCT	1997	153	10					541	546					6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	YG630	WOS:A1997YG63000002	9684017				2022-02-06	
J	Yorkston, KM; Jaffe, KM; Polissar, NL; Liao, SQ; Fay, GC				Yorkston, KM; Jaffe, KM; Polissar, NL; Liao, SQ; Fay, GC			Written language production and neuropsychological function in children with traumatic brain injury	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article							CLOSED-HEAD-INJURY; ADOLESCENTS; PERFORMANCE; DISCOURSE; CHILDHOOD; RECOVERY; COHORT	Objective: To establish the early consequences of traumatic brain injury (TBI) on spontaneous written language production in children by examining writing deficits as a function of injury severity and con-elating written performance with neuropsychological data. Design: Case-control cohort study. Setting: Two regional medical centers. Patients: Seventy-six children, aged 8 to 15 years, with mild, moderate, or severe closed head injury were compared with controls who were individually matched on the premorbid characteristics of age, gender, school grade, behavior, and academic performance. Main Outcome Measures: Assessment of written language production and neuropsychological function was undertaken approximately I month following resolution of posttraumatic amnesia. Case-control differences on 16 measures of spontaneous written narratives were computed. Results: Factor analysis and conceptual similarities suggested that the measures of written language fell into five domains: Efficiency, Completeness, General Readability, Error, and Vocabulary. A highly significant, moderate correlation between these measures and severity of injury was found. The highest correlations were found for the written language domains of Efficiency and Completeness and the lowest for the Vocabulary domain. Moderate correlations were also found between measures of written language and neuropsychological function. Conclusions: At 1 month after resolution of posttraumatic amnesia, written language production in children with TBI is negatively correlated with severity of injury. Some aspects of written language production are affected to a greater extent than others. Considerable common around was found between written language production and neuropsychological function. (C) 1997 by the American Congress of Rehabilitation Medicine.	UNIV WASHINGTON, DEPT REHABIL MED, LEARNING SERV, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT REHABIL MED, BEHAV SERV, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT PEDIAT, SEATTLE, WA 98195 USA; UNIV WASHINGTON, DEPT NEUROL SURG, SEATTLE, WA 98195 USA; CHILDRENS HOSP & MED CTR, DEPT REHABIL MED, SEATTLE, WA 98105 USA; UNIV WASHINGTON, DEPT BIOSTAT, SEATTLE, WA 98195 USA; MT WHISPER LIGHT STAT CONSULTING, SEATTLE, WA USA; STATPRO CONSULTANTS, SEATTLE, WA USA		Yorkston, KM (corresponding author), UNIV WASHINGTON, DEPT REHABIL MED, NW NEUROPSYCHOL, BOX 356490, SEATTLE, WA 98195 USA.				PHS HHSUnited States Department of Health & Human ServicesUnited States Public Health Service [CCR002299/7] Funding Source: Medline		BRUININKS RH, 1984, WOODCOCK JOHNSON P 4; CAMPBELL TF, 1990, J SPEECH HEAR DISORD, V55, P567, DOI 10.1044/jshd.5503.567; CHAPMAN SB, 1992, BRAIN LANG, V43, P42, DOI 10.1016/0093-934X(92)90020-F; CROSSON B, 1993, CLIN NEUROPSYCHOL, V7, P250, DOI 10.1080/13854049308401897; Delis DC, 1989, CALIFORNIA VERBAL LE; DENNIS M, 1990, BRAIN LANG, V39, P428, DOI 10.1016/0093-934X(90)90149-B; EWINGCOBBS L, 1987, J CLIN EXP NEUROPSYC, V9, P575, DOI 10.1080/01688638708410770; EWINGCOBBS L, 1989, J PEDIATR PSYCHOL, V14, P531, DOI 10.1093/jpepsy/14.4.531; FAY GC, 1994, ARCH PHYS MED REHAB, V75, P733; FAY GC, 1993, ARCH PHYS MED REHAB, V74, P895; FREDERICKSON CH, 1990, DISCOURSE ABILITY BR, P1; GRAHAM S, 1986, J SCHOOL PSYCHOL, V24, P63, DOI 10.1016/0022-4405(86)90043-9; HAMMILL DD, 1978, TEST WRITTEN LANGUAG; Hasbrouck J, 1994, TEACHING EXCEPTIONAL, V26, P18; HUNT KW, 1970, SOC RES CHILD REV MO, V35, P69; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; JAFFE KM, 1995, ARCH PHYS MED REHAB, V76, P17, DOI 10.1016/S0003-9993(95)80037-9; JAFFE KM, 1992, ARCH PHYS MED REHAB, V73, P540; JAFFE KM, 1993, ARCH PHYS MED REHAB, V74, P681, DOI 10.1016/0003-9993(93)90024-5; JENNETT B, 1975, LANCET, V1, P480; JORDAN F M, 1990, Brain Injury, V4, P27; Jordan F M, 1988, Brain Inj, V2, P179, DOI 10.3109/02699058809150943; JORDAN FM, 1995, APHASIOLOGY, V9, P23, DOI 10.1080/02687039508248686; JORDAN FM, 1994, BRAIN INJURY, V8, P501, DOI 10.3109/02699059409151002; LEVIN HS, 1979, J NEUROSURG, V50, P412, DOI 10.3171/jns.1979.50.4.0412; Lezak MD., 1983, NEUROPSYCHOLOGICAL A, V2nd ed.; LINCOLN RK, 1994, CLIN NEUROPSYCHOL, V8, P140, DOI 10.1080/13854049408401553; NELSON NW, 1991, COMMUNICATION DISORD, P191; Reitan R.M., 1974, CLIN NEUROPSYCHOLOGY; Stevens J.P., 1992, APPL MULTIVARIATE ST, V2nd; WALLACH GP, 1994, LANGUAGE LEARNING DI, P2; Wechsler D., 1974, WECHSLER ADULT INTEL; Wilkinson, 1984, WIDE RANGE ACHIEVEME; Ylvisaker M., 1986, J HEAD TRAUMA REHAB, V1, P48	34	16	19	1	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	OCT	1997	78	10					1096	1102		10.1016/S0003-9993(97)90134-9			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	YA044	WOS:A1997YA04400008	9339159				2022-02-06	
J	Michalodimitrakis, EN; Tsatsakis, AM				Michalodimitrakis, EN; Tsatsakis, AM			Vehicular accidents and cardiac concussion - A traumatic connection	AMERICAN JOURNAL OF FORENSIC MEDICINE AND PATHOLOGY			English	Article						cardiac concussion; trauma; vehicular accident		Concussion of the heart (commotio cordis) occurs in traffic accidents in which blunt force impact over the precordial area occurs, even in the absence of multiple blunt force injuries, The functional dynamics of the heart, with ventricular arrythmias and conduction disturbances, serve: as the pathophysiological basis of this condition. As a cause of death in vehicular accidents, it is less common than other causes. However, it should be considered in the differential diagnosis, especially in cases with minor or no apparent injuries.			Michalodimitrakis, EN (corresponding author), UNIV CRETE,SCH MED,DEPT FORENS SCI,POB 1393,GR-71409 IRAKLION,GREECE.		Tsatsakis, Aristidis M./H-2890-2013	Tsatsakis, Aristidis M./0000-0003-3824-2462			DIMAIO DJ, 1989, FORENSCI PATHOL, P261; FRASER M, 1984, AM J FOREN MED PATH, V5, P249; FROEDE RC, 1979, J FORENSIC SCI, V24, P752; GRATTAN E, 1973, MODERN TRENDS FORENS, V3, P139; Hedinger Christoph, 1944, CARDIOLOGIA, V8, P1, DOI 10.1159/000164766; LIEDTKE AJ, 1974, AM J PHYSIOL, V226, P377, DOI 10.1152/ajplegacy.1974.226.2.377; LINDSEY D, 1978, CHEST, V74, P15, DOI 10.1378/chest.74.1.15; MITTLEMAN R, 1988, J FORENSIC SCI, V35, P1198; PARMLEY LF, 1958, CIRCULATION, V18, P371, DOI 10.1161/01.CIR.18.3.371; Spitz W. U., 1993, SPITZ FISHERS MEDICO, P199; VIANO DC, 1978, J TRAUMA, V18, P452, DOI 10.1097/00005373-197806000-00010	11	16	19	0	2	LIPPINCOTT-RAVEN PUBL	PHILADELPHIA	227 EAST WASHINGTON SQ, PHILADELPHIA, PA 19106	0195-7910			AM J FOREN MED PATH	Am. J. Forensic Med. Pathol.	SEP	1997	18	3					282	284		10.1097/00000433-199709000-00010			3	Medicine, Legal; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine; Pathology	YA810	WOS:A1997YA81000010	9290876				2022-02-06	
J	Whyte, J; Fleming, M; Polansky, M; Cavallucci, C; Coslett, HB				Whyte, J; Fleming, M; Polansky, M; Cavallucci, C; Coslett, HB			Phasic arousal in response to auditory warnings after traumatic brain injury	NEUROPSYCHOLOGIA			English	Article						attention; arousal; brain injury; reaction time	CLOSED-HEAD-INJURY; REACTION-TIME; ATTENTION; INFORMATION; SCALE; TASK; COMA	Traumatic brain injury (TBI) is believed to have adverse effects on attention, but because of the multifaceted nature of the arousal and attentional network, the precise impact of TBI on various subcomponents of this network remains controversial. As part of a larger program of research on attention in TBI, we studied the effects of auditory warning signals on accuracy, reaction time, and response bias, as indices of phasic arousal in a visual go/no-go task. Warnings were presented randomly at various pre-stimulus intervals to a sample of recently injured patients and control subjects. For each subject and performance index, we examined the time interval required to reach maximal phasic arousal, the degree of performance change occurring at this maximal point, and the ability to maintain this state of increased arousal over longer warning intervals. After adjustment for baseline differences, there were no significant differences between patients and controls in any aspect of performance. Examination of effect sizes suggested that this was not due to limited statistical power, but that any differences between groups, if present, must have been small. In contrast, in our prior research on sustained attention and observable behaviors related to attention, large group differences have been found. These data suggest that mechanisms responsible for auditorily-induced phasic arousal responses are largely preserved in severe TBI. (C) 1997 Elsevier Science Ltd.	TEMPLE UNIV,SCH MED,DEPT PHYS MED & REHABIL,PHILADELPHIA,PA 19122; ALLEGHENY UNIV HLTH SCI,PHILADELPHIA,PA 19102; TEMPLE UNIV,SCH MED,DEPT NEUROL,PHILADELPHIA,PA 19122		Whyte, J (corresponding author), MOSS REHABIL RES INST,1200 W TABOR RD,PHILADELPHIA,PA 19141, USA.			Whyte, John/0000-0002-4381-1474			AKRITAS MG, 1991, J AM STAT ASSOC, V86, P457, DOI 10.2307/2290594; ALIVISATOS B, 1989, NEUROPSYCHOLOGIA, V27, P495, DOI 10.1016/0028-3932(89)90054-7; AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BEATTY J, 1982, PSYCHOL BULL, V91, P276, DOI 10.1037/0033-2909.91.2.276; BRUYER R, 1989, INT J NEUROSCI, V49, P87, DOI 10.3109/00207458909087043; COSLETT HB, 1987, NEUROLOGY, V37, P957, DOI 10.1212/WNL.37.6.957; CREMONAMETEYARD SL, 1994, NEUROPSYCHOLOGIA, V32, P649, DOI 10.1016/0028-3932(94)90026-4; CREMONAMETEYARD SL, 1994, BRAIN INJURY, V8, P541, DOI 10.3109/02699059409151006; CURRY SH, 1981, PROGR BRAIN RES, V54, P507; HOLLOWAY FA, 1972, PSYCHOPHYSIOLOGY, V9, P189, DOI 10.1111/j.1469-8986.1972.tb00753.x; JACOBS HE, 1988, ARCH PHYS MED REHAB, V69, P425; LEVIN HS, 1989, DEMOS TRAUMATIC BRAI, V2, P53; Macmillan NA., 1991, DETECTION THEORY USE; Maxwell, 1985, MULTIVARIATE ANAL VA; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; NATIV A, 1994, ARCH PHYS MED REHAB, V75, P1322; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; POSNER MI, 1986, CHRONOMETRIC EXPLORA, P122; POSNER MI, 1986, ENERGETICS HUMAN INF; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; RIZZO PA, 1978, ELECTROEN CLIN NEURO, V45, P281, DOI 10.1016/0013-4694(78)90012-3; RUGG MD, 1989, BRAIN, V112, P489, DOI 10.1093/brain/112.2.489; SEGALOWITZ SJ, 1992, J CLIN EXP NEUROPSYC, V14, P545, DOI 10.1080/01688639208402844; TEASDALE G, 1974, LANCET, V2, P81; TROMP E, 1991, J CLIN EXP NEUROPSYC, V13, P821, DOI 10.1080/01688639108405100; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANWOERKOM TCA, 1977, LANCET, V1, P821; VANZOMEREN AH, 1981, REACTION TIME ATTENT, P9; VANZOMEREN AH, 1987, NEUROBEHAVIORAL RECO; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P940; Whyte J, 1996, J Int Neuropsychol Soc, V2, P274; WHYTE J, 1995, NEUROPSYCHOLOGIA, V33, P797, DOI 10.1016/0028-3932(95)00029-3; WHYTE J, 1992, ARCH PHYS MED REHAB, V73, P1094; WHYTE J, 1993, REHABILITATION MED P; WILKINS AJ, 1987, NEUROPSYCHOLOGIA, V25, P359, DOI 10.1016/0028-3932(87)90024-8	35	16	16	1	2	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0028-3932			NEUROPSYCHOLOGIA	Neuropsychologia	MAR	1997	35	3					313	324		10.1016/S0028-3932(96)00092-9			12	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	WH248	WOS:A1997WH24800009	9051679				2022-02-06	
J	Starkstein, SE; Sabe, L; Dorrego, MF				Starkstein, SE; Sabe, L; Dorrego, MF			Severe retrograde amnesia after a mild closed head injury	NEUROCASE			English	Article						closed head injury; traumatic brain injury; anterograde amnesia; retrograde amnesia	AUTOBIOGRAPHICAL MEMORY; IMPAIRMENT	We describe a patient (RP) who developed a severe retrograde amnesia in the absence of anterograde memory deficits after a minor closed head injury. The retrograde amnesia affected RP's autobiographical memory as well as his memory for famous people, well known events and semantics. He showed no structural brain lesion on the MRI, but a SPECT study showed right frontal, parietal and thalamic perfusion deficit. While RP could partially relearn some of the lost memories, 1 year after the accident he still showed a dense retrograde amnesia. Our case demonstrates that severe and long-lasting retrograde memory deficits may occur after a 'minor' closed head injury.	RAUL CARRERA INST NEUROL RES,DEPT NEUROPSYCHIAT,BUENOS AIRES,DF,ARGENTINA								BADDELEY AD, 1986, AUTOBIOGRAPHICAL MEM, P225; BROWN JW, 1995, APHASIOLOGY, V9, P163, DOI 10.1080/02687039508248703; DALLORA P, 1989, CORTEX, V25, P197, DOI 10.1016/S0010-9452(89)80037-1; DERENZI E, 1993, CORTEX, V29, P449, DOI 10.1016/S0010-9452(13)80253-5; DERENZI E, 1995, CORTEX, V31, P531, DOI 10.1016/S0010-9452(13)80064-0; HODGES JR, 1993, BRAIN, V116, P921, DOI 10.1093/brain/116.4.921; KAPUR N, 1993, CORTEX, V29, P217, DOI 10.1016/S0010-9452(13)80177-3; KOPELMAN MD, 1994, NEUROPSYCHOLOGIA, V32, P675, DOI 10.1016/0028-3932(94)90028-0; KOPELMAN MD, 1991, BRAIN, V114, P117; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; MARKOWITSCH HJ, 1993, J NEUROL NEUROSUR PS, V56, P988, DOI 10.1136/jnnp.56.9.988; MARKOWITSCH HJ, 1993, J CLIN EXP NEUROPSYC, V15, P947, DOI 10.1080/01688639308402610; Mattioli F, 1996, CORTEX, V32, P121, DOI 10.1016/S0010-9452(96)80021-9; OCONNOR M, 1992, J CLIN EXP NEUROPSYC, V14, P159, DOI 10.1080/01688639208402821; STRACCIARI A, 1994, CORTEX, V30, P459, DOI 10.1016/S0010-9452(13)80341-3; YONEDA Y, 1992, EUR NEUROL, V32, P340, DOI 10.1159/000116857	16	16	16	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD, ENGLAND OX2 6DP	1355-4794			NEUROCASE	Neurocase		1997	3	2					105	109		10.1093/neucas/3.2.105			5	Clinical Neurology; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	XL491	WOS:A1997XL49100003					2022-02-06	
J	Twyman, D				Twyman, D			Nutritional management of the critically ill neurologic patient	CRITICAL CARE CLINICS			English	Article							HEAD-INJURED PATIENTS; ACUTE BRAIN-DAMAGE; SEPTIC MORBIDITY; ABDOMINAL-TRAUMA; FEEDINGS; PEPTIDE; HORMONE; BLUNT	The metabolic sequelae and importance of nutritional support of the patient with severe neurologic injury have received extensive attention. Most of the research of the last 14 years has focused on the nutritional and metabolic management of the patient with head trauma. This article focuses on the metabolic and physiologic consequences of traumatic and ischemic brain injury and the role of nutritional support in their management.			Twyman, D (corresponding author), NUTRASWEET KELCO CO,COMMERCIAL DEV DEPT,1751 LAKE COOK RD,RD BOX 830,DEERFIELD,IL 60015, USA.						BORLASE BC, 1992, SURG GYNECOL OBSTET, V174, P181; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CLIFTON GL, 1984, J NEUROSURG, V60, P687, DOI 10.3171/jns.1984.60.4.0687; *CLINT NUTR CO, 1995, MAN CAR NUTR SUPP US; DAMASK MC, 1982, ANESTHESIOLOGY, V57, P213, DOI 10.1097/00000542-198209000-00011; DONALD P, 1994, NUTR RES, V14, P3, DOI 10.1016/S0271-5317(05)80362-8; DREW JH, 1947, J NEUROSURG, V4, P7, DOI 10.3171/jns.1947.4.1.0007; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P115, DOI 10.1007/BF00571658; HAIDER W, 1975, EUR J INTEN CARE MED, V1, P19, DOI 10.1007/BF00735865; HASSETT JM, 1988, SURG GYNECOL OBSTET, V167, P383; KINSELLA JE, 1990, NUTRITION, V6, P24; KUDSK KA, 1992, ANN SURG, V215, P503, DOI 10.1097/00000658-199205000-00013; LANGKAMPHENKEN B, 1995, CRIT CARE MED, V23, P660, DOI 10.1097/00003246-199504000-00013; MASCIOLI E, 1988, LIPIDS, V23, P623, DOI 10.1007/BF02535609; MCCLAIN CJ, 1986, J NEUROSURG, V64, P224, DOI 10.3171/jns.1986.64.2.0224; MEREDITH JW, 1990, J TRAUMA, V30, P825, DOI 10.1097/00005373-199007000-00011; MOORE FA, 1989, J TRAUMA, V29, P916, DOI 10.1097/00005373-198907000-00003; NORTON JA, 1988, J NEUROSURG, V68, P62, DOI 10.3171/jns.1988.68.1.0062; Nyswonger G D, 1992, J Neurosci Nurs, V24, P220; ONEILL PA, 1991, STROKE, V22, P842, DOI 10.1161/01.STR.22.7.842; OTT L, 1985, JPEN-PARENTER ENTER, V9, P110; RAPP RP, 1983, J NEUROSURG, V58, P906, DOI 10.3171/jns.1983.58.6.0906; ROBERTSON CS, 1984, NEUROSURGERY, V15, P307, DOI 10.1227/00006123-198409000-00003; SAITO H, 1985, ABSTR AM BURN ASS, V17, P27; SAKE JM, 1994, J TRAUMA, V37, P581; TWYMAN D, 1985, JPEN-PARENTER ENTER, V9, P679, DOI 10.1177/0148607185009006679; TWYMAN DL, 1985, SURG FORUM, V26, P515; WEISSMAN C, 1982, CRIT CARE MED, V10, P231, DOI 10.1097/00003246-198203000-00119; YOUNG B, 1985, NEUROSURGERY, V17, P784, DOI 10.1227/00006123-198511000-00010	30	16	18	0	2	W B SAUNDERS CO	PHILADELPHIA	INDEPENDENCE SQUARE WEST CURTIS CENTER, STE 300, PHILADELPHIA, PA 19106-3399	0749-0704			CRIT CARE CLIN	Crit. Care Clin.	JAN	1997	13	1					39	&		10.1016/S0749-0704(05)70295-5			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	WE065	WOS:A1997WE06500004	9012575				2022-02-06	
J	vonEuler, M; LiLi, M; Whittemore, S; Seiger, A; Sundstrom, E				vonEuler, M; LiLi, M; Whittemore, S; Seiger, A; Sundstrom, E			No protective effect of the NMDA antagonist memantine in experimental spinal cord injuries	JOURNAL OF NEUROTRAUMA			English	Article						memantine; neuroprotection; N-methyl-D-aspartate receptor; spinal cord injury	METHYL-D-ASPARTATE; RECEPTOR ANTAGONIST; ISCHEMIC DAMAGE; AMINO-ACIDS; RAT; MK-801; BRAIN; IMPAIRMENT; RESPONSES; GLUTAMATE	We have investigated the effect of memantine, a clinically used NMDA receptor antagonist, in two experimental animal models of spinal cord injury. The lesions were laser-induced photothrombosis to induce focal spinal cord ischemia and clip compression to mimic traumatic spinal cord injury. Pre- or posttreatment of rats with a dose of memantine (20 mg/kg ip) previously shown to be neuroprotective in cerebral ischemia, failed to affect both the neurological and morphological outcome of ischemic spinal cord injury. Likewise, memantine had no effects on neurological and morphological outcome after experimental traumatic injury. In view of the regional heterogeneity of NMDA receptors, the affinity of memantine for spinal cord NMDA receptors was also determined by studying displacement of [H-3](+)-5-methyl-10,11-dihydro-5H-dibenzo[a,d]cyclohepten-5-10- imine (MK-801) to rat and human spinal cord homogenates. We found that memantine had an affinity for NMDA receptors in the spinal cord (K-i = 0.58 mu M) that was significantly lower compared to that of the cerebral cortex (K-i = 0.23 mu M) and that the affinity for NMDA receptors in human spinal cord was even lower. We conclude that in view of available data, memantine should not be chosen for clinical studies on neuroprotection in spinal cord injuries and that the lack of protective effect is most likely due to insufficient affinity of memantine for spinal cord NMDA receptors.	HUDDINGE UNIV HOSP, KAROLINSKA INST, DEPT CLIN NEUROSCI & FAMILY MED, DIV GERIATR MED, S-14186 HUDDINGE, SWEDEN; UNIV MIAMI, SCH MED, DEPT NEUROL SURG, MIAMI, FL 33136 USA; UNIV MIAMI, SCH MED, MIAMI PROJECT CURE PARALYSIS, MIAMI, FL 33136 USA					von Euler, Mia/0000-0002-3845-8100			Albin M S, 1965, Surg Forum, V16, P423; BACKHAUSS C, 1992, EUR J PHARMACOL, V215, P265, DOI 10.1016/0014-2999(92)90037-5; Bernert H, 1996, P NATL ACAD SCI USA, V93, P5235, DOI 10.1073/pnas.93.11.5235; BORMANN J, 1989, EUR J PHARMACOL, V166, P591, DOI 10.1016/0014-2999(89)90385-3; BRESINK I, 1995, NEUROPHARMACOLOGY, V34, P533, DOI 10.1016/0028-3908(95)00017-Z; BUCHAN A, 1990, J NEUROSCI, V10, P311; CHEN HSV, 1992, J NEUROSCI, V12, P4427; CHENG Y, 1973, BIOCHEM PHARMACOL, V22, P3099; ELNASR MS, 1990, EUR J PHARMACOL, V185, P19, DOI 10.1016/0014-2999(90)90206-L; ERDO SL, 1991, EUR J PHARMACOL, V198, P215, DOI 10.1016/0014-2999(91)90625-Z; FADEN AI, 1990, EUR J PHARMACOL, V175, P165, DOI 10.1016/0014-2999(90)90227-W; FADEN AI, 1988, ANN NEUROL, V23, P623, DOI 10.1002/ana.410230618; GALE K, 1985, EXP NEUROL, V88, P123, DOI 10.1016/0014-4886(85)90118-9; GOMEZPINILLA F, 1989, EXP NEUROL, V104, P118, DOI 10.1016/S0014-4886(89)80004-4; HAO JX, 1992, EXP NEUROL, V118, P143, DOI 10.1016/0014-4886(92)90031-K; Hayes RL, 1988, J NEUROTRAUM, V5, P259, DOI 10.1089/neu.1988.5.259; HERRERO JF, 1994, NEUROSCI LETT, V165, P37, DOI 10.1016/0304-3940(94)90703-X; KOCHHAR A, 1988, ARCH NEUROL-CHICAGO, V45, P148, DOI 10.1001/archneur.1988.00520260034016; KORNHUBER J, 1989, EUR J PHARMACOL, V166, P589, DOI 10.1016/0014-2999(89)90384-1; LIU DX, 1991, BRAIN RES, V547, P344, DOI 10.1016/0006-8993(91)90984-4; MINAMISAWA H, 1990, STROKE, V21, P758, DOI 10.1161/01.STR.21.5.758; NIETOSAMPEDRO M, 1991, RESTOR NEUROL NEUROS, V2, P175, DOI 10.3233/RNN-1991-245604; PARSONS CG, 1993, NEUROPHARMACOLOGY, V32, P1337, DOI 10.1016/0028-3908(93)90029-3; PENCALET P, 1993, J NEUROSURG, V78, P603, DOI 10.3171/jns.1993.78.4.0603; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; RIVLIN AS, 1978, SURG NEUROL, V10, P39; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; SIMON RP, 1984, SCIENCE, V226, P850, DOI 10.1126/science.6093256; SIMPSON RK, 1990, NEUROCHEM RES, V15, P635, DOI 10.1007/BF00973755; Souverbie F, 1996, EUR J PHARMACOL, V307, P347, DOI 10.1016/0014-2999(96)00273-7; TARLOV IM, 1954, AMA ARCH NEUROL PSY, V71, P271, DOI 10.1001/archneurpsyc.1954.02320390001001; vonEuler M, 1996, EXP NEUROL, V137, P242, DOI 10.1006/exnr.1996.0023; VONEULER M, 1994, EXP NEUROL, V129, P163, DOI 10.1006/exnr.1994.1157; WATSON BD, 1993, NEUROPROTOCOLS, V3, P3; Wrathall JR, 1996, EXP NEUROL, V137, P119, DOI 10.1006/exnr.1996.0012; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; YUM SW, 1990, ARCH NEUROL-CHICAGO, V47, P277, DOI 10.1001/archneur.1990.00530030043014	37	16	16	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	1997	14	1					53	61		10.1089/neu.1997.14.53			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	WK032	WOS:A1997WK03200006	9048311				2022-02-06	
J	Franzen, KM; Roberts, MA; Schmits, D; Verduyn, W; Manshadi, F				Franzen, KM; Roberts, MA; Schmits, D; Verduyn, W; Manshadi, F			Cognitive remediation in pediatric traumatic brain injury	CHILD NEUROPSYCHOLOGY			English	Article							MILD HEAD-INJURY; DEFICITS	Robinson's (1970) elaborative encoding technique (PQRST) was implemented as the active cognitive intervention strategy to address verbal memory deficits in 2 fourth-grade boys following mild or moderate traumatic brain injury (TBI). A metacognitive reading comprehension technique (Smith & Dauer, 1984) was also implemented for comparison purposes. Single-case methodology was employed using a counterbalanced crossover of the two intervention strategies controlling for the effects of attention. The performance of both boys was significantly better during strategy training with the PQRST technique and approached the performance level of the normal comparison subject. In contrast, the performance of both subjects with TBI remained at, or returned to, baseline levels during the metacognitive intervention. These findings suggest that Robinson's cognitive remediation intervention holds promise in addressing memory and reading comprehension deficits following pediatric traumatic brain injury. Future research should focus on enhancing generalization and transfer of training to classroom assignments.	UNIV NO IOWA,CEDAR FALLS,IA 50614; PHYS MED & REHABIL ASSOCIATES,WATERLOO,IA; UNIV IOWA,UNIV HOSP SCH 351,IOWA CITY,IA 52242								American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; BEERS SR, 1992, NEUROPSYCHOL REV, V3, P281, DOI 10.1007/BF01108414; BIGLER ED, 1995, ARCH CLIN NEUROPSYCH, V10, P159, DOI 10.1016/0887-6177(94)E0003-8; BLOSSER JL, 1989, TOP LANG DISORD, V9, P67, DOI 10.1097/00011363-198903000-00007; Doak CC, 1996, TEACHING PATIENTS LO; FRY E, 1977, J READING, V21, P242; GLASGOW RE, 1977, J CLIN PSYCHOL, V33, P1049, DOI 10.1002/1097-4679(197710)33:4<1049::AID-JCLP2270330429>3.0.CO;2-V; Hamsher K., 1989, MULTILINGUAL APHASIA; Lehr E, 1990, PSYCHOL MANAGEMENT T; LEVIN HS, 1987, J NEUROSURG, V66, P706, DOI 10.3171/jns.1987.66.5.0706; LEVIN HS, 1995, TRAUMATIC HEAD INJUR, P70; MUESER AM, 1984, PRACTICING COMPREHEN; NEWCOMER P, 1986, STANDARDIZED READING; Roberts M A, 1994, Appl Neuropsychol, V1, P45, DOI 10.1207/s15324826an0101&2_9; ROBERTS MA, IN PRES APPL NEUROPS; ROBINSON FP, 1970, EFFECTIVE STUDY; SEGALOWITZ SJ, 1991, J LEARN DISABIL, V24, P551, DOI 10.1177/002221949102400907; Sheslow D., 1990, WIDE RANGE ASSESSMEN; SLIFER KJ, 1993, ARCH PHYS MED REHAB, V74, P810, DOI 10.1016/0003-9993(93)90006-V; SMITH RJ, 1984, J READING, V28, P144; TELZROW CF, 1991, J HEAD TRAUMA REHAB, V6, P23; Wechsler D, 1991, WECHSLER INTELLIGENC, VTHIRD; WILSON B, 1987, REHABILITATION MEMOR; YLVISAKER M, 1994, ED DIMENSIONS ACQUIR, P121	24	16	17	0	4	SWETS ZEITLINGER PUBLISHERS	LISSE	P O BOX 825, 2160 SZ LISSE, NETHERLANDS	0929-7049			CHILD NEUROPSYCHOL	Child Neuropsychol.	DEC	1996	2	3					176	184		10.1080/09297049608402250			9	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	WM941	WOS:A1996WM94100002					2022-02-06	
J	Steiger, HJ; Ciessinna, E; Seiler, RW				Steiger, HJ; Ciessinna, E; Seiler, RW			Identification of posttraumatic ischemia and hyperperfusion by determination of the effect of induced arterial hypertension on carbon dioxide reactivity	STROKE			English	Article						cerebral ischemia; head injury; ultrasonics	CEREBRAL BLOOD-FLOW; SEVERE HEAD-INJURY; ACUTE BRAIN INJURY; TRANSCRANIAL DOPPLER ULTRASOUND; INTRACRANIAL HYPERTENSION; NEUROLOGICAL STATUS; COMATOSE PATIENTS; PRESSURE; VELOCITY; VASOREACTIVITY	Background and Purpose Both ischemia and hyperperfusion are known phenomena that follow traumatic brain injury. Cerebral carbon dioxide reactivity is diminished in both conditions. Differentiation is important because ischemia is thought to be a major factor of secondary neuronal loss and is potentially amenable to therapy by manipulation of cerebral perfusion pressure. Methods The response of transcranial Doppler-based carbon dioxide reactivity to pharmacologically induced hypertension was studied sequentially in 29 patients with severe to moderate head injury to identify ischemia and luxury perfusion. After simultaneous baseline registration of the carbon dioxide reactivity of both middle cerebral arteries by two-channel transcranial Doppler, systolic arterial pressure was raised approximately 20 mm HE by means of phenylephrine (Neosynephrine) infusion, and the carbon dioxide reactivity test was repeated. Results A significant improvement of impaired (<2%/mm Hg) carbon dioxide reactivity after arterial pressure was raised by 20 mm Hg (signaling ischemia) was found in 32 of 124 evaluated middle cerebral arteries. Further deterioration of impaired reactivity occurred in only four tested hemispheres. While ischemic conditions were identified during the entire study period, hyperperfusion was encountered only after day 3. Conclusions Ischemia after traumatic brain injury is a frequent phenomenon, whereas hyperperfusion is rare. Whether therapeutic optimization of carbon dioxide reactivity can improve the outcome of head-injury patients needs to be evaluated in further studies.	UNIV HOSP BERN,DEPT NEUROSURG,CH-3010 BERN,SWITZERLAND								BOUMA GJ, 1992, J NEUROSURG, V77, P15, DOI 10.3171/jns.1992.77.1.0015; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; CHAN KH, 1992, J NEUROSURG, V77, P55, DOI 10.3171/jns.1992.77.1.0055; CHAN KH, 1992, SURG NEUROL, V38, P433, DOI 10.1016/0090-3019(92)90111-Y; CHAN KH, 1993, NEUROSURGERY, V32, P547, DOI 10.1227/00006123-199304000-00009; CHAN KH, 1992, NEUROSURGERY, V30, P697; CHAN KH, 1992, J NEUROL NEUROSUR PS, V55, P787, DOI 10.1136/jnnp.55.9.787; CRUZ J, 1993, J NEUROSURG, V79, P228, DOI 10.3171/jns.1993.79.2.0228; CRUZ J, 1991, NEUROSURGERY, V29, P743, DOI 10.1227/00006123-199111000-00017; CRUZ J, 1990, J NEUROSURG, V73, P725, DOI 10.3171/jns.1990.73.5.0725; ENEVOLDSEN EM, 1976, J NEUROSURG, V44, P191, DOI 10.3171/jns.1976.44.2.0191; MARTIN NA, 1992, J NEUROSURG, V77, P575, DOI 10.3171/jns.1992.77.4.0575; MUTTAQIN Z, 1993, ACTA NEUROCHIR, V123, P76, DOI 10.1007/BF01476289; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; OBRIST WD, 1979, J NEUROSURG, V51, P292, DOI 10.3171/jns.1979.51.3.0292; ROBERTSON CS, 1989, J NEUROSURG, V70, P222, DOI 10.3171/jns.1989.70.2.0222; SAHUQUILLO J, 1993, ACTA NEUROCHIR, V122, P204, DOI 10.1007/BF01405530; STEIGER HJ, 1994, NEUROSURGERY, V34, P79; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; UNTERBERG A, 1993, NEUROSURGERY, V32, P17, DOI 10.1227/00006123-199301000-00003; WEBER M, 1990, NEUROSURGERY, V27, P106, DOI 10.1227/00006123-199007000-00015	23	16	16	0	0	AMER HEART ASSOC	DALLAS	7272 GREENVILLE AVENUE, DALLAS, TX 75231-4596	0039-2499			STROKE	Stroke	NOV	1996	27	11					2048	2051		10.1161/01.STR.27.11.2048			4	Clinical Neurology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Cardiovascular System & Cardiology	VQ163	WOS:A1996VQ16300021	8898814				2022-02-06	
J	Gauggel, S; Niemann, T				Gauggel, S; Niemann, T			Evaluation of a short-term computer-assisted training programme for the remediation of attentional deficits after brain injury: A preliminary study	INTERNATIONAL JOURNAL OF REHABILITATION RESEARCH			English	Article						attention; remediation; brain injury; computer; evaluation	HEAD-INJURY	In this study the efficiency of a computer-assisted training programme designed to remedy attention deficits caused by cerebrovascular accident and closed head injury was evaluated. Four patients, aged between 40 and 53 years of age at a neurological rehabilitation hospital, received 2 to 4 weeks of training in alertness, vigilance, divided attention and selective attention after they had undergone a 2-week waiting period. Their performance in several tests of attention, verbal and visual memory, and intelligence was measured at three points in time; before and after the waiting period and after the training was completed. Furthermore, their general life satisfaction and mood were measured across time. The patients demonstrated improvements in training tasks, tests of attention and a visual memory test, despite there having been no improvements in two verbal memory tests and a general intelligence test. However, it is not possible to relate these gains in performance solely to the training itself. Spontaneous recovery and positive transfer between the assessments have added to the increase in performance.			Gauggel, S (corresponding author), UNIV MARBURG,DEPT PSYCHOL,GUTENBERGSTR 18,D-35032 MARBURG,GERMANY.			Gauggel, Siegfried/0000-0002-2742-4917			Anastasi A., 1988, PSYCHOL TESTING; Baumler G., 1985, FARBE WORT INTERFERE; BEMYISHAY Y, 1987, NEUROPSYCHOLOGICAL R, P155; BRACY OL, 1983, COGNITIVE REHABILITA, V1, P7; Brickenkamp R., 1975, TEST D2 AUFMERKSAMKE, V5; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Gray J M, 1989, Brain Inj, V3, P163, DOI 10.3109/02699058909004548; Horn W, 1983, LEISTUNGSPRUFSYSTEM; KEWMAN DG, 1985, REHABIL PSYCHOL, V9, P297; Klauer K. J., 1993, KOGNITIVES TRAINING, P15; Lienert G.A., 1969, TESTAUFBAU TESTANALY; MALEC J, 1984, COGNITIVE REHABILITA, V2, P18; NIEMANN H, 1990, J CONSULT CLIN PSYCH, V58, P811, DOI 10.1037/0022-006X.58.6.811; Osterrieth PA, 1994, ARCH PSYCHOL, V30, P286; OSWALD WD, 1978, ZAHLEN VERBINDUNGS T; PONSFORD JL, 1988, J CLIN EXP NEUROPSYC, V10, P693, DOI 10.1080/01688638808402808; Poser U., 1992, Z NEUROPSYCHOLOGIE, V1, P3; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; ROBERTSON I, 1990, APHASIOLOGY, V4, P381, DOI 10.1080/02687039008249090; Ruff R. M., 1989, J HEAD TRAUMA REHAB, V4, P20, DOI [10.1097/00001199-198909000-00006, DOI 10.1097/00001199-198909000-00006]; SCHUHFRIED G, 1977, HDB WIENER DETERMINA; SIVAK M, 1984, ARCH PHYS MED REHAB, V65, P163; SOHLBERG MM, 1987, J CLIN EXP NEUROPSYC, V9, P117, DOI 10.1080/01688638708405352; STRACHE W, 1987, International Journal of Rehabilitation Research, V10, P141, DOI 10.1097/00004356-198700105-00028; STURM W, 1983, ARCH PSYCHIAT NERVEN, V233, P9, DOI 10.1007/BF00540034; Sturm W., 1994, Z NEUROPSYCHOL, V5, P15; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VANZOMEREN AH, 1978, J NEUROL NEUROSUR PS, V41, P452, DOI 10.1136/jnnp.41.5.452; VANZOMEREN AH, 1994, CLIN NEUROPSYCHOL AT; Weber A. M., 1990, J HEAD TRAUMA REHABI, V5, P73, DOI [10.1097/00001199-199003000-00012, DOI 10.1097/00001199-199003000-00012]; WEBSTER JS, 1983, CLIN NEUROPSYCHOL, V5, P69; WECHSLER D, 1945, J PSYCHOL, V19, P21; Wood R L, 1987, Int Disabil Stud, V9, P149; WOOD RL, 1986, J HEAD TRAUMA REHAB, V1, P43, DOI DOI 10.1097/00001199-198609000-00008; [No title captured]	35	16	16	0	1	CHAPMAN HALL LTD	LONDON	2-6 BOUNDARY ROW, LONDON, ENGLAND SE1 8HN	0342-5282			INT J REHABIL RES	Int. J. Rehabil. Res.	SEP	1996	19	3					229	239		10.1097/00004356-199609000-00004			11	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	VP115	WOS:A1996VP11500004	8910125				2022-02-06	
J	Iverson, GL; Myers, B; Bengtson, ML; Adams, RL				Iverson, GL; Myers, B; Bengtson, ML; Adams, RL			Concurrent validity of a WAIS-R seven-subtest short form in patients with brain impairment	PSYCHOLOGICAL ASSESSMENT			English	Article								The concurrent validity of a Wechsler Adult Intelligence Scale-Revised (WAIS-R) seven-subtest short form was examined in 138 patients with closed-head injuries and 49 patients with presumed dementia. In patients with closed-head injuries, the average short form IQ score was within 1 point of the actual Verbal, Performance, and Full Scale IQ (VIQ, PIQ, and FSIQ) scores. The validity coefficients for these patients ranged from .90 to .95. In patients with presumed dementia, the short form underestimated the average VIQ by nearly 5 points and the average FSIQ by 3.5 points. However, the validity coefficients for these patients were uniformly high (.91 to .95). Examination of the frequency distributions revealed that there was a percentage of patients whose short form IQs and actual IQs were highly discrepant. Research designed to determine the variables that reduce the accuracy of the short form in clinical populations is needed.	UNIV OKLAHOMA,HLTH SCI CTR,DEPT PSYCHIAT & BEHAV SCI,NORMAN,OK 73019					Iverson, Grant/0000-0001-7348-9570			Benedict R. H. B., 1992, PSYCHOL ASSESSMENT, V4, P322, DOI DOI 10.1037//1040-3590.4.3.322; DOPPELT JD, 1956, J CONSULT PSYCHOL, V1, P63; KEPPEL G, 1982, DESIGN ANAL RES HDB; Paolo A. M, 1993, PSYCHOL ASSESSMENT, V5, P425; Schretlen D., 1994, PSYCHOL ASSESSMENT, V6, P188; SILVERSTEIN AB, 1982, J CONSULT CLIN PSYCH, V50, P415, DOI 10.1037/0022-006X.50.3.415; SILVERSTEIN AB, 1985, J CLIN PSYCHOL, V41, P676, DOI 10.1002/1097-4679(198509)41:5<676::AID-JCLP2270410515>3.0.CO;2-K; WARD LC, 1987, J CLIN PSYCHOL, V43, P276, DOI 10.1002/1097-4679(198703)43:2<276::AID-JCLP2270430219>3.0.CO;2-U; WARD LC, 1990, J CLIN PSYCHOL, V46, P436, DOI 10.1002/1097-4679(199007)46:4<436::AID-JCLP2270460411>3.0.CO;2-M; Wechsler, 1997, WECHSLER ADULT INTEL	10	16	16	0	3	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242	1040-3590			PSYCHOL ASSESSMENT	Psychol. Assess.	SEP	1996	8	3					319	323		10.1037/1040-3590.8.3.319			5	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	VK726	WOS:A1996VK72600010					2022-02-06	
J	Emanuelson, I; vonWendt, L; Lundalv, E; Larsson, J				Emanuelson, I; vonWendt, L; Lundalv, E; Larsson, J			Rehabilitation and follow-up of children with severe traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						traumatic brain injury; children; follow-up	CLOSED-HEAD-INJURY; CEREBRAL-PALSY; TERM; ADOLESCENTS; PERFORMANCE; SEQUELAE; SWEDEN; MEMORY	We studied the outcome of 25 patients [12 girls and 13 boys; mean age 13.7 (SD 3.9 years)] with severe traumatic brain injury (TBI). The Glasgow Coma Scale (GCS) score 6 h after the injury was (mean) 4.5 (SD 2.7), and the mean duration of unconsciousness was 15.8 (SD 10.6) days. Being the mast severely brain-injured children in the health care region, they were all referred to its only regional pediatric rehabilitation center during 1986-1990. At discharge, 1 patient was healthy, 1 was in a vegetative state and 18 had multiple impairments. Motor problems were present in 22, epilepsy in 7 and speech impairment in 14. It was not possible to assess cognition in 3 of the children, and 15 of the remaining 22 fell in the normal range. At follow up 2-6 years after trauma, all 23 survivors reported at least one sequela, and 21 had multiple sequelae. As many as two-thirds had normal I.Q. and only 3 were non-ambulatory, but behavioral and personality disturbances were so disabling that none of the patients in this group had been able to readjust to a normal life in society after the trauma.			Emanuelson, I (corresponding author), BRACKE OSTERGARD REG PEDIAT REHABIL CTR, PB 21062, S-41804 GOTHENBURG, SWEDEN.						BAWDEN HN, 1985, J CLIN EXP NEUROPSYC, V7, P39, DOI 10.1080/01688638508401241; BILLE B, 1992, PEDIAT HABILITATION; BRINK JD, 1980, J PEDIATR-US, V97, P721, DOI 10.1016/S0022-3476(80)80253-8; BROWN G, 1981, PSYCHOL MED, V11, P63, DOI 10.1017/S0033291700053289; CHADWICK O, 1981, PSYCHOL MED, V11, P49, DOI 10.1017/S0033291700053277; CHAPLIN D, 1993, ARCH PHYS MED REHAB, V74, P161; COSTEFF H, 1990, J NEUROSURG, V73, P684, DOI 10.3171/jns.1990.73.5.0684; Costeff H, 1985, Scand J Rehabil Med Suppl, V12, P10; DENNIS M, 1985, J CLIN EXP NEUROPSYC, V7, P526, DOI 10.1080/01688638508401283; DENNIS M, 1985, J CLIN EXP NEUROPSYC, V9, P555; DUSSER A, 1989, ELECTROEN CLIN NEURO, V73, P85, DOI 10.1016/0013-4694(89)90187-9; EIKEN CF, 1984, ARCH PHYS MED REHAB, V65, P168; EMANUELSON I, 1993, IC PS WORKSH BERN; FERNELL E, 1987, ACTA PAEDIATR SCAND, V76, P418, DOI 10.1111/j.1651-2227.1987.tb10492.x; FUGLMEYER AR, 1975, SCAND J REHABIL MED, V7, P13; HAGBERG B, 1989, ACTA PAEDIATR SCAND, V78, P283, DOI 10.1111/j.1651-2227.1989.tb11071.x; HJERN B, 1962, ARCH DIS CHILD, V37, P113, DOI 10.1136/adc.37.192.113; HOFFER MM, 1973, J BONE JOINT SURG AM, VA 55, P137, DOI 10.2106/00004623-197355010-00014; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; Kloti J, 1988, Schweiz Rundsch Med Prax, V77, P522; KRAGELOHMANN I, 1994, DEV MED CHILD NEUROL, V36, P473; KRIEL R, 1993, NATURAL HIST VEGETAT, P228; KRIEL RL, 1988, PEDIATR NEUROL, V4, P337, DOI 10.1016/0887-8994(88)90079-3; LEVIN HS, 1982, NEUROSURGERY, V11, P668, DOI 10.1227/00006123-198211000-00009; LEVIN HS, 1988, NEUROSURGERY, V22, P1043, DOI 10.1227/00006123-198806010-00012; MAHONEY WJ, 1983, PEDIATRICS, V71, P756; MICHAUD LJ, 1992, NEUROSURGERY, V31, P254, DOI 10.1227/00006123-199208000-00010; RANTAKALLIO P, 1985, J EPIDEMIOL COMMUN H, V39, P353, DOI 10.1136/jech.39.4.353; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; RUIJS MBM, 1993, EUR J PEDIATR, V152, P844, DOI 10.1007/BF02073384; STOVER SL, 1976, ARCH PHYS MED REHAB, V57, P201; WINOGRON HW, 1984, J CLIN NEUROPSYCHOL, V6, P269, DOI 10.1080/01688638408401218	32	16	16	1	5	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0256-7040			CHILD NERV SYST	Childs Nerv. Syst.	AUG	1996	12	8					460	465		10.1007/BF00261625			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	VH536	WOS:A1996VH53600009	8891364				2022-02-06	
J	Dreinhofer, KE; Schwarzkopf, SR; Haas, NP; Tscherne, H				Dreinhofer, KE; Schwarzkopf, SR; Haas, NP; Tscherne, H			Fractures of the femoral head - Long-term results of conservative and operative treatment	UNFALLCHIRURG			German	Article						fractures; femoral head; multiple injuries	HIP; DISLOCATION; THERAPY	From 1974 to 1989, we treated 32 patients with a femoral head fracture: 28 were associated with a traumatic posterosuperior dislocation of the hip (6 Pipkin type I, 7 type II, 4 type III and 11 type IV), 1 with a posteroinferior and 3 with an anterior displacement of the femoral head. Twenty-four patients had been involved in a traffic accident, 23 had associated injuries, and the average polytrauma score (PTS) was 21. All dislocations primarily treated at our hospital were reduced by closed methods within 4 h (mean 105 min). Eleven patients received no further operative treatment, 21 were treated by open reduction and screw fixation of the fragment of the head (n=7), fixation of the acetabular fracture (n=3) or removal of the fragments of the head (n=10). Four Pipkin type III fractures received primary total hip replacement. Twenty-six of the surviving 29 patients were reviewed after an average follow-up of 5 years (2-11). Radiological signs of mild arthrosis were seen in 4, moderate degeneration in 2. Partial avascular necrosis was found in 4, subchondral collapse in 1 and heterotopic ossification in 8 patients. According to the Thompson and Epstein criteria 15 of 26 patients presented fair to poor results.			Dreinhofer, KE (corresponding author), UNIV ULM,ORTHOPAD KLIN,REHABIL KRANKENHAUSES,ORTHOPAD ABT,OBERER ESELSBERG 45,D-89081 ULM,GERMANY.		Dreinhoefer, Karsten/AAO-9680-2021	Dreinhoefer, Karsten/0000-0001-6021-2804			BARNBECK F, 1987, ZBL CHIR, V112, P783; Birkett J, 1869, Med Chir Trans, V52, P133; BRAV EA, 1962, J BONE JOINT SURG AM, V44, P1115, DOI 10.2106/00004623-196244060-00007; BROOKER AF, 1973, J BONE JOINT SURG AM, VA 55, P1629, DOI 10.2106/00004623-197355080-00006; BRUMBACK RJ, 1986, HIP, P181; BUTLER JE, 1981, J BONE JOINT SURG AM, V63, P1292, DOI 10.2106/00004623-198163080-00011; CANALE ST, 1979, J BONE JOINT SURG AM, V61, P7, DOI 10.2106/00004623-197961010-00003; CAUCHOIX J, 1951, Rev Chir Orthop Reparatrice Appar Mot, V37, P266; CHARNLEY J, 1972, Journal of Bone and Joint Surgery British Volume, V54, P61; DELEE JC, 1980, J BONE JOINT SURG AM, V62, P960, DOI 10.2106/00004623-198062060-00012; DELEE JC, 1991, FRACTURES DISLOCATIO; DUQUENNOY A, 1975, REV CHIR ORTHOP, V61, P209; DUSSAULT RG, 1980, RADIOLOGY, V135, P627, DOI 10.1148/radiology.135.3.7384446; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, V201, P9; EPSTEIN HC, 1972, ORTHOP REV, V1, P33; FRIEDL W, 1994, CHIRURG, V65, P981; Funsten RV, 1938, J BONE JOINT SURG, V20, P124; Gruen G S, 1988, J Orthop Trauma, V2, P5, DOI 10.1097/00005131-198802000-00002; HAAG C, 1993, HEFTE UNFALLHEILKD, V228, P76; HOUGAARD K, 1986, ARCH ORTHOP TRAUM SU, V106, P32, DOI 10.1007/BF00435649; HOUGAARD K, 1988, J BONE JOINT SURG AM, V70A, P233, DOI 10.2106/00004623-198870020-00011; HOUGAARD K, 1994, CORTHOP INTER ED, V2, P507; JACOB JR, 1987, CLIN ORTHOPAEDICS, V214, P249; KELLY RP, 1971, J TRAUM, V11, P97, DOI 10.1097/00005373-197102000-00001; KLASEN HJ, 1984, J BONE JOINT SURG BR, V66, P45, DOI 10.1302/0301-620X.66B1.6693476; LEVIN PE, 1991, HIP ITS DISORDERS, P222; MAROSKE D, 1983, CHIRURG, V54, P400; MERLEDAUBIGNE R, 1954, J BONE JOINT SURG AM, V36, P451; MULLER ME, 1991, MANUAL INTERNAL FIXA, P519; OBERHAMMER J, 1975, HEFTE UNFALLHEILKD, V24, P272; OESTERN HJ, 1985, UNFALLCHIRURG, V88, P465; POHLEMANN T, 1991, HUFTKOPF NEKROSE, P187; ROEDER LF, 1980, CLIN ORTHOP RELAT R, V147, P121; ROSENTHAL RE, 1979, J TRAUMA, V19, P572, DOI 10.1097/00005373-197908000-00005; SCHWEIKERT CH, 1979, HEFTE UNFALLHEILKD, V140, P113; STEWART MJ, 1975, ACTA ORTHOP SCAND, V46, P507; STOCKENHUBER N, 1994, CHIRURG, V65, P976; STULBERG BN, 1989, CLIN ORTHOP RELAT R, V240, P181; SUDKAMP NP, 1990, ORTHOPADE, V19, P369; Swiontkowski M F, 1992, J Orthop Trauma, V6, P437, DOI 10.1097/00005131-199212000-00008; SWIONTKOWSKI MF, 1991, CURR ORTHOPAED, V5, P99; THOMPSON VP, 1951, J BONE JOINT SURG AM, V33-A, P746, DOI 10.2106/00004623-195133030-00023; TSCHERNE H, 1987, CHIRURG, V58, P631; Webb L X, 1990, J Orthop Trauma, V4, P376, DOI 10.1097/00005131-199012000-00002; WECKBACH A, 1989, UNFALLHEILKUNDE, V207, P121; WENDA K, 1991, KURZFASSUNG REFERATE, P163	46	16	17	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	JUN	1996	99	6					400	409					12	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	UV689	WOS:A1996UV68900003	8767135				2022-02-06	
J	Nakata, K; Masuhara, K; Nakamura, N; Shibuya, T; Sugano, N; Matsui, M; Ochi, T; Ohzono, K				Nakata, K; Masuhara, K; Nakamura, N; Shibuya, T; Sugano, N; Matsui, M; Ochi, T; Ohzono, K			Inducible osteonecrosis in a rabbit serum sickness model: Deposition of immune complexes in bone marrow	BONE			English	Article						osteonecrosis; microcirculatory injury; serum sickness; immune complex; animal model	SYSTEMIC LUPUS-ERYTHEMATOSUS; PLATELET-ACTIVATING-FACTOR; AVASCULAR NECROSIS; ARTHUS REACTION; FEMORAL-HEAD; PATHOGENESIS; RAT; ALVEOLITIS	We established inducible osteonecrosis in a rabbit serum sickness model. Osteonecrosis with marrow necrosis could be induced by the intravenous injection of horse serum in two doses separated in time by a period of three weeks, In this model, osteonecrosis could be successfully produced in rabbit femoral metaphysis. The incidence of marrow necrosis was 45% (9 of 20 rabbits) and trabecular necrosis occurred in 6 of 20 rabbits (30%) at 7 days after the second injection of the horse serum, In bone marrow of the femoral metaphysis, extravasation of erythrocytes and the formation of microthrombi in arterioles were often observed in an early stage of the present model and both findings correlate well each other (p = 0.0001). Immune complexes could be demonstrated using immunohistochemistry in bone marrow of the femoral metaphysis as well as in glomeruli of the kidney, Extravasation of erythrocytes in bone marrow of the femoral metaphysis was observed in 8 of 12 (67%) cases with immune complex deposition in the sinusoidal space of the femoral metaphysis and in 12 of 21 (57%) cases with immune complex deposition in glomeruli of the kidney, Immune complex deposition both in the sinusoidal space of femoral bone marrow (p = 0.0385) and in glomeruli of the kidney (p = 0.0209) closely related to extravasation of erythrocytes and microthrombi in arterioles in the early stage of this model, Early microcirculatory injury (extravasation of erythrocytes and microthrombi in arterioles) adjacent to osteonecrosis could be induced by immune complex deposition in femoral bone marrow and might be predictable characteristics for the inducible osteonecrosis in the present serum sickness model, The important findings in this study were that early microcirculatory injury was closely related to the deposition of immune complexes in femoral bone marrow, and that early microcirculatory injury associated with immune complex deposition was located close to osteonecrotic regions.	OSAKA NATL HOSP, DEPT ORTHOPAED SURG, OSAKA, JAPAN		Nakata, K (corresponding author), OSAKA UNIV, SCH MED, DEPT ORTHOPAED SURG, 2-2 YAMADAOKA, SUITA, OSAKA 565, JAPAN.		Sugano, Nobuhiko/AAA-3359-2020	Sugano, Nobuhiko/0000-0002-5305-3179			ABELES M, 1978, ARCH INTERN MED, V138, P750, DOI 10.1001/archinte.138.5.750; BERGSTEIN JM, 1974, J PEDIATR-US, V85, P31, DOI 10.1016/S0022-3476(74)80281-7; BERKOVITS L, 1966, MAGY RADIOL, V18, P24; BOUGHTONSMITH NK, 1993, BRIT J PHARMACOL, V110, P896, DOI 10.1111/j.1476-5381.1993.tb13897.x; CHANG CC, 1993, SEMIN ARTHRITIS RHEU, V23, P47, DOI 10.1016/S0049-0172(05)80026-5; Cochrane C G, 1973, Adv Immunol, V16, P185, DOI 10.1016/S0065-2776(08)60298-9; CRAWFORD JP, 1985, EXP MOL PATHOL, V42, P175, DOI 10.1016/0014-4800(85)90026-7; CRUESS RL, 1968, J BONE JOINT SURG AM, VA 50, P1577, DOI 10.2106/00004623-196850080-00006; DUBOIS EL, 1960, JAMA-J AM MED ASSOC, V174, P966, DOI 10.1001/jama.1960.03030080028005; FERRETTI M, 1994, J CLIN INVEST, V94, P449, DOI 10.1172/JCI117345; FICAT RP, 1980, ISCHEMIA NECROSES BO, P53; FISHER DE, 1972, CLIN ORTHOP RELAT R, P200, DOI 10.1097/00003086-197205000-00033; GOLD EW, 1978, CLIN ORTHOP RELAT R, V135, P272; GOSLING DC, 1987, TRANSPLANTATION, V43, P751, DOI 10.1097/00007890-198705000-00032; HEIMANN WG, 1960, NEW ENGL J MED, V263, P672, DOI 10.1056/NEJM196010062631404; JONES JP, 1966, J BONE JOINT SURG AM, VA 48, P149, DOI 10.2106/00004623-196648010-00015; JONES JP, 1992, CLIN ORTHOP RELAT R, V277, P41; KAWAI K, 1985, J BONE JOINT SURG AM, V67A, P755, DOI 10.2106/00004623-198567050-00010; LANDMANN J, 1987, J BONE JOINT SURG AM, V69A, P1226, DOI 10.2106/00004623-198769080-00017; MALE D, 1993, IMMUNOLOGY, V21, P1; MARTEL W, 1964, ARTHRITIS RHEUM, V7, P717; MATSUI M, 1995, VIRCHOWS ARCH, V427, P205; MATSUI M, 1992, CLIN ORTHOP RELAT R, P61; MULLIGAN MS, 1992, J IMMUNOL, V149, P331; NAITO S, 1993, BONE, V14, P745, DOI 10.1016/8756-3282(93)90206-P; PONS F, 1993, BRIT J PHARMACOL, V109, P234, DOI 10.1111/j.1476-5381.1993.tb13559.x; RAMOS BF, 1994, J IMMUNOL, V152, P1380; Rich AR, 1943, B JOHNS HOPKINS HOSP, V72, P65; Rutishauser E, 1966, Rev Chir Orthop Reparatrice Appar Mot, V52, P197; SIEMSEN JK, 1962, ARTHRITIS RHEUM, V5, P492, DOI 10.1002/art.1780050506; Solomon L, 1973, J Bone Joint Surg Br, V55, P246; VRONINKS P, 1972, SEM HOP PARIS, V48, P3001; WANG GJ, 1977, J BONE JOINT SURG AM, V59, P729, DOI 10.2106/00004623-197759060-00003; WANG GJ, 1984, BONE CIRCULATION, P35; WARREN JS, 1991, CLIN IMMUNOL IMMUNOP, V61, P249, DOI 10.1016/S0090-1229(05)80028-5; WARREN JS, 1992, AM J PATHOL, V141, P551; WILLIAMS TJ, 1986, AGENTS ACTIONS, V19, P66, DOI 10.1007/BF01977260	37	16	21	0	0	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	8756-3282	1873-2763		BONE	Bone	JUN	1996	18	6					609	615		10.1016/8756-3282(96)00078-6			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	UT997	WOS:A1996UT99700018	8806003				2022-02-06	
J	Schmitt, U; Cross, R; Pazdernik, TL; Sabel, BA				Schmitt, U; Cross, R; Pazdernik, TL; Sabel, BA			Loss and subsequent recovery of local cerebral glucose use in visual targets after controlled optic nerve crush in adult rats	EXPERIMENTAL NEUROLOGY			English	Article							RETINAL GANGLION-CELLS; SUPERIOR COLLICULUS; METABOLIC-ACTIVITY; 2-DEOXYGLUCOSE UPTAKE; AXONAL INJURY; GRADED CRUSH; BRAIN INJURY; ALBINO-RAT; HOODED RAT; SYSTEM	A mild crush of the adult rat optic nerve serves as a model to study the restoration of function after traumatic brain injury. It causes a progressive degeneration of retinal ganglion cells, but visually guided behavior is partially restored within 2-3 weeks. The purpose of this study was to determine to what extent local cerebral glucose use (LCGU) decreases and if it recovers in retinofugal targets following unilateral optic nerve crush. At intervals of 2, 9, and 22 days after crush, LCGU was monitored in rats in which the visual system was stimulated by a strobe-light and pattern. In the ipsilateral retinofugal targets there was only a minimal loss of LCGU use, but in the contralateral retinofugal targets, LCGU was reduced at Postlesion Day 2: to 50% in the superior colliculus (SC), to 60% in the lateral geniculate nucleus of the thalamus (LGN), and to 87% in the visual cortex. On Postoperative Days 9 and 22 we observed a partial restoration of LCGU in the contralateral SC and LGN to 68 and 79%, respectively. As recovery of visual performance is known to follow a similar time course, we conclude that restoration of metabolic activity in target structures may contribute to the restoration of vision after optic nerve crush. (C) 1996 Academic Press, Inc.	UNIV KANSAS,MED CTR,RL SMITH RES CTR,KANSAS CITY,KS 66160		Schmitt, U (corresponding author), OTTO VONGUERICKE UNIV,INST MED PSYCHOL,SCH MED,LEIPZIGERSTR 44,D-39120 MAGDEBURG,GERMANY.		Sabel, Bernhard A./E-6579-2013	Sabel, Bernhard/0000-0002-4472-5543			ALLCUTT D, 1984, DEV BRAIN RES, V16, P219, DOI 10.1016/0165-3806(84)90027-0; ALLCUTT D, 1984, DEV BRAIN RES, V16, P231, DOI 10.1016/0165-3806(84)90028-2; COOPER RM, 1984, EXP NEUROL, V86, P261, DOI 10.1016/0014-4886(84)90185-7; COOPER RM, 1985, EXP NEUROL, V89, P322, DOI 10.1016/0014-4886(85)90093-7; COOPER RM, 1991, EXP NEUROL, V113, P79, DOI 10.1016/0014-4886(91)90149-7; DREHER B, 1985, BRAIN BEHAV EVOLUT, V26, P10, DOI 10.1159/000118764; DUVDEVANI R, 1990, RESTOR NEUROL NEUROS, V2, P31, DOI 10.3233/RNN-1990-2104; ERB DE, 1991, EXP BRAIN RES, V83, P253; FERRARI R, 1991, INT J NEUROSCI, V58, P199, DOI 10.3109/00207459108985435; Finger S., 1982, BRAIN DAMAGE RECOVER; GENNARELLI TA, 1989, J NEUROSURG, V71, P244, DOI 10.3171/jns.1989.71.2.0244; HERTA MF, 1984, COMP NEUROLOGY OPTIC, P687; HEYWOD CA, 1988, EXP BRAIN RES, V70, P513; Laurence S., 1978, RECOVERY BRAIN DAMAG, P369; LINDEN R, 1983, BRAIN RES, V272, P145, DOI 10.1016/0006-8993(83)90371-2; MCINTOSH AR, 1989, BEHAV BRAIN RES, V32, P1, DOI 10.1016/S0166-4328(89)80066-X; PAZDERNIK TL, 1982, BRAIN RES, V243, P197, DOI 10.1016/0006-8993(82)91139-8; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; ROONEY BJ, 1988, BRAIN RES, V439, P311, DOI 10.1016/0006-8993(88)91488-6; SAUTTER J, 1993, EUR J NEUROSCI, V5, P680, DOI 10.1111/j.1460-9568.1993.tb00533.x; SAUTTER J, 1991, BRAIN RES, V565, P23, DOI 10.1016/0006-8993(91)91732-G; SCHMITT UW, 1994, INVEST OPHTAL VIS SC, V35, P1125; SOKOLOFF L, 1977, J NEUROCHEM, V28, P897, DOI 10.1111/j.1471-4159.1977.tb10649.x; STEIN DG, 1992, ADV EXP MED BIOL, V325, P1; THURLOW GA, 1988, EXP NEUROL, V100, P563, DOI 10.1016/0014-4886(88)90040-4; THURLOW GA, 1989, EXP NEUROL, V104, P272, DOI 10.1016/0014-4886(89)90040-X; THURLOW GA, 1991, J COMP NEUROL, V306, P697, DOI 10.1002/cne.903060411; THURLOW GA, 1988, J COMP NEUROL, V274, P595, DOI 10.1002/cne.902740408; TOGA AW, 1981, J COMP NEUROL, V199, P443, DOI 10.1002/cne.901990402; TOGA AW, 1987, DEV BRAIN RES, V37, P209, DOI 10.1016/0165-3806(87)90242-2; YAMADORI T, 1981, J HIRNFORSCH, V22, P313; [No title captured]	32	16	19	0	0	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0014-4886			EXP NEUROL	Exp. Neurol.	MAY	1996	139	1					17	24		10.1006/exnr.1996.0076			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	UK439	WOS:A1996UK43900003	8635564				2022-02-06	
J	Wolf, AP; Gleckman, AD; Cifu, DX; Ginsburg, PC				Wolf, AP; Gleckman, AD; Cifu, DX; Ginsburg, PC			The prevalence of agitation and brain injury in skilled nursing facilities: A survey	BRAIN INJURY			English	Article							CLOSED HEAD-INJURY; BEHAVIOR; PROPRANOLOL; MANAGEMENT; TRAZODONE; DISORDERS; PATIENT; DISEASE	All skilled nursing facilities (SNF) in the state of Connecticut were surveyed to determine the number of residents with a primary diagnosis of brain injury, the incidence of agitation among these residents, and management strategies utilized for agitation in these residents, including consultation with brain injury specialists. One hundred and sixty-two, or 64%, of the SNF responded to the survey, and reported on 140 individuals with a primary diagnosis of brain injury. These individuals were residing in 39, or 24%, of the 162 facilities. Forty-five per cent of these 39 facilities had brain-injured residents who met the definition of agitation presented in the survey. Management of agitation was equally distributed between environmental manipulation, formal behaviour care plans and medications. The availability of specialist consultation was variable and included physiatrists (38%), psychiatrists (67%), neurologists (41%), and psychologists (36%). This survey study defined the prevalence of brain-injured residents in Connecticut's SNF, and examined management strategies for agitation in this patient population.	CONNECTICUT SUBACUTE CORP, WATERBURY, CT 06705 USA; VIRGINIA COMMONWEALTH UNIV, MED COLL VIRGINIA, DEPT PHYS MED & REHABIL, RICHMOND, VA 23298 USA; UNIV CONNECTICUT, CTR HLTH SCI, FARMINGTON, CT 06032 USA					Cifu, David/0000-0003-1600-9387			BROOKE MM, 1992, ARCH PHYS MED REHAB, V73, P320, DOI 10.1016/0003-9993(92)90003-F; CARDENAS DD, 1992, PHYS MED REH CLIN N, V3, P273; CASSIDY JW, 1990, NEUROBEHAVIOURAL SEQUELAE OF TRAUMATIC BRAIN INJURY, P219; Chandler M C, 1988, Brain Inj, V2, P309; Cifu D X, 1993, Arch Phys Med Rehabil, V74, pS406; CORRIGAN JD, 1989, J CLIN EXP NEUROPSYC, V11, P261, DOI 10.1080/01688638908400888; EDLUND MJ, 1991, INT J PSYCHIAT MED, V21, P173, DOI 10.2190/Q21D-EWW7-53EJ-FUC6; ELLIOTT FA, 1977, ANN NEUROL, V1, P489, DOI 10.1002/ana.410010516; FAUMAN MA, 1978, JAMA-J AM MED ASSOC, V240, P380, DOI 10.1001/jama.240.4.380; Frankowski R F, 1986, Adv Psychosom Med, V16, P153; FRANKOWSKI RF, 1985, CNS TRAUMA STATUS RE, V109, P33; GREENDYKE RM, 1986, J NERV MENT DIS, V174, P290, DOI 10.1097/00005053-198605000-00005; GUALTIERI CT, 1991, NEUROPSYCHIATRY BEHA, P37; Herbel K, 1990, Rehabil Nurs, V15, P66; JACKSON RD, 1985, ARCH PHYS MED REHAB, V66, P180; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; Levine A M, 1988, Brain Inj, V2, P165, DOI 10.3109/02699058809150940; LUDWIG BI, 1989, J NEUROL REHABIL, V3, P147; MYSIW WJ, 1988, AM J PHYS MED REHAB, V67, P29, DOI 10.1097/00002060-198802000-00006; OSHANICK GJ, 1988, PSYCHIATRY, P61; Patterson T S, 1990, Rehabil Nurs, V15, P248; PINNER E, 1988, AM J PSYCHIAT, V145, P1295; RATEY JJ, 1993, PSYCHOPHARMACOL BULL, V29, P65; REYES RL, 1981, ARCH PHYS MED REHAB, V62, P20; SCHNEIDER LS, 1992, PSYCHOPHARMACOL BULL, V28, P71; SCHROEDER JA, 1994, ANESTHESIA ANALGESIA, V78, P59; SIMPSON DM, 1986, J CLIN PSYCHIAT, V47, P191; SLAGLE DA, 1990, INT J PSYCHIAT MED, V20, P1, DOI 10.2190/BE6W-DCY1-V71N-N7J7; *STAT CONN DEP PUB, NURS HOM FAC 1994 19, P1; TESAR GE, 1993, HOSP COMMUNITY PSYCH, V44, P329; VANWOERKOM TCAM, 1977, LANCET, V1, P812; WILLIAMS, 1990, REHABILITATION NURSI, V15, P30; ZASLER N D, 1992, Brain Injury, V6, P1, DOI 10.3109/02699059209008117	33	16	16	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	APR	1996	10	4					241	245		10.1080/026990596124412			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	UJ541	WOS:A1996UJ54100001	9044689				2022-02-06	
J	Horner, PJ; Reier, PJ; Stokes, BT				Horner, PJ; Reier, PJ; Stokes, BT			Quantitative analysis of vascularization and cytochrome oxidase following fetal transplantation in the contused rat spinal cord	JOURNAL OF COMPARATIVE NEUROLOGY			English	Article						angiogenesis; graft; metabolism; spinal cord injury; image analysis	FIBROBLAST GROWTH-FACTOR; BLOOD-BRAIN-BARRIER; ADULT-RATS; FUNCTIONAL-ACTIVITY; METABOLIC-ACTIVITY; NEURONAL-ACTIVITY; GRAFTS; INJURY; ANGIOGENESIS; SURVIVAL	In the normal adult central nervous system, a coupling between energy consumption and vascular density is well established. Likewise, the survival of fetal neural tissue grafts is highly dependent on the establishment of functional vascular integration with the host. However, to what degree graft vascularization and tissue metabolism influence the normal host response to traumatic injury has not been extensively studied. In the present report, embryonic day 14 fetal spinal cord suspension grafts were made into the lesion epicenter of subchronic (10 days) contusion-injured rats. Three months later, intraspinal transplants were analyzed using correlative cytochrome oxidase histochemistry and vascular morphometric analysis. The same approaches were applied to the host spinal cord and injured, non-transplanted animals in order to determine the ability of a graft to alter the level of post-injury vascularization and/or metabolism. In general, graft vascular density was increased over that measured in normal or injured gray matter. Vascular density in gray matter near the host/graft interface was markedly increased when compared to either gray matter of the same spinal level in injured non-grafted animals or normal control spinal gray matter. Vascular changes were not noted in gray matter 3 mm distal to the lesion epicenter (rostral or caudal) in all groups analyzed. Cytochrome oxidase was up-regulated at this time in the graft and gray matter at the host/graft interfaces when compared to either gray matter of the same spinal level in injured, non-grafted animals or that of uninjured controls. These data indicate that an intraspinal transplant placed into the contused adult rat spinal cord reaches a metabolic capacity that is likely to be associated with high levels of oxidative metabolism in the well-vascularized graft neuropil. In addition, transplantation chronically alters vascularization and metabolic patterns of adjacent spinal gray matter following contusion injury. (C) 1996 Wiley-Liss, Inc.	UNIV FLORIDA, COLL MED, DEPT NEUROSCI, GAINESVILLE, FL 32610 USA; UNIV FLORIDA, COLL MED, DEPT NEUROL SURG, GAINESVILLE, FL 32610 USA		Horner, PJ (corresponding author), OHIO STATE UNIV, COLL MED, DEPT PHYSIOL, 302 HAMILTON HALL, 1645 NEIL AVE, COLUMBUS, OH 43212 USA.		Horner, Philip J./AAF-7012-2021				ADAIR TH, 1990, AM J PHYSIOL, V259, pR393, DOI 10.1152/ajpregu.1990.259.3.R393; BEHRMANN DL, 1992, J NEUROTRAUM, V9, P197, DOI 10.1089/neu.1992.9.197; BJORKLUND A, 1983, ACTA PHYSIOL SCAND, P1; BLACK JE, 1991, EXP NEUROL, V111, P204, DOI 10.1016/0014-4886(91)90008-Z; BLIGHT AR, 1991, J NEUROL SCI, V106, P158, DOI 10.1016/0022-510X(91)90253-4; BROADWELL RD, 1994, MICROSC RES TECHNIQ, V27, P471, DOI 10.1002/jemt.1070270603; BROADWELL RD, 1991, EXP NEUROL, V112, P1, DOI 10.1016/0014-4886(91)90110-X; BROADWELL RD, 1990, PROG BRAIN RES, V82, P95; CHALMERS GR, 1992, BRAIN RES, V570, P1, DOI 10.1016/0006-8993(92)90556-O; DIROCCO RJ, 1989, COMPUT MED IMAG GRAP, V13, P81, DOI 10.1016/0895-6111(89)90080-3; DUAN WM, 1993, NEUROSCIENCE, V57, P261, DOI 10.1016/0306-4522(93)90061-J; DUNNETT SJ, 1992, NEURAL TRANSPLANTATI, P57; DYSON SE, 1988, J NEUROSCI, V8, P1822; EBNER FF, 1989, P NATL ACAD SCI USA, V86, P730, DOI 10.1073/pnas.86.2.730; GAGE FH, 1986, NEUROSCIENCE, V17, P89, DOI 10.1016/0306-4522(86)90227-7; GOLDBERGER ME, 1993, EXP NEUROL, V123, P74, DOI 10.1006/exnr.1993.1141; GROSS PM, 1987, J CEREBR BLOOD F MET, V7, P154, DOI 10.1038/jcbfm.1987.38; HEVNER RF, 1990, J NEUROSCI, V10, P1331; HORNER P J, 1991, Society for Neuroscience Abstracts, V17, P235; HORNER PJ, 1993, NEURONAL TRANSPLANTA, P119; HOULE JD, 1989, NEUROSCI LETT, V103, P253, DOI 10.1016/0304-3940(89)90108-0; JAKEMAN LB, 1989, EXP NEUROL, V103, P17, DOI 10.1016/0014-4886(89)90181-7; JAKEMAN LB, 1991, J COMP NEUROL, V307, P311, DOI 10.1002/cne.903070211; JENSEN JA, 1986, LAB INVEST, V54, P574; KELLY PAT, 1985, EXP BRAIN RES, V58, P570; KNIGHTON DR, 1983, SCIENCE, V221, P1283, DOI 10.1126/science.6612342; KOSHINAGA M, 1993, EXP NEUROL, V120, P32, DOI 10.1006/exnr.1993.1038; KRUM JM, 1988, J COMP NEUROL, V271, P331, DOI 10.1002/cne.902710304; KUGLER P, 1988, HISTOCHEMISTRY, V89, P269, DOI 10.1007/BF00493151; LAWRENCE JM, 1990, NEUROSCIENCE, V37, P431, DOI 10.1016/0306-4522(90)90413-X; LAWRENCE JM, 1984, NEUROSCIENCE, V12, P745, DOI 10.1016/0306-4522(84)90167-2; LU SY, 1991, EXP NEUROL, V113, P109, DOI 10.1016/0014-4886(91)90168-C; MEININGER CJ, 1988, AM J PHYSIOL, V255, pH554, DOI 10.1152/ajpheart.1988.255.3.H554; MUFSON EJ, 1987, BRAIN RES, V401, P162, DOI 10.1016/0006-8993(87)91177-2; NEEDELS DL, 1986, NEUROSCIENCE, V18, P517, DOI 10.1016/0306-4522(86)90055-2; NIETOSAMPEDRO M, 1987, ANN NY ACAD SCI, V495, P108, DOI 10.1111/j.1749-6632.1987.tb23670.x; NOBLE LJ, 1990, J COMP NEUROL, V296, P674, DOI 10.1002/cne.902960411; RISAU W, 1988, EMBO J, V7, P959, DOI 10.1002/j.1460-2075.1988.tb02901.x; ROSENSTEIN JM, 1993, EXP NEUROL, V124, P208, DOI 10.1006/exnr.1993.1191; SCHMIDT RH, 1982, J NEUROCHEM, V38, P737, DOI 10.1111/j.1471-4159.1982.tb08693.x; SCHMIDT RH, 1983, NERVE ORGAN TISSUE R, P325; SHARKEY J, 1991, NEUROSCIENCE, V41, P703, DOI 10.1016/0306-4522(91)90361-Q; SHARP FR, 1984, NEUROLOGY, V34, P1305, DOI 10.1212/WNL.34.10.1305; SLOAN DJ, 1991, TRENDS NEUROSCI, V14, P341, DOI 10.1016/0166-2236(91)90159-R; Stahl W L, 1986, Adv Neurol, V44, P681; STOKES B T, 1990, Society for Neuroscience Abstracts, V16, P37; STOKES BT, 1992, EXP NEUROL, V116, P1, DOI 10.1016/0014-4886(92)90171-L; STOKES BT, 1992, J NEUROTRAUM, V9, P129, DOI 10.1089/neu.1992.9.129; STOKES BT, 1991, EXP NEUROL, V111, P312, DOI 10.1016/0014-4886(91)90098-W; STOKES BT, 1990, ADV EXP MED BIOL, V277, P363; SWEETNAM PM, 1991, J NEUROCHEM, V57, P237, DOI 10.1111/j.1471-4159.1991.tb02121.x; TESSLER A, 1988, J COMP NEUROL, V270, P537, DOI 10.1002/cne.902700407; TESSLER A, 1988, PROG BRAIN RES, V78, P213; TVETEN L, 1976, ACTA RADIOL DIAGN, V17, P385, DOI 10.1177/028418517601700401; VANRAAMSDONK W, 1987, ACTA HISTOCHEM, V81, P129, DOI 10.1016/S0065-1281(87)80001-6; WEIBEL ER, 1979, STEREOLOGICAL METHOD; WILBANKS GA, 1992, EUR J IMMUNOL, V22, P1031, DOI 10.1002/eji.1830220423; WONGRILEY MTT, 1989, TRENDS NEUROSCI, V12, P94, DOI 10.1016/0166-2236(89)90165-3; WONGRILEY MTT, 1986, J COMP NEUROL, V245, P41, DOI 10.1002/cne.902450104; WONGRILEY MTT, 1981, ANN OTO RHINOL LARYN, V90, P30, DOI 10.1177/00034894810902S211; ZHOU CF, 1986, NEUROSCIENCE, V17, P803, DOI 10.1016/0306-4522(86)90046-1	61	16	16	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9967	1096-9861		J COMP NEUROL	J. Comp. Neurol.	JAN 22	1996	364	4					690	703		10.1002/(SICI)1096-9861(19960122)364:4<690::AID-CNE7>3.0.CO;2-Z			14	Neurosciences; Zoology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Zoology	TT583	WOS:A1996TT58300007	8821455				2022-02-06	
J	Gil, M; Cohen, M; Korn, C; Groswasser, Z				Gil, M; Cohen, M; Korn, C; Groswasser, Z			Vocational outcome of aphasic patients following severe traumatic brain injury	BRAIN INJURY			English	Article							SEVERE HEAD-INJURY; SOCIAL-ADJUSTMENT; REHABILITATION; RECOVERY	The incidence and course of aphasia, and its impact on vocational outcome, were determined in a group of 351 patients with severe traumatic brain injury (TBI). Aphasia was found in 11.1%, the common forms being amnestic (56%, 22/39), expressive (10.3%, 4/39) and receptive (10.5%, 8/39), as found on the first language assessment. No age difference was found between the aphasic and non-aphasic patients. Coma was more common in the aphasics than the non-aphasics (95% and 82%, respectively), although its mean duration was shorter. Aphasics had more severe locomotor deficits (p < 0.01, Fisher test) and tended towards more severe cognitive disorders (p = 0.07, Fisher test). There was no difference between the groups in incidence of behavioural disturbances or occupational outcome. Most of the aphasic patients improved after therapy, and two recovered completely. The presence of aphasia did not have negative prognostic implications for occupational outcome.	LOEWENSTEIN HOSP & REHABIL CTR,DEPT TRAUMAT BRAIN INJURY REHABIL,IL-43100 RAANANA,ISRAEL; TEL AVIV UNIV,SACKLER FAC MED,IL-69978 TEL AVIV,ISRAEL		Gil, M (corresponding author), LOEWENSTEIN HOSP & REHABIL CTR,DEPT SPEECH & LANGUAGE PATHOL,278 ACHUZA ST,POB 3,IL-43100 RAANANA,ISRAEL.						ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; BENSON DF, 1979, APHASIA ALEXIA AGRAP, P189; CRANBERG LD, 1987, NEUROLOGY, V37, P1165, DOI 10.1212/WNL.37.7.1165; DEJERINE J, 1914, REV NEUROL, V2, P388; EISENSON J, 1964, ADULT APHASIA ASSESS; Goodglass H, 1983, ASSESSMENT APHASIA R; GROSWASSER Z, 1977, SCAND J REHABIL MED, V9, P147; HEILMAN KM, 1971, J NEUROL NEUROSUR PS, V34, P265, DOI 10.1136/jnnp.34.3.265; KERTESZ A, 1977, BRAIN, V100, P1, DOI 10.1093/brain/100.1.1; Kertesz A., 1982, W APHASIA BATTERY; LECOURS AR, 1983, APHASIOLOGY, P446; LENNENBERG E, 1967, BIOL F LANGUAGE; LEVIN HS, 1976, J NEUROL NEUROSUR PS, V39, P1062, DOI 10.1136/jnnp.39.11.1062; Luria A.R., 1970, TRAUMATIC APHASIA; NAJENSON T, 1975, SCAND J REHABIL MED, V7, P101; NAJENSON T, 1978, SCAND J REHABIL MED, V10, P15; NAJENSON T, 1974, SCAND J REHABIL MED, V6, P5; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Penn C, 1988, Brain Inj, V2, P3, DOI 10.3109/02699058809150928; PRIGATANO GP, 1984, J NEUROL NEUROSUR PS, V47, P505, DOI 10.1136/jnnp.47.5.505; RAO N, 1990, Brain Injury, V4, P49, DOI 10.3109/02699059009026148; ROSENTHAL M, 1990, REHABILITATION ADULT; SATZ P, 1981, ACQUIRED APHASIA, P399; TATE RL, 1989, J NEUROL NEUROSUR PS, V52, P1128, DOI 10.1136/jnnp.52.10.1128; TAYLORSARNO M, 1981, ACQUIRED APHASIA, P496; TAYLORSARNO M, 1986, ARCH PHYSICAL MED RE, V76, P400; THOMSEN IV, 1984, J NEUROL NEUROSUR PS, V47, P260, DOI 10.1136/jnnp.47.3.260; WEDDELL R, 1980, PSYCHOL MED, V10, P257, DOI 10.1017/S0033291700044019; WINGFIELD A, 1966, IDENTIFICATION NAMIN; WYCKOFF LH, 1984, THESIS U FLORIDA	30	16	20	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1996	10	1					39	45		10.1080/026990596124700			7	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	TY049	WOS:A1996TY04900004	8680391				2022-02-06	
J	NILSSON, F; MESSETER, K; GRANDE, PO; ROSEN, I; RYDING, E; NORDSTROM, CH				NILSSON, F; MESSETER, K; GRANDE, PO; ROSEN, I; RYDING, E; NORDSTROM, CH			EFFECTS OF DIHYDROERGOTAMINE ON CEREBRAL-CIRCULATION DURING EXPERIMENTAL INTRACRANIAL HYPERTENSION	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article						INTRACRANIAL HYPERTENSION; CEREBRAL BLOOD FLOW; EXTRADURAL MASS; DIHYDROERGOTAMINE; EEG; PIG	SEVERE HEAD-INJURY; TRAUMATIC BRAIN-LESIONS; BLOOD-FLOW; CLINICAL-TRIAL; ERGOTAMINE; PRESSURE; VASOREACTIVITY; DEXAMETHASONE; RESISTANCE; HEMATOMA	Different cerebral vasoconstrictors have recently been suggested for the treatment of raised intracranial pressure (ICP) in patients with severe traumatic brain lesions. Such treatment may be associated with severe side effects. A porcine model simulating an intracranial mass lesion was utilized to examine the haemodynamic cerebral effects of dihydroergotamine (DHE), a recently introduced pharmacological treatment for raised intracranial pressure. Intracranial hypertension was induced by inflation of two tonometric gastric balloons placed extradurally covering the parieto-occipital region bilaterally. The animals were randomized into one group with six animals receiving 1.0 mg of DHE i.v. followed by a continuous infusion of 0.2 mg/h (high dose) and another group of six animals receiving 0.15 mg i.v. followed by 0.03 mg/h (low dose). Measurements of cerebral blood flow (CBF) and arterio-venous difference in oxygen content (Cavo(2)) were performed 5, 20, and 60 min after the DHE infusion. Intracranial pressure (ICP), mean arterial blood pressure (MAP) and cerebral electrical activity (EEG) were recorded continuously In both groups infusion of DHE caused a lasting decrease in ICP probably achieved mainly by a decrease in cerebral blood volume due to constriction of both arterial and venous capacitance vessels. In the group treated with high-dose DHE, but not in that given low-dose DHE, a progressive increase in Cavo(2), a fall in jugular venous pH and an increase in EEG delta activity were observed indicating cerebral hypoxia. The study supports the view that DHE may be a valuable tool in the pharmacological treatment of increased ICP in traumatic brain lesions but underscores the importance of a proper dosage.	UNIV LUND HOSP,DEPT ANAESTHESIA & INTENS CARE,S-22185 LUND,SWEDEN; UNIV LUND HOSP,DEPT CLIN NEUROPHYSIOL,S-22185 LUND,SWEDEN; UNIV LUND HOSP,DEPT NEUROSURG,S-22185 LUND,SWEDEN		NILSSON, F (corresponding author), LUND UNIV,MALMO GEN HOSP,DEPT ANAESTHESIA & INTENS CARE,S-21401 MALMO,SWEDEN.						AKESON J, 1992, ACTA ANAESTH SCAND, V36, P419, DOI 10.1111/j.1399-6576.1992.tb03491.x; ALBRECHT RF, 1987, STROKE, V18, P649, DOI 10.1161/01.STR.18.3.649; ANDERSEN AR, 1987, STROKE, V18, P120, DOI 10.1161/01.STR.18.1.120; ASGEIRSSON B, 1994, INTENS CARE MED, V20, P260, DOI 10.1007/BF01708961; BRAAKMAN R, 1983, J NEUROSURG, V58, P326, DOI 10.3171/jns.1983.58.3.0326; COLD GE, 1978, ACTA ANAESTH SCAND, V22, P270, DOI 10.1111/j.1399-6576.1978.tb01301.x; COOPER PR, 1979, J NEUROSURG, V51, P307, DOI 10.3171/jns.1979.51.3.0307; DEARDEN NM, 1986, J NEUROSURG, V64, P81, DOI 10.3171/jns.1986.64.1.0081; GLUSA E, 1988, ARCH INT PHARMACOD T, V296, P66; GORDON E, 1971, ACTA ANAESTH SCAND, V15, P193, DOI 10.1111/j.1399-6576.1971.tb05461.x; GRANDE PO, 1990, INTENS CARE MED, V16, P399, DOI 10.1007/BF01735179; GRANDE PO, 1989, INTENS CARE MED, V15, P523, DOI 10.1007/BF00273564; GRANDE PO, 1993, RECENT ADVANCES IN NEUROTRAUMATOLOGY, P319; GUDEMAN SK, 1979, J NEUROSURG, V51, P301, DOI 10.3171/jns.1979.51.3.0301; HACHINSKI V, 1978, STROKE, V9, P594, DOI 10.1161/01.STR.9.6.594; KAUFMAN AM, 1992, J NEUROSURG, V77, P854; KUSHINSKY W, 1982, ADV MICROCIRCULAT, V11, P1; LUNDBERG N, 1959, ACTA PSYCHIAT N S139, V34; MARSHALL LF, 1978, J NEUROSURG, V48, P169, DOI 10.3171/jns.1978.48.2.0169; MELLANDER S, 1970, CLIN SCI, V39, P183, DOI 10.1042/cs0390183; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; MILLER JD, 1977, J NEUROSURG, V47, P503, DOI 10.3171/jns.1977.47.4.0503; MUIZELAAR JP, 1984, J NEUROSURG, V61, P700, DOI 10.3171/jns.1984.61.4.0700; MULLER H, 1988, PHARMACOLOGY, V37, P248, DOI 10.1159/000138473; MULLERSCHWEINIT.E, 1983, GEN PHARMACOL, V14, P95; NILSSON B, 1976, THESIS LUND; NILSSON F, 1995, ACTA ANAESTH SCAND, V39, P827, DOI 10.1111/j.1399-6576.1995.tb04179.x; NORDSTROM CH, 1988, J NEUROSURG, V68, P424, DOI 10.3171/jns.1988.68.3.0424; ROQUEBERT J, 1986, ARCH INT PHARMACOD T, V284, P30; ROSSANDA M, 1968, SCAN J CLIN LAB IN S, V102, pR13; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; SCHALEN W, 1991, ACTA ANAESTH SCAND, V35, P113, DOI 10.1111/j.1399-6576.1991.tb03258.x; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; SHORBOUGH FW, 1973, STROKE, V4, P674	34	16	16	0	0	MUNKSGAARD INT PUBL LTD	COPENHAGEN	35 NORRE SOGADE, PO BOX 2148, DK-1016 COPENHAGEN, DENMARK	0001-5172			ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	OCT	1995	39	7					916	921		10.1111/j.1399-6576.1995.tb04198.x			6	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	RX864	WOS:A1995RX86400011	8848892				2022-02-06	
J	SMITH, DH; GENNARELLI, TA; MCINTOSH, TK				SMITH, DH; GENNARELLI, TA; MCINTOSH, TK			THE POTENTIAL OF 21-AMINOSTEROIDS (LAZAROIDS) AS NEUROPROTECTIVE THERAPIES IN CNS INJURY	CNS DRUGS			English	Article							SPINAL-CORD INJURY; LIPID-PEROXIDATION; TIRILAZAD MESYLATE; CEREBRAL EDEMA; BRAIN INJURY; VITAMIN-E; U74006F; ISCHEMIA; METHYLPREDNISOLONE; RECOVERY	Following injury to the CNS, highly reactive free radicals may produce secondary or delayed tissue damage via peroxidation of lipids in cellular membranes. This extensive generation of free radicals appears to overwhelm natural defence mechanisms, dramatically reducing the levels of endogenous antioxidant compounds. In numerous studies utilising models of CNS injury, treatment with a synthetic antioxidant, the nongrlucocorticoid 21-aminosteroid (lazaroid) tirilazad, has been shown to maintain the level of endogenous antioxidants, improve neurological outcome, decrease cell loss, reduce cerebral oedema formation and improve survival. As a result of these encouraging results, clinical trials have been initiated to evaluate the utility of tirilazad in the treatment of subarachnoid haemorrhage, spinal cord injury, traumatic brain injury and stroke.			SMITH, DH (corresponding author), UNIV PENN,DIV NEUROSURG,240 S 33RD ST,SUITE 105,PHILADELPHIA,PA 19104, USA.		smith, douglas/A-1321-2007				ALTHAUS J S, 1991, Society for Neuroscience Abstracts, V17, P164; Anderson D K, 1985, Cent Nerv Syst Trauma, V2, P257; ANDERSON DK, 1986, J NEUROTRAUME, V2, P257; Anderson DK, 1991, J NEUROTRAUM, V8, P187, DOI 10.1089/neu.1991.8.187; AUDUS KL, 1991, FREE RADICAL BIO MED, V11, P361, DOI 10.1016/0891-5849(91)90152-S; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; BRACKEN MB, 1992, J NEUROSURG, V76, P23, DOI 10.3171/jns.1992.76.1.0023; BRAUGHLER J, 1987, J BIOL CHEM, V262, P10434; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V7, P125, DOI 10.1016/0891-5849(89)90003-8; BRAUGHLER JM, 1988, J NEUROSURG, V64, P985; BRAUGHLER JM, 1981, J NEUROSURG, V56, P838; CHAN PH, 1987, ANN NEUROL, V21, P540, DOI 10.1002/ana.410210604; DEMOPOULOS HB, 1980, ACTA PHYSL SCAND S, V492, P91; GUTTERIDGE JMC, 1990, TRENDS BIOCHEM SCI, V15, P129, DOI 10.1016/0968-0004(90)90206-Q; Hall E D, 1986, Cent Nerv Syst Trauma, V3, P281; HALL E D, 1989, Journal of Neurotrauma, V6, P169, DOI 10.1089/neu.1989.6.169; HALL ED, 1985, J NEUROSURG, V62, P882, DOI 10.3171/jns.1985.62.6.0882; HALL ED, 1988, J NEUROSURG, V68, P456, DOI 10.3171/jns.1988.68.3.0456; HALL ED, 1991, STROKE, V22, P361, DOI 10.1161/01.STR.22.3.361; HALLIWELL B, 1992, J NEUROCHEM, V59, P1609, DOI 10.1111/j.1471-4159.1992.tb10990.x; KANAMARU K, 1991, J NEUROSURG, V74, P454, DOI 10.3171/jns.1991.74.3.0454; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; LESIUK H, 1991, STROKE, V22, P896, DOI 10.1161/01.STR.22.7.896; MARUKI Y, 1993, STROKE, V24, P724, DOI 10.1161/01.STR.24.5.724; MCINTOSH TK, 1992, J NEUROTRAUM, V9, P33, DOI 10.1089/neu.1992.9.33; MONYER H, 1990, NEURON, V5, P121, DOI 10.1016/0896-6273(90)90302-V; PERKINS WJ, 1991, STROKE, V22, P902, DOI 10.1161/01.STR.22.7.902; SANADA T, 1993, J NEUROTRAUM, V10, P65, DOI 10.1089/neu.1993.10.65; SATO PH, 1992, J NEUROCHEM, V58, P2263, DOI 10.1111/j.1471-4159.1992.tb10972.x; SHAPIRA Y, 1989, Neurological Research, V11, P169; TORNHEIM PA, 1978, J NEUROSURG, V48, P220, DOI 10.3171/jns.1978.48.2.0220; UMEMURA K, 1994, EUR J PHARMACOL, V251, P69, DOI 10.1016/0014-2999(94)90444-8; YOSHIDA S, 1985, J NEUROCHEM, V44, P1593, DOI 10.1111/j.1471-4159.1985.tb08800.x; ZUCCARELLO M, 1989, J NEUROSURG, V71, P98, DOI 10.3171/jns.1989.71.1.0098	34	16	16	0	0	ADIS INTERNATIONAL LTD	AUCKLAND	41 CENTORIAN DR, PRIVATE BAG 65901, MAIRANGI BAY, AUCKLAND 10, NEW ZEALAND	1172-7047			CNS DRUGS	CNS Drugs	MAR	1995	3	3					159	164		10.2165/00023210-199503030-00001			6	Clinical Neurology; Pharmacology & Pharmacy; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy; Psychiatry	QL201	WOS:A1995QL20100001					2022-02-06	
J	HELLER, KD; FORST, J; FORST, R				HELLER, KD; FORST, J; FORST, R			RECOMMENDATIONS FOR THE TREATMENT OF PERSISTENT POSTERIOR DISLOCATION OF THE SHOULDER - A REVIEW OF THE LITERATURE	UNFALLCHIRURG			German	Article								Three-hundred and twenty-nine cases of posterior dislocation of the shoulder documented in 300 articles published in the international literature are reviewed. They included 130 cases in which the duration of the dislocation was longer than 6 weeks and the dislocation could be classified as persistent primary dislocation. This group is the second largest group following that with acute primary dislocation. The mechanism of injury may be direct or indirect force: trauma, convulsions or electrocution are usually responsible for this type of dislocation, which often persists for longer than 6 weeks. Anatomically, 97.5% of dislocations are classified as subacromial. Posterior dislocation of the shoulder is commonly misdiagnosed on plain antero-posterior radiographs, and in over 50% of cases the diagnosis was missed on first examination. The typical signs of primary traumatic posterior dislocation of the shoulder are described. Management of persistent traumatic posterior dislocation of the shoulder depends on the size of the anterior Hill-Sachs lesion, the precipitating mechanism and the duration of dislocation. The results of 109 surgically and 24 conservatively treated dislocations of this type that have been published in the international literature are reviewed. Closed reduction is indicated in carefully selected cases with an anterior Kill-Sachs lesion under 15% of the size of humeral head (measured in the axillary view) that has been dislocation for less than 2 months. In most due to convulsions there was a distinct anterior Hill-Sachs lesion, which led to recurrence. In 83% of cases of convulsive origin there was a recurrence, whereas in the traumatic group redislocation occurred in 43%. In the group of 109 operative treated shoulders, isolated soft-tissue procedures have not been shown to produce good long-term results. In the case of a small anterior Hill-Sachs lesion, posterior bone block combined with anterior capsulotomy and stripping of the subscapularis muscle, as described by Augereau et al., gave good results in 5 of 6 cases. When a defect of 15-25% of the humeral head is present, subscapularis transposition is indicated. This method gave good or excellent results in 63% of cases seen after a mean follow-up time of 42 months. In 89% of the cases treated with the transposition to the lesser tuberosity as described by Neer the treatment was successful. Alternative treatment options in this group include the use of an autogeneous corticocancellous bone graft to fill the defect (Ahlers and Ritter), combined with a rotational osteotomy of the humerus if necessary. A hemiarthroplasty or total arthroplasty is indicated where these surgical treatments have been unsuccessful and when degenerative arthritis is present.			HELLER, KD (corresponding author), RHEIN WESTFAL TH AACHEN,FAK MED,ORTHOPAD KLIN,PAUWELSSTR 30,D-52057 AACHEN,GERMANY.			Forst, Jurgen/0000-0002-8447-3993				0	16	16	0	2	SPRINGER VERLAG	NEW YORK	175 FIFTH AVE, NEW YORK, NY 10010	0177-5537			UNFALLCHIRURG	Unfallchirurg	JAN	1995	98	1					6	12					7	Emergency Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine; Surgery	QD254	WOS:A1995QD25400002	7886466				2022-02-06	
J	TURKSTRA, LS				TURKSTRA, LS			ELECTRODERMAL RESPONSE AND OUTCOME FROM SEVERE BRAIN INJURY	BRAIN INJURY			English	Article							PERSISTENT VEGETATIVE STATE; CLOSED-HEAD-INJURY; ORIENTING RESPONSE; SCORING CRITERIA; TRAUMATIC COMA; FOLLOW-UP; RECOVERY; HABITUATION; ATTENTION; EMOTION	The relation of electrodermal response measures to outcome from early post-traumatic vegetative state (VS) was investigated in 15 brain-injured and five control subjects. Brain-injured subjects were in acute VS or persistent VS (PVS), or had recovered from acute VS (RVS). Significant group differences were found on all electrodermal response measures, primarily due to the greater amplitude, number and consistency of responses in control subjects. Group differences in electrodermal habituation and orientation to auditory tones reflected the absence of orientation in most RVS subjects and the absence of both habituation and orientation PVS subjects. The groups differed in their response to matching fades and names. All of the control subjects, two of five RVS subjects and none of five acute subjects produced significant responses. Surprisingly, two PVS subjects also produced significant responses. For acute subjects a positive outcome at 6 months post-trauma was associated with early electrodermal startle amplitude and baseline lability. These results indicate that electrodermal responsiveness is generally reduced following acute VS, even in subjects with a relatively good recovery. Greater electrodermal activity in early VS may be associated with better potential for recovery.			TURKSTRA, LS (corresponding author), UNIV ARIZONA, NATL CTR NEUROGEN COMMUN DISORDERS, BLDG 71, TUCSON, AZ 85721 USA.		Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NIDCD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Deafness & Other Communication Disorders (NIDCD) [DC-00030] Funding Source: Medline; ODCDC CDC HHS [CD-01409] Funding Source: Medline		ADHOUTE H, 1992, PHOTODERMATOL PHOTO, V9, P99; ANDERSON NB, 1991, PSYCHOL ASSESSMENT J, V3, P376, DOI DOI 10.1037/1040-3590.3.3.376; ANDREASSI JL, 1989, PSYCHOPHYSIOLOGY HUM; ANSELL BJ, 1991, J SPEECH HEAR RES, V34, P1017, DOI 10.1044/jshr.3405.1017; ARTS WFM, 1985, J NEUROL NEUROSUR PS, V48, P1300, DOI 10.1136/jnnp.48.12.1300; BARRY RJ, 1990, PSYCHOPHYSIOLOGY, V27, P94, DOI 10.1111/j.1469-8986.1990.tb02185.x; BAUER RM, 1984, NEUROPSYCHOLOGIA, V22, P457, DOI 10.1016/0028-3932(84)90040-X; BIRO V, 1989, ACTIV NERV SUPER, V31, P166; BRICOLO A, 1980, J NEUROSURG, V52, P625, DOI 10.3171/jns.1980.52.5.0625; CHILDS NL, 1993, NEUROLOGY, V43, P1465, DOI 10.1212/WNL.43.8.1465; COHADON F, 1983, BIRTH DEFECTS-ORIG, V19, P375; CRANFORD RE, 1988, HASTINGS CTR REP FEB, P27; DAVIDSON RA, 1992, NEUROPSYCHOLOGIA, V30, P1053, DOI 10.1016/0028-3932(92)90098-7; DEJONG RN, 1985, CLIN NEUROLOGY, V1, P1; Edelberg R., 1972, HDB PSYCHOPHYSIOLOGY, V12, P1011; FOWLES DC, 1981, PSYCHOPHYSIOLOGY, V18, P232, DOI 10.1111/j.1469-8986.1981.tb03024.x; FRUTIGER A, 1991, J TRAUMA, V31, P1216, DOI 10.1097/00005373-199109000-00004; Gronwall D, 1989, MILD HEAD INJURY, P153; HAGEN C, 1984, LANGUAGE DISORDERS A; HAIG AJ, 1990, ARCH PHYS MED REHAB, V71, P1081; HEILMAN KM, 1987, HDB PHYSL 1, V5, P461; HIGASHI K, 1977, J NEUROL NEUROSUR PS, V40, P876, DOI 10.1136/jnnp.40.9.876; HIGASHI K, 1981, J NEUROL NEUROSUR PS, V44, P552, DOI 10.1136/jnnp.44.6.552; JENNETT B, 1972, LANCET, V1, P734; JENNETT B, 1975, LANCET, V1, P480; KEPPELL G, 1982, DESIGN ANAL RES HDB; KIMBLE DP, 1965, NEUROPSYCHOLOGIA, V3, P121, DOI 10.1016/0028-3932(65)90038-2; LACY J, 1958, BRAIN HUM BEHAV, P144; LANG PJ, 1990, PSYCHOL REV, V97, P377, DOI 10.1037/0033-295X.97.3.377; LANG PJ, 1992, PSYCHOL SCI, V3, P44, DOI 10.1111/j.1467-9280.1992.tb00255.x; LAPUMA J, 1988, ARCH NEUROL-CHICAGO, V45, P20; LEHRER PM, 1989, PSYCHOPHYSIOLOGY, V26, P668, DOI 10.1111/j.1469-8986.1989.tb03169.x; LEVIN H, 1982, BEHAVIOURAL SEQUELAE; LEVIN HS, 1991, ARCH NEUROL-CHICAGO, V48, P580, DOI 10.1001/archneur.1991.00530180032013; LEVINSON DF, 1985, PSYCHOPHYSIOLOGY, V22, P417, DOI 10.1111/j.1469-8986.1985.tb01626.x; MOLINARI GF, 1991, J NEUROL SCI, V102, P125, DOI 10.1016/0022-510X(91)90059-G; MORROW L, 1981, NEUROPSYCHOLOGIA, V19, P65, DOI 10.1016/0028-3932(81)90045-2; OKSENBERG A, 1989, SLEEP 88, P286; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; Rader M.A., 1989, SENSORY STIMULATION; RAPS S P, 1991, Society for Neuroscience Abstracts, V17, P882; ROSENBERG GA, 1977, ANN NEUROL, V2, P167, DOI 10.1002/ana.410020215; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; ROSS DT, UNPUB J NEUROSCIENCE; SAZBON L, 1990, J NEUROSURG, V72, P75, DOI 10.3171/jns.1990.72.1.0075; SAZBON L, 1991, Brain Injury, V5, P3, DOI 10.3109/02699059108998505; SCHURI U, 1979, ARCH PSYCHIAT NERVEN, V227, P143; SOKOLOV EN, 1963, ANNU REV PHYSIOL, V25, P545, DOI 10.1146/annurev.ph.25.030163.002553; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; TRANEL D, 1989, NEUROPSYCHOLOGIA, V27, P381, DOI 10.1016/0028-3932(89)90046-8; van Zomeren AH, 1987, NEUROBEHAVIORAL RECO, P398; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21; VERFAELLIE M, 1991, BRAIN COGNITION, V15, P10, DOI 10.1016/0278-2626(91)90012-W; WATERS WF, 1977, PSYCHOPHYSIOLOGY, V14, P228, DOI 10.1111/j.1469-8986.1977.tb01166.x; WHYTE J, 1986, J HEAD TRAUMA REHAB, V1, P39; WILSON S L, 1991, Brain Injury, V5, P393, DOI 10.3109/02699059109008112; WYATT R, 1969, PSYCHOPHYSIOLOGY, V6, P133, DOI 10.1111/j.1469-8986.1969.tb02892.x; 1993, ANN NEUROL, V33, P388; 1988, NEUROLOGY, V39, P125	59	16	17	0	0	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN	1995	9	1					61	80		10.3109/02699059509004573			20	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	QB052	WOS:A1995QB05200009	7874098				2022-02-06	
J	CALLAHAN, CD; JOHNSTONE, B				CALLAHAN, CD; JOHNSTONE, B			THE CLINICAL UTILITY OF THE REY AUDITORY-VERBAL LEARNING TEST IN MEDICAL REHABILITATION	JOURNAL OF CLINICAL PSYCHOLOGY IN MEDICAL SETTINGS			English	Article						NEUROPSYCHOLOGY; REHABILITATION; COGNITIVE FUNCTIONING; MEMORY	AVLT	Recent research has reported the Rey Auditory-Verbal Learning Test Trial V (RAVLT-V) score to be a sensitive indicator of global cognitive functioning, not merely verbal learning skills. The concurrent validity of the RAVLT-V relative to other neuropsychological measures frequently utilized in medical rehabilitation was investigated in a sample of 64 outpatients diagnosed with traumatic brain injury (TBI). The sample was predominantly male (77%), white (97%), youthful (31.4 +/- 11.5 years), high school educated, and an average of 53 months postinjury. Using stepwise multiple regression analysis, a three-variable model consisting of gender, Wechsler Memory Scale-Revised Delayed Memory Index, and Tarilmaking Part B (time) accounted for 61% of the variance in RAVLT-V scores. These findings suggest that in TBI patients, the RAVLT taps not only specific verbal learning and memory, but also global cognitive functions. Sensitivity to diffuse neuropsychological changes and ease/speed of administration make the RAVLT a valuable tool in medical rehabilitation settings.	UNIV MISSOURI,SCH MED,COLUMBIA,MO		CALLAHAN, CD (corresponding author), MEM MED CTR,CTR NEUROMUSCULAR SCI,800 N RUTLEDGE ST,SPRINGFIELD,IL 62781, USA.			Johnstone, Brick/0000-0001-8845-9649			AUERBACH SH, 1986, J HEAD TRAUMA REHAB, V1, P1, DOI DOI 10.1097/00001199-198609000-00004; BIGLER ED, 1989, J CLIN PSYCHOL, V45, P277, DOI 10.1002/1097-4679(198903)45:2<277::AID-JCLP2270450216>3.0.CO;2-M; Bolla-Wilson K, 1986, DEV NEUROPSYCHOL, V2, P203, DOI 10.1080/87565648609540342; BURTON DB, 1993, ARCH CLIN NEUROPSYCH, V8, P467, DOI 10.1016/0887-6177(93)90047-5; CRAWFORD JR, 1989, J CLIN EXP NEUROPSYC, V11, P975, DOI 10.1080/01688638908400950; DELIS D, 1987, CALIFORNIA VERBAL LE; Franzen M. D., 1989, RELIABILITY VALIDITY; Geffen Gina, 1990, Clin Neuropsychol, V4, P45, DOI 10.1080/13854049008401496; HAUT M, 1992, STATE ART REV PHYSIC; HUPPERT FA, 1991, HDB NEUROPSYCHOLOGY, V4; KREUTZER JS, 1993, J HEAD TRAUMA REHAB, V8, P47; LEZAK MD, 1983, NEUROPSYCHOLOGICAL A; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; QUERY WT, 1983, J CLIN PSYCHOL, V39, P136, DOI 10.1002/1097-4679(198301)39:1<136::AID-JCLP2270390125>3.0.CO;2-Q; REZAI K, 1993, ARCH NEUROL-CHICAGO, V50, P636, DOI 10.1001/archneur.1993.00540060066020; ROSENTHAL M, 1994, TRAUMATIC BRAIN INJU; ROTH DL, 1990, J CLIN EXP NEUROPSYC, V12, P834; RYAN JJ, 1984, INT J CLIN NEUROPSYC, V6, P239; Sohlberg M, 1993, J HEAD TRAUMA REHAB, V8, P45, DOI DOI 10.1097/00001199-199303000-00006; Sohlberg M.M., 1989, INTRO COGNITIVE REHA; Spreen O, 1991, COMPENDIUM NEUROPSYC; UCHIYAMA CL, 1994, ARCH CLIN NEUROPSYCH, V9, P215, DOI 10.1016/0887-6177(94)90027-2; Wolfson, 1988, TRAUMATIC BRAIN INJU, VII	23	16	16	0	5	PLENUM PUBL CORP	NEW YORK	233 SPRING ST, NEW YORK, NY 10013	1068-9583			J CLIN PSYCHOL MED S	J. Clin. Psychol. Med. Settings	SEP	1994	1	3					261	268		10.1007/BF01989627			8	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	QY244	WOS:A1994QY24400008	24227393				2022-02-06	
J	WALKER, AE				WALKER, AE			THE PHYSIOLOGICAL-BASIS OF CONCUSSION - 50 YEARS LATER	JOURNAL OF NEUROSURGERY			English	Article						JOURNAL OF NEUROSURGERY; NEUROSURGICAL HISTORY		In this brief narrative, the author compares what is known today about the physiological basis of concussion with the results of studies described 50 years ago in the Journal of Neurosurgery. The author was a member of the team that originally reported these findings in the first volume of the Journal of Neurosurgery.									BORNSTEIN MB, 1946, J NEUROPHYSIOL, V9, P349, DOI 10.1152/jn.1946.9.5.349; BRICOLO AP, 1990, HDB CLIN NEUROLOGY, V57, P207; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; ESCHUN G, 1992, SURG NEUROL, V37, P101, DOI 10.1016/0090-3019(92)90184-O; FOLTZ EL, 1956, J NEUROSURG, V13, P145, DOI 10.3171/jns.1956.13.2.0145; KOCHER T, 1901, SPECIELLE PATHOLOGIE, V9; MEYER JS, 1955, ELECTROEN CLIN NEURO, V7, P529, DOI 10.1016/0013-4694(55)90078-X; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; OMMAYA AK, 1966, HEAD INJURY, P260; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; TOWER DB, 1948, J CLIN INVEST, V27, P558; VANDENPOL AN, 1990, J COMP NEUROL, V296, P654, DOI 10.1002/cne.902960410; von Haller A, 1753, COMMENTARII SOC REGI, VII, P114; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; WARD AA, 1966, HEAD INJURY C P, P203; WEISEND M P, 1989, Society for Neuroscience Abstracts, V15, P69; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; [No title captured]	18	16	16	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	1994	81	3					493	494		10.3171/jns.1994.81.3.0493			2	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PC762	WOS:A1994PC76200025	8057163				2022-02-06	
J	RUIJS, MBM; GABREELS, FJM; THIJSSEN, HOM				RUIJS, MBM; GABREELS, FJM; THIJSSEN, HOM			THE UTILITY OF ELECTROENCEPHALOGRAPHY AND CEREBRAL COMPUTED-TOMOGRAPHY IN CHILDREN WITH MILD AND MODERATELY SEVERE CLOSED-HEAD INJURIES	NEUROPEDIATRICS			English	Article						CLOSED HEAD INJURY; COMA; COMPUTED TOMOGRAPHY; ELECTROENCEPHALOGRAPHY; POSTTRAUMATIC AMNESIA	INTRAVENTRICULAR HEMORRHAGE; TRAUMA	The utility of electroencephalography and computed tomography has been studied in a prospective follow-up study of 54 children with mild and moderately severe closed head injuries. EEG and CT scan were recorded in the acute phase. Furthermore the duration of coma and of post-traumatic amnesia were registrated. During a two years follow up period the presence of residual disorders in various faculties was evaluated at fixed time intervals after discharge. The data have been subjected to correlation analyses to study the relation of EEG and CT scan findings with the severity of the trauma and with the occurrence of long-term sequelae. Both the EEG and the CT scan abnormalities are found to correlate appreciably with the degree of severity and with the occurrence of, in particular, long-term sequelae in the fields of neurological disturbances and school performance. It is concluded that EEG and CT are useful diagnostic tools in children with mild and moderately severe closed head injuries.	UNIV HOSP NIJMEGEN,DEPT CLIN NEUROPHYSIOL,6500 HB NIJMEGEN,NETHERLANDS; UNIV HOSP NIJMEGEN,DEPT CHILD NEUROL,6500 HB NIJMEGEN,NETHERLANDS; UNIV HOSP NIJMEGEN,DEPT NEURORADIOL,6500 HB NIJMEGEN,NETHERLANDS		RUIJS, MBM (corresponding author), UNIV HOSP NIJMEGEN,INST NEUROL,POB 9101,6500 HB NIJMEGEN,NETHERLANDS.						BLUME WT, 1982, ATLAS PEDIATRIC ELEC; Bricolo A, 1979, Acta Neurochir Suppl (Wien), V28, P35; ESPERSEN JO, 1982, ACTA NEUROCHIR, V65, P81, DOI 10.1007/BF01405444; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1983, MANAGEMENT HEAD INJU; KELLAWAY P, 1955, ELECTROEN CLIN NEURO, V7, P497; KLONOFF H, 1977, J NEUROL NEUROSUR PS, V40, P1211, DOI 10.1136/jnnp.40.12.1211; KOUFEN H, 1977, EEG-EMG-Z ELEK ELEKT, V8, P29; LANDAUFEREY J, 1980, ELECTROEN CLIN NEURO, V49, P173, DOI 10.1016/0013-4694(80)90364-8; LEE JP, 1991, ACTA NEUROL SCAND, V84, P85, DOI 10.1111/j.1600-0404.1991.tb04913.x; LEROUX PD, 1992, NEUROSURGERY, V31, P678, DOI 10.1227/00006123-199210000-00010; MARSHALL LF, 1985, NEUROSURGERY, P1605; MENKES JH, 1980, TXB CLIN NEUROLOGY; MERINODEVILLASANTE J, 1976, AM J ROENTGENOL, V126, P765, DOI 10.2214/ajr.126.4.765; MINDERHOUD JM, 1984, TRAUMATISCHE HERSENL; MIZRAHI EM, 1984, PEDIATRICS, V73, P419; Niedermeyer E, 1993, ELECTROENCEPHALOGRAP; Ogawa T, 1992, Acta Neurochir Suppl (Wien), V55, P8; Posner JB., 1980, DIAGNOSIS STUPOR COM, V3; RUIJS MBM, 1992, DEV MED CHILD NEUROL, V34, P885; RUIJS MBM, 1990, CLIN NEUROL NEUROSUR, V92, P323, DOI 10.1016/0303-8467(90)90058-D; RUIJS MBM, 1993, EUR J PEDIATR, V152, P844, DOI 10.1007/BF02073384; RUMPL E, 1979, ELECTROEN CLIN NEURO, V46, P487, DOI 10.1016/0013-4694(79)90002-6; RUSSELL WR, 1971, TRAUMATIC AMNESIA; SHAPIRO K, 1983, PEDIATRIC HEAD TRAUM; SINGER HS, 1978, PEDIATRICS, V62, P819; SNOEK J, 1979, J NEUROL NEUROSUR PS, V42, P25; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004	29	16	16	0	1	HIPPOKRATES VERLAG GMBH	STITTGART	PO BOX 30 05 04 RUDIGERSTRASSE 14, 70469 STITTGART, GERMANY	0174-304X			NEUROPEDIATRICS	Neuropediatrics	APR	1994	25	2					73	77		10.1055/s-2008-1071589			5	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	NQ679	WOS:A1994NQ67900003	8072678				2022-02-06	
J	SALZMAN, SK; KELLY, G; CHAVIN, J; WANG, L; PUNIAK, MA; AGRESTA, CA; AZIM, S				SALZMAN, SK; KELLY, G; CHAVIN, J; WANG, L; PUNIAK, MA; AGRESTA, CA; AZIM, S			CHARACTERIZATION OF MIANSERIN NEUROPROTECTION IN EXPERIMENTAL SPINAL TRAUMA - DOSE/ROUTE RESPONSE AND LATE TREATMENT	JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS			English	Article							SEROTONIN RECEPTORS; 5-HT1C RECEPTOR; BINDING-SITES; RAT-BRAIN; CORD; 5-HYDROXYTRYPTAMINE; INJURY; CORTEX; DAMAGE; TRH	The neuroprotective action of the 5-hydroxytryptamine (5-HT2/5-HT1C) antagonist mianserin was examined with respect to optimal dosage, route of administration and time of treatment after a moderate spinal impact trauma (50 g.cm by the weight-drop method) to the thoracic region of the rat. in a previous study (Salzman et al., 1991b) a single 1-mg/kg i.v. dose of mianserin improved multiple measures of functional outcome when given 15 min after injury, whereas higher doses (5 and 10 mg/kg i.v.) displayed lesser therapeutic actions as well as pulmonary depressant effects. In these studies, lower dosages of minanserin (0.5 and 0.1 mg/kg i.v.) also were not associated with neuroprotection. Although the 1-mg/kg i.v. dosage again displayed significant efficacy when administered at 15 min delaying treatment to 30 min resulted in only marginal therapeutic actions. Nonetheless, i.p. dosage of 10 mg/kg (but not 2.5 mg/kg) at 15 min retained therapeutic efficacy, suggesting a pharmacodynamic influence. In support of this conclusion, the intrathecal administration of a 50-fold lower dose of minanserin (0.006 mg) at 15 min after injury resulted in neuroprotection that was superior to that of peripheral doses and was retained when this intrathecal dosage was administered at 1 hr after trauma. These results suggest a central mechanism of action for mianserin. Consistent with this was the lack of effect of mianserin (1 mg/kg i.v. at 15 min) upon post-traumatic spinal edema but its ability to reverse the decrease in central 5-HT oxidative metabolism after injury. Moreover, the inability of the selective 5-HT2 antagonist ketanserin to produce this action, as well as its lack of neuroprotective efficacy, indicates the role of central 5-HT1C receptors in the therapeutic mechanism of mianserin.	ALFRED I DUPONT INST, DEPT MED CELL BIOL, SPINAL TRAUMA RES LAB, WILMINGTON, DE USA								Abraham J, 1985, Cent Nerv Syst Trauma, V2, P45; BARBEAU H, 1981, NEUROPHARMACOLOGY, V20, P477, DOI 10.1016/0028-3908(81)90181-7; BERRIDGE MJ, 1984, BIOCHEM J, V220, P345, DOI 10.1042/bj2200345; COHEN ML, 1983, BIOCHEM PHARMACOL, V32, P567, DOI 10.1016/0006-2952(83)90541-5; CONN PJ, 1986, P NATL ACAD SCI USA, V83, P4086, DOI 10.1073/pnas.83.11.4086; DAPRADA M, 1979, BRIT J PHARMACOL, V65, P653; ENGEL G, 1986, N-S ARCH PHARMACOL, V332, P1, DOI 10.1007/BF00633189; GOODMAN VG, 1979, J NEUROSURG, V63, P390; JULIUS D, 1988, COLD SPRING HARB SYM, V53, P385, DOI 10.1101/SQB.1988.053.01.046; LIU D, 1990, Journal of Neurotrauma, V7, P219, DOI 10.1089/neu.1990.7.219; MITCHELL R, 1981, EUR J PHARMACOL, V76, P119, DOI 10.1016/0014-2999(81)90020-0; MITCHELL RH, 1975, BIOCHIM BIOPHYS ACTA, V415, P81; MOLINEAUX SM, 1989, P NATL ACAD SCI USA, V86, P6793, DOI 10.1073/pnas.86.17.6793; OKIYAMA K, 1992, J NEUROSURG, V77, P607, DOI 10.3171/jns.1992.77.4.0607; PAPPIUS HM, 1987, J NEUROCHEM, V49, P321, DOI 10.1111/j.1471-4159.1987.tb03433.x; PAZOS A, 1985, BRAIN RES, V346, P205, DOI 10.1016/0006-8993(85)90856-X; PRANZATELLI MR, 1992, J PHARMACOL EXP THER, V261, P161; Puniak MA, 1991, J NEUROTRAUM, V8, P193, DOI 10.1089/neu.1991.8.193; RIVLIN AS, 1977, J NEUROSURG, V47, P577, DOI 10.3171/jns.1977.47.4.0577; Salzman S K, 1987, Cent Nerv Syst Trauma, V4, P181; SALZMAN SK, 1991, ANN NEUROL, V30, P533, DOI 10.1002/ana.410300405; SALZMAN SK, 1987, J NEUROSURG, V66, P431, DOI 10.3171/jns.1987.66.3.0431; Salzman SK, 1991, J NEUROTRAUM, V8, P45, DOI 10.1089/neu.1991.8.45; SARUHASHI Y, 1991, J NEUROTRAUMA, V7, P237; SHARMA HS, 1990, ACTA NEUROPATHOL, V80, P12, DOI 10.1007/BF00294216; SHARMA HS, 1988, PHARM CEREBRAL ISCHE, P317; SIEGAL T, 1993, J NEUROSURG, V78, P929, DOI 10.3171/jns.1993.78.6.0929; Tarlov I.M., 1957, SPINAL CORD COMPRESS; YAKSH TL, 1976, PHYSIOL BEHAV, V17, P1031, DOI 10.1016/0031-9384(76)90029-9; ZIVIN JA, 1976, NEUROLOGY, V26, P99, DOI 10.1212/WNL.26.2.99; ZIVIN JA, 1984, NEUROLOGY, V34, P469, DOI 10.1212/WNL.34.4.469	31	16	16	0	0	AMER SOC PHARMACOLOGY EXPERIMENTAL THERAPEUTICS	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3995 USA	0022-3565	1521-0103		J PHARMACOL EXP THER	J. Pharmacol. Exp. Ther.	APR	1994	269	1					322	328					7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	NJ323	WOS:A1994NJ32300045	8169839				2022-02-06	
J	IKEDA, Y; WANG, M; NAKAZAWA, S				IKEDA, Y; WANG, M; NAKAZAWA, S			SIMPLE QUANTITATIVE-EVALUATION OF BLOOD-BRAIN-BARRIER DISRUPTION IN VASOGENIC BRAIN EDEMA	ACTA NEUROCHIRURGICA			English	Article						VASOGENIC BRAIN EDEMA; COLD INJURY; EVANS BLUE; BLOOD-BRAIN BARRIER	EVANS BLUE FLUORESCENCE; VASCULAR-PERMEABILITY	Traumatic damage to the brain results in blood-brain barrier disruption with subsequent formation of vasogenic brain edema. The goal of this study was to evaluate a colorimetric assay of Evans blue extravasation for quantitatively studying blood-brain barrier disruption. Vasogenic brain edema was produced by a cortical freezing lesion. 52 male Wistar rats were sacrificed and cardiac perfusion was performed. A volume of dimethylformamide, twice the brain weight, was added to the brain and this was incubated for 72 hours. The supernatant was analyzed spectrophotometrically. Evans blue contents in the lesioned hemisphere was significantly increased within one hour after the lesion production relative to the normal brain and continued to increase for 24 hours (p < 0.01). This quantitative assay of Evans blue is a simple method for evaluation of blood-brain barrier disruption in vasogenic brain edema.			IKEDA, Y (corresponding author), NIPPON MED COLL, DEPT NEUROSURG, 1-1-5 SENDAGI, BUNKYO KU, TOKYO 113, JAPAN.						Johansson B B, 1986, Acta Neurochir Suppl (Wien), V36, P137; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; SARIA A, 1983, J NEUROSCI METH, V8, P41, DOI 10.1016/0165-0270(83)90050-X; UYAMA O, 1988, J CEREBR BLOOD F MET, V8, P282, DOI 10.1038/jcbfm.1988.59; WEISSMAN DE, 1988, J NEUROSCI METH, V23, P207, DOI 10.1016/0165-0270(88)90004-0	5	16	21	0	0	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.		1994				60			119	120					2	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	NX226	WOS:A1994NX22600031	7976520				2022-02-06	
J	MASSAGLI, TL; JAFFE, KM				MASSAGLI, TL; JAFFE, KM			PEDIATRIC TRAUMATIC BRAIN INJURY - PROGNOSIS AND REHABILITATION	PEDIATRIC ANNALS			English	Article											MASSAGLI, TL (corresponding author), CHILDRENS HOSP & MED CTR,DEPT REHABIL MED,CH-71,4800 SAND POINT WAY NE,POB 5371,SEATTLE,WA 98105, USA.							0	16	17	0	0	SLACK INC	THOROFARE	6900 GROVE RD, THOROFARE, NJ 08086	0090-4481			PEDIATR ANN	Pediatr. Annu.	JAN	1994	23	1					29	&		10.3928/0090-4481-19940101-08			0	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	MU563	WOS:A1994MU56300005	8152862				2022-02-06	
J	YOUNGSON, HA; ALDERMAN, N				YOUNGSON, HA; ALDERMAN, N			FEAR OF INCONTINENCE AND ITS EFFECTS ON A COMMUNITY-BASED REHABILITATION PROGRAM AFTER SEVERE BRAIN INJURY - SUCCESSFUL REMEDIATION OF ESCAPE BEHAVIOR USING BEHAVIOR-MODIFICATION	BRAIN INJURY			English	Article								The presence of continence problems following severe traumatic brain injury may be attributable to either organic or psychological factors. In the case of the latter this in turn may lead to the development of behaviours that result in avoidance of or escape from rehabilitation activities. In this paper, a single case study is described in which verbalized fear of incontinence prevented participation within a community rehabilitation programme. Assessment suggested that behaviours that led to escape from this programme were being maintained by negative reinforcement through reduction in anxiety associated with this activity. An intervention was implemented using graded exposure and differential reinforcement of incompatible behaviour. Treatment led to a significant reduction in escape behaviour; this had been maintained and consolidated further at 9-month follow-up. However, no change occurred to the client's prompted self-ratings of anxiety. Reasons for the discrepancy between improvement in behaviour but not self-report are discussed. The potential limitations of using cognitive-behavioural therapy with some survivors of severe traumatic brain injury are also discussed. Finally, comments are made concerning the applicability of the treatment techniques described here in the modification of escape and avoidance behaviours that may be acquired following brain injury. ,	ST ANDREWS HOSP,KEMSLEY UNIT,NORTHAMPTON NN1 5DG,ENGLAND					Alderman, Nick/0000-0002-8523-4142			ALDERMAN N, 1991, Brain Injury, V5, P77, DOI 10.3109/02699059108998516; ALDERMAN N, 1992, PHYSIOTHERAPY, V78, P335; ALDERMAN N, 1990, COGNITIVE REHABILITA, P204; BURGESS PW, 1990, NEUROBEHAVIOURAL SEQ, P183; IWATA BA, 1987, J APPL BEHAV ANAL, V20, P361, DOI 10.1901/jaba.1987.20-361; MILLER E, 1984, BRIT J CLIN PSYCHOL, V23, P52; NELSON HE, 1978, CORTEX, V14, P234, DOI 10.1016/S0010-9452(78)80049-5; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Osterrieth P., 1944, ARCH PSYCHOLOGIE, V30, P206; PAPWORTH MA, 1990, J BEHAVIOR THERAPY E, V20, P265; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; SAZBON L, 1991, Brain Injury, V5, P3, DOI 10.3109/02699059108998505; Warrington E, 1984, RECOGNITION MEMORY T, V1; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1945, J PSYCHOL, V19, P87, DOI 10.1080/00223980.1945.9917223; WILSON BA, 1991, HDB BEHAV THERAPY PS, P227; Wood R. L., 1987, BRAIN INJURY REHABIL; [No title captured]; [No title captured]	19	16	16	0	3	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	JAN	1994	8	1					23	36		10.3109/02699059409150956			14	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MQ291	WOS:A1994MQ29100004	8124314				2022-02-06	
J	GORAN, DA; FABIANO, RJ				GORAN, DA; FABIANO, RJ			THE SCALING OF THE KATZ ADJUSTMENT SCALE IN A TRAUMATIC BRAIN INJURY REHABILITATION SAMPLE	BRAIN INJURY			English	Article							BLUNT HEAD-INJURY; SEQUELAE	Based on the KAS-R1 ratings completed by 88 relatives of clients who had enrolled in a post-acute rehabilitation programme, the 10 component groups discerned by Fabiano and Goran [1] were submitted to a classical analysis of tests. Seventy-nine items were found to contribute to the internal consistency of their respective component groups, resulting in alpha values ranging from 0.75 to 0.93 for the component groups. Intercorrelations between components suggested that while some degree of overlap existed between groups, they represented discrete categories of neurobehavioural functioning. Second-order components, as determined by principal-component analysis, discern two significant component groups. These two components correlated moderately, yielding a value of 0-49. The findings indicate that the revised KAS-R1 exhibits considerable potential for clinical utility. Future research is needed to investigate the validity of this instrument in accurately depicting behavioural manifestations of those who have incurred traumatic brain injury.	MICHIGAN STATE UNIV,PSYCHOL ASSOCIATES REHABIL,LANSING,MI 48910; MICHIGAN STATE UNIV,REHABIL COUNSELOR EDUC PROGRAM,LANSING,MI 48910								BOND M, 1984, CLOSED HEAD INJURY P; BROOKS DN, 1983, J NEUROL NEUROSUR PS, V46, P336, DOI 10.1136/jnnp.46.4.336; CRIPE L, 1991, NEUROPSYCHOLOCIAL EX; DEATON AV, 1986, REHABIL PSYCHOL, V31, P231, DOI 10.1037//0090-5550.31.4.231; FABIANO RJ, IN PRESS REHABILITAT; FERGUSON SM, 1969, ARCH GEN PSYCHIAT, V21, P363; FLORHENRY P, 1969, EPILEPSIA, V10, P363, DOI 10.1111/j.1528-1157.1969.tb03853.x; Gainotti G, 1972, Cortex, V8, P41; GINGIS M, 1980, LIMBIC EPILEPSY DYSC; Goldstein K, 1952, PSYCHIATR, V15, P245, DOI 10.1080/00332747.1952.11022878; GRAHAM JR, 1972, J CLIN PSYCHOL, V28, P380, DOI 10.1002/1097-4679(197207)28:3+<380::AID-JCLP2270280323>3.0.CO;2-B; GRANT I, 1987, NEUROBEHAVIORAL RECO, P232; Guilford J. P., 1956, FUNDAMENTAL STATISTI; HAFFEY WJ, 1989, REHABIL PSYCHOL, V34, P147, DOI 10.1037//0090-5550.34.2.147; Heilman KM, 1985, CLIN NEUROPSYCHOLOGY, P377; JACKSON JK, 1989, MAR INT BRAIN INJ S; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; KATZ MM, 1963, PSYCHOL REP, V13, P503, DOI 10.2466/pr0.1963.13.2.503; KLONOFF PS, 1986, J CLIN EXP NEUROPSYC, V8, P469, DOI 10.1080/01688638608405171; Lam C S, 1988, Brain Inj, V2, P235, DOI 10.3109/02699058809150947; LEVIN HS, 1987, J NEUROL NEUROSUR PS, V50, P183, DOI 10.1136/jnnp.50.2.183; LEVIN HS, 1985, CENTRAL NERVOUS SYST, P281; LEZAK MD, 1980, 8TH ANN M INT NEUR S; LEZAK MD, 1978, J CLIN PSYCHIAT, V29, P592; LISHMAN WA, 1973, PSYCHOL MED, V3, P304, DOI 10.1017/S003329170004959X; MCKINLAY WW, 1983, J NEUROL NEUROSUR PS, V46, P1084, DOI 10.1136/jnnp.46.12.1084; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; PRIBRAM KH, 1975, PSYCHOL REV, V82, P116, DOI 10.1037/h0076780; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1982, PERCEPT MOTOR SKILL, V54, P859, DOI 10.2466/pms.1982.54.3.859; PRIGATANO GP, 1987, NEUROBEHAVIORAL RECO; ROBINSON RG, 1985, J NERV MENT DIS, V173, P221, DOI 10.1097/00005053-198504000-00003; ROSS ED, 1979, ARCH NEUROL-CHICAGO, V36, P144, DOI 10.1001/archneur.1979.00500390062006; Spiers P. A., 1985, PRINCIPLES BEHAVIORA, P289; STENSON H, 1986, TESTAT SUPPLEMENTARY; STRAUSS E, 1982, ARCH NEUROL-CHICAGO, V39, P626, DOI 10.1001/archneur.1982.00510220024005; [No title captured]	37	16	17	0	2	TAYLOR & FRANCIS LTD	LONDON	ONE GUNDPOWDER SQUARE, LONDON, ENGLAND EC4A 3DE	0269-9052			BRAIN INJURY	Brain Inj.	MAY-JUN	1993	7	3					219	229		10.3109/02699059309029674			11	Neurosciences; Rehabilitation	Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	MA170	WOS:A1993MA17000003	8508178				2022-02-06	
J	KITCHENER, PD; BOURREAU, JP; DIAMOND, J				KITCHENER, PD; BOURREAU, JP; DIAMOND, J			NADPH-DIAPHORASE HISTOCHEMISTRY IDENTIFIES ISOLATED ENDOTHELIAL-CELLS AT SITES OF TRAUMATIC INJURY IN THE ADULT-RAT BRAIN	NEUROSCIENCE			English	Article							NITRIC-OXIDE SYNTHASE; CENTRAL NERVOUS-SYSTEM; MAMMALIAN BRAIN; PROTEIN; NEOVASCULARIZATION; PROLIFERATION; MICROGLIA; INTERLEUKIN-1; ANGIOGENESIS; MACROPHAGES	In addition to labelling endothelium, some ependymal cells (including tanycytes), and a subpopulation of neurons, nicotinamide adenine dinucleotide phosphate (NADPH)-diaphorase histochemistry of stab lesion sites in the neocortex revealed a large population of cells concentrated within several hundred micrometres of the lesion site. To determine the identity of these cells, NADPH-diaphorase reactivity was compared to binding with either the I-B4 isolectin from Bandeiraea simplicifolia (which has previously been shown to identify endothelial cells and activated mononuclear phagocytes), or a monoclonal antibody (OX-42) that recognizes activated mononuclear phagocytes. Many I-B4 lectin-labelled cells were also NADPH-diaphorase reactive, and other I-B4 lectin-labelled cells were also OX-42 immunoreactive, but co-existence of OX-42 immunoreactivity and NADPH-diaphorase reactivity was not observed. Only a small minority of NADPH-diaphorase-reactive cells did not exhibit I-B4 lectin binding. In contrast to the simple somatic morphology of the majority of NADPH-diaphorase-reactive cells, the I-B4 lectin-negative cells had a ramified appearance, and while readily observed at two days postlesion, they were only rarely seen at three days postlesion. Primary cultures of bovine aortic endothelial cells also exhibited NADPH-diaphorase reactivity which occupied most of the cytoplasm in a filamentous web pattern. Endothelial cells possess a constitutive form of nitric oxide synthase which, as demonstrated in NADPH-diaphorase-reactive neurons, may be the basis of their NADPH-diaphorase reactivity. These findings indicate that NADPH-diaphorase-reactive cells observed at lesion sites are probably angiogenic endothelial cells not associated with extant blood vessels. Thus, NADPH-diaphorase histochemistry offers an effective method of visualizing neovascularization in the brain and other tissues.	MCMASTER UNIV,DIV PHYSIOL & PHARMACOL,SMOOTH MUSCLE RES GRP,HAMILTON L8N 3Z5,ONTARIO,CANADA; MCMASTER UNIV,DEPT BIOMED SCI,DIV NEUROSCI,HAMILTON L8N 3Z5,ONTARIO,CANADA		KITCHENER, PD (corresponding author), UNIV QUEENSLAND,DEPT ANAT SCI,BRISBANE,QLD 4072,AUSTRALIA.			Kitchener, Peter/0000-0003-4324-5270			ADRIAN EK, 1973, J COMP NEUROL, V151, P1, DOI 10.1002/cne.901510102; AUSPRUNK DH, 1977, MICROVASC RES, V14, P53, DOI 10.1016/0026-2862(77)90141-8; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; BREDT DS, 1991, NEURON, V7, P615, DOI 10.1016/0896-6273(91)90374-9; CLIFF WJ, 1963, PHILOS T ROY SOC B, V246, P305, DOI 10.1098/rstb.1963.0008; COFFIN JD, 1991, DEV BIOL, V148, P51, DOI 10.1016/0012-1606(91)90316-U; DAWSON TM, 1991, P NATL ACAD SCI USA, V88, P7797, DOI 10.1073/pnas.88.17.7797; Edelman GM, 1985, CELL CONTACT ADHESIO; FORSTERMANN U, 1991, BIOCHEM PHARMACOL, V42, P1849, DOI 10.1016/0006-2952(91)90581-O; GARTHWAITE J, 1991, TRENDS NEUROSCI, V14, P60, DOI 10.1016/0166-2236(91)90022-M; GIULIAN D, 1989, J NEUROSCI, V9, P4416; GIULIAN D, 1986, J EXP MED, V164, P594, DOI 10.1084/jem.164.2.594; GIULIAN D, 1988, J NEUROSCI, V8, P2485; GRAEBER MB, 1988, J NEUROSCI RES, V21, P18, DOI 10.1002/jnr.490210104; GRAEBER MB, 1989, J NEUROSCI RES, V22, P103, DOI 10.1002/jnr.490220114; HOPE BT, 1991, P NATL ACAD SCI USA, V88, P2811, DOI 10.1073/pnas.88.7.2811; HOPE BT, 1989, J HISTOCHEM CYTOCHEM, V37, P653, DOI 10.1177/37.5.2703701; HOPE BT, 1992, TRENDS NEUROSCI, V15, P108; IMAMOTO K, 1977, J COMP NEUROL, V174, P255, DOI 10.1002/cne.901740205; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; KITCHENER PD, 1991, P AUST PHYSL PHARM S, V22, pP186; LAITINEN L, 1987, HISTOCHEM J, V19, P225, DOI 10.1007/BF01680633; LATERRA J, 1991, J NEUROCHEM, V57, P1231, DOI 10.1111/j.1471-4159.1991.tb08284.x; LATOV N, 1979, DEV BIOL, V72, P381, DOI 10.1016/0012-1606(79)90127-1; Leibovich S J, 1988, Prog Clin Biol Res, V266, P131; LOJDA Z, 1961, J ATHEROSCLER RES, V1, P101, DOI 10.1016/S0368-1319(61)80039-2; MADDOX DE, 1982, P NATL ACAD SCI-BIOL, V79, P166, DOI 10.1073/pnas.79.1.166; MITRO A, 1981, BIBLIOTHECA ANATOMIC, V21; MIZUKAWA K, 1989, J COMP NEUROL, V279, P281, DOI 10.1002/cne.902790210; MONCADA S, 1991, PHARMACOL REV, V43, P109; MURPHY LA, 1977, J BIOL CHEM, V252, P4739; OEHMICHEN M, 1983, PROG NEUROPATH, V5, P277; PENFIELD W, 1932, CYTOLOGY CELLULAR PA, V2; RAMONYCAJAL S, 1927, DEGENERATION REGENER, V2; REIDY MA, 1989, AM J PATHOL, V134, P857; ROBINSON AP, 1986, IMMUNOLOGY, V57, P239; SCHERERSINGLER U, 1983, J NEUROSCI METH, V9, P229, DOI 10.1016/0165-0270(83)90085-7; SHIGEMATSU K, 1989, BRAIN RES, V501, P215, DOI 10.1016/0006-8993(89)90639-2; SHOLLEY MM, 1984, LAB INVEST, V51, P624; STREIT WJ, 1987, J NEUROCYTOL, V16, P249, DOI 10.1007/BF01795308; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; VINCENT SR, 1992, NEUROSCIENCE, V46, P755, DOI 10.1016/0306-4522(92)90184-4; ZEMPLENYI T, 1963, ATHEROSCLEROSIS ITS	43	16	16	0	0	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD, ENGLAND OX5 1GB	0306-4522			NEUROSCIENCE	Neuroscience	APR	1993	53	3					613	624		10.1016/0306-4522(93)90610-R			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	KW547	WOS:A1993KW54700002	8487946				2022-02-06	
J	ANTONAK, RF; LIVNEH, H				ANTONAK, RF; LIVNEH, H			A REVIEW OF RESEARCH ON PSYCHOSOCIAL ADJUSTMENT TO IMPAIRMENT AMONG PERSONS WITH EPILEPSY	JOURNAL OF EPILEPSY			English	Article						PSYCHOSOCIAL ADJUSTMENT; EPILEPSY; REACTIONS; ADAPTATION; IMPAIRMENT; INSTRUMENTS; STIGMA		This review begins with a general discussion of the concept of psychosocial adjustment to impairment among persons with epilepsy. The research literature is then reviewed in three areas: (a) research subsuming adjustment within the domain of psychopathology, (b) research focusing on specific psychosocial reactions, and (c) investigations of the characteristics associated with adjustment (e.g., age at onset, seizure type and frequency, societal attitudes). The next sections review the research concerning (a) comparison of adjustment to epilepsy with adjustment to other impairments (e.g., amyotrophic lateral sclerosis, closed head injury), (b) the roots of the poor psychosocial adjustment among persons with epilepsy, and (c) two measures of adjustment specific to epilepsy. Research problems identified in this review are then listed and suggestions for future investigations provided.	PORTLAND STATE UNIV, PORTLAND, OR 97207 USA		ANTONAK, RF (corresponding author), UNIV N CAROLINA, CHARLOTTE, NC 28223 USA.						Ajzen I., 1980, UNDERSTANDING ATTITU; ANTONAK RF, 1982, SOC SCI MED, V16, P1591, DOI 10.1016/0277-9536(82)90170-8; ANTONAK RF, 1988, COMMUNICATION ASSESS, P9; ANTONAK RF, UNPUB J HEAD TRAUMA; ANTONAK RF, UNPUB UINT J PSYCHIA; ARANGIO AJ, 1975, STIGMA EPILEPSY; ARNSTON P, 1986, PSYCHOPATHOLOGY EPIL, P143; ATHELSTAN G, 1981, HDB SEVERE DISABILIT, P13; AUSTIN JK, 1984, NURS RES, V33, P92; AWARITEFE A, 1985, EPILEPSIA, V26, P1, DOI 10.1111/j.1528-1157.1985.tb05181.x; BAGLEY C, 1972, EPILEPSIA, V13, P33, DOI 10.1111/j.1528-1157.1972.tb04547.x; BATZEL LW, 1991, EPILEPSIA, V32, P202, DOI 10.1111/j.1528-1157.1991.tb05245.x; Bear D., 1984, PSYCHIATRIC ASPECTS, P197; BEITJONES MS, 1985, SOC WORK HEALTH CARE, V11, P17; Beran R G, 1985, Clin Exp Neurol, V21, P183; BERAN RG, 1983, EPILEPSIA, V24, P79, DOI 10.1111/j.1528-1157.1983.tb04869.x; BERAN RG, 1981, EPILEPSIA, V22, P397, DOI 10.1111/j.1528-1157.1981.tb06150.x; BERAN RG, 1987, EPILEPSIA, V28, P107, DOI 10.1111/j.1528-1157.1987.tb03634.x; BERAN RG, 1980, CLIN EXP NEUROL, V17, P69; BLUMER D, 1967, ARCH NEUROL-CHICAGO, V16, P37, DOI 10.1001/archneur.1967.00470190041005; Bridge EA, 1947, NERV CHILD, V6, P11; BROOKS NA, 1982, SOC SCI MED, V16, P2129, DOI 10.1016/0277-9536(82)90262-3; BROUGHTON RJ, 1984, EPILEPSIA, V25, P423, DOI 10.1111/j.1528-1157.1984.tb03438.x; BROWN SW, 1986, BRIT J PSYCHIAT, V148, P300, DOI 10.1192/bjp.148.3.300; CANGER R, 1985, EPILEPSIA, V26, P221, DOI 10.1111/j.1528-1157.1985.tb05409.x; Carter JD, 1947, NERV CHILD, V6, P34; CAVENESS W, 1980, REHABIL COUNS BULL, V21, P509; CAVENESS WF, 1974, EPILEPSIA, V15, P523, DOI 10.1111/j.1528-1157.1974.tb04026.x; COLLINGS JA, 1990, EPILEPSIA, V31, P418, DOI 10.1111/j.1528-1157.1990.tb05497.x; DANESI MA, 1984, EPILEPSIA, V25, P184, DOI 10.1111/j.1528-1157.1984.tb04175.x; DEHAAS AML, 1962, EPILEPSIA, V3, P44, DOI 10.1111/j.1528-1157.1962.tb05233.x; Dell J. L., 1986, PSYCHOPATHOLOGY EPIL, P185; DODRILL CB, 1984, EPILEPSIA, V25, P168, DOI 10.1111/j.1528-1157.1984.tb04173.x; DODRILL CB, 1980, EPILEPSIA, V21, P123, DOI 10.1111/j.1528-1157.1980.tb04053.x; DODRILL CB, 1986, EPILEPSIA, V27, P399, DOI 10.1111/j.1528-1157.1986.tb03559.x; DODRILL CB, 1984, EPILEPSIA, V25, P176, DOI 10.1111/j.1528-1157.1984.tb04174.x; DODRILL CB, 1983, EPILEPSY, P341; DORENBAUM D, 1985, CLIN PEDIATR, V24, P634, DOI 10.1177/000992288502401106; DREISBACH M, 1982, J SPEC EDUC, V16, P111, DOI 10.1177/002246698201600111; ELLISON JM, 1982, PSYCHOSOMATICS, V23, P499; Flanagan P J, 1985, Clin Exp Neurol, V21, P189; FRANK RG, 1987, J REHABIL, V53, P43; GALLHOFER B, 1984, PSYCHOPATHOLOGY, V17, P187, DOI 10.1159/000284053; Goffman E., 1963, STIGMA NOTES MANAGEM; GOLDIN GJ, 1975, EPILEPSY REHABILITAT, P66; GOTTESMAN D, 1982, J CONSULT CLIN PSYCH, V50, P381, DOI 10.1037/0022-006X.50.3.381; GUTTELING JM, 1986, EPILEPSIA, V27, P739, DOI 10.1111/j.1528-1157.1986.tb03604.x; HACKNEY A, 1976, EPILEPSIA, V17, P275, DOI 10.1111/j.1528-1157.1976.tb03406.x; HARTLAGE LC, 1972, EPILEPSIA, V13, P21, DOI 10.1111/j.1528-1157.1972.tb04544.x; HAUCK G, 1972, EPILEPSIA, V13, P79, DOI 10.1111/j.1528-1157.1972.tb04554.x; HAWTON K, 1980, J NEUROL NEUROSUR PS, V43, P168, DOI 10.1136/jnnp.43.2.168; HELGESON DC, 1990, EPILEPSIA, V31, P75, DOI 10.1111/j.1528-1157.1990.tb05363.x; HERMANN BP, 1981, J CLIN PSYCHOL, V37, P714, DOI 10.1002/1097-4679(198110)37:4<714::AID-JCLP2270370405>3.0.CO;2-C; HERMANN BP, 1984, PSYCHOL BULL, V95, P451, DOI 10.1037/0033-2909.95.3.451; HERMANN BP, 1990, BRIT J PSYCHIAT, V156, P98, DOI 10.1192/bjp.156.1.98; HERMANN BP, 1980, EPILEPSIA, V21, P15, DOI 10.1111/j.1528-1157.1980.tb04040.x; HERMANN BP, 1980, EPILEPSIA, V21, P691, DOI 10.1111/j.1528-1157.1980.tb04322.x; Hermann BP, 1986, PSYCHOPATHOLOGY EPIL, P5; HERMANN BP, 1988, HDB DEV PHYSICAL DIS, P247; Himmelhoch J, 1984, PSYCHIATRIC ASPECTS, P271; HOARE P, 1986, J PSYCHOSOM RES, V30, P471, DOI 10.1016/0022-3999(86)90086-3; HOLDSWORTH L, 1974, DEV MED CHILD NEUROL, V16, P759; HOLMES DA, 1981, J REHABIL, V47, P20; KAPLAN BJ, 1983, COPING CHRONIC DISEA, P259; Kaplan S. P., 1988, J APPLIED REHABILITA, V19, P3; Kerr W G, 1972, Paraplegia, V10, P94; KLOVE H, 1962, J CLIN PSYCHOL, V18, P149, DOI 10.1002/1097-4679(196204)18:2<149::AID-JCLP2270180214>3.0.CO;2-S; KOGEORGOS J, 1982, BRIT J PSYCHIAT, V140, P236, DOI 10.1192/bjp.140.3.236; LAI CW, 1990, EPILEPSIA, V31, P182, DOI 10.1111/j.1528-1167.1990.tb06304.x; Landisberg S, 1947, AM J MENT DEF, V52, P16; LECHTENBERG R, 1984, EPILEPSY FAMILY; LECHTENBERG R, 1985, DIAGNOSIS TREATMENT; LEONARD BJ, 1984, CHRONIC ILLNESS DISA, P239; LIPOWSKI ZJ, 1970, PSYCHIAT MED, V1, P91, DOI 10.2190/19Q3-9QL8-XYV1-8XC2; LIVANAINEN M, 1980, EPILEPSIA, V21, P413; LIVINGSTON S, 1977, J CLIN CHILD PSYCHOL, V6, P6, DOI 10.1080/15374417709532773; Livneh H, 1990, J APPLIED REHABILITA, V21, P13; LONG CG, 1979, J CHILD PSYCHOL PSYC, V20, P299, DOI 10.1111/j.1469-7610.1979.tb00516.x; MARTIN JW, 1974, J SCHOOL HEALTH, V44, P144, DOI 10.1111/j.1746-1561.1974.tb07629.x; MASON C, 1990, EPILEPSIA, V31, P95, DOI 10.1111/j.1528-1157.1990.tb05366.x; MATTHEWS CG, 1968, EPILEPSIA, V9, P43, DOI 10.1111/j.1528-1157.1968.tb04956.x; MATTHEWS WS, 1981, PSYCHOSOMATICS, V22, P515; MATTHEWS WS, 1982, EPILEPSIA, V23, P671, DOI 10.1111/j.1528-1157.1982.tb05083.x; MATTSSON A, 1972, PEDIATRICS, V50, P801; MENDEZ MF, 1986, ARCH NEUROL-CHICAGO, V43, P766, DOI 10.1001/archneur.1986.00520080014012; MERKENS MJ, 1989, J DEV BEHAV PEDIATR, V10, P1; OZUMA J, 1979, J NEUROSURG NURS, V11, P242; PARNAS J, 1982, ACTA PSYCHIAT SCAND, V66, P89, DOI 10.1111/j.1600-0447.1982.tb00917.x; PAZZAGLIA P, 1976, EPILEPSIA, V17, P361, DOI 10.1111/j.1528-1157.1976.tb04446.x; PINCUS JH, 1980, NEUROLOGY, V30, P304, DOI 10.1212/WNL.30.3.304; POLLOCK SE, 1990, NURS RES, V39, P300; RADER K, 1986, INT J REHABIL RES, V9, P325; REMSCHMIDT H, 1973, EPILEPSIA, V14, P347, DOI 10.1111/j.1528-1157.1973.tb03970.x; RICHARDSON DW, 1974, CLIN PEDIATR, V13, P121, DOI 10.1177/000992287401300203; ROBERTSON MM, 1983, EPILEPSIA, V24, pS109, DOI 10.1111/j.1528-1157.1983.tb04647.x; RODIN EA, 1973, ARCH GEN PSYCHIAT, V28, P210, DOI 10.1001/archpsyc.1973.01750320044007; RYAN R, 1980, EPILEPSIA, V21, P433, DOI 10.1111/j.1528-1157.1980.tb04091.x; SANDS H, 1972, EPILEPSIA, V13, P87, DOI 10.1111/j.1528-1157.1972.tb04555.x; SCHIFFER RB, 1984, ARCH NEUROL-CHICAGO, V41, P1067, DOI 10.1001/archneur.1984.04050210065016; SCOTT DF, 1978, BRIT J PSYCHIAT, V132, P417, DOI 10.1192/bjp.132.5.417; STANDAGE KF, 1975, PSYCHOL MED, V5, P152, DOI 10.1017/S0033291700056403; STUDE E, 1973, REHABILITATION COUNS, V16, P146; TAN SY, 1986, J CLIN PSYCHOL, V42, P528, DOI 10.1002/1097-4679(198605)42:3<528::AID-JCLP2270420321>3.0.CO;2-5; TARTER RE, 1972, DIS NERV SYST, V33, P763; TELLIER A, 1990, J CONSULT CLIN PSYCH, V58, P531; Temkin O., 1971, FALLING SICKNESS HIS, V2nd; TERDAL LG, 1981, PSYCHOL BEHAVIORAL A, P147; TIZARD B, 1962, PSYCHOL BULL, V59, P196, DOI 10.1037/h0041102; TROSTLE JA, 1989, NEUROLOGY, V39, P633, DOI 10.1212/WNL.39.5.633; WARD F, 1978, DEV MED CHILD NEUROL, V20, P1; WHITMAN S, 1986, PSYCHOPATHOLOGY EPIL, P284; WHITMAN S, 1986, PSYCHOPATHOLOGY EPIL; WHITMAN S, 1986, PSYCHOPATHOLOGY EPIL, pR8; WILEY L, 1974, NURSING, V4, P36; Wright GN, 1975, EPILEPSY REHABILITAT, P1; ZIELINSKI JJ, 1972, EPILEPSIA, V13, P133, DOI 10.1111/j.1528-1157.1972.tb04560.x; [No title captured]; [No title captured]	118	16	16	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0896-6974			J EPILEPSY	J. Epilepsy		1992	5	3					194	205		10.1016/S0896-6974(05)80141-0			12	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	LA886	WOS:A1992LA88600010					2022-02-06	
J	HALL, S; BORNSTEIN, RA				HALL, S; BORNSTEIN, RA			THE RELATIONSHIP BETWEEN INTELLIGENCE AND MEMORY FOLLOWING MINOR OR MILD CLOSED HEAD-INJURY - GREATER IMPAIRMENT IN MEMORY THAN INTELLIGENCE	JOURNAL OF NEUROSURGERY			English	Article						CLOSED HEAD INJURY; INTELLIGENCE; MEMORY	EDUCATION; SEQUELAE; WAIS	This study investigated the performance of patients with minor or mild closed head injury and age/education-matched normal controls on the Wechsler Adult Intelligence Scale-Revised (WAIS-R) and the Wechsler Memory Scale-Revised (WMS-R). The results demonstrated that the control group had significantly higher scores than the patients with closed head injury on all WAIS-R and WMS-R index scores. Further analysis revealed that the patients with closed head injury showed a greater impairment in delayed memory when directly compared to intellectual performance that was not seen in the control group. These results are discussed in relation to findings in patients with more severe closed head injury, the construction of the WAIS-R and the WMS-R, and the performance patterns of the two groups.	OHIO STATE UNIV,COLL MED,DEPT PSYCHIAT,NEUROPSYCHOL LAB,473 W 12TH AVE,COLUMBUS,OH 43210; OHIO STATE UNIV,COLL MED,DIV HLTH PSYCHOL,COLUMBUS,OH 43210								BARTH JT, 1983, NEUROSURGERY, V13, P529, DOI 10.1227/00006123-198311000-00008; BECKER DP, 1979, ARCH NEUROL-CHICAGO, V36, P750, DOI 10.1001/archneur.1979.00500480024005; BIGLER E D, 1981, Clinical Neuropsychology, V3, P13; BIGLER ED, 1988, DIAGNOSTIC CLIN NEUR; BORNSTEIN RA, 1983, J CLIN PSYCHOL, V39, P470, DOI 10.1002/1097-4679(198307)39:4<470::AID-JCLP2270390403>3.0.CO;2-F; BORNSTEIN RA, 1989, PSYCHOL ASSESSMENT J, V1, P203; BUTTERS N, 1988, CLIN NEUROPSYCHOL, V2, P133; DIKMEN S, 1987, J NEUROL NEUROSUR PS, V50, P1613, DOI 10.1136/jnnp.50.12.1613; FINLAYSON MAJ, 1977, J CONSULT CLIN PSYCH, V45, P536, DOI 10.1037/0022-006X.45.4.536; HORN JL, 1967, ACTA PSYCHOL, V26, P107, DOI 10.1016/0001-6918(67)90011-X; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; Levin HS., 1982, NEUROBEHAVIORAL CONS; MATARAZZO JD, 1984, J CONSULT CLIN PSYCH, V52, P631, DOI 10.1037/0022-006X.52.4.631; NEWCOMBE F, 1979, HDB BEHAVIORAL NEURO, V2; RUSSELL EW, 1979, J CLIN PSYCHOL, V35, P611, DOI 10.1002/1097-4679(197907)35:3<611::AID-JCLP2270350325>3.0.CO;2-V; SCHACTER DL, 1977, CORTEX, V8, P150; STUSS DT, 1985, NEUROSURGERY, V17, P41, DOI 10.1227/00006123-198507000-00007; Wechsler, 1997, WECHSLER ADULT INTEL; Wechsler D, 1987, MEMORY SCALE REVISED	20	16	16	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	CHARLOTTESVILLE	UNIV VIRGINIA, 1224 WEST MAIN ST, STE 450, CHARLOTTESVILLE, VA 22903	0022-3085			J NEUROSURG	J. Neurosurg.	SEP	1991	75	3					378	381		10.3171/jns.1991.75.3.0378			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Surgery	GC311	WOS:A1991GC31100007	1869937				2022-02-06	
J	HAUT, MW; PETROS, TV; FRANK, RG; HAUT, JS				HAUT, MW; PETROS, TV; FRANK, RG; HAUT, JS			SPEED OF PROCESSING WITHIN SEMANTIC MEMORY FOLLOWING SEVERE CLOSED HEAD-INJURY	BRAIN AND COGNITION			English	Article							SPREADING ACTIVATION; LEXICAL DECISION; APHASIA; DEFICIT		W VIRGINIA UNIV,MED CTR,SCH MED,DEPT NEUROL,MORGANTOWN,WV 26506; UNIV N DAKOTA,GRAND FORKS,ND 58201; UNIV MISSOURI,MED CTR,SCH MED,DEPT PHYS MED & REHABIL,COLUMBIA,MO 65201		HAUT, MW (corresponding author), W VIRGINIA UNIV,MED CTR,SCH MED,DEPT BEHAV MED & PSYCHIAT,MORGANTOWN,WV 26506, USA.			Haut, Marc/0000-0003-0235-362X			Bigler E, 1990, TRAUMATIC BRAIN INJU, P13; BLUMSTEIN SE, 1982, BRAIN LANG, V17, P301, DOI 10.1016/0093-934X(82)90023-2; Brooks N, 1987, Brain Inj, V1, P5, DOI 10.3109/02699058709034439; COLLINS AM, 1975, PSYCHOL REV, V82, P407, DOI 10.1037/0033-295X.82.6.407; COLLINS AM, 1969, J VERB LEARN VERB BE, V8, P240, DOI 10.1016/S0022-5371(69)80069-1; CRAIK FIM, 1975, J EXP PSYCHOL GEN, V104, P268, DOI 10.1037/0096-3445.104.3.268; CROSSON B, 1988, J CLIN EXP NEUROPSYC, V10, P754, DOI 10.1080/01688638808402812; CROSSON B, 1989, CLIN NEUROPSYCHOL, V3, P29, DOI DOI 10.1080/13854048908404074; GOLDSTEIN FC, 1989, CORTEX, V25, P541, DOI 10.1016/S0010-9452(89)80016-4; GOLDSTEIN FC, 1990, J CLIN EXP NEUROPSYC, V12, P286, DOI 10.1080/01688639008400975; GRAF P, 1985, J EXP PSYCHOL LEARN, V11, P386, DOI 10.1037/0278-7393.11.2.386; Haut M W, 1990, Arch Clin Neuropsychol, V5, P299, DOI 10.1016/0887-6177(90)90028-N; HAUT M W, 1990, Brain Injury, V4, P281, DOI 10.3109/02699059009026178; LEVIN HS, 1990, J CLIN EXP NEUROPSYC, V12, P129, DOI 10.1080/01688639008400960; LEVIN HS, 1986, J CLIN EXP NEUROPSYC, V8, P643, DOI 10.1080/01688638608405185; LEVIN HS, 1988, J NEUROL NEUROSUR PS, V51, P1294, DOI 10.1136/jnnp.51.10.1294; LEVIN HS, 1988, SCANDINAVIAN J REH S, V20, P33; LORCH RF, 1982, J VERB LEARN VERB BE, V21, P468, DOI 10.1016/S0022-5371(82)90736-8; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V48, P21; MILBERG W, 1981, BRAIN LANG, V14, P371, DOI 10.1016/0093-934X(81)90086-9; Miller E, 1970, Cortex, V6, P121; ROSCH E, 1975, J EXP PSYCHOL GEN, V104, P192, DOI 10.1037/0096-3445.104.3.192; SCHACTER DL, 1987, J EXP PSYCHOL LEARN, V13, P501, DOI 10.1037/0278-7393.13.3.501; Stuss DT, 1989, CLIN NEUROPSYCHOL, V3, P145, DOI [DOI 10.1080/13854048908403287, 10.1080/ 13854048908403287]; van Zomeren AH, 1984, CLOSED HEAD INJURY P, P74; VANZOMEREN AH, 1985, J NEUROL NEUROSUR PS, V48, P21, DOI 10.1136/jnnp.48.1.21	26	16	17	0	8	ACADEMIC PRESS INC JNL-COMP SUBSCRIPTIONS	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495	0278-2626			BRAIN COGNITION	Brain Cogn.	SEP	1991	17	1					31	41		10.1016/0278-2626(91)90064-F			11	Neurosciences; Psychology, Experimental	Social Science Citation Index (SSCI); Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	GV410	WOS:A1991GV41000003	1781979				2022-02-06	
J	STEIN, DG				STEIN, DG			FETAL BRAIN-TISSUE GRAFTING AS THERAPY FOR BRAIN DYSFUNCTIONS - UNANSWERED QUESTIONS, UNKNOWN FACTORS, AND PRACTICAL CONCERNS	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						BRAIN DAMAGE AND TREATMENT; NEURAL TRANSPLANTS; GRAFTING INTO CNS; FUNCTIONAL RECOVERY; FUNCTIONAL ASSESSMENT OF NEURAL GRAFTS	ADRENAL CHROMAFFIN CELLS; CENTRAL-NERVOUS-SYSTEM; PARKINSONS-DISEASE; NEURAL TRANSPLANTATION; AGED RATS; HIPPOCAMPAL-NEURONS; HORMONE DEFICIENCY; DOPAMINE NEURONS; CAUDATE-NUCLEUS; SEPTAL GRAFTS	Grafting of embryonic neural tissue into the brains of adult patients is being given serious consideration as therapy for a variety of degenerative and traumatic disorders. It has been argued that neural transplantation can promote functional recovery by replacement of damaged nerve cells, the reestablishment of specific nerve pathways lost as a result of injury, the release of specific neurotransmitters, or the production of factors that promote neuronal growth. This review evaluates the use of transplants to promote recovery from brain injury and highlights the kinds of questions and problems that clinicians need to consider before recommending this form of therapy to patients.			STEIN, DG (corresponding author), RUTGERS STATE UNIV, INST ANIM BEHAV, BRAIN RES & CNS PLASTIC LAB, NEWARK, NJ 07102 USA.				NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 25685] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS025685] Funding Source: NIH RePORTER		AHLSKOG JE, 1990, MAYO CLIN PROC, V65, P305, DOI 10.1016/S0025-6196(12)62532-4; BACKAY R, 1990, NEURAL TRANSPLANTATI, P603; BACKLUND EO, 1985, NEURAL GRAFTING MAMM, P551; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bjorklund A, 1985, NEURAL GRAFTING MAMM, P3; Bjorklund A., 1985, NEURAL GRAFTING MAMM; BUZSAKI G, 1989, EXP NEUROL, V105, P10, DOI 10.1016/0014-4886(89)90167-2; CATTANACH BM, 1977, NATURE, V269, P338, DOI 10.1038/269338a0; CHOI DW, 1988, J NEUROSCI, V8, P185; CLARKE DJ, 1990, EXP NEUROL, V107, P11, DOI 10.1016/0014-4886(90)90059-2; COLLIER TJ, 1988, BRAIN RES, V448, P77, DOI 10.1016/0006-8993(88)91103-1; COLLIER TJ, 1988, ALZHEIMERS PARKINSON, P291; COLLIER TJ, 1985, HOMEOSTATIC FUNCTION; COTMAN CW, 1988, PROG BRAIN RES, V78, P311; COYLE JT, 1983, SCIENCE, V219, P1184, DOI 10.1126/science.6338589; DAS GD, 1990, NEUROSCI BIOBEHAV R, V14, P389, DOI 10.1016/S0149-7634(05)80061-2; DAS GD, 1983, NEURAL TISSUE TRANSP, P1; DUNBAR GL, 1988, PHARM APPROACHES TRE, P195; Dunn EH, 1917, J COMP NEUROL, V27, P565, DOI 10.1002/cne.900270403; FEENEY DM, 1987, CRIT REV NEUROBIOL, V3, P135; FIANDACA MS, 1988, PROG BRAIN RES, V78, P287; FINE A, 1990, BRAIN RES REV, V15, P121, DOI 10.1016/0165-0173(90)90014-F; FREED WJ, 1990, SCIENCE, V250, P1434; FREED WJ, 1981, NATURE, V292, P351, DOI 10.1038/292351a0; FREED WJ, 1990, EXP NEUROL, V110, P139, DOI 10.1016/0014-4886(90)90026-O; GAGE FH, 1984, SCIENCE, V225, P533, DOI 10.1126/science.6539949; GAGE FH, 1986, J NEUROSCI, V6, P2837; GAGE R, 1989, NEURAL GRAFTING ALZH; GASH DM, 1985, NEUROBIOL AGING, V6, P131, DOI 10.1016/0197-4580(85)90031-4; GASH DM, 1987, J NEURAL TRANSM, P301; GIBSON MJ, 1984, SCIENCE, V225, P949, DOI 10.1126/science.6382608; GOLDSTEIN M, 1990, ANN NEUROL, V27, P327, DOI 10.1002/ana.410270315; GREELEY HT, NEW ENGL J MED, V320, P1093; HANSEN JT, 1990, PROG BRAIN RES, V82, P573; HART T, 1978, BRAIN RES BULL, V3, P245, DOI 10.1016/0361-9230(78)90122-3; HODGES H, 1990, PROG BRAIN RES, V82, P347; IKEGAMI S, 1989, NEUROSCI LETT, V101, P17, DOI 10.1016/0304-3940(89)90433-3; KESSLAK JP, 1986, EXP NEUROL, V92, P377, DOI 10.1016/0014-4886(86)90089-0; KRIEGER DT, 1982, NATURE, V298, P468, DOI 10.1038/298468a0; LABBE R, 1983, SCIENCE, V221, P470, DOI 10.1126/science.6683427; LEE SM, 1990, PROG BRAIN RES, V82, P301; LINDEVALL O, 1985, ARCH NEUROL-CHICAGO, V6, P157; LINDVALL O, 1990, SCIENCE, V247, P574, DOI 10.1126/science.2105529; LOPEZLOZANO JJ, 1990, TRANSPL P, V22, P2243; LOW WC, 1985, NEURAL GRAFTING MAMM, P575; MADRAZO I, 1990, TRANSPLANTATION, V49, P1026, DOI 10.1097/00007890-199005000-00047; MADRAZO I, 1988, NEW ENGL J MED, V318, P51; MAHADIK SP, 1988, DRUG DEVELOP RES, V15, P337, DOI 10.1002/ddr.430150402; MATTSON MP, 1990, INT J DEV NEUROSCI, V8, P399, DOI 10.1016/0736-5748(90)90073-B; MUDRICK LA, 1989, EXP BRAIN RES, V76, P333; MUFSON EJ, 1987, BRAIN RES, V401, P162, DOI 10.1016/0006-8993(87)91177-2; NEUHAUS RJ, 1989, NAT REV, V41, P12; NICOLAS MK, 1988, TRANSPLANTATION MAMM, P249; Nieto-Sampedro M, 1988, PHARM APPROACHES TRE, P301; NIETOSAMPEDRO M, 1984, P NATL ACAD SCI-BIOL, V81, P6250, DOI 10.1073/pnas.81.19.6250; NIETOSAMPEDRO M, 1983, J NEUROSCI, V3, P2219; NILSSON OG, 1990, BRAIN RES, V515, P193, DOI 10.1016/0006-8993(90)90596-4; PERLOW MJ, 1979, SCIENCE, V204, P643, DOI 10.1126/science.571147; Polezhaev L.V., 1972, LOSS RESTORATION REG; POLLACK IF, 1990, EXP NEUROL, V108, P114, DOI 10.1016/0014-4886(90)90017-M; PORTERASANCHEZ A, 1987, NEUROPLASTICITY NEW, P9; Ramon y Cajal, 1928, DEGENERATION REGENER; RAO K, 1988, PROG BRAIN RES, V78, P281; Sabel B., 1988, PHARM APPROACHES TRE; SEGAL M, 1989, BRAIN RES, V500, P139, DOI 10.1016/0006-8993(89)90307-7; SILVERMAN AJ, 1990, BIOL REPROD, V42, P29, DOI 10.1095/biolreprod42.1.29; SLADEK JR, 1988, PROG BRAIN RES, V78, P497; STEECECOLLIER K, 1990, EXP NEUROL, V110, P201, DOI 10.1016/0014-4886(90)90031-M; STEIN DG, 1985, BEHAV NEURAL BIOL, V44, P266, DOI 10.1016/S0163-1047(85)90282-1; STEIN DG, 1988, BEHAV NEUROSCI, V102, P260, DOI 10.1037/0735-7044.102.2.260; STEIN DG, 1985, NEUROBIOL AGING, V6, P157, DOI 10.1016/0197-4580(85)90036-3; STEIN DG, 1987, ANN NY ACAD SCI, V495, P444, DOI 10.1111/j.1749-6632.1987.tb23693.x; STEIN DG, 1988, BRAIN INJURY RECOVER, P249; STEWART GR, 1990, EXP NEUROL, V110, P127, DOI 10.1016/0014-4886(90)90057-Y; STODDARD SL, 1989, EXP NEUROL, V104, P218, DOI 10.1016/0014-4886(89)90032-0; SUNDE N, 1984, NATURE, V310, P51, DOI 10.1038/310051a0; TAYLOR JR, 1990, NEURAL TRANSPLANTATI, P573; THOMPSON WG, 1890, NY MED J, V51, P701; WIDNER H, 1988, BRAIN RES REV, V13, P287, DOI 10.1016/0165-0173(88)90010-0; WILL B, 1989, RES PER ALZ, P189; WILL B, 1988, PHARM APPROACHES TRE, P339; WOODRUFF ML, 1990, PROG BRAIN RES, V82, P367; YONG VW, 1989, J NEUROL SCI, V94, P51, DOI 10.1016/0022-510X(89)90217-7	83	16	17	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	SEP	1991	3	3					170	189		10.1097/00008506-199109000-00002			20	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	GD661	WOS:A1991GD66100002	10150141				2022-02-06	
J	WOOLF, PD; COX, C; MCDONALD, JV; KELLY, M; NICHOLS, D; HAMILL, RW; FELICIANO, DV				WOOLF, PD; COX, C; MCDONALD, JV; KELLY, M; NICHOLS, D; HAMILL, RW; FELICIANO, DV			EFFECTS OF INTOXICATION ON THE CATECHOLAMINE RESPONSE TO MULTISYSTEM INJURY	JOURNAL OF TRAUMA-INJURY INFECTION AND CRITICAL CARE			English	Article; Proceedings Paper	4TH ANNUAL SCIENTIFIC ASSEMBLY OF THE EASTERN ASSOC FOR SURGERY OF TRAUMA	JAN 17-19, 1991	LONGBOAT KEY, FL	E ASSOC SURG TRAUMA			TRAUMATIC BRAIN INJURY; SEVERE HEAD-INJURY; PLASMA-CATECHOLAMINES; ALCOHOL; STRESS; NECROSIS; ETHANOL	In patients suffering isolated head trauma, we have previously shown that levels of circulating catecholamines obtained within 48 hours of trauma correlate with the severity of brain injury and predict outcome and that intoxication blunts this response. The effects of alcohol on the increase in catecholamines in systemically injured patients, however, have not been well defined. From 1983 to 1990, 78 patients (74% male; median age 30 years) with blunt head and multisystem injury, who also had alcohol levels measured within 5 hours of injury, were studied. Norepinephrine and epinephrine levels were assayed by a radioenzymatic technique. Injury severity was assessed by the admission Glasgow Coma Scale (GCS) score (4-15; median, 12), the Injury Severity Score (ISS) (13-50; median, 25) and the volume of blood products administered within the first 24 hours (0-14.4 L; median, 0.5 L). The impact of alcohol on the norepinephrine response to injury was analyzed using multiple linear regression models, including polynomial interaction terms. Norepinephrine levels significantly (p < 0.0001) correlated with the GCS score and ISS. However, alcohol significantly lowered the norepinephrine response to decreasing GCS score (R = 0.49, p < 0.002) and to increasing ISS (R = 0.51, p < 0.0006). The blunting of the catecholamine response was most marked in those severely injured. The rise in norepinephrine concentrations seen with increasing volume of blood replacement was not affected by intoxication. An association between injury severity and epinephrine levels was also present, but not as consistently. Epinephrine concentrations rose with falling GCS score and with increasing ISS values, but unlike norepinephrine, there were no apparent effects of alcohol on changes in epinephrine levels. Thus, in patients suffering head and multisystem injury, catecholamine changes reflect the severity of injury using three different scalers. Furthermore, intoxication blunts only the norepinephrine component of this important biologic response.	UNIV ROCHESTER,DEPT MED,ROCHESTER,NY 14642; UNIV ROCHESTER,DIV BIOSTAT,ROCHESTER,NY 14642; UNIV ROCHESTER,DIV NEUROSURG,ROCHESTER,NY 14642; UNIV ROCHESTER,DEPT NEUROL,ROCHESTER,NY 14642; UNIV ROCHESTER,DEPT SURG,ROCHESTER,NY 14642						NIAAA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [AA 7066] Funding Source: Medline		ARKWRIGHT PD, 1982, CIRCULATION, V66, P515, DOI 10.1161/01.CIR.66.3.515; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CLIFTON GL, 1983, J NEUROSURG, V59, P447, DOI 10.3171/jns.1983.59.3.0447; CLIFTON GL, 1985, CENTRAL NERVOUS SYST, P139; CRUICKSHANK JM, 1987, LANCET, V2, P585, DOI 10.1016/s0140-6736(87)92984-9; DAVIES CL, 1984, J TRAUMA, V24, P99, DOI 10.1097/00005373-198402000-00002; DRAPER NR, 1981, APPLIED REGRESSION A; EISENHOFER G, 1986, J PSYCHOSOM RES, V30, P93, DOI 10.1016/0022-3999(86)90070-X; GALBRAITH S, 1976, BRIT J SURG, V63, P128, DOI 10.1002/bjs.1800630210; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; HOWES LG, 1985, CLIN SCI, V69, P423, DOI 10.1042/cs0690423; HUTH JF, 1983, J TRAUMA, V23, P494, DOI 10.1097/00005373-198306000-00009; JAGGER J, 1908, NEUROSURGERY, V15, P303; JENNETT B, 1979, NEUROSURGERY, V4, P283, DOI 10.1227/00006123-197904000-00001; MCLEOD AA, 1982, BRIT HEART J, V47, P221; MUIZELAAR JP, 1985, CENTRAL NERVOUS SYST, P123; NEILDWYER G, 1978, BRIT MED J, V2, P990, DOI 10.1136/bmj.2.6143.990; NEWSOME HH, 1988, J TRAUMA, V28, P1, DOI 10.1097/00005373-198801000-00001; OPPENHEIMER SM, 1990, ARCH NEUROL-CHICAGO, V47, P513, DOI 10.1001/archneur.1990.00530050029008; PAYEN D, 1990, CRIT CARE MED, V18, P392, DOI 10.1097/00003246-199004000-00008; ROBERTSON CS, 1983, J NEUROSURG, V59, P455, DOI 10.3171/jns.1983.59.3.0455; SHOEMAKER WC, 1988, CHEST, V94, P1176, DOI 10.1378/chest.94.6.1176; TEASDALE G, 1974, LANCET, V2, P81; UDELSMAN R, 1987, J CLIN ENDOCR METAB, V64, P986, DOI 10.1210/jcem-64-5-986; WALLER PF, 1986, JAMA-J AM MED ASSOC, V256, P1461, DOI 10.1001/jama.256.11.1461; WARD RE, 1982, AM J SURG, V144, P153, DOI 10.1016/0002-9610(82)90617-1; WILMORE DW, 1974, ANN SURG, V180, P653, DOI 10.1097/00000658-197410000-00031; WOOLF PD, 1987, J NEUROSURG, V66, P875, DOI 10.3171/jns.1987.66.6.0875; WOOLF PD, 1990, ALCOHOL CLIN EXP RES, V14, P205, DOI 10.1111/j.1530-0277.1990.tb00473.x; 1985, ABBREVIATED INJURY S	31	16	17	0	3	WILLIAMS & WILKINS	BALTIMORE	351 WEST CAMDEN ST, BALTIMORE, MD 21201-2436	1079-6061			J TRAUMA	J. Trauma-Injury Infect. Crit. Care	SEP	1991	31	9					1271	1276		10.1097/00005373-199109000-00012			6	Critical Care Medicine; Surgery	Conference Proceedings Citation Index - Science (CPCI-S); Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	GH567	WOS:A1991GH56700013	1920559				2022-02-06	
J	JAEGER, CB; WINN, SR; TRESCO, PA; AEBISCHER, P				JAEGER, CB; WINN, SR; TRESCO, PA; AEBISCHER, P			REPAIR OF THE BLOOD-BRAIN-BARRIER FOLLOWING IMPLANTATION OF POLYMER CAPSULES	BRAIN RESEARCH			English	Article						RAT; MACROCAPSULE; ALBUMIN IMMUNOCYTOCHEMISTRY; NEURAL TRANSPLANTATION; EVANS BLUE	ENDOTHELIAL-CELLS; GROWTH-FACTOR; ASTROCYTES; IMMUNOFLUORESCENCE; VERTEBRATES; PATTERNS; INVITRO; TISSUE; RATS	Past studies of polymer-encapsulated cell lines implanted in the brain indicated their usefulness for transmitter replacement therapy in animal models. Such grafts may have potentially important clinical applications, but their placement into neural parenchyma may cause a traumatic injury resulting in a leaky blood-brain barrier around the implant. This study investigated whether or not injury repair and reformation of the barrier takes place near a polymer capsule implanted in the brain of Sprague-Dawley rats. The two methods used for detection of a leaky barrier were immunocytochemical localization of extravasated serum albumin and circulating Evans blue that binds to serum albumin. Immunocytochemical staining for glial filament protein provided a measure for evaluating injury associated gliosis. Polymer capsules implanted for 10, 16 and 18 days were surrounded by microvessels that leaked detectable quantities of serum albumin into interstitial spaces and, by secondary uptake, into some nearby neurons and reactive astrocytes. Reactive astroglia were observed within the outer regions of the capsule wall and in the near vicinity of the implant after these early survival times. In contrast, at post-implantation times of 46 and 54 days, serum albumin was no longer detected in the neural parenchyma near the macrocapsules and only few reactive astrocytes remained. These findings show that polymer capsules implanted within the cerebrum permit (a) reformation of the blood-brain barrier and (b) occurrence of repair processes that lead to minimal deposition of reactive astroglia near the implanted polymer capsule.	BROWN UNIV, ARTIFICIAL ORGAN LAB, PROVIDENCE, RI 02912 USA		JAEGER, CB (corresponding author), PURDUE UNIV, SCH VET MED, DEPT ANAT, CTR PARALYSIS RES, W LAFAYETTE, IN 47907 USA.		Aebischer, Patrick/E-1387-2013		NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS 27694] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS027694] Funding Source: NIH RePORTER		AEBISCHER P, 1991, EXP NEUROL, V111, P269, DOI 10.1016/0014-4886(91)90093-R; AEBISCHER P, 1988, BRAIN RES, V448, P364, DOI 10.1016/0006-8993(88)91278-4; BIGNAMI A, 1976, NEUROPATH APPL NEURO, V2, P99, DOI 10.1111/j.1365-2990.1976.tb00488.x; BLAKEMORE WF, 1969, J NEUROPATH EXP NEUR, V28, P139, DOI 10.1097/00005072-196901000-00008; Bradbury M.W.B., 1979, CONCEPT BLOOD BRAIN; CSERR HF, 1984, AM J PHYSIOL, V246, pR277, DOI 10.1152/ajpregu.1984.246.3.R277; FOLKMAN J, 1987, SCIENCE, V235, P442, DOI 10.1126/science.2432664; FREEDMAN FB, 1969, AM J PHYSIOL, V216, P675, DOI 10.1152/ajplegacy.1969.216.3.675; GOLDSTEIN GW, 1986, SCI AM, V255, P74, DOI 10.1038/scientificamerican0986-74; HYMER WC, 1981, NEUROENDOCRINOLOGY, V32, P339, DOI 10.1159/000123184; JAEGER CB, 1985, EXP BRAIN RES, V59, P615; JAEGER CB, 1985, J COMP NEUROL, V231, P121, DOI 10.1002/cne.902310110; JAEGER CB, 1986, ANN NY ACAD SCI, V481, P361; JANZER RC, 1987, NATURE, V325, P253, DOI 10.1038/325253a0; KARNOVSKY MJ, 1964, J HISTOCHEM CYTOCHEM, V12, P219, DOI 10.1177/12.3.219; KARNOVSKY MJ, 1967, J CELL BIOL, V35, P312; KRUM JM, 1988, J COMP NEUROL, V271, P331, DOI 10.1002/cne.902710304; MILICI AJ, 1985, P NATL ACAD SCI USA, V82, P6181, DOI 10.1073/pnas.82.18.6181; NITSCH C, 1983, J NEUROL SCI, V59, P305, DOI 10.1016/0022-510X(83)90016-3; POWELL EM, 1990, BRAIN RES, V515, P309, DOI 10.1016/0006-8993(90)90612-F; ROSENSTEIN JM, 1987, SCIENCE, V235, P772, DOI 10.1126/science.2433767; SAWADA M, 1989, BRAIN RES, V491, P394, DOI 10.1016/0006-8993(89)90078-4; SCHWEIGERER L, 1987, NATURE, V325, P257, DOI 10.1038/325257a0; TAOCHENG JH, 1987, J NEUROSCI, V7, P3293; WILMES F, 1979, ACTA NEUROPATHOL, V45, P47, DOI 10.1007/BF00691804; WINN SR, 1989, J BIOMED MATER RES, V23, P31, DOI 10.1002/jbm.820230104; WINN SR, 1990, NEUR ABSTR, V16, P39; WOLMAN M, 1981, ACTA NEUROPATHOL, V54, P55, DOI 10.1007/BF00691332	28	16	16	0	3	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0006-8993	1872-6240		BRAIN RES	Brain Res.	JUN 14	1991	551	1-2					163	170		10.1016/0006-8993(91)90929-P			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FV304	WOS:A1991FV30400025	1913150				2022-02-06	
J	RAPPAPORT, M; HEMMERLE, AV; RAPPAPORT, ML				RAPPAPORT, M; HEMMERLE, AV; RAPPAPORT, ML			INTERMEDIATE AND LONG LATENCY SEPS IN RELATION TO CLINICAL DISABILITY IN TRAUMATIC BRAIN INJURY PATIENTS	CLINICAL ELECTROENCEPHALOGRAPHY			English	Article											RAPPAPORT, M (corresponding author), AGNEWS DEV CTR,UC BRAIN FUNCT STUDY UNIT,RES BLDG,SAN JOSE,CA 95134, USA.						ALLISON T, 1987, EVOKED POTENTIALS, V3, pCH6; DATE ES, 1988, CLIN ELECTROENCEPHAL, V19, P144, DOI 10.1177/155005948801900308; JABBARI B, 1987, ELECTROEN CLIN NEURO, V67, P289, DOI 10.1016/0013-4694(87)90115-5; Klem G H, 1999, Electroencephalogr Clin Neurophysiol Suppl, V52, P3; LARREA LG, 1988, ELECTROEN CLIN NEURO, V71, P180, DOI 10.1016/0168-5597(88)90003-2; NEWLON PG, 1983, REHABILITATION HEAD, pCH6; RAPPAPORT M, 1985, CLIN ELECTROENCEPHAL, V16, P183, DOI 10.1177/155005948501600404; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P154, DOI 10.1177/155005948101200402; RAPPAPORT M, 1981, CLIN ELECTROENCEPHAL, V12, P167, DOI 10.1177/155005948101200403; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rappaport M, 1989, J HEAD TRAUMA REHAB, V4, P45; SCHWARZ G, 1988, Klinische Wochenschrift, V66, P48; SPHELMANN R, 1985, EVOKED POTENTIAL PRI, pCH15; TOMBERG C, 1989, ELECTROEN CLIN NEURO, V74, P347, DOI 10.1016/0168-5597(89)90002-6; VEILLEUX M, 1987, ELECTROEN CLIN NEURO, V68, P415, DOI 10.1016/0168-5597(87)90053-0; ZEMAN BD, 1989, J NEUROL NEUROSUR PS, V52, P242, DOI 10.1136/jnnp.52.2.242	16	16	16	0	0	CLINICAL EEG	ELM GROVE	850 ELM GROVE RD,SUITE 11, ELM GROVE, WI 53122	0009-9155			CLIN ELECTROENCEPHAL	Clin. Electroencephalogr.	OCT	1990	21	4					188	191		10.1177/155005949002100406			4	Engineering, Biomedical; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Neurosciences & Neurology	EB322	WOS:A1990EB32200005	2225467				2022-02-06	
J	Chute, DL; Conn, G; Dipasquale, MC; Hoag, M				Chute, Douglas L.; Conn, Gretchen; Dipasquale, Madeline C.; Hoag, Melanie			ProsthesisWare: A New Class of Software Supporting the Activities of Daily Living	NEUROPSYCHOLOGY			English	Article						Cognitive rehabilitation; aphasia; head injury; prosthesis; Macintosh computer; HyperCard		To use the microcomputer as a prosthetic tool in rehabilitation has a number of advantages over using it as a tutor for cognitive retraining. As a tool, the microcomputer program directly addresses ecologically relevant issues in activities of daily living. New classes of software like HyperCard (TM) and MacLaboratory Controller (c), can be readily customized for each patient's needs. Unlike tutors used for cognitive retraining, rehabilitation tools provide prosthetic support that does not presuppose any required reorganization or restructuring of damaged neural tissue. As this new approach to using microcomputers in rehabilitation is implemented, new types and styles of neuropsychological assessment will need to evolve, especially to provide sequential monitoring for adjustments to various iterations of the computer programs. We used the Macintosh (TM) computer with ProsthesisWare tools written in HyperCard for its ease and speed of design. The standard user interface relieves a patient's memory overburden by providing external function and sequencing cues. We present the case of Cecelia R., a patient with an expressive aphasia secondary to a traumatic brain injury. The development of successive approximations of a speech prosthesis for her-SpeakEasy (c), SpeakEasier (c), and SpeakEasiest (c)-illustrates how new hardware and software capabilities permit the rapid iterative design and redesign of cognitive prosthesis tools. This case also illustrates some limitations of the approach and new requirements that would be placed on the rehabilitation environment. We conclude that the emergence of ProsthesisWare constitutes a new application of microcomputers in rehabilitation that offers utilitarian prosthetic aids for the everyday activities of daily living for a select group of people with cognitive impairments.	[Chute, Douglas L.] Drexel Univ, Neuropsychol Program, Philadelphia, PA 19104 USA; Drexel Univ, Software Dev Grp, Philadelphia, PA 19104 USA		Chute, DL (corresponding author), Drexel Univ, Neuropsychol Program, Philadelphia, PA 19104 USA.				Apple Computer, Inc.; Drexel University; Solon Foundation	This work was supported in part by grants to Douglas L. Chute from Apple Computer, Inc., Drexel University, and the Solon Foundation. The authors thank Professor T.T. Hewett for his insights and suggestions.	BOWE F, 1984, PERSONAL COMPUTERS S; Bracy O, 1985, COGNITIVE REHABILITA, P10; BROOKS DN, 1976, NEUROPSYCHOLOGIA, V14, P111, DOI 10.1016/0028-3932(76)90012-9; Carr J, 1980, BEHAV MODIFICATION M; Chase W. G., 1981, COGNITIVE SKILLS THE; CHUTE D, 1988, MACLABORATORY PSYCHO; Chute D. L., 1987, ACAD COMP, V2, P40; Chute D. L., 1987, M NAT AC NEUR CHIC; Chute D. L., 1981, M CAN PSYCH ASS TOR; Chute D.L., 1988, SPEAKEASY SPEAKEASIE; CHUTE DL, 1986, BEHAV RES METH INSTR, V18, P205, DOI 10.3758/BF03201023; CHUTE DL, 1987, BEHAV RES METH INSTR, V19, P205, DOI 10.3758/BF03203786; Cohen N. J., 1984, NEUROPSYCHOLOGY MEMO, P83; CRAIK FIM, 1972, J VERB LEARN VERB BE, V11, P671, DOI 10.1016/S0022-5371(72)80001-X; DILLER L, 1981, J CONSULT CLIN PSYCH, V49, P822, DOI 10.1037/0022-006X.49.6.822; Erikson R.C., 1977, PSYCHOL BULL, V84, P1130; Gianutsos R., 1980, J REHABIL, P37; GIANUTSOS R, 1987, REHABIL PSYCHOL, P453; Hayden M.E., 1987, WORKSH M NAT AC NEUR; Hewett T.T., 1986, BEHAV RES INSTRUMENT, V19, P188; HEWETT TA, 1986, PEOPLE COMPUTERS DES; Hutchins S., 1987, J REHABILITATION RES, V25, P340; Incagnoli T., 1986, CLIN APPL NEUROPSYCH, P1; INTONSPETERSON MJ, 1986, J EXP PSYCHOL GEN, V115, P267, DOI 10.1037/0096-3445.115.3.267; Jacoby L.L., 1979, LEVELS PROCESSING HU, P1; JONES GH, 1979, B BRIT PSYCHOL SOC, V32, P165; Lynch W. J., 1988, M PHIL CLIN NEUR GRO; MAYER NH, 1986, CLIN NEUROPSYCHOLOGY, P205; Moscovitch M., 1984, NEUROPSYCHOLOGY MEMO, P104; Parkin A. J., 1987, MEMORY AMNESIA INTRO; Perkey M. N., 1986, BEHAV RES INSTRUMENT, V19, P196; Prigatano G., 1987, J NEUROL NEUROSUR PS, V47, P505; Russell EW, 1987, NEUROPSYCHOLOGY, V1, P2; Schacter DL, 1986, CLIN NEUROPSYCHOLOGY, P257; Schofield J. M., 1981, MICROCOMPUTER BASED; Shute G., 1986, ARCH CLIN NEUROPSYCH, V1, P259; Smith A. L., 1984, Collegiate Microcomputer, V2, P107; Syndulko K., 1983, AGING TECHNOLOGICAL; WILSON B, 1987, J CLIN EXP NEUROPSYC, V9, P527, DOI 10.1080/01688638708410767; WILSON B, 1987, REHABILITATION MEMOR; Wilson B. A., 1985, RIVERMEADE BEHAV MEM; WILSON BA, 1983, EVERYDAY MEMORY ACTI; [No title captured]	43	16	16	0	2	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology		1988	2	1					41	57		10.1037//0894-4105.2.1.41			17	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	V44JQ	WOS:000209745700005					2022-02-06	
J	DAVIDOFF, G; ROTH, E; MORRIS, J; BLEIBERG, J; MEYER, PR				DAVIDOFF, G; ROTH, E; MORRIS, J; BLEIBERG, J; MEYER, PR			ASSESSMENT OF CLOSED HEAD-INJURY IN TRAUMA-RELATED SPINAL-CORD INJURY	PARAPLEGIA			English	Article									REHABIL INST CHICAGO,DEPT PSYCHOL,ROOM 903,345 E SUPER,CHICAGO,IL 60611; NORTHWESTERN UNIV,SCH MED,DEPT REHABIL MED,CHICAGO,IL 60611					Bleiberg, Joseph/0000-0003-0867-5494				0	16	16	0	1	STOCKTON PRESS	BASINGSTOKE	HOUNDMILLS, BASINGSTOKE, HAMPSHIRE, ENGLAND RG21 6XS	0031-1758			PARAPLEGIA	Paraplegia		1986	24	2					97	104		10.1038/sc.1986.13			8	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	A9933	WOS:A1986A993300004	3714296	Bronze			2022-02-06	
J	OLBRICH, HM; NAU, HE; ZERBIN, D; LANCZOS, L; LODEMANN, E; ENGELMEIER, MP; GROTE, W				OLBRICH, HM; NAU, HE; ZERBIN, D; LANCZOS, L; LODEMANN, E; ENGELMEIER, MP; GROTE, W			CLINICAL-APPLICATION OF EVENT RELATED POTENTIALS IN PATIENTS WITH BRAIN-TUMORS AND TRAUMATIC HEAD-INJURIES	ACTA NEUROCHIRURGICA			English	Article									UNIV ESSEN GESAMTHSCH KLINIKUM,NEUROSURG CLIN,D-4300 ESSEN 1,FED REP GER		OLBRICH, HM (corresponding author), UNIV ESSEN GESAMTHSCH KLINIKUM,DEPT PSYCHIAT,HUFELANDSTR 55,D-4300 ESSEN 1,FED REP GER.						Brown W S, 1982, Bull Los Angeles Neurol Soc, V47, P91; Callaway E, 1978, EVENT RELATED BRAIN; COURJON J, 1982, CLIN APPLICATIONS EV; GAILLARD AW, 1983, TUTORIALS EVENT RELA; GOODIN DS, 1978, BRAIN, V101, P635, DOI 10.1093/brain/101.4.635; HALGREN E, 1980, SCIENCE, V210, P803, DOI 10.1126/science.7434000; HALLIDAY AM, 1982, EVOKED POTENTIALS CL; JOHNSON R, 1983, 7 INT C EV REL POT B, P182; KNIGHT RT, 1980, ELECTROEN CLIN NEURO, V50, P112, DOI 10.1016/0013-4694(80)90328-4; MICHEL F, 1980, BRAIN LANG, V10, P367, DOI 10.1016/0093-934X(80)90062-0; OKADA YC, 1983, ELECTROEN CLIN NEURO, V55, P417, DOI 10.1016/0013-4694(83)90130-X; OWEN MP, 1980, SURG NEUROL, V12, P271; PERONNET F, 1977, PROGR CLIN NEUROPHYS, V2, P130; PFEFFERBAUM A, 1984, ELECTROEN CLIN NEURO, V59, P104, DOI 10.1016/0168-5597(84)90027-3; RAUDZENS PA, 1982, J NEUROSURG, V57, P341, DOI 10.3171/jns.1982.57.3.0341; RITTER W, 1983, PSYCHOPHYSIOLOGY, V20, P168, DOI 10.1111/j.1469-8986.1983.tb03283.x; Ritter W., 1983, TUTORIALS ERP RES EN, P143; SIMSON R, 1976, ELECTROEN CLIN NEURO, V40, P33, DOI 10.1016/0013-4694(76)90177-2; Syndulko K, 1982, Adv Neurol, V32, P279; VAUGHAN HG, 1970, ELECTROEN CLIN NEURO, V28, P360, DOI 10.1016/0013-4694(70)90228-2; Wood C C, 1980, Prog Brain Res, V54, P51, DOI 10.1016/S0079-6123(08)61605-2; WOOD CC, 1984, ANN NY ACAD SCI, V425, P681, DOI 10.1111/j.1749-6632.1984.tb23595.x; 1977, CIPS COLLEGIUM INT P	23	16	16	0	0	SPRINGER-VERLAG WIEN	VIENNA	SACHSENPLATZ 4-6, PO BOX 89, A-1201 VIENNA, AUSTRIA	0001-6268			ACTA NEUROCHIR	Acta Neurochir.		1986	80	3-4					116	122		10.1007/BF01812285			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	C0732	WOS:A1986C073200009	3716890				2022-02-06	
J	FROEDE, RC; LINDSEY, D; STEINBRONN, K				FROEDE, RC; LINDSEY, D; STEINBRONN, K			SUDDEN UNEXPECTED DEATH FROM CARDIAC CONCUSSION (COMMOTIO CORDIS) WITH UNUSUAL LEGAL COMPLICATIONS	JOURNAL OF FORENSIC SCIENCES			English	Article											FROEDE, RC (corresponding author), UNIV ARIZONA,COLL MED,DEPT PATHOL,TUCSON,AZ 85724, USA.							0	16	16	1	2	AMER SOC TESTING MATERIALS	W CONSHOHOCKEN	100 BARR HARBOR DR, W CONSHOHOCKEN, PA 19428-2959	0022-1198			J FORENSIC SCI	J. Forensic Sci.		1979	24	4					752	756					5	Medicine, Legal	Science Citation Index Expanded (SCI-EXPANDED)	Legal Medicine	HR364	WOS:A1979HR36400006	541638				2022-02-06	
J	LEWIN, W				LEWIN, W			FACTORS IN THE MORTALITY OF CLOSED HEAD INJURIES	BMJ-BRITISH MEDICAL JOURNAL			English	Article																	CAMERON GR, 1948, BRIT MED J, V1, P965, DOI 10.1136/bmj.1.4559.965; Cumings JN, 1942, J NEUROL PSYCHIATRY, V5, P40, DOI 10.1136/jnnp.5.1-2.40; ECHOLS DH, 1950, SURGERY, V28, P801; HIGGINS G, 1951, LANCET, V260, P1295; HIGGINS G, 1953, IN PRESS LANCET; HOWKINS J, 1946, LANCET, V250, P488; JAMES TGI, 1951, LANCET, V261, P45; LEWIN W, 1949, ANN ROY COLL SURG, V5, P240; Munro D., 1938, CRANIO CEREBRAL INJU	9	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal		1953	1	4822					1239	1244		10.1136/bmj.1.4822.1239			6	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	XV212	WOS:A1953XV21200002	13042203	Green Published			2022-02-06	
J	WARD, JW; CLARK, SL				WARD, JW; CLARK, SL			THE ELECTROENCEPHALOGRAM IN EXPERIMENTAL CONCUSSION AND RELATED CONDITIONS	JOURNAL OF NEUROPHYSIOLOGY			English	Article																	Beecher HK, 1938, J NEUROPHYSIOL, V1, P324, DOI 10.1152/jn.1938.1.4.324; BERGER H, 1931, ARCH PSYCHIAT NERVEN, V94, P20; Clark S. L., 1943, SURG GYNECOL OBSTET, V77, P403; CLARK SL, 1945, J NEUROPHYSIOL, V8, P99; Clark SL, 1939, J NEUROPHYSIOL, V2, P19, DOI 10.1152/jn.1939.2.1.19; CLARK SL, 1944, ANAT REC, V88, P10; Cobb WA, 1944, J NEUROL NEUROSUR PS, V7, P96, DOI 10.1136/jnnp.7.3-4.96; Cushing H, 1902, AM J MED SCI, V124, P375, DOI 10.1097/00000441-190209000-00001; DOW RS, 1945, J NEUROPHYSIOL, V8, P161; Dubner HH, 1939, J NEUROPHYSIOL, V2, P142; Forster FM, 1942, ARCH NEURO PSYCHIATR, V47, P449, DOI 10.1001/archneurpsyc.1942.02290030107009; GERMAN WJ, 1944, J NEUROSURG, V1, P350; Gibbs FA, 1940, J NEUROPHYSIOL, V3, P49, DOI 10.1152/jn.1940.3.1.49; GIBBS FA, 1941, T AM NEUROL ASSOC, V67, P143; Grinker RR, 1938, J NEUROPHYSIOL, V1, P573, DOI 10.1152/jn.1938.1.6.573; Groat RA, 1944, AM J PHYSIOL, V141, P0117, DOI 10.1152/ajplegacy.1944.141.1.117; Heinbecker P, 1940, J NEUROPHYSIOL, V3, P219, DOI 10.1152/jn.1940.3.3.219; Hoagland H, 1939, J NEUROPHYSIOL, V2, P276, DOI 10.1152/jn.1939.2.4.276; Holbourn AHS, 1943, LANCET, V2, P438; Kennard MA, 1943, J NEUROPHYSIOL, V6, P233, DOI 10.1152/jn.1943.6.4.233; KREMS A. D., 1942, PROC SOC EXP BIOL AND MED, V49, P73; Krohn PL, 1942, LANCET, V1, P252; Lowenbach H, 1940, J NEUROL PSYCHIATRY, V3, P336, DOI 10.1136/jnnp.3.4.336; Mott FW, 1916, LANCET, V1, P331; Obrador S, 1943, J NEUROPHYSIOL, V6, P81; Rubin MA, 1940, J NEUROPHYSIOL, V3, P33; Rubin MA, 1938, J NEUROPHYSIOL, V1, P527; Scott WW, 1940, ARCH NEURO PSYCHIATR, V43, P270, DOI 10.1001/archneurpsyc.1940.02280020078006; Stewart WA, 1941, B JOHNS HOPKINS HOSP, V69, P240; Sugar O, 1938, J NEUROPHYSIOL, V1, P558, DOI 10.1152/jn.1938.1.6.558; TENCATE J, 1940, ARCH NEERL PHYSIOL, V25, P27; Walker AE, 1944, J NEUROSURG, V1, P103, DOI 10.3171/jns.1944.1.2.0103; Walter W G, 1937, Proc R Soc Med, V30, P579; Walter WG, 1938, J NEUROL PSYCHIATRY, V1, P359, DOI 10.1136/jnnp.1.4.359; Williams D, 1941, BRAIN, V64, P223, DOI 10.1093/brain/64.4.223; Williams D, 1939, BRAIN, V62, P321, DOI 10.1093/brain/62.3.321; Windle W. F., 1944, SURG GYNECOL AND OBSTET, V79, P561	37	16	16	0	0	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814	0022-3077			J NEUROPHYSIOL	J. Neurophysiol.		1948	11	2					59	74		10.1152/jn.1948.11.2.59			16	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	XZ785	WOS:A1948XZ78500001	18905648				2022-02-06	
J	Osborn, GR				Osborn, GR			Pulmonary concussion ("Blast")	BMJ-BRITISH MEDICAL JOURNAL			English	Article																	[Anonymous], 1940, BRIT MED J, V1, P992; Hadfield G, 1941, BRIT MED J, V1941, P77, DOI 10.1136/bmj.1.4176.77; Hadfield G, 1940, LANCET, V2, P478; Osborn G R, 1940, Br Med J, V2, P317; Ross JM, 1941, BMJ-BRIT MED J, V1941, P79, DOI 10.1136/bmj.1.4176.79; TAYLOR, 1928, PRINCIPLES PRACTICE, V1, P609; TAYLOR, 1928, PRINCIPLES PRACTICE, V1, P613; Zuckerman S, 1940, LANCET, V2, P219; ZUCKERMAN S, 1941, BRIT MED J, V1, P94; 1940, LANCET, V2, P369	10	16	16	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	1756-1833			BMJ-BRIT MED J	BMJ-British Medical Journal	JAN-JUN	1941	1941		1				506	510		10.1136/bmj.1.4187.506			5	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	V07WL	WOS:000200531500535	20783596	Green Published			2022-02-06	
J	Zeiler, FA; Ercole, A; Cabeleira, M; Beqiri, E; Zoerle, T; Carbonara, M; Stocchetti, N; Menon, DK; Lazaridis, C; Smielewski, P; Czosnyka, M				Zeiler, Frederick A.; Ercole, Ari; Cabeleira, Manuel; Beqiri, Erta; Zoerle, Tommaso; Carbonara, Marco; Stocchetti, Nino; Menon, David K.; Lazaridis, Christos; Smielewski, Peter; Czosnyka, Marek		CTR-TBI High Resolution ICU Sub-St	Patient-specific ICP Epidemiologic Thresholds in Adult Traumatic Brain Injury: A CENTER-TBI Validation Study	JOURNAL OF NEUROSURGICAL ANESTHESIOLOGY			English	Article						ICP threshold; individual ICP threshold; patient-specific thresholds; pressure reactivity; PRx	CEREBRAL PERFUSION-PRESSURE; NEUROTRAUMA EFFECTIVENESS RESEARCH; INTRACRANIAL-PRESSURE; REACTIVITY; AUTOREGULATION; MANAGEMENT	Background: Patient-specific epidemiologic intracranial pressure (ICP) thresholds in adult traumatic brain injury (TBI) have emerged, using the relationship between pressure reactivity index (PRx) and ICP, displaying stronger association with outcome over existing guideline thresholds. The goal of this study was to explore this relationship in a multi-center cohort in order to confirm the previous finding. Methods: Using the Collaborative European Neuro Trauma Effectiveness Research in TBI (CENTER-TBI) high-resolution intensive care unit cohort, we derived individualized epidemiologic ICP thresholds for each patient using the relationship between PRx and ICP. Mean hourly dose of ICP was calculated for every patient for the following thresholds: 20, 22 mm Hg and the patient's individual ICP threshold. Univariate logistic regression models were created comparing mean hourly dose of ICP above thresholds to dichotomized outcome at 6 to 12 months, based on Glasgow Outcome Score-Extended (GOSE) (alive/dead-GOSE >= 2/GOSE=1; favorable/unfavorable-GOSE 5 to 8/GOSE 1 to 4, respectively). Results: Individual thresholds were identified in 65.3% of patients (n=128), in keeping with previous results (23.0 +/- 11.8 mm Hg [interquartile range: 14.9 to 29.8 mm Hg]). Mean hourly dose of ICP above individual threshold provides superior discrimination (area under the receiver operating curve [AUC]=0.678, P=0.029) over mean hourly dose above 20 mm Hg (AUC=0.509, P=0.03) or above 22 mm Hg (AUC=0.492, P=0.035) on univariate analysis for alive/dead outcome at 6 to 12 months. The AUC for mean hourly dose above individual threshold trends to higher values for favorable/unfavorable outcome, but fails to reach statistical significance (AUC=0.610, P=0.060). This was maintained when controlling for baseline admission characteristics. Conclusions: Mean hourly dose of ICP above individual epidemiologic ICP threshold has stronger associations with mortality compared with the dose above Brain Trauma Foundation defined thresholds of 20 or 22 mm Hg, confirming prior findings. Further studies on patient-specific epidemiologic ICP thresholds are required.	[Zeiler, Frederick A.; Ercole, Ari; Menon, David K.] Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Zeiler, Frederick A.; Cabeleira, Manuel; Beqiri, Erta; Smielewski, Peter; Czosnyka, Marek] Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zoerle, Tommaso; Carbonara, Marco; Stocchetti, Nino] Milan Univ, Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Beqiri, Erta; Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Lazaridis, Christos] Univ Chicago, Dept Neurol, Sect Neurocrit Care, 5841 S Maryland Ave, Chicago, IL 60637 USA; [Lazaridis, Christos] Univ Chicago, Dept Neurosurg, Sect Neurocrit Care, Chicago, IL 60637 USA; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Addenbrookes Hosp, Div Anaesthesia, Cambridge, England.; Zeiler, FA (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada.; Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada.	umzeiler@myumanitoba.ca	Ercole, Ari/B-6288-2009	Ercole, Ari/0000-0001-8350-8093; Zeiler, Frederick/0000-0003-1737-0510; Takala, Riikka/0000-0001-6342-0043	European Union 7th Framework program (EC grant) [602150]; National Institute for Health Research (NIHR, UK)National Institute for Health Research (NIHR); Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust; NIHR Clinical Research network; University of Manitoba Rudy Falk ClinicianScientist Professorship; Hannelore Kohl Stiftung (Germany); OneMind; Integra LifeSciences Corporation	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind and from Integra LifeSciences Corporation. D.K.M. was also supported by funding from the National Institute for Health Research (NIHR, UK) through a Senior Investigator award and the Cambridge Biomedical Research Centre at the Cambridge University Hospitals NHS Foundation Trust. The study also received additional support from the NIHR Clinical Research network. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR or the Department of Health and Social Care, UK. F.A.Z. is supported by the University of Manitoba Thorlakson Chair for Surgical Research Establishment Grant, University of Manitoba VPRI Research Investment Fund (RIF), Winnipeg Health Sciences Centre (HSC) Foundation, and the University of Manitoba Rudy Falk ClinicianScientist Professorship.	Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Calviello L, 2018, NEUROCRIT CARE, V28, P212, DOI 10.1007/s12028-017-0475-7; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Fan JY, 2008, AM J CRIT CARE, V17, P545; Lazaridis C, 2016, ACTA NEUROCHIR SUPPL, V122, P117, DOI 10.1007/978-3-319-22533-3_23; Lazaridis C, 2014, J NEUROSURG, V120, P892; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Needham E, 2017, J NEUROTRAUM, V34, P963, DOI 10.1089/neu.2016.4450; Nucci CG, 2016, ACTA NEUROCHIR, V158, P581, DOI 10.1007/s00701-015-2672-5; Ropper AE, 2013, NEUROSURGERY, V72, pN19, DOI 10.1227/01.neu.0000428424.83867.87; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Zeiler FA, 2018, J NEUROTRAUM, V35, P2803, DOI 10.1089/neu.2017.5603; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zeiler FA, 2018, ACTA NEUROCHIR, V160, P2277, DOI 10.1007/s00701-018-3681-y; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	24	15	15	1	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0898-4921	1537-1921		J NEUROSURG ANESTH	J. Neurosurg. Anesthesiol.	JAN	2021	33	1					28	38		10.1097/ANA.0000000000000616			11	Anesthesiology; Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology; Neurosciences & Neurology; Surgery	PG4LS	WOS:000599709000007	31219937	Green Submitted	Y	N	2022-02-06	
J	Jayakumar, N; Kennion, O; Villabona, AR; Paranathala, M; Holliman, D				Jayakumar, Nithish; Kennion, Oliver; Villabona, Alvaro Rojas; Paranathala, Menaka; Holliman, Damian			Neurosurgical Referral Patterns During the Coronavirus Disease 2019 Pandemic: A United Kingdom Experience	WORLD NEUROSURGERY			English	Article						COVID-19; Neurosurgery; Pandemics; Physicians; Practice patterns; Referral and consultation; Workload	COVID-19	BACKGROUND: Coronavirus disease 2019 (COVID-19) is a severe respiratory viral illness that has spread rapidly across the world. However, the United Kingdom has been particularly affected. Evidence has suggested that stroke, cardiac, and spinal presentations decreased during the pandemic as the public avoided seeking care. The effect on neurosurgical presentations and referrals during COVID-19 is unclear. Our aim, therefore, was to describe the referral patterns to a high-volume neurosurgical department in the United Kingdom during the COVID-19 pandemic. METHODS: Electronic referrals were identified from the referrals database from January 1, 2020 to May 31, 2020, inclusive, with January used as the baseline. The demographic data and referral diagnoses were captured on Excel (Microsoft, Redmond, Washington, USA). Statistical analyses were performed using SPSS, version 22 (IBM Corp., Armonk, New York, USA). Differences between referral volumes were evaluated using chi(2) goodness-of-fit tests. RESULTS: A total of 2293 electronic referrals had been received during the study period. The median age was 63 years. Overall, the referrals had decreased significantly in volume during the study period [chi(2)(4) = 60.95; P < 0.001]. We have described the patterns in the daily referrals as the pandemic progressed. The reduction in the volume of referrals for degenerative spine cases and traumatic brain injuries was statistically significant (P < 0.001). CONCLUSIONS: The referrals for degenerative spine and traumatic brain injuries decreased significantly during the pandemic, which can be explained by the lower vehicular traffic and patient avoidance of healthcare services, respectively. The risk of neurological deterioration and increased morbidity and mortality, as a consequence, is of concern, and neurosurgeons worldwide should consider the optimal strategies to mitigate these risks as the pandemic eases.	[Jayakumar, Nithish; Kennion, Oliver; Villabona, Alvaro Rojas; Paranathala, Menaka; Holliman, Damian] Royal Victoria Infirm, Dept Neurosurg, Newcastle Upon Tyne, Tyne & Wear, England		Jayakumar, N (corresponding author), Royal Victoria Infirm, Dept Neurosurg, Newcastle Upon Tyne, Tyne & Wear, England.	nithish.jayakumar90@gmail.com	Paranathala, Menaka/AAM-6673-2020	Paranathala, Menaka/0000-0002-9272-5441; Kennion, Oliver/0000-0003-3128-9401			Agosti E, 2020, SPINAL CORD, V58, P726, DOI 10.1038/s41393-020-0480-0; [Anonymous], 2020, BBC NEWS; Bamps Sven, 2020, Surg Neurol Int, V11, P75, DOI 10.25259/SNI_153_2020; Brembilla C, 2020, NEUROSPINE, V17, P354, DOI 10.14245/ns.2040268.134; Cabrera JP, 2020, WORLD NEUROSURG, V139, P724, DOI 10.1016/j.wneu.2020.05.003; Cofano F, 2020, NEUROSURGERY, V87, pE211, DOI 10.1093/neuros/nyaa174; Dixon H, ENGLAND GETS BACK RO; Finlay I, 2020, BMJ-BRIT MED J, V369, DOI 10.1136/bmj.m1987; Ghogawala Z, J NEUROSURG SPINE, DOI 10.3171/2020.4.SPINE20468; GOV.UK, COR COVID 19 UK; Haagsma JA, 2016, INJURY PREV, V22, P3, DOI 10.1136/injuryprev-2015-041616; Mehta AI, 2020, SPINE, V45, P942, DOI 10.1097/BRS.0000000000003571; Rihn JA, 2011, J BONE JOINT SURG AM, V93A, P1906, DOI 10.2106/JBJS.J.00878; Roxby P., 2020, BBC NEWS; Royal College of Surgeons, REC SURG SERV COVID; Samson K, 2020, NEUROL TODAY, V20, P1; Schraer R., 2020, BBC NEWS; Stewart H, 2020, GUARDIAN; Tartara F, 2020, ACTA NEUROCHIR, V162, P1501, DOI 10.1007/s00701-020-04385-8; Teo KC, 2020, STROKE, V51, P2228, DOI 10.1161/STROKEAHA.120.030105; The Society of British Neurosurgeons, COVID 19 GUID; Tsermoulas G, 2020, WORLD NEUROSURG, V139, P519, DOI 10.1016/j.wneu.2020.05.108; WHO, 2014, INJ VIOL FACTS 2014; Wilson MP, 2020, CLIN NEUROL NEUROSUR, V193, DOI 10.1016/j.clineuro.2020.105866; World Health Organization, WHO COR DIS COVID 19; World Stoke Organization, GLOB IMP COVID 19 ST	26	15	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2020	144						E414	E420		10.1016/j.wneu.2020.08.162			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	PH8PV	WOS:000600668300048	32890845	Bronze, Green Published			2022-02-06	
J	DeKosky, ST; Kochanek, PM; Valadka, AB; Clark, RSB; Chou, SHY; Au, AK; Horvat, C; Jha, RM; Mannix, R; Wisniewski, SR; Wintermark, M; Rowell, SE; Welch, RD; Lewis, L; House, S; Tanzi, RE; Smith, DR; Vittor, AY; Denslow, ND; Davis, MD; Glushakova, OY; Hayes, RL				DeKosky, Steven T.; Kochanek, Patrick M.; Valadka, Alex B.; Clark, Robert S. B.; Chou, Sherry H. -Y.; Au, Alicia K.; Horvat, Christopher; Jha, Ruchira M.; Mannix, Rebekah; Wisniewski, Stephen R.; Wintermark, Max; Rowell, Susan E.; Welch, Robert D.; Lewis, Lawrence; House, Stacey; Tanzi, Rudolph E.; Smith, Darci R.; Vittor, Amy Y.; Denslow, Nancy D.; Davis, Michael D.; Glushakova, Olena Y.; Hayes, Ronald L.			Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients	JOURNAL OF NEUROTRAUMA			English	Article						blood biomarkers; CNS injury; COVID-19; GFAP; SARS-CoV-2; UCH-L1	FIBRILLARY ACIDIC PROTEIN; NEURON-SPECIFIC ENOLASE; C-TERMINAL HYDROLASE-L1; ACUTE ISCHEMIC-STROKE; TARGETED TEMPERATURE MANAGEMENT; HOSPITAL CARDIAC-ARREST; CEREBROSPINAL-FLUID; INTRACEREBRAL HEMORRHAGE; PROGNOSTIC VALUE; SERUM-LEVELS	The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus attacks multiple organs of coronavirus disease 2019 (COVID-19) patients, including the brain. There are worldwide descriptions of neurological deficits in COVID-19 patients. Central nervous system (CNS) symptoms can be present early in the course of the disease. As many as 55% of hospitalized COVID-19 patients have been reported to have neurological disturbances three months after infection by SARS-CoV-2. The mutability of the SARS-COV-2 virus and its potential to directly affect the CNS highlight the urgency of developing technology to diagnose, manage, and treat brain injury in COVID-19 patients. The pathobiology of CNS infection by SARS-CoV-2 and the associated neurological sequelae of this infection remain poorly understood. In this review, we outline the rationale for the use of blood biomarkers (BBs) for diagnosis of brain injury in COVID-19 patients, the research needed to incorporate their use into clinical practice, and the improvements in patient management and outcomes that can result. BBs of brain injury could potentially provide tools for detection of brain injury in COVID-19 patients. Elevations of BBs have been reported in cerebrospinal fluid (CSF) and blood of COVID-19 patients. BB proteins have been analyzed in CSF to detect CNS involvement in patients with infectious diseases, including human immunodeficiency virus and tuberculous meningitis. BBs are approved by the U.S. Food and Drug Administration for diagnosis of mild versus moderate traumatic brain injury and have identified brain injury after stroke, cardiac arrest, hypoxia, and epilepsy. BBs, integrated with other diagnostic tools, could enhance understanding of viral mechanisms of brain injury, predict severity of neurological deficits, guide triage of patients and assignment to appropriate medical pathways, and assess efficacy of therapeutic interventions in COVID-19 patients.	[DeKosky, Steven T.] Univ Florida, Coll Med, McKnight Brain Inst, Gainesville, FL USA; [Kochanek, Patrick M.] Univ Pittsburgh, Dept Anesthesiol Pediat Bioengn & Clin & Translat, Dept Crit Care Med, Safar Ctr Resuscitat Res,Sch Med,UPMC Childrens H, Pittsburgh, PA USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA USA; [Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Chou, Sherry H. -Y.] Univ Pittsburgh, Dept Crit Care Med Neurol & Neurosurg, Pittsburgh, PA USA; [Au, Alicia K.] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Pittsburgh, PA USA; [Horvat, Christopher] Univ Pittsburgh, UPMC Childrens Hosp Pittsburgh, Div Pediat Crit Care, Dept Crit Care Med,Sch Med, Pittsburgh, PA USA; [Jha, Ruchira M.] Univ Pittsburgh, Dept Crit Med, Clin & Translat Sci Inst, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Jha, Ruchira M.] Univ Pittsburgh, Dept Neurol, Clin & Translat Sci Inst, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Jha, Ruchira M.] Univ Pittsburgh, Dept Neurol Surg, Clin & Translat Sci Inst, Safar Ctr Resuscitat Res, Pittsburgh, PA 15260 USA; [Mannix, Rebekah] Harvard Med Sch, Boston Childrens Hosp, Div Emergency Med, Dept Pediat & Emergency Med,Dept Med, Boston, MA 02115 USA; [Wisniewski, Stephen R.] Univ Pittsburgh, Pittsburgh, PA USA; [Wintermark, Max] Stanford Univ, Dept Neuroradiol, Stanford, CA 94305 USA; [Rowell, Susan E.] Duke Univ, Sch Med, Durham, NC USA; [Welch, Robert D.] Wayne State Univ, Sch Med, Dept Emergency Med, Detroit Receiving Hosp,Univ Hlth Ctr, Detroit, MI USA; [Lewis, Lawrence] Washington Univ, Dept Emergency Med, St Louis, MO 63110 USA; [House, Stacey] Washington Univ, Sch Med, Dept Emergency Med, St Louis, MO USA; [Tanzi, Rudolph E.] Harvard Med Sch, Massachusetts Gen Hosp, Genet & Aging Res Unit,Dept Neurol Res,Dept Neuro, McCance Ctr Brain Hlth,Mass Gen Inst Neurodegener, Charlestown, MA USA; [Smith, Darci R.] US Navy, Immunodiagnost Dept, Med Res Ctr, Biol Def Res Directorate, Ft Detrick, MD USA; [Vittor, Amy Y.] Univ Florida, Emerging Pathogens Inst, Div Infect Dis & Global Med, Gainesville, FL USA; [Denslow, Nancy D.] Univ Florida, Dept Physiol Sci, Ctr Environm & Human Toxicol, Gainesville, FL 32610 USA; [Denslow, Nancy D.] Univ Florida, Dept Biochem & Mol Biol, Ctr Environm & Human Toxicol, Gainesville, FL 32610 USA; [Davis, Michael D.] Indiana Univ, Riley Hosp Children, Dept Pediat, Wells Ctr Pediat Res Pulmonol Allergy & Sleep Med, Indianapolis, IN 46204 USA; [Glushakova, Olena Y.] Univ Virginia, Canc Ctr, Charlottesville, VA 22908 USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, 13400 Progress Blvd, Alachua, FL 32615 USA		Hayes, RL (corresponding author), Banyan Biomarkers Inc, 13400 Progress Blvd, Alachua, FL 32615 USA.	rhayes@banyanbio.com	Glushakova, Olena/AAY-1130-2021	Glushakova, Olena/0000-0002-2109-3651	National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [P01 HL128192]; Indiana Clinical and Translational Sciences Institute; Lilly Endowment; Riley Children's Foundation; Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [1K23HD099331-01A1]; NIH/National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23101036]; Chuck Noll Foundation; Dean's Faculty Award	Michael D. Davis is funded by the National Institutes of Health (NIH)/National Heart, Lung, and Blood Institute (NHLBI; P01 HL128192), the Indiana Clinical and Translational Sciences Institute, the Lilly Endowment, and the Riley Children's Foundation. Christopher M. Horvat is funded by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD; 1K23HD099331-01A1). Ruchira M. Jha receives grant funding from the NIH/National Institute of Neurological Disorders and Stroke (NINDS; K23101036), Chuck Noll Foundation, and Dean's Faculty Award.	Abdel-Mannan O, 2020, JAMA NEUROL, V77, P1440, DOI 10.1001/jamaneurol.2020.2687; Abdi S, 2020, J NEUROL SCI, V416, DOI 10.1016/j.jns.2020.117001; Abdulle S, 2007, J NEUROL, V254, P1026, DOI 10.1007/s00415-006-0481-8; Abiodun OA, 2020, SAUDI J BIOL SCI, V27, P905, DOI 10.1016/j.sjbs.2020.01.026; Abo-Elwafa H.A., 2019, NEUROSCI MED, V10, P1; Aboughdir M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12050527; Afshar H, 2020, MULT SCLER RELAT DIS, V43, DOI 10.1016/j.msard.2020.102216; Al Saiegh F, 2020, J NEUROL NEUROSUR PS, V91, P846, DOI 10.1136/jnnp-2020-323522; Al-olama M, 2020, ACTA NEUROCHIR, V162, P1495, DOI 10.1007/s00701-020-04402-w; Alatas OD, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002007; Alcamo AM, 2020, PEDIATR CRIT CARE ME, V21, P804, DOI 10.1097/PCC.0000000000002355; Almqvist J, 2020, ANN CLIN TRANSL NEUR, V7, P2057, DOI 10.1002/acn3.51166; Ameres M, 2020, J NEUROL, V267, P3476, DOI 10.1007/s00415-020-10050-y; Anderson AM, 2018, J NEUROVIROL, V24, P695, DOI 10.1007/s13365-018-0664-y; Anderson TN, 2020, J TRAUMA ACUTE CARE, V89, P80, DOI 10.1097/TA.0000000000002706; Arentz M, 2020, JAMA-J AM MED ASSOC, V323, P1612, DOI 10.1001/jama.2020.4326; Armah HB, 2007, MALARIA J, V6, DOI 10.1186/1475-2875-6-147; Asken BM, 2020, J NEUROTRAUM, V37, P1537, DOI 10.1089/neu.2019.6831; Au AK, 2018, NEUROCRIT CARE, V28, P26, DOI 10.1007/s12028-017-0414-7; Avula A, 2020, BRAIN BEHAV IMMUN, V87, P115, DOI 10.1016/j.bbi.2020.04.077; Bai L., 2018, NEUROTRAUMA, P189; Baig AM, 2020, ACS CHEM NEUROSCI, V11, P995, DOI 10.1021/acschemneuro.0c00122; Bailey DM, 2011, EXP PHYSIOL, V96, P1196, DOI 10.1113/expphysiol.2011.060178; Balloy G, 2020, CLIN NEUROPHYSIOL, V131, P2059, DOI 10.1016/j.clinph.2020.05.005; Barnkob MB, 2020, BLOOD ADV, V4, P4990, DOI 10.1182/bloodadvances.2020002657; Barrios-Lopez JM, 2020, NEUROLOGIA, V35, P295, DOI 10.1016/j.nrl.2020.05.002; Bastard P, 2020, SCIENCE, V370, P423, DOI 10.1126/science.abd4585; Baz-Martinez M, 2016, SCI REP-UK, V6, DOI 10.1038/srep37007; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Bell RD, 2012, NATURE, V485, P512, DOI 10.1038/nature11087; Bembea MM, 2015, CRIT CARE MED, V43, P2202, DOI 10.1097/CCM.0000000000001145; Bembea MM, 2011, PEDIATR CRIT CARE ME, V12, P572, DOI 10.1097/PCC.0b013e3181fe3ec7; Benameur K, 2020, EMERG INFECT DIS, V26, P2016, DOI 10.3201/eid2609.202122; Bernard-Valnet R, 2020, EUR J NEUROL, V27, pE43, DOI 10.1111/ene.14298; Bharosay A, 2012, INDIAN J CLIN BIOCHE, V27, P186, DOI 10.1007/s12291-011-0172-9; Bi XJ, 2020, PLATELETS, V31, P674, DOI 10.1080/09537104.2020.1760230; Bianchetti A, 2020, J NUTR HEALTH AGING, V24, P560, DOI 10.1007/s12603-020-1389-1; Bielewicz J, 2011, J MOL NEUROSCI, V43, P241, DOI 10.1007/s12031-010-9403-4; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Bodro M, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000821; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bohmwald K, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00386; Boscolo-Rizzo P, 2020, JAMA OTOLARYNGOL, V146, P729, DOI 10.1001/jamaoto.2020.1379; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Bradshaw MJ, 2016, NEUROTHERAPEUTICS, V13, P493, DOI 10.1007/s13311-016-0433-7; Brann DH, 2020, SCI ADV, V6, DOI 10.1126/sciadv.abc5801; Ferreira MLB, 2020, LANCET NEUROL, V19, P826, DOI 10.1016/S1474-4422(20)30232-5; Bruggemann R, 2020, THROMB RES, V191, P153, DOI 10.1016/j.thromres.2020.04.046; Butowt R, 2020, ACS CHEM NEUROSCI, V11, P1200, DOI 10.1021/acschemneuro.0c00172; Buttner T, 1997, STROKE, V28, P1961, DOI 10.1161/01.STR.28.10.1961; Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; Can S, 2015, PAK J MED SCI, V31, P1110, DOI 10.12669/pjms.315.7702; Carfi A, 2020, JAMA-J AM MED ASSOC, V324, P603, DOI 10.1001/jama.2020.12603; Cariddi LP, 2020, J NEUROL, V267, P3157, DOI 10.1007/s00415-020-10001-7; Carpenter AM, 2016, NAT REV NEUROL, V12, DOI 10.1038/nrneurol.2015.226; Carrabba G, 2020, LANCET, V395, pE76, DOI 10.1016/S0140-6736(20)30927-2; Carroll E, 2021, NEUROCRIT CARE, V34, P354, DOI 10.1007/s12028-020-00993-5; Chachkhiani D, 2020, CLIN NEUROL NEUROSUR, V197, DOI 10.1016/j.clineuro.2020.106173; Chen H, 2021, J NEURORADIOLOGY, V48, P104, DOI 10.1016/j.neurad.2019.07.002; Chen MF, 2020, EUR RESPIR J, V56, DOI 10.1183/13993003.01948-2020; Chen W, 2020, SEIZURE-EUR J EPILEP, V81, P198, DOI 10.1016/j.seizure.2020.08.022; Ciancanelli MJ, 2015, SCIENCE, V348, P448, DOI 10.1126/science.aaa1578; Co COC, 2020, J CLIN NEUROSCI, V77, P234, DOI 10.1016/j.jocn.2020.05.006; Colizzi M., 2020, BRAIN BEHAV IMMUN HL, DOI [https://doi.org/10.1016/j.bbih.2020.100073, DOI 10.1016/J.BBIH.2020.100073]; Lima CFC, 2020, ARQ NEURO-PSIQUIAT, V78, P454, DOI [10.1590/0004-282x20200057, 10.1590/0004-282X20200057]; Covino M, 2020, GERIATR GERONTOL INT, V20, P704, DOI 10.1111/ggi.13960; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Dadas A, 2018, NEUROPSYCH DIS TREAT, V14, P2989, DOI 10.2147/NDT.S125620; Datta D, 2020, CLIN INFECT DIS, V70, P1161, DOI 10.1093/cid/ciz325; de Oliveira FAA, 2020, NEUROL SCI, V41, P3021, DOI 10.1007/s10072-020-04694-x; De Stefano P, 2020, CLIN NEUROPHYS PRACT, V5, P125, DOI 10.1016/j.cnp.2020.05.004; Deliwala S, 2020, CUREUS, V12, DOI 10.7759/cureus.8121; Desforges M, 2020, VIRUSES-BASEL, V12, DOI 10.3390/v12010014; Di Micco P, 2020, J CLIN MED, V9, DOI 10.3390/jcm9051371; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Dittrich S, 2015, AM J TROP MED HYG, V93, P232, DOI 10.4269/ajtmh.15-0119; Dixon L, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000789; Dogan L, 2020, BRAIN BEHAV IMMUN, V87, P155, DOI 10.1016/j.bbi.2020.05.022; Dogra S, 2020, J STROKE CEREBROVASC, V29, DOI 10.1016/j.jstrokecerebrovasdis.2020.104984; Douglas-Escobar MV, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00273; Duong LS, 2020, BRAIN BEHAV IMMUN, V87, P33, DOI 10.1016/j.bbi.2020.04.024; Dvorak F, 2009, CEREBROVASC DIS, V27, P37, DOI 10.1159/000172632; Ebner F, 2020, RESUSCITATION, V154, P61, DOI 10.1016/j.resuscitation.2020.05.016; Efe IE, 2020, WORLD NEUROSURG, V140, P46, DOI 10.1016/j.wneu.2020.05.194; Ehrenreich H, 2011, MOL MED, V17, P1306, DOI 10.2119/molmed.2011.00259; Elcioglu HK, 2016, MOL CELL BIOCHEM, V420, P21, DOI 10.1007/s11010-016-2762-6; Ellinghaus D, 2020, NEW ENGL J MED, V383, P1522, DOI 10.1056/NEJMoa2020283; Ellul MA, 2020, LANCET NEUROL, V19, P767, DOI 10.1016/S1474-4422(20)30221-0; Elting JW, 2000, J NEUROL SCI, V181, P104, DOI 10.1016/S0022-510X(00)00442-1; Escalard S, 2020, STROKE, V51, P2540, DOI 10.1161/STROKEAHA.120.030574; Espinosa PS, 2020, CUREUS, V12, DOI 10.7759/cureus.7930; Farhadian Shelli, 2020, BMC Neurol, V20, P248, DOI [10.21203/rs.3.rs-28583/v1, 10.1186/s12883-020-01812-2]; Fasano A, 2020, NEUROL SCI, V41, P1651, DOI 10.1007/s10072-020-04460-z; Ferguson I, 2011, ANN EMERG MED, V58, pS213, DOI 10.1016/j.annemergmed.2011.06.133; Ferini-Strambi L, 2021, J NEUROL, V268, P409, DOI 10.1007/s00415-020-10070-8; Filatov A, 2020, CUREUS, V12, DOI 10.7759/cureus.7352; Fink EL, 2016, RESUSCITATION, V101, P65, DOI 10.1016/j.resuscitation.2016.01.024; Fink EL, 2014, CRIT CARE MED, V42, P664, DOI 10.1097/01.ccm.0000435668.53188.80; Fitzgerald S., 2020, NEUROLOGY TODAY; Fletcher-Sandersjoo A, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00512; Foerch C, 2006, J NEUROL NEUROSUR PS, V77, P181, DOI 10.1136/jnnp.2005.074823; Foerch C, 2012, CLIN CHEM, V58, P237, DOI 10.1373/clinchem.2011.172676; Fotuhi M, 2020, J ALZHEIMERS DIS, V76, P3, DOI 10.3233/JAD-200581; Franceschi AM, 2020, AM J NEURORADIOL, V41, P1173, DOI 10.3174/ajnr.A6595; Frankel M, 2019, J NEUROTRAUM, V36, P2863, DOI 10.1089/neu.2018.5809; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Frontera JA, 2021, NEUROLOGY, V96, pE575, DOI 10.1212/WNL.0000000000010979; Garaci F, 2020, J NEUROL SCI, V414, DOI 10.1016/j.jns.2020.116871; Garcia-Montojo M, 2018, CRIT REV MICROBIOL, V44, P715, DOI 10.1080/1040841X.2018.1501345; Geocadin RG, 2019, CIRCULATION, V140, pE517, DOI 10.1161/CIR.0000000000000702; Ghani MU, 2020, J NEUROVIROL, V26, P602, DOI 10.1007/s13365-020-00869-6; Gill CM, 2019, SEMIN NEUROL, V39, P419, DOI 10.1055/s-0039-1687839; Gisslen M, 2016, EBIOMEDICINE, V7, P287, DOI 10.1016/j.ebiom.2016.04.021; Gisslen M, 2016, EBIOMEDICINE, V3, P135, DOI 10.1016/j.ebiom.2015.11.036; Glushakova Olena Y, 2017, Brain Circ, V3, P87, DOI 10.4103/bc.bc_27_16; Glushakova Olena Y, 2016, Brain Circ, V2, P28, DOI 10.4103/2394-8108.178546; Glushakova OY, 2014, J NEUROTRAUM, V31, P1180, DOI 10.1089/neu.2013.3080; Glushakova OY, 2012, TOXICOL SCI, V130, P158, DOI 10.1093/toxsci/kfs224; Glushakova OY, 2018, HDB NEUROEMERGENCY C, P139, DOI [10.1016/B978-0-12-804064-5.00008, DOI 10.1016/B978-0-12-804064-5.00008]; Goldberg MF, 2020, AM J NEURORADIOL, V41, P1170, DOI 10.3174/ajnr.A6588; Gonzalez-Garcia S, 2012, CLIN BIOCHEM, V45, P1302, DOI 10.1016/j.clinbiochem.2012.07.094; Gonzalez-Pinto T, 2020, EUR J NEUROL, V27, pE35, DOI 10.1111/ene.14286; Griffin DO, 2020, BRIT J HAEMATOL, V190, pE11, DOI 10.1111/bjh.16792; Grossetete M, 2009, NEUROSURGERY, V65, P702, DOI 10.1227/01.NEU.0000351768.11363.48; Guha D, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1617-y; Guha D, 2019, AIDS, V33, P615, DOI 10.1097/QAD.0000000000002121; Gulko E, 2020, AM J NEURORADIOL, V41, pE65, DOI 10.3174/ajnr.A6657; Guo LH, 2013, ALZ DIS ASSOC DIS, V27, P337, DOI 10.1097/WAD.0b013e31827b60d2; Gupta A, 2020, NAT MED, V26, P1017, DOI 10.1038/s41591-020-0968-3; Hamming I, 2004, J PATHOL, V203, P631, DOI 10.1002/path.1570; Hascup ER, 2020, GEROSCIENCE, V42, P1083, DOI 10.1007/s11357-020-00207-y; Hayashida H, 2010, NEUROCRIT CARE, V12, P252, DOI 10.1007/s12028-009-9318-5; HEITHOFF B, 2020, GLIA 0921, DOI DOI 10.1101/2020.03.16.993691; Helms J, 2020, NEW ENGL J MED, V382, P2268, DOI 10.1056/NEJMc2008597; Heman-Ackah SM, 2020, NEUROSURGERY, V87, pE147, DOI 10.1093/neuros/nyaa198; Hemasian H, 2020, REV NEUROL-FRANCE, V176, P521, DOI 10.1016/j.neurol.2020.04.013; Hepburn M, 2021, NEUROCRIT CARE, V34, P139, DOI 10.1007/s12028-020-01006-1; Hermansson L, 2019, PLOS ONE, V14, DOI 10.1371/journal.pone.0226276; Hernandez-Fernandez F, 2020, BRAIN, V143, P3089, DOI 10.1093/brain/awaa239; Hoiland RL, 2020, BLOOD ADV, V4, P4981, DOI 10.1182/bloodadvances.2020002623; Hu HT, 2012, CLIN BIOCHEM, V45, P1320, DOI 10.1016/j.clinbiochem.2012.06.003; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Huang XJ, 2015, J NEUROTRAUM, V32, P1179, DOI 10.1089/neu.2015.3873; Huang YH, 2020, BRAIN BEHAV IMMUN, V87, P149, DOI 10.1016/j.bbi.2020.05.012; Iliff JJ, 2013, STROKE, V44, pS93, DOI 10.1161/STROKEAHA.112.678698; Iwasaki A, 2021, LANCET INFECT DIS, V21, P3, DOI 10.1016/S1473-3099(20)30783-0; Jain V, 2008, MALARIA J, V7, DOI 10.1186/1475-2875-7-83; Jasti M, 2021, J NEUROL, V268, P2007, DOI 10.1007/s00415-020-09950-w; Jauch EC, 2006, STROKE, V37, P2508, DOI 10.1161/01.STR.0000242290.01174.9e; JENKINS LW, 1989, BRAIN RES, V477, P211, DOI 10.1016/0006-8993(89)91409-1; Jha RM, 2019, J NEUROTRAUM, V36, P1804, DOI 10.1089/neu.2018.6124; Jha RM, 2018, J NEUROL NEUROSUR PS, V89, P1152, DOI 10.1136/jnnp-2017-317741; John S, 2020, AM J NEURORADIOL, V41, P2263, DOI 10.3174/ajnr.A6799; Kamil K, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00087; Kanberg N, 2020, NEUROLOGY, V95, pE1754, DOI 10.1212/WNL.0000000000010111; Kandemirli SG, 2020, RADIOLOGY, V297, pE232, DOI 10.1148/radiol.2020201697; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Karadas O, 2020, NEUROL SCI, V41, P1991, DOI 10.1007/s10072-020-04547-7; Karimi N, 2020, IRAN RED CRESCENT ME, V22, DOI 10.5812/ircmj.102828; Khan N, 2002, J IMMUNOL, V169, P1984, DOI 10.4049/jimmunol.169.4.1984; Kim BJ, 2014, J STROKE CEREBROVASC, V23, P2437, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.020; Kinney Jefferson W, 2018, Alzheimers Dement (N Y), V4, P575, DOI 10.1016/j.trci.2018.06.014; Kishfy L, 2020, J NEUROL SCI, V414, DOI 10.1016/j.jns.2020.116943; Klok FA, 2020, THROMB RES, V191, P145, DOI 10.1016/j.thromres.2020.04.013; Kochanek PM, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00640; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Koh SXT, 2014, SPORTS MED, V44, P369, DOI 10.1007/s40279-013-0119-9; Koralnik IJ, 2020, ANN NEUROL, V88, P1, DOI 10.1002/ana.25807; Korber B., 2020, SPIKE MUTATION PIPEL, DOI [DOI 10.1101/2020.04.29.069054, 10.1101/2020.04.29.069054]; Korber B, 2020, CELL, V182, P812, DOI 10.1016/j.cell.2020.06.043; Kou ZF, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080296; Kox M, 2020, JAMA-J AM MED ASSOC, V324, P1565, DOI 10.1001/jama.2020.17052; Koyama A, 2012, ARCH NEUROL-CHICAGO, V69, P824, DOI 10.1001/archneurol.2011.1841; Kremer S, 2020, RADIOLOGY, V297, pE242, DOI [10.1148/radiol.2020202222, 10.1148/radiol.202020222]; Kumar H, 2015, J NEUROSCI RURAL PRA, V6, P326, DOI 10.4103/0976-3147.158751; Larsson IM, 2014, RESUSCITATION, V85, P1654, DOI 10.1016/j.resuscitation.2014.09.007; Li JW, 2020, THROMB RES, V193, P22, DOI 10.1016/j.thromres.2020.05.050; Li W, 2015, SCI TRANSL MED, V7, DOI 10.1126/scitranslmed.aac8201; Li YC, 2020, J MED VIROL, V92, P552, DOI 10.1002/jmv.25728; Li YN, 2020, STROKE VASC NEUROL, V5, P279, DOI 10.1136/svn-2020-000431; Lindblad C, 2020, J NEUROTRAUM, V37, P1381, DOI 10.1089/neu.2019.6741; Liotta EM, 2020, ANN CLIN TRANSL NEUR, V7, P2221, DOI 10.1002/acn3.51210; Llombart V, 2016, J NEUROCHEM, V136, P416, DOI 10.1111/jnc.13419; Lodigiani C, 2020, THROMB RES, V191, P9, DOI 10.1016/j.thromres.2020.04.024; Long SW, 2020, MBIO, V11, DOI 10.1128/mBio.02707-20; Lu KL, 2015, J NEUROL SCI, V359, P202, DOI 10.1016/j.jns.2015.10.034; Lu L, 2020, EPILEPSIA, V61, pE49, DOI 10.1111/epi.16524; Lu YP, 2020, ECLINICALMEDICINE, V25, DOI 10.1016/j.eclinm.2020.100484; Ludlow M, 2016, ACTA NEUROPATHOL, V131, P159, DOI 10.1007/s00401-015-1511-3; Luger S, 2017, CLIN CHEM, V63, P377, DOI 10.1373/clinchem.2016.263335; Lukiw WJ, 2022, CELL MOL NEUROBIOL, V42, P217, DOI 10.1007/s10571-020-00947-7; Maas AIR, 2007, J NEUROTRAUM, V24, P232, DOI 10.1089/neu.2006.0024; Mahammedi A, 2020, RADIOLOGY, V297, pE270, DOI 10.1148/radiol.2020201933; Mao L, 2020, JAMA NEUROL, V77, P683, DOI 10.1001/jamaneurol.2020.1127; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Mattsson N, 2019, JAMA NEUROL, V76, P791, DOI 10.1001/jamaneurol.2019.0765; Mattsson N, 2017, ANN NEUROL, V82, P665, DOI 10.1002/ana.25067; Mazza MG, 2020, BRAIN BEHAV IMMUN, V89, P594, DOI 10.1016/j.bbi.2020.07.037; McAbee GN, 2020, PEDIATR NEUROL, V109, P94, DOI 10.1016/j.pediatrneurol.2020.04.013; McFadyen CA, 2021, J NEUROTRAUM, V38, P1124, DOI 10.1089/neu.2018.6052; McKibbin W.J., 2020, 622020 CAMA, DOI 10.2139/ssrn.3635103; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Medana IM, 2005, T ROY SOC TROP MED H, V99, P610, DOI 10.1016/j.trstmh.2004.11.017; Medana IM, 2007, J NEUROL SCI, V258, P93, DOI 10.1016/j.jns.2007.03.005; Mehta Puja, 2020, Lancet, V395, P1033, DOI 10.1016/S0140-6736(20)30628-0; Meier TB, 2020, ANN NEUROL, V87, P907, DOI 10.1002/ana.25725; Merkler Alexander E, 2020, medRxiv, DOI 10.1101/2020.05.18.20105494; Misra S, 2017, PROTEOM CLIN APPL, V11, DOI 10.1002/prca.201700007; Mofid B, 2016, INT IMMUNOPHARMACOL, V32, P103, DOI 10.1016/j.intimp.2016.01.015; Moir RD, 2018, ALZHEIMERS DEMENT, V14, P1602, DOI 10.1016/j.jalz.2018.06.3040; Mokhtari M, 2018, J CLIN PHARMACOL, V58, P42, DOI 10.1002/jcph.980; Molad J, 2019, J ALZHEIMERS DIS, V70, P889, DOI 10.3233/JAD-190339; Mondello S, 2021, J NEUROTRAUM, V38, P1086, DOI 10.1089/neu.2017.5182; Mondello S, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-85; Mondello S, 2012, J NEUROTRAUM, V29, P1096, DOI 10.1089/neu.2011.2092; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Montalvan V, 2020, CLIN NEUROL NEUROSUR, V194, DOI 10.1016/j.clineuro.2020.105921; Montaner J, 2012, J PROTEOMICS, V75, P4758, DOI 10.1016/j.jprot.2012.01.033; Morassi M, 2020, J NEUROL, V267, P2185, DOI 10.1007/s00415-020-09885-2; Moreau A, 2021, J NEUROL, V268, P1592, DOI 10.1007/s00415-020-10164-3; Moriguchi T, 2020, INT J INFECT DIS, V94, P55, DOI 10.1016/j.ijid.2020.03.062; Mortberg E, 2011, ACTA ANAESTH SCAND, V55, P1132, DOI 10.1111/j.1399-6576.2011.02505.x; Moseby-Knappe M, 2019, JAMA NEUROL, V76, P64, DOI 10.1001/jamaneurol.2018.3223; Muhammad S, 2020, BRAIN BEHAV IMMUN, V87, P150, DOI 10.1016/j.bbi.2020.05.015; Munz M, 2020, J NEUROL, V267, P2196, DOI 10.1007/s00415-020-09934-w; Novi G, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000797; Oeckl P, 2019, J ALZHEIMERS DIS, V67, P481, DOI 10.3233/JAD-180325; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Olivecrona Z, 2015, BRAIN INJURY, V29, P446, DOI 10.3109/02699052.2014.989403; Oliveira MF, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006112; Onteddu Sanjeeva Reddy, 2020, Brain Behav Immun Health, V8, P100131, DOI 10.1016/j.bbih.2020.100131; Otluoglu GD, 2020, BRIT J NEUROSURG, DOI 10.1080/02688697.2020.1787342; Overhage JM, 2012, J AM MED INFORM ASSN, V19, P54, DOI 10.1136/amiajnl-2011-000376; Oxley TJ, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2009787; Pandey A, 2014, NEUROCHEM RES, V39, P1426, DOI 10.1007/s11064-014-1328-9; Paniz-Mondolfi A, 2020, J MED VIROL, V92, P699, DOI 10.1002/jmv.25915; Papa L, 2017, J NEUROTRAUM, V34, P2187, DOI 10.1089/neu.2017.5030; Parker AM, 2015, CRIT CARE MED, V43, P1121, DOI 10.1097/CCM.0000000000000882; Parsons T, 2020, J NEUROL, V267, P2799, DOI 10.1007/s00415-020-09951-9; Patanavanich R, 2020, NICOTINE TOB RES, V22, P1653, DOI 10.1093/ntr/ntaa082; Paterson RW, 2020, BRAIN, V143, P3104, DOI 10.1093/brain/awaa240; Pendlebury ST, 2020, STROKE, V51, P751, DOI 10.1161/STROKEAHA.119.026927; Pilotto A, 2020, ANN NEUROL, V88, P423, DOI 10.1002/ana.25783; Pinto AA, 2020, NEUROL-NEUROIMMUNOL, V7, DOI 10.1212/NXI.0000000000000813; Plog BA, 2018, ANNU REV PATHOL-MECH, V13, P379, DOI 10.1146/annurev-pathol-051217-111018; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Politi LS, 2020, JAMA NEUROL, V77, P1028, DOI 10.1001/jamaneurol.2020.2125; Posti JP, 2016, NEUROSURGERY, V79, P456, DOI 10.1227/NEU.0000000000001226; Poyiadji N, 2020, RADIOLOGY, V296, pE119, DOI 10.1148/radiol.2020201187; Preische O, 2019, NAT MED, V25, P277, DOI 10.1038/s41591-018-0304-3; Purrucker JC, 2014, EUR NEUROL, V72, P278, DOI 10.1159/000363569; Radmanesh A, 2020, AM J NEURORADIOL, V41, P1179, DOI 10.3174/ajnr.A6610; Radmanesh A, 2020, RADIOLOGY, V297, pE223, DOI 10.1148/radiol.2020202040; Ragin AB, 2015, ANN CLIN TRANSL NEUR, V2, P12, DOI 10.1002/acn3.136; Ramani A, 2020, EMBO J, V39, DOI 10.15252/embj.2020106230; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Reichard RR, 2020, ACTA NEUROPATHOL, V140, P1, DOI 10.1007/s00401-020-02166-2; Ren CH, 2016, SCI REP-UK, V6, DOI 10.1038/srep24588; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Robinson Christopher P, 2020, Crit Care Explor, V2, pe0107, DOI 10.1097/CCE.0000000000000107; Roh HT, 2017, J SPORT HEALTH SCI, V6, P225, DOI 10.1016/j.jshs.2016.06.005; Rohlwink UK, 2017, CLIN INFECT DIS, V65, P1298, DOI 10.1093/cid/cix540; Rohlwink UK, 2014, CLIN CHEM, V60, P823, DOI 10.1373/clinchem.2013.212472; Romero-Sanchez CM, 2020, NEUROLOGY, V95, pE1060, DOI 10.1212/WNL.0000000000009937; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Sanchez-Aguilar M, 2013, J NEUROSURG, V118, P669, DOI 10.3171/2012.12.JNS121084; Sasannejad C, 2019, CRIT CARE, V23, DOI 10.1186/s13054-019-2626-z; Schrage B, 2019, RESUSCITATION, V136, P14, DOI 10.1016/j.resuscitation.2019.01.011; Senel M, 2020, EUR J NEUROL, V27, P2378, DOI 10.1111/ene.14473; Shahrokhi N, 2016, ARCH TRAUMA RES, V5, DOI 10.5812/atr.37005; Sharifi-Razavi A, 2020, NEW MICROB NEW INFEC, V35, DOI 10.1016/j.nmni.2020.100669; Sharifian-Dorche M, 2020, J NEUROL SCI, V417, DOI 10.1016/j.jns.2020.117085; Shelton JF, 2020, TRANSETHNIC ANAL REV, DOI [DOI 10.1101/2020.09.04.20188318, 10.1101/2020.09.04.20188318]; Sierra-Hidalgo F, 2020, J NEUROL, V267, P3441, DOI 10.1007/s00415-020-09967-1; Singh HV, 2013, CLIN CHIM ACTA, V419, P136, DOI 10.1016/j.cca.2013.02.014; Sironi M, 2017, J INFECT DIS, V215, P1430, DOI 10.1093/infdis/jix166; Sohal S, 2020, IDCases, V20, DOI 10.1016/j.idcr.2020.e00782; Solomon IH, 2020, NEW ENGL J MED, V383, P989, DOI 10.1056/NEJMc2019373; Somani S, 2020, ANN CLIN TRANSL NEUR, V7, P1240, DOI 10.1002/acn3.51071; Stammet P, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1729-7; Stammet P, 2015, J AM COLL CARDIOL, V65, P2104, DOI 10.1016/j.jacc.2015.03.538; Stanca DM, 2015, J CELL MOL MED, V19, P2253, DOI 10.1111/jcmm.12614; Stang PE, 2010, ANN INTERN MED, V153, P600, DOI 10.7326/0003-4819-153-9-201011020-00010; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stoyanov GS, 2020, CUREUS, V12, DOI 10.7759/cureus.8070; Sudre CH, 2020, SYMPTOM CLUSTERS COV, DOI [10.1101/2020.06.12.20129056, DOI 10.1101/2020.06.12.20129056]; Sun HL, 2020, P NATL ACAD SCI USA, V117, P17204, DOI 10.1073/pnas.1921186117; Tahar R, 2016, MALARIA J, V15, DOI 10.1186/s12936-016-1378-3; Takala RSK, 2016, WORLD NEUROSURG, V87, P8, DOI 10.1016/j.wneu.2015.10.066; Tang N, 2020, J THROMB HAEMOST, V18, P1094, DOI 10.1111/jth.14817; Tasker RC, 2016, JAMA-J AM MED ASSOC, V315, P749, DOI 10.1001/jama.2016.0701; Tenforde MW, 2020, MMWR-MORBID MORTAL W, V69, P993, DOI 10.15585/mmwr.mm6930e1externalicon; Thomas W, 2020, THROMB RES, V191, P76, DOI 10.1016/j.thromres.2020.04.028; Tillett RL, 2021, LANCET INFECT DIS, V21, P52, DOI 10.1016/S1473-3099(20)30764-7; Tobin MJ, 2020, AM J RESP CRIT CARE, V202, P356, DOI 10.1164/rccm.202006-2157CP; Troyer EA, 2020, BRAIN BEHAV IMMUN, V87, P34, DOI 10.1016/j.bbi.2020.04.027; Tsai ST, 2020, FRONT NEUROL, V11, DOI 10.3389/fneur.2020.00498; Turbin RE, 2020, ORBIT-ABINGDON, V39, P305, DOI 10.1080/01676830.2020.1768560; Turtle L, 2020, J MED VIROL, V92, P705, DOI 10.1002/jmv.25828; U.S. Food and Drug Administration, 2020, EV AUT CLASS 3 DES B; U.S . Food and Drug Administration Center for Drug Evaluation and Research, 2018, BIOM LETT SUPP; Unden J, 2009, J NEUROL, V256, P72, DOI 10.1007/s00415-009-0054-8; Valiuddin Hisham, 1800, Brain Behav Immun Health, V5, P100091, DOI 10.1016/j.bbih.2020.100091; Varatharaj A., 2020, LANCET PSYCHIAT, V7, P875, DOI [DOI 10.1016/S2215-0366(20)30287-X, 10.1016/S2215-0366(20)30287-X]; Villaverde C, 2020, J PEDIAT INF DIS SOC, V9, P580, DOI 10.1093/jpids/piz082; Virhammar J, 2020, NEUROLOGY, V95, P445, DOI 10.1212/WNL.0000000000010250; von Weyhern CH, 2020, LANCET, V395, pE109, DOI 10.1016/S0140-6736(20)31282-4; Vu D, 2020, EMERG RADIOL, V27, P229, DOI 10.1007/s10140-020-01775-4; Wahlstrom MR, 2014, SPRINGERPLUS, V3, DOI 10.1186/2193-1801-3-98; Wan XY, 2020, J NEUROSURG, V133, P496, DOI 10.3171/2019.4.JNS183472; Wang AR, 2020, J NEUROINTERV SURG, V12, P648, DOI 10.1136/neurintsurg-2020-016220; Wang KK, 2018, EXPERT REV MOL DIAGN, V18, P165, DOI 10.1080/14737159.2018.1428089; Wee NK, 2020, AM J NEURORADIOL, V41, pE76, DOI 10.3174/ajnr.A6672; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Whittaker A, 2020, ACTA NEUROL SCAND, V142, P14, DOI 10.1111/ane.13266; Wiberg S, 2017, RESUSCITATION, V121, P49, DOI 10.1016/j.resuscitation.2017.10.006; Wintermark M, 2018, J NEUROTRAUM, V35, P2665, DOI 10.1089/neu.2017.5311; Wong PF, 2020, CLIN MED, V20, P293, DOI 10.7861/clinmed.2020-0182; Wright DK, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-51267-w; Wu YS, 2020, BRAIN BEHAV IMMUN, V87, P18, DOI 10.1016/j.bbi.2020.03.031; Wunderlich MT, 2006, CLIN NEUROL NEUROSUR, V108, P558, DOI 10.1016/j.clineuro.2005.12.006; Wunderlich MT, 2004, J NEUROL SCI, V227, P49, DOI 10.1016/j.jns.2004.08.005; Xiong LJ, 2015, NEUROL SCI, V36, P2081, DOI 10.1007/s10072-015-2317-8; Xiong WX, 2020, NEUROLOGY, V95, pE1479, DOI 10.1212/WNL.0000000000010034; Xu Z, 2020, LANCET RESP MED, V8, P420, DOI 10.1016/S2213-2600(20)30076-X; Yaeger KA, 2020, AM J NEURORADIOL, V41, P1357, DOI 10.3174/ajnr.A6652; Yamazaki Y, 2019, NAT REV NEUROL, V15, P501, DOI 10.1038/s41582-019-0228-7; Yao YM, 2020, J INTENSIVE CARE, V8, DOI 10.1186/s40560-020-00466-z; Ye MX, 2020, BRAIN BEHAV IMMUN, V88, P945, DOI [10.1016/j.bbi.2020.04.017, 10.1016/J.bbi.2020.04.017]; Yeager, 2020, SCIENTIST; Zachariadis A, 2020, J NEUROL, V267, P3459, DOI 10.1007/s00415-020-09997-9; Zaheer S, 2013, ANN INDIAN ACAD NEUR, V16, P504, DOI 10.4103/0972-2327.120442; Zanin L, 2020, ACTA NEUROCHIR, V162, P1491, DOI 10.1007/s00701-020-04374-x; Zayet S, 2020, EMERG INFECT DIS, V26, P2258, DOI 10.3201/eid2609.201791; Zhang BZ, 2020, CELL RES, V30, P928, DOI 10.1038/s41422-020-0390-x; Zhang CX, 2016, EUR REV MED PHARMACO, V20, P1474; Zhang LT, 2020, J THROMB HAEMOST, V18, P1324, DOI 10.1111/jth.14859; Zhang Q, 2020, SCIENCE, V370, DOI 10.1126/science.abd4570; Zhang YP, 2015, INT J MED SCI, V12, P576, DOI 10.7150/ijms.12111; Zhang Y, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2007575; Zhao K., 2020, ACUTE MYELITIS SARS, DOI [10.1101/2020.03.16.20035105, DOI 10.1101/2020.03.16.20035105, DOI 10.1101/2020.03.16]; Zhou LY, 2020, TRAVEL MED INFECT DI, V36, DOI 10.1016/j.tmaid.2020.101642; Zoghi A, 2020, MULT SCLER RELAT DIS, V44, DOI 10.1016/j.msard.2020.102324; Zubair AS, 2020, JAMA NEUROL, V77, P1018, DOI 10.1001/jamaneurol.2020.2065; Zulfiqar AA, 2020, NEW ENGL J MED, V382, DOI 10.1056/NEJMc2010472	345	15	15	1	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 1	2021	38	1					1	43		10.1089/neu.2020.7332		NOV 2020	43	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	PN6IA	WOS:000590896000001	33115334	Green Published, hybrid			2022-02-06	
J	Peltz, CB; Kenney, K; Gill, J; Diaz-Arrastia, R; Gardner, RC; Yaffe, K				Peltz, Carrie B.; Kenney, Kimbra; Gill, Jessica; Diaz-Arrastia, Ramon; Gardner, Raquel C.; Yaffe, Kristine			Blood biomarkers of traumatic brain injury and cognitive impairment in older veterans	NEUROLOGY			English	Article							ALZHEIMERS-DISEASE; HEAD-INJURY; PLASMA-LEVELS; AMYLOID-BETA; RISK; DEMENTIA; TAU; TBI; IDENTIFICATION; ASSOCIATION	Objective To determine whether blood-based biomarkers can differentiate older veterans with and without traumatic brain injury (TBI) and cognitive impairment (CogI). Methods We enrolled 155 veterans from 2 veterans' retirement homes: 90 without TBI and 65 with TBI history. Participants were further separated into CogI groups: controls (no TBI, no CogI), n = 60; no TBI with CogI, n = 30; TBI without CogI, n = 30; and TBI with CogI, n = 35. TBI was determined by the Ohio State University TBI Identification Method. CogI was defined as impaired cognitive testing, dementia diagnosis, or use of dementia medication. Blood specimens were enriched for CNS-derived exosomes. Proteins (neurofilament light [NfL], total tau, glial fibrillary acidic protein [GFAP], alpha-synuclein, beta-amyloid 42 [A beta 42], and phosphorylated tau [p-tau]) and cytokines (tumor necrosis factor-alpha [TNF-alpha], interleukin-6 [IL-6], and interleukin-10) were measured using ultrasensitive immunoassays. Results Veterans were, on average, 79 years old. In participants with TBI history, 65% had mild TBI; average time from most recent TBI was 37 years. In adjusted analyses, the TBI and CogI groups differed on CNS-enriched exosome concentration of p-tau, NfL, IL-6, TNF-alpha (allp< 0.05), and GFAP (p= 0.06), but not on A beta 42 or other markers. Adjusted area under the curve (AUC) analyses found that all significantly associated biomarkers combined separated TBI with/without CogI (AUC, 0.85; 95% confidence interval [CI], 0.74-0.95) and CogI with/without TBI (AUC, 0.88; 95% CI, 0.77-0.99). Conclusions Increased levels of blood-based, CNS-enriched exosomal biomarkers associated with TBI and CogI can be detected even decades after TBI. Classification of evidence This study provides Class II evidence that in veterans with a history of TBI, CNS-enriched exosome concentration of p-tau, NfL, IL-6, and TNF-alpha are associated with CogI.	[Peltz, Carrie B.; Gardner, Raquel C.; Yaffe, Kristine] San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA 94121 USA; [Peltz, Carrie B.] Northern Calif Inst Res & Educ, San Francisco, CA 94121 USA; [Kenney, Kimbra] Uniformed Serv Univ Hlth Sci, Rockville, MD USA; [Gill, Jessica] NIH, Bldg 10, Bethesda, MD 20892 USA; [Diaz-Arrastia, Ramon] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA; [Gardner, Raquel C.; Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, San Francisco, CA USA		Peltz, CB (corresponding author), San Francisco Vet Affairs Hlth Care Syst, San Francisco, CA 94121 USA.; Peltz, CB (corresponding author), Northern Calif Inst Res & Educ, San Francisco, CA 94121 USA.	carrie.peltz@ncire.org			Department of DefenseUnited States Department of Defense [W81XWH-14-2-0137]	This project was supported by the Department of Defense (W81XWH-14-2-0137). The views expressed in this publication are those of the authors and do not represent official views or policy of the Department of Defense, Department of Veterans Affairs, or the United States Government.	Andreasson Ulf, 2016, Alzheimers Dement (Amst), V3, P98, DOI 10.1016/j.dadm.2016.05.005; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Cameron KL, 2012, J NEUROTRAUM, V29, P1313, DOI 10.1089/neu.2011.2168; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Donohue MC, 2014, JAMA NEUROL, V71, P961, DOI 10.1001/jamaneurol.2014.803; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gill J, 2018, BRAIN INJURY, V32, P1277, DOI 10.1080/02699052.2018.1471738; Goetzl EJ, 2020, J NEUROTRAUM, V37, P382, DOI 10.1089/neu.2019.6711; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Ivnik R.J., 1990, PSYCHOL ASSESSMENT J, V2, P304, DOI [10.1037/1040-3590.2.3.304, DOI 10.1037/1040-3590.2.3.304]; Kaup AR, 2017, J INT NEUROPSYCH SOC, V23, P56, DOI 10.1017/S1355617716000849; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Kenney K, 2018, J NEUROPATH EXP NEUR, V77, P50, DOI 10.1093/jnen/nlx101; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Mattsson N, 2017, JAMA NEUROL, V74, P557, DOI 10.1001/jamaneurol.2016.6117; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Rey A., 1964, EXAMEN CLIN PSYCHOL; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shirk SD, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt94; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Tangalos, 1992, CLIN NEUROPSYCHOL, V6, P83, DOI [10.1080/13854049208401880, DOI 10.1080/13854049208401880]; Taylor E., 1959, PSYCHOL APPRAISAL CH; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Wechsler D., 1997, WAIS 3 ADM SCORING M WAIS 3 ADM SCORING M; Wiesmann M, 2010, ACTA NEUROL SCAND, V121, P178, DOI 10.1111/j.1600-0404.2009.01196.x; Winston Charisse N, 2016, Alzheimers Dement (Amst), V3, P63, DOI 10.1016/j.dadm.2016.04.001; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	46	15	15	2	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0028-3878	1526-632X		NEUROLOGY	Neurology	SEP 1	2020	95	9					E1126	E1133		10.1212/WNL.0000000000010087			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	OH2DA	WOS:000582378800011	32571850	Green Published			2022-02-06	
J	Xu, S; Wang, J; Jiang, JY; Song, J; Zhu, W; Zhang, F; Shao, MH; Xu, HC; Ma, XS; Lyu, FZ				Xu, Shun; Wang, Jin; Jiang, Jianyuan; Song, Jian; Zhu, Wei; Zhang, Fan; Shao, Minghao; Xu, Haocheng; Ma, Xiaosheng; Lyu, Feizhou			TLR4 promotes microglial pyroptosis via lncRNA-F630028O10Rik by activating PI3K/AKT pathway after spinal cord injury	CELL DEATH & DISEASE			English	Article							LONG NONCODING RNAS; TRAUMATIC BRAIN; RECEPTOR 4; TLR4/NF-KAPPA-B; INFLAMMATION; POLARIZATION; ISCHEMIA; MALAT1; DAMAGE	Neuroinflammation plays a crucial role in the secondary phase of spinal cord injury (SCI), and is initiated following the activation of toll-like receptor 4 (TLR4). However, the downstream mechanism remains unknown. Pyroptosis is a form of inflammatory programmed cell death, which is closely involved in neuroinflammation, and it can be regulated by TLR4 according to a recent research. In addition, several studies have shown that long non-coding RNAs (lncRNAs) based mechanisms were related to signal transduction downstream of TLR4 in the regulation of inflammation. Thus, in this study, we want to determine whether TLR4 can regulate pyroptosis after SCI via lncRNAs. Our results showed that TLR4 was activated following SCI and promoted the expression of lncRNA-F630028O10Rik. This lncRNA functioned as a ceRNA for miR-1231-5p/Col1a1 axis and enhanced microglial pyroptosis after SCI by activating the PI3K/AKT pathway. Furthermore, we determined STAT1 was the upstream transcriptional factor of IncRNA-F630028O10Rik and was induced by the damage-responsive TLR4/MyD88 signal. Our findings provide new insights and a novel therapeutic strategy for treating SCI.	[Xu, Shun; Lyu, Feizhou] Fudan Univ, Shanghai Fifth Peoples Hosp, Dept Orthoped, Shanghai 200240, Peoples R China; [Xu, Shun; Wang, Jin; Jiang, Jianyuan; Song, Jian; Zhu, Wei; Zhang, Fan; Shao, Minghao; Xu, Haocheng; Ma, Xiaosheng; Lyu, Feizhou] Fudan Univ, Huashan Hosp, Dept Orthoped, Shanghai 200040, Peoples R China		Lyu, FZ (corresponding author), Fudan Univ, Shanghai Fifth Peoples Hosp, Dept Orthoped, Shanghai 200240, Peoples R China.; Ma, XS; Lyu, FZ (corresponding author), Fudan Univ, Huashan Hosp, Dept Orthoped, Shanghai 200040, Peoples R China.	mxs_huashan@163.com; lfzsubmission@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772385, 81871522]; Shanghai Sailing Program [20YF1438100, 20YF1429900]	This work was supported by the National Natural Science Foundation of China [grant number 81772385, 81871522]. This work was also sponsored by Shanghai Sailing Program [grant number 20YF1438100, 20YF1429900].	Ahmad A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057208; Bell MT, 2013, CIRCULATION, V128, pS152, DOI 10.1161/CIRCULATIONAHA.112.000024; Bossi L, 2016, NAT REV MICROBIOL, V14, P775, DOI 10.1038/nrmicro.2016.129; Caso JR, 2007, CIRCULATION, V115, P1599, DOI 10.1161/CIRCULATIONAHA.106.603431; Courtine G, 2019, NAT MED, V25, P898, DOI 10.1038/s41591-019-0475-6; Dias MS, 2004, PEDIATR CLIN N AM, V51, P271, DOI 10.1016/S0031-3955(03)00211-6; Ding JJ, 2016, NATURE, V535, P111, DOI 10.1038/nature18590; Du M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-02229-1; Ghosh AK, 2017, AGING-US, V9, P1971, DOI 10.18632/aging.101288; Grammatikakis I, 2014, AGING-US, V6, P992, DOI 10.18632/aging.100710; Gupta SC, 2010, BBA-GENE REGUL MECH, V1799, P775, DOI 10.1016/j.bbagrm.2010.05.004; Hagberg H, 2015, NAT REV NEUROL, V11, P192, DOI 10.1038/nrneurol.2015.13; Halstead JM, 2015, SCIENCE, V347, P1367, DOI 10.1126/science.aaa3380; Han LL, 2017, CELL PHYSIOL BIOCHEM, V43, P2457, DOI 10.1159/000484452; Hayden MS, 2011, CELL RES, V21, P223, DOI 10.1038/cr.2011.13; He ZL, 2017, J CELL MOL MED, V21, P3010, DOI 10.1111/jcmm.13212; Huang MD, 2017, MOL THER, V25, P1014, DOI 10.1016/j.ymthe.2017.01.017; Hutson TH, 2019, NAT REV NEUROL, V15, P732, DOI 10.1038/s41582-019-0280-3; Impellizzeri D, 2015, IMMUNOBIOLOGY, V220, P1039, DOI 10.1016/j.imbio.2015.05.013; Jain S, 2017, RNA BIOL, V14, P522, DOI 10.1080/15476286.2016.1172756; Jen JY, 2017, MOL CANCER, V16, DOI 10.1186/s12943-017-0674-z; Kong XY, 2017, J CELL MOL MED, V21, P941, DOI 10.1111/jcmm.13034; Liang YL, 2014, BRAIN RES, V1590, P75, DOI 10.1016/j.brainres.2014.09.020; Lou YT, 2017, INFLAMMATION, V40, P1698, DOI 10.1007/s10753-017-0611-8; Luu K, 2014, IMMUNOL CELL BIOL, V92, P761, DOI 10.1038/icb.2014.51; Ma PZ, 2019, CURR ALZHEIMER RES, V16, P596, DOI 10.2174/1567205016666190725130134; Maroso M, 2010, NAT MED, V16, P413, DOI 10.1038/nm.2127; Meng L, 2018, MOL IMMUNOL, V94, P7, DOI 10.1016/j.molimm.2017.12.008; Molokanova O, 2018, MATRIX BIOL, V66, P34, DOI 10.1016/j.matbio.2017.11.002; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Paneru B, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-26753-2; Paraskevopoulou MD, 2016, METHODS MOL BIOL, V1402, P271, DOI 10.1007/978-1-4939-3378-5_21; Riva P, 2016, CURR ALZHEIMER RES, V13, P1219, DOI 10.2174/1567205013666160622112234; Schmitt AM, 2016, CANCER CELL, V29, P452, DOI 10.1016/j.ccell.2016.03.010; Shao QH, 2019, NEUROPHARMACOLOGY, V144, P388, DOI 10.1016/j.neuropharm.2018.04.008; Shi ZJ, 2018, J CELL MOL MED, V22, P2055, DOI 10.1111/jcmm.13515; Shoulders MD, 2009, ANNU REV BIOCHEM, V78, P929, DOI 10.1146/annurev.biochem.77.032207.120833; Silva NA, 2014, PROG NEUROBIOL, V114, P25, DOI 10.1016/j.pneurobio.2013.11.002; Song ZY, 2019, J CELL BIOCHEM, V120, P10452, DOI 10.1002/jcb.28330; Sun DY, 2017, EMBO REP, V18, P1801, DOI 10.15252/embr.201643668; Thomson DW, 2016, NAT REV GENET, V17, P272, DOI 10.1038/nrg.2016.20; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vande Walle L, 2016, CURR BIOL, V26, pR568, DOI 10.1016/j.cub.2016.02.019; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wan PX, 2020, CELL DEATH DIFFER, V27, P176, DOI 10.1038/s41418-019-0351-4; Wang B, 2019, EUR REV MED PHARMACO, V23, P3190, DOI 10.26355/eurrev_201904_17677; Wang YT, 2015, CURR PHARM BIOTECHNO, V16, P492, DOI 10.2174/138920101606150407112646; Wang YL, 2019, FRONT ENDOCRINOL, V10, DOI 10.3389/fendo.2019.00603; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Xu S, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1183-8; Yoon JH, 2014, SEMIN CELL DEV BIOL, V34, P9, DOI 10.1016/j.semcdb.2014.05.015; Zendedel A, 2016, MOL NEUROBIOL, V53, P3063, DOI 10.1007/s12035-015-9203-5; Zhang X, 2019, J NEUROINFLAMM, V16, DOI 10.1186/s12974-019-1464-x; Zhang X, 2019, INT IMMUNOPHARMACOL, V76, DOI 10.1016/j.intimp.2019.105845; Zhang XJ, 2017, RNA BIOL, V14, P1705, DOI 10.1080/15476286.2017.1358347; Zhang XJ, 2017, J NEUROSCI, V37, P1797, DOI 10.1523/JNEUROSCI.3389-16.2017; Zhang Y, 2018, J PINEAL RES, V64, DOI 10.1111/jpi.12449; Zhong JJ, 2017, BRAIN BEHAV IMMUN, V65, P183, DOI 10.1016/j.bbi.2017.05.001	58	15	16	4	14	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	AUG 10	2020	11	8							693	10.1038/s41419-020-02824-z			16	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	NN6HX	WOS:000568888300003	32826878	gold, Green Published			2022-02-06	
J	Pinggera, D; Klein, B; Thome, C; Grassner, L				Pinggera, Daniel; Klein, Barbara; Thome, Claudius; Grassner, Lukas			The influence of the COVID-19 pandemic on traumatic brain injuries in Tyrol: experiences from a state under lockdown	EUROPEAN JOURNAL OF TRAUMA AND EMERGENCY SURGERY			English	Article						Traumatic brain injury; COVID-19; Quarantine; Outcome	EPIDEMIOLOGY; MANAGEMENT; MORTALITY; VISITS	Purpose In February 2020, the federal state of Tyrol in Austria has become one of the epicenters of the COVID-19 pandemic. Tyrol is known for numerous skiing areas. Thus, winter sport resorts became a starting point for COVID-19 infections spreading towards the rest of the state, Austria and other countries, leading to a mandatory quarantine for almost a million people, who were placed under a curfew and restrictions in daily life. Additionally, all ski resorts and hotels were closed. We aimed to analyze the influence of the COVID-19 quarantine on traumatic brain injury (TBI) cases in Tyrol. Methods We retrospectively compared demographical and injury characteristics from all TBI patients within the 2020 strict quarantine period with the respective time periods from 2016 to 2019. As our department is the only neurosurgical unit in Tyrol, all patients with moderate or severe TBI are transferred to our hospital. Results During 3 weeks of the full quarantine period, the weekly TBI cases load decreased significantly in comparison to the same time periods in the years 2016-2019. Furthermore, concomitant skull fractures decreased significantly (p < 0.016), probably reflecting different causative mechanisms. The other demographical and injury characteristics and particularly falls at home stayed relatively unchanged. Conclusion TBI remained an important contributor to the neurosurgical workflow during the COVID-19 pandemic. Strategies to ensure neurosurgical care also under pandemic-induced lockdown are important.	[Pinggera, Daniel; Thome, Claudius; Grassner, Lukas] Med Univ Innsbruck, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria; [Klein, Barbara] Paracelsus Med Univ, Inst Mol Regenerat Med, Salzburg, Austria; [Klein, Barbara] Paracelsus Med Univ, Spinal Cord Injury & Tissue Regenerat Ctr Salzbur, Salzburg, Austria		Grassner, L (corresponding author), Med Univ Innsbruck, Dept Neurosurg, Anichstr 35, A-6020 Innsbruck, Austria.	Lukas.grassner@googlemail.com					Ackery A, 2007, INJURY PREV, V13, P368, DOI 10.1136/ip.2007.017285; Arnaout O, 2020, NEUROSURGERY, V87, pE173, DOI 10.1093/neuros/nyaa146; Bossers SM, 2018, EUR J TRAUMA EMERG S, V44, P889, DOI 10.1007/s00068-017-0861-z; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Connors JM, 2020, BLOOD, V135, P2033, DOI 10.1182/blood.2020006000; Daou BJ, 2020, NEUROSURGERY, V87, pE234, DOI 10.1093/neuros/nyaa186; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Eichberg DG, 2020, NEUROSURGERY, V87, pE63, DOI 10.1093/neuros/nyaa118; Hartholt KA, 2011, J NEUROTRAUM, V28, P739, DOI 10.1089/neu.2010.1488; Hofman M, 2020, EUR J TRAUMA EMERG S, V46, P11, DOI 10.1007/s00068-019-01179-1; Huang CL, 2020, LANCET, V395, P497, DOI 10.1016/S0140-6736(20)30183-5; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Iaccarino C, 2018, J NEUROSURG SCI, V62, P535, DOI 10.23736/S0390-5616.18.04532-0; Kirkman MA, 2013, J NEUROTRAUM, V30, P1385, DOI 10.1089/neu.2013.2881; Kondziolka D, 2020, J NEUROSURG, V133, P1, DOI 10.3171/2020.3.JNS201007; Kumar RG, 2020, J TRAUMA ACUTE CARE, V88, P491, DOI 10.1097/TA.0000000000002562; Kurihara H, 2020, J TRAUMA ACUTE CARE, V88, P719, DOI 10.1097/TA.0000000000002695; Marion DW, 2006, NEUROSURGERY, V58, P655; Mauritz W, 2014, BRAIN INJURY, V28, P1295, DOI 10.3109/02699052.2014.916418; Mauritz W, 2014, WIEN KLIN WOCHENSCHR, V126, P42, DOI 10.1007/s00508-013-0456-6; McLaughlin C, 2019, J TRAUMA ACUTE CARE, V87, P818, DOI 10.1097/TA.0000000000002237; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Nishtala PS, 2014, PHARMACOEPIDEM DR S, V23, P753, DOI 10.1002/pds.3624; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; Poyry T, 2013, J HEAD TRAUMA REHAB, V28, P89, DOI 10.1097/HTR.0b013e318250eadd; Rickels E, 2017, EUR J TRAUMA EMERG S, V43, P729, DOI 10.1007/s00068-017-0866-7; Rocklov J, 2020, J TRAVEL MED, V27, DOI 10.1093/jtm/taaa030; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rusticali B, 2008, MINERVA ANESTESIOL, V74, P583; Samuels JM, 2019, J TRAUMA ACUTE CARE, V86, P686, DOI 10.1097/TA.0000000000002173; Schoppl IJA, 2019, ANAL PRAVENTIONSANSA; Sun H, 2017, WORLD NEUROSURG, V104, P909, DOI 10.1016/j.wneu.2017.05.108; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wang C, 2020, LANCET, V395, P470, DOI 10.1016/S0140-6736(20)30185-9; Zhu N, 2020, NEW ENGL J MED, V382, P727, DOI 10.1056/NEJMoa2001017	35	15	15	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1863-9933	1863-9941		EUR J TRAUMA EMERG S	Eur. J. Trauma Emerg. Surg.	JUN	2021	47	3			SI		653	658		10.1007/s00068-020-01445-7		JUL 2020	6	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	SO8AZ	WOS:000551365600003	32699916	Green Published, Bronze			2022-02-06	
J	Sauerbeck, AD; Gangolli, M; Reitz, SJ; Salyards, MH; Kim, SH; Hemingway, C; Gratuze, M; Makkapati, T; Kerschensteiner, M; Holtzman, DM; Brody, DL; Kummer, TT				Sauerbeck, Andrew D.; Gangolli, Mihika; Reitz, Sydney J.; Salyards, Maverick H.; Kim, Samuel H.; Hemingway, Christopher; Gratuze, Maud; Makkapati, Tejaswi; Kerschensteiner, Martin; Holtzman, David M.; Brody, David L.; Kummer, Terrance T.			SEQUIN Multiscale Imaging of Mammalian Central Synapses Reveals Loss of Synaptic Connectivity Resulting from Diffuse Traumatic Brain Injury	NEURON			English	Article							METABOTROPIC GLUTAMATE RECEPTORS; SCANNING-ELECTRON-MICROSCOPY; LONG-TERM POTENTIATION; ALZHEIMERS-DISEASE; NEUROTRANSMITTER RELEASE; DENDRITIC SPINES; HEAD-INJURY; PATHOLOGY; LOCALIZATION; ACTIVATION	The brain's complex microconnectivity underlies its computational abilities and vulnerability to injury and disease. It has been challenging to illuminate the features of this synaptic network due to the small size and dense packing of its elements. Here, we describe a rapid, accessible super-resolution imaging and analysis workflow-SEQUIN-that quantifies central synapses in human tissue and animal models, characterizes their nanostructural and molecular features, and enables volumetric imaging of mesoscale synaptic networks without the production of large histological arrays. Using SEQUIN, we identify cortical synapse loss resulting from diffuse traumatic brain injury, a highly prevalent connectional disorder. Similar synapse loss is observed in three murine models of Alzheimer-related neurodegeneration, where SEQUIN mesoscale mapping identifies regional synaptic vulnerability. These results establish an easily implemented and robust nano-to-mesoscale synapse quantification and characterization method. They furthermore identify a shared mechanism-synaptopathy-between Alzheimer neurodegeneration and its best-established epigenetic risk factor, brain trauma.	[Sauerbeck, Andrew D.; Reitz, Sydney J.; Salyards, Maverick H.; Kim, Samuel H.; Gratuze, Maud; Makkapati, Tejaswi; Holtzman, David M.; Brody, David L.; Kummer, Terrance T.] Washington Univ, Hope Ctr Neurol Disorders, Knight Alzheimers Dis Res Ctr, Dept Neurol,Sch Med, St Louis, MO 63110 USA; [Gangolli, Mihika] Washington Univ, McKelvey Sch Engn, St Louis, MO 63130 USA; [Gangolli, Mihika; Brody, David L.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Hemingway, Christopher; Kerschensteiner, Martin] Ludwig Maximilians Univ Munchen, Inst Clin Neuroimmunol, D-82152 Munich, Germany; [Kerschensteiner, Martin] Munich Cluster Syst Neurol SyNergy, D-81377 Munich, Germany		Kummer, TT (corresponding author), Washington Univ, Hope Ctr Neurol Disorders, Knight Alzheimers Dis Res Ctr, Dept Neurol,Sch Med, St Louis, MO 63110 USA.	kummert@wustl.edu	gratuze, maud/W-4524-2019	gratuze, maud/0000-0002-1552-8815; Kim, Samuel/0000-0002-1814-4032	BrightFocusBrightFocus Foundation; Brain Research Foundation; McDonnell Center for Cellular and Molecular Neurobiology; NIH K08 grantUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1K08NS094760-01]; Washington University School of Medicine; Children's Discovery Institute; St. Louis Children's Hospital [CDI-CORE-2015-505]; Foundation for Barnes-Jewish Hospital [3770]; NIH Office of Research Infrastructure ProgramsUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [OD021629]	The authors wish to thank Drs. Jens Rettig, Haining Zhong, and Hao Jiang for providing synaptobrevin and PSD-95-labeled mouse lines, Dr. James Fitzpatrick and MatthewCurtis for imaging discussions, Drs. Krikor Dikranian and Joseph Ojo for discussion of EM data, and Dr. James Fitzpatrick for manuscript appraisal.; This study was supported by the BrightFocus and Brain Research Foundation, the McDonnell Center for Cellular and Molecular Neurobiology, and an NIH K08 grant (1K08NS094760-01; all to T.T.K.). Experiments were performed in part through the Washington University Center for Cellular Imaging supported by Washington University School of Medicine, The Children's Discovery Institute, St. Louis Children's Hospital (CDI-CORE-2015-505), the Foundation for Barnes-Jewish Hospital (3770), and the NIH Office of Research Infrastructure Programs (OD021629).	ANDERSEN P, 1980, J PHYSIOL-LONDON, V307, P273, DOI 10.1113/jphysiol.1980.sp013435; Anton-Sanchez L, 2014, FRONT NEUROANAT, V8, DOI 10.3389/fnana.2014.00085; Baddeley A, 2016, CHAP HALL CRC INTERD, P1; Bartol TM, 2015, ELIFE, V4, DOI 10.7554/eLife.10778; Bayes A, 2011, NAT NEUROSCI, V14, P19, DOI 10.1038/nn.2719; Bero AW, 2012, J NEUROSCI, V32, P4334, DOI 10.1523/JNEUROSCI.5845-11.2012; Betzig E, 2006, SCIENCE, V313, P1642, DOI 10.1126/science.1127344; Bierbaum M, 2017, PHYS REV X, V7, DOI 10.1103/PhysRevX.7.041007; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bohland JW, 2009, PLOS COMPUT BIOL, V5, DOI 10.1371/journal.pcbi.1000334; Borchelt DR, 1996, NEURON, V17, P1005, DOI 10.1016/S0896-6273(00)80230-5; Bourne JN, 2013, J COMP NEUROL, V521, P3898, DOI 10.1002/cne.23384; Briggman KL, 2012, CURR OPIN NEUROBIOL, V22, P154, DOI 10.1016/j.conb.2011.10.022; Broadhead MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep24626; Castejon O J, 1995, J Neurosurg Sci, V39, P47; Cesca F, 2010, PROG NEUROBIOL, V91, P313, DOI 10.1016/j.pneurobio.2010.04.006; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Cole JH, 2018, BRAIN, V141, P822, DOI 10.1093/brain/awx354; Collman F, 2015, J NEUROSCI, V35, P5792, DOI 10.1523/JNEUROSCI.4274-14.2015; Crocker JC, 1996, J COLLOID INTERF SCI, V179, P298, DOI 10.1006/jcis.1996.0217; Dani A, 2010, NEURON, V68, P843, DOI 10.1016/j.neuron.2010.11.021; Danielson NB, 2016, NEURON, V91, P652, DOI 10.1016/j.neuron.2016.06.020; DAVIES CA, 1987, J NEUROL SCI, V78, P151, DOI 10.1016/0022-510X(87)90057-8; Deerinck T.J., 2010, NCMIR METHODS 3D EM; DEKOSKY ST, 1990, ANN NEUROL, V27, P457, DOI 10.1002/ana.410270502; Denk W, 2004, PLOS BIOL, V2, P1900, DOI 10.1371/journal.pbio.0020329; Dixon PM., 2002, ENCY ENV, P1796; Dong HX, 2007, J COMP NEUROL, V500, P311, DOI 10.1002/cne.21176; Eisenstein M, 2015, NATURE, V526, P459, DOI 10.1038/526459a; Emes RD, 2012, ANNU REV NEUROSCI, V35, P111, DOI 10.1146/annurev-neuro-062111-150433; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Feng GP, 2000, NEURON, V28, P41, DOI 10.1016/S0896-6273(00)00084-2; Ferro M, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01335-4; Fleminger S, 2003, J NEUROL NEUROSUR PS, V74, P857, DOI 10.1136/jnnp.74.7.857; Fortin DA, 2014, J NEUROSCI, V34, P16698, DOI 10.1523/JNEUROSCI.3888-14.2014; Fremeau RT, 2001, NEURON, V31, P247, DOI 10.1016/S0896-6273(01)00344-0; Gerth F, 2017, P NATL ACAD SCI USA, V114, P12057, DOI 10.1073/pnas.1715341114; Gregor I, 2019, CURR OPIN CHEM BIOL, V51, P74, DOI 10.1016/j.cbpa.2019.05.011; Gurcan O, 2014, BIOL CYBERN, V108, P713, DOI 10.1007/s00422-014-0619-1; HARRIS KM, 1989, J NEUROSCI, V9, P2982; HELL SW, 1994, OPT LETT, V19, P780, DOI 10.1364/OL.19.000780; Henstridge CM, 2016, AGEING RES REV, V28, P72, DOI 10.1016/j.arr.2016.04.005; Hess ST, 2006, BIOPHYS J, V91, P4258, DOI 10.1529/biophysj.106.091116; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Holtzman DM, 2011, SCI TRANSL MED, V3, DOI 10.1126/scitranslmed.3002369; Hu B, 2005, DEVELOPMENT, V132, P4285, DOI 10.1242/dev.02017; Huff J, 2017, NAT METHODS, V14, piv, DOI 10.1038/nmeth.f.404; Huff J, 2015, NAT METHODS, V12, DOI 10.1038/nmeth.f.388; Igarashi KM, 2014, FEBS LETT, V588, P2470, DOI 10.1016/j.febslet.2014.06.004; Ikonomovic MD, 2017, AGEING RES REV, V34, P51, DOI 10.1016/j.arr.2016.11.003; Jankowsky JL, 2001, BIOMOL ENG, V17, P157, DOI 10.1016/S1389-0344(01)00067-3; Kasthuri N, 2015, CELL, V162, P648, DOI 10.1016/j.cell.2015.06.054; Ke MT, 2016, CELL REP, V14, P2718, DOI 10.1016/j.celrep.2016.02.057; Keith D, 2008, FRONT MOL NEUROSCI, V1, DOI 10.3389/neuro.02.004.2008; Knott G, 2008, J NEUROSCI, V28, P2959, DOI 10.1523/JNEUROSCI.3189-07.2008; Koffie RM, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-63; Koffie RM, 2009, P NATL ACAD SCI USA, V106, P4012, DOI 10.1073/pnas.0811698106; Korogod N, 2015, ELIFE, V4, DOI 10.7554/eLife.05793; Kuljis RO, 1997, P NATL ACAD SCI USA, V94, P12688, DOI 10.1073/pnas.94.23.12688; Kummer TT, 2015, BRAIN, V138, P2608, DOI 10.1093/brain/awv180; Lambert TJ, 2017, J CELL BIOL, V216, P53, DOI 10.1083/jcb.201610011; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; LASSMANN H, 1993, ANN NY ACAD SCI, V695, P59, DOI 10.1111/j.1749-6632.1993.tb23028.x; Lein ES, 2007, NATURE, V445, P168, DOI 10.1038/nature05453; Leranth C, 2008, P NATL ACAD SCI USA, V105, P14187, DOI 10.1073/pnas.0806139105; Long JM, 2019, CELL, V179, P312, DOI 10.1016/j.cell.2019.09.001; Lujan R, 1997, J CHEM NEUROANAT, V13, P219, DOI 10.1016/S0891-0618(97)00051-3; Mallucci GR, 2009, PRION, V3, P195, DOI 10.4161/pri.3.4.9981; Masch JM, 2018, P NATL ACAD SCI USA, V115, pE8047, DOI 10.1073/pnas.1807104115; MASLIAH E, 1991, ACTA NEUROPATHOL, V81, P428, DOI 10.1007/BF00293464; MASLIAH E, 1989, NEUROSCI LETT, V103, P234, DOI 10.1016/0304-3940(89)90582-X; Matti U, 2013, NAT COMMUN, V4, DOI 10.1038/ncomms2467; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Micheva KD, 2007, NEURON, V55, P25, DOI 10.1016/j.neuron.2007.06.014; Micheva KD, 2010, NEURON, V68, P639, DOI 10.1016/j.neuron.2010.09.024; Morrison JH, 2012, NAT REV NEUROSCI, V13, P240, DOI 10.1038/nrn3200; Namjoshi DR, 2014, MOL NEURODEGENER, V9, DOI 10.1186/1750-1326-9-55; Nordstrom A, 2018, PLOS MED, V15, DOI 10.1371/journal.pmed.1002496; O'Rourke NA, 2012, NAT REV NEUROSCI, V13, P365, DOI 10.1038/nrn3170; Paquet M, 2003, J NEUROSCI, V23, P7659; Perez EJ, 2016, NEUROBIOL DIS, V94, P73, DOI 10.1016/j.nbd.2016.06.007; Perez-Alvarez A, 2019, FREE ZEFRAME IMAGING, DOI [10.1101/538041, DOI 10.1101/538041]; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Przekwas A, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00002; Reiner A, 2018, NEURON, V98, P1080, DOI 10.1016/j.neuron.2018.05.018; Renner M, 2010, NEURON, V66, P739, DOI 10.1016/j.neuron.2010.04.029; Ribeiro FM, 2017, PHARMACOL RES, V115, P179, DOI 10.1016/j.phrs.2016.11.013; Richardson DS, 2015, CELL, V162, P246, DOI 10.1016/j.cell.2015.06.067; Rodrigues SM, 2002, J NEUROSCI, V22, P5219, DOI 10.1523/JNEUROSCI.22-12-05219.2002; Rollenhagen Astrid, 2010, Front Synaptic Neurosci, V2, P2, DOI 10.3389/fnsyn.2010.00002; Rust MJ, 2006, NAT METHODS, V3, P793, DOI 10.1038/nmeth929; Saito T, 2014, NAT NEUROSCI, V17, P661, DOI 10.1038/nn.3697; Santuy A, 2018, BRAIN STRUCT FUNCT, V223, P77, DOI 10.1007/s00429-017-1470-7; Sauerbeck AD, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-25737-6; Scheff SW, 2007, NEUROLOGY, V68, P1501, DOI 10.1212/01.wnl.0000260698.46517.8f; SCHEFF SW, 1993, ANN NEUROL, V33, P190, DOI 10.1002/ana.410330209; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Scheff SW, 2003, NEUROBIOL AGING, V24, P1029, DOI 10.1016/j.neurobiolaging.2003.08.002; Schikorski T, 1997, J NEUROSCI, V17, P5858; Selkoe DJ, 2002, SCIENCE, V298, P789, DOI 10.1126/science.1074069; Shahim P, 2017, NEUROLOGY, V88, P1400, DOI 10.1212/WNL.0000000000003816; SHEPPARD CJR, 1988, OPTIK, V80, P53; Shostak Y, 2014, EYE BRAIN, V6, P29, DOI 10.2147/EB.S51817; Sporns O, 2005, PLOS COMPUT BIOL, V1, P245, DOI 10.1371/journal.pcbi.0010042; Swanson LW, 2016, ANNU REV NEUROSCI, V39, P197, DOI 10.1146/annurev-neuro-071714-033954; Takamori S, 2006, CELL, V127, P831, DOI 10.1016/j.cell.2006.10.030; Tang AH, 2016, NATURE, V536, P210, DOI 10.1038/nature19058; TERRY RD, 1991, ANN NEUROL, V30, P572, DOI 10.1002/ana.410300410; THIEL G, 1993, BRAIN PATHOL, V3, P87, DOI 10.1111/j.1750-3639.1993.tb00729.x; Tran HT, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025475; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Um JW, 2013, NEURON, V79, P887, DOI 10.1016/j.neuron.2013.06.036; Vascak M, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00157; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang CC, 2011, NEURON, V72, P789, DOI 10.1016/j.neuron.2011.09.023; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Yoshiyama Y, 2007, NEURON, V53, P337, DOI 10.1016/j.neuron.2007.01.010; Zhu F, 2018, NEURON, V99, P781, DOI 10.1016/j.neuron.2018.07.007	119	15	15	0	5	CELL PRESS	CAMBRIDGE	50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, MA 02139 USA	0896-6273	1097-4199		NEURON	Neuron	JUL 22	2020	107	2					257	+		10.1016/j.neuron.2020.04.012			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MO2RX	WOS:000551380900010	32392471	Bronze, Green Accepted, Green Submitted			2022-02-06	
J	Monteiro, M; Newcombe, VFJ; Mathieu, F; Adatia, K; Kamnitsas, K; Ferrante, E; Das, T; Whitehouse, D; Rueckert, D; Menon, DK; Glocker, B				Monteiro, Miguel; Newcombe, Virginia F. J.; Mathieu, Francois; Adatia, Krishma; Kamnitsas, Konstantinos; Ferrante, Enzo; Das, Tilak; Whitehouse, Daniel; Rueckert, Daniel; Menon, David K.; Glocker, Ben			Multiclass semantic segmentation and quantification of traumatic brain injury lesions on head CT using deep learning: an algorithm development and multicentre validation study	LANCET DIGITAL HEALTH			English	Article							CENTER-TBI; MRC CRASH; HEMORRHAGE; PROGRESSION; OUTCOMES; ADULTS; TRIAL; CARE	Background CT is the most common imaging modality in traumatic brain injury (TBI). However, its conventional use requires expert clinical interpretation and does not provide detailed quantitative outputs, which may have prognostic importance. We aimed to use deep learning to reliably and efficiently quantify and detect different lesion types. Methods Patients were recruited between Dec 9, 2014, and Dec 17, 2017, in 60 centres across Europe. We trained and validated an initial convolutional neural network (CNN) on expert manual segmentations (dataset 1). This CNN was used to automatically segment a new dataset of scans, which we then corrected manually (dataset 2). From this dataset, we used a subset of scans to train a final CNN for multiclass, voxel-wise segmentation of lesion types. The performance of this CNN was evaluated on a test subset. Performance was measured for lesion volume quantification, lesion progression, and lesion detection and lesion volume classification. For lesion detection, external validation was done on an independent set of 500 patients from India. Findings 98 scans from one centre were included in dataset 1. Dataset 2 comprised 839 scans from 38 centres: 184 scans were used in the training subset and 655 in the test subset. Compared with manual reference, CNN-derived lesion volumes showed a mean difference of 0.86 mL (95% CI -5.23 to 6.94) for intraparenchymal haemorrhage, 1.83 mL (-12.01 to 15.66) for extra-axial haemorrhage, 2.09 mL (-9.38 to 13.56) for perilesional oedema, and 0.07 mL (-1.00 to 1.13) for intraventricular haemorrhage. Interpretation We show the ability of a CNN to separately segment, quantify, and detect multiclass haemorrhagic lesions and perilesional oedema. These volumetric lesion estimates allow clinically relevant quantification of lesion burden and progression, with potential applications for personalised treatment strategies and clinical research in TBI. Copyright (C) 2020 The Author(s). Published by Elsevier Ltd.	[Monteiro, Miguel; Kamnitsas, Konstantinos; Rueckert, Daniel; Glocker, Ben] Imperial Coll London, Dept Comp, Biomed Image Anal Grp, London, England; [Newcombe, Virginia F. J.; Mathieu, Francois; Adatia, Krishma; Das, Tilak; Whitehouse, Daniel; Menon, David K.] Univ Cambridge, Div Anaesthesia, Dept Med, Cambridge, England; [Ferrante, Enzo] Univ Nacl Litoral, CONICET, FICH, Sinc I, Santa Fe, Argentina		Monteiro, M (corresponding author), Imperial Coll London, Dept Comp, London SW7 2AZ, England.	miguel.monteiro@imperial.ac.uk	Das, Tilak/AAY-5310-2020; Adatia, Krishma/AAQ-1340-2020; Monteiro, Miguel/AAE-6334-2021; Ferrante, Enzo/AAU-6518-2020	Das, Tilak/0000-0003-0655-412X; Adatia, Krishma/0000-0001-8877-071X; Whitehouse, Daniel/0000-0002-0216-1866; Newcombe, Virginia/0000-0001-6044-9035	European Union 7th Framework Programme; Hannelore Kohl Stiftung; OneMind; NeuroTrauma Sciences; Integra Neurosciences; European Research Council Horizon 2020; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/R005036/1] Funding Source: UKRI	European Union 7th Framework Programme, Hannelore Kohl Stiftung, OneMind, NeuroTrauma Sciences, Integra Neurosciences, European Research Council Horizon 2020	Amyot F, 2015, J NEUROTRAUM, V32, P1693, DOI 10.1089/neu.2013.3306; Bardera A, 2009, COMPUT MED IMAG GRAP, V33, P304, DOI 10.1016/j.compmedimag.2009.02.001; Bhadauria HS, 2013, COMPUT ELECTR ENG, V39, P1527, DOI 10.1016/j.compeleceng.2013.04.010; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; CENTER-TBI, ETH APPR; Chilamkurthy S, 2018, LANCET, V392, P2388, DOI 10.1016/S0140-6736(18)31645-3; Clopper CJ, 1934, BIOMETRIKA, V26, P404, DOI 10.2307/2331986; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Edwards P, 2005, LANCET, V365, P1957; Vieira GFR, 2020, NEURORADIOLOGY, V62, P653, DOI 10.1007/s00234-020-02383-2; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; Jain S, 2019, J NEUROTRAUM, V36, P1794, DOI 10.1089/neu.2018.6183; Kamnitsas K, 2016, LECT NOTES COMPUT SC, V10154, P138, DOI 10.1007/978-3-319-55524-9_14; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kuo WC, 2019, P NATL ACAD SCI USA, V116, P22737, DOI 10.1073/pnas.1908021116; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Mathieu F, 2020, NEUROCRIT CARE, V32, P373, DOI 10.1007/s12028-019-00885-3; Menze BH, 2015, IEEE T MED IMAGING, V34, P1993, DOI 10.1109/TMI.2014.2377694; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Roy S, 2015, P SPIE, V9413; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; Zaki WMDW, 2011, 2011 IEEE REGION 10 CONFERENCE TENCON 2011, P369, DOI 10.1109/TENCON.2011.6129127	31	15	16	1	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS		2589-7500		LANCET DIGIT HEALTH	Lancet Digit. Health	JUN	2020	2	6					E314	E322		10.1016/S2589-7500(20)30085-6			9	Medical Informatics; Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	Medical Informatics; General & Internal Medicine	LR0DI	WOS:000535366700016	33328125	gold, Green Published			2022-02-06	
J	Tang, JS; Kang, YY; Huang, LJ; Wu, L; Peng, Y				Tang, Jingshu; Kang, Yuying; Huang, Longjian; Wu, Lei; Peng, Ying			TIMP1 preserves the blood-brain barrier through interacting with CD63/integrin beta 1 complex and regulating downstream FAK/RhoA signaling	ACTA PHARMACEUTICA SINICA B			English	Article						Tissue inhibitor of metalloproteinase-1; Blood-brain barrier; Junctional proteins; CD63; Integrin beta 1	FOCAL ADHESION KINASE; STIMULATES TYROSINE PHOSPHORYLATION; GENE KNOCK-OUT; TISSUE-INHIBITOR; MATRIX METALLOPROTEINASE-1; TIGHT JUNCTIONS; VE-CADHERIN; MATRIX-METALLOPROTEINASE-9; DISRUPTION; ACTIVATION	Blood-brain barrier (BBB) breakdown and the associated microvascular hyperpermeability are hallmark features of several neurological disorders, including traumatic brain injury (TBI). However, there is no viable therapeutic strategy to rescue BBB function. Tissue inhibitor of metalloproteinase-1 (TIMP1) has been considered to be beneficial for vascular integrity, but the molecular mechanisms underlying the functions of TIMP1 remain elusive. Here, we report that TIMP1 executes a protective role on neuroprotective function via ameliorating BBB disruption in mice with experimental TBI. In human brain microvessel endothelial cells (HBMECs) exposed to hypoxia and inflammation injury, the recombinant TIMP1 (rTIMP1) treatment maintained integrity of junctional proteins and trans-endothelial tightness. Mechanistically, TIMP1 interacts with CD63/integrin beta 1 complex and activates downstream FAK signaling, leading to attenuation of RhoA activation and F-actin depolymerization for endothelial cells structure stabilization. Notably, these effects depend on CD63/integrin beta 1 complex, instead of the MMP-inhibitory function. Together, our results identified a novel MMP-independent function of TIMP1 in regulating endothelial barrier integrity. Therapeutic interventions targeting TIMP1 and its downstream signaling may be beneficial to protect BBB function following brain injury and neurological disorders. (C) 2020 Chinese Pharmaceutical Association and Institute of Materia Medica, Chinese Academy of Medical Sciences. Production and hosting by Elsevier B.V.	[Tang, Jingshu; Kang, Yuying; Huang, Longjian; Wu, Lei; Peng, Ying] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China		Peng, Y (corresponding author), Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, State Key Lab Bioact Subst & Funct Nat Med, Beijing 100050, Peoples R China.	ypeng@imm.ac.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81872855, 81673420]; CAMS Innovation Fund for Medical Sciences (China) [2017-I2M-2-004]; National Science and Technology Major Project on Major New Drug Innovation of China [2018ZX09711001-003-005, 2018ZX09711001-003-009]; Fundamental Research Funds for the Central Universities (China)Fundamental Research Funds for the Central Universities [3332019070]; Disciplines construction project (China) [20190200802]	This project was supported by the grants from National Natural Science Foundation of China (Nos. 81872855 and 81673420), CAMS Innovation Fund for Medical Sciences (No. 2017-I2M-2-004, China), National Science and Technology Major Project on Major New Drug Innovation of China (2018ZX09711001-003-005 and 2018ZX09711001-003-009), Fundamental Research Funds for the Central Universities (3332019070, China) and Disciplines construction project (20190200802, China).	Abedi H, 1997, J BIOL CHEM, V272, P15442, DOI 10.1074/jbc.272.24.15442; Abu Taha A, 2014, CELL ADHES MIGR, V8, P125, DOI 10.4161/cam.28243; Alluri H, 2015, METAB BRAIN DIS, V30, P1093, DOI 10.1007/s11011-015-9651-7; Althoff GEM, 2010, AM J PATHOL, V177, P840, DOI 10.2353/ajpath.2010.090918; Asahi M, 2001, J NEUROSCI, V21, P7724, DOI 10.1523/JNEUROSCI.21-19-07724.2001; Boulday G, 2004, ANN NY ACAD SCI, V1030, P28, DOI 10.1196/annals.1329.004; Burridge K, 2013, J CELL BIOL, V200, P9, DOI 10.1083/jcb.201210090; Caley MP, 2015, ADV WOUND CARE, V4, P225, DOI 10.1089/wound.2014.0581; Carbajal JM, 2000, AM J PHYSIOL-CELL PH, V279, pC195; Chen F, 2013, J CEREBR BLOOD F MET, V33, P1041, DOI 10.1038/jcbfm.2013.45; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Cheng CJ, 2017, INT J MED SCI, V14, P927, DOI 10.7150/ijms.18812; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Crocker SJ, 2006, AM J PATHOL, V169, P2104, DOI 10.2353/ajpath.2006.060626; Cui H, 2015, ONCOGENE, V34, P3640, DOI 10.1038/onc.2014.300; Dietrich W, 2013, MED KLIN-INTENSIVMED, V108, P157, DOI 10.1007/s00063-013-0232-4; Drouin-Ouellet J, 2015, ANN NEUROL, V78, P160, DOI 10.1002/ana.24406; Forte D, 2017, ONCOTARGET, V8, P2261, DOI 10.18632/oncotarget.13664; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Fujimoto M, 2008, J CEREBR BLOOD F MET, V28, P1674, DOI 10.1038/jcbfm.2008.59; Ortiz GG, 2014, ARCH MED RES, V45, P687, DOI 10.1016/j.arcmed.2014.11.013; Giannotta M, 2013, DEV CELL, V26, P441, DOI 10.1016/j.devcel.2013.08.020; GomisRuth FX, 1997, NATURE, V389, P77, DOI 10.1038/37995; Gopalakrishnan S, 1998, AM J PHYSIOL-CELL PH, V275, pC798, DOI 10.1152/ajpcell.1998.275.3.C798; Holinstat M, 2006, J BIOL CHEM, V281, P2296, DOI 10.1074/jbc.M511248200; Ichiyama T, 2007, J NEUROL SCI, V252, P45, DOI 10.1016/j.jns.2006.10.005; Jung KK, 2006, EMBO J, V25, P3934, DOI 10.1038/sj.emboj.7601281; Kim JG, 2018, J CELL PHYSIOL, V233, P6381, DOI 10.1002/jcp.26487; Kim KH, 2005, AM J RESP CELL MOL, V33, P271, DOI 10.1165/rcmb.2005-0111OC; Komarova Y, 2010, ANNU REV PHYSIOL, V72, P463, DOI 10.1146/annurev-physiol-021909-135833; Korczyn AD, 2015, NAT REV NEUROL, V11, P319, DOI 10.1038/nrneurol.2015.61; Lee SY, 2014, BIOCHEM J, V459, P565, DOI 10.1042/BJ20131119; Li DD, 2013, NEUROSCI LETT, V550, P168, DOI 10.1016/j.neulet.2013.06.034; Magnoni S, 2007, GENE THER, V14, P621, DOI 10.1038/sj.gt.3302894; Mandel ER, 2017, J CELL PHYSIOL, V232, P831, DOI 10.1002/jcp.25491; Mehta D, 2002, J PHYSIOL-LONDON, V539, P779, DOI 10.1113/jphysiol.2001.013289; Meister S, 2015, J CEREBR BLOOD F MET, V35, P1112, DOI 10.1038/jcbfm.2015.57; Murakami T, 2009, J BIOL CHEM, V284, P21036, DOI 10.1074/jbc.M109.016766; Murphy FR, 2002, J BIOL CHEM, V277, P11069, DOI 10.1074/jbc.M111490200; Murray KN, 2015, FRONTIERS CELLULAR N, V9, P1; Neuwelt EA, 2011, NAT REV NEUROSCI, V12, P169, DOI 10.1038/nrn2995; Obermeier B, 2016, HAND CLINIC, V133, P39, DOI 10.1016/B978-0-444-63432-0.00003-7; Obermeier B, 2013, NAT MED, V19, P1584, DOI 10.1038/nm.3407; OSHEA M, 1992, BIOCHEMISTRY-US, V31, P10146, DOI 10.1021/bi00157a002; Palus M, 2014, J INFECTION, V68, P165, DOI 10.1016/j.jinf.2013.09.028; Park JC, 2017, AGING CELL, V16, P149, DOI 10.1111/acel.12530; Pla-Navarro I, 2018, HISTOL HISTOPATHOL, V33, P1253, DOI 10.14670/HH-18-003; Ries C, 2014, CELL MOL LIFE SCI, V71, P659, DOI 10.1007/s00018-013-1457-3; Schlaepfer DD, 2004, CURR OPIN GENET DEV, V14, P92, DOI 10.1016/j.gde.2003.12.002; Schmidt TT, 2013, AM J PHYSIOL-LUNG C, V305, pL291, DOI 10.1152/ajplung.00094.2013; Schnoor M, 2017, CELL MOL LIFE SCI, V74, P1985, DOI 10.1007/s00018-016-2449-x; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Shi YJ, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms10523; Stilley JAW, 2012, BIOL REPROD, V86, DOI 10.1095/biolreprod.111.094680; Taddei A, 2008, NAT CELL BIOL, V10, P923, DOI 10.1038/ncb1752; Takawale A, 2017, HYPERTENSION, V69, P1092, DOI 10.1161/HYPERTENSIONAHA.117.09045; Thal SC, 2014, ARCH MED RES, V45, P698, DOI 10.1016/j.arcmed.2014.11.006; Vepa S, 1999, AM J PHYSIOL-LUNG C, V277, pL150, DOI 10.1152/ajplung.1999.277.1.L150; Wang XY, 2000, J NEUROSCI, V20, P7037, DOI 10.1523/JNEUROSCI.20-18-07037.2000; WOESSNER JF, 1991, FASEB J, V5, P2145, DOI 10.1096/fasebj.5.8.1850705; Yan EB, 2014, J NEUROTRAUM, V31, P618, DOI 10.1089/neu.2013.3087; Yang Y, 2015, BRAIN RES, V1623, P30, DOI 10.1016/j.brainres.2015.04.024; Yang Y, 2011, STROKE, V42, P3323, DOI 10.1161/STROKEAHA.110.608257; Zenaro E, 2017, NEUROBIOL DIS, V107, P41, DOI 10.1016/j.nbd.2016.07.007; Zhao Z, 2015, CELL, V163, P1064, DOI 10.1016/j.cell.2015.10.067; Zhou X, 2019, ACTA PHARM SIN B, V9, P711, DOI 10.1016/j.apsb.2019.02.008; Zieseniss A, 2014, HYPOXIA, V2, P11, DOI 10.2147/HP.S53575	67	15	15	1	7	INST MATERIA MEDICA, CHINESE ACAD MEDICAL SCIENCES	BEIJING	C/O EDITORIAL BOARD OF ACTA PHARMACEUTICA SINICA, 1 XIANNONGTAN ST, BEIJING, 100050, PEOPLES R CHINA	2211-3835	2211-3843		ACTA PHARMACOL SIN B	Acta Pharm. Sin. B	JUN	2020	10	6					987	1003		10.1016/j.apsb.2020.02.015			17	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	MF5FB	WOS:000545366900004	32642407	Green Published, gold			2022-02-06	
J	Veksler, R; Vazana, U; Serlin, Y; Prager, O; Ofer, J; Shemen, N; Fisher, AM; Minaeva, O; Hua, N; Saar-Ashkenazy, R; Benou, I; Riklin-Raviv, T; Parker, E; Mumby, G; Kamintsky, L; Beyea, S; Bowen, CV; Shelef, I; O'Keeffe, E; Campbell, M; Kaufer, D; Goldstein, LE; Friedman, A				Veksler, Ronel; Vazana, Udi; Serlin, Yonatan; Prager, Ofer; Ofer, Jonathan; Shemen, Nofar; Fisher, Andrew M.; Minaeva, Olga; Hua, Ning; Saar-Ashkenazy, Rotem; Benou, Itay; Riklin-Raviv, Tammy; Parker, Ellen; Mumby, Griffin; Kamintsky, Lyna; Beyea, Steven; Bowen, Chris, V; Shelef, Ilan; O'Keeffe, Eoin; Campbell, Matthew; Kaufer, Daniela; Goldstein, Lee E.; Friedman, Alon			Slow blood-to-brain transport underlies enduring barrier dysfunction in American football players	BRAIN			English	Article						blood-brain barrier; repetitive mild traumatic brain injury; dynamic contrast-enhanced magnetic resonance imaging; American football; transcellular transport	CHRONIC TRAUMATIC ENCEPHALOPATHY; DIFFUSION-TENSOR; CONCUSSIVE CONVULSIONS; HEAD-INJURY; IN-VIVO; PERMEABILITY; MRI; DISRUPTION; BREAKDOWN; MODEL	Repetitive mild traumatic brain injury in American football players has garnered increasing public attention following reports of chronic traumatic encephalopathy, a progressive tauopathy. While the mechanisms underlying repetitive mild traumatic brain injury-induced neurodegeneration are unknown and antemortem diagnostic tests are not available, neuropathology studies suggest a pathogenic role for microvascular injury, specifically blood-brain barrier dysfunction. Thus, our main objective was to demonstrate the effectiveness of a modified dynamic contrast-enhanced MRI approach we have developed to detect impairments in brain microvascular function. To this end, we scanned 42 adult male amateur American football players and a control group comprising 27 athletes practicing a non-contact sport and 26 non-athletes. MRI scans were also performed in 51 patients with brain pathologies involving the blood-brain barrier, namely malignant brain tumours, ischaemic stroke and haemorrhagic traumatic contusion. Based on data from prolonged scans, we generated maps that visualized the permeability value for each brain voxel. Our permeability maps revealed an increase in slow blood-to-brain transport in a subset of amateur American football players, but not in sex- and age-matched controls. The increase in permeability was region specific (white matter, midbrain peduncles, red nucleus, temporal cortex) and correlated with changes in white matter, which were confirmed by diffusion tensor imaging. Additionally, increased permeability persisted for months, as seen in players who were scanned both on- and off-season. Examination of patients with brain pathologies revealed that slow tracer accumulation characterizes areas surrounding the core of injury, which frequently shows fast blood-to-brain transport. Next, we verified our method in two rodent models: rats and mice subjected to repeated mild closed-head impact injury, and rats with vascular injury inflicted by photothrombosis. In both models, slow blood-to-brain transport was observed, which correlated with neuropathological changes. Lastly, computational simulations and direct imaging of the transport of Evans blue-albumin complex in brains of rats subjected to recurrent seizures or focal cerebrovascular injury suggest that increased cellular transport underlies the observed slow blood-to-brain transport. Taken together, our findings suggest dynamic contrast-enhanced-MRI can be used to diagnose specific microvascular pathology after traumatic brain injury and other brain pathologies.	[Veksler, Ronel; Vazana, Udi; Serlin, Yonatan; Prager, Ofer; Ofer, Jonathan; Shemen, Nofar; Saar-Ashkenazy, Rotem; Friedman, Alon] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Physiol & Cell Biol, Beer Sheva, Israel; [Veksler, Ronel; Vazana, Udi; Serlin, Yonatan; Prager, Ofer; Ofer, Jonathan; Shemen, Nofar; Saar-Ashkenazy, Rotem; Friedman, Alon] Ben Gurion Univ Negev, Zlotowski Ctr Neurosci, Dept Brain & Cognit Sci, Beer Sheva, Israel; [Serlin, Yonatan] McGill Univ, Neurol Residency Training Program, Montreal, PQ, Canada; [Fisher, Andrew M.; Minaeva, Olga; Hua, Ning; Goldstein, Lee E.] Boston Univ, Alzheimers Dis & CTE Ctr, Coll Engn, Mol Aging & Dev Lab,Sch Med, Boston, MA 02215 USA; [Fisher, Andrew M.; Minaeva, Olga; Hua, Ning; Goldstein, Lee E.] Boston Univ, Photon Ctr, Boston, MA 02215 USA; [Saar-Ashkenazy, Rotem] Ashkelon Acad Coll, Dept Psychol, Ashqelon, Israel; [Saar-Ashkenazy, Rotem] Ashkelon Acad Coll, Sch Social Work, Ashqelon, Israel; [Benou, Itay; Riklin-Raviv, Tammy] Ben Gurion Univ Negev, Dept Elect Engn, Beer Sheva, Israel; [Parker, Ellen; Mumby, Griffin; Kamintsky, Lyna; Friedman, Alon] Dalhousie Univ, Fac Med, Dept Med Neurosci, Halifax, NS, Canada; [Beyea, Steven; Bowen, Chris, V] Dalhousie Univ, Biomed Translat Imaging Ctr BIOTIC, IWK Hlth Ctr, Halifax, NS, Canada; [Beyea, Steven; Bowen, Chris, V] Dalhousie Univ, QEII Hlth Sci Ctr, Halifax, NS, Canada; [Shelef, Ilan] Soroka Univ Med Ctr, Dept Med Imaging, Beer Sheva, Israel; [O'Keeffe, Eoin; Campbell, Matthew] Trinity Coll Dublin, Smurfit Inst Genet, Dublin, Ireland; [Kaufer, Daniela] Univ Calif Berkeley, Dept Integrat Biol, Berkeley, CA 94720 USA; [Kaufer, Daniela] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA		Friedman, A (corresponding author), Ben Gurion Univ Negev, POB 653, IL-8410501 Beer Sheva, Israel.	alonf@bgu.ac.il	Raviv, Tammy Riklin/A-3462-2013; Vazana, Udi/ABE-7655-2020	, Alon/0000-0003-4780-8456; Parker, Ellen/0000-0002-6072-8197; Beyea, Steven/0000-0001-7851-0017; Kamintsky, Lyna/0000-0001-6776-0969	European UnionEuropean Commission [602102]; Israel Science FoundationIsrael Science Foundation; Israel-USA binational Science FoundationUS-Israel Binational Science Foundation; Nova Scotia Health Research Foundation; Canada Institute for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Crown Family Foundation; NIH-NIA Boston University Alzheimer's Disease Center [P30 AG013846]; Thermo Scientific; Office of the Dean, Boston University School of Medicine	This study was supported by the European Union's Seventh Framework Program (FP7/2007-2013; grant #602102, A.F.), the Israel Science Foundation (A.F.), the Israel-USA binational Science Foundation (A.F. and D.K.), the Nova Scotia Health Research Foundation and Canada Institute for Health Research (CIHR), Crown Family Foundation (L.E.G. and A.F.), NIH-NIA Boston University Alzheimer's Disease Center (P30 AG013846, L.E.G.), Thermo Scientific (in kind support; L.E.G.), Office of the Dean, Boston University School of Medicine (L.E.G.).	Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Andreone BJ, 2017, NEURON, V94, P581, DOI 10.1016/j.neuron.2017.03.043; Aoki Y, 2012, J NEUROL NEUROSUR PS, V83, P870, DOI 10.1136/jnnp-2012-302742; Artzi M, 2016, MAGN RESON IMAGING, V34, P1242, DOI 10.1016/j.mri.2016.07.003; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bar-Klein G, 2017, BRAIN, V140, P1692, DOI 10.1093/brain/awx073; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Benou I, 2019, NEUROIMAGE, V200, P674, DOI 10.1016/j.neuroimage.2019.05.003; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Boyd BJ, 2015, J DRUG TARGET, V23, P847, DOI 10.3109/1061186X.2015.1034280; Chassidim Y, 2013, FLUIDS BARRIERS CNS, V10, DOI 10.1186/2045-8118-10-9; Cramer SP, 2014, J CEREBR BLOOD F MET, V34, P1655, DOI 10.1038/jcbfm.2014.126; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; D'Ambrosio R, 2009, BRAIN, V132, P2805, DOI 10.1093/brain/awp217; De Bock M, 2016, GLIA, V64, P1097, DOI 10.1002/glia.22960; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Haley MJ, 2017, J CEREBR BLOOD F MET, V37, P456, DOI 10.1177/0271678X16629976; Hay JR, 2015, J NEUROPATH EXP NEUR, V74, P1147, DOI [10.1093/jnen/74.12.1147, 10.1097/NEN.0000000000000261]; Heye AK, 2014, NEUROIMAGE-CLIN, V6, P262, DOI 10.1016/j.nicl.2014.09.002; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Hutchinson EB, 2016, SHOCK, V46, P167, DOI 10.1097/SHK.0000000000000659; Kamintsky L, 2020, NEUROIMAGE-CLIN, V26, DOI 10.1016/j.nicl.2019.102049; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Kang EJ, 2013, NEUROBIOL DIS, V52, P204, DOI 10.1016/j.nbd.2012.12.007; Kassner A, 2015, STROKE, V46, P3310, DOI 10.1161/STROKEAHA.115.008861; Knowland D, 2014, NEURON, V82, P603, DOI 10.1016/j.neuron.2014.03.003; Kuhl NO, 2018, PHYSICIAN SPORTSMED, V46, P1, DOI 10.1080/00913847.2018.1419775; Li W, 2016, BRAIN RES, V1646, P53, DOI 10.1016/j.brainres.2016.05.036; Ling HL, 2017, ACTA NEUROPATHOL, V133, P337, DOI 10.1007/s00401-017-1680-3; Lublinsky S, 2019, EBIOMEDICINE, V43, P460, DOI 10.1016/j.ebiom.2019.04.054; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Matsushita M, 2011, J NEUROSURG, V115, P130, DOI 10.3171/2011.2.JNS101547; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrory PR, 1997, BRIT MED J, V314, P171, DOI 10.1136/bmj.314.7075.171; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Montagne A, 2015, NEURON, V85, P296, DOI 10.1016/j.neuron.2014.12.032; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mychasiuk R, 2014, J NEUROTRAUM, V31, P749, DOI 10.1089/neu.2013.3132; Nahirney PC, 2016, J CEREBR BLOOD F MET, V36, P413, DOI 10.1177/0271678X15608396; Nation DA, 2019, NAT MED, V25, P270, DOI 10.1038/s41591-018-0297-y; Omalu BI, 2006, NEUROSURGERY, V59, P1086, DOI 10.1227/01.NEU.0000245601.69451.27; PATLAK CS, 1985, J CEREBR BLOOD F MET, V5, P584, DOI 10.1038/jcbfm.1985.87; Robinson S, 2017, J NEUROSCI RES, V95, P1025, DOI 10.1002/jnr.23848; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Ruber T, 2018, BRAIN, V141, P2952, DOI 10.1093/brain/awy242; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Salehi A, 2017, J CEREB BLOOD FLOW M, V37; Sashindranath M, 2012, BRAIN, V135, P3251, DOI 10.1093/brain/aws178; Schoknecht K, 2014, J CEREBR BLOOD F MET, V34, P1791, DOI 10.1038/jcbfm.2014.147; Senatorov VV, 2019, SCI TRANSL MED, V11, P1946; Serlin Y, 2019, STROKE, V50, P1266, DOI 10.1161/STROKEAHA.119.025247; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Sourbron SP, 2013, NMR BIOMED, V26, P1004, DOI 10.1002/nbm.2940; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein TD, 2015, CURR PAIN HEADACHE R, V19, DOI 10.1007/s11916-015-0522-z; Strain JF, 2017, J NEUROTRAUM, V34, P372, DOI 10.1089/neu.2016.4446; Sweeney MD, 2019, PHYSIOL REV, V99, P21, DOI 10.1152/physrev.00050.2017; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Tofts PS, 1999, J MAGN RESON IMAGING, V10, P223, DOI 10.1002/(SICI)1522-2586(199909)10:3<223::AID-JMRI2>3.0.CO;2-S; Tofts PS, 1997, JMRI-J MAGN RESON IM, V7, P91, DOI 10.1002/jmri.1880070113; TOFTS PS, 1991, MAGNET RESON MED, V17, P357, DOI 10.1002/mrm.1910170208; Tomkins O, 2008, J NEUROL NEUROSUR PS, V79, P774, DOI 10.1136/jnnp.2007.126425; Tu TW, 2017, J NEUROTRAUM, V34, P248, DOI 10.1089/neu.2015.4355; Vazana U, 2016, J NEUROSCI, V36, P7727, DOI 10.1523/JNEUROSCI.0587-16.2016; Veksler R, 2014, ARCH MED RES, V45, P646, DOI 10.1016/j.arcmed.2014.11.016; Vidarsson L, 2009, MAGN RESON IMAGING, V27, P1216, DOI 10.1016/j.mri.2009.01.019; Villringer K, 2017, NEUROLOGY, V88, P433, DOI 10.1212/WNL.0000000000003566; Weissberg I, 2014, JAMA NEUROL, V71, P1453, DOI 10.1001/jamaneurol.2014.2682; Yang Y, 2017, J AM HEART ASS, V6; Zach L, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052008; Zhang JL, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00086; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	81	15	15	3	9	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JUN	2020	143		6				1826	1842		10.1093/brain/awaa140			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	MA3AA	WOS:000541788700027	32464655	Green Published, hybrid			2022-02-06	
J	Hamer, J; Churchill, NW; Hutchison, MG; Graham, SJ; Schweizer, TA				Hamer, Julia; Churchill, Nathan W.; Hutchison, Michael G.; Graham, Simon J.; Schweizer, Tom A.			Sex Differences in Cerebral Blood Flow Associated with a History of Concussion	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; concussion; neuroimaging; sex differences; traumatic brain injury	TRAUMATIC BRAIN-INJURY; PROFESSIONAL FOOTBALL; NEUROCOGNITIVE PERFORMANCE; COGNITIVE IMPAIRMENT; RECURRENT CONCUSSION; IMPACT EXPOSURE; WORKING-MEMORY; FEMALE; MILD; RECOVERY	Growing evidence suggests that a history of sport concussion may lead to long-term changes in brain physiology, with cerebral blood flow (CBF) being particularly sensitive to injury. However, it is unknown whether these changes are sex specific. The goal of this study was to evaluate sex differences in CBF of asymptomatic athletes, with and without a history of concussion (HOC) using arterial spin labeling (ASL). Scans were acquired for 122 athletes, including those without HOC (33 male, 33 female) and those with HOC (28 male, 28 female). Males with HOC had lower CBF bilaterally than males without HOC, seen predominantly in the temporal lobes. In contrast, females with HOC showed no significant differences relative to females without HOC, although they had significantly higher variability in temporal CBF values compared with males with HOC. Additional analyses within the HOC groups found that females with multiple concussion had lower CBF posteriorly compared with those with a single concussion, whereas males showed no significant effects. This study provides the first evidence of sex differences in CBF associated with HOC.	[Hamer, Julia; Churchill, Nathan W.; Hutchison, Michael G.; Schweizer, Tom A.] St Michaels Hosp, Li Ka Shing Knowledge Inst, Keenan Res Ctr, Toronto, ON, Canada; [Hamer, Julia] Univ Sydney, Sydney, NSW, Australia; [Churchill, Nathan W.; Schweizer, Tom A.] St Michaels Hosp, Neurosci Res Program, Toronto, ON, Canada; [Hutchison, Michael G.] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Graham, Simon J.] Univ Toronto, Dept Med Biophys, Toronto, ON, Canada; [Graham, Simon J.] Sunnybrook Hlth Sci Ctr, Sunnybrook Res Inst, Phys Sci Platform, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Fac Med Neurosurg, Toronto, ON, Canada; [Schweizer, Tom A.] Univ Toronto, Inst Biomat & Biomed Engn IBBME, Toronto, ON, Canada		Schweizer, TA (corresponding author), St Michaels Hosp, Keenan Res Ctr, 209 Victoria St, Toronto, ON M5B 1M8, Canada.	Tom.Schweizer@unityhealth.to			CIHRCanadian Institutes of Health Research (CIHR) [RN294001-367456] Funding Source: Medline		Armstead William M, 2016, Anesthesiol Clin, V34, P465, DOI 10.1016/j.anclin.2016.04.002; Baker JG, 2016, CLIN PEDIATR, V55, P771, DOI 10.1177/0009922815606417; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Black AM, 2017, CLIN J SPORT MED, V27, P52, DOI 10.1097/JSM.0000000000000308; Bramlett HM, 2001, J NEUROTRAUM, V18, P891, DOI 10.1089/089771501750451811; Bretzin AC, 2018, AM J SPORT MED, V46, P2263, DOI 10.1177/0363546518778251; Cable RG, 2012, TRANSFUSION, V52, P1031, DOI 10.1111/j.1537-2995.2011.03389.x; Churchill N, 2017, J NEUROTRAUM, V34, P765, DOI 10.1089/neu.2016.4531; Churchill NW, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00390; Churchill NW, 2017, NEUROIMAGE-CLIN, V16, P234, DOI 10.1016/j.nicl.2017.07.019; CLARKE S, 1990, J COMP NEUROL, V298, P188, DOI 10.1002/cne.902980205; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Covassin T, 2003, J ATHL TRAINING, V38, P238; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2013, AM J SPORT MED, V41, P2890, DOI 10.1177/0363546513509962; Covassin T, 2012, AM J SPORT MED, V40, P1303, DOI 10.1177/0363546512444554; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; DEVINSKY O, 1995, BRAIN, V118, P279, DOI 10.1093/brain/118.1.279; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P895, DOI 10.1136/bjsports-2016-097466; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Helmer KG, 2014, J NEUROSURG, V120, P864, DOI [10.3171/2013.12.JNS132090, 10.3171/2013.12.JNS132093]; Hsu HL, 2015, RADIOLOGY, V276, P828, DOI 10.1148/radiol.2015142549; Kane RL, 2007, ARCH CLIN NEUROPSYCH, V22, pS115, DOI 10.1016/j.acn.2006.10.006; Kimberly WT, 2013, NEUROLOGY, V80, P719, DOI 10.1212/WNL.0b013e31828250ff; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; MacIntosh BJ, 2010, MAGN RESON MED, V63, P641, DOI 10.1002/mrm.22256; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGlade E, 2015, BRAIN IMAGING BEHAV, V9, P535, DOI 10.1007/s11682-015-9379-3; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Monti JM, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00041; Morton SM, 2004, NEUROSCIENTIST, V10, P247, DOI 10.1177/1073858404263517; Nelson LD, 2016, J ATHL TRAINING, V51, P142, DOI 10.4085/1062-6050-51.4.04; Preiss-Farzanegan SJ, 2009, PM&R, V1, P245, DOI 10.1016/j.pmrj.2009.01.011; Sicard V, 2018, INT J PSYCHOPHYSIOL, V132, P3, DOI 10.1016/j.ijpsycho.2018.03.011; Squire LR, 2004, NEUROBIOL LEARN MEM, V82, P171, DOI 10.1016/j.nlm.2004.06.005; Stein Donald G, 2003, Pediatr Rehabil, V6, P13, DOI 10.1080/1363849031000095279; Strain J, 2013, NEUROLOGY, V81, P25, DOI 10.1212/WNL.0b013e318299ccf8; Tan H, 2009, J MAGN RESON IMAGING, V29, P1134, DOI 10.1002/jmri.21721; Terwilliger VK, 2016, J NEUROTRAUM, V33, P761, DOI 10.1089/neu.2015.4082; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Viano DC, 2005, NEUROSURGERY, V57, P891, DOI 10.1227/01.NEU.0000186950.54075.3B; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Wilcox BJ, 2015, J BIOMECH, V48, P2201, DOI 10.1016/j.jbiomech.2015.04.005; Wilcox BJ, 2014, J BIOMECH, V47, P109, DOI 10.1016/j.jbiomech.2013.10.004; Wunderle K, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000006	52	15	15	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 15	2020	37	10					1197	1203		10.1089/neu.2019.6800			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LL3VP	WOS:000531484000003	31650894				2022-02-06	
J	Zeiler, FA; Beqiri, E; Cabeleira, M; Hutchinson, PJ; Stocchetti, N; Menon, DK; Czosnyka, M; Smielewski, P; Ercole, A				Zeiler, Frederick A.; Beqiri, Erta; Cabeleira, Manuel; Hutchinson, Peter J.; Stocchetti, Nino; Menon, David K.; Czosnyka, Marek; Smielewski, Peter; Ercole, Ari		Collaborative European NeuroTrauma	Brain Tissue Oxygen and Cerebrovascular Reactivity in Traumatic Brain Injury: A Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury Exploratory Analysis of Insult Burden	JOURNAL OF NEUROTRAUMA			English	Article						autoregulation; brain tissue oxygen; ICP; physiological burden	CEREBRAL PERFUSION-PRESSURE; MULTIDISCIPLINARY CONSENSUS CONFERENCE; NEUROCRITICAL CARE SOCIETY; INTRACRANIAL-PRESSURE; CLASSIFICATION; PROFESSIONALS; THRESHOLDS; MANAGEMENT; STATEMENT	Pressure reactivity index (PRx) and brain tissue oxygen (PbtO(2)) are associated with outcome in traumatic brain injury (TBI). This study explores the relationship between PRx and PbtO(2) in adult moderate/severe TBI. Using the Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI) high resolution intensive care unit (ICU) sub-study cohort, we evaluated those patients with archived high-frequency digital intraparenchymal intracranial pressure (ICP) and PbtO(2) monitoring data of, a minimum of 6 h in duration, and the presence of a 6 month Glasgow Outcome Scale -Extended (GOSE) score. Digital physiological signals were processed for ICP, PbtO(2), and PRx, with the % time above/below defined thresholds determined. The duration of ICP, PbtO(2), and PRx derangements was characterized. Associations with dichotomized 6-month GOSE (alive/dead, and favorable/unfavorable outcome; <= 4 = unfavorable), were assessed. A total of 43 patients were included. Severely impaired cerebrovascular reactivity was seen during elevated ICP and low PbtO(2) episodes. However, most of the acute ICU physiological derangements were impaired cerebrovascular reactivity, not ICP elevations or low PbtO(2) episodes. Low PbtO(2) without PRx impairment was rarely seen. % time spent above PRx threshold was associated with mortality at 6 months for thresholds of 0 (area under the curve [AUC] 0.734, p = 0.003), > +0.25 (AUC 0.747, p = 0.002) and > +0.35 (AUC 0.745, p = 0.002). Similar relationships were not seen for % time with ICP >20 mm Hg, and PbtO(2) < 20 mm Hg in this cohort. Extreme impairment in cerebrovascular reactivity is seen during concurrent episodes of elevated ICP and low PbtO(2). However, the majority of the deranged cerebral physiology seen during the acute ICU phase is impairment in cerebrovascular reactivity, with most impairment occurring in the presence of normal PbtO(2) levels. Measures of cerebrovascular reactivity appear to display the most consistent associations with global outcome in TBI, compared with ICP and PbtO(2).	[Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Beqiri, Erta; Cabeleira, Manuel; Czosnyka, Marek; Smielewski, Peter] Univ Cambridge, Addenbrookes Hosp, Brain Phys Lab, Cambridge, England; [Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Biomed Engn, Fac Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Ctr Aging, Winnipeg, MB, Canada; [Stocchetti, Nino] Neuro ICU Fdn IRCCS Ca Granda Osped Maggiore Poli, Milan, Italy; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland		Zeiler, FA (corresponding author), Univ Manitoba, Rady Fac Hlth Sci, Dept Surg, FRCSC Neurosurg, Winnipeg, MB R3A 1R9, Canada.	umzeiler@myumanitoba.ca	Ercole, Ari/B-6288-2009; Sahuquillo, Juan/B-3577-2008; Moller, Kirsten/A-4751-2009	Ercole, Ari/0000-0001-8350-8093; Sahuquillo, Juan/0000-0003-0713-5875; Sakowitz, Oliver/0000-0003-3248-6335; Zeiler, Frederick/0000-0003-1737-0510; Radoi, Andreea/0000-0002-0677-3544; Moller, Kirsten/0000-0003-3058-1072	European Union 7th Framework program (EC) [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA); National Institute for Health Research (NIHR, UK)National Institute for Health Research (NIHR); Cambridge Biomedical Research Centre (BRC) at the Cambridge University Hospitals NHS Foundation Trust; NIHR Clinical Research network; United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS); Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); University of Manitoba Vice President Research and International (VPRI) Research Investment Fund (RIF); University of Manitoba Centre on Aging; University of Manitoba Rudy Falk Clinician-Scientist Professorship; Health Sciences Centre Foundation Winnipeg; NIHR Cambridge BRC; NIHR (Research Professorship, Cambridge BRC, Global Health Research Group on Neurotrauma); Royal College of Surgeons of England	Data used in preparation of this manuscript were obtained in the context of CENTER-TBI, a large collaborative project with the support of the European Union 7th Framework program (EC grant 602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). D.K.M. was also supported by funding from the National Institute for Health Research (NIHR, UK) through a Senior Investigator award and the Cambridge Biomedical Research Centre (BRC) at the Cambridge University Hospitals NHS Foundation Trust. The study also received additional support from the NIHR Clinical Research network. The views expressed are those of the authors and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care, UK. F.A.Z. receives research support from the United States National Institutes of Health (NIH) through the National Institute of Neurological Disorders and Stroke (NINDS), the Canadian Institutes for Health Research (CIHR), the University of Manitoba Vice President Research and International (VPRI) Research Investment Fund (RIF), the University of Manitoba Centre on Aging, the University of Manitoba Rudy Falk Clinician-Scientist Professorship, and the Health Sciences Centre Foundation Winnipeg. M.C.is supported by NIHR Cambridge BRC. P.J.H. is supported by the NIHR (Research Professorship, Cambridge BRC, Global Health Research Group on Neurotrauma) and the Royal College of Surgeons of England.	Andresen M, 2018, NEUROCRIT CARE, V28, P162, DOI 10.1007/s12028-017-0438-z; Aries MJH, 2012, CRIT CARE MED, V40, P2456, DOI 10.1097/CCM.0b013e3182514eb6; Beqiri E, 2019, BMJ OPEN, V9, DOI 10.1136/bmjopen-2019-030727; Bragin DE, 2014, CRIT CARE MED, V42, P2582, DOI 10.1097/CCM.0000000000000655; Budohoski KP, 2012, BRIT J ANAESTH, V108, P89, DOI 10.1093/bja/aer324; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 2016, ACTA NEUROCHIR SUPPL, V122, P113, DOI 10.1007/978-3-319-22533-3_22; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Doiron D, 2017, INT J EPIDEMIOL, V46, P1372, DOI 10.1093/ije/dyx180; Donnelly J, 2020, NEUROCRIT CARE, V32, P437, DOI 10.1007/s12028-019-00748-x; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Hawryluk GWJ, 2016, J NEUROSURG, V125, P1217, DOI 10.3171/2015.7.JNS15809; Khellaf A, 2019, J NEUROL, V266, P2878, DOI 10.1007/s00415-019-09541-4; Lazaridis C, 2014, J NEUROSURG, V120, P893, DOI 10.3171/2014.1.JNS131292; Le Roux P, 2014, NEUROCRIT CARE, V21, P297, DOI 10.1007/s12028-014-0081-x; Le Roux P, 2014, NEUROCRIT CARE, V21, P282, DOI 10.1007/s12028-014-0077-6; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Okonkwo DO, 2017, CRIT CARE MED, V45, P1907, DOI 10.1097/CCM.0000000000002619; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Steiner LA, 2002, CRIT CARE MED, V30, P733, DOI 10.1097/00003246-200204000-00002; Vande Vyvere T, 2019, J NEUROTRAUM, V36, P1080, DOI 10.1089/neu.2018.6061; Xie Q, 2017, WORLD NEUROSURG, V100, P118, DOI 10.1016/j.wneu.2016.12.097; Zeiler FA, 2019, J NEUROSURG ANESTHES; Zeiler FA, 2020, J NEUROTRAUM, V37, P1233, DOI 10.1089/neu.2019.6808; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2017, J NEUROTRAUM, V34, P3070, DOI 10.1089/neu.2017.5129	30	15	16	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2020	37	17					1854	1863		10.1089/neu.2020.7024		MAY 2020	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NK7JF	WOS:000530256700001	32253987	Green Published, Green Submitted			2022-02-06	
J	Vergara, VM; Salman, M; Abrol, A; Espinoza, FA; Calhoun, VD				Vergara, Victor M.; Salman, Mustafa; Abrol, Anees; Espinoza, Flor A.; Calhoun, Vince D.			Determining the number of states in dynamic functional connectivity using cluster validity indexes	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Magnetic resonance imaging; Dynamic functional network connectivity; Clustering analysis; Cluster validity index; k-means clustering; Elbow-Criterion; GAP-Statistics; Davies-Bouldin; Calinski-Harabasz; Silhouette; Wemmert-Gancarski; Ray-Turi; Ratkowsky-Lance; SD_Dis; Dunn; Point-Biserial; McClain-Rao; Xie-Beni; PBM; Ball-Hall; Banfeld-Raftery; Ksq_DetW; Log_Det_Ratio; Log_SS_ratio; Scott-Symons; SD_scat; Trace_W; Trace_WiB; Det_Ratio	TRAUMATIC BRAIN-INJURY; NETWORK CONNECTIVITY; CEREBRAL-CORTEX; VALIDATION; FMRI; NICOTINE; ALCOHOL	Background: Clustering analysis is employed in brain dynamic functional connectivity (dFC) to cluster the data into a set of dynamic states. These states correspond to different patterns of functional connectivity that iterate through time. Although several cluster validity index (CVI) methods to determine the best clustering partition exists, the appropriateness of methods to apply in the case of dynamic connectivity analysis has not been determined. New Method: Currently employed indexes do not provide a crisp answer on what is the best number of clusters. In addition, there is a lack of CVI testing in the context of dFC data. This work tests a comprehensive set of twenty four cluster validity indexes applied to addiction data and suggest the best ones for clustering dynamic functional connectivity. Results: Out of the twenty four considered CVIs, Davies-Bouldin and Ray-Turi were the most suitable methods to find the number of clusters in both simulation and real data. The solution for these two CVIs is to find a local minimum critical point, which can be automated using computational algorithms. Comparison with Existing Methods: Elbow-Criterion, Silhouette and GAP-Statistic methods have been widely used in dFC studies. These methods are included among the tested CVIs where the performances of all twenty four CVIs are compared. Conclusions: Davies-Bouldin and Ray-Turi CVIs showed better performance among a group of twenty four CVIs in determining the number of clusters to use in dFC analysis.	[Vergara, Victor M.; Salman, Mustafa; Abrol, Anees; Espinoza, Flor A.; Calhoun, Vince D.] Emory Univ, Georgia State Univ, Triinst Ctr Translat Res Neuroimaging & Data Sci, Georgia Inst Technol, Atlanta, GA 30322 USA; [Vergara, Victor M.; Espinoza, Flor A.; Calhoun, Vince D.] Mind Res Network, Albuquerque, NM USA; [Vergara, Victor M.; Espinoza, Flor A.; Calhoun, Vince D.] Lovelace Biomed & Environm Res Inst, Albuquerque, NM USA; [Salman, Mustafa; Calhoun, Vince D.] Georgia Inst Technol, Sch Elect & Comp Engn, Atlanta, GA 30332 USA		Vergara, VM (corresponding author), Triinst Ctr Translat Res Neuroimaging & Data Sci, 55 Pk Pl, Atlanta, GA 30303 USA.	vvergara@gsu.edu; msalman@gsu.edu; aabrol@gsu.edu; fespinoza.science@gmail.com; vcalhoun@gsu.edu	Abrol, Anees/AAQ-1382-2020	Abrol, Anees/0000-0001-9223-5314; Vergara, Victor/0000-0001-9404-0924	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P20GM103472/1R01EB006841/R01REB020407]; National Science FoundationNational Science Foundation (NSF) [1539067]	This work was funded by the following NIH grants P20GM103472/1R01EB006841/R01REB020407 and National Science Foundation (#1539067) to V.C.	Abrol A, 2017, NEUROIMAGE, V163, P160, DOI 10.1016/j.neuroimage.2017.09.020; Agosta F, 2017, NEUROL SCI, V38, P41, DOI 10.1007/s10072-016-2764-x; Allen EA, 2014, CEREB CORTEX, V24, P663, DOI 10.1093/cercor/bhs352; Arbelaitz O, 2013, PATTERN RECOGN, V46, P243, DOI 10.1016/j.patcog.2012.07.021; Ball G.H., 1965, 699616 NTIS AD; BANFIELD JD, 1993, BIOMETRICS, V49, P803, DOI 10.2307/2532201; Brun M, 2007, PATTERN RECOGN, V40, P807, DOI 10.1016/j.patcog.2006.06.026; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Calhoun VD, 2014, NEURON, V84, P262, DOI 10.1016/j.neuron.2014.10.015; Calhoun Vince D, 1800, IEEE Rev Biomed Eng, V5, P60, DOI 10.1109/RBME.2012.2211076; Calinski TT., 1974, COMMUN STAT, V3, P1, DOI 10.1080/03610927408827101; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Damaraju E, 2014, NEUROIMAGE-CLIN, V5, P298, DOI 10.1016/j.nicl.2014.07.003; DAVIES DL, 1979, IEEE T PATTERN ANAL, V1, P224, DOI 10.1109/TPAMI.1979.4766909; Desgraupes B., 2013, CLUSTERING INDICES 1; Dunn J. C., 1974, J CYBERNETICS, V4, P95, DOI [10.1080/01969727408546059, DOI 10.1080/01969727408546059]; EDWARDS AWF, 1965, BIOMETRICS, V21, P362, DOI 10.2307/2528096; Espinoza FA, 2019, HUM BRAIN MAPP, V40, P1955, DOI 10.1002/hbm.24504; Espinoza FA, 2018, BRAIN CONNECT, V8, P166, DOI 10.1089/brain.2017.0538; Figueroa CA, 2019, HUM BRAIN MAPP, V40, P2771, DOI 10.1002/hbm.24559; Fox MD, 2010, FRONT SYST NEUROSCI, V4, DOI [10.3389/fnsys.2010.00019, 10.3389/fnsys.2010.0001]; FRIEDMAN HP, 1967, J AM STAT ASSOC, V62, P1159, DOI 10.2307/2283767; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Guyon I., 2009, NIPS 2009 WORKSH CLU, P1; Halkidi M, 2001, J INTELL INF SYST, V17, P107, DOI 10.1023/A:1012801612483; Hartigan JA., 1975, CLUSTERING ALGORITHM; Himberg J, 2004, NEUROIMAGE, V22, P1214, DOI 10.1016/j.neuroimage.2004.03.027; Hindriks R, 2016, NEUROIMAGE, V127, P242, DOI 10.1016/j.neuroimage.2015.11.055; Hutchison RM, 2013, NEUROIMAGE, V80, P360, DOI 10.1016/j.neuroimage.2013.05.079; K/tter, 2003, NEUROSCIENCE DATABAS, P237, DOI [10.1007/978-1-4615-1079-6_16, DOI 10.1007/978-1-4615-1079-6{\_}16]; Kodinariya TM., 2013, INT J-TORONTO, V1, P2321; Larson J, 2016, OPTIM ENG, V17, P205, DOI 10.1007/s11081-015-9289-7; Leonardi N, 2015, NEUROIMAGE, V104, P430, DOI 10.1016/j.neuroimage.2014.09.007; Lin SJ, 2018, HUM BRAIN MAPP, V39, P5039, DOI 10.1002/hbm.24343; Lindquist MA, 2014, NEUROIMAGE, V101, P531, DOI 10.1016/j.neuroimage.2014.06.052; Ma S, 2011, IEEE T BIO-MED ENG, V58, P3406, DOI 10.1109/TBME.2011.2167149; MARRIOTT FH, 1971, BIOMETRICS, V27, P501, DOI 10.2307/2528592; McClain JO, 1975, J MARKETING RES, V12, P456; MILLIGAN GW, 1981, PSYCHOMETRIKA, V46, P187, DOI 10.1007/BF02293899; Mooneyham BW, 2017, J COGNITIVE NEUROSCI, V29, P495, DOI 10.1162/jocn_a_01066; Pakhira MK, 2004, PATTERN RECOGN, V37, P487, DOI 10.1016/j.patcog.2003.06.005; Pal NR, 1997, PATTERN RECOGN, V30, P847, DOI 10.1016/S0031-3203(96)00127-6; Preti MG, 2017, NEUROIMAGE, V160, P41, DOI 10.1016/j.neuroimage.2016.12.061; Rachakonda S., 2007, GROUP ICA FMRI TOOLB; Ratkowsky D., 1978, CRITERION DETERMININ; Ray S., 1999, P 4 INT C ADV PATT R, P137, DOI DOI 10.1109/TKDE.2008.158; ROUSSEEUW PJ, 1987, J COMPUT APPL MATH, V20, P53, DOI 10.1016/0377-0427(87)90125-7; Sakoglu U, 2010, MAGN RESON MATER PHY, V23, P351, DOI 10.1007/s10334-010-0197-8; Savva AD, 2019, BRAIN BEHAV, V9, DOI 10.1002/brb3.1255; Schulz D, 2002, J NEUROSCI METH, V121, P129, DOI 10.1016/S0165-0270(02)00224-8; SCOTT AJ, 1971, BIOMETRICS, V27, P387, DOI 10.2307/2529003; Shakil S, 2016, NEUROIMAGE, V133, P111, DOI 10.1016/j.neuroimage.2016.02.074; Shakil S, 2015, IEEE INT C BIOINFORM, P363, DOI 10.1109/BIBM.2015.7359708; Singer W, 1999, NEURON, V24, P49, DOI 10.1016/S0896-6273(00)80821-1; Tibshirani R, 2001, J ROY STAT SOC B, V63, P411, DOI 10.1111/1467-9868.00293; van der Horn HJ, 2020, HUM BRAIN MAPP, V41, P617, DOI 10.1002/hbm.24827; Vergara V.M., 2019, MILD TRAUMATIC BRAIN; Vergara VM, 2019, HUM BRAIN MAPP, V40, P2089, DOI 10.1002/hbm.24509; Vergara VM, 2018, NEUROIMAGE-CLIN, V19, P30, DOI 10.1016/j.nicl.2018.03.017; Vergara VM, 2018, NEUROPSYCHOPHARMACOL, V43, P877, DOI 10.1038/npp.2017.280; Vergara VM, 2017, NEUROIMAGE, V151, P45, DOI 10.1016/j.neuroimage.2016.11.012; Vergara VM, 2017, J NEUROTRAUM, V34, P1045, DOI 10.1089/neu.2016.4526; XIE XLL, 1991, IEEE T PATTERN ANAL, V13, P841, DOI 10.1109/34.85677; Yeo BTT, 2011, J NEUROPHYSIOL, V106, P1125, DOI 10.1152/jn.00338.2011; Zalesky A, 2015, NEUROIMAGE, V114, P466, DOI 10.1016/j.neuroimage.2015.03.047; Zalesky A, 2014, P NATL ACAD SCI USA, V111, P10341, DOI 10.1073/pnas.1400181111	66	15	15	3	15	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	MAY 1	2020	337								108651	10.1016/j.jneumeth.2020.108651			13	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	LD5ZG	WOS:000526108300005	32109439	Green Accepted			2022-02-06	
J	Kiraz, M; Demir, E				Kiraz, Murat; Demir, Emre			A Bibliometric Analysis of Publications on Spinal Cord Injury During 1980-2018	WORLD NEUROSURGERY			English	Article						Bibliometric analysis; Spinal cord injury; Trends	INTERNATIONAL STANDARDS; FUNCTIONAL RECOVERY; METHYLPREDNISOLONE; REHABILITATION; CLASSIFICATION	BACKGROUND: Spinal cord injury (SCI) could cause motor, sensory loss, severe functional insufficiency, and social problems. This study aims to provide a holistic summary of the global scientific outputs about SCI through bibliometric analyses and reveal the trend topics. METHODS: All publications about SCI published between 1980 and 2018 in Web of Science (WoS) index were downloaded (Access date: 01.09.2019) and analyzed using bibliometric methods. In the Title search section in WoS, the documents with the words "spinal cord injury" were identified. Correlation analysis between SCI publication productivity and economic development indicators of the world countries were analyzed using the Spearman correlation coefficient. RESULTS: There were 20,322 publications, 13,662 of which were articles. The top 3 productive countries were the USA, China, and Canada. British Columbia (403; 2.9%), Toronto (401; 2.9%), and Miami (387; 2.8%) were the prominent cities. The top productive journals were Spinal Cord (1,399; 10.24%), Archives of Physical Medicine and Rehabilitation (835; 6.11%), and Journal of Neurotrauma (631; 4.61%). A statistically significant, high-level correlation was found between the number of publications about SCI and the countries' gross domestic product and gross domestic product per capita (r = 0.711, P < 0.001; r = 0.699, P < 0.001). CONCLUSIONS: This study provides a systematic analysis of SCI and could be a beneficial guide for clinicians and scientists.	[Kiraz, Murat] Hitit Univ, Fac Med, Dept Neurosurg, Corum, Turkey; [Demir, Emre] Hitit Univ, Fac Med, Dept Biostat, Corum, Turkey		Kiraz, M (corresponding author), Hitit Univ, Fac Med, Dept Neurosurg, Corum, Turkey.	kirazmurat@gmail.com	Demir, Emre/AAA-8193-2020; kiraz, murat/ABC-2965-2020	Demir, Emre/0000-0002-3834-3864; /0000-0001-6692-444X			Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; BRACKEN MB, 1990, NEW ENGL J MED, V322, P1405, DOI 10.1056/NEJM199005173222001; Bracken MB, 1997, JAMA-J AM MED ASSOC, V277, P1597, DOI 10.1001/jama.277.20.1597; Bradbury EJ, 2002, NATURE, V416, P636, DOI 10.1038/416636a; Crowe MJ, 1997, NAT MED, V3, P73, DOI 10.1038/nm0197-73; Demir E, 2020, J FORENSIC LEG MED, V69, DOI 10.1016/j.jflm.2019.101885; Demir E, 2020, IRISH J MED SCI, V189, P267, DOI 10.1007/s11845-019-02080-x; Demir E, 2019, J RELIG HEALTH, V58, P1, DOI 10.1007/s10943-018-00739-w; Dogan G, 2019, EUR J PEDIATR SURG, DOI [10.1055/s-0039-3400514, DOI 10.1055/S-0039-]; Dogan G, 2020, J RELIG HEALTH, V59, P96, DOI 10.1007/s10943-019-00886-8; Faulkner JR, 2004, J NEUROSCI, V24, P2143, DOI 10.1523/JNEUROSCI.3547-03.2004; Fehlings MG, 2017, NEUROSURGERY, V80, P51, DOI 10.1093/neuros/nyw112; Jazayeri SB, 2017, EUR SPINE J, V24, P905; Keirstead HS, 2005, J NEUROSCI, V25, P4694, DOI 10.1523/JNEUROSCI.0311-05.2005; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Liu XX, 2019, THER CLIN RISK MANAG, V15, P1, DOI 10.2147/TCRM.S163881; Maynard FM, 1997, SPINAL CORD, V35, P266, DOI 10.1038/sj.sc.3100432; Nas K, 2015, WORLD J ORTHOP, V6, P8, DOI 10.5312/wjo.v6.i1.8; Nori S, 2017, NEUROSURGERY, V64, P119, DOI 10.1093/neuros/nyx217; Nowrouzi B, 2017, EUR SPINE J, V26, P28, DOI 10.1007/s00586-016-4669-z; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Singh A, 2014, CLIN EPIDEMIOL, V6, P309, DOI 10.2147/CLEP.S68889; Teng YD, 2002, P NATL ACAD SCI USA, V99, P3024, DOI 10.1073/pnas.052678899; van Eck NJ, 2010, SCIENTOMETRICS, V84, P523, DOI 10.1007/s11192-009-0146-3	26	15	15	3	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2020	136						E504	E513		10.1016/j.wneu.2020.01.064			10	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	KW0BN	WOS:000520838600054	31954906				2022-02-06	
J	Nellamattathil, M; Amber, I				Nellamattathil, Michael; Amber, Ian			An evaluation of scooter injury and injury patterns following widespread adoption of E-scooters in a major metropolitan area	CLINICAL IMAGING			English	Article						Scooter; Trauma; Musculoskeletal; Fall		Objective: Despite the increasing use of e-scooters globally, the pattern of injuries on diagnostic imaging had not been well-documented to date. We performed a retrospective study utilizing our health system's radiology database to characterize the injury distribution and imaging features of scooter injuries. Methods: We utilized our radiology report database searching for any imaging report containing the word "scooter", beginning September 1, 2017, when scooters were first introduced to our area through December 1, 2018. Results: Our search yielded a total of 54 patients with 105 imaging studies. The injuries predominantly affected the musculoskeletal system, with a predilection to the upper extremity. We had no cases of visceral or neurotrauma. Conclusion: Musculoskeletal injuries were the predominant form of scooter injury. The lack of visceral injury suggests that emergency physicians should consider having a higher clinical threshold for ordering these studies in patients with scooter injuries.	[Nellamattathil, Michael; Amber, Ian] Medstar Georgetown Univ Hosp, Dept Radiol, 3800 Reservoir Rd NW, Washington, DC 20007 USA		Nellamattathil, M (corresponding author), Medstar Georgetown Univ Hosp, Dept Radiol, 3800 Reservoir Rd NW, Washington, DC 20007 USA.	mnella23@gmail.com; ian.b.amber@medstar.net					[Anonymous], 2019, NEW YORK POST; Bird, 2019, BIRD RENTAL AGREEMEN; Dobush G., 2018, BOOMING E SCOOTER MA; Felton R., 2019, E SCOOTER RIDE SHARE; Hall E, 2017, TLS-TIMES LIT SUPPL, P26; Mesh A., 2018, WEEK; Munk PL, 2007, TEACHING ATLAS MUSCU; Siman-Tov M, 2017, TRAFFIC INJ PREV, V18, P318, DOI 10.1080/15389588.2016.1246723; Southard P, 1989, J Emerg Nurs, V15, P393; Trivedi TK, 2019, JAMA NETW OPEN, V2, DOI DOI 10.1001/JAMANETW0RK0PEN.2018.7381]; Warth RJ, 2013, CURR REV MUSCULOSKE, V6, P71, DOI 10.1007/s12178-012-9144-9; Xu J, 2016, ACCIDENT ANAL PREV, V89, P128, DOI 10.1016/j.aap.2016.01.013	12	15	15	0	4	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0899-7071	1873-4499		CLIN IMAG	Clin. Imaging	APR	2020	60	2					200	203		10.1016/j.clinimag.2019.12.012			4	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	KX1PJ	WOS:000521654800010	31927494				2022-02-06	
J	Patton, DA; Huber, CM; McDonald, CC; Margulies, SS; Master, CL; Arbogast, KB				Patton, Declan A.; Huber, Colin M.; McDonald, Catherine C.; Margulies, Susan S.; Master, Christina L.; Arbogast, Kristy B.			Video Confirmation of Head Impact Sensor Data From High School Soccer Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						head injuries; concussion; pediatric sports medicine; football (soccer); injury prevention	ACCELERATION	Background: Recent advances in technology have enabled the development of head impact sensors, which provide a unique opportunity for sports medicine researchers to study head kinematics in contact sports. Studies have suggested that video or observer confirmation of head impact sensor data is required to remove false positives. In addition, manufacturer filtering algorithms may be ineffective in identifying true positives and removing true negatives. Purpose: To (1) identify the percentage of video-confirmed events recorded by headband-mounted sensors in high school soccer through video analysis, overall and by sex; (2) compare video-confirmed events with the classification by the manufacturer filtering algorithms; and (3) quantify and compare the kinematics of true- and false-positive events. Study Design: Cohort study; Level of evidence, 2. Methods: Adolescent female and male soccer teams were instrumented with headband-mounted impact sensors (SIM-G; Triax Technologies) during games over 2 seasons of suburban high school competition. Sensor data were sequentially reduced to remove events recorded outside of game times, associated with players not on the pitch (ie, field) and players outside the field of view of the camera. With video analysis, the remaining sensor-recorded events were identified as an impact event, trivial event, or nonevent. The mechanisms of impact events were identified. The classifications of sensor-recorded events by the SIM-G algorithm were analyzed. Results: A total of 6796 sensor events were recorded during scheduled varsity game times, of which 1893 (20%) were sensor-recorded events associated with players on the pitch in the field of view of the camera during verified game times. Most video-confirmed events were impact events (n = 1316, 70%), followed by trivial events (n = 396, 21%) and nonevents (n = 181, 10%). Female athletes had a significantly higher percentage of trivial events and nonevents with a significantly lower percentage of impact events. Most impact events were head-to-ball impacts (n = 1032, 78%), followed by player contact (n = 144, 11%) and falls (n = 129, 10%) with no significant differences between male and female teams. The SIM-G algorithm correctly identified 70%, 52%, and 66% of video-confirmed impact events, trivial events, and nonevents, respectively. Conclusion: Video confirmation is critical to the processing of head impact sensor data. Percentages of video-confirmed impact events, trivial events, and nonevents vary by sex in high school soccer. Current manufacturer filtering algorithms and magnitude thresholds are ineffective at correctly classifying sensor-recorded events and should be used with caution.	[Patton, Declan A.; Huber, Colin M.; McDonald, Catherine C.; Margulies, Susan S.; Master, Christina L.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Patton, Declan A.; Huber, Colin M.; McDonald, Catherine C.; Master, Christina L.; Arbogast, Kristy B.] Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, 734 Schuylkill Ave, Philadelphia, PA 19104 USA; [Huber, Colin M.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [McDonald, Catherine C.] Univ Penn, Sch Nursing, Philadelphia, PA 19104 USA; [Margulies, Susan S.] Georgia Inst Technol, Wallace H Coulter Dept Biomed Engn, Atlanta, GA 30332 USA; [Margulies, Susan S.] Emory Univ, Atlanta, GA 30322 USA; [Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Master, Christina L.; Arbogast, Kristy B.] Univ Penn, Perelman Sch Med, Philadelphia, PA 19104 USA		Patton, DA (corresponding author), Childrens Hosp Philadelphia, Ctr Injury Res & Prevent, 734 Schuylkill Ave, Philadelphia, PA 19104 USA.	pattonda@email.chop.edu		McDonald, Catherine/0000-0003-3856-8542; HUBER, COLIN/0000-0002-0045-5940	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS097549] Funding Source: Medline		Bussone WR, 2017, SAE INT J TRANSP SAF, V5, P194, DOI 10.4271/2017-01-1465; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Cortes N, 2017, AM J SPORT MED, V45, P2379, DOI 10.1177/0363546517706703; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Dezman ZDW, 2013, SPORTS HEALTH, V5, P320, DOI 10.1177/1941738113480935; Kuo C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0199238; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lynall RC, 2019, J NEUROTRAUM, V36, P1752, DOI 10.1089/neu.2018.6236; Nevins D, 2017, J SPORTS ENG TECHNOL, V232, P242; Patton DA, 2016, APPL BIONICS BIOMECH, V2016, DOI 10.1155/2016/7049743; Powell JW, 2001, J ATHL TRAINING, V36, P307; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Rosene JM, 2019, INT J ATHL THER TRAI, V24, P213, DOI 10.1123/ijatt.2018-0052; Swartz EE, 2019, J SCI MED SPORT, V22, P1102, DOI 10.1016/j.jsams.2019.05.018; Tierney RT, 2008, J ATHL TRAINING, V43, P578, DOI 10.4085/1062-6050-43.6.578; Time and Date Aksjeselskap, CURR LOC TIM PHIL PE; Triax Technologies, 2014, LAB VAL SIM G HEAD I	17	15	15	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	APR	2020	48	5					1246	1253	0363546520906406	10.1177/0363546520906406		MAR 2020	8	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	KZ1QM	WOS:000523777100001	32130020	Green Accepted			2022-02-06	
J	Hoffman, NL; Weber, ML; Broglio, SP; McCrea, M; McAllister, TW; Schmidt, JD				Hoffman, Nicole L.; Weber, Michelle L.; Broglio, Steven P.; McCrea, Michael; McAllister, Thomas W.; Schmidt, Julianne D.		Care Consortium Investigators	Influence of Postconcussion Sleep Duration on Concussion Recovery in Collegiate Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						cognition; symptom severity; asymptomatic	QUALITY-OF-LIFE; POSTURAL STABILITY; IMPACT; DISTURBANCES; HEALTH; PERFORMANCE; TIME; DEPRIVATION	Objective: To determine whether decreased sleep duration postconcussion influences days to asymptomatic and assessment of performance throughout recovery. Design: Prospective. Setting: Institutional Clinical Research Laboratory. Patients: Four hundred twenty-three collegiate athletes were diagnosed with concussion. Interventions: Multidimensional concussion assessment battery was conducted at baseline, within 24 to 48 hours, daily [2-4 days postinjury (PI); symptoms only], once asymptomatic, and after return-to-play. The battery included the following: 22-item symptom checklist, Standardized Assessment of Concussion (SAC), Balance Error Scoring System (BESS), and computerized neurocognitive test [Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT)]. Main Outcome Measures: We subtracted baseline sleep duration from 24 to 48 hours postconcussion sleep duration and categorized athletes into the following groups: shorter sleep (<=-1 hour), no change (>-1 hour, <+1 hour), and longer sleep (>=+1 hour). A 1-way analysis of variance (ANOVA) was conducted to compare days to asymptomatic and separate mixed-model ANOVAs to compare total symptom scores, SAC total scores, BESS total error scores, and ImPACT composite scores between sleep categories across time points (alpha = 0.05). Results: Sleep groups did not differ in days to asymptomatic. The shorter sleep group had greater symptom severity than no sleep change and longer sleep groups at 24 to 48 hours (shorter: 39.1 +/- 20.7; no change: 25.1 +/- 18.4,P= 0.007; longer: 25.7 +/- 21.8,P= 0.004), and at 2 to 4 days PI (shorter: 21.8 +/- 21.8; no change: 10.5 +/- 10.8,P= 0.013; longer: 11.9 +/- 14.2,P= 0.007), but did not differ at other time points (ie, asymptomatic and return-to-play). Participants with shorter sleep exhibited slower ImPACT reaction times at 24 to 48 hours (shorter: 0.68 +/- 0.14; no change: 0.61 +/- 0.09,P= 0.016; and longer: 0.62 +/- 0.12,P= 0.028) and asymptomatic time points (shorter: 0.62 +/- 0.11; no change: 0.56 +/- 0.05;P= 0.015). Conclusion: Postinjury sleep declines may be associated with symptom severity and worsened reaction time during initial stages of recovery or may be the result of the concussion itself. Clinicians should be aware of alterations in sleep duration and manage appropriately to mitigate initial symptom burden postconcussion.	[Hoffman, Nicole L.; Weber, Michelle L.; Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA; [Hoffman, Nicole L.; Weber, Michelle L.; Schmidt, Julianne D.] Univ Georgia, UGA Concuss Res Lab, Athens, GA 30602 USA; [Broglio, Steven P.] Univ Michigan, Injury Ctr, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		Hoffman, NL (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA.	nhoffman25@uga.edu		Cameron, Kenneth/0000-0002-6276-4482	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium - National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	The authors also thank Jody Harland, Janetta Matesan, and Larry Riggen (Indiana University); Ashley Rettmann (University of Michigan); Melissa Koschnitzke (Medical College of Wisconsin); Michael Jarrett, Vibeke Brinck, and Bianca Byrne (Quesgen); Thomas Dompier, Melissa Niceley Baker, and Sara Dalton (Datalys Center for Sports Injury Research and Prevention); and the research and medical staff at each of the participating sites. This publication was made possible, in part, with support from the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium, funded by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The USAMRAA, Fort Detrick, MD 21702-5014, USA, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the DoD (DHP funds).	Belenky G, 2003, J SLEEP RES, V12, P1, DOI 10.1046/j.1365-2869.2003.00337.x; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Carrier J, 2014, PATHOL BIOL, V62, P231, DOI 10.1016/j.patbio.2014.09.001; Cohen-Zion M, 2016, J INT NEUROPSYCH SOC, V22, P388, DOI 10.1017/S1355617716000072; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Fitzpatrick J, 2017, ORTHOP J SPORTS MED, V5, DOI 10.1177/2325967116675272; Gosselin N, 2009, SLEEP MED, V10, P35, DOI 10.1016/j.sleep.2007.11.023; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Jaffee MS, 2015, BRAIN INJURY, V29, P221, DOI 10.3109/02699052.2014.983978; Kamdar BB, 2004, SLEEP MED, V5, P441, DOI 10.1016/j.sleep.2004.05.003; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; Lufi D, 2011, J CLIN SLEEP MED, V7, P137; Lund HG, 2010, J ADOLESCENT HEALTH, V46, P124, DOI 10.1016/j.jadohealth.2009.06.016; Magnee EHB, 2015, AM J ADDICTION, V24, P515, DOI 10.1111/ajad.12243; Mah CD, 2011, SLEEP, V34, P943, DOI 10.5665/SLEEP.1132; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; Mick E, 2000, J CHILD ADOL PSYCHOP, V10, P223, DOI 10.1089/10445460050167331; Mihalik JP, 2013, CLIN J SPORT MED, V23, P343, DOI 10.1097/JSM.0b013e318295a834; National Center on Sleep Disorders Research (National Heart Lung and Blood Institute) Trans-NIH Sleep Research Coordinating Committee, 2003, 2003 NAT SLEEP DIS R; O'Brien E, 2016, BEHAV SLEEP MED, V14, P539, DOI 10.1080/15402002.2015.1048447; Parcell DL, 2006, ARCH PHYS MED REHAB, V87, P278, DOI 10.1016/j.apmr.2005.10.024; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Silverberg ND, 2016, CLIN J SPORT MED, V26, P226, DOI 10.1097/JSM.0000000000000241; Strine TW, 2005, SLEEP MED, V6, P23, DOI 10.1016/j.sleep.2004.06.003; Sufrinko A, 2015, AM J SPORT MED, V43, P830, DOI 10.1177/0363546514566193; Taylor DJ, 2003, PERS INDIV DIFFER, V34, P1179, DOI 10.1016/S0191-8869(02)00108-3; Tham SW, 2015, J NEUROTRAUM, V32, P847, DOI 10.1089/neu.2014.3559; Wiggs LD, 2012, OXFORD HDB SLEEP SLE, P787	38	15	15	0	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2020	30			1			S29	S35		10.1097/JSM.0000000000000538			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	NQ6DX	WOS:000570961700003	32132474				2022-02-06	
J	Bennis, FC; Teeuwen, B; Zeiler, FA; Elting, JW; van der Naalt, J; Bonizzi, P; Delhaas, T; Aries, MJ				Bennis, Frank C.; Teeuwen, Bibi; Zeiler, Frederick A.; Elting, Jan Willem; van der Naalt, Joukje; Bonizzi, Pietro; Delhaas, Tammo; Aries, Marcel J.			Improving Prediction of Favourable Outcome After 6 Months in Patients with Severe Traumatic Brain Injury Using Physiological Cerebral Parameters in a Multivariable Logistic Regression Model	NEUROCRITICAL CARE			English	Article						Traumatic brain injury; Neuromonitoring; Outcome; Prediction; Logistic regression	PERFUSION-PRESSURE; THRESHOLDS; REACTIVITY; TOOL	Background/Objective Current severe traumatic brain injury (TBI) outcome prediction models calculate the chance of unfavourable outcome after 6 months based on parameters measured at admission. We aimed to improve current models with the addition of continuously measured neuromonitoring data within the first 24 h after intensive care unit neuromonitoring. Methods Forty-five severe TBI patients with intracranial pressure/cerebral perfusion pressure monitoring from two teaching hospitals covering the period May 2012 to January 2019 were analysed. Fourteen high-frequency physiological parameters were selected over multiple time periods after the start of neuromonitoring (0-6 h, 0-12 h, 0-18 h, 0-24 h). Besides systemic physiological parameters and extended Corticosteroid Randomisation after Significant Head Injury (CRASH) score, we added estimates of (dynamic) cerebral volume, cerebral compliance and cerebrovascular pressure reactivity indices to the model. A logistic regression model was trained for each time period on selected parameters to predict outcome after 6 months. The parameters were selected using forward feature selection. Each model was validated by leave-one-out cross-validation. Results A logistic regression model using CRASH as the sole parameter resulted in an area under the curve (AUC) of 0.76. For each time period, an increased AUC was found using up to 5 additional parameters. The highest AUC (0.90) was found for the 0-6 h period using 5 parameters that describe mean arterial blood pressure and physiological cerebral indices. Conclusions Current TBI outcome prediction models can be improved by the addition of neuromonitoring bedside parameters measured continuously within the first 24 h after the start of neuromonitoring. As these factors might be modifiable by treatment during the admission, testing in a larger (multicenter) data set is warranted.	[Bennis, Frank C.; Teeuwen, Bibi; Delhaas, Tammo] Maastricht Univ, Dept Biomed Engn, POB 616, NL-6200 MD Maastricht, Netherlands; [Bennis, Frank C.; Aries, Marcel J.] Maastricht Univ, MHeNS Sch Mental Hlth & Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands; [Bennis, Frank C.; Delhaas, Tammo] Maastricht Univ, CARIM Sch Cardiovasc Dis, POB 616, NL-6200 MD Maastricht, Netherlands; [Zeiler, Frederick A.] Univ Manitoba, Dept Surg, Sect Neurosurg, Rady Fac Hlth Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Human Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Fac Engn, Biomed Engn, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge, England; [Elting, Jan Willem] Univ Groningen, Univ Med Ctr Groningen, Dept Clin Neurophysiol, Groningen, Netherlands; [Elting, Jan Willem; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Bonizzi, Pietro] Maastricht Univ, Dept Data Sci & Knowledge Engn, Maastricht, Netherlands; [Aries, Marcel J.] Maastricht Univ, Med Ctr, Dept Intens Care, Maastricht, Netherlands		Bennis, FC (corresponding author), Maastricht Univ, Dept Biomed Engn, POB 616, NL-6200 MD Maastricht, Netherlands.; Bennis, FC (corresponding author), Maastricht Univ, MHeNS Sch Mental Hlth & Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands.; Bennis, FC (corresponding author), Maastricht Univ, CARIM Sch Cardiovasc Dis, POB 616, NL-6200 MD Maastricht, Netherlands.	f.bennis@maastrichtuniversity.nl		van der Naalt, Joukje/0000-0001-9873-2418; Zeiler, Frederick/0000-0003-1737-0510; Bennis, Frank/0000-0002-6233-9101	University of Manitoba VPRI Research Investment Fund (RIF); University of Manitoba Rudy Falk Clinician-Scientist Professorship; Health Sciences Centre Foundation (HSCF) in Winnipeg	FAZ is supported by the University of Manitoba VPRI Research Investment Fund (RIF), University of Manitoba Rudy Falk Clinician-Scientist Professorship and the Health Sciences Centre Foundation (HSCF) in Winnipeg.	Andrews PJD, 2002, J NEUROSURG, V97, P326, DOI 10.3171/jns.2002.97.2.0326; Austin PC, 2014, STAT MED, V33, P517, DOI 10.1002/sim.5941; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Donnelly J, 2019, NEUROSURGERY, V85, pE75, DOI 10.1093/neuros/nyy468; Donnelly J, 2017, CRIT CARE MED, V45, P1464, DOI 10.1097/CCM.0000000000002575; Gupta P, 2018, CRIT CARE MED, V46, P108, DOI 10.1097/CCM.0000000000002753; Guyon I., 2003, J MACH LEARN RES, V3, P1157, DOI DOI 10.1162/153244303322753616; Hastie T., 2009, ELEMENTS STAT LEARNI, V2nd ed., P745, DOI DOI 10.1007/978-0-387-84858-7; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Meiring C, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0206862; Merck LH, 2019, CRIT CARE MED, V47, P623, DOI 10.1097/CCM.0000000000003680; Moorman JR, 2011, PHYSIOL MEAS, V32, P1821, DOI 10.1088/0967-3334/32/11/S08; Park S, 2019, J CLIN MONIT COMPUT, V33, P95, DOI 10.1007/s10877-018-0132-5; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Pratt AK, 2019, CRIT CARE MED, V47, P591, DOI 10.1097/CCM.0000000000003647; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1318-1; Stocchetti N, 2014, NEW ENGL J MED, V370, P2121, DOI 10.1056/NEJMra1208708; Walker WC, 2018, J NEUROTRAUM, V35, P1587, DOI 10.1089/neu.2017.5359; Wartenberg KE, 2019, NEUROCRIT CARE, V31, P1; Weersink CSA, 2015, CRIT CARE MED, V43, P1952, DOI 10.1097/CCM.0000000000001165; YOUDEN WJ, 1950, CANCER, V3, P32, DOI 10.1002/1097-0142(1950)3:1<32::AID-CNCR2820030106>3.0.CO;2-3; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1955, DOI 10.1007/s00701-019-03980-8; Zeiler FA, 2019, ACTA NEUROCHIR, V161, P1217, DOI 10.1007/s00701-019-03844-1; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472	31	15	15	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2020	33	2					542	551		10.1007/s12028-020-00930-6		FEB 2020	10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	NS0NU	WOS:000516117100001	32056131	Green Published, hybrid			2022-02-06	
J	Robba, C; Galimberti, S; Graziano, F; Wiegers, EJA; Lingsma, HF; Iaquaniello, C; Stocchetti, N; Menon, D; Citerio, G				Robba, Chiara; Galimberti, Stefania; Graziano, Francesca; Wiegers, Eveline J. A.; Lingsma, Hester F.; Iaquaniello, Carolina; Stocchetti, Nino; Menon, David; Citerio, Giuseppe		CTR-TBI ICU Participants	Tracheostomy practice and timing in traumatic brain-injured patients: a CENTER-TBI study	INTENSIVE CARE MEDICINE			English	Article						Traumatic Brain Injury; Tracheostomy; Mechanical ventilation; Outcome	PROLONGED ENDOTRACHEAL INTUBATION; MECHANICALLY VENTILATED PATIENTS; CRITICALLY-ILL PATIENTS; EPIDEMIOLOGY; TRACHEOTOMY; MULTICENTER; GUIDELINES; TRIAL	Purpose Indications and optimal timing for tracheostomy in traumatic brain-injured (TBI) patients are uncertain. This study aims to describe the patients' characteristics, timing, and factors related to the decision to perform a tracheostomy and differences in strategies among different countries and assess the effect of the timing of tracheostomy on patients' outcomes. Methods We selected TBI patients from CENTER-TBI, a prospective observational longitudinal cohort study, with an intensive care unit stay >= 72 h. Tracheostomy was defined as early (<= 7 days from admission) or late (> 7 days). We used a Cox regression model to identify critical factors that affected the timing of tracheostomy. The outcome was assessed at 6 months using the extended Glasgow Outcome Score. Results Of the 1358 included patients, 433 (31.8%) had a tracheostomy. Age (hazard rate, HR = 1.04, 95% CI = 1.01-1.07, p = 0.003), Glasgow coma scale <= 8 (HR = 1.70, 95% CI = 1.22-2.36 at 7; p < 0.001), thoracic trauma (HR = 1.24, 95% CI = 1.01-1.52, p = 0.020), hypoxemia (HR = 1.37, 95% CI = 1.05-1.79, p = 0.048), unreactive pupil (HR = 1.76, 95% CI = 1.27-2.45 at 7; p < 0.001) were predictors for tracheostomy. Considerable heterogeneity among countries was found in tracheostomy frequency (7.9-50.2%) and timing (early 0-17.6%). Patients with a late tracheostomy were more likely to have a worse neurological outcome, i.e., mortality and poor neurological sequels (OR = 1.69, 95% CI = 1.07-2.67, p = 0.018), and longer length of stay (LOS) (38.5 vs. 49.4 days, p = 0.003). Conclusions Tracheostomy after TBI is routinely performed in severe neurological damaged patients. Early tracheostomy is associated with a better neurological outcome and reduced LOS, but the causality of this relationship remains unproven.	[Robba, Chiara] Policlin San Martino IRCCS Oncol & Neurosci, Dept Anaesthesia & Intens Care, Genoa, Italy; [Robba, Chiara; Galimberti, Stefania; Graziano, Francesca; Iaquaniello, Carolina; Citerio, Giuseppe] Univ Milano Bicocca, Sch Med & Surg, Monza, Italy; [Galimberti, Stefania; Graziano, Francesca] Univ Milano Bicocca, Ctr Biostat Clin Epidemiol, Monza, Italy; [Wiegers, Eveline J. A.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Stocchetti, Nino] Fdn IRCCS Ca Granda Osped Maggiore Policlin, Neuro ICU, Milan, Italy; [Menon, David] Univ Cambridge, Dept Anaesthesia, Cambridge, England; [Citerio, Giuseppe] San Gerardo Hosp, ASST Monza, Neurointens Care Unit, Monza, Italy		Citerio, G (corresponding author), Univ Milano Bicocca, Sch Med & Surg, Monza, Italy.	giuseppe.citerio@unimib.it	Badenes, Rafael/K-6628-2019; Sahuquillo, Juan/B-3577-2008; Ercole, Ari/B-6288-2009; Posti, Jussi P./Y-2908-2019; Laureys, Steven/AAN-2097-2021; Castano-Leon, Ana M/ABF-6322-2020; Robba, Chiara/AAS-7421-2020; Cooper, D. James/G-7961-2013; Lagares, Alfonso/B-2969-2011; galimberti, stefania/H-2594-2012; Gomez, Pedro/E-2411-2014; Raj, Rahul/K-7693-2012	Badenes, Rafael/0000-0001-7017-0150; Sahuquillo, Juan/0000-0003-0713-5875; Ercole, Ari/0000-0001-8350-8093; Posti, Jussi P./0000-0002-5925-5193; Laureys, Steven/0000-0002-3096-3807; Castano-Leon, Ana M/0000-0002-7918-5049; Cooper, D. James/0000-0002-5872-9051; Lagares, Alfonso/0000-0003-3996-0554; Sakowitz, Oliver/0000-0003-3248-6335; Della Corte, Francesco/0000-0003-1736-2318; Rossi, Sandra/0000-0002-9963-8121; Zeiler, Frederick/0000-0003-1737-0510; Kolias, Angelos/0000-0003-3992-0587; Gomez, Pedro/0000-0002-4185-5238; Blaabjerg, Morten/0000-0001-6007-1861; Raj, Rahul/0000-0003-4243-9591; Kondziella, Daniel/0000-0001-5562-9808; Newcombe, Virginia/0000-0001-6044-9035; Graziano, Francesca/0000-0003-1825-3527; Sanchez-Porras, Renan/0000-0002-9084-8114; Van Essen, Thomas/0000-0003-4657-5283; Coles, Jonathan/0000-0003-4013-679X; Radoi, Andreea/0000-0002-0677-3544	Framework 7 program of the European Union [602150]; Hannelore Kohl Stiftung (Germany); OneMind (USA); Integra LifeSciences Corporation (USA)	Data used in the preparation of this manuscript were obtained in the context of The Collaborative European NeuroTrauma Effectiveness Research in Traumatic Brain Injury (CENTER-TBI study, registered at clinicaltrials.gov NCT02210221), a large collaborative project, supported by the Framework 7 program of the European Union (602150). Additional funding was obtained from the Hannelore Kohl Stiftung (Germany), from OneMind (USA) and from Integra LifeSciences Corporation (USA). The funder had no role in the design of the study, the collection, analysis, and interpretation of data, or in writing the manuscript.	Abe T, 2018, CRIT CARE, V22, DOI 10.1186/s13054-018-2126-6; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Andriolo BNG, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007271.pub3; Blot F, 2008, INTENS CARE MED, V34, P1779, DOI 10.1007/s00134-008-1195-4; Bosel J, 2013, STROKE, V44, P21, DOI 10.1161/STROKEAHA.112.669895; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Computing RFfS R Core Team, 2019, R: A language and environment for statistical computing; Durbin Charles G Jr, 2005, Respir Care, V50, P483; Frutos-Vivar F, 2005, CRIT CARE MED, V33, P290, DOI 10.1097/01.CCM.0000150026.85210.13; Khalili H, 2017, WORLD NEUROSURG, V103, P88, DOI 10.1016/j.wneu.2017.02.060; Lazaridis C, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.08.018; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; MacIntyre N, 2007, CHEST, V132, P1049, DOI 10.1378/chest.06-2862; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; McCredie V, 2017, NEUROCRIT CARE, V26, P14, DOI 10.1007/s12028-016-0297-z; Mehta AB, 2015, AM J RESP CRIT CARE, V192, P446, DOI 10.1164/rccm.201502-0239OC; Merlo J, 2006, J EPIDEMIOL COMMUN H, V60, P290, DOI 10.1136/jech.2004.029454; Navalesi P, 2008, CRIT CARE MED, V36, P2986, DOI 10.1097/CCM.0b013e31818b35f2; Raimondi N, 2017, J CRIT CARE, V38, P304, DOI 10.1016/j.jcrc.2016.10.009; Rumbak MJ, 2004, CRIT CARE MED, V32, P1689, DOI 10.1097/01.CCM.0000134835.05161.B6; Sewell MD, 2018, WORLD NEUROSURG, V118, pE161, DOI 10.1016/j.wneu.2018.06.146; Siempos II, 2015, LANCET RESP MED, V3, P150, DOI 10.1016/S2213-2600(15)00007-7; Steyerberg EW, 2019, LANCET NEUROL, V18, P923, DOI 10.1016/S1474-4422(19)30232-7; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Wang Y, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/5895830; Watkins JF, 1996, STATISTICS, V45, P391; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zhang ZH, 2016, ANN TRANSL MED, V4, DOI 10.3978/j.issn.2305-5839.2015.12.63	28	15	17	3	5	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0342-4642	1432-1238		INTENS CARE MED	Intensive Care Med.	MAY	2020	46	5					983	994		10.1007/s00134-020-05935-5		FEB 2020	12	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	LK9CU	WOS:000515836300001	32025780	Green Published, Green Submitted, Bronze			2022-02-06	
J	Khalili, H; Ahl, R; Paydar, S; Sjolin, G; Cao, Y; Fard, HA; Niakan, A; Hanna, K; Joseph, B; Mohseni, S				Khalili, Hosseinali; Ahl, Rebecka; Paydar, Shahram; Sjolin, Gabriel; Cao, Yang; Fard, Hossein Abdolrahimzadeh; Niakan, Amin; Hanna, Kamil; Joseph, Bellal; Mohseni, Shahin			Beta-Blocker Therapy in Severe Traumatic Brain Injury: A Prospective Randomized Controlled Trial	WORLD JOURNAL OF SURGERY			English	Article							EARLY PROPRANOLOL; CATECHOLAMINES; COMPLICATIONS; SECONDARY; HYPOXIA	Background Observational studies have demonstrated improved outcomes in TBI patients receiving in-hospital beta-blockers. The aim of this study is to conduct a randomized controlled trial examining the effect of beta-blockers on outcomes in TBI patients. Methods Adult patients with severe TBI (intracranial AIS >= 3) were included in the study. Hemodynamically stable patients at 24 h after injury were randomized to receive either 20 mg propranolol orally every 12 h up to 10 days or until discharge (BB+) or no propranolol (BB-). Outcomes of interest were in-hospital mortality and Glasgow Outcome Scale-Extended (GOS-E) score on discharge and at 6-month follow-up. Subgroup analysis including only isolated severe TBI (intracranial AIS >= 3 with extracranial AIS <= 2) was carried out. Poisson regression models were used. Results Two hundred nineteen randomized patients of whom 45% received BB were analyzed. There were no significant demographic or clinical differences between BB+ and BB- cohorts. No significant difference in inhospital mortality (adj. IRR 0.6 [95% CI 0.3-1.4], p = 0.2) or long-term functional outcome was measured between the cohorts (p = 0.3). One hundred fifty-four patients suffered isolated severe TBI of whom 44% received BB. The BB? group had significantly lower mortality relative to the BB- group (18.6% vs. 4.4%, p = 0.012). On regression analysis, propranolol had a significant protective effect on in-hospital mortality (adj. IRR 0.32, p = 0.04) and functional outcome at 6-month follow-up (GOS-E >= 5 adj. IRR 1.2, p = 0.02). Conclusion Propranolol decreases in-hospital mortality and improves long-term functional outcome in isolated severe TBI. This randomized trial speaks in favor of routine administration of beta-blocker therapy as part of a standardized neurointensive care protocol.	[Khalili, Hosseinali; Niakan, Amin] Shiraz Univ Med Sci, Shahid Rajaee Emtiaz Trauma Hosp, Trauma Res Ctr, Dept Neurosurg, Shiraz, Iran; [Ahl, Rebecka; Fard, Hossein Abdolrahimzadeh] Karolinska Univ Hosp, Dept Surg, Stockholm, Sweden; [Paydar, Shahram; Fard, Hossein Abdolrahimzadeh] Shiraz Univ Med Sci, Rajaee Emtiaz Trauma Hosp, Trauma Res Ctr, Shiraz, Iran; [Paydar, Shahram] Shiraz Univ Med Sci, Dept Surg, Shiraz, Iran; [Sjolin, Gabriel] Orebro Univ Hosp, Dept Surg, S-70185 Orebro, Sweden; [Ahl, Rebecka; Sjolin, Gabriel; Mohseni, Shahin] Orebro Univ, Sch Med Sci, S-70281 Orebro, Sweden; [Cao, Yang] Orebro Univ, Sch Med Sci, Clin Epidemiol & Biostat, S-70182 Orebro, Sweden; [Hanna, Kamil; Joseph, Bellal] Univ Arizona, Coll Med, Dept Surg, Tucson, AZ USA; [Mohseni, Shahin] Orebro Univ Hosp, Dept Surg, Div Trauma & Emergency Surg, S-70185 Orebro, Sweden		Mohseni, S (corresponding author), Orebro Univ, Sch Med Sci, S-70281 Orebro, Sweden.; Mohseni, S (corresponding author), Orebro Univ Hosp, Dept Surg, Div Trauma & Emergency Surg, S-70185 Orebro, Sweden.	khalilih@yahoo.com; rebecka.ahl@cantab.net; paydarsh@gmail.com; gabriel.sjolin@regionorebrolan.se; yang.cao@oru.se; Dr.h.a.fard@gmail.com; aminniakan@yahoo.com; kamilhanna@surgery.arizona.edu; bjoseph@surgery.arizona.edu; mohsenishahin@yahoo.com	Ahl, Rebecka/AAG-4162-2020; Cao, Yang/C-6185-2008; Khalili, Hosseinali/I-1087-2016; Niakan, Amin/A-6818-2019; Paydar, Shahram/U-3074-2018	Ahl, Rebecka/0000-0001-7930-3845; Cao, Yang/0000-0002-3552-9153; Khalili, Hosseinali/0000-0002-3390-4212; Niakan, Amin/0000-0003-2644-8543; Paydar, Shahram/0000-0002-6980-2576	research department of Shiraz University of Medical Sciences [1396-01-3814792]	The study received funding from research department of Shiraz University of Medical Sciences (Proposal ID#1396-01-3814792).	Ahl R, 2017, EUR J TRAUMA EMERG S, V43, P783, DOI 10.1007/s00068-017-0779-5; Alali AS, 2017, ANN SURG, V266, P952, DOI 10.1097/SLA.0000000000002286; Alali AS, 2014, NEUROCRIT CARE, V20, P514, DOI 10.1007/s12028-013-9903-5; ALEXANDER RW, 1975, NATURE, V258, P437, DOI 10.1038/258437a0; Carney N, 2017, GUIDELINES MANAGEMEN; Chen ZF, 2017, J CRIT CARE, V41, P240, DOI 10.1016/j.jcrc.2017.05.035; Chen ZL, 2017, CIRC RES, V121, P451, DOI 10.1161/CIRCRESAHA.117.311170; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CLIFTON GL, 1981, NEUROSURGERY, V8, P10, DOI 10.1227/00006123-198101000-00003; CONNOR RCR, 1969, AM HEART J, V78, P145, DOI 10.1016/0002-8703(69)90001-5; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; CRUICKSHANK JM, 1987, LANCET, V2, P585, DOI 10.1016/s0140-6736(87)92984-9; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; HAMILL RW, 1987, ANN NEUROL, V21, P438, DOI 10.1002/ana.410210504; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Kemp CD, 2008, AM SURGEON, V74, P866; Ko A, 2016, J TRAUMA ACUTE CARE, V80, P637, DOI 10.1097/TA.0000000000000959; Koskinen LOD, 2014, NEUROSCIENCE, V283, P245, DOI 10.1016/j.neuroscience.2014.06.039; Ley EJ, 2018, J TRAUMA ACUTE CARE, V84, P234, DOI 10.1097/TA.0000000000001747; Ley EJ, 2012, J TRAUMA ACUTE CARE, V73, P33, DOI 10.1097/TA.0b013e31825a769b; Ley EJ, 2009, J TRAUMA, V66, P154, DOI 10.1097/TA.0b013e31819388be; MACKENZIE ET, 1976, AM J PHYSIOL, V231, P489, DOI 10.1152/ajplegacy.1976.231.2.489; Manley G, 2001, ARCH SURG-CHICAGO, V136, P1118, DOI 10.1001/archsurg.136.10.1118; MEYER JS, 1974, STROKE, V5, P180; Mohseni S, 2014, J TRAUMA ACUTE CARE, V76, P804, DOI 10.1097/TA.0000000000000139; Murry JS, 2016, J SURG RES, V200, P221, DOI 10.1016/j.jss.2015.06.045; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901	28	15	15	0	1	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0364-2313	1432-2323		WORLD J SURG	World J.Surg.	JUN	2020	44	6					1844	1853		10.1007/s00268-020-05391-8		JAN 2020	10	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	LI2TW	WOS:000510269300001	32002583	hybrid			2022-02-06	
J	Beitchman, JA; Griffiths, DR; Hur, Y; Ogle, SB; Bromberg, CE; Morrison, HW; Lifshitz, J; Adelson, PD; Thomas, TC				Beitchman, Joshua A.; Griffiths, Daniel R.; Hur, Yerin; Ogle, Sarah B.; Bromberg, Caitlin E.; Morrison, Helena W.; Lifshitz, Jonathan; Adelson, P. David; Thomas, Theresa Currier			Experimental Traumatic Brain Injury Induces Chronic Glutamatergic Dysfunction in Amygdala Circuitry Known to Regulate Anxiety-Like Behavior	FRONTIERS IN NEUROSCIENCE			English	Article						diffuse traumatic brain injury; amperometry; glutamate neurotransmission; amygdala; chronic	LATERAL FLUID PERCUSSION; AGE-RELATED-CHANGES; NEUROTROPHIC FACTOR; EXTRACELLULAR GLUTAMATE; MICROGLIAL ACTIVATION; POSTTRAUMATIC SLEEP; WHISKER CIRCUIT; ANIMAL-MODELS; RAT STRIATUM; LATE-ONSET	Up to 50% of traumatic brain injury (TBI) survivors demonstrate persisting and late-onset anxiety disorders indicative of limbic system dysregulation, yet the pathophysiology underlying the symptoms is unclear. We hypothesize that the development of TBI-induced anxiety-like behavior in an experimental model of TBI is mediated by changes in glutamate neurotransmission within the amygdala. Adult, male Sprague-Dawley rats underwent midline fluid percussion injury or sham surgery. Anxiety-like behavior was assessed at 7 and 28 days post-injury (DPI) followed by assessment of real-time glutamate neurotransmission in the basolateral amygdala (BLA) and central nucleus of the amygdala (CeA) using glutamate-selective microelectrode arrays. The expression of anxiety-like behavior at 28 DPI coincided with decreased evoked glutamate release and slower glutamate clearance in the CeA, not BLA. Numerous factors contribute to the changes in glutamate neurotransmission over time. In two additional animal cohorts, protein levels of glutamatergic transporters (Glt-1 and GLAST) and presynaptic modulators of glutamate release (mGluR2, TrkB, BDNF, and glucocorticoid receptors) were quantified using automated capillary western techniques at 28 DPI. Astrocytosis and microglial activation have been shown to drive maladaptive glutamate signaling and were histologically assessed over 28 DPI. Alterations in glutamate neurotransmission could not be explained by changes in protein levels for glutamate transporters, mGluR2 receptors, astrocytosis, and microglial activation. Presynaptic modulators, BDNF and TrkB, were significantly decreased at 28 DPI in the amygdala. Dysfunction in presynaptic regulation of glutamate neurotransmission may contribute to anxiety-related behavior and serve as a therapeutic target to improve circuit function.	[Beitchman, Joshua A.; Griffiths, Daniel R.; Hur, Yerin; Ogle, Sarah B.; Bromberg, Caitlin E.; Lifshitz, Jonathan; Adelson, P. David; Thomas, Theresa Currier] Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA; [Beitchman, Joshua A.; Griffiths, Daniel R.; Hur, Yerin; Ogle, Sarah B.; Bromberg, Caitlin E.; Lifshitz, Jonathan; Adelson, P. David; Thomas, Theresa Currier] Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ 85004 USA; [Beitchman, Joshua A.] Midwestern Univ, Coll Grad Studies, Glendale, AZ USA; [Ogle, Sarah B.] Banner Univ, Med Ctr, Phoenix, AZ USA; [Morrison, Helena W.] Univ Arizona, Coll Nursing, Tucson, AZ 85721 USA; [Lifshitz, Jonathan; Thomas, Theresa Currier] Phoenix VA Hlth Care Syst, Phoenix, AZ 85012 USA		Thomas, TC (corresponding author), Phoenix Childrens Hosp, Barrow Neurol Inst, Phoenix, AZ 85016 USA.; Thomas, TC (corresponding author), Univ Arizona, Dept Child Hlth, Coll Med Phoenix, Phoenix, AZ 85004 USA.; Thomas, TC (corresponding author), Phoenix VA Hlth Care Syst, Phoenix, AZ 85012 USA.	theresathomas@email.arizona.edu		Ogle, Sarah/0000-0003-0160-5311; Thomas, Theresa/0000-0002-9619-7666	National Institute of Neurological Disorders and Stroke of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100793]; Valley Research Partnership (VRP) P1 [P1201607]; Phoenix Children's Hospital (PCH) Leadership Circle Grant; PCH Mission Support Funds; Arizona Biomedical Research Commission through Arizona Department of Health Services [ADHS14-00003606]; Director's Research and Education Fund at PCH Foundation; Midwestern University ORSP; Midwestern Biomedical Sciences Department Funds; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS100793] Funding Source: NIH RePORTER	Research reported in this publication was supported in part by the National Institute of Neurological Disorders and Stroke of the National Institutes of Health under Award Number R01NS100793 awarded to TC, the Valley Research Partnership (VRP) P1 (P1201607) awarded to JB, the Phoenix Children's Hospital (PCH) Leadership Circle Grant awarded to TC, the PCH Mission Support Funds awarded to TC, the Arizona Biomedical Research Commission through Arizona Department of Health Services (ADHS14-00003606) awarded to TC, the Director's Research and Education Fund at PCH Foundation awarded to TC, and the Midwestern University ORSP and Midwestern Biomedical Sciences Department Funds awarded to JB. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Almeida-Suhett CP, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102627; Babaev O, 2018, EXP MOL MED, V50, DOI 10.1038/s12276-018-0063-8; Buchsbaum MS, 2015, J NEUROTRAUM, V32, P1736, DOI 10.1089/neu.2014.3660; Burmeister JJ, 2002, J NEUROSCI METH, V119, P163, DOI 10.1016/S0165-0270(02)00172-3; Burmeister JJ, 2001, ANAL CHEM, V73, P1037, DOI 10.1021/ac0010429; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; CARLSEN J, 1988, J COMP NEUROL, V273, P513, DOI 10.1002/cne.902730407; Carola V, 2002, BEHAV BRAIN RES, V134, P49, DOI 10.1016/S0166-4328(01)00452-1; CASS WA, 1992, J NEUROCHEM, V59, P259, DOI 10.1111/j.1471-4159.1992.tb08899.x; Chiba S, 2012, PROG NEURO-PSYCHOPH, V39, P112, DOI 10.1016/j.pnpbp.2012.05.018; Cho HB, 2018, BIOMED RES INT, V2018, DOI 10.1155/2018/8142631; Clausen F, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00039; Collins KA, 2004, CLIN PSYCHOL REV, V24, P583, DOI 10.1016/j.cpr.2004.06.001; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Costa R, 2012, J AM ASSOC LAB ANIM, V51, P548; Danbolt NC, 2001, PROG NEUROBIOL, V65, P1, DOI 10.1016/S0301-0082(00)00067-8; DePalma RG, 2018, BEHAV BRAIN RES, V340, P102, DOI 10.1016/j.bbr.2016.08.036; Depue BE, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/691505; Elder GA, 2012, J NEUROTRAUM, V29, P2564, DOI 10.1089/neu.2012.2510; Ennaceur A, 2014, PHYSIOL BEHAV, V135, P55, DOI 10.1016/j.physbeh.2014.05.032; Etkin A, 2007, AM J PSYCHIAT, V164, P1476, DOI 10.1176/appi.ajp.2007.07030504; Etkin A, 2009, ARCH GEN PSYCHIAT, V66, P1361, DOI 10.1001/archgenpsychiatry.2009.104; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; French LM, 2010, ANN NY ACAD SCI, V1208, P38, DOI 10.1111/j.1749-6632.2010.05696.x; FRIEDEMANN MN, 1992, NEUROBIOL AGING, V13, P325, DOI 10.1016/0197-4580(92)90046-Z; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; Gould S, 2009, IEEE I CONF COMP VIS, P1, DOI 10.1109/ICCV.2009.5459211; Griesbach GS, 2012, NEUROSCIENCE, V210, P393, DOI 10.1016/j.neuroscience.2012.03.005; Griesbach GS, 2011, NEUROSCIENCE, V178, P147, DOI 10.1016/j.neuroscience.2011.01.028; Grosch J, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00293; Grossman Elan J, 2010, Top Magn Reson Imaging, V21, P379, DOI 10.1097/RMR.0b013e31823e65b8; Guerin F, 2006, NEUROREHABILITATION, V21, P295; Hall KD, 2010, BRAIN RES, V1323, P161, DOI 10.1016/j.brainres.2010.01.067; Hallam TM, 2004, J NEUROTRAUM, V21, P521, DOI 10.1089/089771504774129865; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Harrison JL, 2014, EXP BRAIN RES, V232, P2709, DOI 10.1007/s00221-014-3948-3; Henstridge CM, 2019, FRONT CELL NEUROSCI, V13, DOI 10.3389/fncel.2019.00063; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Hinzman JM, 2010, J NEUROTRAUM, V27, P889, DOI 10.1089/neu.2009.1238; Hoffman AN, 2017, J NEUROTRAUM, V34, P213, DOI 10.1089/neu.2015.4339; Hoge CW, 2014, PSYCHIAT SERV, V65, P997, DOI 10.1176/appi.ps.201300307; Hosseini AH, 2009, MED SCI SPORT EXER, V41, P1687, DOI 10.1249/MSS.0b013e31819fcd1b; Hou JM, 2017, J NEUROTRAUM, V34, P2456, DOI 10.1089/neu.2016.4851; Hrybouski S, 2016, NEUROIMAGE, V133, P98, DOI 10.1016/j.neuroimage.2016.02.056; Hughes EG, 2004, MOL BRAIN RES, V124, P114, DOI 10.1016/j.molbrainres.2004.02.021; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Jacob TC, 2008, NAT REV NEUROSCI, V9, P331, DOI 10.1038/nrn2370; Jaiswal S, 2019, BRAIN RES, V1723, DOI 10.1016/j.brainres.2019.146400; Janak PH, 2015, NATURE, V517, P284, DOI 10.1038/nature14188; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kalin NH, 2004, J NEUROSCI, V24, P5506, DOI 10.1523/JNEUROSCI.0292-04.2004; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P593, DOI 10.1001/archpsyc.62.6.593; Kim SY, 2013, NATURE, V496, P219, DOI 10.1038/nature12018; Koenigs M, 2009, NEUROSCIENTIST, V15, P540, DOI 10.1177/1073858409333072; Kovesdi E, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00042; Kulkarni P, 2019, FRONT SYST NEUROSCI, V13, DOI 10.3389/fnsys.2019.00034; Kunugi H, 2010, PSYCHIAT CLIN NEUROS, V64, P447, DOI 10.1111/j.1440-1819.2010.02135.x; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Lakens D, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00863; Larter R, 2005, CHAOS, V15, DOI 10.1063/1.2102467; Learoyd AE, 2012, BEHAV BRAIN RES, V226, P197, DOI 10.1016/j.bbr.2011.09.016; Lee Bruce, 2005, NeuroRx, V2, P372; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P673; Lifshitz J, 2016, BRAIN INJURY, V30, P1293, DOI 10.1080/02699052.2016.1193628; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Lisembee A, 2008, J NEUROTRAUM, V25, P875; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Liu M, 2017, J NEUROTRAUM, V34, P414, DOI 10.1089/neu.2015.4361; Loane David J, 2012, Wiley Interdiscip Rev Membr Transp Signal, V1, P136; Loughney JW, 2014, ANAL BIOCHEM, V461, P49, DOI 10.1016/j.ab.2014.05.004; MacGregor AJ, 2011, J HEAD TRAUMA REHAB, V26, P312, DOI 10.1097/HTR.0b013e3181e94404; Madalena KM, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/8640970; Maragakis NJ, 2004, NEUROBIOL DIS, V15, P461, DOI 10.1016/j.nbd.2003.12.007; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; MCDONALD AJ, 1982, J COMP NEUROL, V208, P401, DOI 10.1002/cne.902080409; McIntosh T K, 1987, Cent Nerv Syst Trauma, V4, P119; McNamara KCS, 2010, J NEUROTRAUM, V27, P695, DOI 10.1089/neu.2009.1237; Meis S, 2012, J PHYSIOL-LONDON, V590, P193, DOI 10.1113/jphysiol.2011.220434; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Miremami JD, 2014, SOMATOSENS MOT RES, V31, P127, DOI 10.3109/08990220.2014.897602; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; MOUSSY F, 1994, ANAL CHEM, V66, P674, DOI 10.1021/ac00077a015; Murugan M, 2013, CNS NEUROL DISORD-DR, V12, P773, DOI 10.2174/18715273113126660174; Nickell J, 2005, J NEURAL TRANSM, V112, P87, DOI 10.1007/s00702-004-0151-x; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pal B, 2018, CELL MOL LIFE SCI, V75, P2917, DOI 10.1007/s00018-018-2837-5; Palmer CP, 2016, EXP NEUROL, V277, P215, DOI 10.1016/j.expneurol.2016.01.004; PARPURA V, 1994, NATURE, V369, P744, DOI 10.1038/369744a0; Pascual O, 2012, P NATL ACAD SCI USA, V109, pE197, DOI 10.1073/pnas.1111098109; Paxinos G., 2007, RAT BRAIN STEREOTAXI, V6; Phelps EA, 2005, NEURON, V48, P175, DOI 10.1016/j.neuron.2005.09.025; Pitkanen A, 1997, TRENDS NEUROSCI, V20, P517, DOI 10.1016/S0166-2236(97)01125-9; Quintero JE, 2007, EXP NEUROL, V208, P238, DOI 10.1016/j.expneurol.2007.08.002; Rajkowska G., 2007, CNS & Neurological Disorders-Drug Targets, V6, P219, DOI 10.2174/187152707780619326; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Reger ML, 2012, BIOL PSYCHIAT, V71, P335, DOI 10.1016/j.biopsych.2011.11.007; Riess P, 2002, NEUROSURGERY, V51, P1043, DOI 10.1097/00006123-200210000-00035; ROTH KA, 1979, NEUROSCI BIOBEHAV R, V3, P247, DOI 10.1016/0149-7634(79)90012-5; Rowe RK, 2019, J NEUROTRAUM, V36, P1318, DOI 10.1089/neu.2018.5980; Rowe RK, 2016, ENDOCR CONNECT, V5, P152, DOI 10.1530/EC-16-0031; Rowe RK, 2014, SLEEP, V37, P743, DOI 10.5665/sleep.3582; Rowe RK, 2013, LAB ANIMAL, V42, P286, DOI 10.1038/laban.257; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Shultz SR, 2013, EPILEPSIA, V54, P1240, DOI 10.1111/epi.12223; SMITH Y, 1994, J COMP NEUROL, V342, P232, DOI 10.1002/cne.903420207; Stevens JS, 2017, BIOL PSYCHIAT, V81, P1023, DOI 10.1016/j.biopsych.2016.11.015; Swanson LW, 1998, TRENDS NEUROSCI, V21, P323, DOI 10.1016/S0166-2236(98)01265-X; Tejeda GS, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020268; Thomas TC, 2018, BEHAV BRAIN RES, V340, P137, DOI 10.1016/j.bbr.2016.12.038; Thomas TC, 2017, BRAIN RES, V1672, P10, DOI 10.1016/j.brainres.2017.07.003; Thomas TC, 2012, J NEUROTRAUM, V29, P187, DOI 10.1089/neu.2011.2091; Thompson HJ, 2005, J NEUROTRAUM, V22, P42, DOI 10.1089/neu.2005.22.42; Tovote P, 2015, NAT REV NEUROSCI, V16, P317, DOI 10.1038/nrn3945; Trahan DE, 2001, ARCH CLIN NEUROPSYCH, V16, P435, DOI 10.1016/S0887-6177(00)00051-2; Tye KM, 2011, NATURE, V471, P358, DOI 10.1038/nature09820; Ueda Y, 2001, J NEUROCHEM, V76, P892, DOI 10.1046/j.1471-4159.2001.00087.x; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Kolk BA., 2002, TREATING TRAUMA SURV, P127; Vyas A, 2004, NEUROSCIENCE, V128, P667, DOI 10.1016/j.neuroscience.2004.07.013; Watt AJ, 2000, NEURON, V26, P659, DOI 10.1016/S0896-6273(00)81202-7; Witgen BM, 2005, NEUROSCIENCE, V133, P1, DOI 10.1016/j.neuroscience.2005.01.052; Young K., 2018, JOVE-J VIS EXP, V136, P57648, DOI DOI 10.3791/57648; Zhang X, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00367; Zhao J, 2018, J NEUROTRAUM, V35, P149, DOI 10.1089/neu.2016.4898; Zhou XY, 2019, FRONT MOL NEUROSCI, V12, DOI 10.3389/fnmol.2019.00136	128	15	15	0	8	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND		1662-453X		FRONT NEUROSCI-SWITZ	Front. Neurosci.	JAN 21	2020	13								1434	10.3389/fnins.2019.01434			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	KH8UU	WOS:000510926700001	32038140	gold, Green Published			2022-02-06	
J	Greenberg, J; Mace, RA; Funes, CJ; Silverberg, ND; Iverson, GL; Caplan, DN; Vranceanu, AM				Greenberg, Jonathan; Mace, Ryan A.; Funes, Christopher J.; Silverberg, Noah D.; Iverson, Grant L.; Caplan, David N.; Vranceanu, Ana-Maria			Pain Catastrophizing and Limiting Behavior Mediate the Association Between Anxiety and Postconcussion Symptoms	PSYCHOSOMATICS			English	Article						mild traumatic brain injury; anxiety; pain catastrophizing; limiting behavior; mediation	TRAUMATIC BRAIN-INJURY; POST-CONCUSSION SYMPTOMS; FEAR-AVOIDANCE MODEL; UNITED-STATES; QUESTIONNAIRE; POPULATION; DISORDERS; FATIGUE; DEATHS	Background: Despite growing evidence that anxiety is critical in the development and maintenance of postconcussion symptoms after mild traumatic brain injury (mTBI), little is known about potential mechanisms through which anxiety may affect these symptoms. Objective: To test the strength and reliability of cognitive (pain catastrophizing) and behavioral (limiting behaviors) pathways mediating the relationship between anxiety and postconcussion symptoms among patients with mTBI. Method: Patients with mTBI (N = 57) completed self-report measures of anxiety, postconcussion symptoms, pain catastrophizing, and limiting behavior. After preliminary simple-mediation models (for pain catastrophizing and limiting behavior separately), we ran a multiplemediation model (pathways modeled simultaneously). Bootstrapping with 10,000 resampling iterations assessed mediation reliability. Results: In preliminary simple mediation models, both pain catastrophizing (beta = 0.24, 95% confidence interval [CI] = 0.03-0.44, P = 0.02) and limiting behaviors (beta = 0.14, 95% CI = 0.03-0.26, P = 0.01) partially mediated the relationship between anxiety and postconcussion symptoms. In the multiple mediation model, pain catastrophizing was a less reliable but numerically stronger mediator (beta = 0.19, 95% CI = -0.01 to 0.38; P = 0.05) and explained more variance in postconcussion symptoms (R-2 = 0.41) than limiting behavior (beta = 0.10, 95% CI = 0.02-0.21, P = 0.03; R-2 = 0.22), although mediators did not significantly differ in strength (beta = 0.08, 95% CI = -0.16 to 0.32; P = 0.49). Results provide novel evidence for the role of pain catastrophizing and limiting behaviors in explaining the association between anxiety and postconcussion symptoms. Addressing both factors may improve the recovery trajectory of individuals with mTBI. Emphasizing limiting behavior may yield more consistent and reliable effects. Conclusion: Results support developing interventions to directly target anxiety, for pain catastrophizing, and for activity engagement despite symptoms, to decrease symptom severity among patients with mTBI.	[Greenberg, Jonathan; Mace, Ryan A.; Vranceanu, Ana-Maria] Massachusetts Gen Hosp, Dept Psychiat, Integrated Brain Hlth Clin & Res Program, Boston, MA 02114 USA; [Greenberg, Jonathan; Mace, Ryan A.; Caplan, David N.; Vranceanu, Ana-Maria] Harvard Med Sch, Boston, MA 02115 USA; [Funes, Christopher J.] Massachusetts Gen Hosp, Dept Psychiat, Div Neuropsychiat, Boston, MA 02114 USA; [Funes, Christopher J.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Boston, MA 02114 USA; [Silverberg, Noah D.] Univ British Columbia, Div Phys Med & Rehabil, Vancouver, BC, Canada; [Silverberg, Noah D.] Vancouver Coastal Hlth Res Inst, Rehabil Res Program, Vancouver, BC, Canada; [Iverson, Grant L.] Harvard Med Sch, Spaulding Rehabil Hosp, Dept Phys Med & Rehabil, Charlestown, MA USA; [Iverson, Grant L.] Harvard Med Sch, Spaulding Res Inst, Charlestown, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] Red Sox Fdn, Home Base, Charlestown, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Charlestown, MA USA; [Caplan, David N.] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA		Greenberg, J (corresponding author), Harvard Med Sch, Massachusetts Gen Hosp, Dept Psychiat, Integrated Brain Hlth Clin & Res Program, One Bowdoin Sq,1st Floor,Suite 100, Boston, MA 02115 USA.	jgreenberg5@mgh.harvard.edu	Vranceanu, Ana-Maria/AAF-4429-2020	Greenberg, Jonathan/0000-0002-4875-2207	Allison and Henry McCance Center for Brain Health	This study was possible because of support from the Allison and Henry McCance Center for Brain Health.	Alison J, 2010, HDB DIS BURDENS QUAL; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Chan RCK, 2001, CLIN REHABIL, V15, P266, DOI 10.1191/026921501675253420; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Crombez G, 2012, CLIN J PAIN, V28, P475, DOI 10.1097/AJP.0b013e3182385392; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Elliott MR, 2010, BIOSTATISTICS, V11, P353, DOI 10.1093/biostatistics/kxp060; Fairchild AJ, 2017, AM J CLIN NUTR, V105, P1259, DOI 10.3945/ajcn.117.152546; Fritz MS, 2012, MULTIVAR BEHAV RES, V47, P61, DOI 10.1080/00273171.2012.640596; Garland EL, 2012, J BEHAV MED, V35, P591, DOI 10.1007/s10865-011-9391-z; Gershon RC, 2012, QUAL LIFE RES, V21, P475, DOI 10.1007/s11136-011-9958-8; Hayes A, 2013, INTRO MEDIATION MODE, P3, DOI DOI 10.1111/JEDM.12050; Hayes AF, 2013, PSYCHOL SCI, V24, P1918, DOI 10.1177/0956797613480187; Hofmann SG, 2010, J CONSULT CLIN PSYCH, V78, P169, DOI 10.1037/a0018555; Kabat-Zinn J., 1990, FULL CATASTROPHE LIV; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Mooney CZ, 2006, J AM STAT ASSOC, V89, P1150; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Nijs J, 2013, CLIN RHEUMATOL, V32, P1121, DOI 10.1007/s10067-013-2277-4; NISBETT RE, 1977, PSYCHOL REV, V84, P231, DOI 10.1037/0033-295X.84.3.231; Oldenburg C, 2016, BRAIN INJURY, V30, P146, DOI 10.3109/02699052.2015.1089598; R Core Team, 2018, STATS PACK LANG ENV; RStudio Team, 2016, RSTUDIO INT DEV R; Scholten AC, 2016, J NEUROTRAUM, V33, P1969, DOI 10.1089/neu.2015.4252; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; Silverberg ND, 2018, J NEUROTRAUM, V35, P1864, DOI 10.1089/neu.2018.5662; Silverberg ND, 2015, J NEUROTRAUM, V32, P517, DOI 10.1089/neu.2014.3600; Spence M, 2005, PSYCHOL MED, V35, P583, DOI 10.1017/S0033291704003484; Sullivan MJL, 1995, PSYCHOL ASSESSMENT, V7, P524, DOI 10.1037/1040-3590.7.4.524; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wideman TH, 2013, PAIN, V154, P2262, DOI 10.1016/j.pain.2013.06.005; Wijenberg MLM, 2017, BRAIN INJURY, V31, P1597, DOI 10.1080/02699052.2017.1366551; Wijenberg MLM, 2016, J BEHAV MED, V39, P815, DOI 10.1007/s10865-016-9749-3; Zahniser E, 2019, J NEUROTRAUM, V36, P1786, DOI 10.1089/neu.2018.6172	34	15	15	2	6	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0033-3182	1545-7206		PSYCHOSOMATICS	Psychosomatics	JAN-FEB	2020	61	1					49	55		10.1016/j.psym.2019.09.004			7	Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry; Psychology	KD6RX	WOS:000507993400007	31653327				2022-02-06	
J	Chen, LF; Mou, S; Li, FY; Zeng, YY; Sun, Y; Horch, RE; Wei, W; Wang, ZX; Sun, JM				Chen, Lifeng; Mou, Shan; Li, Fangying; Zeng, Yuyang; Sun, Yang; Horch, Raymund E.; Wei, Wei; Wang, Zhenxing; Sun, Jiaming			Self-Assembled Human Adipose-Derived Stem Cell-Derived Extracellular Vesicle-Functionalized Biotin-Doped Polypyrrole Titanium with Long-Term Stability and Potential Osteoinductive Ability	ACS APPLIED MATERIALS & INTERFACES			English	Article						polypyrrole; adipose stem cell-derived extracellular vesicles; biotin-streptavidin complex; surface modification; osteoinductivity	SURFACE FUNCTIONALIZATION; STRATEGY; DIFFERENTIATION; PROTEINS	Mesenchymal stem cell-derived extracellular vesicles (MSC-EVs), containing proteins or microRNAs (miRNAs), possessing various biological activity and low immunogenicity, are considered promising for surface modification of bone grafts. However, the modification efficiency is not satisfied yet, resulting in compromised therapy effects. Here, we report a novel immobilized method by self-assembling biotinylated MSCEVs onto the surface of biotin-doped polypyrrole titanium (Bio-Ppy-Ti) to improve its biofunctions in vitro and in vivo. Using this method, the amount of human adipose derived stem cell-EVs (hASC-EVs) anchored onto the Bio-Ppy-Ti surface was 185-fold higher than that of pure Ti after ultrasonic concussion for 30 s and it remained stable on the Bio-Ppy-Ti surface for 14 days at 4 degrees C. Compared to pristine Ti, EV-Bio-Ppy-Ti exhibited enhanced cell compatibility and osteoinductivity for osteoblasts in vitro and antiapoptosis ability in the ectopic bone formation mode. Gene chip analysis further demonstrated that several osteoinductive miRNAs were encapsulated in hASC-EVs, which may explain the high bone regeneration ability of EV-Bio-Ppy-Ti. Thus, this MSC-EV biotin-immobilized method appears to be highly efficient and long-term stable for demonstrating its potential for clinical metal implants.	[Chen, Lifeng; Mou, Shan; Zeng, Yuyang; Wang, Zhenxing; Sun, Jiaming] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Plast Surg, Wuhan 430022, Hubei, Peoples R China; [Sun, Yang] Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Med Records Management & Stat, Wuhan 430022, Hubei, Peoples R China; [Li, Fangying; Wei, Wei] Wuhan Text Univ, Hubei Int Sci & Technol Cooperat Base Intelligent, Hubei Key Lab Adv Text Mat & Applicat, Wuhan 430200, Hubei, Peoples R China; [Horch, Raymund E.] Friedrich Alexander Univ Erlangen Nuenberg, Univ Hosp Erlangen, Dept Plast & Hand Surg, FAU, Schlosspl 4, D-91054 Erlangen, Bavaria, Germany; [Horch, Raymund E.] Friedrich Alexander Univ Erlangen Nuenberg, Univ Hosp Erlangen, Lab Tissue Engn & Regenerat Med, FAU, Schlosspl 4, D-91054 Erlangen, Bavaria, Germany		Wang, ZX; Sun, JM (corresponding author), Huazhong Univ Sci & Technol, Tongji Med Coll, Union Hosp, Dept Plast Surg, Wuhan 430022, Hubei, Peoples R China.; Wei, W (corresponding author), Wuhan Text Univ, Hubei Int Sci & Technol Cooperat Base Intelligent, Hubei Key Lab Adv Text Mat & Applicat, Wuhan 430200, Hubei, Peoples R China.	wei.wei@wtu.edu.cn; benjamin.wzx@163.com; sunjm1592@sina.com			National Key R&D Program of China [2019YEA0110500]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701922, 81873941, 51703170]	This work was supported by the National Key R&D Program of China (2019YEA0110500) and the National Natural Science Foundation of China (no. 81701922, no. 81873941, and no. 51703170). The authors thank the Analytical & Testing Center of the HUST.	Agrahari V, 2019, TRENDS BIOTECHNOL, V37, P707, DOI 10.1016/j.tibtech.2018.11.012; Bacakova L, 2018, BIOTECHNOL ADV, V36, P1111, DOI 10.1016/j.biotechadv.2018.03.011; BILLIAU A, 1977, ANTIMICROB AGENTS CH, V12, P11, DOI 10.1128/AAC.12.1.11; Castanotto D, 2009, NATURE, V457, P426, DOI 10.1038/nature07758; Chai ZL, 2019, ACS NANO, V13, P5591, DOI 10.1021/acsnano.9b00661; Chaudhuri O, 2016, NAT MATER, V15, P326, DOI [10.1038/nmat4489, 10.1038/NMAT4489]; Clancy JW, 2019, NAT CELL BIOL, V21, P856, DOI 10.1038/s41556-019-0345-y; Della Pia EA, 2014, ACS NANO, V8, P1844, DOI 10.1021/nn406252h; Diomede F, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-0850-0; Dong D, 2019, TALANTA, V200, P408, DOI 10.1016/j.talanta.2019.03.069; Ehrenfest DMD, 2010, TRENDS BIOTECHNOL, V28, P198, DOI 10.1016/j.tibtech.2009.12.003; Ferreira AD, 2017, STEM CELLS INT, V2017, DOI 10.1155/2017/9841035; Fraioli R, 2016, ACTA BIOMATER, V43, P269, DOI 10.1016/j.actbio.2016.07.049; Geeurickx E, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-11182-0; Hong W, 2016, BIOSENS BIOELECTRON, V86, P920, DOI 10.1016/j.bios.2016.07.014; Ibraheem D, 2014, INT J PHARMACEUT, V477, P578, DOI 10.1016/j.ijpharm.2014.10.059; Jang D, 2016, ANAL CHEM, V88, P968, DOI 10.1021/acs.analchem.5b03722; Kang SM, 2012, ADV FUNCT MATER, V22, P2949, DOI 10.1002/adfm.201200177; Lee H, 2015, THERANOSTICS, V5, P1021, DOI 10.7150/thno.12389; Li J, 2007, ANAL CHIM ACTA, V596, P222, DOI 10.1016/j.aca.2007.05.057; Li WY, 2018, ACS APPL MATER INTER, V10, P5240, DOI 10.1021/acsami.7b17620; Lorincz AM, 2014, J EXTRACELL VESICLES, V3, DOI 10.3402/jev.v3.25465; Lu B, 2019, BIOFABRICATION, V11, DOI 10.1088/1758-5090/ab0676; Lu ZF, 2017, TISSUE ENG PT A, V23, P1212, DOI 10.1089/ten.tea.2016.0548; Luong JHT, 2019, BIOTECHNOL ADV, V37, P634, DOI 10.1016/j.biotechadv.2019.03.007; Malda J, 2016, NAT REV RHEUMATOL, V12, P243, DOI 10.1038/nrrheum.2015.170; Meng YB, 2016, ACS APPL MATER INTER, V8, P5783, DOI 10.1021/acsami.5b10650; Mushahary D, 2018, CYTOM PART A, V93A, P19, DOI 10.1002/cyto.a.23242; Pizzicannella J, 2019, INT J MOL SCI, V20, DOI 10.3390/ijms20133256; Pizzicannella J, 2019, FRONT PHYSIOL, V10, DOI 10.3389/fphys.2019.00512; Puhm F, 2019, CIRC RES, V125, P43, DOI 10.1161/CIRCRESAHA.118.314601; Qiu JJ, 2017, ACS APPL MATER INTER, V9, P12253, DOI 10.1021/acsami.7b00314; Riazifar M, 2017, ANNU REV PHARMACOL, V57, P125, DOI 10.1146/annurev-pharmtox-061616-030146; Sandfeld-Paulsen B, 2016, J THORAC ONCOL, V11, P1701, DOI 10.1016/j.jtho.2016.05.034; Sokolova V, 2011, COLLOID SURFACE B, V87, P146, DOI 10.1016/j.colsurfb.2011.05.013; Suh A, 2019, AGEING RES REV, V54, DOI 10.1016/j.arr.2019.100933; Tofino-Vian M, 2018, CELL PHYSIOL BIOCHEM, V47, P11, DOI 10.1159/000489739; Ullal AV, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3007361; Vader P, 2016, ADV DRUG DELIVER REV, V106, P148, DOI 10.1016/j.addr.2016.02.006; Violatto MB, 2019, ACS NANO, V13, P4410, DOI 10.1021/acsnano.8b09655; Vyas N, 2017, ULTRASONICS, V81, P66, DOI 10.1016/j.ultras.2017.05.015; Wan Y, 2017, NAT BIOMED ENG, V1, DOI 10.1038/s41551-017-0058; Ward TR, 2011, ACCOUNTS CHEM RES, V44, P47, DOI 10.1021/ar100099u; Wayment JR, 2009, ANAL CHEM, V81, P336, DOI 10.1021/ac801818t; Xie H, 2017, SCI REP-UK, V7, DOI 10.1038/srep45622; Zhang L, 2015, SCI REP-UK, V5, DOI 10.1038/srep10860; Zhang ZP, 2015, ADV FUNCT MATER, V25, P350, DOI 10.1002/adfm.201402618; Zhang ZW, 2016, J AM HEART ASSOC, V5, DOI 10.1161/JAHA.115.002856	48	15	15	1	47	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1944-8244	1944-8252		ACS APPL MATER INTER	ACS Appl. Mater. Interfaces	DEC 11	2019	11	49					46183	46196		10.1021/acsami.9b17015			14	Nanoscience & Nanotechnology; Materials Science, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics; Materials Science	JV9OL	WOS:000502689000086	31718127				2022-02-06	
J	Zhou, Z; Li, XG; Kleiven, S				Zhou, Zhou; Li, Xiaogai; Kleiven, Svein			Biomechanics of Periventricular Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain-ventricle interface; finite element analysis; fluid-structure interaction; periventricular injury	DIFFUSE AXONAL INJURY; TRAUMATIC BRAIN-INJURIES; CLOSED-HEAD INJURY; LATERAL VENTRICLES; PERIODIC MOTION; MRI BRAIN; IMPACT; MODEL; RESPONSES; DAMAGE	Periventricular injury is frequently noted as one aspect of severe traumatic brain injury (TBI) and the presence of the ventricles has been hypothesized to be a primary pathogenesis associated with the prevalence of periventricular injury in patients with TBI. Although substantial endeavors have been made to elucidate the potential mechanism, a thorough explanation for this hypothesis appears lacking. In this study, a three-dimensional (3D) finite element (FE) model of the human head with an accurate representation of the cerebral ventricles is developed accounting for the fluid properties of the intraventricular cerebrospinal fluid (CSF) as well as its interaction with the brain. An additional model is developed by replacing the intraventricular CSF with a substitute with brain material. Both models are subjected to rotational accelerations with magnitudes suspected to induce severe diffuse axonal injury. The results reveal that the presence of the ventricles leads to increased strain in the periventricular region, providing a plausible explanation for the vulnerability of the periventricular region. In addition, the strain-exacerbation effect associated with the presence of the ventricles is also noted in the paraventricular region, although less pronounced than that in the periventricular region. The current study advances the understanding of the periventricular injury mechanism as well as the detrimental effects that the ventricles exert on the periventricular and paraventricular brain tissue.	[Zhou, Zhou; Li, Xiaogai; Kleiven, Svein] Royal Inst Technol KTH, Div Neuron Engn, SE-14152 Huddinge, Sweden		Zhou, Z (corresponding author), Royal Inst Technol KTH, Div Neuron Engn, SE-14152 Huddinge, Sweden.	zhouz@kth.se	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Li, Xiaogai/0000-0001-8522-4705	European Union's Horizon 2020 research and innovation program under the Marie-Curie grant [642662]	This research has received funding from the European Union's Horizon 2020 research and innovation program under the Marie-Curie grant agreement number 642662. The simulations were performed on resources provided by the Swedish National Infrastructure for Computing (SNIC) at the PDC Center.	Aimedieu P, 2004, J NEUROSURG, V100, P111, DOI 10.3171/jns.2004.100.1.0111; Al-Bsharat A.S., 2001, THESIS, pUniversity; Anata K., 2012, JPN SOC MECH ENG A, VA78, P758, DOI DOI 10.1299/KIKAIA.78.758; Anderson RWG, 2003, J NEUROTRAUM, V20, P961, DOI 10.1089/089771503770195812; Antona-Makoshi J., 2016, THESIS, pTechnology; Batterbee DC, 2011, P I MECH ENG H, V225, P1036, DOI 10.1177/0954411911420002; BERRY K, 1994, AM J FOREN MED PATH, V15, P132, DOI 10.1097/00000433-199406000-00008; BESENSKI N, 1992, NEURORADIOLOGY, V34, P126, DOI 10.1007/BF00588158; Bonnier C, 2002, BRAIN PATHOL, V12, P320; Bouley J, 2017, J NEUROTRAUM, V34, P2190, DOI 10.1089/neu.2017.5005; Cecil KM, 1998, J NEUROCHEM, V70, P2038; Chen Y, 2010, ACTA MECH, V213, P155, DOI 10.1007/s00707-009-0274-0; Cheng J, 2010, J BIOMECH, V43, P2887, DOI 10.1016/j.jbiomech.2010.07.023; Davidsson Johan, 2011, Front Neurol, V2, P41, DOI 10.3389/fneur.2011.00041; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Fillmore PT, 2015, FRONT AGING NEUROSCI, V7, DOI 10.3389/fnagi.2015.00044; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Gabler LF, 2018, ANN BIOMED ENG, V46, P972, DOI 10.1007/s10439-018-2015-9; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giudice J.S., 2018, ANN BIOMED ENG, VEng., P1; Grevi N., 1982, RAD JUGOSL AKAD ZNAN, V402, P265; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Ho J, 2017, J BIOMECH, V60, P243, DOI 10.1016/j.jbiomech.2017.06.023; Ho J, 2009, J BIOMECH, V42, P2074, DOI 10.1016/j.jbiomech.2009.06.051; Holbourn AHS, 1943, LANCET, V2, P438; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ibrahim NG, 2010, J NEUROTRAUM, V27, P1021, DOI 10.1089/neu.2009.1212; Ivarsson J, 2002, J BIOMECH ENG-T ASME, V124, P422, DOI 10.1115/1.1485752; Ivarsson J, 2000, J BIOMECH, V33, P181, DOI 10.1016/S0021-9290(99)00144-X; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Kimpara Hideyuki, 2006, Stapp Car Crash J, V50, P509; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Klug C., 2013, IRCOBI C GOTH, P483; Kuroda N, 2009, LEG MED, V11, P180; Kuroda N, 2010, ROM J LEG MED, V18, P103, DOI 10.4323/rjlm.2010.103; Laksari K, 2018, PHYS REV LETT, V120, DOI 10.1103/PhysRevLett.120.138101; Li XY, 2010, NEUROSCIENCE, V169, P357, DOI 10.1016/j.neuroscience.2010.04.075; Li XG, 2019, FORENSIC SCI INT, V294, P173, DOI 10.1016/j.forsciint.2018.11.008; Li XG, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33393-z; Li XG, 2017, BIOMECH MODEL MECHAN, V16, P823, DOI 10.1007/s10237-016-0855-5; Liu J, 2014, NEURAL REGEN RES, V9, P1222, DOI 10.4103/1673-5374.135330; Makino Y, 2004, J NEUROTRAUM, V21, P585, DOI 10.1089/089771504774129919; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Marechal L, 2009, PROCEEDINGS OF THE 18TH INTERNATIONAL MESHING ROUNDTABLE, P65, DOI 10.1007/978-3-642-04319-2_5; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Maxeiner H., 2009, Legal Medicine, V11, P278, DOI 10.1016/j.legalmed.2009.08.005; Meng X, 2013, IEEE T MICROW THEORY, V61, P316, DOI 10.1109/TMTT.2012.2224361; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Miller R.T., 1998, STAPP CAR CRASH J, P155; Nishimoto T, 1998, J BIOMECH ENG-T ASME, V120, P140, DOI 10.1115/1.2834294; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Pieper S, 2004, IEEE INT S BIOMED IM, V1, P632, DOI DOI 10.1109/ISBI.2004.1398617; Resnick SM, 2000, CEREB CORTEX, V10, P464, DOI 10.1093/cercor/10.5.464; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Schirmer C, 2016, ROM J LEG MED, V24, P180, DOI 10.4323/rjlm.2016.180; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tu TW, 2017, J NEUROTRAUM, V34, P248, DOI 10.1089/neu.2015.4355; VANNOORT R, 1981, BIOMATERIALS, V2, P41, DOI 10.1016/0142-9612(81)90086-7; Zhou C., 1994, P 38 STAPP CAR CRASH, P133; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714; Zhou Z, 2019, CELL SIGNAL, V63, DOI 10.1016/j.cellsig.2019.109378; Zhou Z, 2019, J NEUROTRAUM, V36, P2099, DOI 10.1089/neu.2018.6143; Zhou Zhou, 2018, Stapp Car Crash J, V62, P293; Zhou Z, 2019, BIOMECH MODEL MECHAN, V18, P155, DOI 10.1007/s10237-018-1074-z; ZIMMERMAN RA, 1978, RADIOLOGY, V127, P393, DOI 10.1148/127.2.393; ZUCCARELLO M, 1981, ACTA NEUROCHIR, V55, P283, DOI 10.1007/BF01808444	69	15	15	2	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2020	37	8					1074	1090		10.1089/neu.2019.6634		DEC 2019	17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	LC5EK	WOS:000505208100001	31701809	hybrid, Green Published			2022-02-06	
J	Mathieu, F; Zeiler, FA; Whitehouse, DP; Das, T; Ercole, A; Smielewski, P; Hutchinson, PJ; Czosnyka, M; Newcombe, VFJ; Menon, DK				Mathieu, Francois; Zeiler, Frederick A.; Whitehouse, Daniel P.; Das, Tilak; Ercole, Ari; Smielewski, Peter; Hutchinson, Peter J.; Czosnyka, Marek; Newcombe, Virginia F. J.; Menon, David K.			Relationship Between Measures of Cerebrovascular Reactivity and Intracranial Lesion Progression in Acute TBI Patients: an Exploratory Analysis	NEUROCRITICAL CARE			English	Article						Neurophysiological monitoring; Traumatic brain injury; Traumatic intracranial hemorrhage	TRAUMATIC BRAIN-INJURY; CEREBRAL PERFUSION-PRESSURE; HEAD TRAUMA; INTRACEREBRAL HEMORRHAGE; SUBARACHNOID HEMORRHAGE; AUTOREGULATION; PREDICTORS; CONTUSIONS; VOLUME	Background Failure of cerebral autoregulation and progression of intracranial lesion have both been shown to contribute to poor outcome in patients with acute traumatic brain injury (TBI), but the interplay between the two phenomena has not been investigated. Preliminary evidence leads us to hypothesize that brain tissue adjacent to primary injury foci may be more vulnerable to large fluctuations in blood flow in the absence of intact autoregulatory mechanisms. The goal of this study was therefore to assess the influence of cerebrovascular reactivity measures on radiological lesion expansion in a cohort of patients with acute TBI. Methods We conducted a retrospective cohort analysis on 50 TBI patients who had undergone high-frequency multimodal intracranial monitoring and for which at least two brain computed tomography (CT) scans had been performed in the acute phase of injury. We first performed univariate analyses on the full cohort to identify non-neurophysiological factors (i.e., initial lesion volume, timing of scan, coagulopathy) associated with traumatic lesion growth in this population. In a subset analysis of 23 patients who had intracranial recording data covering the period between the initial and repeat CT scan, we then correlated changes in serial volumetric lesion measurements with cerebrovascular reactivity metrics derived from the pressure reactivity index (PRx), pulse amplitude index (PAx), and RAC (correlation coefficient between the pulse amplitude of intracranial pressure and cerebral perfusion pressure). Using multivariate methods, these results were subsequently adjusted for the non-neurophysiological confounders identified in the univariate analyses. Results We observed significant positive linear associations between the degree of cerebrovascular reactivity impairment and progression of pericontusional edema. The strongest correlations were observed between edema progression and the following indices of cerebrovascular reactivity between sequential scans: % time PRx > 0.25 (r = 0.69, p = 0.002) and % time PAx > 0.25 (r = 0.64, p = 0.006). These associations remained significant after adjusting for initial lesion volume and mean cerebral perfusion pressure. In contrast, progression of the hemorrhagic core and extra-axial hemorrhage volume did not appear to be strongly influenced by autoregulatory status. Conclusions Our preliminary findings suggest a possible link between autoregulatory failure and traumatic edema progression, which warrants re-evaluation in larger-scale prospective studies.	[Mathieu, Francois] Univ Toronto, Div Neurosurg, Toronto, ON, Canada; [Mathieu, Francois; Zeiler, Frederick A.; Whitehouse, Daniel P.; Ercole, Ari; Newcombe, Virginia F. J.; Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Hills Rd,Box 93, Cambridge CB2 0QQ, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Sect Neurosurg, Dept Surg, Winnipeg, MB, Canada; [Das, Tilak] Addenbrookes Hosp, Cambridge Univ Hosp NHS Fdn Trust, Dept Radiol, Hills Rd,Box 218, Cambridge CB2 0QQ, England; [Smielewski, Peter; Czosnyka, Marek] Cambridge Univ Hosp NHS Fdn Trust, Addenbrookes Hosp, Div Neurosurg, Brain Phys Lab, Cambridge, England; [Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Brain Phys Lab, Div Neurosurg, Hills Rd,Box 167, Cambridge CB2 0QQ, England; [Czosnyka, Marek] Warsaw Univ Technol, Inst Elect Syst, Warsaw, Poland; [Mathieu, Francois] Univ Cambridge, Dept Clin Neurosci, Cambridge, England; [Zeiler, Frederick A.] Univ Manitoba, Rady Fac Hlth Sci, Dept Anat & Cell Sci, Winnipeg, MB, Canada; [Zeiler, Frederick A.] Univ Manitoba, Biomed Engn, Fac Engn, Winnipeg, MB, Canada		Mathieu, F (corresponding author), Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Hills Rd,Box 93, Cambridge CB2 0QQ, England.	fm494@cam.ac.uk	Das, Tilak/AAY-5310-2020; Ercole, Ari/B-6288-2009	Das, Tilak/0000-0003-0655-412X; Ercole, Ari/0000-0001-8350-8093; Newcombe, Virginia/0000-0001-6044-9035; Mathieu, Francois/0000-0002-7894-2466; Zeiler, Frederick/0000-0003-1737-0510; Whitehouse, Daniel/0000-0002-0216-1866	Cambridge Commonwealth, European and International Trust [10465227]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G0601025] Funding Source: UKRI	Funding was provided by Cambridge Commonwealth, European and International Trust (Grant No. 10465227).	Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; Aries MJH, 2012, NEUROCRIT CARE, V17, P67, DOI 10.1007/s12028-012-9687-z; Beaumont A, 2000, ACT NEUR S, V76, P147; Brady KM, 2008, STROKE, V39, P2531, DOI 10.1161/STROKEAHA.108.514877; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Carnevale JA, 2018, J NEUROSURG, V129, P1305, DOI 10.3171/2017.7.JNS17988; Chang EF, 2007, NEUROSURGERY, V61, P222, DOI [10.1227/01.NEU.0000197101.68538.E6, 10.1227/01.neu.0000279217.45881.69]; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Czosnyka M, 2005, J NEUROSURG, V102, P450, DOI 10.3171/jns.2005.102.3.0450; Czosnyka M, 1997, NEUROSURGERY, V41, P11, DOI 10.1097/00006123-199707000-00005; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Fainardi E, 2004, ACTA NEUROCHIR, V146, P257, DOI 10.1007/s00701-003-0207-y; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; GUDEMAN SK, 1979, NEUROSURGERY, V5, P309, DOI 10.1227/00006123-197909000-00002; Hardman JM, 2002, NEUROIMAG CLIN N AM, V12, P175, DOI 10.1016/S1052-5149(02)00009-6; Hutchinson PJA, 2000, BRIT J NEUROSURG, V14, P46; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Matsuyama T, 1997, SURG NEUROL, V48, P193, DOI 10.1016/S0090-3019(96)00484-3; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Rivera-Lara L, 2017, CRIT CARE MED, V45, P695, DOI 10.1097/CCM.0000000000002251; SERVADEI F, 1995, NEUROSURGERY, V37, P899, DOI 10.1227/00006123-199511000-00008; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Sorrentino E, 2012, NEUROCRIT CARE, V16, P258, DOI 10.1007/s12028-011-9630-8; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; STEIN SC, 1993, NEUROSURGERY, V32, P25, DOI 10.1227/00006123-199301000-00004; Stocchetti N, 2000, J NEUROL NEUROSUR PS, V68, P14, DOI 10.1136/jnnp.68.1.14; Tseng Sheng-Hong, 1992, Journal of the Formosan Medical Association, V91, P585; UK Health Departments, 2011, GOV ARR RES ETH COMM; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Zeiler FA, 2018, J NEUROTRAUM, V35, P963, DOI 10.1089/neu.2017.5241; Zeiler FA, 2019, J NEUROTRAUM, V36, P1505, DOI 10.1089/neu.2018.6182; Zeiler FA, 2018, J NEUROTRAUM, V35, P1107, DOI 10.1089/neu.2017.5472; Zeiler FA, 2018, J NEUROTRAUM, V35, P1569, DOI 10.1089/neu.2017.5595; Zimmerman RD, 2006, AM J NEURORADIOL, V27, P666	37	15	15	0	1	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	APR	2020	32	2					373	382		10.1007/s12028-019-00885-3		DEC 2019	10	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	KV8ES	WOS:000500287800003	31797278	Green Published, hybrid			2022-02-06	
J	Honig, MG; Del Mar, NA; Henderson, DL; Ragsdale, TD; Doty, JB; Driver, JH; Li, CY; Fortugno, AP; Mitchell, WM; Perry, AM; Moore, BM; Reiner, A				Honig, Marcia G.; Del Mar, Nobel A.; Henderson, Desmond L.; Ragsdale, Tyler D.; Doty, John B.; Driver, Jake H.; Li, Chunyan; Fortugno, Andrew P.; Mitchell, William M.; Perry, Aaron M.; Moore, Bob M.; Reiner, Anton			Amelioration of visual deficits and visual system pathology after mild TBI via the cannabinoid Type-2 receptor inverse agonism of raloxifene	EXPERIMENTAL NEUROLOGY			English	Article						TBI; Visual deficits; Microglia; CB2 receptors; Therapy	TRAUMATIC BRAIN-INJURY; RETINAL GANGLION-CELLS; MOUSE MODEL; CB2 RECEPTOR; BLAST; MICROGLIA; NEUROINFLAMMATION; POLARIZATION; THRESHOLDS; RESPONSES	Visual deficits after traumatic brain injury (TBI) are common, but interventions that limit the post-trauma impairments have not been identified. We have found that treatment with the cannabinoid type-2 receptor (C82) inverse agonist SMM-189 for 2 weeks after closed-head blast TBI greatly attenuates the visual deficits and retinal pathology this otherwise produces in mice, by modulating the deleterious role of microglia in the injury process after trauma. SMM-189, however, has not yet been approved for human use. Raloxifene is an FDA-approved estrogen receptor drug that is used to treat osteoporosis, but it was recently found to also show noteworthy CB2 inverse agonism. In the current studies, we found that a high pressure air blast in the absence of raloxifene treatment yields deficits in visual acuity and contrast sensitivity, reductions in the A-wave and B-wave of the scotopic electroretinogram (ERG), light aversion, and increased pupil constriction to light. Raloxifene delivered daily for two weeks after blast at 5-10 mg/kg mitigates or eliminates these abnormalities (with the higher dose generally more effective). This functional rescue with raloxifene is accompanied by a biasing of microglia from the harmful M1 to the helpful M2 state, and reductions in retinal, optic nerve, and oculomotor nucleus pathology. We also found that raloxifene treatment is still effective even when delayed until 48 h after TBI, and that raloxifene benefit appears attributable to its CB2 inverse agonism rather than its estrogenic actions. Our studies show raloxifene is effective in treating visual injury after brain and/or eye trauma, and they provide basis for phase-2 efficacy testing in human clinical trials.	[Honig, Marcia G.; Del Mar, Nobel A.; Henderson, Desmond L.; Ragsdale, Tyler D.; Doty, John B.; Driver, Jake H.; Li, Chunyan; Fortugno, Andrew P.; Mitchell, William M.; Perry, Aaron M.; Reiner, Anton] Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, 855 Monroe Ave, Memphis, TN 38163 USA; [Reiner, Anton] Univ Tennessee, Dept Pharmaceut Sci, Hlth Sci Ctr, Memphis, TN 38163 USA; [Moore, Bob M.] Univ Tennessee, Dept Ophthalmol, Hlth Sci Ctr, Memphis, TN 38163 USA		Reiner, A (corresponding author), Univ Tennessee, Dept Anat & Neurobiol, Hlth Sci Ctr, 855 Monroe Ave, Memphis, TN 38163 USA.	areiner@uthsc.edu	Reiner, Anton/AAG-8860-2020	Reiner, Anton/0000-0002-2146-5232; Mitchell, William/0000-0003-3127-1631	Methodist Hospitals Endowed Professorship in Neuroscience; UTHSC Neuroscience Institute; NIH Medical Student Research Fellowship Program at UTHSCUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; DoDUnited States Department of Defense [W81XWH-16-1-0076]	Special thanks to Marion Joni, Conor Dorian, and Dr. Natalie Guley for technical assistance. The research was supported by The Methodist Hospitals Endowed Professorship in Neuroscience (AR), UTHSC Neuroscience Institute (CL), NIH Medical Student Research Fellowship Program at UTHSC (JBD & JHD), and DoD grant W81XWH-16-1-0076 (AR, MGH).	Armstrong RA, 2018, CLIN EXP OPTOM, V101, P716, DOI 10.1111/cxo.12670; Ashton JC, 2007, CURR NEUROPHARMACOL, V5, P73, DOI 10.2174/157015907780866884; Atwood BK, 2012, PROG NEURO-PSYCHOPH, V38, P16, DOI 10.1016/j.pnpbp.2011.12.001; Baver SB, 2008, EUR J NEUROSCI, V27, P1763, DOI 10.1111/j.1460-9568.2008.06149.x; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Benedetto MM, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00417; Berson DM, 2010, J COMP NEUROL, V518, P2405, DOI 10.1002/cne.22381; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Boudard DL, 2009, EUR J NEUROSCI, V30, P1527, DOI 10.1111/j.1460-9568.2009.06935.x; Bricker-Anthony C, 2017, OPTOMETRY VISION SCI, V94, P20, DOI 10.1097/OPX.0000000000000898; Bricker-Anthony C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0131921; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Bruce BB, 2006, J NEUROL NEUROSUR PS, V77, P986, DOI 10.1136/jnnp.2006.088799; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Caeyenberghs K, 2010, NEUROPSYCHOLOGIA, V48, P1472, DOI 10.1016/j.neuropsychologia.2010.01.017; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Collison FT, 2015, INVEST OPHTH VIS SCI, V56, P7130, DOI 10.1167/iovs.15-17467; Deng YP, 2016, J COMP NEUROL, V524, P3518, DOI 10.1002/cne.24013; Dimaraki EV, 2004, EUR J ENDOCRINOL, V150, P481, DOI 10.1530/eje.0.1500481; Dobolyi A, 2012, INT J MOL SCI, V13, P8219, DOI 10.3390/ijms13078219; Donat CK, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00208; Donat CK, 2014, ACTA NEUROBIOL EXP, V74, P197; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Draper MW, 1996, J BONE MINER RES, V11, P835; Du T, 2005, BRAIN INJURY, V19, P1125, DOI 10.1080/02699050500149817; Fernandez-Arjona MD, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00235; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Frick KM, 2015, LEARN MEMORY, V22, P472, DOI 10.1101/lm.037267.114; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Guley NM, 2019, EXP EYE RES, V182, P109, DOI 10.1016/j.exer.2019.03.013; Habib P., 2015, J STEROID BIOCH MOL, V146; Hanisch UK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00065; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hughes S, 2013, CURR BIOL, V23, P1696, DOI 10.1016/j.cub.2013.07.010; Jacobs SM, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0389-5; Jha MK, 2016, BIOCHEM PHARMACOL, V103, P1, DOI 10.1016/j.bcp.2015.11.003; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kumar P, 2013, BIOCHEM BIOPH RES CO, V435, P76, DOI 10.1016/j.bbrc.2013.04.040; Lachapelle J, 2004, VISION RES, V44, P2835, DOI 10.1016/j.visres.2004.06.007; Lawrence T, 2011, NAT REV IMMUNOL, V11, P750, DOI 10.1038/nri3088; Li XM, 2017, METAB BRAIN DIS, V32, P259, DOI 10.1007/s11011-016-9913-z; Liebelhart B., 2009, CLIN CASES MINER BON, V6, P163; Lin B, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0068084; Liu Y, 2017, BMC BIOCHEM, V18, DOI 10.1186/s12858-017-0079-z; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lunn CA, 2008, BRIT J PHARMACOL, V153, P226, DOI 10.1038/sj.bjp.0707480; Lunn CA, 2006, J PHARMACOL EXP THER, V316, P780, DOI 10.1124/JPET.105.093500; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; Magid L, 2019, J NEUROTRAUM, V36, P1836, DOI 10.1089/neu.2018.6063; Matynia A, 2016, FRONT NEURAL CIRCUIT, V10, DOI 10.3389/fncir.2016.00060; Matynia A, 2015, EXP EYE RES, V137, P57, DOI 10.1016/j.exer.2015.05.025; Matynia A, 2012, EXP EYE RES, V105, P60, DOI 10.1016/j.exer.2012.09.012; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Ouk K, 2016, HUM MOL GENET, V25, P5418, DOI 10.1093/hmg/ddw359; Pisani SL, 2016, ENDOCRINOLOGY, V157, P292, DOI 10.1210/en.2015-1616; Presley C, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.159; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; Schmidt TM, 2011, TRENDS NEUROSCI, V34, P572, DOI 10.1016/j.tins.2011.07.001; Schomberg D, 2012, EXP NEUROL, V234, P262, DOI 10.1016/j.expneurol.2011.12.021; Smith MR, 2004, J CLIN ENDOCR METAB, V89, P3841, DOI 10.1210/jc.2003-032058; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Waters EM, 2009, BRAIN RES, V1290, P1, DOI 10.1016/j.brainres.2009.06.090	67	15	15	1	3	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	DEC	2019	322								113063	10.1016/j.expneurol.2019.113063			19	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	JU1CS	WOS:000501416100011	31518568	hybrid			2022-02-06	
J	Lee, YS; Cho, DC; Kim, CH; Han, I; Gil, EY; Kim, KT				Lee, Young-Seok; Cho, Dae-Chul; Kim, Chi Heon; Han, Inbo; Gil, Eun Young; Kim, Kyoung-Tae			Effect of curcumin on the inflammatory reaction and functional recovery after spinal cord injury in a hyperglycemic rat model	SPINE JOURNAL			English	Article						Spinal cord injury; Hyperglycemia; Curcumin; Inflammation; Oxidative stress; Functional recovery; Neuroprotective effect	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; VALPROIC ACID; INHIBITION; METABOLITES; ABSORPTION; EXPRESSION; PROMOTES; IMPACT; TISSUE	BACKGROUND CONTEXT: Curcumin has anti-inflammatory and antioxidant activities. OBJECTIVE: This study aimed to investigate the effects of curcumin on the histological changes and functional recovery following spinal cord injury (SCI). STUDY DESIGN: One hundred twenty-eight Sprague-Dawley rats were distributed into a sham, SCI only, SCI-hyperglycemia, and SCI-hyperglycemia-curcumin (200 mg/kg/day, i.p.) groups. METHODS: SCI was induced using a clip at T9-10 and hyperglycemia was induced by streptozotocin (60-70 mg/kg, i.v.). Plasma malondialdehyde levels and superoxide dismutase activity was measured to determine oxidative stress. The activity of macrophages in the spinal cord after SCI was stained by the anti-CD68 antibody (ED-1). The tumor necrosis factor (TNF)-alpha, interleukin (IL)-6, and IL-8 levels were measured by enzyme-linked immunosorbent assay and Western blot was used to verify the levels of mitogen-activated protein kinases and STAT3. The glial fibrillary acidic protein expression was evaluated by immunofluorescence analysis. Functional recovery was assessed according to the Basso, Beattie, and Bresnahan scale and histologic outcome was evaluated by the lesion volume and spared tissue area. RESULTS: Superoxide dismutase activity increased, the malondialdehyde level decreased, and ED-1 macrophage marker level decreased in the SCI-hyperglycemia-curcumin group than in the SCI-hyperglycemia group at 2 weeks after SCI (p<.01). The SCI-hyperglycemia-curcumin group showed a statistically significant reduction in IL-6, IL-8, and TNF-alpha levels compared with the SCI-hyperglycemia group after SCI. The phosphorylated-extracellular signal-regulated kinase, phosphorylated-JNK, and phospho-p38 levels were significantly lower in the SCI-hypoglycemia-curcumin group than in the SCI-hypoglycemia group. The SCI-hyperglycemia-curcumin group showed a decrease in glial fibrillary acidic protein expression after SCI compared with the SCI-hyperglycemia group. The SCI-hyperglycemia-curcumin group showed a lower lesion volume, higher spared tissue, and better functional recovery than the SCI-hyperglycemia group. CONCLUSIONS: Curcumin may have a potential neuroprotective effect in SCI with hyperglycemia. CLINICAL SIGNIFICANCE: Curcumin decreased the inflammatory response and decreased astrogliosis and improved the functional recovery and histologic outcomes in SCI with hyperglycemia. (C) 2019 Elsevier Inc. All rights reserved.	[Lee, Young-Seok] Gyeongsang Natl Univ, Gyeongsang Natl Univ Hosp, Dept Neurosurg, Jinju, South Korea; [Cho, Dae-Chul; Gil, Eun Young; Kim, Kyoung-Tae] Kyungpook Natl Univ, Kyungpook Natl Univ Hosp, Sch Med, Dept Neurosurg, Daegu, South Korea; [Kim, Chi Heon] Seoul Natl Univ Hosp, Dept Neurosurg, Seoul, South Korea; [Kim, Chi Heon] Seoul Natl Univ, Dept Neurosurg, Coll Med, 103 Daehak Ro, Seoul 03080, South Korea; [Han, Inbo] CHA Univ, CHA Bundang Med Ctr, Dept Neurosurg, Seongnam Si, Gyeonggido, South Korea		Kim, KT (corresponding author), Kyungpook Natl Univ Hosp, Spine Ctr, Dept Neurosurg, 130 Dongdeok Ro, Daegu 700721, South Korea.	nskimkt7@gmail.com			Basic Science Research Program through the National Research Foundation of Korea (NRF) - Ministry of Science and ICT [NRF-2012R1A1A1014361, NRF-2015R1C1A1A01056299]	This research was supported by Basic Science Research Program through the National Research Foundation of Korea (NRF) funded by the Ministry of Science and ICT (NRF-2012R1A1A1014361, NRF-2015R1C1A1A01056299).	Adams MM, 2005, SPINAL CORD, V43, P577, DOI 10.1038/sj.sc.3101757; Al-Omar FA, 2006, NEUROCHEM RES, V31, P611, DOI 10.1007/s11064-006-9059-1; Anand P, 2007, MOL PHARMACEUT, V4, P807, DOI 10.1021/mp700113r; Bang WS, 2013, J KOREAN NEUROSURG S, V54, P8, DOI 10.3340/jkns.2013.54.1.8; Baum L, 2008, J CLIN PSYCHOPHARM, V28, P110, DOI 10.1097/jcp.0b013e318160862c; Beattie MS, 2004, TRENDS MOL MED, V10, P580, DOI 10.1016/j.molmed.2004.10.006; Chen S, 2009, CLIN ORTHOP RELAT R, V467, P1670, DOI 10.1007/s11999-009-0740-y; Chen ZR, 2018, MOL MED REP, V17, P4369, DOI 10.3892/mmr.2018.8422; Constantin G, 1999, J IMMUNOL, V162, P1144; Daverey A, 2016, NEUROSCIENCE, V333, P92, DOI 10.1016/j.neuroscience.2016.07.012; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Garcea G, 2004, BRIT J CANCER, V90, P1011, DOI 10.1038/sj.bjc.6601623; Gu F, 2005, J NEUROSCI RES, V81, P163, DOI 10.1002/jnr.20561; Hong JI, 2004, CARCINOGENESIS, V25, P1671, DOI 10.1093/carcin/bgh165; Ireson C, 2001, CANCER RES, V61, P1058; Jo MJ, 2018, FRONT PHARMACOL, V9, DOI 10.3389/fphar.2018.00445; Kim GY, 2005, J IMMUNOL, V174, P8116, DOI 10.4049/jimmunol.174.12.8116; Kim KT, 2017, SPINE J, V17, P203, DOI 10.1016/j.spinee.2016.08.029; Kim KT, 2015, SPINE J, V15, P2055, DOI 10.1016/j.spinee.2015.04.032; Kim KT, 2014, NEUROL MED-CHIR, V54, P387, DOI 10.2176/nmc.oa.2013-0251; Kim KT, 2011, J KOREAN NEUROSURG S, V49, P205, DOI 10.3340/jkns.2011.49.4.205; Ko WK, 2019, MOL NEUROBIOL, V56, P267, DOI 10.1007/s12035-018-0994-z; Kobata H, 2017, J NEUROTRAUM, V34, P987, DOI 10.1089/neu.2016.4662; Kobayakawa K, 2014, SCI TRANSL MED, V6, DOI 10.1126/scitranslmed.3009430; Koyfman L, 2018, THER ADV ENDOCRINOL, V9, P223, DOI 10.1177/2042018818779746; Lin MS, 2011, J SURG RES, V166, P280, DOI 10.1016/j.jss.2009.07.001; Liu ZQ, 2013, J SPINAL CORD MED, V36, P147, DOI 10.1179/2045772312Y.0000000028; Machino M, 2014, SPINE, V39, P220, DOI 10.1097/BRS.0000000000000102; Moon Y, 2005, J PHARMACOL EXP THER, V315, P788, DOI 10.1124/jpet.105.084434; Pan MH, 1999, DRUG METAB DISPOS, V27, P486; Pfeiffer E, 2007, J AGR FOOD CHEM, V55, P538, DOI 10.1021/jf0623283; RAVINDRANATH V, 1980, TOXICOLOGY, V16, P259, DOI 10.1016/0300-483X(80)90122-5; RAVINDRANATH V, 1981, TOXICOLOGY, V20, P251, DOI 10.1016/0300-483X(81)90056-1; Sandur SK, 2007, CARCINOGENESIS, V28, P1765, DOI 10.1093/carcin/bgm123; Sonneville R, 2012, J CLIN ENDOCR METAB, V97, P2113, DOI 10.1210/jc.2011-2971; Tiwari V, 2013, NEUROSCIENCE, V244, P147, DOI 10.1016/j.neuroscience.2013.03.042; Wang YF, 2014, NEUROSCI LETT, V560, P51, DOI 10.1016/j.neulet.2013.11.050; Wu AG, 2006, EXP NEUROL, V197, P309, DOI 10.1016/j.expneurol.2005.09.004; Yang KY, 2007, J CHROMATOGR B, V853, P183, DOI 10.1016/j.jchromb.2007.03.010; Yi JH, 2007, NEUROCHEM INT, V50, P1014, DOI 10.1016/j.neuint.2007.04.019; Yu SH, 2012, J KOREAN NEUROSURG S, V51, P191, DOI 10.3340/jkns.2012.51.4.191; Zhou YY, 2015, CELL PHYSIOL BIOCHEM, V36, P631, DOI 10.1159/000430126	42	15	19	4	10	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1529-9430	1878-1632		SPINE J	Spine Journal	DEC	2019	19	12					2025	2039		10.1016/j.spinee.2019.07.013			15	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	JP0OR	WOS:000497972000016	31421247				2022-02-06	
J	Lu, JJ; Guan, FY; Cui, FZ; Sun, XD; Zhao, LY; Wang, Y; Wang, XM				Lu, Jiaju; Guan, Fengyi; Cui, Fuzhai; Sun, Xiaodan; Zhao, Lingyun; Wang, Ying; Wang, Xiumei			Enhanced angiogenesis by the hyaluronic acid hydrogels immobilized with a VEGF mimetic peptide in a traumatic brain injury model in rats	REGENERATIVE BIOMATERIALS			English	Article						traumatic brain injury; hyaluronic acid; angiogenesis; VEGF mimetic peptide	ENDOTHELIAL GROWTH-FACTOR; MECHANICAL-PROPERTIES; AXONAL REGENERATION; TISSUE-REPAIR; NEUROGENESIS; SCAFFOLDS; CELLS; EXPRESSION; ISCHEMIA; RECOVERY	Angiogenesis plays an important role in brain injury repair, which contributes to the reconstruction of regenerative neurovascular niche for promoting axonal regeneration in the lesion area. As a major component of developing brain extracellular matrix, hyaluronic acid (HA) has attracted more attention as a supporting matrix for brain repair. In the present study, HA-KLT hydrogel was developed via modifying HA with a VEGF mimetic peptide of KLT (KLTWQELYQLKYKGI). The characterization of the hydrogel shows that it could provide a porous, three-dimensional scaffold structure, which has a large specific surface area available for cell adhesion and interaction. Compared with the unmodified HA hydrogel, the HA-KLT hydrogel could effectively promote the attachment, spreading and proliferation of endothelial cells in vitro. Furthermore, the pro-angiogenic ability of hydrogels in vivo was evaluated by implanting them into the lesion cavities in the injured rat brain. Our results showed that the hydrogels could form a permissive interface with the host tissues at 4 weeks after implantation. Moreover, they could efficiently inhibit the formation of glial scars at the injured sites. The HA-KLT hydrogel could significantly increase the expression of endoglin/CD105 and promote the formation of blood vessels, suggesting that HA-KLT hydrogel promoted angiogenesis in vivo. Collectively, the HA-KLT hydrogel has the potential to repair brain defects by promoting angiogenesis and inhibiting the formation of glial-derived scar tissue.	[Lu, Jiaju; Guan, Fengyi; Cui, Fuzhai; Sun, Xiaodan; Zhao, Lingyun; Wang, Xiumei] Tsinghua Univ, Sch Mat Sci & Engn, Minist Educ, State Key Lab New Ceram & Fine Proc,Key Lab Adv M, Beijing 100084, Peoples R China; [Wang, Ying] Capital Med Univ, Minist Educ, Key Lab Neurodegenerat Dis, Beijing Ctr Neutral Regenerat & Repair, Beijing 100069, Peoples R China		Wang, XM (corresponding author), Tsinghua Univ, Sch Mat Sci & Engn, Minist Educ, State Key Lab New Ceram & Fine Proc,Key Lab Adv M, Beijing 100084, Peoples R China.; Wang, Y (corresponding author), Capital Med Univ, Minist Educ, Key Lab Neurodegenerat Dis, Beijing Ctr Neutral Regenerat & Repair, Beijing 100069, Peoples R China.	wangying@ccmu.edu.cn; wxm@mail.tsinghua.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31771056, 81200931]; Tsinghua University Initiative Scientific Research Program [20161080091]; 111 ProjectMinistry of Education, China - 111 Project [B17026]; Key laboratory of Neurodegenerative diseases, Ministry of Education [PXM2019_026283_000002]	This work was supported by the National Natural Science Foundation of China (31771056 and 81200931), the Tsinghua University Initiative Scientific Research Program (20161080091), the 111 Project (B17026) and a special fund from Key laboratory of Neurodegenerative diseases, Ministry of Education (PXM2019_026283_000002).	Allison DD, 2006, TISSUE ENG, V12, P2131, DOI 10.1089/ten.2006.12.2131; Arai K, 2009, FEBS J, V276, P4644, DOI 10.1111/j.1742-4658.2009.07176.x; ARUFFO A, 1990, CELL, V61, P1303, DOI 10.1016/0092-8674(90)90694-A; Bai F, 2011, BIOMED MATER, V6, DOI 10.1088/1748-6041/6/1/015007; Baumgartner I, 2000, ANN INTERN MED, V132, P880, DOI 10.7326/0003-4819-132-11-200006060-00005; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bruzauskaite I, 2016, CYTOTECHNOLOGY, V68, P355, DOI 10.1007/s10616-015-9895-4; Carmeliet P, 2000, NAT MED, V6, P389, DOI 10.1038/74651; Cheng TY, 2013, BIOMATERIALS, V34, P2005, DOI 10.1016/j.biomaterials.2012.11.043; Collins MN, 2008, J MATER SCI-MATER M, V19, P3335, DOI 10.1007/s10856-008-3476-4; Cuevas P, 1997, NEUROL RES, V19, P254, DOI 10.1080/01616412.1997.11758613; Cui FZ, 2006, J MATER SCI-MATER M, V17, P1393, DOI 10.1007/s10856-006-0615-7; Cui FZ, 2003, J BIOACT COMPAT POL, V18, P413, DOI 10.1177/0883911503040470; D'Andrea LD, 2005, P NATL ACAD SCI USA, V102, P14215, DOI 10.1073/pnas.0505047102; FeijAo T., 2018, BIOMEDICAL APPL FUNC, P599, DOI DOI 10.1016/B978-0-323-50878-0.00020-3; Finetti F, 2012, BIOCHEM PHARMACOL, V84, P303, DOI 10.1016/j.bcp.2012.04.011; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; GOUGOS A, 1988, J IMMUNOL, V141, P1925; Gu F, 2004, J CONTROL RELEASE, V96, P463, DOI 10.1016/j.jconrel.2004.02.021; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Hou SP, 2005, J NEUROSCI METH, V148, P60, DOI 10.1016/j.jneumeth.2005.04.016; Hu YS, 2019, BRAIN, V142, P312, DOI 10.1093/brain/awy328; ITO A, 1995, PATHOL INT, V45, P715, DOI 10.1111/j.1440-1827.1995.tb03387.x; Jeon O, 2007, CARBOHYD POLYM, V70, P251, DOI 10.1016/j.carbpol.2007.04.002; Kogan G, 2007, BIOTECHNOL LETT, V29, P17, DOI 10.1007/s10529-006-9219-z; Lee C, 2010, J NEUROTRAUM, V27, P541, DOI 10.1089/neu.2009.0905; Li SH, 2012, BRAIN RES, V1444, P76, DOI 10.1016/j.brainres.2011.12.055; Lin CM, 2009, SURG NEUROL, V72, P50, DOI 10.1016/j.wneu.2009.09.004; Logan Ann, 1994, Progress in Growth Factor Research, V5, P379, DOI 10.1016/0955-2235(94)00008-9; Loh QL, 2013, TISSUE ENG PART B-RE, V19, P485, DOI [10.1089/ten.teb.2012.0437, 10.1089/ten.TEB.2012.0437]; Louissaint A, 2002, NEURON, V34, P945, DOI 10.1016/S0896-6273(02)00722-5; Mancuso Michael R., 2008, Lymphatic Research and Biology, V6, P173, DOI 10.1089/lrb.2008.1014; Matsubara S, 2000, STROKE, V31, P2653, DOI 10.1161/01.STR.31.11.2653; Mitsos S, 2012, ANGIOGENESIS, V15, P1, DOI 10.1007/s10456-011-9240-2; Montesano R, 1996, LAB INVEST, V75, P249; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Murphy JF, 2005, FASEB J, V19, P446, DOI 10.1096/fj.03-1376fje; Nagy JA, 2002, J EXP MED, V196, P1497, DOI 10.1084/jem.20021244; Nisbet DR, 2008, J BIOMED MATER RES B, V87B, P251, DOI 10.1002/jbm.b.31000; Ouasti S, 2011, BIOMATERIALS, V32, P6456, DOI 10.1016/j.biomaterials.2011.05.044; PEARSON KG, 1976, J EXP BIOL, V64, P251; Peattie RA, 2004, BIOMATERIALS, V25, P2789, DOI 10.1016/j.biomaterials.2003.09.054; PERIDES G, 1991, BIOCHIM BIOPHYS ACTA, V1075, P248, DOI 10.1016/0304-4165(91)90273-J; Prestwich GD, 1998, J CONTROL RELEASE, V53, P93, DOI 10.1016/S0168-3659(97)00242-3; Rauch U, 2004, CELL MOL LIFE SCI, V61, P2031, DOI 10.1007/s00018-004-4043-x; Santulli G, 2009, J TRANSL MED, V7, DOI 10.1186/1479-5876-7-41; Shen Q, 2004, SCIENCE, V304, P1338, DOI 10.1126/science.1095505; Shi W, 2012, BIOMATERIALS, V33, P3119, DOI 10.1016/j.biomaterials.2012.01.009; Sun QH, 2005, PHARM RES-DORDR, V22, P1110, DOI 10.1007/s11095-005-5644-2; Thau-Zuchman O, 2010, J CEREBR BLOOD F MET, V30, P1008, DOI 10.1038/jcbfm.2009.271; Tian WM, 2005, TISSUE ENG, V11, P513, DOI 10.1089/ten.2005.11.513; Vallon M, 2014, CELL MOL LIFE SCI, V71, P3489, DOI 10.1007/s00018-014-1625-0; Wang XM, 2012, INTERFACE FOCUS, V2, P278, DOI 10.1098/rsfs.2012.0016; Wang XM, 2008, SOFT MATTER, V4, P2388, DOI 10.1039/b807155a; Wei YT, 2007, BIOMED MATER, V2, pS142, DOI 10.1088/1748-6041/2/3/S11; Wei YT, 2009, J BIOACT COMPAT POL, V24, P205, DOI 10.1177/0883911509102266; Woerly S, 1998, J BIOMAT SCI-POLYM E, V9, P681, DOI 10.1163/156856298X00091; Wong DY, 2007, TISSUE ENG, V13, P2515, DOI 10.1089/ten.2006.0440; Xiong Y, 2010, CURR OPIN INVEST DR, V11, P298; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956	61	15	15	9	24	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	2056-3418	2056-3426		REGEN BIOMATER	Regen. Biomater.	DEC	2019	6	6					325	334		10.1093/rb/rbz027			10	Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science	KQ8EC	WOS:000517151900002	31827886	Green Published, gold			2022-02-06	
J	Raj, R; Luostarinen, T; Pursiainen, E; Posti, JP; Takala, RSK; Bendel, S; Konttila, T; Korja, M				Raj, Rahul; Luostarinen, Teemu; Pursiainen, Eetu; Posti, Jussi P.; Takala, Riikka S. K.; Bendel, Stepani; Konttila, Teijo; Korja, Miikka			Machine learning-based dynamic mortality prediction after traumatic brain injury	SCIENTIFIC REPORTS			English	Article							INTENSIVE-CARE-UNIT; INTRACRANIAL-PRESSURE; HOSPITAL MORTALITY; SECONDARY INSULTS; HEAD-INJURY; CLASSIFICATION; EPIDEMIOLOGY; MANAGEMENT; COMA; GUIDELINES	Our aim was to create simple and largely scalable machine learning-based algorithms that could predict mortality in a real-time fashion during intensive care after traumatic brain injury. We performed an observational multicenter study including adult TBI patients that were monitored for intracranial pressure (ICP) for at least 24 h in three ICUs. We used machine learning-based logistic regression modeling to create two algorithms (based on ICP, mean arterial pressure [MAP], cerebral perfusion pressure [CPP] and Glasgow Coma Scale [GCS]) to predict 30-day mortality. We used a stratified crossvalidation technique for internal validation. Of 472 included patients, 92 patients (19%) died within 30 days. Following cross-validation, the ICP-MAP-CPP algorithm's area under the receiver operating characteristic curve (AUC) increased from 0.67 (95% confidence interval [CI] 0.60-0.74) on day 1 to 0.81 (95% CI 0.75-0.87) on day 5. The ICP-MAP-CPP-GCS algorithm's AUC increased from 0.72 (95% CI 0.64-0.78) on day 1 to 0.84 (95% CI 0.78-0.90) on day 5. Algorithm misclassification was seen among patients undergoing decompressive craniectomy. In conclusion, we present a new concept of dynamic prognostication for patients with TBI treated in the ICU. Our simple algorithms, based on only three and four main variables, discriminated between survivors and non-survivors with accuracies up to 81% and 84%. These open-sourced simple algorithms can likely be further developed, also in low and middleincome countries.	[Raj, Rahul; Korja, Miikka] Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5,PB 266, Helsinki 00029, Finland; [Raj, Rahul; Luostarinen, Teemu; Korja, Miikka] Univ Helsinki, Topeliuksenkatu 5,PB 266, Helsinki 00029, Finland; [Luostarinen, Teemu] Helsinki Univ Hosp, Dept Anesthesiol Intens Care & Pain Med, Div Anesthesiol, Topeliuksenkatu 5,PB 266, Helsinki 00029, Finland; [Pursiainen, Eetu; Konttila, Teijo] Helsinki Univ Hosp, HUS IT Management, Analyt & AI Dev Serv, Haartmaninkatu 4,PB 340, Helsinki 00029, Finland; [Posti, Jussi P.] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Hameentie 11, Turku 20521, Finland; [Posti, Jussi P.] Turku Univ Hosp, Turku Brain Injury Ctr, Hameentie 11, Turku 20521, Finland; [Posti, Jussi P.; Takala, Riikka S. K.] Univ Turku, Hameentie 11, Turku 20521, Finland; [Takala, Riikka S. K.] Turku Univ Hosp, Intens Care Med & Pain Management, Perioperat Serv, Hameentie 11, Turku 20521, Finland; [Bendel, Stepani] Kuopio Univ Hosp, Dept Anesthesiol Intens Care & Pain Med, Div Intens Care, Puijonlaaksontie 2, SF-70210 Kuopio, Finland		Raj, R (corresponding author), Helsinki Univ Hosp, Dept Neurosurg, Topeliuksenkatu 5,PB 266, Helsinki 00029, Finland.; Raj, R (corresponding author), Univ Helsinki, Topeliuksenkatu 5,PB 266, Helsinki 00029, Finland.	rahul.raj@hus.fi	Raj, Rahul/K-7693-2012; Posti, Jussi P./Y-2908-2019; Korja, Miikka/E-4292-2016	Raj, Rahul/0000-0003-4243-9591; Posti, Jussi P./0000-0002-5925-5193; Korja, Miikka/0000-0002-4463-6954	internal Helsinki University Hospital research grant [Y201812205]; Finska Lakaresallskapet; Medicinska Understodsforeningen Liv Halsa; Government's Special Financial Transfer tied to academic research in Health Sciences; EVO grant [13132]	The authors wish to thank Mikko Kemppainen (data scientist) and Olli Paakkunainen (software engineer) from Qvik (qvik.com) for helping with the machine learning analyses. The study was funded by an internal Helsinki University Hospital research grant (Y201812205), Finska Lakaresallskapet (RR), Medicinska Understodsforeningen Liv & Halsa (RR) and by Government's Special Financial Transfer tied to academic research in Health Sciences (JPP) and by EVO grant 13132 (RSKT). The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams H, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002353; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; [Anonymous], 2008, BMJ-BRIT MED J, V336, P425, DOI DOI 10.1136/bmj.39461.643438.25; Beck B, 2018, J NEUROTRAUM, V35, P1021, DOI 10.1089/neu.2017.5287; Bonds BW, 2015, J TRAUMA ACUTE CARE, V79, P85, DOI 10.1097/TA.0000000000000698; Brain Trauma Foundation. American Association of Neurological Surgeons & Congress of Neurological Surgeons, 2007, J NEUROTRAUM, V24, pi, DOI DOI 10.1089/NEU.2007.9999; Bullock RM, 2000, J NEUROTRAUM, V17, P449; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Carter EL, 2016, BRIT J NEUROSURG, V30, P227, DOI 10.3109/02688697.2016.1139048; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Donald R, 2019, J CLIN MONIT COMPUT, V33, P39, DOI 10.1007/s10877-018-0139-y; FOULKES MA, 1991, J NEUROSURG, V75, pS8, DOI 10.3171/sup.1991.75.1s.00s8; Guiza F, 2013, CRIT CARE MED, V41, P554, DOI 10.1097/CCM.0b013e3182742d0a; Komorowski M, 2018, NAT MED, V24, P1716, DOI 10.1038/s41591-018-0213-5; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2012, J NEUROTRAUM, V29, P32, DOI 10.1089/neu.2010.1599; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Marklund N, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00540; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Metnitz PGH, 2005, INTENS CARE MED, V31, P1336, DOI 10.1007/s00134-005-2762-6; Moons KGM, 2015, ADV ANAT PATHOL, V22, P303, DOI 10.1097/PAP.0000000000000072; Moreno RP, 2005, INTENS CARE MED, V31, P1345, DOI 10.1007/s00134-005-2763-5; Myburgh JA, 2008, J TRAUMA, V64, P854, DOI 10.1097/TA.0b013e3180340e77; Nattino G, 2016, STAT MED, V35, P709, DOI 10.1002/sim.6744; Raj R, 2014, NEUROSURGERY, V75, P632, DOI 10.1227/NEU.0000000000000533; Rau M, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0208225; Reith FCM, 2017, INJURY, V48, P1932, DOI 10.1016/j.injury.2017.05.038; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P23, DOI 10.1007/s00508-006-0760-5; Stevens RD, 2013, CRIT CARE MED, V41, P1104, DOI 10.1097/CCM.0b013e318287ee79; Steyerberg EW, 2018, J CLIN EPIDEMIOL, V103, P131, DOI 10.1016/j.jclinepi.2018.07.010; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Stocchetti N, 2017, LANCET NEUROL, V16, P452, DOI 10.1016/S1474-4422(17)30118-7; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; TEASDALE G, 1974, LANCET, V2, P81; van der Ploeg T, 2016, J CLIN EPIDEMIOL, V78, P83, DOI 10.1016/j.jclinepi.2016.03.002; WHO. World Health Organization, 2018, GLOBAL STATUS REPORT; Zimmerman JE, 2006, CRIT CARE MED, V34, P1297, DOI 10.1097/01.CCM.0000215112.84523.F0	41	15	15	0	2	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 27	2019	9								17672	10.1038/s41598-019-53889-6			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	JQ8IL	WOS:000499182100001	31776366	gold, Green Published			2022-02-06	
J	Jha, KA; Pentecost, M; Lenin, R; Gentry, J; Klaic, L; Del Mar, N; Reiner, A; Yang, CH; Pfeffer, LM; Sohl, N; Gangaraju, R				Jha, Kumar Abhiram; Pentecost, Mickey; Lenin, Raji; Gentry, Jordy; Klaic, Lada; Del Mar, Nobel; Reiner, Anton; Yang, Chuan He; Pfeffer, Lawrence M.; Sohl, Nicolas; Gangaraju, Rajashekhar			TSG-6 in conditioned media from adipose mesenchymal stem cells protects against visual deficits in mild traumatic brain injury model through neurovascular modulation	STEM CELL RESEARCH & THERAPY			English	Article						Endothelial; ERG; OKN; Retina; Microglia; Muller; Paracrine; TBI; MSC; SOD2; Stat3	MURINE MODEL; INFLAMMATION; ACTIVATION; MICROGLIA; DEGENERATION; MINOCYCLINE; EXPRESSION; RESPONSES; MEMORY; BLAST	Background Retinal inflammation affecting the neurovascular unit may play a role in the development of visual deficits following mild traumatic brain injury (mTBI). We have shown that concentrated conditioned media from adipose tissue-derived mesenchymal stem cells (ASC-CCM) can limit retinal damage from blast injury and improve visual function. In this study, we addressed the hypothesis that TNF alpha-stimulated gene-6 (TSG-6), an anti-inflammatory protein released by mesenchymal cells, mediates the observed therapeutic potential of ASCs via neurovascular modulation. Methods About 12-week-old C57Bl/6 mice were subjected to 50-psi air pulse on the left side of the head overlying the forebrain resulting in an mTBI. Age-matched sham blast mice served as control. About 1 mu l of ASC-CCM (siControl-ASC-CCM) or TSG-6 knockdown ASC-CCM (siTSG-6-ASC-CCM) was delivered intravitreally into both eyes. One month following injection, the ocular function was assessed followed by molecular and immunohistological analysis. In vitro, mouse microglial cells were used to evaluate the anti-inflammatory effect of ASC-CCM. Efficacy of ASC-CCM in normalizing retinal vascular permeability was assessed using trans-endothelial resistance (TER) and VE-cadherin expression in the presence of TNF alpha (1 ng/ml). Results We show that intravitreal injection of ASC-CCM (siControl-ASC-CCM) but not the TSG-6 knockdown ASC-CCM (siTSG-6-ASC-CCM) mitigates the loss of visual acuity and contrast sensitivity, retinal expression of genes associated with microglial and endothelial activation, and retinal GFAP immunoreactivity at 4 weeks after blast injury. In vitro, siControl-ASC-CCM but not the siTSG-6-ASC-CCM not only suppressed microglial activation and STAT3 phosphorylation but also protected against TNF alpha-induced endothelial permeability as measured by transendothelial electrical resistance and decreased STAT3 phosphorylation. Conclusions Our findings suggest that ASCs respond to an inflammatory milieu by secreting higher levels of TSG-6 that mediates the resolution of the inflammatory cascade on multiple cell types and correlates with the therapeutic potency of the ASC-CCM. These results expand our understanding of innate mesenchymal cell function and confirm the importance of considering methods to increase the production of key analytes such as TSG-6 if mesenchymal stem cell secretome-derived biologics are to be developed as a treatment solution against the traumatic effects of blast injuries and other neurovascular inflammatory conditions of the retina.	[Jha, Kumar Abhiram; Lenin, Raji; Gentry, Jordy; Gangaraju, Rajashekhar] Univ Tennessee, Coll Med, Hlth Sci Ctr, Dept Ophthalmol, 930 Madison Ave,Suite 768, Memphis, TN 38163 USA; [Pentecost, Mickey; Klaic, Lada; Sohl, Nicolas] Cell Care Therapeut Inc, Los Angeles, CA USA; [Pentecost, Mickey] Pathways Stem Cell Sci, Monrovia, CA USA; [Del Mar, Nobel; Reiner, Anton; Gangaraju, Rajashekhar] Univ Tennessee, Coll Med, Hlth Sci Ctr, Dept Anat & Neurobiol, 855 Monroe Ave,Suite 515, Memphis, TN 38163 USA; [Yang, Chuan He; Pfeffer, Lawrence M.] Univ Tennessee, Coll Med, Hlth Sci Ctr, Dept Pathol, 19 South Manassas St,Suite 214, Memphis, TN 38163 USA		Gangaraju, R (corresponding author), Univ Tennessee, Coll Med, Hlth Sci Ctr, Dept Ophthalmol, 930 Madison Ave,Suite 768, Memphis, TN 38163 USA.; Gangaraju, R (corresponding author), Univ Tennessee, Coll Med, Hlth Sci Ctr, Dept Anat & Neurobiol, 855 Monroe Ave,Suite 515, Memphis, TN 38163 USA.	sgangara@uthsc.edu	Reiner, Anton/AAG-8860-2020; Gangaraju, Rajashekhar/I-7852-2019	Reiner, Anton/0000-0002-2146-5232; Gangaraju, Rajashekhar/0000-0002-6664-8286	Department of DefenseUnited States Department of Defense [W81XWH-16-1-0761, W81XWH-16-1-0076]; National Eye InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [EY023427]; Research to Prevent BlindnessResearch to Prevent Blindness (RPB); Neuroscience Institute, UTHSC	This study was funded by grants from the Department of Defense (W81XWH-16-1-0761), National Eye Institute (EY023427), and unrestricted funds from Research to Prevent Blindness to RG and Department of Defense (W81XWH-16-1-0076) to AR. KAJ is a recipient of a postdoc fellowship award from the Neuroscience Institute, UTHSC. The funders played no role in the conduct of the study, collection of data, management of the study, analysis of data, interpretation of data, or preparation of the manuscript.	Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Brennan CW, 2013, CELL, V155, P462, DOI 10.1016/j.cell.2013.09.034; Cahoon JM, 2015, DIABETES, V64, P4247, DOI 10.2337/db14-1030; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Choi H, 2019, CURR EYE RES, V44, P873, DOI 10.1080/02713683.2019.1597893; Danchuk S, 2011, STEM CELL RES THER, V2, DOI 10.1186/scrt68; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Di GH, 2017, INVEST OPHTH VIS SCI, V58, P4344, DOI 10.1167/iovs.17-21506; Duan L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073768; Elshaer SL, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1059-y; Ganguly D, 2018, STEM CELLS, V36, P1804, DOI 10.1002/stem.2909; Guley NH, 2016, J NEUROTRAUM, V33, P403, DOI 10.1089/neu.2015.3886; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; Heldt SA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00002; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Hutchins AP, 2012, BLOOD, V119, pE110, DOI 10.1182/blood-2011-09-381483; Jha KA, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19072016; Jiang SY, 2016, CLIN EXP MED, V16, P219, DOI 10.1007/s10238-015-0339-4; Kim SJ, 2015, SCI REP-UK, V5, DOI 10.1038/srep11872; Kumar A, 2016, J NEUROTRAUM, V33, P1732, DOI 10.1089/neu.2015.4268; Landiev I, 2006, EXP EYE RES, V82, P449, DOI 10.1016/j.exer.2005.07.018; Lee RH, 2009, CELL STEM CELL, V5, P54, DOI 10.1016/j.stem.2009.05.003; Lenin R, 2018, EXP BIOL MED, V243, P976, DOI 10.1177/1535370218794915; Lenin R, 2018, J CELL BIOCHEM, V119, P8460, DOI 10.1002/jcb.27072; Li Q, 2018, STEM CELL RES THER, V9, DOI 10.1186/s13287-018-1009-8; Li R, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1279-1; Liu Y, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-135; Mammadova N, 2017, AM J PATHOL, V187, P1459, DOI 10.1016/j.ajpath.2017.03.005; Masuda T, 2012, CELL REP, V1, P334, DOI 10.1016/j.celrep.2012.02.014; Menge T, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004660; Mittal M, 2016, P NATL ACAD SCI USA, V113, pE8151, DOI 10.1073/pnas.1614935113; Oh JY, 2010, P NATL ACAD SCI USA, V107, P16875, DOI 10.1073/pnas.1012451107; Osborne A, 2018, STEM CELLS, V36, P65, DOI 10.1002/stem.2722; Ozawa Y, 2008, J BIOL CHEM, V283, P24561, DOI 10.1074/jbc.M802238200; Pawlowska E, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/9682318; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; Presley C, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.159; Prockop DJ, 2016, MATRIX BIOL, V51, P7, DOI 10.1016/j.matbio.2016.01.010; Rajashekhar G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084671; Redell JB, 2007, NEUROSCI LETT, V413, P36, DOI 10.1016/j.neulet.2006.11.060; Swaidani S, 2013, J BIOL CHEM, V288, P412, DOI 10.1074/jbc.M112.389874; Taib T, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0184811; Tuo JS, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-59; Vonder Haar C, 2014, J NEUROTRAUM, V31, P961, DOI 10.1089/neu.2013.3119; Watanabe J, 2013, NEUROBIOL DIS, V59, P86, DOI 10.1016/j.nbd.2013.06.017; Weichel ED, 2008, OPHTHALMOLOGY, V115, P2235, DOI 10.1016/j.ophtha.2008.08.033; WISNIEWSKI HG, 1993, J IMMUNOL, V151, P6593; Xiao GM, 2008, CRIT CARE, V12, DOI 10.1186/cc6887; Yun JH, 2017, J CELL PHYSIOL, V232, P1123, DOI 10.1002/jcp.25575; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106	50	15	15	2	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1757-6512		STEM CELL RES THER	Stem Cell Res. Ther.	NOV 5	2019	10	1							318	10.1186/s13287-019-1436-1			15	Cell & Tissue Engineering; Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	JK3EC	WOS:000494727400001	31690344	Green Published, gold			2022-02-06	
J	Foss, KDB; Yuan, WH; Diekfuss, JA; Leach, J; Meehan, W; DiCesare, CA; Solomon, G; Schneider, DK; MacDonald, J; Dudley, J; Cortes, N; Galloway, R; Halstead, M; Walker, G; Myer, GD				Foss, Kim D. Barber; Yuan, Weihong; Diekfuss, Jed A.; Leach, James; Meehan, William; DiCesare, Christopher A.; Solomon, Gary; Schneider, Daniel K.; MacDonald, James; Dudley, Jon; Cortes, Nelson; Galloway, Ryan; Halstead, Mark; Walker, Gregory; Myer, Gregory D.			Relative Head Impact Exposure and Brain White Matter Alterations After a Single Season of Competitive Football: A Pilot Comparison of Youth Versus High School Football	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						football; head impacts; white matter; mild traumatic brain injury; concussion	DIFFUSION TENSOR; COMPRESSION COLLAR; 1ST EXPOSURE; LATER-LIFE; INJURY; CONCUSSION; SPORT; EXERCISE; AGE; MICROSTRUCTURE	Objective: Youth athletes are believed to be more susceptible to white matter (WM) degradation resulting from head impact exposure relative to high school (HS) athletes; this hypothesis has not been objectively tested. The purpose of this study was to determine preseason to postseason changes in WM integrity from repetitive head impacts for youth football (YFB) players compared with HS football players during a competitive football season. Design: Prospective cohort. Setting: One season of YFB (grades 7 and 8) and varsity HS football (grades 10-12). Patients or Other Participants: Twelve YFB (13.08 +/- 0.64 years) and 21 HS (17.5 +/- 0.78 years) athletes. Interventions: Participants completed 2 magnetic resonance imaging sessions: preseason and postseason. Head impact exposure was recorded during practice and games using a helmet-mounted accelerometer. Main Outcome Measures: Tract-based spatial statistics were used to evaluate group differences in preseason to postseason changes in diffusion tensor imaging, including fractional anisotropy and mean diffusivity (MD), axial diffusivity (AD), and radial diffusivity (RD). Results: The HS group exhibited significant preseason to postseason reductions in MD, AD, and RD (P<0.05, corrected) in widespread WM areas. Significant WM reductions for the YFB group were only observed for AD (P<0.05, corrected), but was more limited in extent compared with HS. Conclusions: Significant preseason to postseason AD reduction was found in both YFB and HS groups after one season of competitive play. Our results did not confirm recent speculation that younger children are more susceptible to the deleterious effects of repetitive head impacts compared with their older counterparts.	[Foss, Kim D. Barber; Diekfuss, Jed A.; DiCesare, Christopher A.; Schneider, Daniel K.; Galloway, Ryan; Walker, Gregory; Myer, Gregory D.] Cincinnati Childrens Hosp Med Ctr, Div Sports Med, SPORT Ctr, Cincinnati, OH 45229 USA; [Foss, Kim D. Barber] Rocky Mt Univ Hlth Profess, Provo, UT USA; [Yuan, Weihong; Dudley, Jon] Cincinnati Childrens Hosp Med Ctr, Pediat Neuroimaging Res Consortium, Cincinnati, OH 45229 USA; [Yuan, Weihong; Leach, James] Cincinnati Childrens Hosp Med Ctr, Div Radiol, Cincinnati, OH 45229 USA; [Yuan, Weihong; Leach, James] Univ Cincinnati, Coll Med, Dept Radiol, Cincinnati, OH USA; [Leach, James] Cincinnati Childrens Hosp Med Ctr, Div Neurol, Cincinnati, OH 45229 USA; [Meehan, William; Myer, Gregory D.] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Solomon, Gary] Vanderbilt Univ, Vanderbilt Sports Concuss Ctr, Dept Neurol Surg, 221 Kirkland Hall, Nashville, TN 37235 USA; [Schneider, Daniel K.] Riverside Methodist Hosp, Columbus, OH USA; [MacDonald, James] Ohio State Univ, Coll Med, Columbus, OH 43210 USA; [MacDonald, James] Nationwide Childrens Hosp, Sports Med, Columbus, OH USA; [Cortes, Nelson] George Mason Univ, Sports Med Assessment Res & Testing SMART Lab, Manassas, VA USA; [Cortes, Nelson] George Mason Univ, Dept Bioengn, Manassas, VA USA; [Halstead, Mark] Washington Univ, Sch Med, Dept Pediat, St Louis, MO 63110 USA; [Halstead, Mark] Washington Univ, Sch Med, Dept Orthoped, St Louis, MO USA; [Walker, Gregory; Myer, Gregory D.] Univ Cincinnati, Coll Med, Dept Pediat, Cincinnati, OH USA; [Walker, Gregory] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO USA; [Walker, Gregory] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Myer, Gregory D.] Univ Cincinnati, Dept Orthopaed Surg, Cincinnati, OH USA		Myer, GD (corresponding author), Cincinnati Childrens Hosp, 3333 Burnet Ave,MLC 10001, Cincinnati, OH 45229 USA.	Greg.Myer@cchmc.org	DiCesare, Christopher/ABH-9573-2020; Diekfuss, Jed/ABD-7372-2020; DiCesare, Christopher/AAA-3327-2021; Myer, Gregory/H-6572-2016	Diekfuss, Jed/0000-0003-3835-363X; DiCesare, Christopher/0000-0002-6576-4904; Myer, Gregory/0000-0002-9983-8422; Dudley, Jonathan/0000-0002-5189-9568; MacDonald, James/0000-0002-0432-0808; Cortes, Nelson/0000-0001-8762-3144			Andersen SL, 2008, TRENDS NEUROSCI, V31, P183, DOI 10.1016/j.tins.2008.01.004; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Basser PJ, 1998, MAGNET RESON MED, V39, P928, DOI 10.1002/mrm.1910390610; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bruner MW, 2017, RES Q EXERCISE SPORT, V88, P209, DOI 10.1080/02701367.2017.1296100; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Campbell KR, 2016, ANN BIOMED ENG, V44, P1246, DOI 10.1007/s10439-015-1391-7; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Chen Z, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00716; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Dohle S, 2013, BMC PUBLIC HEALTH, V13, DOI 10.1186/1471-2458-13-1100; Epstein HT, 1999, BRAIN DEV-JPN, V21, P535, DOI 10.1016/S0387-7604(99)00066-2; Faigenbaum AD, 2012, CURR SPORT MED REP, V11, P196, DOI 10.1249/JSR.0b013e31825da961; Fakhran S, 2014, RADIOLOGY, V272, P815, DOI 10.1148/radiol.14132512; Fiuza-Luces C, 2013, PHYSIOLOGY, V28, P330, DOI 10.1152/physiol.00019.2013; Giedd JN, 1999, NAT NEUROSCI, V2, P861, DOI 10.1038/13158; Giza CC, 2005, BEHAV BRAIN RES, V157, P11, DOI 10.1016/j.bbr.2004.06.003; Grieve SM, 2011, NEUROIMAGE, V55, P868, DOI 10.1016/j.neuroimage.2010.12.087; Hessen E, 2007, BRAIN INJURY, V21, P963, DOI 10.1080/02699050701528454; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kelly AMC, 2009, CEREB CORTEX, V19, P640, DOI 10.1093/cercor/bhn117; Kerr ZY, 2017, J ATHL TRAINING, V52, P167, DOI 10.4085/1062-6050-51.6.05; Kiefer AW, 2018, J SCI MED SPORT, V21, P4, DOI 10.1016/j.jsams.2017.06.016; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; Kokkinos P, 2011, CARDIOL RES PRACT, V2011, DOI 10.4061/2011/924945; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kuhn AW, 2017, BRIT J SPORT MED, V51, P1732, DOI 10.1136/bjsports-2016-096508; Kuhn AW, 2017, SPORTS HEALTH, V9, P30, DOI 10.1177/1941738116674006; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lenroot RK, 2006, NEUROSCI BIOBEHAV R, V30, P718, DOI 10.1016/j.neubiorev.2006.06.001; Li J, 2011, EUR J NEUROSCI, V33, P933, DOI 10.1111/j.1460-9568.2010.07573.x; MacDonald J, 2017, BRIT J SPORT MED, V51, P1448, DOI 10.1136/bjsports-2016-096833; Mayinger MC, 2018, BRAIN IMAGING BEHAV, V12, P44, DOI 10.1007/s11682-017-9672-4; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; Meier TB, 2015, J SCI MED SPORT, V18, P507, DOI 10.1016/j.jsams.2014.07.008; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Murphy AM, 2017, SPORT EXERC PERFORM, V6, P230, DOI 10.1037/spy0000102; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Myer GD, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00074; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; O'Connor KL, 2017, J ATHL TRAINING, V52, P175, DOI 10.4085/1062-6050-52.1.15; Pareja-Galeano H, 2015, PROG MOL BIOL TRANSL, V135, P497, DOI 10.1016/bs.pmbts.2015.07.019; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Sasaki Takeshi, 2014, J Neurosurg, V120, P882, DOI 10.3171/2013.12.JNS132092; SCHNEIDER GE, 1979, NEUROPSYCHOLOGIA, V17, P557, DOI 10.1016/0028-3932(79)90033-2; Shaw P, 2008, J NEUROSCI, V28, P3586, DOI 10.1523/JNEUROSCI.5309-07.2008; Sim A, 2008, J NEUROSURG, V108, P511, DOI 10.3171/JNS/2008/108/3/0511; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Smith SM, 2009, NEUROIMAGE, V44, P83, DOI 10.1016/j.neuroimage.2008.03.061; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Stamm JM, 2015, J NEUROTRAUM, V32, P1768, DOI 10.1089/neu.2014.3822; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stone James L, 2014, Evid Based Med, V19, P157, DOI 10.1136/eb-2014-101750; Uematsu A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046970; Wendel KM, 2019, J NEUROTRAUM, V36, P152, DOI 10.1089/neu.2018.5670; WHO. World Health Organization, 2011, GLOBAL RECOMMENDATIO; Williamson IJS, 2006, BRIT J SPORT MED, V40, P128, DOI 10.1136/bjsm.2005.021832; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859; Yuan WH, 2017, J NEUROTRAUM, V34, P2432, DOI 10.1089/neu.2016.4834; Zuckerman Scott L, 2012, Surg Neurol Int, V3, P130, DOI 10.4103/2152-7806.102945	71	15	15	1	1	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	NOV	2019	29	6					442	450		10.1097/JSM.0000000000000753			9	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Physiology; Sport Sciences	KG1IB	WOS:000509694100010	31688173				2022-02-06	
J	Liebert, A; Bicknell, B; Johnstone, DM; Gordon, LC; Kiat, H; Hamblin, MR				Liebert, Ann; Bicknell, Brian; Johnstone, Daniel M.; Gordon, Luke C.; Kiat, Hosen; Hamblin, Michael R.			"Photobiomics": Can Light, Including Photobiomodulation, Alter the Microbiome?	PHOTOBIOMODULATION PHOTOMEDICINE AND LASER SURGERY			English	Article						photobiomodulation; microbiome; bacteria; metabolome	LEVEL LASER THERAPY; BIPHASIC DOSE-RESPONSE; DORSAL-ROOT GANGLION; CHAIN FATTY-ACIDS; GUT-BRAIN AXIS; MOUSE MODEL; STEM-CELLS; DISEASE PROGRESSION; PARKINSON DISEASE; NERVOUS-SYSTEM	Objective: The objective of this review is to consider the dual effects of microbiome and photobiomodulation (PBM) on human health and to suggest a relationship between these two as a novel mechanism. Background: PBM describes the use of low levels of visible or near-infrared (NIR) light to heal and stimulate tissue, and to relieve pain and inflammation. In recent years, PBM has been applied to the head as an investigative approach to treat diverse brain diseases such as stroke, traumatic brain injury (TBI), Alzheimer's and Parkinson's diseases, and psychiatric disorders. Also, in recent years, increasing attention has been paid to the total microbial population that colonizes the human body, chiefly in the gut and the mouth, called the microbiome. It is known that the composition and health of the gut microbiome affects many diseases related to metabolism, obesity, cardiovascular disorders, autoimmunity, and even brain disorders. Materials and methods: A literature search was conducted for published reports on the effect of light on the microbiome. Results: Recent work by our research group has demonstrated that PBM (red and NIR light) delivered to the abdomen in mice, can alter the gut microbiome in a potentially beneficial way. This has also now been demonstrated in human subjects. Conclusions: In consideration of the known effects of PBM on metabolomics, and the now demonstrated effects of PBM on the microbiome, as well as other effects of light on the microbiome, including modulating circadian rhythms, the present perspective introduces a new term "photobiomics" and looks forward to the application of PBM to influence the microbiome in humans. Some mechanisms by which this phenomenon might occur are considered.	[Liebert, Ann] Australasian Res Inst, 185 Fox Valley Rd, Wahroonga, NSW 2076, Australia; [Liebert, Ann] Univ Sydney, Dept Med, Camperdown, NSW, Australia; [Bicknell, Brian] Australian Catholic Univ, Fac Hlth Sci, Sydney, NSW, Australia; [Johnstone, Daniel M.; Gordon, Luke C.] Univ Sydney, Discipline Physiol, Camperdown, NSW, Australia; [Kiat, Hosen] Macquarie Univ, Fac Med & Hlth Sci, Marsfield, Australia; [Kiat, Hosen] Univ New South Wales, Fac Med, Kensington, NSW, Australia; [Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Hamblin, Michael R.] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA; [Hamblin, Michael R.] Harvard MIT Div Hlth Sci & Technol, Cambridge, MA USA		Liebert, A (corresponding author), Australasian Res Inst, 185 Fox Valley Rd, Wahroonga, NSW 2076, Australia.	ann.liebert@sah.org.au	Hamblin, Michael R/H-2758-2019; Johnstone, Daniel/E-9929-2013	Hamblin, Michael R/0000-0001-6431-4605; Johnstone, Daniel/0000-0003-2876-3299; Kiat, Hosen/0000-0002-2899-118X			Abrahamse H, 2012, PHOTOMED LASER SURG, V30, P681, DOI 10.1089/pho.2012.9881; Ad N, 2001, INT J CARDIOL, V80, P109, DOI 10.1016/S0167-5273(01)00503-4; de Sousa NTA, 2016, LASER MED SCI, V31, P549, DOI 10.1007/s10103-016-1907-x; Anderson George, 2017, BioMolecular Concepts, V8, P185, DOI 10.1515/bmc-2017-0009; [Anonymous], 2019, BRAIN STIMUL; Arora HC, 2017, ANN TRANSL MED, V5, DOI 10.21037/atm.2016.12.32; Auboyer L, 2019, SPIE PHOTONICS W; Bagheri M, 2018, PHOTOMED LASER SURG, V36, P415, DOI 10.1089/pho.2018.4453; Basha A. Ahamed, 2018, Indian Journal of Physiology and Pharmacology, V62, P187; Baxter NT, 2019, MSPHERE, V4, DOI [10.1128/mSphere.00528-18, 10.1128/msphere.00528-18]; Beauchemin KM, 1998, J ROY SOC MED, V91, P352, DOI 10.1177/014107689809100703; Bicknell B, 2019, LASER MED SCI, V34, P317, DOI 10.1007/s10103-018-2594-6; Bien J, 2013, THER ADV GASTROENTER, V6, P53, DOI 10.1177/1756283X12454590; Blivet Guillaume, 2018, Alzheimers Dement (N Y), V4, P54, DOI 10.1016/j.trci.2017.12.003; Boswell M, 2019, GENES-BASEL, V10, DOI 10.3390/genes10040271; Boulange CL, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0303-2; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brial F, 2018, CELL MOL LIFE SCI, V75, P3977, DOI 10.1007/s00018-018-2901-1; Chen M, 1993, LASER LIFE SCI, V5, P237; Chen SG, 2016, SCI REP-UK, V6, DOI 10.1038/srep34477; Chow RT, 2007, J PERIPHER NERV SYST, V12, P28, DOI 10.1111/j.1529-8027.2007.00114.x; Cui M, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17111786; de Freitas LF, 2016, IEEE J SEL TOP QUANT, V22, DOI 10.1109/JSTQE.2016.2561201; de la Fuente-Nunez C, 2018, ACS CHEM NEUROSCI, V9, P141, DOI 10.1021/acschemneuro.7b00373; Deaver JA, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.00737; Derkinderen P, 2011, NEUROLOGY, V77, P1761, DOI 10.1212/WNL.0b013e318236ef60; Disanto G, 2012, BMC MED, V10, DOI 10.1186/1741-7015-10-69; Durieux J, 2011, CELL, V144, P79, DOI 10.1016/j.cell.2010.12.016; Emanuel AJ, 2015, NEURON, V85, P1043, DOI 10.1016/j.neuron.2015.02.011; Farfara D, 2015, J MOL NEUROSCI, V55, P430, DOI 10.1007/s12031-014-0354-z; Fekrazad R, 2016, PHOTOMED LASER SURG, V34, P533, DOI 10.1089/pho.2015.4029; Ferraresi C, 2016, J BIOPHOTONICS, V9, P1273, DOI 10.1002/jbio.201600176; Figueiro MG, 2012, INT J ENDOCRINOL, V2012, P6; Flyktman A, 2015, J EXP BIOL, V218, P1521, DOI 10.1242/jeb.111864; Forslund K, 2015, NATURE, V528, P262, DOI 10.1038/nature15766; Fu JY, 2015, CIRC RES, V117, P817, DOI 10.1161/CIRCRESAHA.115.306807; Fukuda TY, 2013, LASER MED SCI, V28, P1305, DOI 10.1007/s10103-012-1231-z; Ganeshan V, 2019, NEUROSCIENCE, V400, P85, DOI 10.1016/j.neuroscience.2018.12.050; Gao J, 2018, FRONT CELL INFECT MI, V8, DOI 10.3389/fcimb.2018.00013; Geneva II, 2016, INT J OPHTHALMOL-CHI, V9, P145, DOI 10.18240/ijo.2016.01.24; Gershon MD, 2007, GASTROENTEROLOGY, V132, P397, DOI 10.1053/j.gastro.2006.11.002; Gonzalez A, 2016, MSYSTEMS, V1; Gooley JJ, 2011, J CLIN ENDOCR METAB, V96, pE463, DOI 10.1210/jc.2010-2098; Grosicki GJ, 2018, CALCIFIED TISSUE INT, V102, P433, DOI 10.1007/s00223-017-0345-5; Grzybowski A, 2012, CLIN DERMATOL, V30, P451, DOI 10.1016/j.clindermatol.2011.11.019; Gubatan J, 2018, CURR OPIN GASTROEN, V34, P217, DOI 10.1097/MOG.0000000000000449; Hamblin MR, 2018, PHOTOCHEM PHOTOBIOL, V94, P199, DOI 10.1111/php.12864; Hamblin Michael R, 2017, Adv Exp Med Biol, V996, P295, DOI 10.1007/978-3-319-56017-5_25; Hamblin MR, 2017, AIMS BIOPHYS, V4, P337, DOI 10.3934/biophy.2017.3.337; Hamblin MR, 2016, J BIOPHOTONICS, V9, P1122, DOI 10.1002/jbio.201670113; Hamblin MR, 2018, PHOTOCHEM PHOTOBIOL, V95, P126; Heiman ML, 2016, MOL METAB, V5, P317, DOI 10.1016/j.molmet.2016.02.005; Ho M. D., 2016, J INT NEUROPSYCH SOC, V22, P229; Holanda VM, 2017, LASER SURG MED, V49, P516, DOI 10.1002/lsm.22628; Holanda VM, 2016, LASER SURG MED, V48, P653, DOI 10.1002/lsm.22522; Horta-Baas G, 2017, J IMMUNOL RES, V2017, DOI 10.1155/2017/4835189; Huang C, 2016, PHOTOMED LASER SURG, V34, P313, DOI 10.1089/pho.2015.4077; Huang YY, 2011, DOSE-RESPONSE, V9, P602, DOI 10.2203/dose-response.11-009.Hamblin; Huang YY, 2009, DOSE-RESPONSE, V7, P358, DOI 10.2203/dose-response.09-027.Hamblin; Imhann F, 2018, GUT, V67, P108, DOI 10.1136/gutjnl-2016-312135; Imhann F, 2016, GUT, V65, P740, DOI 10.1136/gutjnl-2015-310376; Ivandic BT, 2008, PHOTOMED LASER SURG, V26, P241, DOI 10.1089/pho.2007.2132; Jandhyala SM, 2015, WORLD J GASTROENTERO, V21, P8787, DOI 10.3748/wjg.v21.i29.8787; Jenkins TA, 2016, NUTRIENTS, V8, DOI 10.3390/nu8010056; Jiang CM, 2017, J ALZHEIMERS DIS, V58, P1, DOI 10.3233/JAD-161141; Jie ZY, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-00900-1; Johnstone DM, 2014, NEUROSCIENCE, V274, P93, DOI 10.1016/j.neuroscience.2014.05.023; Johnstone DM, 2016, FRONT NEUROSCI-SWITZ, V9, DOI [10.3389/fninc.2015.00500, 10.3389/fnins.2015.00500]; Johnstone DM, 2015, NEURAL REGEN RES, V10, P349, DOI 10.4103/1673-5374.153673; Kaelberer MM, 2018, SCIENCE, V361, P1219, DOI 10.1126/science.aat5236; KARU T, 1989, HEALTH PHYS, V56, P691, DOI 10.1097/00004032-198905000-00015; KARU TJ, 1983, NUOVO CIMENTO D, V2, P1138, DOI 10.1007/BF02457148; Kau AL, 2011, NATURE, V474, P327, DOI 10.1038/nature10213; Kelly JR, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00392; Kennedy PJ, 2017, NEUROPHARMACOLOGY, V112, P399, DOI 10.1016/j.neuropharm.2016.07.002; Kent A, 2018, J PAEDIATR CHILD H, V54, P27; Khan I, 2015, ADV WOUND CARE, V4, P724, DOI 10.1089/wound.2014.0623; Khuman J, 2012, J NEUROTRAUM, V29, P408, DOI 10.1089/neu.2010.1745; Kim B, 2018, IBRO REP, V4, P14, DOI 10.1016/j.ibror.2018.01.001; Kim B, 2017, AGEING RES REV, V37, P69, DOI 10.1016/j.arr.2017.05.005; Kimura I, 2011, P NATL ACAD SCI USA, V108, P8030, DOI 10.1073/pnas.1016088108; Kitai Takeshi, 2016, Curr Heart Fail Rep, V13, P103, DOI 10.1007/s11897-016-0285-9; Klingelhoefer L, 2017, INT REV NEUROBIOL, V134, P787, DOI 10.1016/bs.irn.2017.05.027; Klingelhoefer L, 2015, NAT REV NEUROL, V11, P625, DOI 10.1038/nrneurol.2015.197; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Koliada A, 2017, BMC MICROBIOL, V17, DOI 10.1186/s12866-017-1027-1; Komaroff AL, 2018, JAMA-J AM MED ASSOC, V319, P2381, DOI 10.1001/jama.2018.5240; Leone V, 2015, CELL HOST MICROBE, V17, P681, DOI 10.1016/j.chom.2015.03.006; Liang X, 2017, J BIOL RHYTHM, V32, P505, DOI 10.1177/0748730417729066; Liebert A, 2018, PHOTOMED LASER SURG, V36, P515, DOI 10.1089/pho.2018.4527; Liebert AD, 2016, J EXP NEUROSCI, V10, P1, DOI 10.4137/JEN.S33444; Liebert AD, 2014, MED HYPOTHESES, V82, P275, DOI 10.1016/j.mehy.2013.12.009; Lim CK, 2017, PROG NEUROBIOL, V155, P76, DOI 10.1016/j.pneurobio.2015.12.009; Lima PLV, 2019, J PHOTOCH PHOTOBIO B, V194, P71, DOI 10.1016/j.jphotobiol.2019.03.015; Lovelace MD, 2017, NEUROPHARMACOLOGY, V112, P373, DOI 10.1016/j.neuropharm.2016.03.024; Lozupone CA, 2012, NATURE, V489, P220, DOI 10.1038/nature11550; Luczynski P, 2017, ELIFE, V6, DOI 10.7554/eLife.25887; Luthold RV, 2017, METABOLISM, V69, P76, DOI 10.1016/j.metabol.2017.01.007; Mahony SMO, 2017, PAIN, V158, pS19, DOI 10.1097/j.pain.0000000000000779; Maier L, 2018, NATURE, V555, P623, DOI 10.1038/nature25979; Mariat D, 2009, BMC MICROBIOL, V9, DOI 10.1186/1471-2180-9-123; Marsland BJ, 2015, ANN AM THORAC SOC, V12, pS150, DOI 10.1513/AnnalsATS.201503-133AW; Mayer EA, 2015, J CLIN INVEST, V125, P926, DOI 10.1172/JCI76304; Mazidi M, 2016, DIABETES METAB SYND, V10, pS150, DOI 10.1016/j.dsx.2016.01.024; Meckel K, 2016, AM J CLIN NUTR, V104, P113, DOI 10.3945/ajcn.115.123786; Mester E., 1968, LASER REV, V1, P3; Milani C, 2016, SCI REP-UK, V6, DOI 10.1038/srep25945; Montagner A, 2016, SCI REP-UK, V6, DOI 10.1038/srep20127; Muili KA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0030655; Nakamura K, 2016, BIOSCI MICROB FOOD H, V35, P57, DOI 10.12938/bmfh.2015-019; Natoli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0072135; Neish AS, 2013, FREE RADICAL RES, V47, P950, DOI 10.3109/10715762.2013.833331; Nissila JS, 2017, CHRONOBIOL INT, V34, P37, DOI 10.1080/07420528.2016.1232269; Noseda R, 2017, P NATL ACAD SCI USA, V114, pE5683, DOI 10.1073/pnas.1708361114; Oldham MA, 2014, CHRONOBIOL INT, V31, P305, DOI 10.3109/07420528.2013.833935; Olsen I, 2016, J ORAL MICROBIOL, V8, DOI 10.3402/jom.v8.33029; Ondrusova K, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-16689-4; Ooi JH, 2013, J NUTR, V143, P1679, DOI 10.3945/jn.113.180794; Oron A, 2016, PHOTOMED LASER SURG, V34, P627, DOI 10.1089/pho.2015.4072; Oron U, 2001, CIRCULATION, V103, P296; Ottman N, 2017, BEST PRACT RES CL GA, V31, P637, DOI 10.1016/j.bpg.2017.10.001; Venegas DP, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00277; Paramsothy S, 2017, LANCET, V389, P1218, DOI 10.1016/S0140-6736(17)30182-4; Parashar A, 2017, PARKINSONISM RELAT D, V38, P1, DOI 10.1016/j.parkreldis.2017.02.002; Parekh PJ, 2014, FRONT ENDOCRINOL, V5, DOI 10.3389/fendo.2014.00047; Patra V, 2018, FRONT MED-LAUSANNE, V5, DOI [10.3389/fmed.2018.00166, 10.3339/fmed.2013.00166]; Pavlov VA, 2012, NAT REV ENDOCRINOL, V8, P743, DOI 10.1038/nrendo.2012.189; Perez-Pardo P, 2017, EUR J PHARMACOL, V817, P86, DOI 10.1016/j.ejphar.2017.05.042; Oliveira DAAP, 2009, PHOTOMED LASER SURG, V27, P461, DOI 10.1089/pho.2008.2290; Pistollato F, 2016, NUTR REV, V74, P624, DOI 10.1093/nutrit/nuw023; Purkayastha S, 2013, MOL METAB, V2, P356, DOI 10.1016/j.molmet.2013.09.005; Qin JJ, 2010, NATURE, V464, P59, DOI 10.1038/nature08821; Raza GS, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-05259-3; Ricci R, 2009, J PHOTOCH PHOTOBIO B, V95, P6, DOI 10.1016/j.jphotobiol.2008.11.007; Roager HM, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-05470-4; Rodriguez-Santana E, 2014, PHOTOMED LASER SURG, V32, P240, DOI 10.1089/pho.2013.3682; Rutten S, 2012, PARKINSONS DIS-US, V2012, DOI 10.1155/2012/767105; Salem I, 2018, FRONT MICROBIOL, V9, DOI 10.3389/fmicb.2018.01459; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Santana-Blank L, 2010, PHOTOMED LASER SURG, V28, pS173, DOI 10.1089/pho.2009.2745; Fernandes KPS, 2015, J PHOTOCH PHOTOBIO B, V153, P344, DOI 10.1016/j.jphotobiol.2015.10.015; Sekirov I, 2010, PHYSIOL REV, V90, P859, DOI 10.1152/physrev.00045.2009; Sherwin E, 2017, ANN NY ACAD SCI, V30, P1019; Sibley CH, 2016, OCUL IMMUNOL INFLAMM, V24, P460, DOI 10.1080/09273948.2016.1175641; Sikka G, 2014, P NATL ACAD SCI USA, V111, P17977, DOI 10.1073/pnas.1420258111; Singh MM, 2017, INTEGRATIVE ENV MED, P115; Song JW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00553-6; Song P, 2017, CELL MOL LIFE SCI, V74, P2899, DOI 10.1007/s00018-017-2504-2; Stone J, 2013, 9 WALT C GOLD COAST; Sun MF, 2018, BRAIN BEHAV IMMUN, V70, P48, DOI 10.1016/j.bbi.2018.02.005; Tang WHW, 2017, CIRC RES, V120, P1183, DOI 10.1161/CIRCRESAHA.117.309715; Taylor RC, 2014, NAT REV MOL CELL BIO, V15, P211, DOI 10.1038/nrm3752; Tetel MJ, 2018, J NEUROENDOCRINOL, V30, DOI 10.1111/jne.12548; Thaiss CA, 2016, CELL, V167, P1495, DOI 10.1016/j.cell.2016.11.003; Tilg H, 2011, J CLIN INVEST, V121, P2126, DOI 10.1172/JCI58109; Tremlett H, 2017, ANN NEUROL, V81, P369, DOI 10.1002/ana.24901; Tsimakouridze Elena V, 2015, Front Pharmacol, V6, P77, DOI 10.3389/fphar.2015.00077; Tuby H, 2011, LASER SURG MED, V43, P401, DOI 10.1002/lsm.21063; Turnbaugh PJ, 2009, J PHYSIOL-LONDON, V587, P4153, DOI 10.1113/jphysiol.2009.174136; Vandeputte D, 2017, GUT, V66, P1968, DOI 10.1136/gutjnl-2016-313271; Vandewalle G, 2010, P NATL ACAD SCI USA, V107, P19549, DOI 10.1073/pnas.1010180107; Vandewalle G, 2009, TRENDS COGN SCI, V13, P429, DOI 10.1016/j.tics.2009.07.004; Wang Y, 2017, SCI REP, V7, P415; Wang YG, 2017, BBA-GEN SUBJECTS, V1861, P441, DOI 10.1016/j.bbagen.2016.10.008; Wang YG, 2016, SCI REP-UK, V6, DOI 10.1038/srep33719; Wang ZN, 2011, NATURE, V472, P57, DOI 10.1038/nature09922; Willis GL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00741; Woting A, 2016, NUTRIENTS, V8, DOI 10.3390/nu8040202; Wu H, 2017, NAT MED, V23, P850, DOI 10.1038/nm.4345; Wu XM, 2016, J PHOTOCH PHOTOBIO B, V157, P89, DOI 10.1016/j.jphotobiol.2016.02.007; Wu ZH, 2010, LASER SURG MED, V42, P503, DOI 10.1002/lsm.20924; Yin K, 2017, STEM CELLS DEV, V26, P762, DOI 10.1089/scd.2016.0332; Zhang DC, 2015, NATURE, V525, P528, DOI 10.1038/nature15367; Zomorrodi R, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42693-x	174	15	16	1	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA		2578-5478		PHOTOBIOMOD PHOTOMED	Photobiomodulation Photomed. Laser Surg.	NOV 1	2019	37	11					681	693		10.1089/photob.2019.4628			13	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	JL5CN	WOS:000495548100003	31596658	hybrid, Green Published			2022-02-06	
J	Goetzl, EJ; Peltz, CB; Mustapic, M; Kapogiannis, D; Yaffe, K				Goetzl, Edward J.; Peltz, Carrie B.; Mustapic, Maja; Kapogiannis, Dimitrios; Yaffe, Kristine			Neuron-Derived Plasma Exosome Proteins after Remote Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						amyloid; biomarkers; phospho-tau; prion cellular protein; proteinopathic neurodegeneration; synaptogyrin-3	SYNAPTIC PROTEINS; IDENTIFICATION; PROGRESSION; DEMENTIA; STATE	To identify long-term effects of traumatic brain injury (TBI) on levels of plasma neuron-derived exosome (NDE) protein biomarkers of cognitive impairment (CI), plasmas were obtained from four groups of older veterans, who were matched for age and sex: no TBI or CI (n = 42), no TBI with CI (n = 19), TBI without CI (n = 21), and TBI with CI (n = 26). The TBI was sustained 12 to 74 years before the study in 75%. The NDEs were enriched by sequential precipitation and anti-L1CAM antibody immunoabsorption, and extracted protein biomarkers were quantified by enzyme-linked immunosorbent assays. Chronic NDE biomarkers known to increase for three to 12 months after TBI, including cellular prion protein (PrPc), synaptogyrin-3, P-T181-tau, P-S396-tau, A beta 42, and interleukin (IL)-6, were elevated significantly in subjects who had TBI and CI compared with controls with TBI but no CI. Chronic NDE biomarker levels in subjects without TBI showed significantly higher levels of PrPc, synaptogyrin-3, P-T181-tau, and A beta 42, but not P-S396-tau and IL-6, in those with CI compared with controls without CI. The acute NDE biomarkers claudin-5, annexin VII, and aquaporin-4 were not increased in either group with CI. The NDE biomarkers P-S396-tau and IL-6, which are increased distinctively with CI after TBI, may prove useful in evaluating CI in older patients. A beta 42 and P-tau species, as well as their respective putative receptors, PrPc and synaptogyrin-3, remain elevated for decades after TBI and may mediate TBI-associated CI and be useful targets for development of drugs.	[Goetzl, Edward J.] Univ Calif San Francisco, Dept Med, San Francisco, CA 94143 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol Psychiat, San Francisco, CA 94143 USA; [Peltz, Carrie B.; Yaffe, Kristine] San Francisco VA Med Ctr, 4150 Clement St, San Francisco, CA 94121 USA; [Peltz, Carrie B.] Northern Calif Inst Res & Educ, San Francisco, CA USA; [Mustapic, Maja; Kapogiannis, Dimitrios] NIA, Intramural Res Program, Baltimore, MD 21224 USA		Yaffe, K (corresponding author), San Francisco VA Med Ctr, 4150 Clement St, San Francisco, CA 94121 USA.; Goetzl, EJ (corresponding author), Geriatr Res Ctr, 1719 Broderick St, San Francisco, CA 94115 USA.	edward.goetzl@ucsf.edu; kristine.yaffe@ucsf.edu	Kapogiannis, Dimitrios/AAW-4934-2020; Mustapic, Maja/AAV-3212-2020	Kapogiannis, Dimitrios/0000-0003-2181-3118; 	Department of DefenseUnited States Department of Defense [W81XHW-14-2-0137]; Intramural Research Program of the National Institute on Aging of the National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA)	This research was supported in part by the Department of Defense (W81XHW-14-2-0137) (KY) and the Intramural Research Program of the National Institute on Aging of the National Institutes of Health (MM, DK). The authors thank the research participants, the Veterans Home of California in Yountville, CA, and the dedicated study staff, including Kim Kelley and Dan Freimer. The authors are grateful to J.H. Goetzl for expert preparation of the illustrations.	Agoston DV, 2017, BRAIN INJURY, V31, P1195, DOI 10.1080/02699052.2017.1357836; Barnes DE, 2018, JAMA NEUROL, V75, P1055, DOI 10.1001/jamaneurol.2018.0815; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Di Battista AP, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00044; Donohue MC, 2014, JAMA NEUROL, V71, P961, DOI 10.1001/jamaneurol.2014.803; Fiandaca MS, 2015, ALZHEIMERS DEMENT, V11, P600, DOI 10.1016/j.jalz.2014.06.008; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Goetzl EJ, 2019, FRONT NEUROSCI-SWITZ, V13, DOI 10.3389/fnins.2019.00452; Goetzl EJ, 2019, FASEB J, V33, P5082, DOI 10.1096/fj.201802319R; Goetzl EJ, 2018, FASEB J, V32, P888, DOI 10.1096/fj.201700731R; Goetzl EJ, 2016, FASEB J, V30, P4141, DOI 10.1096/fj.201600816R; Hawryluk Gregory W J, 2015, Handb Clin Neurol, V127, P15, DOI 10.1016/B978-0-444-52892-6.00002-7; Ivnik R.J., 1990, PSYCHOL ASSESSMENT J, V2, P304, DOI [10.1037/1040-3590.2.3.304, DOI 10.1037/1040-3590.2.3.304]; Jarosz-Griffiths HH, 2019, J BIOL CHEM, V294, P7085, DOI 10.1074/jbc.RA118.005364; Kenney Kimbra, 2018, Brain Inj, V32, P1276, DOI 10.1080/02699052.2018.1483530; Kim HJ, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.97105; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mustapic M, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00278; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Rey A., 1964, EXAMENCCLINIQUE PSYC; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roselli F, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00458; Shirk SD, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt94; Smith LM, 2019, J BIOL CHEM, V294, P6042, DOI 10.1074/jbc.RA118.006252; Tangalos, 1992, CLIN NEUROPSYCHOL, V6, P83, DOI [10.1080/13854049208401880, DOI 10.1080/13854049208401880]; Taylor E., 1959, PSYCHOL APPRAISAL CH; Werhane Madeleine L, 2017, Concussion, V2, pCNC30, DOI 10.2217/cnc-2016-0022; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018	31	15	16	3	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2020	37	2					382	388		10.1089/neu.2019.6711		OCT 2019	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JZ2YM	WOS:000489734100001	31441374	Green Published			2022-02-06	
J	Kang, JH; Sherill, GC; Sinha, SR; Swisher, CB				Kang, Jennifer H.; Sherill, G. Clay; Sinha, Saurabh R.; Swisher, Christa B.			A Trial of Real-Time Electrographic Seizure Detection by Neuro-ICU Nurses Using a Panel of Quantitative EEG Trends	NEUROCRITICAL CARE			English	Article						Quantitative EEG; qEEG; Seizures; ICU; EEG; Non-convulsive seizures	NONCONVULSIVE STATUS EPILEPTICUS; AMPLITUDE INTEGRATED EEG; TRAUMATIC BRAIN-INJURY; IDENTIFICATION; SENSITIVITY; ELECTROENCEPHALOGRAPHY; NEUROPHYSIOLOGISTS; ACCURACY; BURDEN	Background Non-convulsive seizures (NCS) are a common occurrence in the neurologic intensive care unit (Neuro-ICU) and are associated with worse outcomes. Continuous electroencephalogram (cEEG) monitoring is necessary for the detection of NCS; however, delays in interpretation are a barrier to early treatment. Quantitative EEG (qEEG) calculates a time-compressed simplified visual display from raw EEG data. This study aims to evaluate the performance of Neuro-ICU nurses utilizing bedside, real-time qEEG interpretation for detecting recurrent NCS. Methods This is a prospective, single-institution study of patients admitted to the Duke Neuro-ICU between 2016 and 2018 who had NCS identified on traditional cEEG review. The accuracy of recurrent seizure detection on hourly qEEG review by bedside Neuro-ICU nurses was compared to the gold standard of cEEG interpretation by two board-certified neurophysiologists. The nurses first received brief qEEG training, individualized for their specific patient. The bedside qEEG display consisted of rhythmicity spectrogram (left and right hemispheres) and amplitude-integrated EEG (left and right hemispheres) in 1-h epochs. Results Twenty patients were included and 174 1-h qEEG blocks were analyzed. Forty-seven blocks contained seizures (27%). The sensitivity was 85.1% (95% CI 71.1-93.1%), and the specificity was 89.8% (82.8-94.2%) for the detection of seizures for each 1-h block when compared to interpretation of conventional cEEG by two neurophysiologists. The false positive rate was 0.1/h. Hemispheric seizures (> 4 unilateral EEG electrodes) were more likely to be correctly identified by nurses on qEEG than focal seizures (<= 4 unilateral electrodes) (p = 0.03). Conclusions After tailored training sessions, Neuro-ICU nurses demonstrated a good sensitivity for the interpretation of bedside real-time qEEG for the detection of recurrent NCS with a low false positive rate. qEEG is a promising tool that may be used by non-neurophysiologists and may lead to earlier detection of NCS.	[Kang, Jennifer H.; Sherill, G. Clay; Sinha, Saurabh R.; Swisher, Christa B.] Duke Univ, Dept Neurol, Med Ctr, DUMC 2905, Durham, NC 27710 USA; [Sinha, Saurabh R.] Vet Affairs Med Ctr, Neurodiagnost Ctr, Durham, NC USA		Kang, JH (corresponding author), Duke Univ, Dept Neurol, Med Ctr, DUMC 2905, Durham, NC 27710 USA.	Jennifer.kang@duke.edu		Swisher, Christa/0000-0001-7753-7023; Kang, Jennifer/0000-0002-0859-3942	Donald B. Sanders Neurology Fellows Research Grant (Duke University)	This study was funded by the Donald B. Sanders Neurology Fellows Research Grant (Internal grant within Duke University).	Abend NS, 2011, NEUROLOGY, V76, P1071, DOI 10.1212/WNL.0b013e318211c19e; Akman CI, 2011, EPILEPSY RES, V93, P66, DOI 10.1016/j.eplepsyres.2010.10.018; Amorim E, 2017, J CLIN NEUROPHYSIOL, V34, P359, DOI 10.1097/WNP.0000000000000368; Brophy GM, 2012, NEUROCRIT CARE, V17, P3, DOI 10.1007/s12028-012-9695-z; Cheng JY, 2016, J NEUROL SCI, V370, P290, DOI 10.1016/j.jns.2016.10.004; Claassen J, 2004, NEUROLOGY, V62, P1743, DOI 10.1212/01.WNL.0000125184.88797.62; De Marchis GM, 2016, NEUROLOGY, V86, P253, DOI 10.1212/WNL.0000000000002281; DeLorenzo RJ, 1998, EPILEPSIA, V39, P833, DOI 10.1111/j.1528-1157.1998.tb01177.x; Dhiman V, 2013, EPILEPSIA, V54, P109; Evans E, 2010, ARCH DIS CHILD-FETAL, V95, pF169, DOI 10.1136/adc.2009.165969; Fernandez IS, 2018, NEUROLOGY, V90, pE1692, DOI 10.1212/WNL.0000000000005488; Friedman D, 2009, ANESTH ANALG, V109, P506, DOI 10.1213/ane.0b013e3181a9d8b5; Ganesan SL, 2018, CRIT CARE MED, V46, pE1105, DOI 10.1097/CCM.0000000000003385; Gavvala J, 2014, EPILEPSIA, V55, P1864, DOI 10.1111/epi.12809; Glauser T, 2016, EPILEPSY CURR, V16, P48, DOI 10.5698/1535-7597-16.1.48; Gutierrez-Viedma A, 2018, EPILEPSY BEHAV, V82, P11, DOI 10.1016/j.yebeh.2018.02.029; Haider HA, 2016, NEUROLOGY, V87, P935, DOI 10.1212/WNL.0000000000003034; Hill CE, 2017, ANN NEUROL, V82, P155, DOI 10.1002/ana.24986; Leitinger M, 2015, EPILEPSY BEHAV, V49, P158, DOI 10.1016/j.yebeh.2015.05.007; Mazarati AM, 1998, BRAIN RES, V814, P179, DOI 10.1016/S0006-8993(98)01080-4; McBride MC, 2000, NEUROLOGY, V55, P506, DOI 10.1212/WNL.55.4.506; Nitzschke R, 2011, J CLIN MONIT COMPUT, V25, P329, DOI 10.1007/s10877-011-9312-2; Payne ET, 2014, BRAIN, V137, P1429, DOI 10.1093/brain/awu042; Pisani F, 2008, J CHILD NEUROL, V23, P394, DOI 10.1177/0883073807309253; Rao SK, 2018, EPILEPTIC DISORD, V20, P265, DOI 10.1684/epd.2018.0987; Rennie JM, 2004, ARCH DIS CHILD-FETAL, V89, pF37, DOI 10.1136/fn.89.1.F37; Shellhaas RA, 2007, PEDIATRICS, V120, P770, DOI 10.1542/peds.2007-0514; Sinha SR, 2013, HANDBOOK OF ICU EEG MONITORING, P221; Swisher CB, 2016, J CLIN NEUROPHYSIOL, V33, P538, DOI 10.1097/WNP.0000000000000287; Swisher CB, 2015, J CLIN NEUROPHYSIOL, V32, P324, DOI 10.1097/WNP.0000000000000144; Towne AR, 2000, NEUROLOGY, V54, P340, DOI 10.1212/WNL.54.2.340; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Westover MB, 2015, CLIN NEUROPHYSIOL, V126, P463, DOI 10.1016/j.clinph.2014.05.037; Williamson CA, 2014, NEUROCRIT CARE, V20, P32, DOI 10.1007/s12028-013-9912-4	35	15	15	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	OCT	2019	31	2					312	320		10.1007/s12028-019-00673-z			9	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JA0OX	WOS:000487511700013	30788707				2022-02-06	
J	Marcus, HJ; Paine, H; Sargeant, M; Wolstenholme, S; Collins, K; Marroney, N; Arshad, Q; Tsang, K; Jones, B; Smith, R; Wilson, MH; Rust, HM; Seemungal, BM				Marcus, Hani J.; Paine, Heidi; Sargeant, Matthew; Wolstenholme, Susie; Collins, Katie; Marroney, Natalie; Arshad, Qadeer; Tsang, Kevin; Jones, Brynmor; Smith, Rebecca; Wilson, Mark H.; Rust, Heiko M.; Seemungal, Barry M.			Vestibular dysfunction in acute traumatic brain injury	JOURNAL OF NEUROLOGY			English	Article						Head trauma; Head injury; Concussion; Dizziness; Vertigo	HEAD-INJURY; VERTIGO	Traumatic brain injury (TBI) is the commonest cause of disability in under-40-year-olds. Vestibular features of dizziness (illusory self-motion) or imbalance which affects 50% of TBI patients at 5 years, increases unemployment threefold in TBI survivors. Unfortunately, vestibular diagnoses are cryptogenic in 25% of chronic TBI cases, impeding therapy. We hypothesized that chronic adaptive brain mechanisms uncouple vestibular symptoms from signs. This predicts a masking of vestibular diagnoses chronically but not acutely. Hence, defining the spectrum of vestibular diagnoses in acute TBI should clarify vestibular diagnoses in chronic TBI. There are, however, no relevant acute TBI data. Of 111 Major Trauma Ward adult admissions screened (median 38-years-old), 96 patients (87%) had subjective dizziness (illusory self-motion) and/or objective imbalance were referred to the senior author (BMS). Symptoms included: feeling unbalanced (58%), headache (50%) and dizziness (40%). In the 47 cases assessed by BMS, gait ataxia was the commonest sign (62%) with half of these cases denying imbalance when asked. Diagnoses included BPPV (38%), acute peripheral unilateral vestibular loss (19%), and migraine phenotype headache (34%), another potential source of vestibular symptoms. In acute TBI, vestibular signs are common, with gait ataxia being the most frequent one. However, patients underreport symptoms. The uncoupling of symptoms from signs likely arises from TBI affecting perceptual mechanisms. Hence, the cryptogenic nature of vestibular symptoms in TBI (acute or chronic) relates to a complex interaction between injury (to peripheral and central vestibular structures and perceptual mechanisms) and brain-adaptation, emphasizing the need for acute prospective, mechanistic studies.	[Marcus, Hani J.; Paine, Heidi; Wolstenholme, Susie; Collins, Katie; Marroney, Natalie; Arshad, Qadeer; Tsang, Kevin; Jones, Brynmor; Wilson, Mark H.; Rust, Heiko M.; Seemungal, Barry M.] Imperial Coll Healthcare NHS Trust, London, England; [Marcus, Hani J.; Sargeant, Matthew; Arshad, Qadeer; Smith, Rebecca; Rust, Heiko M.; Seemungal, Barry M.] Imperial Coll London, Neurootol Unit, Brain & Vestibular Grp BAVG, Room 10L 17,Charing Cross Campus, London W6 8RF, England		Seemungal, BM (corresponding author), Imperial Coll Healthcare NHS Trust, London, England.; Seemungal, BM (corresponding author), Imperial Coll London, Neurootol Unit, Brain & Vestibular Grp BAVG, Room 10L 17,Charing Cross Campus, London W6 8RF, England.	b.seemungal@imperial.ac.uk		Smith, Rebecca/0000-0003-2628-9861; Seemungal, Barry/0000-0002-6578-0904; Wilson, Mark/0000-0002-2346-4911	Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/P006493/1]; Imperial College NIHR Biomedical Research Centre; Imperial Charity [GG1516\100028]; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [MR/P006493/1] Funding Source: UKRI	This work was supported by the Medical Research Council (Grant no. MR/P006493/1), Imperial College NIHR Biomedical Research Centre (Grant no. P64219_WMCT), Imperial Charity (Grant no. GG1516\100028).	Abdo WF, 2006, J NEUROL NEUROSUR PS, V77, P1367, DOI 10.1136/jnnp.2006.091322; Arshad Q, 2017, CLIN NEUROL NEUROSUR, V155, P17, DOI 10.1016/j.clineuro.2017.01.021; BERMAN JM, 1978, J OTOLARYNGOL, V7, P237; Brandt T, 1999, LANCET, V354, P746, DOI 10.1016/S0140-6736(99)03179-7; Chamelian L, 2004, ARCH PHYS MED REHAB, V85, P1662, DOI 10.1016/j.apmr.2004.02.012; Gordon CR, 2004, ARCH NEUROL-CHICAGO, V61, P1590, DOI 10.1001/archneur.61.10.1590; Greenwood R, 2002, J NEUROL NEUROSUR PS, V73, pI8; Hoffer Michael E, 2007, Int Tinnitus J, V13, P69; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Sargeant M, 2018, J CONCUSSION, DOI [10.1177/2059700218808121., DOI 10.1177/2059700218808121]	10	15	15	2	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	OCT	2019	266	10					2430	2433		10.1007/s00415-019-09403-z			4	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JA6AF	WOS:000487923200008	31201499	Green Published, hybrid			2022-02-06	
J	Schweitzer, AD; Niogi, SN; Whitlow, CJ; Tsiouris, AJ				Schweitzer, Andrew D.; Niogi, Sundt N.; Whitlow, Christopher J.; Tsiouris, A. John			Traumatic Brain Injury: Imaging Patterns and Complications	RADIOGRAPHICS			English	Article							DIFFUSE AXONAL INJURY; VENOUS SINUS THROMBOSIS; GLASGOW COMA SCALE; MAGNETIC-RESONANCE; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; WHITE-MATTER; HEAD-INJURY; PROGNOSTIC VALUE; OUTCOME PREDICTION	While the diagnosis of traumatic brain injury (TBI) is a clinical decision, neuroimaging remains vital for guiding management on the basis of identification of intracranial pathologic conditions. CT is the mainstay of imaging of acute TBI for both initial triage and follow-up, as it is fast and accurate in detecting both primary and secondary injuries that require neurosurgical intervention. MRI is more sensitive for the detection of certain intracranial injuries (eg, axonal injuries) and blood products 24-48 hours after injury, but it has limitations (eg, speed, accessibility, sensitivity to motion, and cost). The evidence primarily supports the use of MRI when CT findings are normal and there are persistent unexplained neurologic findings or at subacute and chronic periods. Radiologists should understand the role and optimal imaging modality to use, in addition to patterns of primary brain injury and their influence on the risk of developing secondary brain injuries related to herniation. (C) RSNA, 2019	[Schweitzer, Andrew D.; Niogi, Sundt N.; Tsiouris, A. John] New York Presbyterian Hosp, Weill Cornell Med, Dept Radiol, 525 E 68th St,Starr 630C, New York, NY 10075 USA; [Whitlow, Christopher J.] Wake Forest Sch Med, Dept Radiol, Winston Salem, NC USA		Tsiouris, AJ (corresponding author), New York Presbyterian Hosp, Weill Cornell Med, Dept Radiol, 525 E 68th St,Starr 630C, New York, NY 10075 USA.	apt9001@med.cornell.edu	Schweitzer, Andrew/M-3702-2013	Schweitzer, Andrew/0000-0001-9538-8076	ACR	S.N.N. Activities related to the present article: grant from the ACR to develop TBIRADS. Activities not related to the present article: disclosed no relevant relationships. Other activities: disclosed no relevant relationships. A.J.T. Activities related to the present article: disclosed no relevant relationships. Activities not related to the present article: blinded structured expert readings for clinical trails for BioClinica, Parexel, and ICON; expert medicolegal testimony for medical negligence and personal injury litigation, primarily for TBI that involves DTI. Other activities: disclosed no relevant relationships.	Abe O, 2002, NEUROBIOL AGING, V23, P433, DOI 10.1016/S0197-4580(01)00318-9; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Al-Nakshabandi NA, 2001, RADIOLOGY, V218, P433, DOI 10.1148/radiology.218.2.r01fe09433; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Allen B, 2017, DIAGNOSIS, V4, P113, DOI 10.1515/dx-2017-0020; Almandoz JED, 2010, RADIOLOGY, V255, P570, DOI 10.1148/radiol.10091565; Anon J, 2008, J MAGN RESON IMAGING, V28, P823, DOI 10.1002/jmri.21495; Bae Dong-Hyeon, 2014, Korean J Neurotrauma, V10, P35, DOI 10.13004/kjnt.2014.10.2.35; Ban SP, 2018, RADIOLOGY, V286, P909, DOI 10.1148/radiol.2017170053; Baugnon KL, 2014, NEUROIMAG CLIN N AM, V24, P439, DOI 10.1016/j.nic.2014.03.001; Beauchamp MH, 2011, J NEUROTRAUM, V28, P915, DOI 10.1089/neu.2010.1712; Bender AR, 2016, NEUROIMAGE, V125, P74, DOI 10.1016/j.neuroimage.2015.10.030; Biffl WL, 1999, AM J SURG, V178, P517, DOI 10.1016/S0002-9610(99)00245-7; Bodanapally UK, 2017, AM J NEURORADIOL, V38, P1946, DOI 10.3174/ajnr.A5318; Bodanapally UK, 2015, J NEUROSURG, V122, P219, DOI 10.3171/2014.9.JNS14679; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Brown JB, 2014, J TRAUMA ACUTE CARE, V77, P95, DOI 10.1097/TA.0000000000000280; Chieregato A, 2005, NEUROSURGERY, V56, P671, DOI 10.1227/01.NEU.0000156200.76331.7A; Chou R., 2017, GLASGOW COMA SCALE F; Cicuendez M, 2018, J NEURORADIOL; Cothren CC, 2003, J TRAUMA, V55, P811, DOI 10.1097/01.TA.0000092700.92587.32; Cramer JA, 2014, APPL RADIOL; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Ellis H, 2012, SURGERY, V30, P99; Ezaki Y, 2006, ACTA RADIOL, V47, P733, DOI 10.1080/02841850600771486; Franz RW, 2012, J AM COLL SURGEONS, V214, P313, DOI 10.1016/j.jamcollsurg.2011.11.012; Fujii Y, 2009, J TRAUMA, V66, P1002, DOI 10.1097/TA.0b013e31819a0277; Gean AD, 2010, RADIOLOGY, V257, P212, DOI 10.1148/radiol.10092075; GENTRY LR, 1988, AM J ROENTGENOL, V150, P673, DOI 10.2214/ajr.150.3.673; Geurts BHJ, 2012, BRAIN INJURY, V26, P1439, DOI 10.3109/02699052.2012.694563; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Haghbayan H, 2017, CRIT CARE MED, V45, pe1280, DOI 10.1097/CCM.0000000000002731; HAN JS, 1984, RADIOLOGY, V150, P71, DOI 10.1148/radiology.150.1.6689790; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hergan K, 2002, EUR RADIOL, V12, P2536, DOI 10.1007/s00330-002-1333-2; HESSELINK JR, 1988, AM J ROENTGENOL, V150, P1133; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; James SL, 2019, LANCET NEUROL, V18, P56, DOI 10.1016/S1474-4422(18)30415-0; Johnson NF, 2013, AGE, V35, P2045, DOI 10.1007/s11357-012-9493-8; Johnson PL, 2002, NEUROIMAG CLIN N AM, V12, P217, DOI 10.1016/S1052-5149(02)00008-4; Kara A, 2008, TURK NEUROSURG, V18, P1; KELLY AB, 1988, AM J NEURORADIOL, V9, P699; Kim SC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102229; Lemkaddem A, 2012, NEUROIMAGE, V62, P87, DOI 10.1016/j.neuroimage.2012.04.045; Li X, 2016, EUR RADIOL, V26, P2899, DOI 10.1007/s00330-015-4116-2; Link TW, 2019, NEUROSURGERY, V85, P801, DOI 10.1093/neuros/nyy521; Liu AY, 1999, AM J NEURORADIOL, V20, P1636; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Management of Concussion/mTBI Working Group, 2009, J Rehabil Res Dev, V46, pCP1; Marincowitz C, 2018, J NEUROTRAUM, V35, P703, DOI 10.1089/neu.2017.5259; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Mata-Mbemba D, 2018, J NEUROSURG, V129, P1317, DOI 10.3171/2017.6.JNS17466; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Mitchell P, 2001, J NEUROL NEUROSUR PS, V70, P205, DOI 10.1136/jnnp.70.2.205; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Noguchi K, 2000, AM J NEURORADIOL, V21, P923; Noguchi K, 1997, RADIOLOGY, V203, P257, DOI 10.1148/radiology.203.1.9122404; Ohtani T, 2017, NEUROSCIENCE, V341, P52, DOI 10.1016/j.neuroscience.2016.11.002; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Peres CMA, 2018, J NEUROSURG, V128, P1044, DOI 10.3171/2016.11.JNS161398; Perrein A, 2015, MINERVA ANESTESIOL, V81, P1219; Ricciardi MC, 2017, J NEUROTRAUM, V34, P23, DOI 10.1089/neu.2015.4338; Rischall MA, 2016, AM J ROENTGENOL, V207, P852, DOI 10.2214/AJR.15.15972; Rivkin MA, 2014, ACTA NEUROCHIR, V156, P999, DOI 10.1007/s00701-014-2025-9; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rutman AM, 2018, RADIOGRAPHICS, V38, P542, DOI 10.1148/rg.2018170140; Saeki N, 1998, BRIT J NEUROSURG, V12, P151, DOI 10.1080/02688699845302; Salmela MB, 2017, J AM COLL RADIOL, V14, pS34, DOI 10.1016/j.jacr.2017.01.051; Scheid R, 2007, J NEUROTRAUM, V24, P1811, DOI 10.1089/neu.2007.0382; Servadei F, 2002, NEUROSURGERY, V50, P261, DOI 10.1097/00006123-200202000-00006; Shetty T, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00836; Shetty VS, 2016, J AM COLL RADIOL, V13, P668, DOI 10.1016/j.jacr.2016.02.023; Sieswerda-Hoogendoorn T, 2014, EUR J RADIOL, V83, P1257, DOI 10.1016/j.ejrad.2014.03.015; Slasky SE, 2017, J COMPUT ASSIST TOMO, V41, P891, DOI 10.1097/RCT.0000000000000620; SNOW RB, 1986, NEUROSURGERY, V18, P45, DOI 10.1227/00006123-198601000-00008; Sperry JL, 2013, J TRAUMA ACUTE CARE, V75, P936, DOI 10.1097/TA.0b013e31829e20e3; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Sussman ES, 2018, HAND CLINIC, V158, P21, DOI 10.1016/B978-0-444-63954-7.00003-3; TAKENAKA N, 1990, SURG NEUROL, V34, P30, DOI 10.1016/0090-3019(90)90169-P; Tawil I, 2008, J TRAUMA, V64, P849, DOI 10.1097/TA.0b013e318160c08a; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Trifan G, 2017, MAGN RESON IMAGING, V37, P243, DOI 10.1016/j.mri.2016.12.009; Unterberg AW, 2004, NEUROSCIENCE, V129, P1021, DOI 10.1016/j.neuroscience.2004.06.046; Vezina G, 2009, PEDIATR RADIOL, V39, P586, DOI 10.1007/s00247-009-1212-y; Wei SC, 2010, AM J NEURORADIOL, V31, P334, DOI 10.3174/ajnr.A1824; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White NS, 2013, HUM BRAIN MAPP, V34, P327, DOI 10.1002/hbm.21454; Wintermark M, 2018, J NEUROTRAUM, V35, P2665, DOI 10.1089/neu.2017.5311; Wintermark Max, 2015, J Am Coll Radiol, V12, pe1, DOI 10.1016/j.jacr.2014.10.014; Woodcock RJ, 2001, AM J NEURORADIOL, V22, P1698; Xie Y, 2017, AM J NEURORADIOL, V38, P617, DOI 10.3174/ajnr.A5042; Xiong Y, 2017, J MAGN RESON IMAGING, V45, P1371, DOI 10.1002/jmri.25463; Yue JK, 2018, NEUROL RES, V40, P972, DOI 10.1080/01616412.2018.1505416; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Yuh EL, 2012, J NEUROTRAUM, V29, P735, DOI 10.1089/neu.2011.2008; Zanini MA, 2008, J TRAUMA, V64, P705, DOI 10.1097/TA.0b013e3180485cfc; Zayas JO, 2011, RADIOGRAPHICS, V31, P1741, DOI 10.1148/rg.316115506; Zhang H, 2012, NEUROIMAGE, V61, P1000, DOI 10.1016/j.neuroimage.2012.03.072; ZIMMERMAN RA, 1986, AM J ROENTGENOL, V147, P1215, DOI 10.2214/ajr.147.6.1215; Zouros A, 2004, J NEUROSURG, V100, P512, DOI 10.3171/ped.2004.100.5.0512	108	15	15	1	6	RADIOLOGICAL SOC NORTH AMERICA	OAK BROOK	820 JORIE BLVD, OAK BROOK, IL 60523 USA	0271-5333			RADIOGRAPHICS	Radiographics	OCT	2019	39	6			SI		1571	+		10.1148/rg.2019190076			25	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	JC2MD	WOS:000489110200002	31589576				2022-02-06	
J	Swartz, EE; Myers, JL; Cook, SB; Guskiewicz, KM; Ferrara, MS; Cantu, RC; Chang, H; Broglio, SP				Swartz, Erik E.; Myers, Jay L.; Cook, Summer B.; Guskiewicz, Kevin M.; Ferrara, Michael S.; Cantu, Robert C.; Chang, Hong; Broglio, Steven P.			A helmetless-tackling intervention in American football for decreasing head impact exposure: A randomized controlled trial	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Athletic injuries; Adolescent; Risk reduction behavior; Concussion; Tackling	HIGH-SCHOOL FOOTBALL; RISK-TAKING; CONCUSSION; PLAYERS; ACQUISITION; PERFORMANCE; DEVICES; INJURY; BRAIN; SPINE	Objectives: To evaluate a behavioral intervention to reduce head impact exposure in youth playing American football. Design: Nested randomized controlled trial. Methods: Participants, ages 14-17 years, wore head impact sensors (SIM-G (TM)) during two seasons of play. Those randomized to the intervention group underwent weekly tackling/blocking drills performed without helmets (WoH) and shoulder pads while the control group trained as normal, matching frequency and duration. Research personnel provided daily oversight to maintain fidelity. Head impact frequency (>= 10 g) per athlete exposure (ImpAE) was analyzed over time (two 11-week seasons) using mixed effect models or ANCOVA. Secondary outcomes included exposure-type (training, game) and participation level (entry-level versus upper-level secondary education). Results: One-hundred fifteen participants (59 WoH, 56 control) met compliance criteria, contributing 47,382 head impacts and 10,751 athlete exposures for analysis. WoH had fewer ImpAE during games compared to control participants at weeks 4 (p = 0.0001 season 1, p = 0.0005 season 2) and 7 (p = 0.0001 both seasons). Upper-level WoH participants had less ImpAE during games than their matched controls at weeks 4 (p = 0.017 and p = 0.026) and 7 (p = 0.037 and p = 0.014) in both seasons, respectively. Upper-level WoH also had fewer ImpAE during training at week 7 (p = 0.015) in season one. Conclusions: Tackling and blocking drills performed without a helmet during training reduced the frequency of head impacts during play, especially during games. However, these differences disappeared by the end of the season. Future research should explore the frequency of behavioral intervention and a dose-response relationship considering years of player experience. (C) 2019 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Swartz, Erik E.; Myers, Jay L.] Univ Massachusetts Lowell, Dept Phys Therapy & Kinesiol, Lowell, MA 01854 USA; [Guskiewicz, Kevin M.] Univ N Carolina, Chapel Hill, NC USA; [Cantu, Robert C.] Emerson Hosp, Dept Neurosurg, Concord, MA USA; [Chang, Hong] Tufts Univ, Clin & Translat Sci Inst, Medford, MA 02155 USA; [Broglio, Steven P.] Univ Michigan, Sch Kinesiol, Ann Arbor, MI 48109 USA; [Swartz, Erik E.; Myers, Jay L.; Cook, Summer B.; Ferrara, Michael S.] Univ New Hampshire, Dept Kinesiol, Durham, NH 03824 USA		Swartz, EE (corresponding author), Univ Massachusetts Lowell, Dept Phys Therapy & Kinesiol, Lowell, MA 01854 USA.; Swartz, EE (corresponding author), Univ New Hampshire, Dept Kinesiol, Durham, NH 03824 USA.	erik_swartz@uml.edu			NineSigma Head Health Challenge 2 (Cleveland) [01-1]; National Football League; Under Armour; General ElectricGeneral Electric	This work was grant supported by the NineSigma Head Health Challenge 2 (Cleveland, 01-1). Study sponsors, National Football League, General Electric, and Under Armour, had no role in the (1) study design; (2) the collection, analysis, and interpretation of data; (3) the writing of the report; or (4) the decision to submit the manuscript for publication.	Brennan JH, 2017, SPORTS MED, V47, P469, DOI 10.1007/s40279-016-0582-1; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2013, AM J SPORT MED, V41, P2877, DOI 10.1177/0363546513502458; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Broglio SP, 2011, NEW ENGL J MED, V365, P279, DOI 10.1056/NEJMc1102689; Broglio SP, 2009, J ATHL TRAINING, V44, P342, DOI 10.4085/1062-6050-44.4.342; Campbell KR, 2016, J ATHL TRAINING, V51, pS; Colley Rachel, 2010, Health Rep, V21, P63; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Dompier TP, 2015, JAMA PEDIATR, V169, P659, DOI 10.1001/jamapediatrics.2015.0210; Ericsson KA, 2008, ACAD EMERG MED, V15, P988, DOI 10.1111/j.1553-2712.2008.00227.x; Gamble T, 2016, PSYCHOL SCI, V27, P289, DOI 10.1177/0956797615620784; Karton C, 2016, 34 INT C BIOM SPORTS; Keilman J., 2015, CHICAGO TRIBUNE; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115594578; Kerr ZY, 2014, PEDIATRICS, V134, P489, DOI 10.1542/peds.2014-0770; King DA, 2016, J NEUROSURG-PEDIATR, V18, P65, DOI 10.3171/2015.12.PEDS15605; Kontos AP, 2004, J PEDIATR PSYCHOL, V29, P447, DOI 10.1093/jpepsy/jsh048; Kucera KL, 2017, MMWR-MORBID MORTAL W, V65, P1465, DOI 10.15585/mmwr.mm6552a2; Martini D, 2013, MED SCI SPORT EXER, V45, P755, DOI 10.1249/MSS.0b013e3182798758; McIntosh AS, 2001, BRIT J SPORT MED, V35, P167, DOI 10.1136/bjsm.35.3.167; O'Connor KL, 2017, J ATHL TRAINING, V52, P206, DOI 10.4085/1062-6050.52.2.05; Oeur RA, 2016, 34 INT C BIOM SPORTS; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Torg JS, 2002, J BONE JOINT SURG AM, V84A, P112, DOI 10.2106/00004623-200201000-00017; TUKEY JW, 1962, ANN MATH STAT, V33, P1, DOI 10.1214/aoms/1177704711; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Viano DC, 2012, ANN BIOMED ENG, V40, P175, DOI 10.1007/s10439-011-0395-1; Wegman E, 1999, PERCEPT MOTOR SKILL, V88, P182, DOI 10.2466/PMS.88.1.182-187; Wilde G J, 1998, Inj Prev, V4, P89	33	15	14	0	3	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	OCT	2019	22	10					1102	1107		10.1016/j.jsams.2019.05.018			6	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	JF2LX	WOS:000491218000009	31204104				2022-02-06	
J	van de Wouw, M; Boehme, M; Dinan, TG; Cryan, JF				van de Wouw, Marcel; Boehme, Marcus; Dinan, Timothy G.; Cryan, John F.			Monocyte mobilisation, microbiota & mental illness	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Microbiota; Monocytes; Brain; Behaviour; Immune system; Stress; Ageing; Traumatic brain injury; Stroke; Neurodegeneration	TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; CHAIN FATTY-ACIDS; REPEATED SOCIAL DEFEAT; CHEMOKINE RECEPTOR 2; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; INTERNATIONAL SCIENTIFIC ASSOCIATION; IMPROVES COGNITIVE FUNCTION; TRANSGENIC MOUSE MODEL; GUT MICROBIOTA	The gastrointestinal microbiome has emerged as a key player in regulating brain and behaviour. This has led to the strategy of targeting the gut microbiota to ameliorate disorders of the central nervous system. Understanding the underlying signalling pathways in which the microbiota impacts these disorders is crucial for the development of future therapeutics for improving CNS functionality. One of the major pathways through which the microbiota influences the brain is the immune system, where there is an increasing appreciation for the role of monocyte trafficking in regulating brain homeostasis. In this review, we will shed light on the role of monocyte trafficking as a relay of microbiota signals in conditions where the central nervous system is in disorder, such as stress, peripheral inflammation, ageing, traumatic brain injury, stroke, multiple sclerosis, Alzheimer's disease and Parkinson's disease. We also cover how the gastrointestinal microbiota is implicated in these mental illnesses. In addition, we aim to discuss how the monocyte system can be modulated by the gut microbiota to mitigate disorders of the central nervous system, which will lead to novel microbiota-targeted strategies.	[van de Wouw, Marcel; Boehme, Marcus; Dinan, Timothy G.; Cryan, John F.] Univ Coll Cork, APC Microbiome Ireland, Cork, Ireland; [Dinan, Timothy G.] Univ Coll Cork, Dept Psychiat & Neurobehav Sci, Cork, Ireland; [Boehme, Marcus; Cryan, John F.] Univ Coll Cork, Dept Anat & Neurosci, Cork, Ireland		Cryan, JF (corresponding author), Univ Coll Cork, Dept Anat & Neurosci, APC Microbiome Ireland, Cork, Ireland.	j.cryan@ucc.ie	Dinan, Timothy/ABA-8284-2020; Cryan, John F./A-6950-2013; Boehme, Marcus/D-7460-2019	Cryan, John F./0000-0001-5887-2723; Boehme, Marcus/0000-0002-5678-8226; van de Wouw, Marcel/0000-0002-2607-314X	Science Foundation Ireland (SFI) through the Irish Government's National Development PlanScience Foundation Ireland [SFI/12/RC/2273]; SFI Grant AMBROSIAC [15/JP-HDHL/3270]	The APC Microbiome Institute is a research institute funded by Science Foundation Ireland (SFI) through the Irish Government's National Development Plan (Grant No. SFI/12/RC/2273), and SFI Grant AMBROSIAC (15/JP-HDHL/3270).	Aguilar-Toala JE, 2018, TRENDS FOOD SCI TECH, V75, P105, DOI 10.1016/j.tifs.2018.03.009; Aho VTE, 2019, EBIOMEDICINE, V44, P691, DOI 10.1016/j.ebiom.2019.05.064; Ajami B, 2007, NAT NEUROSCI, V10, P1538, DOI 10.1038/nn2014; Ajami B, 2011, NAT NEUROSCI, V14, P1142, DOI 10.1038/nn.2887; Akbari E, 2016, FRONT AGING NEUROSCI, V8, DOI 10.3389/fnagi.2016.00256; Allen AP, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.191; Andersson Hannah, 2016, Int J Microbiol, V2016, P8469018, DOI 10.1155/2016/8469018; Andonegui G, 2018, JCI INSIGHT, V3, DOI 10.1172/jci.insight.99364; Ang ZW, 2016, SCI REP-UK, V6, DOI 10.1038/srep34145; ARZT E, 1991, LIFE SCI, V48, P2557, DOI 10.1016/0024-3205(91)90612-F; Atashrazm F, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-33921-x; Auffray C, 2007, SCIENCE, V317, P666, DOI 10.1126/science.1142883; Bailey MT, 2007, AM J PHYSIOL-REG I, V293, pR1180, DOI 10.1152/ajpregu.00307.2007; Bailey MT, 2011, BRAIN BEHAV IMMUN, V25, P397, DOI 10.1016/j.bbi.2010.10.023; Bakker G.J., 2017, MICROBIOL SPECTR, V5, P5, DOI [10.1128/microbiolspec.BAD-0008-2017, DOI 10.1128/microbiolspec.BAD-0008-2017, DOI 10.1128/MICROBIOLSPEC.BAD-0008-2017]; Balmer ML, 2014, J IMMUNOL, V193, P5273, DOI 10.4049/jimmunol.1400762; Barichella M, 2019, MOVEMENT DISORD, V34, P396, DOI 10.1002/mds.27581; Barrera-Bugueno C, 2017, NEUROSCIENCE, V359, P18, DOI 10.1016/j.neuroscience.2017.06.064; Baufeld C, 2018, J NEURAL TRANSM, V125, P809, DOI 10.1007/s00702-017-1795-7; Benakis C, 2016, NAT MED, V22, P516, DOI 10.1038/nm.4068; Berer K, 2017, P NATL ACAD SCI USA, V114, P10719, DOI 10.1073/pnas.1711233114; Bettcher BM, 2019, FRONT AGING NEUROSCI, V11, DOI 10.3389/fnagi.2019.00025; Bharwani A, 2017, BMC MED, V15, DOI 10.1186/s12916-016-0771-7; Bhatnagar S, 2006, J NEUROENDOCRINOL, V18, P13, DOI 10.1111/j.1365-2826.2005.01375.x; Biagi E, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0010667; Bindels LB, 2015, NAT REV GASTRO HEPAT, V12, P303, DOI 10.1038/nrgastro.2015.47; Bloemen JG, 2009, CLIN NUTR, V28, P657, DOI 10.1016/j.clnu.2009.05.011; Boehme M, 2020, MOL PSYCHIATR, V25, P2567, DOI 10.1038/s41380-019-0425-1; Bonaz B, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00049; Bonfili L, 2018, MOL NEUROBIOL, V55, P7987, DOI 10.1007/s12035-018-0973-4; Bonfili L, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-02587-2; Bordon Y, 2014, NAT REV IMMUNOL, V14, P713, DOI 10.1038/nri3759; Brattsand R, 1996, ALIMENT PHARM THERAP, V10, P81, DOI 10.1046/j.1365-2036.1996.22164025.x; Bravo JA, 2011, P NATL ACAD SCI USA, V108, P16050, DOI 10.1073/pnas.1102999108; Brazaitis M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0109020; Brenner LA, 2017, BRAIN BEHAV IMMUN, V65, P57, DOI 10.1016/j.bbi.2017.06.003; Bruunsgaard H, 1999, J GERONTOL A-BIOL, V54, pM357, DOI 10.1093/gerona/54.7.M357; Burokas A, 2017, BIOL PSYCHIAT, V82, P472, DOI 10.1016/j.biopsych.2016.12.031; Butovsky O, 2014, NAT NEUROSCI, V17, P131, DOI 10.1038/nn.3599; Campbell CL, 2019, DIABET METAB SYND OB, V12, P97, DOI 10.2147/DMSO.S192228; Canivet C, 2019, J NEUROVIROL, V25, P372, DOI 10.1007/s13365-019-00730-5; Cavaillon JM, 2018, TOXICON, V149, P45, DOI 10.1016/j.toxicon.2017.10.016; Cekanaviciute E, 2017, P NATL ACAD SCI USA, V114, P10713, DOI 10.1073/pnas.1711235114; Chen J, 2016, SCI REP-UK, V6, DOI 10.1038/srep28484; Chen ML, 2016, MBIO, V7, DOI 10.1128/mBio.02210-15; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Chou A, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19061616; Chung YC, 2014, J FUNCT FOODS, V10, P465, DOI 10.1016/j.jff.2014.07.007; Cignarella F, 2018, CELL METAB, V27, P1222, DOI 10.1016/j.cmet.2018.05.006; Claesson MJ, 2012, NATURE, V488, P178, DOI 10.1038/nature11319; Clarke G, 2013, MOL PSYCHIATR, V18, P666, DOI 10.1038/mp.2012.77; Cleophas MCP, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-018-37246-7; Cloez-Tayarani I, 2003, INT IMMUNOL, V15, P233, DOI 10.1093/intimm/dxg027; Collins SM, 2012, NAT REV MICROBIOL, V10, P735, DOI 10.1038/nrmicro2876; Columba-Cabezas S, 2002, J NEUROIMMUNOL, V130, P10, DOI 10.1016/S0165-5728(02)00170-4; Cooper MA, 2010, PHYSIOL BEHAV, V101, P527, DOI 10.1016/j.physbeh.2010.08.003; Jordao MJC, 2019, SCIENCE, V363, P365, DOI 10.1126/science.aat7554; Costantini L, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122645; Coutinho AE, 2011, MOL CELL ENDOCRINOL, V335, P2, DOI 10.1016/j.mce.2010.04.005; Crapser J, 2016, AGING-US, V8, P1049, DOI 10.18632/aging.100952; Cronk JC, 2018, J EXP MED, V215, P1627, DOI 10.1084/jem.20180247; Cryan J. F., 2019, PHYSL REV; Cryan JF, 2012, NAT REV NEUROSCI, V13, P701, DOI 10.1038/nrn3346; CUMMINGS JH, 1987, GUT, V28, P1221, DOI 10.1136/gut.28.10.1221; D'Mello C, 2017, GASTROENTEROLOGY, V153, P1416, DOI 10.1053/j.gastro.2017.08.011; D'Mello C, 2015, J NEUROSCI, V35, P10821, DOI 10.1523/JNEUROSCI.0575-15.2015; D'Mello C, 2013, J NEUROSCI, V33, P14878, DOI 10.1523/JNEUROSCI.1329-13.2013; D'Mello C, 2009, J NEUROSCI, V29, P2089, DOI 10.1523/JNEUROSCI.3567-08.2009; Dalmasso M, 2014, TRENDS MICROBIOL, V22, P399, DOI 10.1016/j.tim.2014.02.010; Dantzer R, 2008, NAT REV NEUROSCI, V9, P46, DOI 10.1038/nrn2297; Dantzer R, 2014, TRENDS NEUROSCI, V37, P39, DOI 10.1016/j.tins.2013.10.003; de Arruda ISF, 2004, CLIN SCI, V106, P287, DOI 10.1042/CS20030251; de las Casas-Engel M, 2013, J IMMUNOL, V190, P2301, DOI 10.4049/jimmunol.1201133; Derrien M, 2015, TRENDS MICROBIOL, V23, P354, DOI 10.1016/j.tim.2015.03.002; Dhabhar FS, 2012, PSYCHONEUROENDOCRINO, V37, P1345, DOI 10.1016/j.psyneuen.2012.05.008; DHABHAR FS, 1994, BRAIN BEHAV IMMUN, V8, P66, DOI 10.1006/brbi.1994.1006; Dhabhar FS, 1996, J IMMUNOL, V156, P2608; DHABHAR FS, 1995, J IMMUNOL, V154, P5511; Dhaliwal J, 2018, J APPL MICROBIOL, V125, P257, DOI 10.1111/jam.13765; Dinan TG, 2013, BIOL PSYCHIAT, V74, P720, DOI 10.1016/j.biopsych.2013.05.001; Diop L, 2008, NUTR RES, V28, P1, DOI 10.1016/j.nutres.2007.10.001; Doherty FD, 2018, BRAIN BEHAV IMMUN, V68, P261, DOI 10.1016/j.bbi.2017.10.024; Drevets DA, 2004, J IMMUNOL, V172, P4418, DOI 10.4049/jimmunol.172.7.4418; Durk T, 2005, INT IMMUNOL, V17, P599, DOI 10.1093/intimm/dxh242; Ehrchen J, 2007, BLOOD, V109, P1265, DOI 10.1182/blood-2006-02-001115; El Khoury J, 2007, NAT MED, V13, P432, DOI 10.1038/nm1555; Engler H, 2005, J NEUROIMMUNOL, V163, P110, DOI 10.1016/j.jneuroim.2005.03.002; Engler H, 2004, J NEUROIMMUNOL, V148, P106, DOI 10.1016/j.jneuroim.2003.11.011; Engler H, 2008, PSYCHONEUROENDOCRINO, V33, P108, DOI 10.1016/j.psyneuen.2007.10.007; Erny D, 2015, NAT NEUROSCI, V18, P965, DOI 10.1038/nn.4030; FAUCI AS, 1974, J CLIN INVEST, V53, P240, DOI 10.1172/JCI107544; Fife BT, 2000, J EXP MED, V192, P899, DOI 10.1084/jem.192.6.899; Finger BC, 2011, NEUROSCIENCE, V192, P351, DOI 10.1016/j.neuroscience.2011.06.072; Fischer HJ, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01200; Foertsch S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-15897-2; Franceschi C, 2000, ANN NY ACAD SCI, V908, P244; Frank MG, 2010, BRAIN BEHAV IMMUN, V24, P19, DOI 10.1016/j.bbi.2009.07.008; Fransen F, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01385; Frasca D, 2016, BIOGERONTOLOGY, V17, P7, DOI 10.1007/s10522-015-9578-8; Fuchsl AM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0084161; Fukui H, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-30943-3; Fulling C, 2019, NEURON, V101, P998, DOI 10.1016/j.neuron.2019.02.008; Galley JD, 2017, SCI REP-UK, V7, DOI 10.1038/srep45012; Galley JD, 2014, BMC MICROBIOL, V14, DOI 10.1186/1471-2180-14-189; Garcia-Bonilla L, 2018, J NEUROSCI, V38, P6722, DOI 10.1523/JNEUROSCI.0324-18.2018; Garre JM, 2017, NAT MED, V23, P714, DOI 10.1038/nm.4340; Ge RM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0909-3; Geissmann F, 2003, IMMUNITY, V19, P71, DOI 10.1016/S1074-7613(03)00174-2; Getts DR, 2008, J EXP MED, V205, P2319, DOI 10.1084/jem.20080421; Gibson GR, 2017, NAT REV GASTRO HEPAT, V14, P491, DOI 10.1038/nrgastro.2017.75; Ginhoux F, 2014, NAT REV IMMUNOL, V14, P392, DOI 10.1038/nri3671; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Guarda G, 2011, IMMUNITY, V34, P213, DOI 10.1016/j.immuni.2011.02.006; Guilliams M, 2018, IMMUNITY, V49, P595, DOI 10.1016/j.immuni.2018.10.005; Guo HF, 2019, J ALZHEIMERS DIS, V68, P1391, DOI 10.3233/JAD-181177; Gururajan A, 2019, BRAIN BEHAV IMMUN, V80, P583, DOI 10.1016/j.bbi.2019.05.004; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Hanke ML, 2012, BRAIN BEHAV IMMUN, V26, P1150, DOI 10.1016/j.bbi.2012.07.011; Harach T, 2017, SCI REP-UK, V7, DOI 10.1038/srep41802; Harden LM, 2015, BRAIN BEHAV IMMUN, V50, P322, DOI 10.1016/j.bbi.2015.07.012; Harms AS, 2018, EXP NEUROL, V300, P179, DOI 10.1016/j.expneurol.2017.11.010; Hasegawa S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0142164; Hashimoto D, 2013, IMMUNITY, V38, P792, DOI 10.1016/j.immuni.2013.04.004; He BK, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.00385; Hearps AC, 2012, AGING CELL, V11, P867, DOI 10.1111/j.1474-9726.2012.00851.x; Heidt T, 2014, NAT MED, V20, P754, DOI 10.1038/nm.3589; HENCH PS, 1950, JAMA-J AM MED ASSOC, V144, P1327, DOI 10.1001/jama.1950.02920160001001; Herisson F, 2018, NAT NEUROSCI, V21, P1209, DOI 10.1038/s41593-018-0213-2; Herr N, 2017, FRONT CARDIOVASC MED, V4, DOI 10.3389/fcvm.2017.00048; Hickman SE, 2013, NAT NEUROSCI, V16, P1896, DOI 10.1038/nn.3554; Hill C, 2014, NAT REV GASTRO HEPAT, V11, P506, DOI 10.1038/nrgastro.2014.66; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Ianiro G, 2016, GUT, V65, P1906, DOI 10.1136/gutjnl-2016-312297; Iniguez SD, 2014, STRESS, V17, P247, DOI 10.3109/10253890.2014.910650; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104754; Izikson L, 2000, J EXP MED, V192, P1075, DOI 10.1084/jem.192.7.1075; Jakubzick CV, 2017, NAT REV IMMUNOL, V17, P349, DOI 10.1038/nri.2017.28; Jeong JJ, 2015, MICROBIOL BIOTECHN L, V25, P1532, DOI 10.4014/jmb.1505.05002; Johnson JD, 2002, BRAIN BEHAV IMMUN, V16, P461, DOI 10.1006/brbi.2001.0638; Kaufer C, 2018, P NATL ACAD SCI USA, V115, pE8929, DOI 10.1073/pnas.1806754115; Kang DW, 2019, SCI REP-UK, V9, DOI 10.1038/s41598-019-42183-0; Karlmark KR, 2012, EUR J MICROBIOL IMMU, V2, P97, DOI 10.1556/EuJMI.2.2012.2.1; Kelly JR, 2016, J PSYCHIATR RES, V82, P109, DOI 10.1016/j.jpsychires.2016.07.019; Kelly KA, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0190546; Kerfoot SM, 2006, HEPATOLOGY, V43, P154, DOI 10.1002/hep.21003; Keshavarzian A, 2015, MOVEMENT DISORD, V30, P1351, DOI 10.1002/mds.26307; Khosravi A, 2014, CELL HOST MICROBE, V15, P374, DOI 10.1016/j.chom.2014.02.006; Kim Binna, 2016, Prev Nutr Food Sci, V21, P297, DOI 10.3746/pnf.2016.21.4.297; Kim HS, 2011, IMMUNE NETW, V11, P191, DOI [DOI 10.4110/IN.2011.11.4.191, 10.4110/in.2011.11.4.191]; Kim KA, 2016, BMC MICROBIOL, V16, DOI 10.1186/s12866-016-0625-7; Kim S, 2019, NEURON, V103, P627, DOI 10.1016/j.neuron.2019.05.035; Klaus F, 2016, BRAIN BEHAV IMMUN, V58, P310, DOI 10.1016/j.bbi.2016.08.001; Koh A, 2016, CELL, V165, P1332, DOI 10.1016/j.cell.2016.05.041; Korin B, 2017, NAT NEUROSCI, V20, P1300, DOI 10.1038/nn.4610; Kouchaki E, 2017, CLIN NUTR, V36, P1245, DOI 10.1016/j.clnu.2016.08.015; Lach G, 2018, NEUROTHERAPEUTICS, V15, P36, DOI 10.1007/s13311-017-0585-0; Lafuse WP, 2017, J IMMUNOL, V198, P2383, DOI 10.4049/jimmunol.1601269; Langdon A, 2016, GENOME MED, V8, DOI 10.1186/s13073-016-0294-z; Langgartner D, 2019, PFLUG ARCH EUR J PHY, V471, P237, DOI 10.1007/s00424-018-2228-7; Langgartner D, 2017, BRAIN BEHAV IMMUN, V64, P23, DOI 10.1016/j.bbi.2016.12.019; Lasitschka F, 2017, IMMUN INFLAMM DIS, V5, P480, DOI 10.1002/iid3.184; Lehmann ML, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-018-28737-8; Lehmann ML, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0672-x; Li H, 2018, NEUROGASTROENT MOTIL, V30, DOI 10.1111/nmo.13260; Li JG, 2018, FRONT PSYCHIATRY, V9, DOI 10.3389/fpsyt.2018.00454; Li M, 2018, EUR J PHARMACOL, V831, P52, DOI 10.1016/j.ejphar.2018.05.003; Li NN, 2018, FRONT BEHAV NEUROSCI, V12, DOI 10.3389/fnbeh.2018.00266; Liang S, 2015, NEUROSCIENCE, V310, P561, DOI 10.1016/j.neuroscience.2015.09.033; Lisboa SF, 2018, NEUROPSYCHOPHARMACOL, V43, P1924, DOI 10.1038/s41386-018-0064-2; Liu BJ, 2017, NEUROLOGY, V88, P1996, DOI 10.1212/WNL.0000000000003961; Liu K, 2009, SCIENCE, V324, P392, DOI 10.1126/science.1170540; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Long-Smith C., 2019, ANN REV PHARM TOXICO, V60; Lund H, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-07295-7; Luo YY, 2018, TRANSL PSYCHIAT, V8, DOI 10.1038/s41398-018-0240-5; Luthold RV, 2017, METABOLISM, V69, P76, DOI 10.1016/j.metabol.2017.01.007; Ma YY, 2019, J NUTR, V149, P1543, DOI 10.1093/jn/nxz105; Macfarlane S, 2003, P NUTR SOC, V62, P67, DOI 10.1079/PNS2002207; Mackos AR, 2016, MUCOSAL IMMUNOL, V9, P515, DOI 10.1038/mi.2015.81; Maehata H, 2019, BIOSCI BIOTECH BIOCH, V83, P1239, DOI 10.1080/09168451.2019.1591263; Makinde HM, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0202722; Makinde HM, 2017, J IMMUNOL, V199, P3583, DOI 10.4049/jimmunol.1700896; Marin IA, 2017, SCI REP-UK, V7, DOI 10.1038/srep43859; Markowiak P, 2017, NUTRIENTS, V9, DOI 10.3390/nu9091021; Marsland AL, 2017, BRAIN BEHAV IMMUN, V64, P208, DOI 10.1016/j.bbi.2017.01.011; Martin E, 2017, AGING CELL, V16, P27, DOI 10.1111/acel.12522; Martinez L, 2015, ONCOTARGET, V6, P17054, DOI 10.18632/oncotarget.3881; Matt SM, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01832; McEwen BS, 2015, J ENDOCRINOL, V226, pT67, DOI 10.1530/JOE-15-0121; Mckim DB, 2018, CELL REP, V25, P2552, DOI 10.1016/j.celrep.2018.10.102; McKim DB, 2016, BIOL PSYCHIAT, V79, P803, DOI 10.1016/j.biopsych.2015.07.010; Mestre L, 2019, FRONT IMMUNOL, V10, DOI 10.3389/fimmu.2019.01374; Michaud JP, 2013, CELL REP, V5, P646, DOI 10.1016/j.celrep.2013.10.010; Mika A, 2017, EUR J NEUROSCI, V45, P342, DOI 10.1111/ejn.13444; Mildner A, 2011, J NEUROSCI, V31, P11159, DOI 10.1523/JNEUROSCI.6209-10.2011; Mildner A, 2009, BRAIN, V132, P2487, DOI 10.1093/brain/awp144; Miller AH, 1998, CELL IMMUNOL, V186, P45, DOI 10.1006/cimm.1998.1293; Miller GE, 2002, HEALTH PSYCHOL, V21, P531, DOI 10.1037//0278-6133.21.6.531; Minter MR, 2016, SCI REP-UK, V6, DOI 10.1038/srep30028; Mohle L, 2016, CELL REP, V15, P1945, DOI 10.1016/j.celrep.2016.04.074; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Most J, 2017, EUR J CLIN NUTR, V71, P1040, DOI 10.1038/ejcn.2017.89; Mrdjen D, 2018, IMMUNITY, V48, P599, DOI 10.1016/j.immuni.2018.02.014; Naert G, 2012, MOL MED, V18, P297, DOI 10.2119/molmed.2011.00306; Naert G, 2011, J NEUROSCI, V31, P6208, DOI 10.1523/JNEUROSCI.0299-11.2011; Nie X, 2018, NEURON, V99, P464, DOI 10.1016/j.neuron.2018.06.035; Niraula A, 2019, BIOL PSYCHIAT, V85, P679, DOI 10.1016/j.biopsych.2018.09.030; Niraula A, 2018, J NEUROSCI, V38, P2328, DOI 10.1523/JNEUROSCI.2568-17.2018; Ohsawa K, 2018, INT J FOOD SCI NUTR, V69, P369, DOI 10.1080/09637486.2017.1365824; Oishi Y, 2016, NPJ AGING MECH DIS, V2, DOI 10.1038/npjamd.2016.18; Okutsu M, 2008, BRAIN BEHAV IMMUN, V22, P1066, DOI 10.1016/j.bbi.2008.03.006; Olnes MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep23002; Otstlund-Lagerstrom L, 2016, NUTR J, V15, DOI 10.1186/s12937-016-0198-1; Palframan RT, 2001, J EXP MED, V194, P1361, DOI 10.1084/jem.194.9.1361; Palin K, 2007, J NEUROIMMUNOL, V187, P55, DOI 10.1016/j.jneuroim.2007.04.011; Paradis A, 2016, J NEUROIMMUNOL, V295, P12, DOI 10.1016/j.jneuroim.2016.03.019; PASSLICK B, 1989, BLOOD, V74, P2527, DOI 10.1182/blood.V74.7.2527.2527; Patel AA, 2017, J EXP MED, V214, P1913, DOI 10.1084/jem.20170355; Penton-Rol G, 1999, J IMMUNOL, V163, P3524; Peterlik D, 2017, BRAIN BEHAV IMMUN, V59, P79, DOI 10.1016/j.bbi.2016.08.007; PETERS SG, 1992, GUT, V33, P1249, DOI 10.1136/gut.33.9.1249; Plovier Hubert, 2017, Endocr Dev, V32, P139, DOI 10.1159/000475736; Powell ND, 2013, P NATL ACAD SCI USA, V110, P16574, DOI 10.1073/pnas.1310655110; Prinz M, 2011, NAT NEUROSCI, V14, P1227, DOI 10.1038/nn.2923; Prinz M, 2010, J NEUROIMMUNOL, V224, P80, DOI 10.1016/j.jneuroim.2010.05.015; Provensi G, 2019, P NATL ACAD SCI USA, V116, P9644, DOI 10.1073/pnas.1820832116; Puchta A, 2016, PLOS PATHOG, V12, DOI 10.1371/journal.ppat.1005368; Pusceddu MM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139721; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Ramirez K, 2017, CURR TOP BEHAV NEURO, V31, P155, DOI 10.1007/7854_2016_25; Ransohoff RM, 2011, NAT NEUROSCI, V14, P1098, DOI 10.1038/nn.2917; Ransohoff RM, 2010, NATURE, V468, P253, DOI 10.1038/nature09615; Rea K, 2016, NEUROBIOL STRESS, V4, P23, DOI 10.1016/j.ynstr.2016.03.001; Rhee SH, 2009, NAT REV GASTRO HEPAT, V6, P306, DOI 10.1038/nrgastro.2009.35; Rhodes JKJ, 2009, J NEUROTRAUM, V26, P507, DOI 10.1089/neu.2008.0686; Ridaura VK, 2013, SCIENCE, V341, P1079, DOI 10.1126/science.1241214; Rieder R, 2017, BRAIN BEHAV IMMUN, V66, P9, DOI 10.1016/j.bbi.2017.01.016; Robertson RC, 2017, BRAIN BEHAV IMMUN, V59, P21, DOI 10.1016/j.bbi.2016.07.145; Rodriguez-Arias M, 2017, ADDICT BIOL, V22, P129, DOI 10.1111/adb.12301; Rohleder N, 2014, PSYCHOSOM MED, V76, P181, DOI 10.1097/PSY.0000000000000049; Rooks MG, 2016, NAT REV IMMUNOL, V16, P341, DOI 10.1038/nri.2016.42; Rosadini CV, 2017, CURR OPIN IMMUNOL, V44, P14, DOI 10.1016/j.coi.2016.10.005; Rosso M, 2011, CRIT REV IMMUNOL, V31, P379, DOI 10.1615/CritRevImmunol.v31.i5.20; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Saemann MD, 2000, FASEB J, V14, P2380; Salam AP, 2018, MOL PSYCHIATR, V23, P170, DOI 10.1038/mp.2017.186; Sampson TR, 2016, CELL, V167, P1469, DOI 10.1016/j.cell.2016.11.018; Sandhu KV, 2017, TRANSL RES, V179, P223, DOI 10.1016/j.trsl.2016.10.002; Santiago-Tirado FH, 2017, PLOS PATHOG, V13, DOI 10.1371/journal.ppat.1006680; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Saresella M, 2014, J ALZHEIMERS DIS, V38, P403, DOI 10.3233/JAD-131160; Sarkar A, 2016, TRENDS NEUROSCI, V39, P763, DOI 10.1016/j.tins.2016.09.002; Savignac HM, 2016, BRAIN BEHAV IMMUN, V52, P120, DOI 10.1016/j.bbi.2015.10.007; Sawicki CM, 2015, NEUROSCIENCE, V302, P151, DOI 10.1016/j.neuroscience.2014.10.004; Scheperjans F, 2015, MOVEMENT DISORD, V30, P350, DOI 10.1002/mds.26069; Schmidt K, 2015, PSYCHOPHARMACOLOGY, V232, P1793, DOI 10.1007/s00213-014-3810-0; Schulthess J, 2019, IMMUNITY, V50, P432, DOI 10.1016/j.immuni.2018.12.018; Scott KA, 2017, BRAIN BEHAV IMMUN, V65, P20, DOI 10.1016/j.bbi.2017.02.004; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shen C, 2016, PLOS GENET, V12, DOI 10.1371/journal.pgen.1006259; Sima P, 2018, INT J MOL MED, V41, P1799, DOI 10.3892/ijmm.2018.3411; Simard AR, 2006, NEURON, V49, P489, DOI 10.1016/j.neuron.2006.01.022; Singh V, 2018, J CEREBR BLOOD F MET, V38, P1293, DOI 10.1177/0271678X18780130; Singh V, 2016, J NEUROSCI, V36, P7428, DOI 10.1523/JNEUROSCI.1114-16.2016; Smits LP, 2013, GASTROENTEROLOGY, V145, P946, DOI 10.1053/j.gastro.2013.08.058; Sorrells SF, 2013, J NEUROSCI, V33, P7877, DOI 10.1523/JNEUROSCI.4705-12.2013; Sorrells SF, 2010, BRAIN BEHAV IMMUN, V24, P17, DOI 10.1016/j.bbi.2009.10.004; Spychala MS, 2018, ANN NEUROL, V84, P23, DOI 10.1002/ana.25250; Stanley D, 2018, SCI REP-UK, V8, DOI 10.1038/s41598-017-18904-8; Stanley D, 2016, NAT MED, V22, P1277, DOI 10.1038/nm.4194; Steer JH, 1998, ANN RHEUM DIS, V57, P732, DOI 10.1136/ard.57.12.732; Stephen AM, 2017, NUTR RES REV, V30, P149, DOI 10.1017/S095442241700004X; Stilling RM, 2016, NEUROCHEM INT, V99, P110, DOI 10.1016/j.neuint.2016.06.011; Sudo N, 2004, J PHYSIOL-LONDON, V558, P263, DOI 10.1113/jphysiol.2004.063388; Sun BL, 2019, J ALZHEIMERS DIS, V70, P397, DOI 10.3233/JAD-181220; Sun MJ, 2019, BRAIN BEHAV IMMUN, V80, P536, DOI 10.1016/j.bbi.2019.04.038; Sun Y, 2019, FOOD FUNCT, V10, P925, DOI [10.1039/c8fo02096e, 10.1039/C8FO02096E]; Sung MM, 2017, DIABETES, V66, P418, DOI 10.2337/db16-0680; Svensson E, 2015, ANN NEUROL, V78, P522, DOI 10.1002/ana.24448; Szmydynger-Chodobska J, 2012, J CEREBR BLOOD F MET, V32, P93, DOI 10.1038/jcbfm.2011.111; Szyszkowicz JK, 2017, BRAIN BEHAV IMMUN, V66, P45, DOI 10.1016/j.bbi.2017.06.009; Takada M, 2016, NEUROGASTROENT MOTIL, V28, P1027, DOI 10.1111/nmo.12804; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tan M, 2011, CRIT CARE, V15, DOI 10.1186/cc10579; Tankou SK, 2018, ANN NEUROL, V83, P1147, DOI 10.1002/ana.25244; Tarr AJ, 2015, BRAIN BEHAV IMMUN, V50, P166, DOI 10.1016/j.bbi.2015.06.025; Thevaranjan N, 2017, CELL HOST MICROBE, V21, P455, DOI 10.1016/j.chom.2017.03.002; Thome AD, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0293-1; Treangen TJ, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.02757; Tsianakas A, 2012, IMMUNOBIOLOGY, V217, P329, DOI 10.1016/j.imbio.2011.10.002; Tsou CL, 2007, J CLIN INVEST, V117, P902, DOI 10.1172/JCI29919; Unger MM, 2016, PARKINSONISM RELAT D, V32, P66, DOI 10.1016/j.parkreldis.2016.08.019; Uschold-Schmidt N, 2013, J ENDOCRINOL, V218, P193, DOI 10.1530/JOE-13-0027; Uschold-Schmidt N, 2012, PSYCHONEUROENDOCRINO, V37, P1676, DOI 10.1016/j.psyneuen.2012.02.015; van de Wouw M, 2018, J PHYSIOL-LONDON, V596, P4923, DOI 10.1113/JP276431; van de Wouw M, 2017, J NUTR, V147, P727, DOI 10.3945/jn.116.240481; van der Lugt B, 2018, AGING-US, V10, P930, DOI 10.18632/aging.101439; van Duin D, 2007, J IMMUNOL, V178, P970, DOI 10.4049/jimmunol.178.2.970; van Kessel SP, 2019, NAT COMMUN, V10, DOI 10.1038/s41467-019-08294-y; Varga G, 2008, J LEUKOCYTE BIOL, V84, P644, DOI 10.1189/jlb.1107768; Varga G, 2014, J IMMUNOL, V193, P1090, DOI 10.4049/jimmunol.1300891; Varol C, 2007, J EXP MED, V204, P171, DOI 10.1084/jem.20061011; Varol C, 2009, IMMUNITY, V31, P502, DOI 10.1016/j.immuni.2009.06.025; Veenstra M, 2017, J LEUKOCYTE BIOL, V102, P1173, DOI 10.1189/jlb.3HI0517-167R; Vitlic A, 2014, AGE, V36, P1169, DOI 10.1007/s11357-014-9631-6; Vodicka M, 2018, BRAIN BEHAV IMMUN, V73, P615, DOI 10.1016/j.bbi.2018.07.007; Vogt NM, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13601-y; Wagner KV, 2011, PSYCHONEUROENDOCRINO, V36, P579, DOI 10.1016/j.psyneuen.2010.09.007; Wattananit S, 2016, J NEUROSCI, V36, P4182, DOI 10.1523/JNEUROSCI.4317-15.2016; Weise G, 2017, BRAIN BEHAV IMMUN, V60, P15, DOI 10.1016/j.bbi.2016.08.008; White KA, 2016, BRAIN BEHAV IMMUN, V57, P68, DOI 10.1016/j.bbi.2016.06.007; Wijeyekoon RS, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00870; Winek K, 2016, STROKE, V47, P1354, DOI 10.1161/STROKEAHA.115.011800; Wohleb ES, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00544; Wohleb ES, 2014, BIOL PSYCHIAT, V75, P970, DOI 10.1016/j.biopsych.2013.11.029; Wohleb ES, 2013, J NEUROSCI, V33, P13820, DOI 10.1523/JNEUROSCI.1671-13.2013; Woo V, 2017, CURR OPIN IMMUNOL, V44, P52, DOI 10.1016/j.coi.2016.12.001; Xia GH, 2019, FRONT NEUROL, V10, DOI 10.3389/fneur.2019.00397; Yano JM, 2015, CELL, V161, P264, DOI 10.1016/j.cell.2015.02.047; Yeager MP, 2016, BRAIN BEHAV IMMUN, V54, P86, DOI 10.1016/j.bbi.2016.01.004; Yin WY, 2019, BRAIN BEHAV IMMUN, V78, P131, DOI 10.1016/j.bbi.2019.01.015; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Zanier ER, 2016, J NEUROTRAUM, V33, P1060, DOI 10.1089/neu.2015.4041; Zeng Q, 2019, NEUROCHEM INT, V129, DOI 10.1016/j.neuint.2019.104468; Zeraati M, 2019, NEUROPHARMACOLOGY, V157, DOI 10.1016/j.neuropharm.2019.107685; Zhang RZ, 2013, J NEUROIMMUNOL, V256, P38, DOI 10.1016/j.jneuroim.2013.01.002; Zheng X, 2016, SCI REP-UK, V6, DOI 10.1038/srep19406; Zhou J, 2018, J NUTR BIOCHEM, V61, P68, DOI 10.1016/j.jnutbio.2018.07.018; Zhuang ZQ, 2018, J ALZHEIMERS DIS, V63, P1337, DOI 10.3233/JAD-180176; Ziegler-Heitbrock L, 2013, FRONT IMMUNOL, V4, DOI 10.3389/fimmu.2013.00023; Ziegler-Heitbrock L, 2010, BLOOD, V116, pE74, DOI 10.1182/blood-2010-02-258558	336	15	15	2	19	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	OCT	2019	81						74	91		10.1016/j.bbi.2019.07.019			18	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Immunology; Neurosciences & Neurology; Psychiatry	JA8XY	WOS:000488135800016	31330299				2022-02-06	
J	Wasicek, PJ; Gebran, SG; Ngaage, LM; Liang, YY; Ottochian, M; Morrison, JJ; Rasko, Y; Liang, F; Grant, MP; Nam, AJ				Wasicek, Philip J.; Gebran, Selim G.; Ngaage, Ledibabari M.; Liang, Yuanyuan; Ottochian, Marcus; Morrison, Jonathan J.; Rasko, Yvonne; Liang, Fan; Grant, Michael P.; Nam, Arthur J.			Contemporary Characterization of Injury Patterns, Initial Management, and Disparities in Treatment of Facial Fractures Using the National Trauma Data Bank	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						facial fracture; healthcare disparity; national trauma data bank; operation; trauma	INSURANCE STATUS; UNITED-STATES; RACE; MORTALITY; OUTCOMES; CONTROVERSIES; EPIDEMIOLOGY; PREDICTORS; VIOLENCE; PATIENT	Background: Contemporary description of facial fracture patterns and factors associated with early operative intervention at trauma centers is lacking. The purpose of this study was to characterize injuries and initial treatment patterns of patients suffering from facial fractures. Methods: Using the National Trauma Databank from 2007 to 2015, patients suffering from facial fractures were included. Demographics, injury characteristics, and outcomes including operative interventions were assessed. Results: Over 9 years, 626,270 patients were included: 74.5% were male, 39.0% suffered traumatic brain injury (TBI), and 23.3% severe noncraniofacial injuries (chest, abdomen, and/or extremity Abbreviated Injury Score >= 3). A total of 537,594 (85.8%) patients were admitted and 184,206 (34.3%) underwent operations for their facial injuries during the index hospitalization. The frequency and patterns of fractures varied by age, sex, race, and mechanism of injury. Operative intervention rates were highest for mandible (63.2%) and lowest for orbit fractures (1.0%). Multiple regression revealed that multiple factors were independently associated with the odds of early fracture repair including: female versus male (odds ratio [95% confidence interval]: 0.96 [0.94-0.98]), age >65 versus <18 years (0.62 [0.59-0.64]), non-white race (0.95 [0.94-0.97]), uninsured versus Medicaid (0.88 [0.86-0.90]), hospital bed size (>600 vs <= 200 beds, 1.67 [1.61-1.73]), TBI (0.70 [0.69-0.71]), and C-spine injury (0.93 [0.90-0.96]). Conclusions: Facial fractures are common among many demographic cohorts, and multiple patient and injury-specific factors influenced fracture patterns and management. Early	[Wasicek, Philip J.; Gebran, Selim G.; Ngaage, Ledibabari M.; Rasko, Yvonne; Liang, Fan; Grant, Michael P.; Nam, Arthur J.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Div Plast & Reconstruct Surg, 22 S Greene St, Baltimore, MD 21201 USA; [Liang, Yuanyuan] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Dept Epidemiol & Publ Hlth, Baltimore, MD 21201 USA; [Ottochian, Marcus; Morrison, Jonathan J.] Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Baltimore, MD 21201 USA		Wasicek, PJ (corresponding author), Univ Maryland, Sch Med, R Adams Cowley Shock Trauma Ctr, Div Plast & Reconstruct Surg, 22 S Greene St, Baltimore, MD 21201 USA.	pwasicek@som.umaryland.edu		Morrison, Jonathan/0000-0001-7462-8456; Ngaage, Ledibabari/0000-0001-5802-779X			Abramowicz S, 2017, J ORAL MAXIL SURG, V75, P2170, DOI 10.1016/j.joms.2017.05.035; Afrooz PN, 2015, J ORAL MAXIL SURG, V73, P2361, DOI 10.1016/j.joms.2015.04.032; Ali MT, 2013, SURGERY, V154, P461, DOI 10.1016/j.surg.2013.05.036; Allareddy V, 2014, JAMA OTOLARYNGOL, V140, P303, DOI 10.1001/jamaoto.2014.61; Allareddy V, 2014, J ORAL MAXIL SURG, V72, P1756, DOI 10.1016/j.joms.2014.03.015; Allareddy V, 2011, J ORAL MAXIL SURG, V69, P2613, DOI 10.1016/j.joms.2011.02.057; [Anonymous], 2019, NATL TRAUMA DATA BAN; Atisha DM, 2016, PLAST RECONSTR SURG, V137, P587, DOI 10.1097/01.prs.0000475791.31361.9a; Balsa AI, 2005, HEALTH SERV RES, V40, P227, DOI 10.1111/j.1475-6773.2005.00351.x; Beard JH, 2017, AM J PUBLIC HEALTH, V107, P371, DOI 10.2105/AJPH.2016.303620; Cauley JA, 2011, CLIN ORTHOP RELAT R, V469, P1891, DOI 10.1007/s11999-011-1863-5; Faul M, TRAUMATIC BRAIN INJU; Fiscella K, 2016, ANNU REV PUBL HEALTH, V37, P375, DOI 10.1146/annurev-publhealth-032315-021439; Giannoudis PV, 2002, AM J SURG, V183, P261, DOI 10.1016/S0002-9610(02)00783-3; Haider AH, 2008, ARCH SURG-CHICAGO, V143, P945, DOI 10.1001/archsurg.143.10.945; Haider AH, 2015, JAMA SURG, V150, P457, DOI 10.1001/jamasurg.2014.4038; Haider AH, 2013, J AM COLL SURGEONS, V216, P482, DOI 10.1016/j.jamcollsurg.2012.11.014; Haider AH, 2012, ARCH SURG-CHICAGO, V147, P63, DOI 10.1001/archsurg.2011.254; Hanba C, 2016, JAMA FACIAL PLAST SU, V18, P441, DOI 10.1001/jamafacial.2016.0714; Hoppe IC, 2015, J CRANIOFAC SURG, V26, P1446, DOI 10.1097/SCS.0000000000001822; Hoppe IC, 2014, J CRANIO MAXILL SURG, V42, P1408, DOI 10.1016/j.jcms.2014.04.002; Hoppe IC, 2014, J CRANIOFAC SURG, V25, P400, DOI 10.1097/SCS.0000000000000657; Hurrell MJL, 2014, INT J ORAL MAX SURG, V43, P944, DOI 10.1016/j.ijom.2014.03.003; Hyman DA, 2016, JAMA FACIAL PLAST SU, V18, P455, DOI 10.1001/jamafacial.2016.0733; Imahara SD, 2008, J AM COLL SURGEONS, V207, P710, DOI 10.1016/j.jamcollsurg.2008.06.333; Kloss FR, 2006, EXP GERONTOL, V41, P123, DOI 10.1016/j.exger.2005.11.005; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Meara DJ, 2017, ORAL MAXIL SURG CLIN, V29, P391, DOI 10.1016/j.coms.2017.06.002; Mendelson B, 2012, AESTHET PLAST SURG, V36, P753, DOI 10.1007/s00266-012-9904-3; Mundinger GS, 2016, PLAST RECONSTR SURG, V137, p386E, DOI 10.1097/01.prs.0000475800.15221.cd; Putman MS, 2013, J BONE MINER RES, V28, P2177, DOI 10.1002/jbmr.1953; Radabaugh JP, 2016, JAMA FACIAL PLAST SU, V18, P177, DOI 10.1001/jamafacial.2015.2101; Rodman RE, 2016, FACIAL PLAST SURG CL, V24, P299, DOI 10.1016/j.fsc.2016.03.006; Schoenfeld AJ, 2013, SPINE J, V13, P1766, DOI 10.1016/j.spinee.2013.03.024; Sethi RKV, 2014, OTOLARYNG HEAD NECK, V151, P776, DOI 10.1177/0194599814546112; Sheats KJ, 2018, AM J PREV MED, V55, P462, DOI 10.1016/j.amepre.2018.05.017; Stone N, 2018, PRS-GLOB OPEN, V6, DOI 10.1097/GOX.0000000000001829; Weygandt PL, 2012, J SURG RES, V177, P288, DOI 10.1016/j.jss.2012.07.003	38	15	15	0	0	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	OCT	2019	30	7					2052	2056		10.1097/SCS.0000000000005862			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Surgery	JS5VN	WOS:000500374200077	31425409				2022-02-06	
J	Matsuo, K; Aihara, H; Nakai, T; Morishita, A; Tohma, Y; Kohmura, E				Matsuo, Kazuya; Aihara, Hideo; Nakai, Tomoaki; Morishita, Akitsugu; Tohma, Yoshiki; Kohmura, Eiji			Machine Learning to Predict In-Hospital Morbidity and Mortality after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						artificial intelligence; machine learning; outcome predictor; traumatic brain injury	ARTIFICIAL NEURAL-NETWORK; SEVERE HEAD-INJURY; PROGNOSIS; CLASSIFICATION; VALIDATION; SURGERY; MODELS	Recently, successful predictions using machine learning (ML) algorithms have been reported in various fields. However, in traumatic brain injury (TBI) cohorts, few studies have examined modern ML algorithms. To develop a simple ML model for TBI outcome prediction, we conducted a performance comparison of nine algorithms: ridge regression, least absolute shrinkage and selection operator (LASSO) regression, random forest, gradient boosting, extra trees, decision tree, Gaussian naive Bayes, multi-nomial naive Bayes, and support vector machine. Fourteen feasible parameters were introduced in the ML models, including age, Glasgow Coma Scale (GCS), systolic blood pressure (SBP), abnormal pupillary response, major extracranial injury, computed tomography (CT) findings, and routinely collected laboratory values (glucose, C-reactive protein [CRP], and fibrin/fibrinogen degradation products [FDP]). Data from 232 patients with TBI were randomly divided into a training sample (80%) for hyperparameter tuning and validation sample (20%). The bootstrap method was used for validation. Random forest demonstrated the best performance for in-hospital poor outcome prediction and ridge regression for in-hospital mortality prediction: the mean statistical measures were 100% sensitivity, 72.3% specificity, 91.7% accuracy, and 0.895 area under the receiver operating characteristic curve (AUC); and 88.4% sensitivity, 88.2% specificity, 88.6% accuracy, and 0.875 AUC, respectively. Based on the feature selection method using the tree-based ensemble algorithm, age, Glasgow Coma Scale, fibrin/fibrinogen degradation products, and glucose were identified as the most important prognostic factors for poor outcome and mortality. Our results indicate the relatively good predictive performance of modern ML for TBI outcome. Further external validation is required for more heterogeneous samples to confirm our results.	[Matsuo, Kazuya; Nakai, Tomoaki; Kohmura, Eiji] Kobe Univ, Grad Sch Med, Dept Neurosurg, Kobe, Hyogo, Japan; [Aihara, Hideo; Morishita, Akitsugu] Hyogo Prefectural Kakogawa Med Ctr, Dept Neurosurg, Kakogawa, Hyogo, Japan; [Tohma, Yoshiki] Hyogo Prefectural Kakogawa Med Ctr, Dept Emergency & Crit Care Med, Kakogawa, Hyogo, Japan		Matsuo, K (corresponding author), Kobe Univ, Grad Sch Med, Dept Neurosurg, Chuo Ku, 7-5-1 Kusunoki Cho, Kobe, Hyogo 6500017, Japan.	kkmatsuo@outlook.jp	Matsuo, Kazuya/AAX-6757-2021	Matsuo, Kazuya/0000-0001-6721-1353			Bernau C, 2014, BIOINFORMATICS, V30, P105, DOI 10.1093/bioinformatics/btu279; Bland JM, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h2622; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Brunelli A, 2006, J THORAC CARDIOV SUR, V131, P1243, DOI 10.1016/j.jtcvs.2006.02.002; Chen JH, 2017, NEW ENGL J MED, V376, P2507, DOI 10.1056/NEJMp1702071; Chesnut RM, 2000, J NEUROTRAUM, V17, P555; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Cui SS, 2018, INJURY, V49, P1865, DOI 10.1016/j.injury.2018.07.025; Eftekhar Behzad, 2005, BMC Med Inform Decis Mak, V5, P3; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Figueroa RL, 2012, BMC MED INFORM DECIS, V12, DOI 10.1186/1472-6947-12-8; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; JENNETT B, 1975, LANCET, V1, P480; Koch M, 2018, CELL, V173, P531, DOI 10.1016/j.cell.2018.04.007; Lingsma HF, 2010, LANCET NEUROL, V9, P543, DOI 10.1016/S1474-4422(10)70065-X; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Meisner M, 2006, CRIT CARE, V10, DOI 10.1186/cc3910; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Musoro JZ, 2014, BMC MED RES METHODOL, V14, DOI 10.1186/1471-2288-14-116; Olsony RS, 2018, BIOCOMPUT-PAC SYM, P192; Pedregosa F, 2011, J MACH LEARN RES, V12, P2825; Perel P, 2007, J EVAL CLIN PRACT, V13, P464, DOI 10.1111/j.1365-2753.2006.00713.x; Rovlias A, 2004, J NEUROTRAUM, V21, P886, DOI 10.1089/0897715041526249; Rughani AI, 2010, J NEUROSURG, V113, P585, DOI 10.3171/2009.11.JNS09857; Saggar V, 2009, J NEUROTRAUM, V26, P1665, DOI 10.1089/neu.2008.0799; Shi HY, 2013, J NEUROSURG, V118, P746, DOI 10.3171/2013.1.JNS121130; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Van Beek JGM, 2007, J NEUROTRAUM, V24, P315, DOI 10.1089/neu.2006.0034; Wang TJ, 2018, BMJ OPEN, V8, DOI 10.1136/bmjopen-2018-023670; WEISSMAN C, 1990, ANESTHESIOLOGY, V73, P308, DOI 10.1097/00000542-199008000-00020; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	32	15	15	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2018.6276		SEP 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IZ0OO	WOS:000486790500001	31359814	Green Accepted			2022-02-06	
J	Wang, CF; Zhao, CC; Liu, WL; Huang, XJ; Deng, YF; Jiang, JY; Li, WP				Wang, Chuan-fang; Zhao, Cheng-cheng; Liu, Wen-lan; Huang, Xian-jian; Deng, Yue-fei; Jiang, Ji-yao; Li, Wei-ping			Depletion of Microglia Attenuates Dendritic Spine Loss and Neuronal Apoptosis in the Acute Stage of Moderate Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						apoptosis; colony-stimulating factor 1 receptor inhibitor; microglia; spines; traumatic brain injury	CELL-DEATH; STRESS; ACCUMULATION; IMPACT; GAP-43; MODEL	Microglia are the primary immune cells in the central nervous system and undergo significant morphological and transcriptional changes after traumatic brain injury (TBI). However, their exact contribution to the pathogenesis of TBI is still debated and remains to be elucidated. In the present study, thy-1 GFP mice received a colony-stimulating factor 1 receptor inhibitor (PLX3397) for 21 consecutive days, then were subjected to moderate fluid percussion injury (FPI). Brain samples were collected at 1 day and 3 days after FPI for flow cytometry analysis, immunofluorescence, dendrite spine quantification, terminal deoxynucleotidyl transferase dUTP nick end labeling assay, and Western blot. We found that PLX3397 treatment significantly attenuated the percentages of resident microglia and infiltrated immune cells. Depletion of microglia promoted neurite outgrowth, preserved dendritic spines and reduced total brain cell and neuronal apoptosis after FPI, which was accompanied by decreased the protein levels of endoplasmic reticulum stress marker proteins, C/EBP-homologous protein and inositol-requiring kinase 1 alpha. Taken together, these findings suggest that microglial depletion may exert beneficial effects in the acute stage of FPI.	[Wang, Chuan-fang; Liu, Wen-lan; Huang, Xian-jian; Li, Wei-ping] Shenzhen Univ, Peoples Hosp 2, Affiliated Hosp 1, Brain Ctr,Shenzhen Key Lab Neurosurg, Shenzhen, Guangdong, Peoples R China; [Zhao, Cheng-cheng; Deng, Yue-fei] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Neurosurg, Guangzhou, Guangdong, Peoples R China; [Jiang, Ji-yao] Shanghai Jiao Tong Univ, Ren Ji Hosp, Sch Med, Dept Neurosurg, Shanghai, Peoples R China		Li, WP (corresponding author), Shenzhen Univ, Shenzhen Peoples Hosp 2, Brain Ctr, Shenzhen Key Lab Neurosurg, 3002 Sungang Rd, Shenzhen 518035, Guangdong, Peoples R China.	wpli@szu.edu.cn			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81772685, 81772058]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2018M643330]; Natural Science Foundation of Guangdong ProvinceNational Natural Science Foundation of Guangdong Province [2018A030310042]; international cooperation research projects of Shenzhen Science and Technology Program [GJHZ20160301163419476]; Shenzhen Science and Technology Program [JCYJ20170413173149177]; Shenzhen Development and Reform Commissions Stroke Screening and Prevention Public Service Platform improving program	This research was supported by grants from the National Natural Science Foundation of China (81772685; 81772058), the China Postdoctoral Science Foundation (2018M643330), the Natural Science Foundation of Guangdong Province (2018A030310042), the international cooperation research projects of Shenzhen Science and Technology Program (GJHZ20160301163419476), the basic research projects (subject arrangement) of Shenzhen Science and Technology Program (JCYJ20170413173149177) and Shenzhen Development and Reform Commissions Stroke Screening and Prevention Public Service Platform improving program.	Alder J, 2011, JOVE-J VIS EXP, DOI 10.3791/3063; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Benowitz LI, 1997, TRENDS NEUROSCI, V20, P84, DOI 10.1016/S0166-2236(96)10072-2; Campbell JN, 2012, J NEUROTRAUM, V29, P201, DOI 10.1089/neu.2011.1761; Carbonell WS, 1998, J NEUROTRAUM, V15, P217, DOI 10.1089/neu.1998.15.217; Chio CC, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-33; Chourbaji S, 2008, FASEB J, V22, P3129, DOI 10.1096/fj.08-106450; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Dammeijer F, 2017, CANCER IMMUNOL RES, V5, P535, DOI 10.1158/2326-6066.CIR-16-0309; DANI JW, 1991, NEUROSCIENCE, V40, P277, DOI 10.1016/0306-4522(91)90190-Y; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Dohi K, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-41; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Elmore MRP, 2014, NEURON, V82, P380, DOI 10.1016/j.neuron.2014.02.040; Erblich B, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026317; Erturk A, 2016, J NEUROSCI, V36, P9962, DOI 10.1523/JNEUROSCI.1898-15.2016; Harris NG, 2010, J NEUROPATH EXP NEUR, V69, P139, DOI 10.1097/NEN.0b013e3181cb5bee; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hood KN, 2018, J NEUROSCI, V38, P2372, DOI 10.1523/JNEUROSCI.1756-17.2018; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jin WN, 2017, J CEREBR BLOOD F MET, V37, P2224, DOI 10.1177/0271678X17694185; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lalancette-Hebert M, 2007, J NEUROSCI, V27, P2596, DOI 10.1523/JNEUROSCI.5360-06.2007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larner SF, 2006, J NEUROTRAUM, V23, P807, DOI 10.1089/neu.2006.23.807; LAWSON LJ, 1992, NEUROSCIENCE, V48, P405, DOI 10.1016/0306-4522(92)90500-2; Li MS, 2017, J CEREBR BLOOD F MET, V37, P2383, DOI 10.1177/0271678X16666551; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Madathil SK, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00964; Migaud M, 1998, NATURE, V396, P433, DOI 10.1038/24790; Morrison H, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-13581-z; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Peranzoni E, 2018, P NATL ACAD SCI USA, V115, pE4041, DOI 10.1073/pnas.1720948115; Popescu C, 2015, J Med Life, V8, P272; Rice RA, 2015, J NEUROSCI, V35, P9977, DOI 10.1523/JNEUROSCI.0336-15.2015; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Salter MW, 2014, CELL, V158, P15, DOI 10.1016/j.cell.2014.06.008; Sauter KA, 2014, J LEUKOCYTE BIOL, V96, P265, DOI 10.1189/jlb.2A0114-006R; Schafer DP, 2012, NEURON, V74, P691, DOI 10.1016/j.neuron.2012.03.026; Shi QQ, 2017, SCI TRANSL MED, V9, DOI 10.1126/scitranslmed.aaf6295; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Sword J, 2013, BRAIN, V136, P1446, DOI 10.1093/brain/awt026; Szegezdi E, 2006, EMBO REP, V7, P880, DOI 10.1038/sj.embor.7400779; Thored P, 2009, GLIA, V57, P835, DOI 10.1002/glia.20810; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Witcher KG, 2018, GLIA, V66, P2719, DOI 10.1002/glia.23523; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Xavier AL, 2014, PHILOS T R SOC B, V369, DOI 10.1098/rstb.2013.0593; Zhao CC, 2017, J NEUROTRAUM, V34, P1636, DOI 10.1089/neu.2016.4759; Ziebell JM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-247	58	15	16	3	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2019.6460		SEP 2019	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IZ0PE	WOS:000486792100001	31397209				2022-02-06	
J	Chen, T; Zhu, J; Wang, YH; Hang, CH				Chen, Tao; Zhu, Jie; Wang, Yu-Hai; Hang, Chun-Hua			ROS-Mediated Mitochondrial Dysfunction and ER Stress Contribute to Compression-Induced Neuronal Injury	NEUROSCIENCE			English	Article						Intracranial hypertension; Compression; Mitochondrial dysfunction; ER stress; Ca2+ homeostasis	TRAUMATIC BRAIN-INJURY; ENDOPLASMIC-RETICULUM; INTRACRANIAL HYPERTENSION; CELL-DEATH; MDIVI-1; APOPTOSIS; PRESSURE; DYNAMICS; DISEASES; POLYPHENOLS	Intracranial hypertension (IH) is a medical or surgical emergency that can be the common ending of various neurological disorders, such as traumatic brain injury, cerebral vascular diseases and brain tumors. However, the molecular mechanisms underlying IH-induced neuronal apoptosis have not been fully determined, and the treatments are symptomatic, insufficient and complicated by side-effects. In this study, a cellular model induced by compressed gas treatment in primary cultured rat cortical neurons was performed to mimic IH-induced neuronal injury in vitro. We found that compression induced cytotoxicity and apoptosis in cortical neurons in a dose- and time-dependent manner. Compression resulted in oxidative stress, which could be prevented by the ROS scavenger N-acetylcysteine (NAC). Compression produced mitochondrial oxidative stress, ATP loss and mitochondrial fragmentation. The results of western blot showed that compression differently regulated the expression of mitochondrial dynamic proteins, and the Drp1 inhibitor mdivi-1 partially reversed the compression-induced cytotoxicity. Compression significantly increased the expression of ER stress-associated factors in a time-dependent manner. The results of calcium imaging showed that compression induced intracellular calcium overload via promoting ER calcium release. Furthermore, the results using inhibitors of each signaling pathway demonstrated that ROS mediated the compression-induced ER stress and mitochondrial dysfunction in cortical neurons. In conclusion, our results demonstrated that compression induced apoptosis in primary cultured cortical neurons, which was associated with ROS mediated ER stress and mitochondrial dysfunction. Pharmacological compounds or agents targeting mitochondrial dysfunction and ER stress associated oxidative stress might be ideal candidates for the treatment of IH-related neurological diseases. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.	[Chen, Tao; Hang, Chun-Hua] Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurosurg, Nanjing 210000, Jiangsu, Peoples R China; [Chen, Tao; Zhu, Jie; Wang, Yu-Hai] Anhui Med Univ, Med Sch, Hosp PLA 904, Dept Neurosurg, Wuxi 214044, Jiangsu, Peoples R China		Hang, CH (corresponding author), Nanjing Univ, Med Sch, Drum Tower Hosp, Dept Neurosurg, Nanjing 210000, Jiangsu, Peoples R China.; Wang, YH (corresponding author), Anhui Med Univ, Med Sch, Hosp PLA 101, Dept Neurosurg, Wuxi 214044, Jiangsu, Peoples R China.	prof_wyh101@163.com; hang-ch_neuro@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81701932, 81871598, 81771291, 81601719]; Clinical Medical Science and Technology Development Foundation of Jiangsu University [JLY20180028]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2019 M651803]	This work was supported by the National Natural Science Foundation of China (NO. 81701932, No. 81871598, No. 81771291 and No. 81601719), Clinical Medical Science and Technology Development Foundation of Jiangsu University (No. JLY20180028), and China Postdoctoral Science Foundation funded project (No. 2019 M651803).	Adasme T, 2015, BIOCHEM BIOPH RES CO, V458, P57, DOI 10.1016/j.bbrc.2015.01.065; Godoy DA, 2018, NEUROSURG CLIN N AM, V29, P195, DOI 10.1016/j.nec.2017.12.001; Bahar E, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17091558; Balestreri M, 2006, NEUROCRIT CARE, V4, P8, DOI 10.1385/NCC:4:1:008; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bruno V, 2001, J CEREBR BLOOD F MET, V21, P1013, DOI 10.1097/00004647-200109000-00001; Cassina P, 2008, J NEUROSCI, V28, P4115, DOI 10.1523/JNEUROSCI.5308-07.2008; Celli J, 2015, NAT REV MICROBIOL, V13, P71, DOI 10.1038/nrmicro3393; Chaturvedi RK, 2013, FREE RADICAL BIO MED, V63, P1, DOI 10.1016/j.freeradbiomed.2013.03.018; Chen T, 2017, NEUROSCI LETT, V661, P23, DOI 10.1016/j.neulet.2017.09.024; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Csordas G, 2006, J CELL BIOL, V174, P915, DOI 10.1083/jcb.200604016; Ding F, 2012, APOPTOSIS, V17, P579, DOI 10.1007/s10495-012-0708-3; Dong GT, 2016, MITOCHONDRION, V26, P7, DOI 10.1016/j.mito.2015.11.003; Esposti MD, 2004, BIOCHEM SOC T, V32, P493; Giorgi C, 2009, INT J BIOCHEM CELL B, V41, P1817, DOI 10.1016/j.biocel.2009.04.010; Heyes S, 2015, PROG NEUROBIOL, V134, P36, DOI 10.1016/j.pneurobio.2015.09.002; Hutton WC, 1999, SPINE, V24, P1507, DOI 10.1097/00007632-199908010-00002; Idris Zamzuri, 2014, Asian J Neurosurg, V9, P7, DOI 10.4103/1793-5482.131058; IKEDA Y, 1990, NEUROSURGERY, V27, P1; Laker RC, 2014, J BIOL CHEM, V289, P12005, DOI 10.1074/jbc.M113.530527; Lory P, 2010, IDRUGS, V13, P467; MacVicar T, 2016, J CELL SCI, V129, P2297, DOI 10.1242/jcs.159186; Magnoni S, 2014, MINERVA ANESTESIOL, V80, P1251; Malhotra JD, 2007, SEMIN CELL DEV BIOL, V18, P716, DOI 10.1016/j.semcdb.2007.09.003; Marciniak SJ, 2006, PHYSIOL REV, V86, P1133, DOI 10.1152/physrev.00015.2006; Mason RP, 2016, REDOX BIOL, V8, P422, DOI 10.1016/j.redox.2016.04.003; Mason RP, 2004, FREE RADICAL BIO MED, V36, P1214, DOI 10.1016/j.freeradbiomed.2004.02.077; Naia L, 2017, BIOCHEM BIOPH RES CO, V483, P1069, DOI 10.1016/j.bbrc.2016.07.122; Nakagawa T, 2000, NATURE, V403, P98, DOI 10.1038/47513; Oyadomari S, 2004, CELL DEATH DIFFER, V11, P381, DOI 10.1038/sj.cdd.4401373; Panickar KS, 2011, INT J MOL SCI, V12, P8181, DOI 10.3390/ijms12118181; Ruiz A, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00003; Ruszkiewicz J, 2015, NEUROCHEM INT, V88, P66, DOI 10.1016/j.neuint.2014.12.012; Salih F, 2012, ANASTH INTENSIV NOTF, V47, P50, DOI 10.1055/s-0032-1301381; SanMartin CD, 2014, FRONT MOL NEUROSCI, V7, DOI 10.3389/fnmol.2014.00013; Saotome M, 2008, P NATL ACAD SCI USA, V105, P20728, DOI 10.1073/pnas.0808953105; Senft D, 2015, TRENDS BIOCHEM SCI, V40, P141, DOI 10.1016/j.tibs.2015.01.002; Skau M, 2006, CEPHALALGIA, V26, P384, DOI 10.1111/j.1468-2982.2005.01055.x; Smith G, 2017, DEV NEUROBIOL, V77, P1260, DOI 10.1002/dneu.22519; Stefani IC, 2012, CURR ALZHEIMER RES, V9, P373; Thornton C, 2018, FEBS LETT, V592, P812, DOI 10.1002/1873-3468.12943; Verkhratsky A, 2004, BIOL RES, V37, P693; Verkhratsky A, 2002, CELL CALCIUM, V32, P393, DOI 10.1016/S0143416002001896; Vik A, 2008, J NEUROSURG, V109, P678, DOI 10.3171/JNS/2008/109/10/0678; Wilkerson DC, 2011, INT J BIOCHEM CELL B, V43, P1252, DOI 10.1016/j.biocel.2011.05.005; Wu P, 2017, NEUROCHEM RES, V42, P1449, DOI 10.1007/s11064-017-2201-4; Wu Q, 2016, BRAIN RES, V1630, P134, DOI 10.1016/j.brainres.2015.11.016; Xin YG, 2019, OXID MED CELL LONGEV, V2019, DOI 10.1155/2019/3649808; Yu DS, 2015, J MOL NEUROSCI, V56, P388, DOI 10.1007/s12031-015-0564-z; Zhang N, 2013, NEUROSCI LETT, V535, P104, DOI 10.1016/j.neulet.2012.12.049	51	15	15	2	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	SEP 15	2019	416						268	280		10.1016/j.neuroscience.2019.08.007			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JF4JZ	WOS:000491355300024	31425734				2022-02-06	
J	Thau-Zuchman, O; Ingram, R; Harvey, GG; Cooke, T; Palmas, F; Pallier, PN; Brook, J; Priestley, JV; Dalli, J; Tremoleda, JL; Michael-Titus, AT				Thau-Zuchman, Orli; Ingram, Rachael; Harvey, Georgina G.; Cooke, Thomas; Palmas, Francesco; Pallier, Patrick N.; Brook, Joseph; Priestley, John V.; Dalli, Jesmond; Tremoleda, Jordi L.; Michael-Titus, Adina T.			A Single Injection of Docosahexaenoic Acid Induces a Pro-Resolving Lipid Mediator Profile in the Injured Tissue and a Long-Lasting Reduction in Neurological Deficit after Traumatic Brain Injury in Mice	JOURNAL OF NEUROTRAUMA			English	Article; Early Access						docosahexaenoic acid; functional improvement; lipid mediator profile; neuroprotection; traumatic brain injury	CONTROLLED CORTICAL IMPACT; POLYUNSATURATED FATTY-ACIDS; SERUM NEUROFILAMENT LIGHT; CLOSED-HEAD-INJURY; SPINAL-CORD-INJURY; CELLULAR PROLIFERATION; MICROGLIAL ACTIVATION; NEUROPROTECTION; OMEGA-3-FATTY-ACIDS; PATHOPHYSIOLOGY	Traumatic brain injury (TBI) can lead to life-changing neurological deficits, which reflect the fast-evolving secondary injury post-trauma. There is a need for acute protective interventions, and the aim of this study was to explore in an experimental TBI model the neuroprotective potential of a single bolus of a neuroactive omega-3 fatty acid, docosahexaenoic acid (DHA), administered in a time window feasible for emergency services. Adult mice received a controlled cortical impact injury (CCI) and neurological impairment was assessed with the modified Neurological Severity Score (mNSS) up to 28 days post-injury. DHA (500 nmol/kg) or saline were injected intravenously at 30 min post-injury. The lipid mediator profile was assessed in the injured hemisphere at 3 h post-CCI. After completion of behavioral tests and lesion assessment using magnetic resonance imaging, over 7 days or 28 days post-TBI, the tissue was analyzed by immunohistochemistry. The single DHA bolus significantly reduced the injury-induced neurological deficit and increased pro-resolving mediators in the injured brain. DHA significantly reduced lesion size, the microglia and astrocytic reaction, and oxidation, and decreased the accumulation of beta-amyloid precursor protein (APP), indicating a reduced axonal injury at 7 days post-TBI. DHA reduced the neurofilament light levels in plasma at 28 days. Therefore, an acute single bolus of DHA post-TBI, in a time window relevant for acute emergency intervention, can induce a long-lasting and significant improvement in neurological outcome, and this is accompanied by a marked upregulation of neuroprotective mediators, including the DHA-derived resolvins and protectins.	[Thau-Zuchman, Orli; Ingram, Rachael; Harvey, Georgina G.; Cooke, Thomas; Pallier, Patrick N.; Priestley, John V.; Tremoleda, Jordi L.; Michael-Titus, Adina T.] Queen Mary Univ London, Ctr Neurosci Surg & Trauma, London, England; [Brook, Joseph] Queen Mary Univ London, Ctr Mol Oncol, London, England; [Palmas, Francesco; Dalli, Jesmond] Queen Mary Univ London, Lipid Mediator Unit, William Harvey Res Inst, London, England		Thau-Zuchman, O (corresponding author), Queen Mary Univ London, Ctr Neurosci Surg & Trauma, London, England.; Thau-Zuchman, O (corresponding author), Queen Mary Univ London, Ctr Neurosci Surg & Trauma, Blizard Inst, 4 Newark St, London E1 2AT, England.	o.thau-zuchman@qmul.ac.uk	Palmas, Francesco/AAV-8482-2021	Palmas, Francesco/0000-0001-8578-6871; Ingram, Rachael/0000-0001-5300-4337; Cooke, Thomas/0000-0001-8954-7472; Thau-Zuchman, Orli/0000-0003-0403-7962	European Research Council under the European UnionEuropean Research Council (ERC) [677542]; Sir Henry Dale Fellowship - Wellcome TrustWellcome Trust [107613/Z/15/Z]; Royal SocietyRoyal Society of LondonEuropean Commission [107613/Z/15/Z]; Barts Charity [MGU0343]	This work was supported by funding from the European Research Council under the European Union's Horizon 2020 research and innovation program (Grant 677542) to JD, a Sir Henry Dale Fellowship jointly funded by the Wellcome Trust and the Royal Society (Grant 107613/Z/15/Z), and the Barts Charity (Grant MGU0343) to JD. OT-Z and JL-T were supported by a Barts Charity award to the Centre for Trauma Sciences.	Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bazan NG, 2011, MOL NEUROBIOL, V44, P216, DOI 10.1007/s12035-011-8200-6; Bazinet RP, 2014, NAT REV NEUROSCI, V15, P771, DOI 10.1038/nrn3820; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Belayev L, 2011, TRANSL STROKE RES, V2, P33, DOI 10.1007/s12975-010-0046-0; Beni-Adani L, 2001, J PHARMACOL EXP THER, V296, P57; Bhowmick S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010011; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Chen CT, 2015, SCI REP-UK, V5, DOI 10.1038/srep15791; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; Dalli J, 2018, METHODS MOL BIOL, V1730, P59, DOI 10.1007/978-1-4939-7592-1_4; Dinh MM, 2013, INJURY, V44, P606, DOI 10.1016/j.injury.2012.01.011; Dyall SC, 2008, NEUROMOL MED, V10, P219, DOI 10.1007/s12017-008-8036-z; Eady TN, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046151; Faden AI, 2007, ARCH NEUROL-CHICAGO, V64, P794, DOI 10.1001/archneur.64.6.794; Fox GB, 1998, J NEUROTRAUM, V15, P599, DOI 10.1089/neu.1998.15.599; Frati A, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18122600; Gaiottino J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0075091; Hall JCE, 2012, J NEUROCHEM, V121, P738, DOI 10.1111/j.1471-4159.2012.07726.x; Harrison JL, 2015, BRAIN BEHAV IMMUN, V47, P131, DOI 10.1016/j.bbi.2015.01.001; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Hernadez-Ontiveros D., 2013, FRONT NEUROL, V4; Hogan SR, 2018, J PROTEOME RES, V17, P2131, DOI 10.1021/acs.jproteome.8b00068; Huang WL, 2007, BRAIN, V130, P3004, DOI 10.1093/brain/awm223; Janes KA, 2006, NAT REV MOL CELL BIO, V7, P820, DOI 10.1038/nrm2041; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Jouvene C, 2018, LIPIDS, V53, P103, DOI 10.1002/lipd.12006; Katsumoto A, 2018, J NEUROINFLAMM, V15, DOI 10.1186/s12974-018-1075-y; Keenan S, 2017, WILD ENVIRON MED, V28, pS135, DOI 10.1016/j.wem.2017.02.001; King VR, 2006, J NEUROSCI, V26, P4672, DOI 10.1523/JNEUROSCI.5539-05.2006; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lacombe RJS, 2018, NUTR RES, V53, P85, DOI 10.1016/j.nutres.2018.02.007; Lim SN, 2013, EXP NEUROL, V239, P13, DOI 10.1016/j.expneurol.2012.09.015; Liu ZH, 2015, J NEUROSCI, V35, P12733, DOI 10.1523/JNEUROSCI.0605-15.2015; Lyon RM, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-1; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mayurasakorn K, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0160870; McCoy CE, 2013, ANN EMERG MED, V61, P167, DOI 10.1016/j.annemergmed.2012.08.026; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Ramaswamy S, 2005, BRAIN RES, V1053, P38, DOI 10.1016/j.brainres.2005.06.042; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rodriguez-Rodriguez A, 2014, CURR MED CHEM, V21, P1201, DOI 10.2174/0929867321666131217153310; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Salem NM, 2015, PROSTAG LEUKOTR ESS, V100, P13, DOI 10.1016/j.plefa.2015.06.002; Sato M, 2001, BRAIN RES, V917, P45, DOI 10.1016/S0006-8993(01)02905-5; Scott G, 2018, BRAIN, V141, P459, DOI 10.1093/brain/awx339; Serhan CN, 2011, CHEM REV, V111, P5922, DOI 10.1021/cr100396c; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; SHAPIRA Y, 1988, CRIT CARE MED, V16, P258, DOI 10.1097/00003246-198803000-00010; Shinozaki Y, 2017, CELL REP, V19, P1151, DOI 10.1016/j.celrep.2017.04.047; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; SWANSON RA, 1990, J CEREBR BLOOD F MET, V10, P290, DOI 10.1038/jcbfm.1990.47; Turtzo LC, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-82; Umhau JC, 2009, J LIPID RES, V50, P1259, DOI 10.1194/jlr.M800530-JLR200; Urrea C, 2007, RESTOR NEUROL NEUROS, V25, P65; Wang XT, 2016, J NEUROTRAUM, V33, P721, DOI 10.1089/neu.2015.4097; Ward RE, 2010, J NEUROTRAUM, V27, P1769, DOI 10.1089/neu.2010.1348; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williams JJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056233; Wilson L, 2017, LANCET NEUROL, V16, P813, DOI 10.1016/S1474-4422(17)30279-X; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wright DK, 2016, SCI REP-UK, V6, DOI 10.1038/srep28713; Wu AG, 2011, J NEUROTRAUM, V28, P2113, DOI 10.1089/neu.2011.1872; Yi Y, 2018, MOL NEUROBIOL, V55, P2454, DOI 10.1007/s12035-017-0504-8; Zanier Elisa R, 2015, Intensive Care Med Exp, V3, P39, DOI 10.1186/s40635-015-0039-0; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zhu W, 2017, EXP THER MED, V14, P4411, DOI 10.3892/etm.2017.5054; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	75	15	15	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma												10.1089/neu.2019.6420		SEP 2019	14	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IX2JW	WOS:000485517200001	31256709	Green Submitted			2022-02-06	
J	Chen, W; Zhao, L; Zhang, JX; Wang, BB; Xu, GH; Lin, C; Liu, N				Chen, Wei; Zhao, Lin; Zhang, Junxia; Wang, Binbin; Xu, Guanhua; Lin, Chao; Liu, Ning			Elevated expression of miR-302 cluster improves traumatic brain injury by inhibiting phosphorylation of connexin43 via ERK signaling	JOURNAL OF CHEMICAL NEUROANATOMY			English	Article						Traumatic brain injury (TBI); Connexin43; ERK1/2; miR-302 cluster; Cognitive function	MORRIS WATER MAZE; MICRORNA; DIFFERENTIATION; MODELS	We have previously found that connexin43 is phosphorylated by extracellular-signal-regulated kinase (ERK)1/2 in rats of cerebral ischemia. Here, we investigated the potential roles of microRNA (miR)-302 cluster in the regulation of ERK1/2 mediated connexin43 phosphorylation and protection from traumatic brain injury (TBI) induced brain damage. We examined apoptosis and ERK1/2 and connexin43 phosphorylation in SH-SY5Y cells undergoing pulsatile shear stress treatment. We assessed expression of miR-302 cluster members and exogenously expressed miR-302 cluster in stressed cells to determine its effect on ERK1/2 and connexin43 phosphorylation. Finally, we investigated the effects of elevated miR-302 expression on cognitive function and brain damage in TBI rats generated by the controlled cortical impact method. Pulsatile shear stress leads to increased apoptosis and upregulation of ERK1/2 and connexin43 phosphorylation in vitro. Additionally, pulsatile shear stress significantly suppressed miR-302 expression and exogenously expression of miR-302 cluster inhibited ERK1/2 and connexin43 phosphorylation. Finally, elevated expression of miR-302 cluster not only improved cognitive function of TBI rats but also attenuated brain damage by suppressing edema and reducing contusion volume. Our study suggests that miR-302 protects rats from TBI induced brain damage and cognitive impairment and may represent an effective therapeutic strategy for TBI.	[Chen, Wei; Zhao, Lin; Zhang, Junxia; Wang, Binbin; Xu, Guanhua; Lin, Chao; Liu, Ning] Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China		Zhao, L; Liu, N (corresponding author), Nanjing Med Univ, Affiliated Hosp 1, Dept Neurosurg, 300 Guangzhou Rd, Nanjing 210029, Jiangsu, Peoples R China.	liuning_1958@sina.com; zl_nirvana@126.com		Chen, Wei/0000-0001-7438-3241	Natural Science Foundation of Jiangsu ProvinceNatural Science Foundation of Jiangsu Province [BK20160047]; Livelihood Project of Shanghai Science and Technology Commission [PKJ2016-Y31]	Natural Science Foundation of Jiangsu Province (BK20160047), Livelihood Project of Shanghai Science and Technology Commission (PKJ2016-Y31).	Anokye-Danso F, 2011, CELL STEM CELL, V8, P376, DOI 10.1016/j.stem.2011.03.001; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Cheng W., 2017, SCI REP-UK, V7, P1; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Gao ZQ, 2015, OPEN BIOL, V5, DOI 10.1098/rsob.150138; Georgiou AP, 2013, BRIT J ANAESTH, V110, P357, DOI 10.1093/bja/aes500; Ghasemi-Kasman M, 2017, BIOMED PHARMACOTHER, V96, P1222, DOI 10.1016/j.biopha.2017.11.094; Ghasemi-Kasman M, 2018, MOL CELL NEUROSCI, V86, P50, DOI 10.1016/j.mcn.2017.11.012; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Kloosterman WP, 2006, DEV CELL, V11, P441, DOI 10.1016/j.devcel.2006.09.009; Lei P, 2009, BRAIN RES, V1284, P191, DOI 10.1016/j.brainres.2009.05.074; Lipchina I, 2012, CELL CYCLE, V11, P1517, DOI 10.4161/cc.19846; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Pan YB, 2017, NEUROSCIENCE, V367, P189, DOI 10.1016/j.neuroscience.2017.10.046; Parchem RJ, 2015, CELL REP, V12, P760, DOI 10.1016/j.celrep.2015.06.074; Pi JJ, 2017, CIRC RES, V120, P85, DOI 10.1161/CIRCRESAHA.116.309757; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Redell JB, 2009, J NEUROSCI RES, V87, P1435, DOI 10.1002/jnr.21945; Scheff SW, 1997, J NEUROTRAUM, V14, P615, DOI 10.1089/neu.1997.14.615; Triyoso DH, 1999, J PHYSIOL-LONDON, V515, P355, DOI 10.1111/j.1469-7793.1999.355ac.x; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Wang H, 2013, NEUROL SCI, V34, P11, DOI 10.1007/s10072-012-1145-3; Whiting MD, 2016, METHODS MOL BIOL, V1462, P553, DOI 10.1007/978-1-4939-3816-2_30; Yang SL, 2015, DEV BIOL, V408, P140, DOI 10.1016/j.ydbio.2015.09.020; Zhang B, 2008, BRAIN RES, V1226, P181, DOI 10.1016/j.brainres.2008.05.085	27	15	17	2	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	0891-0618	1873-6300		J CHEM NEUROANAT	J. Chem. Neuroanat.	SEP	2019	99						1	8		10.1016/j.jchemneu.2019.05.003			8	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	IQ3SJ	WOS:000480671100001	31096001				2022-02-06	
J	Howell, DR; Kriz, P; Mannix, RC; Kirchberg, T; Master, CL; Meehan, WP				Howell, David R.; Kriz, Peter; Mannix, Rebekah C.; Kirchberg, Tyler; Master, Christina L.; Meehan, William P., III			Concussion Symptom Profiles Among Child, Adolescent, and Young Adult Athletes	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						pediatric; adolescent; athlete; mild traumatic brain injury; management; sports	SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; RECOVERY; DURATION; STATEMENT	Objectives: (1) To examine how age influences initial symptom presentation following concussion; and (2) to determine whether specific symptomprofiles are associated with duration of postconcussion symptoms, andwhether they vary by age group. Design: A total of 689 patients (20% children 7-12 years of age, 69% adolescents 13-18 years of age, and 11% young adults 19-30 years of age) were seen and diagnosed with a concussion within 21 days after injury. Patients completed the Post-Concussion Symptom Scale (PCSS) and were followed until they no longer required care. Setting: Two specialty care sport concussion clinical practices. Main outcome measures: Overall PCSS score was obtained, as well as severity ratings from somatic, vestibular-ocular, cognitive, sleep, and emotional symptomdomains. We also calculated total symptomduration time. Results: No significantmain effect of age, or age by sex associations were identified among the symptomdomains. Females endorsed a higher somatic symptomseverity rating than males (9.8 +/- 6.7 vs 8.1 +/- 6.7; P=0.03). For patients between 7 and 12 years of age, higher somatic [beta-coefficient = 1.57, 95% confidence interval (CI), 1.47-1.67] and cognitive (beta-coefficient = 2.50, 95% CI, 2.32-2.68) symptom severities were associated with longer duration of concussion symptoms. Among adolescents, longer total symptom duration was associated with more severe somatic (beta-coefficient = 1.25, 95% CI, 0.34-2.15) and vestibular-ocular (beta-coefficient = 2.36, 95% CI, 1.49-3.23) symptoms. Conclusions: Within 21 days after concussion, symptom-reporting behavior seems to be similar across the age spectrum, but the relationship between symptom profiles and time to symptomresolution varies by age. Although overall symptomratings are beneficial in determining clinical pathways, symptom domain use may provide a beneficial method to determine individualized patient care that differs between children and adolescents after concussion.	[Howell, David R.] Childrens Hosp Colorado, Sports Med Ctr, 13123 East 16th Ave, Aurora, CO 80045 USA; [Howell, David R.] Univ Colorado, Dept Orthoped, Sch Med, Aurora, CO USA; [Howell, David R.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA; [Kriz, Peter; Kirchberg, Tyler] Brown Univ, Rhode Isl Hosp, Hasbro Childrens Hosp, Div Sports Med,Dept Orthoped,Warren Alpert Med Sc, Providence, RI 02903 USA; [Kriz, Peter; Kirchberg, Tyler] Brown Univ, Rhode Isl Hosp, Hasbro Childrens Hosp, Div Sports Med Dept Pediat,Warren Alpert Med Sch, Providence, RI 02903 USA; [Mannix, Rebekah C.] Boston Childrens Hosp, Div Emergency Med, Boston, MA USA; [Mannix, Rebekah C.; Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Master, Christina L.] Childrens Hosp Philadelphia, Sports Med & Performance Ctr, Philadelphia, PA 19104 USA; [Master, Christina L.] Univ Penn, Div Sports Med, Dept Orthoped, Perelman Sch Med, Philadelphia, PA 19104 USA; [Meehan, William P., III] Boston Childrens Hosp, Dept Orthoped, Div Sports Med, Boston, MA USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, 13123 East 16th Ave, Aurora, CO 80045 USA.	David.-Howell@ucdenver.edu		Master, Christina/0000-0002-6717-4270; Kirchberg, Tyler/0000-0001-9787-019X	Boston Children's Hospital; Cincinnati Children's Hospital Medical Center; ElMindA Ltd.; National Hockey League Alumni Association; Football Players Health Study at Harvard University - NFL Players Association	D. R. Howell's research is funded, in part, through a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd. W. P. Meehan receives royalties from (1) ABC-Clio publishing for the sale of his books, Kids, Sports, and Concussion: A guide for coaches and parents, and Concussions; (2) Springer International for the book Head and Neck Injuries in Young Athlete, and (3) Wolters Kluwer for working as an author for UpToDate. His research is funded, in part, by philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament and by a grant from the Football Players Health Study at Harvard University, which is funded by the NFL Players Association.	Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Brooks MA, 2017, JAMA PEDIATR, V171, P670, DOI 10.1001/jamapediatrics.2017.0592; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Henry LC, 2016, NEUROSURGERY, V78, P232, DOI 10.1227/NEU.0000000000001041; Howell DR, 2016, ACTA PAEDIATR, V105, pE426, DOI 10.1111/apa.13486; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kroshus E, 2017, J ADOLESCENCE, V54, P110, DOI 10.1016/j.adolescence.2016.11.002; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2016, J SCI MED SPORT, V19, P722, DOI 10.1016/j.jsams.2015.12.002; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, CLIN SPORT MED, V30, P133, DOI 10.1016/j.csm.2010.08.004; Mott M., 2015, CONCUSSION, V1, pCNC10; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Resch JE, 2015, J ATHL TRAINING, V50, P1292, DOI 10.4085/1062-6050-50.12.03; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203	22	15	15	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	SEP	2019	29	5					391	397		10.1097/JSM.0000000000000629			7	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	KG1HH	WOS:000509692100008	29933282				2022-02-06	
J	Purkayastha, S; Williams, B; Murphy, M; Lyng, S; Sabo, T; Bell, KR				Purkayastha, Sushmita; Williams, Benjamin; Murphy, Megan; Lyng, Sydney; Sabo, Tonia; Bell, Kathleen R.			Reduced heart rate variability and lower cerebral blood flow associated with poor cognition during recovery following concussion	AUTONOMIC NEUROSCIENCE-BASIC & CLINICAL			English	Article						Concussion; Traumatic brain injury; Autonomic nervous system; Heart rate variability; Cerebral blood flow	AUTONOMIC NEURAL-CONTROL; RESISTANCE; REST; VASCULATURE; CONDUCTANCE; DYSFUNCTION; HUMANS	Although physiological deficits such as altered cerebral blood flow (CBF), and autonomic nervous system (ANS) dysregulation have been reported following a concussion, the relationship between CBF and ANS with functional outcome post-injury remains unclear. Our present study was designed to examine heart-rate variability (HRV) using percentage of successive NN intervals (pNN50) and CBF on day-3 (T1), day-21 (T2), and day-90 (T3) following a concussion in collegiate athletes (N = 31) in comparison to non-injured controls (N = 31). Continuous RR-interval (3-lead electrocardiogram), middle cerebral artery blood velocity (MCAV; transcranial Doppler ultrasonography), mean arterial pressure (MAP; finger photoplethysmography) were obtained at rest. Cerebrovascular conductance index (CVCi) was estimated as a ratio of MCAV to MAP. Cognition was evaluated with standard assessment of concussion (SAC), and Trails A & B. Compared to the controls, lower HRV (43 +/- 15 vs. 27 +/- 20%; p < 0.0001) was observed at T1 with normalization at T2 and T3. No difference in MCAV between the control and the concussed groups across the three time points were observed. However, post-hoc analyses indicated a positive relationship between MCAV at T1 phase with HRV and CVCi during T2, and T3 phases. Higher MCAV at T1 was also associated with better cognition scores during the asymptomatic T2 phase in the concussed athletes. Therefore, our results indicate ANS dysregulation during the acute recovery phase after a concussion. Differences in CBF may be one of the underlying causes behind heterogeneity in clinical symptoms and functional outcomes after a concussion and future studies are warranted to validate this finding.	[Purkayastha, Sushmita; Murphy, Megan; Lyng, Sydney] Southern Methodist Univ, Dept Appl Physiol & Wellness, Simmons Sch Educ & Human Dev, 3101 Univ Blvd,Rm 118 A, Dallas, TX 75205 USA; [Purkayastha, Sushmita; Bell, Kathleen R.] Univ Texas Southwestern Med Ctr, Dept Phys Med & Rehabil, 5323 Harry Hines Blvd, Dallas, TX 75390 USA; [Williams, Benjamin] Southern Methodist Univ, Dept Stat Sci, 3225 Daniel Ave, Dallas, TX 75205 USA; [Sabo, Tonia] Univ Texas Southwestern Med Ctr, Dept Pediat, Div Pediat Neurol & Pain Management, 5323 Harry Hines Blvd, Dallas, TX 75390 USA		Purkayastha, S (corresponding author), Southern Methodist Univ, Dept Appl Physiol & Wellness, Simmons Sch Educ & Human Dev, 3101 Univ Blvd,Rm 118 A, Dallas, TX 75205 USA.	spurkayastha@smu.edu	Purkaysastha, Sushmita/Y-8908-2019	Williams, Benjamin/0000-0001-8474-5066; Sabo, Tonia/0000-0002-7293-4764; Bell, Kathleen/0000-0002-0928-2046	University Research Council Grant at the Southern Methodist University (SMU), Dallas, Texas; Texas Institute for Brain Injury & Repair (TIBIR) at University of Texas Southwestern Medical Center, Dallas, Texas; Athletic Department at SMU	This study was supported in part by funds provided by the University Research Council Grant at the Southern Methodist University (SMU), Dallas, Texas and the Texas Institute for Brain Injury & Repair (TIBIR) at University of Texas Southwestern Medical Center, Dallas, Texas. The authors also wish to thank the athletes for volunteering in the study and the Athletic Department at SMU for their support.	AASLID R, 1984, J NEUROSURG, V60, P37, DOI 10.3171/jns.1984.60.1.0037; Abaji JP, 2016, J NEUROTRAUM, V33, P811, DOI 10.1089/neu.2015.3989; Allen B, 2015, PSYCHOPHYSIOLOGY, V52, P277, DOI 10.1111/psyp.12321; Billman GE, 2013, FRONT PHYSIOL, V4, DOI [10.3389/fphys.2013.00222, 10.3389/fphys.2013.00026]; Bishop SA, 2018, CLIN PHYSIOL FUNCT I, V38, P733, DOI 10.1111/cpf.12487; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Camm AJ, 1996, EUR HEART J, V17, P354; Churchill NW, 2017, NEUROIMAGE-CLIN, V14, P480, DOI 10.1016/j.nicl.2017.02.015; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Dobson JL, 2017, AM J PHYSIOL-REG I, V312, pR575, DOI 10.1152/ajpregu.00499.2016; Draghici AE, 2016, J PHYSIOL ANTHROPOL, V35, DOI 10.1186/s40101-016-0113-7; Gall B, 2004, MED SCI SPORT EXER, V36, P1269, DOI 10.1249/01.MSS.0000135787.73757.4D; Giza CC, 2018, JAMA NEUROL, V75, P399, DOI 10.1001/jamaneurol.2018.0006; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Hilz MJ, 2015, J NEUROTRAUM, V32, P1796, DOI 10.1089/neu.2014.3842; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kemp AH, 2017, NEUROSCI BIOBEHAV R, V83, P547, DOI 10.1016/j.neubiorev.2017.09.006; Kemp AH, 2016, BIOL PSYCHOL, V117, P216, DOI 10.1016/j.biopsycho.2016.04.006; Kim DH, 2006, J AM GERIATR SOC, V54, P1751, DOI 10.1111/j.1532-5415.2006.00940.x; La Fountaine MF, 2018, INT J PSYCHOPHYSIOL, V132, P155, DOI 10.1016/j.ijpsycho.2017.11.016; La Fountaine MF, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00013; Laborde S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00213; LAUTT WW, 1989, MICROVASC RES, V37, P230, DOI 10.1016/0026-2862(89)90040-X; Leddy J, 2017, J ATHL TRAINING, V52, P299, DOI 10.4085/1062-6050-51.11.08; MacFarlane MP, 2015, BRAIN INJURY, V29, P139, DOI 10.3109/02699052.2014.965208; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Metting Z, 2014, BRAIN COGNITION, V86, P24, DOI 10.1016/j.bandc.2014.01.012; Ogoh S, 2008, STROKE, V39, P1979, DOI 10.1161/STROKEAHA.107.510008; OLEARY DS, 1991, AM J PHYSIOL, V260, pH632, DOI 10.1152/ajpheart.1991.260.2.H632; Purkayastha S, 2012, SEMIN NEUROL, V32, P411, DOI 10.1055/s-0032-1331812; Purkayastha S, 2013, EXP PHYSIOL, V98, P451, DOI 10.1113/expphysiol.2012.066118; Quintana DS, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.73; Saus ER, 2006, MIL PSYCHOL, V18, pS3, DOI 10.1207/s15327876mp1803s_2; Senthinathan A, 2017, CLIN J SPORT MED, V27, P288, DOI 10.1097/JSM.0000000000000337; Serrador JM, 2000, STROKE, V31, P1672, DOI 10.1161/01.STR.31.7.1672; SMITH JJ, 1994, J CLIN PHARMACOL, V34, P375, DOI 10.1002/j.1552-4604.1994.tb04977.x; Tarvainen MP, 2014, COMPUT METH PROG BIO, V113, P210, DOI 10.1016/j.cmpb.2013.07.024; Thayer JF, 2009, ANN BEHAV MED, V37, P141, DOI 10.1007/s12160-009-9101-z; Thayer JF, 2009, NEUROSCI BIOBEHAV R, V33, P81, DOI 10.1016/j.neubiorev.2008.08.004; Ture U, 2000, J NEUROSURG, V92, P676, DOI 10.3171/jns.2000.92.4.0676; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Wang Y, 2016, J NEUROTRAUM, V33, P1227, DOI 10.1089/neu.2015.4072; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE	47	15	15	0	8	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1566-0702	1872-7484		AUTON NEUROSCI-BASIC	Auton. Neurosci-Basic Clin.	SEP	2019	220								102548	10.1016/j.autneu.2019.04.004			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IN5JF	WOS:000478711000008	31331690				2022-02-06	
J	Barati, S; Kashani, IR; Moradi, F; Tahmasebi, F; Mehrabi, S; Barati, M; Joghataei, MT				Barati, Shirin; Kashani, Iraj Ragerdi; Moradi, Fateme; Tahmasebi, Fatemeh; Mehrabi, Soraya; Barati, Mahmood; Joghataei, Mohammad Taghi			Mesenchymal stem cell mediated effects on microglial phenotype in cuprizone-induced demyelination model	JOURNAL OF CELLULAR BIOCHEMISTRY			English	Article						cuprizone model; immunomodulation; mesenchymal stem cells; microglial phenotype; multiple sclerosis	MULTIPLE-SCLEROSIS; TRAUMATIC BRAIN; MOUSE MODEL; CORD; IMMUNOPATHOLOGY; REMYELINATION; FRACTALKINE; INJURY	Microglial cells have an essential role in neurodegenerative disorders, such as multiple sclerosis. They are divided into two subgroups: M1 and M2 phenotypes. Mesenchymal stem cells (MSC), with neuroprotective and immunomodulating properties, could improve these diseases. We evaluate the immunomodulating effects of MSC on microglial phenotypes and the improvement of demyelination in a cuprizone (CPZ) model of multiple sclerosis (MS). For inducing the chronic demyelination model, C57BL6 mice were given a diet with 0.2% CPZ (w/w) for 12 weeks. In the MSC group, cells were transplanted into the right lateral ventricle of mice. The expression of targeted genes was assessed by real-time polymerase chain reaction. M1 and M2 microglial phenotypes were assessed by immunohistochemistry of inducible nitric oxide synthase (iNOS) and Arg-1, respectively. Remyelination was studied by luxal fast blue (LFB) staining and electron microscopy (EM). We found that MSC transplantation reduced the expression level of M1-specific messenger RNA (mRNA; iNOS and CD86) but increased the expression level of M2 specific genes (CD206, Arg-1, and CX3CR1) in comparison to the CPZ group. Moreover, cell therapy significantly decreased the M1 marker (iNOS(+) cells), but M2 marker (Arg-1(+) cells) significantly increased in comparison with the CPZ group. In addition, MSC treatment significantly increased the CX3CL1 expression level in comparison with the CPZ group and led to improvement in remyelination, which was confirmed by LFB and EM images. The results showed that MSC transplantation increases the M2 and decreases the M1 phenotype in MS. This change was accompanied by decrease in demyelination and axonal injury and indicated that MSCs have a positive effect on MS by modification of microglia cells.	[Barati, Shirin; Moradi, Fateme; Joghataei, Mohammad Taghi] Iran Univ Med Sci, Dept Anat, Fac Med, Tehran, Iran; [Kashani, Iraj Ragerdi; Tahmasebi, Fatemeh] Univ Tehran Med Sci, Dept Anat, Fac Med, Tehran, Iran; [Mehrabi, Soraya] Iran Univ Med Sci, Dept Physiol, Fac Med, Tehran, Iran; [Barati, Mahmood] Iran Univ Med Sci, Fac Allied Med, Dept Med Biotechnol, Tehran, Iran		Joghataei, MT (corresponding author), Iran Univ Med Sci, Sch Med, Dept Anat, Tehran 1449614535, Iran.	mt.joghataei@yahoo.com	tahmasebi, fatemeh/AAY-5577-2020; barati, shirin/ABG-2727-2021; barati, shirin/AAY-3015-2021		Iran University of Medical Sciences and Health Services [96-02-30- 30473]	Iran University of Medical Sciences and Health Services, Grant/Award Number: 96-02-30- 30473	Arnoux I, 2015, NEURAL PLAST, V2015, P1; Bai LH, 2009, GLIA, V57, P1192, DOI 10.1002/glia.20841; Baksh D, 2007, STEM CELLS, V25, P1384, DOI 10.1634/stemcells.2006-0709; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Cardona AE, 2006, NAT NEUROSCI, V9, P917, DOI 10.1038/nn1715; Chami M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178622; Chen SL, 2014, SCI REP-UK, V4, DOI 10.1038/srep07458; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cruz-Martinez P, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2016.130; Cruz-Martinez P, 2014, REGEN MED, V9, P579, DOI [10.2217/RME.14.38, 10.2217/rme.14.38]; Durafourt BA, 2012, GLIA, V60, P717, DOI 10.1002/glia.22298; Franco R, 2015, PROG NEUROBIOL, V131, P65, DOI 10.1016/j.pneurobio.2015.05.003; Ghareghani M, 2017, CLIN EXP PHARMACOL P, V44, P52, DOI 10.1111/1440-1681.12678; Glenn JD, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0139008; Guglielmetti C, 2014, NEUROIMAGE, V86, P99, DOI 10.1016/j.neuroimage.2013.07.080; Gutierrez-Fernandez M, 2015, J TRANSL MED, V13, DOI 10.1186/s12967-015-0406-3; Harizanova E, 2018, SCRIPTA SCI VOX STUD, V2, P59; Hass R, 2011, CELL COMMUN SIGNAL, V9, DOI 10.1186/1478-811X-9-12; Inden M, 2016, ANN NEURODEGENER DIS, V1, P1002; Ishida Y, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17007-8; Jaramillo-Merchan J, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.304; Kim KW, 2011, BLOOD, V118, P156; Koh SH, 2009, STEM CELLS DEV, V18, P411, DOI 10.1089/scd.2008.0040; Lassmann H, 2007, BRAIN PATHOL, V17, P210, DOI 10.1111/j.1750-3639.2007.00064.x; Luo C, 2017, NEUROPSYCH DIS TREAT, V13, P1661, DOI 10.2147/NDT.S140634; Lv JF, 2018, BRAIN RES, V1685, P91, DOI 10.1016/j.brainres.2018.01.032; Mikita J, 2011, MULT SCLER J, V17, P2, DOI 10.1177/1352458510379243; Nessler J, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069795; Noh MY, 2016, STEM CELL TRANSL MED, V5, P1538, DOI 10.5966/sctm.2015-0217; Orihuela R, 2016, BRIT J PHARMACOL, V173, P649, DOI 10.1111/bph.13139; Orije J, 2015, NEUROIMAGE, V114, P128, DOI 10.1016/j.neuroimage.2015.04.012; Poniatowski LA, 2017, MOL NEUROBIOL, V54, P2167, DOI 10.1007/s12035-016-9787-4; Prineas JW, 2001, ANN NEUROL, V50, P646, DOI 10.1002/ana.1255; Rath M, 2014, FRONT IMMUNOL, V5, DOI 10.3389/fimmu.2014.00532; Ruytinx P, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.01930; Saijo K, 2011, NAT REV IMMUNOL, V11, P775, DOI 10.1038/nri3086; Singer NG, 2011, ANNU REV PATHOL-MECH, V6, P457, DOI 10.1146/annurev-pathol-011110-130230; Slusarczyk J, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19071965; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Uccelli A, 2013, CELL J, V15, P2044; Volkman R, 2017, STEM CELLS, V35, P1867, DOI 10.1002/stem.2651; Yang JY, 2014, BIOMARK RES, V2, DOI 10.1186/2050-7771-2-1; Zhang F, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00282	43	15	17	0	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0730-2312	1097-4644		J CELL BIOCHEM	J. Cell. Biochem.	AUG	2019	120	8					13952	13964		10.1002/jcb.28670			13	Biochemistry & Molecular Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Cell Biology	ID5LQ	WOS:000471718300180	30963634				2022-02-06	
J	Ko, IG; Kim, CJ; Kim, H				Ko, Il-Gyu; Kim, Chang-Ju; Kim, Hong			Treadmill exercise improves memory by up-regulating dopamine and down-regulating D-2 dopamine receptor in traumatic brain injury rats	JOURNAL OF EXERCISE REHABILITATION			English	Article						Brain injuries; Exercise; Memory; Dopamine; Dopamine D-2 receptor	COGNITIVE DYSFUNCTION; EXPRESSION; LTP	Traumatic brain injury (TBI) causes a variety of neuropathological manifestations including cognitive, emotional, physiological and psychological deficits. Physical exercise is known to ameliorate neurological impairments induced by various brain injuries. We investigated the effects of treadmill exercise on memory impairments due to TBI in relation to dopamine and D-2 dopamine receptor. TBI was induced with an electromagnetic-controlled cortical impact device. The rats in the exercise groups were scheduled to run on a treadmill for 30 min once a day for 28 days after TBI induction. Then, step-down avoidance task, radial 8-arm maze test, immunohistochemistry for tyrosine hydroxylase (TH), and western blot for D-2 dopamine receptor were performed. TBI impaired short-term and spatial learning memories. TBI decreased TH expressions in the prefrontal cortex (PFC), striatum, hippocampus dentate gyrus, and substantia nigra (SN). By contrast, the expressions of D-2 dopamine receptor in the PFC, striatum, hippocampus, and SN were increased by TBI. Treadmill exercise alleviated the impairments of short-term and spatial learning memories observed in TBI rats. TH expression was decreased and D-2 dopamine receptor expression was increased in TBI rats. Treadmill exercise enhanced TH expression and suppressed D-2 dopamine receptor expression in TBI rats. TBI deteriorated short-term and spatial learning memories, in contrast treadmill exercise alleviated the TBI-induced memory impairments by up-regulating dopamine level and down-regulating D-2 dopamine receptor expression.	[Ko, Il-Gyu; Kim, Chang-Ju] Kyung Hee Univ, Coll Med, Dept Physiol, Seoul, South Korea; [Kim, Hong] Daegu Haany Univ, Coll Biomed Sci, Dept Oriental Sports Med, 1 Haanydae Ro, Gyongsan 38610, South Korea		Kim, H (corresponding author), Daegu Haany Univ, Coll Biomed Sci, Dept Oriental Sports Med, 1 Haanydae Ro, Gyongsan 38610, South Korea.	joshua@dhu.ac.kr			National Research Foundation of Korea Grant Funded by the Korean GovernmentNational Research Foundation of Korea [NRF-2011-327-G00121]	This work was supported by the National Research Foundation of Korea Grant Funded by the Korean Government (NRF-2011-327-G00121).	Archer T, 2012, ACTA NEUROL SCAND, V125, P293, DOI 10.1111/j.1600-0404.2011.01638.x; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Beaulieu JM, 2011, PHARMACOL REV, V63, P182, DOI 10.1124/pr.110.002642; Crosson B, 2003, J INT NEUROPSYCH SOC, V9, P1027, DOI 10.1017/S1355617703970068; Granado N, 2008, CEREB CORTEX, V18, P1, DOI 10.1093/cercor/bhm026; Griesbach GS, 2011, PM&R, V3, pS64, DOI 10.1016/j.pmrj.2011.02.008; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Huang EYK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086354; Kim DH, 2010, PHYSIOL BEHAV, V101, P660, DOI 10.1016/j.physbeh.2010.09.021; Klinker F, 2013, BEHAV BRAIN RES, V242, P117, DOI 10.1016/j.bbr.2012.12.038; Ko IG, 2018, J EXERC REHABIL, V14, P327, DOI 10.12965/jer.1836248.124; Ko IG, 2013, MOL MED REP, V8, P393, DOI 10.3892/mmr.2013.1531; Lee JM, 2018, J EXERC REHABIL, V14, P713, DOI 10.12965/jer.36394.197; Lenard L, 2017, BEHAV BRAIN RES, V321, P99, DOI 10.1016/j.bbr.2017.01.005; Li SM, 2003, NAT NEUROSCI, V6, P526, DOI 10.1038/nn1049; Mabandla MV, 2009, METAB BRAIN DIS, V24, P525, DOI 10.1007/s11011-009-9161-6; Massucci JL, 2004, NEUROSCI LETT, V372, P127, DOI 10.1016/j.neulet.2004.09.026; McAllister TW, 2005, AM J PSYCHIAT, V162, P1749, DOI 10.1176/appi.ajp.162.9.1749; O'Dell SJ, 2007, NEUROSCIENCE, V144, P1141, DOI 10.1016/j.neuroscience.2006.10.042; Piao CS, 2013, NEUROBIOL DIS, V54, P252, DOI 10.1016/j.nbd.2012.12.017; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Sung YH, 2012, LIFE SCI, V91, P1309, DOI 10.1016/j.lfs.2012.10.003; Wagner AK, 2014, J CEREBR BLOOD F MET, V34, P1328, DOI 10.1038/jcbfm.2014.87; Zhang X, 2015, JPEN-PARENTER ENTER, V39, P114, DOI 10.1177/0148607113501881	24	15	16	3	9	KOREAN SOC EXERCISE REHABILITATION	SEOUL	264 BAEKJEGOBUN-RO, SONGPA-GU, SEOUL, 138-841, SOUTH KOREA	2288-176X	2288-1778		J EXERC REHABIL	J. Exerc. Rehabil.	AUG	2019	15	4					504	511		10.12965/jer.1938316.158			8	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	IV0RW	WOS:000483987300003	31523669	Green Submitted, Green Published, gold			2022-02-06	
J	Pellegrino, R; Han, PF; Reither, N; Hummel, T				Pellegrino, Robert; Han, Pengfei; Reither, Nicole; Hummel, Thomas			Effectiveness of olfactory training on different severities of posttraumatic loss of smell	LARYNGOSCOPE			English	Article						Smell; olfactory training; impairment; traumatic brain injury; imaging	SUPERIOR FRONTAL GYRUS; BULB VOLUME; SEMANTIC SYSTEM; DYSFUNCTION; DISORDERS; LANGUAGE; HEMISPHERE; HANDEDNESS; INCREASES; RECOVERY	Objective/Hypothesis A common, lasting condition from traumatic brain injury is impairment to smell. In patients with olfactory impairment, recent meta-analyses have demonstrated that olfactory training consistently improves higher-order functions, such as odor identification. The focus of this work was to assess effects of olfactory training (OT) in posttraumatic olfactory loss patients through several metrics including psychophysical, olfactory bulb (OB) volume, and functional magnetic resonance imaging. Study Design Prospective cohort study. Methods Sniffin' Sticks were used to classify two patient groups (anosmic [N = 23] and hyposmic [N = 14]) and measure changes after OT. Additionally patients were asked the intensity, valence, and uncued identification of odors presented (coffee and peach) within the magnetic resonance imaging scanner before and after olfactory training. Olfactory training was performed twice daily with a four-odor training set for 24 weeks, and sets were replaced halfway through the entire training session (similar to 12 weeks). Results Patients had an increase in test scores (threshold and identification) and in-scanner intensity ratings and identification. Anosmic patients showed improved olfactory thresholds to 2-phenylethanol, increased intensity ratings, and activation in the right superior frontal gyrus (SFG) to odors after OT. Hyposmic patients were able to identify odors better after training. This behavior was mirrored with increased, ipsilateral activations in semantic processing areas such as Broca's area, left angular gyrus, and left SFG. Conclusions Taken together, along with neither patient group showing changes in OB volumes, OT improves olfactory performance in patients with posttraumatic olfactory loss and seems to be driven, at least in part, by top-down processes (central) rather than bottom-up (peripheral). Levels of Evidence 2 Laryngoscope, 129:1737-1743, 2019	[Pellegrino, Robert; Han, Pengfei; Reither, Nicole; Hummel, Thomas] Tech Univ Dresden, Dept Otorhinolaryngol, Smell & Taste Clin, Dresden, Germany; [Pellegrino, Robert] Univ Tennessee, Inst Agr, Dept Food Sci, Knoxville, TN 37901 USA		Pellegrino, R (corresponding author), Univ Tennessee, Ctr Sensory Sci, 2510 River Dr, Knoxville, TN 37996 USA.	pellegr@utk.edu		Han, Pengfei/0000-0001-8266-6655	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [DFG HU411/18-1]	This research was supported by a grant from the Deutsche Forschungsgemeinschaft (DFG HU411/18-1).	Aschenbrenner K, 2008, LARYNGOSCOPE, V118, P135, DOI 10.1097/MLG.0b013e318155a4b9; Bensafi M, 2008, NEUROSCIENCE, V154, P832, DOI 10.1016/j.neuroscience.2008.03.079; Binder JR, 2009, CEREB CORTEX, V19, P2767, DOI 10.1093/cercor/bhp055; Buschuter D, 2008, NEUROIMAGE, V42, P498, DOI 10.1016/j.neuroimage.2008.05.004; Costanzo RM, 1986, CLIN MEASUREMENTS TA, P565; Croy I, 2014, CHEM SENSES, V39, P185, DOI 10.1093/chemse/bjt072; Cummings DM, 1997, J NEUROSCI, V17, P7433; Damm M, 2014, LARYNGOSCOPE, V124, P826, DOI 10.1002/lary.24340; Delank KW, 1996, LARYNGO RHINO OTOL, V75, P154, DOI 10.1055/s-2007-997554; Doty RL, 1997, ARCH NEUROL-CHICAGO, V54, P1131, DOI 10.1001/archneur.1997.00550210061014; Ferreira RA, 2015, BRAIN LANG, V143, P69, DOI 10.1016/j.bandl.2015.02.005; Fournel A, 2017, HUM BRAIN MAPP, V38, P5958, DOI 10.1002/hbm.23801; Fujii M, 2002, AURIS NASUS LARYNX, V29, P35, DOI 10.1016/S0385-8146(01)00118-3; Fujii M, 2015, J NEUROSURG, V122, P1390, DOI 10.3171/2014.10.JNS14945; Gabrieli JDE, 1998, P NATL ACAD SCI USA, V95, P906, DOI 10.1073/pnas.95.3.906; Gellrich J, 2018, LARYNGOSCOPE, V128, P1531, DOI 10.1002/lary.27045; Gudziol V, 2009, BRAIN, V132, P3096, DOI 10.1093/brain/awp243; Haehner A, 2008, ARCH OTOLARYNGOL, V134, P621, DOI 10.1001/archotol.134.6.621; HASEGAWA S, 1986, ARCH OTO-RHINO-LARYN, V243, P112, DOI 10.1007/BF00453761; Hummel T, 2007, EUR ARCH OTO-RHINO-L, V264, P237, DOI 10.1007/s00405-006-0173-0; Hummel T, 2009, LARYNGOSCOPE, V119, P496, DOI 10.1002/lary.20101; Ikeda Katsuhisa, 1995, Rhinology (Utrecht), V33, P162; Jiang RS, 2015, OTOLARYNG HEAD NECK, V152, P954, DOI 10.1177/0194599815571272; Jiang RS, 2010, EUR ARCH OTO-RHINO-L, V267, P1563, DOI 10.1007/s00405-010-1240-0; Kinoshita M, 2012, J NEUROSURG, V116, P323, DOI 10.3171/2011.10.JNS11434; Kollndorfer K, 2015, NEUROIMAGE-CLIN, V9, P401, DOI 10.1016/j.nicl.2015.09.004; Kollndorfer K, 2014, NEURAL PLAST, V2014, DOI 10.1155/2014/140419; Konstantinidis I, 2013, LARYNGOSCOPE, V123, pE85, DOI 10.1002/lary.24390; Langdon C, 2018, J NEUROTRAUM, V35, P2641, DOI 10.1089/neu.2017.5230; Li W, 2013, NEUROIMAGE, V78, P46, DOI 10.1016/j.neuroimage.2013.04.011; Lotsch J, 2015, RHINOLOGY, V53, P365, DOI 10.4193/Rhino15.010; Lubke K, 2012, CHEMOSENS PERCEPT, V5, P22, DOI 10.1007/s12078-011-9115-3; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Mueller A, 2005, NEUROREPORT, V16, P475, DOI 10.1097/00001756-200504040-00011; Negoias S, 2017, BRAIN IMAGING BEHAV, V11, P998, DOI 10.1007/s11682-016-9567-9; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Pekala K, 2016, INT FORUM ALLERGY RH, V6, P299, DOI 10.1002/alr.21669; Reden J, 2006, ARCH OTOLARYNGOL, V132, P265, DOI 10.1001/archotol.132.3.265; Reden J, 2012, LARYNGOSCOPE, V122, P1906, DOI 10.1002/lary.23405; Rochefort C, 2002, J NEUROSCI, V22, P2679, DOI 10.1523/JNEUROSCI.22-07-02679.2002; Rombaux P, 2012, RHINOLOGY, V50, P13, DOI 10.4193/Rhino11.126; Rombaux P, 2009, RHINOLOGY, V47, P3; Royet Jean-Pierre, 2011, Front Hum Neurosci, V5, P65, DOI 10.3389/fnhum.2011.00065; Royet JP, 1999, J COGNITIVE NEUROSCI, V11, P94, DOI 10.1162/089892999563166; Schwob James E., 2002, Anatomical Record, V269, P33, DOI 10.1002/ar.10047; Seghier ML, 2010, J NEUROSCI, V30, P16809, DOI 10.1523/JNEUROSCI.3377-10.2010; Sezille C, 2015, NEUROSCIENCE, V287, P23, DOI 10.1016/j.neuroscience.2014.12.011; Sommer JU, 2012, J NEUROSCI METH, V209, P189, DOI 10.1016/j.jneumeth.2012.05.026; Sorokowska A, 2017, RHINOLOGY, V55, P17, DOI 10.4193/Rhin16.195; Stocker T, 2006, MAGN RESON MED, V56, P824, DOI 10.1002/mrm.21011; SUMNER D, 1967, BRAIN, V90, P187, DOI 10.1093/brain/90.1.187; Temmel AFP, 2002, ARCH OTOLARYNGOL, V128, P635, DOI 10.1001/archotol.128.6.635; Tomii M, 2012, NEUROSURG REV, V35, P555, DOI 10.1007/s10143-012-0378-1; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Welge-Lussen A, 2012, RHINOLOGY, V50, P67, DOI 10.4193/Rhino11.141; Yousem DM, 1999, ACAD RADIOL, V6, P264, DOI 10.1016/S1076-6332(99)80449-8; Yousem DM, 1996, AM J NEURORADIOL, V17, P1171; ZUSHO H, 1982, ARCH OTOLARYNGOL, V108, P90	58	15	18	2	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0023-852X	1531-4995		LARYNGOSCOPE	Laryngoscope	AUG	2019	129	8					1737	1743		10.1002/lary.27832			7	Medicine, Research & Experimental; Otorhinolaryngology	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Otorhinolaryngology	IS0JQ	WOS:000481836100011	30848489				2022-02-06	
J	Pozzato, I; Tate, RL; Rosenkoetter, U; Cameron, ID				Pozzato, Ilaria; Tate, Robyn L.; Rosenkoetter, Ulrike; Cameron, Ian D.			Epidemiology of hospitalised traumatic brain injury in the state of New South Wales, Australia: a population-based study	AUSTRALIAN AND NEW ZEALAND JOURNAL OF PUBLIC HEALTH			English	Article						brain injury; epidemiology; incidence	NEW-ZEALAND; HEAD; MORTALITY; SEVERITY; ALCOHOL; ADULTS; RISK; PREVALENCE; DISCHARGE; CHILDREN	Objective: To describe the population-based incidence and epidemiological characteristics of hospitalised traumatic brain injury (TBI) in New South Wales (NSW), Australia. Methods: One-year statewide hospital admission data from the NSW Department of Health were analysed. TBI cases were identified using a combination of TBI-related diagnostic and external cause codes from the International Classification of Diseases (ICD-10(th) Revision). Sociodemographics, causes, associated factors, severity and medical details of hospitalisation were examined. Results: There were 6,827 hospitalised TBI cases that met review criteria. Incidence rate was 99.1/100,000 population. Incidence in persons older than 75 years of age and residents in remote areas was three times higher. Aboriginal and Torres Strait Islander peoples were 1.7 times more likely to sustain a TBI than the general population, and risk was greater for all NSW residents from areas that were remote and disadvantaged-socioeconomically. Older adults and those with severe injuries showed prolonged hospitalisation, higher morbidity and mortality. Conclusions: Overall TBI incidence in NSW is lower than international estimates. Nevertheless, groups with higher incidence rates and/or poor in-hospital outcomes were identified, highlighting directions for prevention and future research.	[Pozzato, Ilaria; Tate, Robyn L.; Rosenkoetter, Ulrike; Cameron, Ian D.] Univ Sydney, Kolling Inst Med Res, Sydney Med Sch Northern, John Walsh Ctr Rehabil Res, Sydney, NSW, Australia		Tate, RL (corresponding author), Univ Sydney, Royal North Shore Hosp, Kolling Inst Med Res, John Walsh Ctr Rehabil Res,Sydney Med Sch Norther, Level 12, St Leonards, NSW 2065, Australia.	robyn.tate@sydney.edu.au					*AUSTR BUR STAT, 2007, 32010 ABS; Australian Bureau of Statistics, 2006, 12160 ABS; Australian Bureau of Statistics, 2006, CENS POP HOUS SOC IN; Australian Bureau of Statistics, 2006, POP CHAR AB TORR STR; Bakhshaei M, 2016, MCGILL J EDUC, V51, P689, DOI 10.7202/1038598ar; Ballestas T, 2011, EPIDEMIOLOGY INJURY; Barker-Collo SL, 2009, NEUROEPIDEMIOLOGY, V32, P1, DOI 10.1159/000170084; Berry JG, 2010, INJURY PREV, V16, P198, DOI 10.1136/ip.2009.022442; Chan V, 2013, BMC GERIATR, V13, DOI 10.1186/1471-2318-13-97; Chang VC, 2014, OCCUP ENVIRON MED, V71, P695, DOI 10.1136/oemed-2014-102097; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Erlebach R, 2017, MINERVA ANESTESIOL, V83, P1169, DOI 10.23736/S0375-9393.17.11837-7; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feigin VL, 2010, BEST PRACT RES-CLIN, V24, P485, DOI 10.1016/j.bpa.2010.10.006; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Harradine PG, 2004, MED J AUSTRALIA, V181, P130, DOI 10.5694/j.1326-5377.2004.tb06202.x; Harvey LA, 2012, INJURY, V43, P1821, DOI 10.1016/j.injury.2012.07.188; Helps Y, 2008, INJURY RES STAT SERI, V45; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; JENNETT B, 1976, J NEUROL NEUROSUR PS, V39, P647, DOI 10.1136/jnnp.39.7.647; KRAUS JF, 1989, AM J PUBLIC HEALTH, V79, P294, DOI 10.2105/AJPH.79.3.294; Kumar RG, 2018, J HEAD TRAUMA REHAB, V33, P15, DOI 10.1097/HTR.0000000000000273; Lakhani A, 2017, BRAIN INJURY, V31, P1718, DOI 10.1080/02699052.2017.1374468; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Mollayeva T, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2017-018626; Moore E, 2014, J HEAD TRAUMA REHAB, V29, P239, DOI 10.1097/HTR.0b013e31828f9876; Moorin R, 2014, J NEUROL, V261, P1726, DOI 10.1007/s00415-014-7411-y; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Opreanu RC, 2010, J AM COLL SURGEONS, V210, P997, DOI 10.1016/j.jamcollsurg.2010.01.036; Pasco JA, 2011, J BONE MINER RES, V26, P1648, DOI 10.1002/jbmr.393; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Quan HD, 2011, AM J EPIDEMIOL, V173, P676, DOI 10.1093/aje/kwq433; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shandro JR, 2009, J TRAUMA, V66, P1584, DOI 10.1097/TA.0b013e318182af96; Stephenson S, 2004, INJURY PREV, V10, P379, DOI 10.1136/ip.2004.005561; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tate RL, 1998, AUST NZ J PUBL HEAL, V22, P419, DOI 10.1111/j.1467-842X.1998.tb01406.x; Wagner AK, 2000, J TRAUMA, V49, P404, DOI 10.1097/00005373-200009000-00004; WHO, 2004, ICD 10 INT STAT CLAS, V2; World Health Organization, 2014, INJ VIOL FACTS 2014	41	15	15	0	0	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1326-0200	1753-6405		AUST NZ J PUBL HEAL	Aust. N. Z. Publ. Health	AUG	2019	43	4					382	388		10.1111/1753-6405.12878			7	Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	IN7WE	WOS:000478891700014	30830715	gold			2022-02-06	
J	Ruston, SW; Kamrath, JK; Zanin, AC; Posteher, K; Corman, SR				Ruston, Scott W.; Kamrath, Jessica K.; Zanin, Alaina C.; Posteher, Karlee; Corman, Steven R.			Performance Versus Safety: Understanding the Logics of Cultural Narratives Influencing Concussion Reporting Behaviors	COMMUNICATION & SPORT			English	Article						concussion reporting; cultural narrative; narrative logic; media influence; sports communication	SPORT; MEDIA; EXPERIENCES; INJURY; FEMALE; IMPACT	Athlete safety and concussion injury have garnered considerable attention recently, and appropriate evaluation of athletes following head impacts depends, in part, on athletes' self-reporting of the symptoms. The National Collegiate Athletic Association has focused primarily on concussion injury education to encourage self-reporting; however, such efforts have not been especially effective and many potential injuries continue to go unreported. This research investigates cultural narratives, derived from sports media and popular culture, and how their narrative logics contribute to the context in which student-athletes make head injury reporting decisions and how these narratives offer templates for understanding potential consequences. We argue that performance-oriented narratives are more prevalent and showcase pathways to more immediate satisfaction of desires or goals. Ultimately, we argue that not only does analysis of prevailing cultural narratives illuminate the context in which athletes make reporting decisions but also that such understanding could inform narrative-based interventions in order to emphasize and model recommended behaviors, such as injury reporting, and values, such as long-term brain health and player wellness.	[Ruston, Scott W.; Kamrath, Jessica K.; Zanin, Alaina C.; Posteher, Karlee; Corman, Steven R.] Arizona State Univ, Tempe, AZ USA		Ruston, SW (corresponding author), Arizona State Univ, GSI, POB 5603, Tempe, AZ 85287 USA.	scott.ruston@asu.edu			NCAA Mind Matters Research Challenge program	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Funding for this research was provided by the NCAA Mind Matters Research Challenge program.	Adams A, 2010, J LANG SOC PSYCHOL, V29, P278, DOI 10.1177/0261927X10368833; Anderson E, 2012, MEN MASC, V15, P152, DOI 10.1177/1097184X11430127; [Anonymous], 2011, ESPN; Baezconde-Garbanati L. A., 2014, Journal of Communication in Healthcare, V7, P82; Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Baker, 2003, CONTESTING IDENTITIE; Baker Aaron., 1997, OUT BOUNDS SPORTS ME; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Bernstein R., 2015, GIRLS INTERRUPTED VI; Bernstein RJ, 2016, ROUTL STUD AMER PHIL, P100; Boyd Todd, 2008, YOUNG BLACK RICH FAM; Branigan E, 1992, NARRATIVE COMPREHENS; Brennan D., 2018, OTTAWA SUN      0127; Bruce T, 2015, INT REV SOCIOL SPORT, V50, P380, DOI 10.1177/1012690214539483; Burke C., 2016, SI COM          1219; Burke Kenneth., 1989, SYMBOLS SOC; Busanich R, 2014, PSYCHOL SPORT EXERC, V15, P705, DOI 10.1016/j.psychsport.2013.10.002; Charmaz K., 2014, BROKERAGE CLOSURE IN; Demovsky R., 2017, ESPN; DUNNING E, 2005, BARBARIANS GENTLEMEN; Ellingson LL, 2009, ROUTLEDGE HANDBOOK OF APPLIED COMMUNICATION RESEARCH, P129; Fink JS, 2013, SPORT MANAG REV, V16, P17, DOI 10.1016/j.smr.2011.12.005; FISHER WR, 1984, COMMUN MONOGR, V51, P1, DOI 10.1080/03637758409390180; Halverson JR, 2011, MASTER NARRATIVES OF ISLAMIST EXTREMISM, P1; HERMAN D, 2012, NARRATIVE THEORY COR; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Korman C., 2018, US TODAY; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lewis N., 2013, COMMUNICATION SPORT, V3, P219; Marie J., 2013, BLEACHER REPORT 0618; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; National Collegiate Athletic Association, 2017, PROB COMP HIGH SCH; National Collegiate Athletic Association, 2014, NCAA DOD LAUNCH CONC; National Collegiate Athletic Association, 2015, MIND MATT CHALL; New J., 2015, INSIDE HIGHER ED; NFL Films (Production company), 2017, NFL TOP 10 AM RUNS T; NIXON HL, 1993, SOCIOL SPORT J, V10, P183, DOI 10.1123/ssj.10.2.183; Polkinghorne, 1988, NARRATIVE KNOWING HU; Porter M., 2018, PALM BEACH POST 0108; Puskar G. J., 2016, NY TIMES; Raney A. A., 2009, HDB SPORTS MEDIA; Reichertz J., 2007, SAGE HDB GROUNDED TH, P214, DOI DOI 10.4135/9781848607941.N10; Riddle R., 2015, BLEACHER REPORT 0308; Rodriguez T., 2017, SUNDIAL         0507; Ruston S., 2016, MODELING SOCIOCULTUR, P27; Sabo D., 2009, J INTERCOLLEGIATE SP, V2, P145, DOI [10.1123/jis.2.1.145, DOI 10.1123/jis.2.1.145]; Sanderson J, 2017, COMMUN SPORT, V5, P267, DOI 10.1177/2167479515623455; Sanderson J, 2016, COMMUN SPORT, V4, P3, DOI 10.1177/2167479514536982; Schank R, 1977, SCRIPTS PLANS GOALS; Scott R., 2015, CONCUSSION MOTION PI; Smith B, 2009, PSYCHOL SPORT EXERC, V10, P279, DOI 10.1016/j.psychsport.2008.07.012; Spence C. D, 1983, PSYCHOANALYSIS CONT, V6, P457; Tovares AV, 2010, J LANG SOC PSYCHOL, V29, P261, DOI 10.1177/0261927X10368829; Tracy S.J., 2013, QUALITATIVE RES METH; Trotter J., 2015, ESPN; Tull T., 2013, 42 MOTION PICTURE; Viera M., 2010, NY TIMES; Walsh AJ, 2001, J PHILOS SPORT, V28, P53, DOI 10.1080/00948705.2001.9714600; Wetzel D., 2016, YAHOO SPORTS    1219; Winterbottom A, 2008, SOC SCI MED, V67, P2079, DOI 10.1016/j.socscimed.2008.09.037	60	15	15	1	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2167-4795	2167-4809		COMMUN SPORT	Commun. Sport	AUG	2019	7	4					529	548		10.1177/2167479518786709			20	Communication; Hospitality, Leisure, Sport & Tourism	Social Science Citation Index (SSCI)	Communication; Social Sciences - Other Topics	IF7FF	WOS:000473246200006					2022-02-06	
J	Sun, MJ; Brady, RD; Casillas-Espinosa, PM; Wright, DK; Semple, BD; Kim, HA; Mychasiuk, R; Sobey, CG; O'Brien, TJ; Vinh, A; McDonald, SJ; Shultz, SR				Sun, Mujun; Brady, Rhys D.; Casillas-Espinosa, Pablo M.; Wright, David K.; Semple, Bridgette D.; Kim, Hyun Ah; Mychasiuk, Richelle; Sobey, Christopher G.; O'Brien, Terence J.; Vinh, Antony; McDonald, Stuart J.; Shultz, Sandy R.			Aged rats have an altered immune response and worse outcomes after traumatic brain injury	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Neuroinflammation; Aging; Immunosenescence; Immunology; MRI; DTI	TELOMERE LENGTH; JUVENILE RATS; ANIMAL-MODELS; TISSUE; NEUROINFLAMMATION; BIOMARKERS; INCREASES; RECOVERY; NEURONS; MICE	Initial studies suggest that increased age is associated with worse outcomes after traumatic brain injury (TBI), though the pathophysiological mechanisms responsible for this remain unclear. Immunosenescence (i.e., dysregulation of the immune system due to aging) may play a significant role in influencing TBI outcomes. This study therefore examined neurological outcomes and immune response in young-adult (i.e., 10 weeks old) compared to middle-aged (i.e., 1 year old) rats following a TBI (i.e., fluid percussion) or sham-injury. Rats were euthanized at either 24 h or one-week post-injury to analyze immune cell populations in the brain and periphery via flow cytometry, as well as telomere length (i.e., a biomarker of neurological health). Behavioral testing, as well as volumetric and diffusion-weighted MRI, were also performed in the one-week recovery rats to assess for functional deficits and brain damage. Middle-aged rats had worse sensorimotor deficits and shorter telomeres after TBI compared to young rats. Both aging and TBI independently worsened cognitive function and cortical volume. These changes occurred in the presence of fewer total leukocytes, fewer infiltrating myeloid cells, and fewer microglia in the brains of middle-aged TBI rats compared to young rats. These findings indicate that middle-aged rats have worse sensorimotor deficits and shorter telomeres after TBI than young rats, and this may be related to an altered neuroimmune response. Although further studies are required, these findings have important implications for understanding the pathophysiology and optimal treatment strategies in TBI patients across the life span.	[Sun, Mujun; Brady, Rhys D.; Casillas-Espinosa, Pablo M.; Wright, David K.; Semple, Bridgette D.; Mychasiuk, Richelle; O'Brien, Terence J.; McDonald, Stuart J.; Shultz, Sandy R.] Monash Univ, Dept Neurosci, Cent Clin Sch, Melbourne, Vic, Australia; [Sun, Mujun; Brady, Rhys D.; Casillas-Espinosa, Pablo M.; Semple, Bridgette D.; O'Brien, Terence J.; Shultz, Sandy R.] Univ Melbourne, Royal Melbourne Hosp, Dept Med, Melbourne, Vic, Australia; [Kim, Hyun Ah; Sobey, Christopher G.; Vinh, Antony; McDonald, Stuart J.] La Trobe Univ, Dept Physiol Anat & Microbiol, Bundoora, Vic, Australia; [Mychasiuk, Richelle] Univ Calgary, Dept Psychol, Calgary, AB, Canada		Shultz, SR (corresponding author), Monash Univ, Dept Neurosci, Melbourne, Vic 3004, Australia.	sandy.shultz@monash.edu	O'Brien, Terence/AAU-5525-2021; O'Brien, Terence/L-8102-2013	Wright, David/0000-0002-7535-8651; Sun, Mujun/0000-0002-9923-9913; O'Brien, Terence/0000-0002-7198-8621	National Health and Medical Research CouncilNational Health and Medical Research Council of Australia	This study was funded by grants and fellowship to SRS from the National Health and Medical Research Council.	Abdullah AI, 2012, MOL NEUROBIOL, V45, P586, DOI 10.1007/s12035-012-8277-6; Bao F, 2012, J NEUROTRAUM, V29, P2375, DOI 10.1089/neu.2012.2408; Brady RD, 2019, NEUROBIOL DIS, V123, P8, DOI 10.1016/j.nbd.2018.08.007; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Damani MR, 2011, AGING CELL, V10, P263, DOI 10.1111/j.1474-9726.2010.00660.x; Doran SJ, 2019, J NEUROTRAUM, V36, P1040, DOI 10.1089/neu.2018.6019; Forero DA, 2016, J GERONTOL A-BIOL, V71, P1069, DOI 10.1093/gerona/glw053; Frugier T, 2010, J NEUROTRAUM, V27, P497, DOI 10.1089/neu.2009.1120; Gon Y, 1996, CLIN EXP IMMUNOL, V106, P120; Goronzy JJ, 2013, NAT IMMUNOL, V14, P428, DOI 10.1038/ni.2588; Guan JZ, 2008, J GERONTOL A-BIOL, V63, P467, DOI 10.1093/gerona/63.5.467; Gupta R, 2016, REV NEUROSCIENCE, V27, P93, DOI 10.1515/revneuro-2015-0017; HAMM RJ, 1992, NEUROSURGERY, V31, P1072, DOI 10.1227/00006123-199212000-00013; Hefendehl JK, 2014, AGING CELL, V13, P60, DOI 10.1111/acel.12149; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Hoane MR, 2004, BEHAV BRAIN RES, V153, P189, DOI 10.1016/j.bbr.2003.11.012; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jin XM, 2012, PLOS ONE, V7, DOI [10.1371/journal.pone.0041892, 10.1371/journal.pone.0040637]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kim HA, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00365; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Natrajan MS, 2015, BRAIN, V138, P3581, DOI 10.1093/brain/awv289; Ndode-Ekane XE, 2019, EPILEPSY RES, V151, P7, DOI 10.1016/j.eplepsyres.2019.01.006; Nissinen J, 2017, EPILEPSY RES, V136, P18, DOI 10.1016/j.eplepsyres.2017.07.005; Onyszchuk G, 2008, J NEUROTRAUM, V25, P153, DOI 10.1089/neu.2007.0430; Ritzel RM, 2019, NEUROBIOL AGING, V77, P194, DOI 10.1016/j.neurobiolaging.2019.02.010; Rossi DJ, 2005, P NATL ACAD SCI USA, V102, P9194, DOI 10.1073/pnas.0503280102; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; SAUL TG, 1981, J NEUROSURG, V54, P596, DOI 10.3171/jns.1981.54.5.0596; Scherbel U, 1999, P NATL ACAD SCI USA, V96, P8721, DOI 10.1073/pnas.96.15.8721; Shakur H, 2009, TRIALS, V10, DOI 10.1186/1745-6215-10-109; Shaw AC, 2013, NAT REV IMMUNOL, V13, P875, DOI 10.1038/nri3547; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Shultz SR, 2015, BRAIN, V138, P1297, DOI 10.1093/brain/awv053; Shultz SR, 2014, J NEUROTRAUM, V31, P976, DOI 10.1089/neu.2013.3106; Shultz SR, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-26; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Sierra A, 2007, GLIA, V55, P412, DOI 10.1002/glia.20468; Sun MJ, 2018, BRAIN BEHAV IMMUN, V69, P618, DOI 10.1016/j.bbi.2018.01.007; Sun MJ, 2017, BRAIN BEHAV IMMUN, V66, P359, DOI 10.1016/j.bbi.2017.08.005; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Tucker AM, 2011, CURR ALZHEIMER RES, V8, P354; Tucker LB, 2018, NEUROSCI BIOBEHAV R, V88, P187, DOI 10.1016/j.neubiorev.2018.03.010; von Zglinicki T, 2005, CURR MOL MED, V5, P197; Wasserman JK, 2008, EUR J NEUROSCI, V28, P1316, DOI 10.1111/j.1460-9568.2008.06442.x; Webster KM, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-016-0786-1; Webster KM, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0457-7; Wortman RC, 2018, ANN CLIN TRANSL NEUR, V5, P1588, DOI 10.1002/acn3.667; Wright DK, 2018, NEUROIMAGE-CLIN, V18, P315, DOI 10.1016/j.nicl.2018.01.033; Wright DK, 2017, ANN CLIN TRANSL NEUR, V4, P640, DOI 10.1002/acn3.441; Xiong Y, 2018, CHIN J TRAUMATOL, V21, P137, DOI 10.1016/j.cjtee.2018.02.003; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yates MA, 2007, BRAIN RES, V1142, P13, DOI 10.1016/j.brainres.2007.01.043; Zhang C, 2005, J NEUROTRAUM, V22, P1456, DOI 10.1089/neu.2005.22.1456; Zhao C, 2006, NEUROBIOL AGING, V27, P1298, DOI 10.1016/j.neurobiolaging.2005.06.008	58	15	16	2	22	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	AUG	2019	80						536	550		10.1016/j.bbi.2019.04.038			15	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	IM6LX	WOS:000478105500052	31039431				2022-02-06	
J	Bivona, U; Costa, A; Contrada, M; Silvestro, D; Azicnuda, E; Aloisi, M; Catania, G; Ciurli, P; Guariglia, C; Caltagirone, C; Formisano, R; Prigatano, GP				Bivona, U.; Costa, A.; Contrada, M.; Silvestro, D.; Azicnuda, E.; Aloisi, M.; Catania, G.; Ciurli, P.; Guariglia, C.; Caltagirone, C.; Formisano, R.; Prigatano, G. P.			Depression, apathy and impaired self-awareness following severe traumatic brain injury: a preliminary investigation	BRAIN INJURY			English	Article						Severe traumatic brain injury; mood disorders; apathy; self-awareness; neuropsychological rehabilitation	COMPETENCE RATING-SCALE; CARD SORTING TEST; CLOSED-HEAD-INJURY; TORONTO-ALEXITHYMIA-SCALE; EXECUTIVE FUNCTION; BEHAVIORAL LIMITATIONS; EMOTIONAL ADJUSTMENT; FRONTAL-LOBE; DEFICITS; PATIENT	Primary Objective: The primary aim of this study was to determine the frequency of severe impaired self-awareness (ISA) in patients with severe traumatic brain injury (TBI) and the correlates of selected clinical, neuropsychiatric and cognitive variables. The secondary aim of the study was to assess depression and apathy on the basis of their level of self-awareness. Methods: Thirty patients with severe TBI and 30 demographically matched healthy control subjects (HCs) were compared on measures of ISA, depression, anxiety, alexithymia, neuropsychiatric symptoms and cognitive flexibility. Results: Twenty percent of the patients demonstrated severe ISA. Severe post-acute ISA was associated with more severe cognitive inflexibility, despite the absence of differences in TBI severity, as evidenced by a Glasgow Coma Scale (GCS) score lower than 9 in all cases in the acute phase. Patients with severe ISA showed lower levels of depression and anxiety but tended to show more apathy and to have greater difficulty describing their emotional state than patients with severe TBI who showed minimal or no disturbance in self-awareness. Conclusion: These findings support the general hypothesis that severe ISA following severe TBI is typically not associated with depression and anxiety, but rather with apathy and cognitive inflexibility.	[Bivona, U.; Contrada, M.; Silvestro, D.; Azicnuda, E.; Aloisi, M.; Catania, G.; Ciurli, P.; Guariglia, C.; Caltagirone, C.; Formisano, R.] IRCCS, Santa Lucia Fdn, Rome, Italy; [Costa, A.; Guariglia, C.; Caltagirone, C.] Unicusano Univ, Rome, Italy; [Guariglia, C.; Caltagirone, C.] Sapienza Univ, Rome, Italy; [Caltagirone, C.] Tor Vergata Univ, Rome, Italy; [Prigatano, G. P.] St Josephs Hosp, Barrow Neurol Inst, Dept Clin Neuropsychol, Phoenix, AZ USA		Bivona, U (corresponding author), Santa Lucia Fdn, Postcoma Unit, Rome, Italy.	u.bivona@hsantalucia.it	Contrada, MArianna/AAB-6049-2022	Aloisi, Marta/0000-0002-8907-5847; guariglia, cecilia/0000-0001-7474-6030; BIVONA, UMBERTO/0000-0001-6951-8017; CONTRADA, MARIANNA/0000-0002-9825-1347			Al-Adawi S, 2007, BRAIN INJURY, V21, P385, DOI 10.1080/02699050701311059; ALLOY LB, 1979, J EXP PSYCHOL GEN, V108, P441, DOI 10.1037/0096-3445.108.4.441; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Andersson S, 1999, PSYCHOL MED, V29, P447, DOI 10.1017/S0033291798008046; Arciniegas DB, 2014, PSYCHIAT CLIN N AM, V37, P31, DOI 10.1016/j.psc.2013.12.001; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Arnould A, 2018, J NEUROPSYCHOL, V12, P101, DOI 10.1111/jnp.12107; Babinski J, 1914, REV NEUROL, V27, P845; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P33, DOI 10.1016/0022-3999(94)90006-X; BAGBY RM, 1994, J PSYCHOSOM RES, V38, P23, DOI 10.1016/0022-3999(94)90005-1; Barcelo F, 2002, NEUROPSYCHOLOGIA, V40, P349, DOI 10.1016/S0028-3932(01)00110-5; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bivona U, 2014, J HEAD TRAUMA REHAB, V29, P157, DOI 10.1097/HTR.0b013e3182864f0b; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Borgaro SR, 2003, BRAIN INJURY, V17, P847, DOI 10.1080/0269905031000089350; Bowden SC, 1998, NEUROPSYCHOL REHABIL, V8, P243, DOI 10.1080/713755573; Carroll E, 2011, NEUROPSYCHOL REHABIL, V21, P289, DOI 10.1080/09602011.2011.555972; Chiou KS, 2011, J INT NEUROPSYCH SOC, V17, P720, DOI 10.1017/S1355617711000658; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; Cooper-Evans S, 2008, NEUROPSYCHOL REHABIL, V18, P607, DOI 10.1080/09602010801948516; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Demakis GJ, 2003, NEUROPSYCHOLOGY, V17, P255, DOI 10.1037/0894-4105.17.2.255; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dimarco, 2002, EURA MEDICOPHYS, V38, P167; Dockree PM, 2015, J INT NEUROPSYCH SOC, V21, P473, DOI 10.1017/S1355617715000594; Douven E, 2017, NEUROPSYCHOL REV, V27, P202, DOI 10.1007/s11065-017-9356-2; Evans CC, 2005, J HEAD TRAUMA REHAB, V20, P488, DOI 10.1097/00001199-200511000-00002; Fann J, 1996, J HEAD TRAUMA REHAB, V11, P96, DOI DOI 10.1176/ajp.152.10.1493; Pagulayan KF, 2007, J INT NEUROPSYCH SOC, V13, P561, DOI 10.1017/S1355617707070713; FEDOROFF JP, 1992, AM J PSYCHIAT, V149, P918; Finset A, 2000, BRAIN INJURY, V14, P887; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Fleming JM, 1996, BRAIN INJURY, V10, P1; FORDYCE DJ, 1983, J NEUROL NEUROSUR PS, V46, P620, DOI 10.1136/jnnp.46.7.620; Forgas JP, 1998, J PERS SOC PSYCHOL, V74, P565, DOI 10.1037/0022-3514.74.3.565; Gainotti G, 2002, CURR OPIN NEUROL, V15, P85, DOI 10.1097/00019052-200202000-00013; Gasquoine P., 1992, NEUROPSYCHOLOGY, V6, P187, DOI [10.1037/0894-4105.6.3.187., DOI 10.1037/0894-4105.6.3.187, https://doi.org/10.1037/0894-4105.6.3.187]; Gasquoine PG, 2016, NEUROPSYCHOL REHABIL, V26, P261, DOI 10.1080/09602011.2015.1011665; Geldmacher DS, 1997, BRAIN INJURY, V11, P59, DOI 10.1080/026990597123818; GODFREY HPD, 1993, NEW ZEAL MED J, V106, P301; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Greve KW, 1999, ARCH CLIN NEUROPSYCH, V14, P497; Greve KW, 1998, ARCH CLIN NEUROPSYCH, V13, P597; Hagen C., 1972, LEVELS COGNITIVE FUN; Ham TE, 2014, BRAIN, V137, P586, DOI 10.1093/brain/awt350; Hama S, 2007, EUR ARCH PSY CLIN N, V257, P149, DOI 10.1007/s00406-006-0698-7; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hart T, 2005, J HEAD TRAUMA REHAB, V20, P333, DOI 10.1097/00001199-200507000-00005; Hart T, 2003, ARCH PHYS MED REHAB, V84, P204, DOI 10.1053/apmr.2003.50019; Heaton R.K., 1993, ODESSA PSYCHOL ASSES, V4, P1; Heaton RK, 2000, WCST WISCONSIN CARD, P1; Heilman K. M., 2010, STUDY ANOSOGNOSIA, P89; Heilman K.M., 1991, AWARENESS DEFICIT BR, P53; Hoofien D, 2006, ISR J PSYCHIATR REL, V43, P296; JENNETT B, 1975, LANCET, V1, P480; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Jorge RE, 2014, PSYCHIAT CLIN N AM, V37, P13, DOI 10.1016/j.psc.2013.11.005; Kaufman AS, 1990, ASSESSING ADULT ADOL; Keenan J.P., 2003, FACE MIRROR SEARCH O; Lane-Brown A, 2009, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006341.pub2; Lange F, 2017, NEUROSCI BIOBEHAV R, V83, P496, DOI 10.1016/j.neubiorev.2017.09.011; Larsen JK, 2003, J PSYCHOSOM RES, V54, P533, DOI 10.1016/S0022-3999(02)00466-X; Leahy BJ, 1998, BRAIN INJURY, V12, P1025, DOI 10.1080/026990598121936; Leathem JM, 1998, J CLIN EXP NEUROPSYC, V20, P694, DOI 10.1076/jcen.20.5.694.1122; Lehtonen S, 2005, BRAIN INJURY, V19, P239, DOI 10.1080/0269905040004310; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; LEVIN HS, 1995, J NEUROTRAUM, V12, P601, DOI 10.1089/neu.1995.12.601; Levy ML, 1998, J NEUROPSYCH CLIN N, V10, P314, DOI 10.1176/jnp.10.3.314; Luria, 1996, HIGHER CORTICAL FUNC; Malec JF, 2007, J HEAD TRAUMA REHAB, V22, P156, DOI 10.1097/01.HTR.0000271116.12028.af; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; MATTSON AJ, 1990, J NERV MENT DIS, V178, P282, DOI 10.1097/00005053-199005000-00002; Mauri MC, 2014, ASIAN J PSYCHIATR, V12, P118, DOI 10.1016/j.ajp.2014.07.003; McCullagh S., 2011, TRAUMATIC BRAIN INJU, P279; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Miller EK, 2001, ANNU REV NEUROSCI, V24, P167, DOI 10.1146/annurev.neuro.24.1.167; Moriguchi Y, 2007, CEREB CORTEX, V17, P2223, DOI 10.1093/cercor/bhl130; Morton N, 2010, J INT NEUROPSYCH SOC, V16, P1089, DOI 10.1017/S1355617710000925; Murphy KJ., 2000, NEUROPSYCHOLOGY EMOT, P340; Nelson T.O., 1990, PSYCHOL LEARN MOTIV, V26, P125, DOI [10.1016/s0079-7421(08)60053-5, DOI 10.1016/S0079-7421(08)60053-5]; Njomboro P, 2014, BMC NEUROL, V14, DOI 10.1186/1471-2377-14-18; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Nyhus E, 2009, BRAIN COGNITION, V71, P437, DOI 10.1016/j.bandc.2009.03.005; O'Keeffe F, 2007, J INT NEUROPSYCH SOC, V13, P38, DOI 10.1017/S1355617707070075; Ogiwara H, 2008, 2008 5TH INTERNATIONAL SYMPOSIUM ON TURBO CODES AND RELATED TOPICS, P373, DOI 10.1109/TURBOCODING.2008.4658728; Ownsworth T., 2005, NEUROPSYCHOANALYSIS, V7, P83; Ownsworth T, 2008, DISABIL REHABIL, V30, P531, DOI 10.1080/09638280701355694; Ownsworth T, 2007, NEUROPSYCHOL REHABIL, V17, P129, DOI 10.1080/09602010600615506; Paholpak P, 2016, GENOMICS, CIRCUITS, AND PATHWAYS IN CLINICAL NEUROPSYCHIATRY, P327, DOI 10.1016/B978-0-12-800105-9.00021-4; POLLENS RD, 1988, J COGNITIVE REHABILI, V6, P26; Ponsford J, 2011, J NEUROTRAUM, V28, P937, DOI 10.1089/neu.2010.1516; Prigatano G. P., 1991, AWARENESS DEFICIT BR; Prigatano G.P., 1999, PRINCIPLES NEUROPSYC; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano G.P., 2010, STUDY ANOSOGNOSIA; Prigatano GP, 2014, CORTEX, V61, P81, DOI 10.1016/j.cortex.2014.07.014; Prigatano George P, 1993, Clin Neuropsychol, V7, P123, DOI 10.1080/13854049308401514; Prigatano GP, 1999, ARCH PHYS MED REHAB, V80, P77, DOI 10.1016/S0003-9993(99)90311-8; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 2003, NEUROPSYCHOL REHABIL, V13, P13, DOI 10.1080/09602010244000282; Prigatano GP, 1996, CLIN NEUROPSYCHOL, V10, P191, DOI 10.1080/13854049608406680; PRIGATANO GP, 1990, ARCH PHYS MED REHAB, V71, P1058; Prigatano GP, 1998, J HEAD TRAUMA REHAB, V13, P29, DOI 10.1097/00001199-199810000-00005; Prigatano GP, 2009, NEUROPSYCHOLOGICAL A, V3; Rao V, 2013, PSYCHOSOMATICS, V54, P403, DOI 10.1016/j.psym.2013.01.001; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; RAPP SR, 1990, PSYCHOL ASSESSMENT, V2, P243, DOI DOI 10.1037/1040-3590.2.3.243; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Richardson C, 2015, J HEAD TRAUMA REHAB, V30, pE43, DOI 10.1097/HTR.0000000000000048; Sawchyn JM, 2005, J HEAD TRAUMA REHAB, V20, P301, DOI 10.1097/00001199-200507000-00003; Schefft BK, 1997, CLIN NEUROPSYCHOLOGY, P237; Schonberger M, 2011, J INT NEUROPSYCH SOC, V17, P781, DOI 10.1017/S1355617711000701; Sherer M, 1998, BRAIN INJURY, V12, P63, DOI 10.1080/026990598122863; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Sherer M, 1998, J HEAD TRAUMA REHAB, V13, P52, DOI 10.1097/00001199-199810000-00007; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Smeets SMJ, 2012, J HEAD TRAUMA REHAB, V27, P433, DOI 10.1097/HTR.0b013e3182242f98; Spielberger CD, 1989, MANUAL STATE TRAIT A, V2nd; Stuss D., 1991, AWARENESS DEFICIT BR, P63; Stuss DT, 1999, J NEUROSURG, V90, P635, DOI 10.3171/jns.1999.90.4.0635; Tranel D., 2002, AM PSYCHIAT ASS PUBL, P93; VanReekum R, 1996, BRAIN INJURY, V10, P319, DOI 10.1080/026990596124340; WALKER SN, 1987, NURS RES, V36, P76; Wallace CA, 2000, BRAIN INJURY, V14, P549; Watanabe Y, 2000, CLIN REHABIL, V14, P172, DOI 10.1191/026921500666833742; Williams C, 2010, J CLIN EXP NEUROPSYC, V32, P259, DOI 10.1080/13803390902976940; Worthington A, 2018, NEUROPSYCHOLOGIA, V118, P40, DOI 10.1016/j.neuropsychologia.2018.04.012; Wortzel HS, 2009, J NEUROPSYCH CLIN N, V21, P463, DOI 10.1176/appi.neuropsych.21.4.463; Zgaljardic DJ, 2015, J NEUROTRAUM, V32, P1911, DOI 10.1089/neu.2014.3569; Zimmermann N, 2017, COGN NEUROPSYCHIATRY, V22, P346, DOI 10.1080/13546805.2017.1330191	132	15	15	0	6	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JUL 29	2019	33	9					1245	1256		10.1080/02699052.2019.1641225		JUL 2019	12	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	IO0TH	WOS:000476038300001	31304792				2022-02-06	
J	Bernardo-Colon, A; Vest, V; Cooper, ML; Naguib, SA; Calkins, DJ; Rex, TS				Bernardo-Colon, Alexandra; Vest, Victoria; Cooper, Melissa L.; Naguib, Sarah A.; Calkins, David J.; Rex, Tonia S.			Progression and Pathology of Traumatic Optic Neuropathy From Repeated Primary Blast Exposure	FRONTIERS IN NEUROSCIENCE			English	Article						optic neuropathy; axon degeneration; axonopathy; blast; indirect traumatic optic neuropathy; repeat neurotrauma; intraocular pressure; retinal ganglion cells	MOUSE MODEL; HUMAN EYE; AXONOPATHY; INJURY; NEUROINFLAMMATION; NEURODEGENERATION; REDISTRIBUTION; VISION	Indirect traumatic optic neuropathy (ITON) is a condition that is often associated with traumatic brain injury and can result in significant vision loss due to degeneration of retinal ganglion cell (RGC) axons at the time of injury or within the ensuing weeks. We used a mouse model of eye-directed air-blast exposure to characterize the histopathology of blast-induced ITON. This injury caused a transient elevation of intraocular pressure with subsequent RGC death and axon degeneration that was similar throughout the length of the optic nerve (ON). Deficits in active anterograde axon transport to the superior colliculus accompanied axon degeneration and first appeared in peripheral representations of the retina. Glial area in the ON increased early after injury and involved a later period of additional expansion. The increase in area involved a transient change in astrocyte organization independent of axon degeneration. While levels of many cytokines and chemokines did not change, IL-1 alpha and IL-1 beta increased in both the ON and retina. In contrast, glaucoma shows distal to proximal axon degeneration with astrocyte remodeling and increases in many cytokines and chemokines. Further, direct traumatic optic neuropathies have a clear site of injury with rapid, progressive axon degeneration and cell death. These data show that blast-induced ITON is a distinct neuropathology from other optic neuropathies.	[Bernardo-Colon, Alexandra; Vest, Victoria; Calkins, David J.; Rex, Tonia S.] Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN 37232 USA; [Cooper, Melissa L.; Naguib, Sarah A.; Calkins, David J.; Rex, Tonia S.] Vanderbilt Univ, Med Ctr, Dept Ophthalmol & Visual Sci, Nashville, TN 37232 USA		Rex, TS (corresponding author), Vanderbilt Univ, Med Ctr, Vanderbilt Eye Inst, Nashville, TN 37232 USA.; Rex, TS (corresponding author), Vanderbilt Univ, Med Ctr, Dept Ophthalmol & Visual Sci, Nashville, TN 37232 USA.	tonia.rex@vanderbilt.edu		Cooper, Melissa/0000-0003-4337-8356; Calkins, David/0000-0002-8475-9959	DoDUnited States Department of Defense [W81XWH-15-1-0096, W81XWH-17-2-0055]; NEIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [R01 EY022349, P30EY008126]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 NS094595]; Potocsnak Discovery Grant in Regenerative Medicine; Ayers Foundation Regenerative Visual Neuroscience Pilot Grant; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01EY024997]; Glaucoma Research Foundation; Stanley Cohen Innovation Fund; Vanderbilt University Medical Center Cell Imaging Shared Resource core facility (Clinical and Translational Science Award from the National Center for Research Resources) [UL1 RR024975]; Research Prevent Blindness, Inc.;  [T32 EY021833]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM062459] Funding Source: NIH RePORTER	Support for TR was provided by DoD W81XWH-15-1-0096 and W81XWH-17-2-0055, NEI R01 EY022349, NIA R01 NS094595, Potocsnak Discovery Grant in Regenerative Medicine, Ayers Foundation Regenerative Visual Neuroscience Pilot Grant, and Jones Gift. Support for DC was provided by NIH R01EY024997, the Glaucoma Research Foundation, and the Stanley Cohen Innovation Fund. Support for MC and SN was provided by T32 EY021833. All investigators were supported by the Vanderbilt University Medical Center Cell Imaging Shared Resource core facility (Clinical and Translational Science Award Grant UL1 RR024975 from the National Center for Research Resources), NEI P30EY008126, and the Research Prevent Blindness, Inc.	Adornetto A, 2019, NEURAL REGEN RES, V14, P391, DOI 10.4103/1673-5374.245465; Agarwal R, 2012, INDIAN J OPHTHALMOL, V60, P255, DOI 10.4103/0301-4738.98700; Agrawal R, 2013, INT OPHTHALMOL, V33, P435, DOI 10.1007/s10792-012-9698-y; Bernardo-Colon A, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-1061-4; Bhardwaj R, 2014, BIOMECH MODEL MECHAN, V13, P123, DOI 10.1007/s10237-013-0490-3; Bond WS, 2016, MOL THER, V24, P230, DOI 10.1038/mt.2015.198; Bricker-Anthony C, 2017, OPTOMETRY VISION SCI, V94, P20, DOI 10.1097/OPX.0000000000000898; Bricker-Anthony C, 2014, INVEST OPHTH VIS SCI, V55, P4853, DOI 10.1167/iovs.14-14353; Calkins DJ, 2012, PROG RETIN EYE RES, V31, P702, DOI 10.1016/j.preteyeres.2012.07.001; Cooper ML, 2018, ACTA NEUROPATHOL COM, V6, DOI 10.1186/s40478-018-0542-0; Cooper ML, 2016, EXP EYE RES, V150, P22, DOI 10.1016/j.exer.2015.11.016; Crish SD, 2010, P NATL ACAD SCI USA, V107, P5196, DOI 10.1073/pnas.0913141107; DRAGER UC, 1976, J NEUROPHYSIOL, V39, P91, DOI 10.1152/jn.1976.39.1.91; Echevarria FD, 2017, FRONT NEUROSCI-SWITZ, V11, DOI 10.3389/fnins.2017.00318; Esposito L, 2015, COMPUT METHOD BIOMEC, V18, P107, DOI 10.1080/10255842.2013.779684; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Hines-Beard J, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0499-5; Hines-Beard J, 2012, EXP EYE RES, V99, P63, DOI 10.1016/j.exer.2012.03.013; Karimi A, 2016, INJURY, V47, P1042, DOI 10.1016/j.injury.2016.01.030; Koliatsos VE, 2011, J NEUROPATH EXP NEUR, V70, P399, DOI 10.1097/NEN.0b013e3182189f06; Lambert WS, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-4; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Mortezaee K, 2018, J CELL PHYSIOL, V233, P5160, DOI 10.1002/jcp.26287; Notghi B, 2017, J BIOMECH ENG-T ASME, V139, DOI 10.1115/1.4037072; Ou Y, 2016, J NEUROSCI, V36, P9240, DOI 10.1523/JNEUROSCI.0940-16.2016; Rossi T, 2012, INVEST OPHTH VIS SCI, V53, P8057, DOI 10.1167/iovs.12-10591; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Sanchez-Migallon MC, 2018, EXP EYE RES, V170, P40, DOI 10.1016/j.exer.2018.02.010; Sarkies N, 2004, EYE, V18, P1122, DOI 10.1038/sj.eye.6701571; STEINSAPIR KD, 1994, SURV OPHTHALMOL, V38, P487, DOI 10.1016/0039-6257(94)90145-7; Valiente-Soriano FJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121134; Vest V, 2019, J NEUROTRAUM, V36, P1646, DOI 10.1089/neu.2018.6046; Ward NJ, 2014, J NEUROSCI, V34, P3161, DOI 10.1523/JNEUROSCI.4089-13.2014; Yu-Wai-Man Patrick, 1800, Taiwan J Ophthalmol, V5, P3	34	15	15	0	3	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-453X			FRONT NEUROSCI-SWITZ	Front. Neurosci.	JUL 11	2019	13								719	10.3389/fnins.2019.00719			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	II8DH	WOS:000475421200001	31354422	Green Published, gold			2022-02-06	
J	Minkkinen, M; Iverson, GL; Kotilainen, AK; Pauniaho, SL; Mattila, VM; Lehtimaki, T; Berghem, K; Posti, JP; Luoto, TM				Minkkinen, Mira; Iverson, Grant L.; Kotilainen, Anna-Kerttu; Pauniaho, Satu-Liisa; Mattila, Ville M.; Lehtimaki, Terho; Berghem, Ksenia; Posti, Jussi P.; Luoto, Teemu M.			Prospective Validation of the Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries in Adults	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; computed tomography; emergency treatment; guideline; head injury	TRAUMATIC BRAIN-INJURY; SERUM S100B LEVELS; COMPUTED-TOMOGRAPHY; EMERGENCY-DEPARTMENT; EXTERNAL VALIDATION; EPIDEMIOLOGY; BIOMARKER; PROTEIN; COHORT; RULE	The Scandinavian Guidelines for Initial Management of Minimal, Mild, and Moderate Head Injuries in Adults (Scandinavian guidelines) are the first to incorporate serum measurement of the S100 astroglial calcium-binding protein B (S100B) to emergency department (ED) triage of patients with head injury (HI). This prospective validation study was conducted in the ED of the Tampere University Hospital, Finland, between November 2015 and November 2016. All consecutive adult patients with HI presenting to the ED within 24 h from injury were eligible for inclusion. Venous blood for S100B sampling was drawn from all patients, and the result was available at the ED. Computed tomography (CT) scans of the head were performed according to the on-call physician's evaluation. Only the samples collected within 6 h after injury were used. A one-week follow-up was conducted to identify possible HI-related complications. A total of 295 patients (median age, 67.0 years, range, 18-100; women, 48.8%) were enrolled. Of those, 196 (66.4%) underwent scanning. Acute traumatic lesions were detected on 31 (15.8%) of the scans. Two of the CT-positive patients were scanned without a guidelines-based indication. These lesions did not require any specific treatment or repeated imaging. The guidelines-based sensitivity was 0.94 (95% confidence interval [CI], 0.77-0.99) and specificity 0.19 (95% CI, 0.13-0.26) for predicting traumatic intracranial CT abnormalities. The positive and negative predictive value for positive head CT was 0.18 (95% CI, 0.12-0.25) and 0.94 (95% CI, 0.78-0.99), respectively. In the mild-low risk group, no false negative S100B values were recorded. Thirteen patients (4.4%) were re-admitted to the ED, and two patients (0.7%) died one week after the primary HI. The deaths were unrelated to the injury. None of these adverse events were directly caused by a primarily undiagnosed intracranial injury. The Scandinavian guidelines incorporated with S100B are a valid means of screening clinically significant acute traumatic lesions after HI and have the potential to reduce unnecessary CT scanning.	[Minkkinen, Mira; Kotilainen, Anna-Kerttu; Mattila, Ville M.; Lehtimaki, Terho] Tampere Univ, Fac Med & Hlth Technol, Arvo Ylpon Katu 34, Tampere 33520, Finland; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, Boston, MA USA; [Iverson, Grant L.] Spaulding Res Inst, Boston, MA USA; [Iverson, Grant L.] MassGen Hosp Children, Sports Concuss Program, Boston, MA USA; [Iverson, Grant L.] A Red Sox Fdn, Home Base, Boston, MA USA; [Iverson, Grant L.] Massachusetts Gen Hosp Program, Boston, MA USA; [Pauniaho, Satu-Liisa] Tampere Univ Hosp, Emergency Div, Pirkanmaa Hosp Dist, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ Hosp, Dept Neurosurg, Tampere, Finland; [Luoto, Teemu M.] Tampere Univ, Tampere, Finland; [Mattila, Ville M.] Tampere Univ Hosp, Div Orthoped & Traumatol, Dept Trauma Musculoskeletal Surg & Rehabil, Tampere, Finland; [Berghem, Ksenia] Tampere Univ Hosp, Med Imaging Ctr, Dept Radiol, Tampere, Finland; [Lehtimaki, Terho] Fimlab Labs, Dept Clin Chem, Tampere, Finland; [Posti, Jussi P.] Turku Univ Hosp, Dept Neurosurg, Div Clin Neurosci, Turku, Finland; [Posti, Jussi P.] Turku Univ Hosp, Turku Brain Injury Ctr, Turku, Finland; [Posti, Jussi P.] Univ Turku, Turku, Finland		Minkkinen, M (corresponding author), Tampere Univ, Fac Med & Hlth Technol, Arvo Ylpon Katu 34, Tampere 33520, Finland.	mira.t.minkkinen@gmail.com	Luoto, Teemu/W-6468-2018; Posti, Jussi P./Y-2908-2019; Lehtimaki, Terho/AAD-1094-2022	Luoto, Teemu/0000-0002-7329-3284; Posti, Jussi P./0000-0002-5925-5193; Lehtimaki, Terho/0000-0002-2555-4427	Finnish State Research Funding; Finnish Medical Society Duodecim; Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Finnish Brain Foundation sr; Emil Aaltonen Foundation sr; Maire Taponen Foundation; Competitive Research Funding of the Tampere University Hospital; Academy of FinlandAcademy of FinlandEuropean Commission [104821]	The study was financially supported by the Finnish State Research Funding and the Finnish Medical Society Duodecim. Dr. Luoto and Dr. Posti have received funding from Government's Special Financial Transfer tied to academic research in Health Sciences (Finland). Dr. Posti has received a grant from Finnish Brain Foundation sr, a grant from Emil Aaltonen Foundation sr, and Maire Taponen Foundation. The Competitive Research Funding of the Tampere University Hospital (for Dr Lehtimaki), and Academy of Finland (Grant no. 104821 Dr. Lehtimaki).	Allouchery G, 2018, CLIN CHEM LAB MED, V56, P1897, DOI 10.1515/cclm-2018-0471; Ananthaharan A, 2018, BMC EMERG MED, V18, DOI 10.1186/s12873-018-0193-2; Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Bazarian JJ, 2018, LANCET NEUROL, V17, P782, DOI 10.1016/S1474-4422(18)30231-X; Calcagnile O, 2016, BMC NEUROL, V16, DOI 10.1186/s12883-016-0723-z; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; Chang JCY, 2016, EMERG MED AUSTRALAS, V28, P153, DOI 10.1111/1742-6723.12557; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Foks KA, 2018, BMJ-BRIT MED J, V362, DOI 10.1136/bmj.k3527; Foks KA, 2017, J NEUROTRAUM, V34, P2529, DOI 10.1089/neu.2016.4919; Geijerstam JLA, 2003, ACTA NEUROCHIR, V145, P843, DOI 10.1007/s00701-003-0115-1; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Ingebrigtsen T, 2000, J TRAUMA, V48, P760, DOI 10.1097/00005373-200004000-00029; Egea-Guerrero JJ, 2018, BRAIN INJURY, V32, P459, DOI 10.1080/02699052.2018.1429019; Lee J, 2010, ANN EMERG MED, V56, P591, DOI 10.1016/j.annemergmed.2010.05.027; Niska R, 2007, NATL HLTH STAT REPOR, V2010, P1; Royall DR, 2016, AGING-US, V8, P3241, DOI 10.18632/aging.101091; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Schroeter ML, 2013, CURR DRUG TARGETS, V14, P1237; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 1997, ANN EMERG MED, V30, P14, DOI 10.1016/S0196-0644(97)70104-5; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Thaler HW, 2015, J NEUROSURG, V123, P1202, DOI 10.3171/2014.12.JNS142276; Thelin EP, 2016, EUR J TRAUMA EMERG S, V42, P617, DOI 10.1007/s00068-015-0583-z; (UK) NCGC, 2014, HEAD INJURY; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Ye H, 2015, J NEUROL SCI, V348, P81, DOI 10.1016/j.jns.2014.11.010; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	33	15	16	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2019	36	20					2904	2912		10.1089/neu.2018.6351		JUL 2019	9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	JC0JD	WOS:000474976600001	31111795				2022-02-06	
J	Yue, JK; Levin, HS; Suen, CG; Morrissey, MR; Runyon, SJ; Winkler, EA; Puffer, RC; Deng, HS; Robinson, CK; Rick, JW; Phelps, RRL; Sharma, S; Taylor, SR; Vassar, MJ; Cnossen, MC; Lingsma, HF; Gardner, RC; Temkin, NR; Barber, J; Dikmen, SS; Yuh, EL; Mukherjee, P; Stein, MB; Cage, TA; Valadka, AB; Okonkwo, DO; Manley, GT; Cooper, SR; Dams-O'Connor, K; Gordon, WA; Borrasso, AJ; Maas, AIR; Menon, DK; Puccio, AM; Schnyer, DM				Yue, John K.; Levin, Harvey S.; Suen, Catherine G.; Morrissey, Molly Rose; Runyon, Sarah J.; Winkler, Ethan A.; Puffer, Ross C.; Deng, Hansen; Robinson, Caitlin K.; Rick, Jonathan W.; Phelps, Ryan R. L.; Sharma, Sourabh; Taylor, Sabrina R.; Vassar, Mary J.; Cnossen, Maryse C.; Lingsma, Hester F.; Gardner, Raquel C.; Temkin, Nancy R.; Barber, Jason; Dikmen, Sureyya S.; Yuh, Esther L.; Mukherjee, Pratik; Stein, Murray B.; Cage, Tene A.; Valadka, Alex B.; Okonkwo, David O.; Manley, Geoffrey T.; Cooper, Shelly R.; Dams-O'Connor, Kristen; Gordon, Wayne A.; Borrasso, Allison J.; Maas, Andrew I. R.; Menon, David K.; Puccio, Ava M.; Schnyer, David M.		TRACK-TBI Investigators	Age and sex-mediated differences in six-month outcomes after mild traumatic brain injury in young adults: a TRACK-TBI study	NEUROLOGICAL RESEARCH			English	Article						Age factors; common data elements; functional disability; mild traumatic brain injury (mTBI); post-traumatic stress disorder (PTSD); risk factors; sex; young adults	COMMON DATA ELEMENTS; POST-CONCUSSION SYMPTOMS; CORTICAL THICKNESS; HEAD-INJURY; GENDER-DIFFERENCE; RECOMMENDATIONS; PREDICTION; SEVERITY; HEALTH; NEUROPROTECTION	Introduction: Risk factors for young adults with mTBI are not well understood. Improved understanding of age and sex as risk factors for impaired six-month outcomes in young adults is needed.Methods: Young adult mTBI subjects aged 18-39 years (18-29y; 30-39y) with six-month outcomes were extracted from the Transforming Research and Clinical Knowledge in Traumatic Brain Injury Pilot (TRACK-TBI Pilot) study. Multivariable regressions were performed for outcomes with age, sex, and the interaction factor age-group*sex as variables of interest, controlling for demographic and injury variables. Mean-differences (B) and 95% CIs are reported.Results: One hundred mTBI subjects (18-29y, 70%; 30-39y, 30%; male, 71%; female, 29%) met inclusion criteria. On multivariable analysis, age-group*sex was associated with six-month post-traumatic stress disorder (PTSD; PTSD Checklist-Civilian version); compared with female 30-39y, female 18-29y (B= -19.55 [-26.54, -4.45]), male 18-29y (B= -19.70 [-30.07, -9.33]), and male 30-39y (B= -15.49 [-26.54, -4.45]) were associated with decreased PTSD symptomatology. Female sex was associated with decreased six-month functional outcome (Glasgow Outcome Scale-Extended (GOSE): B= -0.6 [1.0, -0.1]). Comparatively, 30-39y scored higher on six-month nonverbal processing speed (Wechsler Adult Intelligence Scale-Processing Speed Index (WAIS-PSI); B= 11.88, 95% CI [1.66, 22.09]).Conclusions: Following mTBI, young adults aged 18-29y and 30-39y may have different risks for impairment. Sex may interact with age for PTSD symptomatology, with females 30-39y at highest risk. These results may be attributable to cortical maturation, biological response, social modifiers, and/or differential self-report. Confirmation in larger samples is needed; however, prevention and rehabilitation/counseling strategies after mTBI should likely be tailored for age and sex.	[Yue, John K.; Morrissey, Molly Rose; Runyon, Sarah J.; Winkler, Ethan A.; Deng, Hansen; Robinson, Caitlin K.; Rick, Jonathan W.; Phelps, Ryan R. L.; Sharma, Sourabh; Taylor, Sabrina R.; Vassar, Mary J.; Cage, Tene A.; Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA; [Yue, John K.; Morrissey, Molly Rose; Runyon, Sarah J.; Winkler, Ethan A.; Deng, Hansen; Robinson, Caitlin K.; Rick, Jonathan W.; Phelps, Ryan R. L.; Sharma, Sourabh; Taylor, Sabrina R.; Vassar, Mary J.; Yuh, Esther L.; Mukherjee, Pratik; Cage, Tene A.; Manley, Geoffrey T.] Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Levin, Harvey S.] Baylor Coll Med, Dept Neurosurg, Houston, TX 77030 USA; [Suen, Catherine G.] Univ Utah, Dept Neurol, Salt Lake City, UT USA; [Puffer, Ross C.] Mayo Clin, Dept Neurol Surg, Rochester, MN USA; [Puffer, Ross C.; Okonkwo, David O.] Univ Pittsburgh, Med Ctr, Dept Neurol Surg, Pittsburgh, PA USA; [Cnossen, Maryse C.; Lingsma, Hester F.] Erasmus MC, Dept Publ Hlth, Rotterdam, Netherlands; [Gardner, Raquel C.] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Gardner, Raquel C.] Vet Affairs Med Ctr, Dept Neurol, San Francisco, CA 94121 USA; [Temkin, Nancy R.; Barber, Jason] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Temkin, Nancy R.; Barber, Jason] Univ Washington, Dept Biostat, Seattle, WA 98195 USA; [Dikmen, Sureyya S.] Univ Washington, Dept Rehabil Med, Seattle, WA 98195 USA; [Yuh, Esther L.; Mukherjee, Pratik] Univ Calif San Francisco, Dept Radiol, San Francisco, CA USA; [Stein, Murray B.] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Stein, Murray B.] Univ Calif San Diego, Dept Family Med, San Diego, CA 92103 USA; [Valadka, Alex B.] Virginia Commonwealth Univ, Dept Neurol Surg, Richmond, VA USA; [Cooper, Shelly R.] Washington Univ, Dept Psychol, St Louis, MO 63130 USA; [Dams-O'Connor, Kristen; Gordon, Wayne A.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Borrasso, Allison J.; Puccio, Ava M.] Univ Pittsburgh, Med Ctr, Dept Neurosurg, Pittsburgh, PA USA; [Maas, Andrew I. R.] Antwerp Univ Hosp, Dept Neurosurg, Edegem, Belgium; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Div Anaesthesia, Cambridge, England; [Schnyer, David M.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA		Manley, GT (corresponding author), Zuckerberg San Francisco Gen Hosp, Brain & Spinal Injury Ctr, 1001 Potrero Ave,Bldg 1,Room 101, San Francisco, CA 94110 USA.	manleyg@neurosurg.ucsf.edu	Schnyer, David/ABD-6372-2021; Yue, John K/P-1348-2015	Schnyer, David/0000-0002-7472-2853; Yue, John K/0000-0001-9694-7722	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1RC 2NS069409-01, 3RC2NS069409-02S1, 5RC2NS069409-02, 1U01NS086090-01, 3U01NS086090-02S1, 3U01 NS086090-02S2, 5U01NS086090-03, 3U01NS086090-03S1, 5U01NS086090-02]; U.S. Department of DefenseUnited States Department of Defense [W81XWH-13-1-0441, W81XWH-14-2-0176]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086090] Funding Source: NIH RePORTER	This work was supported by the following grants: National Institute of Neurological Disorders and Stroke [1RC 2NS069409-01]; [3RC2NS069409-02S1]; [5RC2NS069409-02]; [1U01NS086090-01]; [3U01NS086090-02S1]; [3U01 NS086090-02S2]; [5U01NS086090-03]; [3U01NS086090-03S1]; [5U01NS086090-02]; U.S. Department of Defense [W81XWH-13-1-0441]; U.S. Department of Defense [W81XWH-14-2-0176] (to G. T. M.).	Addis ME, 2003, AM PSYCHOL, V58, P5, DOI 10.1037/0003-066X.58.1.5; Agrawal Amit, 2012, Int J Crit Illn Inj Sci, V2, P167, DOI 10.4103/2229-5151.100915; Arain M, 2013, NEUROPSYCH DIS TREAT, V9, P449, DOI 10.2147/NDT.S39776; Arevalo MA, 2010, BBA-GEN SUBJECTS, V1800, P1106, DOI 10.1016/j.bbagen.2009.10.002; Baumrind D, 1987, New Dir Child Dev, P93; Bazarian JJ, 2010, J NEUROTRAUM, V27, P527, DOI 10.1089/neu.2009.1068; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Biswas RK, 2017, ARCH PUBLIC HEALTH, V75, DOI 10.1186/s13690-017-0211-y; Brickell TA, 2017, J NEUROTRAUM, V34, P300, DOI 10.1089/neu.2016.4403; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Burnett S, 2009, ANN NY ACAD SCI, V1167, P51, DOI 10.1111/j.1749-6632.2009.04509.x; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Cnossen MC, 2017, J NEUROTRAUM, V34, P2396, DOI 10.1089/neu.2016.4819; Colvin AC, 2009, AM J SPORT MED, V37, P1699, DOI 10.1177/0363546509332497; Delis D.C., 2000, CALIFORNIA VERBAL LE; Derogatis LR., 2001, BSI 18 BRIEF SYMPTOM; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Dick RW, 2009, BRIT J SPORT MED, V43, pI46, DOI 10.1136/bjsm.2009.058172; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; Dikmen S, 2017, J NEUROTRAUM, V34, P1524, DOI 10.1089/neu.2016.4618; Drapeau A, 2009, J BEHAV HEALTH SER R, V36, P372, DOI 10.1007/s11414-009-9168-0; Duhaime AC, 2010, ARCH PHYS MED REHAB, V91, P1661, DOI 10.1016/j.apmr.2010.07.238; Farace E, 2000, Neurosurg Focus, V8, pe6; Haarbauer-Krupa J, 2017, J NEUROTRAUM, V34, P50, DOI 10.1089/neu.2015.4158; Hawley CA, 2004, BRAIN INJURY, V18, P645, DOI 10.1080/02699050310001646189; Im K, 2006, NEUROIMAGE, V31, P31, DOI 10.1016/j.neuroimage.2005.11.042; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Iverson KM, 2011, WOMEN HEALTH ISS, V21, pS210, DOI 10.1016/j.whi.2011.04.019; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Johann S, 2013, J STEROID BIOCHEM, V137, P71, DOI 10.1016/j.jsbmb.2012.11.006; Kaul RP, 2014, CRANIOMAX TRAUM REC, V7, P126, DOI 10.1055/s-0034-1371539; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kraus J F, 2000, Neurosurg Focus, V8, pe5; LEVINSON DJ, 1986, AM PSYCHOL, V41, P3, DOI 10.1037/0003-066X.41.1.3; Lexell J, 2016, BRAIN INJURY, V30, P969, DOI 10.3109/02699052.2016.1148196; Lippa SM, 2018, J HEAD TRAUMA REHAB, V33, P101, DOI 10.1097/HTR.0000000000000353; Luders E, 2006, HUM BRAIN MAPP, V27, P314, DOI 10.1002/hbm.20187; Luders E, 2005, NEUROIMAGE, V26, P493, DOI 10.1016/j.neuroimage.2005.02.010; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Mackenzie CS, 2006, AGING MENT HEALTH, V10, P574, DOI 10.1080/13607860600641200; Majdan M, 2016, LANCET PUBLIC HEALTH, V1, pE76, DOI 10.1016/S2468-2667(16)30017-2; Manley GT, 2010, ARCH PHYS MED REHAB, V91, P1667, DOI 10.1016/j.apmr.2010.05.018; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Nott MT, 2015, AUSTRALAS J AGEING, V34, pE1, DOI 10.1111/ajag.12151; Paus T, 2010, HORM BEHAV, V57, P63, DOI 10.1016/j.yhbeh.2009.08.004; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Rapoport MJ, 2001, BRAIN INJURY, V15, P857, DOI 10.1080/02699050110065303; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; Roe C, 2009, DISABIL REHABIL, V31, P1235, DOI 10.1080/09638280802532720; ROOF RL, 1993, BRAIN RES, V607, P333, DOI 10.1016/0006-8993(93)91526-X; Roof RL, 2000, J NEUROTRAUM, V17, P367, DOI 10.1089/neu.2000.17.367; Schattner A, 2014, AM J MED, V127, P268, DOI 10.1016/j.amjmed.2013.11.015; Seabury SA, 2018, JAMA NETW OPEN, V1, DOI 10.1001/jamanetworkopen.2018.0210; Sinclair D, 2014, PSYCHOPHARMACOLOGY, V231, P1581, DOI 10.1007/s00213-013-3415-z; Sowell ER, 2007, CEREB CORTEX, V17, P1550, DOI 10.1093/cercor/bhl066; Stein MB, 2019, JAMA PSYCHIAT, V76, P249, DOI 10.1001/jamapsychiatry.2018.4288; Stulemeijer M, 2008, J NEUROL NEUROSUR PS, V79, P936, DOI 10.1136/jnnp.2007.131250; Tamnes CK, 2010, CEREB CORTEX, V20, P534, DOI 10.1093/cercor/bhp118; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; VA National Center for PTSD, 2012, US PTSD CHECKL PCL; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 2001, J CLIN EXP NEUROPSYC, V23, P837, DOI 10.1076/jcen.23.6.837.1018; Waljas M, 2014, J HEAD TRAUMA REHAB, V29, P443, DOI 10.1097/HTR.0000000000000002; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Witte AV, 2010, NEUROIMAGE, V49, P1205, DOI 10.1016/j.neuroimage.2009.09.046; Yue JK, 2018, NEUROL RES, V40, P972, DOI 10.1080/01616412.2018.1505416; Yue JK, 2018, NEUROREHABILITATION, V43, P169, DOI 10.3233/NRE-172375; Yue JK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7080093; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970; Zatzick DF, 2007, PSYCHIATRY, V70, P260, DOI 10.1521/psyc.2007.70.3.260	74	15	15	1	8	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0161-6412	1743-1328		NEUROL RES	Neurol. Res.	JUL 3	2019	41	7					609	623		10.1080/01616412.2019.1602312			15	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	IK9PK	WOS:000476927700003	31007155	Green Submitted, Green Accepted			2022-02-06	
J	Bockbrader, M; Annetta, N; Friedenberg, D; Schwemmer, M; Skomrock, N; Colachis, S; Zhang, MM; Bouton, C; Rezai, A; Sharma, G; Mysiw, WJ				Bockbrader, Marcie; Annetta, Nicholas; Friedenberg, David; Schwemmer, Michael; Skomrock, Nicholas; Colachis, Samuel; Zhang, Mingming; Bouton, Chad; Rezai, Ali; Sharma, Gaurav; Mysiw, Walter J.			Clinically Significant Gains in Skillful Grasp Coordination by an Individual With Tetraplegia Using an Implanted Brain-Computer Interface With Forearm Transcutaneous Muscle Stimulation	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article; Proceedings Paper	Institute-of Electrical-and-Electronics-Engineers Engineering in Medicine and Biology Conference	JUN, 2018	Honolulu, HI	Inst Elect & Elect Engineers		Activities of daily living; Brain-computer interfaces; Hand strength; Quadriplegia; Rehabilitation; Transcutaneous electric nerve stimulation	FUNCTIONAL ELECTRICAL-STIMULATION; SPINAL-CORD-INJURY; GRADED REDEFINED ASSESSMENT; UPPER-LIMB; HAND GRASP; NEUROMUSCULAR STIMULATION; FUNCTION-TESTS; RELEASE TEST; NEUROPROSTHESIS; RELIABILITY	Objective: To demonstrate naturalistic motor control speed, coordinated grasp, and carryover from trained to novel objects by an individual with tetraplegia using a brain-computer interface (BCI)-controlled neuroprosthetic. Design: Phase I trial for an intracortical BCI integrated with forearm functional electrical stimulation (FES). Data reported span postimplant days 137 to 1478. Setting: Tertiary care outpatient rehabilitation center. Participant: A 27-year-old man with C5 class A (on the American Spinal Injury Association Impairment Scale) traumatic spinal cord injury Interventions: After array implantation in his left (dominant) motor cortex, the participant trained with BCI-FES to control dynamic, coordinated forearm, wrist, and hand movements. Main Outcome Measures: Performance on standardized tests of arm motor ability (Graded Redefined Assessment of Strength, Sensibility, and Prehension [GRASSP], Action Research Arm Test [ARAT], Grasp and Release Test [GRT], Box and Block Test), grip myometry, and functional activity measures (Capabilities of Upper Extremity Test [CUE-T], Quadriplegia Index of Function-Short Form [QIF-SF], Spinal Cord Independence Measure-Self-Report [SCIM-SR]) with and without the BCI-FES. Results: With BCI-FES, scores improved from baseline on the following: Grip force (2.9 kg); ARAT cup, cylinders, ball, bar, and blocks; GRT can, fork, peg, weight, and tape; GRASSP strength and prehension (unscrewing lids, pouring from a bottle, transferring pegs); and CUE-T wrist and hand skills. QIF-SF and SCIM-SR eating, grooming, and toileting activities were expected to improve with home use of BCI-FES. Pincer grips and mobility were unaffected. BCI-FES grip skills enabled the participant to play an adapted "Battleship" game and manipulate household objects. Conclusions: Using BCI-FES, the participant performed skillful and coordinated grasps and made clinically significant gains in tests of upper limb function. Practice generalized from training objects to household items and leisure activities. Motor ability improved for palmar, lateral, and tip-to-tip grips. The expects eventual home use to confer greater independence for activities of daily living, consistent with observed neurologic level gains from C5-6 to C7-T1. This marks a critical translational step toward clinical viability for BCI neuroprosthetics. (C) 2019 by the American Congress of Rehabilitation Medicine. Published by Elsevier Inc.	[Bockbrader, Marcie; Colachis, Samuel; Mysiw, Walter J.] Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA; [Bockbrader, Marcie; Rezai, Ali; Mysiw, Walter J.] Ohio State Univ, Wexner Med Ctr, Neurol Inst, Columbus, OH 43210 USA; [Bockbrader, Marcie; Colachis, Samuel] Ohio State Univ, Dept Biomed Engn, Columbus, OH 43210 USA; [Annetta, Nicholas; Friedenberg, David; Schwemmer, Michael; Skomrock, Nicholas; Colachis, Samuel; Zhang, Mingming; Bouton, Chad; Sharma, Gaurav] Battelle Mem Inst, 505 King Ave, Columbus, OH 43201 USA; [Bouton, Chad] Feinstein Inst Med Res, Ctr Bioelect Med, Manhasset, NY USA; [Rezai, Ali] West Virginia Univ, Rockefeller Neurosci Inst, Morgantown, WV 26506 USA		Bockbrader, M (corresponding author), Ohio State Univ, Dept Phys Med & Rehabil, 480 Med Ctr Dr, Columbus, OH 43210 USA.	Bockbrader.13@osu.edu	Bockbrader, Marcia/J-6203-2013; Bockbrader, Marcia/U-7844-2019	Bockbrader, Marcia/0000-0001-6419-0630; Bockbrader, Marcia/0000-0001-6419-0630; Friedenberg, David/0000-0002-4404-8941			Academy of Neurologic Physical Therapy, SPIN CORD INJ EDGE T; Ajiboye AB, 2017, LANCET, V389, P1821, DOI 10.1016/S0140-6736(17)30601-3; Alexander MS, 2009, SPINAL CORD, V47, P582, DOI 10.1038/sc.2009.18; Anderson KD, 2004, J NEUROTRAUM, V21, P1371, DOI 10.1089/neu.2004.21.1371; Bhadra N, 1997, J CLIN NEUROPHYSIOL, V14, P378, DOI 10.1097/00004691-199709000-00004; Blabe CH, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/4/043002; Boakye M, 2012, J NEUROSURG-SPINE, V17, P141, DOI 10.3171/2012.5.AOSPINE1296; Bockbrader M, 2018, 40 ANN INT C IEEE EN; Bouton CE, 2016, NATURE, V533, P247, DOI 10.1038/nature17435; Carlozzi NE, 2017, ARCH CLIN NEUROPSYCH, V32, P555, DOI 10.1093/arclin/acx020; Chen HM, 2009, NEUROREHAB NEURAL RE, V23, P435, DOI 10.1177/1545968308331146; Colachis SC, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00208; Colachis SC, 2018, THESIS, P42; Collinger JL, 2013, LANCET, V381, P557, DOI 10.1016/S0140-6736(12)61816-9; Collinger JL, 2013, J REHABIL RES DEV, V50, P145, DOI 10.1682/JRRD.2011.11.0213; Connell LA, 2012, ARCH PHYS MED REHAB, V93, P221, DOI 10.1016/j.apmr.2011.09.015; Downey JE, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-17222-3; Flesher SN, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf8083; Friedenberg DA, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-08120-9; Friedenberg DA, 2016, IEEE ENG MED BIO, P3084, DOI 10.1109/EMBC.2016.7591381; Grimm F, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00367; Hochberg LR, 2006, NATURE, V442, P164, DOI 10.1038/nature04970; Huggins JE, 2014, BRAIN-COMPUT INTERFA, V1, P27, DOI 10.1080/2326263X.2013.876724; Ibitoye MO, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149024; Kalsi-Ryan S, 2009, TOP SPINAL CORD INJ, V14, P34, DOI DOI 10.1310/sci1404-34; Kalsi-Ryan S, 2016, J NEUROTRAUM, V33, P307, DOI 10.1089/neu.2015.4217; Kalsi-Ryan S, 2012, J NEUROSURG-SPINE, V17, P65, DOI 10.3171/2012.6.AOSPINE1258; Kalsi-Ryan S, 2012, J NEUROTRAUM, V29, P905, DOI 10.1089/neu.2010.1504; Kilgore KL, 2001, J REHABIL RES DEV, V38, P655; Koutsou AD, 2016, J NEUROENG REHABIL, V13, DOI 10.1186/s12984-016-0165-2; Kreilinger A, 2013, BIOMED TECH BERL, V58; Lang CE, 2008, ARCH PHYS MED REHAB, V89, P1693, DOI 10.1016/j.apmr.2008.02.022; Lauer RT, 1999, NEUROREPORT, V10, P1767, DOI 10.1097/00001756-199906030-00026; Lin KC, 2010, J REHABIL RES DEV, V47, P563, DOI 10.1682/JRRD.2009.09.0155; Mangold S, 2005, SPINAL CORD, V43, P1, DOI 10.1038/sj.sc.3101644; Marino RJ, 1999, SPINAL CORD, V37, P289, DOI 10.1038/sj.sc.3100772; Marino RJ, 1998, ARCH PHYS MED REHAB, V79, P1512, DOI 10.1016/S0003-9993(98)90412-9; MATHIOWETZ V, 1985, AM J OCCUP THER, V39, P386, DOI 10.5014/ajot.39.6.386; MATHIOWETZ V, 1985, ARCH PHYS MED REHAB, V66, P69; Miller WC, 2013, SPINAL CORD INJURY R; Mulcahey MJ, 2007, J REHABIL RES DEV, V44, P91, DOI 10.1682/JRRD.2005.10.0167; Mulcahey MJ, 2004, SPINAL CORD, V42, P146, DOI 10.1038/sj.sc.3101573; Mulcahey MJ, 2004, J SPINAL CORD MED, V27, P41, DOI 10.1080/10790268.2004.11753729; Muller-Putz GR, 2005, NEUROSCI LETT, V382, P169, DOI 10.1016/j.neulet.2005.03.021; Oleson CV, 2014, SPINAL CORD, V52, P625, DOI 10.1038/sc.2014.77; Peckham PH, 2001, ARCH PHYS MED REHAB, V82, P1380, DOI 10.1053/apmr.2001.25910; Pfurtscheller G, 2003, NEUROSCI LETT, V351, P33, DOI 10.1016/S0304-3940(03)00947-9; Popovic MR, 2011, NEUROREHAB NEURAL RE, V25, P433, DOI 10.1177/1545968310392924; Prodinger B, 2016, J REHABIL MED, V48, P149, DOI 10.2340/16501977-2059; Ptasinski J, 2013, OPEN J THER REHABIL, V1, P17; Rick Hansen Institute Spinal Cord Injury Research Evidence (SCIRE) Project, OUTC MEAS TOOLK IMPL; Rupp R, 2013, BIOMED TECH BERL S1, V58; Sayenko DG, 2014, EUR J APPL PHYSIOL, V114, P793, DOI 10.1007/s00421-013-2807-4; Schaffelhofer S, 2015, J NEUROSCI, V35, P1068, DOI 10.1523/JNEUROSCI.3594-14.2015; Serruya MD, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00226; Sharma G, 2017, SPRBRIEF ELECT, P9, DOI 10.1007/978-3-319-64373-1_2; Sharma G, 2016, SCI REP-UK, V6, DOI 10.1038/srep33807; Simpson LA, 2012, J NEUROTRAUM, V29, P1548, DOI 10.1089/neu.2011.2226; Sinnott KA, 2016, ARCH PHYS MED REHAB, V97, pS169, DOI 10.1016/j.apmr.2015.10.110; Smith BT, 1996, PARAPLEGIA, V34, P16, DOI 10.1038/sc.1996.3; Snoek GJ, 2004, SPINAL CORD, V42, P526, DOI 10.1038/sj.sc.3101638; Van der Lee JH, 2001, ARCH PHYS MED REHAB, V82, P14, DOI 10.1053/apmr.2001.18668; van Tuijl JH, 2002, SPINAL CORD, V40, P51, DOI 10.1038/sj.sc.3101261; Wodlinger B, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/1/016011; World Health Organization, 2007, INT CLASS FUNCT DIS; WUOLLE KS, 1994, J HAND SURG-AM, V19A, P209, DOI 10.1016/0363-5023(94)90008-6; Yozbatiran N, 2008, NEUROREHAB NEURAL RE, V22, P78, DOI 10.1177/1545968307305353	67	15	15	1	19	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	JUL	2019	100	7					1201	1217		10.1016/j.apmr.2018.07.445			17	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI); Conference Proceedings Citation Index - Science (CPCI-S)	Rehabilitation; Sport Sciences	IJ2IG	WOS:000475720900001	30902630	hybrid			2022-02-06	
J	Caccese, JB; Best, C; Lamond, LC; Difabio, M; Kaminski, TW; Watson, D; Getchell, N; Buckley, TA				Caccese, Jaclyn B.; Best, Chelsea; Lamond, Lindsey C.; Difabio, Melissa; Kaminski, Thomas W.; Watson, Dan; Getchell, Nancy; Buckley, Thomas A.			Effects of Repetitive Head Impacts on a Concussion Assessment Battery	MEDICINE AND SCIENCE IN SPORTS AND EXERCISE			English	Article						SOCCER; FOOTBALL; SUBCONCUSSION; MTBI; HEAD ACCELERATION	KING-DEVICK TEST; TANDEM GAIT; COLLEGIATE; CONTACT; SPORT; CONSEQUENCES; MANAGEMENT; EXPOSURE	Purpose The purpose of this study was to determine the relationship between repetitive head impacts (RHI) and clinical concussion assessments across a season among collegiate football (FB) and women's soccer (WSOC) players. Methods Fifteen male FB and 23 WSOC players participated in this study. Participants were included if they were medically cleared for unrestricted athletic participation. Participants were tested in a university athletic training room on two occasions: preseason (PRE) and postseason (POST). The outcome measures consisted of tandem gait (TG), Standardized Assessment of Concussion, Balance Error Scoring System, King-Devick (KD), clinical reaction time, and Immediate Post-Concussion Assessment and Cognitive Testing. Repetitive head impact during the season was quantified using the Head Impact Telemetry System (Simbex, NH) for FB and the Smart Impact Monitor (SIM; Triax Technologies, Norwalk, CT) for WSOC. Independent variables included total number of impacts, average magnitude of peak linear acceleration, cumulative linear exposure, and number of impacts >= 98g. Results Results from direct-entry multiple regression analyses suggest significant associations between RHI and both visual memory (R-2 = 0.670, F = 6.487, P = 0.002) and TG (R-2 = 0.636, F = 3.841, P = 0.029) for WSOC and between RHI and KD (R-2 = 0.756, F = 5.579, P = 0.013) for FB, whereby those with greater exposure performed worse. No other regression analyses within or across groups were significant. Conclusions These data suggest that RHI do not represent clinically meaningful changes on a multifaceted and multimodal concussion assessment battery. However, there may be subtle visual/vestibular impairments as observed by the associations between RHI and visual memory/TG among WSOC, RHI, and KD among FB.	[Caccese, Jaclyn B.; Difabio, Melissa; Kaminski, Thomas W.; Getchell, Nancy; Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Caccese, Jaclyn B.; Difabio, Melissa; Kaminski, Thomas W.; Getchell, Nancy; Buckley, Thomas A.] Univ Delaware, Interdisciplinary Biomech & Movement Sci Program, Newark, DE USA; [Best, Chelsea] Indiana Univ Athlet, Bloomington, IN USA; [Lamond, Lindsey C.] Wake Forest Baptist Hlth, Dept Family Med, Winston Salem, NC USA; [Watson, Dan] Univ Delaware Athlet, Newark, DE USA		Buckley, TA (corresponding author), 100 Discovery Blvd, Newark, DE 19713 USA.	tbuckley@udel.edu	Buckley, Thomas A/B-7525-2016; Getchell, Nancy/AAT-7985-2020; Caccese, Jaclyn B./AAH-4571-2020	Buckley, Thomas A/0000-0002-0515-0150; Getchell, Nancy/0000-0001-9230-9838; Caccese, Jaclyn B./0000-0003-2329-3603	Grand Alliance CARE Consortium - NCAA; DoDUnited States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This publication was made possible, in part, with support from the Grand Alliance CARE Consortium, funded by the NCAA and the DoD. The USAMRAA, Ford Detrick, MD, USA, is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151. Opinions, interpretations, conclusions and recommendations are those of the authors and are not necessarily endorsed by the DoD (DHP funds).	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Buckley TA, 2019, MED SCI SPORT EXER, V51, P132, DOI 10.1249/MSS.0000000000001761; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P61, DOI 10.1016/j.jshs.2016.01.007; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Caplan B, 2016, J HEAD TRAUMA REHAB, V31, P1, DOI 10.1097/HTR.0000000000000211; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Dozza M, 2007, J VESTIBUL RES-EQUIL, V17, P195; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Huber BR, 2016, PHYS MED REH CLIN N, V27, P503, DOI 10.1016/j.pmr.2015.12.007; Hunter LE, 2019, NEUROBIOL DIS, V123, P122, DOI 10.1016/j.nbd.2018.06.016; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Katz BP, 2018, SPORTS MED, V48, P1971, DOI 10.1007/s40279-018-0875-7; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Mainwaring L, 2018, INT J PSYCHOPHYSIOL, V132, P39, DOI 10.1016/j.ijpsycho.2018.01.007; Master CL, 2018, CLIN J SPORT MED, V28, P139, DOI 10.1097/JSM.0000000000000507; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; McCrea M, 2001, J ATHL TRAINING, V36, P274; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Mollayeva Tatyana, 2018, Concussion, V3, pCNC51, DOI 10.2217/cnc-2017-0015; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Oldham JR, 2017, SPORTS HEALTH, V9, P305, DOI 10.1177/1941738116680999; Reynolds BB, 2017, J NEUROTRAUM, V34, P38, DOI 10.1089/neu.2015.4308; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Sollmann N, 2018, NEUROIMAGE-CLIN, V17, P642, DOI 10.1016/j.nicl.2017.11.020; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Stern Y, 2009, NEUROPSYCHOLOGIA, V47, P2015, DOI 10.1016/j.neuropsychologia.2009.03.004; Stewart WF, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00240; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tarnutzer AA, 2017, BRIT J SPORT MED, V51, P1592, DOI 10.1136/bjsports-2016-096593; Tremblay S, 2018, INT J PSYCHOPHYSIOL, V132, P167, DOI 10.1016/j.ijpsycho.2017.09.005	45	15	15	0	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0195-9131	1530-0315		MED SCI SPORT EXER	Med. Sci. Sports Exerc.	JUL	2019	51	7					1355	1361		10.1249/MSS.0000000000001905			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	ID4WK	WOS:000471676800001	30649104	Bronze			2022-02-06	
J	Fridman, EA; Osborne, JR; Mozley, PD; Victor, JD; Schiff, ND				Fridman, Esteban A.; Osborne, Joseph R.; Mozley, Paul D.; Victor, Jonathan D.; Schiff, Nicholas D.			Presynaptic dopamine deficit in minimally conscious state patients following traumatic brain injury	BRAIN			English	Article						minimally conscious state; dopamine 2-like receptors; C-11-raclopride; basal ganglia; central thalamus	VEGETATIVE STATE; AMANTADINE; MODULATION; MECHANISMS; RECEPTORS; STRIATUM; DISEASE; MODEL	Dopaminergic stimulation has been proposed as a treatment strategy for post-traumatic brain injured patients in minimally conscious state based on a clinical trial using amantadine, a weak dopamine transporter blocker. However, a specific contribution of dopaminergic neuromodulation in minimally conscious state is undemonstrated. In a phase 0 clinical trial, we evaluated 13 normal volunteers and seven post-traumatic minimally conscious state patients using C-11-raclopride PET to estimate dopamine 2-like receptors occupancy in the striatum and central thalamus before and after dopamine transporter blockade with dextroamphetamine. If a presynaptic deficit was observed, a third and a fourth C-11-raclopride PET were acquired to evaluate changes in dopamine release induced by L-DOPA and L-DOPA + dextroamphetamine. Permutation analysis showed a significant reduction of dopamine release in patients, demonstrating a presynaptic deficit in the striatum and central thalamus that could not be reversed by blocking the dopamine transporter. However, administration of the dopamine precursor L-DOPA reversed the presynaptic deficit by restoring the biosynthesis of dopamine from both ventral tegmentum and substantia nigra. The advantages of alternative pharmacodynamic approaches in post-traumatic minimally conscious state patients should be tested in clinical trials, as patients currently refractory to amantadine might benefit from them.	[Fridman, Esteban A.; Victor, Jonathan D.; Schiff, Nicholas D.] Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA; [Osborne, Joseph R.] Mem Sloan Kettering Canc Ctr, Dept Radiol, 1275 York Ave, New York, NY 10021 USA; [Mozley, Paul D.] Weill Cornell Med Coll, Radiol Dept, New York, NY USA		Schiff, ND (corresponding author), Weill Cornell Med Coll, Feil Family Brain & Mind Res Inst, New York, NY 10065 USA.; Fridman, EA (corresponding author), LC-802A, New York, NY 10065 USA.	esf2005@med.cornell.edu; nds2001@med.cornell.edu		Fridman, Esteban A./0000-0001-7879-8874	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1TR000457]; National Institute for Neurological Disorders and Stroke of the National Institutes of Health (USA) [R21 NS093268]	Funding for the work was provided by the National Institutes of Health UL1TR000457 of the Clinical and Translation Science Center at Weill Cornell Medicine (USA); and the National Institute for Neurological Disorders and Stroke of the National Institutes of Health (USA) R21 NS093268 (E.A.F).	Alakurtti K, 2011, J CEREBR BLOOD F MET, V31, P155, DOI 10.1038/jcbfm.2010.64; Arai A, 2003, BRAIN RES, V972, P229, DOI 10.1016/S0006-8993(03)02531-9; Baker JL, 2016, J NEUROPHYSIOL, V116, P2383, DOI 10.1152/jn.01129.2015; BECKSTEAD RM, 1979, BRAIN RES, V175, P191, DOI 10.1016/0006-8993(79)91001-1; Breier A, 1997, P NATL ACAD SCI USA, V94, P2569, DOI 10.1073/pnas.94.6.2569; Brown EN, 2010, NEW ENGL J MED, V363, P2638, DOI 10.1056/NEJMra0808281; Bruno MA, 2011, J NEUROL, V258, P1373, DOI 10.1007/s00415-011-6114-x; Buckholtz JW, 2010, SCIENCE, V329, P532, DOI 10.1126/science.1185778; Esterlis I, 2018, MOL PSYCHIATR, V23, P824, DOI 10.1038/mp.2017.58; Fan XT, 2014, BRAIN RES, V1552, P34, DOI 10.1016/j.brainres.2013.12.035; Fridman EA, 2014, CURR OPIN NEUROBIOL, V29, P172, DOI 10.1016/j.conb.2014.09.008; Fridman EA, 2014, P NATL ACAD SCI USA, V111, P6473, DOI 10.1073/pnas.1320969111; Gerfen CR, 2011, ANNU REV NEUROSCI, V34, P441, DOI 10.1146/annurev-neuro-061010-113641; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; Giacino JT, 2004, ARCH PHYS MED REHAB, V85, P2020, DOI 10.1016/j.apmr.2004.02.033; Giacino JT, 2002, NEUROLOGY, V58, P349, DOI 10.1212/WNL.58.3.349; Grillner S, 2005, TRENDS NEUROSCI, V28, P364, DOI 10.1016/j.tins.2005.05.004; Haider B, 2009, NEURON, V62, P171, DOI 10.1016/j.neuron.2009.04.008; HALL H, 1994, NEUROPSYCHOPHARMACOL, V11, P245, DOI 10.1038/sj.npp.1380111; HUGHES AJ, 1991, NEUROLOGY, V41, P1723, DOI 10.1212/WNL.41.11.1723; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Liu J, 2015, ELIFE, V4, DOI 10.7554/eLife.09215; Liu M, 2016, J NEUROTRAUMA, V9; Matsuda W, 2003, J NEUROL NEUROSUR PS, V74, P1571, DOI 10.1136/jnnp.74.11.1571; Rieck RW, 2004, NEUROPSYCHOPHARMACOL, V29, P362, DOI 10.1038/sj.npp.1300336; SANO I, 1959, BIOCHIM BIOPHYS ACTA, V32, P586, DOI 10.1016/0006-3002(59)90652-3; Schiff ND, 2010, TRENDS NEUROSCI, V33, P1, DOI 10.1016/j.tins.2009.11.002; Schmahmann JD, 1999, NEUROIMAGE, V10, P233, DOI 10.1006/nimg.1999.0459; Sommerauer C, 2012, NEUROPHARMACOLOGY, V62, P1708, DOI 10.1016/j.neuropharm.2011.11.017; Stender J, 2015, J CEREBR BLOOD F MET, V35, P58, DOI 10.1038/jcbfm.2014.169; Tabrez S, 2012, CNS NEUROL DISORD-DR, V11, P395, DOI 10.2174/187152712800792785; Thengone DJ, 2016, SCI TRANSL MED, V8, DOI 10.1126/scitranslmed.aaf6113; Volkow ND, 1997, NATURE, V386, P830, DOI 10.1038/386830a0; Volonte MA, 2001, NEUROL SCI, V22, P107, DOI 10.1007/s100720170067; Wise RA, 2004, NAT REV NEUROSCI, V5, P483, DOI 10.1038/nrn1406; Wu YJ, 2002, J CEREBR BLOOD F MET, V22, P1440, DOI 10.1097/01.WCB.0000033967.83623.34	36	15	15	1	7	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	JUL	2019	142		7				1887	1893		10.1093/brain/awz118			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IR4QU	WOS:000481420100016	31505542	Green Published			2022-02-06	
J	Iverson, KM; Dardis, CM; Grillo, AR; Galovski, TE; Pogoda, TK				Iverson, Katherine M.; Dardis, Christina M.; Grillo, Alessandra R.; Galovski, Tara E.; Pogoda, Terri K.			Associations between traumatic brain injury from intimate partner violence and future psychosocial health risks in women	COMPREHENSIVE PSYCHIATRY			English	Article						Concussion; Partner abuse; Physical health; Psychological Health; PTSD; Revictimization; Screening; Sleep	POSTTRAUMATIC-STRESS-DISORDER; DISTINCT PTSD SYMPTOMS; POSTCONCUSSIVE SYMPTOMS; VETERANS; DEPRESSION; SEVERITY; REVICTIMIZATION; CONSEQUENCE; AFGHANISTAN; OUTCOMES	Objective: The effects of traumatic brain injury (TBI) incurred during military service are widely studied: however, less is known about TBI resulting from intimate partner violence ("IPV-related TBI"). Women Veterans are at high risk for IPV, yet no research has examined future psychosocial health risks associated with IPV-related TBI history in this population. Methods: We examined psychiatric and physical health outcomes, as well as IPV, in a sample of women Veterans who, at Time 1, reported IPV-related TBI with (n = 13) or without (n = 20) persistent symptoms: that is, symptoms such as memory problems, balance problems or dizziness, sensitivity to bright light, irritability, headaches, and sleep problems that began or got worse immediately following the IPV-related TBI and occurred within the past week. These women completed web-based surveys 18 months later (Time 2), which included validated measures of psychiatric and physical health symptoms as well as past-year IPV. We conducted linear regressions to model whether T1 IPV-related T61 with persistent symptoms predicted worse health outcomes at 12, in comparison to T1 IPV-related without persistent symptoms. Results: Controlling for significant covariates (i.e., military sexual trauma; MST), IPV-related TBI with persistent symptoms at Time I was associated with significantly worse outcomes at Time 2 across all health outcome domains (sr(2) range: 0.12-0.37). After controlling for MST and probable posttraumatic stress disorder (PTSD) at Time 1, WV-related TBI with persistent symptoms at Time 1 remained significantly associated with worse Time 2 symptoms of insomnia, depression, and physical health (sr(2) range: 0.12-025). Conclusion: Women who experience IPV-related TBI with persistent symptoms are at higher risk for worse psychosocial health outcomes 18 months later. Findings necessitate screening IPV survivors for TBI with persistent symptoms and tailoring TBI and psychosocial interventions to reduce risk for ongoing health sequelae. Published by Elsevier Inc.	[Iverson, Katherine M.; Grillo, Alessandra R.; Galovski, Tara E.] VA Boston Healthcare Syst, Womens Hlth Sci Div, Natl Ctr PTSD, Boston, MA 02130 USA; [Iverson, Katherine M.; Galovski, Tara E.] Boston Univ, Sch Med, Boston, MA 02118 USA; [Dardis, Christina M.] Towson Univ, Dept Psychol, Towson, MD 21252 USA; [Pogoda, Terri K.] VA Boston Healthcare Syst, Ctr Healthcare Org & Implementat Res, Boston, MA 02130 USA; [Pogoda, Terri K.] Boston Univ, Sch Publ Hlth, Boston, MA 02118 USA		Iverson, KM (corresponding author), VA Boston Healthcare Syst, Boston, MA 02130 USA.	Katherine.Iverson@va.gov		Grillo, Alessandra/0000-0002-9800-5541	Department of Veterans Affairs (VA), Office of Research and Development, Health Services Research and Development ServicesUS Department of Veterans Affairs [IIR 16-062, CDA 10-029]; Dr. Iverson's Presidential Early Career Award for Scientists and Engineers [USA 14-275]	This work was supported, in part, by grants from the Department of Veterans Affairs (VA), Office of Research and Development, Health Services Research and Development Services (IIR 16-062; CDA 10-029; Iverson) and Dr. Iverson's Presidential Early Career Award for Scientists and Engineers (USA 14-275). This work does not represent the position or views of the United States government or the VA.	Amara J, 2014, MIL MED, V179, P964, DOI 10.7205/MILMED-D-13-00559; Amara JH, 2019, J HEAD TRAUMA REHAB, V34, P11, DOI 10.1097/HTR.0000000000000404; American Psychiatric Association, 2013, DIAGN STAT MAN MENT; Amoroso T, 2017, J NERV MENT DIS, V205, P318, DOI 10.1097/NMD.0000000000000621; ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; Bair-Merritt MH, 2014, AM J PREV MED, V46, P188, DOI 10.1016/j.amepre.2013.10.001; Banks ME, 2007, TRAUMA VIOLENCE ABUS, V8, P290, DOI 10.1177/1524838007303503; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Benge JF, 2009, REHABIL PSYCHOL, V54, P270, DOI 10.1037/a0016736; BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; BJORGVINSSON T, 2013, PSYCHOMETRIC PROPERT, V20, P429, DOI DOI 10.1177/1073191113481998; Bovin MJ, 2016, PSYCHOL ASSESSMENT, V28, P1379, DOI 10.1037/pas0000254; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Curry Parichat, 2011, Int J Crit Illn Inj Sci, V1, P57, DOI 10.4103/2229-5151.79283; Curry SJ, 2018, JAMA-J AM MED ASSOC, V320, P1678, DOI 10.1001/jama.2018.14741; DANESHVAR DH, 2011, J TRAUMA STRESS, V22, P683, DOI DOI 10.1016/J.PMR.2011.08.009; Dardis CM, 2018, PSYCHIAT RES, V266, P103, DOI 10.1016/j.psychres.2018.05.034; Defense and Veterans Brain Injury Center, DOD WORLDW NUMB RBI; Defense Manpower Data Center, 2018, TABL ACT DUT FEM RAN; Department of Defense Department of Veterans Affairs, 2016, VA DOD CLIN PRACT GU; Dichter ME, 2017, J TRAUMA STRESS, V30, P555, DOI 10.1002/jts.22241; Dichter ME, 2015, MIL MED, V180, P1124, DOI 10.7205/MILMED-D-14-00582; Dichter ME, 2011, WOMEN HEALTH ISS, V21, pS190, DOI 10.1016/j.whi.2011.04.008; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fortier MA, 2009, PSYCHOL WOMEN QUART, V33, P308, DOI 10.1111/j.1471-6402.2009.01503.x; Frieden TR, 2013, C TRAUM BRAIN INJ US; Galovski TE, 2009, J TRAUMA STRESS, V22, P197, DOI 10.1002/jts.20418; Gerber MR, 2014, J WOMENS HEALTH, V23, P302, DOI 10.1089/jwh.2013.4513; GfK, 2013, KNOWLEDGE PANEL DESI; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Gradus JL, 2015, J TRAUMA STRESS, V28, P361, DOI 10.1002/jts.22021; Grillo AR, 2021, J INTERPERS VIOLENCE, V36, pNP8431, DOI [10.1177/0886260519846408, 10.1177/0886260519840408]; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2016, GEN HOSP PSYCHIAT, V40, P33, DOI 10.1016/j.genhosppsych.2016.03.001; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Iverson KM, 2013, J TRAUMA STRESS, V26, P767, DOI 10.1002/jts.21867; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Iverson KM, 2013, J TRAUMA STRESS, V26, P102, DOI 10.1002/jts.21781; Jackson H, 2002, PROF PSYCHOL-RES PR, V33, P39, DOI 10.1037//0735-7028.33.1.39; Kimerling R, 2010, AM J PUBLIC HEALTH, V100, P1409, DOI 10.2105/AJPH.2009.171793; Krause ED, 2006, J TRAUMA STRESS, V19, P507, DOI 10.1002/jts.20136; Kroenke K, 2002, PSYCHOSOM MED, V64, P258, DOI 10.1097/00006842-200203000-00008; Kwako LE, 2011, TRAUMA VIOLENCE ABUS, V12, P115, DOI 10.1177/1524838011404251; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; LOVIBOND PF, 1995, BEHAV RES THER, V33, P335, DOI 10.1016/0005-7967(94)00075-U; Mitchell MC, 2008, SPINAL CORD, V46, P547, DOI 10.1038/sj.sc.3102154; Monahan K, 2018, SOC WORK, V63, P179, DOI 10.1093/sw/swy005; Murray CE, 2016, TRAUMA VIOLENCE ABUS, V17, P298, DOI 10.1177/1524838015584364; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Polytrauma Rehabilitation Center Richmond VAMedical Center Department of Veterans Affairs, 2018, TRAUM BRAIN INJ POL; Porter KE, 2018, J PSYCHIATR RES, V102, P8, DOI 10.1016/j.jpsychires.2018.03.004; PRINCE C, 2017, J TRAUMA STRESS, V7, DOI DOI 10.3390/BRAINSCI7080105; Seal KH, 2016, J REHABIL RES DEV, V53, P185, DOI 10.1682/JRRD.2014.12.0301; Sohal H, 2007, BMC FAM PRACT, V8, DOI 10.1186/1471-2296-8-49; St Ivany A, 2016, FAM COMMUNITY HEALTH, V39, P129, DOI 10.1097/FCH.0000000000000094; Straus MA, 1996, J FAM ISSUES, V17, P283, DOI 10.1177/019251396017003001; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera EM, 2019, J AGGRESSION MALTREA; Valera EM, 1997, URBANA CHAMPAIGN DIS; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2012, PTSD MILD TRAUMATIC; Warshaw C, 2013, SYSTEMATIC REV TRAUM, P1; Weathers F.W., 2013, PTSD CHECKLIST DSM5; Women Veterans Health Strategic Health Care Group Department of Veterans Affairs, 2012, PROF WOM VET TOD; Yee MK, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070079	70	15	15	0	4	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0010-440X	1532-8384		COMPR PSYCHIAT	Compr. Psychiat.	JUL	2019	92						13	21		10.1016/j.comppsych.2019.05.001			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	LD0WW	WOS:000525755200003	31203176	gold			2022-02-06	
J	Adzemovic, T; Murray, T; Jenkins, P; Ottosen, J; Iyegha, U; Raghavendran, K; Napolitano, LM; Hemmila, MR; Gipson, J; Park, P; Tignanelli, CJ				Adzemovic, Tessa; Murray, Thomas; Jenkins, Peter; Ottosen, Julie; Iyegha, Uroghupatei; Raghavendran, Krishnan; Napolitano, Lena M.; Hemmila, Mark R.; Gipson, Jonathan; Park, Pauline; Tignanelli, Christopher J.			Should they stay or should they go? Who benefits from interfacility transfer to a higher-level trauma center following initial presentation at a lower-level trauma center	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	77th Annual Meeting of the American-Association-for-the-Surgery-of-Trauma (AAST) / Clinical Congress of Acute Care Surgery / 4th World Trauma Congress	SEP 24-29, 2018	San Diego, CA	Amer Assoc Surg Trauma		Interfacility transfer; triage; secondary overtriage; undertriage; trauma systems	SECONDARY OVERTRIAGE; SURGEONS COMMITTEE; AMERICAN-COLLEGE; MAJOR TRAUMA; IMPACT	BACKGROUND Interfacility transfer of patients from Level III/IV to Level I/II (tertiary) trauma centers has been associated with improved outcomes. However, little data are available classifying the specific subsets of patients that derive maximal benefit from transfer to a tertiary trauma center. Drawbacks to transfer include increased secondary overtriage. Here, we ask which injury patterns are associated with improved survival following interfacility transfer. METHODS Data from the National Trauma Data Bank was utilized. Inclusion criteria were adults (>= 16 years). Patients with Injury Severity Score of 10 or less or those who arrived with no signs of life were excluded. Patients were divided into two cohorts: those admitted to a Level III/IV trauma center versus those transferred into a tertiary trauma center. Multiple imputation was performed for missing values, and propensity scores were generated based on demographics, injury patterns, and disease severity. Using propensity score-stratified Cox proportional hazards regression, the hazard ratio for time to death was estimated. RESULTS Twelve thousand five hundred thirty-four (5.2%) were admitted to Level III/IV trauma centers, and 227,315 (94.8%) were transferred to a tertiary trauma center. Patients transferred to a tertiary trauma center had reduced mortality (hazard ratio, 0.69; p < 0.001). We identified that patients with traumatic brain injury with Glasgow Coma Scale score less than 13, pelvic fracture, penetrating mechanism, solid organ injury, great vessel injury, respiratory distress, and tachycardia benefited from interfacility transfer to a tertiary trauma center. In this sample, 56.8% of the patients benefitted from transfer. Among those not transferred, 49.5% would have benefited from being transferred. CONCLUSION Interfacility transfer is associated with a survival benefit for specific patients. These data support implementation of minimum evidence-based criteria for interfacility transfer.	[Adzemovic, Tessa] Univ Michigan, Sch Med, Ann Arbor, MI USA; [Murray, Thomas] Univ Minnesota, Div Biostat, Minneapolis, MN USA; [Jenkins, Peter] Indiana Univ, Dept Surg, Indianapolis, IN 46204 USA; [Ottosen, Julie; Tignanelli, Christopher J.] Univ Minnesota, Dept Surg, 420 Delaware St SE,MMC 195, Minneapolis, MN 55455 USA; [Ottosen, Julie; Gipson, Jonathan; Tignanelli, Christopher J.] North Mem Hlth Hosp, Dept Surg, Robbinsdale, MN USA; [Iyegha, Uroghupatei] Reg Hosp, Dept Surg, St Paul, MN USA; [Raghavendran, Krishnan; Napolitano, Lena M.; Hemmila, Mark R.; Park, Pauline] Univ Michigan, Dept Surg, Ann Arbor, MI 48109 USA; [Tignanelli, Christopher J.] Univ Minnesota, Inst Hlth Informat, Minneapolis, MN USA		Tignanelli, CJ (corresponding author), Univ Minnesota, Dept Surg, 420 Delaware St SE,MMC 195, Minneapolis, MN 55455 USA.	ctignane@umn.edu	Napolitano, Lena/AAZ-8651-2021	Tignanelli, Christopher/0000-0002-8079-5565			American College of Surgeon Committee on Trauma, 2014, RES OPT CAR INJ PAT; American College of Surgeons, 2012, ADV TRAUM LIF SUPP S, V9th; Bible JE, 2014, SPINE J, V14, P2877, DOI 10.1016/j.spinee.2014.01.065; Brasel KJ, 2013, J TRAUMA ACUTE CARE, V74, P1363, DOI 10.1097/TA.0b013e31828b82f5; Brier GW, 1950, MON WEATHER REV, V78, P1, DOI DOI 10.1175/1520-0493(1950)078<0001:VOFEIT>2.0.CO;2; Ciesla DJ, 2008, J AM COLL SURGEONS, V206, P131, DOI 10.1016/j.jamcollsurg.2007.06.285; Con J, 2015, J SURG RES, V198, P462, DOI 10.1016/j.jss.2015.03.077; Garwe T, 2010, ACAD EMERG MED, V17, P1223, DOI 10.1111/j.1553-2712.2010.00918.x; Glance LG, 2009, ANN SURG, V249, P1032, DOI 10.1097/SLA.0b013e3181a38f28; Haas B, 2012, J TRAUMA ACUTE CARE, V72, P1510, DOI 10.1097/TA.0b013e318252510a; Hill AD, 2011, J TRAUMA, V71, P1885, DOI 10.1097/TA.0b013e31823ac642; Imbens GW, 2015, CAUSAL INFERENCE FOR STATISTICS, SOCIAL, AND BIOMEDICAL SCIENCES: AN INTRODUCTION, P1, DOI 10.1017/CBO9781139025751; Lynch KT, 2016, J SURG RES, V204, P460, DOI 10.1016/j.jss.2016.05.035; Newgard CD, 2007, J TRAUMA, V63, P965, DOI 10.1097/TA.0b013e31803c5665; Osen HB, 2010, J TRAUMA, V69, P602, DOI 10.1097/TA.0b013e3181e7db37; Pickering A, 2015, J TRAUMA ACUTE CARE, V78, P164, DOI 10.1097/TA.0000000000000483; R Development Core Team, 2012, R LANG ENV STAT COMP; Ruppert D., 2003, CAMBRIDGE SERIES STA; Schuster T, 2016, J CLIN EPIDEMIOL, V80, P97, DOI 10.1016/j.jclinepi.2016.05.017; Sorensen MJ, 2013, JAMA SURG, V148, P763, DOI 10.1001/jamasurg.2013.2132; Tignanelli CJ, 2018, J TRAUMA ACUTE CARE, V84, P273, DOI 10.1097/TA.0000000000001743; Tignanelli CJ, 2018, J TRAUMA ACUTE CARE, V84, P287, DOI 10.1097/TA.0000000000001745; van Buuren S, 2011, J STAT SOFTW, V45, P1	23	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2019	86	6					952	960		10.1097/TA.0000000000002248			9	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	IB1CM	WOS:000470001200003	31124892				2022-02-06	
J	Erdodi, LA; Taylor, B; Sabelli, AG; Malleck, M; Kirsch, NL; Abeare, CA				Erdodi, Laszlo A.; Taylor, Brian; Sabelli, Alana G.; Malleck, Malayna; Kirsch, Ned L.; Abeare, Christopher A.			Demographically Adjusted Validity Cutoffs on the Finger Tapping Test Are Superior to Raw Score Cutoffs in Adults with TBI	PSYCHOLOGICAL INJURY & LAW			English	Article						Finger tapping test; Demographically adjusted cutoffs; Performance validity; Erdodi Index; Modality specificity	TRAUMATIC BRAIN-INJURY; EMBEDDED PERFORMANCE VALIDITY; VERBAL-LEARNING TEST; INTELLIGENCE SCALE-4TH EDITION; COMPLEX FIGURE TEST; WORD MEMORY TEST; CROSS-VALIDATION; RECOGNITION TRIAL; RESPONSE BIAS; TEST-II	This study was designed to develop validity cutoffs within the Finger Tapping Test (FTT) using demographically adjusted T-scores, and to compare their classification accuracy to existing cutoffs based on raw scores. Given that FTT performance is known to vary with age, sex, and level of education, failure to correct for these demographic variables poses the risk of elevated false positive rates in examinees who, at the level of raw scores, have inherently lower FTT performance (women, older, and less educated individuals). Data were collected from an archival sample of 100 adult outpatients (M-Age=38.8years, M-Education=13.7years, 56% men) consecutively referred for neuropsychological assessment at an academic medical center in the Midwestern USA after sustaining a traumatic brain injury (TBI). Performance validity was psychometrically defined using the Word Memory Test and two validity composites based on five embedded performance validity indicators. Previously published raw score-based validity cutoffs disproportionately sacrificed sensitivity (.13-.33) for specificity (.98-1.00). Worse yet, they were confounded by sex and education. Newly introduced demographically adjusted cutoffs (T33 for the dominant hand, T37 for both hands) produced high levels of specificity (.89-.98) and acceptable sensitivity (.36-.55) across criterion measures. Equally importantly, they were robust to injury severity and demographic variables. The present findings provide empirical support for a growing trend of demographically adjusted performance validity cutoffs. They provide a practical and epistemologically superior alternative to raw score cutoffs, while also reducing the potential bias against examinees inherently vulnerable to lower raw score level FTT performance.	[Erdodi, Laszlo A.; Malleck, Malayna; Abeare, Christopher A.] Univ Windsor, Dept Psychol, Neuropsychol Track, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada; [Taylor, Brian; Sabelli, Alana G.] Univ Windsor, Behav Cognit Neurosci Program, Windsor, ON, Canada; [Kirsch, Ned L.] Univ Michigan, Dept Phys Med & Rehabil, Adult Outpatient Neurehabil Program, Ann Arbor, MI 48109 USA		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, Neuropsychol Track, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com		Abeare, Christopher/0000-0002-7163-7434	Faculty of Arts, Humanities, and Social Sciences at the University of Windsor	This research was supported by a Collaborative Research Grant from the Faculty of Arts, Humanities, and Social Sciences at the University of Windsor.	Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Allen L, 1999, ARCH CLIN NEUROPSYCH, V14, P789, DOI 10.1016/S0887-6177(99)80328-X; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; Armistead-Jehle P, 2015, APPL NEUROPSYCH-ADUL, V22, P147, DOI 10.1080/23279095.2014.880842; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bortnik KE, 2010, CLIN NEUROPSYCHOL, V24, P344, DOI 10.1080/13854040903307268; Brooks BL, 2015, ARCH CLIN NEUROPSYCH, V30, P200, DOI 10.1093/arclin/acv017; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carone DA, 2008, BRAIN INJURY, V22, P960, DOI 10.1080/02699050802491297; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Clark AL, 2014, CLIN NEUROPSYCHOL, V28, P802, DOI 10.1080/13854046.2014.904928; Committee on Psychological Testing IVT Populations B on the H of S Medicine I of, 2015, COGN TESTS PERF VAL; Conners, 2004, CONNERS CONTINUOUS P; Costabile T, 2018, PSYCHIAT CLIN NEUROS, V72, P189, DOI 10.1111/pcn.12630; Cottingham ME, 2014, CLIN NEUROPSYCHOL, V28, P1030, DOI 10.1080/13854046.2014.951397; Critchfield E, 2019, CLIN NEUROPSYCHOL, V33, P1083, DOI 10.1080/13854046.2018.1508615; Curtis KL, 2009, ASSESSMENT, V16, P401, DOI 10.1177/1073191109338161; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Delis D.C., 2000, CALIFORNIA VERBAL LE; Donders J, 2005, CHILD NEUROPSYCHOL, V11, P221, DOI 10.1080/09297040490917298; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Donders J, 2013, J CLIN EXP NEUROPSYC, V35, P827, DOI 10.1080/13803395.2013.824557; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Dunn, 2007, PPVT 4 PEABODY PICTU; Erdodi, 2018, J PEDIAT NEUROPSYCHO, V4, P94, DOI [10.1007/s40817-018-0057-4, DOI 10.1007/s40817-018-0057-4, DOI 10.1007/S40817-018-0057-4]; Erdodi L. A., 2019, ASSESSMENT FEIGNED C; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, APPL NEUROPSYCH-CHIL, V6, P355, DOI 10.1080/21622965.2016.1198908; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green P, 2003, CHILD NEUROPSYCHOL, V9, P189, DOI 10.1076/chin.9.3.189.16460; Green P, 2009, BRAIN INJURY, V23, P741, DOI 10.1080/02699050903133962; Green P, 1999, BRAIN INJURY, V13, P813, DOI 10.1080/026990599121205; Green P., 2003, GREENS WORD MEMORY T; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Guilmette T.J., 2013, MILD TRAUMATIC BRAIN, P31; HAALAND KY, 1994, J CLIN EXP NEUROPSYC, V16, P448, DOI 10.1080/01688639408402655; Halstead WC, 1947, BRAIN INTELLIGENCE Q; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton R. K., 2004, REVISED COMPREHENSIV; HEATON RK, 1978, J CONSULT CLIN PSYCH, V46, P892, DOI 10.1037/0022-006X.46.5.892; Heaton RK, 1991, COMPREHENSIVE NORMS; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Henry GK, 2018, J INT NEUROPSYCH SOC, V24, P735, DOI 10.1017/S1355617718000218; HILL AB, 1965, P ROY SOC MED, V58, P295, DOI 10.1177/003591576505800503; Homann CN, 2003, J NEURAL TRANSM, V110, P885, DOI 10.1007/s00702-003-0009-7; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson G., 1999, J COGNITIVE REHABILI, V17, P4; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kalfon TBO, 2016, J PSYCHOSOM RES, V87, P30, DOI 10.1016/j.jpsychores.2016.06.004; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; Lemeshow S, 2000, APPL LOGISTIC REGRES; Lichtenstein J. D., 2019, PSYCHOL INJURY LAW, DOI [10.1007/s12207-019-0935, DOI 10.1007/S12207-019-0935]; Lichtenstein JD, 2019, DEV NEUROPSYCHOL, V44, P159, DOI 10.1080/87565641.2019.1565535; Lichtenstein JD, 2018, CHILD NEUROPSYCHOL, V24, P247, DOI 10.1080/09297049.2016.1259402; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Lippa SM, 2014, REHABIL PSYCHOL, V59, P306, DOI 10.1037/a0037217; Locke DEC, 2008, NEUROREHABILITATION, V23, P273; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Matthews C, 1964, INSTRUCTION MANUAL A, P36; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P271, DOI 10.1016/0887-6177(95)00040-2; Newcombe F., 1969, MISSILE WOUNDS BRAIN; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Pearson, 2009, ADV CLIN SOLUTIONS W; Persinger VC, 2018, CLIN NEUROPSYCHOL, V32, P1039, DOI 10.1080/13854046.2017.1419507; Prigatano GP, 2003, J INT NEUROPSYCH SOC, V9, P128, DOI 10.1017/S1355617703000134; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; RAI J, 2019, APPL NEUROPSYCHOL, DOI DOI 10.1080/23279095.2019.161.1613994; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Rapport LJ, 1998, J CLIN EXP NEUROPSYC, V20, P89, DOI 10.1076/jcen.20.1.89.1488; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Reitan R, 1969, MANUAL ADM NEUROPSYC; Reitan R, 1985, HALSTEAD REITAN NEUR; REITAN R. M., 1958, PERCEPT MOT SKILLS, V8, P271; Reitan RM, 1955, J CONSULT PSYCHOL, V19, P393, DOI 10.1037/h0044509; RUFF RM, 1993, PERCEPT MOTOR SKILL, V76, P1219, DOI 10.2466/pms.1993.76.3c.1219; Schatz P, 2011, ENCY NEUROPSYCHOLOGY; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Shimoyama I, 2012, INT MED J, V19, P138; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Sussman ZW, 2019, APPL NEUROPSYCH-CHIL, V8, P70, DOI 10.1080/21622965.2017.1382359; Sweet JJ, 2013, BEHAV SCI LAW, V31, P756, DOI 10.1002/bsl.2088; Tan JE, 2002, CLIN NEUROPSYCHOL, V16, P495, DOI 10.1076/clin.16.4.495.13909; TRUEBLOOD W, 1994, J CLIN EXP NEUROPSYC, V16, P597, DOI 10.1080/01688639408402671; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; Wechsler D., 2009, WECHSLER MEMORY SCAL; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Williamson DJ, 2012, CLIN NEUROPSYCHOL, V26, P588, DOI 10.1080/13854046.2012.670266; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791	137	15	15	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	JUN	2019	12	2					113	126		10.1007/s12207-019-09352-y			14	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	IF6ZK	WOS:000473231100002					2022-02-06	
J	Lichtenstein, JD; Greenacre, MK; Cutler, L; Abeare, K; Baker, SD; Kent, KJ; Ali, S; Erdodi, LA				Lichtenstein, Jonathan D.; Greenacre, Matthew K.; Cutler, Laura; Abeare, Kaitlyn; Baker, Shannon D.; Kent, Katrina J.; Ali, Sami; Erdodi, Laszlo A.			Geographic Variation and Instrumentation Artifacts: in Search of Confounds in Performance Validity Assessment in Adults with Mild TBI	PSYCHOLOGICAL INJURY & LAW			English	Article						Geographic variability in cognitive ability; Performance validity; Instrumentation artifacts	TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; CARD SORTING TEST; MALINGERED NEUROCOGNITIVE DYSFUNCTION; RECOGNITION MEMORY TEST; RELIABLE DIGIT SPAN; COMPLEX IDEATIONAL MATERIAL; CANADIAN NORMATIVE DATA; FALSE-POSITIVE RATES; WORD CHOICE TEST	Regional fluctuations in cognitive ability have been reported worldwide. Given perennial concerns that the outcome of performance validity tests (PVTs) may be contaminated by genuine neuropsychological deficits, geographic differences may represent a confounding factor in determining the credibility of a given neurocognitive profile. This pilot study was designed to investigate whether geographic location affects base rates of failure (BRFail) on PVTs. BRFail were compared across a number of free-standing and embedded PVTs in patients with mild traumatic brain injury (mTBI) from two regions of the US (Midwest and New England). Retrospective archival data were collected from clinically referred patients with mTBI at two different academic medical centers (n(Midwest)=76 and n(New England)=84). One free-standing PVT (Word Choice Test) and seven embedded PVTs were administered to both samples. The embedded validity indicators were combined into a single composite score using two different previously established aggregation methods. The New England sample obtained a higher score on the Verbal Comprehension Index of the WAIS-IV (d=.34, small-medium). The difference between the two regions in Full Scale IQ (FSIQ) was small (d=.28). When compared with the omnibus population mean (100), the effect of mTBI on FSIQ was small (d=.22) in the New England sample and medium (d=.53) in the Midwestern one. However, contrasts using estimates of regional FSIQ produced equivalent effect sizes (d: .47-.53). BRFail was similar on free-standing PVTs, but varied at random for embedded PVTs. Aggregating individual indices into a validity composite effectively neutralized regional variability in BRFail. Classification accuracy varied as a function of both geographic region and instruments. Despite small overall effect sizes, regional differences in cognitive ability may potentially influence clinical decision making, both in terms of diagnosis and performance validity assessment. There was an interaction between geographic region and instruments in terms of the internal consistency of PVT profiles. If replicated, the findings of this preliminary study have potentially important clinical, forensic, methodological, and epidemiological implications.	[Lichtenstein, Jonathan D.] Geisel Sch Med Dartmouth, Dept Psychiat, Hanover, NH USA; [Greenacre, Matthew K.; Baker, Shannon D.; Kent, Katrina J.] Western Univ, Shulich Sch Med, London, ON, Canada; [Cutler, Laura; Abeare, Kaitlyn; Ali, Sami; Erdodi, Laszlo A.] Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada		Erdodi, LA (corresponding author), Univ Windsor, Dept Psychol, 168 Chrysler Hall South,401 Sunset Ave, Windsor, ON N9B 3P4, Canada.	lerdodi@gmail.com	Cutler, Laura/AAI-6283-2021	Cutler, Laura/0000-0003-2957-8693	Schulich-UWindsor Opportunities for Research Excellence Program; Faculty of Arts, Humanities, and Social Sciences at the University of Windsor	This research was supported by the Schulich-UWindsor Opportunities for Research Excellence Program, the Dean of the Faculty of Arts, Humanities, and Social Sciences at the University of Windsor, and a Collaborative Research Grant from the Faculty of Arts, Humanities, and Social Sciences at the University of Windsor.	Abeare C., 2018, J HEAD TRAUMA REHABI, V1; Abeare C, 2019, J HEAD TRAUMA REHAB, V34, pE20, DOI 10.1097/HTR.0000000000000451; ALTMAN DG, 1994, BRIT MED J, V309, P188, DOI 10.1136/bmj.309.6948.188; An KY, 2019, J CLIN EXP NEUROPSYC, V41, P15, DOI 10.1080/13803395.2018.1483488; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; [Anonymous], 2013, DIAGNOSTIC STAT MANU; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Arsenault-Lapierre G, 2011, J CLIN EXP NEUROPSYC, V33, P596, DOI 10.1080/13803395.2010.547459; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Aslaksen PM, 2018, BEHAV BRAIN RES, V351, P131, DOI 10.1016/j.bbr.2018.06.008; Axelrod BN, 1996, J CLIN EXP NEUROPSYC, V18, P338, DOI 10.1080/01688639608408991; Axelrod BN, 2006, CLIN NEUROPSYCHOL, V20, P513, DOI 10.1080/13854040590967117; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Bain KM, 2019, ASSESSMENT, V26, P1320, DOI 10.1177/1073191117725172; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Barhon LI, 2015, APPL NEUROPSYCH-ADUL, V22, P114, DOI 10.1080/23279095.2013.863775; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bigler ED, 2015, BRAIN IMAGING BEHAV, V9, P421, DOI 10.1007/s11682-015-9409-1; Bigler ED, 2014, BRAIN INJURY, V28, P1623, DOI 10.3109/02699052.2014.947627; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Bilder RM, 2014, CLIN NEUROPSYCHOL, V28, P1212, DOI 10.1080/13854046.2014.969774; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Boone K.B., 2013, CLIN PRACTICE FORENS; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Brennan A, 2009, CLIN NEUROPSYCHOL, V23, P314, DOI 10.1080/13854040802054151; Brooks BL, 2015, ARCH CLIN NEUROPSYCH, V30, P200, DOI 10.1093/arclin/acv017; Bush SS, 2014, PSYCHOL INJ LAW, V7, P197, DOI 10.1007/s12207-014-9198-7; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chafetz MD, 2015, CLIN NEUROPSYCHOL, V29, P723, DOI 10.1080/13854046.2015.1099738; Chevalier TM, 2016, ARCH CLIN NEUROPSYCH, V31, P446, DOI 10.1093/arclin/acw031; Chu O, 2012, LATERALITY, V17, P306, DOI 10.1080/1357650X.2011.568490; Coleman RD, 1998, J CLIN EXP NEUROPSYC, V20, P201, DOI 10.1076/jcen.20.2.201.1164; Curtis KL, 2006, ASSESSMENT, V13, P46, DOI 10.1177/1073191105285210; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1224, DOI 10.1080/13854046.2014.987167; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1278, DOI 10.1080/13854046.2014.975844; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; Davis JJ, 2013, J CLIN EXP NEUROPSYC, V35, P413, DOI 10.1080/13803395.2013.781134; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Donders J, 2001, J INT NEUROPSYCH SOC, V7, P892, DOI 10.1017/S1355617701777132; Duggan EC, 2019, ARCH CLIN NEUROPSYCH, V34, P657, DOI 10.1093/arclin/acy074; Erdodi L. A., 2019, ASSESSMENT FEIGNED C; Erdodi L.A., 2017, PSYCHOL NEUROSCIENCE, V10, P325, DOI [10.1037/pne0000103, DOI 10.1037/PNE0000103, https://doi.org//10.1037/pne0000103, DOI https://doi.org/10.1037/pne0000103]; Erdodi L, 2017, APPL NEUROPSYCH-ADUL, V24, P264, DOI 10.1080/23279095.2016.1154856; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P307, DOI 10.1007/s12207-018-9337-7; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P327, DOI 10.1080/23279095.2017.1298600; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2018, ARCH CLIN NEUROPSYCH, V33, P845, DOI 10.1093/acn/acx110; Erdodi LA, 2017, BRAIN INJURY, V31, P1362, DOI 10.1080/02699052.2017.1332386; Erdodi LA, 2017, J CLIN EXP NEUROPSYC, V39, P369, DOI 10.1080/13803395.2016.1230181; Erdodi LA, 2016, PSYCHOL INJ LAW, V9, P112, DOI 10.1007/s12207-016-9254-6; Erdodi LA, 2017, PSYCHOL ASSESSMENT, V29, P148, DOI 10.1037/pas0000319; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Etherton JL, 2006, J CLIN EXP NEUROPSYC, V28, P1218, DOI 10.1080/13803390500346595; Fazio RL, 2017, CLIN NEUROPSYCHOL, V31, P251, DOI 10.1080/13854046.2016.1213316; Gervais RO, 2004, ARCH CLIN NEUROPSYCH, V19, P475, DOI 10.1016/j.acn.2003.05.001; Gilsanz P, 2017, JAMA NEUROL, V74, P1056, DOI 10.1001/jamaneurol.2017.1553; Glassmire DM, 2019, PSYCHOL ASSESSMENT, V31, P120, DOI 10.1037/pas0000650; Goodglass H., 1972, ASSESSMENT APHASIA R; Goodglass H., 1983, BOSTON DIAGNOSTIC AP; Green P., 2003, GREENS WORD MEMORY T; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve KW, 2006, J CLIN EXP NEUROPSYC, V28, P1176, DOI 10.1080/13803390500263550; Greve KW, 2009, ASSESSMENT, V16, P237, DOI 10.1177/1073191108326227; Greve KW, 2009, CLIN NEUROPSYCHOL, V23, P534, DOI 10.1080/13854040802232690; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Heaton R. K., 2004, REVISED COMPREHENSIV; Heaton RK, 1991, COMPREHENSIVE NORMS; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Hudson CG, 2012, SOC WORK, V57, P107, DOI 10.1093/sw/sws001; Inman TH, 2002, ARCH CLIN NEUROPSYCH, V17, P1, DOI 10.1016/S0887-6177(00)00073-1; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; Jasinski LJ, 2011, J CLIN EXP NEUROPSYC, V33, P300, DOI 10.1080/13803395.2010.516743; Jelicic M, 2011, J CLIN PSYCHOL, V67, P850, DOI 10.1002/jclp.20805; Jones A, 2013, CLIN NEUROPSYCHOL, V27, P1043, DOI 10.1080/13854046.2013.804949; Kanser RJ, 2019, CLIN NEUROPSYCHOL, V33, P90, DOI 10.1080/13854046.2018.1440006; Kanser RJ, 2017, CLIN NEUROPSYCHOL, V31, P644, DOI 10.1080/13854046.2016.1278040; Kim N, 2010, ARCH CLIN NEUROPSYCH, V25, P420, DOI 10.1093/arclin/acq040; Kraemer HC, 2006, BIOL PSYCHIAT, V59, P990, DOI 10.1016/j.biopsych.2005.09.014; Kulas JF, 2014, PSYCHOL INJ LAW, V7, P236, DOI 10.1007/s12207-014-9200-4; Kura K, 2013, INTELLIGENCE, V41, P512, DOI 10.1016/j.intell.2013.07.001; LAMBERTY GJ, 1994, NEUROPSY NEUROPSY BE, V7, P230; Larrabee G.L., 2012, FORENSIC NEUROPSYCHO, V2nd ed, P116; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Leon FR, 2014, INTELLIGENCE, V46, P291, DOI 10.1016/j.intell.2014.07.011; Levine B, 1998, J INT NEUROPSYCH SOC, V4, P247, DOI 10.1017/S1355617798002471; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Liu SY, 2015, J INT NEUROPSYCH SOC, V21, P677, DOI 10.1017/S1355617715000806; Lombardi WJ, 1999, J CLIN EXP NEUROPSYC, V21, P2, DOI 10.1076/jcen.21.1.2.940; Lundervold AJ, 2019, J ATTEN DISORD, V23, P1188, DOI 10.1177/1087054715580842; Lynn R, 2010, INTELLIGENCE, V38, P93, DOI 10.1016/j.intell.2009.07.004; Mathias CW, 2002, ASSESSMENT, V9, P301, DOI 10.1177/1073191102009003009; McAllister TW, 2012, J NEUROTRAUM, V29, P1111, DOI 10.1089/neu.2011.1930; McDaniel MA, 2006, INTELLIGENCE, V34, P607, DOI 10.1016/j.intell.2006.08.007; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; Miele AS, 2012, ARCH CLIN NEUROPSYCH, V27, P10, DOI 10.1093/arclin/acr084; Millis SR, 1995, PSYCHOL ASSESSMENT, V7, P463; MITTENBERG W, 1995, PROF PSYCHOL-RES PR, V26, P491, DOI 10.1037/0735-7028.26.5.491; Mittenberg W, 2001, CLIN NEUROPSYCHOL, V15, P440; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; O'Bryant SE, 2008, APPL NEUROPSYCHOL, V15, P113, DOI 10.1080/09084280802083921; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Pearson, 2009, ADV CLIN SOLUTIONS W; Pena ED, 2006, AM J SPEECH-LANG PAT, V15, P247, DOI 10.1044/1058-0360(2006/023); Perneger TV, 1998, BRIT MED J, V316, P1236, DOI 10.1136/bmj.316.7139.1236; Persinger VC, 2018, CLIN NEUROPSYCHOL, V32, P1039, DOI 10.1080/13854046.2017.1419507; Piffer D, 2014, INTELLIGENCE, V46, P246, DOI 10.1016/j.intell.2014.07.006; Powell MR, 2011, CLIN NEUROPSYCHOL, V25, P108, DOI 10.1080/13854046.2010.532912; Powell MR, 2004, ARCH CLIN NEUROPSYCH, V19, P693, DOI 10.1016/j.acn.2004.04.001; RAI J, 2019, APPL NEUROPSYCHOL, DOI DOI 10.1080/23279095.2019.161.1613994; Rai J., 2019, PSYCHOL NEUROSCIENCE, V12, P451, DOI [10.1037/pne0000175, DOI 10.1037/PNE0000175]; Rothman K J, 1990, Epidemiology, V1, P43, DOI 10.1097/00001648-199001000-00010; Roye S, 2019, CLIN NEUROPSYCHOL, V33, P1138, DOI 10.1080/13854046.2018.1520303; SAVITZ DA, 1995, AM J EPIDEMIOL, V142, P904, DOI 10.1093/oxfordjournals.aje.a117737; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schutte C, 2015, PSYCHOL INJ LAW, V8, P100, DOI 10.1007/s12207-015-9225-3; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Silk-Eglit GM, 2015, APPL NEUROPSYCH-ADUL, V22, P335, DOI 10.1080/23279095.2014.938809; Slick DJ, 2000, J CLIN EXP NEUROPSYC, V22, P569, DOI 10.1076/1380-3395(200010)22:5;1-9;FT569; Sollman MJ, 2010, PSYCHOL ASSESSMENT, V22, P325, DOI 10.1037/a0018857; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Stuss D. T, 1987, NEUROBEHAVIORAL RECO, V166; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sussman ZW, 2019, APPL NEUROPSYCH-CHIL, V8, P70, DOI 10.1080/21622965.2017.1382359; Sweet JJ, 2000, ARCH CLIN NEUROPSYCH, V15, P105, DOI 10.1016/S0887-6177(98)00153-X; Tayim FM, 2016, J CLIN EXP NEUROPSYC, V38, P1005, DOI 10.1080/13803395.2016.1182968; Thirthalli J, 2009, ASIAN J PSYCHIATR, V2, P74, DOI 10.1016/j.ajp.2009.04.004; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tremblay MP, 2016, ARCH CLIN NEUROPSYCH, V31, P926, DOI 10.1093/arclin/acw029; Trueblood W., 1994, J CLIN EXPT NEUROPSY, V4, P697, DOI DOI 10.1080/01688639408402671; Tyson BT, 2018, EPILEPSY BEHAV, V87, P39, DOI 10.1016/j.yebeh.2018.08.010; VALENCIA RR, 2001, INTELLIGENCE TESTING; Wadley VG, 2011, ANN NEUROL, V70, P229, DOI 10.1002/ana.22432; Walker LAS, 2017, CAN J NEUROL SCI, V44, P547, DOI 10.1017/cjn.2017.199; Wechsler D., 2008, TECHNICAL INTERPRETI; Weinborn M, 2012, CLIN NEUROPSYCHOL, V26, P832, DOI 10.1080/13854046.2012.686630; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063; Zuccato BG, 2018, PSYCHOL ASSESSMENT, V30, P1491, DOI 10.1037/pas0000596	149	15	15	0	4	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1938-971X	1938-9728		PSYCHOL INJ LAW	Psychol. Inj. Law	JUN	2019	12	2					127	145		10.1007/s12207-019-09354-w			19	Psychology, Clinical	Emerging Sources Citation Index (ESCI)	Psychology	IF6ZK	WOS:000473231100003					2022-02-06	
J	Lynall, RC; Lempke, LB; Johnson, RS; Anderson, MN; Schmidt, JD				Lynall, Robert C.; Lempke, Landon B.; Johnson, Rachel S.; Anderson, Melissa N.; Schmidt, Julianne D.			A Comparison of Youth Flag and Tackle Football Head Impact Biomechanics	JOURNAL OF NEUROTRAUMA			English	Article						concussion; mild traumatic brain injury; repetitive head impacts; sport	EXPOSURE; MAGNITUDE; PLAYERS	Our purpose was to describe the youth flag football head impact burden and make comparisons with youth tackle football. Head impact frequency and magnitude (linear acceleration [g], rotational acceleration [rad/s(2)]) were collected from 25 tackle and 25 flag youth football players over one season. Athlete exposure (AE) was defined as one player participating in one session. Head impact rates (IR) were calculated and impact rate ratios (IRR) were used to compare youth tackle and flag football. Random-intercept generalized logit models with odds ratios compared the probabilities of sustaining an impact with a linear acceleration of 20.00-29.99g, 30.00-39.99g, and >= 40.00g against the reference of 14.00-19.99g and an impact with a rotational acceleration of 2500.00-7499.99 rad/s(2) or >= 7500.00 rad/s(2) against the reference of <= 2499.99 rad/s(2) between youth flag and tackle football. We observed 1908 tackle football head impacts (735 in games, 38.5%) across 624 AE and 169 flag football head impacts (101 in games, 59.8%) across 255 AE. Youth tackle football players experienced higher overall IR (3.06, 95% confidence interval [CI]: 2.61, 3.58; IRR = 4.61, 95% CI: 3.94, 5.40) compared with flag football (IR = 0.66, 95% CI: 0.57, 0.78). Youth flag football players had lower odds of sustaining impacts >20g but higher odds of sustaining impacts between 2500.00-7499.99 rad/s(2) compared with youth tackle players. Our preliminary sample of youth flag football players sustained less frequent head impacts at higher rotational accelerations than tackle football players. Flag football is considered a limited-contact sport, but little is known about the true head impact burden. Our findings may be important for policymakers when debating potential changes to youth football participation.	[Lynall, Robert C.; Lempke, Landon B.; Johnson, Rachel S.; Anderson, Melissa N.; Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, UGA Concuss Res Lab, Athens, GA 30602 USA		Lynall, RC (corresponding author), Univ Georgia, Dept Kinesiol, 330 River Rd, Athens, GA 30602 USA.	rlynall@uga.edu	Lempke, Landon/C-4800-2018; Lynall, Robert/M-2888-2014	Lempke, Landon/0000-0003-0007-1362; Lynall, Robert/0000-0002-0785-6640			Abbas K, 2015, DEV NEUROPSYCHOL, V40, P51, DOI 10.1080/87565641.2014.990455; Bellamkonda S, 2018, J APPL BIOMECH, V34, P354, DOI 10.1123/jab.2017-0207; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Campolettano ET, 2017, J NEUROSURG-PEDIATR, V20, P604, DOI 10.3171/2017.5.PEDS17185; Campolettano ET, 2016, J NEUROSURG-PEDIATR, V18, P536, DOI 10.3171/2016.5.PEDS1696; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Cummiskey B, 2017, P I MECH ENG P-J SPO, V231, P144, DOI 10.1177/1754337116658395; Daniel RW, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027872; Feldman J., 2018, 4 STATES CONSIDERING; Kaplen D.C., 2018, YOUTH TACKLE FOOTBAL; Karton C, 2016, 34 INT C BIOM SPORTS; Kellermann M, 2019, J SPORT REHABIL, V28, P72, DOI 10.1123/jsr.2017-0123; Kelley ME, 2017, J NEUROSURG-PEDIATR, V20, P489, DOI 10.3171/2017.5.PEDS16627; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Marchesseault ER, 2018, PHYSICIAN SPORTSMED, V46, P324, DOI 10.1080/00913847.2018.1470888; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Oeur RA, 2016, 34 INT C BIOM SPORTS; Rice SG, 2008, PEDIATRICS, V121, P841, DOI 10.1542/peds.2008-0080; Schmidt JD, 2014, AM J SPORT MED, V42, P2056, DOI 10.1177/0363546514536685; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; The Aspen Institute, 2017, STAT PLAY 2017 TREND; Tyson AM, 2018, J APPL BIOMECH, V34, P320, DOI 10.1123/jab.2017-0256; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Yoganandan N, 2009, J BIOMECH, V42, P1177, DOI 10.1016/j.jbiomech.2009.03.029; YOUNG T, 2008, CLIN J SPORT MED, V24, P416	32	15	14	3	8	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2019	36	11					1752	1757		10.1089/neu.2018.6236			6	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IB1EQ	WOS:000470007600005	30654683				2022-02-06	
J	Pearce, AJ; Tommerdahl, M; King, DA				Pearce, Alan J.; Tommerdahl, Mark; King, Doug A.			Neurophysiological abnormalities in individuals with persistent post-concussion symptoms	NEUROSCIENCE			English	Article						post concussion symptoms; fatigue; transcranial magnetic stimulation; somatosensory; vibrotactile; self-assessment questionnaire	TRANSCRANIAL MAGNETIC STIMULATION; TRAUMATIC BRAIN-INJURY; SPORT-RELATED CONCUSSION; CORTICOMOTOR EXCITABILITY; NEUROSENSORY ASSESSMENTS; SILENT PERIOD; MOTOR; MILD; FATIGUE; COMPLAINTS	Concussion injury results in a rapid onset of transient neurological impairment that can resolve quickly, or sometimes evolve over time, but usually resolve within seven to 10 days. However, a small but noticeable cohort (similar to 10%) of individuals continues to experience persistent lingering effects, particularly fatigue, recognized as post-concussion symptoms (PCS). This study explored neurophysiological mechanisms in people with persistent PCS. Studies involved using self-report post-concussion fatigue scale, transcranial magnetic stimulation (TMS) and somatosensory stimulation in those with diagnosed PCS (n = 20; 36.1 +/- 14.0 yr., 4 female; mean time post-concussion 15.4 +/- 7.6 months) to fully recovered individuals (n = 20; 33.8 +/- 6.6 yr., 2 female; post-concussion 12.9 +/- 6.6 months) and healthy controls (n = 20; 37.7 +/- 8.0 yr., 3 female). PCS participants demonstrated a significantly higher self-report fatigue (score: PCS 20.2 [95% CI 17.4-22.9], Recovered 6.2 [3.1-9.3], Control 2.75 [0.6-4.8]). PCS participants showed a worsening of reaction time (F-2.(57) = 4.214; p = 0.020) and increased reaction time variability (F-2.(57) = 5.505; p = 0.007). Somatosensory differences were observed for amplitude discrimination (F-2.(57) = 5.166; p = 0.009), temporal order judgment (F-2.(57) = 4.606; p = 0.014) and duration discrimination (F-2.(57) = 6.081; p = 0.004). Increased intracortical inhibition in TMS single pulse suprathreshold stimulation (110%: F-2.(57) = 6.842; p = 0.002; 130%: F-2.(57) = 4.900; p = 0.011; 150%: F-2.(57) = 4.638; p = 0.014; 170%: F-2.(57) = 9.845; p < 0.001) and paired pulse protocols was also seen (SICI: F-2.(57) = 23.390; p < 0.001, and LICI: F-2.(57) = 21.603; p < 0.001). Using noninvasive stimulation techniques, this novel study showed increased cortical inhibition and compromised central information processing, suggesting neural mechanisms underpinning ongoing fatigue, allowing for potential clinical rehabilitation strategies. (C) 2019 IBRO. Published by Elsevier Ltd. All rights reserved.	[Pearce, Alan J.] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia; [Tommerdahl, Mark] Univ N Carolina, Dept Biomed Engn, Chapel Hill, NC 27515 USA; [King, Doug A.] Auckland Univ Technol, Fac Hlth & Environm Sci, SPRINZ, Auckland, New Zealand		Pearce, AJ (corresponding author), La Trobe Univ, Kingsbury Dr, Melbourne, Vic, Australia.	alan.pearce@latrobe.edu.au	Pearce, Alan J/W-1195-2018	Pearce, Alan J/0000-0002-9264-9880	Sports Health Check charity; Australian Football League; Samsung CorporationSamsung; Office of Naval ResearchOffice of Naval Research; Impact Technologies Inc.	This research did not receive any specific grant from funding agencies in the public, commercial, or not-for-profit sectors. AJP currently receives partial research salary funding from Sports Health Check charity. AJP has previously received partial research funding from the Australian Football League, Impact Technologies Inc., and Samsung Corporation. MT has received partial funding from the Office of Naval Research. MT is a director of Cortical Metrics LLC who manufactures the Brain Gauge device used in this study. No other author has any declaration of interest.	APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Belmont A., 2006, Annales de Readaptation et de Medecine Physique, V49, P370, DOI 10.1016/j.annrmp.2006.04.018; Bestmann S, 2015, EXP BRAIN RES, V233, P679, DOI 10.1007/s00221-014-4183-7; Block L, 2013, NEUROSCIENCE, V250, P536, DOI 10.1016/j.neuroscience.2013.07.033; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; BROUWER B, 1994, MUSCLE NERVE, V17, P1210, DOI 10.1002/mus.880171012; Cohen J., 2013, STAT POWER ANAL BEHA; Crow JF, 2010, J SCI MED SPORT, V13, P202, DOI 10.1016/j.jsams.2009.03.007; De Beaumont L, 2013, BMC NEUROL, V13, DOI 10.1186/1471-2377-13-109; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; de Kruijk JR, 2002, J NEUROL NEUROSUR PS, V73, P727, DOI 10.1136/jnnp.73.6.727; Dimou S, 2014, J NEUROTRAUM, V31, P413, DOI 10.1089/neu.2013.3050; Duff J, 2004, CLIN EEG NEUROSCI, V35, P198, DOI 10.1177/155005940403500410; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Folger SE, 2008, BMC NEUROSCI, V9, DOI 10.1186/1471-2202-9-87; French LM, 2014, J REHABIL RES DEV, V51, P933, DOI 10.1682/JRRD.2013.10.0226; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Greiffenstein M F, 1996, J Int Neuropsychol Soc, V2, P477; Guinto G, 2014, WORLD NEUROSURG, V82, P627, DOI 10.1016/j.wneu.2013.10.016; Hallett M, 2000, NATURE, V406, P147, DOI 10.1038/35018000; Hanajima R., 2008, OXFORD HDB TRANSCRAN, P103; Hermens HJ., 1999, EUROPEAN RECOMMENDAT; Holden JK, 2012, J NEUROSCI METH, V204, P215, DOI 10.1016/j.jneumeth.2011.11.007; Johansson B., 2014, TRAUMATIC BRAIN INJU; Johansson B., 2012, BRAIN INJURY FUNCTIO, V1, P3, DOI [10.5772/27042, DOI 10.5772/27042]; Johansson B, 2009, BRAIN INJURY, V23, P1027, DOI 10.3109/02699050903421099; Kidgell DJ, 2010, HUM MOVEMENT SCI, V29, P631, DOI 10.1016/j.humov.2010.01.004; Kobayashi M, 2003, LANCET NEUROL, V2, P145, DOI 10.1016/S1474-4422(03)00321-1; Kuppuswamy A, 2017, BRAIN, V140, P2240, DOI 10.1093/brain/awx153; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Major BP, 2015, CLIN EXP PHARMACOL P, V42, P394, DOI 10.1111/1440-1681.12363; Mateer CA, 2006, NEUROREHABILITATION, V21, P315; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McGinley M, 2010, EXP GERONTOL, V45, P671, DOI 10.1016/j.exger.2010.04.005; Motta C, 2018, J NEUROL NEUROSUR PS, V89, P1237, DOI 10.1136/jnnp-2017-317879; Nguyen RH, 2013, BRAIN RES, V1498, P50, DOI 10.1016/j.brainres.2012.12.043; Padovani A, 2018, J ALZHEIMERS DIS, P1; Pearce AJ, 2000, EXP BRAIN RES, V130, P238, DOI 10.1007/s002219900236; Pearce AJ, 2018, CLOSER LOOK MOTOR EV; Pearce AJ, 2018, BRAIN INJURY, V32, P498, DOI 10.1080/02699052.2018.1430376; Pearce AJ, 2015, J SCI MED SPORT, V18, P500, DOI 10.1016/j.jsams.2014.07.010; Pearce AJ, 2014, J NEUROTRAUM, V31, P1139, DOI 10.1089/neu.2013.3219; Pearce AJ, 2013, BRAIN STIMUL, V6, P306, DOI 10.1016/j.brs.2012.05.010; Pearce AJ, 2010, J SCI MED SPORT, V13, P167, DOI 10.1016/j.jsams.2008.12.632; Pearce AJ, 2009, J SCI MED SPORT, V12, P280, DOI 10.1016/j.jsams.2007.12.005; Rau TF, 2017, CONCUSSION, V2, pCNC46; Ronnback L, 2012, LONG LASTING MENTAL; Ronnback L, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-22; Ropper AH, 2008, HARRISONS PRINCIPLES, P2596; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Sacco P, 1999, CLIN NEUROPHYSIOL, V110, P1883, DOI 10.1016/S1388-2457(99)00144-3; Silverberg ND, 2011, NEUROREHABILITATION, V29, P317, DOI 10.3233/NRE-2011-0708; Starr A, 2000, CLIN NEUROPHYSIOL, V111, P2025, DOI 10.1016/S1388-2457(00)00444-2; Steele JD, 2000, PSYCHOL MED, V30, P565, DOI 10.1017/S0033291799002032; Stulemeijer M, 2006, J NEUROL, V253, P1041, DOI 10.1007/s00415-006-0156-5; Tommerdahl, 2018, J PHYSIOTHER RES, V2, P13; Tommerdahl M, 2016, MIL MED, V181, P45, DOI 10.7205/MILMED-D-15-00172; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223; WILSON SA, 1993, NEUROSCI LETT, V154, P52, DOI 10.1016/0304-3940(93)90169-L; WILSON SA, 1993, J NEUROL SCI, V114, P216, DOI 10.1016/0022-510X(93)90301-E; World Health Organization, 1992, ICD 10 CLASSIFICATIO; Zhang Z, 2011, FRONT AGING NEUROSCI, V3, DOI 10.3389/fnagi.2011.00018; Zhang Z, 2011, CLIN J PAIN, V27, P755, DOI 10.1097/AJP.0b013e31821c98ec; Ziemann Ulf, 2013, Handb Clin Neurol, V116, P387, DOI 10.1016/B978-0-444-53497-2.00032-2	65	15	15	0	5	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	JUN 1	2019	408						272	281		10.1016/j.neuroscience.2019.04.019			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	IB2QL	WOS:000470113700023	31004695				2022-02-06	
J	Southam, KA; Stennard, F; Pavez, C; Small, DH				Southam, Katherine A.; Stennard, Fiona; Pavez, Cassandra; Small, David H.			Knockout of Amyloid Protein Precursor (APP) Expression Alters Synaptogenesis, Neurite Branching and Axonal Morphology of Hippocampal Neurons	NEUROCHEMICAL RESEARCH			English	Article						Amyloid; APP; Neurite outgrowth; Axon pathfinding; Alzheimer's disease	TRAUMATIC BRAIN-INJURY; CELL-ADHESION MOLECULES; NERVE GROWTH-FACTOR; ALZHEIMERS-DISEASE; DYSTROPHIC NEURITES; BETA ACCUMULATION; OUTGROWTH; DOMAIN; PEPTIDES; PLAQUES	The function of the -A4 amyloid protein precursor (APP) of Alzheimer's disease (AD) remains unclear. APP has a number of putative roles in neuronal differentiation, survival, synaptogenesis and cell adhesion. In this study, we examined the development of axons, dendrites and synapses in cultures of hippocampus neutrons derived from APP knockout (KO) mice. We report that loss of APP function reduces the branching of cultured hippocampal neurons, resulting in reduced synapse formation. Using a compartmentalised culture approach, we found reduced axonal outgrowth in cultured hippocampal neurons and we also identified abnormal growth characteristics of isolated hippocampal neuron axons. Although APP has previously been suggested to play an important role in promoting cell adhesion, we surprisingly found that APPKO hippocampal neurons adhered more strongly to a poly-l-lysine substrate and their neurites displayed an increased density of focal adhesion puncta. The findings suggest that the function of APP has an important role in both dendritic and axonal growth and that endogenous APP may regulate substrate adhesion of hippocampal neurons. The results may explain neuronal and synaptic morphological abnormalities in APPKO mice and the presence of abnormal APP expression in dystrophic neurites around amyloid deposits in AD.	[Southam, Katherine A.; Stennard, Fiona; Pavez, Cassandra; Small, David H.] Univ Tasmania, Menzies Inst Med Res, Hobart, Tas 7000, Australia; [Southam, Katherine A.] Univ Tasmania, Sch Med, Fac Hlth, 17 Liverpool St, Hobart, Tas 7000, Australia		Southam, KA (corresponding author), Univ Tasmania, Menzies Inst Med Res, Hobart, Tas 7000, Australia.; Southam, KA (corresponding author), Univ Tasmania, Sch Med, Fac Hlth, 17 Liverpool St, Hobart, Tas 7000, Australia.	Katherine.Southam@utas.edu.au			National Health and Medical Research Council of Australia (NHMRC)National Health and Medical Research Council of Australia; University of Tasmania Research Enhancement Grants Scheme (REGS); Alzheimer's Australia Dementia Research Foundation (AADRF) postdoctoral fellowship	This work was supported by Grants from the National Health and Medical Research Council of Australia (NHMRC) to DHS, and the University of Tasmania Research Enhancement Grants Scheme (REGS) and an Alzheimer's Australia Dementia Research Foundation (AADRF) postdoctoral fellowship to KAS.	BANKER GA, 1979, J COMP NEUROL, V187, P469, DOI 10.1002/cne.901870302; Bolos M, 2014, J BIOL CHEM, V289, P31253, DOI 10.1074/jbc.M114.581918; BREEN KC, 1991, J NEUROSCI RES, V28, P90, DOI 10.1002/jnr.490280109; Bukhari H, 2017, PROG NEUROBIOL, V156, P189, DOI 10.1016/j.pneurobio.2017.05.005; Chapman PF, 1999, NAT NEUROSCI, V2, P271, DOI 10.1038/6374; Chen KP, 2012, J MOL NEUROSCI, V46, P203, DOI 10.1007/s12031-011-9578-3; Clarris HJ, 1997, J NEUROCHEM, V68, P1164; CLARRIS HJ, 1995, DEV BRAIN RES, V88, P87, DOI 10.1016/0165-3806(95)00083-P; CLARRIS HJ, 1994, J NEUROSCI RES, V38, P248, DOI 10.1002/jnr.490380303; Cline HT, 2001, CURR OPIN NEUROBIOL, V11, P118, DOI 10.1016/S0959-4388(00)00182-3; COCHRAN E, 1991, AM J PATHOL, V139, P485; Corrigan F, 2014, J NEUROCHEM, V128, P196, DOI 10.1111/jnc.12391; CRAS P, 1991, P NATL ACAD SCI USA, V88, P7552, DOI 10.1073/pnas.88.17.7552; Dawkins E, 2014, J NEUROCHEM, V129, P756, DOI 10.1111/jnc.12675; Dawson GR, 1999, NEUROSCIENCE, V90, P1, DOI 10.1016/S0306-4522(98)00410-2; Del Turco D, 2016, FRONT MOL NEUROSCI, V9, DOI 10.3389/fnmol.2016.00134; deSilva HAR, 1997, MOL BRAIN RES, V47, P147; Eva R, 2014, CURR OPIN NEUROBIOL, V27, P179, DOI 10.1016/j.conb.2014.03.018; GENTLEMAN D, 1994, INJURY, V25, P571, DOI 10.1016/0020-1383(94)90030-2; GLENNER GG, 1984, BIOCHEM BIOPH RES CO, V120, P885, DOI 10.1016/S0006-291X(84)80190-4; Harper SJ, 1998, NEUROREPORT, V9, P3053, DOI 10.1097/00001756-199809140-00025; Hosie KA, 2012, ASN NEURO, V4, P47, DOI 10.1042/AN20110031; Hsiao K, 1996, SCIENCE, V274, P99, DOI 10.1126/science.274.5284.99; Hu YL, 2013, J BIOL CHEM, V288, P18853, DOI 10.1074/jbc.M112.443671; Ivanov A, 2009, J CELL SCI, V122, P524, DOI 10.1242/jcs.033464; Jankowsky JL, 2017, MOL NEURODEGENER, V12, DOI 10.1186/s13024-017-0231-7; JIN LW, 1994, J NEUROSCI, V14, P5461; JOACHIM C, 1991, AM J PATHOL, V138, P373; KAWARABAYASHI T, 1991, BRAIN RES, V563, P334, DOI 10.1016/0006-8993(91)91558-I; Kerr ML, 2005, J NEUROSCI RES, V80, P151, DOI 10.1002/jnr.20408; KIBBEY MC, 1993, P NATL ACAD SCI USA, V90, P10150, DOI 10.1073/pnas.90.21.10150; Kreshuk A, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024899; LeBlanc AC, 1996, J NEUROCHEM, V66, P2300; Lyckman AW, 1998, J BIOL CHEM, V273, P11100, DOI 10.1074/jbc.273.18.11100; MASTERS CL, 1985, P NATL ACAD SCI USA, V82, P4245, DOI 10.1073/pnas.82.12.4245; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; MILWARD EA, 1992, NEURON, V9, P129, DOI 10.1016/0896-6273(92)90228-6; Missaire M, 2015, DEV NEUROBIOL, V75, P569, DOI 10.1002/dneu.22267; Mok SS, 2002, EUR J BIOCHEM, V269, P3014, DOI 10.1046/j.1432-1033.2002.02976.x; Nalivaeva NN, 2013, FEBS LETT, V587, P2046, DOI 10.1016/j.febslet.2013.05.010; O'Mara A, 2017, J OPEN RES SOFTWARE; PATTERSON D, 1988, P NATL ACAD SCI USA, V85, P8266, DOI 10.1073/pnas.85.21.8266; Perez RG, 1997, J NEUROSCI, V17, P9407; Pollerberg GE, 2013, MECH DEVELOP, V130, P359, DOI 10.1016/j.mod.2012.11.002; Postuma RB, 2000, J NEUROCHEM, V74, P1122; Rossjohn J, 1999, NAT STRUCT BIOL, V6, P327; Sadleir KR, 2016, ACTA NEUROPATHOL, V132, P235, DOI 10.1007/s00401-016-1558-9; SHOJI M, 1990, BRAIN RES, V512, P164, DOI 10.1016/0006-8993(90)91187-L; SIMAN R, 1989, NEURON, V3, P275, DOI 10.1016/0896-6273(89)90252-3; SMALL DH, 1994, J NEUROSCI, V14, P2117; SMALL DH, 1992, J NEUROSCI, V12, P4143; Small DH, 2001, NAT REV NEUROSCI, V2, P595, DOI 10.1038/35086072; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sosa LJ, 2017, J NEUROCHEM, V143, P11, DOI 10.1111/jnc.14122; Southam KA, 2016, ENCY SIGNALING MOL, P367; Southam KA, 2013, J NEUROSCI METH, V218, P164, DOI 10.1016/j.jneumeth.2013.06.002; Steinbach JP, 1998, CELL DEATH DIFFER, V5, P858, DOI 10.1038/sj.cdd.4400391; Stuart KE, 2016, J COMP NEUROL; Taylor AM, 2005, NAT METHODS, V2, P599, DOI 10.1038/NMETH777; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tyan SH, 2012, MOL CELL NEUROSCI, V51, P43, DOI 10.1016/j.mcn.2012.07.009; Uryu K, 2007, EXP NEUROL, V208, P185, DOI 10.1016/j.expneurol.2007.06.018; Wang SW, 2016, MOL CELL NEUROSCI, V77, P21, DOI 10.1016/j.mcn.2016.09.002; Williamson TG, 1996, J BIOL CHEM, V271, P31215, DOI 10.1074/jbc.271.49.31215; Yoon SY, 2013, NEUROPATH APPL NEURO, V39, P800, DOI 10.1111/nan.12032; ZHENG H, 1995, CELL, V81, P525, DOI 10.1016/0092-8674(95)90073-X; Zuko A, 2011, ADV PROTEIN CHEM STR, V84, P143, DOI 10.1016/B978-0-12-386483-3.00001-X	67	15	16	0	9	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	JUN	2019	44	6			SI		1346	1355		10.1007/s11064-018-2512-0			10	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	HY8CL	WOS:000468364900009	29572646				2022-02-06	
J	Suarez, JI; Sheikh, MK; Macdonald, RL; Amin-Hanjani, S; Brown, RD; Manoel, ALD; Derdeyn, CP; Etminan, N; Keller, E; Leroux, PD; Mayer, SA; Morita, A; Rinkel, G; Rufennacht, D; Stienen, MN; Torner, J; Vergouwen, MDI; Wong, GKC; Bijlenga, P; Ko, N; McDougall, CG; Mocco, J; Murayama, Y; Werner, MJH; Damani, R; Broderick, J; Dhar, R; Jauch, EC; Kirkpatrick, PJ; Martin, RH; Mocco, J; Muehlschlegel, S; Mutoh, T; Nyquist, P; Olson, D; Mejia-Mantilla, JH; Manoel, ALDO; van der Jagt, M; Bambakidis, NC; Brophy, G; Bulsara, K; Claassen, J; Connolly, ES; Hoffer, SA; Hoh, BL; Holloway, RG; Kelly, A; Mayer, S; Nakaji, P; Rabinstein, A; Suarez, JI; Vajkoczy, P; Vergouwen, MDI; Woo, H; Zipfel, GJ; Keller, E; Chou, S; Dore, S; Dumont, AS; Gunel, M; Kasuya, H; Roederer, A; Ruigrok, Y; Vespa, PM; Sarrafzadeh-Khorrasani, AS; Huston, J; Krings, T; Lanzino, G; Meyers, PM; Rinkel, G; Rufennacht, D; Wintermark, M; Torner, J; Wong, GKC; Broderick, J; Daly, J; Ogilvy, C; Rhoney, DH; Roos, YB; Siddiqui, A; Etminan, N; Rinkel, G; Hackenberg, K; Algra, A; Frosen, J; Hasan, D; Juvela, S; Langer, DJ; Meyers, PM; Morita, A; Salman, RA; Stienen, MN; Vergouwen, MDI; Hanggi, D; Schweizer, T; Visser-Meily, J; Amos, L; Ludet, C; Moy, C; Odenkirchen, J; Ala'i, S; Esterlitz, J; Joseph, K; Sheikh, M				Suarez, Jose I.; Sheikh, Muniza K.; Macdonald, R. Loch; Amin-Hanjani, Sepideh; Brown, Robert D., Jr.; Manoel, Airton Leonardo de Oliveira; Derdeyn, Colin P.; Etminan, Nima; Keller, Emanuela; Leroux, Peter D.; Mayer, Stephan A.; Morita, Akio; Rinkel, Gabriel; Rufennacht, Daniel; Stienen, Martin N.; Torner, James; Vergouwen, Mervyn D. I.; Wong, George K. C.; Bijlenga, Philippe; Ko, Nerissa; McDougall, Cameron G.; Mocco, J.; Murayama, Yuuichi; Werner, Marieke J. H.; Damani, Rahul; Broderick, Joseph; Dhar, Raj; Jauch, Edward C.; Kirkpatrick, Peter J.; Martin, Renee H.; Mocco, J.; Muehlschlegel, Susanne; Mutoh, Tatsushi; Nyquist, Paul; Olson, Daiwai; Mejia-Mantilla, Jorge H.; Manoel, Airton Leonardo de Oliveira; van der Jagt, Mathieu; Bambakidis, Nicholas C.; Brophy, Gretchen; Bulsara, Ketan; Claassen, Jan; Connolly, E. Sander; Hoffer, S. Alan; Hoh, Brian L.; Holloway, Robert G.; Kelly, Adam; Mayer, Stephan; Nakaji, Peter; Rabinstein, Alejandro; Suarez, Jose I.; Vajkoczy, Peter; Vergouwen, Mervyn D. I.; Woo, Henry; Zipfel, Gregory J.; Keller, Emanuela; Chou, Sherry; Dore, Sylvain; Dumont, Aaron S.; Gunel, Murat; Kasuya, Hidetoshi; Roederer, Alexander; Ruigrok, Ynte; Vespa, Paul M.; Sarrafzadeh-Khorrasani, Asita Simone; Huston, John, III; Krings, Timo; Lanzino, Giuseppe; Meyers, Philip M.; Rinkel, Gabriel; Rufennacht, Daniel; Wintermark, Max; Torner, James; Wong, George K. C.; Broderick, Joseph; Daly, Janis; Ogilvy, Christopher; Rhoney, Denise H.; Roos, Y. B.; Siddiqui, Adnan; Etminan, Nima; Rinkel, Gabriel; Hackenberg, Katharina; Algra, Ale; Frosen, Juhanna; Hasan, David; Juvela, Seppo; Langer, David J.; Meyers, Philip M.; Morita, Akio; Salman, Rustam Al-Shahi; Stienen, Martin N.; Vergouwen, Mervyn D. I.; Hanggi, Daniel; Schweizer, Tom; Visser-Meily, Johanna; Amos, Liz; Ludet, Christophe; Moy, Claudia; Odenkirchen, Joanne; Ala'i, Sherita; Esterlitz, Joy; Joseph, Kristen; Sheikh, Muniza		Unruptured Intracranial Aneurysms	Common Data Elements for Unruptured Intracranial Aneurysms and Subarachnoid Hemorrhage Clinical Research: A National Institute for Neurological Disorders and Stroke and National Library of Medicine Project	NEUROCRITICAL CARE			English	Article						Subarachnoid hemorrhage; Unruptured intracranial aneurysms; Common data elements; Clinical trials; Observational studies; Outcomes	TRAUMATIC BRAIN-INJURY; GRADING SCALES; RECOMMENDATIONS; IMPLEMENTATION; PREVALENCE	ObjectivesThe goal for this project was to develop a comprehensive set of common data elements (CDEs), data definitions, case report forms and guidelines for use in unruptured intracranial aneurysm (UIA) and subarachnoid hemorrhage (SAH) clinical research, as part of a new joint effort between the National Institute of Neurological Disorders and Stroke (NINDS) and the National Library of Medicine of the US National Institutes of Health. These UIA and SAH CDEs will join several other neurological disease-specific CDEs that have already been developed and are available for use by research investigators.MethodsA Working Group (WG) divided into eight sub-groups and a Steering Committee comprised of international UIA and SAH experts reviewed existing NINDS CDEs and instruments, created new elements when needed and provided recommendations for UIA and SAH clinical research. The recommendations were compiled, internally reviewed by the entire UIA and SAH WG and posted online for 6weeks for external public comments. The UIA and SAH WG and the NINDS CDE team reviewed the final version before posting the SAH Version 1.0 CDE recommendations.ResultsThe NINDS UIA and SAH CDEs and supporting documents are publicly available on the NINDS CDE (https://www.commondataelements.ninds.nih.gov/#page=Default) and NIH Repository (https://cde.nlm.nih.gov/home) websites. The recommendations are organized into domains including Participant Characteristics and Outcomes and Endpoints.ConclusionDissemination and widespread use of CDEs can facilitate UIA and SAH clinical research and clinical trial design, data sharing, and analyses of observational retrospective and prospective data. It is vital to maintain an international and multidisciplinary collaboration to ensure that these CDEs are implemented and updated when new information becomes available.	[Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, 1800 Orleans St,Sheikh Zayed Bldg,3014C, Baltimore, MD 21287 USA; [Sheikh, Muniza K.] Emmes Corp, Rockville, MD USA; [Macdonald, R. Loch; Manoel, Airton Leonardo de Oliveira] Univ Toronto, Toronto, ON, Canada; [Amin-Hanjani, Sepideh] Univ Illinois, Chicago, IL USA; [Brown, Robert D., Jr.] Mayo Clin, Rochester, MN USA; [Derdeyn, Colin P.; Torner, James] Univ Iowa, Iowa City, IA USA; [Etminan, Nima] Univ Duesseldorf, Dusseldorf, Germany; [Keller, Emanuela; Stienen, Martin N.] Univ Zurich, Zurich, Switzerland; [Leroux, Peter D.] Main Line Hlth Care, Wynnewood, PA USA; [Mayer, Stephan A.] Henry Ford Hosp, Detroit, MI 48202 USA; [Morita, Akio] Nippon Med Sch, Tokyo, Japan; [Rinkel, Gabriel; Vergouwen, Mervyn D. I.] Univ Utrecht, Univ Med Ctr Utrecht, Utrecht, Netherlands; [Rufennacht, Daniel] Klin Hirslanden, Zurich, Switzerland; [Wong, George K. C.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Macdonald, R. Loch] Univ Toronto, Toronto, ON, Canada; [Amin-Hanjani, Sepideh] Univ Illinois, Chicago, IL USA; [Brown, Robert D., Jr.] Mayo Clin, Rochester, MN USA; [Manoel, Airton Leonardo de Oliveira] Univ Toronto, Toronto, ON, Canada; [Derdeyn, Colin P.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Keller, Emanuela] Univ Zurich, Zurich, Switzerland; [Leroux, Peter D.] Main Line Hlth, Wynnewood, PA USA; [Mayer, Stephan] Henry Ford Hosp, Detroit, MI 48202 USA; [Morita, Akio] Nippon Med Sch, Tokyo, Japan; [Rinkel, Gabriel] Univ Med Ctr, Utrecht, Netherlands; [Rufennacht, Daniel] Klin Hirslanden, Zurich, Switzerland; [Stienen, Martin N.] Univ Zurich, Zurich, Switzerland; [Torner, James] Univ Iowa, Iowa City, IA USA; [Vergouwen, Mervyn D. I.] Univ Med Ctr, Utrecht, Netherlands; [Wong, George K. C.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Brown, Robert D., Jr.] Mayo Clin, Rochester, MN USA; [Morita, Akio] Nippon Med Sch, Tokyo, Japan; [Bijlenga, Philippe] Geneva Univ Hosp, Geneva, Switzerland; [Mayer, Stephan] Henry Ford Hosp, Detroit, MI USA; [Suarez, Jose I.] Johns Hopkins Univ, Sch Med, Baltimore, MD USA; [Damani, Rahul] Baylor Coll Med, Houston, TX 77030 USA; [Amin-Hanjani, Sepideh] Univ Illinois, Chicago, IL USA; [Manoel, Airton Leonardo de Oliveira] Univ Toronto, Toronto, ON, Canada; [van der Jagt, Mathieu] Erasmus MC, Rotterdam, Netherlands; [Keller, Emanuela] Univ Zurich, Zurich, Switzerland; [Macdonald, R. Loch] Univ Toronto, Toronto, ON, Canada; [Derdeyn, Colin P.] Univ Iowa, Carver Coll Med, Iowa City, IA USA; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Hackenberg, Katharina] Univ Hosp Mannheim, Mannheim, Germany; [Torner, James] Univ Iowa, Iowa City, IA USA; [Wong, George K. C.] Chinese Univ Hong Kong, Shatin, Hong Kong, Peoples R China; [Etminan, Nima] Univ Hosp Mannheim, Mannheim, Germany; [Rinkel, Gabriel] Univ Med Ctr, Utrecht, Netherlands; [Hackenberg, Katharina] Univ Hosp Mannheim, Mannheim, Germany; [Stienen, Martin N.] Univ Zurich, FEBNS, Zurich, Switzerland; [Vergouwen, Mervyn D. I.] Univ Med Ctr, Utrecht, Netherlands; [Amos, Liz] Natl Lib Med, Natl Informat Ctr Hlth Serv Res & Hlth Care Techn, Bethesda, MD USA; [Ludet, Christophe] Natl Lib Med, Bethesda, MD USA; [Moy, Claudia; Odenkirchen, Joanne] NINDS, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA; [Ala'i, Sherita; Esterlitz, Joy; Joseph, Kristen; Sheikh, Muniza] Emmes Corp, Rockville, MD USA		Suarez, JI (corresponding author), Johns Hopkins Univ, Sch Med, Div Neurosci Crit Care, 1800 Orleans St,Sheikh Zayed Bldg,3014C, Baltimore, MD 21287 USA.	jsuarez5@jhmi.edu	Olson, DaiWai/I-5932-2019; de Oliveira Manoel, Airton Leonardo/C-4724-2018; Claassen, Jan/AAA-5451-2020; Wong, George Kwok Chu/L-4344-2016; Dore, Sylvain/AAG-1470-2020; van der Jagt, Mathieu/G-1905-2017	Olson, DaiWai/0000-0002-9280-078X; de Oliveira Manoel, Airton Leonardo/0000-0002-9593-1013; Morita, Akio/0000-0002-2497-5772; Keller, Emanuela, Elisabeth, Sophia/0000-0002-7560-7574; van der Jagt, Mathieu/0000-0003-2566-8325; Derdeyn, Colin/0000-0002-5932-2683; Al-Shahi Salman, Rustam/0000-0002-2108-9222	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HHSN271201200034C]	Logistical support for this project was provided in part through NIH Contract HHSN271201200034C, the Intramural Research Program of the NIH, NLM, The Neurocritical Care Society and the CHI Baylor St Luke's Medical Center in Houston, TX.	Berger RP, 2012, J NEUROTRAUM, V29, P672, DOI 10.1089/neu.2011.1861; Biering-Sorensen F, 2015, SPINAL CORD, V53, P265, DOI 10.1038/sc.2014.246; Bijlenga P, 2019, NEUROCRIT CARE, V30, P20, DOI 10.1007/s12028-019-00724-5; Chou SHY, 2019, NEUROCRIT CARE, V30, P46, DOI 10.1007/s12028-019-00725-4; Connolly ES, 2012, STROKE, V43, P1711, DOI 10.1161/STR.0b013e3182587839; Damani R, 2019, NEUROCRIT CARE, V30, P28, DOI 10.1007/s12028-019-00736-1; de Oliveira Manoel AL, 2019, NEUROCRIT CARE; Degen LAR, 2011, STROKE, V42, P1546, DOI 10.1161/STROKEAHA.110.601211; Diringer MN, 2011, NEUROCRIT CARE, V15, P211, DOI 10.1007/s12028-011-9605-9; Go AS, 2014, CIRCULATION, V129, pE28, DOI 10.1161/01.cir.0000441139.02102.80; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hackenberg KAM, 2019, NEUROCRIT CARE, V30, P60, DOI 10.1007/s12028-019-00728-1; Hicks R, 2013, J NEUROTRAUM, V30, P1852, DOI 10.1089/neu.2013.2938; Hop JW, 1997, STROKE, V28, P660, DOI 10.1161/01.STR.28.3.660; Jaja BNR, 2018, BMJ-BRIT MED J, V360, DOI 10.1136/bmj.j5745; Jaja BNR, 2013, NEUROCRIT CARE, V18, P143, DOI 10.1007/s12028-012-9792-z; Johnston SC, 1998, NEUROLOGY, V50, P1413, DOI 10.1212/WNL.50.5.1413; Kirkpatrick PJ, 2014, LANCET NEUROL, V13, P666, DOI 10.1016/S1474-4422(14)70084-5; Loring DW, 2011, EPILEPSIA, V52, P1186, DOI 10.1111/j.1528-1167.2011.03018.x; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Mees SMD, 2012, LANCET, V380, P44, DOI 10.1016/S0140-6736(12)60724-7; National Institute of Neurological Disorders and Stroke, 2018, NINDS COMM DAT EL; National Library of Medicine, 2019, NIH CDE REP; Rinkel GJE, 1998, STROKE, V29, P251, DOI 10.1161/01.STR.29.1.251; Roos YBWEM, 2002, STROKE, V33, P1595, DOI 10.1161/01.STR.0000016401.49688.2F; Rosen DS, 2005, NEUROCRIT CARE, V2, P110, DOI 10.1385/NCC:2:2:110; Saver JL, 2012, STROKE, V43, P967, DOI 10.1161/STROKEAHA.111.634352; Sheehan J, 2016, CLIN TRIALS, V13, P671, DOI 10.1177/1740774516653238; Siironen J, 2003, J NEUROSURG, V99, P953, DOI 10.3171/jns.2003.99.6.0953; Stienen MN, 2019, NEUROCRIT CARE, V30, P102, DOI 10.1007/s12028-019-00737-0; Suarez JI, 2006, NEW ENGL J MED, V354, P387, DOI 10.1056/NEJMra052732; Sudlow CLM, 1997, STROKE, V28, P491, DOI 10.1161/01.STR.28.3.491; van Gijn J, 2001, BRAIN, V124, P249, DOI 10.1093/brain/124.2.249; Vlak MHM, 2011, LANCET NEUROL, V10, P626, DOI 10.1016/S1474-4422(11)70109-0; Wong GKC, 2019, NEUROCRIT CARE, V30, P79, DOI 10.1007/s12028-019-00727-2; Yue JK, 2013, J NEUROTRAUM, V30, P1831, DOI 10.1089/neu.2013.2970	36	15	15	2	8	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	JUN	2019	30			1			4	19		10.1007/s12028-019-00723-6			16	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	IF3IS	WOS:000472974700002	31087257				2022-02-06	
J	Xia, DY; Zhai, XF; Wang, HL; Chen, ZY; Fu, CJ; Zhu, MH				Xia, Dayong; Zhai, Xiaofu; Wang, Honglian; Chen, Zhiyong; Fu, Chuanjing; Zhu, Meihua			Alpha lipoic acid inhibits oxidative stress-induced apoptosis by modulating of Nrf2 signalling pathway after traumatic brain injury	JOURNAL OF CELLULAR AND MOLECULAR MEDICINE			English	Article						ALA; neuronal apoptosis; Nrf2; traumatic brain injury	GENE-EXPRESSION; MICE; SUPPLEMENTATION; BREVISCAPINE; RATS	Alpha lipoic acid (ALA) is a powerful antioxidant which has been widely used in the treatment of different system diseases, such as cardiovascular and cerebrovascular diseases. But, there are few studies that refer to protective effects and potential mechanisms on traumatic brain injury (TBI). This study was carried out to investigate the neuroprotective effect following TBI and illuminate the underlying mechanism. Weight drop-injured model in rats was induced by weight-drop. ALA was administrated via intraperitoneal injection after TBI. Neurologic scores were examined following several tests. Neurological score was performed to measure behavioural outcomes. Nissl staining and TUNEL were performed to evaluate the neuronal apoptosis. Western blotting was engaged to analyse the protein content of the Nuclear factor erythroid 2-related factor 2 (Nrf2) and its downstream protein factors, including hemeoxygenase-1 (HO-1) and quinine oxidoreductase-1 (NQO1). ALA treatment alleviated TBI-induced neuron cell apoptosis and improved neurobehavioural function by up-regulation of Nrf2 expression and its downstream protein factors after TBI. This study presents new perspective of the mechanisms responsible for the neuronal apoptosis of ALA, with possible involvement of Nrf2 pathway.	[Xia, Dayong] Wannan Med Coll, Affiliated Hosp 1, Dept Neurosurg, Wuhu, Anhui, Peoples R China; [Zhai, Xiaofu] Xuzhou Med Coll, Huaian Peoples Hosp 2, Dept Neurosurg, Huaian, Jiangsu, Peoples R China; [Wang, Honglian] Huaian Fourth Peoples Hosp, Dept Radiol, Huaian, Jiangsu, Peoples R China; [Chen, Zhiyong; Zhu, Meihua] Nanjing Univ Chinese Med, Affiliated Hosp 2, Dept Anesthesiol, Nanjing 210017, Jiangsu, Peoples R China; [Fu, Chuanjing] Jiangsu Hosp Tradit Chinese Med, Dept Neurosurg, Nanjing 210029, Jiangsu, Peoples R China		Zhu, MH (corresponding author), Nanjing Univ Chinese Med, Affiliated Hosp 2, Dept Anesthesiol, Nanjing 210017, Jiangsu, Peoples R China.; Fu, CJ (corresponding author), Jiangsu Hosp Tradit Chinese Med, Dept Neurosurg, Nanjing 210029, Jiangsu, Peoples R China.	zhu_zmh@yeah.net; fcj_5150@163.com		Xia, Dayong/0000-0002-3777-7038	Natural Science Research Project in Higher Education of Anhui Province [KJ2018A0253]	The Natural Science Research Project in Higher Education of Anhui Province, Grant/Award Number: No. KJ2018A0253	Ambrosi N, 2018, INT J MOL SCI, V19, DOI 10.3390/ijms19010102; Bi W, 2018, FOOD FUNCT, V9, P2809, DOI 10.1039/c8fo00054a; El-Beshbishy HA, 2011, EUR J PHARMACOL, V668, P278, DOI 10.1016/j.ejphar.2011.06.051; El-Senousey HK, 2018, POULTRY SCI, V97, P30, DOI 10.3382/ps/pex298; Gao F, 2018, FRONT NEUROSCI-SWITZ, V12, DOI 10.3389/fnins.2018.00357; Gao JL, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00289; Giammattei L, 2018, WORLD NEUROSURG, V116, P322, DOI 10.1016/j.wneu.2018.05.176; Gumus S, 2010, ARCH MED SCI, V6, P848, DOI 10.5114/aoms.2010.19290; Guven A, 2008, SURG TODAY, V38, P1029, DOI 10.1007/s00595-007-3752-9; Hu Y, 2018, ENVIRON TOXICOL PHAR, V62, P79, DOI 10.1016/j.etap.2018.05.012; Huerta AE, 2017, BIOFACTORS, V43, P117, DOI 10.1002/biof.1317; Jiang CS, 2018, J ENZYM INHIB MED CH, V33, P833, DOI 10.1080/14756366.2018.1461856; Jiang L, 2017, NEURAL REGEN RES, V12, P90, DOI 10.4103/1673-5374.198990; Kinoshita T, 2018, WORLD NEUROSURG, V118, pE792, DOI 10.1016/j.wneu.2018.07.053; Lin YZ, 2016, J SURG RES, V203, P268, DOI 10.1016/j.jss.2016.02.013; Ozbal S, 2015, BIOTECH HISTOCHEM, V90, P206, DOI 10.3109/10520295.2014.977950; Ozbeyli D, 2017, CLIN EXP PHARMACOL P, V44, P62, DOI 10.1111/1440-1681.12682; Piechota-Polanczyk A, 2018, OXID MED CELL LONGEV, V2018, DOI 10.1155/2018/2028936; Ren F, 2018, CRYOBIOLOGY; Silva MD, 2018, MOLECULES, V23, DOI 10.3390/molecules23071803; Sun X, 2018, ENVIRON TOXICOL PHAR, V60, P110, DOI 10.1016/j.etap.2018.04.016; Uchendu C, 2018, ENVIRON SCI POLLUT R, V25, P19605, DOI 10.1007/s11356-018-2185-x; Vidovic B, 2017, J MED FOOD, V20, P79, DOI 10.1089/jmf.2016.0070; Wei WT, 2015, NEUROCHEM INT, V87, P85, DOI 10.1016/j.neuint.2015.06.003; Xia XM, 2014, INT IMMUNOPHARMACOL, V22, P293, DOI 10.1016/j.intimp.2014.07.008; Zhang DF, 2016, PAK J PHARM SCI, V29, P1365; Zhang L, 2018, FRONT MOL NEUROSCI, V11, DOI 10.3389/fnmol.2018.00190; Zhao XJ, 2018, REDOX BIOL, V18, P124, DOI 10.1016/j.redox.2018.07.002	28	15	16	1	7	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA		1582-4934		J CELL MOL MED	J. Cell. Mol. Med.	JUN	2019	23	6					4088	4096		10.1111/jcmm.14296			9	Cell Biology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine	IC0OL	WOS:000470659500028	30989783	Green Published, gold			2022-02-06	
J	Yang, LD; Dong, Y; Wu, CY; Li, Y; Guo, YC; Yang, BC; Zong, XM; Hamblin, MR; Liu, TCY; Zhang, QG				Yang, Luodan; Dong, Yan; Wu, Chongyun; Li, Yong; Guo, Yichen; Yang, Baocheng; Zong, Xuemei; Hamblin, Michael R.; Liu, Timon C. -Y.; Zhang, Quanguang			Photobiomodulation preconditioning prevents cognitive impairment in a neonatal rat model of hypoxia-ischemia	JOURNAL OF BIOPHOTONICS			English	Article						cognitive impairment; hypoxia-ischemia; mitochondria; neuroprotection; photobiomodulation preconditioning	TRAUMATIC BRAIN-INJURY; LEVEL LASER THERAPY; MITOCHONDRIA-MEDIATED APOPTOSIS; ALTERED EXPRESSION; MEMORY DEFICITS; EMBOLIC STROKES; SPATIAL MEMORY; HYPOTHERMIA; SYNAPTOPHYSIN; BETA	Neonatal hypoxia-ischemia (HI) injury caused by oxygen deprivation is the most common cause of mortality and severe neurologic deficits in neonates. The present work evaluated the preventative effect of photobiomodulation (PBM) preconditioning, and its underlying mechanism of action on brain damage in an HI model in neonatal rats. According to the optimal time response of ATP levels in brain samples removed from normal rats, a PBM preconditioning (PBM-P) regimen (808 nm CW laser, 1 cm(2) spot, 100 mW/cm(2), 12 J/cm(2)) was delivered to the scalp 6 hours before HI. PBM-P significantly attenuated cognitive impairment, volume shrinkage in the brain, neuron loss, dendritic and synaptic injury after HI. Further mechanistic investigation found that PBM-P could restore HI-induced mitochondrial dynamics and inhibit mitochondrial fragmentation, followed by a robust suppression of cytochrome c release, and prevention of neuronal apoptosis by inhibition of caspase activation. Our work suggests that PBM-P can attenuate HI-induced brain injury by maintaining mitochondrial dynamics and inhibiting the mitochondrial apoptotic pathway.	[Yang, Luodan; Wu, Chongyun; Liu, Timon C. -Y.; Zhang, Quanguang] South China Normal Univ, Coll Phys Educ & Sports Sci, Lab Laser Sports Med, Guangzhou 510006, GD, Peoples R China; [Yang, Luodan; Dong, Yan; Li, Yong; Guo, Yichen; Yang, Baocheng; Zong, Xuemei] Augusta Univ, Med Coll Georgia, Dept Neurosci & Regenerat Med, Augusta, GA USA; [Hamblin, Michael R.] Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA; [Hamblin, Michael R.] Harvard Med Sch, Dept Dermatol, Boston, MA 02115 USA; [Hamblin, Michael R.] Harvard Mit Div Hlth Sci & Technol, Cambridge, MA USA		Liu, TCY; Zhang, QG (corresponding author), South China Normal Univ, Coll Phys Educ & Sports Sci, Lab Laser Sports Med, Guangzhou 510006, GD, Peoples R China.; Hamblin, MR (corresponding author), Massachusetts Gen Hosp, Wellman Ctr Photomed, Boston, MA 02114 USA.	hamblin@helix.mgh.harvard.edu; liutcy@foxmail.com; qgzhang@ustc.edu	Hamblin, Michael R/H-2758-2019; Yang, Luodan/AAB-8891-2022	Hamblin, Michael R/0000-0001-6431-4605; 	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS086929, R01AI050875, R21AI121700]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [61575065]; NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Allergy & Infectious Diseases (NIAID) [R01AI050875, R21AI121700] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS086929] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG058603] Funding Source: NIH RePORTER	National Institutes of Health, Grant/Award Numbers: NS086929, R01AI050875, R21AI121700; National Natural Science Foundation of China, Grant/Award Number: 61575065	Agrawal T, 2014, DOSE-RESPONSE, V12, P619, DOI 10.2203/dose-response.14-032.Agrawal; Al Rahim M, 2013, NEUROBIOL DIS, V50, P59, DOI 10.1016/j.nbd.2012.10.003; Arteaga O, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020265; Beraki S, 2009, INT J NEUROPSYCHOPH, V12, P243, DOI 10.1017/S1461145708009152; Bernstein HG, 2018, NEUROCHEM INT, V114, P55, DOI 10.1016/j.neuint.2018.01.005; Blomgren K, 2006, FREE RADICAL BIO MED, V40, P388, DOI 10.1016/j.freeradbiomed.2005.08.040; Blomgren K, 2001, J BIOL CHEM, V276, P10191, DOI 10.1074/jbc.M007807200; Brake WG, 2001, ENDOCRINOLOGY, V142, P1284, DOI 10.1210/en.142.3.1284; Burke PJ, 2017, TRENDS CANCER, V3, P857, DOI 10.1016/j.trecan.2017.10.006; Busija DW, 2008, ADV DRUG DELIVER REV, V60, P1471, DOI 10.1016/j.addr.2008.03.020; Chen W, 2016, PEERJ, V4, DOI 10.7717/peerj.2306; Chinopoulos C, 2006, FEBS J, V273, P433, DOI 10.1111/j.1742-4658.2005.05103.x; Chung H, 2012, ANN BIOMED ENG, V40, P516, DOI 10.1007/s10439-011-0454-7; Colver A, 2014, LANCET, V383, P1240, DOI 10.1016/S0140-6736(13)61835-8; Cortes-Canteli M, 2002, J BIOL CHEM, V277, P5460, DOI 10.1074/jbc.M108761200; CURRIE RW, 1987, J MOL CELL CARDIOL, V19, P795; Darios F, 2003, HUM MOL GENET, V12, P517, DOI 10.1093/hmg/ddg044; Das M, 2008, IUBMB LIFE, V60, P199, DOI 10.1002/iub.31; Devi L, 2008, J BIOL CHEM, V283, P9089, DOI 10.1074/jbc.M710012200; Dorn GW, 1999, P NATL ACAD SCI USA, V96, P12798, DOI 10.1073/pnas.96.22.12798; Eastwood SL, 2007, J PSYCHOPHARMACOL, V21, P635, DOI 10.1177/0269881106068825; Ebrahimkhani S, 2020, MOL NEUROBIOL, V57, P1245, DOI 10.1007/s12035-019-01792-6; Fan JJ, 2017, NEUROSCI LETT, V647, P45, DOI 10.1016/j.neulet.2017.02.065; Feng J, 2000, P NATL ACAD SCI USA, V97, P9287, DOI 10.1073/pnas.97.16.9287; Ferraresi C, 2015, LASER MED SCI, V30, P1259, DOI 10.1007/s10103-015-1723-8; Flippo KH, 2017, J CELL SCI, V130, P671, DOI 10.1242/jcs.171017; Ghavami S, 2014, PROG NEUROBIOL, V112, P24, DOI 10.1016/j.pneurobio.2013.10.004; Gluckman PD, 2005, LANCET, V365, P663, DOI 10.1016/S0140-6736(05)17946-X; Griva M, 2017, BRAIN RES, V1667, P55, DOI 10.1016/j.brainres.2017.05.004; Hagberg H, 2014, LANCET NEUROL, V13, P217, DOI 10.1016/S1474-4422(13)70261-8; Hamblin MR, 2018, PHOTOCHEM PHOTOBIOL, V94, P199, DOI 10.1111/php.12864; Hamblin MR, 2018, J NEUROSCI RES, V96, P731, DOI 10.1002/jnr.24190; Hamblin MR, 2017, AIMS BIOPHYS, V4, P337, DOI 10.3934/biophy.2017.3.337; Hamblin MR, 2016, BBA CLIN, V6, P113, DOI 10.1016/j.bbacli.2016.09.002; Haraldstad K, 2017, EUR REV AGING PHYS A, V14, DOI 10.1186/s11556-017-0177-3; Hashmi JT, 2010, PM&R, V2, pS292, DOI 10.1016/j.pmrj.2010.10.013; Hennessy M, 2017, J OPTICS-UK, V19, DOI 10.1088/2040-8986/19/1/013003; Jellinger KA, 2000, J NEURAL TRANSM-SUPP, P95; Johnston MV, 2011, LANCET NEUROL, V10, P372, DOI 10.1016/S1474-4422(11)70016-3; Juul SE, 2014, CLIN PERINATOL, V41, P119, DOI 10.1016/j.clp.2013.09.004; Kaang BK, 2009, NEUROSCIENTIST, V15, P430, DOI 10.1177/1073858408331374; Kim YM, 2012, RESUSCITATION, V83, P188, DOI 10.1016/j.resuscitation.2011.07.031; Kiriyama Y, 2018, CELLS-BASEL, V7, DOI 10.3390/cells7010001; Koch S, 2014, J CEREBR BLOOD F MET, V34, P933, DOI 10.1038/jcbfm.2014.42; Kumral A, 2004, BEHAV BRAIN RES, V153, P77, DOI 10.1016/j.bbr.2003.11.002; Lapchak PA, 2007, NEUROSCIENCE, V148, P907, DOI 10.1016/j.neuroscience.2007.07.002; Lapchak PA, 2004, STROKE, V35, P1985, DOI 10.1161/01.STR.0000131808.69640.b7; Lapchak PA, 2008, STROKE, V39, P3073, DOI 10.1161/STROKEAHA.108.516393; Laptook AR, 2017, JAMA-J AM MED ASSOC, V318, P1550, DOI 10.1001/jama.2017.14972; Le Lec F, 2017, BEHAV BRAIN SCI, V40, P27, DOI 10.1017/S0140525X16000534; Leaw B, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00199; Li CJ, 2004, P NATL ACAD SCI USA, V101, P2185, DOI 10.1073/pnas.0307313101; Li X, 2018, J CELL MOL MED, V22, P883, DOI 10.1111/jcmm.13313; Liu G, 2017, Eur Rev Med Pharmacol Sci, V21, P50; Liu HX, 2005, MOL BRAIN RES, V139, P169, DOI 10.1016/j.molbrainres.2005.05.014; Low JA, 2004, J OBSTET GYNAECOL RE, V30, P276, DOI 10.1111/j.1447-0756.2004.00194.x; Lu Q, 2016, MOL NEUROBIOL, V53, P5344, DOI 10.1007/s12035-015-9455-0; Lu YJ, 2017, NEUROBIOL AGING, V49, P165, DOI 10.1016/j.neurobiolaging.2016.10.003; Lu Yujiao, 2015, J Neurosci Rehabil, V2, P1; Mergenthaler P, 2013, TRENDS NEUROSCI, V36, P587, DOI 10.1016/j.tins.2013.07.001; Mi ZP, 2017, NEUROBIOL AGING, V55, P159, DOI 10.1016/j.neurobiolaging.2017.01.022; MURRY CE, 1986, CIRCULATION, V74, P1124, DOI 10.1161/01.CIR.74.5.1124; Naeser MA, 2015, PHOTOMED LASER SURG, V33, P443, DOI 10.1089/pho.2015.3986; Nielsen N, 2011, INT J CARDIOL, V151, P333, DOI 10.1016/j.ijcard.2010.06.008; Nielsen N, 2011, CRIT CARE MED, V39, P57, DOI 10.1097/CCM.0b013e3181fa4301; Nijboer CH, 2011, ANN NEUROL, V70, P255, DOI 10.1002/ana.22413; Otera H, 2016, J CELL BIOL, V212, P531, DOI 10.1083/jcb.201508099; Pfister RH, 2010, J PERINATOL, V30, pS82, DOI 10.1038/jp.2010.91; Puka-Sundvall M, 2000, DEV BRAIN RES, V125, P31, DOI 10.1016/S0165-3806(00)00110-3; Salehpour F, 2018, MOL NEUROBIOL, V55, P6601, DOI 10.1007/s12035-017-0852-4; Salmaso N, 2014, NAT NEUROSCI, V17, P341, DOI 10.1038/nn.3604; Scott EK, 2001, NAT NEUROSCI, V4, P359, DOI 10.1038/86006; Semenza GL, 2011, BBA-MOL CELL RES, V1813, P1263, DOI 10.1016/j.bbamcr.2010.08.006; Shankar GM, 2008, NAT MED, V14, P837, DOI 10.1038/nm1782; Shi MC, 2017, PLOS NEGLECT TROP D, V11, DOI 10.1371/journal.pntd.0006074; Stetler RA, 2014, PROG NEUROBIOL, V114, P58, DOI 10.1016/j.pneurobio.2013.11.005; Tampellini D, 2010, J NEUROSCI, V30, P14299, DOI 10.1523/JNEUROSCI.3383-10.2010; Tampellini D, 2009, J NEUROSCI, V29, P9704, DOI 10.1523/JNEUROSCI.2292-09.2009; Tarsa L, 2002, P NATL ACAD SCI USA, V99, P1012, DOI 10.1073/pnas.022575999; Theurey P, 2018, GENES-BASEL, V9, DOI 10.3390/genes9010022; Thornton C, 2015, CLIN CHIM ACTA, V451, P35, DOI 10.1016/j.cca.2015.01.026; Tucker LD, 2018, J MOL NEUROSCI, V65, P514, DOI 10.1007/s12031-018-1121-3; van Handel M, 2007, EUR J PEDIATR, V166, P645, DOI 10.1007/s00431-007-0437-8; Vannucci SJ, 2004, J EXP BIOL, V207, P3149, DOI 10.1242/jeb.01064; Volpe JJ, 2001, MENT RETARD DEV D R, V7, P56, DOI 10.1002/1098-2779(200102)7:1<56::AID-MRDD1008>3.0.CO;2-A; Wang CX, 2016, NATURE, V530, P288, DOI 10.1038/530288a; Wang RZ, 2015, J BIOL CHEM, V290, P9299, DOI 10.1074/jbc.M114.595926; WESTIN B, 1959, SURGERY, V45, P868; Wu CY, 2018, MED SCI SPORT EXER, V50, P945, DOI 10.1249/MSS.0000000000001519; Wu QH, 2012, LASER SURG MED, V44, P218, DOI 10.1002/lsm.22003; Xiao J, 2016, NEUROSCI BULL, V32, P99, DOI 10.1007/s12264-015-0003-8; Xiong SB, 2014, PROTEIN CELL, V5, P737, DOI 10.1007/s13238-014-0089-1; Xu F, 2012, J CEREBR BLOOD F MET, V32, P1909, DOI 10.1038/jcbfm.2012.93; Xu ZQ, 2017, MOL NEUROBIOL, V54, P4551, DOI 10.1007/s12035-016-9983-2; Yang LD, 2018, EXP NEUROL, V299, P86, DOI 10.1016/j.expneurol.2017.10.013; Yang XL, 2010, CARDIOVASC DRUG THER, V24, P225, DOI 10.1007/s10557-010-6236-x; Yenari MA, 2012, NAT REV NEUROSCI, V13, P267, DOI 10.1038/nrn3174; Yin K, 2017, STEM CELLS DEV, V26, P762, DOI 10.1089/scd.2016.0332; Zhang FX, 2014, CELL MOL NEUROBIOL, V34, P813, DOI 10.1007/s10571-014-0068-3; Zhang J, 2018, NEUROCHEM INT, V116, P1, DOI 10.1016/j.neuint.2018.03.004; Zhu CL, 2007, J EXP MED, V204, P1741, DOI 10.1084/jem.20070193; Zhu ZH, 2017, ADV EXP MED BIOL, V1038, P219, DOI 10.1007/978-981-10-6674-0_15	102	15	15	0	7	WILEY-V C H VERLAG GMBH	WEINHEIM	POSTFACH 101161, 69451 WEINHEIM, GERMANY	1864-063X	1864-0648		J BIOPHOTONICS	J. Biophotonics	JUN	2019	12	6							e201800359	10.1002/jbio.201800359			13	Biochemical Research Methods; Biophysics; Optics	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Optics	IC0YY	WOS:000470687300009	30652418	Green Accepted			2022-02-06	
J	Morganti, JM; Goulding, DS; Van Eldik, LJ				Morganti, Josh M.; Goulding, Danielle S.; Van Eldik, Linda J.			Deletion of p38 MAPK in microglia blunts trauma-induced inflammatory responses in mice	JOURNAL OF NEUROINFLAMMATION			English	Article						TBI; p38; Kinase; Microglia; Monocytes; Cytokines; Chemokines; Neuroinflammation; Knockout	SPINAL-CORD-INJURY; BRAIN-INJURY; ACTIVATION; MOUSE; MODELS; CELLS	Traumatic brain injury (TBI) is a significant cause of morbidity and mortality in the USA and other developed countries worldwide. Following the initial mechanical insult, the brain's primary innate immune effector, microglia, initiate inflammatory signaling cascades and pathophysiological responses that can lead to chronic neuroinflammation and neurodegenerative sequelae. The p38 MAPK signaling pathway in microglia is a key contributor to inflammatory responses to diverse disease-relevant stressors and injury conditions. Therefore, we tested here whether microglia p38 contributes to acute and persistent inflammatory responses induced by a focal TBI. We generated conditional cell-specific knockout of p38 in microglia using a CX3CR1 Cre-lox system, subjected the p38 knockout and wild-type mice to a controlled cortical impact TBI, and measured inflammatory responses at acute (1-day) and subacute (7-day) post-injury time points. We found that deletion of p38 in microglia only was sufficient to attenuate multiple pro-inflammatory responses following TBI, notably reducing pro-inflammatory cytokine/chemokine production and recruitment of inflammatory monocytes into the brain and preventing the persistent microglial morphological activation. These data provide strong evidence supporting a role for microglial p38 in propagation of a chronic and potentially neurotoxic pro-inflammatory environment in the brain following TBI.	[Morganti, Josh M.; Goulding, Danielle S.; Van Eldik, Linda J.] Univ Kentucky, Sanders Brown Ctr Aging, 101 Sanders Brown Bldg,800 S Limestone St, Lexington, KY 40536 USA; [Morganti, Josh M.; Van Eldik, Linda J.] Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA; [Morganti, Josh M.; Van Eldik, Linda J.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		Van Eldik, LJ (corresponding author), Univ Kentucky, Sanders Brown Ctr Aging, 101 Sanders Brown Bldg,800 S Limestone St, Lexington, KY 40536 USA.; Van Eldik, LJ (corresponding author), Univ Kentucky, Dept Neurosci, Lexington, KY 40506 USA.; Van Eldik, LJ (corresponding author), Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA.	linda.vaneidik@uky.edu	Morganti, Josh/AAL-9727-2020	Morganti, Josh/0000-0002-4183-0049	National Institute of Neurological DisordersUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS093920]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R21AG058006, P30AG028383] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institute of Neurological Disorders R01 NS093920 (LJVE). The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health.	Bachstetter AD, 2013, J NEUROSCI, V33, P6143, DOI 10.1523/JNEUROSCI.5399-12.2013; Bachstetter AD, 2010, AGING DIS, V1, P199; Bruchas MR, 2011, NEURON, V71, P498, DOI 10.1016/j.neuron.2011.06.011; Cao T, 2012, NEUROSCIENCE, V225, P65, DOI 10.1016/j.neuroscience.2012.08.058; Cardona AE, 2006, NAT PROTOC, V1, P1947, DOI 10.1038/nprot.2006.327; Correa Sonia A L, 1800, J Signal Transduct, V2012, P649079, DOI 10.1155/2012/649079; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; Donnelly DJ, 2011, J NEUROSCI, V31, P9910, DOI 10.1523/JNEUROSCI.2114-11.2011; Ghasemlou N, 2010, J NEUROSCI, V30, P13750, DOI 10.1523/JNEUROSCI.2998-10.2010; Gibbs KL, 2018, CELL DEATH DIS, V9, DOI 10.1038/s41419-018-0624-8; Giunta B, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-185; Gurtner GC, 2008, NATURE, V453, P314, DOI 10.1038/nature07039; Hellewell S, 2015, BRAIN RES; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Kelley BJ, 2006, EXP NEUROL, V198, P350, DOI 10.1016/j.expneurol.2005.12.017; Kigerl KA, 2009, J NEUROSCI, V29, P13435, DOI 10.1523/JNEUROSCI.3257-09.2009; Lloyd E, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-28; Morganti JM, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0547-1; Morganti JM, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0148001; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Orthgiess J, 2016, EUR J IMMUNOL, V46, P1529, DOI 10.1002/eji.201546108; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schnoder L, 2016, J BIOL CHEM, V291, P2067, DOI 10.1074/jbc.M115.695916; Stirling DP, 2008, NEUROSCIENCE, V155, P128, DOI 10.1016/j.neuroscience.2008.05.007; Xing B, 2011, MOL NEURODEGENER, V6, DOI 10.1186/1750-1326-6-84; Xu Z, 2006, LIFE SCI, V79, P1895, DOI 10.1016/j.lfs.2006.06.023; Yona S, 2013, IMMUNITY, V38, P79, DOI 10.1016/j.immuni.2012.12.001; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	32	15	16	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	MAY 10	2019	16								98	10.1186/s12974-019-1493-5			9	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	HX6WS	WOS:000467545000001	31077217	Green Published, gold			2022-02-06	
J	Howell, DR; Wilson, JC; Brilliant, AN; Gardner, AJ; Iverson, GL; Meehan, WP				Howell, David R.; Wilson, Julie C.; Brilliant, Anna N.; Gardner, Andrew J.; Iverson, Grant L.; Meehan, William P., III			Objective clinical tests of dual-task dynamic postural control in youth athletes with concussion	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Gait; Balance; Mild traumatic brain injury; Sports medicine	SINGLE-TASK; TANDEM GAIT; RELIABILITY; ADOLESCENTS; BALANCE; PERFORMANCE; DURATION; DEFICITS; INJURY; BRAIN	Objectives: To prospectively evaluate single/dual-task timed-up-and-go (TUG) and tandem gait performance among children and adolescents with concussion and healthy controls. Design: Repeated measures. Methods: Participants with concussion (n =23; age = 14.1 +/- 2.5 years; 52% female) completed single/dualtask TUG, tandem gait, and symptom assessments 6.7 +/- 2.6 and 23.3 +/- 6.1 days post injury. The control group (n =27; age =14.1 +/- 2.3 years; 48% female) completed the same protocol initially and 10.7 +/- 16.1 days later. All participants completed single-task (undivided attention) and dual-task (divided attention) tests. The primary outcome variable was test completion time. Results: The concussion group completed single-task (concussion group mean =11.1 +/- 1.9 vs. control group mean 9.9 +/- 1.4 s, p = 0.027) and dual-task (concussion group mean = 14.4 +/- 3.3 vs. control group mean 12.7 +/- 1.9 s, p= 0.047) TUG tests slower than the control group across both time points. The concussion group completed dual-task tandem gait tests slower than the control group at both time points (21.3 +/- 6.3 vs. 16.8 +/- 5.5 s, p = 0.006), and were slower in the single-task condition at the first test (19.8 +/- 5.4 vs. 13.8 +/- 4.4 s, p = 0.003). Symptoms were significantly worse for the concussion group compared to the control group at the first (34.1 +/- 21.4 vs. 3.9 +/- 9.1, p<0.001), but not the second test (9.1 +/- 12.0 vs. 2.2 +/- 6.8; p = 0.08). Conclusions: Slower dual-task TUG and tandem gait times were detected across both time points for the concussion group relative to the control group. In contrast, single-task tandem gait deficits appeared to improve in a similar fashion as symptoms, suggesting increased complexity from the addition of a cognitive task allows for the detection of persistent post-concussion deficits that might take longer to resolve. (C) 2018 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Howell, David R.; Wilson, Julie C.] Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA; [Howell, David R.; Wilson, Julie C.] Univ Colorado, Sch Med, Dept Orthoped, Boulder, CO 80309 USA; [Howell, David R.; Brilliant, Anna N.; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA; [Brilliant, Anna N.; Meehan, William P., III] Boston Childrens Hosp, Dept Orthopaed, Div Sports Med, Boston, MA USA; [Gardner, Andrew J.] Hunter New England Local Hlth Dist Sport Concuss, Newcastle, NSW, Australia; [Gardner, Andrew J.] Univ Newcastle, Fac Hlth & Med, Sch Med & Publ Hlth, Ctr Stroke & Brain Injury, Callaghan, NSW, Australia; [Iverson, Grant L.] Harvard Med Sch, Dept Phys Med & Rehabil, Boston, MA 02115 USA; [Iverson, Grant L.] Spaulding Rehabil Hosp, MassGen Hosp ChildrenTM Sports Concuss Program, Home Base, Boston, MA USA; [Meehan, William P., III] Harvard Med Sch, Dept Pediat, Boston, MA 02115 USA; [Meehan, William P., III] Harvard Med Sch, Dept Orthopaed Surg, Boston, MA 02115 USA		Howell, DR (corresponding author), Childrens Hosp Colorado, Sports Med Ctr, Aurora, CO 80045 USA.; Howell, DR (corresponding author), Univ Colorado, Sch Med, Dept Orthoped, Boulder, CO 80309 USA.; Howell, DR (corresponding author), Micheli Ctr Sports Injury Prevent, Waltham, MA 02453 USA.	David.Howell@ucdenver.edu		Gardner, Andrew/0000-0001-5031-5586; Howell, David/0000-0002-2955-0191; Iverson, Grant/0000-0001-7348-9570	Australian Football League (AFL); NSW Sporting Injuries Committee; Brain Foundation (Australia); Hunter Medical Research Institute (HMRI); HMRI; NHMRC Early Career FellowshipNational Health and Medical Research Council of Australia; HNELHD Research, Innovation and Partnerships -Health Research & Translation Centre and Clinical Research Fellowship Scheme; University of Newcastle's Priority Research Centre for Stroke and Brain Injury; Mooney-Reed Charitable Foundation; ImPACT Applications, Inc.; Heniz Family Foundation	DRH has received research support not related to this study from the Eunice Kennedy Shriver National Institute of Child Health & Human Development (1R03HD094560-01), the National Institute of Neurological Disorders And Stroke (1R01NS100952-01A1 and 1R41NS103698-01A1), and from a research contract between Boston Children's Hospital, Cincinnati Children's Hospital Medical Center, and ElMindA Ltd.; AJG has a clinical practice in neuropsychology involving individuals who have sustained sport-related concussion (including current and former athletes). He has operated as a contracted concussion consultant to the Rugby Australia (Rugby AU) from July 2016. He has received travel funding from the Australian Football League (AFL) to present at the Concussion in Football Conference in 2013 and 2017. Previous grant funding includes the NSW Sporting Injuries Committee, the Brain Foundation (Australia), the Hunter Medical Research Institute (HMRI), supported by Jennie Thomas, and HMRI, supported by Anne Greaves. He is currently funded through an NHMRC Early Career Fellowship, the HNELHD Research, Innovation and Partnerships -Health Research & Translation Centre and Clinical Research Fellowship Scheme, and the University of Newcastle's Priority Research Centre for Stroke and Brain Injury.; GLI acknowledges unrestricted philanthropic support from the Mooney-Reed Charitable Foundation, and ImPACT Applications, Inc., and the Heniz Family Foundation. He is a strategic scientific advisor for BioDirection, Inc. He received past salary support for chairing the Brain and Behavior committee for the Harvard Integrated Program to Protect and Improve the Health of NFLPA Members.	Alsalaheen BA, 2010, J NEUROL PHYS THER, V34, P87, DOI 10.1097/NPT.0b013e3181dde568; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Berkner J, 2017, J ATHL TRAINING, V52, P1089, DOI 10.4085/1062-6050-52.11.23; Buckley TA, 2018, CLIN J SPORT MED, V28, P174, DOI 10.1097/JSM.0000000000000426; Chin EY, 2016, AM J SPORT MED, V44, P2276, DOI 10.1177/0363546516648141; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Fino PC, 2018, GAIT POSTURE, V62, P157, DOI 10.1016/j.gaitpost.2018.03.021; Grants L, 2017, INT J SPORTS PHYS TH, V12, P1011, DOI 10.26603/ijspt20171011; Horak F, 2015, PHYS THER, V95, P461, DOI 10.2522/ptj.20140253; Howell DR, 2019, CLIN J SPORT MED, V29, P238, DOI 10.1097/JSM.0000000000000509; Howell DR, 2018, SPORTS MED, V48, P1097, DOI 10.1007/s40279-018-0871-y; Howell DR, 2018, ARCH PHYS MED REHAB, V99, P1318, DOI 10.1016/j.apmr.2018.01.025; Howell DR, 2018, GAIT POSTURE, V62, P291, DOI 10.1016/j.gaitpost.2018.03.038; Howell DR, 2017, J SCI MED SPORT, V20, P622, DOI 10.1016/j.jsams.2016.11.020; Howell DR, 2016, AM J SPORT MED, V44, P1040, DOI 10.1177/0363546515625045; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Howell DR, 2013, ARCH PHYS MED REHAB, V94, P1513, DOI 10.1016/j.apmr.2013.04.015; King LA, 2017, ANN BIOMED ENG, V45, P2135, DOI 10.1007/s10439-017-1856-y; Littleton A, 2013, J SPORT HEALTH SCI, V2, P227, DOI 10.1016/j.jshs.2013.04.003; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Manaseer TS, 2020, CLIN J SPORT MED, V30, pS11, DOI 10.1097/JSM.0000000000000537; Mancini M, 2012, J NEUROENG REHABIL, V9, DOI 10.1186/1743-0003-9-59; McCrory P, 2016, BRIT J SPORT MED, V2017, P838, DOI DOI 10.1136/BJSP0RTS-2017-097699; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Nicolini-Panisson Renata D'Agostini, 2013, Rev. paul. pediatr., V31, P377, DOI 10.1590/S0103-05822013000300016; Oldham JR, 2018, MED SCI SPORT EXER, V50, P1162, DOI 10.1249/MSS.0000000000001540; Salarian A, 2010, IEEE T NEUR SYS REH, V18, P303, DOI 10.1109/TNSRE.2010.2047606; Stephens J, 2018, AM J OCCUP THER, V72, DOI 10.5014/ajot.2018.025361; Tamura K, 2018, GAIT POSTURE, V60, P22, DOI 10.1016/j.gaitpost.2017.11.002; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007	30	15	15	1	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	MAY	2019	22	5					521	525		10.1016/j.jsams.2018.11.014			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HY6RB	WOS:000468256300006	30509865				2022-02-06	
J	Weber, MT; Arena, JD; Xiao, R; Wolf, JA; Johnson, VE				Weber, Maura T.; Arena, John D.; Xiao, Rui; Wolf, John A.; Johnson, Victoria E.			CLARITY reveals a more protracted temporal course of axon swelling and disconnection than previously described following traumatic brain injury	BRAIN PATHOLOGY			English	Article						traumatic brain injury; TBI; axonal pathology; CLARITY; amyloid precursor protein; axon degeneration; diffuse axonal injury	AMYLOID PRECURSOR PROTEIN; INTRAAXONAL NEUROFILAMENT COMPACTION; MEDIATED CYTOSKELETAL DEGRADATION; HEAD-INJURY; CALPAIN ACTIVATION; UNMYELINATED AXONS; CORPUS-CALLOSUM; CYCLOSPORINE-A; WHITE-MATTER; BETA-APP	Diffuse axonal injury (DAI) is an important consequence of traumatic brain injury (TBI). At the moment of trauma, axons rarely disconnect, but undergo cytoskeletal disruption and transport interruption leading to protein accumulation within swellings. The amyloid precursor protein (APP) accumulates rapidly and the standard histological evaluation of axonal pathology relies upon its detection. APP+ swellings first appear as varicosities along intact axons, which can ultimately undergo secondary disconnection to leave a terminal "axon bulb" at the disconnected, proximal end. However, sites of disconnection are difficult to determine with certainty using standard, thin tissue sections, thus limiting the comprehensive evaluation of axon degeneration. The tissue-clearing technique, CLARITY, permits three-dimensional visualization of axons that would otherwise be out of plane in standard tissue sections. Here, we examined the morphology and connection status of APP+ swellings using CLARITY at 6 h, 24 h, 1 week and 1 month following the controlled cortical impact (CCI) model of TBI in mice. Remarkably, many APP+ swellings that appeared as terminal bulbs when viewed in standard 8-mu m-thick regions of tissue were instead revealed to be varicose swellings along intact axons when three dimensions were fully visible. Moreover, the percentage of these potentially viable axon swellings differed with survival from injury and may represent the delayed onset of distinct mechanisms of degeneration. Even at 1-month post-CCI, 10% of apparently terminal bulbs were revealed as connected by CLARITY and are thus potentially salvageable. Intriguingly, the diameter of swellings decreased with survival, including varicosities along intact axons, and may reflect reversal of, or reduced, axonal transport interruption in the chronic setting. These data indicate that APP immunohistochemistry on standard thickness tissue sections overestimates axon disconnection, particularly acutely post-injury. Evaluating cleared tissue demonstrates a surprisingly delayed process of axon disconnection and thus longer window of therapeutic opportunity than previously appreciated. Intriguingly, a subset of axon swellings may also be capable of recovery.	[Weber, Maura T.; Arena, John D.; Johnson, Victoria E.] Univ Penn, Perelman Sch Med, Penn Ctr Brain Injury & Repair, Dept Neurosurg, Philadelphia, PA 19104 USA; [Xiao, Rui] Univ Penn, Dept Biostat Epidemiol & Informat, Philadelphia, PA 19104 USA; [Wolf, John A.] Corporal Michael J Crescenz VA Med Ctr, Philadelphia, PA USA		Johnson, VE (corresponding author), Univ Penn, Penn Ctr Brain Injury & Repair, Dept Neurosurg, 173 Stemmler Hall,3450 Hamilton Walk, Philadelphia, PA 19104 USA.	vje@pennmedicine.upenn.edu	Lang, Steven/AAE-8102-2021	Lang, Steven/0000-0003-1669-9146; Arena, John/0000-0002-4322-4472	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS092398, TL1TR001880, R01NS101108]; United States (U.S.) Department of Veterans Affairs, Rehabilitation Research and Development Service ProgramUS Department of Veterans Affairs [RX002705]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [U54HD086984] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [TL1TR001880] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS101108, R01NS094003, R01NS092398] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX002705] Funding Source: NIH RePORTER	Research reported in this publication was supported by the National Institutes of Health under award numbers R01NS092398, TL1TR001880, and R01NS101108. In addition, work was supported in part by Merit Review, Award No. RX002705 (JAW)from the United States (U.S.) Department of Veterans Affairs, Rehabilitation Research and Development Service Program. The content is solely the responsibility of the authors and does not necessarily represent the official views of the National Institutes of Health, the U.S. Department of Veterans Affairs or the United States Government.	ADAMS JH, 1991, J NEUROL NEUROSUR PS, V54, P481, DOI 10.1136/jnnp.54.6.481; ADAMS JH, 1984, LANCET, V2, P1420; ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Bramlett HM, 2002, ACTA NEUROPATHOL, V103, P607, DOI 10.1007/s00401-001-0510-8; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Buki A, 2003, J NEUROTRAUM, V20, P261, DOI 10.1089/089771503321532842; Buki A, 1999, EXP NEUROL, V159, P319, DOI 10.1006/exnr.1999.7139; Buki A, 1999, J NEUROTRAUM, V16, P511, DOI 10.1089/neu.1999.16.511; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Chen XH, 2009, BRAIN PATHOL, V19, P214, DOI 10.1111/j.1750-3639.2008.00176.x; Christman CW, 1997, ACTA NEUROPATHOL, V94, P329, DOI 10.1007/s004010050715; CHRISTMAN CW, 1994, J NEUROTRAUM, V11, P173, DOI 10.1089/neu.1994.11.173; Chung K, 2013, NATURE, V497, P332, DOI 10.1038/nature12107; Deng Y, 2007, EXP NEUROL, V205, P154, DOI 10.1016/j.expneurol.2007.01.023; Deng-Bryant Y, 2008, J CEREBR BLOOD F MET, V28, P1114, DOI 10.1038/jcbfm.2008.10; Fujita M, 2011, J NEUROTRAUM, V28, P1209, DOI 10.1089/neu.2011.1852; Gale S D, 1995, J Int Neuropsychol Soc, V1, P17; Geddes JF, 2000, NEUROPATH APPL NEURO, V26, P105, DOI 10.1046/j.1365-2990.2000.026002105.x; Geddes JF, 1997, NEUROPATH APPL NEURO, V23, P339, DOI 10.1046/j.1365-2990.1997.4498044.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; GENTLEMAN SM, 1993, NEUROSCI LETT, V160, P139, DOI 10.1016/0304-3940(93)90398-5; GENTLEMAN SM, 1995, ACTA NEUROPATHOL, V89, P537; GRADY MS, 1993, J NEUROPATH EXP NEUR, V52, P143, DOI 10.1097/00005072-199303000-00007; GRAHAM DI, 1995, BRAIN PATHOL, V5, P397, DOI 10.1111/j.1750-3639.1995.tb00618.x; Graham DI, 2004, FORENSIC SCI INT, V146, P89, DOI 10.1016/S0379-0738(03)00274-3; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hayashi Takahito, 2009, Leg Med (Tokyo), V11 Suppl 1, pS171, DOI 10.1016/j.legalmed.2009.01.076; Iwata A, 2004, J NEUROSCI, V24, P4605, DOI 10.1523/JNEUROSCI.0515-03.2004; Iwata A, 2002, J NEUROPATH EXP NEUR, V61, P1056, DOI 10.1093/jnen/61.12.1056; Johnson VE, 2018, ACTA NEUROPATHOL, V135, P711, DOI 10.1007/s00401-018-1824-0; Johnson VE, 2016, ACTA NEUROPATHOL, V131, P115, DOI 10.1007/s00401-015-1506-0; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kampfl A, 1996, J NEUROCHEM, V67, P1575; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Mac Donald CL, 2007, EXP NEUROL, V205, P116, DOI 10.1016/j.expneurol.2007.01.035; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; MAXWELL WL, 1991, J ANAT, V176, P71; Maxwell WL, 2003, J NEUROTRAUM, V20, P151, DOI 10.1089/08977150360547071; McGinn MJ, 2009, J NEUROPATH EXP NEUR, V68, P241, DOI 10.1097/NEN.0b013e3181996bfe; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Mustafa AG, 2011, J NEUROCHEM, V117, P579, DOI 10.1111/j.1471-4159.2011.07228.x; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Okonkwo DO, 1999, J CEREBR BLOOD F MET, V19, P443, DOI 10.1097/00004647-199904000-00010; PETTUS EH, 1994, J NEUROTRAUM, V11, P507, DOI 10.1089/neu.1994.11.507; POVLISHOCK JT, 1985, LAB INVEST, V52, P540; Povlishock JT, 1996, ACT NEUR S, V66, P81; POVLISHOCK JT, 1983, J NEUROPATH EXP NEUR, V42, P225, DOI 10.1097/00005072-198305000-00002; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Povlishock JT, 1999, ACT NEUR S, V73, P15; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Ramon Y, 1928, DEGENERATION REGENER; RAND CW, 1946, ARCH NEURO PSYCHIATR, V55, P79, DOI 10.1001/archneurpsyc.1946.02300130003001; Reeves TM, 2012, J NEUROPATH EXP NEUR, V71, P198, DOI 10.1097/NEN.0b013e3182482590; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; ROSS DT, 1994, EXP NEUROL, V126, P291, DOI 10.1006/exnr.1994.1067; Saatman KE, 2003, J CEREBR BLOOD F MET, V23, P34, DOI 10.1097/01.WCB.0000035040.10031.B0; Saatman KE, 1996, J NEUROPATH EXP NEUR, V55, P850, DOI 10.1097/00005072-199607000-00010; SCHWEITZER JB, 1993, ACTA NEUROPATHOL, V85, P503; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; SHOJI M, 1992, SCIENCE, V258, P126, DOI 10.1126/science.1439760; Singleton RH, 2001, J NEUROTRAUM, V18, P607, DOI 10.1089/089771501750291846; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Smith DH, 1999, J NEUROSCI, V19, P4263; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; Smith DH, 2003, J HEAD TRAUMA REHAB, V18, P307, DOI 10.1097/00001199-200307000-00003; Smith DH, 1997, J NEUROPATH EXP NEUR, V56, P822; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Staal JA, 2010, J NEUROCHEM, V112, P1147, DOI 10.1111/j.1471-4159.2009.06531.x; Stone JR, 2001, EXP NEUROL, V172, P320, DOI 10.1006/exnr.2001.7818; STRICH SJ, 1956, J NEUROL NEUROSUR PS, V19, P163, DOI 10.1136/jnnp.19.3.163; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Tomaiuolo F, 2012, BRAIN RES BULL, V87, P373, DOI 10.1016/j.brainresbull.2012.01.008; von Reyn CR, 2009, J NEUROSCI, V29, P10350, DOI 10.1523/JNEUROSCI.2339-09.2009; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; YAGHMAI A, 1992, J NEUROPATH EXP NEUR, V51, P158, DOI 10.1097/00005072-199203000-00006; Ziogas NK, 2018, J NEUROSCI, V38, P4031, DOI 10.1523/JNEUROSCI.2343-17.2018	90	15	15	4	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1015-6305	1750-3639		BRAIN PATHOL	Brain Pathol.	MAY	2019	29	3					437	450		10.1111/bpa.12677			14	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	HU7AA	WOS:000465432300011	30444552	Green Published, Green Accepted, Bronze			2022-02-06	
J	Post, A; Hoshizaki, TB; Karton, C; Clark, JM; Dawson, L; Cournoyer, J; Taylor, K; Oeur, RA; Gilchrist, MD; Cusimano, MD				Post, Andrew; Hoshizaki, T. Blaine; Karton, Clara; Clark, J. Michio; Dawson, Lauren; Cournoyer, Janie; Taylor, Karen; Oeur, R. Anna; Gilchrist, Michael D.; Cusimano, Michael D.			The biomechanics of concussion for ice hockey head impact events	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Ice hockey; concussion; biomechanics; helmet	SYSTEMATIC VIDEO ANALYSIS; ACCIDENT RECONSTRUCTION; AXONAL DAMAGE; BRAIN-INJURY; LEAGUE NHL; ACCELERATION; THRESHOLD; FOOTBALL; SPORT; MODEL	The purpose of this research was to conduct reconstructions of concussive and non-concussive impacts in ice hockey to determine the biomechanics and thresholds of concussive injury in ice hockey. Videos of concussive and non-concussive impacts in an elite professional ice hockey league in North America were reconstructed using physical and finite element model methods. Eighty concussive and 45 non-concussive events were studied. Logistic regressions indicate significant thresholds for concussion for linear/rotational acceleration and CSDM10%. Impacts in ice hockey were mostly long duration events, longer than 15 ms. These results have significant implications for helmet standards and development to prevent concussion.	[Post, Andrew; Hoshizaki, T. Blaine; Karton, Clara; Dawson, Lauren; Cournoyer, Janie; Taylor, Karen; Oeur, R. Anna; Gilchrist, Michael D.] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Post, Andrew; Cusimano, Michael D.] Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada; [Clark, J. Michio; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Univ Ottawa, Human Kinet, Ottawa, ON, Canada.; Post, A (corresponding author), Univ Toronto, St Michaels Hosp, Div Neurosurg, Toronto, ON, Canada.	apost@uottawa.ca	Cusimano, Michael/X-4059-2019	Post, Andrew/0000-0002-5960-5552; Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health Research Strategic Team Grant in Applied Injury ResearchCanadian Institutes of Health Research (CIHR) [TIR-103946]; Ontario Neurotrauma Foundation; Canadian Institutes of Health Research Postdoctoral FellowshipCanadian Institutes of Health Research (CIHR)	This research was supported by the Canadian Institutes of Health Research Strategic Team Grant in Applied Injury Research # TIR-103946, the Ontario Neurotrauma Foundation, as well as the Canadian Institutes of Health Research Postdoctoral Fellowship.	Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Clark JM, 2016, ANN BIOMED ENG, V44, P3693, DOI 10.1007/s10439-016-1686-3; Cusimano MD., 2011, OPEN MED-WARSAW, V5, P57; Donaldson L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0069122; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Frechede B, 2009, MED SCI SPORT EXER, V41, P390, DOI 10.1249/MSS.0b013e318186b1c5; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; GURDJIAN ES, 1953, NEUROLOGY, V3, P417, DOI 10.1212/WNL.3.6.417; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Ho J, 2008, THESIS; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki TB, 2017, TRAUMA, V19, P196, DOI 10.1177/1460408616676503; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hoshizaki TB, 2004, NEUROSURGERY, V55, P956, DOI 10.1227/01.NEU.0000137275.50246.0B; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; Karton C, 2018, HAND CLINIC, V158, P39, DOI 10.1016/B978-0-444-63954-7.00005-7; Kendall M., 2016, THESIS; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; Miller R.T., 1998, STAPP CAR CRASH J, P155; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; Newman J A, 2000, Stapp Car Crash J, V44, P215; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2013, J APPL BIOMECH, V29, P721, DOI 10.1123/jab.29.6.721; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2018, SPORTS ENG, V21, P235, DOI 10.1007/s12283-018-0263-4; Post A, 2017, J NEUROSURG-PEDIATR, V19, P641, DOI 10.3171/2016.11.PEDS16383; Post A, 2017, SPORTS ENG, V20, P111, DOI 10.1007/s12283-016-0219-5; Post A, 2017, J NEUROSURG-PEDIATR, V19, P502, DOI 10.3171/2016.10.PEDS16449; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Rousseau P., 2014, THESIS; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Ruan J, 1994, THESIS; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Sahoo D, 2016, ACCIDENT ANAL PREV, V92, P53, DOI 10.1016/j.aap.2016.03.013; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Van Lierde C, 2005, THESIS K U LEUVEN BR; Walsh ES, 2018, SPORTS ENG, V21, P479, DOI 10.1007/s12283-018-0286-x; Willinger R, 1995, P IRCOBI C; Yang JK, 2011, COMPUTATIONAL BIOMECHANICS FOR MEDICINE: SOFT TISSUES AND THE MUSCULOSKELETAL SYSTEM, P5, DOI 10.1007/978-1-4419-9619-0_2; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	50	15	15	4	21	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.	APR 26	2019	22	6					631	643		10.1080/10255842.2019.1577827			13	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	HY2NQ	WOS:000467959900007	30829543				2022-02-06	
J	Chitturi, J; Santhakumar, V; Kannurpatti, SS				Chitturi, Jyothsna; Santhakumar, Vijayalakshmi; Kannurpatti, Sridhar S.			Beneficial Effects of Kaempferol after Developmental Traumatic Brain Injury Is through Protection of Mitochondrial Function, Oxidative Metabolism, and Neural Viability	JOURNAL OF NEUROTRAUMA			English	Article						calcium uniporter; dietary flavonoid; kaempferol; metabolomics; mitochondrial; N-acetyl aspartate; oxidative metabolism; pediatric; traumatic brain injury	ACETYL-L-CARNITINE; CEREBRAL PERFUSION; RAT; MATURATION; NEUROPROTECTION; METABOANALYST; METABOLOMICS; EXCITABILITY; HOMEOSTASIS; INCREASES	Oxidative energy metabolism is depressed after mild/moderate traumatic brain injury (TBI) during early development, accompanied by behavioral debilitation and secondary neuronal death. A TBI metabolome analysis revealed broad effects with a striking impact on energy metabolism. Our studies on mitochondrial modulators and their effects on brain function have shown that kaempferol, a stimulator of the mitochondrial Ca2+ uniporter channel (mCU), enhanced neural and neurovascular activity in the normal brain and improved stimulus-induced brain activation and behavior after TBI during early development. Because kaempferol enhances mitochondrial Ca2+ uptake and cycling, with protective effects after TBI, we tested the hypothesis that kaempferol treatment during the acute/subacute stage after TBI (0-72 h) acted on mitochondria in improving TBI outcome. Developmental age rats (P31) underwent TBI and were treated with vehicle or kaempferol (1 mg/kg intraperitoneally) in three doses at 1, 24, and 48 h after TBI. Brains were harvested at 72 h and subjected to liquid chromatography mass spectrometric measurements. Decrease in pyruvate and tricarboxylic acid (TCA) cycle flux were observed in the untreated and vehicle-treated group, consistent with previously established energy metabolic decline after TBI. Kaempferol improved TCA cycle flux, maintained mitochondrial functional integrity as observed by decreased acyl carnitines, improved neural viability as evidenced by higher N-acetyl aspartate levels. The positive outcomes of kaempferol on metabolic profile corresponded with improved sensorimotor behavior.	[Chitturi, Jyothsna; Kannurpatti, Sridhar S.] Rutgers New Jersey Med Sch, Dept Radiol, Newark, NJ USA; [Santhakumar, Vijayalakshmi] Rutgers New Jersey Med Sch, Dept Pharmacol Physiol & Neurosci, Newark, NJ USA; [Santhakumar, Vijayalakshmi] Univ Calif Riverside, Mol Cell & Syst Biol, Riverside, CA 92521 USA		Kannurpatti, SS (corresponding author), Rutgers Biomed & Hlth Sci, New Jersey Med Sch, Dept Radiol, ADMC5,Room 575,30 Bergen St, Newark, NJ 07101 USA.	kannursr@njms.rutgers.edu	Santhakumar, Viji/K-4856-2019; Chitturi, Jyothsna/AAR-3986-2020	Santhakumar, Viji/0000-0001-6278-4187; 	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS069861, R01NS097750] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS097750, R01 NS069861] Funding Source: Medline		Biagi L, 2007, J MAGN RESON IMAGING, V25, P696, DOI 10.1002/jmri.20839; Casey P, 2006, CRIT CARE MED, V34, pA17, DOI 10.1097/00003246-200612002-00067; CHIRON C, 1992, J NUCL MED, V33, P696; Chitturi J, 2018, NEUROCHEM INT, V120, P75, DOI 10.1016/j.neuint.2018.08.003; CHUGANI HT, 1987, ANN NEUROL, V22, P487, DOI 10.1002/ana.410220408; Di Giorgio AM, 2008, RESTOR NEUROL NEUROS, V26, P501; Di Pietro V, 2014, MOL MED, V20, P147, DOI 10.2119/molmed.2013.00153; DOBBING J, 1973, ARCH DIS CHILD, V48, P757, DOI 10.1136/adc.48.10.757; DuPont MS, 2004, EUR J CLIN NUTR, V58, P947, DOI 10.1038/sj.ejcn.1601916; Ferreira GC, 2017, NEUROCHEM RES, V42, P1661, DOI 10.1007/s11064-017-2288-7; Fluegge D, 2012, NAT NEUROSCI, V15, P754, DOI 10.1038/nn.3074; Greene JG, 1996, PROG NEUROBIOL, V48, P613, DOI 10.1016/0301-0082(96)00006-8; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Hales PW, 2014, J CEREBR BLOOD F MET, V34, P776, DOI 10.1038/jcbfm.2014.17; Hosseini-Zare MS, 2017, EXP NEUROL, V295, P155, DOI 10.1016/j.expneurol.2017.05.002; Jones LL, 2010, PROG LIPID RES, V49, P61, DOI 10.1016/j.plipres.2009.08.004; Kannurpatti SS, 2017, J CEREBR BLOOD F MET, V37, P381, DOI 10.1177/0271678X16680637; Kannurpatti SS, 2015, NMR BIOMED, V28, P1579, DOI 10.1002/nbm.3421; Kelley BJ, 2007, J NEUROPATH EXP NEUR, V66, P989, DOI 10.1097/NEN.0b013e3181588245; Labarthe DR, 2009, AM J PREV MED, V37, pS86, DOI 10.1016/j.amepre.2009.04.014; Len TK, 2011, CLIN PHYSIOL FUNCT I, V31, P85, DOI 10.1111/j.1475-097X.2010.00990.x; Li Y, 2015, NEUROBIOL DIS, V74, P240, DOI 10.1016/j.nbd.2014.11.021; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lifshitz J, 2012, BRAIN STRUCT FUNCT, V217, P49, DOI 10.1007/s00429-011-0323-z; Lyons DN, 2018, J NEUROTRAUM, V35, P2435, DOI 10.1089/neu.2018.5663; Marino S, 2007, J NEUROL NEUROSUR PS, V78, P501, DOI 10.1136/jnnp.2006.099796; Mathiesen C, 2011, J NEUROSCI, V31, P18327, DOI 10.1523/JNEUROSCI.4526-11.2011; Moffett John R, 2013, Front Neuroenergetics, V5, P11, DOI 10.3389/fnene.2013.00011; Montero M, 2004, BIOCHEM J, V384, P19, DOI 10.1042/BJ20040990; Murugan M, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00019; Parent M., 2018, J NEUROTRAUMA; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Paus T, 2001, BRAIN RES BULL, V54, P255, DOI 10.1016/S0361-9230(00)00434-2; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Putatunda R, 2018, CHIN J TRAUMATOL, V21, P125, DOI 10.1016/j.cjtee.2018.02.002; Reiss AL, 1996, BRAIN, V119, P1763, DOI 10.1093/brain/119.5.1763; Robertson CL, 2013, J NEUROTRAUM, V30, P2066, DOI 10.1089/neu.2013.3007; Sanganahalli BG, 2013, J CEREBR BLOOD F MET, V33, P1115, DOI 10.1038/jcbfm.2013.61; Sanganahalli BG, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063317; Scafidi S, 2010, DEV NEUROSCI-BASEL, V32, P480, DOI 10.1159/000323178; Scafidi S, 2010, J NEUROCHEM, V114, P820, DOI 10.1111/j.1471-4159.2010.06807.x; Schallert T, 2000, NEUROPHARMACOLOGY, V39, P777, DOI 10.1016/S0028-3908(00)00005-8; Tang L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0096944; Vay L, 2007, J PHYSIOL-LONDON, V580, P39, DOI 10.1113/jphysiol.2006.126391; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Winter JD, 2011, PEDIATR RES, V69, P418, DOI 10.1203/PDR.0b013e3182110f7e; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2010, BIOINFORMATICS, V26, P2342, DOI 10.1093/bioinformatics/btq418; Xia JG, 2010, NUCLEIC ACIDS RES, V38, pW71, DOI 10.1093/nar/gkq329; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356	52	15	15	0	12	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR 15	2019	36	8					1264	1278		10.1089/neu.2018.6100			15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HS4DK	WOS:000463812000006	30430900	Green Published			2022-02-06	
J	Bouley, J; Chung, DY; Ayata, C; Brown, RH; Henninger, N				Bouley, James; Chung, David Y.; Ayata, Cenk; Brown, Robert H., Jr.; Henninger, Nils			Cortical Spreading Depression Denotes Concussion Injury	JOURNAL OF NEUROTRAUMA			English	Article						cerebral blood flow; cerebral microbleed; concussion; cortical spreading depolarization; traumatic brain injury	TRAUMATIC BRAIN-INJURY; HEAD-INJURY; DEPOLARIZATIONS; CORTEX; SEIZURES; STRAIN; MODEL; MICE	Cortical spreading depression (CSD) has been described after moderate-to-severe traumatic brain injury (TBI). It is uncertain, however, whether CSD occurs after mild, concussive TBI and whether it relates to brain pathology and functional outcome. Male C57BL6/J mice (n=62) were subjected to closed head TBI with a 25g weight (n=11), 50g weight (n=45), or sham injury (n=6). Laser Doppler flowmetry and optical intrinsic signal imaging were used to determine cerebral blood flow dynamics after concussive CSD. Functional deficits were assessed at baseline, 2h, 24h, and 48h. TUNEL and Prussian blue staining were used to determine cell death and presence of cerebral microbleeds at 48h. No CSD was observed in mice subjected to a 25g weight drop whereas 58.9% of mice subjected to a 50g weight drop developed a CSD. Mice with concussive CSD displayed significantly greater numbers of apoptotic cell profiles in the ipsilesional hemisphere compared with mice without a CSD that underwent the same 50g weight drop paradigm (p<0.05, each). All investigated animals had at least one cerebral microbleed (range 1 to 24). Compared with mice without a CSD, mice with a CSD had significantly more microbleeds in the traumatized hemisphere (p<0.05, each) and showed impaired functional recovery (p<0.05). Incidence of CSD after mild TBI depended on impact severity and was associated with histological and behavioral outcomes. These observations indicate that concussive CSD may serve as viable marker for concussion severity and provide novel avenues for outcome prediction and therapeutic decision making.	[Bouley, James; Brown, Robert H., Jr.; Henninger, Nils] Univ Massachusetts, Sch Med, Dept Neurol, Worcester, MA USA; [Chung, David Y.; Ayata, Cenk] Massachusetts Gen Hosp, Dept Neurol, Boston, MA 02114 USA; [Chung, David Y.; Ayata, Cenk] Massachusetts Gen Hosp, Dept Radiol, Boston, MA USA; [Henninger, Nils] Univ Massachusetts, Sch Med, Dept Psychiat, Worcester, MA 01655 USA		Henninger, N (corresponding author), Univ Massachusetts, Sch Med, 55 Lake Ave North, Worcester, MA 01655 USA.	nils.henninger@umassmed.edu	Chung, David/AAG-1359-2019	Chung, David/0000-0002-7149-5851	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS091499, NS055104, NS102969, NS065743, NS088689, FD004127, HD060848]; Fondation LeducqLeducq Foundation; Heitman Foundation; Ellison FoundationLawrence Ellison Foundation; Angel Fund; ALS Association; ALSFindingaCure; Cellucci Fund for ALS Research; Pierre deBourghknect ALS Fund; Project ALS; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [P50HD060848, U54HD060848] Funding Source: NIH RePORTER; FOOD AND DRUG ADMINISTRATIONUnited States Department of Health & Human Services [R01FD004127] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002541] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R25NS065743, R01NS102969, R01NS088689, P01NS055104, K08NS091499] Funding Source: NIH RePORTER	We gratefully acknowledge expert assistance provided by Y. Liu (Morphology Core Laboratory; University of Massachusetts Medical School) for histotechnological assistance, A. Weiss for animal husbandry, K. van der Marel (Department of Radiology, University of Massachusetts Medical School) for implementation of the Matlab code to process COIS images, and K. Benoit for tireless logistical assistance and administrative support. This study was supported by institutional grants, National Institutes of Health grant NS091499 to N.H., NS055104, NS102969 to C.A., NS065743 to D.Y.C., and NS088689, FD004127, HD060848 to R.H.B. N.H. serves on the advisory board of Omniox, Inc. C.A receives support from the Fondation Leducq, the Heitman Foundation, and the Ellison Foundation. R.H.B. receives support from the Angel Fund, the ALS Association, ALSFindingaCure, the Cellucci Fund for ALS Research, Project ALS and the Pierre deBourghknect ALS Fund. R.H.B. is a co-founder of AviTx.	Altamura C, 2007, CEREB CORTEX, V17, P1394, DOI 10.1093/cercor/bhl051; Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Chung D.Y., 2018, CEREB CORTEX; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; ECHLIN F, 1948, T AM NEUROL ASSOC, P199; ECHLIN FA, 1950, ARCH NEURO PSYCHIATR, V63, P830; Eikermann-Haerter K, 2009, J CLIN INVEST, V119, P99, DOI 10.1172/JCI36059; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Faul M, 2010, TRAUMATIC BRAIN INJU; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Hansen JM, 2013, BRAIN, V136, P3589, DOI 10.1093/brain/awt309; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Hartings JA, 2011, BRAIN, V134, P1529, DOI 10.1093/brain/awr048; Henninger N, 2016, BRAIN, V139, P1094, DOI 10.1093/brain/aww001; Hinzman JM, 2016, J NEUROTRAUM, V33, P1775, DOI 10.1089/neu.2015.4226; Hinzman JM, 2014, BRAIN, V137, P2960, DOI 10.1093/brain/awu241; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kaufmann D., 2016, J CEREB BLOOD FLOW M; Kochanek PM, 2016, J NEUROTRAUM, V33, P606, DOI 10.1089/neu.2015.4133; Kochanek PM, 2011, J TRAUMA, V71, pS15, DOI 10.1097/TA.0b013e31822117fe; Leao AAP, 1944, J NEUROPHYSIOL, V7, P391, DOI 10.1152/jn.1944.7.6.391; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; Levchakov A, 2006, J NEUROTRAUM, V23, P1570, DOI 10.1089/neu.2006.23.1570; MATSUURA T, 1971, EXP BRAIN RES, V12, P238, DOI 10.1007/BF00237916; McAllister TW, 2001, NEUROIMAGE, V14, P1004, DOI 10.1006/nimg.2001.0899; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; OKA H, 1977, BRAIN, V100, P287, DOI 10.1093/brain/100.2.287; Paxinos G., 2013, MOUSE BRAIN STEREOTA, VFourth; Rogatsky GG, 2003, J NEUROTRAUM, V20, P1315, DOI 10.1089/089771503322686111; Rowson S, 2018, J NEUROTRAUM, V35, P681, DOI 10.1089/neu.2017.5169; Samoriski GM, 1997, J NEUROSCI, V17, P5581; Shaw NA, 2002, PROG NEUROBIOL, V67, P281, DOI 10.1016/S0301-0082(02)00018-7; Stalnacke BM, 2007, J REHABIL MED, V39, P405, DOI 10.2340/16501977-0057; Tagge CA, 2018, BRAIN, V141, P422, DOI 10.1093/brain/awx350; TAKAHASHI H, 1981, J NEUROSURG, V55, P708, DOI 10.3171/jns.1981.55.5.0708; TAKAHASHI H, 1980, CHILD BRAIN, V7, P124; WEST M, 1982, ELECTROEN CLIN NEURO, V53, P192, DOI 10.1016/0013-4694(82)90023-2; Woitzik J, 2013, NEUROLOGY, V80, P1095, DOI 10.1212/WNL.0b013e3182886932; Yuzawa I, 2012, J CEREBR BLOOD F MET, V32, P376, DOI 10.1038/jcbfm.2011.148	43	15	15	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1008	1017		10.1089/neu.2018.5844			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HR6BY	WOS:000463234200004	29999455	Green Published			2022-02-06	
J	Carlozzi, NE; Hanks, R; Lange, RT; Brickell, TA; Ianni, PA; Miner, JA; French, LM; Kallen, MA; Sander, AM				Carlozzi, Noelle E.; Hanks, Robin; Lange, Rael T.; Brickell, Tracey A.; Ianni, Phillip A.; Miner, Jennifer A.; French, Louis M.; Kallen, Michael A.; Sander, Angelle M.			Understanding Health-related Quality of Life in Caregivers of Civilians and Service Members/Veterans With Traumatic Brain Injury: Establishing the Reliability and Validity of PROMIS Mental Health Measures	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Anger; Anxiety; Caregiver; Depression; Emotion; Patient reported outcome measures; Psychometrics; Rehabilitation; Traumatic brain injury	EMOTIONAL DISTRESS; SOCIAL SUPPORT; RELATIVES; OUTCOMES; INDIVIDUALS; REHABILITATION; BURDEN; SATISFACTION; PREDICTORS; DEPRESSION	Objective: To provide important reliability and validity data to support the use of the Patient-Reported Outcomes Measurement Information System (PROMIS) mental health measures in caregivers of civilians or service members/veterans (SMVs) with traumatic brain injury (TBI). Design: Patient-reported outcome surveys administered through an electronic data collection platform. Setting: Three TBI model systems rehabilitation hospitals, an academic medical center, and a military medical treatment facility. Participants: Caregivers (N=560) of individuals with a documented TBI (344 civilians and 216 military). Intervention: Not applicable. Main Outcome Measures: PROMIS anxiety, depression, and anger item banks. Results: Internal consistency for all the PROMIS Mental Health item banks was very good (all alpha>.86) and 3-week test-retest reliability was good to adequate (ranged from .65 to .85). Convergent validity and discriminant validity of the PROMIS measures were also supported. Caregivers of individuals who were low functioning had worse emotional health-related quality of life (HRQOL) (as measured by the 3 PROMIS measures) than caregivers of high functioning individuals, supporting known groups validity. Finally, levels of distress, as measured by the PROMIS measures, were elevated for those caring for low-functioning individuals in both samples (rates ranged from 26.2% to 43.6% for caregivers of low-functioning individuals). Conclusions: Results support the reliability and validity of the PROMIS anxiety, depression, and anger item banks in caregivers of civilians and SMVs with TBI. Ultimately, these measures can be used to provide a standardized assessment of HRQOL because it relates to mental health in these caregivers. (C) 2018 by the American Congress of Rehabilitation Medicine	[Carlozzi, Noelle E.; Ianni, Phillip A.; Miner, Jennifer A.] Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA; [Hanks, Robin] Rehabil Inst Michigan, Dept Psychol & Neuropsychol, Detroit, MI USA; [Hanks, Robin] Wayne State Univ, Dept Phys Med & Rehabil, Detroit, MI USA; [Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Def & Vet Brain Injury Ctr, Bethesda, MD USA; [Lange, Rael T.; Brickell, Tracey A.; French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Lange, Rael T.] Univ British Columbia, Vancouver, BC, Canada; [Brickell, Tracey A.; French, Louis M.] Uniformed Serv Univ Hlth Sci, Bethesda, MD 20814 USA; [Kallen, Michael A.] Northwestern Univ, Feinberg Sch Med, Dept Med Social Sci, Chicago, IL 60611 USA; [Sander, Angelle M.] Baylor Coll Med, H Ben Taub Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Sander, Angelle M.] Harris Hlth Syst, Houston, TX USA; [Sander, Angelle M.] TIRR Mem Hermann, Brain Injury Res Ctr, Houston, TX USA		Carlozzi, NE (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, North Campus Res Complex,2800 Plymouth Rd, Ann Arbor, MI 48109 USA.	carlozzi@med.umich.edu	french, louis/AAB-2083-2020	Hanks, Robin/0000-0002-3432-4789; french, louis/0000-0002-9451-0604	National Institutes of Health National Institute of Nursing ResearchUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR); National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [ULITR000433]; Defense and Veterans Brain Injury CenterUS Department of Veterans Affairs; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR002240, UL1TR000433] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [R01NR013658] Funding Source: NIH RePORTER	Supported by the National Institutes of Health National Institute of Nursing Research (grant no. R01NR013658), the National Center for Advancing Translational Sciences (grant no. ULITR000433), and the Defense and Veterans Brain Injury Center.	Adams D, 2016, NEUROREHABILITATION, V39, P223, DOI 10.3233/NRE-161353; Amtmann D, ARCH PHYS MED REHABI; Anderson MI, 2002, BRAIN INJURY, V16, P743, DOI 10.1080/02699050210128906; Andresen EM, 2000, ARCH PHYS MED REHAB, V81, pS15, DOI 10.1053/apmr.2000.20619; Arango-Lasprilla JC, 2011, J REHABIL MED, V43, P983, DOI 10.2340/16501977-0883; Bayen E, 2016, J HEAD TRAUMA REHAB, V31, pE59, DOI 10.1097/HTR.0000000000000079; Bulmer, 1979, PRINCIPLES STAT; CAMPBELL DT, 1959, PSYCHOL BULL, V56, P81, DOI 10.1037/h0046016; Carlozzi NE, 2019, ARCH PHYS MED REHAB, V100, pS1, DOI 10.1016/j.apmr.2018.08.175; Carlozzi NE, 2016, J REHABIL RES DEV, V53, P669, DOI 10.1682/JRRD.2015.07.0136; Carlozzi NE, 2015, ARCH PHYS MED REHAB, V96, P105, DOI 10.1016/j.apmr.2014.08.021; Cella D, 2007, MED CARE, V45, pS3, DOI 10.1097/01.mlr.0000258615.42478.55; CELLA DF, 1995, SEMIN ONCOL, V22, P73; Cohen J., 2013, STAT POWER ANAL BEHA; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; Corrigan JD, 2012, J HEAD TRAUMA REHAB, V27, P391, DOI 10.1097/HTR.0b013e3182238cdd; Cramer D., 2004, SAGE DICT STAT; Cuthbert JP, 2015, ARCH PHYS MED REHAB, V96, P2128, DOI 10.1016/j.apmr.2015.07.020; Dahm J, 2015, J REHABIL MED, V47, P932, DOI 10.2340/16501977-2016; DEMPSTER AP, 1977, J ROY STAT SOC B MET, V39, P1, DOI 10.1111/j.2517-6161.1977.tb01600.x; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Derogatis L. R., 1975, SYMPTOM CHECKLIST 90; DeVellis R.F., 2017, SCALE DEV THEORY APP; DeVellis RF, 2006, MED CARE, V44, pS50, DOI 10.1097/01.mlr.0000245426.10853.30; Douglas JM, 1996, BRAIN INJURY, V10, P819, DOI 10.1080/026990596123936; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Gillen R, 1998, J HEAD TRAUMA REHAB, V13, P31, DOI 10.1097/00001199-199806000-00004; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Hahn EA, 2014, HEALTH PSYCHOL, V33, P490, DOI 10.1037/hea0000055; Hanauer DA, 2015, J BIOMED INFORM, V55, P290, DOI 10.1016/j.jbi.2015.05.003; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Hays RD, 1995, USERS MANUAL MED OUT; Heaton R. K., 2004, REVISED COMPREHENSIV; Jourdan C, 2016, ANN PHYS REHABIL MED, V59, P100, DOI 10.1016/j.rehab.2015.10.009; KINSELLA G, 1991, J NEUROL NEUROSUR PS, V54, P422, DOI 10.1136/jnnp.54.5.422; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, BRAIN INJURY, V8, P211, DOI 10.3109/02699059409150974; Langlois Jean A, 2003, MMWR Surveill Summ, V52, P1; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; LIVINGSTON MG, 1985, J NEUROL NEUROSUR PS, V48, P876, DOI 10.1136/jnnp.48.9.876; Malec JF, 2003, J HEAD TRAUMA REHAB, V18, P479, DOI 10.1097/00001199-200311000-00002; Malec JF, MAYO PORTLAND ADAPTA; Manskow US, 2015, J HEAD TRAUMA REHAB, V30, P411, DOI 10.1097/HTR.0000000000000085; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; Mazlan M, 2016, DISABIL REHABIL, V38, P2198, DOI 10.3109/09638288.2015.1123307; Norup A, 2017, NEUROPSYCHOL REHABIL, V27, P196, DOI 10.1080/09602011.2015.1076484; Norup A, 2015, BRAIN INJURY, V29, P822, DOI 10.3109/02699052.2015.1016451; Norup A, 2013, J REHABIL MED, V45, P827, DOI 10.2340/16501977-1181; Norup A, 2012, BRAIN INJURY, V26, P1192, DOI 10.3109/02699052.2012.672790; Norup A, 2011, NEUROPSYCHOL REHABIL, V21, P306, DOI 10.1080/09602011.2011.558766; Norup A, 2010, BRAIN INJURY, V24, P81, DOI 10.3109/02699050903508200; ODDY M, 1978, BRIT J PSYCHIAT, V133, P507, DOI 10.1192/bjp.133.6.507; Perlesz A, 2000, J HEAD TRAUMA REHAB, V15, P909, DOI 10.1097/00001199-200006000-00005; Petranovich CL, 2015, J PEDIATR PSYCHOL, V40, P680, DOI 10.1093/jpepsy/jsv001; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Pilkonis PA, 2011, ASSESSMENT, V18, P263, DOI 10.1177/1073191111411667; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Powell JM, 2017, J HEAD TRAUMA REHAB, V32, pE33, DOI 10.1097/HTR.0000000000000219; Rivara JB, 1996, ARCH PHYS MED REHAB, V77, P754, DOI 10.1016/S0003-9993(96)90253-1; Rotondi AJ, 2007, J HEAD TRAUMA REHAB, V22, P14, DOI 10.1097/00001199-200701000-00002; Saban KL, 2016, BIOL RES NURS, V18, P50, DOI 10.1177/1099800414568661; Sander AM, 2013, BRAIN IMPAIR, V14, P113, DOI 10.1017/BrImp.2013.12; Sander AM, 2012, ARCH PHYS MED REHAB, V93, P842, DOI 10.1016/j.apmr.2011.11.031; Snaith RP, 1976, LEEDS SCALES SELF AS; Stern J M, 1988, Brain Inj, V2, P259, DOI 10.3109/02699058809150951; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; ZARIT SH, 1980, GERONTOLOGIST, V20, P649, DOI 10.1093/geront/20.6.649	73	15	15	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	APR	2019	100	4		1			S94	S101		10.1016/j.apmr.2018.05.021			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	HR2FV	WOS:000462951900011	29932885	Green Accepted			2022-02-06	
J	Harriss, A; Johnson, AM; Walton, DM; Dickey, JP				Harriss, Alexandra; Johnson, Andrew M.; Walton, David M.; Dickey, James P.			Head impact magnitudes that occur from purposeful soccer heading depend on the game scenario and head impact location	MUSCULOSKELETAL SCIENCE AND PRACTICE			English	Article						Adolescent; Heading; Female; Repetitive; Youth	NEUROCOGNITIVE PERFORMANCE; NECK STRENGTH; CONCUSSION; FOOTBALL; PLAYERS; INJURY; RISK; ACCELERATIONS; BIOMECHANICS; FREQUENCY	Purpose: This study quantified the linear and angular kinematics that result from purposeful heading during youth soccer games, and the influence of game scenario and head impact location on these magnitudes. Method: This observational study recruited thirty-six female soccer players (13.4 +/- 0.9 years old) from three elite youth soccer teams (U13, U14, U15) and followed for an entire soccer season. Players wore wireless sensors during each game to quantify head impact magnitudes. A total of 60 regular season games (20 games per team) were video recorded, and purposeful heading events were categorized by game scenario (e.g. throw in), and head impact location (e.g. front of head). Results: Game scenario had a statistically significant effect on the linear head acceleration, and rotational head velocity, that resulted from purposeful headers. Rotational velocity from purposeful headers varied significantly between head impact locations, with impacts to the top of the head (improper technique) resulting in larger peak rotational velocities than impacts to the front of the head (proper technique); this was also the case for the linear acceleration for punts. Conclusion: Our findings suggest that the magnitude for both linear and angular head impact kinematics depend on the game scenario and head impact location. Headers performed with the top of the head (improper technique) result in larger rotational velocities compared to the front of the head (proper technique). Accordingly, youth players should be educated on how to execute proper heading technique to reduce head impact accelerations.	[Harriss, Alexandra; Johnson, Andrew M.] Univ Western Ontario, Hlth & Rehabil Sci, London, ON, Canada; [Johnson, Andrew M.; Walton, David M.] Univ Western Ontario, Sch Hlth Studies, London, ON, Canada; [Walton, David M.] Univ Western Ontario, Sch Phys Therapy, London, ON, Canada; [Dickey, James P.] Univ Western Ontario, Sch Kinesiol, 1151 Richmond St,3M Ctr,Room 3159A, London, ON N6A 3K7, Canada		Dickey, JP (corresponding author), Univ Western Ontario, Sch Kinesiol, 1151 Richmond St,3M Ctr,Room 3159A, London, ON N6A 3K7, Canada.	jdickey@uwo.ca	Dickey, James P/K-6776-2013; Walton, David M/C-9902-2015; Johnson, Andrew M/B-2048-2012	Dickey, James P/0000-0002-4101-835X; Walton, David M/0000-0001-9155-3337; Johnson, Andrew M./0000-0002-7269-3016	Ontario Soccer Association	The authors would like to thank GForce Tracker for their generous contribution of equipment. We would like to thank the Ontario Soccer Association, and the Burlington Bayhawks for supporting this study.	Bates D, 2015, J STAT SOFTW, V67, P1, DOI 10.18637/jss.v067.i01; Black AM, 2016, BRIT J SPORT MED, V50, P55, DOI 10.1136/bjsports-2015-095103; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Caccese JB, 2018, SPORT BIOMECH, V17, P462, DOI 10.1080/14763141.2017.1360385; Caccese JB, 2018, RES SPORTS MED, V26, P64, DOI 10.1080/15438627.2017.1393756; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Chrisman SPD, 2019, CLIN J SPORT MED, V29, P3, DOI 10.1097/JSM.0000000000000497; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Collins CL, 2014, J PRIM PREV, V35, P309, DOI 10.1007/s10935-014-0355-2; Diakogeorgiou E, 2018, ORTHOP J SPORTS MED, V6, DOI 10.1177/2325967118761031; Dorminy M, 2015, BRAIN INJURY, V29, P1158, DOI 10.3109/02699052.2015.1035324; Eckner JT, 2014, AM J SPORT MED, V42, P566, DOI 10.1177/0363546513517869; Elkin BS, 2019, CLIN BIOMECH, V64, P49, DOI 10.1016/j.clinbiomech.2018.03.021; Gutierrez GM, 2014, PEDIATR EXERC SCI, V26, P33, DOI 10.1123/pes.2013-0102; Hanlon EM, 2012, MED SCI SPORT EXER, V44, P1102, DOI 10.1249/MSS.0b013e3182444d7d; Harriss A., 2018, SCI MED FOOTBALL, DOI [10.1080/24733938.2018, DOI 10.1080/24733938.2018]; Harriss A, 2018, RES SPORTS MED, V26, P191, DOI 10.1080/15438627.2018.1431534; Janda David H, 2002, Inj Control Saf Promot, V9, P25, DOI 10.1076/icsp.9.1.25.3324; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Koerte IK, 2017, J NEUROTRAUM, V34, P2389, DOI 10.1089/neu.2016.4960; Kontos AP, 2011, BRAIN INJURY, V25, P1234, DOI 10.3109/02699052.2011.608209; Kuznetsova A., 2016, IMERTEST TESTS LINEA; Lamond LC, 2018, J ATHL TRAINING, V53, P115, DOI 10.4085/1062-6050-90-17; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; McCuen E, 2015, J BIOMECH, V48, P3720, DOI 10.1016/j.jbiomech.2015.08.003; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Muise DP, 2016, INT J ATHL THER TRAI, V21, P36, DOI 10.1123/ijatt.2016-0005; Mussack T, 2003, EUR J MED RES, V8, P457; Naunheim RS, 2003, MED SCI SPORT EXER, V35, P1406, DOI 10.1249/01.MSS.0000078933.84527.AE; Paus T, 2010, BRAIN COGNITION, V72, P26, DOI 10.1016/j.bandc.2009.06.002; Poole VN, 2015, DEV NEUROPSYCHOL, V40, P12, DOI 10.1080/87565641.2014.984810; Press JN, 2017, CLIN J SPORT MED, V27, P104, DOI 10.1097/JSM.0000000000000313; Reynolds BB, 2016, J NEUROSURG, V124, P501, DOI 10.3171/2015.5.JNS15573; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Rubin TG, 2018, RADIOLOGY, V289, P478, DOI 10.1148/radiol.2018180217; Ruestow PS, 2015, J OCCUP ENVIRON HYG, V12, P875, DOI 10.1080/15459624.2015.1072632; Self B. P., 2016, ENG SPORT 6, P81, DOI [10.1007/978-0-387-46051-2_15, DOI 10.1007/978-0-387-46051-2_15]; Shewchenko N, 2005, BRIT J SPORT MED, V39, pI26, DOI 10.1136/bjsm.2005.019042; Stewart WF, 2017, NEUROLOGY, V88, P901, DOI 10.1212/WNL.0000000000003657; Team R, 2016, RSTUDIO INT DEV R, V3.6.1; USAClubSoccer, 2016, REC REC IMPL GUID US; Yang YT, 2016, JAMA PEDIATR, V170, P413, DOI 10.1001/jamapediatrics.2016.0338; Zhang MR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057364	44	15	15	2	13	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	2468-7812			MUSCULOSKEL SCI PRAC	Musculoskelet. Sci. Pract.	APR	2019	40						53	57		10.1016/j.msksp.2019.01.009			5	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	HN3TZ	WOS:000460108500008	30708266				2022-02-06	
J	Monson, KL; Converse, MI; Manley, GT				Monson, Kenneth L.; Converse, Matthew I.; Manley, Geoffrey T.			Cerebral blood vessel damage in traumatic brain injury	CLINICAL BIOMECHANICS			English	Article						Traumatic brain injury; Cerebral blood vessel damage; Biomechanics	FINITE-ELEMENT-ANALYSIS; CORTICAL IMPACT INJURY; VASCULAR-PERMEABILITY CHANGES; ACUTE SUBDURAL HEMATOMAS; DIFFUSE AXONAL INJURY; BRIDGING VEINS; MECHANICAL-PROPERTIES; HEAD-INJURY; FAILURE PROPERTIES; CEREBROVASCULAR DYSFUNCTION	Traumatic brain injury is a devastating cause of death and disability. Although injury of brain tissue is of primary interest in head trauma, nearly all significant cases include damage of the cerebral blood vessels. Because vessels are critical to the maintenance of the healthy brain, any injury or dysfunction of the vasculature puts neural tissue at risk. It is well known that these vessels commonly tear and bleed as an immediate consequence of traumatic brain injury. It follows that other vessels experience deformations that are significant though not severe enough to produce bleeding. Recent data show that such subfailure deformations damage the microstructure of the cerebral vessels, altering both their structure and function. Little is known about the prognosis of these injured vessels and their potential contribution to disease development. The objective of this review is to describe the current state of knowledge on the mechanics of cerebral vessels during head trauma and how they respond to the applied loads. Further research on these topics will clarify the role of blood vessels in the progression of traumatic brain injury and is expected to provide insight into improved strategies for treatment of the disease.	[Monson, Kenneth L.; Converse, Matthew I.] Univ Utah, Dept Mech Engn, Salt Lake City, UT 84112 USA; [Monson, Kenneth L.] Univ Utah, Dept Bioengn, Salt Lake City, UT 84112 USA; [Manley, Geoffrey T.] Univ Calif San Francisco, Dept Neurol Surg, San Francisco, CA 94143 USA		Monson, KL (corresponding author), 1495 E 100 S,MEK 1550, Salt Lake City, UT 84112 USA.	ken.monson@utah.edu		Monson, Ken/0000-0002-8461-6034			ABEL JM, 1978, 22 STAPP CAR CRASH C; Adams J. H., 1980, NEUROPATHOL APPL NEU, V6; ADAMS JH, 1980, J CLIN PATHOL, V33, P1132, DOI 10.1136/jcp.33.12.1132; AKIMA M, 1986, LAB INVEST, V55, P482; ALCOLADO R, 1988, NEUROPATH APPL NEURO, V14, P1, DOI 10.1111/j.1365-2990.1988.tb00862.x; Alford P. W., 2011, P NATL ACAD SCI US P; ANDREWS BT, 1989, NEUROSURGERY, V24, P514, DOI 10.1227/00006123-198904000-00005; Balabanov R, 2001, NEUROL RES, V23, P175, DOI 10.1179/016164101101198514; Baldwin SA, 1996, J NEUROSURG, V85, P476, DOI 10.3171/jns.1996.85.3.0476; Bandak F.A., 1994, STAPP CAR CRASH C SO, V38, P145; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; Bell ED, 2017, J MECH BEHAV BIOMED, V65, P627, DOI 10.1016/j.jmbbm.2016.09.028; Bell ED, 2015, FRONT BIOENG BIOTECH, V3, DOI 10.3389/fbioe.2015.00002; Bell ED, 2013, J BIOMECH, V46, P91, DOI 10.1016/j.jbiomech.2012.10.015; Bjornsson CS, 2006, J NEURAL ENG, V3, P196, DOI 10.1088/1741-2560/3/3/002; Boock R, 1991, THESIS; Brozici M, 2003, STROKE, V34, P2750, DOI 10.1161/01.STR.0000095791.85737.65; Bukoski RD, 1997, AM J PHYSIOL-HEART C, V272, pH1406; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; BUSBY DE, 1965, CAN J PHYSIOL PHARM, V43, P185, DOI 10.1139/y65-018; CAMPBELL GJ, 1981, STROKE, V12, P489, DOI 10.1161/01.STR.12.4.489; Cantu RC, 2010, J NEUROTRAUM, V27, P1557, DOI 10.1089/neu.2010.1334; Cassot F, 2006, MICROCIRCULATION, V13, P1, DOI 10.1080/10739680500383407; Cassot F, 2010, BRAIN RES, V1313, P62, DOI 10.1016/j.brainres.2009.12.007; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chalupnik J. D., 1971, MAT PROPERTIES CEREB; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; COHEN J, 1972, J SURG RES, V13, P321, DOI 10.1016/0022-4804(72)90083-2; Converse MI, 2018, ACTA BIOMATER, V67, P307, DOI 10.1016/j.actbio.2017.11.052; Coulson RJ, 2004, J BIOMECH ENG-T ASME, V126, P76, DOI 10.1115/1.1645525; Coulson RJ, 2002, AM J PHYSIOL-HEART C, V283, pH2268, DOI 10.1152/ajpheart.00542.2002; COURVILLE C B, 1950, Bull Los Angel Neuro Soc, V15, P72; CROOKS DA, 1991, VIRCHOWS ARCH A, V418, P479, DOI 10.1007/BF01606496; Daneman R, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020412; Delye Hans, 2006, Stapp Car Crash J, V50, P625; Denny-Brown D, 1941, BRAIN, V64, P93, DOI 10.1093/brain/64.2-3.93; Depreitere B, 2006, J NEUROSURG, V104, P950, DOI 10.3171/jns.2006.104.6.950; Dewitt DS, 2003, J NEUROTRAUM, V20, P795, DOI 10.1089/089771503322385755; DIXON CE, 1991, J NEUROSCI METH, V39, P253; DIXON DA, 1996, NEUROTRAUMA, P43; Dore-Duffy P, 2000, MICROVASC RES, V60, P55, DOI 10.1006/mvre.2000.2244; DUVERNOY HM, 1981, BRAIN RES BULL, V7, P519, DOI 10.1016/0361-9230(81)90007-1; ELLISON MD, 1989, STROKE, V20, P911, DOI 10.1161/01.STR.20.7.911; Famaey N, 2015, J MECH BEHAV BIOMED, V41, P222, DOI 10.1016/j.jmbbm.2014.06.009; Faul M, 2010, TRAUMATIC BRAIN INJU; Feng Y, 2010, J R SOC INTERFACE, V7, P1677, DOI 10.1098/rsif.2010.0210; FENTON TR, 1986, J BIOMECH, V19, P501, DOI 10.1016/0021-9290(86)90123-5; Finkelstein E., 2006, INCIDENCE EC BURDEN; FINLAY HM, 1995, J VASC RES, V32, P301, DOI 10.1159/000159104; Finlay HM, 1998, STROKE, V29, P1595, DOI 10.1161/01.STR.29.8.1595; Fox RJ, 1996, NEUROSURGERY, V39, P84, DOI 10.1097/00006123-199607000-00017; Fung Y. C., 1993, BIOMECHANICS MECH PR; GALLAGHEJP, 1968, J NEUROSURG, V29, P1; GENNARELLI TA, 1982, J TRAUMA, V22, P680, DOI 10.1097/00005373-198208000-00005; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Gennarelli TA, 1979, STAPP CAR CRASH C, P563; Gennarelli TA, 1972, STAPP CAR CRASH J, V16, P296; Goggio AF, 1941, J NEUROL PSYCHIATRY, V4, P11, DOI 10.1136/jnnp.4.1.11; Golding EM, 1999, AM J PHYSIOL-HEART C, V277, pH1457, DOI 10.1152/ajpheart.1999.277.4.H1457; Golding EM, 2000, J CEREBR BLOOD F MET, V20, P820, DOI 10.1097/00004647-200005000-00008; Golding EM, 2002, BRAIN RES REV, V38, P377, DOI 10.1016/S0165-0173(02)00141-8; Golding EM, 1998, J NEUROTRAUM, V15, P973, DOI 10.1089/neu.1998.15.973; Golding EM, 1999, CLIN EXP HYPERTENS, V21, P299, DOI 10.3109/10641969909068668; Golding EM, 1998, J NEUROTRAUM, V15, P635, DOI 10.1089/neu.1998.15.635; GOLDSMITH W, 1981, J BIOMECH, V14, P883, DOI 10.1016/0021-9290(81)90016-6; Goldsmith W, 1989, P IRCOBI C 1989 SEPT, P1; Goldsmith Werner, 2005, Critical Reviews in Biomedical Engineering, V33, P105, DOI 10.1615/CritRevBiomedEng.v33.i2.20; Guo SZ, 2016, J NEUROTRAUM, V33, P1303, DOI 10.1089/neu.2015.4101; GURDJIAN ES, 1961, J NEUROSURG, V18, P58, DOI 10.3171/jns.1961.18.1.0058; GURDJIAN ES, 1962, JAMA-J AM MED ASSOC, V182, P509, DOI 10.1001/jama.1962.03050440001001; Gurduian ES, 1944, LANCET, V1, P389; HAINES DE, 1991, ANAT RECORD, V230, P3, DOI 10.1002/ar.1092300103; HAINES DE, 1993, NEUROSURGERY, V32, P111, DOI 10.1227/00006123-199301000-00017; HAJDU MA, 1990, CIRC RES, V66, P1747, DOI 10.1161/01.RES.66.6.1747; HAJDU MA, 1994, AM J PHYSIOL, V266, pH1027, DOI 10.1152/ajpheart.1994.266.3.H1027; Han H, 2007, NEURORADIOLOGY, V49, P169, DOI 10.1007/s00234-006-0175-z; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; HASSLER O, 1962, ACTA ANAT, V48, P1; HAYASHI K, 1980, BIORHEOLOGY, V17, P211; HAYASHI K, 1993, J BIOMECH ENG-T ASME, V115, P481, DOI 10.1115/1.2895528; HAYASHI K, 1980, J BIOMECH, V13, P175, DOI 10.1016/0021-9290(80)90191-8; Ho J, 2007, J BIOMECH, V40, P3006, DOI 10.1016/j.jbiomech.2007.02.011; Hodgson V. R, 1971, 15 STAPP CAR CRASH C; Hodgson V. R., 1969, ADV UNDERSTANDING EX; Holbourn AHS, 1943, LANCET, V2, P438; Holbourn AHS, 1944, LANCET, V1, P483; Holzapfel GA, 2000, J ELASTICITY, V61, P1, DOI 10.1023/A:1010835316564; Hua Y, 2015, COMPUT MATH METHOD M, V2015, DOI 10.1155/2015/928236; Huang HM, 1999, J TRAUMA, V47, P538, DOI 10.1097/00005373-199909000-00019; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; Humphrey JD, 1995, CRIT REV BIOMED ENG, V23, P1; Humphrey JD, 2002, CARDIOVASCULAR SOLID; itny R., 2010, B APPL MECH, V6, P1, DOI DOI 10.1007/978-3-642-13039-7_194; Jullienne A, 2016, J NEUROSCI RES, V94, P609, DOI 10.1002/jnr.23732; Kelleher CM, 2004, CURR TOP DEV BIOL, V62, P153; Kenney K, 2016, EXP NEUROL, V275, P353, DOI 10.1016/j.expneurol.2015.05.019; King AI, 2011, CLIN ANAT, V24, P294, DOI 10.1002/ca.21151; Kleiven S, 2003, J NEUROTRAUM, V20, P365, DOI 10.1089/089771503765172327; KONTOS HA, 1992, J NEUROTRAUM, V9, P349, DOI 10.1089/neu.1992.9.349; Lee M-C, 1987, 31 STAPP CAR CRASH C; LEE MC, 1989, J BIOMECH, V22, P537, DOI 10.1016/0021-9290(89)90005-5; LEE RMKW, 1995, PHARMACOL THERAPEUT, V66, P149, DOI 10.1016/0163-7258(94)00071-A; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; LIU HM, 1988, FORENSIC SCI INT, V38, P285, DOI 10.1016/0379-0738(88)90174-0; LOWENHIELM P, 1975, J BIOMECH, V8, P351, DOI 10.1016/0021-9290(75)90069-X; LOWENHIELM P, 1978, J BIOENG, V2, P501; LOWENHIELM P, 1974, Z RECHTSMED, V75, P131, DOI 10.1007/BF02114709; LOWENHIELM P, 1974, Z RECHTSMED, V74, P55, DOI 10.1007/BF01869185; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MACFARLANE TWR, 1980, J BIOMECH, V13, P265, DOI 10.1016/0021-9290(80)90369-3; Mack J, 2009, PEDIATR RADIOL, V39, P200, DOI 10.1007/s00247-008-1084-6; Maher E, 2012, J BIOMECH, V45, P1393, DOI 10.1016/j.jbiomech.2012.02.026; Maikos JT, 2007, J NEUROTRAUM, V24, P492, DOI 10.1089/neu.2006.0149; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Mao HJ, 2010, BIOMECH MODEL MECHAN, V9, P763, DOI 10.1007/s10237-010-0212-z; Mao HJ, 2010, J NEUROTRAUM, V27, P877, DOI 10.1089/neu.2008.0616; Mao Haojie, 2006, Stapp Car Crash J, V50, P583; Martins Carolina, 2005, Neurosurgery, V56, P211, DOI 10.1227/01.NEU.0000144823.94402.3D; Mathew BP, 1999, J NEUROTRAUM, V16, P1177, DOI 10.1089/neu.1999.16.1177; Mathew P, 1996, J NEUROSURG, V85, P860, DOI 10.3171/jns.1996.85.5.0860; Maxeiner H, 2002, NEUROSURGERY, V50, P503, DOI 10.1097/00006123-200203000-00013; Maxeiner H, 1997, FORENSIC SCI INT, V89, P103, DOI 10.1016/S0379-0738(97)00124-2; MAXWELL WL, 1988, J PATHOL, V155, P327, DOI 10.1002/path.1711550408; MCKISSOCK W, 1960, LANCET, V2, P167; MEDER JF, 1994, J NEURORADIOLOGY, V21, P118; Melvin J, 1993, ACCIDENTAL INJURY BI; Miller JD, 2014, J NEUROSURG, V120, P1378, DOI 10.3171/2013.10.JNS13272; Mitchell P, 2002, BRIT J NEUROSURG, V16, P578; Monson K, 2008, J NEUROTRAUM, V25, P864; Monson KL, 2008, ANN BIOMED ENG, V36, P2028, DOI 10.1007/s10439-008-9578-9; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Monson KL, 2003, J BIOMECH ENG-T ASME, V125, P288, DOI 10.1115/1.1554412; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; Nahum A., 1980, 24TH STAPP CAR CRASH, P43; Nahum A. M, 1976, STAPP CAR CRASH C, P785; NAKAI K, 1989, SCANNING MICROSCOPY, V3, P337; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Neary J. P, 2011, CLIN PHYSL FUNCT IMA, V31; Nonaka H, 2003, NEUROPATHOLOGY, V23, P111, DOI 10.1046/j.1440-1789.2003.00486.x; Nonaka H, 2003, NEUROPATHOLOGY, V23, P129, DOI 10.1046/j.1440-1789.2003.00487.x; Nonaka H, 2003, J NEUROPATH EXP NEUR, V62, P154, DOI 10.1093/jnen/62.2.154; Nusholtz G.S., 1984, 841657 SAE, P41; Nye KS, 2017, ANN BIOMED ENG, V45, P1101, DOI 10.1007/s10439-016-1741-0; OBRIEN PK, 1974, J NEUROSURG, V41, P435, DOI 10.3171/jns.1974.41.4.0435; OKA K, 1985, NEUROSURGERY, V17, P711, DOI 10.1227/00006123-198511000-00003; OLSSON Y, 1971, ACTA NEUROPATHOL, V19, P225, DOI 10.1007/BF00684599; OMMAYA AK, 1964, J NEUROSURG, V21, P249, DOI 10.3171/jns.1964.21.4.0249; OMMAYA AK, 1968, J AMER MED ASSOC, V204, P285, DOI 10.1001/jama.204.4.285; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; OMMAYA AK, 1973, J NEUROSURG, V39, P152, DOI 10.3171/jns.1973.39.2.0152; Ommaya AK, 1967, 11 STAPP CAR CRASH C; Omori K., 2000, ASME APPL MECH DIV, V246, P167; Ono K., 1980, SAE TECH PAP, V89, P101, DOI [10.4271/801303, DOI 10.4271/801303]; Parnaik Yednesh, 2004, Stapp Car Crash J, V48, P259; POZZATI E, 1989, STROKE, V20, P412, DOI 10.1161/01.STR.20.3.412; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Reina-De La Torre F, 1998, ANAT RECORD, V251, P87, DOI 10.1002/(SICI)1097-0185(199805)251:1<87::AID-AR14>3.0.CO;2-7; RINDER L, 1968, ACTA NEUROPATHOL, V11, P201; Rinder L, 1972, Scand J Rehabil Med, V4, P97; RINDER L, 1968, ACTA NEUROPATHOL, V11, P183; ROACH MR, 1957, CAN J BIOCHEM PHYS, V35, P681, DOI 10.1139/o57-080; ROACH MR, 1986, CONNECT TISSUE RES, V15, P77, DOI 10.3109/03008208609001976; Rodriguez-Baeza A, 2003, ANAT REC PART A, V273A, P583, DOI 10.1002/ar.a.10069; Rowe AJ, 2003, J VASC RES, V40, P406, DOI 10.1159/000072831; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Sangiorgi S, 2013, J NEUROSURG, V118, P763, DOI 10.3171/2012.11.JNS12627; Sano K, 1967, Neurol Med Chir (Tokyo), V9, P21, DOI 10.2176/nmc.9.21; SCHACHENMAYR W, 1978, AM J PATHOL, V92, P53; Scott G. G., 2015, BIOMECH MODEL MECHAN, P1; Shatsky SA, 1974, P STAPP CAR CRASH C, P351; Shelden CH, 1944, J NEUROSURG, V1, P67, DOI 10.3171/jns.1944.1.1.0067; SHIRAISHI T, 1990, SCANNING MICROSCOPY, V4, P191; Shreiber D.I., 1997, STAPP CAR CRASH J, V41, P277; Shreiber DI, 1999, NEUROSCI LETT, V259, P5, DOI 10.1016/S0304-3940(98)00853-2; Shreiber DI, 1999, J NEUROPATH EXP NEUR, V58, P153, DOI 10.1097/00005072-199902000-00005; Simard JM, 2009, J NEUROTRAUM, V26, P2257, DOI 10.1089/neu.2009.1021; Sliker CW, 2008, RADIOGRAPHICS, V28, P1689, DOI 10.1148/rg.286085521; SMITH D R, 1969, Journal of Neurosurgery, V30, P664, DOI 10.3171/jns.1969.30.6.0664; Stalnaker IL., 1977, 770921 SAE, P303; Stalnaker R.L., 1973, 17 STAPP CAR CRASH C; STEIGER H J, 1989, Heart and Vessels, V5, P41, DOI 10.1007/BF02058357; Stemper BD, 2005, J BIOMECH, V38, P2491, DOI 10.1016/j.jbiomech.2004.10.021; Stemper BD, 2007, J TRAUMA, V62, P1171, DOI 10.1097/TA.0b013e31804d4950; Stemper BD, 2007, J BIOMECH, V40, P1806, DOI 10.1016/j.jbiomech.2006.07.005; Stemper BD, 2007, ANN BIOMED ENG, V35, P285, DOI 10.1007/s10439-006-9229-y; Stephens R.B., 1969, ARTERIES VEINS HUMAN; Suehiro E, 2003, J NEUROTRAUM, V20, P381, DOI 10.1089/089771503765172336; SUTTON RL, 1993, J NEUROTRAUM, V10, P135, DOI 10.1089/neu.1993.10.135; TAKAHASHI A, 1994, ARCH HISTOL CYTOL, V57, P341, DOI 10.1679/aohc.57.341; Takhounts Erik G, 2003, Stapp Car Crash J, V47, P107; Takhounts EG, 2008, STAPP CAR C, V52, P1; THUBRIKAR MJ, 1990, J BIOMECH, V23, P15, DOI 10.1016/0021-9290(90)90365-A; Tubbs RS, 2007, J NEUROSURG, V107, P155, DOI 10.3171/JNS-07/07/0155; Ueda Y, 2003, J NEUROSURG, V99, P899, DOI 10.3171/jns.2003.99.5.0899; UENO K, 1995, J NEUROTRAUM, V12, P695, DOI 10.1089/neu.1995.12.695; UNTERHARNSCHEIDT F, 1969, TEX REP BIOL MED, V27, P127; UNTERHARNSCHEIDT F, 1969, ACTA NEUROPATHOL, V12, P200, DOI 10.1007/BF00692508; Vance BM, 1927, ARCH SURG-CHICAGO, V14, P1023, DOI 10.1001/archsurg.1927.01130170071005; VOIGT GE, 1977, ACTA NEUROPATHOL, V39, P201, DOI 10.1007/BF00691698; Vossoughi J., 1996, TRAUMATIC BRAIN INJU, P207; Wagenseil JE, 2009, PHYSIOL REV, V89, P957, DOI 10.1152/physrev.00041.2008; WALMSLEY JG, 1983, STROKE, V14, P781, DOI 10.1161/01.STR.14.5.781; Wei EP, 2009, J NEUROTRAUM, V26, P527, DOI 10.1089/neu.2008.0797; WEI EP, 1980, CIRC RES, V46, P37, DOI 10.1161/01.RES.46.1.37; Weisbecker H, 2012, J MECH BEHAV BIOMED, V12, P93, DOI 10.1016/j.jmbbm.2012.03.012; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolff HG, 1936, PHYSIOL REV, V16, P0545, DOI 10.1152/physrev.1936.16.4.545; YAMASHIMA T, 1984, J NEUROL NEUROSUR PS, V47, P121, DOI 10.1136/jnnp.47.2.121; Yeoh S., 2011, ASME 2011 SUMM BIOEN; ZHANG ET, 1990, J ANAT, V170, P111; Zhang L., 2001, STAPP CAR CRASH J, V45; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zitnay JL, 2017, NAT COMMUN, V8, DOI 10.1038/ncomms14913; Zoghi-Moghadam M, 2009, COMPUT METHOD BIOMEC, V12, P1, DOI [10.1080/10255840802020420, 10.1080/10255840903064897]	220	15	15	3	8	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	APR	2019	64				SI		98	113		10.1016/j.clinbiomech.2018.02.011			16	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	HY6ON	WOS:000468249700013	29478776				2022-02-06	
J	Ellis, MJ; McDonald, PJ; Olson, A; Koenig, J; Russell, K				Ellis, Michael J.; McDonald, Patrick J.; Olson, Ashley; Koenig, James; Russell, Kelly			Cervical Spine Dysfunction Following Pediatric Sports-Related Head Trauma	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cervical spine dysfunction; pediatric; predictor; SCIWORA; sports-related concussion; whiplash	CORD-INJURY; RADIOGRAPHIC ABNORMALITY; CONCUSSION; CHILDREN; NEURAPRAXIA; SYMPTOMS; SCIWORA	Objective: To examine the prevalence of cervical spine injuries among children and adolescents referred with suspected and diagnosed sports-related concussion (SRC); and evaluate the effect of cervical spine dysfunction (CSD) on physician-documented clinical recovery following SRC. Setting: A multidisciplinary pediatric concussion program. Participants: A total of 266 patients (6-19 years) referred with suspected SRC. Design: A retrospective cohort study. Main Measures: CSD defined as neurological symptoms localized to the cervical spine or the presence of neck pain, headache, or dizziness and abnormal cervical spine examination findings; physician-documented clinical recovery. Results: One patient was diagnosed with a T1 compression fracture. Of the 246 patients diagnosed with SRC, 80 (32.5%) met the clinical criteria for CSD including 4 patients with central cord neuropraxia and 1 with a spinal cord injury without radiographic abnormality (SCIWORA). Excluding patients with central cord neuropraxia OR SCIWORA, patients with SRC with CSD took longer to achieve physician-documented clinical recovery (28.5 days vs 17 days, P < .0001) and were 3.95 times more likely to experience delayed physician-documented clinical recovery (>4 weeks postinjury) compared with those without CSD. Conclusions: Patients with suspected and diagnosed SRC can present with a wide spectrum of coincident cervical spine injuries. Cervical spine dysfunction may be a risk factor for delayed clinical recovery.	[Ellis, Michael J.] Univ Manitoba, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.; Russell, Kelly] Univ Manitoba, Pediat & Child Hlth, Winnipeg, MB, Canada; [Koenig, James] Univ Manitoba, Diagnost Radiol, Winnipeg, MB, Canada; [Ellis, Michael J.] Univ Manitoba, Sect Neurosurg, Winnipeg, MB, Canada; [Ellis, Michael J.; Koenig, James] Pan Clin, Pan Concuss Program, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada; [Ellis, Michael J.; Russell, Kelly] Childrens Hosp, Res Inst Manitoba, Winnipeg, MB, Canada; [Olson, Ashley] Univ Manitoba, Max Rady Coll Med, Winnipeg, MB, Canada; [Ellis, Michael J.; McDonald, Patrick J.; Russell, Kelly] Canada North Concuss Network, Winnipeg, MB, Canada; [Ellis, Michael J.; Koenig, James; Russell, Kelly] Univ Manitoba, Winnipeg, MB, Canada		Ellis, MJ (corresponding author), Pan Clin, Pan Concuss Program, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mellis3@panamclinic.com		Russell, Kelly/0000-0002-9159-9201			Anderson PA, 2010, J ORTHOP TRAUMA, V24, P100, DOI 10.1097/BOT.0b013e3181b16494; Babcock L, 2018, PEDIATR EMERG CARE, V34, P677, DOI 10.1097/PEC.0000000000000819; Boockvar JA, 2001, SPINE, V26, P2709, DOI 10.1097/00007632-200112150-00015; Bosch PP, 2002, SPINE, V27, P2788, DOI 10.1097/00007632-200212150-00009; Cantu RC, 2013, CURR SPORT MED REP, V12, P14, DOI 10.1249/JSR.0b013e31827dc1fb; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Chung S, 2011, J TRAUMA, V70, P873, DOI 10.1097/TA.0b013e3182108823; Cordingley D, 2016, J NEUROSURG-PEDIATR, V18, P693, DOI 10.3171/2016.5.PEDS16139; Davis GA, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097415; Ellis MJ, 2017, J NEUROSURG-PEDIATR, V19, P38, DOI 10.3171/2016.7.PEDS16310; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ellis MJ, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15600; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P248, DOI 10.3171/2015.1.PEDS14524; Iverson GL, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097729; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Morin Michael, 2016, J Sports Med (Hindawi Publ Corp), V2016, P1590161, DOI 10.1155/2016/1590161; O'Brien AM, 2018, APPL NEUROPSYCH-CHIL, V7, P208, DOI 10.1080/21622965.2017.1290529; Pang D, 2004, NEUROSURGERY, V55, P1325, DOI 10.1227/01.NEU.0000143030.85589.E6; PANG D, 1989, J TRAUMA, V29, P654, DOI 10.1097/00005373-198905000-00021; POLLACK IF, 1988, J NEUROSURG, V69, P177, DOI 10.3171/jns.1988.69.2.0177; Reneker Jennifer C, 2015, Inj Epidemiol, V2, P22; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Schneider KJ, 2014, BRIT J SPORT MED, V48, P1294, DOI 10.1136/bjsports-2013-093267; Stiell IG, 1997, CAN MED ASSOC J, V156, P1537; Torg JS, 1996, J BONE JOINT SURG AM, V78A, P1308, DOI 10.2106/00004623-199609000-00003; Torg JS, 1997, J NEUROSURG, V87, P843, DOI 10.3171/jns.1997.87.6.0843; Torg JS, 1997, CLIN SPORT MED, V16, P501, DOI 10.1016/S0278-5919(05)70037-5	32	15	15	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		103	110		10.1097/HTR.0000000000000411			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400013	30045221				2022-02-06	
J	Haarbauer-Krupa, J; King, TZ; Wise, J; Gillam, S; Trapani, J; Weissman, B; DePompei, R				Haarbauer-Krupa, Juliet; King, Tricia Z.; Wise, Justin; Gillam, Schauna; Trapani, Julie; Weissman, Barbara; DePompei, Roberta			Early Elementary School Outcome in Children With a History of Traumatic Brain Injury Before Age 6 Years	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						outcomes; pediatrics; preschool children; TBI; traumatic brain injury	YOUNG-CHILDREN; RISK-FACTORS; HEAD-INJURY; CHILDHOOD; TERM; IMPACT; VULNERABILITY; ADOLESCENTS; PREDICTORS; SEVERITY	Objective: To describe elementary school outcomes for children who experienced a traumatic brain injury (TBI) before age 6 years compared with a control group of children with orthopedic injuries. Participants: Children ages 6 to 9 years recruited from community and trauma registries in a large southeastern state. Design: Descriptive findings from the first year of a 3-year longitudinal study. Main Measures: Child assessment and parent report measures were administered to capture cognitive, language, reading, and behavior outcomes. Medical record review confirmed injuries and injury severity. Results: The TBI group (n = 39) had a mean age of 7.55 years (standard deviation = 1.29) and was 5.15 (standard deviation = 1.56) years postinjury. The TBI group had primarily classified as mild complicated TBI (63%). On average, children in both groups performed within normal limits on most cognitive, language, and reading measures. Group differences were identified in verbal IQ, receptive language, and reading comprehension, with robust performance differences in pragmatic language, story retell and word fluency, and parent report of executive functions. Conclusions: Findings indicate the importance of in-depth follow-up specialist assessments (eg, neuropsychologist and speech and language pathologists) to identify potential nuanced difficulties in children with mild complicated TBI that may be missed by general evaluations.	[Haarbauer-Krupa, Juliet; Weissman, Barbara] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Weissman, Barbara] Emory Univ, Sch Med, Childrens Ctr Neurosci Res Georgia, Atlanta, GA USA; [Haarbauer-Krupa, Juliet; Gillam, Schauna; Trapani, Julie; Weissman, Barbara] Childrens Healthcare Atlanta, Atlanta, GA USA; [King, Tricia Z.] Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA; [King, Tricia Z.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Wise, Justin] Oglethorpe Univ, Dept Psychol, Atlanta, GA USA; [DePompei, Roberta] Univ Akron, Sch Speech Language Pathol, Akron, OH 44325 USA		Haarbauer-Krupa, J (corresponding author), Emory Univ, Sch Med, Dept Pediat, 3172 Wicks Creek Trail, Marietta, GA 30062 USA.	jhkrupa@me.com			National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133G110109]	This study is sponsored by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (Formerly the National Institute National Institute on Disability and Rehabilitation Research), grant number H133G110109.	ABUAREFEH I, 1994, BRIT MED J, V309, P765, DOI 10.1136/bmj.309.6957.765; Anderson V, 2005, PEDIATRICS, V116, P1374, DOI 10.1542/peds.2004-1728; Anderson V, 2000, PEDIATR NEUROSURG, V32, P282, DOI 10.1159/000028956; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Anderson VA, 2004, BRAIN, V127, P2608, DOI 10.1093/brain/awh320; Anderson V, 2010, J PEDIATR PSYCHOL, V35, P716, DOI 10.1093/jpepsy/jsp100; Arroyos-Jurado E, 2000, J SCHOOL PSYCHOL, V38, P571, DOI 10.1016/S0022-4405(00)00053-4; Barnes MA, 1999, DEV NEUROPSYCHOL, V15, P1, DOI 10.1080/87565649909540737; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Blume HK, 2012, PEDIATRICS, V129, pE31, DOI 10.1542/peds.2011-1742; Brownell R., 2000, EXPRESSIVE ONE WORD; Carrow-Woolfolk E ., 1999, COMPREHENSIVE ASSESS; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catroppa C, 2009, FUTUR NEUROL, V4, P811, DOI 10.2217/FNL.09.52; Catts H W, 2000, Logoped Phoniatr Vocol, V25, P3, DOI 10.1080/140154300750045858; Clark E, 1997, CHILDHOOD TRAUMATIC, P342; Crowe C, 2015, HDB CLIN NEUROLOGY, V128; Crowe LM, 2014, J HEAD TRAUMA REHAB, V29, P217, DOI 10.1097/HTR.0b013e31829babfd; Dennis M, 1989, CLIN NEUROPSYCHOLOGY, P88; DePompei R, 2003, COMMUNICATION COMMUN; Dunn LM., 1981, PEABODY PICTURE VOCA; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2003, DEV NEUROPSYCHOL, V24, P669, DOI 10.1207/S15326942DN242&3_08; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Ewing-Cobbs Linda, 2002, Semin Pediatr Neurol, V9, P209, DOI 10.1053/spen.2002.35502; Faul M, 2010, TRAUMATIC BRAIN INJU; Fuentes M, 2017, PM&R, V9, pS176; Gagner C, 2015, J NEUROTRAUM, V32, P1539, DOI 10.1089/neu.2014.3753; Gioia GA, 2000, BEHAV RATING SCALE E; Gioia GA, 2010, J HEAD TRAUMA REHAB, V25, P433, DOI 10.1097/HTR.0b013e3181fbc272; Greenham M, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00022; Gronwall D, 1997, J INT NEUROPSYCH SOC, V6, P592; Haarbauer-Krupa J, 1984, HEAD INJURY REHABILI, P311; Harrison P. L., 2003, ADAPTIVE BEHAV ASSES, V2nd; Hotz G., 2010, PEDIAT TEST BRAIN IN; Hux K, 2013, BRAIN INJURY, V27, P1348, DOI 10.3109/02699052.2013.823657; Kacperski J, 2016, SEMIN PEDIATR NEUROL, V23, P27, DOI 10.1016/j.spen.2015.08.005; Kaufman AS, 1990, KAUFMAN BRIEF TEST I; Kehle T, 1997, CHILDHOOD TRAUMATIC, P342; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Lowenthal B., 1998, TRANSDISCIPLINARY J, V8, P377; Muscara F, 2009, NEUROPSYCHOL REHABIL, V19, P541, DOI 10.1080/09602010802365223; Prasad MR, 2017, J HEAD TRAUMA REHAB, V32, pE24, DOI 10.1097/HTR.0000000000000218; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P1371, DOI 10.1016/j.apmr.2012.02.031; Rosema S, 2012, J NEUROTRAUM, V29, P1277, DOI 10.1089/neu.2011.2144; Ryan NP, 2014, J NEUROTRAUM, V31, P649, DOI 10.1089/neu.2013.3153; Savage RC, 1995, PERSPECT NETW, pV; Schell A, 2016, OTOLARYNG HEAD NECK, V154, P175, DOI 10.1177/0194599815609114; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Shay N, 2014, J NEUROTRAUM, V31, P1305, DOI 10.1089/neu.2013.3275; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor HG, 2008, J INT NEUROPSYCH SOC, V14, P734, DOI 10.1017/S1355617708081150; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; Taylor HG, 2015, J HEAD TRAUMA REHAB, V4, P1; Tham SW, 2012, J NEUROTRAUM, V29, P154, DOI 10.1089/neu.2011.2126; Tonks J, 2009, DEV MED CHILD NEUROL, V51, P8, DOI 10.1111/j.1469-8749.2008.03219.x; Treble-Barna A., 2016, J NEUROTRAUM, V33, P1; Treble-Barna A, 2017, NEUROPSYCHOLOGY, V31, P486, DOI 10.1037/neu0000325; Wade SL, 2016, JAMA PEDIATR, V170, P343, DOI 10.1001/jamapediatrics.2015.4485; Wilde EA, 2012, MILD TRAUMATIC BRAIN, P3; Woodstock RW, 1987, WOODSTOCK READING MA; Yeates KO, 2010, NEUROPSYCHOLOGY, V24, P345, DOI 10.1037/a0018387; Yeates KO, 2002, NEUROPSYCHOLOGY, V16, P514, DOI 10.1037//0894-4105.16.4.514	63	15	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		111	121		10.1097/HTR.0000000000000414			11	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400014	30045217				2022-02-06	
J	Kaushal, M; Espana, LY; Nencka, AS; Wang, Y; Nelson, LD; McCrea, MA; Meier, TB				Kaushal, Mayank; Espana, Lezlie Y.; Nencka, Andrew S.; Wang, Yang; Nelson, Lindsay D.; McCrea, Michael A.; Meier, Timothy B.			Resting-state functional connectivity after concussion is associated with clinical recovery	HUMAN BRAIN MAPPING			English	Article						athletes; functional MRI; mild traumatic brain injury; postconcussion symptoms	TRAUMATIC BRAIN-INJURY; NETWORK; IMPACT; FMRI; RELIABILITY; ACCURATE; HISTORY; ROBUST; SPORT	There has been a recent call for longitudinal imaging studies to better characterize the time course of physiological recovery following sport-related concussion (SRC) and its relationship with clinical recovery. To address this, we evaluated changes to resting-state functional connectivity (rs-FC) of the whole-brain network following SRC and explored associations between rs-FC and measures of clinical outcome. High school and collegiate football athletes were enrolled during preseason. Athletes that suffered SRC (N = 62) were assessed across the acute (within 48 hr) and sub-acute (days 8, 15, and 45) phases. Matched football athletes without concussion served as controls (N = 60) and participated in similar visits. Multi-band resting-state fMRI was used to assess whole-brain rs-FC at each visit using network-based statistic and average nodal strength from regions of interest defined using a common whole-brain parcellation. Concussed athletes had elevated symptoms, psychological distress, and oculomotor, balance, and memory deficits at 48 hr postconcussion relative to controls, with diminished yet significant elevations in symptoms and psychological distress at 8 days. Both rs-FC analyses showed that concussed athletes had a global increase in connectivity at 8 days postconcussion relative to controls, with no differences at the 48-hr, 15-day, or 45-day visits. Further analysis revealed the group effect at the 8-day visit was driven by the large minority of concussed athletes still symptomatic at their visit; asymptomatic concussed athletes did not differ from controls. Findings from this large-scale, prospective study suggest whole-brain rs-FC alterations following SRC are delayed in onset but associated with the presence of self-reported symptoms.	[Kaushal, Mayank; Espana, Lezlie Y.; Nelson, Lindsay D.; McCrea, Michael A.; Meier, Timothy B.] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [Nencka, Andrew S.; Wang, Yang] Med Coll Wisconsin, Dept Radiol, 8700 W Wisconsin Ave, Milwaukee, WI 53226 USA; [Nelson, Lindsay D.; McCrea, Michael A.] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [Meier, Timothy B.] Med Coll Wisconsin, Dept Cell Biol Neurobiol & Anat, Milwaukee, WI 53226 USA		Meier, TB (corresponding author), Med Coll Wisconsin, 8701 Watertown Plank Rd, Milwaukee, WI 53226 USA.	tmeier@mcw.edu		Espana, Lezlie/0000-0002-6466-4653	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1TR001436]; National Center for Advancing Translational SciencesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS); Department of DefenseUnited States Department of Defense [W81XWH-14-1-0561]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001436] Funding Source: NIH RePORTER	National Institutes of Health, Grant/Award Number: UL1TR001436; National Center for Advancing Translational Sciences; Department of Defense, Grant/Award Number: W81XWH-14-1-0561	Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Birn RM, 2013, NEUROIMAGE, V83, P550, DOI 10.1016/j.neuroimage.2013.05.099; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Churchill NW, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-07742-3; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Craddock RC, 2012, HUM BRAIN MAPP, V33, P1914, DOI 10.1002/hbm.21333; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Greve DN, 2009, NEUROIMAGE, V48, P63, DOI 10.1016/j.neuroimage.2009.06.060; Hallquist MN, 2018, NETW NEUROSCI, V3, P1, DOI 10.1162/netn_a_00054; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Hillary FG, 2015, NEUROPSYCHOLOGY, V29, P59, DOI 10.1037/neu0000110; Iraji A, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/4072402; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Manning KY, 2017, NEUROLOGY, V89, P2157, DOI 10.1212/WNL.0000000000004669; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McCrea M, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097447; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Meier TB, 2017, J NEUROTRAUM, V34, P824, DOI 10.1089/neu.2016.4599; Messe A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065470; Mijalkov M, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0178798; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P791, DOI 10.1093/arclin/act077; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Taylor PA, 2013, BRAIN CONNECT, V3, P523, DOI 10.1089/brain.2013.0154; van den Heuvel MP, 2017, NEUROIMAGE, V152, P437, DOI 10.1016/j.neuroimage.2017.02.005; van der Horn HJ, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171031; WechslerD, 2001, WECHSLER TEST ADULT; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yan Y, 2017, J CLIN NEUROSCI, V44, P114, DOI 10.1016/j.jocn.2017.05.010; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zhu DC, 2015, J NEUROTRAUM, V32, P327, DOI 10.1089/neu.2014.3413	48	15	15	0	16	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	MAR	2019	40	4					1211	1220		10.1002/hbm.24440			10	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	HM4UM	WOS:000459470400012	30451340	Green Accepted, Bronze, Green Published			2022-02-06	
J	Rose, SC; Yeates, KO; Fuerst, DR; Ercole, PM; Nguyen, JT; Pizzimenti, NM				Rose, Sean C.; Yeates, Keith O.; Fuerst, Darren R.; Ercole, Patrick M.; Nguyen, Joseph T.; Pizzimenti, Natalie M.			Head Impact Burden and Change in Neurocognitive Function During a Season of Youth Football	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive performance; concussion; mild traumatic brain injury; pediatrics; subconcussive impacts	NEUROLOGIC FUNCTION; CLINICAL MEASURES; 1ST EXPOSURE; LATER-LIFE; CONCUSSION; SPORT; CONTACT; DEFICITS; AGE; PARTICIPATION	Objective: To determine the association of repetitive subconcussive head impacts with functional outcomes in primary and high school tackle football players. Setting: Youth football fields and an outpatient sports neurology clinic. Participants: A total of 112 primary school (n=55, age 9-12 years) and high school (n=57, age 15-18 years) football players. Design: A prospective cohort study. Main Measures: Helmet-based sensors were used to record head impacts during practices and games during the 2016 football season. Impact g-forces were summed to yield a measure of cumulative impact. History of self-reported premorbid medical diagnoses was obtained preseason. Players completed assessments of a variety of outcomes both pre-and postseason: neuropsychological test performance, symptoms, vestibular and ocular-motor screening, balance, parent-completed attention-deficit hyperactivity disorder (ADHD) symptoms, and self-reported behavioral adjustment. Results: Average cumulative impact was 3700 (standard deviation=2700) g-forces for the season and did not differ between age groups (P=.594). Cumulative impact did not predict pre-to postseason change scores on any outcome measures (all P >.05). Instead, younger age group and reported history of premorbid ADHD predicted change scores on several cognitive testing measures and parent-reported ADHD symptoms, while reported history of premorbid anxiety and depression predicted change scores on symptom reporting. Conclusions: In youth tackle football, subconcussive head impacts sustained over the course of a single season may not be associated with neurocognitive functional outcomes. The absence of a significant association may reflect the relatively short follow-up interval, and signals the need for studies across multiple seasons.	[Rose, Sean C.] Nationwide Childrens Hosp, Div Child Neurol, Columbus, OH USA; [Rose, Sean C.] Ohio State Univ, Columbus, OH 43210 USA; [Yeates, Keith O.] Univ Calgary, Alberta Childrens Hosp, Res Inst, Dept Psychol, Calgary, AB, Canada; Univ Calgary, Hotchkiss Brain Inst, Calgary, AB, Canada; [Fuerst, Darren R.] Wayne State Univ, Detroit, MI USA; [Fuerst, Darren R.] Dept Phys Med & Rehabil Beaumont, Detroit, MI USA; [Ercole, Patrick M.; Nguyen, Joseph T.] Sansom Consulting, Phoenix, AZ USA; [Pizzimenti, Natalie M.] MORE Fdn, Phoenix, AZ USA		Rose, SC (corresponding author), Nationwide Childrens Hosp, Dept Neurol, 700 Childrens Dr, Columbus, OH 43205 USA.	sean.rose@nationwidechildrens.org	Yeates, Keith/AAJ-4223-2020	Rose, Sean/0000-0001-5177-7715; Yeates, Keith/0000-0001-7680-2892			Alosco ML, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.197; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Broglio SP, 2016, J ATHL TRAINING, V51, P511, DOI 10.4085/1062-6050-51.7.04; Broglio SP, 2009, J ATHL TRAINING, V44, P497, DOI 10.4085/1062-6050-44.5.497; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Fishman M, 2017, J PEDIATR-US, V184, P19, DOI 10.1016/j.jpeds.2017.01.048; Goodman R, 1998, EUR CHILD ADOLES PSY, V7, P125, DOI 10.1007/s007870050057; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Gysland SM, 2012, ANN BIOMED ENG, V40, P14, DOI 10.1007/s10439-011-0421-3; Jennings D, 2015, INT J SPORTS PHYS TH, V10, P667; Martini DN, 2017, AM J SPORT MED, V45, P1420, DOI 10.1177/0363546516686785; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Mulligan I, 2012, J ORTHOP SPORT PHYS, V42, P625, DOI 10.2519/jospt.2012.3798; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Solomon GS, 2016, AM J SPORT MED, V44, P1106, DOI 10.1177/0363546515626164; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Swanson James M, 2012, Int J Educ Psychol Assess, V10, P51; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; USA Football, 2015, SPORTS FITN IND ASS	28	15	14	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2019	34	2			SI		87	95		10.1097/HTR.0000000000000441			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HU9CK	WOS:000465590400011	30320727				2022-02-06	
J	Wang, Y; Tye, AE; Zhao, JL; Ma, DQ; Raddant, AC; Bu, F; Spector, BL; Winslow, NK; Wang, MY; Russo, AF				Wang, Yan; Tye, Anne E.; Zhao, Junli; Ma, Dongqing; Raddant, Ann C.; Bu, Fan; Spector, Benjamin L.; Winslow, Nolan K.; Wang, Minyan; Russo, Andrew F.			Induction of calcitonin gene-related peptide expression in rats by cortical spreading depression	CEPHALALGIA			English	Article						CGRP; migraine; traumatic brain injury; post-traumatic headache; gene expression	TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; MIGRAINE; CGRP; TRIGGERS; PATHOPHYSIOLOGY; ACTIVATION; HEMORRHAGE; ANTIBODIES; ALLODYNIA	Objective The neuropeptide calcitonin gene-related peptide (CGRP) has now been established as a key player in migraine. However, the mechanisms underlying the reported elevation of CGRP in the serum and cerebrospinal fluid of some migraineurs are not known. A candidate mechanism is cortical spreading depression (CSD), which is associated with migraine with aura and traumatic brain injury. The aim of this study was to investigate whether CGRP gene expression may be induced by experimental CSD in the rat cerebral cortex. Methods CSD was induced by topical application of KCl and monitored using electrophysiological methods. Quantitative PCR and ELISA were used to measure CGRP mRNA and peptide levels in discrete ipsilateral and contralateral cortical regions of the rat brain 24 hours following CSD events and compared with sham treatments. Results The data show that multiple, but not single, CSD events significantly increase CGRP mRNA levels at 24 hours post-CSD in the ipsilateral rat cerebral cortex. Increased CGRP was observed in the ipsilateral frontal, motor, somatosensory, and visual cortices, but not the cingulate cortex, or contralateral cortices. CSD also induced CGRP peptide expression in the ipsilateral, but not contralateral, cortex. Conclusions Repeated CSD provides a mechanism for prolonged elevation of CGRP in the cerebral cortex, which may contribute to migraine and post-traumatic headache.	[Wang, Yan; Zhao, Junli; Ma, Dongqing; Bu, Fan; Wang, Minyan] Xian Jiaotong Liverpool Univ XJTLU, Ctr Neurosci, SIP, Suzhou 215123, Peoples R China; [Ma, Dongqing; Bu, Fan; Wang, Minyan] Xian Jiaotong Liverpool Univ XJTLU, Dept Biol Sci, SIP, Suzhou 215123, Peoples R China; [Tye, Anne E.; Russo, Andrew F.] Univ Iowa, Neurosci Program, Iowa City, IA 52242 USA; [Raddant, Ann C.; Spector, Benjamin L.; Winslow, Nolan K.; Russo, Andrew F.] Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA; [Russo, Andrew F.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA; [Russo, Andrew F.] Vet Affairs Med Ctr, Iowa City, IA 52246 USA		Russo, AF (corresponding author), Univ Iowa, Dept Mol Physiol & Biophys, Iowa City, IA 52242 USA.	andrew-russo@uiowa.edu		Bu, Fan/0000-0002-0051-6037; Russo, Andrew/0000-0002-8156-5649	Wangwenli Charitable Foundation [RD0006]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS075599]; Veterans Affairs Medical Center [1IO1RX002101]; Department of Defense USAMRAAUnited States Department of Defense [W81XWH-16-1-0071]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T35HL007485] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [T32NS045549, R01NS075599] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX002101] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: Wangwenli Charitable Foundation (RD0006), NIH (NS075599), Veterans Affairs Medical Center (1IO1RX002101), and Department of Defense USAMRAA (W81XWH-16-1-0071).	Ayata C, 2015, PHYSIOL REV, V95, P953, DOI 10.1152/physrev.00027.2014; Ayata C, 2013, CEPHALALGIA, V33, P604, DOI 10.1177/0333102412470216; Bellamy J, 2006, EUR J NEUROSCI, V23, P2057, DOI 10.1111/j.1460-9568.2006.04742.x; Bhatt DK, 2014, NEUROSCI LETT, V559, P99, DOI 10.1016/j.neulet.2013.11.057; Bigal ME, 2015, BRIT J CLIN PHARMACO, V79, P886, DOI 10.1111/bcp.12591; Bolay H, 2002, NAT MED, V8, P136, DOI 10.1038/nm0202-136; Borkum JM, 2016, HEADACHE, V56, P12, DOI 10.1111/head.12725; Charles A, 2009, CEPHALALGIA, V29, P1115, DOI 10.1111/j.1468-2982.2009.01983.x; Costa C, 2013, J HEADACHE PAIN, V14, DOI 10.1186/1129-2377-14-62; Cutrer FM, 2007, NEUROLOGIST, V13, P118, DOI 10.1097/01.nrl.0000252943.82792.38; Dirnagl U, 2010, J CEREBR BLOOD F MET, V30, P1, DOI [10.1038/jcbfm.2009.252, 10.1038/jcbfm.2010.191]; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Edvinsson L, 2015, BRIT J CLIN PHARMACO, V80, P193, DOI 10.1111/bcp.12618; Eiselt M, 2004, BRAIN RES, V1028, P83, DOI 10.1016/j.brainres.2004.09.002; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Fioravanti B, 2011, CEPHALALGIA, V31, P1090, DOI 10.1177/0333102411410609; Hadjikhani N, 2001, P NATL ACAD SCI USA, V98, P4687, DOI 10.1073/pnas.071582498; Hang CH, 2004, WORLD J GASTROENTERO, V10, P875; Hansen JM, 2014, CEPHALALGIA, V34, P695, DOI 10.1177/0333102413520084; Hansen JM, 2010, CEPHALALGIA, V30, P1179, DOI 10.1177/0333102410368444; Hartings JA, 2017, J CEREBR BLOOD F MET, V37, P1571, DOI 10.1177/0271678X16654495; Hartings JA, 2011, LANCET NEUROL, V10, P1058, DOI 10.1016/S1474-4422(11)70243-5; Jander S, 2001, J CEREBR BLOOD F MET, V21, P218, DOI 10.1097/00004647-200103000-00005; Karatas H, 2013, SCIENCE, V339, P1092, DOI 10.1126/science.1231897; Lassen LH, 2002, CEPHALALGIA, V22, P54, DOI 10.1046/j.1468-2982.2002.00310.x; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Noseda R, 2013, PAIN, V154, pS44, DOI 10.1016/j.pain.2013.07.021; Park KY, 2011, CEPHALALGIA, V31, P614, DOI 10.1177/0333102410391487; Pietrobon D, 2013, ANNU REV PHYSIOL, V75, P365, DOI 10.1146/annurev-physiol-030212-183717; PIPER RD, 1993, CEPHALALGIA, V13, P180, DOI 10.1046/j.1468-2982.1993.1303180.x; Raddant AC, 2014, HEADACHE, V54, P472, DOI 10.1111/head.12301; Rangel YM, 2001, MOL BRAIN RES, V88, P103, DOI 10.1016/S0169-328X(01)00037-7; Richter F, 2014, ANN NEUROL, V76, P43, DOI 10.1002/ana.24176; Russo AF, 2015, ANNU REV PHARMACOL, V55, P533, DOI 10.1146/annurev-pharmtox-010814-124701; Shatillo A, 2013, NEUROSCIENCE, V253, P341, DOI 10.1016/j.neuroscience.2013.09.002; Song Y, 2012, MOL MED REP, V5, P432, DOI 10.3892/mmr.2011.645; Takizawa T, 2016, CEPHALALGIA, V36, P44, DOI 10.1177/0333102415580100; Tepe N, 2015, EUR J NEUROSCI, V41, P120, DOI 10.1111/ejn.12753; Tozzi A, 2012, P NATL ACAD SCI USA, V109, P18985, DOI 10.1073/pnas.1215435109; Urbach A, 2006, EUR J NEUROSCI, V24, P841, DOI 10.1111/j.1460-9568.2006.04862.x; van Dongen RM, 2017, CEPHALALGIA, V37, P49, DOI 10.1177/0333102415625614; Vandesompele J, 2002, GENOME BIOL, V3, DOI 10.1186/gb-2002-3-7-research0034; Viggiano A, 2011, BRAIN RES, V1368, P11, DOI 10.1016/j.brainres.2010.10.062; von Baumgarten L, 2008, J CEREBR BLOOD F MET, V28, P1353, DOI 10.1038/jcbfm.2008.30; Wang MY, 2013, NEUROPEPTIDES, V47, P463, DOI 10.1016/j.npep.2013.10.006; Yisarakun W, 2015, NEUROPEPTIDES, V51, P9, DOI 10.1016/j.npep.2015.03.008; Zhang XC, 2011, ANN NEUROL, V69, P855, DOI 10.1002/ana.22329; Zhang XC, 2010, J NEUROSCI, V30, P8807, DOI 10.1523/JNEUROSCI.0511-10.2010	49	15	15	0	4	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0333-1024	1468-2982		CEPHALALGIA	Cephalalgia	MAR	2019	39	3					333	341		10.1177/0333102416678388			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN6LT	WOS:000460298300002	27919019	Green Accepted			2022-02-06	
J	Yang, MN; Clements-Nolle, K; Parrish, B; Yang, W				Yang, Max N.; Clements-Nolle, Kristen; Parrish, Brian; Yang, Wei			Adolescent Concussion and Mental Health Outcomes: A Population-based Study	AMERICAN JOURNAL OF HEALTH BEHAVIOR			English	Article						adolescent health; concussion; mental health; suicidal behaviors; YBRSS	TRAUMATIC BRAIN-INJURY; DEPRESSION; SPORT; PARTICIPATION; SUICIDE	Objectives: Population-based research on the relationship between concussions and self-harm, depression, and suicidal behaviors among adolescents is limited. Methods: A statewide Youth Risk Behavior Surveillance Survey (YRBSS) was conducted among students from 98 high schools in Nevada in 2017. Students were asked if they had a concussion from playing a sport as well as their mental health outcomes 12 months before the survey. Weighted multiple logistic regression was used to assess the relationship between experiencing a concussion and adverse mental health outcomes. Results: Among 3427 students who were physically active at least 60 minutes per day on 5 or more days per week, or played on at least one sport team, 19.5% (95% CI: 17.31%-21.60%) reported they had a concussion during the past 12 months. After controlling for sex, age, race/ethnicity, and academic performance, students who had a concussion had higher odds of: self-harm [aOR = 1.59 (1.16-2.17), p = .003], depressive symptoms [aOR = 1.48 (1.12-1.94), p = .006], attempted suicide [aOR = 3.10 (2.12-4.53), p < .001] and injury from attempted suicide [aOR = 2.61 (1.31-5.20), p = .006]. Conclusions: Students who experience a concussion may be at increased risk for poor mental health outcomes, including suicide attempts. Psychological evaluation following a concussion should complement medical evaluation and treatment..	[Yang, Max N.; Clements-Nolle, Kristen; Yang, Wei] Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA; [Parrish, Brian] Nevada State Div Publ & Behav Hlth, Carson City, NV USA		Yang, W (corresponding author), Univ Nevada, Sch Community Hlth Sci, Reno, NV 89557 USA.	weiyang@unr.edu			US Centers for Disease Control and PreventionUnited States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [CDC-PS13-1308]; Nevada State Division of Public and Behavioral Health [4332]	This research was partially supported by a grant from the US Centers for Disease Control and Prevention [CDC-PS13-1308] and received supplemental funding from the Nevada State Division of Public and Behavioral Health (work order 4332).	Babiss LA, 2009, J DEV BEHAV PEDIATR, V30, P376, DOI 10.1097/DBP.0b013e3181b33659; Brent DA, 2017, CURR PSYCHIAT REP, V19, DOI 10.1007/s11920-017-0862-y; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Clements-Nolle K, 2018, J ADOLESCENT HEALTH, V62, P198, DOI 10.1016/j.jadohealth.2017.09.022; Comstock R, 2015, NATL HIGH SCH SPORTS; DePadilla L, 2018, MMWR-MORBID MORTAL W, V67, P682, DOI 10.15585/mmwr.mm6724a3; Ellis MJ, 2015, J NEUROSURG-PEDIATR, V16, P709, DOI 10.3171/2015.5.PEDS15220; Emery CA, 2016, CAN J PSYCHIAT, V61, P259, DOI 10.1177/0706743716643741; Fazel S, 2014, JAMA PSYCHIAT, V71, P326, DOI 10.1001/jamapsychiatry.2013.3935; Fogelberg DJ, 2012, ARCH PHYS MED REHAB, V93, P1313, DOI 10.1016/j.apmr.2012.04.031; Fralick M, 2016, CAN MED ASSOC J, V188, P497, DOI 10.1503/cmaj.150790; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Ilie G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094936; Jewett R, 2014, J ADOLESCENT HEALTH, V55, P640, DOI 10.1016/j.jadohealth.2014.04.018; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; McPhie ML, 2015, J ADOLESCENCE, V40, P83, DOI 10.1016/j.adolescence.2015.01.008; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Mrazik M, 2016, ARCH CLIN NEUROPSYCH, V31, P297, DOI 10.1093/arclin/acw013; National Federation of State High School Associations (NFHS), HIGH SCH SPORTS PART; Rice SM, 2018, SPORTS MED, V48, P447, DOI 10.1007/s40279-017-0810-3; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Substance Abuse and Mental Health Services Administration (SAMHSA) Center for Behavioral Health Statistics and Quality, 2017, HHS PUBL, V17-5037; U.S Centers for Disease Control and Prevention, YOUTH RISK BEH SURV; US Centers for Disease Control and Prevention, TRAUM BRAIN INJ CONC; US Centers for Disease Control and Prevention, CDCS WISQARS WEB BAS; Weissman MM, 1999, JAMA-J AM MED ASSOC, V281, P1707, DOI 10.1001/jama.281.18.1707; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Zhang AL, 2016, ORTHOP J SPORTS MED, V4, DOI 10.1177/2325967116662458; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	30	15	15	4	17	PNG PUBLICATIONS	OAK RIDGE	2205-K OAK RIDGE RD, #115, OAK RIDGE, NC 27310 USA	1945-7359			AM J HEALTH BEHAV	Am. J. Health Behav.	MAR	2019	43	2					258	265		10.5993/AJHB.43.2.3			8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	HM9DE	WOS:000459782200003	30808466				2022-02-06	
J	Zonner, SW; Ejima, K; Fulgar, CC; Charleston, CN; Huibregtse, ME; Bevilacqua, ZW; Kawata, K				Zonner, Steven W.; Ejima, Keisuke; Fulgar, Ciara C.; Charleston, Carmen N.; Huibregtse, Megan E.; Bevilacqua, Zachary W.; Kawata, Keisuke			Oculomotor Response to Cumulative Subconcussive Head Impacts in US High School Football Players A Pilot Longitudinal Study	JAMA OPHTHALMOLOGY			English	Article							CONVERGENCE; CONCUSSION; POINT	IMPORTANCE Repetitive subconcussive head impacts in sports have emerged as a complex public health issue. Most of these head impacts remain asymptomatic yet have the potential to cause insidious neurological deficit if sustained repetitively. Near point of convergence (NPC) values have shown to reflect subclinical neuronal damage; however, the longitudinal pattern of NPC changes in association with subconcussive head impacts remains unclear. OBJECTIVES To examine the NPC response to recurring subconcussive head impacts in a single high school football season through a series of repeated measurements. DESIGN, SETTING, AND PARTICIPANTS This prospective case-series study of US varsity high school football players included baseline measurements of NPC, measurements at pregame and postgame points from 6 in-season games, and postseason follow-up measurements (a total of 14 points). An accelerometer-embedded mouthguard measured head impact frequency and magnitude from all practices and games. During the 6 games, players wore chest-strap heart rate monitors to record heart rate and estimate their excess postexercise oxygen consumption, accounting for possible physical exertion effects on NPC values. EXPOSURES Players participated in practices and games with no restrict on. MAIN OUTCOMES AND MEASURES Near point of convergence. RESULTS The 12 included players were all boys, with a mean (SD) age of 16.4 (0.5) years. A total of 8009 head impacts, 177 907g of peak linear acceleration, and 16 123 371 rad/s(2) of peak rotational acceleration were recorded from the players in a single football season. There was a significant increase in NPC over time until the middle of the season (mean [SD] NPC: baseline, 5.25 [1.49] cm; pregame 3, 6.42 [1.93] cm; P = .01), which was significantly associated with subconcussiye head impact frequency and magnitude (0.02 cm per 100 g of peak linear acceleration [SE, 0.0108; 95% CI, [0.0436-0.004]; P = .01; 0.023 cm per 10 000 rad/s(2) of peak rotational acceleration [SE, 0.009; 95% [I, 0.041-0.0105]; P = .02). However, NPC values began to normalize toward baseline level from midseason (mean [SD] NPC: baseline, 5.25 [1.49] cm; pregame 6, 5.75 [2.23] cm; P = .32), as supported by a significant quadratic trend (beta [SE], -0.002 [0.001] cm/d; P = .003), while participants continued to incur subconcussive head impacts. CONCLUSIONS AND RELEVANCE This longitudinal case series study suggests that NPC can be perturbed over the longterm by subconcussive head impacts but may normalize over time. The oculomotor system may have an adaptational capacity to subclinical head impacts, yet the mechanism for such remains an open question and warrants further investigation.	[Zonner, Steven W.] Washington Township Med Fdn, Dept Sports Med, Union City, CA USA; [Ejima, Keisuke] Indiana Univ, Dept Epidemiol & Biostat, Sch Publ Hlth, Bloomington, IN USA; [Fulgar, Ciara C.] Univ Calif Davis, Ctr Hlth & Environm, Davis, CA 95616 USA; [Charleston, Carmen N.] Irvington High Sch, Div Washington Sports Med, Fremont, CA USA; [Huibregtse, Megan E.; Bevilacqua, Zachary W.; Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth, Bloomington, IN 47405 USA; [Kawata, Keisuke] Indiana Univ, Neurosci Program, Coll Arts & Sci, Bloomington, IN USA		Kawata, K (corresponding author), Indiana Univ, Sch Publ Hlth, 1025 E 7th St,C215, Bloomington, IN 47405 USA.	kkawata@indiana.edu			Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health [0019939]; Indiana University School of Public Health faculty research grant program [2246237]	This work was supported from the Indiana Spinal Cord & Brain Injury Research Fund from the Indiana State Department of Health (grant 0019939; Dr Kawata) and Indiana University School of Public Health faculty research grant program (grant 2246237; Dr Kawata).	Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Capo-Aponte JE, 2018, MIL MED, V183, P9, DOI 10.1093/milmed/usx166; Capo-Aponte JE, 2012, MIL MED, V177, P804, DOI 10.7205/MILMED-D-12-00061; Carmer S. G., 1985, J AGRO EDU, V14, P19, DOI [10.2134/jae1985.0019, DOI 10.2134/JAE1985.0019]; Cheever KM, 2018, INT J SPORTS MED, V39, P141, DOI 10.1055/s-0043-118339; DuPrey KM, 2017, AM J SPORT MED, V45, P2388, DOI 10.1177/0363546517705640; Hedeker D., 2006, LONGITUDINAL DATA AN; HUNG GK, 1986, DOC OPHTHALMOL, V62, P165, DOI 10.1007/BF00229128; Johnson B, 2015, NEUROLOGY, V85, P1163, DOI 10.1212/WNL.0000000000001968; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Lipton ML, 2013, RADIOLOGY, V268, P850, DOI 10.1148/radiol.13130545; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; NCAA-Research, EST PROB COMP COLL A; Rusko H. K., 2003, Medicine & Science in Sports & Exercise, V35, pS183, DOI 10.1097/00005768-200305001-01014; Spiotta AM, 2012, NEUROSURGERY, V70, P1, DOI 10.1227/NEU.0b013e31823021b2; Storey EP, 2018, J NEUROL PHYS THER, V42, P134, DOI 10.1097/NPT.0000000000000228; Storey EP, 2017, OPTOMETRY VISION SCI, V94, P96, DOI 10.1097/OPX.0000000000000910; Williams CS, 2016, UNDERSEA HYPERBAR M, V43, P511	23	15	15	0	1	AMER MEDICAL ASSOC	CHICAGO	330 N WABASH AVE, STE 39300, CHICAGO, IL 60611-5885 USA	2168-6165	2168-6173		JAMA OPHTHALMOL	JAMA Ophthalmol.	MAR	2019	137	3					265	270		10.1001/jamaophthalmol.2018.6193			6	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	HO8LL	WOS:000461203100011	30570665	Bronze, Green Published			2022-02-06	
J	Brandi, G; Stocchetti, N; Pagnamenta, A; Stretti, F; Steiger, P; Klinzing, S				Brandi, Giovanna; Stocchetti, Nino; Pagnamenta, Alberto; Stretti, Federica; Steiger, Peter; Klinzing, Stephanie			Cerebral metabolism is not affected by moderate hyperventilation in patients with traumatic brain injury	CRITICAL CARE			English	Article						Traumatic brain injury; Hyperventilation; Intracranial pressure; Brain metabolites; Brain oxygenation; Transcranial color-coded duplex sonography	TISSUE OXYGEN-TENSION; HEAD-INJURY; BLOOD-FLOW; INTRACRANIAL-PRESSURE; PROLONGED HYPERVENTILATION; COMATOSE PATIENTS; CHILDREN	Hyperventilation-induced hypocapnia (HV) reduces elevated intracranial pressure (ICP), a dangerous and potentially fatal complication of traumatic brain injury (TBI). HV decreases the arteriolar diameter of intracranial vessels, raising the risk of cerebral ischemia. The aim of this study was to characterize the effects of moderate short-term HV in patients with severe TBI by using concomitant monitoring of cerebral metabolism, brain tissue oxygen tension (PbrO(2)), and cerebral hemodynamics with transcranial color-coded duplex sonography (TCCD). This prospective trial was conducted between May 2014 and May 2017 in the surgical intensive care unit (ICU) at the University Hospital of Zurich. Patients with nonpenetrating TBI older than 18 years of age with a Glasgow Coma Scale (GCS) score < 9 at presentation and with ICP monitoring, PbrO(2), and/or microdialysis (MD) probes during ICU admission within 36 h after injury were included in our study. Data collection and TCCD measurements were performed at baseline (A), at the beginning of moderate HV (C), after 50 min of moderate HV (D), and after return to baseline (E). Moderate HV was defined as arterial partial pressure of carbon dioxide 4-4.7 kPa. Repeated measures analysis of variance was used to compare variables at the different time points, followed by post hoc analysis with Bonferroni adjustment as appropriate. Eleven patients (64% males, mean age 36 +/- 14 years) with an initial median GCS score of 7 (IQR 3-8) were enrolled. During HV, ICP and mean flow velocity (CBFV) in the middle cerebral artery decreased significantly. Glucose, lactate, and pyruvate in the brain extracellular fluid did not change significantly, whereas PbrO(2) showed a statistically significant reduction but remained within the normal range. Moderate short-term hyperventilation has a potent effect on the cerebral blood flow, as shown by TCCD, with a concomitant ICP reduction. Under the specific conditions of this study, this degree of hyperventilation did not induce pathological alterations of brain metabolites and oxygenation.	[Brandi, Giovanna; Stretti, Federica; Steiger, Peter; Klinzing, Stephanie] Univ Hosp Zurich, Inst Intens Care Med, Ramistr 100, CH-8091 Zurich, Switzerland; [Stocchetti, Nino] Milan Univ, Dept Physiopathol & Transplantat, Milan, Italy; [Stocchetti, Nino] Neuro ICU Fdn IRCCSCa Granda Osped Maggiore Polic, Milan, Italy; [Pagnamenta, Alberto] Ente Osped Cantonale, Unit Clin Epidemiol, Bellinzona, Switzerland; [Stretti, Federica] Westmead Hosp, Dept Intens Care, Westmead, NSW 2145, Australia		Brandi, G (corresponding author), Univ Hosp Zurich, Inst Intens Care Med, Ramistr 100, CH-8091 Zurich, Switzerland.	giovanna.brandi@usz.ch					Ainslie PN, 2008, BRAIN RES, V1230, P115, DOI 10.1016/j.brainres.2008.07.048; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; Chesnut RM, 2018, J NEUROTRAUM, V35, P54, DOI 10.1089/neu.2016.4472; COLD GE, 1989, ACTA NEUROCHIR, V96, P100, DOI 10.1007/BF01456166; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; Diringer MN, 2000, J NEUROSURG, V92, P7, DOI 10.3171/jns.2000.92.1.0007; Eriksson EA, 2012, CLIN NEUROPHYSIOL, V123, P1255, DOI 10.1016/j.clinph.2011.08.035; Godoy DA, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00250; Hawryluk GWJ, 2016, J NEUROSURG, V125, P1217, DOI 10.3171/2015.7.JNS15809; Klinzing S, 2015, MINERVA ANESTESIOL, V81, P298; Le Roux P, 2014, INTENS CARE MED, V40, P1189, DOI 10.1007/s00134-014-3369-6; McCarville MB, 2008, PEDIATR BLOOD CANCER, V50, P818, DOI 10.1002/pbc.21430; Minhas JS, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aae469; Minhas JS, 2018, PHYSIOL MEAS, V39, DOI 10.1088/1361-6579/aac76b; Minhas JS, 2019, J CLIN ULTRASOUND, V47, P14, DOI 10.1002/jcu.22645; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; MUIZELAAR JP, 1988, J NEUROSURG, V69, P923, DOI 10.3171/jns.1988.69.6.0923; OBRIST WD, 1984, J NEUROSURG, V61, P241, DOI 10.3171/jns.1984.61.2.0241; Reinstrup P, 2000, NEUROSURGERY, V47, P701, DOI 10.1097/00006123-200009000-00035; Rohlwink UK, 2012, NEUROSURGERY, V70, P1220, DOI 10.1227/NEU.0b013e318243fc59; Rosenthal G, 2008, CRIT CARE MED, V36, P1917, DOI 10.1097/CCM.0b013e3181743d77; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Willie CK, 2012, J PHYSIOL-LONDON, V590, P3261, DOI 10.1113/jphysiol.2012.228551; Zweifel C, 2012, NEUROSURGERY, V71, P853, DOI 10.1227/NEU.0b013e3182675b42	26	15	18	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	FEB 13	2019	23								45	10.1186/s13054-018-2304-6			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	HL7KJ	WOS:000458919400002	30760295	Green Published, gold, Green Accepted			2022-02-06	
J	Bhowmick, S; D'Mello, V; Abdul-Muneer, PM				Bhowmick, Saurav; D'Mello, Veera; Abdul-Muneer, P. M.			Synergistic Inhibition of ERK1/2 and JNK, Not p38, Phosphorylation Ameliorates Neuronal Damages After Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Fluid percussion injury; Mitogen-activated protein kinase; Neurodegeneration	ACTIVATED PROTEIN-KINASE; NF-KAPPA-B; MAP KINASE; OXIDATIVE STRESS; SIGNALING PATHWAYS; ANIMAL-MODEL; IN-VITRO; NEUROINFLAMMATION; MECHANISMS; APOPTOSIS	Mitogen-activated protein (MAP) kinases are serine/threonine protein kinases that play a critical role in signal transduction and are activated by phosphorylation in response to a variety of pathophysiology stimuli. While MAP kinase signaling has a significant role in the pathophysiology of several neurodegenerative diseases, the precise function of activation of MAP kinase in traumatic brain injury (TBI) is unknown. Therefore, it is important to study the role of MAP kinase signaling in TBI-associated neurological ailments. In this study, using an in vitro stretch injury model in rat embryo neuronal cultures and the in vivo fluid percussion injury (FPI) model in rats, we explored the role of MAP kinase signaling in the mechanisms of cell death in TBI. Our study demonstrated that the stretch injury in vitro and FPI in vivo upregulated the phosphorylation of MAP kinase proteins ERK1/2 and JNK, but not p38. Using ERK1/2 inhibitor U0126, JNK inhibitor SP600125, and p38 inhibitor SB203580, we validated the role of MAP kinase proteins in the activation of NF-kB and caspase-3. By immunofluorescence and western blotting, further, we demonstrated the role of ERK1/2 and JNK phosphorylation in neurodegeneration by analyzing cell death proteins annexin V and Poly-ADP-Ribose-Polymerase p85. Interestingly, combined use of ERK1/2 and JNK inhibitors further attenuated the cell death in stretch-injured neurons. In conclusion, this study could establish the significance of MAP kinase signaling in the pathophysiology of TBI and may have significant implications for developing therapeutic strategies using ERK1/2 and JNK inhibitors for TBI-associated neurological complications.	[Bhowmick, Saurav; D'Mello, Veera; Abdul-Muneer, P. M.] Hackensack Meridian Hlth JFK Med Ctr, JFK Neurosci Inst, Lab CNS Injury & Repair, 65 James St, Edison, NJ 08820 USA		Abdul-Muneer, PM (corresponding author), Hackensack Meridian Hlth JFK Med Ctr, JFK Neurosci Inst, Lab CNS Injury & Repair, 65 James St, Edison, NJ 08820 USA.	Mohammed.Muneer@hackensackmeridian.org	Bhowmick, Saurav/Y-6011-2019	Abdul-Muneer, P. M/0000-0001-8231-4385	JFK Neuroscience Institute at Hackensack Meridian Health JFK Medical Center, Edison NJ	This work was funded by the JFK Neuroscience Institute at Hackensack Meridian Health JFK Medical Center, Edison NJ to P.M. Abdul-Muneer.	Abdul-Muneer PM, 2018, MOL NEUROBIOL, V55, P5937, DOI 10.1007/s12035-017-0811-0; Abdul-Muneer PM, 2018, MOL NEUROBIOL, V55, P5901, DOI 10.1007/s12035-017-0812-z; Abdul-Muneer PM, 2017, MOL NEUROBIOL, V54, P3964, DOI 10.1007/s12035-016-9949-4; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V62, P291, DOI 10.1016/j.bbi.2017.02.014; Abdul-Muneer PM, 2017, BRAIN BEHAV IMMUN, V59, P190, DOI 10.1016/j.bbi.2016.09.002; Abdul-Muneer PM, 2016, MOL NEUROBIOL, V53, P6106, DOI 10.1007/s12035-015-9520-8; Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Aikawa R, 1997, J CLIN INVEST, V100, P1813, DOI 10.1172/JCI119709; Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Augustine C, 2014, NEUROSCIENCE, V274, P1, DOI 10.1016/j.neuroscience.2014.05.009; Bhowmick S, 2018, BRAIN SCI, V8, DOI 10.3390/brainsci8010011; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; BOULTON TG, 1991, CELL, V65, P663, DOI 10.1016/0092-8674(91)90098-J; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Camello-Almaraz C, 2006, AM J PHYSIOL-CELL PH, V291, pC1082, DOI 10.1152/ajpcell.00217.2006; Chen X, 2010, BRAIN RES, V1357, P104, DOI 10.1016/j.brainres.2010.07.082; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Chernigovskaya EV, 2017, DOKL BIOCHEM BIOPHYS, V476, P296, DOI 10.1134/S1607672917050015; Cobb MH, 1999, PROG BIOPHYS MOL BIO, V71, P479, DOI 10.1016/S0079-6107(98)00056-X; Cooney SJ, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-155; Crown ED, 2008, EXP NEUROL, V213, P257, DOI 10.1016/j.expneurol.2008.05.025; Faul M, 2010, TRAUMATIC BRAIN INJU; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; Ghatan S, 2000, J CELL BIOL, V150, P335, DOI 10.1083/jcb.150.2.335; Glushakova OY, 2018, J NEUROTRAUM, V35, P157, DOI 10.1089/neu.2017.4999; Grewal SS, 1999, CURR OPIN NEUROBIOL, V9, P544, DOI 10.1016/S0959-4388(99)00010-0; Hayden MS, 2006, ONCOGENE, V25, P6758, DOI 10.1038/sj.onc.1209943; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hsieh HL, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-88; Huang QY, 2016, EXP NEUROL, V277, P296, DOI 10.1016/j.expneurol.2015.10.010; Ittner AA, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0149-z; Javelaud D, 2005, ONCOGENE, V24, P5742, DOI 10.1038/sj.onc.1208928; Johnson GVW, 2003, EXP NEUROL, V183, P263, DOI 10.1016/S0014-4886(03)00268-1; Kim EK, 2010, BBA-MOL BASIS DIS, V1802, P396, DOI 10.1016/j.bbadis.2009.12.009; Kim SJ, 2017, BIOCHEM BIOPH RES CO, V493, P358, DOI 10.1016/j.bbrc.2017.09.017; Koli K, 2008, ANTIOXID REDOX SIGN, V10, P333, DOI 10.1089/ars.2007.1914; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; KURINO M, 1995, J NEUROCHEM, V65, P1282; Liu YL, 2017, J NEUROTRAUM, V34, P2119, DOI 10.1089/neu.2016.4764; Lotocki G, 2009, J NEUROTRAUM, V26, P1123, DOI 10.1089/neu.2008.0802; Malinin NL, 1997, NATURE, V385, P540, DOI 10.1038/385540a0; Mattson MP, 2003, NEUROMOL MED, V4, P109, DOI 10.1385/NMM:4:1-2:109; McCubrey JA, 2006, ANTIOXID REDOX SIGN, V8, P1775, DOI 10.1089/ars.2006.8.1775; Morgan MJ, 2011, CELL RES, V21, P103, DOI 10.1038/cr.2010.178; Mori T, 2002, J CEREBR BLOOD F MET, V22, P444, DOI 10.1097/00004647-200204000-00008; Muneer PMA, 2012, ARTERIOSCL THROM VAS, V32, P1167, DOI 10.1161/ATVBAHA.112.247668; Namura S, 2001, P NATL ACAD SCI USA, V98, P11569, DOI 10.1073/pnas.181213498; Nateri AS, 2007, EMBO J, V26, P4891, DOI 10.1038/sj.emboj.7601911; Nicholls DG, 1998, BIOFACTORS, V8, P287, DOI 10.1002/biof.5520080317; Otani N, 2002, J CEREBR BLOOD F MET, V22, P327, DOI 10.1097/00004647-200203000-00010; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Perkins ND, 2007, NAT REV MOL CELL BIO, V8, P49, DOI 10.1038/nrm2083; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Rehman SU, 2018, CEREB CORTEX, V28, P2854, DOI 10.1093/cercor/bhx164; Robinson MJ, 1997, CURR OPIN CELL BIOL, V9, P180, DOI 10.1016/S0955-0674(97)80061-0; Rodriguez UA, 2018, J NEUROTRAUM, V35, P375, DOI 10.1089/neu.2017.5256; Salvador E, 2013, JOVE-J VIS EXP, DOI 10.3791/50928; Saporito MS, 2002, PROGR MED CHEM, V40, P23, DOI 10.1016/S0079-6468(08)70081-X; Schulze-Osthoff K, 1997, IMMUNOBIOLOGY, V198, P35, DOI 10.1016/S0171-2985(97)80025-3; Shih RH, 2015, FRONT MOL NEUROSCI, V8, DOI 10.3389/fnmol.2015.00077; Shultz SR, 2011, BEHAV BRAIN RES, V224, P326, DOI 10.1016/j.bbr.2011.06.012; Skaper SD, 1998, MOL CELL NEUROSCI, V12, P179, DOI 10.1006/mcne.1998.0714; Son Y, 2013, METHOD ENZYMOL, V528, P27, DOI 10.1016/B978-0-12-405881-1.00002-1; Sun J, 2016, J MOL NEUROSCI, V59, P90, DOI 10.1007/s12031-016-0717-8; Sweatt JD, 2004, CURR OPIN NEUROBIOL, V14, P311, DOI 10.1016/j.conb.2004.04.001; Tai TY, 2017, NEUROSCIENCE, V349, P35, DOI 10.1016/j.neuroscience.2017.02.024; Tavazzi B, 2005, NEUROSURGERY, V56, P582, DOI 10.1227/01.NEU.0000156715.04900.E6; Taylor DM, 2013, J NEUROSCI, V33, P2313, DOI 10.1523/JNEUROSCI.4965-11.2013; von Leden RE, 2017, J NEUROTRAUM, V34, P755, DOI 10.1089/neu.2016.4486; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Wang XT, 1998, BIOCHEM J, V333, P291, DOI 10.1042/bj3330291; Zanke BW, 1996, CURR BIOL, V6, P606, DOI 10.1016/S0960-9822(02)00547-X; Zhao WQ, 2002, NEUROBIOL DIS, V11, P166, DOI 10.1006/nbdi.2002.0520	74	15	15	0	1	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	FEB	2019	56	2					1124	1136		10.1007/s12035-018-1132-7			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN8TY	WOS:000460470300026	29873042				2022-02-06	
J	Fickling, SD; Smith, AM; Pawlowski, G; Hajra, SG; Liu, CC; Farrell, K; Jorgensen, J; Song, XW; Stuart, MJ; D'Arcy, RCN				Fickling, Shaun D.; Smith, Aynsley M.; Pawlowski, Gabriela; Hajra, Sujoy Ghosh; Liu, Careesa C.; Farrell, Kyle; Jorgensen, Janelle; Song, Xiaowei; Stuart, Michael J.; D'Arcy, Ryan C. N.			Brain vital signs detect concussion-related neurophysiological impairments in ice hockey	BRAIN			English	Article						quantified electroencephalography; cognitive evoked potentials; event-related potentials	WHITE-MATTER; IMPACTS	There is a growing demand for objective evaluations of concussion. We developed a portable evoked potential framework to extract brain vital signs' using electroencephalography. Brain vital signs were derived from well established evoked responses representing auditory sensation (N100), basic attention (P300), and cognitive processing (N400) amplitudes and latencies, converted to normative metrics (six total). The study evaluated whether concussion-related neurophysiological impairments were detected over the duration of ice hockey seasons using brain vital signs. Forty-seven Tier III, Junior A, male ice hockey players were monitored over two seasons. Twelve sustained concussions after baseline testing then completed post-injury and return-to-play assessments. Twenty-three were not diagnosed with a concussion during the season and completed both baseline and post-season testing. Scores were evaluated using a repeated-measures analysis of variance with post hoc two-tailed paired t-tests. Concussion resulted in significantly increased amplitude and delayed latency scores for all six brain vital signs (P < 0.0001). Importantly, significant changes at return-to-play were also detected in basic attention (P300) amplitude, indicating persistent subclinical impairment. In the non-concussed group, there was also a significant change between baseline and post-season (P = 0.0047), with specific decreases in cognitive processing (N400) speed (P = 0.011) and overall total score (P = 0.002).	[Fickling, Shaun D.; Pawlowski, Gabriela; Hajra, Sujoy Ghosh; Liu, Careesa C.; Song, Xiaowei; D'Arcy, Ryan C. N.] Simon Fraser Univ, Fac Sci Appl, Metro Vancouver, BC, Canada; [Fickling, Shaun D.; Pawlowski, Gabriela; Hajra, Sujoy Ghosh; Liu, Careesa C.; Song, Xiaowei; D'Arcy, Ryan C. N.] Surrey Mem Hosp, Fraser Hlth, Hlth Sci & Innovat, Metro Vancouver, BC, Canada; [Smith, Aynsley M.; Farrell, Kyle; Jorgensen, Janelle] Mayo Clin, Sports Med Ctr, Dept Orthoped Surg & Phys Med & Rehabil, Rochester, MN USA; [Stuart, Michael J.] Mayo Clin, Sports Med Ctr, Dept Orthoped Surg, Rochester, MN USA; [D'Arcy, Ryan C. N.] HealthTech Connex Inc, Surrey, BC, Canada		D'Arcy, RCN (corresponding author), Simon Fraser Univ, Fac Sci Appl, Metro Vancouver, BC, Canada.	rdarcy@sfu.ca			Mathematics of Information Technology and Complex Systems (MITACS) [IT03240]; Natural Sciences and Engineering Council Canada (NSERC)Natural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR); Johannson-Gund Endowment; USA Hockey	Financial support was provided by Mathematics of Information Technology and Complex Systems (MITACS, Grant #IT03240), Natural Sciences and Engineering Council Canada (NSERC), and Canadian Institutes for Health Research (CIHR) for this study. The research study was designed and carried out by the Mayo Clinic Sports Medicine Ice Hockey Research team, partially funded by USA Hockey and the Johannson-Gund Endowment.	Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Cassidy SM, 2012, PSYCHOPHYSIOLOGY, V49, P659, DOI 10.1111/j.1469-8986.2011.01349.x; Connolly JF, 2000, INT J PSYCHOPHYSIOL, V37, P31, DOI 10.1016/S0167-8760(00)00093-3; D'Arcy RCN, 2003, CLIN NEUROPHYSIOL, V114, P662, DOI 10.1016/S1388-2457(03)00007-5; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Davis PA, 1939, J NEUROPHYSIOL, V2, P494, DOI 10.1152/jn.1939.2.6.494; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Gavett B, 2012, NEUROSURGERY, V30, P1; Gawryluk JR, 2010, BMC NEUROL, V10, DOI 10.1186/1471-2377-10-11; Gawryluk JR, 2010, HDB PHYS MED BIOL, P548; Giza CC, 2015, NEUROSURGERY, V75, pS24, DOI DOI 10.1227/NEU.0000000000000505; Gosselin N, 2006, NEUROSURGERY, V58, P1151, DOI 10.1227/01.NEU.0000215953.44097.FA; Hajra SG, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00211; Hajra SG, 2018, J TRANSL MED, V16, DOI 10.1186/s12967-018-1527-2; He P, 2004, MED BIOL ENG COMPUT, V42, P407, DOI 10.1007/BF02344717; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; KUTAS M, 1980, SCIENCE, V207, P203, DOI 10.1126/science.7350657; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Ledwidge PS, 2016, J NEUROTRAUM, V33, P2081, DOI 10.1089/neu.2015.4251; Luck S.J, 2005, MONOGR SOC RES CHILD, V78, P388; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; Marchand Y, 2002, CLIN NEUROPHYSIOL, V113, P1715, DOI 10.1016/S1388-2457(02)00224-9; McCrory P, 2017, BRIT J SPORT MED, V51, P838, DOI 10.1136/bjsports-2017-097699; Moore RD, 2017, INT J PSYCHOPHYSIOL, V112, P22, DOI 10.1016/j.ijpsycho.2016.11.011; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Smith AM, 2017, CLIN J SPORT MED, V27, P503, DOI 10.1097/JSM.0000000000000412; SUTTON S, 1967, SCIENCE, V155, P1436, DOI 10.1126/science.155.3768.1436; Talavage TM, 2010, J NEUROTRAUM, V338, P1; Wilson MJ, 2015, SOUTH MED J, V108, P559, DOI 10.14423/SMJ.0000000000000342	30	15	16	0	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0006-8950	1460-2156		BRAIN	Brain	FEB	2019	142		2				255	262		10.1093/brain/awy317			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HQ7QT	WOS:000462616700012	30649205	Green Published, hybrid			2022-02-06	
J	Galliazzo, S; Bianchi, MD; Virano, A; Trucchi, A; Donadini, MP; Dentali, F; Bertu, L; Grandi, AM; Ageno, W				Galliazzo, S.; Bianchi, M. D.; Virano, A.; Trucchi, A.; Donadini, M. P.; Dentali, F.; Bertu, L.; Grandi, A. M.; Ageno, W.			Intracranial bleeding risk after minor traumatic brain injury in patients on antithrombotic drugs	THROMBOSIS RESEARCH			English	Article						Minor traumatic brain injury; Intracranial bleeding complications; Antithrombotic users; Brain computed tomography	CT HEAD RULE; EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; VISITS; IMPACT	Background: Intracranial haemorrhage (ICH) risk after minor traumatic brain injury (mTBI) in patients on antithrombotic treatment is unclear. We compared ICH rates in mTBI patients on single, double and no antithrombotic therapy. Antithrombotic drugs encompassed vitamin K antagonists (VKAs), direct oral anticoagulants (DOACs) and antiplatelets. Secondary aim was to identify potential predictors of ICH. Methods: We retrospectively analysed consecutive adults referred to our emergency department for mTBI. All clinical information was retrieved by patients' charts review. Patients were divided in 5 groups: 1) no antithrombotic users, 2) antiplatelet users, 3) vitamin K antagonist users, 4) direct oral anticoagulants users, and 5) double antithrombotic users. Results: A total of 1846 patients were enrolled, mean age 71 years (IQR 46-83); 1222 (66.2%) were in group 1, 407 (22.0%) in group 2, 120 (6.5%) in group 3, 51 (2.7%) in group 4 and 46 (2.5%) in group 5. At entry, 1387 (75.1%) patients underwent brain CT, 787 (64.4%) in group 1, 387 (95.1%) in group 2, 119 (99.2%) in group 3 and 51 (100%) in group 4 and 43 (93.5%) in group 5. ICH was documented in 36 patients (4.6%; CI 95%: 3.2-6.3) in group 1, 22 (5.9%; CI 95%: 3.6-8.5) in group 2, 5 (4.2%; CI 95%: 1.4-9.5) in group 3, 2 (3.9%; CI 95%: 0.5-13.5) in group 4 and 3 (7.0%; CI 95%: 1.5-19.1) in group 5 (p-value for across groups comparison = 0.86). At multivariable analysis GCS < 15 (OR 7.95 CI 95%: 3.12-20.28), post-traumatic amnesia (OR 6.49; CI 95%: 3.57-11.82), vomiting (OR 4.45 CI 95%: 1.47-13.50), clinical signs of cranial fractures (OR 8.41 CI 95%: 2.12-33.33), scalp lesions (OR 2.31 CI 95%: 1.09-4.89), but none of antithrombotic drugs were independently associated with ICH. Conclusion: mTBI-related ICH rate was similar in patients with and without antithrombotic use. Potential predictors of ICH can be drawn from patients' clinical examination.	Univ Insubria, Dept Med & Surg, Varese, Italy; Osped Circolo Varese, Emergency Dept, Varese, Italy		Galliazzo, S (corresponding author), ASST Settelaghi, Dipartimento Med & Chirurg, Viale Borri 57, I-21100 Varese, Italy.	sgalliazzo@studenti.uninsubria.it	Donadini, Marco P/Q-9599-2016				Brehaut JC, 2005, ACAD EMERG MED, V12, P948, DOI 10.1197/j.aem.2005.04.024; DeAngelis J, 2017, WEST J EMERG MED, V18, P821, DOI 10.5811/westjem.2017.6.33685; Department of Health and Human Service. Centers for Disease Control and Prevention, 2014, HEADS FACTS PHYS MIL; Fabbri A, 2010, J NEUROL NEUROSUR PS, V81, P1275, DOI 10.1136/jnnp.2009.197467; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; HODGKINSON S, 2014, BMJ-BRIT MED J, V348, DOI DOI 10.1136/BMJ.G104; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Kristman Vicki L, 2014, Arch Phys Med Rehabil, V95, pS265, DOI 10.1016/j.apmr.2013.04.026; Lambert L, 2017, WIEN KLIN WOCHENSCHR, V129, P159, DOI 10.1007/s00508-016-1025-6; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mason S, 2017, BMJ OPEN, V7, DOI 10.1136/bmjopen-2016-014324; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; National Institute for Health and Care Excellence (UK), 2014, HEAD INJ TRIAG ASS I; Pandor A, 2011, HEALTH TECHNOL ASSES, V15, P1, DOI 10.3310/hta15270; Smits M, 2007, ANN INTERN MED, V146, P397, DOI 10.7326/0003-4819-146-6-200703200-00004; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; van den Brand CL, 2017, J NEUROTRAUM, V34, P1, DOI 10.1089/neu.2015.4393; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	26	15	15	0	1	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0049-3848			THROMB RES	Thromb. Res.	FEB	2019	174						113	120		10.1016/j.thromres.2018.12.015			8	Hematology; Peripheral Vascular Disease	Science Citation Index Expanded (SCI-EXPANDED)	Hematology; Cardiovascular System & Cardiology	HJ1UD	WOS:000456949100019	30593997				2022-02-06	
J	Park, DW; Park, SH; Hwang, SK				Park, Dae-Won; Park, Seong-Hyun; Hwang, Sung-Kyoo			Serial measurement of S100B and NSE in pediatric traumatic brain injury	CHILDS NERVOUS SYSTEM			English	Article						Biomarkers; NSE; S100B; Traumatic brain injury	NEURON-SPECIFIC ENOLASE; BIOCHEMICAL SERUM MARKERS; PROTEIN; DAMAGE; MILD; S-100B; BLOOD; HEAD; BIOMARKERS; UTILITY	PurposeIncreased serum biomakers, such as S100 calcium-binding protein B (S100B) and neuron-specific enolase (NSE), are associated with traumatic brain injury (TBI). The purpose of this study is to investigate the serum levels of S100B and NSE in pediatric TBI patients and to predict a clinical outcome.MethodsPeripheral venous blood was collected within 6h of injury and at 1week to measure S100B and NSE. The serum S100B and NSE levels were measured using commercially available enzyme-linked immunosorbent assay kits. The authors divided participants into two groups at admission: a favorable group (patients with Glasgow Coma Scale [GCS] scores of 10-15) and an unfavorable group (patients with GCS scores of less than 9). Both S100B and NSE levels were compared between the two groups at the time of admission and 1week later.ResultsTen pediatric patients were enrolled (5 in the favorable group, 5 in the unfavorable group). The median serum S100B level of 134.21pg/ml (range, 51.00-789.65pg/ml) in patients with TBI at admission dropped to 41.49pg/ml (range, 25.65-260.93pg/ml) after 1week, with significant differences between the traumatic event and 1week later (p=0.007). The median serum NSE level of 14.76ng/ml (range, 6.48-21.23ng/ml) in patients with TBI at admission was higher than that after 1week (4.96ng/ml, range, 3.01-31.21ng/ml), with significant differences (p=0.015). A significant difference was observed in S100B after 1week between patients in the favorable and unfavorable groups (p=0.047). One patient whose serum S100B and NSE levels were elevated 1week after TBI eventually died.ConclusionsElevated serum S100B and NSE levels in pediatric TBI patients decreased 1week after traumatic events. The serum S100B level 1week after TBI was related to the severity of brain damage. These results indicated that serum S100B and NSE might play a role in predicting the prognosis and monitoring ongoing brain injury in pediatric TBI patients.	[Park, Dae-Won; Park, Seong-Hyun; Hwang, Sung-Kyoo] Kyungpook Natl Univ, Dept Neurosurg, Sch Med, 130 Dongdeok Ro, Daegu 41944, South Korea		Park, SH (corresponding author), Kyungpook Natl Univ, Dept Neurosurg, Sch Med, 130 Dongdeok Ro, Daegu 41944, South Korea.	nsdoctor@naver.com			Biomedical Research Institute grant, Kyungpook National University Hospital (2016) [2016-General-08]	This work was supported by Biomedical Research Institute grant (No. 2016-General-08), Kyungpook National University Hospital (2016).	Bandyopadhyay S, 2005, ACAD EMERG MED, V12, P732, DOI 10.1197/j.aem.2005.02.017; Beers SR, 2007, J NEUROTRAUM, V24, P97, DOI 10.1089/neu.2006.0055; Berger RP, 2010, DEV NEUROSCI-BASEL, V32, P396, DOI 10.1159/000316803; Berger RP, 2005, J NEUROSURG, V103, P61, DOI 10.3171/ped.2005.103.1.0061; Cotena S, 2006, J NEUROSURG, V104, P435, DOI 10.3171/ped.2006.104.6.435; de Kruijk JR, 2001, ACTA NEUROL SCAND, V103, P175, DOI 10.1034/j.1600-0404.2001.103003175.x; Gazzolo D, 2003, CLIN CHEM, V49, P967, DOI 10.1373/49.6.967; Graham EM, 2018, CURR OPIN PEDIATR, V30, P199, DOI 10.1097/MOP.0000000000000591; Herrmann M, 2000, J NEUROTRAUM, V17, P113, DOI 10.1089/neu.2000.17.113; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Ingebrigtsen T, 2003, RESTOR NEUROL NEUROS, V21, P171; Ingebrigtsen T, 2002, J TRAUMA, V52, P798, DOI 10.1097/00005373-200204000-00038; Jackson RGM, 2000, CLIN CHEM LAB MED, V38, P1165, DOI 10.1515/CCLM.2000.179; Kellermann I, 2016, CLIN NEUROL NEUROSUR, V145, P79, DOI 10.1016/j.clineuro.2016.04.005; Korfias S, 2007, INTENS CARE MED, V33, P255, DOI 10.1007/s00134-006-0463-4; Marchi N, 2003, RESTOR NEUROL NEUROS, V21, P109; Ramont L, 2005, CLIN CHEM LAB MED, V43, P1215, DOI 10.1515/CCLM.2005.210; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Savola O, 2004, J TRAUMA, V56, P1229, DOI 10.1097/01.TA.0000096644.08735.72; Serpero LD, 2015, CLIN CHIM ACTA, V444, P193, DOI 10.1016/j.cca.2015.02.028; Stalnacke BM, 2005, J REHABIL MED, V37, P300, DOI 10.1080/16501970510032910; Thelin EP, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1450-y; Thompson WH, 2016, NEUROIMAGE-CLIN, V12, P1004, DOI 10.1016/j.nicl.2016.05.005; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Vos PE, 2004, NEUROLOGY, V62, P1303, DOI 10.1212/01.WNL.0000120550.00643.DC	25	15	19	1	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0256-7040	1433-0350		CHILD NERV SYST	Childs Nerv. Syst.	FEB	2019	35	2					343	348		10.1007/s00381-018-3955-y			6	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	HJ4HU	WOS:000457135900020	30171330				2022-02-06	
J	Elbourn, E; Kenny, B; Power, E; Honan, C; McDonald, S; Tate, R; Holland, A; MacWhinney, B; Togher, L				Elbourn, Elise; Kenny, Belinda; Power, Emma; Honan, Cynthia; McDonald, Skye; Tate, Robyn; Holland, Audrey; MacWhinney, Brian; Togher, Leanne			Discourse recovery after severe traumatic brain injury: exploring the first year	BRAIN INJURY			English	Article						Traumatic brain injury; speech pathology; cognitive-communication; recovery; discourse	CLOSED-HEAD INJURY; COGNITIVE REHABILITATION; STORY NARRATIVES; MAIN CONCEPTS; OUTCOMES; LANGUAGE; ADULTS; TBI; CONSCIOUSNESS; IMPAIRMENT	Objectives: Although much is known about discourse impairment, little is known about discourse recovery after severe traumatic brain injury (TBI). This paper explores discourse recovery across the critical first year, controlling for pre-injury, injury and post-injury variables. Design and methods: An inception cohort comprising 57 participants with severe TBI was examined at 3, 6, 9 and 12 months post-injury and compared to a cross-section of matched healthy control participants. A narrative discourse task was analyzed with main concept analysis (MCA). A mixed linear model approach was used to track recovery controlling for pre-injury, injury and post-injury variables. Results: An upward trajectory of recovery was observed, with peak periods of improvement between 3-6 and 9-12 months and all time points were significantly below controls. Years of education and PTA duration were significant covariates in the recovery model. Presence of aphasia also influenced the recovery model. Conclusions: Individuals with TBI typically improve over the first year, however many will continue to have discourse deficits at 12 months. Years of education, PTA duration and aphasia should be considered when planning services. The 3-6- and 9-12-month periods may offer optimal periods for discourse recovery and increased supports may be beneficial between 6-9 months.	[Elbourn, Elise; Kenny, Belinda; Power, Emma; Tate, Robyn; Togher, Leanne] Univ Sydney, Fac Hlth Sci, Lidcombe, NSW, Australia; [Honan, Cynthia] Univ Tasmania, Sch Med, Hobart, Tas, Australia; [McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW, Australia; [Holland, Audrey] Univ Arizona, Speech Language & Hearing Sci, Tucson, AZ USA; [MacWhinney, Brian] Carnegie Mellon Univ, Dept Psychol, Pittsburgh, PA 15213 USA		Elbourn, E (corresponding author), Univ Sydney, Discipline Speech Pathol, Fac Hlth Sci, POB 170, Lidcombe, NSW 1825, Australia.	elise.elbourn@sydney.edu.au	Togher, Leanne/AAC-7083-2019; Power, Emma/A-9263-2015; Honan, Cynthia/O-6332-2017; McDonald, Skye/G-4118-2014	Togher, Leanne/0000-0002-4518-6748; Power, Emma/0000-0002-2638-0406; Honan, Cynthia/0000-0001-5735-4270; McDonald, Skye/0000-0003-0723-6094	National Health and Medical Research Council (NHMRC) Postgraduate ScholarshipNational Health and Medical Research Council of Australia [GNT1056000]; NHMRCNational Health and Medical Research Council of Australia [632681]; SEED Grant from the Moving Ahead NHMRC Centre of Research Excellence in Brain Recovery (2013)National Health and Medical Research Council of Australia; Postgraduate Student Research Grant from Speech Pathology Australia (2013)	This research was funded by a National Health and Medical Research Council (NHMRC) Postgraduate Scholarship (#GNT1056000) and an NHMRC Grant (#632681). Funding for transcription was provided by a SEED Grant from the Moving Ahead NHMRC Centre of Research Excellence in Brain Recovery (2013) and a Postgraduate Student Research Grant from Speech Pathology Australia (2013).	Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Bransby JJ, 2017, PERCEIVED COMMUNICAT; Braun CMJ, 1987, SUBCLINICAL APHASIA, P326; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; Campbell M., 2000, REHABILITATION TRAUM; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; COELHO CA, 1991, ARCH PHYS MED REHAB, V72, P465; Coelho CA, 2002, J SPEECH LANG HEAR R, V45, P1232, DOI 10.1044/1092-4388(2002/099); Coelho Carl, 2005, Seminars in Speech and Language, V26, P223, DOI 10.1055/s-2005-922102; Coelho Carl A., 2007, Seminars in Speech and Language, V28, P122, DOI 10.1055/s-2007-970570; Corrigan JD, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0000000000000020; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Cupit J, 2010, APHASIOLOGY, V24, P1486, DOI 10.1080/02687031003615235; Dahlberg CA, 2007, ARCH PHYS MED REHAB, V88, P1561, DOI 10.1016/j.apmr.2007.07.033; Dillow E., 2013, THESIS; Douglas JM, 2019, NEUROPSYCHOL REHABIL, V29, P73, DOI 10.1080/09602011.2016.1259114; Draper K, 2007, J HEAD TRAUMA REHAB, V22, P278, DOI 10.1097/01.HTR.0000290972.63753.a7; Elbourn E, 2017, INT J SPEECH-LANG PA, V19, P1, DOI 10.1080/17549507.2016.1193896; Enderby P, 2007, FRENCHAY DYSARTHRIA, V2; Enders CK, 2011, PSYCHOL METHODS, V16, P1, DOI 10.1037/a0022640; Forducey PG, 2003, NEUROREHABILITATION, V18, P103; Frasca Diana, 2013, Front Hum Neurosci, V7, P31, DOI 10.3389/fnhum.2013.00031; Fromm D, 2017, AM J SPEECH-LANG PAT, V26, P762, DOI 10.1044/2016_AJSLP-16-0071; Galski T, 1998, BRAIN INJURY, V12, P769, DOI 10.1080/026990598122160; Grimes, 2005, W DISNEYS CINDERELLA; HALPERN H, 1973, J SPEECH HEAR DISORD, V38, P162, DOI 10.1044/jshd.3802.162; HARTLEY L L, 1992, Brain Injury, V6, P271, DOI 10.3109/02699059209029669; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P369, DOI 10.1080/026990598122502; Hinchliffe FJ, 1998, BRAIN INJURY, V12, P109, DOI 10.1080/026990598122746; Jacobson NS, 1999, J CONSULT CLIN PSYCH, V67, P300, DOI 10.1037/0022-006X.67.3.300; Johnstone B, 2003, ARCH PHYS MED REHAB, V84, P238, DOI 10.1053/apmr.2003.50097; Katz DI, 2009, PROG BRAIN RES, V177, P73, DOI 10.1016/S0079-6123(09)17707-5; Kertesz A, 2012, W APHASIA BATTERY; Le K, 2011, APHASIOLOGY, V25, P748, DOI 10.1080/02687038.2010.539696; LeBlanc J, 2014, BRAIN INJURY, V28, P951, DOI 10.3109/02699052.2014.888760; Lippert-Gruner M, 2002, J REHABIL MED, V34, P211, DOI 10.1080/165019702760279198; Macdonald S, 2005, BRAIN INJURY, V19, P895, DOI 10.1080/02699050400004294; MacWhinney B, 2011, APHASIOLOGY, V25, P1286, DOI 10.1080/02687038.2011.589893; MALEC JF, 1993, BRAIN INJURY, V7, P383, DOI 10.3109/02699059309029682; Marsh NV, 1998, BRAIN INJURY, V12, P1045, DOI 10.1080/026990598121954; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Morley S, 2014, MANUAL LEEDS RELIABL; NICHOLAS LE, 1995, J SPEECH HEAR RES, V38, P146, DOI 10.1044/jshr.3801.145; PERDICES M, 2005, BRAIN IMPAIRMENT, V0006, P00219; Richardson JD, 2016, APHASIOLOGY, V30, P45, DOI 10.1080/02687038.2015.1057891; Salazar AM, 2000, JAMA-J AM MED ASSOC, V283, P3075, DOI 10.1001/jama.283.23.3075; SARNO MT, 1980, J NERV MENT DIS, V168, P685, DOI 10.1097/00005053-198011000-00008; Shek DTL, 2011, THESCIENTIFICWORLDJO, V11, P42, DOI 10.1100/tsw.2011.2; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Snow PC, 1999, APHASIOLOGY, V13, P529, DOI 10.1080/026870399401993; Snow PC, 2000, BRAIN INJURY, V14, P397; Stark JA, 2010, APHASIOLOGY, V24, P709, DOI 10.1080/02687030903524729; Steel J, 2017, BRAIN INJURY, V31, P1889, DOI 10.1080/02699052.2017.1373200; Stubbs E, 2018, BRAIN INJURY, V32, P167, DOI 10.1080/02699052.2017.1291989; TEASDALE G, 1974, LANCET, V2, P81; Temkin NR, 1999, J INT NEUROPSYCH SOC, V5, P357, DOI 10.1017/S1355617799544068; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Turkstra Lyn S., 2005, Seminars in Speech and Language, V26, P215, DOI 10.1055/s-2005-922101; Wallace SJ, 2014, APHASIOLOGY, V28, P1364, DOI 10.1080/02687038.2014.930262; Young E, 2017, DISCOURSE CHANGES FO; [No title captured]	64	15	15	1	10	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	JAN 28	2019	33	2					143	159		10.1080/02699052.2018.1539246			17	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HG9RL	WOS:000455346300005	30465440				2022-02-06	
J	Shaji, CA; Robinson, BD; Yeager, A; Beeram, MHR; Davis, ML; Isbell, CL; Huang, JH; Tharakan, B				Shaji, Chinchusha Anasooya; Robinson, Bobby D.; Yeager, Antonia; Beeram, Mad Hava R.; Davis, Matthew L.; Isbell, Claire L.; Huang, Jason H.; Tharakan, Binu			The Tri-phasic Role of Hydrogen Peroxide in Blood-Brain Barrier Endothelial cells	SCIENTIFIC REPORTS			English	Article							REACTIVE OXYGEN; OXIDATIVE STRESS; TRAUMATIC BRAIN; BIPHASIC REGULATION; FREE-RADICALS; HYPERPERMEABILITY; ANGIOGENESIS; MECHANISMS; APOPTOSIS; H2O2	Hydrogen peroxide (H2O2) plays an important role physiologically as the second messenger and pathologically as an inducer of oxidative stress in injury, ischemia and other conditions. However, it is unclear how H2O2 influences various cellular functions in health and disease differentially, particularly in the blood-brain barrier (BBB). We hypothesized that the change in cellular concentrations of H2O2 is a major contributor in regulation of angiogenesis, barrier integrity/permeability and cell death/apoptosis in BBB endothelial cells. Rat brain microvascular endothelial cells were exposed to various concentrations of H2O2 (1 nM to 25 mM). BBB tight junction protein (zonula ocludens-1; ZO-1) localization and expression, cytoskeletal organization, monolayer permeability, angiogenesis, cell viability and apoptosis were evaluated. H2O2 at low concentrations (0.001 mu M to 1 mu M) increased endothelial cell tube formation indicating enhanced angiogenesis. H2O2 at 100 mu M and above induced monolayer hyperpermeability significantly (p < 0.05). H2O2 at 10 mM and above decreased cell viability and induced apoptosis (p < 0.05). There was a decrease of ZO-1 tight junction localization with 100 mu m H2O2, but had no effect on protein expression. Cytoskeletal disorganizations were observed starting at 1 mu m. In conclusion H2O2 influences angiogenesis, permeability, and cell death/apoptosis in a tri-phasic and concentration-dependent manner in microvascular endothelial cells of the blood-brain barrier.	[Shaji, Chinchusha Anasooya; Robinson, Bobby D.; Yeager, Antonia; Davis, Matthew L.; Isbell, Claire L.; Tharakan, Binu] Texas A&M Univ, Coll Med, Dept Surg, Hlth Sci Ctr, Temple, TX 76508 USA; [Shaji, Chinchusha Anasooya; Robinson, Bobby D.; Yeager, Antonia; Beeram, Mad Hava R.; Davis, Matthew L.; Isbell, Claire L.; Huang, Jason H.; Tharakan, Binu] Baylor Scott & White Hlth, Temple, TX 76508 USA; [Beeram, Mad Hava R.] Texas A&M Univ, Coll Med, Dept Pediat, Hlth Sci Ctr, Temple, TX 76508 USA; [Huang, Jason H.] Texas A&M Univ, Coll Med, Dept Neurosurg, Hlth Sci Ctr, Temple, TX 76508 USA		Tharakan, B (corresponding author), Texas A&M Univ, Coll Med, Dept Surg, Hlth Sci Ctr, Temple, TX 76508 USA.; Tharakan, B (corresponding author), Baylor Scott & White Hlth, Temple, TX 76508 USA.	Binu.Tharakan@BSWHealth.org	Huang, Jason H/J-4739-2019	Huang, Jason H/0000-0002-4426-0168			Alluri H, 2016, J BIOL CHEM, V291, P26958, DOI 10.1074/jbc.M116.735365; Alluri H, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0154427; Alluri H, 2014, MICROCIRCULATION, V21, P187, DOI 10.1111/micc.12110; Apoptosis, 2010, NON TRADITIONAL REF, V2; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Chen X, 2012, NEUROSCIENCE, V226, P89, DOI 10.1016/j.neuroscience.2012.08.043; Clement MV, 1998, FEBS LETT, V440, P13, DOI 10.1016/S0014-5793(98)01410-0; COHEN G, 1994, ANN NY ACAD SCI, V738, P8; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Freeman LR, 2012, BBA-MOL BASIS DIS, V1822, P822, DOI 10.1016/j.bbadis.2011.12.009; Goldstein N, 2012, BIOCHEMISTRY-MOSCOW+, V77, P419, DOI 10.1134/S000629791205001X; Granger DN, 2015, REDOX BIOL, V6, P524, DOI 10.1016/j.redox.2015.08.020; HALLIWELL B, 1988, HUM TOXICOL, V7, P7, DOI 10.1177/096032718800700102; Huang SS, 2006, PHARMAZIE, V61, P223; Kevil CG, 1998, FREE RADICAL BIO MED, V24, P1015, DOI 10.1016/S0891-5849(97)00433-4; Kim YW, 2014, BLOOD, V123, P625, DOI 10.1182/blood-2013-09-512749; Larochelle C, 2011, FEBS LETT, V585, P3770, DOI 10.1016/j.febslet.2011.04.066; Lee HS, 2009, FEBS J, V276, P4622, DOI 10.1111/j.1742-4658.2009.07174.x; Lennicke C, 2015, CELL COMMUN SIGNAL, V13, DOI 10.1186/s12964-015-0118-6; Lewen A, 2000, J NEUROTRAUM, V17, P871, DOI 10.1089/neu.2000.17.871; Li JF, 2003, BRAIN RES BULL, V62, P101, DOI 10.1016/j.brainresbull.2003.08.011; Lochhead JJ, 2017, AAPS J, V19, P910, DOI 10.1208/s12248-017-0076-6; Lopez-Lazaro M, 2007, CANCER LETT, V252, P1, DOI 10.1016/j.canlet.2006.10.029; Luissint AC, 2012, FLUIDS BARRIERS CNS, V9, DOI 10.1186/2045-8118-9-23; Maulik N, 2002, ANTIOXID REDOX SIGN, V4, P805, DOI 10.1089/152308602760598963; MCCORD JM, 1993, CLIN BIOCHEM, V26, P351, DOI 10.1016/0009-9120(93)90111-I; Mu P, 2010, CELL BIOL INT, V34, P1013, DOI 10.1042/CBI20090092; Nitta T, 2003, J CELL BIOL, V161, P653, DOI 10.1083/jcb.200302070; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Park WH, 2013, INT J MOL MED, V31, P471, DOI 10.3892/ijmm.2012.1215; Pun PBL, 2009, FREE RADICAL RES, V43, P348, DOI 10.1080/10715760902751902; Quillinan Nidia, 2016, Anesthesiol Clin, V34, P453, DOI 10.1016/j.anclin.2016.04.011; Risau W, 1997, NATURE, V386, P671, DOI 10.1038/386671a0; Saito Y, 2006, FREE RADICAL RES, V40, P619, DOI 10.1080/10715760600632552; Siflinger-Birnboim A, 1996, New Horiz, V4, P87; SIFLINGERBIRNBOIM A, 1992, LAB INVEST, V67, P24; Stamatovic SM, 2016, TISSUE BARRIERS, V4, DOI 10.1080/21688370.2016.1154641; Teramoto S, 1999, JPN J PHARMACOL, V79, P33, DOI 10.1254/jjp.79.33; Tharakan B, 2010, SHOCK, V33, P56, DOI 10.1097/SHK.0b013e3181a7fb7c; Weidinger A, 2015, BIOMOLECULES, V5, P472, DOI 10.3390/biom5020472; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yasuda M, 1998, LIFE SCI, V64, P249, DOI 10.1016/S0024-3205(98)00560-8; Yoo SY, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/127170; Yun J, 2009, ANTIOXID REDOX SIGN, V11, P1961, DOI 10.1089/ARS.2009.2476; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097	45	15	15	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JAN 15	2019	9								133	10.1038/s41598-018-36769-3			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	HH3BJ	WOS:000455593600018	30644421	Green Published, gold			2022-02-06	
J	Anzalone, A; Carbuhn, A; Jones, L; Gallop, A; Smith, A; Johnson, P; Swearingen, L; Moore, C; Rimer, E; McBeth, J; Harris, W; Kirk, KM; Gable, D; Askow, A; Jennings, W; Oliver, JM				Anzalone, Anthony; Carbuhn, Aaron; Jones, Lauren; Gallop, Ally; Smith, Alex; Johnson, Palmer; Swearingen, Lisa; Moore, Craig; Rimer, Ernest; McBeth, Joe; Harris, William; Kirk, K. Michelle; Gable, David; Askow, Andrew; Jennings, Will; Oliver, Jonathan M.			The Omega-3 Index in National Collegiate Athletic Association Division I Collegiate Football Athletes	JOURNAL OF ATHLETIC TRAINING			English	Article						eicosapentaenoic acid; docosahexaenoic acid; cardiovascular disease risk; head impacts; concussion	DOCOSAHEXAENOIC ACID; EICOSAPENTAENOIC ACID; BLOOD-PRESSURE; FATTY-ACIDS; OMEGA-3-FATTY-ACIDS; SUPPLEMENTATION; EXERCISE; PLAYERS	Context: The essential omega-3 fatty acids (omega-3 FAs) eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA) exhibit vital biological roles and are critical for cardiovascular and neurologic health. Compared with the general population, football athletes may be at an increased risk of cardiovascular disease. Further, those same athletes are also exposed to repetitive head impacts, which may lead to long-term neurologic deficits. Both diets high in omega-3 FAs and supplementation with omega-3 FAs have been reported to reduce the risk of cardiovascular disease, and early evidence suggests a potential neuroprotective effect of supplementation. Objective: To determine the (1) erythrocyte content of DHA and EPA, as measured by the Omega-3 Index, expressed as a percentage of total fatty acids, in National Collegiate Athletic Association Division I football athletes and (2) distribution across the Omega-3 Index risk zones established for cardiovascular disease: high risk, <4%; intermediate risk, 4% to 8%; and low risk, >8%. Design: Cross-sectional descriptive study. Setting: Multicenter trial. Patients or Other Participants: Deidentified data including complete erythrocyte fatty acid profile from the 2017-2018 season, age at time of testing, height, weight, and ethnicity were collected from 404 athletes. Main Outcome Measure(s): Omega-3 Index. Results: About 34% of athletes (n = 138) had an Omega-3 Index considered high risk (<4%), and 66% (n = 266) had a risk considered intermediate (4%-8%). None had a low-risk Omega-3 Index. Conclusions: The Omega-3 Index is a simple, minimally invasive test of omega-3 FA status. Our data indicate that football athletes may be deficient in the omega-3 FAs DHA and EPA. The fact that no athlete had an Omega-3 Index associated with low risk suggests football athletes may be at increased risk for cardiovascular disease in later life.	[Anzalone, Anthony; Askow, Andrew; Jennings, Will; Oliver, Jonathan M.] Texas Christian Univ, Sport Sci Ctr, Box 297730, Ft Worth, TX 76129 USA; [Carbuhn, Aaron] Univ Kansas, Med Ctr, Dept Dietet & Nutr, Kansas City, KS 66103 USA; [Jones, Lauren; Gallop, Ally; Smith, Alex; Moore, Craig; Rimer, Ernest; McBeth, Joe] Univ Utah Athlet, Salt Lake City, UT USA; [Johnson, Palmer] Univ Missouri, Athlet, Columbia, MO USA; [Swearingen, Lisa] Univ South Carolina Athlet, Columbia, SC USA; [Harris, William] Univ South Dakota, Sanford Sch Med, Dept Internal Med, Vermillion, SD USA; [Harris, William; Gable, David] OmegaQuant LLC, Sioux Falls, SD USA; [Kirk, K. Michelle] Texas Christian Univ, Athlet, Ft Worth, TX 76129 USA; [Kirk, K. Michelle] Texas Christian Univ, JPS Sports Med Fellowship, Ft Worth, TX 76129 USA		Oliver, JM (corresponding author), Texas Christian Univ, Sport Sci Ctr, Box 297730, Ft Worth, TX 76129 USA.	jonathan.oliver@tcu.edu	Harris, William Stephen/T-1674-2019	Harris, William Stephen/0000-0003-3042-9353; Askow, Andrew/0000-0002-0757-8943	Brain Armor Foundation	This study was partially funded by the Brain Armor Foundation.	ABDELHAMID AS, 2018, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD012345.PUB2; Arterburn LM, 2006, AM J CLIN NUTR, V83, p1467S, DOI 10.1093/ajcn/83.6.1467S; Bailes JE, 2010, J NEUROTRAUM, V27, P1617, DOI 10.1089/neu.2009.1239; Blasbalg TL, 2011, AM J CLIN NUTR, V93, P950, DOI 10.3945/ajcn.110.006643; Buell JL, 2008, J ATHL TRAINING, V43, P608, DOI 10.4085/1062-6050-43.6.608; Burdge GC, 2002, BRIT J NUTR, V88, P355, DOI 10.1079/BJN2002662; Crouse SF, 2016, AM J CARDIOL, V117, P131, DOI 10.1016/j.amjcard.2015.09.049; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Desai A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086472; Fenton JI, 2016, PROSTAG LEUKOTR ESS, V112, P12, DOI 10.1016/j.plefa.2016.06.004; Harp JB, 2005, JAMA-J AM MED ASSOC, V293, P1061, DOI 10.1001/jama.293.9.1061-b; Harris WS, 2008, AM J CLIN NUTR, V87, p1997S, DOI 10.1093/ajcn/87.6.1997S; Harris WS, 2017, ATHEROSCLEROSIS, V262, P51, DOI 10.1016/j.atherosclerosis.2017.05.007; Kim JH, 2018, J AM HEART ASSOC, V7, DOI 10.1161/JAHA.118.008620; Leslie MA, 2015, LIPIDS HEALTH DIS, V14, DOI 10.1186/s12944-015-0049-7; Lewis M, 2013, AM J EMERG MED, V31, DOI 10.1016/j.ajem.2012.05.014; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Metcalf RG, 2010, AM J CLIN NUTR, V91, P528, DOI 10.3945/ajcn.2009.28302; Miller PE, 2014, AM J HYPERTENS, V27, P885, DOI 10.1093/ajh/hpu024; Montenigro PH, 2017, J NEUROTRAUM, V34, P328, DOI 10.1089/neu.2016.4413; Nikolaidis MG, 2004, SPORTS MED, V34, P1051, DOI 10.2165/00007256-200434150-00004; Norton K, 2001, SPORTS MED, V31, P763, DOI 10.2165/00007256-200131110-00001; Oliver JM, J NEUROSURG, DOI [10.3171/2017.12JNS172035, DOI 10.3171/2017.12JNS172035]; Oliver JM, 2018, SPORTS MED, V48, pS39, DOI 10.1007/s40279-017-0847-3; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Oliver JM, 2016, MED SCI SPORT EXER, V48, P974, DOI 10.1249/MSS.0000000000000875; Oliver JM, 2012, J ATHL TRAINING, V47, P257, DOI 10.4085/1062-6050-47.3.12; Roberts L, 2008, J AM COLL SURGEONS, V207, P276, DOI 10.1016/j.jamcollsurg.2008.02.015; Schober ME, 2016, J NEUROTRAUM, V33, P390, DOI 10.1089/neu.2015.3945; Smith DH, 2000, NEUROSCIENTIST, V6, P483, DOI 10.1177/107385840000600611; Stark KD, 2016, PROG LIPID RES, V63, P132, DOI 10.1016/j.plipres.2016.05.001; von Schacky C, 2014, INT J SPORT NUTR EXE, V24, P559, DOI 10.1123/ijsnem.2014-0041; Wang T, 2013, RESTOR NEUROL NEUROS, V31, P647, DOI 10.3233/RNN-130316; Wu A, 2013, NEUROSCIENCE, V248, P655, DOI 10.1016/j.neuroscience.2013.06.041; Yamamoto Joelle B, 2008, Res Sports Med, V16, P111, DOI 10.1080/15438620802103320	35	15	15	0	4	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JAN	2019	54	1					7	11		10.4085/1062-6050-387-18			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HO1BA	WOS:000460639000002	30645147	gold, Green Published			2022-02-06	
J	Braeckman, K; Descamps, B; Pieters, L; Vral, A; Caeyenberghs, K; Vanhove, C				Braeckman, Kim; Descamps, Benedicte; Pieters, Leen; Vral, Anne; Caeyenberghs, Karen; Vanhove, Christian			Dynamic changes in hippocampal diffusion and kurtosis metrics following experimental mTBI correlate with glial reactivity	NEUROIMAGE-CLINICAL			English	Article						Mild traumatic brain injury; Diffusion magnetic resonance imaging; DTI; DKI; White matter model	TRAUMATIC BRAIN-INJURY; MATTER TRACT INTEGRITY; WHITE-MATTER; AXONAL INJURY; BIDIRECTIONAL CHANGES; COGNITIVE IMPAIRMENT; TENSOR; MRI; IMPACT; PARAMETERS	Diffusion magnetic resonance imaging biomarkers can provide quantifiable information of the brain tissue after a mild traumatic brain injury (mTBI). However, the commonly applied diffusion tensor imaging (DTI) model is not very specific to changes in the underlying cellular structures. To overcome these limitations, other diffusion models have recently emerged to provide a more complete view on the damage profile following TBI. In this study, we investigated longitudinal changes in advanced diffusion metrics following experimental mTBI, utilising three different diffusion models in a rat model of mTBI, including DTI, diffusion kurtosis imaging and a white matter model. Moreover, we investigated the association between the diffusion metrics with histological markers, including glial fibrillary acidic protein (GFAP), neurofilaments and synaptophysin in order to investigate specificity. Our results revealed significant decreases in mean diffusivity in the hippocampus and radial diffusivity and radial extra axonal diffusivity (RadEAD) in the cingulum one week post injury. Furthermore, correlation analysis showed that increased values of fractional anisotropy one day post injury in the hippocampus was highly correlated with GFAP reactivity three months post injury. Additionally, we observed a positive correlation between GFAP on one hand and the kurtosis parameters in the hippocampus on the other hand three months post injury. This result indicated that prolonged glial activation three months post injury is related to higher kurtosis values at later time points. In conclusion, our findings point out to the possible role of kurtosis metrics as well as metrics from the white matter model as prognostic biomarker to monitor prolonged glial reactivity and inflammatory responses after a mTBI not only at early timepoints but also several months after injury.	[Braeckman, Kim; Descamps, Benedicte; Vanhove, Christian] UGent, Infin Lab, Med Imaging & Signal Proc Grp, Ghent, Belgium; [Pieters, Leen; Vral, Anne] UGent, Dept Human Struct & Repair, Ghent, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Mary MacKillop Inst Hlth Res, Melbourne, Vic, Australia; [Braeckman, Kim; Descamps, Benedicte] MEDISIP IBiTech, Infin Lab, Blok B-5,Ingang 36,Campus UZ Gent, B-9000 Ghent, Belgium; [Pieters, Leen; Vral, Anne] Dept Human Struct & Repair, Radiobiol Res Unit, 6B3,Ingang 46,Campus UZ Gent, B-9000 Ghent, Belgium; [Caeyenberghs, Karen] Mary MacKillop Insitute Hlth Res, Bldg 470,Level 5,Room 470-5-02,215 Spring St, Melbourne, Vic 3000, Australia		Braeckman, K (corresponding author), UGent, Infin Lab, Med Imaging & Signal Proc Grp, Ghent, Belgium.	kim.braeckman@ugent.be; benedicte.descamps@ugent.be; leen.pieters@ugent.be; anne.vral@ugent.be; karen.caeyenberghs@acu.edu.au; christian.vanhove@ugent.be	Vral, Anne/R-5778-2019	Descamps, Benedicte/0000-0001-8879-1772; Vanhove, Christian/0000-0002-3988-5980	Research Foundation - Flanders (FWO)FWO [G027815N]	This work was supported by the Research Foundation - Flanders (FWO) [grant number G027815N].	Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Asken BM, 2018, BRAIN IMAGING BEHAV, V12, P585, DOI 10.1007/s11682-017-9708-9; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Billiet T, 2015, NEUROBIOL AGING, V36, P2107, DOI 10.1016/j.neurobiolaging.2015.02.029; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Burda JE, 2016, EXP NEUROL, V275, P305, DOI 10.1016/j.expneurol.2015.03.020; Chung S, 2018, J NEUROTRAUM, V35, P1015, DOI 10.1089/neu.2017.5320; de Kouchkovsky I, 2016, J NEUROL, V263, P1146, DOI 10.1007/s00415-016-8118-z; De Santis S, 2014, NEUROIMAGE, V89, P35, DOI 10.1016/j.neuroimage.2013.12.003; Dewan MC, 2016, WORLD NEUROSURG, V91, P497, DOI 10.1016/j.wneu.2016.03.045; Duricki DA, 2016, NAT PROTOC, V11, P1112, DOI 10.1038/nprot.2016.048; Fieremans E, 2013, AM J NEURORADIOL, V34, P2105, DOI 10.3174/ajnr.A3553; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Grossman EJ, 2013, AM J NEURORADIOL, V34, P951, DOI 10.3174/ajnr.A3358; Grossman EJ, 2015, NEUROIMAGE, V118, P334, DOI 10.1016/j.neuroimage.2015.05.061; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guglielmetti C, 2016, NEUROIMAGE, V125, P363, DOI 10.1016/j.neuroimage.2015.10.052; Harris NG, 2016, NEUROIMAGE, V133, P129, DOI 10.1016/j.neuroimage.2016.03.012; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hutchinson EB, 2018, J NEUROSCI RES, V96, P612, DOI 10.1002/jnr.24065; Jelescu IO, 2016, NEUROIMAGE, V132, P104, DOI 10.1016/j.neuroimage.2016.02.004; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Kelma ND, 2016, NEUROIMAGE, V124, P612, DOI 10.1016/j.neuroimage.2015.09.028; Lazar M, 2014, NEUROIMAGE-CLIN, V4, P417, DOI 10.1016/j.nicl.2014.01.014; Lebel C, 2012, NEUROIMAGE, V60, P340, DOI 10.1016/j.neuroimage.2011.11.094; Lebel C, 2019, NMR BIOMED, V32, DOI 10.1002/nbm.3778; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; Li SX, 2013, INT J LEGAL MED, V127, P159, DOI 10.1007/s00414-012-0712-8; Li XY, 2009, J CLIN NEUROSCI, V16, P614, DOI 10.1016/j.jocn.2008.08.005; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Loening Andreas Markus, 2003, Mol Imaging, V2, P131, DOI 10.1162/153535003322556877; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; McDonald JH, 2014, HDB BIOL STAT, P233; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Novikov DS, 2018, MAGN RESON MED, V79, P3172, DOI 10.1002/mrm.27101; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Qin Y, 2018, BEHAV BRAIN RES, V340, P41, DOI 10.1016/j.bbr.2016.08.008; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Siedler DG, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00429; Singh K, 2016, EXP NEUROL, V275, P427, DOI 10.1016/j.expneurol.2015.07.016; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Szczepankiewicz F, 2013, NEUROIMAGE, V76, P145, DOI 10.1016/j.neuroimage.2013.02.078; Thurman DJ, 2016, J CHILD NEUROL, V31, P20, DOI 10.1177/0883073814544363; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Veraart J, 2016, NEUROIMAGE, V142, P384, DOI 10.1016/j.neuroimage.2016.08.016; Veraart J, 2016, MAGN RESON MED, V76, P1582, DOI 10.1002/mrm.26059; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Veraart J, 2011, MAGN RESON MED, V65, P138, DOI 10.1002/mrm.22603; Wallace EJ, 2018, BRAIN IMAGING BEHAV, V12, P1607, DOI 10.1007/s11682-018-9823-2; Yu FS, 2017, J NEUROTRAUM, V34, P1364, DOI 10.1089/neu.2016.4569; Zhang S, 2018, IRAN J RADIOL, V15, P1, DOI [10.5812/iranjradiol.56115.Research, DOI 10.5812/IRANJRADIOL.56115.RESEARCH]; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	56	15	15	0	6	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	21								101669	10.1016/j.nicl.2019.101669			12	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HN6ZP	WOS:000460337700082	30658945	gold, Green Published			2022-02-06	
J	Brown, JB; Kheng, M; Carney, NA; Rubiano, AM; Puyana, JC				Brown, Joshua B.; Kheng, Marin; Carney, Nancy A.; Rubiano, Andres M.; Puyana, Juan Carlos			Geographical Disparity and Traumatic Brain Injury in America: Rural Areas Suffer Poorer Outcomes	JOURNAL OF NEUROSCIENCES IN RURAL PRACTICE			English	Article						Disparity; geographic; lower-middle-income countries; rural; traumatic brain injury	INCOME COUNTRIES; HEAD-INJURY; GUIDELINES; MANAGEMENT; CARE; URBAN; EPIDEMIOLOGY	Introduction: Significant heterogeneity exists in traumatic brain injury (TBI) outcomes. In the United States, TBI remains a primary driver of injury-related mortality and morbidity. Prior work has suggested that disparity exists in rural areas; our objective was to evaluate potential differences in TBI mortality across urban and rural areas on a national scale. Methods: Age-adjusted TBI fatality rates were obtained at the county level across the U.S. from 2008 to 2014. To evaluate geography, urban influence codes (UIC) were also obtained at the county level. UIC codes range from 1 (most urban) to 12 (most rural). Metropolitan counties are defined as those with an UIC <= 2, while nonmetropolitan counties are defined as an UIC >= 3. County-level fatality rates and UIC classification were geospatially mapped. Linear regression was used to evaluate the change in TBI fatality rate at each category of UIC. The median TBI fatality rate was also compared between metropolitan and nonmetropolitan counties. Results: Geospatial analysis demonstrated higher fatality rates distributed among nonmetropolitan counties across the United States. The TBI fatality rate was 13.00 deaths per 100,000 persons higher in the most rural UIC category compared to the most urban UIC category (95% confidence interval 12.15, 13.86; P < 0.001). The median TBI rate for nonmetropolitan counties was significantly higher than metropolitan counties (22.32 vs. 18.22 deaths per 100,000 persons, P < 0.001). Conclusions: TBI fatality rates are higher in rural areas of the United States. Additional studies to evaluate the mechanisms and solutions to this disparity are warranted and may have implications for lower-and middle-income countries.	[Brown, Joshua B.] Univ Pittsburgh, Dept Surg, Med Ctr, Div Trauma & Gen Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA; [Kheng, Marin] Univ Pittsburgh, Sch Med, Pittsburgh, PA 15213 USA; [Kheng, Marin] Univ Pittsburgh, Sch Publ Hlth, Pittsburgh, PA 15213 USA; [Puyana, Juan Carlos] Univ Pittsburgh, Dept Crit Care Med & Surg Global Hlth, Div Trauma & Surg, Pittsburgh, PA 15213 USA; [Carney, Nancy A.] Oregon Hlth & Sci Univ, Dept Med Informat & Clin Epidemiol, Portland, OR 97201 USA; [Rubiano, Andres M.] Univ El Bosque, Fdn Meditech, Bogota, Colombia		Brown, JB (corresponding author), Univ Pittsburgh, Dept Surg, Med Ctr, Div Trauma & Gen Surg, 200 Lothrop St, Pittsburgh, PA 15213 USA.	brownjb@upmc.edu	RUBIANO, ANDRES M/K-6704-2012	RUBIANO, ANDRES M/0000-0001-8931-3254			Alkhoury F, 2011, AM SURGEON, V77, P277; [Anonymous], 2008, INJ PREV CONTR DAT S; [Anonymous], 2008, WISQARS FAT INJ MAPP; [Anonymous], 2015, REP C TRAUM BRAIN IN; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; Bonow RH, 2018, WORLD NEUROSURG, V111, pE82, DOI 10.1016/j.wneu.2017.11.171; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Bullock MR, 1996, J NEUROTRAUM, V13, P643; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Charry JD, 2016, BRIT J NEUROSURG, V30, P235, DOI 10.3109/02688697.2015.1096905; Chesnut RM, 2018, J NEUROTRAUM, V35, P54, DOI 10.1089/neu.2016.4472; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; De Silva MJ, 2009, INT J EPIDEMIOL, V38, P452, DOI 10.1093/ije/dyn189; Dewan MC, 2019, J NEUROSURG, V130, P1080, DOI 10.3171/2017.10.JNS17352; Alarcon JD, 2013, J TRAUMA ACUTE CARE, V75, P311, DOI 10.1097/TA.0b013e3182924bf8; DuBose JJ, 2008, ARCH SURG-CHICAGO, V143, P1213, DOI 10.1001/archsurg.143.12.1213; Eaton J, 2017, WORLD NEUROSURG, V108, P650, DOI 10.1016/j.wneu.2017.09.084; Fakhry SM, 2004, J TRAUMA, V56, P492, DOI 10.1097/01.TA.0000115650.07193.66; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Gupta D, 2016, WORLD NEUROSURG, V89, P169, DOI 10.1016/j.wneu.2015.12.097; Hall SA, 2006, J URBAN HEALTH, V83, P162, DOI 10.1007/s11524-005-9016-3; Harrison AL, 2017, DISABIL REHABIL, V39, P2071, DOI 10.1080/09638288.2016.1217081; Hesdorffer DC, 2002, J TRAUMA, V52, P1202, DOI 10.1097/00005373-200206000-00031; Jarman MP, 2016, SURGERY, V160, P1551, DOI 10.1016/j.surg.2016.06.020; Kesinger MR, 2014, WORLD J SURG, V38, P1869, DOI 10.1007/s00268-014-2534-y; Klein RJ, 2001, STAT NOTES NATL CTR; Maas AIR, 2017, LANCET NEUROL, V16, P987, DOI 10.1016/S1474-4422(17)30371-X; Mauritz W, 2008, EUR J PUBLIC HEALTH, V18, P575, DOI 10.1093/eurpub/ckn079; Nielsen K, 2012, PREHOSP EMERG CARE, V16, P381, DOI 10.3109/10903127.2012.664245; Patel A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0161554; Picetti E, 2017, NEUROSURGERY, V81, pE2, DOI 10.1093/neuros/nyx086; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Rudehill A, 2002, J NEUROTRAUM, V19, P855, DOI 10.1089/08977150260190447; Schootman M, 1999, BRAIN INJURY, V13, P995; Sorinola A, 2018, TURK NEUROSURG, V28, P410, DOI 10.5137/1019-5149.JTN.19396-16.1; Stukel TA, 2007, JAMA-J AM MED ASSOC, V297, P278, DOI 10.1001/jama.297.3.278; Tiesman H, 2007, J NEUROTRAUM, V24, P1189, DOI 10.1089/neu.2006.0196; Van Essen TA, 2016, J NEUROTRAUM, V33, pA20; W.H. Organization, 2006, NEUR DIS PUBL HLTH C	40	15	15	0	1	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0976-3147	0976-3155		J NEUROSCI RURAL PRA	J. Neurosci. Rural Pract.	JAN-MAR	2019	10	1					10	15		10.4103/jnrp.jnrp_310_18			6	Clinical Neurology	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	HH2SK	WOS:000455568600006	30765964	Green Published, gold			2022-02-06	
J	Lee, JY; Acosta, S; Tuazon, JP; Xu, KY; Nguyen, H; Lippert, T; Liska, MG; Semechkin, A; Garitaonandia, I; Gonzalez, R; Kern, R; Borlongan, CV				Lee, Jea-Young; Acosta, Sandra; Tuazon, Julian P.; Xu, Kaya; Hung Nguyen; Lippert, Trenton; Liska, Michael G.; Semechkin, Andrey; Garitaonandia, Ibon; Gonzalez, Rodolfo; Kern, Russell; Borlongan, Cesario V.			Human parthenogenetic neural stem cell grafts promote multiple regenerative processes in a traumatic brain injury model	THERANOSTICS			English	Article						neuroprotection; traumatic brain injury; human parthenogenetic neural stem cells; inflammation; stem cell transplantation	TRANSPLANTATION; THERAPIES; NEURONS; SPLEEN; RATS	International Stem Cell Corporation human parthenogenetic neural stem cells (ISC-hpNSC) have potential therapeutic value for patients suffering from traumatic brain injury (TBI). Here, we demonstrate the behavioral and histological effects of transplanting ISC-hpNSC intracerebrally in an animal model of TBI. Methods: Sprague-Dawley rats underwent a moderate controlled cortical impact TBI surgery. Transplantation occurred at 72 h post-TBI with functional readouts of behavioral and histological deficits conducted during the subsequent 3-month period after TBI. We characterized locomotor, neurological, and cognitive performance at baseline (before TBI), then on days 0, 1, 7, 14, 30, 60, and 90 (locomotor and neurological), and on days 28-30, 58-60, and 88-90 (cognitive) after TBI. Following completion of behavioral testing at 3 months post-TBI, animals were euthanized by transcardial perfusion and brains harvested to histologically characterize the extent of brain damage. Neuronal survival was revealed by Nissl staining, and stem cell engraftment and host tissue repair mechanisms such as the anti-inflammatory response in peri-TBI lesion areas were examined by immunohistochemical analyses. Results: We observed that TBI groups given high and moderate doses of ISC-hpNSC had an improved swing bias on an elevated body swing test for motor function, increased scores on forelimb akinesia and paw grasp neurological tests, and committed significantly fewer errors on a radial arm water maze test for cognition. Furthermore, histological analyses indicated that high and moderate doses of stem cells increased the expression of phenotypic markers related to the neural lineage and myelination and decreased reactive gliosis and inflammation in the brain, increased neuronal survival in the peri-impact area of the cortex, and decreased inflammation in the spleen at 90 days post-TBI. Conclusion: These results provide evidence that high and moderate doses of ISC-hpNSC ameliorate TBI-associated histological alterations and motor, neurological, and cognitive deficits.	[Lee, Jea-Young; Acosta, Sandra; Tuazon, Julian P.; Xu, Kaya; Hung Nguyen; Lippert, Trenton; Liska, Michael G.; Borlongan, Cesario V.] USF Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA; [Semechkin, Andrey; Garitaonandia, Ibon; Gonzalez, Rodolfo; Kern, Russell] Int Stem Cell Corp, Carlsbad, CA USA; [Kern, Russell] Cyto Therapeut, Melbourne, Vic, Australia		Borlongan, CV (corresponding author), USF Morsani Coll Med, Dept Neurosurg & Brain Repair, Ctr Excellence Aging & Brain Repair, Tampa, FL 33612 USA.	cborlong@health.usf.edu					Acosta SA, 2017, J CELL PHYSIOL, V232, P665, DOI 10.1002/jcp.25629; Acosta SA, 2015, STROKE, V46, P2616, DOI 10.1161/STROKEAHA.115.009854; Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Ajmo CT, 2008, J NEUROSCI RES, V86, P2227, DOI 10.1002/jnr.21661; Altumbabic M, 1998, STROKE, V29, P1917, DOI 10.1161/01.STR.29.9.1917; Borlongan CV, 1998, EXP NEUROL, V149, P310, DOI 10.1006/exnr.1997.6730; BORLONGAN CV, 1995, J NEUROSCI, V15, P5372; Boutajangout A, 2017, CURR ALZHEIMER RES, V14, P104, DOI 10.2174/1567205013666161004151416; Carpenter MK, 2009, NAT BIOTECHNOL, V27, P606, DOI 10.1038/nbt0709-606; Chen BJ, 2004, BLOOD, V103, P4344, DOI 10.1182/blood-2003-07-2534; Chen Q, 2005, J NEUROSCI RES, V80, P611, DOI 10.1002/jnr.20494; Daughtry B, 2014, STEM CELL TRANSL MED, V3, P290, DOI 10.5966/sctm.2013-0127; Faul M, 2010, TRAUMATIC BRAIN INJU; Frey-Vasconcells J, 2012, STEM CELL TRANSL MED, V1, P353, DOI 10.5966/sctm.2012-0018; Garbuzova-Davis S, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-00993-0; Garitaonandia I, 2018, STEM CELLS DEV, V27, P951, DOI 10.1089/scd.2018.0001; Garitaonandia I, 2016, SCI REP-UK, V6, DOI 10.1038/srep34478; Gonzalez R, 2016, CELL TRANSPLANT, V25, P1945, DOI 10.3727/096368916X691682; Gonzalez R, 2015, CELL TRANSPLANT, V24, P681, DOI 10.3727/096368915X687769; Gonzalez R, 2013, SCI REP-UK, V3, DOI 10.1038/srep01463; Isaev DA, 2012, REGEN MED, V7, P37, DOI [10.2217/RME.11.110, 10.2217/rme.11.110]; Johannesson B, 2014, CELL STEM CELL, V15, P634, DOI 10.1016/j.stem.2014.10.002; Li M, 2011, J TRAUMA, V71, P141, DOI [10.1097/TA.0b013e3181f30fc9, 10.1088/1742-5468/2011/12/P12001]; Lo B, 2009, ENDOCR REV, V30, P204, DOI 10.1210/er.2008-0031; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Quyyumi AA, 2011, AM HEART J, V161, DOI 10.1016/j.ahj.2010.09.025; Ratcliffe E, 2013, BRIT MED BULL, V108, P73, DOI 10.1093/bmb/ldt034; Revazova ES, 2008, CLONING STEM CELLS, V10, P11, DOI 10.1089/clo.2007.0063; Revazova ES, 2007, CLONING STEM CELLS, V9, P432, DOI 10.1089/clo.2007.0033; Robinson AM, 2017, STEM CELL RES THER, V8, DOI 10.1186/s13287-017-0540-3; Saporta S, 1999, NEUROSCIENCE, V91, P519, DOI 10.1016/S0306-4522(98)00610-1; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; SWANSON LW, 1980, NEUROENDOCRINOLOGY, V31, P410, DOI 10.1159/000123111; Tajiri N, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00116; Tajiri N, 2014, J NEUROSCI, V34, P313, DOI 10.1523/JNEUROSCI.2425-13.2014; Tajiri N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078851; Taylor CJ, 2005, LANCET, V366, P2019, DOI 10.1016/S0140-6736(05)67813-0; Turovets N, 2012, CELL TRANSPLANT, V21, P217, DOI 10.3727/096368911X582723; Uchida H, 2017, STROKE, V48, P428, DOI 10.1161/STROKEAHA.116.014950; Wang GH, 2011, J NEUROTRAUM, V28, P2123, DOI 10.1089/neu.2011.1939; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wislet-Gendebien S, 2004, BMC NEUROSCI, V5, DOI 10.1186/1471-2202-5-33; Wood KJ, 2012, NAT REV IMMUNOL, V12, P417, DOI 10.1038/nri3227; Yasuhara T, 2008, J CEREBR BLOOD F MET, V28, P1804, DOI 10.1038/jcbfm.2008.68; Yasuhara T, 2009, STEM CELLS DEV, V18, P1501, DOI 10.1089/scd.2009.0011	46	15	15	1	4	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1838-7640			THERANOSTICS	Theranostics		2019	9	4					1029	1046		10.7150/thno.29868			18	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	HJ5DV	WOS:000457199500009	30867814	gold, Green Published, Green Submitted			2022-02-06	
J	Lesman-Segev, OH; La Joie, R; Stephens, ML; Sonni, I; Tsai, R; Bourakova, V; Visani, AV; Edwards, L; O'Neil, JP; Baker, SL; Gardner, RC; Janabi, M; Chaudhary, K; Perry, DC; Kramer, JH; Miller, BL; Jagust, WJ; Rabinovici, GD				Lesman-Segev, Orit H.; La Joie, Renaud; Stephens, Melanie L.; Sonni, Ida; Tsai, Richard; Bourakova, Viktoriya; Visani, Adrienne V.; Edwards, Lauren; O'Neil, James P.; Baker, Suzanne L.; Gardner, Raquel C.; Janabi, Mustafa; Chaudhary, Kiran; Perry, David C.; Kramer, Joel H.; Miller, Bruce L.; Jagust, William J.; Rabinovici, Gil D.			Tau PET and multimodal brain imaging in patients at risk for chronic traumatic encephalopathy	NEUROIMAGE-CLINICAL			English	Article						Chronic traumatic encephalopathy (CTE); Imaging; Positron emission tomography (PET); Tau; Amyloid; Magnetic resonance imaging (MRI)	EMISSION-TOMOGRAPHY TRACER; AMYLOID PROTEIN DEPOSITION; ALZHEIMERS-DISEASE; FDG-PET; A-BETA; INJURY; DIAGNOSIS; PATHOLOGY; PLAYERS; HYPOMETABOLISM	Objective: To characterize individual and group-level neuroimaging findings in patients at risk for Chronic Traumatic Encephalopathy (CTE). Methods: Eleven male patients meeting criteria for Traumatic Encephalopathy Syndrome (TES, median age: 64) underwent neurologic evaluation, 3-Tesla MRI, and PET with [F-18]-Flortaucipir (FTP, tau-PET) and [C-11]-Pittsburgh compound B (PIB, amyloid-PET). Six patients underwent [F-18]-Fluorodeoxyglucose-PET (FDG, glucose metabolism). We assessed imaging findings at the individual patient level, and in group-level comparisons with modality-specific groups of cognitively normal older adults (CN). Tau-PET findings in patients with TES were also compared to a matched group of patients with mild cognitive impairment or dementia due to Alzheimer's disease (AD). Results: All patients with TES sustained repetitive head injury participating in impact sports, ten in American football. Three patients ma criteria for dementia and eight had mild cognitive impairment. Two patients were amyloid-PET positive and harbored the most severe MRI atrophy, FDG hypometabolism, and FTP-tau PET binding. Among the nine amyloid-negative patients, tau-PET showed either mildly elevated frontotemporal binding, a "dot-like" pattern, or no elevated binding. Medial temporal FTP was mildly elevated in a subset of amyloid-negative patients, but values were considerably lower than in AD. Voxelwise analyses revealed a convergence of imaging abnormalities (higher FTP binding, lower FDG, lower gray matter volumes) in fronto-temporal areas in TES compared to controls. Conclusions: Mildly elevated tau-PET binding was observed in a subset of amyloid-negative patients at risk for CTE, in a distribution consistent with CTE pathology stages III-IV. FTP-PET may be useful as a biomarker of tau pathology in CTE but is unlikely to be sensitive to early disease stages.	[Lesman-Segev, Orit H.; La Joie, Renaud; Stephens, Melanie L.; Tsai, Richard; Bourakova, Viktoriya; Visani, Adrienne V.; Edwards, Lauren; Gardner, Raquel C.; Chaudhary, Kiran; Perry, David C.; Kramer, Joel H.; Miller, Bruce L.; Rabinovici, Gil D.] Univ Calif San Francisco, Weill Inst Neurosci, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94158 USA; [Rabinovici, Gil D.] Univ Calif San Francisco, Dept Radiol, San Francisco, CA 94158 USA; [Rabinovici, Gil D.] Univ Calif San Francisco, Dept Biomed Imaging, San Francisco, CA 94158 USA; [Sonni, Ida; O'Neil, James P.; Baker, Suzanne L.; Janabi, Mustafa; Jagust, William J.; Rabinovici, Gil D.] Lawrence Berkeley Natl Lab, Div Life Sci, Berkeley, CA 94720 USA; [Gardner, Raquel C.] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Jagust, William J.; Rabinovici, Gil D.] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA		Lesman-Segev, OH (corresponding author), Univ Calif San Francisco, Weill Inst Neurosci, Dept Neurol, Memory & Aging Ctr, San Francisco, CA 94158 USA.	lesmano@gmail.com	La Joie, Renaud/AAC-8569-2021; Jagust, William/ABE-6426-2020	La Joie, Renaud/0000-0003-2581-8100; Miller, Bruce/0000-0002-2152-4220; Perry, David/0000-0003-3098-8593; Edwards, Lauren/0000-0002-8434-9669; Sonni, Ida/0000-0002-8802-7704	National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01-AG045611, R01-AG034570, P50-AG023501]; Tau Consortium; Alzheimer's AssociationAlzheimer's Association [AARF-16-443577]	This work was supported by the National Institute on Aging grants (R01-AG045611; to G.D.R.), (R01-AG034570; to W.J.J.), (P50-AG023501; to B.L.M. and G.D.R); Tau Consortium(to G.D.R. and W.J.J) and the Alzheimer's Association (AARF-16-443577 to R.L.J).	Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Bang SA, 2016, J NEUROTRAUM, V33, P1005, DOI 10.1089/neu.2015.4051; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Baugh CM, 2014, CURR TREAT OPTION NE, V16, DOI 10.1007/s11940-014-0306-5; Bevan-Jones WR, 2018, J NEUROL NEUROSUR PS, V89, P1032, DOI 10.1136/jnnp-2017-316402; Bruinsma TJ, 2017, ANN NUCL MED, V31, P736, DOI 10.1007/s12149-017-1205-0; Buckley RF, 2019, JAMA NEUROL, V76, P542, DOI 10.1001/jamaneurol.2018.4693; Cho H, 2017, NEUROLOGY, V89, P1170, DOI 10.1212/WNL.0000000000004364; Delis D.C., 2000, CALIFORNIA VERBAL LE; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Dickstein DL, 2016, TRANSL PSYCHIAT, V6, DOI 10.1038/tp.2016.175; Diedrichsen J, 2009, NEUROIMAGE, V46, P39, DOI 10.1016/j.neuroimage.2009.01.045; Falcon B, 2019, NATURE, V568, P420, DOI 10.1038/s41586-019-1026-5; Gardner Raquel C, 2015, Neurol Clin Pract, V5, P285; Gardner RC, 2016, J NEUROTRAUM, V33, P157, DOI 10.1089/neu.2014.3805; Homack S, 2005, J CLIN EXP NEUROPSYC, V27, P599, DOI 10.1080/13803390490918444; Ikonomovic MD, 2004, EXP NEUROL, V190, P192, DOI 10.1016/j.expneurol.2004.06.011; Ikonomovic MD, 2008, BRAIN, V131, P1630, DOI 10.1093/brain/awn016; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Joshi A, 2009, NEUROIMAGE, V46, P154, DOI 10.1016/j.neuroimage.2009.01.057; Koerte IK, 2016, J NEUROTRAUM, V33, P346, DOI 10.1089/neu.2015.3880; Kramer Joel H, 2003, Cogn Behav Neurol, V16, P211, DOI 10.1097/00146965-200312000-00002; La Joie R, 2019, ALZHEIMERS DEMENT, V15, P205, DOI 10.1016/j.jalz.2018.09.001; La Joie R, 2018, NEUROLOGY, V90, pE282, DOI 10.1212/WNL.0000000000004860; La Joie R, 2012, J NEUROSCI, V32, P16265, DOI 10.1523/JNEUROSCI.2170-12.2012; Lee CM, 2018, J ALZHEIMERS DIS, V62, P1691, DOI 10.3233/JAD-170840; Lehmann M, 2013, BRAIN, V136, P844, DOI 10.1093/brain/aws327; Little DM, 2014, ALZHEIMERS DEMENT, V10, pS188, DOI 10.1016/j.jalz.2014.04.002; Lockhart SN, 2017, NEUROLOGY, V88, P1095, DOI 10.1212/WNL.0000000000003724; Lowe VJ, 2018, BRAIN, V141, P271, DOI 10.1093/brain/awx320; Lowe VJ, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0315-6; Maass A, 2017, NEUROIMAGE, V157, P448, DOI 10.1016/j.neuroimage.2017.05.058; Makaretz SJ, 2018, J NEUROL NEUROSUR PS, V89, P1024, DOI 10.1136/jnnp-2017-316409; Malone IB, 2015, NEUROIMAGE, V104, P366, DOI 10.1016/j.neuroimage.2014.09.034; Marquie M, 2017, ACTA NEUROPATHOL COM, V5, DOI 10.1186/s40478-017-0482-0; Marquie M, 2015, ANN NEUROL, V78, P787, DOI 10.1002/ana.24517; McKee AC, 2018, HAND CLINIC, V158, P297, DOI 10.1016/B978-0-444-63954-7.00028-8; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKhann GM, 2011, ALZHEIMERS DEMENT, V7, P263, DOI 10.1016/j.jalz.2011.03.005; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; Omalu B, 2018, NEUROSURGERY, V82, P237, DOI 10.1093/neuros/nyx536; Orrison WW, 2009, J NEUROTRAUM, V26, P689, DOI 10.1089/neu.2008.0636; Ossenkoppele R, 2016, BRAIN, V139, P1551, DOI 10.1093/brain/aww027; Ossenkoppele R, 2012, EUR J NUCL MED MOL I, V39, P990, DOI 10.1007/s00259-012-2102-3; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Potvin O, 2017, NEUROIMAGE, V156, P315, DOI 10.1016/j.neuroimage.2017.05.019; Provenzano FA, 2010, NUCL MED COMMUN, V31, P952, DOI 10.1097/MNM.0b013e32833e37c4; Rabinovici GD, 2011, NEUROLOGY, V77, P2034, DOI 10.1212/WNL.0b013e31823b9c5e; Rabinovici Gil D, 2015, Continuum (Minneap Minn), V21, P646, DOI 10.1212/01.CON.0000466658.05156.54; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROBERTS GW, 1991, LANCET, V338, P1422, DOI 10.1016/0140-6736(91)92724-G; Sander K, 2016, ALZHEIMERS DEMENT, V12, P1116, DOI 10.1016/j.jalz.2016.01.003; Schonhaut DR, 2017, ANN NEUROL, V82, P622, DOI 10.1002/ana.25060; Seo SW, 2017, NEUROIMAGE-CLIN, V13, P130, DOI 10.1016/j.nicl.2016.11.008; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Smid LM, 2006, BRAIN PATHOL, V16, P124, DOI 10.1111/j.1750-3639.2006.00006.x; Smith R, 2017, NEUROLOGY, V89, P845, DOI 10.1212/WNL.0000000000004264; Staffaroni AM, 2018, J NEUROSCI, V38, P2809, DOI 10.1523/JNEUROSCI.3067-17.2018; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2019, NEW ENGL J MED, V380, P1716, DOI 10.1056/NEJMoa1900757; Stroop JR, 1935, J EXP PSYCHOL, V18, P643, DOI 10.1037/h0054651; Utianski RL, 2018, CORTEX, V99, P358, DOI 10.1016/j.cortex.2017.12.021; Victoroff J, 2013, NEUROREHABILITATION, V32, P211, DOI 10.3233/NRE-130839; Wang Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062789; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	71	15	15	1	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2019	24								102025	10.1016/j.nicl.2019.102025			13	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	JY8MY	WOS:000504663800127	31670152	Green Published, gold			2022-02-06	
J	Lichtenstein, JD; Flaro, L; Baldwin, FS; Rai, J; Erdodi, LA				Lichtenstein, Jonathan D.; Flaro, Lloyd; Baldwin, Fern S.; Rai, Jaspreet; Erdodi, Laszlo A.			Further Evidence for Embedded Performance Validity Tests in Children within the Conners' Continuous Performance Test - Second Edition	DEVELOPMENTAL NEUROPSYCHOLOGY			English	Article							CARD SORTING TEST; TRAUMATIC BRAIN-INJURY; VERBAL-LEARNING TEST; CLINICAL UTILITY; DIGIT SPAN; TEST-II; ATTENTION; TRAIL; SPECIFICITY; INDICATORS	Objective: To replicate previous research on Conners' Continuous Performance Test - Second Edition subscales as performance validity tests (PVTs) in children.Method: Classification accuracy for the Omissions (OMI), Hit Reaction Time (HRT), and Perseverations (PER) subscales was computed for 414 children and adolescents.Results: Overall, OMI, HRT, and PER demonstrated good specificity but low and variable sensitivity across cutoffs.Conclusions: Results suggest that OMI, HRT, and PER can function as embedded PVTs in mixed clinical samples of children, although their clinical utility is limited by their low sensitivity. Implications for the use of these PVTs in the context of attention-deficit/hyperactivity disorder evaluations, medication-seeking patients, and sports concussion clinics are discussed.	[Lichtenstein, Jonathan D.; Baldwin, Fern S.] Geisel Sch Med Dartmouth, Dept Psychiat, Pediat Neuropsychol Program, Lebanon, NH USA; [Lichtenstein, Jonathan D.] Geisel Sch Med Dartmouth, Dept Pediat, Lebanon, NH USA; [Lichtenstein, Jonathan D.] Geisel Sch Med Dartmouth, Dartmouth Inst Hlth Policy & Clin Practice, Lebanon, NH USA; [Rai, Jaspreet; Erdodi, Laszlo A.] Univ Windsor, Neuropsychol Track, Dept Psychol, Windsor, ON, Canada		Lichtenstein, JD (corresponding author), DHMC, Dept Psychiat, One Med Ctr Dr, Lebanon, NH 03756 USA.	jonathan.d.lichtenstein@hitchcock.org					Abeare CA, 2018, JAMA NEUROL, V75, P697, DOI 10.1001/jamaneurol.2018.0031; Altman D.G., 1994, BMJ, V309; An KY, 2017, CLIN NEUROPSYCHOL, V31, P193, DOI 10.1080/13854046.2016.1217046; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; Ashendorf L, 2017, CLIN NEUROPSYCHOL, V31, P857, DOI 10.1080/13854046.2017.1285961; Baker DA, 2014, CLIN NEUROPSYCHOL, V28, P116, DOI 10.1080/13854046.2013.858184; Baron I. S., 2004, NEUROPSYCHOLOGICAL E; Bernstein J. H., 1999, NEUROMETHODS, V17, P311; Bernstein J. H., 2010, PRINCIPLES PRACTICE, P17; Blaskewitz N, 2008, ARCH CLIN NEUROPSYCH, V23, P379, DOI 10.1016/j.acn.2008.01.008; Boone K.B., 2013, CLIN PRACTICE FORENS; Bordoff B, 2017, PSYCHOL INJ LAW, V10, P114, DOI 10.1007/s12207-017-9288-4; Brooks B.L., 2015, CHILDREN ADOLESCENT; Brooks BL, 2016, CHILD NEUROPSYCHOL, V22, P1001, DOI 10.1080/09297049.2015.1075491; Brooks BL, 2015, ARCH CLIN NEUROPSYCH, V30, P200, DOI 10.1093/arclin/acv017; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Busse M, 2012, CLIN NEUROPSYCHOL, V26, P675, DOI 10.1080/13854046.2012.679623; Conners, 2004, CONNERS CONTINUOUS P; Cowan N, 2006, MEM COGNITION, V34, P1754, DOI 10.3758/BF03195936; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Erdodi, 2018, J PEDIAT NEUROPSYCHO, V4, P94, DOI [10.1007/s40817-018-0057-4, DOI 10.1007/s40817-018-0057-4, DOI 10.1007/S40817-018-0057-4]; Erdodi LA, 2019, APPL NEUROPSYCH-ADUL, V26, P155, DOI 10.1080/23279095.2017.1384925; Erdodi LA, 2018, PSYCHOL ASSESSMENT, V30, P1082, DOI 10.1037/pas0000561; Erdodi LA, 2018, PSYCHOL INJ LAW, V11, P1, DOI 10.1007/s12207-017-9309-3; Erdodi LA, 2018, APPL NEUROPSYCH-ADUL, V25, P19, DOI 10.1080/23279095.2016.1232262; Erdodi LA, 2017, APPL NEUROPSYCH-CHIL, V6, P355, DOI 10.1080/21622965.2016.1198908; Erdodi LA, 2017, CLIN NEUROPSYCHOL, V31, P168, DOI 10.1080/13854046.2016.1224392; Erdodi LA, 2014, PSYCHOL INJ LAW, V7, P255, DOI 10.1007/s12207-014-9197-8; Erdodi LA, 2014, ARCH CLIN NEUROPSYCH, V29, P456, DOI 10.1093/arclin/acu026; Figueroa I.J., 2013, P HUM FACT ERG SOC A, V57, P828; GLAROS AG, 1988, J CLIN PSYCHOL, V44, P1013, DOI 10.1002/1097-4679(198811)44:6<1013::AID-JCLP2270440627>3.0.CO;2-Z; GOEBEL RA, 1983, J CLIN PSYCHOL, V39, P731, DOI 10.1002/1097-4679(198309)39:5<731::AID-JCLP2270390515>3.0.CO;2-T; Green P., 2003, MANUAL COMPUTERIZED; Green P., 2008, GREENS NONVERBAL MED; Green P, 2004, GREENS MED SYMPTOM V; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Greve KW, 1996, ARCH CLIN NEUROPSYCH, V11, P215; Greve KW, 2002, CLIN NEUROPSYCHOL, V16, P179, DOI 10.1076/clin.16.2.179.13241; Greve KW, 2002, J CLIN EXP NEUROPSYC, V24, P48, DOI 10.1076/jcen.24.1.48.968; Grimes DA, 2005, LANCET, V365, P1500, DOI 10.1016/S0140-6736(05)66422-7; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heston TF, 2011, J MAGN RESON IMAGING, V33, P505, DOI 10.1002/jmri.22466; Huang-Pollock CL, 2002, DEV PSYCHOL, V38, P363, DOI 10.1037//0012-1649.38.3.363; Hurtubise JL, 2017, PSYCHOL INJ LAW, V10, P121, DOI 10.1007/s12207-017-9287-5; Iverson GL, 2002, CLIN NEUROPSYCHOL, V16, P398, DOI 10.1076/clin.16.3.398.13861; King JH, 2002, CLIN NEUROPSYCHOL, V16, P506, DOI 10.1076/clin.16.4.506.13912; Kirkwood M. W., 2015, VALIDITY TESTING CHI; Kirkwood MW, 2011, ARCH CLIN NEUROPSYCH, V26, P377, DOI 10.1093/arclin/acr040; Lange RT, 2017, CLIN NEUROPSYCHOL, V31, P1015, DOI 10.1080/13854046.2017.1335438; Lange RT, 2013, PSYCHOL ASSESSMENT, V25, P339, DOI 10.1037/a0030915; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lichtenstein JD, 2018, CHILD NEUROPSYCHOL, V24, P247, DOI 10.1080/09297049.2016.1259402; Lichtenstein JD, 2017, CHILD NEUROPSYCHOL, V23, P284, DOI 10.1080/09297049.2015.1135422; Marshall P, 2010, CLIN NEUROPSYCHOL, V24, P1204, DOI 10.1080/13854046.2010.514290; Merten T, 2007, J CLIN EXP NEUROPSYC, V29, P308, DOI 10.1080/13803390600693607; O'Bryant SE, 2003, CLIN NEUROPSYCHOL, V17, P69, DOI 10.1076/clin.17.1.69.15624; Ord JS, 2010, J CLIN EXP NEUROPSYC, V32, P380, DOI 10.1080/13803390903066881; Powell MR, 2011, CLIN NEUROPSYCHOL, V25, P108, DOI 10.1080/13854046.2010.532912; Qiu DQ, 2008, NEUROIMAGE, V41, P223, DOI 10.1016/j.neuroimage.2008.02.023; Ross TP, 2016, ARCH CLIN NEUROPSYCH, V31, P97, DOI 10.1093/arclin/acv062; Ruffolo LF, 2000, CLIN NEUROPSYCHOL, V14, P223, DOI 10.1076/1385-4046(200005)14:2;1-Z;FT223; Sagar S, 2017, PSYCHOL INJ LAW, V10, P105, DOI 10.1007/s12207-017-9286-6; Santos OA, 2014, ARCH CLIN NEUROPSYCH, V29, P609, DOI 10.1093/arclin/acu039; Sherman E.M.S., 2016, MEMORY VALIDITY PROF; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Somsen RJM, 2007, DEVELOPMENTAL SCI, V10, P664, DOI 10.1111/j.1467-7687.2007.00613.x; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Suhr J, 2008, ARCH CLIN NEUROPSYCH, V23, P521, DOI 10.1016/j.acn.2008.05.003; Sussman ZW, 2019, APPL NEUROPSYCH-CHIL, V8, P70, DOI 10.1080/21622965.2017.1382359; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Welsh AJ, 2012, ARCH CLIN NEUROPSYCH, V27, P735, DOI 10.1093/arclin/acs063	72	15	15	2	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	8756-5641	1532-6942		DEV NEUROPSYCHOL	Dev. Neuropsychol.		2019	44	2					159	171		10.1080/87565641.2019.1565535			13	Psychology, Developmental; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	HP3RJ	WOS:000461594600001	30646768				2022-02-06	
J	Valera, EM; Campbell, J; Gill, J; Iverson, KM				Valera, Eve M.; Campbell, Jacquelyn; Gill, Jessica; Iverson, Katherine M.			Correlates of Brain Injuries in Women Subjected to Intimate Partner Violence: Identifying the Dangers and Raising Awareness	JOURNAL OF AGGRESSION MALTREATMENT & TRAUMA			English	Article						Traumatic brain injury; intimate partner violence; family domestic violence; health outcomes	SEX-DIFFERENCES; NETWORK CONNECTIVITY; TOTAL TAU; IN-VIVO; VETERANS; CONCUSSION; ACTIVATION; MILITARY; RISK; IMPAIRMENT	Awareness of the highly detrimental and long-term sequelae of brain injuries, and in particular repetitive mild traumatic brain injuries (mTBIs/concussions), has been rapidly growing. Specifically, there has been significant focus on repetitive mTBIs in male athletes and military personnel. Unfortunately, what is likely the largest group of repetitive mTBI sufferers, namely women who experience intimate partner violence (IPV), has received scant attention. Women experiencing IPV sustain both repetitive mTBIs at a high rate and also strangulation-related anoxic/hypoxic brain injuries. Due to biological, psychosocial and trauma-related differences between these women and the (mostly) men who have been studied to date, we cannot generalize what is leamed from these studies to women suffering from IPV-related TBIs. Here we summarize some research aimed at understanding the occurrence and sequelae of IPV-related TBIs among various samples (i.e., women in shelters or primary care, from the community, veterans). These data show that IPV-related TBIs are highly prevalent, and associated with a range of negative cognitive and psychological outcomes as well as structural and functional brain connectivity. These associations could not be accounted for by potential confounds (e.g., abuse severity, psychiatric symptoms), making it dear that these negative health outcomes were not merely artifacts of being in an abusive relationship. We highlight gaps in research and provide recommendations for clinical practice. We present ideas for future research to elucidate the mechanisms underlying the associations noted above, in hopes of providing new insights into the links between TBIs and health risks in women who have experienced IPV.	[Valera, Eve M.] Harvard Med Sch, Psychiat, Rm 2660,149 Thirteenth St, Charlestown, MA 02129 USA; [Valera, Eve M.] Massachusetts Gen Hosp, Rm 2660,149 Thirteenth St, Charlestown, MA 02129 USA; [Campbell, Jacquelyn] Johns Hopkins Univ, Sch Nursing, Baltimore, MD USA; [Gill, Jessica] NIH, Tissue Injury Branch, Ctr Neurosci & Regenerat Med, Bldg 10, Bethesda, MD 20892 USA; [Iverson, Katherine M.] VA Boston Healthcare Syst, Womens Hlth Sci Div, Natl Ctr PTSD, Boston, MA USA; [Iverson, Katherine M.] Boston Univ, Sch Med, Boston, MA 02118 USA		Valera, EM (corresponding author), Harvard Med Sch, Psychiat, Rm 2660,149 Thirteenth St, Charlestown, MA 02129 USA.; Valera, EM (corresponding author), Massachusetts Gen Hosp, Rm 2660,149 Thirteenth St, Charlestown, MA 02129 USA.	eve_valera@hms.harvard.edu	Gill, Gill M/Q-2020-2017		Harvard Center of Excellence Award; Rappaport Scholarship; Department of Veterans Affairs Health Services Research and Development ServicesUS Department of Veterans Affairs [IIR-16-032]; Presidential Early Career Award for Scientists and Engineers USA	Harvard Center of Excellence Award and Rappaport Scholarship (Valera); Department of Veterans Affairs Health Services Research and Development Services IIR-16-032 and Presidential Early Career Award for Scientists and Engineers USA 14-275 (Iverson). The views expressed in this article are those of the authors and do not represent the views or official position of the United States Government or the Department of Veterans Affairs.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Alosco ML, 2018, ALZHEIMERS DEMENT, V14, P1159, DOI 10.1016/j.jalz.2018.05.004; Amoroso T, 2017, J NERV MENT DIS, V205, P318, DOI 10.1097/NMD.0000000000000621; Arosarena OA, 2009, ARCH FACIAL PLAST S, V11, P48, DOI 10.1001/archfacial.2008.507; Aupperle RL, 2016, J TRAUMA STRESS, V29, P33, DOI 10.1002/jts.22068; Bazarian JJ, 2001, ACAD EMERG MED, V8, P788, DOI 10.1111/j.1553-2712.2001.tb00208.x; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Campbell JC, 2018, J WOMENS HEALTH, V27, P761, DOI 10.1089/jwh.2016.6311; Campbell JC, 2009, J INTERPERS VIOLENCE, V24, P653, DOI 10.1177/0886260508317180; Coughlin JM, 2017, JAMA NEUROL, V74, P67, DOI 10.1001/jamaneurol.2016.3764; Covassin T, 2003, J ATHL TRAINING, V38, P238; DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; Department of Veterans Affairs, 2010, SCREEN EV POSS TRAUM; Devries KM, 2013, SCIENCE, V340, P1527, DOI 10.1126/science.1240937; Dichter ME, 2011, WOMEN HEALTH ISS, V21, pS190, DOI 10.1016/j.whi.2011.04.008; Doeppner TR, 2015, STEM CELL TRANSL MED, V4, P1131, DOI 10.5966/sctm.2015-0078; Dolle JP, 2018, EXP NEUROL, V300, P121, DOI 10.1016/j.expneurol.2017.11.001; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; Fonzo GA, 2013, PSYCHIAT RES-NEUROIM, V211, P93, DOI 10.1016/j.pscychresns.2012.08.006; Fonzo GA, 2010, BIOL PSYCHIAT, V68, P433, DOI 10.1016/j.biopsych.2010.04.028; Gajawelli N, 2013, WORLD NEUROSURG, V80, P824, DOI 10.1016/j.wneu.2013.10.020; Gerber MR, 2014, J WOMENS HEALTH, V23, P302, DOI 10.1089/jwh.2013.4513; Goldin Y, 2016, PM&R, V8, P1104, DOI 10.1016/j.pmrj.2016.05.006; Hendricks AM, 2013, BRAIN INJURY, V27, P125, DOI 10.3109/02699052.2012.729284; Iverson KM, 2017, COMPR PSYCHIAT, V74, P80, DOI 10.1016/j.comppsych.2017.01.007; Iverson KM, 2015, MED CARE, V53, pS112, DOI 10.1097/MLR.0000000000000263; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Kasper CE, 2015, ANNU REV NURS RES-SE, V33, P13, DOI 10.1891/0739-6686.33.13; Kelly AMC, 2008, NEUROIMAGE, V39, P527, DOI 10.1016/j.neuroimage.2007.08.008; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Makris N, 2005, CEREB CORTEX, V15, P854, DOI 10.1093/cercor/bhh186; Makris N, 2007, NEUROIMAGE, V37, P1100, DOI 10.1016/j.neuroimage.2007.05.042; Manley G, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2017-097791; McAllister T, 2017, J ATHL TRAINING, V52, P309, DOI 10.4085/1062-6050-52.1.14; Menon V, 2010, BRAIN STRUCT FUNCT, V214, P655, DOI 10.1007/s00429-010-0262-0; Messing JT, 2018, WOMEN HEALTH ISS, V28, P104, DOI 10.1016/j.whi.2017.10.002; Monahan K, 1999, HEALTH SOC WORK, V24, P269, DOI 10.1093/hsw/24.4.269; Monahan K., 2018, J NEUROLOGY NEUROMED, V3, P3, DOI [10.29245/2572.942X/2018/3.1181, DOI 10.29245/2572.942X/2018/3.1181]; Musunuri S, 2016, J ALZHEIMERS DIS, V54, P1671, DOI 10.3233/JAD-160271; Nelson B, 2015, CAMBRIDGE INTRO LIT, P32; Neumeister P, 2017, SOC COGN AFFECT NEUR, V12, P555, DOI 10.1093/scan/nsw165; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Pogoda TK, 2012, J REHABIL RES DEV, V49, P971, DOI 10.1682/JRRD.2011.06.0099; Polytrauma Rehabilitation Center Richmond VA Medical Center Department of veterans affairs, 2018, INT PARTN VIOL MIL S; Roos A, 2017, BRAIN IMAGING BEHAV, V11, P1629, DOI 10.1007/s11682-016-9644-0; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Sharp KG, 2014, EXP NEUROL, V257, P186, DOI 10.1016/j.expneurol.2014.04.008; Simmons AN, 2008, BIOL PSYCHIAT, V64, P681, DOI 10.1016/j.biopsych.2008.05.027; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smock B., 2017, RECOMMENDATIONS MED; St Ivany A, 2018, QUAL HEALTH RES, V28, P1708, DOI 10.1177/1049732318786705; Straus M. A., 1990, PHYS VIOLENCE AM FAM, DOI DOI 10.4324/9781315126401; STRAUS MA, 1979, J MARRIAGE FAM, V41, P75, DOI 10.2307/351733; Strigo IA, 2010, BIOL PSYCHIAT, V68, P442, DOI 10.1016/j.biopsych.2010.03.034; Valera E., 2016, TRAUMA BRAIN IMAGING, V11, P1664, DOI DOI 10.1007/s11682-016-9643-1; Valera E. M., 1997, BRAIN INJURY SEVERIT; Valera EM, 2003, J CONSULT CLIN PSYCH, V71, P797, DOI 10.1037/0022-006X.71.4.797; Valera EM, 2019, J NEUROTRAUM, V36, P661, DOI 10.1089/neu.2018.5734; Wu V, 2010, TRAUMA VIOLENCE ABUS, V11, P71, DOI 10.1177/1524838010367503; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]	64	15	15	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1092-6771	1545-083X		J AGGRESS MALTREAT T	J. Aggress. Maltreatment Trauma		2019	28	6			SI		695	713		10.1080/10926771.2019.1581864			19	Psychology, Clinical; Criminology & Penology; Family Studies; Psychiatry	Social Science Citation Index (SSCI)	Psychology; Criminology & Penology; Family Studies; Psychiatry	IM2YW	WOS:000477859700004					2022-02-06	
J	Chanda, A; Callaway, C; Clifton, C; Unnikrishnan, V				Chanda, Arnab; Callaway, Christian; Clifton, Cassie; Unnikrishnan, Vinu			Biofidelic human brain tissue surrogates	MECHANICS OF ADVANCED MATERIALS AND STRUCTURES			English	Article						Brain tissue; grey matter; surrogates; traumatic brain injury (TBI); white matter	WHITE-MATTER CHANGES; NORMAL ADULT BRAIN; TOTAL GRAY-MATTER; SILICONE-RUBBER; INJURY; DEMENTIA; BEHAVIOR; MODELS; DAMAGE; SKIN	Traumatic brain injury (TBI) due to blast exposure or head impacts in accidents or contact sports is one of the most critical and poorly understood areas of research in the 21st century. To date, the unavailability of human brain tissues (grey and white matter especially) due to ethical and biosafety issues has not allowed for much experimental research into the study of the mechanics of brain tissues under impact or dynamic loading. In the current work, for the first time, biofidelic brain tissue surrogates have been developed using a low cost, castable (to any shape or size), two-part silicone-based material system to precisely mimic the nonlinear mechanical properties of both the white and the grey matter. The fabrication methodology involves the iterative mixing of the two parts of silicone at certain mix ratios (by weight) to generate a biomechanical behavior similar to the white and the grey matter tissues, respectively, at two different strain rates (low and high). The nonlinear behavior of these novel brain tissue surrogates have been characterized using five hyperelastic material models. These brain tissue simulant materials would be indispensable not only for the study of TBI, but also to allow doctors to practice brain surgeries (for training purposes) in a clinical setting. Additionally, crucial brain tissue modifications in Alzheimer's disease and dementia can be studied in the future with such accessible biofidelic brain tissue surrogate materials.	[Chanda, Arnab; Unnikrishnan, Vinu] Univ Alabama, Dept Aerosp Engn & Mech, Box 870280, Tuscaloosa, AL USA; [Callaway, Christian; Clifton, Cassie] Univ Alabama, Dept Mech Engn, Tuscaloosa, AL USA		Unnikrishnan, V (corresponding author), Univ Alabama, Dept Aerosp Engn & Mech, Box 870280, Tuscaloosa, AL USA.	vunnikrishnan@ua.edu			University of Alabama	VU would like to acknowledge the faculty start-up funds and 2014 RGC grants from The University of Alabama.	Bigler ED, 2009, TXB ALZHEIMER DIS OT, P229; BIRD TD, 1983, ANN NEUROL, V14, P284, DOI 10.1002/ana.410140306; Chafi MS, 2011, INT J APPL MECH, V3, P803, DOI 10.1142/S175882511100124X; Chanda A., 2015, U. S. Patent Application, Patent No. [62/189,504, 62189504, US 62/189,504]; Chanda A, 2015, AIMS MATER SCI, V2, P425, DOI 10.3934/matersci.2015.4.425; Chanda A, 2015, APPL MECH REV, V67, DOI 10.1115/1.4030967; Chandra N, 2012, SHOCK WAVES, V22, P403, DOI 10.1007/s00193-012-0399-2; Christ AF, 2010, J BIOMECH, V43, P2986, DOI 10.1016/j.jbiomech.2010.07.002; Control and Prevention, 1997, INT J TRAUMA NURS, V3, P88; CRUTCHER KA, 1993, J NEUROSCI, V13, P2540, DOI 10.1523/JNEUROSCI.13-06-02540.1993; Cunningham AS, 2005, BRAIN, V128, P1931, DOI 10.1093/brain/awh536; de Leeuw FE, 2002, BRAIN, V125, P765, DOI 10.1093/brain/awf077; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; ENGLUND E, 1988, BRAIN, V111, P1425, DOI 10.1093/brain/111.6.1425; Estes M.S., 1970, RESPONSE BRAIN TISSU; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Ganpule S, 2012, COMPUT METHOD BIOMEC, V15, P1233, DOI 10.1080/10255842.2011.597353; Ganpule S., 2010, ASME 2010 INT MECH E, P181; Ganpule S., 2009, ASME INT MECH ENG C, P339; Ganpule S., 2013, ASME 2013 SUMM BIOEN; Ge YL, 2002, AM J NEURORADIOL, V23, P1327; Ge YL, 2002, AM J NEURORADIOL, V23, P1334; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gonzalez L.Y.S., 2005, HYPERELASTIC MAT MOD; Gu LX, 2012, COMPOS PART B-ENG, V43, P3160, DOI 10.1016/j.compositesb.2012.04.014; Gupta RS, 2013, FRONT MICROBIOL, V4, DOI 10.3389/fmicb.2013.00217; Holzapfel G.A., 2000, NONLINEAR SOLID MECH, V24; Ikram MA, 2010, NEUROBIOL AGING, V31, P378, DOI 10.1016/j.neurobiolaging.2008.04.008; Jenson D., 2014, ASME 2014 INT MECH E; Jenson D, 2015, COMPOS STRUCT, V121, P211, DOI 10.1016/j.compstruct.2014.08.028; Jin X, 2013, J BIOMECH, V46, P2795, DOI 10.1016/j.jbiomech.2013.09.001; Kangarlou K., 2013, NATIONALPARK FORSCHU, V12, P511; Kelly JP, 1997, NEUROLOGY, V48, P575, DOI 10.1212/WNL.48.3.575; Mai JK, 1997, ATLAS HUMAN BRAIN; Martins PALS, 2006, STRAIN, V42, P135, DOI 10.1111/j.1475-1305.2006.00257.x; Meaney DF, 2003, BIOMECH MODEL MECHAN, V1, P279, DOI 10.1007/s10237-002-0020-1; Mejia ROS, 2001, NEUROSURGERY, V48, P1393, DOI 10.1097/00006123-200106000-00051; MIELKE R, 1992, ARCH NEUROL-CHICAGO, V49, P909, DOI 10.1001/archneur.1992.00530330031011; Miller K, 2005, J BIOMECH, V38, P153, DOI 10.1016/j.jbiomech.2004.03.004; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; NOVITZKY D, 1988, TRANSPLANTATION, V45, P32; Pantoni L, 1996, STROKE, V27, P1641, DOI 10.1161/01.STR.27.9.1641; Pervin F, 2009, J BIOMECH, V42, P731, DOI 10.1016/j.jbiomech.2009.01.023; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2012, J MECH BEHAV BIOMED, V10, P23, DOI 10.1016/j.jmbbm.2012.01.022; Shergold OA, 2006, INT J IMPACT ENG, V32, P1384, DOI 10.1016/j.ijimpeng.2004.11.010; Sundaramurthy A, 2012, J NEUROTRAUM, V29, P2352, DOI 10.1089/neu.2012.2413; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131	50	15	16	2	3	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1537-6494	1537-6532		MECH ADV MATER STRUC	Mech. Adv. Mater. Struct.	DEC 10	2018	25	15-16			SI		1335	1341		10.1080/15376494.2016.1143749			7	Materials Science, Multidisciplinary; Mechanics; Materials Science, Characterization & Testing; Materials Science, Composites	Science Citation Index Expanded (SCI-EXPANDED)	Materials Science; Mechanics	HE5ES	WOS:000453396900009		Bronze			2022-02-06	
J	Barker-Collo, S; Theadom, A; Jones, K; Starkey, N; Kahan, M; Feigin, V				Barker-Collo, Suzanne; Theadom, Alice; Jones, Kelly; Starkey, Nicola; Kahan, Michael; Feigin, Valery			Depression and anxiety across the first 4 years after mild traumatic brain injury: findings from a community-based study	BRAIN INJURY			English	Article						Mild brain injury; depression; anxiety; trajectories	POSTTRAUMATIC-STRESS-DISORDER; HOSPITAL ANXIETY; POSTCONCUSSIVE SYMPTOMS; MAJOR DEPRESSION; HEAD-INJURY; PREDICTORS; PREVALENCE; VALIDITY; OUTCOMES; ADULTS	Background: Emotional disorders are considered to contribute to persistent difficulties after mild traumatic brain injury (TBI). Few studies have examined anxiety after mild TBI, and fewer have examined comorbid depression and anxiety and their trajectories over time. This study describes depression and anxiety across 48-months after mild TBI in adults (aged >15 years at injury). Methods: Depression and anxiety were assessed using the Hospital Anxiety and Depression Scale in a sample of 341 adults with mild TBI within 2 weeks of injury and then at 6-, 12- and 48-months post-injury. Results: Mean anxiety and depression total scores decreased significantly over time. Prevalence of depression ranged from 0% to 7.7%, whilst anxiety was present in 3.7-29.5% of cases. Comorbid anxiety and depression prevalence ranged from 10.2% to 20.7%. At each time of assessment, the greatest proportion of individuals had neither depression nor anxiety (range 28-49%). The findings suggest multiple trajectories over time. Conclusions: The findings indicate that both anxiety and depression need to be screened regularly after mild TBI. Furthermore, it cannot be assumed that someone who initially presents without depression or anxiety will remain free of these as they negotiate life after injury.	[Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Theadom, Alice; Jones, Kelly; Feigin, Valery] Auckland Univ Technol, Natl Inst Stroke & Appl Neurosci, Sch Publ Hlth & Psychosocial Studies, Auckland, New Zealand; [Starkey, Nicola] Univ Waikato, Sch Psychol, Hamilton, New Zealand; [Kahan, Michael] Waikato Dist Hlth Board, Waikato Occupat Serv, Hamilton, New Zealand		Barker-Collo, S (corresponding author), Univ Auckland, Sch Psychol, Clin Training Programme, Private Bag 92019, Auckland, New Zealand.	s.barker-collo@auckland.ac.nz	Starkey, Nicola/AAJ-3795-2020; Feigin, Valery/AAF-2313-2019	Starkey, Nicola/0000-0002-4370-8186; Feigin, Valery L./0000-0002-6372-1740	New Zealand Health Research CouncilHealth Research Council of New Zealand [09/063A, 11/192, 13/408]	This research was funded by the New Zealand Health Research Council Project grants 09/063A, 11/192, and 13/408.	Albicini M, 2020, J MENT HEALTH, V29, P439, DOI 10.1080/09638237.2017.1385733; Albicini M, 2015, J CLIN EXP NEUROPSYC, V37, P776, DOI 10.1080/13803395.2015.1053843; Alexander M.P., 1992, J HEAD TRAUMA REHAB, V7, P60, DOI DOI 10.1097/00001199-199206000-00009; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Arciniegas DB, 2013, NEUROPSYCHOLOGY; Ballenger James C., 2000, Prim Care Companion J Clin Psychiatry, V2, P71; Barker-Collo S, 2015, BRAIN INJURY, V29, P859, DOI 10.3109/02699052.2015.1004759; Bjelland I, 2002, J PSYCHOSOM RES, V52, P69, DOI 10.1016/S0022-3999(01)00296-3; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Canterbury District Health Board, 2012, REC MILD TRAUM BRAIN; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Corrigan JD, 2003, ARCH PHYS MED REHAB, V84, P153, DOI 10.1053/apmr.2003.50093; Ehlers A, 2000, BEHAV RES THER, V38, P319, DOI 10.1016/S0005-7967(99)00123-0; Emanuelson I, 2003, ACTA NEUROL SCAND, V108, P332, DOI 10.1034/j.1600-0404.2003.00155.x; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Hibbird MR, 1998, AM J PSYCHIAT, V156, P374; Holsinger T, 2002, ARCH GEN PSYCHIAT, V59, P17, DOI 10.1001/archpsyc.59.1.17; Inzaghi M G, 2005, Eura Medicophys, V41, P265; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kessler RC, 2008, PSYCHOL MED, V38, P365, DOI 10.1017/S0033291707002012; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Landre N, 2006, ARCH CLIN NEUROPSYCH, V21, P255, DOI 10.1016/j.acn.2005.12.007; Lanius RA, 2006, J PSYCHIATR RES, V40, P709, DOI 10.1016/j.jpsychires.2005.07.007; Lavoie S, 2017, FRONT PSYCHOL, V8, DOI 10.3389/fpsyg.2017.00634; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McPherson K, 2018, J HEAD TRAUMA REHAB, V33, pE44, DOI 10.1097/HTR.0000000000000321; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; National Institute of Health, 2002, TRAUM BRAIN INJ HOP; Osborn AJ, 2017, J AFFECT DISORDERS, V213, P214, DOI 10.1016/j.jad.2016.09.045; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Ponsford J, 2012, NEUROPSYCHOLOGY, V26, P304, DOI 10.1037/a0027888; Rao V, 2010, J NEUROPSYCH CLIN N, V22, P100, DOI 10.1176/appi.neuropsych.22.1.100; Rapoport MJ, 2003, PSYCHOSOMATICS, V44, P31, DOI 10.1176/appi.psy.44.1.31; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; SCHOENHUBER R, 1988, J NEUROL NEUROSUR PS, V51, P722, DOI 10.1136/jnnp.51.5.722; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746; Theadom A, 2016, BRIT J GEN PRACT, V66, pE16, DOI 10.3399/bjgp16X683161; Whelan-Goodinson R, 2009, J AFFECT DISORDERS, V114, P94, DOI 10.1016/j.jad.2008.06.007; Wood RL, 2004, BRAIN INJURY, V18, P1135, DOI 10.1080/02699050410001675906; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	47	15	17	0	3	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1651	1658		10.1080/02699052.2018.1540797			8	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600006	30373399				2022-02-06	
J	Guillotte, AR; Herbert, JP; Madsen, R; Hammer, RD; Litofsky, NS				Guillotte, Andrew R.; Herbert, Joseph P.; Madsen, Richard; Hammer, Richard D.; Litofsky, N. Scott			Effects of platelet dysfunction and platelet transfusion on outcomes in traumatic brain injury patients	BRAIN INJURY			English	Article						Coagulopathy; platelet dysfunction; thromboelastography; TEG; traumatic brain injury	ADENOSINE-DIPHOSPHATE; COAGULOPATHY; THROMBOELASTOGRAPHY; INHIBITION	Objective: Platelet inhibition in traumatic brain injury (TBI) may be due to injury or antiplatelet medication use pre-injury. This study aims to identify factors associated with increased platelet arachidonic acid (AA) and adenosine diphosphate (ADP) inhibition and determine if platelet transfusion reduces platelet dysfunction and affects outcome. Methods: Prospective thromboelastography (TEG) assays were collected on adult patients with TBI with intracranial injuries detected by computed tomography (CT). Outcomes included in-hospital mortality, and CT lesion expansion. Results: Of 153 patients, ADP inhibition was increased in moderate and severe TBI compared to mild TBI (p = 0.0011). P2Y12 inhibiting medications had increased ADP inhibition (p = 0.0077). Admission ADP inhibition was not associated with in-hospital mortality (p = 0.24) or CT lesion expansion (p = 0.94). Mean reduction of ADP inhibition from platelet transfusion (-15.1%) relative to no transfusion (+ 11.7%) was not statistically different (p = 0.0472). Conclusions: Mild TBI results in less ADP inhibition compared to moderate and severe TBI, suggesting a dose response relationship between TBI severity and degree of platelet dysfunction. Further, study is warranted to determine efficacy and parameters for platelet transfusion in patients with TBI.	[Guillotte, Andrew R.; Herbert, Joseph P.; Litofsky, N. Scott] Univ Missouri, Sch Med, Div Neurol Surg, One Hosp Dr,MC 321, Columbia, MO 65212 USA; [Madsen, Richard] Univ Missouri, Sch Med, Biostat & Res Design, Columbia, MO USA; [Hammer, Richard D.] Univ Missouri, Sch Med, Dept Pathol & Anat Sci, Columbia, MO USA		Litofsky, NS (corresponding author), Univ Missouri, Sch Med, Div Neurol Surg, One Hosp Dr,MC 321, Columbia, MO 65212 USA.	litofskyn@health.missouri.edu		Guillotte, Andrew/0000-0001-7222-5856	University of Missouri School of Medicine Office of Research; University of Missouri School of Medicine Department of Surgery; Division of Neurological Surgery of University of Missouri School of Medicine	Andrew R. Guillotte was funded through a Summer Medical Student Research Fellowship from University of Missouri School of Medicine Office of Research and Department of Surgery. Additional funding was from scholarship funds of the Division of Neurological Surgery of University of Missouri School of Medicine.	Abdelmalik PA, 2016, NEUROCRIT CARE, V24, P361, DOI 10.1007/s12028-015-0191-0; [Anonymous], 2017, SAMPLE SIZE ISSUES P; Bartels AN, 2016, US CAN AC PATH 105 A; Bartels AN, 2016, SURGERY, V160, P954, DOI 10.1016/j.surg.2016.07.012; Bolliger D, 2012, TRANSFUS MED REV, V26, P1, DOI 10.1016/j.tmrv.2011.07.005; Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chang R, 2016, BLOOD, V128, P1043, DOI 10.1182/blood-2016-01-636423; Chen LQ, 2004, J THORAC CARDIOV SUR, V128, P425, DOI 10.1016/j.jtcvs.2004.02.019; Curran PJ, 2010, J COGN DEV, V11, P121, DOI 10.1080/15248371003699969; Daley MJ, 2017, EUR J TRAUMA EMERG S, V43, P105, DOI 10.1007/s00068-016-0643-z; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Gozal Yair M, 2017, Surg Neurol Int, V8, P48, DOI 10.4103/sni.sni_265_16; Herbert JP, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7070092; Hoffman M, 2009, STROKE, V40, P2882, DOI 10.1161/STROKEAHA.109.555433; Holzmacher JL, 2018, BRAIN INJURY, V32, P325, DOI 10.1080/02699052.2018.1425804; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; Kreitzer NP, 2015, NEUROCRIT CARE, V23, P427, DOI 10.1007/s12028-015-0187-9; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Lindblad C, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00015; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Reddy GD, 2015, CURR TREAT OPTION NE, V17, DOI 10.1007/s11940-015-0379-9; Schochl H, 2011, J NEUROTRAUM, V28, P2033, DOI 10.1089/neu.2010.1744; Schochl H, 2010, CRIT CARE, V14, DOI 10.1186/cc8948; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050	31	15	16	0	1	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2018	32	13-14					1849	1857		10.1080/02699052.2018.1536805			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HE5DS	WOS:000453393600031	30346865				2022-02-06	
J	Maruta, J; Lumba-Brown, A; Ghajar, J				Maruta, Jun; Lumba-Brown, Angela; Ghajar, Jamshid			Concussion Subtype Identification With the Rivermead Post-concussion Symptoms Questionnaire	FRONTIERS IN NEUROLOGY			English	Article						mild traumatic brain injury (mTBI); epidemiology; cognitive; fatigue; vestibular; migraine; sleep	TRAUMATIC BRAIN-INJURY; ANXIETY DISORDERS; SPORTS; SLEEP	Classifying concussion in key subtypes according to presenting symptomatology at an early post-injury stage is an emerging approach that may allow prediction of clinical trajectories and delivery of targeted treatments. The Rivermead Post-concussion Symptoms Questionnaire (RPQ) is a simple, freely available, and widely used tool for assessment of the presence and severity of various post-concussion symptoms. We aimed to probe the prevalence among athletes of symptom classes associated with identified concussion phenotypes using the RPQ at baseline and acutely after a concussion. Participants of organized sports aged 12-30 years were baseline-assessed with the expectation that some would experience a concussion during the study period. Concussed athletes were re-assessed within 2 weeks of their injuries. The RPQ was supplemented with three specific questions and reworded for baseline assessment. A binomial test was used to contrast the prevalence of an attribute in the concussed cohort against the probability established by the baseline observation. Three thousand and eighty-eight athletes were baseline-assessed and eighty-nine were re-assessed post-concussion. All concussed athletes endorsed having some elevated symptoms in the RPQ, and such endorsements were more prevalent than those among normal athletes. Moderate-to-severe post-concussion symptoms of specific classes tended to be endorsed with few additional symptoms of other classes of similar intensities. Elevated symptoms detected with the RPQ within as short as 2 weeks after a concussion may help delineate patients' clinical subtypes and guide their treatment. Further refinement of symptom questionnaires and use of objective measures will be needed to properly populate the concussion subtype classification.	[Maruta, Jun; Ghajar, Jamshid] Brain Trauma Fdn, New York, NY 10007 USA; [Maruta, Jun; Ghajar, Jamshid] Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA; [Maruta, Jun] Dept Rehabil & Human Performance, New York, NY 10029 USA; [Lumba-Brown, Angela] Stanford Univ, Sch Med, Dept Emergency Med, Stanford, CA USA		Maruta, J (corresponding author), Brain Trauma Fdn, New York, NY 10007 USA.; Maruta, J (corresponding author), Stanford Univ, Sch Med, Dept Neurosurg, Stanford, CA 94305 USA.; Maruta, J (corresponding author), Dept Rehabil & Human Performance, New York, NY 10029 USA.	jun.maruta@mssm.edu	Maruta, Jun/I-3790-2019	Maruta, Jun/0000-0002-5054-6605	U.S. Department of DefenseUnited States Department of Defense [W911QY-12-C-0005, W911QY-14-C-0086]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM121312] Funding Source: NIH RePORTER	The authors thank Brain Trauma Foundation's clinical research staff for assistance with data collection and maintenance. This work was supported by U.S. Department of Defense contracts W911QY-12-C-0005 and W911QY-14-C-0086.	Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Beesdo K, 2009, PSYCHIAT CLIN N AM, V32, P483, DOI 10.1016/j.psc.2009.06.002; BELLDOLAN DJ, 1990, J AM ACAD CHILD PSY, V29, P759, DOI 10.1097/00004583-199009000-00014; Broglio SP, 2015, CLIN SPORT MED, V34, P213, DOI 10.1016/j.csm.2014.12.005; Capo-Aponte JE, 2017, OPTOMETRY VISION SCI, V94, P7, DOI 10.1097/OPX.0000000000000825; Ciuffreda KJ, 2014, MIL MED, V179, P1212, DOI 10.7205/MILMED-D-14-00059; Collins MW, 2016, NEUROSURGERY, V79, P912, DOI 10.1227/NEU.0000000000001447; Collins MW, 2014, KNEE SURG SPORT TR A, V22, P235, DOI 10.1007/s00167-013-2791-6; Covassin T, 2003, J ATHL TRAINING, V38, P238; Ellis MJ, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00136; Ettenhofer ML, 2012, J INT NEUROPSYCH SOC, V18, P451, DOI 10.1017/S1355617711001895; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Iverson GL, 2003, APPL NEUROPSYCHOL, V10, P137, DOI 10.1207/S15324826AN1003_02; Kenzie ES, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00203; Kenzie ES, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00513; KING NS, 1995, J NEUROL, V242, P587, DOI 10.1007/BF00868811; Kontos A. P., 2018, CONCUSSION CLIN PROF; Lincoln AE, 2011, AM J SPORT MED, V39, P958, DOI 10.1177/0363546510392326; Maruta J, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00611; Maruta J, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00640; Maruta J, 2014, PROG NEUROL SURG, V28, P226, DOI 10.1159/000358786; Maruta J, 2010, ANN NY ACAD SCI, V1208, P58, DOI 10.1111/j.1749-6632.2010.05695.x; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Panczykowski DM, 2014, PROG NEUROL SURG, V28, P195, DOI 10.1159/000358780; Rathbone ATL, 2015, BRAIN BEHAV IMMUN, V46, P1, DOI 10.1016/j.bbi.2015.02.009; Ventura RE, 2016, J NEUROL SCI, V361, P79, DOI 10.1016/j.jns.2015.12.010; Wickwire EM, 2016, NEUROTHERAPEUTICS, V13, P403, DOI 10.1007/s13311-016-0429-3	27	15	15	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	DEC 3	2018	9								1034	10.3389/fneur.2018.01034			7	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	HC7AS	WOS:000451953400001	30559709	Green Published, gold			2022-02-06	
J	Ernst, G; Qeadan, F; Carlson, AP				Ernst, Griffin; Qeadan, Fares; Carlson, Andrew P.			Subcutaneous bone flap storage after emergency craniectomy: cost-effectiveness and rate of resorption	JOURNAL OF NEUROSURGERY			English	Article						subcutaneous pocket; cranioplasty; bone resorption; autologous bone	COMPLICATIONS FOLLOWING CRANIOPLASTY; DECOMPRESSIVE CRANIECTOMY; AUTOLOGOUS BONE; RISK-FACTORS; CRYOPRESERVED BONE; INFECTION; HEMICRANIECTOMY; EXPERIENCE; MANAGEMENT	OBJECTIVE Decompressive craniectomy is used for uncontrolled intracranial pressure in traumatic brain injury and malignant hemispheric stroke. Subcutaneous preservation of the autologous bone flap in the abdomen is a simple, portable technique but has largely been abandoned due to perceived concerns of resorption. The authors sought to characterize their experience with subcutaneous preservation of the bone flap and cranioplasty. METHODS The authors performed a retrospective single-institution review of subcutaneous preservation of the autologous bone flap after decompressive craniectomy from 2005 to 2015. The primary outcome was clinically significant bone resorption, defined as requiring a complete mesh implant at the time of cranioplasty, or delayed revision. The outcome also combined cases with any minor bone resorption to determine predictors of this outcome. Logistic regression modeling was used to determine the risk factors for predicting resorption. A cost comparison analysis was also used via the 2-sided t-test to compare the cost of cranioplasty using an autologous bone flap with standard custom implant costs. RESULTS A total of 193 patients with craniectomy were identified, 108 of whom received a cranioplasty. The mean time to cranioplasty was 104.31 days. Severe resorption occurred in 10 cases (9.26%): 4 were clinically significant (2 early and 2 late) and 6 demonstrated type II (severe) necrosis on CT, but did not require revision. Early resorption of any kind (mild or severe) occurred in 28 (25.93%) of 108 cases. Of the 108 patients, 26 (24.07%) required supplemental cranioplasty material. Late resorption of any kind (mild or severe) occurred in 6 (5.88%) of 102 cases. Of these, a clinically noticeable but nonoperative deformity was noted in 4 (3.92%) and minor (type I) necrosis on CT in 37 (37%) of 100. Bivariate analysis identified fragmentation of bone (OR 3.90, 95% CI 1.03-14.8), shunt-dependent hydrocephalus (OR 7.97, 95% CI 1.57-40.46), and presence of post-cranioplasty drain (OR 9.39, 95% CI 1.14-1000) to be significant risk factors for bone resorption. A binary logistic regression optimized using Fisher's scoring determined the optimal multivariable combination of factors. Fragmentation of bone (OR 5.84, 95% CI 1.38-28.78), diabetes (OR 7.61, 95% CI 1.37-44.56), and shunt-dependent hydrocephalus (OR 9.35, 95% CI 1.64-56.21) were found to be most predictive of resorption, with a C value of 0.78. Infections occurred in the subcutaneous pocket in 5 (2.60%) of the 193 cases and after cranioplasty in 10 (9.26%) of the 108 who underwent cranioplasty. The average cost of cranioplasty with autologous bone was $2156.28 +/- $ 1144.60 (n = 15), and of a custom implant was $35,118.60 +/- $2067.51 (3 different sizes; p < 0.0001). CONCLUSIONS Craniectomy with autologous bone cranioplasty using subcutaneous pocket storage is safe and compares favorably to cryopreservation in terms of resorption and favorably to a custom synthetic implant in terms of cost. While randomized data are required to definitively prove the superiority of one method, subcutaneous preservation has enough practical advantages with low risk to warrant routine use for most patients.	[Ernst, Griffin] Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA; [Qeadan, Fares] Univ New Mexico, Sch Med, Clin & Translat Sci Ctr, Albuquerque, NM 87131 USA; [Carlson, Andrew P.] Univ New Mexico, Sch Med, Dept Neurosurg, Albuquerque, NM 87131 USA		Carlson, AP (corresponding author), Univ New Mexico, Sch Med, Albuquerque, NM 87131 USA.	andrewcarlson@salud.unm.edu	Carlson, Andrew P/B-4369-2012; Qeadan, Fares/ABD-3131-2020; Qeadan, Fares/B-9482-2014	Carlson, Andrew P/0000-0003-2189-3699; Qeadan, Fares/0000-0002-3376-220X			Agrawal D, 2005, EUR J CLIN MICROBIOL, V24, P772, DOI 10.1007/s10096-005-0017-7; Ashayeri K, 2016, NEUROSURGERY, V79, P525, DOI 10.1227/NEU.0000000000001366; Beauchamp KM, 2010, J TRAUMA, V69, P270, DOI 10.1097/TA.0b013e3181e491c2; Bobinski L, 2013, CLIN NEUROL NEUROSUR, V115, P1788, DOI 10.1016/j.clineuro.2013.04.013; Bonda DJ, 2015, NEUROSURGERY, V77, P814, DOI 10.1227/NEU.0000000000000899; Bonfield CM, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.1.FOCUS13504; Bowers CA, 2013, J NEUROSURG-PEDIATR, V11, P526, DOI 10.3171/2013.1.PEDS12483; Cheng Cheng-Hsin, 2014, Clin Neurol Neurosurg, V124, P85, DOI 10.1016/j.clineuro.2014.06.029; Corliss B, 2016, WORLD NEUROSURG, V96, P510, DOI 10.1016/j.wneu.2016.09.025; Di Rienzo A, 2008, ACTA NEUROCHIR, V150, P1057, DOI 10.1007/s00701-008-0019-1; Dunisch P, 2013, J NEUROSURG, V118, P1141, DOI 10.3171/2013.1.JNS12860; Feroze AH, 2015, J NEUROSURG, V123, P1098, DOI 10.3171/2014.11.JNS14622; Ferro JM, 2011, STROKE, V42, P2825, DOI 10.1161/STROKEAHA.111.615393; FISHER CM, 1994, SURG NEUROL, V41, P65, DOI 10.1016/0090-3019(94)90210-0; Grant GA, 2004, J NEUROSURG, V100, P163, DOI 10.3171/ped.2004.100.2.0163; Harris DA, 2014, NEUROSURG FOCUS, V36, DOI 10.3171/2014.2.FOCUS13560; HAUPTLI J, 1980, HELV CHIR ACTA, V47, P121; Honeybul S, 2013, BRAIN INJURY, V27, P979, DOI 10.3109/02699052.2013.794974; Honeybul S, 2017, J NEUROSURG, V126, P81, DOI 10.3171/2015.12.JNS152004; Honeybul S, 2012, PLAST RECONSTR SURG, V130, P1110, DOI 10.1097/PRS.0b013e318267d4de; Honeybul S, 2011, J NEUROTRAUM, V28, P929, DOI 10.1089/neu.2010.1612; Iaccarino C, 2015, J ORAL MAXIL SURG, V73, P2375, DOI 10.1016/j.joms.2015.07.008; Inamasu J, 2010, J TRAUMA, V68, P183, DOI 10.1097/TA.0b013e3181c45384; Jasielski Piotr, 2013, Acta Neurochir Suppl, V118, P125, DOI 10.1007/978-3-7091-1434-6_22; Malcolm JG, 2016, J CLIN NEUROSCI, V33, P39, DOI 10.1016/j.jocn.2016.04.017; Matsuno A, 2006, ACTA NEUROCHIR, V148, P535, DOI 10.1007/s00701-006-0740-6; Morton RP, 2016, J NEUROSURG, V125, P766, DOI 10.3171/2015.8.JNS151390; Movassaghi K, 2006, PLAST RECONSTR SURG, V117, P202, DOI 10.1097/01.prs.0000187152.48402.17; Pasaoglu A, 1996, NEUROSURG REV, V19, P153, DOI 10.1007/BF00512044; Pepe MS, 2000, BIOMETRICS, V56, P352, DOI 10.1111/j.0006-341X.2000.00352.x; Polin RS, 1997, NEUROSURGERY, V41, P84, DOI 10.1097/00006123-199707000-00018; Riordan MA, 2016, WORLD NEUROSURG, V87, P207, DOI 10.1016/j.wneu.2015.11.070; Schoekler B, 2014, CLIN NEUROL NEUROSUR, V120, P64, DOI 10.1016/j.clineuro.2014.02.014; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Schwab S, 1998, STROKE, V29, P1888, DOI 10.1161/01.STR.29.9.1888; Schwarz F, 2016, J NEUROSURG, V124, P710, DOI 10.3171/2015.4.JNS159; Scotter J, 2014, BRIT J NEUROSURG, V28, P534, DOI 10.3109/02688697.2013.841855; Shoakazemi A, 2009, NEUROSURGERY, V65, P505, DOI 10.1227/01.NEU.0000350870.69891.86; Sultan SM, 2011, PLAST RECONSTR SURG, V127, P1855, DOI 10.1097/PRS.0b013e31820e89a5; Sundseth J, 2014, ACTA NEUROCHIR, V156, P805, DOI 10.1007/s00701-013-1992-6; Takeuchi H, 2016, ACTA NEUROCHIR, V158, P571, DOI 10.1007/s00701-015-2679-y; Wachter D, 2013, CLIN NEUROL NEUROSUR, V115, P1293, DOI 10.1016/j.clineuro.2012.12.002; Zingale A, 2003, J Neurosurg Sci, V47, P137	43	15	16	0	1	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	DEC	2018	129	6					1604	1610		10.3171/2017.6.JNS17943			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	HE4YU	WOS:000453376800025	29303450	Bronze			2022-02-06	
J	Estrup, S; Kjer, CKW; Vilhelmsen, F; Poulsen, LM; Gogenur, I; Mathiesen, O				Estrup, Stine; Kjer, Cilia K. W.; Vilhelmsen, Frederik; Poulsen, Lone M.; Gogenur, Ismail; Mathiesen, Ole			Cognitive Function 3 and 12 Months After ICU DischargeA Prospective Cohort Study	CRITICAL CARE MEDICINE			English	Article						aftercare; cognitive dysfunction; intensive care; postintensive care syndrome; rehabilitation	INTENSIVE-CARE-UNIT; CRITICAL ILLNESS; ECONOMIC-IMPLICATIONS; REPEATABLE BATTERY; IMPAIRMENT; SURVIVORS; REHABILITATION; DISABILITY; DELIRIUM; RBANS	Objectives: Studies have shown impaired cognitive function after ICU discharge. We aimed to describe long-term cognitive function in Danish ICU patients. Design: Prospective cohort study. Setting: Single-center ICU at Zealand University Hospital, KOge, Denmark. Patients: Adult patients admitted for over 24 hours. Intervention: Three and 12 months after discharge, the patients were visited at home and tested with the Repeatable Battery for the Assessment of Neuropsychological Status. Measurements and Main Results: We included 161 patients, 79 patients had a 3-month and 53 a 12-month follow-up visit. The primary reasons for not being visited at 3-month were death (44 patients), decline (26 patients), or transferal to another ICU (6 patients). Visited patients were median 67 years old (interquartile range, 59-73), had a median Acute Physiology and Chronic Health Evaluation score of 20 (interquartile range, 16-26), 58% were on a ventilator, and 30% were surgical patients. The mean Repeatable Battery for the Assessment of Neuropsychological Status score was 67 (sd, 21), compared with a normal value of 100 (15). A total of 57% had Repeatable Battery for the Assessment of Neuropsychological Status scores corresponding to moderate traumatic brain injury, 46% scored corresponding to light Alzheimer's disease, and 73% corresponding to mild cognitive impairment. After 12 months, the Repeatable Battery for the Assessment of Neuropsychological Status was still reduced (71 [25]). We examined protective and risk factors using multiple linear regression and found protective effects of being employed before admission (p = 0.0005) or being admitted from a surgical ward (p = 0.019). Conclusions: In this prospective cohort study of Danish ICU patients, we found significantly reduced cognitive function for intensive care patients 3 and 12 months after discharge.	[Estrup, Stine; Kjer, Cilia K. W.; Vilhelmsen, Frederik; Poulsen, Lone M.; Mathiesen, Ole] Zealand Univ Hosp, Ctr Anaesthesiol Res, Dept Anesthesiol, Koge, Denmark; [Gogenur, Ismail] Zealand Univ Hosp, Ctr Surg Sci, Dept Gastrointestinal Surg, Koge, Denmark		Estrup, S (corresponding author), Zealand Univ Hosp, Ctr Anaesthesiol Res, Dept Anesthesiol, Koge, Denmark.	sed@regionsjaelland.dk		Poulsen, Lone Musaeus/0000-0002-7030-3395; Gogenur, Ismail/0000-0002-3753-268X; Estrup, Stine/0000-0002-1467-7085; Mathiesen, Ole/0000-0003-4544-0619	Aase and Ejnar Danielsens Fund; Danish Society for Anaesthesiology and Intensive Care Medicine's research initiative; Intensive Care Symposium Hindsgavl; Aase og Ejnar Danielsens fund	Supported, in part, by Aase and Ejnar Danielsens Fund, The Danish Society for Anaesthesiology and Intensive Care Medicine's research initiative, and the Intensive Care Symposium Hindsgavl.; Drs. Estrup's, Kjer's, Vilhelmsen's, and Mathiesen's institution received funding from Aase og Ejnar Danielsens fund, The Danish Society for Anaesthesiology and Intensive Care Medicine's Research Initiative, and Intensive Care Symposium Hindsgavl. The remaining authors have disclosed that they do not have any potential conflicts of interest.	Agard AS, 2014, INTENS CRIT CARE NUR, V30, P101, DOI 10.1016/j.iccn.2013.11.001; Aguero-Torres H, 2001, J CLIN EPIDEMIOL, V54, P795, DOI 10.1016/S0895-4356(00)00371-1; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Brummel NE, 2012, PHYS THER REHABIL J, V92, P1580, DOI 10.2522/ptj.20110414; Corner EJ, 2013, PHYSIOTHERAPY, V99, P33, DOI 10.1016/j.physio.2012.01.003; Davydow DS, 2008, PSYCHOSOM MED, V70, P512, DOI 10.1097/PSY.0b013e31816aa0dd; Duff K, 2008, ARCH CLIN NEUROPSYCH, V23, P603, DOI 10.1016/j.acn.2008.06.004; Duff K, 2010, ARCH CLIN NEUROPSYCH, V25, P429, DOI 10.1093/arclin/acq045; Ely EW, 2001, JAMA-J AM MED ASSOC, V286, P2703, DOI 10.1001/jama.286.21.2703; Estrup S, 2018, ACTA ANAESTH SCAND, V62, P367, DOI 10.1111/aas.13037; Fonsmark L, 2015, DAN MED J, V62; Girard TD, 2010, CRIT CARE MED, V38, P1513, DOI 10.1097/CCM.0b013e3181e47be1; Griffiths J, 2013, CRIT CARE, V17, DOI 10.1186/cc12745; Herridge Margaret S, 2011, N Engl J Med, V364, P1293, DOI 10.1056/NEJMoa1011802; Herridge MS, 2003, NEW ENGL J MED, V348, P683, DOI 10.1056/NEJMoa022450; Hobson VL, 2010, INT J GERIATR PSYCH, V25, P525, DOI 10.1002/gps.2382; Hopkins RO, 2012, SEMIN RESP CRIT CARE, V33, P348, DOI 10.1055/s-0032-1321984; Hopkins RO, 1999, AM J RESP CRIT CARE, V160, P50, DOI 10.1164/ajrccm.160.1.9708059; Iwashyna TJ, 2012, SEMIN RESP CRIT CARE, V33, P327, DOI 10.1055/s-0032-1321982; Iwashyna TJ, 2012, J AM GERIATR SOC, V60, P1070, DOI 10.1111/j.1532-5415.2012.03989.x; Iwashyna TJ, 2010, JAMA-J AM MED ASSOC, V304, P1787, DOI 10.1001/jama.2010.1553; Jones C, 2003, CRIT CARE MED, V31, P2456, DOI 10.1097/01.CCM.0000089938.56725.33; Kress JP, 2012, SEMIN RESP CRIT CARE, V33, P339, DOI 10.1055/s-0032-1321983; McKay C, 2007, ARCH CLIN NEUROPSYCH, V22, P91, DOI 10.1016/j.acn.2006.11.003; Mehlhorn J, 2014, CRIT CARE MED, V42, P1263, DOI 10.1097/CCM.0000000000000148; Misak C, 2009, CRIT CARE, V13, DOI 10.1186/cc7962; Mitchell ML, 2018, AUST CRIT CARE, V31, P204, DOI 10.1016/j.aucc.2017.07.002; Nedergaard HK, 2017, ACTA ANAESTH SCAND, V61, P135, DOI 10.1111/aas.12832; Pandharipande PP, 2013, NEW ENGL J MED, V369, P1306, DOI 10.1056/NEJMoa1301372; Perna L, 2015, AGE AGEING, V44, P445, DOI 10.1093/ageing/afu188; Randolph C, 1998, J CLIN EXP NEUROPSYC, V20, P310, DOI 10.1076/jcen.20.3.310.823; Svenningsen H, 2013, ACTA ANAESTH SCAND, V57, P288, DOI 10.1111/aas.12048; van Ewijk CE, 2016, ANN INTENSIVE CARE, V6, DOI 10.1186/s13613-016-0186-9; von Elm E, 2007, ANN INTERN MED, V147, P573, DOI 10.7326/0003-4819-147-8-200710160-00010; Wilcox ME, 2013, CRIT CARE MED, V41, pS81, DOI 10.1097/CCM.0b013e3182a16946; Wolters A, 2015, J CLIN NURS, V24, P876, DOI 10.1111/jocn.12678; Wolters AE, 2014, CRIT CARE, V18, DOI 10.1186/cc13929; Wunsch H, 2011, AM J RESP CRIT CARE, V183, P1666, DOI 10.1164/rccm.201012-1961OC; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	39	15	15	0	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	DEC	2018	46	12					E1121	E1127		10.1097/CCM.0000000000003391			7	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	HA6ZY	WOS:000450431600005	30188383				2022-02-06	
J	Flygt, J; Ruscher, K; Norberg, A; Mir, A; Gram, H; Clausen, F; Marklund, N				Flygt, Johanna; Ruscher, Karsten; Norberg, Amanda; Mir, Anis; Gram, Hermann; Clausen, Fredrik; Marklund, Niklas			Neutralization of Interleukin-1 beta following Diffuse Traumatic Brain Injury in the Mouse Attenuates the Loss of Mature Oligodendrocytes	JOURNAL OF NEUROTRAUMA			English	Article						fluid percussion injury; inflammation; IL-1 beta; microglia; oligodendrocyte; oligodendrocyte progenitor cells; Olig2; traumatic brain injury	FLUID PERCUSSION INJURY; MICROGLIAL ACTIVATION; INFLAMMATORY RESPONSE; KINASE-ACTIVITY; AXONAL INJURY; DEATH; EXPRESSION; IL-1-BETA; PATHOLOGY; CELLS	Traumatic brain injury (TBI) commonly results in injury to the components of the white matter tracts, causing post-injury cognitive deficits. The myelin-producing oligodendrocytes (OLs) are vulnerable to TBI, although may potentially be replaced by proliferating oligodendrocyte progenitor cells (OPCs). The cytokine interleukin-1 beta (IL-1 beta) is a key mediator of the complex inflammatory response, and when neutralized in experimental TBI, behavioral outcome was improved. To evaluate the role of IL-1 beta on oligodendrocyte cell death and OPC proliferation, 116 adult male mice subjected to sham injury or the central fluid percussion injury (cFPI) model of traumatic axonal injury, were analyzed at two, seven, and 14 days post-injury. At 30 min post-injury, mice were randomly administered an IL-1 beta neutralizing or a control antibody. OPC proliferation (5-ethynyl 2 '- deoxyuridine (EdU)/Olig2 co-labeling) and mature oligodendrocyte cell loss was evaluated in injured white matter tracts. Microglia/macrophages immunohistochemistry and ramification using Sholl analysis were also evaluated. Neutralizing IL-1 beta resulted in attenuated cell death, indicated by cleaved caspase-3 expression, and attenuated loss of mature OLs from two to seven days post-injury in brain-injured animals. IL-1 beta neutralization also attenuated the early, two day post-injury increase of microglia/macrophage immunoreactivity and altered their ramification. The proliferation of OPCs in brain-injured animals was not altered, however. Our data suggest that IL-1 beta is involved in the TBI-induced loss of OLs and early microglia/macrophage activation, although not the OPC proliferation. Attenuated oligodendrocyte cell loss may contribute to the improved behavioral outcome observed by IL-1 beta neutralization in this mouse model of diffuse TBI.	[Flygt, Johanna; Norberg, Amanda; Clausen, Fredrik; Marklund, Niklas] Uppsala Univ, Sect Neurosurg, Dept Neurosci, Uppsala, Sweden; [Ruscher, Karsten] Novartis Inst Biomed Res, Basel, Switzerland; [Mir, Anis; Gram, Hermann; Marklund, Niklas] Lund Univ, Skane Univ Hosp, Dept Clin Sci Lund, Neurosurg, Lund, Sweden		Marklund, N (corresponding author), Uppsala Univ Hosp, Dept Neurosurg, Sjukhusvagen 1,Ing 85,2nd Floor, SE-75185 Uppsala, Sweden.	niklas.marklund@neuro.uu.se		Clausen, Fredrik/0000-0003-3592-4417			ANDERSON CV, 1995, J NEUROPSYCH CLIN N, V7, P42; ANKARCRONA M, 1994, EXP CELL RES, V213, P172, DOI 10.1006/excr.1994.1187; Bachstetter AD, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0149451; Bachstetter AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0289-5; Basu A, 2004, J NEUROSCI RES, V78, P151, DOI 10.1002/jnr.20266; Beer R, 2000, J NEUROCHEM, V75, P1264, DOI 10.1046/j.1471-4159.2000.0751264.x; Bradl M, 2010, ACTA NEUROPATHOL, V119, P37, DOI 10.1007/s00401-009-0601-5; Brogi A, 1997, J CELL BIOCHEM, V66, P532, DOI 10.1002/(SICI)1097-4644(19970915)66:4<532::AID-JCB12>3.0.CO;2-D; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Clausen F, 2011, EUR J NEUROSCI, V34, P110, DOI 10.1111/j.1460-9568.2011.07723.x; Clausen F, 2009, EUR J NEUROSCI, V30, P385, DOI 10.1111/j.1460-9568.2009.06820.x; Cole JT, 2011, J NEUROTRAUM, V28, P359, DOI 10.1089/neu.2010.1427; Dent KA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121541; Desmond DW, 2002, CEREBROVASC DIS, V13, P53, DOI 10.1159/000049151; Di Iorio A, 2003, CYTOKINE, V22, P198, DOI 10.1016/S1043-4666(03)00152-2; Dinarello C A, 1998, Int Rev Immunol, V16, P457, DOI 10.3109/08830189809043005; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Ekmark-Lewen S, 2016, EUR J NEUROSCI, V43, P1016, DOI 10.1111/ejn.13190; Ekmark-Lewen S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-44; Fischer CP, 2004, J PHYSIOL-LONDON, V558, P633, DOI 10.1113/jphysiol.2004.066779; Flygt J, 2013, EUR J NEUROSCI, V38, P2153, DOI 10.1111/ejn.12179; Flygt J, 2017, RESTOR NEUROL NEUROS, V35, P251, DOI 10.3233/RNN-160675; Flygt J, 2016, J NEUROPATH EXP NEUR, V75, P503, DOI 10.1093/jnen/nlw025; Friedlander RM, 1996, J EXP MED, V184, P717, DOI 10.1084/jem.184.2.717; Gutierrez H, 2007, J NEUROSCI METH, V163, P24, DOI 10.1016/j.jneumeth.2007.02.002; Haber M., 2017, J CEREB BLOOD FLOW M; Helmy A, 2016, J CEREBR BLOOD F MET, V36, P1434, DOI 10.1177/0271678X15620204; Helmy A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039677; Herx LM, 2000, J IMMUNOL, V165, P2232, DOI 10.4049/jimmunol.165.4.2232; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; Holmin S, 1999, NEUROREPORT, V10, P1889, DOI 10.1097/00001756-199906230-00017; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Iwamoto Y, 1997, NEUROSURGERY, V40, P163, DOI 10.1097/00006123-199701000-00036; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Juurlink BHJ, 1998, GLIA, V22, P371, DOI 10.1002/(SICI)1098-1136(199804)22:4<371::AID-GLIA6>3.0.CO;2-6; Kaiser CL, 2009, LARYNGOSCOPE, V119, P1770, DOI 10.1002/lary.20557; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Karperien A, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00003; Kinoshita K, 2002, NEUROSURGERY, V51, P195, DOI 10.1097/00006123-200207000-00027; Knoblach SM, 2000, NEUROSCI LETT, V289, P5, DOI 10.1016/S0304-3940(00)01263-5; Kuhlow CJ, 2003, GLIA, V44, P76, DOI 10.1002/glia.10273; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; LI YH, 1993, CARDIOVASC RES, V27, P525, DOI 10.1093/cvr/27.3.525; Lotocki G, 2011, NEUROSCI LETT, V499, P143, DOI 10.1016/j.neulet.2011.05.056; Mason JL, 2001, J NEUROSCI, V21, P7046, DOI 10.1523/JNEUROSCI.21-18-07046.2001; McTigue DM, 2008, J NEUROCHEM, V107, P1, DOI 10.1111/j.1471-4159.2008.05570.x; Merrill JE, 1996, TRENDS NEUROSCI, V19, P331, DOI 10.1016/0166-2236(96)10047-3; Mierzwa AJ, 2015, J NEUROPATH EXP NEUR, V74, P218, DOI 10.1097/NEN.0000000000000165; Miron VE, 2013, NAT NEUROSCI, V16, P1211, DOI 10.1038/nn.3469; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Nave KA, 2010, NATURE, V468, P244, DOI 10.1038/nature09614; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Qiu JH, 2002, J NEUROSCI, V22, P3504; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Ruscher K, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045118; Salter MG, 2005, NATURE, V438, P1167, DOI 10.1038/nature04301; Sanderson KL, 1999, J CEREBR BLOOD F MET, V19, P1118, DOI 10.1097/00004647-199910000-00008; Schneider H, 1998, P NATL ACAD SCI USA, V95, P7778, DOI 10.1073/pnas.95.13.7778; Soares HD, 1995, J NEUROSCI, V15, P8223; Sullivan GM, 2013, J NEUROPATH EXP NEUR, V72, P1106, DOI 10.1097/NEN.0000000000000009; Takahashi JL, 2003, ANN NEUROL, V53, P588, DOI 10.1002/ana.10519; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00351; TOULMOND S, 1995, BRAIN RES, V671, P261, DOI 10.1016/0006-8993(94)01343-G; Vela JM, 2002, MOL CELL NEUROSCI, V20, P489, DOI 10.1006/mcne.2002.1127; Wang XJ, 2005, ACTA PHARMACOL SIN, V26, P934, DOI 10.1111/j.1745-7254.2005.00152.x; Wheeler NA, 2016, EXP NEUROL, V283, P512, DOI 10.1016/j.expneurol.2016.03.019; Williams MR, 2008, ENDOTHELIUM-J ENDOTH, V15, P73, DOI 10.1080/10623320802092443; Xu X, 1997, P NATL ACAD SCI USA, V94, P12655, DOI 10.1073/pnas.94.23.12655; Yakovlev AG, 1997, J NEUROSCI, V17, P7415; Yeo YA, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-173; Yirmiya R, 2002, NEUROBIOL LEARN MEM, V78, P379, DOI 10.1006/nlme.2002.4072; Zeng CB, 2010, BRAIN RES, V1319, P21, DOI 10.1016/j.brainres.2009.12.092; Zhang DD, 2008, IEEE ENG MED BIO, P4712, DOI 10.1109/IEMBS.2008.4650265; Zhang XP, 2006, J NEUROTRAUM, V23, P1583, DOI 10.1089/neu.2006.23.1583; Zhao SC, 2017, ACTA PHARMACOL SIN, V38, P445, DOI 10.1038/aps.2016.162	81	15	15	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2018	35	23					2837	2849		10.1089/neu.2018.5660			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HB1WO	WOS:000450819000010	29690837	Green Submitted, hybrid, Green Published			2022-02-06	
J	Tierney, GJ; Simms, CK				Tierney, Gregory J.; Simms, Ciaran K.			Can tackle height influence head injury assessment risk in elite rugby union?	JOURNAL OF SCIENCE AND MEDICINE IN SPORT			English	Article						Concussion; Head impact; Tackling; Injury prevention	VIDEO ANALYSIS; EPIDEMIOLOGY; CONCUSSION; EVENTS	Objectives: Tackle height laws are an area of controversy in rugby union. It is reported that the tackler is at most risk of a Head Injury Assessment (HIA). Therefore, the aim of this study was to use match video evidence of tackles in elite level rugby union to examine the effect of tackle heights on HIA risk for the tackler. Design: Qualitative observational case-control study. Methods: Each HIA (n = 74) and control tackle (n = 965) was categorised based on tackle direction (front- or side-on), tackle type (arm, shoulder or smother) and tackle height (upper trunk, mid-trunk, lower trunk, upper leg or lower leg). The Relative Risk (RR), 95% Confidence Interval (CI) and probability (p) values were calculated for each tackle height. Results: Intended primary contact at the upper trunk of the ball carrier had a greater propensity to result in a HIA for the tackler for front-on upper body shoulder tackles (RR = 1.48; 95%CI = 1.16-1.90; p < 0.01) and side-on upper body smother tackles (RR = 2.30; 95%CI = 1.82-2.92; p < 0.01). Intended primary contact at the upper leg of the ball carrier had a greater propensity to result in a HIA for the tackler for front-on (RR = 2.60; 95%CI = 1.70-3.97; p < 0.01) and side-on (RR = 3.34; 95%CI = 1.65-6.79; p < 0.01) lower body shoulder tackles. Conclusions: To reduce tackler HIA risk, the results suggest tackling below the upper trunk for upper body tackles. The results also suggest tackling at the lower trunk for lower body tackles and avoiding the upper legs. Prevention strategies should place emphasis on tackling lower risk body regions such as the mid- and lower trunk. (C) 2018 Sports Medicine Australia. Published by Elsevier Ltd. All rights reserved.	[Tierney, Gregory J.; Simms, Ciaran K.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland		Tierney, GJ (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin, Ireland.	gtierne@tcd.ie			Irish Research CouncilIrish Research Council for Science, Engineering and Technology	The authors would like to thank the Irish Research Council for funding this study.	Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Cross MJ, 2019, BRIT J SPORT MED, V53, P1021, DOI 10.1136/bjsports-2017-097912; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Fuller GW, 2017, J SCI MED SPORT, V20, P246, DOI 10.1016/j.jsams.2016.07.008; Gabbett T, 2007, INT J SPORTS SCI COA, V2, P467, DOI [10.1260/174795407783359731, DOI 10.1260/174795407783359731]; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hendricks S, 2014, J SPORT SCI MED, V13, P715; Hopkins W.G., 2010, SPORTSCIENCE, V14, P49; Koch Gary G., 1977, BIOMETRICS, V15, P9; Mc Fie S., 2016, BMJ OPEN SPORT EXERC, V2, P000053, DOI [10.1136/bmjsem-2015-000053, DOI 10.1136/BMJSEM-2015-000053]; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Montgomery C, 2018, BRIT J SPORT MED, V52, P994, DOI 10.1136/bjsports-2016-096425; Quarrie KL, 2008, AM J SPORT MED, V36, P1705, DOI 10.1177/0363546508316768; Rugby Football Union, ENGL PROF RUGB INJ S; Scher A., 1978, DRUG RES, V5, P197; Simms CK., 2017, IRCOBI C P; Tierney GJ, 2015, IRCOBI C P; Tierney GJ, 2016, ISBS C P ARCH; Tierney GJ, 2018, MED SCI SPORT EXER, V50, P603, DOI 10.1249/MSS.0000000000001461; Tierney Gregory J, 2018, J Sci Med Sport, V21, P221, DOI 10.1016/j.jsams.2017.06.023; Tierney GJ, 2018, INT J SPORTS SCI COA, V13, P415, DOI 10.1177/1747954117751345; Tierney GJ, 2017, BRAIN INJURY, V31, P1925, DOI 10.1080/02699052.2017.1385853; Tierney Gregory J, 2018, Sports Biomech, V17, P33, DOI 10.1080/14763141.2016.1271905; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Tucker R, 2017, BRIT J SPORT MED, V51, P1147, DOI 10.1136/bjsports-2017-097883; Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774	29	15	15	0	11	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	1440-2440	1878-1861		J SCI MED SPORT	J. Sci. Med. Sport	DEC	2018	21	12					1210	1214		10.1016/j.jsams.2018.05.010			5	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	HF4FM	WOS:000454188600007	29801755	Green Published, Green Accepted			2022-02-06	
J	Younis, SMZ; Ammar, A				Younis, Syed Muhammad Zubair; Ammar, Ahmad			Quantification of impact of changes in land use-land cover on hydrology in the upper Indus Basin, Pakistan	EGYPTIAN JOURNAL OF REMOTE SENSING AND SPACE SCIENCES			English	Article						HEC-HMS; Indus above Tarbela; LULC change; LandSat; TRMM		Empirically based lumped hydrologic models have an extensive track record of use for various watershed managements and flood related studies. This study focuses on the impacts of land use land cover change for a 10 year period (2000-2010) on the stream discharge in a sub-watershed of Indus River using lumped model HEC-HMS. The input variables for model building in HEC-HMS were calculated based on the DEM, LULC, soil and precipitation data which was collected and pre-processed in HEC-GeoHMS. The model was calibrated for the year 2000 and validation was done for 2010. The statistics shows correlation coefficient = 0.96, relative Bias = -9% and Nash-Sutcliffe coefficient of efficiency (NSCE) = 0.87. The validation statistics are Correlation Coefficient = 0.95, Bias = -14% and NSCE = 0.91. The model results shows that LULC change analysis using Landsat images in 10 years the overall concussion of change on discharge has been negligible in the study area. Due to decrease in forest the percent of bare soil and built up area increases. This conclusion was further supported by the LULC change analysis conducted on a local scale metropolitan district of Mansehra (16 km(2)). Soil and built up area in this sub-watershed increased from 69%, 8.2% in 2000 to 78%, 13.76% in 2010 respectively, whereas the corresponding river discharge increased by 33.61% from year 2000-2010, proving strong positive correlation on a local scale between the LULC and the river discharge. (C) 2017 National Authority for Remote Sensing and Space Sciences. Production and hosting by Elsevier B.V.	[Younis, Syed Muhammad Zubair; Ammar, Ahmad] Natl Univ Sci & Technol, Sch Civil & Environm Engn, Inst Geog Informat Syst, H-12 Sect, Islamabad, Pakistan		Younis, SMZ (corresponding author), Natl Univ Sci & Technol, Sch Civil & Environm Engn, Inst Geog Informat Syst, H-12 Sect, Islamabad, Pakistan.	zubair10@igis.nust.edu.pk	Zubair, Syed/Y-7112-2019	Zubair, Syed/0000-0002-3560-1821			Ali KF, 2007, J HYDROL, V334, P368, DOI 10.1016/j.jhydrol.2006.10.013; Andreassian V, 2001, J HYDROL, V250, P206, DOI 10.1016/S0022-1694(01)00437-1; Bookhagen B, 2010, J GEOPHYS RES-EARTH, V115, DOI 10.1029/2009JF001426; Dai XL, 1999, IEEE T GEOSCI REMOTE, V37, P2351, DOI 10.1109/36.789634; Draper CS, 2009, REMOTE SENS ENVIRON, V113, P703, DOI 10.1016/j.rse.2008.11.011; Foody GM, 2004, PHOTOGRAMM ENG REM S, V70, P627, DOI 10.14358/PERS.70.5.627; Jha AK, 2012, CITIES AND FLOODING: A GUIDE TO INTEGRATED URBAN FLOOD RISK MANAGEMENT FOR THE 21ST CENTURY, P1, DOI 10.1596/978-0-8213-8866-2; Lan J, 2012, EVALUATION IMPACT LA; Maity D.K, 2009, HYDROLOGICAL 1 D HYD; Majidi A, 2013, CURR ADV ENV SCI, V1, P7; Melesse AM, 2002, COMPUT ELECTRON AGR, V37, P173, DOI 10.1016/S0168-1699(02)00111-4; Younis SMZ, 2015, EGYPT J REMOTE SENS, V18, P151, DOI 10.1016/j.ejrs.2015.10.001; Zhou TJ, 2008, J CLIMATE, V21, P3997, DOI 10.1175/2008JCLI2028.1	13	15	15	0	2	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1110-9823	2090-2476		EGYPT J REMOTE SENS	Egypt. J. Remote Sens. Space Sci.	DEC	2018	21	3					255	263		10.1016/j.ejrs.2017.11.001			9	Environmental Sciences; Remote Sensing	Science Citation Index Expanded (SCI-EXPANDED)	Environmental Sciences & Ecology; Remote Sensing	HC1JD	WOS:000451555900007		gold			2022-02-06	
J	Zhang, M; Wu, YQ; Xie, L; Teng, CH; Wu, FF; Xu, KB; Chen, X; Xiao, J; Zhang, HY; Chen, DQ				Zhang, Man; Wu, Yanqing; Xie, Ling; Teng, Chen-Huai; Wu, Fang-Fang; Xu, Ke-Bin; Chen, Xiong; Xiao, Jian; Zhang, Hong-Yu; Chen, Da-Qing			Isoliquiritigenin protects against blood-brain barrier damage and inhibits the secretion of pro-inflammatory cytokines in mice after traumatic brain injury	INTERNATIONAL IMMUNOPHARMACOLOGY			English	Article						Isoliquiritigenin; Traumatic brain injury (TBI); Blood-brain barrier (BBB); Inflammation; PI3K/AKT/GSK-3 beta/NF-kappa B signalling pathway	NF-KAPPA-B; ACTIVATION; GROWTH; AKT; CELLS	Traumatic brain injury (TBI) caused by an external mechanical force acting on the brain is a serious neurological condition. Inflammation plays an important role in prolonging secondary tissue injury after TBI, leading to neuronal cell death and dysfunction. Isoliquiritigenin (ILG) is a flavonoid monomer with anti-inflammatory characteristic. Thus, we had investigated the potential protective effects of ILG on TBI-induced injuries and identified the mechanisms underlying it. Here, we have demonstrated that ILG preserves blood brain barrier (BBB) integrity in vivo, suppresses the activation of microglia and inflammatory responses in mice after TBI, consequently leading to neurofunctional deficits, brain oedema, structural damage, and macrophage infiltration. In vitro, ILG exerts anti-inflammatory effect, and upregulates tight junction proteins 120-beta-catenin and occludin in SH-SY5Y cells under oxygen glucose deprivation/reoxygenation (OGD/D) condition. Additionally, we found that PI3K/AKT/GSK-3 beta signalling pathway is involved in ILG treatment for TBI. To further confirm it, we had used SC79 (ethyl 2-amino-6-chloro-4-(1-cyano-2-ethcory-2-oxoethyl)-4H-chromene-3-carboxylate), an Akt specific activator, to activate Akt, we found that SC79 partially reduces the protective effect of ILG for TBI. Overall, our current study reveals the neuroprotective role of ILG on TBI-induced BBB damage, downregulated tight junction proteins via PI3K/AKT/GSK-3 beta signalling pathway. Furthermore, ILG suppresses the secretion of pro inflammatory cytokines after TBI through inhibiting the PI3K/AKT/GSK-3 beta/NF-kappa B signalling pathway. Our findings suggest that GSK-3 beta is a key regulatory factor during TBI-induced secretion of inflammatory cytokines, neuronal apoptosis and destruction of BBB.	[Zhang, Man; Teng, Chen-Huai; Wu, Fang-Fang; Chen, Da-Qing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou, Zhejiang, Peoples R China; [Zhang, Man; Teng, Chen-Huai; Wu, Fang-Fang; Chen, Da-Qing] Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China; [Wu, Yanqing; Xie, Ling; Xu, Ke-Bin; Xiao, Jian; Zhang, Hong-Yu] Wenzhou Med Univ, Sch Pharmaceut Sci, Mol Pharmacol Res Ctr, Wenzhou, Zhejiang, Peoples R China; [Chen, Xiong] Wenzhou Med Univ, Affiliated Hosp 1, Dept Endocrinol, Wenzhou, Zhejiang, Peoples R China; [Wu, Yanqing] Wenzhou Univ, Inst Life Sci, Wenzhou 325035, Zhejiang, Peoples R China		Chen, DQ (corresponding author), Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou, Zhejiang, Peoples R China.; Chen, DQ (corresponding author), Wenzhou Med Univ, Yuying Childrens Hosp, Wenzhou, Zhejiang, Peoples R China.; Zhang, HY (corresponding author), Wenzhou Med Univ, Sch Pharmaceut Sci, Mol Pharmacol Res Ctr, Wenzhou, Zhejiang, Peoples R China.	hyzhang@wmu.edu.cn; cdg1965@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81472165, 81772450, 81572237, 81501953]; National Science Fund for Outstanding Young ScholarsNational Natural Science Foundation of China (NSFC)National Science Fund for Distinguished Young Scholars [81722028]; Zhejiang Provincial Natural Science Funding [Q18H150013]	Funding from the National Natural Science Foundation of China (81472165, 81772450, 81572237, 81501953), The National Science Fund for Outstanding Young Scholars (81722028) and Zhejiang Provincial Natural Science Funding (Q18H150013).	Abbott NJ, 2013, J INHERIT METAB DIS, V36, P437, DOI 10.1007/s10545-013-9608-0; Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Bao H, 2015, KIDNEY INT, V87, P1176, DOI 10.1038/ki.2014.428; Bhat RV, 2000, P NATL ACAD SCI USA, V97, P11074, DOI 10.1073/pnas.190297597; Chen TB, 2017, BMC PHARMACOL TOXICO, V18, DOI 10.1186/s40360-017-0165-2; Chen X, 2018, BIOCHEM BIOPH RES CO, V496, P245, DOI 10.1016/j.bbrc.2017.11.159; Fan CD, 2013, J BIOL CHEM, V288, P1674, DOI 10.1074/jbc.M112.416339; Gao F, 2017, INT J NANOMED, V12, P4147, DOI 10.2147/IJN.S134148; Gatson JW, 2015, BRAIN RES BULL, V112, P35, DOI 10.1016/j.brainresbull.2015.01.008; Gong RJ, 2008, J BIOL CHEM, V283, P7401, DOI 10.1074/jbc.M710396200; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Han XF, 2018, ONCOL LETT, V16, P2638, DOI 10.3892/ol.2018.8905; He ZL, 2017, J CELL MOL MED, V21, P3010, DOI 10.1111/jcmm.13212; Honda H, 2012, J LEUKOCYTE BIOL, V91, P967, DOI 10.1189/jlb.0112038; Hsieh CL, 2013, EUR J IMMUNOL, V43, P2010, DOI 10.1002/eji.201243084; Jo H, 2012, P NATL ACAD SCI USA, V109, P10581, DOI 10.1073/pnas.1202810109; Jung SK, 2014, J BIOL CHEM, V289, P35839, DOI 10.1074/jbc.M114.585513; Kumar A, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0819-4; Kumar A, 2016, BRAIN BEHAV IMMUN, V58, P291, DOI 10.1016/j.bbi.2016.07.158; Li N, 2018, ONCOTARGETS THER, V11, P1633, DOI 10.2147/OTT.S149295; Li ZM, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18020315; Liang X, 2015, ELIFE, V4, DOI 10.7554/eLife.08973; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Liu QM, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01518; Liu Y, 2010, J NEUROSCI, V30, P15210, DOI 10.1523/JNEUROSCI.3950-10.2010; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; McLellan Gillian J., 2016, J OCUL BIOL, V4; Morganti JM, 2015, J NEUROSCI, V35, P748, DOI 10.1523/JNEUROSCI.2405-14.2015; Nicholson-Fish JC, 2016, NEUROCHEM RES, V41, P534, DOI 10.1007/s11064-015-1663-5; Phukan S, 2010, BRIT J PHARMACOL, V160, P1, DOI 10.1111/j.1476-5381.2010.00661.x; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Sayas CL, 2006, MOL BIOL CELL, V17, P1834, DOI 10.1091/mbc.E05-07-0688; Silva-Garcia O, 2018, FRONT IMMUNOL, V9, DOI 10.3389/fimmu.2018.00092; Skovira JW, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0769-2; Vanhaesebroeck B, 2000, BIOCHEM J, V346, P561, DOI 10.1042/0264-6021:3460561; Wang ZX, 2016, MOL NEUROBIOL, V53, P1905, DOI 10.1007/s12035-015-9143-0; Xiao H, 2017, J NEUROCHEM, V142, P194, DOI 10.1111/jnc.14051; Xu KB, 2018, CHEM-BIOL INTERACT, V286, P96, DOI 10.1016/j.cbi.2018.02.028; Zeng J, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0895-5; Zhang L, 2011, J BIOL CHEM, V286, P16879, DOI 10.1074/jbc.M110.186932; Zhang X, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/631326; Zhou YL, 2014, ONCOL REP, V31, P298, DOI 10.3892/or.2013.2849; Zou P., 2018, INFLAMMOPHARMACOLOGY	43	15	15	0	11	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1567-5769	1878-1705		INT IMMUNOPHARMACOL	Int. Immunopharmacol.	DEC	2018	65						64	75		10.1016/j.intimp.2018.09.046			12	Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Pharmacology & Pharmacy	HE0EV	WOS:000452940500010	30290368				2022-02-06	
J	Radford, KD; Park, TY; Jaiswal, S; Pan, HN; Knutsen, A; Zhang, M; Driscoll, M; Osborne-Smith, LA; Dardzinski, BJ; Choi, KH				Radford, Kennett D.; Park, Thomas Y.; Jaiswal, Shalini; Pan, Hongna; Knutsen, Andrew; Zhang, Michael; Driscoll, Mercedes; Osborne-Smith, Lisa A.; Dardzinski, Bernard J.; Choi, Kwang H.			Enhanced fear memories and brain glucose metabolism (F-18-FDG-PET) following sub-anesthetic intravenous ketamine infusion in Sprague-Dawley rats	TRANSLATIONAL PSYCHIATRY			English	Article							POSTTRAUMATIC-STRESS-DISORDER; DOSE-RESPONSE CHARACTERISTICS; ANIMAL-MODEL; NMDA ANTAGONIST; SEX-DIFFERENCES; EXTINCTION; CONSOLIDATION; LOCOMOTION; PSYCHOSIS; ACQUISITION	Ketamine is a multimodal dissociative anesthetic, which provides powerful analgesia for victims with traumatic injury. However, the impact of ketamine administration in the peri-trauma period on the development of post-traumatic stress disorder (PTSD) remains controversial. Moreover, there is a major gap between preclinical and clinical studies because they utilize different doses and routes of ketamine administration. Here, we investigated the effects of sub-anesthetic doses of intravenous (IV) ketamine infusion on fear memory and brain glucose metabolism (BGluM) in rats. Male Sprague-Dawley rats received an IV ketamine infusion (0, 2, 10, and 20 mg/kg, 2 h) or an intraperitoneal (IP) injection (0 and 10 mg/kg) following an auditory fear conditioning (3 pairings of tone and foot shock [0.6 mA, 1 s]) on day 0. Fear memory retrieval, fear extinction, and fear recall were tested on days 2, 3, and 4, respectively. The effects of IV ketamine infusion (0 and 10 mg/kg) on BGluM were measured using F-18-fluoro-deoxyglucose positron emission tomography (FDG-PET) and computed tomography (CT). The IV ketamine infusion dose-dependently enhanced fear memory retrieval, delayed fear extinction, and increased fear recall in rats. The IV ketamine (10 mg/kg) increased BGluM in the hippocampus, amygdala, and hypothalamus, while decreasing it in the cerebellum. On the contrary, a single ketamine injection (10 mg/kg, IP) after fear conditioning facilitated fear memory extinction in rats. The current findings suggest that ketamine may produce differential effects on fear memory depending on the route and duration of ketamine administration.	[Radford, Kennett D.; Choi, Kwang H.] Uniformed Serv Univ Hlth Sci, Daniel K Inouye Grad Sch Nursing, Bethesda, MD 20814 USA; [Park, Thomas Y.; Zhang, Michael; Choi, Kwang H.] Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA; [Park, Thomas Y.; Zhang, Michael; Choi, Kwang H.] Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Bethesda, MD 20814 USA; [Jaiswal, Shalini; Pan, Hongna; Knutsen, Andrew; Dardzinski, Bernard J.] Uniformed Serv Univ Hlth Sci, Ctr Neurosci & Regenerat Med, Bethesda, MD 20814 USA; [Driscoll, Mercedes] Walter Reed Natl Mil Med Ctr, Natl Capital Consortium, Psychiat Residency Program, Bethesda, MD 20814 USA; [Osborne-Smith, Lisa A.] Oregon Hlth & Sci Univ, Nurse Anesthesia Program, Portland, OR 97239 USA; [Dardzinski, Bernard J.] Uniformed Serv Univ Hlth Sci, Dept Radiol & Radiol Sci, Bethesda, MD 20814 USA		Choi, KH (corresponding author), Uniformed Serv Univ Hlth Sci, Daniel K Inouye Grad Sch Nursing, Bethesda, MD 20814 USA.; Choi, KH (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Psychiat, Bethesda, MD 20814 USA.; Choi, KH (corresponding author), Uniformed Serv Univ Hlth Sci, Ctr Study Traumat Stress, Bethesda, MD 20814 USA.	kwang.choi@usuhs.edu		Dardzinski, Bernard/0000-0001-7098-9131	Tri-Service Nursing Research Program [N16-P14]; Jonas Center for Nursing and Veterans Healthcare	This work was financially supported by a Tri-Service Nursing Research Program Grant #: N16-P14. K.D.R. is a Jonas Scholar (2016-2018) and is supported by the Jonas Center for Nursing and Veterans Healthcare. We would like to thank Dr. Irwin Lucki for the critical review of the manuscript.	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Averill LA, 2017, NEUROSCI LETT, V649, P147, DOI 10.1016/j.neulet.2016.11.064; Baker JD, 1996, BEHAV NEUROSCI, V110, P618, DOI 10.1037/0735-7044.110.3.618; Becker A, 2003, PROG NEURO-PSYCHOPH, V27, P687, DOI 10.1016/S0278-5846(03)00080-0; Breier A, 1997, AM J PSYCHIAT, V154, P805; Burghardt NS, 2013, BIOL PSYCHIAT, V73, P1078, DOI 10.1016/j.biopsych.2012.10.012; Carlson PJ, 2013, BIOL PSYCHIAT, V73, P1213, DOI 10.1016/j.biopsych.2013.02.008; Carrier N, 2013, NEUROPHARMACOLOGY, V70, P27, DOI 10.1016/j.neuropharm.2012.12.009; Clifton NE, 2018, J PSYCHOPHARMACOL, V32, P156, DOI 10.1177/0269881117748903; COHEN ML, 1973, ANESTHESIOLOGY, V39, P370, DOI 10.1097/00000542-197310000-00003; Corlett PR, 2007, J PSYCHOPHARMACOL, V21, P238, DOI 10.1177/0269881107077716; Corlett PR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065088; CROSBY G, 1982, ANESTHESIOLOGY, V56, P437, DOI 10.1097/00000542-198206000-00005; Davis Michael, 2011, Dialogues Clin Neurosci, V13, P463; Franceschelli A, 2015, NEUROSCIENCE, V290, P49, DOI 10.1016/j.neuroscience.2015.01.008; Gao M, 2016, ACTA PHARMACOL SIN, V37, P865, DOI 10.1038/aps.2016.5; Getova Damianka P, 2011, Folia Med (Plovdiv), V53, P53; Girgenti MJ, 2017, NEUROBIOL DIS, V100, P1, DOI 10.1016/j.nbd.2016.12.026; Goulart BK, 2010, NEUROSCIENCE, V167, P969, DOI 10.1016/j.neuroscience.2010.03.032; HETZLER BE, 1985, PHARMACOL BIOCHEM BE, V22, P653, DOI 10.1016/0091-3057(85)90291-6; Honsberger MJ, 2015, SCHIZOPHR RES, V164, P227, DOI 10.1016/j.schres.2015.02.009; Imre G, 2006, BRAIN RES BULL, V69, P338, DOI 10.1016/j.brainresbull.2006.01.010; Johnson PL, 2015, PHARMACOL BIOCHEM BE, V138, P174, DOI 10.1016/j.pbb.2015.09.021; Jovanovic T, 2012, NEUROPHARMACOLOGY, V62, P695, DOI 10.1016/j.neuropharm.2011.02.023; Juven-Wetzler A, 2014, EUR NEUROPSYCHOPHARM, V24, P469, DOI 10.1016/j.euroneuro.2013.08.007; Kotermanski SE, 2013, PHARMACOL BIOCHEM BE, V109, P67, DOI 10.1016/j.pbb.2013.05.005; KRYSTAL JH, 1994, ARCH GEN PSYCHIAT, V51, P199, DOI 10.1001/archpsyc.1994.03950030035004; Lally N, 2015, J PSYCHOPHARMACOL, V29, P596, DOI 10.1177/0269881114568041; Liu JL, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007548; MARIETTA MP, 1976, J PHARMACOL EXP THER, V196, P536; McGhee LL, 2014, MIL MED, V179, P41, DOI 10.7205/MILMED-D-13-00481; McGowan JC, 2017, NEUROPSYCHOPHARMACOL, V42, P1577, DOI 10.1038/npp.2017.19; Mion G, 2017, ANAESTHESIA, V72, P1476, DOI 10.1111/anae.14079; Moghaddam B, 1997, J NEUROSCI, V17, P2921; Moosavi M, 2012, EUR J PHARMACOL, V677, P107, DOI 10.1016/j.ejphar.2011.12.021; Morena M, 2017, BEHAV BRAIN RES, V329, P215, DOI 10.1016/j.bbr.2017.04.048; Morris C, 2009, ANAESTHESIA, V64, P532, DOI 10.1111/j.1365-2044.2008.05835.x; Palenicek T, 2011, NEUROPSYCHOBIOLOGY, V63, P202, DOI 10.1159/000321803; Park TY, 2017, EUR J NEUROSCI, V45, P922, DOI 10.1111/ejn.13542; Pollard M, 2012, BEHAV BRAIN RES, V227, P184, DOI 10.1016/j.bbr.2011.10.050; Radford KD, 2017, PHARMACOL BIOCHEM BE, V153, P130, DOI 10.1016/j.pbb.2016.12.014; Radvansky B. M, 2015, BIOMED RES INT, V2015, P1; Saur L, 2017, NEUROSCI LETT, V658, P6, DOI 10.1016/j.neulet.2017.08.026; Schonenberg M, 2008, J PSYCHOPHARMACOL, V22, P493, DOI 10.1177/0269881107082481; Silvestre J S, 1997, Depress Anxiety, V5, P29, DOI 10.1002/(SICI)1520-6394(1997)5:1<29::AID-DA5>3.0.CO;2-0; Travis CMG, 2015, PHARMACOL BIOCHEM BE, V139, P84, DOI 10.1016/j.pbb.2015.10.013; Trujillo KA, 2011, ILAR J, V52, P366, DOI 10.1093/ilar.52.3.366; Vollenweider FX, 1997, EUR NEUROPSYCHOPHARM, V7, P9, DOI 10.1016/S0924-977X(96)00039-9; WATERMAN AE, 1978, BRIT J ANAESTH, V50, P885, DOI 10.1093/bja/50.9.885; Wicking M, 2016, NEUROBIOL LEARN MEM, V136, P116, DOI 10.1016/j.nlm.2016.09.016; Winter H, 2004, AM J PSYCHIAT, V161, P2194, DOI 10.1176/appi.ajp.161.12.2194; Zhang LM, 2015, PSYCHOPHARMACOLOGY, V232, P663, DOI 10.1007/s00213-014-3697-9; Zhu YQ, 2016, J NUCL MED, V57, P1474, DOI 10.2967/jnumed.116.173443	53	15	15	1	3	NATURE PUBLISHING GROUP	NEW YORK	75 VARICK ST, 9TH FLR, NEW YORK, NY 10013-1917 USA	2158-3188			TRANSL PSYCHIAT	Transl. Psychiatr.	NOV 30	2018	8								263	10.1038/s41398-018-0310-8			12	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Psychiatry	HD2CO	WOS:000452318900001	30504810	Green Published, gold			2022-02-06	
J	Jiang, YJ; Cao, SQ; Gao, LB; Wang, YY; Zhou, B; Hu, X; Pu, Y; Li, ZL; Wang, Q; Xiao, X; Zhao, L; Wang, S; Liang, WB; Zhang, L				Jiang, You-jing; Cao, Shu-qiang; Gao, Lin-bo; Wang, Yan-yun; Zhou, Bin; Hu, Xin; Pu, Yan; Li, Zhi-long; Wang, Qian; Xiao, Xiao; Zhao, Li; Wang, Shuan; Liang, Wei-bo; Zhang, Lin			Circular Ribonucleic Acid Expression Profile in Mouse Cortex after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						bioinformatic analysis; ceRNA; circular RNAs (circRNAs); RNA-seq; traumatic brain injury (TBI)	CONTROLLED CORTICAL IMPACT; PROTECTS CEREBRAL AUTOREGULATION; SPINAL-CORD-INJURY; NEURAL STEM-CELLS; HIPPOCAMPAL NECROSIS; ERK MAPK; RECEPTORS; KINASE; RNAS; PATHOPHYSIOLOGY	Traumatic brain injury (TBI) causes high rates of worldwide death and morbidity because of the complex secondary injury cascade. Circular ribonucleic acid (RNA) (circRNA), a type of RNA that forms a covalently closed continuous loop, may be involved in the regulation of secondary injury because it is expressed widely in the brain and contributes to a large class of post-transcriptional regulators. Deep RNA sequencing (RNA-seq) and bioinformatic analysis were performed to investigate the expression profile and function of circRNAs in the mouse cortex after controlled cortical impact (CCI). A total of 19,794 circRNAs were identified, and 1315 were annotated in circBase. There were 191 filtered differentially expressed circRNAs (98 for up-regulated and 93 for down-regulated). The gene ontology and Kyoto Encyclopedia of Genes and Genomes analyses indicated that inflammation, cell death, and repair of damage were the main biological processes and molecular mechanisms related to altered circRNAs. The pathway-circRNA interaction network revealed three core circRNAs and five corepathways related to TBI. The circRNA-messenger RNA (mRNA) interaction network and competitive endogenous RNA (ceRNA) analysis suggested potential microRNA (miRNA) sponges and target mRNAs. In addition to five optimal circRNA-miRNA-mRNA pairs were analyzed, circRNA_16895-miRNA myosin-10 (Myo 10) was predicted to regulate fragment crystallizable gamma receptors (Fc gamma R)-mediated phagocytosis pathway. Four circRNAs were selected for quantitative real-time polymerase chain reaction analysis to validate the sequencing data. Our results provide promising functions of circRNAs aberrantly expressed in TBI to explore molecular mechanisms and potential therapeutic targets for its therapy.	[Jiang, You-jing; Cao, Shu-qiang; Pu, Yan; Li, Zhi-long; Wang, Qian; Xiao, Xiao; Zhao, Li; Wang, Shuan; Liang, Wei-bo; Zhang, Lin] Sichuan Univ, West China Sch Basic Sci & Forens Med, Dept Forens Genet, Chengdu 610041, Sichuan, Peoples R China; [Gao, Lin-bo; Wang, Yan-yun; Zhou, Bin; Zhang, Lin] Sichuan Univ, Lab Mol Translat Med,West China Univ Hosp 2, West China Inst Women & Childrens Hlth,Minist Edu, Key Lab Obstet & Gynecol & Pediat Dis & Birth Def, Chengdu, Sichuan, Peoples R China; [Hu, Xin] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu, Sichuan, Peoples R China; [Hu, Xin] Sichuan Univ, West China Hosp, West China Brain Res Ctr, Chengdu, Sichuan, Peoples R China		Liang, WB; Zhang, L (corresponding author), Sichuan Univ, West China Sch Basic Sci & Forens Med, Dept Forens Genet, Chengdu 610041, Sichuan, Peoples R China.	liangweibo@scu.edu.cn; zhanglin@scu.edu.cn	liang, weibo/G-8456-2011	liang, weibo/0000-0002-8487-3575	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471827]	We would like to thank Yuan-cun Zhao, Qi-zhao Ma, Ya-ping Song, and Xue-lian Zheng for their technical assistance. This work was supported by grants from the National Natural Science Foundation of China (No. 81471827).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Armstead WM, 2016, J NEUROTRAUM, V33, P1761, DOI 10.1089/neu.2015.4290; Bell JD, 2009, CELL DEATH DIFFER, V16, P1665, DOI 10.1038/cdd.2009.106; Berrout J, 2012, BRAIN RES, V1436, P1, DOI 10.1016/j.brainres.2011.11.044; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Brody DL, 2015, MOL CELL NEUROSCI, V66, P91, DOI 10.1016/j.mcn.2015.02.005; Chen T, 2017, NEUROCHEM RES, V42, P3073, DOI 10.1007/s11064-017-2340-7; Chen W, 2016, TRENDS NEUROSCI, V39, P597, DOI 10.1016/j.tins.2016.06.006; Curvello V, 2017, BRAIN RES, V1670, P118, DOI 10.1016/j.brainres.2017.06.010; Deng Z.F., 2018, CEREB CORTEX 2018; Ferguson AR, 2008, J NEUROSCI, V28, P11391, DOI 10.1523/JNEUROSCI.3708-08.2008; Filiano AJ, 2017, NAT REV NEUROSCI, V18, P375, DOI 10.1038/nrn.2017.39; Finsterer J, 2014, INT J CARDIOL, V177, P322, DOI 10.1016/j.ijcard.2014.08.101; Fiorino A, 2016, INT J BIOCHEM CELL B, V78, P162, DOI 10.1016/j.biocel.2016.07.013; Gao Y, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-014-0571-3; Glazar P, 2014, RNA, V20, P1666, DOI 10.1261/rna.043687.113; Guilliams M, 2014, NAT REV IMMUNOL, V14, P94, DOI 10.1038/nri3582; Hansen TB, 2013, NATURE, V495, P384, DOI 10.1038/nature11993; Herman DS, 2012, NEW ENGL J MED, V366, P619, DOI 10.1056/NEJMoa1110186; Hinson JT, 2015, SCIENCE, V349, P982, DOI 10.1126/science.aaa5458; Hipp N, 2017, NAT COMMUN, V8, DOI 10.1038/s41467-017-01475-7; Hoppmann N, 2015, BRAIN, V138, P902, DOI 10.1093/brain/awu408; Ju XD, 2014, CEREB CORTEX, V24, P1259, DOI 10.1093/cercor/bhs407; Kipnis J, 2016, SCIENCE, V353, P766, DOI 10.1126/science.aag2638; Krishnamoorthy V, 2016, CHEST, V149, P1325, DOI 10.1016/j.chest.2015.12.014; Kuwahara M, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12596; Kuwahara M, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms4555; Lange S, 2005, SCIENCE, V308, P1599, DOI 10.1126/science.1110463; Li D, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0841-6; Li D, 2017, BRAIN RES, V1654, P1, DOI 10.1016/j.brainres.2016.10.013; Li ML, 2017, CANCER LETT, V391, P20, DOI 10.1016/j.canlet.2016.12.027; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Lu D, 2016, FRONT GENET, V7, DOI [10.3389/fgene.2015.00053, 10.3389/fgene.2016.00053]; Lu KT, 2015, PFLUG ARCH EUR J PHY, V467, P1651, DOI 10.1007/s00424-014-1588-x; Lyu Q, 2017, CELL TRANSPLANT, V26, P1622, DOI 10.1177/0963689717723014; Ma CC, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0367-2; Ma J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0172178; Meldrum BS, 2000, J NUTR, V130, p1007S, DOI 10.1093/jn/130.4.1007S; Mellios N, 2018, MOL PSYCHIATR, V23, P1051, DOI 10.1038/mp.2017.86; Memczak S, 2013, NATURE, V495, P333, DOI 10.1038/nature11928; Micu I, 2006, NATURE, V439, P988, DOI 10.1038/nature04474; Miller G, 2010, SCIENCE, V328, P297, DOI 10.1126/science.328.5976.297; Mo MS, 2017, ONCOTARGET, V8, P15, DOI 10.18632/oncotarget.13905; Modigliani SD, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5335; Moon Y, 2011, NEUROREPORT, V22, P304, DOI 10.1097/WNR.0b013e3283460265; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; Ozisik K, 2004, AM J TRANSPLANT, V4, P900, DOI 10.1111/j.1600-6143.2004.00448.x; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Rubiano AM, 2015, NATURE, V527, pS193, DOI 10.1038/nature16035; Russo MV, 2016, SCIENCE, V353, P783, DOI 10.1126/science.aaf6260; Saika R, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0884-8; Santra M, 2016, J NEUROCHEM, V136, P118, DOI 10.1111/jnc.13394; Schafer S, 2017, NAT GENET, V49, P46, DOI 10.1038/ng.3719; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; Spaethling J, 2012, NEUROBIOL DIS, V46, P646, DOI 10.1016/j.nbd.2012.03.003; Sung JK, 2003, BRAIN RES, V959, P29, DOI 10.1016/S0006-8993(02)03717-4; Truettner JS, 2011, J CEREBR BLOOD F MET, V31, P1897, DOI 10.1038/jcbfm.2011.33; Venneti S, 2012, BRAIN PATHOL, V22, P522, DOI 10.1111/j.1750-3639.2011.00551.x; Wang CF, 2017, J NEUROTRAUM, V34, P2100, DOI 10.1089/neu.2016.4642; Wang WX, 2017, PROG NEURO-PSYCHOPH, V73, P104, DOI 10.1016/j.pnpbp.2016.02.011; Weber KL, 2004, NATURE, V431, P325, DOI 10.1038/nature02834; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xia HP, 2010, J BIOL CHEM, V285, P36995, DOI 10.1074/jbc.M110.133744; Xiong ZG, 2004, CELL, V118, P687, DOI 10.1016/j.cell.2004.08.026; Yang H, 2017, ACTA PHARMACOL SIN, V38, P168, DOI 10.1038/aps.2016.130; Yang J, 2015, CELL, V160, P161, DOI 10.1016/j.cell.2014.11.053; Yang TS, 2018, REDOX BIOL, V15, P159, DOI 10.1016/j.redox.2017.11.025; Yilmaz G, 2006, CIRCULATION, V113, P2105, DOI 10.1161/CIRCULATIONAHA.105.593046; Zhao B, 2017, MED SCI MONITOR, V23, P1872, DOI 10.12659/MSM.901055; Zheng QP, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11215	70	15	17	5	14	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2019	36	7					1018	1028		10.1089/neu.2018.5647		NOV 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	HQ4DT	WOS:000450807900001	30261810				2022-02-06	
J	Bae, YH; Joo, H; Bae, J; Hyeon, SJ; Her, S; Ko, E; Choi, HG; Ryu, H; Hur, EM; Bu, Y; Lee, BD				Bae, Yun-Hee; Joo, Hyejin; Bae, Jinhyun; Hyeon, Seung Jae; Her, Song; Ko, Eunhwa; Choi, Hwan Geun; Ryu, Hoon; Hur, Eun-Mi; Bu, Youngmin; Lee, Byoung Dae			Brain injury induces HIF-1 alpha-dependent transcriptional activation of LRRK2 that exacerbates brain damage	CELL DEATH & DISEASE			English	Article							INDUCIBLE FACTOR (HIF)-1-ALPHA; GENOME-WIDE ASSOCIATION; PARKINSONS-DISEASE; KINASE-ACTIVITY; DOPAMINERGIC-NEURONS; SIGNALING PATHWAY; CORTICAL-NEURONS; IN-VITRO; EXPRESSION; PHOSPHORYLATION	Leucine-rich repeat kinase 2 (LRRK2), originally identified as a causative genetic factor in Parkinson's disease, is now associated with a number of pathologies. Here, we show that brain injury induces a robust expression of endogenous LRRK2 and suggest a role of LRRK2 after injury. We found that various in vitro and in vivo models of traumatic brain injury (TBI) markedly enhanced LRRK2 expression in neurons and also increased the level of hypoxia-inducible factor (HIF)-1 alpha. Luciferase reporter assay and chromatin immunoprecipitation revealed direct binding of HIF-1 alpha in LRRK2 proximal promoter. We also found that HIF-1 alpha-dependent transcriptional induction of LRRK2 exacerbated neuronal cell death fol lowing injury. Furthermore, application of G1023, a specific, brain-permeable inhibitor of LRRK2, substantially prevented brain tissue damage, cell death, and inflammatory response and alleviated motor and cognitive defects induced by control led cortical impact injury. Together, these results suggest HIF-1 alpha-LRRK2 axis as a potential therapeutic target for brain injury.	[Bae, Yun-Hee; Lee, Byoung Dae] Kyung Hee Univ, Grad Sch, Dept Neurosci, Seoul 02447, South Korea; [Joo, Hyejin] Kyung Hee Univ, Grad Sch, Dept Sci Korean Med, Seoul 02447, South Korea; [Bae, Jinhyun; Bu, Youngmin] Kyung Hee Univ, Coll Korean Med, Dept Herbal Pharmacol, Seoul 02447, South Korea; [Hyeon, Seung Jae; Ryu, Hoon] Korea Inst Sci & Technol, Brain Sci Inst, Ctr Neurosci, Seoul 02792, South Korea; [Her, Song] Korea Basic Sci Inst, Seoul 03759, South Korea; [Ko, Eunhwa; Choi, Hwan Geun] Daegu Gyeongbuk Med Innovat Fdn, New Drug Dev Ctr, Daegu 41061, South Korea; [Ryu, Hoon] Vet Affairs Boston Healthcare Syst, Boston, MA 02130 USA; [Ryu, Hoon] Boston Univ, Sch Med, Alzheimers Dis Ctr, Boston, MA 02118 USA; [Ryu, Hoon] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Hur, Eun-Mi] Seoul Natl Univ, Dept Neurosci, Coll Vet Med, Res Inst Vet Sci, Seoul 08826, South Korea; [Hur, Eun-Mi] Seoul Natl Univ, BK21 PLUS Program Creat Vet Sci Res, Seoul 08826, South Korea; [Lee, Byoung Dae] Kyung Hee Univ, Sch Med, Dept Physiol, Seoul 02447, South Korea		Lee, BD (corresponding author), Kyung Hee Univ, Grad Sch, Dept Neurosci, Seoul 02447, South Korea.; Bu, Y (corresponding author), Kyung Hee Univ, Coll Korean Med, Dept Herbal Pharmacol, Seoul 02447, South Korea.; Lee, BD (corresponding author), Kyung Hee Univ, Sch Med, Dept Physiol, Seoul 02447, South Korea.	ymbu@khu.ac.kr; bdaelee@khu.ac.kr	Hur, Eun Mi/AAU-4906-2021		Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF), MSIP [NRF-2017M3A9A8028619]; Brain Research Program through NRF - Ministry of Science, ICT & Future Planning [NRF-2016M3C7A1905386, NRF-2017M3C7A1043848]; Korea Institute of Science and TechnologyKorea Institute of Science & Technology (KIST) [H.R.2E27860]; Research Institute for Veterinary Science, Seoul National University	This research was supported by the Bio & Medical Technology Development Program of the National Research Foundation of Korea (NRF), MSIP (NRF-2017M3A9A8028619), the Brain Research Program through NRF funded by the Ministry of Science, ICT & Future Planning (NRF-2016M3C7A1905386, NRF-2017M3C7A1043848), Korea Institute of Science and Technology (H.R. 2E27860), and by the Research Institute for Veterinary Science, Seoul National University.	Alegre-Abarrategui J, 2009, HUM MOL GENET, V18, P4022, DOI 10.1093/hmg/ddp346; Avramovich-Tirosh Y, 2010, CURR ALZHEIMER RES, V7, P300, DOI 10.2174/156720510791162403; Barrett JC, 2008, NAT GENET, V40, P955, DOI 10.1038/ng.175; Biskup S, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-102; Biskup S, 2006, ANN NEUROL, V60, P557, DOI 10.1002/ana.21019; Chen CY, 2012, CELL DEATH DIFFER, V19, P1623, DOI 10.1038/cdd.2012.42; Choi W, 2017, EVID-BASED COMPL ALT, V2017; Cook DA, 2017, NPJ PARKINSONS DIS, V3, DOI 10.1038/s41531-017-0010-8; Cruz-Haces M, 2017, TRANSL NEURODEGENER, V6, DOI 10.1186/s40035-017-0088-2; Dengler VL, 2014, CRIT REV BIOCHEM MOL, V49, P1, DOI 10.3109/10409238.2013.838205; Di Fonzo A, 2005, LANCET, V365, P412; Gallo KA, 2002, NAT REV MOL CELL BIO, V3, P663, DOI 10.1038/nrm906; Gardet A, 2010, J IMMUNOL, V185, P5577, DOI 10.4049/jimmunol.1000548; Gilks WP, 2005, LANCET, V365, P415, DOI 10.1016/S0140-6736(05)17830-1; Gillardon F, 2012, NEUROSCIENCE, V208, P41, DOI 10.1016/j.neuroscience.2012.02.001; Gloeckner CJ, 2009, J NEUROCHEM, V109, P959, DOI 10.1111/j.1471-4159.2009.06024.x; Greggio E, 2006, NEUROBIOL DIS, V23, P329, DOI 10.1016/j.nbd.2006.04.001; Guzy RD, 2005, CELL METAB, V1, P401, DOI 10.1016/j.cmet.2005.05.001; Habig K, 2013, BBA-MOL BASIS DIS, V1832, P2352, DOI 10.1016/j.bbadis.2013.09.009; Hakimi M, 2011, J NEURAL TRANSM, V118, P795, DOI 10.1007/s00702-011-0653-2; Han BS, 2008, NEUROSCI LETT, V442, P190, DOI 10.1016/j.neulet.2008.06.086; Han ZL, 2014, BRAIN RES, V1582, P12, DOI 10.1016/j.brainres.2014.07.045; Jeong GR, 2018, MOL NEURODEGENER, V13, DOI 10.1186/s13024-018-0240-1; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kuss M, 2014, J NEUROCHEM, V129, P980, DOI 10.1111/jnc.12668; Lee BD, 2010, NAT MED, V16, P998, DOI 10.1038/nm.2199; Lee DW, 2009, J BIOL CHEM, V284, P29065, DOI 10.1074/jbc.M109.000638; Li AH, 2013, J MOL NEUROSCI, V51, P1052, DOI 10.1007/s12031-013-0084-7; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Maas AI, 2010, ARCH PHYS MED REHAB, V91, P1641, DOI 10.1016/j.apmr.2010.07.232; Mabjeesh NJ, 2003, CANCER CELL, V3, P363, DOI 10.1016/S1535-6108(03)00077-1; Maekawa T, 2010, BIOCHEM BIOPH RES CO, V392, P431, DOI 10.1016/j.bbrc.2010.01.041; Martin I, 2014, CELL, V157, P472, DOI 10.1016/j.cell.2014.01.064; Matta S, 2012, NEURON, V75, P1008, DOI 10.1016/j.neuron.2012.08.022; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; Melrose HL, 2007, NEUROSCIENCE, V147, P1047, DOI 10.1016/j.neuroscience.2007.05.027; Migheli R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0077198; Moehle MS, 2012, J NEUROSCI, V32, P1602, DOI 10.1523/JNEUROSCI.5601-11.2012; Mole DR, 2009, J BIOL CHEM, V284, P16767, DOI 10.1074/jbc.M901790200; Niu JW, 2012, J NEUROCHEM, V122, P650, DOI 10.1111/j.1471-4159.2012.07809.x; Orenstein SJ, 2013, NAT NEUROSCI, V16, P394, DOI 10.1038/nn.3350; Osier ND, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00134; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Rui Q, 2018, FRONT CELL NEUROSCI, V12, DOI 10.3389/fncel.2018.00051; Schodel J, 2011, BLOOD, V117, pE207, DOI 10.1182/blood-2010-10-314427; Sheng ZJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004485; Shi HL, 2009, CURR MED CHEM, V16, P4593, DOI 10.2174/092986709789760779; Smith WLW, 2006, NAT NEUROSCI, V9, P1231, DOI 10.1038/nn1776; Thevenet J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021519; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Wang JL, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0215-5; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; West AB, 2005, P NATL ACAD SCI USA, V102, P16842, DOI 10.1073/pnas.0507360102; Wiener CM, 1996, BIOCHEM BIOPH RES CO, V225, P485, DOI 10.1006/bbrc.1996.1199; Yeh SH, 2011, BRAIN PATHOL, V21, P249, DOI 10.1111/j.1750-3639.2010.00443.x; Yin J, 2017, CANCER RES, V77, P4973, DOI 10.1158/0008-5472.CAN-17-0388; Yoon JH, 2017, BBA-MOL CELL RES, V1864, P2356, DOI 10.1016/j.bbamcr.2017.09.001; Yu R, 2001, Chin J Traumatol, V4, P218; Zhang FR, 2009, NEW ENGL J MED, V361, P2609, DOI 10.1056/NEJMoa0903753; Zhang Z, 2011, CURR MED CHEM, V18, P4335, DOI 10.2174/092986711797200426; Zimprich A, 2004, NEURON, V44, P601, DOI 10.1016/j.neuron.2004.11.005	62	15	15	2	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	NOV 12	2018	9								1125	10.1038/s41419-018-1180-y			19	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	GZ9FV	WOS:000449803600001	30420654	gold, Green Published			2022-02-06	
J	Cherry, JD; Mez, J; Crary, JF; Tripodis, Y; Alvarez, VE; Mahar, I; Huber, BR; Alosco, ML; Nicks, R; Abdolmohammadi, B; Kiernan, PT; Evers, L; Svirsky, S; Babcock, K; Gardner, HM; Meng, GY; Nowinski, CJ; Martin, BM; Dwyer, B; Kowall, NW; Cantu, RC; Goldstein, LE; Katz, DI; Stern, RA; Farrer, LA; McKee, AC; Stein, TD				Cherry, Jonathan D.; Mez, Jesse; Crary, John F.; Tripodis, Yorghos; Alvarez, Victor E.; Mahar, Ian; Huber, Bertrand R.; Alosco, Michael L.; Nicks, Raymond; Abdolmohammadi, Bobak; Kiernan, Patrick T.; Evers, Laney; Svirsky, Sarah; Babcock, Katharine; Gardner, Hannah M.; Meng, Gaoyuan; Nowinski, Christopher J.; Martin, Brett M.; Dwyer, Brigid; Kowall, Neil W.; Cantu, Robert C.; Goldstein, Lee E.; Katz, Douglas I.; Stern, Robert A.; Farrer, Lindsay A.; McKee, Ann C.; Stein, Thor D.			Variation in TMEM106B in chronic traumatic encephalopathy	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						Chronic traumatic encephalopathy; TMEM106B; Neuroinflammation; Football; Traumatic brain injury; Tau; Genetics; TDP-43; Dementia	FRONTOTEMPORAL LOBAR DEGENERATION; CENTRAL-NERVOUS-SYSTEM; COGNITIVE IMPAIRMENT; NATIONAL INSTITUTE; ALZHEIMERS-DISEASE; CRITERIA; MICROGLIA; VARIANTS; BRAIN; NEUROPATHOLOGY	The genetic basis of chronic traumatic encephalopathy (CTE) is poorly understood. Variation in transmembrane protein 106B (TMEM106B) has been associated with enhanced neuroinflammation during aging and with TDP-43-related neurodegenerative disease, and rs3173615, a missense coding SNP in TMEM106B, has been implicated as a functional variant in these processes. Neuroinflammation and TDP-43 pathology are prominent features in CTE. The purpose of this study was to determine whether genetic variation in TMEM106B is associated with CTE risk, pathological features, and ante-mortem dementia. Eighty-six deceased male athletes with a history of participation in American football, informant-reported Caucasian, and a positive postmortem diagnosis of CTE without comorbid neurodegenerative disease were genotyped for rs3173615. The minor allele frequency (MAF=0.42) in participants with CTE did not differ from previously reported neurologically normal controls (MAF=0.43). However, in a case-only analysis among CTE cases, the minor allele was associated with reduced phosphorylated tau (ptau) pathology in the dorsolateral frontal cortex (DLFC) (AT8 density, odds ratio [OR] of increasing one quartile=0.42, 95% confidence interval [CI] 0.22-0.79, p=0.008), reduced neuroinflammation in the DLFC (CD68 density, OR of increasing one quartile=0.53, 95% CI 0.29-0.98, p=0.043), and increased synaptic protein density (=0.306, 95% CI 0.065-0.546, p=0.014). Among CTE cases, TMEM106B minor allele was also associated with reduced ante-mortem dementia (OR=0.40, 95% CI 0.16-0.99, p=0.048), but was not associated with TDP-43 pathology. All case-only models were adjusted for age at death and duration of football play. Taken together, variation in TMEM106B may have a protective effect on CTE-related outcomes.	[Cherry, Jonathan D.; Mez, Jesse; Alvarez, Victor E.; Mahar, Ian; Huber, Bertrand R.; Alosco, Michael L.; Abdolmohammadi, Bobak; Kiernan, Patrick T.; Evers, Laney; Svirsky, Sarah; Babcock, Katharine; Nowinski, Christopher J.; Kowall, Neil W.; Goldstein, Lee E.; Stern, Robert A.; McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, 72 E Concord St,B7800, Boston, MA 02118 USA; [Cherry, Jonathan D.; Mez, Jesse; Alvarez, Victor E.; Mahar, Ian; Huber, Bertrand R.; Alosco, Michael L.; Abdolmohammadi, Bobak; Kiernan, Patrick T.; Evers, Laney; Nowinski, Christopher J.; Dwyer, Brigid; Kowall, Neil W.; Katz, Douglas I.; Stern, Robert A.; Farrer, Lindsay A.; McKee, Ann C.] Boston Univ, Dept Neurol, Sch Med, 72 E Concord St,B7800, Boston, MA 02118 USA; [Cherry, Jonathan D.; Alvarez, Victor E.; Huber, Bertrand R.; Svirsky, Sarah; Babcock, Katharine; Gardner, Hannah M.; Meng, Gaoyuan; Kowall, Neil W.; McKee, Ann C.; Stein, Thor D.] VA Boston Healthcare Syst, 150 S Huntington Ave, Boston, MA 02130 USA; [Tripodis, Yorghos; Martin, Brett M.; Farrer, Lindsay A.] Boston Univ, Dept Biostat, Sch Publ Hlth, Boston, MA 02118 USA; [Alvarez, Victor E.; Nicks, Raymond; Svirsky, Sarah; Babcock, Katharine; Meng, Gaoyuan; McKee, Ann C.; Stein, Thor D.] Dept Vet Affairs Med Ctr, Bedford, MA 01730 USA; [Crary, John F.] Icahn Sch Med Mt Sinai, Ronald M Loeb Ctr Alzheimers Dis, Friedman Brain Inst, Dept Pathol,Fishberg Dept Neurosci, New York, NY 10029 USA; [Cantu, Robert C.; Stern, Robert A.] Boston Univ, Dept Anat & Neurobiol, Sch Med, Boston, MA 02118 USA; [Nowinski, Christopher J.; Cantu, Robert C.] Concuss Legacy Fdn, Boston, MA 02115 USA; [Cantu, Robert C.] Boston Univ, Dept Neurosurg, Sch Med, 72 E Concord St,B7800, Boston, MA 02118 USA; [Cantu, Robert C.; Stern, Robert A.] Emerson Hosp, Dept Neurosurg, Concord, MA 01742 USA; [Goldstein, Lee E.] Boston Univ, Mol Aging & Dev Lab, Sch Med, 72 E Concord St,B7800, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Photon Ctr, Boston, MA 02118 USA; [Goldstein, Lee E.] Boston Univ, Coll Engn, Boston, MA 02215 USA; [Dwyer, Brigid; Katz, Douglas I.] Braintree Rehabil Hosp, Boston, MA 02118 USA; [McKee, Ann C.; Stein, Thor D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, 72 E Concord St,B7800, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Med Biomed Genet, 72 E Concord St,B7800, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Med, Dept Ophthalmol, 72 E Concord St,B7800, Boston, MA 02118 USA; [Farrer, Lindsay A.] Boston Univ, Sch Publ Hlth, Dept Epidemiol, Boston, MA 02118 USA; [Kiernan, Patrick T.] Midwestern Univ, Arizona Coll Osteopath Med, Glendale, AZ 85308 USA		McKee, AC; Stein, TD (corresponding author), Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, 72 E Concord St,B7800, Boston, MA 02118 USA.	amckee@bu.edu; tdstein@bu.edu	Farrer, Lindsay/AAS-1035-2020; Dwyer, Brigid/AAI-6199-2020; , Bob/ABA-8507-2020	Dwyer, Brigid/0000-0002-6446-8054; Tripodis, Yorghos/0000-0003-2190-7608	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659, R01NS078337, R56NS078337, U01NS093334, K23NS102399]; National Institute on AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K23AG046377, P30AG13846, 0572063345, RF1AG057902, RF1AG054156, R56AG057768]; US Department of DefenseUnited States Department of Defense [W81XWH-13-2-0064]; US Department of Veterans AffairsUS Department of Veterans Affairs [I01CX001038]; Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; Department of Defense Peer Reviewed Alzheimer's Research Program [13267017]; Alzheimer's AssociationAlzheimer's Association [NIRG-15-362697, NIRG-305779, AARF-17-529888]; Concussion Legacy Foundation; Andlinger Family Foundation; NFL; Veterans Affairs Biorepository [BX002466]; Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) AwardUnited States Department of Defense [W81XWH-13-2-0095]; Department of Veterans Affairs CENC AwardUS Department of Veterans Affairs [I01CX001135]; National Center for PTSD; National Operating Committee on Standards for Athletic Equipment; WWE; Nick and Lynn Buoniconti Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659, R01NS078337, R56NS078337, K23NS102399, U01NS093334] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RF1AG054156, P30AG013846, K23AG046377, RF1AG057902, R56AG057768] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001038, I01CX001135, I01BX002466] Funding Source: NIH RePORTER	This study received support from National Institute of Neurological Disorders and Stroke (U01NS086659, R01NS078337, R56NS078337, U01NS093334, and K23NS102399), National Institute on Aging (K23AG046377, P30AG13846 and supplement 0572063345, RF1AG057902, RF1AG054156, R56AG057768), US Department of Defense (grant W81XWH-13-2-0064), US Department of Veterans Affairs (I01CX001038), Veterans Affairs Biorepository (BX002466), Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C), Department of Defense Peer Reviewed Alzheimer's Research Program (13267017), Department of Defense, Chronic Effects of Neurotrauma Consortium (CENC) Award W81XWH-13-2-0095, Department of Veterans Affairs CENC Award I01CX001135, National Center for PTSD, National Operating Committee on Standards for Athletic Equipment, Alzheimer's Association (NIRG-15-362697, NIRG-305779, AARF-17-529888), Nick and Lynn Buoniconti Foundation, Concussion Legacy Foundation, Andlinger Family Foundation, WWE, and NFL. The views, opinions and/or findings contained in this article are those of the authors and should not be construed as an official Veterans Affairs or Department of Defense position, policy or decision, unless so designated by other official documentation.	Alosco ML, 2018, ANN NEUROL, V83, P886, DOI 10.1002/ana.25245; Asai H, 2015, NAT NEUROSCI, V18, P1584, DOI 10.1038/nn.4132; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Bigio EH, 2008, J NEUROPATH EXP NEUR, V67, P635, DOI 10.1097/NEN.0b013e31817d751c; Brady OA, 2013, HUM MOL GENET, V22, P685, DOI 10.1093/hmg/dds475; BROWNELL B, 1970, J NEUROL NEUROSUR PS, V33, P338, DOI 10.1136/jnnp.33.3.338; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Cherry JD, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0185541; Cherry JD, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0382-8; Cherry JD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0411-8; Chung WS, 2015, NAT NEUROSCI, V18, P1539, DOI 10.1038/nn.4142; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Gong YS, 2010, AM J ALZHEIMERS DIS, V25, P547, DOI 10.1177/1533317510382893; Jun G, 2016, MOL PSYCHIATR, V21, P108, DOI 10.1038/mp.2015.23; Litvan I, 1996, J NEUROPATH EXP NEUR, V55, P97, DOI 10.1097/00005072-199601000-00010; Mackenzie IRA, 2010, ACTA NEUROPATHOL, V119, P1, DOI 10.1007/s00401-009-0612-2; Mahar I, 2017, NEUROSCI BIOBEHAV R, V83, P622, DOI 10.1016/j.neubiorev.2017.08.023; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McKeith IG, 2006, ALZHEIMER'S DISEASE: A CENTURY OF SCIENTIFIC AND CLINICAL RESEARCH, P417; Mez Jesse, 2017, Alzheimers Dement (Amst), V8, P188, DOI 10.1016/j.dadm.2017.07.002; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Mez J, 2015, ALZHEIMERS RES THER, V7, DOI 10.1186/s13195-015-0148-8; Montine TJ, 2012, ACTA NEUROPATHOL, V123, P1, DOI 10.1007/s00401-011-0910-3; Nelson PT, 2015, J NEUROPATH EXP NEUR, V74, P75, DOI 10.1097/NEN.0000000000000151; Newell KL, 1999, J NEUROPATH EXP NEUR, V58, P1147, DOI 10.1097/00005072-199911000-00004; Nicholson AM, 2013, J NEUROCHEM, V126, P781, DOI 10.1111/jnc.12329; Norden DM, 2013, NEUROPATH APPL NEURO, V39, P19, DOI 10.1111/j.1365-2990.2012.01306.x; Perry VH, 2013, SEMIN IMMUNOPATHOL, V35, P601, DOI 10.1007/s00281-013-0382-8; Piras A, 2016, ACTA NEUROPATHOL COM, V4, DOI 10.1186/s40478-016-0292-9; Rhinn H, 2017, CELL SYST, V4, P404, DOI 10.1016/j.cels.2017.02.009; Rutherford NJ, 2012, NEUROLOGY, V79, P717, DOI 10.1212/WNL.0b013e318264e3ac; Satoh JI, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt247; Sheng M, 2011, CSH PERSPECT BIOL, V3, DOI 10.1101/cshperspect.a005678; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Suzuki H, 2016, J BIOL CHEM, V291, P21448, DOI 10.1074/jbc.M116.737171; van Blitterswijk M, 2014, ACTA NEUROPATHOL, V127, P397, DOI 10.1007/s00401-013-1240-4; Van Deerlin VM, 2010, NAT GENET, V42, P234, DOI 10.1038/ng.536; Vass R, 2011, ACTA NEUROPATHOL, V121, P373, DOI 10.1007/s00401-010-0782-y; VONSATTEL JPG, 1995, J NEUROPATH EXP NEUR, V54, P42; Walt GS, 2018, J NEUROPATH EXP NEUR, V77, P1091, DOI 10.1093/jnen/nly092	46	15	15	0	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	NOV 4	2018	6								115	10.1186/s40478-018-0619-9			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GZ1BK	WOS:000449100200001	30390709	Green Published, gold			2022-02-06	
J	Ostermann, RC; Joestl, J; Tiefenboeck, TM; Lang, N; Platzer, P; Hofbauer, M				Ostermann, Roman C.; Joestl, Julian; Tiefenboeck, Thomas M.; Lang, Nikolaus; Platzer, Patrick; Hofbauer, Marcus			Risk factors predicting prognosis and outcome of elderly patients with isolated traumatic brain injury	JOURNAL OF ORTHOPAEDIC SURGERY AND RESEARCH			English	Article						Elderly patients; Isolated severe traumatic brain injuries (TBI); Respiratory failure; Outcome prediction	SEVERE HEAD-INJURY; DECOMPRESSIVE CRANIECTOMY; AGE; MORTALITY; IMPACT	BackgroundTraumatic brain injury (TBI), particularly in the elderly patient population, is known to be the single largest cause of death and disability worldwide. The purpose of this retrospective study was to evaluate clinical factors predicting poor outcome with special emphasis on the impact of respiratory failure (RF) on mortality in elderly patients with isolated severe TBI.MethodsAll elderly patients (age 65years) with isolated severe head injury, admitted to this level I trauma center, during a period of 18years (from January 1992 to December 2010) were identified from the trauma registry. The medical records were reviewed for demographics, mechanism of injury (MOI), GCS score at admission, RF, pupillary light reflex (LR), CT findings (subdural hematoma, subarachnoid hematoma, edema, midline-shift), and whether there was conservative treatment or surgical intervention and the Glasgow Outcome Score (GOS) at hospital discharge. Stepwise logistic regression analysis was used to identify risk factors for a poor prognosis and outcome.ResultsThe following variables influenced the mortality: respiratory failure, pupillary response, and the injury severity score (ISS). A significant increased risk of death was also found for patients with a midline shift of over 15mm.ConclusionsThe present study predicts a strong correlation between respiratory failure, pathological pupillary response, a higher ISS, and substantial midline shift with poor outcomes in elderly patients sustaining an isolated severe TBI.Trial registrationClinical trials: ID: NCT02386865. Registered 12 March 2015retrospectively registered.	[Ostermann, Roman C.; Joestl, Julian; Tiefenboeck, Thomas M.; Lang, Nikolaus; Platzer, Patrick; Hofbauer, Marcus] Med Univ Vienna, Dept Orthopaed & Trauma Surg, Div Trauma Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria; [Ostermann, Roman C.] Med Univ Vienna, St Vincent Hosp, Dept Orthopead & Trauma Surg, Div Trauma Surg,Shoulder & Sports Clin, Baumgasse 20A, A-1030 Vienna, Austria; [Platzer, Patrick] Karl Landsteiner Univ Hlth, Univ Hosp St Poelten, Dept Trauma Surg, St Polten, Austria		Ostermann, RC (corresponding author), Med Univ Vienna, Dept Orthopaed & Trauma Surg, Div Trauma Surg, Waehringer Guertel 18-20, A-1090 Vienna, Austria.; Ostermann, RC (corresponding author), Med Univ Vienna, St Vincent Hosp, Dept Orthopead & Trauma Surg, Div Trauma Surg,Shoulder & Sports Clin, Baumgasse 20A, A-1030 Vienna, Austria.	roman.ostermann@me.com		Tiefenboeck, Thomas/0000-0002-8698-8341			Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Berg J, 2005, EUR J NEUROL, V12, P85, DOI 10.1111/j.1468-1331.2005.01200.x; CAGETTI B, 1992, BRIT J NEUROSURG, V6, P227, DOI 10.3109/02688699209002930; CHOI SC, 1991, J NEUROSURG, V75, P251, DOI 10.3171/jns.1991.75.2.0251; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Guerra WKW, 1999, J NEUROSURG, V90, P187, DOI 10.3171/jns.1999.90.2.0187; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; JENNETT B, 1975, LANCET, V1, P480; Kilaru S, 1996, J TRAUMA, V41, P957, DOI 10.1097/00005373-199612000-00003; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Mina AA, 2002, J TRAUMA, V53, P668, DOI 10.1097/00005373-200210000-00008; Mitra B, 2008, ANZ J SURG, V78, P588, DOI 10.1111/j.1445-2197.2008.04579.x; Mohindra S, 2008, SURG NEUROL, V69, P474, DOI 10.1016/j.surneu.2007.02.031; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nelson DW, 2010, J NEUROTRAUM, V27, P51, DOI 10.1089/neu.2009.0986; PENNINGS JL, 1993, ARCH SURG-CHICAGO, V128, P787; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; Ross A M, 1992, J Neurosci Nurs, V24, P88; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Ushewokunze S, 2004, BRIT J NEUROSURG, V18, P604, DOI 10.1080/02688690400022763; Wutzler S, 2015, INJURY, V46, P1706, DOI 10.1016/j.injury.2015.02.013	24	15	16	0	2	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1749-799X			J ORTHOP SURG RES	J. Orthop. Surg. Res.	NOV 3	2018	13								277	10.1186/s13018-018-0975-y			6	Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics	GZ1DO	WOS:000449106200001	30390698	gold, Green Published			2022-02-06	
J	Abdulle, AE; de Koning, ME; van der Horn, HJ; Scheenen, ME; Roks, G; Hageman, G; Spikman, JM; van der Naalt, J				Abdulle, Amaal Eman; de Koning, Myrthe E.; van der Horn, Harm J.; Scheenen, Myrthe E.; Roks, Gerwin; Hageman, Gerard; Spikman, Jacoba M.; van der Naalt, Joukje			Early Predictors for Long-Term Functional Outcome After Mild Traumatic Brain Injury in Frail Elderly Patients	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						aging; brain injuries; depression; follow-up studies; frail elderly; outcome assessment (healthcare); prognosis; rehabilitation	OLDER-ADULTS; HEAD-INJURY; AGE; PREVALENCE; DEPRESSION; COMPLAINTS; MORTALITY; ANXIETY; CARE; MULTICENTER	Objective: To identify the effect of frailty and early postinjury measures on the long-term outcome after mild traumatic brain injury in elderly patients. Setting: Patients admitted to 3 Dutch hospitals designated as level 1 trauma centers. Participants: The elderly (60 years) with mild traumatic brain injury (N = 161). Design: A prospective observational cohort study. Main Measures: Posttraumatic complaints and the Hospital Anxiety and Depression Scale determined 2 weeks postinjury; the Glasgow Outcome Scale Extended and Groningen frailty indicator determined 1 to 3 years postinjury. Results: A total of 102 nonfrail (63%) and 59 frail elderly (37%) patients, mean age of 70.8 (6.3) years were included. Most patients (54%; 72% nonfrail and 24% frail) recovered completely 1 to 3 years postinjury. Two weeks postinjury, 81% had posttraumatic complaints (83% frail and 80% nonfrail elderly), and 30% showed emotional distress (50% frail and 20% nonfrail). Frailty (odds ratio, 2.1; 95% confidence interval, 1.59-2.77) and presence of early complaints (odds ratio, 1.13; 95% confidence interval, 1.01-1.27) (Nagelkerke R-2 = 46%) were found to predict long-term outcome, whereas age was not a significant predictor. Conclusion: The frail elderly had worse long-term outcome, and early complaints were found to be a stronger predictor of unfavorable outcome than age. Understanding the implications of frailty on outcome could help clinicians recognize patients at risk of a poor outcome and allocate care more efficiently.	[Abdulle, Amaal Eman; de Koning, Myrthe E.; van der Horn, Harm J.; van der Naalt, Joukje] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Groningen, Netherlands; [Scheenen, Myrthe E.; Spikman, Jacoba M.] Univ Groningen, Dept Clin Neuropsychol, Groningen, Netherlands; [Roks, Gerwin] Elisabeth Hosp, Dept Neurol, Tilburg, Netherlands; [Hageman, Gerard] Hosp Med Spectrum Twente, Dept Neurol, Enschede, Netherlands		van der Naalt, J (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol AB51, Hanzepl 1, NL-9713 GZ Groningen, Netherlands.	j.van.der.naalt@umcg.nl		van der Naalt, Joukje/0000-0001-9873-2418; Spikman, Jacoba/0000-0002-6477-0763; Eman Abdulle, Amaal/0000-0003-3766-2238	Dutch Brain Foundation [Ps2012-06]	This study is supported by the Dutch Brain Foundation (grant Ps2012-06).	Aarts S, 2015, J FRALITY AGING, V4, P131, DOI 10.14283/jfa.2015.45; Andersen FH, 2012, ACTA ANAESTH SCAND, V56, P1298, DOI 10.1111/j.1399-6576.2012.02782.x; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Choi J, 2015, J AM MED DIR ASSOC, V16, P548, DOI 10.1016/j.jamda.2015.02.004; Clegg A, 2015, AGE AGEING, V44, P148, DOI 10.1093/ageing/afu157; Clegg A, 2013, LANCET, V381, P752, DOI 10.1016/S0140-6736(12)62167-9; Corrigan JD, 2015, ARCH PHYS MED REHAB, V96, pS209, DOI 10.1016/j.apmr.2015.03.026; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; de la Plata CAM, 2008, ARCH PHYS MED REHAB, V89, P896, DOI 10.1016/j.apmr.2007.12.030; Fried LP, 2001, J GERONTOL A-BIOL, V56, pM146, DOI 10.1093/gerona/56.3.M146; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Gaastra B, 2016, BRIT J NEUROSURG, V30, P221, DOI 10.3109/02688697.2015.1119240; Gobbens RJJ, 2010, J AM MED DIR ASSOC, V11, P344, DOI 10.1016/j.jamda.2009.11.003; Heikkinen E, 2003, WHAT ARE MAIN RISK F; Hofhuis JGM, 2014, J TRAUMA ACUTE CARE, V76, P549, DOI 10.1097/TA.0b013e3182a9d105; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; Le Maguet P, 2014, INTENS CARE MED, V40, P674, DOI 10.1007/s00134-014-3253-4; Leblanc J, 2006, BRAIN INJURY, V20, P779, DOI 10.1080/02699050600831835; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; McMillan T, 2016, NAT REV NEUROL, V12, P477, DOI 10.1038/nrneurol.2016.89; Mhaolain AMN, 2012, INT PSYCHOGERIATR, V24, P1265, DOI 10.1017/S1041610211002110; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Nordstrom A, 2013, BMJ-BRIT MED J, V346, DOI 10.1136/bmj.f723; Peters LL, 2015, EXP GERONTOL, V69, P129, DOI 10.1016/j.exger.2015.05.006; Puts MTE, 2005, J AM GERIATR SOC, V53, P40, DOI 10.1111/j.1532-5415.2005.53008.x; Rapoport MJ, 2000, BRAIN INJURY, V14, P749; Rockwood K, 2004, J GERONTOL A-BIOL, V59, P1310, DOI 10.1093/gerona/59.12.1310; Roe C, 2015, BEHAV NEUROL, V2015, DOI 10.1155/2015/845491; Rothweiler B, 1998, ARCH PHYS MED REHAB, V79, P881, DOI 10.1016/S0003-9993(98)90082-X; Schuurmans H, 2004, J GERONTOL A-BIOL, V59, P962; Searle Samuel D, 2008, BMC Geriatr, V8, P24, DOI 10.1186/1471-2318-8-24; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; Testa JA, 2005, ARCH PHYS MED REHAB, V86, P1815, DOI 10.1016/j.apmr.2005.03.010; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Tillou A, 2014, JAMA SURG, V149, P83, DOI 10.1001/jamasurg.2013.4244; Torres OH, 2006, INTENS CARE MED, V32, P1052, DOI 10.1007/s00134-006-0170-1; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van der Naalt J, 2017, LANCET NEUROL, V16, P532, DOI 10.1016/S1474-4422(17)30117-5; Villacampa-Fernandez P, 2017, MATURITAS, V95, P31, DOI 10.1016/j.maturitas.2016.10.008; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	47	15	15	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2018	33	6					E59	E67		10.1097/HTR.0000000000000368			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QK	WOS:000450886600007	29385011	Green Published			2022-02-06	
J	Allouchery, G; Moustafa, F; Roubin, J; Pereira, B; Schmidt, J; Raconnat, J; Pic, D; Sapin, V; Bouvier, D				Allouchery, Gautier; Moustafa, Fares; Roubin, Jean; Pereira, Bruno; Schmidt, Jeannot; Raconnat, Julien; Pic, Daniel; Sapin, Vincent; Bouvier, Damien			Clinical validation of S100B in the management of a mild traumatic brain injury: issues from an interventional cohort of 1449 adult patients	CLINICAL CHEMISTRY AND LABORATORY MEDICINE			English	Article						mild traumatic brain injury; mTBI; S100B	MINOR HEAD-INJURY; SECONDARY INTRACRANIAL HEMORRHAGE; COMPUTED-TOMOGRAPHY; PROTEIN	Background: This study's primary objective was to validate the routine use of S100B via a prospective study. The aim was a reduction of cranial computed tomography (CCT) scans by 30%. The secondary goal was to investigate the influence of age and associated risk factors on the reduction of CCT. Methods: S100B (sampling within 3 h postinjury) was used for patients with mild traumatic brain injury (mTBIs) presenting a medium risk of complications and requiring a CCT scan. Patients with negative S100B (S100B-) were discharged without a CCT scan. Results: Of the 1449 patients included in this study, 468 (32.3%) had S100B-with a sensitivity of 96.4% (95% CI: 87.5%-99.6%), a specificity of 33.4% (95% CI: 31%-36%) and a negative predictive value of 99.6% (95% CI: 98.5%-99.9%). No significant difference in serum levels or the S100B+ rate was observed if patients had retrograde amnesia (0.16 mu g/L; 63.8%), loss of consciousness (0.13; 63.6%) or antiplatelet therapy (0.20; 77.9%). Significant differences were found between the S100B concentrations and S100B positivity rates in patients > 65 years old and all the groups with patients < 55 years old (18-25, 26-35, 36-45 and 46-55). From 18 to 65 years old (n = 874), the specificity is 39.3% (95% CI: 36%-42.6%) compared to 18.7% (95% CI: 15.3%-22.3%) for patients > 65 years old (n = 504). Conclusions: The clinical use of S100B in mTBI management reduces the use of CCTs by approximately one-third; furthermore, the percentage of CCTs reduction is influenced by the age of the patient.	[Bouvier, Damien] CHU Gabriel Montpied, Lab Biochim Med, Ctr Biol, 58 Rue Montalembert, F-63000 Clermont Ferrand, France; [Allouchery, Gautier; Sapin, Vincent; Bouvier, Damien] CHU Clermont Ferrand, Biochem & Mol Genet Dept, Clermont Ferrand, France; [Sapin, Vincent; Bouvier, Damien] Univ Clermont Auvergne, GReD, INSERM, CNRS, Clermont Ferrand, France; [Moustafa, Fares; Roubin, Jean; Schmidt, Jeannot; Raconnat, Julien; Pic, Daniel] CHU Clermont Ferrand, Adult Emergency Dept, Clermont Ferrand, France; [Pereira, Bruno] CHU Clermont Ferrand, Biostat Unit, DRCI Dept, Clermont Ferrand, France		Bouvier, D (corresponding author), CHU Gabriel Montpied, Lab Biochim Med, Ctr Biol, 58 Rue Montalembert, F-63000 Clermont Ferrand, France.; Bouvier, D (corresponding author), CHU Clermont Ferrand, Biochem & Mol Genet Dept, Clermont Ferrand, France.; Bouvier, D (corresponding author), Univ Clermont Auvergne, GReD, INSERM, CNRS, Clermont Ferrand, France.	dbouvier@chu-clermontferrand.fr	Moustafa, Fares/Z-2829-2019	Bouvier, Damien/0000-0002-2707-4320			Anderson RE, 2001, NEUROSURGERY, V48, P1255, DOI 10.1097/00006123-200106000-00012; Biberthaler P, 2006, SHOCK, V25, P446, DOI 10.1097/01.shk.0000209534.61058.35; Bouvier D, 2009, ANN BIOL CLIN-PARIS, V67, P425, DOI 10.1684/abc.2009.0347; Bouvier D, 2012, CLIN CHEM, V58, P1116, DOI 10.1373/clinchem.2011.180828; Calcagnile O, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-52; Calcagnile O, 2012, BMC EMERG MED, V12, DOI 10.1186/1471-227X-12-13; Chouhdari A, 2018, IRAN J NEUROL, V17, P82; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Ernstbrunner L, 2016, BRAIN INJURY, V30, P43, DOI 10.3109/02699052.2015.1087593; Haydel MJ, 2000, NEW ENGL J MED, V343, P100, DOI 10.1056/NEJM200007133430204; INGEBRIGTSEN T, 1995, J NEUROL NEUROSUR PS, V59, P103, DOI 10.1136/jnnp.59.1.103-a; Jehle E, 2012, ANN FR MED URGENCE, V2, P199, DOI 10.1007/s13341-012-0202-4; Jonsson H, 2000, J CARDIOTHOR VASC AN, V14, P698, DOI 10.1053/jcan.2000.18444; Laribi S, 2014, CLIN CHEM LAB MED, V52, P527, DOI 10.1515/cclm-2013-0621; Oris C, 2018, PEDIATRICS, V141, DOI 10.1542/peds.2018-0037; Pham N, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012691; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Tauber M, 2009, J TRAUMA, V67, P521, DOI 10.1097/TA.0b013e3181a7c184; Tazarourte K, EMC MED URGENCE; TIRET L, 1989, AM J PUBLIC HEALTH, V79, P316, DOI 10.2105/AJPH.79.3.316; Unden J, 2005, J TRAUMA, V58, P59, DOI 10.1097/01.TA.0000130613.35877.75; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; Unden J, 2010, J HEAD TRAUMA REHAB, V25, P228, DOI 10.1097/HTR.0b013e3181e57e22; Unden L, 2015, BMC MED, V13, DOI 10.1186/s12916-015-0533-y; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; ZIMMER DB, 1995, BRAIN RES BULL, V37, P417, DOI 10.1016/0361-9230(95)00040-2; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	28	15	15	0	8	WALTER DE GRUYTER GMBH	BERLIN	GENTHINER STRASSE 13, D-10785 BERLIN, GERMANY	1434-6621	1437-4331		CLIN CHEM LAB MED	Clin. Chem. Lab. Med.	NOV	2018	56	11					1897	1904		10.1515/cclm-2018-0471			8	Medical Laboratory Technology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Medical Laboratory Technology	GV8UV	WOS:000446425900020	29924734				2022-02-06	
J	Furay, E; Daley, M; Teixeira, PG; Coopwood, TB; Aydelotte, JD; Malesa, N; Tellinghuisen, C; Ali, S; Brown, LH; Brown, CVR				Furay, Elisa; Daley, Mitch; Teixeira, Pedro G.; Coopwood, Thomas B.; Aydelotte, Jayson D.; Malesa, Natalia; Tellinghuisen, Christian; Ali, Sadia; Brown, Lawrence H.; Brown, Carlos V. R.			Goal-directed platelet transfusions correct platelet dysfunction and may improve survival in patients with severe traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	48th Annual Meeting of the Western-Trauma-Association (WTA)	FEB 15-MAR 03, 2018	Whistler, CANADA	Western Trauma Assoc		Platelet dysfunction; TBI; TEG; Platelet transfusion	INTRACRANIAL HEMORRHAGE; ADENOSINE-DIPHOSPHATE; ANTIPLATELET THERAPY; COAGULOPATHY; COAGULATION; PROGRESSION; INHIBITION; RISK	BACKGROUND Platelet dysfunction, defined as adenosine diphosphate inhibition greater than 60% on thromboelastogram, is an independent predictor of increased mortality in patients with severe traumatic brain injury (TBI). We changed our practice to transfuse platelets for all patients with severe TBI and platelet dysfunction. We hypothesized that platelet transfusions would correct platelet dysfunction and improve mortality in patients with severe TBI. METHODS This retrospective review included adult trauma patients admitted to our Level I trauma center from July 2015 to October 2016 with severe TBI (head Abbreviated Injury Scale score 3) who presented with platelet dysfunction and subsequently received a platelet transfusion. Serial thromboelastograms were obtained to characterize the impact of platelet transfusion on clot strength. Subsequently, the platelet transfusion group was compared to a group of historical controls with severe TBI patients and platelet dysfunction who did not receive platelet transfusion. RESULTS A total of 35 patients with severe TBI presented with platelet dysfunction. Following platelet transfusion clot strength improved as represented by decreased K time, increased angle, maximum amplitude, and G-value, as well as correction of adenosine diphosphate inhibition. When comparing to 51 historic controls with severe TBI and platelet dysfunction, the 35 study patients who received a platelet transfusion had a lower mortality (9% vs. 35%; p = 0.005). In stepwise logistic regression, platelet transfusion was independently associated with decreased mortality (odds ratio, 0.23; 95% confidence interval, 0.06-0.92; p = 0.038). CONCLUSION In patients with severe TBI and platelet dysfunction, platelet transfusions correct platelet inhibition and may be associated with decreased mortality. LEVEL OF EVIDENCE Therapeutic, level II.	[Furay, Elisa; Daley, Mitch; Teixeira, Pedro G.; Coopwood, Thomas B.; Aydelotte, Jayson D.; Malesa, Natalia; Tellinghuisen, Christian; Ali, Sadia; Brown, Lawrence H.; Brown, Carlos V. R.] Dell Med Sch, Dept Surg & Perioperat Care, Austin, TX USA		Furay, E (corresponding author), Univ Texas Attn, Dell Seton Med Ctr, Gen Surg, 1500 Red River St, Austin, TX 78701 USA.	Efuray@ascension.org		Brown, Lawrence/0000-0002-5940-1840			Alexiou GA, 2014, BRAIN INJURY, V28, P438, DOI 10.3109/02699052.2014.888769; Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Carroll RC, 2009, TRANSL RES, V154, P34, DOI 10.1016/j.trsl.2009.04.001; Castellino FJ, 2014, J TRAUMA ACUTE CARE, V76, P1169, DOI 10.1097/TA.0000000000000216; Chen LQ, 2004, J THORAC CARDIOV SUR, V128, P425, DOI 10.1016/j.jtcvs.2004.02.019; Daley MJ, 2017, EUR J TRAUMA EMERG S, V43, P105, DOI 10.1007/s00068-016-0643-z; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Manoel ALD, 2015, NEUROCRIT CARE, V22, P34, DOI 10.1007/s12028-014-0026-4; Einersen PM, 2017, J TRAUMA ACUTE CARE, V82, P114, DOI 10.1097/TA.0000000000001270; Epstein DS, 2014, INJURY, V45, P819, DOI 10.1016/j.injury.2014.01.011; Faul M, 2002, NATL CTR INJURY PREV, P2002; Greuters S, 2011, CRIT CARE, V15, DOI 10.1186/cc9399; Harhangi BS, 2008, ACTA NEUROCHIR, V150, P165, DOI 10.1007/s00701-007-1475-8; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P121, DOI 10.1097/TA.0b013e3182a9cc95; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Leong LB, 2015, J EMERG MED, V49, P561, DOI 10.1016/j.jemermed.2015.02.023; Lustenberger T, 2010, J TRAUMA, V69, P1410, DOI 10.1097/TA.0b013e3181cdae81; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; Nekludov M, 2007, J NEUROTRAUM, V24, P1699, DOI 10.1089/neu.2007.0322; Sangkuhl K, 2011, PHARMACOGENET GENOM, V21, P516, DOI 10.1097/FPC.0b013e3283406323; Schnuriger B, 2010, J TRAUMA, V68, P881, DOI 10.1097/TA.0b013e3181d3cc58; Sirajuddin S, 2016, J TRAUMA ACUTE CARE, V81, P328, DOI 10.1097/TA.0000000000001057; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Spinella PC, 2011, J TRAUMA, V71, pS343, DOI 10.1097/TA.0b013e318227ef2d; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stein SC, 2002, J NEUROSURG, V97, P1373, DOI 10.3171/jns.2002.97.6.1373; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Wafaisade A, 2010, NEUROCRIT CARE, V12, P211, DOI 10.1007/s12028-009-9281-1; Washington CW, 2011, J TRAUMA, V71, P358, DOI 10.1097/TA.0b013e318220ad7e; WikkelsO A, 2016, COCHRANE DB SYST REV, V22; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050	33	15	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2018	85	5					881	887		10.1097/TA.0000000000002047			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GZ0NG	WOS:000449060100008	30124626				2022-02-06	
J	Gong, NJ; Kuzminski, S; Clark, M; Fraser, M; Sundman, M; Guskiewicz, K; Petrella, JR; Liu, CL				Gong, Nan-Jie; Kuzminski, Samuel; Clark, Michael; Fraser, Melissa; Sundman, Mark; Guskiewicz, Kevin; Petrella, Jeffrey R.; Liu, Chunlei			Microstructural alterations of cortical and deep gray matter over a season of high school football revealed by diffusion kurtosis imaging	NEUROBIOLOGY OF DISEASE			English	Article						Diffusion kurtosis imaging (DM); Quantitative susceptibility mapping (QSM); Gray matter; Football; Head impact	HEAD IMPACT EXPOSURE; CHRONIC TRAUMATIC ENCEPHALOPATHY; MILD COGNITIVE IMPAIRMENT; GAUSSIAN WATER DIFFUSION; COMPRESSION COLLAR; ALZHEIMERS-DISEASE; BRAIN-INJURY; SUSCEPTIBILITY; IRON; QUANTIFICATION	Objectives: To probe microstructural changes that are associated with subconcussive head impact exposure in deep and cortical gray matter of high school football players over a single season. Methods: Players underwent diffusion kurtosis imaging (DKI) and quantitative susceptibility mapping (QSM) scans. Head impact data was recorded. Association between parametric changes and frequency of frontal head impact was assessed. Results: In deep gray matter, significant decreases in mean kurtosis (MK) and increases in mean diffusivity (MD) over the season were observed in the thalamus and putamen. Correlations between changes in DKI metrics and frequency of frontal impacts were observed in the putamen and caudate. In cortical gray matter, decreases in MK were observed in regions including the pars triangularis and inferior parietal. In addition, increases in MD were observed in the rostral middle frontal cortices. Negative correlations between MK and frequency of frontal impacts were observed in the posterior part of the brain including the pericalcarine, lingual and middle temporal cortices. Magnetic susceptibility values exhibited no significant difference or correlation, suggesting these diffusion changes common within the group may not be associated with iron-related mechanisms. Conclusion: Microstructural alterations over the season and correlations with head impacts were captured by DKI metrics, which suggested that DKI imaging of gray matter may yield valuable biomarkers for evaluating brain injuries associated with subconcussive head impact. Findings of associations between frontal impacts and changes in posterior cortical gray matter also indicated that contrecoup injury rather than coup injury might be the dominant mechanism underlying the observed microstructural alterations. Advances in knowledge: Significant microstructural changes, as reflected by DKI metrics, in cortical gray matter such as the rostral middle frontal cortices, and in deep gray matter such as the thalamus were observed in high school football players over the course of a single season without clinically diagnosed concussion. QSM showed no evidence of iron-related changes in the observed subconcussive brain injuries. The detected microstructural changes in cortical and deep gray matter correlated with frequency of sub concussive head impacts. Implications for patient care: DKI may yield valuable biomarkers for evaluating the severity of brain injuries associated with subconcussive head impacts in contact sport athletes.	[Gong, Nan-Jie; Liu, Chunlei] Univ Calif Berkeley, Elect Engn & Comp Sci, 550 Cory Hall, Berkeley, CA 94720 USA; [Gong, Nan-Jie; Liu, Chunlei] Duke Univ, Sch Med, Brain Imaging & Anal Ctr, Durham, NC USA; [Kuzminski, Samuel] Univ Oklahoma, Neuroradiol, Norman, OK 73019 USA; [Clark, Michael] Univ N Carolina, Sch Med, Human Movement Sci, Chapel Hill, NC 27515 USA; [Fraser, Melissa] Univ N Carolina, Sch Med, Allied Hlth Sci, Chapel Hill, NC 27515 USA; [Sundman, Mark] Univ Arizona, Dept Psychol, Tucson, AZ 85721 USA; [Guskiewicz, Kevin] Univ N Carolina, Sch Med, Exercise Sports Sci, Chapel Hill, NC 27515 USA; [Petrella, Jeffrey R.; Liu, Chunlei] Duke Univ, Sch Med, Radiol, Durham, NC USA; [Liu, Chunlei] Univ Calif Berkeley, Helen Wills Neurosci Inst, Berkeley, CA 94720 USA		Gong, NJ; Liu, CL (corresponding author), Univ Calif Berkeley, Elect Engn & Comp Sci, 550 Cory Hall, Berkeley, CA 94720 USA.	nanjie.gong@gmail.com; sam@kuzminskis.com; michael_clark@med.unc.edu; mafraser@live.unc.edu; alexis@unc.edu; jeffrey.petrella@duke.edu; chunlei.liu@berkeley.edu	; Gong, Nan-Jie/H-8002-2012	Liu, Chunlei/0000-0001-8816-4832; Gong, Nan-Jie/0000-0001-9249-413X; Fraser, Missy/0000-0002-5753-8798			Bahrami N, 2016, RADIOLOGY; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Beckwith JG, 2012, ANN BIOMED ENG, V40, P237, DOI 10.1007/s10439-011-0422-2; Bester M, 2015, MULT SCLER J, V21, P935, DOI 10.1177/1352458514556295; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Chen WW, 2014, RADIOLOGY, V270, P496, DOI 10.1148/radiol.13122640; Cobb BR, 2013, ANN BIOMED ENG, V41, P2463, DOI 10.1007/s10439-013-0867-6; Courville CB, 1942, ARCH SURG-CHICAGO, V45, P19, DOI 10.1001/archsurg.1942.01220010022002; Coutu JP, 2014, NEUROBIOL AGING, V35, P1412, DOI 10.1016/j.neurobiolaging.2013.12.001; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Davenport EM, 2016, J NEUROTRAUM, V33, P2133, DOI 10.1089/neu.2015.4267; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; Funk JR, 2012, ANN BIOMED ENG, V40, P79, DOI 10.1007/s10439-011-0400-8; Gardner A, 2014, BRIT J SPORT MED, V48, P84, DOI 10.1136/bjsports-2013-092646; Gong NJ, 2017, HUM BRAIN MAPP, V38, P2495, DOI 10.1002/hbm.23535; Gong NJ, 2015, NMR BIOMED, V28, P1267, DOI 10.1002/nbm.3366; Gong NJ, 2014, NEUROBIOL AGING, V35, P2203, DOI 10.1016/j.neurobiolaging.2014.03.011; Gong NJ, 2013, MAGN RESON IMAGING, V31, P688, DOI 10.1016/j.mri.2012.10.027; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; Guskiewicz KM, 2004, J ATHL TRAINING, V39, P280; He NY, 2017, NMR BIOMED, V30, DOI 10.1002/nbm.3554; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kamagata K, 2017, HUM BRAIN MAPP, V38, P3704, DOI 10.1002/hbm.23628; Kelley ME, 2017, J NEUROTRAUM, V34, P1939, DOI 10.1089/neu.2016.4812; Kuzminski SJ, 2018, AM J NEURORADIOL, V39, P245, DOI 10.3174/ajnr.A5489; Langkammer C, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0162460; Li W, 2016, NMR BIOMED, V29, P896, DOI 10.1002/nbm.3536; Li W, 2014, HUM BRAIN MAPP, V35, P2698, DOI 10.1002/hbm.22360; Li W, 2014, NMR BIOMED, V27, P219, DOI 10.1002/nbm.3056; Liu CL, 2015, TOMOGRAPHY, V1, P3, DOI 10.18383/j.tom.2015.00136; Liu CL, 2015, J MAGN RESON IMAGING, V42, P23, DOI [10.3969/j.issn.1001-2400.2015.01.004, 10.1002/jmri.24768]; Liu CL, 2010, MAGN RESON MED, V63, P243, DOI 10.1002/mrm.22192; Liu CL, 2004, MAGN RESON MED, V51, P924, DOI 10.1002/mrm.20071; Liu W, 2013, P INT SOC MAG RESON, V21; Manoogian S, 2006, BIOMED SCI INSTRUM, V42, P383; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Munce TA, 2015, MED SCI SPORT EXER, V47, P1567, DOI 10.1249/MSS.0000000000000591; Myer GD, 2016, BRIT J SPORT MED, V50, P1276, DOI 10.1136/bjsports-2016-096134; Nisenbaum EJ, 2014, J NEUROTRAUM, V31, P301, DOI 10.1089/neu.2013.3102; Omalu BI, 2010, AM J FOREN MED PATH, V31, P130, DOI 10.1097/PAF.0b013e3181ca7f35; Raz E, 2011, AM J NEURORADIOL, V32, P1851, DOI 10.3174/ajnr.A2637; Reuter M, 2010, NEUROIMAGE, V53, P1181, DOI 10.1016/j.neuroimage.2010.07.020; Saulle M, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/816069; Small GW, 2013, AM J GERIAT PSYCHIAT, V21, P138, DOI 10.1016/j.jagp.2012.11.019; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Stokum JA, 2015, BRAIN INJURY, V29, P47, DOI 10.3109/02699052.2014.947628; Urban JE, 2013, ANN BIOMED ENG, V41, P2474, DOI 10.1007/s10439-013-0861-z; Young TJ, 2014, CLIN J SPORT MED, V24, P416, DOI 10.1097/JSM.0000000000000055; Yuan WH, 2018, HUM BRAIN MAPP, V39, P491, DOI 10.1002/hbm.23859; Yuan WH, 2017, J NEUROTRAUM, V34, P2432, DOI 10.1089/neu.2016.4834; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	57	15	15	0	17	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	NOV	2018	119						79	87		10.1016/j.nbd.2018.07.020			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU5JV	WOS:000445322700007	30048802				2022-02-06	
J	Kornblith, LZ; Robles, AJ; Conroy, AS; Hendrickson, CM; Calfee, CS; Fields, AT; Callcut, RA; Cohen, MJ				Kornblith, Lucy Z.; Robles, Anamaria J.; Conroy, Amanda S.; Hendrickson, Carolyn M.; Calfee, Carolyn S.; Fields, Alexander T.; Callcut, Rachael A.; Cohen, Mitchell J.			Perhaps it's not the platelet: Ristocetin uncovers the potential role of von Willebrand factor in impaired platelet aggregation following traumatic brain injury	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article; Proceedings Paper	48th Annual Meeting of the Western-Trauma-Association (WTA)	FEB 15-MAR 03, 2018	Whistler, CANADA	Western Trauma Assoc		Platelet; ristocetin; trauma; von Willebrand factor	FRESH-FROZEN PLASMA; INDUCED COAGULOPATHY; HEMORRHAGIC-SHOCK; VALPROIC ACID; EX-VIVO; DYSFUNCTION; DESMOPRESSIN; ENDOTHELIOPATHY; RESUSCITATION; TRANSFUSION	BACKGROUND Injury to the blood-brain barrier exposes endothelium rich in von Willebrand factor (vWF), which may play a role in altered platelet aggregation following traumatic brain injury (TBI). Ristocetin is an antimicrobial substance that induces vWF-mediated aggregation of platelets. We examined these mechanisms in injured patients by measuring the aggregation response of platelets to stimulating agonists (including ristocetin) via whole-blood multiple-electrode platelet aggregometry. We hypothesized that patients with TBI have an altered platelet aggregation response to ristocetin stimulation compared with patients without TBI. METHODS Blood was collected from 233 trauma patients without thrombocytopenia. Platelet aggregation was assessed using multiple-electrode platelet aggregometry (Multiplate). Platelet aggregation response to stimulating agonists collagen, thrombin receptor-activating peptide 6, adenosine diphosphate, arachidonic acid, and ristocetin was measured. Factor activity was measured. RESULTS Of the 233 patients, 23% had TBI. There were no differences in platelet aggregation responses to any agonists between TBI and non-TBI patients except ristocetin. Platelet aggregation response to ristocetin stimulation was significantly lower in TBI patients (p = 0.03). Patients with TBI also had higher factor VIII activity (215% vs. 156%, p = 0.01). In multivariate analysis, there was a significant independent association of impaired platelet aggregation response to ristocetin stimulation with TBI (odds ratio, 3.05; p = 0.04). CONCLUSIONS Given the importance of platelets in hemostasis, understanding the mechanisms of impaired platelet aggregation following injury is critical. The impaired platelet aggregation response to ristocetin stimulation and corresponding increase in factor VIII activity in TBI patients may be secondary to a TBI-induced effect on vWF quantity (due to injury-driven consumption of vWF) or vWF function with resultant increase in circulating factor VIII activity (due to impaired carrying capacity of vWF). Given there are multiple known therapies for vWF deficits including desmopressin, purified and recombinant vWF, and estrogens, these lines of investigation are particularly compelling in patients with TBI and hemorrhage. LEVEL OF EVIDENCE Prognostic study, level II.	[Kornblith, Lucy Z.; Robles, Anamaria J.; Conroy, Amanda S.; Fields, Alexander T.; Callcut, Rachael A.] Zuckerberg San Francisco Gen Hosp, Dept Surg, San Francisco, CA USA; Univ Calif San Francisco, San Francisco, CA 94143 USA; [Hendrickson, Carolyn M.; Calfee, Carolyn S.] San Francisco Gen Hosp, Dept Med, San Francisco, CA 94110 USA; [Cohen, Mitchell J.] Denver Hlth Med Ctr, Dept Surg, Denver, CO USA; Univ Colorado, Denver, CO 80202 USA		Kornblith, LZ (corresponding author), San Francisco Gen Hosp, Dept Surg, Ward 3A,1001 Potrero Ave, San Francisco, CA 94110 USA.	lucy.kornblith@ucsf.edu	Callcut, Rachael/ABE-1484-2021	Robles, Anamaria/0000-0002-3693-314X	DoDUnited States Department of Defense [W911QY-15-C-0044]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K01ES026834, UM1HL120877, HL110969];  [K23 HL133495]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL110969, UM1HL120877, K23HL133495] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [K01ES026834] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [K23GM130892] Funding Source: NIH RePORTER	M.J.C. is supported by DoD W911QY-15-C-0044 and NIH UM1HL120877. R.A.C. is supported by NIH K01ES026834 and DoD W911QY-15-C-0044. C.S.C. is supported by NIH HL110969. C.M.H. is supported by K23 HL133495.	Baimukanova G, 2016, TRANSFUSION, V56, pS65, DOI 10.1111/trf.13532; Baimukanova G, 2016, TRANSFUSION, V56, pS52, DOI 10.1111/trf.13455; Bambakidis T, 2017, BLOOD COAGUL FIBRIN, V28, P479, DOI 10.1097/MBC.0000000000000626; Briggs A, 2015, J SURG RES, V193, P802, DOI 10.1016/j.jss.2014.08.016; Brown LM, 2011, J TRAUMA, V71, pS337, DOI 10.1097/TA.0b013e318227f67c; Davenport RA, 2009, CURR OPIN ANESTHESIO, V22, P261, DOI 10.1097/ACO.0b013e328325a6d9; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; De Oliveira CO, 2007, J NEUROTRAUM, V24, P1331, DOI 10.1089/neu.2006.0159; Ding N, 2014, CIRC-CARDIOVASC GENE, V7, P615, DOI 10.1161/CIRCGENETICS.113.000398; Diz-Kucukkaya R, 2013, HEMATOL-AM SOC HEMAT, P268, DOI 10.1182/asheducation-2013.1.268; Donahue DL, 2014, J NEUROTRAUM, V31, P404, DOI 10.1089/neu.2013.3089; Eikenboom J C J, 2006, Neth Heart J, V14, P277; Eikenboom JCJ, 2002, THROMB HAEMOSTASIS, V87, P252; FLORDAL PA, 1993, BRIT J SURG, V80, P723, DOI 10.1002/bjs.1800800616; GRATZ I, 1992, J THORAC CARDIOV SUR, V104, P1417; Hendrickson CM, 2016, J TRAUMA ACUTE CARE, V80, P989, DOI 10.1097/TA.0000000000000982; Henriksen HH, 2017, J SURG RES, V214, P154, DOI 10.1016/j.jss.2017.02.037; Hess JR, 2008, J TRAUMA, V65, P748, DOI 10.1097/TA.0b013e3181877a9c; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Jacoby RC, 2001, J TRAUMA, V51, P639, DOI 10.1097/00005373-200110000-00003; Johansson PI, 2017, ANN SURG, V265, P597, DOI 10.1097/SLA.0000000000001751; Kapapa T, 2014, NEUROL RES INT, V2014, DOI 10.1155/2014/298767; Kim DY, 2015, J NEUROTRAUM, V32, P1815, DOI 10.1089/neu.2014.3728; Kornblith LZ, 2014, J TRAUMA ACUTE CARE, V76, P255, DOI 10.1097/TA.0000000000000108; Kutcher ME, 2014, ANN SURG, V260, P1103, DOI 10.1097/SLA.0000000000000366; Kutcher ME, 2012, J TRAUMA ACUTE CARE, V73, P13, DOI 10.1097/TA.0b013e318256deab; Li RZ, 2016, J TRAUMA ACUTE CARE, V80, P440, DOI 10.1097/TA.0000000000000915; McMillian WD, 2009, J TRAUMA, V66, P942, DOI 10.1097/TA.0b013e3181978e7b; Murray CJL, 1997, LANCET, V349, P1269, DOI 10.1016/S0140-6736(96)07493-4; Nachman RL, 2008, NEW ENGL J MED, V359, P1261, DOI 10.1056/NEJMra0800887; Naidech AM, 2014, STROKE, V45, P2451, DOI 10.1161/STROKEAHA.114.006061; National Center for Injury Prevention and Control (NCIPC), NAT VIOL DEATH REP S; Naumann DN, 2018, SHOCK, V49, P420, DOI 10.1097/SHK.0000000000000999; Nikolian VC, 2018, CRIT CARE MED, V46, pE59, DOI 10.1097/CCM.0000000000002800; Norton R, 2013, NEW ENGL J MED, V368, P1723, DOI 10.1056/NEJMra1109343; Pati S, 2016, J TRAUMA ACUTE CARE, V80, P576, DOI 10.1097/TA.0000000000000961; Ranucci M, 2007, J CARDIOTHOR VASC AN, V21, P851, DOI 10.1053/j.jvca.2007.05.009; Rodriguez EG, 2018, SHOCK, V50, P31, DOI 10.1097/SHK.0000000000001036; Rodriguez EG, 2017, J AM COLL SURGEONS, V225, P419, DOI 10.1016/j.jamcollsurg.2017.05.012; SAUAIA A, 1994, ARCH SURG-CHICAGO, V129, P39; Skrifvars MB, 2017, INTENS CARE MED, V43, P419, DOI 10.1007/s00134-016-4655-2; Solomon C, 2011, THROMB HAEMOSTASIS, V106, P322, DOI 10.1160/TH11-03-0175; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Stansbury LG, 2013, TRANSFUSION, V53, P783, DOI 10.1111/j.1537-2995.2012.03828.x; Walters T, 2006, J TRAUMA, V61, P1107, DOI 10.1097/01.ta.0000195655.30837.29; White NJ, 2017, J TRAUMA ACUTE CARE, V82, pS41, DOI 10.1097/TA.0000000000001436; Wohlauer MV, 2012, J AM COLL SURGEONS, V214, P739, DOI 10.1016/j.jamcollsurg.2012.01.050; Yamamoto K, 1998, BLOOD, V92, P2791, DOI 10.1182/blood.V92.8.2791.420k24_2791_2801	48	15	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	NOV	2018	85	5					873	880		10.1097/TA.0000000000002025			8	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	General & Internal Medicine; Surgery	GZ0NG	WOS:000449060100007	29985231	Green Accepted			2022-02-06	
J	O'Rourke, A; Power, E; O'Halloran, R; Rietdijk, R				O'Rourke, Angela; Power, Emma; O'Halloran, Robyn; Rietdijk, Rachael			Common and distinct components of communication partner training programmes in stroke, traumatic brain injury and dementia	INTERNATIONAL JOURNAL OF LANGUAGE & COMMUNICATION DISORDERS			English	Article						neuropathology; health communication; speech-language pathology; in-service training; communication partner training (CPT)	CONVERSATION THERAPY; APHASIA; PEOPLE; CARE; FACILITATORS; STRATEGIES; WORKING; SPEECH; ADULTS; TALK	Background: Communication partner training (CPT) programmes for health and care staff working with people with the neurologically based communication disorders associated with stroke, traumatic brain injury (TBI) and dementia are efficacious in improving communication. However, current programmes are lengthy and disorder specific, and therefore may not be suitable as staff training tools in environments with people with multiple communication disorders, and services with a variety of neurological populations. Aims: To identify common and distinct components of CPT programmes for stroke, TBI and dementia in order to determine whether there are common delivery methods and content that can be consolidated to improve implementation of CPT in health and care services. Methods & Procedures: A qualitative enquiry was used. Four CPT programmes targeting three disorders were identified from systematic reviews and literature searches. Programme data were recorded onto data sheets from manuals, study articles and supplementary materials, and were categorized using the Intervention Taxonomy (ITAX). Content analysis and elements of constant comparative analysis were employed to analyse the CPT programmes. Outcomes & Results: Delivery characteristics were similar across all four programmes. All were delivered face to face in either group or individual contexts. However, duration varied from 1 to 35 h. Six of the 12 categories of information provided were common across all programmes, including 'strategy' 'background to disorder', 'information about communication', 'information about program', 'negative behaviours to avoid' and 'purpose of program'. Programmes differed in the types of skill-building techniques used, with the most common being videos (3/4 programmes), discussions (2/4 programmes) and trainer demonstrations (2/4 programmes). While strategies provided to trained partners targeted similar domains of communication, only 3/96 individual strategies were common to all programmes. Conclusions & Implications: There are both common and distinct components in content and delivery methods across CPT programmes. Further research is needed to evaluate the distinct components of the programmes, to determine which individual strategies are efficacious, and which approach to skill-building techniques is most effective. The present study has contributed a comprehensive list of programme components, which can form a basis for describing and refining CPT programmes in future.	[O'Rourke, Angela; Power, Emma; Rietdijk, Rachael] Univ Sydney, Discipline Speech Pathol, Fac Hlth Sci, Sydney, NSW, Australia; [O'Halloran, Robyn] La Trobe Univ, Sch Allied Hlth, Discipline Speech Pathol, Melbourne, Vic, Australia		O'Rourke, A (corresponding author), Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia.; O'Rourke, A (corresponding author), POB 170, Lidcombe, NSW 1825, Australia.	aoro4068@uni.sydney.edu.au	Rietdijk, Rachael/J-6573-2012; Power, Emma/A-9263-2015	Rietdijk, Rachael/0000-0003-4343-4039; Power, Emma/0000-0002-2638-0406			Allwood R, 2017, SOC SCI MED, V191, P212, DOI 10.1016/j.socscimed.2017.09.014; Baikie E., 2002, SEX RELATSH THER, V17, P289, DOI 10.1080/14681990220149095; Beckley F, 2017, INT J LANG COMM DIS, V52, P197, DOI 10.1111/1460-6984.12265; Behn N, 2015, BRAIN INJURY, V29, P1554, DOI 10.3109/02699052.2015.1077992; Behn N, 2012, BRAIN INJURY, V26, P1702, DOI 10.3109/02699052.2012.722258; Broughton M, 2011, INT J NURS STUD, V48, P1436, DOI 10.1016/j.ijnurstu.2011.05.007; Burgio LD, 2001, GERONTOLOGIST, V41, P449, DOI 10.1093/geront/41.4.449; Chang HF, 2018, INT J LANG COMM DIS, V53, P1094, DOI 10.1111/1460-6984.12421; Conway ER, 2016, J CLIN NURS, V25, P1145, DOI 10.1111/jocn.13134; Coupland N., 2010, CONTEXTS ACCOMMODATI, DOI [10.1017/cbo9780511663673.001, DOI 10.1017/CBO9780511663673.001, DOI 10.1017/CBO9780511663673]; Crotty M., 1998, FDN SOCIAL RES MEANI; Czaja SJ, 2016, IMPLEMENT SCI, V11, DOI 10.1186/s13012-016-0433-3; Eggenberger E, 2013, INT PSYCHOGERIATR, V25, P345, DOI 10.1017/S1041610212001664; GLASER BG, 1965, SOC PROBL, V12, P436, DOI 10.1525/sp.1965.12.4.03a00070; Hadely KA, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-110; Hemsley B, 2013, APHASIOLOGY, V27, P706, DOI 10.1080/02687038.2012.748181; Hersh D, 2016, APHASIOLOGY, V30, P609, DOI 10.1080/02687038.2014.933520; Hoffmann TC, 2014, BMJ-BRIT MED J, V348, DOI [10.1136/bmj.g1687, 10.1055/s-0041-111066]; Hsieh HF, 2005, QUAL HEALTH RES, V15, P1277, DOI 10.1177/1049732305276687; Johansson MB, 2011, DISABIL REHABIL, V33, P51, DOI 10.3109/09638288.2010.486465; Johnson FM, 2017, INT J LANG COMM DIS, V52, P374, DOI 10.1111/1460-6984.12279; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Legg C, 2005, APHASIOLOGY, V19, P559, DOI 10.1080/02687030544000029; Lindsay M, 2016, GLOBAL STROKE GUIDEL; Lock S, 2001, INT J LANG COMM DIS, V36, P25, DOI 10.3109/13682820109177853; Lokker C, 2015, IMPLEMENT SCI, V10, DOI 10.1186/s13012-015-0220-6; McDonald S., 2016, COMMUNICATION DISORD; O'Brien BC, 2014, ACAD MED, V89, P1245, DOI 10.1097/ACM.0000000000000388; O'Halloran R, 2009, INT J SPEECH-LANG PA, V11, P438, DOI 10.3109/17549500902741363; Papathanasiou I., 2016, APHASIA RELATED NEUR; Pendlebury ST, 2009, LANCET NEUROL, V8, P1006, DOI 10.1016/S1474-4422(09)70236-4; Pierce CA, 2006, AM J PHYS MED REHAB, V85, P889, DOI 10.1097/01.phm.0000242615.43129.ae; Pilnick A, 2002, SOCIOL HEALTH ILL, V24, P66, DOI 10.1111/1467-9566.00004; Polgar S., 2014, INTRO RES HLTH SCI, P33; Samuelsson C, 2017, INT J SPEECH-LANG PA, V19, P454, DOI 10.1080/17549507.2016.1221448; Schulz KF, 2010, BMC MED, V8, DOI 10.1186/1741-7015-8-18; Schulz R, 2010, AM J HEALTH BEHAV, V34, P811; Shehata GA, 2015, J AFFECT DISORDERS, V172, P312, DOI 10.1016/j.jad.2014.10.027; Simmons-Mackie N, 2016, ARCH PHYS MED REHAB, V97, P2202, DOI 10.1016/j.apmr.2016.03.023; Simmons-Mackie N, 2014, INT J LANG COMM DIS, V49, P511, DOI 10.1111/1460-6984.12097; Stanyon MR, 2016, AGE AGEING, V45, P164, DOI 10.1093/ageing/afv161; Togher L, 1997, BRAIN INJURY, V11, P169, DOI 10.1080/026990597123629; Togher L., 2010, TBI EXPRESS SOCIAL C; Togher L, 2014, J HEAD TRAUMA REHAB, V29, P353, DOI 10.1097/HTR.0000000000000071; Vasse E, 2010, INT PSYCHOGERIATR, V22, P189, DOI 10.1017/S1041610209990615; Williams KN, 2009, AM J ALZHEIMERS DIS, V24, P11, DOI 10.1177/1533317508318472; Wiltshire GE, 2014, J SOC INCL, V5, P9, DOI 10.36251/josi.73; World Health Organization (WHO), 2012, INT CAR PEOPL DEM	48	15	15	1	48	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1368-2822	1460-6984		INT J LANG COMM DIS	Int. J. Lang. Commun. Disord.	NOV-DEC	2018	53	6					1150	1168		10.1111/1460-6984.12428			19	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Rehabilitation	HC4LK	WOS:000451774800007	30295014				2022-02-06	
J	Shin, SS; Krishnan, V; Stokes, W; Robertson, C; Celnik, P; Chen, YR; Song, XL; Lu, HZ; Liu, PY; Pelled, G				Shin, Samuel S.; Krishnan, Vijai; Stokes, William; Robertson, Courtney; Celnik, Pablo; Chen, Yanrong; Song, Xiaolei; Lu, Hanzhang; Liu, Peiying; Pelled, Galit			Transcranial magnetic stimulation and environmental enrichment enhances cortical excitability and functional outcomes after traumatic brain injury	BRAIN STIMULATION			English	Article						Traumatic brain injury; TBI; Transcranial magnetic stimulation; TMS; Environmental enrichment	MOTOR CORTEX; CHRONIC STROKE; PARKINSONS-DISEASE; HEAD-INJURY; RAT; PERFORMANCE; POSTSTROKE; RECOVERY; REHABILITATION; REORGANIZATION	Background: Therapeutic strategies for traumatic brain injury (TBI) in the last three decades have failed to show significant benefit in large scale studies. Given the multitude of pathological mechanisms involved in TBI, strategies focusing on multimodality regimen have gained interest as promising future interventions. Hypothesis: We hypothesized that combining noninvasive transcranial magnetic stimulation (TMS) with rehabilitative training in an environmental enrichment (EE) can facilitate post-TBI recovery in rats via cortical excitability and reorganization. Methods: We subjected rats to controlled cortical impact, and then assigned them to one of four groups: 1. No treatments (TBI), 2. EE after injury (TBI + EE), 3. TMS for one week (TBI + TMS), and 4. TMS for one week combined with EE (TBI + TMS/EE). For TMS, a 10 Hz repetitive TMS protocol was used. Results: At 7 days, TBI + TMS and TBI + TMS/EE groups had significantly increased primary somatosensory cortex local field potential (LFP) compared to TBI and TBI + EE groups (P < 0.05). Also, TBI + TMS/EE group had significantly improved performance on beam walk test compared to TBI group (P < 0.005). At 6 weeks, there was significantly higher response in TBI + TMS/EE group compared to TBI + TMS for somatosensory cortex LFP (P < 0.05), bicep motor evoked potentials (MEP) (P < 0.05), challenge ladder test performance (P < 0.01), and fMRI responses to tactile forepaw stimulation. Conclusions: We demonstrate here for the first time the mechanism by which combined therapy using TMS and EE after TBI leads to functional improvement, possibly via cortical excitability and reorganization. (C) 2018 Elsevier Inc. All rights reserved.	[Shin, Samuel S.; Celnik, Pablo] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Shin, Samuel S.; Krishnan, Vijai; Stokes, William; Chen, Yanrong; Song, Xiaolei; Lu, Hanzhang; Liu, Peiying; Pelled, Galit] Kennedy Krieger Inst, FM Kirby Res Ctr Funct Brain Imaging, Baltimore, MD USA; [Robertson, Courtney] Johns Hopkins Univ, Sch Med, Dept Anesthesiol Crit Care Med & Pediat, Baltimore, MD USA; [Celnik, Pablo] Johns Hopkins Univ, Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Shin, Samuel S.; Krishnan, Vijai; Stokes, William; Chen, Yanrong; Song, Xiaolei; Lu, Hanzhang; Liu, Peiying; Pelled, Galit] Johns Hopkins Univ, Russell H Morgan Dept Radiol, Sch Med, Baltimore, MD USA; [Krishnan, Vijai; Pelled, Galit] Michigan State Univ, Dept Biomed Engn, E Lansing, MI 48824 USA; [Krishnan, Vijai; Pelled, Galit] Michigan State Univ, Inst Quantitat Hlth Sci & Engn, E Lansing, MI 48824 USA; [Pelled, Galit] Michigan State Univ, Dept Radiol, E Lansing, MI 48824 USA		Pelled, G (corresponding author), Michigan State Univ, Biomed Engn Radiol & Neurosci, Div Neuroengn, Inst Quantitat Hlth Sci & Engn, 775 Woodlot Dr,Room 2112, E Lansing, MI 48824 USA.	pelledga@egr.msu.edu	Liu, Peiying/D-7512-2017	Liu, Peiying/0000-0003-0830-5960	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092747, 5R01NS079288]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072171, R01NS092747, R01NS079288] Funding Source: NIH RePORTER	Galit Pelled is supported by NINDS R01NS072171, 5R01NS079288. Courtney Robertson is supported by NINDS R01NS092747.	Allitt BJ, 2016, NEUROSCIENCE, V334, P290, DOI 10.1016/j.neuroscience.2016.08.018; Andreou AP, 2016, BRAIN, V139, P2002, DOI 10.1093/brain/aww118; [Anonymous], 2016, DEV MULT THER BRAIN; Bagnato S, 2012, CLIN NEUROPHYSIOL, V123, P1937, DOI 10.1016/j.clinph.2012.03.014; Banerjee J, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0170528; Barnes WL, 2014, IEEE ENG MED BIO, P6129, DOI 10.1109/EMBC.2014.6945028; Beaumont A, 1999, NEUROL RES, V21, P742, DOI 10.1080/01616412.1999.11741008; Bocci T, 2016, CLIN NEUROPHYSIOL, V127, P1750, DOI 10.1016/j.clinph.2015.10.036; Boggio PS, 2006, AM J PHYS MED REHAB, V85, P927, DOI 10.1097/01.phm.0000242635.88129.38; Bolognini N, 2011, NEUROREHAB NEURAL RE, V25, P819, DOI 10.1177/1545968311411056; Bondi CO, 2014, J NEUROTRAUM, V31, P873, DOI 10.1089/neu.2014.3328; Brys M, 2016, NEUROLOGY, V87, P1907, DOI 10.1212/WNL.0000000000003279; Celnik P, 2009, STROKE, V40, P1764, DOI 10.1161/STROKEAHA.108.540500; Cha HG, 2017, TECHNOL HEALTH CARE, V25, P521, DOI 10.3233/THC-171294; Cheng JP, 2012, J NEUROTRAUM, V29, P2684, DOI 10.1089/neu.2012.2560; Chistyakov AV, 2001, J NEUROL NEUROSUR PS, V70, P580, DOI 10.1136/jnnp.70.5.580; Chollet F, 2011, LANCET NEUROL, V10, P123, DOI 10.1016/S1474-4422(10)70314-8; Cinnera AM, 2016, FUNCT NEUROL, V31, P117; Costa-Ribeiro A, 2016, J REHABIL MED, V48, P819, DOI 10.2340/16501977-2134; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Emara TH, 2010, EUR J NEUROL, V17, P1203, DOI 10.1111/j.1468-1331.2010.03000.x; Fecteau S, 2015, NEUROREHAB NEURAL RE, V29, P548, DOI 10.1177/1545968314558603; FERBERT A, 1992, J PHYSIOL-LONDON, V453, P525, DOI 10.1113/jphysiol.1992.sp019243; Frost Shawn B, 2016, PM R, V8, pS158, DOI 10.1016/j.pmrj.2016.07.038; Garman RH, 2011, J NEUROTRAUM, V28, P947, DOI 10.1089/neu.2010.1540; Graef P, 2016, J NEUROL SCI, V369, P149, DOI 10.1016/j.jns.2016.08.016; Guo TF, 2015, IEEE T BIO-MED ENG, V62, P2352, DOI 10.1109/TBME.2015.2427339; Haefeli J, 2017, SCI REP-UK, V7, DOI 10.1038/srep42474; Hajela N, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/516427; Hara T, 2016, NEURAL REGEN RES, V11, P1932, DOI 10.4103/1673-5374.197134; Harris-Love M, 2012, J NEUROL PHYS THER, V36, P87, DOI 10.1097/NPT.0b013e3182564d26; Johnstone VPA, 2014, J NEUROTRAUM, V31, P1881, DOI 10.1089/neu.2014.3343; Jones TA, 2015, PHYSIOLOGY, V30, P358, DOI 10.1152/physiol.00014.2015; Kim YH, 2006, STROKE, V37, P1471, DOI 10.1161/01.STR.0000221233.55497.51; Kline AE, 2016, PROG NEUROBIOL, V142, P45, DOI 10.1016/j.pneurobio.2016.05.002; Li N, 2014, J NEUROTRAUM, V31, P395, DOI 10.1089/neu.2013.3059; Lu HY, 2015, SCI REP-UK, V5, DOI 10.1038/srep14769; Luft AR, 2002, EXP BRAIN RES, V142, P562, DOI 10.1007/s00221-001-0952-1; Luft AR, 2001, EXP BRAIN RES, V140, P112, DOI 10.1007/s002210100805; Maegele M, 2005, J NEUROTRAUM, V22, P772, DOI 10.1089/neu.2005.22.772; Meehan SK, 2011, NEUROSCI LETT, V500, P26, DOI 10.1016/j.neulet.2011.05.237; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Moosavi SH, 1999, J NEUROL SCI, V164, P179, DOI 10.1016/S0022-510X(99)00065-9; Mueller JK, 2014, NAT NEUROSCI, V17, P1130, DOI 10.1038/nn.3751; Nguyen JP, 2017, NEUROPHYSIOL CLIN, V47, P47, DOI 10.1016/j.neucli.2017.01.001; Nishibe M, 2015, NEUROREHAB NEURAL RE, V29, P472, DOI 10.1177/1545968314543499; Noh NA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035080; Nudo RJ, 2015, NATURE, V527, P314, DOI 10.1038/527314a; Pariente J, 2001, ANN NEUROL, V50, P718, DOI 10.1002/ana.1257; Pisegna JM, 2016, CLIN NEUROPHYSIOL, V127, P956, DOI 10.1016/j.clinph.2015.04.069; ROBINSON SE, 1990, BRAIN RES, V511, P141, DOI 10.1016/0006-8993(90)90233-2; Seeger TA, 2017, BRAIN STIMUL, V10, P305, DOI 10.1016/j.brs.2016.11.011; Shin SS, 2017, FRONT NEURAL CIRCUIT, V11, DOI 10.3389/fncir.2017.00015; Spagnolo F, 2013, BRAIN STIMUL, V6, P892, DOI 10.1016/j.brs.2013.05.004; Sung WH, 2013, STROKE, V44, P1375, DOI 10.1161/STROKEAHA.111.000522; Takeuchi N, 2008, J REHABIL MED, V40, P298, DOI 10.2340/16501977-0181; Thompson GJ, 2013, NEUROIMAGE, V83, P826, DOI 10.1016/j.neuroimage.2013.07.036; Tischler H, 2012, NEUROBIOL DIS, V48, P464, DOI 10.1016/j.nbd.2012.07.021; TOPKA H, 1991, NEUROLOGY, V41, P1276, DOI 10.1212/WNL.41.8.1276; Wu D, 2016, NEUROIMAGE, V125, P84, DOI 10.1016/j.neuroimage.2015.10.051	60	15	15	5	21	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1935-861X	1876-4754		BRAIN STIMUL	Brain Stimul.	NOV-DEC	2018	11	6					1306	1313		10.1016/j.brs.2018.07.050			8	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GY0LW	WOS:000448212900012	30082198	Green Accepted			2022-02-06	
J	Madhavan, R; Joel, SE; Mullick, R; Cogsil, T; Niogi, SN; Tsiouris, AJ; Mukherjee, P; Masdeu, JC; Marinelli, L; Shetty, T				Madhavan, Radhika; Joel, Suresh E.; Mullick, Rakesh; Cogsil, Taylor; Niogi, Sumit N.; Tsiouris, A. John; Mukherjee, Pratik; Masdeu, Joseph C.; Marinelli, Luca; Shetty, Teena			Longitudinal Resting State Functional Connectivity Predicts Clinical Outcome in Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						connectivity; fractional amplitude of low frequency fluctuations (fALFF); longitudinal; predict; resting state fMRI	TENSOR IMAGING FINDINGS; WHOLE-BRAIN; HIGH-RESOLUTION; HIGH-SCHOOL; CONCUSSION; NETWORKS; FMRI; MRI; ASSOCIATION; INFERENCES	Mild traumatic brain injury (mTBI) affects about 42 million people worldwide. It is often associated with headache, cognitive deficits, and balance difficulties but rarely shows any abnormalities on conventional computed tomography (CT) or magnetic resonance imaging (MRI). Although in most mTBI patients the symptoms resolve within 3 months, 10-15% of patients continue to exhibit symptoms beyond a year. Also, it is known that there exists a vulnerable period post-injury, when a second injury may exacerbate clinical prognosis. Identifying this vulnerable period may be critical for patient outcome, but very little is known about the neural underpinnings of mTBI and its recovery. In this work, we used advanced functional neuroimaging to study longitudinal changes in functional organization of the brain during the 3-month recovery period post-mTBI. Fractional amplitude of low frequency fluctuations (fALFF) measured from resting state functional MRI (rs-fMRI) was found to be associated with symptom severity score (SSS, r=-0.28, p=0.002). Decreased fALFF was observed in specific functional networks for patients with higher SSS, and fALFF returned to higher values when the patient recovered (lower SSS). In addition, functional connectivity of the same networks was found to be associated with concurrent SSS, and connectivity immediately after injury (<10 days) was capable of predicting SSS at a later time-point (3 weeks to 3 months, p<0.05). Specific networks including motor, default-mode, and visual networks were found to be associated with SSS (p<0.001), and connectivity between these networks predicted 3-month clinical outcome (motor and visual: p<0.001, default-mode: p<0.006). Our results suggest that functional connectivity in these networks comprise potential biomarkers for predicting mTBI recovery profiles and clinical outcome.	[Madhavan, Radhika; Joel, Suresh E.; Mullick, Rakesh] GE Global Res, Artificial Intelligence, Bangalore, Karnataka, India; [Mullick, Rakesh; Cogsil, Taylor; Shetty, Teena] Hosp Special Surg, Dept Neurol, 535 E 70th St, New York, NY 10021 USA; [Niogi, Sumit N.; Tsiouris, A. John] Weill Cornell Med Coll, Dept Radiol, New York, NY USA; [Mukherjee, Pratik] Univ Calif San Francisco, Radiol & Bioengn, San Francisco, CA 94143 USA; [Masdeu, Joseph C.] Houston Methodist Hosp, Stanley H Appel Dept Neurol, Houston, TX USA; [Marinelli, Luca] GE Global Res, Biol & Phys, Niskayuna, NY USA		Madhavan, R; Joel, SE (corresponding author), GE Global Res, Plot 122,Export Promot Ind Pk,Phase 2, Bengaluru 560066, Karnataka, India.	radhika.madhavan@ge.com; suresh.joel@ge.com	Marinelli, Luca/AAB-5933-2021	Cogsil, Taylor/0000-0002-5127-7566; Madhavan, Radhika/0000-0002-9833-437X	GE/NFL Head Health Initiative (HHI)General Electric	We thank the General Electric Company (GE)/National Football League (NFL) Medical Advisory Board for their comments and advice. At GE, we thank Dr. Victor Miranda and Amy Gallenberg for their role in the execution of the study, and the neuro MRI team, in particular Pauline Worters, Matthew Middione, and Ajit Shankaranarayanan, for MRI pulse sequence design. We would also like to thank the technical and clinical staff at Hospital for Special Surgery, Houston Methodist Hospital, and University of California, San Francisco (specifically Nicholas Pojman, Nhu Nhu Nguyen, and Chelsea Camara) for their role in patient recruitment and data acquisition. The clinical staff at Hospital for Special Surgery included Kelianne Cummings, Lorena Loci, Dan Zuchelli, Megan Parmenter, and Kristin Halvorsen, all of whom were integral in recruiting patients and collecting data. Finally, we thank the GE/NFL Head Health Initiative (HHI) for sponsoring and funding the study.	Behzadi Y, 2007, NEUROIMAGE, V37, P90, DOI 10.1016/j.neuroimage.2007.04.042; Benson RR, 2012, NEUROREHABILITATION, V31, P261, DOI 10.3233/NRE-2012-0795; Birn RM, 2012, NEUROIMAGE, V62, P864, DOI 10.1016/j.neuroimage.2012.01.016; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Calhoun VD, 2001, HUM BRAIN MAPP, V14, P140, DOI 10.1002/hbm.1048; Carney N, 2014, NEUROSURGERY, V75, pS1, DOI 10.1227/NEU.0000000000000434; Castellanos FX, 2008, BIOL PSYCHIAT, V63, P332, DOI 10.1016/j.biopsych.2007.06.025; Chachra P., 2017, ANN M ORG HUM BRAIN; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; Dall'Acqua P, 2017, FRONT HUM NEUROSCI, V11, DOI 10.3389/fnhum.2017.00280; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; De Luca M, 2006, NEUROIMAGE, V29, P1359, DOI 10.1016/j.neuroimage.2005.08.035; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Eklund A, 2016, P NATL ACAD SCI USA, V113, P7900, DOI 10.1073/pnas.1602413113; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fox MD, 2009, J NEUROPHYSIOL, V101, P3270, DOI 10.1152/jn.90777.2008; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Grool AM, 2016, JAMA-J AM MED ASSOC, V316, P2504, DOI 10.1001/jama.2016.17396; Haacke EM, 2004, MAGN RESON MED, V52, P612, DOI 10.1002/mrm.20198; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jaiswal MK, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00148; Joel SE, 2011, MAGN RESON MED, V66, P644, DOI 10.1002/mrm.22818; Katz D.I., 2015, HDB CLIN NEUROLOGY, P131; Kurca E, 2006, NEURORADIOLOGY, V48, P661, DOI 10.1007/s00234-006-0109-9; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Le TH, 2009, MT SINAI J MED, V76, P145, DOI 10.1002/msj.20102; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Madhavan R., 2016, 5 BIENN C REST STAT; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; McCrea M, 2002, NEUROSURGERY, V50, P1032, DOI 10.1097/00006123-200205000-00017; McCrory P, 2009, BRIT J SPORT MED, V43, pI76, DOI 10.1136/bjsm.2009.058248; McInnes K, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0174847; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2008, BRAIN, V131, P3209, DOI 10.1093/brain/awn247; O'Kane JW, 2014, JAMA PEDIATR, V168, P258, DOI 10.1001/jamapediatrics.2013.4518; Palacios EM, 2012, NEUROLOGY, V78, P852, DOI 10.1212/WNL.0b013e31824c465a; Palacios EM, 2017, J NEUROTRAUM, V34, P1546, DOI 10.1089/neu.2016.4752; Power JD, 2014, NEUROIMAGE, V84, P320, DOI 10.1016/j.neuroimage.2013.08.048; Preibisch C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0136961; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rashid B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00897; Ravishankar H, 2016, IEEE ENG MED BIO, P4071, DOI 10.1109/EMBC.2016.7591621; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Seeley WW, 2007, J NEUROSCI, V27, P2349, DOI 10.1523/JNEUROSCI.5587-06.2007; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Shirer WR, 2012, CEREB CORTEX, V22, P158, DOI 10.1093/cercor/bhr099; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Theadom A, 2014, J SCI MED SPORT, V17, P591, DOI 10.1016/j.jsams.2014.02.001; Todd N, 2016, NEUROIMAGE, V124, P32, DOI 10.1016/j.neuroimage.2015.08.056; Wang K, 2007, HUM BRAIN MAPP, V28, P967, DOI 10.1002/hbm.20324; Weissenbacher A, 2009, NEUROIMAGE, V47, P1408, DOI 10.1016/j.neuroimage.2009.05.005; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; Zhan J, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00027; Zhou J, 2010, BRAIN, V133, P1352, DOI 10.1093/brain/awq075; Zhou YX, 2014, J MAGN RESON IMAGING, V39, P1558, DOI 10.1002/jmri.24310; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zou QH, 2008, J NEUROSCI METH, V172, P137, DOI 10.1016/j.jneumeth.2008.04.012	61	15	15	1	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2019	36	5					650	660		10.1089/neu.2018.5739		OCT 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	HR2BG	WOS:000446276100001	30024343				2022-02-06	
J	Hendricks, S; Till, K; Oliver, JL; Johnston, RD; Attwood, M; Brown, J; Drake, D; MacLeod, S; Mellalieu, SD; Treu, P; Jones, B				Hendricks, Sharief; Till, Kevin; Oliver, Jon L.; Johnston, Rich D.; Attwood, Matthew; Brown, James; Drake, David; MacLeod, Simon; Mellalieu, Stephen D.; Treu, Paul; Jones, Ben			Technical Skill Training Framework and Skill Load Measurements for the Rugby Union Tackle	STRENGTH AND CONDITIONING JOURNAL			English	Article						rugby; collision sports; tackle; skill training; skill conditioning; training load; injury prevention; performance	INJURY RISK; LEAGUE; PERFORMANCE; CONCUSSION; STRATEGIES; PARADOX; FATIGUE; ILLNESS; PART	Drawing from skill acquisition and development literature, we present a novel tackle skill training framework. The framework outlines the training purpose (technique proficiency, technique capacity, skill proficiency, and skill capacity), skill workload measurements (available information, task difficulty, rating of perceived challenge, and skill load), as well as the training conditions and coaching style for the tackle in rugby union. Using this framework and skill load measurements, we propose a preseason tackle training plan. this tackle skill framework and skill load measurements serve as potential preventive measures for tackle injury risk while improving players' tackle performance. For a video abstract of this article, see supplemental digital content 1 (see video, http://linksiww.com/scj/a243).	[Hendricks, Sharief; Brown, James] Univ Cape Town, Dept Human Biol, Div Exercise Sci & Sports Med, Cape Town, South Africa; [Hendricks, Sharief; Till, Kevin; Jones, Ben] Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England; [Till, Kevin; Jones, Ben] Yorkshire Carnegie Rugby Union Football Club, Leeds, W Yorkshire, England; [Oliver, Jon L.; Attwood, Matthew; Mellalieu, Stephen D.] Cardiff Metropolitan Univ, Cardiff Sch Sport & Heath Sci, Cardiff, S Glam, Wales; [Oliver, Jon L.] Auckland Univ Technol, Sports Performance Res Inst New Zealand, Auckland, New Zealand; [Johnston, Rich D.] Australian Catholic Univ, Sch Exercise Sci, Brisbane, Qld, Australia; [Johnston, Rich D.] Norths Devils Rugby Football League, Nundah, Qld, Australia; [Attwood, Matthew] Cardiff Metropolitan Univ, Rugby Union Football Club, Cardiff, S Glam, Wales; [Brown, James] Stellenbosch Univ, Inst Sport & Exercise Med, Stellenbosch, South Africa; [Brown, James] IOC, Res Ctr, Cape Town, South Africa; [Drake, David] Kingspan Stadium, Ulster Rugby, Belfast, Antrim, North Ireland; [MacLeod, Simon] Western Prov Rugby & Stormers, Cape Town, South Africa; [Jones, Ben] Rugby Football League, Leeds, W Yorkshire, England; [Till, Kevin; Jones, Ben] Leeds Rhinos Rugby League Club, Leeds, W Yorkshire, England		Hendricks, S (corresponding author), Univ Cape Town, Dept Human Biol, Div Exercise Sci & Sports Med, Cape Town, South Africa.; Hendricks, S (corresponding author), Leeds Beckett Univ, Inst Sport Phys Act & Leisure, Leeds, W Yorkshire, England.	sharief.hendricks01@gmail.com	Mellalieu, Stephen/Y-5171-2019; Till, Kevin/AAP-7379-2021; Brown, James Craig/H-7637-2019; Attwood, Matthew J/N-2057-2019	Brown, James Craig/0000-0002-7778-7783; Attwood, Matthew J/0000-0002-3911-1897; Jones, Ben/0000-0002-4274-6236; Mellalieu, Stephen/0000-0003-2868-3328			Brown JC, 2016, INT J SPORTS SCI COA, V11, P637, DOI 10.1177/1747954116667100; Burger N, 2017, AM J SPORT MED, V45, P278, DOI 10.1177/0363546516677548; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Burger N, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005556; Campbell PG, 2018, INT J SPORT PHYSIOL, V13, P496, DOI 10.1123/ijspp.2017-0082; Cross MJ, 2016, INT J SPORT PHYSIOL, V11, P350, DOI 10.1123/ijspp.2015-0187; Davids K., 2008, DYNAMICS SKILL ACQUI; den Hollander S, 2016, J SPORT SCI MED, V15, P501; Drew MK, 2016, SPORTS MED, V46, P861, DOI 10.1007/s40279-015-0459-8; Duthie G, 2005, J SPORT SCI, V23, P523, DOI 10.1080/02640410410001730188; Farrow D, 2017, SPORTS MED, V47, P1043, DOI 10.1007/s40279-016-0646-2; Finch CF, 2010, BRIT J SPORT MED, V44, P973, DOI 10.1136/bjsm.2008.056069; Finch C, 2006, J SCI MED SPORT, V9, P3, DOI 10.1016/j.jsams.2006.02.009; Fraas MR, 2016, EUR J SPORT SCI, V16, P1212, DOI 10.1080/17461391.2016.1170207; Gabbett TJ, 2016, BRIT J SPORT MED, V50, P273, DOI 10.1136/bjsports-2015-095788; Gabbett TJ, 2011, J SCI MED SPORT, V14, P210, DOI 10.1016/j.jsams.2011.01.002; Gabbett TJ, 2008, J STRENGTH COND RES, V22, P625, DOI 10.1519/JSC.0b013e3181635a6a; Guadagnoli MA, 2004, J MOTOR BEHAV, V36, P212, DOI 10.3200/JMBR.36.2.212-224; Hendricks S., 2013, South African Journal of Sports Medicine, V25, P8; Hendricks S, 2016, BMJ OPEN SPORT EXERC; Hendricks S, 2017, INT J SPORTS SCI COA, V12, P708, DOI 10.1177/1747954117738880; Hendricks S, 2018, J SPORT SCI, V36, P522, DOI 10.1080/02640414.2017.1322216; Hendricks S, 2017, BRIT J SPORT MED, V51, P829, DOI 10.1136/bjsports-2016-096347; Hendricks S, 2015, INT J SPORTS SCI COA, V10, P949, DOI 10.1260/1747-9541.10.5.949; Hendricks S, 2015, EUR J SPORT SCI, V15, P557, DOI 10.1080/17461391.2015.1046192; Hendricks S, 2014, EUR J SPORT SCI, V14, P753, DOI 10.1080/17461391.2014.905982; Hendricks S, 2014, J SPORT SCI MED, V13, P715; Hendricks S, 2010, INT J SPORTS SCI COA, V5, P117, DOI 10.1260/1747-9541.5.1.117; Hulin BT, 2016, BRIT J SPORT MED, V50, P231, DOI 10.1136/bjsports-2015-094817; Jones CM, 2017, SPORTS MED, V47, P943, DOI 10.1007/s40279-016-0619-5; LEVENTHAL H, 1965, J PERS SOC PSYCHOL, V2, P20, DOI 10.1037/h0022089; Mc Fie S, 2016, CLIN J SPORT MED, V26, P398, DOI 10.1097/JSM.0000000000000276; Patricios J, 2014, CURR SPORT MED REP, V13, P142, DOI 10.1249/JSR.0000000000000049; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Quarrie KL, 2017, BRIT J SPORT MED, V51, P421, DOI 10.1136/bjsports-2016-096191; Quarrie KL, 2013, J SCI MED SPORT, V16, P353, DOI 10.1016/j.jsams.2012.08.005; Read Dale, 2016, BMJ Open Sport Exerc Med, V2, pe000147, DOI 10.1136/bmjsem-2016-000147; Roberts SP, 2008, J SPORT SCI, V26, P825, DOI 10.1080/02640410801942122; Roberts SP, 2015, BRIT J SPORT MED, V49, P536, DOI 10.1136/bjsports-2013-092988; ROSS LEE, 2011, THE PERSON AND THE S; Smart DJ, 2008, BRIT J SPORT MED, V42, P198, DOI 10.1136/bjsm.2007.040162; Soligard T, 2016, BRIT J SPORT MED, V50, P1030, DOI 10.1136/bjsports-2016-096581; Tierney GJ, 2018, INT J SPORTS SCI COA, V13, P16, DOI 10.1177/1747954117711866; Tierney Gregory J, 2018, J Sci Med Sport, V21, P221, DOI 10.1016/j.jsams.2017.06.023; Tucker R, 2017, BRIT J SPORT MED, V51, P1152, DOI 10.1136/bjsports-2017-097895; Tucker R, 2016, BRIT J SPORT MED, V50, P921, DOI 10.1136/bjsports-2016-096322; Wheeler KW, 2010, EUR J SPORT SCI, V10, P237, DOI 10.1080/17461391.2010.482595; Windt J, 2017, BRIT J SPORT MED, V51, P645, DOI 10.1136/bjsports-2016-095973; World Rugby, 2016, YEAR IN REV, P44; Ziv G, 2016, J STRENGTH COND RES, V30, P881, DOI 10.1519/JSC.0000000000001129	50	15	15	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1524-1602	1533-4295		STRENGTH COND J	Strength Cond. J.	OCT	2018	40	5					44	59		10.1519/SSC.0000000000000400			16	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GV6XZ	WOS:000446264700005		Green Accepted			2022-02-06	
J	Mirshekar, MA; Sarkaki, A; Farbood, Y; Naseri, MKG; Badavi, M; Mansouri, MT; Haghparast, A				Mirshekar, Mohammad Ali; Sarkaki, Alireza; Farbood, Yaghoub; Naseri, Mohammad Kazem Gharib; Badavi, Mohammad; Mansouri, Mohammad Taghi; Haghparast, Abbas			Neuroprotective effects of gallic acid in a rat model of traumatic brain injury: behavioral, electrophysiological and molecular studies	IRANIAN JOURNAL OF BASIC MEDICAL SCIENCES			English	Article						Brain inflammation; Gallic acid; Long-term potentiation; Memory; Rat; Traumatic brain injury	TERM POTENTIATION DEFICITS; INFLAMMATORY CYTOKINES; ANTIOXIDANT ACTIVITY; ELLAGIC ACID; TNF-ALPHA; KAPPA-B; MEMORY; PROGESTERONE; SUPPRESSION; IMPAIRMENT	Objective(s): Traumatic brain injury (TBI) is one of the main causes of intellectual and cognitive disabilities. Clinically, it is essential to limit the development of cognitive impairment after TBI. In the present study, the neuroprotective effects of gallic acid (GA) on neurological score, memory, long-term potentiation (LTP) from hippocampal dentate gyrus (hDG), brain lipid peroxidation and cytokines after TBI were evaluated. Materials and Methods: Seventy-two adult male Wistar rats divided randomly into three groups with 24 in each: Veh + Sham, Veh + TBI and GA + TBI (GA; 100 mg/kg, PO for 7 days before TBI induction). Brain injury was made by Marmarou's method. Briefly, a 200 g weight was fallen down from a 2 m height through a free-falling tube onto the head of anesthetized animal. Results: Veterinary coma scores (VCS), memory and recorded hDG -LTP significantly reduced in Veh + TBI group at 1 and 24 hr after TBI when compared to Veh + Sham (P<0.001), respectively, while brain tissue content of interleukin-1 beta (IL-1 beta), IL-6, tumor necrosis factor-alpha (TNF-alpha) and malondialdehyde (MDA) were increased significantly (P<0.001). Pretreatment of TBI rats with GA improved clinical signs, memory and hDG-LTP significantly (P<0.001) compared to Veh + TBI group, while brain tissue content of IL-1 beta, IL-6, TNF-alpha and MDA were decreased significantly (P<0.001). Conclusion: Our results propose that GA has neuroprotective effect on memory and LTP impairment due to TBI through decrement of brain lipid peroxidation and cerebral pro-inflammatory cytokines.	[Mirshekar, Mohammad Ali; Sarkaki, Alireza; Farbood, Yaghoub; Badavi, Mohammad] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Physiol, Ahvaz, Iran; [Mirshekar, Mohammad Ali] Zahedan Univ Med Sci, Sch Med, Dept Physiol, Zahedan, Iran; [Mirshekar, Mohammad Ali] Zahedan Univ Med Sci, Clin Immunol Res Ctr, Zahedan, Iran; [Sarkaki, Alireza; Farbood, Yaghoub; Naseri, Mohammad Kazem Gharib; Badavi, Mohammad; Mansouri, Mohammad Taghi] Ahvaz Jundishapur Univ Med Sci, Ahvaz Physiol Res Ctr, Ahvaz, Iran; [Mansouri, Mohammad Taghi] Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Pharmacol, Ahvaz, Iran; [Haghparast, Abbas] Shahid Beheshti Univ Med Sci, Neurosci Res Ctr, Tehran, Iran		Sarkaki, A (corresponding author), Ahvaz Jundishapur Univ Med Sci, Sch Med, Dept Physiol, Ahvaz, Iran.; Sarkaki, A (corresponding author), Ahvaz Jundishapur Univ Med Sci, Ahvaz Physiol Res Ctr, Ahvaz, Iran.	sarkaki_a@ajums.ac.ir	Haghparast, Abbas/AAW-3722-2021; Mirshekar, Mohammad Ali/S-4167-2017; Farbood, Yaghoob/M-3076-2017; Badavi, Mohammad/C-1452-2013; Mansouri, Seyed Mohammad Taghi/F-3847-2014; Haghparast, Abbas/B-3023-2009	Mirshekar, Mohammad Ali/0000-0002-0449-6440; Farbood, Yaghoob/0000-0002-6390-0079; Badavi, Mohammad/0000-0003-2290-8565; Mansouri, Seyed Mohammad Taghi/0000-0002-7549-0708; Haghparast, Abbas/0000-0003-1084-180X	Ahvaz Jundishapur University of Medical Sciences, Physiology Research Center [APRC-146]	This article was extracted from Mohammad Ali Mirshekar's PhD thesis. This project was supported financially by Ahvaz Jundishapur University of Medical Sciences, Physiology Research Center (grant no. APRC-146). We all thanks to Dr. Shahram Mashhadizadeh, Dr. Soltani and Miss Naderi from Physiology Research Center, Kerman University of Medical Sciences for technical assistance and we are also grateful to Dr Ghorbangol Ashabi for editing the manuscript.	Albensi BC, 2000, EXP NEUROL, V162, P385, DOI 10.1006/exnr.1999.7338; Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; BRAMLETT HM, 1995, J NEUROTRAUM, V12, P289, DOI 10.1089/neu.1995.12.289; Brooks JC, 2013, ARCH PHYS MED REHAB, V94, P2203, DOI 10.1016/j.apmr.2013.07.005; Cai YZ, 2004, LIFE SCI, V74, P2157, DOI 10.1016/j.lfs.2003.09.047; Cavaglia M, 2001, BRAIN RES, V910, P81, DOI 10.1016/S0006-8993(01)02637-3; Chen G, 2008, ANN CLIN LAB SCI, V38, P65; CHOI DW, 1995, TRENDS NEUROSCI, V18, P58; COLLINGRIDGE GL, 1995, TRENDS NEUROSCI, V18, P54, DOI 10.1016/0166-2236(95)93868-X; De Beer D, 2003, J AGR FOOD CHEM, V51, P902, DOI 10.1021/jf026011o; Deadwyler SA, 1996, J NEUROSCI, V16, P354; del Zoppo G J, 2000, Thromb Res, V98, P73, DOI 10.1016/S0049-3848(00)00218-8; DeVries HE, 1997, PHARMACOL REV, V49, P143; Dubal DB, 2001, ENDOCRINOLOGY, V142, P43, DOI 10.1210/en.142.1.43; Fan L, 1996, MOL BRAIN RES, V36, P287, DOI 10.1016/0169-328X(95)00274-V; Farbood Y, 2015, LIFE SCI, V124, P120, DOI 10.1016/j.lfs.2015.01.013; Farkas E, 2007, BRAIN RES REV, V54, P162, DOI 10.1016/j.brainresrev.2007.01.003; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Greenberg G, 2008, ARCH PHYS MED REHAB, V89, pS45, DOI 10.1016/j.apmr.2008.08.211; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; Hang CH, 2005, J SURG RES, V123, P188, DOI 10.1016/j.jss.2004.08.002; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Holmin S, 2004, NEUROSCI LETT, V369, P108, DOI 10.1016/j.neulet.2004.07.044; Isuzugawa K, 2001, BIOL PHARM BULL, V24, P1022, DOI 10.1248/bpb.24.1022; Kamm K, 2006, J TRAUMA, V60, P152, DOI 10.1097/01.ta.0000196345.81169.a1; Kim YJ, 2007, BIOL PHARM BULL, V30, P1052, DOI 10.1248/bpb.30.1052; King DR, 2004, SURGERY, V136, P355, DOI 10.1016/j.surg.2004.05.011; Kratz JM, 2008, MEM I OSWALDO CRUZ, V103, P437, DOI 10.1590/S0074-02762008000500005; Kratz JM, 2008, BIOL PHARM BULL, V31, P903, DOI 10.1248/bpb.31.903; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lashgari R, 2006, BEHAV BRAIN RES, V171, P324, DOI 10.1016/j.bbr.2006.04.013; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mansouri MT, 2013, FOOD CHEM, V138, P1028, DOI 10.1016/j.foodchem.2012.11.022; Mashhadizadeh S, 2017, IRAN J BASIC MED SCI, V20, P399, DOI 10.22038/IJBMS.2017.8581; McIntosh TK, 1998, J NEUROTRAUM, V15, P731, DOI 10.1089/neu.1998.15.731; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Morais MCC, 2010, NAT PROD RES, V24, P1758, DOI 10.1080/14786410903335232; O'Connor CA, 2005, BRAIN RES, V1062, P171, DOI 10.1016/j.brainres.2005.09.011; Ozen LJ, 2012, ARCH CLIN NEUROPSYCH, V27, P85, DOI 10.1093/arclin/acr087; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Qi FH, 2009, LETT APPL MICROBIOL, V49, P98, DOI 10.1111/j.1472-765X.2009.02626.x; RAO B, 1989, GAMETE RES, V24, P127, DOI 10.1002/mrd.1120240202; Roohbakhsh A, 2007, CLIN EXP PHARMACOL P, V34, P223, DOI 10.1111/j.1440-1681.2007.04576.x; Rostworowski M, 1997, J NEUROSCI, V17, P3664; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Sarkaki AR, 2013, J NEUROTRAUM, V30, P47, DOI 10.1089/neu.2010.1686; Sarkaki A, 2015, CAN J PHYSIOL PHARM, V93, P687, DOI 10.1139/cjpp-2014-0546; Sarkaki A, 2013, IRAN J BASIC MED SCI, V16, P1004; Sirota L, 2001, BIOL NEONATE, V79, P103, DOI 10.1159/000047075; Stein DG, 2008, ANN EMERG MED, V51, P164, DOI 10.1016/j.annemergmed.2007.05.001; Sun J, 2002, J AGR FOOD CHEM, V50, P7449, DOI 10.1021/jf0207530; Tate DF, 2000, LEARN MEMORY, V7, P442, DOI 10.1101/lm.33000; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Trivedi MA, 2007, J NEUROTRAUM, V24, P766, DOI 10.1089/neu.2006.0205; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Williamson G, 2005, AM J CLIN NUTR, V81, p243S, DOI [10.1093/ajcn/81.1.243S, 10.1093/ajcn/81.1.230S]; Wolfe K, 2003, J AGR FOOD CHEM, V51, P609, DOI 10.1021/jf020782a; Yaka R, 2007, FASEB J, V21, P2033, DOI 10.1096/fj.06-7856com; Yang HL, 2006, FOOD CHEM TOXICOL, V44, P1978, DOI 10.1016/j.fct.2006.06.027	62	15	16	0	3	MASHHAD UNIV MED SCIENCES	MASHHAD	VICE-CHANCELLOR FOR RES CTR OFF IJBMS, DANESHGAH ST, PO BOX 9138813944 - 445, MASHHAD, 00000, IRAN	2008-3866	2008-3874		IRAN J BASIC MED SCI	Iran. J. Basic Med. Sci.	OCT	2018	21	10					1056	1063					8	Medicine, Research & Experimental; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine; Pharmacology & Pharmacy	GR4HZ	WOS:000442565400011	30524680				2022-02-06	
J	Moquin, A; Ji, J; Neibert, K; Winnik, FM; Maysinger, D				Moquin, Alexandre; Ji, Jeff; Neibert, Kevin; Winnik, Francoise M.; Maysinger, Dusica			Encapsulation and Delivery of Neutrophic Proteins and Hydrophobic Agents Using PMOXA-PDMS-PMOXA Triblock Polymersomes	ACS OMEGA			English	Article							NERVE GROWTH-FACTOR; TRAUMATIC BRAIN-INJURY; SYNAPTIC PLASTICITY; DRUG-DELIVERY; TGF-BETA; CANCER; DOXORUBICIN; COPOLYMER; EXOSOMES; CURCUMIN	Polymersomes are attractive nanocarriers for hydrophilic and lipophilic drugs; they are more stable than liposomes, tunable, and relatively easy to prepare. The copolymer composition and molar mass are critical features that determine the physicochemical properties of the polymersomes including the rate of drug release. We used the triblockcopolymer, poly(2-methyl-2-oxazoline)-block-poly-(dimethysiloxane)-block-poly(2-methyl-2-oxazoline) (PIVIOXA-PDIVIS-PMOXA), to form amphipathic polymersomes capable of loading proteins and small hydrophobic agents. The selected agents were unstable neurotrophins (nerve growth factor and brain -derived neurotrophic factor), a large protein CD109, and the fluorescent drug curcumin. We prepared, characterized, and tested polymersomes loaded with selected agents in 2D and 3D biological models. Curcumin-loaded and rhodamine-bound PMOXA-PDMS-PMOXA polymersomes were used to visualize them inside cells. NMethyl-D-aspartate receptor (NNIDAR) agonists and antagonists were also covalently attached to the surface of polymersomes for targeting neurons. Labeled and unlabeled polymersomes with or without loaded agents were characterized using dynamic light scattering (DLS), UV-vis fluorescence spectroscopy, and asymmetrical flow field-flow fractionation (AF(4)). Polymersomes were imaged and tested for biological activity in human and murine fibroblasts, murine macrophages, primary murine dorsal root ganglia, and murine hippocampal cultures. Polymersomes were rapidly internalized and there was a clear intracellular co-localization of the fluorescent drug (curcumin) with the fluorescent rhodamine-labeled polymersomes. Polymersomes containing CD109, a glycosylphosphatidylinositol-anchored protein, promoted cell migration in the model of wound healing. Nerve growth factor-loaded polymersomes effectively enhanced neurite outgrowth in dissociated and explanted dorsal root ganglia. Brain -derived neurotrophic factor increased dendritic spine density in serum-deprived hippocampal slice cultures. NMDAR agonist-and antagomst-functionalized polymersomes targeted selectively neurons over filial cells in mixed cultures. Collectively, the study reveals the successful incorporation into polymersomes of biologically active trophic factors and small hydrophilic agents that retain their biological activity in vitro, as demonstrated in selected central and peripheral tissue models.	[Moquin, Alexandre; Ji, Jeff; Neibert, Kevin; Maysinger, Dusica] McGill Univ, Dept Pharmacol & Therapeut, Fac Med, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada; [Winnik, Francoise M.] Univ Montreal, Dept Chim, CP 6128 Succursale Ctr Ville, Montreal, PQ H3C 3J7, Canada; [Winnik, Francoise M.] NIMS, Int Ctr Mat Nanoarchitecton MANA, 1-1 Namiki, Tsukuba, Ibaraki 3050044, Japan; [Winnik, Francoise M.] Univ Helsinki, Dept Chem, FI-00014 Helsinki, Finland		Maysinger, D (corresponding author), McGill Univ, Dept Pharmacol & Therapeut, Fac Med, 3655 Promenade Sir William Osler, Montreal, PQ H3G 1Y6, Canada.	dusica.maysinger@mcgill.ca		Maysinger, Dusica/0000-0002-0017-5201	Natural Sciences and Engineering Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC); Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR)	This work was supported by a grant from Natural Sciences and Engineering Council of Canada (F.M.W. and D.M.) and Canadian Institutes for Health Research (CIHR) to D.M.	Ahmed F, 2006, J CONTROL RELEASE, V116, P150, DOI 10.1016/j.jconrel.2006.07.012; Akbik D, 2014, LIFE SCI, V116, P1, DOI 10.1016/j.lfs.2014.08.016; Anajafi T, 2017, MOL PHARMACEUT, V14, P1916, DOI 10.1021/acs.molpharmaceut.7b00014; Aungst SL, 2014, J CEREBR BLOOD F MET, V34, P1223, DOI 10.1038/jcbfm.2014.75; Ayen WY, 2012, PHARM RES-DORDR, V29, P2522, DOI 10.1007/s11095-012-0783-8; Bai LC, 2014, J MATER CHEM B, V2, P7785, DOI 10.1039/c4tb01383b; Bizet AA, 2011, BBA-MOL CELL RES, V1813, P742, DOI 10.1016/j.bbamcr.2011.01.028; Boateng JS, 2008, J PHARM SCI-US, V97, P2892, DOI 10.1002/jps.21210; BOCCHINI V, 1970, EUR J BIOCHEM, V15, P127, DOI 10.1111/j.1432-1033.1970.tb00986.x; Calfa G, 2012, HIPPOCAMPUS, V22, P1493, DOI 10.1002/hipo.20990; Chahar HS, 2015, VIRUSES-BASEL, V7, P3204, DOI 10.3390/v7062770; Chen JL, 2005, J CEREBR BLOOD F MET, V25, P281, DOI 10.1038/sj.jcbfm.9600034; Chen Y, 2015, ACS APPL MATER INTER, V7, P2919, DOI 10.1021/am508399w; Christian DA, 2009, EUR J PHARM BIOPHARM, V71, P463, DOI 10.1016/j.ejpb.2008.09.025; Cummings KA, 2015, J GEN PHYSIOL, V145, P513, DOI 10.1085/jgp.201411302; De Oliveira H, 2012, WIRES NANOMED NANOBI, V4, P525, DOI 10.1002/wnan.1183; Demidova-Rice TN, 2012, ADV SKIN WOUND CARE, V25, P304, DOI 10.1097/01.ASW.0000416006.55218.d0; DIAMOND J, 1992, J NEUROSCI, V12, P1454; Elkabes S, 1996, J NEUROSCI, V16, P2508; Fang Y, 2017, SLAS DISCOV, V22, P456, DOI 10.1177/1087057117696795; Finetti F, 2013, IMMUNOL REV, V251, P97, DOI 10.1111/imr.12018; Finnson KW, 2006, FASEB J, V20, P1525, DOI 10.1096/fj.05-5229fje; Gahwiler BH, 1997, TRENDS NEUROSCI, V20, P471, DOI 10.1016/S0166-2236(97)01122-3; Gantwerker EA, 2012, CLIN PLAST SURG, V39, P85, DOI 10.1016/j.cps.2011.09.005; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; GERONEMUS RG, 1979, ARCH DERMATOL, V115, P1311, DOI 10.1001/archderm.115.11.1311; Ginty DD, 2002, CURR OPIN NEUROBIOL, V12, P268, DOI 10.1016/S0959-4388(02)00326-4; Griesbach GS, 2004, NEUROSCIENCE, V125, P129, DOI 10.1016/j.neuroscience.2004.01.030; Guan LJ, 2015, NANOMEDICINE-UK, V10, P2757, DOI 10.2217/nnm.15.110; HEFTI F, 1986, J NEUROSCI, V6, P2155; Hermes B, 2001, J INVEST DERMATOL, V116, P387, DOI 10.1046/j.1523-1747.2001.01284.x; Johnson JW, 2006, CURR OPIN PHARMACOL, V6, P61, DOI 10.1016/j.coph.2005.09.007; Kawamoto K, 2004, PROG BRAIN RES, V146, P369; Kempe K, 2010, MACROMOL RAPID COMM, V31, P1869, DOI 10.1002/marc.201000283; KJOLSETH D, 1994, J AM COLL SURGEONS, V179, P305; Krausz AE, 2015, NANOMED-NANOTECHNOL, V11, P195, DOI 10.1016/j.nano.2014.09.004; Kulac M, 2013, J MOL HISTOL, V44, P83, DOI 10.1007/s10735-012-9452-9; Lau CG, 2007, NAT REV NEUROSCI, V8, P413, DOI 10.1038/nrn2153; Le Meins JF, 2011, EUR PHYS J E, V34, DOI 10.1140/epje/i2011-11014-y; Leal G, 2015, BRAIN RES, V1621, P82, DOI 10.1016/j.brainres.2014.10.019; Lee JS, 2012, J CONTROL RELEASE, V161, P473, DOI 10.1016/j.jconrel.2011.10.005; Leitman J, 2013, DNA CELL BIOL, V32, P2, DOI 10.1089/dna.2012.1889; Li C, 2016, BIOCHEM J, V473, P537, DOI 10.1042/BJ20141488; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Ma PL, 2010, BIOMACROMOLECULES, V11, P549, DOI 10.1021/bm901345q; MALENKA RC, 1993, TRENDS NEUROSCI, V16, P521, DOI 10.1016/0166-2236(93)90197-T; Maysinger D, 2018, ACS CHEM NEUROSCI, V9, P260, DOI 10.1021/acschemneuro.7b00301; Medda L, 2015, CHEM COMMUN, V51, P6663, DOI 10.1039/c5cc01538c; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Meng FH, 2009, BIOMACROMOLECULES, V10, P197, DOI 10.1021/bm801127d; Micera A, 2001, P NATL ACAD SCI USA, V98, P6162, DOI 10.1073/pnas.101130898; Mondal S, 2016, J PHOTOCH PHOTOBIO B, V158, P212, DOI 10.1016/j.jphotobiol.2016.03.004; Morimoto N, 2014, CHEM COMMUN, V50, P8350, DOI 10.1039/c4cc03199g; Muller LK, 2015, BIOCHEM BIOPH RES CO, V468, P411, DOI 10.1016/j.bbrc.2015.08.088; Nakajima K, 2001, J NEUROSCI RES, V65, P322, DOI 10.1002/jnr.1157; Nardin C, 2000, LANGMUIR, V16, P1035, DOI 10.1021/la990951u; Oltra NS, 2014, ANNU REV CHEM BIOMOL, V5, P281, DOI 10.1146/annurev-chembioeng-060713-040447; Onaca O, 2009, MACROMOL BIOSCI, V9, P129, DOI 10.1002/mabi.200800248; Pampaloni F, 2007, NAT REV MOL CELL BIO, V8, P839, DOI 10.1038/nrm2236; Pasca SP, 2018, NATURE, V553, P437, DOI 10.1038/nature25032; Saari H., 2015, J CONTROL RELEASE, V10, P2963; Sakane T, 1997, PHARMACEUT RES, V14, P1085, DOI 10.1023/A:1012117815460; Saman S, 2014, J ALZHEIMERS DIS, V40, pS47, DOI 10.3233/JAD-132135; Sampey GC, 2014, J NEUROVIROL, V20, P199, DOI 10.1007/s13365-014-0238-6; Song JB, 2015, ACCOUNTS CHEM RES, V48, P2506, DOI 10.1021/acs.accounts.5b00059; Stoenescu R, 2004, MACROMOL BIOSCI, V4, P930, DOI 10.1002/mabi.200400065; Stroncek John D., 2008, P3; Tam J, 2002, BIOCHEM BIOPH RES CO, V291, P649, DOI 10.1006/bbrc.2002.6497; Tran TH, 2015, CLIN IMMUNOL, V160, P46, DOI 10.1016/j.clim.2015.03.021; Toffoli G., 2015, NANOMEDICINE, V40, pS47; Tyler WJ, 2003, J PHYSIOL-LONDON, V553, P497, DOI 10.1113/jphysiol.2003.052639; Upadhyay KK, 2010, MACROMOL BIOSCI, V10, P503, DOI 10.1002/mabi.200900415; Velnar T, 2009, J INT MED RES, V37, P1528, DOI 10.1177/147323000903700531; Vorstenbosch J, 2017, J INVEST DERMATOL, V137, P641, DOI 10.1016/j.jid.2016.09.039; Wang L, 2004, STROKE, V35, P1732, DOI 10.1161/01.STR.0000132196.49028.a4; Waterhouse EG, 2009, MOL CELL NEUROSCI, V42, P81, DOI 10.1016/j.mcn.2009.06.009; Yallapu MM, 2015, AAPS J, V17, P1341, DOI 10.1208/s12248-015-9811-z; Yildirim T, 2017, BIOMACROMOLECULES, V18, P3280, DOI 10.1021/acs.biomac.7b00931; Zaretski AV, 2016, NANO LETT, V16, P1375, DOI 10.1021/acs.nanolett.5b04821; Zhao LX, 2014, BIOMATERIALS, V35, P1284, DOI 10.1016/j.biomaterials.2013.10.063; Zheng XJ, 2015, J MATER CHEM B, V3, P1921, DOI 10.1039/c4tb01766h; Zhu GZ, 2000, NAT BIOTECHNOL, V18, P52, DOI 10.1038/71916; Zou T, 2015, J BIOTECHNOL, V214, P147, DOI 10.1016/j.jbiotec.2015.09.034	83	15	15	1	21	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	2470-1343			ACS OMEGA	ACS Omega	OCT	2018	3	10					13882	13893		10.1021/acsomega.8b02311			12	Chemistry, Multidisciplinary	Science Citation Index Expanded (SCI-EXPANDED)	Chemistry	GZ0CZ	WOS:000449026500168	30411053	gold, Green Published			2022-02-06	
J	Gorse, KM; Lafrenaye, AD				Gorse, Karen M.; Lafrenaye, Audrey D.			The Importance of Inter-Species Variation in Traumatic Brain Injury-Induced Alterations of Microglial-Axonal Interactions	FRONTIERS IN NEUROLOGY			English	Article						traumatic brain injury; microglia; axonal injury; microglial-neuronal interaction; rat; micro pig; species differences	INTRACRANIAL-PRESSURE; INFLAMMATION; ISOFLURANE; CELLS; ACTIVATION; RECEPTORS; NEURONS; FLUID; TIME	Interactions between microglia and neuronal components are important for normal CNS function. They are also associated with neuroinflammation and many pathological processes and several studies have explored these interactions in terms of phagocytic engulfment. Much progress has also been made in understanding the consequences of chronic neuroinflammatory changes following trauma. However, little is known about acute alterations to these physical non-phagocytic microglial-neuronal interactions following traumatic brain injury (TBI), and particularly to what degree these post-injury interactions may be influenced by the animal species utilized in pre-clinical models of TBI. To investigate these problems, we evaluated the physical interactions between microglia and injured axons acutely (6 h and 1 day) following central fluid percussion injury (cFPI) in both rats and micro pigs. The physical interactions between lba-1+ microglia and either normal MBP+myelinated fibers or APP+ injured axonal swellings in the thalamus were assessed following injury or sham via quantitative image analysis of 3D confocal micrographs. The results indicated that the physical interactions between microglia and injured axonal swellings decreased by nearly half in rats 6 h following cFPI but was consistent with sham control at 1 day post-cFPI. This reduction was also observed in non-injured intact fibers at both timepoints following TBI in the rat. Microglial process interactions with injured axons in the micro pig, however, increased nearly 2-fold compared to interactions with intact axonal segments 1 day post-cFPI. This study shows that the species utilized for in vivo pre-clinical studies influences the manner in which microglial-axonal interactions change following TBI. These species differences can be leveraged to further our understanding of the mechanisms involved in microglial process convergence and how these neuro-immune interactions alter the progression of axonal injury following TBI.	[Gorse, Karen M.; Lafrenaye, Audrey D.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA		Lafrenaye, AD (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23284 USA.	audrey.lafrenaye@vcuhealth.org			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS096143]; U.S. Army [W81XWH-10-1-0623, WH81XWH-14-2-0018]; NIH-NINDS Center core grant [5P30NS047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096143, P30NS047463] Funding Source: NIH RePORTER	We would like to thank Dr. John Povlishock for his encouragement throughout this project and Dr. Carmen Sato-Bigbee for editorial insight. We would also like to recognize Dr. Scott Henderson for his expertise in microscopy and image analysis, Dr. Robert Hamm for his biostatistical assistance and knowledge as well as Lynn Davis, Judy Williamson, Frances White, Susan Walker, Masaki Todani and Chuck Blocher for invaluable technical assistance. This work was supported by the NINDS grant 1R01NS096143. This work was also performed as a component of the Operation Brain Trauma Therapy consortium, which is supported by U.S. Army grants W81XWH-10-1-0623 and WH81XWH-14-2-0018. Microscopy was performed at the VCU Department of Anatomy and Neurobiology Microscopy Facility, supported, in part, with funding from NIH-NINDS Center core grant 5P30NS047463.	Altay O, 2014, NEUROBIOL DIS, V62, P365, DOI 10.1016/j.nbd.2013.09.016; Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Baalman K, 2015, J NEUROSCI, V35, P2283, DOI 10.1523/JNEUROSCI.3751-14.2015; Bahney J, 2018, ANAT REC, V301, P697, DOI 10.1002/ar.23728; Batchelor PE, 2002, MOL CELL NEUROSCI, V21, P436, DOI 10.1006/mcne.2002.1185; Bechmann I, 1997, GLIA, V20, P145, DOI 10.1002/(SICI)1098-1136(199706)20:2<145::AID-GLIA6>3.0.CO;2-8; Bell MJ, 1997, J NEUROTRAUM, V14, P451, DOI 10.1089/neu.1997.14.451; Benusa SD, 2017, J NEUROINFLAMM, V14, DOI 10.1186/s12974-017-0889-3; Cheng ZQ, 2016, JOURNAL PRACT, V10, P744, DOI [10.1111/jnc.13062, 10.1080/17512786.2015.1063079]; Davalos D, 2005, NAT NEUROSCI, V8, P752, DOI 10.1038/nn1472; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Eyo UB, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0209-16.2016; Eyo UB, 2017, GLIA, V65, P5, DOI 10.1002/glia.23006; Eyo UB, 2015, J NEUROSCI, V35, P2417, DOI 10.1523/JNEUROSCI.3279-14.2015; Eyo UB, 2014, J NEUROSCI, V34, P10528, DOI 10.1523/JNEUROSCI.0416-14.2014; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Gorse KM, 2018, J NEUROTRAUM, V35, P1694, DOI 10.1089/neu.2017.5275; Herculano-Houzel S, 2014, GLIA, V62, P1377, DOI 10.1002/glia.22683; Hinson HE, 2015, J TRAUMA ACUTE CARE, V78, P184, DOI 10.1097/TA.0000000000000468; Hu WL, 2018, EXP THER MED, V15, P1568, DOI 10.3892/etm.2017.5527; Jassam YN, 2017, NEURON, V95, P1246, DOI 10.1016/j.neuron.2017.07.010; Jelsing J, 2006, J EXP BIOL, V209, P1454, DOI 10.1242/jeb.02141; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kato G, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0004-16.2016; Kokiko-Cochran O, 2016, J NEUROTRAUM, V33, P625, DOI 10.1089/neu.2015.3970; Krabbe G, 2012, BRAIN BEHAV IMMUN, V26, P419, DOI 10.1016/j.bbi.2011.12.002; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lafrenaye AD, 2016, NEURAL REGEN RES, V11, P538, DOI 10.4103/1673-5374.180726; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; MARGULIES S S, 1989, Journal of Biomechanical Engineering, V111, P241; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Norden DM, 2015, NEUROPHARMACOLOGY, V96, P29, DOI 10.1016/j.neuropharm.2014.10.028; Oehmichen M, 1999, ACTA NEUROPATHOL, V97, P491, DOI 10.1007/s004010051018; Ortega FJ, 2012, EXP NEUROL, V235, P282, DOI 10.1016/j.expneurol.2012.02.010; Parkhurst CN, 2013, CELL, V155, P1596, DOI 10.1016/j.cell.2013.11.030; Plachinta RV, 2003, ANESTHESIOLOGY, V98, P89, DOI 10.1097/00000542-200301000-00017; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Schirmer L, 2013, BRAIN PATHOL, V23, P2, DOI 10.1111/j.1750-3639.2012.00608.x; Solga AC, 2015, GLIA, V63, P531, DOI 10.1002/glia.22754; Sopka S, 2013, ANN ANAT, V195, P166, DOI 10.1016/j.aanat.2012.07.013; Statler KD, 2006, BRAIN RES, V1076, P216, DOI 10.1016/j.brainres.2005.12.106; Statler KD, 2000, J NEUROTRAUM, V17, P1179, DOI 10.1089/neu.2000.17.1179; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Venkatesan C, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-32; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Watanitanon A, 2018, CRIT CARE MED, V46, P781, DOI 10.1097/CCM.0000000000002991; Wofford KL, 2017, EXP NEUROL, V290, P85, DOI 10.1016/j.expneurol.2017.01.004; Wohleb ES, 2018, BIOL PSYCHIAT, V83, P38, DOI 10.1016/j.biopsych.2017.05.026; Wu X, 2012, NEUROBIOL AGING, V33, P1364, DOI 10.1016/j.neurobiolaging.2010.11.002; Yamasaki R, 2014, J EXP MED, V211, P1533, DOI 10.1084/jem.20132477; Ziebell JM, 2017, BRAIN BEHAV IMMUN, V59, P1, DOI 10.1016/j.bbi.2016.03.008	55	15	15	0	1	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	SEP 20	2018	9								778	10.3389/fneur.2018.00778			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GU2PC	WOS:000445111200001	30294296	Green Published, gold			2022-02-06	
J	Qin, XJ; Li, LZ; Lv, Q; Shu, QM; Zhang, YL; Wang, YP				Qin, Xiaojing; Li, Lingzhi; Lv, Qi; Shu, Qingming; Zhang, Yongliang; Wang, Yaping			Expression profile of plasma microRNAs and their roles in diagnosis of mild to severe traumatic brain injury	PLOS ONE			English	Article							CIRCULATING MICRORNAS; CLINICAL UTILITY; MESSENGER-RNAS; BIOMARKERS; PROGNOSIS; SERUM; NEUROPROTECTION; MANAGEMENT; INFECTION; RAPAMYCIN	Traumatic brain injury (TBI) is associated with trauma-related death. In this study, we evaluated differences in the expression of plasma microRNAs (miRNAs) in patients with different degrees of TBI, and explored the potential of miRNAs for use as diagnostic TBI biomarkers. The miRNA microarray results showed upregulation of 65, 33, and 16 miRNAs and downregulation of 29, 27, and 6 miRNAs in patients with mild, moderate, and severe TBI, respectively, compared with healthy controls. Thirteen miRNAs (seven upregulated and six downregulated) were found to be present in all TBI groups. Seven upregulated miRNAs were selected for validation in an enlarged cohort of samples and showed good diagnostic accuracy. The expression levels of miR-3195 and miR-328-5p were higher in the severe TBI group than in the mild and moderate TBI groups. In summary, our study demonstrates different expression profiles in plasma miRNAs among patients with mild to severe TBI. A subset of seven miRNAs can be used for diagnosis of TBI. Moreover, miR-3195 and miR-328-5p may be utilized during diagnosis to distinguish mild and moderate TBI from severe TBI.	[Qin, Xiaojing; Wang, Yaping] Chongqing Med Univ, Dept Histol & Embryol, Chongqing, Peoples R China; [Qin, Xiaojing] Logist Univ PAP, Dept Pathol, Affiliated Hosp, Tianjin, Peoples R China; [Li, Lingzhi; Zhang, Yongliang] Tianjin Key Lab Prevent & Control Occupat & Envir, Tianjin, Peoples R China; [Lv, Qi] Tianjin Univ, Inst Disaster Med, Tianjin, Peoples R China; [Shu, Qingming] Gen Hosp PAP, Beijing, Peoples R China		Wang, YP (corresponding author), Chongqing Med Univ, Dept Histol & Embryol, Chongqing, Peoples R China.; Zhang, YL (corresponding author), Tianjin Key Lab Prevent & Control Occupat & Envir, Tianjin, Peoples R China.	Zhang78127@sina.com; cnyapingwang@163.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81471823]	This work is supported by Natural Science Foundation of China (81471823) (YZ).; This work is supported by Natural Science Foundation of China (81471823). We would like to thank Department of Neurosurgery, Affiliated Hospital of Logistic University of PAP, for their help on the collection of TBI patients' plasma samples.	Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Ambros V, 2004, NATURE, V431, P350, DOI 10.1038/nature02871; Balu R, 2014, CURR NEUROL NEUROSCI, V14, DOI 10.1007/s11910-014-0484-2; Bhomia M, 2016, SCI REP-UK, V6, DOI 10.1038/srep28148; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Borrebaeck CAK, 2017, NAT REV CANCER, V17, P199, DOI 10.1038/nrc.2016.153; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Califf RM, 2018, EXP BIOL MED, V243, P213, DOI 10.1177/1535370217750088; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Chen HY, 2014, J ENDOCRINOL, V222, pR1, DOI 10.1530/JOE-13-0544; Chen K, 2007, NAT REV GENET, V8, P93, DOI 10.1038/nrg1990; Chen SY, 2007, J CEREBR BLOOD F MET, V27, P939, DOI 10.1038/sj.jcbfm.9600393; Chen X, 2008, CELL RES, V18, P997, DOI 10.1038/cr.2008.282; Cheng PC, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002332; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Dash PK, 2010, NEUROTHERAPEUTICS, V7, P100, DOI 10.1016/j.nurt.2009.10.019; De Guzman E, 2017, CRIT CARE CLIN, V33, P423, DOI 10.1016/j.ccc.2017.03.011; Di Leva G, 2014, ANNU REV PATHOL-MECH, V9, P287, DOI 10.1146/annurev-pathol-012513-104715; Di Pietro V, 2017, J NEUROTRAUM, V34, P1948, DOI 10.1089/neu.2016.4857; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; FDA-NIH Biomarker Working Group, BEST BIOM ENDPOINTS; Foye C, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0189165; Friedman RC, 2009, GENOME RES, V19, P92, DOI 10.1101/gr.082701.108; Goffus AM, 2010, OXID MED CELL LONGEV, V3, P145, DOI 10.4161/oxim.3.2.11315; Ikeda S, 2007, PHYSIOL GENOMICS, V31, P367, DOI 10.1152/physiolgenomics.00144.2007; Jin XF, 2013, CELL MOL NEUROBIOL, V33, P601, DOI 10.1007/s10571-013-9940-9; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kanehisa M, 2017, NUCLEIC ACIDS RES, V45, pD353, DOI 10.1093/nar/gkw1092; Kaplan GB, 2010, BEHAV PHARMACOL, V21, P427, DOI 10.1097/FBP.0b013e32833d8bc9; Khella HWZ, 2013, AM J KIDNEY DIS, V61, P798, DOI 10.1053/j.ajkd.2012.09.018; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Liu BY, 2015, CHIN J TRAUMATOL, V18, P135, DOI 10.1016/j.cjtee.2015.04.002; Ma L, 2016, SCI REP-UK, V6, DOI 10.1038/srep31535; Maegele M, 2017, LANCET NEUROL, V16, P630, DOI 10.1016/S1474-4422(17)30197-7; McDonald JS, 2011, CLIN CHEM, V57, P833, DOI 10.1373/clinchem.2010.157198; Mitchell PS, 2008, P NATL ACAD SCI USA, V105, P10513, DOI 10.1073/pnas.0804549105; Napieralski JA, 1999, MOL BRAIN RES, V71, P78, DOI 10.1016/S0169-328X(99)00155-2; Omahen DA, 2011, NEUROSURGERY, V69, P440, DOI 10.1227/NEU.0b013e318215a3b3; Patel RK, 2017, BRAIN BEHAV IMMUN, V64, P244, DOI 10.1016/j.bbi.2017.04.012; Pizzamiglio S, 2017, ONCOL LETT, V13, P315, DOI 10.3892/ol.2016.5452; Redell JB, 2010, J NEUROTRAUM, V27, P2147, DOI 10.1089/neu.2010.1481; Royo NC, 2007, NEUROSCIENCE, V148, P359, DOI 10.1016/j.neuroscience.2007.06.014; Saadat S, 2012, ULUS TRAVMA ACIL CER, V18, P219, DOI [10.5505/tjtes.2012.03453, 10.5505/tjtes.2012. 03453]; Schmittgen TD, 2008, NAT PROTOC, V3, P1101, DOI 10.1038/nprot.2008.73; Sohel M.H., 2016, ACHIEV LIFE SCI, V10, P175, DOI [10.1016/j.als.2016.11.007, DOI 10.1016/J.ALS.2016.11.007]; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Tonkin AM, 2015, INT J CARDIOL, V201, P499, DOI 10.1016/j.ijcard.2015.07.080; Valadi H, 2007, NAT CELL BIOL, V9, P654, DOI 10.1038/ncb1596; van Hooij A, 2016, SCI REP-UK, V6, DOI 10.1038/srep34260; van Rooij E, 2011, CIRC RES, V108, P219, DOI 10.1161/CIRCRESAHA.110.227496; Witwer KW, 2011, AIDS, V25, P2057, DOI 10.1097/QAD.0b013e32834b95bf; Xiong SD, 2017, CLIN CHEM LAB MED, V55, P82, DOI 10.1515/cclm-2016-0118; Xue Liang, 2004, Zhonghua Wai Ke Za Zhi, V42, P236; Zetterberg H, 2016, NAT REV NEUROL, V12, P563, DOI 10.1038/nrneurol.2016.127	55	15	17	0	3	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	SEP 18	2018	13	9							e0204051	10.1371/journal.pone.0204051			15	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GU0DL	WOS:000444918300039	30226895	Green Published, gold, Green Submitted			2022-02-06	
J	Anada, RP; Wong, KT; Jayapalan, JJ; Hashim, OH; Ganesan, D				Anada, Raj Poovindran; Wong, Kum Thong; Jayapalan, Jaime Jacqueline; Hashim, Onn Haji; Ganesan, Dharmendra			Panel of serum protein biomarkers to grade the severity of traumatic brain injury	ELECTROPHORESIS			English	Article						Biomarker; Glasgow Coma Scale; iTRAQ; Serum proteins; Traumatic brain injury	GLASGOW COMA SCALE; HEAD-INJURY; EPIDEMIOLOGY; APOLIPOPROTEINS; LOCALIZATION; RECEPTOR	The Glasgow Coma Scale (GCS), which classifies patients into mild, moderate or severe traumatic brain injury (TBI), is a system used to prioritize treatment and prognosticate the severity of head injury. In this study, sera of patients with various stages of TBI, as well as control subjects, were analyzed to screen for proteins that may be used to complement the GCS system. By subjecting pooled serum samples to iTRAQ analysis for quantitative comparison of protein abundance, and attesting their altered levels using ELISA, we have detected increased levels of serum amyloid A, C-reactive protein, leucine-rich alpha-2-glycoprotein, lipopolysaccharide-binding protein, fibronectin, vitronectin and alpha-1-antichymotrypsin in patients across all strata of TBI relative to the controls. However, kininogen was decreased only in moderate and severe TBI, whereas apolipoprotein E and zinc-alpha-2-glycoprotein were only increased in severe TBI. Hence, we propose a panel of serum biomarkers, which if analyzed within 24 h of the injury, can be used to diagnose patients with TBI into mild, moderate or severe stratification objectively, thus complementing the traditional GCS.	[Anada, Raj Poovindran; Ganesan, Dharmendra] Univ Malaya, Dept Surg, Fac Med, Kuala Lumpur, Malaysia; [Wong, Kum Thong] Univ Malaya, Dept Pathol, Fac Med, Kuala Lumpur, Malaysia; [Jayapalan, Jaime Jacqueline; Hashim, Onn Haji] Univ Malaya, Ctr Prote Res, Fac Med, Kuala Lumpur, Malaysia; [Hashim, Onn Haji] Univ Malaya, Dept Mol Med, Fac Med, Kuala Lumpur, Malaysia		Ganesan, D (corresponding author), Univ Malaya, Dept Surg, Fac Med, Div Neurosurg, Kuala Lumpur 50603, Malaysia.	dharmendra@um.edu.my	Jayapalan, Jaime/C-7354-2015; Hashim, Onn H/B-9459-2010; GANESAN, DHARMENDRA/B-8437-2010; Wong, Kum Thong/B-2788-2010	Jayapalan, Jaime/0000-0001-6708-1800; Hashim, Onn H/0000-0002-0196-6793; 	University of Malaya, Kuala Lumpur, MalaysiaUniversiti Malaya [RG249/10HTM, PV064/2011A]	This study was supported by research grants RG249/10HTM and PV064/2011A from the University of Malaya, Kuala Lumpur, Malaysia. This concept has been submitted for patent filing in Malaysia (PI2014700972).	af Geijerstam JL, 2005, EMERG MED J, V22, P103, DOI 10.1136/emj.2004.015396; AKIYAMA H, 1991, J NEUROIMMUNOL, V32, P19, DOI 10.1016/0165-5728(91)90067-H; Al Nimer F, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132177; Bao Y, 2005, FEBS LETT, V579, P41, DOI 10.1016/j.febslet.2004.11.042; Colman R. W., 1998, THROMB HAEMOSTASIS, V60, P340; Cunningham Steven C, 2006, Surg Infect (Larchmt), V7, P251, DOI 10.1089/sur.2006.7.251; Davies MG, 1997, BRIT J SURG, V84, P920, DOI 10.1002/bjs.1800840707; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; Hajba L, 2016, ANAL CHIM ACTA, V943, P8, DOI 10.1016/j.aca.2016.08.035; Hashim OH, 2017, PEERJ, V5, DOI 10.7717/peerj.3784; Hergenroeder G, 2008, J NEUROTRAUM, V25, P79, DOI 10.1089/neu.2007.0386; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; KABBAJ O, 1989, ANN BIOL CLIN-PARIS, V47, P35; Lee D.G., 2005, J KOREAN NEUROTRAUMA, V1, P57, DOI [10.13004/jknts.2005.1.1.57, DOI 10.13004/JKNTS.2005.1.1.57]; Lewis LM, 2017, ACAD EMERG MED, V24, P710, DOI 10.1111/acem.13174; Lowe G D, 2001, Ann Periodontol, V6, P1, DOI 10.1902/annals.2001.6.1.1; MAHLEY RW, 1988, SCIENCE, V240, P622, DOI 10.1126/science.3283935; Malle E, 1996, EUR J CLIN INVEST, V26, P427, DOI 10.1046/j.1365-2362.1996.159291.x; MARION DW, 1994, J TRAUMA, V36, P89, DOI 10.1097/00005373-199401000-00014; MURRAY LS, 1993, LANCET, V341, P1487, DOI 10.1016/0140-6736(93)90631-P; Nakajima M, 2012, ACTA NEUROCHIR SUPPL, V113, P97, DOI 10.1007/978-3-7091-0923-6_20; Nakajima M, 2011, ACTA NEUROCHIR, V153, P1339, DOI 10.1007/s00701-011-0963-z; Padmanabhan J, 2006, BRAIN, V129, P3020, DOI 10.1093/brain/awl255; Papa L., 2015, SOURCEBRAIN NEUROTRA; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ross PL, 2004, MOL CELL PROTEOMICS, V3, P1154, DOI 10.1074/mcp.M400129-MCP200; SAILE R, 1990, J CLIN CHEM CLIN BIO, V28, P519; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 2014, LANCET NEUROL, V13, P844, DOI 10.1016/S1474-4422(14)70120-6; Thelin EP, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00300; Wu Y, 2015, THROMB J, V13, DOI 10.1186/s12959-015-0048-y; Yin GN, 2009, BRAIN RES, V1265, P158, DOI 10.1016/j.brainres.2009.01.058	34	15	16	0	2	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	SEP	2018	39	18			SI		2308	2315		10.1002/elps.201700407			8	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	GT8OV	WOS:000444799300004	29570807				2022-02-06	
J	Crocker, LD; Jurick, SM; Thomas, KR; Keller, AV; Sanderson-Cimino, M; Boyd, B; Rodgers, C; Twamley, EW; Jak, AJ				Crocker, Laura D.; Jurick, Sarah M.; Thomas, Kelsey R.; Keller, Amber V.; Sanderson-Cimino, Mark; Boyd, Briana; Rodgers, Carie; Twamley, Elizabeth W.; Jak, Amy J.			Worse baseline executive functioning is associated with dropout and poorer response to trauma-focused treatment for veterans with PTSD and comorbid traumatic brain injury	BEHAVIOUR RESEARCH AND THERAPY			English	Article						Executive function; PTSD; Treatment; Dropout; Cognition; Traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; COGNITIVE PROCESSING THERAPY; RANDOMIZED CONTROLLED-TRIAL; IRAQI FREEDOM VETERANS; PERFORMANCE VALIDITY TESTS; POSTCONCUSSION SYNDROME; BEHAVIORAL THERAPY; SERVICE MEMBERS; VERBAL MEMORY; MILD TBI	Although trauma-focused treatment, including Cognitive Processing Therapy (CPT), effectively reduces PTSD symptoms, treatment dropout, nonresponse, and relapse are substantial. Executive functioning (EF) is essential to engage the cognitive skills involved in CPT (e.g., inhibiting/evaluating distorted thoughts, flexibly generating alternative thoughts). It was hypothesized that worse baseline EF would be associated with reduced CPT completion and responsivity. Seventy-four Iraq/Afghanistan-era Veterans with PTSD and history of mild-to-moderate traumatic brain injury were randomized to either standard CPT or modified CPT that included cognitive rehabilitation strategies (SMART-CPT). Those who dropped out of treatment prematurely performed more poorly on EF tests at baseline than treatment completers. Worse baseline performances on EF tests of working memory, inhibition, and inhibition/switching were associated with poorer response to CPT (less reduction in PTSD symptoms). In addition, a three-way interaction indicated that individuals with worse baseline cognitive flexibility did not benefit as much from standard CPT but demonstrated significant PTSD symptom improvement in the SMART-CPT condition, comparable to those with better baseline cognitive flexibility. Modifying CPT to accommodate executive dysfunction may boost treatment effectiveness and allow Veterans to fully engage in and benefit more from components of CPT (e.g., cognitive restructuring).	[Crocker, Laura D.; Keller, Amber V.; Twamley, Elizabeth W.] VA San Diego Healthcare Syst, Res Serv, 3350 La Jolla Village Dr,151B, San Diego, CA 92161 USA; [Crocker, Laura D.; Twamley, Elizabeth W.; Jak, Amy J.] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Jurick, Sarah M.; Sanderson-Cimino, Mark] Univ Calif San Diego, San Diego State Univ, Joint Doctoral Program Clin Psychol, La Jolla, CA 92093 USA; [Thomas, Kelsey R.; Jak, Amy J.] VA San Diego Healthcare Syst, Psychol Serv, San Diego, CA USA; [Thomas, Kelsey R.; Twamley, Elizabeth W.; Jak, Amy J.] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Boyd, Briana] Vet Med Res Fdn, San Diego, CA USA; [Rodgers, Carie] PsychArmor Inst, San Diego, CA USA		Crocker, LD (corresponding author), VA San Diego Healthcare Syst, Res Serv, 3350 La Jolla Village Dr,151B, San Diego, CA 92161 USA.	laura.crocker@va.gov		Sanderson-Cimino, Mark/0000-0002-5872-3186; Thomas, Kelsey/0000-0003-4277-8876; Keller, Amber/0000-0002-2972-784X	Department of DefenseUnited States Department of Defense [W81XWH-11-1-0641]; VA Rehabilitation RD Service [IK2 RX002459]; Veterans AffairsUS Department of Veterans Affairs [IK2RX002459] Funding Source: NIH RePORTER	Funding for the clinical trial was provided by Department of Defense award W81XWH-11-1-0641. The funding agency had no involvement in the study design, data collection, data analysis, interpretation of data, writing of the report, and in the decision to submit the article for publication, Laura Crocker received salary support during this work from the VA Interprofessional Polytrauma and TBI Fellowship and Career Development Award Number IK2 RX002459 from the VA Rehabilitation R&D Service. Special thanks to Liljana Trenova, Henry Orff, and Samantha Hoffman.	Aharonovich E, 2008, DRUG ALCOHOL DEPEN, V95, P279, DOI 10.1016/j.drugalcdep.2008.01.009; Amick MM, 2013, J INT NEUROPSYCH SOC, V19, P792, DOI 10.1017/S1355617713000544; Armistead-Jehle P, 2016, APPL NEUROPSYCH-ADUL, V23, P264, DOI 10.1080/23279095.2015.1055564; Armistead-Jehle P, 2010, APPL NEUROPSYCHOL, V17, P52, DOI 10.1080/09084280903526182; Aupperle RL, 2012, NEUROPHARMACOLOGY, V62, P686, DOI 10.1016/j.neuropharm.2011.02.008; Banich MT, 2009, CURR DIR PSYCHOL SCI, V18, P89, DOI 10.1111/j.1467-8721.2009.01615.x; Belanger HG, 2010, J INT NEUROPSYCH SOC, V16, P194, DOI 10.1017/S1355617709990841; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P215, DOI 10.1017/S1355617705050277; Bigler ED, 2012, J INT NEUROPSYCH SOC, V18, P632, DOI 10.1017/S1355617712000252; Bisson JI, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003388.pub4; Bomyea J, 2012, J BEHAV THER EXP PSY, V43, P844, DOI 10.1016/j.jbtep.2011.12.001; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Bryant R. A., 2012, PTSD MILD TRAUMATIC, P219; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Chard KM, 2010, J TRAUMA STRESS, V23, P25, DOI 10.1002/jts.20500; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Cooper DB, 2015, BRAIN IMAGING BEHAV, V9, P403, DOI 10.1007/s11682-015-9440-2; Crocker LD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00261; D'Alcante CC, 2012, PROG NEURO-PSYCHOPH, V39, P310, DOI 10.1016/j.pnpbp.2012.07.002; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Defense and Veterans Brain Injury Center, 2017, DOD WORLDW NUMB TRAU; DeGutis J, 2015, J INT NEUROPSYCH SOC, V21, P342, DOI 10.1017/S1355617715000235; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Diamond A, 2016, DEV COGN NEUROS-NETH, V18, P34, DOI 10.1016/j.dcn.2015.11.005; Dolan S, 2012, NEUROPSYCHOL REV, V22, P21, DOI 10.1007/s11065-012-9190-5; Erbes CR, 2009, PSYCHOL SERV, V6, P175, DOI 10.1037/a0016662; Etkin Amit, 2013, Dialogues Clin Neurosci, V15, P419; Evans CT, 2013, PM&R, V5, P210, DOI 10.1016/j.pmrj.2012.12.004; Falconer E, 2013, J CLIN PSYCHIAT, V74, P895, DOI 10.4088/JCP.12m08020; Fals-Stewart W, 2010, EXP CLIN PSYCHOPHARM, V18, P87, DOI 10.1037/a0018058; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Garety P, 1997, BRIT J PSYCHIAT, V171, P420, DOI 10.1192/bjp.171.5.420; Granholm E, 2008, SCHIZOPHR RES, V100, P133, DOI 10.1016/j.schres.2007.11.032; Grohman K., 2003, J COGNITIVE REHABILI, V21, P10; Haaland KY, 2016, J INT NEUROPSYCH SOC, V22, P643, DOI 10.1017/S1355617716000424; Heaton R., 2000, WISCONSIN CARD SORTI; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Institute of Medicine, 2008, TREATM POSTTR STR DI; Jak A. J., SMART CPT TREATMENT; Jak A. J., 2016, CURRENT TOPICS BEHAV; Jak A. J., 2017, 45 ANN M INT NEUR SO; Jak AJ, 2015, CONTEMP CLIN TRIALS, V45, P210, DOI 10.1016/j.cct.2015.10.009; Jak AJ, 2015, J CLIN EXP NEUROPSYC, V37, P379, DOI 10.1080/13803395.2015.1020769; Jaycox, 2008, INVISIBLE WOUNDS WAR; Jurick SM, 2018, J HEAD TRAUMA REHAB, V33, pE41, DOI 10.1097/HTR.0000000000000313; Kehle-Forbes S. M., 2015, PSYCHOL TRAUMA THEOR, V8; Kessler RC, 2005, ARCH GEN PSYCHIAT, V62, P617, DOI 10.1001/archpsyc.62.6.617; Kilpatrick DG, 2013, J TRAUMA STRESS, V26, P537, DOI 10.1002/jts.21848; Klingberg T, 2010, TRENDS COGN SCI, V14, P317, DOI 10.1016/j.tics.2010.05.002; Kuckertz JM, 2014, BEHAV RES THER, V63, P25, DOI 10.1016/j.brat.2014.09.002; Lagarde E, 2014, JAMA PSYCHIAT, V71, P1032, DOI 10.1001/jamapsychiatry.2014.666; Lange RT, 2012, J CLIN EXP NEUROPSYC, V34, P453, DOI 10.1080/13803395.2011.648175; Lee DJ, 2016, DEPRESS ANXIETY, V33, P792, DOI 10.1002/da.22511; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Li HJ, 2011, AGEING RES REV, V10, P285, DOI 10.1016/j.arr.2010.11.003; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lippa SM, 2014, ARCH CLIN NEUROPSYCH, V29, P236, DOI 10.1093/arclin/acu002; Mac Donald CL, 2017, J NEUROTRAUM, V34, P2206, DOI 10.1089/neu.2016.4434; Management of Concussion/ mTBI Working Group Department of Veterans Affairs Department of Defense, 2016, VA DOD CLIN PRACT GU; Management of Posttraumatic Stress Disorder Work Group Department of Veterans Affairs/Department of Defense, 2017, VA DOD CLIN PRACT GU; McDermott TJ, 2016, COGN AFFECT BEHAV NE, V16, P1140, DOI 10.3758/s13415-016-0459-7; Meares S, 2011, NEUROPSYCHOLOGY, V25, P454, DOI 10.1037/a0022580; Meyers JE., 1995, REY COMPLEX FIGURE T; Miyake A, 2000, COGNITIVE PSYCHOL, V41, P49, DOI 10.1006/cogp.1999.0734; Mohlman J, 2005, BEHAV RES THER, V43, P447, DOI 10.1016/j.brat.2004.03.007; Mohlman J, 2013, J ANXIETY DISORD, V27, P131, DOI 10.1016/j.janxdis.2012.12.001; Monson CM, 2008, PSYCHOL ASSESSMENT, V20, P131, DOI 10.1037/1040-3590.20.2.131; Mott JM, 2014, J TRAUMA STRESS, V27, P265, DOI 10.1002/jts.21927; Nelson LA, 2009, J HEAD TRAUMA REHAB, V24, P32, DOI 10.1097/HTR.0b013e3181957016; Nijdam MJ, 2015, J CLIN PSYCHIAT, V76, pE1023, DOI 10.4088/JCP.14m09438; Polak AR, 2012, J AFFECT DISORDERS, V141, P11, DOI 10.1016/j.jad.2012.01.001; Proto DA, 2014, ARCH CLIN NEUROPSYCH, V29, P614, DOI 10.1093/arclin/acu044; Ramchand R, 2010, J TRAUMA STRESS, V23, P59, DOI 10.1002/jts.20486; Resick P.A., 2017, COGN PROCESS; Russo AC, 2012, ARCH CLIN NEUROPSYCH, V27, P840, DOI 10.1093/arclin/acs090; Schafer JL, 2002, PSYCHOL METHODS, V7, P147, DOI 10.1037//1082-989X.7.2.147; Schnurr PP, 2009, CLIN PSYCHOL REV, V29, P727, DOI 10.1016/j.cpr.2009.08.006; Schottenbauer MA, 2008, PSYCHIATRY, V71, P134, DOI 10.1521/psyc.2008.71.2.134; Scott JC, 2017, BEHAV RES THER, V91, P24, DOI 10.1016/j.brat.2017.01.004; Singer J, 2003, APPL LONGITUDINAL DA APPL LONGITUDINAL DA, DOI [10.1093/acprof:oso/ 9780195152968.003.0001, DOI 10.1093/ACPROF:OSO/9780195152968.003.0001]; Spencer RJ, 2013, CLIN NEUROPSYCHOL, V27, P1362, DOI 10.1080/13854046.2013.845248; Stein MB, 2015, AM J PSYCHIAT, V172, P1101, DOI 10.1176/appi.ajp.2015.14121572; Streeter CC, 2008, NEUROPSYCHOPHARMACOL, V33, P827, DOI 10.1038/sj.npp.1301465; Swick D, 2012, J INT NEUROPSYCH SOC, V18, P917, DOI 10.1017/S1355617712000458; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Twamley EW, 2015, J HEAD TRAUMA REHAB, V30, P391, DOI 10.1097/HTR.0000000000000076; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Verfaellie M, 2012, PTSD MILD TRAUMATIC, P82; Walter KH, 2012, REHABIL PSYCHOL, V57, P13, DOI 10.1037/a0026254; Watts BV, 2013, J CLIN PSYCHIAT, V74, pE541, DOI 10.4088/JCP.12r08225; Weathers F.W., 1993, 9 ANN C ISTSS; Wechsler D., 2008, WECHSLER ADULT INTEL; Wild J, 2008, BRIT J PSYCHIAT, V193, P254, DOI 10.1192/bjp.bp.107.045922; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME	101	15	15	0	10	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0005-7967	1873-622X		BEHAV RES THER	Behav. Res. Ther.	SEP	2018	108						68	77		10.1016/j.brat.2018.07.004			10	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	GS5AN	WOS:000443669100008	30031369				2022-02-06	
J	Engel, BJ; Gammon, ST; Chaudhari, R; Lu, Z; Pisaneschi, F; Yang, HL; Ornelas, A; Yan, V; Kelderhouse, L; Najjar, AM; Tong, WP; Zhang, SX; Piwnica-Worms, D; Bast, RC; Millward, SW				Engel, Brian J.; Gammon, Seth T.; Chaudhari, Rajan; Lu, Zhen; Pisaneschi, Federica; Yang, Hailing; Ornelas, Argentina; Yan, Victoria; Kelderhouse, Lindsay; Najjar, Amer M.; Tong, William P.; Zhang, Shuxing; Piwnica-Worms, David; Bast, Robert C., Jr.; Millward, Steven W.			Caspase-3 Substrates for Noninvasive Pharmacodynamic Imaging of Apoptosis by PET/CT	BIOCONJUGATE CHEMISTRY			English	Article							VIVO; INHIBITION; DESIGN	Quantitative imaging of apoptosis in vivo could enable real-time monitoring of acute cell death pathologies such as traumatic brain injury, as well as the efficacy and safety of cancer therapy. Here, we describe the development and validation of F-18-labeled caspase-3 substrates for PET/CT imaging of 0 apoptosis. Preliminary studies identified the O-benzylthreonine-containing substrate 2MP-TbD-AFC as a highly caspase 3-selective and cell-permeable fluorescent reporter. This lead compound was converted into the radiotracer [F-18]-TBD, which was obtained at 10% decay-corrected yields with molar activities up to 149 GBq/mu mol on an automated radiosynthesis platform. [F-18]-TBD accumulated in ovarian cancer cells in a caspase- and cisplatin-dependent fashion. PET imaging of a Jo2-induced hepatotoxicity model showed a significant increase in [F-18]-TBD signal in the livers of Jo2-treated mice compared to controls, driven through a reduction in hepatobiliary clearance. A chemical control tracer that could not be cleaved by caspase 3 showed no change in liver accumulation after induction of hepatocyte apoptosis. Our data demonstrate that [F-18]-TBD provides an immediate pharmacodynamic readout of liver apoptosis in mice by dynamic PET/CT and suggest that [F-18]-TBD could be used to interrogate apoptosis in other disease states.	[Engel, Brian J.; Gammon, Seth T.; Pisaneschi, Federica; Ornelas, Argentina; Yan, Victoria; Kelderhouse, Lindsay; Tong, William P.; Piwnica-Worms, David; Millward, Steven W.] Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Chaudhari, Rajan; Lu, Zhen; Yang, Hailing; Zhang, Shuxing; Bast, Robert C., Jr.] Univ Texas MD Anderson Canc Ctr, Dept Expt Therapeut, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Najjar, Amer M.] Univ Texas MD Anderson Canc Ctr, Dept Pediat Res, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Piwnica-Worms, David] Univ Texas MD Anderson Canc Ctr, Dept Canc Biol, 1515 Holcombe Blvd, Houston, TX 77030 USA; [Zhang, Shuxing] Univ Texas Hlth Sci Ctr Houston, Sch Biomed Informat, Houston, TX 77030 USA		Millward, SW (corresponding author), Univ Texas MD Anderson Canc Ctr, Dept Canc Syst Imaging, 1515 Holcombe Blvd, Houston, TX 77030 USA.	SMillward@mdanderson.org	Pisaneschi, Federica/AAJ-9912-2020; Bast, Robert C/E-6585-2011	Pisaneschi, Federica/0000-0002-1989-4417; Bast, Robert C/0000-0003-4621-8462; Engel, Brian/0000-0002-8464-7885; Gammon, Seth/0000-0001-8647-0975; Yan, Victoria/0000-0003-0837-5184; Lu, Zhen/0000-0002-9596-0148	UTMDACC startup funds; UTMDACC Moonshot Knowledge Gap Pilot Project [1R21CA181994-01, 2R44CA206771]; G.E. In-kind Multi-investigator Imaging (MI2) Research Award; cancer prevention educational award [R25T CA057730]; MD Anderson SPORE in Ovarian Cancer [NCI P50 CA 83639]; National Foundation for Cancer Research; Mossy foundation; Roberson endowment; MD Anderson Cancer Center Support Grant [CA016672]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [R44CA206771, R25CA057730, R21CA181994, P30CA016672] Funding Source: NIH RePORTER	This work was supported by UTMDACC startup funds (SWM), a UTMDACC Moonshot Knowledge Gap Pilot Project (SWM), 1R21CA181994-01 (SWM, ZL), 2R44CA206771 (SWM), and a G.E. In-kind Multi-investigator Imaging (MI2) Research Award (SWM). AO was supported by a cancer prevention educational award (R25T CA057730, Shine Chang). ZL, HY, and RB were supported by the MD Anderson SPORE in Ovarian Cancer NCI P50 CA 83639, the National Foundation for Cancer Research, the philanthropic support from generous donations from Stuart and Gaye-Lynn Zarrow, the Mossy foundation and the Roberson endowment. MD Anderson's Nuclear Magnetic Resonance Facility and Small Animal Imaging Facility (SAIF) are supported by the MD Anderson Cancer Center Support Grant CA016672 (Pisters).	Bauwens M, 2011, NUCL MED BIOL, V38, P381, DOI 10.1016/j.nucmedbio.2010.09.008; Becker JW, 2004, J MED CHEM, V47, P2466, DOI 10.1021/jm0305523; Biniossek ML, 2011, J PROTEOME RES, V10, P5363, DOI 10.1021/pr200621z; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Bullok KE, 2006, MOL IMAGING, V5, P1, DOI 10.2310/7290.2006.00001; Choe Y, 2006, J BIOL CHEM, V281, P12824, DOI 10.1074/jbc.M513331200; de Almagro M. C., 2012, Experimental Oncology, V34, P200; Demko ZP, 2001, ORG LETT, V3, P4091, DOI 10.1021/ol010220x; Elmore S, 2007, TOXICOL PATHOL, V35, P495, DOI 10.1080/01926230701320337; Favaloro B, 2012, AGING-US, V4, P330, DOI 10.18632/aging.100459; Fuchs Y, 2011, CELL, V147, P742, DOI 10.1016/j.cell.2011.10.033; Glaser M, 2007, BIOCONJUGATE CHEM, V18, P989, DOI 10.1021/bc060301j; Goetz M, 2011, AM J PHYSIOL-GASTR L, V301, pG764, DOI 10.1152/ajpgi.00175.2011; He B, 2009, CURR OPIN CELL BIOL, V21, P900, DOI 10.1016/j.ceb.2009.08.008; Lipinski CA, 2001, ADV DRUG DELIVER REV, V46, P3, DOI 10.1016/S0169-409X(00)00129-0; Liu SQ, 2001, CLIN CANCER RES, V7, P1716; Methot N, 2004, J BIOL CHEM, V279, P27905, DOI 10.1074/jbc.M400247200; Micale N, 2004, J MED CHEM, V47, P6455, DOI 10.1021/jm049248f; Neves AA, 2014, J NUCL MED, V55, P1, DOI 10.2967/jnumed.112.114264; Nishimura Y, 1997, INT IMMUNOL, V9, P307, DOI 10.1093/intimm/9.2.307; OGASAWARA J, 1993, NATURE, V364, P806, DOI 10.1038/364806a0; Pedersen DS, 2011, EUR J ORG CHEM, V2011, P2399, DOI 10.1002/ejoc.201100157; Pisaneschi F, 2017, BIOCONJUGATE CHEM, V28, P583, DOI 10.1021/acs.bioconjchem.6b00678; Poreba M, 2014, CELL DEATH DIFFER, V21, P1482, DOI 10.1038/cdd.2014.64; Reshef A, 2010, J NUCL MED, V51, P837, DOI 10.2967/jnumed.109.063917; Thornberry NA, 1997, J BIOL CHEM, V272, P17907, DOI 10.1074/jbc.272.29.17907; Walsh JG, 2008, P NATL ACAD SCI USA, V105, P12815, DOI 10.1073/pnas.0707715105; Yang WJ, 2013, NUCLEIC ACIDS RES, V41, pD955, DOI 10.1093/nar/gks1111; Zhang LJ, 2008, ANTI-CANCER DRUG, V19, P159, DOI 10.1097/CAD.0b013e3282f30d05; Zhou D, 2006, BIOORG MED CHEM LETT, V16, P5041, DOI 10.1016/j.bmcl.2006.07.045	30	15	15	2	5	AMER CHEMICAL SOC	WASHINGTON	1155 16TH ST, NW, WASHINGTON, DC 20036 USA	1043-1802			BIOCONJUGATE CHEM	Bioconjugate Chem.	SEP	2018	29	9					3180	3195		10.1021/acs.bioconjchem.8b00514			16	Biochemical Research Methods; Biochemistry & Molecular Biology; Chemistry, Multidisciplinary; Chemistry, Organic	Science Citation Index Expanded (SCI-EXPANDED); Index Chemicus (IC)	Biochemistry & Molecular Biology; Chemistry	GU6QA	WOS:000445439500032	30168713	Green Accepted			2022-02-06	
J	Jochems, D; Leenen, LPH; Hietbrink, F; Houwert, RM; van Wessem, KJP				Jochems, D.; Leenen, L. P. H.; Hietbrink, F.; Houwert, R. M.; van Wessem, K. J. P.			Increased reduction in exsanguination rates leaves brain injury as the only major cause of death in blunt trauma	INJURY-INTERNATIONAL JOURNAL OF THE CARE OF THE INJURED			English	Article						Trauma; Cause of death; Brain injury; Exsanguination	EPIDEMIOLOGY; MORTALITY; PATTERNS; SYSTEMS	Introduction: Central nervous system (CNS) related injuries and exsanguination have been the most common causes of death in trauma for decades. Despite improvements in haemorrhage control in recent years exsanguination is still a major cause of death. We conducted a prospective database study to investigate the current incidence of haemorrhage related mortality. Materials and methods: A prospective database study of all trauma patients admitted to an urban major trauma centre between January 2007 and December 2016 was conducted. All in-hospital trauma deaths were included. Cause of death was reviewed by a panel of trauma surgeons. Patients who were dead on arrival were excluded. Trends in demographics and outcome were analysed per year. Further, 2 time periods (2007-2012 and 2013-2016) were selected representing periods before and after implementation of haemostatic resuscitation and damage control procedures in our hospital to analyse cause of death into detail. Results: 11,553 trauma patients were admitted, 596 patients (5.2%) died. Mean age of deceased patients was 61 years and 61% were male. Mechanism of injury (MOI) was blunt in 98% of cases. Mean ISS was 28 with head injury the most predominant injury (mean AIS head 3.4). There was no statistically significant difference in sex and MOI over time. Even though deceased patients were older in 2016 compared to 2007 (67 vs. 46 years, p <0.001), mortality was lower in later years (p = 0.02). CNS related injury was the main cause of death in the whole decade; 58% of patients died of CNS in 2007-2012 compared to 76% of patients in 2013-2016 (p = 0.001). In 2007-2012 9% died of exsanguination compared to 3% in 2013-2016 (p = 0.001). Discussion: In this cohort in a major trauma centre death by exsanguination has decreased to 3% of trauma deaths. The proportion of traumatic brain injury has increased over time and has become the most common cause of death in blunt trauma. Besides on-going prevention of brain injury future studies should focus on treatment strategies preventing secondary damage of the brain once the injury has occurred (C) 2018 Elsevier Ltd. All rights reserved.	[Jochems, D.; Leenen, L. P. H.; Hietbrink, F.; Houwert, R. M.; van Wessem, K. J. P.] Univ Med Ctr Utrecht, Dept Trauma Surg, Suite G04-232,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands		van Wessem, KJP (corresponding author), Univ Med Ctr Utrecht, Dept Trauma Surg, Suite G04-232,Heidelberglaan 100, NL-3584 CX Utrecht, Netherlands.	kwessem@umcutrecht.nl	Houwert, Roderick/K-7887-2019	Houwert, Roderick/0000-0003-3497-659X			BAKER CC, 1980, AM J SURG, V140, P144, DOI 10.1016/0002-9610(80)90431-6; Dutton RP, 2010, J TRAUMA, V69, P620, DOI 10.1097/TA.0b013e3181bbfe2a; Evans JA, 2010, WORLD J SURG, V34, P158, DOI 10.1007/s00268-009-0266-1; Gunning AC, 2015, WORLD J SURG, V39, P2677, DOI 10.1007/s00268-015-3162-x; Gunning AC, 2014, J TRAUMA ACUTE CARE, V77, P614, DOI 10.1097/TA.0000000000000415; Kahl JE, 2013, J TRAUMA ACUTE CARE, V75, P195, DOI 10.1097/TA.0b013e3182997865; Lansink KWW, 2013, EUR J TRAUMA EMERG S, V39, P375, DOI 10.1007/s00068-013-0278-2; Lefering R, 2012, EUR J TRAUMA EMERG S, V38, P3, DOI 10.1007/s00068-011-0168-4; Oyeniyi BT, 2017, INJURY, V48, P5, DOI 10.1016/j.injury.2016.10.037; Palmer CS, 2016, INJURY, V47, P109, DOI 10.1016/j.injury.2015.07.003; Pang JM, 2008, INJURY, V39, P102, DOI 10.1016/j.injury.2007.05.022; Pfeifer R, 2009, INJURY, V40, P907, DOI 10.1016/j.injury.2009.05.006; SAUAIA A, 1995, J TRAUMA, V38, P185, DOI 10.1097/00005373-199502000-00006; van Wessem KJP, 2018, SHOCK, V49, P33, DOI 10.1097/SHK.0000000000000938	14	15	15	0	0	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0020-1383	1879-0267		INJURY	Injury-Int. J. Care Inj.	SEP	2018	49	9					1661	1667		10.1016/j.injury.2018.05.012			7	Critical Care Medicine; Emergency Medicine; Orthopedics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine; Orthopedics; Surgery	GQ5UE	WOS:000441756900006	29903577				2022-02-06	
J	Mkrtchyan, GV; Ucal, M; Mullebner, A; Dumitrescu, S; Kames, M; Moldzio, R; Molcanyi, M; Schaefer, S; Weidinger, A; Schaefer, U; Hescheler, J; Duvigneau, JC; Redl, H; Bunik, VI; Kozlov, AV				Mkrtchyan, Garik V.; Uecal, Muammer; Muellebner, Andrea; Dumitrescu, Sergiu; Kames, Martina; Moldzio, Rudolf; Molcanyi, Marek; Schaefer, Samuel; Weidinger, Adelheid; Schaefer, Ute; Hescheler, Juergen; Duvigneau, Johanna Catharina; Redl, Heinz; Bunik, Victoria I.; Kozlov, Andrey V.			Thiamine preserves mitochondrial function in a rat model of traumatic brain injury, preventing inactivation of the 2-oxoglutarate dehydrogenase complex	BIOCHIMICA ET BIOPHYSICA ACTA-BIOENERGETICS			English	Article; Proceedings Paper	20th European Bioenergetics Conference (EBEC)	AUG 25-30, 2018	Budapest, HUNGARY			Thiamine; Traumatic brain injury (TBI); Mitochondria; TCA cycle; 2-Oxoglutarate dehydrogenase complex; Neuroinflammation	ENDOPLASMIC-RETICULUM STRESS; UNFOLDED PROTEIN RESPONSE; NITRIC-OXIDE; ER STRESS; INFLAMMATORY RESPONSE; OXIDATIVE STRESS; MOLECULAR-MECHANISMS; GLUTAMATE RELEASE; CELL-SURVIVAL; DYSFUNCTION	Background and purpose: Based on the fact that traumatic brain injury is associated with mitochondrial dysfunction we aimed at localization of mitochondrial defect and attempted to correct it by thiamine. Experimental approach: Interventional controlled experimental animal study was used. Adult male Sprague-Dawley rats were subjected to lateral fluid percussion traumatic brain injury. Thiamine was administered 1 h prior to trauma; cortex was extracted for analysis 4 h and 3 d after trauma. Key results: Increased expression of inducible nitric oxide synthase (iNOS) and tumor necrosis factor receptor 1 (TNF-R1) by 4 h was accompanied by a decrease in mitochondrial respiration with glutamate but neither with pyruvate nor succinate. Assays of TCA cycle flux-limiting 2-oxoglutarate dehydrogenase complex (OGDHC) and functionally linked enzymes (glutamate dehydrogenase, glutamine synthetase, pyruvate dehydrogenase, malate dehydrogenase and malic enzyme) indicated that only OGDHC activity was decreased. Application of the OGDHC coenzyme precursor thiamine rescued the activity of OGDHC and restored mitochondrial respiration. These effects were not mediated by changes in the expression of the OGDHC sub-units (E1k and E3), suggesting post-translational mechanism of thiamine effects. By the third day after TBI, thiamine treatment also decreased expression of TNF-R1. Specific markers of unfolded protein response did not change in response to thiamine. Conclusion and implications: Our data point to OGDHC as a major site of damage in mitochondria upon traumatic brain injury, which is associated with neuroinflammation and can be corrected by thiamine. Further studies are required to evaluate the pathological impact of these findings in clinical settings.	[Mkrtchyan, Garik V.; Muellebner, Andrea; Dumitrescu, Sergiu; Kames, Martina; Weidinger, Adelheid; Redl, Heinz; Kozlov, Andrey V.] Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, A-1200 Vienna, Austria; [Mkrtchyan, Garik V.; Bunik, Victoria I.] Lomonosov Moscow State Univ, Fac Bioengn & Bioinforrnat, Moscow, Russia; [Uecal, Muammer; Molcanyi, Marek; Schaefer, Samuel; Schaefer, Ute] Med Univ Graz, Dept Neurosurg, Graz, Austria; [Muellebner, Andrea; Kames, Martina; Moldzio, Rudolf; Duvigneau, Johanna Catharina] Univ Vet Med Vienna, Inst Med Biochem, Vienna, Austria; [Molcanyi, Marek; Hescheler, Juergen] Univ Cologne, Inst Neurophysiol, Fac Med, Cologne, Germany; [Bunik, Victoria I.] Lomonosov Moscow State Univ, Belozersky Inst Physicochem Biol, Moscow, Russia; [Mkrtchyan, Garik V.] Univ Copenhagen, Dept Cellular & Mol Med, Ctr Hlth Aging, Copenhagen, Denmark		Kozlov, AV (corresponding author), Ludwig Boltzmann Inst Expt & Clin Traumatol, Donaueschingenstr 13, A-1200 Vienna, Austria.	andrey.kozlov@trauma.lbg.ac.at	Bunik, Victoria/E-3427-2012; Duvigneau, J. Catharina/AAE-6992-2019; Redl, Heinz/AAD-8157-2019	Bunik, Victoria/0000-0002-2552-8560; Duvigneau, J. Catharina/0000-0002-2433-3120; Kozlov, Andrey/0000-0002-0834-4997	Austrian Exchange Service (OeAD) Fellowship [ICM-2014-07013]; Russian Science FoundationRussian Science Foundation (RSF) [N 18-14-00116]; Russian Science FoundationRussian Science Foundation (RSF) [18-14-00116] Funding Source: Russian Science Foundation	The research stay of GM in Austria was funded by Austrian Exchange Service (OeAD) Fellowship # ICM-2014-07013.; Research work of VB is supported by Russian Science Foundation, grant N 18-14-00116.	Araujo WL, 2013, AMINO ACIDS, V44, P683, DOI 10.1007/s00726-012-1392-x; Bal-Price A, 2001, J NEUROSCI, V21, P6480; Bayir H, 2007, J NEUROCHEM, V101, P168, DOI 10.1111/j.1471-4159.2006.04353.x; Begum G, 2014, J NEUROSCI, V34, P3743, DOI 10.1523/JNEUROSCI.2872-13.2014; Boyko A., 2017, FRONT MED, V4, P249; Bunik V., 2017, VITAMIN DEPENDENT MU; Bunik VI, 2017, STUD NAT PROD CHEM, V53, P375, DOI 10.1016/B978-0-444-63930-1.00011-9; Bunik VI, 2009, BIOCHEM J, V422, P405, DOI 10.1042/BJ20090722; Calingasan NY, 2000, BRAIN RES, V885, P62, DOI 10.1016/S0006-8993(00)02933-4; Chen YN, 2016, NEUROBIOL DIS, V94, P139, DOI 10.1016/j.nbd.2016.06.011; Cheshchevik V., 2010, OGDHC EXERTED CONTRO, P76; Graf A, 2013, INT J BIOCHEM CELL B, V45, P175, DOI 10.1016/j.biocel.2012.07.002; Harding HP, 2000, MOL CELL, V5, P897, DOI 10.1016/S1097-2765(00)80330-5; Hiller S, 2016, BBA-GEN SUBJECTS, V1860, P36, DOI 10.1016/j.bbagen.2015.09.001; Holmberg MJ, 2018, J CRIT CARE, V43, P61, DOI 10.1016/j.jcrc.2017.08.022; Hu P, 2006, MOL CELL BIOL, V26, P3071, DOI 10.1128/MCB.26.8.3071-3084.2006; Huang HM, 2010, NEUROCHEM RES, V35, P2107, DOI 10.1007/s11064-010-0242-z; Ikeda K, 2016, RESUSCITATION, V105, P138, DOI 10.1016/j.resuscitation.2016.04.024; Kilbaugh TJ, 2011, J NEUROTRAUM, V28, P763, DOI 10.1089/neu.2010.1635; Kozlov AV, 2017, BBA-MOL BASIS DIS, V1863, P2627, DOI 10.1016/j.bbadis.2016.12.020; Kozlov AV, 2009, BBA-MOL BASIS DIS, V1792, P521, DOI 10.1016/j.bbadis.2009.03.004; Kraitsy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097750; LEVINTOW L, 1954, J NATL CANCER I, V15, P347; Lifshitz J, 2003, J CEREBR BLOOD F MET, V23, P219, DOI 10.1097/01.WCB.0000040581.43808.03; Lin MT, 2006, NATURE, V443, P787, DOI 10.1038/nature05292; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; Mkrtchyan G, 2016, NEUROCHEM INT, V101, P66, DOI 10.1016/j.neuint.2016.10.009; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Mota SI, 2015, BBA-MOL BASIS DIS, V1852, P1428, DOI 10.1016/j.bbadis.2015.03.015; Mullebner A, 2015, BIOMOLECULES, V5, P679, DOI 10.3390/biom5020679; Olmos G, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/861231; Regenold WT, 2008, J NEUROL SCI, V275, P106, DOI 10.1016/j.jns.2008.07.032; Rimessi A, 2016, INT J BIOCHEM CELL B, V81, P281, DOI 10.1016/j.biocel.2016.06.015; Robertson CL, 2004, J BIOENERG BIOMEMBR, V36, P363, DOI 10.1023/B:JOBB.0000041769.06954.e4; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Shi Q, 2007, NEUROCHEM INT, V50, P921, DOI 10.1016/j.neuint.2007.03.010; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Takeuchi H, 2006, J BIOL CHEM, V281, P21362, DOI 10.1074/jbc.M600504200; Truettner JS, 2007, J NEUROTRAUM, V24, P599, DOI 10.1089/neu.2006.0186; Tsepkova PM, 2017, BIOCHEMISTRY-MOSCOW+, V82, P723, DOI 10.1134/S0006297917060098; Ucal M, 2017, J NEUROTRAUM, V34, P475, DOI 10.1089/neu.2016.4411; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Walko TD, 2014, SHOCK, V41, P499, DOI 10.1097/SHK.0000000000000160; Wang X, 2007, NEUROSCIENCE, V144, P1045, DOI 10.1016/j.neuroscience.2006.10.008; Weidinger A, 2015, ANTIOXID REDOX SIGN, V22, P572, DOI 10.1089/ars.2014.5996; Welser-Alves JV, 2013, NEUROCHEM INT, V63, P47, DOI 10.1016/j.neuint.2013.04.007; Yoshida H, 2001, CELL, V107, P881, DOI 10.1016/S0092-8674(01)00611-0; Yoshida H, 2003, DEV CELL, V4, P265, DOI 10.1016/S1534-5807(03)00022-4; Zhang KZ, 2008, NATURE, V454, P455, DOI 10.1038/nature07203	52	15	15	0	14	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0005-2728	0006-3002		BBA-BIOENERGETICS	Biochim. Biophys. Acta-Bioenerg.	SEP	2018	1859	9			SI		925	931		10.1016/j.bbabio.2018.05.005			7	Biochemistry & Molecular Biology; Biophysics	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Biochemistry & Molecular Biology; Biophysics	GR5UU	WOS:000442708200029	29777685				2022-02-06	
J	Murdaugh, DL; King, TZ; Sun, BJ; Jones, RA; Ono, KE; Reisner, A; Burns, TG				Murdaugh, Donna L.; King, Tricia Z.; Sun, Binjian; Jones, Richard A.; Ono, Kim E.; Reisner, Andrew; Burns, Thomas G.			Longitudinal Changes in Resting State Connectivity and White Matter Integrity in Adolescents With Sports-Related Concussion	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Sports-related concussion; American football; Adolescents; Resting state fMRI; Diffusion imaging; Longitudinal; Memory	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; DEFAULT MODE NETWORK; FUNCTIONAL CONNECTIVITY; DIFFUSION TENSOR; HIGH-SCHOOL; INDEPENDENT COMPONENT; RECURRENT CONCUSSION; UNITED-STATES; HISTORY	Objectives: The aim of this study was to investigate alterations in functional connectivity, white matter integrity, and cognitive abilities due to sports-related concussion (SRC) in adolescents using a prospective longitudinal design. Methods: We assessed male high school football players (ages 14-18) with (n = 16) and without (n = 12) SRC using complementary resting state functional MRI (rs-fMRI) and diffusion tensor imaging (DTI) along with cognitive performance using the Immediate Post-Concussive Assessment and Cognitive Testing (ImPACT). We assessed both changes at the acute phase (<7 days post-SRC) and at 21 days later, as well as, differences between athletes with SRC and age- and team-matched control athletes. Results: The results revealed rs-fMRI hyperconnectivity within posterior brain regions (e.g., precuneus and cerebellum), and hypoconnectivity in more anterior areas (e.g., inferior and middle frontal gyri) when comparing SRC group to control group acutely. Performance on the ImPACT (visual/verbal memory composites) was correlated with resting state network connectivity at both time points. DTI results revealed altered diffusion in the SRC group along a segment of the corticospinal tract and the superior longitudinal fasciculus in the acute phase of SRC. No differences between the SRC group and control group were seen at follow-up imaging. Conclusions: Acute effects of SRC are associated with both hyperconnectivity and hypoconnectivity, with disruption of white matter integrity. In addition, acute memory performance was most sensitive to these changes. After 21 days, adolescents with SRC returned to baseline performance, although chronic hyperconnectivity of these regions could place these adolescents at greater risk for secondary neuropathological changes, necessitating future follow-up.	[Murdaugh, Donna L.] Univ Alabama Birmingham, Dept Pediat, Birmingham, AL USA; [King, Tricia Z.] Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA; [King, Tricia Z.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA; [Sun, Binjian; Jones, Richard A.] Childrens Healthcare Atlanta, Dept Radiol, Atlanta, GA USA; [Ono, Kim E.; Burns, Thomas G.] Childrens Healthcare Atlanta, Dept Neuropsychol, Atlanta, GA USA; [Reisner, Andrew] Childrens Healthcare Atlanta, Dept Neurosurg, Atlanta, GA USA		Murdaugh, DL (corresponding author), 1600 7th Ave S,Lowder 500, Birmingham, AL 35233 USA.	dlmurdaugh@gmail.com		Murdaugh, Donna/0000-0001-8550-8353	Georgia State University/Georgia Institute of Technology Joint Center for Advanced Brain Imaging (CABI) Seed Grant; GSU Second Century Initiative (2CI) Fellowship in Human Neuroimaging	This research was supported by a grant from the Georgia State University/Georgia Institute of Technology Joint Center for Advanced Brain Imaging (CABI) Seed Grant (PIs TZK & TB). We thank Dr. Susan McManus and Dr. Ana Arenivas for their valuable help with data collection and Dr. Ryan Brewster and the King Developmental Neuropsychology Across the Lifespan Research Team for their data scoring and data management. RB was supported by the GSU Second Century Initiative (2CI) Fellowship in Human Neuroimaging. The authors declare no conflict of interest.	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Broyd SJ, 2009, NEUROSCI BIOBEHAV R, V33, P279, DOI 10.1016/j.neubiorev.2008.09.002; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Calhoun VD, 2001, HUM BRAIN MAPP, V13, P43, DOI 10.1002/hbm.1024; Calhoun VD, 2008, HUM BRAIN MAPP, V29, P828, DOI 10.1002/hbm.20581; Churchill N, 2017, BRAIN INJURY, V31, P39, DOI 10.1080/02699052.2016.1221135; Churchill NW, 2017, HUM BRAIN MAPP, V38, P4201, DOI 10.1002/hbm.23658; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Czerniak SM, 2015, BRAIN IMAGING BEHAV, V9, P323, DOI 10.1007/s11682-014-9312-1; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Griffanti L, 2017, NEUROIMAGE, V154, P188, DOI 10.1016/j.neuroimage.2016.12.036; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Henry LC, 2011, J NEUROTRAUM, V28, P2049, DOI 10.1089/neu.2011.1836; Hillary FG, 2017, TRENDS COGN SCI, V21, P385, DOI 10.1016/j.tics.2017.03.003; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; Jantzen KJ, 2004, AM J NEURORADIOL, V25, P738; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kamins J, 2017, BRIT J SPORT MED, V51, DOI 10.1136/bjsports-2016-097464; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; Koziol LF, 2012, CEREBELLUM, V11, P505, DOI 10.1007/s12311-011-0321-y; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Li YO, 2007, HUM BRAIN MAPP, V28, P1251, DOI 10.1002/hbm.20359; Lovell M, 2015, IMPACT RES REPORT, V3, P1; Manto M, 2012, CEREBELLUM, V11, P457, DOI 10.1007/s12311-011-0331-9; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, J SCI MED SPORT, V16, P178, DOI 10.1016/j.jsams.2013.02.009; Meier TB, 2017, BRAIN IMAGING BEHAV, V11, P129, DOI 10.1007/s11682-016-9520-y; Murugavel M, 2014, J NEUROTRAUM, V31, P1860, DOI 10.1089/neu.2014.3368; Oouchi H, 2007, AM J NEURORADIOL, V28, P1102, DOI 10.3174/ajnr.A0488; Orr CA, 2016, J NEUROTRAUM, V33, P803, DOI 10.1089/neu.2014.3721; Pruim RHR, 2015, NEUROIMAGE, V112, P278, DOI 10.1016/j.neuroimage.2015.02.063; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Smith EE, 1998, P NATL ACAD SCI USA, V95, P12061, DOI 10.1073/pnas.95.20.12061; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Toledo E, 2012, NEUROSCI BIOBEHAV R, V36, P1510, DOI 10.1016/j.neubiorev.2012.03.007; Virji-Babul N, 2014, J NEUROTRAUM, V31, P1914, DOI 10.1089/neu.2014.3450; Virji-Babul N, 2013, PEDIATR NEUROL, V48, P24, DOI 10.1016/j.pediatrneurol.2012.09.005; Yeh FC, 2016, NEUROIMAGE, V125, P162, DOI 10.1016/j.neuroimage.2015.10.053; Yeh FC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080713; Yeh FC, 2013, NEUROIMAGE-CLIN, V2, P912, DOI 10.1016/j.nicl.2013.06.014; Yeh FC, 2010, IEEE T MED IMAGING, V29, P1626, DOI 10.1109/TMI.2010.2045126; Yuh Esther L, 2014, Neurosurgery, V75 Suppl 4, pS50, DOI 10.1227/NEU.0000000000000491; Zhang K, 2010, EXP BRAIN RES, V204, P57, DOI 10.1007/s00221-010-2294-3	57	15	15	1	5	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	SEP	2018	24	8					781	792		10.1017/S1355617718000413			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	HG6MJ	WOS:000455095800003	30139405				2022-02-06	
J	O'Neill, B; Best, C; O'Neill, L; Ramos, SDS; Gillespie, A				O'Neill, Brian; Best, Catherine; O'Neill, Lauren; Ramos, Sara D. S.; Gillespie, Alex			Efficacy of a Micro-Prompting Technology in Reducing Support Needed by People With Severe Acquired Brain Injury in Activities of Daily Living: A Randomized Control Trial	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						activities of daily living; assistive technology; brain injuries; caregiving; cognition; rehabilitation	ASSISTIVE TECHNOLOGY; NEUROBEHAVIORAL REHABILITATION; COST-BENEFITS; MEMORY AID; FIELD	Objective: To evaluate the effectiveness of an automated interactive prompting technology in supporting the morning routine of persons with acquired brain injury. The morning routine included maintaining personal hygiene and dressing. Setting: An inpatient neurorehabilitation hospital. Participants: Persons with acquired brain injury who required prompting when following their morning routine (n = 24), but were not limited by physical disability or dysphasia, took part in the study. Participants (67% with traumatic brain injury) had impairment on indices of memory and executive function. Design: A randomized control trial evaluated the effect of an automated interactive micro-prompting device on the number of prompts by trained staff required for successful completion of the morning routine. Main Measures: Study-specific checklists assessed sequence performance, errors, and verbal prompts required over baseline, rehabilitation as usual, intervention, and return to baseline conditions. Results: The intervention significantly reduced the support required to complete the task compared with usual rehabilitation. Conclusions: Micro-prompting technology is an effective assistive technology for cognition, which reduces support needs in people with significant cognitive impairments.	[O'Neill, Brian; O'Neill, Lauren; Ramos, Sara D. S.] Brain Injury Rehabil Trust, Graham Anderson House,1161 Springburn Rd, Glasgow G21 1UU, Lanark, Scotland; [O'Neill, Brian] Univ Glasgow, Mental Hlth & Wellbeing, Glasgow, Lanark, Scotland; [Best, Catherine] Univ Stirling, Hlth Sci & Sport, Stirling, Scotland; [Gillespie, Alex] London Sch Econ, London, England		O'Neill, B (corresponding author), Brain Injury Rehabil Trust, Graham Anderson House,1161 Springburn Rd, Glasgow G21 1UU, Lanark, Scotland.	brian.oneill@thedtgroup.org			Chief Scientist Office, Scottish Government [CZH/4/598]; Disabilities Trust, a not-for-profit organization, parent charity of the Brain Injury Rehabilitation Trust	Research supported by a grant from the Chief Scientist Office, Scottish Government (CZH/4/598). The authors thank Michael Oddy, Paula Gribben, and Donna Lindop for consultation on the needs of persons with brain injury; Naomi Bowers for help with data collection; and rehabilitation support workers who allowed their scaffolding of sequences to be recorded and used in the development of Guide activity protocols. The authors are forever indebted to the service users who agreed to participate in the development and clinical trial phases of this study.; The article reports the efficacy of a micro-prompting device (called "Guide"), developed with support from the Chief Scientist Office, and, as an Android and iOS compatible application, with support from the Disabilities Trust, a not-for-profit organization, parent charity of the Brain Injury Rehabilitation Trust and, therefore, employer of SDSR, BON, and LON.	AlZoubi O, 2015, ASSIST TECHNOL, P47; Aunger R, 2010, TECHNOL FORECAST SOC, V77, P762, DOI 10.1016/j.techfore.2010.01.008; Boman IL, 2010, DISABIL REHABIL-ASSI, V5, P339, DOI 10.3109/17483100903131777; Cahn-Weiner Deborah A, 2002, Appl Neuropsychol, V9, P187, DOI 10.1207/S15324826AN0903_8; Gillespie A, 2015, ASSISTIVE TECHNOLOGY; Gillespie A, 2012, J INT NEUROPSYCH SOC, V18, P1, DOI 10.1017/S1355617711001548; Jamieson M, 2014, NEUROPSYCHOL REHABIL, V24, P419, DOI 10.1080/09602011.2013.825632; Klarborg B, 2012, ACCIDENT ANAL PREV, V48, P57, DOI 10.1016/j.aap.2011.05.004; Lemoncello R, 2011, NEUROPSYCHOL REHABIL, V21, P825, DOI 10.1080/09602011.2011.618661; Lloyd J, 2009, NEUROPSYCHOL REHABIL, V19, P98, DOI 10.1080/09602010802117392; LoPresti EF, 2004, NEUROPSYCHOL REHABIL, V14, P5, DOI 10.1080/09602010343000101; McLuhan M., 1994, UNDERSTANDING MEDIA; Mihailidis Alex, 2008, BMC Geriatr, V8, P28, DOI 10.1186/1471-2318-8-28; Moir J, 2014, THESIS; Mumford Lewis., 1934, TECHNICS CIVILIZATIO; O'Neill B, 2010, NEUROPSYCHOL REHABIL, V20, P509, DOI 10.1080/09602010903519652; O'Neill B, 2008, J ASSIST TECHNOL, V2, P22, DOI 10.1108/17549450200800015; O'Neill L., 2013, SOCIAL CARE NEURODIS, V4, P17, DOI DOI 10.1108/20420911311302281; Oddy M, 2013, BRAIN INJURY, V27, P1500, DOI 10.3109/02699052.2013.830332; Oddy M, 2013, NEUROREHABILITATION, V32, P781, DOI 10.3233/NRE-130902; Parish L, 2007, NEUROPSYCHOL REHABIL, V17, P230, DOI 10.1080/09602010600750675; Pea RD, 2004, J LEARN SCI, V13, P423, DOI 10.1207/s15327809jls1303_6; Peters C, 2014, ACM T ACCESS COMPUT, V5, DOI 10.1145/2579700; Plehn K, 2004, CLIN NEUROPSYCHOL, V18, P101, DOI 10.1080/13854040490507190; Rogers JC, 1999, J AM GERIATR SOC, V47, P1049, DOI 10.1111/j.1532-5415.1999.tb05226.x; Semkovska M, 2004, SCHIZOPHR RES, V69, P289, DOI 10.1016/j.schres.2003.07.005; Shepherd A., 2001, HIERARCHICAL TASK AN; Stone CA, 1998, J LEARN DISABIL-US, V31, P344, DOI 10.1177/002221949803100404; Svoboda E, 2009, J INT NEUROPSYCH SOC, V15, P629, DOI 10.1017/S1355617709090791; Van Hulle A, 2006, BRAIN INJURY, V20, P101, DOI 10.1080/02699050500309684; Vygotsky Lev Semionovich, 1994, VYGOTSKY READER, P99; Wilson BA, 2001, J NEUROL NEUROSUR PS, V70, P477, DOI 10.1136/jnnp.70.4.477; Wimo A, 2010, WORLD ALZHEIMER REPO; Wood RL, 2001, BRAIN DAM B, P107; Wood RL, 1999, BRAIN INJURY, V13, P69, DOI 10.1080/026990599121746; Worthington AD, 2006, BRAIN INJURY, V20, P947, DOI 10.1080/02699050600888314; Yasuda K, 2002, NEUROPSYCHOL REHABIL, V12, P155, DOI 10.1080/09602010143000239	37	15	15	2	8	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2018	33	5					E33	E41		10.1097/HTR.0000000000000358			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	HB2QJ	WOS:000450886500005	29194177	Green Accepted			2022-02-06	
J	Montanino, A; Kleiven, S				Montanino, Annaclaudia; Kleiven, Svein			Utilizing a Structural Mechanics Approach to Assess the Primary Effects of Injury Loads Onto the Axon and Its Components	FRONTIERS IN NEUROLOGY			English	Article						diffuse axonal injury; axon; axon finite element model; axolemma; microtubules	TRAUMATIC BRAIN-INJURY; HUMAN ERYTHROCYTE-MEMBRANES; DYNAMIC STRETCH INJURY; MECHANOSENSITIVE CHANNELS; NEUROFILAMENT COMPACTION; VISCOELASTIC PROPERTIES; QUANTITATIVE-ANALYSIS; MICROTUBULE BUNDLES; YIELD STRENGTH; SENSORY AXONS	Diffuse axonal injury (DAI) occurs as a result of the transmission of rapid dynamic loads from the head to the brain and specifically to its neurons. Despite being one of the most common and most deleterious types of traumatic brain injury (TBI), the inherent cell injury mechanism is yet to be understood. Experimental observations have led to the formulation of different hypotheses, such as mechanoporation of the axolemma and microtubules (MTs) breakage. With the goal of singling out the mechanical aspect of DAI and to resolve the ambiguity behind its injury mechanism, a composite finite element (FE) model of a representative volume of an axon was developed. Once calibrated and validated against published experimental data, the axonal model was used to simulate injury scenarios. The resulting strain distributions along its components were then studied in dependence of strain rate and of typical modeling choices such as the applied MT constraints and tau proteins failure. Results show that oversimplifying the MT bundle kinematic entails a systematic attenuation (cf = 2.33) of the computed maximum MT strain. Nevertheless, altogether, results support the hypothesis of axolemma mechanoporation as a cell-injury trigger. Moreover, for the first time the interconnection between the axolemma and the MT bundle is shown to play a role in damage localization. The proposed FE axonal model is a valuable tool to understand the axonal injury mechanism from a mechanical perspective and could be used in turn for the definition of well-informed injury criteria at the tissue and organ level.	[Montanino, Annaclaudia; Kleiven, Svein] Royal Inst Technol KTH, Div Neuron Engn, Huddinge, Sweden		Montanino, A (corresponding author), Royal Inst Technol KTH, Div Neuron Engn, Huddinge, Sweden.	annacl2@kth.se			European Union Horizon 2020 Research and Innovation Framework Programme under the Marie Sklodowska-Curie grant [642662]	This study was supported by the European Union Horizon 2020 Research and Innovation Framework Programme under the Marie Sklodowska-Curie grant agreement No. 642662.	Ahmadzadeh H, 2015, BIOPHYS J, V109, P2328, DOI 10.1016/j.bpj.2015.09.010; Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bain AC, 2001, J NEUROTRAUM, V18, P499, DOI 10.1089/089771501300227305; Bar-Kochba E, 2016, SCI REP-UK, V6, DOI 10.1038/srep30550; Bavi N, 2014, P NATL ACAD SCI USA, V111, P13864, DOI 10.1073/pnas.1409011111; Beck R, 2010, NAT MATER, V9, P40, DOI [10.1038/nmat2566, 10.1038/NMAT2566]; Bernal R, 2007, PHYS REV LETT, V99, DOI 10.1103/PhysRevLett.99.018301; Bernick KB, 2011, ACTA BIOMATER, V7, P1210, DOI 10.1016/j.actbio.2010.10.018; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; BRAY D, 1981, J NEUROCYTOL, V10, P589, DOI 10.1007/BF01262592; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chen X, 2008, BIOPHYS J, V95, P563, DOI 10.1529/biophysj.107.128488; Chetta J, 2010, CYTOSKELETON, V67, P650, DOI 10.1002/cm.20478; Conde C, 2009, NAT REV NEUROSCI, V10, P319, DOI 10.1038/nrn2631; Cullen DK, 2011, J NEUROTRAUM, V28, P2219, DOI 10.1089/neu.2011.1841; Dao M, 2003, J MECH PHYS SOLIDS, V51, P2259, DOI 10.1016/j.jmps.2003.09.019; de Rooij R, 2018, BIOPHYS J, V114, P201, DOI 10.1016/j.bpj.2017.11.010; DENNERLL TJ, 1988, J CELL BIOL, V107, P665, DOI 10.1083/jcb.107.2.665; Dobrynin AV, 2011, MACROMOLECULES, V44, P140, DOI 10.1021/ma102154u; Duke T, 1996, BIOPHYS J, V71, P1235, DOI 10.1016/S0006-3495(96)79323-2; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; Evans E, 2003, BIOPHYS J, V85, P2342, DOI 10.1016/S0006-3495(03)74658-X; FADIC R, 1985, J COMP NEUROL, V236, P258, DOI 10.1002/cne.902360209; Faul M, 2010, TRAUMATIC BRAIN INJU; Fitzpatrick MO, 1998, J NEUROL NEUROSUR PS, V64, P285, DOI 10.1136/jnnp.64.3.285; Gavara N, 2012, NAT NANOTECHNOL, V7, P733, DOI [10.1038/nnano.2012.163, 10.1038/NNANO.2012.163]; Geddes DM, 2003, J NEUROTRAUM, V20, P1039, DOI 10.1089/089771503770195885; Gennarelli TA, 1998, NEUROSCIENTIST, V4, P202, DOI 10.1177/107385849800400316; Giordano C, 2014, STAPP CAR CRASH J, V58, P81; Grevesse T, 2015, SCI REP-UK, V5, DOI 10.1038/srep09475; Hill CS, 2016, TRENDS NEUROSCI, V39, P311, DOI 10.1016/j.tins.2016.03.002; HIROKAWA N, 1982, J CELL BIOL, V94, P129, DOI 10.1083/jcb.94.1.129; HIROKAWA N, 1984, J CELL BIOL, V98, P1523, DOI 10.1083/jcb.98.4.1523; Humphreys I, 2013, CLINICOECONOMIC OUTC, V5, P281, DOI 10.2147/CEOR.S44625; JANMEY PA, 1991, J CELL BIOL, V113, P155, DOI 10.1083/jcb.113.1.155; Jerusalem A, 2012, ACTA BIOMATER, V8, P3360, DOI 10.1016/j.actbio.2012.04.039; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Krieg M, 2017, ELIFE, V6, DOI [10.7554/eLife.20172, 10.7554/elife.20172]; Lazarus C, 2015, BIOPHYS J, V109, P231, DOI 10.1016/j.bpj.2015.06.029; Leterrier C, 2017, NAT REV NEUROSCI, V18, P713, DOI 10.1038/nrn.2017.129; Leterrier JF, 1996, J BIOL CHEM, V271, P15687, DOI 10.1074/jbc.271.26.15687; Li FF, 2014, BIOPHYS J, V106, P1832, DOI 10.1016/j.bpj.2014.03.010; Li FF, 2013, BIOPHYS J, V105, P872, DOI 10.1016/j.bpj.2013.06.045; Lu YB, 2006, P NATL ACAD SCI USA, V103, P17759, DOI 10.1073/pnas.0606150103; MALBOUISSON AMB, 1985, ANAT EMBRYOL, V171, P339, DOI 10.1007/BF00347022; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Morrison Barclay 3rd, 2003, Stapp Car Crash J, V47, P93; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Murphy MA, 2016, MODEL SIMUL MATER SC, V24, DOI 10.1088/0965-0393/24/5/055008; NEEDHAM D, 1990, BIOPHYS J, V58, P997, DOI 10.1016/S0006-3495(90)82444-9; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Ouyang H, 2013, J BIOL ENG, V7, DOI 10.1186/1754-1611-7-21; Peter SJ, 2012, BIOPHYS J, V102, P749, DOI 10.1016/j.bpj.2011.11.4024; Pfister BJ, 2003, ANN BIOMED ENG, V31, P589, DOI 10.1114/1.1566445; Pijak DS, 1996, J COMP NEUROL, V368, P569; Rajagopalan J, 2010, BIOPHYS J, V99, P3208, DOI 10.1016/j.bpj.2010.09.029; Rammensee S, 2007, EUR BIOPHYS J BIOPHY, V36, P661, DOI 10.1007/s00249-007-0141-7; Rosenberg KJ, 2008, P NATL ACAD SCI USA, V105, P7445, DOI 10.1073/pnas.0802036105; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Shigematsu T, 2015, SCI REP-UK, V5, DOI 10.1038/srep15369; Shreiber D. I, 1997, VIVO THRESHOLDS MECH; Smith DH, 1999, J NEUROSCI, V19, P4263; Soheilypour M, 2015, BIOPHYS J, V108, P1718, DOI 10.1016/j.bpj.2015.01.030; Suresh S, 2007, ACTA MATER, V55, P3989, DOI 10.1016/j.actamat.2007.04.022; Tang-Schomer MD, 2012, EXP NEUROL, V233, P364, DOI 10.1016/j.expneurol.2011.10.030; Tang-Schomer MD, 2010, FASEB J, V24, P1401, DOI 10.1096/fj.09-142844; Thibault L. E., 1993, P IRCOBI C EINDH NET, P3; Tolpekina TV, 2004, J CHEM PHYS, V121, P8014, DOI 10.1063/1.1796254; Wagner OI, 2007, EXP CELL RES, V313, P2228, DOI 10.1016/j.yexcr.2007.04.025; WONG PC, 1995, J CELL BIOL, V130, P1413, DOI 10.1083/jcb.130.6.1413; Xu K, 2013, SCIENCE, V339, P452, DOI 10.1126/science.1232251; Yao NY, 2010, BIOPHYS J, V98, P2147, DOI 10.1016/j.bpj.2010.01.062; YU WQ, 1994, J NEUROSCI, V14, P2818; Zhang J, 2014, BIOMECH MODEL MECHAN, V13, P1175, DOI 10.1007/s10237-014-0564-x; Zhang Y, 2017, PLOS COMPUT BIOL, V13, DOI 10.1371/journal.pcbi.1005567; Zhu F, 2016, J NEUROTRAUM, V33, P859, DOI 10.1089/neu.2015.4007	83	15	16	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	AUG 6	2018	9								643	10.3389/fneur.2018.00643			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GP4EE	WOS:000440810200001	30127763	gold, Green Published			2022-02-06	
J	Christian, CW; Levin, AV				Christian, Cindy W.; Levin, Alex V.		Council Child Abuse Neglect; Sect Ophthalmology; American Assoc Certified Orthopt; Amer Assoc Pediat Ophthalmol; Amer Acad Ophthalmology	The Eye Examination in the Evaluation of Child Abuse	PEDIATRICS			English	Article							SHAKEN-BABY-SYNDROME; PEDIATRIC ORBITAL FRACTURES; PERIMACULAR RETINAL FOLDS; HEAD TRAUMA; CARDIOPULMONARY-RESUSCITATION; NONACCIDENTAL INJURY; COMPUTED-TOMOGRAPHY; BRAIN-INJURY; CASE SERIES; FOLLOW-UP	Child abuse can cause injury to any part of the eye. The most common manifestations are retinal hemorrhages (RHs) in infants and young children with abusive head trauma (AHT). Although RHs are an important indicator of possible AHT, they are also found in other conditions. Distinguishing the number, type, location, and pattern of RHs is important in evaluating a differential diagnosis. Eye trauma can be seen in cases of physical abuse or AHT and may prompt referral for ophthalmologic assessment. Physicians have a responsibility to consider abuse in the differential diagnosis of pediatric eye trauma. Identification and documentation of inflicted ocular trauma requires a thorough examination by an ophthalmologist, including indirect ophthalmoscopy, most optimally through a dilated pupil, especially for the evaluation of possible RHs. An eye examination is helpful in detecting abnormalities that can help identify a medical or traumatic etiology for previously well young children who experience unexpected and unexplained mental status changes with no obvious cause, children with head trauma that results in significant intracranial hemorrhage and brain injury, and children with unexplained death.	[Christian, Cindy W.] Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA; [Christian, Cindy W.] Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA; [Levin, Alex V.] Thomas Jefferson Univ, Wills Eye Hosp, Dept Pediat Ophthalmol & Ocular Genet, Philadelphia, PA 19107 USA; [Levin, Alex V.] Thomas Jefferson Univ, Sidney Kimmel Med Coll, Dept Ophthalmol & Pediat, Philadelphia, PA 19107 USA		Christian, CW (corresponding author), Univ Penn, Dept Pediat, Perelman Sch Med, Philadelphia, PA 19104 USA.; Christian, CW (corresponding author), Childrens Hosp Philadelphia, Philadelphia, PA 19104 USA.	christian@email.chop.edu					Agrawal S, 2012, PEDIATRICS, V129, pE1388, DOI 10.1542/peds.2011-2772; Al-Holou WN, 2009, J NEUROSURG-PEDIATR, V3, P474, DOI 10.3171/2009.1.PEDS08365; Altman RL, 2003, ARCH PEDIAT ADOL MED, V157, P1011, DOI 10.1001/archpedi.157.10.1011; Barlow KM, 2005, PEDIATRICS, V116, pE174, DOI 10.1542/peds.2004-2739; Bhardwaj G, 2010, OPHTHALMOLOGY, V117, P983, DOI 10.1016/j.ophtha.2009.09.040; Bielory BP, 2012, ARCH OPHTHALMOL-CHIC, V130, P383, DOI 10.1001/archopthalmol.2011.1674; Binenbaum G, 2016, J AAPOS, V20, P131, DOI 10.1016/j.jaapos.2015.12.008; Binenbaum G, 2015, JAMA OPHTHALMOL, V133, P1261, DOI 10.1001/jamaophthalmol.2015.2868; Binenbaum G, 2013, J AAPOS, V17, P603, DOI 10.1016/j.jaapos.2013.09.002; Binenbaum G, 2013, PEDIATRICS, V132, pE430, DOI 10.1542/peds.2013-0262; Binenbaum G, 2009, J AAPOS, V13, P268, DOI 10.1016/j.jaapos.2009.03.005; Callaway NF, 2016, OPHTHALMOLOGY, V123, P1043, DOI 10.1016/j.ophtha.2016.01.004; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Curcoy AI, 2009, ARCH DIS CHILD, V94, P873, DOI 10.1136/adc.2007.132522; DeRidder CA, 2013, PEDIATR EMERG CARE, V29, P222, DOI 10.1097/PEC.0b013e318280d663; Duhaime AC, 1996, PEDIATR NEUROSURG, V25, P116, DOI 10.1159/000121108; Emerson MV, 2001, OPHTHALMOLOGY, V108, P36, DOI 10.1016/S0161-6420(00)00474-7; Forbes BJ, 2008, J AAPOS, V12, P177, DOI 10.1016/j.jaapos.2007.07.009; Forbes BJ, 2010, J AAPOS, V14, P267, DOI 10.1016/j.jaapos.2010.03.002; Ganesh A, 2004, OPHTHALMOLOGY, V111, P1428, DOI 10.1016/j.ophtha.2003.10.028; GEORGE NDL, 1995, BRIT J OPHTHALMOL, V79, P653, DOI 10.1136/bjo.79.7.653; Gilles EE, 2003, J PEDIATR-US, V143, P494, DOI 10.1067/S0022-3476(03)00416-5; Gilliland MGF, 2007, AM J FOREN MED PATH, V28, P323, DOI 10.1097/PAF.0b013e31815b4c00; Gnanaraj L, 2007, EYE, V21, P5, DOI 10.1038/sj.eye.6702174; Goldenberg DT, 2010, OPHTHALMOLOGY, V117, P561, DOI 10.1016/j.ophtha.2009.08.013; Goldman M, 2006, J PEDIATR-US, V148, P835, DOI 10.1016/j.jpeds.2005.12.052; Gumus Koray, 2007, International Ophthalmology, V27, P379, DOI 10.1007/s10792-007-9089-y; Pham H, 2013, AM J FOREN MED PATH, V34, P122, DOI 10.1097/PAF.0b013e31828c38f9; Hughes LA, 2006, J AAPOS, V10, P102, DOI 10.1016/j.jaapos.2005.12.005; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Kivlin JD, 2008, ARCH OPHTHALMOL-CHIC, V126, P800, DOI 10.1001/archopht.126.6.800; Laghmari M, 2014, J FR OPHTALMOL, V37, P313, DOI 10.1016/j.jfo.2013.06.005; Lantz PE, 2005, J FORENSIC SCI, V50, P1450; Lantz PE, 2004, BRIT MED J, V328, P754, DOI 10.1136/bmj.328.7442.754; Levin Alex V, 2014, Trans Am Ophthalmol Soc, V112, P1; Levin AV, 2010, PEDIATRICS, V126, P961, DOI 10.1542/peds.2010-1220; Levin AV, 2009, PEDIATR CLIN N AM, V56, P333, DOI 10.1016/j.pcl.2009.02.003; LEVIN AV, 2000, RECENT ADV PAEDIAT, V18, P151; Levinson JD, 2016, J AAPOS, V20, P166, DOI 10.1016/j.jaapos.2015.11.003; Lind K, 2016, CHILD ABUSE NEGLECT, V51, P358, DOI 10.1016/j.chiabu.2015.08.001; Losee JE, 2008, PLAST RECONSTR SURG, V122, P886, DOI 10.1097/PRS.0b013e3181811e48; Lueder GT, 2006, ARCH OPHTHALMOL-CHIC, V124, P1782, DOI 10.1001/archopht.124.12.1782; Maguire S, 2009, ARCH DIS CHILD, V94, P860, DOI 10.1136/adc.2008.150110; Maguire SA, 2013, EYE, V27, P28, DOI 10.1038/eye.2012.213; Morad Y, 2004, J AAPOS, V8, P521, DOI 10.1016/j.jaapos.2004.07.009; Morad Y, 2004, J AAPOS, V8, P445, DOI 10.1016/j.jaapos.2004.06.007; Morad Y, 2003, J PEDIATR-US, V142, P431, DOI 10.1067/mpd.2003.161; Morad Y, 2002, AM J OPHTHALMOL, V134, P354, DOI 10.1016/S0002-9394(02)01628-8; Muni Rajeev H, 2010, Retina, V30, pS45, DOI 10.1097/IAE.0b013e3181dc048c; Odom A, 1997, PEDIATRICS, V99, part. no., DOI 10.1542/peds.99.6.e3; Oppenheimer AJ, 2013, CRANIOMAX TRAUM REC, V6, P9, DOI 10.1055/s-0032-1332213; Parisi MT, 2015, PEDIATR EMERG CARE, V31, P779, DOI 10.1097/PEC.0000000000000199; Reddie IC, 2010, EYE, V24, P1426, DOI 10.1038/eye.2010.70; Riggs BJ, 2016, ANN EMERG MED, V67, P620, DOI 10.1016/j.annemergmed.2015.09.027; Rubin DM, 2003, PEDIATRICS, V111, P1382, DOI 10.1542/peds.111.6.1382; Shiau T, 2012, ARCH PEDIAT ADOL MED, V166, P623, DOI 10.1001/archpediatrics.2012.46; SooHoo JR, 2013, J AAPOS, V17, P565, DOI 10.1016/j.jaapos.2013.07.007; Squier W, 2011, ACTA NEUROPATHOL, V122, P519, DOI 10.1007/s00401-011-0875-2; Sturm V, 2008, AM J OPHTHALMOL, V146, P363, DOI 10.1016/j.ajo.2008.04.023; Vinchon M, 2010, CHILD NERV SYST, V26, P637, DOI 10.1007/s00381-009-1048-7; Watts P, 2013, J AAPOS, V17, P70, DOI 10.1016/j.jaapos.2012.07.012; Wygnanski-Jaffe T, 2006, AM J OPHTHALMOL, V142, P233, DOI 10.1016/j.ajo.2006.03.038	62	15	15	0	5	AMER ACAD PEDIATRICS	ELK GROVE VILLAGE	141 NORTH-WEST POINT BLVD,, ELK GROVE VILLAGE, IL 60007-1098 USA	0031-4005	1098-4275		PEDIATRICS	Pediatrics	AUG	2018	142	2							e20181411	10.1542/peds.2018-1411			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	GO9WX	WOS:000440459900043	30037976	Bronze			2022-02-06	
J	Henry, GK; Heilbronner, RL; Suhr, J; Gornbein, J; Wagner, E; Drane, DL				Henry, George K.; Heilbronner, Robert L.; Suhr, Julie; Gornbein, Jeffrey; Wagner, Eveleigh; Drane, Daniel L.			Illness Perceptions Predict Cognitive Performance Validity	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Performance validity; Symptom validity; Illness perceptions; Health beliefs; Cogniphobia; Symptom identity	MALINGERED NEUROCOGNITIVE DYSFUNCTION; PSYCHOGENIC NONEPILEPTIC SEIZURES; RESTRUCTURED FORM MMPI-2-RF; TRAUMATIC BRAIN-INJURY; COMMON-SENSE MODEL; MILD HEAD-INJURY; SYMPTOM VALIDITY; RESPONSE BIAS; DISSOCIATIVE TENDENCIES; FORENSIC SETTINGS	Objectives: The aim of this study was to investigate the relationship of psychological variables to cognitive performance validity test (PVT) results in mixed forensic and nonforensic clinical samples. Methods: Participants included 183 adults who underwent comprehensive neuropsychological examination. Criterion groups were formed, that is, Credible Group or Noncredible Group, based upon their performance on the Word Memory Test and other stand-alone and embedded PVT measures. Results: Multivariate logistic regression analysis identified three significant predictors of cognitive performance validity. These included two psychological constructs, for example, Cogniphobia (perception that cognitive effort will exacerbate neurological symptoms), and Symptom Identity (perception that current symptoms are the result of illness or injury), and one contextual factor (forensic). While there was no interaction between these factors, elevated scores were most often observed in the forensic sample, suggesting that these independently contributing intrinsic psychological factors are more likely to occur in a forensic environment. Conclusions: Illness perceptions were significant predictors of cognitive performance validity particularly when they reached very elevated levels. Extreme elevations were more common among participants in the forensic sample, and potential reasons for this pattern are explored.	[Henry, George K.; Gornbein, Jeffrey] UCLA, David Geffen Sch Med, Los Angeles, CA 90095 USA; [Heilbronner, Robert L.] Chicago Neuropsychol Grp, Chicago, IL USA; [Heilbronner, Robert L.] Northwestern Univ, Feinberg Sch Med, Chicago, IL 60611 USA; [Suhr, Julie] Ohio Univ, Athens, OH 45701 USA; [Wagner, Eveleigh] Vanderbilt Univ, Med Ctr, Nashville, TN USA; [Drane, Daniel L.] Emory Univ, Sch Med, Atlanta, GA USA		Henry, GK (corresponding author), 11601 Wilshire Blvd,5th Floor, Los Angeles, CA 90025 USA.	GHenry0249@aol.com			NCS Pearson, Minneapolis, MN	Authors (G.H., R.H.) declare there was a fee for service for the 81 forensic referrals, while authors (J.S., J.G., W.E., D.D.) report no potential conflicts of interest. Partial funding was provided by NCS Pearson, Minneapolis, MN, for MMPI-2-RF scoring costs.	Amrhein C, 2008, J TRAUMA DISSOCIATIO, V9, P525, DOI 10.1080/15299730802226332; An KY, 2012, ARCH CLIN NEUROPSYCH, V27, P849, DOI 10.1093/arclin/acs085; Ardolf BR, 2007, CLIN NEUROPSYCHOL, V21, P899, DOI 10.1080/13825580600966391; Bandura A., 1997, SELF EFFICACY EXERCI; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Belanger HG, 2013, CLIN NEUROPSYCHOL, V27, P159, DOI 10.1080/13854046.2012.758780; BERNSTEIN EM, 1986, J NERV MENT DIS, V174, P727, DOI 10.1097/00005053-198612000-00004; Boone KB, 2005, ARCH CLIN NEUROPSYCH, V20, P301, DOI 10.1016/j.acn.2004.08.001; Boone KB, 2002, J CLIN EXP NEUROPSYC, V24, P561, DOI 10.1076/jcen.24.5.561.1004; Crombez G, 1998, BEHAV MODIF, V22, P62, DOI 10.1177/01454455980221004; Dean AC, 2008, CLIN NEUROPSYCHOL, V22, P705, DOI 10.1080/13854040701440493; Dean AC, 2009, CLIN NEUROPSYCHOL, V23, P133, DOI 10.1080/13854040701819050; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC, 2007, ARCH CLIN NEUROPSYCH, V22, P589, DOI 10.1016/j.acn.2007.04.001; DePrince AP, 1999, PSYCHOL SCI, V10, P449, DOI 10.1111/1467-9280.00185; DeRight J, 2015, CLIN NEUROPSYCHOL, V29, P101, DOI 10.1080/13854046.2014.989267; Diefenbach MA, 1996, J SOC DISTRESS HOMEL, V5, P11, DOI 10.1007/BF02090456; Drane DL, 2006, EPILEPSIA, V47, P1879, DOI 10.1111/j.1528-1167.2006.00611.x; Drane DL, 2016, EPILEPSY BEHAV, V56, P131, DOI 10.1016/j.yebeh.2016.01.001; Forbey JD, 2013, ASSESSMENT, V20, P448, DOI 10.1177/1073191113478154; Forbey JD, 2011, J PERS ASSESS, V93, P556, DOI 10.1080/00223891.2011.608757; Fragale A., 2004, PERSONALITY SOCIAL P, V30, P226; Freyd JJ, 1998, APPL COGNITIVE PSYCH, V12, pS91, DOI 10.1002/(SICI)1099-0720(199812)12:7<S91::AID-ACP599>3.0.CO;2-Z; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2011, J PERS ASSESS, V93, P508, DOI 10.1080/00223891.2011.594132; Green P., 2005, GREENS WORD MEMORY T, Vrev. ed.; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Haggerty KA, 2007, CLIN NEUROPSYCHOL, V21, P917, DOI 10.1080/13854040600899724; Henry GK, 2013, CLIN NEUROPSYCHOL, V27, P509, DOI 10.1080/13854046.2012.739644; Ingram PB, 2016, CLIN NEUROPSYCHOL, V30, P473, DOI 10.1080/13854046.2016.1187769; Johnson S., 2008, MED UNEXPLAINED ILLN; Jones A, 2012, CLIN NEUROPSYCHOL, V26, P790, DOI 10.1080/13854046.2012.693202; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kemp S, 2008, J PSYCHOSOM RES, V65, P319, DOI 10.1016/j.jpsychores.2008.02.010; Kotor R.I., 2004, MULTIDIMENSIONAL IOW; Lamberty G. J., 2008, UNDERSTANDING SOMATI; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Lees-Haley PR, 2002, J FORENSIC NEUROPSYC, V3, P167, DOI DOI 10.1300/J151V03N01_01; Loring DW, 2005, J CLIN EXP NEUROPSYC, V27, P610, DOI 10.1080/13803390490918471; Martelli M.F., 1999, KINESIOPHOBIA COGNIP; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Martin PK, 2015, ARCH CLIN NEUROPSYCH, V30, P377, DOI 10.1093/arclin/acv032; Mittenberg W, 1996, ARCH CLIN NEUROPSYCH, V11, P139, DOI 10.1016/0887-6177(95)00006-2; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Moss-Morris R, 2002, PSYCHOL HEALTH, V17, P1, DOI 10.1080/08870440290001494; Nelson NW, 2011, CLIN NEUROPSYCHOL, V25, P716, DOI 10.1080/13854046.2011.579174; Nguyen CT, 2015, CLIN NEUROPSYCHOL, V29, P255, DOI 10.1080/13854046.2015.1033020; Peck CP, 2013, CLIN NEUROPSYCHOL, V27, P693, DOI 10.1080/13854046.2013.779032; Rogers R, 2011, J PSYCHOPATHOL BEHAV, V33, P355, DOI 10.1007/s10862-011-9222-0; Schroeder RW, 2016, CLIN NEUROPSYCHOL, V30, P515, DOI 10.1080/13854046.2016.1177118; Schroeder RW, 2012, CLIN NEUROPSYCHOL, V26, P129, DOI 10.1080/13854046.2011.639314; Schroeder RW, 2011, CLIN NEUROPSYCHOL, V25, P437, DOI 10.1080/13854046.2011.556668; Schwarzer R., 1995, MEASURES HLTH PSYCHO; Sellbom M, 2010, PSYCHOL ASSESSMENT, V22, P757, DOI 10.1037/a0020825; Sellbom M, 2010, PSYCHOL ASSESSMENT, V22, P22, DOI 10.1037/a0018222; Silk-Eglit GM, 2014, ARCH CLIN NEUROPSYCH, V29, P415, DOI 10.1093/arclin/acu028; Slick D.J., 1997, VICTORIA SYMPTOM VAL; Snell DL, 2013, NEUROPSYCHOL REHABIL, V23, P333, DOI 10.1080/09658211.2012.758419; Suhr JA, 2003, J PSYCHOSOM RES, V55, P321, DOI 10.1016/S0022-3999(02)00628-1; Suhr J, 2012, CLIN NEUROPSYCHOL, V26, P1128, DOI 10.1080/13854046.2012.713121; Sweet J.J., 2008, CLIN ASSESSMENT MALI; Tarescavage AM, 2013, CLIN NEUROPSYCHOL, V27, P313, DOI 10.1080/13854046.2012.744099; Tellegen, 2008, MINNESOTA MULTIPHASI; Thomas ML, 2009, CLIN NEUROPSYCHOL, V23, P1067, DOI 10.1080/13854040902795000; Todd D.D., 1998, CISC VIS NETW IND GL; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Tutz G, 2006, BIOMETRICS, V62, P961, DOI 10.1111/j.1541-0420.2006.00578.x; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Vazquez-Justo E, 2003, PSYCHIAT CLIN NEUROS, V57, P251, DOI 10.1046/j.1440-1819.2003.00113.x; Whittaker R, 2007, J NEUROL NEUROSUR PS, V78, P644, DOI 10.1136/jnnp.2006.101105; Williamson DJ, 2012, CLIN NEUROPSYCHOL, V26, P588, DOI 10.1080/13854046.2012.670266; Williamson DJ, 2005, EPILEPSIA, V46, P74; Wolfe PL, 2010, CLIN NEUROPSYCHOL, V24, P153, DOI 10.1080/13854040903107791; Wygant DB, 2010, PSYCHOL ASSESSMENT, V22, P745, DOI 10.1037/a0020042; Wygant DB, 2009, ARCH CLIN NEUROPSYCH, V24, P671, DOI 10.1093/arclin/acp073; Youngjohn JR, 2011, CLIN NEUROPSYCHOL, V25, P463, DOI [10.1080/13854046.2011.554444, 10.1080/13854046.2010.550635]	78	15	15	0	3	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2018	24	7					735	745		10.1017/S1355617718000218			11	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	GR6FA	WOS:000442739900009	29704907	Bronze			2022-02-06	
J	Magalhaes, DM; Pereira, N; Rombo, DM; Beltrao-Cavacas, C; Sebastiao, AM; Valente, CA				Magalhaes, Daniela M.; Pereira, Noemia; Rombo, Diogo M.; Beltrao-Cavacas, Claudia; Sebastiao, Ana M.; Valente, Claudia A.			Ex vivo model of epilepsy in organotypic slices-a new tool for drug screening	JOURNAL OF NEUROINFLAMMATION			English	Article						Epilepsy; Organotypic slice cultures; Neuroinflammation; Gliosis; Proinflammatory cytokines; Interleukin-1 beta; NLRP3 inflammasome	INDUCED STATUS EPILEPTICUS; TRAUMATIC BRAIN-INJURY; ALPHA-II-SPECTRIN; CELL-DEATH; INFLAMMATORY CYTOKINES; NLRP3 INFLAMMASOME; INTERICTAL SPIKES; IN-VITRO; OXIDATIVE STRESS; RAT HIPPOCAMPUS	Background: Epilepsy is a prevalent neurological disorder worldwide. It is characterized by an enduring predisposition to generate seizures and its development is accompanied by alterations in many cellular processes. Organotypic slice cultures represent a multicellular environment with the potential to assess biological mechanisms, and they are used as a starting point for refining molecules for in vivo studies. Here, we investigated organotypic slice cultures as a model of epilepsy. Methods: We assessed, by electrophysiological recordings, the spontaneous activity of organotypic slices maintained under different culture protocols. Moreover, we evaluated, through molecular-based approaches, neurogenesis, neuronal death, gliosis, expression of proinflammatory cytokines, and activation of NLRP3 inflammasome (nucleotide-binding, leucine-rich repeat, pyrin domain) as biomarkers of neuroinflammation. Results: We demonstrated that organotypic slices, maintained under a serum deprivation culture protocol, develop epileptic-like activity. Furthermore, throughout a comparative study with slices that do not depict any epileptiform activity, slices with epileptiform activity were found to display significant differences in terms of inflammation-related features, such as (1) increased neuronal death, with higher incidence in CA1 pyramidal neurons of the hippocampus; (2) activation of astrocytes and microglia, assessed through western blot and immunohistochemistry; (3) upregulation of proinflammatory cytokines, specifically interleukin-1 beta (IL-1 beta), interleukin-6, and tumor necrosis factor a, revealed by qPCR; and (4) enhanced expression of NLRP3, assessed by western blot, together with increased NLRP3 activation, showed by IL-1 beta quantification. Conclusions: Thus, organotypic slice cultures gradually deprived of serum mimic the epileptic-like activity, as well as the inflammatory events associated with in vivo epilepsy. This system can be considered a new tool to explore the interplay between neuroinflammation and epilepsy and to screen potential drug candidates, within the inflammatory cascades, to reduce/halt epileptogenesis.	[Magalhaes, Daniela M.; Pereira, Noemia; Rombo, Diogo M.; Beltrao-Cavacas, Claudia; Sebastiao, Ana M.; Valente, Claudia A.] Univ Lisbon, Fac Med, Inst Farmacol & Neurociencias, Lisbon, Portugal; [Magalhaes, Daniela M.; Pereira, Noemia; Rombo, Diogo M.; Beltrao-Cavacas, Claudia; Sebastiao, Ana M.; Valente, Claudia A.] Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal		Valente, CA (corresponding author), Univ Lisbon, Fac Med, Inst Farmacol & Neurociencias, Lisbon, Portugal.; Valente, CA (corresponding author), Univ Lisbon, Fac Med, Inst Med Mol, Lisbon, Portugal.	cvalentecastro@medicina.ulisboa.pt	Valente, CA/AAE-1250-2020	Valente, CA/0000-0001-5405-3130; Magalhaes, Daniela/0000-0002-1662-2002; Rombo, Diogo/0000-0002-9922-7381; Sebastiao, Ana M/0000-0001-9030-6115	FEDER through POR Lisboa 2020-Programa Operacional Regional de Lisboa, PORTUGAL 2020; Fundacao para a Ciencia e a TecnologiaPortuguese Foundation for Science and TechnologyEuropean Commission [SFRH/BD/60386/2009];  [LISBOA-01-0145-FEDER-007391]	The funding reference is LISBOA-01-0145-FEDER-007391, and the project was cofunded by FEDER, through POR Lisboa 2020-Programa Operacional Regional de Lisboa, PORTUGAL 2020, and Fundacao para a Ciencia e a Tecnologia. Diogo M. Rombo was in receipt of a fellowship from Fundacao para a Ciencia e a Tecnologia, SFRH/BD/60386/2009.	Abraham MC, 2004, TRENDS CELL BIOL, V14, P184, DOI 10.1016/j.tcb.2004.03.002; Albus K, 2013, J NEUROSCI METH, V217, P1, DOI 10.1016/j.jneumeth.2013.04.014; Araque A, 1999, TRENDS NEUROSCI, V22, P208, DOI 10.1016/S0166-2236(98)01349-6; Aroeira RI, 2011, J NEUROCHEM, V118, P339, DOI 10.1111/j.1471-4159.2011.07197.x; Berdichevsky Y, 2012, NEUROBIOL DIS, V45, P774, DOI 10.1016/j.nbd.2011.11.001; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Binder DK, 2006, GLIA, V54, P358, DOI 10.1002/glia.20394; Block ML, 2005, PROG NEUROBIOL, V76, P77, DOI 10.1016/j.pneurobio.2005.06.004; Brentnall M, 2013, BMC CELL BIOL, V14, DOI 10.1186/1471-2121-14-32; Chapleau CA, 2008, J NEUROSCI METH, V169, P182, DOI 10.1016/j.jneumeth.2007.12.006; Cho S, 2007, CURR NEUROPHARMACOL, V5, P19, DOI 10.2174/157015907780077105; Coltman BW, 1996, INT J DEV NEUROSCI, V14, P707, DOI 10.1016/S0736-5748(96)00071-8; Daviaud N, 2013, EXP NEUROL, V248, P429, DOI 10.1016/j.expneurol.2013.07.012; De Simoni A, 2003, J PHYSIOL-LONDON, V550, P135, DOI 10.1113/jphysiol.2003.039099; De Simoni MG, 2000, EUR J NEUROSCI, V12, P2623, DOI 10.1046/j.1460-9568.2000.00140.x; Devinsky O, 2013, TRENDS NEUROSCI, V36, P174, DOI 10.1016/j.tins.2012.11.008; Dingledine R, 2014, ADV EXP MED BIOL, V813, P109, DOI 10.1007/978-94-017-8914-1_9; Doussau F, 2017, EXPERT OPIN DRUG DIS, V12, P1011, DOI 10.1080/17460441.2017.1356285; Dyhrfjeld-Johnsen J, 2010, J CLIN NEUROPHYSIOL, V27, P418, DOI 10.1097/WNP.0b013e3181fe0709; Edye M.E., 2014, INFLAMMASOME, V1, P36; Engel J, 2007, EPILEPSY COMPREHENSI; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Finkel T, 2003, CURR OPIN CELL BIOL, V15, P247, DOI 10.1016/S0955-0674(03)00002-4; Fisher RS, 2005, EPILEPSIA, V46, P470, DOI 10.1111/j.0013-9580.2005.66104.x; Foresti ML, 2011, BRAIN RES REV, V66, P115, DOI 10.1016/j.brainresrev.2010.09.002; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Hamilton NB, 2010, NAT REV NEUROSCI, V11, P227, DOI 10.1038/nrn2803; Harwood SM, 2005, ANN CLIN BIOCHEM, V42, P415, DOI 10.1258/000456305774538238; Heinemann U, 2006, MODELS OF SEIZURES AND EPILEPSY, P35, DOI 10.1016/B978-012088554-1/50006-2; Holopainen IE, 2005, NEUROCHEM RES, V30, P1521, DOI 10.1007/s11064-005-8829-5; Humpel C, 2015, NEUROSCIENCE, V305, P86, DOI 10.1016/j.neuroscience.2015.07.086; Jessberger S, 2005, EXP NEUROL, V196, P342, DOI 10.1016/j.expneurol.2005.08.010; Jessberger S, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020677; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Lee SB, 2010, APOPTOSIS, V15, P204, DOI 10.1007/s10495-009-0411-1; Li Q, 2016, MOL NEUROBIOL, V53, P4226, DOI 10.1007/s12035-015-9362-4; Loscher W, 2002, EPILEPSY RES, V50, P105, DOI 10.1016/S0920-1211(02)00073-6; Lossi L, 2009, PROG NEUROBIOL, V88, P221, DOI 10.1016/j.pneurobio.2009.01.002; Lukasiuk K, 2014, NEUROTHERAPEUTICS, V11, P319, DOI 10.1007/s13311-014-0261-6; McIlwain DR, 2013, CSH PERSPECT BIOL, V5, DOI 10.1101/cshperspect.a008656; Meldrum BS, 2002, PROG BRAIN RES, V135, P3; Meng XF, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0212-5; Naundorf B, 2005, J COMPUT NEUROSCI, V18, P297, DOI 10.1007/s10827-005-0329-8; Noraberg J, 1999, BRAIN RES PROTOC, V3, P278, DOI 10.1016/S1385-299X(98)00050-6; Noraberg J, 2005, CNS NEUROL DISORD-DR, V4, P435, DOI 10.2174/1568007054546108; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Parent JM, 1997, J NEUROSCI, V17, P3727; Parent JM, 2002, J NEUROSCI, V22, P3174, DOI 10.1523/JNEUROSCI.22-08-03174.2002; Pekny M, 2005, GLIA, V50, P427, DOI 10.1002/glia.20207; Perea G, 2009, TRENDS NEUROSCI, V32, P421, DOI 10.1016/j.tins.2009.05.001; Pfaffl MW, 2001, NUCLEIC ACIDS RES, V29, DOI 10.1093/nar/29.9.e45; Pike BR, 2004, J CEREBR BLOOD F MET, V24, P98, DOI 10.1097/01.WCB.0000098520.11962.37; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Prinz M, 2011, GLIA, V59, P177, DOI 10.1002/glia.21104; Sadgrove MP, 2006, J COMP NEUROL, V497, P397, DOI 10.1002/cne.21000; Sarkisian MR, 2001, EPILEPSY BEHAV, V2, P201, DOI 10.1006/ebeh.2001.0193; Singhal G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00315; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song LM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00063; Staley KJ, 2011, NEUROSCI LETT, V497, P247, DOI 10.1016/j.neulet.2011.03.070; STOPPINI L, 1991, J NEUROSCI METH, V37, P173, DOI 10.1016/0165-0270(91)90128-M; Sundstrom L, 2005, DRUG DISCOV TODAY, V10, P993, DOI 10.1016/S1359-6446(05)03502-6; Tambuyzer BR, 2009, J LEUKOCYTE BIOL, V85, P352, DOI 10.1189/jlb.0608385; Tschopp J, 2010, NAT REV IMMUNOL, V10, P210, DOI 10.1038/nri2725; Tsirka SE, 2011, CLIN GENETIC ASPECTS; Vezzani A, 2005, EPILEPSIA, V46, P1724, DOI 10.1111/j.1528-1167.2005.00298.x; Vezzani A, 2002, EPILEPSIA, V43, P30, DOI 10.1046/j.1528-1157.43.s.5.14.x; Vezzani A, 2015, NEUROPHARMACOLOGY, V96, P70, DOI 10.1016/j.neuropharm.2014.10.027; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Vezzani A, 2011, BIOMARK MED, V5, P607, DOI [10.2217/bmm.11.61, 10.2217/BMM.11.61]; Vezzani A, 2011, NAT REV NEUROL, V7, P31, DOI 10.1038/nrneurol.2010.178; Vismer MS, 2015, FRONT NEURAL CIRCUIT, V9, DOI 10.3389/fncir.2015.00027; Vitaliti G, 2014, HUM VACC IMMUNOTHER, V10, P868, DOI 10.4161/hv.28400; Vogel C, 2012, NAT REV GENET, V13, P227, DOI 10.1038/nrg3185; Walker L, 2012, EPILEPSY CURR, V12, P8, DOI 10.5698/1535-7511-12.1.8; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Williams PA, 2009, J NEUROSCI, V29, P2103, DOI 10.1523/JNEUROSCI.0980-08.2009; Wu H, 2011, J CEREBR BLOOD F MET, V31, P1243, DOI 10.1038/jcbfm.2010.209; Yan XX, 2013, CURR TRANSL GERIATR, V1, P85; Zhou RB, 2010, NAT IMMUNOL, V11, P136, DOI 10.1038/ni.1831	83	15	16	2	4	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1742-2094			J NEUROINFLAMM	J. Neuroinflamm.	JUL 11	2018	15								203	10.1186/s12974-018-1225-2			18	Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology	GM6FS	WOS:000438258400001	29996878	Green Published, gold			2022-02-06	
J	Lagerstedt, L; Egea-Guerrero, JJ; Bustamante, A; Rodriguez-Rodriguez, A; El Rahal, A; Quintana-Diaz, M; Garcia-Armengol, R; Prica, CM; Andereggen, E; Rinaldi, L; Sarrafzadeh, A; Schaller, K; Montaner, J; Sanchez, JC				Lagerstedt, Linnea; Jose Egea-Guerrero, Juan; Bustamante, Alejandro; Rodriguez-Rodriguez, Ana; El Rahal, Amir; Quintana-Diaz, Manuel; Garcia-Armengol, Roser; Melinda Prica, Carmen; Andereggen, Elisabeth; Rinaldi, Lara; Sarrafzadeh, Asita; Schaller, Karl; Montaner, Joan; Sanchez, Jean-Charles			Combining H-FABP and GFAP increases the capacity to differentiate between CT-positive and CT-negative patients with mild traumatic brain injury	PLOS ONE			English	Article							COMPUTED-TOMOGRAPHY FINDINGS; FIBRILLARY ACIDIC PROTEIN; BINDING-PROTEIN; INTERLEUKIN-10 EXPRESSION; INTRACRANIAL LESIONS; ADHESION MOLECULE-1; TISSUE DISTRIBUTION; BLOOD BIOMARKERS; EARLY-DIAGNOSIS; STROKE	Mild traumatic brain injury (mTBI) patients may have trauma-induced brain lesions detectable using CT scans. However, most patients will be CT-negative. There is thus a need for an additional tool to detect patients at risk. Single blood biomarkers, such as S100B and GFAP, have been widely studied in mTBI patients, but to date, none seems to perform well enough. In many different diseases, combining several biomarkers into panels has become increasingly interesting for diagnoses and to enhance classification performance. The present study evaluated 13 proteins individually-H-FABP, MMP-1, MMP-3, MMP-9, VCAM, ICAM, SAA, CRP, GSTP, NKDA, PRDX1, DJ-1 and IL-10-for their capacity to differentiate between patients with and without a brain lesion according to CT results. The best performing proteins were then compared and combined with the S100B and GFAP proteins into a CT-scan triage panel. Patients diagnosed with mTBI, with a Glasgow Coma Scale score of 15 and one additional clinical symptom were enrolled at three different European sites. A blood sample was collected at hospital admission, and a CT scan was performed. Patients were divided into two two-centre cohorts and further dichotomised into CT-positive and CT-negative groups for statistical analysis. Single markers and panels were evaluated using Cohort 1. Four proteins-H-FABP, IL-10, S100B and GFAP-showed significantly higher levels in CT-positive patients. The best-performing biomarker was H-FABP, with a specificity of 32% (95% CI 23-40) and sensitivity reaching 100%. The best-performing two-marker panel for Cohort 1, subsequently validated in Cohort 2, was a combination of H-FABP and GFAP, enhancing specificity to 46% (95% CI 36-55). When adding IL-10 to this panel, specificity reached 52% (95% CI 43-61) with 100% sensitivity. These results showed that proteins combined into panels could be used to efficiently classify CT-positive and CT-negative mTBI patients.	[Lagerstedt, Linnea; Sanchez, Jean-Charles] Univ Geneva, Fac Med, Dept Special Internal Med, Geneva, Switzerland; [Jose Egea-Guerrero, Juan; Rodriguez-Rodriguez, Ana] Virgen del Rocio Univ Hosp, NeuroCrit Care Unit, Seville, Spain; [Bustamante, Alejandro; Montaner, Joan] Univ Autonoma Barcelona, VHIR, Neurovasc Res Lab, Barcelona, Spain; [El Rahal, Amir; Sarrafzadeh, Asita; Schaller, Karl] Geneva Univ Hosp, Geneva Neurosci Ctr, Dept Clin Neurosci, Div Neurosurg, Geneva, Switzerland; [Quintana-Diaz, Manuel] Univ Autonoma Madrid, Hosp Univ La Paz, Dept Med, Intens Med Unit,idiPAZ, Madrid, Spain; [Garcia-Armengol, Roser] Hosp Univ Germans Trias i Pujol, Neurosurg Dept, Neurosci Unit, Badalona, Spain; [Melinda Prica, Carmen] Hosp Tortosa Verge de la Cinta, Emergency Dept, Tortosa, Spain; [Andereggen, Elisabeth; Rinaldi, Lara] Geneva Univ Hosp, Emergency Ctr, Geneva, Switzerland; [Andereggen, Elisabeth] Geneva Univ Hosp, Dept Surg, Geneva, Switzerland; [Montaner, Joan] Univ Seville, Stroke Res Programme, CSIC, Hosp Univ Virgen del Rocio,IBiS, Seville, Spain; [Montaner, Joan] Hosp Univ Virgen Macarena, Dept Neurol, Seville, Spain		Sanchez, JC (corresponding author), Univ Geneva, Fac Med, Dept Special Internal Med, Geneva, Switzerland.	Jean-Charles.Sanchez@unige.ch	IBiS, Neurovascular/P-5842-2016; Egea-Guerrero, Juan Jose JJ/P-5080-2014; Montaner, Joan/D-3063-2015	IBiS, Neurovascular/0000-0001-9511-0672; Egea-Guerrero, Juan Jose JJ/0000-0002-4166-313X; Montaner, Joan/0000-0003-4845-2279			Allard L, 2005, CLIN CHEM, V51, P2043, DOI 10.1373/clinchem.2005.053942; Azurmendi L, 2017, CLIN PROTEOM, V14, DOI 10.1186/s12014-017-9162-0; Azurmendi Leire S A, 2017, J TRANSL SCI, P3; Bogoslovsky T, 2016, DIAGNOSTICS, V6, DOI 10.3390/diagnostics6040037; Borg J, 2004, J REHABIL MED, V36, P61, DOI 10.1080/16501960410023822; Calderon-Santiago M, 2015, ANAL BIOANAL CHEM, V407, P5381, DOI 10.1007/s00216-015-8700-8; Freire-Aragon M, 2017, MED CLIN-BARCELONA, V149, P122, DOI 10.1016/j.medcli.2017.05.002; Egea-Guerrero JJ, 2012, BRAIN INJURY, V26, P76, DOI 10.3109/02699052.2011.635360; Hainard A, 2013, TRANSLANT PROTEOMICS, V1, P57, DOI [10.1016/J.TRPROT.2013.04.003, DOI 10.1016/J.TRPROT.2013.04.003, 10.1016/j.trprot.2013.04.003]; Hainard A, 2011, TROP MED INT HEALTH, V16, P119, DOI 10.1111/j.1365-3156.2010.02642.x; Hainard A, 2009, PLOS NEGLECT TROP D, V3, DOI 10.1371/journal.pntd.0000459; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Jeter CB, 2013, J NEUROTRAUM, V30, P657, DOI 10.1089/neu.2012.2439; Junker R, 2010, DTSCH ARZTEBL INT, V107, P561, DOI 10.3238/arztebl.2010.0561; Kawata K, 2016, NEUROSCI BIOBEHAV R, V68, P460, DOI 10.1016/j.neubiorev.2016.05.009; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Kulbe JR, 2016, EXP NEUROL, V275, P334, DOI 10.1016/j.expneurol.2015.05.004; Lagerstedt L, 2018, PLOS ONE, V13, DOI 10.1371/journal.pone.0193278; Lagerstedt L, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0175572; Lescuyer Pierre, 2005, Mol Diagn, V9, P1, DOI 10.2165/00066982-200509010-00001; Maas MB, 2009, BIOMARK MED, V3, P363, DOI 10.2217/BMM.09.30; Mayer CA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062101; Melnick ER, 2012, JT COMM J QUAL PATIE, V38, P483, DOI 10.1016/S1553-7250(12)38064-1; North SH, 2012, ANNU REV ANAL CHEM, V5, P35, DOI 10.1146/annurev-anchem-062011-143105; Nylen K, 2006, J NEUROL SCI, V240, P85, DOI 10.1016/j.jns.2005.09.007; Papa L, 2016, JAMA NEUROL, V73, P551, DOI 10.1001/jamaneurol.2016.0039; Papa L, 2014, J NEUROTRAUM, V31, P1815, DOI 10.1089/neu.2013.3245; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Pelsers MMAL, 2004, CLIN CHEM, V50, P1568, DOI 10.1373/clinchem.2003.030361; Posti JP, 2017, J NEUROTRAUM, V34, P1427, DOI 10.1089/neu.2016.4442; Richard S, 2016, DIAGNOSTIC PERFORMAN, V6, P38300, DOI [10.1038/srep38300, DOI 10.1038/SREP38300]; Richard S, 2015, J INFLAMM-LOND, V12, DOI 10.1186/s12950-015-0106-z; Robin X, 2009, EXPERT REV PROTEOMIC, V6, P675, DOI 10.1586/EPR.09.83; Rutz S, 2016, ADV EXP MED BIOL, V941, P89, DOI 10.1007/978-94-024-0921-5_5; Shan RZ, 2016, J NEUROTRAUM, V33, P49, DOI 10.1089/neu.2014.3811; Sharma R, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173798; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Tiberti N, 2013, CLIN TRANSL MED, V2, DOI 10.1186/2001-1326-2-1; Trifunovic J, 2015, BIOCHEM MEDICA, V25, P36, DOI 10.11613/BM.2015.004; Turck N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043830; Turck N, 2010, INTENS CARE MED, V36, P107, DOI 10.1007/s00134-009-1641-y; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Unden J, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-50; VEERKAMP JH, 1990, MOL CELL BIOCHEM, V98, P11, DOI 10.1007/BF00231362; Walder B, 2013, J NEUROTRAUM, V30, P1631, DOI 10.1089/neu.2012.2791; Welch RD, 2016, J NEUROTRAUM, V33, P203, DOI 10.1089/neu.2015.4149; Woodcock T, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00018; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zimmerman AW, 2002, CELL MOL LIFE SCI, V59, P1096, DOI 10.1007/s00018-002-8490-y; Zimmermann-Ivol CG, 2004, MOL CELL PROTEOMICS, V3, P66, DOI 10.1074/mcp.M300066-MCP200	50	15	15	0	7	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	JUL 9	2018	13	7							e0200394	10.1371/journal.pone.0200394			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GM3UN	WOS:000438035500039	29985933	gold, Green Published, Green Submitted			2022-02-06	
J	Garcia-Gonzalez, D; Race, NS; Voets, NL; Jenkins, DR; Sotiropoulos, SN; Acosta, G; Cruz-Haces, M; Tang, J; Shi, RY; Jerusalem, A				Garcia-Gonzalez, Daniel; Race, Nicholas S.; Voets, Natalie L.; Jenkins, Damian R.; Sotiropoulos, Stamatios N.; Acosta, Glen; Cruz-Haces, Marcela; Tang, Jonathan; Shi, Riyi; Jerusalem, Antoine			Cognition based bTBI mechanistic criteria; a tool for preventive and therapeutic innovations	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; OXIDATIVE STRESS; MOOD DISORDERS; RAT MODEL; BLAST; DEFICITS; DAMAGE; INFLAMMATION; MICROSTRUCTURE; DYSFUNCTION	Blast-induced traumatic brain injury has been associated with neurodegenerative and neuropsychiatric disorders. To date, although damage due to oxidative stress appears to be important, the specific mechanistic causes of such disorders remain elusive. Here, to determine the mechanical variables governing the tissue damage eventually cascading into cognitive deficits, we performed a study on the mechanics of rat brain under blast conditions. To this end, experiments were carried out to analyse and correlate post-injury oxidative stress distribution with cognitive deficits on a live rat exposed to blast. A computational model of the rat head was developed from imaging data and validated against in vivo brain displacement measurements. The blast event was reconstructed in silico to provide mechanistic thresholds that best correlate with cognitive damage at the regional neuronal tissue level, irrespectively of the shape or size of the brain tissue types. This approach was leveraged on a human head model where the prediction of cognitive deficits was shown to correlate with literature findings. The mechanistic insights from this work were finally used to propose a novel protective device design roadmap and potential avenues for therapeutic innovations against blast traumatic brain injury.	[Garcia-Gonzalez, Daniel; Jerusalem, Antoine] Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England; [Race, Nicholas S.; Cruz-Haces, Marcela; Tang, Jonathan; Shi, Riyi] Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA; [Race, Nicholas S.] Indiana Univ Sch Med, Med Scientist Training Program, Indianapolis, IN 46202 USA; [Voets, Natalie L.] Univ Oxford, John Radcliffe Hosp, Oxford Ctr Funct MRI Brain, Nuffield Dept Clin Neurosci, Oxford OX3 9DU, England; [Jenkins, Damian R.] St Hughs Coll, Neurol, St Margarets Rd, Oxford OX2 6LE, England; [Jenkins, Damian R.] St Hughs Coll, Med & Physiol, St Margarets Rd, Oxford OX2 6LE, England; [Sotiropoulos, Stamatios N.] Univ Oxford, Ctr Funct MRI Brain, Oxford, England; [Sotiropoulos, Stamatios N.] Univ Nottingham, Sir Peter Mansfield Imaging Ctr, Sch Med, Queens Med Ctr, Nottingham, England; [Sotiropoulos, Stamatios N.] Univ Nottingham, NIHR Nottingham, Biomed Res Ctr, Queens Med Ctr, Nottingham, England; [Acosta, Glen; Shi, Riyi] Purdue Univ, Coll Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA; [Shi, Riyi] Purdue Univ, PULSe Interdisciplinary Life Sci Program, W Lafayette, IN 47907 USA; [Shi, Riyi] Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA		Jerusalem, A (corresponding author), Univ Oxford, Dept Engn Sci, Parks Rd, Oxford OX1 3PJ, England.; Shi, RY (corresponding author), Purdue Univ, Weldon Sch Biomed Engn, W Lafayette, IN 47907 USA.; Shi, RY (corresponding author), Purdue Univ, Coll Vet Med, Dept Basic Med Sci, W Lafayette, IN 47907 USA.; Shi, RY (corresponding author), Purdue Univ, PULSe Interdisciplinary Life Sci Program, W Lafayette, IN 47907 USA.; Shi, RY (corresponding author), Purdue Univ, Purdue Inst Integrat Neurosci, W Lafayette, IN 47907 USA.	riyi@purdue.edu; antoine.jerusalem@eng.ox.ac.uk	Garcia-Gonzalez, Daniel/K-7349-2017; Sotiropoulos, Stamatios/I-1163-2019	Garcia-Gonzalez, Daniel/0000-0003-4692-3508; Sotiropoulos, Stamatios/0000-0003-4735-5776; Race, Nicholas/0000-0002-2683-1692; Jerusalem, Antoine/0000-0001-5026-8038; Jenkins, Damian/0000-0003-4154-7881	European Union ERCEuropean Research Council (ERC)European Commission [306587]; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS090244-01]; McDonnell Center for Systems Neuroscience at Washington University; EPSRC GrantUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/M02833X/1]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [U54MH091657] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS090244] Funding Source: NIH RePORTER; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N020987/1, EP/L023067/1] Funding Source: UKRI	D.G.-G. and A.J. acknowledge funding from the European Union's Seventh Framework Programme (FP7 2007-2013) ERC Grant Agreement No. 306587. R.S. acknowledges the funding support from National Institute of Health (NS090244-01). Human MRI data were provided by the Human Connectome Project, WU-Minn Consortium (Principal Investigators: David Van Essen and Kamil Ugurbil; 1U54MH091657) funded by the 16 NIH Institutes and Centers that support the NIH Blueprint for Neuroscience Research; and by the McDonnell Center for Systems Neuroscience at Washington University. Finally, we would like to thank Dr. S Barhli and Prof. J Marrow for valuable assistance with the X-ray tomography; the machine used was bought from EPSRC Grant EP/M02833X/1 "University of Oxford: experimental equipment upgrade".	Abdallah CG, 2017, TRANSL PSYCHIAT, V7, DOI 10.1038/tp.2017.12; Alley MD, 2011, NEUROIMAGE, V54, pS45, DOI 10.1016/j.neuroimage.2010.05.030; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Barnham KJ, 2004, NAT REV DRUG DISCOV, V3, P205, DOI 10.1038/nrd1330; Bartlett E.L., 2017, J NEUROPHYSIOL, P9; Cebak JE, 2017, J NEUROTRAUM, V34, P1302, DOI 10.1089/neu.2016.4624; Centers for Disease Control and Prevention, 2013, BLAST INJ FACT SHEET; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Chatelin Simon, 2013, Journal of Biorheology, V27, P26, DOI 10.1007/s12573-012-0055-6; Chen Z, 2016, J NEUROCHEM, V138, P328, DOI 10.1111/jnc.13639; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Clark RSB, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0180280; Corrigan F, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0738-9; Dassault Systemes Abaqus v6.14 Documentation, 2014, DASS SYST AB V6 14 D; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; DeFelipe J, 2002, J NEUROCYTOL, V31, P299, DOI 10.1023/A:1024130211265; DePalma RG, 2005, NEW ENGL J MED, V352, P1335, DOI 10.1056/NEJMra042083; Dixit P, 2017, ARCH COMPUT METHOD E, V24, P979, DOI 10.1007/s11831-016-9196-x; Due MR, 2014, J NEUROCHEM, V128, P776, DOI 10.1111/jnc.12500; Elliott MB, 2012, HEADACHE, V52, P966, DOI 10.1111/j.1526-4610.2012.02160.x; Fu SH, 2014, N-S ARCH PHARMACOL, V387, P87, DOI 10.1007/s00210-013-0922-8; Fukuda AM, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-279; Galarneau MR, 2008, J NEUROSURG, V108, P950, DOI 10.3171/JNS/2008/108/5/0950; Garcia-Gonzalez D, 2018, J MECH PHYS SOLIDS, V112, P209, DOI 10.1016/j.jmps.2017.12.001; Garcia-Gonzalez D, 2017, J MECH BEHAV BIOMED, V69, P342, DOI 10.1016/j.jmbbm.2017.01.012; Ghajari M, 2017, BRAIN, V140, P333, DOI 10.1093/brain/aww317; Giordano C, 2017, BIOMECH MODEL MECHAN, V16, P1269, DOI 10.1007/s10237-017-0887-5; Glasser MF, 2013, NEUROIMAGE, V80, P105, DOI 10.1016/j.neuroimage.2013.04.127; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gordon EM, 2018, J NEUROTRAUM, V35, P767, DOI 10.1089/neu.2017.5428; Grossman EJ, 2016, J NEUROTRAUM, V33, P163, DOI 10.1089/neu.2015.3965; Gruss E, 2006, J TRAUMA, V60, P1284, DOI 10.1097/01.ta.0000220015.21948.ec; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Jerusalem A, 2014, BIOMECH MODEL MECHAN, V13, P883, DOI 10.1007/s10237-013-0543-7; Jerusalem A, 2012, ACTA BIOMATER, V8, P3360, DOI 10.1016/j.actbio.2012.04.039; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jorge RE, 2016, JAMA PSYCHIAT, V73, P1041, DOI 10.1001/jamapsychiatry.2016.2189; Karr JE, 2014, NEUROPSYCHOL REV, V24, P428, DOI 10.1007/s11065-014-9271-8; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kiseleva I, 2008, MECHANOSENSITIVITY N, V2; Lee Bruce, 2005, NeuroRx, V2, P372; Leung G, 2011, NEUROSCIENCE, V173, P150, DOI 10.1016/j.neuroscience.2010.11.018; Lin WM, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/340936; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; McAllister TW, 2016, NEUROPSYCHOPHARMACOL, V41, P1191, DOI 10.1038/npp.2015.282; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Milchenko M, 2013, NEUROINFORMATICS, V11, P65, DOI 10.1007/s12021-012-9160-3; Miller DR, 2017, BRAIN IMAGING BEHAV, V11, P1129, DOI 10.1007/s11682-016-9593-7; Moore DF, 2009, NEUROIMAGE, V47, pT10, DOI 10.1016/j.neuroimage.2009.02.019; Panzer MB, 2012, ANN BIOMED ENG, V40, P1530, DOI 10.1007/s10439-012-0519-2; Park E, 2013, NEUROBIOL DIS, V52, P150, DOI 10.1016/j.nbd.2012.12.002; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Race N.S, PSYCHOSOCIAL DYSFUNC; Rahimzadeh T, 2015, J MECH PHYS SOLIDS, V85, P98, DOI 10.1016/j.jmps.2015.09.009; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Rodriguez-Millan M, 2017, MATER DESIGN, V117, P58, DOI 10.1016/j.matdes.2016.12.081; Rodriguez-Rodriguez A, 2017, CLIN CHEM LAB MED; Scott G, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0445-y; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shi R, J NEUROCHEMISTRY; Shi R, 2006, J NEUROPHYSIOL, V95, P3384, DOI 10.1152/jn.00350.2005; Shohami E, 1997, J CEREBR BLOOD F MET, V17, P1007, DOI 10.1097/00004647-199710000-00002; Shridharani Jay K, 2012, Front Neurol, V3, P70, DOI 10.3389/fneur.2012.00070; Smith S, 2005, P 11 ANN M ORG HUM B; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Song H, 2016, BEHAV BRAIN RES; Song S, 2015, SCI REP-UK, V5, DOI 10.1038/srep16959; Spitz G, 2017, J NEUROTRAUM, V34, P807, DOI 10.1089/neu.2016.4527; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Stoodley CJ, 2010, CORTEX, V46, P831, DOI 10.1016/j.cortex.2009.11.008; Stover JF, 2014, J NEUROTRAUM, V31, P1599, DOI 10.1089/neu.2014.3344; Strange BA, 2014, NAT REV NEUROSCI, V15, P655, DOI 10.1038/nrn3785; Tagge C.A, BRAIN, P1; Taylor PA, 2014, BRAIN INJURY, V28, P879, DOI 10.3109/02699052.2014.888478; Taylor PA, 2009, J BIOMECH ENG-T ASME, V131, DOI 10.1115/1.3118765; Tse KM, 2015, ACCIDENT ANAL PREV, V79, P13, DOI 10.1016/j.aap.2015.03.012; Van Essen DC, 2013, NEUROIMAGE, V80, P62, DOI 10.1016/j.neuroimage.2013.05.041; Walls MK, 2016, J NEUROSURG, V124, P675, DOI 10.3171/2015.1.JNS141571; Wang C. C, 2013, THESIS; Wang XK, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00012; Watson C, 1998, RAT BRAIN STEREOTAXI, V3; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wood PL, 2006, BRAIN RES, V1122, P184, DOI 10.1016/j.brainres.2006.09.003; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Zhang LL, 2017, SCI REP-UK, V7, DOI 10.1038/s41598-017-06827-3	88	15	15	0	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 6	2018	8								10273	10.1038/s41598-018-28271-7			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	GL9RD	WOS:000437673200047	29980750	gold, Green Published			2022-02-06	
J	Gorse, KM; Lantzy, MK; Lee, ED; Lafrenaye, AD				Gorse, Karen M.; Lantzy, Mary Kate; Lee, Eun D.; Lafrenaye, Audrey D.			Transient Receptor Potential Melastatin 4 Induces Astrocyte Swelling But Not Death after Diffuse Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						astrocyte; cell death; diffuse pathology; traumatic brain injury; Trpm4	CATION CHANNEL TRPM4; CEREBRAL EDEMA; INTRACRANIAL-PRESSURE; NERVOUS-SYSTEM; AXONAL INJURY; HEMORRHAGE; EXPRESSION; PATHOBIOLOGY; HIPPOCAMPUS; MECHANISMS	Traumatic brain injury (TBI) is a prevalent disease with significant costs. Although progress has been made in understanding the complex pathobiology of focal lesions associated with TBI, questions remain regarding the diffuse responses to injury. Expression of the transient receptor potential melastatin 4 (Trpm4) channel is linked to cytotoxic edema during hemorrhagic contusion expansion. However, little is known about Trpm4 following diffuse TBI. To explore Trpm4 expression in diffuse TBI, rats were subjected to a diffuse central fluid percussion injury (CFPI) and survived for 1.5h to 8 weeks. The total number of Trpm4+ cells, as well as individual cellular intensity/expression of Trpm4, were assessed. Hemotoxylin and eosin (H&E) labeling was performed to evaluate cell damage/death potentially associated with Trpm4 expression following diffuse TBI. Finally, ultrastructural assessments were performed to evaluate the integrity of Trpm4+ cells and the potential for swelling associated with Trpm4 expression. Trpm4 was primarily restricted to astrocytes within the hippocampus and peaked at 6h post-injury. While the number of Trpm4+ astrocytes returned to sham levels by 8 weeks post-CFPI, cellular intensity occurred in region-specific waves following injury. Correlative H&E assessments demonstrated little evidence of hippocampal damage, suggesting that Trpm4 expression by astrocytes does not precipitate cell death following diffuse TBI. Additionally, ultrastructural assessments showed Trpm4+ astrocytes exhibited twice the soma size compared with Trpm4- astrocytes, indicating that astrocyte swelling is associated with Trpm4 expression. This study provides a foundation for future investigations into the role of Trpm4 in astrocyte swelling and edema following diffuse TBI.	[Gorse, Karen M.; Lafrenaye, Audrey D.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Lee, Eun D.] Virginia Commonwealth Univ, Dept Obstet & Gynecol, Richmond, VA 23298 USA; [Lantzy, Mary Kate] Glen Allen High Sch, Glen Allen, VA USA		Lafrenaye, AD (corresponding author), Virginia Commonwealth Univ, Med Ctr, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	audrey.lafrenaye@vcuhealth.org			National Institute of Neurological Disorders and Stroke (NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R01NS096143]; Commonwealth fund; NIH-NINDS Center core grant [5P30NS047463]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS096143] Funding Source: NIH RePORTER	The authors would like to thank Dr. Mark Simard, Dr. Nikki Miller Ferguson, and Dr. John Povlishock for stimulating scientific discussion, and Dr. Mark Simard for the kind gift of the rabbit anti-Sur1 antibody. We would also like to thank Sue Walker, Judy Williamson, and Lynn Davis for instrumental technical and regulatory assistance. This work was supported in part by National Institute of Neurological Disorders and Stroke (NINDS) grants 1R01NS096143 and the Commonwealth fund. Microscopy was performed at the Virginia Commonwealth University Department of Anatomy and Neurobiology Microscopy Facility, supported in part by funding from NIH-NINDS Center core grant 5P30NS047463.	Andriezen W L, 1893, Br Med J, V2, P227; [Anonymous], 2012, SCIENCETECHBLOG; Boggs DH, 2014, EXPERT REV NEUROTHER, V14, P379, DOI 10.1586/14737175.2014.890891; Cernak I, 2004, NEUROBIOL DIS, V17, P29, DOI 10.1016/j.nbd.2004.05.011; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; ERB DE, 1991, EXP BRAIN RES, V83, P253; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Fenn AM, 2015, J NEUROTRAUM, V32, P127, DOI 10.1089/neu.2014.3514; Gerzanich V, 2009, NAT MED, V15, P185, DOI 10.1038/nm.1899; Guinamard R, 2010, PHYSIOLOGY, V25, P155, DOI 10.1152/physiol.00004.2010; Hayman EG, 2017, NEUROCRIT CARE, V26, P301, DOI 10.1007/s12028-016-0354-7; Jha RM, 2017, NEUROCRIT CARE, V26, P213, DOI 10.1007/s12028-016-0309-z; Jiang B, 2017, TRANSL STROKE RES, V8, P183, DOI 10.1007/s12975-016-0506-2; Kasahara M, 2010, NEUROLOGY, V75, P168, DOI 10.1212/WNL.0b013e3181e7ca58; Kurland DB, 2013, PHARMACEUTICALS, V6, P1287, DOI 10.3390/ph6101287; Lafrenaye AD, 2014, J CEREBR BLOOD F MET, V34, P1628, DOI 10.1038/jcbfm.2014.122; Lafrenaye AD, 2012, J CEREBR BLOOD F MET, V32, P1919, DOI 10.1038/jcbfm.2012.95; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Launay P, 2002, CELL, V109, P397, DOI 10.1016/S0092-8674(02)00719-5; Martinez-Valverde T, 2015, J NEUROTRAUM, V32, P1478, DOI 10.1089/neu.2014.3706; Matthias K, 2003, J NEUROSCI, V23, P1750; Mehta RI, 2015, J NEUROPATH EXP NEUR, V74, P835, DOI 10.1097/NEN.0000000000000223; Nilius B, 2005, J BIOL CHEM, V280, P6423, DOI 10.1074/jbc.M411089200; Nilius B, 2004, PFLUG ARCH EUR J PHY, V448, P70, DOI 10.1007/s00424-003-1221-x; Oberheim NA, 2012, METHODS MOL BIOL, V814, P23, DOI 10.1007/978-1-61779-452-0_3; Papadopoulos MC, 2013, NAT REV NEUROSCI, V14, P265, DOI 10.1038/nrn3468; Popovich PG, 2012, EXP NEUROL, V233, P615, DOI 10.1016/j.expneurol.2010.11.016; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Ramsey IS, 2006, ANNU REV PHYSIOL, V68, P619, DOI 10.1146/annurev.physiol.68.040204.100431; Sala-Rabanal M, 2012, J BIOL CHEM, V287, P8746, DOI 10.1074/jbc.M111.336131; Simard JM, 2007, J CLIN INVEST, V117, P2105, DOI 10.1172/JCI32041; Simard JM, 2012, PFLUG ARCH EUR J PHY, V464, P573, DOI 10.1007/s00424-012-1166-z; Simard JM, 2012, J CEREBR BLOOD F MET, V32, P1699, DOI 10.1038/jcbfm.2012.91; Simard JM, 2012, EXP NEUROL, V233, P566, DOI 10.1016/j.expneurol.2011.11.044; Simard JM, 2010, J NEUROSURG, V113, P622, DOI 10.3171/2009.11.JNS081052; Simard JM, 2006, NAT MED, V12, P433, DOI 10.1038/nm1390; Somjen GG, 2002, NEUROSCIENTIST, V8, P254, DOI 10.1177/1073858402008003011; Stokum JA, 2018, GLIA, V66, P108, DOI 10.1002/glia.23231; Stokum JA, 2015, NEUROCHEM RES, V40, P317, DOI 10.1007/s11064-014-1374-3; Wallraff A, 2004, GLIA, V48, P36, DOI 10.1002/glia.20040; Woo SK, 2013, J BIOL CHEM, V288, P3655, DOI 10.1074/jbc.M112.428219; Zhang Y, 2010, CURR OPIN NEUROBIOL, V20, P588, DOI 10.1016/j.conb.2010.06.005	43	15	15	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUL	2018	35	14					1694	1704		10.1089/neu.2017.5275			11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	GK9FP	WOS:000436548100014	29390943	Green Published			2022-02-06	
J	Lang, M; Skrifvars, MB; Siironen, J; Tanskanen, P; Ala-Peijari, M; Koivisto, T; Djafarzadeh, S; Bendel, S				Lang, M.; Skrifvars, M. B.; Siironen, J.; Tanskanen, P.; Ala-Peijari, M.; Koivisto, T.; Djafarzadeh, S.; Bendel, S.			A pilot study of hyperoxemia on neurological injury, inflammation and oxidative stress	ACTA ANAESTHESIOLOGICA SCANDINAVICA			English	Article							TRAUMATIC BRAIN-INJURY; ACUTE LUNG INJURY; NORMOBARIC HYPEROXIA; CRITICAL ILLNESS; OXYGEN-THERAPY; IMPACT; ASSOCIATION; METABOLISM; INCREASE; SYSTEM	BackgroundNormobaric hyperoxia is used to alleviate secondary brain ischaemia in patients with traumatic brain injury (TBI), but clinical evidence is limited and hyperoxia may cause adverse events. MethodsAn open label, randomised controlled pilot study comparing blood concentrations of reactive oxygen species (ROS), interleukin 6 (IL-6) and neuron-specific enolase (NSE) between two different fractions of inspired oxygen in severe TBI patients on mechanical ventilation. ResultsWe enrolled 27 patients in the Fi O-2 0.40 group and 38 in the Fi O-2 0.70 group; 19 and 23 patients, respectively, completed biochemical analyses. In baseline, there were no differences between Fi O-2 0.40 and Fi O-2 0.70 groups, respectively, in ROS (64.8 nM [22.6-102.1] vs. 64.9 nM [26.8-96.3], P = 0.80), IL-6 (group 92.4 pg/ml [52.9-171.6] vs. 94.3 pg/ml [54.8-133.1], P = 0.52) or NSE (21.04 ug/l [14.0-30.7] vs. 17.8 ug/l [14.1-23.9], P = 0.35). ROS levels did not differ at Day 1 (24.2 nM [20.6-33.5] vs. 29.2 nM [22.7-69.2], P = 0.10) or at Day 2 (25.4 nM [21.7-37.4] vs. 47.3 nM [34.4-126.1], P = 0.95). IL-6 concentrations did not differ at Day 1 (112.7 pg/ml [65.9-168.9) vs. 83.9 pg/ml [51.8-144.3], P = 0.41) or at Day 3 (55.0 pg/ml [34.2-115.6] vs. 49.3 pg/ml [34.4-126.1], P = 0.95). NSE levels did not differ at Day 1 (15.9 ug/l [9.0-24.3] vs. 15.3 ug/l [12.2-26.3], P = 0.62). There were no differences between groups in the incidence of pulmonary complications. ConclusionHigher fraction of inspired oxygen did not increase blood concentrations of markers of oxidative stress, inflammation or neurological injury or the incidence of pulmonary complications in severe TBI patients on mechanical ventilation.	[Lang, M.; Bendel, S.] Kuopio Univ Hosp, Dept Intens Care Med, POB 100, Kys 70029, Finland; [Skrifvars, M. B.; Tanskanen, P.] Univ Helsinki, Dept Anaesthesiol Intens Care & Pain Med, Helsinki, Finland; [Lang, M.; Siironen, J.; Tanskanen, P.] Helsinki Univ Hosp, Helsinki, Finland; [Siironen, J.] Univ Helsinki, Dept Neurosurg, Helsinki, Finland; [Ala-Peijari, M.] Tampere Univ Hosp, Dept Intens Care Med, Tampere, Finland; [Koivisto, T.] Kuopio Univ Hosp, Dept Neurosurg, Kys, Finland; [Djafarzadeh, S.] Bern Univ Hosp, Inselspital, Dept Intens Care Med, Bern, Switzerland		Lang, M (corresponding author), Kuopio Univ Hosp, Dept Intens Care Med, POB 100, Kys 70029, Finland.	Maarit.lang@kuh.fi					Ahn ES, 2008, J NEUROSURG, V108, P124, DOI 10.3171/JNS/2008/108/01/0124; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Bulte DP, 2007, J CEREBR BLOOD F MET, V27, P69, DOI 10.1038/sj.jcbfm.9600319; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Damiani E, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0711-x; de Jonge E, 2008, CRIT CARE, V12, DOI 10.1186/cc7150; Deepika A, 2015, ACTA NEUROCHIR, V157, P2033, DOI 10.1007/s00701-015-2575-5; Dong TT, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0663-y; Doppenberg EMR, 1998, J NEUROTRAUM, V15, P337, DOI 10.1089/neu.1998.15.337; Fernandez-Perez ER, 2009, THORAX, V64, P121, DOI 10.1136/thx.2008.102228; Fujita M, 2017, J NEUROTRAUMA; Hafner S, 2015, ANN INTENSIVE CARE, V5, DOI 10.1186/s13613-015-0084-6; Hazelton JL, 2010, J NEUROTRAUM, V27, P753, DOI 10.1089/neu.2009.1186; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Huang D, 2016, EUR REV MED PHARMACO, V20, P1399; Kallet RH, 2013, RESP CARE, V58, P123, DOI 10.4187/respcare.01963; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Martin DS, 2013, CRIT CARE MED, V41, P423, DOI 10.1097/CCM.0b013e31826a44f6; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Nortje J, 2008, CRIT CARE MED, V36, P273, DOI 10.1097/01.CCM.0000292014.60835.15; Puccio AM, 2009, J NEUROTRAUM, V26, P1241, DOI [10.1089/neu.2008.0624, 10.1089/neu.2008-0624]; Quintard H, 2015, NEUROCRIT CARE, V22, P243, DOI 10.1007/s12028-014-0062-0; Raheja A, 2016, J NEUROSURG, V125, P631, DOI 10.3171/2015.6.JNS15674; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Six S, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1368-4; Stover JF, 2008, CRIT CARE MED, V36, P1697, DOI 10.1097/CCM.0b013e31817104ac; Suzuki S, 2015, J CRIT CARE, V30, P1232, DOI 10.1016/j.jcrc.2015.07.033; Taher A, 2016, TRAUMA MON, V21, DOI 10.5812/traumamon.26772; Tieves Kelly S, 2005, WMJ, V104, P22; Tisdall MM, 2008, J NEUROSURG, V109, P424, DOI 10.3171/JNS/2008/109/9/0424; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Vincent JL, 1996, INTENS CARE MED, V22, P707, DOI 10.1007/BF01709751; Weaver J, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0032-4; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	37	15	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-5172	1399-6576		ACTA ANAESTH SCAND	Acta Anaesthesiol. Scand.	JUL	2018	62	6					801	810		10.1111/aas.13093			10	Anesthesiology	Science Citation Index Expanded (SCI-EXPANDED)	Anesthesiology	GI2MP	WOS:000434205100010	29464691	Green Published			2022-02-06	
J	Yang, YJ; Chien, WC; Chung, CH; Hong, KT; Yu, YL; Hueng, DY; Chen, YH; Ma, HI; Chang, HA; Kao, YC; Yeh, HW; Tzeng, NS				Yang, Yun-Ju; Chien, Wu-Chien; Chung, Chi-Hsiang; Hong, Kun-Ting; Yu, Yi-Lin; Hueng, Dueng-Yuan; Chen, Yuan-Hao; Ma, Hsin-I; Chang, Hsin-An; Kao, Yu-Chen; Yeh, Hui-Wen; Tzeng, Nian-Sheng			Risk of Erectile Dysfunction After Traumatic Brain Injury: A Nationwide Population-Based Cohort study in Taiwan	AMERICAN JOURNAL OF MENS HEALTH			English	Article						traumatic brain injury; erectile dysfunction; sexuality; epidemiology of men's health; general health and wellness; sexual dysfunction; sexual disorders	INTERNATIONAL INDEX; SEXUAL DYSFUNCTION; ADULTS; HYPOPITUITARISM; INDIVIDUALS; PATTERNS; BEHAVIOR; PREDICTORS; DEPRESSION; SEVERITY	Introduction: In our study, we aimed to investigate the association between a traumatic brain injury (TBI) and subsequent erectile dysfunction (ED). This is a population-based study using the claims dataset from The National Health Insurance Research Database. Methods: We included 72,642 patients with TBI aged over 20 years, retrospectively, selected from the longitudinal health insurance database during 2000-2010, according to the ICD-9-CM. The control group consisted of 217,872 patients without TBI that were randomly chosen from the database at a ratio of 1:3, with age- and index year matched. Cox proportional hazards analysis was used to estimate the association between the TBI and subsequent ED. Results: After a 10-year follow-up, the incidence rate of ED was higher in the TBI patients when compared with the non-TBI control group (24.66 and 19.07 per 100,000, respectively). Patients with TBI had a higher risk of developing ED than the non-TBI cohort after the adjustment of the confounding factors, such as age, comorbidity, residence of urbanization and locations, seasons, level of care, and insured premiums (adjusted hazard ratio (HR) = 2.569, 95% CI [1.890, 3.492], p < .001). Conclusion: This is the first study using a comprehensive nationwide database to analyze the association of ED and TBI in the Asian population. After adjusted the confounding factors, patients with TBI have a significantly higher risk of developing ED, especially organic ED, than the general population. This finding might remind clinicians that it's crucial in early identification and treatment of ED in post-TBI patients.	[Yang, Yun-Ju; Hong, Kun-Ting; Yu, Yi-Lin; Hueng, Dueng-Yuan; Chen, Yuan-Hao; Ma, Hsin-I] Tri Serv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Neurol Surg, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Tri Serv Gen Hosp, Natl Def Med Ctr, Dept Med Res, Taipei, Taiwan; [Chien, Wu-Chien; Chung, Chi-Hsiang] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Chung, Chi-Hsiang] Taiwanese Injury Prevent & Safety Promot Assoc, Taipei, Taiwan; [Chang, Hsin-An; Kao, Yu-Chen; Yeh, Hui-Wen; Tzeng, Nian-Sheng] Tri Serv Gen Hosp, Natl Def Med Ctr, Sch Med, Dept Psychiat, Taipei, Taiwan; [Chang, Hsin-An; Tzeng, Nian-Sheng] Natl Def Med Ctr, Student Counseling Ctr, Taipei, Taiwan; [Kao, Yu-Chen] Tri Serv Gen Hosp, Natl Def Med Ctr, Song Shan Branch, Dept Psychiat, Taipei, Taiwan; [Yeh, Hui-Wen] Natl Chiao Tung Univ, Inst Bioinformat & Syst Biol, Hsinchu, Taiwan; [Yeh, Hui-Wen] Tri Serv Gen Hosp, Dept Nursing, Taipei, Taiwan; [Yeh, Hui-Wen] Natl Def Med Ctr, Sch Nursing, Taipei, Taiwan; [Yeh, Hui-Wen] Kang Ning Univ, Dept Nursing, Taipei Campus, Taipei, Taiwan		Tzeng, NS (corresponding author), Tri Serv Gen Hosp, Natl Def Med Ctr,Community Psychiat, Dept Psychiat,Joint Program Geriatr Psychiat & Ps, Student Counseling Ctr,Traing Program Forens Psyc, 325 Chung Gung Rd,Sec 2, Taipei, Taiwan.	pierrens@mail.ndmctsgh.edu.tw	Tzeng, Nian-Sheng/AAU-4945-2021; Hueng, Dueng-Yuan/AAM-7807-2021; Chung, Chi-Hsiang/AAY-3386-2021	Hong, Kun-Ting/0000-0002-6918-7550; Chang, Hsin-An/0000-0001-5572-7109; Hueng, Dueng-Yuan/0000-0001-7868-3161	Tri-Service General Hospital Research Foundation [TSGH-C105-130, TSGH-C106-002]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was funded by Tri-Service General Hospital Research Foundation (TSGH-C105-130, TSGH-C105-130, and TSGH-C106-002).	Alavi SA, 2016, BRIT J NEUROSURG, V30, P302, DOI 10.3109/02688697.2015.1109060; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bivona U, 2016, BRAIN INJURY, V30, P1082, DOI 10.3109/02699052.2016.1165867; Chan WSH, 2010, EPMA J, V1, P563, DOI 10.1007/s13167-010-0056-8; Chao CH, 2015, ANDROLOGY-US, V3, P666, DOI 10.1111/andr.12052; Chaudhary RK, 2016, J INT MED RES, V44, P718, DOI 10.1177/0300060515621637; Chen KF, 2016, SLEEP MED, V17, P64, DOI 10.1016/j.sleep.2015.05.018; Cheng CL, 2011, PHARMACOEPIDEM DR S, V20, P236, DOI 10.1002/pds.2087; Chi YC, 2016, J AFFECT DISORDERS, V191, P56, DOI 10.1016/j.jad.2015.11.035; Chien WC, 2017, RES DEV DISABIL, V65, P57, DOI 10.1016/j.ridd.2017.04.011; Chien WC, 2014, INT J INJ CONTROL SA, V21, P3, DOI 10.1080/17457300.2012.717084; Chinese Hospital Association, 2000, ICD9CM CHIN HOSP ASS; Chinese Hospital Association, 2000, ICD9CM CHIN HIST ASS; Chou IC, 2013, J DEV BEHAV PEDIATR, V34, P181, DOI 10.1097/DBP.0b013e3182829f2b; Clavijo Raul I, 2014, Rev Urol, V16, P167; Cuesta M, 2016, CLIN ENDOCRINOL, V84, P92, DOI 10.1111/cen.12874; Downing MG, 2013, J HEAD TRAUMA REHAB, V28, P171, DOI 10.1097/HTR.0b013e31828b4f63; Farre JM, 2004, INT J IMPOT RES, V16, pS46, DOI 10.1038/sj.ijir.3901243; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Hanks RA, 2013, J HEAD TRAUMA REHAB, V28, P179, DOI 10.1097/HTR.0b013e31828b4fae; Hibbard MR, 1998, J HEAD TRAUMA REHAB, V13, P24, DOI 10.1097/00001199-199808000-00003; Hwang TIS, 2010, J SEX MED, V7, P2817, DOI 10.1111/j.1743-6109.2010.01837.x; Johannes CB, 2000, J UROLOGY, V163, P460, DOI 10.1016/S0022-5347(05)67900-1; Kao CC, 2016, INFLAMM BOWEL DIS, V22, P1065, DOI 10.1097/MIB.0000000000000695; Kaya E, 2015, J SEX MED, V12, P856, DOI 10.1111/jsm.12828; Lane J, 2010, BRIT J NEUROSURG, V24, P8, DOI 10.3109/02688690903550240; Laumann EO, 2009, INT J IMPOT RES, V21, P171, DOI 10.1038/ijir.2009.7; Leoni LAB, 2014, AGING MALE, V17, P125, DOI 10.3109/13685538.2014.923836; Liang JA, 2011, CANCER EPIDEM BIOMAR, V20, P473, DOI 10.1158/1055-9965.EPI-10-1280; Lizza EF, 1999, INT J IMPOT RES, V11, P141, DOI 10.1038/sj.ijir.3900396; Maiorino MI, 2015, ASIAN J ANDROL, V17, P5, DOI 10.4103/1008-682X.137687; Michalowsky B, 2016, INT PSYCHOGERIATR, V28, P359, DOI 10.1017/S1041610215001453; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; National Health Insurance Administration, 2016, NAT HLTH INS REG; Nicolosi A, 2005, BJU INT, V95, P609, DOI 10.1111/j.1464-410X.2005.05348.x; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; Pastuszak Alexander W, 2014, Curr Sex Health Rep, V6, P164; Phe V, 2012, DIABETES METAB, V38, P1, DOI 10.1016/j.diabet.2011.09.003; Ponsford J, 2003, NEUROPSYCHOL REHABIL, V13, P275, DOI 10.1080/09602010244000363; Ponsford JL, 2013, J HEAD TRAUMA REHAB, V28, P195, DOI 10.1097/HTR.0b013e31828b4f7b; Rhoden EL, 2002, INT J IMPOT RES, V14, P245, DOI 10.1038/sj.ijir.3900859; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosen RC, 2002, INT J IMPOT RES, V14, P226, DOI 10.1038/sj.ijir.3900857; Sander AM, 2016, ARCH PHYS MED REHAB, V97, P753, DOI 10.1016/j.apmr.2016.01.009; Sander AM, 2013, J HEAD TRAUMA REHAB, V28, P186, DOI 10.1097/HTR.0b013e31828b4f91; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Shamloul R, 2013, LANCET, V381, P153, DOI 10.1016/S0140-6736(12)60520-0; Shen YC, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0102055; Sherer M, 2014, ARCH PHYS MED REHAB, V95, P1162, DOI [10.1016/j.apmr.2013.06.004, 10.1016/j.apmr.2014.02.006]; Siddiqui MA, 2012, SPINE, V37, P797, DOI 10.1097/BRS.0b013e318232601c; Silva PPB, 2015, J NEUROTRAUM, V32, P1789, DOI 10.1089/neu.2015.3998; Simpson GK, 2016, NEUROREHABILITATION, V38, P281, DOI 10.3233/NRE-161319; Stocchetti N, 2014, LANCET NEUROL, V13, P14, DOI 10.1016/S1474-4422(13)70280-1; STONER HB, 1980, J ROY SOC MED, V73, P19, DOI 10.1177/014107688007300105; Turner D, 2015, CURR OPIN PSYCHIATR, V28, P180, DOI 10.1097/YCO.0000000000000144; Wang HY, 2016, INT J IMPOT RES, V28, P143, DOI 10.1038/ijir.2016.17; War F. A., 2014, J NEUROSURG, V9, P29, DOI [10.4103/1793-5482.131061, DOI 10.4103/1793-5482.131061]; Wimo A, 2017, ALZHEIMERS DEMENT, V13, P1, DOI 10.1016/j.jalz.2016.07.150; Wu CL, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0171999; Wu SH, 2016, MEDICINE, V95, DOI 10.1097/MD.0000000000003065; Wyllie Michael G, 2005, Clin Cornerstone, V7, P19, DOI 10.1016/S1098-3597(05)80045-6; Yafi FA, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.3; Yang WH, 2016, SCI REP-UK, V6, DOI 10.1038/srep32987; Yang Y, 2016, EXPERT OPIN DRUG SAF, V15, P31, DOI 10.1517/14740338.2016.1112376; Zaninotto AL, 2016, FRONT PSYCHIATRY, V7, DOI 10.3389/fpsyt.2016.00095	65	15	17	1	3	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1557-9883	1557-9891		AM J MENS HEALTH	Am. J. Mens Health	JUL	2018	12	4					913	925		10.1177/1557988317750970			13	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	GK3DB	WOS:000436019700028	29325484	Green Published, gold			2022-02-06	
J	Robinson, S; Winer, JL; Chan, LAS; Oppong, AY; Yellowhair, TR; Maxwell, JR; Andrews, N; Yang, YR; Sillerud, LO; Meehan, WP; Mannix, R; Brigman, JL; Jantzie, LL				Robinson, Shenandoah; Winer, Jesse L.; Chan, Lindsay A. S.; Oppong, Akosua Y.; Yellowhair, Tracylyn R.; Maxwell, Jessie R.; Andrews, Nicholas; Yang, Yirong; Sillerud, Laurel O.; Meehan, William P., III; Mannix, Rebekah; Brigman, Jonathan L.; Jantzie, Lauren L.			Extended Erythropoietin Treatment Prevents Chronic Executive Functional and Microstructural Deficits Following Early Severe Traumatic Brain Injury in Rats	FRONTIERS IN NEUROLOGY			English	Article						controlled cortical impact; diffusion tensor imaging; diffusivity; infant; touchscreen; cognition; cognitive flexibility	ABUSIVE HEAD TRAUMA; EXPRESSION PATTERNS; VENTRAL STRIATUM; TESTING METHOD; RECEPTOR; MICE; NEUROPROTECTION; PROGESTERONE; NEUROGENESIS; CHILDREN	Survivors of infant traumatic brain injury (TBI) are prone to chronic neurological deficits that impose lifelong individual and societal burdens. Translation of novel interventions to clinical trials is hampered in part by the lack of truly representative preclinical tests of cognition and corresponding biomarkers of functional outcomes. To address this gap, the ability of a high-dose, extended, post-injury regimen of erythropoietin (EPO, 3000U/kg/dose x 6d) to prevent chronic cognitive and imaging deficits was tested in a postnatal day 12 (P12) controlled-cortical impact (CCI) model in rats, using touch-screen operant chambers and regional analysis of diffusion tensor imaging (DTI). Results indicate that EPO prevents functional injury and MRI injury after infant TBI. Specifically, subacute DTI at P30 revealed widespread microstructural damage that is prevented by EPO. Assessment of visual discrimination on a touchscreen operant chamber platform demonstrated that all groups can performvisual discrimination. However, CCI rats treated with vehicle failed to pass reversal learning, and perseverated, in contrast to sham and CCI-EPO rats. Chronic DTI at P90 showed EPO treatment prevented contralateral white matter and ipsilateral lateral prefrontal cortex damage. This DTI improvement correlated with cognitive performance. Taken together, extended EPO treatment restores executive function and prevents microstructural brain abnormalities in adult rats with cognitive deficits in a translational preclinical model of infant TBI. Sophisticated testing with touchscreen operant chambers and regional DTI analyses may expedite translation and effective yield of interventions from preclinical studies to clinical trials. Collectively, these data support the use of EPO in clinical trials for human infants with TBI.	[Robinson, Shenandoah; Winer, Jesse L.; Chan, Lindsay A. S.; Oppong, Akosua Y.] Harvard Med Sch, Boston Childrens Hosp, Neurosurg, Boston, MA 02115 USA; [Robinson, Shenandoah] Harvard Med Sch, Boston Childrens Hosp, Neurol, Boston, MA 02115 USA; [Robinson, Shenandoah; Andrews, Nicholas] Harvard Med Sch, Boston Childrens Hosp, FM Kirby Ctr Neurobiol, Boston, MA 02115 USA; [Yellowhair, Tracylyn R.; Maxwell, Jessie R.; Jantzie, Lauren L.] Univ New Mexico, Dept Pediat, Albuquerque, NM 87131 USA; [Yang, Yirong] Univ New Mexico, Dept Pharmaceut Sci, Albuquerque, NM 87131 USA; [Sillerud, Laurel O.] Univ New Mexico, Dept Neurol, Albuquerque, NM 87131 USA; [Meehan, William P., III] Harvard Med Sch, Boston Childrens Hosp, Sports Med, Boston, MA USA; [Mannix, Rebekah] Harvard Med Sch, Boston Childrens Hosp, Emergency Med, Boston, MA USA; [Brigman, Jonathan L.; Jantzie, Lauren L.] Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA; [Robinson, Shenandoah] Johns Hopkins Univ, Pediat Neurosurg, Baltimore, MD 21218 USA		Robinson, S (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Neurosurg, Boston, MA 02115 USA.; Robinson, S (corresponding author), Harvard Med Sch, Boston Childrens Hosp, Neurol, Boston, MA 02115 USA.; Robinson, S (corresponding author), Harvard Med Sch, Boston Childrens Hosp, FM Kirby Ctr Neurobiol, Boston, MA 02115 USA.; Jantzie, LL (corresponding author), Univ New Mexico, Dept Pediat, Albuquerque, NM 87131 USA.; Jantzie, LL (corresponding author), Univ New Mexico, Dept Neurosci, Albuquerque, NM 87131 USA.; Robinson, S (corresponding author), Johns Hopkins Univ, Pediat Neurosurg, Baltimore, MD 21218 USA.	srobin81@jhmi.edu; ljantzie@salud.unm.edu	Maxwell, Jessie R./N-1890-2019; Mannix, Rebekah/AAD-8702-2020	Maxwell, Jessie R./0000-0001-8990-7239; 	Dedicated Health Research funds from the University of New Mexico School of Medicine; University of New Mexico Brain and Behavioral Health Institute (BBHI); Center for Biomedical Research Excellence Pilot Award [CoBRE P30GM103400]; Department of Neurosurgery at Boston Children's Hospital; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P30GM103400, P20GM109089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [P50AA022534] Funding Source: NIH RePORTER	The authors are exceptionally grateful to Dave Fuller, Jessie Newville, Andrea Allan PhD for statistical expertise, and the generous funding provided by the Dedicated Health Research funds from the University of New Mexico School of Medicine, the University of New Mexico Brain and Behavioral Health Institute (BBHI), a Center for Biomedical Research Excellence Pilot Award to LJ (CoBRE P30GM103400/PI:Liu), and the Department of Neurosurgery at Boston Children's Hospital.	Aung Wint Yan, 2013, Imaging Med, V5, P427; Basar K, 2010, PROG NEUROBIOL, V92, P533, DOI 10.1016/j.pneurobio.2010.08.007; Bondi CO, 2015, NEUROSCI BIOBEHAV R, V58, P123, DOI 10.1016/j.neubiorev.2014.12.004; Bondi CO, 2014, J NEUROTRAUM, V31, P926, DOI 10.1089/neu.2013.3295; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Brigman JL, 2013, NAT NEUROSCI, V16, P1101, DOI 10.1038/nn.3457; Brigman JL, 2010, CEREB CORTEX, V20, P1955, DOI 10.1093/cercor/bhp266; Brines M, 2005, NAT REV NEUROSCI, V6, P484, DOI 10.1038/nrn1687; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Bussey TJ, 2012, NEUROPHARMACOLOGY, V62, P1191, DOI 10.1016/j.neuropharm.2011.04.011; Bussey TJ, 2008, LEARN MEMORY, V15, P516, DOI 10.1101/lm.987808; Chen C, 2017, INT J ENV RES PUB HE, V14, DOI 10.3390/ijerph14040414; Chudasama Y, 2003, J NEUROSCI, V23, P8771; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dias RB, 2018, CEREB CORTEX, V28, P2795, DOI 10.1093/cercor/bhx159; Digicaylioglu M, 2001, NATURE, V412, P641, DOI 10.1038/35088074; Egger K, 2016, NEUROIMAGE, V127, P1, DOI 10.1016/j.neuroimage.2015.10.091; Faber J, 2016, BRAIN INJURY, V30, P1635, DOI 10.1080/02699052.2016.1199910; Ferguson NM, 2017, CRIT CARE MED, V45, P1398, DOI 10.1097/CCM.0000000000002378; Ghezzi P, 2010, LANCET, V375, P2142, DOI 10.1016/S0140-6736(10)60992-0; Graybeal C, 2011, NAT NEUROSCI, V14, P1507, DOI 10.1038/nn.2954; Hasselblatt M, 2006, J NEUROSURG ANESTH, V18, P132, DOI 10.1097/00008506-200604000-00007; Hassouna I, 2016, MOL PSYCHIATR, V21, P1752, DOI 10.1038/mp.2015.212; Hellewell SC, 2018, CRIT CARE MED, V46, P554, DOI 10.1097/CCM.0000000000002938; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Iwai M, 2010, STROKE, V41, P1032, DOI 10.1161/STROKEAHA.109.570325; Izquierdo A, 2006, BEHAV BRAIN RES, V171, P181, DOI 10.1016/j.bbr.2006.03.029; Jantzie LL, 2014, MOL CELL NEUROSCI, V61, P152, DOI 10.1016/j.mcn.2014.06.009; Jantzie LL, 2018, FRONT NEUROL, V9, DOI 10.3389/fneur.2018.00233; Jantzie LL, 2016, DEV NEUROSCI-BASEL, V38, P15, DOI 10.1159/000441024; Jantzie LL, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00347; Jantzie LL, 2015, DEV NEUROSCI-BASEL, V37, P277, DOI 10.1159/000371721; Jantzie LL, 2013, PEDIATR RES, V74, P658, DOI 10.1038/pr.2013.155; Keller M, 2006, NEUROBIOL DIS, V24, P357, DOI 10.1016/j.nbd.2006.07.007; Knabe W, 2005, ANAT EMBRYOL, V210, P209, DOI 10.1007/s00429-005-0019-3; Knabe W, 2004, ANAT EMBRYOL, V207, P503, DOI 10.1007/s00429-003-0365-y; Leach PT, 2018, GENES BRAIN BEHAV, V17, DOI 10.1111/gbb.12452; Levin HS, 2005, PEDIATR NEUROL, V33, P79, DOI 10.1016/j.pediatrneurol.2005.02.002; Mar AC, 2017, PSYCHOPHARMACOLOGY, V234, P2837, DOI 10.1007/s00213-017-4679-5; Marquardt K, 2014, ALCOHOL CLIN EXP RES, V38, P2962, DOI 10.1111/acer.12577; Mazur M, 2010, J NEUROSURG-PEDIATR, V6, P206, DOI 10.3171/2010.5.PEDS1032; Miller TR, 2014, PEDIATRICS, V134, pE1545, DOI 10.1542/peds.2014-1385; Miskowiak K, 2007, J NEUROSCI, V27, P2788, DOI 10.1523/JNEUROSCI.5013-06.2007; Nichols JN, 2017, J NEUROTRAUM, V34, P2481, DOI 10.1089/neu.2017.4998; Nithianantharajah J, 2013, NEUROBIOL LEARN MEM, V105, P13, DOI 10.1016/j.nlm.2013.06.006; Noguchi Constance Tom, 2008, Expert Reviews in Molecular Medicine, V10, P1, DOI 10.1017/S1462399408000860; O'Gorman RL, 2015, BRAIN, V138, P388, DOI 10.1093/brain/awu363; Ohls RK, 2016, PEDIATRICS, V137, DOI 10.1542/peds.2015-3859; Ohls RK, 2014, PEDIATRICS, V133, P1023, DOI 10.1542/peds.2013-4307; Ott C, 2015, MOL MED, V21, P803, DOI 10.2119/molmed.2015.00192; Pullela R, 2006, DEV NEUROSCI-BASEL, V28, P396, DOI 10.1159/000094166; Rajesh A, 2017, J NEUROTRAUM, V34, P3280, DOI 10.1089/neu.2017.5047; Rangarajan V, 2014, PEDIATR NEUROL, V51, P481, DOI 10.1016/j.pediatrneurol.2014.06.008; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Robinson S, 2018, EXP NEUROL, V302, P1, DOI 10.1016/j.expneurol.2017.12.010; Robinson S, 2016, J NEUROSURG-PEDIATR, V17, P739, DOI 10.3171/2015.10.PEDS15554; Ryan NP, 2018, PSYCHOL MED, V48, P679, DOI 10.1017/S0033291717002057; Schober ME, 2018, BRAIN DEV-JPN, V40, P367, DOI 10.1016/j.braindev.2018.01.003; Schober ME, 2014, BRAIN RES, V1574, P105, DOI 10.1016/j.brainres.2014.05.046; Schober ME, 2014, J NEUROTRAUM, V31, P358, DOI 10.1089/neu.2013.2922; Schumacher M, 2016, J STEROID BIOCHEM, V160, P53, DOI 10.1016/j.jsbmb.2015.11.010; Semple BD, 2013, PROG NEUROBIOL, V106, P1, DOI 10.1016/j.pneurobio.2013.04.001; Shah S, 2012, BRAIN INJURY, V26, P201, DOI 10.3109/02699052.2012.654591; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Simard F, 2011, CEREB CORTEX, V21, P1084, DOI 10.1093/cercor/bhq182; Siren AL, 2001, P NATL ACAD SCI USA, V98, P4044, DOI 10.1073/pnas.051606598; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Tsai PT, 2006, J NEUROSCI, V26, P1269, DOI 10.1523/JNEUROSCI.4480-05.2006; van de Looij Y, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095643; Vonder Haar C, 2017, J NEUROTRAUM, V34, P2790, DOI 10.1089/neu.2016.4813; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Xiong Y, 2010, J NEUROTRAUM, V27, P205, DOI 10.1089/neu.2009.1001; Yellowhair TR, 2018, EXP NEUROL, V301, P110, DOI 10.1016/j.expneurol.2017.11.002; Yu XB, 2002, DEVELOPMENT, V129, P505; Zhou ZW, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.827	78	15	16	0	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1664-2295			FRONT NEUROL	Front. Neurol.	JUN 19	2018	9								451	10.3389/fneur.2018.00451			12	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GK0TO	WOS:000435825000001	29971038	Green Published, gold			2022-02-06	
J	Boggs, JM; Beck, A; Hubley, S; Peterson, EL; Hu, Y; Williams, LK; Prabhakar, D; Rossom, RC; Lynch, FL; Lu, CY; Waitzfelder, BE; Owen-Smith, AA; Simon, GE; Ahmedani, BK				Boggs, Jennifer M.; Beck, Arne; Hubley, Sam; Peterson, Edward L.; Hu, Yong; Williams, L. Keoki; Prabhakar, Deepak; Rossom, Rebecca C.; Lynch, Frances L.; Lu, Christine Y.; Waitzfelder, Beth E.; Owen-Smith, Ashli A.; Simon, Gregory E.; Ahmedani, Brian K.			General Medical, Mental Health, and Demographic Risk Factors Associated With Suicide by Firearm Compared With Other Means	PSYCHIATRIC SERVICES			English	Article							EMERGENCY-DEPARTMENT; COMPLETED SUICIDE; CHRONIC PAIN; CARE; POPULATION; PREVENTION; INDIVIDUALS; DEPRESSION; DISORDERS; PROVIDERS	Objective: Mitigation of suicide risk by reducing access to lethal means, such as firearms and potentially lethal medications, is a highly recommended practice. To better understand groups of patients at risk of suicide in medical settings, the authors compared demographic and clinical risk factors between patients who died by suicide by using firearms or other means with matched patients who did not die by suicide (control group). Methods: In a case-control study in 2016 from eight health care systems within the Mental Health Research Network, 2,674 suicide cases from 2010-2013 were matched to a control group (N=267,400). The association between suicide by firearm or other means and medical record information on demographic characteristics, general medical disorders, and mental disorders was assessed. Results: The odds of having a mental disorder were higher among cases of suicide involving a method other than a firearm. Fourteen general medical disorders were associated with statistically significant (p<.001) greater odds of suicide by firearm, including traumatic brain injury (TBI) (odds ratio [OR] = 23.53), epilepsy (OR = 3.17), psychogenic pain (OR = 2.82), migraine (OR = 2.35), and stroke (OR = 2.20). Fifteen general medical disorders were associated with statistically significant (p<.001) greater odds of suicide by other means, with particularly high odds for TBI (OR = 7.74), epilepsy (OR = 3.28), HIV/AIDS (OR = 6.03), and migraine (OR = 3.17). Conclusions: Medical providers should consider targeting suicide risk screening for patients with any mental disorder, TBI, epilepsy, HIV, psychogenic pain, stroke, and migraine. When suicide risk is detected, counseling on reducing access to lethal means should include both firearms and other means for at-risk groups.	[Boggs, Jennifer M.; Beck, Arne] Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80205 USA; [Hubley, Sam] Univ Colorado, Sch Med, Dept Family Med, Boulder, CO 80309 USA; [Peterson, Edward L.] Henry Ford Hlth Syst, Dept Publ Hlth Sci, Detroit, MI USA; [Williams, L. Keoki; Ahmedani, Brian K.] Henry Ford Hlth Syst, Ctr Hlth Policy & Hlth Serv Res, Detroit, MI USA; [Williams, L. Keoki] Henry Ford Hlth Syst, Dept Internal Med, Detroit, MI USA; [Prabhakar, Deepak] Henry Ford Hlth Syst, Dept Behav Hlth Serv, Detroit, MI USA; [Rossom, Rebecca C.] Hlth Partners Inst, Bloomington, MN USA; [Lynch, Frances L.] Kaiser Permanente Northwest, Ctr Hlth Res, Portland, OR USA; [Lu, Christine Y.] Harvard Med Sch, Dept Populat Med, Boston, MA USA; [Lu, Christine Y.] Harvard Pilgrim Hlth Care Inst, Boston, MA USA; [Waitzfelder, Beth E.] Kaiser Permanente Hawaii, Ctr Hlth Res, Honolulu, HI USA; [Owen-Smith, Ashli A.] Kaiser Permanente Georgia, Ctr Clin & Outcomes Res, Atlanta, GA USA; [Owen-Smith, Ashli A.] Georgia State Univ, Sch Publ Hlth, Atlanta, GA 30303 USA; [Simon, Gregory E.] Kaiser Permanente Washington, Hlth Res Inst, Seattle, WA USA		Boggs, JM (corresponding author), Kaiser Permanente Colorado, Inst Hlth Res, Denver, CO 80205 USA.	jennifer.m.boggs@kp.org	Rossom, Rebecca/R-7103-2019	Rossom, Rebecca/0000-0002-9531-914X; Hubley, Samuel/0000-0001-7188-6003	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH103539]; MerckMerck & Company; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH103539] Funding Source: NIH RePORTER	The work was supported by a grant from the National Institute of Mental Health (R01MH103539).; Dr. Williams reports receipt of payment for serving as scientific advisor on a project from Merck. The other authors report no financial relationships with commercial interests.	Ahmedani BK, 2017, AM J PREV MED, V53, P308, DOI 10.1016/j.amepre.2017.04.001; Ahmedani BK, 2014, J GEN INTERN MED, V29, P870, DOI 10.1007/s11606-014-2767-3; [Anonymous], 2015, PUB SMA, P15; Baca-Garcia E, 2001, J CLIN PSYCHIAT, V62, P560, DOI 10.4088/JCP.v62n07a11; Basham C, 2011, SUICIDE LIFE-THREAT, V41, P287, DOI 10.1111/j.1943-278X.2011.00028.x; Beghi M, 2013, NEUROPSYCH DIS TREAT, V9, P1725, DOI 10.2147/NDT.S40213; Betz ME, 2013, DEPRESS ANXIETY, V30, P1005, DOI 10.1002/da.22071; Bostwick JM, 2016, AM J PSYCHIAT, V173, P1094, DOI 10.1176/appi.ajp.2016.15070854; Brent DA, 2003, AM BEHAV SCI, V46, P1192, DOI 10.1177/0002764202250662; Bruffaerts R, 2015, J PAIN, V16, P42, DOI 10.1016/j.jpain.2014.10.002; Bryan CJ, 2011, PROF PSYCHOL-RES PR, V42, P339, DOI 10.1037/a0025051; Cavanagh JTO, 2003, PSYCHOL MED, V33, P395, DOI 10.1017/S0033291702006943; [Center for Behavioral Health Statistics and Quality Substance Abuse and Mental Health Services Administration], 2015, NSDUH SER H, VH-50; Centers for Disease Control and Prevention Injury Prevention and Control Data and Statistics (WISQARS), 2016, FAT INJ REP; Centers for Disease Control and Prevention National Center for Health Statistics, 2014, SUIC SELF INFL INJ; Clinical Modification, 1995, INT CLASS DIS; Colman I, 2016, HEADACHE, V56, P132, DOI 10.1111/head.12710; Edlund MJ, 2010, CLIN J PAIN, V26, P1, DOI 10.1097/AJP.0b013e3181b99f35; Ferrer P, 2014, NEUROEPIDEMIOLOGY, V42, P107, DOI 10.1159/000356807; Friedman LE, 2017, CLIN J PAIN, V33, P659, DOI 10.1097/AJP.0000000000000440; Go AS, 2008, CIRC-CARDIOVASC QUAL, V1, P138, DOI 10.1161/CIRCOUTCOMES.108.801654; Hepburn L, 2007, INJURY PREV, V13, P15, DOI 10.1136/ip.2006.013607; Hornbrook Mark C, 2005, J Natl Cancer Inst Monogr, P12; http://www.sprc.org/resources-programs/calm-counseling-access-lethal-means, 2017, CALM COUNS ACC LETH; Ilgen MA, 2010, ARCH GEN PSYCHIAT, V67, P1152, DOI 10.1001/archgenpsychiatry.2010.129; Keiser O, 2010, AM J PSYCHIAT, V167, P143, DOI 10.1176/appi.ajp.2009.09050651; Kochanek Kenneth D, 2016, Natl Vital Stat Rep, V65, P1; Kruesi MJP, 1999, J AM ACAD CHILD PSY, V38, P250, DOI 10.1097/00004583-199903000-00010; Lewiecki EM, 2013, AM J PUBLIC HEALTH, V103, P27, DOI 10.2105/AJPH.2012.300964; Luoma JB, 2002, AM J PSYCHIAT, V159, P909, DOI 10.1176/appi.ajp.159.6.909; Mack KA, 2013, MMWR-MORBID MORTAL W, V62, P537; McDowell AK, 2011, MAYO CLIN PROC, V86, P792, DOI 10.4065/mcp.2011.0076; McManus BL, 1997, AM J EMERG MED, V15, P357, DOI 10.1016/S0735-6757(97)90124-8; Mula M, 2007, EPILEPSY BEHAV, V11, P130, DOI 10.1016/j.yebeh.2007.04.008; Munce SEP, 2007, PSYCHOSOMATICS, V48, P394, DOI 10.1176/appi.psy.48.5.394; Outcalt SD, 2015, J BEHAV MED, V38, P535, DOI 10.1007/s10865-015-9628-3; Rossom RC, 2016, PSYCHIAT SERV, V67, P830, DOI 10.1176/appi.ps.201600068; Sentinel Event Alert, 2016, DET TREAT SUIC ID AL; Shea S., 2002, PRACTICAL ART SUICID; Simon TR, 2001, SUICIDE LIFE-THREAT, V32, P49, DOI 10.1521/suli.32.1.5.49.24212; Spicer RS, 2000, AM J PUBLIC HEALTH, V90, P1885, DOI 10.2105/AJPH.90.12.1885; Stone DM, 2014, AM J LIFESTYLE MED, V8, P404, DOI 10.1177/1559827614551130; Sullivan GR, 2004, THESIS; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Vyrostek Sara B., 2004, Morbidity and Mortality Weekly Report, V53, P1; Wagner Edward H, 2005, J Natl Cancer Inst Monogr, P3, DOI 10.1093/jncimonographs/lgi032; World Health Organization, 2012, INT CLASS DIS	47	15	15	0	5	AMER PSYCHIATRIC PUBLISHING, INC	WASHINGTON	800 MAINE AVE SW, SUITE 900, WASHINGTON, DC 20024 USA	1075-2730	1557-9700		PSYCHIAT SERV	Psychiatr. Serv.	JUN	2018	69	6					677	684		10.1176/appi.ps.201700237			8	Health Policy & Services; Public, Environmental & Occupational Health; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services; Public, Environmental & Occupational Health; Psychiatry	GL6TF	WOS:000437323400011	29446332	Green Accepted, Bronze			2022-02-06	
J	Ganslandt, O; Mourtzoukos, S; Stadlbauer, A; Sommer, B; Rammensee, R				Ganslandt, Oliver; Mourtzoukos, Stylianos; Stadlbauer, Andreas; Sommer, Bjoern; Rammensee, Rudolf			Evaluation of a novel noninvasive ICP monitoring device in patients undergoing invasive ICP monitoring: preliminary results	JOURNAL OF NEUROSURGERY			English	Article						intracranial pressure monitoring; diagnostic technique; traumatic brain injury	TRAUMATIC BRAIN-INJURY; INTRACRANIAL-PRESSURE MONITORS; FLUID PRESSURE; INTENSIVE-CARE; CHILDREN; SYSTEM; RISK	OBJECTIVE There is no established method of noninvasive intracranial pressure (NI-ICP) monitoring that can serve as an alternative to the gold standards of invasive monitoring with external ventricular drainage or intraparenchymal monitoring. In this study a new method of NI-ICP monitoring performed using algorithms to determine ICP based on acoustic properties of the brain was applied in patients undergoing invasive ICP (I-ICP) monitoring, and the results were analyzed. METHODS In patients with traumatic brain injury and subarachnoid hemorrhage who were undergoing treatment in a neurocritical intensive care unit, the authors recorded ICP using the gold standard method of invasive external ventricular drainage or intraparenchymal monitoring. In addition, the authors simultaneously measured the ICP noninvasively with a device (the HS-1000) that uses advanced signal analysis algorithms for acoustic signals propagating through the cranium. To assess the accuracy of the NI-ICP method, data obtained using both I-ICP and NI-ICP monitoring methods were analyzed with MATLAB to determine the statistical significance of the differences between the ICP measurements obtained using NI-ICP and I-ICP monitoring. RESULTS Data were collected in 14 patients, yielding 2543 data points of continuous parallel ICP values in recordings obtained from I-ICP and NI-ICP. Each of the 2 methods yielded the same number of data points. For measurements at the >= 17-mm Hg cutoff, which was arbitrarily chosen for this preliminary analysis, the sensitivity and specificity for the NI-ICP monitoring were found to be 0.7541 and 0.8887, respectively. Linear regression analysis indicated that there was a strong positive relationship between the measurements. Differential pressure between NI-ICP and I-ICP was within +/- 3 mm Hg in 63% of data-paired readings and within +/- 5 mm Hg in 85% of data-paired readings. The receiver operating characteristic-area under the curve analysis revealed that the area under the curve was 0.895, corresponding to the overall performance of NI-ICP monitoring in comparison with I-ICP monitoring. CONCLUSIONS This study provides the first clinical data on the accuracy of the HS-1000 NI-ICP monitor, which uses advanced signal analysis algorithms to evaluate properties of acoustic signals traveling through the brain in patients undergoing I-ICP monitoring. The findings of this study highlight the capability of this NI-ICP device to accurately measure ICP noninvasively. Further studies should focus on clinical validation for elevated ICP values.	[Ganslandt, Oliver; Mourtzoukos, Stylianos] Klinikum Stuttgart, Dept Neurosurg, Stuttgart, Germany; [Stadlbauer, Andreas; Sommer, Bjoern; Rammensee, Rudolf] Univ Erlangen Nurnberg, Dept Neurosurg, Erlangen, Germany		Ganslandt, O (corresponding author), Katharinenhospital, Klinikum Stuttgart, Kriegsbergstr 60, D-70174 Stuttgart, Germany.	o.ganslandt@klinikum-stuttgart.de	Sommer, Bjorn/AAD-6069-2022; Stadlbauer, Andreas/ABF-6235-2020	Sommer, Bjorn/0000-0003-1717-2258; Stadlbauer, Andreas/0000-0001-8348-2620			ANDREWS BT, 1988, J NEUROSURG, V69, P518, DOI 10.3171/jns.1988.69.4.0518; Berlin T, 2008, J NEUROTRAUM, V25, P276; Berlin T, 2015, SPRINGERPLUS, V4, DOI 10.1186/2193-1801-4-10; Bhatia A, 2007, INTENS CARE MED, V33, P1263, DOI 10.1007/s00134-007-0678-z; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Bratton SL, 2007, J NEUROTRAUMA S1, V24, P555, DOI DOI 10.1089/NEU.2007.9988; Chambers IR, 2001, J NEUROL NEUROSUR PS, V71, P383, DOI 10.1136/jnnp.71.3.383; Collins CDE, 2014, CHILD NERV SYST, V30, P1671, DOI 10.1007/s00381-014-2523-3; Cremer OL, 2008, EUR J ANAESTH, V25, P87, DOI 10.1017/S0265021507003237; Czosnyka M, 2004, J NEUROL NEUROSUR PS, V75, P813, DOI 10.1136/jnnp.2003.033126; Fernandes HM, 1998, ACT NEUR S, V71, P44; GALETTA S, 1989, J CLIN NEURO-OPHTHAL, V9, P79; Gwer S, 2013, CHILD NERV SYST, V29, P927, DOI 10.1007/s00381-013-2036-5; Hightower Stephanie, 2012, J Spec Oper Med, V12, P19; Kakarla UK, 2008, NEUROSURGERY, V63, P162, DOI 10.1227/01.NEU.0000312390.83127.7F; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Koskinen LOD, 2010, NEUROSURGERY, V67, pE221, DOI [10.1227/01.neu.0000371142.74277.b9, 10.1227/01.NEU.0000371142.74277.B9, 10.1227/01.neu.0000371143.51407.78, 10.1227/01.NEU.0000371143.51407.78]; Lescot T, 2011, INTENS CARE MED, V37, P875, DOI 10.1007/s00134-011-2182-8; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Maissan IM, 2015, J NEUROSURG, V123, P743, DOI 10.3171/2014.10.JNS141197; March K, 2005, AACN ADV CRIT CARE, V16, P456, DOI 10.1097/00044067-200510000-00004; McKeating EG, 1998, BRIT J NEUROSURG, V12, P7; Padayachy LC, 2010, CHILD NERV SYST, V26, P441, DOI 10.1007/s00381-009-1034-0; POPLE IK, 1995, PEDIATR NEUROSURG, V23, P64, DOI 10.1159/000120938; Raboel PH, 2012, CRIT CARE RES PRACT, V2012, DOI 10.1155/2012/950393; Rajajee V, 2011, NEUROCRIT CARE, V15, P506, DOI 10.1007/s12028-011-9606-8; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Rosenberg JB, 2011, NEUROCRIT CARE, V15, P599, DOI 10.1007/s12028-011-9545-4; Saladino A, 2009, NEUROCRIT CARE, V10, P248, DOI 10.1007/s12028-008-9154-z; Schimpf Melissa M, 2012, J Trauma Nurs, V19, P160, DOI 10.1097/JTN.0b013e318261cfb4; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Steiner LA, 2006, BRIT J ANAESTH, V97, P26, DOI 10.1093/bja/ael110; Wakerley BR, 2015, J NEUROIMAGING, V25, P111, DOI 10.1111/jon.12100; Yuan Q, 2015, J NEUROSURG, V122, P574, DOI 10.3171/2014.10.JNS1460; Zhong J, 2003, NEUROL RES, V25, P339, DOI 10.1179/016164103101201661	35	15	15	1	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	JUN	2018	128	6					1653	1660		10.3171/2016.11.JNS152268			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GP2IM	WOS:000440653000007	28784032	Bronze			2022-02-06	
J	van der Horn, HJ; de Haan, S; Spikman, JM; de Groot, JC; van der Naalt, J				van der Horn, H. J.; de Haan, S.; Spikman, J. M.; de Groot, J. C.; van der Naalt, J.			Clinical relevance of microhemorrhagic lesions in subacute mild traumatic brain injury	BRAIN IMAGING AND BEHAVIOR			English	Article						Mild traumatic brain injury; MRI; Microhemorrhages; Microbleeds; Post-traumatic complaints	CT	Magnetic resonance imaging (MRI) is often performed in patients with persistent complaints after mild traumatic brain injury (mTBI). However, the clinical relevance of detected microhemorrhagic lesions is still unclear. In the current study, 54 patients with uncomplicated mTBI and 20 matched healthy controls were included. Post-traumatic complaints were measured at two weeks post-injury. Susceptibility weighted imaging and T2*-gradient echo imaging (at 3 Tesla) were performed at four weeks post-injury. Microhemorrhagic lesions (1-10 mm) were subdivided based on depth (superficial or deep) and anatomical location (frontal, temporoparietal and other regions). Twenty-eight per cent of patients with mTBI had >= 1 lesions compared to 0 % of the healthy controls. Lesions in patients with mTBI were predominantly located within the superficial frontal areas. Number, depth and anatomical location of lesions did not differ between patients with and without post-traumatic complaints. Within the group of patients with complaints, number of complaints was not correlated with number of lesions. In summary, microhemorrhages were found in one out of four patients with uncomplicated mTBI during follow-up at four weeks post-injury, but they were not related to early complaints.	[van der Horn, H. J.; van der Naalt, J.] Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands; [Spikman, J. M.] Univ Groningen, Univ Med Ctr Groningen, Dept Neuropsychol, Groningen, Netherlands; [de Haan, S.; de Groot, J. C.] Univ Groningen, Univ Med Ctr Groningen, Dept Radiol, Groningen, Netherlands		van der Horn, HJ (corresponding author), Univ Groningen, Univ Med Ctr Groningen, Dept Neurol, Hanzepl 1, NL-9700 RB Groningen, Netherlands.	h.j.van.der.horn@umcg.nl		Spikman, Jacoba/0000-0002-6477-0763; van der Naalt, Joukje/0000-0001-9873-2418	Dutch Brain Foundation [Ps2012-06]	This work was funded by the Dutch Brain Foundation (grant no. Ps2012-06).	Carroll Linda J, 2014, Arch Phys Med Rehabil, V95, pS152, DOI 10.1016/j.apmr.2013.08.300; de Koning ME, 2016, INJURY, V47, P2041, DOI 10.1016/j.injury.2016.04.036; Dischinger PC, 2009, J TRAUMA, V66, P289, DOI 10.1097/TA.0b013e3181961da2; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Greenberg SM, 2009, LANCET NEUROL, V8, P165, DOI 10.1016/S1474-4422(09)70013-4; Hofman PAM, 2001, AM J NEURORADIOL, V22, P441; Huang YL, 2015, NEUROLOGY, V84, P580, DOI 10.1212/WNL.0000000000001237; Hughes DG, 2004, NEURORADIOLOGY, V46, P550, DOI 10.1007/s00234-004-1227-x; Iverson GL, 2000, BRAIN INJURY, V14, P1057; Iverson GL, 2012, REHABIL RES PRACT, V2012, DOI 10.1155/2012/415740; Lee H, 2008, J NEUROTRAUM, V25, P1049, DOI 10.1089/neu.2008.0566; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Matuseviciene G, 2016, J REHABIL MED, V48, P19, DOI 10.2340/16501977-2025; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Panenka WJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0122746; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Verhage F, 1964, INTELLIGENCE AGE STU; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	18	15	15	0	2	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	JUN	2018	12	3					912	916		10.1007/s11682-017-9743-6			5	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GI6PB	WOS:000434491400027	28664231	Green Published, hybrid			2022-02-06	
J	Weber, ML; Dean, JHL; Hoffman, NL; Broglio, SP; McCrea, M; McAllister, TW; Schmidt, JD				Weber, Michelle L.; Dean, John-Henry L.; Hoffman, Nicole L.; Broglio, Steven P.; McCrea, Michael; McAllister, Thomas W.; Schmidt, Julianne D.		CARE Consortium Investigators	Influences of Mental Illness, Current Psychological State, and Concussion History on Baseline Concussion Assessment Performance	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						concussions; baseline assessments; anxiety; depression; concussion history	PROFESSIONAL FOOTBALL PLAYERS; SPORT-RELATED CONCUSSION; INTERNATIONAL-CONFERENCE; RECURRENT CONCUSSION; DEPRESSION; SYMPTOMS; RECOVERY; IMPACT; ASSOCIATION; DISTRESS	Background: A student-athlete's mental state, including history of trait anxiety and depression, or current psychological state may affect baseline concussion assessment performance. Purpose: (1) To determine if mental illness (anxiety, depression, anxiety with depression) influences baseline scores, (2) to determine if psychological state correlates with baseline performance, and (3) to determine if history of concussion affects Brief Symptom Inventory-18 (BSI-18) subscores of state anxiety, depression, and somatization. Study Design: Cross-sectional study; Level of evidence, 3. Methods: A sample of 8652 collegiate student-athletes (54.5% males, 45.5% females) participated in the Concussion Assessment, Research and Education (CARE) Consortium. Baseline assessments included a demographic form, a symptom evaluation, Standardized Assessment of Concussion, Balance Error Scoring System, a psychological state assessment (BSI-18), and Immediate Post-concussion Assessment and Cognitive Test. Baseline scores were compared between individuals with a history of anxiety (n = 59), depression (n = 283), and anxiety with depression (n = 68) and individuals without a history of those conditions (n = 8242). Spearman's rho correlations were conducted to assess the relationship between baseline and psychological state subscores (anxiety, depression, somatization) ( = .05). Psychological state subscores were compared between individuals with a self-reported history of concussions (0, 1, 2, 3, 4+) using Kruskal-Wallis tests (alpha = .05). Results: Student-athletes with anxiety, depression, and anxiety with depression demonstrated higher scores in number of symptoms reported (anxiety, 4.3 +/- 4.2; depression, 5.2 +/- 4.8; anxiety with depression, 5.4 +/- 3.9; no anxiety/depression, 2.5 +/- 3.4), symptom severity (anxiety, 8.1 +/- 9.8; depression, 10.4 +/- 12.4; anxiety with depression, 12.4 +/- 10.7; no anxiety/depression, 4.1 +/- 6.9), and psychological distress in state anxiety (anxiety, 3.7 +/- 4.7; depression, 2.5 +/- 3.6; anxiety with depression, 3.8 +/- 4.2; no anxiety/depression, 0.8 +/- 1.8), depression (anxiety, 2.4 +/- 4.0; depression, 3.2 +/- 4.5; anxiety with depression, 3.8 +/- 4.8; no anxiety/depression, 0.8 +/- 1.8), and somatization (anxiety, 2.3 +/- 2.9; depression, 1.8 +/- 2.8; anxiety with depression, 2.2 +/- 2.4; no anxiety/depression, 0.9 +/- 1.7). A moderate positive relationship existed between all BSI-18 subscores and total symptom number (n = 8377; anxiety: r(s) = 0.43, P < .001; depression: r(s) = 0.42, P < .001; somatization: r(s) = 0.45, P < .001), as well as total symptom severity (anxiety: r(s) = 0.43, P < .001; depression: r(s) = 0.41, P < .001; somatization: r(s) = 0.45, P < .001). Anxiety, depression, and somatization subscores were greater among student-athletes that self-reported more concussions. Conclusion: Clinicians should be cognizant that student-athletes with a history of trait anxiety, depression, and anxiety with depression may report higher symptom score and severity at baseline. Individuals with extensive concussion history may experience greater state anxiety, depression, and somatization.	[Weber, Michelle L.; Hoffman, Nicole L.; Schmidt, Julianne D.] Univ Georgia, Dept Kinesiol, Concuss Res Lab, 330 River Rd, Athens, GA 30602 USA; [Dean, John-Henry L.] Univ Virginia, Sch Med, Charlottesville, VA 22908 USA; [Broglio, Steven P.] Univ Michigan, Injury Ctr, NeuroTrauma Res Lab, Ann Arbor, MI 48109 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurosurg, Milwaukee, WI 53226 USA; [McCrea, Michael] Med Coll Wisconsin, Dept Neurol, Milwaukee, WI 53226 USA; [McAllister, Thomas W.] Indiana Univ Sch Med, Dept Psychiat, Indianapolis, IN 46202 USA		Weber, ML (corresponding author), Univ Georgia, Dept Kinesiol, Concuss Res Lab, 330 River Rd, Athens, GA 30602 USA.	mlw76648@uga.edu		Ortega, Justus/0000-0002-9931-5605; Clugston, James/0000-0002-2103-1039; Chrisman, Sara/0000-0001-5373-7223; Master, Christina/0000-0002-6717-4270; Dean, John-Henry/0000-0002-2783-0325	Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium; National Collegiate Athletic Association (NCAA); Department of Defense (DOD)United States Department of Defense; Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program [W81XWH-14-2-0151]	This project was supported, in part, by the Grand Alliance Concussion Assessment, Research, and Education (CARE) Consortium and was funded, in part, by the National Collegiate Athletic Association (NCAA) and the Department of Defense (DOD). The U.S. Army Medical Research Acquisition Activity, 820 Chandler Street, Ford Detrick, MD 21702-5014 is the awarding and administering acquisition office. This work was supported by the Office of the Assistant Secretary of Defense for Health Affairs through the Psychological Health and Traumatic Brain Injury Program under Award No. W81XWH-14-2-0151.	Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Broglio SP, 2018, SPORTS MED, V48, P1255, DOI 10.1007/s40279-017-0813-0; Broglio SP, 2017, SPORTS MED, V47, P1437, DOI 10.1007/s40279-017-0707-1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Buckley TA, 2016, J SPORT HEALTH SCI, V5, P417, DOI 10.1016/j.jshs.2015.03.010; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Cook NE, 2017, CLIN NEUROPSYCHOL, V31, P1341, DOI 10.1080/13854046.2017.1317031; Corwin DJ, 2014, J PEDIATR-US, V165, P1207, DOI 10.1016/j.jpeds.2014.08.034; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Decq P, 2016, ACTA NEUROCHIR, V158, P289, DOI 10.1007/s00701-015-2681-4; Derogatis L.R., 2001, BRIEF SYMPTOM INVENT; Esopenko C, 2017, J NEUROL NEUROSUR PS, V88, P512, DOI 10.1136/jnnp-2016-315260; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Hedges L.V., 1985, STAT METHODS META AN; Iverson GL, 2006, BRIT J SPORT MED, V40, P72, DOI 10.1136/bjsm.2005.020651; JACOBSON NS, 1984, BEHAV THER, V15, P336, DOI 10.1016/S0005-7894(84)80002-7; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Kuehl MD, 2010, CLIN J SPORT MED, V20, P86, DOI 10.1097/JSM.0b013e3181cf4534; Lancaster MA, 2016, CLIN NEUROPSYCHOL, V30, P321, DOI 10.1080/13854046.2016.1138504; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 2001, CLIN J SPORT MED, V11, P176, DOI 10.1097/00042752-200107000-00008; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; National Collegiate Athletic Association, 2014, CONC MAN DIAGN BEST; Nelson LD, 2016, NEUROLOGY, V86, P1856, DOI 10.1212/WNL.0000000000002679; Parsons TD, 2009, INT J NEUROSCI, V119, P492, DOI 10.1080/00207450802330876; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Solomon GS, 2016, PHYSICIAN SPORTSMED, V44, P14, DOI 10.1080/00913847.2016.1121091; Spira JL, 2014, J NEUROTRAUM, V31, P1823, DOI 10.1089/neu.2014.3363; Yang JZ, 2015, DEV NEUROPSYCHOL, V40, P18, DOI 10.1080/87565641.2014.973499; Yengo-Kahn AM, 2015, PHYSICIAN SPORTSMED, V43, P227, DOI 10.1080/00913847.2015.1071638	35	15	15	9	25	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	JUN	2018	46	7					1742	1751		10.1177/0363546518765145			10	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Sport Sciences	GH7IJ	WOS:000433616400030	29672135				2022-02-06	
J	Cai, YL; Wu, SJ; Zhao, W; Li, ZG; Wu, ZY; Ji, SB				Cai, Yunliang; Wu, Shaoju; Zhao, Wei; Li, Zhigang; Wu, Zheyang; Ji, Songbai			Concussion classification via deep learning using whole-brain white matter fiber strains	PLOS ONE			English	Article							INJURY PREDICTION; VERIFICATION; RESPONSES	Developing an accurate and reliable injury predictor is central to the biomechanical studies of traumatic brain injury. State-of-the-art efforts continue to rely on empirical, scalar metrics based on kinematics or model-estimated tissue responses explicitly pre-defined in a specific brain region of interest. They could suffer from loss of information. A single training dataset has also been used to evaluate performance but without cross-validation. In this study, we developed a deep learning approach for concussion classification using implicit features of the entire voxel-wise white matter fiber strains. Using reconstructed American National Football League (NFL) injury cases, leave-one-out cross-validation was employed to objectively compare injury prediction performances against two baseline machine learning classifiers (support vector machine (SVM) and random forest (RF)) and four scalar metrics via univariate logistic regression (Brain Injury Criterion (BrIC), cumulative strain damage measure of the whole brain (CSDM-WB) and the corpus callosum (CSDM-CC), and peak fiber strain in the CC). Feature-based machine learning classifiers including deep learning, SVM, and RF consistently outperformed all scalar injury metrics across all performance categories (e.g., leave-one-out accuracy of 0.828-0.862 vs. 0.690-0.776, and .632+ error of 0.148 +/- 0.176 vs. 0.207-0.292). Further, deep learning achieved the best cross-validation accuracy, sensitivity, AUC, and .632+ error. These findings demonstrate the superior performances of deep learning in concussion prediction and suggest its promise for future applications in biomechanical investigations of traumatic brain injury.	[Cai, Yunliang; Wu, Shaoju; Zhao, Wei; Ji, Songbai] Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA; [Li, Zhigang] Dartmouth Coll, Geisel Sch Med, Dept Biomed Data Sci, Hanover, NH 03755 USA; [Wu, Zheyang] Worcester Polytech Inst, Dept Math Sci, Worcester, MA 01609 USA; [Ji, Songbai] Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA		Ji, SB (corresponding author), Worcester Polytech Inst, Dept Biomed Engn, Worcester, MA 01609 USA.; Ji, SB (corresponding author), Worcester Polytech Inst, Dept Mech Engn, Worcester, MA 01609 USA.	sji@wpi.edu	WU, SHAOJU/S-1930-2019; Cai, Yunliang/AAF-2375-2019	Ji, Songbai/0000-0002-2886-5781	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 NS092853, R21 NS088781]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA023108] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [P20GM104416] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS092853, R21NS088781] Funding Source: NIH RePORTER	Funding is provided by the NIH grants R01 NS092853 and R21 NS088781. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	A KB, 2015, ACAD EMERG MED, P22; Anderson Andrew E., 2007, Computer Methods in Biomechanics and Biomedical Engineering, V10, P171, DOI 10.1080/10255840601160484; Beleites C, 2005, CHEMOMETR INTELL LAB, V79, P91, DOI 10.1016/j.chemolab.2005.04.008; Bengio Yoshua, 2012, Neural Networks: Tricks of the Trade. Second Edition: LNCS 7700, P437, DOI 10.1007/978-3-642-35289-8_26; Bengio Y, 2013, IEEE T PATTERN ANAL, V35, P1798, DOI 10.1109/TPAMI.2013.50; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Billones CD, 2016, PROCEEDINGS OF THE 2016 IEEE REGION 10 CONFERENCE (TENCON), P3724, DOI 10.1109/TENCON.2016.7848755; Bishop C.M., 1995, AGR ENG INT J SCI RE, DOI [10.1016/S0065-2458(08)60404-0, DOI 10.1016/S0065-2458(08)60404-0]; Bishop C.M., 2006, J ELECTRON IMAGING, V4, P738, DOI 10.1117/1.2819119; Breiman L, 2001, MACH LEARN, V45, P5, DOI 10.1023/A:1010933404324; Cai Y, 2016, LECT NOTES COMPUT SC, V10154, P259, DOI 10.1007/978-3-319-55524-9_24; CDC, 2015, REP C TRAUM BRAIN IN, DOI [10.1161/HYPERTENSIONAHA.111.186106, DOI 10.1161/HYPERTENSIONAHA.111.186106]; Chen YW, 2006, STUD FUZZ SOFT COMP, V207, P315; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Cybenko G., 1989, MATH CONTROL SIGNAL; de Brebisson Alexandre, 2015, 2015 IEEE Conference on Computer Vision and Pattern Recognition Workshops (CVPRW), P20, DOI 10.1109/CVPRW.2015.7301312; Duhaime AC, 2012, J NEUROSURG, V117, P1092, DOI 10.3171/2012.8.JNS112298; Eppinger RH, 1995, STAPP CAR CRASH J, V38, P145; Fan Y, 2005, LECT NOTES COMPUT SC, V3749, P1; Gabler LF, 2016, ANN BIOMED ENG, V44, P3705, DOI 10.1007/s10439-016-1697-0; Giordano C, 2014, STAPP CAR CRASH J, P29; Graham R, 2014, SPORTS RELATED CONCU; Gray KR, 2013, NEUROIMAGE, V65, P167, DOI 10.1016/j.neuroimage.2012.09.065; Greenspan H, 2016, IEEE T MED IMAGING, V35, P1153, DOI 10.1109/TMI.2016.2553401; Gupta V, 2017, BIORXIV, DOI [10.1007/978-3-319-66182-7_63, DOI 10.1007/978-3-319-66182-7_63]; Guyon I, 2006, STUD FUZZ SOFT COMP, V207, P1; Hastie T., 2008, RANDOM FORESTS, DOI DOI 10.1007/978-0-387-84858-7_15; Hernandez F, 2015, ANN BIOMED ENG, V43, P1918, DOI 10.1007/s10439-014-1212-4; Hinton GE, 2006, SCIENCE, V313, P504, DOI 10.1126/science.1127647; Hinton GE, 2006, NEURAL COMPUT, V18, P1527, DOI 10.1162/neco.2006.18.7.1527; Ioannidou A, 2017, ACM COMPUT SURV, V50, DOI 10.1145/3042064; Ioffe S, 2015, PR MACH LEARN RES, V37, P448; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Jia YQ, 2014, PROCEEDINGS OF THE 2014 ACM CONFERENCE ON MULTIMEDIA (MM'14), P675, DOI 10.1145/2647868.2654889; Kamnitsas K, 2016, LECT NOTES COMPUT SC, V10154, P138, DOI 10.1007/978-3-319-55524-9_14; Khvostikov A, 2018, 3D CNN BASED CLASSIF; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; King A. I., 2003, IRCOBI C LISB PORT; Kingma D.P., 2015, P 3 INT C LEARN REPR, DOI DOI 10.1145/1830483.1830503; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Kuo C, 2018, BIOMECH MODEL MECHAN, V17, P235, DOI 10.1007/s10237-017-0957-8; Lecun Y, 1998, P IEEE, V86, P2278, DOI 10.1109/5.726791; Lecun Y, 1998, NEURAL NETWORKS TRIC, P1689, DOI [10.1017/CBO9781107415324.004, DOI 10.1017/CBO9781107415324.004]; LeCun Y, 2015, NATURE, V521, P436, DOI 10.1038/nature14539; Litjens G, 2017, MED IMAGE ANAL, V42, P60, DOI 10.1016/j.media.2017.07.005; Nair V., 2010, P 27 INT C MACH LEAR; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Nisbet R., 2009, HDB STAT ANAL DATA M; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; Ruck D, 1990, IEEE T; RUMELHART DE, 1986, NATURE, V323, P533, DOI 10.1038/323533a0; Salakhutdinov R., 2009, J MACH LEARN RES, P448, DOI DOI 10.1109/CVPRW.2009.5206577; Schmidhuber J, 2015, NEURAL NETWORKS, V61, P85, DOI 10.1016/j.neunet.2014.09.003; Shi J, 2018, IEEE J BIOMED HEALTH, V22, P173, DOI 10.1109/JBHI.2017.2655720; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takahashi Y., 2015, 2015011439 SAE, DOI DOI 10.4271/2015-01-1439; Takhounts EG, 2013, STAPP CAR CRASH J, V57, P243, DOI DOI 10.4271/2013-22-0010; Tibshirani R, 1996, NEURAL COMPUT, V8, P152, DOI 10.1162/neco.1996.8.1.152; Vu TD, 2017, INT CONF BIG DATA, P309, DOI 10.1109/BIGCOMP.2017.7881683; Wagner R, LEARNING CONVOLUTION; Wang SQ, 2017, LECT NOTES COMPUT SC, V10613, P373, DOI 10.1007/978-3-319-68600-4_43; Wu GR, 2013, LECT NOTES COMPUT SC, V8150, P649, DOI 10.1007/978-3-642-40763-5_80; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhao W, 2017, ANN BIOMED ENG, V45, P2437, DOI 10.1007/s10439-017-1888-3; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P1709, DOI 10.1007/s10237-017-0915-5; Zhao W, 2017, BIOMECH MODEL MECHAN, V16, P449, DOI 10.1007/s10237-016-0829-7; Zhao W, 2016, J NEUROTRAUM, V33, P1834, DOI 10.1089/neu.2015.4239	69	15	15	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197992	10.1371/journal.pone.0197992			21	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	WOS:000433084300110	29795640	gold, Green Published, Green Submitted			2022-02-06	
J	Wulsin, AC; Franco-Villanueva, A; Romancheck, C; Morano, RL; Smith, BL; Packard, BA; Danzer, SC; Herman, JP				Wulsin, Aynara C.; Franco-Villanueva, Ana; Romancheck, Christian; Morano, Rachel L.; Smith, Brittany L.; Packard, Benjamin A.; Danzer, Steve C.; Herman, James P.			Functional disruption of stress modulatory circuits in a model of temporal lobe epilepsy	PLOS ONE			English	Article							C-FOS EXPRESSION; INDUCED STATUS-EPILEPTICUS; PITUITARY-ADRENOCORTICAL AXIS; TRAUMATIC BRAIN-INJURY; MESSENGER-RNA LEVELS; PILOCARPINE MODEL; RESTRAINT STRESS; TIME-COURSE; RAT-BRAIN; SPONTANEOUS SEIZURES	Clinical data suggest that the neuroendocrine stress response is chronically dysregulated in a subset of patients with temporal lobe epilepsy (TLE), potentially contributing to both disease progression and the development of psychiatric comorbidities such as anxiety and depression. Whether neuroendocrine dysregulation and psychiatric comorbidities reflect direct effects of epilepsy-related pathologies, or secondary effects of disease burden particular to humans with epilepsy (i.e. social estrangement, employment changes) is not clear. Animal models provide an opportunity to dissociate these factors. Therefore, we queried whether epileptic mice would reproduce neuroendocrine and behavioral changes associated with human epilepsy. Male FVB mice were exposed to pilocarpine to induce status epilepticus (SE) and the subsequent development of spontaneous recurrent seizures. Morning baseline corticosterone levels were elevated in pilocarpine treated mice at 1, 7 and 10 weeks post-SE relative to controls. Similarly, epileptic mice had increased adrenal weight when compared to control mice. Exposure to acute restraint stress resulted in hypersecretion of corticosterone 30 min after the onset of the challenge. Anatomical analyses revealed reduced Fos expression in infralimbic and prelimbic prefrontal cortex, ventral subiculum and basal amygdala following restraint. No differences in Fos immunoreactivity were found in the paraventricular nucleus of the hypothalamus, hippocampal subfields or central amygdala. In order to assess emotional behavior, a second cohort of mice underwent a battery of behavioral tests, including sucrose preference, open field, elevated plus maze, 24h home-cage monitoring and forced swim. Epileptic mice showed increased anhedonic behavior, hyperactivity and anxiety-like behaviors. Together these data demonstrate that epileptic mice develop HPA axis hyperactivity and exhibit behavioral dysfunction. Endocrine and behavioral changes are associated with impaired recruitment of forebrain circuits regulating stress inhibition and emotional reactivity. Loss of forebrain control may underlie pronounced endocrine dysfunction and comorbid psychopathologies seen in temporal lobe epilepsy.	[Wulsin, Aynara C.; Franco-Villanueva, Ana; Romancheck, Christian; Morano, Rachel L.; Smith, Brittany L.; Packard, Benjamin A.; Herman, James P.] Univ Cincinnati, Sch Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45220 USA; [Wulsin, Aynara C.; Danzer, Steve C.] Cincinnati Childrens Hosp Med Ctr, Dept Anesthesia, Cincinnati, OH USA		Herman, JP (corresponding author), Univ Cincinnati, Sch Med, Dept Psychiat & Behav Neurosci, Cincinnati, OH 45220 USA.	james.herman@uc.edu	Franco-Villanueva, Ana/X-9013-2019	Franco-Villanueva, Ana/0000-0003-4971-0591; Wulsin, Aynara/0000-0002-4501-6845	University of Cincinnati Retention;  [R01-NS-062806];  [R01-NS-065020];  [T32-GM063483];  [F30-NS-095578]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM063483] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065020, F30NS095578, R01NS062806] Funding Source: NIH RePORTER	This work was supported by University of Cincinnati Retention Grant to James Herman, R01-NS-062806 and R01-NS-065020 to SCD, T32-GM063483 and F30-NS-095578 to ACW. The University of Cincinnati nor NIH had further role in the study design; data collection, analysis and interpretation; writing of the report nor in the decision to submit for publication.	Allendorfer JB, 2014, EPILEPSY BEHAV, V36, P115, DOI 10.1016/j.yebeh.2014.05.003; Barros VN, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00072; Bernasconi N, 2003, BRAIN, V126, P462, DOI 10.1093/brain/awg034; Buckmaster PS, 2012, EPILEPSY RES, V102, P153, DOI 10.1016/j.eplepsyres.2012.05.012; Castro OW, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046044; CAVALHEIRO EA, 1991, EPILEPSIA, V32, P778, DOI 10.1111/j.1528-1157.1991.tb05533.x; CHEN X, 1995, NEUROSCIENCE, V64, P675, DOI 10.1016/0306-4522(94)00532-A; Chowdhury GMI, 2000, BRAIN RES BULL, V52, P171; CULLINAN WE, 1995, NEUROSCIENCE, V64, P477, DOI 10.1016/0306-4522(94)00355-9; Curia G, 2014, CURR MED CHEM, V21, P663, DOI 10.2174/0929867320666131119152201; Curia G, 2008, J NEUROSCI METH, V172, P143, DOI 10.1016/j.jneumeth.2008.04.019; De Kloet ER, 2016, COPING FORCED SWIM S, P2016; de Oliveira CV, 2015, PHYSIOL BEHAV, V143, P142, DOI 10.1016/j.physbeh.2015.03.004; do Nascimento AL, 2012, BRAIN RES, V1470, P98, DOI 10.1016/j.brainres.2012.06.008; Engel J, 1996, EPILEPSY RES, V26, P141, DOI 10.1016/S0920-1211(96)00043-5; FELDMAN RG, 1976, J NERV MENT DIS, V162, P345, DOI 10.1097/00005053-197605000-00005; Figueiredo HF, 2003, EUR J NEUROSCI, V18, P2357, DOI 10.1046/j.1460-9568.2003.02932.x; Giordano C, 2016, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00281; Giordano C, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141221; Groticke I, 2007, EXP NEUROL, V207, P329, DOI 10.1016/j.expneurol.2007.06.021; Haneef Z, 2014, EPILEPSIA, V55, P137, DOI 10.1111/epi.12476; Herman JP, 2006, BEHAV BRAIN RES, V174, P215, DOI 10.1016/j.bbr.2006.05.035; Herman JP, 2016, COMPR PHYSIOL, V6, P603, DOI 10.1002/cphy.c150015; Herman JP, 2005, PROG NEURO-PSYCHOPH, V29, P1201, DOI 10.1016/j.pnpbp.2005.08.006; Herman JP, 2003, FRONT NEUROENDOCRIN, V24, P151, DOI 10.1016/j.yfrne.2003.07.001; Hester MS, 2016, EXP NEUROL, V280, P1, DOI 10.1016/j.expneurol.2016.03.015; Hester MS, 2014, EPILEPSY BEHAV, P2, DOI [DOI 10.1016/J.YEBEH.2013.12.022, 10.1016/j.yebeh.2013.12.022]; Hosford B, 2016, J NEUROSCI; Howell K, 2002, EXP PHYSIOL, V87, P747, DOI 10.1113/eph8702477; Jankord R, 2008, ANN NY ACAD SCI, V1148, P64, DOI 10.1196/annals.1410.012; Kanner AM, 2003, BIOL PSYCHIAT, V54, P388, DOI 10.1016/S0006-3223(03)00469-4; Klein S, 2015, EXP NEUROL, V263, P263, DOI 10.1016/j.expneurol.2014.09.004; Kling MA, 2009, DEPRESS ANXIETY, V26, P641, DOI 10.1002/da.20546; Kondziella D, 2007, J NEUROCHEM, V103, P2136, DOI 10.1111/j.1471-4159.2007.04926.x; Lopes MW, 2016, EPILEPSY BEHAV, V55, P92, DOI 10.1016/j.yebeh.2015.12.001; Maccotta L, 2013, NEUROIMAGE-CLIN, V2, P862, DOI 10.1016/j.nicl.2013.06.011; Mahbod P, 2018, ENDOCRINOLOGY, V159, P388, DOI 10.1210/en.2017-00540; Marques AH, 2009, ANN NY ACAD SCI, V1179, P1, DOI 10.1111/j.1749-6632.2009.04987.x; Martinez M, 2002, STRESS, V5, P3, DOI 10.1080/102538902900012369; Mathern GW, 2002, PROG BRAIN RES, V135, P237; Matsuda S, 1996, NEUROSCI RES, V26, P157, DOI 10.1016/S0168-0102(96)01088-7; Mazarati AM, 2009, NEUROBIOL DIS, V34, P457, DOI 10.1016/j.nbd.2009.02.018; McCullers DL, 2001, J NEUROSCI RES, V64, P277; McCullers DL, 2002, BRAIN RES, V947, P41, DOI 10.1016/S0006-8993(02)02904-9; McEwen BS, 2016, NEUROPSYCHOPHARMACOL, V41, P3, DOI 10.1038/npp.2015.171; McKlveen JM, 2015, J NEUROENDOCRINOL, V27, P446, DOI 10.1111/jne.12272; MORGAN JI, 1995, TRENDS NEUROSCI, V18, P66; Muller CJ, 2009, EXP NEUROL, V219, P284, DOI 10.1016/j.expneurol.2009.05.035; Mustafa T, 2015, STRESS, V18, P408, DOI 10.3109/10253890.2015.1025044; Myers B, 2012, CELL MOL NEUROBIOL, V32, P683, DOI 10.1007/s10571-012-9801-y; O'Mahony CM, 2010, BEHAV BRAIN RES, V213, P148, DOI 10.1016/j.bbr.2010.04.038; O'Toole KK, 2014, EPILEPSY RES, V108, P29, DOI 10.1016/j.eplepsyres.2013.10.013; Pariante CM, 2008, TRENDS NEUROSCI, V31, P464, DOI 10.1016/j.tins.2008.06.006; Peng ZC, 2005, J NEUROSCI, V25, P7210, DOI 10.1523/JNEUROSCI.0838-05.2005; Pittau F, 2012, EPILEPSIA, V53, P1013, DOI 10.1111/j.1528-1167.2012.03464.x; Sah P, 2003, PHYSIOL REV, V83, P803, DOI 10.1152/physrev.00002.2003; Sapolsky RM, 2000, ARCH GEN PSYCHIAT, V57, P925, DOI 10.1001/archpsyc.57.10.925; Sarkisova K, 2011, PROG NEURO-PSYCHOPH, V35, P854, DOI 10.1016/j.pnpbp.2010.11.010; Savitz JB, 2009, NEUROSCIENCE, V164, P300, DOI 10.1016/j.neuroscience.2009.03.082; Shibley H, 2002, EPILEPSY RES, V49, P109, DOI 10.1016/S0920-1211(02)00012-8; Singewald N, 2007, NEUROSCI BIOBEHAV R, V31, P18, DOI 10.1016/j.neubiorev.2006.02.003; Solomon MB, 2010, J NEUROENDOCRINOL, V22, P13, DOI 10.1111/j.1365-2826.2009.01933.x; Soussi R, 2015, BRAIN STRUCT FUNCT, V220, P2449, DOI 10.1007/s00429-014-0800-2; Spencer SS, 2002, EPILEPSIA, V43, P219, DOI 10.1046/j.1528-1157.2002.26901.x; Steimer T, 2002, DIALOGUES CLIN NEURO, P4; Stewart LS, 2003, EPILEPSY BEHAV, V4, P153, DOI 10.1016/S1525-5050(03)00006-4; Suleymanova EM, 2016, NEUROSCIENCE, V315, P79, DOI 10.1016/j.neuroscience.2015.11.061; Tsukiyama N, 2011, STRESS, V14, P368, DOI 10.3109/10253890.2010.544345; Ulrich-Lai YM, 2009, NAT REV NEUROSCI, V10, P397, DOI 10.1038/nrn2647; Umeoka EHL, 2011, BRAIN RES, V1381, P141, DOI 10.1016/j.brainres.2011.01.042; Vahl TP, 2005, AM J PHYSIOL-ENDOC M, V289, pE823, DOI 10.1152/ajpendo.00122.2005; Varga D, 2015, FRONT BEHAV NEUROSCI, V9, P14, DOI 10.3389/fnbeh.2015.00157; Vollmer LL, 2016, BIOL PSYCHIAT, V80, P541, DOI 10.1016/j.biopsych.2016.04.022; Warden MR, 2012, NATURE, V492, P428, DOI 10.1038/nature11617; Webb NE, 2014, NEUROREHABILITATION, V34, P625, DOI 10.3233/NRE-141074; Weinberg MS, 2007, NEUROSCIENCE, V150, P478, DOI 10.1016/j.neuroscience.2007.09.013; Wieser HG, 2004, EPILEPSIA, V45, P32; Wulsin AC, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00214; Wulsin AC, 2016, PHYSIOL BEHAV, V166, P22, DOI 10.1016/j.physbeh.2016.05.015; Wulsin AC, 2010, PSYCHONEUROENDOCRINO, V35, P1100, DOI 10.1016/j.psyneuen.2010.01.011; Yang JX, 2015, J NEUROSCI, V35, P36, DOI 10.1523/JNEUROSCI.1161-14.2015; Zobel A, 2004, EUR ARCH PSY CLIN N, V254, P303, DOI 10.1007/s00406-004-0499-9	82	15	16	0	6	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	MAY 24	2018	13	5							e0197955	10.1371/journal.pone.0197955			19	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GH0HY	WOS:000433084300103	29795651	Green Submitted, Green Published, gold			2022-02-06	
J	Atsumi, N; Nakahira, Y; Tanaka, E; Iwamoto, M				Atsumi, Noritoshi; Nakahira, Yuko; Tanaka, Eiichi; Iwamoto, Masami			Human Brain Modeling with Its Anatomical Structure and Realistic Material Properties for Brain Injury Prediction	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Traumatic brain injury; Diffuse axonal injury; Constitutive model; Anisotropy; Viscoelasticity; Brain FE model; Accident reconstruction analyses	AXONAL DAMAGE; ANISOTROPY; HEAD	Impairments of executive brain function after traumatic brain injury (TBI) due to head impacts in traffic accidents need to be obviated. Finite element (FE) analyses with a human brain model facilitate understanding of the TBI mechanisms. However, conventional brain FE models do not suitably describe the anatomical structure in the deep brain, which is a critical region for executive brain function, and the material properties of brain parenchyma. In this study, for better TBI prediction, a novel brain FE model with anatomical structure in the deep brain was developed. The developed model comprises a constitutive model of brain parenchyma considering anisotropy and strain rate dependency. Validation was performed against postmortem human subject test data associated with brain deformation during head impact. Brain injury analyses were performed using head acceleration curves obtained from reconstruction analysis of rear-end collision with a human whole-body FE model. The difference in structure was found to affect the regions of strain concentration, while the difference in material model contributed to the peak strain value. The injury prediction result by the proposed model was consistent with the characteristics in the neuroimaging data of TBI patients due to traffic accidents.	[Atsumi, Noritoshi; Nakahira, Yuko; Iwamoto, Masami] Toyota Cent R&D Labs, Human Sci Res Domain, 41-1 Yokomichi, Nagakute, Aichi 4801192, Japan; [Tanaka, Eiichi] Nagoya Univ, Grad Sch Engn, Dept Mech Sci & Engn, Chikusa Ku, Furo Cho, Nagoya, Aichi 4648603, Japan; [Tanaka, Eiichi] Tokai Polytech Coll, 1-2 Furukawa, Ono, Gifu 5010502, Japan		Atsumi, N (corresponding author), Toyota Cent R&D Labs, Human Sci Res Domain, 41-1 Yokomichi, Nagakute, Aichi 4801192, Japan.	atsumi@mosk.tytlabs.co.jp					Asano Y, 2012, NEUROL MED-CHIR, V52, P31, DOI 10.2176/nmc.52.31; Atsumi N, 2016, 2016011485 SAE; Atsumi N., 2016, INT J VEH SAF, V9, P1, DOI [10.1504/ijvs.2016.077145, DOI 10.1504/IJVS.2016.077145]; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; El Sayed T, 2008, J BIOMECH, V41, P1458, DOI 10.1016/j.jbiomech.2008.02.023; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Franklyn Melanie, 2005, Stapp Car Crash J, V49, P1; Gehre C., 2011, P 22 ESV C; Gehre C., 2009, P 21 ESV C; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Giordano C., 2016, STAPP CAR CRASH J, V60, P336; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Giordano C, 2014, J R SOC INTERFACE, V11, DOI 10.1098/rsif.2013.0914; Hagmann P, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000597; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holzapfel G. A., 2000, NONLINEAR SOLID MECH, P282; Hrapko M, 2006, BIORHEOLOGY, V43, P623; HUMPHREY JD, 1990, J BIOMECH ENG-T ASME, V112, P333, DOI 10.1115/1.2891193; Ito D, 2010, J MECH BEHAV BIOMED, V3, P85, DOI 10.1016/j.jmbbm.2009.05.001; Iwamoto M., 2017, P 4 FAST ZER C; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; Krafft M., 1998, P 16 ESV C; Mao HJ, 2013, J BIOMECH ENG-T ASME, V135, DOI 10.1115/1.4025101; Maxwell WL, 1997, J NEUROTRAUM, V14, P419, DOI 10.1089/neu.1997.14.419; Medana IM, 2003, BRAIN, V126, P515, DOI 10.1093/brain/awg061; Miller LE, 2017, COMPUT METHOD BIOMEC, V20, P1273, DOI 10.1080/10255842.2017.1340462; Nakayama N, 2006, J NEUROL NEUROSUR PS, V77, DOI 10.1136/jnnp.2005.077875; OGDEN RW, 1972, PROC R SOC LON SER-A, V328, P567, DOI 10.1098/rspa.1972.0096; Rashid B, 2014, J MECH BEHAV BIOMED, V33, P43, DOI 10.1016/j.jmbbm.2012.07.015; Sahoo D., 2015, P IRCOBI C; Sahoo D, 2014, J MECH BEHAV BIOMED, V33, P24, DOI 10.1016/j.jmbbm.2013.08.022; Schunke M, 2009, PROMETHEUS LERNATLAS, P292; Shinoda J., 2013, JPN J NEUROSURG TOKY, V22, P842, DOI DOI 10.7887/JCNS.22.842; Shinoda Jun, 2011, No Shinkei Geka, V39, P115; Smith DH, 2000, J NEUROSURG, V93, P315, DOI 10.3171/jns.2000.93.2.0315; The International Organization for Standardization (ISO), 2013, 16250 ISO ISOTR; The International Organization for Standardization (ISO), 1999, 9790 ISO ISOTR; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	43	15	15	5	18	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	MAY	2018	46	5					736	748		10.1007/s10439-018-1988-8			13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	GC5GP	WOS:000429815200007	29404847				2022-02-06	
J	Celius, EG; Vila, C				Celius, Elisabeth G.; Vila, Carlos			The influence of THC:CBD oromucosal spray on driving ability in patients with multiple sclerosis-related spasticity	BRAIN AND BEHAVIOR			English	Article						driving ability; multiple sclerosis; oromucosal; Sativex; spasticity; tetrahydrocannabinol/cannabidiol	MOTOR-VEHICLE CRASHES; POSTMARKETING SAFETY REGISTRY; TRAUMATIC BRAIN-INJURY; MARIJUANA USE; CANNABIS; DELTA(9)-TETRAHYDROCANNABINOL; SATIVEX(R); SYMPTOMS; DRIVERS; RISK	Background: Driving ability is a key function for the majority of patients with multiple sclerosis (MS) to help maintain daily interactions. Both physical and cognitive disability, as well as treatments, may affect the ability to drive. Spasticity is a common symptom associated with MS, and it may affect driving performance either directly or via the medications used to treat it. In this article, we review the evidence relating the antispasticity medicine, Delta(9)-tetrahydrocannabinol:cannabidiol (THC:CBD) oromucosal spray (Sativex((R))), and its potential impact on driving performance. Methods: Articles were identified by searching PubMed from 1/1/2000 to 30/6/2017 using a specified list of search terms. The articles identified using these search terms were augmented with relevant references from these papers and other articles known to the authors. Results: The results from THC:CBD oromucosal spray driving studies and real-world registries did not show any evidence of an increase in motor vehicle accidents associated with THC:CBD oromucosal spray. The majority of patients reported an improvement in driving ability after starting THC:CBD oromucosal spray, and it was speculated that this may be related to reduced spasticity and/or better cognitive function. It should be noted that THC blood levels are significantly lower than the levels associated with recreational use of herbal cannabis. Conclusions: THC:CBD oromucosal spray was shown not to impair driving performance. However, periodic assessment of patients with MS driving ability is recommended, especially after relapses and changes in treatment. Blood THC measurements might be above authorized thresholds for some countries following administration of THC:CBD oromucosal spray, thus specific knowledge of each country's driving regulations and a medical certificate are recommended.	[Celius, Elisabeth G.] Univ Oslo, Oslo Univ Hosp, Dept Neurol, Oslo, Norway; [Celius, Elisabeth G.] Univ Oslo, Inst Hlth & Soc, Oslo, Norway; [Vila, Carlos] Almirall Neurol Global Med Affairs, Barcelona, Spain		Celius, EG (corresponding author), Oslo Univ Hosp, Dept Neurol, Oslo, Norway.	uxelgu@ous-hf.no	Celius, Elisabeth Gulowsen/S-1387-2019	Celius, Elisabeth Gulowsen/0000-0002-9127-6488	Almirall SAAlmirall	Editorial support in the preparation of the manuscript was provided by Dr Steve Clissold (Content Ed Net, Spain) which was funded by Almirall SA.	[Anonymous], 2017, SUMMARY PRODUCT CHAR; Asbridge M, 2012, BMJ-BRIT MED J, V344, DOI 10.1136/bmj.e536; Badenes D, 2014, J INT NEUROPSYCH SOC, V20, P555, DOI 10.1017/S1355617714000368; Berning A., 2017, 812118 DOT HS NAT HI; Coclitu C, 2016, EXPERT REV NEUROTHER, V16, P1341, DOI 10.1080/14737175.2016.1243056; Cofield SS, 2017, NEUROL-CLIN PRACT, V7, P333, DOI 10.1212/CPJ.0000000000000383; Coleman RD, 2002, ARCH PHYS MED REHAB, V83, P1415, DOI 10.1053/apmr.2002.35111; Collin C, 2007, EUR J NEUROL, V14, P290, DOI 10.1111/j.1468-1331.2006.01639.x; Collin C, 2010, NEUROL RES, V32, P451, DOI 10.1179/016164109X12590518685660; Drummer OH, 2004, ACCIDENT ANAL PREV, V36, P239, DOI 10.1016/S0001-4575(02)00153-7; Etges T, 2015, MULT SCLER J, V21, P610; Etges T, 2016, THER CLIN RISK MANAG, V12, P1667, DOI 10.2147/TCRM.S115014; European Monitoring Centre for Drugs and Drug Addiction, 2008, DRUG US IMP DRIV TRA; Flachenecker P, 2016, NEURODEGENER DIS MAN, V6, P9, DOI 10.2217/nmt-2016-0047; Flachenecker P, 2014, EUR NEUROL, V71, P271, DOI 10.1159/000357427; Freidel M, 2015, ACTA NEUROL SCAND, V131, P9, DOI 10.1111/ane.12287; GOVUK, 2017, DRUGS DRIV LAW; GOVUK, 2017, DRUG DRIV; Grotenhermen F, 2007, ADDICTION, V102, P1910, DOI 10.1111/j.1360-0443.2007.02009.x; Guevara CO, 2015, CLIN EXP PHARMACOL P, V05, DOI [10.4172/2161-1459.1000184, DOI 10.4172/2161-1459.1000184]; Hartman RL, 2013, CLIN CHEM, V59, P478, DOI 10.1373/clinchem.2012.194381; Huestis MA, 2004, J ANAL TOXICOL, V28, P394, DOI 10.1093/jat/28.6.394; HUESTIS MA, 1992, J ANAL TOXICOL, V16, P276, DOI 10.1093/jat/16.5.276; Jagatsinh Y, 2009, INDIAN J ORTHOP, V43, P46, DOI 10.4103/0019-5413.45323; Karschner EL, 2011, CLIN CHEM, V57, P66, DOI 10.1373/clinchem.2010.152439; Kelly E, 2004, DRUG ALCOHOL REV, V23, P319, DOI 10.1080/09595230412331289482; Kister Ilya, 2013, Int J MS Care, V15, P146, DOI 10.7224/1537-2073.2012-053; KNECHT J, 1977, SCHWEIZ MED WSCHR, V107, P373; Kotterba S, 2003, EUR NEUROL, V50, P160, DOI 10.1159/000073057; Kust J, 2014, NERVENARZT, V85, P829, DOI 10.1007/s00115-014-4009-7; Lacey J., 2009, 811249 DOT HS NAT HI; Landro NI, 2000, ARCH CLIN NEUROPSYCH, V15, P37, DOI 10.1016/S0887-6177(98)00151-6; Lenne MG, 2010, ACCIDENT ANAL PREV, V42, P859, DOI 10.1016/j.aap.2009.04.021; Lerdal A, 2003, MULT SCLER J, V9, P509, DOI 10.1191/1352458503ms943oa; Li MC, 2012, EPIDEMIOL REV, V34, P65, DOI 10.1093/epirev/mxr017; Lings Svend, 2002, Ugeskr Laeger, V164, P5134; Marcotte TA, 2008, ARCH PHYS MED REHAB, V89, P1753, DOI 10.1016/j.apmr.2007.12.049; McCabe MP, 2002, J CLIN PSYCHOL MED S, V9, P287, DOI 10.1023/A:1020734901150; Murphy N, 1998, PHARMACOECONOMICS, V13, P607, DOI 10.2165/00019053-199813050-00013; Neale J., 2000, RECREATIONAL DRUG US; Niewoehner P., 2017, DRIVING MULTIPLE SCL; Novotna A, 2011, EUR J NEUROL, V18, P1122, DOI 10.1111/j.1468-1331.2010.03328.x; Patti F, 2016, J NEUROL NEUROSUR PS, V87, P944, DOI 10.1136/jnnp-2015-312591; Pugliatti M, 2006, EUR J NEUROL, V13, P700, DOI 10.1111/j.1468-1331.2006.01342.x; Ramaekers JG, 2004, DRUG ALCOHOL DEPEN, V73, P109, DOI 10.1016/j.drugalcdep.2003.10.008; Ranchet M, 2015, ARCH PHYS MED REHAB, V96, P1840, DOI 10.1016/j.apmr.2015.06.010; Rapport L, 2006, J HEAD TRAUMA REHAB, V21, P34, DOI 10.1097/00001199-200601000-00004; Rogeberg O, 2016, ADDICTION, V111, P1348, DOI 10.1111/add.13347; Ronen A, 2010, ACCIDENT ANAL PREV, V42, P1855, DOI 10.1016/j.aap.2010.05.006; Ryan KA, 2009, J CLIN EXP NEUROPSYC, V31, P126, DOI 10.1080/13803390802119922; Schanke AK, 2000, SCAND J PSYCHOL, V41, P113, DOI 10.1111/1467-9450.00179; Schultheis MT, 2002, ARCH PHYS MED REHAB, V83, P1175, DOI 10.1053/apmr.2002.34279; Stott CG, 2013, EUR J CLIN PHARMACOL, V69, P1135, DOI 10.1007/s00228-012-1441-0; Substance Abuse and Mental Health Services Administration, 2011, RES 2010 NAT SURV DR; Trojano M, 2015, EUR NEUROL, V74, P178, DOI 10.1159/000441619; United Nations Office On Drugs And Crime (UNODC), 2011, WORLD DRUG REP 2011, P272; Vermersch P, 2015, NEURODEGENER DIS MAN, V5, P23, DOI 10.2217/nmt.15.57; Verstraete A. G., 2017, DRUG USE IMPAIRED DR; Wong Kristin, 2014, Inj Epidemiol, V1, P26; World Health Organization, 2015, GLOB STAT REP ROAD S	60	15	15	0	13	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN, NJ 07030 USA	2162-3279			BRAIN BEHAV	Brain Behav.	MAY	2018	8	5							e00962	10.1002/brb3.962			11	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology	GF4YN	WOS:000431970500014	29761015	Green Published, gold			2022-02-06	
J	Chang, PP; Weykamp, M; Dennahy, IS; Williams, AM; Bhatti, UF; Liu, BL; Nikolian, VC; Li, YQ; Alam, HB				Chang, Panpan; Weykamp, Michael; Dennahy, Isabel S.; Williams, Aaron M.; Bhatti, Umar F.; Liu, Baoling; Nikolian, Vahagn C.; Li, Yongqing; Alam, Hasan B.			Histone deacetylase inhibitors: Isoform selectivity improves survival in a hemorrhagic shock model	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Histone deacetylase inhibitors; isoform-selective; valproic acid; hemorrhagic shock; prosurvival pathways	TRAUMATIC BRAIN-INJURY; VALPROIC ACID; CELL-DEATH; PROSURVIVAL PHENOTYPE; RESUSCITATION FLUIDS; MOLECULAR-MECHANISMS; RAT MODEL; RECOVERY; PHOSPHORYLATION; APOPTOSIS	BACKGROUND Hemorrhage is a leading preventable cause of death. Nonselective histone deacetylase inhibitors (HDACIs), such as valproic acid (VPA), have been shown to improve outcomes in hemorrhagic shock (HS). The HDACs can be divided into four functional classes (I, IIa/IIb, III, and IV). Classes I, IIa/IIb, and III have previously been implicated in the pathophysiology of HS. This study aimed to determine which HDAC class, or classes, are responsible for the survival benefit observed with nonselective HDACIs. METHODS Survival study: Sprague-Dawley rats were subjected to lethal HS (50% hemorrhage) and randomized to the following groups (n = 8): (1) no treatment, (2) normal saline vehicle, (3) cyclodextrin vehicle, (4) MS275 (class I HDACI), (5) VPA (class I/IIa HDACI), (6) MC1568 (class IIa HDACI), (7) ACY1083 (class IIb HDACI), and (8) EX527 (class III HDACI). Survival was monitored for 24 hours. Mechanistic study: Sprague-Dawley rats were subjected to sublethal HS (40% hemorrhage) and randomized to the same groups (n = 3), excluding EX527, based on results of the survival study. Tissues were harvested at 3 hours posttreatment, and expression of phosphorylated-AKT, -catenin, acetylated histones H3 and H4, and acetylated -tubulin were analyzed in myocardial tissue. RESULTS Survival rate was 12.5% in the untreated group, and did not improve with vehicle or MS275 treatment. EX527 improved survival to 50%, although this did not achieve statistical significance (p = 0.082). However, treatment with VPA, MC1568, and ACY1083 improved survival rates to 87.5%, 75%, and 75%, respectively (p < 0.05). The VPA-induced acetylation of both histones H3 and H4, while MC1568 and ACY1083 increased acetylation of histone H4. ACY1083 also induced acetylation of -tubulin. All treatment groups, except MS275, increased phosphorylated-AKT, and -catenin. CONCLUSION Inhibition of HDAC classes IIa or IIb, but not class I, activates prosurvival pathways, which may be responsible for the improved outcomes in rodent models of HS.	[Chang, Panpan] China Med Univ, Hosp 1, Dept Neurosurg, Shenyang, Liaoning, Peoples R China; [Chang, Panpan; Weykamp, Michael; Dennahy, Isabel S.; Williams, Aaron M.; Bhatti, Umar F.; Liu, Baoling; Nikolian, Vahagn C.; Li, Yongqing; Alam, Hasan B.] Univ Michigan Hlth Syst, Dept Surg, Ann Arbor, MI USA		Li, YQ (corresponding author), Univ Michigan Hosp, Dept Surg, 2920,Taubman Ctr 5331,1500 E Med Ctr Dr, Ann Arbor, MI 48109 USA.	yqli@med.umich.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RO1 GM084127]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM084127] Funding Source: NIH RePORTER	Funding: NIH RO1 GM084127 (Alam, HB).	Alam HB, 2017, PLOS MED, V14, DOI 10.1371/journal.pmed.1002350; Bambakidis T, 2015, J SURG RES, V196, P159, DOI 10.1016/j.jss.2015.02.036; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bolden JE, 2006, NAT REV DRUG DISCOV, V5, P769, DOI 10.1038/nrd2133; Bolger TA, 2005, J NEUROSCI, V25, P9544, DOI 10.1523/JNEUROSCI.1826-05.2005; Brogdon JL, 2007, BLOOD, V109, P1123, DOI 10.1182/blood-2006-04-019711; Butler KV, 2010, J AM CHEM SOC, V132, P10842, DOI 10.1021/ja102758v; Butt MU, 2009, J SURG RES, V156, P290, DOI 10.1016/j.jss.2009.04.012; Cardone MH, 1998, SCIENCE, V282, P1318, DOI 10.1126/science.282.5392.1318; Chang ZG, 2015, J TRAUMA ACUTE CARE, V79, P905, DOI 10.1097/TA.0000000000000784; Chen CH, 2015, ONCOTARGET, V6, P35991, DOI 10.18632/oncotarget.5475; Chen H, 2007, RESUSCITATION, V74, P526, DOI 10.1016/j.resuscitation.2007.01.031; Collins LM, 2015, MOL NEUROBIOL, V51, P1432, DOI 10.1007/s12035-014-8820-8; Datta SR, 1997, CELL, V91, P231, DOI 10.1016/S0092-8674(00)80405-5; Dokmanovic M, 2007, MOL CANCER RES, V5, P981, DOI 10.1158/1541-7786.MCR-07-0324; Fischer A, 2007, NATURE, V447, P178, DOI 10.1038/nature05772; Franke TF, 2003, ONCOGENE, V22, P8983, DOI 10.1038/sj.onc.1207115; Fukudome EY, 2010, J SURG RES, V163, P118, DOI 10.1016/j.jss.2010.04.013; Georgoff PE, 2017, CLIN PHARMACOKINET; Gottlicher M, 2004, Ann Hematol, V83 Suppl 1, pS91; Guida N, 2016, TOXICOL SCI, V154, P227, DOI 10.1093/toxsci/kfw157; Halaweish I, 2015, SHOCK, V44, P6, DOI 10.1097/SHK.0000000000000319; Huang XP, 2009, CANCER RES, V69, P8403, DOI 10.1158/0008-5472.CAN-09-2146; Hubbert C, 2002, NATURE, V417, P455, DOI 10.1038/417455a; Hwabejire JO, 2014, J SURG RES, V186, P363, DOI 10.1016/j.jss.2013.09.016; Jin G, 2014, SURGERY, V156, P221, DOI 10.1016/j.surg.2014.03.038; Kauvar DS, 2006, J TRAUMA, V60, pS3, DOI 10.1097/01.ta.0000199961.02677.19; Kochanek AR, 2012, J SURG RES, V176, P185, DOI 10.1016/j.jss.2011.06.007; Lee CC, 2005, SHOCK, V24, P177, DOI 10.1097/01.shk.0000171870.42900.15; LEE HB, 1985, J NUCL MED, V26, P72; Li YQ, 2008, SURGERY, V144, P217, DOI 10.1016/j.surg.2008.03.037; Li YQ, 2015, J TRAUMA ACUTE CARE, V78, P378, DOI 10.1097/TA.0000000000000510; Liu ZC, 2014, SHOCK, V41, P104, DOI 10.1097/SHK.0000000000000074; Martin-Clemente B, 2004, J BIOL CHEM, V279, P52984, DOI 10.1074/jbc.M409028200; Minetti GC, 2006, NAT MED, V12, P1147, DOI 10.1038/nm1479; Nikolian VC, 2017, J TRAUMA ACUTE CARE, V83, P1066, DOI 10.1097/TA.0000000000001612; Pearson WS, 2012, PREHOSP EMERG CARE, V16, P323, DOI 10.3109/10903127.2012.682701; Rhee P, 2003, J TRAUMA, V54, pS52, DOI 10.1097/01.TA.0000064507.80390.10; Routy JP, 2005, LANCET, V366, P523, DOI 10.1016/S0140-6736(05)67074-2; Shang S, 2017, ONCOTARGET, V8, P33972, DOI 10.18632/oncotarget.15687; Shires GT, 2005, AM J SURG, V189, P85, DOI 10.1016/j.amjsurg.2004.06.040; Suliman BA, 2012, IMMUNOL CELL BIOL, V90, P23, DOI 10.1038/icb.2011.92; Thiagalingam S, 2003, ANN NY ACAD SCI, V983, P84, DOI 10.1111/j.1749-6632.2003.tb05964.x; Valkenburg Kenneth C, 2011, Cancers (Basel), V3, P2050, DOI 10.3390/cancers3022050; Wohltmann CD, 2001, AM J SURG, V181, P297, DOI 10.1016/S0002-9610(01)00582-7; Wu Q, 2015, INT J CLIN EXP PATHO, V8, P9360; Zacharias N, 2011, RESUSCITATION, V82, P105, DOI 10.1016/j.resuscitation.2010.09.469; Zhang L, 2014, CHEMMEDCHEM, V9, P638, DOI 10.1002/cmdc.201300297; Zhao T, 2014, J TRAUMA ACUTE CARE, V77, P913, DOI 10.1097/TA.0000000000000347	49	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	MAY	2018	84	5					795	801		10.1097/TA.0000000000001824			7	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	GE7LT	WOS:000431415300015	29401190	Green Accepted			2022-02-06	
J	Moriarty, H; Winter, L; Short, TH; True, G				Moriarty, Helene; Winter, Laraine; Short, Thomas H.; True, Gala			Exploration of Factors Related to Depressive Symptomatology in Family Members of Military Veterans With Traumatic Brain Injury	JOURNAL OF FAMILY NURSING			English	Article						traumatic brain injury; family; military veterans; depression	POSTTRAUMATIC-STRESS-DISORDER; CAREGIVER BURDEN; MENTAL-HEALTH; COMMUNITY REINTEGRATION; PSYCHOLOGICAL DISTRESS; INTERVENTION IMPACT; SOCIAL SUPPORT; TBI; REHABILITATION; AFGHANISTAN	Traumatic brain injury (TBI) is a family affair, affecting those with the injury and their families. Psychological distress, often measured as depression or depressive symptoms, is highly prevalent among family members. Predictors of depression in family members of civilians with TBI have been examined, but predictors of depression in family members of military veterans have received very little research attention and are poorly understood. To address the knowledge gap, this study explored factors related to depressive symptoms in family members of veterans in the United States, using an ecological framework. Baseline data from 83 family members were used. Family members with higher caregiver burden, presence of a veteran with posttraumatic stress disorder (PTSD), and greater financial difficulty experienced significantly more depressive symptoms. Findings suggest that efforts to support family members and decrease their depression should aim to reduce caregiver burden and financial difficulty, and help family members cope with veteran PTSD and TBI. Family-focused interventions are needed.	[Moriarty, Helene] Villanova Univ, Villanova, PA 19085 USA; [Moriarty, Helene] Villanova Univ, Nursing Res, Villanova, PA 19085 USA; [Moriarty, Helene] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia, PA USA; [Winter, Laraine] Corporal Michael J Crescenz Vet Affairs Med Ctr, Philadelphia Res & Educ Fdn, Philadelphia, PA USA; [Short, Thomas H.] West Chester Univ, Dept Math, Stat Program, W Chester, PA 19380 USA; [True, Gala] Tulane Univ, Med, New Orleans, LA 70118 USA; [True, Gala] Southeast Louisiana Vet Hlth Care Syst, South Cent Mental Illness Res Educ & Clin Ctr, New Orleans, LA USA		Moriarty, H (corresponding author), Villanova Univ, M Louise Fitzpatrick Coll Nursing, 800 Lancaster Ave, Villanova, PA 19085 USA.	helene.moriarty@villanova.edu			Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R21 HD068857-01]; Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The project described was supported by Award Number R21 HD068857-01 from the Eunice Kennedy Shriver National Institute of Child Health & Human Development, National Institutes of Health, USA. The content is solely the responsibility of the authors and does not necessarily represent the official views of the Eunice Kennedy Shriver National Institute of Child Health & Human Development or the National Institutes of Health. This material is the result of work also supported with resources and the use of facilities at the Corporal Michael J. Crescenz VA Medical Center, Philadelphia, PA, USA.	ANDRESEN EM, 1994, AM J PREV MED, V10, P77, DOI 10.1016/S0749-3797(18)30622-6; [Anonymous], 2010, VA DOD CLIN PRACT GU; Arciniegas David B., 2002, Curr Treat Options Neurol, V4, P43, DOI 10.1007/s11940-002-0004-6; Backhaus SL, 2010, ARCH PHYS MED REHAB, V91, P840, DOI 10.1016/j.apmr.2010.03.015; Bagalman E, 2013, R40941 C RES SERV; Belle SH, 2006, ANN INTERN MED, V145, P727, DOI 10.7326/0003-4819-145-10-200611210-00005; Ben Arzi N, 2000, BRAIN INJURY, V14, P725; Blais MC, 2005, BRAIN INJURY, V19, P1223, DOI 10.1080/02699050500309387; Boschen K, 2007, NEUROREHABILITATION, V22, P19; Brain Trauma Foundation, 2018, TRAUM BRAIN INJ FREQ; Bronfenbrenner U., 1979, ECOLOGY HUMAN DEV EX; Calhoun PS, 2002, J TRAUMA STRESS, V15, P205, DOI 10.1023/A:1015251210928; Calvete E, 2012, BRAIN INJURY, V26, P834, DOI 10.3109/02699052.2012.655363; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carnevale GJ, 2006, ARCH PHYS MED REHAB, V87, P1289, DOI 10.1016/j.apmr.2006.06.010; Carpenter J S, 1998, Issues Ment Health Nurs, V19, P481; Centers for Disease Control and Prevention (CDC) National Centre for Injury Prevention and Control, 2016, TRAUM BRAIN INJ US F; Centers for Disease Control and Prevention National Institutes of Health Department of Defense VA Leadership Panel, 2013, REP C TRAUM BRAIN IN; Chan A, 2002, SOC INDIC RES, V57, P263, DOI 10.1023/A:1014787712820; Cohen J., 1983, APPL MULTIPLE REGRES; Collins E, 2013, NURS OUTLOOK, V61, P375, DOI 10.1016/j.outlook.2013.07.004; Daggett VS, 2013, J REHABIL RES DEV, V50, P327, DOI 10.1682/JRRD.2011.09.0168; Dausch BM, 2009, REHABIL PSYCHOL, V54, P279, DOI 10.1037/a0016809; Defense and Veterans Brain Injury Center, 2014, DOD WORLDW NUMB TBI; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Driesenga SA, 2015, CRIT CARE NURS CLIN, V27, P247, DOI 10.1016/j.cnc.2015.02.001; Ennis N, 2013, NEUROPSYCHOL REHABIL, V23, P1, DOI 10.1080/09602011.2012.712871; Folkman S., 1984, STRESS; Ford JH, 2014, J REHABIL RES DEV, V51, P1311, DOI 10.1682/JRRD.2014.03.0066; Foster AM, 2012, DISABIL REHABIL, V34, P1855, DOI 10.3109/09638288.2012.670028; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Glynn SM, 2013, CLIN CHILD FAM PSYCH, V16, P410, DOI 10.1007/s10567-013-0153-z; Griffin JM, 2017, AM J ORTHOPSYCHIAT, V87, P139, DOI 10.1037/ort0000207; Hanks RA, 2012, ARCH PHYS MED REHAB, V93, P1297, DOI 10.1016/j.apmr.2012.04.027; Harris JKJ, 2001, BRAIN INJURY, V15, P223; Hart T, 2007, J HEAD TRAUMA REHAB, V22, P122, DOI 10.1097/01.HTR.0000265100.37059.44; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; International Family Nursing Association, 2017, IFNA POS STAT ADV PR; International Family Nursing Association, 2015, IFNA POS STAT GEN CO; Irwin M, 1999, ARCH INTERN MED, V159, P1701, DOI 10.1001/archinte.159.15.1701; Jak AJ, 2015, CONTEMP CLIN TRIALS, V45, P210, DOI 10.1016/j.cct.2015.10.009; Jaycox, 2008, INVISIBLE WOUNDS WAR, P3; Kilbourne AM, 2002, J GEN INTERN MED, V17, P512, DOI 10.1046/j.1525-1497.2002.10803.x; Kim E, 2007, J NEUROPSYCH CLIN N, V19, P106, DOI 10.1176/appi.neuropsych.19.2.106; Knight RG, 1998, BRAIN INJURY, V12, P467, DOI 10.1080/026990598122430; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; KREUTZER JS, 1994, BRAIN INJURY, V8, P197, DOI 10.3109/02699059409150973; KREUTZER JS, 1994, J HEAD TRAUMA REHAB, V9, P104, DOI 10.1097/00001199-199409000-00009; LAWTON MP, 1991, J GERONTOL, V46, pP181, DOI 10.1093/geronj/46.4.P181; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; LEACH LR, 1994, BRAIN INJURY, V8, P599, DOI 10.3109/02699059409151012; Lequerica AH, 2013, J HEAD TRAUMA REHAB, V28, pE14, DOI 10.1097/HTR.0b013e31826e3ca8; Lerner D, 2008, J OCCUP ENVIRON MED, V50, P401, DOI 10.1097/JOM.0b013e31816bae50; Machamer J, 2002, J CLIN EXP NEUROPSYC, V24, P420, DOI 10.1076/jcen.24.4.420.1040; Malec JF, 2017, BRAIN INJURY, V31, P1235, DOI 10.1080/02699052.2016.1274778; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Marsh NV, 2002, J CLIN EXP NEUROPSYC, V24, P434, DOI 10.1076/jcen.24.4.434.1030; McCabe P, 2007, BRAIN INJURY, V21, P231, DOI 10.1080/02699050701201631; McPherson KM, 2000, DISABIL REHABIL, V22, P683, DOI 10.1080/096382800445489; Monson CM, 2009, CLIN PSYCHOL REV, V29, P707, DOI 10.1016/j.cpr.2009.09.002; Moriarty H, 2016, PM&R, V8, P495, DOI 10.1016/j.pmrj.2015.10.008; Moriarty H, 2015, J AM PSYCHIAT NURSES, V21, P195, DOI 10.1177/1078390315591879; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; NEWPORT FRANK, 2012, GALLUPCOM; Otis JD, 2011, J CLIN PSYCHOL MED S, V18, P145, DOI 10.1007/s10880-011-9239-2; Phelan SM, 2011, DISABIL HEALTH J, V4, P177, DOI 10.1016/j.dhjo.2011.03.003; Ponsford J, 2003, BRAIN INJURY, V17, P453, DOI 10.1080/0269905031000070143; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Ramchand R., 2014, HIDDEN HEROES AM MIL; Riley GA, 2007, CLIN REHABIL, V21, P82, DOI 10.1177/0269215506071279; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Sander AM, 2007, NEUROREHABILITATION, V22, P1; Sayer NA, 2008, ARCH PHYS MED REHAB, V89, P163, DOI 10.1016/j.apmr.2007.05.025; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Steger MF, 2009, J COUNS PSYCHOL, V56, P289, DOI 10.1037/a0015416; Stejskal TM, 2012, NEUROREHABILITATION, V31, P75, DOI 10.3233/NRE-2012-0776; Stevens LF, 2017, J HEAD TRAUMA REHAB, V32, P234, DOI 10.1097/HTR.0000000000000324; Stevens LF, 2012, NEUROREHABILITATION, V31, P443, DOI 10.3233/NRE-2012-00815; Street AE, 2013, J GEN INTERN MED, V28, pS556, DOI 10.1007/s11606-013-2333-4; Struchen MA, 2002, J HEAD TRAUMA REHAB, V17, P132, DOI 10.1097/00001199-200204000-00005; Sun F, 2009, PSYCHOL AGING, V24, P177, DOI 10.1037/a0014760; Tanev KS, 2014, BRAIN INJURY, V28, P261, DOI 10.3109/02699052.2013.873821; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; US Department of Veterans Affairs, 2004, IRAQ WAR CLIN GUIDE; US Department of Veterans Affairs & Department of Defense, 2009, CLIN GUID MAN CONC M; US Department of Veterans Affairs Quality Enhancement Research Initiative News, 2015, ASS FAM CTR PRACT TR; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wagner AW, 2000, J TRAUMA STRESS, V13, P41, DOI 10.1023/A:1007716813407; Wall PLH, 2012, J AM PSYCHIAT NURSES, V18, P278, DOI 10.1177/1078390312460578; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Winter L, 2016, BRAIN INJURY, V30, P373, DOI 10.3109/02699052.2016.1144080; Wisniewski SR, 2003, PSYCHOL AGING, V18, P375, DOI 10.1037/0882-7974.18.3.375; Yambo T, 2014, J AM PSYCHIAT NURSES, V20, P31, DOI 10.1177/1078390313516998; Zatzick DF, 2007, PSYCHOL MED, V37, P1469, DOI 10.1017/S0033291707000943	98	15	15	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1074-8407	1552-549X		J FAM NURS	J. Fam. Nurs.	MAY	2018	24	2					184	216		10.1177/1074840718773470			33	Family Studies; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Family Studies; Nursing	GH8JP	WOS:000433914800004	29848196				2022-02-06	
J	Tierney, GJ; Richter, C; Denvir, K; Simms, CK				Tierney, Gregory J.; Richter, Christopher; Denvir, Karl; Simms, Ciaran K.			Could lowering the tackle height in rugby union reduce ball carrier inertial head kinematics?	JOURNAL OF BIOMECHANICS			English	Article						Injury prevention; Brain injury; Chronic injury; Concussion	CHRONIC TRAUMATIC ENCEPHALOPATHY; BRAIN WHITE-MATTER; CONCUSSION HISTORY; IMPACT SENSORS; PLAYERS; INJURIES; CONTACT; FOOTBALL; SEASON; SPORT	There is mounting evidence of reduced long-term cognitive ability in rugby players, even in those without a reported history of concussion. The tackle height law is an area of controversy. However, little is known about the effects of repetitive inertial head loading in rugby. Furthermore, the magnitude and influencing factors for head kinematics are generally unknown. In this exploratory study, 45 multibody front-on shoulder tackles simulated with the MADYMO pedestrian model and 20 staged rugby tackles executed by professional rugby players in a marker-based 3D motion laboratory were used to assess the effect of tackle height on ball carrier head kinematics. The peak resultant head linear accelerations, angular accelerations and change in angular velocities were measured and examined. The results suggest that tackle height strongly affects the head kinematics experienced by the ball carrier. In particular, higher ball carrier head kinematic values were identified for upper trunk tackles compared to mid/lower trunk tackles in both the multibody simulations and the staged rugby tackles. Average ball carrier peak resultant head linear acceleration, angular acceleration and change in angular velocity values for upper trunk tackles were greater than for mid/lower trunk tackles by a factor of 1.5, 2.5 and 1.7, in the multibody simulations, respectively, and 1.8 (p = 0.102), 2.2 (p = 0.025) and 2.3 (p = 0.004), in the staged tackles, respectively. The results of the study support the proposition of lowering the current tackle height laws to below the chest. (C) 2018 Elsevier Ltd. All rights reserved.	[Tierney, Gregory J.; Simms, Ciaran K.] Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin 2, Ireland; [Richter, Christopher] Santry Sports Surg Clin, Dublin, Ireland; [Denvir, Karl] Leinster Rugby, Dublin, Ireland		Tierney, GJ (corresponding author), Trinity Coll Dublin, Trinity Ctr Bioengn, Dublin 2, Ireland.	gtierne@tcd.ie; ChrisRichter@sportssurgeryclinic.com; Karl.Denvir@leinsterrugby.ie; csimms@tcd.ie	Simms, Ciaran/K-3100-2019	Simms, Ciaran/0000-0001-5564-1620; Tierney, Gregory/0000-0002-4666-4473	Irish Research CouncilIrish Research Council for Science, Engineering and Technology	The authors would like to acknowledge the Irish Research Council for funding this study.	Alexander DG, 2015, BRAIN INJURY, V29, P1113, DOI 10.3109/02699052.2015.1031699; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Bernick C., 2015, BRIT J SPORT MED; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Burger N, 2016, BRIT J SPORT MED, V50, P932, DOI 10.1136/bjsports-2015-095295; Elliott JR, 2012, P I MECH ENG K-J MUL, V226, P266, DOI 10.1177/1464419311430176; Field A., 2018, DISCOVERING STAT USI, V5th ed.; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fuller CW, 2010, BRIT J SPORT MED, V44, P159, DOI 10.1136/bjsm.2008.050864; Hendricks S, 2012, J SPORT SCI, V30, P1215, DOI 10.1080/02640414.2012.707328; Hume PA, 2017, SPORTS MED, V47, P1209, DOI 10.1007/s40279-016-0608-8; Killam C, 2005, ARCH CLIN NEUROPSYCH, V20, P599, DOI 10.1016/j.acn.2005.02.001; KIM W, 1994, HUM MOVEMENT SCI, V13, P221, DOI 10.1016/0167-9457(94)90038-8; King D, 2015, AM J SPORT MED, V43, P614, DOI 10.1177/0363546514560876; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Mc Fie S., 2016, BMJ OPEN SPORT EXERC, V2, P000053, DOI [10.1136/bmjsem-2015-000053, DOI 10.1136/BMJSEM-2015-000053]; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McIntosh A., 2007, P ENH SAF VEH C; McIntosh AS, 2014, BMJ OPEN, V4, DOI 10.1136/bmjopen-2014-005078; McIntosh AS, 2005, BRIT J SPORT MED, V39, P2, DOI 10.1136/bjsm.2004.016188; Merchant-Borna K, 2016, ANN BIOMED ENG, V44, P3679, DOI 10.1007/s10439-016-1680-9; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Neselius S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033606; Sankarasubramanian H., 2011, P ESV C; Scher A., 1978, DRUG RES, V5, P197; Shin W, 2014, AM J NEURORADIOL, V35, P285, DOI 10.3174/ajnr.A3676; Shuttleworth-Rdwards AB, 2008, ARCH CLIN NEUROPSYCH, V23, P511, DOI 10.1016/j.acn.2008.05.002; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Tierney G.J., 2015, P IRCOBI C; Tierney G.J., 2017, P IRCOBI C; Tierney GJ, 2016, ISBS C P ARCH; Tierney GJ, 2018, MED SCI SPORT EXER, V50, P603, DOI 10.1249/MSS.0000000000001461; Tierney GJ, 2018, J SCI MED SPORT, V21, P221, DOI 10.1016/j.jsams.2017.06.023; Tierney GJ, 2018, INT J SPORTS SCI COA, V13, P415, DOI 10.1177/1747954117751345; Tierney GJ, 2017, BRAIN INJURY, V31, P1925, DOI 10.1080/02699052.2017.1385853; Tierney Gregory J, 2018, Sports Biomech, V17, P33, DOI 10.1080/14763141.2016.1271905; Tierney GJ, 2016, BRAIN INJURY, V30, P1350, DOI 10.1080/02699052.2016.1193630; TNO, 2015, MAD HUM BOD MOD MAN, P103; Usman J, 2011, J SCI MED SPORT, V14, P547, DOI 10.1016/j.jsams.2011.05.006; Van Rooij L., 2003, P ESV C 18 ESV C; Wu LC, 2016, J BIOMECH, V49, P2918, DOI 10.1016/j.jbiomech.2016.07.004; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3; Yin S, 2017, ACCIDENT ANAL PREV, V106, P285, DOI 10.1016/j.aap.2017.06.005	48	15	15	1	13	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	APR 27	2018	72						29	36		10.1016/j.jbiomech.2018.02.023			8	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biophysics; Engineering	GE0FL	WOS:000430889400005	29525242	Green Accepted			2022-02-06	
J	Fiandaca, MS; Mapstone, M; Mahmoodi, A; Gross, T; Macciardi, F; Cheema, AK; Merchant-Borna, K; Bazarian, J; Federoff, HJ				Fiandaca, Massimo S.; Mapstone, Mark; Mahmoodi, Amin; Gross, Thomas; Macciardi, Fabio; Cheema, Amrita K.; Merchant-Borna, Kian; Bazarian, Jeffrey; Federoff, Howard J.			Plasma metabolomic biomarkers accurately classify acute mild traumatic brain injury from controls	PLOS ONE			English	Article							C-TERMINAL HYDROLASE; LIPID-PEROXIDATION; CEREBROSPINAL-FLUID; PROTEIN-LEVELS; FATTY-ACIDS; HEAD-INJURY; SERUM; CONCUSSION; S100B; DISEASE	Past and recent attempts at devising objective biomarkers for traumatic brain injury (TBI) in both blood and cerebrospinal fluid have focused on abundance measures of time-dependent proteins. Similar independent determinants would be most welcome in diagnosing the most common form of TBI, mild TBI (mTBI), which remains difficult to define and confirm based solely on clinical criteria. There are currently no consensus diagnostic measures that objectively define individuals as having sustained an acute mTBI. Plasma metabolomic analyses have recently evolved to offer an alternative to proteomic analyses, offering an orthogonal diagnostic measure to what is currently available. The purpose of this study was to determine whether a developed set of metabolomic biomarkers is able to objectively classify college athletes sustaining mTBI from non-injured teammates, within 6 hours of trauma and whether such a biomarker panel could be effectively applied to an independent cohort of TBI and control subjects. A 6-metabolite panel was developed from biomarkers that had their identities confirmed using tandem mass spectrometry (MS/MS) in our Athlete cohort. These biomarkers were defined at <= 6 hours following mTBI and objectively classified mTBI athletes from teammate controls, and provided similar classification of these groups at the 2, 3, and 7 days post-mTBI. The same 6-metabolite panel, when applied to a separate, independent cohort provided statistically similar results despite major differences between the two cohorts. Our confirmed plasma biomarker panel objectively classifies acute mTBI cases from controls within 6 hours of injury in our two independent cohorts. While encouraged by our initial results, we expect future studies to expand on these initial observations.	[Fiandaca, Massimo S.; Mapstone, Mark; Mahmoodi, Amin; Gross, Thomas; Macciardi, Fabio; Federoff, Howard J.] Univ Calif Irvine, Dept Neurol, Translat Lab & Biorepository, Irvine, CA 92717 USA; [Fiandaca, Massimo S.] Univ Calif Irvine, Dept Neurol Surg, Irvine, CA USA; [Fiandaca, Massimo S.] Univ Calif Irvine, Dept Anat & Neurobiol, Irvine, CA 92717 USA; [Macciardi, Fabio] Univ Calif Irvine, Dept Psychiat & Human Behav, Irvine, CA 92717 USA; [Cheema, Amrita K.] Georgetown Univ, Med Ctr, Lombardi Comprehens Canc Ctr, Dept Oncol, Washington, DC 20007 USA; [Cheema, Amrita K.] Georgetown Univ, Med Ctr, Dept Biochem & Mol, Washington, DC 20007 USA; [Cheema, Amrita K.] Georgetown Univ, Med Ctr, Cellular Biol, Washington, DC 20007 USA; [Merchant-Borna, Kian; Bazarian, Jeffrey] Univ Rochester, Sch Med & Dent, Dept Emergency Med, Rochester, NY USA		Federoff, HJ (corresponding author), Univ Calif Irvine, Dept Neurol, Translat Lab & Biorepository, Irvine, CA 92717 USA.	Federoff@uci.edu		Federoff, Howard/0000-0002-7595-6520; Mahmoodi, Amin/0000-0003-0012-9245	Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K24 HD064754]; United States (US) Department of Defense (DoD); US Army Medical Research and Material Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-09-1-0107]; Georgetown University Proteomics and Metabolomics Shared Resource through a Cancer Center Support Grant [NIH/NCI P30-CA051008]	This work was supported in part by the Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) for the collegiate athlete study (K24 HD064754 to JB), and the United States (US) Department of Defense (DoD), US Army Medical Research and Material Command (USAMRMC) related to this biomarker investigation (W81XWH-09-1-0107 to HJF). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript. We acknowledge the partial support provided to the Georgetown University Proteomics and Metabolomics Shared Resource through a Cancer Center Support Grant (NIH/NCI P30-CA051008). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.; We graciously acknowledge Lawrence L. Latour (Stroke Branch, National Institute of Neurological Disorders and Stroke, Bethesda, MD), Rao P. Gullapalli (Diagnostic Radiology and Nuclear Medicine, University of Maryland, Shock Trauma Center, Baltimore, MD), and Lindell K. Weaver (Department of Medicine, University of Utah, Latter Day Saints Hospital, Salt Lake City, UT) for their contributions of de-identified blood specimens and demographic information from their clinical investigations for use in the External cohort of our study. We thank Kirsten Ross, Stephanie Amalfe, and Nikita Bourque for Athlete study coordination, and Eric Rozen for assistance with Athlete study data collection. We acknowledge the partial support provided to the Georgetown University Proteomics and Metabolomics Shared Resource through a Cancer Center Support Grant (NIH/NCI P30-CA051008). We also thank Robert Padilla, Ishmael Conteh, Jamie McCann, Daniele Phelps, Rond Malhas, and Ricardo Miramontes for collecting and processing the study's blood specimens, Tyrone Dowdy and Steven Payton for technical assistance in developing the metabolomic data, and Nick Morris for technical expertise with the MSF Metabolomics website and application.	Abdelmagid SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0116195; Abdullah L, 2014, FASEB J, V28, P5311, DOI 10.1096/fj.14-258228; Adrian H, 2016, ENEURO, V3, DOI 10.1523/ENEURO.0294-16.2016; Agoston Denes V, 2012, Front Neurol, V3, P107, DOI 10.3389/fneur.2012.00107; Alderson NL, 2004, J BIOL CHEM, V279, P48562, DOI 10.1074/jbc.M406649200; Aylward LL, 2014, J TOXICOL ENV HEAL B, V17, P45, DOI 10.1080/10937404.2013.864250; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-1044-3; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI [10.1007/s11306-016-0960-6, DOI 10.1007/S11306-016-0960-6]; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; BAKAY RAE, 1983, J NEUROSURG, V58, P27, DOI 10.3171/jns.1983.58.1.0027; Braverman NE, 2012, BBA-MOL BASIS DIS, V1822, P1442, DOI 10.1016/j.bbadis.2012.05.008; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen TL, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/298183; CORTES C, 1995, MACH LEARN, V20, P273, DOI 10.1007/BF00994018; Cristofori L, 2001, J INVEST MED, V49, P450, DOI 10.2310/6650.2001.33790; Croset M, 2000, BIOCHEM J, V345, P61, DOI 10.1042/0264-6021:3450061; Dambinova SA, 2013, J MOL BIOMARK DIA S1, V3, DOI [10.4172/2155-9929.S3-003, DOI 10.4172/2155-9929.S3-003]; DHILLON HS, 1994, J NEUROTRAUM, V11, P405, DOI 10.1089/neu.1994.11.405; DVBIC, 2016, DOB TBI WORLD NUMB S; Evans AM, 2009, ANAL CHEM, V81, P6656, DOI 10.1021/ac901536h; Farooqui AA, 2000, J MOL NEUROSCI, V14, P123, DOI 10.1385/JMN:14:3:123; Fiandaca MS, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00237; Foulon V, 2005, J BIOL CHEM, V280, P9802, DOI 10.1074/jbc.M413362200; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Gonzalez-Dominguez R, 2016, EBIOMEDICINE, V12, P8, DOI 10.1016/j.ebiom.2016.09.024; Gronbeck KR, 2016, NEUROCRIT CARE, V25, P153, DOI 10.1007/s12028-015-0225-7; Hama H, 2010, BBA-MOL CELL BIOL L, V1801, P405, DOI 10.1016/j.bbalip.2009.12.004; HANLEY JA, 1982, RADIOLOGY, V143, P29, DOI 10.1148/radiology.143.1.7063747; HOLM S, 1979, SCAND J STAT, V6, P65; HOSHI M, 1973, J BIOL CHEM, V248, P4123; Huan T, 2017, NAT METHODS, V14, P461, DOI 10.1038/nmeth.4260; Illig T, 2010, NAT GENET, V42, P137, DOI 10.1038/ng.507; Ingebrigtsen T, 1996, J NEUROSURG, V85, P945, DOI 10.3171/jns.1996.85.5.0945; Johnson WE, 2007, BIOSTATISTICS, V8, P118, DOI 10.1093/biostatistics/kxj037; Kaur P, 2013, MOL BIOSYST, V9, P307, DOI 10.1039/c2mb25384d; Lancaster MA, 2016, HUM BRAIN MAPP, V37, P3821, DOI 10.1002/hbm.23278; LANDS WEM, 1958, J BIOL CHEM, V231, P883; Mapstone M, 2017, NEUROBIOL AGING, V51, P148, DOI 10.1016/j.neurobiolaging.2016.11.007; Mapstone M, 2014, NAT MED, V20, P415, DOI 10.1038/nm.3466; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; McCrory P, 2013, J AM COLL SURGEONS, V216, pE55, DOI 10.1016/j.jamcollsurg.2013.02.020; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Norton WT, 1984, MYELIN, V2nd, P147; O'Bryant SE, 2015, ALZHEIMERS DEMENT, V11, P549, DOI 10.1016/j.jalz.2014.08.099; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Papa L, 2017, J NEUROTRAUM, V34, P2132, DOI 10.1089/neu.2016.4806; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Pasvogel AE, 2008, BIOL RES NURS, V10, P113, DOI 10.1177/1099800408323218; Pelinka LE, 2004, J NEUROTRAUM, V21, P1553, DOI 10.1089/0897715042441846; POSMANTUR R, 1994, J NEUROTRAUM, V11, P533, DOI 10.1089/neu.1994.11.533; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Rapoport SI, 1999, NEUROCHEM RES, V24, P1403, DOI 10.1023/A:1022584707352; Romisch-Margl W, 2011, METABOLOMICS, V8, P133, DOI DOI 10.1007/S11306-011-0293-4; Romner B, 2000, J NEUROTRAUM, V17, P641, DOI 10.1089/089771500415391; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Shahim P, 2017, NEUROLOGY, V88, P1788, DOI 10.1212/WNL.0000000000003912; Sheth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129735; Steyerberg EW, 2001, J CLIN EPIDEMIOL, V54, P774, DOI 10.1016/S0895-4356(01)00341-9; Tautenhahn R, 2012, ANAL CHEM, V84, P5035, DOI 10.1021/ac300698c; Thelin EP, 2017, ACTA NEUROCHIR, V159, P209, DOI 10.1007/s00701-016-3046-3; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Vagnozzi R, 1999, J NEUROTRAUM, V16, P903, DOI 10.1089/neu.1999.16.903; Vandal M, 2014, J NEUROCHEM, V129, P516, DOI 10.1111/jnc.12640; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; Vos PE, 2010, NEUROLOGY, V75, P1786, DOI 10.1212/WNL.0b013e3181fd62d2; Welch RD, 2017, J NEUROTRAUM, V34, P1957, DOI 10.1089/neu.2016.4772; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Wood PL, 2012, ALZHEIMERS RES THER, V4, DOI 10.1186/alzrt103; Worley B, 2013, CURR METABOL, V1, P92, DOI 10.2174/2213235X11301010092; Xi Bowei, 2014, Methods Mol Biol, V1198, P333, DOI 10.1007/978-1-4939-1258-2_22; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Xie WJ, 2016, CHEM CENT J, V10, DOI 10.1186/s13065-016-0187-7; Zhao ZW, 2010, J LIPID RES, V51, P652, DOI 10.1194/jlr.D001503	76	15	15	1	11	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	APR 20	2018	13	4							e0195318	10.1371/journal.pone.0195318			22	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	GD6SO	WOS:000430638900010	29677216	Green Published, gold			2022-02-06	
J	Busl, KM				Busl, Katharina Maria			Nosocomial Infections in the Neurointensive Care Unit	NEUROSURGERY CLINICS OF NORTH AMERICA			English	Article						Nosocomial infections; Hospital -acquired pneumonia; Ventriculitis; Urinary tract infection; EVD-related infection	TRAUMATIC BRAIN-INJURY; ACUTE ISCHEMIC-STROKE; LENGTH-OF-STAY; VENTILATOR-ASSOCIATED PNEUMONIA; HOSPITAL-ACQUIRED PNEUMONIA; DELAYED CEREBRAL-ISCHEMIA; NEUROSURGICAL BACTERIAL-MENINGITIS; ANEURYSMAL SUBARACHNOID HEMORRHAGE; VENTRICULOSTOMY-RELATED INFECTIONS; CLOSTRIDIUM-DIFFICILE INFECTIONS	Infectious complications in the neurointensive care unit (neuro-ICU) are common, including pneumonia, urinary tract infection, bloodstream infection, and intracranial infection. The neuro-ICU population poses a specific challenge in the diagnosis of infections, because of the high incidence of fever in acutely brain injured patients. Furthermore, susceptibility to infections is likely enhanced by brain injury (induced immune modulation). This article reviews the concept of brain injury-induced immune modulation, and summarizes available data and knowledge on nosocomial meningitis and ventriculitis, and systemic infectious complications in patients with traumatic brain injury, ischemic stroke, intracerebral hemorrhage, subarachnoid hemorrhage, and status epilepticus.	[Busl, Katharina Maria] Univ Florida, Dept Neurol, Coll Med, McKnight Brain Inst L3-100,1149 Newell Dr, Gainesville, FL 32610 USA		Busl, KM (corresponding author), Univ Florida, Dept Neurol, Coll Med, McKnight Brain Inst L3-100,1149 Newell Dr, Gainesville, FL 32610 USA.	Katharina.busl@neurology.ufl.edu					Ala-Kokko TI, 2006, ANAESTH INTENS CARE, V34, P639, DOI 10.1177/0310057X0603400509; Alleyne CH, 2000, NEUROSURGERY, V47, P1124, DOI 10.1097/00006123-200011000-00020; Alsumrain M, 2013, J INTENSIVE CARE MED, V28, P118, DOI 10.1177/0885066612437512; [Anonymous], 2005, AM J RESP CRIT CARE, V171, P388, DOI 10.1164/rccm.200405-644ST; Arabi Y, 2005, AM J INFECT CONTROL, V33, P137, DOI 10.1016/j.ajic.2004.11.008; Arbabi S, 2007, J TRAUMA, V62, P56, DOI 10.1097/TA.0b013e31802d972b; Aslanyan S, 2004, EUR J NEUROL, V11, P49, DOI 10.1046/j.1468-1331.2003.00749.x; AUCOIN PJ, 1986, AM J MED, V80, P369, DOI 10.1016/0002-9343(86)90708-4; Badjatia N, 2010, NEUROSURGERY, V66, P696, DOI 10.1227/01.NEU.0000367618.42794.AA; Bakovic D, 2013, CLIN PHYSIOL FUNCT I, V33, P30, DOI 10.1111/j.1475-097X.2012.01156.x; Beer R, 2008, J NEUROL, V255, P1617, DOI 10.1007/s00415-008-0059-8; Beer R, 2010, CURR OPIN CRIT CARE, V16, P117, DOI 10.1097/MCC.0b013e328338cb5f; Beer R, 2009, NEUROCRIT CARE, V10, P363, DOI 10.1007/s12028-008-9155-y; Bellinger DL, 2008, CELL IMMUNOL, V252, P27, DOI 10.1016/j.cellimm.2007.09.005; Bercault N, 2001, CRIT CARE MED, V29, P2303, DOI 10.1097/00003246-200112000-00012; Berger C, 2002, CRIT CARE MED, V30, P1778, DOI 10.1097/00003246-200208000-00017; Bhimraj A, 2012, CLEV CLIN J MED, V79, P393, DOI 10.3949/ccjm.79gr.12003; Bleck TP, 2010, EPILEPSY CURR, V10, P31, DOI 10.1111/j.1535-7511.2009.01345.x; Blomstedt G C, 1992, Neurosurg Clin N Am, V3, P375; Bobo LD, 2011, CHEST, V140, P1643, DOI 10.1378/chest.11-0556; Bociaga-Jasik M, 2012, ADV MED SCI-POLAND, V57, P142, DOI 10.2478/v10039-012-0013-y; Boehme AK, 2013, J STROKE CEREBROVASC, V22, pE582, DOI 10.1016/j.jstrokecerebrovasdis.2013.07.020; BOHR V, 1984, ARCH NEUROL-CHICAGO, V41, P1045, DOI 10.1001/archneur.1984.04050210043012; Bratzler Dale W, 2013, Am J Health Syst Pharm, V70, P195, DOI 10.2146/ajhp120568; Bronchard G, 2004, ANESTHESIOLOGY, V100, P234, DOI 10.1097/00000542-200402000-00009; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Brown EM, 2000, BRIT J NEUROSURG, V14, P7; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; Camacho EF, 2011, INFECTION, V39, P47, DOI 10.1007/s15010-010-0073-5; Cardozo Júnior Luis Carlos Maia, 2014, Rev. bras. ter. intensiva, V26, P148, DOI 10.5935/0103-507X.20140022; Catania A, 2009, BRAIN BEHAV IMMUN, V23, P877, DOI 10.1016/j.bbi.2009.04.006; Cazzadori A, 1997, RESP MED, V91, P193, DOI 10.1016/S0954-6111(97)90038-X; Chamorro A, 2007, STROKE, V38, P1097, DOI 10.1161/01.STR.0000258346.68966.9d; Chamorro A, 2007, J NEUROL SCI, V252, P29, DOI 10.1016/j.jns.2006.10.001; Chang LL, 2011, BRAIN BEHAV IMMUN, V25, P260, DOI 10.1016/j.bbi.2010.09.017; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Chauv S, 2016, NEUROCRIT CARE, V25, P128, DOI 10.1007/s12028-016-0254-x; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101961; Chen YY, 2005, INFECT CONT HOSP EP, V26, P281, DOI 10.1086/502540; Chen ZQ, 2012, CLIN CHIM ACTA, V413, P1512, DOI 10.1016/j.cca.2012.06.018; Chumbler NR, 2010, NEUROEPIDEMIOLOGY, V34, P193, DOI 10.1159/000289350; Cinotti R, 2014, EUR J CLIN MICROBIOL, V33, P823, DOI 10.1007/s10096-013-2020-8; Citerio G, 2015, CRIT CARE MED, V43, P1630, DOI 10.1097/CCM.0000000000001019; Commichau C, 2003, NEUROLOGY, V60, P837, DOI 10.1212/01.WNL.0000047344.28843.EB; Conen A, 2008, CLIN INFECT DIS, V47, P73, DOI 10.1086/588298; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Cotton BA, 2007, J TRAUMA, V62, P26, DOI 10.1097/TA.0b013e31802d02d0; Coutinho LG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-326; Crabtree SJ, 2011, BURNS, V37, P42, DOI 10.1016/j.burns.2010.06.008; Croce MA, 2013, J TRAUMA ACUTE CARE, V74, P354, DOI 10.1097/TA.0b013e31827a0c65; Davenport RJ, 1996, STROKE, V27, P415, DOI 10.1161/01.STR.27.3.415; de Almeida SM, 2009, CLIN CHEM LAB MED, V47, P755, DOI 10.1515/CCLM.2009.160; Dellit TH, 2014, INFECT CONT HOSP EP, V35, P589, DOI 10.1086/675828; Desai A, 2009, J NEUROS-PEDIATR, V4, P184, DOI 10.3171/2009.4.PEDS08279; Dettenkofer M, 1999, ACTA NEUROCHIR, V141, P1303, DOI 10.1007/s007010050434; Dettenkofer M, 2001, J NEUROL, V248, P959, DOI 10.1007/s004150170048; Dhar R, 2008, NEUROCRIT CARE, V8, P253, DOI 10.1007/s12028-007-9020-4; Ding RY, 2000, DYSPHAGIA, V15, P51, DOI 10.1007/s004550010001; Diringer MN, 2004, CRIT CARE MED, V32, P1489, DOI 10.1097/01.CCM.0000129484.61912.84; Dirnagl U, 2007, STROKE, V38, P770, DOI 10.1161/01.STR.0000251441.89665.bc; Divani AA, 2015, NEUROCRIT CARE, V22, P234, DOI 10.1007/s12028-014-0065-x; Douds GL, 2012, NEUROL RES INT, V2012, DOI 10.1155/2012/479865; Dziedzic T, 2007, J NEUROL SCI, V252, P53, DOI 10.1016/j.jns.2006.10.007; Dziewas R, 2004, J NEUROL NEUROSUR PS, V75, P852, DOI 10.1136/jnnp.2003.019075; Emerson CB, 2012, INFECT CONT HOSP EP, V33, P539, DOI 10.1086/665725; Emsley HC, 2008, LANCET NEUROL, V7, P341, DOI 10.1016/S1474-4422(08)70061-9; Enderson BL, 2007, J TRAUMA, V62, P33; Fichtner J, 2010, J NEUROSURG, V112, P840, DOI 10.3171/2009.8.JNS091297; Flibotte JJ, 2004, NEUROCRIT CARE, V1, P61, DOI 10.1385/NCC:1:1:61; Foreman PM, 2016, J NEUROSURG, V125, P1383, DOI 10.3171/2015.10.JNS151959; Frontera JA, 2008, NEUROSURGERY, V62, P80, DOI 10.1227/01.NEU.0000311064.18368.EA; Fukui MB, 2001, AM J NEURORADIOL, V22, P1510; Garey KW, 2008, J HOSP INFECT, V70, P142, DOI 10.1016/j.jhin.2008.06.026; Glance LG, 2011, ARCH SURG-CHICAGO, V146, P794, DOI 10.1001/archsurg.2011.41; Grau AJ, 1999, J NEUROL SCI, V171, P115, DOI 10.1016/S0022-510X(99)00261-0; Griesshammer M, 1999, J INTERN MED, V245, P295, DOI 10.1046/j.1365-2796.1999.00452.x; Haeusler KG, 2008, CEREBROVASC DIS, V25, P50, DOI 10.1159/000111499; Hallevi H, 2008, NEUROLOGY, V70, P848, DOI 10.1212/01.wnl.0000304930.47751.75; Hamidon B. B., 2003, SMJ Singapore Medical Journal, V44, P344; Hanna H, 2004, INFECT CONT HOSP EP, V25, P646, DOI 10.1086/502455; Hannawi Y, 2013, CEREBROVASC DIS, V35, P430, DOI 10.1159/000350199; Heimes J, 2011, SURG INFECT, V12, P99, DOI 10.1089/sur.2009.028; Higgins TL, 2003, CRIT CARE MED, V31, P45, DOI 10.1097/00003246-200301000-00007; Hilker R, 2003, STROKE, V34, P975, DOI 10.1161/01.STR.0000063373.70993.CD; Hinduja A, 2015, AM J CRIT CARE, V24, P227, DOI 10.4037/ajcc2015422; Hoefnagel D, 2008, ACTA NEUROCHIR, V150, P209, DOI 10.1007/s00701-007-1458-9; Hoffmann S, 2012, STROKE, V43, P2617, DOI 10.1161/STROKEAHA.112.653055; Holevar M, 2009, J TRAUMA, V67, P870, DOI 10.1097/TA.0b013e3181b5a960; Holloway KL, 1996, J NEUROSURG, V85, P419, DOI 10.3171/jns.1996.85.3.0419; Hopkins SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-255; Horan TC, 2008, AM J INFECT CONTROL, V36, P309, DOI 10.1016/j.ajic.2008.03.002; Howitz MF, 2014, EPIDEMIOL INFECT, V142, P1300, DOI 10.1017/S0950268813001878; Hug A, 2009, STROKE, V40, P3226, DOI 10.1161/STROKEAHA.109.557967; Hull E, 2017, CLIN NEUROL NEUROSUR, V157, P95, DOI 10.1016/j.clineuro.2017.03.021; Hwang BY, 2010, NEUROCRIT CARE, V13, P141, DOI 10.1007/s12028-010-9382-x; Inaba K, 2008, J AM COLL SURGEONS, V206, P432, DOI 10.1016/j.jamcollsurg.2007.10.005; Ingeman A, 2011, STROKE, V42, P3214, DOI 10.1161/STROKEAHA.110.610881; Jacobs DG, 1998, J NATL MED ASSOC, V90, P417; Ji RJ, 2014, STROKE, V45, P2620, DOI 10.1161/STROKEAHA.114.005023; Ji RJ, 2013, CRIT CARE, V17, DOI 10.1186/cc13130; Ji RJ, 2013, STROKE, V44, P1303, DOI 10.1161/STROKEAHA.111.000598; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jovanovic B, 2015, INT J INFECT DIS, V38, P46, DOI 10.1016/j.ijid.2015.07.005; Kammersgaard L P, 2001, J Stroke Cerebrovasc Dis, V10, P217, DOI 10.1053/jscd.2001.30366; Kasius KM, 2010, CEREBROVASC DIS, V29, P576, DOI 10.1159/000306645; Katzan IL, 2007, NEUROLOGY, V68, P1938, DOI 10.1212/01.wnl.0000263187.08969.45; Katzan IL, 2003, NEUROLOGY, V60, P620, DOI 10.1212/01.WNL.0000046586.38284.60; Kenneally C, 2007, CHEST, V132, P418, DOI 10.1378/chest.07-0202; Kesinger MR, 2015, J TRAUMA ACUTE CARE, V78, P396, DOI 10.1097/TA.0000000000000526; Kestle JRW, 2006, J NEUROSURG, V105, P177, DOI 10.3171/ped.2006.105.3.177; Kilpatrick MM, 2000, NEUROSURGERY, V47, P850, DOI 10.1097/00006123-200010000-00011; Kim JH, 2012, WORLD NEUROSURG, V77, P135, DOI 10.1016/j.wneu.2011.04.017; Klehmet J, 2009, NEUROSCIENCE, V158, P1184, DOI 10.1016/j.neuroscience.2008.07.044; Korinek AM, 1997, NEUROSURGERY, V41, P1073, DOI 10.1097/00006123-199711000-00010; KORINEK AM, 1992, ANN FR ANESTH, V11, P711, DOI 10.1016/S0750-7658(05)80795-6; Korinek AM, 2006, NEUROSURGERY, V59, P126, DOI 10.1227/01.NEU.0000220477.47323.92; Kourbeti IS, 2012, CLIN MICROBIOL INFEC, V18, P359, DOI 10.1111/j.1469-0691.2011.03625.x; Kourbeti IS, 2015, J NEUROSURG, V122, P1113, DOI 10.3171/2014.8.JNS132557; Kourbeti IS, 2011, BRIT J NEUROSURG, V25, P9, DOI 10.3109/02688697.2010.500411; Kumar RG, 2015, J HEAD TRAUMA REHAB, V30, P369, DOI 10.1097/HTR.0000000000000067; Kwan J, 2007, ACTA NEUROL SCAND, V115, P331, DOI 10.1111/j.1600-0404.2006.00783.x; Kwon HM, 2006, AM J INFECT CONTROL, V34, P64, DOI 10.1016/j.ajic.2005.06.011; Laban KG, 2015, INT J STROKE, V10, P763, DOI 10.1111/ijs.12494; LABORDE G, 1993, ANAESTHESIST, V42, P724; Lackner P, 2008, NEUROCRIT CARE, V8, P360, DOI 10.1007/s12028-008-9071-1; Lakshminarayan K, 2010, STROKE, V41, P2849, DOI 10.1161/STROKEAHA.110.597039; Langhorne P, 2000, STROKE, V31, P1223, DOI 10.1161/01.STR.31.6.1223; Launey Y, 2014, CRIT CARE, V18, DOI 10.1186/s13054-014-0689-4; Leib SL, 1999, CLIN INFECT DIS, V29, P69, DOI 10.1086/520184; Li YR, 2015, CLIN BIOCHEM, V48, P50, DOI 10.1016/j.clinbiochem.2014.10.007; Liu ZH, 2015, CRIT CARE MED, V43, P2416, DOI 10.1097/CCM.0000000000001188; Lo CH, 2007, J NEUROSURG, V106, P378, DOI 10.3171/jns.2007.106.3.378; Loo VG, 2005, NEW ENGL J MED, V353, P2442, DOI 10.1056/NEJMoa051639; Lozier AP, 2008, NEUROSURGERY, V62, P688, DOI [10.1227/01.neu.0000316273.35833.7c, 10.1227/01.NEU.0000017465.78245.6C]; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Lucas SM, 2006, BRIT J PHARMACOL, V147, pS232, DOI 10.1038/sj.bjp.0706400; Lyke KE, 2001, CLIN INFECT DIS, V33, P2028, DOI 10.1086/324492; MAHE V, 1995, ANN FR ANESTH, V14, P8, DOI 10.1016/S0750-7658(05)80144-3; Maramattom BV, 2006, NEUROCRIT CARE, V5, P115, DOI 10.1385/NCC:5:2:115; Marciniak C, 2009, AM J PHYS MED REHAB, V88, P30, DOI 10.1097/PHM.0b013e3181909b73; Marra AR, 2007, BMC INFECT DIS, V7, DOI 10.1186/1471-2334-7-42; Martinez R, 2002, INTENS CARE MED, V28, P208, DOI 10.1007/s00134-001-1176-3; Martino R, 2005, STROKE, V36, P2756, DOI 10.1161/01.STR.0000190056.76543.eb; May Addison K, 2006, Surg Infect (Larchmt), V7, P409, DOI 10.1089/sur.2006.7.409; MAYHALL CG, 1984, NEW ENGL J MED, V310, P553, DOI 10.1056/NEJM198403013100903; McClelland S, 2007, CLIN INFECT DIS, V45, P55, DOI 10.1086/518580; McDonald LC, 2006, EMERG INFECT DIS, V12, P409, DOI 10.3201/eid1203.051064; McMahon CJ, 2013, J NEUROINTERV SURG, V5, P512, DOI 10.1136/neurintsurg-2012-010386; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; MOLLMAN HD, 1986, J NEUROSURG, V64, P902, DOI 10.3171/jns.1986.64.6.0902; Monton C, 1999, CRIT CARE MED, V27, P1745, DOI 10.1097/00003246-199909000-00008; Moore F, 2013, J TRAUMA ACUTE CARE, V74, P360; Morganti-Kossmann Maria Cristina, 2002, Curr Opin Crit Care, V8, P101; Mracsko E, 2014, BRAIN BEHAV IMMUN, V41, P200, DOI 10.1016/j.bbi.2014.05.015; Munoz-Gomez S, 2015, HEART LUNG, V44, P158, DOI 10.1016/j.hrtlng.2015.01.003; Muroi C, 2013, NEUROSURGERY, V72, P367, DOI 10.1227/NEU.0b013e31828048ce; Musa SA, 2010, NEUROCRIT CARE, V13, P87, DOI 10.1007/s12028-010-9374-x; Musa SA, 2011, J CARDIOTHOR VASC AN, V25, P263, DOI 10.1053/j.jvca.2010.05.004; MUSTAFA MM, 1989, J PEDIATR-US, V115, P208, DOI 10.1016/S0022-3476(89)80067-8; Muttaiyah S, 2008, J MED MICROBIOL, V57, P207, DOI 10.1099/jmm.0.47518-0; NAROTAM PK, 1994, NEUROSURGERY, V34, P409, DOI 10.1227/00006123-199403000-00004; Oda S, 2005, CYTOKINE, V29, P169, DOI 10.1016/j.cyto.2004.10.010; Offner H, 2006, J CEREBR BLOOD F MET, V26, P654, DOI 10.1038/sj.jcbfm.9600217; OHGA S, 1994, ARCH DIS CHILD, V70, P123, DOI 10.1136/adc.70.2.123; Ohwaki K, 2008, NEUROCRIT CARE, V8, P271, DOI 10.1007/s12028-007-9007-1; Ovbiagele Bruce, 2006, J Stroke Cerebrovasc Dis, V15, P209; PATIR R, 1992, ACTA NEUROCHIR, V119, P80, DOI 10.1007/BF01541786; Maskin LP, 2013, CLIN NEUROL NEUROSUR, V115, P1820, DOI 10.1016/j.clineuro.2013.05.034; Pegoli M, 2015, J NEUROSURG, V122, P414, DOI 10.3171/2014.10.JNS14290; Peterson K, 2008, J NEUROTRAUM, V25, P62, DOI 10.1089/neu.2007.0424; Pfausler B, 2004, ACTA NEUROCHIR, V146, P477, DOI 10.1007/s00701-004-0258-8; Pfisterer W, 2003, J NEUROL NEUROSUR PS, V74, P929, DOI 10.1136/jnnp.74.7.929; PIEK J, 1992, J NEUROSURG, V77, P901, DOI 10.3171/jns.1992.77.6.0901; Poon WS, 1998, ACT NEUR S, V71, P146; Prasad R, 2014, PEDIATR NEUROL, V50, P60, DOI 10.1016/j.pediatrneurol.2013.08.016; Prass K, 2003, J EXP MED, V198, P725, DOI 10.1084/jem.20021098; Prass K, 2006, STROKE, V37, P2607, DOI 10.1161/01.STR.0000240409.68739.2b; Pryor JP, 2007, J TRAUMA, V62, P61; Raad I, 2007, LANCET INFECT DIS, V7, P645, DOI 10.1016/S1473-3099(07)70235-9; Ramanan M, 2015, BMC INFECT DIS, V15, DOI 10.1186/s12879-014-0712-z; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Razine Rachid, 2012, Int Arch Med, V5, P26, DOI 10.1186/1755-7682-5-26; Rebuck JA, 2000, J NEUROL NEUROSUR PS, V69, P381, DOI 10.1136/jnnp.69.3.381; Reichert MCF, 2002, AM J INFECT CONTROL, V30, P158, DOI 10.1067/mic.2002.119925; Richards MJ, 2000, INFECT CONT HOSP EP, V21, P510, DOI 10.1086/501795; Rincon-Ferrari MD, 2004, J TRAUMA, V57, P1234, DOI 10.1097/01.TA.0000119200.70853.23; Riquelme R, 1996, AM J RESP CRIT CARE, V154, P1450, DOI 10.1164/ajrccm.154.5.8912763; Robinson TG, 2003, STROKE, V34, P705, DOI 10.1161/01.STR.0000058493.94875.9F; Roos YBWEM, 2000, J NEUROL NEUROSUR PS, V68, P337, DOI 10.1136/jnnp.68.3.337; Roquilly A, 2011, JAMA-J AM MED ASSOC, V305, P1201, DOI 10.1001/jama.2011.360; Rosengart AJ, 2007, STROKE, V38, P2315, DOI 10.1161/STROKEAHA.107.484360; Saloheimo P, 2006, STROKE, V37, P487, DOI 10.1161/01.STR.0000198868.78546.fc; Saposnik G, 2008, STROKE, V39, P2522, DOI 10.1161/STROKEAHA.107.507145; Savardekar Amey, 2013, Surg Neurol Int, V4, P24, DOI 10.4103/2152-7806.107894; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; Schade RP, 2005, J NEUROSURG, V102, P229, DOI 10.3171/jns.2005.102.2.0229; Schirmer-Mikalsen K, 2013, ACTA ANAESTH SCAND, V57, P46, DOI 10.1111/j.1399-6576.2012.02785.x; Schmidt OI, 2005, BRAIN RES REV, V48, P388, DOI 10.1016/j.brainresrev.2004.12.028; Schoch B, 2008, ZBL NEUROCHIR, V69, P80, DOI 10.1055/s-2007-1022559; Schultz M, 1993, J Neurosci Nurs, V25, P158; Seguin P, 2014, CRIT CARE MED, V42, P1, DOI 10.1097/CCM.0b013e3182a2770f; Selassie AW, 2011, J TRAUMA, V71, P1226, DOI 10.1097/TA.0b013e318226ecfc; Sellars C, 2007, STROKE, V38, P2284, DOI 10.1161/STROKEAHA.106.478156; SHAFER SQ, 1993, J NATL MED ASSOC, V85, P31; Singh TD, 2017, J NEUROSURG SCI, V61, P117, DOI 10.23736/S0390-5616.16.03298-7; Sirvent JM, 1997, AM J RESP CRIT CARE, V155, P1729, DOI 10.1164/ajrccm.155.5.9154884; Stenehjem E, 2012, INFECT DIS CLIN N AM, V26, P89, DOI 10.1016/j.idc.2011.09.006; Stocchetti N, 2002, INTENS CARE MED, V28, P1555, DOI 10.1007/s00134-002-1513-1; Sykora M, 2008, CRIT CARE MED, V36, P3074, DOI 10.1097/CCM.0b013e31818b306d; Sykora M, 2011, STROKE, V42, P1218, DOI 10.1161/STROKEAHA.110.604637; Takahashi W, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.02.020; Tang RB, 2001, CHILD NERV SYST, V17, P453, DOI 10.1007/s003810000422; Tarkowski E, 1998, SCAND J IMMUNOL, V47, P30; Titsworth WL, 2013, STROKE, V44, P3154, DOI 10.1161/STROKEAHA.111.000204; Tripathy S, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00082; Upadya A, 2004, J CRIT CARE, V19, P16, DOI 10.1016/j.jcrc.2004.02.004; van de Beek D, 2009, ARCH NEUROL-CHICAGO, V66, P1076, DOI 10.1001/archneurol.2009.176; Vargas M, 2006, STROKE, V37, P461, DOI 10.1161/01.STR.0000199138.73365.b3; Vergouwen MDI, 2011, STROKE, V42, P3093, DOI 10.1161/STROKEAHA.111.619510; Vergouwen MDI, 2011, STROKE, V42, P924, DOI 10.1161/STROKEAHA.110.597914; Viallon A, 2011, CRIT CARE, V15, DOI 10.1186/cc10254; Vitaz TW, 2003, SURG NEUROL, V60, P285, DOI 10.1016/S0090-3019(03)00378-1; Walter U, 2013, EUR J NEUROL, V20, P153, DOI 10.1111/j.1468-1331.2012.03818.x; Walter U, 2007, J NEUROL, V254, P1323, DOI 10.1007/s00415-007-0520-0; Wang F, 2013, APMIS, V121, P197, DOI 10.1111/j.1600-0463.2012.02956.x; Wang JP, 2015, BRAIN BEHAV IMMUN, V43, P172, DOI 10.1016/j.bbi.2014.07.022; Wang KW, 2013, J NEUROSURG, V118, P358, DOI 10.3171/2012.10.JNS127; Wartenberg KE, 2006, CRIT CARE MED, V34, P617, DOI 10.1097/01.CCM.0000201903.46435.35; Weimar C, 2002, EUR NEUROL, V48, P133, DOI 10.1159/000065512; Weisfelt M, 2007, J HOSP INFECT, V66, P71, DOI 10.1016/j.jhin.2007.02.017; Westendorp WF, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-110; Wong GK, 2008, J CLIN NEUROSCI, V15, P654, DOI 10.1016/j.jocn.2007.03.011; Yang CC, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-289; Zabramski JM, 2003, J NEUROSURG, V98, P725, DOI 10.3171/jns.2003.98.4.0725; Zarrouk V, 2007, CLIN INFECT DIS, V44, P1555, DOI 10.1086/518169; Ziai WC, 2006, CRIT CARE CLIN, V22, P661, DOI 10.1016/j.ccc.2006.11.009; Zolldann D, 2005, INFECT CONT HOSP EP, V26, P726, DOI 10.1086/502610; Zygun DA, 2006, NEUROCRIT CARE, V5, P108, DOI 10.1385/NCC:5:2:108	239	15	17	0	13	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1042-3680	1558-1349		NEUROSURG CLIN N AM	Neurosurg. Clin. N. Am.	APR	2018	29	2					299	+		10.1016/j.nec.2017.11.008			17	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GB6MJ	WOS:000429183000010	29502719				2022-02-06	
J	Coppieters, I; De Pauw, R; Caeyenberghs, K; Lenoir, D; DeBlaere, K; Genbrugge, E; Meeus, M; Cagnie, B				Coppieters, I.; De Pauw, R.; Caeyenberghs, K.; Lenoir, D.; DeBlaere, K.; Genbrugge, E.; Meeus, M.; Cagnie, B.			Differences in white matter structure and cortical thickness between patients with traumatic and idiopathic chronic neck pain: Associations with cognition and pain modulation?	HUMAN BRAIN MAPPING			English	Article						chronic idiopathic neck pain; chronic whiplash-associated disorders; central sensitization; cognitive performance; cortical thickness; magnetic resonance imaging; white matter	WHIPLASH-ASSOCIATED DISORDERS; IRRITABLE-BOWEL-SYNDROME; HUMAN CEREBRAL-CORTEX; DIFFUSION TENSOR MRI; BRAIN-INJURY; FUNCTIONAL CONNECTIVITY; CINGULATE CORTEX; SEX-DIFFERENCES; SENSORY HYPERSENSITIVITY; GEOMETRICALLY ACCURATE	Brain alterations are hypothesized to be present in patients with chronic whiplash-associated disorders (CWAD). The aim of this case-control study was to examine alterations in cortical thickness and white matter (WM) structure, and the presence of brain microhemorrhages in a patient group encountering chronic neck pain of traumatic origin (i.e., CWAD) when compared with a patient group characterized by nontraumatic chronic neck pain [i.e., chronic idiopathic neck pain (CINP)], and healthy controls. Furthermore, we aimed to investigate associations between brain structure on one hand and cognitive performance and central sensitization (CS) on the other hand. T1-weighted, diffusion-weighted and T2*-weighted magnetic resonance images of the brain were acquired in 105 women (31 controls, 37 CINP, 37 CWAD) to investigate regional cortical thickness, WM structure, and microhemorrhages, respectively. Next, cognitive performance, and CS encompassing distant hyperalgesia and conditioned pain modulation (CPM) efficacy were examined. Cortical thinning in the left precuneus was revealed in CWAD compared with CINP patients. Also, decreased fractional anisotropy, together with increased values of mean diffusivity and radial diffusivity could be observed in the left cingulum hippocampus and tapetum in CWAD compared with CINP, and in the left tapetum in CWAD patients compared with controls. Moreover, the extent of WM structural deficits in the left tapetum coincided with decreased CPM efficacy in the CWAD group. This yields evidence for associations between decreased endogenous pain inhibition, and the degree of regional WM deficits in CWAD. Our results emphasize the role of structural brain alterations in women with CWAD compared with CINP.	[Coppieters, I.; De Pauw, R.; Lenoir, D.; Meeus, M.; Cagnie, B.] Univ Ghent, Dept Rehabil Sci & Physiotherapy, Fac Med & Hlth Sci, Ghent, Belgium; [Coppieters, I.; Meeus, M.] Pain Mot Int Res Grp, Ghent, Belgium; [Coppieters, I.] Vrije Univ Brussel, Fac Phys Educ & Physiotherapy, Dept Physiotherapy Human Physiol & Anat KIMA, Brussels, Belgium; [Caeyenberghs, K.] Australian Catholic Univ, Sch Psychol, Fac Hlth Sci, Banyo, Australia; [DeBlaere, K.; Genbrugge, E.] Univ Ghent, Dept Radiol, Ghent, Belgium; [Meeus, M.] Univ Antwerp, Dept Rehabil Sci & Physiotherapy, Fac Med & Hlth Sci, Antwerp, Belgium		Coppieters, I (corresponding author), Rehabil Sci & Physiotherapy Ghent, Campus Heymans UZ 3 B3,De Pintelaan 185, Ghent, Belgium.	iris.coppieters@vub.ac.be	De Pauw, Robby/ABF-6976-2020; Meeus, Mira/B-3332-2011; cagnie, barbara/D-9830-2017; Coppieters, Iris/M-8749-2014; Coppieters, Iris/AAI-3812-2021	De Pauw, Robby/0000-0002-4242-9062; Meeus, Mira/0000-0002-2022-5114; cagnie, barbara/0000-0003-4342-4519; Coppieters, Iris/0000-0003-1598-632X; Caeyenberghs, Karen/0000-0001-7009-6843	Special Research Fund of Ghent University (BOF-Ghent) [BOF13/DOC/276]	Special Research Fund of Ghent University (BOF-Ghent), Grant Number: BOF13/DOC/276.	Aerts H, 2016, BRAIN, V139, P3063, DOI 10.1093/brain/aww194; Alexander MP, 1998, NEUROLOGY, V51, P336, DOI 10.1212/WNL.51.2.336; Apkarian AV, 2011, PAIN, V152, pS49, DOI 10.1016/j.pain.2010.11.010; Baek SO, 2013, NEUROREHABILITATION, V33, P465, DOI 10.3233/NRE-130979; Baliki MN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106133; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 1996, J MAGN RESON SER B, V111, P209, DOI 10.1016/j.jmr.2011.09.022; Bay E, 2012, BRAIN INJURY, V26, P941, DOI 10.3109/02699052.2012.666365; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Borsook D, 2016, NEUROSCI BIOBEHAV R, V68, P282, DOI 10.1016/j.neubiorev.2016.05.033; Bowie CR, 2006, NAT PROTOC, V1, P2277, DOI 10.1038/nprot.2006.390; Breivik H, 2006, EUR J PAIN, V10, P287, DOI 10.1016/j.ejpain.2005.06.009; Buckalew N, 2010, PAIN MED, V11, P1183, DOI 10.1111/j.1526-4637.2010.00899.x; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bulls HW, 2015, J PAIN RES, V8, P311, DOI 10.2147/JPR.S84607; Cagnie B, 2014, SEMIN ARTHRITIS RHEU, V44, P68, DOI 10.1016/j.semarthrit.2014.01.001; Cathcart Stuart, 2006, J Headache Pain, V7, P21, DOI 10.1007/s10194-006-0265-7; Cauda F, 2014, NEUROIMAGE-CLIN, V4, P676, DOI 10.1016/j.nicl.2014.04.007; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chen JYW, 2011, BRAIN RES, V1392, P121, DOI 10.1016/j.brainres.2011.03.069; Chong CD, 2017, NEUROIMAGE-CLIN, V13, P223, DOI 10.1016/j.nicl.2016.10.023; Chua NHL, 2012, J MUSCULOSKELET PAIN, V20, P292, DOI 10.3109/10582452.2012.733803; Coppieters I, 2017, PAIN PHYSICIAN, V20, pE1025; Coppieters I, 2017, PHYS THER, V97, P338, DOI 10.2522/ptj.20160259; Coppieters I, 2016, J PAIN, V17, P949, DOI 10.1016/j.jpain.2016.04.005; Coppieters I, 2015, PAIN PHYSICIAN, V18, pE389; Curran K. M., 2016, DIFFUSION TENSOR IMA, P65, DOI DOI 10.1007/978-1-4939-3118-7_5; Daenen L, 2013, CLIN RHEUMATOL, V32, P23, DOI 10.1007/s10067-012-2085-2; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davis CG, 2013, J FORENSIC LEG MED, V20, P74, DOI 10.1016/j.jflm.2012.05.004; Davis KD, 2013, J NEUROIMMUNE PHARM, V8, P518, DOI 10.1007/s11481-012-9386-8; De Pauw R, 2017, PAIN PHYSICIAN, V20, P245; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; DeSouza DD, 2014, PAIN, V155, P37, DOI 10.1016/j.pain.2013.08.029; Diaz-Piedra C, 2016, BRAIN IMAGING BEHAV, V10, P1184, DOI 10.1007/s11682-015-9485-2; Drijkoningen D, 2015, NEUROIMAGE-CLIN, V7, P240, DOI 10.1016/j.nicl.2014.12.006; Erpelding N, 2012, PAIN, V153, P1602, DOI 10.1016/j.pain.2012.03.012; Fischl B, 2001, IEEE T MED IMAGING, V20, P70, DOI 10.1109/42.906426; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fischl B, 2012, NEUROIMAGE, V62, P774, DOI 10.1016/j.neuroimage.2012.01.021; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Geha PY, 2008, NEURON, V60, P570, DOI 10.1016/j.neuron.2008.08.022; Govindarajan KA, 2016, J NEUROTRAUM, V33, P1809, DOI 10.1089/neu.2015.4253; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; Horsfield MA, 2002, NMR BIOMED, V15, P570, DOI 10.1002/nbm.787; Hsu MC, 2009, PAIN, V143, P262, DOI 10.1016/j.pain.2009.03.017; Ichesco E, 2016, EUR J PAIN, V20, P1079, DOI 10.1002/ejp.832; Janve VA, 2013, NEUROIMAGE, V74, P298, DOI 10.1016/j.neuroimage.2013.02.034; Jensen KB, 2013, ARTHRITIS RHEUM-US, V65, P3293, DOI 10.1002/art.38170; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Jorritsma W, 2012, EUR SPINE J, V21, P93, DOI 10.1007/s00586-011-1920-5; Jorritsma W, 2010, EUR SPINE J, V19, P1695, DOI 10.1007/s00586-010-1406-x; Kennedy DL, 2016, PAIN, V157, P2410, DOI 10.1097/j.pain.0000000000000689; Killgore WDS, 2016, NEUROSCI LETT, V612, P238, DOI 10.1016/j.neulet.2015.12.033; Kim DJ, 2014, ARTHRITIS RHEUMATOL, V66, P3190, DOI 10.1002/art.38771; Koenig KA, 2015, MULT SCLER J, V21, P1794, DOI 10.1177/1352458515576983; Koerte IK, 2016, TRANSLATIONAL RES TR; Kosek E, 1999, SCAND J REHABIL MED, V31, P89; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kregel J, 2015, SEMIN ARTHRITIS RHEU, V45, P229, DOI 10.1016/j.semarthrit.2015.05.002; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Lee DH, 2015, J PAIN, V16, P580, DOI 10.1016/j.jpain.2015.03.006; Leemans A. J. B., 2009, 17 ANN MEEN INT SOC, P35; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lewis GN, 2012, PAIN RES MANAG, V17, P98, DOI 10.1155/2012/610561; Lieberman G, 2014, J PAIN, V15, P1110, DOI 10.1016/j.jpain.2014.08.002; Lin L, 2015, J MOL NEUROSCI, V56, P363, DOI 10.1007/s12031-015-0550-5; Liu GB, 2015, ACTA RADIOL, V56, P1256, DOI 10.1177/0284185114552883; Luerding R, 2008, BRAIN, V131, P3222, DOI 10.1093/brain/awn229; Lutz J, 2008, ARTHRITIS RHEUM-US, V58, P3960, DOI 10.1002/art.24070; Ly M, 2016, J INT NEUROPSYCH SOC, V22, P191, DOI 10.1017/S1355617715001216; Malfliet A, 2017, EUR J PAIN, V21, P769, DOI 10.1002/ejp.1003; Malfliet A, 2015, PAIN PHYSICIAN, V18, P223; Mansour AR, 2013, PAIN, V154, P2160, DOI 10.1016/j.pain.2013.06.044; MCALLISTER TW, 1992, PSYCHIAT CLIN N AM, V15, P395; Meeus M, 2015, CLIN RHEUMATOL, V34, P545, DOI 10.1007/s10067-013-2446-5; Misdraji EL, 2010, J CLIN EXP NEUROPSYC, V32, P159, DOI 10.1080/13803390902881942; Mori S, 2008, NEUROIMAGE, V40, P570, DOI 10.1016/j.neuroimage.2007.12.035; Moriarty O, 2011, PROG NEUROBIOL, V93, P385, DOI 10.1016/j.pneurobio.2011.01.002; Morris R, 1999, J COMP NEUROL, V407, P183, DOI 10.1002/(SICI)1096-9861(19990503)407:2<183::AID-CNE3>3.0.CO;2-N; MUFSON EJ, 1984, J COMP NEUROL, V225, P31, DOI 10.1002/cne.902250105; Nampiaparampil DE, 2008, JAMA-J AM MED ASSOC, V300, P711, DOI 10.1001/jama.300.6.711; Ng TS, 2014, CLIN J PAIN, V30, P436, DOI 10.1097/AJP.0b013e3182a03940; PERELLE IB, 1994, BEHAV GENET, V24, P217, DOI 10.1007/BF01067189; Piche M, 2013, J PAIN, V14, P1217, DOI 10.1016/j.jpain.2013.05.009; RAKIC P, 1988, PROG BRAIN RES, V73, P15; Ruigrok ANV, 2014, NEUROSCI BIOBEHAV R, V39, P34, DOI 10.1016/j.neubiorev.2013.12.004; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Sanchez-Cubillo I, 2009, J INT NEUROPSYCH SOC, V15, P438, DOI 10.1017/S1355617709090626; Sarikcioglu L, 2007, J HIST NEUROSCI, V16, P432, DOI 10.1080/09647040600719013; Schwedt TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0099791; Scott D, 2005, CLIN J PAIN, V21, P175, DOI 10.1097/00002508-200503000-00009; Segonne F, 2004, NEUROIMAGE, V22, P1060, DOI 10.1016/j.neuroimage.2004.03.032; Segonne F, 2007, IEEE T MED IMAGING, V26, P518, DOI 10.1109/TMI.2006.887364; Sled JG, 1998, IEEE T MED IMAGING, V17, P87, DOI 10.1109/42.668698; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Sterling M, 2004, MANUAL THER, V9, P60, DOI 10.1016/j.math.2004.01.006; Suleyman Sener P. P. M., 2016, DIFFUSION TENSOR IMA, P373; Sun SW, 2007, NEUROBIOL DIS, V28, P30, DOI 10.1016/j.nbd.2007.06.011; Todd E., 2007, FUNDAMENTALS DIAGNOS, P217; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tousignant-Laflamme Y, 2008, BRAIN RES, V1230, P73, DOI 10.1016/j.brainres.2008.06.120; Upadhyay J, 2010, BRAIN, V133, P2098, DOI 10.1093/brain/awq138; Urban KJ, 2017, J NEUROTRAUM, V34, P816, DOI 10.1089/neu.2016.4502; van Hemmen J, 2017, CEREB CORTEX, V27, P2994, DOI 10.1093/cercor/bhw156; Van Oosterwijck J, 2013, EUR J PAIN, V17, P299, DOI 10.1002/j.1532-2149.2012.00193.x; Van Oosterwijck J, 2012, J PAIN, V13, P242, DOI 10.1016/j.jpain.2011.11.006; Veeramuthu V, 2015, J NEUROTRAUM, V32, P1497, DOI 10.1089/neu.2014.3750; Vernon H, 2008, J MANIP PHYSIOL THER, V31, P491, DOI 10.1016/j.jmpt.2008.08.006; VOGT BA, 1987, J COMP NEUROL, V262, P256, DOI 10.1002/cne.902620207; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Whiteside A, 2004, PAIN, V109, P497, DOI 10.1016/j.pain.2004.02.029; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Xiong KL, 2016, NEURORADIOLOGY, V58, P733, DOI 10.1007/s00234-016-1675-0; Xiong KL, 2014, BRAIN RES, V1591, P86, DOI 10.1016/j.brainres.2014.10.030; Yarnitsky D, 2010, CURR OPIN ANESTHESIO, V23, P611, DOI 10.1097/ACO.0b013e32833c348b; Yunus MB, 2007, SEMIN ARTHRITIS RHEU, V36, P339, DOI 10.1016/j.semarthrit.2006.12.009; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023	122	15	16	0	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1065-9471	1097-0193		HUM BRAIN MAPP	Hum. Brain Mapp.	APR	2018	39	4					1721	1742		10.1002/hbm.23947			22	Neurosciences; Neuroimaging; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Radiology, Nuclear Medicine & Medical Imaging	FY8LW	WOS:000427117300019	29327392	Green Published, Green Accepted			2022-02-06	
J	Kroshus, E; Stellino, MB; Chrisman, SPD; Rivara, FP				Kroshus, Emily; Stellino, Megan Babkes; Chrisman, Sara P. D.; Rivara, Frederick P.			Threat, Pressure, and Communication About Concussion Safety: Implications for Parent Concussion Education	HEALTH EDUCATION & BEHAVIOR			English	Article						communication; concussion; parents; pressure; sport	YOUTH SPORTS; INJURY; RISK; BEHAVIOR; METAANALYSIS; PERCEPTIONS; PROTECTION; ATTITUDES; BELIEFS; FATHERS	Background. Parental communication about the importance of reporting concussion symptoms can influence a child's attitudes about such reporting, and is likely related to perceived threat of concussion. However, parental investment in child sport achievement might impede this communication. Purpose. To examine the relationship between perceived threat of concussion and parent-child communication regarding concussion symptom reporting, and the potential interaction with parental pressure regarding child sport achievement. Method. A total of 236 parents of youth soccer players completed an anonymous online survey. Results. There were greater odds of encouraging concussion reporting among parents who perceived that their child had a greater likelihood of sustaining a concussion (OR = 1.03, 95% CI [1.01, 1.04]) and lower odds among parents who exhibited greater parental sport pressure (OR = 0.88, 95% CI [0.78, 0.99]). Parents whose child had a prior concussion were much more likely to communicate with their child about concussion reporting (OR = 7.86, 95% CI [3.00, 20.55]). Conclusion. Initiatives are needed to support healthy sport parenting, particularly focusing on parental encouragement of concussion reporting. Possible directions for concussion education for parents based on the results of this study include providing parents with concrete guidance about the important role they can play in encouraging their child to report symptoms of a concussion, communicating the athletic consequences of continued sport involvement while experiencing symptoms of a concussion, and using narrative messaging with exemplars to personalize the information for parents of youth who have not previously sustained a concussion.	[Kroshus, Emily; Chrisman, Sara P. D.; Rivara, Frederick P.] Univ Washington, Seattle, WA 98195 USA; [Kroshus, Emily; Chrisman, Sara P. D.; Rivara, Frederick P.] Seattle Childrens Res Inst, 2001 W 8th Ave,Suite 400, Seattle, WA 98121 USA; [Stellino, Megan Babkes] Univ Colorado, Greeley, CO USA; [Chrisman, Sara P. D.; Rivara, Frederick P.] Harborview Injury Prevent & Res Ctr, Seattle, WA USA		Kroshus, E (corresponding author), Seattle Childrens Res Inst, 2001 W 8th Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@uw.edu		Chrisman, Sara/0000-0001-5373-7223			Asken BM, 2016, J ATHL TRAINING, V51, P329, DOI 10.4085/1062-6050-51.5.02; Babkes ML, 1999, PEDIATR EXERC SCI, V11, P44, DOI 10.1123/pes.11.1.44; Brewer NT, 2007, HEALTH PSYCHOL, V26, P136, DOI 10.1037/0278-6133.26.2.136; Brussoni M, 2013, CHILD CARE HLTH DEV, V39, P237, DOI 10.1111/j.1365-2214.2011.01361.x; Brussoni M, 2013, AM J MENS HEALTH, V7, P77, DOI 10.1177/1557988312462739; Brussoni M, 2011, J DEV BEHAV PEDIATR, V32, P491, DOI 10.1097/DBP.0b013e31821bd1f5; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Creighton G, 2017, J FAM ISSUES, V38, P1043, DOI 10.1177/0192513X15584679; Dahlstrom MF, 2014, P NATL ACAD SCI USA, V111, P13614, DOI 10.1073/pnas.1320645111; DIEFENBACH MA, 1993, HEALTH EDUC RES, V8, P181, DOI 10.1093/her/8.2.181; DiFiori JP, 2014, BRIT J SPORT MED, V48, DOI 10.1136/bjsports-2013-093299; Eccles J.S., 1983, ACHIEVEMENT ACHIEVEM, P75, DOI DOI 10.1007/S11251-015-9352-Y; ECCLES JS, 1993, NEBR SYM MOTIV, V40, P145; Eckner JT, 2014, BRIT J SPORT MED, V48, P112, DOI 10.1136/bjsports-2012-091579; Elbin RJ, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2016-0910; Faigenbaum AD, 2009, J STRENGTH COND RES, V23, pS60, DOI 10.1519/JSC.0b013e31819df407; Fraser-Thomas J. L., 2005, Physical Education and Sport Pedagogy, V10, P19, DOI 10.1080/1740898042000334890; Gielen AC, 2004, J URBAN HEALTH, V81, P545, DOI 10.1093/jurban/jth139; Glang A, 2010, INT J SPORTS SCI COA, V5, P1, DOI 10.1260/1747-9541.5.1.1; GLIK D, 1991, HEALTH EDUC QUART, V18, P285, DOI 10.1177/109019819101800303; Gottzen L, 2012, GENDER SOC, V26, P639, DOI 10.1177/0891243212446370; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Malina RM, 2010, CURR SPORT MED REP, V9, P364, DOI 10.1249/JSR.0b013e3181fe3166; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Marshall Stephen W, 2015, Inj Epidemiol, V2, P13; O'Rourke DJ, 2014, J APPL SPORT PSYCHOL, V26, P395, DOI 10.1080/10413200.2014.907838; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; ROSENSTOCK IM, 1974, HEALTH EDUC QUART, V2, P354, DOI 10.1177/109019817400200405; Sanchez-Miguel PA, 2013, J HUM KINET, V36, P169, DOI 10.2478/hukin-2013-0017; TINSLEY BJ, 1992, CHILD DEV, V63, P1043, DOI 10.2307/1131518; US Soccer, 2015, KEY STAT; Wheeler S, 2014, LEISURE STUD, V33, P267, DOI 10.1080/02614367.2012.707227; White SA, 2004, SCAND J MED SCI SPOR, V14, P57, DOI 10.1111/j.1600-0838.2003.00314.x; Witte K, 2000, HEALTH EDUC BEHAV, V27, P591, DOI 10.1177/109019810002700506; [No title captured]	39	15	15	0	5	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1090-1981	1552-6127		HEALTH EDUC BEHAV	Health Educ. Behav.	APR	2018	45	2					254	261		10.1177/1090198117715669			8	Public, Environmental & Occupational Health	Social Science Citation Index (SSCI)	Public, Environmental & Occupational Health	GC5EX	WOS:000429809500011	28789571				2022-02-06	
J	Lu, Q; Xie, YL; Qi, XC; Li, XW; Yang, SX; Wang, YR				Lu, Qin; Xie, Yonglin; Qi, Xunchen; Li, Xinwei; Yang, Shuxu; Wang, Yirong			Is Early Tracheostomy Better for Severe Traumatic Brain Injury? A Meta-Analysis	WORLD NEUROSURGERY			English	Article						Early tracheostomy; Meta-analysis; Outcome; Traumatic brain injury	INTUBATION; TRIAL; BLUNT; CARE	BACKGROUND: Tracheostomy has proven benefits for patients requiring prolonged mechanical ventilation. However, whether early tracheostomy (ET; <10 days after injury) can also improve outcomes in patients with severe traumatic brain injury (TBI) (Glasgow Coma Scale score <= 8) remains controversial. The aim of this study was to clarify this question. METHODS: We searched 4 databases (PubMed, Web of Science, Elsevier ScienceDirect, and Cochrane Library) for articles comparing the outcomes of ET with late tracheotomy or prolonged intubation in patients with severe TBI. Two reviewers were asked to record the major outcome data as follows: length of intensive care unit (ICU) stay, duration of mechanical ventilation, mortality, and incidence of pneumonia. Both random-effects and fixed-effects models were used. RESULTS: Eight studies met our inclusion criteria, with a total of 797 patients in the ET group and 871 patients in the late tracheostomy or prolonged intubation (not-ET) group. A meta-analysis of these 8 studies suggested that ET could reduce the length of ICU stay (mean difference [MD], -3.08; 95% confidence interval [CI], -3.75 to -2.41), duration of mechanical ventilation (MD, -4.92; 95% CI, -6.82 to -3.02), length of hospital stay (MD, -4.79; 95% CI, -8.63 to - 0.94), and incidence of pneumonia (odds ratio [OR], 0.64; 95% CI, 0.530.78), but seemed to be independent of mortality (OR, 1.25; 95% CI, 0.90-1.75). CONCLUSIONS: The available evidence suggests that ET may reduce the length of ICU and hospital stays, duration of mechanical ventilation, and incidence of pneumonia in patients with severe TBI. Well-designed randomized controlled trials are needed to confirm these findings.	[Lu, Qin; Qi, Xunchen; Li, Xinwei; Yang, Shuxu; Wang, Yirong] Zhejiang Univ, Sch Med, Dept Neurosurg, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China; [Xie, Yonglin] Hangzhou Hosp Zhejiang CAPR, Dept Rehabil, Hangzhou, Zhejiang, Peoples R China		Wang, YR (corresponding author), Zhejiang Univ, Sch Med, Dept Neurosurg, Sir Run Run Shaw Hosp, Hangzhou, Zhejiang, Peoples R China.	happycatlq1001@gmail.com	LU, QIN/AAU-1992-2021	LU, QIN/0000-0001-8211-6127	Zhejiang Provincial Natural Science Foundation of ChinaNatural Science Foundation of Zhejiang Province [Y14H160098]; National Science Foundation for Young Scientists of China [81702974]	This study was supported by the Zhejiang Provincial Natural Science Foundation of China (Grant Y14H160098) and the National Science Foundation for Young Scientists of China (Grant 81702974). The authors declare that the article content was composed in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.	Ahmed Nasim, 2007, Surg Infect (Larchmt), V8, P343, DOI 10.1089/sur.2006.065; Alali AS, 2014, J TRAUMA ACUTE CARE, V76, P76; Alali Aziz S, 2014, J Trauma Acute Care Surg, V76, P70, DOI 10.1097/TA.0b013e3182a8fd6a; Arabi YM, 2010, J CRIT CARE, V25, P190, DOI 10.1016/j.jcrc.2009.05.004; BEGG CB, 1994, BIOMETRICS, V50, P1088, DOI 10.2307/2533446; Bosel J, 2013, STROKE, V44, P21, DOI 10.1161/STROKEAHA.112.669895; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Cai SQ, 2017, INJURY, V48, P866, DOI 10.1016/j.injury.2017.02.023; Chastre J, 2002, AM J RESP CRIT CARE, V165, P867, DOI 10.1164/ajrccm.165.7.2105078; Combes A, 2002, CHEST, V121, P1618, DOI 10.1378/chest.121.5.1618; DERSIMONIAN R, 1986, CONTROL CLIN TRIALS, V7, P177, DOI 10.1016/0197-2456(86)90046-2; Dunham CM, 2014, INT J BURNS TRAUMA, V4, P14; Gurkin MA, 2002, AM SURGEON, V68, P324; GURKIN SA, 2002, AM SURGEON, V68, P328; Haddad SH, 2012, SCAND J TRAUMA RESUS, V20, DOI 10.1186/1757-7241-20-12; Hosokawa K, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1138-8; Khalili H, 2017, WORLD NEUROSURG, V103, P88, DOI 10.1016/j.wneu.2017.02.060; Kleffmann J, 2012, NEUROCRIT CARE, V17, P85, DOI 10.1007/s12028-012-9709-x; LESNIK I, 1992, AM SURGEON, V58, P346; Major KM, 2003, AM J SURG, V186, P615, DOI 10.1016/j.amjsurg.2003.08.012; Mallick A, 2010, EUR J ANAESTH, V27, P676, DOI 10.1097/EJA.0b013e32833b1ba0; McCredie V, 2017, NEUROCRIT CARE, V26, P14, DOI 10.1007/s12028-016-0297-z; Protheroe RT, 2011, ANAESTHESIA, V66, P1035, DOI 10.1111/j.1365-2044.2011.06874.x; Seder DB, 2012, THE NEURO ICU BOOK, P723; Siddiqui Usman Tariq, 2015, Surg Neurol Int, V6, P65, DOI 10.4103/2152-7806.155757; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Wang HK, 2012, INJURY, V43, P1432, DOI 10.1016/j.injury.2011.03.059	28	15	16	2	9	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	APR	2018	112						E324	E330		10.1016/j.wneu.2018.01.043			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	GG8FH	WOS:000432932700038	29337171				2022-02-06	
J	Ma, DL; Wang, N; Fan, XT; Zhang, L; Luo, Y; Huang, R; Zhang, L; Li, YL; Zhao, GG; Li, L				Ma, Denglei; Wang, Na; Fan, Xiaotong; Zhang, Lan; Luo, Yi; Huang, Rui; Zhang, Li; Li, Yali; Zhao, Guoguang; Li, Lin			Protective Effects of Cornel Iridoid Glycoside in Rats After Traumatic Brain Injury	NEUROCHEMICAL RESEARCH			English	Article						Cornel iridoid glycoside; Traumatic brain injury; Behavior impairment; Apoptosis; Neurotrophic factor; Synaptic protein	NERVE GROWTH-FACTOR; NEUROLOGICAL FUNCTION; NEUROTROPHIC FACTORS; OBJECT RECOGNITION; CORTICAL IMPACT; MESSENGER-RNA; RODENT MODEL; IN-VITRO; APOPTOSIS; EXPRESSION	Cornel iridoid glycoside (CIG) is the active ingredient extracted from Cornus officinalis. Our previous studies showed that CIG had protective effects on several brain injury models. In the present study, we aimed to examine the effects and elucidate the mechanisms of CIG against traumatic brain injury (TBI). TBI was induced in the right cerebral cortex of male adult rats. The neurological and cognitive functions were evaluated by modified neurological severity score (mNSS) and object recognition test (ORT), respectively. The level of serum S100 beta was measured by an ELISA method. Nissl staining was used to estimate the neuron survival in the brain. The expression of proteins was determined by western blot and/or immunohistochemical staining. We found that intragastric administration of CIG in TBI rats ameliorated the neurological defects and cognitive impairment, and alleviated the neuronal loss in the injured brain. In the acute stage of TBI (24-72 h), CIG decreased the level of S100 beta in the serum and brain, increased the ratio of Bcl-2/Bax and decreased the expression of caspase-3 in the injured cortex. Moreover, the treatment with CIG for 30 days increased the levels of nerve growth factor (NGF) and brain-derived neurotrophic factor (BDNF), enhanced the expression of synapsin I, synaptophysin and postsynaptic density protein 95 (PSD-95), and inhibited the apoptosis-regulating factors in the chronic stage of TBI. The present study demonstrated that CIG had neuroprotective effects against TBI through inhibiting apoptosis in the acute stage and promoting neurorestoration in the chronic stage. The results suggest that CIG may be beneficial to TBI therapy.	[Ma, Denglei; Wang, Na; Zhang, Lan; Luo, Yi; Huang, Rui; Zhang, Li; Li, Yali; Li, Lin] Capital Med Univ, Xuanwu Hosp, Dept Pharmacol, Beijing 100053, Peoples R China; [Ma, Denglei; Wang, Na; Zhang, Lan; Luo, Yi; Huang, Rui; Zhang, Li; Li, Yali; Li, Lin] Beijing Engn Res Ctr Nerve Syst Drugs, Beijing 100053, Peoples R China; [Ma, Denglei; Wang, Na; Zhang, Lan; Luo, Yi; Huang, Rui; Zhang, Li; Li, Yali; Li, Lin] Minist Educ, Key Lab Neurodegenerat Dis, Beijing 100053, Peoples R China; [Fan, Xiaotong; Zhao, Guoguang] Capital Med Univ, Dept Neurosurg, Xuanwu Hosp, Beijing 100053, Peoples R China; [Zhao, Guoguang] Beijing Inst Brain Disorders, Beijing 100053, Peoples R China		Li, L (corresponding author), Capital Med Univ, Xuanwu Hosp, Dept Pharmacol, Beijing 100053, Peoples R China.; Li, L (corresponding author), Beijing Engn Res Ctr Nerve Syst Drugs, Beijing 100053, Peoples R China.; Li, L (corresponding author), Minist Educ, Key Lab Neurodegenerat Dis, Beijing 100053, Peoples R China.; Zhao, GG (corresponding author), Capital Med Univ, Dept Neurosurg, Xuanwu Hosp, Beijing 100053, Peoples R China.; Zhao, GG (corresponding author), Beijing Inst Brain Disorders, Beijing 100053, Peoples R China.	ggzhao@vip.sina.com; linlixw@126.com	Li, Lin/S-4015-2019; MA, DENGLEI/AAN-2435-2021		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81273498, 81341087, 81473373]; National Key Research and Development Program of China [2016YFC0103909]; Beijing Municipal Science & Technology Commission projectBeijing Municipal Science & Technology Commission [Z161100000516008]; Beijing High-level Health and Technical Personal Plan [2011-1-7, 2014-2-014]	This research was supported by National Natural Science Foundation of China (81273498, 81341087, 81473373); National Key Research and Development Program of China (2016YFC0103909); Beijing Municipal Science & Technology Commission project (Z161100000516008); Beijing High-level Health and Technical Personal Plan (2011-1-7, 2014-2-014).	Aloe L, 2012, J TRANSL MED, V10, DOI 10.1186/1479-5876-10-239; Alonso M, 2004, LEARN MEMORY, V11, P172, DOI 10.1101/lm.67804; Bamji SX, 2006, J CELL BIOL, V174, P289, DOI 10.1083/jcb.200601087; Berninger B, 1999, LEARN MEMORY, V6, P232; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Campbell SJ, 2007, NEUROBIOL DIS, V27, P151, DOI 10.1016/j.nbd.2007.04.013; Chen Zhi-gang, 2003, Chin J Traumatol, V6, P23; Chiaretti A, 2017, BRAIN INJURY, V31, P1538, DOI 10.1080/02699052.2017.1376760; Clark RSB, 2000, J NEUROCHEM, V74, P740, DOI 10.1046/j.1471-4159.2000.740740.x; Conti AC, 1998, J NEUROSCI, V18, P5663; Csuka E, 1999, J NEUROIMMUNOL, V101, P211, DOI 10.1016/S0165-5728(99)00148-4; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feng Y, 2016, MOL MED REP, V13, P5248, DOI 10.3892/mmr.2016.5201; Finkbeiner S, 2000, NEURON, V25, P11, DOI 10.1016/S0896-6273(00)80866-1; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; Hicks RR, 1999, J NEUROTRAUM, V16, P501, DOI 10.1089/neu.1999.16.501; Hilfiker S, 1999, PHILOS T ROY SOC B, V354, P269, DOI 10.1098/rstb.1999.0378; Khuman J, 2011, J CEREBR BLOOD F MET, V31, P778, DOI 10.1038/jcbfm.2010.172; Kim HJ, 2010, J NEUROTRAUM, V27, P131, DOI [10.1089/neu.2008.0818, 10.1089/neu.2008-0818]; Kleindienst A, 2007, PROG BRAIN RES, V161, P317, DOI 10.1016/S0079-6123(06)61022-4; Lin T, 2008, HEILONGJIANG MED PHA, V31, P3; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Logsdon AE, 2016, BRAIN RES, V1643, P140, DOI 10.1016/j.brainres.2016.04.063; Lu B, 2014, Handb Exp Pharmacol, V220, P223, DOI 10.1007/978-3-642-45106-5_9; Luikart BW, 2008, J NEUROSCI, V28, P7006, DOI 10.1523/JNEUROSCI.0195-08.2008; Ma DL, 2016, BEHAV BRAIN RES, V312, P20, DOI 10.1016/j.bbr.2016.06.008; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Meng YL, 2011, J NEUROSURG, V115, P550, DOI 10.3171/2011.3.JNS101721; Merlo L, 2014, J NEUROTRAUM, V31, P1375, DOI 10.1089/neu.2014.3385; Minambres E, 2008, J NEUROTRAUM, V25, P581, DOI 10.1089/neu.2007.0398; Nathoo N, 2004, J NEUROSURG, V101, P233, DOI 10.3171/jns.2004.101.2.0233; Oyesiku NM, 1999, BRAIN RES, V833, P161, DOI 10.1016/S0006-8993(99)01501-2; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Riggio S, 2011, NEUROL CLIN, V29, P35, DOI 10.1016/j.ncl.2010.10.008; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rubovitch V, 2017, SCI REP-UK, V7, DOI 10.1038/srep41269; Song S, 2006, JILIN J TRADIT CHIN, V26, P3; Stoica B, 2009, NEUROTHERAPEUTICS, V6, P14, DOI 10.1016/j.nurt.2008.10.029; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; SUDHOF TC, 1995, NATURE, V375, P645, DOI 10.1038/375645a0; Tamaoki S, 2016, EUR J PHARMACOL, V779, P168, DOI 10.1016/j.ejphar.2016.03.024; Tang WJ, 2016, BIOMED RES INT, V2016, DOI 10.1155/2016/6725381; Thau-Zuchman O, 2012, NEUROSCIENCE, V202, P334, DOI 10.1016/j.neuroscience.2011.11.071; Wakade C, 2010, J NEUROSURG, V113, P1195, DOI 10.3171/2010.3.JNS091212; [王娜 Wang Na], 2010, [中国临床药理学与治疗学, Chinese Journal of Clinical Pharmacology and Therapeutics], V15, P255; Wen ZJ, 2017, NEURAL PLAST, V2017, DOI 10.1155/2017/4296075; Winters BD, 2005, J NEUROSCI, V25, P52, DOI 10.1523/JNEUROSCI.3827-04.2005; Wu QL, 2016, NEUROCHEM RES, V41, P2810, DOI 10.1007/s11064-016-1997-7; Xiong Y, 2010, DISCOV MED, V10, P434; Ya BL, 2010, NEUROCHEM RES, V35, P773, DOI 10.1007/s11064-010-0134-2; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Yao RQ, 2009, BRAIN RES BULL, V79, P69, DOI 10.1016/j.brainresbull.2008.12.010; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje; Yuan JY, 2000, NATURE, V407, P802, DOI 10.1038/35037739; Zhang GX, 2016, NEUROCHEM RES, V41, P2948, DOI 10.1007/s11064-016-2013-y; Zhang L, 2006, BEHAV BRAIN RES, V173, P246, DOI 10.1016/j.bbr.2006.06.034; Zhao LH, 2010, EUR J PHARMACOL, V647, P68, DOI 10.1016/j.ejphar.2010.08.016; Zhao ZR, 2015, J NEUROTRAUM, V32, P1347, DOI 10.1089/neu.2014.3739; Zuo DY, 2016, NEUROTOX RES, V30, P159, DOI 10.1007/s12640-016-9611-y; 赵耀武, 2010, [时珍国医国药, Lishizhen Medicine and Materia Medica Research], V21, P677	63	15	19	3	18	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0364-3190	1573-6903		NEUROCHEM RES	Neurochem. Res.	APR	2018	43	4					959	971		10.1007/s11064-018-2501-3			13	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	GB9US	WOS:000429420200018	29492766				2022-02-06	
J	Pedersen, AL; Brownrout, JL; Saldanha, CJ				Pedersen, Alyssa L.; Brownrout, Jenna L.; Saldanha, Colin J.			Neuroinflammation and neurosteroidogenesis: Reciprocal modulation during injury to the adult zebra finch brain	PHYSIOLOGY & BEHAVIOR			English	Article						Estrogen; Songbird; TBI	MALIGNANT BREAST TISSUES; AROMATASE MESSENGER-RNA; CENTRAL-NERVOUS-SYSTEM; ESTROGEN-RECEPTOR 1; GROWTH-FACTOR-I; SEX-DIFFERENCES; TAENIOPYGIA-GUTTATA; NEUROPROTECTIVE ACTIONS; MONONUCLEAR-CELLS; ISCHEMIC-STROKE	Estrogens like estradiol (E-2) via their receptors are pluripotent steroid hormones that exert a profound influence on the developing and adult brain in many vertebrates. In songbirds and mammals, acute brain injury resulting from mechanical damage, anoxia and ischemia rapidly upregulates aromatase and E-2 synthesis. Interestingly, this E-2 provision occurs due to the induction of aromatase expression in reactive astrocytes in areas surrounding brain injury. The resultant increase in E-2 is neuroprotective with established influences on apoptosis, gliosis, cytogenesis, neurogenesis and neuroinflammation. Correspondingly, E-2 decreases secondary damage following acute brain trauma and may improve recovery. Until very recently however, the signals responsible for the induction of astrocytic aromatase expression in reactive astrocytes were unknown. In the current review, we discuss what is known about the role of astrocytic E-2 in neuroprotection with a particular emphasis on a recently discovered interaction between neuroinflammatory and steroidogenic signaling in the zebra finch. We first describe the role of acute inflammatory signaling in the regulation of astrocytic aromatase and central E-2 levels. Next, we discuss the emerging role of central E-2 in the control of chronic neuroinflammation. Finally, we provide a framework for further work investigating the important role of the interaction between inflammatory and steroidogenic signaling in the protection of neural circuits and behavior following traumatic brain injury (TBI). We also highlight dimorphisms that point to important aspects of sex-specific pathways that underlie the interactions of neuroinflammation and neurosteroidogenesis.	[Pedersen, Alyssa L.; Brownrout, Jenna L.; Saldanha, Colin J.] Amer Univ, Dept Biol, Washington, DC 20016 USA; [Pedersen, Alyssa L.; Brownrout, Jenna L.; Saldanha, Colin J.] Amer Univ, Ctr Behav Neurosci, Washington, DC 20016 USA		Saldanha, CJ (corresponding author), Dept Biol, 4400 Massachusetts Ave NW, Washington, DC 20016 USA.	saldanha@american.edu	Brownrout, Jenna/N-6563-2019	Brownrout, Jenna/0000-0002-8385-7151; Saldanha, Colin/0000-0003-4034-6877	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS 042787, 080585]	The work from our laboratory discussed herein was supported by NIH, NS 042787 & 080585.	ADKINSREGAN E, 1990, HORM BEHAV, V24, P114, DOI 10.1016/0018-506X(90)90031-R; Arevalo MA, 2015, NAT REV NEUROSCI, V16, P17, DOI 10.1038/nrn3856; ARNOLD AP, 1984, ANNU REV NEUROSCI, V7, P413, DOI 10.1146/annurev.ne.07.030184.002213; Azcoitia I, 2003, AGING CELL, V2, P31, DOI 10.1046/j.1474-9728.2003.00013.x; Azcoitia I, 2001, J NEUROBIOL, V47, P318, DOI 10.1002/neu.1038; Azcoitia I, 2002, NEUROTOX RES, V4, P235, DOI 10.1080/10298420290033232; BALTHAZART J, 1983, GEN COMP ENDOCR, V51, P191, DOI 10.1016/0016-6480(83)90072-2; BALTHAZART J, 1984, J EXP ZOOL, V232, P595, DOI 10.1002/jez.1402320328; BARRETTCONNOR E, 1991, JAMA-J AM MED ASSOC, V265, P1861, DOI 10.1001/jama.265.14.1861; Benkovic SA, 2006, BRAIN RES, V1070, P215, DOI 10.1016/j.brainres.2005.11.065; Berry C, 2009, J TRAUMA, V67, P950, DOI 10.1097/TA.0b013e3181ba3354; BREEDLOVE SM, 1981, BRAIN RES, V225, P297; Brotfain E, 2016, CURR NEUROPHARMACOL, V14, P641, DOI 10.2174/1570159X14666160309123554; Brown CM, 2010, ENDOCRINOLOGY, V151, P4916, DOI 10.1210/en.2010-0371; Bulun SE, 2012, SEMIN REPROD MED, V30, P39, DOI 10.1055/s-0031-1299596; Chakrabarti M, 2015, REV NEUROSCI; Che Q, 2014, INT J CANCER, V135, P282, DOI 10.1002/ijc.28679; Day NL, 2013, J NEUROTRAUM, V30, P1531, DOI 10.1089/neu.2013.2854; Dean SL, 2012, ENDOCRINOLOGY, V153, P5415, DOI 10.1210/en.2012-1350; Dean SL, 2012, EUR J NEUROSCI, V35, P1218, DOI 10.1111/j.1460-9568.2012.08032.x; Delpy L, 2005, J IMMUNOL, V175, P5050, DOI 10.4049/jimmunol.175.8.5050; Denes A, 2010, BRAIN BEHAV IMMUN, V24, P708, DOI 10.1016/j.bbi.2009.09.010; Duncan KA, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-81; Fairbanks SL, 2012, NEUROSCIENCE, V219, P183, DOI 10.1016/j.neuroscience.2012.05.048; Feeser VR, 2011, J NEUROIMMUNOL, V237, P4, DOI 10.1016/j.jneuroim.2011.06.007; Garcia-Segura LM, 1999, J NEUROBIOL, V40, P574, DOI 10.1002/(SICI)1097-4695(19990915)40:4<574::AID-NEU12>3.0.CO;2-8; Garcia-Segura LM, 1999, NEUROSCIENCE, V89, P567, DOI 10.1016/S0306-4522(98)00340-6; Garcia-Segura LM, 2004, ENDOCRINOLOGY, V145, P1082, DOI 10.1210/en.2003-1383; Garcia-Segura LM, 2006, GLIA, V54, P485, DOI 10.1002/glia.20404; Ghirnikar RS, 1998, NEUROCHEM RES, V23, P329, DOI 10.1023/A:1022453332560; Gibson CL, 2008, BRAIN, V131, P318, DOI 10.1093/brain/awm183; GRADY D, 1992, ANN INTERN MED, V117, P1016, DOI 10.7326/0003-4819-117-12-1016; Green PS, 1996, NEUROSCI LETT, V218, P165, DOI 10.1016/S0304-3940(96)13148-7; Groswasser Z, 1998, BRAIN INJURY, V12, P805, DOI 10.1080/026990598122197; GURNEY ME, 1980, SCIENCE, V208, P1380, DOI 10.1126/science.208.4450.1380; HALL ED, 1991, J CEREBR BLOOD F MET, V11, P292, DOI 10.1038/jcbfm.1991.61; Herson PS, 2009, SEMIN REPROD MED, V27, P229, DOI 10.1055/s-0029-1216276; Irahara N, 2006, INT J CANCER, V118, P1915, DOI 10.1002/ijc.21562; Keselman A, 2015, FRONT IMMUNOL, V6, P1, DOI 10.3389/fimmu.2015.00568; Li JM, 1996, SCIENCE, V272, P398, DOI 10.1126/science.272.5260.398; Lin C, 2015, SCI REP-UK, V5, DOI 10.1038/srep13442; Liu FD, 2012, NEUROCHEM INT, V61, P1255, DOI 10.1016/j.neuint.2012.10.003; LYNCH EA, 1994, J IMMUNOL, V153, P300; MACLUSKY NJ, 1981, SCIENCE, V211, P1294, DOI 10.1126/science.6163211; Marciano PG, 2002, NEUROCHEM RES, V27, P1147, DOI 10.1023/A:1020973308941; McEwen B, 2002, RECENT PROG HORM RES, V57, P357, DOI 10.1210/rp.57.1.357; McEwen BS, 2017, J NEUROSCI RES, V95, P24, DOI 10.1002/jnr.23809; Mehos C. J., 2015, J NEUROENDOCRINOL; Miki T, 2010, MOL CANCER RES, V8, P665, DOI 10.1158/1541-7786.MCR-09-0351; Mirzatoni A, 2010, J NEUROTRAUM, V27, P1875, DOI 10.1089/neu.2010.1330; Mize AL, 2003, ENDOCRINOLOGY, V144, P306, DOI 10.1210/en.2002-220698; Morris PG, 2011, CANCER PREV RES, V4, P1021, DOI 10.1158/1940-6207.CAPR-11-0110; PACIFICI R, 1991, P NATL ACAD SCI USA, V88, P5134, DOI 10.1073/pnas.88.12.5134; Pedersen AL, 2017, ENDOCRINOLOGY, V158, P2585, DOI 10.1210/en.2017-00346; Pedersen AL, 2016, ENDOCRINOLOGY, V157, P2041, DOI 10.1210/en.2015-1991; Perry VH, 2007, NAT REV IMMUNOL, V7, P161, DOI 10.1038/nri2015; Perry VH, 2004, BRAIN BEHAV IMMUN, V18, P407, DOI 10.1016/j.bbi.2004.01.004; Peterson RS, 2004, J COMP NEUROL, V475, P261, DOI 10.1002/cne.20157; Peterson RS, 2001, J NEUROENDOCRINOL, V13, P317, DOI 10.1046/j.1365-2826.2001.00647.x; Pfeilschifter J, 2002, ENDOCR REV, V23, P90, DOI 10.1210/er.23.1.90; PHILLIPS CA, 1978, FEBS LETT, V94, P115, DOI 10.1016/0014-5793(78)80919-3; Ponsford J, 2008, J INT NEUROPSYCH SOC, V14, P233, DOI 10.1017/S1355617708080272; Purohit A, 2005, J STEROID BIOCHEM, V94, P167, DOI 10.1016/j.jsbmb.2005.01.015; PUROHIT A, 1995, J CLIN ENDOCR METAB, V80, P3052, DOI 10.1210/jc.80.10.3052; Ramachandran B, 1999, GENE, V240, P209, DOI 10.1016/S0378-1119(99)00399-6; Rau SW, 2003, J NEUROSCI, V23, P11420; Robic A, 2014, J STEROID BIOCHEM, V140, P44, DOI 10.1016/j.jsbmb.2013.11.001; ROTHWELL NJ, 1995, INT J DEV NEUROSCI, V13, P179, DOI 10.1016/0736-5748(95)00018-C; Saldanha CJ, 2013, J NEUROENDOCRINOL, V25, P1032, DOI 10.1111/jne.12067; Saldanha CJ, 2005, J NEUROBIOL, V64, P192, DOI 10.1002/neu.20147; Saldanha CJ, 2009, FRONT NEUROENDOCRIN, V30, P106, DOI 10.1016/j.yfrne.2009.04.016; Sapir-Koren R, 2017, BONE, V103, P102, DOI 10.1016/j.bone.2017.06.020; Sarkari A, 2010, INDIAN J NEUROTRAUM, V7, P135, DOI 10.1016/S0973-0508(10)80028-0; Scotland RS, 2011, BLOOD, V118, P5918, DOI 10.1182/blood-2011-03-340281; Selvamani A, 2010, J NEUROSCI, V30, P6852, DOI 10.1523/JNEUROSCI.0761-10.2010; Shahrokhi N., 2010, EFFECT SEX STEROID H; Simpson ER, 2002, ANNU REV PHYSIOL, V64, P93, DOI 10.1146/annurev.physiol.64.081601.142703; Singh A, 1997, J STEROID BIOCHEM, V61, P185; Sohrabji F, 2013, J NEUROENDOCRINOL, V25, P1173, DOI 10.1111/jne.12059; Stein DG, 2015, BRAIN INJURY, V29, P1259, DOI 10.3109/02699052.2015.1065344; Stein DG, 2013, HORM BEHAV, V63, P291, DOI 10.1016/j.yhbeh.2012.05.004; Turgeon JL, 2006, ENDOCR REV, V27, P575, DOI 10.1210/er.2005-0020; Veerapaneni P, 2009, GYNECOL ONCOL, V114, P496, DOI 10.1016/j.ygyno.2009.05.041; Walters BJ, 2011, DEV NEUROBIOL, V71, P170, DOI 10.1002/dneu.20839; Wang ZF, 2017, BIOCHEM BIOPH RES CO, V482, P948, DOI 10.1016/j.bbrc.2016.11.138; Wynne RD, 2004, J NEUROENDOCRINOL, V16, P676, DOI 10.1111/j.1365-2826.2004.01217.x; Wynne RD, 2008, GLIA, V56, P97, DOI 10.1002/glia.20594; Yague JG, 2006, NEUROSCIENCE, V138, P389, DOI 10.1016/j.neuroscience.2005.11.054; Yeung JHH, 2011, ARCH SURG-CHICAGO, V146, P436, DOI 10.1001/archsurg.2011.46; Zeng YH, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0140624	90	15	16	1	8	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	APR 1	2018	187				SI		51	56		10.1016/j.physbeh.2017.10.013			6	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	GA7DH	WOS:000428494300009	29031551				2022-02-06	
J	Silva, PE; Maldaner, V; Vieira, L; de Carvalho, KL; Gomes, H; Melo, P; Babault, N; Cipriano, G; Durigan, JLQ				Silva, Paulo Eugenio; Maldaner, Vinicius; Vieira, Luciana; de Carvalho, Karina Livino; Gomes, Hedian; Melo, Priscilla; Babault, Nicolas; Cipriano, Gerson, Jr.; Quagliotti Durigan, Joao Luiz			Neuromuscular electrophysiological disorders and muscle atrophy in mechanically-ventilated traumatic brain injury patients: New insights from a prospective observational study	JOURNAL OF CRITICAL CARE			English	Article						Chronaxie; Critical illness polyneuropathy; Intensive care unit-acquired weakness; Neuromuscular disorder; Neuromuscular electrical stimulation; Rehabilitation	INTENSIVE-CARE-UNIT; ELECTRICAL-STIMULATION; ACQUIRED WEAKNESS; CRITICAL ILLNESS; MILLIAMPERAGE REQUIREMENTS; PERIPHERAL-NERVE; ILL PATIENTS; FIBER TYPES; CHRONAXIE; STRENGTH	Purpose: It is unclear whether the muscular changes in mechanically-ventilated traumatic brain injury patients (TBI) are only associated with disuse or additionally to neuromuscular electrophysiological disorders (NED). The correlation between muscle atrophy and NED may affect functional outcomes and rehabilitation programs significantly. Material and methods: An observational study was performed to investigate the presence of NED and muscle atrophy in TBI patients undergoing mechanical ventilation. NED was diagnosed by the stimulus electrodiagnosis test when chronaxie was >= 1000 mu s. The muscle structure (thickness and echogenicity) was assessed by B-mode ultrasound. Tibialis anterior (TA), rectus femoris (RF), and biceps brachialis (BB) muscles were analyzed. Patients were followed from the first day of admission in the intensive care unit (ICU) to the fourteenth day. Results: Twenty-two patients were analyzed. An increase of 48% in NED from day 1 to day 14 was detected in TA (p = 0.004). All muscles presented a significant decrease in thickness (similar to 18%, p < 0.05), but echogenicity increased only in TA (19%), p < 0.01 and RF (23%), p < 0.01. Conclusions: Mechanically-ventilated patients with TBI developed NED in addition to changes inmuscle structure during their stay in the ICU. (C) 2017 Elsevier Inc. All rights reserved.	[Silva, Paulo Eugenio] Univ Brasilia, Univ Hosp Brasilia, Phys Therapy Div, Brasilia, DF, Brazil; [Silva, Paulo Eugenio; Vieira, Luciana; Melo, Priscilla] Univ Brasilia, Hlth Sci & Technol PhD Program, Brasilia, DF, Brazil; [Silva, Paulo Eugenio; Maldaner, Vinicius] Hosp Base Dist Fed, Phys Therapy Div, Brasilia, DF, Brazil; [Maldaner, Vinicius] Hlth Sci Master Program, Hlth Sci Sch, Brasilia, DF, Brazil; [Vieira, Luciana] Hosp Base Dist Fed, Clin Res Ctr, Brasilia, DF, Brazil; [de Carvalho, Karina Livino] Univ Brasilia, Rehabil Sci Master Program, Brasilia, DF, Brazil; [Gomes, Hedian] Fisioterapia Integrada Brasilia, Phys Therapy Div, Brasilia, DF, Brazil; [Babault, Nicolas] Univ Bourgogne Franche Comte, INSERM, Cognit Act & Plast Senorimotrice U1093, Dijon, France; [Babault, Nicolas] Univ Bourgogne Franche Comte, UFR STAPS, Dijon, France; [Cipriano, Gerson, Jr.; Quagliotti Durigan, Joao Luiz] Univ Brasilia, Phys Therapy Div, Brasilia, DF, Brazil		Silva, PE (corresponding author), Univ Hosp Brasilia, Phys Therapy Div, SGAN, Quadra 604,Ave L2 Norte S-N, BR-70840901 Brasilia, DF, Brazil.	pauloeugenio.bsb@gmail.com	Durigan, Joao Luiz Quagliotti/D-1110-2012; Babault, Nicolas/D-7541-2013; Gerson C, G Cipriano/K-6317-2014; da Silva, Vinicius Z M/A-1306-2016	Durigan, Joao Luiz Quagliotti/0000-0002-7511-5289; Babault, Nicolas/0000-0001-6563-503X; Gerson C, G Cipriano/0000-0001-6323-7003; da Silva, Vinicius Z M/0000-0002-7804-7517; Silva, Paulo Eugenio/0000-0001-9153-0848	Fundacao de Amparo a Pesquisa do Distrito Federal (FAPDF) [193.000.862/2014]; Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [447529/2014-5, 310359/2014-7]; CAPES (Programa Ciencias sem Fronteiras, Pesquisador Visitante Especial)Coordenacao de Aperfeicoamento de Pessoal de Nivel Superior (CAPES) [88881.068106/2014-01]	This work was supported by the Fundacao de Amparo a Pesquisa do Distrito Federal (FAPDF; Process number: 193.000.862/2014); Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq Process number: 447529/2014-5; 310359/2014-7) and by CAPES (Programa Ciencias sem Fronteiras, Pesquisador Visitante Especial; Process number: 88881.068106/2014-01).	Abramoff M.D., 2004, BIOPHOTONICS INT, V11, P36, DOI [DOI 10.1117/1.3589100, DOI 10.1201/9781420005615.AX4]; Ali NA, 2008, AM J RESP CRIT CARE, V178, P261, DOI 10.1164/rccm.200712-1829OC; Arts IMP, 2010, MUSCLE NERVE, V41, P32, DOI 10.1002/mus.21458; Batt J, 2013, AM J RESP CRIT CARE, V187, P238, DOI 10.1164/rccm.201205-0954SO; Bednarik J, 2003, INTENS CARE MED, V29, P1505, DOI 10.1007/s00134-003-1858-0; Bloomfield SA, 1997, MED SCI SPORT EXER, V29, P197, DOI 10.1097/00005768-199702000-00006; Bolton CF, 2005, MUSCLE NERVE, V32, P140, DOI 10.1002/mus.20304; Bolton CF, 1996, INTENS CARE MED, V22, P841; Bostock H, 1998, MUSCLE NERVE, V21, P137, DOI 10.1002/(SICI)1097-4598(199802)21:2<137::AID-MUS1>3.0.CO;2-C; Botter A, 2011, EUR J APPL PHYSIOL, V111, P2461, DOI 10.1007/s00421-011-2093-y; Brown A, 2003, J CELL BIOL, V160, P817, DOI 10.1083/jcb.200212017; De Jonghe B, 2002, JAMA-J AM MED ASSOC, V288, P2859, DOI 10.1001/jama.288.22.2859; Dirks ML, 2015, CLIN SCI, V128, P357, DOI 10.1042/CS20140447; Dorsch S, 2012, ARCH PHYS MED REHAB, V93, P1072, DOI 10.1016/j.apmr.2012.01.005; ELDER GCB, 1982, J APPL PHYSIOL, V53, P1473, DOI 10.1152/jappl.1982.53.6.1473; Fenzi F, 2003, ACTA NEUROPATHOL, V106, P75, DOI 10.1007/s00401-003-0704-3; Fernandes LFRM, 2016, BRAZ J PHYS THER, V20, P126, DOI 10.1590/bjpt-rbf.2014.0138; Gondin J, 2011, EUR J APPL PHYSIOL, V111, P2473, DOI 10.1007/s00421-011-2101-2; Gosselink R, 2008, INTENS CARE MED, V34, P1188, DOI 10.1007/s00134-008-1026-7; Grimm A, 2013, CRIT CARE, V17, DOI 10.1186/cc13050; Gruther W, 2010, J REHABIL MED, V42, P593, DOI 10.2340/16501977-0564; Hargens AR, 2016, J APPL PHYSIOL, V120, P891, DOI 10.1152/japplphysiol.00935.2015; Harper NJN, 2001, BRIT J ANAESTH, V87, P625, DOI 10.1093/bja/87.4.625; HENRIKSSONLARSEN KB, 1983, HISTOCHEM J, V15, P167, DOI 10.1007/BF01042285; Hermans G, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0993-7; Hirose T, 2013, J CRIT CARE, V28, DOI 10.1016/j.jcrc.2013.02.010; Itoh S, 2016, IEEE ENG MED BIO, P5845, DOI 10.1109/EMBC.2016.7592057; JOHNSON MA, 1973, J NEUROL SCI, V18, P111, DOI 10.1016/0022-510X(73)90023-3; Kho ME, 2015, J CRIT CARE, V30, P32, DOI 10.1016/j.jcrc.2014.09.014; KOPMAN AF, 1984, ANESTHESIOLOGY, V61, P83, DOI 10.1097/00000542-198461010-00015; Kress JP, 2014, NEW ENGL J MED, V370, P1626, DOI 10.1056/NEJMra1209390; Lacomis D, 2013, MUSCLE NERVE, V47, P452, DOI 10.1002/mus.23615; Lapicque L, 1909, COMPTES RENDUS SOC B, P280; Latronico N, 1996, LANCET, V347, P1579, DOI 10.1016/S0140-6736(96)91074-0; Latronico N, 2014, F1000RESEARCH, P3; Latronico N, 2007, CRIT CARE, V11, DOI 10.1186/cc5671; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maffiuletti NA, 2013, BMC MED, V11, DOI 10.1186/1741-7015-11-137; Maffiuletti NA, 2011, EUR J APPL PHYSIOL, V111, P2391, DOI 10.1007/s00421-011-2133-7; Medeiros FVA, 2015, BRAZ J PHYS THER, V19, P466, DOI 10.1590/bjpt-rbf.2014.0114; Parry SM, 2015, J CRIT CARE, V30, DOI 10.1016/j.jcrc.2015.05.024; Parry SM, 2013, CRIT CARE MED, V41, P2406, DOI 10.1097/CCM.0b013e3182923642; Paternostro-Sluga T, 2002, AM J PHYS MED REHAB, V81, P253, DOI 10.1097/00002060-200204000-00003; Peviani SM, 2010, NEUROL RES, V32, P891, DOI 10.1179/174313209X459093; Pieber K, 2015, J NEUROENG REHABIL, V12, DOI 10.1186/s12984-015-0046-0; Pillen S, 2008, MUSCLE NERVE, V37, P679, DOI 10.1002/mus.21015; Pillen S, 2006, ULTRASOUND MED BIOL, V32, P1315, DOI 10.1016/j.ultrasmedbio.2006.05.028; Poulsen JB, 2011, CRIT CARE MED, V39, P456, DOI 10.1097/CCM.0b013e318205c7bc; Puthucheary ZA, 2013, JAMA-J AM MED ASSOC, V310, P1591, DOI 10.1001/jama.2013.278481; Recoskie BJ, 2009, PHYS MED BIOL, V54, P5965, DOI 10.1088/0031-9155/54/19/020; Rodriguez PO, 2011, J CRIT CARE, V27, P1; Routsi C, 2010, CRIT CARE, V14, DOI 10.1186/cc8987; Schuhfried O, 2005, IEEE T NEUR SYS REH, V13, P105, DOI 10.1109/TNSRE.2005.843439; Schweickert WD, 2007, CHEST, V131, P1541, DOI 10.1378/chest.06-2065; Schweickert WD, 2009, LANCET, V373, P1874, DOI 10.1016/S0140-6736(09)60658-9; Segers J, 2014, J CRIT CARE, V29, P1082, DOI 10.1016/j.jcrc.2014.06.024; Seymour JM, 2009, THORAX, V64, P418, DOI 10.1136/thx.2008.103986; Sharma B, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00879; Silva PE, 2017, J CRIT CARE, V37, P141, DOI 10.1016/j.jcrc.2016.09.012; Stevens Robert D, 2009, Crit Care Med, V37, pS299, DOI 10.1097/CCM.0b013e3181b6ef67; ten Haaf D, 2017, AM J PHYS MED REHAB, V96, P634, DOI 10.1097/PHM.0000000000000711; Tillquist M, 2014, JPEN-PARENTER ENTER, V38, P886, DOI 10.1177/0148607113501327; Van den Berghe G, 2005, NEUROLOGY, V64, P1348, DOI 10.1212/01.WNL.0000158442.08857.FC; Wijayatilake DS, 2015, CURR OPIN ANESTHESIO, V28, P525, DOI 10.1097/ACO.0000000000000236	64	15	16	0	8	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0883-9441	1557-8615		J CRIT CARE	J. Crit. Care	APR	2018	44						87	94		10.1016/j.jcrc.2017.10.026			8	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FY1IL	WOS:000426565300017	29078131	hybrid			2022-02-06	
J	Xu, Z; Lv, XA; Dai, Q; Lu, M; Jin, Z				Xu, Zhen; Lv, Xiao-Ai; Dai, Qun; Lu, Man; Jin, Zhang			Exogenous BDNF Increases Mitochondrial pCREB and Alleviates Neuronal Metabolic Defects Following Mechanical Injury in a MPTP-Dependent Way	MOLECULAR NEUROBIOLOGY			English	Article						TBI; Metabolic defects; BDNF; Mitochondria; CREB; Complex V	TRAUMATIC BRAIN-INJURY; ELEMENT-BINDING PROTEIN; NEUROTROPHIC FACTOR; CYCLOSPORINE-A; CREB; TRANSCRIPTION; SURVIVAL; CRISIS; RATS; DYSFUNCTION	Metabolic defects are common pathological phenomena following traumatic brain injury (TBI) which contribute to poor prognosis. Brain-derived neurotrophic factor (BDNF) is an important regulator of neuronal survival, development, function, and plasticity. This study was designed to investigate the potential effects of BDNF on TBI-induced metabolic defects and their underlying molecular mechanisms. BDNF was added into cultured neurons to a concentration of 25, 50, and 100 ng/ml, respectively, right after mechanical injury and metabolite levels were analyzed 4 h post injury. The mitochondrial phosphorylated cAMP response element-binding protein (pCREB) distribution and complex V synthesis, as well as their roles in metabolic defects, were evaluated. We found that exogenous BDNF improved metabolic defects, especially the uncoupling of oxidative phosphorylation. BDNF increased pCREB in mitochondrial inner membrane and matrix and promoted mitochondrial complex V synthesis. We also found that these results were negatively regulated by the mitochondrial permeability transition pore (MPTP) antagonist CsA and positively regulated by the MPTP agonist atractyloside. BDNF's protectional effects on metabolic defects were abolished by CREB knockout. When administrated in a dominant interfering CREB mutant (A-CREB) model, mitochondrial pCREB accumulation could still be observed, but the synthesis of complex V and alleviation of metabolic defects were repressed. Our data demonstrate that exogenous BDNF mitigates neuronal metabolic defects following mechanical injury by promoting the pCREB accumulation in mitochondrial inner membrane and matrix, which is regulated by MPTP opening, thus facilitating the synthesis of mitochondrial complex V.	[Xu, Zhen] Zhejiang Chinese Med Univ, Dept Neurosurg, Affiliated Hosp 1, 54 Youdian Lane, Hangzhou 310006, Zhejiang, Peoples R China; [Lv, Xiao-Ai] Zhejiang Chinese Med Univ, Dept Surg, Affiliated Hosp 1, 54 Youdian Lane, Hangzhou 310006, Zhejiang, Peoples R China; [Dai, Qun] Zhejiang Chinese Med Univ, Cent Lab, Affiliated Hosp 1, 54 Youdian Lane, Hangzhou 310006, Zhejiang, Peoples R China; [Lu, Man] Zhejiang Chinese Med Univ, Dept Anesthesiol, Affiliated Hosp 1, 54 Youdian Lane, Hangzhou 310006, Zhejiang, Peoples R China; [Jin, Zhang] Peoples Hosp Lishui, Dept Spine Surg, 15 Dazong Rd, Lishui 323000, Peoples R China		Xu, Z (corresponding author), Zhejiang Chinese Med Univ, Dept Neurosurg, Affiliated Hosp 1, 54 Youdian Lane, Hangzhou 310006, Zhejiang, Peoples R China.	xuzhenhangzhou@yeah.net			Zhejiang Provincial Medical Health and Science and Technology Project Foundation [2016KYB213]; Zhejiang Provincial Natural Science FoundationNatural Science Foundation of Zhejiang Province [LY16H090014]	This work was supported by Zhejiang Provincial Natural Science Foundation (LY16H090014) and Zhejiang Provincial Medical Health and Science and Technology Project Foundation (2016KYB213).	Ahn S, 1998, MOL CELL BIOL, V18, P967, DOI 10.1128/MCB.18.2.967; BARDE YA, 1982, EMBO J, V1, P549, DOI 10.1002/j.1460-2075.1982.tb01207.x; Bijur GN, 2003, J NEUROCHEM, V87, P1427, DOI 10.1046/j.1471-4159.2003.02113.x; Binder DK, 2004, GROWTH FACTORS, V22, P123, DOI 10.1080/08977190410001723308; Boyer PD, 1997, ANNU REV BIOCHEM, V66, P717, DOI 10.1146/annurev.biochem.66.1.717; BRINDLE P, 1995, P NATL ACAD SCI USA, V92, P10521, DOI 10.1073/pnas.92.23.10521; Cammarota M, 1999, J NEUROCHEM, V72, P2272, DOI 10.1046/j.1471-4159.1999.0722272.x; Carre E, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00146; Cox LJ, 2008, NAT CELL BIOL, V10, P149, DOI 10.1038/ncb1677; De Rasmo D, 2009, FEBS J, V276, P4325, DOI 10.1111/j.1742-4658.2009.07133.x; DiMauro S, 2003, NEW ENGL J MED, V348, P2656, DOI 10.1056/NEJMra022567; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; Glenn TC, 2003, J CEREBR BLOOD F MET, V23, P1239, DOI 10.1097/01.WCB.0000089833.23606.7F; Jiang DM, 2001, J BIOL CHEM, V276, P47524, DOI 10.1074/jbc.M108834200; Khalin I, 2016, DRUG DELIV, V2016, P1; Lee J, 2005, J BIOL CHEM, V280, P40398, DOI 10.1074/jbc.C500140200; Luo CL, 2013, J NEUROTRAUM, V30, P597, DOI 10.1089/neu.2012.2425; Milon L, 2000, J BIOL CHEM, V275, P14264, DOI 10.1074/jbc.275.19.14264; Oliveira MD, 2014, J NEUROTRAUM, V31, P1750, DOI 10.1089/neu.2014.3386; Puehringer D, 2013, NAT NEUROSCI, V16, P407, DOI 10.1038/nn.3333; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Robertson CL, 2007, J NEUROCHEM, V101, P1248, DOI 10.1111/j.1471-4159.2007.04489.x; Sakamoto K, 2011, J NEUROCHEM, V116, P1, DOI 10.1111/j.1471-4159.2010.07080.x; Sharov VG, 2005, HEART FAIL REV, V10, P305, DOI 10.1007/s10741-005-7545-1; Shaywitz AJ, 1999, ANNU REV BIOCHEM, V68, P821, DOI 10.1146/annurev.biochem.68.1.821; SIESJO BK, 1984, J NEUROSURG, V60, P883, DOI 10.3171/jns.1984.60.5.0883; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Stein NR, 2012, NEUROCRIT CARE, V17, P49, DOI 10.1007/s12028-012-9708-y; SZABO I, 1991, J BIOL CHEM, V266, P3376; Veech RL, 2012, IUBMB LIFE, V64, P203, DOI 10.1002/iub.590; Verweij BH, 2007, PROG BRAIN RES, V161, P111, DOI 10.1016/S0079-6123(06)61008-X; Verweij BH, 2000, J NEUROSURG, V93, P815, DOI 10.3171/jns.2000.93.5.0815; Vespa P, 2005, J CEREBR BLOOD F MET, V25, P763, DOI 10.1038/sj.jcbfm.9600073; Vink R, 1988, J NEUROTRAUM, V5, P315, DOI 10.1089/neu.1988.5.315; Wender R, 2000, J NEUROSCI, V20, P6804, DOI 10.1523/JNEUROSCI.20-18-06804.2000; Wright MJ, 2013, BRAIN IMAGING BEHAV, V7, P307, DOI 10.1007/s11682-013-9231-6; Xia ZG, 1996, J NEUROSCI, V16, P5425; Xu Z, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0257-8; Yan Q, 1997, J COMP NEUROL, V378, P135; Yang JL, 2014, NEUROMOL MED, V16, P161, DOI 10.1007/s12017-013-8270-x; Yang JY, 2013, J MOL CELL CARDIOL, V59, P167, DOI 10.1016/j.yjmcc.2013.02.016; Zhang H., 2014, MATH PROBL ENG, V2014, P9, DOI DOI 10.1371/J0URNAL.P0NE.0088909	42	15	15	0	4	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	APR	2018	55	4					3499	3512		10.1007/s12035-017-0576-5			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY8EX	WOS:000427097500059	28508150				2022-02-06	
J	Busquets, O; Ettcheto, M; Verdaguer, E; Castro-Torres, RD; Auladell, C; Beas-Zarate, C; Folch, J; Camins, A				Busquets, Oriol; Ettcheto, Miren; Verdaguer, Ester; Castro-Torres, Ruben D.; Auladell, Carme; Beas-Zarate, Carlos; Folch, Jaume; Camins, Antoni			JNK1 inhibition by Licochalcone A leads to neuronal protection against excitotoxic insults derived of kainic acid	NEUROPHARMACOLOGY			English	Article						Kainic acid; Epilepsy; Neurodegeneration; Licochalcone A; Hippocampus	N-TERMINAL KINASE; TEMPORAL-LOBE EPILEPSY; TRAUMATIC BRAIN-INJURY; C-JUN; CEREBRAL-ISCHEMIA; STATUS EPILEPTICUS; KAINATE MODEL; SEIZURES; DEGENERATION; PHOSPHORYLATION	The mitogen-activated protein kinase family (MAPK) is an important group of enzymes involved in cellular responses to diverse external stimuli. One of the members of this family is the c-Jun-N-terminal kinase (JNK). The activation of the JNK pathway has been largely associated with the pathogenesis that occurs in epilepsy and neurodegeneration. Kainic acid (KA) administration in rodents is an experimental approach that induces status epilepticus (SE) and replicates many of the phenomenological features of human temporal lobe epilepsy (TLE). Recent studies in our group have evidenced that the absence of the JNK1 gene has neuroprotective effects against the damage induced by MA, as it occurs with the absence of JNK3. The aim of the present study was to analyse whether the pharmacological inhibition of JNK1 by Licochalcone A (Lic-A) had similar effects and if it may be considered as a new molecule for the treatment of SE. In order to achieve this objective, animals were pre-treated with Lic-A and posteriorly administered with KA as a model for TLE. In addition, a comparative study with MA was performed between wild type pre-treated with Lic-A and single knock-out transgenic mice for the Jnk1(-/-) gene. Our results showed that JNK1 inhibition by Lic-A, previous to KA administration, caused a reduction in the convulsive pattern. Furthermore, it reduced phosphorylation levels of the JNK, as well as its activity. In addition, Lic-A prevented hippocampal neuronal degeneration, increased pro-survival anti-apoptotic mechanisms, reduced pro-apoptotic biomarkers, decreased cellular stress and neuroinflammatory processes. Thus, our results suggest that inhibition of the JNK1 by Lic-A has neuroprotective effects and that; it could be a new potential approach for the treatment of SE and neurodegeneration. (C) 2017 Elsevier Ltd. All rights reserved.	[Busquets, Oriol; Ettcheto, Miren; Folch, Jaume] Univ Rovira & Virgili, Fac Med & Ciencies Salut, Dept Bioquim & Biotecnol, Tarragona, Spain; [Busquets, Oriol; Ettcheto, Miren; Castro-Torres, Ruben D.; Camins, Antoni] Univ Barcelona, Fac Farm & Ciencies Alimentacio, Dept Farmacol Toxicol & Quim Terapeut, Barcelona, Spain; [Busquets, Oriol; Ettcheto, Miren; Verdaguer, Ester; Auladell, Carme; Folch, Jaume; Camins, Antoni] Biomed Res Networking Ctr Neurodegenerat Dis CIBE, Madrid, Spain; [Busquets, Oriol; Ettcheto, Miren; Verdaguer, Ester; Auladell, Carme; Camins, Antoni] Univ Barcelona, Inst Neurociencias, Barcelona, Spain; [Verdaguer, Ester; Castro-Torres, Ruben D.; Auladell, Carme] Univ Barcelona, Fac Biol, Dept Biol Cellular Fisiol & Immunol, Barcelona, Spain; [Castro-Torres, Ruben D.; Beas-Zarate, Carlos] Univ Guadalajara, Dept Biol Celular & Mol, CUCBA, Sierra Mojada 800, Guadalajara 44340, Jalisco, Mexico; [Castro-Torres, Ruben D.; Beas-Zarate, Carlos] Div Neurociencias, Sierra Mojada 800, Guadalajara 44340, Jalisco, Mexico		Camins, A (corresponding author), Univ Barcelona, Fac Farm & Ciencies Alimentacio, Dept Farmacol Toxicol & Quim Terapeut, Barcelona, Spain.; Folch, J (corresponding author), Biomed Res Networking Ctr Neurodegenerat Dis CIBE, Madrid, Spain.	camins@ub.edu	Camins, Antonio/J-5126-2019; Figueras, Oriol Busquets/L-2624-2017	Camins, Antonio/0000-0002-1229-5956; Figueras, Oriol Busquets/0000-0002-1372-9699; Ettcheto, Miren/0000-0002-4301-7297	Spanish Ministry of Science and InnovationSpanish Government [PI2016/01, CB06/05/0024]; European Regional Development Founds; CONACyT MexicoConsejo Nacional de Ciencia y Tecnologia (CONACyT) [0177594]; CONACYTConsejo Nacional de Ciencia y Tecnologia (CONACyT) [298337, 000091]	This work was supported by grants from the Spanish Ministry of Science and Innovation P12016/01, CB06/05/0024 (CIBERNED) and the European Regional Development Founds. Research team from UB and URV belongs to 2014SGR-525 from Generalitat de Catalunya. CBZ is supported by grants from CONACyT Mexico (No. 0177594) and RDCT from Postdoctoral fellowship CONACYT No. 298337 and the Doctoral Program in Sciences in Molecular Biology in Medicine, LGAC Molecular Bases of Chronic Diseases Degenerative and its Applications (000091, PNPC, CONACyT). The authors are grateful to Roxanne Rowles for the English revision of the manuscript.	Auladell C, 2017, FRONT BIOSCI-LANDMRK, V22, P795, DOI 10.2741/4517; BENARI Y, 1979, BRAIN RES, V163, P176, DOI 10.1016/0006-8993(79)90163-X; Benito E, 2010, TRENDS NEUROSCI, V33, P230, DOI 10.1016/j.tins.2010.02.001; Bennett BL, 2001, P NATL ACAD SCI USA, V98, P13681, DOI 10.1073/pnas.251194298; Borsello T, 2003, NAT MED, V9, P1180, DOI 10.1038/nm911; Brecht S, 2005, EUR J NEUROSCI, V21, P363, DOI 10.1111/j.1460-9568.2005.03857.x; Carboni S, 2008, BRIT J PHARMACOL, V153, P157, DOI 10.1038/sj.bjp.0707574; de Lemos L, 2017, MOL NEUROBIOL; de Lemos L, 2010, J NEUROCHEM, V114, P1315, DOI 10.1111/j.1471-4159.2010.06853.x; DERIJARD B, 1994, CELL, V76, P1025, DOI 10.1016/0092-8674(94)90380-8; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Dong C, 1998, SCIENCE, V282, P2092, DOI 10.1126/science.282.5396.2092; Dunleavy M, 2013, J MOL NEUROSCI, V49, P202, DOI 10.1007/s12031-012-9927-x; Ettcheto M, 2015, MOL NEUROBIOL, V52, P120, DOI 10.1007/s12035-014-8836-0; Fernandez-Espejo E, 1996, Rev Neurol, V24, P779; Franklin Paxinos, 2012, MOUSE BRAIN STEREOTA; FRENCH ED, 1982, NEUROSCIENCE, V7, P2525, DOI 10.1016/0306-4522(82)90212-3; Funakoshi-Tago M, 2010, INT IMMUNOPHARMACOL, V10, P562, DOI 10.1016/j.intimp.2010.02.003; Hammer J, 2008, GLIA, V56, P856, DOI 10.1002/glia.20659; Harper SJ, 2001, CELL SIGNAL, V13, P299, DOI 10.1016/S0898-6568(01)00148-6; Huovila APJ, 2005, TRENDS BIOCHEM SCI, V30, P413, DOI 10.1016/j.tibs.2005.05.006; Jefferys J, 2016, J NEUROSCI METH, V260, P53, DOI 10.1016/j.jneumeth.2015.04.011; Jeon SH, 2000, EXP MOL MED, V32, P227, DOI 10.1038/emm.2000.37; Jessberger S, 2007, J NEUROSCI, V27, P9400, DOI 10.1523/JNEUROSCI.2002-07.2007; Junyent F, 2009, J NEUROSCI RES, V87, P1500, DOI 10.1002/jnr.21950; Kallunki T, 1996, CELL, V87, P929, DOI 10.1016/S0092-8674(00)81999-6; KALLUNKI T, 1994, GENE DEV, V8, P2996, DOI 10.1101/gad.8.24.2996; Kuan CY, 2003, P NATL ACAD SCI USA, V100, P15184, DOI 10.1073/pnas.2336254100; KYRIAKIS JM, 1994, NATURE, V369, P156, DOI 10.1038/369156a0; Lerma J, 2013, NEURON, V80, P292, DOI 10.1016/j.neuron.2013.09.045; Levesque M, 2013, NEUROSCI BIOBEHAV R, V37, P2887, DOI 10.1016/j.neubiorev.2013.10.011; Liou AKF, 2003, PROG NEUROBIOL, V69, P103, DOI 10.1016/S0301-0082(03)00005-4; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; MATHERN GW, 1993, ELECTROEN CLIN NEURO, V87, P326, DOI 10.1016/0013-4694(93)90186-Y; Mechanisms B., 2002, PATHOPHYSIOLOGY SEIZ, P9; Morrison R. S., 1996, LOSS P53 TUMOR SUPPR, V76, P1337; NADLER JV, 1980, BRAIN RES, V195, P47; NADLER JV, 1980, J COMP NEUROL, V192, P333, DOI 10.1002/cne.901920209; Olloquequi J, 2010, RESP MED, V104, P1310, DOI 10.1016/j.rmed.2010.03.002; Parent JM, 2008, EPILEPSIA, V49, P19, DOI 10.1111/j.1528-1167.2008.01634.x; Park MJ, 2015, MATH PROBL ENG, V2015, P1, DOI DOI 10.1007/S13592-015-0383-9; Repici M, 2007, NEUROSCIENCE, V150, P40, DOI 10.1016/j.neuroscience.2007.08.021; Sabapathy K, 2004, MOL CELL, V15, P713, DOI 10.1016/j.molcel.2004.08.028; Sabapathy K., 2012, PROGR MOL BIOL TRANS; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Shibata S, 2000, YAKUGAKU ZASSHI, V120, P849, DOI 10.1248/yakushi1947.120.10_849; Spigolon G, 2010, EUR J NEUROSCI, V31, P1261, DOI 10.1111/j.1460-9568.2010.07158.x; St-Pierre J, 2006, CELL, V127, P397, DOI 10.1016/j.cell.2006.09.024; Tai TY, 2017, NEUROSCIENCE, V349, P35, DOI 10.1016/j.neuroscience.2017.02.024; Verdaguer E, 2003, ANN NY ACAD SCI, V1010, P671, DOI 10.1196/annals.1299.122; Yao K, 2014, CANCER PREV RES, V7, P139, DOI 10.1158/1940-6207.CAPR-13-0117; Zhao Y, 2012, MOL CELL NEUROSCI, V49, P300, DOI 10.1016/j.mcn.2011.12.005; Zheng YF, 2004, J BIOL CHEM, V279, P42898, DOI 10.1074/jbc.M403193200	53	15	16	2	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	MAR 15	2018	131						440	452		10.1016/j.neuropharm.2017.10.030			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	FZ1DK	WOS:000427316000039	29111385				2022-02-06	
J	Ghazale, H; Ramadan, N; Mantash, S; Zibara, K; El-Sitt, S; Darwish, H; Chamaa, F; Boustany, RM; Mondello, S; Abou-Kheir, W; Soueid, J; Kobeissy, F				Ghazale, Hussein; Ramadan, Naify; Mantash, Sara; Zibara, Kazem; El-Sitt, Sally; Darwish, Hala; Chamaa, Farah; Boustany, Rose Mary; Mondello, Stefania; Abou-Kheir, Wassim; Soueid, Jihane; Kobeissy, Firas			Docosahexaenoic acid (DHA) enhances the therapeutic potential of neonatal neural stem cell transplantation post-Traumatic brain injury	BEHAVIOURAL BRAIN RESEARCH			English	Article						Traumatic brain injury; Neural stem cells; Docosahexaenoic acid; Neurogenesis; Reactive ghosts; Motor function	CENTRAL-NERVOUS-SYSTEM; CONTROLLED CORTICAL IMPACT; STEM/PROGENITOR CELLS; NEURONAL DIFFERENTIATION; IN-VITRO; PROGENITOR CELLS; MOUSE MODEL; AGED RATS; HIPPOCAMPAL NEUROGENESIS; BREAKDOWN PRODUCTS	Traumatic Brain Injury (TBI) is a major cause of death and disability worldwide with 1.5 million people inflicted yearly. Several neurotherapeutic interventions have been proposed including drug administration as well as cellular therapy involving neural stem cells (NSCs). Among the proposed drugs is docosahexaenoic acid (DHA), a polyunsaturated fatty acid, exhibiting neuroprotective properties. In this study, we utilized an innovative intervention of neonatal NSCs transplantation in combination with DHA injections in order to ameliorate brain damage and promote functional recovery in an experimental model of TBI. Thus, NSCs derived from the sub ventricular zone of neonatal pups were cultured into neurospheres and transplanted in the cortex of an experimentally controlled cortical impact mouse model of TBI. The effect of NSC transplantation was assessed alone and/or in combination with DHA administration. Motor deficits were evaluated using pole climbing and rotarod tests. Using immunohistochemistry, the effect of transplanted NSCs and DHA treatment was used to assess astrocytic (Glial fibrillary acidic protein, GFAP) and microglial (ionized calcium binding adaptor molecule-1, IBA-1) activity. In addition, we quantified neuroblasts (doublecortin; DCX) and dopaminergic neurons (tyrosine hydroxylase; TH) expression levels. Combined NSC transplantation and DHA injections significantly attenuated TBI-induced motor function deficits (pole climbing test), promoted neurogenesis, coupled with an increase in glial reactivity at the cortical site of injury. In addition, the number of tyrosine hydroxylase positive neurons was found to increase markedly in the ventral tegmental area and substantia nigra in the combination therapy group. Immunoblotting analysis indicated that DHA + NSCs treated animals showed decreased levels of 38 kDa GFAP-BDP (breakdown product) and 145 kDa all-spectrin SBDP indicative of attenuated calpain/caspase activation. These data demonstrate that prior treatment with DHA may be a desirable strategy to improve the therapeutic efficacy of NSC transplantation in TBI.	[Ghazale, Hussein; Ramadan, Naify; Mantash, Sara; El-Sitt, Sally; Darwish, Hala; Boustany, Rose Mary; Soueid, Jihane; Kobeissy, Firas] Amer Univ Beirut, Fac Med, Dept Biochem & Mol Genet, Beirut, Lebanon; [Zibara, Kazem] Lebanese Univ, DSST, Lab Stem Cells, ER045, Beirut, Lebanon; [Zibara, Kazem] Lebanese Univ, Fac Sci 1, Dept Biol, Beirut, Lebanon; [Chamaa, Farah; Abou-Kheir, Wassim] Amer Univ Beirut, Fac Med, Dept Anat Cell Biol & Physiol Sci, Beirut, Lebanon; [Kobeissy, Firas] Univ Florida, Ctr Neuroprote & Biomarkers Res, Dept Psychiat, Gainesville, FL USA; [Boustany, Rose Mary] Amer Univ Beirut Med Ctr, Special Kids Clin, Neurogenet Program, Beirut, Lebanon; [Boustany, Rose Mary] Amer Univ Beirut Med Ctr, Special Kids Clin, Div Pediat Neurol, Dept Pediat, Beirut, Lebanon; [Boustany, Rose Mary] Amer Univ Beirut Med Ctr, Special Kids Clin, Div Pediat Neurol, Dept Adolescent Med, Beirut, Lebanon; [Mondello, Stefania] Univ Messina, AOU Policlin G Martino, Dept Biomed & Dent Sci & Morphofunct Imaging, Via Consolare Valeria, I-98125 Messina, Italy		Abou-Kheir, W; Soueid, J; Kobeissy, F (corresponding author), Amer Univ Beirut, Dept Biochem & Mol Genet, DTS Bldg,Room 419,POB 11-0236, Beirut 11072020, Lebanon.	wa12@aub.edu.lb; js61@aub.edu.lb; Firasko@gmail.com	Kobeissy, Firas/E-7042-2017; Abou-Kheir, Wassim/AAP-2587-2020; Mondello, Stefania/A-1813-2012	Kobeissy, Firas/0000-0002-5008-6944; Abou-Kheir, Wassim/0000-0001-9719-9324; Mondello, Stefania/0000-0002-8587-3614; Zibara, Kazem/0000-0002-9887-072X; Ramadan, Naify/0000-0001-7339-0263; Darwish, Hala/0000-0001-5744-6466	Lebanese National Council for Scientific Research (CNRS)Centre National de la Recherche Scientifique (CNRS); AUB-MPP grant "Dual Neurotherapeutic Effects of Docosahexaenoic Acid (DHA) and Arachidonic Acid (AA) with Neonatal Neural Stem Cell transplantation Post-Traumatic Brain Injury"	This work was undertaken at the American University of Beirut (AUB) and is supported by a grant from the Lebanese National Council for Scientific Research (CNRS) [Grant title: Cell-Based Therapy Using Neural Stem Cell Coupled with BMP-4 as New treatment in traumatic Brain Injury; Lead PI: Firas Kobeissy, Co-PIs:Jihane Soueid & Wassim Abou-Kheir. In addition, this work was supported by the AUB-MPP grant "Dual Neurotherapeutic Effects of Docosahexaenoic Acid (DHA) and Arachidonic Acid (AA) with Neonatal Neural Stem Cell transplantation Post-Traumatic Brain Injury" PI: FK.	Ahmad SO, 2009, NEUROSCI LETT, V450, P102, DOI 10.1016/j.neulet.2008.11.065; Aligholi H, 2016, BRAIN RES, V1642, P197, DOI 10.1016/j.brainres.2016.03.043; Androutsellis-Theotokis A, 2006, NATURE, V442, P823, DOI 10.1038/nature04940; Arsenault D., PLOS ONE, V6; Bellenchi GC, 2013, J NEUROCHEM, V124, P159, DOI 10.1111/jnc.12084; BLANCHARD V, 1995, J NEUROCHEM, V64, P1669; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Boockvar JA, 2005, NEUROSURGERY, V56, P163, DOI 10.1227/01.NEU.0000145866.25433.FF; Boutte AM, 2016, J NEUROTRAUM, V33, P147, DOI 10.1089/neu.2014.3672; BURKE DC, 1995, BRAIN INJURY, V9, P735, DOI 10.3109/02699059509008229; Butovsky O, 2006, MOL CELL NEUROSCI, V31, P149, DOI 10.1016/j.mcn.2005.10.006; Cacci E, 2008, GLIA, V56, P412, DOI 10.1002/glia.20616; Cao DH, 2009, J NEUROCHEM, V111, P510, DOI 10.1111/j.1471-4159.2009.06335.x; Chang YL, 2012, CELL TRANSPLANT, V21, P313, DOI 10.3727/096368911X580572; Chen SY, 2016, EXP THER MED, V11, P2049, DOI 10.3892/etm.2016.3153; Chirumamilla S, 2002, J NEUROTRAUM, V19, P693, DOI 10.1089/08977150260139084; De Feo D, 2012, CURR OPIN NEUROL, V25, P322, DOI 10.1097/WCO.0b013e328352ec45; Decimo I, 2012, CURR PHARM DESIGN, V18, P1755, DOI 10.2174/138161212799859611; Deierborg T, 2010, NEUROSCIENCE, V171, P1386, DOI 10.1016/j.neuroscience.2010.09.045; Desai AJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085237; DIXON CE, 1991, J NEUROSCI METH, V39, P253; Dixon KJ, 2015, J NEUROTRAUM, V32, P753, DOI 10.1089/neu.2014.3390; Failla M.D., 2015, BRAIN NEUROTRAUMA MO; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Fitch MT, 2008, EXP NEUROL, V209, P294, DOI 10.1016/j.expneurol.2007.05.014; Fleming SM, 2013, JOVE-J VIS EXP, DOI 10.3791/50303; Gamoh S, 1999, NEUROSCIENCE, V93, P237, DOI 10.1016/S0306-4522(99)00107-4; Gamoh S, 2001, CLIN EXP PHARMACOL P, V28, P266, DOI 10.1046/j.1440-1681.2001.03437.x; GILAD GM, 1995, LIFE SCI, V58, pPL41, DOI 10.1016/0024-3205(95)02274-0; Goodus MT, 2015, DEV NEUROSCI-BASEL, V37, P29, DOI 10.1159/000367784; Green P, 1998, J NEUROSCI RES, V52, P129, DOI 10.1002/(SICI)1097-4547(19980415)52:2<129::AID-JNR1>3.0.CO;2-C; Hagan M, 2003, NEUROSCI LETT, V351, P149, DOI 10.1016/j.neulet.2003.07.021; Halford J, 2017, J CEREBR BLOOD F MET, V37, P3278, DOI 10.1177/0271678X17724681; Hall ED, 2016, TRANSLATIONAL RES TR; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harvey LD, 2015, ASN NEURO, V7, DOI 10.1177/1759091415618969; Hattiangady B, 2007, STEM CELLS, V25, P2104, DOI 10.1634/stemcells.2006-0726; Haus DL, 2016, EXP NEUROL, V281, P1, DOI 10.1016/j.expneurol.2016.04.008; He QQ, 2016, BEHAV BRAIN FUNCT, V12, DOI 10.1186/s12993-016-0093-0; Heile Anna, 2011, Dialogues Clin Neurosci, V13, P279; Hoane MR, 2004, J NEUROTRAUM, V21, P163, DOI 10.1089/089771504322778622; Ikemoto A, 1999, ARCH BIOCHEM BIOPHYS, V364, P67, DOI 10.1006/abbi.1999.1110; Itoh T, 2013, J NEURAL TRANSM, V120, P361, DOI 10.1007/s00702-012-0895-7; Katakura M, 2009, NEUROSCIENCE, V160, P651, DOI 10.1016/j.neuroscience.2009.02.057; Katakura M, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/490476; Kawakita E, 2006, NEUROSCIENCE, V139, P991, DOI 10.1016/j.neuroscience.2006.01.021; Kermer P, 1999, CELL TISSUE RES, V298, P383, DOI 10.1007/s004410050061; Kindler V, 2005, J LEUKOCYTE BIOL, V78, P836, DOI 10.1189/jlb.0505272; Koutsoudaki PN, 2016, GLIA, V64, P763, DOI 10.1002/glia.22959; Lam PK, 2016, ACTA NEUROCHIR SUPPL, V122, P21, DOI 10.1007/978-3-319-22533-3_4; Lam PK, 2013, J CLIN NEUROSCI, V20, P300, DOI 10.1016/j.jocn.2012.03.028; Lee IS, 2010, PEDIATR INT, V52, P855, DOI 10.1111/j.1442-200X.2010.03266.x; Leon-Carrion Jose, 2005, Pituitary, V8, P197, DOI 10.1007/s11102-006-6041-5; Li MF, 2013, CELL PHYSIOL BIOCHEM, V32, P1776, DOI 10.1159/000356611; LIGHTHALL J W, 1989, Journal of Neurotrauma, V6, P83, DOI 10.1089/neu.1989.6.83; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu SJ, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-66; Lo Van A, 2016, BIOCHIMIE, V130, P163, DOI 10.1016/j.biochi.2016.07.011; Madhavan L, 2010, NEUROPHARMACOLOGY, V58, P835, DOI 10.1016/j.neuropharm.2009.10.005; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; MARSHALL JF, 1974, J COMP PHYSIOL PSYCH, V87, P808, DOI 10.1037/h0037223; Matsuura K, 1997, J NEUROSCI METH, V73, P45, DOI 10.1016/S0165-0270(96)02211-X; Maxwell WL, 2013, BRAIN SCI, V3, P1374, DOI 10.3390/brainsci3031374; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Miller AP, 2017, PLOS ONE, V12, DOI 10.1371/journal.pone.0173167; Monaco CM, 2013, EXP NEUROL, V247, P410, DOI 10.1016/j.expneurol.2013.01.007; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Monje ML, 2003, SCIENCE, V302, P1760, DOI 10.1126/science.1088417; Mura A, 2003, MOVEMENT DISORD, V18, P860, DOI 10.1002/mds.10472; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Nakagawa H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.62; Ngalula KP, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00212; NORTON WT, 1992, NEUROCHEM RES, V17, P877, DOI 10.1007/BF00993263; Okonkwo DO, 2013, J NEUROTRAUM, V30, P1490, DOI 10.1089/neu.2013.2883; Osier N. D., 2015, BRAIN NEUROTRAUMA MO; Osier ND, 2015, J NEUROTRAUM, V32, P1861, DOI 10.1089/neu.2014.3680; Ourednik J, 2002, NAT BIOTECHNOL, V20, P1103, DOI 10.1038/nbt750; Owens BD, 2008, J TRAUMA, V64, P295, DOI 10.1097/TA.0b013e318163b875; Pan JP, 2011, BRAIN RES, V1412, P18, DOI 10.1016/j.brainres.2011.07.015; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2011, J NEUROTRAUM, V28, pA63; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Park DH, 2010, STEM CELLS DEV, V19, P175, DOI 10.1089/scd.2009.0172; Peron S, 2017, J NEUROSCI, V37, P1820, DOI 10.1523/JNEUROSCI.2936-16.2017; Picard-Riera N, 2004, J NEUROSCI RES, V76, P223, DOI 10.1002/jnr.20040; Pike BR, 2001, J NEUROCHEM, V78, P1297, DOI 10.1046/j.1471-4159.2001.00510.x; Pleasant JM, 2011, J NEUROTRAUM, V28, P2245, DOI 10.1089/neu.2010.1499; Reeves TM, 2010, BRAIN PATHOL, V20, P1055, DOI 10.1111/j.1750-3639.2010.00412.x; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Richardson RM, 2010, J NEUROSURG, V112, P1125, DOI 10.3171/2009.4.JNS081087; Ringger NC, 2004, J NEUROTRAUM, V21, P1443, DOI 10.1089/neu.2004.21.1443; Sakayori N, 2011, GENES CELLS, V16, P778, DOI 10.1111/j.1365-2443.2011.01527.x; Seri B, 2001, J NEUROSCI, V21, P7153, DOI 10.1523/JNEUROSCI.21-18-07153.2001; Shear DA, 2004, BRAIN RES, V1026, P11, DOI 10.1016/j.brainres.2004.07.087; Shear DA, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00073; Shinoyama M, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00128; Sun D, 2005, J NEUROTRAUM, V22, P95, DOI 10.1089/neu.2005.22.95; Sun D, 2011, J NEUROTRAUM, V28, P961, DOI 10.1089/neu.2010.1697; Sun D, 2010, J NEUROTRAUM, V27, P923, DOI 10.1089/neu.2009.1209; Sun D, 2009, EXP NEUROL, V216, P56, DOI 10.1016/j.expneurol.2008.11.011; Taguchi A, 2004, J CLIN INVEST, V114, P330, DOI 10.1172/jci200420622; Tan KKB, 2015, BIOMATERIALS, V43, P32, DOI 10.1016/j.biomaterials.2014.11.036; Tan XF, 2014, NEUROSCI LETT, V571, P23, DOI 10.1016/j.neulet.2014.04.019; Tate CC, 2009, J TISSUE ENG REGEN M, V3, P208, DOI 10.1002/term.154; Wallenquist U, 2009, RESTOR NEUROL NEUROS, V27, P323, DOI 10.3233/RNN-2009-0481; Wang JY, 2015, SCI REP-UK, V5, DOI 10.1038/srep09621; Wennersten A, 2004, J NEUROSURG, V100, P88, DOI 10.3171/jns.2004.100.1.0088; Wu A, 2008, NEUROSCIENCE, V155, P751, DOI 10.1016/j.neuroscience.2008.05.061; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu KJ, 2015, CELL TRANSPLANT, V24, P459, DOI 10.3727/096368915X686922; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yan ZJ, 2013, NEUROCHEM RES, V38, P1022, DOI 10.1007/s11064-013-1012-5; Yang H, 2012, NEUROCHEM INT, V61, P175, DOI 10.1016/j.neuint.2012.04.020; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Zhang ZH, 2014, PLOS ONE, V9	118	15	17	1	34	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		1	13		10.1016/j.bbr.2017.11.007			13	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400001	29126932				2022-02-06	
J	Toklu, HZ; Yang, ZH; Oktay, S; Sakarya, Y; Kirichenko, N; Matheny, MK; Muller-Delp, J; Strang, K; Scarpace, PJ; Wang, KKW; Tumer, N				Toklu, Hale Z.; Yang, Zhihui; Oktay, Sehkar; Sakarya, Yasemin; Kirichenko, Nataliya; Matheny, Michael K.; Muller-Delp, Judy; Strang, Kevin; Scarpace, Philip J.; Wang, Kevin K. W.; Tumer, Nihal			Overpressure blast injury-induced oxidative stress and neuroinflammation response in rat frontal cortex and cerebellum	BEHAVIOURAL BRAIN RESEARCH			English	Article						Overpressure blast injury; Brain; Trauma; Lung; Edema; NGF; NF kappa B; GFAP; Iba1; NSE	TRAUMATIC BRAIN-INJURY; SUBARACHNOID HEMORRHAGE; BARRIER PERMEABILITY; BLOOD; MODEL; INFLAMMATION; DAMAGE; EXPRESSION; BIOMARKERS; SEVERITY	Background & aim: Overpressure blast-wave induced brain injury (OBI) and its long-term neurological outcome pose significant concerns for military personnel. Our aim is to investigate the mechanism of injury due to OBI. Methods: Rats were divided into 3 groups: (1) Control, (2) OBI (exposed 30 psi peak pressure, 2-2.5 ms), (3) Repeated OBI (r-OBI) (three exposures over one-week period). Lung and brain (cortex and cerebellum) tissues were collected at 24 h post injury. Results: The neurological examination score was worse in OBI and r-OBI (4.2 +/- 0.6 and 3.7 +/- 0.5, respectively) versus controls (0.7 +/- 0.2). A significant positive correlation between lung and brain edema was found. Malondialdehyde (index for lipid peroxidation), significantly increased in OBI and r-OBI groups in cortex (p < 0.05) and cerebellum (p < 0.01-0.001). The glutathione (endogenous antioxidant) level decreased in cortex (p < 0.01) and cerebellum (p < 0.05) of r-OBI group when compared with the controls. Myeloperoxidase activity indicating neutrophil infiltration, was significantly (p < 0.01-0.05) elevated in r-OBI. Additionally, tissue thromboplastin activity, a coagulation marker, was elevated, indicating a tendency to bleed. NGF and NF-kappa B proteins along with Iba-1 and GFAP immunoreactivity significantly augmented in the frontal cortex demonstrating microglial activation. Serum biomarkers of injury, NSE, TNF-alpha and leptin, were also elevated. Conclusion: OBI triggers both inflammation and oxidative injury in the brain. This data in conjunction with our previous observations suggests that OBI triggers a cascade of events beginning with impaired cerebral vascular function leading to ischemia and chronic neurological consequences.	[Toklu, Hale Z.; Sakarya, Yasemin; Kirichenko, Nataliya; Tumer, Nihal] Malcom Randall Vet Affairs Med Ctr, Geriatr Res Educ & Clin Ctr, St Augustine, FL USA; [Toklu, Hale Z.; Oktay, Sehkar; Sakarya, Yasemin; Kirichenko, Nataliya; Matheny, Michael K.; Scarpace, Philip J.; Tumer, Nihal] Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA; [Yang, Zhihui; Strang, Kevin; Wang, Kevin K. W.] Univ Florida, Coll Med, McKnight Brain Inst, Ctr Neuroprote & Biomarker Res, Gainesville, FL 32610 USA; [Yang, Zhihui; Strang, Kevin; Wang, Kevin K. W.] Univ Florida, Coll Med, Dept Psychiat & Neurosci, Gainesville, FL 32610 USA; [Oktay, Sehkar] Marmara Univ, Sch Dent, Dept Biochem, Istanbul, Turkey; [Muller-Delp, Judy] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA		Tumer, N (corresponding author), Univ Florida, Coll Med, Dept Pharmacol & Therapeut, Gainesville, FL 32610 USA.; Toklu, HZ (corresponding author), North Florida Reg Med Ctr, Dept Grad Med Educ, 6500 Newberry Rd, Gainesville, FL 32605 USA.	haletoklu@yahoo.com; ntumer@ufl.edu	Toklu, Hale/AAR-2330-2020	Toklu, Hale/0000-0002-9797-3591; Muller-Delp, Judy/0000-0001-5322-0611; Wang, Kevin/0000-0002-9343-6473	North Florida/South Georgia Veterans Health System, Research/GRECC, Gainesville, Florida; McKnight Brain Institute, University of Florida, Gainesville, Florida	This study was supported by the North Florida/South Georgia Veterans Health System, Research/GRECC, Gainesville, Florida and McKnight Brain Institute, University of Florida, Gainesville, Florida. The authors would like to express their special thanks to Prof. Russell M. Bauer for his leadership for the support of the project.	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; BEUTLER E, 1963, J LAB CLIN MED, V61, P882; Biber N, 2009, BRAIN INJURY, V23, P577, DOI 10.1080/02699050902926317; Brown R, 2008, NEUROSCI LETT, V432, P73, DOI 10.1016/j.neulet.2007.12.008; Buege J A, 1978, Methods Enzymol, V52, P302; Cemak I, 2011, NEUROBIOL DIS, V41, P538; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Chavko M, 2006, J TRAUMA, V61, P933, DOI 10.1097/01.ta.0000233742.75450.47; Cheng JM, 2010, J NEUROL SCI, V294, P23, DOI 10.1016/j.jns.2010.04.010; Chhabra Gaurav, 2013, J Emerg Trauma Shock, V6, P180, DOI 10.4103/0974-2700.115332; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Covey Dana C, 2010, J Surg Orthop Adv, V19, P8; Daoud H, 2014, NEUROCRIT CARE, V20, P427, DOI 10.1007/s12028-013-9879-1; DeWitt DS, 2009, J NEUROTRAUM, V26, P877, DOI 10.1089/neu.2007.0439; Elsayed NM, 2007, TOXICOL SCI, V95, P289, DOI 10.1093/toxsci/kfl138; Engelmann C, 2014, NEURAL REGEN RES, V9, P707, DOI 10.4103/1673-5374.131572; Ersahin M, 2011, TURK NEUROSURG, V21, P599, DOI [10.5137/1019-5149.JTN .4736-11.0, 10.5137/1019-5149.JTN.4736-11.0]; Ersahin M, 2010, J NEUROTRAUM, V27, P1143, DOI 10.1089/neu.2009.1210; Fan XF, 2013, PEPTIDES, V48, P70, DOI 10.1016/j.peptides.2013.08.002; Gonzalvo R., CRIT CARE, V11; HILLEGASS LM, 1990, J PHARMACOL METHOD, V24, P285, DOI 10.1016/0160-5402(90)90013-B; INGRAM GIC, 1976, THROMB HAEMOSTASIS, V36, P237, DOI 10.1055/s-0038-1648029; Ito D, 2001, STROKE, V32, P1208, DOI 10.1161/01.STR.32.5.1208; Kamnaksh A., 2014, TRANSL PROTEOM, V3, P22, DOI [10.1016/j.trprot.2013.11.001, DOI 10.1016/J.TRPROT.2013.11.001]; Kamnaksh A, 2014, SCI REP-UK, V4, DOI 10.1038/srep04809; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; Kobeissy F, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00186; Lin C, 2012, PEPTIDES, V35, P166, DOI 10.1016/j.peptides.2012.03.024; Liu MD, 2015, FRONT CELL NEUROSCI, V9, DOI [10.3389/fincel.2015.00168, 10.3389/fncel.2015.00168]; Pathak A, 2005, Neurol India, V53, P178; Pelosi P, 2011, CRIT CARE, V15, DOI 10.1186/cc10259; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Sajja VSSS, 2016, FRONT INTEGR NEUROSC, V10, DOI [10.3389/fnint.2016.00007, 10.3389/fnint.7016.00007]; Svetlov S. I., J TRAUMA INJ INFECT, V69; Svetlov Stanislav I, 2012, Front Neurol, V3, P15, DOI 10.3389/fneur.2012.00015; Toklu HZ, 2015, J CEREBR BLOOD F MET, V35, P1950, DOI 10.1038/jcbfm.2015.151; Toklu HZ, 2009, J SURG RES, V152, P238, DOI 10.1016/j.jss.2008.03.013; Toklu HZ, 2015, BRAIN NEUROTRAUMA MO; Tran LV, 2014, J TRAUMA NURS, V21, P30, DOI 10.1097/JTN.0000000000000026; Verein M, 2010, SEMIN CARDIOTHORAC V, V14, P226, DOI 10.1177/1089253210388295; Vuceljic M, 2005, CLIN CHIM ACTA, V355, pS318; Wijdicks EFM, 2006, NEUROLOGY, V67, P203, DOI 10.1212/01.wnl.0000227183.21314.cd; Yang ZH, 2015, SCI REP-UK, V5, DOI 10.1038/srep11178; Yang ZH, 2014, J CEREBR BLOOD F MET, V34, P1444, DOI 10.1038/jcbfm.2014.105	49	15	16	1	16	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	MAR 15	2018	340				SI		14	22		10.1016/j.bbr.2017.04.025			9	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	FU9JY	WOS:000424173400002	28419850				2022-02-06	
J	Abidi, AH; Presley, CS; Dabbous, M; Tipton, DA; Mustafa, SM; Moore, BM				Abidi, Ammaar H.; Presley, Chaela S.; Dabbous, Mustafa; Tipton, David A.; Mustafa, Suni M.; Moore, Bob M., II			Anti-inflammatory activity of cannabinoid receptor 2 ligands in primary hPDL fibroblasts	ARCHIVES OF ORAL BIOLOGY			English	Article						Endocannabinoids; Cannabis; Cytokine; Chemokine; Inflammation; Periodontal inflammation	MONOCYTE CHEMOATTRACTANT PROTEIN-1; NF-KAPPA-B; HUMAN PERIODONTAL-LIGAMENT; TRAUMATIC BRAIN-INJURY; PORPHYROMONAS-GINGIVALIS; CB2 RECEPTORS; INVERSE AGONIST; NUCLEAR-FACTOR; IN-VITRO; CELLS	Objectives: Approximately 65 million adults in the US have periodontitis, causing tooth loss and decreased quality of life. Cannabinoids modulate immune responses, and endocannabinoids are prevalent during oral cavity inflammation. Targets for intervention in periodontal inflammation are cannabinoid type 1 and 2 receptors (CB1R, CB2R), particularly CB2R because its levels increase during inflammation. We previously demonstrated that SMM-189 (CB2R inverse agonist) decreased pro-inflammatory cytokine production in primary microglial cells. The hypothesis of this study was that cannabinoids anandamide (AEA), HU-308 (CB2R selective agonist), and SMM-189 decrease pro-inflammatory IL-6 and MCP-1 production by primary human periodontal ligament fibroblasts (hPDLFs) stimulated with P. gingivalis LPS, TNF-alpha, or IL-1 beta. Design: Cytotoxic effects of cannabinoid compounds (10(-4)-10(-6.5) M), LPS (1-1000 ng/ml), TNF alpha (10 ng/ml) and IL-1 beta (1 ng/ml) were assessed by measuring effects on cellular dehydrogenase activity. IL-6 and MCP-1 production were measured using Mesoscale Discovery (MSD) Human Pro-Inflammatory IL-6 and MSD Human Chemokine MCP-1 kits and analyzed using MSD Sector 2400 machine. Results: EC50 values for AEA, SMM-189, and HU-308 were 16 mu M, 13 mu M, and 7.3 mu M respectively. LPS (1 mu g/ml), TNF-alpha (10 ng/ml), and IL-1 beta (1 ng/ml) increased IL-6 and MCP-1 production, which were inhibited by AEA, SMM-189, and HU-308. AEA alone significantly increased IL-6, but not MCP-1 levels, but the other cannabinoids alone had no effect. Conclusion: The effective inhibition of LPS, TNF-alpha, IL-1 beta stimulated IL-6 and MCP-1 production by CB2R ligands in hPDLFs suggests that targeting the endocannabinoid system may lead to development of novel drugs for periodontal therapy, aiding strategies to improve oral health.	[Abidi, Ammaar H.] Univ Tennessee, Hlth Sci Ctr, Coll Dent, Dept Gen Practice Dent, Memphis, TN USA; [Abidi, Ammaar H.; Presley, Chaela S.; Mustafa, Suni M.; Moore, Bob M., II] Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA; [Dabbous, Mustafa; Tipton, David A.] Univ Tennessee, Hlth Sci Ctr, Coll Dent, Dept Biosci Res, Memphis, TN USA; [Dabbous, Mustafa] Univ Tennessee, Hlth Sci Ctr, Coll Med, Dept Microbiol Immunol & Biochem, Memphis, TN USA		Moore, BM (corresponding author), Univ Tennessee, Hlth Sci Ctr, Coll Pharm, Dept Pharmaceut Sci, Memphis, TN 38163 USA.	bmoore@uthsc.edu		Abidi, Ammaar/0000-0003-1826-9377			Agarwal S, 1998, INFECT IMMUN, V66, P932, DOI 10.1128/IAI.66.3.932-937.1998; Ardila CM, 2010, J PERIODONTAL RES, V45, P557, DOI 10.1111/j.1600-0765.2010.01274.x; Axmann R, 2009, ARTHRITIS RHEUM-US, V60, P2747, DOI 10.1002/art.24781; Bab I, 2008, J NEUROENDOCRINOL, V20, P69, DOI 10.1111/j.1365-2826.2008.01675.x; Beklen A, 2007, J DENT RES, V86, P347, DOI 10.1177/154405910708600409; Borner C, 2009, J BIOL CHEM, V284, P35450, DOI 10.1074/jbc.M109.006338; Bu W, 2016, FRONT NEUROSCI-SWITZ, V10, DOI 10.3389/fnins.2016.00449; Cabral GA, 2009, EXPERT REV MOL MED, V11, DOI 10.1017/S1462399409000957; CARR MW, 1994, P NATL ACAD SCI USA, V91, P3652, DOI 10.1073/pnas.91.9.3652; Correa F, 2010, GLIA, V58, P135, DOI 10.1002/glia.20907; Craig RG, 2003, J CLIN PERIODONTOL, V30, P1075, DOI 10.1046/j.0303-6979.2003.00421.x; Croxford JL, 2005, J NEUROIMMUNOL, V166, P3, DOI 10.1016/j.jneuroim.2005.04.023; DELAMATA J, 1995, J CLIN INVEST, V95, P2846, DOI 10.1172/JCI117990; Demuth DG, 2006, LIFE SCI, V78, P549, DOI 10.1016/j.lfs.2005.05.055; Eke PI, 2012, J DENT RES, V91, P914, DOI 10.1177/0022034512457373; FELDMAN RS, 1983, J CLIN PERIODONTOL, V10, P131, DOI 10.1111/j.1600-051X.1983.tb02201.x; Gemmell E, 1997, PERIODONTOL 2000, V14, P112, DOI 10.1111/j.1600-0757.1997.tb00194.x; Graves D. T., 2011, J ORAL MICROBIOLOGY, V3; Gui H, 2014, RHEUMATOLOGY, V53, P802, DOI 10.1093/rheumatology/ket447; Gutierrez-Venegas G, 2006, LIFE SCI, V78, P2577, DOI 10.1016/j.lfs.2005.10.033; HANAZAWA S, 1993, INFECT IMMUN, V61, P5219, DOI 10.1128/IAI.61.12.5219-5224.1993; Hatakeyama J, 2003, ORAL MICROBIOL IMMUN, V18, P14, DOI 10.1034/j.1399-302X.2003.180103.x; Holt SC, 1999, PERIODONTOL 2000, V20, P168, DOI 10.1111/j.1600-0757.1999.tb00162.x; Jean-Gilles L, 2015, ACTA PHYSIOL, V214, P63, DOI 10.1111/apha.12474; Jiang YL, 1996, INFECT IMMUN, V64, P4450, DOI 10.1128/IAI.64.11.4450-4455.1996; Juttler E, 2004, NEUROPHARMACOLOGY, V47, P580, DOI 10.1016/j.neuropharm.2004.05.009; Kaplan B. L. F., 2007, J IMMUNOL S, V178, pS175; Kaplan BLF, 2008, BIOCHEM PHARMACOL, V76, P726, DOI 10.1016/j.bcp.2008.06.022; Kim J, 2006, ODONTOLOGY, V94, P10, DOI 10.1007/s10266-006-0060-6; Klein TW, 2005, NAT REV IMMUNOL, V5, P400, DOI 10.1038/nri1602; Koziel J, 2014, CURR RHEUMATOL REP, V16, DOI 10.1007/s11926-014-0408-9; Kozono S, 2010, BIOCHEM BIOPH RES CO, V394, P928, DOI 10.1016/j.bbrc.2010.03.080; Kreitzer FR, 2009, PHARMACOL THERAPEUT, V122, P83, DOI 10.1016/j.pharmthera.2009.01.005; Kusumoto Y, 2004, J PERIODONTOL, V75, P370, DOI 10.1902/jop.2004.75.3.370; Loesche WJ, 2001, CLIN MICROBIOL REV, V14, P727, DOI 10.1128/CMR.14.4.727-752.2001; Lunn CA, 2008, BRIT J PHARMACOL, V153, P226, DOI 10.1038/sj.bjp.0707480; Mackie B., 2009, BEHAV NEUROBIOLOGY E; Merighi S, 2012, BRIT J PHARMACOL, V165, P1773, DOI 10.1111/j.1476-5381.2011.01673.x; Montecucco F, 2008, AM J PHYSIOL-HEART C, V294, pH1145, DOI 10.1152/ajpheart.01328.2007; Morandini ACF, 2010, J PERIODONTOL, V81, P310, DOI 10.1902/jop.2009.090375; Nakajima Y, 2006, FEBS LETT, V580, P613, DOI 10.1016/j.febslet.2005.12.079; NIDCR NIoDaCR, 2013, PER GUM DIS; Okada N, 1997, J PERIODONTAL RES, V32, P559, DOI 10.1111/j.1600-0765.1997.tb00932.x; Ossola CA, 2016, J PERIODONTOL, V87, P725, DOI 10.1902/jop.2016.150612; Ossola CA, 2012, INFLAMM RES, V61, P941, DOI 10.1007/s00011-012-0485-z; Ozaki K, 1996, ORAL MICROBIOL IMMUN, V11, P109, DOI 10.1111/j.1399-302X.1996.tb00344.x; Ozdemir B, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0107407; Pihlstrom BL, 2005, LANCET, V366, P1809, DOI 10.1016/S0140-6736(05)67728-8; Presley C, 2015, PHARMACOL RES PERSPE, V3, DOI 10.1002/prp2.159; Qian H, 2010, J PERIODONTAL RES, V45, P504, DOI 10.1111/j.1600-0765.2009.01265.x; Qian H, 2013, OPEN J STOMATOLOGY, V3, P44; Reiner A, 2015, INT J MOL SCI, V16, P758, DOI 10.3390/ijms16010758; REINHARDT RA, 1993, J CLIN PERIODONTOL, V20, P225, DOI 10.1111/j.1600-051X.1993.tb00348.x; SAFKAN B, 1984, J CLIN PERIODONTOL, V11, P515, DOI 10.1111/j.1600-051X.1984.tb00903.x; Soares GMS, 2012, J APPL ORAL SCI, V20, P295, DOI 10.1590/S1678-77572012000300002; Sostres C, 2010, BEST PRACT RES CL GA, V24, P121, DOI 10.1016/j.bpg.2009.11.005; Tabrizi MA, 2016, CHEM REV, V116, P519, DOI 10.1021/acs.chemrev.5b00411; TAKAHASHI K, 1994, J PERIODONTOL, V65, P147, DOI 10.1902/jop.1994.65.2.147; Tishler M, 1999, RHEUMATOL INT, V18, P125, DOI 10.1007/s002960050070; Toguri JT, 2014, BRIT J PHARMACOL, V171, P1448, DOI 10.1111/bph.12545; WAITE IM, 1981, J PERIODONTAL RES, V16, P100, DOI 10.1111/j.1600-0765.1981.tb00953.x; Wang PL, 2002, CRIT REV ORAL BIOL M, V13, P132, DOI 10.1177/154411130201300204; Wen AY, 2010, J IMMUNOL, V185, P6413, DOI 10.4049/jimmunol.1001829; Xu LL, 1996, J LEUKOCYTE BIOL, V60, P365, DOI 10.1002/jlb.60.3.365; YAMAZAKI K, 1994, J ORAL PATHOL MED, V23, P347, DOI 10.1111/j.1600-0714.1994.tb00074.x	65	15	16	1	13	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0003-9969	1879-1506		ARCH ORAL BIOL	Arch. Oral Biol.	MAR	2018	87						79	85		10.1016/j.archoralbio.2017.12.005			7	Dentistry, Oral Surgery & Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Dentistry, Oral Surgery & Medicine	FY9TB	WOS:000427208700010	29274621				2022-02-06	
J	Aiolfi, A; Khor, D; Cho, J; Benjamin, E; Inaba, K; Demetriades, D				Aiolfi, Alberto; Khor, Desmond; Cho, Jayun; Benjamin, Elizabeth; Inaba, Kenji; Demetriades, Demetrios			Intracranial pressure monitoring in severe blunt head trauma: does the type of monitoring device matter?	JOURNAL OF NEUROSURGERY			English	Article						isolated severe head trauma; ICP monitoring devices; outcomes; traumatic brain injury	BRAIN-INJURY; MORTALITY; IMPACT	OBJECTIVE Intracranial pressure (ICP) monitoring has become the standard of care in the management of severe head trauma. Intraventricular devices (IVDs) and intraparenchymal devices (IPDs) are the 2 most commonly used techniques for ICP monitoring. Despite the widespread use of these devices, very few studies have investigated the effect of device type on outcomes. The purpose of the present study was to compare outcomes between 2 types of ICP monitoring devices in patients with isolated severe blunt head trauma. METHODS This retrospective observational study was based on the American College of Surgeons Trauma Quality Improvement Program database, which was searched for all patients with isolated severe blunt head injury who had an ICP monitor placed in the 2-year period from 2013 to 2014. Extracted variables included demographics, comorbidities, mechanisms of injury, head injury specifics (epidural, subdural, subarachnoid, intracranial hemorrhage, and diffuse axonal injury), Abbreviated Injury Scale (AIS) score for each body area, Injury Severity Score (ISS), vital signs in the emergency department, and craniectomy. Outcomes included 30-day mortality, complications, number of ventilation days, intensive care unit and hospital lengths of stay, and functional independence. RESULTS During the study period, 105,721 patients had isolated severe traumatic brain injury (head AIS score >= 3). Overall, an ICP monitoring device was placed in 2562 patients (2.4%): 1358 (53%) had an IVD and 1204 (47%) had an IPD. The severity of the head AIS score did not affect the type of ICP monitoring selected. There was no difference in the median ISS; ISS > 15; head AIS Score 3, 4, or 5; or the need for craniectomy between the 2 device groups. Unadjusted 30-day mortality was significantly higher in the group with IVDs (29% vs 25.5%, p = 0.046); however, stepwise logistic regression analysis showed that the type of ICP monitoring was not an independent risk factor for death, complications, or functional outcome at discharge. CONCLUSIONS This study demonstrated that compliance with the Brain Trauma Foundation guidelines for ICP monitoring is poor. In isolated severe blunt head injuries, the type of ICP monitoring device does not have any effect on survival, systemic complications, or functional outcome.	[Aiolfi, Alberto; Khor, Desmond; Cho, Jayun; Benjamin, Elizabeth; Inaba, Kenji; Demetriades, Demetrios] Univ Southern Calif, Div Acute Care Surg, Inpatient Tower C,2051 Marengo St,Rm C5L100, Los Angeles, CA 90033 USA		Demetriades, D (corresponding author), Univ Southern Calif, Div Acute Care Surg, Inpatient Tower C,2051 Marengo St,Rm C5L100, Los Angeles, CA 90033 USA.	demetria@usc.edu	Benjamin, Elizabeth/AAD-2457-2020; INABA, KENJI/AAC-8532-2020; Aiolfi, Alberto/ABA-7242-2020	Aiolfi, Alberto/0000-0002-7764-6075			Alali AS, 2015, J NEUROSURG-PEDIATR, V16, P523, DOI 10.3171/2015.3.PEDS14507; Bratton SL, 2008, J NEUROTRAUM, V25, P276; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Cremer OL, 2005, CRIT CARE MED, V33, P2207, DOI 10.1097/01.CCM.0000181300.99078.B5; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Kasotakis G, 2012, J AM COLL SURGEONS, V214, P950, DOI 10.1016/j.jamcollsurg.2012.03.004; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu H, 2015, WORLD NEUROSURG, V83, P794, DOI 10.1016/j.wneu.2014.12.040; MacLaughlin BW, 2015, AM J SURG, V210, P1082, DOI 10.1016/j.amjsurg.2015.08.007; Shafi S, 2008, J TRAUMA, V64, P335, DOI 10.1097/TA.0b013e31815dd017; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Valadka AB, 2015, WORLD NEUROSURG, V84, P211, DOI 10.1016/j.wneu.2015.02.013; Yuan Q, 2016, NEUROSURGERY, V78, P361, DOI 10.1227/NEU.0000000000001050	14	15	15	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	MAR	2018	128	3					828	833		10.3171/2016.11.JNS162198			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FX7WD	WOS:000426301400021	28548592				2022-02-06	
J	Arafa, M; Agarwal, A; Al Said, S; Majzoub, A; Sharma, R; Bjugstad, KB; AlRumaihi, K; Elbardisi, H				Arafa, M.; Agarwal, A.; Al Said, S.; Majzoub, A.; Sharma, R.; Bjugstad, K. B.; AlRumaihi, K.; Elbardisi, H.			Semen quality and infertility status can be identified through measures of oxidation-reduction potential	ANDROLOGIA			English	Article						infertility; oxidation-reduction potential; semen analysis; semen quality; spermatozoa	TRAUMATIC BRAIN-INJURY; ANTIOXIDANT CAPACITY; STRESS; FERTILITY; PLASMA; MEN	Standard analyses for evaluating semen quality require technical expertise and are interpretive in nature. Oxidative stress (OS) alters many of the semen parameters; thus, a measure of OS could be an indicator of semen quality. Static oxidation-reduction potential (sORP) is a universal measure of OS traditionally used in environmental applications but is increasingly used in biomedical studies. sORP was measured to determine how well it associates with semen quality and if it differentiates semen from infertile patients and fertile donors. All study participants (Infertile, n=365 and Fertile, n=50) underwent standard semen analyses, and sORP was measured in unprocessed semen. In infertile patients, sORP increased with decreased total sperm number, motility and morphology. sORP values were higher in samples with abnormal quality (low number, motility and/or normal morphology) compared with those of normal quality. Infertile patients had higher sOPR values compared to fertile donors. A sORP cut-off value of 1.38mV/10(6)sperm/ml can differentiate normal from abnormal semen samples, while a cut-off value of 1.41mV/10(6) sperm/ml, can differentiate between infertile and fertile semen samples. In conclusion, sORP provides a quick and unbiased indicator of semen quality that can be a beneficial addition to semen analysis to determine semen quality and fertility status.	[Arafa, M.; Al Said, S.; Majzoub, A.; AlRumaihi, K.; Elbardisi, H.] HMC, Dept Urol, Doha, Qatar; [Arafa, M.] Cairo Univ, Androl Dept, Cairo, Egypt; [Agarwal, A.; Sharma, R.] Cleveland Clin, Amer Ctr Reprod Med, Cleveland, OH 44106 USA; [Bjugstad, K. B.] Aytu BioSci, Englewood, CO USA		Arafa, M (corresponding author), Hamad Gen Hosp, Dept Urol, Male Infertil Unit, Doha, Qatar.	mohamedmostafaarafa@gmail.com	Haitham, Elbardisi/J-3412-2019; Arafa, Mohamed/I-7829-2019; Majzoub, Ahmad/T-1071-2019	Haitham, Elbardisi/0000-0003-3902-7924; Arafa, Mohamed/0000-0003-0107-8857; Majzoub, Ahmad/0000-0001-7423-6241; Bjugstad, Kimberly/0000-0002-0473-5413; Sharma, Rakesh/0000-0002-9664-6978			Agarwal A, 2017, REPROD BIOMED ONLINE, V34, P48, DOI 10.1016/j.rbmo.2016.10.008; Agarwal A, 2016, FERTIL STERIL, V106, P566, DOI 10.1016/j.fertnstert.2016.05.013; Agarwal A, 2014, SYST BIOL REPROD MED, V60, P206, DOI 10.3109/19396368.2014.918675; [Anonymous], 2011, GUID DRINK WAT QUAL, P564; Benedetti S, 2012, REPROD BIOMED ONLINE, V25, P300, DOI 10.1016/j.rbmo.2012.05.011; Bjugstad K. B., 2016, J NEUROLOGY NEUROPHY, V2016, P1; Bjugstad KB, 2016, OXID MED CELL LONGEV, V2016, DOI 10.1155/2016/6974257; Chen QY, 2016, SEMIN CELL DEV BIOL, V59, P157, DOI 10.1016/j.semcdb.2016.01.019; Colagar AH, 2013, IRAN RED CRESCENT ME, V15, P780, DOI 10.5812/ircmj.6409; Cooper TG, 2010, HUM REPROD UPDATE, V16, P231, DOI 10.1093/humupd/dmp048; Copeland A, 2014, J AM WATER WORKS ASS, V106, pE10, DOI 10.5942/jawwa.2014.106.0002; Costantini D, 2009, FUNCT ECOL, V23, P506, DOI 10.1111/j.1365-2435.2009.01546.x; Doshi SB, 2012, REPROD BIOL ENDOCRIN, V10, DOI 10.1186/1477-7827-10-109; Haghighian HK, 2015, FERTIL STERIL, V104, P318, DOI 10.1016/j.fertnstert.2015.05.014; Khosrowbeygi A, 2007, BMC CLIN PATHOL, V7, DOI 10.1186/1472-6890-7-6; Ko EY, 2014, FERTIL STERIL, V102, P1518, DOI 10.1016/j.fertnstert.2014.10.020; Louis GMB, 2014, FERTIL STERIL, V101, P453, DOI 10.1016/j.fertnstert.2013.10.022; McCord JM, 2000, AM J MED, V108, P652, DOI 10.1016/S0002-9343(00)00412-5; Rael LT, 2007, BIOCHEM BIOPH RES CO, V361, P561, DOI 10.1016/j.bbrc.2007.07.078; Rael LT, 2015, ELECTROANAL, V27, P2567, DOI 10.1002/elan.201500178; Rael LT, 2009, J NEUROTRAUM, V26, P1203, DOI 10.1089/neu.2008-0816; Schmelke F. C., 1933, J AM WATER WORKS ASS, V25, P695; SHAPIRO HM, 1972, J SURG RES, V13, P138, DOI 10.1016/0022-4804(72)90057-1; Walczak-Jedrzejowska R, 2013, CENT EUR J UROL, V66, P60, DOI 10.5173/ceju.2013.01.art19; Wang C, 2014, FERTIL STERIL, V102, P1502, DOI 10.1016/j.fertnstert.2014.10.021; WHO, 2010, LAB MAN EX PROC HUM, Vfifth; World Health Organization (WHO), 2006, GUID SAF RECR WAT EN, V2, P146; Wyrobek AJ, 1997, REPROD TOXICOL, V11, P243, DOI 10.1016/S0890-6238(96)00108-6; Zhi LZ, 2013, REDOX REP, V18, P63, DOI 10.1179/1351000213Y.0000000042	29	15	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0303-4569	1439-0272		ANDROLOGIA	Andrologia	MAR	2018	50	2							e12881	10.1111/and.12881			6	Andrology	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	FW0PS	WOS:000424997800041	28771782				2022-02-06	
J	Brenner, LA; Forster, JE; Hoffberg, AS; Matarazzo, BB; Hostetter, TA; Signoracci, G; Simpson, GK				Brenner, Lisa A.; Forster, Jeri E.; Hoffberg, Adam S.; Matarazzo, Bridget B.; Hostetter, Trisha A.; Signoracci, Gina; Simpson, Grahame K.			Window to Hope: A Randomized Controlled Trial of a Psychological Intervention for the Treatment of Hopelessness Among Veterans With Moderate to Severe Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						cognitive behavior therapy; depression; hopelessness; randomized controlled trial; replication; suicide ideation; suicide prevention; traumatic brain injury; Veterans	NEUROPSYCHIATRIC INTERVIEW MINI; SUICIDAL IDEATION; INDIVIDUALS; RELIABILITY; VALIDITY; THERAPY	Objective: To evaluate the efficacy of a psychological intervention to reduce moderate to severe hopelessness among Veterans with moderate to severe traumatic brain injury (TBI). Design: Two-arm parallel group, controlled, randomized crossover trial, with 3-month follow-up for those initially allocated to treatment. Participants were randomly allocated in blocks of 4 on a 1: 1 ratio to treatment (n = 15) or waitlist (n = 20) groups. Setting: A Veterans Affairs Medical Center. Participants: Veterans between the ages of 26 and 65 years, with a history of moderate to severe TBI, and moderate to severe hopelessness. Interventions: A 20-hour manualized small group cognitive-behavioral intervention. Main Outcome Measures: Beck Hopelessness Scale (primary), Beck Depression Inventory, and Beck Scale for Suicide Ideation. Results: A significant difference between groups was found for postintervention scores on the Beck Hopelessness Scale (P =.03). Significant decreases were maintained at followup. For those initially allocated to the waitlist group who completed the intervention, treatment gains were noted in decreased hopelessness (P =.01) and depression (P =.003). Conclusions: Findings from this trial provide additional support for the efficacy of this method of psychological treatment of hopelessness among individuals with moderate to severe TBI.	[Brenner, Lisa A.; Forster, Jeri E.; Hoffberg, Adam S.; Matarazzo, Bridget B.; Hostetter, Trisha A.; Signoracci, Gina] VA Rocky Mt Mental Illness Res Educ & Clin Ctr, Denver, CO USA; [Brenner, Lisa A.; Forster, Jeri E.; Signoracci, Gina] Univ Colorado Anschutz Med Campus, Dept Phys Med & Rehabil, Aurora, CO USA; [Brenner, Lisa A.; Matarazzo, Bridget B.; Signoracci, Gina] Univ Colorado Anschutz Med Campus, Dept Psychiat, Aurora, CO USA; [Brenner, Lisa A.] Univ Colorado Anschutz Med Campus, Dept Neurol, Aurora, CO USA; [Simpson, Grahame K.] Univ Sydney New South Wales, Brain Injury Rehabil Res Grp, Ingham Inst Appl Med Res, Sydney, NSW, Australia; [Simpson, Grahame K.] Univ Sydney New South Wales, John Walsh Ctr Rehabil Res, Kolling Inst, Sydney, NSW, Australia		Brenner, LA (corresponding author), Rocky Mt MIRECC, VA Eastern Colorado Hlth Care Syst, 1055 Clermont St, Denver, CO 80220 USA.	Lisa.Brenner@va.gov	Brenner, Lisa A./AAG-2442-2019; Simpson, Grahame K/W-1074-2019; Signoracci, Gina M./Q-3782-2019	Simpson, Grahame K/0000-0001-8156-9060; Hoffberg, Adam/0000-0002-7036-936X	Military Suicide Research Consortium (MSRC); Office of the Assistant Secretary of Defense for Health Affairs [W81XWEI-10-2-0178]; VA Rocky Mountain MIRE CC	This work was supported by the Military Suicide Research Consortium (MSRC), an effort supported by the Office of the Assistant Secretary of Defense for Health Affairs (under Award No. W81XWEI-10-2-0178, Proposal No. 09162006). Opinions, interpretations, conclusions, and recommendations are those of the authors and are not necessarily endorsed by the MSRC or the Department of Defense. Additional support was provided by the VA Rocky Mountain MIRE CC.	Bahraini NH, 2013, BRAIN IMPAIR, V14, P92, DOI 10.1017/BrImp.2013.11; Beck A., 1993, BECK SCALE SUICIDAL; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Beck A.T., 1988, MANUAL BECK HOPELESS; BECK AT, 1985, AM J PSYCHIAT, V142, P559; Brenner LA, 2011, J HEAD TRAUMA REHAB, V26, P257, DOI 10.1097/HTR.0b013e31821fdb6e; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Fergusson D, 2002, BMJ-BRIT MED J, V325, P652, DOI 10.1136/bmj.325.7365.652; Freedland KE, 2011, PSYCHOSOM MED, V73, P323, DOI 10.1097/PSY.0b013e318218e1fb; Gupta Sandeep K, 2011, Perspect Clin Res, V2, P109, DOI 10.4103/2229-3485.83221; Hopewell S, 2008, LANCET, V371, P281, DOI 10.1016/S0140-6736(07)61835-2; JORGE RE, 1993, J NERV MENT DIS, V181, P91, DOI 10.1097/00005053-199302000-00004; Khan-Bourne N, 2003, NEUROPSYCHOL REHABIL, V13, P89, DOI 10.1080/09602010244000318; Mackelprang JL, 2014, AM J PUBLIC HEALTH, V104, pE100, DOI 10.2105/AJPH.2013.301794; Makel MC, 2012, PERSPECT PSYCHOL SCI, V7, P537, DOI 10.1177/1745691612460688; Matarazzo BB, 2014, BRAIN INJURY, V28, P1238, DOI 10.3109/02699052.2014.916419; McGrath JC, 2006, BRAIN INJURY, V20, P767, DOI 10.1080/02699050600664566; MOHER D, 2010, BMJ BRIT MED J, V340; OTTENBACHER KJ, 1995, ARCH PHYS MED REHAB, V76, P123, DOI 10.1016/S0003-9993(95)80021-2; Schmidt S, 2009, REV GEN PSYCHOL, V13, P90, DOI 10.1037/a0015108; Sheehan DV, 1997, EUR PSYCHIAT, V12, P232, DOI 10.1016/S0924-9338(97)83297-X; Sheehan DV, 1998, J CLIN PSYCHIAT, V59, P22, DOI 10.4088/JCP.09m05305whi; Simpson G, 2002, PSYCHOL MED, V32, P687, DOI 10.1017/S0033291702005561; Simpson GK, 2011, J HEAD TRAUMA REHAB, V26, P290, DOI 10.1097/HTR.0b013e3182225250; Wagenmakers EJ, 2012, PERSPECT PSYCHOL SCI, V7, P632, DOI 10.1177/1745691612463078; Whiting DL, 2012, BRAIN IMPAIR, V13, P360, DOI 10.1017/BrImp.2012.28	26	15	15	1	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	MAR-APR	2018	33	2					E64	E73		10.1097/HTR.0000000000000351			10	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GN6AI	WOS:000439152200007	29084101				2022-02-06	
J	Meredith, L; Ekman, R; Thomson, R				Meredith, Lauren; Ekman, Robert; Thomson, Robert			Horse-related incidents and factors for predicting injuries to the head	BMJ OPEN SPORT & EXERCISE MEDICINE			English	Article								Objectives Head injuries are the leading cause of death in horse-related injury events and, even since the introduction of helmets, represent a sizeable proportion of all horse-related injuries. Falls from horseback and kicks to the head are the most frequent type of incident causing head injuries, but it is unknown whether these incidents are predictors of head injury. This study aimed to investigate head injuries and the association between incident type and head injury. Method Retrospective review of 7815 horse-related injury events was conducted. Data were gathered from hospitals, local healthcare centres and public dental services in Skaraborg, Sweden. Binary logistic regression was used to analyse the association between the incident type and occurrence of head injury while controlling for risk factors. Results Approximately 20% of riders sustained a head injury, mostly soft tissue injuries (56.3%) and concussions (33.4%). A fall from or with the horse was the primary cause of head injury (63.9%). Those who fell from a carriage or other height or who were injured through contact with the horse had no difference in the likelihood of head injury when compared with those that fell from or with the horse. However, those who sustained an injury without any horse contact had lower odd of head injury (OR: 0.640, p<0.00005, 95% CI 0.497 to 0.734). Additionally, the older the rider, the lower the odds of head injury (OR=0.989, p<0.00005, 95% CI 0.985 to 0.993). Conclusion Improved protection for those suffering falls from horseback as well as those who are kicked in the head should be investigated.	[Meredith, Lauren; Thomson, Robert] Chalmers Univ Technol, Vehicle Safety, Gothenburg, Sweden; [Ekman, Robert] Chalmers Univ Technol, Dept Architecture & Civil Engn, Gothenburg, Sweden		Meredith, L (corresponding author), Chalmers Univ Technol, Vehicle Safety, Gothenburg, Sweden.	lauren.meredith@chalmers.se			Vastra Gotalandsregionen; Chalmers University of Technology; Natural Resource Management	This study was funded by Vastra Gotalandsregionen, Natural Resource Management and Chalmers University of Technology.	Abu-Kishk Ibrahim, 2013, Isr Med Assoc J, V15, P169; Abu-Zidan FM, 2003, INJURY, V34, P897, DOI 10.1016/S0020-1383(03)00054-8; Altgarde J, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/s13049-014-0040-8; Antoun JS, 2011, BRIT J ORAL MAX SURG, V49, P213, DOI 10.1016/j.bjoms.2010.03.005; Bixby-Hammett Doris M, 2006, N C Med J, V67, P161; BUCKLEY SM, 1993, AUST J PUBLIC HEALTH, V17, P269; Carmichael SP, 2014, INJURY, V45, P1479, DOI 10.1016/j.injury.2014.03.016; Chitnavis JP, 1996, INJURY, V27, P103, DOI 10.1016/0020-1383(95)00176-X; Clark JM, 2017, IRCOBI C, P215; Cuenca AG, 2009, J PEDIATR SURG, V44, P148, DOI 10.1016/j.jpedsurg.2008.10.025; DANIELSSON LG, 1973, ACTA ORTHOP SCAND, V44, P597, DOI 10.3109/17453677308989097; Davidson SB, 2015, J EMERG MED, V49, P605, DOI 10.1016/j.jemermed.2015.03.025; Eckert V, 2011, CLIN J SPORT MED, V21, P353, DOI 10.1097/JSM.0b013e318221840f; Ekman DS, 2012, INT J INJ CONTROL SA, V19, P213, DOI 10.1080/17457300.2012.707217; Exadaktylos AK, 2002, EMERG MED J, V19, P573, DOI 10.1136/emj.19.6.573; Hasler Rebecca M, 2011, J Trauma Manag Outcomes, V5, P4, DOI 10.1186/1752-2897-5-4; Lloyd R G, 1987, Br J Sports Med, V21, P22; Majeedkutty NA, 2017, J FAM COMMUNITY MED, V24, P18, DOI 10.4103/2230-8229.197177; Schyllander J, 2013, INJURED BICYCLISTS S; The National Board of Health and Welfare, 2018, IDB SVIERG; Theodore JE, 2017, J PAEDIATR CHILD H, V53, P543, DOI 10.1111/jpc.13471; Thomas KE, 2006, BRIT J SPORT MED, V40, P619, DOI 10.1136/bjsm.2006.025858; Ueeck BA, 2004, J ORAL MAXIL SURG, V62, P693, DOI 10.1016/j.joms.2003.12.010; Weber CD, 2017, INT ORTHOP, V41, P2105, DOI 10.1007/s00264-017-3592-1	24	15	15	0	0	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2398-9459	2055-7647		BMJ OPEN SPORT EXERC	BMJ Open Sport Exerc. Med.	MAR	2018	4	1							e000398	10.1136/bmjsem-2018-000398			6	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	VJ4QA	WOS:000596798200099	30167320	gold, Green Published			2022-02-06	
J	Niu, HX; Wang, JZ; Wang, DL; Miao, JJ; Li, H; Liu, ZG; Yuan, X; Liu, W; Zhou, JR				Niu, Hong-Xia; Wang, Jun-Zhe; Wang, Dong-Liang; Miao, Jun-Jie; Li, Hua; Liu, Zhi-Gang; Yuan, Xing; Liu, Wei; Zhou, Jing-Ru			The Orally Active Noncompetitive AMPAR Antagonist Perampanel Attenuates Focal Cerebral Ischemia Injury in Rats	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Stroke; Perampanel; Neuroprotection; Nitric oxide synthase	TRAUMATIC BRAIN-INJURY; NITRIC-OXIDE SYNTHASE; RECEPTOR ANTAGONIST; INFLAMMATORY NEURODEGENERATION; ANTIEPILEPTIC DRUG; STROKE; EPILEPSY; NEUROPROTECTION; ACTIVATION; MECHANISMS	Inhibition of ionotropic glutamate receptors (iGluRs) is a potential target of therapy for ischemic stroke. Perampanel is a potent noncompetitive alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate receptor (AMPAR) antagonist with good oral bioavailability and favorable pharmacokinetic properties. Here, we investigated the potential protective effects of perampanel against focal cerebral ischemia in a middle cerebral artery occlusion (MCAO) model in rats. Oral administration with perampanel significantly reduced MCAO-induced brain edema, brain infarct volume, and neuronal apoptosis. These protective effects were associated with improved functional outcomes, as measured by foot-fault test, adhesive removal test, and modified neurological severity score (mNSS) test. Importantly, perampanel was effective even when the administration was delayed to 1 h after reperfusion. The results of enzyme-linked immunosorbent assay (ELISA) showed that perampanel significantly decreased the expression of pro-inflammatory cytokines IL-1 beta and TNF-alpha, whereas it increased the levels of anti-inflammatory cytokines IL-10 and TGF-beta 1 after MCAO. In addition, perampanel treatment markedly decreased the expression of inducible nitric oxide synthase (iNOS) and neuronal nitric oxide synthase (nNOS), and also inhibited nitric oxide (NO) generation in MCAO-injured rats at 24 and 72 h after reperfusion. In conclusion, this study demonstrated that the orally active AMPAR antagonist perampanel protects against experimental ischemic stroke via regulating inflammatory cytokines and NOS pathways.	[Wang, Dong-Liang; Miao, Jun-Jie; Zhou, Jing-Ru] Peking Univ, Dept Neurosurg, Peoples Hosp, Beijing 100044, Peoples R China; [Niu, Hong-Xia] Beijing Elect Power Hosp, Emergency Dept, Beijing 100071, Peoples R China; [Wang, Jun-Zhe; Liu, Wei] Shaanxi Fourth Peoples Hosp, Basic Med Sci Res Ctr, Xian 710043, Shaanxi, Peoples R China; [Li, Hua; Liu, Zhi-Gang; Yuan, Xing; Liu, Wei] Shaanxi Fourth Peoples Hosp, Dept Neurosurg, Xian 710043, Shaanxi, Peoples R China		Zhou, JR (corresponding author), Peking Univ, Dept Neurosurg, Peoples Hosp, Beijing 100044, Peoples R China.; Liu, W (corresponding author), Shaanxi Fourth Peoples Hosp, Basic Med Sci Res Ctr, Xian 710043, Shaanxi, Peoples R China.; Liu, W (corresponding author), Shaanxi Fourth Peoples Hosp, Dept Neurosurg, Xian 710043, Shaanxi, Peoples R China.	vincelau@163.com; zhoujingru_peking@163.com					Appireddy RMR, 2015, J CLIN NEUROL, V11, P1, DOI 10.3988/jcn.2015.11.1.1; Arundine M, 2004, CELL MOL LIFE SCI, V61, P657, DOI 10.1007/s00018-003-3319-x; Brown GC, 2007, BIOCHEM SOC T, V35, P1119, DOI 10.1042/BST0351119; Brown GC, 2006, BIOCHEM SOC T, V34, P953, DOI 10.1042/BST0340953; Ceolin L, 2012, NEUROCHEM INT, V61, P517, DOI 10.1016/j.neuint.2012.02.035; Chen T, 2017, CELL MOL NEUROBIOL, V37, P43, DOI 10.1007/s10571-016-0341-8; Chen T, 2012, NEUROCHEM RES, V37, P983, DOI 10.1007/s11064-011-0691-z; Chen T, 2012, INT J MOL MED, V29, P630, DOI 10.3892/ijmm.2011.870; Chen ZC, 2014, J NEUROSCI, V34, P9621, DOI 10.1523/JNEUROSCI.3991-13.2014; del Zoppo G, 2000, BRAIN PATHOL, V10, P95; Dias RB, 2012, HIPPOCAMPUS, V22, P276, DOI 10.1002/hipo.20894; Erdo F, 2006, BRAIN RES BULL, V68, P269, DOI 10.1016/j.brainresbull.2005.08.018; Frenkel D, 2003, J IMMUNOL, V171, P6549, DOI 10.4049/jimmunol.171.12.6549; Ginsberg MD, 2008, NEUROPHARMACOLOGY, V55, P363, DOI 10.1016/j.neuropharm.2007.12.007; Hamilton TA, 2002, IMMUNOL RES, V25, P229, DOI 10.1385/IR:25:3:229; Hanada T, 2014, EXPERT OPIN DRUG DIS, V9, P449, DOI 10.1517/17460441.2014.891580; Hanada T, 2011, EPILEPSIA, V52, P1331, DOI 10.1111/j.1528-1167.2011.03109.x; Krauss GL, 2012, ACTA NEUROL SCAND, V125, P8, DOI 10.1111/j.1600-0404.2011.01588.x; Kwan P, 2015, EPILEPSY RES, V117, P117, DOI 10.1016/j.eplepsyres.2015.09.002; Lambertsen KL, 2012, J CEREBR BLOOD F MET, V32, P1677, DOI 10.1038/jcbfm.2012.88; Langan YM, 2003, EPILEPSIA, V44, P46, DOI 10.1046/j.1528-1157.2003.128902.x; Licinio J, 1999, MOL MED TODAY, V5, P225, DOI 10.1016/S1357-4310(99)01453-7; Lin MP, 2015, CARDIOL CLIN, V33, P99, DOI 10.1016/j.ccl.2014.09.009; Liu PK, 2002, ANN NY ACAD SCI, V962, P226, DOI 10.1111/j.1749-6632.2002.tb04071.x; Lv JM, 2016, CELL MOL NEUROBIOL, V36, P745, DOI 10.1007/s10571-015-0257-8; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Menon DK, 2009, CURR OPIN CRIT CARE, V15, P437, DOI 10.1097/MCC.0b013e3283307a26; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Ning R, 2014, NEUROSCIENCE, V257, P76, DOI 10.1016/j.neuroscience.2013.10.071; O'Collins VE, 2006, ANN NEUROL, V59, P467, DOI 10.1002/ana.20741; Ooboshi H, 2005, CIRCULATION, V111, P913, DOI 10.1161/01.CIR.0000155622.68580.DC; Pandya Rachna S., 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P81; Pang L, 2001, STROKE, V32, P544, DOI 10.1161/01.STR.32.2.544; Patsalos PN, 2015, EPILEPSIA, V56, P12, DOI 10.1111/epi.12865; Rogawski MA, 2013, ACTA NEUROL SCAND, V127, P19, DOI 10.1111/ane.12100; SHEARDOWN MJ, 1990, SCIENCE, V247, P571, DOI 10.1126/science.2154034; Simi A, 2007, BIOCHEM SOC T, V35, P1122, DOI 10.1042/BST0351122; Smith S E, 1993, Funct Neurol, V8, P43; Traynor K, 2012, AM J HEALTH-SYST PH, V69, P2024, DOI 10.2146/news120080; Vannucchi MG, 2007, BRAIN RES, V1132, P218, DOI 10.1016/j.brainres.2006.11.029; Yung HW, 2004, J NEUROCHEM, V89, P812, DOI 10.1111/j.1471-4159.2004.02395.x; Zaharchuk G, 1997, MAGNET RESON MED, V37, P170, DOI 10.1002/mrm.1910370204; Zhang BJ, 2013, CHINESE MED J-PEKING, V126, P2354, DOI 10.3760/cma.j.issn.0366-6999.20122483; Zhang Y, 2012, MOLECULES, V17, P341, DOI 10.3390/molecules17010341	44	15	15	0	3	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAR	2018	38	2					459	466		10.1007/s10571-017-0489-x			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	FX4WL	WOS:000426079300006	28401316				2022-02-06	
J	Paniccia, M; Wilson, KE; Hunt, A; Keightley, M; Zabjek, K; Taha, T; Gagnon, I; Reed, N				Paniccia, Melissa; Wilson, Katherine E.; Hunt, Anne; Keightley, Michelle; Zabjek, Karl; Taha, Tim; Gagnon, Isabelle; Reed, Nick			Postural Stability in Healthy Child and Youth Athletes: The Effect of Age, Sex, and Concussion-Related Factors on Performance	SPORTS HEALTH-A MULTIDISCIPLINARY APPROACH			English	Article						postural stability; youth; athletes; concussion; symptom	BASE-LINE; ADOLESCENTS; BALANCE; SYMPTOMS; INJURY; GENDER	Background: Postural stability plays a key role in sport performance, especially after concussion. Specific to healthy child and youth athletes, little is known about the influence development and sex may have on postural stability while considering other subjective clinical measures used in baseline/preinjury concussion assessment. This study aims to describe age- and sex-based trends in postural stability in uninjured child and youth athletes at baseline while accounting for concussion-related factors. Hypotheses: (1) Postural stability performance will improve with age, (2) females will display better postural stability compared to males, and (3) concussion-like symptoms will affect postural stability performance in healthy children and youth. Study Design: Cross-sectional study. Level of Evidence: Level 3. Methods: This study comprised 889 healthy/uninjured child and youth athletes (54% female, 46% male) between the ages of 9 and 18 years old. Participants completed preseason baseline testing, which included demographic information (age, sex, concussion history), self-report of concussion-like symptoms (Post-Concussion Symptom Inventory [PCSI]-Child and PCSI-Youth), and measures of postural stability (BioSway; Biodex Medical Systems). Two versions of the PCSI were used (PCSI-C, 9- to 12-year-olds; PCSI-Y, 13- to 18-year-olds). Postural stability was assessed via sway index under 4 sway conditions of increasing difficulty by removing visual and proprioceptive cues. Results: In children aged 9 to 12 years old, there were significant age- (P < 0.05) and sex-based effects (P < 0.05) on postural stability. Performance improved with age, and girls performed better than boys. For youth ages 13 to 18 years old, postural stability also improved with age (P < 0.05). In both child and youth subgroups, postural stability worsened with increasing concussion-like symptoms (P < 0.05). Conclusion: There are developmental and baseline symptom trends regarding postural stability performance. Clinical Relevance: These findings provide a preliminary foundation for postconcussion comparisons and highlight the need for a multimodal approach in assessing and understanding physical measures such as postural stability.	[Paniccia, Melissa] Univ Toronto, Fac Med, Rehabil Sci Inst, 500 Univ Ave, Toronto, ON M5G 1V7, Canada; [Paniccia, Melissa; Wilson, Katherine E.; Hunt, Anne; Reed, Nick] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Concuss Ctr, Toronto, ON, Canada; [Keightley, Michelle] Holland Bloorview Kids Rehabil Hosp, Bloorview Res Inst, Toronto, ON, Canada; [Keightley, Michelle] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada; [Zabjek, Karl] Univ Toronto, Fac Med, Dept Phys Therapy, Toronto, ON, Canada; [Taha, Tim] Univ Toronto, Fac Kinesiol & Phys Educ, Toronto, ON, Canada; [Gagnon, Isabelle] McGill Univ, Sch Phys & Occupat Therapy, Montreal, PQ, Canada; [Reed, Nick] Univ Toronto, Fac Med, Dept Occupat Sci & Occupat Therapy, Toronto, ON, Canada		Paniccia, M (corresponding author), Univ Toronto, Fac Med, Rehabil Sci Inst, 500 Univ Ave, Toronto, ON M5G 1V7, Canada.	melissa.paniccia@utoronto.ca		Gagnon, Isabelle/0000-0003-2043-1644	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [127048]; Ontario Neurotrauma Foundation (Ontario, Canada); Ontario Brain Institute (Ontario, Canada)	This work was funded by the Canadian Institutes of Health Research (No. 127048) with support from the Ontario Neurotrauma Foundation (Ontario, Canada) and the Ontario Brain Institute (Ontario, Canada).	Biodex Medical Systems Inc, BIOSWAY PORT BAL SYS; Borah Diganta, 2007, Indian J Physiol Pharmacol, V51, P395; Browne GJ, 2006, BRIT J SPORT MED, V40, P163, DOI 10.1136/bjsm.2005.021220; Butz SM, 2015, PEDIATR PHYS THER, V27, P126, DOI 10.1097/PEP.0000000000000128; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cottle JE, 2017, J ATHL TRAINING, V52, P77, DOI 10.4085/1062-6050-51.12.21; Custer A, 2016, J ATHL TRAINING, V51, P136, DOI 10.4085/1062-6050-51.2.12; Demura S., 2006, SPORT SCI HLTH, V1, P158, DOI [10.1007/s11332-006-0028-5, DOI 10.1007/S11332-006-0028-5]; Eime RM, 2013, INT J BEHAV NUTR PHY, V10, DOI 10.1186/1479-5868-10-98; Geldhof E, 2006, EUR J PEDIATR, V165, P779, DOI 10.1007/s00431-006-0173-5; George D., 2010, SPSS WINDOWS STEP ST, V10th; Guskiewicz Kevin M, 2015, Handb Clin Neurol, V127, P157, DOI 10.1016/B978-0-444-52892-6.00010-6; HIRABAYASHI S, 1995, BRAIN DEV-JPN, V17, P111, DOI 10.1016/0387-7604(95)00009-Z; Holden S, 2016, GAIT POSTURE, V48, P171, DOI 10.1016/j.gaitpost.2016.04.019; Holden S, 2014, PEDIATR PHYS THER, V26, P447, DOI 10.1097/PEP.0000000000000071; Hue O, 2007, GAIT POSTURE, V26, P32, DOI 10.1016/j.gaitpost.2006.07.005; Iverson GL, 2015, JAMA PEDIATR, V169, P1132, DOI 10.1001/jamapediatrics.2015.2374; Lee AJY, 2007, J APPL BIOMECH, V23, P173, DOI 10.1123/jab.23.3.173; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Nolan L, 2005, DEV MED CHILD NEUROL, V47, P449, DOI 10.1017/S0012162205000873; Ontario Neurotrauma Foundation, 2014, GUID DIAGN MAN PED C; Peterson ML, 2006, GAIT POSTURE, V23, P455, DOI 10.1016/j.gaitpost.2005.05.003; Quatman-Yates CC, 2012, BRIT J SPORT MED, V46, P649, DOI 10.1136/bjsm.2010.079616; Reed N, 2014, JOVE-J VIS EXP, DOI 10.3791/51892; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Slobounov S, 2008, CLIN NEUROPHYSIOL, V119, P281, DOI 10.1016/j.clinph.2007.10.006; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Steindl R, 2006, DEV MED CHILD NEUROL, V48, P477, DOI 10.1017/S0012162206001022; U.S. Department of Health and Human Services, 2008, PHYS ACT GUID ADV CO; Hunt AW, 2016, J ATHL TRAINING, V51, P749, DOI 10.4085/1062-6050-51.11.12	30	15	15	0	6	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1941-7381	1941-0921		SPORTS HEALTH	Sports Health	MAR-APR	2018	10	2					175	182		10.1177/1941738117741651			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	GC7BT	WOS:000429947700013	29131721	Green Published			2022-02-06	
J	Piromkraipak, P; Sangpairoj, K; Tirakotai, W; Chaithirayanon, K; Unchern, S; Supavilai, P; Power, C; Vivithanaporn, P				Piromkraipak, Pannaree; Sangpairoj, Kant; Tirakotai, Wuttipong; Chaithirayanon, Kulathida; Unchern, Supeenun; Supavilai, Porntip; Power, Christopher; Vivithanaporn, Pornpun			Cysteinyl Leukotriene Receptor Antagonists Inhibit Migration, Invasion, and Expression of MMP-2/9 in Human Glioblastoma	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						Montelukast; Zafirlukast; Gelatinase; Migration; Invasion; Glioma	5-LIPOXYGENASE TRIGGERS APOPTOSIS; TRAUMATIC BRAIN-INJURY; FACTOR-KAPPA-B; MATRIX-METALLOPROTEINASE-9 EXPRESSION; MATRIX METALLOPROTEINASES; GLIOMA-CELLS; DOWN-REGULATION; IDH2 MUTATIONS; BREAST-CANCER; P38 MAPK	Glioblastoma is one of the most malignant and aggressive types of brain tumors. 5-lipoxygenase and cysteinyl leukotriene receptor 1 (CysLT1) play a role in human carcinogenesis. Leukotriene receptor antagonists (LTRAs), anti-asthmatic drugs with mild side effects, have anti-metastatic activity in epidermoid carcinoma, lung carcinoma, and colon cancers as well as neuroprotective effects. Herein, anti-migratory effects of two LTRAs, montelukast and zafirlukast, were investigated in glioblastoma cells. The level of CysLT1 in A172 cells was increased by 3.13 folds after IL-1 beta treatment. The median toxic concentration of LTRAs in A172, U373, and primary astrocytes ranged from 7.17 to 26.28 mu M at 24-h post-exposure. Both LTRAs inhibited migration and invasion of glioma. Additionally, both drugs significantly inhibited the expression and activities of MMP-2 and MMP-9 in A172 and U373 glioblastoma cells and primary human astrocytes, suggesting that CysLT1 plays a role in migration and invasion of glioma, and LTRAs are potential drugs to reduce migration and invasion.	[Piromkraipak, Pannaree; Unchern, Supeenun; Supavilai, Porntip; Vivithanaporn, Pornpun] Mahidol Univ, Dept Pharmacol, Fac Sci, Bangkok, Thailand; [Sangpairoj, Kant; Chaithirayanon, Kulathida] Mahidol Univ, Dept Anat, Fac Sci, Bangkok, Thailand; [Sangpairoj, Kant] Thammasat Univ, Div Anat, Dept Preclin Sci, Fac Med, Pathum Thani, Thailand; [Tirakotai, Wuttipong] Prasat Neurol Inst, Bangkok, Thailand; [Power, Christopher] Univ Alberta, Fac Med & Dent, Dept Med, Edmonton, AB, Canada		Vivithanaporn, P (corresponding author), Mahidol Univ, Dept Pharmacol, Fac Sci, Bangkok, Thailand.	pornpun.viv@mahidol.ac.th		Sangpairoj, Kant/0000-0003-2398-1262	Mahidol University; Department of Medical Services, Ministry of Public Health, Thailand [59-59-407308]	We thank Mr. Piyadon Sathavorasmith and Ms. Suttinee Phuagkhaopong for technical assistance. We thank Ms. Nanapas Bhagaman, a biostatistician at the Department of Epidemiology, Faculty of Public Health, Mahidol University for advice on statistic. This work was supported by research grant from Mahidol University to PP and KC. WT was supported by the Department of Medical Services, Ministry of Public Health, Thailand (Grant Number 59-59-407308).	Allavena P, 2008, CURR OPIN GENET DEV, V18, P3, DOI 10.1016/j.gde.2008.01.003; Anderson R, 2009, BRIT J PHARMACOL, V156, P105, DOI 10.1111/j.1476-5381.2008.00012.x; Aroui S, 2016, TUMOR BIOL, V37, P3831, DOI 10.1007/s13277-015-4230-4; Bjorklund M, 2005, BBA-REV CANCER, V1755, P37, DOI 10.1016/j.bbcan.2005.03.001; Chen XX, 2004, CLIN CANCER RES, V10, P6703, DOI 10.1158/1078-0432.CCR-04-0838; Cheng HY, 1996, PHARM RES-DORDR, V13, P445, DOI 10.1023/A:1016056912698; Choe GY, 2002, CLIN CANCER RES, V8, P2894; Ciceri P, 2001, BRIT J PHARMACOL, V133, P1323, DOI 10.1038/sj.bjp.0704189; Cohen AL, 2013, CURR NEUROL NEUROSCI, V13, DOI 10.1007/s11910-013-0345-4; Cuperlovic-Culf M, 2012, J BIOL CHEM, V287, P20164, DOI 10.1074/jbc.M111.337196; De Vita F, 1998, J EXP CLIN CANC RES, V17, P413; Duran A, 2013, ACTA CHIR BELG, V113, P401, DOI 10.1080/00015458.2013.11680954; El-Sisi AEE, 2015, TOXICOL IND HEALTH, V31, P1024, DOI 10.1177/0748233713485884; Esteve PO, 1998, BBA-MOL CELL RES, V1403, P85, DOI 10.1016/S0167-4889(98)00020-2; Esteve PO, 2002, J BIOL CHEM, V277, P35150, DOI 10.1074/jbc.M108600200; Fanjul-Fernandez M, 2010, BBA-MOL CELL RES, V1803, P3, DOI 10.1016/j.bbamcr.2009.07.004; Ferrari CC, 2004, AM J PATHOL, V165, P1827, DOI 10.1016/S0002-9440(10)63438-4; Friedberg MH, 1998, CANCER, V82, P923, DOI 10.1002/(SICI)1097-0142(19980301)82:5<923::AID-CNCR18>3.0.CO;2-2; Fu YJ, 2012, BIOTECHNOL LETT, V34, P441, DOI 10.1007/s10529-011-0800-8; Funao K, 2008, MOL MED REP, V1, P185; Funk CD, 2005, NAT REV DRUG DISCOV, V4, P664, DOI 10.1038/nrd1796; Germano G, 2008, CYTOKINE, V43, P374, DOI 10.1016/j.cyto.2008.07.014; Gounaris E, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0121402; Griffin WST, 2002, J LEUKOCYTE BIOL, V72, P233; Gunning WT, 2002, CANCER RES, V62, P4199; Hagemann C, 2012, WORLD J CLIN ONCOL, V3, P67, DOI 10.5306/wjco.v3.i5.67; Hagemann Carsten, 2010, BMC Res Notes, V3, P293, DOI 10.1186/1756-0500-3-293; Heise CE, 2000, J BIOL CHEM, V275, P30531, DOI 10.1074/jbc.M003490200; Holland EC, 2000, TOXICOL PATHOL, V28, P171, DOI 10.1177/019262330002800122; Hu H, 2005, ACTA PHARMACOL SIN, V26, P685, DOI 10.1111/j.1745-7254.2005.00092.x; Huang XQ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-145; Hung CH, 2006, PEDIAT ALLERG IMM-UK, V17, P250, DOI 10.1111/j.1399-3038.2006.00385.x; Ichimura K, 2012, BRAIN TUMOR PATHOL, V29, P131, DOI 10.1007/s10014-012-0090-4; Ishii K, 2009, CLIN NEUROPATHOL, V28, P445; Jose MA, 2013, INDIAN J PHARMACOL, V45, P286, DOI 10.4103/0253-7613.111897; Kahnt AS, 2013, BIOCHEM PHARMACOL, V86, P286, DOI 10.1016/j.bcp.2013.05.005; Kumar R, 2016, CARCINOGENESIS, V37, P912, DOI 10.1093/carcin/bgw075; Kunishio Katsuzo, 2003, Brain Tumor Pathol, V20, P39, DOI 10.1007/BF02483445; Lai JE, 2014, NEUROPHARMACOLOGY, V79, P707, DOI 10.1016/j.neuropharm.2014.01.011; Langlois A, 2006, J ALLERGY CLIN IMMUN, V118, P113, DOI 10.1016/j.jaci.2006.03.010; Lin YC, 2018, J MICROBIOL IMMUNOL, V51, P18, DOI 10.1016/j.jmii.2016.04.005; Luchman HA, 2012, NEURO-ONCOLOGY, V14, P184, DOI 10.1093/neuonc/nor207; Magi S, 2014, CANCER SCI, V105, P290, DOI 10.1111/cas.12340; Magnusson C, 2011, INT J CANCER, V129, P9, DOI 10.1002/ijc.25648; Manev H, 2011, PROG NEURO-PSYCHOPH, V35, P315, DOI 10.1016/j.pnpbp.2010.07.032; Massova I, 1998, FASEB J, V12, P1075, DOI 10.1096/fasebj.12.12.1075; Matsuyama M, 2009, MOL MED REP, V2, P163, DOI 10.3892/mmr_00000078; Melstrom LG, 2008, CLIN CANCER RES, V14, P6525, DOI 10.1158/1078-0432.CCR-07-4631; Mendes O, 2005, CLIN EXP METASTAS, V22, P237, DOI 10.1007/s10585-005-8115-6; Meng Z, 2013, UROLOGY, V82, DOI 10.1016/j.urology.2013.08.060; Merched AJ, 2008, FASEB J, V22, P3595, DOI 10.1096/fj.08-112201; Musumeci G, 2015, CELL TISSUE RES, V362, P45, DOI 10.1007/s00441-015-2197-5; Nakada M, 2003, FRONT BIOSCI, V8, pE261, DOI 10.2741/1016; NAKANO A, 1995, J NEUROSURG, V83, P298, DOI 10.3171/jns.1995.83.2.0298; Nishio K, 2016, J ORAL SCI, V58, P59, DOI 10.2334/josnusd.58.59; Nozaki Masako, 2010, Keio Journal of Medicine, V59, P10; Ostrom QT, 2013, NEURO-ONCOLOGY, V15, P1, DOI 10.1093/neuonc/not151; Paruchuri S, 2006, ONCOGENE, V25, P6660, DOI 10.1038/sj.onc.1209666; Patel A, 2016, BRAIN STRUCT FUNCT, V221, P1845, DOI 10.1007/s00429-015-1007-x; Patil V, 2015, ONCOTARGET, V6, P43452, DOI 10.18632/oncotarget.6171; Peters-Golden M, 2005, ANN ALLERG ASTHMA IM, V94, P609, DOI 10.1016/S1081-1206(10)61317-8; Piaskowski S, 2011, BRIT J CANCER, V104, P968, DOI 10.1038/bjc.2011.27; Poeckel D, 2010, CARDIOVASC RES, V86, P243, DOI 10.1093/cvr/cvq016; Rahme GJ, 2015, ONCOGENE, V34, P53, DOI 10.1038/onc.2013.531; Raithatha SA, 2000, NEURO-ONCOLOGY, V2, P145, DOI 10.1093/neuonc/2.3.145; Ramires R, 2004, BIOCHEM BIOPH RES CO, V324, P815, DOI 10.1016/j.bbrc.2004.09.125; Sarkar S, 2009, J NEURO-ONCOL, V91, P157, DOI 10.1007/s11060-008-9695-1; Sarveswaran S, 2011, BBA-MOL CELL RES, V1813, P2108, DOI 10.1016/j.bbamcr.2011.07.015; Savari S, 2014, WORLD J GASTROENTERO, V20, P968, DOI 10.3748/wjg.v20.i4.968; Savari S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073466; Shaftel SS, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-7; Sharma V, 2011, J MOL MED, V89, P123, DOI 10.1007/s00109-010-0683-5; Spinozzi F, 2004, CLIN EXP ALLERGY, V34, P1876, DOI 10.1111/j.1365-2222.2004.02119.x; Sveinbjornsson B, 2008, FASEB J, V22, P3525, DOI 10.1096/fj.07-103457; Tahan F, 2008, CLIN EXP ALLERGY, V38, P805, DOI 10.1111/j.1365-2222.2008.02963.x; Tejima E, 2007, J CEREBR BLOOD F MET, V27, P460, DOI 10.1038/sj.jcbfm.9600354; Thakkar JP, 2014, CANCER EPIDEM BIOMAR, V23, P1985, DOI 10.1158/1055-9965.EPI-14-0275; Theron AJ, 2014, J IMMUNOL RES, V2014, DOI 10.1155/2014/608930; Thorns V, 2003, ANTICANCER RES, V23, P3937; Tintinger GR, 2010, THESCIENTIFICWORLDJO, V10, P2403, DOI 10.1100/tsw.2010.229; Tsai MJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25880; Tsang DS, 2015, CLIN ONCOL-UK, V27, P176, DOI 10.1016/j.clon.2014.11.026; Vecil GG, 2000, J NEUROSCI RES, V61, P212, DOI 10.1002/1097-4547(20000715)61:2<212::AID-JNR12>3.0.CO;2-9; Vivithanaporn P, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012856; Wang Maode, 2003, Brain Tumor Pathol, V20, P65, DOI 10.1007/BF02483449; Wang MD, 2005, J NEURO-ONCOL, V72, P1, DOI 10.1007/s11060-004-1392-0; Wen Z, 2015, ONCOGENE, V34, P1241, DOI 10.1038/onc.2014.85; Wenzel SE, 2003, PROSTAG LEUKOTR ESS, V69, P145, DOI 10.1016/S0952-3278(03)00075-9; Wild-Bode C, 2001, J NEUROSURG, V94, P976, DOI 10.3171/jns.2001.94.6.0978; Woszczek G, 2010, J IMMUNOL, V184, P2219, DOI 10.4049/jimmunol.0900071; Wu CY, 2008, J NEUROCHEM, V105, P1499, DOI 10.1111/j.1471-4159.2008.05318.x; Wu CY, 2009, GLIA, V57, P1775, DOI 10.1002/glia.20890; Wu CY, 2004, J NEUROCHEM, V90, P1477, DOI 10.1111/j.1471-4159.2004.02682.x; Yan H, 2009, NEW ENGL J MED, V360, P765, DOI 10.1056/NEJMoa0808710; Yang CM, 2015, MOL NEUROBIOL, V52, P303, DOI 10.1007/s12035-014-8838-y; Yeung YT, 2013, BRIT J PHARMACOL, V168, P591, DOI 10.1111/bph.12008; Yeung YT, 2012, J NEURO-ONCOL, V109, P35, DOI 10.1007/s11060-012-0875-7; Zhang WP, 2004, NEUROSCI LETT, V363, P247, DOI 10.1016/j.neulet.2004.03.088; Zhao JP, 2012, JPN J CLIN ONCOL, V42, P1060, DOI 10.1093/jjco/hys142; Zhou GX, 2015, ONCOL REP, V33, P661, DOI 10.3892/or.2014.3650	100	15	16	1	8	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	MAR	2018	38	2					559	573		10.1007/s10571-017-0507-z			15	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	FX4WL	WOS:000426079300016	28600709				2022-02-06	
J	Turkstra, LS; Norman, RS; Mutlu, B; Duff, MC				Turkstra, L. S.; Norman, R. S.; Mutlu, B.; Duff, M. C.			Impaired theory of mind in adults with traumatic brain injury: A replication and extension of findings	NEUROPSYCHOLOGIA			English	Article						Adult; Brain injuries; Cognition; Female; Theory of mind; Human	EMOTION RECOGNITION TASK; RADIAL-ARM MAZE; SOCIAL COGNITION; SEX-DIFFERENCES; NORMATIVE DATA; IMPAIRMENTS; DEFICITS; COMPREHENSION; EXPRESSIONS; PERSPECTIVE	Objective: To replicate a previous study of Theory of Mind (ToM) task performance in adults with traumatic brain injury (TBI) under different working memory (WM) demands, and determine if there are sex-based differences in effects of WM load on ToM task performance. Method: 58 adults with moderate-severe TBI (24 females) and 66 uninjured adults (34 females) matched group wise for age, sex, and education viewed a series of video vignettes from the Video Social Inference Task (VSIT) (Turkstra, 2008) and answered ToM questions. Vignette presentation format required updating and maintenance of information, and WM load was manipulated by varying presence of distracters. Results: There were main effects of group and WM load, no significant effect of sex, and a marginal interaction of group by WM load, with larger between-group differences in conditions with higher WM load. VSIT scores for the condition with the highest WM load were significantly correlated with scores on the first trial of the California Verbal Learning Test. Conclusions: We replicated findings of lower scores in adults with TBI on a video-based ToM task, and provided additional evidence of the effect of WM load on social cognition task performance. There were no significant accuracy differences between men and women, inconsistent with prior evidence including our own data using the same test. There is strong evidence of a female advantage on other social cognition tasks, and the parameters of this advantage remain to be discovered.	[Turkstra, L. S.; Norman, R. S.] Univ Wisconsin Madison, Dept Commun Sci & Disorders, Madison, WI USA; [Turkstra, L. S.] Univ Wisconsin Madison, Neurosci Training Program, Madison, WI USA; [Turkstra, L. S.] Univ Wisconsin Madison, Dept Surg, Madison, WI USA; [Mutlu, B.] Univ Wisconsin Madison, Dept Comp Sci, Madison, WI USA; [Duff, M. C.] Vanderbilt Univ, Dept Hearing & Speech Sci, 221 Kirkland Hall, Nashville, TN 37235 USA		Turkstra, LS (corresponding author), McMaster Univ, Sch Rehabil Sci, Inst Appl Hlth Sci, Room 403 G,1400 Main St West, Hamilton, ON L8S 1C7, Canada.	turkstrl@mcmaster.ca	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NIH NICHD/NCMRR awardUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD071089]; NIH/NIGMS award [R25GMO83252]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R25GM083252] Funding Source: NIH RePORTER	This work was supported by NIH NICHD/NCMRR award number R01 HD071089 and NIH/NIGMS award number R25GMO83252. The authors thank Dr. Erica Richmond, Eva Bernstein, and staff and students in the Turkstra and Duff labs for work on data collection and management, and Dr. Jee-Seon Kim for assistance with statistical analysis. The authors have no conflicts of interest to report.	Apperly IA, 2004, J COGNITIVE NEUROSCI, V16, P1773, DOI 10.1162/0898929042947928; Astur RS, 2004, BEHAV BRAIN RES, V151, P103, DOI 10.1016/j.bbr.2003.08.024; BARONCOHEN S, 1985, COGNITION, V21, P37, DOI 10.1016/0010-0277(85)90022-8; Bibby H, 2005, NEUROPSYCHOLOGIA, V43, P99, DOI 10.1016/j.neuropsychologia.2004.04.027; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Bradford EEF, 2015, COGNITION, V138, P21, DOI 10.1016/j.cognition.2015.02.001; Byom Lindsey J, 2013, Front Hum Neurosci, V7, P413, DOI 10.3389/fnhum.2013.00413; Carpenter P. A., 1989, COMPLEX INFORM PROCE, P31; Channon S, 2010, NEUROPSYCHOL REHABIL, V20, P739, DOI 10.1080/09602011003794583; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dennis M, 2013, DEV COGN NEUROS-NETH, V5, P25, DOI 10.1016/j.dcn.2012.11.006; Duff MC, 2012, SEMIN SPEECH LANG, V33, P44, DOI 10.1055/s-0031-1301162; Duran ND, 2011, COGNITION, V121, P22, DOI 10.1016/j.cognition.2011.06.009; Evans KL, 2015, BRAIN COGNITION, V93, P42, DOI 10.1016/j.bandc.2014.11.006; Flavell JH, 2004, MERRILL PALMER QUART, V50, P274, DOI 10.1353/mpq.2004.0018; FLAVELL JH, 1968, DEV ROLE TAKING COMM; Martin-Rodriguez JF, 2010, NEUROPSYCHOLOGIA, V48, P1181, DOI 10.1016/j.neuropsychologia.2010.02.009; Greenfield PM, 2003, ANNU REV PSYCHOL, V54, P461, DOI 10.1146/annurev.psych.54.101601.145221; Haut KM, 2006, NEUROIMAGE, V32, P411, DOI 10.1016/j.neuroimage.2006.01.044; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1623, DOI 10.1016/j.neuropsychologia.2006.03.020; Honan CA, 2015, BRAIN LANG, V150, P69, DOI 10.1016/j.bandl.2015.08.007; Kertesz A., 2006, W APHASIA BATTERY; Kessels RPC, 2014, J NEUROPSYCHOL, V8, P75, DOI 10.1111/jnp.12009; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; Martin I, 2005, APHASIOLOGY, V19, P712, DOI 10.1080/02687030500172203; Matsuoka K, 2012, BRAIN INJURY, V26, P1723, DOI 10.3109/02699052.2012.698789; McDonald S, 2005, J INT NEUROPSYCH SOC, V11, P392, DOI 10.1017/S1355617705050447; McDonald S, 2013, J INT NEUROPSYCH SOC, V19, P231, DOI 10.1017/S1355617712001506; Meulenbroek P, 2016, DISABIL REHABIL, V38, P452, DOI 10.3109/09638288.2015.1044621; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; Muller F, 2010, CORTEX, V46, P1088, DOI 10.1016/j.cortex.2009.08.014; Rahman Q, 2005, BRAIN COGNITION, V58, P312, DOI 10.1016/j.bandc.2005.03.001; Rahman Q, 2004, BRAIN COGNITION, V54, P179, DOI 10.1016/j.bandc.2004.01.002; Ratcliff JJ, 2007, BRAIN INJURY, V21, P1023, DOI 10.1080/02699050701633072; Rigon A, 2016, COGN AFFECT BEHAV NE, V16, P866, DOI 10.3758/s13415-016-0437-0; Rollins, 1998, AWARENESS SOCIAL INF; Russell TA, 2012, COG EMOT, V21, P1554; Rutherford HJV, 2012, PERSONAL DISORD, V3, P393, DOI 10.1037/a0028938; Sabers DL, 1996, LANG SPEECH HEAR SER, V27, P102, DOI 10.1044/0161-1461.2702.102; Schilbach L, 2013, BEHAV BRAIN SCI, V36, P393, DOI 10.1017/S0140525X12000660; Spikman JM, 2013, NEUROPSYCHOL REHABIL, V23, P824, DOI 10.1080/09602011.2013.826138; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Spikman JM, 2012, J NEUROTRAUM, V29, P101, DOI 10.1089/neu.2011.2084; Taylor SJ, 2013, DEV PSYCHOL, V49, P1253, DOI 10.1037/a0029871; Tombaugh TN, 2004, ARCH CLIN NEUROPSYCH, V19, P203, DOI 10.1016/S0887-6177(03)00039-8; Turkstra L, 2005, J MED SPEECH-LANG PA, V13, pIX; Turkstra LS, 2001, J HEAD TRAUMA REHAB, V16, P469, DOI 10.1097/00001199-200110000-00006; Turkstra LS, 2000, APHASIOLOGY, V14, P349, DOI 10.1080/026870300401405; Turkstra LS, 2008, BRAIN INJURY, V22, P397, DOI 10.1080/02699050802027059; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Wechsler D., 2008, WECHSLER ADULT INTEL; Wilde EA, 2010, ARCH PHYS MED REHAB, V91, P1650, DOI 10.1016/j.apmr.2010.06.033; YLVISAKER M, 1989, TOP LANG DISORD, V9, P34, DOI 10.1097/00011363-198903000-00005; Zhang D., 2015, NEUROPSYCHOL REHABIL, P1, DOI DOI 10.1007/978-94-017-9753-5_1	54	15	15	0	6	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3932	1873-3514		NEUROPSYCHOLOGIA	Neuropsychologia	MAR	2018	111						117	122		10.1016/j.neuropsychologia.2018.01.016			6	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	GD6UQ	WOS:000430644300015	29366949	Green Accepted, Bronze			2022-02-06	
J	Yang, ZH; Bramlett, HM; Moghieb, A; Yu, DN; Wang, P; Lin, F; Bauer, C; Selig, TM; Jaalouk, E; Weissman, AS; Rathore, DS; Romo, P; Zhang, ZQ; Hayes, RL; Wang, MY; Dietrich, WD; Wang, KKW				Yang, Zhihui; Bramlett, Helen M.; Moghieb, Ahmed; Yu, Dongnan; Wang, Ping; Lin, Fan; Bauer, Carl; Selig, Tyler M.; Jaalouk, Emily; Weissman, Amanda S.; Rathore, Disa S.; Romo, Pammela; Zhang, Zhiqun; Hayes, Ronald L.; Wang, Michael Y.; Dietrich, W. Dalton; Wang, Kevin K. W.			Temporal Profile and Severity Correlation of a Panel of Rat Spinal Cord Injury Protein Biomarkers	MOLECULAR NEUROBIOLOGY			English	Article						Spinal cord injury; Biomarkers; Neuronal injury; Glial injury; Systems biology	TRAUMATIC AXONAL INJURY; BRAIN-INJURY; CEREBROSPINAL-FLUID; PLASMA; INTERLEUKIN-6; CALPAIN; ALPHA; SERUM	In the USA, there are approximately 12,000 new cases of spinal cord injury (SCI) each year and some 1.2 million people living with paralysis due to SCI. Seven percent of them are paralyzed due to an accident or injury occurring while serving in the military. Here, we report a systematic study on protein biomarker candidates in a rat SCI model with either moderate or severe injury. Tissue, cerebrospinal fluid (CSF), and serum samples were obtained at 4 h, 24 h, and 7 days post-injury. The candidate biomarkers included axonal injury markers alpha II-spectrin breakdown products (SBDP150/145/120), neuronal cell body injury marker ubiquitin C-terminal hydrolase-L1 (UCH-L1), astrogliosis/astroglial injury markers S100 calcium-binding protein-beta (S100 beta), glial fibrillary acidic protein (GFAP) and GFAP breakdown products (GBDPs), demyelination marker myelin basic protein (MBP), axonal injury marker phosphorylated neurofilament-H (pNF-H), and neuroinflammation marker interleukin-6 (IL-6). SBDP150/145, UCH-L1, GFAP, and S100 beta were found as acute biomarkers with significantly elevated levels within 24 h. GBDP44, GBDP38, and pNF-H are acute and subacute biomarkers that were found to have increased at 4 h, 24 h, and 7 days. MBP and SBDP120 were considered subacute biomarkers which were only detectable at 7 days post-injury. These results not only allow us to gain important insight into the patho-mechanisms of SCI but also showcase the possibility of using some of the protein biomarkers to track injury severity and disease progression and resolution. These biomarkers can potentially serve as tools that assist therapy development and clinical trials.	[Yang, Zhihui; Yu, Dongnan; Wang, Ping; Lin, Fan; Bauer, Carl; Selig, Tyler M.; Jaalouk, Emily; Weissman, Amanda S.; Rathore, Disa S.; Romo, Pammela; Zhang, Zhiqun; Wang, Kevin K. W.] Program Neurotrauma Neuroprote & Biomarkers Res, Dept Psychiat, Gainesville, FL 32611 USA; [Yang, Zhihui; Yu, Dongnan; Wang, Ping; Lin, Fan; Bauer, Carl; Selig, Tyler M.; Jaalouk, Emily; Weissman, Amanda S.; Rathore, Disa S.; Romo, Pammela; Zhang, Zhiqun; Wang, Kevin K. W.] Program Neurotrauma Neuroprote & Biomarkers Res, Dept Neurosci, Gainesville, FL 32611 USA; [Bramlett, Helen M.; Wang, Michael Y.; Dietrich, W. Dalton] Univ Miami, Leonard M Miller Sch Med, Miami, FL 33136 USA; [Bramlett, Helen M.] Vet Affairs Med Ctr, Bruce W Carter Dept, Miami, FL 33125 USA; [Moghieb, Ahmed; Wang, Kevin K. W.] Univ Florida, Physiol Sci & Chem, Gainesville, FL 32611 USA; [Yu, Dongnan] Guangdong Gen Hosp, Guangzhou 510080, Guangdong, Peoples R China; [Wang, Ping] Wenzhou Med Univ, Sch Pharmaceut Sci, Wenzhou 325027, Zhejiang, Peoples R China; [Hayes, Ronald L.] Banyan Biomarkers Inc, Alachua, FL 32615 USA		Yang, ZH; Wang, KKW (corresponding author), Program Neurotrauma Neuroprote & Biomarkers Res, Dept Psychiat, Gainesville, FL 32611 USA.; Yang, ZH; Wang, KKW (corresponding author), Program Neurotrauma Neuroprote & Biomarkers Res, Dept Neurosci, Gainesville, FL 32611 USA.; Wang, KKW (corresponding author), Univ Florida, Physiol Sci & Chem, Gainesville, FL 32611 USA.	zhihuiyang@ufl.edu; kwang@ufl.edu		Wang, Kevin/0000-0002-9343-6473; Weissman, Amanda/0000-0002-5873-1995	DOD grants from the US Army [W81XWH-12-1-0276, W81XWH-12-1-0277]	This study is supported in part by the DOD grants W81XWH-12-1-0276 (WDD, MSW) and W81XWH-12-1-0277 (KKW) from the US Army.	Basu S, 2004, J ANDROL, V25, P250; Biglari B, 2015, SPINAL CORD, V53, P510, DOI 10.1038/sc.2015.28; Chatzipanteli K, 2012, THER HYPOTHERMIA TEM, V2, P167, DOI 10.1089/ther.2012.0016; Hajdukova L, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/379071; Huh JW, 2006, DEV NEUROSCI-BASEL, V28, P466, DOI 10.1159/000094172; Johnsson P, 2000, ANN THORAC SURG, V69, P750, DOI 10.1016/S0003-4975(99)01393-4; Kato S, 2015, J CLIN NEUROSCI, V22, P1638, DOI 10.1016/j.jocn.2015.03.047; Kinoshita T, 2013, SPINAL CORD, V51, P508, DOI 10.1038/sc.2013.4; Kwon BK, 2011, CLIN CHEM LAB MED, V49, P425, DOI 10.1515/CCLM.2011.068; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Merisson E, 2016, NEUROCHEM INT, V93, P1, DOI 10.1016/j.neuint.2015.12.003; Mondello S, 2016, J NEUROTRAUM, V33, P595, DOI 10.1089/neu.2015.4132; Mondello S, 2010, J NEUROTRAUM, V27, P1203, DOI 10.1089/neu.2010.1278; Puentes F, 2014, J NEUROL NEUROSUR PS, V85, P274, DOI [10.1136/jnnp-2013-305494, 10.1136/jnnp-2013-307454]; Serbest G, 2007, NEUROCHEM RES, V32, P2006, DOI 10.1007/s11064-007-9318-9; Wang KKW, 2000, TRENDS NEUROSCI, V23, P20, DOI 10.1016/S0166-2236(99)01479-4; Wolf H, 2014, SPINE J, V14, P2918, DOI 10.1016/j.spinee.2014.04.027; Yang ZH, 2015, TRENDS NEUROSCI, V38, P364, DOI 10.1016/j.tins.2015.04.003; Yokobori S, 2015, WORLD NEUROSURG, V83, P867, DOI 10.1016/j.wneu.2013.03.012; Zhang ZQ, 2009, APOPTOSIS, V14, P1289, DOI 10.1007/s10495-009-0405-z	20	15	15	1	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	MAR	2018	55	3					2174	2184		10.1007/s12035-017-0424-7			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY5TG	WOS:000426897800029	28290147				2022-02-06	
J	Lipponen, A; El-Osta, A; Kaspi, A; Ziemann, M; Khurana, I; Harikrishnan, KN; Navarro-Ferrandis, V; Puhakka, N; Paananen, J; Pitkanen, A				Lipponen, Anssi; El-Osta, Assam; Kaspi, Antony; Ziemann, Mark; Khurana, Ishant; Harikrishnan, K. N.; Navarro-Ferrandis, Vicente; Puhakka, Noora; Paananen, Jussi; Pitkanen, Asla			Transcription factors Tp73, Cebpd, Pax6, and Spi1 rather than DNA methylation regulate chronic transcriptomics changes after experimental traumatic brain injury	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article						DNA methylation; LINCS analysis; MBD-seq; Recovery; RNA-seq; Treatment	HISTONE DEACETYLASE INHIBITOR; ACTIVATED PROTEIN-KINASE; CLOSED-HEAD INJURY; GENE-EXPRESSION; MICROGLIAL ACTIVATION; CANNABINOID RECEPTOR; CEREBRAL-CORTEX; MESSENGER-RNA; IN-VITRO; CORTICAL IMPACT	Traumatic brain injury (TBI) induces a wide variety of cellular and molecular changes that can continue for days to weeks to months, leading to functional impairments. Currently, there are no pharmacotherapies in clinical use that favorably modify the post-TBI outcome, due in part to limited understanding of the mechanisms of TBI-induced pathologies. Our system biology analysis tested the hypothesis that chronic transcriptomics changes induced by TBI are controlled by altered DNA-methylation in gene promoter areas or by transcription factors. We performed genome-wide methyl binding domain (MBD)-sequencing (seq) and RNA-seq in perilesional, thalamic, and hippocampal tissue sampled at 3 months after TBI induced by lateral fluid percussion in adult male Sprague-Dawley rats. We investigated the regulated molecular networks and mechanisms underlying the chronic regulation, particularly DNA methylation and transcription factors. Finally, we identified compounds that modulate the transcriptomics changes and could be repurposed to improve recovery. Unexpectedly, DNA methylation was not a major regulator of chronic post-TBI transcriptomics changes. On the other hand, the transcription factors Cebpd, Pax6, Spi1, and Tp73 were upregulated at 3 months after TBI (False discovery rate < 0.05), which was validated using digital droplet polymerase chain reaction. Transcription regulatory network analysis revealed that these transcription factors regulate apoptosis, inflammation, and microglia, which are well-known contributors to secondary damage after TBI. Library of Integrated Network-based Cellular Signatures (LINCS) analysis identified 118 pharmacotherapies that regulate the expression of Cebpd, Pax6, Spi1, and Tp73. Of these, the antidepressant and/or antipsychotic compounds trimipramine, rolipramine, fluspirilene, and chlorpromazine, as well as the anti-cancer therapies pimasertib, tamoxifen, and vorinostat were strong regulators of the identified transcription factors, suggesting their potential to modulate the regulated transcriptomics networks to improve post-TBI recovery.	[Lipponen, Anssi; Navarro-Ferrandis, Vicente; Puhakka, Noora; Pitkanen, Asla] Univ Eastern Finland, AI Virtanen Inst Mol Sci, Epilepsy Res Lab, POB 1627, FIN-70211 Kuopio, Finland; [El-Osta, Assam; Kaspi, Antony; Ziemann, Mark; Khurana, Ishant; Harikrishnan, K. N.] Monash Univ, Fac Med, Cent Clin Sch, Epigenet Human Hlth & Dis Lab, Melbourne, Vic, Australia; [El-Osta, Assam] Chinese Univ Hong Kong, Prince Wales Hosp, Sha Tin, Hong Kong, Peoples R China; [Paananen, Jussi] Univ Eastern Finland, Inst Biomed, Kuopio, Finland; [Paananen, Jussi] Univ Eastern Finland, Bioinformat Ctr, Kuopio, Finland		Pitkanen, A (corresponding author), Univ Eastern Finland, AI Virtanen Inst Mol Sci, Epilepsy Res Lab, POB 1627, FIN-70211 Kuopio, Finland.	asla.pitkanen@uef.fi		Khurana, Ishant/0000-0001-9050-2749; El-Osta, Assam/0000-0001-7968-7375; El-Osta, Assam/0000-0003-2969-9137; Lipponen, Anssi/0000-0002-4403-9084; Ziemann, Mark/0000-0002-7688-6974; Kaspi, Antony/0000-0001-6576-5862	Academy of FinlandAcademy of FinlandEuropean Commission; EpiGENet EUROEPINOMICS; FP7-HEALTH project [602102]	This study was supported by the Academy of Finland (A.P.), EpiGENet EUROEPINOMICS (A.P.), and FP7-HEALTH project 602102 (EPITARGET)(AP).	Abbruscato TJ, 1999, J PHARMACOL EXP THER, V289, P668; Amenta PS, 2014, J NEUROINFLAMM, V11, DOI 10.1186/s12974-014-0191-6; Andrews S., 2010, BABRAHAM BIOINFORMAT; Aras AB, 2015, INFLAMMATION, V38, P1311, DOI 10.1007/s10753-014-0102-0; Arcaro A, 1993, BIOCHEM J, V296, P279; Atmaca A, 2007, BRIT J CANCER, V97, P177, DOI 10.1038/sj.bjc.6603851; Lopez-Rodriguez AB, 2016, EXP NEUROL, V279, P274, DOI 10.1016/j.expneurol.2016.03.018; Bramlett HM, 1997, ACTA NEUROPATHOL, V93, P190, DOI 10.1007/s004010050602; Brunn GJ, 1996, EMBO J, V15, P5256, DOI 10.1002/j.1460-2075.1996.tb00911.x; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Cai LP, 2017, MOL NEUROBIOL, V54, P1263, DOI 10.1007/s12035-016-9695-7; CAPDEVILA J, 1988, ARCH BIOCHEM BIOPHYS, V261, P257, DOI 10.1016/0003-9861(88)90340-2; Castellino RC, 2007, BMC CANCER, V7, DOI 10.1186/1471-2407-7-127; CHERAMY A, 1970, EUR J PHARMACOL, V10, P206, DOI 10.1016/0014-2999(70)90274-8; Chiu CC, 2016, J NEUROSCI METH, V272, P38, DOI 10.1016/j.jneumeth.2016.06.018; Colak T, 2012, INJURY, V43, P1264, DOI 10.1016/j.injury.2012.01.021; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crack P, 2009, J NEURAL TRANSM, V116, P1, DOI 10.1007/s00702-008-0145-1; Crawford F, 2009, NEUROSCIENCE, V159, P1349, DOI 10.1016/j.neuroscience.2009.01.033; Dash PK, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011383; De Jager PL, 2014, NAT NEUROSCI, V17, P1156, DOI 10.1038/nn.3786; Debski KJ, 2016, SCI REP-UK, V6, DOI 10.1038/srep25668; Diamond M, 2006, EUR NEUROPSYCHOPHARM, V16, P481, DOI 10.1016/j.euroneuro.2005.11.011; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; Dixon RA, 2002, PHYTOCHEMISTRY, V60, P205, DOI 10.1016/S0031-9422(02)00116-4; Dobin A, 2013, BIOINFORMATICS, V29, P15, DOI 10.1093/bioinformatics/bts635; Dougall D, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD009221.pub2; Edgar R, 2002, NUCLEIC ACIDS RES, V30, P207, DOI 10.1093/nar/30.1.207; Farrokhnia N, 2008, EUR J CLIN INVEST, V38, P679, DOI 10.1111/j.1365-2362.2008.01990.x; Faul M, 2010, TRAUMATIC BRAIN INJU; Fava M, 2000, NEURON, V28, P335, DOI 10.1016/S0896-6273(00)00112-4; Favata MF, 1998, J BIOL CHEM, V273, P18623, DOI 10.1074/jbc.273.29.18623; Fazekas D, 2013, BMC SYST BIOL, V7, DOI 10.1186/1752-0509-7-7; Figueroa-Romero C, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0052672; Fisher B, 1998, J NATL CANCER I, V90, P1371, DOI 10.1093/jnci/90.18.1371; Frieling H, 2006, EUR ARCH PSY CLIN N, V256, P268, DOI 10.1007/s00406-006-0660-8; Gentleman SM, 2004, FORENSIC SCI INT, V146, P97, DOI 10.1016/j.forsciint.2004.06.027; GLASER T, 1994, NAT GENET, V7, P463, DOI 10.1038/ng0894-463; Goodman JC, 2008, ACTA NEUROCHIR SUPPL, V102, P389, DOI 10.1007/978-3-211-85578-2_75; Haghighi F, 2015, J NEUROTRAUM, V32, P1200, DOI 10.1089/neu.2014.3640; Hamalainen M, 2008, PULM PHARMACOL THER, V21, P331, DOI 10.1016/j.pupt.2007.08.003; Han JW, 2000, CANCER RES, V60, P6068; Hellmich HL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053230; HONG SL, 1980, J BIOL CHEM, V255, P9538; Huang W, 1999, EUR J PHARMACOL, V366, P127, DOI 10.1016/S0014-2999(98)00929-7; Im JY, 2008, CHEM-BIOL INTERACT, V172, P235, DOI 10.1016/j.cbi.2008.01.007; Immonen RJ, 2009, EXP NEUROL, V215, P29, DOI 10.1016/j.expneurol.2008.09.009; Ishikawa Y, 2006, ACTA NEUROCHIR SUPPL, V96, P163; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Johnson V.E., 2017, ADVANCES IN NEUROBIO, V15; Jost CA, 1997, NATURE, V389, P191, DOI 10.1038/38298; Jowaed A, 2010, J NEUROSCI, V30, P6355, DOI 10.1523/JNEUROSCI.6119-09.2010; Kang YJ, 2011, J NAT PROD, V74, P701, DOI 10.1021/np1007735; KATO H, 1995, EUR J PHARMACOL, V272, P107, DOI 10.1016/0014-2999(94)00694-3; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Kim HJ, 2007, J PHARMACOL EXP THER, V321, P892, DOI 10.1124/jpet.107.120188; Kim K, 2010, BRIT J HAEMATOL, V149, P537, DOI 10.1111/j.1365-2141.2010.08127.x; KINOSHITA S, 1992, P NATL ACAD SCI USA, V89, P1473, DOI 10.1073/pnas.89.4.1473; Kline AE, 2000, NEUROSCI LETT, V280, P163, DOI 10.1016/S0304-3940(00)00797-7; Kobori N, 2002, MOL BRAIN RES, V104, P148, DOI 10.1016/S0169-328X(02)00331-5; Korcsmaros T, 2010, BIOINFORMATICS, V26, P2042, DOI 10.1093/bioinformatics/btq310; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; Kraft P, 2013, EXP NEUROL, V247, P80, DOI 10.1016/j.expneurol.2013.03.026; Kukacka J, 2006, NEUROENDOCRINOL LETT, V27, P116; Laing AJ, 2007, J ORTHOP RES, V25, P44, DOI 10.1002/jor.20228; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee AF, 2004, J NEUROSCI, V24, P9174, DOI 10.1523/JNEUROSCI.1588-04.2004; Lee B, 2009, PHARMACOL BIOCHEM BE, V93, P121, DOI 10.1016/j.pbb.2009.04.021; Li HJ, 2014, EUR J PHARMACOL, V735, P38, DOI 10.1016/j.ejphar.2014.04.017; Lipponen A, 2016, SCI REP-UK, V6, DOI 10.1038/srep31570; Logan TT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059250; Love MI, 2014, GENOME BIOL, V15, DOI 10.1186/s13059-014-0550-8; Lu K, 2007, J THORAC CARDIOV SUR, V133, P934, DOI 10.1016/j.jtcvs.2006.11.038; Maas AIR, 2015, NEUROSURGERY, V76, P67, DOI 10.1227/NEU.0000000000000575; Madathil S. K., 2015, BRAIN NEUROTRAUMA MO; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marks PA, 2007, NAT BIOTECHNOL, V25, P84, DOI 10.1038/nbt1272; Matzilevich DA, 2002, J NEUROSCI RES, V67, P646, DOI 10.1002/jnr.10157; McDonald SJ, 2016, J NEUROINFLAMM, V13, DOI 10.1186/s12974-016-0555-1; McGinn Melissa J, 2015, Handb Clin Neurol, V127, P67, DOI 10.1016/B978-0-444-52892-6.00005-2; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; McKercher SR, 1996, EMBO J, V15, P5647, DOI 10.1002/j.1460-2075.1996.tb00949.x; Meng QY, 2017, EBIOMEDICINE, V16, P184, DOI 10.1016/j.ebiom.2017.01.046; MERRITT JE, 1990, BIOCHEM J, V271, P515, DOI 10.1042/bj2710515; Michael DB, 2005, J CLIN NEUROSCI, V12, P284, DOI 10.1016/j.jocn.2004.11.003; Moll UM, 2001, BBA-REV CANCER, V1552, P47, DOI 10.1016/S0304-419X(01)00036-1; Mori T, 2002, J NEUROTRAUM, V19, P1411, DOI 10.1089/089771502320914642; Nakatomi H, 2002, CELL, V110, P429, DOI 10.1016/S0092-8674(02)00862-0; Offertaler L, 2003, MOL PHARMACOL, V63, P699, DOI 10.1124/mol.63.3.699; Pena-Llopis S, 2013, NAT PROTOC, V8, P2240, DOI 10.1038/nprot.2013.141; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Pitkanen A, 2014, NEUROTHERAPEUTICS, V11, P286, DOI 10.1007/s13311-014-0260-7; Polkowski K, 2000, Acta Pol Pharm, V57, P135; Pozniak CD, 2000, SCIENCE, V289, P304, DOI 10.1126/science.289.5477.304; Pozniak CD, 2002, J NEUROSCI, V22, P9800; Puche JE, 2016, BIOFACTORS, V42, P60, DOI 10.1002/biof.1255; Rall JM, 2003, NEUROPATH APPL NEURO, V29, P118, DOI 10.1046/j.1365-2990.2003.00439.x; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Risling M, 2011, NEUROIMAGE, V54, pS89, DOI 10.1016/j.neuroimage.2010.05.031; Rosa A, 2007, P NATL ACAD SCI USA, V104, P19849, DOI 10.1073/pnas.0706963104; Roy SK, 2000, J BIOL CHEM, V275, P12626, DOI 10.1074/jbc.275.17.12626; Sagarkar S, 2017, NEUROBIOL DIS, V106, P101, DOI 10.1016/j.nbd.2017.06.016; SALZMANN MM, 1965, BRIT J PSYCHIAT, V111, P1105, DOI 10.1192/bjp.111.480.1105; Samal BB, 2015, J MOL NEUROSCI, V57, P282, DOI 10.1007/s12031-015-0626-2; Sandhir R, 2010, NEUROCHEM INT, V56, P188, DOI 10.1016/j.neuint.2009.10.002; Schober ME, 2012, J NEUROTRAUM, V29, P2075, DOI 10.1089/neu.2011.2276; Scholar EM, 2015, XPHARM COMPREHENSIVE; Shannon P, 2003, GENOME RES, V13, P2498, DOI 10.1101/gr.1239303; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; Simon DW, 2017, NAT REV NEUROL, V13, P171, DOI 10.1038/nrneurol.2017.13; Smith AM, 2013, GLIA, V61, P929, DOI 10.1002/glia.22486; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Soltani Z, 2015, PHYSIOL BEHAV, V152, P26, DOI 10.1016/j.physbeh.2015.08.037; SOMMER N, 1995, NAT MED, V1, P244, DOI 10.1038/nm0395-244; Statham AL, 2010, BIOINFORMATICS, V26, P1662, DOI 10.1093/bioinformatics/btq247; Subramanian A, 2005, P NATL ACAD SCI USA, V102, P15545, DOI 10.1073/pnas.0506580102; Sukumari-Ramesh S, 2016, TRANSL STROKE RES, V7, P141, DOI 10.1007/s12975-015-0421-y; Sy LK, 2008, CANCER RES, V68, P10229, DOI 10.1158/0008-5472.CAN-08-1983; Thomas MG, 2016, CNS NEUROL DISORD-DR, V15, P73, DOI 10.2174/1871527314666150821101757; Tien LT, 2017, DEV NEUROSCI-BASEL, V39, P443, DOI 10.1159/000477898; Tsai YT, 2014, J SURG RES, V189, P106, DOI 10.1016/j.jss.2014.02.009; Valiyaveettil M, 2013, CHEM-BIOL INTERACT, V203, P371, DOI 10.1016/j.cbi.2012.10.022; von Gertten C, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-69; Vonder Haar C, 2014, J NEUROTRAUM, V31, P961, DOI 10.1089/neu.2013.3119; Walton MR, 2000, J NEUROIMMUNOL, V104, P109, DOI 10.1016/S0165-5728(99)00262-3; Wang L, 2016, J MOL NEUROSCI, V59, P68, DOI 10.1007/s12031-016-0735-6; White TE, 2016, BMC GENOMICS, V17, DOI 10.1186/s12864-016-2412-0; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wong YH, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17020216; Wu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021966; Xuan AG, 2012, LIFE SCI, V90, P463, DOI 10.1016/j.lfs.2012.01.001; YANG K, 1994, BRAIN RES, V664, P141, DOI 10.1016/0006-8993(94)91964-X; YONEDA T, 1991, CANCER RES, V51, P4430; Zakrzeska A, 2010, BRIT J PHARMACOL, V160, P574, DOI 10.1111/j.1476-5381.2009.00579.x; Zhang XY, 2014, GENET MOL RES, V13, P9220, DOI 10.4238/2014.November.7.9	135	15	15	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	FEB 27	2018	6								17	10.1186/s40478-018-0519-z			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FY2QL	WOS:000426660400001	29482641	Green Published, gold			2022-02-06	
J	Taghdiri, F; Chung, J; Irwin, S; Multani, N; Tarazi, A; Ebraheem, A; Khodadadi, M; Goswami, R; Wennberg, R; Mikulis, D; Green, R; Davis, K; Tator, C; Eizenman, M; Tartaglia, MC				Taghdiri, Foad; Chung, Jonathan; Irwin, Samantha; Multani, Namita; Tarazi, Apameh; Ebraheem, Ahmed; Khodadadi, Mozghan; Goswami, Ruma; Wennberg, Richard; Mikulis, David; Green, Robin; Davis, Karen; Tator, Charles; Eizenman, Moshe; Tartaglia, Maria Carmela			Decreased Number of Self-Paced Saccades in Post-Concussion Syndrome Associated with Higher Symptom Burden and Reduced White Matter Integrity	JOURNAL OF NEUROTRAUMA			English	Article						concussion; oculomotor function; post-concussion syndrome; saccades; white matter	TRAUMATIC BRAIN-INJURY; TRANSCRANIAL MAGNETIC STIMULATION; ANTERIOR CINGULATE CORTEX; SPORT-RELATED CONCUSSION; MEMORY-GUIDED SACCADES; TENSOR IMAGING DETECTS; PREFRONTAL CORTEX; POSTCONCUSSION SYNDROME; EYE-MOVEMENTS; HEMISPHERIC-ASYMMETRY	The aim of this study was to examine the potential utility of a self-paced saccadic eye movement as a marker of post-concussion syndrome (PCS) and monitoring the recovery from PCS. Fifty-nine persistently symptomatic participants with at least two concussions performed the self-paced saccade (SPS) task. We evaluated the relationships between the number of SPSs and 1) number of self-reported concussion symptoms, and 2) integrity of major white matter (WM) tracts (as measured by fractional anisotropy [FA] and mean diffusivity) that are directly or indirectly involved in saccadic eye movements and often affected by concussion. These tracts included the uncinate fasciculus (UF), cingulum (Cg) and its three subcomponents (subgenual, retrosplenial, and parahippocampal), superior longitudinal fasciculus, and corpus callosum. Mediation analyses were carried out to examine whether specific WM tracts (left UF and left subgenual Cg) mediated the relationship between the number of SPSs and 1) interval from last concussion or 2) total number of self-reported symptoms. The number of SPSs was negatively correlated with the total number of self-reported symptoms (r=-0.419, p=0.026). The number of SPSs were positively correlated with FA of left UF and left Cg (r=0.421, p=0.013 and r=0.452, p=0.008; respectively). FA of the subgenual subcomponent of the left Cg partially mediated the relationship between the total number of symptoms and the number of SPSs, while FA of the left UF mediated the relationship between interval from last concussion and the number of SPSs. In conclusion, SPS testing as a fast and objective assessment may reflect symptom burden in patients with PCS. In addition, since the number of SPSs is associated with the integrity of some WM tracts, it may be useful as a diagnostic biomarker in patients with PCS.	[Taghdiri, Foad; Multani, Namita; Tartaglia, Maria Carmela] Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 60 Leonard Ave, Toronto, ON M5T 2S8, Canada; [Taghdiri, Foad; Mikulis, David; Green, Robin; Davis, Karen; Tator, Charles; Tartaglia, Maria Carmela] Univ Toronto, Inst Med Sci, Toronto, ON, Canada; [Chung, Jonathan; Eizenman, Moshe] Univ Toronto, Dept Elect & Comp Engn, Toronto, ON, Canada; [Irwin, Samantha] Univ Toronto, Dept Rehabil Sci, Toronto, ON, Canada; [Tarazi, Apameh; Wennberg, Richard; Tartaglia, Maria Carmela] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Tarazi, Apameh; Ebraheem, Ahmed; Khodadadi, Mozghan; Goswami, Ruma; Wennberg, Richard; Mikulis, David; Green, Robin; Davis, Karen; Tator, Charles; Tartaglia, Maria Carmela] Univ Toronto, Dept Ophthalmol, Toronto, ON, Canada; [Goswami, Ruma; Davis, Karen; Tator, Charles; Tartaglia, Maria Carmela] Univ Toronto, Inst Biomat & Biomed Engn, Toronto, ON, Canada; [Mikulis, David] Hosp Sick Children, Dept Neurol, Toronto, ON, Canada; [Green, Robin] Toronto Western Hosp, Krembil Neurosci Ctr, Div Neurol, Toronto, ON, Canada; [Tator, Charles] Toronto Western Hosp, Krembil Neurosci Ctr, Canadian Concuss Ctr, Toronto, ON, Canada; [Davis, Karen] Toronto Western Hosp, Krembil Neurosci Ctr, Div Neurosurg, Toronto, ON, Canada; [Eizenman, Moshe] Univ Hlth Network, Krembil Res Inst, Toronto, ON, Canada; [Eizenman, Moshe] Univ Hlth Network, Joint Dept Med Imaging, Div Neuroradiol, Toronto, ON, Canada		Tartaglia, MC (corresponding author), Univ Toronto, Tanz Ctr Res Neurodegenerat Dis, 60 Leonard Ave, Toronto, ON M5T 2S8, Canada.	foad.taghdiri@mail.utoronto.ca	Mikulis, David J/H-5167-2019; Irwin, Samantha/X-1705-2019	Irwin, Samantha/0000-0002-6564-7986; Green, Robin/0000-0001-9451-3963; Taghdiri, Foad/0000-0002-3280-2804; Mikulis, David/0000-0003-3956-0892			Abel LA, 2009, NEUROLOGY, V72, P1083, DOI 10.1212/01.wnl.0000345040.01917.9d; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Asken B.M., 2017, BRAIN IMAGING BEHAV; Bartnik-Olson BL, 2014, J NEUROTRAUM, V31, P1497, DOI 10.1089/neu.2013.3213; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Behrens TEJ, 2007, NEUROIMAGE, V34, P144, DOI 10.1016/j.neuroimage.2006.09.018; Bennett IJ, 2012, NEUROBIOL AGING, V33, DOI 10.1016/j.neurobiolaging.2011.02.001; Bhatia KD, 2012, STEREOT FUNCT NEUROS, V90, P225, DOI 10.1159/000338083; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Browning PGF, 2008, J NEUROSCI, V28, P3934, DOI 10.1523/JNEUROSCI.0633-08.2008; Bussey TJ, 2002, BEHAV NEUROSCI, V116, P703, DOI 10.1037//0735-7044.116.4.703; Camilleri JA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00219; Chung J., 2014, INT J APPL MATH ELEC, V2, P45; Cifu DX, 2015, J HEAD TRAUMA REHAB, V30, P21, DOI 10.1097/HTR.0000000000000036; Collie A, 2003, BRIT J SPORT MED, V37, P556, DOI 10.1136/bjsm.37.6.556; Collie A, 2001, BRIT J SPORT MED, V35, P297, DOI 10.1136/bjsm.35.5.297; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; D'souza Maria M, 2015, Indian J Radiol Imaging, V25, P404, DOI 10.4103/0971-3026.169445; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Descoteaux M, 2009, IEEE T MED IMAGING, V28, P269, DOI 10.1109/TMI.2008.2004424; DOMESICK VB, 1970, BRAIN RES, V20, P19, DOI 10.1016/0006-8993(70)90150-2; Dyrby TB, 2007, NEUROIMAGE, V37, P1267, DOI 10.1016/j.neuroimage.2007.06.022; Echemendia RJ, 2017, BRIT J SPORT MED, V51, P848, DOI 10.1136/bjsports-2017-097506; Ettenhofer ML, 2016, J NEUROPSYCH CLIN N, V28, P223, DOI 10.1176/appi.neuropsych.15100243; Galantucci S, 2011, BRAIN, V134, P3011, DOI 10.1093/brain/awr099; Gardner A, 2012, J NEUROTRAUM, V29, P2521, DOI 10.1089/neu.2012.2628; Gardner RC, 2015, MOL CELL NEUROSCI, V66, P75, DOI 10.1016/j.mcn.2015.03.001; Gaymard B, 1998, EXP BRAIN RES, V120, P173, DOI 10.1007/s002210050391; GAYMARD B, 1993, ANN NEUROL, V34, P404, DOI 10.1002/ana.410340317; Glasser MF, 2008, CEREB CORTEX, V18, P2471, DOI 10.1093/cercor/bhn011; GOLDMANRAKIC PS, 1984, NEUROSCIENCE, V12, P719, DOI 10.1016/0306-4522(84)90166-0; Gong GL, 2005, HUM BRAIN MAPP, V24, P92, DOI 10.1002/hbm.20072; Goodrich GL, 2013, OPTOMETRY VISION SCI, V90, P105, DOI 10.1097/OPX.0b013e31827f15a1; Goswami R, 2016, BRAIN STRUCT FUNCT, V221, P1911, DOI 10.1007/s00429-015-1012-0; Guestrin ED, 2006, IEEE T BIO-MED ENG, V53, P1124, DOI 10.1109/TBME.2005.863952; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hayes, 2018, INTRO MEDIATION MODE; Hayes AF, 2009, COMMUN MONOGR, V76, P408, DOI 10.1080/03637750903310360; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hiploylee C, 2017, J NEUROTRAUM, V34, P1511, DOI 10.1089/neu.2016.4677; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Jones DK, 2013, NEUROPSYCHOLOGIA, V51, P67, DOI 10.1016/j.neuropsychologia.2012.11.018; Keedwell PA, 2016, CEREB CORTEX, V26, P2850, DOI 10.1093/cercor/bhw030; Khong E, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00156; Kortte Kathleen Bechtold, 2002, Appl Neuropsychol, V9, P106, DOI 10.1207/S15324826AN0902_5; LARRABEE GJ, 1986, INT J NEUROSCI, V30, P11, DOI 10.3109/00207458608985649; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Lezak M. D., 2004, NEUROPSYCHOLOGICAL A; Lovell Mark R, 2002, Curr Sports Med Rep, V1, P7; Maruta J., 2016, FRONT HUM NEUROSCI, P10; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McDowell JE, 2008, BRAIN COGNITION, V68, P255, DOI 10.1016/j.bandc.2008.08.016; Messe A, 2012, BRAIN IMAGING BEHAV, V6, P283, DOI 10.1007/s11682-012-9159-2; Miyauchi S, 2009, EXP BRAIN RES, V192, P657, DOI 10.1007/s00221-008-1579-2; Muri RM, 2008, BRAIN COGNITION, V68, P284, DOI 10.1016/j.bandc.2008.08.018; Muri RM, 1996, J NEUROPHYSIOL, V76, P2102, DOI 10.1152/jn.1996.76.3.2102; Muri RM, 2000, NEUROPSYCHOLOGIA, V38, P1105, DOI 10.1016/S0028-3932(00)00030-0; Newcombe VFJ, 2007, BRIT J NEUROSURG, V21, P340, DOI 10.1080/02688690701400882; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Pandya D., 2009, FIBER PATHWAYS BRAIN; Pena-Casanova J, 2009, ARCH CLIN NEUROPSYCH, V24, P321, DOI 10.1093/arclin/acp038; Phillipou A, 2014, DEV MED CHILD NEUROL, V56, P337, DOI 10.1111/dmcn.12345; Pierrot-Deseilligny C, 2003, PROG BRAIN RES, V142, P3; PIERROTDESEILLIGNY C, 1991, EXP BRAIN RES, V83, P607; PIERROTDESEILLIGNY C, 1995, ANN NEUROL, V37, P557, DOI 10.1002/ana.410370504; Pinhas L, 2014, PSYCHIAT RES, V220, P519, DOI 10.1016/j.psychres.2014.08.006; Polak P, 2015, J HEAD TRAUMA REHAB, V30, pE32, DOI 10.1097/HTR.0000000000000037; Preacher KJ, 2011, PSYCHOL METHODS, V16, P93, DOI 10.1037/a0022658; Putukian M, 2015, CLIN J SPORT MED, V25, P36, DOI 10.1097/JSM.0000000000000102; Ro T, 1997, J COGNITIVE NEUROSCI, V9, P433, DOI 10.1162/jocn.1997.9.4.433; Ryan LM, 2003, INT REV PSYCHIATR, V15, P310, DOI 10.1080/09540260310001606692; Schermuly I, 2010, EUR PSYCHIAT, V25, P355, DOI 10.1016/j.eurpsy.2010.05.001; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Shehata N, 2009, BRIT J SPORT MED, V43, P730, DOI 10.1136/bjsm.2009.059832; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sturm V, 2011, INVEST OPHTH VIS SCI, V52, P708, DOI 10.1167/iovs.09-4911; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Taghdiri F, 2017, J HEAD TRAUMA REHAB, V32, pE55, DOI 10.1097/HTR.0000000000000286; Thomas C, 2015, CORTEX, V72, P65, DOI 10.1016/j.cortex.2015.01.023; Tyler C.W., 2015, FRONT NEUROL, P6; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Williams IM, 1997, J CLIN NEUROSCI, V4, P186, DOI 10.1016/S0967-5868(97)90072-2; Yan H, 2009, NEUROIMAGE, V47, P1579, DOI 10.1016/j.neuroimage.2009.05.080; Yengo-Kahn AM, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15611	94	15	15	6	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2018	35	5					719	729		10.1089/neu.2017.5274		FEB 2018	11	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FX4ZY	WOS:000424839300001	29239265				2022-02-06	
J	Anderson, M; Elmer, J; Shutter, L; Puccio, A; Alexander, S				Anderson, Maighdlin; Elmer, Jonathan; Shutter, Lori; Puccio, Ava; Alexander, Sheila			Integrating Quantitative Pupillometry Into Regular Care in a Neurotrauma Intensive Care Unit	JOURNAL OF NEUROSCIENCE NURSING			English	Article						critical care; intensive care unit (ICU); neurological pupil index (NPi); neurotrauma; nursing; pupillometer; technology; traumatic brain injury (TBI)	TRAUMATIC BRAIN-INJURY; SEVERE HEAD-INJURY; INTRACRANIAL-PRESSURE; DILATED PUPILS; NORMATIVE DATA; SCALE; RELIABILITY; DEATH; SCORE; SIZE	In the setting of acute traumatic brain injury (TBI), an abnormal pupil assessment may suggest a worsening intracranial lesion. Early detection of pupillary changes may expedite emergent care to improve outcomes. Automated, handheld pupillometers have been commercially available for 20 years, and several studies suggest that their use may facilitate early recognition of worsening injury and intracranial hypertension. The use of pupillometry as a bedside tool in the routine care of patients with severe TBI (Glasgow Coma Scale score 8) has not been described. We performed a quality improvement project to implement routine use of quantitative pupillometry in our neurotrauma intensive care unit. Nursing staff were trained on device use and the project's aims in a 30-minute in-service session. Nurses caring for severe TBI patients completed standard pupil assessments using (a) a flashlight and (b) a pupillometer to quantify pupil size and reactivity (Neurological Pupil index) every hour. Abnormal results were reported to on-call providers. We administered surveys to evaluate knowledge, practical use of the pupillometer data, and satisfaction with the device every 3 months. Data were available for 22 nurses at 4 separate time points. Staff were positive about their ability to use and understand the device (mu = 8.7 and 9.1, respectively, on a 10-point scale) and reported that it added value to patient care and critical decision-making. Use of automated pupillometry is acceptable to nursing staff in a neurotrauma intensive care unit, and staff believed that pupillometry results enhanced clinical decision-making.	[Anderson, Maighdlin] UPMC, Pittsburgh, PA 15213 USA; [Elmer, Jonathan] Univ Pittsburgh, Sch Med, Dept Emergency, Pittsburgh, PA USA; [Elmer, Jonathan; Shutter, Lori] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Shutter, Lori] Univ Pittsburgh, Sch Med, Crit Care Med, Educ, Pittsburgh, PA USA; [Shutter, Lori] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Shutter, Lori; Puccio, Ava] Univ Pittsburgh, Sch Med, Dept Neurosurg, Pittsburgh, PA 15261 USA; [Puccio, Ava; Alexander, Sheila] Univ Pittsburgh, Sch Nursing, Dept Acute & Tertiary Care, Pittsburgh, PA 15261 USA; [Puccio, Ava] Univ Pittsburgh, Sch Nursing, Dept Neurosurg, Pittsburgh, PA 15261 USA; [Puccio, Ava] Univ Pittsburgh, Sch Med, Dept Acute & Tertiary Care, Pittsburgh, PA USA; [Alexander, Sheila] Univ Pittsburgh, Sch Nursing, Dept Crit Care Med, Pittsburgh, PA 15261 USA		Anderson, M (corresponding author), UPMC, Pittsburgh, PA 15213 USA.	andersonmw@upmc.edu	Shutter, Lori A/G-2957-2013	Shutter, Lori/0000-0002-1390-0628			ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; BRAAKMAN R, 1980, NEUROSURGERY, V6, P362, DOI 10.1227/00006123-198004000-00002; Carney N, 2016, NEUROSURGERY, DOI [DOI 10.1227/NEU.0000000000001432, 10.1227/NEU.0000000000001432, 10.1227/neu.0000000000001432]; Chen Jeff W, 2011, Surg Neurol Int, V2, P82, DOI 10.4103/2152-7806.82248; Clark A, 2006, EMERG MED J, V23, P440, DOI 10.1136/emj.2005.030247; Clusmann H, 2001, J NEUROL NEUROSUR PS, V71, P175, DOI 10.1136/jnnp.71.2.175; Couret D, 2016, CRIT CARE, V20, DOI 10.1186/s13054-016-1239-z; Egea-Guerrero JJ, 2012, TRANSPL P, V44, P2050, DOI 10.1016/j.transproceed.2012.07.070; Farahvar A, 2011, J NEUROSURG, V114, P1471, DOI 10.3171/2010.11.JNS101116; Fountas KN, 2006, NEUROCRIT CARE, V5, P55, DOI 10.1385/NCC:5:1:55; Karamanos E, 2014, AM J SURG, V208, P363, DOI 10.1016/j.amjsurg.2013.10.026; Kerr RG, 2016, AM J CRIT CARE, V25, P213, DOI 10.4037/ajcc2016554; Litvan I, 2000, NEUROLOGY, V54, P530, DOI 10.1212/WNL.54.2.530; Majdan M, 2015, J NEUROTRAUM, V32, P101, DOI 10.1089/neu.2014.3438; Marmarou A, 2007, J NEUROTRAUM, V24, P270, DOI 10.1089/neu.2006.0029; McNett M, 2017, J NEUROSCI NURS, V49, P229, DOI 10.1097/JNN.0000000000000290; National Institute of Neurological Disorders and Stroke, 2002, TRAUM BRAIN INJ HOP; Olson DM, 2017, J NEUROSCI NURS, V49, P251, DOI 10.1097/JNN.0000000000000296; Olson DM, 2016, NEUROCRIT CARE, V24, P251, DOI 10.1007/s12028-015-0182-1; Ritter AM, 1999, NEUROSURGERY, V44, P941, DOI 10.1097/00006123-199905000-00005; Rogers EM., 2003, DIFFUSION INNOVATION, V5; Sheth KN, 2013, NEUROCRIT CARE, V18, P26, DOI 10.1007/s12028-012-9780-3; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Taylor WR, 2003, J NEUROSURG, V98, P205, DOI 10.3171/jns.2003.98.1.0205; Tien HC, 2006, J TRAUMA, V60, P274, DOI 10.1097/01.ta.0000197177.13379.f4; US Department of Health and Human Services Centers for Disease Control and Prevention & National Center for Injury Prevention and Control, 2016, TBI GET FACTS INJ PR; Zafar SF, 2014, J CRIT CARE, V29, P599, DOI 10.1016/j.jcrc.2014.01.012	27	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	FEB	2018	50	1					30	36		10.1097/JNN.0000000000000333			7	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	FS6VG	WOS:000419935900010	29303836				2022-02-06	
J	Bargellesi, S; Cavasin, L; Scarponi, F; De Tanti, A; Bonaiuti, D; Bartolo, M; Boldrini, P; Estraneo, A				Bargellesi, Stefano; Cavasin, Luisa; Scarponi, Federico; De Tanti, Antonio; Bonaiuti, Donatella; Bartolo, Michelangelo; Boldrini, Paolo; Estraneo, Anna		Heterotopic Ossification Cross	Occurrence and predictive factors of heterotopic ossification in severe acquired brain injured patients during rehabilitation stay: cross-sectional survey	CLINICAL REHABILITATION			English	Article						Heterotopic ossification; rehabilitation; severe acquired brain injury	DISABILITY RATING-SCALE; RISK-FACTORS; SPINAL-CORD; CARE-UNIT; RELIABILITY; CONSENSUS; RECOVERY; COMA	Objectives: To report occurrence and identify patient's features and risk factors of heterotopic ossifications in patients with severe acquired brain injury in intensive rehabilitation centres. Design: Multicentre cross-sectional survey. Setting: A total of 48 severe acquired brain injury rehabilitation institutes. Participants: Traumatic and non-traumatic severe brain-injured patients (N = 689) in rehabilitation centres on 28 May 2016. Main Outcome Measure: Occurrence of heterotopic ossifications diagnosed by standard radiological and/or sonographic evaluation on the basis of clinical suspicion. Results: Heterotopic ossification occurred around one or more joints in 94/689 patients (13.6%) with a significantly higher prevalence in young males. Occurrence did not significantly differ in relation to aetiology (16.3% traumatic, 19.2% anoxic, 11.7% vascular and 11.5% other). Prevalence was significantly higher in patients with diffuse (23.3%) rather than focal brain lesions (12.4%) or unspecified lesions (11.2%; chi-square = 7.81, df = 2, P = 0.020); longer duration of coma (P = 0.0016) and ventilation support (P = 0.0145); paroxysmal sympathetic hyperactivity (22.6% versus 11.6%; chi-square = 10.81, df = 1, P = 0.001); and spasticity (22.7% versus 10.1%; chi-square = 18.63, df = 1, P < 0.0001). A longer interval between acute brain injury and admission to rehabilitation centre was significantly associated with higher frequency of heterotopic ossifications. Conclusion: Occurrence of heterotopic ossifications is frequent in patients with severe traumatic and non-traumatic brain-injury in rehabilitation centres. Our study confirms male gender, young age, paroxysmal sympathetic hyperactivity, spasticity, longer duration of coma and ventilation and longer interval between brain injury onset and admission to rehabilitation centre as possible risk factors. Further studies are necessary to investigate the role of early appropriate rehabilitation pathways to reduce occurrence of heterotopic ossifications.	[Bargellesi, Stefano] Ca Foncello Hosp, Severe Brain Injuries Rehabil Unit, Phys Med & Rehabil, Piazza Osped 1, I-31100 Treviso, Italy; [Cavasin, Luisa] Univ Padua, Sch Phys Med & Rehabil, Padua, Italy; [Scarponi, Federico] San Giovanni Battista Hosp, Severe Brain Injuries Rehabil Unit, Foligno, Italy; [De Tanti, Antonio] Santo Stefano Rehabil Inst, Severe Brain Injuries Rehabil Unit, Cardinal Ferrari Rehabil Ctr, Fontanellato, Italy; [Bonaiuti, Donatella] San Gerardo Hosp, Phys Med & Rehabil Unit, Monza, Italy; [Bartolo, Michelangelo] Habilita Inst, Rehabil Dept, Severe Brain Injuries Rehabil Unit, Bergamo, Italy; [Boldrini, Paolo] Azienda ULSS 2, Rehabil Dept, Treviso, Italy; [Boldrini, Paolo] Italian Soc Phys Med & Rehabil SIMFER, Treviso, Italy; [Estraneo, Anna] ICS Maugeri, Neurorehabil Unit, Telese Terme, Italy; [Estraneo, Anna] ICS Maugeri, Res Lab Disorder Consciousness, Telese Terme, Italy		Bargellesi, S (corresponding author), Ca Foncello Hosp, Severe Brain Injuries Rehabil Unit, Phys Med & Rehabil, Piazza Osped 1, I-31100 Treviso, Italy.	stefano.bargellesi@aulss2.veneto.it	Casanova, Emanuela/AAD-3643-2022; mandala, giorgio/AAC-1842-2019; Antenucci, Roberto/AAA-8195-2020; Scarponi, Federico/K-5714-2018	Casanova, Emanuela/0000-0002-5727-3769; mandala, giorgio/0000-0002-4384-8672; Antenucci, Roberto/0000-0002-7205-8995; Sant'Angelo, Antonino/0000-0001-9972-3679; Scarponi, Federico/0000-0001-9683-8104			Baguley IJ, 2014, J NEUROTRAUM, V31, P1515, DOI 10.1089/neu.2013.3301; Bartolo M, 2016, EUR J PHYS REHAB MED, V52, P90; BOHANNON RW, 1987, PHYS THER, V67, P206, DOI 10.1093/ptj/67.2.206; Cameron S, 2015, J CRIT CARE, V30, P664, DOI 10.1016/j.jcrc.2015.03.032; Castro-Avila AC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0130722; Citak M, 2012, SPINE, V37, P1953, DOI 10.1097/BRS.0b013e31825ee81b; Davies OG, 2015, CALCIFIED TISSUE INT, V97, P432, DOI 10.1007/s00223-015-0034-1; De Tanti A, 2015, EUR J PHYS REHAB MED, V51, P89; Dizdar D, 2013, BRAIN INJURY, V27, P807, DOI 10.3109/02699052.2013.775490; Estraneo A, 2014, ARCH PHYS MED REHAB, V95, P711, DOI 10.1016/j.apmr.2013.11.004; Formisano R, 2017, NEUROL SCI, V38, P181, DOI 10.1007/s10072-016-2724-5; GARLAND DE, 1982, CLIN ORTHOP RELAT R, P133; Genet F, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016632; Gennarelli T A, 1988, Brain Inj, V2, P175, DOI 10.3109/02699058809150942; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Hendricks HT, 2007, CLIN REHABIL, V21, P545, DOI 10.1177/0269215507075260; Ivanhoe CB, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P385; Kaplan FS, 2004, J AM ACAD ORTHOP SUR, V12, P116, DOI 10.5435/00124635-200403000-00007; Ozcakar L, 2013, AM J PHYS MED REHAB, V92, P805, DOI 10.1097/PHM.0b013e3182971269; Pape HC, 2004, J BONE JOINT SURG BR, V86B, P783, DOI 10.1302/0301-620X.86B6.15356; Ranganathan K, 2015, PLAST RECONSTR SURG, V135, P1631, DOI 10.1097/PRS.0000000000001266; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Reznik JE, 2014, J MUSCULOSKEL NEURON, V14, P19; Sullivan MP, 2013, BONE JOINT RES, V2, P51, DOI 10.1302/2046-3758.23.2000152; Taricco M, 2000, EURA MEDICOPHYS, V42, P73; TEASDALE G, 1974, LANCET, V2, P81; Teasell R, 2014, HETEROTOPIC OSSIFICA, V11; van Kampen PJ, 2011, J HEAD TRAUMA REHAB, V26, P384, DOI 10.1097/HTR.0b013e3181f78a59; Vanden Bossche L, 2005, J REHABIL MED, V37, P129, DOI 10.1080/16501970510027628; WATANABE TK, 2001, PHYS MED REHABILITAT, V15, P283; Winkler S, 2015, INT ORTHOP, V39, P2495, DOI 10.1007/s00264-015-2995-0; WITTENBERG RH, 1992, J BONE JOINT SURG BR, V74, P215, DOI 10.1302/0301-620X.74B2.1544955	34	15	15	1	5	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	FEB	2018	32	2					255	262		10.1177/0269215517723161			8	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation	FX3XB	WOS:000426004700013	28805078				2022-02-06	
J	Berger, RP; Saladino, RA; Fromkin, J; Heineman, E; Suresh, S; McGinn, T				Berger, Rachel P.; Saladino, Richard A.; Fromkin, Janet; Heineman, Emily; Suresh, Srinivasan; McGinn, Tom			Development of an electronic medical record-based child physical abuse alert system	JOURNAL OF THE AMERICAN MEDICAL INFORMATICS ASSOCIATION			English	Article						child abuse; physical abuse; electronic medical record	TRAUMATIC BRAIN-INJURY; UNITED-STATES; YOUNG-CHILDREN; HEAD TRAUMA; INFANTS; FRACTURES; GUIDELINE; IDENTIFICATION; MALTREATMENT; DIAGNOSIS	Objective: Physical abuse is a leading cause of pediatric morbidity and mortality. Physicians do not consistently screen for abuse, even in high-risk situations. Alerts in the electronic medical record may help improve screening rates, resulting in early identification and improved outcomes. Methods: Triggers to identify children <2 years old at risk for physical abuse were coded into the electronic medical record at a freestanding pediatric hospital with a level 1 trauma center. The system was run in "silent mode"; physicians were unaware of the system, but study personnel received data on children who triggered the alert system. Sensitivity, specificity, and negative and positive predictive values of the child abuse alert system for identifying physical abuse were calculated. Results: Thirty age-specific triggers were embedded into the electronic medical record. From October 21, 2014, through April 6, 2015, the system was in silent mode. All 226 children who triggered the alert system were considered subjects. Mean (SD) age was 9.1 (6.5) months. All triggers were activated at least once. Sensitivity was 96.8% (95% CI, 92.4-100.0%), specificity was 98.5% (95% CI, 98.3.5-98.7), and positive and negative predictive values were 26.5% (95% CI, 21.2-32.8%) and 99.9% (95% CI, 99.9-100.0%), respectively, for identifying children <2 years old with possible, probable, or definite physical abuse. Discussion/Conclusion: Triggers embedded into the electronic medical record can identify young children with who need to be evaluated for physical abuse with high sensitivity and specificity.	[Berger, Rachel P.; Saladino, Richard A.; Fromkin, Janet; Heineman, Emily; Suresh, Srinivasan] UPMC, Childrens Hosp Pittsburgh, Dept Pediat, Pittsburgh, PA USA; [McGinn, Tom] Hofstra Northwell Sch Med, Dept Med, Manhasset, NY USA		Berger, RP (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Child Advocacy, Dept Pediat, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	rachel.berger@chp.edu			 [PCORI-AD-12-11-4956]	The study was supported by PCORI-AD-12-11-4956. The statements in this article are solely the responsibility of the authors and do not necessarily represent the views of the Patient-Centered Outcomes Research Institute, its Board of Governors or Methodology Committee.	American Cancer Society, 2012, CANC IN CHILDR; Anderst JD, 2013, PEDIATRICS, V131, pE1314, DOI 10.1542/peds.2013-0195; Berger RP, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-3756; Berger RP, 2006, PEDIATRICS, V117, P325, DOI 10.1542/peds.2005-0711; Berger RP, 2004, CHILD ABUSE NEGLECT, V28, P739, DOI 10.1016/j.chiabu.2004.01.007; Cebul RD, 2011, NEW ENGL J MED, V365, P825, DOI 10.1056/NEJMsa1102519; Christian CW, 2015, PEDIATRICS, V135, pE1337, DOI 10.1542/peds.2015-0356; Eckenrode J, 2014, PEDIATRICS, V133, P454, DOI 10.1542/peds.2013-1707; Fang XM, 2012, CHILD ABUSE NEGLECT, V36, P156, DOI 10.1016/j.chiabu.2011.10.006; Flaherty EG, 2014, PEDIATRICS, V133, pE477, DOI 10.1542/peds.2013-3793; Gill JM, 2011, ANN FAM MED, V9, P22, DOI 10.1370/afm.1172; Guenther E, 2010, J PEDIATR-US, V157, P821, DOI 10.1016/j.jpeds.2010.04.072; Guerra CE, 2007, J GEN INTERN MED, V22, P1681, DOI 10.1007/s11606-007-0396-9; Jenny C, 1999, JAMA-J AM MED ASSOC, V281, P621, DOI 10.1001/jama.281.7.621; Keenan HT, 2004, PEDIATRICS, V114, P633, DOI 10.1542/peds.2003-1020-L; Keenan HT, 2003, JAMA-J AM MED ASSOC, V290, P621, DOI 10.1001/jama.290.5.621; King WK, 2006, PEDIATR EMERG CARE, V22, P211, DOI 10.1097/01.pec.0000208180.94166.dd; Lane WG, 2007, CLIN ORTHOP RELAT R, P219, DOI 10.1097/BLO.0b013e31805c0849; Lane WG, 2002, JAMA-J AM MED ASSOC, V288, P1603, DOI 10.1001/jama.288.13.1603; Lanier P, 2014, J DEV BEHAV PEDIATR, V35, P419, DOI 10.1097/DBP.0000000000000083; Madlon-Kay DJ, 2012, J AM BOARD FAM MED, V25, P437, DOI 10.3122/jabfm.2012.04.110307; Oral R, 2008, PEDIATR EMERG CARE, V24, P816, DOI 10.1097/PEC.0b013e31818e9f5d; Pierce MC, 2009, PEDIATR EMERG CARE, V25, P845, DOI 10.1097/PEC.0b013e3181c06217; Rangel EL, 2009, J PEDIATR SURG, V44, P1229, DOI 10.1016/j.jpedsurg.2009.02.044; Ravichandiran N, 2010, PEDIATRICS, V125, P60, DOI 10.1542/peds.2008-3794; Schiff GD, 2012, BMJ QUAL SAF, V21, P89, DOI 10.1136/bmjqs-2011-000590; Shiffman RN, 1999, J AM MED INFORM ASSN, V6, P104, DOI 10.1136/jamia.1999.0060104; Smythe MA, 2012, AM J HEALTH-SYST PH, V69, P241, DOI 10.2146/ajhp110313; Thackeray JD, 2007, PEDIATR EMERG CARE, V23, P735, DOI 10.1097/PEC.0b013e3181568039; Thorpe EL, 2014, PEDIATR EMERG CARE, V30, P771, DOI 10.1097/PEC.0000000000000257; Trokel M, 2006, PEDIATRICS, V117, P722, DOI 10.1542/peds.2004-2731; Vernacchio L, 2007, PEDIATRICS, V120, P281, DOI 10.1542/peds.2006-3601; Wood JN, 2012, PEDIATRICS, V130, P853, DOI 10.1542/peds.2012-0244; Wood JN, 2010, PEDIATRICS, V126, P408, DOI 10.1542/peds.2010-0031; Wood JN, 2009, PEDIATRICS, V123, pE247, DOI 10.1542/peds.2008-2467	35	15	15	1	6	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1067-5027	1527-974X		J AM MED INFORM ASSN	J. Am. Med. Inf. Assoc.	FEB	2018	25	2					142	149		10.1093/jamia/ocx063			8	Computer Science, Information Systems; Computer Science, Interdisciplinary Applications; Health Care Sciences & Services; Information Science & Library Science; Medical Informatics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science; Health Care Sciences & Services; Information Science & Library Science; Medical Informatics	FV9TC	WOS:000424930900006	28641385	Green Published			2022-02-06	
J	Cheever, KM; McDevitt, J; Tierney, R; Wright, WG				Cheever, Kelly M.; McDevitt, Jane; Tierney, Ryan; Wright, W. Geoffrey			Concussion Recovery Phase Affects Vestibular and Oculomotor Symptom Provocation	INTERNATIONAL JOURNAL OF SPORTS MEDICINE			English	Article						near point convergence; optokinetic stimulation; concussion; vestibular; balance	SPORTS-RELATED CONCUSSION; EXERTIONAL HEAT ILLNESS; FOOTBALL PLAYERS; POSTURAL CONTROL; INJURY; ASSESSMENTS; DIZZINESS; MANAGEMENT; STATEMENT; POSITION	Vestibular and oculomotor testing is emerging as a valuable assessment in sport-related concussion (SRC). However, their usefulness for tracking recovery and guiding return-to-play decisions remains unclear. Therefore the purpose of this study was to evaluate their clinical usefulness for tracking SRC recovery. Vestibular and oculomotor assessments were used to measure symptom provocation in an acute group (n=21) concussed10 days, prolonged symptoms group (n=10) concussed 16 days (median=84 days), healthy group (n=58) no concussions in >6 months. Known-groups approach was used with three groups at three time points (initial, 2-week and 6-week follow-up). Provoked symptoms for Gaze-Stabilization (GST), Rapid Eye Horizontal (REH), Optokinetic Stimulation (OKS), Smooth-Pursuit Slow (SPS) and Fast (SPF) tests, total combined symptoms scores and near point convergence (NPC) distance were significantly greater at initial assessment in both injury groups compared to controls. Injury groups improved on the King-Devick test and combined symptom provocation scores across time. The acute group improved over time on REH and SPF tests, while the prolonged symptoms group improved on OKS. A regression model (REH, OKS, GST) was 90% accurate discriminating concussed from healthy. Vestibular and ocular motor tests give valuable insight during recovery. They can prove beneficial in concussion evaluation given the modest equipment, training and time requirements. The current study demonstrates that when combined, vestibular and oculomotor clinical tests aid in the detection of deficits following a SRC. Additionally, tests such as NPC, GST, REH, SPS, SPF OKS and KD provide valuable information to clinicians throughout the recovery process and may aid in return to play decisions.	[Cheever, Kelly M.; McDevitt, Jane; Tierney, Ryan] Temple Univ, Kinesiol, Philadelphia, PA 19122 USA; [Tierney, Ryan; Wright, W. Geoffrey] Temple Univ, Neuromotor Sci Program, Philadelphia, PA 19122 USA; [Wright, W. Geoffrey] Temple Univ, Phys Therapy, 1301 Cecil B Moore Ave, Philadelphia, PA 19122 USA		Wright, WG (corresponding author), Temple Univ, Phys Therapy, 1301 Cecil B Moore Ave, Philadelphia, PA 19122 USA.	wrightw@temple.edu		Cheever, Kelly/0000-0001-8381-3426			Alosco ML, 2012, INT J ATHL THER TRAI, V17, P22, DOI 10.1123/ijatt.17.5.22; Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Alsalaheen BA, 2016, CLIN J SPORT MED, V26, P46, DOI 10.1097/JSM.0000000000000185; Armstrong LE, 2007, MED SCI SPORT EXER, V39, P556, DOI 10.1249/MSS.0b013e31802fa199; Baugh CM, 2015, J NEUROTRAUM, V32, P314, DOI 10.1089/neu.2014.3582; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Cheever K, 2016, J ATHL TRAINING, V51, P1037, DOI 10.4085/1062-6050-51.12.15; Eichner ER, 2007, J SPORT REHABIL, V16, P197, DOI 10.1123/jsr.16.3.197; Eichner ER, 1998, INT J SPORTS MED, V19, pS150, DOI 10.1055/s-2007-971983; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Field A., 1998, BRIT PSYCHOL SOC MAT, V6, P13; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz Kevin M, 2015, Handb Clin Neurol, V127, P157, DOI 10.1016/B978-0-444-52892-6.00010-6; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harriss DJ, 2015, INT J SPORTS MED, V36, P1121, DOI 10.1055/s-0035-1565186; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Leddy JJ, 2015, CLIN J SPORT MED, V25, P237, DOI 10.1097/JSM.0000000000000128; Lynall RC, 2015, MED SCI SPORT EXER, V47, P2487, DOI 10.1249/MSS.0000000000000716; McCrory P, 2013, J ATHL TRAINING, V48, P554, DOI 10.4085/1062-6050-48.4.05; McDevitt J, 2016, INT J SPORTS MED, V37, P738, DOI 10.1055/s-0042-100470; McLeod TCV, 2009, J ATHL TRAINING, V44, P663, DOI 10.4085/1062-6050-44.6.663; Meehan WP, 2013, CLIN J SPORT MED, V23, P339, DOI 10.1097/JSM.0b013e318291d3b3; Mucha A, 2014, AM J SPORT MED, V42, P2479, DOI 10.1177/0363546514543775; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Reneker JC, 2015, J SCI MED SPORT, V18, P366, DOI 10.1016/j.jsams.2014.05.002; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Teel E, 2016, NEUROPSYCHOLOGY, V30, P474, DOI 10.1037/neu0000261; Teel EF, 2015, CLIN J SPORT MED, V25, P144, DOI 10.1097/JSM.0000000000000109; VANDIE GC, 1986, BRAIN RES, V383, P185, DOI 10.1016/0006-8993(86)90019-3; Wright WG, 2017, J VESTIBUL RES-EQUIL, V27, P27, DOI 10.3233/VES-170607; Wright WG, 2017, DISABIL REHABIL, V39, P1564, DOI 10.1080/09638288.2016.1226432; Wright WG, 2015, 2015 INTERNATIONAL CONFERENCE ON VIRTUAL REHABILITATION PROCEEDINGS (ICVR), P72, DOI 10.1109/ICVR.2015.7358591; Zhou GW, 2015, OTOLARYNG HEAD NECK, V152, P1133, DOI 10.1177/0194599815576720	38	15	15	1	14	GEORG THIEME VERLAG KG	STUTTGART	RUDIGERSTR 14, D-70469 STUTTGART, GERMANY	0172-4622	1439-3964		INT J SPORTS MED	Int. J. Sports Med.	FEB	2018	39	2					141	147		10.1055/s-0043-118339			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	FU8YH	WOS:000424142000009	29190849	Bronze			2022-02-06	
J	Dong, XY; Feng, Z				Dong, Xiao-yang; Feng, Zhen			Wake-promoting effects of vagus nerve stimulation after traumatic brain injury: upregulation of orexin-A and orexin receptor type 1 expression in the prefrontal cortex	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; brain injury; orexin-A; orexin receptor type 1; vagus nerve stimulation; traumatic brain injury; wake-promoting; coma; wakefulness; prefrontal cortex; neurotransmitter; neural regeneration	ELECTRICAL-STIMULATION; INDUCED COMA; DAYTIME SLEEPINESS; EPILEPSY; RAT; MECHANISMS; RECOVERY; POPULATIONS; CASCADES; CELLS	Orexins, produced in the lateral hypothalamus, are important neuropeptides that participate in the sleep/wake cycle, and their expression coincides with the projection area of the vagus nerve in the brain. Vagus nerve stimulation has been shown to decrease the amounts of daytime sleep and rapid eye movement in epilepsy patients with traumatic brain injury. In the present study, we investigated whether vagus nerve stimulation promotes wakefulness and affects orexin expression. A rat model of traumatic brain injury was established using the free fall drop method. In the stimulated group, rats with traumatic brain injury received vagus nerve stimulation (frequency, 30 Hz; current, 1.0 mA; pulse width, 0.5 ms; total stimulation time, 15 minutes). In the antagonist group, rats with traumatic brain injury were intracerebroventricularly injected with the orexin receptor type 1 (OX1R) antagonist SB334867 and received vagus nerve stimulation. Changes in consciousness were observed after stimulation in each group. Enzyme-linked immunosorbent assay, western blot assay and immunohistochemistry were used to assess the levels of orexin-A and OX1R expression in the prefrontal cortex. In the stimulated group, consciousness was substantially improved, orexin-A protein expression gradually increased within 24 hours after injury and OX1R expression reached a peak at 12 hours, compared with rats subjected to traumatic brain injury only. In the antagonist group, the wake-promoting effect of vagus nerve stimulation was diminished, and orexin-A and OX1R expression were decreased, compared with that of the stimulated group. Taken together, our findings suggest that vagus nerve stimulation promotes the recovery of consciousness in comatose rats after traumatic brain injury. The upregulation of orexin-A and OX1R expression in the prefrontal cortex might be involved in the wake-promoting effects of vagus nerve stimulation.	[Dong, Xiao-yang; Feng, Zhen] Nanchang Univ, Dept Rehabil Med, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China		Feng, Z (corresponding author), Nanchang Univ, Dept Rehabil Med, Affiliated Hosp 1, Nanchang, Jiangxi, Peoples R China.	fengzhenly@sina.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81260295]; Graduate Student Innovation Fund of Jiangxi Province of China [YC2015-S090]	This study was supported by the Natural Science Foundation of China, No. 81260295 and the Graduate Student Innovation Fund of Jiangxi Province of China, No. YC2015-S090.	Alo R, 2017, MOL NEUROBIOL, V54, P2674, DOI 10.1007/s12035-016-9847-9; Ansari S, 2007, ACTA NEUROCHIR SUPPL, V97, P281; Belle MDC, 2014, J NEUROSCI, V34, P3607, DOI 10.1523/JNEUROSCI.3388-13.2014; Bonaz B, 2013, NEUROGASTROENT MOTIL, V25, P208, DOI 10.1111/nmo.12076; Boss C, 2015, BIOORG MED CHEM LETT, V25, P2875, DOI 10.1016/j.bmcl.2015.05.012; Conway CR, 2012, BRAIN STIMUL, V5, P163, DOI 10.1016/j.brs.2011.03.001; Cossu G, 2014, BRIT J NEUROSURG, V28, P187, DOI 10.3109/02688697.2013.841845; Durand E, 2017, ANN PHYS REHABIL MED, V60, P95, DOI 10.1016/j.rehab.2017.02.003; Ekmekci Hakan, 2017, Open Access Maced J Med Sci, V5, P391, DOI 10.3889/oamjms.2017.056; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Feng Z, 2016, NEURAL REGEN RES, V11, P951, DOI 10.4103/1673-5374.184494; Feng Z, 2015, NEURAL REGEN RES, V10, P594, DOI 10.4103/1673-5374.155433; Follesa P, 2007, BRAIN RES, V1179, P28, DOI 10.1016/j.brainres.2007.08.045; Frangos E, 2017, BRAIN STIMUL, V10, P19, DOI 10.1016/j.brs.2016.10.008; Fulton SP, 2017, J CHILD NEUROL, V32, P494, DOI 10.1177/0883073816687221; Gray SN, 2017, MED ACUPUNCT, V29, P215, DOI 10.1089/acu.2017.1220; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hiebert JB, 2015, AM J MED SCI, V350, P132, DOI 10.1097/MAJ.0000000000000506; Hue CD, 2016, J NEUROTRAUM, V33, P1202, DOI 10.1089/neu.2015.4067; Jain SV, 2014, EPILEPSIA, V55, P26, DOI 10.1111/epi.12478; Jeter CB, 2013, J NEUROTRAUM, V30, P671, DOI 10.1089/neu.2012.2491; Joseph B, 2018, J NEUROSCI RES, V96, P589, DOI 10.1002/jnr.24132; Kaelber S, 2016, NEURAL REGEN RES, V11, P1575, DOI 10.4103/1673-5374.193231; Kampe J, 2009, EUR J NEUROSCI, V30, P415, DOI 10.1111/j.1460-9568.2009.06818.x; Kosel M, 2011, PSYCHIAT RES-NEUROIM, V191, P153, DOI 10.1016/j.pscychresns.2010.11.004; Kukkonen JP, 2014, BRIT J PHARMACOL, V171, P314, DOI 10.1111/bph.12324; Kukkonen JP, 2016, CELL SIGNAL, V28, P51, DOI 10.1016/j.cellsig.2015.11.009; Kumaria A, 2012, BRIT J NEUROSURG, V26, P316, DOI 10.3109/02688697.2012.663517; Lucke-Wold BP, 2015, TRANSL RES, V166, P509, DOI 10.1016/j.trsl.2015.08.005; Malow BA, 2001, NEUROLOGY, V57, P879, DOI 10.1212/WNL.57.5.879; Manta S, 2013, INT J NEUROPSYCHOPH, V16, P459, DOI 10.1017/S1461145712000387; Mieda M, 2017, NEUROSCI RES, V118, P56, DOI 10.1016/j.neures.2017.03.015; Mihara Y, 2011, J MOL NEUROSCI, V43, P162, DOI 10.1007/s12031-010-9438-6; Neren D, 2016, NEUROCRIT CARE, V24, P308, DOI 10.1007/s12028-015-0203-0; Ramanjaneya M, 2009, J ENDOCRINOL, V202, P249, DOI 10.1677/JOE-08-0536; Shi C, 2013, NEUROL RES, V35, P263, DOI 10.1179/1743132813Y.0000000167; Shu Q, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0095259; Singh IN, 2013, J CEREBR BLOOD F MET, V33, P593, DOI 10.1038/jcbfm.2012.211; Smith CJ, 2015, FRONT NEUROL, V6, DOI [10.3389/fneur.2015.00240, 10.3389/fneur.2015.00073]; Smith DC, 2005, J NEUROTRAUM, V22, P1485, DOI 10.1089/neu.2005.22.1485; Soslow RA, 2000, CANCER, V89, P2637, DOI 10.1002/1097-0142(20001215)89:12<2637::AID-CNCR17>3.0.CO;2-B; STEPHENS JR, 1994, EPILEPSIA, V35, P164, DOI 10.1111/j.1528-1157.1994.tb02928.x; Valdes-Cruz A, 2008, PROG NEURO-PSYCHOPH, V32, P828, DOI 10.1016/j.pnpbp.2007.12.020; Walker LC, 2017, CURR TOP BEHAV NEURO, V33, P221, DOI 10.1007/7854_2016_55; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; [伍鸿鹰 Wu HY], 2007, [中国组织工程研究与临床康复, Journal of Clinical Rehabilitative Tissue Engineering Research], V11, P7966; Xia JX, 2005, NEUROREPORT, V16, P783, DOI 10.1097/00001756-200505120-00025; Xiang YX, 2015, NEURAL REGEN RES, V10, P576, DOI 10.4103/1673-5374.155430; Xu TR, 2013, CELL SIGNAL, V25, P2413, DOI 10.1016/j.cellsig.2013.07.025; Yuan H, 2017, HEADACHE, V57, P29, DOI 10.1111/head.12721; Yuan HK, 2016, HEADACHE, V56, P71, DOI 10.1111/head.12647; Zhong YJ, 2015, MOL MED REP, V12, P4441, DOI 10.3892/mmr.2015.3898; Zhu JQ, 2017, ZHONGGUO ZUZHI GONGC, V21, P71	53	15	16	2	4	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	FEB	2018	13	2					244	251		10.4103/1673-5374.226395			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	GA1MQ	WOS:000428080800018	29557373	gold, Green Published			2022-02-06	
J	Salam, AP; Borsini, A; Zunszain, PA				Salam, A. P.; Borsini, A.; Zunszain, P. A.			Trained innate immunity: a salient factor in the pathogenesis of neuroimmune psychiatric disorders	MOLECULAR PSYCHIATRY			English	Article							CANDIDA-ALBICANS INFECTION; MAJOR DEPRESSIVE DISORDER; MOLECULAR-PATTERNS DAMPS; INTERFERON-ALPHA THERAPY; TRAUMATIC BRAIN-INJURY; HOST-DEFENSE; NEURODEGENERATIVE DISEASE; MICROGLIAL ACTIVATION; IMMUNOLOGICAL MEMORY; BCG VACCINATION	Historically, only cells of the adaptive immune system have been considered capable of retaining memory for infectious challenges. Recently, however, cells of the innate immune system have been shown to be capable of displaying long-term functional memory following a single immunostimulatory challenge, leading to enhanced production of proinflammatory molecules upon other subsequent, and temporally distant, immunostimulatory challenges. This effect has been termed 'trained innate immunity', and is underwritten by stable epigenetic changes in immune and metabolic pathways. Importantly, the long-term training of innate immune cells can occur as a result of infectious as well as and non-infectious challenges, including stress. Given the role that both stress and an activated immune system have in neuropathology, innate immune training has important implications for our understanding and treatment of neuropsychiatric disorders. This review focuses on the evidence for trained innate immunity and highlights some insights into its relevance for psychiatric diseases.	Kings Coll London, Inst Psychiat Psychol Neurosci, Dept Psychol Med, London, England		Salam, AP (corresponding author), Kings Coll London, Inst Psychiat Psychol Neurosci, London SE5 9NU, England.	alexsalam@doctors.org.uk	Borsini, Alessandra/P-5180-2017	Borsini, Alessandra/0000-0003-4410-7865	National Institute for Health Research (NIHR) Biomedical Research Centre-Francis Crick Institute Clinical Training Fellowship; NIHR Maudsley Biomedical Research Centre	APS is supported by a National Institute for Health Research (NIHR) Biomedical Research Centre-Francis Crick Institute Clinical Training Fellowship. PAZ and AB are supported by the NIHR Maudsley Biomedical Research Centre.	Akira S, 2006, CELL, V124, P783, DOI 10.1016/j.cell.2006.02.015; Alexopoulou L, 2001, NATURE, V413, P732, DOI 10.1038/35099560; Aricioglu F, 2016, KLIN PSIKOFARMAKOL B, V26, P429, DOI 10.5455/bcp.20161123044657; Bakunina N, 2015, IMMUNOLOGY, V144, P365, DOI 10.1111/imm.12443; Bekkering S, 2014, ARTERIOSCL THROM VAS, V34, P1731, DOI 10.1161/ATVBAHA.114.303887; Beumer W, 2012, J LEUKOCYTE BIOL, V92, P959, DOI 10.1189/jlb.0212100; Bilbo SD, 2005, J NEUROSCI, V25, P8000, DOI 10.1523/JNEUROSCI.1748-05.2005; BISTONI F, 1986, INFECT IMMUN, V51, P668, DOI 10.1128/IAI.51.2.668-674.1986; BISTONI F, 1988, J MED VET MYCOL, V26, P285; Biswas SK, 2009, TRENDS IMMUNOL, V30, P475, DOI 10.1016/j.it.2009.07.009; Bland ST, 2010, NEUROSCI LETT, V474, P52, DOI 10.1016/j.neulet.2010.03.006; Borsini A, 2015, TRENDS NEUROSCI, V38, P145, DOI 10.1016/j.tins.2014.12.006; Cao M, 2015, FRONT CELL NEUROSCI, V9, P12; Capuron L, 1999, NEW ENGL J MED, V340, P1370, DOI 10.1056/NEJM199904293401716; Celik C, 2010, PROG NEURO-PSYCHOPH, V34, P372, DOI 10.1016/j.pnpbp.2010.01.002; Chauhan VS, 2009, GLIA, V57, P414, DOI 10.1002/glia.20770; Cheng SC, 2014, SCIENCE, V345, P1579, DOI 10.1126/science.1250684; Condliffe AM, 1998, CLIN SCI, V94, P461, DOI 10.1042/cs0940461; Delves P. J., 2011, ROITTS ESSENTIAL IMM; Depino AM, 2015, NEUROSCIENCE, V299, P56, DOI 10.1016/j.neuroscience.2015.04.065; Dieperink E, 2003, PSYCHOSOMATICS, V44, P104, DOI 10.1176/appi.psy.44.2.104; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fleshner M, 2004, PSYCHONEUROENDOCRINO, V29, P1142, DOI 10.1016/j.psyneuen.2004.01.007; Fleshner M, 2013, BRAIN BEHAV IMMUN, V27, P1, DOI 10.1016/j.bbi.2012.08.012; Ginhoux F, 2010, SCIENCE, V330, P841, DOI 10.1126/science.1194637; Giovanoli S, 2013, SCIENCE, V339, P1095, DOI 10.1126/science.1228261; Glover V, 2011, J CHILD PSYCHOL PSYC, V52, P356, DOI 10.1111/j.1469-7610.2011.02371.x; Hauser P, 2002, MOL PSYCHIATR, V7, P942, DOI 10.1038/sj.mp.4001119; Ifrim DC, 2014, CLIN VACCINE IMMUNOL, V21, P534, DOI 10.1128/CVI.00688-13; Jensen KJ, 2015, J INFECT DIS, V211, P956, DOI 10.1093/infdis/jiu508; Jeon SW, 2016, WORLD J PSYCHIATR, V6, P283, DOI 10.5498/wjp.v6.i3.283; Jones KA, 2013, MOL CELL NEUROSCI, V53, P52, DOI 10.1016/j.mcn.2012.10.002; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Khandaker GM, 2015, LANCET PSYCHIAT, V2, P258, DOI 10.1016/S2215-0366(14)00122-9; Kleinnijenhuis J, 2014, J INNATE IMMUN, V6, P152, DOI 10.1159/000355628; Knuesel I, 2014, NAT REV NEUROL, V10, P643, DOI 10.1038/nrneurol.2014.187; Lien E, 2000, J CLIN INVEST, V105, P497, DOI 10.1172/JCI8541; Lull ME, 2010, NEUROTHERAPEUTICS, V7, P354, DOI 10.1016/j.nurt.2010.05.014; Maekawa T, 2009, EMBO J, V29, P196; Maes M, 2012, PROG NEURO-PSYCHOPH, V36, P169, DOI 10.1016/j.pnpbp.2011.09.006; Manson J, 2012, BRIT J SURG, V99, P12, DOI 10.1002/bjs.7717; Martin SF, 2014, CELL MOL LIFE SCI, V71, P4115, DOI 10.1007/s00018-014-1676-2; Maslanik T, 2013, BRAIN BEHAV IMMUN, V28, P54, DOI 10.1016/j.bbi.2012.10.014; Matt U, 2015, CELL MOL LIFE SCI, V72, P1059, DOI 10.1007/s00018-014-1780-3; Michael B., 2013, MED, P11; Najjar S, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-43; Netea MG, 2015, NAT IMMUNOL, V16, P675, DOI 10.1038/ni.3178; Netea MG, 2013, EUR J CLIN INVEST, V43, P881, DOI 10.1111/eci.12132; Netea MG, 2011, CELL HOST MICROBE, V9, P355, DOI 10.1016/j.chom.2011.04.006; Pariante CM, 1999, LANCET, V354, P131, DOI 10.1016/S0140-6736(98)04793-X; Perry VH, 2014, NAT REV NEUROL, V10, P217, DOI 10.1038/nrneurol.2014.38; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Poli A, 2013, J IMMUNOL, V190, P5355, DOI 10.4049/jimmunol.1203401; Puntener U, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-146; Quintin J, 2012, CELL HOST MICROBE, V12, P223, DOI 10.1016/j.chom.2012.06.006; Ramirez K, 2015, BRAIN BEHAV IMMUN, V46, P212, DOI 10.1016/j.bbi.2015.01.016; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Ramos HJ, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1003039; Ransohoff RM, 2009, ANNU REV IMMUNOL, V27, P119, DOI 10.1146/annurev.immunol.021908.132528; RENAULT PF, 1987, ARCH INTERN MED, V147, P1577, DOI 10.1001/archinte.147.9.1577; Saeed S, 2014, SCIENCE, V345, P1578, DOI 10.1126/science.1251086; Sandman CA, 2015, BIOL PSYCHIAT, V77, P324, DOI 10.1016/j.biopsych.2014.06.025; Schaafsma W, 2015, BRAIN BEHAV IMMUN, V48, P205, DOI 10.1016/j.bbi.2015.03.013; Schaefer M, 2003, HEPATOLOGY, V37, P443, DOI 10.1053/jhep.2003.50031; Schroder K, 2006, IMMUNOBIOLOGY, V211, P511, DOI 10.1016/j.imbio.2006.05.007; Seong SY, 2004, NAT REV IMMUNOL, V4, P469, DOI 10.1038/nri1372; Soczynska JK, 2012, BEHAV BRAIN RES, V235, P302, DOI 10.1016/j.bbr.2012.07.026; Streit WJ, 2004, J NEUROINFLAMM, V1, DOI 10.1186/1742-2094-1-14; Talge NM, 2007, J CHILD PSYCHOL PSYC, V48, P245, DOI 10.1111/j.1469-7610.2006.01714.x; TRIBOULEY J, 1978, CR SOC BIOL, V172, P902; van den Bergh BRH, 2008, NEUROPSYCHOPHARMACOL, V33, P536, DOI 10.1038/sj.npp.1301450; VANTWOUT JW, 1992, SCAND J IMMUNOL, V36, P713; Weber MD, 2015, J NEUROSCI, V35, P316, DOI 10.1523/JNEUROSCI.3561-14.2015; Williamson LL, 2011, J NEUROSCI, V31, P15511, DOI 10.1523/JNEUROSCI.3688-11.2011; Wynne AM, 2009, INTEGR COMP BIOL, V49, P254, DOI 10.1093/icb/icp009; Ye M, 2014, BIOCHEM CELL BIOL, V92, P337, DOI 10.1139/bcb-2014-0030; Yirmiya R, 2015, TRENDS NEUROSCI, V38, P637, DOI 10.1016/j.tins.2015.08.001; Yoshida K, 2015, NAT IMMUNOL, V16, P1034, DOI 10.1038/ni.3257; Zheng X, 2015, DRUG DISCOV TODAY, V20, P562, DOI 10.1016/j.drudis.2015.03.015	79	15	15	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1359-4184	1476-5578		MOL PSYCHIATR	Mol. Psychiatr.	FEB	2018	23	2					170	176		10.1038/mp.2017.186			7	Biochemistry & Molecular Biology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Neurosciences & Neurology; Psychiatry	FT8ZM	WOS:000423441700003	29230022	Bronze, Green Submitted			2022-02-06	
J	Verberne, D; Moulaert, V; Verbunt, J; van Heugten, C				Verberne, Daan; Moulaert, Veronique; Verbunt, Jeanine; van Heugten, Caroline			Factors predicting quality of life and societal participation after survival of a cardiac arrest: A prognostic longitudinal cohort study	RESUSCITATION			English	Article						Cardiac arrest; Quality of life; Societal participation; Predictors	TRAUMATIC BRAIN-INJURY; FOCUSED FOLLOW-UP; ANEURYSMAL SUBARACHNOID HEMORRHAGE; COMMUNITY INTEGRATION; STAND STILL; EVENT SCALE; VALIDATION; SYMPTOMS; STROKE; REHABILITATION	Aim: For those patients who suffer unfavourable outcome after survival of cardiac arrest, it is important to know whether this can be predicted at an early stage. Support can subsequently be provided. This study aimed to identify early prognostic factors of quality of life (QOL) and societal participation at one year post-cardiac arrest. Methods: The design was a prospective longitudinal cohort study following cardiac arrest survivors up to one year. Prognostic personal, injury-related, function-related and subjective outcome factors were selected and entered into a hierarchical regression model to assess whether they were predictive of QOL and societal participation at one year post-cardiac arrest. Results: Hundred and ten cardiac arrest survivors were included. Not having a partner, more functional limitations (at two weeks) and cognitive complaints were significantly predictive of lower physical QOL, while higher levels of anxiety and depression symptoms (at three months) were significant predictors of mental QOL. A neurological history and higher levels of anxiety and depression symptoms were significantly predictive of lower brain injury-specific QOL. Societal participation was only predicted by premorbid functioning. Conclusion: This study identified prognostic factors of QOL and societal participation one year after survival of cardiac arrest. Screening of these factors in early stages can identify those survivors with possibly unfavourable QOL at one year post cardiac arrest. For those survivors, preventive and targeted interventions may be offered. (C) 2017 Elsevier B.V. All rights reserved.	[Verberne, Daan; van Heugten, Caroline] Maastricht Univ, Dept Psychiat & Neuropsychol, Fac Hlth Med & Neurosci, Sch Mental Hlth & Neurosci MHeNS, POB 616, NL-6200 MD Maastricht, Netherlands; [Moulaert, Veronique; Verbunt, Jeanine] Adelante, Ctr Expertise Rehabil & Audiol, NL-6432 CC Hoensbroek, Netherlands; [Moulaert, Veronique] Univ Groningen, Univ Med Ctr Groningen, Dept Rehabil Med, NL-9713 GZ Groningen, Netherlands; [Verbunt, Jeanine] Maastricht Univ, Dept Rehabil Med, Sch Publ Hlth & Primary Care, CAPHRI, POB 616, NL-6200 MD Maastricht, Netherlands; [van Heugten, Caroline] Maastricht Univ, Dept Neuropsychol & Psychopharmacol, Fac Psychol & Neurosci, POB 616, NL-6200 MD Maastricht, Netherlands; [van Heugten, Caroline] Limburg Brain Injury Ctr, POB 616, NL-6200 MD Maastricht, Netherlands		van Heugten, C (corresponding author), Maastricht Univ, Sch Mental Hlth & Neurosci MHeNs, PO 616 UNS 40, NL-6200 MD Maastricht, Netherlands.	c.vanheugten@maastrichtuniversity.nl			Netherlands Organisation for Health Research and DevelopmentNetherlands Organization for Health Research and Development [ZonMw 920-03-373]; Fonds Nuts Ohra [0602-069]; Stichting Elisabeth Strouven	This work was supported by the Netherlands Organisation for Health Research and Development (ZonMw 920-03-373); Fonds Nuts Ohra (0602-069) and Stichting Elisabeth Strouven. These funding agencies did not play a role in the study design; collection, analysis and interpretation of the data; writing the manuscript; or decisions in where to submit the manuscript.	Alderson AL, 2003, ARCH PHYS MED REHAB, V84, P668, DOI 10.1016/S0003-9993(03)04842-6; Bennett JA, 2002, HEART LUNG, V31, P262, DOI 10.1067/mhl.2002.124554; Boosman H, 2017, NEUROPSYCHOL REHABIL, V27, P581, DOI 10.1080/09602011.2015.1113996; BROADBENT DE, 1982, BRIT J CLIN PSYCHOL, V21, P1, DOI 10.1111/j.2044-8260.1982.tb01421.x; de Haan R, 1993, Ned Tijdschr Geneeskd, V137, P917; Forslund MV, 2013, ACTA NEUROL SCAND, V128, P220, DOI 10.1111/ane.12130; Grauwmeijer E, 2014, ARCH PHYS MED REHAB, V95, P1268, DOI 10.1016/j.apmr.2014.02.002; Green CR, 2015, ANAESTH INTENS CARE, V43, P568, DOI 10.1177/0310057X1504300504; Haacke C, 2006, STROKE, V37, P193, DOI 10.1161/01.STR.0000196990.69412.fb; Hochstenbach JB, 2001, ARCH PHYS MED REHAB, V82, P1360, DOI 10.1053/apmr.2001.25970; Kleinman L, 2000, QUAL LIFE RES, V9, P499, DOI 10.1023/A:1008960710415; Larsson IM, 2014, RESUSCITATION, V85, P215, DOI 10.1016/j.resuscitation.2013.09.017; Middelkamp W, 2007, CLIN REHABIL, V21, P425, DOI 10.1177/0269215507075307; Moulaert VRM, 2017, NEUROREHAB NEURAL RE, V31, P530, DOI 10.1177/1545968317697032; Moulaert VRM, 2016, RESUSCITATION, V106, P30, DOI 10.1016/j.resuscitation.2016.06.015; Moulaert VRM, 2015, INT J CARDIOL, V193, P8, DOI 10.1016/j.ijcard.2015.04.229; Moulaert VRM, 2014, BMC HEALTH SERV RES, V14, DOI 10.1186/1472-6963-14-34; Moulaert VRMP, 2011, CLIN REHABIL, V25, P867, DOI 10.1177/0269215511399937; Moulaert VRMP, 2010, J REHABIL MED, V42, P553, DOI 10.2340/16501977-0547; Moulaert Veronique R M P, 2007, BMC Cardiovasc Disord, V7, P26, DOI 10.1186/1471-2261-7-26; Nolan JP, 2005, RESUSCITATION, V67, pS39, DOI 10.1016/j.resuscitation.2005.10.009; Nys GMS, 2006, J NEUROL SCI, V247, P149, DOI 10.1016/j.jns.2006.04.005; Orbo M, 2015, J REHABIL MED, V47, P860, DOI 10.2340/16501977-1998; Passier PECA, 2012, NEUROREHABILITATION, V30, P137, DOI 10.3233/NRE-2012-0737; Sander AM, 1999, ARCH PHYS MED REHAB, V80, P1303, DOI 10.1016/S0003-9993(99)90034-5; Spinhoven P, 1997, PSYCHOL MED, V27, P363, DOI 10.1017/S0033291796004382; Stalnacke BM, 2007, BRAIN INJURY, V21, P933, DOI 10.1080/02699050701553189; Sundin EC, 2002, BRIT J PSYCHIAT, V180, P205, DOI 10.1192/bjp.180.3.205; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Turnbull JC, 2000, ARCH PHYS MED REHAB, V81, P1034, DOI 10.1053/apmr.2000.7162; van der Ploeg E, 2004, PSYCHOL ASSESSMENT, V16, P16, DOI 10.1037/1040-3590.16.1.16; van Mierlo M., 2017, DISABIL REHABIL, V13, P1; Visser-Meily JMA, 2009, STROKE, V40, P1526, DOI 10.1161/STROKEAHA.108.531277; Wachelder EM, 2009, RESUSCITATION, V80, P517, DOI 10.1016/j.resuscitation.2009.01.020; Ware J.E., 1994, SF 36 PHYS MENTAL SU; World Health Organization, 2007, INT CLASS FUNCT DIS	36	15	16	0	14	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572			RESUSCITATION	Resuscitation	FEB	2018	123						51	57		10.1016/j.resuscitation.2017.11.069			7	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Emergency Medicine	FR7BZ	WOS:000419222600014	29223603	Green Published			2022-02-06	
J	Verschoof, MA; Zuurbier, CCM; de Beer, F; Coutinho, JM; Eggink, EA; van Geel, BM				Verschoof, Merelijne A.; Zuurbier, Charlotte C. M.; de Beer, Frank; Coutinho, Jonathan M.; Eggink, Evert A.; van Geel, Bjoern M.			Evaluation of the yield of 24-h close observation in patients with mild traumatic brain injury on anticoagulation therapy: a retrospective multicenter study and meta-analysis	JOURNAL OF NEUROLOGY			English	Article						Head trauma; Cranial CT; Delayed intracranial hemmorhage	MINOR HEAD-INJURY; COMPUTED-TOMOGRAPHY SCAN; INTRACRANIAL COMPLICATIONS; OLDER-ADULTS; CT-SCAN; RISK; HOSPITALIZATION; HEMORRHAGE; WARFARIN; OUTCOMES	Patients with mild traumatic brain injury (mTBI) on anticoagulants have an increased risk of intracranial hemorrhage (ICH). However, consensus is lacking on whether to admit them after normal initial cranial CT. We evaluated the yield of 24-h neurological observation. Retrospective multicenter study including adult patients admitted over a 5-year period with mTBI on anticoagulation [therapeutic dose heparin, direct oral anticoagulant, or vitamin K antagonist (VKA) with international normalized ratio (INR) >= 1.7] and reportedly normal cranial CT obtained within 24 h after trauma. Primary endpoint was symptomatic ICH within 24 h of injury. Literature on delayed ICH in patients with mTBI and anticoagulation use was reviewed. Of 17.643 mTBI patients, 905 met the inclusion criteria (median age 82 years). 97% used VKA (median INR 2.9). None developed delayed ICH within 24 h. Nine patients deteriorated neurologically due to ICH, four within 24 h (0.4%, 95% CI 0.1-1.2) and five on day 2, 18, 22, 36 and 52, respectively. In six patients, including all four that developed symptoms within 24 h, ICH was found upon reevaluation of initial imaging. The meta-analysis comprised of 9 studies with data from 2885 patients. The estimated pooled proportion of symptomatic delayed ICH or delayed diagnosis of ICH within 24 h was 0.2% (95% CI 0.0-0.5). Delayed (diagnosis of) ICH within 24 h is very rare in mTBI patients on anticoagulants after reportedly normal initial CT. Routine hospitalization of these patients seems unwarranted when the initial cranial CT is scrupulously evaluated.	[Verschoof, Merelijne A.] Haga Ziekenhuis, Dept Neurol, Els Borst Eilerspl 275, NL-2545 AA The Hague, Netherlands; [Zuurbier, Charlotte C. M.; de Beer, Frank] Spaarne Gasthuis, Dept Neurol, Haarlem, Netherlands; [Coutinho, Jonathan M.] Acad Med Ctr, Dept Neurol, Amsterdam, Netherlands; [Eggink, Evert A.] Noordwest Ziekenhuisgrp, Dept Radiol, Alkmaar, Netherlands; [van Geel, Bjoern M.] Noordwest Ziekenhuisgrp, Dept Neurol, Alkmaar, Netherlands		Verschoof, MA (corresponding author), Haga Ziekenhuis, Dept Neurol, Els Borst Eilerspl 275, NL-2545 AA The Hague, Netherlands.	m.verschoof@hagaziekenhuis.nl; c.c.m.zuurbier@umcutrecht.nl; f.de.beer@spaarnegasthuis.nl; j.coutinho@amc.uva.nl; e.a.eggink@nwz.nl; b.m.van.geel@nwz.nl	Coutinho, Jonathan/AAN-4546-2020	Coutinho, Jonathan/0000-0002-8284-982X			Boyd CM, 2008, J AM GERIATR SOC, V56, P2171, DOI 10.1111/j.1532-5415.2008.02023.x; Brewer ES, 2011, J TRAUMA, V70, pE1, DOI 10.1097/TA.0b013e3181e5e286; Cohen DB, 2006, J TRAUMA, V60, P553, DOI 10.1097/01.ta.0000196542.54344.05; Covinsky KE, 2003, J AM GERIATR SOC, V51, P451, DOI 10.1046/j.1532-5415.2003.51152.x; Gittleman AM, 2005, AM J NEURORADIOL, V26, P603; Gomez PA, 2000, NEUROCIRUGIA, V11, P351; Hageman G, 2010, GUIDELINES MANAGEMEN; Hoogerduijn JG, 2007, J CLIN NURS, V16, P46, DOI 10.1111/j.1365-2702.2006.01579.x; Itshayek E, 2006, NEUROSURGERY, V58, P851, DOI 10.1227/01.NEU.0000209653.B2936.96; Kaen A, 2010, J TRAUMA, V68, P895, DOI 10.1097/TA.0b013e3181b28a76; Li J, 2001, LANCET, V357, P771, DOI 10.1016/S0140-6736(00)04163-5; Li J, 2012, ANN EMERG MED, V59, P469, DOI 10.1016/j.annemergmed.2012.04.017; Lim BL, 2016, AM J EMERG MED, V34, P75, DOI 10.1016/j.ajem.2015.09.009; Livingston DH, 2000, ANN SURG, V232, P126, DOI 10.1097/00000658-200007000-00018; McCammack KC, 2015, WEST J EMERG MED, V16, P43, DOI 10.5811/westjem.2014.10.19488; Menditto VG, 2012, ANN EMERG MED, V59, P451, DOI 10.1016/j.annemergmed.2011.12.003; Nishijima DK, 2012, ANN EMERG MED, V59, P460, DOI 10.1016/j.annemergmed.2012.04.007; Parmar K. A., 2006, SMJ Singapore Medical Journal, V47, P676; Peck KA, 2011, J TRAUMA, V71, P1600, DOI 10.1097/TA.0b013e31823b9ce1; Pieracci FM, 2007, J TRAUMA, V63, P525, DOI 10.1097/TA.0b013e31812e5216; Reynolds FD, 2003, J TRAUMA, V54, P492, DOI 10.1097/01.TA.0000051601.60556.FC; Riccardi A, 2017, AM J EMERG MED, V35, P1317, DOI 10.1016/j.ajem.2017.03.072; Schoonman GG, 2014, EUR J NEUROL, V21, P1021, DOI 10.1111/ene.12429; Stuck AE, 1999, SOC SCI MED, V48, P445, DOI 10.1016/S0277-9536(98)00370-0; Taylor K., 2012, J MED IMAG RADIAT ON, V56, P146; Uccella L, 2016, WORLD NEUROSURG, V93, P100, DOI 10.1016/j.wneu.2016.05.061; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x	27	15	15	0	2	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	0340-5354	1432-1459		J NEUROL	J. Neurol.	FEB	2018	265	2					315	321		10.1007/s00415-017-8701-y			7	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FV6SJ	WOS:000424711600010	29236167				2022-02-06	
J	Yan, XD; Liu, JF; Wang, XJ; Li, WH; Chen, JY; Sun, HH				Yan, Xiaodong; Liu, Juanfang; Wang, Xiji; Li, Wenhao; Chen, Jingyuan; Sun, Honghui			Pretreatment with AQP4 and NKCC1 Inhibitors Concurrently Attenuated Spinal Cord Edema and Tissue Damage after Spinal Cord Injury in Rats	FRONTIERS IN PHYSIOLOGY			English	Article						spinal cord injury; spinal cord edema; AQP4; NKCC1; spinal cord tissue damage	TRAUMATIC BRAIN-INJURY; ISCHEMIA-REPERFUSION INJURY; NEUROPATHIC PAIN; AQUAPORIN-4 EXPRESSION; NEURONAL APOPTOSIS; MICE; COTRANSPORTER-1; IMPROVES; PATHWAY; BARRIER	Spinal cord injury (SCI) affects more than 2.5 million people worldwide. Spinal cord edema plays critical roles in the pathological progression of SCI. This study aimed to delineate the roles of aquaporin 4 (AQP4) and Na+-K+-Cl- cotransporter 1 (NKCC1) in acute phase edema and tissue destruction after SCI and to explore whether inhibiting both AQP4 and NKCC1 could improve SCI-induced spinal edema and damage. Rat SCI model was established by modified Allen's method. Spinal cord water content, cerebrospinal fluid lactose dehydrogenase (LDH) activity, AQP4 and NKCC1 expression, and spinal cord pathology from 30 min to 7 days after SCI were monitored. Additionally, aforementioned parameters in rats treated with AQP4 and/or NKCC1 inhibitors were assessed 2 days after SCI. Spinal cord water content was significantly increased 1 h after SCI while AQP4 and NKCC1 expression and spinal fluid LDH activity elevated 6 h after SCI. Spinal cord edema and spinal cord destruction peaked around 24 h after SCI and maintained at high levels thereafter. Treating rats with AQP4 inhibitor TGN-020 and NKCC1 antagonist bumetanide significantly reduced spinal cord edema, tissue destruction, and AQP4 and NKCC1 expression after SCI in an additive manner. These results demonstrated the benefits of simultaneously inhibiting both AQP4 and NKCC1 after SCI.	[Yan, Xiaodong; Wang, Xiji; Sun, Honghui] Fourth Mil Med Univ, Tangdu Hosp, Dept Orthopaed, Xian, Shaanxi, Peoples R China; [Liu, Juanfang] Fourth Mil Med Univ, Dept Clin Aerosp Med, Xian, Shaanxi, Peoples R China; [Li, Wenhao] Fourth Mil Med Univ, Cadet Brigade, Xian, Shaanxi, Peoples R China; [Chen, Jingyuan] Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian, Shaanxi, Peoples R China		Sun, HH (corresponding author), Fourth Mil Med Univ, Tangdu Hosp, Dept Orthopaed, Xian, Shaanxi, Peoples R China.; Chen, JY (corresponding author), Fourth Mil Med Univ, Sch Publ Hlth, Dept Occupat & Environm Hlth, Xian, Shaanxi, Peoples R China.	chenjingyuanfmmu@126.com; sunhonghuifmmu@126.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81272073, 81401001, 81300926]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M582798]	The authors would like to acknowledge Wei Hu, Li Liang, and Ruichen Wang for technical support. This study was funded in part by National Natural Science Foundation of China (No. 81272073; No. 81401001; No. 81300926), China Postdoctoral Science Foundation (No. 2015M582798).	Ahmed MM, 2014, ANN NEUROSCI, V21, P97, DOI 10.5214/ans.0972.7531.210305; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso DM, 1996, J NEUROTRAUM, V13, P343, DOI 10.1089/neu.1996.13.343; Chan Francis Ka-Ming, 2013, Methods Mol Biol, V979, P65, DOI 10.1007/978-1-62703-290-2_7; Chen MH, 2013, INT J CLIN EXP PATHO, V6, P2312; Cleary RT, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0057148; Cote MP, 2014, J NEUROSCI, V34, P8976, DOI 10.1523/JNEUROSCI.0678-14.2014; Cramer SW, 2008, MOL PAIN, V4, DOI 10.1186/1744-8069-4-36; Cabrera-Aldana EE, 2017, MEDIAT INFLAMM, V2017, DOI 10.1155/2017/4792932; Fan H, 2013, NEUROSCI BULL, V29, P501, DOI 10.1007/s12264-013-1354-7; Furlan JC, 2013, CAN J NEUROL SCI, V40, P456, DOI 10.1017/S0317167100014530; Hasbargen T, 2010, ANN NY ACAD SCI, V1198, P168, DOI 10.1111/j.1749-6632.2010.05462.x; Hu AM, 2015, SPINAL CORD, V53, P98, DOI 10.1038/sc.2014.209; Huang F, 2015, MOL MED REP, V11, P3565, DOI 10.3892/mmr.2015.3162; Hui H, 2016, NEUROCHEM INT, V94, P23, DOI 10.1016/j.neuint.2016.02.002; Igarashi H, 2011, NEUROL SCI, V32, P113, DOI 10.1007/s10072-010-0431-1; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Kapoor S, 2013, J NEUROSCI, V33, P17398, DOI 10.1523/JNEUROSCI.2756-13.2013; Khedkar T, 2012, ANN NEUROSCI, V19, P116, DOI 10.5214/ans.0972.7531.190306; Kimura A, 2010, ANN NEUROL, V67, P794, DOI 10.1002/ana.22023; Leonard AV, 2015, J NEUROTRAUM, V32, P397, DOI 10.1089/neu.2014.3543; Li S, 1999, SPINAL CORD, V37, P820, DOI 10.1038/sj.sc.3100941; Li XQ, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0243-1; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Mahat MYA, 2012, J NEUROSCI METH, V211, P272, DOI 10.1016/j.jneumeth.2012.09.013; Misu T, 2007, BRAIN, V130, P1224, DOI 10.1093/brain/awm047; Nesic O, 2006, NEUROSCIENCE, V143, P779, DOI 10.1016/j.neuroscience.2006.08.079; Nesic O, 2005, J NEUROCHEM, V95, P998, DOI 10.1111/j.1471-4159.2005.03462.x; Norenberg MD, 2004, J NEUROTRAUM, V21, P429, DOI 10.1089/089771504323004575; Oklinski MK, 2015, NEUROSCIENCE, V311, P138, DOI 10.1016/j.neuroscience.2015.10.025; Popa Constantin, 2010, J Med Life, V3, P275; Saadoun S, 2008, BRAIN, V131, P1087, DOI 10.1093/brain/awn014; Sharma HS, 2005, ANN NY ACAD SCI, V1053, P422, DOI 10.1196/annals.1344.037; Shibuya S, 2008, TOHOKU J EXP MED, V215, P313, DOI 10.1620/tjem.215.313; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Wang ZV, 2014, CELL, V156, P1179, DOI 10.1016/j.cell.2014.01.014; Wu Q, 2014, MOL NEUROBIOL, V49, P1327, DOI 10.1007/s12035-013-8607-3; Wu QB, 2014, J MOL NEUROSCI, V54, P714, DOI 10.1007/s12031-014-0430-4; Xiao M, 2014, CNS NEUROSCI THER, V20, P385, DOI 10.1111/cns.12267; Yang BX, 2008, J BIOL CHEM, V283, P15280, DOI 10.1074/jbc.M801425200; Yu WY, 2015, EUR REV MED PHARMACO, V19, P3340; Zhang C, 2015, TISSUE CELL, V47, P291, DOI 10.1016/j.tice.2015.03.007; Zhang MK, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0295-2; Zu JN, 2014, ACTA HISTOCHEM, V116, P1331, DOI 10.1016/j.acthis.2014.08.004	44	15	18	4	13	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-042X			FRONT PHYSIOL	Front. Physiol.	JAN 19	2018	9								6	10.3389/fphys.2018.00006			9	Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Physiology	FT2SL	WOS:000422996200001	29403391	Green Published, gold			2022-02-06	
J	Blixt, J; Gunnarson, E; Wanecek, M				Blixt, Jonas; Gunnarson, Eli; Wanecek, Michael			Erythropoietin Attenuates the Brain Edema Response after Experimental Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						aquaporin; BBB; brain edema; EPO; TBI	AQUAPORIN-4 EXPRESSION; BARRIER DISRUPTION; RAT MODEL; NEUROPROTECTION; INFLAMMATION; PERMEABILITY; HYPOXIA; FLUID; MODULATION; ASTROCYTES	Erythropoietin (EPO) has neuroprotective effects in multiple central nervous system (CNS) injury models; however EPO's effects on traumatic brain edema are elusive. To explore EPO as an intervention in traumatic brain edema, male Sprague-Dawley (SD) rats were subjected to blunt, controlled traumatic brain injury (TBI). Animals were randomized to EPO 5000 IU/kg or saline (control group) intraperitoneally within 30min after trauma and once daily for 4 consecutive days. Brain MRI, immunohistofluorescence, immunohistochemistry, and quantitative protein analysis were performed at days 1 and 4 post- trauma. EPO significantly prevented the loss of the tight junction protein zona occludens 1 (ZO-1) observed in control animals after trauma. The decrease of ZO-1 in the control group was associated with an immunoglobulin (Ig)G increase in the perilesional parenchyma, indicating blood-brain barrier (BBB) dysfunction and increased permeability. EPO treatment attenuated decrease in apparent diffusion coefficient (ADC) after trauma, suggesting a reduction of cytotoxic edema, and reduced the IgG leakage, indicating that EPO contributed to preserve BBB integrity and attenuated vasogenic edema. Animals treated with EPO demonstrated conserved levels of aquaporin 4 (AQP4) protein expression in the perilesional area, whereas control animals showed a reduction of AQP4. We show that post TBI administration of EPO decreases early cytotoxic brain edema and preserves structural and functional properties of the BBB, leading to attenuation of the vasogenic edema response. The data support that the mechanisms involve preservation of the tight junction protein ZO-1 and the water channel AQP4, and indicate that treatment with EPO may have beneficial effects on the brain edema response following TBI.	[Blixt, Jonas] Karolinska Univ Hosp, Karolinska Inst, Perioperat Med & Intens Care, Stockholm, Sweden; [Blixt, Jonas; Wanecek, Michael] Karolinska Univ Hosp, Karolinska Inst, Dept Physiol & Pharmacol, Stockholm, Sweden; [Gunnarson, Eli] Karolinska Univ Hosp, Karolinska Inst, Dept Womens & Childrens Hlth, Stockholm, Sweden		Blixt, J (corresponding author), Karolinska Univ Hosp, Perioperat Med & Intens Care, SE-17176 Stockholm, Sweden.	jonas.blixt@sll.se	Wanecek, Michael/AAE-7998-2021		Swedish Medical Research FoundationSwedish Medical Research Council (SMRC); Swedish Society of Medicine; Magn. Bergvalls Foundation; Marta och Gunnar V. Philipsons Stiftelse; Trygg Hansa Forskningsfond; Karolinska InstitutetKarolinska Institutet; Sallskapet Barnavard; Stockholm County CouncilStockholm County Council	The authors thank Tim Baker for proofreading and language help, and Britt Meijer and Anette Ebberyd for excellent technical assistance. This study was supported by the Swedish Medical Research Foundation, the Swedish Society of Medicine, Magn. Bergvalls Foundation, Marta och Gunnar V. Philipsons Stiftelse, Trygg Hansa Forskningsfond, Funds from the Karolinska Institutet, Sallskapet Barnavard, and the Regional Agreement on Medical Training and Clinical Research (ALF) between the Stockholm County Council and Karolinska Institutet.	Aloizos S, 2015, TURK NEUROSURG, V25, P552, DOI 10.5137/1019-5149.JTN.9685-14.4; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Blixt J, 2015, BRAIN RES, V1611, P18, DOI 10.1016/j.brainres.2015.03.004; Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Brines ML, 2000, P NATL ACAD SCI USA, V97, P10526, DOI 10.1073/pnas.97.19.10526; Brissaud O, 2010, PEDIATR RES, V68, P123, DOI 10.1203/00006450-201011001-00237; BROADWELL RD, 1993, EXP NEUROL, V120, P245, DOI 10.1006/exnr.1993.1059; Candelario-Jalil E, 2009, NEUROSCIENCE, V158, P983, DOI 10.1016/j.neuroscience.2008.06.025; Chen G, 2007, NEUROSCI LETT, V425, P177, DOI 10.1016/j.neulet.2007.08.022; Cherian L, 2011, J PHARMACOL EXP THER, V337, P451, DOI 10.1124/jpet.110.176602; Chi OZ, 2008, PHARMACOLOGY, V82, P38, DOI 10.1159/000127839; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Chong ZZ, 2003, BRIT J PHARMACOL, V138, P1107, DOI 10.1038/sj.bjp.0705161; Clausen T, 2001, CURR PHARM DESIGN, V7, P1517, DOI 10.2174/1381612013397267; Collino M, 2015, PHARMACOL THERAPEUT, V151, P32, DOI 10.1016/j.pharmthera.2015.02.005; Coronado VG, 2015, J HEAD TRAUMA REHAB, V30, P185, DOI 10.1097/HTR.0000000000000156; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; DIXON CE, 1991, J NEUROSCI METH, V39, P253; EISENBERG HM, 1990, J NEUROSURG, V73, P688, DOI 10.3171/jns.1990.73.5.0688; Faul M, 2007, J TRAUMA, V63, P1271, DOI 10.1097/TA.0b013e3181493080; FEENEY DM, 1981, BRAIN RES, V211, P67, DOI 10.1016/0006-8993(81)90067-6; Grasso G, 2001, J Neurosurg Sci, V45, P7; Grasso G, 2007, BRAIN RES, V1182, P99, DOI 10.1016/j.brainres.2007.08.078; Grasso G, 2015, MOL MED, V21, P979, DOI 10.2119/molmed.2015.00177; Gunnarson E, 2009, P NATL ACAD SCI USA, V106, P1602, DOI 10.1073/pnas.0812708106; Hellewell SC, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-156; HENNIG J, 1986, MAGNET RESON MED, V3, P823, DOI 10.1002/mrm.1910030602; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; HOLMIN S, 1995, ACTA NEUROCHIR, V132, P110, DOI 10.1007/BF01404857; Honeybul S, 2011, J NEUROSURG SCI, V55, P343; Jacobs B, 2011, J NEUROTRAUM, V28, P203, DOI 10.1089/neu.2010.1558; Jelkmann W, 2007, EUR J HAEMATOL, V78, P183, DOI 10.1111/j.1600-0609.2007.00818.x; Jou IM, 2000, J APPL PHYSIOL, V89, P1766, DOI 10.1152/jappl.2000.89.5.1766; Juul SE, 1998, PEDIATR RES, V43, P40, DOI 10.1203/00006450-199801000-00007; Kanagy NL, 2003, J CARDIOVASC PHARM, V42, P527, DOI 10.1097/00005344-200310000-00011; Ke CS, 2001, NEUROSCI LETT, V301, P21, DOI 10.1016/S0304-3940(01)01589-0; Kiening KL, 2002, NEUROSCI LETT, V324, P105, DOI 10.1016/S0304-3940(02)00180-5; KLATZO I, 1987, ACTA NEUROPATHOL, V72, P236, DOI 10.1007/BF00691095; Koyama Junji, 2007, Kobe J Med Sci, V53, P199; Kumral A, 2005, BIOL NEONATE, V87, P15, DOI 10.1159/000080490; Lee ST, 2006, J NEUROCHEM, V96, P1728, DOI 10.1111/j.1471-4159.2006.03697.x; Manley GT, 2000, NAT MED, V6, P159, DOI 10.1038/72256; Mark KS, 2002, AM J PHYSIOL-HEART C, V282, pH1485, DOI 10.1152/ajpheart.00645.2001; Marklund N, 2006, CURR PHARM DESIGN, V12, P1645, DOI 10.2174/138161206776843340; Marti HH, 1997, KIDNEY INT, V51, P416, DOI 10.1038/ki.1997.55; MASUDA S, 1994, J BIOL CHEM, V269, P19488; Matsushita H, 2003, NEUROREPORT, V14, P1757, DOI 10.1097/00001756-200309150-00020; Nagai A, 2001, J NEUROPATH EXP NEUR, V60, P386, DOI 10.1093/jnen/60.4.386; Navarro JC, 2014, FRONT IMMUNOL, V5, P1, DOI 10.3389/fimmu.2014.00494; Neal CJ, 2007, J NEUROTRAUM, V24, P1609, DOI 10.1089/neu.2007.0301; Nichol A, 2015, LANCET, V386, P2499, DOI 10.1016/S0140-6736(15)00386-4; Oliva AA, 2011, NEUROSCIENCE, V180, P272, DOI 10.1016/j.neuroscience.2011.02.020; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Papadopoulos MC, 2005, J BIOL CHEM, V280, P13906, DOI 10.1074/jbc.M413627200; Rao KVR, 2011, J NEUROTRAUM, V28, P371, DOI 10.1089/neu.2010.1705; Reinert M, 2000, ACTA NEUROCHIR SUPPL, V76, P439; Ren ZG, 2013, J CEREBR BLOOD F MET, V33, P834, DOI 10.1038/jcbfm.2013.30; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Stein SC, 2010, J NEUROTRAUM, V27, P1343, DOI 10.1089/neu.2009.1206; Taya K, 2010, J NEUROTRAUM, V27, P229, DOI 10.1089/neu.2009.0933; Teng RF, 2011, BASIC RES CARDIOL, V106, P343, DOI 10.1007/s00395-011-0158-z; Tsai TH, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-0761-8; Umeda K, 2004, J BIOL CHEM, V279, P44785, DOI 10.1074/jbc.M406563200; Umeda K, 2006, CELL, V126, P741, DOI 10.1016/j.cell.2006.06.043; Villa P, 2003, J EXP MED, V198, P971, DOI 10.1084/jem.20021067; Villasenor R, 2016, SCI REP-UK, V6, DOI 10.1038/srep25658; Wang KKW, 2006, CURR OPIN NEUROL, V19, P514, DOI 10.1097/WCO.0b013e3280102b10; Weidemann A, 2009, J CLIN INVEST, V119, P3373, DOI 10.1172/JCI39378; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818; Yatsiv I, 2005, FASEB J, V19, P1701, DOI 10.1096/fj.05-3907fje	71	15	16	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB	2018	35	4					671	680		10.1089/neu.2017.5015		JAN 2018	10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FV3OH	WOS:000419868100001	29179621	Bronze, Green Published			2022-02-06	
J	Assis-Nascimento, P; Tsenkina, Y; Liebl, DJ				Assis-Nascimento, Poincyane; Tsenkina, Yanina; Liebl, Daniel J.			EphB3 signaling induces cortical endothelial cell death and disrupts the blood-brain barrier after traumatic brain injury	CELL DEATH & DISEASE			English	Article							DEPENDENCE RECEPTOR FUNCTIONS; PROGENITOR CELLS; GROWTH-FACTOR; ADULT NEUROGENESIS; COMMISSURAL AXONS; EPHRINB LIGANDS; NERVOUS-SYSTEM; RAT MODEL; ANGIOGENESIS; ROLES	Damage to the cerebrovascular network is a major contributor to dysfunction in patients suffering from traumatic brain injury (TBI). Vessels are composed of lumen-forming endothelial cells that associate closely with both glial and neuronal units to establish a functional blood-brain barrier (BBB). Under normal physiological conditions, these vascular units play important roles in central nervous system (CNS) homeostasis by delivering oxygen and nutrients while filtering out molecules and cells that could be harmful; however, after TBI this system is disrupted. Here, we describe a novel role for a class of receptors, called dependence receptors, in regulating vessel stability and BBB integrity after CCI injury in mice. Specifically, we identified that EphB3 receptors function as a pro-apoptotic dependence receptor in endothelial cells (ECs) that contributes to increased BBB damage after CCI injury. In the absence of EphB3, we observed increased endothelial cell survival, reduced BBB permeability and enhanced interactions of astrocyte-EC membranes. Interestingly, the brain's response to CCI injury is to reduce EphB3 levels and its ligand ephrinB3; however, the degree and timing of those reductions limit the protective response of the CNS. We conclude that EphB3 is a negative regulator of cell survival and BBB integrity that undermine tissue repair, and represents a protective therapeutic target for TBI patients.	[Assis-Nascimento, Poincyane; Tsenkina, Yanina; Liebl, Daniel J.] Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, 1095 NW 14th Terrace,R-48, Miami, FL 33136 USA		Liebl, DJ (corresponding author), Univ Miami, Miller Sch Med, Miami Project Cure Paralysis, Dept Neurol Surg, 1095 NW 14th Terrace,R-48, Miami, FL 33136 USA.	dliebl@miami.edu			Miami Project to Cure Paralysis, NIH/NINDS [NS049545, NS098740, F31NS089325]; Lois Pope Life foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS098740, R01NS049545, F31NS089325] Funding Source: NIH RePORTER	We also thank Maria L. Cepero for technical assistance, Jose Mier for assistance with animal husbandry, Dr. Melissa M. Carballosa-Gautam for assistance with microscopes and imaging analysis software, and Dr. Claudia Rodrigues for providing and assisting in culturing HUVECs. This work was supported by the Miami Project to Cure Paralysis, NIH/NINDS NS049545, NS098740 (D.J.L.), F31NS089325 (P.A.N.) and the Lois Pope Life foundation.	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Adams RH, 1999, GENE DEV, V13, P295, DOI 10.1101/gad.13.3.295; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Abengozar MA, 2012, BLOOD, V119, P4565, DOI 10.1182/blood-2011-09-380006; Anselmo A, 2016, CELL DEATH DIFFER, V23, P1322, DOI 10.1038/cdd.2016.10; Assis-Nascimento P, 2016, J NEUROSCI METH, V263, P57, DOI 10.1016/j.jneumeth.2016.01.025; Badaut J, 2014, TRANSL STROKE RES, V5, P394, DOI 10.1007/s12975-013-0304-z; Barber AJ, 1997, DEV DYNAM, V208, P62, DOI 10.1002/(SICI)1097-0177(199701)208:1<62::AID-AJA6>3.0.CO;2-#; Beck H, 2009, ACTA NEUROPATHOL, V117, P481, DOI 10.1007/s00401-009-0483-6; Bell RD, 2010, NEURON, V68, P409, DOI 10.1016/j.neuron.2010.09.043; Bermpohl D, 2007, J CEREBR BLOOD F MET, V27, P1806, DOI 10.1038/sj.jcbfm.9600487; Blits-Huizinga CT, 2004, IUBMB LIFE, V56, P257, DOI 10.1080/15216540412331270076; Chen X, 2013, ACTA RADIOL, V54, P313, DOI 10.1258/ar.2012.120605; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; del Valle K, 2011, INT J DEV NEUROSCI, V29, P9, DOI 10.1016/j.ijdevneu.2010.10.005; DiPietro LA, 2016, J LEUKOCYTE BIOL, V100, P979, DOI 10.1189/jlb.4MR0316-102R; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; Foo SS, 2006, CELL, V124, P161, DOI 10.1016/j.cell.2005.10.034; Foubert P, 2007, J CLIN INVEST, V117, P1527, DOI 10.1172/JCI28338; Furne C, 2009, BBA-MOL CELL RES, V1793, P231, DOI 10.1016/j.bbamcr.2008.09.009; Gao X, 2013, EXP NEUROL, V239, P38, DOI 10.1016/j.expneurol.2012.09.012; Gibert B, 2015, CANCER RES, V75, P5171, DOI 10.1158/0008-5472.CAN-14-3652; Goldschneider D, 2010, ONCOGENE, V29, P1865, DOI 10.1038/onc.2010.13; Goldshmit Y, 2006, BRAIN RES REV, V52, P327, DOI 10.1016/j.brainresrev.2006.04.006; Greenberg JI, 2008, NATURE, V456, P809, DOI 10.1038/nature07424; Guo XB, 2009, J NEUROTRAUM, V26, P1337, DOI [10.1089/neu.2008.0733, 10.1089/neu.2008-0733]; Hayashi T, 2003, J CEREBR BLOOD F MET, V23, P166, DOI 10.1097/00004647-200302000-00004; Henkemeyer M, 1996, CELL, V86, P35, DOI 10.1016/S0092-8674(00)80075-6; Herbert SP, 2009, SCIENCE, V326, P294, DOI 10.1126/science.1178577; Klein R, 2012, DEVELOPMENT, V139, P4105, DOI 10.1242/dev.074997; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mackenzie F, 2012, DEVELOPMENT, V139, P1371, DOI 10.1242/dev.072348; Mehlen P, 2004, APOPTOSIS, V9, P37, DOI 10.1023/B:APPT.0000012120.66221.b2; Meier P, 2000, NATURE, V407, P796, DOI 10.1038/35037734; Melero-Martin JM, 2007, BLOOD, V109, P4761, DOI 10.1182/blood-2006-12-062471; Milner R, 2008, MOL CELL NEUROSCI, V38, P43, DOI 10.1016/j.mcn.2008.01.013; Morgan R, 2007, NEUROL RES, V29, P375, DOI 10.1179/016164107X204693; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Nelersa CM, 2012, J BIOMOL SCREEN, V17, P785, DOI 10.1177/1087057112440880; Nikolakopoulou AM, 2016, ASN NEURO, V8, DOI 10.1177/1759091416630220; Nishida H, 2007, J NEUROSCI, V27, P331, DOI 10.1523/JNEUROSCI.4466-06.2007; Orioli D, 1996, EMBO J, V15, P6035, DOI 10.1002/j.1460-2075.1996.tb00992.x; Overman JJ, 2012, P NATL ACAD SCI USA, V109, pE2230, DOI 10.1073/pnas.1204386109; Palmer A, 2003, GENE DEV, V17, P1429, DOI 10.1101/gad.1093703; Pasquale EB, 2004, NAT NEUROSCI, V7, P417, DOI 10.1038/nn0504-417; Pearn ML, 2017, CELL MOL NEUROBIOL, V37, P571, DOI 10.1007/s10571-016-0400-1; Price L., 2016, FRONTIERS NEUROSCIEN; Ricard J, 2006, MOL CELL NEUROSCI, V31, P713, DOI 10.1016/j.mcn.2006.01.002; Salvucci O, 2006, BLOOD, V108, P2914, DOI 10.1182/blood-2006-05-023341; Salvucci O, 2012, ADV CANCER RES, V114, P21, DOI 10.1016/B978-0-12-386503-8.00002-8; Sayers EW, 2012, NUCLEIC ACIDS RES, V40, pD13, DOI 10.1093/nar/gkr1184; Schindelin J, 2012, NAT METHODS, V9, P676, DOI [10.1038/NMETH.2019, 10.1038/nmeth.2019]; Segura I, 2009, TRENDS MOL MED, V15, P439, DOI 10.1016/j.molmed.2009.08.005; Sorensen I, 2009, BLOOD, V113, P5680, DOI 10.1182/blood-2008-08-174508; Sordillo PP, 2016, BRAIN INJURY, V30, P1043, DOI 10.3109/02699052.2016.1163618; Thau-Zuchman O, 2012, NEUROSCIENCE, V202, P334, DOI 10.1016/j.neuroscience.2011.11.071; Thau-Zuchman O, 2012, J MOL NEUROSCI, V47, P166, DOI 10.1007/s12031-012-9706-8; Theus MH, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.165; Theus MH, 2010, STEM CELLS, V28, P1231, DOI 10.1002/stem.449; Tigges U, 2012, MICROVASC RES, V84, P74, DOI 10.1016/j.mvr.2012.03.008; Timmermans F, 2009, J CELL MOL MED, V13, P87, DOI 10.1111/j.1582-4934.2008.00598.x; Tsenkina Y, 2015, CELL DEATH DIS, V6, DOI 10.1038/cddis.2015.262; Umeda N, 2004, AM J OPHTHALMOL, V138, P270, DOI 10.1016/j.ajo.2004.04.006; Untergasser A, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks596; Wolburg H, 2009, CELL TISSUE RES, V335, P75, DOI 10.1007/s00441-008-0658-9; Wolburg H, 2009, NEUROSCIENTIST, V15, P180, DOI 10.1177/1073858408329509; Xue S, 2010, NEUROSCI LETT, V473, P186, DOI 10.1016/j.neulet.2010.02.035; Yokoyama N, 2001, NEURON, V29, P85, DOI 10.1016/S0896-6273(01)00182-9; Zhuang ZY, 2010, J NEUROSCI, V30, P16015, DOI 10.1523/JNEUROSCI.0481-10.2010	69	15	17	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	JAN 8	2018	9								7	10.1038/s41419-017-0016-5			15	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FZ1OH	WOS:000427346100001	29311672	Green Published, gold			2022-02-06	
S	Albornoz, EA; Woodruff, TM; Gordon, R		Cordero, MD; AlcocerGomez, E		Albornoz, Eduardo A.; Woodruff, Trent M.; Gordon, Richard			Inflammasomes in CNS Diseases	INFLAMMASOMES: CLINICAL AND THERAPEUTIC IMPLICATIONS	Experientia Supplementum		English	Article; Book Chapter						Neuroinflammation; Neurodegeneration; NLRP3; Inflammasome; Microglia; IL-1 beta; ASC	TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; EXPERIMENTAL AUTOIMMUNE ENCEPHALOMYELITIS; PATTERN-RECOGNITION RECEPTORS; NLRP3 INFLAMMASOME; PARKINSONS-DISEASE; MULTIPLE-SCLEROSIS; CEREBROSPINAL-FLUID; ALZHEIMERS-DISEASE; IMMUNE-RESPONSE	Neuroinflammation is a common pathological feature in almost all neurological diseases and is a response triggered as a consequence of the chronic activation of the innate immune response in the CNS against a variety of stimuli, including infection, traumatic brain injury, toxic metabolites, aggregated proteins, or autoimmunity. Crucial mediators of this neurinflammatory process are the intracellular protein complexes known as inflammasomes which can be triggered by pathogens as well as pathogen-associated molecular patterns (PAMPs) and damage-associated molecular patterns (DAMPs). However, chronic inflammasome activation can eventually result in cellular death and tissue damage, leading to the release of DAMPs that can reactivate the inflammasome, thereby propagating a vicious cycle of inflammation. The primary cells involved in CNS inflammasome activation are the immunocompetent microglia and the infiltrating macrophages into the CNS. However, astrocytes and neurons also express inflammasomes, and the understanding of how they are engaged in the pathogenesis of a variety of neurological diseases is crucial to develop effective therapeutic approaches for CNS pathologies that are propagated by chronic inflammasome activation. This chapter covers the activation mechanisms of relevant inflammasomes in the brain and summarizes their roles in the pathogenesis and progression of different neurological conditions.	[Albornoz, Eduardo A.; Woodruff, Trent M.; Gordon, Richard] Univ Queensland, Sch Biomed Sci, Fac Med, Brisbane, Qld, Australia; [Gordon, Richard] Univ Queensland, UQ Ctr Clin Res, Fac Med, Brisbane, Qld, Australia		Gordon, R (corresponding author), Univ Queensland, Sch Biomed Sci, Fac Med, Brisbane, Qld, Australia.; Gordon, R (corresponding author), Univ Queensland, UQ Ctr Clin Res, Fac Med, Brisbane, Qld, Australia.	r.gordon1@uq.edu.au	Gordon, Richard/E-8222-2016; Woodruff, Trent/AAS-4629-2020; Albornoz, Eduardo A/D-2681-2017; Woodruff, Trent M./B-4861-2009; Woodruff, Trent M/ABF-1428-2020	Gordon, Richard/0000-0003-2478-4607; Woodruff, Trent/0000-0003-1382-911X; Albornoz, Eduardo A/0000-0002-9976-6350; Woodruff, Trent M./0000-0003-1382-911X; Woodruff, Trent M/0000-0003-1382-911X			Abulafia DP, 2009, J CEREBR BLOOD F MET, V29, P534, DOI 10.1038/jcbfm.2008.143; Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Alboni S, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-9; Alcocer-Gomez E, 2014, BRAIN BEHAV IMMUN, V36, P111, DOI 10.1016/j.bbi.2013.10.017; Allan SM, 2005, NAT REV IMMUNOL, V5, P629, DOI 10.1038/nri1664; Bamberger ME, 2003, J NEUROSCI, V23, P2665; Barclay W, 2017, BRAIN PATHOL, V27, P213, DOI 10.1111/bpa.12477; Baroja-Mazo A, 2014, NAT IMMUNOL, V15, P738, DOI 10.1038/ni.2919; Barrington J, 2017, BRAIN PATHOL, V27, P205, DOI 10.1111/bpa.12476; Boxer MB, 2010, CHEMMEDCHEM, V5, P730, DOI 10.1002/cmdc.200900531; Bruck W, 2005, J NEUROL, V252, P10, DOI 10.1007/s00415-005-2011-5; Carson MJ, 2006, IMMUNOL REV, V213, P48, DOI 10.1111/j.1600-065X.2006.00441.x; Codolo G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0055375; Coll RC, 2015, NAT MED, V21, P248, DOI 10.1038/nm.3806; Compston A, 2008, LANCET, V372, P1502, DOI 10.1016/S0140-6736(08)61620-7; Coureuil M, 2017, NAT REV MICROBIOL, V15, P149, DOI 10.1038/nrmicro.2016.178; Cutler RG, 2004, P NATL ACAD SCI USA, V101, P2070, DOI 10.1073/pnas.0305799101; Daniels MJD, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms12504; Doens D, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-48; Dong YS, 2001, GLIA, V36, P180, DOI 10.1002/glia.1107; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; Fan KH, 2017, CHEM-BIOL INTERACT, V271, P15, DOI 10.1016/j.cbi.2017.04.021; Fann DYW, 2018, MOL NEUROBIOL, V55, P1082, DOI 10.1007/s12035-017-0394-9; Farina C, 2007, TRENDS IMMUNOL, V28, P138, DOI 10.1016/j.it.2007.01.005; Faustin B, 2007, MOL CELL, V25, P713, DOI 10.1016/j.molcel.2007.01.032; Feigin VL, 2014, LANCET, V383, P245, DOI 10.1016/S0140-6736(13)61953-4; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Franklin BS, 2014, NAT IMMUNOL, V15, P727, DOI 10.1038/ni.2913; Friedlander RM, 1997, J EXP MED, V185, P933, DOI 10.1084/jem.185.5.933; Friedrich RP, 2010, P NATL ACAD SCI USA, V107, P1942, DOI 10.1073/pnas.0904532106; Furman D, 2017, NAT MED, V23, P174, DOI 10.1038/nm.4267; Geldhoff M, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-358; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Gris D, 2010, J IMMUNOL, V185, P974, DOI 10.4049/jimmunol.0904145; Guo CQ, 2017, ACS CHEM NEUROSCI, V8, P2194, DOI 10.1021/acschemneuro.7b00124; Guo HT, 2015, NAT MED, V21, P677, DOI 10.1038/nm.3893; Gustot A, 2015, BIOCHEM J, V471, P323, DOI 10.1042/BJ20150617; Hanamsagar R, 2011, J NEUROCHEM, V119, P736, DOI 10.1111/j.1471-4159.2011.07481.x; Hancock DB, 2008, BMC NEUROL, V8, DOI 10.1186/1471-2377-8-6; Heidary M, 2014, J NEUROL SCI, V343, P41, DOI 10.1016/j.jns.2014.05.013; Heneka MT, 2017, BRAIN PATHOL, V27, P220, DOI 10.1111/bpa.12483; Heneka MT, 2014, NAT REV IMMUNOL, V14, P463, DOI 10.1038/nri3705; Heneka MT, 2013, NATURE, V493, P674, DOI 10.1038/nature11729; Hoegen T, 2011, J IMMUNOL, V187, P5440, DOI 10.4049/jimmunol.1100790; Huang WX, 2004, MULT SCLER J, V10, P482, DOI 10.1191/1352458504ms1071oa; Inoue M, 2013, AUTOIMMUN DIS, V2013, DOI 10.1155/2013/859145; Johann S, 2015, GLIA, V63, P2260, DOI 10.1002/glia.22891; Kabba JA, 2018, CELL MOL NEUROBIOL, V38, P53, DOI 10.1007/s10571-017-0504-2; Kaushal V, 2015, CELL DEATH DIFFER, V22, P1676, DOI 10.1038/cdd.2015.16; Kaushik DK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032270; Kigerl KA, 2014, EXP NEUROL, V258, P5, DOI 10.1016/j.expneurol.2014.01.001; Kim JY, 2015, ONCOTARGET, V6, P44161, DOI 10.18632/oncotarget.6592; Klein RS, 2017, NAT IMMUNOL, V18, P132, DOI 10.1038/ni.3656; Koyuncu OO, 2013, CELL HOST MICROBE, V13, P379, DOI 10.1016/j.chom.2013.03.010; Kuklina EV, 2012, EXPERT REV NEUROTHER, V12, P199, DOI [10.1586/ern.11.99, 10.1586/ERN.11.99]; Kumar M, 2013, J VIROL, V87, P3655, DOI 10.1128/JVI.02667-12; Lammerding L, 2016, NEUROENDOCRINOLOGY, V103, P460, DOI 10.1159/000439435; Latz E, 2013, NAT REV IMMUNOL, V13, P397, DOI 10.1038/nri3452; Lawana V, 2017, J NEUROIMMUNE PHARM, V12, P624, DOI 10.1007/s11481-017-9746-5; Levin HS, 2015, LANCET NEUROL, V14, P506, DOI 10.1016/S1474-4422(15)00002-2; Liang YR, 2015, BRAIN RES, V1622, P43, DOI 10.1016/j.brainres.2015.06.008; Lin C, 2017, EXP NEUROL, V290, P115, DOI 10.1016/j.expneurol.2017.01.005; Lipinska K, 2014, J IMMUNOL METHODS, V411, P66, DOI 10.1016/j.jim.2014.05.018; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Losy J, 2001, ACTA NEUROL SCAND, V104, P171, DOI 10.1034/j.1600-0404.2001.00356.x; Lotharius J, 2002, NAT REV NEUROSCI, V3, P932, DOI 10.1038/nrn983; Louveau A, 2015, NATURE, V523, P337, DOI 10.1038/nature14432; Louyeau A, 2015, TRENDS IMMUNOL, V36, P569, DOI 10.1016/j.it.2015.08.006; Lu M, 2014, NEUROBIOL AGING, V35, P421, DOI 10.1016/j.neurobiolaging.2013.08.015; Luo XG, 2010, MOL NEURODEGENER, V5, DOI 10.1186/1750-1326-5-12; Ma J, 2016, INFLAMMATION, V39, P2094, DOI 10.1007/s10753-016-0446-8; Man SM, 2014, P NATL ACAD SCI USA, V111, P7403, DOI 10.1073/pnas.1402911111; Mao ZJ, 2017, NEUROCHEM RES, V42, P1104, DOI 10.1007/s11064-017-2185-0; Martinon F, 2002, MOL CELL, V10, P417, DOI 10.1016/S1097-2765(02)00599-3; Mhyre Timothy R, 2012, Subcell Biochem, V65, P389, DOI 10.1007/978-94-007-5416-4_16; Ming X, 2002, J NEUROL SCI, V197, P9, DOI 10.1016/S0022-510X(02)00030-8; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Nyul-Toth A, 2017, BRAIN BEHAV IMMUN, V64, P220, DOI 10.1016/j.bbi.2017.04.010; Obeso JA, 2010, NAT MED, V16, P653, DOI 10.1038/nm.2165; Panov A, 2005, J BIOL CHEM, V280, P42026, DOI 10.1074/jbc.M508628200; Rabuffetti M, 2000, J NEUROSCI, V20, P4398, DOI 10.1523/JNEUROSCI.20-12-04398.2000; Ross J, 2007, NEUROPHARMACOLOGY, V53, P638, DOI 10.1016/j.neuropharm.2007.07.015; Rothwell NJ, 2000, TRENDS NEUROSCI, V23, P618, DOI 10.1016/S0166-2236(00)01661-1; Russo FB, 2017, CELL MICROBIOL, V19, DOI 10.1111/cmi.12744; Sajnani G, 2012, PLOS PATHOG, V8, DOI 10.1371/journal.ppat.1002547; Salminen A, 2009, PROG NEUROBIOL, V87, P181, DOI 10.1016/j.pneurobio.2009.01.001; Saresella M, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0088-1; Schapira AHV, 2006, NAT REV DRUG DISCOV, V5, P845, DOI 10.1038/nrd2087; Shi MQ, 2016, FRONT IMMUNOL, V7, DOI 10.3389/fimmu.2016.00292; Singhal G, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00315; Song LM, 2017, FRONT CELL NEUROSCI, V11, DOI 10.3389/fncel.2017.00063; Spittau B, 2017, FRONT AGING NEUROSCI, V9, DOI 10.3389/fnagi.2017.00194; Tan MS, 2014, CELL DEATH DIS E, V1382, P5; Tang Y, 2016, MOL NEUROBIOL, V53, P1181, DOI 10.1007/s12035-014-9070-5; Tarawneh R, 2012, COLD SPRING HARB PER, V2, DOI DOI 10.1101/CSHPERSPECT.A006148; Thonnings S, 2016, CLIN MICROBIOL INFEC, V22, P725, DOI 10.1016/j.cmi.2016.06.006; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Venegas C, 2017, NATURE, V552, P355, DOI 10.1038/nature25158; Waisman A, 2015, TRENDS IMMUNOL, V36, P625, DOI 10.1016/j.it.2015.08.005; Wallisch JS, 2017, NEUROCRIT CARE, V27, P44, DOI 10.1007/s12028-017-0378-7; Walsh JG, 2014, NAT REV NEUROSCI, V15, P84, DOI 10.1038/nrn3638; Wang W, 2016, P NATL ACAD SCI USA, V113, P9587, DOI 10.1073/pnas.1610099113; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; White CS, 2017, BRAIN PATHOL, V27, P223, DOI 10.1111/bpa.12478; Wu JH, 2010, J CLIN IMMUNOL, V30, P693, DOI 10.1007/s10875-010-9425-2; Wyss-Coray T, 2016, NATURE, V539, P180, DOI 10.1038/nature20411; Yan YQ, 2015, CELL, V160, P62, DOI 10.1016/j.cell.2014.11.047; Yang F, 2014, J CEREBR BLOOD F MET, V34, P660, DOI 10.1038/jcbfm.2013.242; Ye XC, 2017, EXP NEUROL, V292, P46, DOI 10.1016/j.expneurol.2017.03.002; Yiannopoulou KG, 2013, THER ADV NEUROL DISO, V6, P19, DOI 10.1177/1756285612461679; Yong VW, 2010, NEUROSCIENTIST, V16, P408, DOI 10.1177/1073858410371379; Youm YH, 2015, NAT MED, V21, P263, DOI 10.1038/nm.3804; Zhang P, 2016, MOVEMENT DISORD, V31, P366, DOI 10.1002/mds.26488; Zhou Y, 2016, MOL NEURODEGENER, V11, DOI 10.1186/s13024-016-0094-3	114	15	15	0	2	SPRINGER INTERNATIONAL PUBLISHING AG	CHAM	GEWERBESTRASSE 11, CHAM, CH-6330, SWITZERLAND	1023-294X		978-3-319-89390-7; 978-3-319-89389-1	EXPERIENTIA SUPPL	Exp. Suppl.		2018	108						41	60		10.1007/978-3-319-89390-7_3	10.1007/978-3-319-89390-7		20	Biochemistry & Molecular Biology; Cell Biology; Medicine, Research & Experimental	Book Citation Index – Science (BKCI-S)	Biochemistry & Molecular Biology; Cell Biology; Research & Experimental Medicine	BL8LR	WOS:000456615100003	30536167				2022-02-06	
J	Attard, MC; Loupis, Y; Togher, L; Rose, ML				Attard, Michelle C.; Loupis, Yasmine; Togher, Leanne; Rose, Miranda L.			The efficacy of an inter-disciplinary community aphasia group for living well with aphasia	APHASIOLOGY			English	Article						Aphasia; community; group; interdisciplinary; spouses	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; FAMILY-MEMBERS; COMMUNICATION PARTNERS; SUPPORTED CONVERSATION; STROKE REHABILITATION; SOCIAL-PARTICIPATION; PEOPLE; THERAPY; ADULTS	Background: Community aphasia groups (CAGs) are argued to have various benefits for people with chronic aphasia. However, there is a paucity of evidence regarding the feasibility of conducting an interdisciplinary programme with content and outcomemeasures encompassing ICF domains, making it difficult to ascertain the full potential of this service option. As another key population living with aphasia, familymembers have received little attention in CAGresearch to date. Aim: To determine potential efficacy of a speech-language pathologist- and social worker-led CAG model for four people with aphasia (PWA) and their spouses on living well with aphasia within a proof-of-concept trial. Methods & Procedures: Informed by extensive study of the existing CAG literature, we developed a comprehensive 12-week interdisciplinary CAG model and trial protocol (the InterD-CAG). We used a Phase I pre-post design with a follow-up phase. The group was co-facilitated by a speech-language pathologist and social worker with support fromaide staff. The group met at a university clinic for 2 h per week over 12 consecutive weeks. The protocol comprised a combination of communication therapy; conversation practice; social, peer, and psychological support; stroke and aphasia information; and participation in meaningful and accessible activities. Group session time was split into two formats: (1) concurrent sessions dedicated to members with aphasia alone/spouses alone and (2) mixed sessions with both members with aphasia and spouses together. The Therapeutic Factors Inventory was administered at regular intervals during the programme to ascertain participants' perceptions of group process. Pre, post, and follow-up outcome measures spanned all WHO ICF domains for PWA, with measures for spouses addressing supported conversation skills, psychological health, and carer burden. Outcomes & Results: Both PWA and spouses perceived the presence of therapeutic factors to be medium or high by Week 12 in the programme. Our hypotheses for significant improvement for PWA in quality of life, aphasia impairment, activity & participation, and contextual factors were partially supported and maintenance of gains was observed in some cases. No clear changes were evident for spouses. Conclusions: This study contributes preliminary evidence for the efficacy of the InterD-CAG model for people with chronic aphasia. Larger-scale studies with comparison groups are required to build on the present findings with specific attention to spouse support needs.	[Attard, Michelle C.; Rose, Miranda L.] La Trobe Univ, Sch Allied Hlth, Melbourne, Vic, Australia; [Loupis, Yasmine] St Vincents Hosp, Social Work, Sydney, NSW, Australia; [Togher, Leanne] Univ Sydney, Fac Hlth Sci, Sydney, NSW, Australia		Rose, ML (corresponding author), La Trobe Univ, Sch Allied Hlth, Bundoora, Vic 3086, Australia.	m.rose@latrobe.edu.au	Togher, Leanne/AAC-7083-2019; Rose, Miranda/P-7995-2015	Rose, Miranda/0000-0002-8892-0965; Togher, Leanne/0000-0002-4518-6748	Australian Research CouncilAustralian Research Council [1010061]; Australian Postgraduate AwardAustralian Government; NHMRCNational Health and Medical Research Council of Australia	This work was supported by the Australian Research Council Future Fellowship under grant #1010061 (fourth author). The first author was supported by an Australian Postgraduate Award and a Postgraduate top-up studentship. The third author was supported by an NHMRC Senior Research Fellowship.	Abels P., 2006, STANDARDS SOCIAL WOR; Adair Ewing S, 2007, GROUP TREATMENT NEUR, P11; Armstrong E, 2000, APHASIOLOGY, V14, P875, DOI 10.1080/02687030050127685; Attard M., STAFF EXPERIENCES IN; Attard M., EXPERIENCES PEOPLE S; Attard MC, 2015, APHASIOLOGY, V29, P983, DOI 10.1080/02687038.2015.1016888; Australian Association of Social Workers, 2013, PRACT STAND; Babbitt EM, 2016, TOP LANG DISORD, V36, P168, DOI 10.1097/TLD.0000000000000089; Babbitt EM, 2011, APHASIOLOGY, V25, P727, DOI 10.1080/02687038.2010.537347; Bakas T, 2006, NURS RES, V55, P346, DOI 10.1097/00006199-200609000-00007; Beeke S., 2016, WORKSH 17 INT APH RE; Beeke S, 2015, APHASIOLOGY, V29, P355, DOI 10.1080/02687038.2014.881459; Beesley K, 2011, DISABIL REHABIL, V33, P2346, DOI 10.3109/09638288.2011.571333; BERTCHER H, 1994, GROUP PARTICIPATION; Blackstone S., 2003, SOCIAL NETWORKS COMM; BORENSTEIN P, 1987, SCAND J REHABIL MED, V19, P51; Cherney Leora R., 2011, Seminars in Speech and Language, V32, P229, DOI 10.1055/s-0031-1286177; Corsten S, 2015, INT J LANG COMM DIS, V50, P788, DOI 10.1111/1460-6984.12173; Corsten S, 2014, APHASIOLOGY, V28, P440, DOI 10.1080/02687038.2013.843154; Cruice M, 2005, APHASIOLOGY, V19, P111, DOI 10.1080/02687030444000651; Cruice M, 2006, APHASIOLOGY, V20, P1210, DOI 10.1080/02687030600790136; Dalton D., 2017, PHASE I PROOF UNPUB; Davidson B, 2008, TOP STROKE REHABIL, V15, P325, DOI 10.1310/tsr1504-325; Deloitte Access Economics, 2013, EC IMP STROK AUSTR; Duke W, 2013, STROKE, V44, pE194; Elman R. J., 2007, GROUP TREATMENT NEUR; Elman RJ, 1999, J SPEECH LANG HEAR R, V42, P411, DOI 10.1044/jslhr.4202.411; Goldberg D., 1978, MANUAL GEN HLTH QUES; Goldberg D., 1972, DETECTION PSYCHIAT I; GOLDBERG DP, 1979, PSYCHOL MED, V9, P139, DOI 10.1017/S0033291700021644; Grawburg M, 2014, DISABIL REHABIL, V36, P1184, DOI 10.3109/09638288.2013.834984; Grawburg M, 2013, APHASIOLOGY, V27, P828, DOI 10.1080/02687038.2013.768330; Grawburg M, 2013, DISABIL REHABIL, V35, P1324, DOI 10.3109/09638288.2012.735341; Hartke RJ, 2007, TOP STROKE REHABIL, V14, P26, DOI 10.1310/tsr1401-26; Hebert D, 2016, INT J STROKE, V11, P459, DOI 10.1177/1747493016643553; Hersh D., 2000, ACQ ISSUES LANGUAGE, V2, P88; Hilari K, 2010, CLIN REHABIL, V24, P181, DOI 10.1177/0269215509346090; Hilari K, 2009, INT J LANG COMM DIS, V44, P193, DOI 10.1080/13682820802008820; Hinckley Jacqueline J, 1995, Top Stroke Rehabil, V2, P53; Hinckley JJ, 2001, J COMMUN DISORD, V34, P241, DOI 10.1016/S0021-9924(01)00049-1; Hoen B, 1997, APHASIOLOGY, V11, P681, DOI 10.1080/02687039708249415; Hula W, 2010, APHASIOLOGY, V24, P1326, DOI 10.1080/02687030903422502; Johannsen-Horbach Helga, 1999, Seminars in Speech and Language, V20, P73, DOI 10.1055/s-2008-1064010; Joyce AS, 2011, GROUP DYN-THEOR RES, V15, P201, DOI 10.1037/a0024677; Kagan A, 1998, APHASIOLOGY, V12, P816, DOI 10.1080/02687039808249575; Kagan A, 2001, J SPEECH LANG HEAR R, V44, P624, DOI 10.1044/1092-4388(2001/051); Kagan A., 2011, ASSESSMENT LIVING AP; Kagan Aura, 2004, Top Stroke Rehabil, V11, P67; KEARNS KP, 2001, LANGUAGE INTERVENTIO, P316; Kertesz A., 2007, WAB R W APHASIA BATT; Kovesy L., 2017, PHASE I PROOF UNPUB; Lanyon LE, 2013, INT J SPEECH-LANG PA, V15, P359, DOI 10.3109/17549507.2012.752865; Le Dorze G, 2010, DISABIL REHABIL, V32, P1073, DOI 10.3109/09638280903374121; LEDORZE G, 1995, APHASIOLOGY, V9, P239; LESSER R, 1978, BRIT MED J, V2, P1045, DOI 10.1136/bmj.2.6144.1045; Levin T, 2007, TOP STROKE REHABIL, V14, P72, DOI 10.1310/tsr1401-72; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; Marshall R., 1993, AM J SPEECH-LANG PAT, V2, P31, DOI DOI 10.1044/1058-0360.0202.31; Mayo NE, 2015, CLIN REHABIL, V29, P1198, DOI 10.1177/0269215514565396; Mumby K, 2012, INT J LANG COMM DIS, V47, P398, DOI 10.1111/j.1460-6984.2012.00153.x; National Clinical Guideline for Stroke, 2012, NAT CLIN GUID STROK; National Stroke Foundation, 2010, CLIN GUID STROK MAN; Northcott S, 2015, FOLIA PHONIATR LOGO, V67, P156, DOI 10.1159/000439217; Parr S., 1997, TALKING APHASIA LIVI; Perkins L, 1999, APHASIOLOGY, V13, P259, DOI 10.1080/026870399402091; Pimentel J., 2009, PERSPECTIVES GERONTO, V14, P12, DOI DOI 10.1044/GERO14.1.12; Purdy M, 2005, APHASIOLOGY, V19, P377, DOI 10.1080/02687030444000822; Purves BA, 2013, AM J SPEECH-LANG PAT, V22, pS370, DOI 10.1044/1058-0360(2013/12-0071); Reblin M, 2008, CURR OPIN PSYCHIATR, V21, P201, DOI 10.1097/YCO.0b013e3282f3ad89; RICE B, 1987, APHASIOLOGY, V1, P247, DOI DOI 10.1080/02687038708248841; Rodriguez AD, 2013, APHASIOLOGY, V27, P1339, DOI 10.1080/02687038.2013.825759; Rohde A, 2012, APHASIOLOGY, V26, P1298, DOI 10.1080/02687038.2012.706799; Rose M, 2014, INT J SPEECH-LANG PA, V16, P169, DOI 10.3109/17549507.2013.794474; Rose ML, 2015, INT J SPEECH-LANG PA, V17, P241, DOI 10.3109/17549507.2015.1010582; Ross A, 2006, APHASIOLOGY, V20, P427, DOI 10.1080/02687030500532786; SARASON IG, 1986, J PERS SOC PSYCHOL, V50, P845, DOI 10.1037/0022-3514.50.4.845; Schlosser RW, 2004, J COMMUN DISORD, V37, P217, DOI 10.1016/j.jcomdis.2003.09.003; Sekhon JK, 2015, INT J SPEECH-LANG PA, V17, P252, DOI 10.3109/17549507.2015.1024170; Shadden BB, 2005, APHASIOLOGY, V19, P211, DOI 10.1080/02687930444000697; Simmons-Mackie N, 2007, TOP LANG DISORD, V27, P5, DOI 10.1097/00011363-200701000-00003; Simmons-Mackie N, 2010, ARCH PHYS MED REHAB, V91, P1814, DOI 10.1016/j.apmr.2010.08.026; Sutcliffe LM, 1998, CLIN REHABIL, V12, P506, DOI 10.1191/026921598672167702; Tamplin J, 2013, NEUROREHABILITATION, V32, P929, DOI 10.3233/NRE-130916; Tarrant M, 2016, BMJ OPEN, V6, DOI 10.1136/bmjopen-2015-009652; Togher L, 2013, J REHABIL MED, V45, P637, DOI 10.2340/16501977-1173; Togher L, 2010, APHASIOLOGY, V24, P914, DOI 10.1080/02687030903422478; Tregea S, 2013, APHASIOLOGY, V27, P581, DOI 10.1080/02687038.2013.796506; van der Gaag A, 2005, CLIN REHABIL, V19, P372, DOI 10.1191/0269215505cr785oa; Wallace SJ, 2017, APHASIOLOGY, V31, P643, DOI 10.1080/02687038.2016.1186265; Wallace SJ, 2017, DISABIL REHABIL, V39, P1364, DOI 10.1080/09638288.2016.1194899; Wallace SJ, 2014, APHASIOLOGY, V28, P1364, DOI 10.1080/02687038.2014.930262; Webber M, 2017, SOC PSYCH PSYCH EPID, V52, P369, DOI 10.1007/s00127-017-1372-2; Wilkinson R, 2010, APHASIOLOGY, V24, P869, DOI 10.1080/02687030903501958; Winstein CJ, 2016, STROKE, V47, pE98, DOI 10.1161/STR.0000000000000098; World Health Organization, 2007, INT CLASS FUNCT DIS; Worrall L, 2011, APHASIOLOGY, V25, P309, DOI 10.1080/02687038.2010.508530; Yalom I. D., 2005, THEORY PRACTICE GROU, V5th; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	98	15	16	1	17	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-7038	1464-5041		APHASIOLOGY	Aphasiology		2018	32	2					105	138		10.1080/02687038.2017.1381877			34	Audiology & Speech-Language Pathology; Linguistics; Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Audiology & Speech-Language Pathology; Linguistics; Neurosciences & Neurology; Rehabilitation	FY9PQ	WOS:000427199100001					2022-02-06	
J	Chimeh, U; Zimmerman, MA; Gilyazova, N; Li, PA				Chimeh, Uchechukwu; Zimmerman, Mary Ann; Gilyazova, Nailya; Li, P. Andy			B355252, A Novel Small Molecule, Confers Neuroprotection Against Cobalt Chloride Toxicity In Mouse Hippocampal Cells Through Altering Mitochondrial Dynamics And Limiting Autophagy Induction	INTERNATIONAL JOURNAL OF MEDICAL SCIENCES			English	Article						Hypoxia; mitochondrial dynamics; cobalt chloride; B355252; fusion; fission	ISCHEMIA-REPERFUSION INJURY; HYPOXIA-INDUCIBLE FACTOR; PROTEIN DRP1; HEART; MITOPHAGY; FISSION; STROKE; DAMAGE; PATHOPHYSIOLOGY; RESPONSES	Cerebral hypoxia as often occurs in cases of stroke, hemorrhage, or other traumatic brain injuries, is one of the leading causes of death worldwide and a main driver of disabilities in the elderly. Using a chemical mimetic of hypoxia, cobalt chloride (CoCl2), we tested the ability of a novel small molecule, 4-chloro-N-(naphthalen-1-ylmethyl)-5-(3-(piperazin-1-yl)phenoxy)thiophene-2-sulfonamide (B355252), to alleviate CoCl2-induced damage in mouse hippocampal HT22 cells. A dose-dependent decrease in cell viability was observed during CoCl2 treatment along with increases in mitochondrial membrane potential and generation of reactive oxygen species (ROS). B355252 conferred protection against these changes. We further found that mitochondrial dynamics, the balance between mitochondrial fusion and fission, were perturbed by CoCl2 treatment. Mitochondrial fusion, which was assessed by measuring the expression of proteins optic atrophy protein 1 (OPAL) and mitofusin 2 (Mfn2), declined due to CoCl2 exposure, but B355252 addition was able to elevate Mfn2 expression while OPA1 expression was unchanged. Mitochondrial fission, measured by phosphorylated dynamin-related protein 1 (p-DRP1) and fission protein 1 (FIST) expression, also decreased following CoCl2 exposure, and was stabilized by B355252 addition. Finally, autophagy was assessed by measuring the conversion of cytosolic microtubule-associated protein 1A/1B-light chain three-I (LC3-I) to autophagosome-bound microtubule-associated protein 1A/1B-light chain three-II (LC3-II) and was found to be increased by CoCl2. B355252 addition significantly reduced autophagy induction. Taken together, our results indicate B355252 has therapeutic potential to reduce the damaging effects caused by CoCl2 and should be further evaluated for applications in cerebral ischemia therapy.	[Chimeh, Uchechukwu; Zimmerman, Mary Ann; Gilyazova, Nailya; Li, P. Andy] North Carolina Cent Univ, Biomfg Res Inst Biotechnol Enterprise BRITE, Dept Pharmaceut Sci, Durham, NC 27707 USA		Li, PA (corresponding author), North Carolina Cent Univ, Biomfg Res Inst Biotechnol Enterprise BRITE, Dept Pharmaceut Sci, Durham, NC 27707 USA.	pli@nccu.edu		Chimeh, Uchechukwu/0000-0002-1346-4088			American Heart Association, 2018, HEART DIS STROK STAT; Borutaite V, 2013, FEBS J, V280, P4999, DOI 10.1111/febs.12353; Burte F, 2015, NAT REV NEUROL, V11, P11, DOI 10.1038/nrneurol.2014.228; Chen WY, 2009, J IMMUNOL, V182, P5003, DOI 10.4049/jimmunol.0803653; Chen XL, 2017, J MOL NEUROSCI, V63, P267, DOI 10.1007/s12031-017-0976-z; Fang B, 2016, NEUROSCIENCE, V328, P107, DOI 10.1016/j.neuroscience.2016.04.019; Fang WL, 2017, CNS NEUROSCI THER, V23, P428, DOI 10.1111/cns.12689; Fluri F, 2015, DRUG DES DEV THER, V9, P3445, DOI 10.2147/DDDT.S56071; Frugier T, 2016, NEUROCHEM INT, V96, P62, DOI 10.1016/j.neuint.2016.02.016; Gallo S, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.155; Gao J, 2017, ANTIOXIDANTS-BASEL, V6, DOI 10.3390/antiox6020025; Ginet V, 2009, AM J PATHOL, V175, P1962, DOI 10.2353/ajpath.2009.090463; Gliyazova NS, 2016, CELL MOL NEUROBIOL, V36, P1109, DOI 10.1007/s10571-015-0304-5; Gliyazova NS, 2013, BMC NEUROSCI, V14, DOI 10.1186/1471-2202-14-93; Golpich M, 2017, CNS NEUROSCI THER, V23, P5, DOI 10.1111/cns.12655; Hagberg H, 2014, LANCET NEUROL, V13, P217, DOI 10.1016/S1474-4422(13)70261-8; Hossmann KA, 2006, CELL MOL NEUROBIOL, V26, P1057, DOI 10.1007/s10571-006-9008-1; Hu CX, 2017, INT J MOL SCI, V18, DOI 10.3390/ijms18010144; Jang Ah-Ram, 2016, Lab Anim Res, V32, P194, DOI 10.5625/lar.2016.32.4.194; Kageyama Y, 2014, EMBO J, V33, P2798, DOI 10.15252/embj.201488658; Knott AB, 2008, ANN NY ACAD SCI, V1147, P283, DOI 10.1196/annals.1427.030; Kumari S, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039382; Kumari S, 2012, TRANSL STROKE RES, V3, P296, DOI 10.1007/s12975-012-0158-9; Liu HY, 2016, INVEST OPHTH VIS SCI, V57, P1807, DOI 10.1167/iovs.15-18066; Lu Y, 2017, BMC ANESTHESIOL, V17, DOI 10.1186/s12871-017-0327-1; Manczak M, 2011, HUM MOL GENET, V20, P2495, DOI 10.1093/hmg/ddr139; Marin-Garcia J, 2016, HEART FAIL REV, V21, P123, DOI 10.1007/s10741-016-9530-2; Moustafa RR, 2008, BRIT J PHARMACOL, V153, pS44, DOI 10.1038/sj.bjp.0707530; Mozaffarian D, 2016, CIRCULATION, V133, pE38, DOI 10.1161/CIR.0000000000000350; Naves T, 2013, BIOCHEM PHARMACOL, V85, P1153, DOI 10.1016/j.bcp.2013.01.022; Nikonenko AG, 2009, ANAT REC, V292, P1914, DOI 10.1002/ar.20969; Panee J, 2007, INT J BIOL SCI, V3, P335; Peng C, 2015, INT J BIOCHEM CELL B, V69, P29, DOI 10.1016/j.biocel.2015.09.011; Qi YM, 2016, SCI REP-UK, V6, DOI 10.1038/srep24700; Qian W, 2012, J CELL SCI, V125, P5745, DOI 10.1242/jcs.109769; Ranieri M, 2013, NEUROL RES INT, V2013, DOI 10.1155/2013/293893; Sanderson TH, 2013, MOL NEUROBIOL, V47, P9, DOI 10.1007/s12035-012-8344-z; SCHAPER J, 1985, CIRC RES, V56, P377, DOI 10.1161/01.RES.56.3.377; Siddiq A, 2007, NEUROCHEM RES, V32, P931, DOI 10.1007/s11064-006-9268-7; Twig G, 2008, EMBO J, V27, P433, DOI 10.1038/sj.emboj.7601963; WHO, 2018, STROK CER ACC; Williams AL, 2010, TETRAHEDRON, V66, P9577, DOI 10.1016/j.tet.2010.09.028; Xu F, 2012, NEUROSCI BULL, V28, P658, DOI 10.1007/s12264-012-1268-9; Yang T, 2015, BRAIN RES, V1614, P60, DOI 10.1016/j.brainres.2015.04.016	44	15	16	0	7	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1449-1907			INT J MED SCI	Int. J. Med. Sci.		2018	15	12					1384	1396		10.7150/ijms.24702			13	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	GX5YA	WOS:000447830200017	30275767	Green Published, gold, Green Submitted			2022-02-06	
J	Donker-Cools, BHPM; Schouten, MJE; Wind, H; Frings-Dresen, MHW				Donker-Cools, Birgit H. P. M.; Schouten, Maria J. E.; Wind, Haije; Frings-Dresen, Monique H. W.			Return to work following acquired brain injury: the views of patients and employers	DISABILITY AND REHABILITATION			English	Article						Acquired brain injury; traumatic brain injury; stroke; return to work; qualitative research; barriers; facilitators	VOCATIONAL-REHABILITATION; QUALITATIVE RESEARCH; SOUTH-AFRICA; PEOPLE; PERSPECTIVES; CANCER; INDIVIDUALS; EXPERIENCES; SURVIVORS	Purpose: To investigate which factors are experienced as facilitators of or barriers to return to work (RTW), or as solutions to RTW-problems, by patients with acquired brain injury (ABI) and by employers. Design: Qualitative study. Method: Ten patients with ABI and seven employers participated in semi-structured interviews. Patients and employers were unrelated. Transcripts were open coded. Factors perceived to be facilitators, barriers, or solutions to RTW-problems were grouped on a thematic basis. Results: Both patients and employers distinguished patient-related and work-related facilitators. When questioned about barriers, both patients and employers emphasized the importance of work-related factors such as sensory overload at the workplace and condition-related factors such as fatigue. Patients regarded poor guidance and support as barriers, but employers did not. Employers and patients suggested that solutions to RTW-problems were work-related, if necessary backed up by professional supervision. Patients also mentioned the need for understanding and acceptance of the limitations resulting from ABI. Conclusions: Both patients and employers mentioned work-related and patient-related facilitators, work-related and condition-related barriers, and work-related solutions to RTW-problems. Patients mentioned lack of guidance and support as barriers, and stressed the need for understanding and acceptance of the limitations resulting from ABI in any RTW-solution.	[Donker-Cools, Birgit H. P. M.; Schouten, Maria J. E.; Wind, Haije; Frings-Dresen, Monique H. W.] Univ Amsterdam, Acad Med Ctr, Dept Coronel Inst Occupat Hlth, POB 22700, NL-1100 DE Amsterdam, Netherlands; [Donker-Cools, Birgit H. P. M.; Schouten, Maria J. E.; Wind, Haije; Frings-Dresen, Monique H. W.] Res Ctr Insurance Med, Amsterdam, Netherlands		Donker-Cools, BHPM (corresponding author), Univ Amsterdam, Acad Med Ctr, Dept Coronel Inst Occupat Hlth, POB 22700, NL-1100 DE Amsterdam, Netherlands.	b.h.cools@amc.uva.nl		Schouten, Maria/0000-0002-5844-3408			Amir Z, 2010, J OCCUP REHABIL, V20, P435, DOI 10.1007/s10926-009-9197-9; Coole C, 2013, J OCCUP REHABIL, V23, P406, DOI 10.1007/s10926-012-9401-1; de Vries G, 2012, J AFFECT DISORDERS, V136, P1017, DOI 10.1016/j.jad.2011.06.035; Dionne CE, 2013, J OCCUP REHABIL, V23, P280, DOI 10.1007/s10926-012-9399-4; Donker-Cools BH, 2015, DISABIL REHABIL, P1; Donker-Cools BHPM, 2016, BRAIN INJURY, V30, P113, DOI 10.3109/02699052.2015.1090014; Dorland HF, 2016, SUPPORT CARE CANCER, V24, P261, DOI 10.1007/s00520-015-2764-z; Foy CML, 2014, J OCCUP REHABIL, V24, P533, DOI 10.1007/s10926-013-9488-z; Kuluski K, 2014, INT J QUAL STUD HEAL, V9, DOI 10.3402/qhw.v9.22252; Lundqvist A, 2012, BRAIN INJURY, V26, P1574, DOI 10.3109/02699052.2012.698363; Morrison TL, 2014, CAN J OCCUP THER, V81, P163, DOI 10.1177/0008417414534398; Saunders SL, 2014, J OCCUP REHABIL, V24, P100, DOI 10.1007/s10926-013-9436-y; Sherron P., 1991, J HEAD TRAUMA REHAB, V6, P1, DOI [DOI 10.1097/00001199-199109000-00004, https://doi.org/10.1097/00001199-199109000-00004]; Soeker MS, 2012, WORK, V43, P171, DOI 10.3233/WOR-2012-1413; Soeker MS, 2012, WORK, V42, P589, DOI 10.3233/WOR-2012-1414; Stergiou-Kita M, 2012, J OCCUP REHABIL, V22, P166, DOI 10.1007/s10926-011-9332-2; Tamminga SJ, 2012, SCAND J WORK ENV HEA, V38, P144, DOI 10.5271/sjweh.3199; Tiedtke C, 2014, J OCCUP REHABIL, V24, P399, DOI 10.1007/s10926-013-9465-6; Tong A, 2007, INT J QUAL HEALTH C, V19, P349, DOI 10.1093/intqhc/mzm042; Tyerman A, 2012, NEUROREHABILITATION, V31, P51, DOI 10.3233/NRE-2012-0774; van Velzen JM, 2009, BRAIN INJURY, V23, P473, DOI 10.1080/02699050902970737; van Velzen JM, 2016, DISABIL REHABIL, V38, P62, DOI 10.3109/09638288.2015.1017057; van Velzen JM, 2011, DISABIL REHABIL, V33, P2237, DOI 10.3109/09638288.2011.563821; World Med Assoc, 2013, JAMA-J AM MED ASSOC, V310, P2191, DOI 10.1001/jama.2013.281053	24	15	15	3	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0963-8288	1464-5165		DISABIL REHABIL	Disabil. Rehabil.		2018	40	2					185	191		10.1080/09638288.2016.1250118			7	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	FQ7WX	WOS:000418575300008	27830952	hybrid			2022-02-06	
J	Giammattei, L; Messerer, M; Oddo, M; Borsotti, F; Levivier, M; Daniel, RT				Giammattei, Lorenzo; Messerer, Mahmoud; Oddo, Mauro; Borsotti, Francois; Levivier, Marc; Daniel, Roy T.			Cisternostomy for Refractory Posttraumatic Intracranial Hypertension	WORLD NEUROSURGERY			English	Article						Cisternostomy; Decompressive craniectomy; Traumatic brain injury	TRAUMATIC BRAIN-INJURY; DECOMPRESSIVE CRANIECTOMY; IMPAIRMENT	BACKGROUND: The current surgical treatment of choice for refractory intracranial hypertension after traumatic brain injury (TBI) is decompressive craniectomy. Despite efficacy in control of intracranial pressure (ICP), its contribution to an improved outcome is debatable. CASE DESCRIPTION: We describe a case of refractory intracranial hypertension successfully managed with cisternostomy. The rationale for this surgical technique is discussed, with a focus on the pathophysiologic processes underlying elevated ICP and its improvement after surgery. CONCLUSION: Cisternostomy proved to have an immediate effect in controlling ICP and improving brain oxygenation and metabolism.	[Giammattei, Lorenzo; Messerer, Mahmoud; Borsotti, Francois; Levivier, Marc; Daniel, Roy T.] Lausanne Univ Hosp, Dept Neurosurg, Lausanne, Switzerland; [Oddo, Mauro] Lausanne Univ Hosp, Dept Intens Care Med, Lausanne, Switzerland		Giammattei, L (corresponding author), Lausanne Univ Hosp, Dept Neurosurg, Lausanne, Switzerland.	lorenzo.giammattei@chuv.ch	Messerer, Mahmoud/AAZ-3527-2020				Barthelemy EJ, 2016, WORLD NEUROSURG, V88, P411, DOI 10.1016/j.wneu.2015.12.044; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cherian I, 2017, J NEUROSCI RES; Cherian I, 2016, WORLD NEUROSURG, V89, P51, DOI 10.1016/j.wneu.2016.01.072; Cherian Iype, 2013, Asian J Neurosurg, V8, P132, DOI 10.4103/1793-5482.121684; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Masoudi Mohammad Sadegh, 2016, Bull Emerg Trauma, V4, P161; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20; von Holst H, 2012, ACTA NEUROCHIR, V154, P1583, DOI 10.1007/s00701-012-1393-2	13	15	17	0	1	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2018	109						460	463		10.1016/j.wneu.2017.10.085			4	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FR4DD	WOS:000419015000190	29081393				2022-02-06	
J	Haarbauer-Krupa, J; Lundine, JP; DePompei, R; King, TZ				Haarbauer-Krupa, Juliet; Lundine, Jennifer P.; DePompei, Roberta; King, Tricia Z.			Rehabilitation and school services following traumatic brain injury in young children	NEUROREHABILITATION			English	Article						Traumatic brain injury; rehabilitation; school service; young children	HEALTH-CARE UTILIZATION; MANAGEMENT; NEEDS	BACKGROUND: Preschool children have the highest incidence of emergency department visits for traumatic brain injury (TBI) with the majority discharged home without a single point of entry into follow-up services. This paper describes families' experience with service access following TBI. OBJECTIVES: To describe parent reported service utilization following preschool TBI and examine predictors of service access. METHODS: Participants (N = 80) were drawn from the first visit of a longitudinal study examining elementary school outcomes following TBI. Parents were interviewed about their service history. Descriptive statistics analyzed sample demographics. Logistic regression examined associations between injury related factors and service utilization. RESULTS: TBI participants had mild injuries (83%) and were either discharged to home or spent less than a week in the hospital. No TBI participants received inpatient rehabilitation and only a portion of the sample (26%) received outpatient treatment. Length of hospital stay was a significant predictor of service access (Wald = 4.33, df = 1, p = 0.040). All children were enrolled in preschool without accommodations. CONCLUSION: Currently no systematic continuum of care exists for children with TBI injured prior to elementary school, despite availability of healthcare, education and state based resources. Healthcare professionals in contact with young children can help with follow-up by educating parents about TBI effects on learning.	[Haarbauer-Krupa, Juliet] Emory Univ, Sch Med, Dept Pediat, Atlanta, GA USA; [Lundine, Jennifer P.] Ohio State Univ, Sch Speech & Hearing Sci, Columbus, OH 43210 USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Div Clin Therapies, Columbus, OH USA; [Lundine, Jennifer P.] Nationwide Childrens Hosp, Inpatient Rehabil Program, Columbus, OH USA; [DePompei, Roberta] Univ Akron, Sch Speech Language Pathol, Akron, OH 44325 USA; [King, Tricia Z.] Georgia State Univ, Dept Psychol, Univ Plaza, Atlanta, GA 30303 USA; [King, Tricia Z.] Georgia State Univ, Neurosci Inst, Atlanta, GA 30303 USA		Haarbauer-Krupa, J (corresponding author), 3172 Wicks Creek Trail, Marietta, GA 30062 USA.	jhkrupa@me.com	Lundine, Jennifer P/P-5184-2018	Lundine, Jennifer P/0000-0002-9113-7875	National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [H133G110109]	This study is sponsored by a grant from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR) (Formerly the National Institute National Institute on Disability and Rehabilitation Research (NIDRR)), Grant number H133G110109.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Bennett TD, 2013, ARCH PHYS MED REHAB, V94, P1268, DOI 10.1016/j.apmr.2013.02.021; Brain and Spinal Injury Trust Fund Commission, 2010, REP NUMB EM DEP VIS; Ciccia AH, 2016, AM J SPEECH-LANG PAT, V25, P508, DOI 10.1044/2016_AJSLP-15-0087; Ewing-Cobbs L, 2006, J NEUROSURG, V105, P287, DOI 10.3171/ped.2006.105.4.287; Gfroerer SD, 2008, BRAIN INJURY, V22, P649, DOI 10.1080/02699050802227162; Glang A, 2008, NEUROREHABILITATION, V23, P477; Greene N. H., 2014, ARCH PHYS MED REHAB, V10, P180; Greenspan AI, 2000, BRAIN INJURY, V14, P417; Haarbauer-Krupa J., 2012, ASHA LEADER, V17, P10; Haarbauer-Krupa J, 2017, J HEAD TRAUMA REHAB, V32, P367, DOI 10.1097/HTR.0000000000000287; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Keenan HT, 2017, J HEAD TRAUMA REHAB, V32, P385, DOI 10.1097/HTR.0000000000000265; Keenan HT, 2013, J HEAD TRAUMA REHAB, V28, P426, DOI 10.1097/HTR.0b013e31825935b8; Kingery KM, 2017, J DEV BEHAV PEDIATR, V38, P728, DOI 10.1097/DBP.0000000000000489; Kirkwood MW, 2008, CLIN NEUROPSYCHOL, V22, P769, DOI 10.1080/13854040701543700; Laughlin L., 2013, WHOS MINDING KIDS CH; Rivara FP, 2012, ARCH PHYS MED REHAB, V93, P381, DOI 10.1016/j.apmr.2011.08.015; Roscigno CI, 2015, DISABIL REHABIL, V37, P523, DOI 10.3109/09638288.2014.933896; Slomine BS, 2006, PEDIATRICS, V117, pE663, DOI 10.1542/peds.2005-1892; Spaw AJ, 2018, J HEAD TRAUMA REHAB, V33, pE1, DOI 10.1097/HTR.0000000000000314; Taylor C. A., 2017, MMWR; Taylor HG, 2003, REHABIL PSYCHOL, V48, P227, DOI 10.1037/0090-5550.48.4.227; U.S. Department of Education ED Facts DataWarehouse (EDW), IDEA B; Varano P, 2015, J TRAUMA ACUTE CARE, V78, P1039, DOI 10.1097/TA.0000000000000604	25	15	15	1	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2018	42	3					259	267		10.3233/NRE-172410			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	GE2RW	WOS:000431063300002	29660968				2022-02-06	
J	Ma, LL; Mu, Y; Zhang, ZB; Sun, QS				Ma, Lili; Mu, Ying; Zhang, Zhaobo; Sun, Qiansan			Eugenol promotes functional recovery and alleviates inflammation, oxidative stress, and neural apoptosis in a rat model of spinal cord injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Eugenol; oxidative stress; inflammation; apoptosis; NF-kappa B; p38 MAPK	BRAIN	Background: Eugenol, a natural phenolic compound found in essential oils, shows a variety of remedial properties, while its effect on spinal cord injury (SCI) is still unknown. Objective: To study the effects of Eugenol on SCI-related impairments in rats. Methods: Rats received SCI or sham surgery were administered by oral gavage with Eugenol or physiological saline 6 hours following SCI and once a day for seven consecutive weeks. Basso, Beattie, Bresnahan (BBB) score and inclined plane test were used to assess locomotion function, while mechanical allodynia and thermal hyperalgesia were used to evaluate the withdrawal response to painful stimuli. Spinal cord water content was counted and permeability of the blood-spinal cord barrier was assessed by Evans blue extravasation. Serum tumor necrosis factor (TNF)-alpha, interleukin (IL)-1 beta, interleukin (IL)-6, nuclear factor (NF)-kappa B p65, superoxide dismutase (SOD), catalase (CAT), malondialdehyde (MDA), and glutathione peroxidase (GSH-Px) were determined by ELISA (enzyme-linked immunosorbent assay), while NF-kappa B p65, p38 mitogenactivated protein kinase (MAPK), inducible nitric oxide synthase (iNOS), and Caspase-3 in the spinal cord were detected by Western blot. Results: Eugenol markedly improved locomotor function and alleviated neuropathic pain, accompanied by decreased inflammation, oxidative stress, and neural apoptosis-associated molecules in the serum and injured spinal cord. Downregulated pathway molecules NF-kappa B and p38 MAPK were also found in the spinal cord. Conclusions: These findings suggest that down-regulating NF-kappa B and MAPK signaling pathway may support the neuroprotective effect of Eugenol against traumatic SCI.	[Ma, Lili; Sun, Qiansan] Shandong Univ, Hosp 2, Dept Phys Med & Rehabil, Jinan 250033, Shandong, Peoples R China; [Ma, Lili; Zhang, Zhaobo] Zibo Cent Hosp, Dept Phys Med & Rehabil, Zibo, Shandong, Peoples R China; [Mu, Ying] Zhangdian Peoples Hosp, Dept Intens Care Med, Zibo, Shandong, Peoples R China		Sun, QS (corresponding author), Shandong Univ, Hosp 2, Dept Phys Med & Rehabil, Jinan 250033, Shandong, Peoples R China.	qiangsansun01@163.com					Ahuja CS, 2017, NAT REV DIS PRIMERS, V3, DOI 10.1038/nrdp.2017.18; Ahuja CS, 2017, NEUROSURGERY, V80, pS9, DOI 10.1093/neuros/nyw080; Baltimore D., 2003, NAT NEUROSCI, V6, P1072; Bao F, 2004, J NEUROCHEM, V90, P1194, DOI 10.1111/j.1471-4159.2004.02580.x; Baskaran Y, 2010, TOXICOLOGY, V268, P204, DOI 10.1016/j.tox.2009.12.018; Basso DM, 1996, EXP NEUROL, V139, P244, DOI 10.1006/exnr.1996.0098; Bezerra DP, 2017, NUTRIENTS, V9, DOI 10.3390/nu9121367; Devi KP, 2010, J ETHNOPHARMACOL, V130, P107, DOI 10.1016/j.jep.2010.04.025; Fonseca DV, 2016, INT IMMUNOPHARMACOL, V38, P402, DOI 10.1016/j.intimp.2016.06.005; Gong G, 2014, PLOS ONE, V9, P1; Guo J, 2014, INT J MOL MED, V34, P74, DOI 10.3892/ijmm.2014.1751; Isaksson J, 2005, SPINAL CORD, V43, P167, DOI 10.1038/sj.sc.3101672; Kim JH, 2012, CELL MOL BIOL, V58, P1780, DOI 10.1170/209; Kong XY, 2017, J CELL MOL MED, V21, P941, DOI 10.1111/jcmm.13034; Kuo CY, 2015, INT J ENV RES PUB HE, V12, P4116, DOI 10.3390/ijerph120404116; Lee JY, 2018, J NEUROTRAUM, V35, P508, DOI 10.1089/neu.2017.5235; Li L, 2015, NEUROSCIENCE, V286, P27, DOI 10.1016/j.neuroscience.2014.11.037; Masoudi A, 2017, BEHAV BRAIN RES, V329, P104, DOI 10.1016/j.bbr.2017.04.026; Nam H, 2013, FOOD CHEM TOXICOL, V55, P106, DOI 10.1016/j.fct.2012.12.050; Pearse DD, 2003, J NEUROPATH EXP NEUR, V62, P1096, DOI 10.1093/jnen/62.11.1096; Penas C, 2007, J NEUROCHEM, V102, P1242, DOI 10.1111/j.1471-4159.2007.04671.x; Rodriguez-Barrera R, 2013, BIOMED RES INT, V2013, DOI 10.1155/2013/827517; Tan JW, 2014, INT J CLIN EXP PATHO, V7, P1911; Wang JS, 2016, EXP THER MED, V12, P3607, DOI 10.3892/etm.2016.3850; Xie YJ, 2015, IND CROP PROD, V77, P780, DOI 10.1016/j.indcrop.2015.09.044; Xiong YQ, 2007, J NEUROCHEM, V100, P639, DOI 10.1111/j.1471-4159.2006.04312.x	26	15	17	0	10	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2018	36	5					659	668		10.3233/RNN-180826			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	GV2ID	WOS:000445910600008	30040768				2022-02-06	
J	Measelle, JR; Ablow, JC				Measelle, Jeffrey R.; Ablow, Jennifer C.			Contributions of early adversity to pro-inflammatory phenotype in infancy: the buffer provided by attachment security	ATTACHMENT & HUMAN DEVELOPMENT			English	Article						Inflammation; infancy; pro-inflammatory cytokines; C-reactive protein; early adversity	C-REACTIVE PROTEIN; ADULT SOCIOECONOMIC-STATUS; INTIMATE PARTNER VIOLENCE; AUTONOMIC NERVOUS-SYSTEM; TRAUMATIC BRAIN-INJURY; AGE-RELATED DISEASE; EARLY-LIFE; PSYCHOLOGICAL STRESS; PROINFLAMMATORY PHENOTYPE; CARDIOVASCULAR-DISEASE	Adversity early in life is associated with systemic inflammation by adolescence and beyond. At present, few studies have investigated the associations between different forms of adversity and inflammation during infancy, making it difficult to specify the origins of disease vulnerability. This study examined the association between multiple forms of early adversity - socioeconomic status disadvantage, familial stress, maternal depression, and security of attachment - and individual differences in a composite measure of pro-inflammatory cytokines (IL-1 beta, IL-6, IL-8, and tumor necrosis factor-alpha) and the inflammatory protein C-reactive protein that were collected via saliva when (n = 49) children were 17 months old. In addition to gauging the direct effects of adversity, we also tested the hypothesis that infants' attachment relationship with their mother might buffer infants against the immunologic effects of early adversity. Results show that familial stress, maternal depression, and security of attachment were directly associated with infant salivary inflammation and that attachment status moderated the effect of maternal depression. The findings suggest that exposure to certain forms of adversity very early in life may engender a pro-inflammatory phenotype with possible life-long implications for health.	[Measelle, Jeffrey R.; Ablow, Jennifer C.] Univ Oregon, Psychol, Eugene, OR 97403 USA		Measelle, JR (corresponding author), Univ Oregon, Psychol, Eugene, OR 97403 USA.	measelle@uoregon.edu		Ablow, Jennifer/0000-0002-4868-9156	National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [1 R03 MH068692-01A1]; National Science FoundationNational Science Foundation (NSF) [BCS-0643393]	This research was supported by a grant from the National Institute of Mental Health: [Grant Number 1 R03 MH068692-01A1] and the National Science Foundation: [Grant Number BCS-0643393] to the second author.	Abidin, 1995, PARENTING STRESS IND; Ainsworth M. D. S., 1978, PATTERNS ATTACHMENT, DOI 10.1037/t28248-000; Bateson P, 2004, NATURE, V430, P419, DOI 10.1038/nature02725; Bernard K, 2010, DEV PSYCHOL, V46, P1771, DOI 10.1037/a0020660; BOYCE WT, 1995, PSYCHOSOM MED, V57, P411, DOI 10.1097/00006842-199509000-00001; Brennan PA, 2008, J CHILD PSYCHOL PSYC, V49, P1099, DOI 10.1111/j.1469-7610.2008.01914.x; Byrne ML, 2017, HEALTH PSYCHOL, V36, P641, DOI 10.1037/hea0000502; Byrne ML, 2017, J FAM PSYCHOL, V31, P374, DOI 10.1037/fam0000254; Byrne ML, 2013, BRAIN BEHAV IMMUN, V34, P164, DOI 10.1016/j.bbi.2013.08.010; Casey BJ, 2005, CURR OPIN NEUROBIOL, V15, P239, DOI 10.1016/j.conb.2005.03.012; Chen E, 2011, MOL PSYCHIATR, V16, P729, DOI 10.1038/mp.2010.53; Cicchetti D, 2005, ANNU REV CLIN PSYCHO, V1, P409, DOI 10.1146/annurev.clinpsy.1.102803.144029; Collins, 2005, DEV PERSON MINNESOTA; Conradt E, 2016, CHILD DEV, V87, P73, DOI 10.1111/cdev.12483; Conradt E, 2013, PSYCHOL SCI, V24, P235, DOI 10.1177/0956797612457381; Danese A, 2007, P NATL ACAD SCI USA, V104, P1319, DOI 10.1073/pnas.0610362104; Danese A, 2012, PHYSIOL BEHAV, V106, P29, DOI 10.1016/j.physbeh.2011.08.019; Danese A, 2009, ARCH PEDIAT ADOL MED, V163, P1135, DOI 10.1001/archpediatrics.2009.214; Deinzer R, 2005, BRIT J HEALTH PSYCH, V10, P269, DOI 10.1348/135910705X26858; DiCorcia JA, 2011, NEUROSCI BIOBEHAV R, V35, P1593, DOI 10.1016/j.neubiorev.2011.04.008; Dixon Denise, 2009, J Pediatr Nurs, V24, P378, DOI 10.1016/j.pedn.2008.02.034; Dowd JB, 2010, AM J PREV MED, V39, P314, DOI 10.1016/j.amepre.2010.05.014; DUNST CJ, 1987, CHILD CARE HLTH DEV, V13, P111, DOI 10.1111/j.1365-2214.1987.tb00528.x; Ehrlich KB, 2016, HANDBOOK OF ATTACHMENT, 3 EDITION, P180; Eklund CM, 2009, ADV CLIN CHEM, V48, P111, DOI 10.1016/S0065-2423(09)48005-3; Fernandez-Botran R, 2011, BRAIN BEHAV IMMUN, V25, P314, DOI 10.1016/j.bbi.2010.09.023; Fuligni AJ, 2009, PSYCHOSOM MED, V71, P329, DOI 10.1097/PSY.0b013e3181921b1f; Galobardes B, 2006, ANN EPIDEMIOL, V16, P91, DOI 10.1016/j.annepidem.2005.06.053; Garcia RI, 2001, PERIODONTOL 2000, V25, P21, DOI 10.1034/j.1600-0757.2001.22250103.x; Giedd JN, 2010, NEURON, V67, P728, DOI 10.1016/j.neuron.2010.08.040; Gouin JP, 2009, BRAIN BEHAV IMMUN, V23, P898, DOI 10.1016/j.bbi.2008.09.016; Granger DA, 2007, PHYSIOL BEHAV, V92, P583, DOI 10.1016/j.physbeh.2007.05.004; Hansel A, 2010, NEUROSCI BIOBEHAV R, V35, P115, DOI 10.1016/j.neubiorev.2009.12.012; Hennessy MB, 2010, NEUROSCI BIOBEHAV R, V34, P782, DOI 10.1016/j.neubiorev.2009.03.012; Herberth G, 2008, PEDIAT ALLERG IMM-UK, V19, P722, DOI 10.1111/j.1399-3038.2008.00727.x; Hertzman C, 1999, ANN NY ACAD SCI, V896, P85, DOI 10.1111/j.1749-6632.1999.tb08107.x; Hill-Soderlund AL, 2015, PSYCHONEUROENDOCRINO, V52, P311, DOI 10.1016/j.psyneuen.2014.08.011; HOROWITZ M, 1977, PSYCHOSOM MED, V39, P413, DOI 10.1097/00006842-197711000-00005; Hostinar CE, 2014, PSYCHOL BULL, V140, P256, DOI 10.1037/a0032671; Howe LD, 2010, INT J OBESITY, V34, P1149, DOI 10.1038/ijo.2010.52; Howren MB, 2009, PSYCHOSOM MED, V71, P171, DOI 10.1097/PSY.0b013e3181907c1b; Iyengar A, 2014, FRONT PEDIATR, V2, DOI 10.3389/fped.2014.00131; Johnson SB, 2013, PEDIATRICS, V131, P319, DOI 10.1542/peds.2012-0469; Juengst SB, 2015, J HEAD TRAUMA REHAB, V30, P207, DOI 10.1097/HTR.0000000000000031; Karrow NA, 2006, BRAIN BEHAV IMMUN, V20, P144, DOI 10.1016/j.bbi.2005.05.003; Kiecolt-Glaser JK, 2010, NEUROSCI BIOBEHAV R, V35, P33, DOI 10.1016/j.neubiorev.2009.09.003; Kiecolt-Glaser JK, 2003, P NATL ACAD SCI USA, V100, P9090, DOI 10.1073/pnas.1531903100; Laurent HK, 2012, DEV PSYCHOL, V48, P35, DOI 10.1037/a0025518; Laurent HK, 2011, DEV PSYCHOPATHOL, V23, P521, DOI 10.1017/S0954579411000083; Li XJ, 2000, CLIN MICROBIOL REV, V13, P547, DOI 10.1128/CMR.13.4.547-558.2000; Luecken LJ, 2004, CLIN PSYCHOL REV, V24, P171, DOI 10.1016/j.cpr.2004.01.003; McDade TW, 2005, AM J PHYS ANTHROPOL, V128, P906, DOI 10.1002/ajpa.20222; McEwen BS, 2012, P NATL ACAD SCI USA, V109, P17180, DOI 10.1073/pnas.1121254109; McEwen BS, 2011, ANNU REV MED, V62, P431, DOI 10.1146/annurev-med-052209-100430; McEwen BS, 2000, NEUROPSYCHOPHARMACOL, V22, P108, DOI 10.1016/S0893-133X(99)00129-3; McEwen BS, 2003, HORM BEHAV, V43, P2, DOI 10.1016/S0018-506X(02)00024-7; McEwen BS, 1998, NEW ENGL J MED, V338, P171, DOI 10.1056/NEJM199801153380307; Meaney MJ, 1996, DEV NEUROSCI-BASEL, V18, P49, DOI 10.1159/000111395; Miller AH, 2013, DEPRESS ANXIETY, V30, P297, DOI 10.1002/da.22084; Miller G, 2007, PSYCHOSOM MED, V69, P402, DOI 10.1097/PSY.0b013e318068fcf9; Miller GE, 2013, CHILD DEV PERSPECT, V7, P67, DOI 10.1111/cdep.12021; Miller GE, 2011, PSYCHOL BULL, V137, P959, DOI 10.1037/a0024768; Miller GE, 2010, PSYCHOL SCI, V21, P848, DOI 10.1177/0956797610370161; Minetto M, 2005, EUR J APPL PHYSIOL, V93, P679, DOI 10.1007/s00421-004-1241-z; Murasko JE, 2008, SOC SCI MED, V67, P1889, DOI 10.1016/j.socscimed.2008.09.018; Navarro VP, 2006, PFLUG ARCH EUR J PHY, V453, P73, DOI 10.1007/s00424-006-0113-2; Nazmi A, 2007, BMC PUBLIC HEALTH, V7, DOI 10.1186/1471-2458-7-212; O'Connor MF, 2009, NEUROIMAGE, V47, P891, DOI 10.1016/j.neuroimage.2009.05.049; Opacka-Juffry J, 2012, STRESS, V15, P1, DOI 10.3109/10253890.2011.560309; Ouellet-Morin I, 2011, BRAIN BEHAV IMMUN, V25, P640, DOI 10.1016/j.bbi.2010.12.020; Out D, 2012, BRAIN BEHAV IMMUN, V26, P543, DOI 10.1016/j.bbi.2012.01.019; Pepys MB, 2003, J CLIN INVEST, V111, P1805, DOI 10.1172/JCI200318921; Pfaffe T, 2011, CLIN CHEM, V57, P675, DOI 10.1373/clinchem.2010.153767; Pollitt RA, 2008, J EPIDEMIOL COMMUN H, V62, P484, DOI 10.1136/jech.2006.054106; Pollitt RA, 2007, EUR J EPIDEMIOL, V22, P55, DOI 10.1007/s10654-006-9082-1; Preacher KJ, 2006, J EDUC BEHAV STAT, V31, P437, DOI 10.3102/10769986031004437; Propper CB, 2013, DEV REV, V33, P151, DOI 10.1016/j.dr.2013.05.001; Punt J, 2001, Trends Immunol, V22, P419, DOI 10.1016/S1471-4906(01)02010-5; RADLOFF L S, 1977, Applied Psychological Measurement, V1, P385, DOI 10.1177/014662167700100306; Repetti RL, 2002, PSYCHOL BULL, V128, P330, DOI 10.1037/0033-2909.128.2.330; Riis JL, 2016, SOC SCI MED, V151, P206, DOI 10.1016/j.socscimed.2015.12.043; Riis JL, 2015, DEV PSYCHOBIOL, V57, P153, DOI 10.1002/dev.21271; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Segerstrom SC, 2004, PSYCHOL BULL, V130, P601, DOI 10.1037/0033-2909.130.4.601; Shirtcliff EA, 2009, P NATL ACAD SCI USA, V106, P2963, DOI 10.1073/pnas.0806660106; Shonkoff JP, 2010, CHILD DEV, V81, P357, DOI 10.1111/j.1467-8624.2009.01399.x; Sjogren E, 2006, BRAIN BEHAV IMMUN, V20, P270, DOI 10.1016/j.bbi.2005.08.001; Slopen N, 2013, PSYCHONEUROENDOCRINO, V38, P2854, DOI 10.1016/j.psyneuen.2013.07.012; Slopen N, 2013, PSYCHONEUROENDOCRINO, V38, P188, DOI 10.1016/j.psyneuen.2012.05.013; Slopen N, 2012, BRAIN BEHAV IMMUN, V26, P239, DOI 10.1016/j.bbi.2011.11.003; Sroufe LA, 2005, ATTACH HUM DEV, V7, P349, DOI 10.1080/14616730500365928; Suh KI, 2009, ARCH ORAL BIOL, V54, P797, DOI 10.1016/j.archoralbio.2009.05.007; Taylor SE, 2006, BIOL PSYCHIAT, V60, P819, DOI 10.1016/j.biopsych.2006.03.016; Vermeer HJ, 2012, PHYSIOL BEHAV, V105, P161, DOI 10.1016/j.physbeh.2011.08.017; Wakelkamp IMMJ, 2003, CLIN ENDOCRINOL, V58, P280, DOI 10.1046/j.1365-2265.2003.01708.x; Waschul B, 2003, J CLIN PERIODONTOL, V30, P238, DOI 10.1034/j.1600-051X.2003.00270.x; Weinberg MK, 1998, J CLIN PSYCHIAT, V59, P53; Williamson S, 2012, NURS RES PRACT, V2012, DOI 10.1155/2012/246178; Wolf JM, 2008, BRAIN BEHAV IMMUN, V22, P433, DOI 10.1016/j.bbi.2007.10.016	99	15	15	0	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1461-6734	1469-2988		ATTACH HUM DEV	Attach. Hum. Dev.		2018	20	1					1	23		10.1080/14616734.2017.1362657			23	Psychology, Developmental	Social Science Citation Index (SSCI)	Psychology	GB0KN	WOS:000428734900001	28797194				2022-02-06	
J	Nabaweesi, R; Ramakrishnaiah, RH; Aitken, ME; Rettiganti, MR; Luo, CQ; Maxson, RT; Glasier, CM; Kenney, PJ; Robbins, JM				Nabaweesi, Rosemary; Ramakrishnaiah, Raghu H.; Aitken, Mary E.; Rettiganti, Mallikarjuna R.; Luo, Chunqiao; Maxson, Robert T.; Glasier, Charles M.; Kenney, Phillip J.; Robbins, James M.			Injured Children Receive Twice the Radiation Dose at Nonpediatric Trauma Centers Compared With Pediatric Trauma Centers	JOURNAL OF THE AMERICAN COLLEGE OF RADIOLOGY			English	Article						Effective radiation dose; nonpediatric hospitals; CT scan	EMERGENCY-DEPARTMENT; COMPUTED-TOMOGRAPHY; EXPOSURE	Background: Use of cranial CT scans in children has been increasing, in part due to increased awareness of sports-related concussions. CT is the largest contributor to medical radiation exposure, a risk factor for cancer. Long-term cancer risks of CT scans can be two to three times higher for children than for adults because children are more radiosensitive and have a longer lifetime in which to accumulate exposure from multiple scans. Study Aim: To compare the radiation exposure injured children receive when imaged at nonpediatric hospitals (NPHs) versus pediatric hospitals. Methods: Injured children younger than 18 years who received a CT scan at a referring hospital during calendar years (CYs) 2010 and 2013 were included. Patient-level factors included demographics, mode of transportation, and Injury Severity Score, and hospital-level factors included region of state, radiology services, and hospital type and size. Our primary outcome of interest was the effective radiation dose. Results: Four hundred eighty-seven children were transferred to the pediatric trauma center during CYs 2010 and 2013, with a median age of 7.2 years (interquartile range 5-13). The median effective radiation dose received at NPHs was twice that received at the pediatric trauma center (3.8versus 1.6 mSv, P< .001). Results were confirmed in independent and paired analyses, after controlling for mode of transportation, emergency department disposition, level of injury severity, and at the NPH trauma center level, hospital type, size, region, and radiology services location. Conclusion: NPHs have the potential to substantially reduce the medical radiation received by injured children. Pediatric CT protocols should be considered.	[Nabaweesi, Rosemary; Aitken, Mary E.; Robbins, James M.] Univ Arkansas Med Sci, Coll Med, Dept Pediat, Little Rock, AR 72202 USA; [Nabaweesi, Rosemary; Aitken, Mary E.; Rettiganti, Mallikarjuna R.; Luo, Chunqiao; Robbins, James M.] Arkansas Childrens Res Inst, Little Rock, AR USA; [Ramakrishnaiah, Raghu H.; Glasier, Charles M.] Univ Arkansas Med Sci, Coll Med, Dept Pediat Radiol, Little Rock, AR 72202 USA; [Maxson, Robert T.] Univ Arkansas Med Sci, Coll Med, Dept Pediat Surg, Little Rock, AR 72202 USA; [Kenney, Phillip J.] Univ Arkansas Med Sci, Coll Med, Dept Radiol, Little Rock, AR 72202 USA; [Rettiganti, Mallikarjuna R.; Luo, Chunqiao] Univ Arkansas Med Sci, Coll Med, Dept Biostat, Little Rock, AR 72202 USA		Nabaweesi, R (corresponding author), Univ Arkansas Med Sci, Arkansas Childrens Hosp, Coll Med, Res Inst, 1 Childrens Way,Slot 512-26, Little Rock, AR 72202 USA.	rnabaweesi@uams.edu	Aitken, Mary/ABG-6119-2021	Aitken, Mary/0000-0002-8318-9755	Arkansas Biosciences Institute; major research component of the Arkansas Tobacco Settlement Proceeds Act; Marion B. Lyon Revocable Trust-New Scientist Development award	Rosemary Nabaweesi was supported in part by the Arkansas Biosciences Institute, the major research component of the Arkansas Tobacco Settlement Proceeds Act of 2000, and the Marion B. Lyon Revocable Trust-New Scientist Development award. The authors have no conflicts of interest related to the material discussed in this article.	Agarwal S, 2015, AM J ROENTGENOL, V205, P409, DOI 10.2214/AJR.14.13715; Agency for Research and Healthcare Quality, 2008, HEALTHC COST UT PROJ; Goske MJ, 2014, PEDIATR RADIOL, V44, P403, DOI 10.1007/s00247-014-3076-z; Graves JM, 2014, J AM COLL RADIOL, V11, P717, DOI 10.1016/j.jacr.2013.12.002; Graves JM, 2014, J AM COLL RADIOL, V11, P161, DOI 10.1016/j.jacr.2013.07.004; Journy N, 2016, J RADIOL PROT, V36, pN1, DOI 10.1088/0952-4746/36/1/N1; Kharbanda AB, 2013, J TRAUMA ACUTE CARE, V74, P907, DOI 10.1097/TA.0b013e318287883e; Kim PK, 2004, J TRAUMA, V57, P510, DOI 10.1097/01.TA.0000141028.97753.67; Kirsch TD, 2011, J EMERG MED, V41, P302, DOI 10.1016/j.jemermed.2010.06.030; Kocher KE, 2011, ANN EMERG MED, V58, P452, DOI 10.1016/j.annemergmed.2011.05.020; Korley FK, 2015, J HEAD TRAUMA REHABI; Linet MS, 2009, PEDIATR RADIOL, V39, pS4, DOI 10.1007/s00247-008-1026-3; Mahesh M, 2012, J AM COLL RADIOL, V9, P931, DOI 10.1016/j.jacr.2012.09.021; Mahesh Mahadevappa, 2011, Pediatr Radiol, V41 Suppl 2, P493, DOI 10.1007/s00247-011-2169-1; Nabaweesi R, 2016, J AM COLL RADIOL; Strauss KJ, 2010, AM J ROENTGENOL, V194, P868, DOI 10.2214/AJR.09.4091; Thomas KE, 2008, PEDIATR RADIOL, V38, P645, DOI 10.1007/s00247-008-0794-0; Wylie MC, 2014, PEDIATR EMERG CARE, V30, P680, DOI 10.1097/PEC.0000000000000227; Zonfrillo MR, 2015, ACAD EMERG MED, V22, P872, DOI 10.1111/acem.12696	19	15	16	0	3	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1546-1440			J AM COLL RADIOL	J. Am. Coll. Radiol.		2018	15	1	A				58	64		10.1016/j.jacr.2017.06.035			7	Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Radiology, Nuclear Medicine & Medical Imaging	FS3EX	WOS:000419663400018	28847467				2022-02-06	
J	Ren, C; Li, XH; Wang, SB; Wang, LX; Dong, N; Wu, Y; Yao, YM				Ren, Chao; Li, Xiu-hua; Wang, Shi-bin; Wang, Li-xue; Dong, Ning; Wu, Yao; Yao, Yong-ming			Activation of Central Alpha 7 Nicotinic Acetylcholine Receptor Reverses Suppressed Immune Function of T Lymphocytes and Protects Against Sepsis Lethality	INTERNATIONAL JOURNAL OF BIOLOGICAL SCIENCES			English	Article						Alpha 7 nicotinic acetylcholine receptor; sepsis; immune response; multiple organ dysfunction syndrome; prognosis	TRAUMATIC BRAIN-INJURY; IMMUNOSUPPRESSION; INFLAMMATION; AGONIST; GTS-21; ENDOTOXEMIA; MANAGEMENT; RELEASE; MICE	Sepsis remains the leading cause of high mortality and huge financial burden in intensive care units (ICU), but with scarce effective treatments due to refractory multiple organ dysfunction and persistent immunosuppression. Treatments that aim at modulating immune function and attenuating multiple organ injury will certainly benefit septic cases. Alpha 7 nicotinic acetylcholine receptor (alpha 7nAchR) has been reported with potent immunomodulatory properties in various diseases as the essential mediator of the cholinergic anti-inflammatory pathway (CAP). Few studies have demonstrated the potential effect of central alpha 7nAchR on the progression and prognosis of septic response, while its expression was first discovered on neurons and most abundant in the central nervous system. In the present study, it was found severe damage of multiple organs under the operation of cecal ligation and puncture (CLP) in rats, including heart, liver, kidneys, and lungs, as evidenced by abnormal histomorphology and notable elevation of injury markers. Concurrently, the function of spleen CD4(+)T cells was disrupted under septic challenge, accompanied by polarization of helper T cell (Th)2, which exhibited outward signs of immunosuppression. Intracerebroventricular injection of PNU282987, a selective agonist of alpha 7nAchR, significantly alleviated multiple organ injury, reversed immunosuppressive state, and improved the outcome of septic rats, while they were exacerbated by treatment with methyllycaconitine, a selective antagonist of alpha 7nAchR. This study provides the first evidence that activation of central alpha 7nAchR is beneficial for attenuating multiple organ dysfunction as well as abnormal immune response, and improving the prognosis of rats when exposed with sepsis.	[Ren, Chao; Li, Xiu-hua; Wang, Shi-bin; Wang, Li-xue; Dong, Ning; Wu, Yao; Yao, Yong-ming] Chinese Peoples Liberat Army Gen Hosp, Hosp 1, Trauma Res Ctr, 51 Fucheng Rd, Beijing 100048, Peoples R China; [Ren, Chao; Yao, Yong-ming] Nankai Univ, Sch Med, Tianjin 300071, Peoples R China; [Li, Xiu-hua] Jin Hua Municipal Cent Hosp, Emergency Dept, Jinhua 321001, Peoples R China; [Yao, Yong-ming] Chinese Peoples Liberat Army Gen Hosp, State Key Lab Kidney Dis, Beijing 100853, Peoples R China		Yao, YM (corresponding author), Chinese Peoples Liberat Army Gen Hosp, Hosp 1, Trauma Res Ctr, 51 Fucheng Rd, Beijing 100048, Peoples R China.	c_ff@sina.com	wang, xl/Y-8251-2019		National Natural Science FoundationNational Natural Science Foundation of China (NSFC) [81730057, 81501664, 81372054]; National Key Research and Development Program of China [2017YFC1103302]	This work was supported by grants from the National Natural Science Foundation (Nos. 81730057, 81501664, 81372054), and the National Key Research and Development Program of China (No. 2017YFC1103302).	Andersen N, 2013, P NATL ACAD SCI USA, V110, P20819, DOI 10.1073/pnas.1315775110; Andersson U, 2012, J EXP MED, V209, P1057, DOI 10.1084/jem.20120571; Antonakos N, 2017, CRIT CARE, V21, DOI 10.1186/s13054-017-1625-1; Beinat C, 2015, CNS DRUGS, V29, P529, DOI 10.1007/s40263-015-0260-0; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; Boomer JS, 2011, JAMA-J AM MED ASSOC, V306, P2594, DOI 10.1001/jama.2011.1829; Deng DM, 2017, INT IMMUNOPHARMACOL, V42, P49, DOI 10.1016/j.intimp.2016.11.011; Fujii T, 2017, FRONT IMMUNOL, V8, DOI 10.3389/fimmu.2017.01085; Gotts JE, 2016, BMJ-BRIT MED J, V353, DOI 10.1136/bmj.i1585; Hall S, 2014, BRIT J NEUROSURG, V28, P181, DOI 10.3109/02688697.2013.835373; Hotchkiss RS, 2013, NAT REV IMMUNOL, V13, P862, DOI 10.1038/nri3552; Hotchkiss RS, 2013, LANCET INFECT DIS, V13, P260, DOI 10.1016/S1473-3099(13)70001-X; Hu SQ, 2015, ACS CHEM NEUROSCI, V6, P1536, DOI 10.1021/acschemneuro.5b00108; Kim TH, 2014, J INFECT DIS, V209, P1668, DOI 10.1093/infdis/jit669; Kong FJ, 2015, J SURG RES, V194, P255, DOI 10.1016/j.jss.2014.09.043; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Livingstone PD, 2009, BIOCHEM PHARMACOL, V78, P744, DOI 10.1016/j.bcp.2009.06.004; Martin GS, 2006, CRIT CARE MED, V34, P15, DOI 10.1097/01.CCM.0000194535.82812.BA; Nullens S, 2016, SHOCK, V45, P450, DOI 10.1097/SHK.0000000000000519; Parrish WR, 2008, MOL MED, V14, P567, DOI 10.2119/2008-00079.Parrish; Pavlov VA, 2006, BIOCHEM SOC T, V34, P1037, DOI 10.1042/BST0341037; Pavlov VA, 2006, P NATL ACAD SCI USA, V103, P5219, DOI 10.1073/pnas.0600506103; Pavlov VA, 2007, CRIT CARE MED, V35, P1139, DOI 10.1097/01.CCM.0000259381.56526.96; Rhodes A, 2017, CRIT CARE MED, V45, P486, DOI 10.1097/CCM.0000000000002255; Rousseau SJ, 2005, NEUROPHARMACOLOGY, V49, P59, DOI 10.1016/j.neuropharm.2005.01.030; Russell JA, 2006, NEW ENGL J MED, V355, P1699, DOI 10.1056/NEJMra043632; Sitapara RA, 2014, MOL MED, V20, DOI 10.2119/molmed.2013.00086; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Sussman ES, 2013, NEUROSURG FOCUS, V34, DOI 10.3171/2013.2.FOCUS1315; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Tsoyi K, 2011, ANTIOXID REDOX SIGN, V14, P2057, DOI 10.1089/ars.2010.3555; Uteshev VV, 2012, ADV EXP MED BIOL, V740, P603, DOI 10.1007/978-94-007-2888-2_27; Vincent JL, 2006, CRIT CARE MED, V34, P344, DOI 10.1097/01.CCM.0000194725.48928.3A; Wallace TL, 2011, BIOCHEM PHARMACOL, V82, P891, DOI 10.1016/j.bcp.2011.06.034; Ward PA, 2012, EMBO MOL MED, V4, P1234, DOI 10.1002/emmm.201201375; Zhang JL, 2011, J BIOL CHEM, V286, P25331, DOI 10.1074/jbc.M111.221754	36	15	15	0	5	IVYSPRING INT PUBL	LAKE HAVEN	PO BOX 4546, LAKE HAVEN, NSW 2263, AUSTRALIA	1449-2288			INT J BIOL SCI	Int. J. Biol. Sci.		2018	14	7					748	759		10.7150/ijbs.24576			12	Biochemistry & Molecular Biology; Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics	GH2WD	WOS:000433261800006	29910685	Green Published, Green Submitted, gold			2022-02-06	
J	Rickards, TA; Cranston, CC; Touradji, P; Bechtold, KT				Rickards, Tyler A.; Cranston, Christopher C.; Touradji, Pegah; Bechtold, Kathleen T.			Embedded performance validity testing in neuropsychological assessment: Potential clinical tools	APPLIED NEUROPSYCHOLOGY-ADULT			English	Article						Assessment; clinical neuropsychology; effort; embedded measures; malingering	TRAUMATIC BRAIN-INJURY; CARD SORTING TEST; RELIABLE DIGIT SPAN; MALINGERED NEUROCOGNITIVE DYSFUNCTION; SURVEY PROFESSIONAL PRACTICES; FORCED-CHOICE RECOGNITION; FALSE-POSITIVE RATES; COMPLEX FIGURE TEST; SYMPTOM VALIDITY; MULTIPLE PERFORMANCE	The article aims to suggest clinically-useful tools in neuropsychological assessment for efficient use of embedded measures of performance validity. To accomplish this, we integrated available validity-related and statistical research from the literature, consensus statements, and survey-based data from practicing neuropsychologists. We provide recommendations for use of 1) Cutoffs for embedded performance validity tests including Reliable Digit Span, California Verbal Learning Test (Second Edition) Forced Choice Recognition, Rey-Osterrieth Complex Figure Test Combination Score, Wisconsin Card Sorting Test Failure to Maintain Set, and the Finger Tapping Test; 2) Selecting number of performance validity measures to administer in an assessment; and 3) Hypothetical clinical decision-making models for use of performance validity testing in a neuropsychological assessment collectively considering behavior, patient reporting, and data indicating invalid or noncredible performance. Performance validity testing helps inform the clinician about an individual's general approach to tasks: response to failure, task engagement and persistence, compliance with task demands. Data-driven clinical suggestions provide a resource to clinicians and to instigate conversation within the field to make more uniform, testable decisions to further the discussion, and guide future research in this area.	[Rickards, Tyler A.; Cranston, Christopher C.; Touradji, Pegah; Bechtold, Kathleen T.] Johns Hopkins Sch Med, Div Rehabil Psychol & Neuropsychol, Dept Phys Med & Rehabil, 600 N Wolfe St,Phipps Bldg 174, Baltimore, MD 21287 USA		Bechtold, KT (corresponding author), Johns Hopkins Sch Med, Div Rehabil Psychol & Neuropsychol, Dept Phys Med & Rehabil, 600 N Wolfe St,Phipps Bldg 174, Baltimore, MD 21287 USA.	kbechto1@jhmi.edu	Cranston, Christopher/AAH-2628-2019				APA, 2013, DIAGNOSTIC STAT MANU, DOI DOI 10.1176/APPI.BOOKS.9780890425596; Arnold G, 2005, CLIN NEUROPSYCHOL, V19, P105, DOI 10.1080/13854040490888567; Axelrod BN, 2007, INT J NEUROSCI, V117, P1591, DOI 10.1080/00207450600941189; Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Axelrod BN, 2011, APPL NEUROPSYCHOL, V18, P27, DOI 10.1080/09084282.2010.523369; Bashem JR, 2014, CLIN NEUROPSYCHOL, V28, P851, DOI 10.1080/13854046.2014.927927; Bauer L, 2005, APPL NEUROPSYCHOL, V12, P202, DOI 10.1207/s15324826an1204_3; Bernard LC, 1996, ARCH CLIN NEUROPSYCH, V11, P231, DOI 10.1016/0887-6177(95)00025-9; Berthelson L, 2013, BRAIN INJURY, V27, P909, DOI 10.3109/02699052.2013.793400; Bianchini Kevin J, 2005, Spine J, V5, P404, DOI 10.1016/j.spinee.2004.11.016; Bilder RM, 2014, CLIN NEUROPSYCHOL, V28, P1212, DOI 10.1080/13854046.2014.969774; Blaskewitz N, 2009, APPL NEUROPSYCHOL, V16, P54, DOI 10.1080/09084280802644227; Boone K.B., 2007, ASSESSMENT FEIGNED C; Boone KB, 2003, CLIN NEUROPSYCHOL, V17, P244, DOI 10.1076/clin.17.2.244.16497; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Bush S.S., 2013, MILD TRAUMATIC BRAIN, P57; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Butters MA, 1998, ARCH CLIN NEUROPSYCH, V13, P721, DOI 10.1016/S0887-6177(98)00010-9; Dandachi-FitzGerald B, 2017, J CLIN EXP NEUROPSYC, V39, P257, DOI 10.1080/13803395.2016.1223278; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P199, DOI 10.1080/13854046.2014.884633; DAWES RM, 1989, SCIENCE, V243, P1668, DOI 10.1126/science.2648573; Delis D.C., 2000, CALIFORNIA VERBAL LE; Denning JH, 2012, ARCH CLIN NEUROPSYCH, V27, P417, DOI 10.1093/arclin/acs044; Donders J, 2011, CLIN NEUROPSYCHOL, V25, P173, DOI 10.1080/13854046.2010.536781; Glassmire DM, 2016, ASSESSMENT, V23, P292, DOI 10.1177/1073191115587551; GRANT DA, 1948, J EXP PSYCHOL, V38, P404, DOI 10.1037/h0059831; Green P, 2001, BRAIN INJURY, V15, P1045, DOI 10.1080/02699050110088254; Green P., 2003, J FORENSIC NEUROPSYC, V2, P97; GREIFFENSTEIN MF, 1995, CLIN NEUROPSYCHOL, V9, P230, DOI 10.1080/13854049508400485; Greiffenstein MF., 1994, PSYCHOL ASSESS, V6, P218, DOI [10.1037/1040-3590.6.3.218, DOI 10.1037/1040-3590.6.3.218]; Greve K, 2009, CLIN NEUROPSYCHOL, V23, P343, DOI 10.1080/13854040802054169; Greve KW, 2002, J CLIN EXP NEUROPSYC, V24, P48, DOI 10.1076/jcen.24.1.48.968; Heaton PDRK., 1993, WISCONSIN CARD SORTI; Heaton RK, 1981, MANUAL WISCONSIN CAR; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heinly MT, 2005, ASSESSMENT, V12, P429, DOI 10.1177/1073191105281099; Iverson GL, 2006, APPL NEUROPSYCHOL, V13, P77, DOI 10.1207/s15324826an1302_3; King JH, 2002, CLIN NEUROPSYCHOL, V16, P506, DOI 10.1076/clin.16.4.506.13912; Larrabee G.J., 2007, ASSESSMENT MALINGERE; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2008, CLIN NEUROPSYCHOL, V22, P666, DOI 10.1080/13854040701494987; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P364, DOI 10.1093/arclin/acu019; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Loring DW, 2016, ARCH CLIN NEUROPSYCH, V31, P313, DOI 10.1093/arclin/acw014; Lu PH, 2003, CLIN NEUROPSYCHOL, V17, P426, DOI 10.1076/clin.17.3.426.18083; Martin PK, 2015, CLIN NEUROPSYCHOL, V29, P741, DOI 10.1080/13854046.2015.1087597; Meyers JE., 1995, REY COMPLEX FIGURE T; Meyers JE, 2011, ARCH CLIN NEUROPSYCH, V26, P8, DOI 10.1093/arclin/acq083; Mittenberg W, 2002, J CLIN EXP NEUROPSYC, V24, P1094, DOI 10.1076/jcen.24.8.1094.8379; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Nelson NW, 2003, CLIN NEUROPSYCHOL, V17, P263, DOI 10.1076/clin.17.2.263.16511; Odland AP, 2015, PSYCHOL INJ LAW, V8, P46, DOI 10.1007/s12207-015-9216-4; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Reese CS, 2012, ARCH CLIN NEUROPSYCH, V27, P176, DOI 10.1093/arclin/acr117; Reitan R, 1985, HALSTEAD REITAN NEUR; Rey A, 1941, ARCH PSYCHOLOGIE, V28, P286; Root JC, 2006, J INT NEUROPSYCH SOC, V12, P688, DOI 10.1017/S1355617706060838; Schroeder RW, 2012, ASSESSMENT, V19, P21, DOI 10.1177/1073191111428764; Schutte C., 2013, MILD TRAUMATIC BRAIN, P159; Schutte C, 2011, CLIN NEUROPSYCHOL, V25, P454, DOI 10.1080/13854046.2010.550635; Schwartz ES, 2016, J INT NEUROPSYCH SOC, V22, P851, DOI 10.1017/S1355617716000746; Sharland MJ, 2007, ARCH CLIN NEUROPSYCH, V22, P213, DOI 10.1016/j.acn.2006.12.004; Shura RD, 2016, APPL NEUROPSYCH-ADUL, V23, P94, DOI 10.1080/23279095.2015.1014556; Silk-Eglit G. M., 2015, APPL NEUROPSYCHOL, V22, P1; Slick D. J., 2012, PEDIAT FORENSIC NEUR, P113; Slick DJ, 1999, CLIN NEUROPSYCHOL, V13, P545, DOI 10.1076/1385-4046(199911)13:04;1-Y;FT545; Smith JJ, 2007, THESIS, P2; Smith K, 2014, CLIN NEUROPSYCHOL, V28, P1048, DOI 10.1080/13854046.2014.931465; Sollman MJ, 2011, ARCH CLIN NEUROPSYCH, V26, P774, DOI 10.1093/arclin/acr066; Spencer R. J., 2010, 8 ANN M AM AC CLIN N; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Suhr JA, 1999, J CLIN EXP NEUROPSYC, V21, P701, DOI 10.1076/jcen.21.5.701.868; Sweet JJ, 2015, CLIN NEUROPSYCHOL, V29, P1069, DOI 10.1080/13854046.2016.1140228; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Van Dyke SA, 2013, CLIN NEUROPSYCHOL, V27, P1234, DOI 10.1080/13854046.2013.835447; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Webb JW, 2012, CLIN NEUROPSYCHOL, V26, P1377, DOI 10.1080/13854046.2012.728248; Wechsler D, 1981, WECHSLER ADULT INTEL; Whearty KM, 2015, J PSYCHIATR RES, V68, P397, DOI 10.1016/j.jpsychires.2015.04.018; Young JC, 2012, CLIN NEUROPSYCHOL, V26, P147, DOI 10.1080/13854046.2011.647083; Zenisek R, 2016, ARCH CLIN NEUROPSYCH, V31, P426, DOI 10.1093/arclin/acw025; [No title captured], DOI DOI 10.1037/H0063633	84	15	16	0	13	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	2327-9095	2327-9109		APPL NEUROPSYCH-ADUL	Appl. Neuropsychol.-Adult		2018	25	3					219	230		10.1080/23279095.2017.1278602			12	Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FY7NK	WOS:000427049000004	28139144				2022-02-06	
J	Vik, BMD; Skeie, GO; Vikane, E; Specht, K				Vik, Berit Marie Dykesteen; Skeie, Geir Olve; Vikane, Eirik; Specht, Karsten			Effects of music production on cortical plasticity within cognitive rehabilitation of patients with mild traumatic brain injury	BRAIN INJURY			English	Article						Mild traumatic brain injury (mTBI); neuroplasticity; cognitive rehabilitation; fMRI; music-supported intervention	THERAPY	Objective: We explored the effects of playing the piano on patients with cognitive impairment after mild traumatic brain injury (mTBI) and, addressed the question if this approach would stimulate neural networks in re-routing neural connections and link up cortical circuits that had been functional inhibited due to disruption of brain tissue. Functional neuroimaging scans (fMRI) and neuropsychological tests were performed pre-post intervention. Method: Three groups participated, one mTBI group (n=7), two groups of healthy participants, one with music training (n=11), one baseline group without music (n=12). The music groups participated in 8weeks music-supported intervention. Results: The patient group revealed training-related neuroplasticity in the orbitofrontal cortex. fMRI results fit well with outcome from neuropsychological tests with significant enhancement of cognitive performance in the music groups. Ninety per cent of mTBI group returned to work post intervention. Conclusion: Here, for the first time, we demonstrated behavioural improvements and functional brain changes after 8weeks of playing piano on patients with mTBI having attention, memory and social interaction problems. We present evidence for a causal relationship between musical training and reorganisation of neural networks promoting enhanced cognitive performance. These results add a novel music-supported intervention within rehabilitation of patients with cognitive deficits following mTBI.	[Vik, Berit Marie Dykesteen; Specht, Karsten] Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway; [Skeie, Geir Olve] Haukeland Hosp, Dept Neurol, Bergen, Norway; [Skeie, Geir Olve] Univ Bergen, Grieg Acad Res Ctr Mus Therapy GAMUT, Bergen, Norway; [Vikane, Eirik] Haukeland Hosp, Dept Phys Med & Rehabil, Bergen, Norway; [Specht, Karsten] UiT, Dept Educ, Tromso, Norway		Vik, BMD (corresponding author), Univ Bergen, Dept Biol & Med Psychol, Bergen, Norway.	vikmusic@online.no	Specht, Karsten/C-3762-2009	Specht, Karsten/0000-0002-9946-3704	Research Council of NorwayResearch Council of Norway [217932]	The authors thank all the participants who took time to participate in the study and the staff of the radiological department of the Haukeland University Hospital (Bergen, Norway) for their help during data acquisition. The study was supported by a grant to KS from the Research Council of Norway (217932: It's time for some music).	Altenmuller E, 2016, CLIN NEUROPHYSIOL, V127, pe22, DOI [10.1016/j.clinph.2015.11.062, DOI 10.1016/J.CLINPH.2015.11.062]; Andelic N, 2009, ACTA NEUROL SCAND, V120, P16, DOI 10.1111/j.1600-0404.2008.01116.x; [Anonymous], 2006, COMPHR REH 4 C UNPUB; Brown S, 2006, EUR J NEUROSCI, V23, P2791, DOI 10.1111/j.1460-9568.2006.04785.x; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Chan AS, 1998, NATURE, V396, P128, DOI 10.1038/24075; Dalla Bella S, 2015, ANN NY ACAD SCI, V1337, P77, DOI 10.1111/nyas.12651; DEUTSCH D, 1982, PSYCHOL MUSIC; Gordon HW, 1983, FUNCTIONS RIGHT CERE; Hebb DO, 1961, BRAIN MECH LEARNING; Hegde S, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00034; Herholz SC, 2016, CEREB CORTEX, V26, P3125, DOI 10.1093/cercor/bhv138; Hugdahl K, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00430; Jancke Lutz, 2009, F1000 Biol Rep, V1, P78, DOI 10.3410/B1-78; Levine B, 2006, J NEUROTRAUM, V23, P1396, DOI 10.1089/neu.2006.23.1396; Pantev C, 2009, NEUROSCIENCES MUSIC; Parsons L, 2008, BRIT RES ASS M; Parsons LM, 2005, NEUROPSYCHOLOGIA, V43, P199, DOI 10.1016/j.neuropsychologia.2004.11.007; Patel AD, 1998, BRAIN LANG, V61, P123, DOI 10.1006/brln.1997.1862; Rojo N, 2011, BRAIN INJURY, V25, P787, DOI 10.3109/02699052.2011.576305; Rolls ET, 2008, PROG NEUROBIOL, V86, P216, DOI 10.1016/j.pneurobio.2008.09.001; Rolls ET, 2014, CORTEX, V59, P185, DOI 10.1016/j.cortex.2014.01.020; Rolls ET, 2004, BRAIN COGNITION, V55, P11, DOI 10.1016/s0278-2626(03)00277-x; Sarkamo T, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00245; Sarkamo T, 2013, WIRES COGN SCI, V4, P441, DOI 10.1002/wcs.1237; Schiavio A, 2015, FRONT NEUROL, V19, P6; Schlaug G., 2009, OXFORD HDB MUSIC PSY, P197; Schlaug G, 2009, OXFORD HDB MUSIC PSY; Stewart L, 2001, CURR BIOL, V11, pR125, DOI 10.1016/S0960-9822(01)00058-6; TEASDALE G, 1974, LANCET, V2, P81; Thaut MH, 2010, MUSIC PERCEPT, V27, P281, DOI 10.1525/MP.2010.27.4.281; Voller B, 2001, BRAIN INJURY, V15, P107, DOI 10.1080/026990501458344; Zatorre R, 2007, COGNITIVE NEUROSCIEN, P232	33	15	16	4	30	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2018	32	5					634	643		10.1080/02699052.2018.1431842			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	FY7WL	WOS:000427074200015	29388854	Bronze			2022-02-06	
J	Weil, ZM; Corrigan, JD; Karelina, K				Weil, Zachary M.; Corrigan, John D.; Karelina, Kate			Alcohol Use Disorder and Traumatic Brain Injury	ALCOHOL RESEARCH-CURRENT REVIEWS			English	Article						alcohol and other drug use (AODU) development; AODU initiation; brain; injury; trauma	POSTTRAUMATIC-STRESS-DISORDER; SUBSTANCE USE DISORDERS; DRUG-USE; LIFE SATISFACTION; YOUNG-ADULTS; HEAD-INJURY; ABUSE; CONSUMPTION; DEPENDENCE; CHILDHOOD	Alcohol use and traumatic brain injury (TBI) are inextricably and bidirectionally linked. Alcohol intoxication is one of the strongest predictors of TBI, and a substantial proportion of TBIs occur in intoxicated individuals. An inverse relationship is also emerging, such that TBI can serve as a risk factor for, or modulate the course of, alcohol use disorder (AUD). Critically, alcohol use after TBI is a key predictor of rehabilitation outcomes, prognosis, and additional head injuries. This review provides a general overview of the bidirectional relationship between TBI and AUD and a discussion of potential neuropsychological and neurobiological mechanisms that might underlie the relationship.	[Weil, Zachary M.; Karelina, Kate] Ohio State Univ, Wexner Med Ctr, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA; [Weil, Zachary M.; Karelina, Kate] Ohio State Univ, Wexner Med Ctr, Grp Behav Neuroendocrinol, Dept Neurosci, Columbus, OH 43210 USA; [Corrigan, John D.] Ohio State Univ, Wexner Med Ctr, Dept Phys Med & Rehabil, Columbus, OH 43210 USA		Weil, ZM (corresponding author), Ohio State Univ, Wexner Med Ctr, Ctr Brain & Spinal Cord Repair, Columbus, OH 43210 USA.; Weil, ZM (corresponding author), Ohio State Univ, Wexner Med Ctr, Grp Behav Neuroendocrinol, Dept Neurosci, Columbus, OH 43210 USA.		Weil, Zachary M/A-2439-2008	Weil, Zachary M/0000-0003-3758-1809	Ohio State University Neurological Institute Pilot Award; National Institute of Neurological Diseases and Stroke Institutional Center Core Grant [P30 NS104177]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [P30NS104177] Funding Source: NIH RePORTER	This article was supported by an Ohio State University Neurological Institute Pilot Award. Additional support was provided by the National Institute of Neurological Diseases and Stroke Institutional Center Core Grant P30 NS104177.	Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Albrecht JS, 2018, AM J EPIDEMIOL, V187, P233, DOI 10.1093/aje/kwx254; Anderson V, 2011, BRAIN, V134, P2197, DOI 10.1093/brain/awr103; Back SE, 2006, J NERV MENT DIS, V194, P690, DOI 10.1097/01.nmd.0000235794.12794.8a; Baguley IJ, 1997, ARCH PHYS MED REHAB, V78, P1248, DOI 10.1016/S0003-9993(97)90339-7; Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; BECHARA A, 1994, COGNITION, V50, P7, DOI 10.1016/0010-0277(94)90018-3; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Blednov YA, 2011, BRAIN BEHAV IMMUN, V25, pS92, DOI 10.1016/j.bbi.2011.01.008; Blednov YA, 2012, ADDICT BIOL, V17, P108, DOI 10.1111/j.1369-1600.2010.00284.x; Bombardier CH, 2003, ARCH PHYS MED REHAB, V84, P185, DOI 10.1053/apmr.2003.50002; Bombardier CH, 2002, ARCH PHYS MED REHAB, V83, P1765, DOI 10.1053/apmr.2002.36085; Bombardier CH, 1999, REHABIL PSYCHOL, V44, P52, DOI 10.1037/0090-5550.44.1.52; BOOTH RE, 1978, INT J ADDICT, V13, P79, DOI 10.3109/10826087809039265; Boyle Eleanor, 2014, Arch Phys Med Rehabil, V95, pS230, DOI 10.1016/j.apmr.2013.08.297; Brady KT, 2009, J ADDICT MED, V3, P179, DOI 10.1097/ADM.0b013e3181aa244f; Bray R, 2009, DEP DEFENSE SURVEY H; Bryant RA, 2000, AM J PSYCHIAT, V157, P629, DOI 10.1176/appi.ajp.157.4.629; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Bryant RA, 2008, NEW ENGL J MED, V358, P525, DOI 10.1056/NEJMe078235; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Corrigan JD, 1997, ARCH PHYS MED REHAB, V78, P132, DOI 10.1016/S0003-9993(97)90253-7; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; Corrigan JD, 2001, J HEAD TRAUMA REHAB, V16, P543, DOI 10.1097/00001199-200112000-00003; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P29; Corrigan JD, 2008, JAMA-J AM MED ASSOC, V300, P720, DOI 10.1001/jama.300.6.720; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1940, DOI 10.1016/j.apmr.2013.05.018; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P135, DOI 10.1089/neu.2013.3019; DIKMEN SS, 1995, ANN EMERG MED, V26, P167, DOI 10.1016/S0196-0644(95)70147-8; ELLERD DA, 1992, J APPL REHABILITATIO, V23, P48; Felger JC, 2012, FRONT NEUROENDOCRIN, V33, P315, DOI 10.1016/j.yfrne.2012.09.003; Finkelstein E., 2006, INCIDENCE EC BURDEN; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Guo J, 2001, J STUD ALCOHOL, V62, P754, DOI 10.15288/jsa.2001.62.754; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; He J, 2008, EXP NEUROL, V210, P349, DOI 10.1016/j.expneurol.2007.11.017; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Ilie G, 2015, J HEAD TRAUMA REHAB, V30, P293, DOI 10.1097/HTR.0000000000000101; Jorge RE, 2005, ARCH GEN PSYCHIAT, V62, P742, DOI 10.1001/archpsyc.62.7.742; Juengst SB, 2015, REHABIL PSYCHOL, V60, P353, DOI 10.1037/rep0000056; Karelina K, 2018, BRAIN BEHAV IMMUN, V69, P532, DOI 10.1016/j.bbi.2018.01.012; Karelina K, 2017, EXP NEUROL, V297, P110, DOI 10.1016/j.expneurol.2017.08.003; Karelina K, 2017, BRAIN BEHAV IMMUN, V60, P304, DOI 10.1016/j.bbi.2016.11.009; Kreutzer JS, 1996, J LEARN DISABIL, V29, P643, DOI 10.1177/002221949602900608; Loane DJ, 2016, EXP NEUROL, V275, P316, DOI 10.1016/j.expneurol.2015.08.018; Lombardi F, 2008, EUR J ANAESTH, V25, P131, DOI 10.1017/S0265021507003316; Maier R V, 2001, Surg Infect (Larchmt), V2, P133, DOI 10.1089/109629601750469456; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Martinez D, 2005, BIOL PSYCHIAT, V58, P779, DOI 10.1016/j.biopsych.2005.04.044; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; McCrea M, 2008, CLIN NEUROPSYCHOL, V22, P10, DOI 10.1080/13854040701760981; McKinlay A, 2014, J HEAD TRAUMA REHAB, V29, P498, DOI 10.1097/HTR.0000000000000001; McKinlay A, 2009, J HEAD TRAUMA REHAB, V24, P221, DOI 10.1097/HTR.0b013e3181a40590; McLeod R, 1999, ADDICTION, V94, P1719, DOI 10.1046/j.1360-0443.1999.941117199.x; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; O'Jile JR, 2004, APPL NEUROPSYCHOL, V11, P107, DOI 10.1207/s15324826an1102_7; ODDY M, 1985, J NEUROL NEUROSUR PS, V48, P564, DOI 10.1136/jnnp.48.6.564; Orsi C, 2014, ACCIDENT ANAL PREV, V65, P97, DOI 10.1016/j.aap.2013.12.019; Petrakis IL, 2006, BIOL PSYCHIAT, V60, P777, DOI 10.1016/j.biopsych.2006.03.074; Ponsford J, 2007, BRAIN INJURY, V21, P1385, DOI 10.1080/02699050701796960; Ponsford J, 2013, J CLIN EXP NEUROPSYC, V35, P103, DOI 10.1080/13803395.2012.752437; Raj R, 2016, J NEUROSURG, V124, P1684, DOI 10.3171/2015.4.JNS141746; ROBINSON TE, 1993, BRAIN RES REV, V18, P247, DOI 10.1016/0165-0173(93)90013-P; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Sacks AL, 2009, J DUAL DIAGN, V5, P404, DOI 10.1080/15504260903182755; Salim A, 2009, ARCH SURG-CHICAGO, V144, P865, DOI 10.1001/archsurg.2009.158; Savola O, 2005, ALCOHOL ALCOHOLISM, V40, P269, DOI 10.1093/alcalc/agh159; Shultz SR, 2017, NEUROSCI BIOBEHAV R, V76, P396, DOI 10.1016/j.neubiorev.2016.09.014; Snell FI, 2010, J PSYCHOSOC NURS MEN, V48, P22, DOI [10.3928/02793695-20100107-01, 10.3928/02793695-20100108-02]; Taylor CA, 2017, MMWR SURVEILL SUMM, V66, P1, DOI 10.15585/mmwr.ss6609a1; Taylor LA, 2003, NEUROPSYCHOL REHABIL, V13, P165, DOI 10.1080/09602010244000336; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Vaaramo K, 2014, EUR J NEUROL, V21, P293, DOI 10.1111/ene.12302; VERMA NP, 1992, CLIN ELECTROENCEPHAL, V23, P147, DOI 10.1177/155005949202300310; Weil ZM, 2017, FRONT BEHAV NEUROSCI, V11, DOI 10.3389/fnbeh.2017.00135; Weil ZM, 2016, J NEUROTRAUM, V33, P895, DOI 10.1089/neu.2015.3953; Weil ZM, 2016, NEUROSCI BIOBEHAV R, V62, P89, DOI 10.1016/j.neubiorev.2016.01.005; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wood RL, 2013, J INT NEUROPSYCH SOC, V19, P181, DOI 10.1017/S135561771200118X; Wu CH, 2016, NEURAL PLAST, V2016, DOI 10.1155/2016/8030676	83	15	15	2	6	NATL INST ALCOHOL ABUSE  ALCOHOLISM	ROCKVILLE	6000 EXECUTIVE BLVD, ROCKVILLE, MD 20892-7003 USA	1535-7414	1930-0573		ALCOHOL RES-CURR REV	Alcohol Res.-Curr. Rev.		2018	39	2					171	180					10	Substance Abuse	Social Science Citation Index (SSCI)	Substance Abuse	IA2RX	WOS:000469410300007	31198656				2022-02-06	
J	Kawata, K; Rubin, LH; Wesley, L; Lee, JH; Sim, T; Takahagi, M; Bellamy, A; Tierney, R; Langford, D				Kawata, Keisuke; Rubin, Leah H.; Wesley, Leroy; Lee, Jong Hyun; Sim, Thomas; Takahagi, Masahiro; Bellamy, Al; Tierney, Ryan; Langford, Dianne			Acute Changes in Plasma Total Tau Levels Are Independent of Subconcussive Head Impacts in College Football Players	JOURNAL OF NEUROTRAUMA			English	Article						biomarker; head impact kinematics; subconcussion; Tau; traumatic brain injury	BRAIN-INJURY; BLOOD; GPS; ASSOCIATION; CONCUSSION; BIOMARKERS; EXPOSURE; PROTEIN; SEASON	Athletes in contact sports sustain repetitive subconcussive head impacts in a brief window, yet neurophysiological sequelae from repetitive subconcussion remain unclear. This prospective longitudinal study examined a relationship between changes in plasma Tau protein levels and subconcussive impact kinematic data in 23 Division I collegiate football players during a series of pre-season practices. Plasma measures for Tau and S100 beta proteins, symptom scores, and near point of convergence were obtained at pre-season baseline and pre-/post-practices. During each practice, impact frequency and linear and rotational head accelerations were recorded via an accelerometer-embedded mouth guard. There were significant elevations in plasma Tau levels at all post-practice time-points, compared with those of pre-practice and baseline levels. However, the highest degree of elevation in plasma Tau was observed after the first practice, for which players sustained the lowest number of hits and magnitudes for these hits. Subconcussive impact exposure during practice (e.g., head impact frequency and magnitude) did not predict increased plasma Tau levels. Concussion history and years of football experience also were unrelated to changes in plasma Tau levels. Increases in plasma Tau levels were associated with increases in S100 beta levels only after the first practice. There were no significant associations between changes in Tau levels, symptom scores, or near point of convergence. These data suggest that the changes in levels of circulating Tau protein were independent of subconcussive head impact exposure, pointing to the possibility that other factors may have played roles in changes in plasma Tau levels.	[Kawata, Keisuke] Indiana Univ, Dept Kinesiol, Sch Publ Hlth, Bloomington, IN 47405 USA; [Rubin, Leah H.] Johns Hopkins Univ, Sch Med, Dept Neurol, Baltimore, MD 21205 USA; [Wesley, Leroy; Lee, Jong Hyun; Tierney, Ryan; Langford, Dianne] Temple Univ, Dept Neurosci, Lewis Katz Sch Med, MERB 750,3500 North Broad St, Philadelphia, PA 19140 USA; [Sim, Thomas] Temple Univ, Dept Kinesiol, Coll Publ Hlth, Philadelphia, PA 19122 USA; [Takahagi, Masahiro; Bellamy, Al] Temple Univ, Dept Athlet, Philadelphia, PA 19122 USA		Langford, D (corresponding author), Temple Univ, Dept Neurosci, Lewis Katz Sch Med, MERB 750,3500 North Broad St, Philadelphia, PA 19140 USA.	tdl@temple.edu			Pennsylvania Athletic Trainers' Society research grant; Marianne Garman Burton Foundation for Caregivers; Temple University Office of the Vice Provost for Research	This work was supported by the Pennsylvania Athletic Trainers' Society research grant (to K. Kawata), generous support from Athole G. Jacobi, MD, and the Marianne Garman Burton Foundation for Caregivers (to D. Langford), and a seed grant from Temple University Office of the Vice Provost for Research (to D. Langford). Sponsors had no role in the design or execution of the study; collection, management, analysis, or interpretation of the data; preparation, review, or approval of the manuscript; or decision to submit the manuscript for publication.	Ahmadzadeh H, 2014, BIOPHYS J, V106, P1123, DOI 10.1016/j.bpj.2014.01.024; Alosco Michael L, 2017, Alzheimers Dement (Amst), V7, P33, DOI 10.1016/j.dadm.2016.11.003; Alves JL, 2014, J NEUROSCI RES, V92, P141, DOI 10.1002/jnr.23300; Bahrami N, 2016, RADIOLOGY, V281, P919, DOI 10.1148/radiol.2016160564; Bailes JE, 2013, J NEUROSURG, V119, P1235, DOI 10.3171/2013.7.JNS121822; Beckwith JG, 2013, MED SCI SPORT EXER, V45, P747, DOI 10.1249/MSS.0b013e3182793067; Broglio SP, 2011, J NEUROTRAUM, V28, P2069, DOI 10.1089/neu.2011.1825; Bulut M, 2006, ADV THER, V23, P12, DOI 10.1007/BF02850342; Camarillo DB, 2013, ANN BIOMED ENG, V41, P1939, DOI 10.1007/s10439-013-0801-y; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Gill J, 2017, NEUROLOGY, V88, P595, DOI 10.1212/WNL.0000000000003587; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Guskiewicz KM, 2011, EXERC SPORT SCI REV, V39, P4, DOI 10.1097/JES.0b013e318201f53e; HUNG GK, 1986, DOC OPHTHALMOL, V62, P165, DOI 10.1007/BF00229128; Hwang S, 2017, J NEUROTRAUM, V34, P8, DOI 10.1089/neu.2015.4238; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; Iliff JJ, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003748; Johnson B, 2014, J NEUROTRAUM, V31, P1907, DOI 10.1089/neu.2014.3415; Kawata K, 2016, INT J SPORTS MED, V37, P405, DOI 10.1055/s-0035-1569290; Kawata K, 2017, J NEUROTRAUM, V34, P2254, DOI 10.1089/neu.2016.4786; Kawata K, 2016, JAMA OPHTHALMOL, V134, P763, DOI 10.1001/jamaophthalmol.2016.1085; Macutkiewicz D, 2011, J SPORT SCI, V29, P967, DOI 10.1080/02640414.2011.570774; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2016, NEUROSURG CLIN N AM, V27, P529, DOI 10.1016/j.nec.2016.05.009; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Olivera A, 2015, JAMA NEUROL, V72, P1109, DOI 10.1001/jamaneurol.2015.1383; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Rissin DM, 2011, ANAL CHEM, V83, P2279, DOI 10.1021/ac103161b; Schnebel B, 2007, NEUROSURGERY, V60, P490, DOI 10.1227/01.NEU.0000249286.92255.7F; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Slobounov SM, 2017, NEUROIMAGE-CLIN, V14, P708, DOI 10.1016/j.nicl.2017.03.006; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Waldron M, 2011, J SPORT SCI, V29, P1223, DOI 10.1080/02640414.2011.587445; Wisbey B, 2010, J SCI MED SPORT, V13, P531, DOI 10.1016/j.jsams.2009.09.002; Xie LL, 2013, SCIENCE, V342, P373, DOI 10.1126/science.1241224	39	15	15	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					260	266		10.1089/neu.2017.5376		DEC 2017	7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000418128000001	29073820				2022-02-06	
J	Munia, TTK; Haider, A; Schneider, C; Romanick, M; Fazel-Rezai, R				Munia, Tamanna T. K.; Haider, Ali; Schneider, Charles; Romanick, Mark; Fazel-Rezai, Reza			A Novel EEG Based Spectral Analysis of Persistent Brain Function Alteration in Athletes with Concussion History	SCIENTIFIC REPORTS			English	Article							EVENT-RELATED SYNCHRONIZATION; RANGE TEMPORAL CORRELATIONS; HUMAN SENSORIMOTOR CORTEX; MILD HEAD-INJURY; APPROXIMATE ENTROPY; THETA-OSCILLATIONS; GAMMA-OSCILLATIONS; SPORT; DYNAMICS; STABILITY	The neurocognitive sequelae of a sport-related concussion and its management are poorly defined. Detecting deficits are vital in making a decision about the treatment plan as it can persist one year or more following a brain injury. The reliability of traditional cognitive assessment tools is debatable, and thus attention has turned to assessments based on electroencephalogram (EEG) to evaluate subtle post-concussive alterations. In this study, we calculated neurocognitive deficits combining EEG analysis with three standard post-concussive assessment tools. Data were collected for all testing modalities from 21 adolescent athletes (seven concussive and fourteen healthy) in three different trials. For EEG assessment, along with linear frequency-based features, we introduced a set of time-frequency (Hjorth Parameters) and nonlinear features (approximate entropy and Hurst exponent) for the first time to explore post-concussive deficits. Besides traditional frequency-band analysis, we also presented a new individual frequency-based approach for EEG assessment. While EEG analysis exhibited significant discrepancies between the groups, none of the cognitive assessment resulted in significant deficits. Therefore, the evidence from the study highlights that our proposed EEG analysis and markers are more efficient at deciphering post-concussion residual neurocognitive deficits and thus has a potential clinical utility of proper concussion assessment and management.	[Munia, Tamanna T. K.; Haider, Ali; Schneider, Charles; Fazel-Rezai, Reza] Univ North Dakota, Dept Elect Engn, Grand Forks, ND 58202 USA; [Romanick, Mark] Univ North Dakota, Dept Phys Therapy, Grand Forks, ND 58202 USA		Fazel-Rezai, R (corresponding author), Univ North Dakota, Dept Elect Engn, Grand Forks, ND 58202 USA.	reza@und.edu	Haider, Ali/AAK-2240-2020	Haider, Ali/0000-0002-2110-1025	University of North Dakota Faculty and Collaborative Seed Money	Financial support from University of North Dakota Faculty and Collaborative Seed Money is gratefully acknowledged. We also gratefully acknowledge Jeffrey Gendreau and Jessica I. Herren for their assistance in data collection. In addition, we would like to thank Dr. Colin Combs and Dr. Kumi Nagamoto-Combs from School of Medicine and Health Sciences of University of North Dakota for their suggestions in the initial study design.	Uriguen JA, 2015, J NEURAL ENG, V12, DOI 10.1088/1741-2560/12/3/031001; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Balkan O, 2015, IEEE ENG MED BIO, P4053, DOI 10.1109/EMBC.2015.7319284; Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Bleiberg J, 2004, NEUROSURGERY, V54, P1073, DOI 10.1227/01.NEU.0000118820.33396.6A; Blythe DAJ, 2014, NEUROIMAGE, V99, P377, DOI 10.1016/j.neuroimage.2014.05.041; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Bruhn J, 2000, ANESTHESIOLOGY, V92, P715, DOI 10.1097/00000542-200003000-00016; Cao C, 2011, CLIN NEUROPHYSIOL, V122, P1314, DOI 10.1016/j.clinph.2010.12.042; Cardin JA, 2009, NATURE, V459, P663, DOI 10.1038/nature08002; CDC, GET STATS TRAUM BRAI; Cecchin T, 2010, CLIN NEUROPHYSIOL, V121, P290, DOI 10.1016/j.clinph.2009.10.033; Chon KH, 2009, IEEE ENG MED BIOL, V28, P18, DOI 10.1109/MEMB.2009.934629; Crick F, 2003, NAT NEUROSCI, V6, P119, DOI 10.1038/nn0203-119; Crick F., 1990, Seminars in the Neurosciences, V2, P263; Crone NE, 2006, PROG BRAIN RES, V159, P275, DOI 10.1016/S0079-6123(06)59019-3; Crone NE, 1998, BRAIN, V121, P2271, DOI 10.1093/brain/121.12.2271; Crone NE, 1998, BRAIN, V121, P2301, DOI 10.1093/brain/121.12.2301; Culic M., 2010, NEIROFIZIOLOGIYA, V42, P64; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davis GA, 2009, BRIT J SPORT MED, V43, pI36, DOI 10.1136/bjsm.2009.058123; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Demos J.N., 2005, GETTING STARTED NEUR, V1st ed.; Elgendi M, 2011, IEEE ENG MED BIO, P6087, DOI 10.1109/IEMBS.2011.6091504; Friedman N, 2012, PHYS REV LETT, V108, DOI 10.1103/PhysRevLett.108.208102; Garg S., 2014, IEEE ENG MED BIOL SO, V29, P2014; Geng SJ, 2011, NEUROL RES, V33, P908, DOI 10.1179/1743132811Y.0000000041; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Gold I, 1999, CONSCIOUS COGN, V8, P186, DOI 10.1006/ccog.1999.0399; Guo L, 2010, J NEUROSCI METH, V193, P156, DOI 10.1016/j.jneumeth.2010.08.030; Hamida STB, 2015, 2015 IEEE INTERNATIONAL SYMPOSIUM ON SIGNAL PROCESSING AND INFORMATION TECHNOLOGY (ISSPIT), P548, DOI 10.1109/ISSPIT.2015.7394397; HintonBayre AD, 1997, J CLIN EXP NEUROPSYC, V19, P275, DOI 10.1080/01688639708403857; HJORTH B, 1970, ELECTROEN CLIN NEURO, V29, P306, DOI 10.1016/0013-4694(70)90143-4; Holler Y, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0080479; Howitt Scott, 2016, J Can Chiropr Assoc, V60, P322; HURST HE, 1951, T AM SOC CIV ENG, V116, P770; Iaccarino HF, 2016, NATURE, V540, P230, DOI 10.1038/nature20587; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2004, J INT NEUROPSYCH SOC, V10, P904, DOI 10.1017/S1355617704106139; Korn A, 2005, J CLIN NEUROPHYSIOL, V22, P1, DOI 10.1097/01.WNP.0000150973.24324.A7; Kumar Y, 2014, NEUROCOMPUTING, V133, P271, DOI 10.1016/j.neucom.2013.11.009; Kwon JS, 1999, ARCH GEN PSYCHIAT, V56, P1001, DOI 10.1001/archpsyc.56.11.1001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Linkenkaer-Hansen K, 2005, J NEUROSCI, V25, P10131, DOI 10.1523/JNEUROSCI.3244-05.2005; Lovell MR, 2003, J NEUROSURG, V98, P296, DOI 10.3171/jns.2003.98.2.0296; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2010, J HEAD TRAUMA REHAB, V25, P283, DOI 10.1097/HTR.0b013e3181e67923; McCrory P, 2013, PM&R, V5, P255, DOI 10.1016/j.pmrj.2013.02.012; Mohammadi MR, 2016, BIOMED ENG LETT, V6, P66, DOI 10.1007/s13534-016-0218-2; Montez T, 2009, P NATL ACAD SCI USA, V106, P1614, DOI 10.1073/pnas.0811699106; Monto S, 2007, CEREB CORTEX, V17, P1386, DOI 10.1093/cercor/bhl049; Munia T. T. K., 2017, IEEE ENG MED BIOL SO, P3212; Munia TTK, 2016, IEEE ENG MED BIO, P41, DOI 10.1109/EMBC.2016.7590635; Nikulin VV, 2012, NEUROIMAGE, V61, P162, DOI 10.1016/j.neuroimage.2012.03.008; Nunez P. L., 2006, ELECT FIELDS BRAIN N; Nuwer MR, 2005, CLIN NEUROPHYSIOL, V116, P2001, DOI 10.1016/j.clinph.2005.05.008; Parker TM, 2005, CLIN BIOMECH, V20, P389, DOI 10.1016/j.clinbiomech.2004.12.004; Parker TM, 2006, MED SCI SPORT EXER, V38, P1032, DOI 10.1249/01.mss.0000222828.56982.a4; Pezard L, 1996, BIOL PSYCHIAT, V39, P991, DOI 10.1016/0006-3223(95)00307-X; PFURTSCHELLER G, 1992, ELECTROEN CLIN NEURO, V83, P62, DOI 10.1016/0013-4694(92)90133-3; Poil SS, 2012, J NEUROSCI, V32, P9817, DOI 10.1523/JNEUROSCI.5990-11.2012; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Pritchett S, 2008, IEEE ENG MED BIO, P825, DOI 10.1109/IEMBS.2008.4649281; Puthankattil S. D., 2014, INT J MED HLTH PHARM, V8, P420; Ray S, 2008, J NEUROSCI, V28, P11526, DOI 10.1523/JNEUROSCI.2848-08.2008; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Slobounov S, 2012, CLIN NEUROPHYSIOL, V123, P1755, DOI 10.1016/j.clinph.2011.12.022; Sohn H, 2010, CLIN NEUROPHYSIOL, V121, P1863, DOI 10.1016/j.clinph.2010.04.007; Stam CJ, 2005, CLIN NEUROPHYSIOL, V116, P2266, DOI 10.1016/j.clinph.2005.06.011; Stuart S, 2017, J SPORT HEALTH SCI, V6, P299, DOI 10.1016/j.jshs.2017.03.009; Swann N. C., MOTOR SYSTEM INTERAC; Takahashi T, 2013, PROG NEURO-PSYCHOPH, V45, P258, DOI 10.1016/j.pnpbp.2012.05.001; Teel EF, 2014, CLIN NEUROPHYSIOL, V125, P703, DOI 10.1016/j.clinph.2013.08.027; THATCHER RW, 1989, ELECTROEN CLIN NEURO, V73, P94, DOI 10.1016/0013-4694(89)90188-0; Thompson JWG, 2006, FOUNDATIONS OF SPORT-RELATED BRAIN INJURIES, P341, DOI 10.1007/0-387-32565-4_15; Vidaurre C, 2009, NEURAL NETWORKS, V22, P1313, DOI 10.1016/j.neunet.2009.07.020; Vijith V.S., 2016, 2016 INT C INV COMP, P1, DOI DOI 10.1109/INVENTIVE.2016.7830193; Whithain EM, 2007, CLIN NEUROPHYSIOL, V118, P1877, DOI 10.1016/j.clinph.2007.04.027; Whitham EM, 2008, CLIN NEUROPHYSIOL, V119, P1166, DOI 10.1016/j.clinph.2008.01.024; Yang LL, 2014, 2014 7TH INTERNATIONAL CONFERENCE ON BIOMEDICAL ENGINEERING AND INFORMATICS (BMEI 2014), P264, DOI 10.1109/BMEI.2014.7002782; Yuval-Greenberg S, 2008, NEURON, V58, P429, DOI 10.1016/j.neuron.2008.03.027; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	85	15	15	0	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	DEC 8	2017	7								17221	10.1038/s41598-017-17414-x			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FP2QQ	WOS:000417463500020	29222477	Green Published, gold			2022-02-06	
J	Chen, J; He, WW; Hu, X; Shen, YW; Cao, JY; Wei, ZD; Luan, YF; He, L; Jiang, FD; Tao, YM				Chen, Jing; He, Wanwan; Hu, Xu; Shen, Yuwen; Cao, Junyan; Wei, Zhengdong; Luan, Yifei; He, Li; Jiang, Fangdun; Tao, Yanmei			A role for ErbB signaling in the induction of reactive astrogliosis	CELL DISCOVERY			English	Article						receptor tyrosine kinase; glia; gliosis; brain injury; anorexia	TRANSFORMING-GROWTH-FACTOR; FIBRILLARY ACIDIC PROTEIN; TRANSCRIPTION FACTOR OLIG2; FOCAL ADHESION KINASE; SCAR FORMATION; GLIAL SCAR; ASTROCYTE PROLIFERATION; NERVOUS-SYSTEM; TYROSINE PHOSPHORYLATION; FACTOR RECEPTOR	Reactive astrogliosis is a hallmark of many neurological disorders, yet its functions and molecular mechanisms remain elusive. Particularly, the upstream signaling that regulates pathological responses of astrocytes is largely undetermined. We used a mouse traumatic brain injury model to induce astrogliosis and revealed activation of ErbB receptors in reactive astrocytes. Moreover, cell-autonomous inhibition of ErbB receptor activity in reactive astrocytes by a genetic approach suppressed hypertrophic remodeling possibly through the regulation of actin dynamics. However, inhibiting ErbB signaling in reactive astrocytes did not affect astrocyte proliferation after brain injury, although it aggravated local inflammation. In contrast, active ErbB signaling in mature astrocytes of various brain regions in mice was sufficient to initiate reactive responses, reproducing characterized molecular and cellular features of astrogliosis observed in injured or diseased brains. Further, prevalent astrogliosis in the brain induced by astrocytic ErbB activation caused anorexia in animals. Therefore, our findings defined an unrecognized role of ErbB signaling in inducing reactive astrogliosis. Mechanistically, inhibiting ErbB signaling in reactive astrocytes prominently reduced Src and focal adhesion kinase (FAK) activity that is important for actin remodeling, although ErbB signaling activated multiple downstream signaling proteins. The discrepancies between the results from loss- and gain-of-function studies indicated that ErbB signaling regulated hypertrophy and proliferation of reactive astrocytes by different downstream signaling pathways. Our work demonstrated an essential mechanism in the pathological regulation of astrocytes and provided novel insights into potential therapeutic targets for astrogliosisimplicated diseases.	[Chen, Jing; He, Wanwan; Hu, Xu; Shen, Yuwen; Cao, Junyan; Wei, Zhengdong; Luan, Yifei; He, Li; Jiang, Fangdun; Tao, Yanmei] Hangzhou Normal Univ, Inst Life Sci, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China; [Chen, Jing; Tao, Yanmei] Key Lab Organ Dev & Regenerat Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China; [Chen, Jing; Tao, Yanmei] Key Lab GEM Resource & Model Res Hangzhou, Hangzhou, Zhejiang, Peoples R China		Tao, YM (corresponding author), Hangzhou Normal Univ, Inst Life Sci, Coll Life & Environm Sci, Hangzhou, Zhejiang, Peoples R China.; Tao, YM (corresponding author), Key Lab Organ Dev & Regenerat Zhejiang Prov, Hangzhou, Zhejiang, Peoples R China.; Tao, YM (corresponding author), Key Lab GEM Resource & Model Res Hangzhou, Hangzhou, Zhejiang, Peoples R China.	ytao@hznu.edu.cn		Tao, Yanmei/0000-0002-4456-5447	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31371075, 31671070, 31700886]; Natural Science Foundation of Zhejiang Province, ChinaNatural Science Foundation of Zhejiang Province [LQ14C090003, 2017C37164]; Open Foundation from Key Lab of Organ Development and Regeneration of Zhejiang Province	We thank the generous gift of pFlag-ErbB2, pcDNA3-ErbB3, pFlag-ErbB4 and pcDNA3-EGFR plasmids from Dr Lin Mei and Dr Wen-Cheng Xiong in Augusta University. Mlc1-tTA transgenic mice were provided by the RIKEN BRC through the National Bio-Resource Project of the MEXT, Japan. This work was supported by grants from the National Natural Science Foundation of China (31371075 and 31671070 to YT; 31700886 to JC), the Natural Science Foundation of Zhejiang Province, China (LQ14C090003 to JC; 2017C37164 to YT), and the Open Foundation from Key Lab of Organ Development and Regeneration of Zhejiang Province. YT is a Distinguished Professor of Zhejiang province (Qianjiang Scholar).	Abbott NJ, 2006, NAT REV NEUROSCI, V7, P41, DOI 10.1038/nrn1824; Abe Y, 2009, NEUROSCIENCE, V161, P95, DOI 10.1016/j.neuroscience.2009.03.022; Amankulor NM, 2009, J NEUROSCI, V29, P10299, DOI 10.1523/JNEUROSCI.2500-09.2009; Anderson MA, 2016, NATURE, V532, P195, DOI 10.1038/nature17623; Bachoo RM, 2004, P NATL ACAD SCI USA, V101, P8384, DOI 10.1073/pnas.0402140101; Beggs HE, 2003, NEURON, V40, P501, DOI 10.1016/S0896-6273(03)00666-4; Ben Haim L, 2015, J NEUROSCI, V35, P2817, DOI 10.1523/JNEUROSCI.3516-14.2015; Benlimame N, 2005, J CELL BIOL, V171, P505, DOI 10.1083/jcb.200504124; Brakebusch C, 2003, EMBO J, V22, P2324, DOI 10.1093/emboj/cdg245; Buffo A, 2005, P NATL ACAD SCI USA, V102, P18183, DOI 10.1073/pnas.0506535102; Buffo A, 2008, P NATL ACAD SCI USA, V105, P3581, DOI 10.1073/pnas.0709002105; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cahoy JD, 2008, J NEUROSCI, V28, P264, DOI 10.1523/JNEUROSCI.4178-07.2008; CALALB MB, 1995, MOL CELL BIOL, V15, P954; CHANG JH, 1995, J CELL BIOL, V130, P355, DOI 10.1083/jcb.130.2.355; Chen CH, 2016, EXP NEUROL, V278, P27, DOI 10.1016/j.expneurol.2016.01.023; Chen Y, 2008, J NEUROSCI, V28, P10983, DOI 10.1523/JNEUROSCI.3545-08.2008; CLARKE SR, 1994, NEUROREPORT, V5, P1885, DOI 10.1097/00001756-199410000-00011; Codeluppi S, 2009, J NEUROSCI, V29, P1093, DOI 10.1523/JNEUROSCI.4103-08.2009; Dudka AA, 2010, CANCER RES, V70, P3391, DOI 10.1158/0008-5472.CAN-09-3033; Dwarkasing JT, 2016, PEPTIDES, V77, P60, DOI 10.1016/j.peptides.2015.06.011; EDDLESTON M, 1993, NEUROSCIENCE, V54, P15, DOI 10.1016/0306-4522(93)90380-X; Englander Jeffrey, 2014, Arch Phys Med Rehabil, V95, P1223, DOI 10.1016/j.apmr.2013.06.002; FRISEN J, 1995, J CELL BIOL, V131, P453, DOI 10.1083/jcb.131.2.453; Gadea A, 2008, J NEUROSCI, V28, P2394, DOI 10.1523/JNEUROSCI.5652-07.2008; Gallo V, 2014, NEURON, V83, P283, DOI 10.1016/j.neuron.2014.06.010; GrausPorta D, 1997, EMBO J, V16, P1647, DOI 10.1093/emboj/16.7.1647; Hara M, 2017, NAT MED, V23, P818, DOI 10.1038/nm.4354; Herrmann JE, 2008, J NEUROSCI, V28, P7231, DOI 10.1523/JNEUROSCI.1709-08.2008; Horton ER, 2016, J CELL BIOL, V212, P349, DOI 10.1083/jcb.201508080; JUNIER MP, 1991, P NATL ACAD SCI USA, V88, P9743, DOI 10.1073/pnas.88.21.9743; Kang WF, 2014, P NATL ACAD SCI USA, V111, pE2987, DOI 10.1073/pnas.1320401111; Kim T, 2011, MOL CELLS, V31, P379, DOI 10.1007/s10059-011-0319-9; Kraft AW, 2013, FASEB J, V27, P187, DOI 10.1096/fj.12-208660; KRISTT DA, 1993, NEUROSURGERY, V33, P106; Laurence JA, 2005, CEREBELLUM, V4, P206, DOI 10.1080/14734220500208846; LeComte MD, 2015, P NATL ACAD SCI USA, V112, P8726, DOI 10.1073/pnas.1501029112; Levy DE, 2002, NAT REV MOL CELL BIO, V3, P651, DOI 10.1038/nrm909; Li XY, 2012, NEURON, V75, P1035, DOI 10.1016/j.neuron.2012.08.031; Liddelow SA, 2017, NATURE, V541, P481, DOI 10.1038/nature21029; Liu Y, 2007, BIOCHEM BIOPH RES CO, V354, P505, DOI 10.1016/j.bbrc.2007.01.009; Macauley SL, 2011, J NEUROSCI, V31, P15575, DOI 10.1523/JNEUROSCI.3579-11.2011; Mandell JW, 2001, GLIA, V34, P283, DOI 10.1002/glia.1062; Mei L, 2014, NEURON, V83, P27, DOI 10.1016/j.neuron.2014.06.007; Okada S, 2006, NAT MED, V12, P829, DOI 10.1038/nm1425; Olayioye MA, 2000, EMBO J, V19, P3159, DOI 10.1093/emboj/19.13.3159; Olayioye MA, 1999, J BIOL CHEM, V274, P17209, DOI 10.1074/jbc.274.24.17209; Pekny M, 1999, J CELL BIOL, V145, P503, DOI 10.1083/jcb.145.3.503; Rabchevsky AG, 1998, J NEUROSCI, V18, P10541, DOI 10.1523/jneurosci.18-24-10541.1998; Ridet JL, 1997, TRENDS NEUROSCI, V20, P570, DOI 10.1016/S0166-2236(97)01139-9; Robel S, 2015, J NEUROSCI, V35, P3330, DOI 10.1523/JNEUROSCI.1574-14.2015; Roh M, 2001, MOL ENDOCRINOL, V15, P600, DOI 10.1210/me.15.4.600; Sahni V, 2010, J NEUROSCI, V30, P1839, DOI 10.1523/JNEUROSCI.4459-09.2010; SCHALLER MD, 1994, MOL CELL BIOL, V14, P1680, DOI 10.1128/MCB.14.3.1680; Schweinhuber SK, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117244; Shao JY, 2008, MOL CELL BIOL, V28, P5196, DOI 10.1128/MCB.00079-08; Sharif A, 2007, ONCOGENE, V26, P2695, DOI 10.1038/sj.onc.1210071; Silver J, 2004, NAT REV NEUROSCI, V5, P146, DOI 10.1038/nrn1326; Silver J, 2016, EXP NEUROL, V286, P147, DOI 10.1016/j.expneurol.2016.06.018; Sirko S, 2013, CELL STEM CELL, V12, P426, DOI 10.1016/j.stem.2013.01.019; Sloan SA, 2014, CURR OPIN NEUROBIOL, V27, P75, DOI 10.1016/j.conb.2014.03.005; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Tanaka KF, 2010, BIOL PSYCHIAT, V67, P770, DOI 10.1016/j.biopsych.2009.12.020; Tao YM, 2014, P NATL ACAD SCI USA, V111, pE4429, DOI 10.1073/pnas.1407139111; Tao YM, 2013, NAT NEUROSCI, V16, P290, DOI 10.1038/nn.3320; Tao YM, 2009, P NATL ACAD SCI USA, V106, P9477, DOI 10.1073/pnas.0901844106; Tehrani S, 2007, P NATL ACAD SCI USA, V104, P11933, DOI 10.1073/pnas.0701077104; Tokita Y, 2001, J NEUROSCI, V21, P1257; Turner N, 2010, NAT REV CANCER, V10, P116, DOI 10.1038/nrc2780; Wang XQ, 2017, MOL NEUROBIOL, V54, P175, DOI 10.1007/s12035-015-9590-7; Wanner IB, 2013, J NEUROSCI, V33, P12870, DOI 10.1523/JNEUROSCI.2121-13.2013; Wilhelmsson U, 2004, J NEUROSCI, V24, P5016, DOI 10.1523/JNEUROSCI.0820-04.2004; Wilhelmsson U, 2006, P NATL ACAD SCI USA, V103, P17513, DOI 10.1073/pnas.0602841103; Xie W, 1999, ONCOGENE, V18, P3593, DOI 10.1038/sj.onc.1202673; Yang L, 2015, CELL REP, V11, P798, DOI 10.1016/j.celrep.2015.04.002; Yarden Y, 2001, NAT REV MOL CELL BIO, V2, P127, DOI 10.1038/35052073; Zamanian JL, 2012, J NEUROSCI, V32, P6391, DOI 10.1523/JNEUROSCI.6221-11.2012; Zhou Q, 2002, CELL, V109, P61, DOI 10.1016/S0092-8674(02)00677-3; Zhu QJ, 2014, P NATL ACAD SCI USA, V111, P13990, DOI 10.1073/pnas.1403493111	79	15	16	4	9	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		2056-5968		CELL DISCOV	Cell Discov.	DEC 5	2017	3								17044	10.1038/celldisc.2017.44			22	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	FP7AT	WOS:000417779400001	29238610	Green Published, gold			2022-02-06	
J	Chiu, HY; Lin, EY; Chiu, HT; Chen, PY				Chiu, Hsiao-Yean; Lin, En-Yuan; Chiu, Hsiao-Ting; Chen, Pin-Yuan			A Feasibility Randomized Controlled Crossover Trial of Home-Based Warm Footbath to Improve Sleep in the Chronic Phase of Traumatic Brain Injury	JOURNAL OF NEUROSCIENCE NURSING			English	Article						alternative medicine; insomnia; sleep; traumatic brain injury; warm footbath	INSOMNIA SEVERITY INDEX; DEPRESSION INVENTORY-II; SKIN TEMPERATURE; POOR SLEEP; METAANALYSIS; ACTIGRAPHY; ONSET	Introduction: Sleep disturbance is a common complaint after traumatic brain injury (TBI). The aim of this study was to examine the effects of a home-based warm footbath intervention on sleep in patients with TBI. Methods: This was a randomized controlled crossover study, and 23 adults with TBI were recruited and randomized to receive first a 30-minute, 41 degrees C warm footbath and then a usual care, or vice versa, with each lasting 3 days and separated by a 3-day washout. Sleep efficiency, sleep onset latency (SOL), total sleep time, and wake after sleep onset (WASO) were assessed by actigraphy. Results: We found that home-based warm footbath significantly had a reduced SOL (difference, -5.11 minutes) and a suppressed WASO (difference, -2.57 minutes) compared with those of usual care, but not in sleep efficiency and total sleep time. No adverse effect was reported. Conclusions: This study suggested that home-based warm footbath is practical and effective in relieving post-TBI sleep disturbances, particular in SOL and WASO. Nurses can use home-based warm footbath as an effective intervention for management of sleep disturbances after TBI.	[Chen, Pin-Yuan] Chang Gung Univ, Sch Med, Taoyuan, Taiwan; [Chen, Pin-Yuan] Chang GungMem Hosp, Dept Neurosurg, Keelung, Taiwan; [Chiu, Hsiao-Ting] Taipei Med Univ, Coll Nursing, Sch Nursing, Taipei, Taiwan; [Lin, En-Yuan] Taipei Med Univ Hosp, Dept Neurosurg, Taipei, Taiwan; [Chiu, Hsiao-Ting] Taoyuan Gen Hosp, Minist Hlth & Welf, Dept Rehabil, Sinwu Branch, Taoyuan, Taiwan		Chen, PY (corresponding author), Chang Gung Univ, Sch Med, Taoyuan, Taiwan.; Chen, PY (corresponding author), Chang GungMem Hosp, Dept Neurosurg, Keelung, Taiwan.	pinyuanc@gmail.com			Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST 106-2314-B-038-058-MY3]	This research was supported by a grant from the Ministry of Science and Technology, Taiwan (MOST 106-2314-B-038-058-MY3).	American Psychiatric Association, 2013, DIAGNOSTIC STAT MANU, V5, DOI [10.1176/appi.books.9780890425596.dsm02, 10.1176/appi.books.9780890425596]; Ancoli-Israel S, 2003, SLEEP, V26, P342, DOI 10.1093/sleep/26.3.342; Arnau RC, 2001, HEALTH PSYCHOL, V20, P112, DOI 10.1037//0278-6133.20.2.112; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Che HH, 2006, FORMOSAN J MED, V10, P447, DOI DOI 10.6320/FJM.2006.10(4).05; COLE RJ, 1992, SLEEP, V15, P461, DOI 10.1093/sleep/15.5.461; Duclos C, 2015, AUST OCCUP THER J, V62, P2, DOI 10.1111/1440-1630.12164; Egan GF, 2005, P NATL ACAD SCI USA, V102, P5262, DOI 10.1073/pnas.0409753102; Faul F, 2007, BEHAV RES METHODS, V39, P175, DOI 10.3758/BF03193146; Iqbal U, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000000483; Kumar Deependra, 2011, Indian J Physiol Pharmacol, V55, P262; KyungmeeChoi, 2014, Translational and Clinical Pharmacology, V22, P78; Liao WC, 2013, INT J NURS STUD, V50, P1607, DOI 10.1016/j.ijnurstu.2013.04.006; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Morin CM, 2011, SLEEP, V34, P601, DOI 10.1093/sleep/34.5.601; Netzer NC, 1999, ANN INTERN MED, V131, P485, DOI 10.7326/0003-4819-131-7-199910050-00002; Nguyen R, 2016, CAN J NEUROL SCI, V43, P774, DOI 10.1017/cjn.2016.290; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Raymann RJEM, 2008, BRAIN, V131, P500, DOI 10.1093/brain/awm315; Raymann RJEM, 2007, PHYSIOL BEHAV, V90, P257, DOI 10.1016/j.physbeh.2006.09.008; Seyyedrasooli Allehe, 2013, J Caring Sci, V2, P305, DOI 10.5681/jcs.2013.036; Shechter A, 2011, J BIOL RHYTHM, V26, P260, DOI 10.1177/0748730411404677; Wang YP, 2013, REV BRAS PSIQUIATR, V35, P416, DOI 10.1590/1516-4446-2012-1048; Yamamoto K, 2011, CANCER NURS, V34, P185, DOI 10.1097/NCC.0b013e3181fe4d2d; Yang CM, 2009, ARCH CLIN PSYCHOL, V4, P95; Yang HL, 2010, CANCER NURS, V33, P454, DOI 10.1097/NCC.0b013e3181d761c1; Zollman FS, 2012, J HEAD TRAUMA REHAB, V27, P135, DOI 10.1097/HTR.0b013e3182051397; Zollman FS, 2010, BRAIN INJURY, V24, P748, DOI 10.3109/02699051003692167	28	15	15	0	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0888-0395	1945-2810		J NEUROSCI NURS	J. Neurosci. Nurs.	DEC	2017	49	6					380	385		10.1097/JNN.0000000000000325			6	Clinical Neurology; Nursing	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Nursing	FN1MM	WOS:000415753900008	29117034				2022-02-06	
J	Davanzo, JR; Sieg, EP; Timmons, SD				Davanzo, Justin R.; Sieg, Emily P.; Timmons, Shelly D.			Management of Traumatic Brain Injury	SURGICAL CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Neurotrauma; Secondary injury; Intracranial monitoring; Intracranial pressure; Craniotomy; Craniectomy; Decompression	SEVERE HEAD-INJURY; VENOUS THROMBOEMBOLISM PROPHYLAXIS; BLUNT CEREBROVASCULAR INJURIES; RANDOMIZED CLINICAL-TRIAL; PLACEBO-CONTROLLED TRIAL; INTRACRANIAL-PRESSURE; POSTTRAUMATIC SEIZURES; DECOMPRESSIVE CRANIECTOMY; MODERATE HYPOTHERMIA; ANTIPLATELET THERAPY	Traumatic brain injury remains a serious public health problem, causing death and disability for millions. To maximize outcomes in the face of a complex injury to a complex organ, a variety of advanced neuromonitoring techniques may be used to guide surgical and medical decision making. Because of the heterogeneity of injury types and the plethora of treatment confounders present in this patient population, the scientific study of specific interventions is challenging. This challenge highlights the need for a firm understanding of the anatomy and pathophysiology of brain injuries when making clinical decisions in the intensive care unit.	[Davanzo, Justin R.; Sieg, Emily P.; Timmons, Shelly D.] Penn State Univ, Coll Med, Milton S Hershey Med Ctr, Dept Neurosurg, 30 Hope Dr,EC 110, Hershey, PA 17033 USA		Timmons, SD (corresponding author), Penn State Univ, Coll Med, Milton S Hershey Med Ctr, Dept Neurosurg, 30 Hope Dr,EC 110, Hershey, PA 17033 USA.	stimmons@mac.com					Adelson PD, 2013, LANCET NEUROL, V12, P546, DOI 10.1016/S1474-4422(13)70077-2; Alali AS, 2013, J NEUROTRAUM, V30, P1737, DOI 10.1089/neu.2012.2802; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Bardt TF, 1998, ACT NEUR S, V71, P153; Berry C, 2012, INJURY, V43, P1833, DOI 10.1016/j.injury.2011.08.014; Biffl WL, 1998, ANN SURG, V228, P462, DOI 10.1097/00000658-199810000-00003; Bilotta F, 2008, NEUROCRIT CARE, V9, P159, DOI 10.1007/s12028-008-9084-9; Bouderka MA, 2004, J TRAUMA, V57, P251, DOI 10.1097/01.TA.0000087646.68382.9A; Bullock M Ross, 2006, Neurosurgery, V58, pS56; Bullock M Ross, 2006, Neurosurgery, V58, pS47; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; *CDCP, 2005, WEB BAS INJ STAT QUE; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Chang JJJ, 2009, CRIT CARE MED, V37, P283, DOI 10.1097/CCM.0b013e318192fbd7; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; CLIFTON GL, 1993, J NEUROTRAUM, V10, P263, DOI 10.1089/neu.1993.10.263; Clifton GL, 2012, J NEUROSURG, V117, P714, DOI 10.3171/2012.6.JNS111690; Clifton GL, 2011, LANCET NEUROL, V10, P131, DOI 10.1016/S1474-4422(10)70300-8; Coester A, 2010, J TRAUMA, V68, P904, DOI 10.1097/TA.0b013e3181c9afc2; Contant CF, 2001, J NEUROSURG, V95, P560, DOI 10.3171/jns.2001.95.4.0560; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Daley MJ, 2015, AM SURGEON, V81, P207; De Fazio M, 2011, NEUROCRIT CARE, V14, P91, DOI 10.1007/s12028-010-9494-3; DIKMEN SS, 1991, JAMA-J AM MED ASSOC, V265, P1271, DOI 10.1001/jama.265.10.1271; Edwards P, 2005, LANCET, V365, P1957; EISENBERG HM, 1988, J NEUROSURG, V69, P15, DOI 10.3171/jns.1988.69.1.0015; Eriksson EA, 2012, J TRAUMA ACUTE CARE, V72, P1345, DOI 10.1097/TA.0b013e318249a0f4; Farahvar A, 2012, J NEUROSURG, V117, P729, DOI 10.3171/2012.7.JNS111816; Farooqui A, 2013, J NEUROSURG, V119, P1576, DOI 10.3171/2013.8.JNS13424; Gerber LM, 2013, J NEUROSURG, V119, P1583, DOI 10.3171/2013.8.JNS13276; Hartl R, 2008, J NEUROSURG, V109, P50, DOI 10.3171/JNS/2008/109/7/0050; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P990, DOI 10.1097/TA.0b013e3182a96591; Kang TM, 2002, ANN PHARMACOTHER, V36, P1453; Kelly DF, 1999, J NEUROSURG, V90, P1042, DOI 10.3171/jns.1999.90.6.1042; KLAUBER MR, 1989, NEUROSURGERY, V24, P31, DOI 10.1227/00006123-198901000-00005; Kowski AB, 2016, EPILEPSY BEHAV, V54, P150, DOI 10.1016/j.yebeh.2015.11.009; Kudsk KA, 2003, AM J SURG, V185, P16, DOI 10.1016/S0002-9610(02)01146-7; Kudsk KA, 1998, NUTRITION, V14, P541, DOI 10.1016/S0899-9007(98)00047-1; Kwiatt ME, 2012, J TRAUMA ACUTE CARE, V73, P625, DOI 10.1097/TA.0b013e318265cab9; Maas AIR, 1999, NEUROSURGERY, V44, P1286, DOI 10.1097/00006123-199906000-00076; Marion DW, 2006, NEUROSURGERY, V58, P655; Marion DW, 1997, NEW ENGL J MED, V336, P540, DOI 10.1056/NEJM199702203360803; Martini RP, 2009, J NEUROSURG, V111, P644, DOI 10.3171/2009.2.JNS08998; Miller PR, 2002, ANN SURG, V236, P386, DOI 10.1097/00000658-200209000-00015; Miller PR, 2001, J TRAUMA, V51, P279, DOI 10.1097/00005373-200108000-00009; Miller PR, 2001, J TRAUMA, V51, P285; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; National Vital Statistics System (NVSS), 2006, DAT SOURC MAINT CDC; NISSENSON AR, 1979, WESTERN J MED, V131, P277; Ratilal B, 2008, J NEUROS-PEDIATR, V1, P48, DOI 10.3171/PED-08/01/048; Roberts I, 2012, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000033.pub2; ROBERTSON C, 1993, ACTA NEUROCHIR, P98; ROBERTSON CS, 1995, J NEUROTRAUM, V12, P891, DOI 10.1089/neu.1995.12.891; Robertson CS, 1999, CRIT CARE MED, V27, P2086, DOI 10.1097/00003246-199910000-00002; Sanchez Jose J, 2013, Acta Neurochir Suppl, V118, P223, DOI 10.1007/978-3-7091-1434-6_42; Scudday T, 2011, J AM COLL SURGEONS, V213, P148, DOI 10.1016/j.jamcollsurg.2011.02.027; Seguin P, 2014, CRIT CARE MED, V42, P1, DOI 10.1097/CCM.0b013e3182a2770f; Stiefel MF, 2006, J NEUROSURG, V105, P568, DOI 10.3171/jns.2006.105.4.568; Sugerman HJ, 1997, J TRAUMA, V43, P741, DOI 10.1097/00005373-199711000-00002; Talving P, 2013, J NEUROSURG, V119, P1248, DOI 10.3171/2013.7.JNS122255; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Temkin NR, 1999, J NEUROSURG, V91, P593, DOI 10.3171/jns.1999.91.4.0593; Timmons SD, 2010, CRIT CARE MED, V38, pS431, DOI 10.1097/CCM.0b013e3181ec57ab; Torbic H, 2013, AM J HEALTH-SYST PH, V70, P759, DOI 10.2146/ajhp120203; Vajkoczy P, 2000, J NEUROSURG, V93, P265, DOI 10.3171/jns.2000.93.2.0265; Valadka AB, 1998, CRIT CARE MED, V26, P1576, DOI 10.1097/00003246-199809000-00029; van den Brink WA, 2000, NEUROSURGERY, V46, P868, DOI 10.1097/00006123-200004000-00018; Vespa P, 2005, J CLIN NEUROPHYSIOL, V22, P99, DOI 10.1097/01.WNP.0000154919.54202.E0; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wang X, 2013, CRIT CARE, V17, DOI 10.1186/cc12608; WARD JD, 1985, J NEUROSURG, V62, P383, DOI 10.3171/jns.1985.62.3.0383; WATRIDGE CB, 1989, J NEUROSURG, V71, P854, DOI 10.3171/jns.1989.71.6.0854; WINKLER SR, 1995, SURG NEUROL, V43, P59, DOI 10.1016/0090-3019(95)80039-J; Yang M, 2009, INT J NURS STUD, V46, P753, DOI 10.1016/j.ijnurstu.2009.01.004; Zhang JN, 2012, J NEUROTRAUM, V29, P2597, DOI 10.1089/neu.2012.2348	83	15	15	0	3	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0039-6109	1558-3171		SURG CLIN N AM	Surg. Clin.-North Am.	DEC	2017	97	6					1237	+		10.1016/j.suc.2017.08.001			19	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FQ8PO	WOS:000418625200005	29132507				2022-02-06	
J	Gu, F; Parada, I; Shen, F; Li, J; Bacci, A; Graber, K; Taghavi, RM; Scalise, K; Schwartzkroin, P; Wenzel, J; Prince, DA				Gu, Feng; Parada, Isabel; Shen, Fran; Li, Judith; Bacci, Alberto; Graber, Kevin; Taghavi, Reza Moein; Scalise, Karina; Schwartzkroin, Philip; Wenzel, Jurgen; Prince, David A.			Structural alterations in fast-spiking GABAergic interneurons in a model of posttraumatic neocortical epileptogenesis	NEUROBIOLOGY OF DISEASE			English	Article						Epilepsy; Parvalbumin; Axonal boutons; BDNF; TrkB; Trophic; GABA; Traumatic injury; Inhibitory synapses	TEMPORAL-LOBE EPILEPSY; V PYRAMIDAL NEURONS; ACTIVITY-DEPENDENT REGULATION; CAT VISUAL-CORTEX; NEUROTROPHIC FACTOR; LAYER-V; IN-VIVO; FUNCTIONAL ALTERATIONS; SYNAPTIC CONNECTIVITY; CORTICOSPINAL NEURONS	Electrophysiological experiments in the partial cortical isolation ("undercut" or "UC") model of injury-induced neocortical epileptogenesis have shown alterations in GABAergic synaptic transmission attributable to abnormalities in presynaptic terminals. To determine whether the decreased inhibition was associated with structural abnormalities in GABAergic interneurons, we used immunocytochemical techniques, confocal microscopy and EM in UC and control sensorimotor rat cortex to analyze structural alterations in fast-spiking parvalbumin-containing interneurons and pyramidal (Pyr) cells of layer V. Principle findings were: 1) there were no decreases in counts of parvalbumin (PV)- or GABA-immunoreactive interneurons in UC cortex, however there were significant reductions in expression of VGAT and GAD-65 and-67 in halos of GABAergic terminals around Pyr somata in layer V. 2) Consistent with previous results, somatic size and density of Pyr cells was decreased in infragranular layers of UC cortex. 3) Dendrites of biocytin-filled FS interneurons were significantly decreased in volume. 4) There were decreases in the size and VGAT content of GABAergic boutons in axons of biocytin-filled FS cells in the UC, together with a decrease in colocalization with postsynaptic gephyrin, suggesting a reduction in GABAergic synapses. Quantitative EM of layer V Pyr somata confirmed the reduction in inhibitory synapses. 5) There were marked and lasting reductions in brain derived neurotrophic factor (BDNF)-IR and-mRNA in Pyr cells and decreased TrkB-IR on PV cells in UC cortex. 6) Results lead to the hypothesis that reduction in trophic support by BDNF derived from Pyr cells may contribute to the regressive changes in axonal terminals and dendrites of FS cells in the UC cortex and decreased GABAergic inhibition. Significance: Injury to cortical structures is a major cause of epilepsy, accounting for about 20% of cases in the general population, with an incidence as high as-50% among brain-injured personnel in wartime. Loss of GABAergic inhibitory intemeurons is a significant pathophysiological factor associated with epileptogenesis following brain trauma and other etiologies. Results of these experiments show that the largest population of cortical interneurons, the parvalbumin-containing fast-spiking (FS) interneurons, are preserved in the partial neocortical isolation model of partial epilepsy. However, axonal terminals of these cells are structurally abnormal, have decreased content of GABA synthetic enzymes and vesicular GABA transporter and make fewer synapses onto pyramidal neurons. These structural abnormalities underlie defects in GABAergic neurotransmission that are a key pathophysiological factor in epileptogenesis found in electrophysiological experiments. BDNF, and its TrkB receptor, key factors for maintenance of interneurons and pyramidal neurons, are decreased in the injured cortex. Results suggest that supplying BDNF to the injured epileptogenic brain may reverse the structural and functional abnormalities in the parvalbumin FS interneurons and provide an antiepileptogenic therapy. (C) 2017 Elsevier Inc. All rights reserved.	[Gu, Feng; Parada, Isabel; Shen, Fran; Li, Judith; Graber, Kevin; Taghavi, Reza Moein; Scalise, Karina; Prince, David A.] Stanford Univ, Sch Med, Epilepsy Res Labs, Stanford, CA 94305 USA; [Bacci, Alberto] ICM Hop Pitie Salpetriere, 7 Bd Hop, F-75013 Paris, France; [Schwartzkroin, Philip; Wenzel, Jurgen] Univ Calif Davis, Dept Neurol Surg, Davis, CA 95616 USA		Prince, DA (corresponding author), Stanford Univ, Sch Med, Epilepsy Res Labs, Stanford, CA 94305 USA.	daprince@stanford.edu		Moein Taghavi, Reza/0000-0001-7583-9079; Bacci, Alberto/0000-0002-3355-5892	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS06477, NS12151, NS39579]; Edward and Irene Thiele Pimley Research Fund; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS039579, P01NS012151, R01NS006477, R56NS039579, P50NS012151] Funding Source: NIH RePORTER	Supported by Grants NS06477; NS12151; NS39579 from the NINDS (DAP) and the Edward and Irene Thiele Pimley Research Fund.	ALCANTARA S, 1993, ANAT EMBRYOL, V188, P63; Avramescu S, 2009, J NEUROTRAUM, V26, P799, DOI 10.1089/neu.2008.0739; Bacci A, 2003, J NEUROSCI, V23, P9664; Bausch SB, 2005, EPILEPSY BEHAV, V7, P390, DOI 10.1016/j.yebeh.2005.07.019; Beierlein M, 2003, J NEUROPHYSIOL, V90, P2987, DOI 10.1152/jn.00283.2003; Berg A, 2012, EXP NEUROL, V237, P8, DOI 10.1016/j.expneurol.2012.06.008; Bergami M, 2013, J NEUROSCI, V33, P11464, DOI 10.1523/JNEUROSCI.4812-12.2013; BERGMANN M, 1991, NEUROSCIENCE, V42, P569, DOI 10.1016/0306-4522(91)90399-9; BLINZING.K, 1968, Z ZELLFORSCH MIK ANA, V85, P145, DOI 10.1007/BF00325030; Brock JH, 2010, J NEUROSCI, V30, P9728, DOI 10.1523/JNEUROSCI.1924-10.2010; Buckmaster PS, 2016, J NEUROSCI, V36, P3295, DOI 10.1523/JNEUROSCI.4049-15.2016; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Chattopadhyaya B, 2004, J NEUROSCI, V24, P9598, DOI 10.1523/JNEUROSCI.1851-04.2004; Chattopadhyaya B, 2007, NEURON, V54, P889, DOI 10.1016/j.neuron.2007.05.015; Chaudhry FA, 1998, J NEUROSCI, V18, P9733; Chauvette S, 2016, J NEUROSCI METH, V260, P185, DOI 10.1016/j.jneumeth.2015.08.030; CHEN DH, 1978, J COMP NEUROL, V177, P635, DOI 10.1002/cne.901770407; Chen HX, 2003, J NEUROPHYSIOL, V89, P150, DOI 10.1152/jn.00325.2002; Chen ZH, 2014, NAT COMMUN, V5, DOI 10.1038/ncomms5486; Chu Y, 2009, NEUROSCIENCE, V162, P339, DOI 10.1016/j.neuroscience.2009.04.003; De Gois S, 2005, J NEUROSCI, V25, P7121, DOI 10.1523/JNEUROSCI.5221-04.2005; DeFelipe J, 1999, BRAIN, V122, P1807, DOI 10.1093/brain/122.10.1807; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; DELGADOGARCIA JM, 1988, NEUROSCIENCE, V24, P143, DOI 10.1016/0306-4522(88)90319-3; Elmariah SB, 2004, J NEUROSCI, V24, P2380, DOI 10.1523/JNEUROSCI.4112-03.2004; Faria LC, 2012, NEUROBIOL DIS, V45, P821, DOI 10.1016/j.nbd.2011.11.006; Faria LC, 2010, J NEUROPHYSIOL, V104, P280, DOI 10.1152/jn.00351.2010; Galarreta M, 1999, NATURE, V402, P72, DOI 10.1038/47029; Georgiev D, 2016, SCHIZOPHRENIA BULL, V42, P992, DOI 10.1093/schbul/sbw022; Gibson JR, 1999, NATURE, V402, P75, DOI 10.1038/47035; Giehl KM, 1998, J NEUROSCI, V18, P7351; Graber KD, 1999, ANN NEUROL, V46, P234, DOI 10.1002/1531-8249(199908)46:2<234::AID-ANA13>3.0.CO;2-Q; Graber KD, 2006, MODELS OF SEIZURES AND EPILEPSY, P477, DOI 10.1016/B978-012088554-1/50040-2; GRUNER JE, 1974, J COMP NEUROL, V154, P1, DOI 10.1002/cne.901540102; Hanno-Iijima Y, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134296; HARRIS KM, 1995, NEUROPHARMACOLOGY, V34, P1387, DOI 10.1016/0028-3908(95)00142-S; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Hong EJ, 2008, NEURON, V60, P610, DOI 10.1016/j.neuron.2008.09.024; Houser CR, 2014, ADV EXP MED BIOL, V813, P151, DOI 10.1007/978-94-017-8914-1_12; HOUSER CR, 1986, BRAIN RES, V383, P129, DOI 10.1016/0006-8993(86)90014-4; Houser CR, 1996, EPILEPSY RES, V26, P207, DOI 10.1016/S0920-1211(96)00054-X; Jiao YY, 2006, J NEUROSCI, V26, P8691, DOI 10.1523/JNEUROSCI.2478-06.2006; Jiao YY, 2011, P NATL ACAD SCI USA, V108, P12131, DOI 10.1073/pnas.1105296108; Jin X, 2003, J NEUROSCI, V23, P5662; Jin XM, 2014, J NEUROPHYSIOL, V112, P1703, DOI 10.1152/jn.00854.2013; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Kilinc D, 2008, EXP NEUROL, V212, P422, DOI 10.1016/j.expneurol.2008.04.025; Kohara K, 2007, J NEUROSCI, V27, P7234, DOI 10.1523/JNEUROSCI.1943-07.2007; Kron M, 2014, DIS MODEL MECH, V7, P1047, DOI 10.1242/dmm.016030; Kumar SS, 2006, J NEUROSCI, V26, P4613, DOI 10.1523/JNEUROSCI.0064-06.2006; KUNO M, 1970, J PHYSIOL-LONDON, V210, P823, DOI 10.1113/jphysiol.1970.sp009244; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; Lin YX, 2008, NATURE, V455, P1198, DOI 10.1038/nature07319; Ma YY, 2012, NEUROBIOL DIS, V47, P102, DOI 10.1016/j.nbd.2012.03.027; Magloczky Z, 2005, TRENDS NEUROSCI, V28, P334, DOI 10.1016/j.tins.2005.04.002; Marco P, 1996, BRAIN, V119, P1327, DOI 10.1093/brain/119.4.1327; Marty S, 1996, J NEUROSCI, V16, P675; Massa SM, 2010, J CLIN INVEST, V120, P1774, DOI 10.1172/JCI41356; MCALLISTER AK, 1995, NEURON, V15, P791, DOI 10.1016/0896-6273(95)90171-X; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Nita DA, 2007, CEREB CORTEX, V17, P272, DOI 10.1093/cercor/bhj145; Peng ZC, 2013, J NEUROSCI, V33, P14392, DOI 10.1523/JNEUROSCI.2045-13.2013; PIERCE JP, 1994, NEUROSCIENCE, V58, P441, DOI 10.1016/0306-4522(94)90071-X; Ping XJ, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0158231; Ping XJ, 2016, J NEUROTRAUM, V33, P354, DOI 10.1089/neu.2015.3913; Prince D. A., 2012, JASPERS BASIC MECH E, V4, P315; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; RIBAK CE, 1982, J NEUROSCI, V2, P1725; RIBAK CE, 1982, CAN J PHYSIOL PHARM, V60, P864, DOI 10.1139/y82-122; RIBAK CE, 1985, BRAIN RES, V326, P251, DOI 10.1016/0006-8993(85)90034-4; Rosen GD, 1998, CEREB CORTEX, V8, P753, DOI 10.1093/cercor/8.8.753; Rutherford LC, 1997, J NEUROSCI, V17, P4527; Sakata K, 2009, P NATL ACAD SCI USA, V106, P5942, DOI 10.1073/pnas.0811431106; Salin P, 1995, J NEUROSCI, V15, P8234; Schmid DA, 2012, J NEUROSCI, V32, P1803, DOI 10.1523/JNEUROSCI.0865-11.2012; SHARPLESS SK, 1962, ELECTROEN CLIN NEURO, V14, P244, DOI 10.1016/0013-4694(62)90034-2; SLOVITER RS, 1987, SCIENCE, V235, P73, DOI 10.1126/science.2879352; Snapyan M, 2009, J NEUROSCI, V29, P4172, DOI 10.1523/JNEUROSCI.4956-08.2009; Takahashi DK, 2016, NEUROBIOL DIS, V91, P166, DOI 10.1016/j.nbd.2016.03.003; TAKATA M, 1981, BRAIN RES, V224, P165, DOI 10.1016/0006-8993(81)91127-6; Tamas G, 1997, J NEUROSCI, V17, P6352; Tamas G, 1997, J PHYSIOL-LONDON, V500, P715, DOI 10.1113/jphysiol.1997.sp022054; Timofeev I, 2010, NEUROSCIENTIST, V16, P19, DOI 10.1177/1073858409333545; Topolnik L, 2003, EUR J NEUROSCI, V18, P486, DOI 10.1046/j.1460-9568.2003.02742.x; Tseng GF, 1996, J NEUROPHYSIOL, V75, P248, DOI 10.1152/jn.1996.75.1.248; Uematsu M, 2008, CEREB CORTEX, V18, P315, DOI 10.1093/cercor/bhm056; Villa KL, 2016, NEURON, V90, P662, DOI 10.1016/j.neuron.2016.03.035; Wenzel HJ, 2001, J NEUROSCI, V21, P983, DOI 10.1523/JNEUROSCI.21-03-00983.2001; Wyeth MS, 2010, J NEUROSCI, V30, P8993, DOI 10.1523/JNEUROSCI.1183-10.2010; Xiang ZX, 2002, J NEUROPHYSIOL, V88, P740, DOI 10.1152/jn.2002.88.2.740; Xiang ZX, 1998, J PHYSIOL-LONDON, V506, P715, DOI 10.1111/j.1469-7793.1998.715bv.x; Yamada J, 2011, NEUROSCIENCE, V182, P1, DOI 10.1016/j.neuroscience.2011.03.030	95	15	17	2	20	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	DEC	2017	108						100	114		10.1016/j.nbd.2017.08.008			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM1GU	WOS:000414723000009	28823934	Green Accepted			2022-02-06	
J	Jang, SH; Lee, J; Yeo, SS				Jang, Sung Ho; Lee, Jun; Yeo, Sang Seok			Central post-stroke pain due to injury of the spinothalamic tract in patients with cerebral infarction: a diffusion tensor tractography imaging study	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; central post-stroke pain; cerebral infarction; spinothalamic tract; diffusion tensor imaging; neural regeneration	TRAUMATIC BRAIN-INJURY; THALAMO-CORTICAL PATHWAY; SENSORY ABNORMALITIES; NEUROPATHIC PAIN; MECHANISMS; PATHOPHYSIOLOGY; MANAGEMENT	Many studies using diffusion tensor tractography (DTT) have demonstrated that injury of the spinothalamic tract (STT) is the pathogenetic mechanism of central post-stroke pain (CPSP) in intracerebral hemorrhage; however, there is no DTT study reporting the pathogenetic mechanism of CPSP in cerebral infarction. In this study, we investigated injury of the STT in patients with CPSP following cerebral infarction, using DTT. Five patients with CPSP following cerebral infarction and eight age-and sex-matched healthy control subjects were recruited for this study. STT was examined using DTT. Among DTT parameters of the affected STT, fractional anisotropy and tract volume were decreased by more than two standard deviations in two patients (patients 1 and 2) and three patients (patients 3, 4, and 5), respectively, compared with those of the control subjects, while mean diffusivity value was increased by more than two standard deviations in one patient (patient 2). Regarding DTT configuration, all affected STTs passed through adjacent part of the infarct and three STTs showed narrowing. These findings suggest that injury of the STT might be a pathogenetic etiology of CPSP in patients with cerebral infarction.	[Jang, Sung Ho] Yeungnam Univ, Coll Med, Dept Phys Med & Rehabil, Daegu, South Korea; [Lee, Jun] Yeungnam Univ, Coll Med, Dept Neurol, Daegu, South Korea; [Yeo, Sang Seok] Dankook Univ, Coll Hlth Sci, Dept Phys Therapy, Chungnam, South Korea		Yeo, SS (corresponding author), Dankook Univ, Coll Hlth Sci, Dept Phys Therapy, Chungnam, South Korea.	eangbul@hanmail.net			National Research Foundation (NRF) of Korea - Korean Government (MSIP) [NRF-2015R1D1A1A01060314]	This work was supported by the National Research Foundation (NRF) of Korea Grant funded by the Korean Government (MSIP), No. NRF-2015R1D1A1A01060314.	Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BOIVIE J, 1989, PAIN, V37, P173, DOI 10.1016/0304-3959(89)90128-0; CESARO P, 1991, PAIN, V47, P329, DOI 10.1016/0304-3959(91)90224-L; Devulder J, 2002, ACTA NEUROL BELG, V102, P97; Dworkin RH, 2003, ARCH NEUROL-CHICAGO, V60, P1524, DOI 10.1001/archneur.60.11.1524; Flaherty S A, 1996, AANA J, V64, P133; Goto T, 2008, PAIN, V140, P509, DOI 10.1016/j.pain.2008.10.009; Hong JH, 2012, EUR NEUROL, V67, P12, DOI 10.1159/000333012; Hong JH, 2010, EUR NEUROL, V64, P163, DOI 10.1159/000319040; Hong JH, 2010, NEUROSCI LETT, V468, P102, DOI 10.1016/j.neulet.2009.10.075; Jang SH, 2016, BRAIN INJURY, V30, P1026, DOI 10.3109/02699052.2016.1146961; Jang SH, 2016, NEURAL REGEN RES, V11, P130, DOI 10.4103/1673-5374.175058; Jang SH, 2013, STROKE, V44, P1099, DOI 10.1161/STROKEAHA.111.000269; Klit H, 2009, LANCET NEUROL, V8, P857, DOI 10.1016/S1474-4422(09)70176-0; Kumar B, 2009, ANESTH ANALG, V108, P1645, DOI 10.1213/ane.0b013e31819d644c; Latremoliere A, 2009, J PAIN, V10, P895, DOI 10.1016/j.jpain.2009.06.012; Ofek H, 2007, PAIN, V131, P330, DOI 10.1016/j.pain.2007.06.015; Seghier ML, 2005, J PAIN, V6, P208, DOI 10.1016/j.jpain.2004.11.004; Seo JP, 2014, J REHABIL MED, V46, P374, DOI 10.2340/16501977-1783; Seo JP, 2013, BRAIN INJURY, V27, P749, DOI 10.3109/02699052.2013.771794; VESTERGAARD K, 1995, PAIN, V61, P177, DOI 10.1016/0304-3959(94)00140-A; Wang CC, 2017, BEHAV BRAIN RES, V317, P251, DOI 10.1016/j.bbr.2016.09.053; Wasner G, 2008, BRAIN, V131, P2387, DOI 10.1093/brain/awn169; Woolf CJ, 1999, LANCET, V353, P1959, DOI 10.1016/S0140-6736(99)01307-0; Yamada K, 2009, MAGN RESON MED SCI, V8, P165, DOI 10.2463/mrms.8.165	25	15	16	0	2	WOLTERS KLUWER MEDKNOW PUBLICATIONS	MUMBAI	WOLTERS KLUWER INDIA PVT LTD , A-202, 2ND FLR, QUBE, C T S  NO 1498A-2 VILLAGE MAROL, ANDHERI EAST, MUMBAI, 400059, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	DEC	2017	12	12					2021	2024		10.4103/1673-5374.221159			4	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	FS7UZ	WOS:000422615700017	29323041	gold, Green Published			2022-02-06	
J	Kornguth, S; Rutledge, N; Perlaza, G; Bray, J; Hardin, A				Kornguth, Steven; Rutledge, Neal; Perlaza, Gabe; Bray, James; Hardin, Allen			A Proposed Mechanism for Development of CTE Following Concussive Events: Head Impact, Water Hammer Injury, Neurofilament Release, and Autoimmune Processes	BRAIN SCIENCES			English	Article						chronic traumatic encephalopathy; brain structure and function; concussion; water hammer effect; neurofilament release from brain; autoimmune disease	TRAUMATIC BRAIN-INJURY; LIGHT PROTEIN; FOOTBALL; CATS; ANTINEUROFILAMENT; ENCEPHALOPATHY; MINOCYCLINE; ANTIBODIES; INDUCTION; SYMPTOMS	During the past decade, there has been an increasing interest in early diagnosis and treatment of traumatic brain injuries (TBI) that lead to chronic traumatic encephalopathy (CTE). The subjects involved range from soldiers exposed to concussive injuries from improvised explosive devices (IEDs) to a significant number of athletes involved in repetitive high force impacts. Although the forces from IEDs are much greater by a magnitude than those from contact sports, the higher frequency associated with contact sports allows for more controlled assessment of the mechanism of action. In our study, we report findings in university-level women soccer athletes followed over a period of four and a half years from accession to graduation. Parameters investigated included T1-, T2-, and susceptibility-weighted magnetic resonance images (SWI), IMPACT (Immediate Post-Concussion Assessment and Cognitive Testing), and C3 Logix behavioral and physiological assessment measures. The MRI Studies show several significant findings: first, a marked increase in the width of sulci in the frontal to occipital cortices; second, an appearance of subtle hemorrhagic changes at the base of the sulci; third was a sustained reduction in total brain volume in several soccer players at a developmental time when brain growth is generally seen. Although all of the athletes successfully completed their college degree and none exhibited long term clinical deficits at the time of graduation, the changes documented by MRI represent a clue to the pathological mechanism following an injury paradigm. The authors propose that our findings and those of prior publications support a mechanism of injury in CTE caused by an autoimmune process associated with the release of neural proteins from nerve cells at the base of the sulcus from a water hammer injury effect. As evidence accumulates to support this hypothesis, there are pharmacological treatment strategies that may be able to mitigate the development of long-term disability from TBI.	[Kornguth, Steven] Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA; [Kornguth, Steven] Univ Texas Austin, Dept Neurol, Dell Med Sch, Austin, TX 78712 USA; [Rutledge, Neal] Austin Radiol Assoc, Res Imaging Ctr, Austin, TX 78705 USA; [Perlaza, Gabe; Bray, James; Hardin, Allen] Univ Texas Austin, Dept Intercollegiate Athlet, Austin, TX 78712 USA; [Bray, James] Univ Texas Austin, Dept Populat Hlth, Austin, TX 78712 USA		Kornguth, S (corresponding author), Univ Texas Austin, Dept Kinesiol & Hlth Educ, Austin, TX 78712 USA.; Kornguth, S (corresponding author), Univ Texas Austin, Dept Neurol, Dell Med Sch, Austin, TX 78712 USA.	steve_kornguth@utexas.edu; nrutledge@austin.rr.com; gabe.perlaza@athletics.utexas.edu; james.bray@athletics.utexas.edu; allen.hardin@athletics.utexas.edu					Aloisi F, 2001, GLIA, V36, P165, DOI 10.1002/glia.1106; Babbs C F, 2001, ScientificWorldJournal, V1, P281; Bargerstock E, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101477; BELL CL, 1991, ARTHRITIS RHEUM, V34, P432, DOI 10.1002/art.1780340408; Bernick C., 2017, P AM AC NEUR SPORTS; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Byrne LM, 2017, LANCET NEUROL, V16, P601, DOI 10.1016/S1474-4422(17)30124-2; Centers for Disease Control and Prevention, 2011, MMWR-MORBID MORTAL W, V60, P1137; CRABTREE JW, 1986, J NEUROSCI, V6, P1199; DeKosky, 1998, Semin Clin Neuropsychiatry, V3, P176; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; Deshpande SK, 2017, JAMA NEUROL, V74, P909, DOI 10.1001/jamaneurol.2017.1317; Dretsch MN, 2016, BRAIN BEHAV, V6, DOI 10.1002/brb3.392; Elewa HF, 2006, PHARMACOTHERAPY, V26, P515, DOI 10.1592/phco.26.4.515; Fagan SC, 2010, STROKE, V41, P2283, DOI 10.1161/STROKEAHA.110.582601; Frommer LJ, 2011, J ATHL TRAINING, V46, P76, DOI 10.4085/1062-6050-46.1.76; Ghidaoui M. S., 2005, Applied Mechanics Review, V58, P49, DOI 10.1115/1.1828050; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRUNWALD GB, 1985, LANCET, V1, P658; Hedman AM, 2012, HUM BRAIN MAPP, V33, P1987, DOI 10.1002/hbm.21334; Hernandez-Ontiveros DG, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00030; Institute of Medicine, 2011, COGN REH THER TRAUM; Jarrett M, 2016, FRONT NEUROL, V7, DOI 10.3389/fneur.2016.00011; Joy J. E., 2002, IS SOCCER BAD CHILDR; Kantarci OH, 2008, ARCH NEUROL-CHICAGO, V65, P349, DOI 10.1001/archneurol.2007.66; KORNGUTH S, 1991, BIOCHEM BIOPH RES CO, V179, P102, DOI 10.1016/0006-291X(91)91340-I; KORNGUTH S, 1995, SCIENCE, V270, P720; KORNGUTH SE, 1986, CANCER RES, V46, P2588; Lu DY, 2004, J NEUROTRAUM, V21, P21, DOI 10.1089/089771504772695913; Mansell JL, 2010, BRAIN INJURY, V24, P1070, DOI 10.3109/02699052.2010.494589; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McCluskey LP, 2000, J NEUROPATH EXP NEUR, V59, P177, DOI 10.1093/jnen/59.3.177; Mez J, 2017, JAMA-J AM MED ASSOC, V318, P360, DOI 10.1001/jama.2017.8334; Neselius S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081249; Neumann H, 1997, J EXP MED, V185, P305, DOI 10.1084/jem.185.2.305; NEUMANN H, 1995, SCIENCE, V269, P549, DOI 10.1126/science.7624779; Neumann H, 1996, EUR J NEUROSCI, V8, P2582, DOI 10.1111/j.1460-9568.1996.tb01552.x; Nizamutdinov D, 2017, BRAIN SCI, V7, DOI 10.3390/brainsci7010011; Oliver JM, 2016, J NEUROTRAUM, V33, P1784, DOI 10.1089/neu.2015.4295; Ottum PA, 2015, FRONT IMMUNOL, V6, DOI 10.3389/fimmu.2015.00539; Poldrack RA, 2015, NAT COMMUN, V6, DOI 10.1038/ncomms9885; Puvenna V, 2016, BRAIN RES, V1630, P225, DOI 10.1016/j.brainres.2015.11.007; Reuter M, 2012, NEUROIMAGE, V61, P1402, DOI 10.1016/j.neuroimage.2012.02.084; ROBBINS ML, 1988, ARTHRITIS RHEUM, V31, P623, DOI 10.1002/art.1780310507; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Rubenstein R, 2017, JAMA NEUROL, V74, P1063, DOI 10.1001/jamaneurol.2017.0655; Seifert HA, 2014, J NEUROIMMUNE PHARM, V9, P679, DOI 10.1007/s11481-014-9560-2; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shahim P, 2016, SCI REP-UK, V6, DOI 10.1038/srep36791; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Sironi L., 2003, THROMB VASC BIOL, V23, P322, DOI [10.1161/01.ATV.0000044458.23905.3B12588778, DOI 10.1161/01.ATV.0000044458.23905.3B12588778]; SPEAR PD, 1986, BRAIN RES, V368, P154, DOI 10.1016/0006-8993(86)91053-X; Turner RC, 2013, INT J MOL SCI, V14, P1890, DOI 10.3390/ijms14011890; Vedantam S., 2015, J NEUROL STROKE, V2, P73, DOI DOI 10.15406/JNSK.2015.02.00073; Wang KKW, 2016, J NEUROTRAUM, V33, P1270, DOI 10.1089/neu.2015.3881; WILLIAMS RW, 1985, BRAIN RES, V336, P57, DOI 10.1016/0006-8993(85)90415-9; Wu HT, 2008, J NEUROSURG, V109, P691, DOI 10.3171/JNS/2008/109/10/0691; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zhang J., 2016, BIOMARKERS TRAUMATIC; Zhang T. G., 2013, P ASME INT MECH ENG; Zhao Q, 2017, J IMMUNOL, V199, P312, DOI 10.4049/jimmunol.1700171	62	15	15	3	22	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND		2076-3425		BRAIN SCI	Brain Sci.	DEC	2017	7	12							164	10.3390/brainsci7120164			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FR6PC	WOS:000419187000009	29257064	gold, Green Published, Green Submitted			2022-02-06	
J	Rajagopal, R; Swaminathan, G; Nair, S; Joseph, M				Rajagopal, Ramanan; Swaminathan, Ganesh; Nair, Shalini; Joseph, Mathew			Hyponatremia in Traumatic Brain Injury: A Practical Management Protocol	WORLD NEUROSURGERY			English	Article						Fludrocortisone; Hyponatremia; Natriuresis; Traumatic brain injury	DIURETIC HORMONE SIADH; INAPPROPRIATE SECRETION; NEUROSURGICAL PATIENTS; HEAD-INJURY; SUBARACHNOID HEMORRHAGE; FLUDROCORTISONE; CONSEQUENCES; NATRIURESIS; THERAPY; DISEASE	BACKGROUND: Hyponatremia (defined as serum sodium <135 mEq/L) is the most common electrolyte abnormality in traumatic brain injury (TBI) and is also an independent predictor of poor neurologic outcome. The reported incidence of hyponatremia varies widely in literature reports, and there is continuing difficulty in clearly differentiating between the 2 common causes of hyponatremia with natriuresis: the syndrome of inappropriate antidiuretic hormone secretion (SIADH) and cerebral salt wasting (CSW). We encounter hyponatremia frequently in our practice, and we therefore decided to review data from our center to estimate the incidence of hyponatremia and the results of our management strategies, and attempt to formulate simple guidelines for the correction of hyponatremia in TBI. METHODS: A retrospective analysis of 1500 consecutively admitted patients with TBI was performed by the use of electronic records and radiographic review. Hyponatremia was defined as serum sodium <135 mEq/L, and natriuresis as a urine spot sodium of more than >40 mEq/L. The incidence of TBI, its management, and the effect of fludrocortisone were evaluated. RESULTS: The incidence of hyponatremia was 13.2%. Early therapy with fludrocortisone significantly reduced the duration of hospital stay (P < 0.05). Traumatic subarachnoid hemorrhage was the most common abnormality on the admission computed tomographic scan in patients who experienced hyponatremia. CONCLUSION: Early initiation of fludrocortisone in the setting of hyponatremia with natriuresis decreases the hospital stay. This protocol is probably safer in a tropical country where fluid restriction might be harmful. It also eliminates the need to differentiate between SIADH and CSW.	[Rajagopal, Ramanan; Swaminathan, Ganesh; Nair, Shalini; Joseph, Mathew] Christian Med Coll & Hosp, Dept Neurol Sci, Vellore, Tamil Nadu, India		Rajagopal, R (corresponding author), Christian Med Coll & Hosp, Dept Neurol Sci, Vellore, Tamil Nadu, India.	ramanashiva@gmail.com					Adrogue HJ, 2000, NEW ENGL J MED, V342, P1581, DOI 10.1056/NEJM200005253422107; Agha A, 2005, QJM-INT J MED, V98, P463, DOI 10.1093/qjmed/hci075; BORN JD, 1985, SURG NEUROL, V23, P383, DOI 10.1016/0090-3019(85)90212-5; Bussmann C, 2001, CHILD NERV SYST, V17, P58; Diringer MN, 2006, NEUROLOGIST, V12, P117, DOI 10.1097/01.nrl.0000215741.01699.77; DOCZI T, 1982, NEUROSURGERY, V10, P685, DOI 10.1227/00006123-198206010-00001; Gill G, 2006, CLIN ENDOCRINOL, V65, P246, DOI 10.1111/j.1365-2265.2006.02583.x; ISHIKAWA SE, 1987, ANN INTERN MED, V106, P187, DOI 10.7326/0003-4819-106-2-187; Kinik ST, 2001, PEDIATR NEUROSURG, V35, P216, DOI 10.1159/000050424; Kirkman MA, 2013, NEUROCRIT CARE, V18, P406, DOI 10.1007/s12028-012-9805-y; Kurokawa Y, 1996, SURG NEUROL, V46, P500, DOI 10.1016/S0090-3019(96)00034-1; Lohani S, 2011, WORLD NEUROSURG, V76, P355, DOI 10.1016/j.wneu.2011.03.042; Meng XF, 2016, J NEUROSURG ANESTH, V28, P21, DOI 10.1097/ANA.0000000000000192; Mori T, 1999, J NEUROSURG, V91, P947, DOI 10.3171/jns.1999.91.6.0947; Moro N, 2007, SURG NEUROL, V68, P387, DOI 10.1016/j.surneu.2006.11.052; NELSON PB, 1981, J NEUROSURG, V55, P938, DOI 10.3171/jns.1981.55.6.0938; Sajadieh A, 2009, AM J MED, V122, P679, DOI 10.1016/j.amjmed.2008.11.033; Sherlock M, 2009, POSTGRAD MED J, V85, P171, DOI 10.1136/pgmj.2008.072819; SIVAKUMAR V, 1994, NEUROSURGERY, V34, P269, DOI 10.1227/00006123-199402000-00010; Sterns RH, 2008, J AM SOC NEPHROL, V19, P194, DOI 10.1681/ASN.2007101118; Verbalis JG, 2013, AM J MED, V126, pS5, DOI 10.1016/j.amjmed.2013.07.006; VINGERHOETS F, 1988, ACTA NEUROCHIR, V91, P50, DOI 10.1007/BF01400528; WIJDICKS EFM, 1985, ANN NEUROL, V17, P137, DOI 10.1002/ana.410170206; Yumoto T, 2015, ACTA MED OKAYAMA, V69, P213	24	15	16	0	6	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	DEC	2017	108						529	533		10.1016/j.wneu.2017.09.013			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FN3CU	WOS:000415874900069	28899834				2022-02-06	
J	Ledig, C; Kamnitsas, K; Koikkalainen, J; Posti, JP; Takala, RSK; Katila, A; Frantzen, J; Ala-Seppala, H; Kyllonen, A; Maanpaa, HR; Tallus, J; Lotjonen, J; Glocker, B; Tenovuo, O; Rueckert, D				Ledig, Christian; Kamnitsas, Konstantinos; Koikkalainen, Juha; Posti, Jussi P.; Takala, Riikka S. K.; Katila, Ari; Frantzen, Janek; Ala-Seppala, Henna; Kyllonen, Anna; Maanpaa, Henna-Riikka; Tallus, Jussi; Lotjonen, Jyrki; Glocker, Ben; Tenovuo, Olli; Rueckert, Daniel			Regional brain morphometry in patients with traumatic brain injury based on acute- and chronic-phase magnetic resonance imaging	PLOS ONE			English	Article							VOXEL-BASED MORPHOMETRY; HUMAN CEREBRAL-CORTEX; WHITE-MATTER INJURY; AXONAL INJURY; HEAD-INJURY; COMPUTERIZED-TOMOGRAPHY; OUTCOME PREDICTION; ALZHEIMERS-DISEASE; DIFFUSION-TENSOR; EARLY ADULTHOOD	Traumatic brain injury (TBI) is caused by a sudden external force and can be very heterogeneous in its manifestation. In this work, we analyse T1-weighted magnetic resonance (MR) brain images that were prospectively acquired from patients who sustained mild to severe TBI. We investigate the potential of a recently proposed automatic segmentation method to support the outcome prediction of TBI. Specifically, we extract meaningful cross-sectional and longitudinal measurements from acute-and chronic-phase MR images. We calculate regional volume and asymmetry features at the acute/subacute stage of the injury (median: 19 days after injury), to predict the disability outcome of 67 patients at the chronic disease stage (median: 229 days after injury). Our results indicate that small structural volumes in the acute stage (e. g. of the hippocampus, accumbens, amygdala) can be strong predictors for unfavourable disease outcome. Further, group differences in atrophy are investigated. We find that patients with unfavourable outcome show increased atrophy. Among patients with severe disability outcome we observed a significantly higher mean reduction of cerebral white matter (3.1%) as compared to patients with low disability outcome (0.7%).	[Ledig, Christian; Kamnitsas, Konstantinos; Glocker, Ben; Rueckert, Daniel] Imperial Coll London, Dept Comp, London, England; [Koikkalainen, Juha; Lotjonen, Jyrki] Combinostics, Tampere, Finland; [Koikkalainen, Juha; Lotjonen, Jyrki] VTT Tech Res Ctr Finland, Tampere, Finland; [Posti, Jussi P.; Frantzen, Janek; Ala-Seppala, Henna; Kyllonen, Anna; Maanpaa, Henna-Riikka; Tallus, Jussi; Tenovuo, Olli] Univ Turku, Dept Clin Med, Turku, Finland; [Posti, Jussi P.; Frantzen, Janek; Tenovuo, Olli] Turku Univ Hosp, Div Clin Neurosci, Turku Brain Injury Ctr, Turku, Finland; [Posti, Jussi P.; Frantzen, Janek] Turku Univ Hosp, Div Clin Neurosci, Dept Neurosurg, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari] Turku Univ Hosp, Perioperat Serv Intens Care Med & Pain Management, Turku, Finland; [Takala, Riikka S. K.; Katila, Ari] Univ Turku, Turku, Finland		Ledig, C (corresponding author), Imperial Coll London, Dept Comp, London, England.	ledig.christian@gmail.com	Posti, Jussi P./Y-2908-2019	Posti, Jussi P./0000-0002-5925-5193; Ledig, Christian/0000-0003-4862-3138; Ala-Seppala, Henna/0000-0002-1577-3028	7th Framework Programme by the European Commission [270259]; Engineering and Physical Sciences Research CouncilUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N023668/1]; Imperial College PhD Scholarship; Government's Special Financial Transfer tied to academic research in Health Sciences (Finland); Emil Aaltonen Foundation; EPSRCUK Research & Innovation (UKRI)Engineering & Physical Sciences Research Council (EPSRC) [EP/N023668/1] Funding Source: UKRI	Funding for this research was provided by the 7th Framework Programme by the European Commission (270259); BG, CL acknowledge funding support from Engineering and Physical Sciences Research Council (EP/N023668/1); KK acknowledges funding support from Imperial College PhD Scholarship. JPP acknowledges funding support from Government's Special Financial Transfer tied to academic research in Health Sciences (Finland) and Emil Aaltonen Foundation. Combinostics provided support in the form of salaries for JK and JL. The specific roles of these authors are articulated in the 'author contributions' section. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Arlinghaus K, 2011, TXB TRAUMATIC BRAIN, P55; Ashburner J, 2000, NEUROIMAGE, V11, P805, DOI 10.1006/nimg.2000.0582; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Blatter DD, 1997, AM J NEURORADIOL, V18, P1; Bonilha L, 2014, FRONT PSYCHIATRY, V4, DOI 10.3389/fpsyt.2013.00186; Brodersen Kay H, 2010, Proceedings of the 2010 20th International Conference on Pattern Recognition (ICPR 2010), P3121, DOI 10.1109/ICPR.2010.764; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Chang CC, 2011, ACM T INTEL SYST TEC, V2, DOI 10.1145/1961189.1961199; Cohen J., 2013, STAT POWER ANAL BEHA; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Ding K, 2008, J NEUROTRAUM, V25, P1433, DOI 10.1089/neu.2008.0683; Fennema-Notestine C, 2009, HUM BRAIN MAPP, V30, P3238, DOI 10.1002/hbm.20744; Fischl B, 2004, CEREB CORTEX, V14, P11, DOI 10.1093/cercor/bhg087; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; GALABURDA AM, 1987, NEUROPSYCHOLOGIA, V25, P853, DOI 10.1016/0028-3932(87)90091-1; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Graham DI, 2000, J NEUROPATH EXP NEUR, V59, P641, DOI 10.1093/jnen/59.8.641; Haneuse S, 2009, NEUROEPIDEMIOLOGY, V32, P229, DOI 10.1159/000197389; Heckemann RA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129211; Heckemann RA, 2011, NEUROIMAGE, V56, P2024, DOI 10.1016/j.neuroimage.2011.03.014; Heckemann RA, 2010, NEUROIMAGE, V51, P221, DOI 10.1016/j.neuroimage.2010.01.072; Irimia A, 2012, NEUROIMAGE-CLIN, V1, P1, DOI 10.1016/j.nicl.2012.08.002; Irimia A, 2011, J NEUROTRAUM, V28, P2287, DOI 10.1089/neu.2011.1920; Jacobs B, 2010, J NEUROTRAUM, V27, P655, DOI 10.1089/neu.2009.1059; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kamnitsas K., 2015, ISCHEMIC STROKE LESI, V13, P13, DOI DOI 10.1016/J.MEDIA.2016.10.004; Kamnitsas K, 2017, LECT NOTES COMPUT SC, V10265, P597, DOI 10.1007/978-3-319-59050-9_47; Kamnitsas K, 2017, MED IMAGE ANAL, V36, P61, DOI 10.1016/j.media.2016.10.004; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Ledig C, 2014, I S BIOMED IMAGING, P673, DOI 10.1109/ISBI.2014.6867960; Ledig C, 2015, MED IMAGE ANAL, V21, P40, DOI 10.1016/j.media.2014.12.003; Leung KK, 2012, NEUROIMAGE, V59, P3995, DOI 10.1016/j.neuroimage.2011.10.068; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDonald BC, 2012, BRAIN IMAGING BEHAV, V6, P193, DOI 10.1007/s11682-012-9173-4; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Newcombe VFJ, 2015, NEUROREHABILITATION; Nyul LG, 1999, MAGNET RESON MED, V42, P1072, DOI 10.1002/(SICI)1522-2594(199912)42:6<1072::AID-MRM11>3.0.CO;2-M; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Salmond CH, 2005, BRAIN, V128, P189, DOI 10.1093/brain/awh352; Schonberger M, 2009, J NEUROTRAUM, V26, P2157, DOI 10.1089/neu.2009.0939; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Smith C., 2011, TXB TRAUMATIC BRAIN, P23; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Strangman GE, 2010, FRONT HUM NEUROSCI, V4, DOI 10.3389/fnhum.2010.00182; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; TEASDALE G, 1974, LANCET, V2, P81; Tustison NJ, 2010, IEEE T MED IMAGING, V29, P1310, DOI 10.1109/TMI.2010.2046908; Wang B, 2013, I S BIOMED IMAGING, P1392; Wang B, 2012, 2012 9TH IEEE INTERNATIONAL SYMPOSIUM ON BIOMEDICAL IMAGING (ISBI), P1152, DOI 10.1109/ISBI.2012.6235764; Wang B, 2012, PROC SPIE, V8314, DOI 10.1117/12.911043; Wang HZ, 2013, IEEE T PATTERN ANAL, V35, P611, DOI 10.1109/TPAMI.2012.143; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Yushkevich PA, 2010, NEUROIMAGE, V50, P434, DOI 10.1016/j.neuroimage.2009.12.007	72	15	15	1	2	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	NOV 28	2017	12	11							e0188152	10.1371/journal.pone.0188152			31	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FN9ZL	WOS:000416402000010	29182625	Green Published, gold, Green Submitted			2022-02-06	
J	Savjani, RR; Taylor, BA; Acion, L; Wilde, EA; Jorge, RE				Savjani, Ricky R.; Taylor, Brian A.; Acion, Laura; Wilde, Elisabeth A.; Jorge, Ricardo E.			Accelerated Changes in Cortical Thickness Measurements with Age in Military Service Members with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						ANTs; cortical thickness; gray matter; mild traumatic brain injury; MRI; mTBI; OEF/OIF/OND Service Members; TBI; traumatic brain injury; volumetrics	HUMAN CEREBRAL-CORTEX; VETERANS; ROBUST; ABNORMALITIES; OPTIMIZATION; REGISTRATION; DISORDER; MOTION; VOLUME; SCALE	Finding objective and quantifiable imaging markers of mild traumatic brain injury (TBI) has proven challenging, especially in the military population. Changes in cortical thickness after injury have been reported in animals and in humans, but it is unclear how these alterations manifest in the chronic phase, and it is difficult to characterize accurately with imaging. We used cortical thickness measures derived from Advanced Normalization Tools (ANTs) to predict a continuous demographic variable: age. We trained four different regression models (linear regression, support vector regression, Gaussian process regression, and random forests) to predict age from healthy control brains from publicly available datasets (n = 762). We then used these models to predict brain age in military Service Members with TBI (n = 92) and military Service Members without TBI (n = 34). Our results show that all four models overpredicted age in Service Members with TBI, and the predicted age difference was significantly greater compared with military controls. These data extend previous civilian findings and show that cortical thickness measures may reveal an association of accelerated changes over time with military TBI.	[Savjani, Ricky R.; Taylor, Brian A.; Wilde, Elisabeth A.; Jorge, Ricardo E.] Michael E DeBakey VA Med Ctr, Houston, TX USA; [Savjani, Ricky R.] Baylor Coll Med, Dept Neurosci, Houston, TX 77030 USA; [Taylor, Brian A.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Radiol, Houston, TX 77030 USA; [Taylor, Brian A.; Wilde, Elisabeth A.] Baylor Coll Med, Dept Phys Med & Rehabil, Houston, TX 77030 USA; [Wilde, Elisabeth A.] Baylor Coll Med, Dept Neurol, Houston, TX 77030 USA; [Acion, Laura; Jorge, Ricardo E.] Baylor Coll Med, Dept Psychiat & Behav Sci, Houston, TX 77030 USA; [Savjani, Ricky R.] Texas A&M Hlth Sci Ctr, Coll Med, Bryan, TX USA; [Acion, Laura] Univ Buenos Aires, CONICET, Fac Ciencias Exactas & Nat, Inst Calculo, Buenos Aires, DF, Argentina		Taylor, BA (corresponding author), Michael E DeBakey VA Med Ctr, 2002 Holcombe Blvd 153 TBI, Houston, TX 77030 USA.	brian.taylor@bcm.edu		Acion, Laura/0000-0001-5213-6012; Savjani, Ricky/0000-0003-4763-2796; Taylor, Brian/0000-0001-9745-1075	U.S. Department of Veterans AffairsUS Department of Veterans Affairs; VA Small Projects in Rehabilitation Research (SPiRE) program [VA 1 I21 RX001565]; VA Rehabilitation Research and Development Merit Award Program: Mood and Anxiety Disorders Due to TBI among OIF/OEF VeteransUS Department of Veterans Affairs	The authors gratefully recognize the support of the U.S. Department of Veterans Affairs for this work. We gratefully acknowledge the assistance and computing resources provided by the CIBR Center for Computational and Integrative Biomedical Research of Baylor College of Medicine in the completion of this work. We would also like to thank Nicholas Tustison for his guidance in using ANTs.; This work was supported by the VA Small Projects in Rehabilitation Research (SPiRE) program (VA 1 I21 RX001565, PI: Taylor) and by the VA Rehabilitation Research and Development Merit Award Program: Mood and Anxiety Disorders Due to TBI among OIF/OEF Veterans (PI: Jorge).	Avants BB, 2011, NEUROIMAGE, V54, P2033, DOI 10.1016/j.neuroimage.2010.09.025; Avants BB, 2010, NEUROIMAGE, V49, P2457, DOI 10.1016/j.neuroimage.2009.09.062; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Cole JH, 2015, ANN NEUROL, V77, P571, DOI 10.1002/ana.24367; Corbo V, 2014, PSYCHIAT RES-NEUROIM, V223, P53, DOI 10.1016/j.pscychresns.2014.04.013; Curran J. M., 2013, HOTELLING HOTELLINGS; Dean PJA, 2015, BRAIN INJURY, V29, P1211, DOI 10.3109/02699052.2015.1035334; Fischl B, 2000, P NATL ACAD SCI USA, V97, P11050, DOI 10.1073/pnas.200033797; Fjell AM, 2009, J NEUROSCI, V29, P8774, DOI 10.1523/JNEUROSCI.0115-09.2009; Fotenos AF, 2005, NEUROLOGY, V64, P1032, DOI 10.1212/01.WNL.0000154530.72969.11; Goddeyne C, 2015, J NEUROPHYSIOL, V113, P3268, DOI 10.1152/jn.00970.2014; Good P, 1994, PERMUTATION TESTS; Gorgolewski Krzysztof, 2011, Front Neuroinform, V5, P13, DOI 10.3389/fninf.2011.00013; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hanford LC, 2016, BIPOLAR DISORD, V18, P4, DOI 10.1111/bdi.12362; Hwang Jihye, 2016, Alzheimers Dement (Amst), V2, P58, DOI 10.1016/j.dadm.2015.11.008; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Jenkinson M, 2001, MED IMAGE ANAL, V5, P143, DOI 10.1016/S1361-8415(01)00036-6; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; JERNIGAN TL, 1991, BIOL PSYCHIAT, V29, P55, DOI 10.1016/0006-3223(91)90210-D; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Klein A, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00171; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Li S., 2016, RADIOLOGY, V280, P547; Li YD, 2015, DRUG ALCOHOL DEPEN, V151, P211, DOI 10.1016/j.drugalcdep.2015.03.023; Lindemer ER, 2013, NEUROIMAGE-CLIN, V2, P601, DOI 10.1016/j.nicl.2013.04.009; List J, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00228; Liu Y, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0039025; Maxwell WL, 2010, BRAIN, V133, P139, DOI 10.1093/brain/awp264; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Michael AP, 2015, J NEUROTRAUM, V32, P1751, DOI 10.1089/neu.2015.3918; Mitra J, 2016, NEUROIMAGE, V129, P247, DOI 10.1016/j.neuroimage.2016.01.056; Omalu B, 2011, NEUROSURGERY, V69, P173, DOI 10.1227/NEU.0b013e318212bc7b; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Roiz-Santianez R, 2015, PSYCHOL MED, V45, P2861, DOI 10.1017/S0033291715000811; Salat DH, 2009, NEUROIMAGE, V48, P21, DOI 10.1016/j.neuroimage.2009.06.074; Salat DH, 2004, CEREB CORTEX, V14, P721, DOI 10.1093/cercor/bhh032; SAUNDERS JB, 1993, ADDICTION, V88, P791, DOI 10.1111/j.1360-0443.1993.tb02093.x; Savjani RR, 2014, DRUG ALCOHOL DEPEN, V145, P134, DOI 10.1016/j.drugalcdep.2014.10.006; Smith E, 2016, HUM BRAIN MAPP, V37, P2616, DOI 10.1002/hbm.23195; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Sowell ER, 2003, NAT NEUROSCI, V6, P309, DOI 10.1038/nn1008; Tate DF, 2014, BRAIN IMAGING BEHAV, V8, P102, DOI 10.1007/s11682-013-9257-9; Thambisetty M, 2010, NEUROIMAGE, V52, P1215, DOI 10.1016/j.neuroimage.2010.04.258; Tremblay S, 2013, CEREB CORTEX, V23, P1159, DOI 10.1093/cercor/bhs102; Tustison NJ, 2014, NEUROIMAGE, V99, P166, DOI 10.1016/j.neuroimage.2014.05.044; van Haren NEM, 2011, ARCH GEN PSYCHIAT, V68, P871, DOI 10.1001/archgenpsychiatry.2011.88; Wang HZ, 2013, IEEE T PATTERN ANAL, V35, P611, DOI 10.1109/TPAMI.2012.143; Wang X, 2015, J NEUROTRAUM, V32, P455, DOI 10.1089/neu.2014.3492; Wolf EJ, 2016, BIOL PSYCHIAT, V80, P363, DOI 10.1016/j.biopsych.2015.11.023	52	15	15	1	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2017	34	22					3107	3116		10.1089/neu.2017.5022			10	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FL9GC	WOS:000414560000006	28657432				2022-02-06	
J	Roselli, F; Karasu, E; Volpe, C; Huber-Lang, M				Roselli, Francesco; Karasu, Ebru; Volpe, Clara; Huber-Lang, Markus			Medusa's Head: The Complement System in Traumatic Brain and Spinal Cord Injury	JOURNAL OF NEUROTRAUMA			English	Article						complement; neuroinflammation; spinal cord injury; traumatic brain injury	MEMBRANE ATTACK COMPLEX; MANNOSE-BINDING LECTIN; C3 CONVERTASES; MOTOR FUNCTION; FRAGMENTS C5A; RECEPTOR; ACTIVATION; INHIBITOR; INFLAMMATION; RECOVERY	Traumatic brain injury (TBI) and spinal cord injury (SCI) are critical medical conditions and a public health problem for which limited therapeutic options are available. The complement cascade is activated after TBI and SCI, and the resulting effects have been investigated in gene-knockout and pharmacological models. Multiple experimental studies support a net detrimental role of C3 and C5 activation in the early stages of TBI and SCI. Less firm experimental evidence suggests that, downstream of C3/C5, effector mechanisms, including the generation of membrane-activated complex and direct damage to membranes and neutrophils infiltration, may bring about the direct damage of central nervous system tissue and enhancement of neuroinflammation. The role of upstream classical, alternative, or extrinsic complement activation cascades remains unclear. Although several issues remain to be investigated, current evidence supports the investigation of a number of complement-targeting agents targeting C3 or C5, such as eculizumab, for repurposing in TBI and SCI treatment.	[Roselli, Francesco; Volpe, Clara] Univ Ulm, Med Sch, Dept Neurol, Ulm, Germany; [Roselli, Francesco] Univ Ulm, Med Sch, Dept Anat & Cell Biol, Ulm, Germany; [Karasu, Ebru; Huber-Lang, Markus] Univ Ulm, Med Sch, Inst Clin & Expt Trauma Immunol, Ulm, Germany		Roselli, F (corresponding author), Ulm Univ, Ctr Biomed Res ZBF, Sch Med, Dept Neurol, Helmholtzstr 8-2 R1-44, D-89081 Ulm, Germany.	francesco.roselli@uni-ulm.de	roselli, francesco/O-8847-2019; Huber-Lang, Markus/AAJ-2209-2020	roselli, francesco/0000-0001-9935-6899; 	DFG as part of the Collaborative Research Center 1149 "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma'' at Ulm University (Ulm, Germany); ERANET-NEURON "European Research Projects on External Insults to the Nervous System'' initiative as part of the MICRO-NET consortium; Baustein Program of Ulm University	F.R., E.K., and M.H. are supported by DFG as part of the Collaborative Research Center 1149 "Danger Response, Disturbance Factors and Regenerative Potential after Acute Trauma'' at Ulm University (Ulm, Germany). F.R. is also supported by the ERANET-NEURON "European Research Projects on External Insults to the Nervous System'' initiative as part of the MICRO-NET consortium and by the Baustein Program of Ulm University. The authors thank Akila Chandrasekar and Rida Rehman for the critical review of the manuscript.	ALPER CA, 1969, SCIENCE, V163, P286, DOI 10.1126/science.163.3864.286; Amara U, 2010, J IMMUNOL, V185, P5628, DOI 10.4049/jimmunol.0903678; Ames RS, 1996, J BIOL CHEM, V271, P20231, DOI 10.1074/jbc.271.34.20231; Baufreton C, 2005, ANN THORAC SURG, V79, P1597, DOI 10.1016/j.athoracsur.2004.08.061; Bayir H, 2003, CRIT CARE MED, V31, pS112, DOI 10.1097/01.CCM.0000042464.46603.0E; Bekker P, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0164646; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Benard M, 2004, J BIOL CHEM, V279, P43487, DOI 10.1074/jbc.M404124200; Biberthaler Peter, 2016, MMW Fortschr Med, V158, P53, DOI 10.1007/s15006-016-8148-6; Biggins PJC, 2017, J NEUROTRAUM, V34, P2075, DOI 10.1089/neu.2016.4701; BJORNSON AB, 1980, ANN SURG, V191, P323, DOI 10.1097/00000658-198003000-00011; Brennan FH, 2015, J NEUROSCI, V35, P6517, DOI 10.1523/JNEUROSCI.5218-14.2015; Burk AM, 2012, SHOCK, V37, P348, DOI 10.1097/SHK.0b013e3182471795; Cain SA, 2002, J BIOL CHEM, V277, P7165, DOI 10.1074/jbc.C100714200; Carron SF, 2016, FRONT SYST NEUROSCI, V10, DOI 10.3389/fnsys.2016.00047; Crane JW, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-34; Crehan H, 2013, NEUROBIOL DIS, V54, P139, DOI 10.1016/j.nbd.2013.02.003; DALMASSO AP, 1992, AM J PATHOL, V140, P1157; Ehrnthaller C, 2011, MOL MED, V17, P317, DOI 10.2119/molmed.2010.00149; Ekdahl KN, 2016, IMMUNOL REV, V274, P245, DOI 10.1111/imr.12471; FEARON DT, 1975, J EXP MED, V142, P856, DOI 10.1084/jem.142.4.856; Fluiter K, 2014, J IMMUNOL, V192, P2339, DOI 10.4049/jimmunol.1302793; Galvan MD, 2008, J NEUROSCI, V28, P13876, DOI 10.1523/JNEUROSCI.2823-08.2008; Gasque P, 2004, MOL IMMUNOL, V41, P1089, DOI 10.1016/j.molimm.2004.06.011; GASQUE P, 1995, J IMMUNOL, V155, P4882; GERARD NP, 1991, NATURE, V349, P614, DOI 10.1038/349614a0; GEWURZ H, 1993, BEHR INST MITT, P138; Guo Q, 2013, CLIN EXP IMMUNOL, V174, P318, DOI 10.1111/cei.12175; Guo Q, 2013, SCAND J IMMUNOL, V77, P224, DOI 10.1111/sji.12001; Guo QA, 2010, NEUROSCI LETT, V485, P32, DOI 10.1016/j.neulet.2010.08.056; Haeffner-Cavaillon N, 1998, REV MED INTERNE, V19, P585, DOI 10.1016/S0248-8663(99)80033-2; Hajela K, 2002, IMMUNOBIOLOGY, V205, P467, DOI 10.1078/0171-2985-00147; Hammond FM, 2004, J HEAD TRAUMA REHAB, V19, P314, DOI 10.1097/00001199-200407000-00006; Hoehlig K, 2013, MOL THER, V21, P2236, DOI 10.1038/mt.2013.178; Hong S, 2016, SCIENCE, V352, P712, DOI 10.1126/science.aad8373; Hourcade DE, 2006, J BIOL CHEM, V281, P2128, DOI 10.1074/jbc.M508928200; Huber-Lang M, 2016, SEMIN IMMUNOL, V28, P278, DOI 10.1016/j.smim.2016.04.005; Huber-Lang M, 2006, NAT MED, V12, P682, DOI 10.1038/nm1419; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; Jore MM, 2016, NAT STRUCT MOL BIOL, V23, P378, DOI 10.1038/nsmb.3196; Karver CL, 2012, REHABIL PSYCHOL, V57, P256, DOI 10.1037/a0029522; KAWASAKI T, 1978, BIOCHEM BIOPH RES CO, V81, P1018, DOI 10.1016/0006-291X(78)91452-3; Klussmann S, 1996, NAT BIOTECHNOL, V14, P1112, DOI 10.1038/nbt0996-1112; Kossmann T, 1997, J NEUROIMMUNOL, V73, P63, DOI 10.1016/S0165-5728(96)00164-6; Lannoo E, 2000, J NEUROTRAUM, V17, P403, DOI 10.1089/neu.2000.17.403; Leinhase I, 2007, J NEUROINFLAMM, V4, DOI 10.1186/1742-2094-4-13; Leinhase I, 2006, BMC NEUROSCI, V7, DOI 10.1186/1471-2202-7-55; Leinhase I, 2006, EXP NEUROL, V199, P454, DOI 10.1016/j.expneurol.2006.01.033; Li LM, 2010, SPINAL CORD, V48, P105, DOI 10.1038/sc.2009.104; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Lu JH, 1998, IMMUNOBIOLOGY, V199, P190, DOI 10.1016/S0171-2985(98)80026-0; Marr A. L., 2005, CENTRAL NERVOUS SYST; Mastellos DC, 2015, EUR J CLIN INVEST, V45, P423, DOI 10.1111/eci.12419; Mathern DR, 2015, CLIN J AM SOC NEPHRO, V10, P1636, DOI 10.2215/CJN.06230614; Mead RJ, 2002, J IMMUNOL, V168, P458, DOI 10.4049/jimmunol.168.1.458; Michailidou I, 2015, ANN NEUROL, V77, P1007, DOI 10.1002/ana.24398; Miyabe Y, 2017, SCI IMMUNOL, V2, DOI 10.1126/sciimmunol.aaj2195; Mollnes TE, 2006, MOL IMMUNOL, V43, P107, DOI 10.1016/j.molimm.2005.06.014; Mollnes Tom E., 2002, Trends in Immunology, V23, P61, DOI 10.1016/S1471-4906(01)02129-9; Moriyama M, 2011, J NEUROSCI, V31, P3981, DOI 10.1523/JNEUROSCI.3617-10.2011; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Nguyen HX, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-26; Noris M, 2013, SEMIN NEPHROL, V33, P479, DOI 10.1016/j.semnephrol.2013.08.001; O'Barr SA, 2001, J IMMUNOL, V166, P4154, DOI 10.4049/jimmunol.166.6.4154; PANGBURN MK, 1981, J EXP MED, V154, P856, DOI 10.1084/jem.154.3.856; Peterson SL, 2015, J NEUROSCI, V35, P4332, DOI 10.1523/JNEUROSCI.4473-12.2015; Pittock SJ, 2013, LANCET NEUROL, V12, P554, DOI 10.1016/S1474-4422(13)70076-0; Prins M, 2013, DIS MODEL MECH, V6, P1307, DOI 10.1242/dmm.011585; Qiao F, 2006, AM J PATHOL, V169, P1039, DOI 10.2353/ajpath.2006.060248; Qiao F, 2010, AM J PATHOL, V177, P3061, DOI 10.2353/ajpath.2010.100158; Rancan M, 2003, J CEREBR BLOOD F MET, V23, P1070, DOI 10.1097/01.WCB.0000084250.20114.2C; Reis ES, 2015, IMMUNOBIOLOGY, V220, P476, DOI 10.1016/j.imbio.2014.10.026; Reis ES, 2006, SCAND J IMMUNOL, V63, P155, DOI 10.1111/j.1365-3083.2006.01729.x; Rich MC, 2016, NEUROSCI LETT, V617, P188, DOI 10.1016/j.neulet.2016.02.025; Ricklin D, 2008, ADV EXP MED BIOL, V632, P273, DOI 10.1007/978-0-387-78952-1_20; Ricklin D, 2013, J IMMUNOL, V190, P3831, DOI 10.4049/jimmunol.1203487; Ricklin D, 2010, NAT IMMUNOL, V11, P785, DOI 10.1038/ni.1923; Riggio S, 2009, MT SINAI J MED, V76, P163, DOI 10.1002/msj.20097; Rostami E, 2013, J NEUROTRAUM, V30, P1954, DOI 10.1089/neu.2012.2583; Rother RP, 2007, NAT BIOTECHNOL, V25, P1256, DOI 10.1038/nbt1344; Ruseva MM, 2015, P NATL ACAD SCI USA, V112, P14319, DOI 10.1073/pnas.1513698112; SCHREIBER RD, 1975, J EXP MED, V142, P760, DOI 10.1084/jem.142.3.760; Sewell DL, 2004, J NEUROIMMUNOL, V155, P55, DOI 10.1016/j.jneuroim.2004.06.003; Stahel PF, 1997, MOL BRAIN RES, V50, P205, DOI 10.1016/S0169-328X(97)00189-7; Stahel PF, 1998, BRAIN RES REV, V27, P243, DOI 10.1016/S0165-0173(98)00015-0; Stahel PF, 2001, J NEUROTRAUM, V18, P773, DOI 10.1089/089771501316919139; Stahel PF, 2009, J NEUROINFLAMM, V6, DOI 10.1186/1742-2094-6-2; Stahl PD, 1998, CURR OPIN IMMUNOL, V10, P50, DOI 10.1016/S0952-7915(98)80031-9; Strainic MG, 2008, IMMUNITY, V28, P425, DOI 10.1016/j.immuni.2008.02.001; Takano M, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-40; TEASDALE G, 1974, LANCET, V2, P81; VanLandingham JW, 2007, NEUROSCI LETT, V425, P94, DOI 10.1016/j.neulet.2007.08.045; Vasek MJ, 2016, NATURE, V534, P538, DOI 10.1038/nature18283; Walport MJ, 2001, NEW ENGL J MED, V344, P1058, DOI 10.1056/NEJM200104053441406; Walport MJ, 2001, NEW ENGL J MED, V344, P1140, DOI 10.1056/NEJM200104123441506; Weston-Davies W. H., 2014, P 56 ANN M AM SOC HE; Yager PH, 2008, J CEREBR BLOOD F MET, V28, P1030, DOI 10.1038/sj.jcbfm.9600605; You ZR, 2007, J CEREBR BLOOD F MET, V27, P1954, DOI 10.1038/sj.jcbfm.9600497	99	15	16	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2018	35	2					226	240		10.1089/neu.2017.5168		NOV 2017	15	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FT1TA	WOS:000416451600001	28816089				2022-02-06	
J	Sosa, MAG; De Gasperi, R; Garcia, GSP; Sosa, H; Searcy, C; Vargas, D; Janssen, PL; Perez, GM; Tschiffely, AE; Janssen, WG; McCarron, RM; Hof, PR; Haghighi, FG; Ahlers, ST; Elder, GA				Sosa, Miguel A. Gama; De Gasperi, Rita; Garcia, Georgina S. Perez; Sosa, Heidi; Searcy, Courtney; Vargas, Danielle; Janssen, Pierce L.; Perez, Gissel M.; Tschiffely, Anna E.; Janssen, William G.; McCarron, Richard M.; Hof, Patrick R.; Haghighi, Fatemeh G.; Ahlers, Stephen T.; Elder, Gregory A.			Lack of chronic neuroinflammation in the absence of focal hemorrhage in a rat model of low-energy blast-induced TBI	ACTA NEUROPATHOLOGICA COMMUNICATIONS			English	Article							TRAUMATIC BRAIN-INJURY; PROTEIN-KINASE PATHWAYS; MICROGLIAL ACTIVATION; EXPLOSIVE BLAST; INFLAMMATION; INVOLVEMENT; IMPAIRMENT; THROMBIN; DISEASE; SINGLE	Blast-related traumatic brain injury (TBI) has been a common cause of injury in the recent conflicts in Iraq and Afghanistan. Blast waves can damage blood vessels, neurons, and glial cells within the brain. Acutely, depending on the blast energy, blast wave duration, and number of exposures, blast waves disrupt the blood-brain barrier, triggering microglial activation and neuroinflammation. Recently, there has been much interest in the role that ongoing neuroinflammation may play in the chronic effects of TBI. Here, we investigated whether chronic neuroinflammation is present in a rat model of repetitive low-energy blast exposure. Six weeks after three 74.5-kPa blast exposures, and in the absence of hemorrhage, no significant alteration in the level of microglia activation was found. At 6 weeks after blast exposure, plasma levels of fractalkine, interleukin-1 beta, lipopolysaccharide-inducible CXC chemokine, macrophage inflammatory protein 1 alpha, and vascular endothelial growth factor were decreased. However, no differences in cytokine levels were detected between blast-exposed and control rats at 40 weeks. In brain, isolated changes were seen in levels of selected cytokines at 6 weeks following blast exposure, but none of these changes was found in both hemispheres or at 40 weeks after blast exposure. Notably, one animal with a focal hemorrhagic tear showed chronic microglial activation around the lesion 16 weeks post-blast exposure. These findings suggest that focal hemorrhage can trigger chronic focal neuroinflammation following blast-induced TBI, but that in the absence of hemorrhage, chronic neuroinflammation is not a general feature of low-level blast injury.	[Sosa, Miguel A. Gama] James J Peters Dept Vet Affairs Med Ctr, Gen Med Res Serv, 130 West Kingsbridge Rd, Bronx, NY 10468 USA; [De Gasperi, Rita; Garcia, Georgina S. Perez; Sosa, Heidi; Searcy, Courtney; Vargas, Danielle; Janssen, Pierce L.; Perez, Gissel M.; Haghighi, Fatemeh G.] James J Peters Dept Vet Affairs Med Ctr, Res & Dev Serv, Bronx, NY USA; [Elder, Gregory A.] James J Peters Dept Vet Affairs Med Ctr, Neurol Serv, Bronx, NY USA; [Sosa, Miguel A. Gama; De Gasperi, Rita; Sosa, Heidi; Searcy, Courtney; Vargas, Danielle] Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA; [Garcia, Georgina S. Perez; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Dept Neurol, New York, NY 10029 USA; [Janssen, Pierce L.; Janssen, William G.; Hof, Patrick R.; Haghighi, Fatemeh G.] Icahn Sch Med Mt Sinai, Fishberg Dept Neurosci, New York, NY 10029 USA; [Hof, Patrick R.] Icahn Sch Med Mt Sinai, Dept Geriatr & Palliat Care, New York, NY 10029 USA; [Sosa, Miguel A. Gama; De Gasperi, Rita; Garcia, Georgina S. Perez; Janssen, William G.; Hof, Patrick R.; Haghighi, Fatemeh G.; Elder, Gregory A.] Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA; [Tschiffely, Anna E.; McCarron, Richard M.; Ahlers, Stephen T.] Naval Med Res Ctr, Operat & Undersea Med Directorate, Silver Spring, MD USA; [McCarron, Richard M.] Uniformed Serv Univ Hlth Sci, Dept Surg, Bethesda, MD 20814 USA		Sosa, MAG (corresponding author), James J Peters Dept Vet Affairs Med Ctr, Gen Med Res Serv, 130 West Kingsbridge Rd, Bronx, NY 10468 USA.; Sosa, MAG (corresponding author), Icahn Sch Med Mt Sinai, Dept Psychiat, New York, NY 10029 USA.; Sosa, MAG (corresponding author), Icahn Sch Med Mt Sinai, Friedman Brain Inst, New York, NY 10029 USA.	miguel.gama-sosa@mssm.edu		Vargas, Danielle/0000-0003-4409-9391	Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [1I01RX000996-01, I21RX002069]; General Medical Research Service, James J. Peters VA Medical Center; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [P50 AG005138]; Uniformed Services University of the Health Sciences [601152 N.0000.000.A1308]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005138] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX000996, I21RX002069] Funding Source: NIH RePORTER	The authors would like to thank the anonymous reviewers for their helpful suggestions and independent statistical analyses of the data provided that strengthened considerably the conclusions of this manuscript. The research described here was supported by the Department of Veterans Affairs, Veterans Health Administration, Rehabilitation Research and Development Service Awards 1I01RX000996-01 and I21RX002069. MAGS was supported in part by the General Medical Research Service, James J. Peters VA Medical Center. PRH is supported in part by NIH grant P50 AG005138. RMM, AET and STA were supported in part by work unit number (WUN) 601152 N.0000.000. A1308 from the Uniformed Services University of the Health Sciences. PLJ was a Carolyn L. Kuckein Student Research Fellow of the Alpha Omega Alpha Honor Medical Society. MAGS, RDG, GMP, GE, AET and STA are employees of the U.S. government. This work was prepared as part of their official duties. Title 17 U.S.C. 105 provides that 'Copyright protection under this title is not available for any work of the United States Government.' Title 17 U.S.C. 101 defines a U.S. Government work as a work prepared by a military service member or employee of the U.S. Government as part of that person's official duties. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the Department of the Navy, Department of Defense, Department of Veterans Affairs, nor the U.S. Government.	Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Alford PW, 2011, P NATL ACAD SCI USA, V108, P12705, DOI 10.1073/pnas.1105860108; Armonda RA, 2006, NEUROSURGERY, V59, P1215, DOI 10.1227/01.NEU.0000249190.46033.94; Cernak I, 1999, J TRAUMA, V47, P96, DOI 10.1097/00005373-199907000-00021; Cernak I, 2001, J TRAUMA, V50, P695, DOI 10.1097/00005373-200104000-00017; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cherry JD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-98; Cho HJ, 2013, NEUROSCIENCE, V253, P9, DOI 10.1016/j.neuroscience.2013.08.037; Eftaxiopoulou T, 2016, INJURY, V47, P625, DOI 10.1016/j.injury.2016.01.017; Elali A, 2016, FRONT CELL DEV BIOL, V4, DOI 10.3389/fcell.2016.00072; Elder GA, 2015, CURR NEUROL NEUROSCI, V15, DOI 10.1007/s11910-015-0591-8; Elder GA, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00048; Elder GA, 2010, PSYCHIAT CLIN N AM, V33, P757, DOI 10.1016/j.psc.2010.08.001; Faden AI, 2015, NEUROTHERAPEUTICS, V12, P143, DOI 10.1007/s13311-014-0319-5; Fatemifar F, 2016, J BIOMECH ENG-T ASME, V138, DOI 10.1115/1.4034785; Fujimoto S, 2007, NEUROSCIENCE, V144, P694, DOI 10.1016/j.neuroscience.2006.09.049; Gill J, 2017, BRAIN BEHAV IMMUN, V65, P90, DOI 10.1016/j.bbi.2017.02.015; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Hald ES, 2014, TRANSL STROKE RES, V5, P385, DOI 10.1007/s12975-013-0300-3; Han HC, 2012, J VASC RES, V49, P185, DOI 10.1159/000335123; Huber BR, 2016, NEUROSCIENCE, V319, P206, DOI 10.1016/j.neuroscience.2016.01.022; Hulse RE, 2004, J NEUROSCI METH, V136, P87, DOI 10.1016/j.jneumeth.2003.12.023; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kabu S, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0127971; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Kamnaksh A, 2011, J NEUROTRAUM, V28, P2145, DOI 10.1089/neu.2011.1983; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Kawoos U, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0167510; Kettenmann H, 2011, PHYSIOL REV, V91, P461, DOI 10.1152/physrev.00011.2010; Kreutzberg GW, 1996, TRENDS NEUROSCI, V19, P312, DOI 10.1016/0166-2236(96)10049-7; Kwon Sook-Kyung C, 2011, Front Neurol, V2, P12, DOI 10.3389/fneur.2011.00012; Li YS, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-52; Ling G, 2007, J TRAUMA, V62, pS102, DOI 10.1097/TA.0b013e318065b442; Ling G, 2009, J NEUROTRAUM, V26, P815, DOI 10.1089/neu.2007.0484; Ling GSF, 2011, CURR OPIN ANESTHESIO, V24, P124, DOI 10.1097/ACO.0b013e32834458da; Mayorga MA, 1997, TOXICOLOGY, V121, P17, DOI 10.1016/S0300-483X(97)03652-4; Morgan JT, 2010, BIOL PSYCHIAT, V68, P368, DOI 10.1016/j.biopsych.2010.05.024; Ohnishi M, 2007, EXP NEUROL, V206, P43, DOI 10.1016/j.expneurol.2007.03.030; Ohnishi M, 2011, NEUROPHARMACOLOGY, V61, P975, DOI 10.1016/j.neuropharm.2011.06.026; Ohsawa K, 2000, J CELL SCI, V113, P3073; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Sajja Venkata Siva Sai S, 2012, Biomed Sci Instrum, V48, P374; Schwulst SJ, 2013, J TRAUMA ACUTE CARE, V75, P780, DOI 10.1097/TA.0b013e318299616a; Sheng JG, 1997, ACTA NEUROPATHOL, V94, P1, DOI 10.1007/s004010050664; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Soltys Z, 2001, J NEUROSCI RES, V63, P90, DOI 10.1002/1097-4547(20010101)63:1<90::AID-JNR11>3.0.CO;2-9; Sosa MAG, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/2051-5960-2-67; Sosa MAG, 2013, ACTA NEUROPATHOL COM, V1, DOI 10.1186/2051-5960-1-51; Stence N, 2001, GLIA, V33, P256, DOI 10.1002/1098-1136(200103)33:3<256::AID-GLIA1024>3.3.CO;2-A; Taber KH, 2006, J NEUROPSYCH CLIN N, V18, P141, DOI 10.1176/appi.neuropsych.18.2.141; Taylor RA, 2013, CLIN DEV IMMUNOL, DOI 10.1155/2013/746068; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Torres-Platas SG, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-12; Valiyaveettil M, 2012, NEUROSCI LETT, V506, P141, DOI 10.1016/j.neulet.2011.10.067; Wang JM, 2016, CHIN J TRAUMATOL, V19, P125, DOI 10.1016/j.cjtee.2016.03.001; Wang WY, 2015, ANN TRANSL MED, V3, DOI 10.3978/j.issn.2305-5839.2015.03.49; Zhou JY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0092828	58	15	15	0	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2051-5960			ACTA NEUROPATHOL COM	Acta Neuropathol. Commun.	NOV 10	2017	5								80	10.1186/s40478-017-0483-z			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FM4TI	WOS:000415014600001	29126430	Green Published, gold			2022-02-06	
J	Feng, DD; Xia, Z; Zhou, J; Lu, HM; Zhang, CH; Fan, R; Xiong, XG; Cui, HJ; Gan, PP; Huang, W; Peng, WJ; He, F; Wang, ZM; Wang, Y; Tang, T				Feng, Dandan; Xia, Zian; Zhou, Jing; Lu, Hongmei; Zhang, Chunhu; Fan, Rong; Xiong, Xingui; Cui, Hanjin; Gan, Pingping; Huang, Wei; Peng, Weijun; He, Feng; Wang, Zhiming; Wang, Yang; Tang, Tao			Metabolomics reveals the effect of Xuefu Zhuyu Decoction on plasma metabolism in rats with acute traumatic brain injury	ONCOTARGET			English	Article						metabolomics; acute traumatic brain injury; traditional Chinese medicine; Xuefu Zhuyu Decoction; gas chromatography/mass spectrometry	SUCCINATE; GLUTAMATE; STRATEGIES; POTASSIUM; PATHWAY; IMPACT; SERUM; ACID; MICE	Xuefu Zhuyu Decoction (XFZY), an important traditional Chinese herbal formula, has been reported effective on traumatic brain injury (TBI) in rats. However, its cerebral protection mechanism has not been clarified at the metabolic level. This work aims to explore the global metabolic characteristics of XFZY in rats during the acute phase of TBI on days 1 and 3. A plasma metabolomics method based on gas chromatography-mass spectrometry coupled with univariate analysis and multivariate statistical analysis was performed in three groups (Sham, Vehicle, XFZY). Then, a pathway analysis using MetaboAnalyst 3.0 was performed to illustrate the pathways of therapeutic action of XFZY in TBI. XFZY treatment attenuates neurological dysfunction and cortical lesion volume post-injury on day 3, and reverses the plasma metabolite abnormalities (glutamic acid, lactic acid, 3-hydroxybutyric acid, and ribitol, etc.). These differential metabolites are mainly involved in D-glutamine and D-glutamate metabolism, alanine, aspartate and glutamate metabolism, and inositol phosphate metabolism. Our study reveals potential biomarkers and metabolic networks of acute TBI and neuroprotection effects of XFZY, and shows this metabolomics approach with MetaboAnalyst would be a feasible way to systematically study therapeutic effects of XFZY on TBI.	[Feng, Dandan; Xia, Zian; Zhou, Jing; Zhang, Chunhu; Fan, Rong; Xiong, Xingui; Cui, Hanjin; Huang, Wei; Wang, Yang; Tang, Tao] Cent S Univ, Xiangya Hosp, Inst Integrat Chinese Med, Changsha 410008, Hunan, Peoples R China; [Lu, Hongmei] Cent S Univ, Coll Chem & Chem Engn, Res Ctr Modernizat Tradit Chinese Med, Changsha 410083, Hunan, Peoples R China; [Gan, Pingping] Cent S Univ, Xiangya Hosp, Dept Oncol, Changsha 410008, Hunan, Peoples R China; [Peng, Weijun] Cent S Univ, Xiangya Hosp 2, Dept Integrated Chinese & Western Med, Changsha 410011, Hunan, Peoples R China; [He, Feng; Wang, Zhiming] Cent S Univ, Xiangya Hosp, Dept Hepatobiliary Surg, Changsha 410008, Hunan, Peoples R China		Wang, Y; Tang, T (corresponding author), Cent S Univ, Xiangya Hosp, Inst Integrat Chinese Med, Changsha 410008, Hunan, Peoples R China.	wangyang_xy87@csu.edu.cn; falcontang@126.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81673719, 81473573, 81403259, 81303074]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2016M600639, 2017T100614]; Natural Science Foundation of Science and Technology Department of Hunan Province [2014SK3035]	This work was supported by the Natural Science Foundation of China (Grant Nos. 81673719, 81473573, 81403259, and 81303074), China Postdoctoral Science Foundation (Nos. 2016M600639 and 2017T100614), and the Natural Science Foundation of Science and Technology Department of Hunan Province (Grant No. 2014SK3035).	[Anonymous], 2010, LANCET NEUROL, V9, P331, DOI 10.1016/S1474-4422(10)70069-7; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Chen J, 2015, J CHROMATOGR B; Chen Y, 1997, NEUROSCIENCE, V80, P1255, DOI 10.1016/S0306-4522(97)00007-9; Cheng T, 2016, FREE RADICAL BIO MED, V92, P15, DOI 10.1016/j.freeradbiomed.2015.12.027; Chouchani ET, 2014, NATURE, V515, P431, DOI 10.1038/nature13909; Chu H, 2016, J CHROMATOGR B, V1015, P50, DOI 10.1016/j.jchromb.2016.02.007; David Y, 2009, J NEUROSCI, V29, P10588, DOI 10.1523/JNEUROSCI.2323-09.2009; Deng-Bryant Y, 2011, J NEUROTRAUM, V28, P1813, DOI 10.1089/neu.2011.1822; Dunn WB, 2011, NAT PROTOC, V6, P1060, DOI 10.1038/nprot.2011.335; Faul M, 2010, TRAUMATIC BRAIN INJU; Fernandez-Gajardo R, 2014, CNS DRUGS, V28, P229, DOI 10.1007/s40263-013-0138-y; Gu Y, 2016, MED SCI MONITOR, V22, P4894, DOI 10.12659/MSM.898185; Guluma K, 2002, SEMIN RESP CRIT CARE, V23, P37, DOI 10.1055/s-2002-20587; Hu ZP, 2012, MOL BIOSYST, V8, P1979, DOI 10.1039/c2mb25061f; Jo YY, 2016, J ANESTH, V30, P637, DOI 10.1007/s00540-016-2169-2; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P187, DOI 10.1097/00001199-200505000-00001; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lee JJ, 2011, J ETHNOPHARMACOL, V134, P824, DOI 10.1016/j.jep.2011.01.033; Leibowitz A, 2012, ACTA NEUROBIOL EXP, V72, P385; Lenz EM, 2007, J PROTEOME RES, V6, P443, DOI 10.1021/pr0605217; Liu JR, 2014, J NEW CHINESE MED, V46, P206; Ma X, 2016, FRONT PHARMACOL, V7, DOI 10.3389/fphar.2016.00014; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mills E, 2014, TRENDS CELL BIOL, V24, P313, DOI 10.1016/j.tcb.2013.11.008; Moro N, 2016, BRAIN RES, V1642, P270, DOI 10.1016/j.brainres.2016.04.005; Nageli M, 2014, CRIT CARE, V18, DOI 10.1186/cc13962; Okorie ON, 2011, CRIT CARE CLIN, V27, P299, DOI 10.1016/j.ccc.2010.12.013; Pell VR, 2016, CARDIOVASC RES, V111, P134, DOI 10.1093/cvr/cvw100; Pfeuffer M, 2016, ADV NUTR, V7, P730, DOI 10.3945/an.115.011387; Shen YC, 2015, J ETHNOPHARMACOL, V173, P370, DOI 10.1016/j.jep.2015.07.018; Sheth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129735; Song XF, 2013, J PHARMACEUT BIOMED, V78-79, P202, DOI 10.1016/j.jpba.2013.02.014; Streijger F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078765; Venkatesh B, 2010, CRIT CARE MED, V38, pS630, DOI 10.1097/CCM.0b013e3181f24406; Viant MR, 2005, NMR BIOMED, V18, P507, DOI 10.1002/nbm.980; WANG PQ, 2015, MEDICINE BALTIMORE, V94; Wang W, 2015, MOL NEUROBIOL; Wolahan SM, 2015, BRAIN NEUROTRAUMA MO; Xing ZH, 2016, SCI REP-UK, V6, DOI 10.1038/srep20040; Yan EB, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0328-2; Yang B, 2016, BMC COMPLEM ALTERN M, V16, DOI 10.1186/s12906-016-1076-2; Yang SG, 2012, J NEUROTRAUM, V29, P2696, DOI 10.1089/neu.2012.2442; Zhang AH, 2013, EVID-BASED COMPL ALT, V2013, DOI 10.1155/2013/257909; Zhou XY, 2016, TALANTA, V147, P82, DOI 10.1016/j.talanta.2015.09.040; Zhu H, 2015, SCI REP-UK, V5, DOI 10.1038/srep17536; Zhu Y, 2015, SCI REP-UK, V5, DOI 10.1038/srep17068	50	15	16	4	32	IMPACT JOURNALS LLC	ORCHARD PARK	6666 E QUAKER ST, STE 1, ORCHARD PARK, NY 14127 USA		1949-2553		ONCOTARGET	Oncotarget	NOV 7	2017	8	55					94692	94710		10.18632/oncotarget.21876			19	Oncology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Cell Biology	FL9VQ	WOS:000414608400120	29212259	gold, Green Published, Green Submitted			2022-02-06	
J	Springer, JE; Visavadiya, NP; Sullivan, PG; Hall, ED				Springer, Joe E.; Visavadiya, Nishant P.; Sullivan, Patrick G.; Hall, Edward D.			Post-Injury Treatment with NIM811 Promotes Recovery of Function in Adult Female Rats after Spinal Cord Contusion: A Dose-Response Study	JOURNAL OF NEUROTRAUMA			English	Article						locomotor function; mitochondria; spinal cord injury	MITOCHONDRIAL PERMEABILITY TRANSITION; TRAUMATIC BRAIN-INJURY; CYCLOSPORINE-A; CYCLOPHILIN-D; CYTOCHROME-C; CELL-DEATH; LIPID-PEROXIDATION; ENDONUCLEASE-G; PORE; INHIBITION	Mitochondrial homeostasis is essential for maintaining cellular function and survival in the central nervous system (CNS). Mitochondrial function is significantly compromised after spinal cord injury (SCI) and is associated with accumulation of high levels of calcium, increased production of free radicals, oxidative damage, and eventually mitochondrial permeability transition (mPT). The formation of the mPT pore (mPTP) and subsequent mPT state are considered to be end stage events in the decline of mitochondrial integrity, and strategies that inhibit mPT can limit mitochondrial demise. Cyclosporine A (CsA) is thought to inhibit mPT by binding to cyclophilin D and has been shown to be effective in models of CNS injury. CsA, however, also inhibits calcineurin, which is responsible for its immunosuppressive properties. In the present study, we conducted a dose-response examination of NIM811, a nonimmunosuppressive CsA analog, on recovery of function and tissue sparing in a rat model of moderate to severe SCI. The results of our experiments revealed that NIM811 (10 mg/kg) significantly improved open field locomotor performance, while the two higher doses tested (20 and 40 mg/kg) significantly improved return of reflexive bladder control and significantly decreased the rostral-caudal extent of the lesion. Taken together, these results demonstrate the ability of NIM811 to improve recovery of function in SCI and support the role of protecting mitochondrial function as a potential therapeutic target.	[Springer, Joe E.; Visavadiya, Nishant P.; Sullivan, Patrick G.; Hall, Edward D.] Univ Kentucky, Med Ctr, Dept Neurosci, Spinal Cord & Brain Injury Res Ctr, 741 S Limestone,BBSRB B443, Lexington, KY 40536 USA		Springer, JE (corresponding author), Univ Kentucky, Med Ctr, Dept Neurosci, Spinal Cord & Brain Injury Res Ctr, 741 S Limestone,BBSRB B443, Lexington, KY 40536 USA.	jspring@uky.edu	Hall, Edward D/F-8930-2013		PHSUnited States Department of Health & Human ServicesUnited States Public Health Service [U01-NS066915, P30 NS051220]; Craig H. Neilsen Foundation	This work was supported by PHS grant U01-NS066915, P30 NS051220, and the Craig H. Neilsen Foundation.	Baines CP, 2005, NATURE, V434, P658, DOI 10.1038/nature03434; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Basso E, 2005, J BIOL CHEM, V280, P18558, DOI 10.1074/jbc.C500089200; Bernardi P, 1996, BBA-BIOENERGETICS, V1275, P5, DOI 10.1016/0005-2728(96)00041-2; Bernardi P, 1998, BIOFACTORS, V8, P273, DOI 10.1002/biof.5520080315; Blight A R, 2001, Curr Opin Investig Drugs, V2, P801; BRAUGHLER JM, 1989, FREE RADICAL BIO MED, V6, P289, DOI 10.1016/0891-5849(89)90056-7; Broekemeier KM, 1995, BIOCHEMISTRY-US, V34, P16440, DOI 10.1021/bi00050a027; Brustovetsky N, 2002, J NEUROCHEM, V80, P207, DOI 10.1046/j.0022-3042.2001.00671.x; Brustovetsky N, 2000, J NEUROSCI, V20, P8229, DOI 10.1523/JNEUROSCI.20-22-08229.2000; Cande C, 2002, BIOCHIMIE, V84, P215, DOI 10.1016/S0300-9084(02)01374-3; Christensen MD, 1997, J NEUROTRAUM, V14, P517, DOI 10.1089/neu.1997.14.517; David BT, 2010, EXP NEUROL, V226, P128, DOI 10.1016/j.expneurol.2010.08.014; Diaz-Ruiz A, 1999, NEUROSCI LETT, V266, P61, DOI 10.1016/S0304-3940(99)00255-4; Diaz-Ruiz A, 2000, NEUROREPORT, V11, P1765, DOI 10.1097/00001756-200006050-00033; Du CY, 2000, CELL, V102, P33, DOI 10.1016/S0092-8674(00)00008-8; Friberg H, 1999, J NEUROCHEM, V72, P2488, DOI 10.1046/j.1471-4159.1999.0722488.x; Friberg H, 2002, BIOCHIMIE, V84, P241, DOI 10.1016/S0300-9084(02)01381-0; Halestrap AP, 2002, BIOCHIMIE, V84, P153, DOI 10.1016/S0300-9084(02)01375-5; Halestrap AP, 1997, MOL CELL BIOCHEM, V174, P167, DOI 10.1023/A:1006879618176; Hall Edward D, 2004, NeuroRx, V1, P80, DOI 10.1602/neurorx.1.1.80; Hansson MJ, 2004, J BIOENERG BIOMEMBR, V36, P407, DOI 10.1023/B:JOBB.0000041776.31885.45; Hansson MJ, 2003, BRAIN RES, V960, P99, DOI 10.1016/S0006-8993(02)03798-8; Hou SP, 2016, EXP NEUROL, V285, P136, DOI 10.1016/j.expneurol.2015.12.001; Hulsebosch CE, 2009, BRAIN RES REV, V60, P202, DOI 10.1016/j.brainresrev.2008.12.010; Ibarra A, 1996, J NEUROTRAUM, V13, P267, DOI 10.1089/neu.1996.13.267; Ibarra A, 2003, BRAIN RES, V979, P165, DOI 10.1016/S0006-8993(03)02898-1; Ibarra A, 1996, J NEUROTRAUM, V13, P569, DOI 10.1089/neu.1996.13.569; Li LY, 2001, NATURE, V412, P95, DOI 10.1038/35083620; Liu XS, 1996, CELL, V86, P147, DOI 10.1016/S0092-8674(00)80085-9; LOEWY AD, 1979, BRAIN RES, V172, P533, DOI 10.1016/0006-8993(79)90584-5; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; McEwen ML, 2007, J NEUROTRAUM, V24, P613, DOI 10.1089/neu.2006.9969; McEwen ML, 2011, NEUROTHERAPEUTICS, V8, P168, DOI 10.1007/s13311-011-0031-7; Nakagawa T, 2005, NATURE, V434, P652, DOI 10.1038/nature03317; Petronilli V, 2001, J BIOL CHEM, V276, P12030, DOI 10.1074/jbc.M010604200; Popovich PG, 1997, J COMP NEUROL, V377, P443, DOI 10.1002/(SICI)1096-9861(19970120)377:3<443::AID-CNE10>3.0.CO;2-S; Rabchevsky AG, 2001, J NEUROTRAUM, V18, P513, DOI 10.1089/089771501300227314; Ravikumar R, 2007, J NEUROTRAUM, V24, P1618, DOI 10.1089/neu.2007.0329; Readnower RD, 2011, J NEUROTRAUM, V28, P1845, DOI 10.1089/neu.2011.1755; Reed JC, 2000, CELL DEATH DIFFER, V7, P1145, DOI 10.1038/sj.cdd.4400777; Scheff SW, 1999, J NEUROTRAUM, V16, P783, DOI 10.1089/neu.1999.16.783; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schinzel AC, 2005, P NATL ACAD SCI USA, V102, P12005, DOI 10.1073/pnas.0505294102; Scorrano L, 1997, MOL CELL BIOCHEM, V174, P181, DOI 10.1023/A:1006887921810; Springer JE, 2010, J NEUROTRAUM, V27, P139, DOI 10.1089/neu.2009.0952; Sullivan PG, 2007, J NEUROTRAUM, V24, P991, DOI 10.1089/neu.2006.0242; Sullivan PG, 2004, J COMP NEUROL, V474, P524, DOI 10.1002/cne.20130; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; SZABO I, 1992, J BIOENERG BIOMEMBR, V24, P111, DOI 10.1007/BF00769537; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; van Loo G, 2001, CELL DEATH DIFFER, V8, P1136, DOI 10.1038/sj.cdd.4400944; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Waldmeier PC, 2002, MOL PHARMACOL, V62, P22, DOI 10.1124/mol.62.1.22; Waldmeier PC, 2003, CURR MED CHEM, V10, P1485, DOI 10.2174/0929867033457160; WRATHALL JR, 1994, J NEUROSCI, V14, P6598; Young Wise, 1993, Journal of Emergency Medicine, V11, P13	57	15	16	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 1	2018	35	3					492	499		10.1089/neu.2017.5167		NOV 2017	8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FU4BP	WOS:000414641200001	28967329	Green Published			2022-02-06	
J	Grzelka, K; Kurowski, P; Gawlak, M; Szulczyk, P				Grzelka, Katarzyna; Kurowski, Przemyslaw; Gawlak, Maciej; Szulczyk, Pawel			Noradrenaline Modulates the Membrane Potential and Holding Current of Medial Prefrontal Cortex Pyramidal Neurons via beta(1)-Adrenergic Receptors and HCN Channels	FRONTIERS IN CELLULAR NEUROSCIENCE			English	Article						pyramidal neurons; prefrontal cortex; adrenergic receptors; HCN channel; beta gamma subunit; membrane potential; holding current; rats	BETA-GAMMA-SUBUNITS; EXCITATORY SYNAPTIC-TRANSMISSION; CURRENT I-H; ACTIVATED CATION CHANNELS; NUCLEOTIDE-GATED CHANNELS; ADRENERGIC-RECEPTOR; LOCUS-COERULEUS; WORKING-MEMORY; NORADRENERGIC MODULATION; GABAERGIC INTERNEURONS	The medial prefrontal cortex (mPFC) receives dense noradrenergic projections from the locus coeruleus. Adrenergic innervation of mPFC pyramidal neurons plays an essential role in both physiology (control of memory formation, attention, working memory, and cognitive behavior) and pathophysiology (attention deficit hyperactivity disorder, posttraumatic stress disorder, cognitive deterioration after traumatic brain injury, behavioral changes related to addiction, Alzheimer's disease and depression). The aim of this study was to elucidate the mechanism responsible for adrenergic receptor-mediated control of the resting membrane potential in layer V mPFC pyramidal neurons. The membrane potential or holding current of synaptically isolated layer V mPFC pyramidal neurons was recorded in perforated-patch and classical wholecell configurations in slices from young rats. Application of noradrenaline (NA), a neurotransmitter with affinity for all types of adrenergic receptors, evoked depolarization or inward current in the tested neurons irrespective of whether the recordings were performed in the perforated-patch or classical whole-cell configuration. The effect of noradrenaline depended on beta(1)- and not alpha(1) -or alpha(2)-adrenergic receptor stimulation. Activation of beta(1)-adrenergic receptors led to an increase in inward Na C current through hyperpolarization-activated cyclic nucleotide-gated (HCN) channels, which carry a mixed Na+/K+ current. The protein kinase A-and C-, glycogen synthase kinase3 beta-and tyrosine kinase-linked signaling pathways were not involved in the signal transduction between beta(1)-adrenergic receptors and HCN channels. The transduction system operated in a membrane-delimited fashion and involved the beta gamma subunit of G-protein. Thus, noradrenaline controls the resting membrane potential and holding current in mPFC pyramidal neurons through beta(1)-adrenergic receptors, which in turn activate HCN channels via a signaling pathway involving the beta gamma subunit.	[Grzelka, Katarzyna; Kurowski, Przemyslaw; Gawlak, Maciej; Szulczyk, Pawel] Med Univ Warsaw, Ctr Preclin Res & Technol, Lab Physiol & Pathophysiol, Warsaw, Poland		Grzelka, K; Szulczyk, P (corresponding author), Med Univ Warsaw, Ctr Preclin Res & Technol, Lab Physiol & Pathophysiol, Warsaw, Poland.	katarzyna.grzelka@wum.edu.pl; pawel.szulczyk@wum.edu.pl	Kurowski, Przemyslaw/M-3090-2018	Kurowski, Przemyslaw/0000-0001-5577-0115; Szulczyk, Pawel/0000-0001-6094-7106	National Science Centre, PolandNational Science Centre, Poland [2014/15/N/NZ4/04760]; Medical University of Warsaw [FW5/PM2/16]; CEPT [POIG.02.02.00-14-024/08-00]	The work was supported by the National Science Centre, Poland, grant 2014/15/N/NZ4/04760; Medical University of Warsaw, grant FW5/PM2/16; and CEPT, grant POIG.02.02.00-14-024/08-00.	Agster KL, 2013, J COMP NEUROL, V521, P2195, DOI 10.1002/cne.23270; AKAIKE N, 1994, JPN J PHYSIOL, V44, P433, DOI 10.2170/jjphysiol.44.433; Akaike Norio, 1999, Folia Pharmacologica Japonica, V113, P339, DOI 10.1254/fpj.113.339; Albarran-Juarez J, 2009, J PHARMACOL EXP THER, V331, P35, DOI 10.1124/jpet.109.157230; Andrews GD, 2006, NEUROPSYCHOPHARMACOL, V31, P594, DOI 10.1038/sj.npp.1300818; Arnsten AFT, 2009, NAT REV NEUROSCI, V10, P410, DOI 10.1038/nrn2648; Atkinson SE, 2009, J NEUROPHYSIOL, V102, P735, DOI 10.1152/jn.00083.2009; Bateman RJ, 2012, NEUROSCIENCE, V210, P58, DOI 10.1016/j.neuroscience.2012.02.033; Belkouch M, 2011, J NEUROSCI, V31, P18381, DOI 10.1523/JNEUROSCI.3386-11.2011; Benovic Jeffrey L., 2002, Journal of Allergy and Clinical Immunology, V110, pS229, DOI 10.1067/mai.2002.129370; BENOVIC JL, 1988, ANNU REV CELL BIOL, V4, P405, DOI 10.1146/annurev.cellbio.4.1.405; Berger T, 2001, J NEUROPHYSIOL, V85, P855, DOI 10.1152/jn.2001.85.2.855; Berridge CW, 2003, BRAIN RES REV, V42, P33, DOI 10.1016/S0165-0173(03)00143-7; Biel M, 2009, PHYSIOL REV, V89, P847, DOI 10.1152/physrev.00029.2008; Branchereau P, 1996, SYNAPSE, V22, P313; BROWN HF, 1979, NATURE, V280, P235, DOI 10.1038/280235a0; Cannavo A, 2013, FRONT PHYSIOL, V4, DOI 10.3389/fphys.2013.00264; Carr DB, 2007, J PHYSIOL-LONDON, V584, P437, DOI 10.1113/jphysiol.2007.141671; Cathel AM, 2014, EUR J NEUROSCI, V40, P3202, DOI 10.1111/ejn.12690; Chamberlain SR, 2013, J PSYCHOPHARMACOL, V27, P694, DOI 10.1177/0269881113480988; Chandler DJ, 2014, P NATL ACAD SCI USA, V111, P6816, DOI 10.1073/pnas.1320827111; Cheng QP, 2013, DNA CELL BIOL, V32, P320, DOI 10.1089/dna.2013.2021; Chung S, 2010, EXP PHYSIOL, V95, P982, DOI 10.1113/expphysiol.2010.053355; Claustre Y, 2008, NEUROSCIENCE, V156, P353, DOI 10.1016/j.neuroscience.2008.07.011; COTECCHIA S, 1990, J BIOL CHEM, V265, P63; Croce A, 2003, J NEUROSCI RES, V71, P516, DOI 10.1002/jnr.10516; Currie KPM, 2010, CHANNELS, V4, P497, DOI 10.4161/chan.4.6.12871; Daaka Y, 1997, NATURE, V390, P88, DOI 10.1038/36362; Dang VC, 2009, J NEUROSCI, V29, P3322, DOI 10.1523/JNEUROSCI.4749-08.2009; Daniels CR, 2012, AM J PHYSIOL-HEART C, V303, pH1459, DOI 10.1152/ajpheart.00401.2012; Dascal N, 2001, TRENDS ENDOCRIN MET, V12, P391, DOI 10.1016/S1043-2760(01)00475-1; Day M, 2005, J NEUROSCI, V25, P8776, DOI 10.1523/JNEUROSCI.2650-05.2005; Delmas P, 1999, J PHYSIOL-LONDON, V518, P23, DOI 10.1111/j.1469-7793.1999.0023r.x; Dembrow NC, 2010, J NEUROSCI, V30, P16922, DOI 10.1523/JNEUROSCI.3644-10.2010; Devilbiss DM, 2000, SYNAPSE, V37, P273, DOI 10.1002/1098-2396(20000915)37:4<273::AID-SYN4>3.0.CO;2-#; DIFRANCESCO D, 1995, CARDIOVASC RES, V30, P307, DOI 10.1016/0008-6363(95)00029-1; DIFRANCESCO D, 1991, NATURE, V351, P145, DOI 10.1038/351145a0; DIFRANCESCO D, 1982, J PHYSIOL-LONDON, V329, P485, DOI 10.1113/jphysiol.1982.sp014315; DiversePierluissi M, 1996, NEURON, V16, P579, DOI 10.1016/S0896-6273(00)80077-X; Fitzgerald PJ, 2015, P NATL ACAD SCI USA, V112, pE3729, DOI 10.1073/pnas.1500682112; Fuxe K, 2015, NEUROCHEM RES, V40, P2600, DOI 10.1007/s11064-015-1574-5; Gamo NJ, 2015, BIOL PSYCHIAT, V78, P860, DOI 10.1016/j.biopsych.2015.01.009; Gannon M, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00220; Gao C, 2008, J NEUROCHEM, V106, P2489, DOI 10.1111/j.1471-4159.2008.05597.x; Gasparini S, 1997, PFLUG ARCH EUR J PHY, V435, P99, DOI 10.1007/s004240050488; Gassner M, 2009, PAIN, V145, P204, DOI 10.1016/j.pain.2009.06.021; Gawlak M, 2017, DEV NEUROBIOL, V77, P1371, DOI 10.1002/dneu.22537; Giovannitti Joseph A Jr, 2015, Anesth Prog, V62, P31, DOI 10.2344/0003-3006-62.1.31; Goodfellow NM, 2009, J NEUROSCI, V29, P10094, DOI 10.1523/JNEUROSCI.1960-09.2009; Gu QH, 2007, J APPL PHYSIOL, V102, P1545, DOI 10.1152/japplphysiol.01010.2006; Hatcher-Solis C, 2014, CURR PHARM BIOTECHNO, V15, P987, DOI 10.2174/1389201015666141031111916; Hein L, 2006, CELL TISSUE RES, V326, P541, DOI 10.1007/s00441-006-0285-2; Huang JY, 2014, J CARDIOVASC PHARM, V63, P533, DOI 10.1097/FJC.0000000000000078; Huang Y, 2017, MOL MED REP, V15, P703, DOI 10.3892/mmr.2016.6038; Imbery TE, 2008, BRAIN RES, V1193, P93, DOI 10.1016/j.brainres.2007.12.016; Ishibashi H, 2003, J PHYSIOL-LONDON, V548, P111, DOI 10.1113/jphysiol.2002.033100; Jenkins PO, 2016, BRAIN, V139, P2345, DOI 10.1093/brain/aww128; Ji XH, 2008, CEREB CORTEX, V18, P1506, DOI 10.1093/cercor/bhm177; Kawaguchi Y, 1998, J NEUROSCI, V18, P6963; Kim BG, 2017, SCI REP-UK, V7, DOI 10.1038/srep42217; Knaus A, 2007, CIRCULATION, V115, P872, DOI 10.1161/CIRCULATIONAHA.106.667675; Kobayashi M, 2007, NEUROSCIENCE, V146, P1772, DOI 10.1016/j.neuroscience.2007.04.001; Kobayashi M, 2009, SYNAPSE, V63, P269, DOI 10.1002/syn.20604; Kodama D, 2013, BRIT J PHARMACOL, V168, P1230, DOI 10.1111/bph.12000; Koshimizu T, 2002, BIOL PHARM BULL, V25, P401, DOI 10.1248/bpb.25.401; Kurowski P, 2015, NEUROSCIENCE, V303, P474, DOI 10.1016/j.neuroscience.2015.07.023; Ladno W, 2017, BRAIN RES, V1665, P95, DOI 10.1016/j.brainres.2017.04.009; Lehmann DM, 2008, MOL PHARMACOL, V73, P410, DOI 10.1124/mol.107.041780; Lemogne C, 2009, SOC COGN AFFECT NEUR, V4, P305, DOI 10.1093/scan/nsp008; Li B, 2017, FRONT CELL NEUROSCI, V10, DOI 10.3389/fncel.2016.00300; Li B, 2010, CEREB CORTEX, V20, P1756, DOI 10.1093/cercor/bhp241; Li Y, 2005, J NEUROSCI, V25, P173, DOI 10.1523/JNEUROSCI.4015-04.2005; Li YC, 2009, J NEUROSCI, V29, P15551, DOI 10.1523/JNEUROSCI.3336-09.2009; Li YJ, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0070390, 10.1371/journal.pone.0080475]; Lin Y, 2011, MOL PHARMACOL, V80, P551, DOI 10.1124/mol.111.073072; Lorincz A, 2002, NAT NEUROSCI, V5, P1185, DOI 10.1038/nn962; Ludwig A, 1998, NATURE, V393, P587, DOI 10.1038/31255; Luo F, 2015, NEUROSCIENCE, V300, P63, DOI 10.1016/j.neuroscience.2015.04.070; Luo F, 2015, J NEUROCHEM, V132, P38, DOI 10.1111/jnc.12941; Luo F, 2014, EUR J NEUROSCI, V39, P1281, DOI 10.1111/ejn.12495; Lv TT, 2016, SCI REP-UK, V6, DOI 10.1038/srep32430; Maccaferri G, 1996, J PHYSIOL-LONDON, V497, P119, DOI 10.1113/jphysiol.1996.sp021754; Magee JC, 1998, J NEUROSCI, V18, P7613; Marzo A, 2010, NEUROSCIENCE, V169, P74, DOI 10.1016/j.neuroscience.2010.04.046; Marzo A, 2009, CURR NEUROPHARMACOL, V7, P286, DOI 10.2174/157015909790031193; Matos SC, 2015, J NEUROSCI, V35, P13244, DOI 10.1523/JNEUROSCI.0799-15.2015; MCCORMICK DA, 1993, CEREB CORTEX, V3, P387, DOI 10.1093/cercor/3.5.387; Meitzen J, 2011, J NEUROCHEM, V116, P984, DOI 10.1111/j.1471-4159.2010.07137.x; Mesquita TRR, 2017, FRONT PHARMACOL, V8, DOI 10.3389/fphar.2017.00220; Montezinho LP, 2006, J NEUROCHEM, V96, P1336, DOI 10.1111/j.1471-4159.2005.03654.x; Morioka N, 2014, J CELL PHYSIOL, V229, P323, DOI 10.1002/jcp.24452; Mueller D, 2008, J NEUROSCI, V28, P369, DOI 10.1523/JNEUROSCI.3248-07.2008; Nakashima N, 2013, J PHYSIOL-LONDON, V591, P1749, DOI 10.1113/jphysiol.2012.247361; NISHIZUKA Y, 1992, SCIENCE, V258, P607, DOI 10.1126/science.1411571; O'Donnell Patricio, 2008, P219, DOI 10.1007/978-0-387-74351-6_11; Oshima N, 2014, HYPERTENS RES, V37, P976, DOI 10.1038/hr.2014.112; Paspalas CD, 2013, CEREB CORTEX, V23, P1643, DOI 10.1093/cercor/bhs152; Pian P, 2007, PFLUG ARCH EUR J PHY, V455, P125, DOI 10.1007/s00424-007-0295-2; Pisani A, 2003, J NEUROSCI, V23, P5272; Radzicki D, 2017, J NEUROSCI, V37, P2292, DOI 10.1523/JNEUROSCI.1553-16.2017; Ramaswamy S, 2015, FRONT CELL NEUROSCI, V9, DOI 10.3389/fncel.2015.00233; Ramos BP, 2007, PHARMACOL THERAPEUT, V113, P523, DOI 10.1016/j.pharmthera.2006.11.006; Rankovic V, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0027474; Rosenkranz JA, 2006, J NEUROSCI, V26, P3229, DOI 10.1523/JNEUROSCI.4333-05.2006; Saitow F, 2000, J NEUROPHYSIOL, V84, P2026, DOI 10.1152/jn.2000.84.4.2026; Santana N, 2013, INT J NEUROPSYCHOPH, V16, P1139, DOI 10.1017/S1461145712001083; Santoro B, 1998, CELL, V93, P717, DOI 10.1016/S0092-8674(00)81434-8; Sara SJ, 2009, NAT REV NEUROSCI, V10, P211, DOI 10.1038/nrn2573; Scheibner J, 2001, BRIT J PHARMACOL, V132, P925, DOI 10.1038/sj.bjp.0703882; Schmidt KT, 2014, MOL PHARMACOL, V85, P640, DOI 10.1124/mol.113.090118; Sheridan MA, 2010, J ATTEN DISORD, V14, P69, DOI 10.1177/1087054709347444; Sierra-Mercado D, 2011, NEUROPSYCHOPHARMACOL, V36, P529, DOI 10.1038/npp.2010.184; Simonds WF, 1999, TRENDS PHARMACOL SCI, V20, P66, DOI 10.1016/S0165-6147(99)01307-3; Simons SB, 2012, NAT NEUROSCI, V15, P23, DOI 10.1038/nn.2962; Smrcka AV, 2013, TRENDS PHARMACOL SCI, V34, P290, DOI 10.1016/j.tips.2013.02.006; Socodato R, 2017, SCI REP-UK, V7, DOI 10.1038/srep40912; Stone EA, 2011, BRAIN RES REV, V67, P193, DOI 10.1016/j.brainresrev.2011.02.002; Stott JB, 2015, P NATL ACAD SCI USA, V112, P6497, DOI 10.1073/pnas.1418605112; Suh BC, 2005, CURR OPIN NEUROBIOL, V15, P370, DOI 10.1016/j.conb.2005.05.005; Szulczyk B, 2015, NEUROSCI LETT, V595, P87, DOI 10.1016/j.neulet.2015.04.015; Talaia C, 2006, NEUROCHEM INT, V49, P698, DOI 10.1016/j.neuint.2006.07.002; Tyurin-Kuzmin PA, 2016, SCI REP-UK, V6, DOI 10.1038/srep32835; Ukhanov K, 2011, J NEUROSCI, V31, P273, DOI 10.1523/JNEUROSCI.3698-10.2011; Ursino MG, 2009, PHARMACOL RES, V59, P221, DOI 10.1016/j.phrs.2009.01.002; van Aerde KI, 2015, CEREB CORTEX, V25, P772, DOI 10.1093/cercor/bht274; van Aerde KI, 2015, CEREB CORTEX, V25, P788, DOI 10.1093/cercor/bht278; Vargas G, 2002, J MEMBRANE BIOL, V188, P115, DOI 10.1007/s00232-001-0178-y; Wainger BJ, 2001, NATURE, V411, P805, DOI 10.1038/35081088; Wang HX, 2013, NEUROSCIENCE, V246, P312, DOI 10.1016/j.neuroscience.2013.05.009; Wang M, 2007, CELL, V129, P397, DOI 10.1016/j.cell.2007.03.015; WANG Z, 1993, J NEUROSCI, V13, P2199; Wang ZM, 2008, INT J NEUROPSYCHOPH, V11, P611, DOI 10.1017/S1461145707008334; Williams SR, 2000, J NEUROPHYSIOL, V83, P3177, DOI 10.1152/jn.2000.83.5.3177; Wolff M, 2007, BRIT J ANAESTH, V98, P353, DOI 10.1093/bja/ael379; Wong CO, 2010, BRIT J PHARMACOL, V159, P1486, DOI 10.1111/j.1476-5381.2010.00636.x; Xing B, 2016, BRAIN RES, V1641, P217, DOI 10.1016/j.brainres.2016.01.005; Yi F, 2013, EUR J NEUROSCI, V38, P2364, DOI 10.1111/ejn.12257; Yuen EY, 2014, J BIOL CHEM, V289, P25177, DOI 10.1074/jbc.M114.567610; Zamponi GW, 1998, CURR OPIN NEUROBIOL, V8, P351, DOI 10.1016/S0959-4388(98)80060-3; Zhang HM, 2009, NEUROSCIENCE, V158, P1577, DOI 10.1016/j.neuroscience.2008.11.039; Zhang WZ, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026581; Zhang ZZ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066122; Zhou HC, 2013, LEARN MEMORY, V20, P274, DOI 10.1101/lm.030411.113; Zong XG, 2005, J BIOL CHEM, V280, P34224, DOI 10.1074/jbc.M506544200	144	15	16	0	6	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5102			FRONT CELL NEUROSCI	Front. Cell. Neurosci.	NOV 2	2017	11								341	10.3389/fncel.2017.00341			22	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FL5HC	WOS:000414262700001	29209170	gold, Green Published			2022-02-06	
J	Kokiko-Cochran, ON; Saber, M; Puntambekar, S; Bemiller, SM; Katsumoto, A; Lee, YS; Bhaskar, K; Ransohoff, RM; Lamb, BT				Kokiko-Cochran, Olga N.; Saber, Maha; Puntambekar, Shweta; Bemiller, Shane M.; Katsumoto, Atsuko; Lee, Yu-Shang; Bhaskar, Kiran; Ransohoff, Richard M.; Lamb, Bruce T.			Traumatic Brain Injury in hTau Model Mice: Enhanced Acute Macrophage Response and Altered Long-Term Recovery	JOURNAL OF NEUROTRAUMA			English	Article						MAPT; neuroinflammation; spatial memory; TBI	TAU PATHOLOGY; MOUSE MODEL; ACTIVATION; HYPERPHOSPHORYLATION; NEUROINFLAMMATION; DEGENERATION; INFLAMMATION; MICROGLIA; ATROPHY; MATTER	Traumatic brain injury (TBI) induces widespread neuroinflammation and accumulation of microtubule associated protein tau (MAPT): two key pathological features of tauopathies. This study sought to characterize the microglial/macrophage response to TBI in genomic-based MAPT transgenic mice in a Mapt knockout background (called hTau). Two-month-old hTau and age-matched control male and female mice received a single lateral fluid percussion TBI or sham injury. Separate groups of mice were aged to an acute (3 days post-injury [DPI]) or chronic (135 DPI) post-injury time point. As judged by tissue immunostaining for macrophage markers, microglial/macrophage response to TBI was enhanced at 3 DPI in hTau mice compared with control TBI and sham mice. However, MAPT phosphorylation increased in hTau mice regardless of injury group. Flow cytometric analysis revealed distinct populations of microglia and macrophages within all groups at 135 DPI. Unexpectedly, microglial reactivity was significantly reduced in hTau TBI mice compared with all other groups. Instead, hTau TBI mice showed a persistent macrophage response. In addition, TBI enhanced MAPT pathology in the temporal cortex and hippocampus of hTau TBI mice compared with controls 135 DPI. A battery of behavioral tests revealed that TBI in hTau mice resulted in compromised use of spatial search strategies to complete a water maze task, despite lack of motor or visual deficits. Collectively, these data indicate that the presence of wild-type human tau alters the microglial/macrophage response to a single TBI, induces delayed, region-specific MAPT pathology, and alters cognitive recovery; however, the causal relationship between these events remains unclear. These results highlight the potential significance of communication between MAPT and microglia/macrophages following TBI, and emphasize the role of neuroinflammation in post-injury recovery.	[Kokiko-Cochran, Olga N.] Ohio State Univ, Coll Med, Dept Neurosci, Columbus, OH 43210 USA; [Saber, Maha] Univ Arizona, Coll Med, Barrow Neurol Inst, Translat Neurotrauma Res Program, Phoenix, AZ USA; [Puntambekar, Shweta; Bemiller, Shane M.; Katsumoto, Atsuko; Lamb, Bruce T.] Indiana Univ, Stark Neurosci Res Inst, Med & Mol Genet, Indianapolis, IN 46204 USA; [Lee, Yu-Shang] Cleveland Clin, Lerner Res Inst, Dept Neurosci, Cleveland, OH 44106 USA; [Bhaskar, Kiran] Univ New Mexico, Dept Mol Genet Microbiol & Neurol, Albuquerque, NM 87131 USA; [Ransohoff, Richard M.] Biogen, Neuroimmunol Acute Neurol & Pain Res & Early Disc, Cambridge, MA USA		Kokiko-Cochran, ON (corresponding author), Ohio State Univ, Dept Neurosci, 257 Inst Behav Med Res Bldg,460 Med Ctr Dr, Columbus, OH 43210 USA.	olga.kokiko-cochran@osumc.edu	Bhaskar, Kiran/AAF-2755-2020	Katsumoto, Atsuko/0000-0002-5582-3050	Department of DefenseUnited States Department of Defense; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [W81XWH-12-1-0629, R21NS077089, R01NS083704, R21NS093442]; Rodent Behavioral Core at the Lerner Research Institute within the Cleveland Clinic; Flow Cytometry Core at the Lerner Research Institute within the Cleveland Clinic; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS093442, R01NS069765, RF1NS083704, R01NS083704] Funding Source: NIH RePORTER	This work was supported by the Department of Defense and National Institutes of Health (W81XWH-12-1-0629, BTL; R21NS077089, R01NS083704, R21NS093442, K.B.). We thank the Rodent Behavioral Core and the Flow Cytometry Core at the Lerner Research Institute within the Cleveland Clinic for technical advice and support. We thank Dr. Imad Najm for use of the fluid percussion device. Author contributions: O.K-C. designed, performed, and analyzed all experiments and wrote the manuscript; M.S. performed surgeries, TBIs, and flow cytometry experiments; S.P. analyzed all flow cytometry data and assisted in interpretation of results; S.B. performed silver staining and assisted with biochemical analysis of data; A.K. performed immunohistochemistry and assisted with data analysis; Y-S.L. provided expertise in use of the fluid percussion device and analysis of data. K.B. provided expertise in use of the hTau mouse model and analysis of data; R.M.R. provided funding and expertise in data analysis and interpretation; and B.T.L. provided funding and expertise and co-edited the manuscript.	Andorfer C, 2005, J NEUROSCI, V25, P5446, DOI 10.1523/JNEUROSCI.4637-04.2005; Andorfer C, 2003, J NEUROCHEM, V86, P582, DOI 10.1046/j.1471-4159.2003.01879.x; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Baskaya MK, 1997, NEUROSCI LETT, V226, P33; Bhaskar K, 2010, NEURON, V68, P19, DOI 10.1016/j.neuron.2010.08.023; Bond-Lamberty B, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150599; Braak H, 1991, BRAIN PATHOL, V1, P213, DOI 10.1111/j.1750-3639.1991.tb00661.x; Brody DL, 2006, EXP NEUROL, V197, P330, DOI 10.1016/j.expneurol.2005.10.020; Collins-Praino LE, 2017, BRAIN BEHAV IMMUN, V60, P369, DOI 10.1016/j.bbi.2016.09.027; Dressler J, 2007, INT J LEGAL MED, V121, P365, DOI 10.1007/s00414-006-0126-6; Duff K, 2000, NEUROBIOL DIS, V7, P87, DOI 10.1006/nbdi.1999.0279; Geissmann F, 2010, SCIENCE, V327, P656, DOI 10.1126/science.1178331; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Grant JL, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3004145; Gyoneva S, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0443-0; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Haar CV, 2016, ACS CHEM NEUROSCI, V7, P1531, DOI 10.1021/acschemneuro.6b00166; HOLNESS CL, 1993, BLOOD, V81, P1607; Holtzman DM, 2016, ALZHEIMERS DEMENT, V12, P1033, DOI 10.1016/j.jalz.2016.03.018; Hsieh CL, 2014, J NEUROTRAUM, V31, P1677, DOI 10.1089/neu.2013.3252; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Katsumoto A, 2014, J IMMUNOL, V193, P2615, DOI 10.4049/jimmunol.1400716; Kokiko-Cochran O, 2016, J NEUROTRAUM, V33, P625, DOI 10.1089/neu.2015.3970; Komuro Y, 2015, NEUROBIOL AGING, V36, P2034, DOI 10.1016/j.neurobiolaging.2015.03.002; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Lin HH, 2010, ADV EXP MED BIOL, V706, P149; Maphis N, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-016-0221-y; Maphis N, 2015, BRAIN, V138, P1738, DOI 10.1093/brain/awv081; Miyasaka T, 2010, FEBS LETT, V584, P3227, DOI 10.1016/j.febslet.2010.06.014; Morganti-Kossmann MC, 2007, INJURY, V38, P1392, DOI 10.1016/j.injury.2007.10.005; Nakagawa Y, 1999, J COMP NEUROL, V411, P390; Nakagawa Y, 2000, EXP NEUROL, V163, P244, DOI 10.1006/exnr.2000.7375; Neumann H, 2009, BRAIN, V132, P288, DOI 10.1093/brain/awn109; Nonaka M, 1999, J NEUROTRAUM, V16, P1023, DOI 10.1089/neu.1999.16.1023; Ojo JO, 2016, J NEUROPATH EXP NEUR, V75, P636, DOI 10.1093/jnen/nlw035; Ojo JO, 2015, J NEUROPATH EXP NEUR, V74, P1012, DOI 10.1097/NEN.0000000000000247; Ojo JO, 2013, J NEUROPATH EXP NEUR, V72, P137, DOI 10.1097/NEN.0b013e3182814cdf; Polydoro M, 2009, J NEUROSCI, V29, P10741, DOI 10.1523/JNEUROSCI.1065-09.2009; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; Saber M, 2017, J NEUROTRAUM, V34, P423, DOI 10.1089/neu.2016.4401; SEDGWICK JD, 1991, P NATL ACAD SCI USA, V88, P7438, DOI 10.1073/pnas.88.16.7438; Smith DH, 1997, J NEUROTRAUM, V14, P715, DOI 10.1089/neu.1997.14.715; Tran HT, 2011, J NEUROSCI, V31, P9513, DOI 10.1523/JNEUROSCI.0858-11.2011; Tzekov R, 2016, BRAIN INJURY, V30, P1428, DOI 10.1080/02699052.2016.1219062; van Groen T, 2003, HIPPOCAMPUS, V13, P133, DOI 10.1002/hipo.10037; Webster SJ, 2015, J NEUROSCI, V35, P6554, DOI 10.1523/JNEUROSCI.0291-15.2015	47	15	15	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN	2018	35	1					73	84		10.1089/neu.2017.5203		NOV 2017	12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FS1WO	WOS:000414522900001	28859549	Green Published, Green Submitted			2022-02-06	
J	Kvint, S; Schuster, J; Kumar, MA				Kvint, Svetlana; Schuster, James; Kumar, Monisha A.			Neurosurgical applications of viscoelastic hemostatic assays	NEUROSURGICAL FOCUS			English	Article						viscoelastic; hemostatic; assays; coagulation; hemostasis; thromboelastography; rotational thromboelastometry	TRAUMATIC BRAIN-INJURY; INTRACEREBRAL HEMORRHAGE; VENOUS THROMBOEMBOLISM; COAGULATION MANAGEMENT; THROMBOELASTOGRAPHY TEG; ANTIPLATELET THERAPY; BLOOD-TRANSFUSION; CARDIAC-SURGERY; THROMBELASTOGRAPHY; COAGULOPATHY	Patients taking antithrombotic agents are very common in neurosurgical practice. The perioperative management of these patients can be extremely challenging especially as newer agents, with poorly defined laboratory monitoring and reversal strategies, become more prevalent. This is especially true with emergent cases in which rapid reversal of anticoagulation is required and the patient's exact medical history is not available. With an aging patient population and the associated increase in diseases such as atrial fibrillation, it is expected that the use of these agents will continue to rise in coming years. Furthermore, thromboembolic complications such as deep venous thrombosis, pulmonary embolism, and myocardial infarction are common complications of major surgery. These trends, in conjunction with a growing understanding of the hemostatic process and its contribution to the pathophysiology of disease, stress the importance of the complete evaluation of a patient's hemostatic profile in guiding management decisions. Viscoelastic hemostatic assays (VHAs), such as thromboelastography and rotational thromboelastometry, are global assessments of coagulation that account for the cellular and plasma components of coagulation. This FDA-approved technology has been available for decades and has been widely used in cardiac surgery and liver transplantation. Although VHAs were cumbersome in the past, advances in software and design have made them more accurate, reliable, and accessible to the neurosurgeon. VHAs have demonstrated utility in guiding intraoperative blood product transfusion, identifying coagulopathy in trauma, and managing postoperative thromboprophylaxis. The first half of this review aims to evaluate and assess VHAs, while the latter half seeks to appraise the evidence supporting their use in neurosurgical populations.	[Kvint, Svetlana; Schuster, James; Kumar, Monisha A.] Univ Penn, Dept Neurosurg, Philadelphia, PA 19104 USA; [Kumar, Monisha A.] Univ Penn, Dept Neurol, Philadelphia, PA 19104 USA		Kumar, MA (corresponding author), Hosp Univ Penn, Dept Neurol, 3 West Gates Bldg,3400 Spruce St, Philadelphia, PA 19104 USA.	monisha.kumar@uphs.upenn.edu					Afshari A, 2011, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007871.pub2; Alexander DC, 2010, THROMB RES, V125, P387, DOI 10.1016/j.thromres.2009.07.001; Baharoglu MI, 2016, LANCET, V387, P2605, DOI 10.1016/S0140-6736(16)30392-0; Bolliger D, 2012, TRANSFUS MED REV, V26, P1, DOI 10.1016/j.tmrv.2011.07.005; Cotton BA, 2012, J TRAUMA ACUTE CARE, V73, P365, DOI 10.1097/TA.0b013e31825c1234; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; Dias JD, 2015, ARCH PATHOL LAB MED, V139, P665, DOI 10.5858/arpa.2014-0170-OA; Dzik Walter H, 2004, Curr Hematol Rep, V3, P324; Fahrendorff M, 2017, SCAND J TRAUMA RESUS, V25, DOI 10.1186/s13049-017-0378-9; Flibotte JJ, 2004, NEUROLOGY, V63, P1059, DOI 10.1212/01.WNL.0000138428.40673.83; Folkerson LE, 2015, SURGERY, V158, P655, DOI 10.1016/j.surg.2015.02.029; Frontera JA, 2017, NEUROCRIT CARE, V26, P48, DOI 10.1007/s12028-016-0292-4; Garcia D, 2013, J THROMB HAEMOST, V11, P245, DOI 10.1111/jth.12096; Gonzalez E, 2010, SEMIN THROMB HEMOST, V36, P723, DOI 10.1055/s-0030-1265289; Gozal Yair M, 2017, Surg Neurol Int, V8, P48, DOI 10.4103/sni.sni_265_16; Haas T, 2012, BRIT J ANAESTH, V108, P36, DOI 10.1093/bja/aer342; Hebert PC, 1999, NEW ENGL J MED, V340, P409, DOI 10.1056/NEJM199902113400601; Herrmann R, 2014, THROMB HAEMOSTASIS, V111, P989, DOI 10.1160/TH13-07-0607; Hoffman M, 2001, THROMB HAEMOSTASIS, V85, P958, DOI 10.1055/s-0037-1615947; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hunt H, 2015, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010438.pub2; Jansohn E, 2017, SCAND J CLIN LAB INV, V77, P289, DOI 10.1080/00365513.2017.1306877; Johansson PI, 2014, BLOOD, V124, P3052, DOI 10.1182/blood-2014-05-575340; Kawano-Castillo J, 2014, STROKE, V45, P683, DOI 10.1161/STROKEAHA.113.003826; Kreitzer NP, 2015, NEUROCRIT CARE, V23, P427, DOI 10.1007/s12028-015-0187-9; Kunio NR, 2012, AM J SURG, V203, P584, DOI 10.1016/j.amjsurg.2011.12.011; Laroche M, 2012, NEUROSURGERY, V70, P1334, DOI 10.1227/NEU.0b013e31824d179b; Larsen CC, 2010, ACTA NEUROCHIR, V152, P1577, DOI 10.1007/s00701-010-0699-1; Levine J, 2010, NEUROSURGERY, V66, P312, DOI 10.1227/01.NEU.0000363747.47587.6C; Li ZJ, 2013, EUR SPINE J, V22, P1950, DOI 10.1007/s00586-013-2774-9; Lindroos AC, 2014, J ANESTH, V28, P189, DOI 10.1007/s00540-013-1711-8; Liotta EM, 2012, STROKE, V43, P2503, DOI 10.1161/STROKEAHA.112.664540; Luostarinen T, 2012, J ANESTH, V26, P770, DOI 10.1007/s00540-012-1400-z; Massaro AM, 2015, NEUROCRIT CARE, V22, P45, DOI 10.1007/s12028-014-0051-3; May AK, 1997, AM SURGEON, V63, P233; McTaggart RA, 2015, J NEUROINTERV SURG, V7, P425, DOI 10.1136/neurintsurg-2013-011089; Mittermayr M, 2007, ANESTH ANALG, V105, P905, DOI 10.1213/01.ane.0000280481.18570.27; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Naik BI, 2015, J NEUROSURG-SPINE, V23, P239, DOI 10.3171/2014.12.SPINE14620; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Norton Robert P, 2013, Evid Based Spine Care J, V4, P157, DOI 10.1055/s-0033-1357364; Ogawa S, 2012, TRANSFUSION, V52, P14, DOI 10.1111/j.1537-2995.2011.03241.x; Phelan HA, 2012, J NEUROTRAUM, V29, P1821, DOI 10.1089/neu.2012.2459; Qian CF, 2016, THROMB RES, V137, P58, DOI 10.1016/j.thromres.2015.11.018; Qureshi AI, 2000, NEUROSURGERY, V46, P1360, DOI 10.1097/00006123-200006000-00014; Raghavan M, 2005, CHEST, V127, P295, DOI 10.1378/chest.127.1.295; Ramchand P, 2016, WORLD NEUROSURG, V96, P215, DOI 10.1016/j.wneu.2016.04.002; REED RL, 1992, J TRAUMA, V33, P465, DOI 10.1097/00005373-199209000-00022; Robertson CS, 2014, JAMA-J AM MED ASSOC, V312, P36, DOI 10.1001/jama.2014.6490; Rossaint R, 2010, CRIT CARE, V14, DOI 10.1186/cc8943; Rotondo MF, 2014, RESOURCES OPTIMAL CA; Salinas D, 2017, AORN J, V105, P370, DOI 10.1016/j.aorn.2017.01.013; Salooja N, 2001, BLOOD COAGUL FIBRIN, V12, P327, DOI 10.1097/00001721-200107000-00001; SAWAYA R, 1992, J NEURO-ONCOL, V14, P119; Serraino GF, 2017, BRIT J ANAESTH, V118, P823, DOI 10.1093/bja/aex100; Shander A, 2007, BEST PRAC RES-CL ANA, V21, P271, DOI 10.1016/j.bpa.2007.01.002; Shen L, 2017, J THORAC DIS, V9, pS299, DOI 10.21037/jtd.2017.03.85; Solbeck S, 2016, INT J CARDIOL, V208, P14, DOI 10.1016/j.ijcard.2016.01.148; Solomon C, 2016, SCAND J CLIN LAB INV, V76, P503, DOI 10.1080/00365513.2016.1200136; STEIN SC, 1992, NEUROSURGERY, V30, P160, DOI 10.1227/00006123-199202000-00002; Stricker PA, 2010, PEDIATR ANESTH, V20, P150, DOI 10.1111/j.1460-9592.2009.03227.x; Tanaka KA, 2012, J CARDIOTHOR VASC AN, V26, P1083, DOI 10.1053/j.jvca.2012.06.015; Velez AM, 2011, NEUROSURGERY, V68, pE1165, DOI 10.1227/NEU.0b013e31820a181a; White N, 2015, J CRANIOFAC SURG, V26, P30, DOI 10.1097/SCS.0000000000001108; Whiting D, 2014, AM J HEMATOL, V89, P228, DOI 10.1002/ajh.23599; Whiting P, 2015, HEALTH TECHNOL ASSES, V19, pv; Whiting P, 2015, HEALTH TECHNOL ASSES, V19, P1, DOI 10.3310/hta19580; Wikkelso A, 2017, ANAESTHESIA, V72, P519, DOI 10.1111/anae.13765; Wikkelso A, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD007871.pub3; Windelov NA, 2011, BLOOD COAGUL FIBRIN, V22, P416, DOI 10.1097/MBC.0b013e3283464f53; Xiao W, 2016, J CLIN ANESTH, V33, P149, DOI 10.1016/j.jclinane.2016.02.040; Yang HC, 2015, INTERV NEURORADIOL, V21, P61, DOI 10.15274/INR-2014-10094; Yoshihara H, 2014, SPINE, V39, P304, DOI 10.1097/BRS.0000000000000123; Yust-Katz S, 2015, J NEURO-ONCOL, V124, P87, DOI 10.1007/s11060-015-1805-2	74	15	16	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2017	43	5							E9	10.3171/2017.8.FOCUS17447			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FL5JE	WOS:000414270800014	29088950	gold			2022-02-06	
J	Rau, CS; Wu, SC; Chen, YC; Chien, PC; Hsieh, HY; Kuo, PJ; Hsieh, CH				Rau, Cheng-Shyuan; Wu, Shao-Chun; Chen, Yi-Chun; Chien, Peng-Chen; Hsieh, Hsiao-Yun; Kuo, Pao-Jen; Hsieh, Ching-Hua			Effect of Age on Glasgow Coma Scale in Patients with Moderate and Severe Traumatic Brain Injury: An Approach with Propensity Score-Matched Population	INTERNATIONAL JOURNAL OF ENVIRONMENTAL RESEARCH AND PUBLIC HEALTH			English	Article						traumatic brain injury (TBI); Glasgow Coma Scale (GCS); age; elderly; propensity-score matching	HEAD-INJURY; MOTOR SCORE; MANAGEMENT; MORTALITY; HYPONATREMIA; PREDICTOR; DISEASE; IMPACT; TRIAL	Background: The most widely used methods of describing traumatic brain injury (TBI) are the Glasgow Coma Scale (GCS) and the Abbreviated Injury Scale (AIS). Recent evidence suggests that presenting GCS in older patients may be higher than that in younger patients for an equivalent anatomical severity of TBI. This study aimed to assess these observations with a propensity-score matching approach using the data from Trauma Registry System in a Level I trauma center. Methods: We included all adult patients (aged 20 years old) with moderate to severe TBI from 1 January 2009 to 31 December 2016. Patients were categorized into elderly (aged 65 years) and young adults (aged 20-64 years). The severity of TBI was defined by an AIS score in the head (AIS 34 and 5 indicate moderate and severe TBI, respectively). We examined the differences in the GCS scores by age at each head AIS score. Unpaired Student's t- and Mann-Whitney U-tests were used to analyze normally and non-normally distributed continuous data, respectively. Categorical data were compared using either the Pearson chi-square or two-sided Fisher's exact tests. Matched patient populations were allocated in a 1:1 ratio according to the propensity scores calculated using NCSS software with the following covariates: sex, pre-existing chronic obstructive pulmonary disease, systolic blood pressure, hemoglobin, sodium, glucose, and alcohol level. Logistic regression was used to evaluate the effects of age on the GCS score in each head AIS stratum. Results: The study population included 2081 adult patients with moderate to severe TBI. These patients were categorized into elderly (n = 847) and young adults (n = 1234): each was exclusively further divided into three groups of patients with head AIS of 3, 4, or 5. In the 162 well-balanced pairs of TBI patients with head AIS of 3, the elderly demonstrated a significantly higher GCS score than the young adults (14.1 +/- 2.2 vs. 13.1 +/- 3.3, respectively; p = 0.002). In the 362 well-balanced pairs of TBI patients with head AIS of 4, the elderly showed a significantly higher GCS score than the young adults (13.1 +/- 3.3 vs. 12.2 +/- 3.8, respectively; p = 0.002). In the 89 well-balance pairs of TBI patients with head AIS of 5, no significant differences were observed for the GCS scores. Conclusions: This study demonstrated that elderly patients with moderate TBI present higher GCS score than younger patients. This study underscores the importance of determining of TBI severity in this group of elderly patients based on the GCS score alone. A lower threshold of GCS cutoff should be adopted in the management of the elderly patients with TBI.	[Rau, Cheng-Shyuan] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Neurosurg, Kaohsiung 83301, Taiwan; [Wu, Shao-Chun] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Anesthesiol, Kaohsiung 83301, Taiwan; [Chen, Yi-Chun; Chien, Peng-Chen; Hsieh, Hsiao-Yun; Kuo, Pao-Jen; Hsieh, Ching-Hua] Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan		Hsieh, CH (corresponding author), Chang Gung Univ, Coll Med, Kaohsiung Chang Gung Mem Hosp, Dept Plast Surg, Kaohsiung 83301, Taiwan.	ersh2127@cloud.cgmh.org.tw; shaochunwu@gmail.com; libe320@yahoo.com.tw; VENU_CHIEN@hotmail.com; sylvia19870714@hotmail.com; bow110470@gmail.com; m93chinghua@gmail.com		Hsieh, Ching-Hua/0000-0002-0945-2746; WU, Shaochun/0000-0002-0984-6921	 [CMRPG8F0261]	We would like to extend our gratitude to the Biostatistics Center of Kaohsiung Chang Gung Memorial Hospital for their assistance with statistical analyses. This research was supported by a grant from CMRPG8F0261.	Bledsoe BE, 2015, PREHOSP DISASTER MED, V30, P46, DOI 10.1017/S1049023X14001289; Brady WJ, 1999, AM J EMERG MED, V17, P4, DOI 10.1016/S0735-6757(99)90002-5; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Ciccone MM, 2010, VASC HEALTH RISK MAN, V6, P297; CoMAoA, 1971, JAMA-J AM MED ASSOC, V215, P277; Dhandapani SS, 2012, J NEUROSCI RURAL PRA, V3, P131, DOI 10.4103/0976-3147.98208; Feldman A, 2015, ANN EMERG MED, V65, P325, DOI 10.1016/j.annemergmed.2014.07.454; Fu TS, 2015, J TRAUMA ACUTE CARE, V79, P449, DOI 10.1097/TA.0000000000000733; Healey C, 2003, J TRAUMA, V54, P671, DOI 10.1097/01.TA.0000058130.30490.5D; Hsieh CH, 2017, BIOMED J, V40, P113, DOI 10.1016/j.bj.2016.10.005; Hsieh CH, 2017, BIOMED J, V40, P121, DOI 10.1016/j.bj.2016.10.006; Huang CY, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13020236; Karnath B, 2004, GERIATRICS, V59, P18; Kehoe A, 2016, EMERG MED J, V33, P381, DOI 10.1136/emermed-2015-205180; Kehoe A, 2015, EMERG MED J, V32, P613, DOI 10.1136/emermed-2013-203488; Kotera A, 2014, J INTENSIVE CARE, V2, DOI 10.1186/2052-0492-2-1; Lai WH, 2016, INT J ENV RES PUB HE, V13, DOI 10.3390/ijerph13040357; Lohani S, 2011, WORLD NEUROSURG, V76, P355, DOI 10.1016/j.wneu.2011.03.042; Mamelak AN, 1996, J TRAUMA, V41, P91, DOI 10.1097/00005373-199607000-00014; McNett Molly, 2007, J Neurosci Nurs, V39, P68; Meng XF, 2016, J NEUROSURG ANESTH, V28, P21, DOI 10.1097/ANA.0000000000000192; Moore L, 2006, J TRAUMA, V60, P1238, DOI 10.1097/01.ta.0000195593.60245.80; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; Mosenthal AC, 2002, J TRAUMA, V52, P907, DOI 10.1097/00005373-200205000-00015; Osler T, 2016, INJURY, V47, P1879, DOI 10.1016/j.injury.2016.04.016; Potter D, 2013, J R Nav Med Serv, V99, P16; Ronning P, 2015, BRAIN INJURY, V29, P1648, DOI 10.3109/02699052.2015.1075154; Ross SE, 1998, J TRAUMA, V45, P42, DOI 10.1097/00005373-199807000-00008; Salottolo K, 2014, JAMA SURG, V149, P727, DOI 10.1001/jamasurg.2014.13; Savitsky B, 2016, BRAIN INJURY, V30, P1194, DOI 10.1080/02699052.2016.1187290; Sekhon MS, 2012, CRIT CARE, V16, DOI 10.1186/cc11431; Sheridan PL, 2007, DEMENT GERIATR COGN, V24, P125, DOI 10.1159/000105126; Singh B, 2013, BRAIN INJURY, V27, P293, DOI 10.3109/02699052.2012.743182; Smith Bryce D., 2012, Morbidity and Mortality Weekly Report, V61, P1; Stiell IG, 2001, LANCET, V357, P1391, DOI 10.1016/S0140-6736(00)04561-X; Susman M, 2002, J TRAUMA, V53, P219, DOI 10.1097/00005373-200208000-00004; TEASDALE G, 1974, LANCET, V2, P81; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Wells AR, 2013, POPUL HEALTH MANAG, V16, P35, DOI 10.1089/pop.2011.0104; Wu X, 2015, INJURY, V46, P35, DOI 10.1016/j.injury.2014.08.002; Yee KF, 2016, CAN RESPIR J, V2016, DOI 10.1155/2016/6803860	42	15	15	0	5	MDPI AG	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	1660-4601			INT J ENV RES PUB HE	Int. J. Environ. Res. Public Health	NOV	2017	14	11							1378	10.3390/ijerph14111378			12	Environmental Sciences; Public, Environmental & Occupational Health	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Environmental Sciences & Ecology; Public, Environmental & Occupational Health	FO1SQ	WOS:000416545200094	29137197	gold, Green Submitted, Green Published			2022-02-06	
J	Shan, HY; Chu, Y; Chang, P; Yang, LJ; Wang, Y; Zhu, SH; Zhang, MY; Tao, LY				Shan, Haiyan; Chu, Yang; Chang, Pan; Yang, Lijun; Wang, Yi; Zhu, Shaohua; Zhang, Mingyang; Tao, Luyang			Neuroprotective effects of hydrogen sulfide on sodium azide-induced autophagic cell death in PC12 cells	MOLECULAR MEDICINE REPORTS			English	Article						hydrogen sulfide; sodium azide; autophagic cell death	TRAUMATIC BRAIN-INJURY; CYTOCHROME-C-OXIDASE; PATHWAY; RAT; MITOCHONDRIA; ACTIVATION; EXPRESSION; APOPTOSIS; SYNTHASE; STRESS	Sodium azide (NaN3) is a chemical of rapidly growing commercial importance. It is very acutely toxic and inhibits cytochrome oxidase (COX) by binding irreversibly to the heme cofactor. A previous study from our group demonstrated that hydrogen sulfide (H2S), the third endogenous gaseous mediator identified, had protective effects against neuronal damage induced by traumatic brain injury (TBI). It is well-known that TBI can reduce the activity of COX and have detrimental effects on the central nervous system metabolism. Therefore, in the present study, it was hypothesized that H2S may provide neuroprotection against NaN3 toxicity. The current results revealed that NaN3 treatment induced non-apoptotic cell death, namely autophagic cell death, in PC12 cells. Expression of the endogenous H2S-producing enzymes, cystathionine-beta-synthase and 3-mercaptopyruvate sulfurtransferase, decreased in a dose-dependent manner following NaN3 treatment. Pretreatment with H2S markedly attenuated the NaN3-induced cell viability loss and autophagic cell death in a dose-dependent manner. The present study suggests that H2S-based strategies may have future potential in the prevention and/or therapy of neuronal damage following NaN3 exposure.	[Shan, Haiyan; Zhang, Mingyang] Minist Justice, Inst Forens Sci, Shanghai Key Lab Forens Med, Shanghai 200063, Peoples R China; [Shan, Haiyan] North Suzhou Municipal Hosp, Dept Obstet & Gynecol, Suzhou 215008, Jiangsu, Peoples R China; [Chu, Yang; Yang, Lijun; Wang, Yi; Zhu, Shaohua; Zhang, Mingyang; Tao, Luyang] Soochow Univ, Inst Forens Sci, 178 Ganjiang East Rd, Suzhou 215123, Jiangsu, Peoples R China; [Chang, Pan] Xian Med Coll, Cent Lab, Affiliated Hosp 2, Xian 710038, Shaanxi, Peoples R China		Zhang, MY; Tao, LY (corresponding author), Soochow Univ, Inst Forens Sci, 178 Ganjiang East Rd, Suzhou 215123, Jiangsu, Peoples R China.	mingyangzhang@suda.edu.cn; taoluyang@suda.edu.cn	Mingyang, Zhang/J-7412-2019	Mingyang, Zhang/0000-0001-7084-6237; Zhang, Mingyang/0000-0003-1612-0763	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81601306, 81301039, 81530062, 81271379, 81172911]; China Postdoctoral Science Foundation Funded ProjectChina Postdoctoral Science Foundation [2015M570476]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Talent Youth Medical Program [QNRC2016245]; Shanghai Key Lab of Forensic Medicine [KF1502]; Key Laboratory of Evidence Science (China University of Political Science and Law), Ministry of Education [2016KFKT05]; Suzhou Science and Technology Development Project [SYSD2015119]	The present study was supported by the National Natural Science Foundation of China (grant nos. 81601306, 81301039, 81530062, 81271379 and 81172911); China Postdoctoral Science Foundation Funded Project (grant no. 2015M570476); the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); Jiangsu Talent Youth Medical Program (grant no. QNRC2016245); Shanghai Key Lab of Forensic Medicine (grant no. KF1502); Key Laboratory of Evidence Science (China University of Political Science and Law), Ministry of Education (grant no. 2016KFKT05); and the Suzhou Science and Technology Development Project (grant no. SYSD2015119).	Amador FC, 2004, NEUROTOXICOL TERATOL, V26, P387, DOI 10.1016/j.ntt.2003.12.007; Bennett MC, 1996, J NEUROCHEM, V66, P2606; Bhatia M, 2012, SCIENTIFICA, V2012, DOI 10.6064/2012/159680; Calvert JW, 2009, CIRC RES, V105, P365, DOI 10.1161/CIRCRESAHA.109.199919; Chang SJ, 2003, INT J TOXICOL, V22, P175, DOI 10.1080/10915810305109; Chen WL, 2015, REV NEUROSCIENCE, V26, P129, DOI 10.1515/revneuro-2014-0051; Cheng G, 2012, BRIT J PHARMACOL, V167, P699, DOI 10.1111/j.1476-5381.2012.02025.x; Fayaz SM, 2014, CNS NEUROL DISORD-DR, V13, P42, DOI 10.2174/18715273113126660189; Gotor C, 2013, AUTOPHAGY, V9, P609, DOI 10.4161/auto.23460; Grammatopoulos TN, 2004, BRAIN RES BULL, V62, P297, DOI 10.1016/j.brainresbull.2003.09.018; Gu YL, 2014, NEUROSCI LETT, V570, P86, DOI 10.1016/j.neulet.2014.04.004; Han M, 2008, ARCH PHARM RES, V31, P749, DOI 10.1007/s12272-001-1222-5; Harris LK, 2001, J NEUROTRAUM, V18, P993, DOI 10.1089/08977150152693692; Huang CW, 2015, HANDB EXP PHARMACOL, V230, P3, DOI 10.1007/978-3-319-18144-8_1; Huttemann M, 2008, NEUROSCIENCE, V151, P148, DOI 10.1016/j.neuroscience.2007.09.029; Inomata K, 2003, J PHARMACOL SCI, V93, P163, DOI 10.1254/jphs.93.163; Kang R, 2011, CELL DEATH DIFFER, V18, P571, DOI 10.1038/cdd.2010.191; Kansanen E, 2013, REDOX BIOL, V1, P45, DOI 10.1016/j.redox.2012.10.001; Kimura H, 2015, HANDB EXP PHARMACOL, V230, P61, DOI 10.1007/978-3-319-18144-8_3; Kimura H, 2014, MOLECULES, V19, P16146, DOI 10.3390/molecules191016146; Kimura Hideo, 2012, Folia Pharmacologica Japonica, V139, P6; Kimura H, 2011, AMINO ACIDS, V41, P113, DOI 10.1007/s00726-010-0510-x; Kimura Y, 2010, ANTIOXID REDOX SIGN, V12, P1, DOI 10.1089/ars.2008.2282; Klionsky DJ, 2012, AUTOPHAGY, V8, P445, DOI 10.4161/auto.19496; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Liu JQ, 2016, CELL BIOSCI, V6, DOI 10.1186/s13578-016-0099-1; Liu LP, 2017, ALCOHOL ALCOHOLISM, V52, P12, DOI 10.1093/alcalc/agw077; Lutton JD, 1996, EXP PHYSIOL, V81, P251, DOI 10.1113/expphysiol.1996.sp003929; MITTENBERG W, 1992, J NEUROL NEUROSUR PS, V55, P200, DOI 10.1136/jnnp.55.3.200; Nagpure BV, 2015, HANDB EXP PHARMACOL, V230, P193, DOI 10.1007/978-3-319-18144-8_10; Ott M, 2007, APOPTOSIS, V12, P913, DOI 10.1007/s10495-007-0756-2; Park Y, 2015, J NEUROTRAUM, V32, P1449, DOI 10.1089/neu.2014.3694; Ryu JR, 2016, MOL BRAIN, V9, DOI 10.1186/s13041-016-0224-4; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Sato E, 2008, MED MOL MORPHOL, V41, P211, DOI 10.1007/s00795-008-0414-y; Satpute R, 2012, IRAN J PHARM RES, V11, P303; Selvatici R, 2009, NEUROCHEM RES, V34, P909, DOI 10.1007/s11064-008-9852-0; Sena LA, 2012, MOL CELL, V48, P158, DOI 10.1016/j.molcel.2012.09.025; Shen HM, 2011, AUTOPHAGY, V7, P457, DOI 10.4161/auto.7.5.14226; Smith CM, 2011, NEUROBIOL DIS, V43, P52, DOI 10.1016/j.nbd.2010.09.014; Whiteman M, 2004, J NEUROCHEM, V90, P765, DOI 10.1111/j.1471-4159.2004.02617.x; Yin F, 2014, ANTIOXID REDOX SIGN, V20, P353, DOI 10.1089/ars.2012.4774; Zhang Li, 2011, Chinese Journal of Natural Medicines, V9, P450, DOI 10.3724/SP.J.1009.2011.00450; Zhang MY, 2017, CELL MOL NEUROBIOL, V37, P291, DOI 10.1007/s10571-016-0369-9; Zhang MY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0087241; Zhang MY, 2013, J MOL NEUROSCI, V51, P57, DOI 10.1007/s12031-012-9948-5; Zhang ZY, 2013, P ROY SOC B-BIOL SCI, V280, DOI 10.1098/rspb.2012.2758	47	15	16	2	12	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	NOV	2017	16	5					5938	5946		10.3892/mmr.2017.7363			9	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	FM0ZU	WOS:000414698900026	28849152	Green Submitted, hybrid, Green Published			2022-02-06	
J	Tariq, A; Aguilar-Salinas, P; Hanel, RA; Naval, N; Chmayssani, M				Tariq, Areej; Aguilar-Salinas, Pedro; Hanel, Ricardo A.; Naval, Neeraj; Chmayssani, Mohamad			The role of ICP monitoring in meningitis	NEUROSURGICAL FOCUS			English	Article						meningitis; intracranial pressure; cerebrospinal fluid; critical care	CEREBRAL-BLOOD-FLOW; INCREASED INTRACRANIAL-PRESSURE; SEVERE BACTERIAL-MENINGITIS; PNEUMOCOCCAL MENINGITIS; DECOMPRESSIVE CRANIECTOMY; BRAIN-BARRIER; HYPERTENSION; ADULTS; MANAGEMENT; MENINGOENCEPHALITIS	Intracranial pressure (ICP) monitoring has been widely accepted in the management of traumatic brain injury. However, its use in other pathologies that affect ICP has not been advocated as strongly, especially in CNS infections. Despite the most aggressive and novel antimicrobial therapies for meningitis, the mortality rate associated with this disease is far from satisfactory. Although intracranial hypertension and subsequent death have long been known to complicate meningitis, no specific guidelines targeting ICP monitoring are available. A review of the literature was performed to understand the pathophysiology of elevated ICP in meningitis, diagnostic challenges, and clinical outcomes in the use of ICP monitoring.	[Tariq, Areej] Ohio State Univ, Dept Neurol, Div Cerebrovasc Dis & Neurocrit Care, Columbus, OH 43210 USA; [Aguilar-Salinas, Pedro; Hanel, Ricardo A.; Naval, Neeraj; Chmayssani, Mohamad] Baptist Neurol Inst, Lyerly Neurosurg, 800 Prudential Dr,Ste 1100, Jacksonville, FL 32207 USA		Chmayssani, M (corresponding author), Baptist Neurol Inst, Lyerly Neurosurg, 800 Prudential Dr,Ste 1100, Jacksonville, FL 32207 USA.	mohamad.chmayssani@bmcjax.com	Aguilar-Salinas, Pedro/AAJ-4444-2020	Aguilar-Salinas, Pedro/0000-0002-5268-6548			Abulhasan YB, 2013, NEUROCRIT CARE, V19, P199, DOI 10.1007/s12028-013-9853-y; Baussart B, 2006, ACTA ANAESTH SCAND, V50, P762, DOI 10.1111/j.1399-6576.2006.01038.x; Bordes J, 2011, ACTA ANAESTH SCAND, V55, P130, DOI 10.1111/j.1399-6576.2010.02355.x; Bromilow J, 2007, BRIT J ANAESTH, V99, P528, DOI 10.1093/bja/aem208; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Cuthbertson BH, 2004, ANAESTHESIA, V59, P908, DOI 10.1111/j.1365-2044.2004.03748.x; Dagdemir A, 2006, PEDIATR NEUROL, V35, P352, DOI 10.1016/j.pediatrneurol.2006.05.014; de Vedia L, 2013, INFECTION, V41, P1073, DOI 10.1007/s15010-013-0538-4; Depreitere B, 2016, ACTA NEUROCHIR SUPPL, V122, P101, DOI 10.1007/978-3-319-22533-3_20; Di Rienzo A, 2008, ACTA NEUROCHIR, V150, P1057, DOI 10.1007/s00701-008-0019-1; DURAND ML, 1993, NEW ENGL J MED, V328, P21, DOI 10.1056/NEJM199301073280104; Gliemroth J, 2002, CLIN NEUROL NEUROSUR, V105, P27, DOI 10.1016/S0303-8467(02)00088-4; Glimaker M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091976; Goh KJ, 2000, NEW ENGL J MED, V342, P1229, DOI 10.1056/NEJM200004273421701; Grande PO, 2002, ACTA ANAESTH SCAND, V46, P264, DOI 10.1034/j.1399-6576.2002.460307.x; JOHNSON RT, 1975, DEV MED CHILD NEUROL, V17, P807; Koedel U, 2002, LANCET INFECT DIS, V2, P721, DOI 10.1016/S1473-3099(02)00450-4; Kumar G, 2009, CLIN NEUROL NEUROSUR, V111, P399, DOI 10.1016/j.clineuro.2009.03.004; Kumar R, 2014, CRIT CARE MED, V42, P1775, DOI 10.1097/CCM.0000000000000298; Larsen L, 2017, INFECT DIS-NOR, V49, P356, DOI 10.1080/23744235.2016.1269265; Lindvall P, 2004, CLIN INFECT DIS, V38, P384, DOI 10.1086/380970; LYONS MK, 1990, MAYO CLIN PROC, V65, P684, DOI 10.1016/S0025-6196(12)65131-3; Macsween KF, 2005, J INFECTION, V51, pE221, DOI 10.1016/j.jinf.2005.02.010; Mactier H, 1998, BMJ-BRIT MED J, V316, P1887, DOI 10.1136/bmj.316.7148.1887; Merkelbach S, 1999, INFECTION, V27, P239, DOI 10.1007/s150100050019; Mertineit C, 2000, CAN J PHYSIOL PHARM, V78, P217, DOI 10.1139/cjpp-78-3-217; Moller K, 2004, STROKE, V35, P1333, DOI 10.1161/01.STR.0000128418.17312.0e; Odetola FO, 2006, PEDIATRICS, V117, P1893, DOI 10.1542/peds.2005-2179; Ozisik HI, 2004, MICROBES INFECT, V6, P861, DOI 10.1016/j.micinf.2004.04.012; Pedersen M, 2008, J CEREBR BLOOD F MET, V28, P126, DOI 10.1038/sj.jcbfm.9600514; Pedersen M, 2007, J APPL PHYSIOL, V102, P72, DOI 10.1152/japplphysiol.00697.2006; Perin A, 2008, ACTA NEUROCHIR, V150, P837, DOI 10.1007/s00701-008-1596-8; PFISTER HW, 1993, ARCH NEUROL-CHICAGO, V50, P575, DOI 10.1001/archneur.1993.00540060015010; PFISTER HW, 1990, J CEREBR BLOOD F MET, V10, P914, DOI 10.1038/jcbfm.1990.148; Pili-Floury S, 2009, ANN FR ANESTH, V28, P709, DOI 10.1016/j.annfar.2009.05.012; QUAGLIARELLO V, 1992, NEW ENGL J MED, V327, P864, DOI 10.1056/NEJM199209173271208; QUAGLIARELLO VJ, 1986, J CLIN INVEST, V77, P1084, DOI 10.1172/JCI112407; Radetsky M, 2014, PEDIATR INFECT DIS J, V33, P204, DOI 10.1097/01.inf.0000435508.67490.f0; REBAUD P, 1988, INTENS CARE MED, V14, P522, DOI 10.1007/BF00263524; REESE TS, 1967, J CELL BIOL, V34, P207, DOI 10.1083/jcb.34.1.207; RENNICK G, 1993, BRIT MED J, V306, P953, DOI 10.1136/bmj.306.6883.953; SCHELD WM, 1980, J CLIN INVEST, V66, P243, DOI 10.1172/JCI109850; Scheld WM, 2002, J INFECT DIS, V186, pS225, DOI 10.1086/344939; Schutte CM, 1998, J INFECTION, V37, P112, DOI 10.1016/S0163-4453(98)80163-1; Sparing R, 2004, NERVENARZT, V75, P1016, DOI 10.1007/s00115-004-1718-3; Spence M, 1979, Int Anesthesiol Clin, V17, P285, DOI 10.1097/00004311-197917020-00011; TAUBER MG, 1989, PEDIATR INFECT DIS J, V8, P842; Thigpen MC, 2007, NEW ENGL J MED, V364, P2016, DOI DOI 10.1056/NEJMoa1005384; Tunkel A R, 1996, Curr Clin Top Infect Dis, V16, P215; Wall ECB, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD008806.pub2; Weisfelt M, 2006, LANCET NEUROL, V5, P332, DOI 10.1016/S1474-4422(06)70409-4; Weisfelt M, 2008, ANN NEUROL, V63, P90, DOI 10.1002/ana.21216; Winkler F, 2002, J NEUROL, V249, P1292, DOI 10.1007/s00415-002-0844-8	53	15	16	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1092-0684			NEUROSURG FOCUS	Neurosurg. Focus	NOV	2017	43	5							E7	10.3171/2017.8.FOCUS17419			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	FL5JE	WOS:000414270800007	29088943	gold			2022-02-06	
J	Liu, CC; Hajra, SG; Cheung, TPL; Song, XW; D'Arcy, RCN				Liu, Careesa C.; Hajra, Sujoy Gosh; Cheung, Teresa P. L.; Song, Xiaowei; D'Arcy, Ryan C. N.			Spontaneous Blinks Activate the Precuneus: Characterizing Blink-Related Oscillations Using Magnetoencephalography	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						blink; blink-related oscillations; precuneus; environmental monitoring; awareness; magnetoencephalography	DEFAULT-MODE NETWORK; TRAUMATIC BRAIN-INJURY; EYE BLINKING; RESTING-STATE; FUNCTIONAL CONNECTIVITY; STRUCTURAL CONNECTIVITY; DELTA OSCILLATIONS; VISUAL SUPPRESSION; CINGULATE CORTEX; EYEBLINKS	Spontaneous blinking occurs 15-20 times per minute. Although blinking has often been associated with its physiological role of corneal lubrication, there is now increasing behavioral evidence suggesting that blinks are also modulated by cognitive processes such as attention and information processing. Recent low-density electroencephalography (EEG) studies have reported so-called blink-related oscillations (BROs) associated with spontaneous blinking at rest. Delta-band (0.5-4Hz) BROs are thought to originate from the precuneus region involved in environmental monitoring and awareness, with potential clinical utility in evaluation of disorders of consciousness. However, the neural mechanisms of BROs have not been elucidated. Using magnetoencephalography (MEG), we characterized delta-band BROs in 36 healthy individuals while controlling for background brain activity. Results showed that, compared to pre-blink baseline, delta-band BROs resulted in increased global field power (p < 0.001) and time-frequency spectral power (p < 0.05) at the sensor level, peaking at similar to 250ms post-blink maximum. Source localization showed that spontaneous blinks activated the bilateral precuneus (p < 0.05 FWE), and source activity within the precuneus was also consistent with sensor-space results. Crucially, these effects were only observed in the blink condition and were absent in the control condition, demonstrating that results were due to spontaneous blinks rather than as part of the inherent brain activity. The current study represents the first MEG examination of BROs. Our findings suggest that spontaneous blinks activate the precuneus regions consistent with environmental monitoring and awareness, and provide important neuroimaging support for the cognitive role of spontaneous blinks.	[Liu, Careesa C.; Hajra, Sujoy Gosh; Cheung, Teresa P. L.; D'Arcy, Ryan C. N.] Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada; [Cheung, Teresa P. L.; Song, Xiaowei; D'Arcy, Ryan C. N.] Fraser Hlth Author, Surrey Mem Hosp, Hlth Sci & Innovat, Surrey, BC, Canada		D'Arcy, RCN (corresponding author), Simon Fraser Univ, Sch Engn Sci, Burnaby, BC, Canada.; D'Arcy, RCN (corresponding author), Fraser Hlth Author, Surrey Mem Hosp, Hlth Sci & Innovat, Surrey, BC, Canada.	rdarcy@sfu.ca		Ghosh Hajra, Sujoy/0000-0002-8347-6578	Surrey Memorial Hospital Foundation; Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR [RGPIN-2015-04018]; Canadian Institutes for Health Research (CIHR)Canadian Institutes of Health Research (CIHR) [GSD-140381]	This study was funded by a grant from the Surrey Memorial Hospital Foundation and the Natural Sciences and Engineering Research Council of Canada (Grant #RGPIN-2015-04018). CL is supported by a scholarship from the Canadian Institutes for Health Research (CIHR, Grant # GSD-140381).	Andrews-Hanna JR, 2012, NEUROSCIENTIST, V18, P251, DOI 10.1177/1073858411403316; Barbato G, 2000, PSYCHIAT RES, V93, P145, DOI 10.1016/S0165-1781(00)00108-6; Bardouille T, 2006, CLIN NEUROPHYSIOL, V117, P952, DOI 10.1016/j.clinph.2006.01.021; Bentivoglio AR, 1997, MOVEMENT DISORD, V12, P1028, DOI 10.1002/mds.870120629; Berman BD, 2012, NEUROIMAGE, V59, P1441, DOI 10.1016/j.neuroimage.2011.08.050; Bethmann A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0047626; Bodis-Wollner I, 1999, NEUROLOGY, V53, P1800, DOI 10.1212/WNL.53.8.1800; Bologna M, 2013, J NEUROL NEUROSUR PS, V84, P681, DOI 10.1136/jnnp-2012-303993; Boly M, 2009, HUM BRAIN MAPP, V30, P2393, DOI 10.1002/hbm.20672; Boly M, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00625; Bonfiglio L, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0093252; Bonfiglio L, 2013, HUM BRAIN MAPP, V34, P2178, DOI 10.1002/hbm.22056; Bonfiglio L, 2011, INT J PSYCHOPHYSIOL, V80, P44, DOI 10.1016/j.ijpsycho.2011.01.002; Bonfiglio L, 2009, NEUROSCI LETT, V449, P57, DOI 10.1016/j.neulet.2008.10.039; Bristow D, 2005, NEUROIMAGE, V27, P136, DOI 10.1016/j.neuroimage.2005.03.037; Bristow D, 2005, CURR BIOL, V15, P1296, DOI 10.1016/j.cub.2005.06.025; Brookes MJ, 2011, NEUROIMAGE, V56, P1082, DOI 10.1016/j.neuroimage.2011.02.054; Brunet D, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/813870; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Cavanna AE, 2006, BRAIN, V129, P564, DOI 10.1093/brain/awl004; Chan K K S, 2010, East Asian Arch Psychiatry, V20, P174; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crone JS, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0026373; DALE AM, 1993, J COGNITIVE NEUROSCI, V5, P162, DOI 10.1162/jocn.1993.5.2.162; DEJONG PJ, 1990, INT J NEUROSCI, V51, P89, DOI 10.3109/00207459009000513; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Farrer C, 2002, NEUROIMAGE, V15, P596, DOI 10.1006/nimg.2001.1009; Fransson P, 2008, NEUROIMAGE, V42, P1178, DOI 10.1016/j.neuroimage.2008.05.059; Friston KJ, 1994, HUMAN BRAIN MAPPING, V2, P189, DOI [DOI 10.1002/HBM.460020402, 10.1002/hbm.460020402]; Gilboa A, 2004, CEREB CORTEX, V14, P1214, DOI 10.1093/cercor/bhh082; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Gusnard DA, 2001, NAT REV NEUROSCI, V2, P685, DOI 10.1038/35094500; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HALL A, 1945, BRIT J OPHTHALMOL, V29, P445, DOI 10.1136/bjo.29.9.445; HARI R, 1994, NATURE, V367, P121, DOI 10.1038/367121b0; Hauk O, 2004, NEUROIMAGE, V21, P1612, DOI 10.1016/j.neuroimage.2003.12.018; Hebart MN, 2012, J NEUROSCI, V32, P8107, DOI 10.1523/JNEUROSCI.1462-12.2012; HEUSERLINK M, 1992, NEUROSCI LETT, V143, P31, DOI 10.1016/0304-3940(92)90226-W; Hillary FG, 2011, INT J PSYCHOPHYSIOL, V82, P115, DOI 10.1016/j.ijpsycho.2011.03.011; Hillebrand A, 2005, HUM BRAIN MAPP, V25, P199, DOI 10.1002/hbm.20102; Hupe JM, 2012, NEUROIMAGE, V61, P149, DOI 10.1016/j.neuroimage.2012.03.001; Kato M, 2003, NEUROIMAGE, V18, P749, DOI 10.1016/S1053-8119(03)00005-3; Kircher TTJ, 2000, COGNITIVE BRAIN RES, V10, P133, DOI 10.1016/S0926-6410(00)00036-7; Kjaer TW, 2002, NEUROIMAGE, V17, P1080, DOI 10.1006/nimg.2002.1230; Laureys S, 2012, NEUROIMAGE, V61, P478, DOI 10.1016/j.neuroimage.2011.12.041; Litvak V, 2008, NEUROIMAGE, V42, P1490, DOI 10.1016/j.neuroimage.2008.06.022; Litvak V, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/852961; Luking KR, 2017, BIOL PSYCHIAT-COGN N, V2, P289, DOI 10.1016/j.bpsc.2016.12.004; Lundstrom BN, 2005, NEUROIMAGE, V27, P824, DOI 10.1016/j.neuroimage.2005.05.008; Makeig S, 1996, ADV NEUR IN, V8, P145; Malouin F, 2003, HUM BRAIN MAPP, V19, P47, DOI 10.1002/hbm.10103; MANNING KA, 1983, PERCEPT PSYCHOPHYS, V34, P250, DOI 10.3758/BF03202953; Margulies DS, 2009, P NATL ACAD SCI USA, V106, P20069, DOI 10.1073/pnas.0905314106; Marinova I., 2010, PHYSICS-BASEL, V4, P140; Mitchell DJ, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00018; Nagahama Y, 1999, NEUROIMAGE, V10, P193, DOI 10.1006/nimg.1999.0451; Nakano T, 2013, P NATL ACAD SCI USA, V110, P702, DOI 10.1073/pnas.1214804110; Nakano T, 2010, EXP BRAIN RES, V205, P577, DOI 10.1007/s00221-010-2387-z; Nakano T, 2009, P ROY SOC B-BIOL SCI, V276, P3635, DOI 10.1098/rspb.2009.0828; NUNEZ PL, 1994, ELECTROEN CLIN NEURO, V90, P40, DOI 10.1016/0013-4694(94)90112-0; Oh J, 2012, HUM MOVEMENT SCI, V31, P1353, DOI 10.1016/j.humov.2012.06.003; ORCHARD L N, 1991, Integrative Physiological and Behavioral Science, V26, P108, DOI 10.1007/BF02691032; Polich J, 2007, CLIN NEUROPHYSIOL, V118, P2128, DOI 10.1016/j.clinph.2007.04.019; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Raz S, 2014, ASSESSMENT, V21, P108, DOI 10.1177/1073191112443409; Reiman EM, 1997, AM J PSYCHIAT, V154, P918; RIGGS LA, 1981, VISION RES, V21, P1075, DOI 10.1016/0042-6989(81)90012-2; SHALLICE T, 1994, NATURE, V368, P633, DOI 10.1038/368633a0; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; SKRANDIES W, 1990, Brain Topography, V3, P137, DOI 10.1007/BF01128870; Snowden JS, 2004, BRAIN, V127, P860, DOI 10.1093/brain/awh099; Tsubota K, 1999, EXP EYE RES, V69, P1, DOI 10.1006/exer.1999.0660; Tsubota K, 1996, ARCH OPHTHALMOL-CHIC, V114, P715, DOI 10.1001/archopht.1996.01100130707012; Utevsky AV, 2014, J NEUROSCI, V34, P932, DOI 10.1523/JNEUROSCI.4227-13.2014; Vanhaudenhuyse A, 2010, BRAIN, V133, P161, DOI 10.1093/brain/awp313; Veltman JA, 1998, ERGONOMICS, V41, P656, DOI 10.1080/001401398186829; Viggiano MP, 2000, NEUROPSYCHOLOGIA, V38, P1098, DOI 10.1016/S0028-3932(99)00159-1; VOLKMANN FC, 1986, VISION RES, V26, P1401, DOI 10.1016/0042-6989(86)90164-1; Wenderoth N, 2005, EUR J NEUROSCI, V22, P235, DOI 10.1111/j.1460-9568.2005.04176.x; Yoon HW, 2005, NEUROSCI LETT, V381, P26, DOI 10.1016/j.neulet.2005.01.077; Zahn R, 2007, P NATL ACAD SCI USA, V104, P6430, DOI 10.1073/pnas.0607061104; Zhang S, 2012, NEUROIMAGE, V59, P3548, DOI 10.1016/j.neuroimage.2011.11.023	82	15	15	1	2	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	OCT 11	2017	11								489	10.3389/fnhum.2017.00489			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	FJ4MD	WOS:000412712400001	29085289	Green Published, gold			2022-02-06	
J	Chapman, SB; Spence, JS; Aslan, S; Keebler, MW				Chapman, Sandra B.; Spence, Jeffrey S.; Aslan, Sina; Keebler, Molly W.			Enhancing Innovation and Underlying Neural Mechanisms Via Cognitive Training in Healthy Older Adults	FRONTIERS IN AGING NEUROSCIENCE			English	Article						innovation; cognitive training; aging; creativity; CBF; functional connectivity; reasoning training; randomized trial	DEFAULT MODE NETWORK; TRAUMATIC BRAIN-INJURY; AGE-RELATED-CHANGES; FUNCTIONAL CONNECTIVITY; DIVERGENT THINKING; LIFE-SPAN; CREATIVE-THINKING; MEMORY; PLASTICITY; VARIABLES	Non-invasive interventions, such as cognitive training (CT) and physical exercise, are gaining momentum as ways to augment both cognitive and brain function throughout life. One of the most fundamental yet little studied aspects of human cognition is innovative thinking, especially in older adults. In this study, we utilize a measure of innovative cognition that examines both the quantity and quality of abstracted interpretations. This randomized pilot trial in cognitively normal adults (56-75 years) compared the effect of cognitive reasoning training (SMART) on innovative cognition as measured by Multiple Interpretations Measure (MIM). We also examined brain changes in relation to MIM using two MRI-based measurement of arterial spin labeling (ASL) to measure cerebral blood flow (CBF) and functional connectivity MRI (fcMRI) to measure default mode and central executive network (CEN) synchrony at rest. Participants (N = 58) were randomized to the CT, physical exercise (physical training, PT) or control (CN) group where CT and PT groups received training for 3 h/week over 12 weeks. They were assessed at baseline-, mid-and post-training using innovative cognition and MRI measures. First, the CT group showed significant gains pre- to post-training on the innovation measure whereas the physical exercise and control groups failed to show significant gains. Next, the CT group showed increased CBF in medial orbitofrontal cortex (mOFC) and bilateral posterior cingulate cortex (PCC), two nodes within the Default Mode Network (DMN) compared to physical exercise and control groups. Last, significant correlations were found between innovation performance and connectivity of two major networks: CEN (positive correlation) and DMN (negative correlation). These results support the view that both the CEN and DMN are important for enhancement of innovative cognition. We propose that neural mechanisms in healthy older adults can be modified through reasoning training to better subserve enhanced innovative cognition.	[Chapman, Sandra B.; Spence, Jeffrey S.; Aslan, Sina; Keebler, Molly W.] Univ Texas Dallas, Dept Behav & Brain Sci, Ctr BrainHlth, Dallas, TX 75275 USA; [Aslan, Sina] Adv MRI LLC, Frisco, TX USA		Chapman, SB (corresponding author), Univ Texas Dallas, Dept Behav & Brain Sci, Ctr BrainHlth, Dallas, TX 75275 USA.	schapman@utdallas.edu			National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [RC1-AG035954, R01-NS067015, R01-AG033106]; T. Boone Pickens Foundation; Lyda Hill Foundation; Dee Wyly Distinguished University Endowment; Dee Wyly Distinguished University Endowed Chair; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS067015] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [RC1AG035954, R01AG033106] Funding Source: NIH RePORTER	This work was supported by a grant from the National Institute of Health (RC1-AG035954, R01-NS067015, R01-AG033106) and by grants from the T. Boone Pickens Foundation, the Lyda Hill Foundation and Dee Wyly Distinguished University Endowment. Funding to pay the Open Access publication charges for this article was provided by funds from the Dee Wyly Distinguished University Endowed Chair held by SBC.	ALPAUGH PK, 1977, HUM DEV, V20, P240, DOI 10.1159/000271559; Anguera JA, 2013, NATURE, V501, P97, DOI 10.1038/nature12486; Aslan S, 2010, MAGN RESON MED, V63, P765, DOI 10.1002/mrm.22245; Baer J, 2006, INTERNATIONAL HANDBOOK OF CREATIVITY, P10; Ball K, 2010, J AM GERIATR SOC, V58, P2107, DOI 10.1111/j.1532-5415.2010.03138.x; Baltes PB, 1999, ANNU REV PSYCHOL, V50, P471, DOI 10.1146/annurev.psych.50.1.471; Beaty RE, 2016, TRENDS COGN SCI, V20, P87, DOI 10.1016/j.tics.2015.10.004; Benedek M, 2014, NEUROIMAGE, V88, P125, DOI 10.1016/j.neuroimage.2013.11.021; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Bonnelle V, 2011, J NEUROSCI, V31, P13442, DOI 10.1523/JNEUROSCI.1163-11.2011; BORG G, 1990, SCAND J WORK ENV HEA, V16, P55, DOI 10.5271/sjweh.1815; Chapman SB, 2016, FRONT HUM NEUROSCI, V10, DOI 10.3389/fnhum.2016.00338; Chapman SB, 2015, CEREB CORTEX, V25, P396, DOI 10.1093/cercor/bht234; Chapman SB, 2014, FRONT SYST NEUROSCI, V8, DOI 10.3389/fnsys.2014.00069; Chapman SB, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00075; Elgamal SA, 2011, CAN GERIATR J, V14, P66, DOI 10.5770/cgj.v14i3.17; Fink A, 2015, HUM BRAIN MAPP, V36, P4104, DOI 10.1002/hbm.22901; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Geerligs L, 2015, CEREB CORTEX, V25, P1987, DOI 10.1093/cercor/bhu012; Green AE, 2015, HUM BRAIN MAPP, V36, P923, DOI 10.1002/hbm.22676; Greenwood PM, 2010, FRONT AGING NEUROSCI, V2, DOI 10.3389/fnagi.2010.00150; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Guilford J. P., 1967, NATURE HUMAN INTELLI; Hafkemeijer A, 2012, BBA-MOL BASIS DIS, V1822, P431, DOI 10.1016/j.bbadis.2011.07.008; Heilman KM, 2016, ARCH CLIN NEUROPSYCH, V31, P285, DOI 10.1093/arclin/acw009; Hohenfeld C, 2017, FRONT NEUROL, V8, DOI 10.3389/fneur.2017.00384; Jung RE, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00330; Kennedy KM, 2009, NEUROPSYCHOLOGIA, V47, P916, DOI 10.1016/j.neuropsychologia.2009.01.001; Kim KH, 2011, CREATIVITY RES J, V23, P285, DOI 10.1080/10400419.2011.627805; Kramer AF, 1999, NATURE, V400, P418, DOI 10.1038/22682; Levine B, 2000, J INT NEUROPSYCH SOC, V6, P299, DOI 10.1017/S1355617700633052; Li WF, 2015, SOC COGN AFFECT NEUR, V10, P191, DOI 10.1093/scan/nsu041; Lu HZ, 2011, CEREB CORTEX, V21, P1426, DOI 10.1093/cercor/bhq224; Mahncke HW, 2006, PROG BRAIN RES, V157, P81, DOI 10.1016/S0079-6123(06)57006-2; Mahncke HW, 2006, P NATL ACAD SCI USA, V103, P12523, DOI 10.1073/pnas.0605194103; Massimiliano P, 2015, HIGH ABIL STUD, V26, P93, DOI 10.1080/13598139.2015.1029117; Mayseless N, 2015, NEUROIMAGE, V116, P232, DOI 10.1016/j.neuroimage.2015.05.030; MCCRAE RR, 1987, PSYCHOL AGING, V2, P130, DOI 10.1037/0882-7974.2.2.130; McFadden SH, 2010, CLIN GERIATR MED, V26, P149, DOI 10.1016/j.cger.2009.11.004; Palmiero M, 2017, EXP BRAIN RES, V235, P1021, DOI 10.1007/s00221-016-4857-4; Raz N, 1997, CEREB CORTEX, V7, P268, DOI 10.1093/cercor/7.3.268; Rebok GW, 2014, J AM GERIATR SOC, V62, P16, DOI 10.1111/jgs.12607; Reese HW, 2001, INT J BEHAV DEV, V25, P491, DOI 10.1080/01650250042000483; Roskos-Ewoldsen B, 2008, J CREATIVE BEHAV, V42, P33, DOI 10.1002/j.2162-6057.2008.tb01079.x; Runco MA, 2012, CREATIVITY RES J, V24, P92, DOI 10.1080/10400419.2012.650092; Saggar M, 2017, CEREB CORTEX, V27, P3542, DOI 10.1093/cercor/bhw171; Sambataro F, 2010, NEUROBIOL AGING, V31, P839, DOI 10.1016/j.neurobiolaging.2008.05.022; Takeuchi H, 2012, CEREB CORTEX, V22, P2921, DOI 10.1093/cercor/bhr371; WALLACH MA, 1968, AM EDUC RES J, V5, P272, DOI 10.3102/00028312005002272	49	15	17	1	19	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1663-4365			FRONT AGING NEUROSCI	Front. Aging Neurosci.	OCT 9	2017	9								314	10.3389/fnagi.2017.00314			11	Geriatrics & Gerontology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Neurosciences & Neurology	FJ1HS	WOS:000412466400001	29062276	Green Published, gold			2022-02-06	
J	Burke, D; Linder, S; Hirsch, J; Dey, T; Kana, D; Ringenbach, S; Schindler, D; Alberts, J				Burke, Daniel; Linder, Susan; Hirsch, Joshua; Dey, Tanujit; Kana, Daniel; Ringenbach, Shannon; Schindler, David; Alberts, Jay			Characterizing Information Processing With a Mobile Device: Measurement of Simple and Choice Reaction Time	ASSESSMENT			English	Article						information processing; reaction time; mobile technology; cognitive assessment	PARKINSONS-DISEASE; HEAD-INJURY; PERFORMANCE; ATTENTION; ACCURACY; DEFICITS; SPEED; RELIABILITY; CONCUSSION; COMPLEXITY	Information processing is typically evaluated using simple reaction time (SRT) and choice reaction time (CRT) paradigms in which a specific response is initiated following a given stimulus. The measurement of reaction time (RT) has evolved from monitoring the timing of mechanical switches to computerized paradigms. The proliferation of mobile devices with touch screens makes them a natural next technological approach to assess information processing. The aims of this study were to determine the validity and reliability of using of a mobile device (Apple iPad or iTouch) to accurately measure RT. Sixty healthy young adults completed SRT and CRT tasks using a traditional test platform and mobile platforms on two occasions. The SRT was similar across test modality: 300, 287, and 280 milliseconds (ms) for the traditional, iPad, and iTouch, respectively. The CRT was similar within mobile devices, though slightly faster on the traditional: 359, 408, and 384 ms for traditional, iPad, and iTouch, respectively. Intraclass correlation coefficients ranged from 0.79 to 0.85 for SRT and from 0.75 to 0.83 for CRT. The similarity and reliability of SRT across platforms and consistency of SRT and CRT across test conditions indicate that mobile devices provide the next generation of assessment platforms for information processing.	[Burke, Daniel; Linder, Susan; Hirsch, Joshua; Dey, Tanujit; Kana, Daniel; Schindler, David; Alberts, Jay] Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA; [Ringenbach, Shannon] Arizona State Univ, Phoenix, AZ USA		Alberts, J (corresponding author), Cleveland Clin, 9500 Euclid Ave, Cleveland, OH 44195 USA.	albertj@ccf.org			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01-NS058706, R01-NS673717]; Edward and Barbara Bell Family	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by the National Institutes of Health (Grants R01-NS058706, R01-NS673717 to JLA) and the Edward and Barbara Bell Family.	Barbarotto R, 1998, ITAL J NEUROL SCI, V19, P161, DOI 10.1007/BF00831566; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; BERKSON G, 1960, J MENT DEFIC RES, V4, P59; BLOXHAM CA, 1987, J NEUROL NEUROSUR PS, V50, P1178, DOI 10.1136/jnnp.50.9.1178; DeLuca J, 2004, J INT NEUROPSYCH SOC, V10, P101; EVARTS EV, 1981, BRAIN, V104, P167, DOI 10.1093/brain/104.1.167; FITTS PM, 1966, J EXP PSYCHOL, V71, P849, DOI 10.1037/h0023232; Gauntlett-Gilbert J, 1998, NEUROSCI BIOBEHAV R, V22, P865, DOI 10.1016/S0149-7634(98)00014-1; Gonzalez R, 2003, J INT NEUROPSYCH SOC, V9, P64, DOI 10.1017/S1355617703910071; HAMSHER KDS, 1977, CORTEX, V13, P306; Heinemann A., 2014, REHABILITATION MEASU; Hervey AS, 2006, CHILD NEUROPSYCHOL, V12, P125, DOI 10.1080/09297040500499081; Hick WE, 1952, Q J EXP PSYCHOL, V4, P11, DOI 10.1080/17470215208416600; Hunt TN, 2007, ARCH CLIN NEUROPSYCH, V22, P615, DOI 10.1016/j.acn.2007.04.005; JAHANSHAHI M, 1992, BRAIN, V115, P539, DOI 10.1093/brain/115.2.539; Kay M., 2013, 7 INT C PERV COMP TE; KLAPP ST, 1995, J EXP PSYCHOL HUMAN, V21, P1015, DOI 10.1037/0096-1523.21.5.1015; Lafayette Instrument, 2004, VIS CHOIC REACT TIM; Laming D.R.J., 1968, INFORM THEORY CHOICE; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Luce RD, 1986, RESPONSE TIMES THEIR; MCDONALD RD, 1964, J NERV MENT DIS, V138, P241, DOI 10.1097/00005053-196403000-00004; Miller JO, 2001, J EXP PSYCHOL HUMAN, V27, P266, DOI 10.1037//0096-1523.27.2.266; NIEMI P, 1981, PSYCHOL BULL, V89, P133, DOI 10.1037/0033-2909.89.1.133; OLBRICH R, 1972, J NERV MENT DIS, V155, P356; PONSFORD J, 1992, J CLIN EXP NEUROPSYC, V14, P822, DOI 10.1080/01688639208402865; RATCLIFF R, 1993, PSYCHOL BULL, V114, P510, DOI 10.1037/0033-2909.114.3.510; Reicker LI, 2007, ARCH CLIN NEUROPSYCH, V22, P655, DOI 10.1016/j.acn.2007.04.008; REPPERGER DW, 1985, J MED ENG TECHNOL, V9, P270, DOI 10.3109/03091908509032111; Rosenbaum DA, 2010, HUMAN MOTOR CONTROL, 2ND EDITION, P1; Schatz P, 2015, ASSESSMENT, V22, P405, DOI 10.1177/1073191114566622; Schwenk M, 2012, PHYSIOL MEAS, V33, P1931, DOI 10.1088/0967-3334/33/11/1931; STUSS DT, 1989, J NEUROL NEUROSUR PS, V52, P742, DOI 10.1136/jnnp.52.6.742; STUSS DT, 1989, CAN J NEUROL SCI, V16, P161, DOI 10.1017/S0317167100028833; TEICHNER WH, 1974, PSYCHOL REV, V81, P75, DOI 10.1037/h0035867; Thomas J., 1997, HIST EXERCISE SPORT; Thomas JR, 2010, RES METHODS PHYS ACT; Tun PA, 2008, DEV PSYCHOL, V44, P1421, DOI 10.1037/a0012845; Warden DL, 2001, NEUROLOGY, V57, P524, DOI 10.1212/WNL.57.3.524; Welford A.T., 1980, REACTION TIMES; WELFORD AT, 1984, EXP AGING RES, V10, P73, DOI 10.1080/03610738408258548; WELFORD AT, 1988, ANN NY ACAD SCI, V515, P1, DOI 10.1111/j.1749-6632.1988.tb32958.x; Whelan R, 2008, PSYCHOL REC, V58, P475, DOI 10.1007/BF03395630; Wrisberg, 2000, MOTOR LEARNING PERFO	44	15	15	3	13	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1073-1911	1552-3489		ASSESSMENT	Assessment	OCT	2017	24	7					885	895		10.1177/1073191116633752			11	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	FH4LC	WOS:000411124400004	26933140				2022-02-06	
J	Katiyar, KS; Winter, CC; Struzyna, LA; Harris, JP; Cullen, DK				Katiyar, Kritika S.; Winter, Carla C.; Struzyna, Laura A.; Harris, James P.; Cullen, D. Kacy			Mechanical elongation of astrocyte processes to create living scaffolds for nervous system regeneration	JOURNAL OF TISSUE ENGINEERING AND REGENERATIVE MEDICINE			English	Article						astrocyte; tissue engineering; cell transplant; regeneration; neurotrauma; neurodegeneration	IN-VITRO; ENGINEERED CONSTRUCTS; CELL-CULTURES; INJURY MODEL; BRAIN-INJURY; RADIAL GLIA; TISSUE; GROWTH; STRETCH; AXONS	Following brain injury or neurodegenerative disease, successful regeneration requires orchestrated migration of neurons and reformation of long-distance communication fibres, or axons. Such extensive regeneration does not occur in the mature brain; however, during embryonic development, pathways formed by glial cells extend several millimeters (mm) to create 'living scaffolds' for targeted neural cell migration and axonal pathfinding. Techniques to recapitulate long process outgrowth in glial cells have proven elusive, preventing the exploitation of this developmental mechanism for regeneration. In the current study, astrocytes were induced to form a network of interconnected processes that were subjected to controlled mechanical tension in vitro using custom-built mechanobioreactors. We discovered a specific micron (mu m)-scale mechanical growth regime that induced elongation of the astrocytic processes to a remarkable length of 2.5 mm at an optimal rate of 12.5 mu m/h. More rapid mechanical regimes (> 20 mu m/h) caused greater incidence of process degeneration or outright breakage, whereas slow regimes (< 4 mu m/h) led to adaptive motility, thus failing to achieve process elongation. Cellular phenotype for this astrocytic 'stretch-growth' was confirmed based on presentation of the intermediate filament glial fibrillary acidic protein (GFAP). Mechanical elongation resulted in the formation of dense bundles of aligned astrocytic processes. Importantly, seeded neurons readily adhered to, and extended neurites directly along, the elongated astrocytic processes, demonstrating permissiveness to support neuronal growth. This is the first demonstration of the controlled application ofmechanical forces to create long astrocytic processes, which may form the backbone of tissue-engineered 'living scaffolds' that structurally emulate radial glia to facilitate neuroregeneration. Copyright (C) 2016 John Wiley & Sons, Ltd.	[Katiyar, Kritika S.; Winter, Carla C.; Struzyna, Laura A.; Harris, James P.; Cullen, D. Kacy] Univ Penn, Dept Neurosurg, Perelman Sch Med, Ctr Brain Injury & Repair, Philadelphia, PA 19104 USA; [Katiyar, Kritika S.] Drexel Univ, Sch Biomed Engn, Philadelphia, PA 19104 USA; [Struzyna, Laura A.; Harris, James P.; Cullen, D. Kacy] Philadelphia Vet Affairs Med Ctr, Philadelphia, PA USA		Cullen, DK (corresponding author), 105 E Hayden Hall,3320 Smith Walk, Philadelphia, PA 19104 USA.	dkacy@mail.med.upenn.edu		Harris, James/0000-0002-8458-5434	US Army Medical Research and Materiel Command through Joint Warfighter Medical Research Program [W81XWH-13-207004]; National Science FoundationNational Science Foundation (NSF) [DGE-1321851]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [T32-NS043126]; Department of Veterans AffairsUS Department of Veterans Affairs [B1097-I]; Penn Medicine Neuroscience Center; Penn's Center for Undergraduate Research and Fellowships; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS094340, F31NS090746, T32NS043126] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX003748] Funding Source: NIH RePORTER	Financial support was provided by the US Army Medical Research and Materiel Command through the Joint Warfighter Medical Research Program (Grant No. W81XWH-13-207004), the National Science Foundation (Graduate Research Fellowship No. DGE-1321851), the National Institutes of Health (NIH; Grant No. T32-NS043126), the Department of Veterans Affairs (RR&D Merit Review No. B1097-I), the Penn Medicine Neuroscience Center, and Penn's Center for Undergraduate Research and Fellowships.	Ahmed SM, 2000, J NEUROCHEM, V74, P1951, DOI 10.1046/j.1471-4159.2000.0741951.x; Alexander JK, 2006, NEURON GLIA BIOL, V2, P93, DOI 10.1017/S1740925X0600010X; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cullen DK, 2007, J NEUROSCI RES, V85, P3642, DOI 10.1002/jnr.21434; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Cullen DK, 2007, J NEURAL ENG, V4, P159, DOI 10.1088/1741-2560/4/2/015; Cullen DK, 2012, TISSUE ENG PT A, V18, P2280, DOI [10.1089/ten.tea.2011.0534, 10.1089/ten.TEA.2011.0534]; Cullen D. Kacy, 2011, Critical Reviews in Biomedical Engineering, V39, P201; Cullen D Kacy, 2006, Conf Proc IEEE Eng Med Biol Soc, V2006, P636; East E, 2010, TISSUE ENG PT A, V16, P3173, DOI 10.1089/ten.tea.2010.0017; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; Filous AR, 2010, DEV NEUROBIOL, V70, P826, DOI 10.1002/dneu.20820; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; GAUL G, 1992, P ROY SOC B-BIOL SCI, V249, P57, DOI 10.1098/rspb.1992.0083; Harris JP, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/1/016019; HATTEN ME, 1990, EXPERIENTIA, V46, P907, DOI 10.1007/BF01939383; Huang JH, 2009, TISSUE ENG PT A, V15, P1677, DOI 10.1089/ten.tea.2008.0294; Irons HR, 2008, J NEURAL ENG, V5, P333, DOI 10.1088/1741-2560/5/3/006; JACOBS JR, 1989, J NEUROSCI, V9, P2402; JAEGER CB, 1988, GLIA, V1, P31, DOI 10.1002/glia.440010105; JOOSTEN EAJ, 1989, NEUROSCIENCE, V31, P439, DOI 10.1016/0306-4522(89)90386-2; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Leavitt BR, 1999, EXP NEUROL, V157, P43, DOI 10.1006/exnr.1999.6982; Liverman CT, 2005, SPINAL CORD INJURY P; Mattotti M, 2012, BIOMATERIALS, V33, P1759, DOI 10.1016/j.biomaterials.2011.10.086; MCCARTHY KD, 1980, J CELL BIOL, V85, P890, DOI 10.1083/jcb.85.3.890; MEANEY DF, 1995, J NEUROTRAUM, V12, P689, DOI 10.1089/neu.1995.12.689; Miller WJ, 2009, J NEUROTRAUM, V26, P789, DOI [10.1089/neu.2008.0727, 10.1089/neu.2008-0727]; Pfister BJ, 2004, J NEUROSCI, V24, P7978, DOI 10.1523/JNEUROSCI.1974-04.2004; Pfister BJ, 2006, J NEUROSCI METH, V153, P95, DOI 10.1016/j.jneumeth.2005.10.012; PIXLEY SKR, 1987, J NEUROSCI RES, V18, P402, DOI 10.1002/jnr.490180304; Recknor JB, 2004, BIOMATERIALS, V25, P2753, DOI 10.1016/j.biomaterials.2003.11.045; Scemes E, 2012, FRONT NEUROSCI, P1; Smith DH, 2009, PROG NEUROBIOL, V89, P231, DOI 10.1016/j.pneurobio.2009.07.006; Stiles J, 2010, NEUROPSYCHOL REV, V20, P327, DOI 10.1007/s11065-010-9148-4; Struzyna LA, 2015, TISSUE ENG PT A, V21, P2744, DOI [10.1089/ten.tea.2014.0557, 10.1089/ten.TEA.2014.0557]; Struzyna LA, 2015, NEURAL REGEN RES, V10, P679, DOI 10.4103/1673-5374.156943; Struzyna LA, 2014, CURR OPIN SOLID ST M, V18, P308, DOI 10.1016/j.cossms.2014.07.004; Vukasinovic J, 2009, BIOMED MICRODEVICES, V11, P1155, DOI 10.1007/s10544-009-9332-6; Yiu G, 2006, NAT REV NEUROSCI, V7, P617, DOI 10.1038/nrn1956; Yu T, 2006, J CELL BIOCHEM, V99, P1096, DOI 10.1002/jcb.20979; ZHOU HF, 1990, J COMP NEUROL, V292, P320, DOI 10.1002/cne.902920213	42	15	15	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1932-6254	1932-7005		J TISSUE ENG REGEN M	J. Tissue Eng. Regen. Med.	OCT	2017	11	10					2737	2751		10.1002/term.2168			15	Cell & Tissue Engineering; Biotechnology & Applied Microbiology; Cell Biology; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Biotechnology & Applied Microbiology; Engineering	FL5LO	WOS:000414287300005	27273796	Green Accepted, Bronze			2022-02-06	
J	Tan, DH; Yu, XP; Chen, MR; Chen, JC; Xu, JC				Tan, Dianhui; Yu, Xiaoping; Chen, Moran; Chen, Junchen; Xu, Jincheng			Lutein protects against severe traumatic brain injury through anti-inflammation and antioxidative effects via ICAM-1/Nrf-2	MOLECULAR MEDICINE REPORTS			English	Article						lutein; severe traumatic brain injury; anti-inflammation; antioxidative; intercellular adhesion molecule-1; nuclear factor erythroid 2 like 2	MODULATING OXIDATIVE STRESS; KAPPA-B ACTIVATION; ISCHEMIA/REPERFUSION INJURY; RAT-BRAIN; NRF2; INHIBITION; EXPRESSION; COMPONENTS; DISEASE; VI	Many studies have reported that lutein may exert its biological activities, including anti-inflammation, anti-oxidase and anti-apoptosis, through effects on reactive oxygen species (ROS). Thus, lutein may prevent the damaging activities of ROS in cells. The current study investigated the effect of lutein against severe traumatic brain injury (STBI) and examined the mechanism of this protective effect. Sprague-Dawley rats were randomly divided into 5 groups: Control group, STBI model group, 40 mg/kg lutein-treated group, 80 mg/kg lutein-treated group and 160 mg/kg lutein-treated group. In this study, lutein protects against STBI, suppressed, interleukin (IL) -1 beta, IL-6 and monocyte chemoattractant protein-1 expression, reduced serum ROS levels, and reduced superoxide dismutase and glutathione peroxidase activities in STBI rats. Treatment with lutein effectively downregulated the expression of NF-kappa B p65 and cyclooxygenase-2, intercellular adhesion molecule (ICAM)-1 protein, and upregulated nuclear factor erythroid 2 like 2 (Nrf-2) and endothelin-1 protein levels in STBI rats. These findings demonstrated that lutein protects against STBI, has anti-inflammation and antioxidative effects and alters ICAM-1/Nrf-2 expression, which may be a novel therapeutic for STBI the clinic.	[Tan, Dianhui; Yu, Xiaoping; Chen, Moran; Chen, Junchen; Xu, Jincheng] Shantou Univ, Affiliated Hosp 1, Dept Neurosurg, Med Coll, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China		Xu, JC (corresponding author), Shantou Univ, Affiliated Hosp 1, Dept Neurosurg, Med Coll, 57 Changping Rd, Shantou 515041, Guangdong, Peoples R China.	jinchengxunb@163.com			Youth Innovative Talents Program of Colleges and Universities in Guangdong Province of China [924-38240211]	The study was supported by the Youth Innovative Talents Program of Colleges and Universities in Guangdong Province of China (no. 924-38240211).	Ahn Edward S, 2005, Clin Neurosurg, V52, P348; Bar-Or D, 2015, REDOX BIOL, V4, P340, DOI 10.1016/j.redox.2015.01.006; Cerecedo-Lopez CD, 2014, MED HYPOTHESES, V82, P171, DOI 10.1016/j.mehy.2013.11.028; Cheng F, 2015, IMMUNOPHARM IMMUNOT, V37, P329, DOI 10.3109/08923973.2015.1049704; Chu WH, 2013, J TRAUMA ACUTE CARE, V74, P1446, DOI 10.1097/TA.0b013e31829246ad; Djordjevic J, 2016, CURR ALZHEIMER RES, V13, P730, DOI 10.2174/1567205013666160222110320; Du SY, 2015, INT J CLIN EXP MED, V8, P8785; Feng D, 2014, NEUROSCIENCE, V268, P21, DOI 10.1016/j.neuroscience.2014.02.053; Guan FQ, 2014, BIOMED REP, V2, P760, DOI 10.3892/br.2014.314; Hsieh HL, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-152; Jin W, 2008, ANN CLIN LAB SCI, V38, P221; Jin W, 2008, MEDIAT INFLAMM, V2008, DOI 10.1155/2008/725174; Khan F, 2016, J REHABIL MED, V48, P442, DOI 10.2340/16501977-2084; Kouloulas EJ, 2013, INT J REHABIL RES, V36, P260, DOI 10.1097/MRR.0b013e32835fd99a; Kumar RG, 2016, BRAIN BEHAV IMMUN, V53, P183, DOI 10.1016/j.bbi.2015.12.008; Lee KM, 2015, BMC COMPLEM ALTERN M, V15, DOI 10.1186/s12906-015-0652-1; Li JY, 2016, J EXP CLIN CANC RES, V35, DOI 10.1186/s13046-016-0331-1; Li SG, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/315205; Liu ZG, 2015, MOL MED REP, V11, P2179, DOI 10.3892/mmr.2014.2982; Saraiva ALL, 2012, BRAIN RES BULL, V87, P180, DOI 10.1016/j.brainresbull.2011.10.010; Lu XY, 2015, CELL MOL NEUROBIOL, V35, P713, DOI 10.1007/s10571-015-0167-9; Lustenberger T, 2016, IMMUNOBIOLOGY, V221, P427, DOI 10.1016/j.imbio.2015.11.011; Lv R, 2008, CROAT MED J, V49, P22, DOI 10.3325/cmj.2008.1.22; Manevich Y, 2014, FREE RADICAL BIO MED, V72, P210, DOI 10.1016/j.freeradbiomed.2014.04.002; McMahon PJ, 2015, J NEUROTRAUM, V32, P527, DOI 10.1089/neu.2014.3635; Nayak CD, 2008, NEUROL INDIA, V56, P31, DOI 10.4103/0028-3886.39309; Niso-Santano M, 2012, AUTOPHAGY, V8, P268, DOI 10.4161/auto.8.2.18845; Petronilho F, 2010, J SURG RES, V164, P316, DOI 10.1016/j.jss.2009.04.031; Rhind SG, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-5; Shu LF, 2016, NEUROSCI LETT, V611, P74, DOI 10.1016/j.neulet.2015.11.012; Wade SL, 2015, J NEUROTRAUM, V32, P967, DOI 10.1089/neu.2014.3684; Wang S, 2014, EUR REV MED PHARMACO, V18, P359; Xu PF, 2015, BRAIN BEHAV IMMUN, V50, P87, DOI 10.1016/j.bbi.2015.06.020; Yin Xiao-Ping, 2015, Drug Des Devel Ther, V9, P5973, DOI 10.2147/DDDT.S79399	34	15	16	3	7	SPANDIDOS PUBL LTD	ATHENS	POB 18179, ATHENS, 116 10, GREECE	1791-2997	1791-3004		MOL MED REP	Mol. Med. Rep.	OCT	2017	16	4					4235	4240		10.3892/mmr.2017.7040			6	Oncology; Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Research & Experimental Medicine	FG9JA	WOS:000410753800070	28731190	Bronze			2022-02-06	
J	Shahim, P; Holleran, L; Kim, JH; Brody, DL				Shahim, Pashtun; Holleran, Laurena; Kim, Joong H.; Brody, David L.			Test-retest reliability of high spatial resolution diffusion tensor and diffusion kurtosis imaging	SCIENTIFIC REPORTS			English	Article							TRAUMATIC BRAIN-INJURY; PRINCIPAL EIGENVECTOR MEASUREMENTS; FRACTIONAL ANISOTROPY; AXONAL INJURY; NEUROCHEMICAL AFTERMATH; MEAN DIFFUSIVITY; REPRODUCIBILITY; MRI; DAMAGE; TISSUE	We assessed the test-retest reliability of high spatial resolution diffusion tensor imaging (DTI) and diffusion kurtosis imaging (DKI). Diffusion MRI was acquired using a Siemens 3 Tesla Prisma scanner with 80 mT/m gradients and a 32-channel head coil from each of 3 concussive traumatic brain injury (cTBI) patients and 4 controls twice 0 to 24 days apart. Coefficients of variation (CoV) for DTI parameters were calculated in each DTI Studio parcellated white matter tract at 1.25 mm and 1.75 mm isotropic voxel resolution, as well as DKI parameters at 1.75 mm isotropic. Overall, fractional anisotropy had the best reliability, with mean CoV at 5% for 1.25 mm and 3.5% for 1.75 mm isotropic voxels. Mean CoV for the other DTI metrics were <7.0% for both 1.25 and 1.75 mm isotropic voxels. The mean CoV was <= 4.5% across the DKI metrics. In the commonly injured orbitofrontal and temporal pole regions CoV was <3.5% for all parameters. Thus, with appropriate processing, high spatial resolution advanced diffusion MRI has good to excellent test-retest reproducibility in both human cTBI patients and controls. However, further technical improvements will be needed to reliably discern the most subtle diffusion abnormalities, especially at high spatial resolution.	[Shahim, Pashtun; Holleran, Laurena; Kim, Joong H.; Brody, David L.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Shahim, Pashtun] Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden; [Shahim, Pashtun] Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden; [Brody, David L.] Washington Univ, Sch Med, Hope Ctr Neurol Disorders, St Louis, MO USA		Shahim, P (corresponding author), Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA.; Shahim, P (corresponding author), Univ Gothenburg, Inst Neurosci & Physiol, Dept Psychiat & Neurochem, Sahlgrenska Acad, Molndal, Sweden.; Shahim, P (corresponding author), Sahlgrens Univ Hosp, Clin Neurochem Lab, Molndal, Sweden.	shahimp@wustl.edu			Health South Inc.; NIH U01United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Mallinckrodt Institute of Radiology	We would like to thank the study participants. We would also like to thank Linda Hood and Mark Harms at Mallinckrodt Institute of Radiology for technical assistance in acquiring the diffusion images, Shiran Su for assistance with test-retest reliability, and Dr. Carlo Pierpaoli for technical assistance with regard to the MRI data analysis protocol. The study was funded by Health South Inc., NIH U01, and Mallinckrodt Institute of Radiology.	Acheson A, 2017, BRAIN BEHAV, V7, DOI 10.1002/brb3.615; Adam O, 2015, NEUROLOGY, V85, P219, DOI 10.1212/WNL.0000000000001758; Alexander AL, 2007, NEUROTHERAPEUTICS, V4, P316, DOI 10.1016/j.nurt.2007.05.011; Assaf Y, 2008, J MOL NEUROSCI, V34, P51, DOI 10.1007/s12031-007-0029-0; BASSER PJ, 1994, BIOPHYS J, V66, P259, DOI 10.1016/S0006-3495(94)80775-1; Basser PJ, 2002, NMR BIOMED, V15, P456, DOI 10.1002/nbm.783; BASSER PJ, 1994, J MAGN RESON SER B, V103, P247, DOI 10.1006/jmrb.1994.1037; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Blain CRV, 2006, NEUROLOGY, V67, P2199, DOI 10.1212/01.wnl.0000249307.59950.f8; Blennow K, 2016, NAT REV DIS PRIMERS, V2, DOI 10.1038/nrdp.2016.84; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Bonekamp D, 2007, NEUROIMAGE, V34, P733, DOI 10.1016/j.neuroimage.2006.09.020; Chang LC, 2005, MAGN RESON MED, V53, P1088, DOI 10.1002/mrm.20426; Farrell JAD, 2007, J MAGN RESON IMAGING, V26, P756, DOI 10.1002/jmri.21053; Fox RJ, 2012, AM J NEURORADIOL, V33, P695, DOI 10.3174/ajnr.A2844; Grinberg F, 2011, NEUROIMAGE, V57, P1087, DOI 10.1016/j.neuroimage.2011.04.050; Heiervang E, 2006, NEUROIMAGE, V33, P867, DOI 10.1016/j.neuroimage.2006.07.037; Hellyer PJ, 2013, ANN NEUROL, V73, P489, DOI 10.1002/ana.23824; Holleran L, 2017, ACTA NEUROPATHOL, V133, P367, DOI 10.1007/s00401-017-1686-x; Irfanoglu MO, 2015, NEUROIMAGE, V106, P284, DOI 10.1016/j.neuroimage.2014.11.042; Irfanoglu MO, 2014, LECT NOTES COMPUT SC, V8673, P218, DOI 10.1007/978-3-319-10404-1_28; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Jezzard P, 1998, MAGNET RESON MED, V39, P801, DOI 10.1002/mrm.1910390518; Kantarci K, 2014, JAMA NEUROL, V71, P1547, DOI 10.1001/jamaneurol.2014.1482; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Landman BA, 2007, NEUROIMAGE, V36, P1123, DOI 10.1016/j.neuroimage.2007.02.056; Lawrenz M, 2015, NEUROIMAGE, V109, P283, DOI 10.1016/j.neuroimage.2015.01.025; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Mori S., 2010, MRI ATLAS HUMAN WHIT; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mysliwiec V, 2013, SLEEP, V36, P167, DOI 10.5665/sleep.2364; OTSU N, 1979, IEEE T SYST MAN CYB, V9, P62, DOI 10.1109/TSMC.1979.4310076; Palacios E. M., 2016, AJNR AM J NEURORADIO; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Shahim P, 2016, JAMA NEUROL, V73, P1308, DOI 10.1001/jamaneurol.2016.2038; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Sotiropoulos SN, 2013, NEUROIMAGE, V80, P125, DOI 10.1016/j.neuroimage.2013.05.057; Taylor PA, 2016, HUM BRAIN MAPP, V37, P4405, DOI 10.1002/hbm.23318; Tu TW, 2016, ANN NEUROL, V79, P907, DOI 10.1002/ana.24641; Veenith TV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065941; Veraart J, 2013, NEUROIMAGE, V81, P335, DOI 10.1016/j.neuroimage.2013.05.028; Veraart J, 2011, MAGN RESON MED, V65, P138, DOI 10.1002/mrm.22603; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Wu WC, 2016, NEUROIMAGE, V143, P1, DOI 10.1016/j.neuroimage.2016.08.054; Zetterberg H, 2006, ARCH NEUROL-CHICAGO, V63, P1277, DOI 10.1001/archneur.63.9.1277; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	52	15	15	3	5	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	SEP 11	2017	7								11141	10.1038/s41598-017-11747-3			14	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FG3LX	WOS:000410063400070	28894296	Green Published, gold			2022-02-06	
J	Zhou, J; Burns, MP; Huynh, L; Villapol, S; Taub, DD; Saavedra, JM; Blackman, MR				Zhou, June; Burns, Mark P.; Huynh, Linda; Villapol, Sonia; Taub, Daniel D.; Saavedra, Juan M.; Blackman, Marc R.			Temporal changes in cortical and hippocampal expression of genes important for Brain glucose Metabolism Following controlled cortical impact injury in Mice	FRONTIERS IN ENDOCRINOLOGY			English	Article						gene expression; glucose metabolism; lactate; hexokinase; GPR81; angiotensin II AT1 receptor; telmisartan; traumatic brain injury	SPONTANEOUSLY HYPERTENSIVE-RATS; POSITRON-EMISSION-TOMOGRAPHY; RECEPTOR-GAMMA ACTIVATION; ALZHEIMERS-DISEASE; ENERGY-METABOLISM; DIABETIC MICE; IN-VIVO; LACTATE; BLOCKADE; TRAUMA	Traumatic brain injury (TBI) causes transient increases and subsequent decreases in brain glucose utilization. The underlying molecular pathways are orchestrated processes and poorly understood. In the current study, we determined temporal changes in cortical and hippocampal expression of genes important for brain glucose/lactate metabolism and the effect of a known neuroprotective drug telmisartan on the expression of these genes after experimental TBI. Adult male C57BL/6J mice (n = 6/group) underwent sham or unilateral controlled cortical impact (CCI) injury. Their ipsilateral and contralateral cortex and hippocampus were collected 6 h, 1, 3, 7, 14, 21, and 28 days after injury. Expressions of several genes important for brain glucose utilization were determined by qRT-PCR. In results, (1) mRNA levels of three key enzymes in glucose metabolism [ hexo kinase (HK) 1, pyruvate kinase, and pyruvate dehydrogenase (PDH)] were all increased 6 h after injury in the contralateral cortex, followed by decreases at subsequent times in the ipsilateral cortex and hippocampus; (2) capillary glucose transporter Glut-1 mRNA increased, while neuronal glucose transporter Glut-3 mRNA decreased, at various times in the ipsilateral cortex and hippocampus; (3) astrocyte lactate transporter MCT-1 mRNA increased, whereas neuronal lactate transporter MCT-2 mRNA decreased in the ipsilateral cortex and hippocampus; (4) HK2 (an isoform of hexokinase) expression increased at all time points in the ipsilateral cortex and hippocampus. GPR81 (lactate receptor) mRNA increased at various time points in the ipsilateral cortex and hippocampus. These temporal alterations in gene expression corresponded closely to the patterns of impaired brain glucose utilization reported in both TBI patients and experimental TBI rodents. The observed changes in hippocampal gene expression were delayed and prolonged, when compared with those in the cortex. The patterns of alterations were specific to different brain regions and exhibited different recovery periods following TBI. Oral administration of telmisartan (1 mg/kg, for 7 days, n = 10 per group) ameliorated cortical or hippocampal mRNA for Glut-1/3, MCT-1/2 and PDH in CCI mice. These data provide molecular evidence for dynamic alteration of multiple critical factors in brain glucose metabolism post-TBI and can inform further research for treating brain metabolic disorders post-TBI.	[Zhou, June; Huynh, Linda; Blackman, Marc R.] Washington DC VA Med Ctr, Res Serv, Washington, DC 20422 USA; [Zhou, June; Blackman, Marc R.] George Washington Univ, Dept Biochem & Mol Med, Sch Med, Washington, DC 20052 USA; [Burns, Mark P.; Villapol, Sonia] Georgetown Univ, Sch Med, Dept Neurosci, Washington, DC USA; [Taub, Daniel D.] Washington DC VA Med Ctr, Translat Med Sect, Washington, DC USA; [Taub, Daniel D.] Georgetown Univ, Dept Biochem & Mol & Cell Biol, Sch Med, Washington, DC USA; [Saavedra, Juan M.] Georgetown Univ, Dept Physiol & Pharmacol, Sch Med, Washington, DC USA; [Blackman, Marc R.] George Washington Univ, Dept Med, Sch Med, Washington, DC USA; [Blackman, Marc R.] Georgetown Univ, Dept Med, Sch Med, Washington, DC USA		Zhou, J (corresponding author), Washington DC VA Med Ctr, Res Serv, Washington, DC 20422 USA.; Zhou, J (corresponding author), George Washington Univ, Dept Biochem & Mol Med, Sch Med, Washington, DC 20052 USA.	june.zhou@va.gov	Saavedra, Juan/AAO-7149-2020; Blackman, Marc/AAT-5771-2021; Villapol, Sonia/D-1949-2014	Saavedra, Juan/0000-0002-7238-9647; Villapol, Sonia/0000-0002-6174-4113; Huynh, Linda/0000-0002-8655-8587; Burns, Mark P/0000-0003-4750-2000	National Center for Advancing Translational Sciences (NCATS), NIH, through the Clinical and Translational Science Awards Program; Federal funds [UL1TR000101]; VA Office of Research and Development Biomedical Laboratory Research & Development Program [I01BX007080]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001409] Funding Source: NIH RePORTER	This research was supported by the National Center for Advancing Translational Sciences (NCATS), NIH, through the Clinical and Translational Science Awards Program, Federal funds UL1TR000101; and by VA Office of Research and Development Biomedical Laboratory Research & Development Program, Award Number I01BX007080.	Alessandri B, 2012, J NEUROTRAUM, V29, P2181, DOI 10.1089/neu.2011.2067; Ando H, 2004, STROKE, V35, P1726, DOI 10.1161/01.STR.0000129788.26346.18; Andriessen TMJC, 2010, J CELL MOL MED, V14, P2381, DOI 10.1111/j.1582-4934.2010.01164.x; Applied Biosysterms, 2016, TAQMAN GEN EXPR ASS; Bak LK, 2006, J CEREBR BLOOD F MET, V26, P1285, DOI 10.1038/sj.jcbfm.9600281; Belousov AB, 2012, NEUROSCI LETT, V524, P16, DOI 10.1016/j.neulet.2012.06.065; Benicky J, 2011, NEUROPSYCHOPHARMACOL, V36, P857, DOI 10.1038/npp.2010.225; Bergersen LH, 2015, J CEREBR BLOOD F MET, V35, P176, DOI 10.1038/jcbfm.2014.206; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Bouzat P, 2014, INTENS CARE MED, V40, P412, DOI 10.1007/s00134-013-3203-6; Cai TQ, 2008, BIOCHEM BIOPH RES CO, V377, P987, DOI 10.1016/j.bbrc.2008.10.088; Carpenter KLH, 2015, FRONT NEUROSCI-SWITZ, V9, DOI 10.3389/fnins.2015.00112; Cureton EL, 2010, J SURG RES, V159, P468, DOI 10.1016/j.jss.2009.04.020; Dash PK, 2004, NEUROCHEM RES, V29, P1275, DOI 10.1023/B:NERE.0000023614.30084.eb; Elkahloun AG, 2016, ALZHEIMERS RES THER, V8, DOI 10.1186/s13195-015-0167-5; Fitzgerald DP, 2008, CLIN EXP METASTAS, V25, P799, DOI 10.1007/s10585-008-9193-z; Garrido-Gil P, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-38; Halestrap AP, 1999, BIOCHEM J, V343, P281, DOI 10.1042/0264-6021:3430281; Hamlin GP, 2001, J NEUROTRAUM, V18, P1011, DOI 10.1089/08977150152693700; HUMAYUN MS, 1989, NUCL MED COMMUN, V10, P335, DOI 10.1097/00006231-198905000-00004; Imabayashi E, 2011, BRAIN BEHAV, V1, P63, DOI 10.1002/brb3.13; Iwanami J, 2010, J HYPERTENS, V28, P1730, DOI 10.1097/HJH.0b013e32833a551a; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Lakshmanan R, 2010, NEUROCRIT CARE, V12, P324, DOI 10.1007/s12028-010-9342-5; Lauritzen KH, 2014, CEREB CORTEX, V24, P2784, DOI 10.1093/cercor/bht136; Lerch MM, 2014, GASTROENTEROLOGY, V146, P1602, DOI 10.1053/j.gastro.2014.04.025; Liu CL, 2009, J BIOL CHEM, V284, P2811, DOI 10.1074/jbc.M806409200; Liu YR, 2010, J NUCL MED, V51, P1788, DOI 10.2967/jnumed.110.078626; Magistretti PJ, 2006, J EXP BIOL, V209, P2304, DOI 10.1242/jeb.02208; Marklund N, 2002, J NEUROTRAUM, V19, P1139, DOI 10.1089/08977150260337958; Mergenthaler P, 2012, P NATL ACAD SCI USA, V109, P1518, DOI 10.1073/pnas.1108225109; Min LJ, 2012, HYPERTENSION, V59, P1079, DOI 10.1161/HYPERTENSIONAHA.112.192401; Moore AH, 2000, J CEREBR BLOOD F MET, V20, P1492, DOI 10.1097/00004647-200010000-00011; Morland C, 2015, J NEUROSCI RES, V93, P1045, DOI 10.1002/jnr.23593; Mosienko V, 2015, J CEREBR BLOOD F MET, V35, P1069, DOI 10.1038/jcbfm.2015.77; Nishimura Y, 2000, STROKE, V31, P2478, DOI 10.1161/01.STR.31.10.2478; O'Connell MT, 2005, ACTA NEUROCHIR SUPPL, V95, P165; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Orhan N, 2016, BRAIN RES, V1631, P113, DOI 10.1016/j.brainres.2015.11.038; Ottens AK, 2010, J NEUROTRAUM, V27, P1837, DOI 10.1089/neu.2010.1374; Palmieri D, 2009, MOL CANCER RES, V7, P1438, DOI 10.1158/1541-7786.MCR-09-0234; Pang T, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-102; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; RUFF RM, 1994, BRAIN INJURY, V8, P297, DOI 10.3109/02699059409150981; Saavedra JM, 2005, REGUL PEPTIDES, V128, P227, DOI 10.1016/j.regpep.2004.12.015; Saavedra JM, 2006, NEUROPSYCHOPHARMACOL, V31, P1123, DOI 10.1038/sj.npp.1300921; Saavedra JM, 2016, CELL MOL NEUROBIOL, V36, P259, DOI 10.1007/s10571-015-0327-y; Saavedra JM, 2012, CLIN SCI, V123, P567, DOI 10.1042/CS20120078; Saavedra JM, 2012, CELL MOL NEUROBIOL, V32, P667, DOI 10.1007/s10571-011-9754-6; Saavedra JM, 2011, PSYCHONEUROENDOCRINO, V36, P1, DOI 10.1016/j.psyneuen.2010.10.001; Sasaki T, 2008, HYPERTENS RES, V31, P921, DOI 10.1291/hypres.31.921; Selwyn RG, 2016, J NEUROTRAUM, V33, P1479, DOI 10.1089/neu.2015.4129; Semple RK, 2006, J CLIN INVEST, V116, P581, DOI 10.1172/JCI28003; Serres S, 2003, NMR BIOMED, V16, P430, DOI 10.1002/nbm.838; Shen Z, 2015, CNS NEUROSCI THER, V21, P271, DOI 10.1111/cns.12362; Simpson IA, 2007, J CEREBR BLOOD F MET, V27, P1766, DOI 10.1038/sj.jcbfm.9600521; SOKOLOFF L, 1977, J NEUROCHEM, V29, P13, DOI 10.1111/j.1471-4159.1977.tb03919.x; Tabernero A, 2006, J NEUROCHEM, V96, P973, DOI 10.1111/j.1471-4159.2005.03623.x; Thal SC, 2008, J NEUROTRAUM, V25, P785, DOI 10.1089/neu.2007.0497; Tweedie D, 2016, J NEUROSCI METH, V272, P4, DOI 10.1016/j.jneumeth.2016.02.003; Vannucci SJ, 1997, GLIA, V21, P2, DOI 10.1002/(SICI)1098-1136(199709)21:1<2::AID-GLIA2>3.0.CO;2-C; Villapol S, 2015, BRAIN, V138, DOI 10.1093/brain/awv172; Villapol S, 2015, AM J HYPERTENS, V28, P289, DOI 10.1093/ajh/hpu197; Villapol S, 2012, NEUROPSYCHOPHARMACOL, V37, P2817, DOI 10.1038/npp.2012.152; Walker KR, 2013, FRONT AGING NEUROSCI, V5, DOI 10.3389/fnagi.2013.00029; Wang J, 2014, NEUROPHARMACOLOGY, V79, P249, DOI 10.1016/j.neuropharm.2013.11.022; Washington PM, 2012, J NEUROTRAUM, V29, P2283, DOI 10.1089/neu.2012.2456; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wolf A, 2011, NEUROBIOL DIS, V44, P84, DOI 10.1016/j.nbd.2011.06.007; Wolf A, 2011, J EXP MED, V208, P313, DOI 10.1084/jem.20101470; Wu P, 2013, J NEUROTRAUM, V30, P775, DOI 10.1089/neu.2012.2391; Xing GQ, 2009, NEUROSCI LETT, V454, P38, DOI 10.1016/j.neulet.2009.01.047	72	15	15	1	9	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1664-2392			FRONT ENDOCRINOL	Front. Endocrinol.	SEP 11	2017	8								231	10.3389/fendo.2017.00231			13	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	FG4WD	WOS:000410276100001	28955302	gold, Green Published			2022-02-06	
J	Belkacemi, T; Niermann, A; Hofmann, L; Wissenbach, U; Birnbaumer, L; Leidinger, P; Backes, C; Meese, E; Keller, A; Bai, XS; Scheller, A; Kirchhoff, F; Philipp, SE; Weissgerber, P; Flockerzi, V; Beck, A				Belkacemi, Thabet; Niermann, Alexander; Hofmann, Laura; Wissenbach, Ulrich; Birnbaumer, Lutz; Leidinger, Petra; Backes, Christina; Meese, Eckart; Keller, Andreas; Bai, Xianshu; Scheller, Anja; Kirchhoff, Frank; Philipp, Stephan E.; Weissgerber, Petra; Flockerzi, Veit; Beck, Andreas			TRPC1-and TRPC3-dependent Ca2+ signaling in mouse cortical astrocytes affects injury-evoked astrogliosis in vivo	GLIA			English	Article						glia; ion channels; membrane currents; migration; proliferation; stab wound injury	TRAUMATIC BRAIN-INJURY; OPERATED CALCIUM-ENTRY; TRPC3 CHANNELS; RECEPTOR; ACTIVATION; INFLUX; PROLIFERATION; EXPRESSION; DIFFERENTIATION; INHIBITION	Following brain injury astrocytes change into a reactive state, proliferate and grow into the site of lesion, a process called astrogliosis, initiated and regulated by changes in cytoplasmic Ca2+. Transient receptor potential canonical (TRPC) channels may contribute to Ca2+ influx but their presence and possible function in astrocytes is not known. By RT-PCR and RNA sequencing we identified transcripts of Trpc1, Trpc2, Trpc3, and Trpc4 in FACS-sorted glutamate aspartate transporter (GLAST)-positive cultured mouse cortical astrocytes and subcloned full-length Trpc1 and Trpc3 cDNAs from these cells. Ca2+ entry in cortical astrocytes depended on TRPC3 and was increased in the absence of Trpc1. After co-expression of Trpc1 and Trpc3 in HEK-293 cells both proteins co-immunoprecipitate and form functional heteromeric channels, with TRPC1 reducing TRPC3 activity. In vitro, lack of Trpc3 reduced astrocyte proliferation and migration whereas the TRPC3 gain-of-function moonwalker mutation and Trpc1 deficiency increased astrocyte migration. In vivo, astrogliosis and cortex edema following stab wound injury were reduced in Trpc3(-/-) but increased in Trpc1(-/-) mice. In summary, our results show a decisive contribution of TRPC3 to astrocyte Ca2+ signaling, which is even augmented in the absence of Trpc1, in particular following brain injury. Targeted therapies to reduce TRPC3 channel activity in astrocytes might therefore be beneficial in traumatic brain injury.	[Belkacemi, Thabet; Niermann, Alexander; Hofmann, Laura; Wissenbach, Ulrich; Philipp, Stephan E.; Weissgerber, Petra; Flockerzi, Veit; Beck, Andreas] Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany; [Birnbaumer, Lutz] Natl Inst Environm Hlth Sci, Neurobiol Lab, Res Triangle Pk, NC 27709 USA; [Birnbaumer, Lutz] Catholic Univ Argentina, Inst Biomed Res BIOMED, C1107AFF, Buenos Aires, DF, Argentina; [Leidinger, Petra; Meese, Eckart] Inst Human Genet & Anthropol, D-66421 Homburg, Germany; [Backes, Christina; Keller, Andreas] Univ Saarland, Klin Bioinformat, D-66123 Saarbrucken, Germany; [Bai, Xianshu; Scheller, Anja; Kirchhoff, Frank] Univ Saarland, Mol Physiol, D-66421 Homburg, Germany; [Beck, Andreas] Zentrum Human & Mol Biol, D-66421 Homburg, Germany		Beck, A (corresponding author), Univ Saarland, Expt & Klin Pharmakol & Toxikol, D-66421 Homburg, Germany.	andreas.beck@uniklinikum-saarland.de	Meese, Eckart Ulrich/ABD-1983-2021; Bai, Xianshu/AAN-8029-2021; Scheller, Anja/B-8577-2018; Kirchhoff, Frank/B-9335-2008; Philipp, Stephan/AAR-7519-2020; Keller, Andreas/ABB-6412-2021	Bai, Xianshu/0000-0002-4758-1645; Scheller, Anja/0000-0001-8955-2634; Kirchhoff, Frank/0000-0002-2324-2761; Keller, Andreas/0000-0002-5361-0895; Philipp, Stephan/0000-0003-1959-9167	Deutsche ForschungsgemeinschaftGerman Research Foundation (DFG) [GRK1326, IRTG1830, SFB894]; Homburg Forschungsforderungsprogramm HOMFOR; Forschungskommission der Universitat des Saarlandes; Intramural Research Program of the NIH Project [ZO1-ES101684]; NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Environmental Health Sciences (NIEHS) [Z01ES101684] Funding Source: NIH RePORTER	The Deutsche Forschungsgemeinschaft, Grant/Award Numbers: GRK1326 (T.B., A.B.), IRTG1830 (L.H., V.F.), SFB894 (A.B., V.F., P.W., S.E.P., F.K.); The Homburg Forschungsforderungsprogramm HOMFOR (A.B., A.S., S.E.P.); The Forschungskommission der Universitat des Saarlandes (A.B., P.W., S.E.P., V.F.); The Intramural Research Program of the NIH Project, Grant/Award Number: ZO1-ES101684 (L.B.).	Ait-Lounis A, 2010, DIABETES, V59, P1674, DOI 10.2337/db09-0986; Akita T, 2011, J PHYSIOL-LONDON, V589, P3909, DOI 10.1113/jphysiol.2011.208173; Bardehle S, 2013, NAT NEUROSCI, V16, P580, DOI 10.1038/nn.3371; Beck A, 2013, J BIOL CHEM, V288, P19471, DOI 10.1074/jbc.M113.478305; Becker EBE, 2014, CEREBELLUM, V13, P628, DOI 10.1007/s12311-014-0564-5; Becker EBE, 2009, P NATL ACAD SCI USA, V106, P6706, DOI 10.1073/pnas.0810599106; Beskina O, 2007, AM J PHYSIOL-CELL PH, V293, pC1103, DOI 10.1152/ajpcell.00249.2007; Bhattaram P, 2010, NAT COMMUN, V1, DOI 10.1038/ncomms1008; Bomben VC, 2011, J CELL PHYSIOL, V226, P1879, DOI 10.1002/jcp.22518; Bomben VC, 2010, GLIA, V58, P1145, DOI 10.1002/glia.20994; Burda JE, 2014, NEURON, V81, P229, DOI 10.1016/j.neuron.2013.12.034; Cheung KK, 2011, MUSCLE NERVE, V44, P358, DOI 10.1002/mus.22060; Chun C, 2016, CELL CYCLE, V15, P957, DOI 10.1080/15384101.2016.1151585; Deliot N, 2015, BBA-BIOMEMBRANES, V1848, P2512, DOI 10.1016/j.bbamem.2015.06.009; Dietrich A, 2007, PFLUG ARCH EUR J PHY, V455, P465, DOI 10.1007/s00424-007-0314-3; Dutton Richard P, 2003, Curr Opin Crit Care, V9, P503, DOI 10.1097/00075198-200312000-00007; Faul M, 2010, INJURY PREV, V16, pA268, DOI 10.1136/ip.2010.029215.951; Gao K, 2013, GLIA, V61, P2063, DOI 10.1002/glia.22577; Gatza ML, 2014, NAT GENET, V46, P1051, DOI 10.1038/ng.3073; Golovina VA, 2005, J PHYSIOL-LONDON, V564, P737, DOI 10.1113/jphysiol.2005.085035; Grimaldi M, 2003, J NEUROSCI, V23, P4737; Hartmann J, 2008, NEURON, V59, P392, DOI 10.1016/j.neuron.2008.06.009; Hofmann T, 1999, NATURE, V397, P259, DOI 10.1038/16711; Kanemaru K, 2013, P NATL ACAD SCI USA, V110, P11612, DOI 10.1073/pnas.1300378110; Kiyonaka S, 2009, P NATL ACAD SCI USA, V106, P5400, DOI 10.1073/pnas.0808793106; Kuang CY, 2012, STEM CELLS DEV, V21, P487, DOI 10.1089/scd.2011.0027; Kwiatkowski AV, 2003, TRENDS CELL BIOL, V13, P386, DOI 10.1016/S0962-8924(03)00130-2; Lee MP, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0029758; Li BM, 2011, CELL CALCIUM, V50, P42, DOI 10.1016/j.ceca.2011.05.001; Lintschinger B, 2000, J BIOL CHEM, V275, P27799; Liu XB, 2005, J BIOL CHEM, V280, P21600, DOI 10.1074/jbc.c400492200; Loikkanen I, 2005, DIFFERENTIATION, V73, P303, DOI 10.1111/j.1432-0436.2005.00036.x; Malarkey EB, 2008, GLIA, V56, P821, DOI 10.1002/glia.20656; Miyano K, 2010, NEUROCHEM INT, V57, P923, DOI 10.1016/j.neuint.2010.09.012; Munakata M, 2013, STROKE, V44, P1981, DOI 10.1161/STROKEAHA.113.679332; Nakao K, 2008, J NEUROSCI RES, V86, P2722, DOI 10.1002/jnr.21711; Peters M, 2012, J NEUROTRAUM, V29, P2831, DOI 10.1089/neu.2012.2575; Pizzo P, 2001, J NEUROCHEM, V79, P98, DOI 10.1046/j.1471-4159.2001.00539.x; Quick K, 2012, OPEN BIOL, V2, DOI 10.1098/rsob.120068; Reyes RC, 2013, CELL CALCIUM, V54, P120, DOI 10.1016/j.ceca.2013.05.005; Schaefer M, 2005, PFLUG ARCH EUR J PHY, V451, P35, DOI 10.1007/s00424-005-1467-6; Schleifer H, 2012, BRIT J PHARMACOL, V167, P1712, DOI 10.1111/j.1476-5381.2012.02126.x; Shirakawa H, 2010, J NEUROSCI, V30, P13116, DOI 10.1523/JNEUROSCI.1890-10.2010; Sofroniew MV, 2009, TRENDS NEUROSCI, V32, P638, DOI 10.1016/j.tins.2009.08.002; Song XY, 2005, GLIA, V49, P418, DOI 10.1002/glia.20128; Storch U, 2012, J BIOL CHEM, V287, P3530, DOI 10.1074/jbc.M111.283218; Streifel KM, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110996; Streifel KM, 2013, NEUROTOXICOLOGY, V34, P160, DOI 10.1016/j.neuro.2012.10.014; Strubing C, 2001, NEURON, V29, P645, DOI 10.1016/S0896-6273(01)00240-9; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Trapnell C, 2012, NAT PROTOC, V7, P562, DOI 10.1038/nprot.2012.016; Trapnell C, 2009, BIOINFORMATICS, V25, P1105, DOI 10.1093/bioinformatics/btp120; Tsvilovskyy VV, 2009, GASTROENTEROLOGY, V137, P1415, DOI 10.1053/j.gastro.2009.06.046; Van Huyen JPD, 2008, J AM SOC NEPHROL, V19, P1965, DOI 10.1681/ASN.2007070781; Wang YA, 2016, J DIABETES RES, V2016, DOI [10.1155/2016/2543268, 10.1155/2016/5639129, 10.1155/2016/2319741]; WINDLE WF, 1952, J COMP NEUROL, V96, P359, DOI 10.1002/cne.900960207; Woo JS, 2014, BIOCHEM BIOPH RES CO, V446, P454, DOI 10.1016/j.bbrc.2014.02.127; Wu XY, 2004, J BIOL CHEM, V279, P43392, DOI 10.1074/jbc.M408959200; Zhan JS, 2017, NEUROCHEM RES, V42, P272, DOI 10.1007/s11064-016-2089-4; Zhao ZK, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045215; Zhu X, 1998, J BIOL CHEM, V273, P133, DOI 10.1074/jbc.273.1.133; Zimmermann J, 2014, J BIOL CHEM, V289, P9766, DOI 10.1074/jbc.M114.557066	62	15	15	0	10	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0894-1491	1098-1136		GLIA	Glia	SEP	2017	65	9					1535	1549		10.1002/glia.23180			15	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FA5IL	WOS:000405476300010	28636132	Green Accepted			2022-02-06	
J	Dong, HJ; Shang, CZ; Li, G; Niu, Q; Luo, YC; Yang, Y; Meng, HP; Yin, HJ; Zhang, HX; Zhao, ML; Lin, L				Dong, Hua-Jiang; Shang, Chong-Zhi; Li, Gang; Niu, Qing; Luo, Yue-Chen; Yang, Yue; Meng, Hui-Peng; Yin, Hui-Juan; Zhang, Hai-Xia; Zhao, Ming-Liang; Lin, Ling			The Distribution of Transplanted Umbilical Cord Mesenchymal Stem Cells in Large Blood Vessel of Experimental Design With Traumatic Brain Injury	JOURNAL OF CRANIOFACIAL SURGERY			English	Article						Homing; human umbilical cord mesenchymal stem cells; large blood vessels; rat; traumatic brain injury; vascular endothelial growth factor	BONE-MARROW; MECHANISMS; THERAPY; RATS; DISEASE; DAMAGE	The authors aim to track the distribution of human umbilical cord mesenchymal stem cells (MSCs) in large blood vessel of traumatic brain injury-rats through immunohistochemical method and small animal imaging system. After green fluorescent protein (GFP) gene was transfected into 293T cell, virus was packaged and MSCs were transfected. Mesenchymal stem cells containing GFP were transplanted into brain ventricle of rats when the infection rate reaches 95%. The immunohistochemical and small animal imaging system was used to detect the distribution of MSCs in large blood vessels of rats. Mesenchymal stem cells could be observed in large vessels with positive GFP expression 10 days after transplantation, while control groups (normal group and traumatic brain injury group) have negative GFP expression. The vascular endothelial growth factor in transplantation group was higher than that in control groups. The in vivo imaging showed obvious distribution of MSCs in the blood vessels of rats, while no MSCs could be seen in control groups. The intravascular migration and homing of MSCs could be seen in rats received MSCs transplantation, and new angiogenesis could be seen in MSCs-transplanted blood vessels.	[Dong, Hua-Jiang; Li, Gang; Yang, Yue; Meng, Hui-Peng; Lin, Ling] Tianjin Univ, State Key Lab Precis Measurement Technol & Instru, Tianjin 300072, Peoples R China; [Shang, Chong-Zhi; Zhao, Ming-Liang] Logist Univ Chinese Peoples Armed Police Forces, Tianjin Key Lab Neurotrauma Repair, Neurol Hosp, Affiliated Hosp, Tianjin 300161, Peoples R China; [Niu, Qing; Luo, Yue-Chen] Chinese Acad Med Sci, State Key Lab Expt Hematol, Inst Hematol, Tianjin, Peoples R China; [Niu, Qing; Luo, Yue-Chen] Chinese Acad Med Sci, Blood Dis Hosp, Tianjin, Peoples R China; [Niu, Qing; Luo, Yue-Chen] Peking Union Med Coll, Tianjin, Peoples R China; [Yin, Hui-Juan; Zhang, Hai-Xia] Chinese Acad Med Sci, Biomed Engn Inst, Tianjin, Peoples R China		Lin, L (corresponding author), Tianjin Univ, State Key Lab Precis Measurement Technol & Instru, Tianjin 300072, Peoples R China.; Zhao, ML (corresponding author), Logist Univ Chinese Peoples Armed Police Forces, Tianjin Key Lab Neurotrauma Repair, Neurol Hosp, Affiliated Hosp, Tianjin 300161, Peoples R China.	linling@tju.edu.cn		, Dong/0000-0002-4141-3077	Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [8140060952]	This project was supported by Natural Science Foundation of China, Project: Role of Dendritic Cell Expressed Voltage-Gated Sodium Channel Mediated Immunomodulation in the Therapy of Acute Myeloid Leukemia (8140060952).	Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Chung HJ, 2016, J VET SCI, V17, P97, DOI 10.4142/jvs.2016.17.1.97; Cui BZ, 2014, EXP THER MED, V7, P1233, DOI 10.3892/etm.2014.1608; Fan HC, 2015, CELL TRANSPLANT, V24, P471, DOI 10.3727/096368915X686931; Harris T, 2012, POSTGRAD MED J, V88, P588, DOI 10.1136/postgradmedj-2010-74245; He H, 2016, CELL DEATH DIS, V7, DOI 10.1038/cddis.2015.417; Israelsson C, 2010, EUR J NEUROSCI, V31, P852, DOI 10.1111/j.1460-9568.2010.07105.x; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Li JP, 2015, GENET MOL RES, V14, P19005, DOI 10.4238/2015.December.29.8; Liu-DeRyke X, 2008, PHARMACOTHERAPY, V28, P485, DOI 10.1592/phco.28.4.485; Lovasik D, 2001, Crit Care Nurs Q, V23, P24; Lucke-Wold BP, 2015, SEIZURE-EUR J EPILEP, V33, P13, DOI 10.1016/j.seizure.2015.10.002; Mareschi K, 2001, HAEMATOLOGICA, V86, P1099; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Nam HS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0144218; Oliveira-Sales EB, 2016, AM J PHYSIOL-RENAL, V310, pF6, DOI 10.1152/ajprenal.00341.2015; Ozdemir M, 2012, STEM CELL REV REP, V8, P953, DOI 10.1007/s12015-012-9376-5; PAIGEN B, 1987, ATHEROSCLEROSIS, V68, P231, DOI 10.1016/0021-9150(87)90202-4; de Freitas ALP, 2014, ACTA CIR BRAS, V29, P29, DOI 10.1590/S0102-86502014001400006; Pittenger MF, 1999, SCIENCE, V284, P143, DOI 10.1126/science.284.5411.143; Prichep LS, 2014, COMPUT BIOL MED, V53, P125, DOI 10.1016/j.compbiomed.2014.07.011; Siegel G, 2009, TRANSPLANTATION, V87, pS45, DOI 10.1097/TP.0b013e3181a285b0; Souza MC, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0093-2; Tepper OM, 2010, DIABETES, V59, P1974, DOI 10.2337/db09-0185; Tokalov SV, 2007, STEM CELLS DEV, V16, P439, DOI 10.1089/scd.2006.0078; Tran LV, 2014, J TRAUMA NURS, V21, P30, DOI 10.1097/JTN.0000000000000026; Yuan Y, 2014, INT J NEUROSCI, V124, P524, DOI 10.3109/00207454.2013.859144; Zhao FY, 2014, INT J DEV NEUROSCI, V38, P147, DOI 10.1016/j.ijdevneu.2014.06.014	28	15	16	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1049-2275	1536-3732		J CRANIOFAC SURG	J. Craniofac. Surg.	SEP	2017	28	6					1615	1619		10.1097/SCS.0000000000003563			5	Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Surgery	FO7IW	WOS:000417048300085	28863113				2022-02-06	
J	Elliott, TR; Hsiao, YY; Kimbrel, NA; Meyer, E; DeBeer, BB; Gulliver, SB; Kwok, OM; Morissette, SB				Elliott, Timothy R.; Hsiao, Yu-Yu; Kimbrel, Nathan A.; Meyer, Eric; DeBeer, Bryann B.; Gulliver, Suzy Bird; Kwok, Oi-Man; Morissette, Sandra B.			Resilience and Traumatic Brain Injury Among Iraq/Afghanistan War Veterans: Differential Patterns of Adjustment and Quality of Life	JOURNAL OF CLINICAL PSYCHOLOGY			English	Article						Resilience; PTSD; depression; combat exposure; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; ACTION QUESTIONNAIRE-II; PSYCHOLOGICAL RESILIENCE; PSYCHOMETRIC PROPERTIES; PERSONALITY PROTOTYPES; LONGITUDINAL EVIDENCE; MENTAL-HEALTH; SYMPTOMS; PTSD; DEPLOYMENT	Objective: We examined the degree to which a resilient personality prototype predicted adjustment among war Veterans with and without a traumatic brain injury (TBI) while covarying the level of combat exposure. Method: A total of 127 war Veterans (107 men, 20 women; average age = 37 years) participated. Personality prototypes were derived from the Multidimensional Personality Questionnaire (Patrick, Curtain, & Tellegen, 2002). Measures were administered at baseline, and a subset was administered at 4-and 8-month follow-ups. Results: Veterans with resilient personalities reported less sleep disturbance, more health-promoting behaviors, psychological flexibility, and emotional distress tolerance than Veterans with undercontrolled or overcontrolled prototypes. Path models revealed that resilience significantly predicted posttraumatic stress disorder (PTSD), depression, quality of life, and social support over time. TBI had unique and consistent effects only on PTSD. Conclusion: Personality characteristics influence distress and quality of life among war Veterans with and without TBI. Implications for assessment, interventions, and research are discussed. (C) 2016 Wiley Periodicals, Inc.	[Elliott, Timothy R.; Hsiao, Yu-Yu; Kwok, Oi-Man] Texas A&M Univ, College Stn, TX 77843 USA; [Kimbrel, Nathan A.] Durham Vet Affairs Med Ctr, Durham, NC USA; [Kimbrel, Nathan A.] VA Midatlantic Mental Illness Res, Educ Clin Ctr, Washington, DC USA; [Kimbrel, Nathan A.] Duke Univ, Med Ctr, Durham, NC 27706 USA; [Meyer, Eric; DeBeer, Bryann B.] Cent Texas Vet Healthcare Syst, VA VISN Ctr Excellence Res Returning War Vet 17, Temple, TX USA; [Meyer, Eric; DeBeer, Bryann B.; Gulliver, Suzy Bird] Texas A&M Univ, Hlth Sci Ctr, College Stn, TX 77843 USA; [Gulliver, Suzy Bird] Baylor Scott & White Hlth, Warrior Res Inst, Dallas, TX USA; [Morissette, Sandra B.] Univ Texas San Antonio, San Antonio, TX USA		Elliott, TR (corresponding author), Dept Educ Psychol, College Stn, TX 77843 USA.	telliott@tamu.edu	Elliott, Timothy R./I-5301-2012; Gulliver, Suzy/X-9776-2019	Elliott, Timothy R./0000-0002-6608-7714; Gulliver, Suzy Bird/0000-0002-6476-9447; Kwok, Oiman/0000-0002-4617-4562	Rehabilitation Research and Development (RD) Service [I01RX000304-01, I01RX000304-04]; Clinical Science R&D Service of the VA Office of RD [1IK2 CX000525]; Veterans AffairsUS Department of Veterans Affairs [IK2CX000525, I01RX000304] Funding Source: NIH RePORTER	This research was supported by Merit Award #I01RX000304-01 to Dr. Morissette and #I01RX000304-04 to Dr. Meyer and Morissette from the Rehabilitation Research and Development (R&D) Service. Dr. Kimbrel was supported by a Career Development Award (#1IK2 CX000525) from the Clinical Science R&D Service of the VA Office of R&D. The views expressed in this article are those of the authors and do not necessarily reflect the position or policy of the Department of Veterans Affairs or the United States government.	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Armed Forces Health Surveillance Center, 2011, DOD NUMB TRAUM BRAIN; Asendorpf JB, 2001, EUR J PERSONALITY, V15, P169, DOI 10.1002/per.408.abs; Bahraini NH, 2014, PSYCHIAT CLIN N AM, V37, P55, DOI 10.1016/j.psc.2013.11.002; Bailie JM, 2016, J HEAD TRAUMA REHAB, V31, P2, DOI 10.1097/HTR.0000000000000142; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Berry JW, 2007, J PERS ASSESS, V89, P292, DOI 10.1080/00223890701629813; Berry JW, 2009, J PERS, V77, P1381, DOI 10.1111/j.1467-6494.2009.00586.x; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Block J, 1996, J PERS SOC PSYCHOL, V70, P349, DOI 10.1037/0022-3514.70.2.349; Block J., 1993, STUDYING LIVES TIME, P9, DOI DOI 10.1037/10127-018; Block J. H., 1980, DEV COGNITION AFFECT, V13, P39; Bonanno GA, 2012, BRIT J PSYCHIAT, V200, P317, DOI 10.1192/bjp.bp.111.096552; Bond FW, 2011, BEHAV THER, V42, P676, DOI 10.1016/j.beth.2011.03.007; Brickell TA, 2014, MIL MED, V179, P827, DOI 10.7205/MILMED-D-13-00506; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; BROWNE MW, 1992, SOCIOL METHOD RES, V21, P230, DOI 10.1177/0049124192021002005; BURCKHARDT CS, 1989, RES NURS HEALTH, V12, P347, DOI 10.1002/nur.4770120604; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Carlson K, 2009, ASSESSMENT TREATMENT; Caruso D, 2014, J REHABIL RES DEV, V51, P1103, DOI 10.1682/JRRD.2013.05.0119; Carver CS, 1997, INT J BEHAV MED, V4, P92, DOI 10.1207/s15327558ijbm0401_6; CASPI A, 1995, CHILD DEV, V66, P486, DOI 10.2307/1131592; Chapman BP, 2011, J PERS SOC PSYCHOL, V101, P593, DOI 10.1037/a0024289; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; Connor KM, 2003, DEPRESS ANXIETY, V18, P76, DOI 10.1002/da.10113; Davydov DM, 2010, CLIN PSYCHOL REV, V30, P479, DOI 10.1016/j.cpr.2010.03.003; Denissen JJA, 2008, J PERS, V76, P67, DOI 10.1111/j.1467-6494.2007.00480.x; Denning LA., 2014, PREVENTING PSYCHOL D; Dretsch MN, 2015, J NEUROTRAUM, V32, P1301, DOI 10.1089/neu.2014.3810; EFRON B, 1988, PSYCHOL BULL, V104, P293; Efron B., 1993, INTRO BOOTSTRAP; Elliott T., 2016, ASSESSMENT HLTH PSYC, P201; Elliott TR, 2015, REHABIL PSYCHOL, V60, P263, DOI 10.1037/rep0000050; Fletcher D, 2013, EUR PSYCHOL, V18, P12, DOI 10.1027/1016-9040/a000124; Forbes D, 2001, BEHAV RES THER, V39, P977, DOI 10.1016/S0005-7967(00)00084-X; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Garden N, 2010, NEUROPSYCHOLOGY, V24, P168, DOI 10.1037/a0017431; Green KT, 2014, ASSESSMENT, V21, P443, DOI 10.1177/1073191114524014; Grosso JA, 2014, J TRAUMA STRESS, V27, P478, DOI 10.1002/jts.21943; Hayes SC, 2004, PSYCHOL REC, V54, P553, DOI 10.1007/BF03395492; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Kazis LE, 2006, J AMBUL CARE MANAG, V29, P310, DOI 10.1097/00004479-200610000-00007; Kennedy JE, 2015, ARCH CLIN NEUROPSYCH, V30, P236, DOI 10.1093/arclin/acv014; King LA, 2006, MIL PSYCHOL, V18, P89, DOI 10.1207/s15327876mp1802_1; Kinnunen ML, 2012, SCAND J PSYCHOL, V53, P512, DOI 10.1111/j.1467-9450.2012.00969.x; Kline R.B., 2005, PRINCIPLES PRACTICE, V2nd; LANDIS JR, 1977, BIOMETRICS, V33, P159, DOI 10.2307/2529310; Lange RT, 2014, ARCH CLIN NEUROPSYCH, V29, P329, DOI 10.1093/arclin/acu013; Lee JEC, 2015, PSYCHOSOM MED, V77, P1006, DOI 10.1097/PSY.0000000000000250; Losoi H, 2015, J NEUROTRAUM, V32, P942, DOI 10.1089/neu.2014.3799; McCauley SR, 2013, J NEUROTRAUM, V30, P642, DOI 10.1089/neu.2012.2393; Merritt VC, 2015, BRAIN INJURY, V29, P1325, DOI 10.3109/02699052.2015.1043948; Meyer EC, 2013, PSYCHOL TRAUMA-US, V5, P521, DOI 10.1037/a0030178; Miskey HM, 2015, BRAIN IMAGING BEHAV, V9, P461, DOI 10.1007/s11682-015-9391-7; Morissette SB, 2011, REHABIL PSYCHOL, V56, P340, DOI 10.1037/a0025462; Muth?n, 2013, MPLUS USERS GUIDE; Ong AD, 2010, PSYCHOL AGING, V25, P516, DOI 10.1037/a0019384; Ong AD, 2009, J PERS, V77, P1777, DOI 10.1111/j.1467-6494.2009.00600.x; Panayiotou A, 2010, J CLIN EXP NEUROPSYC, V32, P463, DOI 10.1080/13803390903164371; Patrick CJ, 2002, PSYCHOL ASSESSMENT, V14, P150, DOI 10.1037//1040-3590.14.2.150; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Robins RW, 1996, J PERS SOC PSYCHOL, V70, P157, DOI 10.1037/0022-3514.70.1.157; Schwab KA, 2007, J HEAD TRAUMA REHAB, V22, P377, DOI 10.1097/01.HTR.0000300233.98242.87; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Steca P, 2010, PERS INDIV DIFFER, V48, P442, DOI 10.1016/j.paid.2009.11.016; Steenkamp MM, 2013, AM J PREV MED, V44, P507, DOI 10.1016/j.amepre.2013.01.013; Sullivan KA, 2015, REHABIL PSYCHOL, V60, P147, DOI 10.1037/rep0000037; Sumpter RE, 2006, BRAIN INJURY, V20, P93, DOI 10.1080/02699050500394090; Telch M. J., 2016, DISTRESS TOLERANCE I; Tsai J, 2012, PSYCHIATRY, V75, P135, DOI 10.1521/psyc.2012.75.2.135; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Vogt DS, 2008, ASSESSMENT, V15, P381, DOI 10.1177/1073191108316030; Walker S, 1995, HLTH PROMOTING LIFES; Walsh MV, 2016, ARCH PHYS MED REHAB, V97, P781, DOI 10.1016/j.apmr.2016.01.016; Weathers F. W., 1993, 9 ANN M INT SOC TRAU; Weston R, 2008, REHABIL PSYCHOL, V53, P340, DOI 10.1037/a0013039; Wilk JE, 2012, PSYCHOSOM MED, V74, P249, DOI 10.1097/PSY.0b013e318244c604; Windle G, 2011, HEALTH QUAL LIFE OUT, V9, DOI 10.1186/1477-7525-9-8; Yu CY, 2002, EVALUATING CUTOFF CR; [No title captured]	84	15	16	0	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0021-9762	1097-4679		J CLIN PSYCHOL	J. Clin. Psychol.	SEP	2017	73	9					1160	1178		10.1002/jclp.22414			19	Psychology, Clinical	Social Science Citation Index (SSCI)	Psychology	FG2ER	WOS:000409896400011	27922725	Green Accepted			2022-02-06	
J	Gardner, RC; Peltz, CB; Kenney, K; Covinsky, KE; Diaz-Arrastia, R; Yaffe, K				Gardner, Raquel C.; Peltz, Carrie B.; Kenney, Kimbra; Covinsky, Kenneth E.; Diaz-Arrastia, Ramon; Yaffe, Kristine			Remote Traumatic Brain Injury Is Associated with Motor Dysfunction in Older Military Veterans	JOURNALS OF GERONTOLOGY SERIES A-BIOLOGICAL SCIENCES AND MEDICAL SCIENCES			English	Article						Falls; Parkinson's disease; Risk factors	MILD PARKINSONIAN SIGNS; ALZHEIMERS-DISEASE; RISK; METAANALYSIS; PREVALENCE; DEMENTIA; OUTCOMES; STATE	Background: Traumatic brain injury (TBI) has been identified as a risk factor for Parkinson's disease (PD). Motor dysfunction among TBI-exposed elders without PD has not been well characterized. We sought to determine whether remote TBI is a risk factor for motor dysfunction on exam and functionally relevant motor dysfunction in day-to-day life among independently living elders without PD. Methods: This is a cross-sectional cohort study of independently living retired military veterans aged 50 or older with (n = 78) and without (n = 85) prior TBI-all without diagnosed PD. To characterize multidimensional aspects of motor function on exam, the Unified Parkinson's Disease Rating Scale (UPDRS) Motor Examination was performed by a board-certified neurologist and used to calculate a modified UPDRS (mUPDRS) global motor score and four domain scores (tremor, rigidity, bradykinesia, and posture/gait). Functionally relevant motor dysfunction was assessed via self-report of falls within the past year. Results: In analyses adjusted for demographics and comorbidities that differed between groups, compared with veterans without TBI, those with moderate-to-severe TBI were more likely to have fallen in past year (33% vs. 14%, risk ratio 2.5 [95% confidence interval 1.1-5.4]), had higher (worse) mUPDRS global motor (p = .03) and posture/gait scores (p = .02), but not higher tremor (p = .70), rigidity (p = .21), or bradykinesia scores (p = .22). Mild TBI was not associated with worse motor function. Conclusions: Remote moderate-to-severe TBI is a risk factor for motor dysfunction-defined as recent falls and impaired posture/gait-among older veterans. TBI-exposed older adults may be ideal candidates for aggressive fall-screening and prevention strategies.	[Gardner, Raquel C.; Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, Memory & Aging Ctr, 4150 Clement St, San Francisco, CA 94121 USA; [Gardner, Raquel C.; Peltz, Carrie B.; Covinsky, Kenneth E.; Yaffe, Kristine] San Francisco VA Med Ctr, San Francisco, CA USA; [Kenney, Kimbra; Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Bethesda, MD 20814 USA; [Covinsky, Kenneth E.] Univ Calif San Francisco, Div Geriatr, 4150 Clement St, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Psychiat, 4150 Clement St, San Francisco, CA 94121 USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol & Biostat, 4150 Clement St, San Francisco, CA 94121 USA		Gardner, RC (corresponding author), Univ Calif San Francisco, Dept Neurol, 4150 Clement St, San Francisco, CA 94121 USA.	raquel.gardner@ucsf.edu		Gardner, Raquel C./0000-0003-4028-440X	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 NS095755, K24 AG029812, P30 AG044281, K24 AG031155]; American Federation for Aging Research; University of California San Francisco Pepper Center; Global Brain Health Institute; Department of DefenseUnited States Department of Defense; Department of Veterans AffairsUS Department of Veterans Affairs [W81XWH-12-1-0581, W81XWH-12-PHTBI-CENC]; Center for Neuroscience and Regenerative MedicineUnited States Department of Defense; Military Clinical Neurosciences Center of Excellence; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS095755] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG044281] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (Beeson K23 NS095755 to R.C.G., K24 AG029812 and P30 AG044281 to K.E.C., and K24 AG031155 to K.Y.); the American Federation for Aging Research (to R.C.G.); the University of California San Francisco Pepper Center (to R.C.G. and K.E.C.); the Global Brain Health Institute (to R.C.G.); the Department of Defense and Department of Veterans Affairs (W81XWH-12-1-0581 and W81XWH-12-PHTBI-CENC to K.Y.); and the Center for Neuroscience and Regenerative Medicine and the Military Clinical Neurosciences Center of Excellence (to K.K. and R.D.A.).	Bennett DA, 1996, NEW ENGL J MED, V334, P71, DOI 10.1056/NEJM199601113340202; Bennett DA, 1999, J GERONTOL A-BIOL, V54, pM191, DOI 10.1093/gerona/54.4.M191; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Buchman AS, 2016, J GERONTOL A-BIOL, V71, P549, DOI 10.1093/gerona/glv153; Buracchio T, 2010, J AM GERIATR SOC, V58, P205, DOI 10.1111/j.1532-5415.2009.02657.x; Bureau USC, 2012, 2012 AM COMM SURV; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Caetano MJD, 2017, J GERONTOL A-BIOL, V72, P1257, DOI 10.1093/gerona/glw171; Crane PK, 2016, JAMA NEUROL, V73, P1062, DOI 10.1001/jamaneurol.2016.1948; Cummings P, 2009, STATA J, V9, P175, DOI 10.1177/1536867X0900900201; Fahn S., 1987, RECENT DEV PARKINSON, P153; Fleischman DA, 2007, EXP AGING RES, V33, P59, DOI 10.1080/03610730601006370; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Formisano R, 2014, J HEAD TRAUMA REHAB, V29, P387, DOI 10.1097/HTR.0000000000000027; Frieden T., 2014, REPORT C TRAUMATIC B; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Jafari S, 2013, MOVEMENT DISORD, V28, P1222, DOI 10.1002/mds.25458; Louis ED, 2006, MOVEMENT DISORD, V21, P411, DOI 10.1002/mds.20735; Louis ED, 2007, MOVEMENT DISORD, V22, P1681, DOI 10.1002/mds.21433; Marshall LM, 2016, J GERONTOL A; MORRIS JC, 1993, NEUROLOGY, V43, P2412, DOI 10.1212/WNL.43.11.2412-a; National Center for Injury Prevention, 2003, MILD TRAUM BRAIN INJ; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Peran P, 2014, J NEUROTRAUM, V31, P642, DOI 10.1089/neu.2013.3103; Pringsheim T, 2014, MOVEMENT DISORD, V29, P1583, DOI 10.1002/mds.25945; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Staudenmayer KL, 2007, J TRAUMA, V63, P1364, DOI 10.1097/TA.0b013e31815b897b; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Topolski T. D., 2006, Preventing Chronic Disease, V3, pA118; United Nations DoEaSA Population Division Population Estimates and Projections Section. United Nations Department of Economic and Social Affairs Population Division Population Estimates and Projections Section, 2012, DETAILED INDICATORS; Veitch DP, 2013, CURR ALZHEIMER RES, V10, P907, DOI 10.2174/15672050113109990142; Walker WC, 2007, J REHABIL RES DEV, V44, P975, DOI 10.1682/JRRD.2006.12.0158; Whiteneck GG, 2016, J HEAD TRAUMA REHAB, V31, pE55, DOI 10.1097/HTR.0000000000000140	33	15	15	0	4	OXFORD UNIV PRESS INC	CARY	JOURNALS DEPT, 2001 EVANS RD, CARY, NC 27513 USA	1079-5006	1758-535X		J GERONTOL A-BIOL	J. Gerontol. Ser. A-Biol. Sci. Med. Sci.	SEP	2017	72	9					1233	1238		10.1093/gerona/glw341			6	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	FD4LC	WOS:000407501600012	28329183	Green Published			2022-02-06	
J	Garvin, R; Mangat, HS				Garvin, Rachel; Mangat, Halinder S.			Emergency Neurological Life Support: Severe Traumatic Brain Injury	NEUROCRITICAL CARE			English	Article						Severe traumatic brain injury; Neurotrauma; Neurocritical care; Emergency	INTRACRANIAL-PRESSURE; DECOMPRESSIVE CRANIECTOMY; BLOOD-PRESSURE; HEAD-INJURY; COMA SCALE; COAGULOPATHY; CHILDREN; HYPOTENSION; INTUBATION; GUIDELINES	Severe traumatic brain injury (TBI) causes substantial morbidity and mortality, and is a leading cause of death in both the developed and developing world. The need for a systematic evidence-based approach to the care of severe TBI patients within the emergency setting has led to its inclusion as an Emergency Neurological Life Support topic. This protocol was designed to enumerate the practice steps that should be considered within the first critical hours of neurological injury from severe TBI.	[Garvin, Rachel] UT Hlth San Antonio, San Antonio, TX USA; [Mangat, Halinder S.] Weill Cornell Med Coll, New York, NY USA		Garvin, R (corresponding author), UT Hlth San Antonio, San Antonio, TX USA.	doctorgarvin@gmail.com; hsm9001@med.cornell.edu	Mangat, HALINDER/AAN-9153-2020	Mangat, HALINDER/0000-0003-3426-2001			Andrews PJD, 2008, INTENS CARE MED, V34, P1362, DOI 10.1007/s00134-008-1103-y; Badjatia N, 2008, PREHOSP EMERG CARE, V12, pS1, DOI 10.1080/10903120701732052; Baron JC, 2001, CEREBROVASC DIS, V11, P2, DOI 10.1159/000049119; Bauer DF, 2011, J TRAUMA, V70, P1112, DOI 10.1097/TA.0b013e3181e7c2ae; Birch AA, 2006, NEUROCRIT CARE, V5, P51, DOI 10.1385/NCC:5:1:51; Bossers SM, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0141034; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Bratton SL, 2007, J NEUROTRAUMA S1, V24, pS45, DOI DOI 10.1089/NEU.2007.9989; Bullock M Ross, 2006, Neurosurgery, V58, pS47; Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Cap AP, 2011, J TRAUMA, V71, pS78, DOI 10.1097/TA.0b013e3182218cd8; Carney N, 2017, NEUROSURGERY, V80, P6, DOI 10.1227/NEU.0000000000001432; Centers for Disease Control and Prevention, 2006, NAT VIT STAT SYST NV; Centers for Disease Control and Prevention National Center for Health Statistics, 2010, NAT HOSP AMB MED CAR; Centers for Disease Control and Prevention National Center for Health Statistics, 2010, NAT HOSP DISCH SURV; Chesnut R M, 1995, New Horiz, V3, P366; Chesnut R, 2014, NEUROCRIT CARE, V21, P64, DOI 10.1007/s12028-014-0048-y; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Coronado V.G., 2012, BRAIN INJURY MED PRI; Davis DP, 2005, J TRAUMA, V58, P933, DOI 10.1097/01.TA.0000162731.53812.58; Ehtisham A, 2009, NEUROCRIT CARE, V10, P241, DOI 10.1007/s12028-008-9097-4; Faul M, 2010, TRAUMATIC BRAIN INJU; Heuer G, 2011, YOUMANS TXB NEUROLOG; Holmes JF, 2005, ACAD EMERG MED, V12, P814, DOI 10.1197/j.aem.2005.04.019; Hutchinson PJ, 2016, NEW ENGL J MED, V375, P1119, DOI 10.1056/NEJMoa1605215; JAMES HE, 1986, PEDIATR ANN, V15, P16, DOI 10.3928/0090-4481-19860101-05; Jensen JL, 2010, CAN J EMERG MED, V12, P135; Kapapa T, 2010, J CHILD NEUROL, V25, P146, DOI 10.1177/0883073809332698; Katsnelson M, 2012, NEUROSURGERY, V70, P1095, DOI 10.1227/NEU.0b013e318240c1ed; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kolias AG, 2016, BRIT J NEUROSURG, V30, P246, DOI 10.3109/02688697.2016.1159655; Kolias AG, 2013, NAT REV NEUROL, V9, P405, DOI 10.1038/nrneurol.2013.106; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Maas AIR, 1997, ACTA NEUROCHIR, V139, P286, DOI 10.1007/BF01808823; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Miller C, 2014, NEUROCRIT CARE, V21, P121, DOI 10.1007/s12028-014-0021-9; MORRAY JP, 1984, CRIT CARE MED, V12, P1018, DOI 10.1097/00003246-198412000-00002; NARAYAN RK, 1982, J NEUROSURG, V56, P650, DOI 10.3171/jns.1982.56.5.0650; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Oddo M, 2009, EVIDENCE BASED PRACT; Pang D, 2004, NEUROSURGERY, V55, P1325, DOI 10.1227/01.NEU.0000143030.85589.E6; Sahuquillo J, 2006, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003983.pub2; SIMPSON D, 1982, LANCET, V2, P450; Smith M, 2008, ANESTH ANALG, V106, P240, DOI 10.1213/01.ane.0000297296.52006.8e; Spaite DW, 2017, JAMA SURG, V152, P360, DOI 10.1001/jamasurg.2016.4686; Stein SC, 2004, NEUROCRIT CARE, V1, P479, DOI 10.1385/NCC:1:4:479; Stiell IG, 2008, CAN MED ASSOC J, V178, P1141, DOI 10.1503/cmaj.071154; Talving P, 2009, J TRAUMA, V66, P55, DOI 10.1097/TA.0b013e318190c3c0; TEASDALE G, 1974, LANCET, V2, P81; TEMKIN NR, 1990, NEW ENGL J MED, V323, P497, DOI 10.1056/NEJM199008233230801; Timofeev I, 2008, ACTA NEUROCHIR SUPPL, V102, P99, DOI 10.1007/978-3-211-85578-2_20; Vavilala MS, 2003, J TRAUMA, V55, P1039, DOI 10.1097/01.TA.0000101759.23607.57; Zehtabchi S, 2014, AM J EMERG MED, V32, P1503, DOI 10.1016/j.ajem.2014.09.023	57	15	18	5	6	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	SEP	2017	27			1			S159	S169		10.1007/s12028-017-0461-0			11	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FU8HO	WOS:000424094100014	28913754				2022-02-06	
J	Heinze, KL; Lu, D				Heinze, Kathryn L.; Lu, Di			Shifting Responses to Institutional Change: The National Football League and Player Concussions	JOURNAL OF SPORT MANAGEMENT			English	Article						institutional change; institutional theory; organizational responses; sport governing body	CHRONIC TRAUMATIC ENCEPHALOPATHY; ORGANIZATIONAL FIELD; RECURRENT CONCUSSION; SPORT; ENTREPRENEURSHIP; RESPONSIBILITY; TRANSFORMATION; EPIDEMIOLOGY; ASSOCIATION; COMPLEXITY	Institutional research increasingly suggests that organizations are not passive recipients of institutional demands. Organizations can adopt a variety of strategies, including dismissing, decoupling, and co-opting, in response to pressure to change. Over time, organizations likely adopt different approaches, particularly as the institutional field continues to evolve. Through a longitudinal case study of the National Football League's responses to player concussions, we investigated shifts in how a powerful sport governing body responds to institutional change over time. We found that the National Football League moved through different responses, from more reactive strategies-including dismissing, decoupling, and acquiescing-to proactive attempts to control institutional change. Using data on the National Football League, we offer propositions about the factors that may influence organizational responses. This study advances understanding of powerful sport governing bodies' responses to institutional change.	[Heinze, Kathryn L.; Lu, Di] Univ Michigan, Sport Management, Sch Kinesiol, Ann Arbor, MI 48109 USA		Heinze, KL (corresponding author), Univ Michigan, Sport Management, Sch Kinesiol, Ann Arbor, MI 48109 USA.	wheelerk@umich.edu					Allison G. T., 1971, ESSENCE DECISION EXP; Babiak K., 2006, SPORT MARKET Q, V15; Babiak K, 2011, CORP SOC RESP ENV MA, V18, P11, DOI 10.1002/csr.229; Battista J, 2013, NY TIMES, pSP6; Binder A, 2007, THEOR SOC, V36, P547, DOI 10.1007/s11186-007-9045-x; Borden S, 2011, NY TIMES, pB13; Branch J, 2006, NY TIMES, pD3; Brown C, 2007, NY TIMES, pD1; Brundage A, 2013, GOING SOURCES GUIDE; Cantelon H., 2000, International Review for the Sociology of Sport, V35, P294, DOI 10.1177/101269000035003004; Comeau GS, 2010, J SPORT SOC ISSUES, V34, P457, DOI 10.1177/0193723510387053; Coughlin JM, 2015, NEUROBIOL DIS, V74, P58, DOI 10.1016/j.nbd.2014.10.019; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Deephouse DL, 1996, ACAD MANAGE J, V39, P1024, DOI 10.2307/256722; DiMaggio Paul., 1988, I PATTERNS ORG CULTU, P3; Ezell Lauren, 2013, TIMELINE NFLS CONCUS; Farber M, 1994, SPORTS ILLUSTRATED, p[38, 39, 46]; Farmer S, 2010, LOS ANGELES TIMES; Freeman M, 1995, NY TIMES, pB12; Freeman M, 1997, NY TIMES, P10; Galvin TL, 2002, ACAD MANAGE J, V45, P673, DOI 10.2307/3069304; Greenwood R, 2006, ACAD MANAGE J, V49, P27; Greenwood R, 2011, ACAD MANAG ANN, V5, P317, DOI 10.1080/19416520.2011.590299; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hack D, 2003, NY TIMES, pD7; Hack D, 2002, NY TIMES, pD5; Haedicke MA, 2012, SOCIOL QUART, V53, P44, DOI 10.1111/j.1533-8525.2011.01225.x; Hallett T, 2010, AM SOCIOL REV, V75, P52, DOI 10.1177/0003122409357044; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hinings C.R., 2002, J APPL BEHAV SCI, V38, P436, DOI [10.1177/002188602237791, DOI 10.1177/002188602237791]; Hoffman AJ, 1999, ACAD MANAGE J, V42, P351, DOI 10.2307/257008; Isidore Chris, 2015, CNNMONEY; Kikulis L. M., 1995, Journal of Sport Management, V9, P135; Kodeih F, 2014, ORGAN STUD, V35, P7, DOI 10.1177/0170840613495333; Kraatz M.S., 2008, SAGE HDB ORG I, VEds, P243; Lawrence TB., 2006, SAGE HDB ORG STUDIES, V2; Lawrence TB, 2009, INSTITUTIONAL WORK: ACTORS AND AGENCY IN INSTITUTIONAL STUDIES OF ORGANIZATIONS, P1, DOI 10.1017/CBO9780511596605.001; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; Mason DS, 1997, J SPORT MANAGE, V11, P203, DOI 10.1123/jsm.11.3.203; McCullough BP, 2010, QUEST, V62, P348, DOI 10.1080/00336297.2010.10483654; McDonnell MH, 2013, ADMIN SCI QUART, V58, P387, DOI 10.1177/0001839213500032; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; NADLER DA, 1990, CALIF MANAGE REV, V32, P77, DOI 10.2307/41166606; O'Brien D, 2003, J SPORT MANAGE, V17, P417, DOI 10.1123/jsm.17.4.417; Oakes LS, 1998, ADMIN SCI QUART, V43, P257, DOI 10.2307/2393853; OLIVER C, 1991, ACAD MANAGE REV, V16, P145, DOI 10.2307/258610; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pache AC, 2010, ACAD MANAGE REV, V35, P455, DOI 10.5465/AMR.2010.51142368; Pacifici A, 2014, BERKELEY J ENTERTAIN, V3, P93, DOI [10.15779/Z38S926, DOI 10.15779/Z38S926]; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Pennington B, 2014, NY TIMES, pSP1; Pierson D, 1999, CHICAGO TRIBUNE; Plaschke B, 1995, LOS ANGELES TIMES; Pratt MG, 2000, ACAD MANAGE REV, V25, P18, DOI 10.2307/259261; ROMANELLI E, 1994, ACAD MANAGE J, V37, P1141, DOI 10.2307/256669; ROSS SF, 1989, MINN LAW REV, V73, P643; SCHWARTZ A, 2007, NY TIMES        0721, pD1; Schwarz A, 2010, NEW YORK TIMES, pB12; SCHWARZ A, 2008, NY TIMES        0201, pD1; Schwarz A, 2007, NY TIMES, pSP1; Schwarz A, 2009, NY TIMES, pB10; Schwarz A, 2010, NY TIMES, pB10; Schwarz A, 2009, NY TIMES        1220; Schwarz A, 2009, NY TIMES, pA1; Schwarz A, 2010, NY TIMES, pB16; Schwarz A, 2010, NY TIMES        0217, pA1; Scott W.R., 2003, ORG RATIONAL NATURAL; Segura M, 2012, SPORTS ILLUSTRA 0618, P21; Shear M. D., 2014, NY TIMES, pB15; Silk M., 2000, CULTURE SPORT SOC, V3, P1, DOI [10.1080/14610980008721859, DOI 10.1080/14610980008721859]; SLACK T, 1994, ORGAN STUD, V15, P803, DOI 10.1177/017084069401500602; Slack T., 1992, Journal of Sport Management, V6, P114; Stevens J. A., 1998, International Review for the Sociology of Sport, V33, P143, DOI 10.1177/101269098033002002; Stevenson S, 1998, NY TIMES, pC4; Tainsky S, 2008, EUR SPORT MANAG Q, V8, P67, DOI 10.1080/16184740701814423; The Associated Press, 2006, NY TIMES; Tilcsik A, 2010, ACAD MANAGE J, V53, P1474, DOI 10.5465/AMJ.2010.57318905; Trendafilova S, 2013, SPORT MANAG REV, V16, P298, DOI 10.1016/j.smr.2012.12.006; Viera M, 2010, NY TIMES, pD2; Vrooman J, 2012, SPORTS ECON MANAGE, V2, P7, DOI 10.1007/978-1-4419-6290-4_2; Washington M, 2004, ORGAN STUD, V25, P393, DOI 10.1177/0170840604040042; Washington M, 2011, SPORT MANAG REV, V14, P1, DOI 10.1016/j.smr.2010.06.003; Westphal JD, 2001, ADMIN SCI QUART, V46, P202, DOI 10.2307/2667086; Wright AL, 2013, J BUS VENTURING, V28, P51, DOI 10.1016/j.jbusvent.2011.11.005; Yin R., 2017, CASE STUDY RES DESIG; Zietsma C, 2010, ADMIN SCI QUART, V55, P189, DOI 10.2189/asqu.2010.55.2.189; Zinser L., 2009, NY TIMES	89	15	15	0	11	HUMAN KINETICS PUBL INC	CHAMPAIGN	1607 N MARKET ST, PO BOX 5076, CHAMPAIGN, IL 61820-2200 USA	0888-4773	1543-270X		J SPORT MANAGE	J.Sport Manage.	SEP	2017	31	5					497	513		10.1123/jsm.2016-0309			17	Hospitality, Leisure, Sport & Tourism; Management; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Business & Economics; Sport Sciences	FL7KH	WOS:000414425900005					2022-02-06	
J	Hosseini-Zare, MS; Gu, F; Abdulla, A; Powell, S; Ziburkus, J				Hosseini-Zare, Mahshid Sadat; Gu, Feng; Abdulla, Ahmad; Powell, Simon; Ziburkus, Jokubas			Effects of experimental traumatic brain injury and impaired glutamate transport on cortical spreading depression	EXPERIMENTAL NEUROLOGY			English	Article						Cortical spreading depression; Traumatic brain injury; Astrocytic glutamate transporter	PERIINFARCT DEPOLARIZATIONS; CLINICAL-RELEVANCE; CEREBRAL-CORTEX; IN-VIVO; RAT; RELEASE; ASPARTATE; EXCITOTOXICITY; ASTROCYTES; RECEPTORS	Cortical spreading depression (CSD) is associated with traumatic brain injury (TBI), stroke, migraines, and seizures. Typically, following TBIs and other insults, neuronal excitability in and around the area of the injury is affected, with reported increases in local glutamate signaling. Astrocytic glutamate transporters are critical for precise regulation of the extracellular glutamate availability. However, it remains unclear how impaired astrocytic glutamate transport or an acute TBI affect characteristics of the CSD. We quantified the properties of CSD using whole-cell and extracellular electrophysiological recordings, and voltage-sensitive dye imaging (VSDI) in rat visual cortex in vitro. To model impaired astrocytic glutamate transport, we used astrocytic glutamate transporter blocker (2S, 35)-3-1.3[4-(trifluoromethyl) benzoylamino] benzyloxy] aspartate (TFB-TBOA). In addition, an acute incision through the superficial cortical layers was used to model the effects of acute traumatic brain injury (TBI) on CSD characteristics. Both manipulations; impaired glutamate cycling and acute cut profoundly affected the physiological properties of cell firing, latency to CSD formation, and its frequency of occurrence. VSD imaging analysis revealed significant changes in spatiotemporal dynamics and propagation of the CSD, suggesting that the cut itself may not initiate CSD depolarizing waves, but rather attract them. Blockade of GLT-1 caused significant reduction in whole-cell sodium currents and changes in CSD wave spatiotemporal characteristics as well, slowing it or even 'trapping' its propagation. Our results reveal new information about CSD properties in these pathological conditions and demonstrate an important role of GLT-1 in regulation of CSD. (C) 2017 Elsevier Inc. All rights reserved.	[Hosseini-Zare, Mahshid Sadat; Gu, Feng; Abdulla, Ahmad; Powell, Simon; Ziburkus, Jokubas] Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA; [Hosseini-Zare, Mahshid Sadat; Abdulla, Ahmad; Ziburkus, Jokubas] TIMES, Houston, TX 77024 USA; [Gu, Feng] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA		Ziburkus, J (corresponding author), Univ Houston, Dept Biol & Biochem, Houston, TX 77204 USA.; Ziburkus, J (corresponding author), TIMES, Houston, TX 77204 USA.	jziburkus@uh.edu			Dravet Syndrome Foundation; University of Houston's Grants	This research was sponsored by the Dravet Syndrome Foundation and University of Houston's Grants to Advance and Enhance Research (GEAR) funds. We thank Dr. Steven J. Schiff for the invaluable discussions about the role of CSD.	Basarsky TA, 1999, J NEUROSCI, V19, P6439; Bozzo L, 2010, BRAIN RES, V1316, P27, DOI 10.1016/j.brainres.2009.12.028; BURES J, 1957, ELECTROEN CLIN NEURO, V9, P121, DOI 10.1016/0013-4694(57)90116-5; Chuquet J, 2007, J NEUROSCI, V27, P4036, DOI 10.1523/JNEUROSCI.0721-07.2007; DELUCA B, 1977, DEV PSYCHOBIOL, V10, P289, DOI 10.1002/dev.420100402; Dulla CG, 2013, NEUROBIOL DIS, V49, P232, DOI 10.1016/j.nbd.2012.09.001; Eikermann-Haerter K, 2010, CURR NEUROL NEUROSCI, V10, P167, DOI 10.1007/s11910-010-0099-1; Eiselt M, 2004, BRAIN RES, V1028, P83, DOI 10.1016/j.brainres.2004.09.002; FABRICIUS M, 1993, BRAIN RES, V612, P61, DOI 10.1016/0006-8993(93)91644-8; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; Fabricius M, 2008, CLIN NEUROPHYSIOL, V119, P1973, DOI 10.1016/j.clinph.2008.05.025; Goodrich GS, 2013, J NEUROTRAUM, V30, P1434, DOI 10.1089/neu.2012.2712; Gorji A, 2001, BRAIN RES REV, V38, P33, DOI 10.1016/S0165-0173(01)00081-9; Gu F, 2014, EPILEPSIA, V55, P245, DOI 10.1111/epi.12487; Hazra A, 2014, J NEUROSCI RES, V92, P1434, DOI 10.1002/jnr.23430; Hazra A, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064318; Hinzman JM, 2015, EXP NEUROL, V267, P243, DOI 10.1016/j.expneurol.2015.03.014; Hossmann KA, 1996, CEREBROVAS BRAIN MET, V8, P195; KIMELBERG HK, 1990, J NEUROSCI, V10, P1583; Kramer DR, 2016, J CLIN NEUROSCI, V24, P22, DOI 10.1016/j.jocn.2015.08.004; Larrosa B, 2006, NEUROSCIENCE, V141, P1057, DOI 10.1016/j.neuroscience.2006.04.005; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Malkov A, 2014, J CEREBR BLOOD F MET, V34, P1540, DOI 10.1038/jcbfm.2014.121; MARRANNES R, 1988, BRAIN RES, V457, P226, DOI 10.1016/0006-8993(88)90690-7; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Obrenovitch TP, 1996, BRIT J PHARMACOL, V117, P931, DOI 10.1111/j.1476-5381.1996.tb15283.x; OBRENOVITCH TP, 1995, CEREBROVAS BRAIN MET, V7, P1; Rao VLR, 1998, J NEUROCHEM, V70, P2020; Rogatsky G, 1996, J Basic Clin Physiol Pharmacol, V7, P23; Rothstein JD, 1996, NEURON, V16, P675, DOI 10.1016/S0896-6273(00)80086-0; Sheldon AL, 2007, NEUROCHEM INT, V51, P333, DOI 10.1016/j.neuint.2007.03.012; Shimamoto K, 2004, MOL PHARMACOL, V65, P1008, DOI 10.1124/mol.65.4.1008; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Somjen GG, 2004, IONS BRAIN NORMAL FU; Strong AJ, 2002, STROKE, V33, P2738, DOI 10.1161/01.STR.0000043073.69602.09; SZATKOWSKI M, 1990, NATURE, V348, P443, DOI 10.1038/348443a0; Torrente D, 2014, NEUROSCI LETT, V565, P2, DOI 10.1016/j.neulet.2013.12.058; Torrente D, 2014, NEUROSCI LETT, V558, P87, DOI 10.1016/j.neulet.2013.11.004; Tozzi A, 2012, P NATL ACAD SCI USA, V109, P18985, DOI 10.1073/pnas.1215435109; Van Harreveld A, 1970, J Neurobiol, V2, P13, DOI 10.1002/neu.480020103; Vilagi I, 2001, BRAIN RES, V898, P288, DOI 10.1016/S0006-8993(01)02196-5; Zhang Y, 2014, EUR J PHARMACOL, V736, P55, DOI 10.1016/j.ejphar.2014.04.036; Zhang Z, 2007, P NATL ACAD SCI USA, V104, P18025, DOI 10.1073/pnas.0704570104; Zhou N, 2013, J CEREBR BLOOD F MET, V33, P1582, DOI 10.1038/jcbfm.2013.113	44	15	15	0	14	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	SEP	2017	295						155	161		10.1016/j.expneurol.2017.05.002			7	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	FC4OS	WOS:000406820900015	28479338				2022-02-06	
J	Knowles, BM; Dennison, CR				Knowles, Brooklynn M.; Dennison, Christopher R.			Predicting Cumulative and Maximum Brain Strain Measures From HybridIII Head Kinematics: A Combined Laboratory Study and Post-Hoc Regression Analysis	ANNALS OF BIOMEDICAL ENGINEERING			English	Article						Head injury; Brain injury; Brain strain; Injury biomechanics; Concussion; Helmet assessment; Sport biomechanics	UNITED-STATES; ICE HOCKEY; INJURY; CONCUSSION; ACCELERATION; EPIDEMIOLOGY; SPORTS	Due to growing concern on brain injury in sport, and the role that helmets could play in preventing brain injury caused by impact, biomechanics researchers and helmet certification organizations are discussing how helmet assessment methods might change to assess helmets based on impact parameters relevant to brain injury. To understand the relationship between kinematic measures and brain strain, we completed hundreds of impacts using a 50th percentile Hybrid III head-neck wearing an ice hockey helmet and input three-dimensional impact kinematics to a finite element brain model called the Simulated Injury Monitor (SIMon) (n = 267). Impacts to the helmet front, back and side included impact speeds from 1.2 to 5.8 ms(-1). Linear regression models, compared through multiple regression techniques, calculating adjusted R-2 and the F-statistic, determined the most efficient set of kinematics capable of predicting SIMon-computed brain strain, including the cumulative strain damage measure (specifically CSDM-15) and maximum principal strain (MPS). Resultant change in angular velocity, Delta omega(R), better predicted CSDM-15 and MPS than the current helmet certification metric, peak g, and was the most efficient model for predicting strain, regardless of impact location. In nearly all cases, the best two-variable model included peak resultant angular acceleration, alpha(R), and Delta omega(R).	[Knowles, Brooklynn M.; Dennison, Christopher R.] Univ Alberta, Biomed Instrumentat Lab, Dept Mech Engn, Edmonton, AB, Canada		Knowles, BM (corresponding author), Univ Alberta, Biomed Instrumentat Lab, Dept Mech Engn, Edmonton, AB, Canada.	brooklyn@ualberta.ca			Natural Science and Engineering Research Council (NSERC) of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC) [435921]; Pashby Sport Safety Fund [RES0028760]; Banting Research Foundation [31214]; Faculty of Engineering and Department of Mechanical Engineering at the University of Alberta	We gratefully acknowledge funding from the Natural Science and Engineering Research Council (NSERC) of Canada (Discovery Grants 435921), the Pashby Sport Safety Fund (2016: RES0028760), the Banting Research Foundation (Discovery Award 31214), and the Faculty of Engineering and Department of Mechanical Engineering at the University of Alberta.	[Anonymous], F104507 ASTM; [Anonymous], 2015, ND00213M15 NOCSAE; Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; BS, 1960, 18691960 BS; CPSC, 1998, SAF STAND BIC HELM F; CSA, 2012, Z262109 CSA; Daneshvar DH, 2011, CLIN SPORT MED, V30, P145, DOI 10.1016/j.csm.2010.09.006; DEVORE JL, 2000, PROBABILITY STAT ENG; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Gennarelli T. A., 1972, PATHOPHYSIOLOGIC RES; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; GURDJIAN ES, 1966, J TRAUM, V6, P600, DOI 10.1097/00005373-196609000-00005; Halldin P., 2014, 158 CENTC; Hardy WN, 2007, STAPP CAR CRASH JO, V51, P17; Holbourn AHS, 1943, LANCET, V2, P438; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Kimpara, 2011, INT J AUTOMOT ENG, V2, P13, DOI [10.20485/jsaeijae.2.2_13, DOI 10.20485/JSAEIJAE.2.2_13]; Kimpara H, 2012, ANN BIOMED ENG, V40, P114, DOI 10.1007/s10439-011-0414-2; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; MARGULIES SS, 1992, J BIOMECH, V25, P917, DOI 10.1016/0021-9290(92)90231-O; Mueller F. O., 2011, AM FOOTB COACH ASS N; Newman J A, 2000, Stapp Car Crash J, V44, P215; Newman J.A, 1986, P 1986 INT IRCOBI C; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Rowson B, 2015, ANN BIOMED ENG, V43, P2429, DOI 10.1007/s10439-015-1278-7; Rowson S, 2013, ANN BIOMED ENG, V41, P873, DOI 10.1007/s10439-012-0731-0; SAE J211, J211 SAE; Takhounts Erik G, 2013, Stapp Car Crash J, V57, P243; Takhounts EG, 2008, STAPP CAR C, V52, P1; Tarlochan F., 2013, INT, V2, P17; Wennberg RA, 2008, CAN J NEUROL SCI, V35, P647, DOI 10.1017/S031716710000946X; YARNELL P, 1969, B NEW YORK ACAD MED, V45, P39	33	15	15	0	6	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0090-6964	1573-9686		ANN BIOMED ENG	Ann. Biomed. Eng.	SEP	2017	45	9					2146	2158		10.1007/s10439-017-1848-y			13	Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Engineering	FE4QF	WOS:000408197700009	28497321	Green Published, hybrid			2022-02-06	
J	Kumaria, A				Kumaria, Ashwin			In Vitro Models as a Platform to Investigate Traumatic Brain Injury	ATLA-ALTERNATIVES TO LABORATORY ANIMALS			English	Article						head injury; in vitro models; neuroprotection; pathophysiology; Three Rs; traumatic brain injury	CULTURED HIPPOCAMPAL SLICES; ON-A-CHIP; NEURONAL INJURY; AXONAL INJURY; CELL-DEATH; ANIMAL EXPERIMENTATION; ORGANOTYPIC CULTURES; CEREBRAL-ISCHEMIA; NEURAL TRAUMA; LIVING BRAIN	Traumatic Brain Injury (TBI) remains a significant cause of mortality and morbidity, affecting individuals of all age groups. Much remains to be learned about its complex pathophysiology, with a view to designing effective neuroprotective strategies to protect sublethally injured brain tissue that would otherwise die in secondary injury processes. Experimental in vivo models offer the potential to study TBI in the laboratory, however, treatments that were neuroprotective in animals have, thus far, largely failed to translate in human clinical studies. In vitro models of neurotrauma can be used to study specific pathophysiological cascades - individually and without confounding factors - and to test potential neuroprotective strategies. These in vitro models include transection, compression, barotrauma, acceleration, hydrodynamic, chemical injury and cell-stretch methodologies. Various cell culture systems can also be utilised, including brain-on-a-chip, immortalised cell lines, primary cultures, acute preparations and organotypic cultures. Potential positive outcomes of the increased use of in vitro platforms to study TBI would be the refinement of in vivo experiments, as well as enhanced translation of the results into clinically meaningful neuroprotective strategies for the future. In addition, the replacement of in vivo experiments by suitable in vitro studies would lead to a welcome reduction in the numbers of animal procedures in this ethically challenging field.	[Kumaria, Ashwin] Queens Med Ctr, Dept Neurosurg, Nottingham NG7 2UH, England		Kumaria, A (corresponding author), Queens Med Ctr, Dept Neurosurg, Nottingham NG7 2UH, England.	ashwin.kumaria@doctors.org.uk					Akhtar A, 2015, CAMB Q HEALTHC ETHIC, V24, P407, DOI 10.1017/S0963180115000079; Armogida M, 2011, INT J IMMUNOPATH PH, V24, P735, DOI 10.1177/039463201102400320; Arundine M, 2003, J NEUROTRAUM, V20, P1377, DOI 10.1089/089771503322686166; Bahr BA, 1995, HIPPOCAMPUS, V5, P425, DOI 10.1002/hipo.450050505; BALENTINE JD, 1988, LAB INVEST, V58, P93; Balls M, 2016, ATLA-ALTERN LAB ANIM, V44, P511, DOI 10.1177/026119291604400605; Balls M, 2016, ATLA-ALTERN LAB ANIM, V44, P95, DOI 10.1177/026119291604400204; Bottlang M, 2007, J NEUROTRAUM, V24, P1068, DOI 10.1089/neu.2006.3772; Boussouf A, 2000, J NEUROSCI RES, V59, P731, DOI 10.1002/(SICI)1097-4547(20000315)59:6<731::AID-JNR5>3.0.CO;2-G; BUCHS PA, 1993, DEV BRAIN RES, V71, P81, DOI 10.1016/0165-3806(93)90108-M; Cargill RS, 1996, J NEUROTRAUM, V13, P395, DOI 10.1089/neu.1996.13.395; Cengiz N, 2012, J NEUROTRAUM, V29, P2465, DOI 10.1089/neu.2009.0947; Chen YC, 2009, J NEUROTRAUM, V26, P861, DOI 10.1089/neu.2008.0645; Chung RS, 2005, J NEUROTRAUM, V22, P1081, DOI 10.1089/neu.2005.22.1081; Church AJ, 2005, J NEUROTRAUM, V22, P277, DOI 10.1089/neu.2005.22.277; Collin C, 1997, J NEUROPHYSIOL, V77, P1614, DOI 10.1152/jn.1997.77.3.1614; Combes RD, 2014, ATLA-ALTERN LAB ANIM, V42, P245, DOI 10.1177/026119291404200406; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Cullen DK, 2006, J NEUROTRAUM, V23, P1304, DOI 10.1089/neu.2006.23.1304; Dizon MLV, 2006, NEUROSCIENCE, V142, P717, DOI 10.1016/j.neuroscience.2006.06.050; Dolle JP, 2014, TECHNOLOGY, V2, P106, DOI 10.1142/S2339547814500095; Dolle JP, 2013, LAB CHIP, V13, P432, DOI 10.1039/c2lc41063j; Elkin BS, 2007, STAPP CAR CRASH JO, V51, P127; ELLIS EF, 1995, J NEUROTRAUM, V12, P325, DOI 10.1089/neu.1995.12.325; EPSTEIN M H, 1971, Journal of Neurosurgery, V35, P517, DOI 10.3171/jns.1971.35.5.0517; Etzion Y, 2000, EUR J NEUROSCI, V12, P4007, DOI 10.1046/j.1460-9568.2000.00303.x; Faden AI, 2005, NEUROPHARMACOLOGY, V49, P410, DOI 10.1016/j.neuropharm.2005.04.001; Garberg P, 2005, TOXICOL IN VITRO, V19, P299, DOI 10.1016/j.tiv.2004.06.011; Geddes-Klein DM, 2006, J NEUROTRAUM, V23, P193, DOI 10.1089/neu.2006.23.193; GROSS GW, 1983, J NEUROSCI, V3, P1979; Gutierrez R, 1999, BRAIN RES, V815, P304, DOI 10.1016/S0006-8993(98)01101-9; Hall RM, 2006, J NEUROSURG-SPINE, V5, P243, DOI 10.3171/spi.2006.5.3.243; Hartel R, 1997, NEUROSCIENCE, V78, P1; Hudson-Shore M, 2016, ATLA-ALTERN LAB ANIM, V44, P569, DOI 10.1177/026119291604400606; Ikonomidou C, 2002, LANCET NEUROL, V1, P383, DOI 10.1016/S1474-4422(02)00164-3; Johnson Victoria E, 2015, Handb Clin Neurol, V127, P115, DOI 10.1016/B978-0-444-52892-6.00008-8; Kawanabe Y, 2006, J NEUROSURG, V105, P288, DOI 10.3171/jns.2006.105.2.288; KIRKPATRICK JB, 1985, J NEUROPATH EXP NEUR, V44, P268, DOI 10.1097/00005072-198505000-00005; Koshinaga M, 2000, J NEUROTRAUM, V17, P185, DOI 10.1089/neu.2000.17.185; KRABBEL G, 1995, J NEUROTRAUM, V12, P735, DOI 10.1089/neu.1995.12.735; Kuebler ES, 2015, SCI REP-UK, V5, DOI 10.1038/srep17718; Kumaria A, 2008, BRIT J NEUROSURG, V22, P200, DOI 10.1080/02688690701772413; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; LaPlaca MC, 1997, ANN BIOMED ENG, V25, P665, DOI 10.1007/BF02684844; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Loane David J, 2015, Handb Clin Neurol, V127, P343, DOI 10.1016/B978-0-444-52892-6.00022-2; Longhi L, 2001, J CEREBR BLOOD F MET, V21, P1241, DOI 10.1097/00004647-200111000-00001; LUCAS JH, 1991, BRAIN RES, V543, P181, DOI 10.1016/0006-8993(91)90027-S; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; MARGULIES SS, 1990, J BIOMECH, V23, P823, DOI 10.1016/0021-9290(90)90029-3; Mckee Ann C, 2015, Handb Clin Neurol, V127, P45, DOI 10.1016/B978-0-444-52892-6.00004-0; Morganti-Kossmann MC, 2010, INJURY, V41, P10, DOI 10.1016/j.injury.2010.03.032; Morrison B, 1998, J NEUROTRAUM, V15, P911, DOI 10.1089/neu.1998.15.911; Morrison B, 1998, ANN BIOMED ENG, V26, P381, DOI 10.1114/1.61; Morrison B, 2000, NEUROSCIENCE, V96, P131, DOI 10.1016/S0306-4522(99)00537-0; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; Mukhin AG, 1998, J NEUROSCI RES, V51, P748, DOI 10.1002/(SICI)1097-4547(19980315)51:6<748::AID-JNR8>3.0.CO;2-B; MURPHY EJ, 1993, J NEUROTRAUM, V10, P431, DOI 10.1089/neu.1993.10.431; Nakayama Y, 2001, J NEUROTRAUM, V18, P545, DOI 10.1089/089771501300227341; Paemeleire K, 2000, J NEUROTRAUM, V17, P345, DOI 10.1089/neu.2000.17.345; Pamies D, 2014, EXP BIOL MED, V239, P1096, DOI 10.1177/1535370214537738; Panickar KS, 2002, NEUROCHEM RES, V27, P161, DOI 10.1023/A:1014875210852; Panizzon KL, 1998, NEUROREPORT, V9, P4131, DOI 10.1097/00001756-199812210-00024; Park E, 2008, CAN MED ASSOC J, V178, P1163, DOI 10.1503/cmaj.080282; Peeters W, 2015, ACTA NEUROCHIR, V157, P1683, DOI 10.1007/s00701-015-2512-7; POVLISHOCK JT, 1995, J NEUROTRAUM, V12, P555, DOI 10.1089/neu.1995.12.555; Raman, 1928, DEGENERATION REGENER; ROBAIN O, 1994, DEV BRAIN RES, V80, P244, DOI 10.1016/0165-3806(94)90109-0; SAHAY KB, 1992, J BIOMECH, V25, P319, DOI 10.1016/0021-9290(92)90029-Z; SHEPARD SR, 1991, J SURG RES, V51, P417, DOI 10.1016/0022-4804(91)90144-B; Sieg F, 1999, J NEUROTRAUM, V16, P1197, DOI 10.1089/neu.1999.16.1197; Smith D, 1999, J NEUROSCI, V19, P4263; TECOMA ES, 1989, NEURON, V2, P1541, DOI 10.1016/0896-6273(89)90042-1; Tolias Christos M, 2004, NeuroRx, V1, P71, DOI 10.1007/BF03206568; Triyoso DH, 1999, J PHYSIOL-LONDON, V515, P355, DOI 10.1111/j.1469-7793.1999.355ac.x; Wallis RA, 1995, EUR J PHARMACOL, V294, P475, DOI 10.1016/0014-2999(95)00568-4; Wilhelmi E, 2002, ATLA-ALTERN LAB ANIM, V30, P275, DOI 10.1177/026119290203000304; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407	81	15	15	5	28	FRAME	NOTTINGHAM	RUSSELL & BURCH HOUSE 96-98 NORTH SHERWOOD ST, NOTTINGHAM NG1 4EE, NOTTS, ENGLAND	0261-1929			ATLA-ALTERN LAB ANIM	ATLA-Altern. Lab. Anim.	SEP	2017	45	4					201	211		10.1177/026119291704500405			11	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	FY4PK	WOS:000426806800009	28994300				2022-02-06	
J	Rajajee, V; Riggs, B; Seder, DB				Rajajee, Venkatakrishna; Riggs, Becky; Seder, David B.			Emergency Neurological Life Support: Airway, Ventilation, and Sedation	NEUROCRITICAL CARE			English	Article						Airway; Ventilation; Sedation; Neurocritical care; Emergency	INTENSIVE-CARE-UNIT; RAPID-SEQUENCE INTUBATION; CEREBRAL-BLOOD-FLOW; CRITICALLY-ILL PATIENTS; TRAUMATIC BRAIN-INJURY; DIFFICULT TRACHEAL INTUBATION; CERVICAL-SPINE MOTION; NASAL CANNULA OXYGEN; HEART-ASSOCIATION GUIDELINES; AWAKE FIBEROPTIC INTUBATION	Airway management and ventilation are central to the resuscitation of the neurologically ill. These patients often have evolving processes that threaten the airway and adequate ventilation. Furthermore, intubation, ventilation, and sedative choices directly affect brain perfusion. Therefore, Airway, Ventilation, and Sedation was chosen as an Emergency Neurological Life Support protocol. Topics include airway management, when and how to intubate with special attention to hemodynamics and preservation of cerebral blood flow, mechanical ventilation settings and the use of sedative agents based on the patient's neurological status.	[Rajajee, Venkatakrishna] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA; [Rajajee, Venkatakrishna] Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA; [Riggs, Becky] Johns Hopkins Univ, Dept Pediat, Baltimore, MD 21218 USA; [Seder, David B.] Tufts Univ, Sch Med, Maine Med Ctr, Dept Crit Care Serv, Boston, MA 02111 USA		Rajajee, V (corresponding author), Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA.; Rajajee, V (corresponding author), Univ Michigan, Dept Neurol, Ann Arbor, MI 48109 USA.	vrajajee@yahoo.com; sederd@mmc.org		Seder, David/0000-0002-9717-1038			Abel M, 2002, MT SINAI J MED, V69, P31; Abou-Chebl A, 2010, STROKE, V41, P1175, DOI 10.1161/STROKEAHA.109.574129; Al MJ, 2010, CRIT CARE, V14, DOI 10.1186/cc9313; Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Amer Soc Anesthesiologists, 2013, ANESTHESIOLOGY, V118, P251, DOI 10.1097/ALN.0b013e31827773b2; [Anonymous], 2009, P ANN M AM SOC AN NE; Austin Naola, 2014, Int J Crit Illn Inj Sci, V4, P50, DOI 10.4103/2229-5151.128013; Avitsian R, 2005, J NEUROSURG ANESTH, V17, P97, DOI 10.1097/01.ana.0000161268.01279.ba; Baillard C, 2006, AM J RESP CRIT CARE, V174, P171, DOI 10.1164/rccm.200509-1507OC; Balan IS, 2006, STROKE, V37, P3008, DOI 10.1161/01.STR.0000248455.73785.b1; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; Barr J, 2013, CRIT CARE MED, V41, P263, DOI 10.1097/CCM.0b013e3182783b72; BEDFORD RF, 1980, ANESTH ANALG, V59, P435; Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; Bennett SS, 2007, NEUROCRIT CARE, V7, P221, DOI 10.1007/s12028-007-0084-y; Bergen Joseph M., 1997, Journal of Emergency Medicine, V15, P221, DOI 10.1016/S0736-4679(96)00350-2; Bergeron N, 2001, INTENS CARE MED, V27, P859, DOI 10.1007/s001340100909; Bittigau P, 2002, P NATL ACAD SCI USA, V99, P15089, DOI 10.1073/pnas.222550499; Bosch J, 2014, EMERG MED J, V31, P750, DOI 10.1136/emermed-2012-202283; Bourgoin A, 2003, CRIT CARE MED, V31, P711, DOI 10.1097/01.CCM.0000044505.24727.16; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS37; Bray RJ, 1998, PAEDIATR ANAESTH, V8, P491; Brinjikji W, 2015, AM J NEURORADIOL, V36, P525, DOI 10.3174/ajnr.A4159; Brock-Utne JG, 2002, PAEDIATR ANAESTH, V12, P1, DOI 10.1046/j.1460-9592.2002.00824.x; Brook AD, 1999, CRIT CARE MED, V27, P2609, DOI 10.1097/00003246-199912000-00001; Brower RG, 2000, NEW ENGL J MED, V342, P1301, DOI 10.1056/nejm200005043421801; Brown CA, 2010, ANN EMERG MED, V56, P83, DOI 10.1016/j.annemergmed.2010.01.033; Brown RL, 2001, J PEDIATR SURG, V36, P1107, DOI 10.1053/jpsu.2001.25665; Brucken A, 2010, RESUSCITATION, V81, P1698, DOI 10.1016/j.resuscitation.2010.06.027; Caricato A, 2005, J TRAUMA, V58, P571, DOI 10.1097/01.TA.0000152806.19198.DB; Carrera E, 2010, J NEUROL NEUROSUR PS, V81, P793, DOI 10.1136/jnnp.2009.174425; Chen HI, 2008, NEUROSURGERY, V63, P880, DOI 10.1227/01.NEU.0000327882.10629.06; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; CHESNUT RM, 1993, ACTA NEUROCHIR, P121; Citerio Giuseppe, 2003, Curr Opin Crit Care, V9, P120, DOI 10.1097/00075198-200304000-00007; Coles JP, 2007, CRIT CARE MED, V35, P568, DOI 10.1097/01.CCM.0000254066.37187.88; Coles JP, 2002, CRIT CARE MED, V30, P1950, DOI 10.1097/00003246-200209000-00002; Collins JS, 2004, OBES SURG, V14, P1171, DOI 10.1381/0960892042386869; Collins SR, 2014, RESP CARE, V59, P865, DOI 10.4187/respcare.03012; Cook TM, 2015, BRIT J ANAESTH, V115, P497, DOI 10.1093/bja/aev156; Cook TM, 2011, BRIT J ANAESTH, V106, P632, DOI 10.1093/bja/aer059; Cook TM, 2011, BRIT J ANAESTH, V106, P617, DOI 10.1093/bja/aer058; Cooper RM, 2013, ANAESTHESIA, V68, P217, DOI 10.1111/anae.12139; Coplin WM, 2000, AM J RESP CRIT CARE, V161, P1530, DOI 10.1164/ajrccm.161.5.9905102; CORMACK RS, 1984, ANAESTHESIA, V39, P1105, DOI 10.1111/j.1365-2044.1984.tb08932.x; Cote C, 2009, PRACTICE ANESTHESIA, P237; Davis DP, 2005, J TRAUMA, V59, P484, DOI 10.1097/00005373-200508000-00037; Davis DP, 2006, CRIT CARE MED, V34, P1202, DOI 10.1097/01.CCM.0000208359.74623.1C; Davis DP, 2004, J TRAUMA, V56, P808, DOI 10.1097/01.TA.0000100217.05066.87; De Jong A, 2014, INTENS CARE MED, V40, P629, DOI 10.1007/s00134-014-3236-5; Deogaonkar A, 2004, CRIT CARE MED, V32, P2403, DOI 10.1097/01.CCM.0000147442.14921.A5; Devabhakthuni S, 2012, ANN PHARMACOTHER, V46, P530, DOI 10.1345/aph.1Q525; Dhakal LP, 2015, STROKE, V46, P1748, DOI 10.1161/STROKEAHA.115.008223; Diringer MN, 2002, J NEUROSURG, V96, P103, DOI 10.3171/jns.2002.96.1.0103; DONEGAN MF, 1980, ANESTHESIOLOGY, V52, P516, DOI 10.1097/00000542-198006000-00014; Downard C, 2000, J TRAUMA, V49, P654, DOI 10.1097/00005373-200010000-00012; Dumont TM, 2010, J NEUROTRAUM, V27, P1233, DOI 10.1089/neu.2009.1216; Dyer BA, 2013, CRIT CARE NURS Q, V36, P310, DOI 10.1097/CNQ.0b013e318294ea8f; ELIASJONES AC, 1992, ARCH DIS CHILD, V67, P1430, DOI 10.1136/adc.67.12.1430; Ellis DY, 2007, ANN EMERG MED, V50, P653, DOI 10.1016/j.annemergmed.2007.05.006; Elmer J, 2015, INTENS CARE MED, V41, P49, DOI 10.1007/s00134-014-3555-6; Ely EW, 2003, JAMA-J AM MED ASSOC, V289, P2983, DOI 10.1001/jama.289.22.2983; Erdman MJ, 2014, CRIT CARE MED, V42, P1696, DOI 10.1097/CCM.0000000000000328; Filanovsky Y, 2010, CAN J EMERG MED, V12, P154; Flandreau G, 2011, RESP CARE, V56, P953, DOI 10.4187/respcare.00862; Fraser GL, 2001, PHARMACOTHERAPY, V21, P1, DOI 10.1592/phco.21.1.1.34444; Freeman SS, 2008, ANESTHESIOLOGY, V108, P588, DOI 10.1097/ALN.0b013e31816725d7; Frerk C, 2015, BRIT J ANAESTH, V115, P827, DOI 10.1093/bja/aev371; Gabriel Edward J., 2002, Journal of Neurotrauma, V19, P111; Galinski M, 2006, ANN EMERG MED, V47, P545, DOI 10.1016/j.annemergmed.2005.08.012; Griesdale DEG, 2012, CAN J ANESTH, V59, P1032, DOI 10.1007/s12630-012-9775-8; Griesdale DEG, 2012, CAN J ANESTH, V59, P41, DOI 10.1007/s12630-011-9620-5; Grof TM, 2010, NEUROCRIT CARE, V12, P356, DOI 10.1007/s12028-008-9156-x; Gronert GA, 2001, ANESTHESIOLOGY, V94, P523, DOI 10.1097/00000542-200103000-00026; Hardman JG, 2003, ANESTH ANALG, V97, P1846, DOI 10.1213/01.ANE.0000090316.46604.89; HAUSWALD M, 1991, AM J EMERG MED, V9, P535, DOI 10.1016/0735-6757(91)90106-T; Helm M, 2003, BRIT J ANAESTH, V90, P327, DOI 10.1093/bja/aeg069; Henzler D, 2007, CRIT CARE MED, V35, P1027, DOI 10.1097/01.CCM.0000259526.45894.08; Himmelseher S, 2005, ANESTH ANALG, V101, P524, DOI 10.1213/01.ANE.0000160585.43587.5B; Hopkins RO, 2006, CHEST, V130, P869, DOI 10.1378/chest.130.3.869; Horinek EL, 2009, ANN PHARMACOTHER, V43, P1964, DOI 10.1345/aph.1M313; Iyer VN, 2009, CRIT CARE MED, V37, P3024, DOI 10.1097/CCM.0b013e3181b08ac7; Jaber S, 2006, CRIT CARE MED, V34, P2355, DOI 10.1097/01.CCM.0000233879.58720.87; Jaber S, 2016, INTENS CARE MED, V42, P1877, DOI 10.1007/s00134-016-4588-9; Jaber S, 2010, INTENS CARE MED, V36, P248, DOI 10.1007/s00134-009-1717-8; Jacobi J, 2002, CRIT CARE MED, V30, P119, DOI 10.1097/00003246-200201000-00020; Jakob SM, 2012, JAMA-J AM MED ASSOC, V307, P1151, DOI 10.1001/jama.2012.304; Janz DR, 2016, CRIT CARE MED, V44, P1980, DOI 10.1097/CCM.0000000000001841; Jevtovic-Todorovic V, 2003, J NEUROSCI, V23, P876, DOI 10.1523/jneurosci.23-03-00876.2003; Jones AE, 2008, RESUSCITATION, V77, P26, DOI 10.1016/j.resuscitation.2007.10.021; Jones C, 2007, INTENS CARE MED, V33, P978, DOI 10.1007/s00134-007-0600-8; Karabinis A, 2004, CRIT CARE, V8, pR268, DOI 10.1186/cc2896; Khine HH, 1997, ANESTHESIOLOGY, V86, P627, DOI 10.1097/00000542-199703000-00015; Kilgannon JH, 2011, CIRCULATION, V123, P2717, DOI 10.1161/CIRCULATIONAHA.110.001016; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; Kilgannon JH, 2008, RESUSCITATION, V79, P410, DOI 10.1016/j.resuscitation.2008.07.019; Kill C, 2013, J EMERG MED, V44, P750, DOI 10.1016/j.jemermed.2012.07.080; KING BR, 1993, ANN EMERG MED, V22, P530, DOI 10.1016/S0196-0644(05)81937-7; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Koenig MA, 2008, NEUROLOGY, V70, P1023, DOI 10.1212/01.wnl.0000304042.05557.60; Koutsoukou A, 2006, INTENS CARE MED, V32, P1947, DOI 10.1007/s00134-006-0406-0; KOVARIK WD, 1994, ANESTH ANALG, V78, P469; Kox WJ, 2006, ANESTH ANALG, V102, P825, DOI 10.1213/01.ane.0000197776.26307.fa; Kress JP, 2000, NEW ENGL J MED, V342, P1471, DOI 10.1056/NEJM200005183422002; Landsman I, 2004, PAEDIATR ANAESTH, V14, P43, DOI 10.1046/j.1460-9592.2003.01202.x; Langsjo JW, 2005, ANESTHESIOLOGY, V103, P258; Larach MG, 1997, CLIN PEDIATR, V36, P9; Lascarrou JB, 2017, JAMA-J AM MED ASSOC, V317, P483, DOI 10.1001/jama.2016.20603; Law JA, 2013, CAN J ANESTH, V60, P1089, DOI 10.1007/s12630-013-0019-3; LAWES EG, 1987, BRIT J ANAESTH, V59, P315, DOI 10.1093/bja/59.3.315; Lee C, 2009, ANESTHESIOLOGY, V110, P1020, DOI 10.1097/ALN.0b013e31819dabb0; Lev Roneet, 1994, Journal of Emergency Medicine, V12, P499, DOI 10.1016/0736-4679(94)90347-6; Levitan RM, 2006, ACAD EMERG MED, V13, P1255, DOI 10.1197/j.aem.2006.06.058; Lewis SR, 2016, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD011136.pub2; Li J, 1999, AM J EMERG MED, V17, P141, DOI 10.1016/S0735-6757(99)90046-3; Loepke AW, 2008, ANESTH ANALG, V106, P1681, DOI 10.1213/ane.0b013e318167ad77; Lucking SMF, 2012, PEDIAT CRITICAL CARE, P690; Malcharek MJ, 2012, J NEUROSURG ANESTH, V24, P217, DOI 10.1097/ANA.0b013e31824da7e5; MALLAMPATI SR, 1985, CAN ANAESTH SOC J, V32, P429, DOI 10.1007/BF03011357; Marik PE, 2012, NEUROCRIT CARE, V17, P219, DOI 10.1007/s12028-012-9739-4; Marshall GT, 2010, J TRAUMA, V69, P275, DOI 10.1097/TA.0b013e3181de74c7; Martyn JAJ, 2006, ANESTHESIOLOGY, V104, P158, DOI 10.1097/00000542-200601000-00022; McConnell RA, 2016, RESP CARE, V61, P902, DOI 10.4187/respcare.04191; Mehta S, 2008, CRIT CARE MED, V36, P2092, DOI 10.1097/CCM.0b013e31817bff85; Miguel-Montanes R, 2015, CRIT CARE MED, V43, P574, DOI 10.1097/CCM.0000000000000743; Mosier JM, 2017, INTENS CARE MED, V43, P226, DOI 10.1007/s00134-016-4426-0; MOSS E, 1979, BRIT J ANAESTH, V51, P347, DOI 10.1093/bja/51.4.347; MOYNIHAN RJ, 1993, ANESTHESIOLOGY, V78, P652, DOI 10.1097/00000542-199304000-00007; Muench E, 2005, CRIT CARE MED, V33, P2367, DOI 10.1097/01.CCM.0000181732.37319.DF; MUIZELAAR JP, 1991, J NEUROSURG, V75, P731, DOI 10.3171/jns.1991.75.5.0731; Murray Michael J, 2002, CJEM, V4, P338; Myatra SN, 2016, INDIAN J ANAESTH, V60, P922, DOI 10.4103/0019-5049.195485; Nemergut ME, 2014, PEDIATR ANESTH, V24, P120, DOI 10.1111/pan.12325; NOLAN JP, 1993, ANAESTHESIA, V48, P630, DOI 10.1111/j.1365-2044.1993.tb07133.x; Noppens RR, 2010, ANAESTHESIA, V65, P716, DOI 10.1111/j.1365-2044.2010.06388.x; Oddo M, 2014, NEUROCRIT CARE, V21, P103, DOI 10.1007/s12028-014-0024-6; Oertel M, 2002, J NEUROSURG, V97, P1045, DOI 10.3171/jns.2002.97.5.1045; Olson DM, 2009, NEUROCRIT CARE, V11, P20, DOI 10.1007/s12028-008-9184-6; Orebaugh SL, 2002, J EMERG MED, V22, P31, DOI 10.1016/S0736-4679(01)00435-8; PARKE TJ, 1992, BRIT MED J, V305, P613, DOI 10.1136/bmj.305.6854.613; Patanwala AE, 2016, PHARMACOTHERAPY, V36, P57, DOI 10.1002/phar.1683; PATEL R, 1994, CAN J ANAESTH, V41, P771, DOI 10.1007/BF03011582; Paule MG, 2011, NEUROTOXICOL TERATOL, V33, P220, DOI 10.1016/j.ntt.2011.01.001; Peberdy MA, 2010, CIRCULATION, V122, pS768, DOI 10.1161/CIRCULATIONAHA.110.971002; Petridis AK, 2010, ACTA NEUROCHIR, V152, P2143, DOI 10.1007/s00701-010-0761-z; Phipps Lorri M, 2005, Pediatr Crit Care Med, V6, P519, DOI 10.1097/01.PCC.0000165802.32383.9E; Piastra M, 2006, RESPIRATION, V73, P791, DOI 10.1159/000090777; Piepho T, 2011, ANAESTHESIA, V66, P1101, DOI 10.1111/j.1365-2044.2011.06872.x; Pohl D, 1999, P NATL ACAD SCI USA, V96, P2508, DOI 10.1073/pnas.96.5.2508; POKELA ML, 1993, DEV PHARMACOL THERAP, V20, P26, DOI 10.1159/000457538; Prough DS, 1997, J TRAUMA, V42, pS10, DOI 10.1097/00005373-199705001-00003; Qureshi AI, 2000, CRIT CARE MED, V28, P1556, DOI 10.1097/00003246-200005000-00049; Rangel-Castilla L, 2010, J NEUROTRAUM, V27, P1853, DOI 10.1089/neu.2010.1339; REDDY RV, 1993, ANESTH ANALG, V77, P1008; Reed MJ, 2005, EMERG MED J, V22, P99, DOI 10.1136/emj.2003.008771; Reinprecht A, 2003, CRIT CARE MED, V31, P1831, DOI 10.1097/01.CCM.0000063453.93855.0A; Reynolds SF, 2005, CHEST, V127, P1397, DOI 10.1378/chest.127.4.1397; Rice MJ, 2009, ANESTH ANALG, V109, P1546, DOI 10.1213/ane.0b013e3181b05404; Riker RR, 2014, NEUROCRIT CARE, V21, P27, DOI 10.1007/s12028-014-0025-5; Riker Richard R, 2011, Anesthesiol Clin, V29, P663, DOI 10.1016/j.anclin.2011.09.006; Riker RR, 1999, CRIT CARE MED, V27, P1325, DOI 10.1097/00003246-199907000-00022; Robitaille A, 2008, ANESTH ANALG, V106, P935, DOI 10.1213/ane.0b013e318161769e; Rosenblatt WH, 1998, ANESTH ANALG, V87, P153, DOI 10.1097/00000539-199807000-00032; Roth C, 2014, NEUROCRIT CARE, V21, P186, DOI 10.1007/s12028-014-0004-x; Sagarin MJ, 2002, PEDIATR EMERG CARE, V18, P417, DOI 10.1097/00006565-200212000-00004; Sagarin MJ, 2005, ANN EMERG MED, V46, P328, DOI 10.1016/j.annemergmed.2005.01.009; Sakles JC, 1998, ANN EMERG MED, V31, P325, DOI 10.1016/S0196-0644(98)70342-7; Sakles JC, 2016, ACAD EMERG MED, V23, P703, DOI 10.1111/acem.12931; Sakles JC, 2012, ACAD EMERG MED, V19, P235, DOI 10.1111/j.1553-2712.2011.01271.x; Salhi B, 2007, ANN EMERG MED, V49, P84, DOI 10.1016/j.annemergmed.2006.09.003; Samaniego EA, 2011, NEUROCRIT CARE, V15, P113, DOI 10.1007/s12028-010-9412-8; Sample GMP, 2010, CRIT CARE S1, V14, P231; SAMSOON GLT, 1987, ANAESTHESIA, V42, P487, DOI 10.1111/j.1365-2044.1987.tb04039.x; Sawin PD, 1996, ANESTHESIOLOGY, V85, P26, DOI 10.1097/00000542-199607000-00005; Schmidt UH, 2008, ANESTHESIOLOGY, V109, P973, DOI 10.1097/ALN.0b013e31818ddb90; Schonenberger S, 2016, JAMA-J AM MED ASSOC, V316, P1986, DOI 10.1001/jama.2016.16623; Schramm P, 2013, J NEUROSURG ANESTH, V25, P162, DOI 10.1097/ANA.0b013e31827c2f46; Seder DB, 2009, CLIN CHEST MED, V30, P103, DOI 10.1016/j.ccm.2008.11.004; Sehdev Rajesh S, 2006, Emerg Med Australas, V18, P37; Semler MW, 2016, AM J RESP CRIT CARE, V193, P273, DOI 10.1164/rccm.201507-1294OC; Seneviratne J, 2008, ARCH NEUROL-CHICAGO, V65, P54, DOI 10.1001/archneurol.2007.1; Sessler CN, 2002, AM J RESP CRIT CARE, V166, P1338, DOI 10.1164/rccm.2107138; Silverberg MJ, 2015, CRIT CARE MED, V43, P636, DOI 10.1097/CCM.0000000000000751; Simpson GD, 2012, BRIT J ANAESTH, V108, P792, DOI 10.1093/bja/aer504; Skippen P, 1997, CRIT CARE MED, V25, P1402, DOI 10.1097/00003246-199708000-00031; Skoglund K, 2009, NEUROCRIT CARE, V11, P135, DOI 10.1007/s12028-009-9255-3; Sorensen MK, 2012, BRIT J ANAESTH, V108, P682, DOI 10.1093/bja/aer503; Spies C, 2011, INTENS CARE MED, V37, P469, DOI 10.1007/s00134-010-2100-5; Stocchetti N, 2005, CHEST, V127, P1812, DOI 10.1378/chest.127.5.1812; Stocchetti N, 1996, J TRAUMA, V40, P764, DOI 10.1097/00005373-199605000-00014; Strom T, 2010, LANCET, V375, P475, DOI 10.1016/S0140-6736(09)62072-9; Su YC, 2011, EUR J ANAESTH, V28, P788, DOI 10.1097/EJA.0b013e32834a34f3; Teitelbaum JS, 2011, CAN J NEUROL SCI, V38, P815, DOI 10.1017/S0317167100012385; Treggiari MM, 2009, CRIT CARE MED, V37, P2527, DOI 10.1097/CCM.0b013e3181a5689f; Trzeciak S, 2009, CRIT CARE MED, V37, P2895, DOI 10.1097/CCM.0b013e3181b01d8c; Turkstra TP, 2005, ANESTH ANALG, V101, P910, DOI 10.1213/01.ane.0000166975.38649.27; van Rompaey B, 2009, CRIT CARE, V13, DOI 10.1186/cc7892; Vourc'h M, 2015, INTENS CARE MED, V41, P1538, DOI 10.1007/s00134-015-3796-z; Walls R. M., 2008, MANUAL EMERGENCY AIR, V3rd; WALLS RM, 1993, ANN EMERG MED, V22, P1008, DOI 10.1016/S0196-0644(05)82743-X; Walsh BK, 2011, RESP CARE, V56, P503, DOI 10.4187/respcare.01175; Wang CH, 2014, RESUSCITATION, V85, P1142, DOI 10.1016/j.resuscitation.2014.05.021; Weiler N, 1995, Prehosp Disaster Med, V10, P101; Weingart S, 2007, ANN EMERG MED, V50, P353, DOI 10.1016/j.annemergmed.2007.02.032; Weiss M, 2009, BRIT J ANAESTH, V103, P867, DOI 10.1093/bja/aep290; Weiss M, 2008, PEDIATR ANESTH, V18, P97, DOI 10.1111/j.1460-9592.2007.02324.x; Yahwak JA, 2008, PHARMACOTHERAPY, V28, P984, DOI 10.1592/phco.28.8.984; Yeganeh N, 2010, J TRAUMA, V69, P1185, DOI 10.1097/TA.0b013e3181cb4434; Yentis SM, 1998, ANAESTHESIA, V53, P1041, DOI 10.1046/j.1365-2044.1998.00605.x; Zelicof-Paul A, 2005, CURR OPIN PEDIATR, V17, P355, DOI 10.1097/01.mop.0000162365.64140.b7	211	15	15	0	2	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	1541-6933	1556-0961		NEUROCRIT CARE	Neurocrit. Care	SEP	2017	27			1			S4	S28		10.1007/s12028-017-0451-2			25	Critical Care Medicine; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FU8HO	WOS:000424094100002	28913751				2022-02-06	
J	Robinson, ME; Clark, DC; Milberg, WP; McGlinchey, RE; Salat, DH				Robinson, Meghan E.; Clark, Dustin C.; Milberg, William P.; McGlinchey, Regina E.; Salat, David H.			Characterization of Differences in Functional Connectivity Associated with Close-Range Blast Exposure	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; military injury; MRI	TRAUMATIC BRAIN-INJURY; SURFACE-BASED ANALYSIS; CONCUSSIVE BLAST; SIGNAL; MODEL; SEGMENTATION; FLUCTUATIONS; POPULATIONS; EXPRESSION; VARIANCE	Despite the prevalence of blast injuries in recent overseas conflicts, knowledge of their impact on neural health is lacking. We have recently published work demonstrating differences in functional magnetic resonance imaging (fMRI) connectivity that were specific to close-range blast exposure (CBE), as opposed to other prevalent military-related factors. Here, we replicate this finding in an independent sample of 135 veterans, again finding that CBE, regardless of concussion, is predictive of persistent changes in brain physiology. Although there was weak overlap anatomically, in both samples, the group differences could be described as spreading of anticorrelation. Using the combined sample, we now seek to identify likely mechanisms that could bring about this effect. We compared participants with (n=116) and without (n=153) CBE by analyzing two networks through group difference maps and correlation distributions to assess spatially homogenous and heterogeneous effects. As boundaries between positive and negative correlations in fcMRI are determined by noise covariates, we compared analyses with and without global signal regression. We found evidence of widespread altered connectivity that was spatially heterogeneous across participants, and that the role of global signal regression was network dependent. These findings are not consistent with expected results from damaged white matter or impaired neural function. Rather, potential biological interpretations include disrupted cerebral blood flow or impaired neurovascular coupling, which have each been observed in animal models of blast exposure. Further targeted work will be necessary to distinguish the contribution of each of these mechanisms to producing changes in brain function associated with CBE.	[Robinson, Meghan E.; Clark, Dustin C.; Salat, David H.] VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, 150 South Huntington Ave, Boston, MA 02132 USA; [Robinson, Meghan E.; Milberg, William P.; McGlinchey, Regina E.; Salat, David H.] VA Boston Healthcare Syst, Translat Res Ctr TBI & Stress Disorders TRACTS, Natl Res Ctr, Boston, MA 02132 USA; [Milberg, William P.; McGlinchey, Regina E.] VA Boston Healthcare Syst, GRECC, Boston, MA 02132 USA; [Robinson, Meghan E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Milberg, William P.; McGlinchey, Regina E.] Harvard Med Sch, Dept Psychiat, Boston, MA USA		Robinson, ME (corresponding author), VA Boston Healthcare Syst, Neuroimaging Res Vet NeRVe Ctr, 150 South Huntington Ave, Boston, MA 02132 USA.	dr.meghan.robinson@gmail.com			Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Research Center [B9254-C]	This research was supported by the Translational Research Center for TBI and Stress Disorders (TRACTS), a VA Rehabilitation Research and Development Traumatic Brain Injury National Research Center (B9254-C).	Abbas K, 2015, BRAIN CONNECT, V5, P91, DOI 10.1089/brain.2014.0279; Bandettini PA, 2014, BRAIN CONNECT, V4, P487, DOI 10.1089/brain.2014.0288; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Behrens TEJ, 2012, CURR OPIN NEUROBIOL, V22, P144, DOI 10.1016/j.conb.2011.08.005; Bir C, 2012, MAGN RESON IMAGING, V30, P527, DOI 10.1016/j.mri.2011.12.003; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Blake D, 2006, J TRAUMA STRESS, V8, P75; Bright MG, 2015, NEUROIMAGE, V114, P158, DOI 10.1016/j.neuroimage.2015.03.070; Cernak I, 2001, BRAIN INJURY, V15, P593, DOI 10.1080/02699050010009559; Cernak Ibolja, 2010, Front Neurol, V1, P151, DOI 10.3389/fneur.2010.00151; Cernak I, 2011, NEUROBIOL DIS, V41, P538, DOI 10.1016/j.nbd.2010.10.025; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; D'Esposito M, 2003, NAT REV NEUROSCI, V4, P863, DOI 10.1038/nrn1246; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Davenport ND, 2012, NEUROIMAGE, V59, P2017, DOI 10.1016/j.neuroimage.2011.10.050; Elder GA, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00269; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fischl B, 1999, NEUROIMAGE, V9, P195, DOI 10.1006/nimg.1998.0396; Fischl B, 2002, NEURON, V33, P341, DOI 10.1016/S0896-6273(02)00569-X; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gonzalez-Castillo J, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00138; Greicius MD, 2009, CEREB CORTEX, V19, P72, DOI 10.1093/cercor/bhn059; Hahamy A, 2014, BRAIN CONNECT, V4, P395, DOI 10.1089/brain.2014.0244; Han K, 2014, NEUROIMAGE, V84, P76, DOI 10.1016/j.neuroimage.2013.08.017; Handwerker DA, 2007, HUM BRAIN MAPP, V28, P846, DOI 10.1002/hbm.20307; Hayes JP, 2015, NEUROIMAGE-CLIN, V8, P148, DOI 10.1016/j.nicl.2015.04.001; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huber BR, 2013, J ALZHEIMERS DIS, V37, P309, DOI 10.3233/JAD-130182; Jenkinson M, 2012, NEUROIMAGE, V62, P782, DOI 10.1016/j.neuroimage.2011.09.015; Kamnaksh A., 2014, TRANSL PROTEOM, V3, P22, DOI [10.1016/j.trprot.2013.11.001, DOI 10.1016/J.TRPROT.2013.11.001]; Kamnaksh A, 2012, ELECTROPHORESIS, V33, P3680, DOI 10.1002/elps.201200319; Lu J, 2012, J NEUROTRAUM, V29, P1434, DOI 10.1089/neu.2010.1591; Mac Donald CL, 2017, NEUROIMAGE-CLIN, V14, P371, DOI 10.1016/j.nicl.2017.02.005; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; McGlinchey R., 2017, INT J METHO IN PRESS; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; Murphy K., 2016, NEUROIMAGE IN PRESS; Murphy K, 2011, NEUROIMAGE, V54, P369, DOI 10.1016/j.neuroimage.2010.07.059; Murphy K, 2009, NEUROIMAGE, V44, P893, DOI 10.1016/j.neuroimage.2008.09.036; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Robinson ME, 2015, HUM BRAIN MAPP, V36, P911, DOI 10.1002/hbm.22675; Saad ZS, 2012, BRAIN CONNECT, V2, P25, DOI 10.1089/brain.2012.0080; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Scholvinck ML, 2010, P NATL ACAD SCI USA, V107, P10238, DOI 10.1073/pnas.0913110107; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Shmuel A, 2008, HUM BRAIN MAPP, V29, P751, DOI 10.1002/hbm.20580; Shmueli K, 2007, NEUROIMAGE, V38, P306, DOI 10.1016/j.neuroimage.2007.07.037; Taber KH, 2015, J HEAD TRAUMA REHAB, V30, pE15, DOI 10.1097/HTR.0000000000000030; Tompkins P, 2013, J NEUROTRAUM, V30, P1888, DOI 10.1089/neu.2012.2674; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Van Dijk KRA, 2010, J NEUROPHYSIOL, V103, P297, DOI 10.1152/jn.00783.2009	55	15	15	0	2	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34			1			S53	S61		10.1089/neu.2016.4709			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	FI2DA	WOS:000411746000007	28486051	Bronze			2022-02-06	
J	Taylor, BC; Campbell, EH; Nugent, S; Bidelspach, DE; Kehle-Forbes, SM; Scholten, J; Stroupe, KT; Sayer, NA				Taylor, Brent C.; Campbell, Emily Hagel; Nugent, Sean; Bidelspach, Douglas E.; Kehle-Forbes, Shannon M.; Scholten, Joel; Stroupe, Kevin T.; Sayer, Nina A.			Three Year Trends in Veterans Health Administration Utilization and Costs after Traumatic Brain Injury Screening among Veterans with Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						brain injuries; healthcare costs; traumatic injury; utilization; veterans	WAR; IRAQ; AFGHANISTAN; SEQUELAE; OUTCOMES	Examination of trends in Veterans Health Administration (VHA) healthcare utilization and costs among veterans with mild traumatic brain injury (mTBI) is needed to inform policy, resource allocation, and treatment planning. The objective of this study was to assess the patterns of VHA healthcare utilization and costs in the 3 years following TBI screening among veterans with mTBI, compared with veterans without TBI. A retrospective cohort study of veterans who underwent TBI screening in fiscal year 2010 was conducted. We used VHA healthcare utilization and associated costs by categories of care to compare veterans diagnosed with mTBI (n = 7318) with those who screened negative (n = 75,294) and those who screened positive but had TBI ruled out (n = 3324). Utilization and costs were greatest in year 1, dropped in year 2, and then leveled off. mTBI diagnosis was associated with high rates of utilization. Each year, healthcare costs for those with mTBI were two to three times higher than for those who screened negative, and 20-25% higher than for those who screened positive but had TBI ruled out. A significant proportion of healthcare use and costs for veterans with mTBI were associated with mental health service utilization. The relatively high rate of VHA utilization and costs associated with mTBI over time demonstrates the importance of long-term planning to meet these veterans' needs. Identifying and engaging patients with mTBI in effective mental health treatments should be considered a critical component of treatment planning.	[Taylor, Brent C.; Campbell, Emily Hagel; Nugent, Sean; Kehle-Forbes, Shannon M.; Sayer, Nina A.] Dept Vet Affairs Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Taylor, Brent C.; Kehle-Forbes, Shannon M.; Sayer, Nina A.] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Taylor, Brent C.] Univ Minnesota, Div Epidemiol & Community Hlth, Minneapolis, MN USA; [Sayer, Nina A.] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Bidelspach, Douglas E.] VA Med Ctr, Vet Hlth Adm, Phys Med Serv, Lebanon, PA USA; [Bidelspach, Douglas E.] VA Med Ctr, Vet Hlth Adm, Rehabil Serv, Lebanon, PA USA; [Bidelspach, Douglas E.; Scholten, Joel] Dept Vet Affairs, Phys Med & Rehabil Program Off, Washington, DC USA; [Scholten, Joel] Washington DC VA Med Ctr, Dept Phys Med & Rehabil, Washington, DC USA; [Stroupe, Kevin T.] Hines VA Hosp, Ctr Innovat Complex Chron Healthcare, Hines, IL USA; [Stroupe, Kevin T.] Loyola Univ Chicago, Dept Publ Hlth Sci, Maywood, IL USA		Taylor, BC (corresponding author), VA Hlth Care Syst 152, 1 Vet Dr, Minneapolis, MN 55417 USA.	Brent.Taylor2@va.gov	Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377	United States Department of Veterans Affairs, Office of Research and DevelopmentUS Department of Veterans Affairs [PLY05-2010-2]	Funding for the study was provided by the United States Department of Veterans Affairs, Office of Research and Development, Health Services Research & Development Service (HSR&D), Washington, DC through a locally initiated project grant (#PLY05-2010-2) from the Polytrauma and Blast-Related Injuries (PT/BRI) Quality Enhancement Research Initiative (QUERI). The funding source had no role in the study design, analysis, interpretation of the data, writing of the article, or decision to submit the article for publication. Preliminary results related to this article were presented at the VA HSR&D Annual Meeting July 8-10, 2015, in Philadelphia, PA.	Belanger HG, 2016, J HEAD TRAUMA REHAB, V31, P204, DOI 10.1097/HTR.0000000000000168; Bryant RA, 2010, AM J PSYCHIAT, V167, P312, DOI 10.1176/appi.ajp.2009.09050617; Cameron CM, 2008, BRAIN INJURY, V22, P437, DOI 10.1080/02699050802060621; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Chard KM, 2011, J TRAUMA STRESS, V24, P347, DOI 10.1002/jts.20644; Corrigan JD, 2013, ARCH PHYS MED REHAB, V94, P1199, DOI 10.1016/j.apmr.2013.01.023; Defense and Veterans Brain Injury Center, 2016, TBI BAS; [Department of Health and Human Services Centers for Disease Control Prevention National Center for Injury Prevention and Control Division of Unintentional Injury Prevention], 2014, REP C TRAUM BRAIN IN; Department of Veterans Affairs & Department of Defense, 2016, VA DOD CLIN PRACT GU; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; Eibner C., 2008, INVISIBLE WOUNDS WAR, P169, DOI 10.7249/mg720ccf; Gawande A, 2004, NEW ENGL J MED, V351, P2471, DOI 10.1056/NEJMp048317; Hendricks A., 2012, PTSD MILD TRAUMATIC, P260; Hodgkinson A, 2000, J HEAD TRAUMA REHAB, V15, P1208, DOI 10.1097/00001199-200012000-00003; Kehle-Forbes SM, 2017, J HEAD TRAUMA REHAB, V32, pE16, DOI 10.1097/HTR.0000000000000227; McCrea M., 2008, MILD TRAUMATIC BRAIN; Mild Traumatic Brain Injury Committee American Congress of Rehabilitation Medicine Head Injury Interdisciplinary Special Interest Group, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; O'Neil M. E., 2012, 05225 VAESP DEP VET; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Pertab JL, 2009, BRAIN INJURY, V23, P498, DOI 10.1080/02699050902927984; Phibbs C.S., 2015, RES GUIDE MANAGERIAL; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Sripada RK, 2013, J TRAUMA STRESS, V26, P369, DOI 10.1002/jts.21813; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Taylor B., 2015, FISCAL YEAR 2014 VA; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Veterans Health Administration, 2010, SCREEN EV POSS TRAUM; Wagner TH, 2003, MED CARE RES REV, V60, p15S, DOI 10.1177/1077558703256485	31	15	15	0	1	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP	2017	34	17					2567	2574		10.1089/neu.2016.4910			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	FE6HI	WOS:000408310200010	28482747				2022-02-06	
J	Subotic, A; Ting, WKC; Cusimano, MD				Subotic, Arsenije; Ting, Windsor Kwan-Chun; Cusimano, Michael D.			Characteristics of the King-Devick test in the assessment of concussed patients in the subacute and later stages after injury	PLOS ONE			English	Article							TRAUMATIC BRAIN-INJURY; VISUAL SCREENING TOOL; BASE-LINE ASSOCIATIONS; AMATEUR RUGBY UNION; ICE HOCKEY PLAYERS; EYE-MOVEMENTS; SLEEP-DEPRIVATION; YOUTH; INTERFERENCE; ATTENTION	Although the King-Devick (K-D) test has been used frequently in assessing sports related concussion early after injury, its characteristics over time after injury and in patients with prolonged persistent symptoms are unknown. The purpose of this paper was to: evaluate the ability of the K-D Test to distinguish patients seen early after concussion from those with symptoms persisting more than 3 months compared to controls, assess changes in the K-D test times over time after concussion, and determine the relationship of K-D times to the Stroop Color and Word Test scores. We performed cross-sectional comparisons of patients with recent concussive brain injury (acute group) and those with symptoms persisting more than 3 months to healthy controls on the K-D test, the Sports Concussion Assessment Tool 3 (SCAT3), and the Stroop Color and Word Test. Longitudinal comparisons of the acute group over time within the first month after injury were also made. Post-concussive syndrome (PCS) patients had significantly higher K-D times compared to controls (p = 0.01), while the acute group did not differ from controls(p = 0.33). K-D times at the second visit for the acute group were similar to those of controls (54.7 vs. 49.6, p = 0.31). While SCAT3 scores improved over time in the acute group, the K-D scores did not change between the first and second visit (55.2 vs. 54.7, p = 0.94). K-D scores correlated significantly with the Stroop scores for all three participant groups. The K-D test is likely useful very early after concussion in conjunction with baseline scores, and while scores in PCS patients remain elevated, they can be confounded by factors such as pre-morbid depression and medication use. High correlations with Stroop scores also suggest that performance on the K-D test can by proxy provide additional insight about cognitive function and predict performance on more cognitively demanding tasks.	[Subotic, Arsenije; Ting, Windsor Kwan-Chun; Cusimano, Michael D.] St Michaels Hosp, Div Neurosurg, Dept Surg, Injury Prevent Res Off, Toronto, ON, Canada; [Cusimano, Michael D.] Univ Toronto, Toronto, ON, Canada		Cusimano, MD (corresponding author), St Michaels Hosp, Div Neurosurg, Dept Surg, Injury Prevent Res Off, Toronto, ON, Canada.; Cusimano, MD (corresponding author), Univ Toronto, Toronto, ON, Canada.	injuryprevention@smh.ca	Cusimano, Michael/X-4059-2019; Ting, Windsor Kwan-Chun/I-4013-2014	Ting, Windsor Kwan-Chun/0000-0003-4293-9617; Cusimano, Michael/0000-0002-9989-0650	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [MOP 123371]	We would like to thank the Canadian Institutes of Health Research MOP 123371 for the study funding. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Benedict PA, 2015, J NEUROL SCI, V353, P111, DOI 10.1016/j.jns.2015.04.029; Broshek DK, 2015, BRAIN INJURY, V29, P228, DOI 10.3109/02699052.2014.974674; Cassidy J David, 2014, Arch Phys Med Rehabil, V95, pS132, DOI 10.1016/j.apmr.2013.08.299; Davies EC, 2012, NEUROLOGY, V78, pE103, DOI 10.1212/WNL.0b013e318251833d; Duenas M, 2014, SURG NEUROL INT, V5, P91, DOI DOI 10.4103/2152-7806.134364; Fransson PA, 2008, J VESTIBUL RES-EQUIL, V18, P209; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Heitger MH, 2009, BRAIN, V132, P2850, DOI 10.1093/brain/awp181; Hessen E, 2006, SCAND J PSYCHOL, V47, P245, DOI 10.1111/j.1467-9450.2006.00514.x; Hoshizaki B, 2013, J NEUROL NEUROPHYSIO; Hou RH, 2012, J NEUROL NEUROSUR PS, V83, P217, DOI 10.1136/jnnp-2011-300767; Iverson GL, 2005, CURR OPIN PSYCHIATR, V18, P301, DOI 10.1097/01.yco.0000165601.29047.ae; King D, 2015, J NEUROL SCI, V351, P58, DOI 10.1016/j.jns.2015.02.035; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; King D, 2012, J NEUROL SCI, V320, P16, DOI 10.1016/j.jns.2012.05.049; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; MacLeod CM, 2000, TRENDS COGN SCI, V4, P383, DOI 10.1016/S1364-6613(00)01530-8; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; Matuszak JM, 2016, SPORTS HEALTH, V8, P260, DOI 10.1177/1941738116641394; McMahon P, 2014, J NEUROTRAUM, V31, P26, DOI 10.1089/neu.2013.2984; Munce TA, 2014, J CHILD NEUROL, V29, P1601, DOI 10.1177/0883073813509887; Naber M, PSYCHOL, V7, P822; Olk B, 2013, PSYCHOL RES-PSYCH FO, V77, P106, DOI 10.1007/s00426-011-0405-9; ORIDE MKH, 1986, AM J OPTOM PHYS OPT, V63, P419; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Post A, 2012, P I MECH ENG P-J SPO, V226, P290, DOI 10.1177/1754337112436629; Reilly JL, 2008, BRAIN COGNITION, V68, P415, DOI 10.1016/j.bandc.2008.08.026; Rizzo JR, 2016, ANN CLIN TRANSL NEUR, V3, P801, DOI 10.1002/acn3.345; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Silverberg ND, 2014, BRAIN INJURY, V28, P1590, DOI 10.3109/02699052.2014.943287; STROOP JR, 1992, J EXP PSYCHOL GEN, V121, P15; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Vernau BT, 2015, DEV NEUROPSYCHOL, V40, P7, DOI 10.1080/87565641.2014.971955; Wright RM, J NEUROTRAUMA, V30, P102	39	15	15	1	4	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	AUG 31	2017	12	8							e0183092	10.1371/journal.pone.0183092			13	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	FF2PY	WOS:000408740500010	28859119	Green Published, gold, Green Submitted			2022-02-06	
J	DeAngelis, J; Lou, V; Li, T; Tran, H; Bremjit, P; McCann, M; Crane, P; Jones, CMC				DeAngelis, John; Lou, Valerie; Li, Timmy; Tran, Henry; Bremjit, Praneeta; McCann, Molly; Crane, Peter; Jones, Courtney M. C.			Head CT for Minor Head Injury Presenting to the Emergency Department in the Era of Choosing Wisely	WESTERN JOURNAL OF EMERGENCY MEDICINE			English	Article							TRAUMATIC BRAIN-INJURY; NEW-ORLEANS CRITERIA; COMPUTED-TOMOGRAPHY; DECISION-MAKING; UNITED-STATES; RULES; PERFORMANCE; CANCER; ADULTS; RISK	Introduction: The Choosing Wisely campaign currently recommends avoiding computed tomography (CT) of the head in low-risk emergency department (ED) patients with minor head injury, based on validated decision rules. However, the degree of adherence to this guideline in clinical practice is unknown. The objective of this study was to evaluate adherence to the Choosing Wisely campaign's recommendations regarding head CT imaging of patients with minor head injury in the ED. Methods: We conducted a retrospective cohort study of adult ED patients at a Level I trauma center. Patients aged >= 18 years who presented to the ED with minor head injury were identified via International Classification of Diseases, 9th Revision, Clinical Modification codes. Medical record abstraction was conducted to determine the presence of clinical symptoms of the NEXUS II criteria, medical resource use, and head CT findings. We used descriptive statistics to characterize the study sample, and proportions were used to quantify guidelines adherence. Results: A total of 489 subjects met inclusion criteria. ED providers appropriately applied the Choosing Wisely criteria for 75.5% of patients, obtaining head CTs when indicated by the NEXUS II rule (41.5%), and not obtaining head CTs when the NEXUS II criteria were not met (34.0%). However, ED providers obtained non-indicated CTs in 23.1% of patients. Less than 2% of the sample did not receive a head CT when imaging was indicated by NEXUS II. Conclusion: ED providers in our sample had variable adherence to the Choosing Wisely head-CT recommendation, especially for patients who did not meet the NEXUS II criteria.	[DeAngelis, John; Lou, Valerie; Li, Timmy; Tran, Henry; Bremjit, Praneeta; McCann, Molly; Crane, Peter; Jones, Courtney M. C.] Univ Rochester, Med Ctr, Dept Emergency Med, 601 Elmwood Ave,Box 655, Rochester, NY 14642 USA; [DeAngelis, John] Cambridge Hlth Alliance, Dept Emergency Med, Cambridge, MA USA; [Bremjit, Praneeta] Jefferson Hosp, Dept Emergency Med, Philadelphia, PA USA		DeAngelis, J (corresponding author), Univ Rochester, Med Ctr, Dept Emergency Med, 601 Elmwood Ave,Box 655, Rochester, NY 14642 USA.	deangelisjg@gmail.com		DeAngelis, John/0000-0002-4223-2526			American College of Emergency Physicians, 2014, 5 THINGS PHYS PAT SH; Committee on the Learning Health Care System in America, 2013, BEST CARE LOWER COST; Harnan SE, 2011, J TRAUMA, V71, P245, DOI 10.1097/TA.0b013e31820d090f; Jagoda AS, 2008, ANN EMERG MED, V52, P714, DOI 10.1016/j.annemergmed.2008.08.021; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Melnick ER, 2015, ACAD EMERG MED, V22, P1474, DOI 10.1111/acem.12824; Miglioretti DL, 2013, JAMA PEDIATR, V167, P700, DOI 10.1001/jamapediatrics.2013.311; Mower WR, 2005, J TRAUMA, V59, P954, DOI 10.1097/01.ta.0000187813.79047.42; Papa L, 2012, ACAD EMERG MED, V19, P2, DOI 10.1111/j.1553-2712.2011.01247.x; Probst MA, 2014, AM J EMERG MED, V32, P645, DOI 10.1016/j.ajem.2014.01.003; Rivara FP, 2015, JAMA-J AM MED ASSOC, V314, P2629, DOI 10.1001/jama.2015.17298; Ro YS, 2011, ACAD EMERG MED, V18, P597, DOI 10.1111/j.1553-2712.2011.01094.x; Rohacek M, 2012, INJURY, V43, P1415, DOI 10.1016/j.injury.2012.01.001; Sierzenski PR, 2014, ANN EMERG MED, V63, P25, DOI 10.1016/j.annemergmed.2013.08.027; Smith-Bindman R, 2009, ARCH INTERN MED, V169, P2078, DOI 10.1001/archinternmed.2009.427; Smits M, 2005, JAMA-J AM MED ASSOC, V294, P1519, DOI 10.1001/jama.294.12.1519; Stiell IG, 2005, JAMA-J AM MED ASSOC, V294, P1511, DOI 10.1001/jama.294.12.1511; Uhl RL, 2013, J AM ACAD ORTHOP SUR, V21, P624, DOI 10.5435/JAAOS-21-10-624; Wennberg JE, 2002, BRIT MED J, V325, P961, DOI 10.1136/bmj.325.7370.961	19	15	15	0	1	WESTJEM	ORANGE	C/O SHAHRAM LOTFIPOUR, MD, MPH, 333 CITY BLVD W STE 640, RT 128-01, ORANGE, CA 92868 USA	1936-900X	1936-9018		WEST J EMERG MED	West. J. Emerg. Med.	AUG	2017	18	5					821	829		10.5811/westjem.2017.6.33685			9	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	FQ6XS	WOS:000418508000006	28874933	gold, Green Published			2022-02-06	
J	Gollihue, JL; Patel, SP; Mashburn, C; Eldahan, KC; Sullivan, PG; Rabchevsky, AG				Gollihue, Jenna L.; Patel, Samir P.; Mashburn, Charlie; Eldahan, Khalid C.; Sullivan, Patrick G.; Rabchevsky, Alexander G.			Optimization of mitochondrial isolation techniques for intraspinal transplantation procedures	JOURNAL OF NEUROSCIENCE METHODS			English	Article						PC-12 cells; Bioenergetics; Spinal cord injury; MitoTracker; Transgenic labeling	SPINAL-CORD-INJURY; ACETYL-L-CARNITINE; ISCHEMIA-REPERFUSION INJURY; GREEN FLUORESCENT PROTEIN; CELL-DEATH; NONSYNAPTIC MITOCHONDRIA; FUNCTIONAL RECOVERY; UNCOUPLING AGENT; ANTIOXIDANT; RESCUE	Background: Proper mitochondrial function is essential to maintain normal cellular bioenergetics and ionic homeostasis. In instances of severe tissue damage, such as traumatic brain and spinal cord injury, mitochondria become damaged and unregulated leading to cell death. The relatively unexplored field of mitochondrial transplantation following neurotrauma is based on the theory that replacing damaged mitochondria with exogenous respiratory-competent mitochondria can restore overall tissue bioenergetics. New method: We optimized techniques in vitro to prepare suspensions of isolated mitochondria for transplantation in vivo. Mitochondria isolated from cell culture were genetically labeled with turbo-green fluorescent protein (tGFP) for imaging and tracking purposes in vitro and in vivo. Results: We used time-lapse confocal imaging to reveal the incorporation of exogenous fluorescently-tagged mitochondria into PC-12 cells after brief co-incubation. Further, we show that mitochondria can be injected into the spinal cord with immunohistochemical evidence of host cellular uptake within 24 h. Comparison to existing methods: Our methods utilize transgenic fluorescent labeling of mitochondria for a nontoxic and photostable alternative to other labeling methods. Substrate addition to isolated mitochondria helped to restore state III respiration at room temperature prior to transplantation. These experiments delineate refined methods to use transgenic cell lines for the purpose of isolating well coupled mitochondria that have a permanent fluorescent label that allows real time tracking of transplanted mitochondria in vitro, as well as imaging in situ. Conclusions: These techniques lay the foundation for testing the potential therapeutic effects of mitochondrial transplantation following spinal cord injury and other animal models of neurotrauma. (C) 2017 Elsevier B.V. All rights reserved.	[Gollihue, Jenna L.; Patel, Samir P.; Eldahan, Khalid C.; Rabchevsky, Alexander G.] Univ Kentucky, Dept Physiol, Lexington, KY 40536 USA; [Sullivan, Patrick G.] Univ Kentucky, Dept Neurosci, Lexington, KY 40536 USA; [Gollihue, Jenna L.; Patel, Samir P.; Mashburn, Charlie; Eldahan, Khalid C.; Sullivan, Patrick G.; Rabchevsky, Alexander G.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr, Lexington, KY 40536 USA		Rabchevsky, AG (corresponding author), B471,BBSRB,741 S Limestone, Lexington, KY 40536 USA.	agrab@uky.edu	Rabchevsky, Alexander/AAQ-2451-2021	Rabchevsky, Alexander/0000-0002-1991-0915	NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [5T32NS077889, F31NS093904, R21NS096670, 2P30NS051220]; Conquer Paralysis Now "Out-of-Box" Award; University of Kentucky Spinal Cord and Brain Injury Center Chair Endowment; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS096670, P30NS051220, T32NS077889, F31NS093904] Funding Source: NIH RePORTER	We would like to thank David Cox for his assistance in surgical procedures. This work was supported by NIH/NINDS 5T32NS077889 (JLG), NIH/NINDS F31NS093904 (JLG), NIH/NINDS R21NS096670 (AGR), Conquer Paralysis Now "Out-of-Box" Award (AGR), University of Kentucky Spinal Cord and Brain Injury Center Chair Endowment (AGR), NIH/NINDS 2P30NS051220.	Armstrong JS, 2007, BRIT J PHARMACOL, V151, P1154, DOI 10.1038/sj.bjp.0707288; Azbill RD, 1997, BRAIN RES, V765, P283, DOI 10.1016/S0006-8993(97)00573-8; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Brand MD, 2011, BIOCHEM J, V435, P297, DOI 10.1042/BJ20110162; Buckman JF, 2001, J NEUROSCI METH, V104, P165, DOI 10.1016/S0165-0270(00)00340-X; Chang J., 2013, CHANGHUA J MED, V11, P8; Chang JC, 2013, NEUROSIGNALS, V21, P160, DOI 10.1159/000341981; CLARK MA, 1982, NATURE, V295, P605, DOI 10.1038/295605a0; Cselenyak A, 2010, BMC CELL BIOL, V11, DOI 10.1186/1471-2121-11-29; Cunha FM, 2011, CURR DRUG TARGETS, V12, P783; Elliott RL, 2012, BREAST CANCER RES TR, V136, P347, DOI 10.1007/s10549-012-2283-2; Fiskum G, 2000, J NEUROTRAUM, V17, P843, DOI 10.1089/neu.2000.17.843; Gilgun-Sherki Y, 2002, PHARMACOL REV, V54, P271, DOI 10.1124/pr.54.2.271; Han JY, 2013, BBA-GEN SUBJECTS, V1830, P5130, DOI 10.1016/j.bbagen.2013.07.001; Hayakawa K, 2016, NATURE, V535, P551, DOI 10.1038/nature18928; Islam MN, 2012, NAT MED, V18, P759, DOI 10.1038/nm.2736; Rodriguez-Jimenez FJ, 2012, STEM CELLS, V30, P2221, DOI 10.1002/stem.1189; Jin H, 2014, BBA-MOL BASIS DIS, V1842, P1282, DOI 10.1016/j.bbadis.2013.09.007; Jin Y, 2004, J NEUROTRAUM, V21, P1396, DOI 10.1089/neu.2004.21.1396; Katrangi E, 2007, REJUV RES, V10, P561, DOI 10.1089/rej.2007.0575; Keij JF, 2000, CYTOMETRY, V39, P203, DOI 10.1002/(SICI)1097-0320(20000301)39:3<203::AID-CYTO5>3.0.CO;2-Z; KING MP, 1988, CELL, V52, P811, DOI 10.1016/0092-8674(88)90423-0; Kitani T, 2014, TRANSPL P, V46, P1233, DOI 10.1016/j.transproceed.2013.11.133; Kitani T, 2014, J CELL MOL MED, V18, P1694, DOI 10.1111/jcmm.12316; Lin HC, 2013, SHOCK, V39, P304, DOI 10.1097/SHK.0b013e318283035f; LUFT R, 1994, P NATL ACAD SCI USA, V91, P8731, DOI 10.1073/pnas.91.19.8731; Masuzawa A, 2013, AM J PHYSIOL-HEART C, V304, pH966, DOI 10.1152/ajpheart.00883.2012; Matz MV, 1999, NAT BIOTECHNOL, V17, P969, DOI 10.1038/13657; McCully JD, 2009, AM J PHYSIOL-HEART C, V296, pH94, DOI 10.1152/ajpheart.00567.2008; Minamikawa T, 1999, J CELL SCI, V112, P2419; Nunnari J, 2012, CELL, V148, P1145, DOI 10.1016/j.cell.2012.02.035; Pacak CA, 2015, BIOL OPEN, V4, P622, DOI 10.1242/bio.201511478; Patel SP, 2012, NEUROSCIENCE, V210, P296, DOI 10.1016/j.neuroscience.2012.03.006; Patel SP, 2014, EXP NEUROL, V257, P95, DOI 10.1016/j.expneurol.2014.04.026; Patel SP, 2010, J NEUROCHEM, V114, P291, DOI 10.1111/j.1471-4159.2010.06764.x; Patel SP, 2009, J NEUROSCI RES, V87, P130, DOI 10.1002/jnr.21814; Patel SP, 2009, INVEST OPHTH VIS SCI, V50, P180, DOI 10.1167/iovs.08-1911; PETRUZZELLA V, 1992, ARCH GERONTOL GERIAT, V14, P131, DOI 10.1016/0167-4943(92)90048-9; Plotnikov EY, 2008, J CELL MOL MED, V12, P1622, DOI 10.1111/j.1582-4934.2007.00205.x; Rabchevsky AG, 2002, J NEUROSCI RES, V68, P7, DOI 10.1002/jnr.10187; RIZZUTO R, 1995, CURR BIOL, V5, P635, DOI 10.1016/S0960-9822(95)00128-X; Rizzuto R, 1996, CURR BIOL, V6, P183, DOI 10.1016/S0960-9822(02)00451-7; RIZZUTO R, 1989, J BIOL CHEM, V264, P10595; Shitara H, 2001, FEBS LETT, V500, P7, DOI 10.1016/S0014-5793(01)02574-1; Smith RAJ, 2008, ANN NY ACAD SCI, V1147, P105, DOI 10.1196/annals.1427.003; Spees JL, 2006, P NATL ACAD SCI USA, V103, P1283, DOI 10.1073/pnas.0510511103; Sullivan PG, 2004, J BIOENERG BIOMEMBR, V36, P353, DOI 10.1023/B:JOBB.0000041767.30992.19; Sullivan PG, 2005, J NEUROSCI RES, V79, P231, DOI 10.1002/jnr.20292; Visavadiya NP, 2016, REDOX BIOL, V8, P59, DOI 10.1016/j.redox.2015.12.011; Wang X, 2015, CELL DEATH DIFFER, V22, P1181, DOI 10.1038/cdd.2014.211; Yang YW, 2012, NUCLEIC ACIDS RES, V40, DOI 10.1093/nar/gks639	51	15	16	0	25	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	AUG 1	2017	287						1	12		10.1016/j.jneumeth.2017.05.023			12	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	FC0YY	WOS:000406565800001	28554833	Green Accepted			2022-02-06	
J	Liu, Y; Wang, R; Zhao, ZW; Dong, W; Zhang, X; Chen, X; Ma, LN				Liu, Yuan; Wang, Rong; Zhao, Zhiwei; Dong, Wen; Zhang, Xu; Chen, Xi; Ma, Lina			Short-term caloric restriction exerts neuroprotective effects following mild traumatic brain injury by promoting autophagy and inhibiting astrocyte activation	BEHAVIOURAL BRAIN RESEARCH			English	Article						Mild traumatic brain injury; Caloric restriction; Learning ability; Autophagy	CLOSED-HEAD INJURY; SPATIAL MEMORY; COGNITIVE DEFICITS; REACTIVE ASTROCYTES; NEUROTROPHIC FACTOR; CELL-DEATH; RAT MODEL; HIGH-FAT; MICE; IMPAIRMENT	Cognitive deficits may occur after mild traumatic brain injury (mTBI), but effective treatment modalities are presently unavailable. Caloric restriction (CR) has beneficial effects on neurodegenerative diseases and brain injury. However, the underlying mechanisms have not yet been clearly defined. Therefore, the aim of the present study was to investigate the short-term effects of CR treatment on cognitive function in mice after mTBI. Forty-five 12-week-old C57/BL6 mice were subjected to closed-head mTBI using a weight drop device. The mice were then randomly divided into three groups according to their diet for 30 days: the normal calorie group (mTBI + NC group, n = 15), the caloric restriction group (mTBI + CR group, n = 15), and the high energy group (mTBI + HE group, n = 15). After 30 days, the Morris water maze test was performed to evaluate learning abilities. Nissl staining, immunohistochemistry, and western blotting were used to monitor pathological changes and changes in autophagy-associated proteins in the hippocampus. The average escape latency was significantly shorter in the mTBI + CR group than in the mTBI + NC and mTBI + HE groups, and the number of target platform crossings in the mTBI + CR group was significantly higher than in the other two groups. In the hippocampus, the expression of GFAP and mTOR was increased in the mTBI + HE group and decreased in the mTBI + CR group. Conversely, the expression of LC3B was decreased in the mTBI + HE group and increased in the mTBI + CR group. Our findings suggest that short-term CR after mTBI may ameliorate cognitive dysfunction induced by mTBI by increasing the level of autophagy and suppressing astrocyte activation.	[Liu, Yuan; Wang, Rong; Zhao, Zhiwei; Dong, Wen; Zhang, Xu] Capital Med Univ, Xuan Wu Hosp, Beijing Inst Brain Disorders, Cent Lab,Ctr Alzheimers Dis, Beijing 100053, Peoples R China; [Wang, Rong] Minist Educ, Beijing Geriatr Med Res Ctr, Key Lab Neurodegenerat Dis, Beijing 100053, Peoples R China; [Chen, Xi] Inner Mongolia Med Univ, Chifeng Clin Med Coll, Chifeng City Hosp, Dept Infect Dis, Chifeng 024000, Inner Mongolia, Peoples R China; [Ma, Lina] Capital Med Univ, Xuan Wu Hosp, Dept Geriatr, Beijing 100053, Peoples R China		Wang, R (corresponding author), Capital Med Univ, Xuan Wu Hosp, Beijing Inst Brain Disorders, Cent Lab,Ctr Alzheimers Dis, Beijing 100053, Peoples R China.; Wang, R (corresponding author), Minist Educ, Beijing Geriatr Med Res Ctr, Key Lab Neurodegenerat Dis, Beijing 100053, Peoples R China.	rong_wang72@126.com			Beijing Natural Science FoundationBeijing Natural Science Foundation [7132033, 7132044, 7174310]; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81600927]	This work was supported by the following grants: Beijing Natural Science Foundation (7132033, 7132044, 7174310), and National Natural Science Foundation of China (81600927).	Bishop NA, 2007, NAT REV GENET, V8, P835, DOI 10.1038/nrg2188; Blagosklonny MV, 2010, CELL CYCLE, V9, P683, DOI 10.4161/cc.9.4.10766; Cao Y, 2007, CELL RES, V17, P839, DOI 10.1038/cr.2007.78; Chen A, 2013, MOL MED REP, V8, P1011, DOI 10.3892/mmr.2013.1628; Clark RSB, 2008, AUTOPHAGY, V4, P88, DOI 10.4161/auto.5173; Cordaro M, 2016, J NEUROTRAUM, V33, P132, DOI 10.1089/neu.2014.3460; Crino PB, 2016, NAT REV NEUROL, V12, P379, DOI 10.1038/nrneurol.2016.81; Daneshvar DH, 2011, PHYS MED REH CLIN N, V22, P683, DOI 10.1016/j.pmr.2011.08.009; Dean PJA, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00030; Dong W, 2016, AGING CLIN EXP RES, V28, P303, DOI 10.1007/s40520-015-0398-0; Dong W, 2015, INT J CLIN EXP MED, V8, P11843; Erlich S, 2007, NEUROBIOL DIS, V26, P86, DOI 10.1016/j.nbd.2006.12.003; Fitzwalter BE, 2015, FEBS J, V282, P4279, DOI 10.1111/febs.13515; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao XA, 2011, J NEUROPATH EXP NEUR, V70, P183, DOI 10.1097/NEN.0b013e31820c6878; Gatson JW, 2013, J TRAUMA ACUTE CARE, V74, P470, DOI 10.1097/TA.0b013e31827e1f51; Gilbert PE, 2009, PROG NEURO-PSYCHOPH, V33, P774, DOI 10.1016/j.pnpbp.2009.03.037; Gottlieb RA, 2010, AM J PHYSIOL-CELL PH, V299, pC203, DOI 10.1152/ajpcell.00097.2010; Haber M, 2013, EXP NEUROL, V249, P169, DOI 10.1016/j.expneurol.2013.09.002; HAMM RJ, 1993, BEHAV BRAIN RES, V59, P169, DOI 10.1016/0166-4328(93)90164-L; HANDELMANN GE, 1981, BRAIN RES, V217, P41, DOI 10.1016/0006-8993(81)90183-9; Hehar H, 2016, NEUROBIOL DIS, V87, P11, DOI 10.1016/j.nbd.2015.12.007; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Kanoski SE, 2010, J EXP PSYCHOL-ANIM B, V36, P313, DOI 10.1037/a0017228; Laird MD, 2008, NEUROSIGNALS, V16, P154, DOI 10.1159/000111560; Lee J, 2000, J MOL NEUROSCI, V15, P99, DOI 10.1385/JMN:15:2:99; Li GM, 2013, NEUROL SCI, V34, P963, DOI 10.1007/s10072-012-1173-z; Lipinski MM, 2015, ANTIOXID REDOX SIGN, V23, P565, DOI 10.1089/ars.2015.6306; Livingstone SA, 2007, BEHAV BRAIN RES, V185, P21, DOI 10.1016/j.bbr.2007.07.015; Loncarevic-Vasiljkovic N, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0037215; Ma LN, 2014, NEUROL SCI, V35, P1381, DOI 10.1007/s10072-014-1717-5; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Mattson MP, 2005, ANNU REV NUTR, V25, P237, DOI 10.1146/annurev.nutr.25.050304.092526; McNeilly AD, 2011, BEHAV BRAIN RES, V217, P134, DOI 10.1016/j.bbr.2010.10.017; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Molteni R, 2002, NEUROSCIENCE, V112, P803, DOI 10.1016/S0306-4522(02)00123-9; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; Mychasiuk R, 2015, FRONT BEHAV NEUROSCI, V9, DOI 10.3389/fnbeh.2015.00017; Myer DJ, 2006, BRAIN, V129, P2761, DOI 10.1093/brain/awl165; Newcombe V.F., 2013, BMJ-BRIT MED J, V346; Nikolaeva I, 2016, J NEUROTRAUM, V33, P183, DOI 10.1089/neu.2015.3899; Papp G, 2007, LEARN MEMORY, V14, P732, DOI 10.1101/lm.687407; Plunet WT, 2008, EXP NEUROL, V213, P28, DOI 10.1016/j.expneurol.2008.04.011; Rich NJ, 2010, J NEUROSCI RES, V88, P2933, DOI 10.1002/jnr.22443; Ruether E, 2001, INT CLIN PSYCHOPHARM, V16, P253, DOI 10.1097/00004850-200109000-00002; Smith DH, 1991, J NEUROTRAUM, V8, P259, DOI 10.1089/neu.1991.8.259; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Steffenach HA, 2002, P NATL ACAD SCI USA, V99, P3194, DOI 10.1073/pnas.042700999; Szczygielski J, 2016, J NEUROTRAUM, V33, P122, DOI 10.1089/neu.2014.3835; Tavazoie SF, 2005, NAT NEUROSCI, V8, P1727, DOI 10.1038/nn1566; Tay SY, 2010, J NEUROTRAUM, V27, P77, DOI 10.1089/neu.2009.1074; Terry AV, 2009, FRONT NEUROSCI, P267; Tzatsos A, 2006, MOL CELL BIOL, V26, P63, DOI 10.1128/MCB.26.1.63-76.2006; Viscomi MT, 2012, AUTOPHAGY, V8, P222, DOI 10.4161/auto.8.2.18599; Xu JG, 2014, FREE RADICAL BIO MED, V71, P186, DOI 10.1016/j.freeradbiomed.2014.03.009; Yang SH, 2013, J SURG RES, V184, P981, DOI 10.1016/j.jss.2013.03.075; Zhang YL, 2015, J NEUROSURG, V122, P843, DOI 10.3171/2014.11.JNS14271	58	15	15	0	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0166-4328	1872-7549		BEHAV BRAIN RES	Behav. Brain Res.	JUL 28	2017	331						135	142		10.1016/j.bbr.2017.04.024			8	Behavioral Sciences; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology	EZ6FZ	WOS:000404815100017	28495608				2022-02-06	
J	Wilkinson, AA; Dennis, M; Simic, N; Taylor, MJ; Morgan, BR; Frndova, H; Choong, K; Campbell, C; Fraser, D; Anderson, V; Guerguerian, AM; Schachar, R; Hutchison, J				Wilkinson, Amy A.; Dennis, Maureen; Simic, Nevena; Taylor, Margot J.; Morgan, Benjamin R.; Frndova, Helena; Choong, Karen; Campbell, Craig; Fraser, Douglas; Anderson, Vicki; Guerguerian, Anne-Marie; Schachar, Russell; Hutchison, Jamie		Canadian Critical Care Trials Grp; Canadian Critical Care Translation	Brain biomarkers and pre-injury cognition are associated with long-term cognitive outcome in children with traumatic brain injury	BMC PEDIATRICS			English	Article						Attention; Executive functions; Traumatic brain injury; Serum biomarkers	SPONDYLOEPIPHYSEAL DYSPLASIA CONGENITA; II COLLAGEN; COL2A1 GENE; SPONDYLOEPIMETAPHYSEAL DYSPLASIA; PHENOTYPIC SPECTRUM; HIP-DYSPLASIA; MUTATION; DISORDERS; SEDC	Background: Children with traumatic brain injury (TBI) are frequently at risk of long-term impairments of attention and executive functioning but these problems are difficult to predict. Although deficits have been reported to vary with injury severity, age at injury and sex, prognostication of outcome remains imperfect at a patient-specific level. The objective of this proof of principle study was to evaluate a variety of patient variables, along with six brain-specific and inflammatory serum protein biomarkers, as predictors of long-term cognitive outcome following paediatric TBI. Method: Outcome was assessed in 23 patients via parent-rated questionnaires related to attention deficit hyperactivity disorder (ADHD) and executive functioning, using the Conners 3rd Edition Rating Scales (Conners-3) and Behaviour Rating Inventory of Executive Function (BRIEF) at a mean time since injury of 3.1 years. Partial least squares (PLS) analyses were performed to identify factors measured at the time of injury that were most closely associated with outcome on (1) the Conners-3 and (2) the Behavioural Regulation Index (BRI) and (3) Metacognition Index (MI) of the BRIEF. Results: Higher levels of neuron specific enolase (NSE) and lower levels of soluble neuron cell adhesion molecule (sNCAM) were associated with higher scores on the inattention, hyperactivity/impulsivity and executive functioning scales of the Conners-3, as well as working memory and initiate scales of the MI from the BRIEF. Higher levels of NSE only were associated with higher scores on the inhibit scale of the BRI. Conclusions: NSE and sNCAM show promise as reliable, early predictors of long-term attention-related and executive functioning problems following paediatric TBI.	[Wilkinson, Amy A.; Dennis, Maureen; Taylor, Margot J.] Univ Toronto, Dept Psychol, Toronto, ON, Canada; [Wilkinson, Amy A.; Dennis, Maureen; Taylor, Margot J.; Guerguerian, Anne-Marie; Schachar, Russell; Hutchison, Jamie] Hosp Sick Children, Program Neurosci Mental Hlth, Toronto, ON, Canada; [Dennis, Maureen] Univ Toronto, Dept Surg, Toronto, ON, Canada; [Simic, Nevena] Hamilton Hlth Sci Corp, Comprehens Pediat Epilepsy Program, Hamilton, ON, Canada; [Taylor, Margot J.; Morgan, Benjamin R.] Hosp Sick Children, Dept Diagnost Imaging, Toronto, ON, Canada; [Frndova, Helena; Guerguerian, Anne-Marie; Hutchison, Jamie] Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada; [Choong, Karen] Childrens Hosp Hamilton, Div Pediat Intens Care, Dept Pediat, Hamilton, ON, Canada; [Campbell, Craig; Fraser, Douglas] Western Univ, Schulich Sch Med, Pediat Clin Neurol Sci & Epidemiol, London, ON, Canada; [Anderson, Vicki] Murdoch Childrens Res Inst, Clin Sci, Melbourne, Vic, Australia; [Anderson, Vicki] Univ Melbourne, Psychol Sci & Pediat, Melbourne, Vic, Australia; [Schachar, Russell] Hosp Sick Children, Dept Psychiat, Toronto, ON, Canada		Wilkinson, AA (corresponding author), Univ Toronto, Dept Psychol, Toronto, ON, Canada.; Wilkinson, AA; Hutchison, J (corresponding author), Hosp Sick Children, Program Neurosci Mental Hlth, Toronto, ON, Canada.; Hutchison, J (corresponding author), Hosp Sick Children, Dept Crit Care Med, Toronto, ON, Canada.	amy.wilkinson@sickkids.ca; jamie.hutchison@sickkids.ca	Choong, Karen/ABB-7867-2021	Choong, Karen/0000-0002-4608-4508	Natural Science FoundationNational Natural Science Foundation of China (NSFC) [2015D012]; Natural Science Foundation of Fujian ProvinceNatural Science Foundation of Fujian Province [2014D003]; Medical Innovation Foundation of Fujian Province [2014-CXB-46]; Science and Technology Project of Xiamen City [3502Z20164029]	This work was supported by the Natural Science Foundation for Distinguished Young Scholars of Fujian Province (project no. 2015D012), Natural Science Foundation of Fujian Province (project no. 2014D003), the Medical Innovation Foundation of Fujian Province (project no. 2014-CXB-46), and the Science and Technology Project of Xiamen City (project no. 3502Z20164029).	Al Kaissi A, 2013, ORTHOPADE, V42, P963, DOI 10.1007/s00132-013-2182-1; ANDERSON IJ, 1990, AM J HUM GENET, V46, P896; Barat-Houari M, 2016, EUR J HUM GENET, V24, P992, DOI 10.1038/ejhg.2015.250; BEIGHTON P, 1984, AM J MED GENET, V19, P161, DOI 10.1002/ajmg.1320190116; BOGAERT R, 1992, J BIOL CHEM, V267, P22522; Chung BHY, 2013, AM J MED GENET A, V161A, P918, DOI 10.1002/ajmg.a.35793; Deng H, 2016, MUTAT RES-REV MUTAT, V768, P1, DOI 10.1016/j.mrrev.2016.02.003; Hoornaert KP, 2006, J MED GENET, V43, P406, DOI 10.1136/jmg.2005.035717; Kaitila I, 1996, AM J MED GENET, V63, P111; Matsubayashi S, 2013, MOL SYNDROMOL, V4, P148, DOI 10.1159/000346644; Mortier GR, 2000, J MED GENET, V37, P263, DOI 10.1136/jmg.37.4.263; Nishimura G, 2005, HUM MUTAT, V26, P36, DOI 10.1002/humu.20179; PROCKOP DJ, 1995, ANNU REV BIOCHEM, V64, P403, DOI 10.1146/annurev.biochem.64.1.403; Silveira KC, 2015, AM J MED GENET A, V167, P894, DOI 10.1002/ajmg.a.36954; SPRANGER J, 1994, EUR J PEDIATR, V153, P56, DOI 10.1007/BF01959208; STICKLER GB, 1965, MAYO CLIN PROC, V40, P433; Terhal PA, 2015, AM J MED GENET A, V167, P461, DOI 10.1002/ajmg.a.36922; TILLER GE, 1995, NAT GENET, V11, P87, DOI 10.1038/ng0995-87; VIKKULA M, 1993, GENOMICS, V16, P282, DOI 10.1006/geno.1993.1179; Walter K, 2007, AM J MED GENET A, V143A, P161, DOI 10.1002/ajmg.a.31516; Warman ML, 2011, AM J MED GENET A, V155A, P943, DOI 10.1002/ajmg.a.33909; Xu LL, 2014, EUR SPINE J, V23, pS271, DOI 10.1007/s00586-014-3292-0	22	15	15	0	13	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1471-2431			BMC PEDIATR	BMC Pediatr.	JUL 24	2017	17								173	10.1186/s12887-017-0925-6			26	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	FB7QA	WOS:000406333900001	28738850	gold, Green Published			2022-02-06	
J	Bai, W; Zhu, WL; Ning, YL; Li, P; Zhao, Y; Yang, N; Chen, X; Jiang, YL; Yang, WQ; Jiang, DP; Chen, LY; Zhou, YG				Bai, Wei; Zhu, Wan-Li; Ning, Ya-Lei; Li, Ping; Zhao, Yan; Yang, Nan; Chen, Xing; Jiang, Yu-Lin; Yang, Wen-Qun; Jiang, Dong-Po; Chen, Li-Yong; Zhou, Yuan-Guo			Dramatic increases in blood glutamate concentrations are closely related to traumatic brain injury-induced acute lung injury	SCIENTIFIC REPORTS			English	Article							NEUROGENIC PULMONARY-EDEMA; PLASMA GLUTAMATE; RISK-FACTORS; MECHANISMS; MANAGEMENT; MORTALITY; SEVERITY	Traumatic brain injury-induced acute lung injury (TBI-ALI) is a serious complication after brain injury for which predictive factors are lacking. In this study, we found significantly elevated blood glutamate concentrations in patients with TBI or multiple peripheral trauma (MPT), and patients with more severe injuries showed higher blood glutamate concentrations and longer durations of elevated levels. Although the increase in amplitude was similar between the two groups, the duration was longer in the patients with TBI. There were no significant differences in blood glutamate concentrations in the patients with MPT with regard to ALI status, but the blood glutamate levels were significantly higher in the patients with TBI-ALI than in those without ALI. Moreover, compared to patients without ALI, patients with TBI showed a clearly enhanced inflammatory response that was closely correlated with the blood glutamate levels. The blood glutamate concentration was also found to be a risk factor (adjusted odds ratio, 2.229; 95% CI, 1.082-2.634) and was a better predictor of TBI-ALI than the Glasgow Coma Scale (GCS) score. These results indicated that dramatically increased blood glutamate concentrations were closely related to the occurrence of TBI-ALI and could be used as a predictive marker for "at-risk" patients.	[Bai, Wei; Ning, Ya-Lei; Li, Ping; Zhao, Yan; Yang, Nan; Chen, Xing; Jiang, Yu-Lin; Zhou, Yuan-Guo] Third Mil Med Univ, Res Inst Surg, Mol Biol Ctr, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China; [Bai, Wei; Zhu, Wan-Li; Ning, Ya-Lei; Li, Ping; Zhao, Yan; Yang, Nan; Chen, Xing; Jiang, Yu-Lin; Yang, Wen-Qun; Jiang, Dong-Po; Chen, Li-Yong; Zhou, Yuan-Guo] Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China; [Zhu, Wan-Li] Third Mil Med Univ, Res Inst Surg, Dept Neurosurg, Chongqing, Peoples R China; [Yang, Wen-Qun; Jiang, Dong-Po] Third Mil Med Univ, Res Inst Surg, Dept ICU, Chongqing, Peoples R China; [Chen, Li-Yong] Third Mil Med Univ, Res Inst Surg, Dept Anesthesiol, Chongqing, Peoples R China		Zhou, YG (corresponding author), Third Mil Med Univ, Res Inst Surg, Mol Biol Ctr, State Key Lab Trauma Burn & Combined Injury, Chongqing, Peoples R China.; Chen, LY; Zhou, YG (corresponding author), Third Mil Med Univ, Daping Hosp, Chongqing, Peoples R China.; Chen, LY (corresponding author), Third Mil Med Univ, Res Inst Surg, Dept Anesthesiol, Chongqing, Peoples R China.	mzkcly@aliyun.com; ygzhou@tmmu.edu.cn	Li, ping/J-6507-2019		National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31171022]	We gratefully acknowledge the assistance and cooperation of the physicians, nurses and patients included in this study. We also thank the technicians and statisticians for their help and guidance. This study was partially supported by the National Natural Science Foundation of China (31171022).	Aliprandi A, 2005, J CEREBR BLOOD F MET, V25, P513, DOI 10.1038/sj.jcbfm.9600039; Arbour RB, 2013, CRIT CARE NURS CLIN, V25, P297, DOI 10.1016/j.ccell.2013.02.010; Bolorunduro OB, 2011, J SURG RES, V166, P40, DOI 10.1016/j.jss.2010.04.012; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Busl KM, 2015, CRIT CARE MED, V43, P1710, DOI 10.1097/CCM.0000000000001101; Chamoun R, 2010, J NEUROSURG, V113, P564, DOI 10.3171/2009.12.JNS09689; Cohen-Kashi-Malina K, 2012, J CEREBR BLOOD F MET, V32, P177, DOI 10.1038/jcbfm.2011.121; Collard CD, 2002, J BIOL CHEM, V277, P14801, DOI 10.1074/jbc.M110557200; da Cunha AA, 2010, CHEST, V137, P297, DOI 10.1378/chest.09-1570; Dai SS, 2013, J EXP MED, V210, P839, DOI 10.1084/jem.20122196; Dai SS, 2010, J NEUROSCI, V30, P5802, DOI 10.1523/JNEUROSCI.0268-10.2010; Davison DL, 2012, CRIT CARE, V16, DOI 10.1186/cc11226; DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Fontes RBV, 2003, J NEUROSURG ANESTH, V15, P144, DOI 10.1097/00008506-200304000-00013; Graham TE, 2000, AM J PHYSIOL-ENDOC M, V278, pE83, DOI 10.1152/ajpendo.2000.278.1.E83; Harr JN, 2013, CRIT CARE MED, V41, P399, DOI 10.1097/CCM.0b013e31826ab38b; Holland MC, 2003, J TRAUMA, V55, P106, DOI 10.1097/01.TA.0000071620.27375.BE; Kalil AC, 2016, CLIN INFECT DIS, V63, pE61, DOI 10.1093/cid/ciw353; Leibowitz A, 2012, INT J MOL SCI, V13, P10041, DOI 10.3390/ijms130810041; Li W, 2008, NEUROSCIENCE, V151, P1198, DOI 10.1016/j.neuroscience.2007.11.020; Maillet I, 2016, CLIN SCI, V130, P1939, DOI 10.1042/CS20160530; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; McNett M, 2014, NEUROCRIT CARE, V21, P52, DOI 10.1007/s12028-013-9947-6; McQuistion K, 2016, J SURG RES, V205, P261, DOI 10.1016/j.jss.2016.06.087; Muroi C, 2008, J NEUROSURG ANESTH, V20, P188, DOI 10.1097/ANA.0b013e3181778156; Oddo M, 2010, NEUROSURGERY, V67, P338, DOI 10.1227/01.NEU.0000371979.48809.D9; Oresic M, 2016, EBIOMEDICINE, V12, P118, DOI 10.1016/j.ebiom.2016.07.015; Ortiz GG, 2006, BIOMED PHARMACOTHER, V60, P86, DOI 10.1016/j.biopha.2005.07.012; Otero HJ, 2014, PEDIATR EMERG CARE, V30, P845, DOI 10.1097/PEC.0000000000000309; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; Pyeron A M, 2001, J Neurosci Nurs, V33, P203; Ranieri VM, 2012, JAMA-J AM MED ASSOC, V307, P2526, DOI 10.1001/jama.2012.5669; Rogachev B, 2013, J NEUROSURG ANESTH, V25, P262, DOI 10.1097/ANA.0b013e318283f86a; Rogachev B, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2012.07.002; Rowell SE, 2011, J TRAUMA, V71, pS384, DOI 10.1097/TA.0b013e3182287c8d; Said SI, 2001, TRENDS PHARMACOL SCI, V22, P344, DOI 10.1016/S0165-6147(00)01744-2; Sedy J, 2015, J NEUROTRAUM, V32, P1135, DOI 10.1089/neu.2014.3609; Smith QR, 2000, J NUTR, V130, p1016S, DOI 10.1093/jn/130.4.1016S; STEGINK LD, 1979, J NUTR, V109, P2173, DOI 10.1093/jn/109.12.2173; Su X, 2010, J IMMUNOL, V184, P401, DOI 10.4049/jimmunol.0901808; Tian HL, 2008, NEUROSURG REV, V31, P431, DOI 10.1007/s10143-008-0153-5; Wu JS, 2012, J EMERG MED, V43, P407, DOI 10.1016/j.jemermed.2009.05.024; Yamagishi T, 2014, J EMERG MED, V46, P683, DOI 10.1016/j.jemermed.2013.11.094; Yuan Q, 2015, CRIT CARE MED, V43, P1405, DOI 10.1097/CCM.0000000000000965	44	15	16	0	1	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	JUL 14	2017	7								5380	10.1038/s41598-017-05574-9			9	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	FA5EA	WOS:000405464200017	28710466	Green Published, gold			2022-02-06	
J	Rajajee, V; Fontana, RJ; Courey, AJ; Patil, PG				Rajajee, Venkatakrishna; Fontana, Robert J.; Courey, Anthony J.; Patil, Parag G.			Protocol based invasive intracranial pressure monitoring in acute liver failure: feasibility, safety and impact on management	CRITICAL CARE			English	Article						Fulminant hepatic failure; Hepatic encephalopathy; Cerebral edema; Intracranial hypertension; Intracranial hemorrhage	FULMINANT HEPATIC-FAILURE; RECOMBINANT FACTOR VIIA; RANDOMIZED CONTROLLED-TRIAL; TRAUMATIC BRAIN-INJURY; ACTIVATED FACTOR-VII; CEREBRAL PERFUSION; TRANSPLANTATION; HYPERTENSION; ENCEPHALOPATHY; COMPLICATIONS	Background: Acute liver failure (ALF) may result in elevated intracranial pressure (ICP). While invasive ICP monitoring (IICPM) may have a role in ALF management, these patients are typically coagulopathic and at risk for intracranial hemorrhage (ICH). Contemporary ICP monitoring techniques and coagulopathy reversal strategies may be associated with a lower risk of hemorrhage. Our objective was to evaluate the safety, feasibility, impact on clinical management and outcomes associated with protocol-directed use of IICPM in ALF. Methods: Adult patients admitted between June 2011 and October 2016, with ALF and grade-4 encephalopathy with a reasonable likelihood of survival, were eligible for IICPM. The coagulopathy reversal protocol included administration of recombinant Factor VIIa (rFVIIa) and desmopressin, a goal platelet count > 50,000/mm(3) and fibrinogen > 100 mg/dL. Monitor insertion was performed within an hour of the rFVIIa dose. Only intraparenchymal monitors were used. Computed tomography of the brain was performed prior to and within 24 hours of monitor placement. Outcomes of interest included ICH, sustained intracranial hypertension, therapeutic intensity level (TIL) for ICP management, mortality and functional outcome on the Glasgow Outcome Scale (GOS) at discharge and 6 months. Results: A total of 24/37 patients (65%) with ALF underwent IICPM. The most common reason for exclusion was encephalopathy grade <4. Four patients underwent liver transplantation. There was one asymptomatic ICH following IICPM, in a patient who had an excellent outcome. Sustained intracranial hypertension occurred in 13/24 monitored patients (54%), 5/24 (21%) required extreme measures (TIL-4) for ICP control, which were successful in 4 patients: 12/24 patients (50%) died but only 4 deaths (17%) were attributed to intracranial hypertension. Six of the 8 survivors with 6-month follow up had good functional outcome (GOS > 3). Conclusions: Protocol-directed use of IICPM in ALF is feasible, associated with a low incidence of serious complications and has a significant impact on clinical management.	[Rajajee, Venkatakrishna] Univ Michigan, Dept Neurosurg, 3552 Taubman Hlth Care Ctr,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA; [Rajajee, Venkatakrishna] Univ Michigan, Dept Neurol, 3552 Taubman Hlth Care Ctr,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA; [Fontana, Robert J.] Univ Michigan, Dept Internal Med, Div Gastroenterol, Ann Arbor, MI 48109 USA; [Courey, Anthony J.] Univ Michigan, Dept Internal Med, Div Pulm & Crit Care Med, Ann Arbor, MI 48109 USA; [Patil, Parag G.] Univ Michigan, Dept Neurosurg, Ann Arbor, MI 48109 USA		Rajajee, V (corresponding author), Univ Michigan, Dept Neurosurg, 3552 Taubman Hlth Care Ctr,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA.; Rajajee, V (corresponding author), Univ Michigan, Dept Neurol, 3552 Taubman Hlth Care Ctr,1500 East Med Ctr Dr, Ann Arbor, MI 48109 USA.	vrajajee@yahoo.com		Rajajee, Venkatakrishna/0000-0002-7183-8324			Aggarwal S, 2005, LIVER TRANSPLANT, V11, P1353, DOI 10.1002/lt.20479; Aggarwal S, 2008, LIVER TRANSPLANT, V14, P1048, DOI 10.1002/lt.21499; Andrews PJD, 2015, NEW ENGL J MED, V373, P2403, DOI 10.1056/NEJMoa1507581; Poca MA, 2007, J NEUROSURG, V106, P548, DOI 10.3171/jns.2007.106.4.548; ATTERBURY CE, 1978, AM J DIG DIS, V23, P398, DOI 10.1007/BF01072921; Bacher A, 2006, TRANSPLANT P, V38, P783, DOI 10.1016/j.transproceed.2006.01.073; Bernal W, 2007, HEPATOLOGY, V46, P1844, DOI 10.1002/hep.21838; Bernal W, 2016, J HEPATOL, V65, P273, DOI 10.1016/j.jhep.2016.03.003; Bernal W, 2013, J HEPATOL, V59, P74, DOI 10.1016/j.jhep.2013.02.010; Bindi M L, 2008, J Clin Monit Comput, V22, P449, DOI 10.1007/s10877-008-9156-6; BLEI AT, 1993, LANCET, V341, P157, DOI 10.1016/0140-6736(93)90016-A; CANALESE J, 1982, GUT, V23, P625, DOI 10.1136/gut.23.7.625; Chan G, 2009, LIVER TRANSPLANT, V15, P1696, DOI 10.1002/lt.21931; Chavez-Tapia NC, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022581; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; Clevenger B, 2014, WORLD J GASTROENTERO, V20, P6146, DOI 10.3748/wjg.v20.i20.6146; DAVIES MH, 1994, LANCET, V343, P1329, DOI 10.1016/S0140-6736(94)92471-6; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; FORBES A, 1989, HEPATOLOGY, V10, P306, DOI 10.1002/hep.1840100309; HANID MA, 1980, GUT, V21, P866, DOI 10.1136/gut.21.10.866; Helmke K, 2000, TRANSPLANTATION, V70, P392, DOI 10.1097/00007890-200007270-00029; Jeffers L, 2002, GASTROENTEROLOGY, V123, P118, DOI 10.1053/gast.2002.34164; JENNETT B, 1975, LANCET, V1, P480; Kamat P, 2012, PEDIATR CRIT CARE ME, V13, pE33, DOI 10.1097/PCC.0b013e31820ac08f; Karvellas CJ, 2014, CRIT CARE MED, V42, P1157, DOI 10.1097/CCM.0000000000000144; Kawakami M, 2010, CLIN IMAG, V34, P327, DOI 10.1016/j.clinimag.2009.09.006; KEAYS RT, 1993, J HEPATOL, V18, P205, DOI 10.1016/S0168-8278(05)80247-8; Krishnamoorthy V, 2013, LIVER TRANSPLANT, V19, P246, DOI 10.1002/lt.23591; Krisl JC, 2011, ANN PHARMACOTHER, V45, P1433, DOI 10.1345/aph.1Q207; Larsen FS, 2016, J HEPATOL, V64, P69, DOI 10.1016/j.jhep.2015.08.018; Le TV, 2010, NEUROSURGERY, V66, P455, DOI 10.1227/01.NEU.0000365517.52586.A2; LEE WM, 1993, NEW ENGL J MED, V329, P1862, DOI 10.1056/NEJM199312163292508; LIDOFSKY SD, 1992, HEPATOLOGY, V16, P1, DOI 10.1002/hep.1840160102; Maas AIR, 2011, J NEUROTRAUM, V28, P177, DOI 10.1089/neu.2010.1617; Maloney PR, 2016, NEUROCRIT CARE, V25, P86, DOI 10.1007/s12028-016-0261-y; Meng ZH, 2003, J TRAUMA, V55, P886, DOI 10.1097/01.TA.0000066184.20808.A5; Munoz SJ, 2008, NEUROCRIT CARE, V9, P103, DOI 10.1007/s12028-008-9087-6; MUNOZ SJ, 1991, HEPATOLOGY, V13, P209, DOI 10.1016/0270-9139(91)92430-G; Paschoal FM, 2016, WORLD J HEPATOL, V8, P915, DOI 10.4254/wjh.v8.i22.915; Pavese P, 2005, CAN J ANAESTH, V52, P26, DOI 10.1007/BF03018576; Pham HP, 2014, CLIN APPL THROMB-HEM, V20, P607, DOI 10.1177/1076029614524621; Porte RJ, 2005, LIVER TRANSPLANT, V11, P872, DOI 10.1002/lt.20447; Rabinowich L, 2016, WORLD J GASTROENTERO, V22, P7595, DOI 10.3748/wjg.v22.i33.7595; Raghavan M, 2006, NEUROCRIT CARE, V4, P179, DOI 10.1385/NCC:4:2:179; Rajajee V, 2012, CRITICAL CARE, V16, P79; Raschke RA, 2008, CRIT CARE MED, V36, P2244, DOI 10.1097/CCM.0b013e31818029a3; Riordan SM, 2008, SEMIN LIVER DIS, V28, P137, DOI 10.1055/s-2008-1073113; Ryan JM, 2013, METAB BRAIN DIS, V28, P7, DOI 10.1007/s11011-012-9363-1; Shami VM, 2003, LIVER TRANSPLANT, V9, P138, DOI 10.1053/jlts.2003.50017; Shawcross DL, 2012, NEUROCHEM INT, V60, P662, DOI 10.1016/j.neuint.2011.10.006; Stravitz RT, 2007, CRIT CARE MED, V35, P2498, DOI 10.1097/01.CCM.0000287592.94554.5F; Tan WF, 2012, TRANSPLANTATION, V94, P768, DOI 10.1097/TP.0b013e3182620596; Vaquero J, 2005, LIVER TRANSPLANT, V11, P1581, DOI 10.1002/lt.20625; WARE AJ, 1971, GASTROENTEROLOGY, V61, P877; Zheng YY, 2012, NEUROCRIT CARE, V17, P77, DOI 10.1007/s12028-012-9721-1; 1991, LANCET, V338, P156	56	15	15	0	1	BIOMED CENTRAL LTD	LONDON	236 GRAYS INN RD, FLOOR 6, LONDON WC1X 8HL, ENGLAND	1466-609X	1364-8535		CRIT CARE	Crit. Care	JUL 11	2017	21								178	10.1186/s13054-017-1762-6			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	FA7AK	WOS:000405596300001	28693567	gold, Green Published			2022-02-06	
J	Catena, RD; Chen, SH; Chou, LS				Catena, Robert D.; Chen, Szu-Hua; Chou, Li-Shan			Does the anthropometric model influence whole-body center of mass calculations in gait?	JOURNAL OF BIOMECHANICS			English	Article						Gait; Anthropometry; Center of mass; Motion capture; Center of gravity	CONTROL FOLLOWING CONCUSSION; BALANCE CONTROL; OLDER-ADULTS; DYNAMIC STABILITY; WALKING; RECOVERY; ACCELEROMETER; ADJUSTMENTS; MOTION; YOUNG	Examining whole-body center of mass (COM) motion is one of method being used to quantify dynamic balance and energy during gait. One common method for estimating the COM position is to apply an anthropometric model to a marker set and calculate the weighted sum from known segmental COM positions. Several anthropometric models are available to perform such a calculation. However, to date there has been no study of how the anthropometric model affects whole-body COM calculations during gait. This information is pertinent to researchers because the choice of anthropometric model may influence gait research findings and currently the trend is to consistently use a single model. In this study we analyzed a single stride of gait data from 103 young adult participants. We compared the whole-body COM motion calculated from 4 different anthropometric models (Plagenhoef et al., 1983; Winter, 1990; de Leva, 1996; Pavol et al., 2002). We found that anterior-posterior motion calculations are relatively unaffected by the anthropometric model. However, medial-lateral and vertical motions are significantly affected by the use of different anthropometric models. Our findings suggest that the researcher carefully choose an anthropometric model to fit their study populations when interested in medial-lateral or vertical motions of the COM. Our data can provide researchers a priori information on the model determination depending on the particular variable and how conservative they may want to be with COM comparisons between groups. (C) 2017 Elsevier Ltd. All rights reserved.	[Catena, Robert D.] Washington State Univ, Kinesiol Program, Gait & Posture Biomech Lab, Pullman, WA 99164 USA; [Chen, Szu-Hua; Chou, Li-Shan] Univ Oregon, Dept Human Physiol, Mot Anal Lab, Eugene, OR 97403 USA		Catena, RD (corresponding author), Washington State Univ, Kinesiol Program, Gait & Posture Biomech Lab, Pullman, WA 99164 USA.	robert.catena@wsu.edu	Catena, Robert/AAT-1510-2021	Catena, Robert/0000-0001-9128-1343			Arvin M, 2016, J BIOMECH, V49, P1264, DOI 10.1016/j.jbiomech.2016.03.011; Catena RD, 2007, GAIT POSTURE, V25, P406, DOI 10.1016/j.gaitpost.2006.05.006; Catena RD, 2011, J NEUROENG REHABIL, V8, DOI 10.1186/1743-0003-8-8; Catena RD, 2009, J NEUROENG REHABIL, V6, DOI 10.1186/1743-0003-6-25; CAVAGNA GA, 1976, J PHYSIOL-LONDON, V262, P639, DOI 10.1113/jphysiol.1976.sp011613; Chambers AJ, 2010, CLIN BIOMECH, V25, P131, DOI 10.1016/j.clinbiomech.2009.10.015; Clauser CE, 1969, WEIGHT VOLUME CTR MA; de Leva P, 1996, J BIOMECH, V29, P1223, DOI 10.1016/0021-9290(95)00178-6; Durkin JL, 2003, J BIOMECH ENG-T ASME, V125, P515, DOI 10.1115/1.1590359; Gard SA, 2004, HUM MOVEMENT SCI, V22, P597, DOI 10.1016/j.humov.2003.11.002; Gutierrez-Farewik EM, 2006, HUM MOVEMENT SCI, V25, P238, DOI 10.1016/j.humov.2005.11.001; Howell D, 2015, J BIOMECH, V48, P3364, DOI 10.1016/j.jbiomech.2015.06.014; Hurt CP, 2015, J BIOMECH, V48, P592, DOI 10.1016/j.jbiomech.2015.01.003; Lee HJ, 2006, ARCH PHYS MED REHAB, V87, P569, DOI 10.1016/j.apmr.2005.11.033; Mancini M, 2009, EUR J NEUROL, V16, P1028, DOI 10.1111/j.1468-1331.2009.02641.x; McCrum C, 2016, J BIOMECH, V49, P1244, DOI 10.1016/j.jbiomech.2016.02.051; Motlagh FN, 2016, P I MECH ENG H, V230, P682, DOI 10.1177/0954411916646402; Nikolova, 2007, J BIOMECH, V40, P3700; Park Se Jin, 1999, Applied Human Science, V18, P91; Pavol MJ, 2002, J BIOMECH, V35, P707, DOI 10.1016/S0021-9290(01)00250-0; PLAGENHOEF S, 1983, RES Q EXERCISE SPORT, V54, P169, DOI 10.1080/02701367.1983.10605290; Rosenblatt NJ, 2012, J APPL BIOMECH, V28, P616, DOI 10.1123/jab.28.5.616; Shin SS, 2016, PM&R, V8, P953, DOI 10.1016/j.pmrj.2016.03.002; van Keeken HG, 2013, MED ENG PHYS, V35, P583, DOI 10.1016/j.medengphy.2012.07.002; Vieira MF, 2017, J BIOMECH, V54, P73, DOI 10.1016/j.jbiomech.2017.01.045; Virmavirta M, 2014, J BIOMECH, V47, P1909, DOI 10.1016/j.jbiomech.2014.04.001; Wikstrom EA, 2010, GAIT POSTURE, V32, P82, DOI 10.1016/j.gaitpost.2010.03.015; Winter D.A., 1990, BIOMECHANICS MOTOR C, VVol. 1; Yang F, 2014, J BIOMECH, V47, P3807, DOI 10.1016/j.jbiomech.2014.10.027; Yeates KH, 2016, J BIOMECH, V49, P2734, DOI 10.1016/j.jbiomech.2016.06.014	30	15	15	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0021-9290	1873-2380		J BIOMECH	J. Biomech.	JUL 5	2017	59						23	28		10.1016/j.jbiomech.2017.05.007			6	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	FA9KB	WOS:000405763400003	28549601				2022-02-06	
J	Carroll-Alfano, M				Carroll-Alfano, Miriam			Mandated High School Concussion Education and Collegiate Athletes' Understanding of Concussion	JOURNAL OF ATHLETIC TRAINING			English	Article						legislation; student-athletes; traumatic brain injuries	FOOTBALL PLAYERS; KNOWLEDGE; ATTITUDES; COACHES; IMPACT	Context: Concussions in student-athletes are a serious problem. Most states have enacted legislation mandating concussion education for student-athletes, under the assumption that education leads to better self-reporting of concussions and improved knowledge of symptoms. Objectives: (1) To determine the effect of state-based concussion legislation on the proportion of student-athletes receiving concussion education and to assess the moderation of this effect by gender and sport and (2) to assess the effect of concussion education on student-athletes' knowledge of concussion symptoms and likelihood of seeking treatment after a concussion. Design: Cross-sectional study. Setting: Private university. Patients or Other Participants: A total of 249 National Association of Intercollegiate Athletics collegiate athletes attending St Xavier University; 160 were surveyed prelegislation and 89 were surveyed postlegislation. Main Outcome Measure(s): Participants completed an anonymous survey that assessed previous involvement in concussion-education programs, degree of self-reporting after a concussion, and ability to enumerate symptoms. Results: The number of athletes who reported having received education increased after the implementation of concussion legislation; however, almost 25% still reported not having received education. Athletes who played football were more likely to report having received education than those who played volleyball. The student-athletes' ability to name a diversity of concussion symptoms or to report seeking medical attention after a concussion did not improve in the postlegislation period relative to the prelegislation period. Conclusions: Legislation has been passed in all 50 states to address concussions in student-athletes; however, improvements are still needed. Concussion education must be delivered in a uniform, effective manner to all student-athletes across sports and genders. Concussion education should emphasize the diversity of symptoms, especially cognitive and behavioral symptoms. We must develop and disseminate evidence-based educational programs that are clinically proven to be effective in improving athletes' knowledge and behaviors.	[Carroll-Alfano, Miriam] St Xavier Univ, Dept Commun Sci & Disorders, 3700 West 103rd St, Chicago, IL 60655 USA		Carroll-Alfano, M (corresponding author), St Xavier Univ, Dept Commun Sci & Disorders, 3700 West 103rd St, Chicago, IL 60655 USA.	alfano@sxu.edu					Bagley AF, 2012, CLIN J SPORT MED, V22, P385, DOI 10.1097/JSM.0b013e3182639bb4; Bramley H, 2012, CLIN PEDIATR, V51, P332, DOI 10.1177/0009922811425233; Chrisman SP, 2014, AM J SPORT MED, V42, P1190, DOI 10.1177/0363546513519073; Chrisman SP, 2013, J ADOLESCENT HEALTH, V52, P330, DOI 10.1016/j.jadohealth.2012.10.271; Collins MW, 2002, NEUROSURGERY, V51, P1175, DOI 10.1097/00006123-200211000-00011; Cournoyer J, 2014, J ATHL TRAINING, V49, P654, DOI 10.4085/1062-6050-49.3.34; Echlin PS, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10187; Ellenbogen Richard G, 2014, Neurosurgery, V75 Suppl 4, pS122, DOI 10.1227/NEU.0000000000000495; Fedor A, 2015, APPL NEUROPSYCH-ADUL, V22, P108, DOI 10.1080/23279095.2013.860604; Kroshus E, 2014, HEALTH EDUC BEHAV, V42, P153; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Kroshus E, 2015, CLIN J SPORT MED, V25, P243, DOI 10.1097/JSM.0000000000000137; Kroshus E, 2014, J ADOLESCENT HEALTH, V54, P269, DOI 10.1016/j.jadohealth.2013.11.011; Kurowski B, 2014, J TRAUMA ACUTE CARE, V77, pS12, DOI 10.1097/TA.0000000000000316; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Manasse-Cohick NJ, 2014, COMMUN DISORD Q, V35, P182, DOI 10.1177/1525740113506605; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; Moser RS, 2005, NEUROSURGERY, V57, P300, DOI 10.1227/01.NEU.0000166663.98616.E4; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Register-Mihalik JK, 2013, BRAIN INJURY, V27, P878, DOI 10.3109/02699052.2013.775508; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Stoler DR, 2013, COPING CONCUSSION MI; Williamson Richard W, 2014, Neurosurgery, V75 Suppl 4, pS131, DOI 10.1227/NEU.0000000000000482	26	15	15	0	13	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	JUL	2017	52	7					689	697		10.4085/1062-6050-52.3.08			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Sport Sciences	FB4RH	WOS:000406128700009	28535096	Green Published, Bronze			2022-02-06	
J	Feng, Y; Gao, Y; Wang, T; Tao, LY; Qiu, SH; Zhao, XF				Feng, Yuan; Gao, Yuan; Wang, Tao; Tao, Luyang; Qiu, Suhao; Zhao, Xuefeng			A longitudinal study of the mechanical properties of injured brain tissue in a mouse model	JOURNAL OF THE MECHANICAL BEHAVIOR OF BIOMEDICAL MATERIALS			English	Article						Biomechanics; Traumatic brain injury; Indentation; Mouse model; Longitudinal effects	MAGNETIC-RESONANCE ELASTOGRAPHY; CONTROLLED CORTICAL IMPACT; IN-VIVO; WHITE-MATTER; VISCOELASTIC PROPERTIES; LARGE-DEFORMATION; ANIMAL-MODEL; SIMPLE SHEAR; STRAIN-RATE; BEHAVIOR	Mechanical properties of brain tissue are crucial to understand the mechanism of traumatic brain injury (TBI). Over the past several decades, most of the studies focused on healthy brain tissues, while few of them are about the injured tissues. Therefore, limited knowledge is known about the mechanical properties of the injured brain tissues. In this study, we used an in vivo mouse model with a weight drop device to study injured brain tissues. Around the injury site, mechanical properties of the injured, neighboring, and the corresponding contralateral regions of interest (ROIs) were measured over five temporal points by indentation. Longitudinal and regional comparisons of the mechanical properties revealed that the ROI of the injured tissue had a higher elastic modulus than the contralateral counterpart one-hour post-injury. However, the elastic modulus decreased one day post-injury and recovered to be close to the contralateral ROI in 7 days. The elastic modulus curves of the injured and the contralateral counterpart ROIs crossed at time points of 12 h and 1 day post-injury, where two significant increases of glial fibrillary acidic protein (GFAP) positive cells were observed. Biological staining results indicated that both the astrocytic responses and the morphological structure could affect the mechanical properties of the injured tissue. The observed longitudinal changes of the mechanical properties at the tissue level and the morphological and biological changes at the cellular level provide insights into understanding the mechanism of TBI. Results are also meaningful for applying emerging in vivo diagnostic tools such as magnetic resonance elastography (MRE) in TBI detection.	[Feng, Yuan; Qiu, Suhao; Zhao, Xuefeng] Soochow Univ, Collaborat Innovat Ctr Radiol Med, Ctr Mol Imaging & Nucl Med, Jiangsu Higher Educ Inst,Sch Radiol & Interdiscip, Suzhou 215123, Jiangsu, Peoples R China; [Feng, Yuan; Qiu, Suhao; Zhao, Xuefeng] Soochow Univ, Sch Mech & Elect Engn, Suzhou 215021, Jiangsu, Peoples R China; [Gao, Yuan; Wang, Tao; Tao, Luyang] Soochow Univ, Dept Forens Sci, Suzhou 215021, Jiangsu, Peoples R China		Feng, Y (corresponding author), Soochow Univ, Ctr Mol Imaging & Nucl Med, Sch Radiol & Interdisciplinary Sci RAD X, 199 RenAiLu,401-1121, Suzhou 215021, Jiangsu, Peoples R China.	fengyuan@suda.edu.cn			National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [61503267]; Jiangsu Province [BK20140356, 16KJB460018]; Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education MinistryScientific Research Foundation for the Returned Overseas Chinese Scholars [K511701515]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD); NSFCNational Natural Science Foundation of China (NSFC) [81530062]	Funding is provided by grant 61503267 (YF) from National Natural Science Foundation of China (NSFC), grant BK20140356 (YF) and 16KJB460018 (YF) from Jiangsu Province, and by grant K511701515 (YF) from Scientific Research Foundation for the Returned Overseas Chinese Scholars, State Education Ministry. Support from Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD) and grant 81530062 (LT) from NSFC are also acknowledged. We thank Prof. Philip V. Bayly for helpful discussions and suggestions.	Alfasi AM, 2013, J NEUROSURG, V119, P1255, DOI 10.3171/2013.7.JNS121973; Arbogast KB, 1998, J BIOMECH, V31, P801, DOI 10.1016/S0021-9290(98)00068-2; Arbogast KB, 1997, J BIOMECH, V30, P757, DOI 10.1016/S0021-9290(97)00023-7; Bayly PV, 2013, PHYS BIOL, V10, DOI 10.1088/1478-3975/10/1/016005; Bayly PV, 2012, ANNU REV BIOMED ENG, V14, P369, DOI [10.1146/annurev-bioeng-071811-150032, 10.1146/annurev.bioeng-071811-150032]; Bayly PV, 2006, J BIOMECH, V39, P1086, DOI 10.1016/j.jbiomech.2005.02.014; Bayly PV, 2004, J NEUROTRAUM, V21, P1276; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Boulet T, 2013, J NEUROTRAUM, V30, P1512, DOI 10.1089/neu.2012.2788; Boulet T, 2011, J NEUROSCI METH, V201, P296, DOI 10.1016/j.jneumeth.2011.08.019; Brody DL, 2007, J NEUROTRAUM, V24, P657, DOI 10.1089/neu.2006.0011; Budday S, 2015, J MECH BEHAV BIOMED, V46, P318, DOI 10.1016/j.jmbbm.2015.02.024; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chen YM, 2003, J CEREBR BLOOD F MET, V23, P137, DOI 10.1097/01.WCB.0000044631.80210.3C; Cheng S, 2007, J BIOMECH, V40, P117, DOI 10.1016/j.jbiomech.2005.11.004; Clayton EH, 2011, PHYS MED BIOL, V56, P2391, DOI 10.1088/0031-9155/56/8/005; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Cullen DK, 2007, BRAIN RES, V1158, P103, DOI 10.1016/j.brainres.2007.04.070; Destrade M, 2015, INT J NONLIN MECH, V75, P54, DOI 10.1016/j.ijnonlinmec.2015.02.014; Elkin B.S., 2013, J BIOMECH ENG-T ASME, P135; Elkin BS, 2011, J BIOMECH ENG-T ASME, V133, DOI 10.1115/1.4004494; Elkin BS, 2011, J NEUROTRAUM, V28, P2235, DOI 10.1089/neu.2010.1604; Elkin BS, 2010, J BIOMECH ENG-T ASME, V132, DOI 10.1115/1.4000164; Feng Y, 2013, J BIOMECH, V46, P863, DOI 10.1016/j.jbiomech.2012.12.024; Feng Y, 2017, J MECH BEHAV BIOMED, V65, P490, DOI 10.1016/j.jmbbm.2016.09.020; Feng Y, 2013, J MECH BEHAV BIOMED, V23, P117, DOI 10.1016/j.jmbbm.2013.04.007; Gefen A, 2004, J BIOMECH, V37, P1339, DOI 10.1016/j.jbiomech.2003.12.032; Goriely A, 2015, BIOMECH MODEL MECHAN, V14, P931, DOI 10.1007/s10237-015-0662-4; Green MA, 2008, NMR BIOMED, V21, P755, DOI 10.1002/nbm.1254; Hrapko M, 2008, BIORHEOLOGY, V45, P663, DOI 10.3233/BIR-2008-0512; Ji SB, 2015, J NEUROTRAUM, V32, P441, DOI 10.1089/neu.2013.3268; Kaster T, 2011, J BIOMECH, V44, P1158, DOI 10.1016/j.jbiomech.2011.01.019; Koizumi H, 1997, BRAIN RES, V747, P304, DOI 10.1016/S0006-8993(96)01240-1; Kulkarni SG, 2016, MATH MECH SOLIDS, V21, P747, DOI 10.1177/1081286514536921; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; LaPlaca MC, 2005, J BIOMECH, V38, P1093, DOI 10.1016/j.jbiomech.2004.05.032; Lee SJ, 2014, J MECH BEHAV BIOMED, V29, P213, DOI 10.1016/j.jmbbm.2013.08.026; Lippert-Gruner M, 2007, PHYSIOL RES, V56, P359, DOI 10.33549/physiolres.930971; Lusardi TA, 2004, ANN BIOMED ENG, V32, P1546, DOI 10.1114/B:ABME.0000049038.75368.75; MacManus DB, 2016, SCI REP-UK, V6, DOI 10.1038/srep21569; Meaney DF, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4026364; Mihai LA, 2015, J R SOC INTERFACE, V12, DOI 10.1098/rsif.2015.0486; Miller LE, 2016, BIOMECH MODEL MECHAN, V15, P1201, DOI 10.1007/s10237-015-0754-1; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Namani R, 2012, J BIOMECH ENG-T ASME, V134, DOI 10.1115/1.4006848; Nicolle S, 2005, BIORHEOLOGY, V42, P209; Ning XG, 2006, J BIOMECH ENG-T ASME, V128, P925, DOI 10.1115/1.2354208; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Rashid B, 2013, J MECH BEHAV BIOMED, V28, P71, DOI 10.1016/j.jmbbm.2013.07.017; Rashid B, 2013, J BIOMECH, V46, P1276, DOI 10.1016/j.jbiomech.2013.02.014; Romano A, 2012, MAGN RESON MED, V68, P1410, DOI 10.1002/mrm.24141; Schiavone P, 2009, MED IMAGE ANAL, V13, P673, DOI 10.1016/j.media.2009.04.001; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; Suarez MW, 2015, ULTRASONICS, V61, P151, DOI 10.1016/j.ultras.2015.04.014; van Dommelen JAW, 2010, J MECH BEHAV BIOMED, V3, P158, DOI 10.1016/j.jmbbm.2009.09.001; Vappou J, 2008, J BIOMECH, V41, P2954, DOI 10.1016/j.jbiomech.2008.07.034; Velardi F, 2006, BIOMECH MODEL MECHAN, V5, P53, DOI 10.1007/s10237-005-0007-9; Xu ZNS, 2014, J ULTRAS MED, V33, P1763, DOI 10.7863/ultra.33.10.1763; Zeng X, 2012, CURR GERIATR REP, V1, P167, DOI 10.1007/s13670-012-0018-1; Zhang JY, 2011, J BIOMECH, V44, P391, DOI 10.1016/j.jbiomech.2010.10.024; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446	62	15	17	1	12	ELSEVIER	AMSTERDAM	RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS	1751-6161	1878-0180		J MECH BEHAV BIOMED	J. Mech. Behav. Biomed. Mater.	JUL	2017	71						407	415		10.1016/j.jmbbm.2017.04.008			9	Engineering, Biomedical; Materials Science, Biomaterials	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Materials Science	EV6LM	WOS:000401880900045	28412646				2022-02-06	
J	Ren, HX; Yang, Z; Luo, CM; Zeng, HT; Li, P; Kang, JX; Wan, JB; He, CW; Su, HX				Ren, Huixia; Yang, Zhen; Luo, Chuanming; Zeng, Haitao; Li, Peng; Kang, Jing X.; Wan, Jian-Bo; He, Chengwei; Su, Huanxing			Enriched Endogenous Omega-3 Fatty Acids in Mice Ameliorate Parenchymal Cell Death After Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						Traumatic brain injury; Omega-3 polyunsaturated fatty acids; Neuroprotection; Two-photon laser scanning microscopy; DHA	SPINAL-CORD-INJURY; DOCOSAHEXAENOIC ACID; NEUROPROTECTIN D1; ANTIOXIDANT THERAPIES; CEREBRAL-ISCHEMIA; OXIDATIVE STRESS; TRANSGENIC MICE; FATTY-ACIDS; SURVIVAL; SUPPLEMENTATION	Currently no effective therapies are available for the treatment of traumatic brain injury (TBI). Early intervention that specifically provides neuroprotection is of most importance which profoundly influences the outcome of TBI. In the present study, we adopted a closed-skull mild TBI model to investigate potential roles of omega-3 polyunsaturated fatty acids (omega-3 PUFAs) in protecting against TBI. Using two-photon laser scanning microscopy (2PLSM), parenchymal cell death and reactive oxidative species (ROS) expression were directly observed and recorded after TBI through a thinned skull bone window. Fat-1 mice with high endogenous omega-3 PUFAs significantly inhibited ROS expression and attenuated parenchymal cell death after compression injury during the early injury phase. Elevated generation of glutathione (GSH) and neuroprotectin D1 (NPD1) in the parenchyma of fat-1 mice could be the contributor to the beneficial role of omega-3 PUFAs in TBI. The results of the study suggest that omega-3 PUFAs is an effective neuroprotectant as an early pharmacological intervention for TBI and the information derived from this study may help guide dietary advice for those who are susceptible to repetitive mild TBI.	[Ren, Huixia; Luo, Chuanming; Li, Peng; Wan, Jian-Bo; He, Chengwei; Su, Huanxing] Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China; [Yang, Zhen] Sun Yat Sen Univ, Affiliated Hosp 1, Dept Cardiol, Guangzhou 510080, Guangdong, Peoples R China; [Zeng, Haitao] Sun Yat Sen Univ, Affiliated Hosp 6, Ctr Reprod Med, Guangzhou, Guangdong, Peoples R China; [Kang, Jing X.] Massachusetts Gen Hosp, Dept Med, Lab Lipid Med & Technol, Boston, MA 02114 USA; [Kang, Jing X.] Harvard Med Sch, Boston, MA USA		Su, HX (corresponding author), Univ Macau, Inst Chinese Med Sci, State Key Lab Qual Res Chinese Med, Macau, Peoples R China.	huanxingsu@umac.mo	He, Chengwei/J-7090-2015; Su, Huanxing/X-3954-2019; Su, Huanxing/X-3980-2019; Wan, Jian-Bo/D-8368-2014	Su, Huanxing/0000-0003-3254-825X; Su, Huanxing/0000-0002-0513-4943; Wan, Jian-Bo/0000-0002-6750-2617	Macao Science and Technology Development Fund [063/2015/A1]; multi-year research grant, University of Macau [MYRG122 (Y1-L3)-ICMS12-SHX, MYRG110 (Y1-L2)-ICMS13-SHX]; National Natural Scientific Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31270992, 30800215]; Zhu Jiang Science and Technology New Star of Guangzhou City [2013 J2200019]; Guangdong Province Science and Technology Plan [2013B021800275]; Fundamental Research Funds for the Central Universities in Sun Yat-Sen University [13ykpy24]	This study was supported by the Macao Science and Technology Development Fund (063/2015/A1), multi-year research grant, University of Macau, MYRG122 (Y1-L3)-ICMS12-SHX and MYRG110 (Y1-L2)-ICMS13-SHX, the National Natural Scientific Foundation of China (31270992 and 30800215), Zhu Jiang Science and Technology New Star of Guangzhou City (2013 J2200019), Guangdong Province Science and Technology Plan (2013B021800275), and the Fundamental Research Funds for the Central Universities in Sun Yat-Sen University (13ykpy24).	Antony R, 2010, J BIOL CHEM, V285, P18301, DOI 10.1074/jbc.M109.095232; Bains M, 2012, BBA-MOL BASIS DIS, V1822, P675, DOI 10.1016/j.bbadis.2011.10.017; Bazan NG, 2006, TRENDS NEUROSCI, V29, P263, DOI 10.1016/j.tins.2006.03.005; Bazan NG, 2014, MOL NEUROBIOL, V50, P1, DOI 10.1007/s12035-014-8897-0; Bazan NG, 2012, MOL NEUROBIOL, V46, P221, DOI 10.1007/s12035-012-8322-5; Bazan NG, 2010, J LIPID RES, V51, P2018, DOI 10.1194/jlr.R001131; Belayev L, 2009, STROKE, V40, P3121, DOI 10.1161/STROKEAHA.109.555979; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Bullock R, 1995, ANN NY ACAD SCI, V765, P290, DOI 10.1111/j.1749-6632.1995.tb16586.x; Casanas-Sanchez V, 2014, J NEUROCHEM, V131, P470, DOI 10.1111/jnc.12833; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Das UN, 2009, LIPIDS HEALTH DIS, V8, DOI 10.1186/1476-511X-8-61; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Hong SH, 2014, J NEUROL SCI, V338, P135, DOI 10.1016/j.jns.2013.12.033; Jennings JS, 2008, MINI-REV MED CHEM, V8, P689, DOI 10.2174/138955708784567377; Kanemaru K, 2013, P NATL ACAD SCI USA, V110, P11612, DOI 10.1073/pnas.1300378110; Kang JX, 2004, NATURE, V427, P504, DOI 10.1038/427504a; Kelly L, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.04.001; Kohli P, 2009, BRIT J PHARMACOL, V158, P960, DOI 10.1111/j.1476-5381.2009.00290.x; KONTOS HA, 1986, J NEUROSURG, V64, P803, DOI 10.3171/jns.1986.64.5.0803; Lalancette-Hebert M, 2011, STROKE, V42, P2903, DOI 10.1161/STROKEAHA.111.620856; Lenzlinger PM, 2001, MOL NEUROBIOL, V24, P169; Lim SN, 2013, NEUROBIOL DIS, V51, P104, DOI 10.1016/j.nbd.2012.10.021; Lim SN, 2013, EXP NEUROL, V239, P13, DOI 10.1016/j.expneurol.2012.09.015; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Lukiw WJ, 2005, J CLIN INVEST, V115, P2774, DOI 10.1172/JCI25420; Luo CM, 2014, J LIPID RES, V55, P1288, DOI 10.1194/jlr.M046466; Michael-Titus AT, 2014, TRENDS NEUROSCI, V37, P30, DOI 10.1016/j.tins.2013.10.005; Mills JD, 2011, NEUROSURGERY, V68, P474, DOI 10.1227/NEU.0b013e3181ff692b; Moraes LA, 2006, PHARMACOL THERAPEUT, V110, P371, DOI 10.1016/j.pharmthera.2005.08.007; Nikolenko V, 2007, NAT METHODS, V4, P943, DOI 10.1038/NMETH1105; Oh DY, 2010, CELL, V142, P687, DOI 10.1016/j.cell.2010.07.041; Orr SK, 2013, J NEUROCHEM, V127, P378, DOI 10.1111/jnc.12392; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Schaffer CB, 2006, PLOS BIOL, V4, P258, DOI 10.1371/journal.pbio.0040022; Schwab JM, 2007, NATURE, V447, P869, DOI 10.1038/nature05877; Shi Z, 2015, MOL NEUROBI IN PRESS; Shih AY, 2012, J CEREBR BLOOD F MET, V32, P1277, DOI 10.1038/jcbfm.2011.196; Signoretti S, 2004, J NEUROTRAUM, V21, P1154, DOI 10.1089/neu.2004.21.1154; Vreugdenhil M, 1996, P NATL ACAD SCI USA, V93, P12559, DOI 10.1073/pnas.93.22.12559; Witcher KG, 2015, TRENDS NEUROSCI, V38, P609, DOI 10.1016/j.tins.2015.08.002; Wolf S, 2015, NAT METHODS, V12, P379, DOI 10.1038/nmeth.3371; Wu A, 2004, J NEUROTRAUM, V21, P1457, DOI 10.1089/neu.2004.21.1457; Wu AG, 2007, J NEUROTRAUM, V24, P1587, DOI 10.1089/neu.2007.0313; Yang R., 2011, CURR PROTOC IMMUNOL; Zhang WT, 2010, STROKE, V41, P2341, DOI 10.1161/STROKEAHA.110.586081	49	15	16	0	17	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	JUL	2017	54	5					3317	3326		10.1007/s12035-016-9931-1			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EV9IQ	WOS:000402100100020	27167127				2022-02-06	
J	Turner-Stokes, L				Turner-Stokes, Lynne			A matter of life and death: controversy at the interface between clinical and legal decision-making in prolonged disorders of consciousness	JOURNAL OF MEDICAL ETHICS			English	Article							NEUROTRAUMA; FUTILITY	Best interests decision-making and end-of-life care for patients in permanent vegetative or minimally conscious states (VS/MCS) is a complex area of clinical and legal practice, which is poorly understood by most clinicians, lawyers and members of the public. In recent weeks, the Oxford Shrieval lecture by Mr Justice Baker ('A Matter of Life and Death', 11 October 2016) and its subsequent reporting in the public press has sparked debate on the respective roles of clinicians, the Court of Protection and the Mental Capacity Act 2005 in decisions to withhold or withdraw life-sustaining treatments from patients with disorders of consciousness. The debate became polarised and confused by misquotation and inaccurate terminology, and highlighted a lack of knowledge about how patients in VS/MCS die in the absence of court approval. This article sets out the background and discussion and attempts to give a more accurate representation of the facts. In the spirit of transparency, I present a mortality review of all the patients in VS/MCS who have died under the care of my own unit in the last decade-with or without referral to the court, but always in accordance with the law. These data demonstrate that clinicians regularly undertake best interests decision-making in conjunction with families that may include life and death decisions (sometimes even the withdrawal or withholding of clinically assisted nutrition and hydration); and that these can be made within the current legal framework without necessarily involving the court in all cases. This is the first published case series of its kind.	[Turner-Stokes, Lynne] Kings Coll London, Fac Life Sci & Med, Dept Palliat Care Policy & Rehabil, London, England; [Turner-Stokes, Lynne] Northwick Pk Hosp & Clin Res Ctr, Reg Hyper Acute Rehabil Unit, Harrow, Middx, England		Turner-Stokes, L (corresponding author), Northwick Pk Hosp & Clin Res Ctr, Reg Rehabil Unit, Watford Rd, Harrow HA1 3UJ, Middx, England.	lynne.turner-stokes@doctors.org.uk	Turner-Stokes, Lynne/F-4418-2012	Turner-Stokes, Lynne/0000-0002-3302-9462	Dunhill Medical TrustDunhill Medical Trust; National Institute for Health ResearchNational Institute for Health Research (NIHR) [RP-PG-0407-10185] Funding Source: researchfish	Financial support for the preparation of this manuscript was provided by the Dunhill Medical Trust.	[Anonymous], 2005, MENT CAP ACT; [Anonymous], 2013, PROLONGED DISORDERS; [Anonymous], 2016, ADV DECISIONS ARE LE; Baker J., 2016, OXFORD SHRIEVAL LECT; Bunn S, 2015, VEGETATIVE MINIMALLY; Formby A., 2015, COST ANAL LEGAL DECL; Giacino JT, 2005, NEUROPSYCHOL REHABIL, V15, P166, DOI 10.1080/09602010443000498; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Honeybul S, 2011, J MED ETHICS, V37, P707, DOI 10.1136/medethics-2011-100081; Honeybul S, 2016, ACTA NEUROCHIR, V158, P1251, DOI 10.1007/s00701-016-2818-0; Honeybul S, 2013, NEUROSURGERY, V73, P917, DOI 10.1227/NEU.0000000000000014; Honeybul S, 2012, J MED ETHICS, V38, P657, DOI 10.1136/medethics-2012-100672; Jackson P., 2014, EWHC, V342; Kitzinger C, 2015, LEGITIMACY MED TREAT; Kitzinger C, 2015, J MED ETHICS, V41, DOI 10.1136/medethics-2013-101799; Kitzinger J, 2017, J MED ETHICS, V43, P459, DOI 10.1136/medethics-2016-103853; Laurie GT, 2016, MASON MCCALL SMITHS; NINDS, 2015, COM INF PAG; Ruck-Keene A., 2017, J MED ETHICS, V43, P435; Ruck-Keene A., 2016, MENTAL CAPACITY LAW; Strauss DJ, 1999, PEDIATR NEUROL, V21, P626, DOI 10.1016/S0887-8994(99)00051-X	21	15	16	0	9	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-6800	1473-4257		J MED ETHICS	J. Med. Ethics	JUL	2017	43	7					469	475		10.1136/medethics-2016-104057			7	Ethics; Medical Ethics; Social Issues; Social Sciences, Biomedical	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Social Sciences - Other Topics; Medical Ethics; Social Issues; Biomedical Social Sciences	EZ2ND	WOS:000404545100010	27986800	Green Published, hybrid			2022-02-06	
J	Yates, NJ; Lydiard, S; Fehily, B; Weir, G; Chin, A; Bartlett, CA; Alderson, J; Fitzgerald, M				Yates, Nathanael J.; Lydiard, Stephen; Fehily, Brooke; Weir, Gillian; Chin, Aaron; Bartlett, Carole A.; Alderson, Jacqueline; Fitzgerald, Melinda			Repeated mild traumatic brain injury in female rats increases lipid peroxidation in neurons	EXPERIMENTAL BRAIN RESEARCH			English	Article						Repeated mild traumatic brain injury; Oxidative stress; Lipid peroxidation; Closed head; Weight drop model; Concussion; Female	CLOSED-HEAD INJURY; OXIDATIVE STRESS; MOUSE MODEL; TEMPORAL WINDOW; CELL-DEATH; PROFESSIONAL FOOTBALL; SYNAPTIC PROTEINS; AXONAL INJURY; TIME-COURSE; CONCUSSION	Negative outcomes of mild traumatic brain injury (mTBI) can be exacerbated by repeated insult. Animal models of repeated closed-head mTBI provide the opportunity to define acute pathological mechanisms as the number of mTBI increases. Furthermore, little is known about the effects of mTBI impact site, and how this may affect brain function. We use a closed head, weight drop model of mTBI that allows head movement following impact, in adult female rats to determine the role of the number and location of mTBI on brain pathology and behaviour. Biomechanical assessment of two anatomically well-defined mTBI impact sites were used, anterior (bregma) and posterior (lambda). Location of the impact had no significant effect on impact forces (450 N), and the weight impact locations were on average 5.4 mm from the desired impact site. No between location vertical linear head kinematic differences were observed immediately following impact, however, in the 300 ms post-impact, significantly higher mean vertical head displacement and velocity were observed in the mTBI lambda trials. Breaches of the blood brain barrier were observed with three mTBI over bregma, associated with immunohistochemical indicators of damage. However, an increased incidence of hairline fractures of the skull and macroscopic haemorrhaging made bregma an unsuitable impact location to model repeated mTBI. Repeated mTBI over lambda did not cause skull fractures and were examined more comprehensively, with outcomes following one, two or three mTBI or sham, delivered at 1 day intervals, assessed on days 1-4. We observe a mild behavioural phenotype, with subtle deficits in cognitive function, associated with no identifiable neuroanatomical or inflammatory changes. However, an increase in lipid peroxidation in a subset of cortical neurons following two mTBI indicates increasing oxidative damage with repeated injury in female rats, supported by increased amyloid precursor protein immunoreactivity with three mTBI. This study of acute events following closed head mTBI identifies lipid peroxidation in neurons at the same time as cognitive deficits. Our study adds to existing literature, providing biomechanics data and demonstrating mild cognitive disturbances associated with diffuse injury, predominantly to grey matter, acutely following repeated mTBI.	[Yates, Nathanael J.; Lydiard, Stephen; Fehily, Brooke; Bartlett, Carole A.; Fitzgerald, Melinda] Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Perth, WA, Australia; [Weir, Gillian; Chin, Aaron; Alderson, Jacqueline] Univ Western Australia, Sch Sport Sci Exercise & Hlth, Perth, WA 6009, Australia; [Alderson, Jacqueline] Auckland Univ Technol, SPRINZ, Auckland, New Zealand; [Fitzgerald, Melinda] Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia; [Fitzgerald, Melinda] Sarich Neurosci Res Inst, Perron Inst Nerurol & Translat Sci, Verdun St, Nedlands, WA 6009, Australia		Fitzgerald, M (corresponding author), Univ Western Australia, Sch Biol Sci, Expt & Regenerat Neurosci, Perth, WA, Australia.; Fitzgerald, M (corresponding author), Curtin Univ, Curtin Hlth Innovat Res Inst, Bentley, WA, Australia.; Fitzgerald, M (corresponding author), Sarich Neurosci Res Inst, Perron Inst Nerurol & Translat Sci, Verdun St, Nedlands, WA 6009, Australia.	lindy.fitzgerald@uwa.edu.au	Yates, Nathanael J/K-8358-2018; Fitzgerald, Melinda/C-4235-2011; Alderson, Jacqueline/V-3491-2019	Yates, Nathanael J/0000-0003-2742-6952; Fitzgerald, Melinda/0000-0002-4823-8179; Alderson, Jacqueline/0000-0002-8866-0913; Fehily, Brooke/0000-0002-8432-4621	Department of Health Western Australia Merit Award; NHMRCNational Health and Medical Research Council of Australia [APP1087114]	We acknowledge financial support from the Department of Health Western Australia Merit Award. MF is supported by an NHMRC Career Development Fellowship (APP1087114). We thank Dr Caitlin Wyrwoll for kindly allowing us to use her ANY-Maze software and Dr Jeremy Smith for providing selected antibodies.	Angoa-Perez M, 2014, J NEUROCHEM, V129, P916, DOI 10.1111/jnc.12690; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2008, J NEUROTRAUM, V25, P513, DOI 10.1089/neu.2007.0451; Bazarian JJ, 1999, BRAIN INJURY, V13, P173, DOI 10.1080/026990599121692; Bennett RE, 2012, NEUROSCI LETT, V513, P160, DOI 10.1016/j.neulet.2012.02.024; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P432, DOI 10.1080/01688639708403871; Bolouri H, 2012, ACTA NEUROL SCAND, V125, P241, DOI 10.1111/j.1600-0404.2011.01614.x; Bolton AN, 2014, J NEUROPATH EXP NEUR, V73, P933, DOI 10.1097/NEN.0000000000000115; Broshek DK, 2005, J NEUROSURG, V102, P856, DOI 10.3171/jns.2005.102.5.0856; Buchele F, 2016, J NEUROTRAUM, V33, P1171, DOI 10.1089/neu.2015.4001; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen Y, 1996, J NEUROTRAUM, V13, P557, DOI 10.1089/neu.1996.13.557; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; DeWitt DS, 2013, J NEUROTRAUM, V30, P688, DOI 10.1089/neu.2012.2349; Doig RLO, 2014, EXP NEUROL, V261, P136, DOI 10.1016/j.expneurol.2014.06.007; Fehily B, 2016, CELL TRANSPLANT, DOI [10.3727/096368916x692807, DOI 10.3727/096368916X692807]; Fitzgerald M, 2010, J NEUROTRAUM, V27, P439, DOI 10.1089/neu.2009.1112; Fuss B, 2000, DEV BIOL, V218, P259, DOI 10.1006/dbio.1999.9574; Gao LM, 2006, DEV BIOL, V290, P277, DOI 10.1016/j.ydbio.2005.11.007; Gregersen R, 2001, EXP BRAIN RES, V138, P384, DOI 10.1007/s002210100715; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hall ED, 2004, J NEUROTRAUM, V21, P9, DOI 10.1089/089771504772695904; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Higgins GC, 2010, J ALZHEIMERS DIS, V20, pS453, DOI 10.3233/JAD-2010-100321; Hohl A, 2012, J CRIT CARE, V27, DOI 10.1016/j.jcrc.2011.06.007; Ito D, 1998, MOL BRAIN RES, V57, P1, DOI 10.1016/S0169-328X(98)00040-0; Itoh T, 2010, NEUROCHEM RES, V35, P348, DOI 10.1007/s11064-009-0061-2; Kane MJ, 2012, J NEUROSCI METH, V203, P41, DOI 10.1016/j.jneumeth.2011.09.003; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kozlowski P, 2008, J NEUROTRAUM, V25, P653, DOI 10.1089/neu.2007.0462; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Loane DJ, 2014, J NEUROPATH EXP NEUR, V73, P14, DOI 10.1097/NEN.0000000000000021; Loane DJ, 2010, NEUROTHERAPEUTICS, V7, P366, DOI 10.1016/j.nurt.2010.07.002; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; Luo J, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00012; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Mannix R, 2013, ANN NEUROL, V74, P65, DOI 10.1002/ana.23858; Meehan WP, 2012, NEUROSURGERY, V71, P885, DOI 10.1227/NEU.0b013e318265a439; MORRIS R, 1984, J NEUROSCI METH, V11, P47, DOI 10.1016/0165-0270(84)90007-4; Mouzon B, 2012, J NEUROTRAUM, V29, P2761, DOI 10.1089/neu.2012.2498; Mouzon BC, 2014, ANN NEUROL, V75, P241, DOI 10.1002/ana.24064; MULLEN RJ, 1992, DEVELOPMENT, V116, P201; Mychasiuk R, 2016, J NEUROSCI METH, V257, P168, DOI 10.1016/j.jneumeth.2015.10.002; Payne SC, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065710; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Pratico D, 2002, J NEUROCHEM, V80, P894, DOI 10.1046/j.0022-3042.2002.00777.x; Psachoulia K, 2009, NEURON GLIA BIOL, V5, P57, DOI 10.1017/S1740925X09990354; Rabadi MH, 2001, CLIN J SPORT MED, V11, P194, DOI 10.1097/00042752-200107000-00011; Ramos-Zuniga R, 2014, WORLD NEUROSURG, V82, P828, DOI 10.1016/j.wneu.2013.09.018; Roof RL, 2000, J NEUROTRAUM, V17, P1155, DOI 10.1089/neu.2000.17.1155; Saunders NR, 2015, FRONT NEUROSCI-SWITZ, V9, DOI [10.3339/fnins.2015.00385, 10.3389/fnins.2015.00385]; Schneider C, 2008, J BIOL CHEM, V283, P15539, DOI 10.1074/jbc.R800001200; Shitaka Y, 2011, J NEUROPATH EXP NEUR, V70, P551, DOI 10.1097/NEN.0b013e31821f891f; Signoretti S, 2010, NEUROSURG FOCUS, V29, DOI 10.3171/2010.9.FOCUS10183; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; SMITH SL, 1994, J NEUROTRAUM, V11, P393, DOI 10.1089/neu.1994.11.393; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Szymanski CR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066448; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Tyurin VA, 2000, J NEUROCHEM, V75, P2178, DOI 10.1046/j.1471-4159.2000.0752178.x; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Valavanidis A, 2009, J ENVIRON SCI HEAL C, V27, P120, DOI 10.1080/10590500902885684; Wells J, 2012, J NEUROSCI RES, V90, P606, DOI 10.1002/jnr.22784; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Yamada KH, 2012, J BIOL CHEM, V287, P13182, DOI 10.1074/jbc.M111.302612; Zhang QG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034504	66	15	15	0	3	SPRINGER	NEW YORK	ONE NEW YORK PLAZA, SUITE 4600, NEW YORK, NY, UNITED STATES	0014-4819	1432-1106		EXP BRAIN RES	Exp. Brain Res.	JUL	2017	235	7					2133	2149		10.1007/s00221-017-4958-8			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EY1IC	WOS:000403718600014	28417146	Green Submitted			2022-02-06	
J	Faria, LC; Gu, F; Parada, I; Barres, B; Luo, ZD; Prince, DA				Faria, Leonardo C.; Gu, Feng; Parada, Isabel; Barres, Ben; Luo, Z. David; Prince, David A.			Epileptiform activity and behavioral arrests in mice overexpressing the calcium channel subunit alpha 2 delta-1	NEUROBIOLOGY OF DISEASE			English	Article						Excitation; EEG; Synaptogenesis; Pyramidal cells; Astrocytes; Epilepsy; Epileptogenesis; Nonconvulsive; Neocortex	TEMPORAL-LOBE EPILEPSY; INJURED EPILEPTOGENIC NEOCORTEX; VESICULAR GLUTAMATE TRANSPORTERS; CELL AXON REORGANIZATION; CENTRAL-NERVOUS-SYSTEM; V PYRAMIDAL NEURONS; UP-REGULATION; IN-VITRO; SYNAPTIC CONNECTIVITY; ALPHA(2)DELTA SUBUNIT	The alpha2delta-1 subunit (alpha 2 delta-1) of voltage-gated calcium channels is a receptor for astrocyte-secreted thrombospondins that promote developmental synaptogenesis. Alpha2delta-1 receptors are upregulated in models of injury-induced peripheral pain and epileptogenic neocortical trauma associated with an enhancement of excitatory synaptic connectivity. These results lead to the hypothesis that overexpression of alpha 2 delta-1 alone in neocortex of uninjured transgenic (TG) mice might result in increased excitatory connectivity and consequent cortical hyperexcitability and epileptiform activity. Whole cell recordings from layer V pyramidal neurons in somatosensory cortical slices of TG mice showed increased frequency and amplitude of miniature and spontaneous EPSCs and prolonged bursts of polysynaptic EPSCs. Epileptiform field potentials were evoked in layers and V of brain slices from TG mice, but not controls. Dual immunoreactivity for Vglut-2 and PSD95 showed increased density of close appositions in TG mice compared to controls, suggesting an increased number of excitatory synapses. Video-EEG monitoring showed that 13/13 implanted TG mice aged >P21, but not controls, had frequent abnormal spontaneous epileptiform events, consisting of variable duration, high amplitude bi-hemispheric irregular bursts of delta activity, spikes and sharp waves lasting many seconds, with a variable peak frequency of similar to 1-3 Hz, associated with behavioral arrest. The epileptiform EEG abnormalities and behavioral arrests were reversibly eliminated by treatment with i.p. ethosuximide. Behavioral seizures, consisting of similar to 15-30 s duration episodes of rigid arched tail and head and body extension, followed by loss of balance and falling, frequently occurred in adult TG mice during recovery from isoflurane-induced anesthesia, but were rare in WT mice. Results show that over-expression of alpha 2 delta-1 subunits increases cortical excitatory connectivity and leads to neocortical hyperexcitability and epileptiform activity associated with behavioral arrests in adult TG mice. Similar increases in expression of alpha 2 delta-1 in models of cortical injury may play an important role in epileptogenesis. Significance: Binding of astrocytic-secreted thrombospondins to their alpha 2 delta-1 receptor facilitates excitatory synapse formation and excitatory transmission during cortical development and after injury. Upregulation of alpha 2 delta-1 is present in models of injury-induced pain and epileptogenic cortical trauma, along with many other molecular alterations. Here we show that overexpression of alpha 2 delta-1 alone in TG mice can enhance excitatory connectivity in neocortex and lead to neural circuit hyperexcitability and episodes of electrographic epileptiform activity, associated with behavioral arrests in transgenic mice. alpha 2 delta-1 is the high-affinity receptor for gabapentinoids and a potential target for prophylactic treatment of posttraumatic epilepsy and other disorders in which excessive aberrant excitatory connectivity is a pathophysiological feature. Published by Elsevier Inc.	[Faria, Leonardo C.; Gu, Feng; Parada, Isabel; Prince, David A.] Stanford Univ, Sch Med, Dept Neurol & Neurol Sci, Stanford, CA 94305 USA; [Barres, Ben] Stanford Univ, Dept Neurobiol, Howard Hughes Med Inst, Stanford Sch Med, Stanford, CA 94305 USA; [Luo, Z. David] Univ Calif Irvine, Irvine Med Ctr, Dept Pharmacol, Dept Anesthesiol & Perioperat Care, Orange, CA 92868 USA		Prince, DA (corresponding author), Stanford Univ, 300 Pasteur Dr SUMC RM MO16, Stanford, CA 94305 USA.	daprince@stanford.edu			NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS12151, NS39579, NS090076, NS40135, NS064341]; Epilepsy Foundation of America/American Epilepsy Society; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS090076] Funding Source: NIH RePORTER	Supported by NINDS grants NS12151, NS39579 and NS090076 (DAP); NS40135, NS064341 (ZDL) and a postdoctoral fellowship to LCF from the Epilepsy Foundation of America/American Epilepsy Society.	Adams J, 2004, INT J BIOCHEM CELL B, V36, P960, DOI 10.1016/j.biocel.2004.02.009; Andresen L, 2014, NEUROBIOL DIS, V71, P305, DOI 10.1016/j.nbd.2014.08.022; Arikkath J, 2003, CURR OPIN NEUROBIOL, V13, P298, DOI 10.1016/S0959-4388(03)00066-7; Boroujerdi A, 2008, PAIN, V139, P358, DOI 10.1016/j.pain.2008.05.004; Buckmaster PS, 1997, J COMP NEUROL, V385, P385; Buckmaster PS, 1997, J NEUROPHYSIOL, V77, P2685, DOI 10.1152/jn.1997.77.5.2685; Caraiscos VB, 2004, J NEUROSCI, V24, P8454, DOI 10.1523/JNEUROSCI.2063-04.2004; Christie JM, 2006, J NEUROSCI, V26, P210, DOI 10.1523/JNEUROSCI.4307-05.2006; Christopherson KS, 2005, CELL, V120, P421, DOI 10.1016/j.cell.2004.12.020; Chu YX, 2010, P NATL ACAD SCI USA, V107, P7975, DOI 10.1073/pnas.0913449107; Cole RL, 2005, J COMP NEUROL, V491, P246, DOI 10.1002/cne.20693; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; COULTER DA, 1989, NEUROSCI LETT, V98, P74, DOI 10.1016/0304-3940(89)90376-5; D'Arco M, 2015, J NEUROSCI, V35, P5891, DOI 10.1523/JNEUROSCI.3997-14.2015; DEJONGH KS, 1990, J BIOL CHEM, V265, P14738; DELANEROLLE NC, 1989, BRAIN RES, V495, P387, DOI 10.1016/0006-8993(89)90234-5; Dolphin AC, 2012, JASPERS BASIC MECH E; DRAGUNOW M, 1987, NEUROSCI LETT, V82, P157, DOI 10.1016/0304-3940(87)90121-2; Erickson JD, 2006, NEUROCHEM INT, V48, P643, DOI 10.1016/j.neuint.2005.12.029; Eroglu C, 2009, CELL, V139, P380, DOI 10.1016/j.cell.2009.09.025; Esclapez M, 1999, J COMP NEUROL, V408, P449, DOI 10.1002/(SICI)1096-9861(19990614)408:4<449::AID-CNE1>3.0.CO;2-R; Faria LC, 2010, J NEUROPHYSIOL, V104, P280, DOI 10.1152/jn.00351.2010; FRANCK JE, 1988, J NEUROSCI, V8, P1991; Fujiyama F, 2001, J COMP NEUROL, V435, P379, DOI 10.1002/cne.1037; Gong HC, 2001, J MEMBRANE BIOL, V184, P35, DOI 10.1007/s00232-001-0072-7; Graber KD, 2004, ANN NEUROL, V55, P860, DOI 10.1002/ana.20124; Gurnett CA, 1996, NEURON, V16, P431, DOI 10.1016/S0896-6273(00)80061-6; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Hoppa MB, 2012, NATURE, V486, P122, DOI 10.1038/nature11033; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; KORN SJ, 1987, J NEUROPHYSIOL, V57, P325, DOI 10.1152/jn.1987.57.1.325; Kumar SS, 2006, J NEUROSCI, V26, P4613, DOI 10.1523/JNEUROSCI.0064-06.2006; Li CY, 2006, PAIN, V125, P20, DOI 10.1016/j.pain.2006.04.022; Li HF, 2005, J NEUROPHYSIOL, V93, P146, DOI 10.1152/jn.00665.2004; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Li HF, 2012, NEUROBIOL DIS, V48, P429, DOI 10.1016/j.nbd.2012.06.019; LLINAS R, 1981, J PHYSIOL-LONDON, V315, P569, DOI 10.1113/jphysiol.1981.sp013764; Loscher W, 2007, EPILEPSIA, V48, P1245, DOI 10.1111/j.1528-1167.2007.01093.x; Luo ZD, 2002, J PHARMACOL EXP THER, V303, P1199, DOI 10.1124/jpet.102.041574; Luo ZD, 2001, J NEUROSCI, V21, P1868, DOI 10.1523/JNEUROSCI.21-06-01868.2001; Ma YY, 2012, NEUROBIOL DIS, V47, P102, DOI 10.1016/j.nbd.2012.03.027; MARKRAM H, 1994, P NATL ACAD SCI USA, V91, P5207, DOI 10.1073/pnas.91.11.5207; Miyazaki T, 2003, EUR J NEUROSCI, V17, P2563, DOI 10.1046/j.1460-9568.2003.02698.x; MORGAN JI, 1987, SCIENCE, V237, P192, DOI 10.1126/science.3037702; Mountney A, 2013, J NEUROTRAUM, V30, P1973, DOI 10.1089/neu.2013.3001; Nahmani M, 2005, J COMP NEUROL, V484, P458, DOI 10.1002/cne.20505; Newton RA, 2001, MOL BRAIN RES, V95, P1, DOI 10.1016/S0169-328X(01)00188-7; Nguyen D, 2009, MOL PAIN, V5, DOI 10.1186/1744-8069-5-6; Nishikawa K, 2000, ANESTHESIOLOGY, V92, P228, DOI 10.1097/00000542-200001000-00035; NOEBELS JL, 1979, SCIENCE, V204, P1334, DOI 10.1126/science.572084; Porrero C, 2010, BRAIN RES, V1345, P59, DOI 10.1016/j.brainres.2010.05.061; POULTON TJ, 1984, ANESTHESIOLOGY, V61, P471, DOI 10.1097/00000542-198410000-00022; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Prince DA, 2009, EPILEPSIA, V50, P30, DOI 10.1111/j.1528-1167.2008.02008.x; Rossi AR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0078516; Romand S, 2011, FRONT NEUROANAT, V5, DOI 10.3389/fnana.2011.00005; Rutherford LC, 1998, NEURON, V21, P521, DOI 10.1016/S0896-6273(00)80563-2; Salin P, 1995, J NEUROSCI, V15, P8234; SAYER RJ, 1990, NEUROSCI LETT, V120, P175, DOI 10.1016/0304-3940(90)90031-4; Su H, 2002, J NEUROSCI, V22, P3645; SUTULA T, 1989, ANN NEUROL, V26, P321, DOI 10.1002/ana.410260303; TAUCK DL, 1985, J NEUROSCI, V5, P1016; Taylor CP, 2008, NEUROSCIENCE, V155, P510, DOI 10.1016/j.neuroscience.2008.05.053; Varoqui H, 2002, J NEUROSCI, V22, P142, DOI 10.1523/JNEUROSCI.22-01-00142.2002; Williamson A, 1999, ANN NEUROL, V45, P92, DOI 10.1002/1531-8249(199901)45:1<92::AID-ART15>3.0.CO;2-N; Zhu WJ, 2000, J NEUROSCI, V20, P8925	67	15	16	0	5	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	JUN	2017	102						70	80		10.1016/j.nbd.2017.01.009			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ES1BG	WOS:000399262300007	28193459				2022-02-06	
J	Jackson, EK; Kotermanski, SE; Menshikova, EV; Dubey, RK; Jackson, TC; Kochanek, PM				Jackson, Edwin K.; Kotermanski, Shawn E.; Menshikova, Elizabeth V.; Dubey, Raghvendra K.; Jackson, Travis C.; Kochanek, Patrick M.			Adenosine production by brain cells	JOURNAL OF NEUROCHEMISTRY			English	Article						5 '-AMP; adenosine; astrocytes; hypoxanthine; inosine; microglia; neurons	RAT HIPPOCAMPAL SLICES; OXYGEN-GLUCOSE DEPRIVATION; CEREBROSPINAL-FLUID; CORTICAL-NEURONS; CULTURED NEURONS; OXIDATIVE-STRESS; DIFFERENT ROLES; FREE-RADICALS; INJURY; RELEASE	The early release of adenosine following traumatic brain injury (TBI) suppresses seizures and brain inflammation; thus, it is important to elucidate the cellular sources of adenosine following injurious stimuli triggered by TBI so that therapeutics for enhancing the early adenosine-release response can be optimized. Using mass spectrometry with C-13-labeled standards, we investigated in cultured rat neurons, astrocytes, and microglia the effects of oxygen-glucose deprivation (OGD; models energy failure), H2O2 (produces oxidative stress), and glutamate (induces excitotoxicity) on intracellular and extracellular levels of 50-AMP (adenosine precursor), adenosine, and inosine and hypoxanthine (adenosine metabolites). In neurons, OGD triggered increases in intracellular 50-AMP (2.8-fold), adenosine (2.6-fold), inosine (2.2-fold), and hypoxanthine (5.3-fold) and extracellular 50-AMP (2.2-fold), adenosine (2.4-fold), and hypoxanthine (2.5-fold). In neurons, H2O2 did not affect intracellular or extracellular purines; yet, glutamate increased intracellular adenosine, inosine, and hypoxanthine (1.7-fold, 1.7-fold, and 1.6-fold, respectively) and extracellular adenosine, inosine, and hypoxanthine (2.9-fold, 2.1-fold, and 1.6-fold, respectively). In astrocytes, neither H2O2 nor glutamate affected intracellular or extracellular purines, and OGD only slightly increased intracellular and extracellular hypoxanthine. Microglia were unresponsive to OGD and glutamate, but were remarkably responsive to H2O2, which increased intracellular 50-AMP (1.6-fold), adenosine (1.6-fold), inosine (2.1-fold), and hypoxanthine (1.6-fold) and extracellular 50-AMP (5.9-fold), adenosine (4.0-fold), inosine (4.3-fold), and hypoxanthine (1.9-fold). Conclusion: Under these particular experimental conditions, cultured neurons are the main contributors to adenosine production/release in response to OGD and glutamate, whereas cultured microglia are the main contributors upon oxidative stress. Developing therapeutics that recruit astrocytes to produce/release adenosine could have beneficial effects in TBI.	[Jackson, Edwin K.; Kotermanski, Shawn E.; Menshikova, Elizabeth V.; Dubey, Raghvendra K.] Univ Pittsburgh, Sch Med, Dept Pharmacol & Chem Biol, Pittsburgh, PA USA; [Dubey, Raghvendra K.] Univ Zurich, Dept Reprod Endocrinol, Univ Zurich Hosp, Zurich, Switzerland; [Dubey, Raghvendra K.] Univ Zurich, Zurich Ctr Integrat Human Physiol ZIHP, Zurich, Switzerland; [Jackson, Travis C.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Jackson, Travis C.; Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Jackson, EK (corresponding author), Dept Pharmacol & Chem Biol, 100 Technol Dr,Room 514, Pittsburgh, PA 15219 USA.	edj@pitt.edu		Jackson, Edwin/0000-0002-8101-6009; Dubey, Raghvendra/0000-0003-1000-7137	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS070003, DK068575, DK079307, DK091190, HL109002, HL069846, NS38087, NS30318]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [R01HL069846, R01HL109002] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [R01DK068575, R01DK091190, P30DK079307] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS070003, P50NS030318, R01NS038087, R01NS087978, P01NS030318] Funding Source: NIH RePORTER	This work was supported by NIH grants NS070003 (PMK/EKJ), DK068575 (EKJ), DK079307 (EKJ), DK091190 (EKJ), HL109002 (EKJ), HL069846 (EKJ), NS38087 (PMK), and NS30318 (PMK). The authors have no conflicts of interest to disclose.	Agostinho P, 2000, NEUROCHEM INT, V36, P255, DOI 10.1016/S0197-0186(99)00113-8; Almeida CG, 2003, NEUROSCI LETT, V339, P127, DOI 10.1016/S0304-3940(02)01478-7; Andreev DE, 2015, GENOME BIOL, V16, DOI 10.1186/s13059-015-0651-z; Baldus S, 2006, FREE RADICAL BIO MED, V41, P1282, DOI 10.1016/j.freeradbiomed.2006.07.010; Bell MJ, 1998, J NEUROTRAUM, V15, P163, DOI 10.1089/neu.1998.15.163; Bell MJ, 2001, CRIT CARE MED, V29, P399, DOI 10.1097/00003246-200102000-00033; BREWER GJ, 1993, J NEUROSCI RES, V35, P567, DOI 10.1002/jnr.490350513; Broad RM, 2000, J AUTONOM NERV SYST, V81, P82, DOI 10.1016/S0165-1838(00)00124-7; Bzowska A, 2000, PHARMACOL THERAPEUT, V88, P349, DOI 10.1016/S0163-7258(00)00097-8; Canals S, 2008, J CEREBR BLOOD F MET, V28, P1835, DOI 10.1038/jcbfm.2008.71; Carswell HV, 1997, J NEUROCHEM, V68, P240; Choo AM, 2013, BRAIN, V136, P65, DOI 10.1093/brain/aws286; Chu S, 2014, PURINERG SIGNAL, V10, P603, DOI 10.1007/s11302-014-9421-8; Cunha RA, 2001, NEUROCHEM INT, V38, P107, DOI 10.1016/S0197-0186(00)00034-6; Cunha RA, 2016, J NEUROCHEM, V139, P1019, DOI 10.1111/jnc.13724; Dale N, 2009, CURR NEUROPHARMACOL, V7, P160, DOI 10.2174/157015909789152146; Eltzschig HK, 2005, J EXP MED, V202, P1493, DOI 10.1084/jem.20050177; Eltzschig HK, 2013, J MOL MED, V91, P141, DOI 10.1007/s00109-013-0999-z; Eltzschig HK, 2012, NEW ENGL J MED, V367, P2322, DOI 10.1056/NEJMra1205750; Eltzschig HK, 2011, NEW ENGL J MED, V364, P656, DOI 10.1056/NEJMra0910283; Ferreira JM, 2001, BRAIN RES, V900, P169, DOI 10.1016/S0006-8993(01)02279-X; Fujita T, 2012, J CEREBR BLOOD F MET, V32, pE1, DOI 10.1038/jcbfm.2011.142; Gomes CV, 2011, BBA-BIOMEMBRANES, V1808, P1380, DOI 10.1016/j.bbamem.2010.12.001; Grenz A, 2007, J AM SOC NEPHROL, V18, P833, DOI 10.1681/ASN.2006101141; Grenz A, 2007, FASEB J, V21, P2863, DOI 10.1096/fj.06-7947com; Grenz A, 2011, ANTIOXID REDOX SIGN, V15, P2221, DOI 10.1089/ars.2010.3665; Hasel P, 2015, BBA-MOL CELL RES, V1853, P2066, DOI 10.1016/j.bbamcr.2014.12.021; Haselkorn ML, 2010, J NEUROTRAUM, V27, P901, DOI 10.1089/neu.2009.1075; Jackson EK, 2009, J BIOL CHEM, V284, P33097, DOI 10.1074/jbc.M109.053876; Jackson TC, 2015, NEUROSCIENCE, V305, P268, DOI 10.1016/j.neuroscience.2015.08.012; Jackson TC, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2012.187; Jackson TC, 2015, J CEREBR BLOOD F MET, V35, P655, DOI 10.1038/jcbfm.2014.242; Jackson TC, 2010, J NEUROCHEM, V115, P941, DOI 10.1111/j.1471-4159.2010.06984.x; Kilbaugh TJ, 2015, EXP NEUROL, V271, P136, DOI 10.1016/j.expneurol.2015.05.009; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Kulik TB, 2010, GLIA, V58, P1335, DOI 10.1002/glia.21011; Lauro C, 2010, NEUROPSYCHOPHARMACOL, V35, P1550, DOI 10.1038/npp.2010.26; Lei BP, 1997, NEUROSCI LETT, V222, P91, DOI 10.1016/S0304-3940(97)13349-3; Lin YC, 2002, J NEUROSCI RES, V67, P484, DOI 10.1002/jnr.10077; Lobner D, 2002, NEUROREPORT, V13, P2075, DOI 10.1097/00001756-200211150-00017; LOBNER D, 1994, STROKE, V25, P2085, DOI 10.1161/01.STR.25.10.2085; Lu Y, 2003, EUR J NEUROSCI, V17, P1213, DOI 10.1046/j.1460-9568.2003.02554.x; Lynch JJ, 1998, NEUROSCI LETT, V252, P207, DOI 10.1016/S0304-3940(98)00376-0; Ma J, 2014, BIOCHEM J, V462, P489, DOI 10.1042/BJ20140235; Maines Mahin D., 2010, CURRENT PROTOCOLS TO; Martin ED, 2007, GLIA, V55, P36, DOI 10.1002/glia.20431; Masino SA, 1999, NEUROSCI LETT, V274, P91, DOI 10.1016/S0304-3940(99)00693-X; Parkinson FE, 2002, NEUROPHARMACOLOGY, V43, P836, DOI 10.1016/S0028-3908(02)00083-7; Parkinson FE, 2004, J NEUROCHEM, V88, P1305, DOI 10.1046/j.1471-4159.2003.02266.x; Rebola N, 2005, NEUROCHEM INT, V47, P317, DOI 10.1016/j.neuint.2005.05.009; Robertson CL, 2001, CRIT CARE MED, V29, P2287, DOI 10.1097/00003246-200112000-00009; Ruppel RA, 2001, J PEDIATR-US, V138, P18, DOI 10.1067/mpd.2001.110979; Sparvero LJ, 2010, J NEUROCHEM, V115, P1322, DOI 10.1111/j.1471-4159.2010.07055.x; Stone TW, 2002, ADV EXP MED BIOL, V513, P249; Theofilas P, 2011, EPILEPSIA, V52, P589, DOI 10.1111/j.1528-1167.2010.02947.x; Timofeev I, 2011, BRAIN, V134, P484, DOI 10.1093/brain/awq353; VansDycke A., 2010, SEIZURE, V19, P390; Verrier JD, 2012, J NEUROCHEM, V122, P115, DOI 10.1111/j.1471-4159.2012.07705.x; Verrier JD, 2011, J NEUROCHEM, V118, P979, DOI 10.1111/j.1471-4159.2011.07392.x	59	15	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0022-3042	1471-4159		J NEUROCHEM	J. Neurochem.	JUN	2017	141	5					676	693		10.1111/jnc.14018			18	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EU7AL	WOS:000401187000004	28294336	Green Accepted, Bronze			2022-02-06	
J	Post, A; Hoshizaki, TB; Zemek, R; Gilchrist, MD; Koncan, D; Dawson, L; Chen, W; Ledoux, AA				Post, Andrew; Hoshizaki, T. Blaine; Zemek, Roger; Gilchrist, Michael D.; Koncan, David; Dawson, Lauren; Chen, Wesley; Ledoux, Andree-Anne		Pediat Emergency Res Canada PERC 5	Pediatric concussion: biomechanical differences between outcomes of transient and persistent (> 4 weeks) postconcussion symptoms	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						concussion; persistent postconcussion symptoms; biomechanics; youth; pediatric; trauma	TRAUMATIC BRAIN-INJURY; HEAD IMPACT EXPOSURE; ANGULAR ACCELERATION; AXONAL DAMAGE; CHILDREN; RECONSTRUCTION; TISSUE; FALLS; PREDICTORS; CIRCUMFERENCE	OBJECTIVE Currently, little is known about the biomechanics of head impact for concussion in youths (ages 5 to 18 years). Even less is known about the biomechanical characteristics and variables related to head impacts that may be useful in differentiating between transient and persistent postconcussion symptoms in a youth population. The purpose of this research was to examine the differences in biomechanics of youth head impact for transient postconcussion symptoms (TPCSs) and persistent postconcussion symptoms (PPCSs) by using data from a hospital population. METHODS In a laboratory setting and using physical, computational, and finite element models, the authors reconstructed falling events in a large cohort of patients who had sustained a brain injury that resulted in transient or persistent postconcussion symptoms. The falling events and resulting concussions for the TPCS and PPCS patient groups were analyzed in terms of force, energy, peak resultant linear and rotational accelerations, and maximum principal strain in the gray and white matter of the brain, as well as measurements of cumulative strain damage. RESULTS The results indicated that there were no significant differences between the groups for any of the variables analyzed. CONCLUSIONS With methods derived for use in an adult population, the magnitudes of peak linear acceleration for the youth data set were determined to be above the 50% risk of injury. The youth data set showed higher brain tissue strain responses for lower energy and impact velocities than measured in adults, suggesting that youths are at higher risk of concussive injury at lower event seventies. A trend shown by some variables indicated that larger magnitudes of response were associated with PPCSs, but no single measurement variable consistently differentiated between the TPCS and PPCS groups. It is possible that using the biomechanics of head and brain responses to predict a subjective symptom load may not be appropriate. To enhance future biomechanical analyses, further investigations should include the use of quantifiable measures of brain injury linked to clinical outcomes and possible confounding factors such as history of brain injury and patient predisposition.	[Post, Andrew; Zemek, Roger; Ledoux, Andree-Anne] Childrens Hosp Eastern Ontario, Res Inst, Ottawa, ON, Canada; [Post, Andrew; Hoshizaki, T. Blaine; Koncan, David; Dawson, Lauren; Chen, Wesley] Univ Ottawa, Human Kinet, Ottawa, ON, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), 200 Lees Ave,Rm A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca	Zemek, Roger/H-1039-2018		Canadian Institutes of Health Research Operating Grant TM1 [127047]; Canadian Institutes of Health Research-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team Grant [126197]	This study was supported by Canadian Institutes of Health Research Operating Grant TM1 No. 127047 and Canadian Institutes of Health Research-Ontario Neurotrauma Foundation Mild Traumatic Brain Injury Team Grant No. 126197.	Adamec J, 2010, J FORENSIC SCI, V55, P1615, DOI 10.1111/j.1556-4029.2010.01445.x; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Bain AC, 2000, J BIOMECH ENG-T ASME, V122, P615, DOI 10.1115/1.1324667; Bandak FA, 1994, STAPP CAR CRASH J, V38, P279; Chatelin S, 2010, BIORHEOLOGY, V47, P255, DOI 10.3233/BIR-2010-0576; Chrisman SPD, 2016, J CHILD NEUROL, V31, P971, DOI 10.1177/0883073816634857; Concussion in Sports Group, 2013, BRIT J SPORT MED, V47, P263; Daniel RW, 2012, ANN BIOMED ENG, V40, P976, DOI 10.1007/s10439-012-0530-7; Dawson L, 2016, THESIS; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Doorly M.C., 2007, THESIS U COLL DUBL D; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Gennarelli TA, 2015, 2015 IRCOBI C P, pIX; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Gioia GA, 2008, J HEAD TRAUMA REHAB, V23, P230, DOI 10.1097/01.HTR.0000327255.38881.ca; Giordano Chiara, 2014, Stapp Car Crash J, V58, P29; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gottshall KR, 2010, J NEUROL PHYS THER, V34, P94, DOI 10.1097/NPT.0b013e3181dead12; GURDJIAN ES, 1954, NEUROLOGY, V4, P674, DOI 10.1212/WNL.4.9.674; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Holbourn AHS, 1943, LANCET, V242, P468; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki T.B., 2014, J NEUROL NEUROPHYS, V5, P1, DOI 10.4172/2155-9562.1000181; Juliusson PB, 2013, ANN HUM BIOL, V40, P220, DOI 10.3109/03014460.2012.759276; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; King A. I., 2003, IRCOBI C LISB PORT; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meaney DF, 2011, CLIN SPORT MED, V30, P19, DOI 10.1016/j.csm.2010.08.009; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Mennes M, 2014, NEUROIMAGE, V98, P513, DOI 10.1016/j.neuroimage.2014.04.030; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller R.T., 1998, STAPP CAR CRASH J, P155; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Morrison III B, 2003, STAPP CAR CRASH J, V47, P39; Nahum A., 1977, 21 STAPP CAR CRASH C, DOI DOI 10.4271/770922; National Centre for Injury Prevention, 2003, REP C MILD TRAUM BRA; NELLHAUS G, 1968, PEDIATRICS, V41, P106; Newman J A, 2000, Stapp Car Crash J, V44, P215; Nguyen AKD, 2012, INT J MORPHOL, V30, P1474, DOI 10.4067/S0717-95022012000400033; O'Riordain K, 2003, CLIN BIOMECH, V18, P590, DOI 10.1016/S0268-0033(03)00111-6; Ommaya AK, 2002, BRIT J NEUROSURG, V16, P220, DOI 10.1080/02688690220148824; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Patton DA, 2015, J APPL BIOMECH, V31, P264, DOI 10.1123/jab.2014-0223; Pellman EJ, 2003, NEUROSURGERY, V53, P799, DOI 10.1093/neurosurgery/53.3.799; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2014, J NEUROSURG, V120, P453, DOI 10.3171/2013.10.JNS131101; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Roth S, 2009, COMPUT METH PROG BIO, V93, P32, DOI 10.1016/j.cmpb.2008.08.001; Rousseau P., 2014, THESIS; Ruan J, 1994, THESIS; [阮世捷 Ruan Shijie], 2012, [中国生物医学工程学报, Chinese Journal of Biomedical Engineering], V31, P502; Rueda MAF, 2009, FORENSIC SCI INT, V191, P52, DOI 10.1016/j.forsciint.2009.06.007; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Selassie AW, 2013, ANN EPIDEMIOL, V23, P750, DOI 10.1016/j.annepidem.2013.07.022; Sullivan S, 2015, ACCIDENT ANAL PREV, V82, P143, DOI 10.1016/j.aap.2015.05.020; THOMAS LM, 1966, J NEUROL NEUROSUR PS, V29, P404, DOI 10.1136/jnnp.29.5.404; Uchiyama HT, 2013, BRAIN DEV-JPN, V35, P228, DOI 10.1016/j.braindev.2012.04.005; Weeks D, 2014, J NEUROTRAUM, V31, P206, DOI 10.1089/neu.2013.3113; Willinger R, 1995, P IRCOBI, V23, P245; Wong RH, 2014, CLIN NEUROL NEUROSUR, V118, P1, DOI 10.1016/j.clineuro.2013.11.036; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Yeates KO, 2012, ARCH PEDIAT ADOL MED, V166, P615, DOI 10.1001/archpediatrics.2011.1082; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Yue JK, 2016, NEUROSURG FOCUS, V40, DOI 10.3171/2016.1.FOCUS15612; Zemek R, 2016, JAMA-J AM MED ASSOC, V315, P1014, DOI 10.1001/jama.2016.1203; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714; Zong XN, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0059569	74	15	15	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	JUN	2017	19	6					641	651		10.3171/2016.11.PEDS16383			11	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	EV6OW	WOS:000401889700005	28347202	Bronze			2022-02-06	
J	Post, A; Clark, JM; Robertson, DGE; Hoshizaki, TB; Gilchrist, MD				Post, Andrew; Clark, J. Michio; Robertson, D. G. E.; Hoshizaki, T. Blaine; Gilchrist, Michael D.			The effect of acceleration signal processing for head impact numeric simulations	SPORTS ENGINEERING			English	Article						Signal processing; Filtering; Concussion; mTBI; Biomechanics; Ice hockey; American football	TRAUMATIC BRAIN-INJURY; ANGULAR ACCELERATION; HELMET IMPACTS; FOOTBALL; RECONSTRUCTION; VALIDATION; CONCUSSION; EXPOSURES; DIRECTION; LOCATION	Brain injury research in sport employs a variety of physical models equipped with accelerometers. These acceleration signals are commonly processed using filters. The purpose of this research was to determine the effect of applying filters with different cutoff frequencies to the acceleration signals used as input for finite element modeling of the brain. Signals were generated from reconstructions of concussion events from American football and ice hockey in the laboratory using a Hybrid III headform. The resulting acceleration signals were used as input for the University College Dublin Brain Trauma Model after being processed with filters. The results indicated that using a filter with a cutoff of 300 Hz or higher had little effect on the resulting strain measures. In some cases there was some effect of the filters on the peak linear (8-30g) and rotational measures (1000-4000 rad/s(2)), but little effect on the finite element strain result (approximately 2-6 %). The short duration and high magnitude accelerations, such as the puck impact, were most affected by the cutoff frequency of different filters.	[Post, Andrew; Clark, J. Michio; Robertson, D. G. E.; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Human Kinet, 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada; [Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland		Post, A (corresponding author), Univ Ottawa, Human Kinet, 200 Lees Ave,Room A106, Ottawa, ON K1N 6N5, Canada.	apost@uottawa.ca		Post, Andrew/0000-0002-5960-5552			Aare Magnus, 2003, Traffic Inj Prev, V4, P240, DOI 10.1080/15389580309879; Allison MA, 2014, MED SCI SPORT EXER, V46, P115, DOI 10.1249/MSS.0b013e3182a32d0d; Beckwith JG, 2007, J APPL BIOMECH, V23, P238, DOI 10.1123/jab.23.3.238; Cournoyer J, 2014, P SPORT CONC C CHIC; Crisco JJ, 2012, J APPL BIOMECH, V28, P174, DOI 10.1123/jab.28.2.174; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hutchison M. G., 2011, THESIS; Karton C, 2013, J ASTM INT, DOI [10.1520/STP155220120175, DOI 10.1520/STP155220120175]; Kendall M, 2012, P I MECH ENG P-J SPO, V226, P260, DOI 10.1177/1754337112436901; King A., 2003, P IRCOBI C LISB PORT; Kleiven S, 2002, J BIOMECH, V35, P153, DOI 10.1016/S0021-9290(01)00202-0; MENDIS KK, 1995, J BIOMECH ENG-T ASME, V117, P279, DOI 10.1115/1.2794182; Miller K, 1997, J BIOMECH, V30, P1115, DOI 10.1016/S0021-9290(97)00092-4; Miller R.T., 1998, STAPP CAR CRASH J, P155; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Oeur RA, 2015, J NEUROSURG, V123, P415, DOI 10.3171/2014.10.JNS14440; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Post A, 2014, P IRCOBI BERL GERM 1; Post A, 2011, COMPUT METHOD BIOMEC, V16, P511; Post A, 2015, J BIOMECH ENG-T ASME, V137, DOI 10.1115/1.4028983; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2012, J BIOMECH, V45, P679, DOI 10.1016/j.jbiomech.2011.12.005; Rousseau P., 2014, THESIS; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Ruan J, 1994, THESIS; Rueda MAF, 2011, COMPUT METHOD BIOMEC, V14, P1021, DOI 10.1080/10255842.2010.504922; Walsh E. S., 2012, ASTM S MECH CONC SPO; Willinger R, 1995, P IRCOBI C; Yoganandan N, 2008, J BIOMECH, V41, P2253, DOI 10.1016/j.jbiomech.2008.04.019; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhang LY, 2001, J NEUROTRAUM, V18, P21, DOI 10.1089/089771501750055749; Zhou C, 1995, P STAPP CAR CRASH J, V39, P121, DOI DOI 10.4271/952714	39	15	15	1	7	SPRINGER LONDON LTD	LONDON	236 GRAYS INN RD, 6TH FLOOR, LONDON WC1X 8HL, ENGLAND	1369-7072	1460-2687		SPORTS ENG	Sports Eng.	JUN	2017	20	2					111	119		10.1007/s12283-016-0219-5			9	Sport Sciences	Emerging Sources Citation Index (ESCI)	Sport Sciences	EV2ZE	WOS:000401625300002		Green Submitted			2022-02-06	
J	Yang, WJ; Chen, W; Chen, L; Guo, YJ; Zeng, JS; Li, GY; Tong, WS				Yang, W-J.; Chen, W.; Chen, L.; Guo, Y-J.; Zeng, J-S.; Li, G-Y.; Tong, W-S.			Involvement of tau phosphorylation in traumatic brain injury patients	ACTA NEUROLOGICA SCANDINAVICA			English	Article						cognitive impairment; GSK-3; PP2A; tau phosphorylation; traumatic brain injury	CSF TOTAL TAU; ALZHEIMERS-DISEASE; COGNITIVE DYSFUNCTION; PROTEIN PHOSPHATASES; CEREBROSPINAL-FLUID; HEAD-INJURY; BIOMARKERS; DISORDERS; TAUOPATHY; PATHOLOGY	ObjectivesTraumatic brain injury (TBI) results in significant morbidity and mortality throughout the world. In TBI patients suffering cognitive, emotional, and behavioral deficits, the leading cause derives from the physical injury to the central nervous system (CNS) that impairs brain function. Materials and MethodsHere, we applied a targeted approach to understand the potential mechanisms of neuron damage after TBI. Tau protein phosphorylation was compared in the brain tissues collected from patients underwent brain surgery based on the assessment of brain injury extent by Glasgow Coma Scale (GCS). ResultsThe results indicated that the levels of phosphorylated tau were significantly higher in the severe and extremely severe TBI groups, compared to the moderate group of patients. Phosphorylated, but not the total tau protein was uniquely correlated with the GCS score (R-2=.7849, P<.01) in 142 TBI patients. Consistently, the activities of key players associated with tau hyperphosphorylation GSK-3 and PP2A showed parallel correlations with the severity of TBI as well. ConclusionThese data suggest that the enhanced tau protein phosphorylation occurs upon severe neuron injures and may contribute to the pathological structural changes of CNS leading to brain damage of TBI.	[Yang, W-J.; Chen, W.; Chen, L.; Guo, Y-J.; Zeng, J-S.; Li, G-Y.; Tong, W-S.] Peoples Hosp Pudong New Area, Dept Neurosurg, Shanghai, Peoples R China		Tong, WS (corresponding author), Peoples Hosp Pudong New Area, Dept Neurosurg, Shanghai, Peoples R China.	tongwusongws@sina.com			Health Planning Commission Project of Pudong New Area Shanghai [PKJ2015-Y45]; Additional Subject of Pudong New Area Key Construction Project [PWZz2013-13]	None of the authors have potential conflict of interests to be disclosed. This work was supported by the following funding: the Health Planning Commission Project of Pudong New Area Shanghai (PKJ2015-Y45) and the Additional Subject of Pudong New Area Key Construction Project (PWZz2013-13).	Bales JW, 2009, NEUROSCI BIOBEHAV R, V33, P981, DOI 10.1016/j.neubiorev.2009.03.011; Ballatore C, 2007, NAT REV NEUROSCI, V8, P663, DOI 10.1038/nrn2194; Blennow K, 2001, MOL NEUROBIOL, V24, P87, DOI 10.1385/MN:24:1-3:087; Buee L, 2000, BRAIN RES REV, V33, P95, DOI 10.1016/S0165-0173(00)00019-9; Buerger K, 2006, BRAIN, V129, P3035, DOI 10.1093/brain/awl269; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; Eldar-Finkelman H, 2002, TRENDS MOL MED, V8, P126, DOI 10.1016/S1471-4914(01)02266-3; Hanger DP, 2009, TRENDS MOL MED, V15, P112, DOI 10.1016/j.molmed.2009.01.003; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Kins S, 2001, J BIOL CHEM, V276, P38193; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Liu F, 2005, EUR J NEUROSCI, V22, P1942, DOI 10.1111/j.1460-9568.2005.04391.x; Ludolph AC, 2009, EUR J NEUROL, V16, P297, DOI 10.1111/j.1468-1331.2008.02513.x; Mandelkow EM, 2012, CSH PERSPECT MED, V2, DOI 10.1101/cshperspect.a006247; Martin L, 2013, AGEING RES REV, V12, P39, DOI 10.1016/j.arr.2012.06.008; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Metcalfe MJ, 2010, MT SINAI J MED, V77, P50, DOI 10.1002/msj.20163; Mitsis EM, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.91; Ost M, 2006, NEUROLOGY, V67, P1600, DOI 10.1212/01.wnl.0000242732.06714.0f; Shapira M, 2007, MOL CELL NEUROSCI, V34, P571, DOI 10.1016/j.mcn.2006.12.006; Wang JW, 2016, EXP THER MED, V11, P1147, DOI 10.3892/etm.2016.3017; Zemlan FP, 1999, J NEUROCHEM, V72, P741, DOI 10.1046/j.1471-4159.1999.0720741.x; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zheng P, 2015, ARCH MED SCI, V11, P696, DOI 10.5114/aoms.2015.52380	25	15	15	0	9	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0001-6314	1600-0404		ACTA NEUROL SCAND	Acta Neurol. Scand.	JUN	2017	135	6					622	627		10.1111/ane.12644			6	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ET3DJ	WOS:000400157100005	27439764				2022-02-06	
J	Badawy, MK; Dayan, PS; Tunik, MG; Nadel, FM; Lillis, KA; Miskin, M; Borgialli, DA; Bachman, MC; Atabaki, SM; Hoyle, JD; Holmes, JF; Kuppermann, N				Badawy, Mohamed K.; Dayan, Peter S.; Tunik, Michael G.; Nadel, Frances M.; Lillis, Kathleen A.; Miskin, Michelle; Borgialli, Dominic A.; Bachman, Michael C.; Atabaki, Shireen M.; Hoyle, John D., Jr.; Holmes, James F.; Kuppermann, Nathan		PECARN	Prevalence of Brain Injuries and Recurrence of Seizures in Children With Posttraumatic Seizures	ACADEMIC EMERGENCY MEDICINE			English	Article							MINOR HEAD-INJURY; REQUIRE HOSPITALIZATION; INTRACRANIAL INJURY; TRAUMA; PREDICTION; MANAGEMENT; YOUNGER	Objectives: Computed tomography (CT) is often used in the emergency department (ED) evaluation of children with posttraumatic seizures (PTS); however, the frequency of traumatic brain injuries (TBIs) and short-term seizure recurrence is lacking. Our main objective was to evaluate the frequency of TBIs on CT and short-term seizure recurrence in children with PTS. We also aimed to determine the associations between the likelihood of TBI on CT with the timing of onset of PTS after the traumatic event and duration of PTS. Finally, we aimed to determine whether patients with normal CT scans and normal neurological examinations are safe for discharge from the ED. Methods: This was a planned secondary analysis from a prospective observational cohort study to derive and validate a neuroimaging decision rule for children after blunt head trauma at 25 EDs in the Pediatric Emergency Care Applied Research Network. We evaluated children < 18 years with head trauma and PTS between June 2004 and September 2006. We assessed TBI on CT, neurosurgical interventions, and recurrent seizures within 1 week. Patients discharged from the ED were contacted by telephone 1 week to 3 months later. Results: Of 42,424 children enrolled, 536 (1.3%, 95% confidence interval [CI] = 1.2%-1.4%) had PTS. A total of 466 of 536 (86.9%, 95% CI = 83.8%-89.7%) underwent CT in the ED. TBIs on CT were identified in 72 (15.5%, 95% CI = 12.3%-19.1%), of whom 20 (27.8%, 95% CI = 17.9%-39.6%) underwent neurosurgical intervention and 15 (20.8%, 95% CI = 12.2%-32.0%) had recurrent seizures. Of the 464 without TBIs on CT (or no CTs performed), 457 had recurrent seizure status known, and five (1.1%, 95 CI = 0.4%-2.5%) had recurrent seizures; four of five presented with Glasgow Coma Scale scores < 15. None of the 464 underwent neurosurgical intervention. We found significant associations between likelihood of TBI on CT with longer time until the PTS after the traumatic event (p = 0.006) and longer duration of PTS (p < 0.001). Conclusions: Children with PTS have a high likelihood of TBI on CT, and those with TBI on CT frequently require neurosurgical interventions and frequently have recurrent seizures. Those without TBIs on CT, however, are at low risk of short-term recurrent seizures, and none required neurosurgical interventions. Therefore, if CT-negative and neurologically normal, patients with PTS may be safely considered for discharge from the ED.	[Badawy, Mohamed K.] Univ Texas Southwestern Med Sch, Dept Pediat, Dallas, TX USA; [Dayan, Peter S.] Columbia Univ Coll Phys & Surg, Dept Pediat, New York, NY 10032 USA; [Tunik, Michael G.] NYU, Sch Med, Dept Emergency Med, New York, NY USA; [Tunik, Michael G.] NYU, Dept Pediat, Sch Med, New York, NY 10016 USA; [Nadel, Frances M.] Univ Penn, Sch Med, Dept Pediat, Philadelphia, PA 19104 USA; [Lillis, Kathleen A.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Pediat, Buffalo, NY USA; [Lillis, Kathleen A.] SUNY Buffalo, Sch Med & Biomed Sci, Dept Emergency Med, Buffalo, NY USA; [Miskin, Michelle] Univ Utah, Dept Pediat, Salt Lake City, UT USA; [Miskin, Michelle] PECARN Data Coordinating Ctr, Salt Lake City, UT USA; [Borgialli, Dominic A.] Univ Michigan, Sch Med, Dept Emergency Med, Flint, MI 48503 USA; [Borgialli, Dominic A.] Hurley Med Ctr, Flint, MI USA; [Bachman, Michael C.] Newark Beth Israel Med Ctr, Dept Emergency Med, Newark, NJ USA; [Bachman, Michael C.] Newark Beth Israel Med Ctr, Dept Pediat, Newark, NJ USA; [Atabaki, Shireen M.] George Washington Univ, Sch Med, Dept Pediat, Washington, DC 20052 USA; [Atabaki, Shireen M.] George Washington Univ, Sch Med, Dept Emergency Med, Washington, DC USA; [Hoyle, John D., Jr.] Michigan State Univ, Sch Med, Div Emergency Med, Helen Devos Childrens Hosp, Grand Rapids, MI USA; [Holmes, James F.; Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA; [Kuppermann, Nathan] Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA		Kuppermann, N (corresponding author), Univ Calif Davis, Sch Med, Dept Emergency Med, Sacramento, CA 95817 USA.; Kuppermann, N (corresponding author), Univ Calif Davis, Sch Med, Dept Pediat, Sacramento, CA 95817 USA.	nkuppermann@ucdavis.edu	; Holmes, Jain/K-2125-2016	Powell, Elizabeth/0000-0003-3147-9889; Holmes, Jain/0000-0003-2465-102X; Tunik, Michael/0000-0002-2368-5933; Alpern, Elizabeth/0000-0001-7887-3563	Health Resources and Services Administration/Maternal and Child Health Bureau (HRSA/MCHB), Division of Research, Education, and TrainingUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); Emergency Medical Services of Children (EMSC) Program [R40MC02461]; HRSAUnited States Department of Health & Human ServicesUnited States Health Resources & Service Administration (HRSA); MCHB; EMSC Network Development Demonstration Program [U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, U03MC22685]	This work was supported by a grant from the Health Resources and Services Administration/Maternal and Child Health Bureau (HRSA/MCHB), Division of Research, Education, and Training and the Emergency Medical Services of Children (EMSC) Program (R40MC02461). This project was also supported in part by HRSA, MCHB, and the EMSC Network Development Demonstration Program under cooperative agreements U03MC00008, U03MC00001, U03MC00003, U03MC00006, U03MC00007, U03MC22684, and U03MC22685. The information or content and conclusions are those of the author and should not be construed as the official position or policy of, nor should any endorsements be inferred by HRSA, HHS, or the U.S. Government.	[Anonymous], 1997, PEDIATRICS; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS83; Chiaretti A, 2000, CHILD NERV SYST, V16, P862, DOI 10.1007/s003810000368; Dias MS, 1999, PEDIATR NEUROSURG, V30, P232, DOI 10.1159/000028803; Dunning J, 2006, ARCH DIS CHILD, V91, P885, DOI 10.1136/adc.2005.083980; Faul M, TRAUMATIC BRAIN INJU; Gorelick MH, 2008, ACAD EMERG MED, V15, P812, DOI 10.1111/j.1553-2712.2008.00206.x; Greenes DS, 1999, PEDIATRICS, V104, P861, DOI 10.1542/peds.104.4.861; Gruskin KD, 1999, ARCH PEDIAT ADOL MED, V153, P15; Haydel MJ, 2003, ANN EMERG MED, V42, P507, DOI 10.1067/S0196-0644(03)00512-2; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Holmes JF, 2004, ANN EMERG MED, V43, P706, DOI 10.1016/j.annemergmed.2003.11.008; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mandal K, 2001, CHILD NERV SYST, V17, P670, DOI 10.1007/s00381-001-0520-9; Osmond MH, 2010, CAN MED ASSOC J, V182, P341, DOI 10.1503/cmaj.091421; RAMUNDO ML, 1995, PEDIATR EMERG CARE, V11, P1, DOI 10.1097/00006565-199502000-00001; Schunk JE, 1996, PEDIATR EMERG CARE, V12, P160, DOI 10.1097/00006565-199606000-00004; Schutzman SA, 2001, PEDIATRICS, V107, P983, DOI 10.1542/peds.107.5.983; YABLON SA, 1993, ARCH PHYS MED REHAB, V74, P983	19	15	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	MAY	2017	24	5					595	605		10.1111/acem.13168			11	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	EU6SY	WOS:000401165800007	28170143	Bronze, Green Published			2022-02-06	
J	Davis, RL; Stevens, CW; Curtis, JT				Davis, Randall L.; Stevens, Craig W.; Curtis, J. Thomas			The opioid antagonist, beta-funaltrexamine, inhibits lipopolysaccharide-induced neuroinflammation and reduces sickness behavior in mice	PHYSIOLOGY & BEHAVIOR			English	Article						Opioid; beta-FNA; LPS; Cytokine; Chemokine; Anti-inflammatory	CHEMOKINE EXPRESSION; RECEPTOR; INFLAMMATION; MECHANISMS; CYTOKINES; MICROGLIA; ANTIDEPRESSANTS; INTERLEUKIN-6; DEPRESSION; ANXIETY	Brain pathologies such as neurodegenerative diseases, infection, traumatic brain injury, and mood disorders produce enormous personal and economic burdens. It is well established that neuroinflammation plays an important role in the etiology and/or manifestation of such disorders. Previously, we discovered that betafunaltrexamine (beta-FNA) inhibits inflammatory signaling in human astrocytes in vitro, resulting in reduced expression of proinflammatory cytokines/chemokines. The present study examines the effects of peripherally administered beta-FNA on lipopolysaccharide (LPS)-induced neuroinflammation and sickness behavior in vivo. Adult male C57BL/6J mice were administered beta-FNA and were then immediately administered bacterial lipopolysaccharide (LPS). At 24 h post-injections, sickness behavior was assessed in an open-field test. Following behavioral analysis plasma and brains were collected. Levels of interleukin-6 (IL-6), interferon-gamma inducible protein-10 (CXCL10), and monocyte chemoattractant protein-1(CCL2) were determined by enzyme-linked immunosorbant assay (ELISA). At 24 h post-LPS injection, IL-6, CCL2 and CXCL10 were increased in the plasma, whereas, only CCL2 and CXCL10 were elevated in the brain. beta-FNA significantly inhibited LPS-induced CXCL10 and CCL2 expression in brain, but minimally or not at all in the plasma. LPS-induced sickness behavior, as indicated by a reduction in distance moved, was prevented by beta-FNA. Overall, CXCL10 expression in the brain was most positively and significantly correlated with sickness behavior; whereas, anxiety-like behavior was most positively and signifitantly correlated with IL-6 and CCL2 levels in the plasma and levels of CXCL10 and CCL2 in the brain. The reduction in sickness behavior may be in part due to decreased chemokine expression in the brain; further examination of the anti-inflammatory and neuroprotective effects of beta-FNA is warranted. (C) 2017 Elsevier Inc. All rights reserved.	[Davis, Randall L.; Stevens, Craig W.; Curtis, J. Thomas] Oklahoma State Univ, Ctr Hlth Sci, Dept Pharmacol Physiol, 1111 W 17th St, Tulsa, OK 74107 USA		Davis, RL (corresponding author), Oklahoma State Univ, Ctr Hlth Sci, Dept Pharmacol Physiol, 1111 W 17th St, Tulsa, OK 74107 USA.	randall.davis@okstate.edu; cw.stevens@okstate.edu; tom.curtis@okstate.edu	Curtis, J. Thomas/J-4193-2019		Oklahoma Health Research Program [HR 14-007]	The authors thank Daniell Buck, Kelly McCracken and Eric Bates for their technical assistance. This work was supported in part by Oklahoma Health Research Program HR 14-007 (RLD)	Bai YM, 2015, BIPOLAR DISORD, V17, P269, DOI 10.1111/bdi.12259; Bailey KR, 2009, FRONT NEUROSCI, P77; Barbosa IG, 2013, EUR ARCH PSY CLIN N, V263, P159, DOI 10.1007/s00406-012-0327-6; Biesmans S, 2013, MEDIAT INFLAMM, V2013, DOI 10.1155/2013/271359; Blank T, 2016, IMMUNITY, V44, P901, DOI 10.1016/j.immuni.2016.04.005; Bluthe RM, 2000, PHYSIOL BEHAV, V70, P367, DOI 10.1016/S0031-9384(00)00269-9; Burton MD, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-54; Chen SL, 2012, J NEUROIMMUNE PHARM, V7, P656, DOI 10.1007/s11481-012-9382-z; Choi SS, 2003, PHARMACOL BIOCHEM BE, V75, P447, DOI 10.1016/S0091-3057(03)00144-8; Curtis JT, 2011, NEUROSCI LETT, V504, P40, DOI 10.1016/j.neulet.2011.08.053; Davis RL, 2008, J NEUROIMMUNE PHARM, V3, P150, DOI 10.1007/s11481-008-9102-x; Davis RL, 2007, J NEUROIMMUNOL, V186, P141, DOI 10.1016/j.jneuroim.2007.03.021; Davis RL, 2015, EUR J PHARMACOL, V762, P193, DOI 10.1016/j.ejphar.2015.05.040; Davis RL, 2013, NEUROCHEM INT, V62, P478, DOI 10.1016/j.neuint.2013.01.013; Davis RL, 2002, ALCOHOL CLIN EXP RES, V26, P1404, DOI 10.1097/01.ALC.0000030841.92766.80; Dodd S, 2013, PROG NEURO-PSYCHOPH, V42, P135, DOI 10.1016/j.pnpbp.2012.11.007; Dowlati Y, 2010, BIOL PSYCHIAT, V67, P446, DOI 10.1016/j.biopsych.2009.09.033; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; Harden LM, 2006, PHYSIOL BEHAV, V89, P146, DOI 10.1016/j.physbeh.2006.05.016; Hutchinson MR, 2014, NEUROPHARMACOLOGY, V76, P218, DOI 10.1016/j.neuropharm.2013.05.039; JANG Y, 1991, EUR J PHARMACOL, V197, P135; Khansari Parto S., 2012, Inflammopharmacology, V20, P103, DOI 10.1007/s10787-012-0124-x; Kolb SA, 1999, J NEUROIMMUNOL, V93, P172, DOI 10.1016/S0165-5728(98)00223-9; Labuz D, 2007, BRAIN RES, V1160, P30, DOI 10.1016/j.brainres.2007.05.049; Lasselin J, 2016, BRAIN BEHAV IMMUN, V57, P30, DOI 10.1016/j.bbi.2016.01.003; Le Thuc O., 2016, EMBO REP; Liu B, 2000, J PHARMACOL EXP THER, V293, P607; Liu B, 2003, J PHARMACOL EXP THER, V304, P1, DOI 10.1124/jpet.102.035048; Liu YX, 2002, J PHARMACOL EXP THER, V302, P1212, DOI 10.1124/jpet.102.035956; Lozano D, 2015, NEUROPSYCH DIS TREAT, V11, P97, DOI 10.2147/NDT.S65815; Mangus LM, 2015, J NEUROPATH EXP NEUR, V74, P38, DOI 10.1097/NEN.0000000000000148; Noto C, 2015, WORLD J BIOL PSYCHIA, V16, P422, DOI 10.3109/15622975.2015.1062552; Ohgi Y, 2013, PHARMACOL BIOCHEM BE, V103, P853, DOI 10.1016/j.pbb.2012.12.003; Ramachandra V, 2011, ALCOHOL CLIN EXP RES, V35, P929, DOI 10.1111/j.1530-0277.2010.01423.x; Salazar A, 2012, HORM BEHAV, V62, P202, DOI 10.1016/j.yhbeh.2012.03.010; Shattuck EC, 2016, BRAIN BEHAV IMMUN, V57, P255, DOI 10.1016/j.bbi.2016.05.002; Spooren A, 2011, BRAIN RES REV, V67, P157, DOI 10.1016/j.brainresrev.2011.01.002; Stevens CW, 2013, BRIT J PHARMACOL, V168, P1421, DOI 10.1111/bph.12028; Stuart MJ, 2014, NEUROSCI BIOBEHAV R, V42, P93, DOI 10.1016/j.neubiorev.2014.02.001; Tynan RJ, 2012, BRAIN BEHAV IMMUN, V26, P469, DOI 10.1016/j.bbi.2011.12.011; Whitton PS, 2010, CURR OPIN INVEST DR, V11, P788; Wong ML, 2008, MOL PSYCHIATR, V13, P800, DOI 10.1038/mp.2008.59; Ziebell JM, 2010, NEUROTHERAPEUTICS, V7, P22, DOI 10.1016/j.nurt.2009.10.016	43	15	15	1	12	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0031-9384			PHYSIOL BEHAV	Physiol. Behav.	MAY 1	2017	173						52	60		10.1016/j.physbeh.2017.01.037			9	Psychology, Biological; Behavioral Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Behavioral Sciences	EP9LW	WOS:000397696100008	28130086				2022-02-06	
J	Eckner, JT; Seifert, T; Pescovitz, A; Zeiger, M; Kutcher, JS				Eckner, James T.; Seifert, Tad; Pescovitz, Allison; Zeiger, Max; Kutcher, Jeffrey S.			Is Migraine Headache Associated With Concussion in Athletes? A Case-Control Study	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						athlete; concussion; headache; migraine	SPORTS-RELATED CONCUSSION; MILD TRAUMATIC BRAIN; CHRONIC POSTTRAUMATIC HEADACHE; WHITE-MATTER INTEGRITY; HIGH-SCHOOL FOOTBALL; RISK-FACTORS; INJURY; PAIN; COHORT; IMPAIRMENT	Objective: The purpose of this study was to investigate the association between migraine headache and concussion in athletes. Design: Case-control observational study. Setting: A university-associated combined sports neurology and orthopedic sports medicine clinic. Participants: A total of 221 male (n = 140) and female (n = 81) athletes aged 12 to 24 years, including 115 concussion cases (52%) and 106 orthopedic controls (48%), were included in this study. Interventions: Participants completed a one-page questionnaire that recorded their age, sex, reason for visit (concussion vs any other injury), concussion history, and self/immediate family member migraine headache history. Main Outcome Measures: The odds of having a previous history of migraine headache were compared in the concussion group versus orthopedic controls. Results: Controlling for between-group differences in age and sex, there was a significant positive association between concussion group status and history of migraine headache [adjusted odds ratio (OR), 1.90; 95% confidence interval (CI), 1.03-3.50. P = 0.039]. However, when including a previous concussion history in the statistical model, this relationship failed to reach significance [adjusted OR, 1.68; 95% CI, 0.89-3.16. P = 0.107]. Conclusions: These results suggest that there is an association between migraine headache and concussion in athletes, but the cause-effect nature of this relationship cannot be determined. Migraine headache should be considered a modifying factor when caring for concussed athletes.	[Eckner, James T.] Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA; [Eckner, James T.; Pescovitz, Allison; Zeiger, Max; Kutcher, Jeffrey S.] Univ Michigan, Michigan NeuroSport, Ann Arbor, MI 48109 USA; [Seifert, Tad] Norton Healthcare, Dept Neurol, Louisville, KY USA; [Seifert, Tad] Univ Kentucky, Dept Neurol, Lexington, KY 40536 USA; [Kutcher, Jeffrey S.] Univ Michigan, Dept Neurol, Ann Arbor, MI USA; [Pescovitz, Allison] Maimonides Hosp, Dept Gen Surg, Brooklyn, NY 11219 USA; [Zeiger, Max] Univ Calif Los Angeles, Div Pediat Neurol, Los Angeles, CA USA; [Kutcher, Jeffrey S.] Sports Neurol Clin, Ann Arbor, MI USA		Eckner, JT (corresponding author), Univ Michigan, Dept Phys Med & Rehabil, 325 E Eisenhower Pkwy, Ann Arbor, MI 48108 USA.	jeckner@med.umich.edu			Rehabilitation Medicine Scientist Training Program; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1 K23 HD078502]; National Collegiate Athletics Association; United States Department of DefenseUnited States Department of Defense [14132004]; University of Michigan Injury Center; Foundation for Physical Medicine and Rehabilitation; National Headache Foundation; American Headache Society; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K23HD078502] Funding Source: NIH RePORTER	Dr Eckner received partial effort support during this project from the Rehabilitation Medicine Scientist Training Program and the National Institutes of Health (1 K23 HD078502). His active research funding includes the National Institutes of Health (1 K23 HD078502), the National Collegiate Athletics Association, the United States Department of Defense (14132004), the University of Michigan Injury Center, and the Foundation for Physical Medicine and Rehabilitation. Dr Seifert is a member of the Kentucky State Boxing Commission and has served as a consultant for the United States Department of Defense. He has received personal compensation as a speaker for the National Headache Foundation and the American Headache Society. Dr Kutcher is a consultant for the National Basketball Association and ElmindA, Ltd. The other authors report no conflicts of interest.	Anselmi Bruno, 1997, Recenti Progressi in Medicina, V88, P321; Bazarian JJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094734; Bazarian JJ, 2012, MAGN RESON IMAGING, V30, P171, DOI 10.1016/j.mri.2011.10.001; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Conidi F., 2015, AM AC NEUR 2015 ANN; Davenport EM, 2014, J NEUROTRAUM, V31, P1617, DOI 10.1089/neu.2013.3233; de Tommaso M, 2012, CNS NEUROL DISORD-DR, V11, P110, DOI 10.2174/187152712800269759; Defrin R, 2015, J NEUROTRAUM, V32, P28, DOI 10.1089/neu.2014.3359; Defrin R, 2014, J MAN MANIP THER, V22, P36, DOI 10.1179/2042618613Y.0000000053; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Gilkey SJ, 1997, HEADACHE, V37, P583, DOI 10.1046/j.1526-4610.1997.3709583.x; Giza CC, 2001, J ATHL TRAINING, V36, P228; Gordon KE, 2006, BRIT J SPORT MED, V40, P184, DOI 10.1136/bjsm.2005.022251; Heyer GL, 2014, PEDIATR NEUROL, V50, P464, DOI 10.1016/j.pediatrneurol.2014.01.040; Hussain A, 2010, HEADACHE, V50, P669, DOI 10.1111/j.1526-4610.2009.01436.x; Koerte IK, 2012, JAMA-J AM MED ASSOC, V308, P1859, DOI 10.1001/jama.2012.13735; Kontos AP, 2013, AM J SPORT MED, V41, P1497, DOI 10.1177/0363546513488751; Kuczynski A, 2013, DEV MED CHILD NEUROL, V55, P636, DOI 10.1111/dmcn.12152; Kutcher JS, 2010, CURR SPORT MED REP, V9, P16, DOI 10.1249/JSR.0b013e3181caa89d; LAURITZEN M, 1994, BRAIN, V117, P199, DOI 10.1093/brain/117.1.199; Lipton RB, 2003, NEUROLOGY, V61, P375, DOI 10.1212/01.WNL.0000078940.53438.83; Lucas S, 2011, PM&R, V3, pS406, DOI 10.1016/j.pmrj.2011.07.016; MATTHEWS WB, 1972, BRIT MED J, V2, P326, DOI 10.1136/bmj.2.5809.326; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McAllister TW, 2014, NEUROLOGY, V82, P63, DOI 10.1212/01.wnl.0000438220.16190.42; McCrory P, 2009, CLIN J SPORT MED, V19, P185, DOI 10.1097/JSM.0b013e3181a501db; MCINTOSH TK, 1987, AM J PHYSIOL, V253, pE565, DOI 10.1152/ajpendo.1987.253.5.E565; Mihalik JP, 2005, J NEUROSURG, V102, P850, DOI 10.3171/jns.2005.102.5.0850; Misra UK, 2013, CEPHALALGIA, V33, P316, DOI 10.1177/0333102412473372; Nahman-Averbuch H, 2013, HEADACHE, V53, P1104, DOI 10.1111/head.12117; Packard RC, 1997, HEADACHE, V37, P142, DOI 10.1046/j.1526-4610.1997.3703142.x; Piovesan Elcio J, 2003, Curr Pain Headache Rep, V7, P377, DOI 10.1007/s11916-003-0037-x; Register-Mihalik J, 2007, CLIN J SPORT MED, V17, P282, DOI 10.1097/JSM.0b013e31804ca68a; Sabin MJ, 2011, CLIN J SPORT MED, V21, P411, DOI 10.1097/JSM.0b013e318223f3a4; Schneider KJ, 2013, CLIN J SPORT MED, V23, P267, DOI 10.1097/JSM.0b013e318281f09f; Seifert T, 2015, AM HEAD SOC 57 ANN S; Seifert T, AM J SPORTS IN PRESS; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; TAYLOR AR, 1966, LANCET, V2, P178; WEISS HD, 1991, HEADACHE, V31, P451, DOI 10.1111/j.1526-4610.1991.hed3107451.x	40	15	15	1	4	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAY	2017	27	3					266	270		10.1097/JSM.0000000000000346			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	ET9NV	WOS:000400635100005	27428679	Green Accepted			2022-02-06	
J	Iacono, D; Shively, SB; Edlow, BL; Perl, DP				Iacono, Diego; Shively, Sharon B.; Edlow, Brian L.; Perl, Daniel P.			Chronic Traumatic Encephalopathy Known Causes, Unknown Effects	PHYSICAL MEDICINE AND REHABILITATION CLINICS OF NORTH AMERICA			English	Article						Traumatic brain injury; Chronic traumatic encephalopathy; Tau; beta-Amyloid; Diffuse axonal injury; Acute and long-term effects; Neurodegeneration; Neuropsychiatric disorders	POSTTRAUMATIC-STRESS-DISORDER; AMYLOID PRECURSOR PROTEIN; LONG-TERM CONSEQUENCES; BRAIN-INJURY; AXONAL INJURY; DEMENTIA-PUGILISTICA; ALZHEIMERS-DISEASE; NEUROFIBRILLARY TANGLES; MAGNETIC-RESONANCE; FOOTBALL PLAYERS	Chronic traumatic encephalopathy (CTE) is a neuropathologic diagnosis typically made in human brains with a history of repetitive traumatic brain injury (rTBI). It remains unknown whether CTE occurs exclusively after rTBI, or whether a single TBI (sTBI) can cause CTE. Similarly, it is unclear whether impact (eg, motor vehicle accidents) and non -impact (eg, blasts) types of energy transfer trigger divergent or common pathologies. While it is established that a history of rTBI increases the risk of multiple neurodegenerative diseases (eg, dementia, parkinsonism, and CTE), the possible pathophysiologic and molecular mechanisms underlying these risks have yet to be elucidated.	[Iacono, Diego; Shively, Sharon B.; Perl, Daniel P.] Uniformed Serv Univ Hlth Sci, CNRM, Brain Tissue Repository & Neuropathol Core, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Iacono, Diego; Shively, Sharon B.] Henry M Jackson Fdn Adv Mil Med HJF, 6720A Rockledge Dr 100, Bethesda, MD 20817 USA; [Shively, Sharon B.; Perl, Daniel P.] Uniformed Serv Univ Hlth Sci, Dept Pathol, F Edward Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Dept Neurol, 175 Cambridge St Suite 300, Boston, MA 02114 USA; [Edlow, Brian L.] Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, 149 13th St, Charlestown, MA 02129 USA		Perl, DP (corresponding author), Uniformed Serv Univ Hlth Sci, CNRM, Brain Tissue Repository & Neuropathol Core, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.; Perl, DP (corresponding author), Uniformed Serv Univ Hlth Sci, Dept Pathol, F Edward Hebert Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA.	daniel.perl@usuhs.edu	Iacono, Diego/K-8203-2016	Iacono, Diego/0000-0001-5511-0950			Absinta M, 2014, J NEUROPATH EXP NEUR, V73, P780, DOI 10.1097/NEN.0000000000000096; Acosta SA, 2015, J CELL PHYSIOL, V230, P1024, DOI 10.1002/jcp.24830; Alexander E Jr, 1991, Br J Neurosurg, V5, P183, DOI 10.3109/02688699108998465; Altmeyer W, 2016, MAGN RESON IMAGING C, V24, P305, DOI 10.1016/j.mric.2015.11.011; American Psychiatric Association, 2015, DIAGN STAT MAN MENT, P271; Aotsuka A, 1990, Rinsho Shinkeigaku, V30, P1243; Bandak F A, 2015, Handb Clin Neurol, V127, P89, DOI 10.1016/B978-0-444-52892-6.00006-4; Barrio JR, 2015, P NATL ACAD SCI USA, V112, pE2039, DOI 10.1073/pnas.1409952112; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; BLUMBERGS PC, 1994, LANCET, V344, P1055, DOI 10.1016/S0140-6736(94)91712-4; Bogoslovsky T, 2017, J NEUROTRAUM, V34, P66, DOI 10.1089/neu.2015.4333; Bouzier-Sore AK, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00179; BRANDENBURG W, 1954, Virchows Arch Pathol Anat Physiol Klin Med, V325, P680, DOI 10.1007/BF00955101; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Carron SF, 2016, J COMP NEUROL, V524, P3530, DOI 10.1002/cne.24014; Cassasa CB, 1924, P NEW YORK PATH SOC, P101; Casson IR, 2014, SPORTS HEALTH, V6, P384, DOI 10.1177/1941738114540270; Chio A, 2009, AMYOTROPH LATERAL SC, V10, P205, DOI 10.1080/17482960902721634; Chuang PY, 2010, J NEUROTRAUM, V27, P999, DOI 10.1089/neu.2009.1129; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Collins MW, 1999, JAMA-J AM MED ASSOC, V282, P964, DOI 10.1001/jama.282.10.964; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; CORSELLIS JA, 1973, PSYCHOL MED, V3, P270, DOI 10.1017/S0033291700049588; CORSELLIS JAN, 1959, J MENT SCI, V105, P714, DOI 10.1192/bjp.105.440.714; Costanza A, 2011, NEUROPATH APPL NEURO, V37, P570, DOI 10.1111/j.1365-2990.2011.01186.x; CRITCHLEY M, 1957, BMJ-BRIT MED J, V1, P357, DOI 10.1136/bmj.1.5015.357; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Dart RA, 1949, AM J PHYS ANTHROP-NE, V7, P1, DOI 10.1002/ajpa.1330070103; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; del Zoppo GJ, 2013, STROKE, V44, P263, DOI 10.1161/STROKEAHA.112.653618; DENST J, 1959, ARCH PATHOL, V67, P134; DePalma RG., 2015, SOURCEBRAIN NEUROTRA, P5; Diaz-Arrastia R, 2003, ARCH NEUROL-CHICAGO, V60, P818, DOI 10.1001/archneur.60.6.818; Diaz-Arrastia R, 2014, J NEUROTRAUM, V31, P19, DOI 10.1089/neu.2013.3040; Doherty CP, 2016, J NEUROPATH EXP NEUR, V75, P656, DOI 10.1093/jnen/nlw036; Edlow BL, 2012, SEMIN NEUROL, V32, P374, DOI 10.1055/s-0032-1331810; Erichsen JE, 1875, CONCUSION SPINE NERV, P15; Erlanger DM, 1999, CLIN NEUROPSYCHOL, V13, P193, DOI 10.1076/clin.13.2.193.1963; Eulion JF, 1942, NEW ENGL J MED, V226, P1; Faul Mark, 2015, Handb Clin Neurol, V127, P3, DOI 10.1016/B978-0-444-52892-6.00001-5; Finkbeiner NWB, 2016, CAN J PSYCHIAT, V61, P270, DOI 10.1177/0706743716644953; Forsyth D, 1915, LANCET, V186, P1399; Friedman G, 1999, NEUROLOGY, V52, P244, DOI 10.1212/WNL.52.2.244; Fulton JJ, 2015, J ANXIETY DISORD, V31, P98, DOI 10.1016/j.janxdis.2015.02.003; Gardner RC, 2015, ANN NEUROL, V77, P987, DOI 10.1002/ana.24396; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; Geddes JF, 1996, NEUROPATH APPL NEURO, V22, P12, DOI 10.1046/j.1365-2990.1996.2598025.x; GENNARELLI TA, 1982, ANN NEUROL, V12, P564, DOI 10.1002/ana.410120611; Glass CK, 2010, CELL, V140, P918, DOI 10.1016/j.cell.2010.02.016; GRAHMANN H, 1957, Psychiatr Neurol (Basel), V134, P261; Gross CG, 2003, TREPANATION: HISTORY, DISCOVERY, THEORY, P307; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; Hetherington H, 2015, Handb Clin Neurol, V127, P309, DOI 10.1016/B978-0-444-52892-6.00020-9; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; Iacono D, 2015, NEUROLOGY, V85, P1670, DOI 10.1212/WNL.0000000000002102; Jellinger KA, 2015, J NEURAL TRANSM, V122, P505, DOI 10.1007/s00702-014-1288-x; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Johnson VE, 2013, EXP NEUROL, V246, P35, DOI 10.1016/j.expneurol.2012.01.013; Johnson VE, 2011, ACTA NEUROPATHOL, V122, P715, DOI 10.1007/s00401-011-0909-9; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jokl E, 1933, MUNCH MED WOCH, V15, P560; Jones E, 2002, BMJ-BRIT MED J, V324, P321, DOI 10.1136/bmj.324.7333.321; Jones Edgar, 2005, MAUDSLEY MONOGRAPHS, V47; Jungner M, 2016, MINERVA ANESTESIOL, V82, P525; Karve IP, 2016, BRIT J PHARMACOL, V173, P692, DOI 10.1111/bph.13125; Kaur B, 1999, J CLIN PATHOL, V52, P203, DOI 10.1136/jcp.52.3.203; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Kovacs GG, 2016, ACTA NEUROPATHOL, V131, P87, DOI 10.1007/s00401-015-1509-x; Kovacs GG, 2013, ACTA NEUROPATHOL, V126, P365, DOI 10.1007/s00401-013-1157-y; Kshettry Varun R, 2007, Neurosurg Focus, V23, pE8; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Lambri M, 2001, CLIN NEUROPATHOL, V20, P263; Lazarus C, 2015, BIOPHYS J, V109, P231, DOI 10.1016/j.bpj.2015.06.029; Lepreux S, 2015, CLIN NEUROPATHOL, V34, P193, DOI 10.5414/NP300838; Li LZ, 2015, MEDICINE, V94, DOI 10.1097/MD.0000000000002028; Ling G, 2015, Handb Clin Neurol, V127, P173, DOI 10.1016/B978-0-444-52892-6.00011-8; Mac Donald CL, 2007, J NEUROSCI, V27, P11869, DOI 10.1523/JNEUROSCI.3647-07.2007; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Martland H., 1928, JAMA-J AM MED ASSOC, V91, P1103, DOI DOI 10.1001/JAMA.1928.02700150029009; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; MAWDSLEY C, 1963, LANCET, V2, P795; McCrory P, 2013, BRIT J SPORT MED, V47, P327, DOI 10.1136/bjsports-2013-092248; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; McKee AC, 2010, J NEUROPATH EXP NEUR, V69, P918, DOI 10.1097/NEN.0b013e3181ee7d85; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; McNab JA, 2013, NEUROIMAGE, V80, P234, DOI 10.1016/j.neuroimage.2013.05.074; MENDEZ MF, 1995, INT J PSYCHIAT MED, V25, P249, DOI 10.2190/CUMK-THT1-X98M-WB4C; Mez J, 2016, JAMA NEUROL, V73, P353, DOI 10.1001/jamaneurol.2015.3998; Michaelson DM, 2014, ALZHEIMERS DEMENT, V10, P861, DOI 10.1016/j.jalz.2014.06.015; Millspaugh JA, 1937, US NAVAL MED B, V35, P297; Minshall D, 2014, J R Nav Med Serv, V100, P252; Missios Symeon, 2007, Neurosurg Focus, V23, pE11; Mohanty AF, 2015, MED CARE, V53, pS143, DOI 10.1097/MLR.0000000000000314; Mortimer JA, 2009, ALZ DIS ASSOC DIS, V23, P152, DOI 10.1097/WAD.0b013e318190a855; Mott F W, 1917, Br Med J, V2, P612; Mott FW, 1916, LANCET, V1, P331; Myers CS, 1915, LANCET, V1, P316; Myrga JM, 2016, NEUROREHAB NEURAL RE, V30, P920, DOI 10.1177/1545968316648409; NEUBUERGER KT, 1959, ARCH NEURO PSYCHIATR, V81, P403, DOI 10.1001/archneurpsyc.1959.02340160001001; Neve RL, 2000, BRAIN RES, V886, P54, DOI 10.1016/S0006-8993(00)02869-9; Niess C, 2002, ACTA NEUROPATHOL, V104, P79, DOI 10.1007/s00401-002-0525-9; Oehmichen M, 1998, FORENSIC SCI INT, V95, P67, DOI 10.1016/S0379-0738(98)00075-9; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; OPPENHEI.DR, 1968, J NEUROL NEUROSUR PS, V31, P299, DOI 10.1136/jnnp.31.4.299; Oppenheim H, 1889, NACH NERVENKLINIK CH; Osier ND, 2017, J NEUROTRAUM, V34, P86, DOI 10.1089/neu.2015.4343; Osnato M, 1927, ARCH NEURO PSYCHIATR, V18, P181, DOI 10.1001/archneurpsyc.1927.02210020025002; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Panourias IG, 2005, NEUROSURGERY, V57, P181, DOI 10.1227/01.NEU.0000163416.66374.48; Parker HL, 1934, J NEUROL PSYCHOPATHO, V15, P20; PAYNE EE, 1968, NEUROCHIRURGIA, V11, P173; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Perry VH, 2010, NAT REV NEUROL, V6, P193, DOI 10.1038/nrneurol.2010.17; Peskind ER, 2013, J CLIN PSYCHIAT, V74, P180, DOI 10.4088/JCP.12011co1c; Pierpaoli C, 1996, RADIOLOGY, V201, P637, DOI 10.1148/radiology.201.3.8939209; Plummer S, 2016, AGING DIS, V7, P163, DOI 10.14336/AD.2015.0907; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Reams N, 2016, JAMA NEUROL, V73, P743, DOI 10.1001/jamaneurol.2015.5015; Reichard RR, 2005, NEUROPATH APPL NEURO, V31, P304, DOI 10.1111/j.1365-2990.2005.00645.x; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Ritter AC, 2016, EPILEPSIA, V57, P984, DOI 10.1111/epi.13397; ROBERTS GW, 1990, J NEUROL NEUROSUR PS, V53, P373, DOI 10.1136/jnnp.53.5.373; Rose F C, 1997, J Hist Neurosci, V6, P154; Rosenfeld JV, 2013, LANCET NEUROL, V12, P882, DOI 10.1016/S1474-4422(13)70161-3; RYAN GA, 1994, J TRAUMA, V36, P469; Scott G, 2016, NEUROLOGY, V86, P821, DOI 10.1212/WNL.0000000000002413; Selkoe DJ, 2016, EMBO MOL MED, V8, P595, DOI 10.15252/emmm.201606210; Sharp DJ, 2011, CURR OPIN NEUROL, V24, P558, DOI 10.1097/WCO.0b013e32834cd523; SHERRIFF FE, 1994, ACTA NEUROPATHOL, V87, P55; Shively SB, 2012, J HEAD TRAUMA REHAB, V27, P234, DOI 10.1097/HTR.0b013e318250e9dd; Shively SB, 2016, LANCET NEUROL, V15, P944, DOI 10.1016/S1474-4422(16)30057-6; Singh AK, 2016, RADIOGRAPHICS, V36, P295, DOI 10.1148/rg.2016150114; Smith C, 2013, NEUROPATH APPL NEURO, V39, P35, DOI 10.1111/nan.12006; Smith DH, 2003, J NEUROSURG, V98, P1072, DOI 10.3171/jns.2003.98.5.1072; Sofroniew MV, 2010, ACTA NEUROPATHOL, V119, P7, DOI 10.1007/s00401-009-0619-8; SORTLAND O, 1989, NEURORADIOLOGY, V31, P44; Southborough Lord, 1922, REPORT WAR OFFICE CO; SPILLANE J D, 1962, Br Med J, V2, P1205; Spillantini MG, 1997, NATURE, V388, P839, DOI 10.1038/42166; Stein TD, 2015, ACTA NEUROPATHOL, V130, P21, DOI 10.1007/s00401-015-1435-y; Stern RA, 2011, PM&R, V3, pS460, DOI 10.1016/j.pmrj.2011.08.008; Tanzi E, 1914, TRATTATO MALATTIE ME, V2, P325; Tartaglia MC, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00030; Tay T.L., 2016, J PHYSL; Trotter BB, 2015, BRAIN, V138, P2278, DOI 10.1093/brain/awv139; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00223; Vick Karl, 2014, Time, V184, P46; Washington PM, 2016, EXP NEUROL, V275, P381, DOI 10.1016/j.expneurol.2015.06.015; West TA, 2014, J NEUROTRAUM, V31, P159, DOI 10.1089/neu.2013.3031; WOLOWSKA J, 1960, Neurol Neurochir Psychiatr Pol, V10, P787; Young L, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00089	157	15	15	1	14	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	1047-9651	1558-1381		PHYS MED REH CLIN N	Phys. Med. Rehabil. Clin. N. Am.	MAY	2017	28	2					301	+		10.1016/j.pmr.2016.12.007			23	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EU5AJ	WOS:000401043700009	28390515				2022-02-06	
J	Yang, R; Guo, L; Huang, L; Wang, P; Tang, Y; Ye, JC; Chen, K; Hu, XM; Cai, ZP; Lu, CY; Wu, YF; Shen, HY				Yang, Rui; Guo, Lan; Huang, Lin; Wang, Peng; Tang, Yong; Ye, Jichao; Chen, Keng; Hu, Xuming; Cai, Zhaopeng; Lu, Ciyong; Wu, Yanfeng; Shen, Huiyong			Epidemiological Characteristics of Traumatic Spinal Cord Injury in Guangdong, China	SPINE			English	Article						China; epidemiology; retrospective study; traumatic spinal cord injuries	PRESSURE ULCERS; RISK-FACTORS; OUTCOMES; CANADA; COMPLICATIONS; AUSTRALIA; FEATURES; TIANJIN; COSTS; CARE	Study Design. A hospital-based retrospective epidemiological study. Objective. The aim of this study was to examine the demographic and epidemiological characteristics of patients with traumatic spinal cord injury (TSCI) in Guangdong to help healthrelated institutions develop measures to determine the best allocation of medical resources. Summary of Background Data. TSCI is a highly disabling and deadly injury. Currently, there is little information regarding the epidemiological characteristics for TSCI in Guangdong. Methods. We retrospectively reviewed the medical records of partial second-grade class-A hospitals (mainly capturing general city and county hospitals and some large-scale affiliated hospitals) in Guangdong province according to the International Classification of Disease Version 10 (ICD-10) and diagnostic code of TSCI. Results. The study included the medical records of 1340 patients with TSCI, and the annual number of TSCI admissions increased during the 2003 to 2011 period. The male-to-female ratio was approximately 3.5: 1. The major causes of spinal cord injuries were high falls (41.0%) and traffic accidents (37.8%). The most common injury among patients with TSCI was cervical injury (818 cases). In addition, 62.9% of the patients had spinal fractures, 24.0% had other fractures, and 13.7% had brain injuries. Furthermore, 25.1% (337/1340) of the patients experienced clinical complications. The differences in the number of patients with and without complete injury who accepted surgery and hyperbaric oxygen therapy were statistically significant (P<0.05), and the difference in total medical cost was significant ( P<0.05). Conclusion. There are specific epidemiological characteristics of TSCI patients in Guangdong, and preventive measures are suggested to focus on high-risk populations, such as adult men.	[Yang, Rui; Huang, Lin; Wang, Peng; Tang, Yong; Ye, Jichao; Chen, Keng; Hu, Xuming; Cai, Zhaopeng; Wu, Yanfeng; Shen, Huiyong] Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped, Guangzhou 510120, Guangdong, Peoples R China; [Guo, Lan; Lu, Ciyong] Sun Yat Sen Univ, Sch Publ Hlth, Dept Med Stat & Epidemiol, Guangzhou, Guangdong, Peoples R China		Shen, HY (corresponding author), Sun Yat Sen Univ, Sun Yat Sen Mem Hosp, Dept Orthoped, Guangzhou 510120, Guangdong, Peoples R China.	shenh.y.@163.com			Department of Health of Guangdong Province, People's Republic of China [C20010021]	Department of Health of Guangdong Province, People's Republic of China (C20010021) funds were received in support of this work.	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Behrman AL, 2012, DEV MED CHILD NEUROL, V54, P1078, DOI 10.1111/j.1469-8749.2012.04440.x; Chopra T, 2016, AM J INFECT CONTROL, V44, P315, DOI 10.1016/j.ajic.2015.10.002; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; DITUNNO JF, 1994, PARAPLEGIA, V32, P70, DOI 10.1038/sc.1994.13; Dong Q, 2004, CHINESE J HOSP STAT, V11, P120; Dryden DM, 2003, CAN J NEUROL SCI, V30, P113, DOI 10.1017/S0317167100053373; Feng HY, 2011, J SPINAL CORD MED, V34, P388, DOI 10.1179/2045772311Y.0000000017; French DD, 2007, J SPINAL CORD MED, V30, P477, DOI 10.1080/10790268.2007.11754581; Galvin J, 2013, SPINE, V38, pE878, DOI 10.1097/BRS.0b013e318294e839; Grossman RG, 2012, J NEUROSURG-SPINE, V17, P119, DOI 10.3171/2012.5.AOSPINE12127; Guzelkucuk U, 2015, SPINAL CORD, V53, P441, DOI 10.1038/sc.2014.211; Jang HJ, 2011, ANN REHABIL MED-ARM, V35, P798, DOI 10.5535/arm.2011.35.6.798; Joseph C, 2016, SPINAL CORD, V54, P535, DOI 10.1038/sc.2015.189; Karacan I, 2000, SPINAL CORD, V38, P697, DOI 10.1038/sj.sc.3101064; Kattail D, 2009, J TRAUMA, V67, P936, DOI 10.1097/TA.0b013e3181a8b431; Li J, 2011, SPINAL CORD, V49, P777, DOI 10.1038/sc.2011.8; McDonald JW, 2002, LANCET, V359, P417, DOI 10.1016/S0140-6736(02)07603-1; McKinley W, 2004, ARCH PHYS MED REHAB, V85, P1818, DOI 10.1016/j.apmr.2004.04.032; Ning GZ, 2011, SPINAL CORD, V49, P386, DOI 10.1038/sc.2010.130; Ning GZ, 2016, J SPINAL CORD MED, V39, P455, DOI 10.1080/10790268.2015.1101982; Noe BB, 2015, SPINAL CORD, V53, P436, DOI 10.1038/sc.2014.181; O'Connor P, 2002, ACCIDENT ANAL PREV, V34, P405, DOI 10.1016/S0001-4575(01)00036-7; Pagliacci MC, 2007, SPINAL CORD, V45, P404, DOI 10.1038/sj.sc.3101991; Pickett GE, 2006, SPINE, V31, P799, DOI 10.1097/01.brs.0000207258.80129.03; Wang HF, 2013, SPINAL CORD, V51, P20, DOI 10.1038/sc.2012.92	26	15	20	0	11	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAY 1	2017	42	9					E555	E561		10.1097/BRS.0000000000001896			7	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	EU4QL	WOS:000401015100008	27607312				2022-02-06	
J	Buckley, TA; Baugh, CM; Meehan, WP; DiFabio, MS				Buckley, Thomas A.; Baugh, Christine M.; Meehan, William P., III; DiFabio, Melissa S.			Concussion Management Plan Compliance: A Study of NCAA Power 5 Conference Schools	ORTHOPAEDIC JOURNAL OF SPORTS MEDICINE			English	Article						mild traumatic brain injury; best practices; public health; head trauma; health policy	CHRONIC TRAUMATIC ENCEPHALOPATHY; FOOTBALL PLAYERS; HEAD IMPACTS; ATHLETIC TRAINERS; PRACTICE PATTERNS; COLLEGIATE; SEASON	Background: In response to concerns over concussions and repeated head impacts that occur during sports, the National Collegiate Athletic Association (NCAA) mandated that all member institutions enact a concussion management plan (CMP). Although institutional and health care provider self-reports have been investigated, compliance with NCAA protocol recommendations has not been examined. Purpose: To examine the CMPs from the 65 institutions within the NCAA Power 5 conferences for compliance with the NCAA 2015 concussion guidelines. Study Design: Descriptive epidemiology study. Methods: Each institution's publicly available CMP was obtained in 2015, reviewed, and coded for compliance with each of the required 47 components. Overall compliance rate, item-level, category-level, and institution-level compliance was assessed. Independent predictors of compliance, including each institution's athletic training staff size, academic performance, and athletic performance, were examined with quasi-binomial regression. Results: CMPs varied substantially in length and level of detail. The overall compliance rate for all components across all institutions was 94.3% (2880/3055). Twelve components achieved 100% (65/65) compliance, and the lowest levels of compliance were clustered in "return to learn." There were 22 institutions that achieved a 100% compliance rate; the lowest institutional compliance was 59.6%. There were no significant associations between the independent predictors and institutional compliance. Conclusion: Overall compliance with NCAA concussion management requirements was high, but there remains room for improvement. The lowest level of compliance was clustered in the return-to-learn section. There were limited details provided in the reducing head trauma component. Items with lower compliance (reducing head trauma, return to learn) tended to be outside the core competencies of the medical staff, indicating an area for improvement. Encouragingly, many institutions and specific components demonstrated full compliance.	[Buckley, Thomas A.] Univ Delaware, Dept Kinesiol & Appl Physiol, Newark, DE USA; [Buckley, Thomas A.; DiFabio, Melissa S.] Univ Delaware, Biomech & Movement Sci Interdisciplinary Program, Newark, DE USA; [Baugh, Christine M.] Harvard Univ, Interfac Initiat Hlth Policy, Cambridge, MA 02138 USA; [Baugh, Christine M.; Meehan, William P., III] Boston Childrens Hosp, Div Sports Med, Micheli Ctr Sport Injury Prevent, Waltham, MA USA		Buckley, TA (corresponding author), Univ Delaware, Dept Kinesiol & Appl Physiol, Human Performance Lab 150, 541 South Coll Ave, Newark, DE 19716 USA.	tbuckley@udel.edu	Buckley, Thomas A/B-7525-2016; Baugh, Christine/AAG-2324-2020	Buckley, Thomas A/0000-0002-0515-0150; Baugh, Christine/0000-0002-9340-6338	NCAA, NCAA/DoD CARE consortium [W81XWH-14-2-0151]; Football Players' Health Study - NFL Players' Association; National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament; NCAA; National Institute of Mental HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733]; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [T32MH019733] Funding Source: NIH RePORTER	One or more of the authors has declared the following potential conflict of interest or source of funding: T.A.B. has received research-related funding from the NCAA as part of the NCAA/DoD CARE consortium (award number W81XWH-14-2-0151). W.P.M. receives royalties from ABC-Clio Publishing, Springer, and Wolters Kluwer, and his research is funded in part by a grant from the Football Players' Health Study, funded by the NFL Players' Association, and philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament. C.M.B. receives research support from the Football Players' Health Study, funded by the NFL Players' Association; has received funding from the NCAA; and is supported by the National Institute of Mental Health (award number T32MH019733).	[Anonymous], CONC MAN PLAN; Baugh CM, 2016, AM J SPORT MED, V44, P1391, DOI 10.1177/0363546516635639; Baugh CM, 2015, AM J SPORT MED, V43, P47, DOI 10.1177/0363546514553090; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Baugh CM, 2016, CONCUSSION, V1, P1; Benson M., 1994, 1994 95 NCAA SPORTS; Breedlove EL, 2012, J BIOMECH, V45, P1265, DOI 10.1016/j.jbiomech.2012.01.034; Buckley TA, 2015, CURR RES CONCUSSION, V2, P59; Buckley TA, 2016, J HEAD TRAUMA REHAB, V31, P233, DOI 10.1097/HTR.0000000000000165; Buckley TA, 2015, J ATHL TRAINING, V50, P879, DOI 10.4085/1062-6050-50.7.04; Caccese JB, 2016, RES SPORTS MED, V24, P407, DOI 10.1080/15438627.2016.1230549; Chun IY, 2015, DEV NEUROPSYCHOL, V40, P92, DOI 10.1080/87565641.2015.1020945; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Diamond D., 2012, ARIZONA JUST BROKE N; Ferrara Michael S., 2001, J Athl Train, V36, P145; Kelly KC, 2014, J ATHL TRAINING, V49, P665, DOI 10.4085/1062-6050-49.3.25; Kerr ZY, 2015, ORTHOP J SPORTS MED, V3, DOI 10.1177/2325967115610545; Kerr ZY, 2015, J ATHL TRAINING, V50, P1174, DOI 10.4085/1062-6050-50.11.11; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2014, BRIT J SPORT MED, V48, P135, DOI 10.1136/bjsports-2013-092498; Lynall RC, 2016, MED SCI SPORT EXER, V48, P1772, DOI 10.1249/MSS.0000000000000951; Marchi N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0056805; McAllister TW, 2012, NEUROLOGY, V78, P1777, DOI 10.1212/WNL.0b013e3182582fe7; McCrory P, 2013, CLIN J SPORT MED, V23, P89, DOI 10.1097/JSM.0b013e31828b67cf; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Moreau M. S., 2014, INT J EXERCISE SCI, V7, P62; National Athletic Trainers' Association, 2011, ATHL TRAIN ED COMP; National Collegiate Athletic Association, CONC SAF PROT COMM R; National Collegiate Athletic Association, GRAD SUCC RAT; National Collegiate Athletic Association, 1933, NAT COLL ATHL ASS ME; National Collegiate Athletic Association, 3 2 4 17 1 CONC MAN; National Collegiate Athletic Association, IND MED CAR GUID; National Collegiate Athletic Association, CONC SAF; National Collegiate Athletic Association Sport Science Institute, CONC SAF PROT CHECKL; Nauman EA, 2015, DEV NEUROPSYCHOL, V40, P85, DOI 10.1080/87565641.2015.1016161; Saunders EA, 2013, ATHLETIC TRAINING SP, V5, P11, DOI DOI 10.3928/19425864-20121217-02; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; SMITH RK, 2000, MARQ SPORTS L REV, V11, P9; Svaldi DO, 2017, BRAIN IMAGING BEHAV, V11, P98, DOI 10.1007/s11682-016-9509-6; Svaldi DO, 2015, DEV NEUROPSYCHOL, V40, P80, DOI 10.1080/87565641.2014.973959; Swartz EE, 2015, J ATHL TRAINING, V50, P1219, DOI 10.4085/1062-6050-51.1.06; Zuckerman SL, 2016, AM J SPORT MED, V44, pNP5, DOI 10.1177/0363546515623241	43	15	15	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	2325-9671			ORTHOP J SPORTS MED	Orthop. J. Sports Med.	APR 25	2017	5	4							2325967117702606	10.1177/2325967117702606			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	ET5ER	WOS:000400307500001	28473995	Green Published, Green Submitted, gold			2022-02-06	
J	Chen, YH; Huang, EYK; Kuo, TT; Hoffer, BJ; Miller, J; Chou, YC; Chiang, YH				Chen, Yuan-Hao; Huang, Eagle Yi-Kung; Kuo, Tung-Tai; Hoffer, Barry J.; Miller, Jonathan; Chou, Yu-Ching; Chiang, Yung-Hsiao			DOPAMINE RELEASE IN THE NUCLEUS ACCUMBENS IS ALTERED FOLLOWING TRAUMATIC BRAIN INJURY	NEUROSCIENCE			English	Article						dopamine; nucleus accumbens; traumatic brain injury; fast-scan cyclic voltammetry	VENTRAL STRIATAL COMPARTMENTS; FLUID PERCUSSION INJURY; TOPOGRAPHICAL ORGANIZATION; EFFERENT PROJECTIONS; BASAL GANGLIA; RAT; REWARD; NEURONS; CORTEX; SHELL	Mild-to-severe traumatic brain injury (TBI) is frequently associated with prolonged dysfunction of reward circuitry, including motivation and salience, which suggests alterations of dopamine (DA) processing within the core and shell of the nucleus accumbens (NAC). Using fast -scan cyclic voltammetry in a rodent model of traumatic brain injury, we found that stimulus-evoked DA release is distinct in the core and shell of the NAC, with the shell being less responsive to tonic stimulation and more sensitive to the number of pulses when phasic stimulation is applied. Exposure to TBI was associated with major changes in both release and reuptake of DA in both the core and shell of NAC, with greater changes seen in the core. These alterations evolved over time, becoming most severe 1-2 weeks after injury with subsequent recovery, and the extent and progression of these abnormalities was correlated with severity of injury. Taken together, these data support behavior and anatomical studies suggesting the NAC core and striatum may subserve parallel functions, whereas the shell is distinct. These data offer a unique window on how different neurological systems respond to TBI and may help explain affective and cognitive changes that are seen. (C) 2017 IBRO. Published by Elsevier Ltd. All rights reserved.	[Chen, Yuan-Hao] Natl Def Med Ctr, Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan; [Huang, Eagle Yi-Kung] Natl Def Med Ctr, Dept Pharmacol, Taipei, Taiwan; [Kuo, Tung-Tai] Natl Taipei Univ Technol, Grad Inst Comp & Commun Engn, Taipei, Taiwan; [Hoffer, Barry J.; Miller, Jonathan] Case Western Reserve Univ, Sch Med, Dept Neurosurg, Cleveland, OH USA; [Chou, Yu-Ching] Natl Def Med Ctr, Sch Publ Hlth, Taipei, Taiwan; [Hoffer, Barry J.; Chiang, Yung-Hsiao] Taipei Med Univ, Grad Program Neuroregenerat, Taipei, Taiwan		Chen, YH (corresponding author), Natl Def Med Ctr, Triserv Gen Hosp, Dept Neurol Surg, Taipei, Taiwan.	chenyh178@gmail.com	Chen, Yuan-Hao/U-6870-2019	Chen, Yuan-Hao/0000-0002-0570-4328	Ministry of Science and Technology of Taiwan, ROC [NSC102-2314-13-016-030-MY3, NSC105-2314-8-016-001-MY3]; Tri-Service General Hospital of Taiwan [TSGH-C105-075, TSGH-C105-078]; National Defense Medical Center [MAB-105-105]; Medical Research Project grants; George R. and Constance P. Lincoln family	This work was supported by the Ministry of Science and Technology of Taiwan, ROC under grant NSC102-2314-13-016-030-MY3, NSC105-2314-8-016-001-MY3, and by Medical Research Project grants; TSGH-C105-075 and TSGH-C105-078 from the Tri-Service General Hospital of Taiwan and MAB-105-105 from National Defense Medical Center. And this project was also supported in part by philanthropic support from the George R. and Constance P. Lincoln family.	ALBIN RL, 1989, TRENDS NEUROSCI, V12, P366, DOI 10.1016/0166-2236(89)90074-X; ALEXANDER GE, 1986, ANNU REV NEUROSCI, V9, P357, DOI 10.1146/annurev.ne.09.030186.002041; Alexander GE, 1990, PROG BRAIN RES, V85, P85; Alheid GF, 2003, ANN NY ACAD SCI, V985, P185; BERENDSE HW, 1990, J COMP NEUROL, V299, P187, DOI 10.1002/cne.902990206; BERENDSE HW, 1992, J COMP NEUROL, V316, P314, DOI 10.1002/cne.903160305; Berridge KC, 2012, EUR J NEUROSCI, V35, P1124, DOI 10.1111/j.1460-9568.2012.07990.x; Bjork JM, 2009, J NEUROTRAUM, V26, P1077, DOI [10.1089/neu.2008.0849, 10.1089/neu.2008-0849]; Bogner J, 2015, BRAIN INJURY, V29, P905, DOI 10.3109/02699052.2015.1005136; BURSTEIN R, 1989, BRAIN RES, V497, P149, DOI 10.1016/0006-8993(89)90981-5; Cacciapaglia F, 2012, NEUROPHARMACOLOGY, V62, P2050, DOI 10.1016/j.neuropharm.2011.12.027; Chen YH, 2008, FASEB J, V22, P261, DOI 10.1096/fj.07-8797com; Chen YH, 2015, CELL TRANSPLANT, V24, P2113, DOI 10.3727/096368914X683584; CLIFFER KD, 1991, J NEUROSCI, V11, P852; Dreyer JK, 2010, J NEUROSCI, V30, P14273, DOI 10.1523/JNEUROSCI.1894-10.2010; Floresco SB, 2015, ANNU REV PSYCHOL, V66, P25, DOI 10.1146/annurev-psych-010213-115159; Good CH, 2013, J NEUROSCI, V 33, P16853, DOI 10.1523/JNEUROSCI.1844-13.2013; Good CH, 2011, FASEB J, V25, P1333, DOI 10.1096/fj.10-173625; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Hammond FM, 2014, J HEAD TRAUMA REHAB, V29, P391, DOI 10.1097/01.HTR.0000438116.56228.de; HEIMER L, 1991, NEUROSCIENCE, V41, P89, DOI 10.1016/0306-4522(91)90202-Y; Huang EYK, 2014, BEHAV BRAIN RES, V267, P156, DOI 10.1016/j.bbr.2014.03.033; Huang EYK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0086354; HURLEY KM, 1991, J COMP NEUROL, V308, P249, DOI 10.1002/cne.903080210; Hutson CB, 2011, J NEUROTRAUM, V28, P1783, DOI 10.1089/neu.2010.1723; KAWAGOE KT, 1993, J NEUROSCI METH, V48, P225, DOI 10.1016/0165-0270(93)90094-8; Kelley AE, 1999, ANN NY ACAD SCI, V877, P71, DOI 10.1111/j.1749-6632.1999.tb09262.x; Malenka R., 2009, MOL NEUROPHARMACOLOG, P364; Matsushita Y, 2000, J NEUROTRAUM, V17, P143, DOI 10.1089/neu.2000.17.143; MOGENSON GJ, 1980, PROG NEUROBIOL, V14, P69, DOI 10.1016/0301-0082(80)90018-0; Pan WX, 2005, J NEUROSCI, V25, P6235, DOI 10.1523/JNEUROSCI.1478-05.2005; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Sabeti J, 2002, J NEUROSCI METH, V121, P41, DOI 10.1016/S0165-0270(02)00229-7; Saddoris Michael P, 2013, Front Biosci (Elite Ed), V5, P273; SESACK SR, 1989, J COMP NEUROL, V290, P213, DOI 10.1002/cne.902900205; Tsai HC, 2009, SCIENCE, V324, P1080, DOI 10.1126/science.1168878; Walder B, 2013, J NEUROTRAUM, V30, P1934, DOI 10.1089/neu.2013.2955; West EA, 2016, J NEUROSCI, V36, P1128, DOI 10.1523/JNEUROSCI.2976-15.2016; Wightman RM, 2002, J NEUROCHEM, V82, P721, DOI 10.1046/j.1471-4159.2002.01005.x; ZABORSZKY L, 1985, NEUROSCIENCE, V14, P427, DOI 10.1016/0306-4522(85)90302-1; ZAHM DS, 1992, NEUROSCIENCE, V50, P751, DOI 10.1016/0306-4522(92)90202-D	41	15	16	0	3	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	APR 21	2017	348						180	190		10.1016/j.neuroscience.2017.02.001			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	ER2VF	WOS:000398651200017	28196657				2022-02-06	
J	Kraus, N; Lindley, T; Colegrove, D; Krizman, J; Otto-Meyer, S; Thompson, EC; White-Schwoch, T				Kraus, Nina; Lindley, Tory; Colegrove, Danielle; Krizman, Jennifer; Otto-Meyer, Sebastian; Thompson, Elaine C.; White-Schwoch, Travis			The neural legacy of a single concussion	NEUROSCIENCE LETTERS			English	Article						Concussion; Mild traumatic brain injury; Sports medicine; Auditory processing; Neurophysiology; FFR	INDIVIDUALS	It has been hypothesized that concussions impart lasting brain damage, even after a patient has ostensibly recovered. This hypothesis is based largely upon neuropathological studies in deceased athletes, however, leaving open the question of whether it can be detected in vivo. We measured neural responses to speech in collegiate student-athletes with a history of a single concussion from which they had recovered. These student-athletes had weaker responses to speech than age- and position-matched peers. This group difference suggests that concussions engender small, but detectable, changes in brain function prior to the emergence of frank behavioral indications. (C) 2017 Elsevier B.V. All rights reserved.	[Kraus, Nina; Krizman, Jennifer; Otto-Meyer, Sebastian; Thompson, Elaine C.; White-Schwoch, Travis] Northwestern Univ, Dept Commun Sci, Auditory Neurosci Lab, Evanston, IL USA; [Kraus, Nina] Northwestern Univ, Dept Neurobiol, Evanston, IL USA; [Kraus, Nina] Northwestern Univ, Dept Otolaryngol, Evanston, IL USA; [Lindley, Tory; Colegrove, Danielle] Northwestern Univ, Sports Med Unit, Dept Athlet, Evanston, IL USA		Kraus, N (corresponding author), 2240 Campus Dr, Evanston, IL 60208 USA.	nkraus@northwestern.edu			Knowles Hearing Center	This work was supported by the Knowles Hearing Center.	Carman AJ, 2015, NAT REV NEUROL, V11, P230, DOI 10.1038/nrneurol.2015.30; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Kraus N., 2016, NAT SCI REP, V6; Kraus N, 2015, TRENDS COGN SCI, V19, P642, DOI 10.1016/j.tics.2015.08.017; Maro II, 2014, EAR HEARING, V35, P306, DOI 10.1097/01.aud.0000439101.07257.ed; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Skoe E, 2015, CEREB CORTEX, V25, P1415, DOI 10.1093/cercor/bht311; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Wilson MJ, 2014, DEV NEUROPSYCHOL, V39, P113, DOI 10.1080/87565641.2013.870177	9	15	15	0	5	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0304-3940	1872-7972		NEUROSCI LETT	Neurosci. Lett.	APR 12	2017	646						21	23		10.1016/j.neulet.2017.03.008			3	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EV3SO	WOS:000401679600004	28279706				2022-02-06	
J	Esopenko, C; Levine, B				Esopenko, Carrie; Levine, Brian			Autobiographical memory and structural brain changes in chronic phase TBI	CORTEX			English	Article						Naturalistic memory; Autobiographical interview; Head injury; Structural neuroimaging; Diffuse injury	MEDIAL-TEMPORAL-LOBE; CLOSED-HEAD-INJURY; EPISODIC MEMORY; RETROGRADE-AMNESIA; FRONTOTEMPORAL DEMENTIA; BEHAVIORAL-VARIANT; ALZHEIMERS-DISEASE; LESION LOCATION; QUANTIFIED MRI; RETRIEVAL	Traumatic brain injury (TBI) is associated with a range of neuropsychological deficits, including attention, memory, and executive functioning attributable to diffuse axonal injury (DAI) with accompanying focal frontal and temporal damage. Although the memory deficit of TBI has been well characterized with laboratory tests, comparatively little research has examined retrograde autobiographical memory (AM) at the chronic phase of TBI, with no prior studies of unselected patients drawn directly from hospital admissions for trauma. Moreover, little is known about the effects of TBI on canonical episodic and non-episodic (e.g., semantic) AM processes. In the present study, we assessed the effects of chronic-phase TBI on AM in patients with focal and DAI spanning the range of TBI severity. Patients and socioeconomic- and age-matched controls were administered the Autobiographical Interview (AI) (Levine, Svoboda, Hay, Winocur, & Moscovitch, 2002) a widely used method for dissociating episodic and semantic elements of AM, along with tests of neuropsychological and functional outcome. Measures of episodic and non-episodic AM were compared with regional brain volumes derived from high-resolution structural magnetic resonance imaging (MRI). Severe TBI (but not mild or moderate TBI) was associated with reduced recall of episodic autobiographical details and increased recall of non-episodic details relative to healthy comparison participants. There were no significant associations between AM performance and neuropsychological or functional outcome measures. Within the full TBI sample, autobiographical episodic memory was associated with reduced volume distributed across temporal, parietal, and prefrontal regions considered to be part of the brain's AM network. These results suggest that TBI-related distributed volume loss affects episodic autobiographical recollection. (C) 2017 Elsevier Ltd. All rights reserved.	[Esopenko, Carrie] Rutgers State Univ, Dept Rehabil & Movement Sci, New Brunswick, NJ USA; [Levine, Brian] Baycrest Hlth Sci, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada; [Levine, Brian] Univ Toronto, Toronto, ON, Canada		Levine, B (corresponding author), Baycrest Hlth Sci, Rotman Res Inst, 3560 Bathurst St, Toronto, ON M6A 2E1, Canada.	blevine@research.baycrest.org	Levine, Brian/G-4328-2010; Levine, Brian/O-2725-2019	Levine, Brian/0000-0003-4343-811X; Levine, Brian/0000-0003-4343-811X; Esopenko, Carrie/0000-0001-8607-5633	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR) [sMT-14744, MOP-37535, MOP-108540]; NIH-NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD42385-01]; Alzheimer's Society of Canada's Research Program Post Doctoral Fellowship awarded	Ann Campbell, Catherine Hynes, Sabitha Kanagasabai, Charlene O'Connor, Colleen O'Toole, Marina Mandic, Karen Philp, Adriana Fecko, Jovanka Skocic, and Gary Turner are thanked for technical assistance. Natasa Kovacevic, Fuqiang Gao, Joel Ramirez, and Sandra Black are thanked for assistance with the neuroimaging pipeline. We gratefully thank the TBI participants and non-injured volunteers for participating in this research. This research was supported by grants from the Canadian Institutes of Health Research (Grant #sMT-14744, MOP-37535, and MOP-108540), and the NIH-NICHD (Grant #HD42385-01) to B.L., and an Alzheimer's Society of Canada's Research Program Post Doctoral Fellowship awarded to C.E.	Addis DR, 2008, PSYCHOL SCI, V19, P33, DOI 10.1111/j.1467-9280.2008.02043.x; Addis DR, 2007, BRAIN, V130, P2327, DOI 10.1093/brain/awm166; Army Individual Test Battery, 1944, MAN DIR SCOR; ARNDT S, 1991, PSYCHIAT RES-NEUROIM, V40, P79; Barry NC, 2015, J CLIN EXP NEUROPSYC, V37, P994, DOI 10.1080/13803395.2015.1038981; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; BERGNER M, 1981, MED CARE, V19, P787, DOI 10.1097/00005650-198108000-00001; Berryhill ME, 2007, J NEUROSCI, V27, P14415, DOI 10.1523/JNEUROSCI.4163-07.2007; Bright P, 2006, LEARN MEMORY, V13, P545, DOI 10.1101/lm.265906; Buckner RL, 2007, TRENDS COGN SCI, V11, P49, DOI 10.1016/j.tics.2006.11.004; Burgess PW, 1998, J INT NEUROPSYCH SOC, V4, P547, DOI 10.1017/S1355617798466037; Cabeza R, 2004, J COGNITIVE NEUROSCI, V16, P1583, DOI 10.1162/0898929042568578; Cabeza R, 2007, TRENDS COGN SCI, V11, P219, DOI 10.1016/j.tics.2007.02.005; Carlesimo GA, 1998, CORTEX, V34, P1, DOI 10.1016/S0010-9452(08)70734-2; Conway MA, 2000, PSYCHOL REV, V107, P261, DOI 10.1037//0033-295X.107.2.261; Conway MA, 2001, PHILOS T R SOC B, V356, P1375, DOI 10.1098/rstb.2001.0940; Coste C, 2011, CORTEX, V47, P771, DOI 10.1016/j.cortex.2010.07.004; Davidson PSR, 2008, NEUROPSYCHOLOGIA, V46, P1743, DOI 10.1016/j.neuropsychologia.2008.01.011; Fujiwara E, 2008, NEUROPSYCHOLOGIA, V46, P461, DOI 10.1016/j.neuropsychologia.2007.08.027; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gilboa A, 2005, HIPPOCAMPUS, V15, P535, DOI 10.1002/hipo.20090; Goste C., 2015, NEUROPSYCHOLOGIA, V71, P133, DOI http://dx.doi.org/10.1016/; Greenberg DL, 2014, MEM COGNITION, V42, P922, DOI 10.3758/s13421-014-0402-5; Guild EB, 2015, J INT NEUROPSYCH SOC, V21, P650, DOI 10.1017/S1355617715000600; HENDERSON DA, 1989, PSYCHOL REP, V64, P251, DOI 10.2466/pr0.1989.64.1.251; Irish M, 2011, NEUROPSYCHOLOGIA, V49, P2694, DOI 10.1016/j.neuropsychologia.2011.05.017; Irish M, 2013, CORTEX, V49, P2377, DOI 10.1016/j.cortex.2013.03.002; Judd CM., 2008, DATA ANAL MODEL COMP, V2; KAY T, 1995, J HEAD TRAUMA REHAB, V10, P12, DOI 10.1097/00001199-199504000-00004; Knight RG, 2009, J CLIN EXP NEUROPSYC, V31, P575, DOI 10.1080/13803390802363710; Kopelman MD, 2003, HIPPOCAMPUS, V13, P879, DOI 10.1002/hipo.10140; KOPELMAN MD, 1989, J CLIN EXP NEUROPSYC, V11, P724, DOI 10.1080/01688638908400928; Kopelman MD, 1999, NEUROPSYCHOLOGIA, V37, P939, DOI 10.1016/S0028-3932(98)00143-2; Kovacevic N, 2013, SPRINGER P MATH STAT, V56, P159, DOI 10.1007/978-1-4614-8283-3_10; Krishnan A, 2011, NEUROIMAGE, V56, P455, DOI 10.1016/j.neuroimage.2010.07.034; LEVIN HS, 1985, J NEUROL NEUROSUR PS, V48, P556, DOI 10.1136/jnnp.48.6.556; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Levine B, 2005, COGN BEHAV NEUROL, V18, P45, DOI 10.1097/01.wnn.0000152227.13001.c3; Levine B, 2002, PSYCHOL AGING, V17, P677, DOI 10.1037//0882-7974.17.4.677; Levine B, 2013, NEUROIMAGE-CLIN, V2, P534, DOI 10.1016/j.nicl.2013.03.015; Mateer C.A., 1987, J HEAD TRAUMA REHAB, V2, P74, DOI DOI 10.1097/00001199-198709000-00009; McDermott KB, 2009, NEUROPSYCHOLOGIA, V47, P2290, DOI 10.1016/j.neuropsychologia.2008.12.025; McKinnon MC, 2008, J COGNITIVE NEUROSCI, V20, P1839, DOI 10.1162/jocn.2008.20126; McKinnon MC, 2015, CLIN PSYCHOL SCI, V3, P487, DOI 10.1177/2167702614542280; Moscovitch M, 2016, ANNU REV PSYCHOL, V67, P105, DOI 10.1146/annurev-psych-113011-143733; Murphy K, 2008, NEUROPSYCHOLOGIA, V46, P3116, DOI 10.1016/j.neuropsychologia.2008.07.004; Palombo DJ, 2015, NEUROPSYCHOLOGY, V29, P543, DOI 10.1037/neu0000198; PETRIDES M, 1982, NEUROPSYCHOLOGIA, V20, P249, DOI 10.1016/0028-3932(82)90100-2; Piolino P, 2002, MEMORY, V10, P239, DOI 10.1080/09658210143000353; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Rasmussen KW, 2014, J NEUROPSYCHOL, V8, P34, DOI 10.1111/jnp.12003; Renoult L, 2012, TRENDS COGN SCI, V16, P550, DOI 10.1016/j.tics.2012.09.003; Rosenbaum RS, 2008, J COGNITIVE NEUROSCI, V20, P1490, DOI 10.1162/jocn.2008.20105; Rubin DC, 1997, MEM COGNITION, V25, P859, DOI 10.3758/BF03211330; Rubin DC, 1998, P NATL ACAD SCI USA, V95, P5413, DOI 10.1073/pnas.95.9.5413; Rugg MD, 2013, CURR OPIN NEUROBIOL, V23, P255, DOI 10.1016/j.conb.2012.11.005; SCHACTER DL, 1977, CORTEX, V13, P150, DOI 10.1016/S0010-9452(77)80006-3; Sheldon S, 2016, ANN NY ACAD SCI, V1369, P76, DOI 10.1111/nyas.13006; Sheldon S, 2016, CORTEX, V74, P206, DOI 10.1016/j.cortex.2015.11.005; Simons JS, 2010, CEREB CORTEX, V20, P479, DOI 10.1093/cercor/bhp116; Simons JS, 2003, NAT REV NEUROSCI, V4, P637, DOI 10.1038/nrn1178; Smith A., 1978, SYMBOL DIGIT MODALIT; Soderlund H, 2014, J ABNORM PSYCHOL, V123, P51, DOI 10.1037/a0035610; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Starkstein SE, 1997, NEUROCASE, V3, P105, DOI 10.1093/neucas/3.2.105; Stuss D.T., 1994, NEUROPSYCHOLOGY, V8, P355, DOI [https://doi.org/10.1037/0894-4105.8.3.355, DOI 10.1037/0894-4105.8.3.355]; Stuss DT, 2000, NEUROPSYCHOLOGIA, V38, P388, DOI 10.1016/S0028-3932(99)00093-7; Stuss DT, 1992, NEUROPSY NEUROPSY BE, V5; Svoboda E, 2006, NEUROPSYCHOLOGIA, V44, P2189, DOI 10.1016/j.neuropsychologia.2006.05.023; TEASDALE G, 1974, LANCET, V2, P81; Vanier M, 2000, ARCH PHYS MED REHAB, V81, P796, DOI 10.1016/S0003-9993(00)90114-X; Wilde EA, 2012, BRAIN IMAGING BEHAV, V6, P404, DOI 10.1007/s11682-012-9150-y; Willoughby KA, 2013, J INT NEUROPSYCH SOC, V19, P419, DOI 10.1017/S1355617712001488; Winocur G, 2011, J INT NEUROPSYCH SOC, V17, P766, DOI 10.1017/S1355617711000683; Zachary R. A., 1986, SHIPLEY I LIVING SCA	76	15	15	1	13	ELSEVIER MASSON	MILANO	VIA PALEOCAPA 7, 20121 MILANO, ITALY	0010-9452	1973-8102		CORTEX	Cortex	APR	2017	89						1	10		10.1016/j.cortex.2017.01.007			10	Behavioral Sciences; Neurosciences; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Behavioral Sciences; Neurosciences & Neurology; Psychology	ES1AT	WOS:000399261000001	28189664				2022-02-06	
J	Krieg, SM; Trabold, R; Plesnila, N				Krieg, Sandro M.; Trabold, Raimund; Plesnila, Nikolaus			Time-Dependent Effects of Arginine-Vasopressin V1 Receptor Inhibition on Secondary Brain Damage after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						AVP; brain edema; ICP; secondary brain damage; TBI	CONTROLLED CORTICAL IMPACT; SUBARACHNOID HEMORRHAGE; VOLUME REGULATION; V-2 RECEPTORS; EXTRAHYPOTHALAMIC VASOPRESSIN; CEREBROSPINAL-FLUID; V-1A RECEPTORS; EDEMA; RATS; MICE	Arginine-vasopressin (AVP) V-1 receptors are known to mediate brain edema formation after traumatic brain injury (TBI). So far, however, AVP V-1 receptors were only inhibited by genetic deletion or prior to trauma. Therefore, the current study aimed to determine the therapeutic window of AVP V-1 receptor antagonization after TBI. Male C57BL/6 mice (n = 7 per group) were subjected to controlled cortical impact (CCI), and 500 ng of a selective peptide V-1 receptor antagonist (V1880) were applied by intracerebroventricular injection 5 min, and 1, 3, and 6 h thereafter. After 24 h, brain water content (BWC), intracranial pressure (ICP), and secondary contusion expansion volume were assessed. Neurological function was assessed daily for 7 days after trauma. Inhibition of AVP V-1 receptors within 1 h after TBI significantly reduced BWC from 81.6 +/- 0.7 to 80.6 +/- 0.7% (means +/- SD; p < 0.05). Reduction of brain edema resulted in a significant decrease in ICP from 25.9 +/- 1.8 mm Hg to 21.0 +/- 1.5 mm Hg (p < 0.05) and a reduction in contusion volume (26.1 +/- 2.5mm(3) vs. 30.1 +/- 2.0mm(3) in controls; p < 0.05). This reduction of brain injury resulted in a significantly improved neurological function 7 days after trauma. Treatments initiated 6 h after TBI had no effect. The results of the current study demonstrate that inhibition of AVP V-1 receptors improve outcome after experimental TBI when given within a clinically relevant time window. Therefore, AVP V-1 receptors may represent a therapeutic target with clinical potential.	[Krieg, Sandro M.; Trabold, Raimund; Plesnila, Nikolaus] Ludwig Maximilians Univ Munchen, Lab Expt Neurosurg, Munich, Germany; [Trabold, Raimund] Ludwig Maximilians Univ Munchen, Dept Neurosurg, Munich, Germany; [Plesnila, Nikolaus] Ludwig Maximilians Univ Munchen, Inst Stroke & Dementia Res, Munich, Germany; [Plesnila, Nikolaus] Ludwig Maximilians Univ Munchen, Munich Cluster Syst Neurol, Munich, Germany		Plesnila, N (corresponding author), Inst Stroke & Dementia Res, Feodor Lynen Str 17, D-81377 Munich, Germany.	nikolaus.plesnila@med.uni-muenchen.de	Krieg, Sandro M./L-8902-2016; Plesnila, Nikolaus/T-7522-2019	Krieg, Sandro M./0000-0003-4050-1531; 	research and medical education (Forderprogramm for Forschung und Lehre) of the Faculty of Medicine; LudwigMaximilians-University, Munich, Germany	This study was supported by grants of the sponsoring program for research and medical education (Forderprogramm for Forschung und Lehre) of the Faculty of Medicine, LudwigMaximilians-University, Munich, Germany. We apologize to all those colleagues whose work could not be cited because of space limitations.	Aimaretti G, 2004, GROWTH HORM IGF RES, V14, pS114, DOI 10.1016/j.ghir.2004.03.025; Amiry-Moghaddam M, 2004, NEUROSCIENCE, V129, P999, DOI 10.1016/j.neuroscience.2004.08.049; Armstead WM, 2001, BRAIN RES, V910, P19, DOI 10.1016/S0006-8993(01)02716-0; Barreca T, 2001, CEREBROVASC DIS, V11, P113, DOI 10.1159/000047622; Bemana I, 1999, NEUROSURGERY, V44, P148, DOI 10.1097/00006123-199901000-00091; Ben Borgens R, 2012, Q REV BIOL, V87, P89, DOI 10.1086/665457; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; BUIJS RM, 1980, J HISTOCHEM CYTOCHEM, V28, P357, DOI 10.1177/28.4.6989899; BUIJS RM, 1978, CELL TISSUE RES, V186, P423, DOI 10.1007/BF00224932; CHEN Y, 1992, CAN J PHYSIOL PHARM, V70, pS367, DOI 10.1139/y92-285; Chodobski A, 1997, MOL BRAIN RES, V48, P67, DOI 10.1016/S0169-328X(97)00079-X; Cintra ED, 2000, ARQ NEURO-PSIQUIAT, V58, P181; de Vries GJ, 1998, PROG BRAIN RES, V119, P3; DELBIGIO MR, 1990, ACT NEUR S, V51, P14; DEPASQUALE M, 1989, AM J PHYSIOL, V256, pF1059, DOI 10.1152/ajprenal.1989.256.6.F1059; DICKINSON LD, 1992, J CEREBR BLOOD F MET, V12, P681, DOI 10.1038/jcbfm.1992.93; DOCZI T, 1993, ACTA NEUROCHIR, V121, P1, DOI 10.1007/BF01405174; DOCZI T, 1982, NEUROSURGERY, V11, P402; FARACI FM, 1990, AM J PHYSIOL, V258, pR94, DOI 10.1152/ajpregu.1990.258.1.R94; Fernandez N, 2001, BRIT J PHARMACOL, V132, P1837, DOI 10.1038/sj.bjp.0704034; GRAHAM DI, 1978, J NEUROL SCI, V39, P213, DOI 10.1016/0022-510X(78)90124-7; Hockel K, 2012, STROKE, V43, P227, DOI 10.1161/STROKEAHA.111.626168; Holmes CL, 2003, CRIT CARE, V7, P427, DOI 10.1186/cc2337; Huang WD, 2008, J ENDOCRINOL INVEST, V31, P996, DOI 10.1007/BF03345638; Kermer P, 1999, CELL TISSUE RES, V298, P383, DOI 10.1007/s004410050061; Kleindienst A, 2013, ACTA NEUROCHIR, V155, P151, DOI 10.1007/s00701-012-1558-z; Krieg SM, 2015, J NEUROTRAUM, V32, P221, DOI 10.1089/neu.2013.3274; Laszlo FA, 1999, EUR J PHARMACOL, V364, P115, DOI 10.1016/S0014-2999(98)00836-X; Lee JC, 2015, INJURY, V46, P854, DOI 10.1016/j.injury.2014.12.023; LIU XF, 1991, CHINESE MED J-PEKING, V104, P480; Marmarou A, 2005, ACT NEUR S, V95, P277; Marshall LF, 2000, NEUROSURGERY, V47, P546, DOI 10.1097/00006123-200009000-00002; MATHER HM, 1981, J NEUROL NEUROSUR PS, V44, P216, DOI 10.1136/jnnp.44.3.216; Maybauer MO, 2008, BEST PRACT RES-CLIN, V22, P253, DOI 10.1016/j.bpa.2008.03.003; MOHRING J, 1978, CIRC RES, V42, P17, DOI 10.1161/01.RES.42.1.17; NAGAO S, 1994, ACTA NEUROCHIR, P502; Papadopoulos MC, 2004, FASEB J, V18, P1291, DOI 10.1096/fj.04-1723fje; Pascale CL, 2006, J PHYSIOL PHARMACOL, V57, P161; Pearl GS, 1998, CLIN LAB MED, V18, P39; RAICHLE ME, 1978, BRAIN RES, V143, P191, DOI 10.1016/0006-8993(78)90766-7; Rauen K, 2013, J NEUROTRAUM, V30, P1442, DOI 10.1089/neu.2012.2807; ROSENBERG GA, 1992, STROKE, V23, P1767, DOI 10.1161/01.STR.23.12.1767; Shuaib A, 2002, STROKE, V33, P3033, DOI 10.1161/01.STR.0000039405.31526.06; SORENSEN PS, 1984, ANN NEUROL, V15, P435, DOI 10.1002/ana.410150506; Szmydynger-Chodobska J, 2004, J NEUROTRAUM, V21, P1090, DOI 10.1089/0897715041651033; Terpolilli NA, 2009, J NEUROTRAUM, V26, P1963, DOI 10.1089/neu.2008.0853; Trabold R, 2008, J NEUROTRAUM, V25, P1459, DOI 10.1089/neu.2008.0597; Vakili A, 2005, J CEREBR BLOOD F MET, V25, P1012, DOI 10.1038/sj.jcbfm.9600097; ZLOKOVIC BV, 1990, BIOCHIM BIOPHYS ACTA, V1025, P191, DOI 10.1016/0005-2736(90)90097-8; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102; Zweckberger K, 2006, J NEUROTRAUM, V23, P1083, DOI 10.1089/neu.2006.23.1083	51	15	15	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	APR	2017	34	7					1329	1336		10.1089/neu.2016.4514			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ER0FB	WOS:000398461600004	27762660				2022-02-06	
J	Liras, IN; Caplan, HW; Stensballe, J; Wade, CE; Cox, CS; Cotton, BA				Liras, Ioannis N.; Caplan, Henry W.; Stensballe, Jakob; Wade, Charles E.; Cox, Charles S.; Cotton, Bryan A.			Prevalence and Impact of Admission Acute Traumatic Coagulopathy on Treatment Intensity, Resource Use, and Mortality: An Evaluation of 956 Severely Injured Children and Adolescents	JOURNAL OF THE AMERICAN COLLEGE OF SURGEONS			English	Article; Proceedings Paper	128th Annual Meeting of the Southern-Surgical-Association	DEC, 2016	Palm Beach, FL	So Surg Assoc			PEDIATRIC TRAUMA; BRAIN-INJURY; RAPID THROMBELASTOGRAPHY; HEAD TRAUMA; OUTCOMES; SHOCK	BACKGROUND: Acute coagulopathy of trauma in children is of potential importance to clinical outcomes, but knowledge is limited and has only been investigated using conventional coagulation testing. The purpose of this study was to assess the prevalence and impact of arrival coagulopathy, determined by viscoelastic hemostatic testing, in severely injured children. STUDY DESIGN: Pediatric patients (younger than 17 years of age) who were admitted January 2010 to May 2016 and met highest-level trauma activation were included. Patients were divided into 2 groups (coagulopathy and controls) based on arrival rapid thrombelastography values. Coagulopathy was defined as the presence of any of the following on rapid thrombelastography: activated clotting time >= 128 seconds, alpha-angle <= 65 degrees, maximum amplitude <= 55 mm, and lysis at 30 minutes from 20-mm amplitude >= 3%. Logistic regression was used to adjust for age, sex, blood pressure, mechanism, and injury severity. RESULTS: Nine hundred and fifty-six patients met inclusion; 507 (57%) were coagulopathic and 449 (43%) were not (noncoagulopathic and control cohort). Coagulopathic patients were younger (median 14 vs 15 years) and more likely to be male (68% vs 60%) and Hispanic (38% vs 31%) (all p < 0.05). Coagulopathic patients received more RBC and plasma transfusions and had fewer ICU and ventilator-free days and higher mortality (12% vs 3%; all p < 0.05). Of these 956, 197 (21%) sustained severe brain injury-123 (62%) were coagulopathic and 74 (38%) were noncoagulopathic. The mortality difference was even greater for coagulopathic head injuries (31% vs 10%; p = 0.002). Adjusting for confounders, admission coagulopathy was an independent predictor of death, with an odds ratio of 3.67 (95% CI 1.768 to 7.632; p < 0.001). CONCLUSIONS: Almost 60% of severely injured children and adolescents arrive with evidence of acute traumatic coagulopathy. The presence of admission coagulopathy is associated with high mortality in children, especially among those with head injuries. (C) 2017 by the American College of Surgeons. Published by Elsevier Inc. All rights reserved.)	[Liras, Ioannis N.; Caplan, Henry W.; Wade, Charles E.; Cotton, Bryan A.] McGovern Med Sch, Dept Surg, Houston, TX USA; [Wade, Charles E.; Cotton, Bryan A.] Ctr Translat Injury Res, 6410 Fannin St,1100-20 UPB, Houston, TX 77030 USA; [Cox, Charles S.] McGovern Med Sch, Dept Pediat Surg, Houston, TX USA; [Cox, Charles S.] McGovern Med Sch, Ctr Surg Trials & Evidence Based Practice, Houston, TX USA; [Stensballe, Jakob] Capital Reg Blood Bank, Transfus Med Sect, Copenhagen, Denmark; [Stensballe, Jakob] Rigshosp, Copenhagen Univ Hosp, Dept Anesthesia, Ctr Head & Orthoped, Copenhagen, Denmark		Cotton, BA (corresponding author), Ctr Translat Injury Res, 6410 Fannin St,1100-20 UPB, Houston, TX 77030 USA.	bryan.a.cotton@uth.tmc.edu		Caplan, Henry/0000-0003-0012-1606			Affonseca CA, 2007, J PEDIAT-BRAZIL, V83, P274, DOI 10.1590/S0021-75572007000400014; Calkins CM, 2002, J TRAUMA, V53, P1058, DOI 10.1097/00005373-200212000-00005; Centers for Disease Control and Prevention, 2014, REP C TRAUM BRAIN IN; Centers for Disease Control and Prevention, 2013, 10 LEAD CAUS DEATH A; Chiaretti A, 2001, PEDIATR NEUROSURG, V34, P131, DOI 10.1159/000056008; Christiaans SC, 2014, SHOCK, V41, P476, DOI 10.1097/SHK.0000000000000151; Cohen MJ, 2013, J TRAUMA ACUTE CARE, V75, pS40, DOI 10.1097/TA.0b013e31828fa43d; Hendrickson JE, 2012, J PEDIATR-US, V160, P204, DOI 10.1016/j.jpeds.2011.08.019; Holcomb JB, 2012, ANN SURG, V256, P476, DOI 10.1097/SLA.0b013e3182658180; Hollingworth W, 2007, PEDIATR CRIT CARE ME, V8, P348, DOI 10.1097/01.PCC.0000270837.66217.3B; Imam AM, 2013, J TRAUMA ACUTE CARE, V75, P976, DOI 10.1097/TA.0b013e31829e2186; Kunitake RC, 2017, J TRAUMA ACUTE CARE, V82, P302, DOI 10.1097/TA.0000000000001313; Lao ZQ, 2012, INT J PREVENTIVE MED, V3, P303; Lee TH, 2014, J TRAUMA ACUTE CARE, V77, P67, DOI 10.1097/TA.0000000000000255; Leeper CM, 2016, J TRAUMA ACUTE CARE, V81, P34, DOI 10.1097/TA.0000000000001002; Leeper CM, 2016, J TRAUMA ACUTE CARE, V80, P711, DOI 10.1097/TA.0000000000000954; Liras IN, 2016, J TRAUMA ACUTE CARE, V80, P778, DOI 10.1097/TA.0000000000000985; Liras IN, 2015, SURGERY, V158, P812, DOI 10.1016/j.surg.2015.05.004; Maegele M, 2013, TRANSFUSION, V53, p28S, DOI 10.1111/trf.12033; Marton E, 2007, CHILD NERV SYST, V23, P873, DOI 10.1007/s00381-007-0314-9; Moore HB, 2016, J AM COLL SURGEONS, V222, P347, DOI 10.1016/j.jamcollsurg.2016.01.006; Nystrup KB, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0097-z; Patregnani JT, 2012, PEDIATR CRIT CARE ME, V13, P273, DOI 10.1097/PCC.0b013e31822f1727; Shore PM, 2006, CRIT CARE MED, V34, P1981, DOI 10.1097/01.CCM.0000220765.22184.ED; Sixta SL, 2015, J NEUROL NEUROPHYSIO, V06; Spinella PC, 2009, BLOOD REV, V23, P231, DOI 10.1016/j.blre.2009.07.003; Stensballe J, 2016, CURR OPIN CRIT CARE, V22, P591, DOI 10.1097/MCC.0000000000000359; Strumwasser A, 2016, J TRAUMA ACUTE CARE, V81, P312, DOI 10.1097/TA.0000000000001060; Suominen P, 1998, INJURY, V29, P425; White NJ, 2015, J THROMB HAEMOST, V13, P978, DOI 10.1111/jth.12919; Whittaker B, 2013, SHOCK, V39, P421, DOI 10.1097/SHK.0b013e31828e08cb	31	15	15	0	1	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1072-7515	1879-1190		J AM COLL SURGEONS	J. Am. Coll. Surg.	APR	2017	224	4					625	632		10.1016/j.jamcollsurg.2016.12.046			8	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	EW4SR	WOS:000402491700044	28131925				2022-02-06	
J	Munoz, MJ; Kumar, RG; Oh, BM; Conley, YP; Wang, ZS; Failla, MD; Wagner, AK				Munoz, Miranda J.; Kumar, Raj G.; Oh, Byung-Mo; Conley, Yvette P.; Wang, Zhensheng; Failla, Michelle D.; Wagner, Amy K.			Cerebrospinal Fluid Cortisol Mediates Brain-Derived Neurotrophic Factor Relationships to Mortality after Severe TBI: A Prospective Cohort Study	FRONTIERS IN MOLECULAR NEUROSCIENCE			English	Article						cortisol; BDNF; TBI; biomarkers; genetics; cerebrospinal fluid	HEART-RATE-VARIABILITY; MESSENGER-RNA EXPRESSION; AGE-RELATED-CHANGES; VAL66MET POLYMORPHISM; RAT HIPPOCAMPUS; LIFE-SPAN; GLUCOCORTICOIDS MODULATE; PROGNOSTIC BIOMARKER; OUTCOME PREDICTION; AGING HIPPOCAMPUS	Distinct regulatory signaling mechanisms exist between cortisol and brain derived neurotrophic factor (BDNF) that may influence secondary injury cascades associated with traumatic brain injury (TBI) and predict outcome. We investigated concurrent CSF BDNF and cortisol relationships in 117 patients sampled days 0-6 after severe TBI while accounting for BDNF genetics and age. We also determined associations between CSF BDNF and cortisol with 6-month mortality. BDNF variants, rs6265 and rs7124442, were used to create a gene risk score (GRS) in reference to previously published hypothesized risk for mortality in "younger patients" (<48 years) and hypothesized BDNF production/secretion capacity with these variants. Group based trajectory analysis (TRAJ) was used to create two cortisol groups (high and low trajectories). A Bayesian estimation approach informed the mediation models. Results show CSF BDNF predicted patient cortisol TRAJ group (P = 0.001). Also, GRS moderated BDNF associations with cortisol TRAJ group. Additionally, cortisol TRAJ predicted 6-month mortality (P = 0.001). In a mediation analysis, BDNF predicted mortality, with cortisol acting as the mediator (P = 0.011), yielding a mediation percentage of 29.92%. Mediation effects increased to 45.45% among younger patients. A BDNF*GRS interaction predicted mortality in younger patients (P = 0.004). Thus, we conclude 6-month mortality after severe TBI can be predicted through a mediation model with CSF cortisol and BDNF, suggesting a regulatory role for cortisol with BDNF's contribution to TBI pathophysiology and mortality, particularly among younger individuals with severe TBI. Based on the literature, cortisol modulated BDNF effects on mortality after TBI may be related to known hormone and neurotrophin relationships to neurological injury severity and autonomic nervous system imbalance.	[Munoz, Miranda J.; Kumar, Raj G.; Oh, Byung-Mo; Conley, Yvette P.; Wagner, Amy K.] Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA; [Munoz, Miranda J.] Carnegie Mellon Univ, Dept Biol Sci, Pittsburgh, PA USA; [Kumar, Raj G.; Conley, Yvette P.] Univ Pittsburgh, Dept Epidemiol, Pittsburgh, PA USA; [Oh, Byung-Mo] Seoul Natl Univ Hosp, Dept Rehabil Med, Seoul, South Korea; [Wang, Zhensheng] Univ Pittsburgh, Dept Nursing, Pittsburgh, PA USA; [Wang, Zhensheng; Wagner, Amy K.] Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Failla, Michelle D.] Vanderbilt Univ Sch Med, Dept Psychiat, Nashville, TN USA; [Wagner, Amy K.] Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA; [Wagner, Amy K.] Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA USA		Wagner, AK (corresponding author), Univ Pittsburgh, Dept Phys Med & Rehabil, Pittsburgh, PA USA.; Wagner, AK (corresponding author), Univ Pittsburgh, Safar Ctr Resuscitat Res, Pittsburgh, PA USA.; Wagner, AK (corresponding author), Univ Pittsburgh, Dept Neurosci, Pittsburgh, PA USA.; Wagner, AK (corresponding author), Univ Pittsburgh, Ctr Neurosci, Pittsburgh, PA USA.	wagnerak@upmc.edu	Failla, Michelle/AAI-3788-2021	Failla, Michelle/0000-0001-9734-3373; Munoz, Miranda/0000-0002-3782-6530; Conley, Yvette/0000-0002-1784-6067	Department of DefenseUnited States Department of Defense [DODW81XWH-071-0701]; National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01 HD048162, R01NR008424, 5P01NS030318]; Centers for Disease Control (CDC)United States Department of Health & Human ServicesCenters for Disease Control & Prevention - USA [R49 CCR 323155]; National Institute for Disability, Independent Living, and Rehabilitation Research [NIDILRR 90DP0041]	This work was supported in part by the Department of Defense (DODW81XWH-071-0701); National Institutes of Health (NIH R01 HD048162, R01NR008424, 5P01NS030318; Centers for Disease Control (CDC) R49 CCR 323155); National Institute for Disability, Independent Living, and Rehabilitation Research (NIDILRR 90DP0041).	Alboni S, 2011, NEUROPHARMACOLOGY, V60, P1337, DOI 10.1016/j.neuropharm.2011.01.050; Alexander N, 2010, PSYCHONEUROENDOCRINO, V35, P949, DOI 10.1016/j.psyneuen.2009.12.008; Antonawich FJ, 1999, NEUROSCIENCE, V88, P319, DOI 10.1016/S0306-4522(98)00213-9; Arango-Lievano M, 2015, P NATL ACAD SCI USA, V112, P15737, DOI 10.1073/pnas.1509045112; Armbruster D, 2016, PSYCHONEUROENDOCRINO, V66, P39, DOI 10.1016/j.psyneuen.2015.12.020; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Barnes P. J., 1979, CLIN SCI LOND ENGL, V94, P557; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Blaha GR, 2000, NEUROSCIENCE, V99, P483, DOI 10.1016/S0306-4522(00)00214-1; Caporali A, 2009, PHYSIOL REV, V89, P279, DOI 10.1152/physrev.00007.2008; Centers for Disease Control and Prevention, 2016, TRAUMATIC BRAIN INJU; Chen X, 2005, NEUROSCIENCE, V135, P11, DOI 10.1016/j.neuroscience.2005.05.041; Clark CG, 2011, J NEUROSCI, V31, P12318, DOI 10.1523/JNEUROSCI.0746-11.2011; Duman RS, 1997, ARCH GEN PSYCHIAT, V54, P597; Egan MF, 2003, CELL, V112, P257, DOI 10.1016/S0092-8674(03)00035-7; Erickson KI, 2012, NEUROSCIENTIST, V18, P82, DOI 10.1177/1073858410397054; Failla MD, 2016, NEUROREHAB NEURAL RE, V30, P83, DOI 10.1177/1545968315586465; Failla MD, 2015, NEUROREHAB NEURAL RE, V29, P234, DOI 10.1177/1545968314542617; Ferrari E, 2001, EUR J ENDOCRINOL, V144, P319, DOI 10.1530/eje.0.1440319; Freedman ML, 2004, NAT GENET, V36, P388, DOI 10.1038/ng1333; Fujimura H, 2002, THROMB HAEMOSTASIS, V87, P728; Gomes JR, 2012, J NEUROSCI, V32, P4610, DOI 10.1523/JNEUROSCI.0374-12.2012; Goyal A, 2013, J NEUROTRAUM, V30, P946, DOI 10.1089/neu.2012.2579; Grundy PL, 2000, NEUROREPORT, V11, P3381, DOI 10.1097/00001756-200010200-00023; Grundy PL, 2001, BRAIN RES, V892, P386, DOI 10.1016/S0006-8993(00)03258-3; Hamra G, 2013, INT J EPIDEMIOL, V42, P627, DOI 10.1093/ije/dyt043; Hicks RR, 1997, MOL BRAIN RES, V48, P401, DOI 10.1016/S0169-328X(97)00158-7; Janssens ACJW, 2011, ANN INTERN MED, V154, P421, DOI 10.7326/0003-4819-154-6-201103150-00008; Jeanneteau F, 2008, P NATL ACAD SCI USA, V105, P4862, DOI 10.1073/pnas.0709102105; Jeanneteau FD, 2012, P NATL ACAD SCI USA, V109, P1305, DOI 10.1073/pnas.1114122109; Joels M, 2008, EUR J PHARMACOL, V583, P312, DOI 10.1016/j.ejphar.2007.11.064; Kennedy KM, 2009, FRONT HUM NEUROSCI, V3, DOI 10.3389/neuro.09.019.2009; Kim JM, 2011, NEUROBIOL AGING, V32, DOI 10.1016/j.neurobiolaging.2010.01.018; Kumamaru E, 2008, MOL ENDOCRINOL, V22, P546, DOI 10.1210/me.2007-0264; Kumamaru E, 2011, FEBS LETT, V585, P3224, DOI 10.1016/j.febslet.2011.09.010; Kumar RG, 2015, BRAIN BEHAV IMMUN, V45, P253, DOI 10.1016/j.bbi.2014.12.021; Kumar RG, 2016, BRAIN BEHAV IMMUN, V53, P183, DOI 10.1016/j.bbi.2015.12.008; Liston C, 2011, P NATL ACAD SCI USA, V108, P16074, DOI 10.1073/pnas.1110444108; Maas AIR, 2010, NEUROTHERAPEUTICS, V7, P115, DOI 10.1016/j.nurt.2009.10.022; Marmigere F, 2003, HIPPOCAMPUS, V13, P646, DOI 10.1002/hipo.10109; McEwen BS, 2015, P NATL ACAD SCI USA, V112, P15544, DOI 10.1073/pnas.1521416112; McEwen BS, 2012, DEV NEUROBIOL, V72, P878, DOI 10.1002/dneu.20968; McEwen BS, 1999, FRONT NEUROENDOCRIN, V20, P49, DOI 10.1006/frne.1998.0173; Morris JA, 2007, J AM COLL SURGEONS, V204, P885, DOI 10.1016/j.jamcollsurg.2007.01.019; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; Nakahashi T, 2000, FEBS LETT, V470, P113, DOI 10.1016/S0014-5793(00)01302-8; Nettiksimmons J, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091339; Niyonkuru C, 2013, J NEUROTRAUM, V30, P938, DOI 10.1089/neu.2012.2578; Notaras MJ, 2017, SCHIZOPHRENIA BULL, V43, P665, DOI 10.1093/schbul/sbw077; Numakawa T, 2009, P NATL ACAD SCI USA, V106, P647, DOI 10.1073/pnas.0800888106; Orefice LL, 2013, J NEUROSCI, V33, P11618, DOI 10.1523/JNEUROSCI.0012-13.2013; Pal R, 2014, AGE, V36, DOI 10.1007/s11357-014-9683-7; Ranganathan P, 2016, BRAIN INJURY, V30, P452, DOI 10.3109/02699052.2016.1144081; Revest JM, 2014, MOL PSYCHIATR, V19, P1001, DOI 10.1038/mp.2013.134; Romanczyk TB, 2002, EUR J NEUROSCI, V15, P269, DOI 10.1046/j.0953-816x.2001.01858.x; Roozenbeek B, 2012, J NEUROTRAUM, V29, P1306, DOI 10.1089/neu.2011.1988; Rostami E, 2014, BRAIN RES, V1542, P195, DOI 10.1016/j.brainres.2013.10.047; Rothman SM, 2013, NEUROSCIENCE, V239, P228, DOI 10.1016/j.neuroscience.2012.10.014; Ryan ML, 2011, J TRAUMA, V70, P1371, DOI 10.1097/TA.0b013e31821858e6; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Santarsieri M, 2014, J NEUROTRAUM, V31, P699, DOI 10.1089/neu.2013.3177; Sapolsky RM, 2000, ENDOCR REV, V21, P55, DOI 10.1210/er.21.1.55; Schule C, 2006, PSYCHONEUROENDOCRINO, V31, P1019, DOI 10.1016/j.psyneuen.2006.06.002; Sebastiani A, 2015, J NEUROTRAUM, V32, P1599, DOI 10.1089/neu.2014.3751; SMITH MA, 1995, J NEUROSCI, V15, P1768, DOI 10.1523/JNEUROSCI.15-03-01768.1995; Stranahan AM, 2011, NEUROENDOCRINOLOGY, V93, P58, DOI 10.1159/000322808; TANNO H, 1992, J NEUROTRAUM, V9, P21, DOI 10.1089/neu.1992.9.21; Tapia-Arancibia L, 2004, FRONT NEUROENDOCRIN, V25, P77, DOI 10.1016/j.yfrne.2004.04.001; Tapia-Arancibia L, 2008, BRAIN RES REV, V59, P201, DOI 10.1016/j.brainresrev.2008.07.007; Vidaurre OG, 2012, CELL DEATH DIS, V3, DOI 10.1038/cddis.2011.143; Wagner AK, 2005, CRIT CARE MED, V33, P407, DOI 10.1097/01.CCM.0000153931.23488.DD; Wagner AK, 2007, J NEUROSURG, V106, P538, DOI 10.3171/jns.2007.106.4.538; Wagner AK, 2011, J CEREBR BLOOD F MET, V31, P1886, DOI 10.1038/jcbfm.2011.31; Wagner AK, 2011, J NEUROTRAUM, V28, P871, DOI 10.1089/neu.2010.1586; Webster MJ, 2006, GENE EXPR PATTERNS, V6, P941, DOI 10.1016/j.modgep.2006.03.009; Werdan K, 2009, CAN J PHYSIOL PHARM, V87, P266, DOI 10.1139/Y09-012; Yang AC, 2010, AM J MED GENET B, V153B, P1024, DOI 10.1002/ajmg.b.31069; Yang K, 1996, J NEUROSCI RES, V44, P157, DOI 10.1002/(SICI)1097-4547(19960415)44:2<157::AID-JNR8>3.0.CO;2-C; Yeager MP, 2004, ACTA ANAESTH SCAND, V48, P799, DOI 10.1111/j.1399-6576.2004.00434.x	79	15	18	1	5	FRONTIERS MEDIA SA	LAUSANNE	AVENUE DU TRIBUNAL FEDERAL 34, LAUSANNE, CH-1015, SWITZERLAND	1662-5099			FRONT MOL NEUROSCI	Front. Molec. Neurosci.	MAR 9	2017	10								44	10.3389/fnmol.2017.00044			16	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EN1QX	WOS:000395786000001	28337122	gold, Green Published			2022-02-06	
J	Brandel, MG; Hirshman, BR; McCutcheon, BA; Tringale, K; Carroll, K; Richtand, NM; Perry, W; Chen, CC; Carter, BS				Brandel, Michael G.; Hirshman, Brian R.; McCutcheon, Brandon A.; Tringale, Kathryn; Carroll, Kate; Richtand, Neil M.; Perry, William; Chen, Clark C.; Carter, Bob S.			The Association between Psychiatric Comorbidities and Outcomes for Inpatients with Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						mortality; OSHPD; outcomes; psychiatric comorbidities; TBI	HOSPITAL MORTALITY; SCHIZOPHRENIA; DISORDERS; GLUTAMATE; HEALTH; REHABILITATION; COMPLICATIONS; DEPRESSION; DISCHARGE; RELEASE	It is well established that traumatic brain injury (TBI) is associated with the development of psychiatric disorders. However, the impact of psychiatric disorders on TBI outcome is less well understood. We examined the outcomes of patients who experienced a traumatic subdural hemorrhage and whether a comorbid psychiatric disorder was associated with a change in outcome. A retrospective observational study was performed in the California Office of Statewide Health Planning and Development (OSHPD) and the Nationwide Inpatient Sample (NIS). Patients hospitalized for acute subdural hemorrhage were identified using International Classification of Diseases, Ninth Revision (ICD-9) diagnosis codes. Patients with coexisting psychiatric diagnoses were identified. Outcomes studied included mortality and adverse discharge disposition. In OSPHD, diagnoses of depression (OR=0.64, p<0.001), bipolar disorder (OR=0.45, p<0.05), and anxiety (OR=0.37, p<0.001) were associated with reduced mortality during hospitalization for TBI, with a trend toward psychosis (OR=0.56, p=0.08). Schizophrenia had no effect. Diagnoses of psychosis (OR=2.12, p<0.001) and schizophrenia (OR=2.60, p<0.001) were associated with increased adverse discharge. Depression and bipolar disorder had no effect, and anxiety was associated with reduced adverse discharge (OR=0.73, p=0.01). Results were confirmed using the NIS. Analysis revealed novel associations between coexisting psychiatric diagnoses and TBI outcomes, with some subgroups having decreased mortality and increased adverse discharge. Potential mechanisms include pharmacological effects of frequently prescribed psychiatric medications, the pathophysiology of individual psychiatric disorders, or under-coding of psychiatric illness in the most severely injured patients. Because pharmacological mechanisms, if validated, might lead to improved outcome in TBI patients, further studies may provide significant public health benefit.	[Brandel, Michael G.; Hirshman, Brian R.; Tringale, Kathryn; Carroll, Kate] Univ Calif San Diego, Sch Med, La Jolla, CA 92093 USA; [Chen, Clark C.; Carter, Bob S.] Univ Calif San Diego, Dept Neurosurg, La Jolla, CA 92093 USA; [Hirshman, Brian R.] Carnegie Mellon Univ, Sch Comp Sci, Pittsburgh, PA 15213 USA; [McCutcheon, Brandon A.] Mayo Clin, Dept Neurol Surg, Rochester, MN USA; [McCutcheon, Brandon A.] Mayo Clin Fdn, Rochester, MN USA; [Richtand, Neil M.; Perry, William] Univ Calif San Diego, Dept Psychiat, San Diego, CA 92103 USA; [Richtand, Neil M.] VA San Diego Healthcare Syst, Psychiat Serv, San Diego, CA USA		Carter, BS (corresponding author), Univ Calif San Diego, 3855 Hlth Sci Dr,MC 0987, La Jolla, CA 92093 USA.	bobcarter@ucsd.edu	Carter, Bob/AAB-4868-2021	Carter, Bob/0000-0002-3586-1324	Czech Duck Research Fellowship	We thank Dr. Hoi Sang U for his guidance and endowment of the Czech Duck Research Fellowship, which funded this project.	Abrams TE, 2008, J GEN INTERN MED, V23, P317, DOI 10.1007/s11606-008-0518-z; Aghajanian GK, 2000, BRAIN RES REV, V31, P302, DOI 10.1016/S0165-0173(99)00046-6; Albrecht JS, 2012, AM J MED QUAL, V27, P503, DOI 10.1177/1062860612436576; Andelic Nada, 2010, J Trauma Manag Outcomes, V4, P6, DOI 10.1186/1752-2897-4-6; Berends AC, 2005, CNS DRUG REV, V11, P379; Boland RJ, 1996, GEN HOSP PSYCHIAT, V18, P28, DOI 10.1016/0163-8343(95)00089-5; Brennan JH, 2015, J CLIN NEUROSCI, V22, P1928, DOI 10.1016/j.jocn.2015.05.034; Cantu D, 2015, CEREB CORTEX, V25, P2306, DOI 10.1093/cercor/bhu041; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; CORRIGAN JD, 1995, ARCH PHYS MED REHAB, V76, P302, DOI 10.1016/S0003-9993(95)80654-7; Daumit GL, 2006, ARCH GEN PSYCHIAT, V63, P267, DOI 10.1001/archpsyc.63.3.267; Dawodu ST, 2015, TRAUMATIC BRAIN INJU; Diaz AP, 2012, J NEUROTRAUM, V29, P1029, DOI 10.1089/neu.2011.2089; Dossa A, 2011, BMC HEALTH SERV RES, V11, DOI 10.1186/1472-6963-11-311; Fatemi SH, 2015, SCHIZOPHR RES, V167, P42, DOI 10.1016/j.schres.2014.10.010; Feinberg M, 2015, SEMIN NEUROL, V35, P50, DOI 10.1055/s-0035-1544244; FRENK H, 1983, BRAIN RES REV, V6, P197, DOI 10.1016/0165-0173(83)90039-5; Graham DP, 2008, ANN NY ACAD SCI, V1141, P148, DOI 10.1196/annals.1441.029; Hammond FM, 2015, ARCH PHYS MED REHAB, V96, pS256, DOI 10.1016/j.apmr.2015.01.025; Hoang U, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5422; Hoffman S, 2013, J LAW MED ETHICS, V41, P56, DOI 10.1111/jlme.12040; IEZZONI LI, 1992, JAMA-J AM MED ASSOC, V267, P2197, DOI 10.1001/jama.267.16.2197; Javitt DC, 2010, ISR J PSYCHIATR REL, V47, P4; JENCKS SF, 1988, JAMA-J AM MED ASSOC, V260, P2240, DOI 10.1001/jama.260.15.2240; Kendler KS, 2010, ARCH GEN PSYCHIAT, V67, P1120, DOI 10.1001/archgenpsychiatry.2010.136; Kokiko ON, 2007, BRAIN INJURY, V21, P259, DOI 10.1080/02699050701209964; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; MARGOLIS RL, 1994, PSYCHOSOMATICS, V35, P485, DOI 10.1016/S0033-3182(94)71743-6; Meller R, 2002, J NEUROSCI RES, V67, P399, DOI 10.1002/jnr.10126; Meyer JM, 2009, ACTA PSYCHIAT SCAND, V119, P4, DOI 10.1111/j.1600-0447.2008.01317.x; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Patil CG, 2007, CANCER, V110, P625, DOI 10.1002/cncr.22819; Phelps TI, 2015, J NEUROTRAUM, V32, P590, DOI 10.1089/neu.2014.3711; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Prina AM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0034821; Rathore SS, 2008, ARCH GEN PSYCHIAT, V65, P1402, DOI 10.1001/archpsyc.65.12.1402; ROMANO PS, 1993, J CLIN EPIDEMIOL, V46, P1075, DOI 10.1016/0895-4356(93)90103-8; Sela-Kaufman M, 2013, J CLIN EXP NEUROPSYC, V35, P584, DOI 10.1080/13803395.2013.799123; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; Wang SJ, 2005, SYNAPSE, V55, P156, DOI 10.1002/syn.20104; Watkins LL, 2013, J AM HEART ASSOC, V2, DOI 10.1161/JAHA.112.000068; YAMAMOTO BK, 1992, J NEUROCHEM, V58, P1736, DOI 10.1111/j.1471-4159.1992.tb10048.x	42	15	15	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR 1	2017	34	5					1005	1016		10.1089/neu.2016.4504			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	EM6EI	WOS:000395405200005	27573722				2022-02-06	
J	Carlson, SW; Yan, H; Dixon, CE				Carlson, Shaun W.; Yan, Hong; Dixon, C. Edward			Lithium increases hippocampal SNARE protein abundance after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; Synapse; SNARE; Hippocampus; Cognition; Vesicle	CONTROLLED CORTICAL IMPACT; SYNAPTIC VESICLE DOCKING; CYSTEINE STRING PROTEIN; REDUCED EVOKED RELEASE; IN-VITRO; RAT-BRAIN; NEUROTROPHIC FACTOR; MESSENGER-RNA; KNOCKOUT MICE; CSP-ALPHA	Rodent models of traumatic brain injury (TBI) reproduce secondary injury sequela and cognitive impairments observed in patients afflicted by a TBI. Impaired neurotransmission has been reported in the weeks following experimental TBI, and may be a contributor to behavioral dysfunction. The soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) complex, the machinery facilitating vesicular docking and fusion, is a highly-conserved mechanism important for neurotransmission. Following TBI, there is a reduction in both the formation of the SNARE complex and the abundance of multiple SNARE proteins, including the chaperone protein cysteine string protein alpha (CSP alpha). Treatment with lithium in na ve rats reportedly increases the expression of CSPa. In the context of TBI, brain-injured rats treated with lithium exhibit improved outcome in published reports, but the mechanisms underlying the improvement are poorly understood. The current study evaluated the effect of lithium administration on the abundance of SNARE proteins and SNARE complex formation, hemispheric tissue loss, and neurobehavioral performance following controlled cortical impact (CCI). Sprague Dawley rats were subjected to CCI or sham injury, and treated daily with lithium chloride or vehicle for up to 14 days. Administration of lithium after TBI modestly improved spatial memory at 14 days post-injury. Semi-quantitative immunoblot analysis of hippocampal lysates revealed that treatment with lithium attenuated reductions in key SNARE proteins and SNARE complex formation at multiple time points post-injury. These findings highlight that treatment with lithium increased the abundance of synaptic proteins that facilitate neurotransmission and may contribute to improved cognitive function after TBI. Published by Elsevier Inc.	Univ Pittsburgh, Dept Neurosurg, Safar Ctr Resuscitat Res, Pittsburgh, PA USA; VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA		Dixon, CE (corresponding author), Safar Ctr Resuscitat Res, Dept Neurosurg, 3434 Fifth Ave, Pittsburgh, PA 15260 USA.	dixoec@upmc.edu		Carlson, Shaun/0000-0002-1413-5075	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NIH-NS40125, NIH-NS060672, 1-F32NS090748]; VA Healthcare System [VAI01RX001127]; Walter L. Copeland Fund of The Pittsburgh Foundation [UN2014-73618]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS060672, R01NS091062, R01NS040125, F32NS090748, R01NS079061] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01RX001127] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health [NIH-NS40125 (CED), NIH-NS060672 (CED), 1-F32NS090748 (SWC)] the VA Healthcare System [VAI01RX001127 (CED)] and The Walter L. Copeland Fund of The Pittsburgh Foundation [UN2014-73618 (SWC)].	Bramlett HM, 2016, J NEUROTRAUM, V33, P538, DOI 10.1089/neu.2015.4116; Burre J, 2010, SCIENCE, V329, P1663, DOI 10.1126/science.1195227; Carlson SW, 2016, J NEUROTRAUM, V33, P113, DOI 10.1089/neu.2014.3839; Chandra S, 2005, CELL, V123, P383, DOI 10.1016/j.cell.2005.09.028; Cordeiro ML, 2003, J NEUROSCI RES, V73, P865, DOI 10.1002/jnr.10707; Cordeiro ML, 2000, J NEUROCHEM, V74, P2365, DOI 10.1046/j.1471-4159.2000.0742365.x; Dash PK, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024648; De Ferrari GV, 2003, MOL PSYCHIATR, V8, P195, DOI 10.1038/sj.mp.4001208; DIETRICH WD, 1994, J NEUROTRAUM, V11, P289, DOI 10.1089/neu.1994.11.289; Dixon CE, 2016, J NEUROTRAUM, V33, P553, DOI 10.1089/neu.2015.4122; DIXON CE, 1995, BEHAV BRAIN RES, V70, P125, DOI 10.1016/0166-4328(95)80002-6; Dixon CE, 1997, BRAIN RES, V749, P127, DOI 10.1016/S0006-8993(96)01310-8; Dixon CE, 1996, PHARMACOL BIOCHEM BE, V53, P679, DOI 10.1016/0091-3057(95)02069-1; DIXON CE, 1995, NEUROSCI LETT, V198, P111, DOI 10.1016/0304-3940(95)11979-7; Dixon CE, 1999, J NEUROTRAUM, V16, P109, DOI 10.1089/neu.1999.16.109; Fiorentini A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014382; Fukumoto T, 2001, PSYCHOPHARMACOLOGY, V158, P100, DOI 10.1007/s002130100871; Gao X, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024566; Greten-Harrison B, 2010, P NATL ACAD SCI USA, V107, P19573, DOI 10.1073/pnas.1005005107; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Hinzman JM, 2012, J NEUROTRAUM, V29, P1197, DOI 10.1089/neu.2011.2261; Jacobsen JPR, 2004, BRAIN RES, V1024, P183, DOI 10.1016/j.brainres.2004.07.065; Janezic S, 2013, P NATL ACAD SCI USA, V110, pE4016, DOI 10.1073/pnas.1309143110; Kim YH, 2011, J NEUROSCI RES, V89, P1666, DOI 10.1002/jnr.22700; Levin HS, 1998, CURR OPIN NEUROL, V11, P643, DOI 10.1097/00019052-199812000-00006; Lundin A, 2006, BRAIN INJURY, V20, P799, DOI 10.1080/02699050600744327; Magarinos AM, 1997, P NATL ACAD SCI USA, V94, P14002, DOI 10.1073/pnas.94.25.14002; Noble W, 2005, P NATL ACAD SCI USA, V102, P6990, DOI 10.1073/pnas.0500466102; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Scarr Elizabeth, 2012, Clin Psychopharmacol Neurosci, V10, P25, DOI 10.9758/cpn.2012.10.1.25; Scheff SW, 2005, J NEUROTRAUM, V22, P719, DOI 10.1089/neu.2005.22.719; Schoch S, 2001, SCIENCE, V294, P1117, DOI 10.1126/science.1064335; Sharma M, 2011, NAT CELL BIOL, V13, P30, DOI 10.1038/ncb2131; Shear DA, 2016, J NEUROTRAUM, V33, P523, DOI 10.1089/neu.2015.4115; Shear DA, 2010, J NEUROTRAUM, V27, P1911, DOI 10.1089/neu.2010.1399; Shin SS, 2011, BRAIN RES, V1369, P208, DOI 10.1016/j.brainres.2010.10.096; SMITH DH, 1995, J NEUROTRAUM, V12, P169, DOI 10.1089/neu.1995.12.169; SOLLNER T, 1993, CELL, V75, P409, DOI 10.1016/0092-8674(93)90376-2; Son H, 2003, J NEUROCHEM, V85, P872, DOI 10.1046/j.1471-4159.2003.01725.x; SUDHOF TC, 2011, CSH PERSPECT BIOL, V3, DOI DOI 10.1101/cshperspect.a005637; Truelle JL, 2010, BRAIN INJURY, V24, P1272, DOI 10.3109/02699052.2010.506865; Vardar G, 2016, J NEUROSCI, V36, P7911, DOI 10.1523/JNEUROSCI.1314-16.2016; Wada A, 2005, J PHARMACOL SCI, V99, P307, DOI 10.1254/jphs.CRJ05009X; Wagner AK, 2009, J NEUROCHEM, V108, P986, DOI 10.1111/j.1471-4159.2008.05840.x; Washbourne P, 2002, NAT NEUROSCI, V5, P19, DOI 10.1038/nn783; Wei H, 2001, NEUROSCIENCE, V106, P603, DOI 10.1016/S0306-4522(01)00311-6; Youdim MBH, 2004, NEUROPHARMACOLOGY, V46, P1130, DOI 10.1016/j.neuropharm.2004.02.005; Yu FS, 2013, J NEUROSURG, V119, P766, DOI 10.3171/2013.6.JNS13135; Yu FS, 2012, J NEUROTRAUM, V29, P362, DOI 10.1089/neu.2011.1942; Zhu ZF, 2010, BRAIN RES BULL, V83, P272, DOI 10.1016/j.brainresbull.2010.07.008	50	15	16	1	11	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAR	2017	289						55	63		10.1016/j.expneurol.2016.12.006			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ9JF	WOS:000393541700006	28011122	Green Accepted			2022-02-06	
J	Ellis, MJ; Ritchie, L; Selci, E; Chu, S; McDonald, P; Russell, K				Ellis, Michael J.; Ritchie, Lesley; Selci, Erin; Chu, Stephanie; McDonald, Patrick; Russell, Kelly			Googling Concussion Care: A Critical Appraisal of Online Concussion Healthcare Providers and Practices in Canada	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						concussion; concussion clinic; healthcare provider; online; Google	INTERNATIONAL-CONFERENCE; SPORT; MANAGEMENT; STATEMENT	Background:Concussion is an emerging public health concern, but care of patients with a concussion is presently unregulated in Canada.Methods:Independent, blinded Google Internet searches were conducted for the terms concussion and concussion clinic and each of the Canadian provinces and territories. The first 10 to 15 concussion healthcare providers per province were identified. A critical appraisal of healthcare personnel and services offered on the provider's Web site was conducted.Results:Fifty-eight concussion healthcare providers were identified using this search methodology. Only 40% listed the presence of an on-site medical doctor (M.D.) as a member of the clinical team. Forty-seven percent of concussion healthcare providers advertised access to a concussion clinic, program, or center on their Web site. Professionals designated as team leaders, directors, or presidents among concussion clinics, programs, and centers included a neuropsychologist (15%), sports medicine physician (7%), neurologist (4%), and neurosurgeon (4%). Services offered by providers included baseline testing (67%), physiotherapy (50%), and hyperbaric oxygen therapy (2%).Conclusions:This study indicates that there are numerous concussion healthcare providers in Canada offering diverse services with clinics operated by professionals with varying levels of training in traumatic brain injury. In some cases, the practices of these concussion clinics do not conform to current expert consensus guidelines.	[Ellis, Michael J.; McDonald, Patrick] Canada North Concuss Network, Dept Surg, Winnipeg, MB, Canada; [Ellis, Michael J.; Selci, Erin; Chu, Stephanie; McDonald, Patrick; Russell, Kelly] Canada North Concuss Network, Pediat & Child Hlth, Winnipeg, MB, Canada; [Ellis, Michael J.; McDonald, Patrick] Univ Manitoba, Sect Neurosurg, Canada North Concuss Network, Winnipeg, MB, Canada; [Ellis, Michael J.; Ritchie, Lesley; McDonald, Patrick] Canada North Concuss Network, Pan Concuss Program, Winnipeg, MB, Canada; [Ellis, Michael J.; Selci, Erin; Chu, Stephanie; McDonald, Patrick; Russell, Kelly] Children Hosp Res Inst Manitoba, Canada North Concuss Network, Winnipeg, MB, Canada; [Ritchie, Lesley] Canada North Concuss Network, Clin Hlth Psychol, Winnipeg, MB, Canada		Ellis, MJ (corresponding author), Pan Am Clin, Pan Am Concuss Program, 75 Poseidon Bay, Winnipeg, MB R3M 3E4, Canada.	mellis3@panamclinic.com		Russell, Kelly/0000-0002-9159-9201			Carson J, 2006, CAN FAM PHYSICIAN, V52, P756; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Ellis MJ, 2015, BRAIN INJURY, V29, P238, DOI 10.3109/02699052.2014.965207; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36	7	15	15	1	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	MAR	2017	27	2					179	182		10.1097/JSM.0000000000000305			4	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	EM8PJ	WOS:000395573100013	26867204				2022-02-06	
J	O'Day, KM; Koehling, EM; Vollavanh, LR; Bradney, D; May, JM; Breedlove, KM; Breedlove, EL; Blair, P; Nauman, EA; Bowman, TG				O'Day, Kathleen M.; Koehling, Elizabeth M.; Vollavanh, Lydia R.; Bradney, Debbie; May, James M.; Breedlove, Katherine M.; Breedlove, Evan L.; Blair, Price; Nauman, Eric A.; Bowman, Thomas G.			Comparison of head impact location during games and practices in Division III men's lacrosse players	CLINICAL BIOMECHANICS			English	Article						Sensor; Linear acceleration; Rotational acceleration	COLLEGIATE FOOTBALL PLAYERS; CONCUSSION; ACCELERATIONS; GENDER	Background: Head impacts have been studied extensively in football, but little similar research has been conducted in men's lacrosse. It is important to understand the location and magnitude of head impacts during men's lacrosse to recognize the risk of head injury. Methods: Descriptive epidemiology study set on collegiate lacrosse fields. Eleven men's lacrosse players (age = 20.9 +/- 1.13 years, mass = 83.91 +/- 9.04 kg, height = 179.88 +/- 5.99 cm) volunteered to participate. We applied X2 sensors behind the right ear of participants for games and practices. Sensors recorded data on linear and rotational accelerations and the location of head impacts. We calculated incidence rates per 1000 exposures with 95% confidence intervals for impact locations and compared the effect of impact location on linear and rotational accelerations with Kruskal-Wallis tests. Findings: We verified 167 head impacts (games = 112; practices = 55). During games, the incidence rate was 651.16 (95% confidence interval = 530.57-771.76). The high and low incidence rates for head impact locations during games were: side = 410.7 (95% confidence interval = 292.02-529.41) and top = 26.79 (95% confidence interval = 3.53-57.10). For games and practices combined, the impact locations did not significantly affect linear (chi(2)(3) = 6.69, P = 0.08) or rotational acceleration (chi(2)(3) = 6.34, P = 0.10). Interpretation: We suggest further research into the location of head impacts during games and practices. We also suggest player and coach education on head impacts as well as behavior modification in men's lacrosse athletes to reduce the incidence of impacts to the side of the head in an effort to reduce potential injury. (C) 2017 Elsevier Ltd. All rights reserved.	[O'Day, Kathleen M.; Koehling, Elizabeth M.; Vollavanh, Lydia R.; Bradney, Debbie; Blair, Price; Bowman, Thomas G.] Lynchburg Coll, Lynchburg, VA 24501 USA; [May, James M.] Univ Idaho, Moscow, ID 83843 USA; [Breedlove, Katherine M.; Breedlove, Evan L.; Nauman, Eric A.] Purdue Univ, W Lafayette, IN 47907 USA; [O'Day, Kathleen M.] 289 Railroad Ave, Norwood, MA 02062 USA		O'Day, KM (corresponding author), Lynchburg Coll, Lynchburg, VA 24501 USA.; O'Day, KM (corresponding author), 289 Railroad Ave, Norwood, MA 02062 USA.	koday@marathonphysicaltherapy.com; koehling.e@gmail.com; lvollavanh@gmail.com; bradney@lynchburg.edu; mayj@uidaho.edu; Blair.p@lynchburg.edu; bowman.t@lynchburg.edu	Bowman, Thomas/AAA-3036-2020; Bowman, Tom/AAU-6473-2020	Bowman, Thomas/0000-0002-0034-2946; 			Brainard LL, 2012, MED SCI SPORT EXER, V44, P297, DOI 10.1249/MSS.0b013e31822b0ab4; Breedlove K.M., 2014, ATHL TRAIN SPORTS HL, V6, P1; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Cummiskey B., 2016, J SPORTS ENG TECH, P1; Duma SM, 2005, CLIN J SPORT MED, V15, P3, DOI 10.1097/00042752-200501000-00002; Guskiewicz KM, 2007, NEUROSURGERY, V61, P1244, DOI 10.1227/01.neu.0000306103.68635.1a; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kindschi K., 2014, THESIS; Krasuski JS, 1998, BIOL PSYCHIAT, V43, P60, DOI 10.1016/S0006-3223(97)00013-9; Lincoln AE, 2013, AM J SPORT MED, V41, P756, DOI 10.1177/0363546513476265; Mihalik JP, 2007, NEUROSURGERY, V61, P1229, DOI 10.1227/01.neu.0000306101.83882.c8; Morrison M., 2015, J BIOSENS BIOELECTRO, V6, P1; Nevens D., 2015, PROOCEDIA ENG, V112, P175; Ng TP, 2006, BIOMED SCI INSTRUM, V42, P25; Patton DA, 2016, REV INSTRUMENTED EQU; Pellman EJ, 2003, NEUROSURGERY, V53, P1328, DOI 10.1227/01.NEU.0000093499.20604.21; Reynolds B.B., 2016, J NEUROTRAUMA; Rowson S., 2009, J BIOMECH ENG, V13, P1; Squire LR, 1996, HIPPOCAMPUS, V6, P546; Talavage TM, 2014, J NEUROTRAUM, V31, P327, DOI 10.1089/neu.2010.1512; Trick E., 2013, NCAA SPORTS SPONSORS; Wu LC, 2016, ANN BIOMED ENG, V44, P1234, DOI 10.1007/s10439-015-1423-3	22	15	15	0	5	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	0268-0033	1879-1271		CLIN BIOMECH	Clin. Biomech.	MAR	2017	43						23	27		10.1016/j.clinbiomech.2017.01.013			5	Engineering, Biomedical; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Engineering; Orthopedics; Sport Sciences	ES9DD	WOS:000399855400004	28178579				2022-02-06	
J	Ramirez, S; Bebarta, VS; Varney, SM; Ganem, V; Zarzabal, LA; Potter, JS				Ramirez, Sasha; Bebarta, Vikhyat S.; Varney, Shawn M.; Ganem, Victoria; Zarzabal, Lee A.; Potter, Jennifer S.			Misuse of Prescribed Pain Medication in a Military Population-A Self-Reported Survey to Assess a Correlation With Age, Deployment, Combat Illnesses, or Injury?	AMERICAN JOURNAL OF THERAPEUTICS			English	Article						military; army; opioid misuse; emergency department; toxicology; opioid abuse	PERSONNEL; IRAQ; CONSEQUENCES; AFGHANISTAN; BEHAVIORS; OPIOIDS; ABUSE	Opioid misuse is a growing epidemic among the civilian and military communities. Five hundred prospective, anonymous surveys were collected in the emergency department waiting room of a military tertiary care hospital over 3 weeks. Demographics, medical and military characteristics were investigated for association with opioid use. Univariate logistic models were used to characterize the probability of misuse in relation to the demographic, medical, and military-specific variables. Traumatic brain injury (TBI) and posttraumatic stress disorder were investigated within different age cohorts with adjustment for deployment. The opioid misuse rate disclosed by the subject was 31%. Subjects with TBI were less likely to misuse opioids. We found a trend among younger cohorts to have a higher likelihood for misusing opioids when diagnosed with TBI or posttraumatic stress disorder with history of deployment in the past 5 years. The most common form of misuse was using a previously prescribed medication for a new pain. Traumatic brain injury and/ or enrollment in post-deployment recovery programs maybe protective against opioid misuse. Chronic opioid use among young soldiers maybe viewed as a weakness that could influence opioid misuse. Younger cohorts of active duty service members could be at higher risk for misuse. Efforts to enhance close monitoring of misuse should address these at- risk populations.	[Ramirez, Sasha] San Antonio Mil Med Ctr, Emergency Med, SAUSHEC, San Antonio, TX USA; [Bebarta, Vikhyat S.; Ganem, Victoria; Zarzabal, Lee A.] US Air Force, Enroute Care Res Ctr, San Antonio Mil Med Ctr, San Antonio, TX USA; [Bebarta, Vikhyat S.] Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO 80045 USA; [Varney, Shawn M.] San Antonio Mil Med Ctr, Dept Emergency Med, San Antonio, TX USA; [Potter, Jennifer S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Anesthesiol, Dept Psychiat, Res Program, San Antonio, TX 78229 USA; [Potter, Jennifer S.] Univ Texas Hlth Sci Ctr San Antonio, Dept Anesthesiol, Dept Psychiat, Student Program, San Antonio, TX 78229 USA		Bebarta, VS (corresponding author), Univ Colorado, Sch Med, Dept Emergency Med, Aurora, CO 80045 USA.	Vikhyat.Bebarta@ucdenver.edu	Bebarta, Vikhyat S/M-1513-2015; Potter, Jennifer Sharpe/C-6720-2008	Potter, Jennifer Sharpe/0000-0002-7250-4422	NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [U10DA020024] Funding Source: NIH RePORTER		Adams LL, 2004, J PAIN SYMPTOM MANAG, V27, P440, DOI 10.1016/j.jpainsymman.2003.10.009; Assistant Secretary of Defense (Health Affairs), 2006, DEP DEF SURV HLTH RE; Bebarta VS, 2012, N AM C CLIN TOX OCT; Bray RM, 2010, MIL MED, V175, P390, DOI 10.7205/MILMED-D-09-00132; Centers for Disease Control and Prevention (CDC), 2012, MMWR MORB MORTAL WKL, V61, P10; Chou R, 2009, J PAIN, V10, P131, DOI 10.1016/j.jpain.2008.10.009; Compton WM, 2006, DRUG ALCOHOL DEPEN, V81, P103, DOI 10.1016/j.drugalcdep.2005.05.009; Golub A, 2013, SUBST USE MISUSE, V48, P811, DOI 10.3109/10826084.2013.796988; Hoge CW, 2006, JAMA-J AM MED ASSOC, V295, P1023, DOI 10.1001/jama.295.9.1023; Jeffery DD, 2013, MIL MED, V178, P180, DOI 10.7205/MILMED-D-12-00192; Levy BS, 2013, LANCET, V381, P949, DOI 10.1016/S0140-6736(13)60254-8; Office of the Army Surgeon General, 2010, PAIN MAN TASK FORC F; Seal KH, 2012, JAMA-J AM MED ASSOC, V307, P940, DOI 10.1001/jama.2012.234; Substance Abuse and Mental Health Services Administration, 2012, SURV NAT DRUG US HLT; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1346, DOI 10.1001/jama.2011.369; Volkow ND, 2011, JAMA-J AM MED ASSOC, V305, P1299, DOI 10.1001/jama.2011.401	16	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1075-2765	1536-3686		AM J THER	Am. J. Ther.	MAR-APR	2017	24	2					E150	E156		10.1097/MJT.0000000000000141			7	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	EP8LJ	WOS:000397626600007	26963723				2022-02-06	
J	Scandola, M; Aglioti, SM; Avesani, R; Bertagnoni, G; Marangoni, A; Moro, V				Scandola, Michele; Aglioti, Salvatore Maria; Avesani, Renato; Bertagnoni, Gianettore; Marangoni, Anna; Moro, Valentina			Corporeal illusions in chronic spinal cord injuries	CONSCIOUSNESS AND COGNITION			English	Article						Spinal cord injuries; Corporeal illusions; Embodied cognition theory; Pain; Body representation	RUBBER-HAND ILLUSION; MOTOR IMAGERY; BODY-IMAGE; PARAPLEGIC PATIENTS; PHANTOM SENSATIONS; PERIPERSONAL SPACE; MENTAL ROTATION; ITALIAN VERSION; HUMAN BRAIN; PAIN	While several studies have investigated corporeal illusions in patients who have suffered from a stroke or undergone an amputation, only anecdotal or single case reports have explored this phenomenon after spinal cord injury. Here we examine various different types of bodily misperceptions in a comparatively large group of 49 people with spinal cord injury in the post-acute and chronic phases after the traumatic lesion onset. An extensive battery of questionnaires concerning a variety of body related feelings was administered and the results were correlated to the main clinical variables. Six different typologies of Corporeal Illusion emerged: Sensations of Body Loss; Body-Part Misperceptions; Somatoparaphrenia-like sensations; Disownership-like sensations; Illusory motion and Misoplegia. All of these (with the exception of Misoplegia) are modulated by clinical variables such as pain (visceral, neuropathic and musculoskeletal), completeness of the lesion, level of the lesion and the length of time since lesion onset. In contrast, no significant correlations between bodily illusions and personality variables were found. These results support data indicating that at least some cognitive functions (in particular the body, action and space representations) are embodied and that somatosensory input and motor output may be necessary to build and maintain a typical self-body representation. (C) 2017 Elsevier Inc. All rights reserved.	[Scandola, Michele; Moro, Valentina] Univ Verona, Dept Human Sci, NPsy Lab VR, Verona, Italy; [Scandola, Michele; Aglioti, Salvatore Maria] IRCCS Fdn S Lucia, Rome, Italy; [Aglioti, Salvatore Maria] Univ Roma La Sapienza, Dept Psychol, SCNLab, Rome, Italy; [Avesani, Renato] Sacra Cuore Hosp, Dept Rehabil, Verona, Italy; [Bertagnoni, Gianettore; Marangoni, Anna] San Bortolo Hosp, Dept Funct Recovery & Rehabil, Vicenza, Italy		Scandola, M (corresponding author), Lungadige Porta Vittoria 17, I-37129 Verona, Italy.	michele.scandola@univr.it	Moro, Valentina/AAM-2224-2021; Moro, Valentina/K-6464-2016; Aglioti, Salvatore M/E-9829-2012; Scandola, Michele/D-8107-2013	Moro, Valentina/0000-0002-7119-7264; Moro, Valentina/0000-0002-7119-7264; Scandola, Michele/0000-0003-0853-8975	EU Information and Communication Technologies Grant (VERE project) [FP7-ICT-2009-5, 257695]; Italian Ministry of HealthMinistry of Health, Italy [RF-2010-2312912]; MIUR ItalyMinistry of Education, Universities and Research (MIUR) [PRIN 20159CZFJK]; University of Verona (grant "La rappresentazione del corpo nei soggetti con lesione spinale") [4469, 7220]; Progetto di Avvio alla Ricerca University of Rome "Sapienza" [C26N13TMFT]	We would like to thank Rosanna Mignolli, Anna Scaia, Stefania Amato, Elena Facci and Valeria Gobbetto for their invaluable help. This work was supported by the EU Information and Communication Technologies Grant (VERE project, FP7-ICT-2009-5, Prot. Num. 257695), the Italian Ministry of Health (RF-2010-2312912) and from MIUR Italy (PRIN 20159CZFJK). M.S. was funded by the University of Verona (grant "La rappresentazione del corpo nei soggetti con lesione spinale", Prot. Num. 4469; COOPERINT project 2014, Prot. Num. 7220) and by the Progetto di Avvio alla Ricerca 2013 University of Rome "Sapienza" (Prot. Num. C26N13TMFT).	AGLIOTI S, 1994, NEUROREPORT, V5, P473, DOI 10.1097/00001756-199401120-00026; AGLIOTI S, 1994, P ROY SOC B-BIOL SCI, V255, P273, DOI 10.1098/rspb.1994.0039; Aglioti S, 1997, BEHAV NEUROSCI, V111, P867, DOI 10.1037/0735-7044.111.5.867; Aguilar J, 2010, J NEUROSCI, V30, P7528, DOI 10.1523/JNEUROSCI.0379-10.2010; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Arrighi R, 2011, CURR BIOL, V21, pR910, DOI 10.1016/j.cub.2011.09.048; Berlucchi G, 2010, EXP BRAIN RES, V200, P25, DOI 10.1007/s00221-009-1970-7; BORS E, 1951, AMA ARCH NEUROL PSY, V66, P610, DOI 10.1001/archneurpsyc.1951.02320110075007; Botvinick M, 1998, NATURE, V391, P756, DOI 10.1038/35784; Bouhassira D, 2005, PAIN, V114, P29, DOI 10.1016/j.pain.2004.12.010; Brugger P, 2000, P NATL ACAD SCI USA, V97, P6167, DOI 10.1073/pnas.100510697; Burke C. D., 1969, PAIN PHANTOM SENSATI; Canzoneri E, 2013, SCI REP-UK, V3, DOI 10.1038/srep02844; Caraceni A, 1996, PAIN, V65, P87, DOI 10.1016/0304-3959(95)00156-5; CONOMY JP, 1973, NEUROLOGY, V23, P842, DOI 10.1212/WNL.23.8.842; Conson M, 2008, NEUROPSYCHOLOGIA, V46, P2622, DOI 10.1016/j.neuropsychologia.2008.04.015; Coslett HB, 2010, EUR J PAIN, V14, P1007, DOI 10.1016/j.ejpain.2010.04.001; Cruz VT, 2003, NEUROREHABILITATION, V18, P299; Curt A, 2011, SPINAL CORD, V49, P588, DOI 10.1038/sc.2010.143; Desmond D, 2001, 10 WORLD C INT SOC P; DiStefano C., 2009, PRACTICAL ASSESSMENT, V14, P1, DOI DOI 10.7275/DA8T-4G52; ELBERT T, 1994, NEUROREPORT, V5, P2593, DOI 10.1097/00001756-199412000-00047; ETTLIN TM, 1980, EUR NEUROL, V19, P12, DOI 10.1159/000115122; EVANS JH, 1962, BRAIN, V85, P687, DOI 10.1093/brain/85.4.687; Fiori F, 2013, EXP BRAIN RES, V226, P537, DOI 10.1007/s00221-013-3465-9; Fiori F, 2014, J NEUROPSYCHOL, V8, P199, DOI 10.1111/jnp.12020; Fiorio M, 2006, BRAIN, V129, P47, DOI 10.1093/brain/awh630; FLOR H, 1995, NATURE, V375, P482, DOI 10.1038/375482a0; Freund P, 2013, LANCET NEUROL, V12, P873, DOI 10.1016/S1474-4422(13)70146-7; Freund P, 2011, EUR J NEUROSCI, V34, P1839, DOI 10.1111/j.1460-9568.2011.07895.x; Fuentes CT, 2013, J NEUROL NEUROSUR PS, V84, P201, DOI 10.1136/jnnp-2012-304001; Funk M, 2008, J INT NEUROPSYCH SOC, V14, P81, DOI 10.1017/S1355617708080041; Fusco G, 2016, RESTOR NEUROL NEUROS, V34, P815, DOI 10.3233/RNN-160660; Gandola M, 2012, CORTEX, V48, P1165, DOI 10.1016/j.cortex.2011.06.012; Giummarra MJ, 2010, PERCEPTION, V39, P103, DOI 10.1068/p6519; Glenberg AM, 2015, CAN J EXP PSYCHOL, V69, P165, DOI 10.1037/cep0000056; GUTTMANN L, 1969, HDB CLINICAL NEUROLO, V2, P178; Hatchett P. E., 2016, J SPINAL CORD MED; Head H, 1911, BRAIN, V34, P102, DOI 10.1093/brain/34.2-3.102; Henderson LA, 2011, J NEUROSCI, V31, P2630, DOI 10.1523/JNEUROSCI.2717-10.2011; Hothorn T, 2006, AM STAT, V60, P257, DOI 10.1198/000313006X118430; Invernizzi M, 2010, DISABIL REHABIL, V32, P1194, DOI 10.3109/09638280903437246; Ionta S, 2016, SCI REP-UK, V6, DOI 10.1038/srep20144; Ji RR, 2001, NEUROBIOL DIS, V8, P1, DOI 10.1006/nbdi.2000.0360; KAISER HF, 1958, PSYCHOMETRIKA, V23, P187, DOI 10.1007/BF02289233; Kirshblum SC, 2011, J SPINAL CORD MED, V34, P547, DOI 10.1179/107902611X13186000420242; Knecht S, 1996, BRAIN, V119, P1213, DOI 10.1093/brain/119.4.1213; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Lenggenhager B, 2013, NEUROREHAB NEURAL RE, V27, P704, DOI 10.1177/1545968313491009; Lenggenhager B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050757; Lomman D., 2006, Australasian Physical & Engineering Sciences in Medicine, V29, P62; MacLachlan M, 2003, J REHABIL RES DEV, V40, P59, DOI 10.1682/JRRD.2003.01.0059; Manson GA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0110250; Maravita A, 2003, CURR BIOL, V13, pR531, DOI 10.1016/S0960-9822(03)00449-4; Melzack R., 2006, ANN NY ACAD SCI, V933, P157; Moro V, 2011, BEHAV BRAIN RES, V225, P259, DOI 10.1016/j.bbr.2011.07.010; Nishimura Y, 2009, NEUROSCIENTIST, V15, P436, DOI 10.1177/1073858408331375; Pavani F, 2007, PERCEPTION, V36, P1547, DOI 10.1068/p5853; Perruchoud D, 2016, J NEURAL ENG, V13, DOI 10.1088/1741-2560/13/4/041001; POCKETT S, 1995, ANESTH ANALG, V80, P173, DOI 10.1097/00000539-199501000-00026; R Core Team, 2015, R LANG ENV STAT COMP; Rammstedt B, 2007, J RES PERS, V41, P203, DOI 10.1016/j.jrp.2006.02.001; Revelle W., 2015, PSYCH PROCEDURES PSY, V1; Riddoch G, 1941, BRAIN, V64, P197, DOI 10.1093/brain/64.4.197; Saurat MT, 2011, CONSCIOUS COGN, V20, P1425, DOI 10.1016/j.concog.2011.05.015; Scandola M., PAIN SCALE DIFFERENT; Scandola M, 2017, J NEUROPSYCHOL, V11, P305, DOI 10.1111/jnp.12098; Scandola M, 2016, SCI REP-UK, V6, DOI 10.1038/srep24126; Scandola M, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00404; Sierra M, 2000, PSYCHIAT RES, V93, P153, DOI 10.1016/S0165-1781(00)00100-1; Song YG, 2015, ANN REHABIL MED-ARM, V39, P696, DOI 10.5535/arm.2015.39.5.696; TELLEGEN A, 1974, J ABNORM PSYCHOL, V83, P268, DOI 10.1037/h0036681; Tidoni E, 2014, RESTOR NEUROL NEUROS, V32, P611, DOI 10.3233/RNN-130385; Tieri G, 2015, EXP BRAIN RES, V233, P1247, DOI 10.1007/s00221-015-4202-3; Tieri G, 2015, SCI REP-UK, V5, DOI 10.1038/srep17139; Tsakiris M, 2005, J EXP PSYCHOL HUMAN, V31, P80, DOI 10.1037/0096-1523.31.1.80; Tsakiris M, 2010, NEUROPSYCHOLOGIA, V48, P2740, DOI 10.1016/j.neuropsychologia.2010.05.021; Vocat R, 2010, BRAIN, V133, P3578, DOI 10.1093/brain/awq297; Wickham H, 2009, USE R, P1, DOI 10.1007/978-0-387-98141-3_1; Woolf CJ, 2000, SCIENCE, V288, P1765, DOI 10.1126/science.288.5472.1765; ZWICK WR, 1986, PSYCHOL BULL, V99, P432, DOI 10.1037/0033-2909.99.3.432	81	15	15	2	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1053-8100	1090-2376		CONSCIOUS COGN	Conscious. Cogn.	MAR	2017	49						278	290		10.1016/j.concog.2017.01.010			13	Psychology, Experimental	Social Science Citation Index (SSCI)	Psychology	EQ1NC	WOS:000397835800025	28222382				2022-02-06	
J	Tate, DF; Gusman, M; Kini, J; Reid, M; Velez, CS; Drennon, AM; Cooper, DB; Kennedy, JE; Bowles, AO; Bigler, ED; Lewis, JD; Ritter, J; York, GE				Tate, David F.; Gusman, Maria; Kini, Jonathan; Reid, Matthew; Velez, Carmen S.; Drennon, Ann Marie; Cooper, Douglas B.; Kennedy, Jan E.; Bowles, Amy O.; Bigler, Erin D.; Lewis, Jeffrey D.; Ritter, John; York, Gerald E.			Susceptibility Weighted Imaging and White Matter Abnormality Findings in Service Members With Persistent Cognitive Symptoms Following Mild Traumatic Brain Injury	MILITARY MEDICINE			English	Article							LESIONS; HYPERINTENSITIES; OUTCOMES; EDITION; RELATE	Mild traumatic brain injury (mTBI) is a major health concern among active duty service members and Veterans returning from combat operations, and it can result in variable clinical and cognitive outcomes. Identifying biomarkers that can improve diagnosis and prognostication has been at the forefront of recent research efforts. The purpose of this study was to compare the sensitivity and specificity of abnormalities identified using more traditional magnetic resonance imaging (MRI) sequences such as fluid attenuation inversion recovery (FLAIR) to more advanced MRI sequences such as susceptibility weighted imaging (SWI) among a cohort of active duty service members experiencing persistent cognitive symptoms after mTBI. One-hundred and fifty-two active duty service members (77 mTBI, 58 orthopedically injured [OI] only, 17 post-traumatic stress disorder [PTSD] only) underwent MRI and neuropsychological evaluation at a large military treatment facility. Results demonstrated that FLAIR white matter hyperintensities (WMHs) were present in all three groups at statistically similar rates (41% mTBI, 49% OI, and 29% PTSD). With the exception of a single OI participant showing a small discrete SWI lesion, SWI abnormalities were overwhelmingly present in mTBI patients (22% mTBI, 1% OI, and 0% PTSD). Functionally, mTBI participants with and without SWI abnormalities did not differ in demographics, symptom reporting, or cognitive performance. However, mTBI participants with and without WMH did differ for on measures of working memory with the mTBI participants with WMH having worse cognitive performance. No other significant differences were noted for those participants with and without imaging abnormalities for either the OI or PTSD only cohorts. These results appear to illustrate the sensitivity and specificity of SWI findings though these results did not have any significant functional impact in this cohort. In contrast, WMHs noted on FLAIR imaging were not sensitive or specific findings, but functionally relevant among mTBI participants. These findings emphasize the complexity of injury and functional outcome in mTBI patients that requires additional examination.	[Tate, David F.; Velez, Carmen S.] Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle, Berkeley, MO 63134 USA; [Gusman, Maria] Brooke Army Med Ctr, Dept Radiol, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA; [Kini, Jonathan; Ritter, John] Austin Radiol Associates, 12554 Riata Vista Circle, Austin, TX 78727 USA; [Reid, Matthew; Drennon, Ann Marie; Cooper, Douglas B.; Kennedy, Jan E.] Brooke Army Med Ctr, Gen Dynam Technol, Def & Vet Brain Injury Ctr, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA; [Bowles, Amy O.] Brooke Army Med Ctr, Dept Rehabil, Brain Injury Rehabil Serv, 3551 Roger Brooke Dr, Ft Sam Houston, TX 78234 USA; [Bigler, Erin D.] Brigham Young Univ, Dept Psychol, 1001 SWKT, Provo, UT 84604 USA; [Bigler, Erin D.] Brigham Young Univ, Ctr Neurosci, 1001 SWKT, Provo, UT 84604 USA; [Lewis, Jeffrey D.] Uniformed Serv Univ Hlth Sci, Dept Neurol, Sch Med, 4301 Jones Bridge Rd, Bethesda, MD 20814 USA; [York, Gerald E.] Alaska Radiol Associates, TBI Imaging & Res, 3650 Piper St,Suite A, Anchorage, AK 99508 USA		Tate, DF (corresponding author), Univ Missouri St Louis, Missouri Inst Mental Hlth, 4633 World Pkwy Circle, Berkeley, MO 63134 USA.		Ritter, John/AAG-8899-2020; Tate, David F/I-3963-2013	Tate, David F/0000-0003-0213-1920	Defense and Veterans Brain Injury Centers; U.S. Army Medical Research and Material Command (USAMRMC)U.S. Army Medical Research & Materiel Command (USAMRMC) [W81XWH-13-2-0025]; Chronic Effects of Neurotrauma Consortium (CENC) [PT108802-SC104835]	This work is supported in part by the Defense and Veterans Brain Injury Centers, the U.S. Army Medical Research and Material Command (USAMRMC; W81XWH-13-2-0025), and the Chronic Effects of Neurotrauma Consortium (CENC; PT108802-SC104835).	Ashwal S, 2006, ARCH PHYS MED REHAB, V87, pS50, DOI 10.1016/j.apmr.2006.07.275; Beauchamp MH, 2013, CORTEX, V49, P591, DOI 10.1016/j.cortex.2012.08.015; Benedictus MR, 2015, STROKE, V46, P2661, DOI 10.1161/STROKEAHA.115.009475; Bigler ED, 2003, NEUROPSYCHOLOGY, V17, P339, DOI 10.1037/0894-4105.17.3.339; Bigler ED, 2002, ALZ DIS ASSOC DIS, V16, P161, DOI 10.1097/00002093-200207000-00006; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; BORCZUK P, 1995, ANN EMERG MED, V25, P731, DOI 10.1016/S0196-0644(95)70199-0; Brickman AM, 2006, BIOL PSYCHIAT, V60, P444, DOI 10.1016/j.biopsych.2006.01.011; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Dahm J, 2015, INJURY, V46, P142, DOI 10.1016/j.injury.2014.07.012; Donders J, 2015, ASSESSMENT, V22, P17, DOI 10.1177/1073191114530776; Fink AZ, 2016, BRIT J RADIOL, V89, DOI 10.1259/bjr.20150753; Guidelines VDCP, 2016, MAN CONC MILD TRAUM; Haacke EM, 2010, J MAGN RESON IMAGING, V32, P516, DOI 10.1002/jmri.22259; Haley AP, 2009, AM J GERIAT PSYCHIAT, V17, P976, DOI 10.1097/JGP.0b013e3181b208ef; Hoofien D, 2005, APPL NEUROPSYCHOL, V12, P30, DOI 10.1207/s15324826an1201_6; Hoth KF, 2007, STROKE, V38, P308, DOI 10.1161/01.STR.0000254517.04275.3f; Jacobs ML, 2008, ARCH CLIN NEUROPSYCH, V23, P113, DOI 10.1016/j.acn.2007.09.003; Kou ZF, 2010, J HEAD TRAUMA REHAB, V25, P267, DOI 10.1097/HTR.0b013e3181e54793; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Liu J, 2015, J NEUROTRAUM, V33, P10; Liu W, 2016, RADIOLOGY, V278, P536, DOI 10.1148/radiol.2015150160; Lloyd AJ, 2009, ACTA PSYCHIAT SCAND, V120, P481, DOI 10.1111/j.1600-0447.2009.01416.x; McGuire SA, 2014, NEUROLOGY, V83, P638, DOI 10.1212/WNL.0000000000000694; McGuire SA, 2012, AVIAT SPACE ENVIR MD, V83, P1117, DOI 10.3357/ASEM.3395.2012; Mittal S, 2009, AM J NEURORADIOL, V30, P232, DOI 10.3174/ajnr.A1461; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Riedy G, 2016, RADIOLOGY, V279, P207, DOI 10.1148/radiol.2015150438; Shen YM, 2007, MAGN RESON IMAGING, V25, P219, DOI 10.1016/j.mri.2006.09.018; Spitz G, 2013, J NEUROTRAUM, V30, P2038, DOI 10.1089/neu.2013.3021; Tate DF, 2008, BRAIN IMAGING BEHAV, V2, P200, DOI 10.1007/s11682-008-9032-5; Tong KA, 2003, RADIOLOGY, V227, P332, DOI 10.1148/radiol.2272020176; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wisse LEM, 2015, NEUROBIOL AGING, V36, P3152, DOI 10.1016/j.neurobiolaging.2015.08.029; Wu Z, 2010, AM J NEURORADIOL, V31, P1302, DOI 10.3174/ajnr.A2022	36	15	15	0	5	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0026-4075	1930-613X		MIL MED	Milit. Med.	MAR-APR	2017	182	3-4					E1651	E1658		10.7205/MILMED-D-16-00132			8	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	ER6WA	WOS:000398948700015	28290939	Bronze			2022-02-06	
J	Turtle, JD; Strain, MM; Aceves, M; Huang, YJ; Reynolds, JA; Hook, MA; Grau, JW				Turtle, Joel D.; Strain, Misty M.; Aceves, Miriam; Huang, Yung-Jen; Reynolds, Joshua A.; Hook, Michelle A.; Grau, James W.			Pain Input Impairs Recovery after Spinal Cord Injury: Treatment with Lidocaine	JOURNAL OF NEUROTRAUMA			English	Article						cell death; pain; polytrauma; secondary injury; spinal cord injury	RATS; BRAIN; INFLAMMATION; PYROPTOSIS; APOPTOSIS; NECROSIS; MORPHINE; MODERATE; SURGERY; MODEL	More than 90% of spinal cord injuries are caused by traumatic accidents and are often associated with other tissue damage (polytrauma) that can provide a source of continued pain input during recovery. In a clinically relevant spinal cord contusion injury model, prior work has shown that noxious stimulation at an intensity that engages pain (C) fibers soon after injury augments secondary injury and impairs functional recovery. Noxious input increases the expression of proinflammatory cytokines (interleukin 1 beta and 18), cellular signals associated with cell death (caspase 3 and 8), and physiological signs of hemorrhage. Here, it is shown that reducing neural excitability after spinal cord injury (SCI) with the local anesthetic lidocaine (micro-injected by means of a lumbar puncture) blocks these adverse cellular effects. In contrast, treatment with an analgesic dose of morphine had no effect. Contused rats that received nociceptive stimulation soon after injury exhibited poor locomotor recovery, less weight gain, and greater tissue loss at the site of injury. Prophylactic application of lidocaine blocked the adverse effect of nociceptive stimulation on behavioral recovery and reduced tissue loss from secondary injury. The results suggest that quieting neural excitability using lidocaine can reduce the adverse effect of pain input (from polytrauma or surgery) after SCI.	[Turtle, Joel D.; Strain, Misty M.; Huang, Yung-Jen; Reynolds, Joshua A.; Grau, James W.] Texas A&M Univ, Dept Psychol, Behav & Cellular Neurosci, College Stn, TX 77843 USA; [Aceves, Miriam; Hook, Michelle A.] Texas A&M Univ, Coll Med, Neurosci & Expt Therapeut, College Stn, TX USA		Turtle, JD (corresponding author), Texas A&M Univ, Dept Psychol, Behav & Cellular Neurosci, College Stn, TX 77843 USA.	joelturtle@gmail.com	Grau, James/S-2372-2019; Hook, Michelle/M-3140-2019	Aceves Rodriguez, Miriam/0000-0002-1778-0213; Reynolds, Joshua/0000-0001-6680-5993; Strain, Misty/0000-0002-7264-7087; Hook, Michelle/0000-0002-8709-936X	Craig H. Neilsen Foundation; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NINDS NS091723]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS091723] Funding Source: NIH RePORTER	The authors would like to thank Mabel Terminel, Melissa Brumley, Ashley DeLeon, and Julia Forsberg for their help with this work. This work was supported by grants from the Craig H. Neilsen Foundation and NIH (NINDS NS091723) to JWG.	BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Bergsbaken T, 2009, NAT REV MICROBIOL, V7, P99, DOI 10.1038/nrmicro2070; Burke D, 1999, REGION ANESTH PAIN M, V24, P519, DOI 10.1016/S1098-7339(99)90042-1; CHAPLAN SR, 1994, J NEUROSCI METH, V53, P55, DOI 10.1016/0165-0270(94)90144-9; Crown ED, 2002, PHYSIOL BEHAV, V77, P259, DOI 10.1016/S0031-9384(02)00859-4; Dietrich WD, 2011, NEUROTHERAPEUTICS, V8, P229, DOI 10.1007/s13311-011-0035-3; Dietrich WD, 2009, J NEUROTRAUM, V26, P301, DOI 10.1089/neu.2008.0806; Ferguson AR, 2004, J NEUROTRAUM, V21, P1601, DOI 10.1089/neu.2004.21.1601; Fink SL, 2005, INFECT IMMUN, V73, P1907, DOI 10.1128/IAI.73.4.1907-1916.2005; Garraway SM, 2011, NEUROSCIENCE, V199, P86, DOI 10.1016/j.neuroscience.2011.10.007; Garraway SM, 2014, PAIN, V155, P2344, DOI 10.1016/j.pain.2014.08.034; Grau JW, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00100; Grau JW, 2012, FRONT PHYSIOL, V3, DOI 10.3389/fphys.2012.00262; Grau JW, 2004, J NEUROTRAUM, V21, P1795, DOI 10.1089/0897715042664948; GRUNER JA, 1992, J NEUROTRAUM, V9, P123, DOI 10.1089/neu.1992.9.123; Haas Daniel A, 2002, J Can Dent Assoc, V68, P546; Hollmann MW, 2000, ANESTHESIOLOGY, V93, P858, DOI 10.1097/00000542-200009000-00038; Hook MA, 2004, J NEUROTRAUM, V21, P109, DOI 10.1089/089771504772695995; Hook MA, 2007, BEHAV BRAIN RES, V179, P281, DOI 10.1016/j.bbr.2007.02.035; Hook MA, 2009, J NEUROTRAUM, V26, P741, DOI 10.1089/neu.2008.0710; Joynes RL, 2003, BEHAV BRAIN RES, V141, P159, DOI 10.1016/S0166-4328(02)00372-8; Lidocaine Wildsmith J., 2011, P HIST ANAESTH SOC, V43, P9; McDonnell JG, 2007, ANESTH ANALG, V104, P193, DOI 10.1213/01.ane.0000250223.49963.0f; MESTRE C, 1994, J PHARMACOL TOX MET, V32, P197, DOI 10.1016/1056-8719(94)90087-6; Michelle J. K., 2011, NAT VITAL STAT REP, V59; Caracas HCPM, 2009, J DENT, V37, P93, DOI 10.1016/j.jdent.2008.10.005; Shultz SR, 2015, J CEREBR BLOOD F MET, V35, P1339, DOI 10.1038/jcbfm.2015.56; Turtle J, 2015, J NEUROTRAUM, V32, pA91; Vaccari JPDR, 2008, J NEUROSCI, V28, P3404, DOI 10.1523/JNEUROSCI.0157-08.2008; Vaccari JPD, 2014, J CEREBR BLOOD F MET, V34, P369, DOI 10.1038/jcbfm.2013.227; van der Wal S, 2015, ACTA ANAESTH SCAND, V59, P47, DOI 10.1111/aas.12417	31	15	15	0	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAR	2017	34	6					1200	1208		10.1089/neu.2016.4778			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EN7ZR	WOS:000396221200008	27912032	Green Published			2022-02-06	
J	Russell, DW; Janz, DR; Emerson, WL; May, AK; Bernard, GR; Zhao, ZG; Koyama, T; Ware, LB				Russell, Derek W.; Janz, David R.; Emerson, William L.; May, Addison K.; Bernard, Gordon R.; Zhao, Zhiguo; Koyama, Tatsuki; Ware, Lorraine B.			Early exposure to hyperoxia and mortality in critically ill patients with severe traumatic injuries	BMC PULMONARY MEDICINE			English	Article							INTENSIVE-CARE-UNIT; ARTERIAL HYPEROXIA; BRAIN-INJURY; CEREBRAL METABOLISM; CARDIAC-ARREST; INTRACRANIAL-PRESSURE; NORMOBARIC HYPEROXIA; HOSPITAL MORTALITY; SEVERE SEPSIS; OXYGEN	Background: Hyperoxia is common early in the course of resuscitation of critically ill patients. It has been associated with mortality in some, but not all, studies of cardiac arrest patients and other critically ill cohorts. Reasons for the inconsistency are unclear and may depend on unmeasured patient confounders, the timing and duration of hyperoxia, population characteristics, or the way that hyperoxia is defined and measured. We sought to determine whether, in a prospectively collected cohort of mechanically ventilated patients with traumatic injuries with and without head trauma, higher maximum partial pressure of arterial oxygen (PaO2) within 24 hours of admission would be associated with increased risk of in-hospital mortality. Methods: Critically ill patients with traumatic injuries undergoing invasive mechanical ventilation enrolled in the Validating Acute Lung Injury biomarkers for Diagnosis (VALID) study were included in this study. All arterial blood gases (ABGs) from the first 24 hours of admission were recorded. Primary analysis was comparison of the highest PaO2 between hospital survivors and non-survivors. Results: A total of 653 patients were evaluated for inclusion. Of these, 182 were not mechanically ventilated or did not have an ABG measured in the first 24 hours, leaving 471 patients in the primary analysis. In survivors, the maximum PaO2 was 141 mmHg (median, interquartile range 103 - 212) compared to 148 mmHg (IQR 105 - 209) in non-survivors (p = 0.82). In the subgroup with head trauma (n = 266), the maximum PaO2 was 133 mmHg (IQR 97 - 187) among survivors and 152 mmHg (108 - 229) among non-survivors (p = 0.19). After controlling for age, injury severity score, number of arterial blood gases, and fraction of inspired oxygen, maximum PaO2 was not associated with increased mortality (OR 1.27 for every fold increase of PaO2 (95% CI 0.72 - 2.25). Conclusions: In mechanically ventilated patients with severe traumatic injuries, hyperoxia in the first 24 hours of admission was not associated with increased risk of death or worsened neurological outcomes in a setting without brain tissue oxygenation monitoring.	[Russell, Derek W.] Univ Alabama Birmingham, Lung Hlth Ctr, Div Pulm & Crit Care Med, 1900 Univ Blvd,THT 423, Birmingham, AL 35233 USA; [Janz, David R.] Louisiana State Univ, Sch Med, Sect Pulm & Crit Care Med, New Orleans, LA 70112 USA; [Emerson, William L.; May, Addison K.; Bernard, Gordon R.; Zhao, Zhiguo; Koyama, Tatsuki; Ware, Lorraine B.] Vanderbilt Univ, Dept Med, Nashville, TN USA; [Emerson, William L.; May, Addison K.; Bernard, Gordon R.; Zhao, Zhiguo; Koyama, Tatsuki; Ware, Lorraine B.] Vanderbilt Univ, Dept Pathol, Dept Microbiol & Immunol, Nashville, TN USA		Russell, DW (corresponding author), Univ Alabama Birmingham, Lung Hlth Ctr, Div Pulm & Crit Care Med, 1900 Univ Blvd,THT 423, Birmingham, AL 35233 USA.	dwrussell@uabmc.edu	Ware, Lorraine/AAJ-9307-2021; Russell, Derek/X-7040-2019	Ware, Lorraine/0000-0002-9429-4702; Russell, Derek/0000-0002-2716-1344	NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [HL103836, 132 HL087738]; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [T32HL087738, K24HL103836] Funding Source: NIH RePORTER	This study was funded by the NIH through the following grants: HL103836 and 132 HL087738.	Ainslie PN, 2014, CLIN SCI, V126, P661, DOI 10.1042/CS20130343; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Bellomo R, 2011, CRIT CARE, V15, DOI 10.1186/cc10090; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS65; Branson RD, 2013, RESP CARE, V58, P86, DOI 10.4187/respcare.02251; Brenner M, 2012, ARCH SURG-CHICAGO, V147, P1042, DOI 10.1001/archsurg.2012.1560; Callcut RA, 2016, J TRAUMA ACUTE CARE, V80, P210, DOI 10.1097/TA.0000000000000930; de Jonge E, 2008, CRIT CARE, V12, DOI 10.1186/cc7150; Diringer MN, 2007, J NEUROSURG, V106, P526, DOI 10.3171/jns.2007.106.4.526; Eastwood G, 2012, INTENS CARE MED, V38, P91, DOI 10.1007/s00134-011-2419-6; Floyd TF, 2003, J APPL PHYSIOL, V95, P2453, DOI 10.1152/japplphysiol.00303.2003; Harrell FE Jr, 2017, REGRESSION MODELING; Helmerhorst HJF, 2015, CRIT CARE, V19, DOI 10.1186/s13054-015-1067-6; Helmerhorst HJF, 2015, CRIT CARE MED, V43, P1508, DOI 10.1097/CCM.0000000000000998; Ihle JF, 2013, CRIT CARE RESUSC, V15, P186; Janz DR, 2012, CRIT CARE MED, V40, P3135, DOI 10.1097/CCM.0b013e3182656976; JENNETT B, 1976, LANCET, V1, P1031; Kilgannon JH, 2010, JAMA-J AM MED ASSOC, V303, P2165, DOI 10.1001/jama.2010.707; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Leitgeb J, 2013, EUR J TRAUMA EMERG S, V39, P285, DOI 10.1007/s00068-013-0269-3; Miyamoto O, 2000, NEUROLOGY, V54, P362, DOI 10.1212/WNL.54.2.362; Murray CJL, 2012, LANCET, V380, P2197, DOI 10.1016/S0140-6736(12)61689-4; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Nelskyla A, 2013, SCAND J TRAUMA RESUS, V21, DOI 10.1186/1757-7241-21-35; Nyquist PA, 2014, CRIT CARE MED, V42, P469, DOI 10.1097/CCM.0b013e3182a525a4; O'Neal HR, 2011, CRIT CARE MED, V39, P1343, DOI 10.1097/CCM.0b013e3182120992; Raj R, 2013, CRIT CARE, V17, DOI 10.1186/cc12856; [RCT] R Core Team, 2014, R LANG ENV STAT COMP; Rincon F, 2014, J NEUROL NEUROSUR PS, V85, P799, DOI 10.1136/jnnp-2013-305505; Rincon F, 2014, CRIT CARE MED, V42, P387, DOI 10.1097/CCM.0b013e3182a27732; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Siew ED, 2010, CLIN J AM SOC NEPHRO, V5, P1497, DOI 10.2215/CJN.09061209; Siew ED, 2009, J AM SOC NEPHROL, V20, P1823, DOI 10.1681/ASN.2008070673; Singhal AB, 2005, STROKE, V36, P797, DOI 10.1161/01.STR.0000158914.66827.2e; Stiefel MF, 2005, J NEUROSURG, V103, P805, DOI 10.3171/jns.2005.103.5.0805; Tolias CM, 2004, J NEUROSURG, V101, P435, DOI 10.3171/jns.2004.101.3.0435; University of Texas Southwestern Medical Center, 2000, BRAIN TISS OXYG MON; Vaahersalo J, 2014, CRIT CARE MED, V42, P1463, DOI 10.1097/CCM.0000000000000228; Ware LB, 2013, CRIT CARE, V17, DOI 10.1186/cc13080	39	15	16	2	5	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1471-2466			BMC PULM MED	BMC Pulm. Med.	FEB 3	2017	17								29	10.1186/s12890-017-0370-1			7	Respiratory System	Science Citation Index Expanded (SCI-EXPANDED)	Respiratory System	EJ6QQ	WOS:000393344300001	28158980	gold, Green Published			2022-02-06	
J	Armstrong, RA; Mckee, AC; Stein, TD; Alvarez, VE; Cairns, NJ				Armstrong, R. A.; Mckee, A. C.; Stein, T. D.; Alvarez, V. E.; Cairns, N. J.			A quantitative study of tau pathology in 11 cases of chronic traumatic encephalopathy	NEUROPATHOLOGY AND APPLIED NEUROBIOLOGY			English	Article						astrocytic tangles; chronic traumatic encephalopathy; neurofibrillary tangles; principal components analysis; tau	ARGYROPHILIC GRAIN DISEASE; FRONTOTEMPORAL LOBAR DEGENERATION; ALZHEIMERS-DISEASE; DEMENTIA-PUGILISTICA; DIAGNOSTIC-CRITERIA; FRONTAL-CORTEX; PICKS-DISEASE; BRAIN-INJURY; HEAD-INJURY; NEUROPATHOLOGY	Aims: To quantify tau pathology of chronic traumatic encephalopathy (CTE) and investigate influence of dot-like lesions (DL), brain region, comorbidity and sporting career length. Methods: Densities of neurofibrillary tangles (NFT), astrocytic tangles (AT), DL, oligodendroglial inclusions (GI), neuropil threads (NT), vacuoles, neurons and enlarged neurons (EN) were measured in tau-immunoreactive sections of upper cortical laminae of frontal and temporal lobes, hippocampus (HC), amygdala and substantia nigra (SN) in 11 cases of CTE. Results: DL were a consistent finding in CTE. Densities of NFT, NT and DL were greatest in sectors CA1 and CA2 of the HC. Densities of AT were lower than NFT, small numbers of GI were recorded in temporal lobe and low densities of vacuoles and EN were consistently present. beta-Amyloid-containing neuritic plaques (NP) also occurred at low density. Densities of NFT, NT, DL and AT were greater in sulci than gyri, while vacuole density was greater in gyri. Principal components analysis (PCA) suggested that sporting career length and densities of NFT in entorhinal cortex, NT in CA2 and SN and vacuolation in the DG were significant sources of variation among cases. Conclusion: DL are frequent in CTE suggesting affinity with argyrophilic grain disease (AGD) and Parkinson's disease dementia (PD-Dem). Densities of AT in all regions and NT/DL in sectors CA2/4 were consistent features of CTE. The 11 cases are neuropathologically heterogeneous which may result from genetic diversity, and variation in anatomical pathways subjected to trauma.	[Armstrong, R. A.] Aston Univ, Vis Sci, Birmingham B4 7ET, W Midlands, England; [Mckee, A. C.] VA Boston HealthCare Syst, Boston, MA USA; [Mckee, A. C.; Alvarez, V. E.] Boston Univ, Sch Med, Dept Neurol, Boston, MA 02118 USA; [Mckee, A. C.; Stein, T. D.] Boston Univ, Sch Med, Dept Pathol & Lab Med, Boston, MA 02118 USA; [Stein, T. D.; Alvarez, V. E.] Dept Vet Affairs Med Ctr, Bedford, MA USA; [Cairns, N. J.] Washington Univ, Sch Med, Dept Neurol, St Louis, MO 63110 USA; [Cairns, N. J.] Washington Univ, Sch Med, Dept Pathol & Immunol, St Louis, MO USA		Armstrong, RA (corresponding author), Aston Univ, Vis Sci, Birmingham B4 7ET, W Midlands, England.	R.A.Armstrong@aston.ac.uk	Armstrong, Richard A/H-4557-2012; Cairns, Nigel/AAB-9713-2020; Armstrong, Richard/AAU-4580-2020	Armstrong, Richard A/0000-0002-5046-3199; Cairns, Nigel/0000-0001-9858-3344; Armstrong, Richard/0000-0002-5046-3199; Stein, Thor/0000-0001-6954-4477	National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1UO1NS086659- 01]; Department of Veterans Affairs, the Veterans Affairs Biorepository [CSP 501]; Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS); Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence [B6796-C]; National Institute of Aging Boston University Alzheimer's Disease Center [P30AG13846, 0572063345-5]; Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA from the National Institute on Aging [P50 AG05681, P01 AG03991]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [U01NS086659] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P50AG005681, P01AG003991, P30AG013846] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01CX001038] Funding Source: NIH RePORTER	The authors gratefully acknowledge the use of the resources and facilities at the Edith Nourse Rogers Memorial Veterans Hospital (Bedford, MA, USA). We also gratefully acknowledge the help of all members of the Chronic Traumatic Encephalopathy Program at Boston University School of Medicine, VA Boston and the Bedford VA, as well as the individuals and families whose participation and contributions made this work possible. This work was supported by the National Institute of Neurological Disorders and Stroke (1UO1NS086659- 01); Department of Veterans Affairs, the Veterans Affairs Biorepository (CSP 501); the Translational Research Center for Traumatic Brain Injury and Stress Disorders (TRACTS); the Veterans Affairs Rehabilitation Research and Development Traumatic Brain Injury Center of Excellence (B6796-C); and the National Institute of Aging Boston University Alzheimer's Disease Center (P30AG13846; supplement 0572063345-5). This work was supported by the Charles F. and Joanne Knight Alzheimer's Disease Research Center, Washington University School of Medicine, St. Louis, MO, USA (P50 AG05681 and P01 AG03991) from the National Institute on Aging.	Armstrong R, 1999, NEUROPATHOLOGY, V19, P64, DOI 10.1046/j.1440-1789.1999.00219.x; ARMSTRONG RA, 1994, DEMENTIA, V5, P1, DOI 10.1159/000106686; Armstrong RA, 2000, EXP NEUROL, V163, P348, DOI 10.1006/exnr.2000.7392; Armstrong RA, 2015, J NEURAL TRANSM, V122, P1355, DOI 10.1007/s00702-015-1402-8; Armstrong RA, 2014, J NEURAL TRANSM, V121, P171, DOI 10.1007/s00702-013-1084-z; Armstrong RA, 2010, J NEURAL TRANSM, V117, P227, DOI 10.1007/s00702-009-0350-6; Braak H, 1998, J NEURAL TRANSM, V105, P801, DOI 10.1007/s007020050096; Cairns NJ, 2007, ACTA NEUROPATHOL, V114, P5, DOI 10.1007/s00401-007-0237-2; Crary JF, 2014, ACTA NEUROPATHOL, V128, P755, DOI 10.1007/s00401-014-1349-0; Dickson DW, 2010, INT J CLIN EXP PATHO, V3, P1; Ding ZT, 2006, ACTA NEUROPATHOL, V111, P450, DOI 10.1007/s00401-005-0015-y; Geddes JF, 1999, ACTA NEUROPATHOL, V98, P171, DOI 10.1007/s004010051066; GENTLEMAN SM, 1992, NEUROSCI LETT, V142, P9, DOI 10.1016/0304-3940(92)90608-A; Goedert M, 2010, TRENDS NEUROSCI, V33, P317, DOI 10.1016/j.tins.2010.04.003; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; GRAHAM DI, 1995, NEUROPATH APPL NEURO, V21, P27, DOI 10.1111/j.1365-2990.1995.tb01025.x; Hazrati LN, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00222; HOF PR, 1992, ACTA NEUROPATHOL, V85, P23, DOI 10.1007/BF00304630; Hyman BT, 2012, ALZHEIMERS DEMENT, V8, P1, DOI 10.1016/j.jalz.2011.10.007; Johnson VE, 2012, BRAIN PATHOL, V22, P142, DOI 10.1111/j.1750-3639.2011.00513.x; Jordan BD, 2013, NAT REV NEUROL, V9, P222, DOI 10.1038/nrneurol.2013.33; Josephs KA, 2008, NEUROBIOL AGING, V29, P566, DOI 10.1016/j.neurobiolaging.2006.10.032; Kieman PT, 2015, SEMIN NEUROL, V35, P20; Lehman EJ, 2012, NEUROLOGY, V79, P1970, DOI 10.1212/WNL.0b013e31826daf50; Maroon JC, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117338; McKee AC, 2016, ACTA NEUROPATHOL, V131, P75, DOI 10.1007/s00401-015-1515-z; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; McKee AC, 2014, ACTA NEUROPATHOL, V127, P29, DOI 10.1007/s00401-013-1230-6; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Montenigro PH, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/s13195-014-0068-z; Randolph C, 2014, CURR SPORT MED REP, V13, P33, DOI [10.1097/OPX.0000000000000170, 10.1249/JSR.0000000000000022]; Sabbagh MN, 2009, ALZ DIS ASSOC DIS, V23, P229, DOI 10.1097/WAD.0b013e318199d833; Saing T, 2012, J NEUROTRAUM, V29, P1054, DOI 10.1089/neu.2011.1957; Shetty AK, 2014, FRONT CELL NEUROSCI, V8, DOI 10.3389/fncel.2014.00232; Snedecor G.W., 1980, STAT METHODS, V7th; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Steiner JA, 2011, CELL DEATH DIFFER, V18, P1425, DOI 10.1038/cdd.2011.53; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tolnay M, 1999, PATHOLOGE, V20, P159, DOI 10.1007/s002920050339; Zhukareva V, 2002, AM J PATHOL, V161, P1135, DOI 10.1016/S0002-9440(10)64390-8; Zhukareva V, 2001, ACTA NEUROPATHOL, V101, P518	41	15	15	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0305-1846	1365-2990		NEUROPATH APPL NEURO	Neuropathol. Appl. Neurobiol.	FEB	2017	43	2					154	166		10.1111/nan.12323			13	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	EO8JB	WOS:000396934200005	26998921	Green Accepted			2022-02-06	
J	Edwards, AB; Anderton, RS; Knuckey, NW; Meloni, BP				Edwards, Adam B.; Anderton, Ryan S.; Knuckey, Neville W.; Meloni, Bruno P.			Characterisation of neuroprotective efficacy of modified poly-arginine-9 (R9) peptides using a neuronal glutamic acid excitotoxicity model	MOLECULAR AND CELLULAR BIOCHEMISTRY			English	Article						Poly-arginine peptides; Arginine-rich peptides; Cortical neurons; Neuroprotection; Glutamate excitotoxicity; Cortical neurons; Cell-penetrating peptides	CELL-PENETRATING PEPTIDES; MEDIATOR PROTEIN-2 CRMP2; TRAUMATIC BRAIN-INJURY; ARGININE-RICH PEPTIDES; NMDA RECEPTOR; POLY-ARGININE; STROKE; DEATH; MITOCHONDRIA; INHIBITION	In a recent study, we highlighted the importance of cationic charge and arginine residues for the neuroprotective properties of poly-arginine and arginine-rich peptides. In this study, using cortical neuronal cultures and an in vitro glutamic acid excitotoxicity model, we examined the neuroprotective efficacy of different modifications to the poly-arginine-9 peptide (R9). We compared an unmodified R9 peptide with R9 peptides containing the following modifications: (i) C-terminal amidation (R9-NH2); (ii) N-terminal acetylation (Ac-R9); (iii) C-terminal amidation with N-terminal acetylation (Ac-R9-NH2); and (iv) C-terminal amidation with D-amino acids (R9D-NH2). The three C-terminal amidated peptides (R9-NH2, Ac-R9-NH2, and R9D-NH2) displayed neuroprotective effects greater than the unmodified R9 peptide, while the N-terminal acetylated peptide (Ac-R9) had reduced efficacy. Using the R9-NH2 peptide, neuroprotection could be induced with a 10 min peptide pre-treatment, 1-6 h before glutamic acid insult, or when added to neuronal cultures up to 45 min post-insult. In addition, all peptides were capable of reducing glutamic acid-mediated neuronal intracellular calcium influx, in a manner that reflected their neuroprotective efficacy. This study further highlights the neuroprotective properties of poly-arginine peptides and provides insight into peptide modifications that affect efficacy.	[Edwards, Adam B.; Anderton, Ryan S.; Knuckey, Neville W.; Meloni, Bruno P.] QEII Med Ctr, Western Australian Neurosci Res Inst, A Block,4th Floor,Verdun St, Nedlands, WA 6009, Australia; [Edwards, Adam B.; Anderton, Ryan S.] Univ Notre Dame Australia, Sch Hlth Sci, Fremantle, WA 6160, Australia; [Knuckey, Neville W.; Meloni, Bruno P.] Univ Western Australia, Ctr Neuromuscular & Neurol Disorders, Nedlands, WA 6009, Australia; [Edwards, Adam B.; Knuckey, Neville W.; Meloni, Bruno P.] QEII Med Ctr, Sir Charles Gardiner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia		Edwards, AB (corresponding author), QEII Med Ctr, Western Australian Neurosci Res Inst, A Block,4th Floor,Verdun St, Nedlands, WA 6009, Australia.; Edwards, AB (corresponding author), Univ Notre Dame Australia, Sch Hlth Sci, Fremantle, WA 6160, Australia.; Edwards, AB (corresponding author), QEII Med Ctr, Sir Charles Gardiner Hosp, Dept Neurosurg, Nedlands, WA 6009, Australia.	adam.edwards1@my.nd.edu.au	Edwards, Adam/U-3386-2019	Edwards, Adam/0000-0002-7503-3232; Anderton, Ryan/0000-0003-0568-9794	University of Notre Dame Australia RIS grant; Neurotrauma Research Program of Western Australia grant; Department of Neurosurgery, Sir Charles Gairdner Hospital	This study in part was supported by the Department of Neurosurgery, Sir Charles Gairdner Hospital, and a University of Notre Dame Australia RIS grant, and a Neurotrauma Research Program of Western Australia grant.	Aarts M, 2002, SCIENCE, V298, P846, DOI 10.1126/science.1072873; Birk AV, 2013, J AM SOC NEPHROL, V24, P1250, DOI 10.1681/ASN.2012121216; Brittain JM, 2011, J BIOL CHEM, V286, P37778, DOI 10.1074/jbc.M111.255455; BRUGIDOU J, 1995, BIOCHEM BIOPH RES CO, V214, P685, DOI 10.1006/bbrc.1995.2340; Brustovetsky T, 2014, J BIOL CHEM, V289, P7470, DOI 10.1074/jbc.M113.518472; Doranz BJ, 2001, AIDS RES HUM RETROV, V17, P475, DOI 10.1089/08892220151126508; FADEN AI, 1989, SCIENCE, V244, P798, DOI 10.1126/science.2567056; Fan J, 2009, J NEUROSCI, V29, P10928, DOI 10.1523/JNEUROSCI.2491-09.2009; Favretto ME, 2014, J CONTROL RELEASE, V180, P81, DOI 10.1016/j.jconrel.2014.02.011; Feldman P, 2013, NEUROSCI LETT, V557, P27, DOI 10.1016/j.neulet.2013.06.057; Ferrer-Montiel AV, 1998, NAT BIOTECHNOL, V16, P286, DOI 10.1038/nbt0398-286; Garcia-Caballero A, 2014, NEURON, V83, P1144, DOI 10.1016/j.neuron.2014.07.036; Hoque A, 2016, PHARMACOL THERAPEUT, V160, P159, DOI 10.1016/j.pharmthera.2016.02.009; Horton KL, 2008, CHEM BIOL, V15, P375, DOI 10.1016/j.chembiol.2008.03.015; Marshall J, 2015, J BIOL CHEM, V290, P22030, DOI 10.1074/jbc.M115.662791; McDougall G, 2016, J MOL NEURO IN PRESS; Meloni BP, 2015, PHARMACOL THERAPEUT, V153, P36, DOI 10.1016/j.pharmthera.2015.06.002; Meloni BP, 2015, J CEREBR BLOOD F MET, V35, P993, DOI 10.1038/jcbfm.2015.11; Meloni BP, 2014, CELL MOL NEUROBIOL, V34, P173, DOI 10.1007/s10571-013-9999-3; Milani D, 2016, STROKE RES TREAT, V2016, DOI 10.1155/2016/2372710; Milani D, 2016, BMC NEUROSCI, V17, DOI 10.1186/s12868-016-0253-z; Planells-Cases R, 2000, FEBS LETT, V481, P131, DOI 10.1016/S0014-5793(00)01982-7; RIGOBELLO MP, 1995, BIOCHEM BIOPH RES CO, V217, P144, DOI 10.1006/bbrc.1995.2756; Rothbard JB, 2005, ADV DRUG DELIVER REV, V57, P495, DOI 10.1016/j.addr.2004.10.003; Sinai L, 2010, LEARN MEMORY, V17, P364, DOI 10.1101/lm.1765710; Tu WH, 2010, CELL, V140, P222, DOI 10.1016/j.cell.2009.12.055; Vaslin A, 2011, J NEUROCHEM, V119, P1243, DOI 10.1111/j.1471-4159.2011.07535.x; Wallbrecher R, 2014, CELL MOL LIFE SCI, V71, P2717, DOI 10.1007/s00018-013-1517-8; Wu QF, 2015, DRUG DISCOV TODAY, V20, P1372, DOI 10.1016/j.drudis.2015.09.001; Zhao KS, 2004, J BIOL CHEM, V279, P34682, DOI 10.1074/jbc.M402999200	30	15	15	2	15	SPRINGER	DORDRECHT	VAN GODEWIJCKSTRAAT 30, 3311 GZ DORDRECHT, NETHERLANDS	0300-8177	1573-4919		MOL CELL BIOCHEM	Mol. Cell. Biochem.	FEB	2017	426	1-2					75	85		10.1007/s11010-016-2882-z			11	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EK8IY	WOS:000394168300008	27844251				2022-02-06	
J	Pletcher, ER; Williams, VJ; Abt, JP; Morgan, PM; Parr, JJ; Wohleber, MF; Lovalekar, M; Sell, TC				Pletcher, Erin R.; Williams, Valerie J.; Abt, John P.; Morgan, Paul M.; Parr, Jeffrey J.; Wohleber, Meleesa F.; Lovalekar, Mita; Sell, Timothy C.			Normative Data for the NeuroCom Sensory Organization Test in US Military Special Operations Forces	JOURNAL OF ATHLETIC TRAINING			English	Article						normative data; NeuroCom; Sensory Organization; Test	POSTURAL STABILITY; DYNAMIC POSTUROGRAPHY; BASKETBALL PLAYERS; INJURY PREVENTION; BALANCE; SPORTS; REHABILITATION; RECONSTRUCTION; EPIDEMIOLOGY; CHILDREN	Context: Postural stability is the ability to control the center of mass in relation to a person's base of support and can be affected by both musculoskeletal injury and traumatic brain injury. The NeuroCom Sensory Organization Test (SOT) can be used to objectively quantify impairments to postural stability. The ability of postural stability to predict injury and be used as an acute injury-evaluation tool makes it essential to the screening and rehabilitation process. To our knowledge, no published normative data for the SOT from a healthy, highly active population are available for use as a reference for clinical decision making. Objective: To present a normative database of SOT scores from a US Military Special Operations population that can be used for future comparison. Design: Cross-sectional study. Setting: Human performance research laboratory. Patients or Other Participants: A total of 542 active military operators from Naval Special Warfare Combatant-Craft Crewmen (n = 149), Naval Special Warfare Command, Sea, Air, and Land (n = 101), US Army Special Operations Command (n = 171), and Air Force Special Operations Command (n = 121). Main Outcome Measure(s): Participants performed each of the 6 SOT conditions 3 times. Scores for each condition, total equilibrium composite score, and ratio scores for the somatosensory, visual, and vestibular systems were recorded. Results: Differences were present across all groups for SOT conditions 1 (P < .001), 2 (P = .001), 4 (P > .001), 5 (P > .001), and 6 (P = .001) and total equilibrium composite (P = .000), visual (P > .001), vestibular (P = .002), and preference (P > .001) NeuroCom scores. Conclusions: Statistical differences were evident in the distribution of postural stability across US Special Operations Forces personnel. This normative database for postural stability, as assessed by the NeuroCom SOT, can provide context when clinicians assess a Special Operations Forces population or any other groups that maintain a high level of conditioning and training.	[Pletcher, Erin R.; Williams, Valerie J.; Lovalekar, Mita] Univ Pittsburgh, Dept Sports Med & Nutr, Neuromuscular Res Lab, Pittsburgh, PA 15260 USA; [Abt, John P.] Univ Kentucky, Lexington, KY 40506 USA; [Morgan, Paul M.] Univ Pittsburgh, Human Performance Res Lab, Stennis Space Ctr, MS USA; [Parr, Jeffrey J.] Univ Pittsburgh, Human Performance Res Lab, Virginia Beach, VA USA; [Wohleber, Meleesa F.] Univ Pittsburgh, Warrior Human Performance Res Lab, Hurlburt Field, FL USA; [Sell, Timothy C.] Duke Univ, Michael W Krzyzewski Human Performance Lab K Lab, DUMC 102916, Durham, NC 27705 USA		Sell, TC (corresponding author), Duke Univ, Michael W Krzyzewski Human Performance Lab K Lab, DUMC 102916, Durham, NC 27705 USA.	timothy.sell@dm.duke.edu		Pletcher, Erin/0000-0002-4945-2601; Lovalekar, Mita/0000-0002-4536-8656	Office of Naval ResearchOffice of Naval Research [N000141110929]; US Army Medical Research and Materiel Command/US Army Research Laboratory [W81XWH1120020, W911NF1010168]; Air Force Materiel Command/Air Force Research Laboratory [FA86501226271]	This research was funded by the Office of Naval Research (Grant No. N000141110929), US Army Medical Research and Materiel Command/US Army Research Laboratory (Grant Nos. W81XWH1120020 and W911NF1010168), and Air Force Materiel Command/Air Force Research Laboratory (Grant No. FA86501226271). The views expressed are those of the authors and do not represent the official policy or position of the Defense Health Agency, the US Army Medical Research and Material Command, the US Army Research Laboratory, the Office of Naval Research, the Air Force Material Command, the Air Force Research Laboratory, or the Department of Defense.	Abt JP, 2014, MIL MED, V179, P1106, DOI 10.7205/MILMED-D-14-00078; Alahmari KA, 2014, ARCH PHYS MED REHAB, V95, P65, DOI 10.1016/j.apmr.2013.09.011; Alexander KM, 1998, J ORTHOP SPORT PHYS, V28, P378, DOI 10.2519/jospt.1998.28.6.378; Alonso AC, 2009, CLINICS, V64, P163, DOI 10.1590/S1807-59322009000300003; ANACKER SL, 1992, PHYS THER, V72, P575, DOI 10.1093/ptj/72.8.575; [Anonymous], 2014, CLIN INT SEM LECT NO; [Anonymous], 2008, BAL MAN SYST CLIN IN; Beynnon BD, 2002, J ATHL TRAINING, V37, P376; Borah Diganta, 2007, Indian J Physiol Pharmacol, V51, P395; Pedalini MEB, 2009, ACTA OTO-LARYNGOL, V129, P962, DOI 10.1080/00016480802468930; Buatois S, 2007, INT J SPORTS MED, V28, P53, DOI 10.1055/s-2006-924054; Chaudhry H, 2004, J REHABIL RES DEV, V41, P713, DOI 10.1682/JRRD.2003.09.0140; Dickin DC, 2007, CLIN J SPORT MED, V17, P109, DOI 10.1097/JSM.0b013e31803bf647; Ferber-Viart C, 2007, INT J PEDIATR OTORHI, V71, P1041, DOI 10.1016/j.ijporl.2007.03.012; FOUDRIAT BA, 1993, INT J PEDIATR OTORHI, V27, P255, DOI 10.1016/0165-5876(93)90231-Q; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Helmick KM, 2015, BRAIN IMAGING BEHAV, V9, P358, DOI 10.1007/s11682-015-9399-z; Henriksson M, 2001, AM J SPORT MED, V29, P359, DOI 10.1177/03635465010290031801; Hubscher M, 2010, MED SCI SPORT EXER, V42, P413, DOI 10.1249/MSS.0b013e3181b88d37; Jacobson GP., 1993, HDB BALANCE FUNCTION; Kaufman KR, 2000, AM J PREV MED, V18, P54, DOI 10.1016/S0749-3797(00)00114-8; Kiers H, 2013, SPORTS MED, V43, P1171, DOI 10.1007/s40279-013-0082-5; McGuine TA, 2000, CLIN J SPORT MED, V10, P239, DOI 10.1097/00042752-200010000-00003; Muaidi QI, 2009, SCAND J MED SCI SPOR, V19, P103, DOI 10.1111/j.1600-0838.2008.00783.x; Perrin PP, 1997, INT J SPORTS MED, V18, P387, DOI 10.1055/s-2007-972651; Pierchala Katarzyna, 2012, Otolaryngol Pol, V66, P274; Romero-Franco N, 2014, J PHYS THER SCI, V26, P683, DOI 10.1589/jpts.26.683; Ruscio BA, 2010, AM J PREV MED, V38, pS19, DOI 10.1016/j.amepre.2009.10.004; Tucker David, 2007, US SPECIAL OPERATION; VOORHEES RL, 1990, OTOLARYNG HEAD NECK, V103, P96, DOI 10.1177/019459989010300114; Woollacott, 2007, MOTOR CONTROL TRANSL	32	15	17	0	11	NATL ATHLETIC TRAINERS ASSOC INC	DALLAS	2952 STEMMONS FREEWAY, DALLAS, TX 75247 USA	1062-6050	1938-162X		J ATHL TRAINING	J. Athl. Train.	FEB	2017	52	2					129	136		10.4085/1062-6050-52.1.05			8	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EP2IW	WOS:000397207600007	28140624	Green Published, Green Submitted, Bronze			2022-02-06	
J	Sun, P; Murphy, RKJ; Gamble, P; George, A; Song, SK; Ray, WZ				Sun, Peng; Murphy, Rory K. J.; Gamble, Paul; George, Ajit; Song, Sheng-Kwei; Ray, Wilson Z.			Diffusion Assessment of Cortical Changes, Induced by Traumatic Spinal Cord Injury	BRAIN SCIENCES			English	Article						magnetic resonance imaging; diffusion tensor imaging; diffusion basis spectrum imaging; spinal cord injury	CERVICAL SPONDYLOTIC MYELOPATHY; WHITE-MATTER PATHOLOGY; EPIDURAL STIMULATION; MULTIPLE-SCLEROSIS; CORPUS-CALLOSUM; IMAGING DETECTS; OPTIC-NERVE; MOUSE MODEL; BRAIN; DEMYELINATION	Promising treatments are being developed to promote functional recovery after spinal cord injury (SCI). Magnetic resonance imaging, specifically Diffusion Tensor Imaging (DTI) has been shown to non-invasively measure both axonal and myelin integrity following traumatic brain and SCI. A novel data-driven model-selection algorithm known as Diffusion Basis Spectrum Imaging (DBSI) has been proposed to more accurately delineate white matter injury. The objective of this study was to investigate whether DTI/DBSI changes that extend to level of the cerebral peduncle and internal capsule following a SCI could be correlated with clinical function. A prospective non-randomized cohort of 23 patients with chronic spinal cord injuries and 17 control subjects underwent cranial diffusion weighted imaging, followed by whole brain DTI and DBSI computations. Region-based analyses were performed on cerebral peduncle and internal capsule. Three subgroups of patients were included in the region-based analysis. Tract-Based Spatial Statistics (TBSS) was also applied to allow whole-brain white matter analysis between controls and all patients. Functional assessments were made using International Standards for Neurological Classification of Spinal Cord Injury (ISNCSCI) as modified by the American Spinal Injury Association (ASIA) Scale. Whole brain white matter analysis using TBSS finds no statistical difference between controls and all patients. Only cervical ASIA A/B patients in cerebral peduncle showed differences from controls in DTI and DBSI results with region-based analysis. Cervical ASIA A/B SCI patients had higher levels of axonal injury and edema/tissue loss as measured by DBSI at the level of the cerebral peduncle. DTI Fractional Anisotropy (FA), Axial Diffusivity (AD) and Radial Diffusivity (RD) was able to detect differences in cervical ASIA A/B patients, but were non-specific to pathologies. Increased water fraction indicated by DBSI non-restricted isotropic diffusion fraction in the cerebral peduncle, explains the simultaneously increased DTI AD and DTI RD values. Our results further demonstrate the utility of DTI to detect disruption in axonal integrity in white matter, yet a clear shortcoming in differentiating true axonal injury from inflammation/tissue loss. Our results suggest a preservation of axonal integrity at the cortical level and has implications for future regenerative clinical trials.	[Sun, Peng; George, Ajit; Song, Sheng-Kwei] Washington Univ, Sch Med, Dept Radiol, St Louis, MO 63110 USA; [Murphy, Rory K. J.; Ray, Wilson Z.] Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA; [Gamble, Paul] Washington Univ, Sch Med, St Louis, MO 63110 USA		Ray, WZ (corresponding author), Washington Univ, Sch Med, Dept Neurol Surg, St Louis, MO 63110 USA.	pengsun@wustl.edu; murphyr@wudosis.wustl.edu; gamblep@wusm.wustl.edu; ajitgeorge@wustl.edu; ssong@wustl.edu; rayz@wudosis.wustl.edu			University of Missouri Spinal Cord Injury Research Program; National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23NS084932]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS084932, R01NS047592] Funding Source: NIH RePORTER	This study was supported by University of Missouri Spinal Cord Injury Research Program (Wilson Z. Ray) and National Institute of Health K23NS084932 (Wilson Z. Ray).	Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Alkadhi H, 2005, CEREB CORTEX, V15, P131, DOI 10.1093/cercor/bhh116; Andersson J. L. R., TR07JA2; Andersson JLR, 2003, NEUROIMAGE, V20, P870, DOI 10.1016/S1053-8119(03)00336-7; Andersson JLR, TR07JA1 FMRIB; Barker GJ, 2001, J NEUROL SCI, V186, pS45, DOI 10.1016/S0022-510X(01)00490-7; Bruehlmeier M, 1998, EUR J NEUROSCI, V10, P3918, DOI 10.1046/j.1460-9568.1998.00454.x; Budde MD, 2007, MAGN RESON MED, V57, P688, DOI 10.1002/mrm.21200; Castro A, 2007, EUR J NEUROSCI, V25, P2927, DOI 10.1111/j.1460-9568.2007.05532.x; Chavakula V, 2016, NEUROSURGERY, V78, pN19, DOI 10.1227/01.neu.0000484059.58417.dc; Chiang CW, 2014, NEUROIMAGE, V101, P310, DOI 10.1016/j.neuroimage.2014.06.064; Cramer SC, 2005, BRAIN, V128, P2941, DOI 10.1093/brain/awh648; Deo AA, 2006, J NEUROSCI RES, V83, P801, DOI 10.1002/jnr.20783; Freund P, 2012, J NEUROL NEUROSUR PS, V83, P629, DOI 10.1136/jnnp-2011-301875; Freund P, 2011, BRAIN, V134, P1610, DOI 10.1093/brain/awr093; Gad P, 2013, J NEUROENG REHABIL, V10, DOI 10.1186/1743-0003-10-2; Gao SJ, 2013, EUR J RADIOL, V82, P1940, DOI 10.1016/j.ejrad.2013.06.011; Halder P, 2006, NEUROIMAGE, V31, P692, DOI 10.1016/j.neuroimage.2005.12.018; Hawasli AH, 2015, GLOB SPINE J, V5, P110, DOI 10.1055/s-0034-1396760; Hotz-Boenden-Naker S, 2008, NEUROIMAGE, V39, P383, DOI 10.1016/j.neuroimage.2007.07.065; Hou JM, 2014, NEUROSCIENCE, V277, P446, DOI 10.1016/j.neuroscience.2014.07.045; Jin Bo, 2014, Zhonghua Yi Xue Za Zhi, V94, P3082; Kim JH, 2006, NEUROBIOL DIS, V21, P626, DOI 10.1016/j.nbd.2005.09.009; Kim JH, 2007, MAGN RESON MED, V58, P253, DOI 10.1002/mrm.21316; Kirshblum S, 2014, PHYS MED REH CLIN N, V25, P505, DOI 10.1016/j.pmr.2014.04.001; Kokotilo KJ, 2009, J NEUROTRAUM, V26, P2113, DOI 10.1089/neu.2008.0688; Koskinen E, 2013, J NEUROTRAUM, V30, P1587, DOI 10.1089/neu.2013.2943; Kuo LW, 2008, NEUROIMAGE, V41, P7, DOI 10.1016/j.neuroimage.2008.02.016; Le Bihan D, 2001, J MAGN RESON IMAGING, V13, P534, DOI 10.1002/jmri.1076; Li X, 2014, SPINE, V39, pE615, DOI 10.1097/BRS.0000000000000288; Mackinnon SE, 2012, J NEUROSURG, V117, P176, DOI 10.3171/2012.3.JNS12328; Mattia D, 2006, HUM BRAIN MAPP, V27, P510, DOI 10.1002/hbm.20195; Min YS, 2015, J NEUROTRAUM, V32, P1422, DOI 10.1089/neu.2014.3661; Minassian K, 2016, NEUROTHERAPEUTICS, V13, P284, DOI 10.1007/s13311-016-0421-y; Miyanji F, 2007, RADIOLOGY, V243, P820, DOI 10.1148/radiol.2433060583; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Moxon KA, 2014, NEUROSCIENCE, V283, P78, DOI 10.1016/j.neuroscience.2014.06.056; Naismith RT, 2013, NEUROLOGY, V80, P2201, DOI 10.1212/WNL.0b013e318296e8f1; Oishi K, 2008, NEUROIMAGE, V43, P447, DOI 10.1016/j.neuroimage.2008.07.009; Oni-Orisan A, 2016, PLOS ONE, V11, DOI 10.1371/journal.pone.0150351; Rueckert D, 1999, IEEE T MED IMAGING, V18, P712, DOI 10.1109/42.796284; Sabbah P, 2002, J NEUROTRAUM, V19, P53, DOI 10.1089/089771502753460231; Shepard MJ, 1999, SPINAL CORD, V37, P833, DOI 10.1038/sj.sc.3100927; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sotak CH, 2002, NMR BIOMED, V15, P561, DOI 10.1002/nbm.786; Sun SW, 2006, MAGN RESON MED, V55, P302, DOI 10.1002/mrm.20774; Vasudeva VS, 2014, NEUROSURGERY, V75, pN14, DOI 10.1227/01.neu.0000457194.09781.8a; Vedantam A, 2015, WORLD NEUROSURG, V83, P824, DOI 10.1016/j.wneu.2013.09.017; Vedantam A, 2014, NEUROSURGERY, V74, P1, DOI 10.1227/NEU.0000000000000171; Wang XJ, 2014, NMR BIOMED, V27, P843, DOI 10.1002/nbm.3129; Wang Y, 2015, BRAIN, V138, P1223, DOI 10.1093/brain/awv046; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Wedeen VJ, 2005, MAGN RESON MED, V54, P1377, DOI 10.1002/mrm.20642; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Wrigley PJ, 2009, CEREB CORTEX, V19, P224, DOI 10.1093/cercor/bhn072; Zalesky A, 2011, MAGN RESON IMAGING, V29, P111, DOI 10.1016/j.mri.2010.06.027	61	15	16	0	2	MDPI	BASEL	ST ALBAN-ANLAGE 66, CH-4052 BASEL, SWITZERLAND	2076-3425			BRAIN SCI	Brain Sci.	FEB	2017	7	2							21	10.3390/brainsci7020021			13	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EO9QG	WOS:000397022600008	28218643	gold, Green Submitted, Green Published			2022-02-06	
J	Tolli, A; Borg, J; Bellander, BM; Johansson, F; Hoybye, C				Tolli, A.; Borg, J.; Bellander, B. -M.; Johansson, F.; Hoybye, C.			Pituitary function within the first year after traumatic brain injury or subarachnoid haemorrhage	JOURNAL OF ENDOCRINOLOGICAL INVESTIGATION			English	Article						Pituitary; Hormone disturbance; Traumatic brain injury; Subarachnoidal haemorrhage	CHRONIC HYPOPITUITARISM; ACUTE-PHASE; HIGH-RISK; DYSFUNCTION; PREVALENCE; EPIDEMIOLOGY; INSUFFICIENCY; UNCOMMON	Purpose Reports on long-term variations in pituitary function after traumatic brain injury (TBI) and subarachnoid haemorrhage (SAH) diverge. The aim of the current study was to evaluate the prevalence and changes in pituitary function during the first year after moderate and severe TBI and SAH and to explore the relation between pituitary function and injury variables. Methods Adults with moderate and severe TBI or SAH were evaluated at 10 days, 3, 6 and 12 months post-injury/ illness. Demographic, clinical, radiological, laboratory, including hormonal data were collected. Results A total of 91 adults, 56 (15 women/41 men) with TBI and 35 (27 women/8 men) with SAH were included. Perturbations in pituitary function were frequent early after the event but declined during the first year of follow-up. The most frequent deficiency was hypogonadotrope hypogonadism which was seen in approximately 25 % of the patients. Most of the variations were transient and without clinical significance. At 12 months, two patients were on replacement with hydrocortisone, four men on testosterone and one man on replacement with growth hormone. No relations were seen between hormonal levels and injury variables. Conclusions Perturbations in pituitary function continue to occur during the first year after TBI and SAH, but only a few patients need replacement therapy. Our study could not identify a marker of increased risk of pituitary dysfunction that could guide routine screening. However, data demonstrate the need for systematic follow-up of pituitary function after moderate or severe TBI or SAH.	[Tolli, A.; Borg, J.] Danderyd Hosp, Karolinska Inst, Dept Clin Sci, S-18288 Stockholm, Sweden; [Bellander, B. -M.] Karolinska Inst, Dept Clin Neurosci, Neurosurg Sect, Stockholm, Sweden; [Johansson, F.] Danderyd Hosp, Med Lib, Stockholm, Sweden; [Hoybye, C.] Karolinska Inst, Dept Mol Med & Surg, Stockholm, Sweden; [Hoybye, C.] Karolinska Univ Hosp, Dept Endocrinol Metab & Diabetol, Stockholm, Sweden		Tolli, A (corresponding author), Danderyd Hosp, Karolinska Inst, Dept Clin Sci, S-18288 Stockholm, Sweden.	anna.tolli@ki.se		Borg, Jorgen/0000-0002-2372-7478	Pfizer, SwedenPfizer; Stockholm County Council (ALF-grants)Stockholm County Council; NovoNordiskNovo Nordisk	The study was partly funded by an unrestricted research grant from Pfizer, Sweden. Anna Tolli has received support by grants from Stockholm County Council (ALF-grants) and NovoNordisk.	Agha A, 2006, CLIN ENDOCRINOL, V64, P481, DOI 10.1111/j.1365-2265.2006.02517.x; Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Al-Khindi T, 2010, STROKE, V41, pE519, DOI 10.1161/STROKEAHA.110.581975; Andelic N, 2012, J NEUROTRAUM, V29, P66, DOI 10.1089/neu.2011.1811; Andriessen TMJC, 2011, J NEUROTRAUM, V28, P2019, DOI 10.1089/neu.2011.2034; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Bondanelli M, 2007, J NEUROTRAUM, V24, P1687, DOI 10.1089/neu.2007.0343; Braet V, 2002, EMERG MED J, V19, P510; Can A, 2016, NEUROSURGERY, V79, P253, DOI 10.1227/NEU.0000000000001157; Castinetti F, 2015, J ENDOCRINOL INVEST, V38, P1, DOI 10.1007/s40618-014-0141-2; Corneli G, 2005, EUR J ENDOCRINOL, V153, P257, DOI 10.1530/eje.1.01967; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; FISHER CM, 1980, NEUROSURGERY, V6, P1, DOI 10.1227/00006123-198001000-00001; Gardner CJ, 2013, EUR J ENDOCRINOL, V168, P473, DOI 10.1530/EJE-12-0849; Godbolt AK, 2015, J HEAD TRAUMA REHAB, V30, pE41, DOI 10.1097/HTR.0000000000000050; Godbolt AK, 2015, BMJ OPEN, V5, DOI 10.1136/bmjopen-2014-007208; Hannon MJ, 2015, CLIN ENDOCRINOL, V82, P115, DOI 10.1111/cen.12533; Hilding A, 1999, J CLIN ENDOCR METAB, V84, P2013, DOI 10.1210/jc.84.6.2013; HUNT WE, 1968, J NEUROSURG, V28, P14, DOI 10.3171/jns.1968.28.1.0014; INAGAWA T, 1995, STROKE, V26, P761, DOI 10.1161/01.STR.26.5.761; Ingall T, 2000, STROKE, V31, P1054, DOI 10.1161/01.STR.31.5.1054; JACOBS HS, 1969, BRIT MED J, V2, P595, DOI 10.1136/bmj.2.5657.595; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Khajeh L, 2015, J NEUROL NEUROSUR PS, V86, P905, DOI 10.1136/jnnp-2014-307897; Khajeh L, 2014, BMC NEUROL, V14, DOI 10.1186/s12883-014-0205-0; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2015, J CLIN MED, V4, P1480, DOI 10.3390/jcm4071480; Klose M, 2010, CLIN ENDOCRINOL, V73, P95, DOI 10.1111/j.1365-2265.2010.03791.x; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Kopczak A, 2014, J NEUROTRAUM, V31, P99, DOI 10.1089/neu.2013.3002; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Kronvall E, 2015, WORLD NEUROSURG, V83, P574, DOI 10.1016/j.wneu.2014.12.007; Kronvall E, 2014, WORLD NEUROSURG, V81, P529, DOI 10.1016/j.wneu.2013.10.038; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Marina D, 2015, EUR J ENDOCRINOL, V172, P813, DOI 10.1530/EJE-14-1152; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Schwab Karen A, 2015, Handb Clin Neurol, V128, P649, DOI 10.1016/B978-0-444-63521-1.00040-6; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Tanriverdi F, 2007, CLIN ENDOCRINOL, V67, P931, DOI 10.1111/j.1365-2265.2007.02989.x; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Tanriverdi F, 2015, ENDOCR REV, V36, P305, DOI 10.1210/er.2014-1065; TEASDALE G, 1974, LANCET, V2, P81; Tolli A, 2015, INT J CLIN MED, V6, P411, DOI DOI 10.4236/ijcm.2015.66054; Turner-Stokes L, 2005, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD004170.pub2; Turner-Stokes L, 2005, COCHRANE DB SYST REV, V3, DOI DOI 10.1016/S0079-6123(09)17707-5; Turner-Stokes L, 2008, J REHABIL MED, V40, P691, DOI 10.2340/16501977-0265; Zheng P, 2015, J NEUROSURG, V123, P75, DOI 10.3171/2014.12.JNS132308	50	15	17	0	3	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0391-4097	1720-8386		J ENDOCRINOL INVEST	J. Endocrinol. Invest.	FEB	2017	40	2					193	205		10.1007/s40618-016-0546-1			13	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	EO7OR	WOS:000396880500010	27671168	hybrid, Green Published			2022-02-06	
J	Troakes, C; Smyth, R; Noor, F; Maekawa, S; Killick, R; King, A; Al-Sarraj, S				Troakes, Claire; Smyth, Rachel; Noor, Farzana; Maekawa, Satomi; Killick, Richard; King, Andrew; Al-Sarraj, Safa			Clusterin expression is upregulated following acute head injury and localizes to astrocytes in old head injury	NEUROPATHOLOGY			English	Article						astrocytes; clusterin; head injury; neurodegeneration; timing	TRAUMATIC BRAIN-INJURY; APOLIPOPROTEIN-J EXPRESSION; MESSENGER-RNA EXPRESSION; ALZHEIMERS-DISEASE; PLASMA CLUSTERIN; RAT-BRAIN; BETA-APP; PROTEIN; RISK; COMPLEMENT	There is mounting evidence linking traumatic brain injury (TBI) to neurodegeneration. Clusterin (apolipoprotein J or ApoJ) is a complement inhibitor that appears to have a neuroprotective effect in response to tissue damage and has been reported to be upregulated in Alzheimer's disease. Here we investigated the time course and cellular expression pattern of clusterin in human TBI. Tissue from 32 patients with TBI of varying survival times (from under 30min to 10 months) was examined using immunohistochemistry for clusterin alongside other markers of neurodegeneration and neuroinflammation. TBI cases were compared to ischemic brain damage, Alzheimer's disease and controls. Double immunofluorescence was carried out in order to examine cellular expression. Clusterin was initially expressed in an axonal location less than 30min following TBI and increased in intensity and the frequency of deposits with increasing survival time up to 24h, after which it appeared to reduce in intensity but was still evident several weeks after injury. Clusterin was first evident in astrocytes after 45min, being increasingly seen up to 48h but remaining intense in TBI cases with long survival times. Our results suggest clusterin plays a role in modulating the inflammatory response of acute and chronic TBI and that it is a useful marker for TBI, particularly in cases with short survival times. Its prominent accumulation in astrocytes, alongside a mounting inflammatory response and activation of microglial cells supports a potential role in the neurodegenerative changes that occur as a result of TBI.	[Troakes, Claire; Smyth, Rachel; Noor, Farzana; Maekawa, Satomi; King, Andrew; Al-Sarraj, Safa] Kings Coll London, Inst Psychiat Psychol & Neurosci, Basic & Clin Neurosci Dept, London, England; [Killick, Richard] Kings Coll London, Inst Psychiat Psychol & Neurosci, Maurice Wohl Clin Neurosci Inst, Old Age Psychiat Dept, London, England; [King, Andrew] Kings Coll Hosp NHS Fdn Trust, Clin Neuropathol Dept, London, England		King, A (corresponding author), Kings Coll Hosp London, Dept Clin Neuropathol, Acad Neurosci Bldg,Denmark Hill, London SE5 9RS, England.	andrewking@nhs.net		Troakes, Claire/0000-0002-1790-7376	MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC); Brains for Dementia Research program - Alzheimer's Research UK; Brains for Dementia Research program - Alzheimer's Society; MRCUK Research & Innovation (UKRI)Medical Research Council UK (MRC) [G1100695, MR/M013944/1, MR/L016397/1] Funding Source: UKRI; Medical Research CouncilUK Research & Innovation (UKRI)Medical Research Council UK (MRC)European Commission [MR/L016397/1, G1100695] Funding Source: researchfish	The London Neurodegenerative Diseases Brain Bank receives funding from the MRC and as part of the Brains for Dementia Research program, jointly funded by Alzheimer's Research UK and Alzheimer's Society. We thank the staff of the Clinical Neuropathology Department at King's College Hospital for diagnostic and technical assistance. We also thank the donors and their families.	Baleriola J, 2015, NEUROTHERAPEUTICS, V12, P57, DOI 10.1007/s13311-014-0308-8; Bellander BM, 2001, J NEUROTRAUM, V18, P1295, DOI 10.1089/08977150152725605; Bramlett HM, 2004, J CEREBR BLOOD F MET, V24, P133, DOI 10.1097/01.WCB.0000111614.19196.04; Braskie MN, 2011, J NEUROSCI, V31, P6764, DOI 10.1523/JNEUROSCI.5794-10.2011; Calero M, 2000, MICROSC RES TECHNIQ, V50, P305, DOI 10.1002/1097-0029(20000815)50:4<305::AID-JEMT10>3.0.CO;2-L; Chauhan NB, 2014, RESTOR NEUROL NEUROS, V32, P337, DOI 10.3233/RNN-130354; Craggs LJL, 2016, NEUROPATH APPL NEURO, V42, P194, DOI 10.1111/nan.12248; Giannakopoulos P, 1998, ACTA NEUROPATHOL, V95, P387, DOI 10.1007/s004010050815; Guo Z, 2000, NEUROLOGY, V54, P1316, DOI 10.1212/WNL.54.6.1316; Han BH, 2001, NAT MED, V7, P338, DOI 10.1038/85487; Harold D, 2009, NAT GENET, V41, P1088, DOI 10.1038/ng.440; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Imhof A, 2006, NEUROBIOL DIS, V22, P274, DOI 10.1016/j.nbd.2005.11.009; Iwata A, 2005, J NEUROSCI RES, V82, P103, DOI 10.1002/jnr.20607; Killick R, 2014, MOL PSYCHIATR, V19, P88, DOI 10.1038/mp.2012.163; King A, 2010, NEUROPATHOLOGY, V30, P408, DOI 10.1111/j.1440-1789.2009.01085.x; Klimaschewski L, 2001, CELL TISSUE RES, V306, P209, DOI 10.1007/s004410100431; Lambri M, 2001, CLIN NEUROPATHOL, V20, P263; Maekawa S, 2009, NEUROPATHOLOGY, V29, P672, DOI 10.1111/j.1440-1789.2009.01029.x; MAY PC, 1990, NEURON, V5, P831, DOI 10.1016/0896-6273(90)90342-D; MAYEUX R, 1993, ANN NEUROL, V33, P494, DOI 10.1002/ana.410330513; McKee AC, 2015, BRAIN PATHOL, V25, P350, DOI 10.1111/bpa.12248; Mckee AC, 2009, J NEUROPATH EXP NEUR, V68, P709, DOI 10.1097/NEN.0b013e3181a9d503; Millar K, 2003, J NEUROL NEUROSUR PS, V74, P1047, DOI 10.1136/jnnp.74.8.1047; MOLGAARD CA, 1990, NEUROEPIDEMIOLOGY, V9, P233, DOI 10.1159/000110778; Mulder SD, 2014, GLIA, V62, P493, DOI 10.1002/glia.22619; Nizard P, 2007, TRAFFIC, V8, P554, DOI 10.1111/j.1600-0854.2007.00549.x; Nuutinen T, 2007, NEUROCHEM INT, V50, P540, DOI 10.1016/j.neuint.2006.11.002; Nuutinen T, 2009, BRAIN RES REV, V61, P89, DOI 10.1016/j.brainresrev.2009.05.007; PASINETTI GM, 1994, J COMP NEUROL, V339, P387, DOI 10.1002/cne.903390307; Rizzi F, 2009, J CELL PHYSIOL, V219, P314, DOI 10.1002/jcp.21671; ROBERTS GW, 1994, J NEUROL NEUROSUR PS, V57, P419, DOI 10.1136/jnnp.57.4.419; ROSENBERG ME, 1995, INT J BIOCHEM CELL B, V27, P633, DOI 10.1016/1357-2725(95)00027-M; Sasaki K, 2002, ACTA NEUROPATHOL, V103, P199, DOI 10.1007/s004010100456; Schrijvers EMC, 2011, JAMA-J AM MED ASSOC, V305, P1322, DOI 10.1001/jama.2011.381; Smith C, 2013, NEUROPATH APPL NEURO, V39, P654, DOI 10.1111/nan.12008; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Strocchi P, 1999, NEUROREPORT, V10, P1789; Tao R, 1999, J NEUROCYTOL, V28, P559, DOI 10.1023/A:1007067305837; Thambisetty M, 2010, ARCH GEN PSYCHIAT, V67, P739, DOI 10.1001/archgenpsychiatry.2010.78; Tornqvist E, 1996, NEUROBIOL AGING, V17, P695; Troakes C, 2017, NEUROPATHOLOGY, V37, P12, DOI 10.1111/neup.12320; Wiggins AK, 2003, MOL BRAIN RES, V114, P20, DOI 10.1016/S0169-328X(03)00124-4; Wright MC, 2014, J NEUROSCI, V34, P1689, DOI 10.1523/JNEUROSCI.3822-13.2014; ZWAIN IH, 1994, MOL CELL NEUROSCI, V5, P229, DOI 10.1006/mcne.1994.1027	45	15	15	1	5	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0919-6544	1440-1789		NEUROPATHOLOGY	Neuropathology	FEB	2017	37	1					12	24		10.1111/neup.12320			13	Clinical Neurology; Neurosciences; Pathology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pathology	EL5KR	WOS:000394660500002	27365216	Green Submitted			2022-02-06	
J	Cobbs, L; Hasanaj, L; Amorapanth, P; Rizzo, JR; Nolan, R; Serrano, L; Raynowska, J; Rucker, JC; Jordan, BD; Galetta, SL; Balcer, LJ				Cobbs, Lucy; Hasanaj, Lisena; Amorapanth, Prin; Rizzo, John-Ross; Nolan, Rachel; Serrano, Liliana; Raynowska, Jenelle; Rucker, Janet C.; Jordan, Barry D.; Galetta, Steven L.; Balcer, Laura J.			Mobile Universal Lexicon Evaluation System (MULES) test: A new measure of rapid picture naming for concussion	JOURNAL OF THE NEUROLOGICAL SCIENCES			English	Article						Concussion; Sports; King-Devick test; Mobile Universal Lexicon Evaluation System; Saccades; Vision	QUALITY-OF-LIFE; PERIRHINAL CORTEX; EYE-MOVEMENTS; REPRESENTATION; HIPPOCAMPUS; KNOWLEDGE; MEMORY	Objective: This study introduces a rapid picture naming test, the Mobile Universal Lexicon Evaluation System (MULES), as a novel, vision-based performance measure for concussion screening. The MULES is a visual-verbal task that includes 54 original photographs of fruits, objects and animals. We piloted MULES in a cohort of volunteers to determine feasibility, ranges of picture naming responses, and the relation of MULES time scores to those of King-Devick (K-D), a rapid number naming test. Methods: A convenience sample (n = 20, age 34 10) underwent MULES and K-D (spiral bound, iPad versions). Administration order was randomized; MULES tests were audio-recorded to provide objective data on temporal variability and ranges of picture naming responses. Results: Scores for the best of two trials for all tests were 40-50 s; average times required to name each MULES picture (0.72 +/- 0.14 s) was greater than those needed for each K-D number ((spiral: 0.33 +/- 0.05 s, iPad: 0.36 +/- 0.06 s, 120 numbers), p < 0.0001, paired t-test). MULES scores showed the greatest degree of improvement between trials (9.4 +/- 4.8 s, p < 0.0001 for trials 1 vs. 2), compared to K-D (spiral 1.5 +/- 3.3 s, iPad 1.8 +/- 3.4 s). Shorter MULES times demonstrated moderate and significant correlations with shorter iPad but not spiral K-D times (r = 0.49, p = 0.03). Conclusion: The MULES test is a rapid picture naming task that may engage more extensive neural systems than more commonly used rapid number naming tasks. Rapid picture naming may require additional processing devoted to color perception, object identification, and categorization. Both tests rely on initiation and sequencing of saccadic eye movements. (C) 2016 Elsevier B.V. All rights reserved.	[Cobbs, Lucy; Hasanaj, Lisena; Nolan, Rachel; Serrano, Liliana; Raynowska, Jenelle; Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Dept Neurol, Sch Med, 240 East 38th St,20th Floor, New York, NY 10016 USA; [Balcer, Laura J.] NYU, Sch Med, Dept Populat Hlth, New York, NY USA; [Rucker, Janet C.; Galetta, Steven L.; Balcer, Laura J.] NYU, Dept Ophthalmol, Sch Med, 550 1st Ave, New York, NY 10016 USA; [Amorapanth, Prin; Rizzo, John-Ross] NYU, Sch Med, Dept Phys Med & Rehabil, New York, NY USA; [Jordan, Barry D.] Burke Rehabil Hosp, White Plains, NY USA		Balcer, LJ (corresponding author), NYU, Dept Neurol, Sch Med, 240 East 38th St,20th Floor, New York, NY 10016 USA.	lucy.cobbs@nyumc.org; lisena.hasanaj@nyumc.org; prin.amorapanth@nyumc.org; johnross.rizzo@nyumc.org; rachel.nolan@nyumc.org; liliana.serrano2@nyumc.org; jenelle.raynowska@nyumc.org; janet.rucker@nyumc.org; bjordan@burke.org; steven.galetta@nyumc.org; laura.balcer@nyumc.org		Rizzo, John-Ross/0000-0002-4084-0085; Rucker, Janet/0000-0002-0397-0999; Amorapanth, Prin/0000-0002-4260-7826	NYU School of Medicine; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12HD001097, R01HD071978] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001073] Funding Source: NIH RePORTER	This study was supported in part by the NYU School of Medicine.	Aggleton JP, 2010, BEHAV NEUROSCI, V124, P55, DOI 10.1037/a0018320; Albasser MM, 2009, BEHAV NEUROSCI, V123, P115, DOI 10.1037/a0013829; Antunes M, 2012, COGN PROCESS, V13, P93, DOI 10.1007/s10339-011-0430-z; Cummine J, 2014, BEHAV BRAIN RES, V275, P157, DOI 10.1016/j.bbr.2014.08.038; Dhawan P., 2015, J OPT, V8, P131; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta K.M., 2016, CONCUSSION, V2; Galetta K. M., 2016, ALZHEIMER DIS ASS DI; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta KM, 2011, J NEUROL SCI, V309, P34, DOI 10.1016/j.jns.2011.07.039; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Grotheer M, 2016, J NEUROSCI, V36, P88, DOI 10.1523/JNEUROSCI.2129-15.2016; Guskiewicz KM, 2001, J ATHL TRAINING, V36, P263; Hammond RS, 2004, NEUROBIOL LEARN MEM, V82, P26, DOI 10.1016/j.nlm.2004.03.005; Hargreaves IS, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00022; Heitger MH, 2002, PROG BRAIN RES, V140, P433; Kandel Eric R, 2012, THE AGE OF INSIGHT; Kellenbach ML, 2005, CORTEX, V41, P121, DOI 10.1016/S0010-9452(08)70887-6; King D, 2013, J NEUROL SCI, V326, P59, DOI 10.1016/j.jns.2013.01.012; Kourtzi Z, 2011, ANNU REV NEUROSCI, V34, P45, DOI 10.1146/annurev-neuro-060909-153218; Lee ACH, 2006, J NEUROSCI, V26, P5198, DOI 10.1523/JNEUROSCI.3157-05.2006; Lin TP, 2014, PARKINSONISM RELAT D, V20, P226, DOI 10.1016/j.parkreldis.2013.10.009; Marinides Z, 2015, NEUROL CLIN PRACT, V5, P25, DOI DOI 10.1212/CPJ.000000000; Mayhew SD, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00075; McCrea M, 1997, NEUROLOGY, V48, P586, DOI 10.1212/WNL.48.3.586; Moster S, 2014, J NEUROL SCI, V343, P105, DOI 10.1016/j.jns.2014.05.047; Nardone A, 1997, ELECTROMYOGR MOTOR C, V105, P309, DOI 10.1016/S0924-980X(97)00040-4; Parrish RK, 1997, ARCH OPHTHALMOL-CHIC, V115, P1447, DOI 10.1001/archopht.1997.01100160617016; Pierrot-Deseilligny C, 2003, BRAIN, V126, P1460, DOI 10.1093/brain/awg148; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Raynowska J., 2016, NEUROLOGY S1, V86; Register-Mihalik JK, 2013, J ATHL TRAINING, V48, P645, DOI 10.4085/1062-6050-48.3.20; Roy JE, 2014, J COGNITIVE NEUROSCI, V26, P1283, DOI 10.1162/jocn_a_00568; Seymour KJ, 2016, CEREB CORTEX, V26, P1997, DOI 10.1093/cercor/bhv021; Shum J, 2013, J NEUROSCI, V33, P6709, DOI 10.1523/JNEUROSCI.4558-12.2013; Torres Daniel M, 2013, Neurol Clin Pract, V3, P279; Ventura RE, 2014, LANCET NEUROL, V13, P1006, DOI 10.1016/S1474-4422(14)70111-5; Watson HC, 2013, J NEUROSCI, V33, P4192, DOI 10.1523/JNEUROSCI.2075-12.2013; White OB, 2012, J NEURO-OPHTHALMOL, V32, P266, DOI 10.1097/WNO.0b013e3182688230	39	15	15	1	6	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0022-510X	1878-5883		J NEUROL SCI	J. Neurol. Sci.	JAN 15	2017	372						393	398		10.1016/j.jns.2016.10.044			6	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EJ1WZ	WOS:000393002500074	27856005	Green Accepted			2022-02-06	
J	Ucal, M; Kraitsy, K; Weidinger, A; Paier-Pourani, J; Patz, S; Fink, B; Molcanyi, M; Schafer, U				Uecal, Muammer; Kraitsy, Klaus; Weidinger, Adelheid; Paier-Pourani, Jamile; Patz, Silke; Fink, Bruno; Molcanyi, Marek; Schaefer, Ute			Comprehensive Profiling of Modulation of Nitric Oxide Levels and Mitochondrial Activity in the Injured Brain: An Experimental Study Based on the Fluid Percussion Injury Model in Rats	JOURNAL OF NEUROTRAUMA			English	Article						brain injury; fluid percussion; glutamate; mitochondria; NO	CEREBRAL-BLOOD-FLOW; CONTROLLED CORTICAL IMPACT; APOPTOTIC CELL-DEATH; OXIDATIVE DAMAGE; PROGRAMMED NECROSIS; SYNTHASE ACTIVATION; NADPH-OXIDASE; TIME-COURSE; L-ARGININE; COMPLEX-I	Nitric oxide (NO) has frequently been associated with secondary damage after brain injury. However, average NO levels in different brain regions before and after traumatic brain injury (TBI) and its role in post-TBI mitochondrial dysfunction remain unclear. In this comprehensive profiling study, we demonstrate for the first time that basal NO levels vary significantly in the healthy cortex (0.44 +/- 0.04 mu M), hippocampus (0.26 +/- 0.03 mu M), and cerebellum (1.24 +/- 0.08 mu M). Within 4 h of severe lateral fluid percussion injury, NO levels almost doubled in these regions, thereby preserving regional differences in NO levels. TBI-induced NO generation was associated with inducible NO synthase (iNOS) increase in ipsilateral but not in contralateral regions. The transient NO increase resulted in a persistent tyrosine nitration adjacent to the injury site. Nitrosative stress-associated cell loss via apoptosis and receptor-interacting serine/threonine-protein kinase 3 (RIPK3)-mediated necrosis were also observed in the ipsilateral cortex, despite high levels of NO in the contralateral cortex. NO-mediated impairment of mitochondrial state 3 respiration dependent on complex I substrates was transient and confined to the ipsilateral cortex. Our results demonstrate that NO dynamics and associated effects differ in various regions of the injured brain. A potential association between the observed mitochondrial electron flow through complex I, but not complex II, and the modulation of TBI induced NO levels in different brain regions has to be prospectively analyzed in more detail.	[Uecal, Muammer; Kraitsy, Klaus; Patz, Silke; Schaefer, Ute] Med Univ Graz, Dept Neurosurg, Res Unit Expt Neurotraumatol, Graz, Austria; [Weidinger, Adelheid; Paier-Pourani, Jamile] Ludwig Boltzmann Inst Clin & Expt Traumatol, Vienna, Austria; [Fink, Bruno] NOXYGEN Sci Transfer & Diagnost GmbH, Elzach, Germany; [Molcanyi, Marek] Univ Cologne, Fac Med, Inst Neurophysiol, Cologne, Germany		Schafer, U (corresponding author), Auenbruggerpl 2 2, A-8036 Graz, Austria.	ute.schaefer@medunigraz.at			BioPersMed (COMET K-project) [825329]; Austrian Federal Ministry of Transport, Innovation, and Technology (BMVIT); Austrian Federal Ministry of Economy, Family, and Youth (BMWFJ); Styrian Business Promotion Agency (SFG)	This work was supported by BioPersMed (COMET K-project 825329), which is funded by the Austrian Federal Ministry of Transport, Innovation, and Technology (BMVIT); the Austrian Federal Ministry of Economy, Family, and Youth (BMWFJ); and the Styrian Business Promotion Agency (SFG).	Abdul-Muneer PM, 2013, FREE RADICAL BIO MED, V60, P282, DOI 10.1016/j.freeradbiomed.2013.02.029; Ahn MJ, 2004, J NEUROTRAUM, V21, P1431, DOI 10.1089/neu.2004.21.1431; Almeida A, 2001, J NEUROCHEM, V77, P676, DOI 10.1046/j.1471-4159.2001.00276.x; Ansari MA, 2008, FREE RADICAL BIO MED, V45, P443, DOI 10.1016/j.freeradbiomed.2008.04.038; Ansari MA, 2014, FREE RADICAL BIO MED, V77, P21, DOI 10.1016/j.freeradbiomed.2014.08.025; Antunes F, 2004, P NATL ACAD SCI USA, V101, P16774, DOI 10.1073/pnas.0405368101; Bayir H, 2005, J CEREBR BLOOD F MET, V25, P673, DOI 10.1038/sj.jcbfm.9600068; Borutaite V, 2003, FREE RADICAL BIO MED, V35, P1457, DOI 10.1016/j.freeradbiomed.2003.08.003; Brown GC, 2004, BBA-BIOENERGETICS, V1658, P44, DOI 10.1016/j.bbabio.2004.03.016; Brown GC, 2007, CARDIOVASC RES, V75, P283, DOI 10.1016/j.cardiores.2007.03.022; Brown GC, 2010, NITRIC OXIDE-BIOL CH, V23, P153, DOI 10.1016/j.niox.2010.06.001; Carreira BP, 2010, STEM CELLS, V28, P1219, DOI 10.1002/stem.444; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Cherian L, 2003, J NEUROTRAUM, V20, P77, DOI 10.1089/08977150360517209; Cheung THC, 2005, BMC NEUROSCI, V6, DOI 10.1186/1471-2202-6-36; Cho Y, 2009, CELL, V137, P1112, DOI 10.1016/j.cell.2009.05.037; Christopherson KS, 1999, J BIOL CHEM, V274, P27467, DOI 10.1074/jbc.274.39.27467; Davis CW, 2010, FREE RADICAL BIO MED, V48, P306, DOI 10.1016/j.freeradbiomed.2009.11.001; Dedon PC, 2004, ARCH BIOCHEM BIOPHYS, V423, P12, DOI 10.1016/j.abb.2003.12.017; DINERMAN JL, 1994, P NATL ACAD SCI USA, V91, P4214, DOI 10.1073/pnas.91.10.4214; Fujii H, 1999, MAGNET RESON MED, V42, P599, DOI 10.1002/(SICI)1522-2594(199909)42:3<599::AID-MRM24>3.3.CO;2-P; Gahm C, 2000, NEUROSURGERY, V46, P169, DOI 10.1093/neurosurgery/46.1.169; Gahm C, 2006, J NEUROTRAUM, V23, P1343, DOI 10.1089/neu.2006.23.1343; Gilmer LK, 2010, J NEUROTRAUM, V27, P939, DOI 10.1089/neu.2009.1181; Greenwood MT, 1997, BIOCHEM BIOPH RES CO, V238, P617, DOI 10.1006/bbrc.1997.7361; Guix FX, 2005, PROG NEUROBIOL, V76, P126, DOI 10.1016/j.pneurobio.2005.06.001; Hara S, 2004, NEUROSCI LETT, V366, P302, DOI 10.1016/j.neulet.2004.05.055; Higgins GC, 2012, FREE RADICAL BIO MED, V53, P1960, DOI 10.1016/j.freeradbiomed.2012.08.586; Hlatky R, 2003, J CEREBR BLOOD F MET, V23, P582, DOI 10.1097/01.WCB.0000059586.71206.F3; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Jung CS, 2014, INT J MOL SCI, V15, P4088, DOI 10.3390/ijms15034088; Keane RW, 2001, J CEREBR BLOOD F MET, V21, P1189, DOI 10.1097/00004647-200110000-00007; Kim YS, 2007, MOL CELL, V26, P675, DOI 10.1016/j.molcel.2007.04.021; Knoblach SM, 2002, J NEUROTRAUM, V19, P1039, DOI 10.1089/089771502760341956; Kraitsy K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0097750; Lau A, 2006, J NEUROSCI, V26, P11540, DOI 10.1523/JNEUROSCI.3507-06.2006; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mbye LH, 2008, EXP NEUROL, V209, P243, DOI 10.1016/j.expneurol.2007.09.025; MCINTOSH TK, 1989, NEUROSCIENCE, V28, P233, DOI 10.1016/0306-4522(89)90247-9; MITROVIC B, 1995, NEUROSCIENCE, V65, P531, DOI 10.1016/0306-4522(94)00491-M; Molcanyi M, 2007, J NEUROTRAUM, V24, P625, DOI 10.1089/neu.2006.0180; Mustafa AG, 2010, J NEUROCHEM, V114, P271, DOI 10.1111/j.1471-4159.2010.06749.x; Northington FJ, 2011, J CEREBR BLOOD F MET, V31, P178, DOI 10.1038/jcbfm.2010.72; Oliva AA, 2012, J NEUROCHEM, V120, P710, DOI 10.1111/j.1471-4159.2011.07610.x; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Packer MA, 2003, P NATL ACAD SCI USA, V100, P9566, DOI 10.1073/pnas.1633579100; Prast H, 2001, PROG NEUROBIOL, V64, P51, DOI 10.1016/S0301-0082(00)00044-7; RINK A, 1995, AM J PATHOL, V147, P1575; ROSKAMS AJ, 1994, NEURON, V13, P289; Royo NC, 2006, EUR J NEUROSCI, V23, P1089, DOI 10.1111/j.1460-9568.2006.04642.x; Santos RM, 2011, NEUROCHEM INT, V59, P90, DOI 10.1016/j.neuint.2011.05.016; SAXON DW, 1994, NEUROREPORT, V5, P809, DOI 10.1097/00001756-199403000-00018; Sharma AC, 1998, NEUROL RES, V20, P632; Shi QL, 2011, J BIOL CHEM, V286, P17640, DOI 10.1074/jbc.M110.203018; Singh IN, 2007, J NEUROSCI RES, V85, P2216, DOI 10.1002/jnr.21360; Singh IN, 2006, J CEREBR BLOOD F MET, V26, P1407, DOI 10.1038/sj.jcbfm.9600297; Takuma K, 2002, JPN J PHARMACOL, V89, P64, DOI 10.1254/jjp.89.64; Toda N, 2009, PHARMACOL REV, V61, P62, DOI 10.1124/pr.108.000547; Tomura S, 2012, J CEREBR BLOOD F MET, V32, P1939, DOI 10.1038/jcbfm.2012.99; Trabace L, 2004, BRAIN RES, V1008, P293, DOI 10.1016/j.brainres.2004.01.090; Uchiyama T, 2002, J MOL CELL CARDIOL, V34, P1049, DOI 10.1006/jmcc.2002.2045; Verweij BH, 1997, NEUROL RES, V19, P334, DOI 10.1080/01616412.1997.11740821; Vink R, 1990, J NEUROTRAUM, V7, P21, DOI 10.1089/neu.1990.7.21; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; Watson William D, 2013, Front Neuroenergetics, V5, P12, DOI 10.3389/fnene.2013.00012; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067; Xiong Y, 1998, J NEUROTRAUM, V15, P531, DOI 10.1089/neu.1998.15.531; Xiong Y, 1997, J NEUROTRAUM, V14, P23, DOI 10.1089/neu.1997.14.23; You ZR, 2008, J CEREBR BLOOD F MET, V28, P1564, DOI 10.1038/jcbfm.2008.44; Yuksel H, 2013, NEUROL SCI, V34, P1941, DOI 10.1007/s10072-013-1411-z; Zhang DW, 2009, SCIENCE, V325, P332, DOI 10.1126/science.1172308; Zhou P, 2005, J CEREBR BLOOD F MET, V25, P348, DOI 10.1038/sj.jcbfm.9600036; Ziaja M, 2007, J NEUROTRAUM, V24, P1845, DOI 10.1089/neu.2007.0303	74	15	15	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JAN 15	2017	34	2					475	486		10.1089/neu.2016.4411			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EH4QD	WOS:000391754800023	27165518				2022-02-06	
J	Altaf, F; Griesdale, DE; Belanger, L; Ritchie, L; Markez, J; Ailon, T; Boyd, MC; Paquette, S; Fisher, CG; Street, J; Dvorak, MF; Kwon, BK				Altaf, F.; Griesdale, D. E.; Belanger, L.; Ritchie, L.; Markez, J.; Ailon, T.; Boyd, M. C.; Paquette, S.; Fisher, C. G.; Street, J.; Dvorak, M. F.; Kwon, B. K.			The differential effects of norepinephrine and dopamine on cerebrospinal fluid pressure and spinal cord perfusion pressure after acute human spinal cord injury	SPINAL CORD			English	Article							TRAUMATIC BRAIN-INJURY; CORTICAL IMPACT INJURY; MANAGEMENT; AUTOREGULATION; MECHANISMS; EDEMA; RATS	Study design: Prospective vasopressor cross-over interventional study Objectives: To examine how two vasopressors used in acute traumatic spinal cord injury (SCI) affect intrathecal cerebrospinal fluid pressure and the corresponding spinal cord perfusion pressure (SCPP). Setting: Vancouver, British Columbia, Canada. Methods: Acute SCI patients over the age of 17 with cervical or thoracic ASIA Impairment Scale (AIS). A, B or C injuries were enrolled in this study. Two vasopressors, norepinephrine and dopamine, were evaluated in a 'crossover procedure' to directly compare their effect on the intrathecal pressure (ITP). The vasopressor cross-over procedures were performed in the intensive care unit where ITP, mean arterial pressure (MAP) and heart rate were being continuously measured. The SCPP was calculated as the difference between MAP and ITP. Results: A total of 11 patients were enrolled and included in our analysis. There were 6 patients with AIS A, 3 with AIS B and 2 with AIS C injuries at baseline. We performed 24 cross-over interventions in these 11 patients. There was no difference in MAP with the use of norepinephrine versus dopamine (84 +/- 1 mm Hg for both; P=0.33). Conversely, ITP was significantly lower with the use of norepinephrine than with dopamine (17 +/- 1 mm Hg vs 20 +/- 1 mm Hg, respectively, P<0.001). This decrease in ITP with norepinephrine resulted in an increased SCPP during the norepinephrine infusion when compared with dopamine (67 +/- 1 mm Hg vs 65 +/- 1 mm Hg respectively, P=0.0049). Conclusion: Norepinephrine was able to maintain MAP with a lower ITP and a correspondingly higher SCPP as compared with dopamine in this study. These results suggest that norepinephrine may be preferable to dopamine if vasopressor support is required post SCI to maintain elevated MAPs in accordance with published guidelines.	[Altaf, F.; Fisher, C. G.; Street, J.; Dvorak, M. F.; Kwon, B. K.] Univ British Columbia, Dept Orthopaed, Vancouver Spine Surg Inst, Blusson Spinal Cord Ctr, 6th Floor,818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada; [Griesdale, D. E.] Univ British Columbia Crit Care Med, Vancouver Gen Hosp, Dept Anesthesiol Pharmacol & Therapeut, Div Crit Care, Vancouver, BC, Canada; [Belanger, L.; Ritchie, L.] Vancouver Gen Hosp, Vancouver Spine Res Program, Vancouver, BC, Canada; [Markez, J.] Vancouver Gen Hosp, Dept Biomed Engn, Vancouver, BC, Canada; [Ailon, T.; Boyd, M. C.; Paquette, S.] Univ British Columbia, Vancouver Spine Surg Inst, Div Neurosurg, Dept Surg, Vancouver, BC, Canada; [Street, J.; Dvorak, M. F.; Kwon, B. K.] Blusson Spinal Cord Ctr, Int Collaborat Repair Discoveries ICORD, Vancouver, BC, Canada		Kwon, BK (corresponding author), Univ British Columbia, Dept Orthopaed, Vancouver Spine Surg Inst, Blusson Spinal Cord Ctr, 6th Floor,818 West 10th Ave, Vancouver, BC V5Z 1M9, Canada.	Brian.Kwon@ubc.ca	Griesdale, Donald/AAT-7762-2021	Griesdale, Donald/0000-0001-5985-8624; Dvorak, Marcel/0000-0002-9404-8448; Ailon, Tamir/0000-0002-1966-5323	Michael Smith Foundation for Health ResearchMichael Smith Foundation for Health Research; Craig H. Neilsen Foundation; Rick Hansen Institute (RHI); VGH & UBC Hospital Foundation Best of Health Fund	We acknowledge the research staff of the Vancouver Spine Research Program, in particular Allan Aludino, Leilani Reichl, Angela Tsang and Jiwan Gill for their assistance with this study. We also acknowledge support for the conduct of this study from the Michael Smith Foundation for Health Research, the Craig H. Neilsen Foundation and the Rick Hansen Institute (RHI), including Daniel Rogers of RHI for project management. Dr Griesdale is supported by the VGH & UBC Hospital Foundation Best of Health Fund. MFD holds the Paetzold Chair in Spinal Cord Injury Research. FKK holds the Canada Research Chair in Spinal Cord Injury and VGH & UBC Hospital Foundation Dvorak Chair in Spine Trauma.	Armstead WM, 2013, PEDIATR CRIT CARE ME, V14, pE103, DOI 10.1097/PCC.0b013e3182712b44; Beaumont A, 2000, ACT NEUR S, V76, P147; Casha S, 2011, J NEUROTRAUM, V28, P1479, DOI 10.1089/neu.2009.1156; Clifton GL, 2001, J NEUROSURG, V95, P751, DOI 10.3171/jns.2001.95.5.0751; Consortium for Spinal Cord Medicine, 2008, J SPINAL CORD MED, V31, P403; Di Gennaro JL, 2010, DEV NEUROSCI-BASEL, V32, P420, DOI 10.1159/000322083; Dumont RJ, 2001, CLIN NEUROPHARMACOL, V24, P254, DOI 10.1097/00002826-200109000-00002; Eriksen VR, 2014, ACTA PAEDIATR, V103, P1221, DOI 10.1111/apa.12817; Hadley Mark N, 2002, Clin Neurosurg, V49, P407; Hawryluk G, 2015, J NEUROTRAUM, V32, P1958, DOI 10.1089/neu.2014.3778; Inoue T, 2014, J NEUROTRAUM, V31, P284, DOI 10.1089/neu.2013.3061; Johnston AJ, 2004, INTENS CARE MED, V30, P791, DOI 10.1007/s00134-003-2155-7; Kong CY, 2013, SPINAL CORD, V51, P466, DOI 10.1038/sc.2013.32; Kroppenstedt SN, 2002, ACT NEUR S, V81, P225; Kroppenstedt SN, 2002, J NEUROTRAUM, V19, P1421, DOI 10.1089/089771502320914651; Kwon BK, 2010, J NEUROTRAUM, V27, P669, DOI 10.1089/neu.2009.1080; Kwon BK, 2009, J NEUROSURG-SPINE, V10, P181, DOI 10.3171/2008.10.SPINE08217; LEVI L, 1993, NEUROSURGERY, V33, P1007, DOI 10.1097/00006123-199312000-00008; Muzevich KM, 2009, NEUROCRIT CARE, V11, P112, DOI 10.1007/s12028-009-9214-z; Pfister D, 2008, EUR J ANAESTH, V25, P98, DOI 10.1017/S0265021507003407; Phang I, 2015, NEUROCRIT CARE, V23, P414, DOI 10.1007/s12028-015-0153-6; Ract C, 2001, INTENS CARE MED, V27, P101, DOI 10.1007/s001340000754; Readdy WJ, 2015, J NEUROSURG SPINE; Ryken TC, 2013, NEUROSURGERY, V72, P84, DOI 10.1227/NEU.0b013e318276ee16; Sookplung P, 2011, NEUROCRIT CARE, V15, P46, DOI 10.1007/s12028-010-9448-9; Steiner LA, 2004, CRIT CARE MED, V32, P1049, DOI 10.1097/01.CCM.0000120054.32845.A6; Tator C H, 1996, J Spinal Cord Med, V19, P206; TATOR CH, 1991, J NEUROSURG, V75, P15, DOI 10.3171/jns.1991.75.1.0015; Vale FL, 1997, J NEUROSURG, V87, P239, DOI 10.3171/jns.1997.87.2.0239; Varsos GV, 2015, J NEUROSURG-SPINE, V14, P1; Werndle MC, 2014, CRIT CARE MED, V42, P646, DOI 10.1097/CCM.0000000000000028	31	15	16	1	3	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	JAN	2017	55	1					33	38		10.1038/sc.2016.79			6	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	EK9XA	WOS:000394276000006	27271117	Bronze			2022-02-06	
J	Bacon, CEW; Erickson, CD; Kay, MC; Weber, ML; McLeod, TCV				Bacon, Cailee E. Welch; Erickson, Casey D.; Kay, Melissa C.; Weber, Michelle L.; McLeod, Tamara C. Valovich			School nurses' perceptions and experiences with an interprofessional concussion management team in the secondary school setting	JOURNAL OF INTERPROFESSIONAL CARE			English	Article						Cognitive rest; concussion policy; education and awareness; interprofessional collaboration; qualitative research; return-to-learn; teamwork	ATHLETIC TRAINERS; SPORT; RETURN; COLLABORATION; PROVIDERS; STATEMENT; KNOWLEDGE; EDUCATION; SERVICES; ENHANCE	Following a concussion, both cognitive and physical rest are imperative aspects of injury management. The inclusion of academic adjustments and the formation of an interprofessional concussion management team (ICMT) provide a mechanism to manage academic issues following a concussion. As one of the sole healthcare providers presents during school hours, the school nurse may offer unique insight regarding the infrastructure of an ICMT in the secondary school setting. The purpose of this study was to explore school nurses' perceptions of and experiences with an ICMT for adolescents following a concussion in the secondary school setting. The consensual qualitative research approach was used to guide this study. Semi-structured individual telephone interviews were conducted with 15 school nurses employed in the secondary school setting across the United States. During data analysis, themes and categories were established based on a consensus process by the research team. Study findings indicated that school nurses identified several stakeholders regarding the concussion management team that are essential to include in the concussion management process. In addition to the school nurse, participants perceived an ICMT should include a physician, athletic trainer, school counsellor, teachers, and other stakeholders such as the patient and their parents. Additionally, participants discussed their perceptions of their own role as a member of an ICMT in the secondary school setting. The inclusion of an ICMT to aid the recovery following a concussion is vital to ensure proper care for the adolescent patient. Furthermore, the school nurse and athletic trainer must effectively collaborate, when possible, to ensure that concussed adolescents are allowed sufficient cognitive rest via the incorporation of academic adjustments during the recovery process.	[Bacon, Cailee E. Welch; Erickson, Casey D.; McLeod, Tamara C. Valovich] AT Still Univ, Athlet Training Programs, 5850 E Still Circle, Mesa, AZ 85206 USA; [Bacon, Cailee E. Welch; McLeod, Tamara C. Valovich] AT Still Univ, Sch Osteopath Med Arizona, 5850 E Still Circle, Mesa, AZ 85206 USA; [Kay, Melissa C.] Univ North Carolina Chapel Hill, Dept Exercise Sci, Chapel Hill, NC USA; [Weber, Michelle L.] Univ Georgia, Dept Kinesiol, Athens, GA 30602 USA		Bacon, CEW (corresponding author), AT Still Univ, Athlet Training Programs, 5850 E Still Circle, Mesa, AZ 85206 USA.; Bacon, CEW (corresponding author), AT Still Univ, Sch Osteopath Med Arizona, 5850 E Still Circle, Mesa, AZ 85206 USA.	cwelch@atsu.edu	Valovich McLeod, Tamara/AAU-9435-2020	Valovich McLeod, Tamara/0000-0001-9082-8722	A.T. Still University Strategic Research Fund	The A.T. Still University Strategic Research Fund provided financial support for this investigation.	Arbogast KB, 2016, JAMA PEDIATR, V170, DOI 10.1001/jamapediatrics.2016.0294; Baker JG, 2014, INT J CLIN PRACT, V68, P1286, DOI 10.1111/ijcp.12517; Baxter SK, 2008, J INTERPROF CARE, V22, P239, DOI 10.1080/13561820802054655; Beatty K, 2010, J RURAL HEALTH, V26, P248, DOI 10.1111/j.1748-0361.2010.00285.x; Blakely Thomas J, 2015, Care Manag J, V16, P184, DOI 10.1891/1521-0987.16.4.184; Broglio SP, 2014, J ATHL TRAINING, V49, P245, DOI 10.4085/1062-6050-49.1.07; Bryan MA, 2016, PEDIATRICS, V138, DOI 10.1542/peds.2015-4635; Corbin J., 2015, BASICS QUALITATIVE R, V4; Cremer J. A, 2016, 10642 U MONT; Croker A, 2012, J INTERPROF CARE, V26, P13, DOI 10.3109/13561820.2011.623802; Diaz Anne L, 2013, NASN Sch Nurse, V28, P110; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Halstead ME, 2013, PEDIATRICS, V132, P948, DOI 10.1542/peds.2013-2867; Harvey HH, 2013, AM J PUBLIC HEALTH, V103, P1249, DOI 10.2105/AJPH.2012.301107; Hill CE, 2005, J COUNS PSYCHOL, V52, P196, DOI 10.1037/0022-0167.52.2.196; Hill CE, 1997, COUNS PSYCHOL, V25, P517, DOI 10.1177/0011000097254001; Hossler P., 2014, PRINCIPALS RES REV, V9, P1; Iverson GL, 2016, PHYS MED REH CLIN N, V27, P429, DOI 10.1016/j.pmr.2015.12.002; Kvarnstrom S, 2008, J INTERPROF CARE, V22, P191, DOI 10.1080/13561820701760600; Lueke L, 2011, J LEGAL MED, V32, P483, DOI 10.1080/01947648.2011.632710; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McGrath N, 2010, J ATHL TRAINING, V45, P492, DOI 10.4085/1062-6050-45.5.492; Minthorn L. M., 2014, J ATHL TRAINING, V49, pS140; Moser RS, 2015, BRAIN INJURY, V29, P58, DOI 10.3109/02699052.2014.964771; Mummert DK, 2014, J ATHL TRAINING, V49, pS142; Patton MQ., 2015, QUALITATIVE RES EVAL, V4; Phan K, 2012, ATHL TRAIN ED J, V7, P103; Pleacher MD, 2006, BRIT J SPORT MED, V40, DOI 10.1136/bjsm.2005.019067; Pryor RR, 2015, J ATHL TRAINING, V50, P156, DOI 10.4085/1062-6050-50.2.03; Rains C., 2010, NASN SCH NURSE, V25, P5, DOI DOI 10.1177/1942602X10376672; Richards KAR, 2015, EUR PHYS EDUC REV, V21, P379, DOI 10.1177/1356336X15574367; Rivara FP, 2014, AM J SPORT MED, V42, P1197, DOI 10.1177/0363546514521774; Sady MD, 2011, PHYS MED REH CLIN N, V22, P701, DOI 10.1016/j.pmr.2011.08.008; Schmies H, 2014, J PHYS EDUC RECREAT, V85, P5, DOI 10.1080/07303084.2014.946845; Thrasher AB, 2015, J ATHL TRAINING, V50, P321, DOI 10.4085/1062-6050-49.3.67; Valovich McLeod TC, 2015, KINESIOL REV, V4, P131, DOI DOI 10.1123/KR.2015-0007; Weber ML, 2015, J SCH NURS, V31, P146, DOI 10.1177/1059840514540939; Welch Bacon C. E, J ATHLETIC IN PRESS; Welch CE, 2014, J ATHL TRAINING, V49, P220, DOI 10.4085/1062-6050-49.2.14; Welch CE, 2014, J ATHL TRAINING, V49, P234, DOI 10.4085/1062-6050-49.2.15; Wing R, 2016, CLIN PEDIATR, V55, P228, DOI 10.1177/0009922815592879; Zonfrillo MR, 2012, PEDIATRICS, V130, P1120, DOI 10.1542/peds.2012-1431	42	15	16	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1356-1820	1469-9567		J INTERPROF CARE	J. Interprofessional Care		2017	31	6					725	733		10.1080/13561820.2017.1345873			9	Health Care Sciences & Services; Health Policy & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	FO2KW	WOS:000416607500007	28876140				2022-02-06	
J	Chakravarty, S; Jhelum, P; Bhat, UA; Rajan, WD; Maitra, S; Pathak, SS; Patel, AB; Kumar, A				Chakravarty, Sumana; Jhelum, Priya; Bhat, Unis Ahmad; Rajan, Wenson D.; Maitra, Swati; Pathak, Salil S.; Patel, Anant B.; Kumar, Arvind			Insights into the epigenetic mechanisms involving histone lysine methylation and demethylation in ischemia induced damage and repair has therapeutic implication	BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR BASIS OF DISEASE			English	Article						Cerebral ischemia; Magnetic resonance imaging (MRI); Inflammatory markers; Histone lysine methyl transferases (KMTs); Histone lysine demethylases (KDMs); Dimethyloxalylglycine (DMOG)	FOCAL CEREBRAL-ISCHEMIA; INTERNAL CAROTID-ARTERY; HYPOXIA-INDUCIBLE FACTOR-1-ALPHA; TRAUMATIC BRAIN-INJURY; GENE-EXPRESSION; CHROMATIN REGULATION; COMPLETE OCCLUSION; OXIDATIVE STRESS; MOUSE MODEL; CELL-DEATH	Cerebral ischemic stroke is one of the leading causes of death and disability worldwide. Therapeutic interventions to minimize ischemia-induced neural damage are limited due to poor understanding of molecular mechanisms mediating complex pathophysiology in stroke. Recently, epigenetic mechanisms mostly histone lysine (K) acetylation and deacetylation have been implicated in ischemic brain damage and have expanded the dimensions of potential therapeutic intervention to the systemic/local administration of histone deacetylase inhibitors. However, the role of other epigenetic mechanisms such as histone lysine methylation and demethylation in stroke-induced damage and subsequent recovery process is elusive. Here, we established an Internal Carotid Artery Occlusion (ICAO) model in CD1 mouse that resulted in mild to moderate level of ischemic damage to the striatum, as suggested by magnetic resonance imaging (MRI), TUNEL and histopathological staining along with an evaluation of neurological deficit score (NDS), grip strength and rotarod performance. The molecular investigations show dysregulation of a number of histone lysine methylases (KMTs) and few of histone lysine demethylases (KDMs) post-ICAO with significant global attenuation in the transcriptionally repressive epigenetic mark H3K9me2 in the striatum. Administration of Dimethyloxalylglycine (DMOG), an inhibitor of KDM4 or JMJD2 class of histone lysine demethylases, significantly ameliorated stroke-induced NDS by restoring perturbed H3K9me2 levels in the ischemia-affected striatum. Overall, these results highlight the novel role of epigenetic regulatory mechanisms controlling the epigenetic mark H3K9me2 in mediating the stroke-induced striatal damage and subsequent repair following mild to moderate cerebral ischemia. (C) 2016 Elsevier B.V. All rights reserved.	[Chakravarty, Sumana; Jhelum, Priya; Maitra, Swati] CSIR, IICT, Chem Biol Div, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India; [Bhat, Unis Ahmad; Rajan, Wenson D.; Pathak, Salil S.; Patel, Anant B.; Kumar, Arvind] CSIR, CCMB, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India		Chakravarty, S (corresponding author), CSIR, IICT, Chem Biol Div, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.; Kumar, A (corresponding author), CSIR, CCMB, Epigenet & Neuropsychiat Disorders Lab, Uppal Rd, Hyderabad 500007, Andhra Pradesh, India.	sumanachak@iict.res.in; akumar@ccmb.res.in	Chakravarty, Sumana/AAW-2823-2021	Chakravarty, Sumana/0000-0001-8223-6508	Department of Biotechnology [BT/PR14338/MED/30/495/2010]; Council of Scientific and Industrial Research (CSIR)Council of Scientific & Industrial Research (CSIR) - India [BSC0103-UNDO]; CSIR, IndiaCouncil of Scientific & Industrial Research (CSIR) - India	This research was initiated under a grant of the Department of Biotechnology [BT/PR14338/MED/30/495/2010 to SC] and supported by the Council of Scientific and Industrial Research (CSIR) network project (BSC0103-UNDO to SC and AK). UAB, SM, and SSP wish to thank CSIR, India for the award of research fellowships. The authors also would like to acknowledge Mrs. B. Jyothilakshmi of CCMB for the maintenance and care of animals throughout the study.	Adhami F, 2006, AM J PATHOL, V169, P566, DOI 10.2353/ajpath.2006.051066; Aminova LR, 2005, J BIOL CHEM, V280, P3996, DOI 10.1074/jbc.M409223200; Aspey BS, 2000, NEUROPATH APPL NEURO, V26, P232, DOI 10.1046/j.1365-2990.2000.00221.x; Baranova O, 2007, J NEUROSCI, V27, P6320, DOI 10.1523/JNEUROSCI.0449-07.2007; Barber PA, 2004, STROKE, V35, P1720, DOI 10.1161/01.STR.0000129653.22241.d7; BEDERSON JB, 1986, STROKE, V17, P1304, DOI 10.1161/01.STR.17.6.1304; Bergeron M, 1999, EUR J NEUROSCI, V11, P4159, DOI 10.1046/j.1460-9568.1999.00845.x; Berti R, 2002, J CEREBR BLOOD F MET, V22, P1068, DOI 10.1097/00004647-200209000-00004; Bouet V, 2007, EXP NEUROL, V203, P555, DOI 10.1016/j.expneurol.2006.09.006; Chen HB, 2006, CANCER RES, V66, P9009, DOI 10.1158/0008-5472.CAN-06-0101; Chisholm NC, 2015, EPIGENETICS-US, V10, P142, DOI 10.1080/15592294.2014.1001219; Corbo JC, 2002, J NEUROSCI, V22, P7548; Covington HE, 2011, NEURON, V71, P656, DOI 10.1016/j.neuron.2011.06.007; Dell'Aversana C, 2012, EXP CELL RES, V318, P1229, DOI 10.1016/j.yexcr.2012.01.025; Doerfler W, 2008, EPIGENETICS-US, V3, P125, DOI 10.4161/epi.3.3.6249; Donnan GA, 2008, LANCET, V371, P1612, DOI 10.1016/S0140-6736(08)60694-7; DYKEN ML, 1974, ARCH NEUROL-CHICAGO, V30, P343, DOI 10.1001/archneur.1974.00490350001001; Endres M, 2000, J NEUROSCI, V20, P3175, DOI 10.1523/JNEUROSCI.20-09-03175.2000; Faraco G, 2006, MOL PHARMACOL, V70, P1876, DOI 10.1124/mol.106.027912; Felling RJ, 2015, EXP NEUROL, V268, P37, DOI 10.1016/j.expneurol.2014.09.017; FISHER M, 1954, AMA ARCH NEUROL PSY, V72, P187, DOI 10.1001/archneurpsyc.1954.02330020055006; Flaherty ML, 2004, STROKE, V35, pE349, DOI 10.1161/01.STR.0000135024.54608.3f; Formisano L, 2007, P NATL ACAD SCI USA, V104, P4170, DOI 10.1073/pnas.0611704104; Formisano L, 2015, J NEUROSCI, V35, P7332, DOI 10.1523/JNEUROSCI.2174-14.2015; Hallenbeck JM, 2002, NAT MED, V8, P1363, DOI 10.1038/nm1202-1363; Hamada S, 2009, BIOORG MED CHEM LETT, V19, P2852, DOI 10.1016/j.bmcl.2009.03.098; HAMM RJ, 1994, J NEUROTRAUM, V11, P187, DOI 10.1089/neu.1994.11.187; HEBBES TR, 1988, EMBO J, V7, P1395, DOI 10.1002/j.1460-2075.1988.tb02956.x; HEILBRUN MP, 1982, NEUROSURGERY, V11, P239; Jhelum P., 2014, NEW DIMENSIONS CHEM; Jin R, 2010, J LEUKOCYTE BIOL, V87, P779, DOI 10.1189/jlb.1109766; Jorgensen H S, 1999, Phys Med Rehabil Clin N Am, V10, P887; Kim H.J., 2007, J PHARMACOL EXP THER, V321, P892; Kumar A, 2005, NEURON, V48, P303, DOI 10.1016/j.neuron.2005.09.023; Leahy KM, 2002, CANCER RES, V62, P625; Leng X, 2015, J NEUROL NEUROSUR PS; LONGA EZ, 1989, STROKE, V20, P84, DOI 10.1161/01.STR.20.1.84; MACRAE IM, 1992, BRIT J CLIN PHARMACO, V34, P302; Marks PA, 2010, BBA-GENE REGUL MECH, V1799, P717, DOI 10.1016/j.bbagrm.2010.05.008; MCAULEY MA, 1995, CEREBROVAS BRAIN MET, V7, P153; Mead GE, 1998, AGE AGEING, V27, P677, DOI 10.1093/ageing/27.6.677; Moskowitz MA, 2010, NEURON, V67, P181, DOI 10.1016/j.neuron.2010.07.002; Nagel S, 2011, J CEREBR BLOOD F MET, V31, P132, DOI 10.1038/jcbfm.2010.60; Narlikar GJ, 2002, CELL, V108, P475, DOI 10.1016/S0092-8674(02)00654-2; Norflus F, 2004, NEUROBIOL DIS, V17, P319, DOI 10.1016/j.nbd.2004.07.011; Ogle ME, 2012, NEUROBIOL DIS, V45, P733, DOI 10.1016/j.nbd.2011.10.020; Palmer GC, 2001, ANN NY ACAD SCI, V939, P283; Qureshi IA, 2010, ARCH NEUROL-CHICAGO, V67, P1316, DOI 10.1001/archneurol.2010.275; Ren M, 2004, J NEUROCHEM, V89, P1358, DOI 10.1111/j.1471-4159.2004.02406.x; SAUNDERS DE, 1995, STROKE, V26, P2272, DOI 10.1161/01.STR.26.12.2272; Schneider A, 1999, NAT MED, V5, P554, DOI 10.1038/8432; Schweizer S., 2015, J CEREB BLOOD FLOW M; Schweizer S, 2013, J CEREBR BLOOD F MET, V33, P1335, DOI 10.1038/jcbfm.2013.93; Shi HL, 2009, CURR MED CHEM, V16, P4593, DOI 10.2174/092986709789760779; SHIGENO T, 1985, J NEUROSURG, V63, P272, DOI 10.3171/jns.1985.63.2.0272; Stenzel-Poore MP, 2007, STROKE, V38, P680, DOI 10.1161/01.STR.0000251444.56487.4c; SUNDT TM, 1969, J NEUROSURG, V31, P311, DOI 10.3171/jns.1969.31.3.0311; TAMURA A, 1981, J CEREBR BLOOD F MET, V1, P53, DOI 10.1038/jcbfm.1981.6; Thanvi B, 2007, POSTGRAD MED J, V83, P95, DOI 10.1136/pgmj.2006.048041; THIELE BL, 1980, NEUROLOGY, V30, P1041, DOI 10.1212/WNL.30.10.1041; Thompson JW, 2013, NEUROTHERAPEUTICS, V10, P789, DOI 10.1007/s13311-013-0202-9; Thurman R. J., 2012, EMERG MED PRACT, V14, P26; Thurman R Jason, 2012, Emerg Med Pract, V14, P1; Tsankova N, 2007, NAT REV NEUROSCI, V8, P355, DOI 10.1038/nrn2132; Tsankova NM, 2006, NAT NEUROSCI, V9, P519, DOI 10.1038/nn1659; Tsankova NM, 2004, J NEUROSCI, V24, P5603, DOI 10.1523/JNEUROSCI.0589-04.2004; van Everdingen KJ, 1998, ANN NEUROL, V44, P167, DOI 10.1002/ana.410440206; Wang R, 2014, CELL PHYSIOL BIOCHEM, V34, P854, DOI 10.1159/000366304; White TE, 2013, BMC GENOMICS, V14, DOI 10.1186/1471-2164-14-282; Wilkinson MB, 2009, J NEUROSCI, V29, P7820, DOI 10.1523/JNEUROSCI.0932-09.2009; Yan G, 2015, MOL MED REP, V11, P4109, DOI 10.3892/mmr.2015.3283; Yeh SH, 2011, BRAIN PATHOL, V21, P249, DOI 10.1111/j.1750-3639.2010.00443.x; Yin DL, 2003, J CEREBR BLOOD F MET, V23, P855, DOI 10.1097/01.WCB.0000073946.29308.55; Zhang YZ, 2010, NEUROSCI RES, V68, P66, DOI 10.1016/j.neures.2010.06.002; Zhao HP, 2016, AGING DIS, V7, P295, DOI 10.14336/AD.2015.1009; Ziemka-Nalecz M, 2014, ACTA NEUROBIOL EXP, V74, P383	76	15	15	1	8	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0925-4439	0006-3002		BBA-MOL BASIS DIS	Biochim. Biophys. Acta-Mol. Basis Dis.	JAN	2017	1863	1					152	164		10.1016/j.bbadis.2016.09.014			13	Biochemistry & Molecular Biology; Biophysics; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Biophysics; Cell Biology	EF9BJ	WOS:000390625400016	27664837	Bronze			2022-02-06	
J	Cicuendez, M; Castano-Leon, A; Ramos, A; Hilario, A; Gomez, PA; Lagares, A				Cicuendez, Marta; Castano-Leon, Ana; Ramos, Ana; Hilario, Amaya; Gomez, Pedro A.; Lagares, Alfonso			Prognostic value of corpus callosum injuries in severe head trauma	ACTA NEUROCHIRURGICA			English	Article						Traumatic axonal injury; Corpus callosum injury; Traumatic brain injury; Severe head trauma; Magnetic resonance imaging	DIFFUSE AXONAL INJURY; BRAIN-INJURY; MAGNETIC-RESONANCE; MRI; IMPACT; STEM; CLASSIFICATION; VALIDATION; INTEGRITY; DIAGNOSIS	Background This study was performed to investigate the relationship between corpus callosum (CC) injury and prognosis in traumatic axonal injury (TAI). Method We retrospectively reviewed 264 patients with severe head trauma who underwent a conventional MR imaging in the first 60 days after injury. They were selected from a prospectively collected database of 1048 patients with severe head trauma admitted in our hospital. TAI lesions were defined as areas of increased signal intensity on T2 and FLAIR or areas of decreased signal on gradient-echo T2. We attempted to determine whether any MR imaging findings of TAI lesions at CC could be related to prognosis. Neurological impairment was assessed at 1 year after injury by means of GOS-E (good outcome being GOS-E 4/5 and bad outcome being GOS-E < 4). We adjusted the multivariable analysis for the prognostic factors according to the IMPACT studies: the Core model (age, motor score at admission, and pupillary reactivity) and the Extended model (including CT information and second insults). Results We found 97 patients (37 %) with TAI at CC and 167 patients (63 %) without CC lesions at MR. A total of 62 % of the patients with CC lesions had poor outcome, whereas 38% showed good prognosis. The presence of TAI lesions at the corpus callosum was associated with poor outcome 1 year after brain trauma (p < 0.001, OR 3.8, 95 % CI: 2.04-7.06). The volume of CC lesions measured on T2 and FLAIR sequences was negatively correlated with the GOS-E after adjustment for independent prognostic factors (p = 0.01, OR 2.23, 95 % CI: 1.17-4.26). Also the presence of lesions at splenium was statistically related to worse prognosis (p = 0.002, OR 8.1, 95 % CI: 2.2-29.82). We did not find statistical significance in outcome between hemorrhagic and non-hemorrhagic CC lesions. Conclusions The presence of CC is associated with a poor outcome. The total volume of the CC lesion is an independent prognostic factor for poor outcome in severe head trauma.	[Cicuendez, Marta] Hosp Univ Vall dHebron, Dept Neurosurg, Barcelona, Spain; [Castano-Leon, Ana; Gomez, Pedro A.; Lagares, Alfonso] Univ Complutense Madrid, Inst Invest I 12, Dept Neurosurg, Hosp Univ Octubre 12, Madrid, Spain; [Ramos, Ana; Hilario, Amaya] Univ Complutense Madrid, Hosp Univ Octubre 12, Dept Neuroradiol, Madrid, Spain		Cicuendez, M (corresponding author), Hosp Univ Vall dHebron, Dept Neurosurg, Barcelona, Spain.	marta.cicuendez@gmail.com	Castano-Leon, Ana M/ABF-6322-2020; Lagares, Alfonso/B-2969-2011; Gomez, Pedro/N-5051-2019	Castano-Leon, Ana M/0000-0002-7918-5049; Lagares, Alfonso/0000-0003-3996-0554; Gomez, Pedro/0000-0002-4185-5238	ISCIIIInstituto de Salud Carlos III; FEDER European institutions [PI14/0157]	This research was jointly funded by the ISCIII and FEDER European institutions, with FIS project number PI14/0157. The sponsor had no role in the design or conduct of this research.	ADAMS JH, 1989, HISTOPATHOLOGY, V15, P49, DOI 10.1111/j.1365-2559.1989.tb03040.x; Bullock MR, 1996, J NEUROTRAUM, V13, P641, DOI 10.1089/neu.1996.13.641; Chastain CA, 2009, J NEUROTRAUM, V26, P1183, DOI 10.1089/neu.2008.0650; Dennis EL, 2015, J NEUROSCI, V35, P10202, DOI 10.1523/JNEUROSCI.1595-15.2015; Firsching R, 2001, ACTA NEUROCHIR, V143, P263; Firsching R, 1998, J NEUROSURG, V89, P707, DOI 10.3171/jns.1998.89.5.0707; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; GENTRY LR, 1988, AM J ROENTGENOL, V150, P663, DOI 10.2214/ajr.150.3.663; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; Hilario A, 2012, AM J NEURORADIOL, V33, P1925, DOI 10.3174/ajnr.A3092; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Jennett B, 1996, J NEUROL NEUROSUR PS, V60, P362, DOI 10.1136/jnnp.60.4.362; Kampfl A, 1998, LANCET, V351, P1763, DOI 10.1016/S0140-6736(97)10301-4; Lagares A, 2006, NEUROCIRUGIA, V17, P105; Lagares A, 2009, ACTA NEUROCHIR, V151, P341, DOI 10.1007/s00701-009-0194-8; Leibson CL, 2011, EPIDEMIOLOGY, V22, P836, DOI 10.1097/EDE.0b013e318231d535; Maas AIR, 2013, LANCET NEUROL, V12, P1200, DOI 10.1016/S1474-4422(13)70234-5; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Messori A, 2003, NEURORADIOLOGY, V45, P881, DOI 10.1007/s00234-003-1048-3; Moen KG, 2014, J NEUROTRAUM, V31, P1486, DOI 10.1089/neu.2013.3258; Moen KG, 2014, J NEUROTRAUM, V31, P56, DOI 10.1089/neu.2013.3000; Moen KG, 2012, J NEUROL NEUROSUR PS, V83, P1193, DOI 10.1136/jnnp-2012-302644; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; OMMAYA AK, 1974, BRAIN, V97, P633, DOI 10.1093/brain/97.1.633; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Paterakis K, 2000, J TRAUMA, V49, P1071, DOI 10.1097/00005373-200012000-00016; Pierallini A, 2000, NEURORADIOLOGY, V42, P860, DOI 10.1007/s002340000447; Scheid R, 2003, AM J NEURORADIOL, V24, P1049; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573	31	15	15	0	3	SPRINGER WIEN	WIEN	SACHSENPLATZ 4-6, PO BOX 89, A-1201 WIEN, AUSTRIA	0001-6268	0942-0940		ACTA NEUROCHIR	Acta Neurochir.	JAN	2017	159	1					25	32		10.1007/s00701-016-3000-4			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EJ2EE	WOS:000393022000009	27796652				2022-02-06	
J	Clark, AL; Bangen, KJ; Sorg, SF; Schiehser, DM; Evangelista, ND; McKenna, B; Liu, TT; Delano-Wood, L				Clark, Alexandra L.; Bangen, Katherine J.; Sorg, Scott F.; Schiehser, Dawn M.; Evangelista, Nicole D.; McKenna, Benjamin; Liu, Thomas T.; Delano-Wood, Lisa			Dynamic association between perfusion and white matter integrity across time since injury in Veterans with history of TBI	NEUROIMAGE-CLINICAL			English	Article						Perfusion; Arterial spin labeling; ASL; Cerebral blood flow; CBF; White matter microstructure; Diffusion tensor imaging; DTI; Traumatic brain injury; TBI; Time since injury; White matter	TRAUMATIC BRAIN-INJURY; CEREBRAL-BLOOD-FLOW; POSTTRAUMATIC-STRESS-DISORDER; DIFFUSION-TENSOR; POSTCONCUSSIVE SYMPTOMS; COGNITIVE DYSFUNCTION; RISK-FACTORS; BLAST; NEUROPATHOLOGY; ABNORMALITIES	Objective: Cerebral blood flow (CBF) plays a critical role in the maintenance of neuronal integrity, and CBF alterations have been linked to deleterious white matter changes. Although both CBF and white matter microstructural alterations have been observed within the context of traumatic brain injury (TBI), the degree to which these pathological changes relate to one another and whether this association is altered by time since injury have not been examined. The current study therefore sought to clarify associations between resting CBF and white matter microstructure post-TBI. Methods: 37 veterans with history of mild or moderate TBI (mmTBI) underwent neuroimaging and completed health and psychiatric symptom questionnaires. Resting CBF was measured with multiphase pseudocontinuous arterial spin labeling (MPPCASL), and white matter microstructural integrity was measured with diffusion tensor imaging (DTI). The cingulate cortex and cingulum bundle were selected as a priori regions of interest for the ASL and DTI data, respectively, given the known vulnerability of these regions to TBI. Results: Regression analyses controlling for age, sex, and posttraumatic stress disorder (PTSD) symptoms revealed a significant time since injury x resting CBF interaction for the left cingulum (p < 0.005). Decreased CBF was significantly associated with reduced cingulum fractional anisotropy (FA) in the chronic phase; however, no such association was observed for participants with less remote TBI. Conclusions: Our results showed that reduced CBF was associated with poorer white matter integrity in those who were further removed from their brain injury. Findings provide preliminary evidence of a possible dynamic association between CBF and white matter microstructure that warrants additional consideration within the context of the negative long-term clinical outcomes frequently observed in those with history of TBI. Additional cross-disciplinary studies integrating multiple imaging modalities (e.g., DTI, ASL) and refined neuropsychiatric assessment are needed to better understand the nature, temporal course, and dynamic association between brain changes and clinical outcomes post-injury. Published by Elsevier Inc.	[Clark, Alexandra L.] San Diego State Univ Univ Calif San Diego SDSU UC, La Jolla, CA 92093 USA; [Clark, Alexandra L.; Bangen, Katherine J.; Sorg, Scott F.; Schiehser, Dawn M.; Evangelista, Nicole D.; McKenna, Benjamin; Delano-Wood, Lisa] VASDHS, San Diego, CA USA; [Schiehser, Dawn M.; Delano-Wood, Lisa] VASDHS, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Bangen, Katherine J.; Sorg, Scott F.; Schiehser, Dawn M.; Evangelista, Nicole D.; McKenna, Benjamin; Delano-Wood, Lisa] Univ Calif San Diego, Sch Med, Dept Psychiat, La Jolla, CA 92093 USA; [Liu, Thomas T.] Univ Calif San Diego, Dept Radiol, Keck Ctr Funct MRI, La Jolla, CA 92093 USA		Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst 151B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ldelano@ucsd.edu		mcKenna, Benjamin/0000-0002-5607-6376; Liu, Thomas/0000-0002-1978-7486	Veterans Affair [2-065-10S, 829-MR-NB-25860]; Department of Defense Investigator-Initiated Research [W81XWH-10-2-0169]	This work was supported by grants awarded by the Veterans Affairs: a Career Development Award to D.S. (2-065-10S) and Merit Award to L.D.-W(829-MR-NB-25860). This work was further supported by a Department of Defense Investigator-Initiated Research Grant to L.D.-W. (W81XWH-10-2-0169).	Appelman APA, 2008, J CEREBR BLOOD F MET, V28, P633, DOI 10.1038/sj.jcbfm.9600563; Bangen KJ, 2014, FRONT AGING NEUROSCI, V6, DOI 10.3389/fnagi.2014.00159; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Beason-Held LL, 2012, STROKE, V43, P1542, DOI 10.1161/STROKEAHA.111.638437; Beck A. T., 1996, MANUAL BECK DEPRESSI, VII; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bernbaum M, 2015, J CEREBR BLOOD F MET, V35, P1610, DOI 10.1038/jcbfm.2015.92; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Bigler ED, 2013, NEUROPSYCHOL REV, V23, P169, DOI 10.1007/s11065-013-9237-2; Bigler ED, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00395; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blennow K, 2012, NEURON, V76, P886, DOI 10.1016/j.neuron.2012.11.021; Brenner Lisa A, 2011, Dialogues Clin Neurosci, V13, P311; Brickman AM, 2009, PSYCHIAT RES-NEUROIM, V172, P117, DOI 10.1016/j.pscychresns.2008.11.006; Burke JF, 2013, NEUROLOGY, V81, P33, DOI 10.1212/WNL.0b013e318297eecf; Burzynska AZ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0120315; Chalela JA, 2000, STROKE, V31, P680, DOI 10.1161/01.STR.31.3.680; Chatelin S, 2011, J MECH BEHAV BIOMED, V4, P1905, DOI 10.1016/j.jmbbm.2011.06.007; Chen JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0062082, 10.1371/journal.pone.0066841, 10.1371/journal.pone.0069704]; Chen YH, 2011, STROKE, V42, P2733, DOI 10.1161/STROKEAHA.111.620112; Clark AL, 2016, BRAIN IMAGING BEHAV, V11, P1; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Cox RW, 1996, COMPUT BIOMED RES, V29, P162, DOI 10.1006/cbmr.1996.0014; Croall ID, 2014, NEUROLOGY, V83, P494, DOI 10.1212/WNL.0000000000000666; Dale AM, 1999, NEUROIMAGE, V9, P179, DOI 10.1006/nimg.1998.0395; Defense and Veterans Brain Injury Center, 2016, DEP DEF NUMB TBI WOR; DeKosky ST, 2013, NAT REV NEUROL, V9, P192, DOI 10.1038/nrneurol.2013.36; Delano-Wood L, 2015, BRAIN IMAGING BEHAV, V9, P500, DOI 10.1007/s11682-015-9432-2; Department of Veterans Affairs and Department of Defense, 2009, VA DOD CLIN PRACT GU; Desikan RS, 2006, NEUROIMAGE, V31, P968, DOI 10.1016/j.neuroimage.2006.01.021; Doshi H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118061; Duering M, 2012, NEUROLOGY, V79, P2025, DOI 10.1212/WNL.0b013e3182749f39; Eierud C, 2014, NEUROIMAGE-CLIN, V4, P283, DOI 10.1016/j.nicl.2013.12.009; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Fridley J, 2015, J NEUROTRAUM, V32, P75, DOI 10.1089/neu.2014.3350; Ge YL, 2009, BRAIN INJURY, V23, P666, DOI 10.1080/02699050903014899; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Johnson VE, 2013, BRAIN, V136, P28, DOI 10.1093/brain/aws322; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Jorge RE, 2012, AM J PSYCHIAT, V169, P1284, DOI 10.1176/appi.ajp.2012.12050600; Jung Y, 2010, MAGN RESON MED, V64, P799, DOI 10.1002/mrm.22465; Kenney K., 2015, EXP NEUROL; King PR, 2012, J REHABIL RES DEV, V49, P879, DOI 10.1682/JRRD.2011.03.0051; LaPlaca MC, 2007, PROG BRAIN RES, V161, P13, DOI 10.1016/S0079-6123(06)61002-9; LaPlaca MC, 2010, J BIOMECH, V43, P71, DOI 10.1016/j.jbiomech.2009.09.011; Lee YK, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062422; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lippa SM, 2015, J TRAUMA STRESS, V28, P25, DOI 10.1002/jts.21979; Lippa SM, 2010, J INT NEUROPSYCH SOC, V16, P856, DOI 10.1017/S1355617710000743; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Magnuson J, 2012, CURR NEUROL NEUROSCI, V12, P570, DOI 10.1007/s11910-012-0303-6; Maillard P, 2015, NEUROBIOL AGING, V36, P1670, DOI 10.1016/j.neurobiolaging.2015.01.007; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McAllister TW, 2001, J CLIN EXP NEUROPSYC, V23, P775, DOI 10.1076/jcen.23.6.775.1026; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Metting Z, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064461; Miller DR, 2016, HUM BRAIN MAPP, V37, P220, DOI 10.1002/hbm.23022; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; O'Sullivan M, 2002, NEUROLOGY, V59, P321, DOI 10.1212/WNL.59.3.321; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Ponto LLB, 2016, J NEUROPSYCH CLIN N, V28, P89, DOI 10.1176/appi.neuropsych.15050106; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Promjunyakul N, 2015, NEUROIMAGE-CLIN, V8, P224, DOI 10.1016/j.nicl.2015.04.012; Promjunyakul NO, 2016, J CEREBR BLOOD F MET, V36, P1528, DOI 10.1177/0271678X16651268; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Salat DH, 2014, NEUROSCIENCE, V276, P174, DOI 10.1016/j.neuroscience.2013.11.041; Schiehser DM, 2015, J HEAD TRAUMA REHAB, V30, pE21, DOI 10.1097/HTR.0000000000000065; Shin DD, 2013, FRONT NEUROINFORM, V7, DOI 10.3389/fninf.2013.00021; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Steketee RME, 2016, NEUROBIOL AGING, V43, P119, DOI 10.1016/j.neurobiolaging.2016.03.031; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Tanielian T., 2008, INVISIBLE WOUNDS WAR; ten Dam VH, 2007, RADIOLOGY, V243, P198, DOI 10.1148/radiol.2431052111; Terrio HP, 2011, REHABIL PSYCHOL, V56, P26, DOI 10.1037/a0022685; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Vanderploeg RD, 2007, J CLIN EXP NEUROPSYC, V29, P585, DOI 10.1080/13803390600826587; Vas A, 2016, NEUROPSYCHOL REHABIL, V26, P502, DOI 10.1080/09602011.2015.1044013; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Wada T, 2012, AM J NEURORADIOL, V33, P2117, DOI 10.3174/ajnr.A3141; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Warden D, 2006, J HEAD TRAUMA REHAB, V21, P398, DOI 10.1097/00001199-200609000-00004; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wilde EA, 2015, BRAIN IMAGING BEHAV, V9, P367, DOI 10.1007/s11682-015-9444-y; Wirth M., 2016, J CEREB BLOOD FLOW M; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeh PH, 2017, HUM BRAIN MAPP, V38, P352, DOI 10.1002/hbm.23365; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	93	15	16	1	1	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2017	14						308	315		10.1016/j.nicl.2016.12.017			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	FB2OY	WOS:000405984300033	28210542	Green Published, gold			2022-02-06	
J	Clark, JM; Hoshizaki, TB; Gilchrist, MD				Clark, J. Michio; Hoshizaki, T. Blaine; Gilchrist, Michael D.			Protective capacity of an ice hockey goaltender helmet for three events associated with concussion	COMPUTER METHODS IN BIOMECHANICS AND BIOMEDICAL ENGINEERING			English	Article						Brain injury; impact biomechanics; dynamic response; finite element modeling; brain tissue response	TRAUMATIC BRAIN-INJURY; SYSTEMATIC VIDEO ANALYSIS; ACCIDENT RECONSTRUCTION; PROFESSIONAL FOOTBALL; HEAD-INJURIES; LEAGUE NHL; IMPACT; BIOMECHANICS; PLAYER; MECHANISMS	The purpose of this study was to assess the protective capacity of an ice hockey goaltender helmet for three concussive impact events. A helmeted and unhelmeted headform was used to test three common impact events in ice hockey (fall, puck impacts and shoulder collisions). Peak linear acceleration, rotational acceleration and rotational velocity as well as maximum principal strain and von Mises stress were measured for each impact condition. The results demonstrated the tested ice hockey goaltender helmet was well designed to manage fall and puck impacts but does not consistently protect against shoulder collisions and an opportunity may exist to improve helmet designs to better protect goaltenders from shoulder collisions.	[Clark, J. Michio; Gilchrist, Michael D.] Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland; [Clark, J. Michio; Hoshizaki, T. Blaine; Gilchrist, Michael D.] Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada		Clark, JM (corresponding author), Univ Coll Dublin, Sch Mech & Mat Engn, Dublin, Ireland.; Clark, JM (corresponding author), Univ Ottawa, Sch Human Kinet, Ottawa, ON, Canada.	michio.clark@ucd.i.e			Ontario Graduate Scholarship in Science and Technology; European Union's Horizon 2020 research and innovation programme under the Marie Skiodowska-Curie [642, 662]	This work was supported by Ontario Graduate Scholarship in Science and Technology (to J.M.C); European Union's Horizon 2020 research and innovation programme under the Marie Skiodowska-Curie [grant agreement number 642,662].	Agel J, 2007, J ATHL TRAINING, V42, P241; American Society for Testing and Materials, 2014, F158712A ASTM INT, DOI [10.1520/F1587-12A, DOI 10.1520/F1587-12A]; Bancroft RW, 1993, SAFETY ICE HOCKEY, V2, DOI [10.1520/STP13121S, DOI 10.1520/STP13121S]; Benson BW, 2011, CAN MED ASSOC J, V183, P905, DOI 10.1503/cmaj.092190; Beusenberg MC., 2000, P INT RES C BIOM IMP; Canadian Standards Association, 2009, Z262109 CAN STAND AS; Canadian Standards Association, 2009, Z262209 CAN STAND AS; Cantu RC, 1996, BRIT J SPORT MED, V30, P289, DOI 10.1136/bjsm.30.4.289; Clark J. M, 2015, EVALUATION PROTECTIV; Clark JM, 2016, ISBS C TSUKUBA JAPAN, V1, P395; da Silva V. D., 2005, MECH STRENGTH MAT; Delaney JS, 2004, CLIN J SPORT MED, V14, P80, DOI 10.1097/00042752-200403000-00005; DENG YC, 1989, ACCIDENT ANAL PREV, V21, P85, DOI 10.1016/0001-4575(89)90051-1; Doorly M. C., 2006, Computer Methods in Biomechanics and Biomedical Engineering, V9, P371, DOI 10.1080/10255840601003551; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Forero Rueda MA, 2009, EQUESTRIAN HELMET DE; Gilchrist MD, 2003, KEY ENG MATER, V245-2, P417, DOI 10.4028/www.scientific.net/KEM.245-246.417; Goodman D, 2001, MED SCI SPORT EXER, V33, P2004, DOI 10.1097/00005768-200112000-00005; Hardy W N, 2001, Stapp Car Crash J, V45, P337; Horgan TJ, 2004, INT J CRASHWORTHINES, V9, P401, DOI 10.1533/ijcr.2004.0299; Horgan TJ, 2003, INT J CRASHWORTHINES, V8, P353, DOI 10.1533/cras.8.4.353.19278; Hoshizaki T Blaine, 2014, Neurosurgery, V75 Suppl 4, pS136, DOI 10.1227/NEU.0000000000000496; Hoshizaki TB, 2012, P I MECH ENG P-J SPO, V226, P226, DOI 10.1177/1754337112448765; Hunt H, 1989, P IRCOBI STOCKH SWED; Hutchison MG, 2015, BRIT J SPORT MED, V49, P552, DOI 10.1136/bjsports-2013-092235; Hutchison MG, 2015, BRIT J SPORT MED, V49, P547, DOI 10.1136/bjsports-2013-092234; International Organization for Standardization, 2003, 10256 ISO; KELLY JP, 1991, JAMA-J AM MED ASSOC, V266, P2867, DOI 10.1001/jama.266.20.2867; Kendall M., 2016, COMP CHARACTERIZATIO; Kendall M., 2012, INT RES COUNC BIOM I, P430, DOI DOI 10.1016/J.JECP.2012.07.001; Kendall M, 2014, AM SOC TEST MATER, V1552, P142, DOI 10.1520/STP155220120150; Kleiven S, 2002, P IRCOBI, P161; Kleiven S, 2007, STAPP CAR CRASH JO, V51, P81; LaPrade R, 2009, P 5 INT S SAF IC HOC, DOI [10.1520/STP48862S, DOI 10.1520/STP48862S]; Liberman M, 2007, CLIN J SPORT MED, V17, P61, DOI 10.1097/01.jsm.0000168072.44003.98; Marchie A, 2003, CAN MED ASSOC J, V169, P124; McIntosh AS, 2000, MED SCI SPORT EXER, V32, P1980, DOI 10.1097/00005768-200012000-00002; Molsa J, 1997, AM J SPORT MED, V25, P495, DOI 10.1177/036354659702500412; Nahum AM, 1977, P 21 STAPP CAR CRASH, P337; Newman JA, 2005, J BIOMECH, V38, P1469, DOI 10.1016/j.jbiomech.2004.06.025; Nur Sarah, 2015, Sports Biomech, V14, P459, DOI 10.1080/14763141.2015.1084035; Ouckama R., 2014, IRCOBI P, P62; PADGAONKAR AJ, 1975, J APPL MECH-T ASME, V42, P552, DOI 10.1115/1.3423640; Pashby T, 2001, CLIN J SPORT MED, V11, P211, DOI 10.1097/00042752-200110000-00001; Post A, SPORTS ENG; Post A., 2014, P IRCOBI C BERL GERM, P72; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; Post A, 2015, J MECH BEHAV BIOMED, V41, P325, DOI 10.1016/j.jmbbm.2014.07.034; Post A, 2013, COMPUT METHOD BIOMEC, V16, P511, DOI 10.1080/10255842.2011.627559; Post A, 2012, P I MECH ENG P-J SPO, V226, P200, DOI 10.1177/1754337112449420; Powell JW, 2001, J ATHL TRAINING, V36, P307; Rousseau P, 2014, AM SOC TEST MATER, V1552, P196, DOI 10.1520/STP155220120159; Rousseau P, 2009, P I MECH ENG P-J SPO, V223, P159, DOI 10.1243/17543371JSET36; Rousseau P, 2009, P 5 INT S SAF IC HOC; Rousseau P., 2014, ANAL CONCUSSION METR; Rousseau P, 2015, SPORT BIOMECH, V14, P57, DOI 10.1080/14763141.2015.1025236; Rowson S, 2012, ANN BIOMED ENG, V40, P1, DOI 10.1007/s10439-011-0392-4; Ruan J. S., 1994, IMPACT BIOMECHANICS; Seemann M. R., 1986, P 30 STAPP CAR CRASH, V30, P291; Sim F, 1977, AM J SPORTS MED, V6, P378; Smith TA, 2015, SPORTS ENG, V18, P165, DOI 10.1007/s12283-015-0175-5; Trosseille X, 1992, 01487191 SAE, P19; Viano DC, 2007, NEUROSURGERY, V61, P313, DOI 10.1227/01.NEU.0000279969.02685.D0; Viano DC, 2005, NEUROSURGERY, V56, P266, DOI 10.1227/01.neu.0000150035.54230.3C; Walsh E. S, 2012, P I MECH ENG P; Walsh ES, 2012, P ASTM S MECH CONC S; Wennberg RA, 2003, CAN J NEUROL SCI, V30, P206, DOI 10.1017/S0317167100002596; Willinger R, 2003, INT J CRASHWORTHINES, V8, P605, DOI 10.1533/ijcr.2003.0264; WILLINGER R, 1995, J NEUROTRAUM, V12, P743, DOI 10.1089/neu.1995.12.743; WILLINGER R, 1994, ACCIDENT ANAL PREV, V26, P767, DOI 10.1016/0001-4575(94)90053-1; Zhang LY, 2004, J BIOMECH ENG-T ASME, V126, P226, DOI 10.1115/1.1691446; Zhou C., 1995, P STAPP CAR CRASH J, P121	72	15	15	0	2	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1025-5842	1476-8259		COMPUT METHOD BIOMEC	Comput. Methods Biomech. Biomed. Eng.		2017	20	12					1299	1311		10.1080/10255842.2017.1341977			13	Computer Science, Interdisciplinary Applications; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Computer Science; Engineering	FH0GM	WOS:000410817600004	28685612	Green Accepted			2022-02-06	
J	Flatt, JD; Williams, BA; Barnes, D; Goldenson, J; Ahalt, C				Flatt, Jason D.; Williams, Brie A.; Barnes, Deborah; Goldenson, Joe; Ahalt, Cyrus			Post-traumatic stress disorder symptoms and associated health and social vulnerabilities in older jail inmates	AGING & MENTAL HEALTH			English	Article						PTSD; incarceration; geriatric; health	TRAUMATIC BRAIN-INJURY; MEDICAL CONDITIONS; COMBAT EXPOSURE; PRISON; ADULTS; PTSD; PREVALENCE; LIFETIME; RISK; CARE	Objectives: To examine post-traumatic stress disorder (PTSD) symptoms in older jail inmates, and to determine whether adverse social and health-related characteristics were associated with having PTSD symptoms.Method: We performed an exploratory cross-sectional study of 238 older (age 55 years) jail inmates from a county jail. PTSD symptoms were determined using the Primary Care PTSD (PC-PTSD) screen. Reporting three or more PTSD symptoms was defined as a positive screen. Descriptive statistics and multiple regression analyses were used to examine the prevalence of a positive PTSD screen and associations with social and health-related characteristics.Results: The mean age was 59years, 64% were Black, and 82% reported an annual income $15,000. Nearly 40% of older jail inmates had a positive PTSD screen and 10% reported a prior PTSD diagnosis by a physician. Older jail inmates with a positive PTSD screen were significantly more likely than those with a negative PTSD screen to report medication insecurity in the past year, impairment in two or more activities of daily living, traumatic brain injury, pain in the past week, and poor self-rated health.Conclusion: Over one in three of the older jail inmates in this study had a positive PTSD screen, though only one in five of those with a positive screen reported a prior PTSD diagnosis. Screening for PTSD in jails may help identify older inmates who would benefit from additional mental health treatment and reentry planning to improve health in this population.	[Flatt, Jason D.] Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA 94143 USA; [Williams, Brie A.; Ahalt, Cyrus] Univ Calif San Francisco, Dept Med, Div Geriatr, San Francisco, CA USA; [Flatt, Jason D.; Williams, Brie A.; Barnes, Deborah] San Francisco VA Med Ctr, San Francisco, CA 94121 USA; [Barnes, Deborah] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA USA; [Goldenson, Joe] San Francisco Dept Publ Hlth, Jail Hlth Serv, San Francisco, CA USA		Flatt, JD (corresponding author), Univ Calif San Francisco, Inst Hlth & Aging, San Francisco, CA 94143 USA.; Flatt, JD (corresponding author), San Francisco VA Med Ctr, San Francisco, CA 94121 USA.	Jason.Flatt@ucsf.edu		Flatt, Jason/0000-0003-1244-738X	National Institute of AgingUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG044281]; Jacob & Valeria Langeloth Foundation; Tideswell at UCSF; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [P30AG044281] Funding Source: NIH RePORTER	This work was supported by the National Institute of Aging [grant number P30AG044281], the Jacob & Valeria Langeloth Foundation, and Tideswell at UCSF. These funding sources had no role in the preparation, review, or approval of the manuscript. Drs Flatt, Barnes and Williams are employees of the Department of Veterans Affairs. The opinions expressed in this manuscript may not represent those of the VA. The views expressed herein do not necessarily reflect the official policies of the City and County of San Francisco; nor does mention of the San Francisco Department of Public Health imply its endorsement.	Ardino V, 2012, EUR J PSYCHOTRAUMATO, V3, DOI 10.3402/ejpt.v3i0.18968; Asmundson GJG, 2000, BEHAV RES THER, V38, P203, DOI 10.1016/S0005-7967(99)00061-3; Baillargeon J, 2009, AM J PSYCHIAT, V166, P103, DOI 10.1176/appi.ajp.2008.08030416; Beck A., 2010, SEXUAL VICTIMIZATION, P26; Beck A. J., 2006, URB I JAIL REENTR RO; Binswanger IA, 2009, J EPIDEMIOL COMMUN H, V63, P912, DOI 10.1136/jech.2009.090662; Binswanger IA, 2007, NEW ENGL J MED, V356, P157, DOI 10.1056/NEJMsa064115; Binswanger IA, 2012, J URBAN HEALTH, V89, P98, DOI 10.1007/s11524-011-9614-1; Bottche M, 2012, INT J GERIATR PSYCH, V27, P230, DOI 10.1002/gps.2725; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; BUSH TL, 1989, AM J PUBLIC HEALTH, V79, P1554, DOI 10.2105/AJPH.79.11.1554; Calhoun PS, 2010, PSYCHIAT RES, V178, P330, DOI 10.1016/j.psychres.2009.11.009; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chodos AH, 2014, AM J PUBLIC HEALTH, V104, P1728, DOI 10.2105/AJPH.2014.301952; Christie-Maples J., 2012, MEDICAID COVERAGE IN; Dannefer D, 2003, J GERONTOL B-PSYCHOL, V58, pS327, DOI 10.1093/geronb/58.6.S327; Elbogen EB, 2012, J CONSULT CLIN PSYCH, V80, P1097, DOI 10.1037/a0029967; Goff Ashley, 2007, Crim Behav Ment Health, V17, P152; Hanson RK, 2012, CRIM JUSTICE BEHAV, V39, P1391, DOI 10.1177/0093854812449217; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Haugebrook Sabrina, 2010, J Correct Health Care, V16, P220, DOI 10.1177/1078345810367482; Hills H., 2004, EFFECTIVE PRISON MEN; Jenkinson C, 1997, J PUBLIC HEALTH MED, V19, P179, DOI 10.1093/oxfordjournals.pubmed.a024606; Kaba F, 2015, AM J PUBLIC HEALTH, V105, P1911, DOI 10.2105/AJPH.2015.302699; Kang S, 2016, GERONTOLOGIST, V56, P22, DOI 10.1093/geront/gnv120; Kennedy JE, 2007, J REHABIL RES DEV, V44, P895, DOI 10.1682/JRRD.2006.12.0166; Kimerling R, 2006, ADDICT BEHAV, V31, P2074, DOI 10.1016/j.addbeh.2006.02.008; Krause N, 2004, GERONTOLOGIST, V44, P615, DOI 10.1093/geront/44.5.615; LAWTON MP, 1969, GERONTOLOGIST, V9, P179, DOI 10.1093/geront/9.3_Part_1.179; Maschi T, 2014, GERONTOLOGIST, V54, P857, DOI 10.1093/geront/gnt069; Maschi T, 2011, GERONTOLOGIST, V51, P675, DOI 10.1093/geront/gnr074; National Institute on Aging National Institutes of Health U. S. Department of Health and Human Services, 2012, GROWING OLDER IN AME; Nowotny KM, 2016, J AGING HEALTH, V28, P935, DOI 10.1177/0898264315614007; Pietrzak RH, 2012, J AM GERIATR SOC, V60, P296, DOI 10.1111/j.1532-5415.2011.03788.x; Prins A, 2003, PRIMARY CARE PSYCHIA, V9, P9; Quanbeck CD, 2005, PSYCHIAT SERV, V56, P847, DOI 10.1176/appi.ps.56.7.847; Sachs-Ericsson N, 2016, GERONTOLOGIST, V56, P82, DOI 10.1093/geront/gnv036; Sadeh N, 2015, CRIM JUSTICE BEHAV, V42, P573, DOI 10.1177/0093854814556880; SKINNER HA, 1982, ADDICT BEHAV, V7, P363, DOI 10.1016/0306-4603(82)90005-3; Slaughter B, 2003, BRAIN INJURY, V17, P731, DOI 10.1080/0269905031000088649; Sledjeski EM, 2008, J BEHAV MED, V31, P341, DOI 10.1007/s10865-008-9158-3; Smoyer AB, 2009, AM J PUBLIC HEALTH, V99, P1746, DOI 10.2105/AJPH.2008.148726; Snyder H., 2012, ARREST US 1990 2010, P26; Stewart AL, 2012, J AGING HEALTH, V24, P992, DOI 10.1177/0898264312440321; Sudore RL, 2006, J GEN INTERN MED, V21, P867, DOI 10.1111/j.1525-1497.2006.00535.x; van Dam D, 2010, J SUBST ABUSE TREAT, V39, P105, DOI 10.1016/j.jsat.2010.05.005; Wang Emily A, 2012, Am J Public Health, V102, pe22, DOI 10.2105/AJPH.2012.300894; Wang EA, 2010, PUBLIC HEALTH REP, V125, P171, DOI 10.1177/003335491012500205; WEISS DS, 1992, J TRAUMA STRESS, V5, P365, DOI 10.1002/jts.2490050304; Williams BA, 2014, J PALLIAT MED, V17, P1336, DOI 10.1089/jpm.2014.0160; Williams BA, 2012, AM J PUBLIC HEALTH, V102, P1475, DOI 10.2105/AJPH.2012.300704; Williams BA, 2010, J GEN INTERN MED, V25, P1038, DOI 10.1007/s11606-010-1416-8; Williams WH, 2010, BRAIN INJURY, V24, P1184, DOI 10.3109/02699052.2010.495697	54	15	15	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1360-7863	1364-6915		AGING MENT HEALTH	Aging Ment. Health		2017	21	10					1106	1112		10.1080/13607863.2016.1201042			7	Geriatrics & Gerontology; Gerontology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology; Psychiatry	FB8KF	WOS:000406387200017	27367335	Green Accepted, Green Submitted			2022-02-06	
J	Gao, J; Lin, MQ; Zhao, JH; Bi, SW; Ni, ZY; Shang, XL				Gao, Jie; Lin, Meiqing; Zhao, Jiuhan; Bi, Siwei; Ni, Ziyan; Shang, Xiuli			Different interventions for post-ischaemic stroke depression in different time periods: a single-blind randomized controlled trial with stratification by time after stroke	CLINICAL REHABILITATION			English	Article						Depression; stroke; rehabilitation; antidepressive agents; psychotherapy	COGNITIVE-BEHAVIORAL THERAPY; TRAUMATIC BRAIN-INJURY; POSTSTROKE DEPRESSION; ANTIDEPRESSANT TREATMENT; FUNCTIONAL DISABILITY; DOSE-RESPONSE; CITALOPRAM; REHABILITATION; PSYCHOTHERAPY; FLUOXETINE	Objective: To determine the appropriate treatments for post-ischaemic stroke depression at different times after stroke. Design: A single-blind, randomized, controlled trial that compared three intervention groups, with subgroups stratified by time after stroke. Setting: Outpatient clinic. Subjects: Eligible patients were recruited at discharge (n = 73) and three (n = 67), six (n = 65), and nine months (n = 69) after discharge, and patients completed mood questionnaires. Interventions: Patients were randomly distributed into three groups: Group A received placebos and participated in general discussions; Group B, received citalopram and participated in general discussions; and Group C, received placebos and underwent cognitive behavioural therapy. All three groups participated in rehabilitation during three months of follow-up. Main measures: Outcome was assessed three months after baseline using the 17-item Hamilton Depression Scale (HAMD(17)) and the Bech-Rafaelsen Melancholia Scale (MES). During treatment, the Udvalg for Kliniske Undersogelser side-effect scale was also administered. Results: When stratification was not considered, the scores of Group B on the Melancholia Scale were lower than those of Group A (P = 0.02); when the four time-based subgroups were analysed, significant differences were observed between Groups A and B (P-MES = 0.02, P-HAMD17 = 0.02) in the group recruited six months after discharge and between Groups A and C (P-MES = 0.01) in the last time period nine months after discharge. Conclusions: The effects of citalopram or cognitive behavioural therapy is similar to the effect of rehabilitation alone for early-onset post-ischaemic depression; rehabilitation and citalopram for delayed-onset post-ischaemic depression; and rehabilitation and cognitive behavioural therapy for late-onset postischaemic depression are more effective than rehabilitation alone.	[Gao, Jie; Lin, Meiqing; Zhao, Jiuhan; Bi, Siwei; Ni, Ziyan; Shang, Xiuli] China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Peoples R China		Shang, XL (corresponding author), China Med Univ, Affiliated Hosp 1, Dept Neurol, Shenyang 110001, Peoples R China.	shang_zhao@sohu.com			Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81100243, 81171131, 81272564, 81272795, 81100893, 81172197, 81372484]; Natural Science Foundation of Liaoning Province in ChinaNatural Science Foundation of Liaoning Province [L2013296]; Liaoning Science and Technology Plan Projects [2011225020]	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This work was supported by grants from the Natural Science Foundation of China [81100243, 81171131, 81272564, 81272795, 81100893, 81172197, and 81372484], the Natural Science Foundation of Liaoning Province in China [No. L2013296], and Liaoning Science and Technology Plan Projects [No. 2011225020].	American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; ANDERSEN G, 1994, STROKE, V25, P1099, DOI 10.1161/01.STR.25.6.1099; ANDERSON CS, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003689.PUB2; Anson K, 2006, BRAIN INJURY, V20, P167, DOI 10.1080/02699050500442956; Arseniou S, 2011, Psychiatriki, V22, P240; BECH P, 1986, ACTA PSYCHIAT SCAND, V73, P1; Bech P, 2002, PSYCHOPHARMACOLOGY, V163, P20, DOI 10.1007/s00213-002-1147-6; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Bedard M, 2003, DISABIL REHABIL, V25, P722, DOI 10.1080/0963828031000090489; Burvill P, 1997, INT J GERIATR PSYCH, V12, P219; Chen Y, 2006, ANN PHARMACOTHER, V40, P2115, DOI 10.1345/aph.1H389; Coppell AL, 2003, NEUROPHARMACOLOGY, V44, P903, DOI 10.1016/S0028-3908(03)00077-7; ERIKSSON S, 1987, J CHRON DIS, V40, P1025, DOI 10.1016/0021-9681(87)90116-0; FEDOROFF JP, 1989, J CLIN PSYCHIAT, V50, P18; Gainotti G, 2001, J NEUROL NEUROSUR PS, V71, P258, DOI 10.1136/jnnp.71.2.258; GUSTAFSON Y, 1995, DRUG AGING, V7, P298, DOI 10.2165/00002512-199507040-00005; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003689.pub3; Hackett ML, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD003437.pub3; Hackett ML, 2004, COCHRANE DB SYST REV, DOI DOI 10.1002/14651858.CD003437.PUB2; Hou WH, 2013, J CLIN PSYCHIAT, V74, pE859, DOI 10.4088/JCP.12m08259; Kauhanen ML, 1999, STROKE, V30, P1875, DOI 10.1161/01.STR.30.9.1875; Klausner EJ, 1998, INT J GERIATR PSYCH, V13, P707, DOI 10.1002/(SICI)1099-1166(1998100)13:10<707::AID-GPS856>3.0.CO;2-Q; Kneebone II, 2000, BRIT J CLIN PSYCHOL, V39, P53, DOI 10.1348/014466500163103; Kootker JA, 2015, CLIN REHABIL, V29, P833, DOI 10.1177/0269215514559987; LAURITZEN L, 1994, PSYCHOPHARMACOLOGY, V114, P119, DOI 10.1007/BF02245452; Lim CM, 2009, J NEUROSCI RES, V87, P1037, DOI 10.1002/jnr.21899; Lincoln NB, 2003, STROKE, V34, P111, DOI 10.1161/01.STR.0000044167.44670.55; Lincoln NB, 1997, CLIN REHABIL, V11, P114, DOI 10.1177/026921559701100204; Lingjaerde O, 1987, Acta Psychiatr Scand Suppl, V334, P1; MAHONEY F I, 1965, Md State Med J, V14, P61; Mohr DC, 2012, JAMA-J AM MED ASSOC, V307, P2278, DOI 10.1001/jama.2012.5588; Neau JP, 1998, CEREBROVASC DIS, V8, P296, DOI 10.1159/000015869; Paolucci S, 2001, CEREBROVASC DIS, V12, P264, DOI 10.1159/000047714; Parker G, 2013, ACTA PSYCHIAT SCAND, V128, P271, DOI 10.1111/acps.12049; Rampello L, 2004, PSYCHOPHARMACOLOGY, V173, P73, DOI 10.1007/s00213-003-1698-1; Russo-Neustadt AA, 2000, NEUROSCIENCE, V101, P305, DOI 10.1016/S0306-4522(00)00349-3; Shin TK, 2009, KOREAN J PHYSIOL PHA, V13, P257, DOI 10.4196/kjpp.2009.13.3.257; Sondergaard MP, 2006, PSYCHOTHER PSYCHOSOM, V75, P244, DOI 10.1159/000092895; STRAND T, 1985, STROKE, V16, P29, DOI 10.1161/01.STR.16.1.29; Taylor-Piliae RE, 2013, J CARDIOVASC NURS, V28, P460, DOI 10.1097/JCN.0b013e318258ad57; WHITLOCK JA, 1995, ARCH PHYS MED REHAB, V76, P1103, DOI 10.1016/S0003-9993(95)80117-0; Zedlitz AMEE, 2012, STROKE, V43, P1046, DOI 10.1161/STROKEAHA.111.632117	42	15	16	3	28	SAGE PUBLICATIONS LTD	LONDON	1 OLIVERS YARD, 55 CITY ROAD, LONDON EC1Y 1SP, ENGLAND	0269-2155	1477-0873		CLIN REHABIL	Clin. Rehabil.	JAN	2017	31	1					71	81		10.1177/0269215515626232			11	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EF5XJ	WOS:000390402800008	26817808				2022-02-06	
J	Gao, M; Dong, Q; Yao, H; Zhang, Y; Yang, Y; Dang, YY; Zhang, HT; Yang, ZJ; Xu, MH; Xu, RX				Gao, Mou; Dong, Qin; Yao, Hui; Zhang, Yan; Yang, Yang; Dang, Yuanyuan; Zhang, Hongtian; Yang, Zhijun; Xu, Minhui; Xu, Ruxiang			Induced neural stem cells modulate microglia activation states via CXCL12/CXCR4 signaling	BRAIN BEHAVIOR AND IMMUNITY			English	Article						Induced neural stem cell; Microglia; CXCR4; Closed head injury; Immunomodulation	NF-KAPPA-B; IMMUNE-RESPONSES; BRAIN; INJURY; INFLAMMATION; MODEL; NEUROGENESIS; MOBILIZATION; MECHANISMS; MIGRATION	We previously reported that induced neural stem cells (iNSCs) directly reprogrammed from mouse embryonic fibroblasts can expand and differentiate into neurons, astrocytes and oligodendrocytes. Whether iNSCs have immunoregulatory properties in addition to facilitating cell replacement remains uncertain. In this study, we aimed to characterize the immunomodulatory effects of iNSCs on the activation states of microglia and to elucidate the mechanisms underlying these effects. Using a mouse model of closed head injury (CHI), we observed that iNSC grafts decreased the levels of ED1(+)/Iba1(+) and TNF-alpha(+)/Iba1(+) microglia but increased the levels of IGF1(+)/Iba1(+) microglia in the injured cortex. Subsequently, using a Transwell co-culture system, we discovered that iNSCs could modulate LPS-pretreated microglia phenotypes in vitro via CXCL12/CXCR4 signaling, which we demonstrated through the administration of the CXCR4 antagonist AMD3100 and CXCR4-specific siRNA treatment. An in vivo loss-of-function study also revealed that iNSC grafts regulated the behavior of resident microglia via CXCL12/CXCR4 signaling, influencing their activation state such that they promoted neurological functional recovery and neuron survival. Furthermore, the beneficial effects of iNSC transplantation were significantly diminished by CXCR4 knockdown. In short, iNSCs have the potential to influence microglia activation and the acquisition of neuroprotective phenotypes via CXCL12/CXCR4 signaling. (C) 2016 Elsevier Inc. All rights reserved.	[Gao, Mou; Xu, Minhui] Third Mil Med Univ, Affiliated Hosp 3, Dept Neurosurg, Chongqing 400042, Peoples R China; [Gao, Mou; Yao, Hui; Zhang, Yan; Yang, Yang; Dang, Yuanyuan; Zhang, Hongtian; Yang, Zhijun; Xu, Ruxiang] PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China; [Dong, Qin] Capital Med Univ, Fu Xing Hosp, Dept Neurol, Beijing 100038, Peoples R China		Xu, MH (corresponding author), Third Mil Med Univ, Affiliated Hosp 3, Dept Neurosurg, Chongqing 400042, Peoples R China.; Xu, RX (corresponding author), PLA Army Gen Hosp, Affiliated Bayi Brain Hosp, Beijing 100700, Peoples R China.	dpmhxu@126.com; jzprofxu@126.com	Yang, Yang/AAL-1670-2020	Yang, Yang/0000-0001-6645-2454	Military Twelfth Five-Year Key Sci-Tech Research Projects [BWS11J002, BWS12J010]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2013M532138]	We thank Dr. Shanshan Wang, Dr. Cuiying Wu, Dr. Mingming Zou, Ms. Chen Chen, Dr. Weiqiang Jia, Dr. Xiaohu Nie, Ms. Ning Liu and Ms. Qinqin Wang for technical support. This work was supported by the Military Twelfth Five-Year Key Sci-Tech Research Projects (Grant Nos. BWS11J002 and BWS12J010) and the China Postdoctoral Science Foundation (2013M532138).	Abdul-Muneer PM, 2015, MOL NEUROBIOL, V51, P966, DOI 10.1007/s12035-014-8752-3; Aloisi F, 2000, J IMMUNOL, V164, P1705, DOI 10.4049/jimmunol.164.4.1705; Alsayed Y, 2007, BLOOD, V109, P2708, DOI 10.1182/blood-2006-07-035857; Amor S., 2014, IMMUNOLOGY, V18, P531; Bramlett HM, 2015, J NEUROTRAUM, V32, P1834, DOI 10.1089/neu.2014.3352; Butovsky O, 2006, P NATL ACAD SCI USA, V103, P11784, DOI 10.1073/pnas.0604681103; Cantoni C, 2015, ACTA NEUROPATHOL, V129, P429, DOI 10.1007/s00401-015-1388-1; Carbajal KS, 2010, P NATL ACAD SCI USA, V107, P11068, DOI 10.1073/pnas.1006375107; Cartier N, 2014, ACTA NEUROPATHOL, V128, P363, DOI 10.1007/s00401-014-1330-y; Das M, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-236; Delano MJ, 2011, J IMMUNOL, V187, P911, DOI 10.4049/jimmunol.1100588; Domanska UM, 2013, EUR J CANCER, V49, P219, DOI 10.1016/j.ejca.2012.05.005; Dou GR, 2016, SCI REP-UK, V6, DOI 10.1038/srep28617; Ebert MS, 2007, NAT METHODS, V4, P721, DOI 10.1038/NMETH1079; Ekdahl CT, 2003, P NATL ACAD SCI USA, V100, P13632, DOI 10.1073/pnas.2234031100; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Gao M, 2016, SCI REP-UK, V6, DOI 10.1038/srep29955; Gennai S, 2015, BRIT J ANAESTH, V115, P203, DOI 10.1093/bja/aev229; Goldman SA, 2016, CELL STEM CELL, V18, P174, DOI 10.1016/j.stem.2016.01.012; Greenbaum A, 2013, NATURE, V495, P227, DOI 10.1038/nature11926; Griffith JW, 2014, ANNU REV IMMUNOL, V32, P659, DOI 10.1146/annurev-immunol-032713-120145; Gyoneva S, 2015, TRENDS PHARMACOL SCI, V36, P471, DOI 10.1016/j.tips.2015.04.003; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; Hopewell EL, 2013, J CLIN INVEST, V123, P2509, DOI 10.1172/JCI67250; Jensen MB, 2013, J STROKE CEREBROVASC, V22, P304, DOI 10.1016/j.jstrokecerebrovasdis.2011.09.008; Joyce JA, 2015, SCIENCE, V348, P74, DOI 10.1126/science.aaa6204; Kaur C, 2014, BRAIN STRUCT FUNCT, V219, P151, DOI 10.1007/s00429-012-0491-5; Kim HS, 2014, STEM CELL RES, V12, P60, DOI 10.1016/j.scr.2013.09.007; Kohman RA, 2013, BRAIN BEHAV IMMUN, V27, P22, DOI 10.1016/j.bbi.2012.09.003; Kokaia Z, 2012, NAT NEUROSCI, V15, P1078, DOI 10.1038/nn.3163; Kumar A, 2012, BRAIN BEHAV IMMUN, V26, P1191, DOI 10.1016/j.bbi.2012.06.008; Lowe JM, 2014, CANCER RES, V74, P2182, DOI 10.1158/0008-5472.CAN-13-1070; Man SM, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003197; Martino G, 2006, NAT REV NEUROSCI, V7, P395, DOI 10.1038/nrn1908; Nervi B, 2009, BLOOD, V113, P6206, DOI 10.1182/blood-2008-06-162123; Olson JK, 2004, J IMMUNOL, V173, P3916, DOI 10.4049/jimmunol.173.6.3916; Pluchino S, 2009, ANN NEUROL, V66, P343, DOI 10.1002/ana.21745; Rabenstein M, 2015, STEM CELL RES THER, V6, DOI 10.1186/s13287-015-0098-x; Reaux-Le Goazigo A, 2013, PROG NEUROBIOL, V104, P67, DOI 10.1016/j.pneurobio.2013.02.001; Richmond A, 2002, NAT REV IMMUNOL, V2, P664, DOI 10.1038/nri887; Santarsieri M, 2015, BRAIN BEHAV IMMUN, V45, P15, DOI 10.1016/j.bbi.2014.09.003; Schiraldi M, 2012, J EXP MED, V209, P551, DOI 10.1084/jem.20111739; Singh AP, 2012, J BIOL CHEM, V287, P39115, DOI 10.1074/jbc.M112.409581; Sofroniew MV, 2015, NAT REV NEUROSCI, V16, P249, DOI 10.1038/nrn3898; Takeshita Y, 2012, IMMUNOL REV, V248, P228, DOI 10.1111/j.1600-065X.2012.01127.x; Tonges L, 2014, GLIA, V62, P217, DOI 10.1002/glia.22601; Xiong Y, 2013, NAT REV NEUROSCI, V14, P128, DOI 10.1038/nrn3407; Yao H, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0137211; Ziv Y, 2006, P NATL ACAD SCI USA, V103, P13174, DOI 10.1073/pnas.0603747103	49	15	15	1	17	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0889-1591	1090-2139		BRAIN BEHAV IMMUN	Brain Behav. Immun.	JAN	2017	59						288	299		10.1016/j.bbi.2016.09.020			12	Immunology; Neurosciences; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Immunology; Neurosciences & Neurology; Psychiatry	EF8YU	WOS:000390618700028	27650112				2022-02-06	
J	Gardner, RM; Yengo-Kahn, A; Bonfield, CM; Solomon, GS				Gardner, Ryan M.; Yengo-Kahn, Aaron; Bonfield, Christopher M.; Solomon, Gary S.			Comparison of baseline and post-concussion ImPACT test scores in young athletes with stimulant-treated and untreated ADHD	PHYSICIAN AND SPORTSMEDICINE			English	Article						Attention Deficit Hyperactivity Disorder (ADHD); sports-related; concussion; ImPACT; stimulant; baseline; post-concussion; mild traumatic brain injury	DEFICIT HYPERACTIVITY DISORDER; SPORTS-RELATED CONCUSSION; ATTENTION-DEFICIT/HYPERACTIVITY-DISORDER; NEUROCOGNITIVE TEST-PERFORMANCE; METABOLIC BRAIN VULNERABILITY; PREDICT PROTRACTED RECOVERY; HIGH-SCHOOL; TEMPORAL WINDOW; NEUROPSYCHOLOGICAL FUNCTION; CLINICAL ARTICLE	Objectives: Baseline and post-concussion neurocognitive testing is useful in managing concussed athletes. Attention deficit hyperactivity disorder (ADHD) and stimulant medications are recognized as potential modifiers of performance on neurocognitive testing by the Concussion in Sport Group. Our goal was to assess whether individuals with ADHD perform differently on post-concussion testing and if this difference is related to the use of stimulants. Methods: Retrospective case-control study in which 4373 athletes underwent baseline and post-concussion testing using the ImPACT battery. 277 athletes self-reported a history of ADHD, of which, 206 reported no stimulant treatment and 69 reported stimulant treatment. Each group was matched with participants reporting no history of ADHD or stimulant use on several biopsychosocial characteristics. Non-parametric tests were used to assess ImPACT composite score differences between groups. Results: Participants with ADHD had worse verbal memory, visual memory, visual motor speed, and reaction time scores than matched controls at baseline and post-concussion, all with p <=.001 and vertical bar r vertical bar >= 0.100. Athletes without stimulant treatment had lower verbal memory, visual memory, visual motor speed, and reaction time scores than controls at baseline (p <= 0.01, vertical bar r vertical bar >= 0.100 [except verbal memory, r=-0.088]) and post-concussion (p=0.000, vertical bar r vertical bar> 0.100). Athletes with stimulant treatment had lower verbal memory (Baseline: p=0.047, r=-0.108; Post-concussion: p=0.023, r=-0.124) and visual memory scores (Baseline: p=0.013, r=-0.134; Post-concussion: p=0.003, r=-0.162) but equivalent visual motor speed and reaction time scores versus controls at baseline and post-concussion. Conclusions: ADHD-specific baseline and post-concussion neuropsychological profiles, as well as stimulant medication status, may need to be considered when interpreting ImPACT test results. Further investigation into the effects of ADHD and stimulant use on recovery from sport-related concussion (SRC) is warranted.	[Gardner, Ryan M.; Yengo-Kahn, Aaron; Bonfield, Christopher M.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, 3000 Vanderbilt Pl,Apartment 147, Nashville, TN 37212 USA; [Yengo-Kahn, Aaron; Bonfield, Christopher M.; Solomon, Gary S.] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA		Gardner, RM (corresponding author), Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, 3000 Vanderbilt Pl,Apartment 147, Nashville, TN 37212 USA.	ryan.m.gardner@vanderbilt.edu	Yengo-Kahn, Aaron/AAV-7647-2020; Solomon, Gary/K-9011-2019	Yengo-Kahn, Aaron/0000-0002-5989-3064; 			Advokat C, 2010, NEUROSCI BIOBEHAV R, V34, P1256, DOI 10.1016/j.neubiorev.2010.03.006; Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; AMADOBOCCARA I, 1995, NEUROSCI BIOBEHAV R, V19, P479, DOI 10.1016/0149-7634(94)00068-C; Bailey CM, 2010, CLIN J SPORT MED, V20, P272, DOI 10.1097/JSM.0b013e3181e8f8d8; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Baune BT, 2014, PSYCHIAT RES, V219, P25, DOI 10.1016/j.psychres.2014.05.013; Bay E, 2012, ARCH PSYCHIAT NURS, V26, P477, DOI 10.1016/j.apnu.2012.06.002; Bonfield CM, 2013, J NEUROSURG-PEDIATR, V12, P97, DOI 10.3171/2013.5.PEDS12424; Cohen J, 1977, STAT POWER ANAL BEHA, p[xv, 474]; Covassin T, 2006, BRIT J SPORT MED, V40, P923, DOI 10.1136/bjsm.2006.029496; Covassin T, 2007, NEUROSURGERY, V61, P345, DOI 10.1227/01.NEU.0000279972.95060.CB; Covassin T, 2012, CLIN J SPORT MED, V22, P98, DOI 10.1097/JSM.0b013e31823403d2; Covassin T, 2010, J NEUROL NEUROSUR PS, V81, P597, DOI 10.1136/jnnp.2009.193797; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Elbin RJ, 2013, ARCH CLIN NEUROPSYCH, V28, P476, DOI 10.1093/arclin/act024; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Fritz CO, 2012, J EXP PSYCHOL GEN, V141, P2, DOI 10.1037/a0024338; GADDIS GM, 1990, ANN EMERG MED, V19, P1054, DOI 10.1016/S0196-0644(05)82571-5; Greydanus DE, 2009, NEUROPSYCH DIS TREAT, V5, P171; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harvey Philip D, 2012, Dialogues Clin Neurosci, V14, P91; Iverson GL, 2006, BRAIN INJURY, V20, P245, DOI 10.1080/02699050500487910; Iverson GL, 2005, J CLIN EXP NEUROPSYC, V27, P683, DOI 10.1081/13803390490918435; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Lakhan SE, 2012, BRAIN BEHAV, V2, P661, DOI 10.1002/brb3.78; Lau BC, 2012, NEUROSURGERY, V70, P371, DOI 10.1227/NEU.0b013e31823150f0; Lau BC, 2011, AM J SPORT MED, V39, P2311, DOI 10.1177/0363546511410655; Lau BC, 2011, AM J SPORT MED, V39, P1209, DOI 10.1177/0363546510392016; Lezak MD, 2004, NEUROPSYCHOLOGICAL A, V2; Littleton AC, 2015, ARCH CLIN NEUROPSYCH, V30, P683, DOI 10.1093/arclin/acv043; Lovell M, 2016, IMPACT VERSION 6 0 C; Mautner K, 2015, CLIN J SPORT MED, V25, P355, DOI 10.1097/JSM.0000000000000151; McCrory P, 2012, BRIT J SPORT MED, V47, P9; Meehan WP, 2012, PEDIATRICS, V129, P38, DOI 10.1542/peds.2011-1972; Merikangas KR, 2013, JAMA PEDIATR, V167, P141, DOI 10.1001/jamapediatrics.2013.431; Morgan CD, 2015, J NEUROSURG-PEDIATR, V15, P589, DOI 10.3171/2014.10.PEDS14356; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Olfson M, 2014, JAMA PSYCHIAT, V71, P81, DOI 10.1001/jamapsychiatry.2013.3074; Prins ML, 2010, DEV NEUROSCI-BASEL, V32, P510, DOI 10.1159/000316800; Ramtekkar UP, 2010, J AM ACAD CHILD PSY, V49, P217, DOI 10.1016/j.jaac.2009.11.011; Reardon CL, 2016, SPORTS MED, V46, P611, DOI 10.1007/s40279-015-0456-y; Salinas CM, 2016, APPL NEUROPSYCH-CHIL, V5, P264, DOI 10.1080/21622965.2015.1052814; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2012, J ATHL TRAINING, V47, P289, DOI 10.4085/1062-6050-47.3.14; Shrey DW, 2011, PHYS MED REH CLIN N, V22, P577, DOI 10.1016/j.pmr.2011.08.002; Solomon GS, 2008, ARCH CLIN NEUROPSYCH, V23, P563, DOI 10.1016/j.acn.2008.05.008; Tavazzi B, 2007, NEUROSURGERY, V61, P390, DOI 10.1227/01.NEU.0000255525.34956.3F; Thomas R, 2015, PEDIATRICS, V135, pE994, DOI 10.1542/peds.2014-3482; Tucha O, 2006, J NEURAL TRANSM, V113, P1575, DOI 10.1007/s00702-005-0437-7; Turner DC, 2005, PSYCHOPHARMACOLOGY, V178, P286, DOI 10.1007/s00213-004-1993-5; VAGNOZZI R, 2007, NEUROSURGERY, V61, P388, DOI DOI 10.1227/01.NEU.0000280002.41696; Vagnozzi R, 2008, NEUROSURGERY, V62, P1286, DOI 10.1227/01.neu.0000333300.34189.74; Vagnozzi R, 2007, NEUROSURGERY, V61, P379, DOI 10.1227/01.NEU.0000280002.41696.D8; Wilson HK, 2006, ARCH CLIN NEUROPSYCH, V21, P797, DOI 10.1016/j.acn.2006.06.016; Wobbrock J.O., 2011, ACM C HUM FACT COMP; Yengo-Kahn AM, 2015, PHYSICIAN SPORTSMED, V43, P227, DOI 10.1080/00913847.2015.1071638; Zuckerman SL, 2013, J NEUROSURG-PEDIATR, V12, P103, DOI 10.3171/2013.5.PEDS12524	60	15	15	0	4	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0091-3847	2326-3660		PHYSICIAN SPORTSMED	Physician Sportsmed.		2017	45	1					1	10		10.1080/00913847.2017.1248221			10	Primary Health Care; Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Orthopedics; Sport Sciences	EL4VJ	WOS:000394618700001	27736285				2022-02-06	
J	Hansen, C; Cushman, D; Chen, W; Bounsanga, J; Hung, M				Hansen, Colby; Cushman, Dan; Chen, Wei; Bounsanga, Jerry; Hung, Man			Reliability Testing of the Balance Error Scoring System in Children Between the Ages of 5 and 14	CLINICAL JOURNAL OF SPORT MEDICINE			English	Article						brain concussion; sports; pediatrics; child; reproducibility of results	HIGH-SCHOOL; POSTURAL STABILITY; CONCUSSION; RECOVERY; PLAYERS; SPORTS	Objective: Pediatric concussion is an extensive public health concern with a complex clinical presentation. Balance assessment has been well-studied in the adult population, but has been limited in children. We aimed to assess the reliability and minimum detectable change (MDC) of the Balance Error Scoring System (BESS) in healthy children. Design: This prospective observational study included 373 healthy children aged 5 to 14. Interrater reliability was assessed by having 4 assessors review videos of 50 random subjects distributed evenly by age and sex across the entire cohort. Intrarater reliability was performed by having assessors review videos of other assessors' live evaluations. Test-retest reliability was obtained by comparing BESS scores as recorded live at the 2 separate time points by the same rater. Setting: Local elementary and junior high schools. Participants: Three hundred and seventy three healthy children between the ages of 5 and 14. Interventions: The BESS was performed on all children. Main Outcome Measures: Intraclass Correlation Coefficients (ICCs) and MDC Scores. Results: The overall interrater ICC was determined to be 0.93 [95% confidence interval (CI), 0.79-0.97] and intrarater ICC was 0.96 (95% CI, 0.95-0.97) with individual intrarater ICCs ranging between 0.69 and 0.99. The test-retest reliability was 0.90 (95% CI, 0.88-0.92). The MDCs were 9.6, 4.6, and 7.3 points at the 95% CIs for interrater, intrarater, and test-retest comparisons, respectively. No learning effect was seen. Conclusions: The BESS demonstrates excellent reliability in the pediatric population without evidence of a learning effect.	[Hansen, Colby; Cushman, Dan] Univ Utah, Div Phys Med & Rehabil, Salt Lake City, UT USA; [Chen, Wei] Univ Utah, Div Epidemiol, Salt Lake City, UT USA; [Bounsanga, Jerry; Hung, Man] Univ Utah, Dept Orthoped, Salt Lake City, UT USA		Hansen, C (corresponding author), 590 Wakara Way, Salt Lake City, UT 84108 USA.	colby.hansen@hsc.utah.edu	Hansen, Colby/AAP-7680-2021	Hansen, Colby/0000-0002-8012-2483; Cushman, Daniel/0000-0002-4580-1173	University of Utah, Division of PM&R pilot research grant fund; University of Utah Department of Orthopedics; Center for Outcomes Research and Assessment; Study Design and Biostatistics Center; National Center for Research ResourcesUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR); National Center for Advancing Translational Sciences, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [Grant 8UL1TR000105]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001067, UL1TR000105] Funding Source: NIH RePORTER	This investigation was supported by the University of Utah, Division of PM&R pilot research grant fund, the University of Utah Department of Orthopedics, the Center for Outcomes Research and Assessment and the Study Design and Biostatistics Center, with funding in part from the National Center for Research Resources and the National Center for Advancing Translational Sciences, National Institutes of Health, through Grant 8UL1TR000105.	[Anonymous], 2013, Br J Sports Med, V47, P259; Bakhos LL, 2010, PEDIATRICS, V126, pE550, DOI 10.1542/peds.2009-3101; Barlow M, 2011, INT J SPORTS PHYS TH, V6, P150; Bell DR, 2011, SPORTS HEALTH, V3, P287, DOI 10.1177/1941738111403122; Davis GA, 2014, BRIT J SPORT MED, V48, P98, DOI 10.1136/bjsports-2012-092132; Erkmen N, 2009, ISOKINET EXERC SCI, V17, P121, DOI 10.3233/IES-2009-0343; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Hansen C, 2016, CLIN J SPORT MED, V26, P497, DOI 10.1097/JSM.0000000000000285; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Hunt TN, 2009, CLIN J SPORT MED, V19, P471, DOI 10.1097/JSM.0b013e3181c12c7b; MANCUSO JJ, 2002, J ATHL TRAINING, V37, pS10; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2009, PM&R, V1, P406, DOI 10.1016/j.pmrj.2009.03.010; McLeod TCV, 2006, J ATHL TRAINING, V41, P399; McLeod TCV, 2009, J SPORT REHABIL, V18, P465, DOI 10.1123/jsr.18.4.465; McLeod TCV, 2004, CLIN J SPORT MED, V14, P287, DOI 10.1097/00042752-200409000-00007; Mulligan IJ, 2013, SPORTS HEALTH, V5, P22, DOI 10.1177/1941738112467755; Murray N, 2014, J ATHL TRAINING, V49, P540, DOI 10.4085/1062-6050-49.3.32; Riemann BL, 1999, J SPORT REHABIL, V8, P71, DOI 10.1123/jsr.8.2.71; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Susco TM, 2004, J ATHL TRAINING, V39, P241; Valovich TC, 2003, J ATHL TRAINING, V38, P51	25	15	15	1	10	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1050-642X	1536-3724		CLIN J SPORT MED	Clin. J. Sport Med.	JAN	2017	27	1					64	68		10.1097/JSM.0000000000000293			5	Orthopedics; Physiology; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Physiology; Sport Sciences	EH9OP	WOS:000392101000012	26829611	Green Accepted			2022-02-06	
J	Jalan, D; Saini, N; Zaidi, M; Pallottie, A; Elkabes, S; Heary, RF				Jalan, Devesh; Saini, Neginder; Zaidi, Mohammad; Pallottie, Alexandra; Elkabes, Stella; Heary, Robert F.			Effects of early surgical decompression on functional and histological outcomes after severe experimental thoracic spinal cord injury	JOURNAL OF NEUROSURGERY-SPINE			English	Article						durotomy; duraplasty; DuraSeal; catwalk; contusion; pain; spinal cord injury; thoracic	CEREBRAL-ARTERY INFARCTION; TRAUMATIC BRAIN-INJURY; HYDROGEL DURAL SEALANT; BLADDER FUNCTION; RISK-FACTORS; CRANIECTOMY; REPAIR; MULTICENTER; SURGERY; TRIAL	OBJECTIVE In acute traumatic brain injury, decompressive craniectomy is a common treatment that involves the removal of bone from the cranium to relieve intracranial pressure. The present study investigated whether neurological function following a severe spinal cord injury improves after utilizing either a durotomy to decompress the intradural space and/or a duraplasty to maintain proper flow of cerebrospinal fluid. METHODS Sixty-four adult female rats (n = 64) were randomly assigned to receive either a 3- or 5-level decompressive laminectomy (Groups A and B), laminectomy + durotomy (Groups C and D), or laminectomy + duraplasty with graft (Group E and F) at 24 hours following a severe thoracic contusion injury (200 kilodynes). Duraplasty involved the use of DuraSeal, a hydrogel dural sealant. Uninjured and injured control groups were included (Groups G, H). Hindlimb locomotor function was assessed by open field locomotor testing (BBB) and CatWalk gait analysis at 35 days postinjury. Bladder function was analyzed and bladder wall thickness was assessed histologically. At 35 days postinjury, mechanical and thermal allodynia were assessed by the Von Frey hair filament and hotplate paw withdrawal tests, respectively. Thereafter, the spinal cords were dissected, examined for gross anomalies at the injury site, and harvested for histological analyses to assess lesion volumes and white matter sparing. ANOVA was used for statistical analyses. RESULTS There was no significant improvement in motor function recovery in any treatment groups compared with injured controls. CatWalk gait analysis indicated a significant decrease in interlimb coordination in Groups B, C, and D (p < 0.05) and swing speed in Groups A, B, and D. Increased mechanical pain sensitivity was observed in Groups A, C, and F (p < 0.05). Rats in Group C also developed thermal pain hypersensitivity. Examination of spinal cords demonstrated increased lesion volumes in Groups C and F and increased white matter sparing in Group E (p < 0.05). The return of bladder automaticity was similar in all groups. Examination of the injury site during tissue harvest revealed that, in some instances, expansion of the hydrogel dural sealant caused compression of the spinal cord. CONCLUSIONS Surgical decompression provided no benefit in terms of neurological improvement in the setting of a severe thoracic spinal cord contusion injury in rats at 24 hours postinjury. Decompressive laminectomy and durotomy did not improve motor function recovery, and rats in both of these treatment modalities developed neuropathic pain. Performing a durotomy also led to increased lesion volumes. Placement of DuraSeal was shown to cause compression in some rats in the duraplasty treatment groups. Decompressive duraplasty of 3 levels does not affect functional outcomes after injury but did increase white matter sparing. Decompressive duraplasty of 5 levels led to neuropathic pain development and increased lesion volumes. Further comparison of dural repair techniques is necessary.	[Jalan, Devesh; Saini, Neginder; Zaidi, Mohammad; Elkabes, Stella; Heary, Robert F.] Rutgers State Univ, Dept Neurol Surg, New Jersey Med Sch, 90 Bergen St,Ste 8100, Newark, NJ 07103 USA; [Pallottie, Alexandra] Rutgers State Univ, Grad Sch Biomed Sci, Newark, NJ USA		Heary, RF (corresponding author), Rutgers State Univ, Dept Neurol Surg, New Jersey Med Sch, 90 Bergen St,Ste 8100, Newark, NJ 07103 USA.	heary@njms.rutgers.edu	Elkabes, Stella/H-7823-2019; Elkabes, Stella/AAR-8212-2020	Zaidi, Mohammad/0000-0002-3024-0414	Reynolds Family Spine Laboratory	This study was financed by the Reynolds Family Spine Laboratory. DuraSeal is a registered trademark and DuraSeal Exact spine sealant was donated by Integra LifeSciences Corp. to the laboratory for use in this study. Dr. Heary reports receipt of royalties from DePuy Spine, Zimmer Inc., and Thieme Medical Publishers.	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Abla AA, 2010, J CRANIOVERTEBRAL JU, V1, P29, DOI 10.4103/0974-8237.65479; [Anonymous], 2016, SPIN CORD INJ SCI FA; BASSO DM, 1995, J NEUROTRAUM, V12, P1, DOI 10.1089/neu.1995.12.1; Blackburn SL, 2007, J NEUROSURG, V106, P302, DOI 10.3171/ped.2007.106.4.302; Boogaarts JD, 2005, NEUROSURGERY, V57, P146, DOI 10.1227/01.NEU.0000164384.05351.59; Bourassa-Moreau E, 2016, J NEUROTRAUM, V33, P301, DOI 10.1089/neu.2015.3957; Cadotte David W, 2010, F1000 Med Rep, V2, P67, DOI 10.3410/M2-67; Conour LA, 2006, ILAR J, V47, P283, DOI 10.1093/ilar.47.4.283; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cosgrove GR, 2007, J NEUROSURG, V106, P52, DOI 10.3171/jns.2007.106.1.52; DELAMARTER RB, 1995, J BONE JOINT SURG AM, V77A, P1042, DOI 10.2106/00004623-199507000-00010; Detloff MR, 2013, J NEUROTRAUM, V30, P884, DOI 10.1089/neu.2012.2632; Diatchenko L, 2005, HUM MOL GENET, V14, P135, DOI 10.1093/hmg/ddi013; Dvorak MF, 2015, J NEUROTRAUM, V32, P645, DOI 10.1089/neu.2014.3632; Fehlings MG, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032037; Fouad K, 2009, SPINAL CORD, V47, P727, DOI 10.1038/sc.2009.10; Fowler CJ, 1996, J NEUROL NEUROSUR PS, V60, P6, DOI 10.1136/jnnp.60.1.6; Furlan JC, 2011, J NEUROTRAUM, V28, P1371, DOI 10.1089/neu.2009.1147; Hofmeijer J, 2009, LANCET NEUROL, V8, P326, DOI 10.1016/S1474-4422(09)70047-X; Houle JD, 2003, EXP NEUROL, V182, P247, DOI 10.1016/S0014-4886(03)00029-3; Huang X, 2010, INT J MED SCI, V7, P385; Hulsebosch CE, 2009, BRAIN RES REV, V60, P202, DOI 10.1016/j.brainresrev.2008.12.010; Hutchinson P, 2009, CRIT CARE S1, pP85; Iannotti C, 2006, J NEUROTRAUM, V23, P853, DOI 10.1089/neu.2006.23.853; Jakeman LB, 2012, ANIMAL MODELS ACUTE, P417, DOI DOI 10.1007/978-1-61779-782-8_37; Kim KD, 2011, SPINE, V36, P1906, DOI 10.1097/BRS.0b013e3181fdb4db; Koopmans GC, 2005, J NEUROTRAUM, V22, P214, DOI 10.1089/neu.2005.22.214; Lee G, 2010, SPINE, V35, pE1522, DOI 10.1097/BRS.0b013e3181edfe2c; Lee Si-Hoon, 2013, Korean J Spine, V10, P44, DOI 10.14245/kjs.2013.10.1.44; Li Yiping, 2014, Front Biol (Beijing), V9, P127; Maikos JT, 2008, J NEUROTRAUM, V25, P38, DOI 10.1089/neu.2007.0348; Mills CD, 2001, J NEUROTRAUM, V18, P743, DOI 10.1089/089771501316919111; Mulder M, 2009, SPINE, V34, pE144, DOI 10.1097/BRS.0b013e31818d5427; Mure PY, 2004, J NEUROSURG, V100, P56, DOI 10.3171/spi.2004.100.1.0056; Nakae A, 2011, J BIOMED BIOTECHNOL, DOI 10.1155/2011/939023; Nesic O, 2005, J NEUROCHEM, V95, P998, DOI 10.1111/j.1471-4159.2005.03462.x; Neuman BJ, 2012, CLIN ORTHOP RELAT R, V470, P1640, DOI 10.1007/s11999-011-2071-z; Neumann M, 2009, J NEUROSCI METH, V176, P34, DOI 10.1016/j.jneumeth.2008.08.026; Osbun JW, 2012, WORLD NEUROSURG, V78, P498, DOI 10.1016/j.wneu.2011.12.011; Piek Jurgen, 2002, Curr Opin Crit Care, V8, P134, DOI 10.1097/00075198-200204000-00008; Qvarlander S, 2013, J APPL PHYSIOL, V115, P1474, DOI 10.1152/japplphysiol.00711.2013; Rahimi-Movaghar V, 2005, J SPINAL CORD MED, V28, P415, DOI 10.1080/10790268.2005.11753841; Reddy S, 2014, PLAST RECONSTR SURG, V133, P864, DOI 10.1097/PRS.0000000000000013; Romner B, 2013, NAT REV NEUROL, V9, P185, DOI 10.1038/nrneurol.2013.37; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Santana-Cabrera Luciano, 2012, Int J Crit Illn Inj Sci, V2, P186, DOI 10.4103/2229-5151.100937; Scheff SW, 2003, J NEUROTRAUM, V20, P179, DOI 10.1089/08977150360547099; Schiariti Marco, 2014, Surg Neurol Int, V5, P171, DOI 10.4103/2152-7806.146154; Siddiqui AM, 2015, PROG BRAIN RES, V218, P15, DOI 10.1016/bs.pbr.2014.12.007; Smith JS, 2010, J BONE JOINT SURG AM, V92A, P1206, DOI 10.2106/JBJS.I.00740; Staykov D, 2011, STROKE, V42, P513, DOI 10.1161/STROKEAHA.110.605642; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Stromqvist F, 2012, EUR SPINE J, V21, P825, DOI 10.1007/s00586-011-2101-2; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; Than KD, 2008, NEUROSURGERY, V63, P182, DOI 10.1227/01.NEU.0000313116.28200.67; Thavarajah D, 2010, SPINE, V35, pE25, DOI 10.1097/BRS.0b013e3181b9fc45; Timofeev I, 2006, INJURY, V37, P1125, DOI 10.1016/j.injury.2006.07.031; Vahedi K, 2007, STROKE, V38, P2506, DOI 10.1161/STROKEAHA.107.485235; Watson C, 2008, THE SPINAL CORD; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Wing PC, 2008, J SPINAL CORD MED, V31, P360, DOI 10.1080/10790268.2008.11760737; Woods BI, 2011, CLIN ORTHOP RELAT R, V469, P688, DOI 10.1007/s11999-010-1653-5; Wright NM, 2015, SPINE, V40, P505, DOI 10.1097/BRS.0000000000000810; Wu JF, 2013, NEUROTHERAPEUTICS, V10, P520, DOI 10.1007/s13311-013-0198-1; Zweckberger K, 2003, J NEUROTRAUM, V20, P1307, DOI 10.1089/089771503322686102	66	15	17	0	8	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	JAN	2017	26	1					62	75		10.3171/2016.6.SPINE16343			14	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EG0LV	WOS:000390725200011	27636866	Bronze			2022-02-06	
J	Kaup, AR; Peltz, C; Kenney, K; Kramer, JH; Diaz-Arrastia, R; Yaffe, K				Kaup, Allison R.; Peltz, Carrie; Kenney, Kimbra; Kramer, Joel H.; Diaz-Arrastia, Ramon; Yaffe, Kristine			Neuropsychological Profile of Lifetime Traumatic Brain Injury in Older Veterans	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						Traumatic brain injury; Head injury; Aging; Veterans; Cognition; Cognitive deficits	ALZHEIMERS-DISEASE; COGNITIVE IMPAIRMENT; DEMENTIA; RISK; MILD; TBI; IDENTIFICATION; DYSFUNCTION; MEMORY; STATE	Objectives: The aim of this study was to characterize the neuropsychological profile of lifetime traumatic brain injury (TBI) in older Veterans. Methods: Participants were 169 older Veterans [mean age = 79.1 years (range, 51-97 years), 89% male, 92% Caucasian], 88 with lifetime TBI and 81 without TBI, living in Veterans' retirement homes in independent residence. TBI history was ascertained with the Ohio State TBI Identification Method structured interview. Cognition was assessed with neuropsychological tests: Raw scores were converted to Z-scores compared to age-corrected normative data and combined into five domain composite Z-scores (attention/working memory, learning/memory, language, processing speed, executive functioning). We investigated the association between TBI and performance in each cognitive domain in linear mixed effects models, with and without adjustment for demographics, medical comorbidities, and psychiatric variables. Results: Compared to those without TBI, older Veterans with TBI had greater deficits in processing speed (estimate = -.52; p = .01; f(2) = .08 in fully adjusted model) and executive functioning (estimate = -.41; p = .02; f(2) = .06 in fully adjusted model) but performed similarly in the attention/working memory, learning/memory, and language domains (all p > .05). TBI-associated deficits were most prominent among individuals with multiple mild TBIs and those with any moderate-to-severe TBI, but were not clearly present among those with single mild TBI. Conclusions: The neuropsychological profile of lifetime TBI in older Veterans is characterized by slowed processing speed and executive dysfunction, especially among those with greater injury burden. This pattern may reflect long-standing deficits or a TBI-associated cognitive decline process distinct from Alzheimer's disease.	[Kaup, Allison R.] Univ Calif San Francisco, San Francisco VA Healthcare Syst, Res Serv, San Francisco, CA 94143 USA; [Kaup, Allison R.] Univ Calif San Francisco, Dept Psychiat, San Francisco, CA 94143 USA; [Peltz, Carrie] NCIRE Vet Hlth Res Inst, San Francisco, CA USA; [Peltz, Carrie] San Francisco VA Healthcare Syst, 4150 Clement St,116B, San Francisco, CA 94121 USA; [Kenney, Kimbra; Diaz-Arrastia, Ramon] Uniformed Serv Univ Hlth Sci, Dept Neurol, Rockville, MD USA; [Kramer, Joel H.; Yaffe, Kristine] Univ Calif San Francisco, Dept Neurol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Epidemiol, San Francisco, CA USA; [Yaffe, Kristine] Univ Calif San Francisco, Dept Biostat, San Francisco, CA 94143 USA		Kaup, AR (corresponding author), San Francisco VA Healthcare Syst, 4150 Clement St,116B, San Francisco, CA 94121 USA.	allison.kaup@ucsf.edu		Diaz-Arrastia, Ramon/0000-0001-6051-3594	Department of Defense grantsUnited States Department of Defense [W81XWH-12-1-0581, W81XWH-14-2-0132]; NIAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG031155]; U.S. Department of Veterans Affairs, Rehabilitation Research and Development ServiceUS Department of Veterans Affairs [1IK2RX001629]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [K24AG031155] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [IK2RX001629] Funding Source: NIH RePORTER	The authors thank our research participants, the Armed Forces Retirement Home in Washington, DC, the Veterans Home of California in Yountville, CA, and our dedicated study staff including Kim Kelley, Ross Passo, Leah Harburg, Daniel Freimer, and Margaret Gross. This research was supported by Department of Defense grants W81XWH-12-1-0581 and W81XWH-14-2-0132 (awarded to K.Y.); and in part by NIA grant K24AG031155 (awarded to K.Y.). This research was also supported by Career Development Award 1IK2RX001629 (awarded to A.R.K.) from the U.S. Department of Veterans Affairs, Rehabilitation Research and Development Service. The contents of this manuscript do not represent the views of the U.S. Department of Veterans Affairs or the United States Government.	[Anonymous], 2012, NINDS COMM DAT EL TR; Ashman TA, 2008, J HEAD TRAUMA REHAB, V23, P139, DOI 10.1097/01.HTR.0000319930.69343.64; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Bieniek KF, 2015, ACTA NEUROPATHOL, V130, P877, DOI 10.1007/s00401-015-1502-4; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bogner J, 2009, J HEAD TRAUMA REHAB, V24, P279, DOI 10.1097/HTR.0b013e3181a66356; Bondi MW, 2008, NEUROPSYCHOL REV, V18, P73, DOI 10.1007/s11065-008-9054-1; Byers AL, 2011, NAT REV NEUROL, V7, P323, DOI 10.1038/nrneurol.2011.60; Chan RCK, 2005, CLIN REHABIL, V19, P188, DOI 10.1191/0269215505cr838oa; Cohen J., 2013, STAT POWER ANAL BEHA; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; Curtiss G, 2001, J INT NEUROPSYCH SOC, V7, P574, DOI 10.1017/S1355617701755051; Dams-O'Connor K, 2013, NEUROREHABILITATION, V32, P199, DOI 10.3233/NRE-130838; Department of Veterans Affairs Department of Defense, 2009, CLIN PRACT GUID MAN; Eramudugolla R, 2014, J INT NEUROPSYCH SOC, V20, P444, DOI 10.1017/S1355617714000174; Finnanger TG, 2013, BRAIN INJURY, V27, P1606, DOI 10.3109/02699052.2013.831127; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Gardner RC, 2014, JAMA NEUROL, V71, P1490, DOI 10.1001/jamaneurol.2014.2668; Gavett BE, 2011, CLIN SPORT MED, V30, P179, DOI 10.1016/j.csm.2010.09.007; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Himanen L, 2006, NEUROLOGY, V66, P187, DOI 10.1212/01.wnl.0000194264.60150.d3; Ivnik R.J., 1990, PSYCHOL ASSESSMENT J, V2, P304, DOI [10.1037/1040-3590.2.3.304, DOI 10.1037/1040-3590.2.3.304]; Johnson VE, 2010, NAT REV NEUROSCI, V11, P361, DOI 10.1038/nrn2808; Kaplan E, 1983, BOSTON NAMING TEST; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kramarow EA, 2012, AGE OMAHA, V25, P25; Kramer J. H., 2014, NIH EXAMINER B UNPUB; Kramer JH, 2014, J INT NEUROPSYCH SOC, V20, P11, DOI 10.1017/S1355617713001094; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McAllister TW, 2006, J NEUROTRAUM, V23, P1450, DOI 10.1089/neu.2006.23.1450; McDonald BC, 2002, NEUROREHABILITATION, V17, P333; Moretti L, 2012, LANCET NEUROL, V11, P1103, DOI 10.1016/S1474-4422(12)70226-0; MORRIS JC, 1989, NEUROLOGY, V39, P1159, DOI 10.1212/wnl.43.12.2457; Okie S, 2005, NEW ENGL J MED, V352, P2043, DOI 10.1056/NEJMp058102; Ommaya AK, 1996, J TRAUMA, V40, P211, DOI 10.1097/00005373-199602000-00007; Peltz CB, 2017, J HEAD TRAUMA REHAB, V32, pE8, DOI 10.1097/HTR.0000000000000245; Perry DC, 2016, J NEUROSURG, V124, P511, DOI 10.3171/2015.2.JNS14503; Plassman BL, 2000, NEUROLOGY, V55, P1158, DOI 10.1212/WNL.55.8.1158; Plassman Brenda L, 2015, Handb Clin Neurol, V128, P711, DOI 10.1016/B978-0-444-63521-1.00044-3; Qiu CX, 2015, NAT REV CARDIOL, V12, P267, DOI 10.1038/nrcardio.2014.223; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Reitan R. M., 1985, HALSTEAD REITAN NEUR, V4; Rey A., 1941, ARCH PSYCHOL; Rochat L, 2009, J NEUROPSYCHOL, V3, P213, DOI 10.1348/174866408X397656; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Scholten AC, 2016, J NEUROTRAUM; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Selya AS, 2012, FRONT PSYCHOL, V3, DOI 10.3389/fpsyg.2012.00111; Setnik L, 2007, BRAIN INJURY, V21, P1, DOI 10.1080/02699050601111419; Shirk SD, 2011, ALZHEIMERS RES THER, V3, DOI 10.1186/alzrt94; Shively S, 2012, ARCH NEUROL-CHICAGO, V69, P1245, DOI 10.1001/archneurol.2011.3747; Smith DH, 2013, NAT REV NEUROL, V9, P211, DOI 10.1038/nrneurol.2013.29; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Stern RA, 2013, NEUROLOGY, V81, P1122, DOI 10.1212/WNL.0b013e3182a55f7f; Tangalos, 1992, CLIN NEUROPSYCHOL, V6, P83, DOI [10.1080/13854049208401880, DOI 10.1080/13854049208401880]; Taylor E., 1959, PSYCHOL APPRAISAL CH; U. S. Department of Veterans Affairs & National Center for PTSD, 2014, US PTSD CHECKL DSM 4; Verma M, 2012, INT J GERIATR PSYCH, V27, P1209, DOI 10.1002/gps.3766; Wechsler D, 1987, WECHSLER MEMORY SCAL; Wechsler D., 1981, WAIS R MANUAL WECHSL; Weintraub S, 2009, ALZ DIS ASSOC DIS, V23, P91, DOI 10.1097/WAD.0b013e318191c7dd; Yaffe K, 2010, ARCH GEN PSYCHIAT, V67, P608, DOI 10.1001/archgenpsychiatry.2010.61; YESAVAGE JA, 1983, J PSYCHIATR RES, V17, P37, DOI 10.1016/0022-3956(82)90033-4	64	15	15	0	4	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	JAN	2017	23	1					56	64		10.1017/S1355617716000849			9	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Psychology	EL4GS	WOS:000394580300006	27697088	Green Accepted			2022-02-06	
J	Kehle-Forbes, SM; Campbell, EH; Taylor, BC; Scholten, J; Sayer, N				Kehle-Forbes, Shannon M.; Campbell, Emily Hagel; Taylor, Brent C.; Scholten, Joel; Sayer, Nina			Does Co-Occurring Traumatic Brain Injury Affect VHA Outpatient Health Service Utilization and Associated Costs Among Veterans With Posttraumatic Stress Disorder? An Examination Based on VHA Administrative Data	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						healthcare costs; healthcare utilization; posttraumatic; stress disorders; TBI (traumatic brain injury); veterans	PTSD SPECIALTY TREATMENT; AFGHANISTAN VETERANS; OEF/OIF VETERANS; IRAQ; VA; PREVALENCE; DIAGNOSES	Objective: To examine whether a traumatic brain injury (TBI) diagnosis was associated with increased outpatient service utilization and associated costs among Iraq and Afghanistan (Operation Enduring Freedom [OEF]/Operation Iraqi Freedom [OIF]/Operation New Dawn [OND]) War veterans with posttraumatic stress disorder (PTSD) who used Veterans Health Affairs (VHA) care in a 1-year period. Setting: N/A. Participants: OEF/OIF/OND veterans with a diagnosis of PTSD and/or TBI who utilized VHA services during fiscal year 2012 (N = 164 644). Design: Observational study using VHA administrative data. Main Measures: Outpatient VHA utilization (total and by category of care) and associated costs (total and by VA Health Economic Resource Center cost category). Results: Veterans in the comorbid PTSD/TBI group had significantly more total outpatient appointment than veterans with PTSD but no TBI. This pattern held for all categories of care except orthopedics. The comorbid TBI/PTSD group ($5769) incurred greater median outpatient healthcare costs than the PTSD ($3168) or TBI-alone ($2815) group. Conclusions: Co-occurring TBI increases the already high level of healthcare utilization by veterans with PTSD, suggesting that OEF/OIF/OND veterans with comorbid PTSD/TBI have complex and wide-ranging healthcare needs. Key words: healthcare costs, healthcare utilization, posttraumatic, stress disorders, TBI (traumatic brain injury), veterans	[Kehle-Forbes, Shannon M.; Campbell, Emily Hagel; Taylor, Brent C.; Sayer, Nina] Minneapolis VHA Hlth Care Syst, Ctr Chron Dis Outcomes Res, Minneapolis, MN USA; [Kehle-Forbes, Shannon M.; Taylor, Brent C.; Sayer, Nina] Univ Minnesota, Dept Med, Box 736 UMHC, Minneapolis, MN 55455 USA; [Sayer, Nina] Univ Minnesota, Dept Psychiat, Minneapolis, MN 55455 USA; [Scholten, Joel] Washington DC VA Med Ctr, Phys Med & Rehabil Serv, Washington, DC USA		Kehle-Forbes, SM (corresponding author), Minneapolis VA Hlth Care Syst, One Vet Dr, Minneapolis, MN 55417 USA.	Shannon.Kehle-Forbes@va.gov	Taylor, Brent C/A-8069-2009	Taylor, Brent C/0000-0002-2140-8377	Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Polytrauma and Blast-Related Injuries Quality Enhancement Research Initiative [PLY 05-2010-2]	This material is based upon work supported by the Department of Veterans Affairs, Veterans Health Administration, Office of Research and Development, Polytrauma and Blast-Related Injuries Quality Enhancement Research Initiative, through a locally initiated project grant (#PLY 05-2010-2).	Aakre JM, 2014, PSYCHIAT SERV, V65, P1066, DOI 10.1176/appi.ps.201300117; [Anonymous], 2014, AN VA HLTH CAR UT OP; Barell V, 2002, INJ PREV, V8, P91, DOI 10.1136/ip.8.2.91; Carlson KF, 2013, BRAIN INJURY, V27, P640, DOI 10.3109/02699052.2013.771795; Cohen BE, 2010, J GEN INTERN MED, V25, P18, DOI 10.1007/s11606-009-1117-3; Combs HL, 2015, J NEUROTRAUM, V32, P956, DOI 10.1089/neu.2014.3585; Davis JJ, 2013, REHABIL PSYCHOL, V58, P36, DOI 10.1037/a0031525; Defense and Veterans Brain Injury Center, DOD NUMB TRAUM BRAIN; Kehle SM, 2010, J TRAUMA STRESS, V23, P33, DOI 10.1002/jts.20480; King PR, 2013, MIL BEHAV HLTH, V1, P74, DOI DOI 10.1080/21635781.2012.759168; Kok BC, 2012, J NERV MENT DIS, V200, P444, DOI 10.1097/NMD.0b013e3182532312; Lu MW, 2011, PSYCHIAT SERV, V62, P943, DOI 10.1176/ps.62.8.pss6208_0943; Phibbs CS, 2003, MED CARE RES REV, V60, p54S, DOI 10.1177/1077558703256725; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Possemato K, 2010, PSYCHOL TRAUMA-US, V2, P218, DOI 10.1037/a0019236; Ragsdale KA, 2013, J ANXIETY DISORD, V27, P420, DOI 10.1016/j.janxdis.2013.04.003; Sayer NA, 2012, ANNU REV MED, V63, P405, DOI 10.1146/annurev-med-061610-154046; Seal KH, 2010, J TRAUMA STRESS, V23, P5, DOI 10.1002/jts.20493; Stroupe KT, 2013, J REHABIL RES DEV, V50, P1047, DOI 10.1682/JRRD.2012.06.0107; Taylor BC, FISCAL YEAR 2012 VA; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; VHA Health Information Management Office of Health Data and Informatics, 2009, FACT SHEET INT COD G; Wagner TH, 2003, MED CARE RES REV, V60, p15S, DOI 10.1177/1077558703256485	23	15	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	JAN-FEB	2017	32	1					E16	E23		10.1097/HTR.0000000000000227			8	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EI2GH	WOS:000392304400008	27022960				2022-02-06	
J	Kisser, J; Waldstein, SR; Evans, MK; Zonderman, AB				Kisser, Jason; Waldstein, Shari R.; Evans, Michele K.; Zonderman, Alan B.			Lifetime prevalence of traumatic brain injury in a demographically diverse community sample	BRAIN INJURY			English	Article						Traumatic brain injury; prevalence; demographics; sex; race: poverty; age	FUNCTIONAL DECLINE; POPULATION; RISK; DEMENTIA; MIDLIFE; HEALTH; RACE	Background: Although incidence rates are well documented for traumatic brain injury, lifetime prevalence in a demographically diverse sample is unknown. We examined the prevalence of self-reported traumatic brain injury (TBI) in a demographically diverse sample.Methods: History of TBI was examined in 2881 African-Americans and Whites in the Healthy Aging in Neighborhoods of Diversity across the Life Span (HANDLS) studya community-based, epidemiological investigation of urban-dwelling adults. Logistic regression analyses examined the odds of TBI as a function of sex, race, poverty status, age quintile and their interactions.Results: A significant 3-way interaction was noted amongst race, poverty status and age (odds ratio (OR) = 1.57, 95% confidence interval (CI) 1.07-2.31, p = 0.021). Amongst Whites living in poverty, younger (30-36 years of age) individuals had greater odds of TBI than older (58-64 years of age) individuals, whereas older African-Americans living in poverty had greater odds of TBI. Additionally, a main effect of sex (OR = 2.36, 95% CI 1.85-3.03, p < 0.001) indicated that men had greater odds of TBI.Conclusions: History of TBI is most prevalent in men, older African-Americans in poverty, and younger Whites in poverty. Preventive measures targeting relevant TBI risk factors in these populations are warranted.	[Kisser, Jason; Waldstein, Shari R.] Univ Maryland Baltimore Cty, Dept Psychol, Baltimore, MD 21228 USA; [Evans, Michele K.] NIA, Hlth Dispar Res Sect, Lab Epidemiol & Populat Sci, Baltimore, MD 21224 USA; [Zonderman, Alan B.] NIA, Behav Epidemiol Sect, Lab Epidemiol & Populat Sci, Baltimore, MD 21224 USA		Kisser, J (corresponding author), Univ Maryland Baltimore Cty, Dept Psychol, Math Psychol 312, 1000 Hilltop Circle, Baltimore, MD 21250 USA.	Jason.kisser@gmail.com	Evans, Michele Kim/AAE-4776-2019; Kisser, Jason/AAA-8217-2021	Evans, Michele/0000-0002-8546-2831	National Institute on Aging's Intramural Research Program; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [1RO1AG034161]; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000513, R01AG034161, ZIAAG000199, Z01AG000194, P30AG028747] Funding Source: NIH RePORTER	The authors report no conflicts of interests. The National Institute on Aging's Intramural Research Program and National Institutes of Health Grant 1RO1AG034161 supported this research.	Anttila T, 2002, NEUROLOGY, V59, P887, DOI 10.1212/WNL.59.6.887; Case A, 2015, P NATL ACAD SCI USA, V112, P15078, DOI 10.1073/pnas.1518393112; Centers for Disease Control and Prevent, 2013, TRAUM BRAIN INJ CONC; Evans MK, 2010, ETHNIC DIS, V20, P267; Faul M, 2010, TRAUMATIC BRAIN INJU, P891, DOI [10.1016/B978-0-444-52910-7.00011-8, DOI 10.1016/B978-0-444-52910-7.00011-8]; Frost RB, 2013, NEUROEPIDEMIOLOGY, V40, P154, DOI 10.1159/000343275; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Guland B, 1997, DIFFERENCE RATES DEM, P233; Harrison DA, 2012, INTENS CARE MED, V38, pS240; Ilie G, 2015, J NEUROTRAUM, V32, P1130, DOI 10.1089/neu.2014.3619; Kraus J, 2006, NEUROLOGY AND TRAUMA, P3; Lunney JR, 2003, JAMA-J AM MED ASSOC, V289, P2387, DOI 10.1001/jama.289.18.2387; National Highway Traffic Safety Administration, 2009, TRAFF SAF FACTS 2006; Nguyen HT, 2007, ANN EPIDEMIOL, V17, P736; Sloan FA, 2009, AM J PUBLIC HEALTH, V99, P2261, DOI 10.2105/AJPH.2007.127621; Smith JP, 2004, POPUL DEV REV, V30, P108; Sosin DM, 1996, BRAIN INJURY, V10, P47; US Department of Health and Human Services, 2004, FED REGISTER, V69, P7336; Wang HK, 2012, J NEUROL NEUROSUR PS, V83, P1080, DOI 10.1136/jnnp-2012-302633; Wee CC, 2011, ANN INTERN MED, V154, P645, DOI 10.7326/0003-4819-154-10-201105170-00003	20	15	15	1	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2017	31	5					620	623		10.1080/02699052.2017.1283057			4	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	EV8OA	WOS:000402039900006	28326858	Green Accepted			2022-02-06	
J	Kroshus, E; Kerr, ZY; DeFreese, JD; Parsons, JT				Kroshus, Emily; Kerr, Zachary Y.; DeFreese, J. D.; Parsons, John T.			Concussion Knowledge and Communication Behaviors of Collegiate Wrestling Coaches	HEALTH COMMUNICATION			English	Article							SELF-DETERMINATION THEORY; HIGH-SCHOOL; NEED SATISFACTION; INTRINSIC MOTIVATION; MEDICINE CLINICIAN; AUTONOMY SUPPORT; ATHLETIC CAREER; INJURY; SPORT; RISK	Sport coaches can play an important role in shaping a team's approach to concussion safety through their communication with team members. However, across all sports, there is limited knowledge about factors that make coaches more or less likely to engage in safety-supportive communication. The objectives of this study were to assess the concussion-related knowledge and attitudes of wrestling coaches, as well as the extent to which they engage in autonomy-supportive coaching practices, and to determine how these factors are related to communication with athletes in support of concussion safety. Data were collected through an online survey of head coaches of National Collegiate Athletic Association (NCAA) wrestling teams (n=89, 40.5% response rate). On average, coaches answered five out of a possible nine knowledge questions correctly and were significantly more likely to think it was acceptable for an athlete to continue playing after sustaining a concussion during a national qualifying competition as compared to during an early-season competition. Engaging in autonomy-supportive coaching behaviors was the coach factor explaining the largest percentage of variability in communication. Findings suggest that while knowledge deficits and attitudes about the acceptability of continued play while symptomatic during more consequential competitive matches should be addressed in educational programming for collegiate wrestling coaches, these changes alone may not be a sufficient for adequately increasing concussion safety communication. Targeting more distal factors such as autonomy-supportive approaches to coaching may hold promise for intervention design and should be explored in future prospective research.	[Kroshus, Emily] Univ Washington, Dept Pediat, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA; [Kroshus, Emily] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Kerr, Zachary Y.; DeFreese, J. D.] Univ N Carolina, Dept Exercise & Sport Sci, Chapel Hill, NC USA; [Parsons, John T.] Natl Collegiate Athlet Assoc, Indianapolis, IN USA		Kroshus, E (corresponding author), Univ Washington, Dept Pediat, 2001 8th Ave,Suite 400, Seattle, WA 98121 USA.	ekroshus@u.washington.edu		Kerr, Zachary/0000-0003-1423-1259			Abrahams S, 2014, BRIT J SPORT MED, V48, P91, DOI 10.1136/bjsports-2013-092734; Amorose AJ, 2007, PSYCHOL SPORT EXERC, V8, P654, DOI 10.1016/j.psychsport.2006.11.003; Amorose AJ, 2009, RES Q EXERCISE SPORT, V80, P386, DOI 10.1080/02701367.2009.10599575; Banack HR, 2011, RES Q EXERCISE SPORT, V82, P722, DOI 10.1080/02701367.2011.10599809; Bartholomew KJ, 2010, J SPORT EXERCISE PSY, V32, P193, DOI 10.1123/jsep.32.2.193; Bianco T, 2001, RES Q EXERCISE SPORT, V72, P376, DOI 10.1080/02701367.2001.10608974; Chrisman SP, 2011, CLIN PEDIATR, V50, P1031, DOI 10.1177/0009922811410970; Covassin T, 2013, AM J SPORT MED, V41, P2885, DOI 10.1177/0363546513499230; CURRY TJ, 1993, SYMB INTERACT, V16, P273, DOI 10.1525/si.1993.16.3.273; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Gagne M, 2003, J APPL SPORT PSYCHOL, V15, P372, DOI 10.1080/714044203; Hollembeak J, 2005, J APPL SPORT PSYCHOL, V17, P20, DOI 10.1080/10413200590907540; Hu LT, 1999, STRUCT EQU MODELING, V6, P1, DOI 10.1080/10705519909540118; Jowett S, 2009, MEAS PHYS EDUC EXERC, V13, P34, DOI 10.1080/10913670802609136; Koester MC, 2000, J ATHL TRAINING, V35, P466; Kroshus E, 2015, J ATHL TRAINING, V50, P944, DOI 10.4085/1062-6050-50.6.03; Kroshus E, 2015, ANN BEHAV MED, V49, P532, DOI 10.1007/s12160-014-9683-y; Kroshus E, 2015, SOC SCI MED, V134, P66, DOI 10.1016/j.socscimed.2015.04.011; Llewellyn T, 2014, CLIN J SPORT MED, V24, P76, DOI 10.1097/01.jsm.0000432853.77520.3d; Mageau GA, 2003, J SPORT SCI, V21, P883, DOI 10.1080/0264041031000140374; National Collegiate Athletic Association, 2015, MEM HEAD WRESTL COAC; National Collegiate Athletic Association, 2014, 2013 2014 NCAA SPORT; National Federation of High School Sports, 2014, 2013 2014 HIGH SCH A; NIXON HL, 1994, SOCIOL SPORT J, V11, P79, DOI 10.1123/ssj.11.1.79; Ntoumanis N, 2009, J APPL SPORT PSYCHOL, V21, P365, DOI 10.1080/10413200903036040; Podlog L, 2010, J SPORT SCI, V28, P1197, DOI 10.1080/02640414.2010.487873; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rosenbaum AM, 2010, J CLIN EXP NEUROPSYC, V32, P44, DOI 10.1080/13803390902806535; Rosenthal JA, 2014, AM J SPORT MED, V42, P1710, DOI 10.1177/0363546514530091; Safai P, 2003, SOCIOL SPORT J, V20, P127, DOI 10.1123/ssj.20.2.127; Stebbings J, 2012, J SPORT EXERCISE PSY, V34, P481, DOI 10.1123/jsep.34.4.481; Weinstein N, 2010, J PERS SOC PSYCHOL, V98, P222, DOI 10.1037/a0016984; Wiese-Bjornstal DM, 2010, SCAND J MED SCI SPOR, V20, P103, DOI 10.1111/j.1600-0838.2010.01195.x; Wigfield A, 2000, CONTEMP EDUC PSYCHOL, V25, P68, DOI 10.1006/ceps.1999.1015; Zuckerman SL, 2015, AM J SPORT MED, V43, P2654, DOI 10.1177/0363546515599634	35	15	15	0	10	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1041-0236	1532-7027		HEALTH COMMUN	Health Commun.		2017	32	8					963	969		10.1080/10410236.2016.1196417			7	Communication; Health Policy & Services	Social Science Citation Index (SSCI)	Communication; Health Care Sciences & Services	EV0XA	WOS:000401468900006	27462963				2022-02-06	
J	Lequerica, AH; Botticello, AL; Lengenfelder, J; Chiaravalloti, N; Bushnik, T; Dijkers, MP; Hammond, FM; Kolakowsky-Hayner, SA; Rosenthal, J				Lequerica, Anthony H.; Botticello, Amanda L.; Lengenfelder, Jean; Chiaravalloti, Nancy; Bushnik, Tamara; Dijkers, Marcel P.; Hammond, Flora M.; Kolakowsky-Hayner, Stephanie A.; Rosenthal, Joseph			Factors associated with remission of post-traumatic brain injury fatigue in the years following traumatic brain injury (TBI): a TBI model systems module study	NEUROPSYCHOLOGICAL REHABILITATION			English	Article						Fatigue; brain injury	CLINICALLY IMPORTANT DIFFERENCE; DISABILITY RATING-SCALE; SLEEP QUALITY INDEX; 1ST 2 YEARS; HEAD-INJURY; LUPUS-ERYTHEMATOSUS; LIFE SCALE; RECOVERY; PARTICIPATION; SATISFACTION	Post-traumatic brain injury fatigue (PTBIF) is a major problem in the years after traumatic brain injury (TBI), yet little is known about its persistence and resolution. The objective of the study was to identify factors related to PTBIF remission and resolution. TBI Model System registrants at five centres participated in interviews at either one and two years post-injury (Y1-2 Cohort), or two and five years post-injury (Y2-5 Cohort). Characteristics of participants with PTBIF remission were compared to those with PTBIF persistence. Variables studied included the presence of and changes in disability, sleep dysfunction, mood, and community participation. The Functional Independence Measure did not differ significantly between groups or over time. In the Y1-2 Cohort the Fatigue Resolved group scored significantly better on the Disability Rating Scale and Pittsburgh Sleep Quality Index. In the Y2-5 Cohort the Fatigue Resolved group scored significantly higher on a measure of community participation. It was concluded that fewer than half of the sample in each cohort experienced a remission of PTBIF between time points. Persistence of PTBIF 1-2 years post-injury is associated with disability, sleep disturbance, and depression while persistence of fatigue beyond 2 years post-injury appears to be related to participation level, underscoring the potential impact of effective surveillance, assessment, and treatment of this condition in optimising life after TBI. Differences in fatigue progression may point to the presence of different types of PTBIF.	[Lequerica, Anthony H.; Botticello, Amanda L.; Lengenfelder, Jean; Chiaravalloti, Nancy] Kessler Fdn, W Orange, NJ 07052 USA; [Bushnik, Tamara] Rusk Rehabil, New York, NY USA; [Dijkers, Marcel P.] Mt Sinai Sch Med, Dept Rehabil Med, New York, NY USA; [Hammond, Flora M.] Indiana Univ Sch Med, Dept Phys Med & Rehabil, Indianapolis, IN 46202 USA; [Kolakowsky-Hayner, Stephanie A.] Stanford Univ, Concuss & Brain Performance Ctr, Palo Alto, CA 94304 USA; [Rosenthal, Joseph] Ohio State Univ, Dept Phys Med & Rehabil, Wexer Med Ctr, Columbus, OH 43210 USA		Lequerica, AH (corresponding author), Kessler Fdn, W Orange, NJ 07052 USA.	alequerica@kesslerfoundation.org	Kolakowsky-Hayner, Stephanie A./I-9858-2019	Kolakowsky-Hayner, Stephanie A./0000-0002-6228-9909; Chiaravalloti, Nancy/0000-0003-2943-7567	National Institute on Disability, Independent Living, and Rehabilitation ResearchUnited States Department of Health & Human Services [H133A070033, H133A070038, H133A070042, H133A070037, H133A070030]	This research was funded by the National Institute on Disability, Independent Living, and Rehabilitation Research [grants H133A070033, H133A070038, H133A070042, H133A070037, and H133A070030] and carried out by Traumatic Brain Injury Model Systems Centers.	Beaulieu-Bonneau S, 2012, SLEEP MED, V13, P598, DOI 10.1016/j.sleep.2012.02.010; BELZA BL, 1995, J RHEUMATOL, V22, P639; Borgaro SR, 2005, J HEAD TRAUMA REHAB, V20, P416, DOI 10.1097/00001199-200509000-00003; Bushnik T, 2008, J HEAD TRAUMA REHAB, V23, P17, DOI 10.1097/01.HTR.0000308717.80590.22; Buysse DJ, 2008, J CLIN SLEEP MED, V4, P563; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cantor JB, 2008, J HEAD TRAUMA REHAB, V23, P41, DOI 10.1097/01.HTR.0000308720.70288.af; Cantor JB, 2013, NEUROREHABILITATION, V32, P875, DOI 10.3233/NRE-130912; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Christensen BK, 2008, ARCH PHYS MED REHAB, V89, pS3, DOI 10.1016/j.apmr.2008.10.002; DIENER E, 1985, J PERS ASSESS, V49, P71, DOI 10.1207/s15327752jpa4901_13; DODDS TA, 1993, ARCH PHYS MED REHAB, V74, P531, DOI 10.1016/0003-9993(93)90119-U; Englander J, 2010, BRAIN INJURY, V24, P1379, DOI 10.3109/02699052.2010.523041; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Fichtenberg NL, 2002, BRAIN INJURY, V16, P197, DOI 10.1080/02699050110103940; Goligher EC, 2008, J RHEUMATOL, V35, P635; GOUVIER WD, 1987, ARCH PHYS MED REHAB, V68, P94; Granger CV, 1998, ARCH PHYS MED REHAB, V79, P235, DOI 10.1016/S0003-9993(98)90000-4; Green RE, 2008, ARCH PHYS MED REHAB, V89, pS16, DOI 10.1016/j.apmr.2008.09.551; Keith R A, 1987, Adv Clin Rehabil, V1, P6; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Leavitt VM, 2010, PM&R, V2, P332, DOI 10.1016/j.pmrj.2010.03.027; McCrimmon S, 2006, BRAIN INJURY, V20, P1037, DOI 10.1080/02699050600909656; MIDDELBOE T, 1992, ACTA NEUROL SCAND, V85, P5; Olver JH, 1996, BRAIN INJURY, V10, P841, DOI 10.1080/026990596123945; Ottenbacher KJ, 1996, ARCH PHYS MED REHAB, V77, P1226, DOI 10.1016/S0003-9993(96)90184-7; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; PAVOT W, 1991, J PERS ASSESS, V57, P149, DOI 10.1207/s15327752jpa5701_17; Pavot W., 1993, PSYCHOL ASSESSMENT, V52, P164, DOI DOI 10.1037/1040-3590.5.2.164; Pettersson S, 2015, SCAND J RHEUMATOL, V44, P206, DOI 10.3109/03009742.2014.988173; Ponsford JL, 2014, PSYCHIAT CLIN N AM, V37, P77, DOI 10.1016/j.psc.2013.10.001; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Resch JA, 2009, REHABIL PSYCHOL, V54, P51, DOI 10.1037/a0015051; Spitzer RL, 1999, JAMA-J AM MED ASSOC, V282, P1737, DOI 10.1001/jama.282.18.1737; Stineman MG, 1996, AM J PHYS MED REHAB, V75, P68, DOI 10.1097/00002060-199601000-00018; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P540, DOI 10.1016/j.apmr.2010.12.002; Whiteneck GG, 2011, ARCH PHYS MED REHAB, V92, P542, DOI 10.1016/j.apmr.2010.08.002	39	15	15	1	4	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0960-2011	1464-0694		NEUROPSYCHOL REHABIL	Neuropsychol. Rehabil.		2017	27	7					1019	1030		10.1080/09602011.2016.1231120			12	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	FB4WK	WOS:000406142500003	27633955	Green Submitted			2022-02-06	
J	Mishra, SK; Rana, P; Khushu, S; Gangenahalli, G				Mishra, Sushanta Kumar; Rana, Poonam; Khushu, Subash; Gangenahalli, Gurudutta			Therapeutic Prospective of Infused Allogenic Cultured Mesenchymal Stem Cells in Traumatic Brain Injury Mice: A Longitudinal Proton Magnetic Resonance Spectroscopy Assessment	STEM CELLS TRANSLATIONAL MEDICINE			English	Article						Mesenchymal stem cells; Magnetic resonance imaging; Stem cell therapy; Proton magnetic resonance spectroscopy; Traumatic brain injury	CORTICAL IMPACT INJURY; METABOLIC-CHANGES; IN-VIVO; BONE-MARROW; TIME-COURSE; RATS; NEUROPROTECTION; MOUSE; GLUTAMATE/GLUTAMINE; TRANSPLANTATION	Improved therapeutic assessment of experimental traumatic brain injury (TBI), using mesenchymal stem cells (MSCs), would immensely benefit its therapeutic management. Neurometabolite patterns at injury site, measured with proton magnetic resonance spectroscopy (1H-MRS) after MSCs transplantation, may serve as a bio-indicator of the recovery mechanism. This study used in vivo magnetic resonance imaging and1H-MRSto evaluate the therapeutic prospects of implanted MSCsat injury site in experimental mice longitudinally up to 21 days. Negative tissue contrast and cytotoxic edema formation were observed in susceptibility-based contrast (T2*) and an apparent diffusion coefficient map, respectively. Lesion site showed decreased N-acetylaspartate, total choline, myo-inositol, total creatine, glutamate-glutamine complex, and taurine neurometabolic concentrations by 1H-MRS investigation. There was a considerable decrease in locomotor activity, depression index, and cognitive index after TBI. It may, therefore, be inferred that MSC transplantation prompted recovery by decreasing negative signals and edema, restoring metabolites to baseline concentrations, and enhancing behavioral activity. Overall findings support the potential of MSC transplantation for the enhancement of endogenous neuroprotective responses, which may provide future clinical applications for translating laboratory research into therapeutic clinical advances.	[Mishra, Sushanta Kumar; Rana, Poonam; Khushu, Subash] Inst Nucl Med & Allied Sci, NMR Res Ctr, Def Res & Dev Org, Delhi 110054, India; [Mishra, Sushanta Kumar; Gangenahalli, Gurudutta] Inst Nucl Med & Allied Sci, Div Stem Cell & Gene Therapy Res, Def Res & Dev Org, Delhi 110054, India		Khushu, S (corresponding author), Inst Nucl Med & Allied Sci, NMR Res Ctr, Def Res & Dev Org, Delhi 110054, India.; Gangenahalli, G (corresponding author), Inst Nucl Med & Allied Sci, Div Stem Cell & Gene Therapy Res, Def Res & Dev Org, Delhi 110054, India.	skhushu@yahoo.com; gugdutta@rediffmail.com	Mishra, Sushanta Kumar/N-5958-2019	Mishra, Sushanta/0000-0002-3403-6891	Defence Research and Development Organization, Ministry of Defence, Government of IndiaDefence Research & Development Organisation (DRDO) [INM-311, 4.1]; Council of Medical Research	The S & T project (INM-311, 4.1) was supported by funding from the Defence Research and Development Organization, Ministry of Defence, Government of India, and we thank them for their valuable assistance. We also express gratitude to Dr. Kailash Manda and Seenu Haridas (research fellow) of the NeuroBehavior Laboratory at Institute of Nuclear Medicine and Allied Sciences, for their guidance and unstinted support in the behavioral study. S.K.M. acknowledges and sincerely thanks the Indian Council of Medical Research for providing a research fellowship in support of the project.	Albert-Weissenberger Christiane, 2010, Exp Transl Stroke Med, V2, P16, DOI 10.1186/2040-7378-2-16; Ashwal S, 2004, PEDIATR RES, V56, P630, DOI 10.1203/01.PDR.0000139928.60530.7D; Baraniak PR, 2010, REGEN MED, V5, P121, DOI 10.2217/RME.09.74; Bensidhoum M, 2004, BLOOD, V103, P3313, DOI 10.1182/blood-2003-04-1121; Bernardo ME, 2013, CELL STEM CELL, V13, P392, DOI 10.1016/j.stem.2013.09.006; Blaya MO, 2015, EXP NEUROL, V264, P67, DOI 10.1016/j.expneurol.2014.11.014; Brooks WM, 2000, J NEUROTRAUM, V17, P629, DOI 10.1089/089771500415382; Chen S, 2003, EXP NEUROL, V182, P87, DOI 10.1016/S0014-4886(03)00002-5; Duan XH, 2012, EUR J RADIOL, V81, P2154, DOI 10.1016/j.ejrad.2011.06.050; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Francois S, 2006, STEM CELLS, V24, P1020, DOI 10.1634/stemcells.2005-0260; Govind V, 2010, J NEUROTRAUM, V27, P483, DOI 10.1089/neu.2009.1159; Hall ED, 2010, NEUROTHERAPEUTICS, V7, P51, DOI 10.1016/j.nurt.2009.10.021; Haridas S, 2013, PHYSIOL BEHAV, V119, P201, DOI 10.1016/j.physbeh.2013.06.015; Harris JL, 2012, J CEREBR BLOOD F MET, V32, P2122, DOI 10.1038/jcbfm.2012.114; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Herynek V, 2009, MAGN RESON MATER PHY, V22, P211, DOI 10.1007/s10334-009-0166-2; Holshouser BA, 2005, AM J NEURORADIOL, V26, P1276; Jackson JS, 2010, STEM CELL RES THER, V1, DOI 10.1186/scrt17; Jain KK, 2008, DRUG DISCOV TODAY, V13, P1082, DOI 10.1016/j.drudis.2008.09.006; Lescot T, 2010, J NEUROTRAUM, V27, P85, DOI 10.1089/neu.2009.0982; Liang XT, 2014, CELL TRANSPLANT, V23, P1045, DOI 10.3727/096368913X667709; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Mahmood A, 2004, J NEUROTRAUM, V21, P33, DOI 10.1089/089771504772695922; MARMAROU A, 1994, J NEUROSURG, V80, P291, DOI 10.3171/jns.1994.80.2.0291; Mishra SK, 2015, EXP CELL RES, V339, P427, DOI 10.1016/j.yexcr.2015.11.010; Morales DM, 2005, NEUROSCIENCE, V136, P971, DOI 10.1016/j.neuroscience.2005.08.030; Park KJ, 2014, J CEREBR BLOOD F MET, V34, P357, DOI 10.1038/jcbfm.2013.216; Pasco A, 2007, J NEUROTRAUM, V24, P1321, DOI 10.1089/neu.2006.0136; Pascual JM, 2007, J NEUROTRAUM, V24, P944, DOI 10.1089/neu.2006.0190; Patel AB, 2005, P NATL ACAD SCI USA, V102, P5588, DOI 10.1073/pnas.0501703102; Rana P, 2013, INT J RADIAT BIOL, V89, P212, DOI 10.3109/09553002.2013.734944; Schuhmann MU, 2003, J NEUROTRAUM, V20, P725, DOI 10.1089/089771503767869962; Sharma A, 2015, SPRINGERPLUS, V4, DOI 10.1186/s40064-015-0794-0; Shutter L, 2004, J NEUROTRAUM, V21, P1693, DOI 10.1089/neu.2004.21.1693; Shyu WC, 2007, STROKE, V38, P367, DOI 10.1161/01.STR.0000254463.24655.14; Signoretti S, 2001, J NEUROTRAUM, V18, P977, DOI 10.1089/08977150152693683; Soleimani M, 2009, NAT PROTOC, V4, P102, DOI 10.1038/nprot.2008.221; Takeuchi H, 2007, NEUROSCI LETT, V426, P69, DOI 10.1016/j.neulet.2007.08.048; Van Putten HP, 2005, J NEUROTRAUM, V22, P857; VERBALIS JG, 1991, BRAIN RES, V567, P274, DOI 10.1016/0006-8993(91)90806-7; VIDEEN JS, 1995, J CLIN INVEST, V95, P788, DOI 10.1172/JCI117728; Wagner J, 2009, CURR OPIN BIOTECH, V20, P531, DOI 10.1016/j.copbio.2009.08.009; Xu S, 2011, J NEUROTRAUM, V28, P2091, DOI 10.1089/neu.2010.1739; Yeo RA, 2011, J NEUROTRAUM, V28, P1, DOI 10.1089/neu.2010.1578	45	15	15	0	3	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2157-6564	2157-6580		STEM CELL TRANSL MED	Stem Cells Transl. Med.	JAN	2017	6	1					316	329		10.5966/sctm.2016-0087			14	Cell & Tissue Engineering	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	EQ6MB	WOS:000398194800033	28170180	Green Published, gold			2022-02-06	
J	Mors, K; Horauf, JA; Kany, S; Wagner, N; Sturm, R; Woschek, M; Perl, M; Marzi, I; Relja, B				Moers, Katharina; Hoerauf, Jason-Alexander; Kany, Shinwan; Wagner, Nils; Sturm, Ramona; Woschek, Mathias; Perl, Mario; Marzi, Ingo; Relja, Borna			Ethanol Decreases Inflammatory Response in Human Lung Epithelial Cells by Inhibiting the Canonical NF-kappa B-Pathway	CELLULAR PHYSIOLOGY AND BIOCHEMISTRY			English	Article						Inflammation; Trauma; Alcohol; Intoxication; NF-kappa B; Canonical; Non-canonical; Lung	TRAUMATIC BRAIN-INJURY; TUMOR-NECROSIS-FACTOR; BLOOD-ALCOHOL CONCENTRATION; SYSTEMIC INTERLEUKIN-6; MAJOR TRAUMA; FACTOR-ALPHA; INTOXICATION; EPIDEMIOLOGY; ACTIVATION; BETA	Background/Aims: Alcohol (ethanol, EtOH) as significant contributor to traumatic injury is linked to suppressed inflammatory response, thereby influencing clinical outcomes. Alcohol-induced immune-suppression during acute inflammation (trauma) was linked to nuclear factor-kappaB (NF-kappa B). Here, we analyzed alcohol's effects and mechanisms underlying its influence on NF-kappa B-signaling during acute inflammation in human lung epithelial cells. Methods: A549-cells were stimulated with interleukin (IL)-1 beta, or sera from trauma patients (TP) or healthy volunteers, with positive/negative blood alcohol concentrations (BAC), and subsequently exposed to EtOH (170 Mm, 1h). IL-6-release and neutrophil adhesion to A549 were analyzed. Specific siRNA-NIK mediated downregulation of non-canonical, and IKK-NBD-inhibition of canonical NF-kappa B signaling were performed. Nuclear levels of activated p50 and p52 NF-kappa B-subunits were detected using TransAm ELISA. Results: Both stimuli significantly induced IL-6-release (39.79 +/- 4.70 vs. 0.58 +/- 0.8 pg/ml) and neutrophil adhesion (132.30 +/- 8.80 vs. 100% control, p < 0.05) to A549-cells. EtOH significantly decreased IL-6-release (22.90 +/- 5.40, p < 0.05) and neutrophil adherence vs. controls (105.40 +/- 14.5%, p < 0.05). IL-1 beta-induced significant activation of canonical/p50 and non-canonical/p52 pathways. EtOH significantly reduced p50 (34.90 +/- 23.70 vs. 197.70 +/- 36.43, p < 0.05) not p52 activation. Inhibition of canonical pathway was further increased by EtOH (less p50-activation), while p52 remained unaltered. Inhibition of non-canonical pathway was unchanged by EtOH. Conclusion: Here, alcohol's anti-inflammatory effects are mediated via decreasing nuclear levels of activated p50-subunit and canonical NF-kappa B signaling pathway. (C) 2017 The Author(s) Published by S. Karger AG, Basel	[Moers, Katharina; Hoerauf, Jason-Alexander; Kany, Shinwan; Wagner, Nils; Sturm, Ramona; Woschek, Mathias; Marzi, Ingo; Relja, Borna] Goethe Univ, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany; [Perl, Mario] Trauma Ctr Murnau, Dept Trauma Surg, Murnau, Germany		Relja, B (corresponding author), Goethe Univ, Univ Hosp Frankfurt, Dept Trauma Hand & Reconstruct Surg, Frankfurt, Germany.	info@bornarelja.com	Relja, Borna/B-6642-2016	Relja, Borna/0000-0002-5625-8823	DFGGerman Research Foundation (DFG)European Commission [PE908/3-1, RE3304/5-1]	We thank Katrin Jurida and Kerstin Kontradowitz for outstanding technical assistance. This work was supported by DFG PE908/3-1 and RE3304/5-1.	Alberdi F, 2014, MED INTENSIVA, V38, P580, DOI 10.1016/j.medin.2014.06.012; Bardenheuer M, 2000, UNFALLCHIRURG, V103, P355, DOI 10.1007/s001130050550; Berry C, 2010, AM SURGEON, V76, P1067; Beydoun H, 2014, J EMERG MED, V47, P387, DOI 10.1016/j.jemermed.2014.06.024; Boe DM, 2001, J INFECT DIS, V184, P1134, DOI 10.1086/323661; Brasier AR, 2006, CARDIOVASC TOXICOL, V6, P111, DOI 10.1385/CT:6:2:111; Crofford LJ, 1997, ARTHRITIS RHEUM-US, V40, P226, DOI 10.1002/art.1780400207; Driessler F, 2004, CLIN EXP IMMUNOL, V135, P64, DOI 10.1111/j.1365-2249.2004.02342.x; Elsharkawy AM, 2010, J HEPATOL, V53, P519, DOI 10.1016/j.jhep.2010.03.025; Field CA, 2001, J TRAUMA, V50, P13, DOI 10.1097/00005373-200101000-00002; Gebhard F, 2000, ARCH SURG-CHICAGO, V135, P291, DOI 10.1001/archsurg.135.3.291; Gilmore TD, 2006, ONCOGENE, V25, P6680, DOI 10.1038/sj.onc.1209954; Goral J, 2005, J IMMUNOL, V174, P456, DOI 10.4049/jimmunol.174.1.456; Goral J, 2008, ALCOHOL, V42, P237, DOI 10.1016/j.alcohol.2008.02.003; Hadjibashi AA, 2012, J SURG RES, V173, P212, DOI 10.1016/j.jss.2011.05.029; Handel ML, 1995, ARTHRITIS RHEUM, V38, P1762, DOI 10.1002/art.1780381209; Hietbrink F, 2006, World J Emerg Surg, V1, P15, DOI 10.1186/1749-7922-1-15; Hoesel B, 2013, MOL CANCER, V12, DOI 10.1186/1476-4598-12-86; JURKOVICH GJ, 1993, JAMA-J AM MED ASSOC, V270, P51, DOI 10.1001/jama.270.1.51; Lefering R, 2012, UNFALLCHIRURG, V115, P30, DOI 10.1007/s00113-011-2141-4; Lenz A, 2007, INJURY, V38, P1336, DOI 10.1016/j.injury.2007.10.003; Lustenberger T, 2011, J NEUROTRAUM, V28, P1699, DOI 10.1089/neu.2011.1866; Mandrekar P, 2006, ALCOHOL CLIN EXP RES, V30, P135, DOI 10.1111/j.1530-0277.2006.00012.x; Mandrekar P, 1999, INT IMMUNOL, V11, P1781, DOI 10.1093/intimm/11.11.1781; Mandrekar P, 1997, ALCOHOL CLIN EXP RES, V21, P988, DOI 10.1097/00000374-199709000-00007; Mandrekar P, 1996, CYTOKINE, V8, P567, DOI 10.1006/cyto.1996.0076; Mandrekar P, 2007, J IMMUNOL, V178, P7686, DOI 10.4049/jimmunol.178.12.7686; Maraslioglu M, 2014, MEDIAT INFLAMM, V2014, DOI 10.1155/2014/808695; Mimasaka S, 2007, INJURY, V38, P1047, DOI 10.1016/j.injury.2007.02.045; NELSON S, 1989, J INFECT DIS, V160, P422, DOI 10.1093/infdis/160.3.422; Pandit V, 2014, J SURG RES, V190, P634, DOI 10.1016/j.jss.2014.04.039; Pickett W, 2002, ARCH PEDIAT ADOL MED, V156, P786, DOI 10.1001/archpedi.156.8.786; Relja B, 2016, INJURY, V47, P640, DOI 10.1016/j.injury.2016.01.016; Relja B, 2016, INT J MOL MED, V37, P517, DOI 10.3892/ijmm.2015.2431; Relja B, 2015, J MOL MED, V93, P1391, DOI 10.1007/s00109-015-1320-0; Relja B, 2012, BRIT J PHARMACOL, V165, P1188, DOI 10.1111/j.1476-5381.2011.01595.x; Relja B, 2014, MEDIAT INFLAMM, V2014, DOI DOI 10.1155/2014/781519; Relja B, 2015, MOL MED REP, V12, P2991, DOI 10.3892/mmr.2015.3764; RIVARA FP, 1993, ARCH SURG-CHICAGO, V128, P907; Rivara FP, 1993, ARCH SURG-CHICAGO, V128, P912; Robin MA, 2005, HEPATOLOGY, V42, P1280, DOI 10.1002/hep.20949; Singh AK, 2004, MEDIAT INFLAMM, V13, P255, DOI 10.1080/09629350400003035; Sun SC, 2011, CELL RES, V21, P71, DOI 10.1038/cr.2010.177; Szabo G, 1996, ALCOHOL CLIN EXP RES, V20, P900, DOI 10.1111/j.1530-0277.1996.tb05269.x; Tak PP, 2001, J CLIN INVEST, V107, P7, DOI 10.1172/JCI11830; Tien HCN, 2006, ARCH SURG-CHICAGO, V141, P1185, DOI 10.1001/archsurg.141.12.1185; Torices S, 2016, ARTHRITIS RES THER, V18, DOI 10.1186/s13075-016-1113-z; Varfolomeev E, 2016, CYTOKINE; Verzola D, 2017, J CACHEXIA SARCOPENI, V8, P131, DOI 10.1002/jcsm.12129; Volpin G, 2014, INT ORTHOP, V38, P1303, DOI 10.1007/s00264-013-2261-2; von Elm E, 2014, INT J SURG, V12, P1495, DOI 10.1016/j.ijsu.2014.07.013; Wagner N, 2016, SHOCK, V46, P261, DOI 10.1097/SHK.0000000000000620; WALKER DW, 1980, SCIENCE, V209, P711, DOI 10.1126/science.7394532; Wang F, 2015, MOL CANCER, V14, DOI 10.1186/s12943-014-0274-0; Wang HF, 2016, CELL PHYSIOL BIOCHEM, V39, P1129, DOI 10.1159/000447820; Wutzler S, 2013, CHIRURG, V84, P753, DOI 10.1007/s00104-013-2477-0; YANNI G, 1994, ANN RHEUM DIS, V53, P39, DOI 10.1136/ard.53.1.39; Zhang JF, 2016, CELL PHYSIOL BIOCHEM, V38, P2230, DOI 10.1159/000445578; Zhou DY, 2016, SHOCK VIB, V2016, DOI 10.1155/2016/8215696	59	15	16	1	3	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1015-8987	1421-9778		CELL PHYSIOL BIOCHEM	Cell. Physiol. Biochem.		2017	43	1					17	30		10.1159/000480313			14	Cell Biology; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Physiology	FM7GA	WOS:000415240500002	28848184	gold, Green Published			2022-02-06	
J	Pang, AL; Xiong, LL; Xia, QJ; Liu, F; Wang, YC; Liu, F; Zhang, P; Meng, BL; Tan, S; Wang, TH				Pang, Ai-Lan; Xiong, Liu-Lin; Xia, Qing-Jie; Liu, Fen; Wang, You-Cui; Liu, Fei; Zhang, Piao; Meng, Bu-Liang; Tan, Sheng; Wang, Ting-Hua			Neural Stem Cell Transplantation Is Associated with Inhibition of Apoptosis, Bcl-xL Upregulation, and Recovery of Neurological Function in a Rat Model of Traumatic Brain Injury	CELL TRANSPLANTATION			English	Article						neural stem cells; traumatic brain injury; neural behavior; cell apoptosis; Bcl-xL overexpression	SPINAL-CORD-INJURY; CEREBRAL ISCHEMIC-INJURY; ALZHEIMERS-DISEASE; COGNITIVE FUNCTION; PARKINSONS-DISEASE; IMPROVE COGNITION; TRANSGENIC MODEL; PROGENITOR CELLS; NERVOUS-SYSTEM; EXPRESSION	Traumatic brain injury (TBI) is a common disease that usually causes severe neurological damage, and current treatment is far from satisfactory. The neuroprotective effects of neural stem cell (NSC) transplantation in the injured nervous system have largely been known, but the underlying mechanisms remain unclear, and their limited sources impede their clinical application. Here, we established a rat model of TBI by dropping a weight onto the cortical motor area of the brain and explored the effect of engrafted NSCs (passage 3, derived from the hippocampus of embryonic 12-to 14-d green fluorescent protein transgenic mice) on TBI rats. Moreover, RT-PCR and Western blotting were employed to investigate the possible mechanism associated with NSC grafts. We found rats with TBI exhibited a severe motor and equilibrium dysfunction, while NSC transplantation could partly improve the motor function and significantly reduce cell apoptosis and increase B-cell lymphoma-extra large (BclxL) expression at 7 d postoperation. However, other genes including Bax, B-cell lymphoma 2, Fas ligand, and caspase3 did not exhibit significant differences in expression. Moreover, to test whether Bcl-xL could be used as a therapeutic target, herpes simplex virus (HSV) 1 carrying Bcl-xL recombinant was constructed and injected into the pericontusional cortices. Bcl-xL overexpression not only resulted in a significant improvement in neurological function but also inhibits cell apoptosis, as compared with the TBI rats, and exhibits the same effects as the administration of NSC. The present study therefore indicated that NSC transplantation could promote the recovery of TBI rats in a manner similar to that of Bcl-xL overexpression. Therefore, Bcl-xL overexpression, to some extent, could be considered as a useful strategy to replace NSC grafting in the treatment of TBI in future clinical practices.	[Pang, Ai-Lan; Tan, Sheng] Southern Med Univ, Dept Neurol, Zhujiang Hosp, Ind Ave 253, Guangzhou 510282, Guangdong, Peoples R China; [Zhang, Piao; Wang, Ting-Hua] Kunming Med Univ, Inst Neurosci, Yuhua St,Spring Rd,1168, Kunming 650500, Peoples R China; [Xiong, Liu-Lin; Xia, Qing-Jie; Liu, Fen; Wang, You-Cui; Liu, Fei; Wang, Ting-Hua] Sichuan Univ, West China Hosp, Translat Neurosci Ctr, Inst Neurol Dis,Dept Anesthesiol, Chengdu, Peoples R China; [Pang, Ai-Lan] Kunming Med Univ, Dept Neurol, Affiliated Hosp 1, Kunming, Yunnan, Peoples R China; [Meng, Bu-Liang] Kunming Med Univ, Dept Human Anat Histol & Embryol, Kunming, Peoples R China		Tan, S (corresponding author), Southern Med Univ, Dept Neurol, Zhujiang Hosp, Ind Ave 253, Guangzhou 510282, Guangdong, Peoples R China.; Wang, TH (corresponding author), Kunming Med Univ, Inst Neurosci, Yuhua St,Spring Rd,1168, Kunming 650500, Peoples R China.	tansheng18@126.com; tinghua_neuron@263.net			National Key Technology Research and Development Program of the Ministry of Science and Technology of ChinaNational Key Technology R&D Program [2014BAI01B10]; Program for IRTSTYN; National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81360267]; program Innovative Research Team in Science and Technology in Yunnan province	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This research was supported by a grant from the National Key Technology Research and Development Program of the Ministry of Science and Technology of China (CN; No. 2014BAI01B10), by the Program for IRTSTYN, together with the program Innovative Research Team in Science and Technology in Yunnan province and the grant from the National Natural Science Foundation of China (Grant No. 81360267).	Ager RR, 2015, HIPPOCAMPUS, V25, P813, DOI 10.1002/hipo.22405; Bergstrom T, 2012, UPSALA J MED SCI, V117, P132, DOI 10.3109/03009734.2012.665096; Blurton-Jones M, 2009, P NATL ACAD SCI USA, V106, P13594, DOI 10.1073/pnas.0901402106; BOISE LH, 1993, CELL, V74, P597, DOI 10.1016/0092-8674(93)90508-N; Chang TP, 2010, J TRAUMA, V68, P1401, DOI 10.1097/TA.0b013e3181bb9a87; Chen S, 2009, MOL CELL BIOL, V29, P6149, DOI 10.1128/MCB.01481-08; Chen ZW, 2016, CURR GENE THER; DAVIS AA, 1994, NATURE, V372, P263, DOI 10.1038/372263a0; Dewall Jeremy, 2010, JEMS, V35, P54, DOI 10.1016/S0197-2510(10)70095-4; Dooley D, 2014, PHARMACOL THERAPEUT, V141, P21, DOI 10.1016/j.pharmthera.2013.08.001; Duan Kuijia, 2016, Nan Fang Yi Ke Da Xue Xue Bao, V36, P32; Fujimoto ST, 2004, NEUROSCI BIOBEHAV R, V28, P365, DOI 10.1016/j.neubiorev.2004.06.002; Gao JL, 2006, EXP NEUROL, V201, P281, DOI 10.1016/j.expneurol.2006.04.039; Guo YL, 2010, BEHAV BRAIN FUNCT, V6, DOI 10.1186/1744-9081-6-43; Harting MT, 2009, J SURG RES, V153, P188, DOI 10.1016/j.jss.2008.03.037; Hong JY, 2014, J BIOL CHEM, V289, DOI 10.1074/jbc.M114.588871; Jaber M, 2013, REV NEUROL-FRANCE, V169, P838, DOI 10.1016/j.neurol.2013.07.026; Krieger DW, 2013, FRONT NEUROL NEUROSC, V32, P76, DOI 10.1159/000346419; Lee DY, 2012, CANCER CELL, V22, P131, DOI 10.1016/j.ccr.2012.05.036; Lee SI, 2009, J NEUROSCI RES, V87, P3186, DOI 10.1002/jnr.22149; Li YQ, 2016, INT J MOL SCI, V17, DOI 10.3390/ijms17060970; Li Z, 2014, GENET MOL RES, V13, P6083, DOI 10.4238/2014.August.7.23; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Liu GY, 2013, BEHAV BRAIN FUNCT, V9, DOI 10.1186/1744-9081-9-36; Lu JK, 2000, SPINE, V25, P1859, DOI 10.1097/00007632-200007150-00022; Lu P, 2003, EXP NEUROL, V181, P115, DOI 10.1016/S0014-4886(03)00037-2; Mansouri S, 2012, J NEUROSCI RES, V90, P759, DOI 10.1002/jnr.22803; Michels Judith, 2013, Int J Cell Biol, V2013, P705294, DOI 10.1155/2013/705294; Namjoshi DR, 2013, DIS MODEL MECH, V6, P1325, DOI 10.1242/dmm.011320; Okano H, 2008, PHILOS T R SOC B, V363, P2111, DOI 10.1098/rstb.2008.2264; Okano H, 2010, P JPN ACAD B-PHYS, V86, P438, DOI 10.2183/pjab.86.438; Olanow CW, 1996, J NEURAL TRANSM-SUPP, P75; Parrondo R, 2013, PEERJ, V1, DOI 10.7717/peerj.144; Piccini P, 2005, BRAIN, V128, P2977, DOI 10.1093/brain/awh649; Qi YH, 2014, GENET MOL RES, V13, P1366, DOI 10.4238/2014.February.28.9; Rahmani M, 2013, CANCER RES, V73, P1340, DOI 10.1158/0008-5472.CAN-12-1365; Salewski RP, 2015, STEM CELLS DEV, V24, P36, DOI 10.1089/scd.2014.0096; Seaberg RM, 2002, J NEUROSCI, V22, P1784, DOI 10.1523/JNEUROSCI.22-05-01784.2002; Sharp KG, 2014, EXP NEUROL, V257, P186, DOI 10.1016/j.expneurol.2014.04.008; Shetty AK, 2004, HIPPOCAMPUS, V14, P595, DOI 10.1002/hipo.10206; Steward O, 2014, J NEUROSCI, V34, P14013, DOI 10.1523/JNEUROSCI.3066-14.2014; Tan XF, 2014, NEUROSCI LETT, V571, P23, DOI 10.1016/j.neulet.2014.04.019; Tomishima M., 2008, STEMBOOK; Umschwief G, 2010, J CEREBR BLOOD F MET, V30, P616, DOI 10.1038/jcbfm.2009.234; Wang SH, 2012, CURR NEUROVASC RES, V9, P20, DOI 10.2174/156720212799297137; Wilcox JT, 2014, STEM CELL TRANSL MED, V3, P1148, DOI 10.5966/sctm.2014-0029; Winkler C, 2005, TRENDS NEUROSCI, V28, P86, DOI 10.1016/j.tins.2004.12.006; Xiao JJ, 2015, OXID MED CELL LONGEV, V2015, DOI 10.1155/2015/618631; Xing RX, 2015, IBRAIN, V1, P36; Yi Bo-Rim, 2013, Lab Anim Res, V29, P131, DOI 10.5625/lar.2013.29.3.131; Zhang W, 2015, NEUROBIOL AGING, V36, P1282, DOI 10.1016/j.neurobiolaging.2014.10.040; Zhang W, 2014, MOL NEUROBIOL, V50, P423, DOI 10.1007/s12035-014-8640-x; Zhao L, 2013, BRAIN RES, V1503, P78, DOI 10.1016/j.brainres.2013.01.051; Zhou FC, 2001, RESTOR NEUROL NEUROS, V18, P95; Zuo FX, 2015, INT J MOL SCI, V16, P26473, DOI 10.3390/ijms161125966	55	15	18	0	10	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0963-6897	1555-3892		CELL TRANSPLANT	Cell Transplant.		2017	26	7					1262	1275		10.1177/0963689717715168			14	Cell & Tissue Engineering; Medicine, Research & Experimental; Transplantation	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Research & Experimental Medicine; Transplantation	EZ4GO	WOS:000404671800013	28933221	gold, Green Published			2022-02-06	
J	Poppen, M; Lindstrom, L; Unruh, D; Khurana, A; Bullis, M				Poppen, Marcus; Lindstrom, Lauren; Unruh, Deanne; Khurana, Atika; Bullis, Michael			Preparing youth with disabilities for employment: An analysis of vocational rehabilitation case services data	JOURNAL OF VOCATIONAL REHABILITATION			English	Article						Transition; youth with disabilities; vocational rehabilitation; employment outcomes	POSTSCHOOL OUTCOMES; YOUNG-ADULTS; PREDICTORS; SCHOOL; STUDENTS	BACKGROUND: Despite national efforts to improve post-school outcomes, many students with disabilities are unprepared to enter the workforce. Coordination with Vocational Rehabilitation (VR) can offer opportunities for improved employment outcomes. OBJECTIVE: This study examined Oregon VR data to identify predictors of positive closure status for youth with disabilities. METHODS: Researchers used logistic regression to explore the effects of individual, in-school, post-school and contextual factors on VR case closure status among 4,443 young adults with disabilities who received and completed services from Oregon VR between 2003 and 2013. RESULTS: Being female, having a mental illness, traumatic brain injury, multiple disabilities, interpersonal or self-care impediments to employment, receiving SSI, and closing with VR in periods of high unemployment reduce the likelihood of a positive VR closure. Participating in a collaborative transition program, earning a high school completion certificate, receiving a greater number of VR services, closing below the median number of days to closure, and closing in low unemployment periods increase the likelihood of a positive VR case closure status. CONCLUSION: These findings highlight specific barriers to employment for vulnerable groups of young adults with disabilities, and identify service and contextual factors that can support positive employment outcomes.	[Poppen, Marcus] Washington State Univ, Dept Teaching & Learning, POB 642132, Pullman, WA 99164 USA; [Lindstrom, Lauren; Khurana, Atika] Univ Oregon, Counseling Pyschol & Human Serv, Eugene, OR 97403 USA; [Unruh, Deanne] Univ Oregon, Special Educ & Clin Sci, Eugene, OR 97403 USA; [Bullis, Michael] Univ Oregon, Educ Methodol Policy & Leadership, Eugene, OR 97403 USA		Poppen, M (corresponding author), Washington State Univ, Dept Teaching & Learning, POB 642132, Pullman, WA 99164 USA.	marcus.poppen@wsu.edu					Allison PD, 2002, SAGE U PAPERS SERIES; Alverson C., 2014, OREGON YOUTH TRANSIT; [Anonymous], 2013, OREGON ANN PERFORMAN; Benz MR, 2000, EXCEPT CHILDREN, V66, P509, DOI 10.1177/001440290006600405; BENZ MR, 1999, J VOCATIONAL REHABIL, V13, P55; Boeltzig H, 2008, INT J REHABIL RES, V31, P217, DOI 10.1097/MRR.0b013e3282fb7ce5; Butterworth J., 2014, TRENDS EMPLOYMENT OU; Carter EW, 2012, J DISABIL POLICY STU, V23, P50, DOI 10.1177/1044207311414680; Chan JY, 2014, REHABIL COUNS BULL, V57, P209, DOI 10.1177/0034355213509855; Cimera RE, 2009, J VOCAT REHABIL, V30, P1, DOI 10.3233/JVR-2009-0448; Crudden A.., 2009, J VISUAL IMPAIRMENT, V103, P329, DOI 10.1177/0145482x0910300603; Doren B, 2013, J ADOLESCENCE, V36, P1083, DOI 10.1016/j.adolescence.2013.08.014; Doren B, 2012, EXCEPT CHILDREN, V79, P7, DOI 10.1177/001440291207900101; Flannery KB, 2011, REHABIL COUNS BULL, V54, P106, DOI 10.1177/0034355210368432; Giesen JM, 2012, J VISUAL IMPAIR BLIN, V106, P475, DOI 10.1177/0145482X1210600804; Gilmore D., 2001, VOCATIONAL REHABILIT; Gonzalez R, 2011, J VOCAT REHABIL, V34, P163, DOI 10.3233/JVR-2011-0544; Honeycutt T., 2013, MATH POLICY RES; Honeycutt T, 2015, J VOCAT REHABIL, V43, P229, DOI 10.3233/JVR-150772; Jun S, 2015, J REHABIL, V81, P47; Kortering L, 2012, HANDBOOK OF ADOLESCENT TRANSITION EDUCATION FOR YOUTH WITH DISABILITIES, P208; Madaus JW, 2013, CAREER DEV TRANSIT E, V36, P4, DOI 10.1177/2165143413485225; Mazzotti VL, 2016, CAREER DEV TRANSIT E, V39, P196, DOI 10.1177/2165143415588047; MCDANIEL M, 2013, REV BLACK POLITICAL, V40, P371, DOI DOI 10.1007/S12114-012-9147-1; McDonough JT, 2010, J VOCAT REHABIL, V32, P89, DOI 10.3233/JVR-2010-0498; Metzel DS, 2007, INTELLECT DEV DISAB, V45, P149, DOI 10.1352/1934-9556(2007)45[149:ACMTCR]2.0.CO;2; Migliore A, 2012, REHABIL COUNS BULL, V55, P176, DOI 10.1177/0034355212438943; Newman L., 2011, 20113005 NLTS2 NCSER; Newman L., 2009, POSTHIGH SCH OUTCOME; Poppen M, 2014, THESIS; Rabren K., 2003, J VOCATIONAL REHABIL, V18, P145; Roux M., 2013, J AM ACAD CHILD ADOL, V52, P897; Samuels C., 2015, ED WEEK, V34, P2; Sanford C., 2011, POSTHIGH SCH OUTCOME; Sima AP, 2015, CAREER DEV TRANSIT E, V38, P89, DOI 10.1177/2165143414534887; Sturdivant RX, 2013, APPL LOGISTIC REGRES, V3rd; Sung C, 2015, J AUTISM DEV DISORD, V45, P3204, DOI 10.1007/s10803-015-2480-z; Test DW, 2009, CAREER DEV TRANSIT E, V32, P160, DOI 10.1177/0885728809346960; U.S. Bureau of Labor Statistics, 2012, BLS SPOTL STAT REC 2; U.S. Bureau of Labor Statistics, DAT RETR CURR POP SU; U.S. Census Bureau, 2014, URB RUR CLASS; U.S. Department of Labor, 2013, PERS DIS LAB FORC CH; U.S. Social Security Administration, 2014, DIS BEN; Wagner MM, 2014, CAREER DEV TRANSIT E, V37, P5, DOI 10.1177/2165143414523980; Washington T., 2002, CAREER DEV EXCEPTION, V25, P123, DOI [10.1177/088572880202500203, DOI 10.1177/088572880202500203]; [No title captured]	46	15	15	0	11	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1052-2263	1878-6316		J VOCAT REHABIL	J. Vocat. Rehabil.		2017	46	2					209	224		10.3233/JVR-160857			16	Rehabilitation	Emerging Sources Citation Index (ESCI)	Rehabilitation	EM4SP	WOS:000395303400010					2022-02-06	
J	Sartore-Baldwin, ML; McCullough, B; Quatman-Yates, C				Sartore-Baldwin, Melanie L.; McCullough, Brian; Quatman-Yates, Catherine			Shared Responsibility and Issues of Injustice and Harm within Sport	QUEST			English	Article						Harm; oppression; shared responsibility; social justice; sport	CORPORATE SOCIAL-RESPONSIBILITY; ORGANIZATIONAL JUSTICE; CONCUSSION EDUCATION; KNOWLEDGE TRANSFER; SEXUAL-ABUSE; IGNORANCE; PERCEPTIONS; CULTURE; IMPACT; POLICY	The purpose of this article is to present a conceptual model of shared responsibility within the sport context. Focusing on issues of harm and injustice, this model proposes that organized sport can exist as an oppressive social structure that endorses ignorance through the presence of asymmetrical power relations. This ignorance reinforces oppressive structures as well as fosters vulnerability, a byproduct that, in turn, also reinforces oppressive structures. Rather than assigning responsibility to any one entity specifically, however, this article proposes that each and every individual with a vested interest in sport possess some degree of responsibility in securing safe, fair, and just sport experiences. Thus, the concept of shared responsibility is offered as a moderating factor through which the processes that result from oppressive structures may be interrupted and the structures themselves broken down.	[Sartore-Baldwin, Melanie L.] East Carolina Univ, Dept Exercise & Sport Sci, Greenville, NC USA; [McCullough, Brian] Seattle Univ, Coll Arts & Sci, Seattle, WA 98122 USA; [Quatman-Yates, Catherine] Cincinnati Childrens Hosp Med Ctr, Div Occupat & Phys Therapy, Cincinnati, OH 45229 USA		Sartore-Baldwin, ML (corresponding author), East Carolina Univ, Dept Kinesiol, 152 Minges Coliseum, Greenville, NC 27858 USA.	sartorem@ecu.edu	McCullough, Brian P./H-8898-2013; Quatman-Yates, Catherine/AAK-4507-2021; Quatman-Yates, Catherine/U-9580-2019	McCullough, Brian P./0000-0002-9085-7926; 			Banerjee SB, 2014, CRIT PERSPECT INT BU, V10, P84, DOI 10.1108/cpoib-06-2013-0021; Best J, 2012, ECON SOC, V41, P84, DOI 10.1080/03085147.2011.637333; Blaikie P, 1994, RISK NATURAL HAZARDS; Brackenridge C. H., 1994, International Review for the Sociology of Sport, V29, P287, DOI 10.1177/101269029402900304; Brown TJ, 1997, J MARKETING, V61, P68, DOI 10.2307/1252190; Burton LJ, 2015, SPORT MANAG REV, V18, P155, DOI 10.1016/j.smr.2014.02.004; Butler Judith, 2004, UNDOING GENDER; Colquitt JA, 2001, J APPL PSYCHOL, V86, P386, DOI 10.1037//0021-9010.86.3.386; Cooky C, 2012, CULT STUD-CRIT METHO, V12, P326, DOI 10.1177/1532708612446432; Cunningham G. B., 2015, DIVERSITY INCLUSION; Cunningham GB, 2008, SEX ROLES, V58, P3, DOI 10.1007/s11199-007-9360-8; David P., 2005, HUMAN RIGHTS YOUTH S; Doherty A. J., 1999, J SPORT MANAGEMENT, V13; Douglass Frederick, 1962, LIFE TIMES F DOUGLAS; Echlin PS, 2014, J NEUROSURG, V121, P1331, DOI 10.3171/2014.8.JNS132804; EITZEN DS, 2000, HDB SPORTS STUDIES, P370; Fainaru-Wada Mark, 2013, LEAGUE DENIAL NFL CO; Feenan D, 2007, SOC LEGAL STUD, V16, P509, DOI 10.1177/0964663907082733; FOUCAULT M, 1978, HIST SEXUALITY INTRO; Freire P., 2000, PEDAGOGY OPPRESSED; Frisby W, 2005, J SPORT MANAGE, V19, P1, DOI 10.1123/jsm.19.1.1; Gilson E, 2011, HYPATIA, V26, P308, DOI 10.1111/j.1527-2001.2010.01158.x; GREENBERG J, 1990, J MANAGE, V16, P399, DOI 10.1177/014920639001600208; Hilhorst D., 2004, MAPPING VULNERABILIT, P1; Johnson AG., 2001, PRIVILEGE POWER DIFF; Kerr GA, 2008, QUEST, V60, P307, DOI 10.1080/00336297.2008.10483583; Kerr ZY, 2014, BRAIN INJURY, V28, P1009, DOI 10.3109/02699052.2014.904049; Kerr ZY, 2013, AM J PREV MED, V44, P8, DOI 10.1016/j.amepre.2012.09.058; Leahy T, 2008, INT J SPORT EXERC PS, V6, P366, DOI 10.1080/1612197X.2008.9671880; May L., 1993, SHARING RESPONSIBILI; Merkel DL, 2013, OPEN ACCESS J SPORTS, V4, P151, DOI 10.2147/OAJSM.S33556; Merkel DL, 2012, INT J SPORTS PHYS TH, V7, P242; Messner M. A., 2002, TAKING FIELD WOMEN M; Miyashita TL, 2013, CLIN J SPORT MED, V23, P349, DOI 10.1097/JSM.0b013e318289c321; MOODYADAMS MM, 1994, ETHICS, V104, P291, DOI 10.1086/293601; Moore EE, 2012, CULT STUD-CRIT METHO, V12, P361, DOI 10.1177/1532708612446439; Murray IR, 2015, CLIN J SPORT MED, V25, P75, DOI 10.1097/JSM.0000000000000134; Noble J, 2014, CHILD YOUTH SERV REV, V38, P52, DOI 10.1016/j.childyouth.2014.01.011; Parent S, 2011, CHILD ABUSE REV, V20, P120, DOI 10.1002/car.1135; Pava ML, 1996, J BUS ETHICS, V15, P321, DOI 10.1007/BF00382958; Prentice DA, 1996, ADV EXP SOC PSYCHOL, V28, P161, DOI 10.1016/S0065-2601(08)60238-5; Proctor, 1995, CANC WARS; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Rappert B, 2012, ECON SOC, V41, P42, DOI 10.1080/03085147.2011.637334; Rayner S, 2012, ECON SOC, V41, P107, DOI 10.1080/03085147.2011.637335; Rogers W, 2012, INT J FEM APPROACHES, V5, P11; Sartore-Baldwin MelanieL., 2013, SEXUAL MINORITIES SP, P1; Schrempf J, 2014, BUS SOC, V53, P300, DOI 10.1177/0007650312449577; Schroder-Butterfill E, 2006, AGEING SOC, V26, P9, DOI 10.1017/S0144686X05004423; SMITHSON M, 1985, J THEOR SOC BEHAV, V15, P151, DOI 10.1111/j.1468-5914.1985.tb00049.x; Stafford A, 2013, CHILD ABUSE REV, V22, P287, DOI 10.1002/car.2289; Stirling AE, 2014, J AGGRESS MALTREAT T, V23, P116, DOI 10.1080/10926771.2014.872747; Stirling AE, 2009, SPORT SOC, V12, P227, DOI 10.1080/17430430802591019; Tator CH, 2012, J CLIN SPORT PSYCHOL, V6, P293, DOI 10.1123/jcsp.6.3.293; Tuana N., 2006, HYPATIA, V21, P1, DOI DOI 10.1111/J.1527-2001.2006.TB01110.X; TUANA Nancy, 2004, HYPATIA, V19, P194, DOI DOI 10.1111/J.1527-2001.2004.TB01275.X; Walker NA, 2015, J SPORT MANAGE, V29, P257, DOI 10.1123/jsm.2013-0079; Washington M, 2011, SPORT MANAG REV, V14, P1, DOI 10.1016/j.smr.2010.06.003; Weinberg R, 2013, J CLIN SPORT PSYCHOL, V7, P41, DOI 10.1123/jcsp.7.1.41; Young I.M., 2011, RESPONSIBILITY JUSTI; Young IM, 2006, SOC PHILOS POLICY, V23, P102, DOI 10.1017/S0265052506060043; Young Iris M., 2004, OPPRESSION PRIVILEGE, P37	63	15	15	2	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0033-6297	1543-2750		QUEST	Quest		2017	69	3					366	383		10.1080/00336297.2016.1238769			18	Education & Educational Research; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Education & Educational Research; Sport Sciences	FM4PO	WOS:000415001800005					2022-02-06	
J	Stephens, J; Salorio, C; Denckla, M; Mostofsky, S; Suskauer, S				Stephens, J.; Salorio, C.; Denckla, M.; Mostofsky, S.; Suskauer, S.			Subtle Motor Findings During Recovery from Pediatric Traumatic Brain Injury: A Preliminary Report	JOURNAL OF MOTOR BEHAVIOR			English	Article						motor; pediatric; rehabilitation; traumatic brain injury	UPPER-LIMB FUNCTION; CHILDREN; GAIT; CONCUSSION; STABILITY; SIGNS	Pediatric traumatic brain injury (TBI) is a heterogeneous condition, varying in both severity and sequelae. The long-term motor deficits following severe TBI requiring inpatient rehabilitation are better established than those following milder forms of TBI. The authors examined motor performance 2 and 12 months postinjury in children without overt motor impairment using standard measures of upper limb function and the Physical and Neurological Examination for Subtle Signs (PANESS). The PANESS was sensitive to differences between children with TBI and uninjured children as well as to changes in children with TBI over time. These data suggest that subtle motor deficits are present after milder forms of TBI and, particularly those related to balance and gait, may persist even 12 months postinjury.	[Stephens, J.; Salorio, C.; Denckla, M.; Mostofsky, S.; Suskauer, S.] Kennedy Krieger Inst, 716 N Broadway,Off 306, Baltimore, MD 21205 USA; [Stephens, J.; Suskauer, S.] Johns Hopkins Sch Med, Dept Phys Med & Rehabil, Baltimore, MD USA; [Denckla, M.; Mostofsky, S.] Johns Hopkins Sch Med, Dept Neurol, Baltimore, MD USA; [Denckla, M.] Johns Hopkins Sch Med, Dept Psychiat, Baltimore, MD USA; [Mostofsky, S.; Suskauer, S.] Johns Hopkins Sch Med, Dept Pediat, Baltimore, MD USA		Stephens, J (corresponding author), Kennedy Krieger Inst, 716 N Broadway,Off 306, Baltimore, MD 21205 USA.	StephensJ@kennedykrieger.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23HD061611]; NIH/ NCRR CTSA ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS)NIH National Center for Research Resources (NCRR) [UL1TR001079-01]; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [T32HD007414, K23HD061611, U54HD079123] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001079] Funding Source: NIH RePORTER	This research was funded by NIH K23HD061611 and NIH/ NCRR CTSA Program UL1TR001079-01.	Ahlander AC, 2013, J REHABIL MED, V45, P815, DOI 10.2340/16501977-1203; American Congress of Rehabilitation Medicine, 1993, J HEAD TRAUMA REHAB, V8, P86, DOI DOI 10.1097/00001199-199309000-00010; Babikian T, 2011, J INT NEUROPSYCH SOC, V17, P886, DOI 10.1017/S1355617711000907; Delis DC., 2001, DELIS KAPLAN EXECUTI; DENCKLA MB, 1985, PSYCHOPHARMACOL BULL, V21, P773; Faul M, 2010, TRAUMATIC BRAIN INJU; Gaddis A, 2015, PSYCHIAT RES-NEUROIM, V233, P488, DOI 10.1016/j.pscychresns.2015.08.001; Gagnon I, 2004, J HEAD TRAUMA REHAB, V19, P391, DOI 10.1097/00001199-200409000-00004; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Howell DR, 2014, EXP BRAIN RES, V232, P1773, DOI 10.1007/s00221-014-3869-1; Katz-Leurer M, 2010, BRAIN INJURY, V24, P1561, DOI 10.3109/02699052.2010.523046; Kuhtz-Buschbeck JP, 2003, ARCH PHYS MED REHAB, V84, P424, DOI 10.1053/apmr.2003.50017; Kuhtz-Buschbeck JP, 2003, DEV MED CHILD NEUROL, V45, P821, DOI 10.1017/S001216220300152X; Lahat E, 1996, PEDIATR NEUROL, V15, P299, DOI 10.1016/S0887-8994(96)00221-4; Larson JCG, 2007, DEV NEUROPSYCHOL, V32, P543; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; MacNeil LK, 2012, NEUROPSYCHOLOGY, V26, P165, DOI 10.1037/a0026955; Martini DN, 2011, ARCH PHYS MED REHAB, V92, P585, DOI 10.1016/j.apmr.2010.11.029; Rhine T., 2015, J HEAD TRAUMA REHABI; Risen SR, 2015, J PEDIATR REHAB MED, V8, P309, DOI 10.3233/PRM-150349; Taylor HG, 2015, J HEAD TRAUMA REHAB, V30, P302, DOI 10.1097/HTR.0000000000000106; VITIELLO B, 1989, J AM ACAD CHILD PSY, V28, P749, DOI 10.1097/00004583-198909000-00017; Wallen MA, 2001, ARCH PHYS MED REHAB, V82, P642, DOI 10.1053/apmr.2001.22620	23	15	15	0	11	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0022-2895	1940-1027		J MOTOR BEHAV	J. Mot. Behav.	JAN-FEB	2017	49	1					20	26		10.1080/00222895.2016.1204267			7	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	EN5EN	WOS:000396028500003	27635631	Green Accepted			2022-02-06	
J	Tuominen, M; Stuart, MJ; Aubry, M; Kannus, P; Parkkari, J				Tuominen, Markku; Stuart, Michael J.; Aubry, Mark; Kannus, Pekka; Parkkari, Jari			Injuries in world junior ice hockey championships between 2006 and 2015	BRITISH JOURNAL OF SPORTS MEDICINE			English	Article							DESCRIPTIVE EPIDEMIOLOGY; SURVEILLANCE SYSTEM; SOCCER INJURIES; NECK INJURIES; MENS; HEAD; TOURNAMENTS; PLAYERS; FEDERATION; 7-YEAR	Background Detailed injury data are not available for international ice hockey tournaments played by junior athletes. We report the incidence, type, mechanism and severity of injuries in males under ages 18 and 20 at junior ice hockey World Championships during 2006-2015. Methods All injuries in the International Ice Hockey Federation World Junior under-20 (WJ U20) Championship and under-18 (WJ U18) Championship were collected over a 9-year period using a strict injury definition, a standardised injury reporting system and diagnoses made by a team physician. Results 633 injuries were recorded in 1326 games over a 9-year period, resulting in an injury rate (IR) of 11.0 per 1000 player-games and 39.8/1000 player-game hours. The IRs in all tournaments were 4.3/1000 player-games for the head and face, 3.2 for the upper body, 2.6 for the lower body and 1.0 for the spine and trunk. A laceration was the most common injury type followed by a sprain. Lacerations accounted for 80% (IR 3.6) of facial injuries in WJ U20 tournaments. The shoulder was the most common injury site (IR 2.0) in WJ U18 tournaments. Board contact was the mechanism for 59% of these shoulder injuries. Concussion was the most common head and face injury (46%; IR 1.2) in WJ U18 tournaments. Conclusions and recommendations The risk of injury among male junior ice hockey players was lower than the reported rates in adult men but higher than that in women. Facial lacerations were common in U20 junior players (WJ U20) since most wear only partial facial protection (visor). The IR for shoulder injuries was high in U18 junior players (WJ U18). Suggested strategies for injury prevention include full facial protection for all players and flexible board and glass for all junior tournaments.	[Tuominen, Markku] Medisport Ltd, Keskisenkatu 5, Tampere 33710, Finland; [Stuart, Michael J.] Mayo Clin, Dept Orthoped, Rochester, MN USA; [Aubry, Mark] Ottawa Sport Med Ctr, Ottawa, ON, Canada; [Kannus, Pekka] UKK Inst, Injury & Osteoporosis Res Ctr, Tampere, Finland; [Parkkari, Jari] UKK Inst, Tampere Res Ctr Sports Med, Tampere, Finland		Tuominen, M (corresponding author), Medisport Ltd, Keskisenkatu 5, Tampere 33710, Finland.	markku.tuominen@medisport.fi			International Ice Hockey Federation; Finnish Ministry of Education and Culture	This study was financially supported by the International Ice Hockey Federation and the Finnish Ministry of Education and Culture.	Agel J, 2007, J ATHL TRAINING, V42, P270; Agel J, 2007, J ATHL TRAINING, V42, P241; Agel J, 2010, CAN J SURG, V53, P319; Asplund C, 2009, BRIT J SPORT MED, V43, P993, DOI 10.1136/bjsm.2009.060152; Benson BW, 1999, JAMA-J AM MED ASSOC, V282, P2328, DOI 10.1001/jama.282.24.2328; Clarsen B, 2014, BRIT J SPORT MED, V48, P510, DOI 10.1136/bjsports-2013-093297; Dick R, 2007, J ATHL TRAINING, V42, P194; Engebretsen L, 2014, BRIT J SPORT MED, V48, P1270, DOI 10.1136/bjsports-2014-093992; Flik K, 2005, AM J SPORT MED, V33, P183, DOI 10.1177/0363546504267349; Fuller CW, 2011, CLIN J SPORT MED, V21, P356, DOI 10.1097/JSM.0b013e31821f5085; Groger A, 2001, SPORTVERLETZ SPORTSC, V15, P82, DOI 10.1055/s-2001-19047; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Junge A, 2013, BRIT J SPORT MED, V47, P782, DOI 10.1136/bjsports-2013-092205; LAPRADE RF, 1995, AM J SPORT MED, V23, P773, DOI 10.1177/036354659502300624; LaPrade RF, 2014, BRIT J SPORT MED, V48, P4, DOI 10.1136/bjsports-2013-093020; Leppanen M, 2014, SPORTS MED, V44, P473, DOI 10.1007/s40279-013-0136-8; Meeuwisse Willem H, 2002, Clin J Sport Med, V12, P406; Mukherjee S, 2012, AM J SPORT MED, V40, P686, DOI 10.1177/0363546511426697; Pinto M, 1999, CLIN J SPORT MED, V9, P70, DOI 10.1097/00042752-199904000-00005; Rechel JA, 2008, J ATHL TRAINING, V43, P197, DOI 10.4085/1062-6050-43.2.197; Rishiraj N, 2009, J SPORT MED PHYS FIT, V49, P159; Ruhe A, 2014, BRIT J SPORT MED, V48, P102, DOI 10.1136/bjsports-2012-091609; STUART MJ, 1995, AM J SPORT MED, V23, P458, DOI 10.1177/036354659502300415; Stuart MJ, 2002, AM J SPORT MED, V30, P39, DOI 10.1177/03635465020300012001; Stuart MJ, 2000, AM SOC TEST MATER, V1341, P19, DOI 10.1520/STP15224S; Tuominen M, 2016, BRIT J SPORT MED, V50, P1406, DOI 10.1136/bjsports-2015-094647; Tuominen M, 2015, BRIT J SPORT MED, V49, P30, DOI 10.1136/bjsports-2014-093688; Yard EE, 2008, AM J SPORT MED, V36, P1930, DOI 10.1177/0363546508318047	28	15	16	1	17	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0306-3674	1473-0480		BRIT J SPORT MED	Br. J. Sports Med.	JAN	2017	51	1					36	+		10.1136/bjsports-2016-095992			9	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	EH0EK	WOS:000391435400010	27281776	Green Published, Bronze			2022-02-06	
J	Von der Brelie, C; Seifert, M; Rot, S; Tittel, A; Sanft, C; Meier, U; Lemcke, J				Von der Brelie, Christian; Seifert, Michael; Rot, Sergej; Tittel, Anja; Sanft, Carsten; Meier, Ullrich; Lemcke, Johannes			Sedation of Patients with Acute Aneurysmal Subarachnoid Hemorrhage with Ketamine Is Safe and Might Influence the Occurrence of Cerebral Infarctions Associated with Delayed Cerebral Ischemia	WORLD NEUROSURGERY			English	Article						Cerebral aneurysm; Delayed cerebral ischemia; Intracranial pressure; Ketamine; Subarachnoid hemorrhage	TRAUMATIC BRAIN-INJURY; LONG-TERM MORTALITY; SPREADING DEPOLARIZATIONS; INTRACRANIAL-PRESSURE; CARE; VASOSPASM; PROPOFOL; ARTERIES; TRIAL	BACKGROUND: Ketamine has neuroprotective characteristics as well as beneficial cardiocirculatory properties and may thus reduce vasopressor consumption. In contrast, sedation with ketamine (like any other sedative drug) has side effects. This study assesses the influence of ketamine on intracranial pressure (ICP), on the consumption of vasopressors in induced hypertension therapy, and on the occurrence of delayed cerebral ischemia (DCI)-associated cerebral infarctions, with particular focus on the complications of sedation in patients with aneurysmal subarachnoid hemorrhage (SAH). METHODS: This is a retrospective, observational study. Sixty-five patients with SAH who underwent a period of sedation were included. The clinical course variables (Richmond Agitation and Sedation scale score, ICP values, consumption of vasopressors, complications of sedation, outcome, and other clinical parameters) were analyzed. Cranial computed tomography results were analyzed. RESULTS: Forty-one patients underwent sedation including ketamine (63.1%). Ketamine decreased the ICP in 92.7% of the cases. Vasopressors was reduced in 53.6%. DCI-associated cerebral infarctions occurred significantly less often in the patient cohort being treated with sedation including ketamine (7.3% vs. 25% in the nonketamine group; P = 0.04). The rate of major complications was not higher in the ketamine group. Outcome was not different regarding the groups if they were sedated with or without ketamine. CONCLUSIONS: Ketamine decreases the ICP and is not associated with a higher rate of complications. The rate of DCI-associated cerebral infarctions was lower in the ketamine group. Ketamine administration led to a reduction of vasopressors used for induced hypertension.	[Von der Brelie, Christian] Univ Gottingen, Dept Neurosurg, Gottingen, Germany; [Von der Brelie, Christian; Rot, Sergej; Meier, Ullrich; Lemcke, Johannes] Unfallkrankenhaus Berlin, Dept Neurosurg, Berlin, Germany; [Seifert, Michael; Sanft, Carsten] Unfallkrankenhaus Berlin, Dept Anesthesiol, Berlin, Germany; [Tittel, Anja] Unfallkrankenhaus Berlin, Dept Radiol, Berlin, Germany		Von der Brelie, C (corresponding author), Univ Gottingen, Dept Neurosurg, Gottingen, Germany.; Von der Brelie, C (corresponding author), Unfallkrankenhaus Berlin, Dept Neurosurg, Berlin, Germany.	cvdb@gmx.net		Lemcke, Johannes/0000-0002-8073-1625			Albanese J, 1997, ANESTHESIOLOGY, V87, P1328, DOI 10.1097/00000542-199712000-00011; Bar-Joseph G, 2009, J NEUROSURG-PEDIATR, V4, P40, DOI 10.3171/2009.1.PEDS08319; BRODERICK JP, 1994, STROKE, V25, P1342, DOI 10.1161/01.STR.25.7.1342; Dasenbrock HH, 2016, WORLD NEUROSURG, V88, P459, DOI 10.1016/j.wneu.2015.10.054; Dreier JP, 2006, BRAIN, V129, P3224, DOI 10.1093/brain/awl297; Dreier JP, 2009, BRAIN, V132, P1866, DOI 10.1093/brain/awp102; FUKUDA S, 1983, ANESTH ANALG, V62, P553; Grace RF, 2003, ANAESTHESIA, V58, P904, DOI 10.1046/j.1365-2044.2003.03341.x; Haley EC, 1997, J NEUROSURG, V86, P467, DOI 10.3171/jns.1997.86.3.0467; HERNANDEZCACERES J, 1987, BRAIN RES, V437, P360, DOI 10.1016/0006-8993(87)91652-0; Hertle DN, 2012, BRAIN, V135, P2390, DOI 10.1093/brain/aws152; Joffe A R, 2000, Pediatr Crit Care Med, V1, P151, DOI 10.1097/00130478-200010000-00011; Kamel IR, 2008, J NEUROSURG ANESTH, V20, P241, DOI 10.1097/ANA.0b013e31817f523f; Kolenda H, 1996, ACTA NEUROCHIR, V138, P1193, DOI 10.1007/BF01809750; Lindquist L A, 2003, J Wound Care, V12, P272; Mees SMD, 2012, J NEUROL, V259, P679, DOI 10.1007/s00415-011-6243-2; Page RL, 2016, CIRCULATION, V134, pE32, DOI 10.1161/CIR.0000000000000426; Pluta RM, 2009, NEUROL RES, V31, P151, DOI 10.1179/174313209X393564; Rodrigues Junior Geraldo Rolim, 2004, Sao Paulo Med. J., V122, P8, DOI 10.1590/S1516-31802004000100003; Rowland MJ, 2012, BRIT J ANAESTH, V109, P315, DOI 10.1093/bja/aes264; Sakowitz OW, 2009, STROKE, V40, pE519, DOI 10.1161/STROKEAHA.109.549303; Sanchez-Porras R, 2014, NEUROPHARMACOLOGY, V84, P52, DOI 10.1016/j.neuropharm.2014.04.018; Sessler CN, 2001, SEMIN RESP CRIT CARE, V22, P211, DOI 10.1055/s-2001-13834; Shehabi Y, 2013, INTENS CARE MED, V39, P910, DOI 10.1007/s00134-013-2830-2; Shehabi Y, 2012, AM J RESP CRIT CARE, V186, P724, DOI 10.1164/rccm.201203-0522OC; Siu K H, 1994, J Clin Neurosci, V1, P243, DOI 10.1016/0967-5868(94)90064-7; Takagaki M, 2014, EXP NEUROL, V252, P12, DOI 10.1016/j.expneurol.2013.11.003; Vergouwen MDI, 2010, STROKE, V41, P2391, DOI 10.1161/STROKEAHA.110.589275; Villa F, 2012, CRIT CARE MED, V40, P2797, DOI 10.1097/CCM.0b013e31825b8bc6; Werner C, 1997, ZBL NEUROCHIR, V58, P90; Zeiler FA, 2014, NEUROCRIT CARE, V21, P163, DOI 10.1007/s12028-013-9950-y	31	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	JAN	2017	97						374	382		10.1016/j.wneu.2016.09.121			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EO1HO	WOS:000396449400051	27742511				2022-02-06	
J	Weise, KK; Swanson, MW; Penix, K; Hale, MH; Ferguson, D				Weise, Katherine K.; Swanson, Mark W.; Penix, Kimberly; Hale, Matthew Heath; Ferguson, Drew			King-Devick and Pre-season Visual Function in Adolescent Athletes	OPTOMETRY AND VISION SCIENCE			English	Article						King-Devick; convergence; pupillometer; alignment; concussion; adolescent; sport	CONCUSSION SCREENING TOOL; ICE HOCKEY PLAYERS; FOOTBALL PLAYERS; REFERENCE VALUES; VISION; ASSOCIATIONS; TESTS	Purpose. The King-Devick test (KD) has been studied as a remove-from-play sideline test in college-age athletes and older; however, studies in younger athletes are limited. A cross-sectional study of the KD and other vision correlates was completed on school-aged athletes during pre-season physicals for a variety of sports to determine the repeatability of the KD. The study also evaluated how convergence, alignment, or pupil function contributed to a slower King-Devick baseline reading. Methods. Seven hundred eighty-five athletes underwent vision screenings in a hospital or school setting by trained/certified staff as part of pre-season physicals. Six hundred nineteen had KD testing completed per the manufacturer's suggested protocol and repeated. Other baseline vision testing included visual acuity, Modified Thorington testing for alignment, convergence testing, and pupil function using the NeurOptics (NPI-200) NPi. Results. The mean fastest, error-minimized KD time for all participants was 43.9 seconds(s) (SD +/- 11.6, range 24-120). Median KD time got faster (+) with age (p < 0.0001). The inter-class correlation coefficient for all scores was 0.92. The absolute mean time difference for any two tests was 3.5 s (SD +/- 2.5, range 0-23). There was no association between the best KD time and reduced NPC (p = 0.63), Modified Thorington measure of alignment (p = 0.55), or NPi pupil function (p = 0.79). The Bland Altman repeated measure limits of agreement was +/- 6.5 seconds for those in the 10th to 12th grades, and +/- 10.2 seconds for those in the 6th to 9th grades. Conclusions. King-Devick score in junior high and high school athletes is variable but gets faster and more repeatable with increasing age. The KD does not correlate significantly with reduced convergence, alignment, or pupil function. Based on grouped data, a slowing of 10 seconds for younger athletes and 6 seconds for older athletes on a second administration represents a true difference in testing speed. Within-player variability should be considered when removal-from-play decisions are influenced by KD results.	[Weise, Katherine K.; Swanson, Mark W.; Penix, Kimberly; Hale, Matthew Heath; Ferguson, Drew] Univ Alabama Birmingham, Sports Med Clin, Childrens Alabama, Birmingham, AL USA		Weise, KK (corresponding author), Univ Alabama Birmingham, Sch Optometry, Henry B Peters Bldg,1716 Univ Blvd, Birmingham, AL 35294 USA.	kweise@uab.edu			UAB Department of Optometry; UAB Vision Science Research Center's National Institutes of Health [P30 EY003039]; NATIONAL EYE INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Eye Institute (NEI) [P30EY003039] Funding Source: NIH RePORTER	This study was supported by the UAB Department of Optometry and the UAB Vision Science Research Center's National Institutes of Health P30 EY003039 core grant.	Alsalaheen B, 2016, SCAND J MED SCI SPOR, V26, P235, DOI 10.1111/sms.12628; Bland JM, 1999, STAT METHODS MED RES, V8, P135, DOI 10.1191/096228099673819272; Brahm KD, 2009, OPTOMETRY VISION SCI, V86, P817, DOI 10.1097/OPX.0b013e3181adff2d; Campbell IG, 2012, P NATL ACAD SCI USA, V109, P5740, DOI 10.1073/pnas.1120860109; Galetta KM, 2011, NEUROLOGY, V76, P1456, DOI 10.1212/WNL.0b013e31821184c9; Galetta KM, 2015, J NEURO-OPHTHALMOL, V35, P235, DOI 10.1097/WNO.0000000000000226; Galetta MS, 2013, J NEUROL SCI, V328, P28, DOI 10.1016/j.jns.2013.02.008; Gilchrist Julie, 2011, Morbidity and Mortality Weekly Report, V60, P1337; Goodrich GL, 2007, J REHABIL RES DEV, V44, P929, DOI 10.1682/JRRD.2007.01.0003; King D, 2015, J NEUROL SCI, V357, P75, DOI 10.1016/j.jns.2015.06.069; King Devick Test, KING DEV TEST; Leong DF, 2014, J SPORT MED PHYS FIT, V54, P70; Leong Danielle F, 2015, J Optom, V8, P131, DOI 10.1016/j.optom.2014.12.005; Master CL, 2016, CLIN PEDIATR, V55, P260, DOI 10.1177/0009922815594367; McCrory Paul, 2013, Phys Ther Sport, V14, pe1, DOI 10.1016/j.ptsp.2013.03.002; Miller JH, 2016, J NEUROSURG-PEDIATR, V17, P491, DOI 10.3171/2015.8.PEDS14332; Scheiman M, 2015, VIS DEV REH, V1, P214; Scheiman M, 2008, OPHTHAL EPIDEMIOL, V15, P24, DOI 10.1080/09286580701772037; Seidman DH, 2015, J NEUROL SCI, V356, P97, DOI 10.1016/j.jns.2015.06.021; Stelmack JA, 2009, OPTOMETRY, V80, P419, DOI 10.1016/j.optm.2009.02.011; Suchoff I B, 1999, J Am Optom Assoc, V70, P301; Tjarks BJ, 2013, J NEUROL SCI, V334, P148, DOI 10.1016/j.jns.2013.08.015; Vartiainen MV, 2015, SCAND J MED SCI SPOR, V25, pe327, DOI 10.1111/sms.12307; Vaz S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073990; Ventura RE, 2015, J NEURO-OPHTHALMOL, V35, P73, DOI 10.1097/WNO.0000000000000223	25	15	16	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1040-5488	1538-9235		OPTOMETRY VISION SCI	Optom. Vis. Sci.	JAN	2017	94	1					89	95		10.1097/OPX.0000000000000938			7	Ophthalmology	Science Citation Index Expanded (SCI-EXPANDED)	Ophthalmology	EM5ZZ	WOS:000395393900012	27464573	Green Accepted			2022-02-06	
J	Zimmermann, N; Mograbi, DC; Hermes-Pereira, A; Fonseca, R; Prigatano, GP				Zimmermann, Nicolle; Mograbi, Daniel C.; Hermes-Pereira, Andressa; Fonseca, RocheleP.; Prigatano, George P.			Memory and executive functions correlates of self-awareness in traumatic brain injury	COGNITIVE NEUROPSYCHIATRY			English	Article						Traumatic brain injury; memory; metacognition; awareness	ALZHEIMERS-DISEASE; WORKING-MEMORY; RATING-SCALE; CONSCIOUSNESS; IMPAIRMENT; ANOSOGNOSIA; UNAWARENESS; COMPETENCE; ATTENTION; DISTRESS	Objective: The purpose of this study was to investigate the contribution of executive functions (EF) components and episodic and working memory variables, as well as clinical and demographic factors, to awareness of cognitive ability in traumatic brain injury (TBI).Methods: Sixty-five TBI patients (mild: n=26; moderate/severe: n=39) took part in the study. Independent stepwise regression models were calculated for EF and memory predictors, with awareness being measured by patient/informant discrepancy in the Patient Competency Rating Scale.Results: Models with EF variables indicated that semantic verbal fluency and age are the best predictors of awareness, whereas models including mnemonic functions suggested verbal delayed episodic recall and TBI severity as predictors.Conclusions: These results are discussed in relation to clinical implications, such as the need to focus efforts of rehabilitation in the cognitive abilities related to awareness, and theoretical models.	[Zimmermann, Nicolle] Univ Fed Rio de Janeiro, Dept Radiol, Rio De Janeiro, Brazil; [Mograbi, Daniel C.] Pontificia Univ Catolica Rio de Janeiro, Dept Psychol, Rio de Janeiro, Brazil; [Mograbi, Daniel C.] Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England; [Zimmermann, Nicolle; Hermes-Pereira, Andressa; Fonseca, RocheleP.] Pontificia Univ Catolica Rio Grande do Sul, Dept Psychol Human Cognit, Porto Alegre, RS, Brazil; [Prigatano, George P.] St Josephs Hosp, Barrow Neurol Inst, Dept Clin Neuropsychol, Phoenix, AZ USA; [Zimmermann, Nicolle] Paulo Niemeyer State Brain Inst, Neuropsychol Serv, Rio De Janeiro, Brazil		Mograbi, DC (corresponding author), Pontificia Univ Catolica Rio de Janeiro, Dept Psychol, Rio de Janeiro, Brazil.; Mograbi, DC (corresponding author), Kings Coll London, Inst Psychiat Psychol & Neurosci, Dept Psychol, London, England.	daniel.mograbi@kcl.ac.uk	Mograbi, Daniel C/O-9352-2014	ZIMMERMANN, NICOLLE/0000-0003-4771-4070; Mograbi, Daniel/0000-0002-4271-2984	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ); Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Brazil)	This work was supported by Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (Brazil) and Fundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio de Janeiro (Brazil).	Aalten P, 2005, AGING MENT HEALTH, V9, P414, DOI 10.1080/13607860500143075; Agnew SK, 1998, AGING MENT HEALTH, V2, P7, DOI 10.1080/13607869856876; AITB, 1944, ARM IND TEST BATT; Baars BJ, 2003, TRENDS COGN SCI, V7, P166, DOI 10.1016/S1364-6613(03)00056-1; BADDELEY A, 1992, CONSCIOUS COGN, V1, P3, DOI 10.1016/1053-8100(92)90037-B; Baird B, 2013, J NEUROSCI, V33, P16657, DOI 10.1523/JNEUROSCI.0786-13.2013; Barkley RA., 2012, EXECUTIVE FUNCTIONS; Birn RM, 2010, NEUROIMAGE, V49, P1099, DOI 10.1016/j.neuroimage.2009.07.036; Bivona U, 2008, J INT NEUROPSYCH SOC, V14, P862, DOI 10.1017/S1355617708081125; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Burgess P.W., 1997, HAYLING BRIXTON TEST; Busch RM, 2005, J CLIN EXP NEUROPSYC, V27, P1022, DOI 10.1080/13803390490919263; Ciurli P, 2010, J INT NEUROPSYCH SOC, V16, P360, DOI 10.1017/S135561770999141X; DANEMAN M, 1983, J EXP PSYCHOL LEARN, V9, P561, DOI 10.1037/0278-7393.9.4.561; DEATON AV, 1986, REHABIL PSYCHOL, V31, P231, DOI 10.1037//0090-5550.31.4.231; Demery JA, 2002, J CLIN EXP NEUROPSYC, V24, P818, DOI 10.1076/jcen.24.6.818.8400; Diamond A, 2013, ANNU REV PSYCHOL, V64, P135, DOI 10.1146/annurev-psych-113011-143750; Dobbins IG, 2002, NEURON, V35, P989, DOI 10.1016/S0896-6273(02)00858-9; Fernandez-Duque D, 2000, CONSCIOUS COGN, V9, P288, DOI 10.1006/ccog.2000.0447; Field A., 2018, DISCOVERING STAT USI, V5th ed.; FLAVELL JH, 1979, AM PSYCHOL, V34, P906, DOI 10.1037/0003-066X.34.10.906; Fleming SM, 2012, PHILOS T R SOC B, V367, P1338, DOI 10.1098/rstb.2011.0417; Fonseca RP, 2008, SPAN J PSYCHOL, V11, P678, DOI 10.1017/S1138741600004686; Fonseca RP, 2008, BATERIA MONTREAL AVA; Fonseca RP, 2009, INSTRUMENTO AVALIACA; Fonseca RPOC, 2010, AVALIACAO PSICOLOGIC, P337; Garcia-Molina A, 2012, BRAIN INJURY, V26, P864, DOI 10.3109/02699052.2012.655362; Hertzog C, 2011, CURR DIR PSYCHOL SCI, V20, P167, DOI 10.1177/0963721411409026; Hill PF, 2013, CONSCIOUS COGN, V22, P677, DOI 10.1016/j.concog.2013.04.002; Hurks PPM, 2010, CHILD NEUROPSYCHOL, V16, P366, DOI 10.1080/09297041003671184; Hurks PPM, 2006, J CLIN EXP NEUROPSYC, V28, P684, DOI 10.1080/13803390590954191; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Karr JE, 2014, NEUROPSYCHOLOGY, V28, P321, DOI 10.1037/neu0000037; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; Malec JF, 2000, REHABIL PSYCHOL, V45, P227, DOI 10.1037/0090-5550.45.3.227; Mograbi DC, 2009, CONSCIOUS COGN, V18, P989, DOI 10.1016/j.concog.2009.07.005; Morin A, 2006, CONSCIOUS COGN, V15, P358, DOI 10.1016/j.concog.2005.09.006; Morris RG, 2013, CORTEX, V49, P1553, DOI 10.1016/j.cortex.2012.09.006; Naccache L, 2005, NEUROPSYCHOLOGIA, V43, P1318, DOI 10.1016/j.neuropsychologia.2004.11.024; NELSON HE, 1976, CORTEX, V12, P313, DOI 10.1016/S0010-9452(76)80035-4; Noe E, 2005, J NEUROL, V252, P168, DOI 10.1007/s00415-005-0625-2; Ownsworth T, 2006, NEUROPSYCHOL REHABIL, V16, P415, DOI 10.1080/09602010500505641; Pergola G, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00162; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; Prigatano GP, 2005, J HEAD TRAUMA REHAB, V20, P19, DOI 10.1097/00001199-200501000-00004; Prigatano GP, 1998, CLIN NEUROPSYCHOL, V12, P56, DOI 10.1076/clin.12.1.56.1721; Prigatano GP, 1997, NEUROPSY NEUROPSY BE, V10, P135; Quinette P, 2006, NEUROPSYCHOLOGIA, V44, P2508, DOI 10.1016/j.neuropsychologia.2006.03.031; Salgado JV, 2011, REV BRAS PSIQUIATR, V33, P234, DOI [10.1590/S1516-44462011005000007, 10.1590/S1516-44462011000300005]; Sbordone RJ, 1998, BRAIN INJURY, V12, P505, DOI 10.1080/026990598122467; Schmitter-Edgecombe M, 2008, J CLIN EXP NEUROPSYC, V30, P212, DOI 10.1080/13803390701363803; Schmitz TW, 2006, NEUROPSYCHOLOGIA, V44, P762, DOI 10.1016/j.neuropsychologia.2005.07.012; Sherer M, 2003, ARCH PHYS MED REHAB, V84, P168, DOI 10.1053/apmr.2003.50045; Sherer M, 2003, BRAIN INJURY, V17, P25, DOI 10.1080/0269905021000010113; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2011, J INT NEUROPSYCH SOC, V17, P759, DOI 10.1017/S1355617711000695; Sveen U, 2008, CLIN REHABIL, V22, P45, DOI 10.1177/0269215507080768; TEASDALE G, 1974, LANCET, V2, P81; Vanderploeg RD, 2010, J CLIN EXP NEUROPSYC, V23, P37; WEINSTEIN EA, 1994, NEUROPSY NEUROPSY BE, V7, P176; Ylikoski R, 2003, INT PSYCHOGERIATR, V15, P219, DOI 10.1017/S1041610203009232; Zimmermann Nicolle, 2015, Dement. neuropsychol., V9, P120, DOI 10.1590/1980-57642015DN92000006; Zimmermann Nicolle, 2014, Trends Psychiatry Psychother., V36, P40, DOI 10.1590/2237-6089-2013-0021	63	15	15	0	9	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1354-6805	1464-0619		COGN NEUROPSYCHIATRY	Cogn. Neuropsychiatry		2017	22	4					346	360		10.1080/13546805.2017.1330191			15	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	EY1HS	WOS:000403717500006	28566003				2022-02-06	
J	Woods, DL; Wyma, JM; Herron, TJ; Yund, EW				Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William			Computerized Analysis of Verbal Fluency: Normative Data and the Effects of Repeated Testing, Simulated Malingering, and Traumatic Brain Injury	PLOS ONE			English	Article							LATENT SEMANTIC ANALYSIS; WORD-ASSOCIATION TEST; COMPONENT ANALYSIS; NEUROPSYCHOLOGICAL OUTCOMES; ALZHEIMERS-DISEASE; EXECUTIVE FUNCTION; CATEGORY FLUENCY; DESIGN FLUENCY; LOBE LESIONS; FREE-RECALL	In verbal fluency (VF) tests, subjects articulate words in a specified category during a short test period (typically 60 s). Verbal fluency tests are widely used to study language development and to evaluate memory retrieval in neuropsychiatric disorders. Performance is usually measured as the total number of correct words retrieved. Here, we describe the properties of a computerized VF (C-VF) test that tallies correct words and repetitions while providing additional lexical measures of word frequency, syllable count, and typicality. In addition, the C-VF permits (1) the analysis of the rate of responding over time, and (2) the analysis of the semantic relationships between words using a new method, Explicit Semantic Analysis (ESA), as well as the established semantic clustering and switching measures developed by Troyer et al. (1997). In Experiment 1, we gathered normative data from 180 subjects ranging in age from 18 to 82 years in semantic ("animals) and phonemic (letter "F") conditions. The number of words retrieved in 90 s correlated with education and daily hours of computeruse. The rate of word production declined sharply over time during both tests. In semantic conditions, correct-word scores correlated strongly with the number of ESA and Troyer-defined semantic switches as well as with an ESA-defined semantic organization index (SOI). In phonemic conditions, ESA revealed significant semantic influences in the sequence of words retrieved. In Experiment 2, we examined the test-retest reliability of different measures across three weekly tests in 40 young subjects. Different categories were used for each semantic ("animals", "parts of the body", and "foods") and phonemic (letters "F", "A", and "S") condition. After regressing out the influences of education and computeruse, we found that correct-word z-scores in the first session did not differ from those of the subjects in Experiment 1. Word production was uniformly greater in semantic than phonemic conditions. Intraclass correlation coefficients (ICCs) of correct-word z-scores were higher for phonemic (0.91) than semantic (0.77) tests. In semantic conditions, good reliability was also seen for the SOI (ICC = 0.68) and ESA-defined switches in semantic categories (ICC = 0.62). In Experiment 3, we examined the performance of subjects from Experiment 2 when instructed to malinger: 38% showed abnormal (p<0.05) performance in semantic conditions. Simulated malingerers with abnormal scores could be distinguished with 80% sensitivity and 89% specificity from subjects with abnormal scores in Experiment 1 using lexical, temporal, and semantic measures. In Experiment 4, we tested patients with mild and severe traumatic brain injury (mTBI and sTBI). Patients with mTBI performed within the normal range, while patients with sTBI showed significant impairments in correct-word z-scores and category shifts. The lexical, temporal, and semantic measures of the C-VF provide an automated and comprehensive description of verbal fluency performance.	[Woods, David L.; Wyma, John M.; Herron, Timothy J.; Yund, E. William] VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA; [Woods, David L.] UC Davis Dept Neurol, Sacramento, CA 95820 USA; [Woods, David L.] Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA; [Woods, David L.] UC Davis Ctr Mind & Brain, Davis, CA 95616 USA; [Woods, David L.; Wyma, John M.] NeuroBehav Syst Inc, Berkeley, CA 94706 USA		Woods, DL (corresponding author), VANCHCS, Human Cognit Neurophysiol Lab, Martinez, CA 94553 USA.; Woods, DL (corresponding author), UC Davis Dept Neurol, Sacramento, CA 95820 USA.; Woods, DL (corresponding author), Univ Calif Davis, Ctr Neurosci, Davis, CA 95616 USA.; Woods, DL (corresponding author), UC Davis Ctr Mind & Brain, Davis, CA 95616 USA.; Woods, DL (corresponding author), NeuroBehav Syst Inc, Berkeley, CA 94706 USA.	dlwoods@ucdavis.edu		Yund, E./0000-0002-6833-0052; Woods, David/0000-0002-8804-3587; Herron, Timothy/0000-0002-4297-014X	"VA Rehabilitation Research and Development Grants'' [CX000583, CX001000]; "VA Research and Development Grants'' [CX000583, CX001000]; Veterans AffairsUS Department of Veterans Affairs [I01CX001000] Funding Source: NIH RePORTER	The funding source should be changed from "VA Rehabilitation Research and Development Grants grant CX000583 and CX001000 to DLW" to "VA Research and Development Grants grant CX000583 and CX001000 to DLW".	Andreou G, 2013, ADHD-ATTEND DEFICIT, V5, P343, DOI 10.1007/s12402-013-0112-z; Baldo JV, 2001, J INT NEUROPSYCH SOC, V7, P586, DOI 10.1017/S1355617701755063; Basso MR, 1999, CLIN NEUROPSYCHOL, V13, P283, DOI 10.1076/clin.13.3.283.1743; Benito-Cuadrado MM, 2002, J CLIN EXP NEUROPSYC, V24, P1117, DOI 10.1076/jcen.24.8.1117.8376; Benton A.L., 1983, MULTILINGUAL APLASIA, V2nd; Bittner RM, 2006, BRAIN INJURY, V20, P971, DOI 10.1080/02699050600909763; BORKOWSKI JG, 1967, NEUROPSYCHOLOGIA, V5, P135, DOI 10.1016/0028-3932(67)90015-2; Bousfield WA, 1944, J GEN PSYCHOL, V30, P149, DOI 10.1080/00221309.1944.10544467; BUTTERS N, 1978, ARCH NEUROL-CHICAGO, V35, P585, DOI 10.1001/archneur.1978.00500330033006; Capitani E, 1999, CORTEX, V35, P273, DOI 10.1016/S0010-9452(08)70800-1; Cavaco S, 2013, ARCH CLIN NEUROPSYCH, V28, P262, DOI 10.1093/arclin/act001; Cohen MJ, 1999, ARCH CLIN NEUROPSYCH, V14, P433, DOI 10.1016/S0887-6177(98)00038-9; Connelly V., 2005, EDUC PSYCHOL-UK, V25, P99, DOI [10.1080/0144341042000294912, DOI 10.1080/0144341042000294912]; Cralidis A, 2014, BRAIN INJURY, V28, P456, DOI 10.3109/02699052.2014.896945; Crowe SF, 1998, J CLIN EXP NEUROPSYC, V20, P391, DOI 10.1076/jcen.20.3.391.810; Curtis KL, 2008, CLIN NEUROPSYCHOL, V22, P930, DOI 10.1080/13854040701563591; Passos VMD, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0454-6; Delis DC., 2001, DELIS KAPLAN EXECUTI; Demakis GJ, 1999, ARCH CLIN NEUROPSYCH, V14, P401, DOI 10.1016/S0887-6177(98)00039-0; Drake AI, 2000, J HEAD TRAUMA REHAB, V15, P1103, DOI 10.1097/00001199-200010000-00004; Dykiert D, 2013, PSYCHOL ASSESSMENT, V25, P1361, DOI 10.1037/a0033623; Egozi Ofer, 2011, ACM T INFORM SYSTEMS, V29, P8, DOI DOI 10.1145/1961209.1961211; Ehlen F, 2015, PSYCHON B REV; Federmeier KD, 2010, BRAIN LANG, V115, P149, DOI 10.1016/j.bandl.2010.07.006; Fernaeus SE, 1998, J CLIN EXP NEUROPSYC, V20, P137, DOI 10.1076/jcen.20.2.137.1170; Fernaeus SE, 2001, DEMENT GERIATR COGN, V12, P52, DOI 10.1159/000051235; Fernaeus SE, 2008, CORTEX, V44, P161, DOI 10.1016/j.cortex.2006.04.002; Fitzpatrick S, 2013, NEUROPSYCHOL REV, V23, P138, DOI 10.1007/s11065-013-9224-7; Gabrilovich E, 2009, J ARTIF INTELL RES, V34, P443, DOI 10.1613/jair.2669; Gladsjo JA, 1999, ASSESSMENT, V6, P147, DOI 10.1177/107319119900600204; Green REA, 2008, J CLIN EXP NEUROPSYC, V30, P163, DOI 10.1080/13803390701300524; GRUENEWALD PJ, 1980, J EXP PSYCHOL-HUM L, V6, P225, DOI 10.1037/0278-7393.6.3.225; Hall JR, 2011, AGING NEUROPSYCHOL C, V18, P353, DOI 10.1080/13825585.2011.557495; Hankee LD, 2013, EXP AGING RES, V39, P515, DOI 10.1080/0361073X.2013.839029; Haugrud N, 2011, J INT NEUROPSYCH SOC, V17, P1153, DOI 10.1017/S1355617711001196; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P621, DOI 10.1037/0894-4105.18.4.621; Henry JD, 2004, NEUROPSYCHOLOGIA, V42, P1212, DOI 10.1016/j.neuropsychologia.2004.02.001; Henry JD, 2004, NEUROPSYCHOLOGY, V18, P284, DOI 10.1037/0894-4105.18.2.284; Henry JD, 2004, J INT NEUROPSYCH SOC, V10, P608, DOI 10.1017/S1355617704104141; Henry Julie D, 2005, Cogn Neuropsychiatry, V10, P1, DOI 10.1080/13546800344000309; Hills TT, 2012, PSYCHOL REV, V119, P431, DOI 10.1037/a0027373; Hoogendam YY, 2014, EUR J EPIDEMIOL, V29, P133, DOI 10.1007/s10654-014-9885-4; Hubel KA, 2013, PERCEPT MOTOR SKILL, V116, P929, DOI 10.2466/25.29.PMS.116.3.929-952; Hubel KA, 2013, J CLIN EXP NEUROPSYC, V35, P745, DOI 10.1080/13803395.2013.824070; Ide N, 2001, PROCEEDINGS OF CORPU; John D, 2009, J PHYS ACT HEALTH, V6, P617, DOI 10.1123/jpah.6.5.617; Jones MN, 2007, PSYCHOL REV, V114, P1, DOI 10.1037/0033-295X.114.1.1; Juhasz BJ, 2012, PSYCHIAT RES, V200, P177, DOI 10.1016/j.psychres.2012.06.035; Kaplan E, 1983, THE ASSESSMENT OF AP; Kave G, 2011, J CLIN EXP NEUROPSYC, V33, P358, DOI 10.1080/13803395.2010.518703; KERTESZ A, 1982, WESTERN APHASIA BATT; Khalil MS, 2010, J CLIN EXP NEUROPSYC, V32, P1028, DOI 10.1080/13803391003672305; Koren R, 2005, ARCH CLIN NEUROPSYCH, V20, P1087, DOI 10.1016/j.acn.2005.06.012; Landauer TK, 1998, DISCOURSE PROCESS, V25, P259, DOI 10.1080/01638539809545028; Lanting S, 2009, J INT NEUROPSYCH SOC, V15, P196, DOI 10.1017/S1355617709090237; Ledoux K, 2014, J CLIN EXP NEUROPSYC, V36, P205, DOI 10.1080/13803395.2013.878689; Llewellyn DJ, 2009, AGING NEUROPSYCHOL C, V16, P433, DOI 10.1080/13825580902773867; Loonstra A S, 2001, Appl Neuropsychol, V8, P161, DOI 10.1207/S15324826AN0803_5; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mathias JL, 2004, J INT NEUROPSYCH SOC, V10, P286, DOI 10.1017/S1355617704102117; McCauley SR, 2014, J NEUROTRAUM, V31, P914, DOI 10.1089/neu.2012.2826; Nicodemus KK, 2014, CORTEX, V55, P182, DOI 10.1016/j.cortex.2013.12.004; OBER BA, 1986, J CLIN EXP NEUROPSYC, V8, P75, DOI 10.1080/01688638608401298; Ostrosky-Solis F, 2007, ARCH CLIN NEUROPSYCH, V22, P367, DOI 10.1016/j.acn.2007.01.011; Pakhomov SVS, 2016, NEUROPSYCHOLOGIA, V89, P42, DOI 10.1016/j.neuropsychologia.2016.05.031; Peskind ER, 2011, NEUROIMAGE, V54, pS76, DOI 10.1016/j.neuroimage.2010.04.008; Raskin SA, 1996, NEUROPSYCHOLOGY, V10, P416, DOI 10.1037/0894-4105.10.3.416; Robert PH, 1997, EUR PSYCHIAT, V12, P124, DOI 10.1016/S0924-9338(97)80200-3; Roberts PM, 1997, BRAIN LANG, V59, P412, DOI 10.1006/brln.1997.1753; Rodriguez-Aranda C, 2006, DEV NEUROPSYCHOL, V30, P697, DOI 10.1207/s15326942dn3002_3; ROHRER D, 1995, J EXP PSYCHOL LEARN, V21, P1127, DOI 10.1037/0278-7393.21.5.1127; Roldan-Tapia L, 2012, APPL NEUROPSYCH-ADUL, V19, P2, DOI 10.1080/09084282.2011.595458; Ross TP, 2007, ARCH CLIN NEUROPSYCH, V22, P475, DOI 10.1016/j.acn.2007.01.026; Ross TP, 2003, ARCH CLIN NEUROPSYCH, V18, P153, DOI 10.1016/S0887-6177(01)00192-5; Rosselli M, 2009, AGING NEUROPSYCHOL C, V16, P721, DOI 10.1080/13825580902912739; Shandera-Ochsner AL, 2013, CLIN NEUROPSYCHOL, V27, P881, DOI 10.1080/13854046.2013.802017; Shao Z, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00772; Stolwyk R, 2015, J CLIN EXP NEUROPSYC, P1; Sugarman MA, 2015, APPL NEUROPSYCH-ADUL, V22, P141, DOI 10.1080/23279095.2013.873439; Takacs A, 2014, CHILD NEUROPSYCHOL, V20, P415, DOI 10.1080/09297049.2013.799645; Tallberg IM, 2008, SCAND J PSYCHOL, V49, P479, DOI 10.1111/j.1467-9450.2008.00653.x; Then FS, 2014, J OCCUP MED TOXICOL, V9, DOI 10.1186/1745-6673-9-23; Tombaugh TN, 1999, ARCH CLIN NEUROPSYCH, V14, P167, DOI 10.1016/S0887-6177(97)00095-4; Troyer AK, 1997, NEUROPSYCHOLOGY, V11, P138, DOI 10.1037/0894-4105.11.1.138; Troyer AK, 1998, NEUROPSYCHOLOGIA, V36, P499, DOI 10.1016/S0028-3932(97)00152-8; Troyer AK, 2000, J CLIN EXP NEUROPSYC, V22, P370, DOI 10.1076/1380-3395(200006)22:3;1-V;FT370; Tsirka V, 2010, INT J NEUROSCI, V120, P184, DOI 10.3109/00207450903585308; Turken And U, 2009, BMC Med Imaging, V9, P20, DOI 10.1186/1471-2342-9-20; Van der Elst W, 2006, J INT NEUROPSYCH SOC, V12, P80, DOI 10.1017/S1355617706060115; van Hooren SAH, 2007, AGING NEUROPSYCHOL C, V14, P40, DOI 10.1080/138255890969483; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Verfaellie M, 2014, NEUROPSYCHOLOGY, V28, P337, DOI 10.1037/neu0000027; Vita MG, 2014, J ALZHEIMERS DIS, V42, P1171, DOI 10.3233/JAD-140570; Vonberg I, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0115846; Wecker NS, 2005, NEUROPSYCHOLOGY, V19, P345, DOI 10.1037/0894-4105.19.3.345; WIXTED JT, 1994, PSYCHON B REV, V1, P89, DOI 10.3758/BF03200763; Woods DL, 2016, MEMORY, V24, P1142, DOI 10.1080/09658211.2015.1076849; Woods DL, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00690; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00595; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00540; Woods DL, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0124345; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00288; Woods DL, 2015, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00193; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P721, DOI 10.1080/13803395.2010.550602; Woods DL, 2011, J CLIN EXP NEUROPSYC, V33, P101, DOI 10.1080/13803395.2010.493149; Woods DL, 2015, FRONT HUM NEUROSCI; Woods DL, 2016, PLOS ONE; Woods DL, 2016, FRONTIERS IN HUMAN N; Woods SP, 2005, J INT NEUROPSYCH SOC, V11, P408, DOI 10.1017/S1355617705050460; Zahodne LB, 2011, J INT NEUROPSYCH SOC, V17, P1039, DOI 10.1017/S1355617711001044; Zakzanis KK, 2013, BRAIN INJURY, V27, P903, DOI 10.3109/02699052.2013.775505; Zakzanis KK, 2011, J CLIN EXP NEUROPSYC, V33, P785, DOI 10.1080/13803395.2011.558496; Zarino B, 2014, NEUROL SCI, V35, P1405, DOI 10.1007/s10072-014-1729-1	113	15	15	0	20	PUBLIC LIBRARY SCIENCE	SAN FRANCISCO	1160 BATTERY STREET, STE 100, SAN FRANCISCO, CA 94111 USA	1932-6203			PLOS ONE	PLoS One	DEC 9	2016	11	12							e0166439	10.1371/journal.pone.0166439			37	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Science & Technology - Other Topics	EE4PU	WOS:000389587100026	27936001	Green Published, gold, Green Submitted			2022-02-06	
J	Annis, RP; Swahari, V; Nakamura, A; Xie, AX; Hammond, SM; Deshmukh, M				Annis, Ryan P.; Swahari, Vijay; Nakamura, Ayumi; Xie, Alison X.; Hammond, Scott M.; Deshmukh, Mohanish			Mature neurons dynamically restrict apoptosis via redundant premitochondrial brakes	FEBS Journal			English	Article						apoptosis; maturation; miR-24; miR-29; neurons	TROPHIC FACTOR DEPENDENCE; TRAUMATIC BRAIN-INJURY; ACTIVATING FACTOR-I; CELL-DEATH; SYMPATHETIC NEURONS; ENDOGENOUS XIAP; CYTOCHROME-C; DIFFERENTIAL EXPRESSION; BAX DELETION; CANCER-CELLS	Apoptotic cell death is critical for the early development of the nervous system, but once the nervous system is established, the apoptotic pathway becomes highly restricted in mature neurons. However, the mechanisms underlying this increased resistance to apoptosis in these mature neurons are not completely understood. We have previously found that members of the miR-29 family of microRNAs (miRNAs) are induced with neuronal maturation and that overexpression of miR-29 was sufficient to restrict apoptosis in neurons. To determine whether endogenous miR-29 alone was responsible for the inhibition of cytochrome c release in mature neurons, we examined the status of the apoptotic pathway in sympathetic neurons deficient for all three miR-29 family members. Unexpectedly, we found that the apoptotic pathway remained largely restricted in miR-29-deficient mature neurons. We therefore probed for additional mechanisms by which mature neurons resist apoptosis. We identify miR-24 as another miRNA that is upregulated in the maturing cerebellum and sympathetic neurons that can act redundantly with miR-29 by targeting a similar repertoire of prodeath BH3-only genes. Overall, our results reveal that mature neurons engage multiple redundant brakes to restrict the apoptotic pathway and ensure their long-term survival.	[Annis, Ryan P.; Swahari, Vijay; Nakamura, Ayumi; Deshmukh, Mohanish] Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27514 USA; [Annis, Ryan P.; Nakamura, Ayumi; Deshmukh, Mohanish] Univ N Carolina, Curriculum Neurobiol, Chapel Hill, NC USA; [Xie, Alison X.] Univ N Carolina, Dept Pharmacol, Chapel Hill, NC USA; [Hammond, Scott M.; Deshmukh, Mohanish] Univ N Carolina, Dept Cell Biol & Physiol, Chapel Hill, NC USA		Deshmukh, M (corresponding author), Univ N Carolina, Ctr Neurosci, Chapel Hill, NC 27514 USA.	mohanish@med.unc.edu			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS042197, NS083384]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [T32GM008719] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS042197, R56NS083384] Funding Source: NIH RePORTER	We thank members of the Deshmukh laboratory for their critical review of the manuscript. We also thank Dr JrGang Cheng for help with generating the luciferase construct, and Dr Ken McCarthy for the use of his electrophysiology equipment. This work was supported by NIH grants NS042197 and NS083384 to MD.	Benn SC, 2002, NEURON, V36, P45, DOI 10.1016/S0896-6273(02)00941-8; Chen Q, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.92; Donovan M, 2002, CELL DEATH DIFFER, V9, P1220, DOI 10.1038/sj.cdd.4401105; Easton RM, 1997, J NEUROSCI, V17, P9656; Gama V, 2014, SCI SIGNAL, V7, DOI 10.1126/scisignal.2005309; Ham J, 2005, CELL DEATH DIFFER, V12, P1015, DOI 10.1038/sj.cdd.4401689; Hu BR, 2000, J CEREBR BLOOD F MET, V20, P1294, DOI 10.1097/00004647-200009000-00003; Johnson R, 2008, NEUROBIOL DIS, V29, P438, DOI 10.1016/j.nbd.2007.11.001; Khanna S, 2013, J CEREBR BLOOD F MET, V33, P1197, DOI 10.1038/jcbfm.2013.68; Kole AJ, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.220; Kole AJ, 2011, GENE DEV, V25, P125, DOI 10.1101/gad.1975411; Kristiansen M, 2011, BMC GENOMICS, V12, DOI 10.1186/1471-2164-12-551; Liu XJ, 2015, INT J CLIN EXP PATHO, V8, P3811; Madden SD, 2007, INT J DEV BIOL, V51, P415, DOI 10.1387/ijdb.062263sm; Mayorga M, 2004, J BIOL CHEM, V279, P34882, DOI 10.1074/jbc.M404616200; Nam YJ, 2004, MOL CELL, V15, P901, DOI 10.1016/j.molcel.2004.08.020; Olah G, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0134227; OPPENHEIM RW, 1991, ANNU REV NEUROSCI, V14, P453, DOI 10.1146/annurev.neuro.14.1.453; Ouyang YB, 2013, GLIA, V61, P1784, DOI 10.1002/glia.22556; Pandi G, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058039; Papadopoulou AS, 2015, NEUROBIOL DIS, V73, P275, DOI 10.1016/j.nbd.2014.10.006; Potts MB, 2005, J CELL BIOL, V171, P925, DOI 10.1083/jcb.200504082; Potts PR, 2003, J CELL BIOL, V163, P789, DOI 10.1083/jcb.200307130; Putcha GV, 2000, J CELL BIOL, V149, P1011, DOI 10.1083/jcb.149.5.1011; Qi YL, 2014, J BIOL CHEM, V289, P10201, DOI 10.1074/jbc.M113.535195; Qian L, 2011, J EXP MED, V208, P549, DOI 10.1084/jem.20101547; Ren DC, 2010, SCIENCE, V330, P1390, DOI 10.1126/science.1190217; Sabirzhanov B, 2014, J NEUROSCI, V34, P10055, DOI 10.1523/JNEUROSCI.1260-14.2014; Sanchis D, 2003, CELL DEATH DIFFER, V10, P977, DOI 10.1038/sj.cdd.4401267; Shioya M, 2010, NEUROPATH APPL NEURO, V36, P320, DOI 10.1111/j.1365-2990.2010.01076.x; Smith MI, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005097; SNIDER WD, 1992, J NEUROBIOL, V23, P1231, DOI 10.1002/neu.480230913; Unsain N, 2015, NEURON, V88, P461, DOI 10.1016/j.neuron.2015.08.029; Vaughn AE, 2008, NAT CELL BIOL, V10, P1477, DOI 10.1038/ncb1807; Wang XD, 2001, GENE DEV, V15, P2922; Werth JL, 2000, EXP NEUROL, V161, P203, DOI 10.1006/exnr.1999.7241; Wright KM, 2007, J CELL BIOL, V179, P825, DOI 10.1083/jcb.200708086; Wright KM, 2006, CELL CYCLE, V5, P1616, DOI 10.4161/cc.5.15.3129; Wright KM, 2004, J CELL BIOL, V167, P303, DOI 10.1083/jcb.200406073; Wyttenbach A, 2006, J NEUROCHEM, V96, P1213, DOI 10.1111/j.1471-4159.2005.03676.x; Xiao RJ, 2011, APOPTOSIS, V16, P221, DOI 10.1007/s10495-010-0566-9; Yakovlev AG, 2001, J NEUROSCI, V21, P7439, DOI 10.1523/JNEUROSCI.21-19-07439.2001	42	15	16	0	1	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1742-464X	1742-4658		FEBS J	FEBS J.	DEC	2016	283	24					4569	4582		10.1111/febs.13944			14	Biochemistry & Molecular Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology	EI8GT	WOS:000392744800013	27797453	Green Accepted, Green Submitted			2022-02-06	
J	Brett, BL; Smyk, N; Solomon, G; Baughman, BC; Schatz, P				Brett, Benjamin L.; Smyk, Nathan; Solomon, Gary; Baughman, Brandon C.; Schatz, Philip			Long-term Stability and Reliability of Baseline Cognitive Assessments in High School Athletes Using ImPACT at 1-, 2-, and 3-year Test-Retest Intervals	ARCHIVES OF CLINICAL NEUROPSYCHOLOGY			English	Article						Head injury; Traumatic brain injury; Practice effects/reliable change; Assessment; Childhood brain insult; Norms/normative studies; Test construction	SPORT-RELATED CONCUSSION; NEUROPSYCHOLOGICAL ASSESSMENT; INTERPRETING CHANGE; CONSTRUCT-VALIDITY; ONLINE VERSION; SCORES; AGE; SPECIFICITY; SENSITIVITY; STATEMENT	Objective: The ImPACT (Immediate Post-Concussion Assessment and Cognitive Testing) neurocognitive testing battery is a widely used tool used for the assessment and management of sports-related concussion. Research on the stability of ImPACT in high school athletes at a 1- and 2-year intervals have been inconsistent, requiring further investigation. We documented 1-, 2-, and 3-year test-retest reliability of repeated ImPACT baseline assessments in a sample of high school athletes, using multiple statistical methods for examining stability. Methods: A total of 1,510 high school athletes completed baseline cognitive testing using online ImPACT test battery at three time periods of approximately 1- (N = 250), 2-(N = 1146), and 3-year (N = 114) intervals. No participant sustained a concussion between assessments. Results: Intraclass correlation coefficients (ICCs) ranged in composite scores from 0.36 to 0.90 and showed little change as intervals between assessments increased. Reliable change indices and regression-based measures (RBMs) examining the test-retest stability demonstrated a lack of significant change in composite scores across the various time intervals, with very few cases (0%-6%) falling outside of 95% confidence intervals. Conclusion: The results suggest ImPACT composites scores remain considerably stability across 1-, 2-, and 3-year test-retest intervals in high school athletes, when considering both ICCs and RBM. Annually ascertaining baseline scores continues to be optimal for ensuring accurate and individualized management of injury for concussed athletes. For instances in which more recent baselines are not available (12 years), clinicians should seek to utilize more conservative range estimates in determining the presence of clinically meaningful change in cognitive performance.	[Brett, Benjamin L.; Baughman, Brandon C.] Semmes Murphey Neurol & Spine Inst, Memphis, TN USA; [Brett, Benjamin L.] Univ Memphis, Dept Counseling Educ Psychol & Res, 100 Ball Hall, Memphis, TN 38152 USA; [Smyk, Nathan; Schatz, Philip] St Josephs Univ, Dept Psychol, Philadelphia, PA 19131 USA; [Solomon, Gary] Vanderbilt Univ, Sch Med, Dept Neurol Surg, Nashville, TN 37212 USA; [Solomon, Gary] Vanderbilt Univ, Sch Med, Vanderbilt Sports Concuss Ctr, Nashville, TN 37212 USA; [Baughman, Brandon C.] Univ Tennessee, Ctr Hlth Sci, Dept Neurosurg, Memphis, TN 38163 USA		Brett, BL (corresponding author), Univ Memphis, Dept Counseling Educ Psychol & Res, 100 Ball Hall, Memphis, TN 38152 USA.	blbrett@memphis.edu	Solomon, Gary/K-9011-2019				Allen BJ, 2011, BRAIN INJURY, V25, P179, DOI 10.3109/02699052.2010.541897; Alsalaheen B, 2015, J HEAD TRAUMA REHABI; Aubry M, 2002, CLIN J SPORT MED, V12, P6, DOI 10.1097/00042752-200201000-00005; Barr William B, 2002, CNS Spectr, V7, P300; Bauer RM, 2012, ARCH CLIN NEUROPSYCH, V27, P362, DOI 10.1093/arclin/acs027; Baumgatner T., 2001, MEAS PHYS EDUC EXERC, V5, P179, DOI [10.1207/S15327841MPEE0503_4, DOI 10.1207/S15327841MPEE0503_4]; Bonate P. L, 2000, ANAL PRETEST POSTTES; Broglio SP, 2007, J ATHL TRAINING, V42, P509; Bruce J, 2014, CLIN NEUROPSYCHOL, V28, P14, DOI 10.1080/13854046.2013.866272; Calamia M, 2012, CLIN NEUROPSYCHOL, V26, P543, DOI 10.1080/13854046.2012.680913; Chelune G.J., 1993, NEUROPSYCHOLOGY, V7, P41, DOI [10.1037/0894-4105.7.1.41, DOI 10.1037/0894-4105.7.1.41]; Choudhury S, 2006, SOC COGN AFFECT NEUR, V1, P165, DOI 10.1093/scan/nsl024; Cicchetti D.V., 1994, PSYCHOL ASSESS, V6, P284, DOI [10.1037/1040-3590.6.4.284, DOI 10.1037/1040-3590.6.4.284]; Cioni G, 2013, HAND CLINIC, V111, P3, DOI 10.1016/B978-0-444-52891-9.00001-4; Cole WR, 2013, ARCH CLIN NEUROPSYCH, V28, P732, DOI 10.1093/arclin/act040; Collie A., 2009, J INT NEUROPSYCH SOC, V9, P419; Covassin T, 2009, J ATHL TRAINING, V44, P639, DOI 10.4085/1062-6050-44.6.639; Crone EA, 2015, WIRES COGN SCI, V6, P53, DOI 10.1002/wcs.1327; Duff K, 2012, ARCH CLIN NEUROPSYCH, V27, P248, DOI 10.1093/arclin/acr120; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Echemendia RJ, 2012, CLIN NEUROPSYCHOL, V26, P1077, DOI 10.1080/13854046.2012.721006; Elbin RJ, 2011, AM J SPORT MED, V39, P2319, DOI 10.1177/0363546511417173; FLIN RH, 1985, J EARLY ADOLESC, V5, P259, DOI DOI 10.1177/0272431685052009; Gartland S, 2001, BRIT J SPORT MED, V35, P308, DOI 10.1136/bjsm.35.5.308; Guskiewicz KM, 2004, NEUROSURGERY, V55, P891, DOI 10.1227/01.NEU.0000143800.49798.19; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Heilbronner RL, 2010, CLIN NEUROPSYCHOL, V24, P1267, DOI 10.1080/13854046.2010.526785; Immediate Post-Concussion Assessment and Cognitive Testing (ImPACT), 2012, IMM POSTCONC ASS TES; Isbell E, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00696; Iverson GL, 2004, ARCH CLIN NEUROPSYCH, V19, P961; Iverson GL, 2003, CLIN NEUROPSYCHOL, V17, P460, DOI 10.1076/clin.17.4.460.27934; Iverson GL, 2001, ARCH CLIN NEUROPSYCH, V16, P183, DOI 10.1016/S0887-6177(00)00060-3; Iverson GL, 2015, BRAIN INJURY, V29, P263, DOI 10.3109/02699052.2014.965214; JACOBSON NS, 1991, J CONSULT CLIN PSYCH, V59, P12, DOI 10.1037/0022-006X.59.1.12; Kelly JP, 1997, NEUROLOGY, V48, P581; Kirschen MP, 2014, NEUROLOGY, V83, P352, DOI 10.1212/WNL.0000000000000613; Kumar Sharma V., 2014, STUDY EFFECT AGE GEN; Lichtenstein JD, 2014, AM J SPORT MED, V42, P479, DOI 10.1177/0363546513509225; Maerlender A, 2010, CLIN NEUROPSYCHOL, V24, P1309, DOI 10.1080/13854046.2010.516072; Maerlender A, 2015, DEV NEUROPSYCHOL, V40, P69, DOI 10.1080/87565641.2015.1014089; Maril A, 2010, NEUROLOGY, V75, P2110, DOI 10.1212/WNL.0b013e318201526e; McClure DJ, 2014, AM J SPORT MED, V42, P472, DOI 10.1177/0363546513510389; McCrory P, 2004, BRIT J SPORT MED, V38, P516, DOI 10.1136/bjsm.2004.014811; McCrory P., 2009, J ATHL TRAINING, V44, P434, DOI [10.4085/1062-6050-44.4.434, DOI 10.4085/1062-6050-44.4.434]; MCSWEENY AJ, 1993, CLIN NEUROPSYCHOL, V7, P460; Miller JR, 2007, AM J SPORT MED, V35, P1284, DOI 10.1177/0363546507300261; Moser RS, 2015, APPL NEUROPSYCH-CHIL, V4, P41, DOI 10.1080/21622965.2013.791825; Moser RS, 2011, AM J SPORT MED, V39, P2325, DOI 10.1177/0363546511417114; Nakayama Y, 2014, AM J SPORT MED, V42, P2000, DOI 10.1177/0363546514535901; Parsons TD, 2009, INT J NEUROSCI, V119, P492, DOI 10.1080/00207450802330876; Register-Mihalik JK, 2012, J ATHL TRAINING, V47, P297, DOI 10.4085/1062-6050-47.3.13; Resch J, 2013, J ATHL TRAINING, V48, P506, DOI 10.4085/1062-6050-48.3.09; Schatz P, 2006, ARCH CLIN NEUROPSYCH, V21, P91, DOI 10.1016/j.acn.2005.08.001; Schatz P, 2014, ARCH CLIN NEUROPSYCH, V29, P625, DOI 10.1093/arclin/acu041; Schatz P, 2013, ARCH CLIN NEUROPSYCH, V28, P499, DOI 10.1093/arclin/act034; Schatz P, 2013, AM J SPORT MED, V41, P321, DOI 10.1177/0363546512466038; Schatz P, 2010, AM J SPORT MED, V38, P47, DOI 10.1177/0363546509343805; Schneider W, 2002, J EDUC PSYCHOL, V94, P751, DOI 10.1037//0022-0663.94.4.751; Spreen E., 2006, COMPENDIUM NEUROPSYC, P1; Sullivan Gail M, 2012, J Grad Med Educ, V4, P279, DOI 10.4300/JGME-D-12-00156.1; Tsushima WT, 2016, ARCH CLIN NEUROPSYCH, V31, P105, DOI 10.1093/arclin/acv066; Vas S, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0059809, 10.1371/journal.pone.0073990]; Vaughan CG, 2014, AM J SPORT MED, V42, P1716, DOI 10.1177/0363546514531732	63	15	15	0	8	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	0887-6177	1873-5843		ARCH CLIN NEUROPSYCH	Arch. Clin. Neuropsychol.	DEC	2016	31	8					904	914		10.1093/arclin/acw055			11	Psychology, Clinical; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology	EJ1MM	WOS:000392974600007	27538440	Bronze			2022-02-06	
J	Jones, TM; Dear, BF; Hush, JM; Titov, N; Dean, CM				Jones, Taryn M.; Dear, Blake F.; Hush, Julia M.; Titov, Nickolai; Dean, Catherine M.			myMoves Program: Feasibility and Acceptability Study of a Remotely Delivered Self-Management Program for Increasing Physical Activity Among Adults With Acquired Brain Injury Living in the Community	PHYSICAL THERAPY			English	Article							RANDOMIZED CONTROLLED-TRIAL; TRANSDIAGNOSTIC INTERNET TREATMENT; ALL-CAUSE MORTALITY; PSYCHOLOGICAL DISTRESS; PAIN-COURSE; STROKE; POPULATION; ACCELEROMETRY; PREVENTION; DEPRESSION	Background. People living with acquired brain injury (ABI) are more likely to be physically inactive and highly sedentary and, therefore, to have increased risks of morbidity and mortality. However, many adults with ABI experience barriers to participation in effective physical activity interventions. Remotely delivered self-management programs focused on teaching patients how to improve and maintain their physical activity levels have the potential to improve the overall health of adults with AB!. Objective. The study objective was to evaluate remotely delivered self-management program aimed adults who dwell in the community and have ABI. the acceptability and feasibility of a at increasing physical activity among adults who dwell in the community and have ABI. Design. A single-group design involving comparison of baseline measures with those taken immediately after intervention and at a 3-month follow-up was used in this study. Methods. The myMoves Program comprises 6 modules delivered over 8 weeks via email. Participants were provided with regular weekly contact with an experienced physical therapist via email and telephone. The primary outcomes were the feasibility (participation, attrition, clinician time, accessibility, and adverse events) and acceptability (satisfaction, worthiness of time, and recommendation) of the myMoves Program. The secondary outcomes were objective physical activity data collected from accelerometers, physical activity selkfficacy, psychological distress, and participation. Results. Twenty-four participants commenced the program (20 with stroke, 4 with traumatic injury), and outcomes were collected for 23 and 22 participants immediately after the program' and at a 3-month follow-up, respectively. The program required very little clinician contact time, with an average of 32.8 minutes (SD=22.8) per participant during the 8-week program. Acceptability was very high, with more than 95% of participants being either very satisfied or satisfied with the myMoves Program and stating that it was worth their time. All participants stated that they would recommend the program to others with A131. Limitations. The results were obtained from a small sample; hence, the results may not be generalizable to a larger ABI population. Conclusions. A remotely delivered self-management program aimed at increasing physical activity is feasible and acceptable for adults with ABI. Further large-scale efficacy trials are warranted.	[Jones, Taryn M.; Hush, Julia M.; Dean, Catherine M.] Macquarie Univ, Dept Hlth Profess, Fac Med & Hlth Sci, Ground Floor,75 Talavera Rd, Sydney, NSW 2109, Australia; [Jones, Taryn M.; Dear, Blake F.; Hush, Julia M.; Titov, Nickolai; Dean, Catherine M.] Macquarie Univ, Ctr Phys Hlth, Sydney, NSW, Australia; [Dear, Blake F.; Titov, Nickolai] Macquarie Univ, Dept Psychol, ECentreClin, Sydney, NSW, Australia		Jones, TM (corresponding author), Macquarie Univ, Dept Hlth Profess, Fac Med & Hlth Sci, Ground Floor,75 Talavera Rd, Sydney, NSW 2109, Australia.; Jones, TM (corresponding author), Macquarie Univ, Ctr Phys Hlth, Sydney, NSW, Australia.	taryn.jones@mq.edu.au		Dear, Blake/0000-0001-9324-3092; Hush, Julia/0000-0002-2805-0339; Titov, Nickolai/0000-0002-7268-729X; Dean, Catherine/0000-0001-7502-1138	Macquarie University; National Health and Medical Research Council Australian Public Health FellowshipNational Health and Medical Research Council of Australia	Dr Jones was supported by a Macquarie University Research Excellence Scholarship. Dr Dear was supported by a National Health and Medical Research Council Australian Public Health Fellowship.	Andrews G, 2001, AUST NZ J PUBL HEAL, V25, P494, DOI 10.1111/j.1467-842X.2001.tb00310.x; Australian Bureau of Statistics, 2011, AUSTR STAND GEOGR CL; Australian Bureau of Statistics, 2012, US KESSL PSYCH DISTR; Bartholomew LK, 2011, PLANNING HLTH PROMOT, P704; Blair SN, 1996, JAMA-J AM MED ASSOC, V276, P205, DOI 10.1001/jama.276.3.205; Cadilhac DA, 2011, STROKE, V42, P1673, DOI 10.1161/STROKEAHA.110.601997; Choi L, 2011, MED SCI SPORT EXER, V43, P357, DOI 10.1249/MSS.0b013e3181ed61a3; Craig P, 2008, BRIT MED J, V337, DOI 10.1136/bmj.a1655; Damush TM, 2011, TRANSL BEHAV MED, V1, P561, DOI 10.1007/s13142-011-0070-y; de Silva D, 2011, EVIDENCE HELPING PEO, P44; Dear BF, 2015, PAIN, V156, P1920, DOI 10.1097/j.pain.0000000000000251; Dear BF, 2013, PAIN, V154, P942, DOI 10.1016/j.pain.2013.03.005; Dear BF, 2011, BEHAV RES THER, V49, P830, DOI 10.1016/j.brat.2011.09.007; Department of Health Australian Government, 2006, ASGC REM AR; Driver S, 2008, ADAPT PHYS ACT Q, V25, P289, DOI 10.1123/apaq.25.4.289; Driver S, 2012, DISABIL HEALTH J, V5, P117, DOI 10.1016/j.dhjo.2011.11.002; English C, 2016, TOP STROKE REHABIL, V23, P62, DOI 10.1179/1945511915Y.0000000009; Foster C, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD010395.pub2; Gordon NF, 2004, STROKE, V35, P1230, DOI 10.1161/01.STR.0000127303.19261.19; Grant PM, 2008, J AGING PHYS ACTIV, V16, P201, DOI 10.1123/japa.16.2.201; Gulsvik AK, 2012, INT J EPIDEMIOL, V41, P521, DOI 10.1093/ije/dyr205; Haskell WL, 2009, PREV MED, V49, P280, DOI 10.1016/j.ypmed.2009.05.002; Hornnes N, 2010, INT J STROKE, V5, P157, DOI 10.1111/j.1747-4949.2010.00424.x; IBM Corp, 2013, IBM SPSS STAT MAC CO; Jones F, 2011, DISABIL REHABIL, V33, P797, DOI 10.3109/09638288.2010.511415; Jones TM, 2016, PHYS THER, V96, P1994, DOI 10.2522/ptj.20150387; Jones TM, 2016, DISABIL HEALTH J, V9, P54, DOI 10.1016/j.dhjo.2015.08.004; Jones TM, 2015, SYST REV-LONDON, V4, DOI 10.1186/s13643-015-0039-x; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Kim H, 2013, J KOREAN ACAD NURS, V43, P331, DOI 10.4040/jkan.2013.43.3.331; Kozey-Keadle S, 2011, MED SCI SPORT EXER, V43, P1561, DOI 10.1249/MSS.0b013e31820ce174; Kroll T, 2007, INT J BEHAV NUTR PHY, V4, DOI 10.1186/1479-5868-4-34; Kunkel D, 2015, DISABIL REHABIL, V37, P304, DOI 10.3109/09638288.2014.918190; LANSKA DJ, 1993, DEMENTIA, V4, P117, DOI 10.1159/000107307; Lee IM, 2001, MED SCI SPORT EXER, V33, pS459, DOI 10.1097/00005768-200106001-00016; Lorig K, 2013, HEALTH EDUC BEHAV, V40, P67, DOI 10.1177/1090198112436969; Lorig KR, 2008, ARTHRIT RHEUM-ARTHR, V59, P1009, DOI 10.1002/art.23817; Macera CA, 2001, MED SCI SPORT EXER, V33, pS635, DOI 10.1097/00005768-200106001-00032; Matthews CE, 2002, MED SCI SPORT EXER, V34, P1376, DOI 10.1097/00005768-200208000-00021; Miller A, 2011, DISABIL REHABIL, V33, P1968, DOI 10.3109/09638288.2011.553707; Nicholson S, 2013, INT J STROKE, V8, P357, DOI 10.1111/j.1747-4949.2012.00880.x; O'Rance L., 2007, BULLETIN, V55, P28; Organization WH. Geneva, 2010, 9789241599979 WHO; PAL Technologies Ltd, ACTIVPAL SPEC BROCH; PERRY J, 1995, STROKE, V26, P982, DOI 10.1161/01.STR.26.6.982; Rand D, 2009, STROKE, V40, P163, DOI 10.1161/STROKEAHA.108.523621; Ridgers ND, 2011, EUR J SPORT SCI, V11, P205, DOI 10.1080/17461391.2010.501116; Santos-Lozano A, 2013, INT J SPORTS MED, V34, P975, DOI 10.1055/s-0033-1337945; Sasaki JE, 2011, J SCI MED SPORT, V14, P411, DOI 10.1016/j.jsams.2011.04.003; Sit JWH, 2007, J CLIN NURS, V16, P272, DOI 10.1111/j.1365-2702.2005.01522.x; Taraldsen K, 2011, PHYS THER, V91, P277, DOI 10.2522/ptj.20100159; Titov N, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089591; Titov N, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0062873; Titov N, 2011, BEHAV RES THER, V49, P441, DOI 10.1016/j.brat.2011.03.007; Tweedy SM, 2005, MED SCI SPORT EXER, V37, P1474, DOI 10.1249/01.mss.0000177584.43330.ae; Warburton DER, 2006, CAN MED ASSOC J, V174, P801, DOI 10.1503/cmaj.051351; Wootton BM, 2011, J ANXIETY DISORD, V25, P1102, DOI 10.1016/j.janxdis.2011.07.009	57	15	15	0	8	AMER PHYSICAL THERAPY ASSOC	ALEXANDRIA	1111 N FAIRFAX ST, ALEXANDRIA, VA 22314 USA	0031-9023	1538-6724		PHYS THER	Phys. Ther.	DEC	2016	96	12					1982	1993		10.2522/ptj.20160028			12	Orthopedics; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Orthopedics; Rehabilitation	EE2FM	WOS:000389399100013	27515944	Bronze			2022-02-06	
J	Latifi, R; Gunn, JKL; Bakiu, E; Boci, A; Dasho, E; Olldashi, F; Pipero, P; Stroster, JA; Qesteri, O; Kucani, J; Sulo, A; Oshafi, M; Osmani, KL; Dogjani, A; Doarn, CR; Shatri, Z; Kociraj, A; Merrell, RC				Latifi, Rifat; Gunn, Jayleen K. L.; Bakiu, Evis; Boci, Arian; Dasho, Erion; Olldashi, Fatos; Pipero, Pellumb; Stroster, John A.; Qesteri, Orland; Kucani, Julian; Sulo, Ardi; Oshafi, Manjola; Osmani, Kalterina L.; Dogjani, Agron; Doarn, Charles R.; Shatri, Zhaneta; Kociraj, Agim; Merrell, Ronald C.			Access to Specialized Care Through Telemedicine in Limited-Resource Country: Initial 1,065 Teleconsultations in Albania	TELEMEDICINE AND E-HEALTH			English	Article						telemedicine; initiate-build-operate-transfer (IBOT); low- and middle-income countries; teleconsultations; teleneurotrauma; telestroke; teleradiology	BUILD-OPERATE-TRANSFER; MEDICAL SYSTEMS; PROGRAM; STRATEGY	Objective: To analyze the initial experience of the nationwide clinical telemedicine program of Albania, as a model of implementation of telemedicine using Initiate-Build-Operate-Transfer strategy. Methods: This was a retrospective study of prospectively collected data from teleconsultations in Albania between January 1, 2014 and August 26, 2015, delivered synchronously, asynchronously, or a combination of both methods. Patient's demographics, mode of consultation, clinical specialty, hospitals providing referral and consultation, time from initial call to completion of consultation, and patient disposition following teleconsultation were analyzed. Challenges of the newly created program have been identified and analyzed as well. Results: There were 1,065 teleconsultations performed altogether during the study period. Ninety-one patients with autism managed via telemedicine were not included in this analysis and will be reported separately. Of 974 teleconsults, the majority were for radiology, neurotrauma, and stroke (55%, 16%, and 10% respectively). Asynchronous technology accounted for nearly two-thirds of all teleconsultations (63.7%), followed by combined (24.3%), and then synchronous (12.0%). Of 974 cases, only 20.0% of patients in 2014 and 22.72% of patients in 2015 were transferred to a tertiary hospital. A majority (98.5%) of all teleconsultations were conducted within the country itself. Conclusions: The Integrated Telemedicine and e-Health program of Albania has become a useful tool to improve access to high-quality healthcare, particularly in high demanding specialty disciplines. A number of challenges were identified and these should serve as lessons for other countries in their quest to establish nationwide telemedicine programs.	[Latifi, Rifat] Westchester Med Ctr, Dept Surg, Valhalla, NY 10595 USA; [Latifi, Rifat] New York Med Coll, Valhalla, NY 10595 USA; [Latifi, Rifat] Univ Arizona, Dept Surg, Tucson, AZ USA; [Latifi, Rifat; Gunn, Jayleen K. L.; Bakiu, Evis; Boci, Arian; Dasho, Erion; Olldashi, Fatos; Pipero, Pellumb; Stroster, John A.; Qesteri, Orland; Kucani, Julian; Sulo, Ardi; Oshafi, Manjola; Osmani, Kalterina L.; Dogjani, Agron; Merrell, Ronald C.] Int Virtual E Hosp Fdn, Tirana, Albania; [Latifi, Rifat; Gunn, Jayleen K. L.; Bakiu, Evis; Boci, Arian; Dasho, Erion; Olldashi, Fatos; Pipero, Pellumb; Stroster, John A.; Qesteri, Orland; Kucani, Julian; Sulo, Ardi; Oshafi, Manjola; Osmani, Kalterina L.; Dogjani, Agron; Merrell, Ronald C.] Integrated Telemed & E Hlth Program Albania, Tirana, Albania; [Gunn, Jayleen K. L.] Univ Arizona, Dept Epidemiol & Biostat, Tucson, AZ USA; [Olldashi, Fatos] Univ Trauma Hosp, Dept Neurosurg, Tirana, Albania; [Dogjani, Agron] Univ Trauma Hosp, Trauma Sect, Tirana, Albania; [Doarn, Charles R.] Univ Cincinnati, Dept Family & Community Med, Cincinnati, OH USA; [Shatri, Zhaneta; Kociraj, Agim] USAID Albania, Tirana, Albania		Latifi, R (corresponding author), Westchester Med Ctr, Dept Surg, Valhalla, NY 10595 USA.; Latifi, R (corresponding author), New York Med Coll, Valhalla, NY 10595 USA.	rifat.latifi@wmchealth.org	Doarn, Charles/L-3934-2019	Latifi, Rifat/0000-0003-1091-3682	USAID in AlbaniaUnited States Agency for International Development (USAID) [182-A-00-09-00101-00]	The Integrated Telemedicine and e-Health Program was funded by the USAID in Albania (Contract No. 182-A-00-09-00101-00). Special thanks to Dr. Petro Mercini for continuous support of the telemedicine program.	Acosta L, 2015, STUD HEALTH TECHNOL, V216, P923, DOI 10.3233/978-1-61499-564-7-923; Bagayoko CO, 2014, BMC HLTH SERV RES S1, V14, P9; Charles B L, 2000, Healthc Financ Manage, V54, P66; Currell R., 2000, COCHRANE DB SYST REV, DOI [10.1002/14651858.CD002098, DOI 10.1002/14651858.CD002098]; Doarn Charles R, 2009, Telemed J E Health, V15, P379, DOI 10.1089/tmj.2009.0023; INSTAT, 2015, POP 2001 2015 REG; Kammerer FJ, 2015, J TELEMED TELECARE, V21, P355, DOI 10.1177/1357633X15575237; Latifi K, 2011, TELEMED E-HEALTH, V17, P757, DOI 10.1089/tmj.2011.0102; Latifi R, 2006, TELEMED J E-HEALTH, V12, P332, DOI 10.1089/tmj.2006.12.332; Latifi R, 2015, TELEMED E-HEALTH, V21, P503, DOI 10.1089/tmj.2014.0138; Latifi R, 2014, TELEMED E-HEALTH, V20, P1027, DOI 10.1089/tmj.2014.0026; Latifi Rifat, 2012, Bull Am Coll Surg, V97, P15; Latifi R, 2012, TELEMED E-HEALTH, V18, P388, DOI [10.1089/tmj.2011.0263, 10.1089/tmj.2011.1263]; Latifi R, 2011, STUD HEALTH TECHNOL, V165, P3, DOI 10.3233/978-1-60750-735-2-3; Latifi Rifat, 2009, Am J Surg, V198, P905, DOI 10.1016/j.amjsurg.2009.08.011; Latifi R, 2009, TELEMED J E-HEALTH, V15, P956, DOI 10.1089/tmj.2009.0084; Sangare M, 2015, J TELEMED TELECARE, V21, P131, DOI 10.1177/1357633X15569966; Wilson LS, 2015, HEALTHC INFORM RES, V21, P213, DOI 10.4258/hir.2015.21.4.213; World Health Organization, 2015, INT CLASS DIS ICD; World Health Organization, 2011, WHO GLOB SER, V2; Yilmaz AO, 2016, COMPUT METH PROG BIO, V123, P159, DOI 10.1016/j.cmpb.2015.10.005	21	15	15	0	6	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1530-5627	1556-3669		TELEMED E-HEALTH	Telemed. e-Health	DEC	2016	22	12					1024	1031		10.1089/tmj.2016.0050			8	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED)	Health Care Sciences & Services	EF5ZB	WOS:000390407500009	27219617				2022-02-06	
J	Moore, RD; Sauve, W; Ellemberg, D				Moore, Robert Davis; Sauve, William; Ellemberg, Dave			Neurophysiological correlates of persistent psycho-affective alterations in athletes with a history of concussion	BRAIN IMAGING AND BEHAVIOR			English	Article						Concussion; Brain function; Affect; Electroencephalogram	TRAUMATIC BRAIN-INJURY; FRONTAL EEG ASYMMETRY; DEPRESSION; SYMPTOMS; EPIDEMIOLOGY; RISK; TIME	Understanding the neuropathological underpinnings of sport-related concussion are critical for diagnosis, prognosis, and remediation. Although electro-encephalographic (EEG) methods have proven invaluable for understanding psycho-affective pathologies in various clinical conditions, they have not been used to understand the psycho-affective outcomes of concussive injuries. Accordingly, we evaluated the relation of electroencephalographic (EEG) power in collegiate athletes to psycho-affective measures. We predicted that athletes with a history of concussion would exhibit alterations in frontal EEG asymmetries indicative of increased depression, anxiety and more general mood disturbance. During this cross-sectional study, resting EEG and measures of mood and affect, including the Beck Depression Inventory-II (BDI-II) and Profile of Mood States (POMS) were collected in 81 young-adult male athletes (52 concussion history; 29 controls). All athletes with a history of concussion (9+ months from injury) reported to be symptom free, and all participants were actively taking part in their sport at the time of testing. Compared to control athletes, the athletes with a history of concussion exhibited alterations in frontal-alpha and frontal-beta asymmetry (p's < .05). Correlational analyses revealed that alterations in frontal-alpha asymmetry were related to self-reported depression and anxiety, and alterations in beta-asymmetry were related to self-reported anger/aggression, but these relations were only significant for athletes with a history of concussion. The current study suggests that athletes with a history of concussion who made a complete return to play and reported to be asymptomatic on a commonly used symptom checklist may still exhibit neural activity associated with increased levels of depression, anxiety and anger/hostility. The current results reinforce the clinical necessity for long-term evaluations of athletes irrespective of apparent symptom resolution, and suggest that EEG may serve as a sensitive tool to identify and track concussion-related alterations in psycho-affective health before they manifest as clinical disorders.	[Moore, Robert Davis; Sauve, William; Ellemberg, Dave] Univ Montreal, Montreal, PQ, Canada		Moore, RD (corresponding author), Univ Montreal, Montreal, PQ, Canada.	robert.moore@umontreal.ca			Canadian Institute of Health ResearchCanadian Institutes of Health Research (CIHR) [R0017986]	This study was funded by a Canadian Institute of Health Research grant (#R0017986), awarded to Dave Ellemberg.	Alhilali L. M., 2015, RADIOLOGY, DOI [10.1148/radiol.2015142974, DOI 10.1148/RADIOL.2015142974.]; Allen JJB, 2004, BIOL PSYCHOL, V67, P1, DOI 10.1016/j.biopsycho.2004.03.001; Baillargeon A, 2012, BRAIN INJURY, V26, P211, DOI 10.3109/02699052.2012.654590; Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; BECK AT, 1993, SUICIDE LIFE-THREAT, V23, P139; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Blackhart GC, 2006, BIOL PSYCHOL, V72, P46, DOI 10.1016/j.biopsycho.2005.06.010; Broglio SP, 2011, INT J PSYCHOPHYSIOL, V82, P16, DOI 10.1016/j.ijpsycho.2011.02.010; Broglio SP, 2009, CLIN J SPORT MED, V19, P377, DOI 10.1097/JSM.0b013e3181b625fe; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; Chen JK, 2004, NEUROIMAGE, V22, P68, DOI 10.1016/j.neuroimage.2003.12.032; Coan JA, 2004, BIOL PSYCHOL, V67, P7, DOI 10.1016/j.biopsycho.2004.03.002; Cook IA, 2009, PSYCHIAT RES-NEUROIM, V174, P152, DOI 10.1016/j.pscychresns.2009.04.011; Curran Shelly L., 1995, Journal of Orofacial Pain, V9, P340; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Davidson R.J., 2000, HDB PSYCHOPHYSIOLOGY, V2, P27; Davidson RJ, 2002, BIOL PSYCHIAT, V51, P68, DOI 10.1016/S0006-3223(01)01328-2; DAVIDSON RJ, 1992, BRAIN COGNITION, V20, P125, DOI 10.1016/0278-2626(92)90065-T; DAVIDSON RJ, 1995, CURR OPIN NEUROBIOL, V5, P217, DOI 10.1016/0959-4388(95)80029-8; Davidson RJ, 2004, BIOL PSYCHOL, V67, P219, DOI 10.1016/j.biopsycho.2004.03.008; Ellemberg D, 2007, CLIN J SPORT MED, V17, P369, DOI 10.1097/JSM.0b013e31814c3e3e; Gaetz M, 2000, BRAIN INJURY, V14, P1077; Gosselin N, 2012, NEUROSURG FOCUS, V33, P1, DOI DOI 10.3171/2012.10.F0CUS12253; Grimshaw GM, 2014, FRONT PSYCHOL, V5, DOI 10.3389/fpsyg.2014.00489; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Harmon-Jones E, 1997, J ABNORM PSYCHOL, V106, P159, DOI 10.1037/0021-843X.106.1.159; Harmon-Jones E., 2009, METHODS SOCIAL NEURO, P170; Harmon-Jones E, 2007, SOCIAL NEUROSCIENCE, P137; Harmon-Jones E, 2010, BIOL PSYCHOL, V84, P451, DOI 10.1016/j.biopsycho.2009.08.010; Hofman D, 2012, SOC COGN AFFECT NEUR, V7, P850, DOI 10.1093/scan/nsr060; Kelly JP, 1997, NEUROLOGY, V48, P581; Kerr ZY, 2012, AM J SPORT MED, V40, P2206, DOI 10.1177/0363546512456193; Lang PJ, 2010, BIOL PSYCHOL, V84, P437, DOI 10.1016/j.biopsycho.2009.10.007; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Mainwaring LM, 2004, J SPORT EXERCISE PSY, V26, P119, DOI 10.1123/jsep.26.1.119; Mainwaring L, 2012, J CLIN SPORT PSYCHOL, V6, P247, DOI 10.1123/jcsp.6.3.247; McCrory P, 2008, S AFR J SPORTS MED, V21, P36; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore RD, 2014, J ATHL TRAINING, V49, P24, DOI 10.4085/1062-6050-49.1.01; Niogi S, 2010, FRONT NEUROANAT, V4, DOI [10.3389/neuro.05.002.2010, 10.3389/fneur.2010.00149]; Nusslock R, 2011, J ABNORM PSYCHOL, V120, P497, DOI 10.1037/a0022940; Plutchik Robert, 1994, PSYCHOL BIOL EMOTION; Pontifex MB, 2009, NEUROPSYCHOLOGIA, V47, P3210, DOI 10.1016/j.neuropsychologia.2009.07.021; Rigotti M, 2013, NATURE, V497, P585, DOI 10.1038/nature12160; Sauve W., 2015, LONG TERM P IN PRESS; Schmitt BM, 2000, PSYCHOPHYSIOLOGY, V37, P473, DOI 10.1017/S0048577200981782; Sinopoli KJ, 2014, J NEUROTRAUM, V31, P1843, DOI 10.1089/neu.2014.3326; Slobounov S, 2012, BRAIN IMAGING BEHAV, V6, P224, DOI 10.1007/s11682-012-9167-2; Urban KJ, 2015, J NEUROTRAUM, V32, P833, DOI 10.1089/neu.2014.3577; Vargas G, 2015, J ATHL TRAINING, V50, P250, DOI 10.4085/1062-6050-50.3.02; Zhang K, 2012, J NEUROTRAUM, V29, P756, DOI 10.1089/neu.2011.2125	54	15	15	1	31	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1931-7557	1931-7565		BRAIN IMAGING BEHAV	Brain Imaging Behav.	DEC	2016	10	4					1108	1116		10.1007/s11682-015-9473-6			9	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EF0LC	WOS:000390015900016	26542620				2022-02-06	
J	Naito, H; Isotani, E; Callaway, CW; Hagioka, S; Morimoto, N				Naito, Hiromichi; Isotani, Eiji; Callaway, Clifton W.; Hagioka, Shingo; Morimoto, Naoki			Intracranial Pressure Increases During Rewarming Period After Mild Therapeutic Hypothermia in Postcardiac Arrest Patients	THERAPEUTIC HYPOTHERMIA AND TEMPERATURE MANAGEMENT			English	Article						intracranial pressure; cerebral edema; heart arrest	INTRA-CRANICAL PRESSURE; TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY-RESUSCITATION; CARDIAC-ARREST; HYPERTENSION; ICP; MODEL	Elevation of intracranial pressure (ICP) may worsen brain injury and neurological outcome. Studies on the use of therapeutic hypothermia (TH) for traumatic brain injury suggests that rapid rewarming from TH is associated with elevated ICP and poorer outcomes. However, few studies describe the time course of ICP changes during TH/rewarming after cardiac arrest (CA). In this study, we observed the changes in ICP during mild TH and rewarming after CA. Secondarily, we examined whether ICP is related to outcome. We studied comatose patients resuscitated from CA, who were treated with TH and who had ICP monitored. Target core temperature was 34 degrees C for 24h and target rewarming rate was 0.25 degrees C/h. ICP and cerebral perfusion pressure (CPP) were monitored during the period. Outcome was rated as cerebral performance category. In nine patients, ICP increased during TH and rewarming (6.0 [4.0-9.0] mmHg to 16.0 [12.0-26.0] mmHg, p=0.008). CPP did not change during the period (83.3 [80.1-91.0] mmHg to 74.3 [52.0-87.3] mmHg). Higher ICP was associated with worse outcomes (p=0.009). All the cases with ICP >25mmHg or CPP <40mmHg died. Major ICP increment was observed during the rewarming period, although, some increase of ICP occurred even during the mild TH. ICP increment was higher in patients with worse outcomes.	[Naito, Hiromichi; Callaway, Clifton W.] Univ Pittsburgh, Sch Med, Dept Emergency Med, 400A Iroquois Bldg,3600 Forbes Ave, Pittsburgh, PA 15261 USA; [Isotani, Eiji] Tokyo Womens Med Univ, Med Ctr East, Dept Emergency & Crit Care Med, Tokyo, Japan; [Hagioka, Shingo; Morimoto, Naoki] Tsuyama Chuo Byoin, Emergency Ctr, Tsuyama, Japan; [Hagioka, Shingo; Morimoto, Naoki] Tsuyama Chuo Byoin, Crit Care Unit, Tsuyama, Japan		Naito, H (corresponding author), Univ Pittsburgh, Sch Med, Dept Emergency Med, 400A Iroquois Bldg,3600 Forbes Ave, Pittsburgh, PA 15261 USA.	naito.hiromichi@gmail.com		Naito, Hiromichi/0000-0002-7308-1716			Callaway CW, 2015, CIRCULATION, V132, pS465, DOI 10.1161/CIR.0000000000000262; DEAN JM, 1981, NEUROSURGERY, V9, P627; Flynn LMC, 2015, THER HYPOTHERMIA TEM, V5, P143, DOI 10.1089/ther.2015.0002; GUEUGNIAUD PY, 1991, INTENS CARE MED, V17, P392, DOI 10.1007/BF01720676; Iida K, 1997, CRIT CARE MED, V25, P971, DOI 10.1097/00003246-199706000-00013; Kim YH, 2014, ACAD EMERG MED, V21, P1121, DOI 10.1111/acem.12477; Kurtz P, 2013, NEUROCRIT CARE, V19, P311, DOI 10.1007/s12028-013-9919-x; Lee KJ, 2015, BIOMED ENG ONLINE, V14, DOI 10.1186/s12938-015-0051-3; Maitinez-Manas RM, 2000, J NEUROL NEUROSUR PS, V69, P82, DOI 10.1136/jnnp.69.1.82; MARMAROU A, 1991, J NEUROSURG, V75, pS59, DOI 10.3171/sup.1991.75.1s.0s59; McIntyre LA, 2003, JAMA-J AM MED ASSOC, V289, P2992, DOI 10.1001/jama.289.22.2992; MILLER JD, 1987, ACTA NEUROCHIR, V85, P80, DOI 10.1007/BF01456102; Moretti R, 2009, J NEUROSURG ANESTH, V21, P16, DOI 10.1097/ANA.0b013e318185996a; Nordmark J, 2009, ACTA ANAESTH SCAND, V53, P289, DOI 10.1111/j.1399-6576.2008.01885.x; Robba C, 2015, NEUROCRIT CARE, V23, P419, DOI 10.1007/s12028-015-0163-4; SAKABE T, 1987, INTENS CARE MED, V13, P256, DOI 10.1007/BF00265114; SENTER HJ, 1981, J NEUROSURG, V54, P489, DOI 10.3171/jns.1981.54.4.0489	17	15	15	0	0	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2153-7658	2153-7933		THER HYPOTHERMIA TEM	Ther. Hypothermia Temp. Manag.	DEC	2016	6	4					189	193		10.1089/ther.2016.0009			5	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	EL1DR	WOS:000394361200006	27213805				2022-02-06	
J	Taubman, B; Rosen, F; McHugh, J; Grady, MF; Elci, OU				Taubman, Bruce; Rosen, Florence; McHugh, Jennifer; Grady, Matthew F.; Elci, Okan U.			The Timing of Cognitive and Physical Rest and Recovery in Concussion	JOURNAL OF CHILD NEUROLOGY			English	Article						concussion; cognitive rest; physical rest; recovery; management	SPORT-RELATED CONCUSSION; PROLONGED RECOVERY; STATEMENT; SYMPTOMS; SCALE	Immediate cognitive and physical rest in the concussed patient is almost universally recommended in the concussion literature. The authors conducted a prospective observational in a primary care pediatric office to examine the effect of delayed cognitive and physical rest had on recovery time in pediatric concussion. The authors found that patients who started cognitive and physical rest immediately after injury were more likely to recover within 30 days compared to patients who delayed cognitive and physical rest for 1-7 days after their injury (67% vs 35%, P = .016). Within the group of patients who recovered within 30 days those with immediate cognitive and physical rest recovered 4.6 days sooner than those with delayed cognitive and physical rest (10.29 +/- 5.83 vs 14.42 +/- 6.15 days, P = .005). These data support the recommendation that cognitive and physical rest should be implemented immediately after injury in concussed patients.	[Taubman, Bruce; Rosen, Florence; McHugh, Jennifer] Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Pediat,Div Gen Pediat,Advocare Cherry Hill P, 600 W Marlton Pike, Cherry Hill, NJ 08002 USA; [Grady, Matthew F.] Univ Penn, Childrens Hosp Philadelphia, Div Sports Med, Dept Surg,Perelman Sch Med, Cherry Hill, NJ USA; [Elci, Okan U.] Childrens Hosp Philadelphia, Westat Biostat & Management Core, Philadelphia, PA 19104 USA		Taubman, B (corresponding author), Univ Penn, Perelman Sch Med, Childrens Hosp Philadelphia, Dept Pediat,Div Gen Pediat,Advocare Cherry Hill P, 600 W Marlton Pike, Cherry Hill, NJ 08002 USA.	taubman@email.chop.edu	Taubman, Bruce/ABG-4612-2020	Taubman, Bruce/0000-0002-7976-1907			Burke MJ, 2014, BRAIN INJURY, V10, P1; Centers for Disease Control and Prevention, 2013, SPORTS CONC; Chen JK, 2007, J NEUROL NEUROSUR PS, V78, P1231, DOI 10.1136/jnnp.2006.110395; DiFazio MP, 2012, PEDIATRICS; Eastman A, 2015, NEUROREHABILITATION, V37, P235, DOI 10.3233/NRE-151256; Gibson S, 2013, BRAIN INJURY, V27, P839, DOI 10.3109/02699052.2013.775494; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Harris PA, 2009, J BIOMED INFORM, V42, P377, DOI 10.1016/j.jbi.2008.08.010; Institute of Medicine and National Research Council, 2013, SPORTS REL CONC YOUT; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Majerske CW, 2008, J ATHL TRAINING, V43, P265, DOI 10.4085/1062-6050-43.3.265; McAbee GN, 2015, J CHILD NEUROL, V30, P1378, DOI 10.1177/0883073814551794; McCrea M, 2014, PROG NEUROL SURG, V28, P112, DOI 10.1159/000358769; McCrea M, 2013, J INT NEUROPSYCH SOC, V19, P22, DOI 10.1017/S1355617712000872; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Moser RS, 2012, J PEDIATR-US, V161, P922, DOI 10.1016/j.jpeds.2012.04.012; Purcell LK, 2012, PAED CHILD HEALT-CAN, V17, P36; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Silverberg ND, 2013, J HEAD TRAUMA REHAB, V28, P250, DOI 10.1097/HTR.0b013e31825ad658; Terrell TR, 2014, SOUTH MED J, V107, P115, DOI 10.1097/SMJ.0000000000000063; Thomas DG, 2015, PEDIATRICS, V135, P213, DOI 10.1542/peds.2014-0966	23	15	15	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0883-0738	1708-8283		J CHILD NEUROL	J. Child Neurol.	DEC	2016	31	14					1555	1560		10.1177/0883073816664835			6	Clinical Neurology; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics	EB7DG	WOS:000387545600006	27581848				2022-02-06	
J	Vaiman, M; Sigal, T; Kimiagar, I; Bekerman, I				Vaiman, Michael; Sigal, Tal; Kimiagar, Itzhak; Bekerman, Inessa			Intracranial Pressure Assessment in Traumatic Head Injury with Hemorrhage Via Optic Nerve Sheath Diameter	JOURNAL OF NEUROTRAUMA			English	Article						CT scan; hematoma; intracranial pressure; optic nerve sheath diameter; traumatic head injury	BRAIN-INJURY; PERFUSION CT; ADULTS; TOMOGRAPHY; STROKE	Our purpose was to improve the technique of measuring optic nerve sheath diameter (ONSD) for intracranial pressure (ICP) monitoring in cases of traumatic head injury with hemorrhage. In a retrospective study, computed tomography (CT) data of 312 adult patients were collected and analyzed. ONSDs were measured at 3mm and 8-10mm distance from the globe together with the eyeball transverse diameter (ETD). The ONSD/ETD ratio was calculated. The correlation analysis was performed with gender, age, Glasgow Coma Scale score, and Glasgow Outcome Score. ONSD was enlarged in all cases when CT scans indicated hematoma. Enlarged right/left ONSDs were 6.5 +/- 1.5/6.4 +/- 1.3 mm at 3 mm and 6.6 +/- 0.8/6.6 +/- 0.6 mm at 8-10 mm from the globe (cut-off value >5.5 mm). ONSD/ETD ratio was 0.29 +/- 0.05, compared with 0.19 +/- 0.02 in healthy adults (p < 0.01). We did not find a correlation between ONSD/ETD ratio and initial Glasgow Coma Scale score, but there was an inverse correlation between ONSD/ETD ratio and Glasgow Outcome Score (r = -0.83). We conclude that in cases with a traumatic head injury with hemorrhage, the ONSD is significantly enlarged, indicating elevated ICP. In ICP assessment, the most accurate results can be obtained if the ONSD is measured 8-10 mm from the globe and the ONSD/ETD ratio is calculated.	[Vaiman, Michael] Tel Aviv Univ, Sackler Fac Med, Assaf Harofe Med Ctr, Dept Otolaryngol Head & Neck Surg, Tel Aviv, Israel; [Sigal, Tal; Bekerman, Inessa] Tel Aviv Univ, Sackler Fac Med, Assaf Harofe Med Ctr, Dept Radiol, Tel Aviv, Israel; [Kimiagar, Itzhak] Tel Aviv Univ, Sackler Fac Med, Assaf Harofe Med Ctr, Dept Neurol, Tel Aviv, Israel		Vaiman, M (corresponding author), 33 Shapiro St, IL-59561 Bat Yam, Israel.	vaimed@yahoo.com					Bekerman I, 2014, J OPHTHALMOL, V2014, DOI 10.1155/2014/503645; Chauvet D, 2010, NEUROSURG REV, V33, P287, DOI 10.1007/s10143-010-0261-x; Chen H, 2015, BMC NEUROL, V15, DOI 10.1186/s12883-015-0361-x; Cihangiroglu M, 2002, NEUROL RES, V24, P7, DOI 10.1179/016164102101199440; Eide PK, 2006, ACTA NEUROCHIR, V148, P1267, DOI 10.1007/s00701-006-0908-0; Giger-Tobler C, 2015, KLIN MONATSBL AUGENH, V232, P467, DOI 10.1055/s-0035-1545711; Granacher RP., 2003, TRAUMATIC BRAIN INJU; Kalra MK, 2006, RADIOLOGY, V241, P657, DOI 10.1148/radiol.2413060102; Kimberly HH, 2008, ACAD EMERG MED, V15, P201, DOI 10.1111/j.1553-2712.2007.00031.x; Kimberly HH, 2008, CRIT CARE, V12, DOI 10.1186/cc7008; Legrand A, 2013, CRIT CARE, V17, DOI 10.1186/cc12589; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Masquere P, 2013, CRIT CARE, V17, DOI 10.1186/cc12728; Osborn A. G., 2004, DIAGNOSTIC IMAGING B, V1st; Smith WS, 2003, AM J NEURORADIOL, V24, P688; Vaiman M, 2015, INT J OPHTHALMOL-CHI, V8, P1240, DOI 10.3980/j.issn.2222-3959.2015.06.30; Vaiman M, 2014, HEAD FACE MED, V10, DOI 10.1186/1746-160X-10-32; van Noort R, 1981, Clin Phys Physiol Meas, V2, P197, DOI 10.1088/0143-0815/2/3/003; Wintermark M, 2000, AM J NEURORADIOL, V21, P1881; Wintermark M, 2005, AM J NEURORADIOL, V26, P104; Zimmerman R. A., 1999, CRANIAL MRI AND CT	21	15	15	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	DEC 1	2016	33	23					2147	2153		10.1089/neu.2015.4293			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	ED2JG	WOS:000388669800010	27048793				2022-02-06	
J	Wang, ZG; Cheng, Y; Yu, XC; Ye, LB; Xia, QH; Johnson, NR; Wei, XJ; Chen, DQ; Cao, GD; Fu, XB; Li, XK; Zhang, HY; Xiao, J				Wang, Zhou-Guang; Cheng, Yi; Yu, Xi-Chong; Ye, Li-Bing; Xia, Qing-Hai; Johnson, Noah R.; Wei, Xiaojie; Chen, Da-Qing; Cao, Guodong; Fu, Xiao-Bing; Li, Xiao-Kun; Zhang, Hong-Yu; Xiao, Jian			bFGF Protects Against Blood-Brain Barrier Damage Through Junction Protein Regulation via PI3K-Akt-Rac1 Pathway Following Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						bFGF; Traumatic brain injury; Blood-brain barrier; PI3K/Akt/Rac-1; RhoA; Tight junction	FIBROBLAST-GROWTH-FACTOR; SPINAL-CORD-INJURY; TIGHT JUNCTIONS; OCCLUDIN EXPRESSION; STRESS; RHO; PATHOPHYSIOLOGY; ACTIVATION; INHIBITION; ERK1/2	Many traumatic brain injury (TBI) survivors sustain neurological disability and cognitive impairments due to the lack of defined therapies to reduce TBI-induced blood-brain barrier (BBB) breakdown. Exogenous basic fibroblast growth factor (bFGF) has been shown to have neuroprotective function in brain injury. The present study therefore investigates the beneficial effects of bFGF on the BBB after TBI and the underlying mechanisms. In this study, we demonstrate that bFGF reduces neurofunctional deficits and preserves BBB integrity in a mouse model of TBI. bFGF suppresses RhoA and upregulates tight junction proteins, thereby mitigating BBB breakdown. In vitro, bFGF exerts a protective effect on BBB by upregulating tight junction proteins claudin-5, occludin, zonula occludens-1, p120-catenin, and beta-catenin under oxygen glucose deprivation/reoxygenation (OGD) in human brain microvascular endothelial cells (HBMECs). Both the in vivo and in vitro effects are related to the activation of the downstream signaling pathway, PI3K/Akt/Rac-1. Inhibition of the PI3K/Akt or Rac-1 by specific inhibitors LY294002 or si-Rac-1, respectively, partially reduces the protective effect of bFGF on BBB integrity. Overall, our results indicate that the protective role of bFGF on BBB involves the regulation of tight junction proteins and RhoA in the TBI model and OGD-induced HBMECs injury, and that activation of the PI3K/Akt /Rac-1 signaling pathway underlies these effects.	[Wang, Zhou-Guang; Cheng, Yi; Yu, Xi-Chong; Ye, Li-Bing; Xia, Qing-Hai; Li, Xiao-Kun; Zhang, Hong-Yu; Xiao, Jian] Wenzhou Med Univ, Sch Pharm, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou 325035, Peoples R China; [Cheng, Yi] Longyou Peoples Hosp, Dept Pharm, Quzhou 324400, Peoples R China; [Johnson, Noah R.] Univ Pittsburgh, Dept Bioengn, Pittsburgh, PA 15219 USA; [Johnson, Noah R.] Univ Pittsburgh, McGowan Inst Regenerat Med, Pittsburgh, PA 15219 USA; [Wei, Xiaojie] Wenzhou Med Univ, Cixi Peoples Hosp, Dept Neurosurg, Ningbo 315300, Zhejiang, Peoples R China; [Chen, Da-Qing] Wenzhou Med Univ, Affiliated Hosp 2, Dept Emergency, Wenzhou 325035, Peoples R China; [Cao, Guodong] Univ Pittsburgh, Sch Med, Dept Neurol, Pittsburgh, PA 15261 USA; [Fu, Xiao-Bing] Chinese Peoples Liberat Army Gen Hosp, Inst Basic Med Sci, Beijing 100853, Peoples R China		Zhang, HY; Xiao, J (corresponding author), Wenzhou Med Univ, Sch Pharm, Key Lab Biotechnol & Pharmaceut Engn, Wenzhou 325035, Peoples R China.	st_hyz@126.com; xfxj2000@126.com	Wang, Zhouguang/F-7918-2017	Wang, Zhouguang/0000-0001-9903-0362	NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS079345] Funding Source: Medline; BLRD VA [I01 BX002346] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079345] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002346] Funding Source: NIH RePORTER		Abbott NJ, 2010, NEUROBIOL DIS, V37, P13, DOI 10.1016/j.nbd.2009.07.030; Antonetti DA, 2002, J NEUROCHEM, V80, P667, DOI 10.1046/j.0022-3042.2001.00740.x; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Engelhardt B, 2009, SEMIN IMMUNOPATHOL, V31, P497, DOI 10.1007/s00281-009-0177-0; GARCIA JH, 1995, STROKE, V26, P627, DOI 10.1161/01.STR.26.4.627; Gerhard R, 2003, MOL PHARMACOL, V63, P1349, DOI 10.1124/mol.63.6.1349; Gibson CL, 2014, J NEUROCHEM, V129, P816, DOI 10.1111/jnc.12681; GRIEB P, 1985, J APPL PHYSIOL, V58, P1929, DOI 10.1152/jappl.1985.58.6.1929; Harhaj NS, 2004, INT J BIOCHEM CELL B, V36, P1206, DOI 10.1016/j.biocel.2003.08.007; Higashida T, 2011, J NEUROSURG, V114, P92, DOI 10.3171/2010.6.JNS10207; Hossain MS, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0083508; Huang B, 2012, NEUROBIOL DIS, V46, P204, DOI 10.1016/j.nbd.2012.01.008; Huber JD, 2001, TRENDS NEUROSCI, V24, P719, DOI 10.1016/S0166-2236(00)02004-X; Jiang WG, 1998, BIOCHEM BIOPH RES CO, V244, P414, DOI 10.1006/bbrc.1998.8288; Kamura S, 2010, BRIT J CANCER, V103, P370, DOI 10.1038/sj.bjc.6605775; Lee JG, 2011, INVEST OPHTH VIS SCI, V52, P417, DOI 10.1167/iovs.10-6140; Lin Y, 2012, LAB INVEST, V92, P1623, DOI 10.1038/labinvest.2012.118; Lo EH, 2003, NAT REV NEUROSCI, V4, P399, DOI 10.1038/nrn1106; Loane DJ, 2010, TRENDS PHARMACOL SCI, V31, P596, DOI 10.1016/j.tips.2010.09.005; Luh C, 2010, J NEUROCHEM, V112, P1015, DOI 10.1111/j.1471-4159.2009.06514.x; Luo CL, 2010, J NEUROSCI RES, V88, P2847, DOI 10.1002/jnr.22453; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Murakami M, 2008, J CLIN INVEST, V118, P3355, DOI 10.1172/JCI35298; Nag S, 2011, NEUROPATH APPL NEURO, V37, P3, DOI 10.1111/j.1365-2990.2010.01138.x; Potts Mathew B, 2006, NeuroRx, V3, P143; Roth TL, 2014, NATURE, V505, P223, DOI 10.1038/nature12808; Shlosberg D, 2010, NAT REV NEUROL, V6, P393, DOI 10.1038/nrneurol.2010.74; Vajtr D, 2009, PHYSIOL RES, V58, P263, DOI 10.33549/physiolres.931253; Wachtel M, 2001, J NEUROCHEM, V78, P155, DOI 10.1046/j.1471-4159.2001.00399.x; Wang ZG, 2015, SCI REP-UK, V5, DOI 10.1038/srep09287; Wang ZG, 2012, TOXICOL LETT, V212, P137, DOI 10.1016/j.toxlet.2012.05.006; Werner C, 2007, BRIT J ANAESTH, V99, P4, DOI 10.1093/bja/aem131; Wojciak-Stothard B, 2003, J CELL BIOL, V161, P429, DOI 10.1083/jcb.200210135; Zandy NL, 2007, P NATL ACAD SCI USA, V104, P17686, DOI 10.1073/pnas.0703077104; Zhang HY, 2013, MOL NEUROBIOL, V48, P452, DOI 10.1007/s12035-013-8432-8; Zhang HY, 2013, CNS NEUROSCI THER, V19, P20, DOI 10.1111/cns.12013; Zhang MY, 2013, NEUROCHEM RES, V38, P714, DOI 10.1007/s11064-013-0969-4; Zhao J, 2015, CNS NEUROSCI THER, V21, P61, DOI 10.1111/cns.12334; Zlokovic BV, 2008, NEURON, V57, P178, DOI 10.1016/j.neuron.2008.01.003	40	15	17	2	24	HUMANA PRESS INC	TOTOWA	999 RIVERVIEW DRIVE SUITE 208, TOTOWA, NJ 07512 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	DEC	2016	53	10					7298	7311		10.1007/s12035-015-9583-6			14	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EC1MQ	WOS:000387870200060	26687235	Green Accepted			2022-02-06	
J	Wang, CF; Zhao, CC; Jiang, G; Gu, X; Feng, JF; Jiang, JY				Wang, Chuan-fang; Zhao, Cheng-cheng; Jiang, Gan; Gu, Xiao; Feng, Jun-feng; Jiang, Ji-yao			The Role of Posttraumatic Hypothermia in Preventing Dendrite Degeneration and Spine Loss after Severe Traumatic Brain Injury	SCIENTIFIC REPORTS			English	Article							CONTROLLED CORTICAL IMPACT; NEUROTROPHIC FACTOR BDNF; NMDA RECEPTOR; MODEL; EXPRESSION; MEMORY; SYNAPTOPHYSIN	Posttraumatic hypothermia prevents cell death and promotes functional outcomes after traumatic brain injury (TBI). However, little is known regarding the effect of hypothermia on dendrite degeneration and spine loss after severe TBI. In the present study, we used thy1-GFP transgenic mice to investigate the effect of hypothermia on the dendrites and spines in layer V/VI of the ipsilateral cortex after severe TBI. We found that hypothermia (33 degrees C) dramatically prevented dendrite degeneration and spine loss 1 and 7 days after CCI. The Morris water maze test revealed that hypothermia preserved the learning and memory functions of mice after CCI. Hypothermia significantly increased the expression of the synaptic proteins GluR1 and PSD-95 at 1 and 7 days after CCI in the ipsilateral cortex and hippocampus compared with that of the normothermia TBI group. Hypothermia also increased cortical and hippocampal BDNF levels. These results suggest that posttraumatic hypothermia is an effective method to prevent dendrite degeneration and spine loss and preserve learning and memory function after severe TBI. Increasing cortical and hippocampal BDNF levels might be the mechanism through which hypothermia prevents dendrite degeneration and spine loss and preserves learning and memory function.	[Wang, Chuan-fang; Zhao, Cheng-cheng; Feng, Jun-feng; Jiang, Ji-yao] Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China; [Wang, Chuan-fang; Zhao, Cheng-cheng; Feng, Jun-feng; Jiang, Ji-yao] Shanghai Inst Head Trauma, Shanghai 200127, Peoples R China; [Jiang, Gan; Gu, Xiao] Shanghai Jiao Tong Univ, Sch Med, Inst Med Sci, Dept Pharmacol, Shanghai 200127, Peoples R China		Jiang, JY (corresponding author), Shanghai Jiao Tong Univ, Sch Med, Ren Ji Hosp, Dept Neurosurg, Shanghai 200127, Peoples R China.; Jiang, JY (corresponding author), Shanghai Inst Head Trauma, Shanghai 200127, Peoples R China.	jiyaojiang16@163.com	Jiang, Gan/AAO-2173-2020	Jiang, Gan/0000-0003-2011-741X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [30901543, 31371406, 81471856]; National Key Basic Research ProgramNational Basic Research Program of China [2012CB518100]; Science and Technology Commission of Shanghai MunicipalityScience & Technology Commission of Shanghai Municipality (STCSM) [13ZR1424500]; Shanghai Municipal Health Bureau [XYQ2013094]; SMC-Star Award for Young Scholars	This research was supported by grants from the National Natural Science Foundation of China (30901543, 31371406 and 81471856) and the National Key Basic Research Program (2012CB518100). JFF has also received funding from the Science and Technology Commission of Shanghai Municipality (13ZR1424500), Shanghai Municipal Health Bureau (XYQ2013094) and SMC-Star Award for Young Scholars (B).	Anderson KJ, 2008, J NEUROTRAUM, V25, P1079, DOI 10.1089/neu.2007.0488; BLISS TVP, 1993, NATURE, V361, P31, DOI 10.1038/361031a0; Brazinova A, 2021, J NEUROTRAUM, V38, P1411, DOI 10.1089/neu.2015.4126; Brodhun M, 2001, ACTA NEUROPATHOL, V101, P424; Caldeira MV, 2007, J BIOL CHEM, V282, P12619, DOI 10.1074/jbc.M700607200; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Choi HA, 2012, NAT REV NEUROL, V8, P214, DOI 10.1038/nrneurol.2012.21; Clark RSB, 1996, J CEREBR BLOOD F MET, V16, P253, DOI 10.1097/00004647-199603000-00010; D'Cruz BJ, 2002, J CEREBR BLOOD F MET, V22, P843, DOI 10.1097/00004647-200207000-00009; Goodfellow MJ, 2016, ALCOHOL CLIN EXP RES, V40, P309, DOI 10.1111/acer.12958; Griesbach GS, 2009, BRAIN RES, V1288, P105, DOI 10.1016/j.brainres.2009.06.045; HOLLMANN M, 1994, ANNU REV NEUROSCI, V17, P31, DOI 10.1146/annurev.ne.17.030194.000335; Hu XD, 2011, J NEUROSCI, V31, P15597, DOI 10.1523/JNEUROSCI.2445-11.2011; Irie M, 1997, SCIENCE, V277, P1511, DOI 10.1126/science.277.5331.1511; Jiang JY, 2000, J NEUROSURG, V93, P546, DOI 10.3171/jns.2000.93.4.0546; JIANG JY, 1992, ACTA NEUROPATHOL, V84, P495, DOI 10.1007/BF00304468; Jin YC, 2015, J NEUROTRAUM, V32, P1090, DOI 10.1089/neu.2014.3649; Kennedy BC, 2016, AM J PHYSIOL-REG I, V311, pR166, DOI 10.1152/ajpregu.00066.2016; Koizumi H, 1998, J NEUROSURG, V89, P303, DOI 10.3171/jns.1998.89.2.0303; Kwon SE, 2011, NEURON, V70, P847, DOI 10.1016/j.neuron.2011.04.001; Ma HY, 2012, NEUROCHEM RES, V37, P69, DOI 10.1007/s11064-011-0584-1; Ma M, 2009, EXP NEUROL, V215, P119, DOI 10.1016/j.expneurol.2008.09.024; Meijering E, 2004, CYTOM PART A, V58A, P167, DOI 10.1002/cyto.a.20022; Minichiello L, 2009, NAT REV NEUROSCI, V10, P850, DOI 10.1038/nrn2738; PARDRIDGE WM, 1994, PHARMACEUT RES, V11, P738, DOI 10.1023/A:1018940732550; Park H, 2013, NAT REV NEUROSCI, V14, P7, DOI 10.1038/nrn3379; Popescu C, 2015, J Med Life, V8, P272; Posmantur RM, 1996, J NEUROTRAUM, V13, P125, DOI 10.1089/neu.1996.13.125; Pyeon HJ, 2012, ANAT CELL BIOL, V45, P97, DOI 10.5115/acb.2012.45.2.97; Rao A, 1997, NEURON, V19, P801, DOI 10.1016/S0896-6273(00)80962-9; Rauskolb S, 2010, J NEUROSCI, V30, P1739, DOI 10.1523/JNEUROSCI.5100-09.2010; Rodriguez A, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0001997; Sun MK, 2015, TRENDS PHARMACOL SCI, V36, P384, DOI 10.1016/j.tips.2015.04.004; Tsien JZ, 1996, CELL, V87, P1327, DOI 10.1016/S0092-8674(00)81827-9; Wang T, 2016, MOL NEUROBIOL, V53, P3740, DOI 10.1007/s12035-015-9312-1; Wearne SL, 2005, NEUROSCIENCE, V136, P661, DOI 10.1016/j.neuroscience.2005.05.053; Winston CN, 2016, AM J PATHOL, V186, P552, DOI 10.1016/j.ajpath.2015.11.006; Winston CN, 2013, J NEUROTRAUM, V30, P1966, DOI 10.1089/neu.2013.2960; Zhang HS, 2016, NAT COMMUN, V7, DOI 10.1038/ncomms11773; Zhao S, 2016, MOL NEUROBIOL, V53, P1884, DOI 10.1007/s12035-015-9128-z	40	15	16	3	18	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2045-2322			SCI REP-UK	Sci Rep	NOV 11	2016	6								37063	10.1038/srep37063			12	Multidisciplinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Science & Technology - Other Topics	EB6FM	WOS:000387477000001	27833158	gold, Green Published			2022-02-06	
J	Fraas, MR; Burchiel, J				Fraas, Michael R.; Burchiel, Jessica			A systematic review of education programmes to prevent concussion in rugby union	EUROPEAN JOURNAL OF SPORT SCIENCE			English	Article						Concussion; rugby union; medical management	KNOWLEDGE TRANSFER; PLAYERS; INJURY; INTERVENTION; BOKSMART; NECK	Background: There is a high incidence of concussion sustained by athletes participating in rugby union, many of which go unreported. A lack of sufficient knowledge about concussion injuries may explain athletes' failure to report. Several rugby union-playing countries have developed injury education and prevention programmes to address this issue. Objective: The aim of the current review was to systematically assess the content and level of evidence on concussion education/prevention programmes in rugby union and to make recommendations for the quality, strength, and consistency of this evidence. Methods: We searched PubMed, PsycInfo, MEDLINE, SPORTDiscuss, Webofscience, and conducted a manual search for articles. Results: Ten articles were included for review. Of these, six focused on the BokSmart injury prevention programme in South Africa, two focused on the RugbySmart injury prevention programme in New Zealand, one was an analysis of prevention programmes, and one was a systematic review of rugby injury prevention strategies. Conclusions: Despite the initiative to develop concussion education and prevention programmes, there is little evidence to support the effectiveness of such programmes. There is evidence to support education of coaches and referees. In addition, there is scant evidence to suggest that education and rule changes may have the benefit of changing athlete behaviours resulting in a reduction in catastrophic injury.	[Fraas, Michael R.; Burchiel, Jessica] Western Washington Univ, Dept Commun Sci & Disorders, 516 High St, Bellingham, WA 98225 USA		Fraas, MR (corresponding author), Western Washington Univ, Dept Commun Sci & Disorders, 516 High St, Bellingham, WA 98225 USA.	michael.fraas@wwu.edu					Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Bathgate A, 2002, BRIT J SPORT MED, V36, P265, DOI 10.1136/bjsm.36.4.265; Bird YN, 1998, BRIT J SPORT MED, V32, P319, DOI 10.1136/bjsm.32.4.319; Boffano P, 2011, J CRANIOFAC SURG, V22, P2053, DOI 10.1097/SCS.0b013e318231988d; Broglio SP, 2010, J SPORT SCI MED, V9, P418; Brown J, 2011, S AFR SPORTS MED, V23, P62; Brown JC, 2015, INJURY PREV, V21, P173, DOI 10.1136/injuryprev-2014-041326; Chalmers DJ, 2004, J SCI MED SPORT, V7, P74, DOI 10.1016/S1440-2440(04)80046-X; Cusimano MD, 2010, NEUROSURGERY, V67, P1404, DOI 10.1227/NEU.0b013e3181f209f1; Ebell M. H., 2004, AM FAM PHYSICIAN, V69, P448; Fraas MR, 2015, IRISH J MED SCI, V184, P425, DOI 10.1007/s11845-014-1137-9; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Freitag A, 2015, BMJ-BRIT MED J, V350, DOI 10.1136/bmj.h1587; Gardner AJ, 2014, SPORTS MED, V44, P1717, DOI 10.1007/s40279-014-0233-3; Gianotti S, 2008, BRIT J SPORT MED, V42, P427, DOI 10.1136/bjsm.2008.046987; Gianotti S, 2007, NEUROREHABILITATION, V22, P181; Gianotti SM, 2009, J SCI MED SPORT, V12, P371, DOI 10.1016/j.jsams.2008.01.002; IRB, 2010, LAWS GAM RUGB UN 201; Lambert M., 2013, S AFR J SPORTS MED, V25, P38, DOI [10.7196/sajsm.493, DOI 10.7196/SAJSM.493]; Marshall SW, 2001, J ATHL TRAINING, V36, P334; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; Provvidenza CF, 2009, BRIT J SPORT MED, V43, pI68, DOI 10.1136/bjsm.2009.058180; Provvidenza C, 2013, BRIT J SPORT MED, V47, P332, DOI 10.1136/bjsports-2012-092099; Quarrie KL, 2007, BRIT MED J, V334, P1150, DOI 10.1136/bmj.39185.605914.AE; Shamseer L, 2015, BMJ-BRIT MED J, V349, DOI [10.1136/bmj.g7647, 10.1016/j.ijsu.2010.02.007, 10.1186/2046-4053-4-1, 10.1136/bmj.i4086]; Sye G, 2006, BRIT J SPORT MED, V40, P1003, DOI 10.1136/bjsm.2005.020511; Tommasone BA, 2006, J ATHL TRAINING, V41, P470; VANMECHELEN W, 1992, SPORTS MED, V14, P82, DOI 10.2165/00007256-199214020-00002; Viljoen W, 2012, BRIT J SPORT MED, V46, P692, DOI 10.1136/bjsports-2012-091278; Viljoen W., 2008, S AFR J SPORTS MED, V20, P64, DOI [10.17159/2078-516X/2008/v20i3a633, DOI 10.17159/2078-516X/2008/V20I3A633]	31	15	16	0	46	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	1746-1391	1536-7290		EUR J SPORT SCI	Eur. J. Sport Sci.	NOV	2016	16	8					1212	1218		10.1080/17461391.2016.1170207			7	Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Sport Sciences	DV4JG	WOS:000382891300041	27063067				2022-02-06	
J	Merritt, VC; Ukueberuwa, DM; Arnett, PA				Merritt, Victoria C.; Ukueberuwa, Dede M.; Arnett, Peter A.			Relationship between the apolipoprotein E gene and headache following sports-related concussion	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Apolipoprotein E gene; Genetics; Mild traumatic brain injury; Headache; Collegiate athletes	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC HEADACHE; ALZHEIMERS-DISEASE; FOOTBALL PLAYERS; RISK-FACTORS; E EPSILON-4; SEVERITY; EPIDEMIOLOGY; MANAGEMENT; MECHANISM	Introduction: Headache is one of the most commonly reported and longest lasting symptoms that concussed athletes report, yet the etiology of headache symptoms following concussion is not entirely clear. The purpose of this study was to determine whether the e4 allele of the apolipoprotein E (APOE) gene influences the presence and severity of postconcussion headache. Method: Participants were composed of 45 concussed athletes and 43 healthy/nonconcussed athletes who were involved in a clinically based sports concussion management program. All athletes completed the Post-Concussion Symptom Scale (PCSS). The headache symptom from the PCSS was the primary outcome variable. Buccal samples were collected and analyzed to determine APOE genotype. Results: A significantly greater proportion of concussed e4+ athletes than e4- athletes endorsed headache. Furthermore, concussed e4+ athletes endorsed more severe headaches than e4- athletes. When examining the healthy/nonconcussed sample (i.e., athletes at baseline), results showed no differences between e4 allele groups with respect to the presence and severity of headache. Conclusions: These findings show that when compared to concussed e4- athletes, e4+ athletes are more likely to (a) endorse postconcussion headache and (b) report more severe headache symptoms following concussion. Conversely, it appears that the e4 allele does not influence baseline reports of headache. Thus, results suggest that those with the e4 genotype may be at a higher risk for experiencing headache-related difficulties only after a concussion is sustained.	[Merritt, Victoria C.; Ukueberuwa, Dede M.; Arnett, Peter A.] Penn State Univ, Dept Psychol, 372 Moore Bldg, University Pk, PA 16802 USA		Merritt, VC (corresponding author), Penn State Univ, Dept Psychol, 372 Moore Bldg, University Pk, PA 16802 USA.	vca106@psu.edu		Merritt, Victoria/0000-0001-5683-4168	American Psychological Foundation	The research described in this manuscript was supported by a grant to the first author from the American Psychological Foundation.	Ariza M, 2006, J NEUROL NEUROSUR PS, V77, P1191, DOI 10.1136/jnnp.2005.085167; Barth JT, 1989, MILD HEAD INJURY SPO; Chamelian L, 2004, BRAIN, V127, P2621, DOI 10.1093/brain/awh296; Christensen Helen, 2008, BMC Geriatr, V8, P14, DOI 10.1186/1471-2318-8-14; Conidi FX, 2012, HEADACHE, V52, P15, DOI 10.1111/j.1526-4610.2012.02138.x; Crystal SC, 2010, CURR PAIN HEADACHE R, V14, P449, DOI 10.1007/s11916-010-0146-2; Dardiotis E, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09215; Erlanger D, 2003, J NEUROSURG, V98, P477, DOI 10.3171/jns.2003.98.3.0477; Finnoff JT, 2011, PM&R, V3, pS452, DOI 10.1016/j.pmrj.2011.07.014; Freeman B, 2003, BEHAV GENET, V33, P67, DOI 10.1023/A:1021055617738; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gupta R, 2009, J HEADACHE PAIN, V10, P115, DOI 10.1007/s10194-008-0094-y; Guskiewicz KM, 2000, AM J SPORT MED, V28, P643, DOI 10.1177/03635465000280050401; Han SD, 2007, J NEUROL NEUROSUR PS, V78, P1103, DOI 10.1136/jnnp.2006.108183; Ingelsson M, 2003, CURR PROTOC HUM GENE, V38, P1; Jordan BD, 2007, NEUROCHEM RES, V32, P905, DOI 10.1007/s11064-006-9251-3; Kontos AP, 2012, AM J SPORT MED, V40, P2375, DOI 10.1177/0363546512455400; Kutner KC, 2000, NEUROSURGERY, V47, P651, DOI 10.1097/00006123-200009000-00026; Liberman JN, 2002, NEUROLOGY, V58, P1038, DOI 10.1212/WNL.58.7.1038; Lovell M, 2000, IMPACT IMMEDIATE POS; Lovell MR, 2006, APPL NEUROPSYCHOL, V13, P166, DOI 10.1207/s15324826an1303_4; Mahley RW, 2006, P NATL ACAD SCI USA, V103, P5644, DOI 10.1073/pnas.0600549103; Makdissi M, 2010, AM J SPORT MED, V38, P464, DOI 10.1177/0363546509349491; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer CL, 2013, HEADACHE, V53, P1523, DOI 10.1111/head.12173; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2010, AM J SPORT MED, V38, P2405, DOI 10.1177/0363546510376737; Merritt VC, 2016, J INT NEUROPSYCH SOC, V22, P89, DOI 10.1017/S1355617715001022; Merritt VC, 2015, J CLIN EXP NEUROPSYC, V37, P265, DOI 10.1080/13803395.2015.1004303; Packard Russell C, 2005, Curr Pain Headache Rep, V9, P59, DOI 10.1007/s11916-005-0076-6; Pardini D., 2004, BR J SPORTS MED, V38, P661; Pizza Vincenzo, 2012, Open Neurol J, V6, P65, DOI 10.2174/1874205X01206010065; Rainero I, 2002, NEUROSCI LETT, V317, P111, DOI 10.1016/S0304-3940(01)02432-6; Ramadan Nabih M, 2004, Curr Pain Headache Rep, V8, P301, DOI 10.1007/s11916-004-0012-1; Rihn BH, 2009, CLIN EXP MED, V9, P61, DOI 10.1007/s10238-008-0012-2; Roses AD, 1996, ANNU REV MED, V47, P387, DOI 10.1146/annurev.med.47.1.387; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Sabin MJ, 2011, CLIN J SPORT MED, V21, P411, DOI 10.1097/JSM.0b013e318223f3a4; Seifert TD, 2013, HEADACHE, V53, P726, DOI 10.1111/head.12087; Seifert TD, 2010, CURR PAIN HEADACHE R, V14, P292, DOI 10.1007/s11916-010-0117-7; Silver JM, 2011, TXB TRAUMATIC BRAIN, VSecond; Sundstrom A, 2004, NEUROLOGY, V62, P1963, DOI 10.1212/01.WNL.0000129268.83927.A8	43	15	15	0	81	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	NOV	2016	38	9					941	949		10.1080/13803395.2016.1177491			9	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DT6FA	WOS:000381577900001	27191930				2022-02-06	
J	Du, LN; Empey, PE; Ji, J; Chao, HL; Kochanek, PM; Bayir, H; Clark, RSB				Du, Lina; Empey, Philip E.; Ji, Jing; Chao, Honglu; Kochanek, Patrick M.; Bayir, Hulya; Clark, Robert S. B.			Probenecid and N-Acetylcysteine Prevent Loss of Intracellular Glutathione and Inhibit Neuronal Death after Mechanical Stretch Injury In Vitro	JOURNAL OF NEUROTRAUMA			English	Article						adenosine triphosphate binding cassette transporter C1; gender; multidrug resistance associated protein 1; primary cortical neurons; spinal cord injury; traumatic brain injury	TRAUMATIC BRAIN-INJURY; CORTICAL-NEURONS; MICE; NEUROPROTECTION; APOPTOSIS; INFLAMMASOME; TRANSPORTER; PROTECTS; DAMAGE; RATS	Probenecid and N-acetylcysteine (NAC) can preserve intracellular levels of the vital antioxidant glutathione (GSH) via two distinct biochemical pathways. Probenecid inhibits transporter-mediated GSH efflux and NAC serves as a cysteine donor for GSH synthesis. We hypothesized that probenecid and NAC alone would maintain intracellular GSH concentrations and inhibit neuronal death after traumatic stretch injury, and that the drugs in combination would produce additive effects. Sex-segregated rat primary cortical neurons were treated with probenecid (100M) and NAC (50M), alone and in combination (Pro-NAC), then subjected to mechanical stretch (10s(-1) strain rate, 50% membrane deformation). At 24h, both probenecid and NAC inhibited trauma-induced intracellular GSH depletion, lactate dehydrogenase (LDH) release, and propidium iodide (PI) uptake in both XY- and XX-neurons. Combined Pro-NAC treatment was superior to probenecid or NAC alone in maintenance of intracellular GSH and neuronal death assessed by PI uptake. Interestingly, caspase 3 activity 24h after mechanical trauma was more prominent in XX-neurons, and treatment effects (probenecid, NAC, and Pro-NAC) were observed in XX- but not XY-neurons; however, XY-neurons were ultimately more vulnerable to mechanical stretch-induced injury than their XX counterparts, as was evidenced by more neuronal death detected by LDH release and PI uptake. In addition, after stretch injury in HT22 hippocampal cells, both NAC and probenecid were highly effective at reducing oxidative stress detected by dichlorofluorescein fluorescence. These in vitro data support further testing of this drug combination in models of traumatic neuronal injury in vivo.	[Du, Lina; Ji, Jing; Chao, Honglu; Kochanek, Patrick M.; Bayir, Hulya; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Crit Care Med, Pittsburgh, PA USA; [Kochanek, Patrick M.; Bayir, Hulya; Clark, Robert S. B.] Univ Pittsburgh, Sch Med, Dept Pediat, Pittsburgh, PA 15261 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Sch Med, Dept Anesthesiol, Pittsburgh, PA USA; [Empey, Philip E.] Univ Pittsburgh, Sch Med, Clin & Translat Sci Inst, Pittsburgh, PA USA; [Empey, Philip E.; Clark, Robert S. B.] Univ Pittsburgh, Sch Pharm, Dept Pharm & Therapeut, Pittsburgh, PA 15261 USA; [Ji, Jing] Nanjing Med Univ, Dept Neurosurg, Affiliated Hosp 1, Nanjing, Jiangsu, Peoples R China; [Kochanek, Patrick M.; Bayir, Hulya; Clark, Robert S. B.] Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Kochanek, Patrick M.; Bayir, Hulya; Clark, Robert S. B.] Childrens Hosp Pittsburgh UPMC, Pittsburgh, PA USA; [Bayir, Hulya] Univ Pittsburgh, Ctr Free Radical & Antioxidant Hlth, Dept Environm & Occupat Hlth, Pittsburgh, PA USA		Clark, RSB (corresponding author), Childrens Hosp Pittsburgh, 4401 Penn Ave, Pittsburgh, PA 15224 USA.	clarkrs@ccm.upmc.edu	Empey, Philip/L-9604-2019	Empey, Philip/0000-0001-7474-2339			Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Baki SGA, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012490; BOGER WP, 1950, J LAB CLIN MED, V36, P276; BREWER GJ, 1995, J NEUROSCI RES, V42, P674, DOI 10.1002/jnr.490420510; Cole SPC, 2014, J BIOL CHEM, V289, P30880, DOI 10.1074/jbc.R114.609248; Decory HH, 2001, DRUG METAB DISPOS, V29, P1256; Du L, 2009, J BIOL CHEM, V284, P2383, DOI 10.1074/jbc.M804396200; Du LN, 2004, J BIOL CHEM, V279, P38563, DOI 10.1074/jbc.M405461200; Eakin K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090617; FRISK AR, 1952, SCAND J CLIN LAB INV, V4, P83, DOI 10.3109/00365515209060641; Guo J, 2015, MOL MED REP, V12, P37, DOI 10.3892/mmr.2015.3390; Hammond CL, 2007, J BIOL CHEM, V282, P14337, DOI 10.1074/jbc.M611019200; Hoffer ME, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0054163, 10.1371/journal.pone.0060061]; Ji J, 2012, NAT NEUROSCI, V15, P1407, DOI 10.1038/nn.3195; Ji J, 2012, J NEUROTRAUM, V29, P776, DOI 10.1089/neu.2010.1602; Kanter MZ, 2006, AM J HEALTH-SYST PH, V63, P1821, DOI 10.2146/ajhp060050; Karalija A, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0041086; Lai YC, 2008, J CEREBR BLOOD F MET, V28, P540, DOI 10.1038/sj.jcbfm.9600551; Naziroglu M, 2013, NEUROSCIENCE, V242, P151, DOI 10.1016/j.neuroscience.2013.03.032; Naziroglu M, 2014, CELL MOL NEUROBIOL, V34, P895, DOI 10.1007/s10571-014-0069-2; Nigam SK, 2015, PHYSIOL REV, V95, P83, DOI 10.1152/physrev.00025.2013; Pandya JD, 2014, EXP NEUROL, V257, P106, DOI 10.1016/j.expneurol.2014.04.020; Samuni Y, 2013, BBA-GEN SUBJECTS, V1830, P4117, DOI 10.1016/j.bbagen.2013.04.016; Silverman WR, 2009, J BIOL CHEM, V284, P18143, DOI 10.1074/jbc.M109.004804; Smith DH, 1999, J NEUROSCI, V19, P4263; Sun HY, 2001, PHARM RES-DORDR, V18, P1542, DOI 10.1023/A:1013074229576; Vanden Berghe T, 2014, NAT REV MOL CELL BIO, V15, P134, DOI 10.1038/nrm3737; Wei R, 2015, NEUROSCIENCE, V301, P168, DOI 10.1016/j.neuroscience.2015.05.070; Willyerd FA, 2016, J NEUROTRAUM, V33, P226, DOI 10.1089/neu.2015.3879; Xiong XX, 2014, NEUROCHEM RES, V39, P216, DOI 10.1007/s11064-013-1212-z; Xiong Y, 1999, J NEUROTRAUM, V16, P1067, DOI 10.1089/neu.1999.16.1067	31	15	15	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2016	33	20					1913	1917		10.1089/neu.2015.4342			5	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EA6YO	WOS:000386775300011	26830358	Green Published			2022-02-06	
J	Effgen, GB; Ong, T; Nammalwar, S; Ortuno, AI; Meaney, DF; Bass, CRD; Morrison, B				Effgen, Gwen B.; Ong, Tiffany; Nammalwar, Shruthi; Ortuno, Andrea I.; Meaney, David F.; Bass, Cameron R.Dale; Morrison, Barclay, III			Primary Blast Exposure Increases Hippocampal Vulnerability to Subsequent Exposure: Reducing Long-Term Potentiation	JOURNAL OF NEUROTRAUMA			English	Article						blast; brain; glia neuron; plasticity	TRAUMATIC BRAIN-INJURY; FLUID PERCUSSION INJURY; ADULT-RAT BRAIN; IN-VITRO MODEL; COGNITIVE IMPAIRMENT; AXONAL INJURY; CELL-DEATH; RECURRENT CONCUSSION; SYNAPTIC PLASTICITY; MICROGLIAL CELLS	Up to 80% of injuries sustained by U.S. soldiers in Operation Enduring Freedom and Operation Iraqi Freedom were the result of blast exposure from improvised explosive devices. Some soldiers experience multiple blasts while on duty, and it has been suggested that symptoms of repetitive blast are similar to those that follow multiple non-blast concussions, such as sport-related concussion. Despite the interest in the effects of repetitive blast exposure, it remains unknown whether an initial blast renders the brain more vulnerable to subsequent exposure, resulting in a synergistic injury response. To investigate the effect of multiple primary blasts on the brain, organotypic hippocampal slice cultures were exposed to single or repetitive (two or three total) primary blasts of varying intensities. Long-term potentiation was significantly reduced following two Level 2 (92.7kPa, 1.4msec, 38.5kPa<bold>msec</bold>) blasts delivered 24h apart without altering basal evoked response. This deficit persisted when the interval between injuries was increased to 72h but not when the interval was extended to 144h. The repeated blast exposure with a 24h interval increased microglia staining and activation significantly but did not significantly increase cell death or damage axons, dendrites, or principal cell layers. Lack of overt structural damage and change in basal stimulated neuron response suggest that injury from repetitive primary blast exposure may specifically affect long-term potentiation. Our studies suggest repetitive primary blasts can exacerbate injury dependent on the injury severity and interval between exposures.	[Effgen, Gwen B.; Ong, Tiffany; Nammalwar, Shruthi; Ortuno, Andrea I.; Morrison, Barclay, III] Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904 1210 Amsterdam Ave, New York, NY 10027 USA; [Meaney, David F.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA; [Bass, Cameron R.Dale] Duke Univ, Dept Biomed Engn, Durham, NC 27706 USA		Morrison, B (corresponding author), Columbia Univ, Dept Biomed Engn, 351 Engn Terrace,MC 8904 1210 Amsterdam Ave, New York, NY 10027 USA.	bm2119@columbia.edu	Morrison, Barclay/B-7132-2008	Morrison, Barclay/0000-0001-7676-0864; Meaney, David/0000-0002-0954-4122	NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS088176] Funding Source: NIH RePORTER; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS088176] Funding Source: Medline		Ahlers Stephen Thomas, 2012, Front Neurol, V3, P32, DOI 10.3389/fneur.2012.00032; Ahmed FA, 2013, ELECTROPHORESIS, V34, P2229, DOI 10.1002/elps.201300077; Albensi BC, 2001, J NEUROSCI RES, V65, P279, DOI 10.1002/jnr.1151; Appelboom G, 2012, ACTA NEUROCHIR, V154, P131, DOI 10.1007/s00701-011-1210-3; Arun P, 2012, NEUROREPORT, V23, P342, DOI 10.1097/WNR.0b013e328351b58d; Arun P, 2011, NEUROREPORT, V22, P379, DOI 10.1097/WNR.0b013e328346b138; Aungst S. L., 2014, J CEREB BLOOD FLOW M, P1223; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Browne KD, 2011, J NEUROTRAUM, V28, P1747, DOI 10.1089/neu.2011.1913; Cater HL, 2006, J BIOMECH, V39, P2810, DOI 10.1016/j.jbiomech.2005.09.023; Centers for Disease Control and Prevention, 2009, BLAST INJ TRAUM BRAI; CLEMEDSON CJ, 1956, AM J PHYSIOL, V184, P119, DOI 10.1152/ajplegacy.1955.184.1.119; Creeley CE, 2004, ACAD EMERG MED, V11, P809, DOI 10.1197/j.aem.2004.03.006; Czapiga M, 1999, J NEUROSCI RES, V56, P644, DOI 10.1002/(SICI)1097-4547(19990615)56:6<644::AID-JNR10>3.0.CO;2-9; De Monte VE, 2005, J CLIN EXP NEUROPSYC, V27, P224, DOI 10.1080/13803390490515766; DeFord SM, 2002, J NEUROTRAUM, V19, P427, DOI 10.1089/08977150252932389; DeKosky ST, 2010, NEW ENGL J MED, V363, P1293, DOI 10.1056/NEJMp1007051; DeRoss AL, 2002, J TRAUMA, V52, P708, DOI 10.1097/00005373-200204000-00017; Effgen G. B., 2012, 2012 INT IRCOBI C BI; Effgen GB, 2014, J NEUROTRAUM, V31, P1202, DOI 10.1089/neu.2013.3227; Effgen Gwen B, 2012, Front Neurol, V3, P23, DOI 10.3389/fneur.2012.00023; Elder GA, 2009, MT SINAI J MED, V76, P111, DOI 10.1002/msj.20098; Evilsizor M. N., 2015, BRAIN NEUROTRAUMA MO, P9; Faul M, 2010, TRAUMATIC BRAIN INJU; Friess SH, 2009, J NEUROTRAUM, V26, P1111, DOI [10.1089/neu.2008.0845, 10.1089/neu.2008-0845]; Girard J, 1996, EUR J PHARMACOL, V300, P43, DOI 10.1016/0014-2999(95)00804-7; Giza CC, 2001, J ATHL TRAINING, V36, P228; Giza CC, 2006, DEV NEUROSCI-BASEL, V28, P364, DOI 10.1159/000094163; Goldstein LE, 2012, SCI TRANSL MED, V4, DOI 10.1126/scitranslmed.3003716; Gullotti DM, 2014, J BIOMECH ENG-T ASME, V136, DOI 10.1115/1.4027873; Gurkoff GG, 2006, BRAIN RES, V1077, P24, DOI 10.1016/j.brainres.2006.01.011; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Hailer NP, 1996, GLIA, V18, P319, DOI 10.1002/(SICI)1098-1136(199612)18:4<319::AID-GLIA6>3.0.CO;2-S; Hannah Fischer, 2015, GUIDE US MILITARY CA; Hicks RR, 2010, J TRAUMA, V68, P1257, DOI 10.1097/TA.0b013e3181d8956d; Hue C. D., 2015, J NEUROTRAUMA; Huh JW, 2007, J NEUROTRAUM, V24, P15, DOI 10.1089/neu.2006.0072; Kane MJ, 2011, BRAIN RES, V1425, P123, DOI 10.1016/j.brainres.2011.09.047; Kang WH, 2015, BIOMECH MODEL MECHAN, V14, P561, DOI 10.1007/s10237-014-0622-4; KAUR C, 1995, NEUROPATH APPL NEURO, V21, P369, DOI 10.1111/j.1365-2990.1995.tb01073.x; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Leonardi AD, 2012, J BIOMECH, V45, P2595, DOI 10.1016/j.jbiomech.2012.08.024; Longhi L, 2005, NEUROSURGERY, V56, P364, DOI 10.1227/01.NEU.0000149008.73513.44; LYETH BG, 1990, BRAIN RES, V526, P249, DOI 10.1016/0006-8993(90)91229-A; Matser JT, 1998, NEUROLOGY, V51, P791, DOI 10.1212/WNL.51.3.791; McCrea M, 2005, J INT NEUROPSYCH SOC, V11, P58, DOI 10.1017/S1355617705050083; MIYAZAKI S, 1992, BRAIN RES, V585, P335, DOI 10.1016/0006-8993(92)91232-4; Morrison B, 2006, J NEUROSCI METH, V150, P192, DOI 10.1016/j.jneumeth.2005.06.014; Nimmerjahn A, 2005, SCIENCE, V308, P1314, DOI 10.1126/science.1110647; Panizzon KL, 1996, NEUROREPORT, V7, P662, DOI 10.1097/00001756-199601310-00067; Panizzon KL, 1998, NEUROREPORT, V9, P4131, DOI 10.1097/00001756-199812210-00024; Panzer Matthew B, 2012, Front Neurol, V3, P46, DOI 10.3389/fneur.2012.00046; Perez-Pena R., 2015, NY TIMES; Prins ML, 2013, J NEUROTRAUM, V30, P30, DOI 10.1089/neu.2012.2399; Rafaels K., 2015, J NEUROTRAUM, p[28, 2319]; Rafaels KA, 2012, J TRAUMA ACUTE CARE, V73, P895, DOI 10.1097/TA.0b013e31825a760e; Raghupathi R, 2004, J NEUROTRAUM, V21, P307, DOI 10.1089/089771504322972095; Readnower RD, 2010, J NEUROSCI RES, V88, P3530, DOI 10.1002/jnr.22510; Ryu J, 2014, ACTA NEUROPATHOL COM, V2, DOI 10.1186/s40478-014-0153-3; Sajja VSSS, 2014, NEUROSCI LETT, V570, P33, DOI 10.1016/j.neulet.2014.03.072; Saljo A, 2002, J NEUROTRAUM, V19, P985, DOI 10.1089/089771502320317131; Saljo A, 2000, J NEUROTRAUM, V17, P719, DOI 10.1089/089771500415454; Saljo Annette, 2001, Pathophysiology, V8, P105, DOI 10.1016/S0928-4680(01)00067-0; Sanders MJ, 2000, BRAIN RES, V861, P69, DOI 10.1016/S0006-8993(00)01986-7; Schafer DP, 2015, CSH PERSPECT BIOL, V7, DOI 10.1101/cshperspect.a020545; Shultz SR, 2012, J NEUROTRAUM, V29, P281, DOI 10.1089/neu.2011.2123; Signoretti S, 2011, PM&R, V3, pS359, DOI 10.1016/j.pmrj.2011.07.018; Slemmer JE, 2005, NEUROBIOL DIS, V18, P421, DOI 10.1016/j.nbd.2004.09.022; Slemmer JE, 2002, BRAIN, V125, P2699, DOI 10.1093/brain/awf271; Tate CM, 2013, J NEUROTRAUM, V30, P1620, DOI 10.1089/neu.2012.2683; Tremblay ME, 2011, J NEUROSCI, V31, P16064, DOI 10.1523/JNEUROSCI.4158-11.2011; U. S. Dept of the Army F-22, 2007, INF RIFL PLAT SQUAD; Uryu K, 2002, J NEUROSCI, V22, P446, DOI 10.1523/JNEUROSCI.22-02-00446.2002; Viano DC, 2009, NEUROSURGERY, V64, P1162, DOI 10.1227/01.NEU.0000345863.99099.C7; Vogel III E. W., 2015, J NEUROTRAUMA; Wake H, 2009, J NEUROSCI, V29, P3974, DOI 10.1523/JNEUROSCI.4363-08.2009; Wallis RA, 1996, BRAIN RES, V710, P169, DOI 10.1016/0006-8993(95)01278-8; Wallis RA, 1995, EUR J PHARMACOL, V294, P475, DOI 10.1016/0014-2999(95)00568-4; Wang Y, 2011, J NEUROTRAUM, V28, P2171, DOI 10.1089/neu.2011.1990; Xing GQ, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00196; Yin TC, 2014, CELL REP, V8, P1731, DOI 10.1016/j.celrep.2014.08.030; Yu GX, 2011, SURGERY, V150, P887, DOI 10.1016/j.surg.2011.04.002; Yu Z, 2009, IEEE ENG MED BIO, P1135; Yuste R, 2001, ANNU REV NEUROSCI, V24, P1071, DOI 10.1146/annurev.neuro.24.1.1071; Zoroya G, 2015, US TODAY	86	15	15	0	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2016	33	20					1901	1912		10.1089/neu.2015.4327			12	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EA6YO	WOS:000386775300010	26699926	Green Published			2022-02-06	
J	Tweedie, D; Rachmany, L; Kim, DS; Rubovitch, V; Lehrmann, E; Zhang, YQ; Becker, KG; Perez, E; Pick, CG; Greig, NH				Tweedie, David; Rachmany, Lital; Kim, Dong Seok; Rubovitch, Vardit; Lehrmann, Elin; Zhang, Yongqing; Becker, Kevin G.; Perez, Evelyn; Pick, Chaim G.; Greig, Nigel H.			Mild traumatic brain injury-induced hippocampal gene expressions: The identification of target cellular processes for drug development	JOURNAL OF NEUROSCIENCE METHODS			English	Article						Mild traumatic brain injury (mTBI); Gene expression; Gene ontology; Molecular pathway; Inflammation; Neurological; Neurodegeneration; Dementia	GLUCAGON-LIKE PEPTIDE-1; REVERSES BEHAVIORAL IMPAIRMENTS; RECEPTOR AGONIST; HEAD-INJURY; DONEPEZIL; ALZHEIMERS; EXENDIN-4; DEATH; NEURODEGENERATION; NEURONS	Background: Neurological dysfunction after traumatic brain injury (TBI) poses short-term or long-lasting health issues for family members and health care providers. Presently there are no approved medicines to treat TBI. Epidemiological evidence suggests that TBI may cause neurodegenerative disease later in life. In an effort to illuminate target cellular processes for drug development, we examined the effects of a mild TBI on hippocampal gene expression in mouse. Methods: mTBI was induced in a closed head, weight drop-system in mice (ICR). Animals were anesthetized and subjected to mTBI (30 g). Fourteen days after injury the ipsilateral hippocampus was utilized for cDNA gene array studies. mTBI animals were compared with sham-operated animals. Genes regulated by TBI were identified to define TBI-induced physiological/pathological processes. mTBI regulated genes were divided into functional groupings to provide gene ontologies. Genes were further divided to identify molecular/cellular pathways regulated by mTBI. Results: Numerous genes were regulated after a single mTBI event that mapped to many ontologies and molecular pathways related to inflammation and neurological physiology/pathology, including neurodegenerative disease. Conclusions: These data illustrate diverse transcriptional changes in hippocampal tissues triggered by a single mild injury. The systematic analysis of individual genes that lead to the identification of functional categories, such as gene ontologies and then molecular pathways, illustrate target processes of relevance to TBI pathology. These processes may be further dissected to identify key factors that can be evaluated at the protein level to highlight possible treatments for TBI in human disease and potential biomarkers of neurodegenerative processes. Published by Elsevier B.V.	[Tweedie, David; Kim, Dong Seok; Greig, Nigel H.] NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Rachmany, Lital; Rubovitch, Vardit; Pick, Chaim G.] Tel Aviv Univ, Sackler Sch Med, Dept Anat & Anthropol, IL-69978 Tel Aviv, Israel; [Pick, Chaim G.] Tel Aviv Univ, Sagol Sch Neurosci, IL-69978 Tel Aviv, Israel; [Kim, Dong Seok] Peptron Inc, 37-24 Yuseong Daero,1628 Beon Gil, Daejeon 305811, South Korea; [Lehrmann, Elin; Zhang, Yongqing; Becker, Kevin G.] NIA, Genet Lab, Intramural Res Program, NIH, Baltimore, MD 21224 USA; [Perez, Evelyn] NIA, Lab Behav Neurosci, Intramural Res Program, NIH, Baltimore, MD 21224 USA		Tweedie, D (corresponding author), NIA, Translat Gerontol Branch, Intramural Res Program, NIH, Baltimore, MD 21224 USA.	tweedieda@grc.nia.nih.gov		Lehrmann, Elin/0000-0002-9869-9475	Intramural Research Program of the National Institute on Aging, National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA); Sackler School of Medicine, Tel-Aviv University; Ari and Regine Aprijaskis Fund at Tel-Aviv University; Israel Science FoundationIsrael Science Foundation [108/09]; Joseph Sagol fellowships; National Science Council of TaiwanMinistry of Science and Technology, Taiwan; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [ZIAAG000333, ZICAG000616, ZIAAG000311] Funding Source: NIH RePORTER	This research was supported in part by (i) the Intramural Research Program of the National Institute on Aging, National Institutes of Health, (ii) the Sackler School of Medicine, Tel-Aviv University, (iii) the Ari and Regine Aprijaskis Fund at Tel-Aviv University, (iv) a grant from the Israel Science Foundation, grant number 108/09, (v) and the Joseph Sagol fellowships and (vi) the National Science Council of Taiwan. This work was performed in partial fulfillment of the requirements for a Ph.D. degree of Lital Rachmany, Sackler Faculty of Medicine, Tel Aviv University, Israel. None of the authors have competing interests in the manuscript.	Azevedo FAC, 2009, J COMP NEUROL, V513, P532, DOI 10.1002/cne.21974; Ballesteros J, 2008, J HEAD TRAUMA REHAB, V23, P171, DOI 10.1097/01.HTR.0000319935.99837.96; Baratz R, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0237-4; Baratz R, 2011, J NEUROCHEM, V118, P1032, DOI 10.1111/j.1471-4159.2011.07377.x; Barkhoudarian G, 2011, CLIN SPORT MED, V30, P33, DOI 10.1016/j.csm.2010.09.001; Barnes DE, 2014, NEUROLOGY, V83, P312, DOI 10.1212/WNL.0000000000000616; Becker RE, 2015, LANCET PSYCHIAT, V2, P756, DOI 10.1016/S2215-0366(15)00214-X; Becker RE, 2014, NAT REV DRUG DISCOV, V13, P157, DOI 10.1038/nrd3842-c2; Becker RE, 2010, SCI TRANSL MED, V2, DOI 10.1126/scitranslmed.3000446; Bergold PJ, 2015, EXP NEUROL, V2, P3; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; CHOI DW, 1987, J NEUROSCI, V7, P357; Cornelius C, 2013, ANTIOXID REDOX SIGN, V19, P836, DOI 10.1089/ars.2012.4981; Daneshvar DH, 2015, MOL CELL NEUROSCI, V66, P81, DOI 10.1016/j.mcn.2015.03.007; Ding J, 2015, ARQ NEURO-PSIQUIAT, V73, P342, DOI 10.1590/0004-282X20150006; Eakin K, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082016; Edut S, 2011, PSYCHOPHARMACOLOGY, V214, P877, DOI 10.1007/s00213-010-2098-y; Faul M, 2010, TRAUMATIC BRAIN INJU; Fujiki M, 2008, J CLIN NEUROSCI, V15, P791, DOI 10.1016/j.jocn.2007.07.002; Gomez PA, 2014, J NEUROSURG, V121, P1314, DOI 10.3171/2014.7.JNS131874; Greig NH, 2014, ALZHEIMERS DEMENT, V10, pS62, DOI 10.1016/j.jalz.2013.12.011; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Gry M, 2009, BMC GENOMICS, V10, DOI 10.1186/1471-2164-10-365; Gupta R, 2015, REV NEUROSCI; Gyorgy AB, 2010, J NEUROSCI METH, V192, P96, DOI 10.1016/j.jneumeth.2010.07.029; Harris NG, 2009, J NEUROSCI RES, V87, P2937, DOI 10.1002/jnr.22115; Holscher C, 2014, BIOCHEM SOC T, V42, P593, DOI 10.1042/BST20140016; Ikonomidou C, 2000, P NATL ACAD SCI USA, V97, P12885, DOI 10.1073/pnas.220412197; Israelsson C, 2008, J NEUROTRAUM, V25, P959, DOI 10.1089/neu.2008.0562; Israelsson C, 2009, J NEUROTRAUM, V26, P1307, DOI [10.1089/neu.2008.0676, 10.1089/neu.2008-0676]; Kabadi SV, 2012, J CEREBR BLOOD F MET, V32, P137, DOI 10.1038/jcbfm.2011.117; Kim SY, 2005, BMC BIOINFORMATICS, V6, DOI 10.1186/1471-2105-6-144; Kondo A, 2015, NATURE, V523, P431, DOI 10.1038/nature14658; Korley FK, 2015, J HEAD TRAUMA REHABI; Kovesdi Erzsebet, 2012, Front Neurol, V3, P111, DOI 10.3389/fneur.2012.00111; Lent R, 2012, EUR J NEUROSCI, V35, P1, DOI 10.1111/j.1460-9568.2011.07923.x; Li YZ, 2015, J NEUROCHEM, V135, P1203, DOI 10.1111/jnc.13169; Li YZ, 2010, J ALZHEIMERS DIS, V19, P1205, DOI 10.3233/JAD-2010-1314; Li YZ, 2009, P NATL ACAD SCI USA, V106, P1285, DOI 10.1073/pnas.0806720106; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maier T, 2009, FEBS LETT, V583, P3966, DOI 10.1016/j.febslet.2009.10.036; Marklund N, 2011, BRIT J PHARMACOL, V164, P1207, DOI 10.1111/j.1476-5381.2010.01163.x; Masanic CA, 2001, ARCH PHYS MED REHAB, V82, P896, DOI 10.1053/apmr.2001.23833; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mukherjee S, 2011, FRONT MOL NEUROSCI, V4, DOI 10.3389/fnmol.2011.00021; Nakamura K, 2012, CELL, V149, P232, DOI 10.1016/j.cell.2012.02.016; Naseem Mehar, 2014, SCI WORLD J; Ozsuer H, 2005, NEUROSURG REV, V28, P143, DOI 10.1007/s10143-004-0374-1; Papa M, 2014, NEUROSCI BIOBEHAV R, V42, P35, DOI 10.1016/j.neubiorev.2014.01.010; Perry T, 2003, J NEUROSCI RES, V72, P603, DOI 10.1002/jnr.10611; Perry T, 2002, J PHARMACOL EXP THER, V302, P881, DOI 10.1124/jpet.102.037481; Rachmany L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079837; Rachmany L, 2013, AGE, V35, P1621, DOI 10.1007/s11357-012-9464-0; Rao VLR, 2001, BRAIN RES, V911, P96; Salcedo I, 2012, BRIT J PHARMACOL, V166, P1586, DOI 10.1111/j.1476-5381.2012.01971.x; Shaw KE, 2013, J NEUROTRAUM, V30, P557, DOI 10.1089/neu.2012.2782; Sheth SA, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0129735; Siman R, 2009, J NEUROTRAUM, V26, P1867, DOI 10.1089/neu.2009.0882; Stein Donald G, 2015, Handb Clin Neurol, V127, P433, DOI 10.1016/B978-0-444-52892-6.00028-3; Stoica BA, 2010, NEUROTHERAPEUTICS, V7, P3, DOI 10.1016/j.nurt.2009.10.023; Tashlykov V, 2009, J MOL NEUROSCI, V37, P16, DOI 10.1007/s12031-008-9094-2; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; Taverni JP, 1998, BRAIN INJURY, V12, P77; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Tweedie D, 2015, ALZHEIMERS DEMENT; Tweedie D, 2007, J NEUROSCI RES, V85, P805, DOI 10.1002/jnr.21160; Tweedie D, 2013, NEUROBIOL DIS, V54, P1, DOI 10.1016/j.nbd.2013.02.006; Tweedie D, 2013, EXP NEUROL, V239, P170, DOI 10.1016/j.expneurol.2012.10.001; Walls MK, 2015, J NEUROSURG, P1; Wang XH, 2015, BRAIN RES, V1627, P101, DOI 10.1016/j.brainres.2015.09.015; Whelan F J, 2000, Ann Clin Psychiatry, V12, P131; Xiong Y, 2015, EXPERT OPIN INV DRUG, V24, P743, DOI 10.1517/13543784.2015.1021919; Xu WJ, 2015, J INVEST MED, V63, P267, DOI 10.1097/JIM.0000000000000129; Yang LY, 2015, EXP NEUROL, V269, P56, DOI 10.1016/j.expneurol.2015.03.015; Yu TS, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0118793; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	76	15	15	0	5	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0165-0270	1872-678X		J NEUROSCI METH	J. Neurosci. Methods	OCT 15	2016	272				SI		4	18		10.1016/j.jneumeth.2016.02.003			15	Biochemical Research Methods; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	EA6LF	WOS:000386740000002	26868732	Green Accepted			2022-02-06	
J	van Klaveren, D; Gonen, M; Steyerberg, EW; Vergouwe, Y				van Klaveren, David; Gonen, Mithat; Steyerberg, Ewout W.; Vergouwe, Yvonne			A new concordance measure for risk prediction models in external validation settings	STATISTICS IN MEDICINE			English	Article						concordance; discrimination; logistic regression; proportional hazards regression; case-mix heterogeneity; censoring	PERCUTANEOUS CORONARY INTERVENTION; TRAUMATIC BRAIN-INJURY; SYNTAX SCORE II; LEFT MAIN; PERFORMANCE; REGRESSION; SURGERY; DISEASE; TRIAL; TESTS	Concordance measures are frequently used for assessing the discriminative ability of risk prediction models. The interpretation of estimated concordance at external validation is difficult if the case-mix differs from the model development setting. We aimed to develop a concordance measure that provides insight into the influence of case-mix heterogeneity and is robust to censoring of time-to-event data. We first derived a model-based concordance (mbc) measure that allows for quantification of the influence of case-mix heterogeneity on discriminative ability of proportional hazards and logistic regression models. This mbc can also be calculated including a regression slope that calibrates the predictions at external validation (c-mbc), hence assessing the influence of overall regression coefficient validity on discriminative ability. We derived variance formulas for both mbc and c-mbc. We compared the mbc and the c-mbc with commonly used concordance measures in a simulation study and in two external validation settings. The mbc was asymptotically equivalent to a previously proposed resampling-based case-mix corrected c-index. The c-mbc remained stable at the true value with increasing proportions of censoring, while Harrell's c-index and to a lesser extent Uno's concordance measure increased unfavorably. Variance estimates of mbc and c-mbc were well in agreement with the simulated empirical variances. We conclude that the mbc is an attractive closed-form measure that allows for a straightforward quantification of the expected change in a model's discriminative ability due to case-mix heterogeneity. The c-mbc also reflects regression coefficient validity and is a censoring-robust alternative for the c-index when the proportional hazards assumption holds. Copyright (c) 2016 John Wiley & Sons, Ltd.	[van Klaveren, David; Steyerberg, Ewout W.; Vergouwe, Yvonne] Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands; [Gonen, Mithat] Mem Sloan Kettering Canc Ctr, Epidemiol & Biostat, 1275 York Ave, New York, NY 10021 USA		van Klaveren, D (corresponding author), Erasmus Univ, Dept Publ Hlth, Med Ctr, Rotterdam, Netherlands.	d.vanklaveren.1@erasmusmc.nl	Gonen, Mithat/E-4826-2012; Steyerberg, Ewout W/C-1509-2018	Gonen, Mithat/0000-0001-8683-8477; Steyerberg, Ewout W/0000-0002-7787-0122	Netherlands Organisation for Scientific ResearchNetherlands Organization for Scientific Research (NWO) [917.11.383.]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA008748] Funding Source: NIH RePORTER	This work was supported by the Netherlands Organisation for Scientific Research (grant 917.11.383.). David van Klaveren, Mithat Gonen, Ewout Steyerberg, and Yvonne Vergouwe designed the study. David van Klaveren and Yvonne Vergouwe analyzed the data and wrote the first draft of the paper. All authors contributed to writing the paper and approved the final version.	Austin PC, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-82; Campos CM, 2014, CIRC J, V78, P1942, DOI 10.1253/circj.CJ-14-0204; Farooq V, 2013, LANCET, V381, P639, DOI 10.1016/S0140-6736(13)60108-7; Gonen M, 2005, BIOMETRIKA, V92, P965, DOI 10.1093/biomet/92.4.965; GRAMBSCH PM, 1994, BIOMETRIKA, V81, P515; HARRELL FE, 1982, JAMA-J AM MED ASSOC, V247, P2543, DOI 10.1001/jama.247.18.2543; Hukkelhoven CWPM, 2002, J NEUROSURG, V97, P549, DOI 10.3171/jns.2002.97.3.0549; Kimura T, 2011, CARDIOVASC INTERV TH, V26, P234, DOI 10.1007/s12928-011-0065-0; KORN EL, 1990, STAT MED, V9, P487, DOI 10.1002/sim.4780090503; Lambert J, 2016, STAT METHODS MED RES, V25, P2088, DOI 10.1177/0962280213515571; Marshall LF, 1998, J NEUROSURG, V89, P519, DOI 10.3171/jns.1998.89.4.0519; Mohr FW, 2013, LANCET, V381, P629, DOI 10.1016/S0140-6736(13)60141-5; Pencina MJ, 2004, STAT MED, V23, P2109, DOI 10.1002/sim.1802; Quade D, 1967, I STAT MIMEO SERIES, V526; R Foundation for Statistical Computing, 2011, R LANG ENV STAT COMP; Royston P, 2013, BMC MED RES METHODOL, V13, DOI 10.1186/1471-2288-13-33; Stare J, 2011, BIOMETRICS, V67, P750, DOI 10.1111/j.1541-0420.2010.01526.x; Steyerberg, 2019, CLIN PREDICTION MODE; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Uno H, 2011, STAT MED, V30, P1105, DOI 10.1002/sim.4154; van Klaveren D, 2014, STAT MED, V33, P714, DOI 10.1002/sim.5928; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223	23	15	15	4	9	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0277-6715	1097-0258		STAT MED	Stat. Med.	OCT 15	2016	35	23					4136	4152		10.1002/sim.6997			17	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Medicine, Research & Experimental; Statistics & Probability	Science Citation Index Expanded (SCI-EXPANDED)	Mathematical & Computational Biology; Public, Environmental & Occupational Health; Medical Informatics; Research & Experimental Medicine; Mathematics	DW5YC	WOS:000383722600005	27251001	Green Accepted			2022-02-06	
J	Wiley, CA; Bissel, SJ; Lesniak, A; Dixon, CE; Franks, J; Stolz, DB; Sun, M; Wang, GJ; Switzer, R; Kochanek, PM; Murdoch, G				Wiley, Clayton A.; Bissel, Stephanie J.; Lesniak, Andrew; Dixon, C. Edward; Franks, Jonathan; Stolz, Donna Beer; Sun, Ming; Wang, Guoji; Switzer, Robert; Kochanek, Patrick M.; Murdoch, Geoffrey			Ultrastructure of Diaschisis Lesions after Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						axonal injury; controlled cortical impact; electron microscopy; light microscopy; TBI	CROSSED CEREBELLAR ATROPHY; CONTROLLED CORTICAL IMPACT; LATERAL GENICULATE-NUCLEUS; AXONAL INJURY; HEAD-INJURY; NEUROFILAMENT COMPACTION; NEURONAL DEGENERATION; CEREBRAL HEMIATROPHY; CELL-DEATH; APOPTOSIS	We used controlled cortical impact in mice to model human traumatic brain injury (TBI). Local injury was accompanied by distal diaschisis lesions that developed within brain regions anatomically connected to the injured cortex. At 7 days after injury, histochemistry documented broadly distributed lesions, particularly in the contralateral cortex and ipsilateral thalamus and striatum. Reactive astrocytosis and microgliosis were noted in multiple neural pathways that also showed silver-stained cell processes and bodies. Wisteria floribunda agglutinin (WFA) staining, a marker of perineuronal nets, was substantially diminished in the ipsilateral, but less so in the contralateral cortex. Contralateral cortical silver positive diaschisis lesions showed loss of both phosphorylated and unphosphorylated neurofilament staining, but overall preservation of microtubule-associated protein (MAP)-2 staining. Thalamic lesions showed substantial loss of MAP-2 and unphosphorylated neurofilaments in addition to moderate loss of phosphorylated neurofilament. One animal demonstrated contralateral cerebellar degeneration at 7 days post-injury. After 21 days, the gliosis had quelled, however persistent silver staining was noted. Using a novel serial section technique, we were able to perform electron microscopy on regions fully characterized at the light microscopy level. Cell bodies and processes that were silver positive at the light microscopy level showed hydropic disintegration consisting of: loss of nuclear heterochromatin; dilated somal and neuritic processes with a paucity of filaments, tubules, and mitochondria; and increased numbers of electron-dense membranous structures. Importantly the cell membrane itself was still intact 3 weeks after injury. Although the full biochemical nature of these lesions remains to be deciphered, the morphological preservation of damaged neurons and processes raises the question of whether this is a reversible process.	[Wiley, Clayton A.; Bissel, Stephanie J.; Lesniak, Andrew; Wang, Guoji; Murdoch, Geoffrey] Univ Pittsburgh, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15213 USA; [Dixon, C. Edward; Kochanek, Patrick M.] Univ Pittsburgh, Dept Neurosurg, Anesthesiol, Phys Med, Pittsburgh, PA 15213 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Dept Pediat, Pittsburgh, PA 15213 USA; [Kochanek, Patrick M.] Univ Pittsburgh, Rehabil & Crit Care Med, Pittsburgh, PA 15213 USA; [Franks, Jonathan; Stolz, Donna Beer; Sun, Ming] Univ Pittsburgh, Ctr Biol Imaging, Pittsburgh, PA 15213 USA; [Dixon, C. Edward; Kochanek, Patrick M.] VA Pittsburgh Healthcare Syst, Pittsburgh, PA USA; [Dixon, C. Edward; Kochanek, Patrick M.] Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Switzer, Robert] NeuroSci Associates, Knoxville, TN USA		Wiley, CA (corresponding author), Univ Pittsburgh, Dept Pathol, 200 Lothrop St, Pittsburgh, PA 15213 USA.	wileyca@upmc.edu			NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS079061] Funding Source: Medline; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS079061] Funding Source: NIH RePORTER		Al-Abdulla NA, 1998, NEUROSCIENCE, V86, P191, DOI 10.1016/S0306-4522(98)00014-1; Al-Abdulla NA, 1998, AM J PATHOL, V153, P447, DOI 10.1016/S0002-9440(10)65588-5; Al-Abdulla NA, 2002, NEUROSCIENCE, V115, P7, DOI 10.1016/S0306-4522(02)00363-9; Anderson CV, 1996, J NEUROTRAUM, V13, P59, DOI 10.1089/neu.1996.13.59; BAUDRIMONT M, 1983, REV NEUROL, V139, P485; Bennett RE, 2014, J NEUROTRAUM, V31, P1647, DOI 10.1089/neu.2013.3320; Bonneh-Barkay D, 2010, J NEUROTRAUM, V27, P1215, DOI 10.1089/neu.2010.1310; Buki A, 1999, J NEUROPATH EXP NEUR, V58, P365; Campo P, 2012, CEREB CORTEX, V22, P1225, DOI 10.1093/cercor/bhr201; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Carrera E, 2014, BRAIN, V137, P2408, DOI 10.1093/brain/awu101; Chen S, 2014, J STROKE CEREBROVASC, V23, P2378, DOI 10.1016/j.jstrokecerebrovasdis.2014.05.009; CHUNG HD, 1985, BRAIN, V108, P881, DOI 10.1093/brain/108.4.881; Conforti L, 2014, NAT REV NEUROSCI, V15, P394, DOI 10.1038/nrn3680; Darnell RB, 2013, ANNU REV NEUROSCI, V36, P243, DOI 10.1146/annurev-neuro-062912-114322; DEOLMOS JS, 1994, NEUROTOXICOL TERATOL, V16, P545, DOI 10.1016/0892-0362(94)90033-7; Dikranian K, 2008, EXP NEUROL, V211, P551, DOI 10.1016/j.expneurol.2008.03.012; DiLeonardi AM, 2009, BRAIN RES, V1263, P174, DOI 10.1016/j.brainres.2009.01.021; Dolenec P, 2015, J NEUROPATH EXP NEUR, V74, P512, DOI 10.1097/NEN.0000000000000194; Duan W, 2015, MOL NEUROBIOL; FEENEY DM, 1986, STROKE, V17, P817, DOI 10.1161/01.STR.17.5.817; Finger S, 2004, ARCH NEUROL-CHICAGO, V61, P283, DOI 10.1001/archneur.61.2.283; Gallyas F, 2002, ACTA NEUROPATHOL, V103, P36, DOI 10.1007/s004010100424; GESSAGA EC, 1985, CLIN NEUROPATHOL, V4, P238; Graffeo CS, 2016, NEUROCRIT CARE, V24, P258, DOI 10.1007/s12028-015-0155-4; Gupta R, 2015, J PEDIATR NEUROSCI, V10, P294, DOI 10.4103/1817-1745.165730; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Hall ED, 2008, J NEUROTRAUM, V25, P235, DOI 10.1089/neu.2007.0383; Huusko N, 2014, NEUROSCIENCE, V267, P30, DOI 10.1016/j.neuroscience.2014.02.026; Iwase T, 2015, NEUROPATHOLOGY, V35, P592, DOI 10.1111/neup.12225; Kochanek PM, 2006, J CEREBR BLOOD F MET, V26, P565, DOI 10.1038/sj.jcbfm.9600218; Komaba Y, 2004, STROKE, V35, P472, DOI 10.1161/01.STR.0000109771.56160.F5; Laker SR, 2011, PM&R, V3, pS354, DOI 10.1016/j.pmrj.2011.07.017; Lee CG, 2009, J EXP MED, V206, P1149, DOI 10.1084/jem.20081271; Lieberman A R, 1971, Int Rev Neurobiol, V14, P49, DOI 10.1016/S0074-7742(08)60183-X; Lifshitz J, 2007, J NEUROPATH EXP NEUR, V66, P218, DOI 10.1097/01.jnen.0000248558.75950.4d; LIGHTHALL J W, 1990, Journal of Neurotrauma, V7, P65, DOI 10.1089/neu.1990.7.65; Lighthall JW, 1988, J NEUROTRAUM, V5, P1, DOI 10.1089/neu.1988.5.1; Ma M, 2013, NEUROBIOL DIS, V60, P61, DOI 10.1016/j.nbd.2013.08.010; Marmarou CR, 2005, J NEUROTRAUM, V22, P1066, DOI 10.1089/neu.2005.22.1066; Maxwell WL, 2004, BRAIN, V127, P2470, DOI 10.1093/brain/awh294; Michikawa M, 1991, Rinsho Shinkeigaku, V31, P44; NAUTA WJH, 1951, STAIN TECHNOL, V26, P5, DOI 10.3109/10520295109113170; Ojo J. O., 2015, J NEUROPATHOL EXP NE; Okonkwo DO, 1998, BRAIN RES, V784, P1, DOI 10.1016/S0006-8993(97)01075-5; PANTANO P, 1986, BRAIN, V109, P677, DOI 10.1093/brain/109.4.677; Povlishock JT, 1996, ACT NEUR S, V66, P81; Povlishock JT, 1997, J NEUROPATH EXP NEUR, V56, P347, DOI 10.1097/00005072-199704000-00003; POVLISHOCK JT, 1995, BRAIN PATHOL, V5, P415, DOI 10.1111/j.1750-3639.1995.tb00620.x; ROBERTSLEWIS JM, 1994, J NEUROSCI, V14, P3934; ROSS DT, 1993, J NEUROTRAUM, V10, P151, DOI 10.1089/neu.1993.10.151; Schmued LC, 2000, BRAIN RES, V874, P123, DOI 10.1016/S0006-8993(00)02513-0; Sinz EH, 1999, J CLIN INVEST, V104, P647, DOI 10.1172/JCI6670; Smith DH, 2013, J NEUROTRAUM, V30, P307, DOI 10.1089/neu.2012.2825; Switzer RC, 2000, TOXICOL PATHOL, V28, P70, DOI 10.1177/019262330002800109; SWITZER RC, 1979, ANAL BIOCHEM, V98, P231, DOI 10.1016/0003-2697(79)90732-2; TAN N, 1984, ACTA NEUROPATHOL, V62, P332, DOI 10.1007/BF00687616; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Teixeira RA, 2002, ARCH NEUROL-CHICAGO, V59, P843, DOI 10.1001/archneur.59.5.843; TIEN RD, 1992, AM J ROENTGENOL, V158, P1155, DOI 10.2214/ajr.158.5.1566683; Wang F, 2007, NEUROSCI LETT, V417, P255, DOI 10.1016/j.neulet.2007.02.080; Wiley CA, 2000, J NEUROPATH EXP NEUR, V59, P955, DOI 10.1093/jnen/59.11.955; Wiley CA, 2015, NEUROPATHOLOGY, V35, P95, DOI 10.1111/neup.12158	63	15	15	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2016	33	20					1866	1882		10.1089/neu.2015.4272			17	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	EA6YO	WOS:000386775300007	26914973	Green Published			2022-02-06	
J	Alhourani, A; Wozny, TA; Krishnaswamy, D; Pathak, S; Walls, SA; Ghuman, AS; Krieger, DN; Okonkwo, DO; Richardson, RM; Niranjan, A				Alhourani, Ahmad; Wozny, Thomas A.; Krishnaswamy, Deepa; Pathak, Sudhir; Walls, Shawn A.; Ghuman, Avniel S.; Krieger, Donald N.; Okonkwo, David O.; Richardson, R. Mark; Niranjan, Ajay			Magnetoencephalography-based identification of functional connectivity network disruption following mild traumatic brain injury	JOURNAL OF NEUROPHYSIOLOGY			English	Article						traumatic brain injury; magnetoencephalography; functional connectivity; resting-state analysis; graph theory; default mode network; concussion; phase locking value	DEFAULT-MODE NETWORK; GRAPH-THEORETICAL ANALYSIS; DELTA WAVES; MEG; EEG; COMPLAINTS	Mild traumatic brain injury (mTBI) leads to long-term cognitive sequelae in a significant portion of patients. Disruption of normal neural communication across functional brain networks may explain the deficits in memory and attention observed after mTBI. In this study, we used magnetoencephalography (MEG) to examine functional connectivity during a resting state in a group of mTBI subjects (n = 9) compared with age-matched control subjects (n = 15). We adopted a data-driven, exploratory analysis in source space using phase locking value across different frequency bands. We observed a significant reduction in functional connectivity in band-specific networks in mTBI compared with control subjects. These networks spanned multiple cortical regions involved in the default mode network (DMN). The DMN is thought to subserve memory and attention during periods when an individual is not engaged in a specific task, and its disruption may lead to cognitive deficits after mTBI. We further applied graph theoretical analysis on the functional connectivity matrices. Our data suggest reduced local efficiency in different brain regions in mTBI patients. In conclusion, MEG can be a potential tool to investigate and detect network alterations in patients with mTBI. The value of MEG to reveal potential neurophysiological biomarkers for mTBI patients warrants further exploration.	[Alhourani, Ahmad; Wozny, Thomas A.; Ghuman, Avniel S.; Krieger, Donald N.; Okonkwo, David O.; Richardson, R. Mark; Niranjan, Ajay] Univ Pittsburgh, Sch Med, Dept Neurol Surg, Pittsburgh, PA 15261 USA; [Krishnaswamy, Deepa; Pathak, Sudhir; Ghuman, Avniel S.; Richardson, R. Mark] Univ Pittsburgh, Sch Med, Dept Neurobiol, Pittsburgh, PA USA; [Ghuman, Avniel S.] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; [Ghuman, Avniel S.; Richardson, R. Mark] Univ Pittsburgh, Ctr Neural Basis Cognit, Pittsburgh, PA USA; [Ghuman, Avniel S.; Richardson, R. Mark] Univ Pittsburgh, Inst Brain, Pittsburgh, PA USA; [Walls, Shawn A.] Univ Pittsburgh, Med Ctr, Brain Mapping Ctr, Pittsburgh, PA USA		Niranjan, A (corresponding author), Univ Pittsburgh, Dept Neurosurg, UPMC Presbyterian, Suite B-400,200 Lothrop St, Pittsburgh, PA 15213 USA.	niranjana@upmc.edu	Richardson, Robert/AAY-4969-2021	Krishnaswamy, Deepa/0000-0002-3235-1222; Ghuman, Avniel/0000-0003-1746-4656; alhourani, ahmad/0000-0002-3523-6131; Krieger, Donald/0000-0002-9789-9731			Baillet S, 2001, IEEE SIGNAL PROC MAG, V18, P14, DOI 10.1109/79.962275; BALL GJ, 1977, ELECTROEN CLIN NEURO, V43, P346, DOI 10.1016/0013-4694(77)90258-9; Brookes MJ, 2012, NEUROIMAGE, V63, P910, DOI 10.1016/j.neuroimage.2012.03.048; Buckner RL, 2008, ANN NY ACAD SCI, V1124, P1, DOI 10.1196/annals.1440.011; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Castellanos NP, 2011, NEUROIMAGE, V55, P1189, DOI 10.1016/j.neuroimage.2010.12.046; Centers for Disease Control and Prevention, 2003, REP C MILD TRAUM BRA; Centers for Disease Control and Prevention, 2014, C TRAUM BRAIN INJ US; Chu CJ, 2012, J NEUROSCI, V32, P2703, DOI 10.1523/JNEUROSCI.5669-11.2012; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; Delorme A, 2004, J NEUROSCI METH, V134, P9, DOI 10.1016/j.jneumeth.2003.10.009; Destrieux C, 2010, NEUROIMAGE, V53, P1, DOI 10.1016/j.neuroimage.2010.06.010; Dimitriadis SI, 2015, NEUROIMAGE-CLIN, V9, P519, DOI 10.1016/j.nicl.2015.09.011; Dubbelink KTEO, 2014, BRAIN, V137, P197, DOI 10.1093/brain/awt316; Dunkley BT, 2015, NEUROIMAGE-CLIN, V7, P611, DOI 10.1016/j.nicl.2015.02.020; Fagerholm ED, 2015, BRAIN, V138, P1696, DOI 10.1093/brain/awv075; Fischl B, 1999, HUM BRAIN MAPP, V8, P272, DOI 10.1002/(SICI)1097-0193(1999)8:4<272::AID-HBM10>3.0.CO;2-4; Fries P, 2015, NEURON, V88, P220, DOI 10.1016/j.neuron.2015.09.034; Ghuman AS, 2011, NEUROIMAGE, V56, P69, DOI 10.1016/j.neuroimage.2011.01.046; GLOOR P, 1977, NEUROLOGY, V27, P326, DOI 10.1212/WNL.27.4.326; Hampson M, 2006, J NEUROSCI, V26, P13338, DOI 10.1523/JNEUROSCI.3408-06.2006; Hillebrand A, 2012, NEUROIMAGE, V59, P3909, DOI 10.1016/j.neuroimage.2011.11.005; Huang MX, 2014, NEUROIMAGE-CLIN, V5, P109, DOI 10.1016/j.nicl.2014.06.004; Huang MX, 1999, PHYS MED BIOL, V44, P423, DOI 10.1088/0031-9155/44/2/010; Kida T, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00713; Koch W, 2012, NEUROBIOL AGING, V33, P466, DOI 10.1016/j.neurobiolaging.2010.04.013; Lachaux JP, 1999, HUM BRAIN MAPP, V8, P194, DOI 10.1002/(SICI)1097-0193(1999)8:4<194::AID-HBM4>3.0.CO;2-C; Latora V, 2001, PHYS REV LETT, V87, DOI 10.1103/PhysRevLett.87.198701; Leech R, 2011, J NEUROSCI, V31, P3217, DOI 10.1523/JNEUROSCI.5626-10.2011; Lewine JD, 1999, AM J NEURORADIOL, V20, P857; Liu ZM, 2010, NEUROIMAGE, V51, P102, DOI 10.1016/j.neuroimage.2010.01.092; Maris E, 2007, J NEUROSCI METH, V164, P177, DOI 10.1016/j.jneumeth.2007.03.024; Mason MF, 2007, SCIENCE, V315, P393, DOI 10.1126/science.1131295; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Nathan DE, 2015, BRAIN CONNECT, V5, P102, DOI 10.1089/brain.2014.0273; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rubinov M, 2010, NEUROIMAGE, V52, P1059, DOI 10.1016/j.neuroimage.2009.10.003; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Smith-Seemiller L, 2003, BRAIN INJURY, V17, P199, DOI 10.1080/0269905021000030823; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Stam CJ, 2009, BRAIN, V132, P213, DOI 10.1093/brain/awn262; Stam CJ, 2007, HUM BRAIN MAPP, V28, P1178, DOI 10.1002/hbm.20346; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tadel F, 2011, COMPUT INTEL NEUROSC, V2011, DOI 10.1155/2011/879716; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Uddin LQ, 2008, J NEUROSCI METH, V169, P249, DOI 10.1016/j.jneumeth.2007.11.031; Van Boven RW, 2009, J REHABIL RES DEV, V46, P717, DOI 10.1682/JRRD.2008.12.0161; van Dellen E, 2014, ANESTHESIOLOGY, V121, P328, DOI 10.1097/ALN.0000000000000329; van Dellen E, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0050122; van der Naalt J, 1999, J NEUROL NEUROSUR PS, V66, P207, DOI 10.1136/jnnp.66.2.207; van Wijk BCM, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013701; Vanderploeg RD, 2005, J INT NEUROPSYCH SOC, V11, P228, DOI 10.1017/S1355617705050289; Whitfield-Gabrieli S, 2009, P NATL ACAD SCI USA, V106, P1279, DOI 10.1073/pnas.0809141106; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748	56	15	16	0	12	AMER PHYSIOLOGICAL SOC	Rockville	6120 Executive Blvd, Suite 600, Rockville, MD, UNITED STATES	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	OCT	2016	116	4					1840	1847		10.1152/jn.00513.2016			8	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	EA7RC	WOS:000386828400028	27466136	Green Published, Bronze			2022-02-06	
J	Chen, YN; Holstein, DM; Aime, S; Bollo, M; Lechleiter, JD				Chen, Yanan; Holstein, Deborah M.; Aime, Sofia; Bollo, Mariana; Lechleiter, James D.			Calcineurin beta protects brain after injury by activating the unfolded protein response	NEUROBIOLOGY OF DISEASE			English	Article						Calcium; Stress; Ischemia; Traumatic brain injury; Endoplasmic reticulum	ENDOPLASMIC-RETICULUM STRESS; CELL-DEATH; OXIDATIVE STRESS; AMYLOID-BETA; ER STRESS; A-ALPHA; PERK; KINASE; GENE; INHIBITION	The Ca2+-dependent phosphatase, calcineurin (CN) is thought to play a detrimental role in damaged neurons; however, its role in astrocytes is unclear. In cultured astrocytes, CN beta expression increased after treatment with a sarco/endoplasmic reticulum Ca2+-ATPase inhibitor, thapsigargin, and with oxygen and glucose deprivation, an in vitro model of ischemia. Similarly, CN beta was induced in astrocytes in vivo in two different mouse models of brain injury - photothrombotic stroke and traumatic brain injury (TBI). Immunoprecipitation and chemical activation dimerization methods pointed to physical interaction of CN beta with the unfolded protein response (UPR) sensor, protein kinase RNA-like endoplasmic reticulum kinase (PERK). In accordance, induction of CN beta resulted in oligomerization and activation of PERK. Strikingly, the presence of a phosphatase inhibitor did not interfere with CN beta-mediated activation of PERK, suggesting a hitherto undiscovered non-enzymatic role for CN beta. Importantly, the cytoprotective function of CN beta was PERK-dependent both in vitro and in vivo. Loss of CN beta in vivo resulted in a significant increase in cerebral damage, and correlated with a decrease in astrocyte size, PERK activity and glial fibrillary acidic protein (GFAP) expression. Taken together, these data reveal a critical role for the CN beta-PERK axis in not only prolonging astrocyte cell survival but also in modulating astrogliosis after brain injury. (C) 2016 The Authors. Published by Elsevier Inc.	[Chen, Yanan; Holstein, Deborah M.; Lechleiter, James D.] Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA; [Aime, Sofia; Bollo, Mariana] Univ Nacl Cordoba, INIMEC CONICET, Inst Invest Med M&M Ferreyra, Cordoba, Argentina; [Lechleiter, James D.] Univ Texas Hlth Sci Ctr San Antonio, Ctr Biomed Neurosci, San Antonio, TX 78229 USA		Bollo, M; Lechleiter, JD (corresponding author), Univ Texas Hlth Sci Ctr San Antonio, Dept Cellular & Struct Biol, 8403 Floyd Curl Dr, San Antonio, TX 78229 USA.; Bollo, M; Lechleiter, JD (corresponding author), Univ Nacl Cordoba, INIMEC CONICET, Inst Invest Med M&M Ferreyra, Cordoba, Argentina.	lechleiter@uthscsa.edu			National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS085732, 155726/155448]; National Institutes of Health (UTHASCA/Institute Ferreyra)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; Ministerio de Ciencia y Tecnologia de Cordoba, Argentina [PID-2010]; Fulbright/CONICET (Argentina) Fellowship; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS085732] Funding Source: NIH RePORTER	This work was supported by the National Institutes of Health (NS085732, 2013 Subaward Agreement 155726/155448; UTHASCA/Institute Ferreyra), Ministerio de Ciencia y Tecnologia de Cordoba, Argentina (PID-2010) and Fulbright/CONICET (Argentina) Fellowship.	Abdul HM, 2009, J NEUROSCI, V29, P12957, DOI 10.1523/JNEUROSCI.1064-09.2009; Agostinho P, 2008, NEUROCHEM INT, V52, P1226, DOI 10.1016/j.neuint.2008.01.005; Axten JM, 2012, J MED CHEM, V55, P7193, DOI 10.1021/jm300713s; Badiola N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.31; Bertolotti A, 2000, NAT CELL BIOL, V2, P326, DOI 10.1038/35014014; Bollo M, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0011925; Brostrom MA, 2003, CELL CALCIUM, V34, P345, DOI 10.1016/S0143-4160(03)00127-1; Ellgaard L, 2003, NAT REV MOL CELL BIO, V4, P181, DOI 10.1038/nrm1052; Farook JM, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.280; Fernandez AM, 2007, J NEUROSCI, V27, P8745, DOI 10.1523/JNEUROSCI.1002-07.2007; Gotoh T, 2002, J BIOL CHEM, V277, P12343, DOI 10.1074/jbc.M107988200; Han D, 2009, CELL, V138, P562, DOI 10.1016/j.cell.2009.07.017; Harding HP, 2001, MOL CELL, V7, P1153, DOI 10.1016/S1097-2765(01)00264-7; Hashimoto T, 1998, J NEUROCHEM, V70, P1289; He SK, 2008, GRAEF ARCH CLIN EXP, V246, P677, DOI 10.1007/s00417-008-0770-2; Holguin A, 2004, J CLIN VIROL, V31, P215, DOI 10.1016/j.jcv.2004.03.015; Honsho M, 1998, J BIOL CHEM, V273, P20860, DOI 10.1074/jbc.273.33.20860; JI XH, 1992, BIOCHEMISTRY-US, V31, P10169, DOI 10.1021/bi00157a004; Kaufman RJ, 2004, TRENDS BIOCHEM SCI, V29, P152, DOI 10.1016/j.tibs.2004.01.004; KLEE CB, 1978, BIOCHEMISTRY-US, V17, P120, DOI 10.1021/bi00594a017; Klee CB, 1998, J BIOL CHEM, V273, P13367, DOI 10.1074/jbc.273.22.13367; Komatsu T, 2010, NAT METHODS, V7, P206, DOI [10.1038/NMETH.1428, 10.1038/nmeth.1428]; Kovacs GG, 2005, AM J PHYSIOL-CELL PH, V289, pC361, DOI 10.1152/ajpcell.00280.2004; Krajewska M, 2011, BRAIN RES, V1370, P227, DOI 10.1016/j.brainres.2010.11.015; Kumar R, 2003, J CEREBR BLOOD F MET, V23, P462, DOI 10.1097/01.WCB.0000056064.25434.CA; Kumar R, 2001, J NEUROCHEM, V77, P1418, DOI 10.1046/j.1471-4159.2001.00387.x; KUNO T, 1992, J NEUROCHEM, V58, P1643, DOI 10.1111/j.1471-4159.1992.tb10036.x; Kurz JE, 2005, J NEUROTRAUM, V22, P476, DOI 10.1089/neu.2005.22.476; Lei H, 2011, FOOD CHEM, V127, P1169, DOI 10.1016/j.foodchem.2011.01.119; Li YF, 2012, PROTEIN EXPRES PURIF, V82, P162, DOI 10.1016/j.pep.2011.12.008; Lim D, 2013, GLIA, V61, P1134, DOI 10.1002/glia.22502; Lin DT, 2007, NEUROBIOL AGING, V28, P99, DOI 10.1016/j.neurobiolaging.2005.11.004; Lin JH, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0004170; Lu PD, 2004, J CELL BIOL, V167, P27, DOI 10.1083/jcb.200408003; Ma K, 2002, J BIOL CHEM, V277, P18728, DOI 10.1074/jbc.M200903200; Moreno JA, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3006767; Moreno JA, 2012, NATURE, V485, P507, DOI 10.1038/nature11058; Mounir Z, 2011, SCI SIGNAL, V4, DOI 10.1126/scisignal.2001630; Nakka VP, 2014, MOL NEUROBIOL, V9; NEDERGAARD M, 1994, SCIENCE, V263, P1768, DOI 10.1126/science.8134839; Norris CM, 2005, J NEUROSCI, V25, P4649, DOI 10.1523/JNEUROSCI.0365-05.2005; Owen CR, 2005, J NEUROCHEM, V94, P1235, DOI 10.1111/j.1471-4159.2005.03276.x; Oyadomari S, 2002, J CLIN INVEST, V109, P525, DOI 10.1172/JCI200214550; Paredes RM, 2013, CELL CALCIUM, V53, P286, DOI 10.1016/j.ceca.2013.01.002; PARKER MW, 1990, J MOL BIOL, V213, P221, DOI 10.1016/S0022-2836(05)80183-4; Paschen W, 2004, CURR NEUROVASC RES, V1, P173, DOI 10.2174/1567202043480125; Pennuto M, 2008, NEURON, V57, P393, DOI 10.1016/j.neuron.2007.12.021; Polley S, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001581; POLLI JW, 1991, DEV BRAIN RES, V63, P105, DOI 10.1016/0165-3806(91)90071-P; Pyrzynska B, 2001, NEUROCHEM INT, V38, P409, DOI 10.1016/S0197-0186(00)00105-4; Reese LC, 2008, AGING CELL, V7, P824, DOI 10.1111/j.1474-9726.2008.00434.x; RICHARME G, 1982, BIOCHEM BIOPH RES CO, V105, P476, DOI 10.1016/0006-291X(82)91459-0; Ron D, 2007, NAT REV MOL CELL BIO, V8, P519, DOI 10.1038/nrm2199; Ryu EJ, 2002, J NEUROSCI, V22, P10690; Shioda N, 2011, YAKUGAKU ZASSHI, V131, P13, DOI 10.1248/yakushi.131.13; Stanley SK, 2004, SPINE, V29, pE510, DOI 10.1097/01.brs.0000145417.94357.39; Stichel CC, 1998, CELL TISSUE RES, V294, P1, DOI 10.1007/s004410051151; Tajiri S, 2004, CELL DEATH DIFFER, V11, P403, DOI 10.1038/sj.cdd.4401365; THASTRUP O, 1990, P NATL ACAD SCI USA, V87, P2466, DOI 10.1073/pnas.87.7.2466; Trendelenburg G, 2005, GLIA, V50, P307, DOI 10.1002/glia.20204; Volmer R, 2013, P NATL ACAD SCI USA, V110, P4628, DOI 10.1073/pnas.1217611110; Wang HG, 1999, SCIENCE, V284, P339, DOI 10.1126/science.284.5412.339; Wang H, 2010, J BIOCHEM, V147, P185, DOI 10.1093/jb/mvp163; Wang R, 2013, J BIOL CHEM, V288, P33824, DOI 10.1074/jbc.M113.503664; Watts LT, 2013, J NEUROTRAUM, V30, P55, DOI 10.1089/neu.2012.2488; Welihinda AA, 1996, J BIOL CHEM, V271, P18181, DOI 10.1074/jbc.271.30.18181; Wu HY, 2004, J BIOL CHEM, V279, P4929, DOI 10.1074/jbc.M309767200; Yamani L, 2014, MOL BIOL CELL, V25, P702, DOI 10.1091/mbc.E13-09-0511; Zheng W, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0014401; Zinszner H, 1998, GENE DEV, V12, P982, DOI 10.1101/gad.12.7.982; Zufferey R, 1997, NAT BIOTECHNOL, V15, P871, DOI 10.1038/nbt0997-871	71	15	15	0	12	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0969-9961	1095-953X		NEUROBIOL DIS	Neurobiol. Dis.	OCT	2016	94						139	156		10.1016/j.nbd.2016.06.011			18	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DT9QF	WOS:000381836700014	27334877	Green Accepted, hybrid, Green Published			2022-02-06	
J	Gardner, EC; Chan, WW; Sutton, KM; Blaine, TA				Gardner, Elizabeth C.; Chan, Wayne W.; Sutton, Karen M.; Blaine, Theodore A.			Shoulder Injuries in Men's Collegiate Lacrosse, 2004-2009	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						lacrosse; shoulder; injury prevention; epidemiology	SURVEILLANCE SYSTEM; HIGH-SCHOOL; UNITED-STATES; EPIDEMIOLOGY; CONCUSSIONS; PREVENTION; SOCCER; GIRLS; BOYS; HEAD	Background: Men's lacrosse has been one of the fastest growing team sports in the United States, at both the collegiate and high school levels. Uniquely, it combines both continuous overhead and contact activity. Thus, an understanding of its injury epidemiology and mechanisms is vital. Shoulder injuries have been shown to be common in the sport, but thus far there has been no dedicated analysis of these injuries with which to better inform injury prevention strategies. Study Design: Descriptive epidemiology study. Methods: All athlete exposures (AEs) and shoulder injuries reported to the National Collegiate Athletic Association (NCAA) Injury Surveillance System for intercollegiate men's lacrosse athletes from 2004-2005 through 2008-2009 were collected. Type of injury was documented and the injury incidence per 1000 AEs was calculated. Event type, injury mechanism, specific injury, outcome, and time lost were recorded. Statistical analysis was performed using 95% CIs, calculated based on a normal approximation to Poisson distribution. Results: There were a total of 124 observed shoulder injuries during 229,591 monitored AEs. With weights, this estimates 1707 shoulder injuries over 2,873,973 AEs, for an incidence of 0.59 per 1000 AEs (95% CI, 0.56-0.62). The incidence of shoulder injury during competition was 1.89 per 1000 AEs (95% CI, 1.76-2.02), compared with 0.35 per 1000 AEs (95% CI, 0.33-0.38) during practice. Acromioclavicular joint injuries were most common (0.29 per 1000 AEs; 95% CI, 0.27-0.31). Labral injuries and instability events were also frequent (0.11 per 1000 AEs; 95% CI, 0.10-0.13). Player-to-player contact caused 57% of all shoulder injuries, with 25% due to contact with the playing surface. The average time lost was 11.0 days, with 41.9% of all shoulder injuries requiring 10 days. Clavicle fractures and posterior shoulder dislocation were particularly severe, with no athletes returning to play during the same season. Conclusion: Shoulder injuries are common in NCAA men's lacrosse and are an important source of lost playing time. Acromioclavicular injuries were the most frequent injury in this series, but labral and instability injuries were also common. In this increasingly popular contact sport, an understanding of the epidemiology and mechanism of shoulder injuries may be used to improve protective equipment and develop injury prevention.	[Gardner, Elizabeth C.; Chan, Wayne W.; Sutton, Karen M.; Blaine, Theodore A.] Yale Univ, Sch Med, Dept Orthopaed Surg, 800 Howard Ave,1st Floor, New Haven, CT 06519 USA		Gardner, EC (corresponding author), Yale Univ, Sch Med, Dept Orthopaed Surg, 800 Howard Ave,1st Floor, New Haven, CT 06519 USA.	elizabeth.gardner@yale.edu			National College Athletic Association (NCAA)	One or more of the authors has declared the following potential conflict of interest or source of funding: The NCAA Injury Surveillance Program data were provided by the Datalys Center for Sports Injury Research and Prevention. The Injury Surveillance Program was funded by the National College Athletic Association (NCAA).	Arendt EA, 1999, J ATHL TRAINING, V34, P86; Covassin T, 2003, APPL NEUROPSYCHOL, V10, P12, DOI 10.1207/S15324826AN1001_3; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Diamond PT, 2001, BRAIN INJURY, V15, P537, DOI 10.1080/02699050010007362; Dick R, 2007, J ATHL TRAINING, V42, P255; Dick R, 2007, J ATHL TRAINING, V42, P173; Dragoo JL, 2012, AM J SPORT MED, V40, P2066, DOI 10.1177/0363546512454653; Gessel LM, 2007, J ATHL TRAINING, V42, P495; Hinton RY, 2005, AM J SPORT MED, V33, P1305, DOI 10.1177/0363546504274148; Hootman JM, 2007, J ATHL TRAINING, V42, P311; Kerr ZY, 2014, J ATHL TRAINING, V49, P552, DOI 10.4085/1062-6050-49.3.58; Kucera KL, 2011, J ATHL TRAINING, V46, P489; Lincoln AE, 2007, AM J SPORT MED, V35, P207, DOI 10.1177/0363546506293900; Mair SD, 1998, AM J SPORT MED, V26, P753, DOI 10.1177/03635465980260060301; Mihata LCS, 2006, AM J SPORT MED, V34, P899, DOI 10.1177/0363546505285582; Owens BD, 2009, AM J SPORT MED, V37, P1750, DOI 10.1177/0363546509334591; Shankar PR, 2007, AM J SPORT MED, V35, P1295, DOI 10.1177/0363546507299745; US Lacrosse, 2013, 2013 PART SURV; Williams RJ, 2003, AM J SPORT MED, V31, P203, DOI 10.1177/03635465030310020801; Xiang J, 2014, AM J SPORT MED, V42, P2082, DOI 10.1177/0363546514539914	20	15	15	0	16	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	OCT	2016	44	10					2675	2681		10.1177/0363546516644246			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	DY8JC	WOS:000385374900033	27159306				2022-02-06	
J	Hamed, M; Schuss, P; Daher, FH; Borger, V; Guresir, A; Vatter, H; Guresir, E				Hamed, Motaz; Schuss, Patrick; Daher, Frederick H.; Borger, Valeri; Gueresir, Agi; Vatter, Hartmut; Gueresir, Erdem			Acute Traumatic Subdural Hematoma: Surgical Management in the Presence of Cerebral Herniation-A Single-Center Series and Multivariate Analysis	WORLD NEUROSURGERY			English	Article						Acute subdural hematoma; Cerebral herniation; Surgical treatment; Traumatic brain injury	DECOMPRESSIVE CRANIECTOMY; BRAIN-INJURY; POSTOPERATIVE COMPLICATIONS; INTRACRANIAL HEMORRHAGE; FUNCTIONAL RECOVERY; COMATOSE PATIENTS; BONE FLAP; MORTALITY; CRANIOTOMY; CRANIOPLASTY	BACKGROUND: Traumatic acute subdural hematoma (aSDH) is a severe disease. Surgical treatment is still controversially discussed, especially in patients with additional signs of cerebral herniation. However, previously investigated patient populations were heterogeneous. We therefore performed an analysis of our institutional data in a large homogenous selection of patients with traumatic aSDH to analyze factors determining clinical outcome. METHODS: Between 2010 and 2014, 196 patients with aSDH underwent surgical treatment in our department. Information including patient characteristics, treatment modality, radiologic features, and functional outcome were analyzed. Outcome was assessed according to the Glasgow Outcome Scale (GOS) at 6 months and was dichotomized into favorable (GOS score, 1-3) and unfavorable (GOS score 4-5) outcome. Furthermore, a multivariate analysis was performed to identify independent predictors of functional outcome. RESULTS: Overall, 26% of patients with aSDH achieved favorable outcome. In further analysis, unilateral or bilateral dilated pupils as a sign of cerebral herniation were present in 47% of the included patients. In the multivariate analysis, age >70 years and the presence of cerebral herniation were significant prognostic predictors for unfavorable outcome in patients with aSDH. However, 15% of patients with aSDH and signs of cerebral herniation achieved favorable outcome during follow-up. CONCLUSIONS: We provide detailed data on patients with aSDH and signs of cerebral herniation. Despite mydriasis, favorable outcome may be achieved in many patients. Nevertheless, careful individual decision making is necessary for each patient, especially when signs of cerebral herniation have persisted for a long time.	[Hamed, Motaz; Schuss, Patrick; Daher, Frederick H.; Borger, Valeri; Gueresir, Agi; Vatter, Hartmut; Gueresir, Erdem] Rhein Friedrich Wilhelms Univ, Dept Neurosurg, Bonn, Germany		Schuss, P (corresponding author), Rhein Friedrich Wilhelms Univ, Dept Neurosurg, Bonn, Germany.	patrick.schuss@ukb.uni-bonn.de	Guresir, Erdem/AAV-7224-2021; Schuss, Patrick/ABC-6469-2020; Guresir, Erdem/AAL-4484-2020	Guresir, Erdem/0000-0001-8319-0847; Schuss, Patrick/0000-0002-5806-2576; Guresir, Agi/0000-0003-1492-5461			ANDREWS BT, 1991, NEUROSURGERY, V29, P227, DOI 10.1227/00006123-199108000-00010; Arifin MZ, 2013, J NEUROSURG SCI, V57, P277; Campbell PG, 2010, WORLD NEUROSURG, V74, P279, DOI 10.1016/j.wneu.2010.05.030; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Guresir E, 2011, J NEUROSURG, V114, P954, DOI 10.3171/2009.12.JNS091065; Herou E, 2015, WORLD NEUROSURG, V83, P996, DOI 10.1016/j.wneu.2015.02.023; Honeybul S, 2016, ACTA NEUROCHIR, V158, P1251, DOI 10.1007/s00701-016-2818-0; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P817, DOI 10.1097/TA.0b013e3182aafcf0; Karibe H, 2014, NEUROL MED-CHIR, V54, P887, DOI 10.2176/nmc.cr.2014-0204; Kim KH, 2009, J KOREAN NEUROSURG S, V45, P143, DOI 10.3340/jkns.2009.45.3.143; Koc RK, 1997, NEUROSURG REV, V20, P239, DOI 10.1007/BF01105894; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; KOTWICA Z, 1993, ACTA NEUROCHIR, V121, P95, DOI 10.1007/BF01809257; Leong BK, 2013, DISABIL REHABIL, V35, P1546, DOI 10.3109/09638288.2012.748832; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Marion DW, 2006, NEUROSURGERY, V58, P655; Nishijima DK, 2012, J TRAUMA ACUTE CARE, V72, P1658, DOI 10.1097/TA.0b013e318256dfc5; Panczykowski DM, 2011, J NEUROSURG, V114, P47, DOI 10.3171/2010.7.JNS10446; Raj R, 2016, WORLD NEUROSURG, V88, P592, DOI 10.1016/j.wneu.2015.10.095; Rush B, 2016, WORLD NEUROSURG, V88, P25, DOI 10.1016/j.wneu.2015.12.034; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Schuss P, 2015, WORLD NEUROSURG, V84, P1051, DOI 10.1016/j.wneu.2015.05.066; Schuss P, 2013, J NEUROTRAUM, V30, P91, DOI 10.1089/neu.2012.2542; Schuss P, 2012, J NEUROTRAUM, V29, P1090, DOI 10.1089/neu.2011.2176; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Senft C, 2009, NEUROL RES, V31, P1012, DOI 10.1179/174313209X409034; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Tsermoulas G, 2016, WORLD NEUROSURG, V88, P569, DOI 10.1016/j.wneu.2015.10.045; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019	30	15	17	0	3	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	OCT	2016	94						501	506		10.1016/j.wneu.2016.07.061			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	EF5EJ	WOS:000390353200066	27465422				2022-02-06	
J	Osborne-Crowley, K; McDonald, S				Osborne-Crowley, Katherine; McDonald, Skye			Hyposmia, Not Emotion Perception, Is Associated With Psychosocial Outcome After Severe Traumatic Brain Injury	NEUROPSYCHOLOGY			English	Article						traumatic brain injury (TBI); social disinhibition; hyposmia; smell impairment; emotion perception	BLUNT HEAD-INJURY; NEUROPSYCHIATRIC INVENTORY; SOCIAL-PERCEPTION; OLFACTORY DYSFUNCTION; FACIAL EXPRESSION; RECOGNITION; ANOSMIA; BEHAVIOR; DEFICITS; SADNESS	Objective: The current study aimed to determine whether 2 variables associated with orbitofrontal damage, hyposmia and emotion perception deficits, are associated with socially disinhibited behavior and psychosocial outcome after traumatic brain injury (TBI). Methods: The Brief Smell Identification Test (BSIT), an emotion labeling task, an emotion intensity rating task, and an observational measure of social disinhibition were completed by 23 individuals with severe TBI. The disinhibition domain of the Neuropsychiatric Inventory and the interpersonal relationships subscale of the Sydney Psychosocial Reintegration Scale (SPRS-IR) were completed by a close other. Fifteen control participants provided norms against which to assess performance on the emotion intensity rating task. Results: BSIT scores predicted informant-reported change in interpersonal relationships on the SPRS-IR. Hyposmia, though, was not associated with informant-reported or observed social disinhibition. An impairment in accuracy scores on both emotion perceptions tasks was found for participants with TBI, yet intensity ratings did not differ between groups. This suggests that people with TBI are not actually impaired at detecting intensity of emotion but are less likely to perceive the target emotion as the dominant emotion. Emotion perception was not related to disinhibition or change in interpersonal relationships. Conclusions: These results support previous claims that hyposmia has prognostic significance following TBI. On the other hand, emotion perception impairment measured by standardized tasks does not appear to be an important factor in interpersonal outcomes. Finally, these results suggest that standardized emotion perception tasks may underestimate the emotion perception capabilities of people with TBI.	[Osborne-Crowley, Katherine; McDonald, Skye] Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia		Osborne-Crowley, K (corresponding author), Univ New South Wales, Sch Psychol, Sydney, NSW 2052, Australia.	k.osbornecrowley@unsw.edu.au		Osborne-Crowley, Katherine/0000-0003-0295-1849			Adolphs R, 2002, CURR OPIN NEUROBIOL, V12, P169, DOI 10.1016/S0959-4388(02)00301-X; Adolphs R, 2004, J COGNITIVE NEUROSCI, V16, P453, DOI 10.1162/089892904322926782; Barker C., 1994, RES METHODS CLIN COU, pxiv, 282; Barrash J, 2000, DEV NEUROPSYCHOL, V18, P355, DOI 10.1207/S1532694205Barrash; Beer JS, 2006, J COGNITIVE NEUROSCI, V18, P871, DOI 10.1162/jocn.2006.18.6.871; Beer JS, 2003, J PERS SOC PSYCHOL, V85, P594, DOI 10.1037/0022-3514.85.4.594; Benson P. J., 1991, EUROPEAN J COGNITIVE, V3, P105, DOI DOI 10.1080/09541449108406222; Bitter T, 2010, BRAIN RES, V1347, P42, DOI 10.1016/j.brainres.2010.06.003; Blair RJR, 2000, BRAIN, V123, P1122, DOI 10.1093/brain/123.6.1122; Blair RJR, 1999, BRAIN, V122, P883, DOI 10.1093/brain/122.5.883; Boraston Z, 2007, NEUROPSYCHOLOGIA, V45, P1501, DOI 10.1016/j.neuropsychologia.2006.11.010; Borgaro SR, 2004, BRAIN INJURY, V18, P33, DOI 10.1080/0269905031000110562; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Callahan CD, 2002, J HEAD TRAUMA REHAB, V17, P251, DOI 10.1097/00001199-200206000-00006; Callahan CD, 1999, J HEAD TRAUMA REHAB, V14, P581, DOI 10.1097/00001199-199912000-00006; Monsalve BC, 2012, REV PSIQUIATR SALUD, V5, P160, DOI 10.1016/j.rpsm.2012.02.004; Ciurli P, 2011, J HEAD TRAUMA REHAB, V26, P116, DOI 10.1097/HTR.0b013e3181dedd0e; Correia S, 2001, ARCH CLIN NEUROPSYCH, V16, P477, DOI 10.1016/S0887-6177(00)00059-7; Costanzo R. M., 1992, J HEAD TRAUMA REHAB, V7, P15, DOI DOI 10.1097/00001199-199203000-00005; CROWE SF, 1996, PSYCHIAT PSYCHOL LAW, V3, P39, DOI DOI 10.1080/13218719609524873; Crowe SF, 2013, J CLIN EXP NEUROPSYC, V35, P298, DOI 10.1080/13803395.2013.771616; Cummings JL, 1997, NEUROLOGY, V48, pS10, DOI 10.1212/WNL.48.5_Suppl_6.10S; CUMMINGS JL, 1994, NEUROLOGY, V44, P2308, DOI 10.1212/WNL.44.12.2308; Dimarco, 2002, EURA MEDICOPHYS, V38, P167; Doty RL, 1995, CHEM SENSES, V20, P645, DOI 10.1093/chemse/20.6.645; Doty RL, 1996, LARYNGOSCOPE, V106, P353, DOI 10.1097/00005537-199603000-00021; Fortin A, 2010, BRAIN INJURY, V24, P27, DOI 10.3109/02699050903446815; Green P, 2003, BRAIN INJURY, V17, P479, DOI 10.1080/0269905031000070242; Green REA, 2004, NEUROPSYCHOLOGIA, V42, P133, DOI 10.1016/j.neuropsychologia.2003.07.005; Haxel BR, 2008, J HEAD TRAUMA REHAB, V23, P407, DOI 10.1097/01.HTR.0000341437.59627.ec; Heberlein AS, 2008, J COGNITIVE NEUROSCI, V20, P721, DOI 10.1162/jocn.2008.20049; Hooker C, 2002, PSYCHIAT RES, V112, P41, DOI 10.1016/S0165-1781(02)00177-4; Ietswaart M, 2008, NEUROPSYCHOLOGIA, V46, P148, DOI 10.1016/j.neuropsychologia.2007.08.002; Jennett B, 1981, MANAGEMENT HEAD INJU; Kats-Gold I, 2007, J ABNORM CHILD PSYCH, V35, P363, DOI 10.1007/s10802-006-9096-x; Kilmer RP, 2006, REHABIL PSYCHOL, V51, P232, DOI 10.1037/0090-5550.51.3.232; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Leppanen JM, 2001, SCAND J PSYCHOL, V42, P429, DOI 10.1111/1467-9450.00255; LEVIN H, 1994, J NEUROPSYCH CLIN N, V6, P443; MARTZKE JS, 1991, NEUROPSYCHOLOGY, V0005, P00213, DOI DOI 10.1037/0894-4105.5.3.213; McDonald S, 2003, J HEAD TRAUMA REHAB, V18, P219, DOI 10.1097/00001199-200305000-00001; McDonald S, 2004, NEUROPSYCHOL REHABIL, V14, P285, DOI 10.1080/09602010343000237; McDonald S, 2006, DISABIL REHABIL, V28, P1529, DOI 10.1080/09638280600646185; MCKINLAY WW, 1981, J NEUROL NEUROSUR PS, V44, P527, DOI 10.1136/jnnp.44.6.527; Milders M, 2003, J CLIN EXP NEUROPSYC, V25, P157, DOI 10.1076/jcen.25.2.157.13642; Milders M, 2008, J INT NEUROPSYCH SOC, V14, P318, DOI 10.1017/S1355617708080351; Montagne B, 2007, PERCEPT MOTOR SKILL, V104, P589, DOI 10.2466/PMS.104.2.589-598; MORRISON RL, 1981, BEHAV THER, V12, P69, DOI 10.1016/S0005-7894(81)80107-4; Namiki C, 2008, NEUROCASE, V14, P474, DOI 10.1080/13554790802459494; Neumann D, 2012, ARCH PHYS MED REHAB, V93, P1414, DOI 10.1016/j.apmr.2012.03.009; Osborne-Crowley K, 2016, J CLIN EXP NEUROPSYC, V38, P341, DOI 10.1080/13803395.2015.1115824; Roberts Richard J, 2010, Indian J Psychol Med, V32, P93, DOI 10.4103/0253-7176.78504; Rosen HJ, 2005, BRAIN, V128, P2612, DOI 10.1093/brain/awh628; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Schofield PW, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00005; Sergi MJ, 2006, AM J PSYCHIAT, V163, P448, DOI 10.1176/appi.ajp.163.3.448; Sigurdardottir S, 2010, NEUROPSYCHOLOGY, V24, P504, DOI 10.1037/a0018934; Spikman JM, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0065581; Tate R, 1999, J HEAD TRAUMA REHAB, V14, P543, DOI 10.1097/00001199-199912000-00003; TROWER P, 1980, J CONSULT CLIN PSYCH, V48, P327, DOI 10.1037/0022-006X.48.3.327; VARNEY NR, 1988, J CLIN EXP NEUROPSYC, V10, P250, DOI 10.1080/01688638808408239; Watts AJ, 2006, APHASIOLOGY, V20, P707, DOI 10.1080/02687030500489953; Winkler D, 2006, J HEAD TRAUMA REHAB, V21, P8, DOI 10.1097/00001199-200601000-00002	64	15	15	2	18	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0894-4105	1931-1559		NEUROPSYCHOLOGY	Neuropsychology	OCT	2016	30	7					820	829		10.1037/neu0000293			10	Psychology, Clinical; Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DY9FX	WOS:000385440400005	27149553	Green Submitted			2022-02-06	
J	Scott, GG; Margulies, SS; Coats, B				Scott, Gregory G.; Margulies, Susan S.; Coats, Brittany			Utilizing multiple scale models to improve predictions of extra-axial hemorrhage in the immature piglet	BIOMECHANICS AND MODELING IN MECHANOBIOLOGY			English	Article						Subarachnoid space; Microstructure; Traumatic brain injury; Finite element modeling; Arachnoid trabeculae	TRAUMATIC BRAIN-INJURY; COLLEGIATE FOOTBALL PLAYERS; FINITE-ELEMENT; BIOMECHANICAL PROPERTIES; BOUNDARY-CONDITIONS; LARGE-DEFORMATION; HEAD; IMPACT; ACCELERATION; RESPONSES	Traumatic brain injury (TBI) is a leading cause of death and disability in the USA. To help understand and better predict TBI, researchers have developed complex finite element (FE) models of the head which incorporate many biological structures such as scalp, skull, meninges, brain (with gray/white matter differentiation), and vasculature. However, most models drastically simplify the membranes and substructures between the pia and arachnoid membranes. We hypothesize that substructures in the pia-arachnoid complex (PAC) contribute substantially to brain deformation following head rotation, and that when included in FE models accuracy of extra-axial hemorrhage prediction improves. To test these hypotheses, microscale FE models of the PAC were developed to span the variability of PAC substructure anatomy and regional density. The constitutive response of these models were then integrated into an existing macroscale FE model of the immature piglet brain to identify changes in cortical stress distribution and predictions of extra-axial hemorrhage (EAH). Incorporating regional variability of PAC substructures substantially altered the distribution of principal stress on the cortical surface of the brain compared to a uniform representation of the PAC. Simulations of 24 non-impact rapid head rotations in an immature piglet animal model resulted in improved accuracy of EAH prediction (to 94 % sensitivity, 100 % specificity), as well as a high accuracy in regional hemorrhage prediction (to 82-100 % sensitivity, 100 % specificity). We conclude that including a biofidelic PAC substructure variability in FE models of the head is essential for improved predictions of hemorrhage at the brain/skull interface.	[Scott, Gregory G.; Coats, Brittany] Univ Utah, Dept Mech Engn, 1495 E 100 S,1550 MEK, Salt Lake City, UT 84112 USA; [Margulies, Susan S.] Univ Penn, Dept Bioengn, Philadelphia, PA 19104 USA		Coats, B (corresponding author), Univ Utah, Dept Mech Engn, 1495 E 100 S,1550 MEK, Salt Lake City, UT 84112 USA.	brittany.coats@utah.edu	Coats, Brittany/A-4523-2009		Primary Children's Medical Center Foundation	This study was funded by the Primary Children's Medical Center Foundation.	Aimedieu P, 2004, J NEUROSURG, V100, P111, DOI 10.3171/jns.2004.100.1.0111; Armstrong DL, 2002, ARCH DIS CHILD-FETAL, V86, P124; BARBER TW, 1970, ACTA NEUROL SCAND, V46, P85, DOI 10.1111/j.1600-0404.1970.tb05606.x; Broglio SP, 2010, MED SCI SPORT EXER, V42, P2064, DOI 10.1249/MSS.0b013e3181dd9156; BYLSKI DI, 1986, J BIOMECH, V19, P19, DOI 10.1016/0021-9290(86)90105-3; Cloots RJH, 2008, ANN BIOMED ENG, V36, P1203, DOI 10.1007/s10439-008-9510-3; Cloots RJH, 2013, BIOMECH MODEL MECHAN, V12, P137, DOI 10.1007/s10237-012-0387-6; Cloots RJH, 2012, J MECH BEHAV BIOMED, V5, P41, DOI 10.1016/j.jmbbm.2011.09.012; Cloots RJH, 2011, BIOMECH MODEL MECHAN, V10, P413, DOI 10.1007/s10237-010-0243-5; Coats B, 2006, J BIOMECH, V39, P2521, DOI 10.1016/j.jbiomech.2005.07.020; Coats B, 2006, J NEUROTRAUM, V23, P1222, DOI 10.1089/neu.2006.23.1222; Coats B, 2012, INT J DEV NEUROSCI, V30, P191, DOI 10.1016/j.ijdevneu.2011.12.009; Couper Z, 2008, BIOMECH MODEL MECHAN, V7, P105, DOI 10.1007/s10237-007-0079-9; Crisco JJ, 2011, J BIOMECH, V44, P2673, DOI 10.1016/j.jbiomech.2011.08.003; Crisco JJ, 2010, J ATHL TRAINING, V45, P549, DOI 10.4085/1062-6050-45.6.549; Eucker SA, 2011, EXP NEUROL, V227, P79, DOI 10.1016/j.expneurol.2010.09.015; Faul MXL., 2010, TRAUMATIC BRAIN INJU, P2002; Frankel DA, 1998, J ULTRAS MED, V17, P411; GALFORD JE, 1970, J BIOMECH, V3, P211, DOI 10.1016/0021-9290(70)90007-2; Giordano C, 2014, J BIOMECH, V47, P1052, DOI 10.1016/j.jbiomech.2013.12.036; Hagmann CF, 2011, EARLY HUM DEV, V87, P341, DOI 10.1016/j.earlhumdev.2011.01.044; Higgins M, 2007, J ATHL TRAINING, V42, P5; Ji SB, 2014, ANN BIOMED ENG, V42, P11, DOI 10.1007/s10439-013-0907-2; Jin Xin, 2006, Stapp Car Crash J, V50, P637; Jin X, 2011, J BIOMECH, V44, P467, DOI 10.1016/j.jbiomech.2010.09.035; Jin X, 2007, STAPP CAR CRASH JO, V51, P115; KUIJPERS AHWM, 1995, J NEUROTRAUM, V12, P715, DOI 10.1089/neu.1995.12.715; Lam WWM, 2001, PEDIATR NEUROL, V25, P380, DOI 10.1016/S0887-8994(01)00349-6; Ma C, 2008, BIOINF BIOM ENG ICBE; McAllister TW, 2012, ANN BIOMED ENG, V40, P127, DOI 10.1007/s10439-011-0402-6; Monson KL, 2005, J BIOMECH, V38, P737, DOI 10.1016/j.jbiomech.2004.05.004; Nahum AM, 1977, P 21 STAPP CAR CRASH; Pang Q, 2001, J VASC RES, V38, P83, DOI 10.1159/000051033; Paolini Brielle M, 2009, Biomed Sci Instrum, V45, P161; Persson C, 2010, ANN BIOMED ENG, V38, P975, DOI 10.1007/s10439-010-9924-6; Prange MT, 2002, J BIOMECH ENG-T ASME, V124, P244, DOI 10.1115/1.1449907; Roth S, 2008, COMPUT METH PROG BIO, V90, P262, DOI 10.1016/j.cmpb.2008.01.007; Sabet AA, 2008, J BIOMECH, V41, P307, DOI 10.1016/j.jbiomech.2007.09.016; Scott G., 2015, IEEE T MED IMAG; Scott G, 2014, ANATOMY BIOMECHANICS; Sullivan S, 2015, BIOMECH MODEL MECHAN, V14, P877, DOI 10.1007/s10237-014-0643-z; Takhounts EG, 2008, STAPP CAR C, V52, P1; Wittek A, 2003, JSME INT J C-MECH SY, V46, P1388, DOI 10.1299/jsmec.46.1388; Wright RM, 2013, J NEUROTRAUM, V30, P102, DOI 10.1089/neu.2012.2418; Wright RM, 2012, BIOMECH MODEL MECHAN, V11, P245, DOI 10.1007/s10237-011-0307-1; Zhang L, 2001, Stapp Car Crash J, V45, P369; Zhang Liying, 2002, Stapp Car Crash J, V46, P145; Zoghi-Moghadam M, 2009, COMPUT METHOD BIOMEC, V12, P1, DOI [10.1080/10255840802020420, 10.1080/10255840903064897]	48	15	15	0	4	SPRINGER HEIDELBERG	HEIDELBERG	TIERGARTENSTRASSE 17, D-69121 HEIDELBERG, GERMANY	1617-7959	1617-7940		BIOMECH MODEL MECHAN	Biomech. Model. Mechanobiol.	OCT	2016	15	5					1101	1119		10.1007/s10237-015-0747-0			19	Biophysics; Engineering, Biomedical	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Engineering	DW4KM	WOS:000383611800008	26586144				2022-02-06	
J	Liao, KH; Sung, CW; Chu, SF; Chiu, WT; Chiang, YH; Hoffer, B; Ou, JC; Chen, KY; Tsai, SH; Lin, CM; Chen, GS; Li, WJ; Wang, JY				Liao, Kuo-Hsing; Sung, Chih-Wei; Chu, Shu-Fen; Chiu, Wen-Ta; Chiang, Yung-Hsiao; Hoffer, Barry; Ou, Ju-Chi; Chen, Kai-Yun; Tsai, Shin-Han; Lin, Chien-Min; Chen, Gunng-Shinng; Li, Wei-Jiun; Wang, Jia-Yi			Reduced power spectra of heart rate variability are correlated with anxiety in patients with mild traumatic brain injury	PSYCHIATRY RESEARCH			English	Article						mTBI; Anxiety; Heart rate variability; Low-frequency (LF) power	FREQUENCY-DOMAIN PARAMETERS; UNITED-STATES; MAJOR DEPRESSION; PSYCHOMETRIC PROPERTIES; RISK FACTOR; VAGAL TONE; DISORDERS; INVENTORY; DISEASE; IMPACT	Anxiety is one of the most frequently diagnosed emotional disorders after a mild traumatic brain injury (mTBI); however, predictors of anxiety after an mTBI remain uncertain. Recent research indicated that anxiety is associated with abnormalities in the autonomic nervous system (ANS) which can be evaluated by a power spectral analysis of heart rate variability (HRV). In this study, we investigated whether a frequency-domain analysis of HRV could correlate with the occurrence of anxiety in mTBI patients. We recruited 165 Taiwanese patients diagnosed with an mTBI and 82 volunteer healthy controls from three affiliated hospitals of Taipei Medical University during 2010-2014. The Beck Anxiety Inventory (BAI) was assessed at the 1st, 6th, and 12th weeks. We found that mTBI patients were more vulnerable to anxiety compared to healthy controls. The power spectral density of HRV was significantly lower in mTBI patients than in healthy controls. A correlation analysis indicated that anxiety was negatively significantly correlated with low- and high-frequency power at the 6th week. Our study suggests the clinical usefulness of HRV as a potential noninvasive tool for evaluating later anxiety in mTBI patients. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Liao, Kuo-Hsing] Taipei Med Univ, Wan Fang Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan; [Sung, Chih-Wei; Chen, Gunng-Shinng; Wang, Jia-Yi] Taipei Med Univ, Grad Inst Med Sci, Coll Med, Taipei, Taiwan; [Sung, Chih-Wei; Li, Wei-Jiun] Taipei Med Univ, Sch Med, Coll Med, Taipei, Taiwan; [Chu, Shu-Fen; Chiu, Wen-Ta; Tsai, Shin-Han] Taipei Med Univ, Grad Inst Injury & Prevent, Coll Publ Hlth, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Taipei Med Univ Hosp, Dept Surg, Div Neurosurg, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Coll Med Sci & Technol, Grad Program Neuroregenerat, Taipei, Taiwan; [Chiang, Yung-Hsiao] Taipei Med Univ, Ctr Neurotrauma & Neuroregenerat, Taipei, Taiwan; [Hoffer, Barry; Chen, Kai-Yun] Taipei Med Univ, Shuang Ho Hosp, Dept Emergency Med, New Taipei, Taiwan; [Ou, Ju-Chi; Lin, Chien-Min] Taipei Med Univ, Shuang Ho Hosp, Dept Surg, Div Neurosurg, New Taipei, Taiwan; [Chen, Gunng-Shinng] Triserv Gen Hosp, Dept Dent, Div Orthodont & Dentofacial Orthoped & Pedodont, Taipei, Taiwan; [Wang, Jia-Yi] Taipei Med Univ, Sch Med, Dept Physiol, Coll Med, 250 Wu Xing St, Taipei 110, Taiwan		Wang, JY (corresponding author), Taipei Med Univ, Sch Med, Dept Physiol, Coll Med, 250 Wu Xing St, Taipei 110, Taiwan.; Wang, JY (corresponding author), Taipei Med Univ, Coll Med, Sch Med, Grad Inst Med Sci, 250 Wu Xing St, Taipei 110, Taiwan.	jywang2010@tmu.edu.tw		Wang, Jia-Yi/0000-0002-9106-3351; Sung, Chih-Wei/0000-0003-3312-2752	Ministry of Science and Technology, TaiwanMinistry of Science and Technology, Taiwan [MOST-103-2321-B-038-002, MOST-104-2923-B-038-001-MY3, MOST-102-2815-C-038-071-B]; Taipei Medical University, Taiwan; Wan Fang Hospital, Taipei, Taiwan [99TMU-WFH-11]	This work was supported in part by Grants from the Ministry of Science and Technology, Taiwan (MOST-103-2321-B-038-002 and MOST-104-2923-B-038-001-MY3) to JYW and (MOST-102-2815-C-038-071-B) to CWS and from Taipei Medical University, Taiwan and Wan Fang Hospital (99TMU-WFH-11), Taipei, Taiwan.	Alvares GA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0070468; Arciniegas DB, 2001, BRAIN INJURY, V15, P649, DOI 10.1080/02699050010019800; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Bayly PV, 2005, J NEUROTRAUM, V22, P845, DOI 10.1089/neu.2005.22.845; BECK AT, 1991, AM J PSYCHIAT, V148, P1195; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; Berntson GG, 2007, BIOL PSYCHOL, V74, P295, DOI 10.1016/j.biopsycho.2006.08.006; Berntson GG, 1997, PSYCHOPHYSIOLOGY, V34, P623, DOI 10.1111/j.1469-8986.1997.tb02140.x; Biswas AK, 2000, CRIT CARE MED, V28, P3907, DOI 10.1097/00003246-200012000-00030; Blom EH, 2010, ACTA PAEDIATR, V99, P604, DOI 10.1111/j.1651-2227.2009.01657.x; Bohnen N., 1992, Brain Injury, V6, P481, DOI 10.3109/02699059209008145; Bushnik T, 2003, ARCH PHYS MED REHAB, V84, P255, DOI 10.1053/apmr.2003.50092; Butcher I, 2007, J NEUROTRAUM, V24, P281, DOI 10.1089/neu.2006.0030; Cameron O, 1996, PSYCHOSOM MED, V58, P111, DOI 10.1097/00006842-199603000-00002; Carney RM, 2002, J PSYCHOSOM RES, V53, P897, DOI 10.1016/S0022-3999(02)00311-2; CARNEY RM, 1995, ANN BEHAV MED, V17, P142, DOI 10.1007/BF02895063; Carroll L.J., 2004, J REHABIL MED S, pS113; Casati D, 2014, EXP PHYSIOL, V99, P466, DOI 10.1113/expphysiol.2013.076539; Chang HA, 2013, PSYCHIAT INVEST, V10, P326, DOI 10.4306/pi.2013.10.4.326; Chen CF, 2013, J CLIN NEUROSCI, V20, P406, DOI 10.1016/j.jocn.2012.02.047; Chiu WT, 1997, NEUROL RES, V19, P261, DOI 10.1080/01616412.1997.11740811; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Cox BJ, 1996, BEHAV RES THER, V34, P949, DOI 10.1016/S0005-7967(96)00037-X; CUMMINGS JL, 1993, ARCH NEUROL-CHICAGO, V50, P873, DOI 10.1001/archneur.1993.00540080076020; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Friedman BH, 1998, BIOL PSYCHOL, V49, P303; Friedman BH, 2007, BIOL PSYCHOL, V74, P185, DOI 10.1016/j.biopsycho.2005.08.009; Glassman AH, 1998, AM J PSYCHIAT, V155, P4, DOI 10.1176/ajp.155.1.4; Gray J A, 1996, Nebr Symp Motiv, V43, P61; Hiott DW, 2002, NEUROREHABILITATION, V17, P345; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kendler KS, 2001, PSYCHOL MED, V31, P605, DOI 10.1017/S0033291701003907; Kurtoglu E, 2014, ACTA ANAESTH SCAND, V58, P370, DOI 10.1111/aas.12261; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Larrabee GJ, 2013, BEHAV SCI LAW, V31, P686, DOI 10.1002/bsl.2087; Licht CMM, 2009, PSYCHOSOM MED, V71, P508, DOI 10.1097/PSY.0b013e3181a292a6; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; Ma VY, 2014, ARCH PHYS MED REHAB, V95, P986, DOI 10.1016/j.apmr.2013.10.032; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Maetzler W, 2015, J NEURAL TRANSM, V122, P419, DOI 10.1007/s00702-014-1276-1; Matthews SC, 2011, NEUROIMAGE, V54, pS69, DOI 10.1016/j.neuroimage.2010.04.269; McCauley SR, 2008, J CLIN EXP NEUROPSYC, V30, P360, DOI 10.1080/13803390701416635; Meyer DL, 2012, EXP NEUROL, V235, P574, DOI 10.1016/j.expneurol.2012.03.012; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Moore EL, 2006, BRAIN INJURY, V20, P117, DOI 10.1080/02699050500443558; Nolen-Hoeksema S, 2001, CURR DIR PSYCHOL SCI, V10, P173, DOI 10.1111/1467-8721.00142; Norris PR, 2005, J SURG RES, V129, P122, DOI 10.1016/j.jss.2005.04.024; Osman A, 1997, J CLIN PSYCHOL, V53, P7, DOI 10.1002/(SICI)1097-4679(199701)53:1<7::AID-JCLP2>3.0.CO;2-S; Piccinelli M, 1999, J PSYCHOSOM RES, V46, P455, DOI 10.1016/S0022-3999(98)00126-3; PODRID PJ, 1990, CIRCULATION, V82, P103; Ruff RL, 2012, JAMA-J AM MED ASSOC, V308, P2032, DOI 10.1001/jama.2012.14008; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Scholten AC, 2016, J NEUROTRAUM; SCHWARTZ PJ, 1981, J CARDIOVASC PHARM, V3, P1251, DOI 10.1097/00005344-198111000-00012; Sosin DM, 1996, BRAIN INJURY, V10, P47; Su CF, 2005, CLIN NEUROPHYSIOL, V116, P1273, DOI 10.1016/j.clinph.2005.01.010; Summers CR, 2009, MT SINAI J MED, V76, P105, DOI 10.1002/msj.20100; Sung C.W., 2015, PSYCHOPHYSIOLOGY; van der Horn HJ, 2013, ARCH PHYS MED REHAB, V94, P867, DOI 10.1016/j.apmr.2012.11.039; van Zyl LT, 2008, BIOPSYCHOSOC MED, V2, DOI 10.1186/1751-0759-2-12; Williams WH, 2010, J NEUROL NEUROSUR PS, V81, P1116, DOI 10.1136/jnnp.2008.171298; Yien HW, 1997, CRIT CARE MED, V25, P258, DOI 10.1097/00003246-199702000-00011; Zheng A, 2008, J NUTR SCI VITAMINOL, V54, P148, DOI 10.3177/jnsv.54.148	63	15	15	0	7	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0165-1781			PSYCHIAT RES	Psychiatry Res.	SEP 30	2016	243						349	356		10.1016/j.psychres.2016.07.001			8	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	DW7EA	WOS:000383812800055	27449003				2022-02-06	
J	Alosco, ML; Aslan, M; Du, MT; Ko, J; Grande, L; Proctor, SP; Concato, J; Vasterling, JJ				Alosco, Michael L.; Aslan, Mihaela; Du, Mengtian; Ko, John; Grande, Laura; Proctor, Susan P.; Concato, John; Vasterling, Jennifer J.			Consistency of Recall for Deployment-Related Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						OIF; PTSD; recall consistency; TBI screening; traumatic brain injury	POSTTRAUMATIC-STRESS-DISORDER; NATIONAL-GUARD; MEMORY; VETERANS; IRAQ; STABILITY; VALIDITY; EVENTS; EXPOSURE; OUTCOMES	Objective: To examine the temporal consistency of self-reported deployment-related traumatic brain injury (TBI) and its association with posttraumatic stress disorder (PTSD) symptom severity. Setting: In-person interviews at US Army installations (postdeployment); phone interviews (long-term follow-up). Participants: A total of 378 US Army soldiers and veterans deployed to Iraq; 14.3% (n = 54) reported TBI with loss of consciousness during an index deployment. Design: Participants were evaluated after returning from deployment and again 5 to 9 years later. Main Measures: Temporal consistency of TBI endorsement based on TBI screening interviews; PTSD Checklist, Civilian Version. Results: The concordance of deployment-related TBI endorsement from the postdeployment to long-term follow-up assessment was moderate (kappa = 0.53). Of the 54 participants reporting (predominantly mild) TBI occurring during an index deployment, 32 endorsed TBI inconsistently over time. More severe PTSD symptoms at postdeployment assessment were independently associated with discordant reporting (P =.0004); each 10-point increase in PCL scores increasing odds of discordance by 69% (odds ratio = 1.69; 95% confidence interval, 1.26-2.26). Conclusions: Deployment-related TBI may not be reported reliably over time, particularly among war-zone veterans with greater PTSD symptoms. Results of screening evaluations for TBI history should be viewed with caution in the context of PTSD symptom history.	[Alosco, Michael L.; Grande, Laura; Vasterling, Jennifer J.] VA Boston Healthcare Syst, Psychol Serv, 150 S Huntington Ave, Boston, MA 02130 USA; [Aslan, Mihaela; Ko, John; Concato, John] VA Connecticut Healthcare Syst, Clin Epidemiol Res Ctr, West Haven, CT USA; [Aslan, Mihaela; Ko, John; Concato, John] Yale Univ, Sch Med, Dept Med, New Haven, CT 06510 USA; [Du, Mengtian] Yale Grad Sch Arts & Sci, Dept Publ Hlth, New Haven, CT USA; [Grande, Laura; Vasterling, Jennifer J.] Boston Univ, Sch Med, Dept Psychiat, Boston, MA 02118 USA; [Proctor, Susan P.] US Army Res Inst Environm Med, Natick, MA USA; [Proctor, Susan P.] Boston Univ, Sch Publ Hlth, Dept Environm Hlth, Boston, MA USA; [Vasterling, Jennifer J.] VA Boston Healthcare Syst, Natl Ctr PTSD, 150 S Huntington Ave, Boston, MA 02130 USA; [Alosco, Michael L.] Boston Univ, Sch Med, Alzheimers Dis & CTE Ctr, Boston, MA 02118 USA		Vasterling, JJ (corresponding author), VA Boston Healthcare Syst, Psychol Serv 116B, 150 S Huntington Ave, Boston, MA 02130 USA.	jennifer.vasterling@va.gov			US Army Medical Research and Materiel CommandU.S. Army Medical Research & Materiel Command (USAMRMC) [DAMD 17-03-0020]; Department of Veterans Affairs (VA) Clinical Sciences Research and Development; VA Cooperative Studies Program (VA CSP) [566]	Funding for the collection of postdeployment data was provided by the US Army Medical Research and Materiel Command (DAMD 17-03-0020) and the Department of Veterans Affairs (VA) Clinical Sciences Research and Development. Funding for all other aspects of the work was provided by VA Cooperative Studies Program (VA CSP# 566). The authors are grateful to the soldiers and military veterans who comprise the Neurocognition Deployment Health Study cohort for their long-standing participation in the research and for their military service more generally.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; [Anonymous], 2008, MILD TRAUM BRAIN INJ; Belanger HG, 2012, ARCH PHYS MED REHAB, V93, P1234, DOI 10.1016/j.apmr.2012.03.003; Belanger HG, 2005, J INT NEUROPSYCH SOC, V11, P345, DOI 10.1017/S1355617705050411; Boake C, 1996, J HEAD TRAUMA REHAB, V11, P98; Brohawn KH, 2010, BIOL PSYCHIAT, V68, P1023, DOI 10.1016/j.biopsych.2010.07.018; Bryant RA, 1996, J TRAUMA STRESS, V9, P621; Donnelly KT, 2011, J HEAD TRAUMA REHAB, V26, P439, DOI 10.1097/HTR.0b013e3182005de3; El Khoury-Malhame M, 2011, BEHAV RES THER, V49, P796, DOI 10.1016/j.brat.2011.08.006; Engelhard IM, 2008, MEMORY, V16, P3, DOI 10.1080/09658210701334022; Felmingham KL, 2011, J ANXIETY DISORD, V25, P668, DOI 10.1016/j.janxdis.2011.02.010; Fortier CB, 2014, J HEAD TRAUMA REHAB, V29, P89, DOI 10.1097/HTR.0b013e3182865859; Gittins CB, 2015, J BEHAV THER EXP PSY, V46, P19, DOI 10.1016/j.jbtep.2014.07.006; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Institute of Medicine, RET HOM IR AFGH ASS; King DW, 2000, J ABNORM PSYCHOL, V109, P624, DOI 10.1037//0021-843X.109.4.624; Luethcke CA, 2011, J INT NEUROPSYCH SOC, V17, P36, DOI 10.1017/S1355617710001207; Palacios EM, 2013, CORTEX, V49, P646, DOI 10.1016/j.cortex.2012.02.011; Peduzzi P, 1996, J CLIN EPIDEMIOL, V49, P1373, DOI 10.1016/S0895-4356(96)00236-3; Polusny MA, 2011, ARCH GEN PSYCHIAT, V68, P79, DOI 10.1001/archgenpsychiatry.2010.172; Ruggiero KJ, 2003, J TRAUMA STRESS, V16, P495, DOI 10.1023/A:1025714729117; Small SA, 2001, ARCH NEUROL-CHICAGO, V58, P360, DOI 10.1001/archneur.58.3.360; Southwick SM, 1997, AM J PSYCHIAT, V154, P173; Tanielian T., 2008, INVISIBLE WOUNDS WAR; Taylor BC, 2012, MED CARE, V50, P342, DOI 10.1097/MLR.0b013e318245a558; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Van Dyke SA, 2010, MIL MED, V175, P947, DOI 10.7205/MILMED-D-10-00337; Vanderploeg RD, 2015, J HEAD TRAUMA REHAB, V30, pE29, DOI 10.1097/HTR.0000000000000095; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Verfaellie M, 2009, NEUROBIOLOGY PTSD, P105; Weber Darren L, 2008, Open Neuroimag J, V2, P29, DOI 10.2174/1874440000802010029; Wessely S, 2003, BRIT J PSYCHIAT, V183, P314, DOI 10.1192/bjp.183.4.314; Wilson ALG, 2010, ANN EPIDEMIOL, V20, P939, DOI 10.1016/j.annepidem.2010.08.007	33	15	15	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					360	368		10.1097/HTR.0000000000000201			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600014	26580696				2022-02-06	
J	Anandalwar, SP; Mau, CY; Gordhan, CG; Majmundar, N; Meleis, A; Prestigiacomo, CJ; Sifri, ZC				Anandalwar, Seema P.; Mau, Christine Y.; Gordhan, Chirag G.; Majmundar, Neil; Meleis, Ahmed; Prestigiacomo, Charles J.; Sifri, Ziad C.			Eliminating unnecessary routine head CT scanning in neurologically intact mild traumatic brain injury patients: implementation and evaluation of a new protocol	JOURNAL OF NEUROSURGERY			English	Article						mild traumatic brain injury; computed tomography; repeat head computed tomography	CRANIAL COMPUTED-TOMOGRAPHY; INTRACRANIAL HEMORRHAGE; REPEAT; PROGRESSION; UTILITY; SCANS	OBJECTIVE The utility of routine repeat head CT (HCT) scans in the management of minimal head injury (MHI) patients with an intracranial hemorrhage (ICH) has been questioned in multiple studies. All these studies analyzed this by obtaining a repeat HCT study, and none examined the effects of eliminating these routine HCT studies in neurologically intact patients. The authors' institution implemented a new "Neurologic Observation without Repeat HCT" (NORH) protocol with no repeat HCT scanning for patients admitted for MHI and ICH whose neurological status was maintained or improved to a Glasgow Coma Scale score of 15 at 24 hours after admission. This purpose of this study was to assess the outcomes and safety of this novel protocol. METHODS Records of patients who sustained blunt trauma MHI and an ICH and/or skull fracture on initial HCT between January 1, 2009, and December 31, 2012, were retrieved from the trauma registry of a Level I trauma center. The authors analyzed 95 patients in whom the NORH protocol was followed. Outcome measures included death, emergency department readmission, neurosurgical intervention, delayed repeat HCT, and length of stay. RESULTS The NORH protocol was followed for 95 patients; 83% of the patients were male, the average age was 38 +/- 16.0 years old, and the most common cause of trauma was assault (35%). Of the 95 patients in whom the NORH protocol was followed, 8 (8%) had a delayed repeat HCT study (> 24 hours) after admission, but none resulted in neurosurgical intervention because of progression of ICH. The average length of stay was 4 +/- 7.2 days. None of the patients were readmitted to the hospital. CONCLUSIONS Implementation of the NORH protocol (eliminating routine follow-up HCT) resulted in very low rates of delayed neurological deterioration, no late neurosurgical interventions resulting from ICH progression, very few emergency department revisits, and no readmissions. For a select group of MHI patients with ICH, the NORH protocol is safe and effective, and can reduce radiation exposure and costs.	[Anandalwar, Seema P.; Gordhan, Chirag G.; Sifri, Ziad C.] Rutgers New Jersey Med Sch, Dept Trauma Surg, Newark, NJ USA; [Mau, Christine Y.; Majmundar, Neil; Meleis, Ahmed; Prestigiacomo, Charles J.] Rutgers New Jersey Med Sch, Dept Neurol Surg, Newark, NJ USA		Sifri, ZC (corresponding author), New Jersey Trauma Ctr, Div Trauma & Crit Care, 150 Bergen St,M232, Newark, NJ 07101 USA.	sifrizi@njms.rutgers.edu	Prestigiacomo, Charles J/B-3911-2018	Prestigiacomo, Charles J/0000-0002-5979-2378; Majmundar, Neil/0000-0001-5910-6094; Mau, Christine/0000-0002-8385-5084			AbdelFattah KR, 2012, J TRAUMA ACUTE CARE, V73, P685, DOI 10.1097/TA.0b013e318265ccd9; Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; Bee TK, 2009, J TRAUMA, V66, P1015, DOI 10.1097/TA.0b013e31819adbc8; Brown CVR, 2007, J TRAUMA, V62, P1339, DOI 10.1097/TA.0b013e318054e25a; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Ding J, 2012, BRAIN INJURY, V26, P1211, DOI 10.3109/02699052.2012.667591; Homnick A, 2012, INJURY, V43, P2122, DOI 10.1016/j.injury.2012.04.013; Huynh T, 2006, AM SURGEON, V72, P1162; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Levin HS, 1996, NEUROTRAUMA, P749; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Nishijima DK, 2011, J TRAUMA, V70, pE101, DOI 10.1097/TA.0b013e3181e88bcb; Park HK, 2009, BRIT J NEUROSURG, V23, P617, DOI 10.3109/02688690902999302; Sharifuddin Ashraf, 2012, Med J Malaysia, V67, P305; Sifri ZC, 2004, AM J SURG, V187, P338, DOI 10.1016/j.amjsurg.2003.12.015; Sifri ZC, 2012, J TRAUMA, V72, P538; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Sifri ZC, 2011, J TRAUMA, V71, P1605, DOI 10.1097/TA.0b013e31822b3728; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Thomas BW, 2010, J AM COLL SURGEONS, V210, P824, DOI 10.1016/j.jamcollsurg.2009.12.039; Thorson CM, 2013, J TRAUMA ACUTE CARE, V74, P967, DOI 10.1097/TA.0b013e3182877fed; Velmahos GC, 2006, J TRAUMA, V60, P494, DOI 10.1097/01.ta.0000203546.14824.0d; Vos PE, 2012, EUR J NEUROL, V19, P191, DOI 10.1111/j.1468-1331.2011.03581.x; Wang MC, 2006, J TRAUMA, V61, P226, DOI 10.1097/01.ta.0000197385.18452.89; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	26	15	15	0	5	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2016	125	3					667	673		10.3171/2015.9.JNS151379			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DT8YS	WOS:000381782300018	26771855	Bronze			2022-02-06	
J	Church, D; Sparks, T; Clond, M				Church, Dawson; Sparks, Terry; Clond, Morgan			EFT (EMOTIONAL FREEDOM TECHNIQUES) AND RESILIENCY IN VETERANS AT RISK FOR PTSD: A RANDOMIZED CONTROLLED TRIAL	EXPLORE-THE JOURNAL OF SCIENCE AND HEALING			English	Article						veterans; PTSD; resiliency; EFT; emotional freedom techniques	POSTTRAUMATIC-STRESS-DISORDER; ACUPUNCTURE; PSYCHOTHERAPY; STIMULATION; PREVALENCE; CHECKLIST; SYMPTOMS; VIETNAM; TRAUMA; CARE	Prior research indicates elevated but subclinical posttraumatic stress disorder (PTSD) symptoms as a risk factor for a later diagnosis of PTSD. This study examined the progression of symptoms in 21 subclinical veterans. Participants were randomized into a treatment as usual (TAU) wait-list group and an experimental group, which received TAU plus six sessions of clinical emotional freedom techniques (EFT). Symptoms were assessed using the PCL-M (Posttraumatic Checklist Military) on which a score of 35 or higher indicates increased risk for PTSD. The mean pretreatment score of participants was 39 +/- 8.7, with no significant difference between groups. No change was found in the TAU group during the wait period. Afterward, the TAU group received an identical clinical EFT protocol. Posttreatment groups were combined for analysis. Scores declined to a mean of 25 (-64%, P < .0001). Participants maintained their gains, with mean three-month and six-month follow-up PCL-M scores of 27 (P < .0001). Similar reductions were noted in the depth and breadth of psychological conditions such as anxiety. A Cohen's d = 1.99 indicates a large treatment effect. Reductions in traumatic brain injury symptoms (P = .045) and insomnia (P = .004) were also noted. Symptom improvements were similar to those assessed in studies of PTSD-positive veterans. EFT may thus be protective against an increase in symptoms and a later PTSD diagnosis. As a simple and quickly learned self-help method, EFT may be a clinically useful element of a resiliency program for veterans and active-duty warriors.	[Church, Dawson] Natl Inst Integrat Healthcare, 3340 Fulton Rd,442, Fulton, CA 95439 USA; [Sparks, Terry] Oklahoma City VA Hlth Care Syst, Oklahoma City, OK USA; [Clond, Morgan] Ben Gurion Univ Negev, Sch Med, Beer Sheva, Israel		Church, D (corresponding author), Natl Inst Integrat Healthcare, 3340 Fulton Rd,442, Fulton, CA 95439 USA.	dawsonchurch@gmail.com		Clond, Morgan/0000-0002-3036-4193	National Institute for Integrative Healthcare	The study was funded by private individual donations to the nonprofit National Institute for Integrative Healthcare.	Agaibi CE, 2005, TRAUMA VIOLENCE ABUS, V6, P195, DOI 10.1177/1524838005277438; American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Andrews B, 2007, AM J PSYCHIAT, V164, P1319, DOI 10.1176/appi.ajp.2007.06091491; Bastien CH, 2001, SLEEP MED, V9, pY307; Berninger A, 2010, AM J IND MED, V53, P1177, DOI 10.1002/ajim.20894; Blake D.D., 1990, CLIN ADM PTSD SCALE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Boath E. H., 2013, ENERGY PSYCHOL J, V5, P29, DOI [DOI 10.9769/EPJ.2013.5.2.EB.AC.AS.SU, 10.9769/EPJ.2013.5.2.EB.AC.AS.SU]; Bougea AM, 2013, EXPLORE-NY, V9, P91, DOI 10.1016/j.explore.2012.12.005; Bradley R, 2005, AM J PSYCHIAT, V162, P214, DOI 10.1176/appi.ajp.162.2.214; Brooks, 2012, TRAUMATOLOGY, V18, P73, DOI [10.1177/1534765611426788, DOI 10.1177/1534765611426788]; Cherkin DC, 2009, ARCH INTERN MED, V169, P858, DOI 10.1001/archinternmed.2009.65; Church D, 2010, TRAUMATOLOGY, V16, P55, DOI DOI 10.1177/1534765609347549; Church D, 2015, C ASS COMPR EN PSYCH; Church D, 2016, EXPLORE-NY, V10, P162; Church D, 2010, INTEGRATIVE MED, V9, P40; Church D., 2009, ENERGY PSYCHOL, V1, P9; Church D, 2016, ARCH SCI PS IN PRESS; Church D, 2014, TRAUMATOL, V20, P172, DOI [DOI 10.1037/H0099831, 10.1037/h0099831]; Church D., 2010, ENERGY PSYCHOL, V2, P9; Church D., 2013, THE EFT MANUAL; Church D, 2009, INT J HEAL CARING, V9, P1; Church D., 2013, PSYCHOLOGY, V4, P646, DOI DOI 10.4236/PSYCH.2013.48092; Church D., 2013, CAPTURE MOMENT SINGL; Church Dawson, 2012, Depress Res Treat, V2012, P257172, DOI 10.1155/2012/257172; Church D, 2014, EXPLORE-NY, V10, P24, DOI 10.1016/j.explore.2013.10.006; Church D, 2013, J NERV MENT DIS, V201, P153, DOI 10.1097/NMD.0b013e31827f6351; Church D, 2012, J NERV MENT DIS, V200, P891, DOI 10.1097/NMD.0b013e31826b9fc1; Connor KM, 2006, J CLIN PSYCHIAT, V67, P46; Craig G, 1995, THE EFT MANUAL; Davison ML, 1997, ASSESSMENT, V4, P259, DOI 10.1177/107319119700400306; Denning LA., 2014, PREVENTING PSYCHOL D; Dhond RP, 2007, J ALTERN COMPLEM MED, V13, P603, DOI 10.1089/acm.2007.7040; Dohrenwend BP, 2006, SCIENCE, V313, P979, DOI 10.1126/science.1128944; Feinstein D, 2009, ENERGY PSYCHOL THEOR, V1, P45, DOI [10.9769.EPJ.2009.1.1.DF, DOI 10.9769/EPJ.2009.1.1.DF]; Feinstein D, 2012, REV GEN PSYCHOL, V16, P364, DOI 10.1037/a0028602; Feinstein D, 2010, REV GEN PSYCHOL, V14, P283, DOI 10.1037/a0021252; Feinstein D, 2010, PSYCHOTHERAPY, V47, P385, DOI 10.1037/a0021171; Felmingham K, 2007, PSYCHOL SCI, V18, P127, DOI 10.1111/j.1467-9280.2007.01860.x; Fox L., 2013, ENERGY PSYCHOL, V5, P15, DOI DOI 10.9769/EPJ.2013.5.2.LF; Gaudiano BA, 2012, RES SOCIAL WORK PRAC, V22, P647, DOI 10.1177/1049731512448468; Geronilla L, 2016, GRAND ROUNDS FORT HO; Goodwin L, 2012, J NERV MENT DIS, V200, P429, DOI 10.1097/NMD.0b013e31825322fe; Gurret J-M, 2012, ENERGY PSYCHOL, V4, P26; Hartung J, 2012, ENERGY PSYCHOL, V4, P33; Hui KKS, 2005, NEUROIMAGE, V27, P479, DOI 10.1016/j.neuroimage.2005.04.037; Karatzias T, 2011, J NERV MENT DIS, V199, P372, DOI 10.1097/NMD.0b013e31821cd262; Kilpatrick G, 2007, J TRAUMA STRESS, V20, P487, DOI 10.1002/jts.20262; Kim Young-Dae, 2013, Evid Based Complement Alternat Med, V2013, P615857, DOI 10.1155/2013/615857; Kulka R., 1988, CONTRACTUAL REPORT F, V1; Lambrou PT, 2003, SUBTLE ENERGIES ENER, V14, P239; Levine SZ, 2009, J TRAUMA STRESS, V22, P282, DOI 10.1002/jts.20409; Monson CM, 2006, J CONSULT CLIN PSYCH, V74, P898, DOI 10.1037/0022-006X.74.5.898; Napadow V, 2007, PAIN, V130, P254, DOI 10.1016/j.pain.2006.12.003; Palmer-Hoffman J, 2011, ENERGY PSYCHOL, V3, P33, DOI DOI 10.9769/EPJ.2011.3.1.JPH; Reynolds AE, 2015, ENERGY PSYCHOL, V7, P14, DOI DOI 10.9769/EPJ.2015.07.01.AR; Rowe JE, 2005, COUNS CLIN PSYCHOL J, V2, P104, DOI DOI 10.1002/JCLP.10189; Schindel-Allon I, 2010, PSYCHOL MED, V40, P1669, DOI 10.1017/S0033291709992248; Schnurr P.P., 2014, PTSD RES Q, V25, P1; Schulz P., 2009, ENERGY PSYCHOL, V1, P15, DOI DOI 10.9769/EPJ.2009.1.1.KS; Smid GE, 2009, J CLIN PSYCHIAT, V70, P1572, DOI 10.4088/JCP.08r04484; Stapleton PB, 2016, C ASS COMPR EN UNPUB; Stapleton Peta, 2013, ISRN Psychiatry, V2013, P573532, DOI 10.1155/2013/573532; Stapleton P, 2011, BEHAV CHANGE, V28, P1, DOI 10.1375/bech.28.1.1; Stein PK, 2011, ENERGY PSYCHOL THEOR, V3, P11, DOI DOI 10.9769/EPJ.2011.3.1.PKS.AJB; Stewart A, 2013, ENERGY PSYCHOL J, V5, P13, DOI DOI 10.9769/EPJ.2013.5.1.AS]; Stewart A, 2016, J PSYCHOL T IN PRESS; Swingle PG, 2004, SUBTLE ENERGIES ENER, V15, P75; Vasterling J., 2005, NEUROPSYCHOLOGY PTSD; Veterans Health Administration, 2012, REP VA FAC SPEC OP E; Weathers F.W., 1991, PTSD CHECKLIST MILIT; WEISS DS, 1992, J TRAUMA STRESS, V5, P365, DOI 10.1002/jts.2490050304; Wolpe J., 1973, PRACTICE BEHAV THERA, V2nd; Zoroya G., 2014, USA TODAY	75	15	17	0	24	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1550-8307	1878-7541		EXPLORE-NY	Explore-J Sci. Heal.	SEP-OCT	2016	12	5					355	365		10.1016/j.explore.2016.06.012			11	Integrative & Complementary Medicine	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Integrative & Complementary Medicine	DX5CU	WOS:000384398200017	27543343				2022-02-06	
J	Kreber, LA; Griesbach, GS; Ashley, MJ				Kreber, Lisa A.; Griesbach, Grace S.; Ashley, Mark J.			Detection of Growth Hormone Deficiency in Adults with Chronic Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						adult brain injury; clinical management of CNS injury; growth hormone deficiency; hypopituitarism; human studies	GH DEFICIENCY; LONG-TERM; PITUITARY DYSFUNCTION; INPATIENT REHABILITATION; CONSENSUS GUIDELINES; UNITED-STATES; RATING-SCALE; HYPOPITUITARISM; PREVALENCE; GLUCAGON	This study examined the prevalence of growth hormone deficiency (GHD) in patients with traumatic brain injury (TBI) during the post-acute phase of recovery and whether GHD was associated with increased disability, decreased independence, and depression. A secondary objective was to determine the accuracy of insulin-like growth factor-1 (IGF-1) levels in predicting GHD in patients with TBI. Anterior pituitary function was assessed in 235 adult patients with TBI through evaluation of fasting morning hormone levels. GH levels were assessed through provocative testing, specifically the glucagon stimulation test. GHD was diagnosed in a significant number of patients, with 45% falling into the severe GHD (<= 3 mu g/L) category. IGF-1 levels were not predictive of GHD. Patients with GHD were more disabled and less independent compared with those patients who were not GHD. Those patients with more severe GHD also showed decreased levels of cortisol and testosterone. Symptoms of depression were also more prevalent in this group. In addition, patients with severe GHD had delayed admission to post-acute rehabilitation. This study confirms the high prevalence of GHD in patients with TBI and the necessity to monitor clinical symptoms and perform provocative testing to definitively diagnose GHD.	[Kreber, Lisa A.; Griesbach, Grace S.; Ashley, Mark J.] UCLA, David Geffen Sch Med, Ctr Neuro Skills, Bakersfield, CA USA; [Griesbach, Grace S.] UCLA, David Geffen Sch Med, Dept Neurosurg, Bakersfield, CA USA; [Kreber, Lisa A.; Griesbach, Grace S.; Ashley, Mark J.] UCLA, David Geffen Sch Med, Ctr Neuro Skills, Clin Educ & Res Fdn, Bakersfield, CA USA		Kreber, LA (corresponding author), Ctr Neuro Skills, 5215 Ashe Rd, Bakersfield, CA 93313 USA.	lkreber@neuroskills.com					Aberg ND, 2010, ENDOCR DEV, V17, P63, DOI 10.1159/000262529; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2005, J CLIN ENDOCR METAB, V90, P6085, DOI 10.1210/jc.2005-0504; Arce VM, 2013, NEUROSCI RES, V76, P179, DOI 10.1016/j.neures.2013.03.014; Ashley MJ, 2001, BRAIN INJURY, V15, P435, DOI 10.1080/02699050010005896; Ashley MJ, 1997, BRAIN INJURY, V11, P677; Bavisetty S, 2008, NEUROSURGERY, V62, P1080, DOI 10.1227/01.neu.0000325870.60129.6a; Beck A., 1996, BECK DEPRESSION INVE, V78, P490; Biller BMK, 2002, J CLIN ENDOCR METAB, V87, P2067, DOI 10.1210/jcem.87.5.8509; Bondanelli M, 2005, EUR J ENDOCRINOL, V152, P679, DOI 10.1530/eje.1.01895; Bondanelli M, 2004, J NEUROTRAUM, V21, P685, DOI 10.1089/0897715041269713; Carlson NE, 2009, BRAIN INJURY, V23, P336, DOI 10.1080/02699050902788535; Carroll PV, 1998, J CLIN ENDOCR METAB, V83, P382, DOI 10.1210/jc.83.2.382; Casanueva FF, 2009, HORM RES, V71, P112, DOI 10.1159/000178051; Conceicao FL, 2003, J ENDOCRINOL INVEST, V26, P1065, DOI 10.1007/BF03345251; Dams-O'Connor K, 2013, J NEUROTRAUM, V30, P2014, DOI 10.1089/neu.2013.3049; Devesa J, 2010, MED CLIN-BARCELONA, V135, P665, DOI 10.1016/j.medcli.2009.10.017; Faul M, 2010, TRAUMATIC BRAIN INJU; Freda Pamela U, 2003, Pituitary, V6, P135, DOI 10.1023/B:PITU.0000011174.79946.10; Freda PU, 1998, J CLIN ENDOCR METAB, V83, P3808, DOI 10.1210/jc.83.11.3808; Gabellieri E, 2010, FRONT HORM RES, V38, P139, DOI 10.1159/000318503; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gomez JM, 2002, CLIN ENDOCRINOL, V56, P329, DOI 10.1046/j.1365-2265.2002.01472.x; Herrmann BL, 2006, EXP CLIN ENDOCR DIAB, V114, P316, DOI 10.1055/s-2006-924254; High WM, 2010, J NEUROTRAUM, V27, P1565, DOI 10.1089/neu.2009.1253; Ho KKY, 2007, EUR J ENDOCRINOL, V157, P695, DOI 10.1530/EJE-07-0631; JONES SL, 1994, CLIN ENDOCRINOL, V41, P123, DOI 10.1111/j.1365-2265.1994.tb03793.x; Kelly DF, 2000, J NEUROSURG, V93, P743, DOI 10.3171/jns.2000.93.5.0743; Klose M, 2007, CLIN ENDOCRINOL, V67, P193, DOI 10.1111/j.1365-2265.2007.02860.x; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Leon-Carrion J, 2007, BRAIN INJURY, V21, P871, DOI 10.1080/02699050701484849; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; Lissett CA, 2003, CLIN ENDOCRINOL, V59, P773, DOI 10.1046/j.1365-2265.2003.01884.x; Malec JF, 2000, J HEAD TRAUMA REHAB, V15, P670, DOI 10.1097/00001199-200002000-00006; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; MCGAULEY GA, 1990, HORM RES, V33, P52, DOI 10.1159/000181584; Popvic V., 2004, J ENDOCRINOL INVEST, V27, P1048; RAPPAPORT M, 1982, ARCH PHYS MED REHAB, V63, P118; Rosario ER, 2013, J HEAD TRAUMA REHAB, V28, P390, DOI 10.1097/HTR.0b013e318250eac6; Rothman MS, 2007, J NEUROPSYCH CLIN N, V19, P363, DOI 10.1176/appi.neuropsych.19.4.363; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Selassie AW, 2008, J HEAD TRAUMA REHAB, V23, P123, DOI 10.1097/01.HTR.0000314531.30401.39; Tanriverdi F, 2006, J CLIN ENDOCR METAB, V91, P2105, DOI 10.1210/jc.2005-2476; Wang C, 2004, J CLIN ENDOCR METAB, V89, P2085, DOI 10.1210/jc.2003-032006; WILLER B, 1994, AM J PHYS MED REHAB, V73, P103; Young TP, 2007, BRAIN INJURY, V21, P645, DOI 10.1080/02699050701210426; Yuen KCJ, 2009, J CLIN ENDOCR METAB, V94, P2702, DOI 10.1210/jc.2009-0299; Zgaljardic DJ, 2011, CLIN ENDOCRINOL, V74, P365, DOI 10.1111/j.1365-2265.2010.03935.x	49	15	17	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	SEP 1	2016	33	17					1607	1613		10.1089/neu.2015.4127			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6EH	WOS:000382306300006	26414093	Green Submitted, Green Published, hybrid			2022-02-06	
J	Kreutzer, JS; Mills, A; Marwitz, JH				Kreutzer, Jeffrey S.; Mills, Ana; Marwitz, Jennifer H.			Ambiguous Loss and Emotional Recovery After Traumatic Brain Injury	JOURNAL OF FAMILY THEORY & REVIEW			English	Article						Ambiguous loss; families; resilience; traumatic brain injury	FAMILY INTERVENTION IMPACT; HEAD-INJURY; MILD; CAREGIVERS; PREDICTORS; EXPERIENCE; RELATIVES; MODERATE; MEMBERS	Traumatic brain injury (TBI) is highly prevalent, with many survivors experiencing long-term disability as a consequence of cognitive impairments, adverse personality changes, and emotional and communication difficulties. Because family members most often assume the long-term role of caregiver, their feelings, relationships, and life plans are often negatively affected. Boss has defined a type of ambiguous loss in which the person is physically present but psychologically absent, which is the case for many families after brain injury. Over the past 2 decades we have developed interventions incorporating ambiguous loss theory to enhance resilience and improve psychological outcomes in families after TBI. This article provides a brief overview of TBI, discusses ambiguous loss in families after TBI, and describes the therapeutic goals and framework of empirically supported family interventions using the lens of ambiguous loss theory.	[Kreutzer, Jeffrey S.; Mills, Ana; Marwitz, Jennifer H.] Virginia Commonwealth Univ, Box 980542, Richmond, VA 23298 USA		Marwitz, JH (corresponding author), Virginia Commonwealth Univ, Box 980542, Richmond, VA 23298 USA.	jennifer.marwitz@vcuhealth.org			National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR)United States Department of Health & Human Services [90DP0033-01-00, 90AR5002-01-01]	The contents of this manuscript were developed under grants from the National Institute on Disability, Independent Living, and Rehabilitation Research (NIDILRR Grant Nos. 90DP0033-01-00 and 90AR5002-01-01). NIDILRR is a center within the Administration for Community Living (ACL), Department of Health and Human Services (HHS). The contents of this manuscript do not necessarily represent the policy of NIDILRR, ACL, HHS, and readers should not assume endorsement by the federal government.	Anderson MI, 2013, J HEAD TRAUMA REHAB, V28, P453, DOI 10.1097/HTR.0b013e31825d6087; Bertalanffy L., 1968, GEN SYSTEM THEORY FD; Blais MC, 2007, BRAIN INJURY, V21, P357, DOI 10.1080/02699050701311075; Boss P, 2002, J CLIN PSYCHOL, V58, P1351, DOI 10.1002/jclp.10083; Boss P., 2011, LOVING SOMEONE WHO H; Boss P., 1999, AMBIGUOUS LOSS LEARN; Boss P.G., 2006, LOSS TRAUMA RESILIEN; Boss P, 2016, J FAM THEOR REV, V8, P269, DOI 10.1111/jftr.12152; BROOKS DN, 1991, J CLIN EXP NEUROPSYC, V13, P155, DOI 10.1080/01688639108407214; BROOKS N, 1986, J NEUROL NEUROSUR PS, V49, P764, DOI 10.1136/jnnp.49.7.764; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Crimmins C., 2000, IS MANGO PRINCESS; Dikmen SS, 2003, ARCH PHYS MED REHAB, V84, P1449, DOI 10.1016/S0003-9993(03)00287-9; Dikmen SS, 2009, J HEAD TRAUMA REHAB, V24, P430, DOI 10.1097/HTR.0b013e3181c133e9; Doser K, 2014, BRAIN INJURY, V28, P1230, DOI 10.3109/02699052.2014.915985; Ellis A., 1975, NEW GUIDE RATIONAL L; Ergh TC, 2002, J HEAD TRAUMA REHAB, V17, P155, DOI 10.1097/00001199-200204000-00006; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; Faul M, 2010, TRAUMATIC BRAIN INJU; Giovannetti AM, 2015, BRAIN INJURY, V29, P473, DOI 10.3109/02699052.2014.990514; Godwin E, 2014, BRAIN INJURY, V28, P398, DOI 10.3109/02699052.2014.880514; Holland JN, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/902802; Kean S, 2010, NURS CRIT CARE, V15, P66, DOI 10.1111/j.1478-5153.2010.00379.x; Kelley E, 2014, J HEAD TRAUMA REHAB, V29, P147, DOI 10.1097/HTR.0b013e31826db6b9; Konrad C, 2011, PSYCHOL MED, V41, P1197, DOI 10.1017/S0033291710001728; Kreutzer J., 2004, BRAIN INJURY FAMILY; Kreutzer JS, 2007, NEUROREHABILITATION, V22, P53; Kreutzer JS, 2015, J HEAD TRAUMA REHAB, V30, P249, DOI 10.1097/HTR.0000000000000144; Kreutzer JS, 2010, NEUROREHABILITATION, V27, P19, DOI 10.3233/NRE-2010-0578; Kreutzer JS, 2009, ARCH PHYS MED REHAB, V90, P939, DOI 10.1016/j.apmr.2009.01.010; Kreutzer JS, 2009, BRAIN INJURY, V23, P535, DOI 10.1080/02699050902926291; Kreutzer JS, 1999, GETTING BETTER BETTE; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; LEVIN HS, 1978, ARCH NEUROL-CHICAGO, V35, P720, DOI 10.1001/archneur.1978.00500350024005; LEZAK MD, 1978, J CLIN PSYCHIAT, V39, P592; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Marsh NV, 1998, BRAIN INJURY, V12, P225, DOI 10.1080/026990598122700; Masel BE, 2010, J NEUROTRAUM, V27, P1529, DOI 10.1089/neu.2010.1358; Mauss-Clum N, 1981, J Neurosurg Nurs, V13, P165; McAllister TW, 2013, BRAIN INJURY MEDICINE: PRINCIPLES AND PRACTICE, SECOND EDITION, P1034; Millis SR, 2001, J HEAD TRAUMA REHAB, V16, P343, DOI 10.1097/00001199-200108000-00005; Ponsford J, 2010, J INT NEUROPSYCH SOC, V16, P306, DOI 10.1017/S1355617709991342; Rabinowitz AR, 2015, J NEUROTRAUM, V32, P1488, DOI 10.1089/neu.2014.3555; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Sterr A, 2006, BMC NEUROL, V6, DOI 10.1186/1471-2377-6-7; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Thurman DJ., 1995, GUIDELINES SURVEILLA	48	15	15	2	21	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1756-2570	1756-2589		J FAM THEOR REV	J. Fam. Theory. Rev.	SEP	2016	8	3			SI		386	397		10.1111/jftr.12150			12	Family Studies	Social Science Citation Index (SSCI)	Family Studies	ED6EU	WOS:000388949500009					2022-02-06	
J	Marcoux, J; Bracco, D; Saluja, RS				Marcoux, Judith; Bracco, David; Saluja, Rajeet S.			Temporal delays in trauma craniotomies	JOURNAL OF NEUROSURGERY			English	Article						traumatic brain injury; trauma craniotomy; acute epidural hematoma; acute subdural hematoma; quality of care; delay in treatment; surgery	ACUTE SUBDURAL-HEMATOMA; ACUTE STROKE; COMATOSE PATIENTS; EPIDURAL HEMATOMA; EMERGENCY; THROMBOLYSIS; PROGNOSIS; MORTALITY; SCALE; CARE	OBJECTIVE The Brain Trauma Foundation recommendation regarding the timing of surgical evacuation of epidural hematomas and subdural hematomas is to perform the procedure as soon as possible. Indeed, faster evacuation is associated with better outcome. However, to the authors' knowledge, no study has looked at where delays in intrahospital care occurred for patients suffering from traumatic intracranial mass lesions. The goals of this study were as follows: 1) to characterize the performance of a Level 1 trauma center in terms of delays for emergency trauma craniotomies, 2) to review step by step where delays occurred in patient care, and 3) to propose ways to improve performance. METHODS A retrospective review was conducted covering a 5-year period of all emergency trauma craniotomies. Demographic data, injury severity, neurological status, and functional outcome data were collected. The time elapsed between emergency department (ED) arrival and CT imaging, between CT imaging and arrival at the operating room (OR), between ED arrival and OR arrival, between OR arrival and skin incision, and between ED arrival and skin incision were calculated. Patients were also subcategorized as either having immediate life-threatening emergencies (EO) or life threatening emergencies (El). The operative technique was also reviewed (standard craniotomy opening vs immediate bur hole decompression followed by craniotomy). RESULTS The study included 166 patients. Of these, 58 (35%) were classified into the EO group and 108 (64.2%) into the El group. The median ED-to-CT delay was 54 minutes with no significant difference between the E0 and the E1 groups. The median CT-to-OR time delay was 57 minutes. The median delay for the EO group was 39 minutes and that for the El group was 70 minutes (p = 0.002). The median delay from ED to OR arrival for patients with a CT scanning done at an outside hospital was 75 minutes. The median delay from ED to OR arrival was 85 minutes for the EO group and 127 minutes for the El group (p < 0.0001). The median delay from OR arrival to skin incision was 35 minutes (EO: median 27 minutes; El: median 39 minutes; p < 0.0001). The median total time elapsed between ED arrival and skin incision was 150 minutes (EO: median 131 minutes; El: median 180 minutes). Overall, only 17% of patients underwent immediate bur hole decompression, but the proportion climbed to 41% in the EO group. A lower Glasgow Coma Scale score was associated with a shorter delay (p = 0.0004). CONCLUSIONS A long delay until surgery still exists for patients requiring urgent mass lesion evacuation. Many factors contribute to this delay, including performing imaging and transfer to and preparation in the OR. Strategies can be implemented to reduce delays and improve the delivery of care.	[Marcoux, Judith; Saluja, Rajeet S.] McGill Univ, Dept Neurol & Neurosurg, Montreal, PQ, Canada; [Marcoux, Judith; Saluja, Rajeet S.] McGill Univ, Ctr Hlth, Dept Neurosurg, Montreal, PQ, Canada; [Bracco, David] McGill Univ, Ctr Hlth, Dept Anesthesia, Montreal, PQ, Canada		Marcoux, J (corresponding author), McGill Univ, Ctr Hlth, Montreal Gen Hosp, Dept Neurosurg, 1650 Cedar Ave,Rm L7-516, Montreal, PQ H3G 1A4, Canada.	judith.marcoux@mcgill.ca					Bullock M Ross, 2006, Neurosurgery, V58, pS7; Bullock MR, 2006, NEUROSURGERY S, V58, pSi; Bullock MR, 2006, NEUROSURGERY S, V58, pS16; Chalfin DB, 2007, CRIT CARE MED, V35, P1477, DOI 10.1097/01.CCM.0000266585.74905.5A; Cohen JE, 1996, J TRAUMA, V41, P120, DOI 10.1097/00005373-199607000-00019; Gomez C R, 1993, J Stroke Cerebrovasc Dis, V3, P1, DOI 10.1016/S1052-3057(10)80125-9; HASELSBERGER K, 1988, ACTA NEUROCHIR, V90, P111, DOI 10.1007/BF01560563; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; JENNETT B, 1975, LANCET, V1, P480; JENNETT B, 1981, J NEUROL NEUROSUR PS, V44, P285, DOI 10.1136/jnnp.44.4.285; Kwan J, 2004, QJM-INT J MED, V97, P273, DOI 10.1093/qjmed/hch054; Lacy CR, 2001, STROKE, V32, P63, DOI 10.1161/01.STR.32.1.63; Lee EJ, 1998, J TRAUMA, V45, P946, DOI 10.1097/00005373-199811000-00017; Lindsberg PJ, 2006, NEUROLOGY, V67, P334, DOI 10.1212/01.wnl.0000224759.44743.7d; Morris DL, 2000, STROKE, V31, P2585, DOI 10.1161/01.STR.31.11.2585; PICKARD JD, 1990, BRIT MED J, V301, P629, DOI 10.1136/bmj.301.6753.629; Rinker CF, 1998, J TRAUMA, V44, P984, DOI 10.1097/00005373-199806000-00009; SAKAS DE, 1995, J NEUROSURG, V82, P961, DOI 10.3171/jns.1995.82.6.0961; Sampalis JS, 1997, J TRAUMA, V43, P288, DOI 10.1097/00005373-199708000-00014; SEELIG JM, 1984, NEUROSURGERY, V15, P617, DOI 10.1227/00006123-198411000-00001; SEELIG JM, 1981, NEW ENGL J MED, V304, P1511, DOI 10.1056/NEJM198106183042503; Sekoranja L, 2009, SWISS MED WKLY, V139, P393, DOI smw-12506; STONE JL, 1986, J TRAUMA, V26, P445, DOI 10.1097/00005373-198605000-00006; Teixeira PGR, 2007, J TRAUMA, V63, P1338, DOI 10.1097/TA.0b013e31815078ae; Tveiten A, 2009, EMERG MED J, V26, P324, DOI 10.1136/emj.2008.063610; Wright KD, 1996, INJURY, V27, P719, DOI 10.1016/S0020-1383(96)00119-2	26	15	15	0	2	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	SEP	2016	125	3					642	647		10.3171/2015.6.JNS15175			6	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DT8YS	WOS:000381782300015	26722857	Bronze			2022-02-06	
J	Rehman, H; Khan, MS; Nafees, M; Attique-ur-Rehman; Habib, A				Rehman, Hina; Khan, Muhammad Saim; Nafees, Muhammad; Attique-ur-Rehman; Habib, Asad			Optic Nerve Sheath Diameter on Sonography in Idiopathic Intracranial Hypertension Versus Normal	JCPSP-JOURNAL OF THE COLLEGE OF PHYSICIANS AND SURGEONS PAKISTAN			English	Article						Optic nerve sheath diameter; Idiopethic intracranial hypertension; Benign intracranial hypertension; Pseudotumor cerebri	TRAUMATIC BRAIN-INJURY; PSEUDOTUMOR CEREBRI; PRESSURE	Objective: To compare the mean optic nerve sheath diameter (ONSD) in patients with idiopathic intracranial hypertension (IIH) versus normal healthy individuals using B-scan ultrasonography as diagnostic tool. Study design: Cross-sectional analytical study. Place and duration of study: Armed Forces Institute of Radiology and Imaging, Rawalpindi, Pakistan, from June to December 2015. Methodology: Participants aged 30 - 50 years were divided into two groups. Group A(GP) comprised of patients who were diagnosed cases of idiopathic intracranial hypertension while normal healthy adults who volunteered to participate in the study were included in Group B (GC). Ocular B mode ultrasound scan was performed on all the participants and each eye was considered separately. The optic nerve head was visualized as a linear hypoechoic structure, and ONSD was measured 3 mm behind the retina. Atotal of three readings were taken by the same radiologist and the average of three was recorded. Mean values of both groups were compared by t-test with significance at p < 0.05. Results: Fifty-two eyes of 26 patients (26 eyes in each group) were included in the study. Twenty-four out of 26 in Group A(GP) and 23 out of 26 in Group B (GC) were females. Mean age of the patients was 33.92 +/- 4.89 years in group A(GP) while it was 34.69 +/- 4.79 years in group B (GC). Mean ONSD was 6.61 +/- 0.39 mm in group A(GP) and 4.33 +/- 0.38 mm in group B(GC) which was significantly different (p < 0.001). Conclusion: Ultrasound can provide a reliable, non-invasive tool to measure optic nerve sheath diameter in monitoring the patients with benign intracranial hypertension (BIH).	[Rehman, Hina; Nafees, Muhammad; Attique-ur-Rehman] Armed Forces Inst Radiol & Imaging, Dept Radiol, Rawalpindi, Pakistan; [Khan, Muhammad Saim; Habib, Asad] Armed Forces Inst Ophthalmol, Dept Ophthalmol, Rawalpindi, Pakistan		Khan, MS (corresponding author), Armed Forces Inst Ophthalmol, Rawalpindi, Pakistan.	saim_amc@hotmail.com					Bauerle J, 2012, J NEUROIMAGING, V22, P42, DOI 10.1111/j.1552-6569.2010.00546.x; Ballantyne S A, 2002, Eur J Ultrasound, V15, P145, DOI 10.1016/S0929-8266(02)00036-8; Chesnut RM, 2012, NEW ENGL J MED, V367, P2471, DOI 10.1056/NEJMoa1207363; D'Amico D, 2012, NEUROL SCI, V33, pS189, DOI 10.1007/s10072-012-1065-2; Dubourg J, 2011, INTENS CARE MED, V37, P1059, DOI 10.1007/s00134-011-2224-2; Ertl M, 2014, ULTRASCHALL MED, V35, P422, DOI 10.1055/s-0034-1366113; Frattalone AR, 2011, INTENS CARE MED, V37, P1051, DOI 10.1007/s00134-011-2226-0; Hawthorne C, 2014, FRONT NEUROL, V5, DOI 10.3389/fneur.2014.00121; Juul N, 2000, J NEUROSURG, V92, P1, DOI 10.3171/jns.2000.92.1.0001; KELMAN SE, 1991, OPHTHALMOLOGY, V98, P1449; Kesler A, 2001, J NEURO-OPHTHALMOL, V21, P15, DOI 10.1097/00041327-200103000-00004; Maude RR, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0081013; Mehrpour M, 2015, NEUROL RES INT, V2015, DOI 10.1155/2015/146059; RADHAKRISHNAN K, 1994, MAYO CLIN PROC, V69, P169, DOI 10.1016/S0025-6196(12)61045-3; Shirodkar CG, 2015, INDIAN J CRIT CARE M, V19, P466, DOI 10.4103/0972-5229.162465; SMITH JL, 1985, J CLIN NEURO-OPHTHAL, V5, P55; Wang LJ, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0117939	17	15	15	0	2	COLL PHYSICIANS & SURGEONS PAKISTAN	KARACHI	SEVENTH CENTRAL ST, DEFENCE HOUSING AUTHORITY, KARACHI, 75500, PAKISTAN	1022-386X	1681-7168		JCPSP-J COLL PHYSICI	JCPSP-J. Coll. Physicians Surg.	SEP	2016	26	9					758	760					3	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	DZ5LP	WOS:000385903900008	27671180				2022-02-06	
J	Sorg, SF; Schiehser, DM; Bondi, MW; Luc, N; Clark, AL; Jacobson, MW; Frank, LR; Delano-Wood, L				Sorg, Scott F.; Schiehser, Dawn M.; Bondi, Mark W.; Luc, Norman; Clark, Alexandra L.; Jacobson, Mark W.; Frank, Lawrence R.; Delano-Wood, Lisa			White Matter Microstructural Compromise Is Associated With Cognition But Not Posttraumatic Stress Disorder Symptoms in Military Veterans With Traumatic Brain Injury	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						diffusion tensor imaging; mild traumatic brain injury; neuropsychology; posttraumatic stress disorder	DIFFUSE AXONAL INJURY; AFGHANISTAN WAR VETERANS; ANTERIOR CINGULATE; TENSOR ANISOTROPY; CORPUS-CALLOSUM; FOLLOW-UP; IRAQ; INTEGRITY; TRACTOGRAPHY; MODERATE	Objective: To investigate white matter microstructure compromise in Veterans with a history of traumatic brain injury (TBI) and its possible contribution to posttraumatic stress disorder (PTSD) symptomatology and neuropsychological functioning via diffusion tensor imaging. Participants and Methods: Thirty-eight Veterans with mild (n = 33) and moderate (n = 5) TBI and 17 military control participants without TBI completed neuropsychological testing and psychiatric screening and underwent magnetic resonance imaging an average of 4 years following their TBI event(s). Fractional anisotropy (FA) and diffusivity measures were extracted from 9 white matter tracts. Results: Compared with military control participants, TBI participants reported higher levels of PTSD symptoms and performed worse on measures of memory and psychomotor-processing speed. Traumatic brain injury was associated with lower FA in the genu of the corpus callosum and left cingulum bundle. Fractional anisotropy negatively correlated with processing speed and/or executive functions in 7 of the 8 tracts. Regional FA did not correlate with memory or PTSD symptom ratings. Conclusion: Results suggest that current PTSD symptoms are independent of TBI-related white matter alterations, as measured by diffusion tensor imaging. In addition, white matter microstructural compromise may contribute to reduced processing speed in our sample of participants with history of neurotrauma. Findings of the current study add insight into the factors associated with complicated recovery from mild to moderate TBI.	[Sorg, Scott F.; Schiehser, Dawn M.; Bondi, Mark W.; Luc, Norman; Jacobson, Mark W.; Delano-Wood, Lisa] Vet Affairs San Diego Healthcare Syst, San Diego, CA USA; [Delano-Wood, Lisa] VA San Diego Healthcare Syst, Ctr Excellence Stress & Mental Hlth, San Diego, CA USA; [Sorg, Scott F.; Schiehser, Dawn M.; Bondi, Mark W.; Jacobson, Mark W.; Delano-Wood, Lisa] Univ Calif San Diego, Dept Psychiat, La Jolla, CA 92093 USA; [Clark, Alexandra L.] Univ Calif San Diego, Joint Doctoral Program Clin Psychol, San Diego State Univ, La Jolla, CA 92093 USA; [Frank, Lawrence R.] Univ Calif San Diego, Dept Radiol, La Jolla, CA 92093 USA		Delano-Wood, L (corresponding author), VA San Diego Healthcare Syst 116B, 3350 La Jolla Village Dr, San Diego, CA 92161 USA.	ldelano@ucsd.edu			Veterans AffairsUS Department of Veterans Affairs; Department of DefenseUnited States Department of Defense; VA Advanced Fellowship Program in Interprofessional Polytrauma and Traumatic Brain Injury Rehabilitation; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R01MH096100] Funding Source: NIH RePORTER	This work was supported by grants awarded by the Veterans Affairs (Career Development Awards [CDA]: LD-W, DS; Merit Award, LD-W) as well as the Department of Defense (Investigator-Initiated Research Grant [IIRG]: LD-W). This material is further supported with resources of the Veterans Affairs Center of Excellence for Stress and Mental Health (CESAMH: LD-W). For the remaining authors, none were declared.; The work was further supported by the VA Advanced Fellowship Program in Interprofessional Polytrauma and Traumatic Brain Injury Rehabilitation (SS).	Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Beaulieu C, 2009, DIFFUSION MRI: FROM QUANTITATIVE MEASUREMENT TO IN VIVO NEUROANATOMY, P105, DOI 10.1016/B978-0-12-374709-9.00006-7; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; Bigler ED, 2001, J HEAD TRAUMA REHAB, V16, P117, DOI 10.1097/00001199-200104000-00003; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Binder LM, 1997, J CLIN EXP NEUROPSYC, V19, P421, DOI 10.1080/01688639708403870; Bremner J Douglas, 2004, Expert Rev Neurother, V4, P275, DOI 10.1586/14737175.4.2.275; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Budde MD, 2011, BRAIN, V134, P2248, DOI 10.1093/brain/awr161; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Concha L, 2005, AM J NEURORADIOL, V26, P2267; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Deoni SCL, 2008, MAGN RESON MED, V60, P1372, DOI 10.1002/mrm.21704; DIKMEN S, 1993, BRAIN INJURY, V7, P113, DOI 10.3109/02699059309008165; Ettenhofer ML, 2009, J CLIN EXP NEUROPSYC, V31, P363, DOI 10.1080/13803390802175270; Frencham KAR, 2005, J CLIN EXP NEUROPSYC, V27, P334, DOI 10.1080/13803390490520328; Gelman N, 2001, MAGNET RESON MED, V45, P71, DOI 10.1002/1522-2594(200101)45:1<71::AID-MRM1011>3.0.CO;2-2; Heaton R.K., 1981, WISCONSIN CARD SORTI; Hofer S, 2006, NEUROIMAGE, V32, P989, DOI 10.1016/j.neuroimage.2006.05.044; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Inglese M, 2005, J NEUROSURG, V103, P298, DOI 10.3171/jns.2005.103.2.0298; Jones DK, 1999, MAGNET RESON MED, V42, P515, DOI 10.1002/(SICI)1522-2594(199909)42:3<515::AID-MRM14>3.0.CO;2-Q; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Kim MJ, 2005, NEUROREPORT, V16, P1049, DOI 10.1097/00001756-200507130-00004; Koponen S, 2002, AM J PSYCHIAT, V159, P1315, DOI 10.1176/appi.ajp.159.8.1315; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Levin HS, 2008, J HEAD TRAUMA REHAB, V23, P197, DOI 10.1097/01.HTR.0000327252.54128.7c; Levin HS, 2010, J NEUROTRAUM, V27, P683, DOI 10.1089/neu.2009.1073; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Liberzon I, 2007, PROG BRAIN RES, V167, P151, DOI 10.1016/S0079-6123(07)67011-3; Lindauer RJL, 2008, PSYCHOL MED, V38, P543, DOI 10.1017/S0033291707001432; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Madler B, 2008, MAGN RESON IMAGING, V26, P874, DOI 10.1016/j.mri.2008.01.047; Moore BA, 2004, BRAIN INJURY, V18, P975, DOI 10.1080/02699050410001672350; Morey RA, 2013, HUM BRAIN MAPP, V34, P2986, DOI 10.1002/hbm.22117; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Pierpaoli C, 1996, MAGNET RESON MED, V36, P893, DOI 10.1002/mrm.1910360612; Protopopescu X, 2005, BIOL PSYCHIAT, V57, P464, DOI 10.1016/j.biopsych.2004.12.026; Ragsdale KA, 2013, J ANXIETY DISORD, V27, P420, DOI 10.1016/j.janxdis.2013.04.003; Rauch SL, 2006, BIOL PSYCHIAT, V60, P376, DOI 10.1016/j.biopsych.2006.06.004; Reese TG, 2003, MAGN RESON MED, V49, P177, DOI 10.1002/mrm.10308; Rohling ML, 2011, CLIN NEUROPSYCHOL, V25, P608, DOI 10.1080/13854046.2011.565076; Ruff R, 2005, J HEAD TRAUMA REHAB, V20, P5, DOI 10.1097/00001199-200501000-00003; Ruff RM, 1996, BRAIN INJURY, V10, P551, DOI 10.1080/026990596124124; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schretlen DJ, 2003, INT REV PSYCHIATR, V15, P341, DOI 10.1080/09540260310001606728; Schuff N, 2011, NEUROIMAGE, V54, pS62, DOI 10.1016/j.neuroimage.2010.05.024; Shin LM, 2005, ARCH GEN PSYCHIAT, V62, P273, DOI 10.1001/archpsyc.62.3.273; Shin LM, 2001, BIOL PSYCHIAT, V50, P932, DOI 10.1016/S0006-3223(01)01215-X; Sidaros A, 2008, BRAIN, V131, P559, DOI 10.1093/brain/awm294; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Sorg SF, 2014, J HEAD TRAUMA REHAB, V29, P21, DOI 10.1097/HTR.0b013e31828a1aa4; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); TEASDALE G, 1974, LANCET, V2, P81; Tombaugh T.N., 1996, TEST MEMORY MALINGER; Traumatic Brain Injury Task Force, 2008, REP SURG GEN TRAUM B; Twamley EW, 2014, J REHABIL RES DEV, V51, P59, DOI 10.1682/JRRD.2013.01.0020; Vasterling JJ, 2012, BRIT J PSYCHIAT, V201, P186, DOI 10.1192/bjp.bp.111.096461; Vasterling JJ, 2009, CLIN PSYCHOL REV, V29, P674, DOI 10.1016/j.cpr.2009.08.004; Wakana S, 2004, RADIOLOGY, V230, P77, DOI 10.1148/radiol.2301021640; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Weathers F.W., 1993, ANN CONV INT SOC TRA; Wechsler D, 2008, WECHSLER AFULT INTEL; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wilkins KC, 2011, DEPRESS ANXIETY, V28, P596, DOI 10.1002/da.20837; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Yarnykh VL, 2015, RADIOLOGY, V274, P210, DOI 10.1148/radiol.14140528; Yuan W, 2007, AM J NEURORADIOL, V28, P1919, DOI 10.3174/ajnr.A0698; Yurgil KA, 2014, JAMA PSYCHIAT, V71, P149, DOI 10.1001/jamapsychiatry.2013.3080	81	15	15	0	6	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	SEP-OCT	2016	31	5					297	308		10.1097/HTR.0000000000000189			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX2ZY	WOS:000384243600008	26360008	Green Accepted			2022-02-06	
J	Spong, KE; Rodriguez, EC; Robertson, RM				Spong, Kristin E.; Rodriguez, Esteban C.; Robertson, R. Meldrum			Spreading depolarization in the brain of Drosophila is induced by inhibition of the Na+/K+-ATPase and mitigated by a decrease in activity of protein kinase G	JOURNAL OF NEUROPHYSIOLOGY			English	Article						anoxic depolarization; Drosophila; extracellular potassium; PKG; spreading depolarization	RAT HIPPOCAMPAL SLICES; EXTRACELLULAR POTASSIUM CONCENTRATION; DEPRESSION-LIKE DEPOLARIZATION; LOCUST CNS; CEREBRAL-CORTEX; CORTICAL DEPRESSION; K+ HOMEOSTASIS; ISCHEMIA; ANOXIA; MELANOGASTER	Spreading depolarization (SD) is characterized by a massive redistribution of ions accompanied by an arrest in electrical activity that slowly propagates through neural tissue. It has been implicated in numerous human pathologies, including migraine, stroke, and traumatic brain injury, and thus the elucidation of control mechanisms underlying the phenomenon could have many health benefits. Here, we demonstrate the occurrence of SD in the brain of Drosophila melanogaster, providing a model system, whereby cellular mechanisms can be dissected using molecular genetic approaches. Propagating waves of SD were reliably induced by disrupting the extracellular potassium concentration ([K+](o)), either directly or by inhibition of the Na+/K+-ATPase with ouabain. The disturbance was monitored by recording the characteristic surges in [K+](o) using K+-sensitive microelectrodes or by monitoring brain activity by measuring direct current potential. With the use of wildtype flies, we show that young adults are more resistant to SD compared with older adults, evidenced by shorter bouts of SD activity and attenuated [K+](o) disturbances. Furthermore, we show that the susceptibility to SD differs between wild- type flies and w1118 mutants, demonstrating that our ouabain model is influenced by genetic strain. Lastly, flies with low levels of protein kinase G (PKG) had increased latencies to onset of both ouabain- induced SD and anoxic depolarization compared with flies with higher levels. Our findings implicate the PKG pathway as a modulator of SD in the fly brain, and given the conserved nature of the signaling pathway, it could likely play a similar role during SD in the mammalian central nervous system.	[Spong, Kristin E.; Rodriguez, Esteban C.; Robertson, R. Meldrum] Queens Univ, Dept Biol, Biosci Complex,Rm 3404, Kingston, ON K7L 3N6, Canada		Spong, KE (corresponding author), Queens Univ, Dept Biol, Biosci Complex,Rm 3404, Kingston, ON K7L 3N6, Canada.	9ks26@queensu.ca	Robertson, Robert M/B-2482-2009	Robertson, Robert M/0000-0002-2666-7861	Natural Sciences and Engineering Research Council of CanadaNatural Sciences and Engineering Research Council of Canada (NSERC)CGIAR	Funding for this work was provided by a Discovery Grant from the Natural Sciences and Engineering Research Council of Canada.	Armstrong GAB, 2012, J INSECT PHYSIOL, V58, P1511, DOI 10.1016/j.jinsphys.2012.09.006; Armstrong GAB, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028994; Armstrong GAB, 2009, J NEUROSCI, V29, P8225, DOI 10.1523/JNEUROSCI.1652-09.2009; Balestrino M, 1999, BRAIN RES, V838, P37, DOI 10.1016/S0006-8993(99)01674-1; Campbell JL, 2001, J NEUROBIOL, V49, P339, DOI 10.1002/neu.10009; Chai Y, 2008, PFLUG ARCH EUR J PHY, V456, P897, DOI 10.1007/s00424-008-0447-z; CHEBABO SR, 1995, BRAIN RES, V695, P203, DOI 10.1016/0006-8993(95)00778-O; Dawson-Scully K, 2010, J EXP BIOL, V213, P2410, DOI 10.1242/jeb.041319; Dreier JP, 2015, NEURON, V86, P902, DOI 10.1016/j.neuron.2015.04.004; Dreier JP, 2011, NAT MED, V17, P439, DOI 10.1038/nm.2333; Fabricius M, 2006, BRAIN, V129, P778, DOI 10.1093/brain/awh716; GRAFSTEIN B, 1956, J NEUROPHYSIOL, V19, P154, DOI 10.1152/jn.1956.19.2.154; Haddad GG, 2006, EXP PHYSIOL, V91, P277, DOI 10.1113/expphysiol.2005.030767; HANSEN AJ, 1977, ACTA PHYSIOL SCAND, V99, P412, DOI 10.1111/j.1748-1716.1977.tb10394.x; Isagai T, 1999, J NEUROPHYSIOL, V81, P1866, DOI 10.1152/jn.1999.81.4.1866; Kang Y, 2007, J NEUROPHYSIOL, V98, P3397, DOI 10.1152/jn.00536.2007; Krnjevic K, 2008, NEUROPHARMACOLOGY, V55, P319, DOI 10.1016/j.neuropharm.2008.01.002; Leao AAP, 1944, J NEUROPHYSIOL, V7, P359, DOI 10.1152/jn.1944.7.6.359; LEBLOND J, 1989, J NEUROPHYSIOL, V62, P1; MARES P, 1976, EXP NEUROL, V53, P12, DOI 10.1016/0014-4886(76)90277-6; MARSHALL WH, 1959, PHYSIOL REV, V39, P239, DOI 10.1152/physrev.1959.39.2.239; Muller M, 2000, J NEUROPHYSIOL, V83, P735, DOI 10.1152/jn.2000.83.2.735; Osborne KA, 1997, SCIENCE, V277, P834, DOI 10.1126/science.277.5327.834; Payne RS, 1996, BRAIN RES, V723, P210, DOI 10.1016/0006-8993(96)00254-5; Pietrobon D, 2014, NAT REV NEUROSCI, V15, P379, DOI 10.1038/nrn3770; Renger JJ, 1999, J NEUROSCI, V19; Rodgers CI, 2010, J INSECT PHYSIOL, V56, P980, DOI 10.1016/j.jinsphys.2010.03.030; Rodgers CI, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0001366; Rodgers CI, 2009, J INSECT PHYSIOL, V55, P599, DOI 10.1016/j.jinsphys.2009.03.004; Rodriguez EC, 2012, J EXP BIOL, V215, P4157, DOI 10.1242/jeb.074468; Sitaraman D, 2008, P NATL ACAD SCI USA, V105, P5579, DOI 10.1073/pnas.0710168105; Somjen GG, 2001, PHYSIOL REV, V81, P1065, DOI 10.1152/physrev.2001.81.3.1065; Spong KE, 2016, J EXP BIOL, V219, P626, DOI 10.1242/jeb.132456; Spong KE, 2015, J NEUROPHYSIOL, V114, P3111, DOI 10.1152/jn.00804.2015; Spong KE, 2014, J INSECT PHYSIOL, V66, P1, DOI 10.1016/j.jinsphys.2014.05.009; Spong KE, 2013, J INSECT PHYSIOL, V59, P1031, DOI 10.1016/j.jinsphys.2013.07.007; VYSKOCIL F, 1972, BRAIN RES, V39, P255, DOI 10.1016/0006-8993(72)90802-5; Wingrove JA, 1999, CELL, V98, P105, DOI 10.1016/S0092-8674(00)80610-8; Xiao CF, 2016, GENETICS, V203, P787, DOI 10.1534/genetics.115.185066; Xiao CF, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0135825; Xie MJ, 2008, J CEREBR BLOOD F MET, V28, P456, DOI 10.1038/sj.jcbfm.9600545	41	15	15	0	5	AMER PHYSIOLOGICAL SOC	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814 USA	0022-3077	1522-1598		J NEUROPHYSIOL	J. Neurophysiol.	SEP	2016	116	3					1152	1160		10.1152/jn.00353.2016			9	Neurosciences; Physiology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Physiology	DZ6ET	WOS:000385955100021	27358319	Green Published, Bronze			2022-02-06	
J	Vaewpanich, J; Reuter-Rice, K				Vaewpanich, Jarin; Reuter-Rice, Karin			Continuous electroencephalography in pediatric traumatic brain injury: Seizure characteristics and outcomes	EPILEPSY & BEHAVIOR			English	Article						Traumatic brain injury; Continuous electroencephalography; Neurocognitive outcome; Pediatric; Posttraumatic seizure; PICU	SEVERE HEAD-INJURY; NONCONVULSIVE ELECTROGRAPHIC SEIZURES; NONACCIDENTAL TRAUMA; CONTINUOUS EEG; UNITED-STATES; POSTTRAUMATIC SEIZURES; CLINICAL INDICATORS; CONSENSUS STATEMENT; PROGNOSTIC-FACTORS; CHILDREN	Background: Traumatic brain injury (TBI) is a major cause of pediatric morbidity and mortality. Secondary injury that occurs as a result of a direct impact plays a crucial role in patient prognosis. The guidelines for the management of severe TBI target treatment of secondary injury. Posttraumatic seizure, one of the secondary injury sequelae, contributes to further damage to the injured brain. Continuous electroencephalography (cEEG) helps detect both clinical and subclinical seizure, which aids early detection and prompt treatment. Objective: The aim of this study was to examine the relationship between cEEG findings in pediatric traumatic brain injury and neurocognitive/functional outcomes. Methods: This study focuses on a subgroup of a larger prospective parent study that examined children admitted to a level-1 trauma hospital. The subgroup included sixteen children admitted to the pediatric intensive care unit (PICU) who received cEEG monitoring. Characteristics included demographics, cEEG reports, and antiseizure medication. We also examined outcome scores at the time of discharge and 4-6 weeks postdischarge using the Glasgow Outcome Scale Extended Pediatrics and center-based speech pathology neurocognitive/functional evaluation scores. Results: Sixteen patients were included in this study. Patients with severe TBI made up the majority of those that received cEEG monitoring. Nonaccidental trauma was the most frequent TBI etiology (75%), and subdural hema-toma was the most common lesion diagnosed by CT scan (75%). Fifteen patients received antiseizure medication, and levetiracetam was the medication of choice. Four patients (25%) developed seizures during PICU admission, and 3 patients had subclinical seizures that were detected by cEEG. One of these patients also had both a clinical and subclinical seizure. Nonaccidental trauma was an etiology of TBI in all patients with seizures. Characteristics of a nonreactive pattern, severe/burst suppression, and lack of sleep architecture, on cEEG, were associated with poor neurocognitive/functional outcome. Conclusion: Continuous electroencephalography demonstrated a pattern that associated seizures and poor outcomes in patients with moderate to severe traumatic brain injury, particularly in a subgroup of patients with nonaccidental trauma. Best practice should include institution-based TBI cEEG protocols, which may detect seizure activity early and promote outcomes. Future studies should include examination of individual cEEG characteristics to help improve outcomes in pediatric TBI. (C) 2016 Elsevier Inc. All rights reserved.	[Vaewpanich, Jarin] Mahidol Univ, Ramathibodi Hosp, Dept Pediat, 270 Rama 6 Rd, Bangkok 10400, Thailand; [Reuter-Rice, Karin] Duke Univ, Duke Inst Brain Sci, 307 Trent Dr,DUMC 3322, Durham, NC 27710 USA; [Reuter-Rice, Karin] Duke Inst Brain Sci, Sch Nursing, 307 Trent Dr,DUMC 3322, Durham, NC 27710 USA; [Reuter-Rice, Karin] Duke Inst Brain Sci, Dept Pediat, Sch Med, 307 Trent Dr,DUMC 3322, Durham, NC 27710 USA; [Vaewpanich, Jarin] Duke Univ, Childrens Hosp, Durham, NC USA		Reuter-Rice, K (corresponding author), Duke Inst Brain Sci, Sch Nursing, 307 Trent Dr,DUMC 3322, Durham, NC 27710 USA.	jarivaew@yahoo.com; karin.reuter-rice@duke.edu		Reuter-Rice, Karin/0000-0003-1501-8994	NATIONAL INSTITUTE OF NURSING RESEARCHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [P30NR014139] Funding Source: NIH RePORTER; NINR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Nursing Research (NINR) [P30 NR014139] Funding Source: Medline		Abend NS, 2013, LANCET NEUROL, V12, P1170, DOI 10.1016/S1474-4422(13)70246-1; Abend NS, 2011, NEUROCRIT CARE, V15, P70, DOI 10.1007/s12028-010-9380-z; [Anonymous], 1993, EPILEPSIA, V34, P592; Arndt DH, 2016, J CHILD NEUROL, V31, P46, DOI 10.1177/0883073814562249; Arndt DH, 2013, EPILEPSIA, V54, P1780, DOI 10.1111/epi.12369; Asikainen I, 1999, EPILEPSIA, V40, P584, DOI 10.1111/j.1528-1157.1999.tb05560.x; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Beers SR, 2012, J NEUROTRAUM, V29, P1126, DOI 10.1089/neu.2011.2272; CHESNUT RM, 1993, J TRAUMA, V34, P216, DOI 10.1097/00005373-199302000-00006; Chiaretti A, 2002, CHILD NERV SYST, V18, P129, DOI 10.1007/s00381-002-0558-3; Chung MG, 2016, PEDIATR CRIT CARE ME, V17, P150, DOI 10.1097/PCC.0000000000000588; Claassen J, 2014, NEUROCRIT CARE, V21, P129, DOI 10.1007/s12028-014-0022-8; Claassen J, 2013, INTENS CARE MED, V39, P1337, DOI 10.1007/s00134-013-2938-4; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Deans KJ, 2013, J TRAUMA ACUTE CARE, V75, P157, DOI 10.1097/TA.0b013e3182984acb; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Estroff JM, 2015, J EMERG MED, V48, P274, DOI 10.1016/j.jemermed.2014.07.030; EVANS BM, 1995, J NEUROL NEUROSUR PS, V59, P17, DOI 10.1136/jnnp.59.1.17; Gallentine WB, 2013, J CLIN NEUROPHYSIOL, V30, P126, DOI 10.1097/WNP.0b013e3182872adf; Greiner MV, 2012, CHILD NERV SYST, V28, P889, DOI 10.1007/s00381-012-1714-z; Hasbani DM, 2013, PEDIATR CRIT CARE ME, V14, P709, DOI 10.1097/PCC.0b013e3182917b83; Herman ST, 2015, J CLIN NEUROPHYSIOL, V32, P87, DOI 10.1097/WNP.0000000000000166; Hofmeijer J, 2014, CLIN NEUROPHYSIOL, V125, P947, DOI 10.1016/j.clinph.2013.10.017; Inaba K, 2013, J TRAUMA ACUTE CARE, V74, P766, DOI 10.1097/TA.0b013e3182826e84; Jagannathan J, 2008, J NEUROSURG-PEDIATR, V2, P240, DOI 10.3171/PED.2008.2.10.240; Keenan HT, 2007, PEDIATRICS, V119, pE616, DOI 10.1542/peds.2006-2313; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Kochanek Patrick M., 2000, Pediatr Crit Care Med, V1, P4, DOI 10.1097/00130478-200007000-00003; Lan YH, 2015, NEUROPEDIATRICS, V46, P211, DOI 10.1055/s-0035-1548673; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Liesemer K, 2011, J NEUROTRAUM, V28, P755, DOI 10.1089/neu.2010.1518; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Patel N, 2013, J TRAUMA ACUTE CARE, V74, P771; RamachandranNair R, 2005, PEDIATR NEUROL, V33, P345, DOI 10.1016/j.pediatrneurol.2005.05.007; RIMEL RW, 1982, NEUROSURGERY, V11, P344, DOI 10.1227/00006123-198209000-00002; Roach JP, 2014, PEDIATR SURG INT, V30, P1103, DOI 10.1007/s00383-014-3598-3; Schneier AJ, 2006, PEDIATRICS, V118, P483, DOI 10.1542/peds.2005-2588; Schreiber JM, 2012, NEUROCRIT CARE, V17, P31, DOI 10.1007/s12028-012-9715-z; Stanley RM, 2012, PEDIATRICS, V129, pE24, DOI 10.1542/peds.2011-2074; Theilen HJ, 2000, CRIT CARE MED, V28, P3522, DOI 10.1097/00003246-200010000-00029; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Vespa PM, 2007, CRIT CARE MED, V35, P2830, DOI 10.1097/01.CCM.0000295667.66853.BC; White JRM, 2001, CRIT CARE MED, V29, P534, DOI 10.1097/00003246-200103000-00011; Zafar SN, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-30	44	15	15	0	4	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	1525-5050	1525-5069		EPILEPSY BEHAV	Epilepsy Behav.	SEP	2016	62						225	230		10.1016/j.yebeh.2016.07.012			6	Behavioral Sciences; Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED)	Behavioral Sciences; Neurosciences & Neurology; Psychiatry	DX5AP	WOS:000384392500040	27500827	Green Accepted			2022-02-06	
J	Wiseman-Hakes, C; Duclos, C; Blais, H; Dumont, M; Bernard, F; Desautels, A; Menon, DK; Gilbert, D; Carrier, J; Gosselin, N				Wiseman-Hakes, Catherine; Duclos, Catherine; Blais, Helene; Dumont, Marie; Bernard, Francis; Desautels, Alex; Menon, David K.; Gilbert, Danielle; Carrier, Julie; Gosselin, Nadia			Sleep in the Acute Phase of Severe Traumatic Brain Injury: A Snapshot of Polysomnography	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						traumatic brain injury; sleep; polysomnography; orthopedic injury; acute care	INTENSIVE-CARE-UNIT; WAKE DISTURBANCES; CLINICAL-IMPLICATIONS; PRACTICAL SCALE; HEAD-INJURY; WAKEFULNESS; STATEMENT; NEURONS; IMPACT; MICE	Background and Objectives. The onset of pervasive sleep-wake disturbances associated with traumatic brain injury (TBI) is poorly understood. This study aimed to (a) determine the feasibility of using polysomnography in patients in the acute, hospitalized stage of severe TBI and (b) explore sleep quality and sleep architecture during this stage of recovery, compared to patients with other traumatic injuries. Methods. A cross-sectional case-control design was used. We examined the sleep of 7 patients with severe TBI (17-47 years; 20.3 +/- 15.0 days postinjury) and 6 patients with orthopedic and/or spinal cord injuries (OSCI; 19-58 years; 16.9 +/- 4.9 days postinjury). One night of ambulatory polysomnography was performed at bedside. Results. Compared to OSCI patients, TBI patients showed a significantly longer duration of nocturnal sleep and earlier nighttime sleep onset. Sleep efficiency was low and comparable in both groups. All sleep stages were observed in both groups with normal proportions according to age. Conclusion. Patients in the acute stage of severe TBI exhibit increased sleep duration and earlier sleep onset, suggesting that the injured brain enhances sleep need and/or decreases the ability to maintain wakefulness. As poor sleep efficiency could compromise brain recovery, further studies should investigate whether strategies known to optimize sleep in healthy individuals are efficacious in acute TBI. While there are several inherent challenges, polysomnography is a useful means of examining sleep in the early stage of recovery in patients with severe TBI.	[Wiseman-Hakes, Catherine; Duclos, Catherine; Blais, Helene; Dumont, Marie; Bernard, Francis; Desautels, Alex; Gilbert, Danielle; Carrier, Julie; Gosselin, Nadia] Hop Sacre Coeur, Montreal, PQ, Canada; [Wiseman-Hakes, Catherine; Duclos, Catherine; Dumont, Marie; Bernard, Francis; Desautels, Alex; Gilbert, Danielle; Carrier, Julie; Gosselin, Nadia] Univ Montreal, Montreal, PQ, Canada; [Menon, David K.] Univ Cambridge, Cambridge, England		Gosselin, N (corresponding author), Hop Sacre Coeur, Ctr Adv Res Sleep Med, 5400 Boul Gouin Ouest,Local E-0330, Montreal, PQ H4J 1C5, Canada.	nadia.gosselin@umontreal.ca	Wiseman-Hakes, Catherine/AAC-8303-2021	Wiseman-Hakes, Catherine/0000-0001-8441-884X; Carrier, Julie/0000-0001-5311-2370	Canadian Institutes of Health ResearchCanadian Institutes of Health Research (CIHR); Fonds pour la recherche du Quebec-Sante; Reseau provincial de recherche en adaptation-readaptation; Consortium pour la recherche en traumatologie du Quebec; Fondation Neurotrauma Marie-Robert; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NF-SI-0512-10090] Funding Source: researchfish	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This study was supported by the Canadian Institutes of Health Research (grant to NG and scholarship to CD), by the Fonds pour la recherche du Quebec-Sante (grant to NG), by the Reseau provincial de recherche en adaptation-readaptation (fellowship to CWH), by the Consortium pour la recherche en traumatologie du Quebec (grant to NG), and by the Fondation Neurotrauma Marie-Robert (scholarship to CD).	Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2005, NEUROLOGY, V65, P147, DOI 10.1212/01.wnl.0000167605.02541.f2; Beecroft JM, 2008, INTENS CARE MED, V34, P2076, DOI 10.1007/s00134-008-1180-y; Bijwadia JS, 2009, CURR OPIN CRIT CARE, V15, P25, DOI 10.1097/MCC.0b013e3283220dc7; Bourne RS, 2007, CRIT CARE, V11, DOI 10.1186/cc5966; Cantor JB, 2012, J HEAD TRAUMA REHAB, V27, pE1, DOI 10.1097/HTR.0b013e318270f91e; Chiu HY, 2014, INT J NURS STUD, V51, P892, DOI 10.1016/j.ijnurstu.2013.10.020; Dimsdale JE, 2007, J CLIN SLEEP MED, V3, P33; Drouot X, 2008, SLEEP MED REV, V12, P391, DOI 10.1016/j.smrv.2007.11.004; Duclos C, 2014, PATHOL BIOL, V62, P252, DOI 10.1016/j.patbio.2014.05.014; Duclos C, 2014, NEUROREHAB NEURAL RE, V28, P472, DOI 10.1177/1545968313517756; Ely EW, 2004, JAMA-J AM MED ASSOC, V291, P1753, DOI 10.1001/jama.291.14.1753; Greve MW, 2009, MT SINAI J MED, V76, P97, DOI 10.1002/msj.20104; Hagen C, 1973, RANCHO LEVELS COGNIT; Hardin KA, 2009, CHEST, V136, P284, DOI 10.1378/chest.08-1546; Iber C., 2007, AASM MANUAL SCORING, P7; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lim MM, 2013, SCI TRANSL MED, V5, DOI 10.1126/scitranslmed.3007092; MARSHALL LF, 1992, J NEUROTRAUM, V9, pS287; Meerlo P, 2009, SLEEP MED REV, V13, P187, DOI 10.1016/j.smrv.2008.07.004; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Mollayeva T, 2013, ENCY SLEEP, V2, P330; Ouellet MC, 2015, LANCET NEUROL, V14, P746, DOI 10.1016/S1474-4422(15)00068-X; ROSENBERG J, 1995, EUR J ANAESTH, V12, P28; Rowe RK, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0082507; Sabir M, 2015, BRAIN BEHAV IMMUN, V47, P118, DOI 10.1016/j.bbi.2014.12.023; Skopin MD, 2015, J NEUROTRAUM, V32, P289, DOI 10.1089/neu.2014.3664; Suchecki Deborah, 2012, Front Neurol, V3, P41, DOI 10.3389/fneur.2012.00041; TEASDALE G, 1974, LANCET, V2, P81; Tononi G, 2014, NEURON, V81, P12, DOI 10.1016/j.neuron.2013.12.025; Valko PO, 2015, ANN NEUROL, V77, P177, DOI 10.1002/ana.24298; VONELM E, 2007, LANCET, V370, P1453, DOI DOI 10.1016/S0140-6736(07)61602-X; Willie JT, 2012, J NEUROTRAUM, V29, P1908, DOI 10.1089/neu.2012.2404; Wiseman-Hakes C., 2009, CRIT REV PHYS REHABI, V21, P317, DOI [10.1615/CritRevPhysRehabilMed.v21.i3-4.70, DOI 10.1615/CRITREVPHYSREHABILMED.V21.I3-4.70]	34	15	15	0	0	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	SEP	2016	30	8					713	721		10.1177/1545968315619697			9	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DU9WJ	WOS:000382568500002	26704256	Green Submitted, Bronze			2022-02-06	
J	Sun, H; Lingsma, HF; Steyerberg, EW; Maas, AIR				Sun, Hong; Lingsma, Hester F.; Steyerberg, Ewout W.; Maas, Andrew I. R.			External Validation of the International Mission for Prognosis and Analysis of Clinical Trials in Traumatic Brain Injury: Prognostic Models for Traumatic Brain Injury on the Study of the Neuroprotective Activity of Progesterone in Severe Traumatic Brain Injuries Trial	JOURNAL OF NEUROTRAUMA			English	Article						case-mix; external validation; outcome; prognostic model; traumatic brain injury	IMPACT; PREDICTION; MODERATE; CRASH	Prediction models for patients with traumatic brain injury (TBI) are important for multiple reasons, including case-mix adjustment, trial design, and benchmarking for quality-of-care evaluation. Models should be generalizable and therefore require regular external validation. We aimed to validate the International Mission for Prognosis and Analysis of Clinical Trials in TBI (IMPACT) prognostic models for moderate and severe TBI in a recent randomized controlled trial. We studied 1124 patients enrolled in the multi-center randomized placebo-controlled Study of the Neuroprotective Activity of Progesterone in Severe Traumatic Brain Injuries (SyNAPSe) trial that evaluated the efficacy of progesterone in TBI. Treatment and placebo groups were combined for analysis. We evaluated the predictive performance of the three prognostic models (core, extended, and lab) from the IMPACT study with regard to discrimination (area under the receiver operating characteristic curve [AUC]) and calibration (comparison of observed to predicted risks). Substantial differences were found in case-mix and outcome distribution between IMPACT and SyNAPSe. In line with the more homogeneous case-mix of a clinical trial, the discriminative performance was reasonable. For the core model, an AUC of 0.677 and 0.684 was obtained for 6-month mortality and unfavorable outcome, respectively. Performance was slightly better for the extended model (0.693 and 0.705) and for the lab model (0.689 and 0.711, respectively). For calibration, we found overestimation ofmortality, especially at higher risk predictions, and underestimation of unfavorable outcome, especially at lower risk predictions. This pattern of miscalibration was consistent across all three models. In a contemporary trial setting, the IMPACT models have reasonable discrimination if enrollment restrictions apply. Observed changes in outcome distribution necessitate updating of previously developed prognostic models.	[Sun, Hong; Maas, Andrew I. R.] Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium; [Sun, Hong; Maas, Andrew I. R.] Univ Antwerp, Edegem, Belgium; [Lingsma, Hester F.; Steyerberg, Ewout W.] Erasmus MC, Dept Publ Hlth, Ctr Med Decis Making, Rotterdam, Netherlands		Maas, AIR (corresponding author), Univ Antwerp Hosp, Dept Neurosurg, Wilrijkstr 10, B-2650 Edegem, Belgium.	andrew.maas@uza.be					DELONG ER, 1988, BIOMETRICS, V44, P837, DOI 10.2307/2531595; Han JL, 2014, J NEUROTRAUM, V31, P1146, DOI 10.1089/neu.2013.3003; Harrell FE Jr, 2017, REGRESSION MODELING; Lingsma H, 2013, J TRAUMA ACUTE CARE, V74, P639, DOI 10.1097/TA.0b013e31827d602e; Lu J, 2010, J NEUROTRAUM, V27, P843, DOI 10.1089/neu.2010.1293; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; Moons KGM, 2015, ANN INTERN MED, V162, pW1, DOI 10.7326/M14-0698; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Mushkudiani NA, 2007, J NEUROTRAUM, V24, P259, DOI 10.1089/neu.2006.0028; Panczykowski DM, 2012, J NEUROTRAUM, V29, P47, DOI 10.1089/neu.2010.1482; Perel P, 2008, BMJ-BRIT MED J, V336, P425, DOI 10.1136/bmj.39461.643438.25; Roozenbeek B, 2012, CRIT CARE MED, V40, P1609, DOI 10.1097/CCM.0b013e31824519ce; Skolnick BE, 2014, NEW ENGL J MED, V371, P2467, DOI 10.1056/NEJMoa1411090; Slieker FJA, 2008, NEUROSURGERY, V62, P1321, DOI 10.1227/01.neu.0000333304.79931.4d; Sorani MD, 2009, J TRAUMA, V67, P75, DOI 10.1097/TA.0b013e31818234e8; Steyerberg, 2019, CLIN PREDICTION MODE; Steyerberg EW, 2010, EPIDEMIOLOGY, V21, P128, DOI 10.1097/EDE.0b013e3181c30fb2; Steyerberg EW, 2008, PLOS MED, V5, P1251, DOI 10.1371/journal.pmed.0050165; Van Buuren S., 2012, FLEXIBLE IMPUTATION; Vergouwe Y, 2010, AM J EPIDEMIOL, V172, P971, DOI 10.1093/aje/kwq223; Wilson JTL, 1998, J NEUROTRAUM, V15, P573, DOI 10.1089/neu.1998.15.573; Wong GKC, 2013, J CLIN NEUROSCI, V20, P1693, DOI 10.1016/j.jocn.2012.12.032	22	15	16	1	3	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	AUG 15	2016	33	16					1535	1543		10.1089/neu.2015.4164			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DU6ED	WOS:000382305900007	26652051				2022-02-06	
J	Palzur, E; Sharon, A; Shehadeh, M; Soustiel, JF				Palzur, Eilam; Sharon, Aviram; Shehadeh, Mona; Soustiel, Jean Francois			INVESTIGATION OF THE MECHANISMS OF NEUROPROTECTION MEDIATED BY Ro5-4864 IN BRAIN INJURY	NEUROSCIENCE			English	Article						18-kDa translocator protein; mitochondrial permeability transition pore; Ro5-4864; cyclosporine A; traumatic brain injury; neuroinflammation	PERIPHERAL BENZODIAZEPINE-RECEPTOR; CONTROLLED CORTICAL IMPACT; TUMOR-NECROSIS-FACTOR; PROTEIN 18 KDA; RAT-BRAIN; MICROGLIAL ACTIVATION; PARKINSONS-DISEASE; TEMPORAL PROFILE; CANCER-CELLS; HEAD-INJURY	Increasing evidence has established the involvement of the 18-kDa translocator protein (TSPO) in the process of mitochondrial membrane permeabilization and subsequent apoptosis through modulation of the mitochondrial permeability transition pore. Recent studies have shown that treatment with Ro5-4864, a TSPO ligand, resulted in a neuroprotective effect in traumatic brain injury. Yet, the nature of this effect remained uncertain as mature neurons are considered to be lacking the TSPO protein. In order to investigate the mechanism of Ro5-4864-mediated neuroprotection, the neuro-inflammatory and neurosteroid response to cortical injury was tested in sham-operated, vehicle, cyclosporine A (CsA) and Ro5-4864-treated rats. As anticipated, the levels of interleukin 1 beta and tumor necrosis factor alpha, as well as the astrocyte and microglia cellular density in the injured area were all decreased by CsA in comparison with the vehicle group. By contrast, no visible effect could be observed in Ro5-4864-treated animals. None of the groups showed any significant difference with any other in respect with the expression of brain-derived neurotrophic factor. Double immunofluorescence staining with NeuN and TSPO confirmed the absence of TSPO in native neurons though showed clear evidence of co-localization of TSPO in the cytoplasm of NeuN-stained injured neurons. Altogether, this study shows that the neuronal protection mediated by Ro5-4864 in brain injury cannot be solely attributed to an indirect effect of the ligand on glial TSPO but may also represent the consequence of the modulation of upregulated TSPO in injured neurons. This observation may be of importance for future pharmacological research in neurotrauma. (C) 2016 IBRO. Published by Elsevier Ltd. All rights reserved.	[Palzur, Eilam; Shehadeh, Mona; Soustiel, Jean Francois] Bar Ilan Univ, Eliachar Res Lab, Med Ctr Galilee, Fac Med Galilee, IL-22100 Nahariyya, Israel; [Sharon, Aviram; Soustiel, Jean Francois] Bar Ilan Univ, Dept Neurosurg, Med Ctr Galilee, Fac Med Galilee, IL-22100 Nahariyya, Israel		Soustiel, JF (corresponding author), Galilee Med Ctr, Dept Neurosurg, POB 21, IL-22100 Nahariyya, Israel.	JeanS@gmc.gov.il		Palzur, Eilam/0000-0003-2032-2974			Aguirre CC, 2009, EUR J NEUROSCI, V29, P447, DOI 10.1111/j.1460-9568.2008.06591.x; Arieli Ran, 1994, Journal of Basic and Clinical Physiology and Pharmacology, V5, P277; Azarashvili T, 2007, CELL CALCIUM, V42, P27, DOI 10.1016/j.ceca.2006.11.004; Banker DE, 2002, LEUKEMIA RES, V26, P91, DOI 10.1016/S0145-2126(01)00112-6; Bartels AL, 2010, PARKINSONISM RELAT D, V16, P57, DOI 10.1016/j.parkreldis.2009.05.005; Bono F, 1999, BIOCHEM BIOPH RES CO, V265, P457, DOI 10.1006/bbrc.1999.1683; BRAESTRUP C, 1977, P NATL ACAD SCI USA, V74, P3805, DOI 10.1073/pnas.74.9.3805; Chen XG, 2002, J NEUROSCI RES, V69, P687, DOI 10.1002/jnr.10334; Choi J, 2011, GLIA, V59, P219, DOI 10.1002/glia.21091; Dalgard CL, 2012, FRONT MOL NEUROSCI, V5, DOI 10.3389/fnmol.2012.00006; Decaudin D, 2002, CANCER RES, V62, P1388; di Michele F, 2000, NEUROSCI LETT, V284, P65, DOI 10.1016/S0304-3940(00)00965-4; Galluzzi L, 2009, NAT REV NEUROSCI, V10, P481, DOI 10.1038/nrn2665; Gerhard A, 2006, NEUROBIOL DIS, V21, P404, DOI 10.1016/j.nbd.2005.08.002; Giatti S, 2009, NEUROSCIENCE, V164, P520, DOI 10.1016/j.neuroscience.2009.08.005; Girard C, 2012, J NEUROENDOCRINOL, V24, P71, DOI 10.1111/j.1365-2826.2011.02215.x; Golani I, 2001, BIOCHEMISTRY-US, V40, P10213, DOI 10.1021/bi010431+; Gonzalez-Polo RA, 2005, ONCOGENE, V24, P7503, DOI 10.1038/sj.onc.1208907; Grossman R, 2003, NEUROIMAGE, V20, P1971, DOI 10.1016/j.neuroimage.2003.06.003; Gulyas B, 2012, J NEUROL SCI, V320, P110, DOI 10.1016/j.jns.2012.06.026; Guo YZ, 2015, SCIENCE, V347, P551, DOI 10.1126/science.aaa1534; Hailer NP, 2008, PROG NEUROBIOL, V84, P211, DOI 10.1016/j.pneurobio.2007.12.001; Hirsch T, 1998, EXP CELL RES, V241, P426, DOI 10.1006/excr.1998.4084; Iwamoto Y, 1996, NEUROREPORT, V7, P609, DOI 10.1097/00001756-199601310-00056; Lacor P, 1999, BRAIN RES, V815, P70, DOI 10.1016/S0006-8993(98)01105-6; Lee TH, 2002, NEUROREPORT, V13, P2271, DOI 10.1097/00001756-200212030-00020; Maaser K, 2001, BRIT J CANCER, V85, P1771, DOI 10.1054/bjoc.2001.2181; McAllister AK, 1999, ANNU REV NEUROSCI, V22, P295, DOI 10.1146/annurev.neuro.22.1.295; MCENERY MW, 1992, P NATL ACAD SCI USA, V89, P3170, DOI 10.1073/pnas.89.8.3170; Mills CD, 2005, MOL CELL NEUROSCI, V30, P228, DOI 10.1016/j.mcn.2005.07.010; Mills C, 2008, EUR J NEUROSCI, V27, P937, DOI 10.1111/j.1460-9568.2008.06065.x; Naert G, 2007, PSYCHONEUROENDOCRINO, V32, P1062, DOI 10.1016/j.psyneuen.2007.09.002; Nakamoto Y, 1996, BRAIN RES, V717, P91, DOI 10.1016/0006-8993(96)00033-9; Papadopoulos V, 2009, EXP NEUROL, V219, P53, DOI 10.1016/j.expneurol.2009.04.016; Pavese N, 2006, NEUROLOGY, V66, P1638, DOI 10.1212/01.wnl.0000222734.56412.17; ROSS SA, 1994, BRIT J NEUROSURG, V8, P419, DOI 10.3109/02688699408995109; Shiotani T, 2000, BRAIN RES, V859, P255, DOI 10.1016/S0006-8993(00)01971-5; Shulga A, 2008, J NEUROSCI, V28, P6996, DOI 10.1523/JNEUROSCI.5268-07.2008; Sohrabji F, 2006, FRONT NEUROENDOCRIN, V27, P404, DOI 10.1016/j.yfrne.2006.09.003; Soustiel JF, 2011, PHARM RES-DORDR, V28, P2945, DOI 10.1007/s11095-011-0463-0; Soustiel JF, 2008, EXP NEUROL, V214, P201, DOI 10.1016/j.expneurol.2008.08.008; Stover JF, 2000, NEUROSCI LETT, V288, P25, DOI 10.1016/S0304-3940(00)01187-3; Sullivan PG, 2011, J NEUROTRAUM, V28, P311, DOI 10.1089/neu.2010.1646; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; Varga B, 2009, NEUROSCI LETT, V462, P257, DOI 10.1016/j.neulet.2009.06.051; Veiga S, 2005, J NEUROSCI RES, V80, P129, DOI 10.1002/jnr.20430; Yasuno F, 2008, BIOL PSYCHIAT, V64, P835, DOI 10.1016/j.biopsych.2008.04.021	47	15	15	0	14	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0306-4522	1873-7544		NEUROSCIENCE	Neuroscience	AUG 4	2016	329						162	170		10.1016/j.neuroscience.2016.05.014			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO6ZW	WOS:000377933000015	27223627				2022-02-06	
J	Guo, ZN; Shao, AW; Tong, LS; Sun, WY; Liu, J; Yang, Y				Guo, Zhen-Ni; Shao, Anwen; Tong, Lu-Sha; Sun, Weiyi; Liu, Jia; Yang, Yi			The Role of Nitric Oxide and Sympathetic Control in Cerebral Autoregulation in the Setting of Subarachnoid Hemorrhage and Traumatic Brain Injury	MOLECULAR NEUROBIOLOGY			English	Article						Cerebral autoregulation; Nitric oxide; Sympathetic nerve; Subarachnoid hemorrhage; Traumatic brain injury	CORTICAL IMPACT INJURY; BLOOD-FLOW; CEREBROVASCULAR REACTIVITY; CEREBROSPINAL-FLUID; NERVOUS-SYSTEM; HEAD-INJURY; SYNTHASE; INHIBITION; VASOSPASM; PRESSURE	Cerebral autoregulation is defined as the mechanism by which constant cerebral blood flow is maintained despite changes of arterial blood pressure, and arterial blood pressure represents the principle aspect of cerebral autoregulation. The impairment of cerebral autoregulation is reported to be involved in several diseases. However, the concept, mechanisms, and pathological dysfunction of cerebral autoregulation are beyond full comprehension. Nitric oxide control and sympathetic control are main contributors to cerebral autoregulation. Although impaired cerebral autoregulation after nitric oxide inhibition or sympathetic ganglia blockade is reported, managing the inhibition or blockade can have negative consequences and needs further exploration. Additionally, impaired cerebral autoregulation following subarachnoid hemorrhage and traumatic brain injury has been proven by several descriptive studies, although without corresponding explanations. As the most important mechanisms of cerebral autoregulation, the changes of nitric oxide and sympathetic stimulation play significant roles in these insults. Therefore, the in-depth researches of nitric oxide and sympathetic nerve in cerebral autoregulation may help to develop new therapeutic targets.	[Guo, Zhen-Ni; Yang, Yi] Jilin Univ, Dept Neurol, Neurosci Ctr, Hosp 1, Xinmin St 71, Changchun 130021, Peoples R China; [Shao, Anwen] Zhejiang Univ, Sch Med, Dept Neurosurg, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China; [Tong, Lu-Sha] Zhejiang Univ, Sch Med, Dept Neurol, Affiliated Hosp 2, Hangzhou 310009, Zhejiang, Peoples R China; [Sun, Weiyi] Jilin Univ, Coll Automobile Engn, Changchun, Peoples R China; [Liu, Jia] Chinese Acad Sci, Shenzhen Inst Adv Technol, Xueyuan Ave, Shenzhen, Peoples R China		Yang, Y (corresponding author), Jilin Univ, Dept Neurol, Neurosci Ctr, Hosp 1, Xinmin St 71, Changchun 130021, Peoples R China.	doctor_yangyi@hotmail.com	邵, 安文/R-9023-2019; Shao, Anwen/L-4860-2019	Shao, Anwen/0000-0001-5616-0394; Shao, Anwen/0000-0001-9986-6290	Jilin Provincial government [440020031172]; Youth development foundation of First Hospital of Jilin University	This article was supported by Jilin Provincial government (Changbai mountain scholars, 440020031172) to Yi Yang and Youth development foundation of First Hospital of Jilin University to Zheni-Ni Guo.	Aguado F, 2002, J NEUROSCI, V22, P9430; Ainslie PN, 2012, J APPL PHYSIOL, V113, P1058, DOI 10.1152/japplphysiol.00463.2012; Ainslie Philip N, 2014, F1000Prime Rep, V6, P14, DOI 10.12703/P6-14; Armstead WM, 2011, J NEUROTRAUM, V28, P451, DOI 10.1089/neu.2010.1659; Azevedo E, 2011, CLIN AUTON RES, V21, P395, DOI 10.1007/s10286-011-0129-3; Baguley IJ, 2006, BRAIN INJURY, V20, P437, DOI 10.1080/02699050600664715; Baguley IJ, 1999, J NEUROL NEUROSUR PS, V67, P39, DOI 10.1136/jnnp.67.1.39; Bailey DM, 2013, CLIN SCI, V124, P177, DOI 10.1042/CS20120259; Banki NM, 2005, CIRCULATION, V112, P3314, DOI 10.1161/CIRCULATIONAHA.105.558239; Bellapart J, 2009, ULTRASOUND MED BIOL, V35, P883, DOI 10.1016/j.ultrasmedbio.2009.01.005; BOHLEN HG, 1984, CIRC RES, V55, P554, DOI 10.1161/01.RES.55.4.554; Budohoski KP, 2012, STROKE, V43, P3230, DOI 10.1161/STROKEAHA.112.669788; Carrera E, 2009, J NEUROL SCI, V285, P191, DOI 10.1016/j.jns.2009.06.041; Cherian L, 2000, J NEUROPHYSIOL, V83, P2171, DOI 10.1152/jn.2000.83.4.2171; Cherian L, 2004, BRAIN PATHOL, V14, P195, DOI 10.1111/j.1750-3639.2004.tb00053.x; Claassen JAHR, 2011, J CEREBR BLOOD F MET, V31, P1572, DOI 10.1038/jcbfm.2011.69; Clark RSB, 1996, CRIT CARE MED, V24, P1243, DOI 10.1097/00003246-199607000-00030; Ding D, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/727428; EDVINSSON L, 1975, STROKE, V6, P525, DOI 10.1161/01.STR.6.5.525; EKLOF B, 1971, ACTA PHYSIOL SCAND, V82, P172, DOI 10.1111/j.1748-1716.1971.tb04956.x; Gierthmuhlen J, 2011, ACTA NEUROL SCAND, V123, P332, DOI 10.1111/j.1600-0404.2010.01424.x; Gommer ED, 2008, PHYSIOL MEAS, V29, P1293, DOI 10.1088/0967-3334/29/11/005; GORDON RD, 1967, J CLIN INVEST, V46, P599, DOI 10.1172/JCI105561; Guo ZN, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0104849; Hanggi D, 2006, ACTA NEUROCHIR, V148, P605, DOI 10.1007/s00701-005-0721-1; Hamner JW, 2014, STROKE, V45, P1771, DOI 10.1161/STROKEAHA.114.005293; Hamner JW, 2012, J PHYSIOL-LONDON, V590, P6343, DOI 10.1113/jphysiol.2012.245100; Hamner JW, 2010, STROKE, V41, P102, DOI 10.1161/STROKEAHA.109.557132; Heffernan DS, 2010, J TRAUMA, V69, P1602, DOI 10.1097/TA.0b013e3181f2d3e8; Immink RV, 2005, STROKE, V36, P2595, DOI 10.1161/01.STR.0000189624.06836.03; Jaeger M, 2012, STROKE, V43, P2097, DOI 10.1161/STROKEAHA.112.659888; Jafarian-Tehrani M, 2005, NITRIC OXIDE-BIOL CH, V12, P61, DOI 10.1016/j.niox.2004.12.001; Jordan J, 2000, HYPERTENSION, V36, P383, DOI 10.1161/01.HYP.36.3.383; Junger EC, 1997, J NEUROSURG, V86, P425, DOI 10.3171/jns.1997.86.3.0425; Kajita Y, 1998, NEUROSURGERY, V42, P834, DOI 10.1097/00006123-199804000-00087; Kim H, 2014, INT J NANOMED, V9, P155, DOI 10.2147/IJN.S48856; Lang EW, 2001, CRIT CARE MED, V29, P158, DOI 10.1097/00003246-200101000-00031; Liu H, 2002, J NEUROTRAUM, V19, P327, DOI 10.1089/089771502753594891; Liu P, 2013, BRAIN RES, V1522, P67, DOI 10.1016/j.brainres.2013.05.032; Liu XY, 2015, J CEREBR BLOOD F MET, V35, P248, DOI 10.1038/jcbfm.2014.192; Louin G, 2006, NEUROPHARMACOLOGY, V50, P182, DOI 10.1016/j.neuropharm.2005.08.020; Mathew RJ, 1997, PSYCHIAT RES-NEUROIM, V74, P93, DOI 10.1016/S0925-4927(97)03106-5; MCCARRON JG, 1989, BLOOD VESSELS, V26, P315; Moussouttas M, 2014, J CLIN NEUROSCI, V21, P256, DOI 10.1016/j.jocn.2013.03.036; Murkin JM, 2007, SEMIN CARDIOTHORAC V, V11, P269, DOI 10.1177/1089253207311159; Osuka K, 2012, NEUROSCI LETT, V514, P2, DOI 10.1016/j.neulet.2011.12.041; Otite F, 2014, STROKE, V45, P677, DOI 10.1161/STROKEAHA.113.002630; Papadimos Thomas J, 2008, J Trauma Manag Outcomes, V2, P1, DOI 10.1186/1752-2897-2-1; Patel MB, 2012, TRIALS, V13, DOI 10.1186/1745-6215-13-177; Phillips AA, 2013, BRAIN SCI, V3, P781, DOI 10.3390/brainsci3020781; Preckel MP, 1996, INT J MICROCIRC, V16, P277, DOI 10.1159/000179186; RangeL-Castilla L, 2008, NEUROSURG FOCUS, V25, DOI 10.3171/FOC.2008.25.10.E7; Rosenthal G, 2011, J NEUROSURG, V114, P62, DOI 10.3171/2010.6.JNS091360; Sabri M, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0017062; Sabri M, 2011, J CEREBR BLOOD F MET, V31, P190, DOI 10.1038/jcbfm.2010.76; SAGAWA K, 1961, AM J PHYSIOL, V200, P711, DOI 10.1152/ajplegacy.1961.200.4.711; Sakamoto KI, 1997, J NEUROTRAUM, V14, P349, DOI 10.1089/neu.1997.14.349; Sviri GE, 2009, J NEUROSURG, V111, P695, DOI 10.3171/2008.10.17686; Tan CO, 2014, EXP PHYSIOL, V99, P3, DOI 10.1113/expphysiol.2013.072355; TANAKA K, 1993, NEUROREPORT, V4, P267, DOI 10.1097/00001756-199303000-00010; Terashvili M, 2006, PEDIATR CLIN N AM, V53, P1029, DOI 10.1016/j.pcl.2006.08.003; Terpolilli NA, 2013, J CEREBR BLOOD F MET, V33, P311, DOI 10.1038/jcbfm.2012.176; Thompson BG, 1996, J NEUROSURG, V84, P71, DOI 10.3171/jns.1996.84.1.0071; TIECKS FP, 1995, STROKE, V26, P1014, DOI 10.1161/01.STR.26.6.1014; Uzan M, 2001, SURG NEUROL, V56, P350, DOI 10.1016/S0090-3019(01)00633-4; van Gijn J, 2007, LANCET, V369, P306, DOI 10.1016/S0140-6736(07)60153-6; Vellimana AK, 2011, STROKE, V42, P776, DOI 10.1161/STROKEAHA.110.607200; Wada K, 1999, J NEUROTRAUM, V16, P203, DOI 10.1089/neu.1999.16.203; Wada K, 1998, NEUROSURGERY, V43, P1427, DOI 10.1097/00006123-199812000-00096; White RP, 2000, CLIN SCI, V99, P555, DOI 10.1042/CS20000064; Zhang HL, 2012, NEUROSCI BULL, V28, P723, DOI 10.1007/s12264-012-1282-y; Zhang R, 2004, AM J PHYSIOL-HEART C, V286, pH863, DOI 10.1152/ajpheart.00373.2003; Zhang R, 2002, CIRCULATION, V106, P1814, DOI 10.1161/01.CIR.0000031798.07790.FE; Zhang R, 2007, STROKE, V38, P1238, DOI 10.1161/01.STR.0000260095.94175.d0	74	15	15	3	16	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0893-7648	1559-1182		MOL NEUROBIOL	Mol. Neurobiol.	AUG	2016	53	6					3606	3615		10.1007/s12035-015-9308-x			10	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DR2AO	WOS:000379707600009	26108186				2022-02-06	
J	Rigon, A; Voss, MW; Turkstra, LS; Mutlu, B; Duff, MC				Rigon, Arianna; Voss, Michelle W.; Turkstra, Lyn S.; Mutlu, Bilge; Duff, Melissa C.			Frontal and Temporal Structural Connectivity Is Associated with Social Communication Impairment Following Traumatic Brain Injury	JOURNAL OF THE INTERNATIONAL NEUROPSYCHOLOGICAL SOCIETY			English	Article						White matter; Communication; Diffusion tensor imaging; Fractional anisotropy; Frontal lobe; Temporal lobe	WHITE-MATTER INTEGRITY; COGNITIVE NEUROSCIENCE; DISCOURSE ABILITIES; BEHAVIORAL-CHANGES; DECISION-MAKING; HEAD-INJURY; DIFFUSION; DAMAGE; DEFICITS; ADULTS	Objectives: Although it has been well documented that traumatic brain injury (TBI) can result in communication impairment, little work to date has examined the relationship between social communication skills and structural brain integrity in patients with TBI. The aim of the current study was to investigate the association between self- and other-perceived communication problems and white matter integrity in patients with mild to severe TBI. Methods: Forty-four individuals (TBI=24) and people with whom they frequently communicate, as well as demographically matched normal healthy comparisons (NC) and their frequent communication partners, were administered, respectively, the La-Trobe Communication Questionnaire Self form (LCQ-SELF) and Other form (LCQ-OTHER). In addition, diffusion tensor imaging data were collected, and fractional anisotropy (FA) measures were extracted for each lobe in both hemispheres. Results: Within the TBI group, but not within the NC group, participants who were perceived by their close others as having more communication problems had lower FA in the left frontal and temporal lobes (p<.01), but not in other brain regions. Conclusions: Frontotemporal white matter microstructural integrity is associated with social communication abilities in adults with TBI. This finding contributes to our understanding of the mechanisms leading to communication impairment following TBI and can inform the development of new neuromodulation therapies as well as diagnostic tools.	[Rigon, Arianna; Voss, Michelle W.; Duff, Melissa C.] Univ Iowa, Interdisciplinary Neurosci Program, Iowa City, IA USA; [Voss, Michelle W.] Univ Iowa, Dept Psychol & Brain Sci, Iowa City, IA USA; [Turkstra, Lyn S.] Univ Wisconsin, Dept Commun Sci & Disorders, Madison, WI 53706 USA; [Turkstra, Lyn S.] Univ Wisconsin, Interdisciplinary Program Neurosci, Madison, WI 53706 USA; [Mutlu, Bilge] Univ Wisconsin, Dept Comp Sci, Madison, WI 53706 USA; [Duff, Melissa C.] Univ Iowa, Dept Commun Sci & Disorders, Iowa City, IA USA; [Duff, Melissa C.] Univ Iowa, Dept Neurol, Iowa City, IA 52242 USA		Rigon, A (corresponding author), 420-1 Seashore Hall,328 Iowa Ave, Iowa City, IA 52242 USA.	arianna-rigon@uiowa.edu	Turkstra, Lyn/ABC-5831-2021	Turkstra, Lyn/0000-0002-6948-6921	NICHD/NCMRR grant [R01 HD071089]; University of Iowa Magnetic Resonance Research Facilities; University of Iowa Graduate and Professional Student Government; EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD071089] Funding Source: NIH RePORTER	This work was supported by NICHD/NCMRR grant R01 HD071089, the University of Iowa Magnetic Resonance Research Facilities and a research grant from the University of Iowa Graduate and Professional Student Government. The authors thank Joel Bruss, Ruth Hansen, and Kristina Warndahl for their help. The authors have no conflicts of interest to disclose.	ADAMS JH, 1984, LANCET, V2, P1420; Adams JH, 2001, J NEUROL NEUROSUR PS, V71, P521, DOI 10.1136/jnnp.71.4.521; Adolphs R, 2003, NAT REV NEUROSCI, V4, P165, DOI 10.1038/nrn1056; Ahles TA, 2003, PSYCHO-ONCOL, V12, P612, DOI 10.1002/pon.742; Andersson JL, 2007, TR07JA1 FMRIB FMRIB TECH REP TRO7J; Andersson JL, 2007, FMRIB TECH REP TRO7J FMRIB TECHNICAL REPO; ARON A, 1992, J PERS SOC PSYCHOL, V63, P596, DOI 10.1037/0022-3514.63.4.596; Basser PJ, 1995, NMR BIOMED, V8, P333, DOI 10.1002/nbm.1940080707; Beauchamp MS, 2015, TRENDS COGN SCI, V19, P489, DOI 10.1016/j.tics.2015.07.002; Beaulieu C, 2002, NMR BIOMED, V15, P435, DOI 10.1002/nbm.782; Bechara A, 2000, BRAIN, V123, P2189, DOI 10.1093/brain/123.11.2189; Behrens TEJ, 2003, MAGN RESON MED, V50, P1077, DOI 10.1002/mrm.10609; Bernicot J, 2001, INT J LANG COMM DIS, V36, P245; Bond F, 1997, BRAIN INJURY, V11, P319, DOI 10.1080/026990597123476; Bornhofen C, 2008, J INT NEUROPSYCH SOC, V14, P511, DOI 10.1017/S1355617708080703; Bosco FM, 2015, INT J LANG COMM DIS, V50, P63, DOI 10.1111/1460-6984.12114; Champagne-Lavau M, 2007, BRAIN, V130, DOI 10.1093/brain/awl311; Ciaramelli E, 2012, J INT NEUROPSYCH SOC, V18, P962, DOI 10.1017/S1355617712000690; COELHO CA, 1995, BRAIN INJURY, V9, P471, DOI 10.3109/02699059509008206; Coelho CA, 1996, J SPEECH HEAR RES, V39, pS5, DOI 10.1044/jshr.3905.s5; Costa PJ, 2014, J BIOPHARM STAT, V24, P1115, DOI 10.1080/10543406.2014.926366; Crewe-Brown SJ, 2011, S AFR J COMMUN DISOR, V58, P48; Cubon VA, 2011, J NEUROTRAUM, V28, P189, DOI 10.1089/neu.2010.1430; Cummings Louise, 2007, Seminars in Speech and Language, V28, P96, DOI 10.1055/s-2007-970568; Dardier V, 2011, J COMMUN DISORD, V44, P359, DOI 10.1016/j.jcomdis.2011.02.001; DELIS DC, 1988, J CONSULT CLIN PSYCH, V56, P123, DOI 10.1037/0022-006X.56.1.123; Despins EH, 2016, ARCH PHYS MED REHAB, V97, pS26, DOI 10.1016/j.apmr.2014.06.023; Docking K, 2000, BRAIN INJURY, V14, P89, DOI 10.1080/026990500120952; Douglas JM, 2007, J HEAD TRAUMA REHAB, V22, P31, DOI 10.1097/00001199-200701000-00004; Douglas JM, 2010, J SPEECH LANG HEAR R, V53, P365, DOI 10.1044/1092-4388(2009/08-0205); Duff MC, 2012, FRONT HUM NEUROSCI, V6, DOI 10.3389/fnhum.2012.00069; Duncan J, 2000, TRENDS NEUROSCI, V23, P475, DOI 10.1016/S0166-2236(00)01633-7; EdwardsLee T, 1997, BRAIN, V120, P1027, DOI 10.1093/brain/120.6.1027; Engberg AW, 2004, BRAIN INJURY, V18, P533, DOI 10.1080/02699050310001645829; Fontaine A, 1999, NEUROLOGY, V53, P1963, DOI 10.1212/WNL.53.9.1963; Gaetz M, 2004, CLIN NEUROPHYSIOL, V115, P4, DOI 10.1016/S1388-2457(03)00258-X; Garcia-Molina A, 2013, MED CLIN-BARCELONA, V140, P527, DOI 10.1016/j.medcli.2012.09.047; GORDON NG, 1972, J CLIN PSYCHOL, V28, P167, DOI 10.1002/1097-4679(197204)28:2<167::AID-JCLP2270280212>3.0.CO;2-X; Gordon RG, 2015, BRAIN INJURY, V29, P1300, DOI 10.3109/02699052.2015.1042408; Gordon RG, 2014, NEUROPSYCHOLOGY, V28, P624, DOI 10.1037/neu0000073; Hayes JP, 2016, J INT NEUROPSYCH SOC, V22, P120, DOI 10.1017/S1355617715000740; Head D, 2004, CEREB CORTEX, V14, P410, DOI 10.1093/cercor/bhh003; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; Hornak J, 1996, NEUROPSYCHOLOGIA, V34, P247, DOI 10.1016/0028-3932(95)00106-9; Hua K, 2008, NEUROIMAGE, V39, P336, DOI 10.1016/j.neuroimage.2007.07.053; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Johnstone B, 1996, ARCH CLIN NEUROPSYCH, V11, P513, DOI 10.1016/0887-6177(96)82330-4; Kennedy MRT, 2009, J INT NEUROPSYCH SOC, V15, P130, DOI 10.1017/S1355617708090024; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Knox L, 2009, BRAIN COGNITION, V69, P442, DOI 10.1016/j.bandc.2008.09.009; Koenigs M, 2007, NATURE, V446, P908, DOI 10.1038/nature05631; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Kumar R, 2009, J NEUROTRAUM, V26, P481, DOI 10.1089/neu.2008.0461; LEVIN HS, 1992, CURR OPIN NEUROL NEU, V5, P673; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; McDonald S, 1998, BRAIN LANG, V61, P88, DOI 10.1006/brln.1997.1846; McDonald S, 2008, ARCH PHYS MED REHAB, V89, P1648, DOI 10.1016/j.apmr.2008.02.029; Pagulayan KF, 2006, ARCH PHYS MED REHAB, V87, P611, DOI 10.1016/j.apmr.2006.01.018; PETTERSEN L, 1991, PERCEPT MOTOR SKILL, V73, P1139, DOI 10.2466/PMS.73.8.1139-1150; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Rosenberg H, 2014, J INT NEUROPSYCH SOC, V20, P994, DOI 10.1017/S1355617714000940; Rousseaux M, 2010, EUR J NEUROL, V17, P922, DOI 10.1111/j.1468-1331.2009.02945.x; Ryan NP, 2015, BRAIN LANG, V142, P86, DOI 10.1016/j.bandl.2015.01.007; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Sen PN, 2005, BIOPHYS J, V89, P2927, DOI 10.1529/biophysj.105.063016; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; SHEWAN CM, 1980, J SPEECH HEAR DISORD, V45, P308, DOI 10.1044/jshd.4503.308; Smith SM, 2002, HUM BRAIN MAPP, V17, P143, DOI 10.1002/hbm.10062; Smith SM, 2004, NEUROIMAGE, V23, pS208, DOI 10.1016/j.neuroimage.2004.07.051; Smith SM, 2006, NEUROIMAGE, V31, P1487, DOI 10.1016/j.neuroimage.2006.02.024; Snow P, 1998, BRAIN INJURY, V12, P911, DOI 10.1080/026990598121981; Stolk A, 2015, CURR BIOL, V25, P1469, DOI 10.1016/j.cub.2015.03.057; Struchen MA, 2008, NEUROREHABILITATION, V23, P185; Struchen MA, 2008, BRAIN INJURY, V22, P940, DOI 10.1080/02699050802425410; Tompkins Connie A., 1998, Seminars in Speech and Language, V19, P303, DOI 10.1055/s-2008-1064052; Vigneau M, 2006, NEUROIMAGE, V30, P1414, DOI 10.1016/j.neuroimage.2005.11.002; Voss MW, 2013, HUM BRAIN MAPP, V34, P2972, DOI 10.1002/hbm.22119; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Werring DJ, 1999, NEUROLOGY, V52, P1626, DOI 10.1212/WNL.52.8.1626; Whelan BM, 2007, J HEAD TRAUMA REHAB, V22, P192, DOI 10.1097/01.HTR.0000271120.04405.db; Wilkinson GS, 2006, WIDE RANGE ACHIEVEME; Winkler AM, 2014, NEUROIMAGE, V92, P381, DOI 10.1016/j.neuroimage.2014.01.060; Zappala G, 2012, CORTEX, V48, P156, DOI 10.1016/j.cortex.2011.06.020	85	15	15	1	23	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1355-6177	1469-7661		J INT NEUROPSYCH SOC	J. Int. Neuropsychol. Soc.	AUG	2016	22	7					705	716		10.1017/S1355617716000539			12	Clinical Neurology; Neurosciences; Psychiatry; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Psychology	DU8SQ	WOS:000382485100002	27405965	Green Accepted			2022-02-06	
J	Brennan, FH; Kurniawan, ND; Vukovic, J; Bartlett, PF; Kasermann, F; Arumugam, TV; Basta, M; Ruitenberg, MJ				Brennan, Faith H.; Kurniawan, Nyoman D.; Vukovic, Jana; Bartlett, Perry F.; Kasermann, Fabian; Arumugam, Thiruma V.; Basta, Milan; Ruitenberg, Marc J.			IVIg attenuates complement and improves spinal cord injury outcomes in mice	ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY			English	Article							DOSE INTRAVENOUS IMMUNOGLOBULIN; WHITE-MATTER PATHOLOGY; FC-GAMMA-RIIB; ACUTE-INFLAMMATION; BRAIN-INJURY; CELL-DEATH; RECOVERY; THERAPY; MODEL; SYSTEM	Objective: Traumatic spinal cord injury ( SCI) elicits immediate neural cell death, axonal damage, and disruption of the blood-spinal cord barrier, allowing circulating immune cells and blood proteins into the spinal parenchyma. The inflammatory response to SCI involves robust complement system activation, which contributes to secondary injury and impairs neurological recovery. This study aimed to determine whether intravenous immunoglobulin ( IVIg), an FDA-approved treatment for inflammatory conditions, can scavenge complement activation products and improve recovery from contusive SCI. Methods: We used functional testing, noninvasive imaging, and detailed postmortem analysis to assess whether IVIg therapy is effective in a mouse model of severe contusive SCI. Results: IVIg therapy at doses of 0.5-2 g/kg improved the functional and histopathological outcomes from SCI, conferring protection against lesion enlargement, demyelination, central canal dilation, and axonal degeneration. The benefits of IVIg were detectable through noninvasive diffusion tensor imaging ( DTI), with IVIg treatment counteracting the progressive SCI-induced increase in radial diffusivity ( RD) in white matter. Diffusion indices significantly correlated with the functional performance of individual mice and accurately predicted the degree of myelin preservation. Further experiments revealed that IVIg therapy reduced the presence of complement activation products and phagocytically active macrophages at the lesion site, providing insight as to its mechanisms of action. Interpretation: Our findings highlight the potential of using IVIg as an immunomodulatory treatment for SCI, and the value of DTI to assess tissue damage and screen for the efficacy of candidate intervention strategies in preclinical models of SCI, both quantitatively and noninvasively.	[Brennan, Faith H.; Vukovic, Jana; Ruitenberg, Marc J.] Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia; [Kurniawan, Nyoman D.] Univ Queensland, Ctr Adv Imaging, Brisbane, Qld 4072, Australia; [Vukovic, Jana; Bartlett, Perry F.; Ruitenberg, Marc J.] Univ Queensland, Queensland Brain Inst, Brisbane, Qld 4072, Australia; [Kasermann, Fabian] CSL Behring, Res, CH-3000 Bern, Switzerland; [Arumugam, Thiruma V.] Natl Univ Singapore, Yong Loo Lin Sch Med, Dept Physiol, Singapore 117597, Singapore; [Basta, Milan] BioVisions Inc, 9012 Wandering Trail Dr, Potomac, MD 20854 USA; [Ruitenberg, Marc J.] Univ Queensland, Brisbane Diamantina Hlth Partners, Trauma Crit Care & Recovery, Brisbane, Qld, Australia		Ruitenberg, MJ (corresponding author), Univ Queensland, Sch Biomed Sci, Brisbane, Qld 4072, Australia.; Basta, M (corresponding author), BioVisions Inc, 9012 Wandering Trail Dr, Potomac, MD 20854 USA.	basta.milan@gmail.com; m.ruitenberg@uq.edu.au	Vukovic, Jana/B-4845-2013; Kurniawan, Nyoman/D-9764-2011; Arumugam, Thiruma/AAG-6958-2019	Vukovic, Jana/0000-0002-3739-1688; Kurniawan, Nyoman/0000-0001-6340-182X; Ruitenberg, Marc/0000-0002-6917-0708; Kasermann, Fabian/0000-0002-4255-9350; Brennan, Faith/0000-0002-9201-2476; Arumugam, Thiruma/0000-0002-3377-0939			Ankeny DP, 2009, J CLIN INVEST, V119, P2990, DOI 10.1172/JCI39780; Arumugam TV, 2007, P NATL ACAD SCI USA, V104, P14104, DOI 10.1073/pnas.0700506104; Bar-Or D, 2006, CRIT CARE MED, V34, P1707, DOI 10.1097/01.CCM.0000217923.53680.4C; BASTA M, 1989, BLOOD, V74, P326; Basta M, 2003, NAT MED, V9, P431, DOI 10.1038/nm836; BASTA M, 1994, J CLIN INVEST, V94, P1729, DOI 10.1172/JCI117520; BASTA M, 1989, J CLIN INVEST, V84, P1974, DOI 10.1172/JCI114387; Basta M, 2008, MOL IMMUNOL, V45, P4073, DOI 10.1016/j.molimm.2008.07.012; Bayry J, 2011, NAT REV RHEUMATOL, V7, P349, DOI 10.1038/nrrheum.2011.61; Belayev L, 1999, BRAIN RES, V845, P107, DOI 10.1016/S0006-8993(99)01952-6; Brennan FH, 2016, SEMIN IMMUNOL, V28, P292, DOI 10.1016/j.smim.2016.03.015; Brennan FH, 2015, NEURAL REGEN RES, V10, P1596, DOI 10.4103/1673-5374.165268; Brennan FH, 2015, J NEUROSCI, V35, P6517, DOI 10.1523/JNEUROSCI.5218-14.2015; Brennan FH, 2013, NEUROIMAGE, V82, P574, DOI 10.1016/j.neuroimage.2013.06.019; Brennan FH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-137; Cain LD, 2007, J NEUROSCI RES, V85, P1558, DOI 10.1002/jnr.21265; Carpenter RS, 2015, EXP NEUROL, V271, P432, DOI 10.1016/j.expneurol.2015.07.011; Chen B, 2014, PEDIATR RES, V75, P612, DOI 10.1038/pr.2014.12; Courtine G, 2007, NAT MED, V13, P561, DOI 10.1038/nm1595; Donnelly DJ, 2008, EXP NEUROL, V209, P378, DOI 10.1016/j.expneurol.2007.06.009; DUCKER TB, 1994, SPINE, V19, P2281, DOI 10.1097/00007632-199410150-00006; Nguyen DH, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-224; Dvorak MF, 2014, J NEUROTRAUM, V31, P1540, DOI 10.1089/neu.2013.3278; Ephrem A, 2005, CLIN EXP MED, V5, P135, DOI 10.1007/s10238-005-0079-y; Gensel JC, 2011, EXPERT OPIN THER TAR, V15, P505, DOI 10.1517/14728222.2011.553605; Hui ES, 2010, NEUROIMAGE, V49, P2366, DOI 10.1016/j.neuroimage.2009.10.022; Jeong S, 2014, J NEUROIMMUNOL, V276, P112, DOI 10.1016/j.jneuroim.2014.08.626; Karsten CM, 2012, NAT MED, V18, P1401, DOI 10.1038/nm.2862; Katz U, 2007, AUTOIMMUN REV, V6, P257, DOI 10.1016/j.autrev.2006.08.011; Kelley BJ, 2014, J NEUROTRAUM, V31, P1362, DOI 10.1089/neu.2013.3238; Kim JH, 2007, MAGN RESON MED, V58, P253, DOI 10.1002/mrm.21316; Kim JH, 2010, J NEUROTRAUM, V27, P587, DOI 10.1089/neu.2009.1063; Konrad S, 2006, BRIT J HAEMATOL, V134, P345, DOI 10.1111/j.1365-2141.2006.06185.x; Loy DN, 2007, J NEUROTRAUM, V24, P979, DOI 10.1089/neu.2006.0253; Miller SM, 2008, J NEUROSURG ANESTH, V20, P140, DOI 10.1097/01.ana.0000314442.40952.0d; Mulcahey MJ, 2012, SPINE, V37, pE797, DOI 10.1097/BRS.0b013e3182470a08; Nakahara J, 2003, DEV CELL, V4, P841, DOI 10.1016/S1534-5807(03)00155-2; Neher MD, 2014, J NEUROINFLAMM, V11, DOI 10.1186/1742-2094-11-95; Neher MD, 2011, J BIOMED SCI, V18, DOI 10.1186/1423-0127-18-90; Okun E, 2010, NEUROMOL MED, V12, P164, DOI 10.1007/s12017-009-8099-5; Popovich PG, 1996, EXP NEUROL, V142, P258, DOI 10.1006/exnr.1996.0196; Radojicic M, 2007, BMC NEUROL, V7, DOI 10.1186/1471-2377-7-30; Schwab I, 2013, NAT REV IMMUNOL, V13, P176, DOI 10.1038/nri3401; Shushakova N, 2002, J CLIN INVEST, V110, P1823, DOI 10.1172/JCI200216577; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Spycher M, 2009, VOX SANG, V97, P348, DOI 10.1111/j.1423-0410.2009.01217.x; Stahel Philip F, 2006, Expert Rev Clin Immunol, V2, P445, DOI 10.1586/1744666X.2.3.445; Sundgren PC, 2004, NEURORADIOLOGY, V46, P339, DOI 10.1007/s00234-003-1114-x; Thomas AJ, 1999, SPINE, V24, P2134, DOI 10.1097/00007632-199910150-00013; Widiapradja Alexander, 2014, Exp Transl Stroke Med, V6, P7, DOI 10.1186/2040-7378-6-7; Widiapradja A, 2012, J NEUROCHEM, V122, P321, DOI 10.1111/j.1471-4159.2012.07754.x	51	15	15	2	6	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	2328-9503			ANN CLIN TRANSL NEUR	Ann. Clin. Transl. Neurol.	JUL	2016	3	7					495	511		10.1002/acn3.318			17	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DX1JJ	WOS:000384122800002	27386499	gold, Green Published			2022-02-06	
J	Chronister, J; Johnson, ET; Chan, F; Tu, WM; Chung, YC; Lee, GK				Chronister, Julie; Johnson, Ebonee T.; Chan, Fong; Tu, Wei-Mo; Chung, Yi-Chieh; Lee, Gloria K.			Positive Person-Environment Factors as Mediators of the Relationship Between Perceived Burden and Quality of Life of Caregivers for Individuals With Traumatic Brain Injuries	REHABILITATION COUNSELING BULLETIN			English	Article						traumatic brain injury; caregiver; social support; quality of life; family adaptation; rehabilitation counseling; stress and coping	SOCIAL SUPPORT; FAMILY CAREGIVERS; STRESS; NEEDS; MODEL; SATISFACTION; PREDICTORS; DEPRESSION; APPRAISAL; MODERATOR	The purpose of this study was to determine whether personal (caregiving mastery and problem-solving coping) and environmental (social support and professional and community support) caregiver resources mediate the relationship between caregiver perceived burden and quality of life (QOL). The sample consisted of 108 caregivers recruited from support groups who were predominantly White women. The majority of care-recipients had a severe head injury. Measures administered were the Interpersonal Support Evaluation List, the COPE, Family Needs Questionnaire, Modified Caregiving Appraisal Scale, and the World Health Organization Quality of Life-Brief Version. Results showed that social, professional, and community supports mediate the link between perceived burden and QOL. Caregivers of persons with traumatic brain injury frequently face elevated levels of burden, stress, and depression. Positive personal and environmental support, particularly social support, professional/community supports, and mastery, could lessen the negative impact of caregiving burden on QOL of the caregiver.	[Chronister, Julie] San Francisco State Univ, San Francisco, CA 94132 USA; [Johnson, Ebonee T.] Southern Univ, Baton Rouge, LA USA; [Chan, Fong; Tu, Wei-Mo] Univ Wisconsin, Madison, WI 53706 USA; [Chan, Fong] Natl Changhua Univ Educ, Changhua, Taiwan; [Chung, Yi-Chieh] Natl Pingtung Univ, Pingtung, Taiwan; [Lee, Gloria K.] Michigan State Univ, E Lansing, MI 48824 USA		Chronister, J (corresponding author), San Francisco State Univ, Dept Counseling Coordinator, Rehabil Counselor Training Program, 1600 Holloway Ave,Burk Hall 525, San Francisco, CA 94131 USA.	jchronis@sfsu.edu		Johnson, Ebonee/0000-0001-9464-2693; Tu, Wei-Mo/0000-0003-2964-542X			ALLEN K, 1994, REHABIL PSYCHOL, V39, P29, DOI 10.1037/0090-5550.39.1.29; Aneshensel C. S., 1995, PROFILES CAREGIVING; Arango-Lasprilla JC, 2010, BRAIN INJURY, V24, P1017, DOI 10.3109/02699052.2010.490516; BARON RM, 1986, J PERS SOC PSYCHOL, V51, P1173, DOI 10.1037/0022-3514.51.6.1173; Beach SR, 2000, PSYCHOL AGING, V15, P259, DOI 10.1037//0882-7974.15.2.259; Bergman MM, 2002, J HEAD TRAUMA REHAB, V17, P431, DOI 10.1097/00001199-200210000-00005; Bishop M, 2006, AUST J REHABIL COUNS, V12, P73, DOI 10.1375/jrc.12.2.73; Brissette I, 2002, J PERS SOC PSYCHOL, V82, P102, DOI 10.1037//0022-3514.82.1.102; Brooks N, 1987, J HEAD TRAUMA REHAB, V2, P1, DOI [10.1097/00001199-198709000-00003, DOI 10.1097/00001199-198709000-00003]; CARVER CS, 1989, J PERS SOC PSYCHOL, V56, P267, DOI 10.1037/0022-3514.56.2.267; Chan F, 2009, REHABIL COUNS BULL, V52, P114, DOI 10.1177/0034355208323947; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; Chronister J, 2010, NEUROREHABILITATION, V27, P49, DOI 10.3233/NRE-2010-0580; Chwalisz K, 1996, REHABIL PSYCHOL, V41, P91, DOI 10.1037/0090-5550.41.2.91; Cohen CA, 2002, INT J GERIATR PSYCH, V17, P184, DOI 10.1002/gps.561; COHEN J, 1992, PSYCHOL BULL, V112, P155, DOI 10.1037/0033-2909.112.1.155; Cohen J., 2013, STAT POWER ANAL BEHA; COHEN S, 1983, J APPL SOC PSYCHOL, V13, P99, DOI 10.1111/j.1559-1816.1983.tb02325.x; COHEN S, 1985, PSYCHOL BULL, V98, P310, DOI 10.1037//0033-2909.98.2.310; Cohen S, 2003, PSYCHOSOM MED, V65, P652, DOI 10.1097/01.PSY.0000077508.57784.DA; Cohen S., 2001, EMOTION SOCIAL RELAT, P221; COHEN S, 1983, SOCIAL SUPPORT THEOR, P73; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Degeneffe CE, 2011, REHABIL PSYCHOL, V56, P243, DOI 10.1037/a0024465; DEW DW, 1989, J REHABIL, V55, P41; Douglas JM, 2000, BRAIN INJURY, V14, P71, DOI 10.1080/026990500120943; Ergh TC, 2003, J CLIN EXP NEUROPSYC, V25, P1090, DOI 10.1076/jcen.25.8.1090.16735; ERGH TC, 2002, THE JOURNAL OF HEAD, V17, P155, DOI DOI 10.1097/00001199-200204000-00006; Evans JP, 2011, T I BRIT GEOGR, V36, P223, DOI 10.1111/j.1475-5661.2010.00420.x; Feldman PJ, 2004, PSYCHOL HEALTH, V19, P353, DOI 10.1080/0887044042000193497; Fleming JM, 1998, J HEAD TRAUMA REHAB, V13, P39, DOI 10.1097/00001199-199810000-00006; Florian V, 1989, Brain Inj, V3, P219, DOI 10.3109/02699058909029637; Gordon W. A., 2003, REH SERV ADM WORK GR; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Harper A, 1998, PSYCHOL MED, V28, P551, DOI 10.1017/S0033291798006667; Harris J, 2001, ENV MANAG HLTH, V12, P529; Hayward B., 2002, STAT OF THE SCI C CO; Hilgeman MM, 2007, PSYCHOL AGING, V22, P361, DOI 10.1037/0882-7974.22.2.361; KREUTZER JS, 1994, THE JOURNAL OF HEAD, V9, P104; LAWTON MP, 1989, J GERONTOL, V44, pP61, DOI 10.1093/geronj/44.3.P61; Lee, 2015, FAMILIES REHABILITAT, P153; MacKinnon DP, 2002, PSYCHOL METHODS, V7, P83, DOI 10.1037/1082-989X.7.1.83; Maki D. R., 2012, PROFESSIONAL PRACTIC, P83; Man DWK, 1998, BRAIN INJURY, V12, P245, DOI 10.1080/026990598122728; McLeod SA, 2010, STRESS MANAGEMENT PR; Moules S, 1999, BRAIN INJURY, V13, P983; Nabors N, 2002, BRAIN INJURY, V16, P1039, DOI 10.1080/02699050210155285; ODDY M, 1978, J NEUROL NEUROSUR PS, V41, P611, DOI 10.1136/jnnp.41.7.611; Parveen S, 2011, J HEALTH PSYCHOL, V16, P862, DOI 10.1177/1359105310392416; Patterson J., 2011, REHABILITATION COUNS, P27; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; PETERS L C, 1990, Brain Injury, V4, P39, DOI 10.3109/02699059009026147; Preacher KJ, 2004, BEHAV RES METH INS C, V36, P717, DOI 10.3758/BF03206553; Prigatano G.P., 1986, NEUROPSYCHOLOGICAL R; PRIGATANO GP, 1990, CLIN NEUROPSYCHOL, V4, P163, DOI DOI 10.1080/13854049008401509; Rapp SR, 2000, AGING MENT HEALTH, V4, P142, DOI 10.1080/13607860050008664; Reinhard SC, 2008, PATIENT SAFETY QUALI, P341; Rivera P, 2007, NEUROREHABILITATION, V22, P3; Rivera PA, 2008, ARCH PHYS MED REHAB, V89, P931, DOI 10.1016/j.apmr.2007.12.032; Rodakowski J, 2012, ARCH PHYS MED REHAB, V93, P2229, DOI 10.1016/j.apmr.2012.07.004; Sandhaug M, 2012, DISABIL REHABIL, V34, P904, DOI 10.3109/09638288.2011.626484; Serio CD, 1997, BRAIN INJURY, V11, P1, DOI 10.1080/026990597123764; Shrout PE, 2002, PSYCHOL METHODS, V7, P422, DOI 10.1037//1082-989X.7.4.422; STRUCHEN MA, 2002, THE JOURNAL OF HEAD, V17, P132; THOITS PA, 1987, J HEALTH SOC BEHAV, V28, P7, DOI 10.2307/2137137; Wade SL, 2001, J CONSULT CLIN PSYCH, V69, P406, DOI 10.1037//0022-006X.69.3.406; Wells R, 2005, BRAIN INJURY, V19, P1105, DOI 10.1080/02699050500150062; World Health Organization, 2007, INT CLASS FUNCT DIS; WORTMAN CB, 1985, SOCIAL SUPPORT HLTH, P281; Zuger R. R., 2002, VOCATIONAL REHABILIT	70	15	15	0	7	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0034-3552	1538-4853		REHABIL COUNS BULL	Rehabil. Couns. Bull.	JUL	2016	59	4					235	246		10.1177/0034355215601072			12	Rehabilitation	Social Science Citation Index (SSCI)	Rehabilitation	EC5GS	WOS:000388162000005					2022-02-06	
J	Yu, S; Li, SJ; Henke, A; Muse, ED; Cheng, B; Welzel, G; Chatterjee, AK; Wang, DL; Roland, J; Glass, CK; Tremblay, M				Yu, Shan; Li, Sijia; Henke, Adam; Muse, Evan D.; Cheng, Bo; Welzel, Gustav; Chatterjee, Arnab K.; Wang, Danling; Roland, Jason; Glass, Christopher K.; Tremblay, Matthew			Dissociated sterol-based liver X receptor agonists as therapeutics for chronic inflammatory diseases	FASEB JOURNAL			English	Article						LXR; traumatic brain injury; ulcerative colitis; drug discovery	ELEMENT-BINDING PROTEIN-1C; LIPID-METABOLISM; LXR AGONIST; GENE; MICE; OXYSTEROLS; PATHWAYS; TRANSREPRESSION; INTEGRATION; LIPOGENESIS	Liver X receptor (LXR), a nuclear hormone receptor, is an essential regulator of immune responses. Activation of LXR-mediated transcription by synthetic agonists, such as T0901317 and GW3965, attenuates progression of inflammatory disease in animal models. However, the adverse effects of these conventional LXR agonists in elevating liver lipids have impeded exploitation of this intriguing mechanism for chronic therapy. Here, we explore the ability of a series of sterol-based LXR agonists to alleviate inflammatory conditions in mice without hepatotoxicity. We show that oral treatment with sterol-based LXR agonists in mice significantly reduces dextran sulfate sodium colitis-induced body weight loss, which is accompanied by reduced expression of inflammatory markers in the large intestine. The anti-inflammatory property of these agonists is recapitulated in vitro in mouse lamina propria mononuclear cells, human colonic epithelial cells, and human peripheral blood mononuclear cells. In addition, treatment with LXR agonists dramatically suppresses inflammatory cytokine expression in a model of traumatic brain injury. Importantly, in both disease models, the sterol-based agonists do not affect the liver, and the conventional agonist T0901317 results in significant liver lipid accumulation and injury. Overall, these results provide evidence for the development of sterol-based LXR agonists as novel therapeutics for chronic inflammatory diseases.	[Yu, Shan; Li, Sijia; Henke, Adam; Cheng, Bo; Welzel, Gustav; Chatterjee, Arnab K.; Wang, Danling; Roland, Jason; Tremblay, Matthew] Calif Inst Biomed Res, 11119 N Torrey Pines Rd,Suite 100, La Jolla, CA 92037 USA; [Muse, Evan D.; Glass, Christopher K.] Univ Calif San Diego, Dept Cellular & Mol Med, La Jolla, CA 92093 USA; [Glass, Christopher K.] Univ Calif San Diego, Dept Med, La Jolla, CA 92093 USA; [Muse, Evan D.] Scripps Hlth, Scripps Translat Sci Inst, La Jolla, CA USA		Tremblay, M (corresponding author), Calif Inst Biomed Res, 11119 N Torrey Pines Rd,Suite 100, La Jolla, CA 92037 USA.; Glass, CK (corresponding author), Univ Calif San Diego, Sch Med, Dept Cellular & Mol Med, GPL Rm 217,9500 Gilman Dr,Mail Code 0651, La Jolla, CA 92093 USA.	cglass@ucsd.edu; mtremblay@calibr.org	Glass, Christopher/AAI-3933-2021	Glass, Christopher/0000-0003-4344-3592	Crohn's and Colitis Foundation of America Research Fellowship Award [368561]; U.S. National Institutes of Health, National Center for Advancing Translational Sciences/Clinical and Translational Science Award [UL1-TR001114]; NATIONAL CANCER INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI) [P30CA023100] Funding Source: NIH RePORTER; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001114] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF DIABETES AND DIGESTIVE AND KIDNEY DISEASESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Diabetes & Digestive & Kidney Diseases (NIDDK) [P30DK063491] Funding Source: NIH RePORTER	This work was supported by a Crohn's and Colitis Foundation of America Research Fellowship Award (368561; to S.Y.), and by a U.S. National Institutes of Health, National Center for Advancing Translational Sciences/Clinical and Translational Science Award (UL1-TR001114; to Scripps Translational Science Institute).	Cha JY, 2007, J BIOL CHEM, V282, P743, DOI 10.1074/jbc.M605023200; Cheng O, 2010, NEUROSCIENCE, V166, P1101, DOI 10.1016/j.neuroscience.2010.01.024; Chisholm JW, 2003, J LIPID RES, V44, P2039, DOI 10.1194/jlr.M300135-JLR200; Danese S, 2015, NAT REV GASTRO HEPAT, V12, P537, DOI 10.1038/nrgastro.2015.135; Ghisletti S, 2007, MOL CELL, V25, P57, DOI 10.1016/j.molcel.2006.11.022; Ghisletti S, 2009, GENE DEV, V23, P681, DOI 10.1101/gad.1773109; Glass CK, 2010, NAT REV IMMUNOL, V10, P365, DOI 10.1038/nri2748; Hong C, 2014, NAT REV DRUG DISCOV, V13, P433, DOI 10.1038/nrd4280; Hong C, 2008, CURR OPIN GENET DEV, V18, P461, DOI 10.1016/j.gde.2008.07.016; Hu BH, 2010, J MED CHEM, V53, P3296, DOI 10.1021/jm100034x; Huang W, 2009, MOL CELL, V35, P48, DOI 10.1016/j.molcel.2009.05.023; Jakobsson T, 2014, MUCOSAL IMMUNOL, V7, P1416, DOI 10.1038/mi.2014.31; Joseph SB, 2003, NAT MED, V9, P213, DOI 10.1038/nm820; Katz A, 2009, J CLIN PHARMACOL, V49, P643, DOI 10.1177/0091270009335768; Kratzer A, 2009, J LIPID RES, V50, P312, DOI 10.1194/jlr.M800376-JLR200; Lehmann JM, 1997, J BIOL CHEM, V272, P3137, DOI 10.1074/jbc.272.6.3137; Liang GS, 2002, J BIOL CHEM, V277, P9520, DOI 10.1074/jbc.M111421200; Lim RKV, 2015, BIOCONJUGATE CHEM, V26, P2216, DOI 10.1021/acs.bioconjchem.5b00203; Loane DJ, 2011, J NEUROTRAUM, V28, P225, DOI 10.1089/neu.2010.1595; Park MC, 2010, RHEUMATOLOGY, V49, P882, DOI 10.1093/rheumatology/keq007; Quinet EM, 2009, J LIPID RES, V50, P2358, DOI 10.1194/jlr.M900037-JLR200; Quinet EM, 2004, J LIPID RES, V45, P1929, DOI 10.1194/jlr.M400257-JLR200; Repa JJ, 2000, GENE DEV, V14, P2819, DOI 10.1101/gad.844900; Shih DM, 2013, FASEB J, V27, P3805, DOI 10.1096/fj.12-223008; Spann NJ, 2013, NAT IMMUNOL, V14, P893, DOI 10.1038/ni.2681; Spann NJ, 2012, CELL, V151, P138, DOI 10.1016/j.cell.2012.06.054; Temml V, 2014, J CHEM INF MODEL, V54, P367, DOI 10.1021/ci400682b; Tice CM, 2014, J MED CHEM, V57, P7182, DOI 10.1021/jm500442z; Traversari C, 2014, EUR J IMMUNOL, V44, P1896, DOI 10.1002/eji.201344292; Vowinkel T, 2004, J CLIN INVEST, V114, P260, DOI 10.1172/JCI200421233; Wang DM, 2011, INT IMMUNOPHARMACOL, V11, P2098, DOI 10.1016/j.intimp.2011.09.002; Weigmann B, 2007, NAT PROTOC, V2, P2307, DOI 10.1038/nprot.2007.315; Zelcer N, 2006, J CLIN INVEST, V116, P607, DOI 10.1172/JCI27883	33	15	15	0	7	FEDERATION AMER SOC EXP BIOL	BETHESDA	9650 ROCKVILLE PIKE, BETHESDA, MD 20814-3998 USA	0892-6638	1530-6860		FASEB J	Faseb J.	JUL	2016	30	7					2570	2579		10.1096/fj.201600244R			10	Biochemistry & Molecular Biology; Biology; Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Life Sciences & Biomedicine - Other Topics; Cell Biology	DQ5MM	WOS:000379249500012	27025962	Green Published			2022-02-06	
J	Abou-Abbass, H; Bahmad, H; Abou-El-Hassan, H; Zhu, R; Zhou, SY; Dong, X; Hamade, E; Mallah, K; Zebian, A; Ramadan, N; Mondello, S; Fares, J; Comair, Y; Atweh, S; Darwish, H; Zibara, K; Mechref, Y; Kobeissy, F				Abou-Abbass, Hussein; Bahmad, Hisham; Abou-El-Hassan, Hadi; Zhu, Rui; Zhou, Shiyue; Dong, Xue; Hamade, Eva; Mallah, Khalil; Zebian, Abir; Ramadan, Naify; Mondello, Stefania; Fares, Jawad; Comair, Youssef; Atweh, Samir; Darwish, Hala; Zibara, Kazem; Mechref, Yehia; Kobeissy, Firas			Deciphering glycomics and neuroproteomic alterations in experimental traumatic brain injury: Comparative analysis of aspirin and clopidogrel treatment	ELECTROPHORESIS			English	Article						Aspirin; Clopidogrel; Neuroproteomics; PTMs; TBI	MANNOSE-BINDING LECTIN; MASS-SPECTROMETRIC ANALYSIS; SOLID-PHASE PERMETHYLATION; SPINAL-CORD-INJURY; INTRACRANIAL HEMORRHAGE; CEREBRAL-ISCHEMIA; PROTEOMIC IDENTIFICATION; PLATELET DYSFUNCTION; ACETYLSALICYLIC-ACID; AUTOMATED ANNOTATION	As populations age, the number of patients sustaining traumatic brain injury (TBI) and concomitantly receiving preinjury antiplatelet therapy such as aspirin (ASA) and clopidogrel (CLOP) is rising. These drugs have been linked with unfavorable clinical outcomes following TBI, where the exact mechanism(s) involved are still unknown. In this novel work, we aimed to identify and compare the altered proteome profile imposed by ASA and CLOP when administered alone or in combination, prior to experimental TBI. Furthermore, we assessed differential glycosylation PTM patterns following experimental controlled cortical impact model of TBI, ASA, CLOP, and ASA + CLOP. Ipsilateral cortical brain tissues were harvested 48 h postinjury and were analyzed using an advanced neuroproteomics LC-MS/MS platform to assess proteomic and glycoproteins alterations. Of interest, differential proteins pertaining to each group (22 in TBI, 41 in TBI + ASA, 44 in TBI + CLOP, and 34 in TBI + ASA + CLOP) were revealed. Advanced bioinformatics/systems biology and clustering analyses were performed to evaluate biological networks and protein interaction maps illustrating molecular pathways involved in the experimental conditions. Results have indicated that proteins involved in neuroprotective cellular pathways were upregulated in the ASA and CLOP groups when given separately. However, ASA + CLOP administration revealed enrichment in biological pathways relevant to inflammation and proinjury mechanisms. Moreover, results showed differential upregulation of glycoproteins levels in the sialylated N-glycans PTMs that can be implicated in pathological changes. Omics data obtained have provided molecular insights of the underlying mechanisms that can be translated into clinical bedside settings.	[Abou-Abbass, Hussein; Zebian, Abir; Ramadan, Naify; Kobeissy, Firas] Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon; [Abou-Abbass, Hussein; Bahmad, Hisham] Beirut Arab Univ, Fac Med, Beirut, Lebanon; [Bahmad, Hisham] Amer Univ Beirut, Dept Anat Cell Biol & Physiol Sci, Fac Med, Beirut, Lebanon; [Abou-El-Hassan, Hadi; Fares, Jawad] Amer Univ Beirut, Fac Med, Beirut, Lebanon; [Zhu, Rui; Zhou, Shiyue; Dong, Xue; Mechref, Yehia] Texas Tech Univ, Dept Chem & Biochem, Lubbock, TX 79409 USA; [Hamade, Eva; Mallah, Khalil; Zibara, Kazem] Lebanese Univ, DSST, Lab Stem Cells ER045, Beirut, Lebanon; [Hamade, Eva; Mallah, Khalil; Zibara, Kazem] Lebanese Univ, Dept Biol, Fac Sci 1, Beirut, Lebanon; [Mondello, Stefania] Univ Messina, Dept Neurosci, Messina, Italy; [Comair, Youssef] Lebanese Amer Univ, Div Neurosurg, Dept Surg, Beirut, Lebanon; [Atweh, Samir] Amer Univ Beirut, Dept Neurol, Fac Med, Beirut, Lebanon; [Darwish, Hala] Amer Univ Beirut, Fac Med, Sch Nursing, New York, NY USA		Kobeissy, F (corresponding author), Amer Univ Beirut, Dept Biochem & Mol Genet, Fac Med, Beirut, Lebanon.	firasko@gmail.com	Mondello, Stefania/A-1813-2012; Bahmad, Hisham/A-5369-2019; Kobeissy, Firas/E-7042-2017; Fares, Jawad/X-4341-2018; Mechref, Yehia/I-5126-2013	Mondello, Stefania/0000-0002-8587-3614; Bahmad, Hisham/0000-0003-3799-2595; Kobeissy, Firas/0000-0002-5008-6944; Fares, Jawad/0000-0002-5368-8764; Mallah, Khalil/0000-0001-7622-8106; Mechref, Yehia/0000-0002-6661-6073; Darwish, Hala/0000-0001-5744-6466; Hamade, Eva/0000-0001-5152-913X; Zibara, Kazem/0000-0002-9887-072X; Ramadan, Naify/0000-0001-7339-0263	National Council for Scientific Research (CNRS), LebanonCentre National de la Recherche Scientifique (CNRS); NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [5R01GM112490-02]; NATIONAL INSTITUTE OF GENERAL MEDICAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of General Medical Sciences (NIGMS) [R01GM112490] Funding Source: NIH RePORTER	This work was supported by the National Council for Scientific Research (CNRS), Lebanon, for the grant entitled "The Effect of Aspirin and Clopidogrel on Bleeding, platelet aggregation and Neuronal Damage after Moderate Brain Injury"; PI: Professor Samir Atweh, MD. This work was also partially supported by a grant from the NIH (5R01GM112490-02) for Professor Dr. Yehia Mechref. The funders had no role in the study design, data collection and analysis, decision to publish, or preparation of the manuscript.	Adams JC, 2015, EXPERT REV MOL DIAGN, V15, P41, DOI 10.1586/14737159.2015.976557; Ahmed N, 2009, SOUTH MED J, V102, P476, DOI 10.1097/SMJ.0b013e31819f97a3; Azcona L, 2012, J PHARM SCI-US, V101, P2821, DOI 10.1002/jps.23201; Banki K, 1996, J BIOL CHEM, V271, P32994, DOI 10.1074/jbc.271.51.32994; Bonnet Agnes, 2009, BMC Proc, V3 Suppl 4, pS11, DOI 10.1186/1753-6561-3-S4-S11; Bruning RS, 2013, MED SCI SPORT EXER, V45, P674, DOI 10.1249/MSS.0b013e31827981dc; Chambers AG, 2015, MOL CELL PROTEOMICS, V14, P3094, DOI 10.1074/mcp.O115.049957; Chen LF, 2011, J NEUROSURG, V114, P1159, DOI 10.3171/2010.10.JNS10861; Daily D, 2001, J BIOL CHEM, V276, P21618, DOI 10.1074/jbc.M101400200; Daraselia N, 2012, AM J CANCER RES, V2, P93; Davis PK, 2013, NEUROCRIT CARE, V18, P201, DOI 10.1007/s12028-012-9745-6; De Cristobal J, 2001, J NEUROCHEM, V79, P456, DOI 10.1046/j.1471-4159.2001.00600.x; De la Cruz JP, 2003, N-S ARCH PHARMACOL, V367, P204, DOI 10.1007/s002100-002-0657-4; de la Rosa X, 2014, STROKE, V45, P1453, DOI 10.1161/STROKEAHA.113.004111; ELLIS EF, 1989, J NEUROSURG, V71, P437, DOI 10.3171/jns.1989.71.3.0437; Fabbri A, 2013, CRIT CARE, V17, DOI 10.1186/cc12575; Fiebich BL, 2003, J NEUROCHEM, V86, P173, DOI 10.1046/j.1471-4159.2003.01822.x; Finamore F, 2015, J PROTEOMICS, V114, P125, DOI 10.1016/j.jprot.2014.11.005; Floyd CN, 2014, BRIT J CLIN PHARMACO, V78, P320, DOI 10.1111/bcp.12335; Fournier AE, 2003, J NEUROSCI, V23, P1416, DOI 10.1523/JNEUROSCI.23-04-01416.2003; Gaetani P, 2012, J NEUROSURG SCI, V56, P231; Gangavati AS, 2009, J AM GERIATR SOC, V57, P1470, DOI 10.1111/j.1532-5415.2009.02344.x; Gao TL, 2012, J TRAUMA ACUTE CARE, V72, P643, DOI 10.1097/TA.0b013e31823c54a6; Gavella M, 2013, ASIAN J ANDROL, V15, P375, DOI 10.1038/aja.2012.144; Gavella M, 2010, INT J ANDROL, V33, P536, DOI 10.1111/j.1365-2605.2009.00962.x; Grunewald A, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0012962; Hahl P, 2013, J NEUROCHEM, V125, P89, DOI 10.1111/jnc.12165; HALL A, 1994, ANNU REV CELL BIOL, V10, P31, DOI 10.1146/annurev.cb.10.110194.000335; Harel A, 2004, MOL CELL, V16, P319, DOI 10.1016/j.molcel.2004.10.026; Hashimoto Y, 2011, J PATHOL, V224, P289, DOI 10.1002/path.2894; HERBERT JM, 1993, ARTERIOSCLER THROMB, V13, P1171, DOI 10.1161/01.ATV.13.8.1171; Hopp S, 2015, NEURAL REGEN RES, V10, P885, DOI 10.4103/1673-5374.158339; Hu YL, 2015, RAPID COMMUN MASS SP, V29, P135, DOI 10.1002/rcm.7093; HYSLOP PA, 1995, BRAIN RES, V671, P181, DOI 10.1016/0006-8993(94)01291-O; Iijima R, 2004, FEBS LETT, V561, P163, DOI 10.1016/S0014-5793(04)00164-4; Iijima R, 2009, CARBOHYD RES, V344, P933, DOI 10.1016/j.carres.2009.02.025; Ivascu FA, 2008, J TRAUMA, V65, P785, DOI 10.1097/TA.0b013e3181848caa; Jones K, 2006, AM J SURG, V192, P743, DOI 10.1016/j.amjsurg.2006.08.037; Kang P, 2005, RAPID COMMUN MASS SP, V19, P3421, DOI 10.1002/rcm.2210; Kang P, 2008, RAPID COMMUN MASS SP, V22, P721, DOI 10.1002/rcm.3395; Keller A, 2002, ANAL CHEM, V74, P5383, DOI 10.1021/ac025747h; Khayyam N, 1999, NEUROREPORT, V10, P371, DOI 10.1097/00001756-199902050-00029; King MD, 2010, NEUROSURG FOCUS, V28, DOI 10.3171/2009.10.FOCUS09223; Kizuka Yasuhiko, 2014, Adv Neurobiol, V9, P117, DOI 10.1007/978-1-4939-1154-7_6; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kobeissy FH, 2006, MOL CELL PROTEOMICS, V5, P1887, DOI 10.1074/mcp.M600157-MCP200; Kobeissy FH, 2015, MOL NEUROBIOL, V52, P696, DOI 10.1007/s12035-014-8898-z; Korobova F, 2008, MOL BIOL CELL, V19, P1561, DOI 10.1091/mbc.E07-09-0964; Kwok JCF, 2012, INT J BIOCHEM CELL B, V44, P582, DOI 10.1016/j.biocel.2012.01.004; Lai C, 2015, MOL MED REP, V12, P1473, DOI 10.3892/mmr.2015.3545; Lazarus JE, 2013, PLOS BIOL, V11, DOI 10.1371/journal.pbio.1001611; Li CX, 2007, BRAIN RES, V1139, P201, DOI 10.1016/j.brainres.2006.12.039; Londono C, 2012, BIOMOLECULES, V2, P143, DOI 10.3390/biom2010143; Longhi L, 2014, CRIT CARE MED, V42, P1910, DOI 10.1097/CCM.0000000000000399; Mak CHK, 2012, CURR GERIATR REP, V1, P171, DOI 10.1007/s13670-012-0017-2; Martinez-Marquez A, 2013, J PROTEOME RES, V12, P5709, DOI 10.1021/pr4006712; McCammack KC, 2015, WEST J EMERG MED, V16, P43, DOI 10.5811/westjem.2014.10.19488; Meller R, 2008, J NEUROSCI, V28, P50, DOI 10.1523/JNEUROSCI.3474-07.2008; Mikami T, 2009, J BIOL CHEM, V284, P4494, DOI 10.1074/jbc.M809227200; Modi KK, 2013, J BIOL CHEM, V288, P18533, DOI 10.1074/jbc.M112.447268; Moore MM, 2012, J TRAUMA ACUTE CARE, V73, P126, DOI 10.1097/TA.0b013e31824b01af; Mori T, 2007, J BIOL CHEM, V282, P19884, DOI 10.1074/jbc.M700770200; Nesvizhskii AI, 2003, ANAL CHEM, V75, P4646, DOI 10.1021/ac0341261; Opii WO, 2007, J NEUROTRAUM, V24, P772, DOI 10.1089/neu.2006.0229; Orsini F, 2012, CIRCULATION, V126, P1484, DOI 10.1161/CIRCULATIONAHA.112.103051; Otis KO, 2006, CURR OPIN NEUROBIOL, V16, P329, DOI 10.1016/j.conb.2006.05.001; Palmer C, 1999, J NEUROSCI RES, V56, P60, DOI 10.1002/(SICI)1097-4547(19990401)56:1<60::AID-JNR8>3.0.CO;2-A; Papastefanaki F, 2015, GLIA, V63, P1101, DOI 10.1002/glia.22809; Patel BN, 2002, J NEUROSCI, V22, P6578; Peck KA, 2014, J TRAUMA ACUTE CARE, V76, P431, DOI 10.1097/TA.0000000000000107; Percy Andrew J, 2013, Methods Mol Biol, V1000, P167, DOI 10.1007/978-1-62703-405-0_13; Pike BR, 1998, NEUROREPORT, V9, P2437, DOI 10.1097/00001756-199808030-00002; Ploplis VA, 2014, J NEUROTRAUM, V31, P1672, DOI 10.1089/neu.2013.3302; Pyatnitskiy M, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0084955; Raslan F, 2010, J CEREBR BLOOD F MET, V30, P1477, DOI 10.1038/jcbfm.2010.28; Sangkuhl K, 2010, PHARMACOGENET GENOM, V20, P463, DOI 10.1097/FPC.0b013e3283385420; Santos SD, 2010, J NEUROCHEM, V115, P1434, DOI 10.1111/j.1471-4159.2010.07047.x; Schwarzer C, 2002, INT J BIOCHEM CELL B, V34, P1059, DOI 10.1016/S1357-2725(02)00026-2; Scornavacca G, 2012, J NEUROCHEM, V122, P1219, DOI 10.1111/j.1471-4159.2012.07874.x; Scott DW, 2013, AM J PHYSIOL-CELL PH, V305, pC228, DOI 10.1152/ajpcell.00116.2013; Shi Geng-Xian, 2011, Central Nervous System Agents in Medicinal Chemistry, V11, P114; Silajdzic E, 2013, J HUNTINGTONS DIS, V2, P125, DOI 10.3233/JHD-130049; SKAPER SD, 1989, EXP NEUROL, V106, P297, DOI 10.1016/0014-4886(89)90163-5; Sura P, 2008, FOLIA BIOL-KRAKOW, V56, P73, DOI 10.3409/fb56_1-2.73-75; Thaler HW, 2015, J NEUROSURG, V123, P1202, DOI 10.3171/2014.12.JNS142276; Trabold R, 2010, J CEREBR BLOOD F MET, V30, P130, DOI 10.1038/jcbfm.2009.196; Tsai TH, 2015, PROTEOMICS, V15, P2369, DOI 10.1002/pmic.201400364; Uslu E., 2002, TURKISH J TRAUMA EME, V8, P74; Wang KKW, 2005, EXPERT REV PROTEOMIC, V2, P603, DOI 10.1586/14789450.2.4.603; Whitehead SN, 2007, STROKE, V38, P381, DOI 10.1161/01.STR.0000254464.05561.72; XU J, 1991, J NEUROCHEM, V57, P975, DOI 10.1111/j.1471-4159.1991.tb08246.x; Yang H, 2011, BIOCHEM BIOPH RES CO, V410, P114, DOI 10.1016/j.bbrc.2011.05.116; Yang WS, 2011, FREE RADICAL BIO MED, V50, P1242, DOI 10.1016/j.freeradbiomed.2011.02.005; Yin XH, 2006, J CELL BIOL, V172, P469, DOI 10.1083/jcb.200509174; Yu CY, 2013, BIOINFORMATICS, V29, P1706, DOI 10.1093/bioinformatics/btt190; Yu W, 2015, CLIN CHIM ACTA, V451, P111, DOI 10.1016/j.cca.2015.10.017; Yuryev A, 2009, EXPERT OPIN DRUG DIS, V4, P1307, DOI 10.1517/17460440903413488; Zhang B, 2008, PLOS ONE, V3, DOI 10.1371/journal.pone.0004077; Zhao X., 2011, CRTOPROTECTIVE ROLE	99	15	15	1	6	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0173-0835	1522-2683		ELECTROPHORESIS	Electrophoresis	JUN	2016	37	11			SI		1562	1576		10.1002/elps.201500583			15	Biochemical Research Methods; Chemistry, Analytical	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Chemistry	DQ3WT	WOS:000379135200018	27249377	Green Accepted			2022-02-06	
J	Adjorlolo, S; Egbenya, DL				Adjorlolo, Samuel; Egbenya, Daniel Lawer			Executive functioning profiles of adult and juvenile male sexual offenders: A systematic review	JOURNAL OF FORENSIC PSYCHIATRY & PSYCHOLOGY			English	Article						Executive functioning; neurocognitive functioning; sexual offenders; juvenile sexual offenders; adult sexual offenders	TRAUMATIC BRAIN-INJURY; NONPEDOPHILIC CHILD MOLESTERS; PRISON PSYCHIATRIC-TREATMENT; OF-THE-LITERATURE; FRONTAL LOBES; NEUROPSYCHOLOGICAL MEASURES; COGNITIVE REHABILITATION; INDIVIDUAL-DIFFERENCES; ANTISOCIAL-BEHAVIOR; INTEGRATED THEORY	Evidence regarding biological correlates of sexual offending, which might enhance the understanding, research, and treatment of these offenders, is rather emerging or in the embryonic stage. In this study, our main objective is to identify specific executive functioning (EF) processes that are commonly impaired in sexual offenders, and to further determine whether these differ as a function of offender subtypes. A search is conducted in ProQuest, Criminal Justice Abstract, EBSCOhost, and Social Science Citation Index electronic journal databases for studies published spanning the period 1990-2015. Google Scholar and Google search engines were also searched and the reference lists of the retrieved papers were searched for additional papers. A total of 1303 papers were retained for consideration. After removing duplicates, and subjecting the retrieved papers to inclusion and exclusion criteria, 24 papers (19 published and 5 unpublished) were deemed appropriate for the review. While several EF processes have been investigated, the available evidence implicates deficits in cognitive flexibility and inhibition of interference as commonly reported among adult male sexual offenders. This finding may be due to the sensitivity of tests of cognitive flexibility (e.g. the Wisconsin Card Sorting Test) and inhibition of interference (e.g. the Stroop Test) to frontal lobe lesions, and also because these tests are among the most frequently administered EF tests as revealed by this study. Juvenile sexual offenders, however, exhibit no distinct EF profiles. The findings of the study, implications for treatment, and recommendations for future studies are succinctly discussed.	[Adjorlolo, Samuel] City Univ Hong Kong, Dept Appl Social Sci, Kowloon, Hong Kong, Peoples R China; [Egbenya, Daniel Lawer] Univ Oslo, Inst Basic Med Sci, Fac Med, Dept Mol Med,Div Anat, Oslo, Norway		Adjorlolo, S (corresponding author), City Univ Hong Kong, Dept Appl Social Sci, Kowloon, Hong Kong, Peoples R China.	sadjorlol2-c@my.cityu.edu.hk	Egbenya, Daniel Lawer/AAV-2279-2020; Adjorlolo, Samuel/AAL-1009-2020	Egbenya, Daniel Lawer/0000-0002-3223-8510; 			Abracen J., 1991, J FORENSIC PSYCHIATR, V2, P167, DOI [10.1080/09585189108407646, DOI 10.1080/09585189108407646]; Adjorlolo S, 2015, APPL NEUROPSYCH-ADUL, V22, P388, DOI 10.1080/23279095.2014.949718; Adjorlolo S, 2015, J FORENSIC PSYCHOL P, V15, P185, DOI 10.1080/15228932.2015.1015363; Alvarez JA, 2006, NEUROPSYCHOL REV, V16, P17, DOI 10.1007/s11065-006-9002-x; Anderson P, 2002, CHILD NEUROPSYCHOL, V8, P71, DOI 10.1076/chin.8.2.71.8724; ANDREWS DA, 1990, CRIM JUSTICE BEHAV, V17, P19, DOI 10.1177/0093854890017001004; Becerra-Garcia JA, 2014, PSYCHIAT PSYCHOL LAW, V21, P585, DOI 10.1080/13218719.2013.873974; Bauman Johnson WL, 2010, ARCH CLIN NEUROPSYCH, V25, P601, DOI 10.1093/arclin/acq049; Blanchard R, 2003, ARCH SEX BEHAV, V32, P573, DOI 10.1023/A:1026093612434; Blanchard R, 2002, ARCH SEX BEHAV, V31, P511, DOI 10.1023/A:1020659331965; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Chan HC, 2016, J INTERPERS VIOLENCE, V31, P2259, DOI 10.1177/0886260515575606; Chan HC, 2011, INT J OFFENDER THER, V55, P228, DOI 10.1177/0306624X10361317; Chan HC, 2009, TRAUMA VIOLENCE ABUS, V10, P31, DOI 10.1177/1524838008326478; Chen CY, 2008, BEHAV BRAIN RES, V187, P483, DOI 10.1016/j.bbr.2007.10.011; Cicerone KD, 2005, ARCH PHYS MED REHAB, V86, P1681, DOI 10.1016/j.apmr.2005.03.024; Cicerone KD, 2011, ARCH PHYS MED REHAB, V92, P519, DOI 10.1016/j.apmr.2010.11.015; Cohen LJ, 2010, J PSYCHIATR PRACT, V16, P405, DOI 10.1097/01.pra.0000390759.04581.7c; Cohen LJ, 2002, PSYCHIAT QUART, V73, P313, DOI 10.1023/A:1020416101092; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Deuthser M., 2004, THESIS SWINBURNE U T; Eastvold A, 2011, J INT NEUROPSYCH SOC, V17, P295, DOI 10.1017/S1355617710001669; Farrer TJ, 2013, CHILD NEUROPSYCHOL, V19, P225, DOI 10.1080/09297049.2011.647901; Farrer TJ, 2011, PROG NEURO-PSYCHOPH, V35, P390, DOI 10.1016/j.pnpbp.2011.01.007; Fazel S, 2007, J CLIN PSYCHIAT, V68, P588, DOI 10.4088/JCP.v68n0415; Fazel S, 2007, INT J GERIATR PSYCH, V22, P87, DOI 10.1002/gps.1648; Fishbein D, 2009, LAW HUMAN BEHAV, V33, P419, DOI 10.1007/s10979-008-9163-7; Flor-Henry P., 1987, VARIANT SEXUALITY RE, P49; Friedman NP, 2008, J EXP PSYCHOL GEN, V137, P201, DOI 10.1037/0096-3445.137.2.201; Gillespie N. K., 2000, J SEX AGGRESS, V5, P21, DOI [10.1080/13552600008413293, DOI 10.1080/13552600008413293]; Goschke T, 2014, INT J METH PSYCH RES, V23, P41, DOI 10.1002/mpr.1410; Greve KW, 2002, BRAIN INJURY, V16, P29, DOI 10.1080/0269905011008803; Hargrave DD, 2012, NEUROPSYCHOL REHABIL, V22, P489, DOI 10.1080/09602011.2012.662333; Joyal CC, 2007, SEX ABUSE-J RES TR, V19, P155, DOI 10.1177/107906320701900206; Joyal CC, 2014, SEX ABUSE-J RES TR, V26, P149, DOI 10.1177/1079063213482842; Jurado MB, 2007, NEUROPSYCHOL REV, V17, P213, DOI 10.1007/s11065-007-9040-z; Kelly T, 2002, CHILD NEUROPSYCHOL, V8, P138, DOI 10.1076/chin.8.2.138.8722; Kruger THC, 2011, J SEX MED, V8, P1650, DOI 10.1111/j.1743-6109.2009.01564.x; Levenson JS, 2015, SEX ABUSE-J RES TR, V27, P258, DOI 10.1177/1079063214544332; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Lord A, 2014, J FORENSIC PRACT, V16, P94, DOI 10.1108/JFP-02-2013-0012; MACLEOD CM, 1991, PSYCHOL BULL, V109, P163, DOI 10.1037/0033-2909.109.2.163; Maes JHR, 2011, J CLIN EXP NEUROPSYC, V33, P366, DOI 10.1080/13803395.2010.524149; Martin J E., 1998, THESIS ADLER SCH PRO; McLeod DA, 2015, J CHILD SEX ABUS, V24, P97, DOI 10.1080/10538712.2015.978925; MILLER AD, 1997, THESIS ADLER SCH PRO; Miyaguchi K, 2014, J INTELLECT DEV DIS, V39, P253, DOI 10.3109/13668250.2014.925103; Miyake A, 2012, CURR DIR PSYCHOL SCI, V21, P8, DOI 10.1177/0963721411429458; Miyake Akira, 2000, Seminars in Speech and Language, V21, P169, DOI 10.1055/s-2000-7563; Morais HB, 2016, SEX ABUSE-J RES TR, V28, P741, DOI 10.1177/1079063215569545; Morgan AB, 2000, CLIN PSYCHOL REV, V20, P113, DOI 10.1016/S0272-7358(98)00096-8; Nee DE, 2007, COGN AFFECT BEHAV NE, V7, P1, DOI 10.3758/CABN.7.1.1; Ogilvie JM, 2011, CRIMINOLOGY, V49, P1063, DOI 10.1111/j.1745-9125.2011.00252.x; Patrick CJ, 2009, DEV PSYCHOPATHOL, V21, P913, DOI 10.1017/S0954579409000492; Pflugradt DM, 2010, J CHILD SEX ABUS, V19, P434, DOI 10.1080/10538712.2010.495701; Rabin LA, 2005, ARCH CLIN NEUROPSYCH, V20, P33, DOI 10.1016/j.acn.2004.02.005; Rimmer L. M., 1998, THESIS CALIFORNIA SC; Rocha NBF, 2014, J FORENSIC PSYCHI PS, V25, P224, DOI 10.1080/14789949.2014.884617; Rodriguez M., 2014, THESIS U SYDNEY AUST; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Ross E., 2012, THESIS U W ONTARIO O; Ross EH, 2010, CRIM JUSTICE BEHAV, V37, P656, DOI 10.1177/0093854810363104; Schiffer B, 2007, J PSYCHIATR RES, V41, P753, DOI 10.1016/j.jpsychires.2006.06.003; Schiffer B, 2011, J SEX MED, V8, P1975, DOI 10.1111/j.1743-6109.2010.02140.x; Shiroma Eric J, 2010, J Correct Health Care, V16, P147, DOI 10.1177/1078345809356538; Sigre-Leiros V, 2015, CHILD ABUSE NEGLECT, V40, P81, DOI 10.1016/j.chiabu.2014.10.003; Simpson G, 1999, J HEAD TRAUMA REHAB, V14, P567, DOI 10.1097/00001199-199912000-00005; Snyder HR, 2015, FRONT PSYCHOL, V6, DOI 10.3389/fpsyg.2015.00328; Spinella M., 2006, INT J FORENSIC PSYCH, V1, P62; Stone M. H., 2001, J INDIV PSYCHOL, V57, P51; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Stuss DT, 2011, CURR OPIN NEUROL, V24, P584, DOI 10.1097/WCO.0b013e32834c7eb9; Stuss DT, 2002, ANNU REV PSYCHOL, V53, P401, DOI 10.1146/annurev.psych.53.100901.135220; Suchy Y, 2009, J INT NEUROPSYCH SOC, V15, P248, DOI 10.1017/S1355617709090353; Veneziano C, 2004, PERCEPT MOTOR SKILL, V98, P661; Ward T, 2006, AGGRESS VIOLENT BEH, V11, P44, DOI 10.1016/j.avb.2005.05.002; Ylvisaker M, 2000, TOP LANG DISORD, V20, P29, DOI 10.1097/00011363-200020020-00005; Young MH, 2012, INT J OFFENDER THER, V56, P1103, DOI 10.1177/0306624X11417361; Young MH, 2010, INT J OFFENDER THER, V54, P92, DOI 10.1177/0306624X08322373	79	15	15	0	28	ROUTLEDGE JOURNALS, TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	1478-9949	1478-9957		J FORENSIC PSYCHI PS	J. Forensic Psychiatry Psychol.	JUN	2016	27	3					349	375		10.1080/14789949.2016.1141431			27	Criminology & Penology; Psychiatry	Social Science Citation Index (SSCI)	Criminology & Penology; Psychiatry	DL8GH	WOS:000375878700003					2022-02-06	
J	Bahado-Singh, RO; Graham, SF; Han, B; Turkoglu, O; Ziadeh, J; Mandal, R; Er, A; Wishart, DS; Stahel, PL				Bahado-Singh, Ray O.; Graham, Stewart F.; Han, BeomSoo; Turkoglu, Onur; Ziadeh, James; Mandal, Rupasri; Er, Anil; Wishart, David S.; Stahel, Philip L.			Serum metabolomic markers for traumatic brain injury: a mouse model	METABOLOMICS			English	Article						Traumatic brain injury; Metabolomics; Serum; Biomarkers; Mouse model	METABOANALYST; GLUTATHIONE; PREVALENCE; SERVER	Introduction Traumatic brain injury (TBI) is physical injury to brain tissue that temporarily or permanently impairs brain function. Objectives Evaluate the use of metabolomics for the development of biomarkers of TBI for the diagnosis and timing of injury onset. Methods A validated model of closed injury TBI was employed using 10 TBI mice and 8 sham operated controls. Quantitative LC-MS/MS metabolomic analysis was performed on the serum. Results Thirty-six (24.0 %) of 150 metabolites were altered with TBI. Principal component analysis (PCA) and Partial least squares discriminant analysis (PLS-DA) analyses revealed clear segregation between TBI versus control sera. The combination of methionine sulfoxide and the lipid PC aa C34:4 accurately diagnosed TBI, AUC (95 % CI) 0.85 (0.644-1.0). A combination of metabolite markers were highly accurate in distinguishing early (4 h post TBI) from late (24 h) TBI: AUC (95 % CI) 1.0 (1.0-1.0). Spermidine, which is known to have an antioxidant effect and which is known to be metabolically disrupted in TBI, was the most discriminating biomarker based on the variable importance ranking in projection (VIP) plot. Several important metabolic pathways were found to be disrupted including: pathways for arginine, proline, glutathione, cysteine, and sphingolipid metabolism. Conclusion Using serum metabolomic analysis we were able to identify novel putative serum biomarkers of TBI. They were accurate for detecting and determining the timing of TBI. In addition, pathway analysis provided important insights into the biochemical mechanisms of brain injury. Potential clinical implications for diagnosis, timing, and monitoring brain injury are discussed.	[Bahado-Singh, Ray O.] Oakland Univ, William Beaumont Sch Med, Dept Obstet & Gynecol, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA; [Graham, Stewart F.; Turkoglu, Onur] Beaumont Hlth, Dept Obstet & Gynecol, 3811 West 13 Mile Rd, Royal Oak, MI 48073 USA; [Han, BeomSoo; Mandal, Rupasri; Wishart, David S.] Univ Alberta, Dept Biol & Comp Sci, Edmonton, AB, Canada; [Ziadeh, James] Oakland Univ, William Beaumont Sch Med, Dept Emergency Med, 3601 W 13 Mile Rd, Royal Oak, MI 48073 USA; [Er, Anil] Dokuz Eylul Univ, Dept Pediat Emergency Med, Sch Med, TR-35340 Izmir, Turkey; [Stahel, Philip L.] Univ Colorado, Sch Med, Dept Neurosurg, Denver Hlth Med Ctr, Denver, CO USA; [Stahel, Philip L.] Univ Colorado, Sch Med, Dept Orthoped, Denver Hlth Med Ctr, Denver, CO USA		Graham, SF (corresponding author), Beaumont Hlth, Dept Obstet & Gynecol, 3811 West 13 Mile Rd, Royal Oak, MI 48073 USA.	stewart.graham@beaumont.edu	Wishart, David Scott/ABI-3181-2020; Graham, Stewart/AAE-9772-2020	Graham, Stewart/0000-0003-1001-0002			Altura BM, 2002, BRAIN RES BULL, V58, P271, DOI 10.1016/S0361-9230(02)00772-4; Bahado-Singh RO, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0957-1; Bahado-Singh RO, 2014, AM J OBSTET GYNECOL, V211, DOI 10.1016/j.ajog.2014.03.056; Bass CR, 2012, ANN BIOMED ENG, V40, P185, DOI 10.1007/s10439-011-0424-0; Boswell JE, 2002, AM J EMERG MED, V20, P177, DOI 10.1053/ajem.2002.32641; Chapman JC, 2014, ALZHEIMERS DEMENT, V10, pS97, DOI 10.1016/j.jalz.2014.04.012; Corso P, 2006, INJURY PREV, V12, P212, DOI 10.1136/ip.2005.010983; Farooqui AA, 2007, J NEUROSCI RES, V85, P1834, DOI 10.1002/jnr.21268; Faul M, 2006, TRAUMATIC BRAIN INJU; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Graham SF, 2016, METABOLOMICS, V12, DOI 10.1007/s11306-016-0986-9; Graham SF, 2014, METABOLOMICS, V10, P744, DOI 10.1007/s11306-013-0610-1; Graham SF, 2013, METABOLOMICS, V9, P974, DOI 10.1007/s11306-013-0516-y; Graham SF, 2013, ANAL CHEM, V85, P1803, DOI 10.1021/ac303163f; HALL ED, 1993, J NEUROCHEM, V60, P588, DOI 10.1111/j.1471-4159.1993.tb03189.x; Hastie T, 2009, ELEMENTS STAT LEARNI, V2nd, DOI 10.1007/978-0-387-84858-7; Jove M, 2014, J NEUROPATH EXP NEUR, V73, P640, DOI 10.1097/NEN.0000000000000091; Langlois JA., 2004, TRAUMATIC BRAIN INJU; Mondello Stefania, 2015, Handb Clin Neurol, V127, P245, DOI 10.1016/B978-0-444-52892-6.00016-7; Neher MD, 2014, SOUTH MED J, V107, P248, DOI 10.1097/SMJ.0000000000000086; Omalu BI, 2005, NEUROSURGERY, V57, P128, DOI 10.1227/01.NEU.0000163407.92769.ED; Pan XB, 2016, NEUROBIOL AGING, V38, P151, DOI 10.1016/j.neurobiolaging.2015.11.014; Park YM, 2015, CYTOTHERAPY, V17, P25, DOI 10.1016/j.jcyt.2014.08.006; Psychogios N, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016957; Reed TT, 2009, J NEUROSCI RES, V87, P408, DOI 10.1002/jnr.21872; Stein TD, 2014, ALZHEIMERS RES THER, V6, DOI 10.1186/alzrt234; Tibshirani R, 1996, J ROY STAT SOC B MET, V58, P267, DOI 10.1111/j.2517-6161.1996.tb02080.x; Wang HC, 2016, WORLD NEUROSURG, V87, P463, DOI 10.1016/j.wneu.2015.10.010; Wishart DS, 2010, METHODS MOL BIOL, V593, P283, DOI 10.1007/978-1-60327-194-3_14; Wu GY, 2004, J NUTR, V134, P489, DOI 10.1093/jn/134.3.489; Xia JG, 2015, NUCLEIC ACIDS RES, V43, pW251, DOI 10.1093/nar/gkv380; Xia JG, 2013, METABOLOMICS, V9, P280, DOI 10.1007/s11306-012-0482-9; Xia JG, 2012, NUCLEIC ACIDS RES, V40, pW127, DOI 10.1093/nar/gks374; Xia JG, 2009, NUCLEIC ACIDS RES, V37, pW652, DOI 10.1093/nar/gkp356; Zahedi K, 2010, J NEUROTRAUM, V27, P515, DOI 10.1089/neu.2009.1097; Zaloshnja E, 2008, J HEAD TRAUMA REHAB, V23, P394, DOI 10.1097/01.HTR.0000341435.52004.ac	36	15	15	1	27	SPRINGER	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	1573-3882	1573-3890		METABOLOMICS	Metabolomics	JUN	2016	12	6							100	10.1007/s11306-016-1044-3			12	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	DP8MS	WOS:000378752900005					2022-02-06	
J	Butler, CR; Boychuk, JA; Smith, BN				Butler, Corwin R.; Boychuk, Jeffery A.; Smith, Bret N.			Differential effects of rapamycin treatment on tonic and phasic GABAergic inhibition in dentate granule cells after focal brain injury in mice	EXPERIMENTAL NEUROLOGY			English	Article						mTOR; Controlled cortical impact; Hippocampus; Inhibition; Dentate gyrus; Tonic current; Synapse; gamma-Aminobutyric acid receptors	TEMPORAL-LOBE EPILEPSY; CONTROLLED CORTICAL IMPACT; MAMMALIAN TARGET; MOUSE MODEL; POSTTRAUMATIC EPILEPSY; SOMATOSTATIN INTERNEURONS; RECURRENT EXCITATION; MEDIATED INHIBITION; SEIZURE FREQUENCY; MURINE MODEL	The cascade of events leading to post-traumatic epilepsy (PTE) after traumatic brain injury (TBI) remains unclear. Altered inhibition in the hippocampal formation and dentate gyrus is a hallmark of several neurological disorders, including TBI and PTE. Inhibitory synaptic signaling in the hippocampus is predominately driven by gamma-aminobutyric acid (GABA) neurotransmission, and is prominently mediated by postsynaptic type A GABA receptors (GABA(A)R's). Subsets of these receptors involved in tonic inhibition of neuronal membranes serve a fundamental role in maintenance of inhibitory state, and GABA(A)R-mediated tonic inhibition is altered functionally in animal models of both TBI and epilepsy. In this study, we assessed the effect of mTOR inhibition on hippocampal hilar inhibitory interneuron loss and synaptic and tonic GABAergic inhibition of dentate gyrus granule cells (DGCs) after controlled cortical impact (CO) to determine if mTOR activation after TBI modulates GABA(A)R function. Hilar inhibitory interneuron density was significantly reduced 72 h after CCI injury in the dorsal two-thirds of the hemisphere ipsilateral to injury compared with the contralateral hemisphere and sham controls. Rapamycin treatment did not alter this reduction in cell density. Synaptic and tonic current measurements made in DGCs at both 1-2 and 8-13 weeks post-injury indicated reduced synaptic inhibition and THIP-induced tonic current density in DGCs ipsilateral to CCI injury at both time points post-injury, with no change in resting tonic GABA(A)R-mediated currents. Rapamycin treatment did not alter the reduced synaptic inhibition observed in ipsilateral DGCs 1-2 weeks post-CCI injury, but further reduced synaptic inhibition of ipsilateral DGCs at 8-13 weeks post-injury. The reduction in THIP-induced tonic current after injury, however, was prevented by rapamycin treatment at both time points. Rapamycin treatment thus differentially modifies CCI-induced changes in synaptic and tonic GABA(A)R-mediated currents in DGCs. (C) 2016 Elsevier Inc. All rights reserved.	[Butler, Corwin R.; Boychuk, Jeffery A.; Smith, Bret N.] Univ Kentucky, Coll Med, Dept Physiol, MS508 Chandler Med Ctr,800 Rose St, Lexington, KY 40536 USA; [Boychuk, Jeffery A.; Smith, Bret N.] Univ Kentucky, Epilepsy Ctr, Lexington, KY 40536 USA; [Boychuk, Jeffery A.] Univ Kentucky, Ctr Adv Translat Stroke Sci, Lexington, KY 40536 USA; [Smith, Bret N.] Univ Kentucky, Spinal Cord & Brain Injury Res Ctr SCoBIRC, Lexington, KY 40536 USA		Smith, BN (corresponding author), Univ Kentucky, Coll Med, Dept Physiol, MS508 Chandler Med Ctr,800 Rose St, Lexington, KY 40536 USA.	bret.smith@uky.edu		Butler, Corwin/0000-0001-5134-4151; Boychuk, Jeffery A/0000-0002-7003-1553	Department of Defense (USAMRMC) Grant [W81XWH-11-1-0502]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS088608]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS088608] Funding Source: NIH RePORTER	This work was supported by the Department of Defense (USAMRMC) Grant W81XWH-11-1-0502 (B.N.S.) and NIH Grant NS088608 (B.N.S.).	Anderson KJ, 2005, EXP NEUROL, V193, P125, DOI 10.1016/j.expneurol.2004.11.025; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Brown N, 2002, BRIT J PHARMACOL, V136, P965, DOI 10.1038/sj.bjp.0704795; Buckmaster PS, 2011, EPILEPSIA, V52, P2057, DOI 10.1111/j.1528-1167.2011.03253.x; Buckmaster PS, 2011, J NEUROSCI, V31, P2337, DOI 10.1523/JNEUROSCI.4852-10.2011; Buckmaster PS, 2009, J NEUROSCI, V29, P8259, DOI 10.1523/JNEUROSCI.4179-08.2009; BUCKMASTER PS, 1994, EPILEPSY RES, V18, P23, DOI 10.1016/0920-1211(94)90030-2; Butler CR, 2015, FRONT SYST NEUROSCI, V9, DOI 10.3389/fnsys.2015.00163; CAVENESS WF, 1979, J NEUROSURG, V50, P545, DOI 10.3171/jns.1979.50.5.0545; Coulter DA, 2007, PROG BRAIN RES, V163, P235, DOI 10.1016/S0079-6123(07)63014-3; Diaz-Arrastia R, 2000, ARCH NEUROL-CHICAGO, V57, P1611, DOI 10.1001/archneur.57.11.1611; EBERT B, 1994, MOL PHARMACOL, V46, P957; Englander J, 2003, ARCH PHYS MED REHAB, V84, P365, DOI 10.1053/apmr.2003.50022; Glykys J, 2007, J PHYSIOL-LONDON, V582, P1163, DOI 10.1113/jphysiol.2007.134460; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; Gupta A, 2012, J NEUROSCI, V32, P2523, DOI 10.1523/JNEUROSCI.4141-11.2012; Halabisky B, 2010, J NEUROPHYSIOL, V104, P2214, DOI 10.1152/jn.00147.2010; Hall ED, 2005, J NEUROTRAUM, V22, P669, DOI 10.1089/neu.2005.22.669; Hall ED, 2005, J NEUROTRAUM, V22, P252, DOI 10.1089/neu.2005.22.252; Halmos KC, 2015, NEUROSCIENCE, V306, P115, DOI 10.1016/j.neuroscience.2015.08.023; Heng K, 2013, EPILEPSIA, V54, P1535, DOI 10.1111/epi.12246; Hester MS, 2013, J NEUROSCI, V33, P8926, DOI 10.1523/JNEUROSCI.5161-12.2013; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; Hudak AM, 2004, J HEAD TRAUMA REHAB, V19, P290, DOI 10.1097/00001199-200407000-00003; Hunt RF, 2012, EPILEPSY RES, V99, P167, DOI 10.1016/j.eplepsyres.2011.10.011; Hunt RF, 2011, J NEUROSCI, V31, P6880, DOI 10.1523/JNEUROSCI.0032-11.2011; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; LOWENSTEIN DH, 1992, J NEUROSCI, V12, P4846; Mody I, 2004, TRENDS NEUROSCI, V27, P569, DOI 10.1016/j.tins.2004.07.002; Mtchedlishvili Z, 2010, NEUROBIOL DIS, V38, P464, DOI 10.1016/j.nbd.2010.03.012; Newcomb JK, 1997, J NEUROTRAUM, V14, P369, DOI 10.1089/neu.1997.14.369; O'Reilly KE, 2006, CANCER RES, V66, P1500, DOI 10.1158/0008-5472.CAN-05-2925; Oliva AA, 2000, J NEUROSCI, V20, P3354, DOI 10.1523/JNEUROSCI.20-09-03354.2000; Pavlov I, 2011, NEUROSCIENCE, V194, P208, DOI 10.1016/j.neuroscience.2011.07.074; Raible DJ, 2015, EXP NEUROL, V271, P445, DOI 10.1016/j.expneurol.2015.07.001; Raible DJ, 2012, J NEUROTRAUM, V29, P2548, DOI 10.1089/neu.2012.2483; Saatman KE, 2006, J NEUROTRAUM, V23, P1241, DOI 10.1089/neu.2006.23.1241; Santhakumar V, 2000, J PHYSIOL-LONDON, V524, P117, DOI 10.1111/j.1469-7793.2000.00117.x; Tabernero J, 2008, J CLIN ONCOL, V26, P1603, DOI 10.1200/JCO.2007.14.5482; Temkin N R, 1998, Adv Neurol, V76, P179; Temkin NR, 2009, EPILEPSIA, V50, P10, DOI 10.1111/j.1528-1167.2008.02005.x; Temkin NR, 2001, DRUGS, V61, P1045, DOI 10.2165/00003495-200161080-00002; Toth Z, 1997, J NEUROSCI, V17, P8106; Wang QH, 2003, NEURON, V38, P915, DOI 10.1016/S0896-6273(03)00356-8; Weston MC, 2012, J NEUROSCI, V32, P11441, DOI 10.1523/JNEUROSCI.1283-12.2012; Winokur RS, 2004, EPILEPSY RES, V58, P93, DOI 10.1016/j.eplepsyres.2004.01.002; Wuarin JP, 1996, J NEUROSCI, V16, P4438; Zeng LH, 2008, ANN NEUROL, V63, P444, DOI 10.1002/ana.21331; Zeng LH, 2009, J NEUROSCI, V29, P6964, DOI 10.1523/JNEUROSCI.0066-09.2009	50	15	15	0	2	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	JUN	2016	280						30	40		10.1016/j.expneurol.2016.03.022			11	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DL7LK	WOS:000375822000004	27018320	Bronze, Green Accepted			2022-02-06	
J	Cepeda, S; Gomez, PA; Castano-Leon, AM; Munarriz, PM; Paredes, I; Lagares, A				Cepeda, Santiago; Gomez, Pedro A.; Maria Castano-Leon, Ana; Munarriz, Pablo M.; Paredes, Igor; Lagares, Alfonso			Contrecoup Traumatic Intracerebral Hemorrhage: A Geometric Study of the Impact Site and Association with Hemorrhagic Progression	JOURNAL OF NEUROTRAUMA			English	Article						contrecoup; contusion; intracerebral hematoma; TICH; traumatic brain injury	SEVERE HEAD-INJURY; FINITE-ELEMENT-ANALYSIS; BRAIN-INJURY; CEREBRAL CONTUSIONS; RISK-FACTORS; EXTRADURAL HEMATOMA; DATA-BASE; MECHANISM; BIOMECHANICS; CONCUSSION	Traumatic intracerebral hemorrhage (TICH) represents 13-48% of the lesions after a traumatic brain injury (TBI). The frequency of TICH-hemorrhagic progression (TICH-HP) is estimated to be approximately 38-63%. The relationship between the impact site and TICH location has been described in many autopsy-based series. This association, however, has not been consistently demonstrated since the introduction of computed tomography (CT) for studying TBI. This study aimed to determine the association between the impact site and TICH location in patients with moderate and severe TBI. We also analyzed the associations between the TICH location, the impact site, the production mechanism (coup or contrecoup), and hemorrhagic progression. We retrospectively analyzed the records of 408 patients after a moderate or severe TBI between January 2010 and November 2014. We identified 177 patients with a total of 369 TICHs. We found a statistically significant association between frontal TICHs and impact sites located on the anterior area of the head (OR 5.8, p<0.001). The temporal TICH location was significantly associated with impact sites located on the posterior head area (OR 4.9, p<0.001). Anterior and lateral TICHs were associated with impact sites located at less than 90 degrees (coup) (OR 1.64, p=0.03) and more than 90 degrees (contrecoup), respectively. Factors independently associated with TICH-HP obtained through logistic regression included an initial volume of <1cc, cisternal compression, falls, acute subdural hematoma, multiple TICHs, and contrecoup TICHs. We demonstrated a significant association between the TICH location and impact site. The contrecoup represents a risk factor independently associated with hemorrhagic progression.	[Cepeda, Santiago; Gomez, Pedro A.; Maria Castano-Leon, Ana; Munarriz, Pablo M.; Paredes, Igor; Lagares, Alfonso] Univ Complutense Madrid, Hosp 12 Octubre, Dept Neurosurg, Madrid, Spain		Cepeda, S (corresponding author), Hosp 12 Octubre, Dept Neurosurg, Avda Cordoba S-N, E-28041 Madrid, Spain.	cepeda_santiago@hotmail.com	Gomez, Pedro/N-5051-2019; Paredes, Igor/AAW-6313-2021; Cepeda, Santiago/AAE-3200-2021; Sansinenea, Igor Paredes/S-6281-2019; Munarriz, Pablo M/S-3398-2018; Castano-Leon, Ana M/ABF-6322-2020; Lagares, Alfonso/B-2969-2011	Gomez, Pedro/0000-0002-4185-5238; Paredes, Igor/0000-0002-3846-4164; Cepeda, Santiago/0000-0003-1667-8548; Munarriz, Pablo M/0000-0002-9888-7046; Castano-Leon, Ana M/0000-0002-7918-5049; Lagares, Alfonso/0000-0003-3996-0554	Mutua Madrilena Foundation (Spain) [2010-007]; FIS - Instituto de Salud Carlos III (ISCIII)Instituto de Salud Carlos III [PI14/01457]; FEDEREuropean Commission	This study was funded by grant no. 2010-007 from the Mutua Madrilena Foundation (Spain) to Pedro A. Gomez, MD, PhD, and by grant FIS PI14/01457 co-financed by Instituto de Salud Carlos III (ISCIII) and FEDER. Portions of this work were presented in abstract form as proceedings at the XX Congress of the Spanish Society of Neurological Surgery, Pamplona, Spain, May 19, 2015.	Adams F, 1849, GENUINE WORKS HIPPOC; ADAMS JH, 1980, NEUROPATH APPL NEURO, V6, P319, DOI 10.1111/j.1365-2990.1980.tb00217.x; ADAMS JH, 1985, NEUROPATH APPL NEURO, V11, P299, DOI 10.1111/j.1365-2990.1985.tb00027.x; Alahmadi H, 2010, J NEUROSURG, V112, P1139, DOI 10.3171/2009.5.JNS081369; Allard CB, 2009, J TRAUMA, V67, P959, DOI 10.1097/TA.0b013e3181ad5d37; [Anonymous], 1996, J Neurosurg Sci, V40, P11; BALASUBRAMANIAM V, 1991, SURG NEUROL, V36, P462, DOI 10.1016/0090-3019(91)90161-2; Besenski N, 1996, NEURORADIOLOGY, V38, pS36; Brott T, 1997, STROKE, V28, P1, DOI 10.1161/01.STR.28.1.1; BULLOCK R, 1989, SURG NEUROL, V32, P181, DOI 10.1016/0090-3019(89)90176-6; Carrick MM, 2005, J TRAUMA, V58, P725, DOI 10.1097/01.TA.0000159249.68363.78; Cepeda S, 2015, J NEUROTRAUM, V32, P1246, DOI 10.1089/neu.2014.3808; Chang EF, 2006, NEUROSURGERY, V58, P647, DOI 10.1227/01.NEU.0000197101.68538.E6; CHU CS, 1994, J BIOMECH, V27, P187, DOI 10.1016/0021-9290(94)90208-9; COURVILLE C B, 1950, Bull Los Angel Neuro Soc, V15, P72; COURVILLE CYRIL B., 1962, BULL LOS ANGELES NEUROL SOC, V27, P22; CROOKS DA, 1991, VIRCHOWS ARCH A, V418, P479, DOI 10.1007/BF01606496; DAWSON SL, 1980, HUM PATHOL, V11, P155, DOI 10.1016/S0046-8177(80)80136-5; Drew LB, 2004, NEUROCRIT CARE, V1, P385, DOI 10.1385/NCC:1:3:385; Engstrom M, 2005, J NEUROTRAUM, V22, P291, DOI 10.1089/neu.2005.22.291; Flint AC, 2008, J NEUROTRAUM, V25, P503, DOI 10.1089/neu.2007.0442; FUKAMACHI A, 1985, ACTA NEUROCHIR, V74, P35, DOI 10.1007/BF01413274; Gean AD, 1994, IMAGING HEAD TRAUMA; Goeller J, 2012, J NEUROTRAUM, V29, P1970, DOI 10.1089/neu.2011.2224; Gomez PA, 1999, NEUROCIRUGIA, V10, P297; Gomez PA, 2014, NEUROCIRUGIA, V25, P199, DOI 10.1016/j.neucir.2014.05.001; GROSS AG, 1958, J NEUROSURG, V15, P548, DOI 10.3171/jns.1958.15.5.0548; GURDJIAN ES, 1975, SURG GYNECOL OBSTET, V140, P845; GURDJIAN ES, 1958, J NEUROSURG, V15, P125, DOI 10.3171/jns.1958.15.2.0125; GURDJIAN ES, 1955, SURG GYNECOL OBSTET, V101, P680; GURDJIAN ES, 1976, J TRAUMA, V16, P35, DOI 10.1097/00005373-197601000-00005; HIRSCH CS, 1975, J NEUROSURG, V42, P530, DOI 10.3171/jns.1975.42.5.0530; Huang HM, 2000, MED BIOL ENG COMPUT, V38, P253, DOI 10.1007/BF02347044; Iaccarino C, 2014, J NEUROSURG, V120, P908, DOI 10.3171/2013.12.JNS131090; JAMIESON KG, 1968, J NEUROSURG, V29, P13, DOI 10.3171/jns.1968.29.1.0013; Juratli TA, 2014, J NEUROTRAUM, V31, P1521, DOI 10.1089/neu.2013.3241; Kurland D, 2012, J NEUROTRAUM, V29, P19, DOI 10.1089/neu.2011.2122; Kurosawa Y, 2009, IEEE ENG MED BIO, P7224, DOI 10.1109/IEMBS.2009.5335260; LINDENBERG R, 1960, ARCH PATHOL, V69, P440; LINDENBERG R, 1957, ARCH PATHOL, V63, P23; Lobato R. D., 2013, NEUROCIRURGIA, V16, P217; LOBATO RD, 1983, J NEUROSURG, V59, P762, DOI 10.3171/jns.1983.59.5.0762; Makela T, 1965, Suom Laakaril, V20, P1869; MANTEL N, 1959, J NATL CANCER I, V22, P719; Marion DW, 2006, NEUROSURGERY, V58, P655; Marmarou A, 2007, J NEUROTRAUM, V24, P239, DOI 10.1089/neu.2006.0036; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; MARSHALL LF, 1991, J NEUROSURG, V75, pS28, DOI 10.3171/sup.1991.75.1s.0s28; Mitsuyama T, 2004, NEUROL MED-CHIR, V44, P584, DOI 10.2176/nmc.44.584; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; NAGELKERKE NJD, 1991, BIOMETRIKA, V78, P691, DOI 10.1093/biomet/78.3.691; Narayan RK, 2008, J NEUROTRAUM, V25, P629, DOI 10.1089/neu.2007.0385; Oertel M, 2002, J NEUROSURG, V96, P109, DOI 10.3171/jns.2002.96.1.0109; OKAMOTO H, 1983, SURG NEUROL, V20, P461, DOI 10.1016/0090-3019(83)90028-9; OMMAYA AK, 1971, J NEUROSURG, V35, P503, DOI 10.3171/jns.1971.35.5.0503; Park HK, 1999, CRIT REV NEUROSURG, V9, P44, DOI 10.1007/s003290050108; Pena A, 2005, ACT NEUR S, V95, P333; Post A, 2015, NEUROSURGERY, V76, P81, DOI 10.1227/NEU.0000000000000554; PUDENZ RH, 1946, J NEUROSURG, V3, P487, DOI 10.3171/jns.1946.3.6.0487; Ratnaike TE, 2011, BRIT J NEUROSURG, V25, P410, DOI 10.3109/02688697.2010.548879; Rowbotham G. F., 1945, ACUTE INJURIES HEAD; Sano K, 1967, Neurol Med Chir (Tokyo), V9, P21, DOI 10.2176/nmc.9.21; Sato S, 2009, J CLIN NEUROSCI, V16, P834, DOI 10.1016/j.jocn.2008.08.023; SCHNEIDER RC, 1953, J NEUROSURG, V10, P122, DOI 10.3171/jns.1953.10.2.0122; Servadei F, 2000, NEUROSURGERY, V46, P70, DOI 10.1093/neurosurgery/46.1.70; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P20, DOI 10.1136/jnnp.66.1.20; Stein SC, 2008, J TRAUMA, V65, P66, DOI 10.1097/TA.0b013e318068d75f; Stewart O W, 1944, Proc R Soc Med, V37, P381; Sturiale CL, 2012, J NEUROTRAUM, V29, P2723, DOI 10.1089/neu.2012.2556; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Tian HL, 2010, NEUROSURG REV, V33, P359, DOI 10.1007/s10143-010-0251-z; VILALTA J, 1991, REV CLIN ESP, V188, P393; WARD JW, 1948, SCIENCE, V107, P349, DOI 10.1126/science.107.2779.349; White CL, 2009, J TRAUMA, V67, P508, DOI 10.1097/TA.0b013e3181b2519f; Yadav YR, 2006, NEUROL INDIA, V54, P377, DOI 10.4103/0028-3886.28109; Yamada SM, 2014, CLIN NEUROL NEUROSUR, V125, P106, DOI 10.1016/j.clineuro.2014.07.021; Zong Z, 2006, J BIOMECH, V39, P284, DOI 10.1016/j.jbiomech.2004.11.015; Zou H, 2007, J BIOMECH, V40, P1183, DOI 10.1016/j.jbiomech.2006.06.018	78	15	17	1	13	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					1034	1046		10.1089/neu.2015.4153			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600007	26391755				2022-02-06	
J	Ellis, MU; Marion, SD; McArthur, DL; Babikian, T; Giza, C; Kernan, CL; Newman, N; Moran, L; Akarakian, R; Houshiarnejad, A; Mink, R; Johnson, J; Babbitt, CJ; Olsen, A; Asarnow, RF				Ellis, Monica U.; Marion, Sarah DeBoard; McArthur, David L.; Babikian, Talin; Giza, Christopher; Kernan, Claudia L.; Newman, Nina; Moran, Lisa; Akarakian, Roy; Houshiarnejad, Asal; Mink, Richard; Johnson, Jeffrey; Babbitt, Christopher J.; Olsen, Alexander; Asarnow, Robert F.			The UCLA Study of Children with Moderate-to-Severe Traumatic Brain Injury: Event-Related Potential Measure of Interhemispheric Transfer Time	JOURNAL OF NEUROTRAUMA			English	Article						corpus callosum; event-related potential; interhemispheric transfer time; neurocognitive functioning; pediatric traumatic brain injury	POSTERIOR CALLOSAL SECTION; CLOSED-HEAD-INJURY; CORPUS-CALLOSUM; EVOKED-POTENTIALS; TRANSMISSION TIME; PARENT EDUCATION; VISUAL PROCESSES; PEDIATRIC TBI; INFORMATION; AGENESIS	Traumatic brain injury (TBI) frequently results in diffuse axonal injury and other white matter damage. The corpus callosum (CC) is particularly vulnerable to injury following TBI. Damage to this white matter tract has been associated with impaired neurocognitive functioning in children with TBI. Event-related potentials can identify stimulus-locked neural activity with high temporal resolution. They were used in this study to measure interhemispheric transfer time (IHTT) as an indicator of CC integrity in 44 children with moderate/severe TBI at 3-5 months post-injury, compared with 39 healthy control children. Neurocognitive performance also was examined in these groups. Nearly half of the children with TBI had IHTTs that were outside the range of the healthy control group children. This subgroup of TBI children with slow IHTT also had significantly poorer neurocognitive functioning than healthy controlseven after correction for premorbid intellectual functioning. We discuss alternative models for the relationship between IHTT and neurocognitive functioning following TBI. Slow IHTT may be a biomarker that identifies children at risk for poor cognitive functioning following moderate/severe TBI.	[Ellis, Monica U.; Babikian, Talin; Kernan, Claudia L.; Newman, Nina; Moran, Lisa; Houshiarnejad, Asal; Olsen, Alexander; Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 48-240 Semel Inst,760 Westwood Plaza, Los Angeles, CA 90024 USA; [McArthur, David L.; Giza, Christopher] Univ Calif Los Angeles, Dept Neurosurg, Los Angeles, CA 90024 USA; [Babikian, Talin; Kernan, Claudia L.; Moran, Lisa] Univ Calif Los Angeles, Mattel Childrens Hosp, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Steve Tisch BrainSPORT Program, Los Angeles, CA 90024 USA; Univ Calif Los Angeles, Brain Injury Res Ctr, Los Angeles, CA 90024 USA; [Giza, Christopher; Mink, Richard] Univ Calif Los Angeles, Dept Pediat, Los Angeles, CA 90024 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA 90024 USA; [Ellis, Monica U.; Marion, Sarah DeBoard] Fuller Grad Sch Psychol, Pasadena, CA USA; [Akarakian, Roy] Wayne State Univ, Sch Med, Detroit, MI USA; [Mink, Richard] Harbor Univ Calif, Los Angeles Med Ctr, Torrance, CA USA; [Johnson, Jeffrey] Univ So Calif, Dept Clin Pediat, Los Angeles, CA USA; [Johnson, Jeffrey] Los Angeles Cty USC Med Ctr, Dept Pediat, Los Angeles, CA USA; [Babbitt, Christopher J.] Miller Childrens Hosp, Dept Pediat, Long Beach, CA USA; [Olsen, Alexander] Norwegian Univ Sci & Technol, Alexander Olsen Dept Psychol, N-7034 Trondheim, Norway; [Olsen, Alexander] Univ Trondheim Hosp, St Olavs Hosp, Dept Phys Med & Rehabil, Trondheim, Norway		Asarnow, RF (corresponding author), Univ Calif Los Angeles, Dept Psychiat & Biobehav Sci, 48-240 Semel Inst,760 Westwood Plaza, Los Angeles, CA 90024 USA.	rasarnow@mednet.ucla.edu	Olsen, Alexander/P-5235-2019	Olsen, Alexander/0000-0001-8691-3860	National Institute of Child Health and Human DevelopmentUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [HD061504]	This research was supported by National Institute of Child Health and Human Development Grant #HD061504. We thank Alma Martinez and Alma Ramirez for their assistance in data collection and the children and their parents who participated in this research.	ANDREASSI JL, 1975, PSYCHOPHYSIOLOGY, V12, P541, DOI 10.1111/j.1469-8986.1975.tb00043.x; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BANICH MT, 1990, CORTEX, V26, P77, DOI 10.1016/S0010-9452(13)80076-7; Benavidez DA, 1999, CORTEX, V35, P315, DOI 10.1016/S0010-9452(08)70803-7; Brown WS, 1999, NEUROPSYCHOLOGIA, V37, P1165, DOI 10.1016/S0028-3932(99)00011-1; BROWN WS, 1993, NEUROPSYCHOLOGIA, V31, P1267, DOI 10.1016/0028-3932(93)90097-J; Buckhalt JA, 2009, CHILD DEV, V80, P875, DOI 10.1111/j.1467-8624.2009.01303.x; DAMASIO AR, 1980, J NEUROL NEUROSUR PS, V43, P351, DOI 10.1136/jnnp.43.4.351; Davis-Kean PE, 2005, J FAM PSYCHOL, V19, P294, DOI 10.1037/0893-3200.19.2.294; Delis D.C., 2000, CALIFORNIA VERBAL LE; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC., 1994, CALIFORNIA VERBAL LE; GAZZANIGA MS, 1973, NEUROLOGY, V23, P1126, DOI 10.1212/WNL.23.10.1126; GENTRY LR, 1988, AM J NEURORADIOL, V9, P1129; Johnson SC, 1996, NEUROPSYCHOLOGY, V10, P408, DOI 10.1037/0894-4105.10.3.408; Kumar R, 2009, BRAIN INJURY, V23, P675, DOI 10.1080/02699050903014915; Larson EB, 1997, NEUROPSYCHOLOGIA, V35, P573; LASSONDE M, 1988, BEHAV BRAIN RES, V30, P165, DOI 10.1016/0166-4328(88)90146-5; LEDLOW A, 1978, ANN NEUROL, V3, P525, DOI 10.1002/ana.410030613; Levin HS, 2008, J NEUROSURG-PEDIATR, V1, P461, DOI 10.3171/PED/2008/1/6/461; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; LINDENBERG R, 1955, AM J PATHOL, V31, P297; Ljungqvist J, 2011, BRAIN INJURY, V25, P370, DOI 10.3109/02699052.2011.558038; Mathias JL, 2004, APPL NEUROPSYCHOL, V11, P134, DOI 10.1207/s15324826an1103_2; MENDELSOHN DB, 1992, NEURORADIOLOGY, V34, P384, DOI 10.1007/BF00596495; Peru A, 2003, NEUROPSYCHOLOGIA, V41, P634, DOI 10.1016/S0028-3932(02)00203-8; Reeves TM, 2005, EXP NEUROL, V196, P126, DOI 10.1016/j.expneurol.2005.07.014; RUGG MD, 1985, J NEUROL NEUROSUR PS, V48, P367, DOI 10.1136/jnnp.48.4.367; SARON CD, 1989, BEHAV NEUROSCI, V103, P1115, DOI 10.1037/0735-7044.103.5.1115; SAUERWEIN H, 1983, NEUROPSYCHOLOGIA, V21, P167, DOI 10.1016/0028-3932(83)90084-2; Shiramizu H, 2008, NEUROL MED-CHIR, V48, P1, DOI 10.2176/nmc.48.1; Slawik H, 2009, J NEUROTRAUM, V26, P1891, DOI 10.1089/neu.2009.0942; SUGISHITA M, 1987, NEUROPSYCHOLOGIA, V25, P329, DOI 10.1016/0028-3932(87)90022-4; Tasker RC, 2010, DEV NEUROSCI-BASEL, V32, P374, DOI 10.1159/000316806; Verger K, 2001, BRAIN INJURY, V15, P211; VUILLEUMIER P, 1995, CLIN NEUROL NEUROSUR, V97, P39, DOI 10.1016/0303-8467(94)00056-C; Wechsler D, 2003, WECHSLER INTELLIGENC; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D, 1997, WECHSLER ADULT INTEL, Vthird; Wilde EA, 2006, J NEUROTRAUM, V23, P1412, DOI 10.1089/neu.2006.23.1412; Wozniak JR, 2007, ARCH CLIN NEUROPSYCH, V22, P555, DOI 10.1016/j.acn.2007.03.004; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058	43	15	16	1	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	JUN 1	2016	33	11					990	996		10.1089/neu.2015.4023			7	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine; Neurosciences & Neurology	DN3SU	WOS:000376984600002	26153851	Green Published, Green Submitted			2022-02-06	
J	Jonas, WB; Bellanti, DM; Paat, CF; Boyd, CC; Duncan, A; Price, A; Zhang, WM; French, LM; Chae, H				Jonas, Wayne B.; Bellanti, Dawn M.; Paat, Charmagne F.; Boyd, Courtney C.; Duncan, Alaine; Price, Ashley; Zhang, Weimin; French, Louis M.; Chae, Heechin			A Randomized Exploratory Study to Evaluate Two Acupuncture Methods for the Treatment of Headaches Associated with Traumatic Brain Injury	MEDICAL ACUPUNCTURE			English	Article						Traumatic Brian Injury; Headache; Pain Management; Acupuncture	POSTTRAUMATIC-STRESS-DISORDER; TRIAL; DEPRESSION	Background: Headaches are prevalent among Service members with traumatic brain injury (TBI); 80% report chronic or recurrent headache. Evidence for nonpharmacologic treatments, such as acupuncture, are needed. Objective: The aim of this research was to determine if two types of acupuncture (auricular acupuncture [AA] and traditional Chinese acupuncture [TCA]) were feasible and more effective than usual care (UC) alone for TBI-related headache. Materials and Methods: Design: This was a three-armed, parallel, randomized exploratory study. Setting: The research took place at three military treatment facilities in the Washington, DC, metropolitan area. Patients: The subjects were previously deployed Service members (18-69 years old) with mild-to-moderate TBI and headaches. Intervention: The interventions explored were UC alone or with the addition of AA or TCA. Outcome Measures: The primary outcome was the Headache Impact Test (HIT). Secondary outcomes were the Numerical Rating Scale (NRS), Pittsburgh Sleep Quality Index, Post-Traumatic Stress Checklist, Symptom Checklist-90-R, Medical Outcome Study Quality of Life (QoL), Beck Depression Inventory, State-Trait Anxiety Inventory, the Automated Neuropsychological Assessment Metrics, and expectancy of outcome and acupuncture efficacy. Results: Mean HIT scores decreased in the AA and TCA groups but increased slightly in the UC-only group from baseline to week 6 [AA, -10.2%(-6.4 points); TCA, -4.6% (-2.9 points); UC, +0.8%(+0.6 points)]. Both acupuncture groups had sizable decreases in NRS (Pain Best), compared to UC (TCA versus UC: P=0.0008, d=1.70; AA versus UC: P=0.0127, d=1.6). No statistically significant results were found for any other secondary outcome measures. Conclusions: Both AA and TCA improved headache-related QoLmore than UC did in Servicemembers with TBI.	[Jonas, Wayne B.; Bellanti, Dawn M.; Paat, Charmagne F.; Boyd, Courtney C.; Price, Ashley; Zhang, Weimin] Samueli Inst, 1737 King St,Suite 600, Alexandria, VA 22314 USA; [Duncan, Alaine] Integrat Healing LLC, Hyattsville, MD USA; [French, Louis M.] Walter Reed Natl Mil Med Ctr, Natl Intrepid Ctr Excellence, Bethesda, MD USA; [Chae, Heechin] Ft Belvoir Community Hosp, Def & Vet Brain Injury Ctr Clin, Ft Belvoir, VA USA		Jonas, WB (corresponding author), Samueli Inst, 1737 King St,Suite 600, Alexandria, VA 22314 USA.	wjonas@samueliinstitute.org	french, louis/AAB-2083-2020	french, louis/0000-0002-9451-0604; Bellanti, Dawn/0000-0003-4507-2625	Department of DefenseUnited States Department of Defense [W81XWH-08-2-0212] Funding Source: Medline		Barker R, 2006, ACAD EMERG MED, V13, P19, DOI 10.1197/j.aem.2005.07.014; Bayliss M., 2002, HIT 6 USERS GUIDE; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Cao WS, 2001, MODERN REHABILITATIO, V5, P110; Chan YY, 2015, J AFFECT DISORDERS, V176, P106, DOI 10.1016/j.jad.2015.01.048; Cifu DX, 2013, J REHABIL RES DEV, V50, P1169, DOI 10.1682/JRRD.2013.01.0006; Coeytaux RR, 2006, J CLIN EPIDEMIOL, V59, P374, DOI 10.1016/j.jclinepi.2005.05.010; Coeytaux RR, 2005, HEADACHE, V45, P1113, DOI 10.1111/j.1526-4610.2005.00235.x; Da Silva AN, 2015, HEADACHE, V55, P470, DOI 10.1111/head.12525; Dasgupta A, 2010, AM J HEALTH-SYST PH, V67, P1337, DOI 10.2146/ajhp090507; Defense and Veteran Brain Injury Center, DOD WORLDW NUMB TBI; Defense and Veterans Brain Injury Center, UPD MILD TRAUM BRAIN; Department of Veterans Affairs (VA) Department of Defense (DoD), 2009, VA DOD CLIN PRACT GU; Domingo C, 2001, Rev Enferm, V24, P50; Engel CC, 2014, MED CARE, V52, pS57, DOI 10.1097/MLR.0000000000000237; FERRAZ MB, 1990, J RHEUMATOL, V17, P1022; Gironda RJ, 2009, REHABIL PSYCHOL, V54, P247, DOI 10.1037/a0016906; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hollifield M, 2007, J NERV MENT DIS, V195, P504, DOI 10.1097/NMD.0b013e31803044f8; Jonas WB, 2011, MED ACUPUNCT, V23, P249, DOI 10.1089/acu.2011.0840; Kadel RP, 2012, ANN SOUTHEAST SAS US; Kalavapalli Ramprasad, 2007, Complement Ther Clin Pract, V13, P184, DOI 10.1016/j.ctcp.2007.01.001; Khusid MA, 2015, MIL MED, V180, P132, DOI 10.7205/MILMED-D-14-00195; Lee C, 2012, SYST REV, V1, DOI 10.1186/2046-4053-1-46; Lee JH, 2013, CLIN J PAIN, V29, P172, DOI 10.1097/AJP.0b013e31824909f9; Lindel K, 2009, CANCER INVEST, V27, P781, DOI 10.1080/07357900802653456; Liu L, 2015, EVID-BASED COMPL ALT, V2015, P18; Manber R, 2004, J AFFECT DISORDERS, V83, P89, DOI 10.1016/j.jad.2004.05.009; Niemtzow RC, 2006, J ALTERN COMPLEM MED, V12, P597, DOI 10.1089/acm.2006.597; Pilkington Karen, 2007, Acupunct Med, V25, P1; Shen J, 2001, J ALTERN COMPLEM MED, V7, pS121; SMITH CA, 2005, COCHRANE DB SYST REV, V2; Sniezek DP, 2013, MED ACUPUNCT, V25, P164, DOI 10.1089/acu.2012.0900; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Wasserstein RL, 2016, AM STAT         0307; Wheway Jayne, 2012, Int J Risk Saf Med, V24, P163, DOI 10.3233/JRS-2012-0569	37	15	15	0	10	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	1933-6586	1933-6594		MED ACUPUNCT	Med. Acupunct.	JUN	2016	28	3					113	130		10.1089/acu.2016.1183			18	Integrative & Complementary Medicine	Emerging Sources Citation Index (ESCI)	Integrative & Complementary Medicine	EB7MF	WOS:000387571000002	27458496	Green Published, Green Submitted, hybrid			2022-02-06	
J	Singh, R; Savitz, J; Teague, TK; Polanski, DW; Mayer, AR; Bellgowan, PSF; Meier, TB				Singh, Rashmi; Savitz, Jonathan; Teague, T. Kent; Polanski, David W.; Mayer, Andrew R.; Bellgowan, Patrick S. F.; Meier, Timothy B.			Mood symptoms correlate with kynurenine pathway metabolites following sports-related concussion	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							TRAUMATIC BRAIN-INJURY; MAJOR DEPRESSIVE DISORDER; PROFESSIONAL FOOTBALL PLAYERS; LIFE COGNITIVE IMPAIRMENT; QUINOLINIC ACID; RECURRENT CONCUSSION; HIGH-SCHOOL; HIPPOCAMPAL; RAT; ANTAGONISTS	Objective An imbalance of neuroactive kynurenine pathway metabolites has been proposed as one mechanism behind the neuropsychiatric sequelae of certain neurological disorders. We hypothesized that concussed football players would have elevated plasma levels of neurotoxic kynurenine metabolites and reduced levels of neuroprotective metabolites relative to healthy football players and that altered kynurenine levels would correlate with post-concussion mood symptoms. Methods Mood scales and plasma concentrations of kynurenine metabolites were assessed in concussed (N=18; 1.61 days post-injury) and healthy football players (N=18). A subset of football players returned at 1-week (N=14; 9.29 days) and 1-month post-concussion (N=14, 30.93 days). Results Concussed athletes had significantly elevated levels of quinolinic acid (QUIN) and significantly lower ratios of kynurenic acid (KYNA) to QUIN at all time points compared with healthy athletes (p's<0.05), with no longitudinal evidence of normalization of KYNA or KYNA/QUIN. At 1-day post-injury, concussed athletes with lower levels of the putatively neuroprotective KYNA/QUIN ratio reported significantly worse depressive symptoms (p=0.04), and a trend toward worse anxiety symptoms (p=0.06), while at 1-month higher QUIN levels were associated with worse mood symptoms (p's<0.01). Finally, concussed athletes with worse concussion outcome, defined as number of days until return-to-play, had higher QUIN and lower KYNA/QUIN at 1-month post-injury (p's<0.05). Conclusions These results converge with existing kynurenine literature on psychiatric patients and provide the first evidence of altered peripheral levels of kynurenine metabolites following sports-related concussion.	[Singh, Rashmi; Savitz, Jonathan; Meier, Timothy B.] Laureate Inst Brain Res, Tulsa, OK USA; [Savitz, Jonathan] Univ Tulsa, Fac Community Med, Tulsa, OK 74104 USA; [Teague, T. Kent] Univ Oklahoma, Coll Med, Dept Surg, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Med, Dept Psychiat, Tulsa, OK USA; [Teague, T. Kent] Univ Oklahoma, Coll Pharm, Dept Pharmaceut Sci, Tulsa, OK USA; [Teague, T. Kent] Oklahoma State Univ, Ctr Hlth Sci, Dept Biochem & Microbiol, Tulsa, OK USA; [Polanski, David W.] Univ Tulsa, Dept Athlet, Tulsa, OK 74104 USA; [Mayer, Andrew R.; Meier, Timothy B.] Lovelace Biomed & Environm Res Inst, Mind Res Network, Pete & Nancy Domenici Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA; [Mayer, Andrew R.] Univ New Mexico, Sch Med, Dept Neurol, Albuquerque, NM 87131 USA; [Mayer, Andrew R.] Univ New Mexico, Dept Psychol, Albuquerque, NM 87131 USA; [Bellgowan, Patrick S. F.] NINDS, NIH, Bldg 36,Rm 4D04, Bethesda, MD 20892 USA		Meier, TB (corresponding author), Lovelace Biomed & Environm Res Inst, Mind Res Network, Pete & Nancy Domenici Hall,1101 Yale Blvd NE, Albuquerque, NM 87106 USA.	timothybmeier@gmail.com	Teague, T. Kent/A-2527-2008; Savitz, Jonathan/C-3088-2009	Teague, T. Kent/0000-0002-4680-5440; Savitz, Jonathan/0000-0001-8143-182X	Laureate Institute for Brain Research; William K Warren Foundation	This research was conducted using internal funds from the Laureate Institute for Brain Research, which is supported by The William K Warren Foundation.	Amaral M, 2013, J MOL MED, V91, P705, DOI 10.1007/s00109-013-1046-9; Bay-Richter C, 2015, BRAIN BEHAV IMMUN, V43, P110, DOI 10.1016/j.bbi.2014.07.012; Bell MJ, 1999, CRIT CARE MED, V27, P493, DOI 10.1097/00003246-199903000-00023; Blaylock Russell L, 2011, Surg Neurol Int, V2, P107, DOI 10.4103/2152-7806.83391; Bombardier CH, 2010, JAMA-J AM MED ASSOC, V303, P1938, DOI 10.1001/jama.2010.599; Cernich A, 2007, ARCH CLIN NEUROPSYCH, V22, pS101, DOI 10.1016/j.acn.2006.10.008; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; HICKS RR, 1994, BRAIN RES, V655, P91, DOI 10.1016/0006-8993(94)91601-2; Kontos AP, 2012, ARCH PHYS MED REHAB, V93, P1751, DOI 10.1016/j.apmr.2012.03.032; Mackay GM, 2006, EUR J NEUROL, V13, P30, DOI 10.1111/j.1468-1331.2006.01220.x; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Meier TB, 2014, J SCI MED SPORT; Meier TB, 2015, JAMA NEUROL, V72, P530, DOI 10.1001/jamaneurol.2014.4778; Patterson ZR, 2012, FRONT CELL NEUROSCI, V6, DOI 10.3389/fncel.2012.00058; Perez-Polo JR, 2013, J NEUROTRAUM, V30, P727, DOI 10.1089/neu.2012.2650; PERKINS MN, 1982, BRAIN RES, V247, P184, DOI 10.1016/0006-8993(82)91048-4; Savitz J, 2015, BRAIN BEHAV IMMUN, V46, P55, DOI 10.1016/j.bbi.2015.02.007; Savitz J, 2015, PSYCHONEUROENDOCRINO, V52, P200, DOI 10.1016/j.psyneuen.2014.11.015; Savitz J, 2015, NEUROPSYCHOPHARMACOL, V40, P463, DOI 10.1038/npp.2014.194; SCHWARCZ R, 1983, SCIENCE, V219, P316, DOI 10.1126/science.6849138; Schwarcz R, 2012, NAT REV NEUROSCI, V13, P465, DOI 10.1038/nrn3257; Singh R, 2014, JAMA-J AM MED ASSOC, V311, P1883, DOI 10.1001/jama.2014.3313; Sinz EH, 1998, J CEREBR BLOOD F MET, V18, P610, DOI 10.1097/00004647-199806000-00002; SMITH DH, 1993, J NEUROSCI, V13, P5383, DOI 10.1523/JNEUROSCI.13-12-05383.1993; Stamm JM, 2015, NEUROLOGY, V84, P1114, DOI 10.1212/WNL.0000000000001358; Steiner J, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-94; Suma T, 2008, NEUROL RES, V30, P420, DOI 10.1179/016164107X251745	32	15	15	0	16	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	JUN	2016	87	6					670	675		10.1136/jnnp-2015-311369			6	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychiatry; Surgery	DM9KX	WOS:000376686100015	26269650				2022-02-06	
J	Stephens, SW; Williams, C; Gray, R; Kerby, JD; Wang, HE; Bosarge, PL				Stephens, Shannon W.; Williams, Carolyn; Gray, Randal; Kerby, Jeffrey D.; Wang, Henry E.; Bosarge, Patrick L.			Using social media for community consultation and public disclosure in exception from informed consent trials	JOURNAL OF TRAUMA AND ACUTE CARE SURGERY			English	Article						Consent; social media; community consultation; ethics; resuscitation	EXPERIENCE; TRAUMA	BACKGROUND The US Food and Drug Administration and the Department of Health and Human Services outline regulations allowing an exception from informed consent (EFIC) for research conducted in an emergency setting. Acute care clinical trials using EFIC must include community consultation and public disclosure (CC/PD) activities. We describe our experience using social media to facilitate the CC/PD process in two trauma resuscitation clinical trials. METHODS We conducted local CC/PD activities for two multicenter trauma clinical trials, Pragmatic, Randomized Optimal Platelet and Plasma Ratios (PROPPR) and Prehospital Tranexamic Acid Use for Traumatic Brain Injury (ROC-TXA). As part of the CC/PD process, we developed research study advertisements using the social media Web site Facebook. The Facebook advertisements directed users to a regional study Web site that contained trial information. We targeted the advertisements to specific demographic users, in specific geographic areas. We analyzed the data using descriptive statistics. RESULTS During the study periods, the PROPPR Facebook advertisement was displayed 5,001,520 times (12 displays per target population) with 374 individuals selecting the advertisement. The ROC-TXA Facebook advertisement was displayed 3,806,448 times (8 per target population) with 790 individuals selecting the advertisement. Respondents to both Facebook advertisements were mostly male (52.6%), with the highest proportion between the ages 15 years and 24 years (28.2%). Collectively, 26.9% of individuals that clicked on the Facebook advertisement spent more than 3 minutes on the study Web site (3-49 minutes). Commonly accessed Web pages were contact us (PROPPR, 5.5%; ROC-TXA, 7.7%), study-specific FAQs (PROPPR, 2.4%; ROC-TXA, 6.7%), and opt out of research (PROPPR, 2.5%; ROC-TXA, 3.8%). Of 51 total individuals viewing the opt out of research information (PROPPR, 19; ROC-TXA, 32), time spent on that specific page was modest (PROPPR, 62 seconds; ROC-TXA, 55 seconds), with no individuals requesting to opt out of either study participation. CONCLUSIONS In clinical trauma trials using EFIC, social media may provide a viable option for facilitating the CC/PD process.	[Stephens, Shannon W.; Williams, Carolyn; Gray, Randal; Wang, Henry E.] Univ Alabama Birmingham, Sch Med, Dept Emergency Med, Birmingham, AL USA; [Kerby, Jeffrey D.; Bosarge, Patrick L.] Univ Alabama Birmingham, Sch Med, Dept Surg, Div Trauma Burns & Surg Crit Care, Birmingham, AL 35294 USA		Stephens, SW (corresponding author), Univ Alabama Birmingham, Dept Emergency Med, OHB 251,619 19th St South, Birmingham, AL 35294 USA.	swstephens@uabmc.edu		Stephens, Shannon/0000-0001-5898-5170	National Heart, Lung, and Blood InstituteUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [5U01HL077863]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory HealthCanadian Institutes of Health Research (CIHR); Defense Research and Development Canada; Heart and Stroke Foundation of CanadaHeart & Stroke Foundation of Canada; NATIONAL HEART, LUNG, AND BLOOD INSTITUTEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Heart Lung & Blood Institute (NHLBI) [U01HL077881, U01HL077863] Funding Source: NIH RePORTER	This work was supported by a cooperative agreement (5U01HL077863) with the National Heart, Lung, and Blood Institute in partnership with the National Institute of Neurological Disorders and Stroke, The Canadian Institutes of Health Research (CIHR)-Institute of Circulatory and Respiratory Health, Defense Research and Development Canada, and the Heart and Stroke Foundation of Canada.	Bolanos F, 2012, SUBST ABUS-RES TREAT, V6, P1, DOI 10.4137/SART.S8485; Callaway CW, 2014, CRIT CARE MED, V42, P451, DOI 10.1097/CCM.0b013e3182a51f37; Chin TL, 2015, SURGERY, V157, P10, DOI 10.1016/j.surg.2014.05.021; Dickert NW, 2014, PREHOSP EMERG CARE, V18, P274, DOI 10.3109/10903127.2013.856503; Farina-Henry E, 2015, JMIR RES PROTOC, V4, DOI 10.2196/resprot.4260; Fenner Y, 2012, J MED INTERNET RES, V14, DOI 10.2196/jmir.1978; Goldstein JN, 2015, ACAD EMERG MED, V22, P365, DOI 10.1111/acem.12618; Holcomb JB, 2015, JAMA-J AM MED ASSOC, V313, P471, DOI 10.1001/jama.2015.12; Holsti M, 2015, CLIN TRIALS, V12, P67, DOI 10.1177/1740774514555586; Kosinski M, 2015, AM PSYCHOL, V70, P543, DOI 10.1037/a0039210; Minei JP, 2010, ANN SURG, V252, P149, DOI 10.1097/SLA.0b013e3181df0401; Mosesso VN, 2004, RESUSCITATION, V61, P29, DOI 10.1016/j.resuscitation.2003.11.016; Nelson M, 2008, PREHOSP EMERG CARE, V12, P417, DOI 10.1080/10903120802290885; Rhee P, 2014, ANN SURG, V260, P13, DOI 10.1097/SLA.0000000000000600; Stephens SW, 2013, CIRCULATION, V128, P267, DOI 10.1161/CIRCULATIONAHA.113.002390; US Centers for Disease Control and Prevention, 2012, INJ PREV CONTR DAT S; Wada K, 2015, J MED ETHICS, V41, P804, DOI 10.1136/medethics-2014-102231	17	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	2163-0755	2163-0763		J TRAUMA ACUTE CARE	J. Trauma Acute Care Surg.	JUN	2016	80	6					1005	1009		10.1097/TA.0000000000001042			5	Critical Care Medicine; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Surgery	DO5MX	WOS:000377828300030	26998781	Green Accepted			2022-02-06	
J	Wright, MJ; Woo, E; Birath, JB; Siders, CA; Kelly, DF; Wang, C; Swerdloff, R; Romero, E; Kernan, C; Cantu, RC; Guskiewicz, K				Wright, Mathew J.; Woo, Ellen; Birath, J. Brandon; Siders, Craig A.; Kelly, Daniel F.; Wang, Christina; Swerdloff, Ronald; Romero, Elizabeth; Kernan, Claudia; Cantu, Robert C.; Guskiewicz, Kevin			An index predictive of cognitive outcome in retired professional American Football players with a history of sports concussion	JOURNAL OF CLINICAL AND EXPERIMENTAL NEUROPSYCHOLOGY			English	Article						Traumatic brain injury; Cognitive reserve; Cerebral concussion; Sports; Cognition	TRAUMATIC BRAIN-INJURY; RECURRENT CONCUSSION; METABOLIC SYNDROME; NCAA CONCUSSION; LEAGUE PLAYERS; BODY-MASS; DEPRESSION; VALIDITY; RESERVE; IMPACT	Objective: Various concussion characteristics and personal factors are associated with cognitive recovery in athletes. We developed an index based on concussion frequency, severity, and timeframe, as well as cognitive reserve (CR), and we assessed its predictive power regarding cognitive ability in retired professional football players. Method: Data from 40 retired professional American football players were used in the current study. On average, participants had been retired from football for 20 years. Current neuropsychological performances, indicators of CR, concussion history, and play data were used to create an index for predicting cognitive outcome. Results: The sample displayed a range of concussions, concussion severities, seasons played, CR, and cognitive ability. Many of the participants demonstrated cognitive deficits. The index strongly predicted global cognitive ability (R-2 = .31). The index also predicted the number of areas of neuropsychological deficit, which varied as a function of the deficit classification system used (Heaton: R-2 = .15; Wechsler: R-2 = .28). Conclusions: The current study demonstrated that a unique combination of CR, sports concussion, and game-related data can predict cognitive outcomes in participants who had been retired from professional American football for an average of 20 years. Such indices may prove to be useful for clinical decision making and research.	[Wright, Mathew J.; Birath, J. Brandon; Siders, Craig A.; Wang, Christina; Swerdloff, Ronald; Romero, Elizabeth] Harbor UCLA Med Ctr, Los Angeles Biomed Res Inst, Torrance, CA 90509 USA; [Wright, Mathew J.; Kernan, Claudia] Univ Calif Los Angeles, Sch Med, Dept Psychiat & Behav Sci, Los Angeles, CA 90024 USA; [Wright, Mathew J.; Birath, J. Brandon; Siders, Craig A.] Harbor UCLA Med Ctr, Dept Psychiat, Div Psychol, Torrance, CA 90509 USA; [Woo, Ellen] Univ Calif Los Angeles, Sch Med, Dept Neurol, Easton Ctr Alzheimers Dis Res, Los Angeles, CA USA; [Kelly, Daniel F.] St Johns Hlth Ctr, Brain Tumor Ctr, Santa Monica, CA USA; [Kelly, Daniel F.] St Johns Hlth Ctr, John Wayne Canc Inst, Pituitary Disorders Program, Santa Monica, CA USA; [Wang, Christina; Swerdloff, Ronald] Harbor UCLA Med Ctr, Dept Med, Div Endocrinol, Torrance, CA 90509 USA; [Cantu, Robert C.] Boston Univ, Sch Med, Boston, MA 02215 USA; [Guskiewicz, Kevin] Univ N Carolina, Ctr Study Retired Athletes, Chapel Hill, NC USA		Wright, MJ (corresponding author), Harbor UCLA Med Ctr, 1124 W Carson St B-4 South,Box 490, Torrance, CA 90502 USA.	mwright@labiomed.org			National Operating Committee on Standards for Athletic Equipment; National Center for Research Resources, USAUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01 RR 19975]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [M01RR019975] Funding Source: NIH RePORTER	This research was supported by National Operating Committee on Standards for Athletic Equipment and the National Center for Research Resources, USA [grant number M01 RR 19975].	Army Individual Test Battery, 1944, MAN DIR SCOR; Babikian T, 2006, CLIN NEUROPSYCHOL, V20, P145, DOI 10.1080/13854040590947362; Backhaus SL, 2004, CLIN NEUROPSYCHOL, V18, P591, DOI 10.1080/13854040490888558; Baron SL, 2012, AM J CARDIOL, V109, P889, DOI 10.1016/j.amjcard.2011.10.050; Bigler Erin D, 2015, Handb Clin Neurol, V128, P691, DOI 10.1016/B978-0-444-63521-1.00043-1; BRAZIER JE, 1992, BMJ-BRIT MED J, V305, P160, DOI 10.1136/bmj.305.6846.160; Brooks BL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P893, DOI 10.1007/978-0-387-76978-3_31; Chen JK, 2008, ARCH GEN PSYCHIAT, V65, P81, DOI 10.1001/archgenpsychiatry.2007.8; Collie A., 2006, SPORTS NEUROPSYCHOLO, P240; Collins MW, 2003, CLIN J SPORT MED, V13, P222, DOI 10.1097/00042752-200307000-00005; Corrigan JD, 2007, J HEAD TRAUMA REHAB, V22, P318, DOI 10.1097/01.HTR.0000300227.67748.77; CORWIN J, 1993, CLIN NEUROPSYCHOL, V7, P3, DOI 10.1080/13854049308401883; DALY J J, 1958, Calif Med, V88, P441; De Beaumont L., 2013, BMC NEUROLOGY, V13; De Beaumont L, 2013, J CLIN EXP NEUROPSYC, V35, P596, DOI 10.1080/13803395.2013.800023; De Beaumont L, 2009, BRAIN, V132, P695, DOI 10.1093/brain/awn347; Delis D.C., 2000, CALIFORNIA VERBAL LE; Dougan BK, 2014, J INT NEUROPSYCH SOC, V20, P64, DOI 10.1017/S1355617712001464; Gilchrist J, 2011, JAMA-J AM MED ASSOC, V306, P2318; Giza CC, 2001, J ATHL TRAINING, V36, P228; GROBER E, 1991, J CLIN EXP NEUROPSYC, V13, P933, DOI 10.1080/01688639108405109; GRONWALL D, 1975, LANCET, V2, P995; Guskiewicz KM, 2007, MED SCI SPORT EXER, V39, P903, DOI 10.1249/mss.0b013e3180383da5; Guskiewicz KM, 2005, NEUROSURGERY, V57, P719, DOI 10.1227/01.NEU.0000175725.75780.DD; Guskiewicz KM, 2003, JAMA-J AM MED ASSOC, V290, P2549, DOI 10.1001/jama.290.19.2549; Horn S, 2009, AM J PHYS MED REHAB, V88, P192, DOI 10.1097/PHM.0b013e318198b622; HUGENHOLTZ H, 1982, CAN MED ASSOC J, V127, P827; Iverson GL, 2011, LITTLE BLACK BOOK OF NEUROPSYCHOLOGY: A SYNDROME-BASED APPROACH, P923, DOI 10.1007/978-0-387-76978-3_32; Kelly DF, 2014, J NEUROTRAUM, V31, P1161, DOI 10.1089/neu.2013.3212; Kerr ZY, 2012, MED SCI SPORT EXER, V44, P377, DOI 10.1249/MSS.0b013e31823240f2; Langlois JA, 2006, J HEAD TRAUMA REHAB, V21, P375, DOI 10.1097/00001199-200609000-00001; Laurer HL, 2001, J NEUROSURG, V95, P859, DOI 10.3171/jns.2001.95.5.0859; Levi Y, 2013, J INT NEUROPSYCH SOC, V19, P664, DOI 10.1017/S1355617713000192; LYNCH S, 1973, AM J PSYCHOL, V86, P643, DOI 10.2307/1421950; Macciocchi S, 2006, SPORTS NEUROPSYCHOLO, P71; McCrea M, 2004, CLIN J SPORT MED, V14, P13, DOI 10.1097/00042752-200401000-00003; McCrea M, 2003, JAMA-J AM MED ASSOC, V290, P2556, DOI 10.1001/jama.290.19.2556; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McMillan TM, 1996, J NEUROL NEUROSUR PS, V60, P422, DOI 10.1136/jnnp.60.4.422; Miller MA, 2008, AM J CARDIOL, V101, P1281, DOI 10.1016/j.amjcard.2007.12.029; Mitrushina M., 2005, HDB NORMATIVE DATA N, V2nd; Prichep LS, 2013, J HEAD TRAUMA REHAB, V28, P266, DOI 10.1097/HTR.0b013e318247b54e; Rassovsky Y, 2015, J CLIN EXP NEUROPSYC, V37, P354, DOI 10.1080/13803395.2015.1015498; Rosen RC, 1997, UROLOGY, V49, P822, DOI 10.1016/S0090-4295(97)00238-0; Satz P, 2011, J CLIN EXP NEUROPSYC, V33, P121, DOI 10.1080/13803395.2010.493151; Scott JG, 1997, CLIN NEUROPSYCHOL, V11, P146, DOI 10.1080/13854049708407043; Smith A., 1991, SYMBOL DIGIT MODALIT; Spiers MV., 2001, PRINCIPLES NEUROPSYC; Spreen O., 1977, NEUROSENSORY CTR COM, VRev; Stern Y, 2000, NEUROLOGY, V55, P1291, DOI 10.1212/WNL.55.9.1291; Stern Y, 2002, J INT NEUROPSYCH SOC, V8, P448, DOI 10.1017/S1355617702813248; Victor T, 2009, CLIN NEUROPSYCHOL, V23, P297, DOI 10.1080/13854040802232682; Willeumier K, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2011.67; ZIGMOND AS, 1983, ACTA PSYCHIAT SCAND, V67, P361, DOI 10.1111/j.1600-0447.1983.tb09716.x	54	15	15	1	46	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	1380-3395	1744-411X		J CLIN EXP NEUROPSYC	J. Clin. Exp. Neuropsychol.	MAY 27	2016	38	5					561	571		10.1080/13803395.2016.1139057			11	Psychology, Clinical; Clinical Neurology; Psychology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Neurosciences & Neurology	DG4HN	WOS:000372033100007	26898803				2022-02-06	
J	Lopez-Rodriguez, AB; Mela, V; Acaz-Fonseca, E; Garcia-Segura, LM; Viveros, MP				Belen Lopez-Rodriguez, Ana; Mela, Virginia; Acaz-Fonseca, Estefania; Miguel Garcia-Segura, Luis; Viveros, Maria-Paz			CB2 cannabinoid receptor is involved in the anti-inflammatory effects of leptin in a model of traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Traumatic brain injury; CB2 cannabinoid receptor antagonist; Leptin; Neuroinflammation; Mice	CLOSED-HEAD INJURY; ENDOCANNABINOID SYSTEM; SICKNESS BEHAVIOR; IMMUNE-RESPONSE; GENE-EXPRESSION; D-AMPHETAMINE; CELL-DEATH; ACTIVATION; MICE; CYTOKINE	Background and purpose: The rates for traumatic brain injury (TBI) have risen in the last decade. Studies in animal models and clinical trials have not yet resulted in an effective treatment for TBI. Leptin, a 16 kDa peptidic hormone is mainly known as a regulator of energy balance and has been shown to exert neuroprotective effects in different models of brain pathology. In this study, we have assessed whether leptin exerts protective actions in a TBI mouse model. In addition, the possible implication of CB2 cannabinoid receptor in leptin actions has been explored, since it is known that the endocannabinoid system interacts with leptin and actively participates in brain recovery after lesions. Methods: Swiss (CD1) male mice were subjected to weigh-drop model for TBI. Prior to the lesion, mice were injected with an antagonist of CB2 receptor (AM630) or the vehicle and immediately after TBI, they received leptin or vehicle treatment. Data were analyzed using a two-way ANOVA or the non-parametric test Kruskal-Wallis when appropriate. For correlation analyses, Spearman's rho test, followed by linear regression test, was used. Results: TBI induced a neurological deficit, which was improved by leptin treatment. Leptin recovered several parameters affected by TBI, including the expression of cannabinoid receptors, axonal injury marker and neuroinflammatory components. The effects of leptin were prevented or reduced when it was administered in combination with the CB2 receptor antagonist, AM630. Conclusions and implications: Since some of the beneficial effects of leptin were not evident in the presence of AM630, our results suggest that CB2 receptor might be involved in the full expression of the neuroprotective effects of the hormone. These findings open new avenues for the study of leptin as a therapeutic treatment for TBI and enhance the importance of CB2 receptor in TBI pathophysiology and recovery. (C) 2016 Published by Elsevier Inc.	[Belen Lopez-Rodriguez, Ana; Mela, Virginia; Viveros, Maria-Paz] Univ Complutense, Fac Biol, Dept Fisiol, Fisiol Anim 2, E-28040 Madrid, Spain; [Belen Lopez-Rodriguez, Ana; Acaz-Fonseca, Estefania; Miguel Garcia-Segura, Luis] CSIC, Inst Cajal, E-28002 Madrid, Spain		Lopez-Rodriguez, AB (corresponding author), CSIC, Inst Cajal, E-28002 Madrid, Spain.	lranabelen@gmail.com	Acaz-Fonseca, Estefania/S-5884-2016; Mela, Virginia/N-4664-2017; Garcia-Segura, Luis M/U-3711-2017; Lopez-Rodriguez, Ana Belen/H-3631-2017; Viveros, Maria-Paz/S-6855-2016	Acaz-Fonseca, Estefania/0000-0003-2549-6420; Mela, Virginia/0000-0001-7702-0972; Garcia-Segura, Luis M/0000-0002-2450-2916; Lopez-Rodriguez, Ana Belen/0000-0002-0747-7966; Viveros, Maria-Paz/0000-0002-4119-4636	Ministerio de Economia y Competitividad, Spain [BFU2011-30217-C03-01, BFU2012-38144]; Redes tematicas de Investigacion Cooperativa en Salud; Red de Trastornos AdictivosInstituto de Salud Carlos III [RD2012/0028/0021-FEDER]; GRUPO UCM [951579]; Precipita-FECYT Crowd funding program	We acknowledge financial support from the Ministerio de Economia y Competitividad, Spain (BFU2011-30217-C03-01 and BFU2012-38144), Redes tematicas de Investigacion Cooperativa en Salud, Red de Trastornos Adictivos (RD2012/0028/0021-FEDER), GRUPO UCM (951579) and Precipita-FECYT Crowd funding program.	Adriani W, 2003, BEHAV NEUROSCI, V117, P695, DOI 10.1037/0735-7044.117.4.695; Adriani W, 1998, BEHAV NEUROSCI, V112, P1152, DOI 10.1037/0735-7044.112.5.1152; Agrawal S, 2011, J CLIN IMMUNOL, V31, P89, DOI [10.1007/s10875-010-9456-8, 10.1007/s10875-010-9507-1]; Aguilar-Valles A, 2015, NEUROPHARMACOLOGY, V96, P124, DOI 10.1016/j.neuropharm.2014.12.023; Arain M, 2015, ANN CLIN TRANSL NEUR, V2, P289, DOI 10.1002/acn3.163; Avraham Y, 2010, CURR NEUROVASC RES, V7, P136, DOI 10.2174/156720210791184943; Baumann H, 1996, P NATL ACAD SCI USA, V93, P8374, DOI 10.1073/pnas.93.16.8374; Lopez-Rodriguez AB, 2015, PSYCHONEUROENDOCRINO, V56, P1, DOI 10.1016/j.psyneuen.2015.02.018; Bosier B, 2013, MOL METAB, V2, P393, DOI 10.1016/j.molmet.2013.08.001; Bruno A, 2005, J IMMUNOL, V174, P8090, DOI 10.4049/jimmunol.174.12.8090; Bruns TJ, 2003, EPILEPSIA, V44, P2, DOI 10.1046/j.1528-1157.44.s10.3.x; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen X, 2014, NEUROSCIENCE, V266, P235, DOI 10.1016/j.neuroscience.2013.11.036; Chodobski A, 2011, TRANSL STROKE RES, V2, P492, DOI 10.1007/s12975-011-0125-x; Coll AP, 2007, CELL, V129, P251, DOI 10.1016/j.cell.2007.04.001; Cook JL, 1998, MOL BRAIN RES, V55, P9, DOI 10.1016/S0169-328X(97)00350-1; Correa F, 2005, BRIT J PHARMACOL, V145, P441, DOI 10.1038/sj.bjp.0706215; Dantzer R, 2009, IMMUNOL ALLERGY CLIN, V29, P247, DOI 10.1016/j.iac.2009.02.002; Deveaux V, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0005844; Di Marzo V, 2001, NATURE, V410, P822, DOI 10.1038/35071088; Dicou E, 2001, NEUROREPORT, V12, P3947, DOI 10.1097/00001756-200112210-00019; Doyle KP, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-62; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Friedman JM, 1998, NATURE, V395, P763, DOI 10.1038/27376; Garcia-Caceres C, 2011, ENDOCRINOLOGY, V152, P1809, DOI 10.1210/en.2010-1252; Gertsch J, 2004, FEBS LETT, V577, P563, DOI 10.1016/j.febslet.2004.10.064; Guo M, 2014, TRANSL PSYCHIAT, V4, DOI 10.1038/tp.2014.126; Guo M, 2012, TRANSL PSYCHIAT, V2, DOI 10.1038/tp.2012.9; Han KH, 2009, CARDIOVASC RES, V84, P378, DOI 10.1093/cvr/cvp240; Hanisch UK, 2007, NAT NEUROSCI, V10, P1387, DOI 10.1038/nn1997; Harvey J, 2007, J NEUROCHEM, V100, P307, DOI 10.1111/j.1471-4159.2006.04205.x; Homsi S, 2010, J NEUROTRAUM, V27, P911, DOI 10.1089/neu.2009.1223; Homsi S, 2009, BRAIN RES, V1291, P122, DOI 10.1016/j.brainres.2009.07.031; Hortobagyi T, 2007, NEUROPATH APPL NEURO, V33, P226, DOI 10.1111/j.1365-2990.2006.00794.x; Howlett AC, 2002, PHARMACOL REV, V54, P161, DOI 10.1124/pr.54.2.161; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; KENT S, 1992, TRENDS PHARMACOL SCI, V13, P24, DOI 10.1016/0165-6147(92)90012-U; Knoblach SM, 1998, EXP NEUROL, V153, P143, DOI 10.1006/exnr.1998.6877; Lafrenaye AD, 2015, J NEUROINFLAMM, V12, DOI 10.1186/s12974-015-0405-6; Lee HF, 2012, RESP PHYSIOL NEUROBI, V182, P1, DOI 10.1016/j.resp.2012.01.016; Li Z, 2013, J ORTHOP RES, V31, P847, DOI 10.1002/jor.22308; Liu J, 2010, PSYCHOPHARMACOLOGY, V207, P535, DOI 10.1007/s00213-009-1684-3; Loane DJ, 2009, NAT MED, V15, P377, DOI 10.1038/nm.1940; Loffreda S, 1998, FASEB J, V12, P57, DOI 10.1096/fasebj.12.1.57; De Jesus ML, 2010, NEUROCHEM INT, V56, P829, DOI 10.1016/j.neuint.2010.03.007; Rodriguez ABL, 2011, CEREB CORTEX, V21, P2046, DOI 10.1093/cercor/bhq277; Lopez-Rodriguez AB, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0128782; Lopez-Rodriguez AB, 2015, CEREB CORTEX, V25, P35, DOI 10.1093/cercor/bht202; Lu JN, 2006, NEUROSCI LETT, V407, P240, DOI 10.1016/j.neulet.2006.08.053; Malan TP, 2001, PAIN, V93, P239, DOI 10.1016/S0304-3959(01)00321-9; Fernandez-Martos CM, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035594; Marwarha G, 2014, BBA-MOL BASIS DIS, V1842, P1587, DOI 10.1016/j.bbadis.2014.05.015; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; MATSUDA LA, 1990, NATURE, V346, P561, DOI 10.1038/346561a0; Mattson MP, 2004, NATURE, V430, P631, DOI 10.1038/nature02621; Naderi V, 2015, IRAN J BASIC MED SCI, V18, P138; Pacher P, 2006, PHARMACOL REV, V58, P389, DOI 10.1124/pr.58.3.2; Palomba L, 2015, J BIOL CHEM, V290, P13669, DOI 10.1074/jbc.M115.646885; Pekny M, 2007, INT REV NEUROBIOL, V82, P95, DOI 10.1016/S0074-7742(07)82005-8; Pinteaux E, 2007, J NEUROCHEM, V102, P826, DOI 10.1111/j.1471-4159.2007.04559.x; Rajesh M, 2007, AM J PHYSIOL-HEART C, V293, pH2210, DOI 10.1152/ajpheart.00688.2007; Rochat L, 2010, NEUROPSYCHOL REHABIL, V20, P778, DOI 10.1080/09602011.2010.495245; Schaible EV, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0071056; Shenaq M, 2012, J NEUROL SCI, V323, P134, DOI 10.1016/j.jns.2012.08.036; Shin SS, 2014, J NEUROSURG, V121, P1219, DOI 10.3171/2014.7.JNS131826; Shohami E, 2011, BRIT J PHARMACOL, V163, P1402, DOI 10.1111/j.1476-5381.2011.01343.x; Siegl D, 2014, ANESTHESIOLOGY, V121, P98, DOI 10.1097/ALN.0000000000000192; Signore AP, 2008, J NEUROCHEM, V106, P1977, DOI 10.1111/j.1471-4159.2008.05457.x; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Smith DH, 1998, AM J PATHOL, V153, P1005, DOI 10.1016/S0002-9440(10)65643-X; Sonia Villapol T. T. L, 2013, TRENDS CELL SIGNALIN; Spear LP, 2000, NEUROSCI BIOBEHAV R, V24, P417, DOI 10.1016/S0149-7634(00)00014-2; Stahel PF, 2000, J CEREBR BLOOD F MET, V20, P369, DOI 10.1097/00004647-200002000-00019; Stella N, 2010, GLIA, V58, P1017, DOI 10.1002/glia.20983; Suarez J, 2009, HIPPOCAMPUS, V19, P623, DOI 10.1002/hipo.20537; Tang BL, 2008, BIOCHEM BIOPH RES CO, V368, P181, DOI 10.1016/j.bbrc.2008.01.063; Tang H., 2015, BRAIN INJURY, P1; Tschop J, 2010, J NEUROSCI, V30, P6036, DOI 10.1523/JNEUROSCI.4875-09.2010; Tsou K, 1998, NEUROSCIENCE, V83, P393, DOI 10.1016/S0306-4522(97)00436-3; Tuttolomondo A, 2014, DRUG DES DEV THER, V8, P2221, DOI 10.2147/DDDT.S67655; Viveros MP, 2012, J PSYCHOPHARMACOL, V26, P164, DOI 10.1177/0269881111408956; Wee HY, 2015, J SURG RES, V197, P382, DOI 10.1016/j.jss.2015.04.052; Whiteside GT, 2005, EUR J PHARMACOL, V528, P65, DOI 10.1016/j.ejphar.2005.10.043; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Xiao EN, 2003, ENDOCRINOLOGY, V144, P4350, DOI 10.1210/en.2003-0532; Yu FS, 2012, J NEUROTRAUM, V29, P2342, DOI 10.1089/neu.2012.2449; Zhang JY, 2013, J CEREBR BLOOD F MET, V33, P567, DOI 10.1038/jcbfm.2012.202	87	15	17	1	15	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2016	279						274	282		10.1016/j.expneurol.2016.03.018			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK0OU	WOS:000374612900024	27006282				2022-02-06	
J	Calhoun, PS; Schry, AR; Wagner, HR; Kimbrel, NA; Dennis, P; McDonald, SD; Beckham, JC; Dedert, EA; Kudler, H; Straits-Troster, K				Calhoun, Patrick S.; Schry, Amie R.; Wagner, H. Ryan; Kimbrel, Nathan A.; Dennis, Paul; McDonald, Scott D.; Beckham, Jean C.; Dedert, Eric A.; Kudler, Harold; Straits-Troster, Kristy			The prevalence of binge drinking and receipt of provider drinking advice among US veterans with military service in Iraq or Afghanistan	AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE			English	Article						Afghanistan; binge drinking; Iraq; provider advice; PTSD; veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; MENTAL-HEALTH PROBLEMS; PRIMARY-CARE; ALCOHOL-USE; COMBAT DEPLOYMENT; OEF/OIF VETERANS; PHYSICAL HEALTH; COLLEGE ALCOHOL; NATIONAL-SURVEY	Background: Binge drinking is a significant public health concern linked to a number of health and psychosocial problems. Military service in Afghanistan (OEF) and Iraq (OIF) has been associated with posttraumatic stress disorder (PTSD) and increased hazardous drinking. Brief alcohol interventions may reduce hazardous drinking but are infrequently provided to at-risk drinkers. Objectives: This study examined the association of combat exposure, PTSD symptoms, binge drinking, use of VA and non-VA healthcare services, and the incidence of provider drinking advice. Methods: OEF/OIF veterans (n=1087) completed measures of demographics, military history, combat exposure, PTSD symptoms, and binge drinking as part of a confidential mail survey study conducted in 2009 and 2010 (response rate=29%). Patient report of receiving advice in the past year from a provider about their drinking was queried for frequent binge drinkers. The association of demographic variables, combat exposure, PTSD, and use of healthcare services with binge drinking and receipt of provider drinking advice was estimated using logistic regression. Results: Overall, 51% of the sample reported at least one episode of binge drinking in the past year and 19% were identified as frequent binge drinkers. PTSD was related to frequent binge drinking. At-risk veterans using VA healthcare services were significantly more likely to receive provider drinking advice (50%) than veterans not using VA (13.4%). Conclusions: There is a need for increased vigilance and action to identify and counsel at-risk veterans about alcohol misuse in this population.	[Calhoun, Patrick S.; Schry, Amie R.; Wagner, H. Ryan; Kimbrel, Nathan A.; McDonald, Scott D.; Beckham, Jean C.; Dedert, Eric A.; Kudler, Harold; Straits-Troster, Kristy] VA Midatlantic Mental Illness Res Educ & Clin Ctr, Durham, NC USA; [Calhoun, Patrick S.; Schry, Amie R.; Wagner, H. Ryan; Kimbrel, Nathan A.; Dennis, Paul; Beckham, Jean C.; Dedert, Eric A.; Kudler, Harold] Durham VA Med Ctr, Durham, NC USA; [Calhoun, Patrick S.; Schry, Amie R.; Wagner, H. Ryan; Kimbrel, Nathan A.; Dennis, Paul; Beckham, Jean C.; Dedert, Eric A.; Kudler, Harold; Straits-Troster, Kristy] Duke Univ, Med Ctr, Dept Psychiat & Behav Sci, Durham, NC USA; [Calhoun, Patrick S.; Dennis, Paul] Ctr Hlth Serv Res Primary Care, Durham, NC USA; [McDonald, Scott D.] Hunter Holmes McGuire VA Med Ctr, Richmond, VA USA; [McDonald, Scott D.] Virginia Commonwealth Univ, Dept Psychol & Phys Med & Rehabil, Richmond, VA USA; [Straits-Troster, Kristy] Phoenix VA Healthcare Syst, Phoenix, AZ USA		Calhoun, PS (corresponding author), Mental Illness Res Educ & Clin Ctr, Bldg 16 DVAMC,508 Fulton St, Durham, NC 27705 USA.	Patrick.Calhoun2@med.va.gov	Kimbrel, Nathan/P-3109-2016	Kimbrel, Nathan/0000-0001-7218-1005	VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center; Clinical Science Research and Development Service of the VA Office of Research and Development [IK2 CX000525, 1IK2CX000718]; VA Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment; Durham VA Medical CenterUS Department of Veterans Affairs; Department of Veterans Affairs, Rehabilitation Research and Development Career Development Award-2 [1IK2RX000703-01]; Veterans AffairsUS Department of Veterans Affairs [IK2CX000718, IK2CX000525, IK6BX003777] Funding Source: NIH RePORTER	This work was supported by the VA Mid-Atlantic Mental Illness Research, Education, and Clinical Center. This work was also supported by a Career Development Award-2 to Dr. Kimbrel (IK2 CX000525) and Dr. Dedert (1IK2CX000718) and a Research Career Scientist Award to Dr. Beckham from the Clinical Science Research and Development Service of the VA Office of Research and Development. Dr. Schry's contributions were also supported by the VA Office of Academic Affiliations Advanced Fellowship Program in Mental Illness Research and Treatment and the Durham VA Medical Center. Work on this article was also supported by a Department of Veterans Affairs, Rehabilitation Research and Development Career Development Award-2 to Dr. McDonald (1IK2RX000703-01).	Adams RS, 2012, J HEAD TRAUMA REHAB, V27, P349, DOI 10.1097/HTR.0b013e318268db94; Blanchard EB, 1996, BEHAV RES THER, V34, P669, DOI 10.1016/0005-7967(96)00033-2; Bouchery EE, 2011, AM J PREV MED, V41, P516, DOI 10.1016/j.amepre.2011.06.045; Bradley KA, 2002, J GEN INTERN MED, V17, P315; Bradley KA, 2006, AM J MANAG CARE, V12, P597; Bradley KA, 2011, J GEN INTERN MED, V26, P299, DOI 10.1007/s11606-010-1509-4; Bradley Katharine A, 2007, Subst Abus, V28, P133, DOI 10.1300/J465v28n04_05; Bray RM, 2007, ADDICTION, V102, P1092, DOI 10.1111/j.1360-0443.2007.01841.x; Burnett-Zeigler I, 2011, ADDICT BEHAV, V36, P801, DOI 10.1016/j.addbeh.2010.12.032; Bush K, 1998, ARCH INTERN MED, V158, P1789, DOI 10.1001/archinte.158.16.1789; Calhoun PS, 2008, J CLIN PSYCHIAT, V69, P1686, DOI 10.4088/JCP.v69n1103; Corrigan JD, 2010, J TRAUMA, V69, P722, DOI 10.1097/TA.0b013e3181e904cc; Crawford EF, 2013, DRUG ALCOHOL DEPEN, V132, P101, DOI 10.1016/j.drugalcdep.2013.01.012; D'Amico EJ, 2005, MED CARE, V43, P229, DOI 10.1097/00005650-200503000-00005; Dillman DA., 2000, MAIL INTERNET SURVEY; Eisen SV, 2012, AM J PUBLIC HEALTH, V102, pS66, DOI 10.2105/AJPH.2011.300609; Erbes C, 2007, MIL MED, V172, P359, DOI 10.7205/MILMED.172.4.359; Fleming MF, 1997, ALCOHOL HEALTH RES W, V21, P340; Garnick DW, 2002, AM J MANAG CARE, V8, P879; Grossbard JR, 2013, J SUBST ABUSE TREAT, V45, P409, DOI 10.1016/j.jsat.2013.04.007; Hawkins EJ, 2010, DRUG ALCOHOL DEPEN, V109, P147, DOI 10.1016/j.drugalcdep.2009.12.025; Heltemes KJ, 2011, MIL MED, V176, P132, DOI 10.7205/MILMED-D-09-00238; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Hoge CW, 2004, NEW ENGL J MED, V351, P13, DOI 10.1056/NEJMoa040603; Hooper R, 2008, ADDICT BEHAV, V33, P1067, DOI 10.1016/j.addbeh.2008.03.010; Iverson KM, 2013, J WOMENS HEALTH, V22, P267, DOI 10.1089/jwh.2012.3755; Jacobson IG, 2008, JAMA-J AM MED ASSOC, V300, P663, DOI 10.1001/jama.300.6.663; Jakupcak M, 2010, ADDICT BEHAV, V35, P840, DOI 10.1016/j.addbeh.2010.03.023; Jonas DE, 2012, ANN INTERN MED, V157, P645, DOI 10.7326/0003-4819-157-9-201211060-00544; Kanny Dafna, 2012, Morbidity and Mortality Weekly Report, V61, P14; Keller S, 2007, ADDICT BEHAV, V32, P505, DOI 10.1016/j.addbeh.2006.05.017; Kroenke K, 2003, MED CARE, V41, P1284, DOI 10.1097/01.MLR.0000093487.78664.3C; Lapham GT, 2012, MED CARE, V50, P179, DOI 10.1097/MLR.0b013e3181e35743; LIN IF, 1995, PUBLIC OPIN QUART, V59, P236, DOI 10.1086/269471; Lowe B, 2005, J PSYCHOSOM RES, V58, P163, DOI 10.1016/j.jpsychores.2004.09.006; Maddock JE, 2001, ADDICT BEHAV, V26, P385, DOI 10.1016/S0306-4603(00)00116-7; McDevitt-Murphy ME, 2010, J TRAUMA STRESS, V23, P108, DOI 10.1002/jts.20482; McDonald SD, 2010, CLIN PSYCHOL REV, V30, P976, DOI 10.1016/j.cpr.2010.06.012; Milliken CS, 2007, JAMA-J AM MED ASSOC, V298, P2141, DOI 10.1001/jama.298.18.2141; Mukamal KJ, 2005, CIRCULATION, V112, P3839, DOI 10.1161/CIRCULATIONAHA.105.574749; Murray RP, 2002, AM J EPIDEMIOL, V155, P242, DOI 10.1093/aje/155.3.242; National Institute on Alcohol Abuse and Alcoholism National Institute of Health US Government, DRINK LEV DEF; Pietrzak RH, 2010, J AFFECT DISORDERS, V120, P188, DOI 10.1016/j.jad.2009.04.015; Rose HL, 2008, ADDICTION, V103, P1271, DOI 10.1111/j.1360-0443.2008.02199.x; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Schwab KA, 2006, NEUROLOGY, V66, pA235; Seal KH, 2007, ARCH INTERN MED, V167, P476, DOI 10.1001/archinte.167.5.476; Vogt D, 2011, J ABNORM PSYCHOL, V120, P797, DOI 10.1037/a0023452; Voogt R.J.J., 1998, ACTA POLIT, V33, P250; Weathers F., 1993, INT SOC TRAUM STRESS; WECHSLER H, 1994, JAMA-J AM MED ASSOC, V272, P1672, DOI 10.1001/jama.272.21.1672; Wechsler H, 2002, J AM COLL HEALTH, V50, P203, DOI 10.1080/07448480209595713; Whitlock EP, 2004, ANN INTERN MED, V140, P557, DOI 10.7326/0003-4819-140-7-200404060-00017; Wilk JE, 2010, DRUG ALCOHOL DEPEN, V108, P115, DOI 10.1016/j.drugalcdep.2009.12.003; Wood MD, 2000, J STUD ALCOHOL, V61, P278, DOI 10.15288/jsa.2000.61.278	55	15	15	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0095-2990	1097-9891		AM J DRUG ALCOHOL AB	Am. J. Drug Alcohol Abuse	MAY	2016	42	3					269	278		10.3109/00952990.2015.1051185			10	Psychology, Clinical; Substance Abuse	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Substance Abuse	DN5FB	WOS:000377090800004	26154366	Green Accepted			2022-02-06	
J	Cope, EC; Morris, DR; Gower-Winter, SD; Brownstein, NC; Levenson, CW				Cope, Elise C.; Morris, Deborah R.; Gower-Winter, Shannon D.; Brownstein, Naomi C.; Levenson, Cathy W.			Effect of zinc supplementation on neuronal precursor proliferation in the rat hippocampus after traumatic brain injury	EXPERIMENTAL NEUROLOGY			English	Article						Brain trauma; Neurogenesis; Hippocampus; Zinc; Depression; Proliferation; Neuronal precursor	ANTIDEPRESSANT-LIKE ACTIVITY; INDUCED NEUROGENESIS; ADULT NEUROGENESIS; CELL-PROLIFERATION; SUBGRANULAR ZONE; DENTATE GYRUS; X-IRRADIATION; ANIMAL-MODEL; DEPRESSION; REDUCTION	There is great deal of debate about the possible role of adult-born hippocampal cells in the prevention of depression and related mood disorders. We first showed that zinc supplementation prevents the development of the depression-like behavior anhedonia associated with an animal model of traumatic brain injury (TBI). This work then examined the effect of zinc supplementation on the proliferation of new cells in the hippocampus that have the potential to participate in neurogenesis. Rats were fed a zinc adequate (ZA, 30 ppm) or zinc supplemented (ZS, 180 ppm) diet for 4 wk followed by TBI using controlled cortical impact. Stereological counts of EdU-positive cells showed that TBI doubled the density of proliferating cells 24 h post-injury (p < 0.05), and supplemental zinc significantly increased this by an additional 2-fold (p < 0.0001). While the survival of these proliferating cells decreased at the same rate in ZA and in ZS rats after injury, the total density of newly born cells was approximately 60% higher in supplemented rats 1 wk after TBI. Furthermore, chronic zinc supplementation resulted in significant increases in the density of new doublecortin-positive neurons one week post-TBI that were maintained for 4 wk after injury (p < 0.01). While the effect of zinc supplementation on neuronal precursor cells in the hippocampus was robust, use of targeted irradiation to eliminate these cells after zinc supplementation and TBI revealed that these cells are not the sole mechanism through which zinc acts to prevent depression associated with brain injury, and suggest that other zinc dependent mechanisms are needed for the antidepressant effect of zinc in this model of TBI. (C) 2016 Elsevier Inc. All rights reserved.	[Cope, Elise C.; Morris, Deborah R.; Gower-Winter, Shannon D.; Levenson, Cathy W.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Levenson, Cathy W.] Florida State Univ, Coll Med, Program Neurosci, Tallahassee, FL 32306 USA; [Brownstein, Naomi C.] Florida State Univ, Coll Med, Dept Behav Sci & Social Med, Tallahassee, FL 32306 USA; [Brownstein, Naomi C.] Florida State Univ, Dept Stat, Tallahassee, FL 32306 USA; [Morris, Deborah R.] Princeton Neurosci Inst, Dept Psychol, Peretsman Scully Hall, Princeton, NJ 08544 USA		Levenson, CW (corresponding author), Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA.; Levenson, CW (corresponding author), Florida State Univ, Coll Med, Tallahassee, FL 32306 USA.	cathy.levenson@med.fsu.edu		Cope, Elise/0000-0001-6239-690X; Levenson, Cathy W/0000-0003-4463-3136; Brownstein, Naomi/0000-0002-9991-427X	U.S. Army Medical Research and Material CommandU.S. Army Medical Research & Materiel Command (USAMRMC); U.S. Army Research Institute of Environmental Medicine [W81XWH-11-2-0121]	The authors would like to thank Charles Badland for his excellent assistance in producing the figures presented in this manuscript, Megan Muroski for her assistance with the fluorescent microscopy for the images, Dr. Tim Megraw for his advice and support of the confocal microscopy, and Dr. Frank Johnson and the members of his lab for their advice and support with the use of stereology, and Daniel Pierce for the technical help with the collection of behavioral data. The authors would also like to acknowledge the U.S. Army Medical Research and Material Command and the U.S. Army Research Institute of Environmental Medicine (W81XWH-11-2-0121) for funding this work.	Airan RD, 2007, SCIENCE, V317, P819, DOI 10.1126/science.1144400; Bregy A, 2012, EXP NEUROL, V233, P821, DOI 10.1016/j.expneurol.2011.12.008; Choi BY, 2014, J TRACE ELEM MED BIO, V28, P474, DOI 10.1016/j.jtemb.2014.07.007; Cope EC, 2012, NEUROREHAB NEURAL RE, V26, P907, DOI 10.1177/1545968311435337; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; Corniola RS, 2008, BRAIN RES, V1237, P52, DOI 10.1016/j.brainres.2008.08.040; Dash PK, 2001, J NEUROSCI RES, V63, P313, DOI 10.1002/1097-4547(20010215)63:4<313::AID-JNR1025>3.0.CO;2-4; Dupret D, 2005, EUR J NEUROSCI, V22, P778, DOI 10.1111/j.1460-9568.2005.04262.x; Eriksson PS, 1998, NAT MED, V4, P1313, DOI 10.1038/3305; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Gage FH, 2000, SCIENCE, V287, P1433, DOI 10.1126/science.287.5457.1433; Gao HL, 2009, NEUROTOX RES, V16, P416, DOI 10.1007/s12640-009-9072-7; Gao X, 2009, EXP NEUROL, V219, P516, DOI 10.1016/j.expneurol.2009.07.007; Gower-Winter SD, 2013, NUTR NEUROSCI, V16, P174, DOI 10.1179/1476830512Y.0000000043; Izumi Y, 2006, J NEUROSCI, V26, P7181, DOI 10.1523/JNEUROSCI.1258-06.2006; Jayatissa MN, 2009, BRAIN RES, V1290, P133, DOI 10.1016/j.brainres.2009.07.001; Jin KL, 2001, P NATL ACAD SCI USA, V98, P4710, DOI 10.1073/pnas.081011098; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; KATZ RJ, 1981, NEUROSCI BIOBEHAV R, V5, P231, DOI 10.1016/0149-7634(81)90004-X; KESSLER RC, 1994, ARCH GEN PSYCHIAT, V51, P8; Klug A, 2010, ANNU REV BIOCHEM, V79, P213, DOI 10.1146/annurev-biochem-010909-095056; Lazic SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113855; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Malberg JE, 2000, J NEUROSCI, V20, P9104, DOI 10.1523/jneurosci.20-24-09104.2000; McGinn MJ, 2008, J NEUROSCI METH, V170, P9, DOI 10.1016/j.jneumeth.2007.12.012; Mizumatsu S, 2003, CANCER RES, V63, P4021; Monje ML, 2002, NAT MED, V8, P955, DOI 10.1038/nm749; Morris DR, 2013, J NUTR BIOCHEM, V24, P1940, DOI 10.1016/j.jnutbio.2013.06.002; Noonan MA, 2010, J NEUROSCI, V30, P304, DOI 10.1523/JNEUROSCI.4256-09.2010; Nowak G, 2003, POL J PHARMACOL, V55, P1143; Paxinos G, 1998, RAT BRAIN IN STEREOTAXIC COORDINATES, FOURTH ED., pix; Rice AC, 2003, EXP NEUROL, V183, P406, DOI 10.1016/S0014-4886(03)00241-3; Rola R, 2004, EXP NEUROL, V188, P316, DOI 10.1016/j.expneurol.2004.05.005; Rola R, 2006, EXP NEUROL, V202, P189, DOI 10.1016/j.expneurol.2006.05.034; Santarelli L, 2003, SCIENCE, V301, P805, DOI 10.1126/science.1083328; Schloesser RJ, 2010, MOL PSYCHIATR, V15, P1152, DOI 10.1038/mp.2010.34; Seth R, 2015, J TRACE ELEM MED BIO, V30, P59, DOI 10.1016/j.jtemb.2014.10.010; Siwek M, 2009, J AFFECT DISORDERS, V118, P187, DOI 10.1016/j.jad.2009.02.014; Slattery DA, 2012, NAT PROTOC, V7, P1009, DOI 10.1038/nprot.2012.044; Snyder JS, 2011, NATURE, V476, P458, DOI 10.1038/nature10287; Snyder JS, 2009, J NEUROSCI, V29, P14484, DOI 10.1523/JNEUROSCI.1768-09.2009; Snyder JS, 2005, NEUROSCIENCE, V130, P843, DOI 10.1016/j.neuroscience.2004.10.009; Suh SW, 2009, J CEREBR BLOOD F MET, V29, P1579, DOI 10.1038/jcbfm.2009.80; Sun D, 2007, EXP NEUROL, V204, P264, DOI 10.1016/j.expneurol.2006.11.005; Szewczyk B, 2015, NEUROPHARMACOLOGY, V99, P517, DOI 10.1016/j.neuropharm.2015.08.026; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; van Praag H, 2002, NATURE, V415, P1030, DOI 10.1038/4151030a; Winocur G, 2006, HIPPOCAMPUS, V16, P296, DOI 10.1002/hipo.20163; Wojtowicz JM, 2006, HIPPOCAMPUS, V16, P261, DOI 10.1002/hipo.20158; Xu H, 2011, HIPPOCAMPUS, V21, P495, DOI 10.1002/hipo.20767; Yau SY, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024263; Young B, 1996, J NEUROTRAUM, V13, P25, DOI 10.1089/neu.1996.13.25; Yu TS, 2016, NEUROSCIENTIST, V22, P61, DOI 10.1177/1073858414563616	53	15	16	1	8	ACADEMIC PRESS INC ELSEVIER SCIENCE	SAN DIEGO	525 B ST, STE 1900, SAN DIEGO, CA 92101-4495 USA	0014-4886	1090-2430		EXP NEUROL	Exp. Neurol.	MAY	2016	279						96	103		10.1016/j.expneurol.2016.02.017			8	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK0OU	WOS:000374612900008	26902472				2022-02-06	
J	Dennis, EL; Hua, X; Villalon-Reina, J; Moran, LM; Kernan, C; Babikian, T; Mink, R; Babbitt, C; Johnson, J; Giza, CC; Thompson, PM; Asarnow, RF				Dennis, Emily L.; Hua, Xue; Villalon-Reina, Julio; Moran, Lisa M.; Kernan, Claudia; Babikian, Talin; Mink, Richard; Babbitt, Christopher; Johnson, Jeffrey; Giza, Christopher C.; Thompson, Paul M.; Asarnow, Robert F.			Tensor-Based Morphometry Reveals Volumetric Deficits in Moderate/Severe Pediatric Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						MRI; pediatric; tensor based morphometry; traumatic brain injury	CORPUS-CALLOSUM; CHILDREN; MRI; ATROPHY; CHILDHOOD; OUTCOMES; GROWTH; TBI	Traumatic brain injury (TBI) can cause widespread and prolonged brain degeneration. TBI can affect cognitive function and brain integrity for many years after injury, often with lasting effects in children, whose brains are still immature. Although TBI varies in how it affects different individuals, image analysis methods such as tensor-based morphometry (TBM) can reveal common areas of brain atrophy on magnetic resonance imaging (MRI), secondary effects of the initial injury, which will differ between subjects. Here we studied 36 pediatric moderate to severe TBI (msTBI) participants in the post-acute phase (1-6 months post-injury) and 18 msTBI participants who returned for their chronic assessment, along with well-matched controls at both time-points. Participants completed a battery of cognitive tests that we used to create a global cognitive performance score. Using TBM, we created three-dimensional (3D) maps of individual and group differences in regional brain volumes. At both the post-acute and chronic time-points, the greatest group differences were expansion of the lateral ventricles and reduction of the lingual gyrus in the TBI group. We found a number of smaller clusters of volume reduction in the cingulate gyrus, thalamus, and fusiform gyrus, and throughout the frontal, temporal, and parietal cortices. Additionally, we found extensive associations between our cognitive performance measure and regional brain volume. Our results indicate a pattern of atrophy still detectable 1-year post-injury, which may partially underlie the cognitive deficits frequently found in TBI.	[Dennis, Emily L.; Hua, Xue; Villalon-Reina, Julio; Thompson, Paul M.] USC, Keck Sch Med, Imaging Genet Ctr, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Neurol, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Pediat, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Psychiat, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Radiol, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Engn, Marina Del Rey, CA USA; [Thompson, Paul M.] USC, Dept Ophthalmol, Marina Del Rey, CA USA; [Moran, Lisa M.; Kernan, Claudia; Babikian, Talin; Asarnow, Robert F.] Univ Calif Los Angeles, Semel Inst Neurosci & Human Behav, Dept Psychiat & Biobehav Sci, Los Angeles, CA 90024 USA; [Asarnow, Robert F.] Univ Calif Los Angeles, Dept Psychol, Los Angeles, CA USA; [Mink, Richard] Harbor UCLA Med Ctr, Torrance, CA 90509 USA; [Mink, Richard] Los Angeles BioMed Res Inst, Dept Pediat, Torrance, CA USA; [Babbitt, Christopher] Miller Childrens Hosp, Long Beach, CA USA; [Johnson, Jeffrey] LAC USC Med Ctr, Dept Pediat, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Brain Injury Res Ctr, Dept Neurosurg, Los Angeles, CA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Brain Injury Res Ctr, Div Pediat Neurol, Los Angeles, CA USA		Dennis, EL (corresponding author), Univ So Calif, Keck Sch Med, 2001 N Soto St, Los Angeles, CA 90033 USA.	emily.dennis@ini.usc.edu	Thompson, Paul M/C-4194-2018; Dennis, Emily/AAD-5223-2021	Thompson, Paul M/0000-0002-4720-8867; Dennis, Emily/0000-0001-7112-4009	EUNICE KENNEDY SHRIVER NATIONAL INSTITUTE OF CHILD HEALTH & HUMAN DEVELOPMENTUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01HD061504] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF BIOMEDICAL IMAGING AND BIOENGINEERINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01EB008432, U54EB020403] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99NS096116, R01NS080655] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG040060] Funding Source: NIH RePORTER; NIA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01 AG040060] Funding Source: Medline; NIBIB NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Biomedical Imaging & Bioengineering (NIBIB) [R01 EB008432, U54 EB020403] Funding Source: Medline; NICHD NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [R01 HD061504] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99 NS096116, R01 NS080655] Funding Source: Medline		[Anonymous], 2015, CONCUSSION MANAGEMEN; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Babikian T, 2009, NEUROPSYCHOLOGY, V23, P283, DOI 10.1037/a0015268; BERRYHILL P, 1995, NEUROSURGERY, V37, P392, DOI 10.1227/00006123-199509000-00004; Delis DC., 2001, DELIS KAPLAN EXECUTI; Delis DC., 1994, CALIFORNIA VERBAL LE; Dennis EL, 2015, NEUROIMAGE-CLIN, V7, P493, DOI 10.1016/j.nicl.2015.02.002; Dennis Emily L, 2013, Dialogues Clin Neurosci, V15, P359; Farbota KDM, 2012, J INT NEUROPSYCH SOC, V18, P1006, DOI 10.1017/S1355617712000835; Gale SD, 2005, J NEUROL NEUROSUR PS, V76, P984, DOI 10.1136/jnnp.2004.036210; Gogtay N, 2004, P NATL ACAD SCI USA, V101, P8174, DOI 10.1073/pnas.0402680101; Himanen L, 2005, BRAIN INJURY, V19, P93, DOI 10.1080/02699050410001720031; Hua X, 2009, HUM BRAIN MAPP, V30, P209, DOI 10.1002/hbm.20498; Hua X, 2008, NEUROIMAGE, V43, P458, DOI 10.1016/j.neuroimage.2008.07.013; Keenan HT, 2006, DEV NEUROSCI-BASEL, V28, P256, DOI 10.1159/000094152; Kim J, 2008, NEUROIMAGE, V39, P1014, DOI 10.1016/j.neuroimage.2007.10.005; Langers DRM, 2007, NEUROIMAGE, V38, P43, DOI 10.1016/j.neuroimage.2007.07.031; Leow A, 2005, LECT NOTES COMPUT SC, V3565, P493; Lepore N, 2007, LECT NOTES COMPUT SC, V4792, P826; Levin HS, 2000, NEUROLOGY, V54, P647, DOI 10.1212/WNL.54.3.647; Marmarou Anthony, 2007, Neurosurg Focus, V22, pE1; Povlishock J T, 2000, Clin Neurosurg, V46, P113; Ramlackhansingh AF, 2011, ANN NEUROL, V70, P374, DOI 10.1002/ana.22455; REKATE HL, 1995, NEUROSURGERY, V37, P399; Sidaros A, 2009, NEUROIMAGE, V44, P1, DOI 10.1016/j.neuroimage.2008.08.030; Tasker RC, 2005, PEDIATR RES, V58, P302, DOI 10.1203/01.PDR.0000169965.08854.25; Teasdale G, 1979, Acta Neurochir Suppl (Wien), V28, P13; Verger K, 2001, BRAIN INJURY, V15, P211; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Wechsler D, 2003, WECHSLER INTELLIGENC; Wilde EA, 2005, J NEUROTRAUM, V22, P333, DOI 10.1089/neu.2005.22.333; Wilde EA, 2007, DEV MED CHILD NEUROL, V49, P294, DOI 10.1111/j.1469-8749.2007.00294.x; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Yount R, 2002, J NEUROPSYCH CLIN N, V14, P416, DOI 10.1176/appi.neuropsych.14.4.416; Zhou YX, 2013, RADIOLOGY, V267, P880, DOI 10.1148/radiol.13122542	35	15	15	0	7	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	MAY 1	2016	33	9					840	852		10.1089/neu.2015.4012			13	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DK7SA	WOS:000375124800006	26393494	Green Submitted, hybrid, Green Published			2022-02-06	
J	Fatima, G; Sharma, VP; Verma, NS				Fatima, G.; Sharma, V. P.; Verma, N. S.			Circadian variations in melatonin and cortisol in patients with cervical spinal cord injury	SPINAL CORD			English	Article							TRAUMATIC BRAIN-INJURY; SLEEP PROPENSITY; LESIONS; RHYTHM; ASSOCIATION; HUMANS; CLOCK; RISE	Purpose: In cervical spinal cord injury (CSCI), afferent and efferent circuits that influence the basal production of melatonin and cortisol may be disrupted and hence disrupt the basal functions of human physiology. Therefore, the aim of this study was to assess circadian changes, if any, in serum cortisol and melatonin in patients with CSCI. Methods: Serum levels of cortisol and melatonin were measured at 6-h intervals of the day (0600, 1200, 1800 and 0000 hours) in 22 CSCI patients, as well as 22 healthy controls. Results: Significantly higher melatonin levels were observed in the patient group in morning hours, whereas a significantly lower level of melatonin was found during the night time in the patient group than in the control group. Moreover, significantly higher values were obtained in the evening and night time serum cortisol levels among the patients compared with controls. Further, when the mean values of cortisol throughout the day were tested among patient and control groups similar circadian rhythm was found. The only difference being that serum cortisol declined much more in controls in evening and night samples as compared with CSCI patients. Conclusion: We conclude that circadian variations exist in the circulating levels of serum cortisol and melatonin in patients with CSCI. Low levels of melatonin secretion during night may contribute to the pervasive sleep disruption and increased pain perception.	[Fatima, G.] King Georges Med Univ, Dept Biochem, C-2946, Lucknow 226003, Uttar Pradesh, India; [Sharma, V. P.] King Georges Med Univ, Dept PMR, Lucknow 226003, Uttar Pradesh, India; [Verma, N. S.] King Georges Med Univ, Dept Physiol, Lucknow 226003, Uttar Pradesh, India		Fatima, G (corresponding author), King Georges Med Univ, Dept Biochem, C-2946, Lucknow 226003, Uttar Pradesh, India.	ghizalfatima8@gmail.com		Fatima, Ghizal/0000-0001-8516-655X			ADEY WR, 1968, ARCH NEUROL-CHICAGO, V19, P377, DOI 10.1001/archneur.1968.00480040043003; Llompart-Pou JA, 2010, NEUROCRIT CARE, V13, P211, DOI 10.1007/s12028-010-9399-1; Barinaga M., 1998, SCIENCE, V277, P480; Bauer ME, 2005, STRESS, V8, P69, DOI 10.1080/10253890500100240; Biering-Sorensen F, 2001, SPINAL CORD, V39, P505, DOI 10.1038/sj.sc.3101197; Budh CN, 2005, SPINAL CORD, V43, P85, DOI 10.1038/sj.sc.3101680; DIJK DJ, 1995, J NEUROSCI, V15, P3526; EISENSTEIN AB, 1962, P SOC EXP BIOL MED, V109, P947; Fatima G, 2009, ANN NEUROSCI, V16, P31, DOI 10.5214/ans.0972.7531.2009.160110; Fujimoto T, 2000, SPINE, V25, P769, DOI 10.1097/00007632-200004010-00003; Gezici AR, 2010, SPINAL CORD, V48, P10, DOI 10.1038/sc.2009.73; Gezici AR, 2009, NEUROL NEUROCHIR POL, V43, P352; Grant J M, 1968, Paraplegia, V6, P29; Jones H, 2014, CHRONOBIOL INT, V31, P157, DOI 10.3109/07420528.2013.833516; Kalpakjian CZ, 2009, REHABIL PSYCHOL, V54, P288, DOI 10.1037/a0016614; KNEISLEY LW, 1978, J NEURAL TRANSM, P311; Korkmaz A, 2008, CURR NEUROVASC RES, V5, P46; Lavie P, 1997, J BIOL RHYTHM, V12, P657, DOI 10.1177/074873049701200622; LYNCH HJ, 1987, ADV PINEAL RES, V2, P181; Mazzoccoli G, 2011, J BIOL REG HOMEOS AG, V25, P249; MCEVOY RD, 1995, THORAX, V50, P613, DOI 10.1136/thx.50.6.613; Mehdi AA, 2011, IJBB, V48, P82; OSBORN W, 1962, J UROLOGY, V88, P1; Parvez S, 2014, SCI WORLD J, V2014, P54; REITER RJ, 1993, EXPERIENTIA, V49, P654, DOI 10.1007/BF01923947; REPPERT SM, 1988, SCIENCE, V242, P78, DOI 10.1126/science.2845576; Sack RL, 1997, SLEEP, V20, P908, DOI 10.1093/sleep/20.10.908; Scheer FAJL, 2006, SPINAL CORD, V44, P78, DOI 10.1038/sj.sc.3101784; Shekleton JA, 2010, NEUROLOGY, V74, P1732, DOI 10.1212/WNL.0b013e3181e0438b; Sun X, 2002, P NATL ACAD SCI USA, V99, P4686, DOI 10.1073/pnas.062585499; Wallerius S, 2003, J ENDOCRINOL INVEST, V26, P616, DOI 10.1007/BF03347017	31	15	16	1	7	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1362-4393	1476-5624		SPINAL CORD	Spinal Cord	MAY	2016	54	5					364	367					4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DM2QQ	WOS:000376192200006	26572605	Bronze			2022-02-06	
J	Graves, JM; Kannan, N; Mink, RB; Wainwright, MS; Groner, JI; Bell, MJ; Giza, CC; Zatzick, DF; Ellenbogen, RG; Boyle, LN; Mitchell, PH; Rivara, FP; Wang, J; Rowhani-Rahbar, A; Vavilala, MS				Graves, Janessa M.; Kannan, Nithya; Mink, Richard B.; Wainwright, Mark S.; Groner, Jonathan I.; Bell, Michael J.; Giza, Christopher C.; Zatzick, Douglas F.; Ellenbogen, Richard G.; Boyle, Linda Ng; Mitchell, Pamela H.; Rivara, Frederick P.; Wang, Jin; Rowhani-Rahbar, Ali; Vavilala, Monica S.		Pediat Guideline Adherence	Guideline Adherence and Hospital Costs in Pediatric Severe Traumatic Brain Injury	PEDIATRIC CRITICAL CARE MEDICINE			English	Article						brain injuries; costs and cost analysis; injuries; pediatrics; quality of healthcare	CARE; CHILDREN; IMPROVEMENT; MANAGEMENT; MORTALITY; REDUCE	Objectives: Adherence to pediatric traumatic brain injury guidelines has been associated with improved survival and better functional outcome. However, the relationship between guideline adherence and hospitalization costs has not been examined. To evaluate the relationship between adherence to pediatric severe traumatic brain injury guidelines, measured by acute care clinical indicators, and the total costs of hospitalization associated with severe traumatic brain injury. Design: Retrospective cohort study. Setting: Five regional pediatric trauma centers affiliated with academic medical centers. Patients: Demographic, injury, treatment, and charge data were included for pediatric patients (17 yr) with severe traumatic brain injury. Interventions: Percent adherence to clinical indicators was determined for each patient. Cost-to-charge ratios were used to estimate ICU and total hospital costs for each patient. Generalized linear models evaluated the association between healthcare costs and adherence rate. Measurements and Main Results: Cost data for 235 patients were examined. Estimated mean adjusted hospital costs were $103,485 (95% CI, 98,553-108,416); adjusted ICU costs were $82,071 (95% CI, 78,559-85,582). No association was found between adherence to guidelines and total hospital or ICU costs, after adjusting for patient and injury characteristics. Adjusted regression model results provided cost ratio equal to 1.01 for hospital and ICU costs (95% CI, 0.99-1.03 and 0.99-1.02, respectively). Conclusions: Adherence to severe pediatric traumatic brain injury guidelines at these five leading pediatric trauma centers was not associated with increased hospitalization and ICU costs. Therefore, cost should not be a factor as institutions and providers strive to provide evidence-based guideline driven care of children with severe traumatic brain injury.	[Graves, Janessa M.] Washington State Univ, Coll Nursing Spokane, Spokane, WA 99202 USA; [Graves, Janessa M.; Kannan, Nithya; Rivara, Frederick P.; Wang, Jin; Rowhani-Rahbar, Ali; Vavilala, Monica S.] Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA; [Kannan, Nithya; Vavilala, Monica S.] Univ Washington, Dept Anesthesiol, Seattle, WA 98195 USA; [Kannan, Nithya; Vavilala, Monica S.] Univ Washington, Dept Pain Med, Seattle, WA 98195 USA; [Mink, Richard B.] Harbor UCLA & Los Angeles BioMed Res Inst, Dept Pediat, Torrance, CA USA; [Wainwright, Mark S.] Northwestern Univ, Dept Pediat, Feinberg Sch Med, Chicago, IL 60611 USA; [Wainwright, Mark S.] Northwestern Univ, Feinberg Sch Med, Dept Neurol, Chicago, IL 60611 USA; [Groner, Jonathan I.] Ohio State Univ, Coll Med, Dept Surg, Columbus, OH 43210 USA; [Bell, Michael J.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Giza, Christopher C.] Univ Calif Los Angeles, Mattel Childrens Hosp, Dept Neurosurg, Div Pediat Neurol, Los Angeles, CA USA; [Zatzick, Douglas F.] Univ Washington, Dept Psychiat & Behav Sci, Seattle, WA 98195 USA; [Ellenbogen, Richard G.] Univ Washington, Dept Neurol Surg, Seattle, WA 98195 USA; [Ellenbogen, Richard G.] Univ Washington, Dept Global Hlth Med, Seattle, WA 98195 USA; [Boyle, Linda Ng] Univ Washington, Dept Ind & Syst Engn, Seattle, WA 98195 USA; [Mitchell, Pamela H.] Univ Washington, Sch Nursing, Biobehav Nursing & Hlth Syst, Seattle, WA 98195 USA; [Rivara, Frederick P.; Rowhani-Rahbar, Ali] Univ Washington, Dept Epidemiol, Seattle, WA 98195 USA; [Rivara, Frederick P.; Wang, Jin; Vavilala, Monica S.] Univ Washington, Dept Pediat, Seattle, WA 98195 USA		Graves, JM (corresponding author), Washington State Univ, Coll Nursing Spokane, Spokane, WA 99202 USA.; Graves, JM (corresponding author), Univ Washington, Harborview Injury Prevent & Res Ctr, Seattle, WA 98195 USA.	janessa.graves@wsu.edu	Graves, Janessa M./J-2596-2019	Graves, Janessa M./0000-0002-7659-2634; Rowhani-Rahbar, Ali/0000-0002-2705-4485	National Institutes of Health (NIH)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NIH/NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NINDS R01 NS072308-03]; NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; NCAA-DOD; Joseph Drown Foundation; UCLA Steve Tisch BrainSPORT Program; NFL-GE; DARPAUnited States Department of DefenseDefense Advanced Research Projects Agency (DARPA); NIH/NCIUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Cancer Institute (NCI); National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS072308-03]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS072308] Funding Source: NIH RePORTER	Dr. Graves received support for article research from the National Institutes of Health (NIH). Her institution received grant support from the NIH/NINDS (The source of support for this work including design and conduct of the study; collection, management, analysis, and interpretation of the data; and preparation, review, or approval of the manuscript was NINDS R01 NS072308-03). Drs. Kannan, Wainwright, Groner, Bell, Zatzick, Boyle, Mitchell, Wang, Rowhani-Rahbar, and Vavilala received support for article research from the NIH. Drs. Kannan, Wainwright, Groner, Bell, Zatzick, Boyle, Mitchell, Wang, Rowhani-Rahbar, and Vavilala and their institutions received grant support from the NIH. Dr. Mink served as a board member for the American Board of Pediatrics (Received honorarium as a member of the Education and Training Committee) and received support for article research from the NIH. Dr. Mink and his institution received grant support from the NIH. His institution received grant support from the NIH (Subcontract with UCLA). Dr. Giza consulted for the NCAA, Major League Soccer, U.S. Soccer Federation (Travel reimbursement for attendance at meetings); Pearson PLC (One-time consultation); and Alcobra (One-time consultation). He lectured for Medical Education Speakers Network, individual institutions (Honoraria for 1-3 medical or educational lectures per month related to pediatric neurology), received royalties from Blackwell Publishing (Royalties from Neurological Differential Diagnosis: A Prioritized Approach book), and received support for article research from the NIH. Dr. Giza and his institution received grant support from the NIH. His institution provided expert testimony for Medicolegal cases (one or two cases annually) and received grant support from NCAA-DOD, Joseph Drown Foundation, UCLA Steve Tisch BrainSPORT Program, NFL-GE, DARPA (Multiple research grants from both public and private funding sources). Dr. Ellenbogen received grant support from the NIH/NCI and received support for article research from the NIH. Dr. Ellenbogen and his institution received grant support from the NIH. Dr. Rivara received support for article research from the NIH. His institution received grant support from the NIH. Dr. Vavilala received support for this article research form National Institute of Neurological Disorders and Stroke (R01 NS072308-03).	Carney Nancy A, 2003, Pediatr Crit Care Med, V4, pS1; COPES WS, 1990, J TRAUMA, V30, P1200, DOI 10.1097/00005373-199010000-00003; Diehr P, 1999, ANNU REV PUBL HEALTH, V20, P125, DOI 10.1146/annurev.publhealth.20.1.125; Faul M, 2010, TRAUMATIC BRAIN INJU; Franschman G, 2009, RESUSCITATION, V80, P1147, DOI 10.1016/j.resuscitation.2009.06.029; Hebert PL, 2014, HEALTH AFFAIR, V33, P980, DOI 10.1377/hlthaff.2013.0893; Hesdorffer DC, 2007, J TRAUMA, V63, P841, DOI 10.1097/TA.0b013e318123fc21; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS1, DOI 10.1097/PCC.0b013e31823f435c; Koeck C, 1998, BRIT MED J, V317, P1267, DOI 10.1136/bmj.317.7168.1267; Kouznetsov E, 2012, PEDIATR NEUROSURG, V48, P1, DOI 10.1159/000340068; Letton C, 2013, J OBSTET GYNAECOL, V33, P296, DOI 10.3109/01443615.2012.758693; Penner S. J., 2004, INTRO HLTH CARE EC F; Pronovost PJ, 2004, J CRIT CARE, V19, P158, DOI 10.1016/j.jcrc.2004.07.003; Rivara FP, 2011, PEDIATRICS, V128, pE1129, DOI 10.1542/peds.2011-0840; Rusnak M, 2007, WIEN KLIN WOCHENSCHR, V119, P64, DOI 10.1007/s00508-006-0765-0; Sherr K, 2014, IMPLEMENT SCI, V9, DOI 10.1186/1748-5908-9-55; Shortell SM, 2007, JAMA-J AM MED ASSOC, V298, P673, DOI 10.1001/jama.298.6.673; Sills MR, 2005, ARCH PEDIAT ADOL MED, V159, P665, DOI 10.1001/archpedi.159.7.665; Vavilala MS, 2014, CRIT CARE MED, V42, P2258, DOI 10.1097/CCM.0000000000000507; Wagner EH, 2012, GUIDING TRANSFORMATI	20	15	15	0	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	1529-7535	1947-3893		PEDIATR CRIT CARE ME	Pediatr. Crit. Care Med.	MAY	2016	17	5					438	443		10.1097/PCC.0000000000000698			6	Critical Care Medicine; Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Pediatrics	DR0KH	WOS:000379595900015	26934664	Green Accepted			2022-02-06	
J	Li, M; Jia, Q; Chen, TH; Zhao, ZL; Chen, JL; Zhang, JN				Li, Min; Jia, Qiang; Chen, Tongheng; Zhao, Zilong; Chen, Jieli; Zhang, Jianning			The role of vascular endothelial growth factor and vascular endothelial growth inhibitor in clinical outcome of traumatic brain injury	CLINICAL NEUROLOGY AND NEUROSURGERY			English	Article						Vascular endothelial growth factor; Vascular endothelial growth inhibitor; TNFSF15; Clinical outcome; Traumatic brain injury; Dynamic change; Prognostic marker	RAT-BRAIN; VEGF; ANGIOGENESIS; PERMEABILITY; INFLAMMATION; BIOLOGY; CELL	Objectives: Tumor necrosis factor superfamily-15 (TNFSF15) also known as vascular endothelial growth inhibitor (VEGI) is a cytokine that modulates anti-angiogenesis and inflammation. Vascular endothelial growth factor (VEGF) promotes angiogenesis and vascular permeability following traumatic brain injury (TBI). The balance of VEGF and VEGI may play a key role in the maintenance of vascular and immune system homeostasis in the brain. However, the dynamic changes of circulating VEGF and VEGI after traumatic brain injury (TBI) and the correlation between plasma VEGF and plasma VEGI remains obscure. In this study, we were to investigate whether circulating VEGF and VEGI can be used as prognostic markers for patients with TBI. Patients and methods: A prospective clinical study was conducted in two neurosurgical intensive care units of Tianjin Medical University General Hospital and Tianjin Huanhu Hospital (Tianjin, China). 40 patients and 30 healthy controls were recruited. The recruited subjects were aged over 18 with randomized gender and GCS. 1 mL of blood was withdrawn on 1, 4, 7, 14, and 21 days after TBI. Blood samples were centrifuged at 3000 rpm and the supernatants were used to measure VEGF and VEGI by ELISA kit. Results: 1) Circulating VEGF in TBI patients was decreased on the 1st day after TBI, then climbed up on the 4th day, reaching a maximum level on the 14th day after TBI, as compared to normal controls. VEGF level returned to normal level on 21th day after TBI. 2) Circulating VEGI in TBI patients was decreased on the 1st and 4th day after TBI, then climbed up on the 7th day after TBI, reaching a maximum level on 14th day after TBI, as compared to normal controls. VEGI levels declined to normal level on 21th day after TBI. 3) There was a significant positive correlation between circulating VEGF and VEGI. 4) However, TBI patients whose conditions had improved exhibited lower VEGF levels 7 days after TBI when compared to TBI patients whose condition had deteriorated. Survivors exhibited higher VEGI levels 7 days after TBI when compared to non-survivors. 5)TBI patients whose condition had improved exhibited higher VEGI levels when compared to TBI patients whose condition had deteriorated 21 days after TBI. Patients with mild TBI exhibited higher VEGI levels than those with moderate and severe TBI 21 days after TBI. 6) A lower rate of recovery and higher hospital mortality were found in patients with VEGF/VEGI ratio >= 2.366 as compared to those with VEGF/VEGI ratio <2.366 7 days after TBI. Conclusions: 1) VEGF level positively correlates with VEGI after TBI. 2) The elevation of VEGF exhibits an adverse effect from 4 to 14 days after TBI while it has an advantageous effect from 14 to 21 days after TBI. Increasing VEGI levels are beneficial in recovery after TBI. Controlling the ratio of VEGF/VEGI may benefit the clinical outcome following TBI. (C) 2016 Elsevier B.V. All rights reserved.	[Li, Min; Zhao, Zilong; Zhang, Jianning] Tianjin Med Univ, Tianjin Neurol Inst, Dept Neurosurg, Gen Hosp, Tianjin 300052, Peoples R China; [Jia, Qiang] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin 300060, Peoples R China; [Chen, Tongheng] Tianjin Med Univ, Dept Neurosurg, Hosp 2, Tianjin 300211, Peoples R China; [Chen, Jieli] Henry Ford Hosp, Dept Neurol, Detroit, MI 48202 USA		Zhang, JN (corresponding author), Tianjin Gen Hosp, Tianjin Neurol Inst, Dept Neurosurg, 154 Anshan Rd, Tianjin 300052, Peoples R China.	812879698@qq.com	Zhao, Zilong/AAZ-2196-2020				Croll SD, 2004, EXP NEUROL, V187, P388, DOI 10.1016/j.expneurol.2004.02.010; Deng WM, 2012, ANGIOGENESIS, V15, P71, DOI 10.1007/s10456-011-9244-y; DVORAK HF, 1995, AM J PATHOL, V146, P1029; Ferrara N, 2003, NAT MED, V9, P669, DOI 10.1038/nm0603-669; Ferrara N, 1997, ENDOCR REV, V18, P4, DOI 10.1210/er.18.1.4; Kovacs Z, 1996, STROKE, V27, P1865, DOI 10.1161/01.STR.27.10.1865; Liu L, 2011, CRIT CARE MED, V39, P1760, DOI 10.1097/CCM.0b013e3182186cee; Migone TS, 2002, IMMUNITY, V16, P479, DOI 10.1016/S1074-7613(02)00283-2; Nag S, 1997, J NEUROPATH EXP NEUR, V56, P912, DOI 10.1097/00005072-199708000-00009; Proescholdt MA, 1999, J NEUROPATH EXP NEUR, V58, P613, DOI 10.1097/00005072-199906000-00006; Qi JW, 2013, P NATL ACAD SCI USA, V110, P13863, DOI 10.1073/pnas.1304529110; ROBERTS WG, 1995, J CELL SCI, V108, P2369; Ryu JK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-18; Tian F, 2009, BLOOD, V113, P5352, DOI 10.1182/blood-2008-08-173773; van Bruggen N, 1999, J CLIN INVEST, V104, P1613, DOI 10.1172/JCI8218	15	15	16	1	10	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0303-8467	1872-6968		CLIN NEUROL NEUROSUR	Clin. Neurol. Neurosurg.	MAY	2016	144						7	13		10.1016/j.clineuro.2016.02.032			7	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DL4TH	WOS:000375629600002	26945876				2022-02-06	
J	Momosaki, R; Yasunaga, H; Matsui, H; Horiguchi, H; Fushimi, K; Abo, M				Momosaki, Ryo; Yasunaga, Hideo; Matsui, Hiroki; Horiguchi, Hiromasa; Fushimi, Kiyohide; Abo, Masahiro			Predictive factors for oral intake after aspiration pneumonia in older adults	GERIATRICS & GERONTOLOGY INTERNATIONAL			English	Article						aspiration pneumonia; dysphagia; elderly; oral intake	ACUTE ISCHEMIC-STROKE; TRAUMATIC BRAIN-INJURY; HOSPITALIZED-PATIENTS; SINGLE-CENTER; DYSPHAGIA; RISK; DATABASE; SYSTEM	Aim: The purpose of the present study was to clarify the predictive factors for achieving oral intake after aspiration pneumonia in elderly patients. Methods: This retrospective observational study used data from the Japanese Diagnosis Procedure Combination inpatient database. We identified patients who were admitted to acute-care hospitals with aspiration pneumonia. The outcome was time to achieve total oral intake. We carried out Cox regression analysis to identify predictors for the early initiation of total oral intake. Results: Of 66 611 elderly patients with aspiration pneumonia, 59% achieved total oral intake within 30 days. Cox regression analysis showed that early initiation of total oral intake was associated with female sex and higher Barthel Index. Delayed initiation of total oral intake was associated with underweight, higher scores of pneumonia severity and comorbidities. Conclusion: We clarified prognostic factors for total oral intake in elderly aspiration pneumonia patients. Our findings will be helpful in nutritional care planning for elderly aspiration pneumonia patients.	[Momosaki, Ryo; Abo, Masahiro] Jikei Univ, Sch Med, Dept Rehabil Med, Tokyo 1058461, Japan; [Momosaki, Ryo; Yasunaga, Hideo; Matsui, Hiroki] Univ Tokyo, Sch Publ Hlth, Dept Clin Epidemiol & Hlth Econ, Tokyo, Japan; [Horiguchi, Hiromasa] Natl Hosp Org Headquarters, Clin Res Ctr, Dept Clin Data Management & Res, Tokyo, Japan; [Fushimi, Kiyohide] Tokyo Med & Dent Univ, Grad Sch Med, Dept Hlth Policy & Informat, Tokyo, Japan		Momosaki, R (corresponding author), Jikei Univ, Sch Med, Dept Rehabil Med, Minato Ku, 3-25-8 Nishi Shinbashi, Tokyo 1058461, Japan.	momosakiryo@gmail.com	Momosaki, Ryo/H-6486-2018	Momosaki, Ryo/0000-0003-3274-3952; Yasunaga, Hideo/0000-0002-6017-469X	Ministry of Health, Labor and Welfare, JapanMinistry of Health, Labour and Welfare, Japan [H26-Policy-011]	This study was funded by a grant from the Ministry of Health, Labor and Welfare, Japan (Research on Policy Planning and Evaluation grant number: H26-Policy-011).	Chang CY, 2013, STROKE, V44, P1182, DOI 10.1161/STROKEAHA.111.000663; Crary MA, 2005, ARCH PHYS MED REHAB, V86, P1516, DOI 10.1016/j.apmr.2004.11.049; Cruz-Jentoft AJ, 2010, AGE AGEING, V39, P412, DOI 10.1093/ageing/afq034; Hansen TS, 2008, ARCH PHYS MED REHAB, V89, P1556, DOI 10.1016/j.apmr.2007.11.063; Kohno S, 2011, INTERNAL MED, V50, P1183, DOI 10.2169/internalmedicine.50.4651; Kuroda Y, 2012, J AM GERIATR SOC, V60, P1785, DOI 10.1111/j.1532-5415.2012.04123.x; Langmore SE, 1998, DYSPHAGIA, V13, P69, DOI 10.1007/PL00009559; Mackay LE, 1999, ARCH PHYS MED REHAB, V80, P365, DOI 10.1016/S0003-9993(99)90271-X; Maeshima S, 2013, J STROKE CEREBROVASC, V22, P926, DOI 10.1016/j.jstrokecerebrovasdis.2013.04.003; Marik PE, 2003, CHEST, V124, P328, DOI 10.1378/chest.124.1.328; Matsuda S, 2008, EUROHEALTH, V14, P27; Morgan A, 2003, J HEAD TRAUMA REHAB, V18, P239, DOI 10.1097/00001199-200305000-00002; Nakajima M, 2014, J REHABIL MED, V46, P200, DOI 10.2340/16501977-1260; Nakajima M, 2012, J NEUROL SCI, V323, P56, DOI 10.1016/j.jns.2012.08.006; Nakajima M, 2012, INTERNAL MED, V51, P45, DOI 10.2169/internalmedicine.51.5593; Nakajima M, 2010, DYSPHAGIA, V25, P192, DOI 10.1007/s00455-009-9242-z; Park YH, 2013, GERIATR NURS, V34, P212, DOI 10.1016/j.gerinurse.2013.02.014; Sainsbury A, 2005, AGE AGEING, V34, P228, DOI 10.1093/ageing/afi063; Sasaki T, 2012, DIGEST ENDOSC, V24, P226, DOI 10.1111/j.1443-1661.2011.01208.x; Serra-Prat M, 2012, AGE AGEING, V41, P376, DOI 10.1093/ageing/afs006; Skull SA, 2008, EPIDEMIOL INFECT, V136, P232, DOI 10.1017/S0950268807008564; Takahata H, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-6; Teramoto S, 2008, J AM GERIATR SOC, V56, P577, DOI 10.1111/j.1532-5415.2008.01597.x; van der Maarel-Wierink CD, 2011, J DENT RES, V90, P1398, DOI 10.1177/0022034511422909; Warnecke T, 2008, J NEUROL NEUROSUR PS, V79, P312, DOI 10.1136/jnnp.2007.134551	25	15	16	0	7	WILEY-BLACKWELL	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1444-1586	1447-0594		GERIATR GERONTOL INT	Geriatr. Gerontol. Int.	MAY	2016	16	5					556	560		10.1111/ggi.12506			5	Geriatrics & Gerontology; Gerontology	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Geriatrics & Gerontology	DK5MS	WOS:000374964600004	25953259				2022-02-06	
J	Murphy, RKJ; Sun, P; Xu, JQ; Wang, Y; Sullivan, S; Gamble, P; Wagner, J; Wright, NN; Dorward, IG; Riew, D; Santiago, P; Kelly, MP; Trinkaus, K; Ray, WZ; Song, SK				Murphy, Rory K. J.; Sun, Peng; Xu, Junqian; Wang, Yong; Sullivan, Samir; Gamble, Paul; Wagner, Joanne; Wright, Neill N.; Dorward, Ian G.; Riew, Daniel; Santiago, Paul; Kelly, Michael P.; Trinkaus, Kathryn; Ray, Wilson Z.; Song, Sheng-Kwei			Magnetic Resonance Imaging Biomarker of Axon Loss Reflects Cervical Spondylotic Myelopathy Severity	SPINE			English	Article						cervical; DBSI; DTI; myelopathy	TRAUMATIC BRAIN-INJURY; SPINAL-CORD-INJURY; DIFFUSION; DISEASE; SURGERY	Study Design. A prospective cohort study. Objective. In this study, we employed diffusion basis spectrum imaging (DBSI) to quantitatively assess axon/myelin injury, cellular inflammation, and axonal loss of cervical spondylotic myelopathy (CSM) spinal cords. Summary of Background Data. A major shortcoming in the management of CSM is the lack of an effective diagnostic approach to stratify treatments and to predict outcomes. No current clinical diagnostic imaging approach is capable of accurately reflecting underlying spinal cord pathologies. Methods. Seven patients with mild (mJOA >= 15), five patients with moderate (14 >= mJOA >= 11), and two patients with severe (mJOA <11) CSM were prospectively enrolled. Given the low number of severe patients, moderate and severe patients were combined for comparison with seven age-matched controls and statistical analysis. We employed the newly developed DBSI to quantitatively measure axon and myelin injury, cellular inflammation, and axonal loss. Results. Median DBSI-inflammation volume is similar in control (266 mu L) and mild CSM (171 mu L) subjects, with a significant overlap of the middle 50% of observations (quartile 3-quartile 1). This was in contrast to moderate CSM subjects that had higher DBSI-inflammation volumes (382 mu L, P=0.033). DBSI-axon volume shows a strong correlation with clinical measures (r=0.79 and 0.87, P=1.9 x10-5 and 2 x10-4 for mJOA and MDI, respectively). In addition to axon and myelin injury, our findings suggest that both inflammation and axon loss contribute to neurological impairment. Most strikingly, DBSI-derived axon volume declines as severity of impairment increases. Conclusion. DBSI-quantified axonal loss may be an imaging biomarker to predict functional recovery following decompression in CSM. Our results demonstrate an increase of about 60% in the odds of impairment relative to the control for each decrease of 100 L in axon volume.	[Murphy, Rory K. J.; Gamble, Paul; Wright, Neill N.; Dorward, Ian G.; Riew, Daniel; Santiago, Paul; Ray, Wilson Z.] Washington Univ, Dept Neurosurg, St Louis, MO USA; [Sun, Peng; Wang, Yong; Sullivan, Samir; Song, Sheng-Kwei] Washington Univ, Dept Radiol, St Louis, MO USA; [Xu, Junqian] Icahn Sch Med Mt Sinai, Translat & Mol Imaging Inst, Dept Radiol, New York, NY 10029 USA; [Wagner, Joanne] St Louis Univ, Dept Phys Therapy & Athlet Training, St Louis, MO 63103 USA; [Riew, Daniel; Santiago, Paul; Kelly, Michael P.] Washington Univ, Dept Orthoped Surg, St Louis, MO USA; [Trinkaus, Kathryn] Washington Univ, Div Biostat, St Louis, MO USA		Ray, WZ (corresponding author), Dept Neurosurg, 660 South Euclid Ave,Box 8057, St Louis, MO 63110 USA.	rayz@wudosis.wustl.edu	Xu, Junqian/D-2247-2009	Xu, Junqian/0000-0001-8438-2066	National Institute of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [R01NS047592, K23NS084932]; Missouri SCIRP; National Multiple Sclerosis Society (NMSS)National Multiple Sclerosis Society [RG 4549A4/1, RG 5265A1]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS084932, R01NS047592] Funding Source: NIH RePORTER	National Institute of Health R01NS047592, K23NS084932, and Missouri SCIRP, National Multiple Sclerosis Society (NMSS) RG 4549A4/1 and RG 5265A1 funds were received in support of this work.	Beattie MS, 2011, BRAIN, V134, P1259, DOI 10.1093/brain/awr088; BENZEL EC, 1991, J SPINAL DISORD, V4, P286, DOI 10.1097/00002517-199109000-00005; Boogaarts HD, 2015, EUR SPINE J, V24, pS139, DOI 10.1007/s00586-013-2781-x; Casey ATH, 1996, ANN RHEUM DIS, V55, P901, DOI 10.1136/ard.55.12.901; Chiang CW, 2014, NEUROIMAGE, V101, P310, DOI 10.1016/j.neuroimage.2014.06.064; Ellingson BM, 2014, SPINE J, V14, P2589, DOI 10.1016/j.spinee.2014.02.027; Fehlings MG, 2013, J BONE JOINT SURG AM, V95A, P1651, DOI 10.2106/JBJS.L.00589; Fehlings MG, 2012, J NEUROSURG-SPINE, V16, P425, DOI 10.3171/2012.1.SPINE11467; Fehlings MG, 2009, J NEUROSURG-SPINE, V11, P97, DOI 10.3171/2009.5.SPINE09210; Furlan JC, 2008, J NEUROTRAUM, V25, P1273, DOI 10.1089/neu.2008.0617; Jones JGA, 2013, AM J NEURORADIOL, V34, P471, DOI 10.3174/ajnr.A3199; Kadanka Z, 2000, EUR SPINE J, V9, P538, DOI 10.1007/s005860000132; Karadimas SK, 2015, EUR SPINE J, V24, pS132, DOI 10.1007/s00586-014-3264-4; Klineberg E, 2010, ORTHOP CLIN N AM, V41, P193, DOI 10.1016/j.ocl.2009.12.010; Krishna V, 2014, J NEUROTRAUM, V31, P215, DOI 10.1089/neu.2013.2982; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Nagata K, 2012, SPINE, V37, P1892, DOI 10.1097/BRS.0b013e31825a2619; Naismith RT, 2013, NEUROLOGY, V80, P2201, DOI 10.1212/WNL.0b013e318296e8f1; Nakamura M, 2012, J NEUROSURG-SPINE, V17, P147, DOI 10.3171/2012.5.SPINE1196; NURICK S, 1972, BRAIN, V95, P101, DOI 10.1093/brain/95.1.101; Song SK, 2002, NEUROIMAGE, V17, P1429, DOI 10.1006/nimg.2002.1267; Song SK, 2005, NEUROIMAGE, V26, P132, DOI 10.1016/j.neuroimage.2005.01.028; Song SK, 2003, NEUROIMAGE, V20, P1714, DOI 10.1016/j.neuroimage.2003.07.005; Uda T, 2013, SPINE, V38, P407; Wang Y, 2011, BRAIN, V134, P3587, DOI 10.1093/brain/awr307; Xiangshui M, 2010, CLIN RADIOL, V65, P465, DOI 10.1016/j.crad.2010.01.019; Xu JQ, 2013, NEUROIMAGE, V67, P64, DOI 10.1016/j.neuroimage.2012.11.014; Yuh EL, 2014, J NEUROTRAUM, V31, P1457, DOI 10.1089/neu.2013.3171	28	15	15	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0362-2436	1528-1159		SPINE	SPINE	MAY	2016	41	9					751	756		10.1097/BRS.0000000000001337			6	Clinical Neurology; Orthopedics	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Orthopedics	DL4QV	WOS:000375623200014	26650876	Green Accepted			2022-02-06	
J	Wang, F; Wang, Y; Sun, T; Yu, HL				Wang, Fei; Wang, Yong; Sun, Tao; Yu, Hua-lin			Hyperbaric oxygen therapy for the treatment of traumatic brain injury: a meta-analysis	NEUROLOGICAL SCIENCES			English	Article						Glasgow coma scale; Glasgow outcome score; Oxygen therapy; Post-concussion syndrome; Traumatic brain injury	CEREBRAL METABOLISM; INTRACRANIAL-PRESSURE; NORMOBARIC HYPEROXIA; SYMPTOMS; TRIAL	Compelling evidence suggests the advantage of hyperbaric oxygen therapy (HBOT) in traumatic brain injury. The present meta-analysis evaluated the outcomes of HBOT in patients with traumatic brain injury (TBI). Prospective studies comparing hyperbaric oxygen therapy vs. control in patients with mild (GCS 13-15) to severe (GCS 3-8) TBI were hand-searched from medical databases using the terms "hyperbaric oxygen therapy, traumatic brain injury, and post-concussion syndrome". Glasgow coma scale (GCS) was the primary outcome, while Glasgow outcome score (GOS), overall mortality, and changes in post-traumatic stress disorder (PTSD) score, constituted the secondary outcomes. The results of eight studies (average age of patients, 23-41 years) reveal a higher post-treatment GCS score in the HBOT group (pooled difference in means = 3.13, 95 % CI 2.34-3.92, P < 0.001), in addition to greater improvement in GOS and lower mortality, as compared to the control group. However, no significant change in the PTSD score was observed. Patients undergoing hyperbaric therapy achieved significant improvement in the GCS and GOS with a lower overall mortality, suggesting its utility as a standard intensive care regimen in traumatic brain injury.	[Wang, Fei; Wang, Yong; Sun, Tao; Yu, Hua-lin] Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg 2, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China		Yu, HL (corresponding author), Kunming Med Univ, Affiliated Hosp 1, Dept Neurosurg 2, 295 Xichang Rd, Kunming 650032, Yunnan, Peoples R China.	hualin_yu@sina.com					BENNETT MH, 2012, COCHRANE DB SYST REV, V12, DOI DOI 10.1002/14651858.CD004609.PUB3; Boussi-Gross R, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0079995; Cifu DX, 2014, J HEAD TRAUMA REHAB, V29, P11, DOI 10.1097/HTR.0b013e3182a6aaf0; Davis MC, 2014, MED GAS RES, V4, DOI 10.1186/2045-9912-4-8; Golden ZL, 2002, INT J NEUROSCI, V112, P119, DOI 10.1080/00207450212027; Harch PG, 2012, J NEUROTRAUM, V29, P168, DOI 10.1089/neu.2011.1895; Higgins JPT, 2011, BMJ-BRIT MED J, V343, DOI 10.1136/bmj.d5928; Hills BA, 1999, MED HYPOTHESES, V52, P259, DOI 10.1054/mehy.1997.0640; Huang L, 2011, MED GAS RES, V1, DOI 10.1186/2045-9912-1-21; Kumaria A, 2009, BRIT J NEUROSURG, V23, P576, DOI 10.3109/02688690903050352; Lin JW, 2008, ACTA NEUROCHIR SUPPL, V101, P145; Mao J-H, 2010, J CLIN NEUROL, V23, P386; Miller RS, 2015, JAMA INTERN MED, V175, P43, DOI 10.1001/jamainternmed.2014.5479; Murray GD, 1999, ACTA NEUROCHIR, V141, P223, DOI 10.1007/s007010050292; Narotam PK, 2009, J NEUROSURG, V111, P672, DOI 10.3171/2009.4.JNS081150; Neubauer RA, 1998, NEUROL RES, V20, pS33; Ren H, 2001, Chin J Traumatol, V4, P239; ROCKSWOLD GL, 1992, J NEUROSURG, V76, P929, DOI 10.3171/jns.1992.76.6.0929; Rockswold SB, 2013, J NEUROSURG, V118, P1317, DOI 10.3171/2013.2.JNS121468; Rockswold SB, 2010, J NEUROSURG, V112, P1080, DOI 10.3171/2009.7.JNS09363; Rockswold SB, 2001, J NEUROSURG, V94, P403, DOI 10.3171/jns.2001.94.3.0403; Sutton AJ, 2000, BMJ-BRIT MED J, V320, P1574, DOI 10.1136/bmj.320.7249.1574; Thurman DJ, 1999, J HEAD TRAUMA REHAB, V14, P602, DOI 10.1097/00001199-199912000-00009; Walker WC, 2014, NEUROREHAB NEURAL RE, V28, P420, DOI 10.1177/1545968313516869; Wolf G, 2012, J NEUROTRAUM, V29, P2606, DOI 10.1089/neu.2012.2549; Zeyu Xie, 2007, Neural Regeneration Research, V2, P314	26	15	20	1	14	SPRINGER-VERLAG ITALIA SRL	MILAN	VIA DECEMBRIO, 28, MILAN, 20137, ITALY	1590-1874	1590-3478		NEUROL SCI	Neurol. Sci.	MAY	2016	37	5					693	701		10.1007/s10072-015-2460-2			9	Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DO8PL	WOS:000378045500005	26746238				2022-02-06	
J	Wang, G; Zhang, JN; Guo, JK; Cai, Y; Sun, HS; Dong, K; Wu, CG				Wang, Guan; Zhang, Jian-ning; Guo, Jia-kui; Cai, Ying; Sun, Hong-sheng; Dong, Kun; Wu, Cheng-gang			Neuroprotective effects of cold-inducible RNA-binding protein during mild hypothermia on traumatic brain injury	NEURAL REGENERATION RESEARCH			English	Article						nerve regeneration; traumatic brain injury; mild hypothermia; cold-inducible RNA-binding protein; mitogen-activated extracellular signal-regulated kinase; anti-apoptosis; neural regeneration	SIGNALING PATHWAY; CIRP EXPRESSION; DOWN-REGULATION; APOPTOSIS; CELLS; NEURONS; ACTIVATION; ERK; SUPPRESSION; SENESCENCE	Cold-inducible RNA-binding protein (CIRP), a key regulatory protein, could be facilitated by mild hypothermia in the brain, heart and liver. This study observed the effects of mild hypothermia at 31 +/- 0.5 degrees C on traumatic brain injury in rats. Results demonstrated that mild hypothermia suppressed apoptosis in the cortex, hippocampus and hypothalamus, facilitated CIRP mRNA and protein expression in these regions, especially in the hypothalamus. The anti-apoptotic effect of mild hypothermia disappeared after CIRP silencing. There was no correlation between mitogen-activated extracellular signal-regulated kinase activation and CIRP silencing. CIRP silencing inhibited extracellular signal-regulated kinase-1/2 activation. These indicate that CIRP inhibits apoptosis by affecting extracellular signal-regulated kinase-1/2 activation, and exerts a neuroprotective effect during mild hypothermia for traumatic brain injury.	[Wang, Guan] Tianjin Med Univ Canc Inst & Hosp, Postgrad Inst, Tianjin, Peoples R China; [Wang, Guan; Guo, Jia-kui; Dong, Kun; Wu, Cheng-gang] Tianjin Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Neurosurg, Tianjin, Peoples R China; [Zhang, Jian-ning] Tianjin Med Univ, Gen Hosp, Dept Neurosurg, Tianjin, Peoples R China; [Cai, Ying; Sun, Hong-sheng] Tianjin Huanhu Hosp, Dept Neurosurg, Tianjin, Peoples R China		Wang, G (corresponding author), Tianjin Med Univ Canc Inst & Hosp, Postgrad Inst, Tianjin, Peoples R China.; Wang, G (corresponding author), Tianjin Univ Tradit Chinese Med, Affiliated Hosp 2, Dept Neurosurg, Tianjin, Peoples R China.	neurocrown@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81303091]	This study was supported by the National Natural Science Foundation of China, No. 81303091.	Al-Fageeh MB, 2009, RNA, V15, P1164, DOI 10.1261/rna.1179109; Andresen M, 2015, SCAND J TRAUMA RESUS, V23, DOI 10.1186/s13049-015-0121-3; Artero-Castro A, 2009, MOL CELL BIOL, V29, P1855, DOI 10.1128/MCB.01386-08; Atkins CM, 2009, NEUROSCI LETT, V459, P52, DOI 10.1016/j.neulet.2009.04.064; Darwazeh R, 2013, NEURAL REGEN RES, V8, P2677, DOI 10.3969/j.issn.1673-5374.2013.28.010; Goodrich JT, 2014, WORLD NEUROSURG, V81, P300, DOI 10.1016/j.wneu.2013.02.036; Idris Zamzuri, 2014, Asian J Neurosurg, V9, P115, DOI 10.4103/1793-5482.142690; Kaneko T, 2012, BRAIN RES, V1466, P128, DOI 10.1016/j.brainres.2012.05.001; Koh PO, 2015, NEUROSCI LETT, V588, P18, DOI 10.1016/j.neulet.2014.12.047; Kumar P, 2014, INT J BIOCHEM CELL B, V53, P302, DOI 10.1016/j.biocel.2014.05.038; Li Q, 2014, FRONT BIOSCI-LANDMRK, V19, P1411, DOI 10.2741/4291; Li SC, 2012, BRAIN RES, V1441, P47, DOI 10.1016/j.brainres.2011.12.053; Liu AJ, 2010, BRAIN RES, V1347, P104, DOI 10.1016/j.brainres.2010.05.029; Nishiyama H, 1997, J CELL BIOL, V137, P899, DOI 10.1083/jcb.137.4.899; Oishi K, 2013, FEBS OPEN BIO, V3, P192, DOI 10.1016/j.fob.2013.03.005; Saito K, 2010, BRAIN RES, V1358, P20, DOI 10.1016/j.brainres.2010.08.048; Sticozzi C, 2013, NEUROSCIENCE, V252, P367, DOI 10.1016/j.neuroscience.2013.07.061; Sumitomo Y, 2012, BMC BIOTECHNOL, V12, DOI 10.1186/1472-6750-12-72; Sun Y, 2015, J RECEPT SIG TRANSD, V35, P600, DOI 10.3109/10799893.2015.1030412; Tan HK, 2008, BIOTECHNOL APPL BIOC, V49, P247, DOI 10.1042/BA20070032; Tong G, 2013, BRAIN RES, V1504, P74, DOI 10.1016/j.brainres.2013.01.041; Wang H, 2016, REPROD TOXICOL, V60, P53, DOI 10.1016/j.reprotox.2016.01.006; Xiong M, 2011, NEUROCHEM INT, V58, P625, DOI 10.1016/j.neuint.2011.01.026; Zhang HT, 2015, BRAIN RES, V1622, P474, DOI 10.1016/j.brainres.2015.07.004; Zhang YH, 2015, MOL NEUROBIOL, V52, P522, DOI 10.1007/s12035-014-8840-4; Zhou M, 2014, BBA-GEN SUBJECTS, V1840, P2253, DOI 10.1016/j.bbagen.2014.02.027	26	15	19	1	15	MEDKNOW PUBLICATIONS & MEDIA PVT LTD	MUMBAI	B-9, KANARA BUSINESS CENTRE, OFF LINK RD, GHAKTOPAR-E, MUMBAI, 400075, INDIA	1673-5374	1876-7958		NEURAL REGEN RES	Neural Regen. Res.	MAY	2016	11	5					771	778		10.4103/1673-5374.182704			8	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DP5LF	WOS:000378537700025	27335561	Green Published, gold			2022-02-06	
J	Wu, Y; Kim, J; Chan, ST; Zhou, IY; Guo, Y; Igarashi, T; Zheng, HR; Guo, G; Sun, PZ				Wu, Yin; Kim, Jinsuh; Chan, Suk-Tak; Zhou, Iris Yuwen; Guo, Yingkun; Igarashi, Takahiro; Zheng, Hairong; Guo, Gang; Sun, Phillip Zhe			Comparison of image sensitivity between conventional tensor-based and fast diffusion kurtosis imaging protocols in a rodent model of acute ischemic stroke	NMR IN BIOMEDICINE			English	Article						acute stroke; contrast-to-noise ratio; diffusion kurtosis imaging; mean diffusion; mean kurtosis	NON-GAUSSIAN DIFFUSION; MILD COGNITIVE IMPAIRMENT; TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; MICROSTRUCTURAL ALTERATIONS; WATER DIFFUSION; TISSUE; MRI; TIME; PH	Diffusion kurtosis imaging (DKI) can offer a useful complementary tool to routine diffusion MRI for improved stratification of heterogeneous tissue damage in acute ischemic stroke. However, its relatively long imaging time has hampered its clinical application in the emergency setting. A recently proposed fast DKI approach substantially shortens the imaging time, which may help to overcome the scan time limitation. However, to date, the sensitivity of the fast DKI protocol for the imaging of acute stroke has not been fully described. In this study, we performed routine and fast DKI scans in a rodent model of acute stroke, and compared the sensitivity of diffusivity and kurtosis indices (i.e. axial, radial and mean) in depicting acute ischemic lesions. In addition, we analyzed the contrast-to-noise ratio (CNR) between the ipsilateral ischemic and contralateral normal regions using both conventional and fast DKI methods. We found that the mean kurtosis shows a relative change of 47.1 +/- 7.3% between the ischemic and contralateral normal regions, being the most sensitive parameter in revealing acute ischemic injury. The two DKI methods yielded highly correlated diffusivity and kurtosis measures and lesion volumes (R(2)0.90, p<0.01). Importantly, the fast DKI method exhibited significantly higher CNR of mean kurtosis (1.6 +/- 0.2) compared with the routine tensor protocol (1.3 +/- 0.2, p<0.05), with its CNR per unit time (CNR efficiency) approximately doubled when the scan time was taken into account. In conclusion, the fast DKI method provides excellent sensitivity and efficiency to image acute ischemic tissue damage, which is essential for image-guided and individualized stroke treatment. Copyright (c) 2016 John Wiley & Sons, Ltd.	[Wu, Yin; Chan, Suk-Tak; Zhou, Iris Yuwen; Guo, Yingkun; Igarashi, Takahiro; Sun, Phillip Zhe] Harvard Univ, Sch Med, Charlestown, MA 02129 USA; [Wu, Yin; Chan, Suk-Tak; Zhou, Iris Yuwen; Guo, Yingkun; Igarashi, Takahiro; Sun, Phillip Zhe] Massachusetts Gen Hosp, Dept Radiol, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA; [Wu, Yin; Zheng, Hairong] Chinese Acad Sci, Shenzhen Inst Adv Technol, Paul C Lauterbur Res Ctr Biomed Imaging, Shenzhen Key Lab MRI, Shenzhen, Guangdong, Peoples R China; [Kim, Jinsuh; Sun, Phillip Zhe] Univ Illinois, Dept Radiol, Chicago, IL USA; [Guo, Gang] Xiamen 2nd Hosp, Dept Radiol, Xiamen, Fujian, Peoples R China		Sun, PZ (corresponding author), Massachusetts Gen Hosp, Athinoula A Martinos Ctr Biomed Imaging, Charlestown, MA 02129 USA.; Sun, PZ (corresponding author), Harvard Univ, Sch Med, Charlestown, MA 02129 USA.	pzhesun@mgh.harvard.edu	Chan, Suk-tak/G-5846-2015; Zhou, Iris Yuwen/A-2089-2017	Zhou, Iris Yuwen/0000-0002-4351-7398; Sun, Phillip Zhe/0000-0003-4872-1192; CHAN, SUK-TAK/0000-0001-6627-3173	National Basic Research Program of ChinaNational Basic Research Program of China [2015CB755500]; National Natural Science Foundation of China (NSFC)National Natural Science Foundation of China (NSFC) [81571668, 81471721]; Shenzhen Science and Technology Program [JCYJ20140610151856743]; National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [1R21NS085574, 1R01NS083654]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R21NS061119, R01NS083654, R21NS085574] Funding Source: NIH RePORTER	This study received funding from the National Basic Research Program of China (2015CB755500), National Natural Science Foundation of China (NSFC) (81571668 and 81471721), Shenzhen Science and Technology Program (JCYJ20140610151856743) and National Institutes of Health/National Institute of Neurological Disorders and Stroke (NIH/NINDS) (1R21NS085574 and 1R01NS083654).	Cheung JS, 2012, STROKE, V43, P2252, DOI 10.1161/STROKEAHA.112.661926; Cheung MM, 2009, NEUROIMAGE, V45, P386, DOI 10.1016/j.neuroimage.2008.12.018; Falangola MF, 2013, MAGN RESON IMAGING, V31, P840, DOI 10.1016/j.mri.2013.02.008; Falangola MF, 2008, J MAGN RESON IMAGING, V28, P1345, DOI 10.1002/jmri.21604; Fieremans E, 2011, NEUROIMAGE, V58, P177, DOI 10.1016/j.neuroimage.2011.06.006; Fukunaga I, 2013, RADIOL PHYS TECHNOL, V6, P343, DOI 10.1007/s12194-013-0206-5; Gao Y, 2012, NMR BIOMED, V25, P1369, DOI 10.1002/nbm.2809; Glenn GR, 2015, NMR BIOMED, V28, P448, DOI 10.1002/nbm.3271; Gong NJ, 2013, MAGN RESON IMAGING, V31, P688, DOI 10.1016/j.mri.2012.10.027; Gooijers J, 2014, BRAIN STRUCT FUNCT, V219, P1627, DOI 10.1007/s00429-013-0590-y; Grinberg F, 2012, NMR BIOMED, V25, P1295, DOI 10.1002/nbm.2802; Grinberg F, 2011, NEUROIMAGE, V57, P1087, DOI 10.1016/j.neuroimage.2011.04.050; Grossman EJ, 2012, J NEUROTRAUM, V29, P2318, DOI 10.1089/neu.2011.1763; HACKE W, 1995, JAMA-J AM MED ASSOC, V274, P1017, DOI 10.1001/jama.274.13.1017; Hansen B, 2014, MAGN RESON MED, V71, P2250, DOI 10.1002/mrm.25090; Hansen MS, 2013, MAGN RESON MED, V69, P1768, DOI [10.1002/mrm.24389, 10.1002/mrm.24743]; Hui ES, 2008, NEUROIMAGE, V42, P122, DOI 10.1016/j.neuroimage.2008.04.237; Hui ES, 2012, STROKE, V43, P2968, DOI 10.1161/STROKEAHA.112.657742; Hui ES, 2012, BRAIN RES, V1451, P100, DOI 10.1016/j.brainres.2012.02.044; Jensen JH, 2014, NMR BIOMED, V27, P363, DOI [10.1002/nbm.3094, 10.1002/nbm.3030]; Jensen JH, 2011, NMR BIOMED, V24, P452, DOI 10.1002/nbm.1610; Jensen JH, 2010, NMR BIOMED, V23, P698, DOI 10.1002/nbm.1518; Jensen JH, 2005, MAGNET RESON MED, V53, P1432, DOI 10.1002/mrm.20508; Kidwell CS, 2004, STROKE, V35, P2662, DOI 10.1161/01.STR.0000143222.13069.70; Kim JH, 2010, J NEUROTRAUM, V27, P587, DOI 10.1089/neu.2009.1063; Lu HZ, 2006, NMR BIOMED, V19, P236, DOI 10.1002/nbm.1020; Nael K, 2015, STROKE, V46, P413, DOI 10.1161/STROKEAHA.114.007000; Raab P, 2010, RADIOLOGY, V254, P876, DOI 10.1148/radiol.09090819; Rose SE, 2008, J MAGN RESON IMAGING, V27, P20, DOI 10.1002/jmri.21231; Rosenkrantz AB, 2012, MAGN RESON IMAGING, V30, P1534, DOI 10.1016/j.mri.2012.04.020; Rudrapatna SU, 2014, NEUROIMAGE, V97, P363, DOI 10.1016/j.neuroimage.2014.04.013; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Saver JL, 2006, STROKE, V37, P263, DOI 10.1161/01.STR.0000196957.55928.ab; Shen Q, 2005, J CEREBR BLOOD F MET, V25, P1336, DOI 10.1038/sj.jcbfm.9600126; Steven AJ, 2014, AM J ROENTGENOL, V202, pW26, DOI 10.2214/AJR.13.11365; Sun PZ, 2007, J CEREBR BLOOD F MET, V27, P1129, DOI 10.1038/sj.jcbfm.9600424; Sun PZ, 2014, NMR BIOMED, V27, P1413, DOI 10.1002/nbm.3188; Sun PZ, 2013, PHYS MED BIOL, V58, pN229, DOI 10.1088/0031-9155/58/17/N229; Sun PZ, 2012, NEUROIMAGE, V60, P1, DOI 10.1016/j.neuroimage.2011.11.091; Tabesh A, 2011, MAGN RESON MED, V65, P823, DOI 10.1002/mrm.22655; Tax CMW, 2015, MAGN RESON MED, V73, P794, DOI 10.1002/mrm.25165; Tietze A, 2015, AM J NEURORADIOL, V36, P1472, DOI 10.3174/ajnr.A4311; Van Cauter S, 2012, RADIOLOGY, V263, P492, DOI 10.1148/radiol.12110927; Vanhoutte G, 2013, MAGN RESON MED, V69, P1115, DOI 10.1002/mrm.24680; Wang JJ, 2011, RADIOLOGY, V261, P210, DOI 10.1148/radiol.11102277; Warach S, 2004, STROKE, V35, P2659, DOI 10.1161/01.STR.0000144051.32131.09; Wardlaw JM, 2014, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD000213.pub3; Weber RA, 2015, STROKE, V46, P545, DOI 10.1161/STROKEAHA.114.006782; Wu EX, 2010, NMR BIOMED, V23, P836, DOI 10.1002/nbm.1506; Wu O, 2007, J CEREBR BLOOD F MET, V27, P196, DOI 10.1038/sj.jcbfm.9600328; Zhuo JC, 2012, NEUROIMAGE, V59, P467, DOI 10.1016/j.neuroimage.2011.07.050	51	15	18	1	17	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0952-3480	1099-1492		NMR BIOMED	NMR Biomed.	MAY	2016	29	5					625	630		10.1002/nbm.3506			6	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	Science Citation Index Expanded (SCI-EXPANDED)	Biophysics; Radiology, Nuclear Medicine & Medical Imaging; Spectroscopy	DJ8XA	WOS:000374495900010	26918411	Green Accepted			2022-02-06	
J	Fink, EL; Berger, RP; Clark, RSB; Watson, RS; Angus, DC; Panigrahy, A; Richichi, R; Callaway, CW; Bell, MJ; Mondello, S; Hayes, RL; Kochanek, PM				Fink, Ericka L.; Berger, Rachel P.; Clark, Robert S. B.; Watson, R. Scott; Angus, Derek C.; Panigrahy, Ashok; Richichi, Rudolph; Callaway, Clifton W.; Bell, Michael J.; Mondello, Stefania; Hayes, Ronald L.; Kochanek, Patrick M.			Exploratory study of serum ubiquitin carboxyl-terminal esterase L1 and glial fibrillary acidic protein for outcome prognostication after pediatric cardiac arrest	RESUSCITATION			English	Article						Biomarker; Pediatric; Brain injury; Outcomes; Cardiac arrest	DELAYED NEURONAL DEATH; TRAUMATIC BRAIN-INJURY; BIOMARKERS; CHILDREN; HYDROLASE	Introduction: Brain injury is the leading cause of morbidity and death following pediatric cardiac arrest. Serum biomarkers of brain injury may assist in outcome prognostication. The objectives of this study were to evaluate the properties of serum ubiquitin carboxyl-terminal esterase-L1 (UCH-L1) and glial fibrillary acidic protein (GFAP) to classify outcome in pediatric cardiac arrest. Methods: Single center prospective study. Serum biomarkers were measured at 2 time points during the initial 72 h in children after cardiac arrest (n = 19) and once in healthy children (controls, n = 43). We recorded demographics and details of the cardiac arrest and resuscitation. We determined the associations between serum biomarker concentrations and Pediatric Cerebral Performance Category (PCPC) at 6 months (favorable (PCPC 1-3) or unfavorable (PCPC 4-6)). Results: The initial assessment (time point 1) occurred at a median (IQR) of 10.5 (5.5-17.0) h and the second assessment (time point 2) at 59.0 (54.5-65.0) h post-cardiac arrest. Serum UCH-L1 was higher among children following cardiac arrest than among controls at both time points (p < 0.05). Serum GFAP in subjects with unfavorable outcome was higher at time point 2 than in controls (p < 0.05). Serum UCH-L1 at time point 1 (AUC 0.782) and both UCH-L1 and GFAP at time point 2 had good classification accuracy for outcome (AUC 0.822 and 0.796), p < 0.05 for all. Conclusion: Preliminary data suggest that serum UCH-L1 and GFAP may be of use to prognosticate outcome after pediatric cardiac arrest at clinically-relevant time points and should be validated prospectively. (C) 2016 Elsevier Ireland Ltd. All rights reserved.	[Fink, Ericka L.; Clark, Robert S. B.; Bell, Michael J.; Kochanek, Patrick M.] UPMC, Childrens Hosp Pittsburgh, Crit Care Med, Pittsburgh, PA USA; [Angus, Derek C.] Univ Pittsburgh, Med Ctr, Crit Care Med, Pittsburgh, PA USA; [Callaway, Clifton W.] Univ Pittsburgh, Med Ctr, Emergency Med, Pittsburgh, PA USA; [Panigrahy, Ashok] UPMC, Childrens Hosp Pittsburgh, Radiol, Pittsburgh, PA USA; [Richichi, Rudolph] Stat Anal & Measurement Consultants Inc, Lanexa, VA USA; [Hayes, Ronald L.] Banyan Biomarkers Inc, Banyan Labs, Alachua, FL USA; [Watson, R. Scott] Seattle Childrens Res Inst, Ctr Child Hlth Behav & Dev, Seattle, WA USA; [Fink, Ericka L.; Watson, R. Scott; Angus, Derek C.] Clin Res Invest & Syst Modeling Acute Illness CRI, Pittsburgh, PA USA; [Fink, Ericka L.; Clark, Robert S. B.; Callaway, Clifton W.; Bell, Michael J.; Kochanek, Patrick M.] Safar Ctr Resuscitat Res, Pittsburgh, PA USA; [Mondello, Stefania] Univ Messina, Neurosci, Messina, Italy; [Berger, Rachel P.] UPMC, Childrens Hosp Pittsburgh, Child Advocacy, Pittsburgh, PA USA		Fink, EL (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Pediat Crit Care Med, 4401 Penn Ave,Fac Pavil,2nd Floor, Pittsburgh, PA 15224 USA.	finkel@ccm.upmc.edu	Mondello, Stefania/A-1813-2012; Fink, Ericka/AAU-9792-2021; Angus, Derek C/E-9671-2012	Mondello, Stefania/0000-0002-8587-3614; Watson, R. Scott/0000-0002-2581-7186	NICHDUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH Eunice Kennedy Shriver National Institute of Child Health & Human Development (NICHD) [K12 HD047349]; NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23 NS065132]; Laerdal Foundation; Banyan Biomarkers, Inc.; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [UL1 RR024153, UL1TR000005]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000005] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS065132] Funding Source: NIH RePORTER	NICHD K12 HD047349 (E.L.F.), NINDS K23 NS065132 (E.L.F.), the Laerdal Foundation (E.L.F.), and Banyan Biomarkers, Inc. (E.L.F.). The project described was supported by the National Institutes of Health through grant numbers UL1 RR024153 and UL1TR000005. Banyan Biomarkers, Inc. performed all biomarker measurements without charge.	Abend NS, 2008, PEDIATR CRIT CARE ME, V9, P32, DOI 10.1097/01.PCC.0000288714.61037.56; Bedell GM, 2008, BRAIN INJURY, V22, P313, DOI 10.1080/02699050801978948; Bembea MM, 2011, PEDIATR CRIT CARE ME, V12, P572, DOI 10.1097/PCC.0b013e3181fe3ec7; Berger RP, 2012, J NEUROTRAUM, V29, P162, DOI 10.1089/neu.2011.1989; Berger RP, 2006, DEV NEUROSCI-BASEL, V28, P327, DOI 10.1159/000094158; Blennow M, 2001, ACTA PAEDIATR, V90, P1171, DOI 10.1080/080352501317061594; Chalak LF, 2014, J PEDIATR-US, V164, P468, DOI 10.1016/j.jpeds.2013.10.067; Chen J, 1998, J NEUROSCI, V18, P4914; Czeiter E, 2012, J NEUROTRAUM, V29, P1770, DOI 10.1089/neu.2011.2127; Day INM, 2010, PROG NEUROBIOL, V90, P327, DOI 10.1016/j.pneurobio.2009.10.020; Douglas-Escobar M, 2010, PEDIATR RES, V68, P531, DOI 10.1203/PDR.0b013e3181f85a03; ENG LF, 1985, J NEUROIMMUNOL, V8, P203, DOI 10.1016/S0165-5728(85)80063-1; Ennen CS, 2011, AM J OBSTET GYNECOL, V205, DOI 10.1016/j.ajog.2011.06.025; Fink EL, 2014, CRIT CARE MED, V42, P664, DOI 10.1097/01.ccm.0000435668.53188.80; FISER DH, 1992, J PEDIATR-US, V121, P68, DOI 10.1016/S0022-3476(05)82544-2; FRASER DD, 2011, CRIT CARE MED, V12, P319, DOI DOI 10.1097/PCC.0B013E3181E8B32D; Fugate JE, 2010, ANN NEUROL, V68, P907, DOI 10.1002/ana.22133; Hayashida H, 2010, NEUROCRIT CARE, V12, P252, DOI 10.1007/s12028-009-9318-5; HORN M, 1992, ACTA NEUROPATHOL, V85, P79, DOI 10.1007/BF00304636; Iliff JJ, 2013, J CLIN INVEST, V123, P1299, DOI 10.1172/JCI67677; Jin KL, 1999, J NEUROCHEM, V72, P1204, DOI 10.1046/j.1471-4159.1999.0721204.x; Kaneko T, 2009, RESUSCITATION, V80, P790, DOI 10.1016/j.resuscitation.2009.04.003; Kochanek PM, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00040; Langhelle A, 2005, RESUSCITATION, V66, P271, DOI 10.1016/j.resuscitation.2005.06.005; Larsson IM, 2014, RESUSCITATION, V85, P1654, DOI 10.1016/j.resuscitation.2014.09.007; LIEHLAI MW, 1992, J PEDIATR-US, V120, P195, DOI 10.1016/S0022-3476(05)80426-3; Moler FW, 2009, CRIT CARE MED, V37, P2259, DOI 10.1097/CCM.0b013e3181a00a6a; Mondello S, 2012, NEUROSURGERY, V70, P666, DOI 10.1227/NEU.0b013e318236a809; Mondello S, 2011, CRIT CARE, V15, DOI 10.1186/cc10286; Mortberg E, 2011, RESUSCITATION, V82, P26, DOI 10.1016/j.resuscitation.2010.10.011; Northington FJ, 2001, NEUROBIOL DIS, V8, P207, DOI 10.1006/nbdi.2000.0371; Papa L, 2012, ANN EMERG MED, V59, P471, DOI 10.1016/j.annemergmed.2011.08.021; Papa L, 2010, CRIT CARE MED, V38, P138, DOI 10.1097/CCM.0b013e3181b788ab; Plog BA, 2015, J NEUROSCI, V35, P518, DOI 10.1523/JNEUROSCI.3742-14.2015; Tiainen M, 2003, STROKE, V34, P2881, DOI 10.1161/01.STR.0000103320.90706.35; Topjian AA, 2009, PEDIATR CRIT CARE ME, V10, P479, DOI 10.1097/PCC.0b013e318198bdb5; Young KD, 2004, PEDIATRICS, V114, P157, DOI 10.1542/peds.114.1.157	37	15	15	0	6	ELSEVIER IRELAND LTD	CLARE	ELSEVIER HOUSE, BROOKVALE PLAZA, EAST PARK SHANNON, CO, CLARE, 00000, IRELAND	0300-9572	1873-1570		RESUSCITATION	Resuscitation	APR	2016	101						65	70		10.1016/j.resuscitation.2016.01.024			6	Critical Care Medicine; Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Emergency Medicine	DL8HR	WOS:000375882300024	26855294	Green Accepted			2022-02-06	
J	Huguenard, AL; Miller, BA; Sarda, S; Capasse, M; Reisner, A; Chern, JJ				Huguenard, Anna L.; Miller, Brandon A.; Sarda, Samir; Capasse, Meredith; Reisner, Andrew; Chern, Joshua J.			Mild traumatic brain injury in children is associated with a low risk for posttraumatic seizures	JOURNAL OF NEUROSURGERY-PEDIATRICS			English	Article						antiepileptic drug; electroencephalography; mild traumatic brain injury; posttraumatic seizure; trauma	BLUNT HEAD TRAUMA; ANTISEIZURE PROPHYLAXIS; SHUNT SURGERY; SYSTEM; RETURN; PREVALENCE; MECHANISMS; EPILEPSY; IMPACT	OBJECTIVE Of the 1.7 million traumatic brain injuries (TBIs) in the US, a third occur in patients under 14 years of age. The rate of posttraumatic epilepsy (PTE) may be as high as 19% after severe pediatric TBI, but the risk for seizures after mild TBI is unknown. Although the rate of seizures after mild TBI may be low, current practice is often driven by high clinical concern for posttraumatic seizures. In this study, the authors evaluated electroencephalography (EEG) results and antiepileptic drug (AED) use in a large cohort of children with mild TBI to estimate the incidence of posttraumatic seizures in this population. METHODS Patients presenting to Children's Hospital of Atlanta for mild TBI from 2010 to 2013 were evaluated. Five thousand one hundred forty-eight patients with mild TBI were studied and divided into 3 groups: 4168 who were discharged from the emergency department, 868 who, ere admitted without neurosurgical intervention, and 112 who underwent neurosurgical procedures (craniotomy for hematoma evacuation or elevation of depressed skull fractures) but were discharged without an extended stay. Demographic information, CT characteristics, EEG reports, and prescriptions for AEDs were analyzed. Long-term follow-up was sought for all patients who underwent EEG. Correlation between EEG result and AED use was also evaluated. RESULTS All patients underwent head CT, and admitted patients were more likely to have an abnormal study (p < 0.0001). EEG evaluations were performed for less than 1.0% of patients in all 3 categories, without significant differences between groups (p = 0.97). Clinicians prescribed AEDs in less than 2.0% of patients for all groups, without significant differences between groups (p = 0.094). Even fewer children continue to see a neurologist for long-term seizure management. The EEG result had good negative predictive value, but only an abnormal EEG reading that was diagnostic of seizures correlated significantly with AED prescription (p = 0.04). CONCLUSIONS EEG utilization and AED prescription was low in all 3 groups, indicating that seizures following mild TBI are likely rare events. EEG has good negative predictive value for patients who did not receive AEDs, but has poorer positive predictive value for AED use.	[Huguenard, Anna L.; Miller, Brandon A.; Reisner, Andrew; Chern, Joshua J.] Emory Univ, Dept Neurosurg, Atlanta, GA 30322 USA; [Sarda, Samir; Capasse, Meredith; Reisner, Andrew; Chern, Joshua J.] Childrens Healthcare Atlanta, Pediat Neurosurg Associates, Atlanta, GA USA		Miller, BA (corresponding author), 1365 Clifton Rd NE,Bldg B,Ste 2200, Atlanta, GA 30322 USA.	brandon.miller@emory.edu		Huguenard, Anna/0000-0002-8625-4698			ANNEGERS JF, 1980, NEUROLOGY, V30, P683, DOI 10.1212/WNL.30.7.683; Annegers JF, 1998, NEW ENGL J MED, V338, P20, DOI 10.1056/NEJM199801013380104; Arango JI, 2012, CHILD NERV SYST, V28, P1925, DOI 10.1007/s00381-012-1863-0; Bhullar IS, 2014, J TRAUMA ACUTE CARE, V76, P54, DOI 10.1097/TA.0b013e3182aafd15; Centers for Disease Control and Prevention, CDCS INJ CTR TRAUM B; Chapman SB, 2000, J COMMUN DISORD, V33, P333, DOI 10.1016/S0021-9924(00)00029-0; Chern JJ, 2014, J NEUROSURG-PEDIATR, V14, P306, DOI 10.3171/2014.6.PEDS13682; Chern JJ, 2014, J NEUROSURG-PEDIATR, V13, P525, DOI 10.3171/2014.2.PEDS13493; ENGEL J, 1983, NEUROLOGY, V33, P400, DOI 10.1212/WNL.33.4.400; Faul M, 2010, TRAUMATIC BRAIN INJU; Gaggero R, 2014, EUR J PAEDIATR NEURO, V18, P376, DOI 10.1016/j.ejpn.2014.01.011; Gordon Kevin E, 2006, Semin Pediatr Neurol, V13, P243, DOI 10.1016/j.spen.2006.09.005; Greenberg JK, 2014, J TRAUMA ACUTE CARE, V76, P1089, DOI 10.1097/TA.0000000000000155; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Hunt RF, 2013, FRONT CELL NEUROSCI, V7, DOI 10.3389/fncel.2013.00089; Kim K, 2002, J KOREAN CHILD NEROL, V10, P63; Kochanek PM, 2012, PEDIATR CRIT CARE ME, V13, pS72, DOI 10.1097/PCC.0b013e31823f681d; Lee HS, 2013, BMC PEDIATR, V13, DOI 10.1186/1471-2431-13-211; Matsumoto JH, 2013, EPILEPSY BEHAV, V27, P233, DOI 10.1016/j.yebeh.2013.01.024; Nigrovic LE, 2012, ARCH PEDIAT ADOL MED, V166, P356, DOI 10.1001/archpediatrics.2011.1156; O'Neill BR, 2015, J NEUROSURG-PEDIATR, V16, P167, DOI 10.3171/2014.12.PEDS14263; Park JT, 2015, PEDIATR NEUROL, V52, P174, DOI 10.1016/j.pediatrneurol.2014.09.013; Sarda S, 2014, J NEUROSURG-PEDIATR, V14, P654, DOI 10.3171/2014.8.PEDS14109; Tavarez MM, 2012, CURR OPIN PEDIATR, V24, P307, DOI 10.1097/MOP.0b013e3283531ce6; Vespa PM, 1999, J NEUROSURG, V91, P750, DOI 10.3171/jns.1999.91.5.0750; Wrubel DM, 2014, J NEUROSURG-PEDIATR, V13, P216, DOI 10.3171/2013.10.PEDS13248	26	15	15	0	3	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1933-0707	1933-0715		J NEUROSURG-PEDIATR	J. Neurosurg.-Pediatr.	APR	2016	17	4					476	482		10.3171/2015.7.PEDS14723			7	Clinical Neurology; Pediatrics; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pediatrics; Surgery	DH3EF	WOS:000372669600015	26613272	Bronze			2022-02-06	
J	Johnson, T; Koria, P				Johnson, Tamina; Koria, Piyush			Expression and Purification of Neurotrophin-Elastin-Like Peptide Fusion Proteins for Neural Regeneration	BIODRUGS			English	Article							NERVE GROWTH-FACTOR; SPINAL-CORD-INJURY; ESCHERICHIA-COLI; DRUG-DELIVERY; GENE-THERAPY; SIGNALING ENDOSOMES; CONTROLLED-RELEASE; HEPARAN-SULFATE; NANOPARTICLES; SYSTEM	Background Neural injuries such as spinal cord injuries, traumatic brain injuries, or nerve transection injuries pose a major health problem. Neurotrophins such as nerve growth factor (NGF) or brain-derived neurotrophic factor (BDNF) have been shown to improve the outcome of neural injuries in several pre-clinical models, but their use in clinics is limited by the lack of a robust delivery system that enhances their bioavailability and half-life. Objectives We describe two fusion proteins comprising NGF or BDNF fused with elastin-like peptides (ELPs). The aim of this study was to investigate the biological activity of neurotrophin-ELP (N-ELP) fusion proteins via in vitro culture models. Methods NGF and BDNF were cloned in front of an elastin-like polypeptide sequence V40C2. These proteins were expressed in bacteria as inclusion bodies. These fusion proteins underwent solubilization via 8 M urea and purification via inverse transition cycling (ITC). We measured the particle size and the effect of temperature on precipitated particles using dynamic light scattering (DLS). We used western blot analysis to confirm the specificity of NGF-ELP to tropomyosin receptor kinase A (TrkA) antibody and to confirm the specificity of BDNF-ELP to TrkB antibody. PC12 cells were used to perform a neurite outgrowth assay to determine the biological activity of NGF-ELP. Bioactivity of BDNF-ELP was ascertained via transfecting human epithelial kidney (HEK 293-T) cells to express the TrkB receptor. Results The proteins were successfully purified to high homogeneity by exploiting the phase transition property of ELPs and urea, which solubilize inclusion bodies. Using PC12 neurite outgrowth assay, we further demonstrated that the biological activity of NGF was retained in the fusion. Similarly, BDNF-ELP phosphorylated the TrkB receptor, suggesting the biological activity of BDNF was also retained in the fusion. We further show that owing to the phase transition property of ELPs in the fusion, these proteins self-assembled into nanoparticles at their respective transition temperatures. Conclusion These fusion proteins are useful for neural regeneration, as they not only retain the biological activity of the neurotrophin but also self-assemble into nanoparticles, thereby simultaneously serving as drug-delivery vehicles. These nanoparticles can serve as drug depots and will increase bioavailability by limiting neurotrophin loss due to diffusion, thereby allowing controlled spatio-temporal delivery of the neurotrophin.	[Johnson, Tamina; Koria, Piyush] Univ S Florida, Dept Chem & Biomed Engn, 4202 E Fowler Ave,ENB 118, Tampa, FL 33620 USA		Koria, P (corresponding author), Univ S Florida, Dept Chem & Biomed Engn, 4202 E Fowler Ave,ENB 118, Tampa, FL 33620 USA.	pkoria@usf.edu			University of South Florida; American Cancer SocietyAmerican Cancer Society [93-032-16]; NSF Florida Georgia Louis Stokes Alliance for Minority Participation Bridge [1139850]; USF Graduate Student Success Diversity Fellowship; Alfred P. Sloan Minority Ph.D. Program	This work was funded by startup funds from the University of South Florida (PK) and the new researcher grant (PK) from University of South Florida, and in part by Institutional Research Grant number 93-032-16 from the American Cancer Society (PK). Tamina Johnson was supported by NSF Florida Georgia Louis Stokes Alliance for Minority Participation Bridge to the Doctorate Award HRD #1139850, the USF Graduate Student Success Diversity Fellowship, and The Alfred P. Sloan Minority Ph.D. Program.	Angelova A, 2013, DRUG DISCOV TODAY, V18, P1263, DOI 10.1016/j.drudis.2013.07.010; Angelova A, 2013, INT J PHARMACEUT, V454, P625, DOI 10.1016/j.ijpharm.2013.06.006; Asai D, 2012, BIOMATERIALS, V33, P5451, DOI 10.1016/j.biomaterials.2012.03.083; Bidwell GL, 2010, ADV DRUG DELIVER REV, V62, P1486, DOI 10.1016/j.addr.2010.05.003; Blesch A, 2009, TRENDS NEUROSCI, V32, P41, DOI 10.1016/j.tins.2008.09.008; Bramham CR, 2005, PROG NEUROBIOL, V76, P99, DOI 10.1016/j.pneurobio.2005.06.003; Byrnes CK, 2001, WOUND REPAIR REGEN, V9, P341, DOI 10.1046/j.1524-475x.2001.00341.x; Cheng PL, 2011, P NATL ACAD SCI USA, V108, P18430, DOI 10.1073/pnas.1115907108; Delcroix JD, 2003, NEURON, V39, P69, DOI 10.1016/S0896-6273(03)00397-0; DICOU E, 1992, NEUROCHEM INT, V20, P129, DOI 10.1016/0197-0186(92)90136-F; Fawcett JW, 1999, BRAIN RES BULL, V49, P377, DOI 10.1016/S0361-9230(99)00072-6; George EM, 2015, VASC CELL, V7, DOI 10.1186/s13221-014-0026-3; GREENE LA, 1976, P NATL ACAD SCI USA, V73, P2424, DOI 10.1073/pnas.73.7.2424; Grill R, 1997, J NEUROSCI, V17, P5560; Hirsch T, 2007, FRONT BIOSCI-LANDMRK, V12, P2507, DOI 10.2741/2251; Howe CL, 2001, NEURON, V32, P801, DOI 10.1016/S0896-6273(01)00526-8; Huang EJ, 2001, ANNU REV NEUROSCI, V24, P677, DOI 10.1146/annurev.neuro.24.1.677; Iglesias R, 2015, MED ONCOL, V32, DOI 10.1007/s12032-015-0708-6; Katz JS, 2009, WIRES NANOMED NANOBI, V1, P128, DOI 10.1002/wnan.10; Koria P, 2011, P NATL ACAD SCI USA, V108, P1034, DOI 10.1073/pnas.1009881108; Le DHT, 2015, BIOPOLYMERS, V103, P175, DOI 10.1002/bip.22582; Lindsey S, 2015, BIOMACROMOLECULES, V16, P2672, DOI 10.1021/acs.biomac.5b00541; Meyer DE, 2002, BIOMACROMOLECULES, V3, P357, DOI 10.1021/bm015630n; Meyer DE, 1999, NAT BIOTECHNOL, V17, P1112, DOI 10.1038/15100; MEYER SL, 1994, J NEUROCHEM, V62, P825; Mie M, 2008, J BIOMED MATER RES B, V86B, P283, DOI 10.1002/jbm.b.31019; Mohtaram NK, 2013, BIOMED MATER, V8, DOI 10.1088/1748-6041/8/2/022001; Mortazavi MM, 2011, CHILD NERV SYST, V27, P1307, DOI 10.1007/s00381-010-1365-x; NEGRO A, 1992, BIOCHEM BIOPH RES CO, V186, P1553, DOI 10.1016/S0006-291X(05)81584-0; Park E, 1998, J DRUG TARGET, V6, P53, DOI 10.3109/10611869808997881; RATNER N, 1985, J CELL BIOL, V101, P744, DOI 10.1083/jcb.101.3.744; Rattenholl A, 2001, EUR J BIOCHEM, V268, P3296, DOI 10.1046/j.1432-1327.2001.02232.x; Sakiyama-Elbert SE, 2000, J CONTROL RELEASE, V69, P149, DOI 10.1016/S0168-3659(00)00296-0; Sakiyama-Elbert SE, 2001, FASEB J, V15, P1300, DOI 10.1096/fj.00-0564fje; Sandow SL, 2000, IMMUNOL CELL BIOL, V78, P430, DOI 10.1046/j.1440-1711.2000.00924.x; Shao YF, 2002, J CELL BIOL, V157, P679, DOI 10.1083/jcb.200201063; Sly DJ, 2012, JARO-J ASSOC RES OTO, V13, P1, DOI 10.1007/s10162-011-0297-9; SNOW AD, 1990, AM J PATHOL, V137, P1253; SOPPET D, 1991, CELL, V65, P895, DOI 10.1016/0092-8674(91)90396-G; Sun WJ, 2009, BIOMATERIALS, V30, P4649, DOI 10.1016/j.biomaterials.2009.05.037; Trumble TE, 2000, HAND CLIN, V16, P105; Valdez G, 2005, J NEUROSCI, V25, P5236, DOI 10.1523/JNEUROSCI.5104-04.2005; Wang TY, 2012, J BIOMATER APPL, V27, P369, DOI 10.1177/0885328212443297; Wang YC, 2008, BIOMATERIALS, V29, P4546, DOI 10.1016/j.biomaterials.2008.07.050; Willerth SM, 2007, ADV DRUG DELIVER REV, V59, P325, DOI 10.1016/j.addr.2007.03.014; Willerth SM, 2007, J BIOMED MATER RES A, V80A, P13, DOI 10.1002/jbm.a.30844; Wolfe D, 2012, NEUROSCI LETT, V527, P85, DOI 10.1016/j.neulet.2012.04.047; Yao F, 2000, WOUND REPAIR REGEN, V8, P443, DOI 10.1046/j.1524-475x.2000.00443.x	48	15	15	2	26	ADIS INT LTD	NORTHCOTE	5 THE WAREHOUSE WAY, NORTHCOTE 0627, AUCKLAND, NEW ZEALAND	1173-8804	1179-190X		BIODRUGS	Biodrugs	APR	2016	30	2					117	127		10.1007/s40259-016-0159-4			11	Oncology; Immunology; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Oncology; Immunology; Pharmacology & Pharmacy	DM6ZG	WOS:000376501000006	26820997				2022-02-06	
J	Kriz, PK; Stein, C; Kent, J; Ruggieri, D; Dolan, E; O'Brien, M; Meehan, WP				Kriz, Peter K.; Stein, Cynthia; Kent, Janet; Ruggieri, Danielle; Dolan, Emilie; O'Brien, Michael; Meehan, William P., III			Physical Maturity and Concussion Symptom Duration among Adolescent Ice Hockey Players	JOURNAL OF PEDIATRICS			English	Article							SPORT-RELATED CONCUSSION; HIGH-SCHOOL FOOTBALL; RISK-FACTORS; SELF-REPORT; PUBERTAL DEVELOPMENT; SEXUAL-MATURATION; YOUTH FOOTBALL; BODY CHECKING; INJURY RATES; RECOVERY	Objective To investigate the association between physical maturity and risk of prolonged concussion symptoms in adolescent ice hockey players. Study design Prospective cohort study of 145 patients ages 13-18 years with concussion referred to 3 hospital-affiliated sports medicine clinics between September 1, 2012 and March 31, 2015. Concussion evaluations included Post Concussive Symptom Score, neurologic examination, and postinjury computerized neurocognitive testing. Pubertal development at initial visit was assessed by the Pubertal Developmental Scale. Duration of concussion symptoms (days) was the main outcome. Statistical comparisons were conducted using Student t test, Wilcoxon rank sum, and logistic regression. Results Mean symptom duration was 44.5 +/- 48.7 days. Nearly one-half (48.3%) of all players enrolled had prolonged concussion symptoms (>= 28 days); most (86.9%) had symptom resolution by 90 days. Among males, less physically mature adolescents took longer to recover than more physically mature players (54.5 days vs 33.4 days; P=.004). " Early" Pubertal Category Score was the strongest predictor of prolonged symptoms (OR=4.29, 95% CI 1.24-14.85; P=.021) among males. Among females, heavier weight increased the odds of experiencing prolonged symptoms (OR 1.07, 95% CI 1.00-1.14; P=.039). Conclusions Among adolescent ice hockey players, early-pubertal stage is independently associated with longer recovery from concussion in males, and heavier weight is associated with longer concussion recovery in females. Until further studies determine valid physical maturity indicators, peripubertal collision sport athletes should compete in leagues grouped by relative age and be discouraged from "playing up" on varsity teams.	[Kriz, Peter K.; Ruggieri, Danielle; Dolan, Emilie] Brown Univ, Warren Alpert Med Sch, Div Sports Med, Dept Orthoped, 2 Dudley St,Suite 200, Providence, RI 02905 USA; [Kriz, Peter K.; Ruggieri, Danielle; Dolan, Emilie] Brown Univ, Warren Alpert Med Sch, Div Sports Med, Dept Pediat, 2 Dudley St,Suite 200, Providence, RI 02905 USA; [Kriz, Peter K.; Ruggieri, Danielle; Dolan, Emilie] Hasbro Childrens Hosp, 2 Dudley St,Suite 200, Providence, RI 02905 USA; [Stein, Cynthia; O'Brien, Michael; Meehan, William P., III] Boston Childrens Hosp, Sports Concuss Clin, Div Sports Med, Dept Orthoped, Boston, MA USA; [Kent, Janet] South Shore Hosp, Youth Sports Concuss Clin, Weymouth, MA USA; [O'Brien, Michael; Meehan, William P., III] Micheli Ctr Sports Injury Prevent, Waltham, MA USA		Kriz, PK (corresponding author), Brown Univ, Warren Alpert Med Sch, Div Sports Med, Dept Orthoped, 2 Dudley St,Suite 200, Providence, RI 02905 USA.; Kriz, PK (corresponding author), Hasbro Childrens Hosp, 2 Dudley St,Suite 200, Providence, RI 02905 USA.	Peter_Kriz@brown.edu			Rhode Island Foundation [20113642]; National Federation of State High School Associations Foundation [701-5917]; National Football League Players Association	Funded in part by Rhode Island Foundation (20113642) and the National Federation of State High School Associations Foundation (701-5917). The content of this report is solely the responsibility of the authors and does not necessarily reflect the official views of the funders. W.M. receives royalties from ABC-Clio publishing for the sale of his book, Kids, Sports, and Concussion: A guide for coaches and parents, and royalties from Wolters Kluwer for working as an author for UpToDate; he is under contract with ABC-Clio publishing for a future book, Concussions, and with Springer International publishing for a future book, Head and Neck Injuries in Young Athletes; and his research is funded, in part, by the National Football League Players Association and philanthropic support from the National Hockey League Alumni Association through the Corey C. Griffin Pro-Am Tournament. The other authors declare no conflicts of interest.	Aspen Institute, 2012, PLAYING SAF FUT YOUT; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Bond L, 2006, J ADOLESCENCE, V29, P709, DOI 10.1016/j.adolescence.2005.10.001; Brenner JS, 2014, PEDIATRICS, V133, P1151, DOI 10.1542/peds.2014-0692; BROOKSGUNN J, 1987, CHILD DEV, V58, P829, DOI 10.1111/j.1467-8624.1987.tb01423.x; BRUST JD, 1992, AM J DIS CHILD, V146, P741, DOI 10.1001/archpedi.1992.02160180101026; CARSKADON MA, 1993, J ADOLESCENT HEALTH, V14, P190, DOI 10.1016/1054-139X(93)90004-9; Coleman L, 2002, J ADOLESCENCE, V25, P535, DOI 10.1006/jado.2002.0494; Collins M, 2006, NEUROSURGERY, V58, P275, DOI 10.1227/01.NEU.0000200441.92742.46; Crockett LJ, 1988, PUBERTAL DEV S UNPUB; Daneshvar DH, 2011, CLIN SPORT MED, V30, P1, DOI 10.1016/j.csm.2010.08.006; Decloe MD, 2014, BRIT J SPORT MED, V48, P51, DOI 10.1136/bjsports-2012-091653; DUKE PM, 1980, PEDIATRICS, V66, P918; Emery C, 2011, CAN MED ASSOC J, V183, P1249, DOI 10.1503/cmaj.101540; Emery CA, 2006, AM J SPORT MED, V34, P1960, DOI 10.1177/0363546506290061; Emery CA, 2010, JAMA-J AM MED ASSOC, V303, P2265, DOI 10.1001/jama.2010.755; Field M, 2003, J PEDIATR-US, V142, P546, DOI 10.1067/mpd.2003.190; Giza CC, 2013, NEUROLOGY, V80, P2250, DOI 10.1212/WNL.0b013e31828d57dd; Halstead ME, 2010, PEDIATRICS, V126, P597, DOI 10.1542/peds.2010-2005; Harmon KG, 2013, BRIT J SPORT MED, V47, P15, DOI 10.1136/bjsports-2012-091941; Le Gall F, 2007, SCAND J MED SCI SPOR, V17, P564, DOI 10.1111/j.1600-0838.2006.00594.x; LINDER MM, 1995, CLIN J SPORT MED, V5, P167, DOI 10.1097/00042752-199507000-00006; Malina RM, 2006, CLIN J SPORT MED, V16, P214, DOI 10.1097/00042752-200605000-00005; Marar M, 2012, AM J SPORT MED, V40, P747, DOI 10.1177/0363546511435626; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; Meehan WP, 2014, NEUROLOGY, V83, P2204, DOI 10.1212/WNL.0000000000001073; Meehan WP, 2013, J PEDIATR-US, V163, P721, DOI 10.1016/j.jpeds.2013.03.012; Meehan WP, 2011, AM J SPORT MED, V39, P2304, DOI 10.1177/0363546511423503; National Federation of High School Associations, 2012 13 HIGH SCH ATH; Pallant J., 2010, SPSS SURVIVAL MANUAL, V4th; PETERSEN AC, 1988, J YOUTH ADOLESCENCE, V17, P117, DOI 10.1007/BF01537962; Roberts WO, 1999, MED SCI SPORT EXER, V31, P46, DOI 10.1097/00005768-199901000-00009; Scherr R., RECENT SURGE POPULAR; SCHLOSSBERGER NM, 1992, J ADOLESCENT HEALTH, V13, P109, DOI 10.1016/1054-139X(92)90075-M; Schmitz KE, 2004, J EARLY ADOLESCENCE, V24, P357, DOI 10.1177/0272431604268531; Spicer M.A.C.M., 2014, SPORTS RELATED CONCU; Straus B., GETTING INVOLVED LAT; USA Hockey, US HOCK OFF PLAYING; Wiggins W., 1999, THESIS LAKEHEAD U TH; Zimmer DM, 2015, TIS SEASON W MILFORD	40	15	15	0	10	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	APR	2016	171						234	+		10.1016/j.jpeds.2015.12.006			8	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Pediatrics	DH4KC	WOS:000372753600048	26781190	Bronze			2022-02-06	
J	Hui, H; Rao, W; Zhang, L; Xie, Z; Peng, C; Su, N; Wang, K; Wang, L; Luo, P; Hao, YL; Zhang, S; Fei, Z				Hui, Hao; Rao, Wei; Zhang, Lei; Xie, Zhen; Peng, Cheng; Su, Ning; Wang, Kai; Wang, Li; Luo, Peng; Hao, Ye-lu; Zhang, Sai; Fei, Zhou			Inhibition of Na+-K+-2Cl(-) Cotransporter-1 attenuates traumatic brain injury-induced neuronal apoptosis via regulation of Erk signaling	NEUROCHEMISTRY INTERNATIONAL			English	Article						Traumatic brain injury; Neurons; NKCC1; Erk; Apoptosis	ACTIVATED PROTEIN-KINASE; K-CL COTRANSPORTER; IN-VITRO; MEDIATED EXCITOTOXICITY; ENDOPLASMIC-RETICULUM; DOWN-REGULATION; HOMER 1A; EDEMA; NA+; MODEL	Traumatic brain injury (TBI) is the leading cause of mortality and morbidity worldwide and is characterized by immediate brain damage and secondary injuries, such as brain edema and ischemia. However, the exact pathological mechanisms that comprise these associated secondary injuries have not been fully elucidated. This study aimed to investigate the role of the Na+-K+-2Cl(-) cotransporter-1 (NKCC1) in the disruption of ion homeostasis and neuronal apoptosis in TBI. Using a traumatic neuron injury (TNI) model in vitro and a controlled cortex injury (CCI) model in vivo, the present study investigated changes in the expression and effects of NKCC1 in TBI using western blot, RNA interference, a lactate dehydrogenase (LDH) release assay, TdT-mediated dUTP Nick end-labeling (TUNEL) analysis, sodium imaging, brain water content, and neurological severity scoring. TBI induced the expression of NKCC1 to be significantly upregulated in the cortex, both in vitro and in vivo. Pharmacological inhibitor bumetanide (Bume) or NKCC1 RNA interference significantly attenuated TBI-induced intracellular Na+ increase, inhibited neuronal apoptosis, and improved brain edema and neurological function. Furthermore, NKCC1 inhibition also significantly inhibited TBI-induced extracellular signal-regulated kinase (Erk) activation. Erk inhibition significantly protected neurons from TBI injury; however, Erk inhibition had no effect on NKCC1 expression or the neuroprotective effect of NKCC1 inhibition against TBI. This study demonstrates the role of NKCC1 in MI-induced brain cortex injury, establishing that NKCC1 may play a neurotoxic role in TBI and that the inhibition of NKCC1 may protect neurons from TBI via the regulation of Erk signaling. (C) 2016 Elsevier Ltd. All rights reserved.	[Hui, Hao; Rao, Wei; Zhang, Lei; Xie, Zhen; Peng, Cheng; Su, Ning; Wang, Kai; Wang, Li; Luo, Peng; Hao, Ye-lu; Fei, Zhou] Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China; [Zhang, Sai] Univ Chinese Armed Police Forces, Affiliated Hosp Logist, Dept Neurosurg, Chenglin Rd, Tianjin 300162, Peoples R China		Fei, Z (corresponding author), Fourth Mil Med Univ, Xijing Hosp, Dept Neurosurg, Xian 710032, Shaanxi, Peoples R China.; Zhang, S (corresponding author), Univ Chinese Armed Police Forces, Affiliated Hosp Logist, Dept Neurosurg, Chenglin Rd, Tianjin 300162, Peoples R China.	zhangsai718@vip.126.com; feizhou@fmmu.edu.cn		Luo, Peng/0000-0003-0746-939X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81430043, 81200949, 30930093]; National Science and Technology Major Project of China [2013ZX09J13109-02C]; National Science and Technology Pillar Program of China [2012BAI11B02]; Science and Technology Project of Shaanxi [2013KTCQ03-01]; Program for Changjiang Scholars and Innovative Research Team in UniversityProgram for Changjiang Scholars & Innovative Research Team in University (PCSIRT) [IRT-14208]; Key Project of the Twelfth Five-year Plan of Scientific Research of China [AWS11J008]	We are indebted to the members of our laboratories in the Department of Neurosurgery, Xijing Hospital of the Fourth Military Medical University. This work was supported by the National Natural Science Foundation of China (Nos. 81430043, 81200949, 30930093), the National Science and Technology Major Project of China (2013ZX09J13109-02C), the National Science and Technology Pillar Program of China (No. 2012BAI11B02), the Science and Technology Project of Shaanxi (No. 2013KTCQ03-01), the Program for Changjiang Scholars and Innovative Research Team in University (No. IRT-14208), and the Key Project of the Twelfth Five-year Plan of Scientific Research of China (AWS11J008).	Algattas H, 2014, INT J MOL SCI, V15, P309, DOI 10.3390/ijms15010309; Beck J, 2003, J NEUROSCI, V23, P5061; Bilgen M, 2005, NEUROREHAB NEURAL RE, V19, P219, DOI 10.1177/1545968305278635; Brandt C, 2010, J NEUROSCI, V30, P8602, DOI 10.1523/JNEUROSCI.0633-10.2010; Cetin A, 2006, NAT PROTOC, V1, P3166, DOI 10.1038/nprot.2006.450; Chen H, 2005, J CEREBR BLOOD F MET, V25, P54, DOI 10.1038/sj.jcbfm.9600006; Chen H, 2007, J NEUROCHEM, V102, P1783, DOI 10.1111/j.1471-4159.2007.04638.x; Chen T, 2012, FREE RADICAL BIO MED, V52, P208, DOI 10.1016/j.freeradbiomed.2011.10.451; Chen XZ, 2008, J NEUROCHEM, V106, P1563, DOI 10.1111/j.1471-4159.2008.05501.x; Chen XZ, 2010, J NEUROCHEM, V112, P173, DOI 10.1111/j.1471-4159.2009.06438.x; Cote MP, 2014, J NEUROSCI, V34, P8976, DOI 10.1523/JNEUROSCI.0678-14.2014; Donkin JJ, 2010, CURR OPIN NEUROL, V23, P293, DOI 10.1097/WCO.0b013e328337f451; Flierl MA, 2009, NAT PROTOC, V4, P1328, DOI 10.1038/nprot.2009.148; Garzon-Muvdi T, 2012, PLOS BIOL, V10, DOI 10.1371/journal.pbio.1001320; HAAS M, 1994, AM J PHYSIOL-CELL PH, V267, pC869, DOI 10.1152/ajpcell.1994.267.4.C869; Hasbargen T, 2010, ANN NY ACAD SCI, V1198, P168, DOI 10.1111/j.1749-6632.2010.05462.x; Impey S, 1998, NEURON, V21, P869, DOI 10.1016/S0896-6273(00)80602-9; Jayakumar AR, 2011, J NEUROCHEM, V117, P437, DOI 10.1111/j.1471-4159.2011.07211.x; Jayakumar AR, 2010, METAB BRAIN DIS, V25, P31, DOI 10.1007/s11011-010-9180-3; Kahle KT, 2009, PHYSIOLOGY, V24, P257, DOI 10.1152/physiol.00015.2009; Kimelberg HK, 2004, NEUROSCIENCE, V129, P851, DOI 10.1016/j.neuroscience.2004.07.033; KLATZO I, 1967, J NEUROPATH EXP NEUR, V26, P1, DOI 10.1097/00005072-196701000-00001; Lee HA, 2010, J NEUROCHEM, V114, P520, DOI 10.1111/j.1471-4159.2010.06772.x; Li Q, 2014, FRONT BIOSCI-LANDMRK, V19, P1411, DOI 10.2741/4291; Liedtke CM, 2002, BBA-MOL CELL RES, V1589, P77, DOI 10.1016/S0167-4889(01)00189-6; Lobner D, 2000, J NEUROSCI METH, V96, P147, DOI 10.1016/S0165-0270(99)00193-4; Lu KT, 2008, CRIT CARE MED, V36, P917, DOI 10.1097/CCM.0B013E31816590C4; Lu KT, 2006, EUR J PHARMACOL, V548, P99, DOI 10.1016/j.ejphar.2006.07.048; Luo J, 2008, J CEREBR BLOOD F MET, V28, P737, DOI 10.1038/sj.jcbfm.9600561; Luo P, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.116; Luo P, 2012, APOPTOSIS, V17, P975, DOI 10.1007/s10495-012-0736-z; Ma YH, 2011, BRAIN RES BULL, V86, P441, DOI 10.1016/j.brainresbull.2011.07.007; Majewska A.K., 2010, J VIS EXP; Margulies S, 2009, J NEUROTRAUM, V26, P925, DOI [10.1089/neu.2008.0794, 10.1089/neu.2008-0794]; Marmarou A, 2006, J NEUROSURG, V104, P720, DOI 10.3171/jns.2006.104.5.720; Morrison B, 2011, ANNU REV BIOMED ENG, V13, P91, DOI 10.1146/annurev-bioeng-071910-124706; Mukhin AG, 1997, J NEUROTRAUM, V14, P651, DOI 10.1089/neu.1997.14.651; O'Donnell ME, 2004, J CEREBR BLOOD F MET, V24, P1046, DOI 10.1097/01.WCB.0000130867.32663.90; Panet R, 2002, J CELL PHYSIOL, V190, P227, DOI 10.1002/JCP.10055; Papadopoulos MC, 2002, MT SINAI J MED, V69, P242; Rao W, 2015, BBA-MOL BASIS DIS, V1852, P2402, DOI 10.1016/j.bbadis.2015.08.014; Rungta RL, 2015, CELL, V161, P610, DOI 10.1016/j.cell.2015.03.029; Tu P, 2009, J NEUROCHEM, V108, P126, DOI 10.1111/j.1471-4159.2008.05752.x; Zhao YB, 2012, EXP NEUROL, V237, P489, DOI 10.1016/j.expneurol.2012.07.004	44	15	15	1	7	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0197-0186	1872-9754		NEUROCHEM INT	Neurochem. Int.	MAR	2016	94						23	31		10.1016/j.neuint.2016.02.002			9	Biochemistry & Molecular Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Neurosciences & Neurology	DI6ZT	WOS:000373649600003	26854573				2022-02-06	
J	Talari, HR; Fakharian, E; Mousavi, N; Abedzadeh-Kalahroudi, M; Akbari, H; Zoghi, S				Talari, Hamid Reza; Fakharian, Esmaeil; Mousavi, Nooshin; Abedzadeh-Kalahroudi, Masoumeh; Akbari, Hossein; Zoghi, Sommayeh			The Rotterdam Scoring System Can Be Used as an Independent Factor for Predicting Traumatic Brain Injury Outcomes	WORLD NEUROSURGERY			English	Article						Computed tomography; Head trauma; Rotterdam scoring system	PROGNOSTIC VALUE; CLASSIFICATION; HEMATOMA	OBJECTIVE: Predicting outcomes in patients with traumatic brain injury is critically important for making sound clinical decisions. This study aimed at determining the prognostic value of the Rotterdam scoring system to predict early death among these patients. MATERIALS AND METHODS: This study was performed prospectively on 150 patients with traumatic brain injury hospitalized in Shahid Beheshti Hospital, Kashan, Iran, Patients' demographic and clinical characteristics such as age, sex, mechanism of trauma, initial Glasgow Coma Scale score, and accompanying lesions were documented. A brain computed tomography was performed for each patient and scored by use of the Rotterdam system, Patients were monitored for 2 weeks after hospital discharge, and their outcomes were documented. Univariate and multiple logistic regression analysis and prognostic values of Rotterdam system were conducted by SPSS software. RESULTS: Nineteen patients (12.7%) died during the course of the study. The mean age of the dead patients was significantly greater than those who survived (P = 0.037). The sensitivity and the specificity of the Rotterdam scoring system at the cutoff score of 4 were 842% and 962%, respectively. Rotterdam score was significantly correlated with patient outcomes (P < 0.0001). Moreover, logistic regression analyses revealed that factors such as age, sex, Glasgow Coma Scale score, and Rotterdam score significantly contributed to patient outcomes. CONCLUSIONS: Rotterdam score is an independent factor for predicting outcomes among patients with traumatic brain injury. At the cutoff score of 4, the Rotterdam system can predict outcomes among patients suffering from traumatic brain injury with acceptable sensitivity and specificity.	[Talari, Hamid Reza; Fakharian, Esmaeil; Mousavi, Nooshin; Abedzadeh-Kalahroudi, Masoumeh; Akbari, Hossein; Zoghi, Sommayeh] Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran		Abedzadeh-Kalahroudi, M (corresponding author), Kashan Univ Med Sci, Trauma Res Ctr, Kashan, Iran.	abedzadeh@kaums.ac.ir	Akbari, Hossein/G-4737-2017; Talari, Hamidreza/H-7838-2017; Abedzadeh-Kalahroudi, Masoumeh/G-4114-2017; Fakharian, Esmaeil/A-1338-2018	Akbari, Hossein/0000-0001-7486-8580; Talari, Hamidreza/0000-0001-6736-8449; Abedzadeh-Kalahroudi, Masoumeh/0000-0002-7318-6294; Moosavi Buki, Nooshin/0000-0003-0888-0068	Kashan University of Medical Sciences, Kashan, Iran [9185]	This study supported by deputy of research, Kashan University of Medical Sciences, Kashan, Iran (grant no: 9185). All Author declare that they have no competing interests.	Cushman JG, 2001, J TRAUMA, V51, P1016, DOI 10.1097/00005373-200111000-00034; Gabella B, 1997, ANN EPIDEMIOL, V7, P207, DOI 10.1016/S1047-2797(96)00150-0; Haaga JR, 2009, CT MRI WHOLE BODY; Huang YH, 2012, NEUROSURGERY, V71, P80, DOI 10.1227/NEU.0b013e3182517aa1; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P199, DOI 10.1007/s00402-012-1652-y; Leitgeb J, 2012, J NEUROSURG, V117, P324, DOI 10.3171/2012.4.JNS111448; Maas AIR, 2005, NEUROSURGERY, V57, P1173, DOI 10.1227/neu.0000186013.6304668; Maas AIR, 2007, J NEUROTRAUM, V24, P303, DOI 10.1089/neu.2006.0033; Marshall LF, 1991, J NEUROSURG S, V75, P14; Mata-Mbemba D, 2014, ACAD RADIOL, V21, P605, DOI 10.1016/j.acra.2014.01.017; Pillai SV, 2003, NEUROL INDIA, V51, P345; Saatman KE, 2008, J NEUROTRAUM, V25, P719, DOI 10.1089/neu.2008.0586; Segun T., TRAUMATIC BRAIN INJU; Signorini DF, 1999, J NEUROL NEUROSUR PS, V66, P26, DOI 10.1136/jnnp.66.1.26; Stocchetti N, 2004, J NEUROTRAUM, V21, P1131, DOI 10.1089/neu.2004.21.1131; Washington CW, 2012, J NEUROSURG, V116, P549, DOI 10.3171/2011.11.JNS111092	16	15	17	0	2	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	MAR	2016	87						195	199		10.1016/j.wneu.2015.11.055			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DI3HR	WOS:000373390200027	26704195				2022-02-06	
J	Vargo, MM; Vargo, KG; Gunzler, D; Fox, KW				Vargo, Mary M.; Vargo, Kevin G.; Gunzler, Douglas; Fox, Kermit W.			Interdisciplinary Rehabilitation Referrals in a Concussion Clinic Cohort: An Exploratory Analysis	PM&R			English	Article							TRAUMATIC BRAIN-INJURY; COMORBIDITY SURVEY REPLICATION; SPORT-RELATED CONCUSSION; HEAD-INJURY; MILD; PREVALENCE; STATEMENT; RECOVERY; SYMPTOMS; NEED	Objective: To assess the frequency and spectrum of referrals to rehabilitation disciplines in a concussion clinic population and factors associated with need for referral. Design: Retrospective study. Setting: Concussion clinic within the Physical Medicine and Rehabilitation Department of an academic medical center. Participants: Patients receiving physiatric management for concussion care. Main Outcome Measures: Referral to physical therapy (PT), occupational therapy, speech therapy (ST), neuropsychology, or any referral (Any), and reasons for referral. Interventions: Demographic and clinical variables were analyzed for possible association with referral to rehabilitation disciplines. These independent variables included mechanism of injury, referral source, age, gender, provider, days since injury, presenting Sports Concussion Assessment Tool 2 (SCAT2) symptom score, insurance type, clinical risk factors, whether the injury was work related and whether the patient had been hospitalized. Results: Among 262 patients meeting inclusion criteria, the most commonly prescribed individual therapy was physical therapy (74 patients; 28%), followed by speech therapy (60 patients, 23%), neuropsychology (27 patients, 10.3%), and occupational therapy (19 patients, 7.2%). In all, 121 (46%) of patients were referred to one or more disciplines. The most common reasons for referral were cognitive strategies (54 patients, 21%), balance/vestibular therapy (50 patients, 19%), and neck pain (32 patients, 12%). Per multivariate logistic regression analysis, covariates associated with PT: age, SCAT2 symptom score, gender, provider, and (inversely) cognitive/learning disorder; ST: time elapsed since injury, gender, and referral source of internal clinic; Any: SCAT2 symptom score. Referrals did not significantly vary by mechanism of injury (sports, fall, vehicular, etc), whether work-related, or whether the patient had been hospitalized. Insurance factors were significant for PT and Any on the univariate analysis but not logistic regression. Conclusions: Relatively little has been described about the typical rehabilitation requirements of individuals recovering from concussion. Although rest and guided return to usual activities have been emphasized as mainstays of management, a large number of patients in this concussion cohort were determined to require additional rehabilitation services to assist in recovery.	[Vargo, Mary M.; Fox, Kermit W.] Case Western Reserve Univ, Phys Med & Rehabil, Metrohlth Med Ctr, 2500 MetroHlth Dr, Cleveland, OH 44019 USA; [Vargo, Kevin G.] Univ Pittsburgh, Sch Hlth & Rehabil Sci, Pittsburgh, PA USA; [Gunzler, Douglas] Case Western Reserve Univ, Ctr Hlth Care Res & Policy, Metrohlth Med Ctr, Cleveland, OH 44019 USA		Vargo, MM (corresponding author), Case Western Reserve Univ, Phys Med & Rehabil, Metrohlth Med Ctr, 2500 MetroHlth Dr, Cleveland, OH 44019 USA.	mvargo@metrohealth.org					Alexander Hamish, 2007, N Z Med J, V120, pU2420; Alsalaheen BA, 2013, PHYSIOTHER RES INT, V18, P100, DOI 10.1002/pri.1532; Anderson T, 2006, PRACTICAL NEUROLOGY, V6, P342, DOI DOI 10.1136/JNNP.2006.106583; Binder LM, 1996, AM J PSYCHIAT, V153, P7; Bodin D, 2012, PEDIATRIC AND ADOLESCENT CONCUSSION: DIAGNOSIS, MANAGEMENT AND OUTCOMES, P9, DOI 10.1007/978-0-387-89545-1_2; Carroll LJ, 2004, J REHABIL MED, V36, P84, DOI 10.1080/16501960410023859; Centers for Disease Control and Prevention, CDCS C TRAUM BRAIN I; Centers for Disease Control and Prevention, 2015, ATTENTION DEFICIT HY; DeMarco AP, 2015, J CHILD NEUROL, V30, P468; EDNA TH, 1987, ACTA NEUROCHIR, V86, P12, DOI 10.1007/BF01419498; ENGLANDER J, 1992, Brain Injury, V6, P161, DOI 10.3109/02699059209029654; Gagnon I, 2009, BRAIN INJURY, V23, P956, DOI 10.3109/02699050903373477; Harmon KG, 2013, CLIN J SPORT MED, V23, P1, DOI 10.1097/JSM.0b013e31827f5f93; Iverson G.L., 2007, BRAIN INJURY MED PRI, P333; Kessler RC, 2006, AM J PSYCHIAT, V163, P716, DOI 10.1176/appi.ajp.163.4.716; Kessler RC, 2003, JAMA-J AM MED ASSOC, V289, P3095, DOI 10.1001/jama.289.23.3095; King NS, 1997, CLIN REHABIL, V11, P13, DOI 10.1177/026921559701100104; Leddy JJ, 2007, NEUROREHABILITATION, V22, P199; Leddy JJ, 2012, SPORTS HEALTH, V4, P147, DOI 10.1177/1941738111433673; Lipton RB, 2007, NEUROLOGY, V68, P343, DOI 10.1212/01.wnl.0000252808.97649.21; Makdissi M, 2013, BRIT J SPORT MED, V47, P308, DOI 10.1136/bjsports-2013-092255; McCrory P, 2005, BRIT J SPORT MED, V39, pI78, DOI 10.1136/bjsm.2005.018614; Meehan WP, 2011, CLIN SPORT MED, V30, P115, DOI 10.1016/j.csm.2010.08.003; RIMEL RW, 1981, NEUROSURGERY, V9, P221, DOI 10.1227/00006123-198109000-00001; Rose JM, 2005, BRAIN INJURY, V19, P29, DOI 10.1080/02699050310001617361; Ruff RM, 2009, ARCH CLIN NEUROPSYCH, V24, P3, DOI 10.1093/arclin/acp006; Ruffolo CF, 1999, ARCH PHYS MED REHAB, V80, P392, DOI 10.1016/S0003-9993(99)90275-7; Schneider KJ, 2013, BRIT J SPORT MED, V47, P304, DOI 10.1136/bjsports-2013-092190; Seiger A, 2015, J HEAD TRAUMA REHAB, V30, pE52, DOI 10.1097/HTR.0000000000000051; Willer Barry, 2006, Curr Treat Options Neurol, V8, P415, DOI 10.1007/s11940-006-0031-9	30	15	15	0	23	ELSEVIER SCIENCE INC	NEW YORK	360 PARK AVE SOUTH, NEW YORK, NY 10010-1710 USA	1934-1482	1934-1563		PM&R	PM&R	MAR	2016	8	3					241	248		10.1016/j.pmrj.2015.07.006			8	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Rehabilitation; Sport Sciences	DG9WQ	WOS:000372434900007	26226207				2022-02-06	
J	Ping, XJ; Jin, XM				Ping, Xingjie; Jin, Xiaoming			Transition from Initial Hypoactivity to Hyperactivity in Cortical Layer V Pyramidal Neurons after Traumatic Brain Injury In Vivo	JOURNAL OF NEUROTRAUMA			English	Article						action potential; neuronal activity; post-traumatic epilepsy; single-unit recording; traumatic brain injury	MIDDLE CEREBRAL-ARTERY; PRIMARY VISUAL-CORTEX; EPILEPTOGENIC NEOCORTEX; HOMEOSTATIC PLASTICITY; EXCITABILITY CHANGES; POSTTRAUMATIC EPILEPSY; SYNAPTIC PLASTICITY; IMPACT INJURY; RAT NEOCORTEX; OCCLUSION	Traumatic brain injury (TBI) often results in structural damage and a loss of neurons that is commonly accompanied by early changes in neuronal electrical activity. Loss of neuronal activity has been hypothesized to contribute to post-traumatic epileptogenesis through the regulation of homeostatic plasticity. The existence of activity loss in cortical neurons after TBI and its subsequent transition into hyperactivity over time is not well characterized, however, particularly in models of TBI in vivo. In the current study, changes in neuronal activity in the primary motor cortex after moderate controlled cortical impact (CCI) in mice were studied using a single-unit recording technique in vivo. Recordings were made at different time points after CCI from cortical layer V pyramidal neurons that were within 1-2mm from the anterior edge of the injured foci. Within 1-4h after CCI, the frequency of spontaneous single-unit activity depressed significantly, with the mean firing frequency decreasing from 2.59 +/- 0.18Hz in the sham group to 1.05 +/- 0.20Hz of the injured group. The firing frequencies recovered to the normal level at 1 day and 7 days post-CCI, but became significantly higher at 3 days and 14 days post-CCI. The results suggest that TBI caused initial loss of activity in neurons of the perilesional cortical region, which was followed by compensatory recovery and enhancement of activity. These time-dependent changes in neuronal activity may contribute to the development of hyperexcitability through homeostatic activity regulation.	[Ping, Xingjie; Jin, Xiaoming] Indiana Univ Sch Med, Indiana Spinal Cord & Brain Injury Res Grp, Stark Neurosci Res Inst, Dept Anat & Cell Biol, Indianapolis, IN 46202 USA		Jin, XM (corresponding author), Indiana Univ Sch Med, Stark Neurosci Res Inst, 320 West 15th St,NB 500C, Indianapolis, IN 46202 USA.	xijin@iupui.edu	ping, xingjie/AAW-4597-2020; Jin, Xiaoming/N-8545-2016; Jin, Xiaoming/AAH-3555-2020	Jin, Xiaoming/0000-0002-8671-8640; 	NCATS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1 TR001108] Funding Source: Medline; NCRR NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1 RR025761, RR025761] Funding Source: Medline; NIDA NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA) [R01 DA039530] Funding Source: Medline; NINDS NIH HHSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS057940] Funding Source: Medline; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR001108] Funding Source: NIH RePORTER; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR025761] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K99NS057940, R00NS057940] Funding Source: NIH RePORTER; NATIONAL INSTITUTE ON DRUG ABUSEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Drug Abuse (NIDA)European Commission [R01DA039530] Funding Source: NIH RePORTER		AGMON A, 1989, NEUROSCI LETT, V99, P137, DOI 10.1016/0304-3940(89)90278-4; Alves OL, 2005, J NEUROTRAUM, V22, P733, DOI 10.1089/neu.2005.22.733; Avramescu S, 2008, J NEUROSCI, V28, P6760, DOI 10.1523/JNEUROSCI.0643-08.2008; Bausch SB, 2006, J NEUROPHYSIOL, V96, P2151, DOI 10.1152/jn.00355.2006; Beck H, 2008, NAT REV NEUROSCI, V9, P357, DOI 10.1038/nrn2371; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Carmichael ST, 2002, J NEUROSCI, V22, P6062; Cerri C, 2010, EUR J NEUROSCI, V32, P1163, DOI 10.1111/j.1460-9568.2010.07363.x; CHAGNACAMITAL Y, 1990, J COMP NEUROL, V296, P598, DOI 10.1002/cne.902960407; Constantinidis C, 2002, J NEUROPHYSIOL, V88, P3487, DOI 10.1152/jn.00188.2002; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; Dinocourt C, 2011, EPILEPSIA, V52, P1656, DOI 10.1111/j.1528-1167.2011.03113.x; Echegoyen J, 2007, PLOS ONE, V2, DOI 10.1371/journal.pone.0000700; Espinosa JS, 2012, NEURON, V75, P230, DOI 10.1016/j.neuron.2012.06.009; Fischer C., 2002, Annales de Readaptation et de Medecine Physique, V45, P448, DOI 10.1016/S0168-6054(02)00295-7; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Guo DJ, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0064078; HEISS WD, 1976, ARCH NEUROL-CHICAGO, V33, P813, DOI 10.1001/archneur.1976.00500120017003; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Houweling AR, 2005, CEREB CORTEX, V15, P834, DOI 10.1093/cercor/bhh184; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Hwang E, 2013, FRONT SYST NEUROSCI, V7, DOI 10.3389/fnsys.2013.00107; Jin XM, 2011, CEREB CORTEX, V21, P1094, DOI 10.1093/cercor/bhq181; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Jin XM, 2005, J NEUROPHYSIOL, V93, P2117, DOI 10.1152/jn.00728.2004; Kao C, 2012, J NEUROSURG, V117, P316, DOI 10.3171/2012.4.JNS111170; Keck T, 2013, NEURON, V80, P327, DOI 10.1016/j.neuron.2013.08.018; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Maffei A, 2004, NAT NEUROSCI, V7, P1353, DOI 10.1038/nn1351; Maffei A, 2008, PROG BRAIN RES, V169, P211, DOI 10.1016/S0079-6123(07)00012-X; MCCORMICK DA, 1985, J NEUROPHYSIOL, V54, P782, DOI 10.1152/jn.1985.54.4.782; Moyanova S, 2003, J NEUROL SCI, V212, P59, DOI 10.1016/S0022-510X(03)00102-3; Munera A, 2012, NEUROSCIENCE, V223, P140, DOI 10.1016/j.neuroscience.2012.07.063; Neumann-Haefelin T, 2000, J CEREBR BLOOD F MET, V20, P45, DOI 10.1097/00004647-200001000-00008; Nita DA, 2006, J NEUROPHYSIOL, V95, P902, DOI 10.1152/jn.00742.2005; PALMER AM, 1993, J NEUROCHEM, V61, P2015, DOI 10.1111/j.1471-4159.1993.tb07437.x; PATEL IM, 1990, ANESTH ANALG, V70, P635; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Reeves TM, 2000, J NEUROSCI RES, V60, P370, DOI 10.1002/(SICI)1097-4547(20000501)60:3<370::AID-JNR12>3.0.CO;2-B; REEVES TM, 1995, EXP BRAIN RES, V106, P248; ROSNER G, 1986, STROKE, V17, P76, DOI 10.1161/01.STR.17.1.76; Safaai H, 2013, J NEUROSCI, V33, P5843, DOI 10.1523/JNEUROSCI.3486-12.2013; Sanabria ERC, 2001, J PHYSIOL-LONDON, V532, P205, DOI 10.1111/j.1469-7793.2001.0205g.x; SHARPLESS SK, 1962, ELECTROEN CLIN NEURO, V14, P244, DOI 10.1016/0013-4694(62)90034-2; Timofeev I, 2000, CEREB CORTEX, V10, P1185, DOI 10.1093/cercor/10.12.1185; Trasande CA, 2007, J CLIN NEUROPHYSIOL, V24, P154, DOI 10.1097/WNP.0b013e318033787f; Turrigiano GG, 1998, NATURE, V391, P892, DOI 10.1038/36103; Turrigiano G, 2012, CSH PERSPECT BIOL, V4, DOI 10.1101/cshperspect.a005736; Turrigiano G, 2011, ANNU REV NEUROSCI, V34, P89, DOI 10.1146/annurev-neuro-060909-153238; Turrigiano GG, 2008, CELL, V135, P422, DOI 10.1016/j.cell.2008.10.008; Yang L, 2010, J NEUROTRAUM, V27, P1541, DOI 10.1089/neu.2009.1244; Zhang XG, 2007, J NEUROSCI METH, V162, P91, DOI 10.1016/j.jneumeth.2006.12.012	52	15	15	0	4	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	FEB 15	2016	33	4					354	361		10.1089/neu.2015.3913			8	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	DD2NH	WOS:000369758800005	26095991	Green Published, Green Submitted			2022-02-06	
J	Glass, L; Moody, L; Grafman, J; Krueger, F				Glass, Leila; Moody, Lara; Grafman, Jordan; Krueger, Frank			Neural signatures of third-party punishment: evidence from penetrating traumatic brain injury	SOCIAL COGNITIVE AND AFFECTIVE NEUROSCIENCE			English	Article						neurolaw; social cognition; altruistic punishment; morality; prefrontal cortex; traumatic brain injury	TRANSCRANIAL MAGNETIC STIMULATION; DORSOLATERAL PREFRONTAL CORTEX; SOCIAL NORMS; ALTRUISTIC PUNISHMENT; DECISION-MAKING; MIND; SELF; NEUROBIOLOGY; JUDGMENTS; COGNITION	The ability to survive within a cooperative society depends on impartial third-party punishment (TPP) of social norm violations. Two cognitive mechanisms have been postulated as necessary for the successful completion of TPP: evaluation of legal responsibility and selection of a suitable punishment given the magnitude of the crime. Converging neuroimaging research suggests two supporting domain-general networks; a mentalizing network for evaluation of legal responsibility and a central-executive network for determination of punishment. A whole-brain voxel-based lesion-symptom mapping approach was used in conjunction with a rank-order TPP task to identify brain regions necessary for TPP in a large sample of patients with penetrating traumatic brain injury. Patients who demonstrated atypical TPP had specific lesions in core regions of the mentalizing (dorsomedial prefrontal cortex [PFC], ventromedial PFC) and central-executive (bilateral dorsolateral PFC, right intraparietal sulcus) networks. Altruism and executive functioning (concept formation skills) were significant predictors of TPP: altruism was uniquely associated with TPP in patients with lesions in right dorsolateral PFC and executive functioning was uniquely associated with TPP in individuals with lesions in left PFC. Our findings contribute to the extant literature to support underlying neural networks associated with TPP, with specific brain-behavior causal relationships confirming recent functional neuroimaging research.	[Glass, Leila] SDSU UCSD Joint Doctoral Program Clin Psychol, Dept Psychol, San Diego, CA USA; [Moody, Lara] Virginia Tech, Carilion Res Inst, Roanoke, VA USA; [Moody, Lara] Virginia Tech, Dept Psychol, Blacksburg, VA USA; [Grafman, Jordan] Rehabil Inst Chicago, Brain Injury Res Program, Chicago, IL 60611 USA; [Krueger, Frank] George Mason Univ, Mol Neurosci Dept, Fairfax, VA 22030 USA; [Krueger, Frank] George Mason Univ, Dept Psychol, Fairfax, VA 22030 USA		Krueger, F (corresponding author), George Mason Univ, Mol Neurosci Dept, Dept Psychol, 4400 Univ Dr,Mail Stop 2A1, Fairfax, VA 22030 USA.	FKrueger@gmu.edu			U.S. National Institute of Neurological Disorders and Stroke Intramural Research ProgramUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS); National Institutes of Health Clinical Research CenterUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA; National Institute on Alcohol Abuse and Alcoholism (NIAAA)United States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F31 AA022261]; NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISMUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Alcohol Abuse & Alcoholism (NIAAA) [F31AA022261] Funding Source: NIH RePORTER	This study was conducted and supported by the U.S. National Institute of Neurological Disorders and Stroke Intramural Research Program and took place at the National Institutes of Health Clinical Research Center. The views expressed in this article are those of the authors and do not necessarily reflect the official policy or position of the US Government. For further information about the Vietnam Head Injury Study, contact J.G. at jgrafman@northwestern.edu. Additional support was provided by National Institute on Alcohol Abuse and Alcoholism (NIAAA) grant number F31 AA022261.	Anderson, 1963, DEV ARMED FORCES QUA; Badre D, 2007, NEUROPSYCHOLOGIA, V45, P2883, DOI 10.1016/j.neuropsychologia.2007.06.015; Barbey AK, 2014, BRAIN, V137, P277, DOI 10.1093/brain/awt312; Barbey AK, 2012, BRAIN, V135, P1154, DOI 10.1093/brain/aws021; BaronCohen S, 1997, J CHILD PSYCHOL PSYC, V38, P813, DOI 10.1111/j.1469-7610.1997.tb01599.x; Baumgartner T, 2013, NEUROIMAGE, V81, P317, DOI 10.1016/j.neuroimage.2013.05.047; Bolla KI, 2004, CEREB CORTEX, V14, P1226, DOI 10.1093/cercor/bhh083; Brown G.K., 1996, BDI 2 BECK DEPRESSIO; Buckholtz JW, 2012, NAT NEUROSCI, V15, P655, DOI 10.1038/nn.3087; Buckholtz JW, 2008, NEURON, V60, P930, DOI 10.1016/j.neuron.2008.10.016; Chatterjee A, 2005, J COGNITIVE NEUROSCI, V17, P847, DOI 10.1162/0898929054021085; DAMASIO AR, 1990, TRENDS NEUROSCI, V13, P95, DOI 10.1016/0166-2236(90)90184-C; Davis M., 1983, J PERS SOC PSYCHOL, V44; de Quervain DJF, 2004, SCIENCE, V305, P1254, DOI 10.1126/science.1100735; Dehaene S, 2003, COGN NEUROPSYCHOL, V20, P487, DOI 10.1080/02643290244000239; Delis DC., 2001, DELIS KAPLAN EXECUTI; Dimitrov M, 1996, CORTEX, V32, P357, DOI 10.1016/S0010-9452(96)80057-8; Fehr E, 2004, TRENDS COGN SCI, V8, P185, DOI 10.1016/j.tics.2004.02.007; Fehr E, 2004, EVOL HUM BEHAV, V25, P63, DOI 10.1016/S1090-5138(04)00005-4; Feng CL, 2015, HUM BRAIN MAPP, V36, P591, DOI 10.1002/hbm.22649; Figner B, 2010, NAT NEUROSCI, V13, P538, DOI 10.1038/nn.2516; Flesch R, 1948, J APPL PSYCHOL, V32, P221, DOI 10.1037/h0057532; Flesch Rudolf, 1949, ART READABLE WRITING; Frith CD, 1999, SCIENCE, V286, P1692, DOI 10.1126/science.286.5445.1692; Gerloff C, 1997, BRAIN, V120, P1587, DOI 10.1093/brain/120.9.1587; Glenn AL, 2008, PSYCHIAT CLIN N AM, V31, P463, DOI 10.1016/j.psc.2008.03.004; GRAFMAN J, 1988, BRAIN, V111, P169, DOI 10.1093/brain/111.1.169; Greene JD, 2004, NEURON, V44, P389, DOI 10.1016/j.neuron.2004.09.027; Guo XY, 2013, NEUROIMAGE, V77, P246, DOI 10.1016/j.neuroimage.2013.03.048; HALSBAND U, 1994, NEUROSCI RES, V20, P149, DOI 10.1016/0168-0102(94)90032-9; Harris LT, 2005, NEUROIMAGE, V28, P763, DOI 10.1016/j.neuroimage.2005.05.021; Heatherton TF, 2006, SOC COGN AFFECT NEUR, V1, P18, DOI 10.1093/scan/nsl001; Heberlein AS, 2004, J COGNITIVE NEUROSCI, V16, P1143, DOI 10.1162/0898929041920423; Kalbe E, 2010, CORTEX, V46, P769, DOI 10.1016/j.cortex.2009.07.010; Kaller CP, 2013, HUM BRAIN MAPP, V34, P36, DOI 10.1002/hbm.21423; Kaller CP, 2011, CEREB CORTEX, V21, P307, DOI 10.1093/cercor/bhq096; Kaplan E., 2001, BOSTON NAMING TEST 2, V2nd; Knoch D, 2008, CEREB CORTEX, V18, P1987, DOI 10.1093/cercor/bhm237; Knoch D, 2006, SCIENCE, V314, P829, DOI 10.1126/science.1129156; Koenigs M, 2011, MOL PSYCHIATR, V16, P792, DOI 10.1038/mp.2010.124; Koenigs M, 2007, J NEUROSCI, V27, P951, DOI 10.1523/JNEUROSCI.4606-06.2007; Krueger F, 2007, CEREB CORTEX, V17, P2346, DOI 10.1093/cercor/bhl143; Krueger F, 2014, SOC COGN AFFECT NEUR, V9, P1143, DOI 10.1093/scan/nst092; Krueger F, 2013, SOC COGN AFFECT NEUR, V8, P494, DOI 10.1093/scan/nss026; Krueger F, 2011, HUM BRAIN MAPP, V32, P1419, DOI 10.1002/hbm.21119; Krueger F, 2009, P NATL ACAD SCI USA, V106, P22486, DOI 10.1073/pnas.0912568106; Krueger F, 2009, TRENDS COGN SCI, V13, P103, DOI 10.1016/j.tics.2008.12.005; Latzman RD, 2010, ASSESSMENT, V17, P172, DOI 10.1177/1073191109356254; Leopold A, 2012, SOC COGN AFFECT NEUR, V7, P871, DOI 10.1093/scan/nsr071; Makale M, 2002, BEHAV RES METH INS C, V34, P6, DOI 10.3758/BF03195419; McNeil MR, 1978, REVISED TOKEN TEST; Mendez MF, 2009, CNS SPECTRUMS, V14, P608, DOI 10.1017/S1092852900023853; Mitchell JP, 2006, NEURON, V50, P655, DOI 10.1016/j.neuron.2006.03.040; Moll J, 2005, NAT REV NEUROSCI, V6, P799, DOI 10.1038/nrn1768; Moran JM, 2006, J COGNITIVE NEUROSCI, V18, P1586, DOI 10.1162/jocn.2006.18.9.1586; Ochsner KN, 2002, J COGNITIVE NEUROSCI, V14, P1215, DOI 10.1162/089892902760807212; Pia L, 2009, BRAIN COGNITION, V69, P81, DOI 10.1016/j.bandc.2008.05.007; Poldrack RA, 2011, NEURON, V72, P692, DOI 10.1016/j.neuron.2011.11.001; PREMACK D, 1978, BEHAV BRAIN SCI, V1, P515, DOI 10.1017/S0140525X00076512; Raymont Vanessa, 2011, Front Neurol, V2, P15, DOI 10.3389/fneur.2011.00015; Robinson PH, 2007, MINN LAW REV, V91, P1829; RUSHTON JP, 1981, PERS INDIV DIFFER, V2, P293; Saxe R, 2006, CURR OPIN NEUROBIOL, V16, P235, DOI 10.1016/j.conb.2006.03.001; Schleim S, 2011, SOC COGN AFFECT NEUR, V6, P48, DOI 10.1093/scan/nsq010; Shamay-Tsoory SG, 2007, NEUROPSYCHOLOGIA, V45, P3054, DOI 10.1016/j.neuropsychologia.2007.05.021; Shen FX, 2011, NEW YORK U LAW REV, V86, P1306; Solomon J, 2007, COMPUT METH PROG BIO, V86, P245, DOI 10.1016/j.cmpb.2007.02.006; Spielberger C. D., 1999, STATE TRAIT ANGER EX; Stein MB, 2007, AM J PSYCHIAT, V164, P318, DOI 10.1176/appi.ajp.164.2.318; Strobel A, 2011, NEUROIMAGE, V54, P671, DOI 10.1016/j.neuroimage.2010.07.051; SULTZER DL, 1992, J AM GERIATR SOC, V40, P549, DOI 10.1111/j.1532-5415.1992.tb02101.x; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van Overwalle F, 2009, HUM BRAIN MAPP, V30, P829, DOI 10.1002/hbm.20547; van't Wout M, 2005, NEUROREPORT, V16, P1849, DOI 10.1097/01.wnr.0000183907.08149.14; Wechsler D., 2011, WECHSLER ABBREVIATED; Wechsler D., 1997, WECHSLER MEMORY SCAL; WOODS RP, 1993, J COMPUT ASSIST TOMO, V17, P536, DOI 10.1097/00004728-199307000-00004; Yamada M, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1757; Young L, 2010, P NATL ACAD SCI USA, V107, P6753, DOI 10.1073/pnas.0914826107	79	15	18	1	28	OXFORD UNIV PRESS	OXFORD	GREAT CLARENDON ST, OXFORD OX2 6DP, ENGLAND	1749-5016	1749-5024		SOC COGN AFFECT NEUR	Soc. Cogn. Affect. Neurosci.	FEB	2016	11	2					253	262		10.1093/scan/nsv105			10	Neurosciences; Psychology; Psychology, Experimental	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology	DJ5DL	WOS:000374226900007	26276809	Green Submitted, hybrid, Green Published			2022-02-06	
J	Jefferson, SC; Clayton, ER; Donlan, NA; Kozlowski, DA; Jones, TA; Adkins, DL				Jefferson, Stephanie C.; Clayton, Elyse Renee; Donlan, Nicole A.; Kozlowski, Dorothy Annette; Jones, Theresa A.; Adkins, DeAnna Lynn			Cortical Stimulation Concurrent With Skilled Motor Training Improves Forelimb Function and Enhances Motor Cortical Reorganization Following Controlled Cortical Impact	NEUROREHABILITATION AND NEURAL REPAIR			English	Article						motor cortex; motor map; TBI; recovery; plasticity; ICMS; CCI	SENSORIMOTOR CORTEX; RECOVERY; PLASTICITY; INFARCT; RATS	Background. Electrical and magnetic brain stimulation can improve motor function following stroke in humans, rats, and nonhuman primates, especially when paired with rehabilitative training (RT). Previously, we found in rodent stroke models that epidural electrical cortical stimulation (CS) of the ipsilesional motor cortex (MC) combined with motor RT enhances motor function and motor cortical plasticity. It was unknown whether CS following experimental traumatic brain injury (TBI) would have similar effects. Objective. To test the effects of CS combined with motor training after moderate/severe TBI on behavioral outcome and motor cortical organization. Methods. Following unilateral controlled cortical impact (CCI) over the caudal forelimb area of the MC in adult male rats, forelimb reach training was administered daily for 9 weeks concurrently with subthreshold, 100-Hz monopolar CS or no-stimulation control procedures. The rate and magnitude of behavioral improvements and changes in forelimb movement representations in the injured MC as revealed by intracortical microstimulation were measured. Results. CCI resulted in severe motor impairments persisting throughout the 9 weeks of training in both groups, but CS-treated animals had significantly greater behavioral improvements. CS also increased wrist motor cortical representation, one of the main movements used in the training task, when compared with RT alone. However, the overall recovery level was modest, leaving animals still extremely impaired. Conclusions. These data suggest that CS may be useful for improving rehabilitation efficacy after TBI but also raise the possibility that the CS parameters that are highly effective following stroke are suboptimal after moderate/severe TBI.	[Jefferson, Stephanie C.; Donlan, Nicole A.; Jones, Theresa A.] Univ Texas Austin, Dept Psychol, Austin, TX 78712 USA; [Clayton, Elyse Renee; Adkins, DeAnna Lynn] Med Univ S Carolina, Dept Neurosci, 173 Ashley Ave,CRI404D,MSC510, Charleston, SC 29425 USA; [Kozlowski, Dorothy Annette] Depaul Univ, Dept Biol Sci, Chicago, IL 60604 USA; [Jones, Theresa A.] Univ Texas Austin, Inst Neurosci, Austin, TX 78712 USA; [Adkins, DeAnna Lynn] Med Univ S Carolina, Dept Hlth Sci & Res, Charleston, SC 29425 USA; [Adkins, DeAnna Lynn] Med Univ S Carolina, Ctr Biomed Imaging, Charleston, SC 29425 USA		Adkins, DL (corresponding author), Med Univ S Carolina, Dept Neurosci, 173 Ashley Ave,CRI404D,MSC510, Charleston, SC 29425 USA.	adkinsdl@musc.edu	Jones, Theresa A/F-1182-2010	Jones, Theresa A/0000-0003-0906-6439; Adkins, DeAnna L/0000-0002-3063-5731	NINDSUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [NS065866]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS065866] Funding Source: NIH RePORTER	The authors disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: This material is the result of work supported by NINDS NS065866 (DLA, TAJ, DAK).	Adkins DL, 2008, EXP NEUROL, V212, P14, DOI 10.1016/j.expneurol.2008.01.031; Adkins DL, 2015, NEUROREHAB NEURAL RE, V29, P989, DOI 10.1177/1545968315576577; Boychuk JA, 2011, NEUROREHAB NEURAL RE, V25, P88, DOI 10.1177/1545968310385126; Jones TA, 2012, J NEUROTRAUM, V29, P1455, DOI 10.1089/neu.2011.2207; Kleim JA, 2003, NEUROL RES, V25, P789, DOI 10.1179/016164103771953862; Kleim JA, 2002, NEUROBIOL LEARN MEM, V77, P63, DOI 10.1006/nlme.2000.4004; Nishibe M, 2010, J NEUROTRAUM, V27, P2221, DOI 10.1089/neu.2010.1456; O'Bryant AJ, 2016, NEUROREHAB NEURAL RE, V30, P143, DOI 10.1177/1545968314562112; Plautz EJ, 2003, NEUROL RES, V25, P801, DOI 10.1179/016164103771953880; Teskey GC, 2003, NEUROL RES, V25, P794, DOI 10.1179/016164103771953871	10	15	15	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1545-9683	1552-6844		NEUROREHAB NEURAL RE	Neurorehabil. Neural Repair	FEB	2016	30	2			SI		155	158		10.1177/1545968315600274			4	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	DC2VO	WOS:000369076400006	26248599	Green Accepted			2022-02-06	
J	Lesniak, A; Pick, CG; Misicka, A; Lipkowski, AW; Sacharczuk, M				Lesniak, Anna; Pick, Chaim G.; Misicka, Aleksandra; Lipkowski, Andrzej W.; Sacharczuk, Mariusz			Biphalin protects against cognitive deficits in a mouse model of mild traumatic brain injury (mTBI)	NEUROPHARMACOLOGY			English	Article						Neuroprotection; Biphalin; Traumatic brain injury; Mouse model	OPIOID RECEPTOR AGONISTS; MORRIS WATER MAZE; ENDOGENOUS OPIOIDS; HEAD-INJURY; NEOCORTICAL NEURONS; EXCITOTOXIC INJURY; DOPAMINE RELEASE; SPINAL-CORD; MICE; DELTA	Traumatic brain injury (TBI) is often a result of traffic accidents, contact sports or battlefield explosions. A mild form of traumatic brain injury (mTBI) is frequently underestimated, as the immediate physical symptoms decrease rapidly and conventional neuroimaging studies often do not show visible evidence of brain lesions. However, cognitive impairments persist for weeks, months or even years after the incident. Endogenous opioids were documented to play a role in thmodulation of mTBI pathology, whereas exogenous opioids were shown to possess neuroprotective properties. In the present study, biphalin, a dimeric enkephalin analog, improved cognitive performance in the Morris Water Maze and Novel Object Recognition tests in a mouse weight-drop model of mTBI. The effect of a single systemic injection of 10 mg/kg biphalin immediately after trauma was reversed by naltrexone, suggesting an opioid receptor-mediated mechanism. Biphalin also reduced cortical and hippocampal neurodegeneration, as shown by silver staining. Our data indicates that opioid receptor activation by biphalin may provide neuroprotection of post-traumatic neurodegeneration processes and may protect against memory impairments. (C) 2015 Elsevier Ltd. All rights reserved.	[Lesniak, Anna; Misicka, Aleksandra; Lipkowski, Andrzej W.] Polish Acad Sci, Dept Neuropeptides, Mossakowski Med Res Ctr, PL-02106 Warsaw, Poland; [Sacharczuk, Mariusz] Polish Acad Sci, Inst Genet & Anim Breeding, Dept Cytogenet, PL-05552 Magdalenka, Poland; [Pick, Chaim G.] Tel Aviv Univ, Dept Anat, Sackler Sch Med, IL-69978 Tel Aviv, Israel; [Lesniak, Anna] Uppsala Univ, Dept Pharmaceut Biosci, SE-75124 Uppsala, Sweden; [Misicka, Aleksandra] Univ Warsaw, Fac Chem, PL-02093 Warsaw, Poland		Sacharczuk, M (corresponding author), Polish Acad Sci, Inst Genet & Anim Breeding, Dept Cytogenet, Postepu 36A, PL-05552 Magdalenka, Poland.	alesniak@imdik.pan.pl; m.sacharczuk@ighz.pl		Lesniak, Anna/0000-0002-6014-9208; Sacharczuk, Mariusz/0000-0002-6309-5292	Polish National Science Centre [2011/03/N/NZ4/02021]	This study was financially supported by the Polish National Science Centre, grant no. 2011/03/N/NZ4/02021.	ARMSTEAD WM, 1994, BRAIN RES, V660, P19, DOI 10.1016/0006-8993(94)90834-6; BAAMONDE A, 1992, EUR J PHARMACOL, V216, P157, DOI 10.1016/0014-2999(92)90356-9; Carlson KF, 2010, J TRAUMA STRESS, V23, P17, DOI 10.1002/jts.20483; Chao DM, 2007, J CELL PHYSIOL, V212, P60, DOI 10.1002/jcp.21000; Dean P.J., 2013, FRONT HUM NEUROSCI, V12, P7, DOI DOI 10.3389/FNHUM.2013.00030; Doppenberg EMR, 2004, J NEUROSURG ANESTH, V16, P87, DOI 10.1097/00008506-200401000-00019; DOURMAP N, 1990, BRAIN RES, V524, P153, DOI 10.1016/0006-8993(90)90505-6; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; FADEN AI, 1990, ANN NEUROL, V27, P67, DOI 10.1002/ana.410270111; Falk AC, 2005, CHILD NERV SYST, V21, P430, DOI 10.1007/s00381-005-1142-4; Farace E, 2000, Neurosurg Focus, V8, pe6; Feng Y, 2012, CURR DRUG TARGETS, V13, P230, DOI 10.2174/138945012799201612; Fox GB, 1998, J NEUROTRAUM, V15, P1037, DOI 10.1089/neu.1998.15.1037; Fromm L, 2004, J AM COLL NUTR, V23, p529S, DOI 10.1080/07315724.2004.10719396; HAYES RL, 1990, J NEUROSURG, V72, P252, DOI 10.3171/jns.1990.72.2.0252; He XZ, 2013, CELL MOL LIFE SCI, V70, P2291, DOI 10.1007/s00018-012-1167-2; Heitger MH, 2007, J REHABIL MED, V39, P612, DOI 10.2340/16501977-0100; HICKS RR, 1993, J NEUROTRAUM, V10, P405, DOI 10.1089/neu.1993.10.405; HORAN PJ, 1993, J PHARMACOL EXP THER, V265, P1446; Husain S, 2012, CURR PHARM DESIGN, V18, P6101, DOI 10.2174/138161212803582441; Jones NC, 2008, J NEUROTRAUM, V25, P1367, DOI 10.1089/neu.2008.0641; Jutkiewicz EM, 2012, NEUROPSYCHOPHARMACOL, V37, P303, DOI 10.1038/npp.2011.244; KATAYAMA Y, 1990, J NEUROSURG, V73, P889, DOI 10.3171/jns.1990.73.6.0889; Kawalec M, 2011, NEUROCHEM RES, V36, P2091, DOI 10.1007/s11064-011-0568-1; Kierans AS, 2014, NEUROLOGY, V82, P521, DOI 10.1212/WNL.0000000000000105; Kim JS, 2009, ACTA HISTOCHEM, V111, P150, DOI 10.1016/j.acthis.2008.05.002; Kosson D, 2005, PHARMACOL REP, V57, P545; LIPKOWSKI AW, 1987, LIFE SCI, V40, P2283, DOI 10.1016/0024-3205(87)90065-8; LIPKOWSKI AW, 1982, PEPTIDES, V3, P697, DOI 10.1016/0196-9781(82)90173-5; Luo J, 2006, P NATL ACAD SCI USA, V103, P18326, DOI 10.1073/pnas.0605077103; LYETH BG, 1995, NEUROPEPTIDES, V29, P11, DOI 10.1016/0143-4179(95)90051-9; MCINTOSH TK, 1987, BRAIN RES, V425, P225, DOI 10.1016/0006-8993(87)90505-1; McKee AC, 2014, ALZHEIMERS DEMENT, V10, pS242, DOI 10.1016/j.jalz.2014.04.003; McKinlay A, 2008, BRAIN INJURY, V22, P175, DOI 10.1080/02699050801888824; Menon DK, 2010, ARCH PHYS MED REHAB, V91, P1637, DOI 10.1016/j.apmr.2010.05.017; Milman A, 2005, J NEUROTRAUM, V22, P1003, DOI 10.1089/neu.2005.22.1003; Mollica A, 2005, BIOORG MED CHEM LETT, V15, P2471, DOI 10.1016/j.bmcl.2005.03.067; Mooney G, 2001, BRAIN INJURY, V15, P865, DOI 10.1080/02699050110065286; Mosenthal AC, 2004, J TRAUMA, V56, P1042, DOI 10.1097/01.TA.0000127767.83267.33; O'Connor C, 2003, J NEUROTRAUM, V20, P985, DOI 10.1089/089771503770195830; Ostermeier AM, 2000, ANESTHESIOLOGY, V93, P1053, DOI 10.1097/00000542-200010000-00029; Pasaoglu H, 1996, NEUROPEPTIDES, V30, P47; Ponsford J, 2000, J INT NEUROPSYCH SOC, V6, P568, DOI 10.1017/S1355617700655066; Sacharczuk M, 2014, ADDICT BIOL, V19, P643, DOI 10.1111/adb.12030; SCHWEGLER H, 1988, BEHAV GENET, V18, P153, DOI 10.1007/BF01067837; Sharma A, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0112019; SHARMA HS, 1993, NEUROPHARMACOLOGY, V32, P711, DOI 10.1016/0028-3908(93)90085-H; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Silver JM, 2009, AM J PSYCHIAT, V166, P653, DOI 10.1176/appi.ajp.2009.08111676; Siopi E, 2012, NEUROSCI LETT, V511, P110, DOI 10.1016/j.neulet.2012.01.051; Skelton RW, 2006, BRAIN INJURY, V20, P189, DOI 10.1080/02699050500456410; SPANAGEL R, 1990, J NEUROCHEM, V55, P1734, DOI 10.1111/j.1471-4159.1990.tb04963.x; Su TP, 2000, J BIOMED SCI, V7, P195, DOI 10.1159/000025448; Sun D, 2014, NEURAL REGEN RES, V9, P688, DOI 10.4103/1673-5374.131567; Sun K, 2009, BRAIN RES, V1292, P100, DOI 10.1016/j.brainres.2009.06.104; Tashlykov V, 2007, BRAIN RES, V1130, P197, DOI 10.1016/j.brainres.2006.10.032; TEASDALE G, 1974, LANCET, V2, P81; Tsaousides T, 2009, MT SINAI J MED, V76, P173, DOI 10.1002/msj.20099; UPCHURCH M, 1988, BEHAV GENET, V18, P55, DOI 10.1007/BF01067075; von Holst H, 2004, J REHABIL MED, V36, P8, DOI 10.1080/16501960410023633; Wolf JA, 2001, J NEUROSCI, V21, P1923, DOI 10.1523/JNEUROSCI.21-06-01923.2001; Xiong Y, 2009, EXPERT OPIN EMERG DR, V14, P67, DOI [10.1517/14728210902769601, 10.1517/14728210902769601 ]; Yang L, 2015, BRAIN RES, V1609, P1, DOI 10.1016/j.brainres.2015.03.022; Yang L, 2011, J PHARMACOL EXP THER, V339, P499, DOI 10.1124/jpet.111.184127; Yang L, 2011, BRAIN RES, V1383, P307, DOI 10.1016/j.brainres.2011.01.083; Zhang JH, 2000, BRAIN RES, V885, P143, DOI 10.1016/S0006-8993(00)02906-1; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579; Zohar O, 2006, NEUROSCI LETT, V394, P239, DOI 10.1016/j.neulet.2005.10.099; Zohar O, 2003, NEUROSCIENCE, V118, P949, DOI 10.1016/S0306-4522(03)00048-4	69	15	16	0	17	PERGAMON-ELSEVIER SCIENCE LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, ENGLAND	0028-3908	1873-7064		NEUROPHARMACOLOGY	Neuropharmacology	FEB	2016	101						506	518		10.1016/j.neuropharm.2015.10.014			13	Neurosciences; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Pharmacology & Pharmacy	DA0JQ	WOS:000367483800047	26474659				2022-02-06	
J	Manchester, LC; Lee, V; Schmithorst, V; Kochanek, PM; Panigrahy, A; Fink, EL				Manchester, Leah C.; Lee, Vince; Schmithorst, Vincent; Kochanek, Patrick M.; Panigrahy, Ashok; Fink, Ericka L.			Global and Regional Derangements of Cerebral Blood Flow and Diffusion Magnetic Resonance Imaging after Pediatric Cardiac Arrest	JOURNAL OF PEDIATRICS			English	Article							TRAUMATIC BRAIN-INJURY; CARDIOPULMONARY-RESUSCITATION; OXYGEN-METABOLISM; IN-VIVO; PERFUSION; CHILDREN; CARE; ASTROCYTES; OUTCOMES; LACTATE	Objective To quantify and examine the relationship between global and regional cerebral blood flow (CBF) and water diffusion on brain magnetic resonance imaging (MRI) in children after cardiac arrest. Study design Children admitted to a tertiary care children's hospital from July 2011 to April 2013 who received a brain MRI within 2 weeks after cardiac arrest that included arterial spin labeling and apparent diffusion coefficient (ADC) sequences were studied. CBF and ADC values were calculated globally and in 19 regions of interest. Outcome variables included survival and favorable neurologic outcome, which was defined as Pediatric Cerebral Performance Category <= 3 at 6 months. We examined global and regional relationships between CBF and ADC and their association with outcome. Results This sample included 14 pediatric patients (mean time to MRI 6 +/- 4 days), 9 of whom survived and 6 who survived with favorable outcome. Global ADC was significantly decreased in patients with unfavorable outcome (P = .02). Increased CBF and decreased ADC often were colocalized in the same region, especially in children who had unfavorable outcomes. Conclusions In this exploratory study, global restricted water diffusion on ADC after pediatric cardiac arrest was associated with unfavorable outcome. MRI assessments of perfusion and diffusion may have prognostic value after pediatric cardiac arrest.	[Manchester, Leah C.] Univ Pittsburgh, Sch Med, Pittsburgh, PA USA; [Lee, Vince; Schmithorst, Vincent; Panigrahy, Ashok] Childrens Hosp Pittsburgh, Dept Radiol, Pittsburgh, PA 15213 USA; [Kochanek, Patrick M.; Fink, Ericka L.] Univ Pittsburgh, Dept Crit Care Med, Pittsburgh, PA USA; [Kochanek, Patrick M.; Fink, Ericka L.] Univ Pittsburgh, Dept Crit Care Med, Safar Ctr Resuscitat Res, Pittsburgh, PA USA		Fink, EL (corresponding author), UPMC, Childrens Hosp Pittsburgh, Div Pediat Crit Care Med, 4401 Penn Ave,Fac Pavil,2nd Floor, Pittsburgh, PA 15224 USA.	FinkEL@ccm.upmc.edu	Fink, Ericka/AAU-9792-2021	Lee, Vincent/0000-0002-1444-8055; Fink, Ericka/0000-0002-3683-4571	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [K23 NS065132, K23NS063371]; Laerdal Foundation; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [K23NS065132, K23NS063371] Funding Source: NIH RePORTER	Funded by the National Institutes of Health (K23 NS065132 [to E.F.] and K23NS063371 [to A.P.]) and Laerdal Foundation (to E.F.). The authors declare no conflicts of interest.	Abend NS, 2008, PEDIATR CRIT CARE ME, V9, P32, DOI 10.1097/01.PCC.0000288714.61037.56; Ashwal S, 1997, ANN NEUROL, V41, P470, DOI 10.1002/ana.410410410; Barzo P, 1997, J NEUROSURG, V87, P900, DOI 10.3171/jns.1997.87.6.0900; Bergsneider M, 1997, J NEUROSURG, V86, P241, DOI 10.3171/jns.1997.86.2.0241; Biagi L, 2007, J MAGN RESON IMAGING, V25, P696, DOI 10.1002/jmri.20839; Blood AB, 2002, J PHYSIOL-LONDON, V543, P1015, DOI 10.1113/jphysiol.2002.023077; Buxton RB, 1998, MAGNET RESON MED, V40, P383, DOI 10.1002/mrm.1910400308; Caesar K, 2008, J PHYSIOL-LONDON, V586, P1337, DOI 10.1113/jphysiol.2007.144154; COHAN SL, 1989, STROKE, V20, P761, DOI 10.1161/01.STR.20.6.761; Dai WY, 2008, MAGN RESON MED, V60, P1488, DOI 10.1002/mrm.21790; Drabek T, 2014, RESUSCITATION, V85, P964, DOI 10.1016/j.resuscitation.2014.03.314; FARACI FM, 1994, STROKE, V25, P692, DOI 10.1161/01.STR.25.3.692; Fernandez-Klett F, 2010, P NATL ACAD SCI USA, V107, P22290, DOI 10.1073/pnas.1011321108; Fink EL, 2013, NEUROCRIT CARE, V19, P31, DOI 10.1007/s12028-012-9706-0; Fiser DH, 2000, CRIT CARE MED, V28, P2616, DOI 10.1097/00003246-200007000-00072; Itoh Y, 2012, J CEREBR BLOOD F MET, V32, P1167, DOI 10.1038/jcbfm.2012.5; Jantzen JPAH, 2007, BEST PRACT RES-CLIN, V21, P517, DOI 10.1016/j.bpa.2007.09.001; Kalogeris T, 2012, INT REV CEL MOL BIO, V298, P229, DOI 10.1016/B978-0-12-394309-5.00006-7; Kleinman ME, 2010, CIRCULATION, V122, pS876, DOI 10.1161/CIRCULATIONAHA.110.971101; Manole MD, 2012, J CEREBR BLOOD F MET, V32, P560, DOI 10.1038/jcbfm.2011.165; Manole MD, 2009, J CEREBR BLOOD F MET, V29, P197, DOI 10.1038/jcbfm.2008.112; Meaney PA, 2006, PEDIATRICS, V118, P2424, DOI 10.1542/peds.2006-1724; Miyasaka N, 2000, AM J NEURORADIOL, V21, P60; Moler FW, 2009, CRIT CARE MED, V37, P2259, DOI 10.1097/CCM.0b013e3181a00a6a; Morishima T, 2008, NEUROSCI RES, V61, P18, DOI 10.1016/j.neures.2008.01.005; Pienaar R, 2012, NEUROIMAGE, V63, P1510, DOI 10.1016/j.neuroimage.2012.07.062; Plesnila N, 1999, J NEUROTRAUM, V16, P831, DOI 10.1089/neu.1999.16.831; Pollock JM, 2008, AM J NEURORADIOL, V29, P1302, DOI 10.3174/ajnr.A1095; Roy C S, 1890, J Physiol, V11, P85; Takahashi T, 1999, AM J NEURORADIOL, V20, P917; Topjian AA, 2008, PEDIATRICS, V122, P1086, DOI 10.1542/peds.2007-3313; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; White ML, 2013, BRIT J RADIOL, V86, DOI 10.1259/bjr.20120464; Wijman CAC, 2009, ANN NEUROL, V65, P394, DOI 10.1002/ana.21632; Wintermark P, 2011, AM J NEURORADIOL, V32, P2023, DOI 10.3174/ajnr.A2708	35	15	15	0	4	MOSBY-ELSEVIER	NEW YORK	360 PARK AVENUE SOUTH, NEW YORK, NY 10010-1710 USA	0022-3476	1097-6833		J PEDIATR-US	J. Pediatr.	FEB	2016	169						28	+		10.1016/j.jpeds.2015.10.003			9	Pediatrics	Science Citation Index Expanded (SCI-EXPANDED)	Pediatrics	DB6AK	WOS:000368595300008	26561380	Green Accepted			2022-02-06	
J	Mao, XR; Kaufman, DM; Crowder, CM				Mao, X. R.; Kaufman, D. M.; Crowder, C. M.			Nicotinamide mononucleotide adenylyltransferase promotes hypoxic survival by activating the mitochondrial unfolded protein response	CELL DEATH & DISEASE			English	Article							WALLERIAN DEGENERATION; C-ELEGANS; AXONAL DEGENERATION; ENZYMATIC-ACTIVITY; NAD BIOSYNTHESIS; LIFE-SPAN; WLD(S); STRESS; MECHANISMS; PROTECTION	Gain-of-function mutations in the mouse nicotinamide mononucleotide adenylyltransferase type 1 (Nmnat1) produce two remarkable phenotypes: protection against traumatic axonal degeneration and reduced hypoxic brain injury. Despite intensive efforts, the mechanism of Nmnat1 cytoprotection remains elusive. To develop a new model to define this mechanism, we heterologously expressed a mouse Nmnat1 non-nuclear-localized gain-of-function mutant gene (m-nonN-Nmnat1) in the nematode Caenorhabditis elegans and show that it provides protection from both hypoxia-induced animal death and taxol-induced axonal pathology. Additionally, we find that m-nonN-Nmnat1 significantly lengthens C. elegans lifespan. Using the hypoxia-protective phenotype in C. elegans, we performed a candidate screen for genetic suppressors of m-nonN-Nmnat1 cytoprotection. Loss of function in two genes, haf-1 and dve-1, encoding mitochondrial unfolded protein response (mitoUPR) factors were identified as suppressors. M-nonN-Nmnat1 induced a transcriptional reporter of the mitoUPR gene hsp-6 and provided protection from the mitochondrial proteostasis toxin ethidium bromide. M-nonN-Nmnat1 was also protective against axonal degeneration in C. elegans induced by the chemotherapy drug taxol. Taxol markedly reduced basal expression of a mitoUPR reporter; the expression was restored by m-nonN-Nmnat1. Taken together, these data implicate the mitoUPR as a mechanism whereby Nmnat1 protects from hypoxic and axonal injury.	[Mao, X. R.; Kaufman, D. M.; Crowder, C. M.] Washington Univ, Dept Anesthesiol, Sch Med, 660 South Euclid Ave, St Louis, MO 63110 USA; [Kaufman, D. M.] Washington Univ, Med Scientist Training Program, Sch Med, 660 South Euclid Ave, St Louis, MO 63110 USA; [Kaufman, D. M.; Crowder, C. M.] Univ Washington, Dept Anesthesiol & Pain Med, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA; [Crowder, C. M.] Univ Washington, Dept Genome Sci, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA; [Mao, X. R.] Univ Washington, Dept Genet, Sch Med, Seattle, WA 98195 USA		Crowder, CM (corresponding author), Univ Washington, Dept Anesthesiol & Pain Med, Sch Med, 1959 NE Pacific St, Seattle, WA 98195 USA.	cmc53@uw.edu			NIH Office of Research Infrastructure Programs [P40 OD010440]; National Institute of Neurological Disorders and StrokeUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01 NS045905, 5R21NS084360-02]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS045905, R21NS084360] Funding Source: NIH RePORTER	We thank members in Crowder laboratory for help and insightful discussions. We thank Michael Nonet and his lab members and Jeffery Milbrandt and Yo Sasaki for reagents, advice and help with technique development. Some strains were provided by the Caenorhabditis Genetics Center, which is funded by NIH Office of Research Infrastructure Programs (P40 OD010440). We also thank National BioResource Project, Japan for strains. This work was supported by funding from the National Institute of Neurological Disorders and Stroke (R01 NS045905 and 5R21NS084360-02).	Ali YO, 2011, J BIOL CHEM, V286, P19089, DOI 10.1074/jbc.M111.219295; Anderson LL, 2009, SCIENCE, V323, P630, DOI 10.1126/science.1166175; Apfeld J, 1999, NATURE, V402, P804, DOI 10.1038/45544; Araki T, 2004, SCIENCE, V305, P1010, DOI 10.1126/science.1098014; Avery MA, 2012, CURR BIOL, V22, P596, DOI 10.1016/j.cub.2012.02.043; Avery MA, 2009, J CELL BIOL, V184, P501, DOI 10.1083/jcb.200808042; Badiola N, 2011, CELL DEATH DIS, V2, DOI 10.1038/cddis.2011.31; Bennett GJ, 2011, EUR J NEUROSCI, V33, P1667, DOI 10.1111/j.1460-9568.2011.07652.x; Bhattacharya MRC, 2012, J NEUROSCI, V32, P5054, DOI 10.1523/JNEUROSCI.4951-11.2012; BRENNER S, 1974, GENETICS, V77, P71; Butler JA, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0046140; Calfon M, 2002, NATURE, V415, P92, DOI 10.1038/415092a; Calixto A, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1003141; Chen LZ, 2011, TRENDS CELL BIOL, V21, P577, DOI 10.1016/j.tcb.2011.08.003; Coleman MP, 2010, ANNU REV NEUROSCI, V33, P245, DOI 10.1146/annurev-neuro-060909-153248; Coleman MP, 1998, P NATL ACAD SCI USA, V95, P9985, DOI 10.1073/pnas.95.17.9985; Conforti L, 2000, P NATL ACAD SCI USA, V97, P11377, DOI 10.1073/pnas.97.21.11377; Court FA, 2012, TRENDS NEUROSCI, V35, P364, DOI 10.1016/j.tins.2012.04.001; Evans TC, 2006, C ELEGANS RES COMMUN, DOI [10.1895/wormbook.1.108.1, DOI 10.1895/WORMBOOK.1.108.1]; Fang YS, 2012, CURR BIOL, V22, P590, DOI 10.1016/j.cub.2012.01.065; Fawcett EM, 2012, JOVE-J VIS EXP, DOI 10.3791/4088; Fay D. S., 2013, CLASSICAL GENETIC ME; Frokjaer-Jensen C, 2008, NAT GENET, V40, P1375, DOI 10.1038/ng.248; Hammarlund M, 2007, J CELL BIOL, V176, P269, DOI 10.1083/jcb.200611117; Haynes CM, 2007, DEV CELL, V13, P467, DOI 10.1016/j.devcel.2007.07.016; Haynes CM, 2010, MOL CELL, V37, P529, DOI 10.1016/j.molcel.2010.01.015; Hill S, 2014, REDOX BIOL, V2, P936, DOI 10.1016/j.redox.2014.07.005; Kaufman DM, 2015, CURR BIOL, V25, P2171, DOI 10.1016/j.cub.2015.06.062; Kim I, 2008, NAT REV DRUG DISCOV, V7, P1013, DOI 10.1038/nrd2755; Larue BL, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0016790; LUNN ER, 1989, EUR J NEUROSCI, V1, P27, DOI 10.1111/j.1460-9568.1989.tb00771.x; Mabon ME, 2009, PLOS ONE, V4, DOI 10.1371/journal.pone.0007937; Mabon ME, 2009, GENETICS, V181, P483, DOI 10.1534/genetics.108.097188; Mack TGA, 2001, NAT NEUROSCI, V4, P1199, DOI 10.1038/nn770; Mahoney MB, 2006, GENETICS, V172, P2309, DOI 10.1534/genetics.104.035170; Mao XR, 2010, MOL CELL BIOL, V30, P5033, DOI 10.1128/MCB.00922-10; Menuz V, 2009, SCIENCE, V324, P381, DOI 10.1126/science.1168532; Mouchiroud L, 2013, CELL, V154, P430, DOI 10.1016/j.cell.2013.06.016; Nargund AM, 2015, MOL CELL, V58, P123, DOI 10.1016/j.molcel.2015.02.008; Nargund AM, 2012, SCIENCE, V337, P587, DOI 10.1126/science.1223560; Nikiforov A, 2011, J BIOL CHEM, V286, P21767, DOI 10.1074/jbc.M110.213298; Powell-Coffman JA, 2010, TRENDS ENDOCRIN MET, V21, P435, DOI 10.1016/j.tem.2010.02.006; SAHENK Z, 1994, ARCH NEUROL-CHICAGO, V51, P726, DOI 10.1001/archneur.1994.00540190110024; Sasaki Y, 2006, J NEUROSCI, V26, P8484, DOI 10.1523/JNEUROSCI.2320-06.2006; Sasaki Y, 2009, J NEUROSCI, V29, P5525, DOI 10.1523/JNEUROSCI.5469-08.2009; Scott BA, 2002, SCIENCE, V296, P2388, DOI 10.1126/science.1072302; Scott B, 2013, J EXP BIOL, V216, P2283, DOI 10.1242/jeb.082263; Verdin E, 2014, NAT MED, V20, P25, DOI 10.1038/nm.3447; Verghese PB, 2011, P NATL ACAD SCI USA, V108, P19054, DOI 10.1073/pnas.1107325108; Vohra BPS, 2010, J NEUROSCI, V30, P13729, DOI 10.1523/JNEUROSCI.2939-10.2010; Wang JT, 2012, J CELL BIOL, V196, P7, DOI 10.1083/jcb.201108111; Yahata N, 2009, J NEUROSCI, V29, P6276, DOI 10.1523/JNEUROSCI.4304-08.2009; Yoneda T, 2004, J CELL SCI, V117, P4055, DOI 10.1242/jcs.01275	53	15	15	1	4	NATURE PUBLISHING GROUP	LONDON	MACMILLAN BUILDING, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	2041-4889			CELL DEATH DIS	Cell Death Dis.	FEB	2016	7								e2113	10.1038/cddis.2016.5			10	Cell Biology	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology	DG5FU	WOS:000372102400018	26913604	Green Published, gold			2022-02-06	
J	Spitz, G; McKenzie, D; Attwood, D; Ponsford, JL				Spitz, Gershon; McKenzie, Dean; Attwood, David; Ponsford, Jennie L.			Cost prediction following traumatic brain injury: model development and validation	JOURNAL OF NEUROLOGY NEUROSURGERY AND PSYCHIATRY			English	Article							POSTTRAUMATIC AMNESIA; MULTICENTER; CHARGES; LENGTH; SELECTION; DURATION; VETERANS; UTILITY; SCALE; STAY	Objective The ability to predict costs following a traumatic brain injury (TBI) would assist in planning treatment and support services by healthcare providers, insurers and other agencies. The objective of the current study was to develop predictive models of hospital, medical, paramedical, and long-term care (LTC) costs for the first 10 years following a TBI. Methods The sample comprised 798 participants with TBI, the majority of whom were male and aged between 15 and 34 at time of injury. Costing information was obtained for hospital, medical, paramedical, and LTC costs up to 10 years postinjury. Demographic and injury-severity variables were collected at the time of admission to the rehabilitation hospital. Results Duration of PTA was the most important single predictor for each cost type. The final models predicted 44% of hospital costs, 26% of medical costs, 23% of paramedical costs, and 34% of LTC costs. Greater costs were incurred, depending on cost type, for individuals with longer PTA duration, obtaining a limb or chest injury, a lower GCS score, older age at injury, not being married or defacto prior to injury, living in metropolitan areas, and those reporting premorbid excessive or problem alcohol use. Conclusions This study has provided a comprehensive analysis of factors predicting various types of costs following TBI, with the combination of injury-related and demographic variables predicting 23-44% of costs. PTA duration was the strongest predictor across all cost categories. These factors may be used for the planning and case management of individuals following TBI.	[Spitz, Gershon; Ponsford, Jennie L.] Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia; [Spitz, Gershon; Ponsford, Jennie L.] Epworth Med Fdn, Monash Epworth Rehabil Res Ctr, Melbourne, Vic, Australia; [McKenzie, Dean] Epworth Healthcare, Clin Trials & Res Ctr, Melbourne, Vic, Australia; [McKenzie, Dean] Monash Univ, Sch Publ Hlth & Prevent Med, Melbourne, Vic 3004, Australia; [Attwood, David] Transport Accid Commiss, Geelong, Vic, Australia		Spitz, G (corresponding author), Monash Univ, Sch Psychol Sci, Clayton, Vic 3800, Australia.	Gershon.Spitz@monash.edu	Spitz, Gershon/H-7755-2014	Spitz, Gershon/0000-0002-7810-1480	Transport Accident Commission (TAC), through the Institute for Safety, Compensation and Recovery Research (ISCRR)	This study was funded by the Transport Accident Commission (TAC), through the Institute for Safety, Compensation and Recovery Research (ISCRR). The cost data used in the current study was supplied by the TAC.	Access Economics , 2009, EC COST SPIN CORD IN; Akaike H., 1973, INT S INF THEOR; Austin PC, 2004, AM STAT, V58, P131, DOI 10.1198/0003130043277; Billah B, 2010, EUR J CARDIO-THORAC, V37, P1086, DOI 10.1016/j.ejcts.2009.11.021; Brown AW, 2010, BRAIN INJURY, V24, P472, DOI 10.3109/02699051003610466; Brown AW, 2005, J NEUROTRAUM, V22, P1040, DOI 10.1089/neu.2005.22.1040; Bryant ET, 1993, J HEAD TRAUMA REHAB, V8, P15; Burnham KP, 2004, SOCIOL METHOD RES, V33, P261, DOI 10.1177/0049124104268644; Burnham KP., 2002, MODEL SELECTION MULT; COWEN TD, 1995, ARCH PHYS MED REHAB, V76, P797, DOI 10.1016/S0003-9993(95)80542-7; Finkelstein E., 2006, INCIDENCE EC BURDEN; High WM, 1996, J HEAD TRAUMA REHAB, V11, P85, DOI 10.1097/00001199-199610000-00008; HOCKING RR, 1967, TECHNOMETRICS, V9, P531, DOI 10.2307/1266192; Homaifar BY, 2009, J REHABIL RES DEV, V46, P1003, DOI 10.1682/JRRD.2008.12.0166; Lehmkuhl L, 1993, J HEAD TRAUMA REHAB, V8, P88; Mayer NH, 2003, ARCH PHYS MED REHAB, V84, P242, DOI 10.1053/apmr.2003.50101; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McKenzie DP, 2006, ADDICT BEHAV, V31, P1683, DOI 10.1016/j.addbeh.2005.12.027; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Norusis M.J., 2011, IBM SPSS STAT 19 STA; Olesen J, 2012, EUR J NEUROL, V19, P155, DOI 10.1111/j.1468-1331.2011.03590.x; Ponsford JL, 2015, J HEAD TRAUMA REHAB, V30, pE1, DOI 10.1097/HTR.0000000000000033; Ponsford JL, 2013, J NEUROTRAUM, V30, P1498, DOI 10.1089/neu.2012.2843; Prang KH, 2012, BRAIN INJURY, V26, P441; Ryan T. P., 2009, MODERN REGRESSION ME; SCHWARZ G, 1978, ANN STAT, V6, P461, DOI 10.1214/aos/1176344136; Sherer M, 2008, J NEUROL NEUROSUR PS, V79, P678, DOI 10.1136/jnnp.2006.111187; SHORES EA, 1986, MED J AUSTRALIA, V144, P569, DOI 10.5694/j.1326-5377.1986.tb112311.x; Walker WC, 2010, J NEUROL NEUROSUR PS, V81, P87, DOI 10.1136/jnnp.2008.161570; Witten IH, 2011, MOR KAUF D, P1; Zar J.H., 2006, BIOSTATISTICAL ANAL	32	15	15	0	10	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	0022-3050	1468-330X		J NEUROL NEUROSUR PS	J. Neurol. Neurosurg. Psychiatry	FEB	2016	87	2					173	180		10.1136/jnnp-2014-309479			8	Clinical Neurology; Psychiatry; Surgery	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry; Surgery	DB0CA	WOS:000368175000012	25694473				2022-02-06	
J	Yadav, K; Sarioglu, E; Choi, HA; Cartwright, WB; Hinds, PS; Chamberlain, JM				Yadav, Kabir; Sarioglu, Efsun; Choi, Hyeong-Ah; Cartwright, Walter B.; Hinds, Pamela S.; Chamberlain, James M.			Automated Outcome Classification of Computed Tomography Imaging Reports for Pediatric Traumatic Brain Injury	ACADEMIC EMERGENCY MEDICINE			English	Article							RADIOLOGY REPORTS; LANGUAGE; STROKE	BackgroundThe authors have previously demonstrated highly reliable automated classification of free-text computed tomography (CT) imaging reports using a hybrid system that pairs linguistic (natural language processing) and statistical (machine learning) techniques. Previously performed for identifying the outcome of orbital fracture in unprocessed radiology reports from a clinical data repository, the performance has not been replicated for more complex outcomes. ObjectivesTo validate automated outcome classification performance of a hybrid natural language processing (NLP) and machine learning system for brain CT imaging reports. The hypothesis was that our system has performance characteristics for identifying pediatric traumatic brain injury (TBI). MethodsThis was a secondary analysis of a subset of 2,121 CT reports from the Pediatric Emergency Care Applied Research Network (PECARN) TBI study. For that project, radiologists dictated CT reports as free text, which were then deidentified and scanned as PDF documents. Trained data abstractors manually coded each report for TBI outcome. Text was extracted from the PDF files using optical character recognition. The data set was randomly split evenly for training and testing. Training patient reports were used as input to the Medical Language Extraction and Encoding (MedLEE) NLP tool to create structured output containing standardized medical terms and modifiers for negation, certainty, and temporal status. A random subset stratified by site was analyzed using descriptive quantitative content analysis to confirm identification of TBI findings based on the National Institute of Neurological Disorders and Stroke (NINDS) Common Data Elements project. Findings were coded for presence or absence, weighted by frequency of mentions, and past/future/indication modifiers were filtered. After combining with the manual reference standard, a decision tree classifier was created using data mining tools WEKA 3.7.5 and Salford Predictive Miner 7.0. Performance of the decision tree classifier was evaluated on the test patient reports. ResultsThe prevalence of TBI in the sampled population was 159 of 2,217 (7.2%). The automated classification for pediatric TBI is comparable to our prior results, with the notable exception of lower positive predictive value. Manual review of misclassified reports, 95.5% of which were false-positives, revealed that a sizable number of false-positive errors were due to differing outcome definitions between NINDS TBI findings and PECARN clinical important TBI findings and report ambiguity not meeting definition criteria. ConclusionsA hybrid NLP and machine learning automated classification system continues to show promise in coding free-text electronic clinical data. For complex outcomes, it can reliably identify negative reports, but manual review of positive reports may be required. As such, it can still streamline data collection for clinical research and performance improvement.	[Yadav, Kabir] Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA; [Sarioglu, Efsun] Portland State Univ, Dept Comp Sci, Portland, OR 97207 USA; [Choi, Hyeong-Ah] George Washington Univ, Dept Comp Sci, Washington, DC USA; [Cartwright, Walter B.] Howard Univ, Sch Med, Washington, DC 20059 USA; [Hinds, Pamela S.] Childrens Natl Hlth Syst, Childrens Res Inst, Washington, DC USA; [Chamberlain, James M.] Childrens Natl Hlth Syst, Div Emergency Med, Washington, DC USA		Yadav, K (corresponding author), Harbor UCLA Med Ctr, Dept Emergency Med, Torrance, CA 90509 USA.	kabir@emedharbor.edu	Kayi, Efsun Selin/AAG-2060-2021; Hinds, Pamela/W-8115-2019	Kayi, Efsun Selin/0000-0002-2357-9807; Yadav, Kabir/0000-0002-1092-9935	National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) programUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000075, KL2TR000076]; National Library of MedicineUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM010016, R01LM008635]; NATIONAL CENTER FOR ADVANCING TRANSLATIONAL SCIENCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Advancing Translational Sciences (NCATS) [UL1TR000075, KL2TR000076] Funding Source: NIH RePORTER; NATIONAL LIBRARY OF MEDICINEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Library of Medicine (NLM) [R01LM008635, R01LM010016] Funding Source: NIH RePORTER	This publication is supported through the National Institutes of Health (NIH) Clinical and Translational Science Award (CTSA) program, grants UL1TR000075 and KL2TR000076. The CTSA program is led by the NIH's National Center for Advancing Translational Sciences (NCATS). Its contents are solely the responsibility of the authors and do not necessarily represent the official views of the NIH. MedLEE was developed with support from the National Library of Medicine (R01LM010016 and R01LM008635).	Bodenreider O, 2004, NUCLEIC ACIDS RES, V32, pD267, DOI 10.1093/nar/gkh061; Elkins JS, 2000, COMPUT BIOMED RES, V33, P1, DOI 10.1006/cbmr.1999.1535; FRIEDMAN C, 1994, J AM MED INFORM ASSN, V1, P161, DOI 10.1136/jamia.1994.95236146; Grinnon ST, 2012, CLIN TRIALS, V9, P322, DOI 10.1177/1740774512438980; Hall M, 2009, SIGKDD EXPLOR, V11, P10, DOI 10.1145/1656274.1656278; Holmes JF, 2011, ANN EMERG MED, V58, P315, DOI 10.1016/j.annemergmed.2011.03.060; Johnson J, 2013, RAD SOC N AM 2013 SC; Krippendorff K, 2003, CONTENT ANAL INTRO I; Kuppermann N, 2009, LANCET, V374, P1160, DOI 10.1016/S0140-6736(09)61558-0; Mendonca EA, 2005, J BIOMED INFORM, V38, P314, DOI 10.1016/j.jbi.2005.02.003; Meystre S M, 2008, Yearb Med Inform, P128; Pham AD, 2014, BMC BIOINFORMATICS, V15, DOI 10.1186/1471-2105-15-266; Salton G., 1989, AUTOMATIC TEXT PROCE; Stanfill MH, 2010, J AM MED INFORM ASSN, V17, P646, DOI 10.1136/jamia.2009.001024; Yadav K, 2013, ACAD EMERG MED, V20, P848, DOI 10.1111/acem.12174; Yu S, 2014, J BIOMED INFORM, V52, P386, DOI 10.1016/j.jbi.2014.08.001	16	15	15	1	18	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1069-6563	1553-2712		ACAD EMERG MED	Acad. Emerg. Med.	FEB	2016	23	2					171	178		10.1111/acem.12859			8	Emergency Medicine	Science Citation Index Expanded (SCI-EXPANDED)	Emergency Medicine	DD8EX	WOS:000370159300007	26766600	Green Accepted, Bronze			2022-02-06	
J	Yokobori, S; Yamaguchi, M; Igarashi, Y; Hironaka, K; Onda, H; Kuwamoto, K; Araki, T; Fuse, A; Yokota, H				Yokobori, Shoji; Yamaguchi, Masahiro; Igarashi, Yutaka; Hironaka, Kohei; Onda, Hidetaka; Kuwamoto, Kentaro; Araki, Takashi; Fuse, Akira; Yokota, Hiroyuki			Outcome and Refractory Factor of Intensive Treatment for Geriatric Traumatic Brain Injury: Analysis of 1165 Cases Registered in the Japan Neurotrauma Data Bank	WORLD NEUROSURGERY			English	Article						Geriatric traumatic brain injury; Intraventricular hemorrhage; Intensive treatment; Morbidity; Mortality	HEAD-INJURY; INTRAVENTRICULAR HEMORRHAGE; HEALTH-CARE; AGE; MANAGEMENT; PROGNOSIS; ADULT; COSTS	OBJECTIVE: With the increase in the aged population, geriatric traumatic brain injury (gTBI) is also rapidly increasing in Japan. There is thus a need to review the effect of intensive treatments for gTBIs. The aim of this study was 1) to assess how intensive treatments influenced patient outcome and 2) to identify the refractory factor against these intensive treatments in gTBI, from the Japan Neurotrauma Data Bank (JNTDB). METHODS: Of all 3194 patients in the JNTDB, 1165 (>= 65 years old) with severe gTBIs were enrolled in this study. The clinical features and their outcomes based on the Glasgow Outcome Scale on discharge and 6 months after injury were compared. RESULTS: Intensive treatments were administered to 71.4% of all patients with severe gTBI showing a significant increase over 15 years. Accordingly, mortality decreased significantly (from 62.7% to 51.1%, P = 0.001). On the other hand, severely disabled dependent survivors, who need daily help from others for living, increased accordingly (from 63.2% to 68.4%). The existence of intraventricular hemorrhage (IVH) rather than the patient's age was identified as the strongest refractory factor (odds ratio, 5.762; 95% confidence interval, 1.317-25.216) against intensive treatment. CONCLUSIONS: This study clarified that 1) intensive treatments are associated with higher survival rates (however, they also increase the incidence of severely disabled survivors) and 2) the strongest refractory factor for intensive treatment in cases of severe gTBI was not age but the existence of IVH. These results warrant further establishment of a seamless strategy for both the acute and the chronic phase of gTBI.	[Yokobori, Shoji; Yamaguchi, Masahiro; Igarashi, Yutaka; Onda, Hidetaka; Kuwamoto, Kentaro; Araki, Takashi; Fuse, Akira; Yokota, Hiroyuki] Nippon Med Sch, Dept Emergency & Crit Care Med, 1-1-5 Sendagi, Tokyo 113, Japan; [Hironaka, Kohei] Nippon Med Sch, Dept Neurosurg, 1-1-5 Sendagi, Tokyo 113, Japan		Yokobori, S (corresponding author), Nippon Med Sch, Dept Emergency & Crit Care Med, 1-1-5 Sendagi, Tokyo 113, Japan.	shoji@nms.ac.jp			General Insurance Association of Japan	This work was supported by the General Insurance Association of Japan.	Atzema C, 2006, J TRAUMA, V60, P1010, DOI 10.1097/01.ta.0000218038.28064.9d; Bouras T, 2007, J NEUROTRAUM, V24, P1355, DOI 10.1089/neu.2005.370; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Calland JF, 2012, J TRAUMA ACUTE CARE, V73, pS345, DOI 10.1097/TA.0b013e318270191f; Clemente JC, 2010, BIOCOMPUT-PAC SYM, P3; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Farhad K, 2013, J NEUROTRAUM, V30, P84, DOI 10.1089/neu.2011.2283; LUERSSEN TG, 1988, J NEUROSURG, V68, P409, DOI 10.3171/jns.1988.68.3.0409; MARSHALL LF, 1983, J NEUROSURG, V59, P276, DOI 10.3171/jns.1983.59.2.0276; Mata-Mbemba D, 2015, J NEUROTRAUM, V32, P359, DOI 10.1089/neu.2014.3453; Matsukawa H, 2012, J NEUROSURG, V117, P334, DOI 10.3171/2012.5.JNS112318; Maurice-Williams RS, 1999, BRIT J NEUROSURG, V13, P5, DOI 10.1080/02688699944104; Miyata H, 2015, LANCET, V385, P2549, DOI 10.1016/S0140-6736(15)61135-7; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Nakamura N, 2006, NEUROL MED-CHIR, V46, P567, DOI 10.2176/nmc.46.567; National Institute of Population and Social Security Research, 2013, EST POP JAP; Shigemori M, 2012, NEUROL MED-CHIR, V52, P1; Stocchetti N, 2012, J NEUROTRAUM, V29, P1119, DOI 10.1089/neu.2011.1995; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thompson HJ, 2012, J NEUROTRAUM, V29, P1864, DOI 10.1089/neu.2011.2284; Tokutomi T, 2008, J NEUROTRAUM, V25, P1407, DOI 10.1089/neu.2008.0577; Utomo WK, 2009, INJURY, V40, P973, DOI 10.1016/j.injury.2009.05.034; Wong GKC, 2011, J NEUROSURG, V114, P1510, DOI 10.3171/2011.1.JNS101102; Yokobori S, 2011, NEUROL MED-CHIR, V51, P265, DOI 10.2176/nmc.51.265	24	15	15	0	2	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	1878-8750	1878-8769		WORLD NEUROSURG	World Neurosurg.	FEB	2016	86						127	+		10.1016/j.wneu.2015.09.105			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DD0QU	WOS:000369625300042	26459712				2022-02-06	
J	Zhao, HX; Liao, Y; Xu, D; Wang, QP; Gan, Q; You, C; Yang, CH				Zhao, He-xiang; Liao, Yi; Xu, Ding; Wang, Qiang-ping; Gan, Qi; You, Chao; Yang, Chao-hua			Prospective randomized evaluation of therapeutic decompressive craniectomy in severe traumatic brain injury with mass lesions (PRECIS): study protocol for a controlled trial	BMC NEUROLOGY			English	Article						Decompressive craniectomy; Traumatic brain injury; Subdural mass lesions; Early surgery; Intracranial pressure	ACUTE SUBDURAL HEMATOMAS; HEAD-INJURY; INTRACRANIAL HYPERTENSION; SURGICAL COMPLICATIONS; MANAGEMENT; CRANIOPLASTY; MULTICENTER; CRANIOTOMY; EVACUATION; EXPERIENCE	Background: For cases of severe traumatic brain injury, during primary operation, neurosurgeons usually face a dilemma of whether or not to remove the bone flap after mass lesion evacuation. Decompressive craniectomy, which involves expansion of fixed cranial cavity, is used to treat intra-operative brain swelling and post-operative malignant intracranial hypertension. However, due to indefinite indication, the decision to perform this procedure heavily relies on personal experiences. In addition, decompressive craniectomy is associated with various complications, and the procedure lacks strong evidence of better outcomes. In the present study, we designed a prospective, randomized, controlled trial to clarify the effect of decompressive craniectomy in severe traumatic brain injury patients with mass lesions. Methods: PRECIS is a prospective, randomized, assessor-blind, single center clinical trial. In this trial, 336 patients with traumatic mass lesions will be randomly allocated to a therapeutic decompressive craniectomy group or a prophylactic decompressive craniectomy group. In the therapeutic decompressive craniectomy group, the bone flap will be removed or replaced depending on the emergence of brain swelling. In the prophylactic decompressive craniectomy group, the bone flap will be removed after mass lesion evacuation. A stepwise management of intracranial pressure will be provided according to the Brain Trauma Foundation guidelines. Salvage decompressive craniectomy will be performed for craniotomy patients once there is evidence of imaging deterioration and post-operative malignant intracranial hypertension. Participants will be assessed at 1, 6 and 12 months after randomization. The primary endpoint is favorable outcome according to the Extended Glasgow Outcome Score (5-8) at 12 months. The secondary endpoints include quality of life measured by EQ-5D, mortality, complications, intracranial pressure and cerebral perfusion pressure control and incidence of salvage craniectomy in craniotomy patients at each investigation time point. Discussion: This study will provide evidence to optimize primary decompressive craniectomy application and assess outcomes and risks for mass lesions in severe traumatic brain injury.	[Zhao, He-xiang; Xu, Ding; Wang, Qiang-ping; Gan, Qi; You, Chao; Yang, Chao-hua] Sichuan Univ, West China Hosp, Dept Neurosurg, Chengdu 610041, Sichuan, Peoples R China; [Liao, Yi] Sichuan Univ, West China Hosp, Dept Neurointens Care Unit, Chengdu 610041, Sichuan, Peoples R China		Yang, CH (corresponding author), Sichuan Univ, West China Hosp, Dept Neurosurg, 37 Guoxue Xiang, Chengdu 610041, Sichuan, Peoples R China.	PRECISCD120@hotmail.com	Wang, Qiang/AAV-7131-2021		Scientific Research and Innovation Foundation of West China Hospital [141100522]	This study is supported by the Scientific Research and Innovation Foundation of West China Hospital (No. 141100522).	Aarabi B, 2006, J NEUROSURG, V104, P469, DOI 10.3171/jns.2006.104.4.469; Aarabi B, 2009, NEUROSURGERY, V64, P927, DOI 10.1227/01.NEU.0000341907.30831.D2; Akyuz M, 2010, TURK NEUROSURG, V20, P382, DOI 10.5137/1019-5149.JTN.2785-09.1; Albanese J, 2003, CRIT CARE MED, V31, P2535, DOI 10.1097/01.CCM.0000089927.67396.F3; [Anonymous], 2007, J NEUROTRAUM, V24, pS1, DOI 10.1089/neu.2007.9997; Ban SP, 2010, J KOREAN NEUROSURG S, V48, P244, DOI 10.3340/jkns.2010.48.3.244; Bullock MR, 2007, J NEUROTRAUM, V24, pVII, DOI 10.1089/neu.2007.9998; Cianchi Giovanni, 2012, J Trauma Manag Outcomes, V6, P8, DOI 10.1186/1752-2897-6-8; Compagnone C, 2005, NEUROSURGERY, V57, P1183; Cooper DJ, 2011, NEW ENGL J MED, V364, P1493, DOI 10.1056/NEJMoa1102077; Cooper P R, 1976, Surg Neurol, V5, P25; De Luca GP, 2000, ACTA NEUROCHIR SUPPL, V76, P401; Eberle BM, 2010, INJURY, V41, P894, DOI 10.1016/j.injury.2010.02.023; ELLENBERG JH, 1996, DRUG INF J, V30, P535, DOI DOI 10.1177/009286159603000229; World Medical Association, 2013, JAMA, V310, P2191, DOI 10.1001/jama.2013.281053; Gillett GR, 2010, J MED ETHICS, V36, P727, DOI 10.1136/jme.2010.037424; Honeybul S, 2014, INJURY, V45, P1332, DOI 10.1016/j.injury.2014.03.007; Honeybul S, 2011, J NEUROTRAUM, V28, P2199, DOI 10.1089/neu.2011.1907; Honeybul S, 2011, ACTA NEUROCHIR, V153, P1105, DOI 10.1007/s00701-011-0974-9; HOSMER DW, 1980, COMMUN STAT A-THEOR, V9, P1043, DOI 10.1080/03610928008827941; Howard JL, 2008, J TRAUMA, V65, P380, DOI 10.1097/TA.0b013e31817c50d4; Hutchinson PJ, 2006, ACTA NEUROCHIR SUPPL, V96, P17; Jasielski Piotr, 2013, Acta Neurochir Suppl, V118, P125, DOI 10.1007/978-3-7091-1434-6_22; Jiang JY, 2005, J NEUROTRAUM, V22, P623, DOI 10.1089/neu.2005.22.623; Kolias AG, 2013, BRIT J NEUROSURG, V27, P330, DOI 10.3109/02688697.2013.779365; Li LM, 2012, ACTA NEUROCHIR, V154, P1555, DOI 10.1007/s00701-012-1428-8; Mangat HS, 2015, J NEUROSURG, V122, P202, DOI 10.3171/2014.10.JNS132545; Marion DW, 2006, NEUROSURGERY, V58, P655; Matthew B.Potts, 2012, SCHMIDEK SWEET OPERA, P1551, DOI [10.1016/B978-1-4160-6839-6.10135-2., DOI 10.1016/B978-1-4160-6839-6.10135-2]; Meier U, 2003, ACTA NEUROCHIR SUPPL, V86, P367; Munch E, 2000, NEUROSURGERY, V47, P315, DOI 10.1097/00006123-200008000-00009; Pompucci A, 2007, J NEUROTRAUM, V24, P1182, DOI 10.1089/neu.2006.0244; RANSOHOFF J, 1971, J NEUROL NEUROSUR PS, V34, P106, DOI 10.1136/jnnp.34.1.106-a; Sahuquillo J, 2006, COCHRANE DB SYST REV, V1, DOI DOI 10.1002/14651858.CD003983-PUB2; Salvatore C, 2008, J NEUROSURG, V108, P74, DOI 10.3171/JNS/2008/108/01/0074; Schneider GH, 2002, ACT NEUR S, V81, P77; Scott NW, 2002, CONTROL CLIN TRIALS, V23, P662, DOI 10.1016/S0197-2456(02)00242-8; Servadei F, 2015, WORLD NEUROSURG, V83, P133, DOI 10.1016/j.wneu.2014.08.031; Stiver SI, 2009, NEUROSURG FOCUS, V26, DOI 10.3171/2009.4.FOCUS0965; Tasiou A, 2014, INTERDISCIP NEUROSUR, V1, P107, DOI 10.1016/j.inat.2014.06.005; Taylor A, 2001, CHILD NERV SYST, V17, P154, DOI 10.1007/s003810000410; Timofeev I, 2006, ACTA NEUROCHIR SUPPL, V96, P11; Ucar T, 2005, J NEUROTRAUM, V22, P1311, DOI 10.1089/neu.2005.22.1311; Weiner GM, 2010, NEUROSURGERY, V66, P1111, DOI 10.1227/01.NEU.0000369607.71913.3E; Wen L, 2011, BRAIN INJURY, V25, P1318, DOI 10.3109/02699052.2011.608214; WHITFIELD P, 1995, STROKE, V26, P1125; Williams RF, 2009, J TRAUMA, V66, P1570, DOI 10.1097/TA.0b013e3181a594c4; Woertgen C, 2006, J CLIN NEUROSCI, V13, P718, DOI 10.1016/j.jocn.2005.08.019; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Xu H, 2015, CLIN NEUROL NEUROSUR, V136, P33, DOI 10.1016/j.clineuro.2015.05.031; Yang CH, 2012, CHIN J TRAUMATOL, V15, P158, DOI 10.3760/cma.j.issn.1008-1275.2012.03.006; Yang XF, 2008, ACTA NEUROCHIR, V150, P1241, DOI 10.1007/s00701-008-0145-9; Yuji O, 2013, INT LESSONS ROAD SAF; Zhao HX, 2015, BMC SURG, V15, DOI 10.1186/s12893-015-0100-7	54	15	15	0	9	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND		1471-2377		BMC NEUROL	BMC Neurol.	JAN 5	2016	16								1	10.1186/s12883-015-0524-9			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DA1QX	WOS:000367571700001	26727957	Green Published, gold			2022-02-06	
J	Adams, D; Dahdah, M				Adams, Deana; Dahdah, Marie			Coping and adaptive strategies of traumatic brain injury survivors and primary caregivers	NEUROREHABILITATION			English	Article						Coping skills; anger; social support; brain injuries; caregivers; mental health	SOCIAL SUPPORT; FAMILY; ADJUSTMENT; QUALITY; PEOPLE; STYLE	BACKGROUND: Qualitative research methods allowed the investigator to contribute to the development of new theories and to examine change in processes over time, which added rich detail to existing knowledge of the use of coping and adaptive strategies by traumatic brain injury survivors and their primary caregivers (Ponsford, Sloan, & Snow, 2013). The advantages of phenomenological study were that it allows flexibility to explore and understand meanings attached by people to well-studied concepts such as coping, resiliency, and adaptation or compensation. Phenomenological study was sensitive to contextual factors. It also permitted the study of in-depth dynamics of coping and adaptive strategies of TBI survivors and primary caregivers, while understanding the social and psychological implications of the phenomenon. OBJECTIVE: To explore the needs and deficits of adult traumatic brain injury (TBI) survivors and primary caregivers; and to identify their self-initiated coping and adaptive strategies. Significant to this study was the development of coping and adaptive strategies by the participants after their discharge from inpatient and rehabilitation treatment. The compensatory skills taught in treatment settings did not transfer to the home environment. Therefore, these strategies developed independently from previous treatment recommendations contributed to the development of theory related to rehabilitation and counseling. Distinctive to this study was the similarity of coping and adaptive strategies developed from both mild and severe traumatic brain injury survivors. METHODS: This study consisted of eleven with TBI and six primary caregivers (N = 17), who participated in a series of semi-structured interviews aimed at discovering the coping and adaptive strategies utilized in dealing with the effects of brain injury. A Qualitative Phenomenological design was employed. RESULTS: Patience and understanding, support, and professional help were identified by TBI survivors and caregivers as being their most relevant needs. Self-reported deficits included short-term memory loss (STM), fatigue, anger, and personality changes, and the strategies that TBI survivors and caregivers identified tended to address their problems with these specific day-to-day deficits. Problem focused, emotion focused, and avoidant coping were utilized to some degree in their adjustment to home life and activities of daily living. Participants offered suggestions for mental health professionals addressing how to more effectively work with brain injury survivors and their primary caregivers. CONCLUSION: TBI survivors and caregivers had multiple self-reported unaddressed needs following their discharge from facility-based treatment. They reported spontaneously engaging in various coping and adaptive strategies to address their needs and deficits. However, further education regarding potential post-TBI challenges and strategies for addressing them are needed, including a need for community and mental health resources.	[Adams, Deana] Hope Brain Injury, POB 136816, Ft Worth, TX 76136 USA; [Adams, Deana] Ctr Counseling & Enrichment, Arlington, TX USA; [Dahdah, Marie] Baylor Inst Rehabil, Dallas, TX USA; [Dahdah, Marie] Baylor Reg Med Ctr Plano, Plano, TX USA		Adams, D (corresponding author), Hope Brain Injury, POB 136816, Ft Worth, TX 76136 USA.	admin@hopeafterbraininjury.org					Brain Injury Association of America, 2011, BIAA AD NEW TBI DEF; Centers for Disease Control and Prevention, 2014, TRAUM BRAIN INJ US E; Chester S. K., 2014, EFFECTIVE PSYCHOTHER; Chronister J, 2006, REHABIL PSYCHOL, V51, P190, DOI 10.1037/0090-5550.51.3.190; CICERONE KD, 1989, REHABIL PSYCHOL, V34, P105, DOI 10.1037//0090-5550.34.2.105; Connors S. H., 2010, CARE MANAGEMENT, V16, P7; Curran CA, 2000, J HEAD TRAUMA REHAB, V15, P1256, DOI 10.1097/00001199-200012000-00006; Folkman S., 1984, STRESS; Gronwall D., 2002, HEAD INJURY FACTS; Haglin C, 1996, J REHABIL, V62, P37; Hanks RA, 2007, NEUROREHABILITATION, V22, P43; Jennett B, 1975, Ciba Found Symp, P309; Jumisko E, 2007, DISABIL REHABIL, V29, P1535, DOI 10.1080/09638280601055816; Kolakowsky-Hayner SA, 2001, J HEAD TRAUMA REHAB, V16, P374, DOI 10.1097/00001199-200108000-00007; KOSCIULEK JF, 1994, REHABIL PSYCHOL, V39, P215, DOI 10.1037/h0080325; Lewis J., 2010, QUALITATIVE STUDY PR; LEZAK MD, 1986, REHABIL PSYCHOL, V31, P241, DOI 10.1037//0090-5550.31.4.241; Lukow HR, 2015, J HEAD TRAUMA REHAB, V30, P241, DOI 10.1097/HTR.0000000000000137; National Institutes of Health, 1998, REH PERS TRAUM BRAIN; O'Callaghan C, 2006, NEUROPSYCHOL REHABIL, V16, P579, DOI 10.1080/09602010500368834; Ouellet MC, 2006, REHABIL PSYCHOL, V51, P140, DOI 10.1037/0090-5550.51.2.140; Perlesz A, 1999, REHABIL PSYCHOL, V44, P6, DOI 10.1037/0090-5550.44.1.6; Ponsford J., 2013, TRAUMATIC BRAIN INJU; Ponterotto J., 2008, SAGE HDB QUALITATIVE, P455; QSR International, 2010, NVIVO SOFTW VERS 9; Spitz G, 2013, J HEAD TRAUMA REHAB, V28, P116, DOI 10.1097/HTR.0b013e3182452f4f; Tomberg T, 2005, BRAIN INJURY, V19, P1181, DOI 10.1080/02699050500150153; WHO, 2004, REH PERS TRAUM BRAIN; [No title captured]	29	15	16	0	17	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1053-8135	1878-6448		NEUROREHABILITATION	Neurorehabilitation		2016	39	2					223	237		10.3233/NRE-161353			15	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DT7HD	WOS:000381656800005	27372358				2022-02-06	
J	Alavi, SA; Tan, CL; Menon, DK; Simpson, HL; Hutchinson, PJ				Alavi, Seyed Alireza; Tan, Chin Lik; Menon, David K.; Simpson, Helen L.; Hutchinson, Peter J.			Incidence of pituitary dysfunction following traumatic brain injury: A prospective study from a regional neurosurgical centre	BRITISH JOURNAL OF NEUROSURGERY			English	Article						Hypopituitarism; pituitary; trauma; traumatic brain injury	POSTTRAUMATIC HYPOPITUITARISM; SUBARACHNOID HEMORRHAGE; PREVALENCE; DEFICIENCY	Patients with traumatic brain injury (TBI) may develop pituitary dysfunction. Although, there is now increasing awareness of and investigations into such post-traumatic hypopituitarism (PTHP), the exact prevalence and incidence remain uncertain. Here, we aim to identify the incidence of PTHP in a selected population of TBI patients deemed at risk of PTHP at a regional neurosurgical centre in the UK. A total of 105 patients have been assessed in two cohorts: (i) 58 patients in serial cohort and (ii) 47 patients in cross-sectional late cohort. We found that in serial cohort, 10.3% (6/58) of TBI patients had abnormalities of the pituitary-adrenal axis in the acute phase (Day 0-7 post injury). In comparison, in cross-sectional late cohort, 21.3% (10/47) of the patients developed dysfunction in at least one of their pituitary axes at 6 months or more post-TBI, with hypogonadotrophic hypogonadism being the most common. Twenty-two patients from these two cohorts had their growth hormone assessment at 12 months or more post-TBI and 9.1% (2/22) were found to have growth hormone deficiency. Our results suggest that PTHP is a common condition amongst sufferers of TBI, and appropriate measures should be taken to detect and manage it.	[Alavi, Seyed Alireza; Tan, Chin Lik; Hutchinson, Peter J.] Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England; [Menon, David K.] Univ Cambridge, Addenbrookes Hosp, Dept Med, Div Anaesthesia, Cambridge CB2 0QQ, England; [Simpson, Helen L.] Univ Cambridge, Addenbrookes Hosp, Dept Endocrinol, Cambridge CB2 0QQ, England		Hutchinson, PJ (corresponding author), Univ Cambridge, Addenbrookes Hosp, Dept Clin Neurosci, Div Neurosurg, Cambridge CB2 0QQ, England.	pjah2@cam.ac.uk		Alavi, Seyed Alireza/0000-0001-7250-3860; Hutchinson, Peter/0000-0002-2796-1835; Tan, Chin Lik/0000-0002-3877-7347	NIHR Research Professorship; NIHR Cambridge BRC; National Institute for Health ResearchNational Institute for Health Research (NIHR) [NIHR-RP-R3-12-013, NF-SI-0512-10090] Funding Source: researchfish	P. J. Hutchinson is supported by a NIHR Research Professorship and the NIHR Cambridge BRC.	Agha A, 2005, EUR J ENDOCRINOL, V152, P371, DOI 10.1530/eje.1.01861; Agha A, 2004, J CLIN ENDOCR METAB, V89, P5987, DOI 10.1210/jc.2004-1058; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Annane D, 2009, JAMA-J AM MED ASSOC, V301, P2362, DOI 10.1001/jama.2009.815; Cryan E., 1918, DTSCH MED WOCHENSCHR, V44, P1261; Dusick Joshua R, 2012, Pituitary, V15, P2, DOI 10.1007/s11102-008-0130-6; Glynn N, 2013, CLIN ENDOCRINOL, V78, P17, DOI 10.1111/cen.12010; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Klose M, 2007, J CLIN ENDOCR METAB, V92, P3861, DOI 10.1210/jc.2007-0901; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kokshoorn NE, 2010, EUR J ENDOCRINOL, V162, P11, DOI 10.1530/EJE-09-0601; Krahulik D, 2010, J NEUROSURG, V113, P581, DOI 10.3171/2009.10.JNS09930; Pickel J, 2009, F1000 MED REP, V1, P63; Schneider HJ, 2007, JAMA-J AM MED ASSOC, V298, P1429, DOI 10.1001/jama.298.12.1429; Schneider HJ, 2006, EUR J ENDOCRINOL, V154, P259, DOI 10.1530/eje.1.02071; Tanriverdi F, 2010, PITUITARY, V13, P146, DOI 10.1007/s11102-009-0215-x	17	15	16	0	5	TAYLOR & FRANCIS LTD	ABINGDON	4 PARK SQUARE, MILTON PARK, ABINGDON OX14 4RN, OXON, ENGLAND	0268-8697	1360-046X		BRIT J NEUROSURG	Br. J. Neurosurg.		2016	30	3					302	306		10.3109/02688697.2015.1109060			5	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DL7SF	WOS:000375839700005	26610235				2022-02-06	
J	Astafiev, SV; Zinn, KL; Shulman, GL; Corbetta, M				Astafiev, Serguei V.; Zinn, Kristina L.; Shulman, Gordon L.; Corbetta, Maurizio			Exploring the physiological correlates of chronic mild traumatic brain injury symptoms	NEUROIMAGE-CLINICAL			English	Article						Traumatic brain injury; MRI; Diffusion tensor imaging; Behavioral assessments	WHITE-MATTER INJURY; DIFFUSION-TENSOR; FUNCTIONAL CONNECTIVITY; MILITARY PERSONNEL; VISUAL-CORTEX; AXONAL INJURY; HEAD-INJURY; MRI; MIGRAINE; ATTENTION	We report on the results of a multimodal imaging study involving behavioral assessments, evoked and resting-state BOLD fMRI, and DTI in chronic mTBI subjects. We found that larger task-evoked BOLD activity in the MT+/LO region in extra-striate visual cortex correlated with mTBI and PTSD symptoms, especially light sensitivity. Moreover, higher FA values near the left optic radiation (OR) were associated with both light sensitivity and higher BOLD activity in the MT+/LO region. The MT+/LO region was localized as a region of abnormal functional connectivity with central white matter regions previously found to have abnormal physiological signals during visual eye movement tracking (Astafiev et al., 2015). We conclude that mTBI symptoms and light sensitivity may be related to excessive responsiveness of visual cortex to sensory stimuli. This abnormal sensitivity may be related to chronic remodeling of white matter visual pathways acutely injured. (C) 2016 The Authors. Published by Elsevier Inc.	[Astafiev, Serguei V.; Zinn, Kristina L.; Shulman, Gordon L.; Corbetta, Maurizio] Washington Univ, Dept Neurol, 660 S Euclid Ave,Campus Box 8225, St Louis, MO 63110 USA		Astafiev, SV (corresponding author), Washington Univ, Dept Neurol, 660 S Euclid Ave,Campus Box 8225, St Louis, MO 63110 USA.	astafiev@npg.wustl.edu; zinnk@npg.wustl.edu; gordon@npg.wustl.edu; mau@npg.wustl.edu	Corbetta, Maurizio/AAZ-5219-2020	Astafiev, Serguei/0000-0003-3736-7095; CORBETTA, MAURIZIO/0000-0001-8295-3304	James S. McDonnell Foundation grant; National Institute of Neurological Disorders (NINDS) grant [R01 NS095741]; Department of Neurology, Washington University in St. Louis; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS095741] Funding Source: NIH RePORTER	This work was supported by a James S. McDonnell Foundation grant to the Attention Dynamics Consortium in Traumatic Brain Injury (ADC-TBI) and by the National Institute of Neurological Disorders (NINDS) grant R01 NS095741. Serguei V. Astafiev, PhD was partially supported by funds from the Department of Neurology, Washington University in St. Louis.	Armstrong R. C., 2015, NEUROPHARMACOLOGY; Ashina Sait, 2005, Curr Pain Headache Rep, V9, P415, DOI 10.1007/s11916-005-0021-8; Astafiev SV, 2015, J NEUROTRAUM, V32, P1254, DOI 10.1089/neu.2014.3547; Aurora SK, 2003, CEPHALALGIA, V23, P258, DOI 10.1046/j.1468-2982.2003.00471.x; Baldassarre A, 2014, BRAIN, V137, P3267, DOI 10.1093/brain/awu297; Barnes SM, 2012, REHABIL PSYCHOL, V57, P18, DOI 10.1037/a0027007; Bendlin BB, 2008, NEUROIMAGE, V42, P503, DOI 10.1016/j.neuroimage.2008.04.254; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Boake C, 2005, J NEUROPSYCH CLIN N, V17, P350, DOI 10.1176/appi.neuropsych.17.3.350; Boes A. D., 2015, BRAIN; Bouix S, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0066205; Boynton GM, 1996, J NEUROSCI, V16, P4207, DOI 10.1523/jneurosci.16-13-04207.1996; Bressler SL, 2008, J NEUROSCI, V28, P10056, DOI 10.1523/JNEUROSCI.1776-08.2008; Bryant Richard, 2011, Dialogues Clin Neurosci, V13, P251; Chen AJW, 2010, NEURON, V66, P11, DOI 10.1016/j.neuron.2010.04.004; Corbetta M, 2002, NAT REV NEUROSCI, V3, P201, DOI 10.1038/nrn755; Crooks Carol Y, 2007, Phys Med Rehabil Clin N Am, V18, P681, DOI 10.1016/j.pmr.2007.06.005; Dagli MS, 1999, NEUROIMAGE, V9, P407, DOI 10.1006/nimg.1998.0424; Datta R, 2013, CEPHALALGIA, V33, P365, DOI 10.1177/0333102412474503; Davenport N. D., 2014, HUM BRAIN MAPP; Dempsey Kenneth E, 2009, J Trauma Nurs, V16, P6, DOI 10.1097/01.JTN.0000348063.41099.a7; DIKMEN S, 1986, ARCH PHYS MED REHAB, V67, P507; Ding ZH, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0082107; Diwakar M, 2015, NEUROIMAGE-CLIN, V8, P210, DOI 10.1016/j.nicl.2015.04.011; Faul M, 2010, TRAUMATIC BRAIN INJU; Fox MD, 2005, P NATL ACAD SCI USA, V102, P9673, DOI 10.1073/pnas.0504136102; GERBER DJ, 1995, J HEAD TRAUMA REHAB, V10, P28, DOI 10.1097/00001199-199508000-00004; Ghajar J, 2000, LANCET, V356, P923, DOI 10.1016/S0140-6736(00)02689-1; Granziera C, 2006, PLOS MED, V3, P1915, DOI 10.1371/journal.pmed.0030402; Halterman CI, 2006, BRAIN, V129, P747, DOI 10.1093/brain/awh705; Hawellek DJ, 2011, P NATL ACAD SCI USA, V108, P19066, DOI 10.1073/pnas.1110024108; Hendler T, 2003, NEUROIMAGE, V19, P587, DOI 10.1016/S1053-8119(03)00141-1; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Huisman TAGM, 2004, AM J NEURORADIOL, V25, P370; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Kovesdi E, 2010, ACTA NEUROCHIR, V152, P1, DOI 10.1007/s00701-009-0463-6; Kushner D, 1998, ARCH INTERN MED, V158, P1617, DOI 10.1001/archinte.158.15.1617; Laitinen T. P., 2009, P INT SOC MAGN RESON; Lauritzen M, 2011, J CEREBR BLOOD F MET, V31, P17, DOI 10.1038/jcbfm.2010.191; Leddy JJ, 2010, CLIN J SPORT MED, V20, P21, DOI 10.1097/JSM.0b013e3181c6c22c; Lewine JD, 2007, J HEAD TRAUMA REHAB, V22, P141, DOI 10.1097/01.HTR.0000271115.29954.27; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Lipton ML, 2012, BRAIN IMAGING BEHAV, V6, P329, DOI 10.1007/s11682-012-9175-2; Lipton ML, 2008, J NEUROTRAUM, V25, P1335, DOI 10.1089/neu.2008.0547; Lucas S, 2014, CEPHALALGIA, V34, P93, DOI 10.1177/0333102413499645; Lucas S, 2012, CEPHALALGIA, V32, P600, DOI 10.1177/0333102412445224; Mac Donald CL, 2015, BRAIN, V138, P1314, DOI 10.1093/brain/awv038; Mac Donald CL, 2014, JAMA NEUROL, V71, P994, DOI 10.1001/jamaneurol.2014.1114; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; MacDonald Christine L, 2014, J Neurotrauma, V31, P889, DOI 10.1089/neu.2013.3173; Martin H, 2011, HEADACHE, V51, P1520, DOI 10.1111/j.1526-4610.2011.02013.x; Maruta J, 2010, J HEAD TRAUMA REHAB, V25, P293, DOI 10.1097/HTR.0b013e3181e67936; Mayer AR, 2015, NEUROSCI BIOBEHAV R, V49, P8, DOI 10.1016/j.neubiorev.2014.11.016; Mayer AR, 2012, BRAIN IMAGING BEHAV, V6, P343, DOI 10.1007/s11682-012-9178-z; McAllister Thomas W, 2011, Dialogues Clin Neurosci, V13, P287; McCrea M, 2009, CLIN NEUROPSYCHOL, V23, P1368, DOI 10.1080/13854040903074652; McDowell S, 1997, NEUROPSYCHOLOGIA, V35, P1341, DOI 10.1016/S0028-3932(97)00082-1; McKee AC, 2013, BRAIN, V136, P43, DOI 10.1093/brain/aws307; Narayan RK, 2002, J NEUROTRAUM, V19, P503, DOI 10.1089/089771502753754037; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Ollinger JM, 2001, NEUROIMAGE, V13, P210, DOI 10.1006/nimg.2000.0710; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Raichle ME, 2001, P NATL ACAD SCI USA, V98, P676, DOI 10.1073/pnas.98.2.676; Rigon A., 2015, J NEUROTRAUMA; Rocca M. A., 2015, HUM BRAIN MAPP; Rowland DJ, 2005, NUCL MED BIOL, V32, P567, DOI 10.1016/j.nucmedbio.2005.05.002; Scheibel RS, 2012, J INT NEUROPSYCH SOC, V18, P89, DOI 10.1017/S1355617711001433; Schneiderman AI, 2008, AM J EPIDEMIOL, V167, P1446, DOI 10.1093/aje/kwn068; Serences JT, 2007, NEURON, V55, P301, DOI 10.1016/j.neuron.2007.06.015; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Spitz G, 2013, BRAIN TOPOGR, V26, P648, DOI 10.1007/s10548-013-0283-0; Strangman GE, 2012, NEUROREHABILITATION, V31, P295, DOI 10.3233/NRE-2012-0797; Talairach J., 1988, COPLANAR STEREOTAXIC; Thornhill S, 2000, BRIT MED J, V320, P1631, DOI 10.1136/bmj.320.7250.1631; Venkatesan UM, 2015, J NEUROTRAUM, V32, P252, DOI 10.1089/neu.2013.3318; Wang P, 2011, FRONT HUM NEUROSCI, V5, DOI 10.3389/fnhum.2011.00085; Windischberger C, 2002, MAGN RESON IMAGING, V20, P575, DOI 10.1016/S0730-725X(02)00563-5; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783	79	15	15	0	9	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	11						10	19		10.1016/j.nicl.2016.01.004			10	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	DQ9BD	WOS:000379504500002	26909324	Green Published, gold			2022-02-06	
J	Barker-Collo, S; Theadom, A; Jones, K; Feigin, VL; Kahan, M				Barker-Collo, Suzanne; Theadom, Alice; Jones, Kelly; Feigin, Valery L.; Kahan, Michael			Accuracy of an International Classification of Diseases Code Surveillance System in the Identification of Traumatic Brain Injury	NEUROEPIDEMIOLOGY			English	Article						TBI; Surveillance; ICD-10; Incidence	CASE-FATALITY; EPIDEMIOLOGY; STROKE	Background: Use of International Classification of Disease (ICD) codes for traumatic brain injury (TBI) in healthcare administrative databases may underestimate the epidemiology of TBI. The present study examined the use of ICD-10 codes in a population-based New Zealand sample. Methods: TBI related ICD-codes within the New Zealand health database were examined for all incident cases from a population based TBI sample (n = 1,369). Impact of age, gender, ethnicity, presence/absence of skull fracture, where the case was located (i.e., hospital) on receipt of an ICD code was examined. Results: Individuals who received a TBI-related ICD-code accounted for 18.6% of the studied population. The most frequent codes were brief loss of consciousness, head injury not otherwise specified, and concussion. Receipt of a code was not impacted by gender. Those with skull fracture (x(2) (1) = 69.983, p < 0.001), and/or attending hospital (x(2) (2) = 81.507, p < 0.001), and of older age (x(2) (1) = 56.473, p < 0.001) were more likely to receive a code. Conclusions: Reported incidence of TBI, when based upon health registration data, is likely to be a significant underestimate. Specific research needs to be conducted to identify the barriers to medical personnel implementing the ICD head injury codes and to identify ways in which the use of the codes can be improved. (C) 2016 S. Karger AG, Basel	[Barker-Collo, Suzanne] Univ Auckland, Sch Psychol, Auckland, New Zealand; [Theadom, Alice; Jones, Kelly; Feigin, Valery L.] AUT Univ, Fac Hlth & Environm Studies, Natl Inst Stroke & Appl Neurosci, Auckland, New Zealand; [Kahan, Michael] Waikato Occupat Serv Ltd, Hamilton, New Zealand		Barker-Collo, S (corresponding author), Univ Auckland, Sch Psychol, Clin Training Programme, Private Bag 892019, Auckland 1141, New Zealand.	s.barker-collo@auckland.ac.nz	Feigin, Valery/AAF-2313-2019; Jones, Kelly/I-5199-2019	Feigin, Valery L./0000-0002-6372-1740			Andelic N, 2013, LANCET NEUROL, V12, P28, DOI 10.1016/S1474-4422(12)70294-6; [Anonymous], 2009, J REHABIL RES DEV, V46, pCP1; Carroll CP, 2012, NEUROSURGERY, V71, P1064, DOI 10.1227/NEU.0b013e31826f7c16; Centers for Disease Control and Prevention, CLASS DIS FUNCT DIS; Corrigan JD, 2010, J HEAD TRAUMA REHAB, V25, P72, DOI 10.1097/HTR.0b013e3181ccc8b4; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Department ot Health and Human services, 2016, ICD10CMPCS; Feigin VL, 2013, LANCET NEUROL, V12, P53, DOI 10.1016/S1474-4422(12)70262-4; Feigin VL, 2009, LANCET NEUROL, V8, P355, DOI 10.1016/S1474-4422(09)70025-0; Feigin VL, 2003, LANCET NEUROL, V2, P43, DOI 10.1016/S1474-4422(03)00266-7; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Kokotailo RA, 2005, STROKE, V36, P1776, DOI 10.1161/01.STR.0000174293.17959.a1; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Shore AD, 2005, BRAIN INJURY, V19, P613, DOI 10.1080/02699050400013568; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; TEASDALE G, 1974, LANCET, V2, P81; Theadom A, 2012, NEUROEPIDEMIOLOGY, V38, P18, DOI 10.1159/000334746	17	15	15	0	4	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	0251-5350	1423-0208		NEUROEPIDEMIOLOGY	Neuroepidemiology		2016	47	1					46	52		10.1159/000448403			7	Public, Environmental & Occupational Health; Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Public, Environmental & Occupational Health; Neurosciences & Neurology	DW0FA	WOS:000383315100008	27504965				2022-02-06	
J	Bressan, S; Takagi, M; Anderson, V; Davis, GA; Oakley, E; Dunne, K; Clarke, C; Doyle, M; Hearps, S; Ignjatovic, V; Seal, M; Babl, FE				Bressan, Silvia; Takagi, Michael; Anderson, Vicki; Davis, Gavin A.; Oakley, Ed; Dunne, Kevin; Clarke, Cathriona; Doyle, Melissa; Hearps, Stephen; Ignjatovic, Vera; Seal, Marc; Babl, Franz E.			Protocol for a prospective, longitudinal, cohort study of postconcussive symptoms in children: the Take CARe (Concussion Assessment and Recovery Research) study	BMJ OPEN			English	Article							TRAUMATIC BRAIN-INJURY; STANDARDIZED ASSESSMENT; UNITED-STATES; SPORT; EPIDEMIOLOGY; IMPAIRMENT; RECOMMENDATIONS; ADOLESCENTS; RELIABILITY; PERFORMANCE	Introduction: A substantial minority of children who sustain a concussion suffer prolonged postconcussive symptoms. These symptoms can persist for more than 1 month postinjury and include physical, cognitive, behavioural and emotional changes. Those affected can develop significant disability, diminishing their quality of life. The precise prevalence of postconcussive symptoms following child concussion is unclear, with heterogeneous and at times conflicting results published regarding factors that predict children at risk for developing long-lasting postconcussive symptoms. The aim of the Take C.A. Re (Concussion Assessment and Recovery Research) study is to provide an in-depth multidimensional description of the postconcussive recovery trajectories from a physical, neurocognitive and psychosocial perspective in the 3 months following concussion, with a focus on the early postconcussive period, and identification of factors associated with prolonged recovery. Methods and analysis: Take C.A. Re is a prospective, longitudinal study at a tertiary children's hospital, recruiting and assessing patients aged 5-<18 years who present to the emergency department with a concussion and following them at 1-4 days, 2 weeks, 1 month and 3 months postinjury. Multiple domains are assessed: postconcussive symptoms, balance and coordination, neurocognition, behaviour, quality of life, fatigue, post-traumatic stress symptoms, parental distress and family burden. 'Delayed recovery' is operationalised as the presence of >= 3 symptoms on the Post Concussive Symptoms Inventory rated as worse compared with baseline. Main analyses comprise analysis of variance (recovery trajectories, delayed vs normal recovery groups) and regression analyses of predictors of recovery (preinjury, acute and family factors). Ethics and dissemination: Ethical approval has been obtained through the Royal Children's Hospital Melbourne Human Research Ethics Committee (33122). We aim to disseminate the findings through	[Bressan, Silvia; Takagi, Michael; Anderson, Vicki; Davis, Gavin A.; Oakley, Ed; Dunne, Kevin; Clarke, Cathriona; Doyle, Melissa; Hearps, Stephen; Ignjatovic, Vera; Seal, Marc; Babl, Franz E.] Murdoch Childrens Res Inst, Melbourne, Vic, Australia; [Bressan, Silvia] Univ Padua, Dept Womens & Childrens Hlth, Padua, Italy; [Takagi, Michael; Anderson, Vicki] Univ Melbourne, Sch Psychol Sci, Melbourne, Vic 3010, Australia; [Anderson, Vicki; Oakley, Ed; Dunne, Kevin; Babl, Franz E.] Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia; [Anderson, Vicki] Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia; [Oakley, Ed; Babl, Franz E.] Royal Childrens Hosp Melbourne, Emergency Dept, Melbourne, Vic, Australia; [Dunne, Kevin] Royal Childrens Hosp, Dept Rehabil Med, Melbourne, Vic, Australia		Anderson, V (corresponding author), Murdoch Childrens Res Inst, Melbourne, Vic, Australia.; Anderson, V (corresponding author), Univ Melbourne, Sch Psychol Sci, Melbourne, Vic 3010, Australia.; Anderson, V (corresponding author), Univ Melbourne, Dept Paediat, Melbourne, Vic 3010, Australia.; Anderson, V (corresponding author), Royal Childrens Hosp, Psychol Serv, Melbourne, Vic, Australia.	Vicki.anderson@rch.org.au	Hearps, Stephen/L-6853-2016; Meijer, Anna/K-5118-2016; Seal, Marc L/J-9290-2019	Seal, Marc L/0000-0002-8396-140X; Ignjatovic, Vera/0000-0002-5548-5813; Hearps, Stephen/0000-0003-2984-1172; Takagi, Michael/0000-0003-2903-7598; Visser, Melissa/0000-0002-5313-3347	Royal Children's Hospital Foundation, Melbourne, Australia [2014-370, 2014-400]; Australian National Health and Medical Research Council Centre of Research Excellence for Paediatric Emergency MedicineNational Health and Medical Research Council of Australia [GNT 1058560]; NHMRCNational Health and Medical Research Council of Australia	The study is funded by a project grant from Royal Children's Hospital Foundation, Melbourne, Australia (2014-370). The study is part funded by an Australian National Health and Medical Research Council Centre of Research Excellence for Paediatric Emergency Medicine grant (GNT 1058560) and received infrastructure support from the Victorian Government's Infrastructure Support Program, Melbourne, Australia. FEB is part funded by a Royal Children's Hospital Foundation grant, Melbourne, Australia (2014-400). VA is part-funded by NHMRC Senior Practitioner fellowship.	Achenbach T M, 2000, Pediatr Rev, V21, P265, DOI 10.1542/pir.21-8-265; Adelson PD, 2012, J NEUROTRAUM, V29, P639, DOI 10.1089/neu.2011.1952; Ayr LK, 2009, J INT NEUROPSYCH SOC, V15, P19, DOI 10.1017/S1355617708090188; Babcock L, 2013, JAMA PEDIATR, V167, P156, DOI 10.1001/jamapediatrics.2013.434; Barlow KM, 2010, PEDIATRICS, V126, pE374, DOI 10.1542/peds.2009-0925; Barr WB, 2001, J INT NEUROPSYCH SOC, V7, P693, DOI 10.1017/S1355617701766052; Bazarian JJ, 2005, BRAIN INJURY, V19, P85, DOI 10.1080/02699050410001720158; Betts J, 2006, CHILD NEUROPSYCHOL, V12, P205, DOI 10.1080/09297040500488522; Blume H, 2012, CURR OPIN PEDIATR, V24, P724, DOI 10.1097/MOP.0b013e328359e4cc; Broglio SP, 2008, SPORTS MED, V38, P53, DOI 10.2165/00007256-200838010-00005; Chrisman SPD, 2014, J ADOLESCENT HEALTH, V54, P582, DOI 10.1016/j.jadohealth.2013.10.006; Collie A, 2003, CLIN J SPORT MED, V13, P28, DOI 10.1097/00042752-200301000-00006; Crowe L, 2009, J PAEDIATR CHILD H, V45, P346, DOI 10.1111/j.1440-1754.2009.01499.x; Echemendia RJ, 2013, BRIT J SPORT MED, V47, P294, DOI 10.1136/bjsports-2013-092186; Eisenberg MA, 2014, PEDIATRICS, V133, P999, DOI 10.1542/peds.2014-0158; Eisenberg MA, 2013, PEDIATRICS, V132, P8, DOI 10.1542/peds.2013-0432; Falleti MG, 2003, J SLEEP RES, V12, P265, DOI 10.1111/j.1365-2869.2003.00363.x; Finch CF, 2013, MED J AUSTRALIA, V198, P427, DOI 10.5694/mja12.11217; Finnoff JT, 2009, PM&R, V1, P50, DOI 10.1016/j.pmrj.2008.06.002; Foa EB, 2001, J CLIN CHILD PSYCHOL, V30, P376, DOI 10.1207/S15374424JCCP3003_9; Gioia GA, 2009, BRIT J SPORT MED, V43, pI13, DOI 10.1136/bjsm.2009.058255; Grubenhoff JA, 2014, PEDIATRICS, V134, P54, DOI 10.1542/peds.2013-2988; Grubenhoff JA, 2010, PEDIATRICS, V126, P688, DOI 10.1542/peds.2009-2804; Guskiewicz Kevin M, 2003, Curr Sports Med Rep, V2, P24; Hajek CA, 2011, CHILD NEUROPSYCHOL, V17, P17, DOI 10.1080/09297049.2010.495058; Haran H. P., 2015, J SCI MED SPORT; Harrell FE, 1996, STAT MED, V15, P361, DOI 10.1002/(SICI)1097-0258(19960229)15:4<361::AID-SIM168>3.0.CO;2-4; Kassam-Adams N, 2011, J TRAUMA STRESS, V24, P252, DOI 10.1002/jts.20640; Kessler RC, 2002, PSYCHOL MED, V32, P959, DOI 10.1017/S0033291702006074; Lyttle MD, 2012, EMERG MED J, V29, P785, DOI 10.1136/emermed-2011-200225; Maruff P, 2005, J SLEEP RES, V14, P21, DOI 10.1111/j.1365-2869.2004.00438.x; McCauley SR, 2012, J NEUROTRAUM, V29, P678, DOI 10.1089/neu.2011.1838; McCrea M, 1998, J HEAD TRAUMA REHAB, V13, P27, DOI 10.1097/00001199-199804000-00005; McCrory P, 2013, BRIT J SPORT MED, V47, P250, DOI 10.1136/bjsports-2013-092313; McNally KA, 2013, NEUROPSYCHOLOGY, V27, P1, DOI 10.1037/a0031370; Meehan WP, 2010, J PEDIATR-US, V157, P889, DOI 10.1016/j.jpeds.2010.06.040; Mollica CM, 2005, CHILD NEUROPSYCHOL, V11, P303, DOI 10.1080/092970490911306; Naunheim RS, 2008, J HEAD TRAUMA REHAB, V23, P116, DOI 10.1097/01.HTR.0000314530.30401.70; Peden M, 2008, WORLD REPORT CHILD I; Quayle KS, 2014, NEW ENGL J MED, V371, P1945, DOI 10.1056/NEJMc1407902; Ransom DM, 2015, PEDIATRICS, V135, P1043, DOI 10.1542/peds.2014-3434; Sady MD, 2014, ARCH CLIN NEUROPSYCH, V29, P348, DOI 10.1093/arclin/acu014; Straume-Naesheim TM, 2005, BRIT J SPORT MED, V39, pI64, DOI 10.1136/bjsm.2005.019620; Varni JW, 1999, MED CARE, V37, P126, DOI 10.1097/00005650-199902000-00003; Varni JW, 2002, CANCER-AM CANCER SOC, V94, P2090, DOI 10.1002/cncr.10428; Wiebe DJ, 2012, PEDIATR EMERG CARE, V28, P498, DOI 10.1097/PEC.0b013e3182586f76; Williams J, 2014, APP NEUROPSYCHOL CHI, P1; Williams RM, 2015, SPORTS MED, V45, P893, DOI 10.1007/s40279-015-0325-8; Yeates KO, 2012, INT J DEV NEUROSCI, V30, P231, DOI 10.1016/j.ijdevneu.2011.05.008; Zemek RL, 2013, JAMA PEDIATR, V167, P259, DOI 10.1001/2013.jamapediatrics.216	50	15	15	1	13	BMJ PUBLISHING GROUP	LONDON	BRITISH MED ASSOC HOUSE, TAVISTOCK SQUARE, LONDON WC1H 9JR, ENGLAND	2044-6055			BMJ OPEN	BMJ Open		2016	6	1							e009427	10.1136/bmjopen-2015-009427			9	Medicine, General & Internal	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	General & Internal Medicine	DD5VX	WOS:000369993900091	26758260	Green Published, gold			2022-02-06	
J	Chong, ZZ; Changyaleket, B; Xu, HL; Dull, RO; Schwartz, DE				Chong, Zhao Zhong; Changyaleket, Benjarat; Xu, Haoliang; Dull, Randy O.; Schwartz, David E.			Identifying S100B as a Biomarker and a Therapeutic Target For Brain Injury and Multiple Diseases	CURRENT MEDICINAL CHEMISTRY			English	Article						RAGE; PI3K; MAPK; neurodegeneration; stroke; diabetes; biomarker	GLYCATION END-PRODUCTS; NEURON-SPECIFIC ENOLASE; NF-KAPPA-B; CEREBROSPINAL-FLUID S100B; NECROSIS-FACTOR-ALPHA; AMYOTROPHIC-LATERAL-SCLEROSIS; NEUROTROPHIC PROTEIN S100B; FIBRILLARY ACIDIC PROTEIN; CALCIUM-BINDING PROTEIN; FOCAL CEREBRAL-ISCHEMIA	The calcium binding protein S100B has attracted great attention as a biomarker for a variety of diseases. S100B is mainly expressed in glial cells and functions through intracellular and extracellular signaling pathways. The biological roles of S100B have been closely associated with its concentrations and its physiological states. The released S100B can bind to the receptor of advanced glycation end products and induce the initiation of multiple cell signaling transductions. The regulation of S100B bioactivities has been suggested through phosphoinositide 3 kinase/Akt, p53, mitogen-activated protein kinases, transcriptional factors including nuclear factor-kappaB, and cyclic adenosine monophosphate. The levels of S100B in the blood may function to predict the progress or the prognosis of many kinds of diseases, such as cerebrovascular diseases, neurodegenerative diseases, motor neuron diseases, traumatic brain injury, schizophrenia, depression, diabetes mellitus, myocardial infarction, cancer, and infectious diseases. Given that the activity of S100B has been implicated in the pathological process of these diseases, S100B should not be simply regarded as a biomarker, it may also function as therapeutic target for these diseases. Further elucidation of the roles of S100B may formulate innovative therapeutic strategies for multiple diseases.	[Chong, Zhao Zhong; Changyaleket, Benjarat; Dull, Randy O.; Schwartz, David E.] Univ Illinois, Dept Anesthesiol, 835 S Wolcott St,Room E713,Bldg 935, Chicago, IL 60612 USA; [Xu, Haoliang] Univ Illinois, Dept Pathol, Chicago, IL USA		Chong, ZZ (corresponding author), Univ Illinois, Dept Anesthesiol, 835 S Wolcott St,Room E713,Bldg 935, Chicago, IL 60612 USA.	zzchong@uic.edu					Adami C, 2004, BBA-MOL CELL RES, V1742, P169, DOI 10.1016/j.bbamcr.2004.09.008; Adami C, 2001, GLIA, V33, P131, DOI 10.1002/1098-1136(200102)33:2<131::AID-GLIA1012>3.0.CO;2-D; Aihara Y, 2001, STROKE, V32, P212, DOI 10.1161/01.STR.32.1.212; Akdemir HU, 2014, HUM EXP TOXICOL, V33, P1113, DOI 10.1177/0960327114521049; Al-Jarrah M, 2007, NEUROSCIENCE, V149, P28, DOI 10.1016/j.neuroscience.2007.07.038; Al-Jarrah M, 2013, NEUROREHABILITATION, V32, P141, DOI 10.3233/NRE-130831; Al-Jarrah MD, 2011, NEUROREHABILITATION, V28, P359, DOI 10.3233/NRE-2011-0664; Aleksovska K, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0106342; Alexanian AR, 1999, FASEB J, V13, P1611, DOI 10.1096/fasebj.13.12.1611; Amiri M, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00065; Arcuri C, 2005, J BIOL CHEM, V280, P4402, DOI 10.1074/jbc.M406440200; Arfvidsson B, 2015, CLIN CHEM LAB MED, V53, P111, DOI 10.1515/cclm-2014-0283; Asano T, 2005, CNS NEUROL DISORD-DR, V4, P127, DOI 10.2174/1568007053544084; Barateiro A., 2015, MOL NEUROBIOL; BARD JA, 1993, J BIOL CHEM, V268, P23422; Bartosik-Psujek H, 2011, ACTA NEUROL SCAND, V123, P252, DOI 10.1111/j.1600-0404.2010.01393.x; Batassini C, 2015, NEURAL PLAST, V2015, DOI 10.1155/2015/387028; BAUDIER J, 1992, P NATL ACAD SCI USA, V89, P11627, DOI 10.1073/pnas.89.23.11627; Baudry A, 2010, SCIENCE, V329, P1537, DOI 10.1126/science.1193692; Baum L, 1996, MOL CHEM NEUROPATHOL, V29, P253, DOI 10.1007/BF02815006; Bayazit H, 2016, EUR ADDICT RES, V22, P177, DOI 10.1159/000442046; Beccafico S, 2011, AGE, V33, P523, DOI 10.1007/s11357-010-9197-x; Ben-Neriah Y, 2011, NAT IMMUNOL, V12, P715, DOI 10.1038/ni.2060; Bialowas-McGoey LA, 2008, GLIA, V56, P1780, DOI 10.1002/glia.20727; Bianchi R, 2011, J BIOL CHEM, V286, P7214, DOI 10.1074/jbc.M110.169342; Bianchi R, 2010, NEUROBIOL AGING, V31, P665, DOI 10.1016/j.neurobiolaging.2008.05.017; Bluhm B, 2015, CEREBELLUM, V14, P119, DOI 10.1007/s12311-014-0606-z; Boespflug A, 2013, EUR J DERMATOL, V23, P719, DOI 10.1684/ejd.2013.2133; Bowman G, 2006, NEUROCRIT CARE, V5, P222, DOI 10.1385/NCC:5:3:222; Bresnick AR, 2015, NAT REV CANCER, V15, P96, DOI 10.1038/nrc3893; BRETT J, 1993, AM J PATHOL, V143, P1699; Brozzi F, 2009, J BIOL CHEM, V284, P8788, DOI 10.1074/jbc.M805897200; Bulavin DV, 1999, EMBO J, V18, P6845, DOI 10.1093/emboj/18.23.6845; Businaro R, 2006, J NEUROSCI RES, V83, P897, DOI 10.1002/jnr.20785; Cagnol S, 2010, FEBS J, V277, P2, DOI 10.1111/j.1742-4658.2009.07366.x; Cai XY, 2011, ATHEROSCLEROSIS, V217, P536, DOI 10.1016/j.atherosclerosis.2011.05.023; Cargnello M, 2011, MICROBIOL MOL BIOL R, V75, P50, DOI 10.1128/MMBR.00031-10; Caricasole A, 2004, J NEUROSCI, V24, P6021, DOI 10.1523/JNEUROSCI.1381-04.2004; Carvalho DZ, 2015, NEUROSCI LETT, V608, P57, DOI 10.1016/j.neulet.2015.10.010; Celikbilek A, 2014, NEUROSCI LETT, V558, P53, DOI 10.1016/j.neulet.2013.10.067; Changyaleket B, 2016, BRAIN RES, V1634, P171, DOI 10.1016/j.brainres.2015.12.061; Chaves ML, 2010, J NEUROINFLAMM, V7, DOI 10.1186/1742-2094-7-6; Chen YL, 2004, J IMMUNOL, V173, P1399, DOI 10.4049/jimmunol.173.2.1399; Cheng CY, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0091426; Cheong KA, 2014, EXP DERMATOL, V23, P165, DOI 10.1111/exd.12332; Chong ZZ, 2015, CURR DRUG TARGETS, V16, P1107, DOI 10.2174/1389450116666150408103448; Chong ZZ, 2013, EXPERT OPIN THER TAR, V17, P707, DOI 10.1517/14728222.2013.780599; Chong ZZ, 2012, FUTUR NEUROL, V7, P733, DOI 10.2217/FNL.12.72; Chong ZZ, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045456; Chong ZZ, 2012, FUTUR CARDIOL, V8, P89, DOI [10.2217/FCA.11.76, 10.2217/fca.11.76]; Chong ZZ, 2005, CURR NEUROVASC RES, V2, P387, DOI 10.2174/156720205774962683; Chong ZZ, 2005, BRAIN RES REV, V49, P1, DOI 10.1016/j.brainresrev.2004.11.005; Chong ZZ, 2004, HISTOL HISTOPATHOL, V19, P495, DOI 10.14670/HH-19.495; Chong ZZ, 2002, J CEREBR BLOOD F MET, V22, P503, DOI 10.1097/00004647-200205000-00001; CHYATTE D, 1984, J NEUROSURG, V60, P923, DOI 10.3171/jns.1984.60.5.0923; CHYATTE D, 1987, NEUROSURGERY, V21, P157, DOI 10.1227/00006123-198708000-00004; Cirillo C, 2015, BIOMED RES INT, V2015, DOI 10.1155/2015/508342; Clatterbuck RE, 2003, J NEUROSURG, V99, P376, DOI 10.3171/jns.2003.99.2.0376; COCCHIA D, 1981, Neurochemistry International, V3, P123, DOI 10.1016/0197-0186(81)90030-9; Compston A, 2002, LANCET, V359, P1221, DOI 10.1016/S0140-6736(02)08220-X; Dang XB, 2014, INT J CLIN EXP PATHO, V7, P3818; Darlot F, 2008, AM J PHYSIOL-RENAL, V295, pF1142, DOI 10.1152/ajprenal.00599.2007; Dattilo BM, 2007, BIOCHEMISTRY-US, V46, P6957, DOI 10.1021/bi7003735; Deloulme JC, 2004, MOL CELL NEUROSCI, V27, P453, DOI 10.1016/j.mcn.2004.07.008; Dhanasekaran DN, 2008, ONCOGENE, V27, P6245, DOI 10.1038/onc.2008.301; Di Legge S, 2003, NEUROL SCI, V24, P351, DOI 10.1007/s10072-003-0188-x; Di Pietro V, 2015, NEUROCHEM RES, V40, P991, DOI 10.1007/s11064-015-1554-9; Donato R, 2013, CURR MOL MED, V13, P24, DOI 10.2174/156652413804486214; Donato R, 2001, INT J BIOCHEM CELL B, V33, P637, DOI 10.1016/S1357-2725(01)00046-2; Donato R, 2007, CURR MOL MED, V7, P711, DOI 10.2174/156652407783220688; Donato R, 2009, BBA-MOL CELL RES, V1793, P1008, DOI 10.1016/j.bbamcr.2008.11.009; Egberts F, 2008, ONKOLOGIE, V31, P380, DOI 10.1159/000135492; Egea-Guerrero JJ, 2013, J NEUROTRAUM, V30, P1762, DOI 10.1089/neu.2012.2606; Ellis EF, 2007, J NEUROCHEM, V101, P1463, DOI 10.1111/j.1471-4159.2007.04515.x; Esposito G, 2008, J CELL MOL MED, V12, P914, DOI 10.1111/j.1582-4934.2008.00159.x; EVENHUIS HM, 1990, ARCH NEUROL-CHICAGO, V47, P263, DOI 10.1001/archneur.1990.00530030029011; Faye RS, 2008, MELANOMA RES, V18, P134, DOI 10.1097/CMR.0b013e3282f623d9; Fernandez-Fernandez MR, 2005, P NATL ACAD SCI USA, V102, P4735, DOI 10.1073/pnas.0501459102; Foerch C, 2004, STROKE, V35, P2160, DOI 10.1161/01.STR.0000138730.03264.ac; Fridman JS, 2003, ONCOGENE, V22, P9030, DOI 10.1038/sj.onc.1207116; Friel LA, 2007, J PERINAT MED, V35, P385, DOI 10.1515/JPM.2007.101; Fritz G, 2010, FEBS J, V277, P4578, DOI 10.1111/j.1742-4658.2010.07887.x; Gaetani P, 1998, NEUROL RES, V20, P337, DOI 10.1080/01616412.1998.11740528; Garg N, 2015, BRAIN BEHAV, V5, DOI 10.1002/brb3.362; Gazzolo D, 2003, CLIN CHIM ACTA, V330, P131, DOI 10.1016/S0009-8981(03)00010-X; Geyer C, 2009, J NEUROS-PEDIATR, V4, P339, DOI 10.3171/2009.5.PEDS08481; Ghosh S, 2008, NAT REV IMMUNOL, V8, P837, DOI 10.1038/nri2423; Glaser N., 2015, BRAIN RES; Gomez-Tourino I, 2015, CLIN EXP IMMUNOL, V180, P207, DOI 10.1111/cei.12572; Gonzalez-Garcia S, 2012, CLIN BIOCHEM, V45, P1302, DOI 10.1016/j.clinbiochem.2012.07.094; Gribenko AV, 1998, J MOL BIOL, V283, P679, DOI 10.1006/jmbi.1998.2116; Hachem S, 2005, GLIA, V51, P81, DOI 10.1002/glia.20184; Hackam DG, 2015, STROKE, V46, P852, DOI 10.1161/STROKEAHA.115.008680; Hanafy KA, 2010, J CLIN NEUROSCI, V17, P853, DOI 10.1016/j.jocn.2009.11.041; Hartman KG, 2013, FUTURE MED CHEM, V5, P97, DOI 10.4155/fmc.12.191; Hayakata T, 2004, SHOCK, V22, P102, DOI 10.1097/01.shk.0000131193.80038.f1; Haynes MP, 2003, J BIOL CHEM, V278, P2118, DOI 10.1074/jbc.M210828200; Hedlund PB, 2004, TRENDS PHARMACOL SCI, V25, P481, DOI 10.1016/j.tips.2004.07.002; Heidari K, 2015, BRAIN INJURY, V29, P1146, DOI [10.3109/02699052.2014.948068, 10.3109/02699052.2015.1037349]; Heizmann CW, 2002, FRONT BIOSCI-LANDMRK, V7, pD1356, DOI 10.2741/heizmann; Hemachandra D., 2015, AUST NZ J PUBL HEAL, P1; Herson PS, 2014, FUTUR NEUROL, V9, P541, DOI 10.2217/FNL.14.44; HESTON LL, 1984, PSYCHIAT DEV, V2, P287; Hofmann MA, 1999, CELL, V97, P889, DOI 10.1016/S0092-8674(00)80801-6; Hudson BI, 2008, FASEB J, V22, P1572, DOI 10.1096/fj.07-9909com; Hudson BI, 2008, J BIOL CHEM, V283, P34457, DOI 10.1074/jbc.M801465200; Huttunen HJ, 2000, J BIOL CHEM, V275, P40096, DOI 10.1074/jbc.M006993200; ISOBE T, 1977, BIOCHIM BIOPHYS ACTA, V494, P222, DOI 10.1016/0005-2795(77)90150-7; Jackson CE, 1998, SEMIN NEUROL, V18, P27, DOI 10.1055/s-2008-1040859; Jiang Y, 2012, J CLIN NEUROSCI, V19, P866, DOI 10.1016/j.jocn.2011.08.038; Jickling GC, 2015, STROKE, V46, P915, DOI 10.1161/STROKEAHA.114.005604; Joanna P, 2015, NEUROL NEUROCHIR POL, V49, P313, DOI 10.1016/j.pjnns.2015.07.006; Jung CS, 2013, STROKE RES TREAT, V2013, DOI 10.1155/2013/560305; Kabadi SV, 2015, J CEREBR BLOOD F MET, V35, P2010, DOI 10.1038/jcbfm.2015.165; Kaneda K, 2010, BRAIN RES BULL, V81, P173, DOI 10.1016/j.brainresbull.2009.10.020; Kapural M, 2002, BRAIN RES, V940, P102, DOI 10.1016/S0006-8993(02)02586-6; Karin M, 1998, ANN NY ACAD SCI, V851, P139, DOI 10.1111/j.1749-6632.1998.tb08987.x; Katayama Y, 2007, STROKE, V38, P2373, DOI 10.1161/STROKEAHA.106.480038; Kleindienst A, 2005, J NEUROTRAUM, V22, P645, DOI 10.1089/neu.2005.22.645; Kleindienst A, 2004, J NEUROTRAUM, V21, P541, DOI 10.1089/089771504774129874; Kleindienst A, 2006, J NEUROTRAUM, V23, P1185, DOI 10.1089/neu.2006.23.1185; Kleine TO, 2003, BRAIN RES BULL, V61, P265, DOI 10.1016/S0361-9230(03)00090-X; KLIGMAN D, 1985, P NATL ACAD SCI USA, V82, P7136, DOI 10.1073/pnas.82.20.7136; Koch M, 2010, STRUCTURE, V18, P1342, DOI 10.1016/j.str.2010.05.017; Koga F, 2006, P NATL ACAD SCI USA, V103, P11318, DOI 10.1073/pnas.0604705103; Kogel D, 2004, NEUROSCIENCE, V127, P913, DOI 10.1016/j.neuroscience.2004.06.013; Koppal T, 2001, NEUROCHEM INT, V39, P401, DOI 10.1016/S0197-0186(01)00047-X; Korczyn AD, 2015, EXPERT REV NEUROTHER, V15, P227, DOI 10.1586/14737175.2015.1014806; Koulis C, 2015, DIABETES METAB, V41, P272, DOI 10.1016/j.diabet.2015.01.006; Landar A, 1997, BBA-PROTEIN STRUCT M, V1343, P117, DOI 10.1016/S0167-4838(97)00126-X; Lanzillotta A, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00098; Lara DR, 2001, J PSYCHIATR RES, V35, P11, DOI 10.1016/S0022-3956(01)00003-6; Leclerc E, 2007, J BIOL CHEM, V282, P31317, DOI 10.1074/jbc.M703951200; Leclerc E, 2015, BBA-MOL BASIS DIS, V1852, P2706, DOI 10.1016/j.bbadis.2015.09.022; Leclerc E, 2009, BBA-MOL CELL RES, V1793, P993, DOI 10.1016/j.bbamcr.2008.11.016; Leis AA, 2012, MUSCLE NERVE, V45, P826, DOI 10.1002/mus.23241; Lesko MM, 2014, BRAIN INJURY, V28, P987, DOI 10.3109/02699052.2014.890743; Li F, 2006, CURR NEUROVASC RES, V3, P187, DOI 10.2174/156720206778018758; Li YK, 1998, J NEUROCHEM, V71, P1421; Liang FR, 2013, J CLIN NEUROSCI, V20, P357, DOI 10.1016/j.jocn.2012.06.005; Lim Ee Tuan, 1800, J Negat Results Biomed, V3, P4, DOI 10.1186/1477-5751-3-4; Lin CL, 2005, SURG NEUROL, V64, P201, DOI 10.1016/j.surneu.2005.04.038; Lin J, 2001, J BIOL CHEM, V276, P35037, DOI 10.1074/jbc.M104379200; Lin J, 2010, J BIOL CHEM, V285, P27487, DOI 10.1074/jbc.M110.155382; Liu JY, 2013, PLOS ONE, V8, DOI [10.1371/journal.pone.0050719, 10.1371/journal.pone.0064143, 10.1371/journal.pone.0057473]; Liu JL, 2011, ARCH MED RES, V42, P1, DOI 10.1016/j.arcmed.2011.01.005; Loquai C, 2013, ONKOLOGIE, V36, P578, DOI 10.1159/000355159; Lu J, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0022126; MACDONALD G, 1991, GENOMICS, V11, P317, DOI 10.1016/0888-7543(91)90138-5; Maiese K, 2008, EXPERT OPIN THER TAR, V12, P905, DOI 10.1517/14728222.12.7.905 ; Maiese K, 2013, EXPERT OPIN DRUG DIS, V8, P35, DOI 10.1517/17460441.2013.736485; Marlatt NM, 2009, BIOCHEMISTRY-US, V48, P1954, DOI 10.1021/bi802086a; Masaoka N., 2015, J MATERN-FETAL NEO M, P1; MICHETTI F, 1983, BRAIN RES, V262, P352, DOI 10.1016/0006-8993(83)91032-6; Michetti F, 2012, J NEUROCHEM, V120, P644, DOI 10.1111/j.1471-4159.2011.07612.x; Miller BA, 2014, BIOMED RES INT, V2014, DOI 10.1155/2014/384342; Missler U, 1997, STROKE, V28, P1956, DOI 10.1161/01.STR.28.10.1956; Mohammadzadeh F, 2013, LIFE SCI, V92, P639, DOI 10.1016/j.lfs.2012.09.011; Montaner J, 2012, J PROTEOMICS, V75, P4758, DOI 10.1016/j.jprot.2012.01.033; Mori T, 2008, STROKE, V39, P2114, DOI 10.1161/STROKEAHA.107.503821; Mori T, 2006, J PHARMACOL EXP THER, V318, P571, DOI 10.1124/jpet.106.105171; Mori T, 2010, GLIA, V58, P300, DOI 10.1002/glia.20924; Moritz S, 2010, J NEUROSURG ANESTH, V22, P21, DOI 10.1097/ANA.0b013e3181bdf50d; Moutsatsou P, 2014, CLIN CHEM LAB MED, V52, P999, DOI 10.1515/cclm-2013-0978; Mrak RE, 2001, NEUROBIOL AGING, V22, P915, DOI 10.1016/S0197-4580(01)00293-7; Netto CB, 2004, CLIN BIOCHEM, V37, P134, DOI 10.1016/j.clinbiochem.2003.09.010; Netto CBO, 2005, CLIN BIOCHEM, V38, P433, DOI 10.1016/j.clinbiochem.2004.12.014; Nishino A, 2010, NEUROL RES, V32, P873, DOI 10.1179/016164109X12608733393791; Nishiyama H, 2002, NEUROSCI LETT, V321, P49, DOI 10.1016/S0304-3940(01)02549-6; Nishiyama H, 2002, P NATL ACAD SCI USA, V99, P4037, DOI 10.1073/pnas.052020999; Niven J, 2015, PLOS ONE, V10, DOI 10.1371/journal.pone.0132688; Ohtaki N, 2007, J VIROL, V81, P5940, DOI 10.1128/JVI.02137-06; Ostendorp T, 2005, ACTA CRYSTALLOGR F, V61, P673, DOI 10.1107/S1744309105018014; Ostendorp T, 2007, EMBO J, V26, P3868, DOI 10.1038/sj.emboj.7601805; Otto M, 1998, NEUROSCI LETT, V240, P171, DOI 10.1016/S0304-3940(97)00947-6; Park JW, 2013, YONSEI MED J, V54, P567, DOI 10.3349/ymj.2013.54.3.567; Paschen A, 2009, CLIN CANCER RES, V15, P5208, DOI 10.1158/1078-0432.CCR-09-0886; Pedersen A, 2008, PROG NEURO-PSYCHOPH, V32, P1789, DOI 10.1016/j.pnpbp.2008.07.017; Perrone L, 2008, J CELL PHYSIOL, V217, P60, DOI 10.1002/jcp.21474; Peskind ER, 2001, NEUROCHEM INT, V39, P409, DOI 10.1016/S0197-0186(01)00048-1; Petzold A, 2003, NEUROSCI LETT, V336, P167, DOI 10.1016/S0304-3940(02)01257-0; Piazza O, 2007, BRIT J ANAESTH, V99, P518, DOI 10.1093/bja/aem201; Piazza O, 2007, PEDIATR NEUROSURG, V43, P258, DOI 10.1159/000103304; Piazza O, 2013, INT J IMMUNOPATH PH, V26, P383, DOI 10.1177/039463201302600211; Piazza O, 2009, NEUROCHEM RES, V34, P1289, DOI 10.1007/s11064-008-9907-2; Ponath G, 2007, J NEUROIMMUNOL, V184, P214, DOI 10.1016/j.jneuroim.2006.12.011; Prunell GF, 2005, NEUROSURGERY, V56, P1082, DOI 10.1227/01.NEU.0000157966.76590.39; Raucci A, 2008, FASEB J, V22, P3716, DOI 10.1096/fj.08-109033; Reddy MA, 2006, J BIOL CHEM, V281, P13685, DOI 10.1074/jbc.M511425200; REEVES RH, 1994, P NATL ACAD SCI USA, V91, P5359, DOI 10.1073/pnas.91.12.5359; Ridley AJ, 2006, TRENDS CELL BIOL, V16, P522, DOI 10.1016/j.tcb.2006.08.006; Riuzzi F, 2006, J CELL PHYSIOL, V207, P461, DOI 10.1002/jcp.20580; Riuzzi F, 2011, J CELL SCI, V124, P2389, DOI 10.1242/jcs.084491; Rohlwink UK, 2014, CLIN CHEM, V60, P823, DOI 10.1373/clinchem.2013.212472; Roizen NJ, 2003, LANCET, V361, P1281, DOI 10.1016/S0140-6736(03)12987-X; Rong LL, 2004, FASEB J, V18, P1812, DOI 10.1096/fj.04-1899com; Rose DZ, 2015, NEUROLOGY, V85, P1177, DOI 10.1212/WNL.0000000000001973; Rothermundt M, 2004, NEUROPSYCHOPHARMACOL, V29, P1004, DOI 10.1038/sj.npp.1300403; Rothermundt M, 2003, MICROSC RES TECHNIQ, V60, P614, DOI 10.1002/jemt.10303; Rothermundt M, 2007, PROG NEURO-PSYCHOPH, V31, P361, DOI 10.1016/j.pnpbp.2006.09.013; Sanchez-Pena P, 2008, CRIT CARE MED, V36, P2267, DOI 10.1097/CCM.0b013e3181809750; Sathe K, 2012, BRAIN, V135, P3336, DOI 10.1093/brain/aws250; Schaf DV, 2005, PARKINSONISM RELAT D, V11, P39, DOI 10.1016/j.parkreldis.2004.07.002; SCHMIDT AM, 1992, J BIOL CHEM, V267, P14987; Schmidt H, 2010, NEUROSCI LETT, V475, P104, DOI 10.1016/j.neulet.2010.03.059; Schroeter ML, 2013, CURR DRUG TARGETS, V14, P1237; Schroeter ML, 2003, SCHIZOPHR RES, V62, P231, DOI 10.1016/S0920-9964(02)00383-3; Schroeter ML, 2002, NEUROREPORT, V13, P1675, DOI 10.1097/00001756-200209160-00021; Scotto C, 1998, J BIOL CHEM, V273, P3901, DOI 10.1074/jbc.273.7.3901; Sedaghat F, 2008, HIPPOKRATIA, V12, P198; Seemann J, 1996, BIOCHEM J, V319, P123, DOI 10.1042/bj3190123; SELINFREUND RH, 1991, P NATL ACAD SCI USA, V88, P3554, DOI 10.1073/pnas.88.9.3554; Shakeril M, 2013, ARCH TRAUMA RES, V2, P76, DOI 10.5812/atr.8549; Shang YC, 2010, CELL SIGNAL, V22, P1317, DOI 10.1016/j.cellsig.2010.04.009; SHINJO K, 1990, P NATL ACAD SCI USA, V87, P9853, DOI 10.1073/pnas.87.24.9853; Sorci G, 2004, J CELL PHYSIOL, V199, P274, DOI 10.1002/jcp.10462; Sorci G, 2003, MOL CELL BIOL, V23, P4870, DOI 10.1128/MCB.23.14.4870-4881.2003; Sorci G, 2011, PLOS PATHOG, V7, DOI 10.1371/journal.ppat.1001315; Sorci Guglielmo, 2010, Cardiovasc Psychiatry Neurol, V2010, DOI 10.1155/2010/656481; Steinacker P, 2013, ACTA NEUROL SCAND, V128, P249, DOI 10.1111/ane.12113; Steiner J, 2006, J NEUROL NEUROSUR PS, V77, P1284, DOI 10.1136/jnnp.2006.093427; Steiner J, 2008, J PSYCHIATR RES, V42, P868, DOI 10.1016/j.jpsychires.2007.10.001; Steiner J, 2007, BMC NEUROSCI, V8, DOI 10.1186/1471-2202-8-2; Steiner J, 2010, PSYCHONEUROENDOCRINO, V35, P321, DOI 10.1016/j.psyneuen.2009.07.012; Steiner J, 2009, BIOL PSYCHIAT, V65, P1107, DOI 10.1016/j.biopsych.2008.10.044; Streicher WW, 2010, BIOPHYS CHEM, V151, P181, DOI 10.1016/j.bpc.2010.06.003; Streitburger DP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043284; Stroth N, 2015, EUR NEUROPSYCHOPHARM, V25, P2372, DOI 10.1016/j.euroneuro.2015.10.003; Sussmuth SD, 2003, NEUROSCI LETT, V353, P57, DOI 10.1016/j.neulet.2003.09.018; Takematsu M, 2014, CLIN TOXICOL, V52, P973, DOI 10.3109/15563650.2014.958614; Tanaka Y, 2008, BRAIN RES, V1227, P248, DOI 10.1016/j.brainres.2008.06.076; Tanaka Y, 2008, NEUROSCI LETT, V436, P40, DOI 10.1016/j.neulet.2008.02.056; Tanaka Y, 2007, BRAIN RES, V1154, P194, DOI 10.1016/j.brainres.2007.03.085; Tasker RC, 2015, CURR OPIN PEDIATR, V27, P694, DOI 10.1097/MOP.0000000000000287; Thelin E. P., 2015, EUR J TRAUMA EMERG S; Thelin EP, 2014, NEUROCRIT CARE, V20, P217, DOI 10.1007/s12028-013-9916-0; Tort ABL, 2004, LIFE SCI, V76, P379, DOI 10.1016/j.lfs.2004.09.003; Tsoporis JN, 2010, CIRC RES, V106, P93, DOI 10.1161/CIRCRESAHA.109.195834; Tsoporis JN, 2005, CIRCULATION, V111, P598, DOI 10.1161/01.CIR.0000154554.65287.F5; Tu PH, 1996, P NATL ACAD SCI USA, V93, P3155, DOI 10.1073/pnas.93.7.3155; Tubaro C, 2010, J CELL PHYSIOL, V223, P270, DOI 10.1002/jcp.22035; Tulner DM, 2009, NEUROPSYCHOBIOLOGY, V59, P87, DOI 10.1159/000209860; Turner MR, 2009, LANCET NEUROL, V8, P94, DOI 10.1016/S1474-4422(08)70293-X; van Dieck J, 2010, FEBS LETT, V584, P3269, DOI 10.1016/j.febslet.2010.06.024; van Zoelen MAD, 2009, J IMMUNOL, V182, P4349, DOI 10.4049/jimmunol.0801199; Vecchione C, 2009, HYPERTENSION, V54, P150, DOI 10.1161/HYPERTENSIONAHA.108.128124; Villarreal A, 2014, J NEUROCHEM, V131, P190, DOI 10.1111/jnc.12790; Villarreal A, 2011, J NEUROCHEM, V117, P321, DOI 10.1111/j.1471-4159.2011.07207.x; VLASSARA H, 1992, DIABETES, V41, P52, DOI 10.2337/diab.41.2.S52; Wafer LN, 2012, BIOCHEMISTRY-US, V51, P7189, DOI 10.1021/bi300865g; Weiss N, 2006, ANESTHESIOLOGY, V104, P658, DOI 10.1097/00000542-200604000-00008; Whitaker-Azmitia PM., 2010, CARDIOVASC PSYCHIAT, V2010; Willoughby KA, 2004, J NEUROCHEM, V91, P1284, DOI 10.1111/j.1471-4159.2004.02812.x; WINNINGHAMMAJOR F, 1989, J CELL BIOL, V109, P3063, DOI 10.1083/jcb.109.6.3063; Winocur G, 2001, NEUROBIOL LEARN MEM, V75, P230, DOI 10.1006/nlme.2000.3961; Wolff V, 2015, CEREBROVASC DIS, V39, P31, DOI 10.1159/000369776; Wolff V, 2013, STROKE, V44, P558, DOI 10.1161/STROKEAHA.112.671347; Yamagishi Sho-ichi, 2010, Front Biosci (Elite Ed), V2, P1184; Yamamoto KI, 2013, ONCOL REP, V29, P1073, DOI 10.3892/or.2012.2191; Yang K, 2009, CAN J PSYCHIAT, V54, P312, DOI 10.1177/070674370905400505; Yoneko M, 2010, METHOD FIND EXP CLIN, V32, P727, DOI 10.1358/mf.2010.32.10.1561078; Yoshimura C, 2013, BIOORGAN MED CHEM, V21, P1109, DOI 10.1016/j.bmc.2012.12.042; Zaccardi F, 2016, POSTGRAD MED J, V92, P63, DOI 10.1136/postgradmedj-2015-133281; Zarogoulidis P, 2015, J CANCER, V6, P9, DOI 10.7150/jca.10560; Zarubin T, 2005, CELL RES, V15, P11, DOI 10.1038/sj.cr.7290257; Zhai JG, 2011, BEHAV BRAIN RES, V217, P363, DOI 10.1016/j.bbr.2010.11.004; Zhukova L, 2004, BBA-MOL CELL RES, V1742, P191, DOI 10.1016/j.bbamcr.2004.10.002; Zimmer Danna B, 2013, Methods Mol Biol, V963, P303, DOI 10.1007/978-1-62703-230-8_18; Zimmer DB, 1997, ENDOCRINOLOGY, V138, P5176, DOI 10.1210/en.138.12.5176	269	15	15	0	14	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	0929-8673	1875-533X		CURR MED CHEM	Curr. Med. Chem.		2016	23	15					1571	1596		10.2174/0929867323666160406121117			26	Biochemistry & Molecular Biology; Chemistry, Medicinal; Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Biochemistry & Molecular Biology; Pharmacology & Pharmacy	DM6HK	WOS:000376451700005	27048377				2022-02-06	
J	Cuesta, M; Hannon, MJ; Crowley, RK; Behan, LA; Tormey, W; Rawluk, D; Delargy, M; Agha, A; Thompson, CJ				Cuesta, Martin; Hannon, Mark J.; Crowley, Rachel K.; Behan, Lucy Ann; Tormey, William; Rawluk, Daniel; Delargy, Mark; Agha, Amar; Thompson, Christopher J.			Symptoms of gonadal dysfunction are more predictive of hypopituitarism than nonspecific symptoms in screening for pituitary dysfunction following moderate or severe traumatic brain injury	CLINICAL ENDOCRINOLOGY			English	Article							GROWTH-HORMONE DEFICIENCY; LONG-TERM; NEUROENDOCRINE DYSFUNCTION; SUBARACHNOID HEMORRHAGE; PREVALENCE; DEPRESSION; PATIENT; FATIGUE; ADULTS; RISK	Objective The economic and logistic burden of screening for hypopituitarism following moderate/severe traumatic brain injury (TBI) is considerable. A key recommendation in published guidelines is to prioritize for screening those patients with symptoms suggestive of pituitary dysfunction. The purpose of this study was to evaluate the utility of targeted screening for hypopituitarism in long-term survivors after moderate/severe TBI using referrals on the basis of symptoms. Design In group 1 (G1), consecutive, unselected patients were screened from the Irish National Neurosurgery Centre, whereas in group 2 (G2) patients were targeted based on the presence of symptoms suggestive of pituitary dysfunction. Patients A total of 137 patients (113 male) were systematically screened (G1) and compared to 112 patients (77 male) referred for pituitary evaluation on the basis of suggestive symptoms (G2). Main outcome measures The rate of GH, ACTH, gonadotrophin (GT), TSH and ADH deficiency was compared among groups. Results Patients referred with menstrual dysfunction had more GH (50% vs 11%, P = 0.001), ACTH (60% vs 14%, P < 0.0001), GT (90% vs 16%, P < 0.0001) deficiency and any pituitary hormone deficit (80% vs 33%, P = 0.003) than G1. Men with symptoms of hypogonadism had more GH (33% vs 11%, P = 0.003), GT (58% vs 16%, P < 0.0001) and TSH (16% vs 1%, P = 0.03) deficiency than G1. Patients with nonspecific symptoms were no more likely to have hypopituitarism than those consecutively screened. Conclusions Symptoms of hypogonadism are sufficiently predictive of hypopituitarism to justify screening for hypopituitarism after moderate/severe TBI. Nonspecific symptoms of hypopituitarism are no more predictive than unselected screening.	[Cuesta, Martin; Hannon, Mark J.; Crowley, Rachel K.; Behan, Lucy Ann; Agha, Amar; Thompson, Christopher J.] Beaumont Hosp, RCSI Med Sch, Acad Dept Endocrinol, Dublin 9, Dublin, Ireland; [Tormey, William] Beaumont Hosp, RCSI Med Sch, Dept Chem Pathol, Dublin 9, Ireland; [Rawluk, Daniel] Beaumont Hosp, RCSI Med Sch, Natl Neurosurg Unit, Dublin 9, Ireland; [Delargy, Mark] Beaumont Hosp, RCSI Med Sch, Natl Rehabil Unit, Dublin 9, Ireland		Thompson, CJ (corresponding author), Beaumont Hosp, RCSI Med Sch, Acad Dept Endocrinol, Beaumont Rd, Dublin 9, Dublin, Ireland.	christhompson@beaumont.ie		Crowley, Rachel/0000-0003-1472-4117	Pfizer PharmaceuticalsPfizer; Novo Nordisk PharmaceuticalsNovo Nordisk	The work in this study was supported by unrestricted grants from Pfizer Pharmaceuticals and Novo Nordisk Pharmaceuticals.	Agha A, 2004, CLIN ENDOCRINOL, V60, P584, DOI 10.1111/j.1365-2265.2004.02023.x; Agha A, 2004, J CLIN ENDOCR METAB, V89, P4929, DOI 10.1210/jc.2004-0511; Agha Amar, 2005, Am J Med, V118, P1416; Aimaretti G, 2004, CLIN ENDOCRINOL, V61, P320, DOI 10.1111/j.1365-2265.2004.02094.x; Aimaretti G, 2007, NAT CLIN PRACT ENDOC, V3, P318, DOI 10.1038/ncpendmet0460; Carroll P.V., 2008, J CLIN ENDOCRINOLOGY, V83, P382; Casanueva FF, 2004, J ENDOCRINOL INVEST, V27, P793, DOI 10.1007/BF03347526; Gasco V, 2012, PITUITARY, V15, P20, DOI 10.1007/s11102-010-0235-6; Ghigo E, 2005, BRAIN INJURY, V19, P711, DOI 10.1080/02699050400025315; Gleeson HK, 2003, J CLIN ENDOCR METAB, V88, P2106, DOI 10.1210/jc.2002-020969; Hannon MJ, 2013, J CLIN ENDOCR METAB, V98, P3229, DOI 10.1210/jc.2013-1555; Heather NL, 2012, J CLIN ENDOCR METAB, V97, P599, DOI 10.1210/jc.2011-2284; Hellawell DJ, 1999, BRAIN INJURY, V13, P489; Hibbard MR, 2000, NEUROREHABILITATION, V15, P109; Kelly D.F., 2004, J NEUROSURG, V93, P743; Khadr SN, 2010, CLIN ENDOCRINOL, V73, P637, DOI 10.1111/j.1365-2265.2010.03857.x; Klose M, 2007, CLIN ENDOCRINOL, V67, P598, DOI 10.1111/j.1365-2265.2007.02931.x; Klose M, 2015, EUR J ENDOCRINOL, V172, P753, DOI 10.1530/EJE-14-1069; Klose M, 2014, J CLIN ENDOCR METAB, V99, P101, DOI 10.1210/jc.2013-2397; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; LaChapelle DL, 1998, BRAIN INJURY, V12, P649, DOI 10.1080/026990598122214; Leal-Cerro A, 2005, CLIN ENDOCRINOL, V62, P525, DOI 10.1111/j.1365-2265.2005.02250.x; Leon-Carrion J, 2001, BRAIN INJURY, V15, P175, DOI 10.1080/026990501458407; Lieberman SA, 2001, J CLIN ENDOCR METAB, V86, P2752, DOI 10.1210/jc.86.6.2752; PAVORD SR, 1992, CLIN ENDOCRINOL, V36, P135, DOI 10.1111/j.1365-2265.1992.tb00947.x; Personnier C, 2014, J CLIN ENDOCR METAB, V99, P2052, DOI 10.1210/jc.2013-4129; Ponsford J, 2014, BRAIN INJURY, V28, P146, DOI 10.3109/02699052.2013.859733; Schneider HJ, 2011, J NEUROTRAUM, V28, P1693, DOI 10.1089/neu.2011.1887; Sigurdardottir S, 2013, J REHABIL MED, V45, P808, DOI 10.2340/16501977-1156; TEASDALE G, 1974, LANCET, V2, P81; TEASDALE G, 1992, J NEUROTRAUM, V9, pS249; Ulfarsson T, 2013, J NEUROTRAUM, V30, P271, DOI 10.1089/neu.2012.2494; Van Baalen B, 2003, DISABIL REHABIL, V25, P9, DOI 10.1080/713813430	33	15	17	0	4	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	0300-0664	1365-2265		CLIN ENDOCRINOL	Clin. Endocrinol.	JAN	2016	84	1					92	98		10.1111/cen.12874			7	Endocrinology & Metabolism	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism	DB2NB	WOS:000368344600013	26252757				2022-02-06	
J	Darkazalli, A; Ismail, AAO; Abad, N; Grant, SC; Levenson, CW				Darkazalli, Ali; Ismail, Abdol Aziz Ould; Abad, Nastaren; Grant, Samuel C.; Levenson, Cathy W.			Use of human mesenchymal stem cell treatment to prevent anhedonia in a rat model of traumatic brain injury	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Traumatic brain injury; mesenchymal stem cells; subventricular zone; X-ray irradiation; depression	BONE-MARROW; HEAD-INJURY; ADULT RATS; DEPRESSION; TRANSPLANTATION; PROLIFERATION	Purpose: Major depression and related mood disorders are the most common long-term outcomes associated with traumatic brain injury (TBI). Given the potentially debilitating consequences of depression, and the fact that TBI patients are frequently refractory to antidepressant drugs, new therapies are clearly needed. We hypothesized that human bone marrow-derived mesenchymal stem cells (hMSC), delivered intravenously, can effectively treat TBI-induced depression and other behavioral deficits associated with TBI. Methods: Rats (n= 8 per group) were subjected to experimental TBI or control sham operation. Six hours post TBI, rats were treated with 1 x 10(6) hMSC or vehicle control Immediately after TBI and prior to hMSC or control treatment, rats were subjected to either targeted precision x-ray irradiation to eliminate subventricular zone (SVZ) proliferation or sham irradiation. One week after TBI, SVZ irradiation, and hMSC treatment, rats were evaluated for the depression -like behavior, anhedonia, using the two-bottle saccharin preference paradigm; and for working memory using the novel object recognition test. Results: TBI resulted in a 54% (p < 0.05) decrease in saccharin preference scores while treatment of TBI with hMSC fully prevented this anhedonic behavior. TBI was also found to produce a 73% (p < 0.05) decrease in novel object interaction time, indicating impaired working memory, and was similarly improved by treatment with hMSC. The ability of hMSC to prevent TBI-associated depression and working memory impairment was eliminated when SVZ proliferation was inhibited by irradiation. Conclusions: This work has identified a possible role for hMSC in the treatment of TBI-induced depression and other behaviors and suggests a mechanistic role for proliferative cells of the SVZ proliferation in hMSC efficacy.	[Darkazalli, Ali; Levenson, Cathy W.] Florida State Univ, Coll Med, Dept Biomed Sci, Tallahassee, FL 32306 USA; [Darkazalli, Ali; Levenson, Cathy W.] Florida State Univ, Coll Med, Program Neurosci, Tallahassee, FL 32306 USA; [Ismail, Abdol Aziz Ould; Abad, Nastaren; Grant, Samuel C.] FAMU FSU Coll Engn, Dept Chem & Biomed Engn, Tallahassee, FL USA; [Ismail, Abdol Aziz Ould; Abad, Nastaren; Grant, Samuel C.] Florida State Univ, Natl High Magnet Field Lab, Tallahassee, FL 32306 USA		Levenson, CW (corresponding author), Coll Med, Res Bldg,MSR 2350-E,1115W Call St, Tallahassee, FL 32306 USA.	cathy.levenson@med.fsu.edu	Abad, Nastaren/AAI-3961-2021; Grant, Samuel/D-8744-2013	Levenson, Cathy W/0000-0003-4463-3136; Abad, Nastaren/0000-0002-7020-0492; Grant, Samuel/0000-0001-7738-168X	National Science FoundationNational Science Foundation (NSF) [DMR-1157490]; State of Florida; NHMFL user collaboration grant program; Department of DefenseUnited States Department of Defense	The authors would like to thank Dr. Thomas J. Morgan Jr. for assistance with stem cell culture and delivery. The authors would also like to thank Dr. Jens Rosenberg for his expertise and support of the imaging portion of this work was performed at the National High Magnetic Field Laboratory (NHMFL) and the FAMU-FSU College of Engineering. The NHMFL is supported by National Science Foundation (DMR-1157490) and the State of Florida. Funding was also provided by NHMFL user collaboration grant program and the Department of Defense.	Ankrum JA, 2014, NAT BIOTECHNOL, V32, P252, DOI 10.1038/nbt.2816; Brenner LA, 2009, REHABIL PSYCHOL, V54, P390, DOI 10.1037/a0017802; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Cope EC, 2011, PHYSIOL BEHAV, V104, P942, DOI 10.1016/j.physbeh.2011.06.007; DINAN TG, 1992, ACTA PSYCHIAT SCAND, V85, P292, DOI 10.1111/j.1600-0447.1992.tb01472.x; Guan J, 2013, BIOMATERIALS, V34, P5937, DOI 10.1016/j.biomaterials.2013.04.047; Johnson EM, 2013, FRONT BEHAV NEUROSCI, V7, DOI 10.3389/fnbeh.2013.00044; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kebriaei P, 2009, BIOL BLOOD MARROW TR, V15, P804, DOI 10.1016/j.bbmt.2008.03.012; Kern S, 2006, STEM CELLS, V24, P1294, DOI 10.1634/stemcells.2005-0342; Lazic SE, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113855; Le Blanc K, 2003, EXP HEMATOL, V31, P890, DOI 10.1016/S0301-472X(03)00110-3; LeBlanc K, 2008, LANCET, V371, P1579, DOI 10.1016/S0140-6736(08)60690-X; Levin HS, 2005, ARCH GEN PSYCHIAT, V62, P523, DOI 10.1001/archpsyc.62.5.523; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Mahmood A, 2003, NEUROSURGERY, V53, P697, DOI 10.1227/01.NEU.0000079333.61863.AA; Mahmood A, 2001, NEUROSURGERY, V49, P1196, DOI 10.1097/00006123-200111000-00031; Nagai R, 2000, SURG NEUROL, V53, P503, DOI 10.1016/S0090-3019(00)00214-7; Nowrangi MA, 2014, PSYCHOSOMATICS, V55, P430, DOI 10.1016/j.psym.2013.11.006; Okuma Y, 2013, NEUROSCI LETT, V554, P156, DOI 10.1016/j.neulet.2013.08.058; Parent JM, 2003, NEUROSCIENTIST, V9, P261, DOI 10.1177/1073858403252680; Prockop DJ, 2010, CYTOTHERAPY, V12, P576, DOI 10.3109/14653249.2010.507330; Salman H, 2004, J NEUROTRAUM, V21, P283, DOI 10.1089/089771504322972077; SARAN AS, 1985, J CLIN PSYCHIAT, V46, P335; Shinohara C, 1997, CANCER RES, V57, P2694; Tada E, 2000, NEUROSCIENCE, V99, P33, DOI 10.1016/S0306-4522(00)00151-2; Tada E, 1999, EXP NEUROL, V160, P66, DOI 10.1006/exnr.1999.7172; Tassabehji NM, 2008, PHYSIOL BEHAV, V95, P365, DOI 10.1016/j.physbeh.2008.06.017; Teasdale TW, 2001, J NEUROL NEUROSUR PS, V71, P436, DOI 10.1136/jnnp.71.4.436; Turner RC, 2015, FRONT NEUROL, V6, DOI 10.3389/fneur.2015.00222; Wan M, 2012, STEM CELLS, V30, P2498, DOI 10.1002/stem.1208; WILLIS P, 1976, NEUROPATH APPL NEURO, V2, P377, DOI 10.1111/j.1365-2990.1976.tb00511.x; Zhang R, 2013, J NEUROINFLAMM, V10, DOI 10.1186/1742-2094-10-106; Zheng WM, 2013, J NEUROTRAUM, V30, P1872, DOI 10.1089/neu.2010.1579	34	15	16	0	3	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2016	34	3					433	441		10.3233/RNN-150628			9	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DQ1EY	WOS:000378945500007	27080073				2022-02-06	
J	Fraiman, D; Miranda, MF; Erthal, F; Buur, PF; Elschot, M; Souza, L; Rombouts, SARB; Schimmelpenninck, CA; Norris, DG; Malessy, MJA; Galves, A; Vargas, CD				Fraiman, D.; Miranda, M. F.; Erthal, F.; Buur, P. F.; Elschot, M.; Souza, L.; Rombouts, S. A. R. B.; Schimmelpenninck, C. A.; Norris, D. G.; Malessy, M. J. A.; Galves, A.; Vargas, C. D.			Reduced functional connectivity within the primary motor cortex of patients with brachial plexus injury	NEUROIMAGE-CLINICAL			English	Article						Resting state; Gray matter; Peripheral lesion; Functional connectivity; Horizontal connections; Correlation decay	MUSCULOCUTANEOUS NERVE TRANSFER; RESTING-STATE FMRI; ROOT AVULSION; INTERCOSTAL; PLASTICITY; MAPS; REORGANIZATION; PROJECTIONS; BRAIN	This study aims at the effects of traumatic brachial plexus lesion with root avulsions (BPA) upon the organization of the primary motor cortex (M1). Nine right-handed patients with a right BPA in whom an intercostal to musculocutaneous (ICN-MC) nerve transfer was performed had post-operative resting state fMRI scanning. The analysis of empirical functional correlations between neighboring voxels revealed faster correlation decay as a function of distance in the M1 region corresponding to the arm in BPA patients as compared to the control group. No differences between the two groups were found in the face area. We also investigated whether such larger decay in patients could be attributed to a gray matter diminution in M1. Structural imaging analysis showed no difference in gray matter density between groups. Our findings suggest that the faster decay in neighboring functional correlations without significant gray matter diminution in BPA patients could be related to a reduced activity in intrinsic horizontal connections in M1 responsible for upper limb motor synergies. (C) 2016 The Authors. Published by Elsevier Inc. This is an open access article under the CC BY-NC-ND license.	[Fraiman, D.] Univ San Andres, Dept Matemat & Ciencias, Buenos Aires, DF, Argentina; [Fraiman, D.] Consejo Nacl Invest Cient & Tecn, Buenos Aires, DF, Argentina; [Miranda, M. F.; Galves, A.] Univ Sao Paulo, Inst Matemat & Estat, Sao Paulo, Brazil; [Buur, P. F.; Elschot, M.; Norris, D. G.] Spinoza Ctr Neuroimaging, Amsterdam, Netherlands; [Rombouts, S. A. R. B.] Leiden Inst Brain & Cognit, Leiden, Netherlands; [Rombouts, S. A. R. B.] Leiden Univ, Inst Psychol, Leiden, Netherlands; [Rombouts, S. A. R. B.; Schimmelpenninck, C. A.] Leiden Univ, Med Ctr, Dept Radiol, Leiden, Netherlands; [Schimmelpenninck, C. A.; Malessy, M. J. A.] Leiden Univ, Med Ctr, Dept Neurosurg, Leiden, Netherlands; [Norris, D. G.] Univ Duisburg Essen, Erwin L Hahn Inst Magnet Resonance Imaging, Essen, Germany; [Erthal, F.; Souza, L.; Vargas, C. D.] Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil; [Erthal, F.; Elschot, M.; Vargas, C. D.] Univ Fed Rio de Janeiro, Inst Neurol Deolindo Couto, Rio De Janeiro, Brazil		Vargas, CD (corresponding author), Univ Fed Rio de Janeiro, Inst Biofis Carlos Chagas Filho, Rio De Janeiro, Brazil.	cdvargas@biof.ufrj.br	Norris, David G/A-1937-2010; Rombouts, Serge A./AAL-7691-2021; Galves, Antonio/Q-6833-2019; Elschot, Mattijs/AAD-4362-2021; Malessy, Martijn/AAZ-9996-2021; Vargas, Claudia D./A-1523-2016; Fraiman, Daniel/E-1581-2018; Erthal, Fatima/L-2795-2013	Norris, David G/0000-0002-3699-6917; Rombouts, Serge A./0000-0001-6351-4779; Galves, Antonio/0000-0001-8757-715X; Elschot, Mattijs/0000-0002-8056-9103; Malessy, Martijn/0000-0003-1936-3664; Vargas, Claudia D./0000-0001-6202-3580; Fraiman, Daniel/0000-0002-0482-9137; Erthal, Fatima/0000-0001-5796-3738	Fundacao de amparo a pesquisa do Estado de Sao Paulo (FAPESP)Fundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [2013/07699-0]; Conselho Nacional de Pesquisa (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [480108/2012-9, 478537/2012-3]; Fundacao de amparo a pesquisa do Rio de Janeiro FAPERJFundacao Carlos Chagas Filho de Amparo a Pesquisa do Estado do Rio De Janeiro (FAPERJ) [E-26/111.655/2012, E-26/110.526/2012]	This work is part of University of Sao Paulo (USP) project Mathematics, computation, language and the brain, Fundacao de amparo a pesquisa do Estado de Sao Paulo (FAPESP) project NeuroMat (grant 2013/07699-0), CAPES NUFFIC (038/12), Conselho Nacional de Pesquisa (CNPq) (grants 480108/2012-9 and 478537/2012-3), Fundacao de amparo a pesquisa do Rio de Janeiro FAPERJ (grants E-26/111.655/2012 and E-26/110.526/2012) and Programa de apoyo a la investigacion de la Universidad San Andre's (PAI UdeSA). The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.	BENJAMINI Y, 1995, J R STAT SOC B, V57, P289, DOI 10.1111/j.2517-6161.1995.tb02031.x; Boucsein C, 2011, FRONT NEUROSCI-SWITZ, V5, DOI 10.3389/fnins.2011.00032; Buonomano DV, 1998, ANNU REV NEUROSCI, V21, P149, DOI 10.1146/annurev.neuro.21.1.149; Cramer SC, 2011, BRAIN, V134, P1591, DOI 10.1093/brain/awr039; Davis KD, 2011, NEUROSCIENTIST, V17, P407, DOI 10.1177/1073858410389185; Dy CJ, 2015, J HAND SURG-AM, V40, P308, DOI 10.1016/j.jhsa.2014.10.033; Garcia-Cordero I, 2015, STROKE, V46, P2673, DOI 10.1161/STROKEAHA.115.009598; Garraghty P E, 1992, Curr Opin Neurobiol, V2, P522, DOI 10.1016/0959-4388(92)90191-M; Gelfand AE, 2010, CH CRC HANDB MOD STA, P1, DOI 10.1201/9781420072884; Geyer S, 1996, NATURE, V382, P805, DOI 10.1038/382805a0; HUNTLEY GW, 1991, J NEUROPHYSIOL, V66, P390, DOI 10.1152/jn.1991.66.2.390; Ibey RJ, 2015, CLIN NEUROPHYSIOL, V126, P1934, DOI 10.1016/j.clinph.2014.12.006; JACOBS KM, 1991, SCIENCE, V251, P944, DOI 10.1126/science.2000496; Jaggi AS, 2011, BRAIN RES, V1381, P187, DOI 10.1016/j.brainres.2011.01.002; KAAS JH, 1991, ANNU REV NEUROSCI, V14, P137, DOI 10.1146/annurev.ne.14.030191.001033; Liu B, 2013, NEUROSCIENCE, V243, P33, DOI 10.1016/j.neuroscience.2013.03.048; Malessy MJA, 1998, J NEUROSURG, V88, P266, DOI 10.3171/jns.1998.88.2.0266; MALESSY MJA, 1993, CLIN NEUROL NEUROSUR, V95, pS95; Malessy MJA, 2003, J NEUROSURG, V98, P261, DOI 10.3171/jns.2003.98.2.0261; MANO Y, 1995, ANN NEUROL, V38, P15, DOI 10.1002/ana.410380106; Midha Rajiv, 2004, Neurosurg Focus, V16, pE5; Miranda MF, 2013, BIOMETRICS, V69, P1074, DOI 10.1111/biom.12085; NARAKAS AO, 1988, CLIN ORTHOP RELAT R, P43; Qiu TM, 2014, J NEUROL NEUROSUR PS, V85, P99, DOI 10.1136/jnnp-2013-304956; Rasmussen T., 1950, CEREBRAL CORTEX MAN; Sanes JN, 2000, ANNU REV NEUROSCI, V23, P393, DOI 10.1146/annurev.neuro.23.1.393; Schieber MH, 2001, J NEUROPHYSIOL, V86, P2125, DOI 10.1152/jn.2001.86.5.2125; Seddon H.J., 2005, EED RES COUNCIL SPEC, V282; Sherman M., 2011, STAT SPATIOTEMPORAL; Simoes EL, 2012, J NEUROSCI, V32, P3211, DOI 10.1523/JNEUROSCI.4592-11.2012; Smith SM, 2009, P NATL ACAD SCI USA, V106, P13040, DOI 10.1073/pnas.0905267106; Souza L, 2016, FRONT HUM NEUROSCI, V9, DOI 10.3389/fnhum.2015.00715; Swayne O, 2006, CLIN NEUROPHYSIOL, V117, P855, DOI 10.1016/j.clinph.2005.12.012; Taylor KS, 2009, BRAIN, V132, P3122, DOI 10.1093/brain/awp231; Ziemann U, 2004, REV NEUROSCIENCE, V15, P253	35	15	15	0	4	ELSEVIER SCI LTD	OXFORD	THE BOULEVARD, LANGFORD LANE, KIDLINGTON, OXFORD OX5 1GB, OXON, ENGLAND	2213-1582			NEUROIMAGE-CLIN	NeuroImage-Clin.		2016	12						277	284		10.1016/j.nicl.2016.07.008			8	Neuroimaging	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	EF3AI	WOS:000390196400032	27547727	Green Published, gold, Green Submitted			2022-02-06	
J	Gallun, FJ; Lewis, MS; Folmer, RL; Hutter, M; Papesh, MA; Belding, H; Leek, MR				Gallun, Frederick J.; Lewis, M. Samantha; Folmer, Robert L.; Hutter, Michele; Papesh, Melissa A.; Belding, Heather; Leek, Marjorie R.			Chronic effects of exposure to high-intensity blasts: Results of tests of central auditory processing	JOURNAL OF REHABILITATION RESEARCH AND DEVELOPMENT			English	Article						auditory dysfunction; auditory processing disorder; blast; central auditory processing; dichotic listening; hearing loss; psychoacoustics; rehabilitation; temporal processing; traumatic brain injury; Veterans	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; HEARING HANDICAP; MILD; COMBAT; PERFORMANCE; OUTCOMES; HEALTH	Patients who have recently experienced high-intensity blasts are more likely to perform abnormally on tests developed to be sensitive to deficits of central auditory processing than were age- and hearing-matched individuals without blast exposures. Here, a group of 59 participants was recruited, 30 of whom were exposed to high-intensity blasts between 4 and 11 yr prior to testing and did not participate in the previous study, along with 29 controls similar in age and hearing thresholds to the blast group. All were tested on a set of behavioral tests that were used in the previous study. Abnormal performance was measured with reference both to published normative data and to the average performance of the control group. Members of the blast-exposed group were again found to be significantly more likely to perform in the abnormal range than were the members of the control group. Because the patients in this study were tested a minimum of 4 yr after blast exposure, these results suggest that for some of those exposed, problems processing auditory information may be a chronic effect of blast exposure even in the absence of significant peripheral hearing loss.	[Gallun, Frederick J.; Lewis, M. Samantha; Folmer, Robert L.; Hutter, Michele; Papesh, Melissa A.; Belding, Heather; Leek, Marjorie R.] VA Portland Hlth Care Syst, Natl Ctr Rehabil Auditory Res, Rehabil Res & Dev Serv, Dept Vet Affairs, Portland, OR USA; [Gallun, Frederick J.; Lewis, M. Samantha; Folmer, Robert L.; Leek, Marjorie R.] Oregon Hlth & Sci Univ, Dept Otolaryngol Head & Neck Surg, Portland, OR 97201 USA; [Leek, Marjorie R.] VA Loma Linda Healthcare Syst, Loma Linda, CA USA; [Leek, Marjorie R.] Loma Linda Univ, Dept Otolaryngol Head & Neck Surg, Healthcare, Loma Linda, CA 92350 USA		Gallun, FJ (corresponding author), NCRAR, 3710 SW US Vet Hosp Rd, Portland, OR 97239 USA.	Frederick.Gallun@va.gov	Gallun, Frederick J./G-3792-2012	Gallun, Frederick J./0000-0002-4145-2199	VA Rehabilitation Research & Development (RRD) Service [C7755I]; Senior Research Career Scientist award [C4042L]; Career Development II award [C7067W]; VA RR&D National Center for Rehabilitative Auditory Research [C4844C]	This material was based on work supported by the following awards from the VA Rehabilitation Research & Development (RR&D) Service: Merit Review Award C7755I (principal investigators: Gallun, Leek), Senior Research Career Scientist award to M.R. Leek (C4042L), and a Career Development II award to M. S. Lewis (C7067W). Support was also provided by the VA RR&D National Center for Rehabilitative Auditory Research (C4844C).	Augustine AM, 2013, INDIAN J OTOLARYNGOL, V65, P120, DOI 10.1007/s12070-012-0586-6; Bazarian JJ, 2013, J HEAD TRAUMA REHAB, V28, P1, DOI 10.1097/HTR.0b013e318256d3d3; Bliese PD, 2008, J CONSULT CLIN PSYCH, V76, P272, DOI 10.1037/0022-006X.76.2.272; Broadbent D.E., 1958, PERCEPTION COMMUNICA, DOI [10.1037/10037-000, DOI 10.1037/10037-000]; Eskridge SL, 2013, J NEUROTRAUM, V30, P1391, DOI 10.1089/neu.2012.2537; FIRE KM, 1991, AM J OTOL, V12, P105; Folstein M. F., 2010, PSYCHOL ASSESSMENT R; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1059, DOI 10.1682/JRRD.2010.09.0166; Gallun FJ, 2012, J REHABIL RES DEV, V49, P1005, DOI 10.1682/JRRD.2012.03.0038; Institute of Medicine, 2014, GULF WAR HLTH LONG T, V9; Jerger J, 1990, J Am Acad Audiol, V1, P75; Katz J., 1998, THE SSW TEST MANUAL; Keppel G., 2004, DESIGN ANAL RES HDB, V4th ed.; Lingsma HF, 2015, J NEUROTRAUM, V32, P83, DOI 10.1089/neu.2014.3384; Musiek FE, 2005, EAR HEARING, V26, P608, DOI 10.1097/01.aud.0000188069.80699.41; MUSIEK FE, 1983, EAR HEARING, V4, P79, DOI 10.1097/00003446-198303000-00002; MUSIEK FE, 1987, AUDIOLOGY, V26, P79; NEWMAN CW, 1990, EAR HEARING, V11, P430, DOI 10.1097/00003446-199012000-00004; Petrie EC, 2014, J NEUROTRAUM, V31, P425, DOI [10.1089/NEU.2013.2952, 10.1089/neu.2013.2952]; Terrio H, 2009, J HEAD TRAUMA REHAB, V24, P14, DOI 10.1097/HTR.0b013e31819581d8; Vanderploeg RD, 2012, ARCH PHYS MED REHAB, V93, P1887, DOI 10.1016/j.apmr.2012.05.024; Wilson Richard H, 2005, J Am Acad Audiol, V16, P367, DOI 10.3766/jaaa.16.6.5; Wilson Richard H, 2003, J Am Acad Audiol, V14, P1, DOI 10.3766/jaaa.14.1.2	23	15	15	0	1	JOURNAL REHAB RES & DEV	BALTIMORE	DEPT OF VETERANS AFFAIRS REHABIL RES & DEVELOP CTR 103 SOUTH GAY STREET, BALTIMORE, MD 21202-4051 USA	0748-7711	1938-1352		J REHABIL RES DEV	J. Rehabil. Res. Dev.		2016	53	6					705	720		10.1682/JRRD.2014.12.0313			16	Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation	EK5SC	WOS:000393985100006		gold			2022-02-06	
J	Geng, FY; Ma, YH; Xing, T; Zhuang, XB; Zhu, JX; Yao, LS				Geng, Fengyang; Ma, Yinghua; Xing, Tao; Zhuang, Xianbo; Zhu, Jianxin; Yao, Lusu			Effects of Hyperbaric Oxygen Therapy on Inflammasome Signaling after Traumatic Brain Injury	NEUROIMMUNOMODULATION			English	Article						Traumatic brain injury; Hyperbaric oxygen therapy; Inflammasomes; High-mobility group box 1	SPINAL-CORD-INJURY; CEREBRAL-CORTEX; CELL-DEATH; EXPRESSION; HMGB1; HMGB1/NF-KAPPA-B; ACTIVATION; PROTEIN; MODEL; MICE	Objective: Neuroinflammation plays an important role in secondary tissue damage after traumatic brain injury (TBI). Recently, the inflammasome-mediated inflammatory pathway has been observed in the inflammatory response of TBI. In this study, we investigated the influence of hyperbaric oxygen therapy (HBOT) on inflammasome activation after TBI. Methods: The experimental mice were randomly divided into 4 groups as follows: sham-operated normobaric air (21% O-2 at one absolute atmosphere), HBOT only, TBI + normobaric air and TBI + HBOT. Following the evaluation of motor deficits and brain edema, the expression of inflammasome components and effectors was measured by qRT-PCR and Western blotting. Moreover, alterations in IL-1 beta, IL-18 and high-mobility group box 1 (HMGB1) were calculated by enzyme-linked immunosorbent assay at each time point after injury. Results: HBOT improved motor score and reduced brain edema. Furthermore, it suppressed protein expression of inflammasome components and reduced the levels of IL-1 beta and IL-18, accompanied by the reduction of HMGB1 in brain tissues and serum. Conclusion: These results suggest that HBOT may alleviate the inflammatory response after TBI by inhibiting the activation of inflammasome signaling. (C) 2016 S. Karger AG, Basel	[Geng, Fengyang; Ma, Yinghua; Xing, Tao; Zhuang, Xianbo; Zhu, Jianxin; Yao, Lusu] Liaocheng Peoples Hosp, Dept Neurosurg, 67 West Dongchang Rd, Liaocheng 252000, Shandong, Peoples R China		Ma, YH (corresponding author), Liaocheng Peoples Hosp, Dept Neurosurg, 67 West Dongchang Rd, Liaocheng 252000, Shandong, Peoples R China.	yinghuamalc@sina.com					Adamczak S, 2012, J NEUROSURG, V117, P1119, DOI 10.3171/2012.9.JNS12815; Adamczak SE, 2014, J CEREBR BLOOD F MET, V34, P621, DOI 10.1038/jcbfm.2013.236; Chen SF, 2008, BRIT J PHARMACOL, V155, P1279, DOI 10.1038/bjp.2008.345; Corps KN, 2015, JAMA NEUROL, V72, P355, DOI 10.1001/jamaneurol.2014.3558; Fernandes-Alnemri T, 2009, NATURE, V458, P509, DOI 10.1038/nature07710; Frank MG, 2015, BRAIN BEHAV IMMUN, V48, P1, DOI 10.1016/j.bbi.2015.03.010; Freeman LC, 2016, J NEUROCHEM, V136, P29, DOI 10.1111/jnc.13217; Guedes VA, 2016, EXPERT REV NEUROTHER, V16, P61, DOI 10.1586/14737175.2016.1126180; Harch PG, 2015, MED GAS RES, V5, DOI 10.1186/s13618-015-0030-6; He Q, 2012, ASIAN PAC J CANCER P, V13, P1365, DOI 10.7314/APJCP.2012.13.4.1365; Hutchinson PJ, 2007, J NEUROTRAUM, V24, P1545, DOI 10.1089/neu.2007.0295; Kang N, 2015, INT J CLIN EXP PATHO, V8, P1141; Li GZ, 2011, BRAIN RES, V1396, P96, DOI 10.1016/j.brainres.2011.04.014; Liang F, 2013, EUR REV MED PHARMACO, V17, P2010; Lim SW, 2013, J SURG RES, V184, P1076, DOI 10.1016/j.jss.2013.04.070; Liu HD, 2013, NEUROCHEM RES, V38, P2072, DOI 10.1007/s11064-013-1115-z; Lu B, 2013, PROTEIN CELL, V4, P163, DOI 10.1007/s13238-012-2118-2; Macher H, 2012, CLIN CHIM ACTA, V414, P12, DOI 10.1016/j.cca.2012.08.001; Minkiewicz J, 2013, GLIA, V61, P1113, DOI 10.1002/glia.22499; Qu CS, 2008, BRAIN RES, V1208, P234, DOI 10.1016/j.brainres.2008.02.042; Vaccari JPD, 2016, TRANSL RES, V167, P35, DOI 10.1016/j.trsl.2015.05.003; Vaccari JPD, 2009, J CEREBR BLOOD F MET, V29, P1251, DOI 10.1038/jcbfm.2009.46; Vande Walle L, 2011, VIRULENCE, V2, P162, DOI 10.4161/viru.2.2.15480; Vlodavsky E, 2006, NEUROPATH APPL NEURO, V32, P40, DOI 10.1111/j.1365-2990.2005.00698.x; Yang J, 2013, SPINE, V38, pE1641, DOI 10.1097/BRS.0000000000000005; Yatsiv I, 2002, J CEREBR BLOOD F MET, V22, P971, DOI 10.1097/00004647-200208000-00008; Zeng XN, 2012, CNS NEUROSCI THER, V18, P388, DOI 10.1111/j.1755-5949.2012.00308.x; Zhang YM, 2014, NEUROCHEM RES, V39, P950, DOI 10.1007/s11064-014-1292-4	28	15	22	0	7	KARGER	BASEL	ALLSCHWILERSTRASSE 10, CH-4009 BASEL, SWITZERLAND	1021-7401	1423-0216		NEUROIMMUNOMODULAT	Neuroimmunomodulation		2016	23	2					122	129		10.1159/000445689			8	Endocrinology & Metabolism; Immunology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Endocrinology & Metabolism; Immunology; Neurosciences & Neurology	DN6NU	WOS:000377192800007	27216735				2022-02-06	
J	Gren, M; Shahim, P; Lautner, R; Wilson, DH; Andreasson, U; Norgren, N; Blennow, K; Zetterberg, H				Gren, Magnus; Shahim, Pashtun; Lautner, Ronald; Wilson, David H.; Andreasson, Ulf; Norgren, Niklas; Blennow, Kaj; Zetterberg, Henrik			Blood biomarkers indicate mild neuroaxonal injury and increased amyloid production after transient hypoxia during breath-hold diving	BRAIN INJURY			English	Article						Amyloid; breath-hold diving; tau; hypoxia; blood biomarkers; neuroaxonal injury	TRAUMATIC BRAIN-INJURY; ALZHEIMERS-DISEASE; CEREBROSPINAL-FLUID; COGNITIVE DECLINE; BETA; SLEEP; TAU; DEMENTIA; PROTEIN; IMPAIRMENT	Objective: To determine whether transient hypoxia during breath-hold diving causes neuronal damage or dysfunction or alters amyloid metabolism as measured by certain blood biomarkers.Design: Sixteen divers competing in the national Swedish championship in breath-hold diving and five age-matched healthy control subjects were included. Blood samples were collected at baseline and over a course of 3 days where the divers competed in static apnea (STA), dynamic apnea without fins (DYN1) and dynamic apnea with fins (DYN2).Main outcomes: Biomarkers reflecting brain injury and amyloid metabolism were analysed in serum (S-100, NFL) and plasma (T-tau, A42) using immunochemical methods.Results: Compared to divers' baseline, A42 increased after the first event of static apnea (p = 0.0006). T-tau increased (p = 0.001) in STA vs baseline and decreased after one of the dynamic events, DYN2 (p = 0.03). Further, T-tau correlated with the length of the apneic time during STA ( = 0.7226, p = 0.004) and during DYN1 ( = 0.66, p = 0.01).Conclusion: The findings suggest that transient hypoxia may acutely increase the levels of A42 and T-tau in plasma of healthy adults, further supporting that general hypoxia may cause mild neuronal dysfunction or damage and stimulate A production.	[Gren, Magnus; Shahim, Pashtun; Lautner, Ronald; Andreasson, Ulf; Blennow, Kaj; Zetterberg, Henrik] Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Clin Neurochem Lab,Inst Neurosci & Physiol, SE-43180 Molndal, Sweden; [Shahim, Pashtun] Linkoping Univ Hosp, Dept Neurosurg, Linkoping, Sweden; [Wilson, David H.] Quanterix, Lexington, MA USA; [Norgren, Niklas] UmanDiagnostics, Umea, Sweden; [Zetterberg, Henrik] UCL Inst Neurol, Dept Mol Neurosci, Reta Lila Weston Labs, London, England		Gren, M (corresponding author), Univ Gothenburg, Sahlgrenska Univ Hosp, Sahlgrenska Acad, Clin Neurochem Lab,Inst Neurosci & Physiol, SE-43180 Molndal, Sweden.	magnus.gren@vgregion.se		Lautner, Ronald/0000-0003-3523-1602			Baugh CM, 2012, BRAIN IMAGING BEHAV, V6, P244, DOI 10.1007/s11682-012-9164-5; Bell RD, 2009, NAT CELL BIOL, V11, P143, DOI 10.1038/ncb1819; Blackwell T, 2015, J AM GERIATR SOC, V63, P453, DOI 10.1111/jgs.13321; Blennow K, 2006, LANCET, V368, P387, DOI 10.1016/S0140-6736(06)69113-7; Blennow K, 2015, NAT MED, V21, P217, DOI 10.1038/nm.3810; Bu XL, 2015, SCI REP-UK, V5, DOI 10.1038/srep13917; CRAIG AB, 1968, J APPL PHYSIOL, V24, P190, DOI 10.1152/jappl.1968.24.2.190; Erecinska M, 2001, RESP PHYSIOL, V128, P263, DOI 10.1016/S0034-5687(01)00306-1; FERRETTI G, 1991, J APPL PHYSIOL, V70, P794, DOI 10.1152/jappl.1991.70.2.794; FRIEDE RL, 1970, ANAT REC, V167, P379, DOI 10.1002/ar.1091670402; Iliff JJ, 2014, J NEUROSCI, V34, P16180, DOI 10.1523/JNEUROSCI.3020-14.2014; JENDROSKA K, 1995, ACTA NEUROPATHOL, V90, P461, DOI 10.1007/bf00294806; Jessen NA, 2015, NEUROCHEM RES, V40, P2583, DOI 10.1007/s11064-015-1581-6; Kalaria RN, 1999, ALZ DIS ASSOC DIS, V13, pS115, DOI 10.1097/00002093-199912003-00017; Kann O, 2014, J CEREBR BLOOD F MET, V34, P1270, DOI 10.1038/jcbfm.2014.104; McHugh GS, 2007, J NEUROTRAUM, V24, P287, DOI 10.1089/neu.2006.0031; Mondello S, 2014, SCI REP-UK, V4, DOI 10.1038/srep06446; Neselius S, 2013, BRAIN INJURY, V27, P425, DOI 10.3109/02699052.2012.750752; Niwa K, 2001, AM J PHYSIOL-HEART C, V281, pH2417, DOI 10.1152/ajpheart.2001.281.6.H2417; Olsson B, 2011, PROG NEUROBIOL, V95, P520, DOI 10.1016/j.pneurobio.2011.04.006; Osorio RS, 2015, NEUROLOGY, V84, P1964, DOI 10.1212/WNL.0000000000001566; Parilkh U, 2015, CRITICAL CARE MED, V43, P2; Qi JP, 2007, J ALZHEIMERS DIS, V12, P335; Qiu CX, 2005, LANCET NEUROL, V4, P487, DOI 10.1016/S1474-4422(05)70141-1; Randall J, 2013, RESUSCITATION, V84, P351, DOI 10.1016/j.resuscitation.2012.07.027; Rissin DM, 2010, NAT BIOTECHNOL, V28, P595, DOI 10.1038/nbt.1641; Shahim P, 2014, JAMA NEUROL, V71, P684, DOI 10.1001/jamaneurol.2014.367; Shahim P, 2013, EUR J PAEDIATR NEURO, V17, P7, DOI 10.1016/j.ejpn.2012.09.005; Smith DH, 1999, J NEUROPATH EXP NEUR, V58, P982, DOI 10.1097/00005072-199909000-00008; Sun X, 2006, P NATL ACAD SCI USA, V103, P18727, DOI 10.1073/pnas.0606298103; Thomas T, 1996, NATURE, V380, P168, DOI 10.1038/380168a0; TROJANOWSKI JQ, 1989, J HISTOCHEM CYTOCHEM, V37, P209, DOI 10.1177/37.2.2492045; Wang HC, 2014, BRAIN INJURY, V28, P1491, DOI 10.3109/02699052.2014.943288; Xie YY, 2003, J NEUROSCI RES, V73, P557, DOI 10.1002/jnr.10667; Yaffe K, 2011, JAMA-J AM MED ASSOC, V306, P613, DOI 10.1001/jama.2011.1115; Zetterberg H, 2013, NAT REV NEUROL, V9, P201, DOI 10.1038/nrneurol.2013.9; Zetterberg H, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0028263; Zongo D, 2012, ANN EMERG MED, V59, P209, DOI 10.1016/j.annemergmed.2011.07.027	38	15	15	0	8	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.		2016	30	10					1226	1230		10.1080/02699052.2016.1179792			5	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DX4BR	WOS:000384324300009	27389622				2022-02-06	
J	Honda, M; Ichibayashi, R; Yokomuro, H; Yoshihara, K; Masuda, H; Haga, D; Seiki, Y; Kudoh, C; Kishi, T				Honda, Mitsuru; Ichibayashi, Ryo; Yokomuro, Hiroki; Yoshihara, Katsunori; Masuda, Hiroyuki; Haga, Daisuke; Seiki, Yoshikatsu; Kudoh, Chiaki; Kishi, Taichi			Early Cerebral Circulation Disturbance in Patients Suffering from Severe Traumatic Brain Injury (TBI): A Xenon CT and Perfusion CT Study	NEUROLOGIA MEDICO-CHIRURGICA			English	Article						severe traumatic brain injury; early cerebral circulation disturbance; a xenon CT; a perfusion CT	ACUTE HEAD-INJURY; BLOOD-FLOW; SUBARACHNOID HEMORRHAGE; COMPUTED-TOMOGRAPHY; INTRACRANIAL-PRESSURE; OUTCOME PREDICTION; VASOSPASM; ISCHEMIA; TIME; METABOLISM	Traumatic brain injury (TBI) is widely known to cause dynamic changes in cerebral blood flow (CBF). Ischemia is a common and deleterious secondary injury following TBI. Detecting early ischemia in TBI patients is important to prevent further advancement and deterioration of the brain tissue. The purpose of this study was to clarify the cerebral circulatory disturbance during the early phase and whether it can be used to predict patient outcome. A total of 90 patients with TBI underwent a xenon-computed tomography (Xe-CT) and subsequently perfusion CT to evaluate the cerebral circulation on days 1-3. We measured CBF using Xe-CT and mean transit time (MTT: the width between two inflection points [maximum upward slope and maximum downward slope from inflow to outflow of the contrast agent]) using perfusion CT and calculated the cerebral blood volume (CBV) using the AZ-7000W98 computer system. The relationships of the hemodynamic parameters CBF, MTT, and CBV to the Glasgow Coma Scale (GCS) score and the Glasgow Outcome Scale (GOS) score were examined. There were no significant differences in CBF, MTT, and CBV among GCS3-4, GCS5-6, and GCS7-8 groups. The patients with a favorable outcome (GR and MD) had significantly higher CBF and lower MTT than those with an unfavorable one (SD, VS, or D). The discriminant analysis of these parameters could predict patient outcome with a probability of 70.6%. During the early phase, CBF reduction and MTT prolongation might influence the clinical outcome of TBI. These parameters are helpful for evaluating the severity of cerebral circulatory disturbance and predicting the outcome of TBI patients.	[Honda, Mitsuru; Ichibayashi, Ryo; Yokomuro, Hiroki; Yoshihara, Katsunori] Toho Univ, Med Ctr, Omori Hosp, Dept Crit Care Ctr, Tokyo, Japan; [Masuda, Hiroyuki; Haga, Daisuke; Seiki, Yoshikatsu] Toho Univ, Med Ctr, Omori Hosp, Neurosurg, Tokyo, Japan; [Kudoh, Chiaki] KUDOH Clin Neurosurg & Neurol, Tokyo, Japan; [Kishi, Taichi] Toho Univ, Fac Med, Sch Med, Dept Educ Planning & Dev, Tokyo, Japan		Honda, M (corresponding author), Toho Univ, Med Ctr, Omori Hosp, Dept Crit Care Ctr,Ota Ku, 6-11-1 Omori Nishi, Tokyo 1438541, Japan.	mhonda@med.toho-u.ac.jp					ABDELDAYEM HM, 1987, RADIOLOGY, V165, P221, DOI 10.1148/radiology.165.1.3498184; Anagisawa M, 1988, NATURE, V332, P411; Araki Yuzo, 2002, No To Shinkei, V54, P581; Bendinelli C, 2013, INJURY, V44, P1208, DOI 10.1016/j.injury.2013.03.039; BOUMA GJ, 1992, J NEUROSURG, V77, P360, DOI 10.3171/jns.1992.77.3.0360; BOUMA GJ, 1991, J NEUROSURG, V75, P685, DOI 10.3171/jns.1991.75.5.0685; BOUMA GJ, 1993, ACTA NEUROCHIR, P34; Chai WN, 2011, ACTA NEUROCHIR SUPPL, V110, P225, DOI 10.1007/978-3-7091-0353-1_39; Coles JP, 2004, J CEREBR BLOOD F MET, V24, P202, DOI 10.1097/01.WCB.0000103022.98348.24; FINEMAN I, 1993, BRAIN RES, V624, P94, DOI 10.1016/0006-8993(93)90064-T; GOBIET W, 1975, ACTA NEUROCHIR, V32, P13, DOI 10.1007/BF01405899; HEKMATPANAH J, 1985, J NEUROSURG, V62, P888, DOI 10.3171/jns.1985.62.6.0888; Hiler M, 2006, J NEUROSURG, V104, P731, DOI 10.3171/jns.2006.104.5.731; Hoeffner EG, 2004, RADIOLOGY, V231, P632, DOI 10.1148/radiol.2313021488; Honda Mitsuru, 2013, Acta Neurochir Suppl, V118, P259, DOI 10.1007/978-3-7091-1434-6_49; Honda M, 2012, NEUROL MED-CHIR, V52, P488, DOI 10.2176/nmc.52.488; JAGGI JL, 1990, J NEUROSURG, V72, P176, DOI 10.3171/jns.1990.72.2.0176; *JAP SOC NEUR, 2001, GUID MAN SEV HEAD IN, P1; JENNETT B, 1975, LANCET, V1, P480; Kaloostian P, 2012, J NEUROTRAUM, V29, P727, DOI 10.1089/neu.2011.2147; Kanazawa R, 2007, SURG NEUROL, V67, P604, DOI 10.1016/j.surneu.2006.09.026; Lang EW, 2003, J NEUROTRAUM, V20, P69, DOI 10.1089/08977150360517191; Laslo AM, 2008, AM J NEURORADIOL, V29, P79, DOI 10.3174/ajnr.A0747; Lefournier V, 2010, J NEURORADIOLOGY, V37, P284, DOI 10.1016/j.neurad.2010.03.003; MARSHALL LF, 1991, J NEUROSURG, V75, pS14, DOI 10.3171/sup.1991.75.1s.0s14; Martin NA, 1997, J NEUROSURG, V87, P9, DOI 10.3171/jns.1997.87.1.0009; MILLER JD, 1992, J NEUROTRAUM, V9, pS317; Muizelaar JP, 1997, STROKE, V28, P1998, DOI 10.1161/01.STR.28.10.1998; Mustonen T, 2008, J NEUROL NEUROSUR PS, V79, P1128, DOI 10.1136/jnnp.2007.142851; OLDENDORF WH, 1967, J NUCL MED, V8, P570; Orbist WD, 1979, J NEUROSURG, V51, P292; OVERGAARD J, 1981, J NEUROSURG, V55, P63, DOI 10.3171/jns.1981.55.1.0063; OVERGAARD J, 1974, J NEUROSURG, V41, P531, DOI 10.3171/jns.1974.41.5.0531; PFENNINGER EG, 1989, J NEUROSURG, V70, P774, DOI 10.3171/jns.1989.70.5.0774; POWERS WJ, 1984, ANN NEUROL, V16, P546, DOI 10.1002/ana.410160504; Robertson CS, 2011, J NEUROTRAUM, V28, P727, DOI 10.1089/neu.2010.1476; ROBERTSON CS, 1992, J NEUROTRAUM, V9, pS349; Sase S, 2005, J COMPUT ASSIST TOMO, V29, P270, DOI 10.1097/01.rct.0000156400.40836.68; Sase S, 2002, J COMPUT ASSIST TOMO, V26, P471, DOI 10.1097/01.RCT.0000014442.08104.F7; SCHRODER ML, 1995, J NEUROSURG, V82, P966, DOI 10.3171/jns.1995.82.6.0966; SHOHAMI E, 1994, J CEREBR BLOOD F MET, V14, P615, DOI 10.1038/jcbfm.1994.76; Soustiel JF, 2008, NEURORADIOLOGY, V50, P189, DOI 10.1007/s00234-007-0337-7; Sviri GE, 2006, NEUROSURGERY, V59, P319, DOI 10.1227/01.NEU.0000222819.18834.33; White R P, 1990, Neurosurg Clin N Am, V1, P401; Wintermark M, 2006, AM J NEURORADIOL, V27, P26; Wintermark M, 2004, RADIOLOGY, V232, P211, DOI 10.1148/radiol.2321030824; Yoshimoto Y, 2004, SURG NEUROL, V62, P115, DOI 10.1016/j.surneu.2003.08.035	47	15	16	0	1	JAPAN NEUROSURGICAL SOC	TOKYO	5-25-16 HONGO, BUNKYO-KU, TOKYO, 113-0033, JAPAN	0470-8105	1349-8029		NEUROL MED-CHIR	Neurol. Med.-Chir.		2016	56	8					501	509		10.2176/nmc.oa.2015-0341			9	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	DW6SY	WOS:000383782700007	27356957	Green Published, Green Submitted, gold			2022-02-06	
J	Hurtig, T; Ebeling, H; Jokelainen, J; Koivumaa-Honkanen, H; Taanila, A				Hurtig, Tuula; Ebeling, Hanna; Jokelainen, Jari; Koivumaa-Honkanen, Heli; Taanila, Anja			The Association Between Hospital-Treated Injuries and ADHD Symptoms in Childhood and Adolescence: A Follow-Up Study in the Northern Finland Birth Cohort 1986	JOURNAL OF ATTENTION DISORDERS			English	Article						ADHD symptoms/diagnosis; ADHD; injury; children; adolescents; epidemiological study; follow-up study	ATTENTION-DEFICIT/HYPERACTIVITY DISORDER; DEFICIT-HYPERACTIVITY-DISORDER; TRAUMATIC BRAIN-INJURY; SCHOOL-AGE-CHILDREN; UNINTENTIONAL INJURY; INCREASED RISK; BEHAVIOR; COMORBIDITY; SEVERITY; VALIDITY	Objective: We examined the risk of hospital-treated injuries related to the symptoms/diagnosis of ADHD. Method: The study population (N = 6,111) was composed from the Northern Finland Birth Cohort 1986. At the age of 8, symptoms of hyperactivity and at the age of 15, symptoms of ADHD were assessed by the parents while the clinical diagnoses of ADHD were set in adolescence. Information on injuries was obtained from national register. Results: The risk for hospital-treated injuries during ages 0 to 7 was 1.7-fold increased among those with symptoms of hyperactivity assessed at age 8. Also, injuries during ages 7 to 15 years were more common among those with symptoms of ADHD at age 15 with respect to any injury, fractures, and intracranial injuries, and among those with the diagnosis of ADHD with respect to any injury. Conclusion: The present study shows an association between hospital-treated injuries and symptoms of ADHD in a large epidemiological sample of 0- to 15-year-old children.	[Hurtig, Tuula; Ebeling, Hanna; Jokelainen, Jari; Koivumaa-Honkanen, Heli; Taanila, Anja] Univ Oulu, Oulu 90014, Finland; [Hurtig, Tuula; Ebeling, Hanna; Taanila, Anja] Univ Hosp Oulu, Oulu, Finland; [Koivumaa-Honkanen, Heli] Univ Eastern Finland, Kuopio, Finland; [Koivumaa-Honkanen, Heli] Kuopio Univ Hosp, Kuopio, Finland; [Koivumaa-Honkanen, Heli] Lapland Hosp Dist, Rovaniemi, Finland; [Koivumaa-Honkanen, Heli] South Savonia Hosp Dist, Kuopio, Finland; [Koivumaa-Honkanen, Heli] North Karelia Cent Hosp, Joensuu, Finland		Hurtig, T (corresponding author), Univ Oulu, Inst Hlth Sci, POB 5000, Oulu 90014, Finland.	tuula.hurtig@oulu.fi	Koivumaa-Honkanen, Heli TJ/L-1274-2015	Jokelainen, Jari/0000-0003-4629-0560	Academy of FinlandAcademy of FinlandEuropean Commission; Emil Aaltonen Foundation; Paulo Foundation	The author(s) disclosed receipt of the following financial support for the research, authorship, and/or publication of this article: The Academy of Finland (grants to T. Hurtig, PhD, and Professor A. Taanila), the Emil Aaltonen Foundation, and Paulo Foundation (grants to T. Hurtig, PhD) are acknowledged for their support.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; American Psychiatric Association American Psychiatric Association American Psychiatric Association, 1994, DIAGN STAT MAN MENT DIAGN STAT MAN MENT, V4th 4th 4th; Angold A, 1999, J CHILD PSYCHOL PSYC, V40, P57, DOI 10.1017/S0021963098003448; Biederman J, 2002, J Atten Disord, V6 Suppl 1, pS7; Ebeling H, 2003, NORD J PSYCHIAT, V57, P345, DOI 10.1080/08039480310002679; Fritz KM, 2007, CURR OPIN PEDIATR, V19, P565, DOI 10.1097/MOP.0b013e3282ef498c; Garzon DL, 2008, ARCH PSYCHIAT NURS, V22, P288, DOI 10.1016/j.apnu.2007.12.006; Hay DA, 2007, BIOL PSYCHIAT, V61, P700, DOI 10.1016/j.biopsych.2006.04.040; Hoare P, 2003, EUR J EMERG MED, V10, P98, DOI 10.1097/01.mej.0000072631.17469.71; Hurtig T, 2007, EUR CHILD ADOLES PSY, V16, P362, DOI 10.1007/s00787-007-0607-2; Hurtig T, 2012, NORD J PSYCHIAT, V66, P320, DOI 10.3109/08039488.2011.644806; JARVELIN MR, 1993, BRIT J OBSTET GYNAEC, V100, P310, DOI 10.1111/j.1471-0528.1993.tb12971.x; Kaufman J, 1997, J AM ACAD CHILD PSY, V36, P980, DOI 10.1097/00004583-199707000-00021; Keenan HT, 2008, BMJ-BRIT MED J, V337, DOI 10.1136/bmj.a1984; Kresanov K, 1998, EUR CHILD ADOLES PSY, V7, P85, DOI 10.1007/s007870050052; Lee LC, 2008, RES DEV DISABIL, V29, P247, DOI 10.1016/j.ridd.2007.05.002; Levin H, 2007, J DEV BEHAV PEDIATR, V28, P108, DOI 10.1097/01.DBP.0000267559.26576.cd; Liisanantti JH, 2010, SUBST USE MISUSE, V45, P1340, DOI 10.3109/10826081003682859; Marcus SC, 2008, J ATTEN DISORD, V12, P64, DOI 10.1177/1087054707305168; Max JE, 2005, J AM ACAD CHILD PSY, V44, P1041, DOI 10.1097/01.chi.0000173292.05817.f8; Maxson RT, 2009, J PEDIATR SURG, V44, P743, DOI 10.1016/j.jpedsurg.2008.08.003; McKinlay A, 2010, CHILD CARE HLTH DEV, V36, P22, DOI 10.1111/j.1365-2214.2009.00947.x; Merrill RM, 2009, ADV MED SCI-POLAND, V54, P20, DOI 10.2478/v10039-009-0022-7; Pastor PN, 2006, AMBUL PEDIATR, V6, P38, DOI 10.1016/j.ambp.2005.07.002; Pittsenbarger ZE, 2008, PEDIATR EMERG CARE, V24, P438, DOI 10.1097/PEC.0b013e31817de130; Polderman TJC, 2007, J CHILD PSYCHOL PSYC, V48, P1080, DOI 10.1111/j.1469-7610.2007.01783.x; Rowe R, 2004, J PEDIATR PSYCHOL, V29, P119, DOI 10.1093/jpepsy/jsh015; Rowe R, 2007, J CHILD PSYCHOL PSYC, V48, P71, DOI 10.1111/j.1469-7610.2006.01674.x; RUTTER M, 1967, J CHILD PSYCHOL PSYC, V8, P1, DOI 10.1111/j.1469-7610.1967.tb02175.x; Schwebel DC, 2006, J SAFETY RES, V37, P167, DOI 10.1016/j.jsr.2005.11.004; Smalley SL, 2007, J AM ACAD CHILD PSY, V46, P1575, DOI 10.1097/chi.0b013e3181573137; Swanson J, 2001, IDENTIFICATION EXTRE; Uslu M, 2007, CLIN ORTHOP RELAT R, P192, DOI 10.1097/BLO.0b013e31805002da; VALENT F, 2004, ENV BURDEN DIS SERIE, V8; Wassenberg R, 2004, BRAIN INJURY, V18, P751, DOI 10.1080/02699050410001671775; World Health Organization, 1993, ICD 10 CLASS MENT BE	36	15	15	0	4	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	1087-0547	1557-1246		J ATTEN DISORD	J. Atten. Disord.	JAN	2016	20	1					3	10		10.1177/1087054713486699			8	Psychology, Developmental; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychology; Psychiatry	CZ6YZ	WOS:000367248400001	23665592				2022-02-06	
J	Lecky, F; Russell, W; Fuller, G; McClelland, G; Pennington, E; Goodacre, S; Han, K; Curran, A; Holliman, D; Freeman, J; Chapman, N; Stevenson, M; Byers, S; Mason, S; Potter, H; Coats, T; Mackway-Jones, K; Peters, M; Shewan, J; Strong, M				Lecky, Fiona; Russell, Wanda; Fuller, Gordon; McClelland, Graham; Pennington, Elspeth; Goodacre, Steve; Han, Kyee; Curran, Andrew; Holliman, Damien; Freeman, Jennifer; Chapman, Nathan; Stevenson, Matt; Byers, Sonia; Mason, Suzanne; Potter, Hugh; Coats, Tim; Mackway-Jones, Kevin; Peters, Mary; Shewan, Jane; Strong, Mark			The Head Injury Transportation Straight to Neurosurgery (HITS-NS) randomised trial: a feasibility study	HEALTH TECHNOLOGY ASSESSMENT			English	Article							TRAUMATIC BRAIN-INJURY; HEALTH TECHNOLOGY-ASSESSMENT; PARTIAL EXPECTED VALUE; COST-EFFECTIVENESS; HYPERTONIC RESUSCITATION; PARAMEDIC PRACTITIONERS; EXTRADURAL HEMATOMA; PERFECT INFORMATION; OUTCOME PREDICTION; DECISION-MAKING	Background: Reconfiguration of trauma services, with direct transport of traumatic brain injury (TBI) patients to neuroscience centres (NCs), bypassing non-specialist acute hospitals (NSAHs), could potentially improve outcomes. However, delays in stabilisation of airway, breathing and circulation (ABC) and the difficulties in reliably identifying TBI at scene may make this practice deleterious compared with selective secondary transfer from nearest NSAH to NC. National Institute for Health and Care Excellence guidance and systematic reviews suggested equipoise and poor-quality evidence - with regard to 'early neurosurgery' in this cohort - which we sought to address. Methods: Pilot cluster randomised controlled trial of bypass to NC conducted in two ambulance services with the ambulance station (n = 74) as unit of cluster [Lancashire/Cumbria in the North West Ambulance Service (NWAS) and the North East Ambulance Service (NEAS)]. Adult patients with signs of isolated TBI [Glasgow Coma Scale (GCS) score of < 13 in NWAS, GCS score of < 14 in NEAS] and stable ABC, injured nearest to a NSAH were transported either to that hospital (control clusters) or bypassed to the nearest NC (intervention clusters). Primary outcomes: recruitment rate, protocol compliance, selection bias as a result of non-compliance, accuracy of paramedic TBI identification (overtriage of study inclusion criteria) and pathway acceptability to patients, families and staff. 'Open-label' secondary outcomes: 30-day mortality, 6-month Extended Glasgow Outcome Scale (GOSE) and European Quality of Life-5 Dimensions. Results: Overall, 56 clusters recruited 293 (169 intervention, 124 control) patients in 12 months, demonstrating cluster randomised pre-hospital trials as viable for heath service evaluations. Overall compliance was 62%, but 90% was achieved in the control arm and when face-to-face paramedic training was possible. Non-compliance appeared to be driven by proximity of the nearest hospital and perceptions of injury severity and so occurred more frequently in the intervention arm, in which the perceived time to the NC was greater and severity of injury was lower. Fewer than 25% of recruited patients had TBI on computed tomography scan (n = 70), with 7% (n = 20) requiring neurosurgery (craniotomy, craniectomy or intracranial pressure monitoring) but a further 18 requiring admission to an intensive care unit. An intention-to-treat analysis revealed the two trial arms to be equivalent in terms of age, GCS and severity of injury. No significant 30-day mortality differences were found (8.8% vs. 9.1/%; p > 0.05) in the 273 (159/113) patients with data available. There were no apparent differences in staff and patient preferences for either pathway, with satisfaction high with both. Very low responses to invitations to consent for follow-up in the large number of mild head injury-enrolled patients meant that only 20% of patients had 6-month outcomes. The trial-based economic evaluation could not focus on early neurosurgery because of these low numbers but instead investigated the comparative cost-effectiveness of bypass compared with selective secondary transfer for eligible patients at the scene of injury. Conclusions: Current NHS England practice of bypassing patients with suspected TBI to neuroscience centres gives overtriage ratios of 13 : 1 for neurosurgery and 4 : 1 for TBI. This important finding makes studying the impact of bypass to facilitate early neurosurgery not plausible using this study design. Future research should explore an efficient comparative effectiveness design for evaluating 'early neurosurgery through bypass' and address the challenge of reliable TBI diagnosis at the scene of injury.	[Lecky, Fiona; Fuller, Gordon; Goodacre, Steve; Freeman, Jennifer; Chapman, Nathan; Stevenson, Matt; Mason, Suzanne; Strong, Mark] Univ Sheffield, Sch Hlth & Related Res SCHaRR, Hlth Serv Res, EMRiS Grp, Sheffield, S Yorkshire, England; [Russell, Wanda] Univ Manchester, Inst Populat, Ctr Occupat & Environm Hlth, Trauma Audit & Res Network, Manchester, Lancs, England; [McClelland, Graham; Han, Kyee; Byers, Sonia] North East Ambulance Serv NHS Fdn Trust, Res & Dev Dept, Newcastle Upon Tyne, Tyne & Wear, England; [Pennington, Elspeth; Curran, Andrew; Mackway-Jones, Kevin; Peters, Mary] North West Ambulance Serv, Res & Dev Dept, Carlisle, Cumbria, England; [Holliman, Damien] Newcastle Tyne Hosp NHS Fdn Trust, Dept Neurosurg, Newcastle Upon Tyne, Tyne & Wear, England; [Potter, Hugh] Potter Rees Serious Injury Solicitors LLP, Manchester, Lancs, England; [Coats, Tim] Univ Leicester, Univ Hosp Leicester NHS Trust, Dept Cardiovasc Sci, Leicester, Leics, England; [Shewan, Jane] Yorkshire Ambulance Serv NHS Trust, Res & Dev Dept, Wakefield, England		Lecky, F (corresponding author), Univ Sheffield, Sch Hlth & Related Res SCHaRR, Hlth Serv Res, EMRiS Grp, Sheffield, S Yorkshire, England.	f.e.lecky@sheffield.ac.uk	Coats, Timothy/AAW-1254-2021; Strong, Mark/A-4638-2010; Russell, Wanda/O-9051-2014	Coats, Timothy/0000-0003-2736-2784; Chapman, Nathan/0000-0002-5600-5439; McClelland, Graham/0000-0002-4502-5821; Pennington, Elspeth/0000-0002-9187-0524; Strong, Mark/0000-0003-1486-8233; Fuller, Gordon Ward/0000-0001-8532-3500; Russell, Wanda/0000-0003-2671-1938; Mason, Suzanne/0000-0002-1701-0577	National Institute for Health Research (NIHR) Health Technology Assessment programmeNational Institute for Health Research (NIHR); National Institute for Health ResearchNational Institute for Health Research (NIHR) [08/116/85, DRF-2011-04-050, PDF-2012-05-258] Funding Source: researchfish	This project was funded by the National Institute for Health Research (NIHR) Health Technology Assessment programme and will be published in full in Health Technology Assessment; Vol. 20, No. 1. See the NIHR Journals Library website for further project information.	Ades AE, 2004, MED DECIS MAKING, V24, P207, DOI 10.1177/0272989X04263162; af Geijerstam JL, 2006, BMJ-BRIT MED J, V333, P465, DOI 10.1136/bmj.38918.669317.4F; Allison PD, 2001, MISSING DATA; Aoki N, 1998, MED DECIS MAKING, V18, P357, DOI 10.1177/0272989X9801800401; Ara R, 2012, VALUE HEALTH, V15, P971, DOI 10.1016/j.jval.2012.05.003; Association for the Advancement of Automotive Medicine, 2005, ABBR INJ SCAL AIS 20; Baker AJ, 2009, J NEUROTRAUM, V26, P1227, DOI 10.1089/neu.2008.0868; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Barton GR, 2008, VALUE HEALTH, V11, P886, DOI 10.1111/j.1524-4733.2008.00358.x; Beecham J, 2009, BRAIN INJURY, V23, P30, DOI 10.1080/02699050802590338; Benger JR, 2013, BMJ OPEN, V3, DOI 10.1136/bmjopen-2012-002467; Bennett C, 2012, BMC MED RES METHODOL, V12, DOI 10.1186/1471-2288-12-168; Bernard SA, 2010, ANN SURG, V252, P959, DOI 10.1097/SLA.0b013e3181efc15f; BICKELL WH, 1994, NEW ENGL J MED, V331, P1105, DOI 10.1056/NEJM199410273311701; Bouamra O, 2006, J TRAUMA, V61, P701, DOI 10.1097/01.ta.0000197175.91116.10; Boutron I, 2008, ANN INTERN MED, V148, P295, DOI 10.7326/0003-4819-148-4-200802190-00008; Brennan A, 2007, MED DECIS MAKING, V27, P448, DOI 10.1177/0272989X07302555; Briggs A, 2006, DECISION MODELLING H; Brooks R, 1996, HEALTH POLICY, V37, P53, DOI 10.1016/0168-8510(96)00822-6; Bulger EM, 2008, ARCH SURG-CHICAGO, V143, P139, DOI 10.1001/archsurg.2007.41; Bulger EM, 2011, ANN SURG, V253, P431, DOI 10.1097/SLA.0b013e3181fcdb22; Bulger EM, 2010, JAMA-J AM MED ASSOC, V304, P1455, DOI 10.1001/jama.2010.1405; Callaham M, 1997, ANN EMERG MED, V30, P785, DOI 10.1016/S0196-0644(97)70049-0; Campbell MK, 2004, BMJ-BRIT MED J, V328, P702, DOI 10.1136/bmj.328.7441.702; Caterino JM, 2011, ACAD EMERG MED, V18, P1014, DOI 10.1111/j.1553-2712.2011.01164.x; Cheung R, 2013, EMERG MED J, V30, P476, DOI 10.1136/emermed-2012-201324; Chilcott J, 2010, HEALTH TECHNOL ASSES, V14, P1, DOI 10.3310/hta14250; Claxton K, 1996, HEALTH ECON, V5, P513, DOI 10.1002/(SICI)1099-1050(199611)5:6<513::AID-HEC237>3.0.CO;2-9; Claxton K, 1999, J HEALTH ECON, V18, P341, DOI 10.1016/S0167-6296(98)00039-3; Claxton K, 2013, 81 CHE U YORK; Cooper DJ, 2004, JAMA-J AM MED ASSOC, V291, P1350, DOI 10.1001/jama.291.11.1350; Crimmins DW, 2000, J NEUROL NEUROSUR PS, V68, P8, DOI 10.1136/jnnp.68.1.8; Culyer Anthony, 1800, J Health Serv Res Policy, V12, P56, DOI 10.1258/135581907779497567; Cummings P, 2009, ARCH PEDIAT ADOL MED, V163, P438, DOI 10.1001/archpediatrics.2009.31; Daneshkhah A., 2006, UNCERTAIN JUDGEMENTS; *DEP HLTH, 2007, OUR NHS OUR FUT; Department of Health, 2008, HIGH QUAL WORKF NHS; Department of Health, HOSP EP STAT; Department of Health, 2008, NHS REF COSTS 2007 2; Devlin N, 2004, HEALTH ECON, V13, P437, DOI 10.1002/hec.864; DiRusso SM, 2005, J TRAUMA, V59, P84, DOI 10.1097/01.TA.0000171462.28379.F3; Dixon S, 2009, EMERG MED J, V26, P446, DOI 10.1136/emj.2008.061424; Donner A, 2004, AM J PUBLIC HEALTH, V94, P416, DOI 10.2105/AJPH.94.3.416; Durham R, 2006, ANN SURG, V243, P775, DOI 10.1097/01.sla.0000219644.52926.f1; Eckermann S, 2007, HEALTH ECON, V16, P195, DOI 10.1002/hec.1161; Fenwick E, 2001, HEALTH ECON, V10, P779, DOI 10.1002/hec.635; Finfer SR, 2001, RESUSCITATION, V48, P77, DOI 10.1016/S0300-9572(00)00321-X; Fuller G, 2015, EUR J EMERG MED, V22, P42, DOI 10.1097/MEJ.0000000000000117; Fuller G, 2014, EMERG MED J, V31, P914, DOI 10.1136/emermed-2013-202575; Fuller G, 2014, BRIT J NEUROSURG, V28, P452, DOI 10.3109/02688697.2013.865708; Ganapathy K, 2002, SURG NEUROL, V58, P388, DOI 10.1016/S0090-3019(02)00924-2; Gausche M, 2000, JAMA-J AM MED ASSOC, V283, P783, DOI 10.1001/jama.283.6.783; Gomes E, 2010, RESUSCITATION, V81, P440, DOI 10.1016/j.resuscitation.2009.12.014; Greenhalgh T, 2010, READ PAPER BASICS EV; HALL A, 2005, ADV TEXTS ECONOMETRI; Hannan EL, 2000, J TRAUMA, V48, P76, DOI 10.1097/00005373-200001000-00013; Hargreaves K, 2014, EMERG MED J, V31, P499, DOI 10.1136/emermed-2013-202346; Harrison DA, 2013, HLTH TECHNOL ASSESS, V17; Hassan Z, 2005, EMERG MED J, V22, P845, DOI 10.1136/emj.2004.021717; Hayes RJ, 2009, INTERD STAT, P3; Holmes M, 2014, HEALTH TECHNOL ASSES, V18, P1, DOI 10.3310/hta18160; Jennings PA, 2012, ANN EMERG MED, V59, P497, DOI 10.1016/j.annemergmed.2011.11.012; Kaltenthaler E, 2011, 13 NICE DSU; Kay A, 2001, WORLD J SURG, V25, P1210, DOI 10.1007/s00268-001-0084-6; Klar, 2000, DESIGN ANAL CLUSTER; Kober A, 2002, MAYO CLIN PROC, V77, P35, DOI 10.4065/77.1.35; Lancaster GA, 2004, J EVAL CLIN PRACT, V10, P307, DOI 10.1111/j..2002.384.doc.x; Leach P, 2007, BRIT J NEUROSURG, V21, P11, DOI 10.1080/02688690701210562; Lecky F, 2008, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD001429.pub2; Lendrum RA, 2013, ANAESTHESIA, V68, P30, DOI 10.1111/anae.12049; Liberati A, 2009, BMJ-BRIT MED J, V339, DOI 10.1136/bmj.b2700; MacKenzie EJ, 2010, J TRAUMA, V69, P1, DOI 10.1097/TA.0b013e3181e03a21; Mason S, 2007, BRIT MED J, V335, P919, DOI 10.1136/bmj.39343.649097.55; McCartan DP, 2008, BRAIN INJURY, V22, P305, DOI 10.1080/02699050801995124; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Mendelow AD, 2008, LANCET, V372, P685, DOI 10.1016/S0140-6736(08)61280-5; MENDELOW AD, 1979, BRIT MED J, V1, P1240, DOI 10.1136/bmj.1.6173.1240; Mooney JS, 2011, EMERG MED J, V28, P778, DOI 10.1136/emj.2009.083360; Moore EE, 2009, J AM COLL SURGEONS, V208, P1, DOI 10.1016/j.jamcollsurg.2008.09.023; Morris S, 2008, ANAESTHESIA, V63, P499, DOI 10.1111/j.1365-2044.2007.05432.x; Morrison LJ, 2011, J CRIT CARE, V26, P363, DOI 10.1016/j.jcrc.2010.08.021; Mullins RJ, 1998, J TRAUMA, V44, P609, DOI 10.1097/00005373-199804000-00009; Murray GD, 2007, J NEUROTRAUM, V24, P329, DOI 10.1089/neu.2006.0035; Muzha I, 2004, LANCET, V364, P1321, DOI 10.1016/S0140-6736(04)17188-2; National confidential enquiry into patient outcome and death, 2007, TRAUM WHO CAR REP NA; National Institute for Health and Care Excellence, 2013, GUID METH TECHN APPR; National Institute for Health and Care Excellence, 2007, HEAD INJ TRIAG ASS I; Nicholl J, 2007, EMERG MED J, V24, P665, DOI 10.1136/emj.2007.047654; Patel HC, 2005, LANCET, V366, P1538, DOI 10.1016/S0140-6736(05)67626-X; Petrou S, 2011, BMJ-BRIT MED J, V342, DOI 10.1136/bmj.d1766; Petsas A, 2010, J NEUROSURG ANESTH, V22, P354, DOI 10.1097/ANA.0b013e3181f0da95; Philips Z, 2006, PHARMACOECONOMICS, V24, P355, DOI 10.2165/00019053-200624040-00006; PICKERING A, 2014, COMP DIRECT TRANSFER; Pickering A, 2012, EMERG MED J, V29, P451, DOI 10.1136/emj.2010.094755; R Development Core Team, 2013, R LANG ENV STAT COMP; Robinson S, 2008, J OPER RES SOC, V59, P278, DOI 10.1057/palgrave.jors.2602368; Robson C., 2011, REAL WORLD RES, VThird; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Royal College of Surgeons of Edinburgh, 2012, TRAUM CAR SCOTL; Ruff LM, 2013, BRIT J NEUROSURG, V27, P19, DOI 10.3109/02688697.2012.709555; Schafer JL, 1999, STAT METHODS MED RES, V8, P3, DOI 10.1191/096228099671525676; Schiferer A, 2007, ANESTH ANALG, V105, P1852, DOI 10.1213/01.ane.0000287676.39323.9e; Schmidt TA, 2009, PREHOSP EMERG CARE, V13, P160, DOI 10.1080/10903120802708852; Seguin J, 1999, J TRAUMA, V47, pS99; Shiel A, 2004, BRIT J NEUROSURG, V18, P5, DOI 10.1080/02688690410001660625; Sleat G, 2011, INJURY, V42, P838, DOI 10.1016/j.injury.2011.05.014; Smits M, 2010, RADIOLOGY, V254, P532, DOI 10.1148/radiol.2541081672; Snooks H, 2004, EMERG MED J, V21, P105, DOI 10.1136/emj.2003.009050; Snooks H, 2010, BMC EMERG MED, V10, DOI 10.1186/1471-227X-10-2; Stevenson MD, 2001, INJURY, V32, P267, DOI 10.1016/S0020-1383(00)00191-1; Stinnett AA, 1998, MED DECIS MAKING, V18, pS68, DOI 10.1177/0272989X9801800209; Strong M, 2014, MED DECIS MAKING, V34, P311, DOI 10.1177/0272989X13505910; Taussky P, 2008, SWISS MED WKLY, V138, P281, DOI 2008/19/smw-12056; Teasdale GM, 1998, J NEUROTRAUM, V15, P587, DOI 10.1089/neu.1998.15.587; Torrance G W, 1989, Int J Technol Assess Health Care, V5, P559; Turner RM, 2009, J R STAT SOC A STAT, V172, P21, DOI 10.1111/j.1467-985X.2008.00547.x; Vondy A, 2011, EMERG MED J, V28, P250, DOI 10.1136/emj.2010.101022; Wang HE, 2011, ANN EMERG MED, V57, P232, DOI 10.1016/j.annemergmed.2010.11.034; Watson DLB, 2012, ANN EMERG MED, V60, P641, DOI 10.1016/j.annemergmed.2011.12.002; Wilson JTL, 2000, J NEUROL NEUROSUR PS, V69, P204, DOI 10.1136/jnnp.69.2.204; Wood S.N., 2017, GEN ADDITIVE MODELS, DOI [10.1201/978131537027, DOI 10.1201/9781315370279]; Woollard M, 2004, EMERG MED J, V21, P362, DOI 10.1136/emj.2004.014324; Yuh EL, 2013, ANN NEUROL, V73, P224, DOI 10.1002/ana.23783; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]; [No title captured]	143	15	15	0	5	NIHR JOURNALS LIBRARY	SOUTHAMPTON	UNIV SOUTHAMPTON, EVALUATION, TRIALS & STUDIES COORDINATING CENTRE, ALPHA HOUSE, ENTERPRISE RD, SOUTHAMPTON, SO16 7NS, ENGLAND	1366-5278	2046-4924		HEALTH TECHNOL ASSES	Health Technol. Assess.	JAN	2016	20	1					1	+		10.3310/hta20010			200	Health Care Sciences & Services	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Health Care Sciences & Services	DC3EA	WOS:000369101000001	26753808	Green Published, Green Accepted, gold, Green Submitted			2022-02-06	
J	Lin, YC; Xu, DZ; Li, XH; Liu, C; Liu, X; Huang, S; Huang, YW; Liu, XJ				Lin, Yuchang; Xu, Dezhi; Li, Xiaohong; Liu, Chun; Liu, Xia; Huang, Shen; Huang, Yuwei; Liu, Xiaojuan			Upregulation of Interferon Regulatory Factor 6 Promotes Neuronal Apoptosis After Traumatic Brain Injury in Adult Rats	CELLULAR AND MOLECULAR NEUROBIOLOGY			English	Article						IRF6; Traumatic brain injury; Neuronal apoptosis; Rat	FACTOR-I; TRANSCRIPTION FACTORS; CASPASE-3 ACTIVATION; REPERFUSION INJURY; ISCHEMIC-STROKE; IRF FAMILY; CELLS; ONCOGENESIS; OVEREXPRESSION; MECHANISMS	The interferon regulatory factor (IRF) family was first discovered as a set of transcriptional regulators of the type I interferon system in 1988. In mammals, the IRF family includes nine members that play important roles in the immune system, oncogenesis, and apoptosis. However, the distribution and the function of IRF6 in the central nervous system are limited. In this study, we established an adult rat traumatic brain injury (TBI) model. Compared to the sham brain cortex, Western blot and immunohistochemistry showed significant upregulation of IRF6 in the ipsilateral brain cortex after TBI. Immunofluorescence double-labeling showed that IRF6 completely co-localized with neurons, not astrocytes or oligodendrocytes. Furthermore, we detected that the neuronal apoptosis marker active caspase-3 co-localized with IRF6 in neurons. Additionally, IRF6 knockdown in PC12 cells in vitro resulted in a decrease in active caspase-3 expression and an increase in Bcl-2 and p-Akt expression. We conclude that IRF6 might promote neuronal apoptosis by inhibiting Akt phosphorylation after TBI.	[Lin, Yuchang; Xu, Dezhi] Nanjing Med Univ, Wuxi Hosp 2, Dept Neurosurg, Wuxi 214002, Jiangsu, Peoples R China; [Li, Xiaohong] Nantong Univ, Affiliated Hosp, Surg Comprehens Lab, Nantong 226001, Jiangsu, Peoples R China; [Liu, Chun] Nantong Univ, Lab Anim Ctr, Nantong 226001, Jiangsu, Peoples R China; [Liu, Xia] Nantong Univ, Dept Pathophysiol, Coll Med, Nantong 226001, Jiangsu, Peoples R China; [Huang, Shen] Nantong Univ, Affiliated Hosp 2, Dept Osteol, Nantong 226001, Peoples R China; [Huang, Yuwei] Nantong Univ, Inst Nav Med, Nantong 226001, Jiangsu, Peoples R China; [Liu, Xiaojuan] Nantong Univ, Dept Pathogen Biol, Coll Med, Nantong 226001, Jiangsu, Peoples R China; [Lin, Yuchang; Xu, Dezhi; Li, Xiaohong; Liu, Chun; Liu, Xia; Huang, Shen; Huang, Yuwei; Liu, Xiaojuan] Nantong Univ, Coll Med, Jiangsu Prov Key Lab Inflammat & Mol Drug Target, Nantong 226001, Jiangsu, Peoples R China		Liu, XJ (corresponding author), Nantong Univ, Dept Pathogen Biol, Coll Med, Nantong 226001, Jiangsu, Peoples R China.	prof_lxj@163.com			National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [81401365, 81373223, 81200918, 81172879, 31200800]; Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD)	This work was supported in part by the National Natural Science Foundation of China (Nos. 81401365, 81373223, 81200918, 81172879 and 31200800) and a project funded by the Priority Academic Program Development of Jiangsu Higher Education Institutions (PAPD).	Alexander M, 2003, ACTA NEUROPATHOL, V105, P420, DOI 10.1007/s00401-002-0658-x; Banerjee S, 2013, PLOS PATHOG, V9, DOI 10.1371/journal.ppat.1003314; Botti E, 2011, P NATL ACAD SCI USA, V108, P13710, DOI 10.1073/pnas.1110931108; Chen FF, 2013, ONCOL LETT, V5, P417, DOI 10.3892/ol.2012.1051; Chen WJ, 2010, CELL SIGNAL, V22, P883, DOI 10.1016/j.cellsig.2009.12.005; Coronado Victor G., 2011, Morbidity and Mortality Weekly Report, V60, P1; Fang J, 2012, APOPTOSIS, V17, P410, DOI 10.1007/s10495-011-0683-0; Ferretti E, 2011, DEV CELL, V21, P627, DOI 10.1016/j.devcel.2011.08.005; Finnie JW, 2013, INFLAMMOPHARMACOLOGY, V21, P309, DOI 10.1007/s10787-012-0164-2; Hafeez A, 2014, AGING DIS, V5, P366, DOI 10.14336/AD.2014.0500366; Hasegawa Y, 2011, ACTA NEUROCHIR SUPPL, V110, P43, DOI 10.1007/978-3-7091-0353-1_8; Jia D, 2014, INT J BIOL MACROMOL, V63, P177, DOI 10.1016/j.ijbiomac.2013.10.034; Kawa L, 2015, J NEUROTRAUM, V32, P1190, DOI 10.1089/neu.2014.3669; Kondo S, 2002, NAT GENET, V32, P285, DOI 10.1038/ng985; KONIGSMARK BW, 1970, NATURE, V228, P1335, DOI 10.1038/2281335a0; Lallemand C, 2007, ONCOGENE, V26, P328, DOI 10.1038/sj.onc.1209795; Melis MHM, 2013, CELL DEATH DIFFER, V20, P765, DOI 10.1038/cdd.2013.8; Minones-Suarez L, 2012, PEDIATR DERMATOL, V29, P768, DOI 10.1111/j.1525-1470.2011.01575.x; Olivecrona M, 2012, BRAIN INJURY, V26, P67, DOI 10.3109/02699052.2011.635351; Panne D, 2007, CELL, V129, P1111, DOI 10.1016/j.cell.2007.05.019; Plantman S, 2012, J NEUROTRAUM, V29, P1219, DOI 10.1089/neu.2011.2182; Qiu W, 2014, CELL DEATH DIS, V5, DOI 10.1038/cddis.2014.153; Raghupathi R, 2004, BRAIN PATHOL, V14, P215, DOI 10.1111/j.1750-3639.2004.tb00056.x; Restivo G, 2011, EMBO J, V30, P4571, DOI 10.1038/emboj.2011.325; Ruiz-Ruiz C, 2004, J BIOL CHEM, V279, P19712, DOI 10.1074/jbc.M313023200; Sarkar C, 2014, AUTOPHAGY, V10, P2208, DOI 10.4161/15548627.2014.981787; Tamura T, 2008, ANNU REV IMMUNOL, V26, P535, DOI 10.1146/annurev.immunol.26.021607.090400; Wang ZT, 2013, J MOL NEUROSCI, V49, P409, DOI 10.1007/s12031-012-9908-0; Wu CH, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0113397; Xiang M, 2014, J NEUROCHEM, V129, P988, DOI 10.1111/jnc.12682; Xu T, 2012, J MOL HISTOL, V43, P335, DOI 10.1007/s10735-012-9408-0; Yanai H, 2012, ONCOIMMUNOLOGY, V1, P1376, DOI 10.4161/onci.22475; Yu S, 2012, J CELL BIOCHEM, V113, P2671; Yun N, 2014, J BIOL CHEM, V289, P22183, DOI 10.1074/jbc.M114.552679; Zhang S, 2014, FASEB J, V28, P4394, DOI 10.1096/fj.14-253625; Zhang X, 2013, CARDIOVASC DIABETOL, V12, DOI 10.1186/1475-2840-12-147; Zhao GN, 2015, BBA-MOL BASIS DIS, V1852, P365, DOI 10.1016/j.bbadis.2014.04.030; Zhuang SG, 1999, EXP CELL RES, V250, P203, DOI 10.1006/excr.1999.4501; Zucchero TM, 2004, NEW ENGL J MED, V351, P769, DOI 10.1056/NEJMoa032909	39	15	16	1	10	SPRINGER/PLENUM PUBLISHERS	NEW YORK	233 SPRING ST, NEW YORK, NY 10013 USA	0272-4340	1573-6830		CELL MOL NEUROBIOL	Cell. Mol. Neurobiol.	JAN	2016	36	1					27	36		10.1007/s10571-015-0217-3			10	Cell Biology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Cell Biology; Neurosciences & Neurology	DA3KF	WOS:000367694900003	26077898				2022-02-06	
J	Parys, M; Nelson, N; Koehl, K; Miller, R; Kaneene, JB; Kruger, JM; Yuzbasiyan-Gurkan, V				Parys, M.; Nelson, N.; Koehl, K.; Miller, R.; Kaneene, J. B.; Kruger, J. M.; Yuzbasiyan-Gurkan, V.			Safety of Intraperitoneal Injection of Adipose Tissue-Derived Autologous Mesenchymal Stem Cells in Cats	JOURNAL OF VETERINARY INTERNAL MEDICINE			English	Article						Feline; Inflammatory disease; Regenerative medicine; Route of injection	TRAUMATIC BRAIN-INJURY; CHRONIC KIDNEY-DISEASE; HUMAN BONE-MARROW; STROMAL CELLS; TNF-ALPHA; INDOLEAMINE 2,3-DIOXYGENASE; INTRAVENOUS-INFUSION; HUMAN BLOOD; CORD BLOOD; IFN-GAMMA	Background: Chronic inflammatory diseases are common in cats and mesenchymal stem cells (MSC) are a promising therapeutic approach for management of these disorders. The purpose of this study was to evaluate the safety of intraperitoneal injection of MSC in cats. Hypothesis: Intrapertioneal injection of autologous MSC in cats is safe. Animals: Ten healthy adult purpose-bred cats. Methods: Mesenchymal stem cells were isolated from subcutaneous adipose tissue collected during ovariohysterectomy and characterized for expression of CD90, CD105 and CD44 and trilineage differentiation. Three weeks postoperatively a complete blood count, serum chemistry profile, urinalysis, and abdominal ultrasound were performed. Five cats then received 1 9 10 6 of autologous MSC/kg of body weight intraperitoneally with ultrasound guidance; 5 additional cats were sham injected. Cats were monitored for 6 weeks with daily physical examinations and weekly clinicopathological evaluations. Abdominal ultrasonography was repeated at weeks 1 and 5 after injection. Results: Serious adverse effects were not observed in any MSC-injected cat. Two animals developed transient lethargy and decreased activity. Jejunal lymph node size was increased in MSC-injected cats compared to controls at weeks 1 (1.38 +/- 0.25 versus 0.88 +/- 0.25 cm(2); P =.036) and 5 (1.75 +/- 0.82 versus 0.79 +/- 0.12 cm(2); P = .047). A hyperechoic renal segmental cortical lesion was observed in 1 MSC-injected cat. Conclusions and Clinical Relevance: Intraperitoneal MSC injection was well tolerated with only mild, self-limiting adverse effects being observed in 2 cats. This route provides a safe means of administration for cell-based treatment in cats.	[Parys, M.; Nelson, N.; Koehl, K.; Kruger, J. M.; Yuzbasiyan-Gurkan, V.] Michigan State Univ, Coll Vet Med, Dept Small Anim Clin Sci, E Lansing, MI 48824 USA; [Miller, R.; Kaneene, J. B.] Michigan State Univ, Coll Vet Med, Dept Large Anim Clin Sci, E Lansing, MI 48824 USA; [Miller, R.; Kaneene, J. B.] Michigan State Univ, Coll Vet Med, Ctr Populat, E Lansing, MI 48824 USA		Kruger, JM (corresponding author), Ctr Vet Med, Dept Small Anim Clin Sci, 736 Wilson Rd,Room D208, E Lansing, MI 48824 USA.	krugerj@cvm.msu.edu	Parys, Maciej/AAF-7081-2021; Yuzbasiyan-Gurkan, Vilma/AAF-8459-2020	Parys, Maciej/0000-0003-4456-3369; 	Morris Animal Foundation Fellowship Award [D13FE-405]; Michigan State University Center for Feline Health and Well-Being; Michigan State University, College of Veterinary Medicine Endowed Research Funds	This study was supported by Morris Animal Foundation Fellowship Award (D13FE-405), and grants from the Michigan State University Center for Feline Health and Well-Being and the Michigan State University, College of Veterinary Medicine Endowed Research Funds.	Akiyama K, 2012, CELL STEM CELL, V10, P544, DOI 10.1016/j.stem.2012.03.007; Aroch I, 2010, J FELINE MED SURG, V12, P466, DOI 10.1016/j.jfms.2010.01.010; Bennet W, 1999, DIABETES, V48, P1907, DOI 10.2337/diabetes.48.10.1907; Beyth S, 2005, BLOOD, V105, P2214, DOI 10.1182/blood-2004-07-2921; Brown JM, 2011, CLIN EXP ALLERGY, V41, P526, DOI 10.1111/j.1365-2222.2010.03685.x; Carrade DD, 2011, CYTOTHERAPY, V13, P419, DOI 10.3109/14653249.2010.536213; Castelo-Branco MTL, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0033360; Chamberlain J, 2007, HEPATOLOGY, V46, P1935, DOI 10.1002/hep.21899; Chang CP, 2013, CLIN SCI, V124, P165, DOI 10.1042/CS20120226; Constantin G, 2009, STEM CELLS, V27, P2624, DOI 10.1002/stem.194; Duijvestein M, 2010, GUT, V59, P1662, DOI 10.1136/gut.2010.215152; Eggenhofer E, 2012, FRONT IMMUNOL, V3, DOI 10.3389/fimmu.2012.00297; English K, 2007, IMMUNOL LETT, V110, P91, DOI 10.1016/j.imlet.2007.04.001; Flemming A, 2011, J CLIN IMMUNOL, V31, P1143, DOI 10.1007/s10875-011-9581-z; Ge W, 2010, TRANSPLANTATION, V90, P1312, DOI 10.1097/TP.0b013e3181fed001; Ghionzoli M, 2010, PEDIATR SURG INT, V26, P79, DOI 10.1007/s00383-009-2504-x; Gustafson EK, 2011, TRANSPLANTATION, V91, P632, DOI 10.1097/TP.0b013e31820ae459; Harting MT, 2009, J NEUROSURG, V110, P1189, DOI 10.3171/2008.9.JNS08158; Hickey MC, 2014, J VET INTERN MED, V28, P319, DOI 10.1111/jvim.12314; Le Blanc K, 2003, SCAND J IMMUNOL, V57, P11, DOI 10.1046/j.1365-3083.2003.01176.x; Li Y, 2012, BLOOD, V120, P3436, DOI 10.1182/blood-2012-03-420612; Liu LS, 2014, AM J PATHOL, V184, P3344, DOI 10.1016/j.ajpath.2014.08.010; Liu W, 2013, THEOR APPL MECH LETT, V3, DOI [10.1063/2.1306201, 10.1186/2045-9912-3-3]; Luz-Crawford P, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0045272; Mader EK, 2013, J TRANSL MED, V11, DOI 10.1186/1479-5876-11-20; Meisel R, 2004, BLOOD, V103, P4619, DOI 10.1182/blood-2003-11-3909; Moll G, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0085040; Moll G, 2012, STEM CELLS, V30, P1565, DOI 10.1002/stem.1111; Moll G, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0021703; Morigi M, 2010, STEM CELLS, V28, P513, DOI 10.1002/stem.293; Najar M, 2013, INT IMMUNOPHARMACOL, V15, P693, DOI 10.1016/j.intimp.2013.02.020; Najar M, 2009, CYTOTHERAPY, V11, P570, DOI 10.1080/14653240903079377; Nemeth K, 2009, NAT MED, V15, P42, DOI 10.1038/nm.1905; Neupane M, 2008, TISSUE ENG PT A, V14, P1007, DOI [10.1089/ten.tea.2007.0207, 10.1089/tea.2007.0207]; Paepe D, 2013, J FELINE MED SURG, V15, P849, DOI 10.1177/1098612X13477415; Piantadosi CA, 2011, J BIOL CHEM, V286, DOI 10.1074/jbc.M110.207738; Porada CD, 2011, EXP HEMATOL, V39, P1124, DOI 10.1016/j.exphem.2011.09.001; Prasanna SJ, 2010, PLOS ONE, V5, DOI [10.1371/journal.pone.0009016, 10.1371/journal.pone.0014189]; Quimby JM, 2013, STEM CELL RES THER, V4, DOI 10.1186/scrt198; Quimby JM, 2011, J FELINE MED SURG, V13, P418, DOI 10.1016/j.jfms.2011.01.005; Ren GW, 2008, CELL STEM CELL, V2, P141, DOI 10.1016/j.stem.2007.11.014; Ryan JM, 2007, CLIN EXP IMMUNOL, V149, P353, DOI 10.1111/j.1365-2249.2007.03422.x; Semon JA, 2014, STEM CELL RES THER, V5, DOI 10.1186/scrt391; Spaggiari GM, 2006, BLOOD, V107, P1484, DOI 10.1182/blood-2005-07-2775; Spaggiari GM, 2008, BLOOD, V111, P1327, DOI 10.1182/blood-2007-02-074997; Spriet M, 2015, VET RADIOL ULTRASOUN, V56, P327, DOI 10.1111/vru.12243; Tang S, 2004, CLIN EXP IMMUNOL, V136, P85, DOI 10.1111/j.1365-2249.2004.02407.x; Trzil JE, 2014, CLIN EXP ALLERGY, V44, P1546, DOI 10.1111/cea.12411; Wang PP, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0043408; Webb TL, 2012, J FELINE MED SURG, V14, P165, DOI 10.1177/1098612X11429224; Zhang AB, 2010, J CELL BIOCHEM, V111, P469, DOI 10.1002/jcb.22729; Zhao YS, 2012, STEM CELL TRANSL MED, V1, P685, DOI 10.5966/sctm.2012-0027	52	15	16	0	8	WILEY	HOBOKEN	111 RIVER ST, HOBOKEN 07030-5774, NJ USA	1939-1676			J VET INTERN MED	J. Vet. Intern. Med.	JAN-FEB	2016	30	1					157	163		10.1111/jvim.13655			7	Veterinary Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Veterinary Sciences	DB9AR	WOS:000368808800022	26512713	gold, Green Published			2022-02-06	
J	Song, SJ; Kong, XY; Acosta, S; Sava, V; Borlongan, C; Sanchez-Ramos, J				Song, Shijie; Kong, Xiaoyuan; Acosta, Sandra; Sava, Vasyl; Borlongan, Cesar; Sanchez-Ramos, Juan			Granulocyte-colony stimulating factor promotes brain repair following traumatic brain injury by recruitment of microglia and increasing neurotrophic factor expression	RESTORATIVE NEUROLOGY AND NEUROSCIENCE			English	Article						Granulocyte-colony stimulating factor; traumatic brain injury; neuro-inflammation; neurogenesis; doublecortin; astrocytosis; microgliosis; chimeric mice; green fluorescent protein	REVERSES COGNITIVE IMPAIRMENT; BONE-MARROW-CELLS; FACTOR G-CSF; CELLULAR PROLIFERATION; FUNCTION RECOVERY; PURKINJE NEURONS; ISCHEMIC-STROKE; NEUROGENESIS; ADULT; TRANSPLANTATION	Purpose: The overall objective was to elucidate cellular mechanisms by which G-CSF enhances recovery from traumatic brain injury in a hippocampal-dependent learning task. Methods: Chimeric mice were prepared by transplanting bone marrow cells that express green fluorescent protein (GFP+) from a transgenic "green" mice into C57BL/6 mice. Two months later, the animals sustained mild controlled cortical impact (CCI) to the right frontal-parietal cortex, followed by G-CSF (100 [kg/kg) treatment for 3 consecutive days. The primary behavioral end-point was performance on the radial arm water maze (RAWM) assessed before and after CCI (days 7 and 14). Secondary endpoints included a), motor performance on a rotating cylinder (rotarod), b) measurement of microglial and astroglial response, c) hippocampal neurogenesis, and d) measures of neurotrophic factors (BDNF, GDNF) in brain homogenates. Results: G-CSF treatment resulted in significantly better performance on the rotorod at one week, and in the RAWM after one and two weeks. The cellular changes found 2 wks after CCI in the G-CSF group included increased numbers of hippocampal newborn neurons as well as astrocytosis and microgliosis in striatum and frontal cortex on both sides of brain. GFP+ cells that co-labeled with Ibal (microglial marker) comprised a significant proportion of striatal microglia in G-CSF treated animals, indicating the capacity of G-CSF to increase microglial recruitment to the site of injury. Neurotrophic factors GDNF and BDNF, elaborated by activated microglia and astrocytes, were increased in G-CSF treated mice. Conclusions: G-CSF serves as a neurotrophic factor that increases hippocampal neurogenesis (or enhances survival of new-born neurons), and activates astrocytes and microglia. In turn, these activated glia release a plethora of cytokines and neurotrophic factors that contribute, in a poorly understood cascade, to the brain's repair response. G-CSF also acts directly on bone marrow-derived cells to enhance recruitment of microglia to the site of CCI from circulating monocytes to the site of CCI.	[Song, Shijie; Kong, Xiaoyuan; Sava, Vasyl; Sanchez-Ramos, Juan] James A Haley VAH Res Serv, Tampa, FL USA; [Song, Shijie; Sava, Vasyl; Sanchez-Ramos, Juan] Univ S Florida, Dept Neurol, Tampa, FL 33620 USA; [Kong, Xiaoyuan; Acosta, Sandra; Borlongan, Cesar] Univ S Florida, Dept Neurosurg, Tampa, FL USA		Sanchez-Ramos, J (corresponding author), 13220 Laurel Dr, Tampa, FL 33612 USA.	jsramos@health.usf.edu	Sanchez-Ramos, Juan/O-7870-2014; Sanchez-Ramos, Juan/A-1188-2009	Sanchez-Ramos, Juan/0000-0002-3391-7857	Veterans Administration Merit Review GrantUS Department of Veterans Affairs; Helen Ellis Research Endowment Funds; Veterans AffairsUS Department of Veterans Affairs [I01BX001407, I01BX004037] Funding Source: NIH RePORTER	Supported by Veterans Administration Merit Review Grant to S. Song and by the Helen Ellis Research Endowment Funds to J. Sanchez-Ramos.	Acosta SA, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0090953; Alvarez-Dolado M, 2003, NATURE, V425, P968, DOI 10.1038/nature02069; Bakhtiary Mehrdad, 2010, Iranian Biomedical Journal, V14, P142; Batchelor PE, 1999, J NEUROSCI, V19, P1708; Boku S, 2013, BIOCHEM BIOPH RES CO, V434, P779, DOI 10.1016/j.bbrc.2013.04.011; Boyd TD, 2010, J ALZHEIMERS DIS, V21, P507, DOI 10.3233/JAD-2010-091471; Catlow BJ, 2013, EXP BRAIN RES, V228, P481, DOI 10.1007/s00221-013-3579-0; Cernak Ibolja, 2005, NeuroRx, V2, P410, DOI 10.1602/neurorx.2.3.410; Chen WF, 2011, PEDIATR RES, V70, P589, DOI 10.1203/PDR.0b013e3182324424; Chen Y, 2005, EXP NEUROL, V196, P87, DOI 10.1016/j.expneurol.2005.07.010; Cheng XW, 2011, CELL RES, V21, P338, DOI 10.1038/cr.2010.141; Diederich K, 2009, J NEUROSCI, V29, P11572, DOI 10.1523/JNEUROSCI.0453-09.2009; DOCZI TP, 1995, ACTA NEUROCHIR, V132, P87, DOI 10.1007/BF01404853; Hartung T, 1998, Curr Opin Hematol, V5, P221, DOI 10.1097/00062752-199805000-00013; Jung KH, 2006, BRAIN RES, V1073, P190, DOI 10.1016/j.brainres.2005.12.037; Kempermann G., 2006, ADULT NEUROGENSIS ST; Mahmood A, 2006, J NEUROSURG, V104, P272, DOI 10.3171/jns.2006.104.2.272; Mahmood A, 2004, NEUROSURGERY, V55, P1185, DOI 10.1227/01.NEU.0000141042.14476.3C; Ringelstein EB, 2013, STROKE, V44, P2681, DOI 10.1161/STROKEAHA.113.001531; Sanchez-Ramos J, 2009, NEUROSCIENCE, V163, P55, DOI 10.1016/j.neuroscience.2009.05.071; Schabitz WR, 2003, STROKE, V34, P745, DOI 10.1161/01.STR.0000057814.70180.17; Schneider A, 2005, CELL CYCLE, V4, P1753, DOI 10.4161/cc.4.12.2213; Schneider A, 2005, J CLIN INVEST, V115, P2083, DOI 10.1172/JCI23559; Semple BD, 2010, J CEREBR BLOOD F MET, V30, P769, DOI 10.1038/jcbfm.2009.262; Shors TJ, 2002, HIPPOCAMPUS, V12, P578, DOI 10.1002/hipo.10103; Shors TJ, 2001, NATURE, V410, P372, DOI 10.1038/35066584; Shyu WC, 2006, CAN MED ASSOC J, V174, P927, DOI 10.1503/cmaj.051322; Sikoglu EM, 2014, BEHAV BRAIN RES, V259, P354, DOI 10.1016/j.bbr.2013.11.008; Six I, 2003, EUR J PHARMACOL, V458, P327, DOI 10.1016/S0014-2999(02)02785-1; Solaroglu I, 2006, STROKE, V37, P1123, DOI 10.1161/01.STR.0000208205.26253.96; Solaroglu I, 2006, NEUROSCIENCE, V143, P965, DOI 10.1016/j.neuroscience.2006.09.014; Song SJ, 2014, J NEUROSCI RES, V92, P975, DOI 10.1002/jnr.23378; Song SJ, 2013, STEM CELLS INT, V2013, DOI 10.1155/2013/205878; Song Shijie, 2002, Methods Mol Biol, V198, P79; Sprigg N, 2006, STROKE, V37, P2979, DOI 10.1161/01.STR.0000248763.49831.c3; Terada N, 2002, NATURE, V416, P542, DOI 10.1038/nature730; Tsai KJ, 2007, J EXP MED, V204, P1273, DOI 10.1084/jem.20062481; Vorhees CV, 2006, NAT PROTOC, V1, P848, DOI 10.1038/nprot.2006.116; Weimann JM, 2003, P NATL ACAD SCI USA, V100, P2088, DOI 10.1073/pnas.0337659100; Yang DY, 2010, NEUROL RES, V32, P1041, DOI 10.1179/016164110X12807570510013; Yu SJ, 2009, BRAIN RES, V1287, P157, DOI 10.1016/j.brainres.2009.06.067	41	15	15	0	7	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	0922-6028	1878-3627		RESTOR NEUROL NEUROS	Restor. Neurol. Neurosci.		2016	34	3					415	431		10.3233/RNN-150607			17	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DQ1EY	WOS:000378945500006	26923619				2022-02-06	
J	Spilman, PR; Corset, V; Gorostiza, O; Poksay, KS; Galvan, V; Zhang, J; Rao, R; Peters-Libeu, C; Vincelette, J; McGeehan, A; Dvorak-Ewell, M; Beyer, J; Campagna, J; Bankiewicz, K; Mehlen, P; John, V; Bredesen, DE				Spilman, Patricia R.; Corset, Veronique; Gorostiza, Olivia; Poksay, Karen S.; Galvan, Veronica; Zhang, Junli; Rao, Rammohan; Peters-Libeu, Clare; Vincelette, Jon; McGeehan, Andrew; Dvorak-Ewell, Melita; Beyer, Janine; Campagna, Jesus; Bankiewicz, Krystof; Mehlen, Patrick; John, Varghese; Bredesen, Dale E.			Netrin-1 Interrupts Amyloid-beta Amplification, Increases sA beta PP alpha in vitro and in vivo, and Improves Cognition in a Mouse Model of Alzheimer's Disease	JOURNAL OF ALZHEIMERS DISEASE			English	Article						A beta(1-42); A beta PP; amplification; CED; inducible; mimetic; netrin-1; sA beta PP alpha	CONVECTION-ENHANCED DELIVERY; TRAUMATIC BRAIN-INJURY; PRECURSOR PROTEIN; NEURODEGENERATIVE DISEASES; ADENOASSOCIATED VIRUS; MONOCLONAL-ANTIBODY; SECRETASE CLEAVAGE; TRANSGENIC MICE; NEURON DEATH; CELL-DEATH	Recent studies have shown that inoculation of susceptible mice with amyloid-beta (A beta) peptides accelerates A beta deposition in the brain, supporting the idea that A beta may be self-amplifying; however, the exact mechanism is not understood. Here we provide evidence that A beta may self-amplify, in part, by inhibiting alpha-secretase ADAM10 (a disintegrin and metalloprotease) cleavage of full-length A beta precursor protein (FLA beta PP) and therefore allow greater beta-secretase processing, and that A beta itself is a substrate for ADAM10. Exposure of primary neuronal cultures from PD Lambda beta PP mice to exogenous rat A beta(1-40) resulted in increased de novo human A beta(1-42) production and exposure of cells to A beta decreased production of ADAM10 cleavage product soluble A beta PP alpha (sA beta PP alpha). In a cell-free assay, A beta decreased ADAM10 cleavage of the chimeric substrate MBP-A beta PPC125 and A beta itself was apparently cleaved by the enzyme. The axonal guidance and trophic factor netrin-1, however, reduced the A beta(1-4)0-induced A beta(1-42) increase, increased sA beta PP alpha, and reversed the A beta-induced sA beta PP alpha decrease in vitro. In vivo, induction of netrin-1 expression in PDA beta PPSwe/Ind transgenic mice resulted in reductions in both A beta(1-42) and A beta(1-40), and ICV delivery of netrin-1 to PDA beta PPSwe/Ind mice increased sA beta PP alpha, decreased A beta, and improved working memory. Finally, to support further study of netrin-1's potential as a therapeutic for Alzheimer's disease, pilot gene therapy studies were performed and a netrin mimetic peptide synthesized and tested that, like netrin, can increase sA beta PP alpha and decrease A beta(1-42) in vitro. Taken together, these data provide mechanistic insights into A beta self-amplification and the ability of netrin-1 to disrupt it.	[Spilman, Patricia R.; Corset, Veronique; Gorostiza, Olivia; Poksay, Karen S.; Galvan, Veronica; Zhang, Junli; Rao, Rammohan; Peters-Libeu, Clare; Campagna, Jesus; John, Varghese; Bredesen, Dale E.] Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA; [Corset, Veronique; Mehlen, Patrick] Univ Lyon, Ctr Canc, Apoptosis Canc & Dev Lab, Ctr Leon Berard, Lyon, France; [Gorostiza, Olivia; Vincelette, Jon; McGeehan, Andrew; Dvorak-Ewell, Melita] Biomarin Pharmaceut, Novato, CA USA; [Spilman, Patricia R.; Campagna, Jesus; John, Varghese; Bredesen, Dale E.] Univ Calif Los Angeles, Dept Neurol, Drug Discovery Lab, Los Angeles, CA 90024 USA; [Spilman, Patricia R.; Campagna, Jesus; John, Varghese; Bredesen, Dale E.] Univ Calif Los Angeles, Easton Ctr AD Res, Los Angeles, CA USA; [Beyer, Janine; Bankiewicz, Krystof] Univ Calif San Francisco, Dept Neurol Surg, Lab Translat Neurosci Res, San Francisco, CA USA; [Galvan, Veronica] Univ Texas Hlth Sci Ctr San Antonio, Dept Physiol, Barshop Inst Longev & Aging Studies, Nathan Shock Aging Ctr, San Antonio, TX 78229 USA; [Zhang, Junli] Gladstone Inst, San Francisco, CA USA; [Dvorak-Ewell, Melita] Ultragenyx, Novato, CA USA		Bredesen, DE (corresponding author), Buck Inst Res Aging, 8001 Redwood Blvd, Novato, CA 94945 USA.	dbredesen@buckinstitute.org			NIHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [AG12282]; Douglas and Ellen Rosenberg Foundation; Joseph Drown Foundation; BioMarin, Inc.; NATIONAL INSTITUTE ON AGINGUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute on Aging (NIA) [R01AG012282, P30AG013319] Funding Source: NIH RePORTER; Veterans AffairsUS Department of Veterans Affairs [I01BX002211] Funding Source: NIH RePORTER	This work was supported by the NIH (AG12282 to D.E.B.), the Douglas and Ellen Rosenberg Foundation, the Joseph Drown Foundation, and BioMarin, Inc.	Barger SW, 1996, MOL BRAIN RES, V40, P116; Barua NU, 2013, J NEUROSCI METH, V220, P1, DOI 10.1016/j.jneumeth.2013.08.011; Bertrand E, 2001, MOL CELL NEUROSCI, V18, P503, DOI 10.1006/mcne.2001.1030; Bevins RA, 2006, NAT PROTOC, V1, P1306, DOI 10.1038/nprot.2006.205; Bredesen DE, 2009, MOL NEURODEGENER, V4, DOI 10.1186/1750-1326-4-27; Cheng X, 2014, DRUG DISCOV TODAY, V19, P1822, DOI 10.1016/j.drudis.2014.06.029; Clavaguera F, 2009, NAT CELL BIOL, V11, P909, DOI 10.1038/ncb1901; de la Monte SM, 2014, BIOCHEM PHARMACOL, V88, P548, DOI 10.1016/j.bcp.2013.12.012; Dickson DW, 1997, AM J PATHOL, V151, P7; Domert J, 2014, NEUROBIOL DIS, V65, P82, DOI 10.1016/j.nbd.2013.12.019; Eichler J, 1997, PROTEIN PEPTIDE LETT, V4, P157; Eisele YS, 2009, P NATL ACAD SCI USA, V106, P12926, DOI 10.1073/pnas.0903200106; Fan YF, 2008, J CEREBR BLOOD F MET, V28, P1543, DOI 10.1038/jcbfm.2008.39; Frost B, 2010, NAT REV NEUROSCI, V11, P155, DOI 10.1038/nrn2786; Frost B, 2009, J BIOL CHEM, V284, P12845, DOI 10.1074/jbc.M808759200; GOEDERT M, 1993, TRENDS NEUROSCI, V16, P460, DOI 10.1016/0166-2236(93)90078-Z; Goldman JS, 2013, J NEUROSCI, V33, P17278, DOI 10.1523/JNEUROSCI.1085-13.2013; Grad LI, 2014, PRION, V8, P33, DOI 10.4161/pri.27602; Guo JL, 2011, J BIOL CHEM, V286, P15317; Hamaguchi T, 2012, ACTA NEUROPATHOL, V123, P31, DOI 10.1007/s00401-011-0912-1; HARDY J, 1991, TRENDS PHARMACOL SCI, V12, P383, DOI 10.1016/0165-6147(91)90609-V; Harris JA, 2010, NEURON, V68, P428, DOI 10.1016/j.neuron.2010.10.020; He XY, 2007, J NEUROSCI, V27, P4052, DOI 10.1523/JNEUROSCI.3993-06.2007; Hsia AY, 1999, P NATL ACAD SCI USA, V96, P3228, DOI 10.1073/pnas.96.6.3228; IKEDA S, 1987, LAB INVEST, V57, P446; KeinoMasu K, 1996, CELL, V87, P175, DOI 10.1016/S0092-8674(00)81336-7; Kim S, 2015, ELIFE, V4, DOI 10.7554/eLife.04158; Langer F, 2011, J NEUROSCI, V31, P14488, DOI 10.1523/JNEUROSCI.3088-11.2011; Liao SJ, 2013, NEUROSCIENCE, V231, P225, DOI 10.1016/j.neuroscience.2012.11.059; Liberski Pawel P, 2014, Parkinsonism Relat Disord, V20 Suppl 1, pS80, DOI 10.1016/S1353-8020(13)70021-X; Libeu CP, 2011, J ALZHEIMERS DIS, V25, P547, DOI 10.3233/JAD-2011-101938; Lonser RR, 2015, J NEUROSURG, V122, P697, DOI 10.3171/2014.10.JNS14229; Lourenco FC, 2009, CELL DEATH DIFFER, V16, P655, DOI 10.1038/cdd.2008.191; Lu DC, 2000, NAT MED, V6, P397, DOI 10.1038/74656; Lu DC, 2003, ANN NEUROL, V54, P781, DOI 10.1002/ana.10761; Marklund N, 2014, J NEUROTRAUM, V31, P42, DOI 10.1089/neu.2013.2964; Matsushita T, 1998, GENE THER, V5, P938, DOI 10.1038/sj.gt.3300680; Mellott TJ, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0094287; Mougenot AL, 2012, NEUROBIOL AGING, V33, P2225, DOI 10.1016/j.neurobiolaging.2011.06.022; Mucke L, 2000, J NEUROSCI, V20, P4050, DOI 10.1523/jneurosci.20-11-04050.2000; Munch C, 2011, P NATL ACAD SCI USA, V108, P3548, DOI 10.1073/pnas.1017275108; Nagahara AH, 2009, NAT MED, V15, P331, DOI 10.1038/nm.1912; Narkiewicz J, 2014, PRION, V8, P19, DOI 10.4161/pri.28125; Nikolaev A, 2009, NATURE, V457, P981, DOI 10.1038/nature07767; Obregon D, 2012, NAT COMMUN, V3, DOI 10.1038/ncomms1781; Park SA, 2009, BIOCHEM BIOPH RES CO, V388, P450, DOI 10.1016/j.bbrc.2009.08.042; Peters-Libeu C, 2015, J ALZHEIMERS DIS, V47, P545, DOI 10.3233/JAD-150282; Popa-Wagner A, 2015, J NEURAL TRANSM, V122, P47, DOI 10.1007/s00702-013-1129-3; Rama N, 2012, J BIOL CHEM, V287, P30014, DOI 10.1074/jbc.M111.324780; Rosenbluth KH, 2011, J NEUROSCI METH, V196, P118, DOI 10.1016/j.jneumeth.2010.12.022; Selkoe DJ, 1996, ANN NY ACAD SCI, V777, P57, DOI 10.1111/j.1749-6632.1996.tb34401.x; Shaked GM, 2006, FASEB J, V20, P1254, DOI 10.1096/fj.05-5032fje; Silveira JR, 2005, NATURE, V437, P257, DOI 10.1038/nature03989; Sinha S, 1999, NATURE, V402, P537, DOI 10.1038/990114; Sivanandam TM, 2012, NEUROSCI BIOBEHAV R, V36, P1376, DOI 10.1016/j.neubiorev.2012.02.013; Steinacker P, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0023600; Stohr J, 2012, P NATL ACAD SCI USA, V109, P11025, DOI 10.1073/pnas.1206555109; Tian YA, 2010, J BIOL CHEM, V285, P32549, DOI 10.1074/jbc.M110.128439; Tuszynski MH, 2015, JAMA NEUROL, V72, P1139, DOI 10.1001/jamaneurol.2015.1807; Utomo ARH, 1999, NAT BIOTECHNOL, V17, P1091, DOI 10.1038/15073; Vassar R, 1999, SCIENCE, V286, P735, DOI 10.1126/science.286.5440.735; Volpicelli-Daley LA, 2011, NEURON, V72, P57, DOI 10.1016/j.neuron.2011.08.033; Wen JF, 2014, EXP THER MED, V8, P881, DOI 10.3892/etm.2014.1818; Wetzel-Smith MK, 2014, NAT MED, V20, P1452, DOI 10.1038/nm.3736; Wright JF, 2003, CURR OPIN DRUG DI DE, V6, P174; Xia WM, 1998, BIOCHEMISTRY-US, V37, P16465, DOI 10.1021/bi9816195; Yang AJ, 1999, J BIOL CHEM, V274, P20650, DOI 10.1074/jbc.274.29.20650; Yin RH, 2014, CURR ALZHEIMER RES, V11, P755, DOI 10.2174/156720501108140910121425	68	15	17	1	16	IOS PRESS	AMSTERDAM	NIEUWE HEMWEG 6B, 1013 BG AMSTERDAM, NETHERLANDS	1387-2877	1875-8908		J ALZHEIMERS DIS	J. Alzheimers Dis.		2016	52	1					223	242		10.3233/JAD-151046			20	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DK6CK	WOS:000375008500021	27060954				2022-02-06	
J	Stocker, RPJ; Paul, BTE; Mammen, O; Khan, H; Cieply, MA; Germain, A				Stocker, Ryan P. J.; Paul, Benjamin T. E.; Mammen, Oommen; Khan, Hassen; Cieply, Marissa A.; Germain, Anne			Effects of Blast Exposure on Subjective and Objective Sleep Measures in Combat Veterans with and without PTSD	JOURNAL OF CLINICAL SLEEP MEDICINE			English	Article						veterans; sleep; blast exposure; mild traumatic brain injury (mTBI); PTSD; REM sleep	TRAUMATIC BRAIN-INJURY; POSTTRAUMATIC-STRESS-DISORDER; EYE-MOVEMENT SLEEP; GULF-WAR VETERANS; PSYCHOMETRIC PROPERTIES; MILITARY PERSONNEL; GLUCOSE-METABOLISM; QUALITY INDEX; REM-SLEEP; DISTURBANCES	Study Objectives: This study examined the extent to which self-reported exposure to blast during deployment to Iraq and Afghanistan affects subjective and objective sleep measures in service members and veterans with and without posttraumatic stress disorder (PTSD). Methods: Seventy-one medication-free service members and veterans (mean age = 29.47 +/- 5.76 years old; 85% men) completed self-report sleep measures and overnight polysomnographic studies. Four multivariate analyses of variance (MANOVAs) were conducted to examine the impact of blast exposure and PTSD on subjective sleep measures, measures of sleep continuity, non-rapid eye movement (NREM) sleep parameters, and rapid eye movement (REM) sleep parameters. Results: There was no significant Blast x PTSD interaction on subjective sleep measures. Rather, PTSD had a main effect on insomnia severity, sleep quality, and disruptive nocturnal behaviors. There was no significant Blast x PTSD interaction, nor were there main effects of PTSD or Blast on measures of sleep continuity and NREM sleep. A significant PTSD x Blast interaction effect was found for REM fragmentation. Conclusions: The results suggest that, although persistent concussive symptoms following blast exposure are associated with sleep disturbances, self-reported blast exposure without concurrent symptoms does not appear to contribute to poor sleep quality, insomnia, and disruptive nocturnal disturbances beyond the effects of PTSD. Reduced REM sleep fragmentation may be a sensitive index of the synergetic effects of both psychological and physical insults.	[Stocker, Ryan P. J.; Paul, Benjamin T. E.; Mammen, Oommen; Khan, Hassen; Cieply, Marissa A.] Univ Pittsburgh, Med Ctr, Pittsburgh, PA USA; [Stocker, Ryan P. J.; Mammen, Oommen; Germain, Anne] Univ Pittsburgh, Sch Med, Dept Psychiat, Pittsburgh, PA USA; Univ Pittsburgh, Sch Med, Psychiat & Psychol, Pittsburgh, PA 15213 USA		Germain, A (corresponding author), Univ Pittsburgh, Sch Med, Psychiat & Psychol, 3811 OHara St, Pittsburgh, PA 15213 USA.	germax@upmc.edu			Department of Defense Congressionally Directed Medical Research ProgramUnited States Department of Defense [PR0504093, PT07396]; National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [MH083035, MH080696, RR024153]; NATIONAL CENTER FOR RESEARCH RESOURCESUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Center for Research Resources (NCRR) [UL1RR024153] Funding Source: NIH RePORTER; NATIONAL INSTITUTE OF MENTAL HEALTHUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Mental Health (NIMH) [R34MH080696, R21MH083035] Funding Source: NIH RePORTER	This study was supported by the Department of Defense Congressionally Directed Medical Research Program (PR0504093 and PT07396; PI: Germain) and the National Institutes of Health (MH083035 and MH080696, PI: Germain; N-CTRC #RR024153; PI: Reis). The views expressed in this article are those of the authors and do not reflect the official policy or position of the DOD. The authors have indicated no financial conflicts of interest.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Aton SJ, 2013, NEUROBIOL LEARN MEM, V106, P1, DOI 10.1016/j.nlm.2013.06.007; Bastien CH, 2001, SLEEP MED, V2, P297, DOI 10.1016/S1389-9457(00)00065-4; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Baumann CR, 2012, NEUROMOL MED, V14, P205, DOI 10.1007/s12017-012-8178-x; BECK AT, 1988, J CONSULT CLIN PSYCH, V56, P893, DOI 10.1037/0022-006X.56.6.893; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BLAKE DD, 1995, J TRAUMA STRESS, V8, P75, DOI 10.1007/BF02105408; Bogdanova Y, 2012, NEUROPSYCHOL REV, V22, P4, DOI 10.1007/s11065-012-9192-3; BUYSSE DJ, 1989, PSYCHIAT RES, V28, P193, DOI 10.1016/0165-1781(89)90047-4; Campbell J, 2009, HIDD CAS WAR 2009 S; Capaldi VF, 2011, MIL MED, V176, P879, DOI 10.7205/MILMED-D-10-00440; Castriotta RJ, 2011, CNS DRUGS, V25, P175, DOI 10.2165/11584870-000000000-00000; Chaput G, 2009, SLEEP MED, V10, P713, DOI 10.1016/j.sleep.2008.07.015; Collen J, 2012, CHEST, V142, P622, DOI 10.1378/chest.11-1603; Dilley M, 2011, PSYCHIAT DISORDERS W; DOMAN J, 1995, INT J BIOMED COMPUT, V38, P277, DOI 10.1016/S0020-7101(05)80010-8; Edgar E, 2009, BAGHDAD ER REVISITED; First M., 1997, STRUCTURED CLIN INTE; French L., 2008, J SPECIAL OPERATIONS, V8, P68; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Germain A, 2004, PSYCHIAT RES-NEUROIM, V130, P259, DOI 10.1016/j.pscychresns.2003.12.003; Germain A, 2004, AM J PSYCHIAT, V161, P1856, DOI 10.1176/appi.ajp.161.10.1856; Germain A, 2013, AM J PSYCHIAT, V170, P372, DOI 10.1176/appi.ajp.2012.12040432; Giza Christopher C, 2014, Neurosurgery, V75 Suppl 4, pS24, DOI 10.1227/NEU.0000000000000505; Gorgoni M, 2013, NEURAL PLAST, V2013, DOI 10.1155/2013/103949; Guilleminault C, 2000, NEUROLOGY, V54, P653, DOI 10.1212/WNL.54.3.653; Henry LC, 2011, BMC NEUROL, V11, DOI 10.1186/1471-2377-11-105; Henry LC, 2010, J NEUROTRAUM, V27, P65, DOI 10.1089/neu.2009.0962; Hoge CW, 2008, NEW ENGL J MED, V358, P453, DOI 10.1056/NEJMoa072972; Insana SP, 2013, J TRAUMA STRESS, V26, P192, DOI 10.1002/jts.21793; Keen SM, 2008, J REHABIL RES DEV, V45, P465, DOI 10.1682/JRRD.2007.09.0138; Kempf J, 2010, J NEUROL NEUROSUR PS, V81, P1402, DOI 10.1136/jnnp.2009.201913; Kobayashi I, 2007, PSYCHOPHYSIOLOGY, V44, P660, DOI 10.1111/j.1469-8986.2007.537.x; Kontos AP, 2013, J NEUROTRAUM, V30, P680, DOI 10.1089/neu.2012.2506; Kroenke K, 1998, J OCCUP ENVIRON MED, V40, P520, DOI 10.1097/00043764-199806000-00004; Lew HL, 2008, J REHABIL RES DEV, V45, pXI, DOI 10.1682/JRRD.2008.05.0064; Lewis V, 2009, MIL MED, V174, P948, DOI 10.7205/MILMED-D-04-0208; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Matson J, 2011, LEGACY MENTAL HLTH P; McLay RN, 2010, MIL MED, V175, P759, DOI 10.7205/MILMED-D-10-00193; Miller NL, 2011, BEHAV SLEEP MED, V9, P53, DOI 10.1080/15402002.2011.533994; Moffett JR, 2007, PROG NEUROBIOL, V81, P89, DOI 10.1016/j.pneurobio.2006.12.003; Mora C.A., 1989, PSYCHOL ASSESSMENT J, V1, P53, DOI [10.1037/1040-3590.1.1.53, DOI 10.1037/1040-3590.1.1.53]; Mott TF, 2012, AM FAM PHYSICIAN, V86, P1045; Mysliwiec V, 2013, CHEST, V144, P549, DOI 10.1378/chest.13-0088; Neylan TC, 1998, AM J PSYCHIAT, V155, P929, DOI 10.1176/ajp.155.7.929; Nofzinger EA, 2004, AM J PSYCHIAT, V161, P2126, DOI 10.1176/appi.ajp.161.11.2126; Nofzinger EA, 2002, BRAIN, V125, P1105, DOI 10.1093/brain/awf103; Nofzinger EA, 2006, J CLIN SLEEP MED, V2, P316; Peterson AL, 2008, MIL MED, V173, P230, DOI 10.7205/MILMED.173.3.230; Rand Corporation, 2008, ISBNEAN9780833044549; RAND Corporation, 2008, INV WOUNDS WAR SUMM; Rona RJ, 2012, J HEAD TRAUMA REHAB, V27, P33, DOI 10.1097/HTR.0b013e318212f814; Roy MJ, 1998, PSYCHOSOM MED, V60, P663, DOI 10.1097/00006842-199811000-00001; Sabir M, 2015, BRAIN BEHAV IMMUN, V47, P118, DOI 10.1016/j.bbi.2014.12.023; Schwab KA, 2006, NEUROLOGY, V66, pA235; Signoretti S, 2008, J NEUROSURG, V108, P42, DOI 10.3171/JNS/2008/108/01/0042; Signoretti S, 2010, MOL CELL BIOCHEM, V333, P269, DOI 10.1007/s11010-009-0228-9; STAHL SM, 2000, ESSENTIAL PHARM NEUR; Stocker RPJ, 2014, NEUROIMAGE, V99, P207, DOI 10.1016/j.neuroimage.2014.05.067; Verma A, 2007, J CLIN SLEEP MED, V3, P357; Wisco BE, 2014, J CLIN PSYCHIAT, V75, P1338, DOI 10.4088/JCP.14m09328	63	15	15	0	8	AMER ACAD SLEEP MEDICINE	DARIEN	2510 N FRONTAGE RD, DARIEN, IL 60561 USA	1550-9389	1550-9397		J CLIN SLEEP MED	J. Clin. Sleep Med.		2016	12	1					49	56		10.5664/jcsm.5392			8	Clinical Neurology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology	DJ3VW	WOS:000374135800008	26414975	Green Published, Bronze			2022-02-06	
J	Turhan, L; Batmaz, S; Kocbiyik, S; Soygur, AH				Turhan, Levent; Batmaz, Sedat; Kocbiyik, Sibel; Soygur, Arif Haldun			The role of tumour necrosis factor alpha and soluble tumour necrosis factor alpha receptors in the symptomatology of schizophrenia	NORDIC JOURNAL OF PSYCHIATRY			English	Article						Immune system; schizophrenia; soluble tumour necrosis factor alpha receptor I; soluble tumour necrosis factor alpha receptor II; tumour necrosis factor alpha	NEGATIVE-SYNDROME-SCALE; INCREASED PLASMA-LEVELS; TRAUMATIC BRAIN-INJURY; TNF-ALPHA; BIPOLAR DISORDER; SERUM-LEVELS; GENE-EXPRESSION; NO ASSOCIATION; POPULATION; CYTOKINES	Background Immunological mechanisms may be responsible for the development and maintenance of schizophrenia symptoms. Aim The aim of this study is to measure tumour necrosis factor-alpha (TNF-alpha), soluble tumour necrosis factor-alpha receptor I (sTNF-alpha RI), and soluble tumour necrosis factor-alpha receptor II (sTNF-alpha RII) levels in patients with schizophrenia and healthy individuals, and to determine their relationship with the symptoms of schizophrenia. Methods Serum TNF-alpha, sTNF-alpha RI and sTNF-alpha RII levels were measured. The Positive and Negative Syndrome Scale (PANSS) was administered for patients with schizophrenia (n = 35), and the results were compared with healthy controls (n = 30). Hierarchical regression analyses were undertaken to predict the levels of TNF-alpha, sTNF-alpha RI and sTNF-alpha RII. Results No significant difference was observed in TNF-alpha levels, but sTNF-alpha RI and sTNF-alpha RII levels were lower in patients with schizophrenia. Serum sTNF-alpha RI and sTNF-alpha RII levels were found to be negatively correlated with the negative subscale score of the PANSS, and sTNF-alpha RI levels were also negatively correlated with the total score of the PANSS. Smoking, gender, body mass index were not correlated with TNF-alpha and sTNF-alpha receptor levels. Conclusions These results suggest that there may be a change in antiinflammatory response in patients with schizophrenia due to sTNF-alpha RI and sTNF-alpha RII levels. The study also supports low levels of TNF activity in schizophrenia patients with negative symptoms.	[Turhan, Levent] Kartal Lutfi Kirdar Training & Res Hosp, Psychiat Clin, Istanbul, Turkey; [Batmaz, Sedat] Gaziosmanpasa Univ, Sch Med, Dept Psychiat, Tokat, Turkey; [Kocbiyik, Sibel] Ataturk Training & Res Hosp, Psychiat Clin, Ankara, Turkey		Batmaz, S (corresponding author), Gaziosmanpasa Univ, Sch Med, Dept Psychiat, Tokat, Turkey.	sedat.batmaz@gop.edu.tr	Batmaz, Sedat/A-2157-2019	Batmaz, Sedat/0000-0003-0585-2184			American Psychiatric Association (APA), 1995, DIAGN STAT MAN MENT; APA, 2000, DIAGNOSTIC AND STATI; Barbosa IG, 2011, EUR ARCH PSY CLIN N, V261, P139, DOI 10.1007/s00406-010-0116-z; Baune BT, 2008, AM J MED GENET B, V147B, P1056, DOI 10.1002/ajmg.b.30712; Baune BT, 2010, TRENDS NEUROSCI, V3, P263; Bette M, 2003, J COMP NEUROL, V465, P417, DOI 10.1002/cne.10877; Brietzke E, 2008, PROG NEURO-PSYCHOPH, V32, P1355, DOI 10.1016/j.pnpbp.2008.01.006; Camara ML, 2015, BEHAV BRAIN RES, V290, P51, DOI 10.1016/j.bbr.2015.04.040; Camara ML, 2013, PSYCHONEUROENDOCRINO, V38, P3102, DOI 10.1016/j.psyneuen.2013.09.010; Carpentier I, 2004, CURR MED CHEM, V11, P2205, DOI 10.2174/0929867043364694; Clark IA, 2010, PHARMACOL THERAPEUT, V128, P519, DOI 10.1016/j.pharmthera.2010.08.007; Coelho FM, 2008, NEUROIMMUNOMODULAT, V15, P140, DOI 10.1159/000148197; Corapcioglu A, 1999, STRUCTURED CLIN INTE; Czerski PM, 2008, NEUROPSYCHOBIOLOGY, V57, P88, DOI 10.1159/000135642; Dean B, 2013, MOL PSYCHIATR, V18, P767, DOI 10.1038/mp.2012.95; Debnath M, 2013, CYTOKINE, V61, P455, DOI 10.1016/j.cyto.2012.10.028; Di Nicola M, 2013, BRAIN BEHAV IMMUN, V31, P90, DOI 10.1016/j.bbi.2012.06.010; Dopp JM, 1997, J NEUROIMMUNOL, V75, P104, DOI 10.1016/S0165-5728(97)00009-X; Duan SW, 2004, NEUROSCI LETT, V366, P139, DOI 10.1016/j.neulet.2004.05.039; Dunjic-Kostic B, 2013, PSYCHIAT DANUB, V25, P55; Ebach DR, 2005, SHOCK, V23, P311, DOI 10.1097/01.shk.0000157301.87051.77; ENGELMANN H, 1990, J BIOL CHEM, V265, P1531; Erbagci AB, 2001, MEDIAT INFLAMM, V10, P109, DOI 10.1080/09629350120072761; Falcone Tatiana, 2015, Clin Schizophr Relat Psychoses, V9, P65, DOI 10.3371/CSRP.FACA.030813; First M.B., 1996, STRUCTURED CLIN INTE; Fontaine V, 2002, J NEUROSCI, V22, DOI 10.1523/JNEUROSCI.22-07-j0001.2002; Fotin-Mleczek M, 2002, J CELL SCI, V115, P2757; Francesconi LP, 2011, PSYCHIAT RES, V189, P305; GATANAGA T, 1990, P NATL ACAD SCI USA, V87, P8781, DOI 10.1073/pnas.87.22.8781; Golan H, 2004, CEREB CORTEX, V14, P97, DOI 10.1093/cercor/bhg108; Haack M, 1999, J PSYCHIATR RES, V33, P407, DOI 10.1016/S0022-3956(99)00021-7; Hope S, 2013, SCHIZOPHR RES, V145, P36, DOI 10.1016/j.schres.2012.12.023; Hope S, 2009, BIPOLAR DISORD, V11, P726, DOI 10.1111/j.1399-5618.2009.00757.x; Horiuchi T, 2010, RHEUMATOLOGY, V49, P1215, DOI 10.1093/rheumatology/keq031; Iosif RE, 2006, J NEUROSCI, V26, P9703, DOI 10.1523/JNEUROSCI.2723-06.2006; Jia PL, 2010, SCHIZOPHR RES, V122, P38, DOI 10.1016/j.schres.2010.07.001; Kassiotis G, 2001, J EXP MED, V193, P427, DOI 10.1084/jem.193.4.427; KAY SR, 1987, SCHIZOPHRENIA BULL, V13, P261, DOI 10.1093/schbul/13.2.261; Kim YK, 2009, NEUROPSYCHOBIOLOGY, V59, P123, DOI 10.1159/000213565; Kinney DK, 2010, MED HYPOTHESES, V74, P555, DOI 10.1016/j.mehy.2009.09.040; Kostakoglu E, 1999, TURK PSIKOL DERG, V14, P23; Kowalski J, 2001, SCHIZOPHR RES, V50, P169, DOI 10.1016/S0920-9964(00)00156-0; Kubistova A, 2012, PSYCHIAT DANUB, V24, pS153; Kunz M, 2011, REV BRAS PSIQUIATR, V33, P268, DOI 10.1590/S1516-44462011000300010; Lewis S., 2009, KAPLAN SADOCKS COMPR, P1433; Li JR, 2008, J NEUROSCI, V28, P5321, DOI 10.1523/JNEUROSCI.3995-07.2008; Longhi L, 2013, J CEREBR BLOOD F MET, V33, P1182, DOI 10.1038/jcbfm.2013.65; Lu Lu-xian, 2004, Di Yi Jun Yi Da Xue Xue Bao, V24, P1251; Lv MH, 2015, PSYCHOPHARMACOLOGY, V232, P165, DOI 10.1007/s00213-014-3650-y; Maddahi A, 2011, J NEUROINFLAMM, V8, DOI 10.1186/1742-2094-8-107; Maschietto M, 2012, PSYCHIAT RES, V200, P1018, DOI 10.1016/j.psychres.2012.04.030; McAfoose J, 2009, NEUROSCI BIOBEHAV R, V33, P355, DOI 10.1016/j.neubiorev.2008.10.005; Mccoy MK, 2008, J NEUROINFLAMM, V5, DOI 10.1186/1742-2094-5-45; Miller BJ, 2011, BIOL PSYCHIAT, V70, P663, DOI 10.1016/j.biopsych.2011.04.013; Mills NT, 2015, TWIN RES HUM GENET, V18, P28, DOI 10.1017/thg.2014.70; Monji A, 2009, PSYCHIAT CLIN NEUROS, V63, P257, DOI 10.1111/j.1440-1819.2009.01945.x; Monteleone P, 1997, PSYCHIAT RES, V71, P11, DOI 10.1016/S0165-1781(97)00036-X; Morar B, 2007, AM J MED GENET B, V144B, P318, DOI 10.1002/ajmg.b.30451; Muller N, 2004, EUR ARCH PSY CLIN N, V254, P14, DOI 10.1007/s00406-004-0478-1; Naudin J, 1997, SCHIZOPHR RES, V26, P227, DOI 10.1016/S0920-9964(97)00059-5; Naz M, 2011, MOL BIOL REP, V38, P4709, DOI 10.1007/s11033-010-0606-0; Neijts M, 2013, TWIN RES HUM GENET, V16, P931, DOI 10.1017/thg.2013.58; Noto C, 2013, J PSYCHIATR RES, V47, P467, DOI 10.1016/j.jpsychires.2012.12.010; O'Brien SM, 2008, PSYCHIAT RES, V160, P256, DOI 10.1016/j.psychres.2007.11.014; Pae CU, 2003, PSYCHIAT CLIN NEUROS, V57, P399, DOI 10.1046/j.1440-1819.2003.01138.x; Pan W, 2002, EXP NEUROL, V174, P193, DOI 10.1006/exnr.2002.7871; Pandey GN, 2015, SCHIZOPHR RES, V164, P193, DOI 10.1016/j.schres.2015.02.004; Pedrini M, 2012, J PSYCHIATR RES, V46, P819, DOI 10.1016/j.jpsychires.2012.03.019; Probert L, 2015, NEUROSCIENCE, V302, P2, DOI 10.1016/j.neuroscience.2015.06.038; Rodriguez M, 2009, BRAIN PATHOL, V19, P12, DOI 10.1111/j.1750-3639.2008.00151.x; Sacchetti E, 2007, BRAIN BEHAV IMMUN, V21, P450, DOI 10.1016/j.bbi.2006.11.009; Saviouk V, 2005, MOL PSYCHIATR, V10, P375, DOI 10.1038/sj.mp.4001582; Schwarz MJ, 2001, MED HYPOTHESES, V56, P483, DOI 10.1054/mehy.2000.1203; SECKINGER P, 1989, J BIOL CHEM, V264, P11966; Sedger LM, 2014, CYTOKINE GROWTH F R, V25, P453, DOI 10.1016/j.cytogfr.2014.07.016; Shu HB, 1996, P NATL ACAD SCI USA, V93, P13973, DOI 10.1073/pnas.93.24.13973; SMITH RS, 1995, MED HYPOTHESES, V45, P135, DOI 10.1016/0306-9877(95)90062-4; Stahl SM, 2013, STAHLS ESSENTIAL PSY; Stellwagen D, 2005, J NEUROSCI, V25, P3219, DOI 10.1523/JNEUROSCI.4486-04.2005; Takei Y, 2008, TRENDS MOL MED, V14, P381, DOI 10.1016/j.molmed.2008.07.002; Teixeira AL, 2015, HUM PSYCHOPHARM CLIN, V30, P52, DOI 10.1002/hup.2450; TRACEY KJ, 1994, ANNU REV MED, V45, P491, DOI 10.1146/annurev.med.45.1.491; van der Gaag M, 2006, SCHIZOPHR RES, V85, P280, DOI 10.1016/j.schres.2006.03.021; Watanabe Y, 2007, PSYCHIAT RES, V153, P1, DOI 10.1016/j.psychres.2006.03.009; Yang JS, 2010, J NEUROTRAUM, V27, P1037, DOI 10.1089/neu.2009.1229	85	15	15	1	7	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0803-9488	1502-4725		NORD J PSYCHIAT	Nord. J. Psychiatr.		2016	70	5					342	350		10.3109/08039488.2015.1122079			9	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	DQ9LU	WOS:000379532200004	26754110				2022-02-06	
J	Uteshev, VV				Uteshev, Victor V.			Allosteric Modulation of Nicotinic Acetylcholine Receptors: The Concept and Therapeutic Trends	CURRENT PHARMACEUTICAL DESIGN			English	Article						Allosteric; cognitive; nociceptive; inflammatory; protection; ischemic; stroke; traumatic; choline; nicotinic; PNU-120596; PNU120596	TRAUMATIC BRAIN-INJURY; VAGUS NERVE-STIMULATION; CULTURED CORTICAL-NEURONS; TIME-DEPENDENT CHANGES; PROOF-OF-CONCEPT; BINDING-SITES; COGNITIVE DEFICITS; PARTIAL AGONIST; ACH RECEPTORS; RAT-BRAIN	Expressing functional nicotinic acetylcholine receptors (nAChRs) may be beneficial to central neurons and neuronal networks because activation of nAChRs enhances neuronal resistance to injury, improves attention, cognitive performance, and produces robust anti-inflammatory and analgesic effects in mammals. Although exogenous orthosteric nAChR ligands present valuable tools in treatment of age-and trauma-related neurological deficits, therapeutic approaches that could amplify the brain's innate ability to maintain cholinergic homeostasis and resist injury may serve as intriguing and promising alternatives and have not been fully explored. One of these novel approaches utilizes positive allosteric modulators (PAMs) of nAChRs. Because of the ubiquitous expression of nAChRs in neuronal, glial and immune tissues, highly selective PAMs could amplify multiple endogenous neuroprotective, pro-cognitive, anti-inflammatory and anti-nociceptive cholinergic pathways to offset cholinergic hypofunction and generate therapeutic efficacy by targeting only a single player: i.e., nAChRs activated by endogenous cholinergic tone. In this article, I review the concept of allosteric modulation and current trends in therapeutic applications of nicotinic PAMs.	[Uteshev, Victor V.] Univ N Texas, Hlth Sci Ctr, Inst Hlth Aging, Ctr Neurosci Discovery, Ft Worth, TX 76107 USA		Uteshev, VV (corresponding author), Univ N Texas, Hlth Sci Ctr, Inst Hlth Aging, Ctr Neurosci Discovery, Ft Worth, TX 76107 USA.	Victor.Uteshev@unthsc.edu					AKAIKE A, 1994, BRAIN RES, V644, P181, DOI 10.1016/0006-8993(94)91678-0; Akaike A, 2010, J MOL NEUROSCI, V40, P211, DOI 10.1007/s12031-009-9236-1; Albuquerque EX, 2001, ALZ DIS ASSOC DIS, V15, pS19, DOI 10.1097/00002093-200108001-00004; Alkondon M, 2000, NEUROPHARMACOLOGY, V39, P2726, DOI 10.1016/S0028-3908(00)00156-8; Alkondon M, 1997, EUR J NEUROSCI, V9, P2734, DOI 10.1111/j.1460-9568.1997.tb01702.x; Alkondon M, 1999, J NEUROSCI, V19, P2693; AlSharari SD, 2013, BIOCHEM PHARMACOL, V86, P1201, DOI 10.1016/j.bcp.2013.06.018; Alvarez B, 2011, CURR OPIN PULM MED, V17, P172, DOI 10.1097/MCP.0b013e3283455c0b; ARENDASH GW, 1995, BRAIN RES, V674, P252, DOI 10.1016/0006-8993(94)01449-R; Arias HR, 2010, ADV PROTEIN CHEM STR, V80, P153, DOI [10.1016/S1876-1623(10)80005-7, 10.1016/B978-0-12-381264-3.00005-9]; Azzopardi E, 2013, GENES BRAIN BEHAV, V12, P414, DOI 10.1111/gbb.12038; BADIO B, 1994, MOL PHARMACOL, V45, P563; Baez-Pagan CA, 2015, J NEUROIMMUNE PHARM, V10, P468, DOI 10.1007/s11481-015-9601-5; Baldini A, 2012, PRIM CARE COMPANION, V14; Banerjee C, 2000, NEUROBIOL DIS, V7, P666, DOI 10.1006/nbdi.2000.0317; BARTUS RT, 1982, SCIENCE, V217, P408, DOI 10.1126/science.7046051; Bencherif M, 2011, CELL MOL LIFE SCI, V68, P931, DOI 10.1007/s00018-010-0525-1; BERTRAND D, 1993, P NATL ACAD SCI USA, V90, P6971, DOI 10.1073/pnas.90.15.6971; Bertrand N, 1996, NEUROCHEM INT, V28, P293, DOI 10.1016/0197-0186(95)00086-0; Bitner RS, 2010, J PHARMACOL EXP THER, V334, P875, DOI 10.1124/jpet.110.167213; Bitner RS, 2007, J NEUROSCI, V27, P10578, DOI 10.1523/JNEUROSCI.2444-07.2007; Blair LAC, 1999, J NEUROSCI, V19, P1940; Bloem B, 2014, FRONT NEURAL CIRCUIT, V8, DOI 10.3389/fncir.2014.00017; Boess FG, 2007, J PHARMACOL EXP THER, V321, P716, DOI 10.1124/jpet.106.118976; Bok J, 2007, MOL CELL NEUROSCI, V36, P13, DOI 10.1016/j.mcn.2007.05.008; Borovikova LV, 2000, NATURE, V405, P458, DOI 10.1038/35013070; Boyce S, 2000, PAIN, V85, P443, DOI 10.1016/S0304-3959(99)00303-6; BRAESTRUP C, 1982, SCIENCE, V216, P1241, DOI 10.1126/science.6281892; Breese CR, 1997, J COMP NEUROL, V387, P385, DOI 10.1002/(SICI)1096-9861(19971027)387:3<385::AID-CNE5>3.0.CO;2-X; Briggs CA, 1997, PHARMACOL BIOCHEM BE, V57, P231, DOI 10.1016/S0091-3057(96)00354-1; Briggs CA, 2009, BRIT J PHARMACOL, V158, P1486, DOI 10.1111/j.1476-5381.2009.00426.x; Brown KL, 2010, FRONT BEHAV NEUROSCI, V4, DOI 10.3389/fnbeh.2010.00166; Brunzell DH, 2012, NEUROPSYCHOPHARMACOL, V37, P1134, DOI 10.1038/npp.2011.299; Buccafusco JJ, 2007, BIOCHEM PHARMACOL, V74, P1202, DOI 10.1016/j.bcp.2007.07.010; Buccafusco JJ, 2005, TRENDS PHARMACOL SCI, V26, P352, DOI 10.1016/j.tips.2005.05.007; BURGEN ASV, 1981, FED PROC, V40, P2723; Burghaus L, 2000, MOL BRAIN RES, V76, P385; Cabrera SM, 2006, BEHAV NEUROSCI, V120, P298, DOI 10.1037/0735-7044.120.2.298; Callahan PM, 2013, NEUROPHARMACOLOGY, V67, P201, DOI 10.1016/j.neuropharm.2012.10.019; CASTRO NG, 1995, BIOPHYS J, V68, P516, DOI 10.1016/S0006-3495(95)80213-4; CHANGEUX JP, 1990, TRENDS PHARMACOL SCI, V11, P485, DOI 10.1016/0165-6147(90)90049-E; Christopoulos A, 2002, NAT REV DRUG DISCOV, V1, P198, DOI 10.1038/nrd746; CLARKE PBS, 1993, PROG BRAIN RES, V98, P77; Clough RW, 2007, NEUROSCIENCE, V147, P286, DOI 10.1016/j.neuroscience.2007.04.043; COLLINS F, 1991, J NEUROSCI, V11, P2582; Conn PJ, 2009, NAT REV DRUG DISCOV, V8, P41, DOI 10.1038/nrd2760; Corringer PJ, 2000, ANNU REV PHARMACOL, V40, P431, DOI 10.1146/annurev.pharmtox.40.1.431; Curzon P, 2006, NEUROSCI LETT, V410, P15, DOI 10.1016/j.neulet.2006.09.061; Dajas-Bailador F, 2004, TRENDS PHARMACOL SCI, V25, P317, DOI 10.1016/j.tips.2004.04.006; Daly JW, 2000, NAT PROD REP, V17, P131, DOI 10.1039/a900728h; Damaj MI, 2000, NEUROPHARMACOLOGY, V39, P2785, DOI 10.1016/S0028-3908(00)00139-8; Damaj MI, 1998, J PHARMACOL EXP THER, V284, P1058; Dani JA, 2007, ANNU REV PHARMACOL, V47, P699, DOI 10.1146/annurev.pharmtox.47.120505.105214; Decker MW, 2004, CURR TOP MED CHEM, V4, P369, DOI 10.2174/1568026043451447; del Barrio L, 2011, TOXICOL SCI, V123, P193, DOI 10.1093/toxsci/kfr163; Demuro A, 2001, NEUROPHARMACOLOGY, V41, P854, DOI 10.1016/S0028-3908(01)00137-X; Dineley KT, 2015, TRENDS PHARMACOL SCI, V36, P96, DOI 10.1016/j.tips.2014.12.002; Dinklo T, 2011, J PHARMACOL EXP THER, V336, P560, DOI 10.1124/jpet.110.173245; DJURICIC B, 1991, J CEREBR BLOOD F MET, V11, P308, DOI 10.1038/jcbfm.1991.63; Dziewczapolski G, 2009, J NEUROSCI, V29, P8805, DOI 10.1523/JNEUROSCI.6159-08.2009; Egea J, 2007, NEUROSCIENCE, V145, P866, DOI 10.1016/j.neuroscience.2006.12.036; Egea J, 2015, BIOCHEM PHARMACOL, V97, P463, DOI 10.1016/j.bcp.2015.07.032; Ehlert FJ, 2013, PROG MOL BIOL TRANSL, V115, P291, DOI 10.1016/B978-0-12-394587-7.00007-5; Engel O, 2015, STROKE, V46, P3232, DOI 10.1161/STROKEAHA.115.008989; Faghih R, 2009, J MED CHEM, V52, P3377, DOI 10.1021/jm9003818; Fastrez J, 2009, CHEMBIOCHEM, V10, P2824, DOI 10.1002/cbic.200900590; Felix R, 1997, NEUROSCIENCE, V81, P1009, DOI 10.1016/S0306-4522(97)00224-8; Ferchmin PA, 2003, J PHARMACOL EXP THER, V305, P1071, DOI 10.1124/jpet.102.048173; Fernandes C, 2006, GENES BRAIN BEHAV, V5, P433, DOI 10.1111/j.1601-183X.2005.00176.x; FREEDMAN R, 1995, BIOL PSYCHIAT, V38, P22, DOI 10.1016/0006-3223(94)00252-X; Freedman R, 2000, J CHEM NEUROANAT, V20, P299, DOI 10.1016/S0891-0618(00)00109-5; Freitas K, 2013, BRIT J PHARMACOL, V169, P567, DOI 10.1111/j.1476-5381.2012.02226.x; Freitas K, 2013, J PHARMACOL EXP THER, V344, P264, DOI 10.1124/jpet.112.197871; Freitas K, 2013, NEUROPHARMACOLOGY, V65, P156, DOI 10.1016/j.neuropharm.2012.08.022; Friedman SD, 1998, AM J NEURORADIOL, V19, P1879; Fucile S, 2004, CELL CALCIUM, V35, P1, DOI 10.1016/j.ceca.2003.08.006; Fujii S, 2000, NEUROSCI LETT, V286, P134, DOI 10.1016/S0304-3940(00)01076-4; Gasull T, 2000, J BIOL CHEM, V275, P18350, DOI 10.1074/jbc.M910468199; Gatson JW, 2015, BRAIN RES BULL, V112, P35, DOI 10.1016/j.brainresbull.2015.01.008; GERZANICH V, 1995, MOL PHARMACOL, V48, P774; GHONEIM MM, 1977, PSYCHOPHARMACOLOGY, V52, P1, DOI 10.1007/BF00426592; Gonzalez-Cestari TF, 2009, J PHARMACOL EXP THER, V328, P504, DOI 10.1124/jpet.108.144576; Grupe M, 2013, BRIT J PHARMACOL, V168, P2000; Guan YZ, 2015, MOL NEUROBIOL, V51, P1480, DOI 10.1007/s12035-014-8825-3; Guan ZZ, 2000, J NEUROCHEM, V74, P237, DOI 10.1046/j.1471-4159.2000.0740237.x; Gusev AG, 2010, J PHARMACOL EXP THER, V332, P588, DOI 10.1124/jpet.109.162099; Guseva MV, 2008, J NEUROTRAUM, V25, P975, DOI 10.1089/neu.2008.0516; Hao JW, 2011, EXP NEUROL, V227, P110, DOI 10.1016/j.expneurol.2010.09.020; Hardingham GE, 2003, TRENDS NEUROSCI, V26, P81, DOI 10.1016/S0166-2236(02)00040-1; Harris JG, 2004, NEUROPSYCHOPHARMACOL, V29, P1378, DOI 10.1038/sj.npp.1300450; Hays SA, 2013, PROG BRAIN RES, V207, P275, DOI 10.1016/B978-0-444-63327-9.00010-2; Hellstrom-Lindahl E, 1999, MOL BRAIN RES, V66, P94, DOI 10.1016/S0169-328X(99)00030-3; Hernandez CM, 2010, J NEUROSCI, V30, P2442, DOI 10.1523/JNEUROSCI.5038-09.2010; Hogg RC, 2003, REV PHYSIOL BIOCH P, V147, P1, DOI 10.1007/s10254-003-0005-1; Hoyle E, 2006, PSYCHOPHARMACOLOGY, V189, P211, DOI 10.1007/s00213-006-0549-2; Hu M, 2009, BRIT J PHARMACOL, V158, P1857, DOI 10.1111/j.1476-5381.2009.00474.x; Hurst RS, 2005, J NEUROSCI, V25, P4396, DOI 10.1523/JNEUROSCI.5269-04.2005; Jamison RN, 2011, PAIN RES TREAT, V2011, DOI 10.1155/2011/941808; JANOWSKY DS, 1974, PSYCHOSOM MED, V36, P248, DOI 10.1097/00006842-197405000-00008; De Rosa MJ, 2009, LIFE SCI, V85, P444, DOI 10.1016/j.lfs.2009.07.010; Kalappa BI, 2013, EUR J PHARMACOL, V718, P226, DOI 10.1016/j.ejphar.2013.08.027; Kalappa BI, 2013, BRIT J PHARMACOL, V169, P1862, DOI 10.1111/bph.12247; Kalappa BI, 2010, PLOS ONE, V5, DOI 10.1371/journal.pone.0013964; Kaneko S, 1997, BRAIN RES, V765, P135, DOI 10.1016/S0006-8993(97)00556-8; Kawashima K, 2004, FRONT BIOSCI-LANDMRK, V9, P2063, DOI 10.2741/1390; Kawashima K, 2003, LIFE SCI, V74, P675, DOI 10.1016/j.lfs.2003.09.037; Kelso ML, 2012, CURR DRUG TARGETS, V13, P631, DOI 10.2174/138945012800398964; Kenakin T, 2005, NAT REV DRUG DISCOV, V4, P919, DOI 10.1038/nrd1875; Kenakin T, 2007, J RECEPT SIG TRANSD, V27, P247, DOI 10.1080/10799890701509000; Kiewert C, 2010, BRAIN RES, V1312, P101, DOI 10.1016/j.brainres.2009.11.068; Kihara T, 1997, ANN NEUROL, V42, P159, DOI 10.1002/ana.410420205; Kihara T, 2001, J BIOL CHEM, V276, P13541, DOI 10.1074/jbc.M008035200; Kitagawa H, 2003, NEUROPSYCHOPHARMACOL, V28, P542, DOI 10.1038/sj.npp.1300028; Klein J, 1998, NEUROCHEM INT, V32, P479, DOI 10.1016/S0197-0186(97)00127-7; KLEIN J, 1991, J NEUROCHEM, V57, P370, DOI 10.1111/j.1471-4159.1991.tb03762.x; KOIKE T, 1989, P NATL ACAD SCI USA, V86, P6421, DOI 10.1073/pnas.86.16.6421; Koval L, 2011, INT J BIOCHEM CELL B, V43, P516, DOI 10.1016/j.biocel.2010.12.003; Kox M, 2008, NEUROLOGY, V70, P480, DOI 10.1212/01.wnl.0000279479.69502.3e; Lee CH, 2011, BIOCHEM PHARMACOL, V82, P959, DOI 10.1016/j.bcp.2011.06.044; Leiser SC, 2009, PHARMACOL THERAPEUT, V122, P302, DOI 10.1016/j.pharmthera.2009.03.009; Lendvai B, 2013, BRAIN RES BULL, V93, P86, DOI 10.1016/j.brainresbull.2012.11.003; Leonard S, 2000, EUR J PHARMACOL, V393, P237, DOI 10.1016/S0014-2999(00)00035-2; LeonS FE, 1997, J CLIN NEUROPHYSIOL, V14, P144, DOI 10.1097/00004691-199703000-00007; Levin ED, 2006, PSYCHOPHARMACOLOGY, V184, P523, DOI 10.1007/s00213-005-0164-7; Levin ED, 2009, BEHAV BRAIN RES, V196, P207, DOI 10.1016/j.bbr.2008.08.048; Li YX, 2002, J NEUROCHEM, V81, P853, DOI 10.1046/j.1471-4159.2002.00891.x; Li YX, 1999, BRAIN RES, V830, P218, DOI 10.1016/S0006-8993(99)01372-4; Liu Y, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-98; Lo EH, 2008, NAT MED, V14, P497, DOI 10.1038/nm1735; LONDON ED, 1989, NEUROCHEM RES, V14, P745, DOI 10.1007/BF00964952; Lopez-Hernandez GY, 2009, NEUROPHARMACOLOGY, V56, P821, DOI 10.1016/j.neuropharm.2009.01.011; Martelli D, 2014, AUTON NEUROSCI-BASIC, V182, P65, DOI 10.1016/j.autneu.2013.12.007; Martin LF, 2007, INT REV NEUROBIOL, V78, P225, DOI 10.1016/S0074-7742(06)78008-4; Marubio LM, 1999, NATURE, V398, P805, DOI 10.1038/19756; Mathew SV, 2007, HUM MOL GENET, V16, P2921, DOI 10.1093/hmg/ddm253; McGaughy J, 1999, PSYCHOPHARMACOLOGY, V144, P175, DOI 10.1007/s002130050991; MCGEHEE DS, 1995, ANNU REV PHYSIOL, V57, P521, DOI 10.1146/annurev.ph.57.030195.002513; McLean SL, 2012, J PSYCHOPHARMACOL, V26, P1265, DOI 10.1177/0269881111431747; McLean SL, 2011, EUR NEUROPSYCHOPHARM, V21, P333, DOI 10.1016/j.euroneuro.2010.06.003; McNicol ED, 2013, COCHRANE DB SYST REV, DOI 10.1002/14651858.CD006146.pub2; Medeiros R, 2014, AM J PATHOL, V184, P520, DOI 10.1016/j.ajpath.2013.10.010; Meisel C, 2005, NAT REV NEUROSCI, V6, P775, DOI 10.1038/nrn1765; Meyer EM, 1997, BRAIN RES, V768, P49, DOI 10.1016/S0006-8993(97)00536-2; Meyer EM, 1998, J PHARMACOL EXP THER, V284, P1026; Meyer EM, 1998, BRAIN RES, V786, P252, DOI 10.1016/S0006-8993(97)00300-4; Mineur YS, 2013, P NATL ACAD SCI USA, V110, P3573, DOI 10.1073/pnas.1219731110; Mohler EG, 2010, PHARMACOL BIOCHEM BE, V95, P146, DOI 10.1016/j.pbb.2009.12.019; MUIR JL, 1993, BEHAV BRAIN RES, V57, P123, DOI 10.1016/0166-4328(93)90128-D; MUIR JL, 1994, J NEUROSCI, V14, P2313; Munro G, 2012, BRIT J PHARMACOL, V167, P421, DOI 10.1111/j.1476-5381.2012.02003.x; Neese SL, 2007, BRAIN RES, V1128, P157, DOI 10.1016/j.brainres.2006.09.073; Neren D, 2015, NEUROCRIT CARE; NEWHOUSE PA, 1992, PSYCHOPHARMACOLOGY, V108, P480, DOI 10.1007/BF02247425; Newhouse PA, 2004, CURR OPIN PHARMACOL, V4, P36, DOI 10.1016/j.coph.2003.11.001; Nordberg A, 2001, BIOL PSYCHIAT, V49, P200, DOI 10.1016/S0006-3223(00)01125-2; NORDBERG A, 1986, NEUROSCI LETT, V72, P115, DOI 10.1016/0304-3940(86)90629-4; NUTTER TJ, 1995, J GEN PHYSIOL, V105, P701, DOI 10.1085/jgp.105.6.701; Olincy A, 2007, BIOCHEM PHARMACOL, V74, P1192, DOI 10.1016/j.bcp.2007.07.015; Olincy A, 2006, ARCH GEN PSYCHIAT, V63, P630, DOI 10.1001/archpsyc.63.6.630; Olofsson PS, 2012, MOL MED, V18, P539, DOI 10.2119/molmed.2011.00405; Pandya AA, 2013, BIOCHEM PHARMACOL, V86, P1054, DOI 10.1016/j.bcp.2013.05.018; Panjkovich A, 2010, BMC STRUCT BIOL, V10, DOI 10.1186/1472-6807-10-9; Papadia S, 2007, NEUROSCIENTIST, V13, P572, DOI 10.1177/1073858407305833; Papke RL, 1996, NEUROSCI LETT, V213, P201; Papke RL, 2002, BRIT J PHARMACOL, V137, P49, DOI 10.1038/sj.bjp.0704833; Parada E, 2013, ANTIOXID REDOX SIGN, V19, P1135, DOI 10.1089/ars.2012.4671; Pavlov VA, 2005, BRAIN BEHAV IMMUN, V19, P493, DOI 10.1016/j.bbi.2005.03.015; Pavlov VA, 2015, IMMUNOL RES, V63, P38, DOI 10.1007/s12026-015-8718-1; PERRY EK, 1995, NEUROSCIENCE, V64, P385, DOI 10.1016/0306-4522(94)00410-7; PETERSEN RC, 1977, PSYCHOPHARMACOLOGY, V52, P283, DOI 10.1007/BF00426713; Pichat P, 2007, NEUROPSYCHOPHARMACOL, V32, P17, DOI 10.1038/sj.npp.1301188; Prada I, 2013, GLIA, V61, P1003, DOI 10.1002/glia.22497; Preskorn SH, 2014, J PSYCHIATR PRACT, V20, P12, DOI 10.1097/01.pra.0000442935.15833.c5; Prickaerts J, 2012, NEUROPHARMACOLOGY, V62, P1099, DOI 10.1016/j.neuropharm.2011.10.024; QIAN CG, 1993, EUR J PHARMACOL, V250, pR13; Quik M, 2015, BIOCHEM PHARMACOL, V97, P399, DOI 10.1016/j.bcp.2015.06.014; Rao AM, 2000, J NEUROCHEM, V75, P2528, DOI 10.1046/j.1471-4159.2000.0752528.x; Razani-Boroujerdi S, 2004, CELL IMMUNOL, V230, P1, DOI 10.1016/j.cellimm.2004.07.007; Ren K, 2007, NEUROSCIENCE, V148, P230, DOI 10.1016/j.neuroscience.2007.05.013; Ren K, 2007, NEUROSCIENCE, V145, P314, DOI 10.1016/j.neuroscience.2006.11.023; Rode F, 2012, BRAIN RES, V1458, P67, DOI 10.1016/j.brainres.2012.03.064; Role LW, 1996, NEURON, V16, P1077, DOI 10.1016/S0896-6273(00)80134-8; Roncarati R, 2009, J PHARMACOL EXP THER, V329, P459, DOI 10.1124/jpet.108.150094; Rowbotham MC, 2009, PAIN, V146, P245, DOI 10.1016/j.pain.2009.06.013; RUPNIAK NMJ, 1994, BRIT J PHARMACOL, V113, P1487, DOI 10.1111/j.1476-5381.1994.tb17164.x; SANDS SB, 1993, BIOPHYS J, V65, P2614, DOI 10.1016/S0006-3495(93)81296-7; Saricicek A, 2012, AM J PSYCHIAT, V169, P851, DOI 10.1176/appi.ajp.2012.11101546; Sarter M, 2005, NAT REV NEUROSCI, V6, P48, DOI 10.1038/nrn1588; Schwartz TW, 2006, J RECEPT SIG TRANSD, V26, P107, DOI 10.1080/10799890600567570; SCREMIN OU, 1991, STROKE, V22, P643, DOI 10.1161/01.STR.22.5.643; SEGUELA P, 1993, J NEUROSCI, V13, P596; Sharma G, 2001, P NATL ACAD SCI USA, V98, P4148, DOI 10.1073/pnas.071540198; Shaw S, 2002, J BIOL CHEM, V277, P44920, DOI 10.1074/jbc.M204610200; Shen JX, 2012, J MOL NEUROSCI, V48, P14, DOI 10.1007/s12031-012-9719-3; Shimohama S, 1998, BRAIN RES, V779, P359, DOI 10.1016/S0006-8993(97)00194-7; SHIMOHAMA S, 1986, J NEUROCHEM, V46, P288, DOI 10.1111/j.1471-4159.1986.tb12960.x; Shimohama S, 2001, BIOL PSYCHIAT, V49, P233, DOI 10.1016/S0006-3223(00)01100-8; Shimohama S, 2009, BIOL PHARM BULL, V32, P332, DOI 10.1248/bpb.32.332; Shytle RD, 2004, J NEUROCHEM, V89, P337, DOI 10.1046/j.1471-4159.2004.02347.x; Shytle RD, 2002, MOL PSYCHIATR, V7, P525, DOI 10.1038/sj.mp.4001035; Si ML, 2002, CIRC RES, V91, P62, DOI 10.1161/01.RES.0000024417.79275.23; Si ML, 2001, J PHARMACOL EXP THER, V298, P122; SPANDE TF, 1992, J AM CHEM SOC, V114, P3475, DOI 10.1021/ja00035a048; St Peters M, 2011, J NEUROSCI, V31, P9760, DOI 10.1523/JNEUROSCI.1902-11.2011; Stevens KE, 1996, NEUROPSYCHOPHARMACOL, V15, P152, DOI 10.1016/0893-133X(95)00178-G; SULLIVAN JP, 1994, J PHARMACOL EXP THER, V271, P624; Sun F, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0073581; SUNDERLAND T, 1986, PROG NEURO-PSYCHOPH, V10, P599, DOI 10.1016/0278-5846(86)90030-8; Takada-Takatori Y, 2009, BIOL PHARM BULL, V32, P318, DOI 10.1248/bpb.32.318; Takeuchi H, 2009, J NEUROSCI RES, V87, P576, DOI 10.1002/jnr.21869; Tatsumi R, 2006, J MED CHEM, V49, P4374, DOI 10.1021/jm060249c; Teaktong T, 2003, GLIA, V41, P207, DOI 10.1002/glia.10132; Thomsen MS, 2012, J NEUROIMMUNOL, V251, P65, DOI 10.1016/j.jneuroim.2012.07.006; Thomsen MS, 2010, CURR PHARM DESIGN, V16, P323, DOI 10.2174/138161210790170094; Timmermann DB, 2012, BRIT J PHARMACOL, V167, P164, DOI 10.1111/j.1476-5381.2012.01989.x; Timmermann DB, 2007, J PHARMACOL EXP THER, V323, P294, DOI 10.1124/jpet.107.120436; Tischkau S, 2014, NEUROSCI LETT, V563, P107, DOI 10.1016/j.neulet.2014.01.047; Tracey KJ, 2009, NAT REV IMMUNOL, V9, P418, DOI 10.1038/nri2566; Tracey KJ, 2002, NATURE, V420, P853, DOI 10.1038/nature01321; Umana IC, 2013, BIOCHEM PHARMACOL, V86, P1208, DOI 10.1016/j.bcp.2013.08.001; Uteshev V, 2016, J NEUROCHEM, V136, P217, DOI 10.1111/jnc.13236; Uteshev VV, 2014, EUR J PHARMACOL, V727, P181, DOI 10.1016/j.ejphar.2014.01.072; Uteshev VV, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0032951; Uteshev VV, 2012, ADV EXP MED BIOL, V740, P603, DOI 10.1007/978-94-007-2888-2_27; Uteshev VV, 2010, ACTA BIOCH BIOPH SIN, V42, P8, DOI 10.1093/abbs/gmp101; Uteshev VV, 2003, J NEUROPHYSIOL, V89, P1797, DOI 10.1152/jn.00943.2002; Uteshev VV, 2002, BRAIN RES, V948, P33, DOI 10.1016/S0006-8993(02)02946-3; Vaillant AR, 1999, J CELL BIOL, V146, P955, DOI 10.1083/jcb.146.5.955; Valant C, 2012, MOL PHARMACOL, V81, P41, DOI 10.1124/mol.111.074872; van der Zanden EP, 2009, GASTROENTEROLOGY, V137, P1029, DOI 10.1053/j.gastro.2009.04.057; van Goethem NP, 2015, BEHAV PHARMACOL, V26, P403, DOI 10.1097/FBP.0000000000000134; van Kampen M, 2004, PSYCHOPHARMACOLOGY, V172, P375, DOI 10.1007/s00213-003-1668-7; Verbois SL, 2000, J NEUROTRAUM, V17, P1001, DOI 10.1089/neu.2000.17.1001; Verbois SL, 2002, J NEUROTRAUM, V19, P1569, DOI 10.1089/089771502762300238; Verbois SL, 2003, NEUROSCIENCE, V119, P1199, DOI 10.1016/S0306-4522(03)00206-9; VERNINO S, 1992, NEURON, V8, P127, DOI 10.1016/0896-6273(92)90114-S; Vida G, 2011, J IMMUNOL, V186, P4340, DOI 10.4049/jimmunol.1003722; Wallace TL, 2013, BIOCHEM PHARMACOL, V85, P1713, DOI 10.1016/j.bcp.2013.04.001; Wallace TL, 2013, EXPERT OPIN THER TAR, V17, P139, DOI 10.1517/14728222.2013.736498; Wallace TL, 2011, J PHARMACOL EXP THER, V336, P242, DOI 10.1124/jpet.110.171892; Wang H, 2003, NATURE, V421, P384, DOI 10.1038/nature01339; Wang Y, 2005, NEUROSCIENCE, V132, P49, DOI 10.1016/j.neuroscience.2004.12.026; White SH, 2012, J NEUROPHYSIOL, V107, P2083, DOI 10.1152/jn.00701.2011; Whiteaker P, 1999, EUR J NEUROSCI, V11, P2689, DOI 10.1046/j.1460-9568.1999.00685.x; Williams DK, 2011, MOL PHARMACOL, V80, P1013, DOI 10.1124/mol.111.074302; Williams DK, 2011, BIOCHEM PHARMACOL, V82, P915, DOI 10.1016/j.bcp.2011.05.001; Wishka DG, 2006, J MED CHEM, V49, P4425, DOI 10.1021/jm0602413; Woodruff-Pak DS, 2000, EXP AGING RES, V26, P323, DOI 10.1080/036107300750015723; Woodruff-Pak DS, 2003, BEHAV BRAIN RES, V143, P159, DOI 10.1016/S0166-4328(03)00039-1; WOODRUFFPAK DS, 1994, BRAIN RES, V645, P309, DOI 10.1016/0006-8993(94)91665-9; Wootten D, 2013, NAT REV DRUG DISCOV, V12, P630, DOI 10.1038/nrd4052; Yang JS, 2012, PLOS COMPUT BIOL, V8, DOI 10.1371/journal.pcbi.1002612; Young JW, 2007, EUR NEUROPSYCHOPHARM, V17, P145, DOI 10.1016/j.euroneuro.2006.03.008; Zhu CZ, 2011, BIOCHEM PHARMACOL, V82, P967, DOI 10.1016/j.bcp.2011.05.007; Zurkovsky L, 2013, BIOCHEM PHARMACOL, V86, P1133, DOI 10.1016/j.bcp.2013.07.032	255	15	15	2	19	BENTHAM SCIENCE PUBL LTD	SHARJAH	EXECUTIVE STE Y-2, PO BOX 7917, SAIF ZONE, 1200 BR SHARJAH, U ARAB EMIRATES	1381-6128	1873-4286		CURR PHARM DESIGN	Curr. Pharm. Design		2016	22	14					1986	1997		10.2174/1381612822666160201115341			12	Pharmacology & Pharmacy	Science Citation Index Expanded (SCI-EXPANDED)	Pharmacology & Pharmacy	DK7ZV	WOS:000375146900003	26831463				2022-02-06	
J	Yan, H; Feng, YQ; Wang, Q				Yan, Hao; Feng, Yanqin; Wang, Qian			Altered Effective Connectivity of Hippocampus-Dependent Episodic Memory Network in mTBI Survivors	NEURAL PLASTICITY			English	Article							TRAUMATIC BRAIN-INJURY; MEDIAL TEMPORAL-LOBE; DEFAULT MODE NETWORK; COGNITIVE NEUROSCIENCE; ATROPHY; BINDING; FUTURE; INFORMATION; RECOGNITION; RETRIEVAL	Traumatic brain injuries (TBIs) are generally recognized to affect episodic memory. However, less is known regarding how external force altered the way functionally connected brain structures of the episodic memory system interact. To address this issue, we adopted an effective connectivity based analysis, namely, multivariate Granger causality approach, to explore causal interactions within the brain network of interest. Results presented that TBI induced increased bilateral and decreased ipsilateral effective connectivity in the episodic memory network in comparison with that of normal controls. Moreover, the left anterior superior temporal gyrus (aSTG, the concept forming hub), left hippocampus (the personal experience binding hub), and left parahippocampal gyrus (the contextual association hub) were no longer network hubs in TBI survivors, who compensated for hippocampal deficits by relying more on the right hippocampus (underlying perceptual memory) and the right medial frontal gyrus (MeFG) in the anterior prefrontal cortex (PFC). We postulated that the overrecruitment of the right anterior PFC caused dysfunction of the strategic component of episodic memory, which caused deteriorating episodic memory in mTBI survivors. Our findings also suggested that the pattern of brain network changes in TBI survivors presented similar functional consequences to normal aging.	[Yan, Hao] Shenzhen Univ, Sch Biomed Engn, Neuroimaging Lab, Hlth Sci Ctr, Shenzhen 518060, Peoples R China; [Yan, Hao] Shenzhen Univ, Coll Optoelect Engn, Minist Educ & Guangdong Prov, Key Lab Optoelect Devices & Syst, Shenzhen 518060, Peoples R China; [Yan, Hao; Feng, Yanqin] Xidian Univ, Dept Linguist, Xian 710071, Peoples R China; [Yan, Hao; Feng, Yanqin] Xidian Univ, Dept Psychol, Xian 710071, Peoples R China; [Wang, Qian] Northwestern Polytech Univ, Sch Foreign Languages, Xian 710029, Peoples R China		Yan, H (corresponding author), Shenzhen Univ, Sch Biomed Engn, Neuroimaging Lab, Hlth Sci Ctr, Shenzhen 518060, Peoples R China.; Yan, H (corresponding author), Shenzhen Univ, Coll Optoelect Engn, Minist Educ & Guangdong Prov, Key Lab Optoelect Devices & Syst, Shenzhen 518060, Peoples R China.; Yan, H (corresponding author), Xidian Univ, Dept Linguist, Xian 710071, Peoples R China.; Yan, H (corresponding author), Xidian Univ, Dept Psychol, Xian 710071, Peoples R China.	yanhao@xidian.edu.cn		Yan, Hao/0000-0002-1854-786X	National Natural Science Foundation of ChinaNational Natural Science Foundation of China (NSFC) [31400962, 81371201, 31371026]; China Postdoctoral Science FoundationChina Postdoctoral Science Foundation [2015M582400]; Fundamental Research Funds for the Central UniversitiesFundamental Research Funds for the Central Universities [RW150401]	This paper is supported by the National Natural Science Foundation of China (31400962, 81371201, and 31371026), China Postdoctoral Science Foundation (2015M582400), and the Fundamental Research Funds for the Central Universities (RW150401).	Aminoff EM, 2013, TRENDS COGN SCI, V17, P379, DOI 10.1016/j.tics.2013.06.009; Anderson V A, 1997, J Int Neuropsychol Soc, V3, P568; Anticevic A, 2012, TRENDS COGN SCI, V16, P584, DOI 10.1016/j.tics.2012.10.008; Ariza M, 2006, NEUROPSYCHOLOGIA, V44, P1956, DOI 10.1016/j.neuropsychologia.2005.11.007; Behrendt RP, 2013, FRONT PSYCHOL, V4, DOI 10.3389/fpsyg.2013.00304; Bigler ED, 2007, NEUROPSYCHOLOGY, V21, P515, DOI 10.1037/0894-4105.21.5.515; Biswal BB, 2010, P NATL ACAD SCI USA, V107, P4734, DOI 10.1073/pnas.0911855107; Bullmore ET, 2009, NAT REV NEUROSCI, V10, P186, DOI 10.1038/nrn2575; Cabeza R, 2002, NEUROIMAGE, V17, P1394, DOI 10.1006/nimg.2002.1280; Carbonnel WS, 1999, ACTA NEUROPATHOL, V98, P396, DOI 10.1007/s004010051100; Carlomagno S, 2011, BRAIN INJURY, V25, P1010, DOI 10.3109/02699052.2011.605097; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Chen G., 2009, P INT SOC MAG RESON, V17; Corrigan JD, 2001, CLIN J WOMENS HLTH, V1, P184; Coste C, 2015, NEUROPSYCHOLOGIA, V71, P133, DOI 10.1016/j.neuropsychologia.2015.03.014; Demirci O, 2009, NEUROIMAGE, V46, P419, DOI 10.1016/j.neuroimage.2009.02.014; Deshpande G, 2010, NEUROIMAGE, V52, P884, DOI 10.1016/j.neuroimage.2009.11.060; Diana RA, 2007, TRENDS COGN SCI, V11, P379, DOI 10.1016/j.tics.2007.08.001; Dischinger P, 2003, Annu Proc Assoc Adv Automot Med, V47, P577; Eichenbaum H, 2007, ANNU REV NEUROSCI, V30, P123, DOI 10.1146/annurev.neuro.30.051606.094328; Eustache F, 2016, NEUROPSYCHOLOGIA, V87, P96, DOI 10.1016/j.neuropsychologia.2016.05.006; Friston KJ, 2011, BRAIN CONNECT, V1, P13, DOI 10.1089/brain.2011.0008; Friston KJ, 2009, PLOS BIOL, V7, P220, DOI 10.1371/journal.pbio.1000033; Geddes DM, 2003, EXP NEUROL, V184, P420, DOI 10.1016/S0014-4886(03)00254-1; Gilboa A, 2006, BRAIN, V129, P1399, DOI 10.1093/brain/awl093; Gottlieb LJ, 2012, LEARN MEMORY, V19, P605, DOI 10.1101/lm.027631.112; Grady C, 2012, NAT REV NEUROSCI, V13, P491, DOI 10.1038/nrn3256; Greicius MD, 2003, P NATL ACAD SCI USA, V100, P253, DOI 10.1073/pnas.0135058100; Gutchess AH, 2005, J COGNITIVE NEUROSCI, V17, P84, DOI 10.1162/0898929052880048; Hassabis D, 2007, TRENDS COGN SCI, V11, P299, DOI 10.1016/j.tics.2007.05.001; Hassabis D, 2007, P NATL ACAD SCI USA, V104, P1726, DOI 10.1073/pnas.0610561104; Holmes AP, 1996, J CEREBR BLOOD F MET, V16, P7, DOI 10.1097/00004647-199601000-00002; Jenkinson M, 2002, NEUROIMAGE, V17, P825, DOI 10.1006/nimg.2002.1132; Kessels RPC, 2007, INT J NEUROSCI, V117, P795, DOI 10.1080/00207450600910218; Knight RG, 2009, J CLIN EXP NEUROPSYC, V31, P575, DOI 10.1080/13803390802363710; Laird AR, 2009, J NEUROSCI, V29, P14496, DOI 10.1523/JNEUROSCI.4004-09.2009; Lekeu F, 2002, NEUROPSYCHOLOGIA, V40, P131, DOI 10.1016/S0028-3932(01)00088-4; Leshikar ED, 2010, CORTEX, V46, P507, DOI 10.1016/j.cortex.2009.07.011; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; Liao W, 2011, NEUROIMAGE, V54, P2683, DOI 10.1016/j.neuroimage.2010.11.007; Liu ZY, 2012, NMR BIOMED, V25, P1311, DOI 10.1002/nbm.2803; Maguire EA, 2013, J EXP PSYCHOL GEN, V142, P1180, DOI 10.1037/a0033650; Marini A, 2011, NEUROPSYCHOLOGIA, V49, P2904, DOI 10.1016/j.neuropsychologia.2011.06.017; Maxwell WL, 2003, J NEUROPATH EXP NEUR, V62, P272, DOI 10.1093/jnen/62.3.272; Morgan VL, 2011, EPILEPSIA, V52, P1741, DOI 10.1111/j.1528-1167.2011.03196.x; Ng K, 2008, ARCH PHYS MED REHAB, V89, pS35, DOI 10.1016/j.apmr.2008.07.006; Nichols TE, 2002, HUM BRAIN MAPP, V15, P1, DOI 10.1002/hbm.1058; OSHAUGHNESSY EJ, 1984, J FAM PRACTICE, V18, P391; Park DC, 2009, ANNU REV PSYCHOL, V60, P173, DOI 10.1146/annurev.psych.59.103006.093656; Park HJ, 2013, SCIENCE, V342, P579, DOI 10.1126/science.1238411; Patterson K, 2007, NAT REV NEUROSCI, V8, P976, DOI 10.1038/nrn2277; Pierce JES, 1998, NEUROSCIENCE, V87, P359, DOI 10.1016/S0306-4522(98)00142-0; Piolino P, 2007, CORTEX, V43, P176, DOI 10.1016/S0010-9452(08)70474-X; Race E, 2011, J NEUROSCI, V31, P10262, DOI 10.1523/JNEUROSCI.1145-11.2011; Ralph M. A. Lambon, 2014, PHILOS T R SOC B, V369; Reuter-Lorenz PA, 2008, CURR DIR PSYCHOL SCI, V17, P177, DOI 10.1111/j.1467-8721.2008.00570.x; Roebroeck A, 2005, NEUROIMAGE, V25, P230, DOI 10.1016/j.neuroimage.2004.11.017; Rogers TT, 2004, PSYCHOL REV, V111, P205, DOI 10.1037/0033-295X.111.1.205; Rosenbaum RS, 2014, ANN NY ACAD SCI, V1316, P105, DOI 10.1111/nyas.12467; Rubin DC, 2015, PSYCHOL REV, V122, P1, DOI 10.1037/a0037907; Schacter DL, 2007, NAT REV NEUROSCI, V8, P657, DOI 10.1038/nrn2213; Shapira-Lichter I, 2013, P NATL ACAD SCI USA, V110, P4950, DOI 10.1073/pnas.1209888110; Smith SM, 2011, NEUROIMAGE, V54, P875, DOI 10.1016/j.neuroimage.2010.08.063; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Sporns O, 2014, NAT NEUROSCI, V17, P652, DOI 10.1038/nn.3690; Squire LR, 2010, P NATL ACAD SCI USA, V107, P19044, DOI 10.1073/pnas.1014391107; Squire LR, 2004, ANNU REV NEUROSCI, V27, P279, DOI 10.1146/annurev.neuro.27.070203.144130; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; St-Laurent M, 2016, CORTEX, V84, P15, DOI 10.1016/j.cortex.2016.08.010; Stevens MC, 2009, HUM BRAIN MAPP, V30, P2356, DOI 10.1002/hbm.20673; Stilla R, 2007, J NEUROSCI, V27, P11091, DOI 10.1523/JNEUROSCI.1808-07.2007; Tagliaferri F, 2006, ACTA NEUROCHIR, V148, P255, DOI 10.1007/s00701-005-0651-y; Talati A, 2005, J COGNITIVE NEUROSCI, V17, P981, DOI 10.1162/0898929054475226; Tromp D, 2015, AGEING RES REV, V24, P232, DOI 10.1016/j.arr.2015.08.006; Tulving E, 2002, ANNU REV PSYCHOL, V53, P1, DOI 10.1146/annurev.psych.53.100901.135114; TULVING E, 1988, BRAIN COGNITION, V8, P3, DOI 10.1016/0278-2626(88)90035-8; Tulving E, 2001, PHILOS T R SOC B, V356, P1505, DOI 10.1098/rstb.2001.0937; Tulving E., 1983, ELEMENTS EPISODIC ME; Vespa PM, 2010, NEUROLOGY, V75, P792, DOI 10.1212/WNL.0b013e3181f07334; Vincent JL, 2006, J NEUROPHYSIOL, V96, P3517, DOI 10.1152/jn.00048.2006; Warner MA, 2010, ARCH NEUROL-CHICAGO, V67, P1336, DOI 10.1001/archneurol.2010.149; Winocur G, 2010, NEUROPSYCHOLOGIA, V48, P2339, DOI 10.1016/j.neuropsychologia.2010.04.016; Yonelinas AP, 2013, BEHAV BRAIN RES, V254, P34, DOI 10.1016/j.bbr.2013.05.030	84	15	15	2	7	HINDAWI LTD	LONDON	ADAM HOUSE, 3RD FLR, 1 FITZROY SQ, LONDON, W1T 5HF, ENGLAND	2090-5904	1687-5443		NEURAL PLAST	Neural. Plast.		2016	2016								6353845	10.1155/2016/6353845			12	Neurosciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology	EF9VY	WOS:000390680300001	28074162	gold, Green Submitted, Green Published			2022-02-06	
J	Van Beek, L; Vanderauwera, J; Ghesquiere, P; Lagae, L; De Smedt, B				Van Beek, Leen; Vanderauwera, Jolijn; Ghesquiere, Pol; Lagae, Lieven; De Smedt, Bert			Longitudinal changes in mathematical abilities and white matter following paediatric mild traumatic brain injury	BRAIN INJURY			English	Article							WORKING-MEMORY; FUNCTIONAL RECOVERY; INDIVIDUAL-DIFFERENCES; ACADEMIC-ACHIEVEMENT; EXECUTIVE FUNCTIONS; CORPUS-CALLOSUM; YOUNG-CHILDREN; SHORT-TERM; DIFFUSION; OUTCOMES		[Van Beek, Leen; Vanderauwera, Jolijn; Ghesquiere, Pol; De Smedt, Bert] Univ Leuven, Fac Psychol & Educ Sci, Parenting & Special Educ, Leuven, Belgium; [Vanderauwera, Jolijn] Univ Leuven, Dept Neurosci, Res Grp ExpORL, Leuven, Belgium; [Lagae, Lieven] Univ Leuven, Dept Dev & Regenerat, Biomed Sci Grp, Leuven, Belgium		De Smedt, B (corresponding author), Parenting & Special Educ Res Unit, Leopold Vanderkelenstr 32 Box 3765, B-3000 Leuven, Belgium.	bert.desmedt@ppw.kuleuven.be	De Smedt, Bert/G-4729-2010; De Smedt, Bert/U-6124-2019; De Smedt, Bert/Q-7020-2019; Ghesquiere, Pol/B-9226-2009	De Smedt, Bert/0000-0002-3313-3278; De Smedt, Bert/0000-0002-3313-3278; Ghesquiere, Pol/0000-0001-9056-7550	'Research Foundation Flanders' FWOFWO [G.A113.11N]	This research was supported by the 'Research Foundation Flanders' FWO (grant number G.A113.11N). We thank the children and their families for their time and contribution to this study.	Alexander DC, 2010, NEUROIMAGE, V52, P1374, DOI 10.1016/j.neuroimage.2010.05.043; Anderson V, 2002, PRINCIPLES FRONTAL L, P504; Anderson VA, 2006, NEUROPSYCHOLOGY, V20, P42, DOI 10.1037/0894-4105.20.1.42; Arfanakis K, 2002, AM J NEURORADIOL, V23, P794; Babikian T, 2010, J NEUROTRAUM, V27, P473, DOI 10.1089/neu.2009.1058; Beaulieu C, 1998, MAGN RESON IMAGING, V16, P1201, DOI 10.1016/S0730-725X(98)00151-9; BERGERGROSS P, 1985, PERCEPT MOTOR SKILL, V61, P254, DOI 10.2466/pms.1985.61.1.254; Campbell JID, 2001, J EXP PSYCHOL GEN, V130, P299, DOI 10.1037//0096-3445.130.2.299; Carroll LJ, 2004, J REHABIL MED, V36, P113, DOI 10.1080/16501960410023877; Cassidy JD, 2004, J REHABIL MED, V36, P28, DOI 10.1080/16501960410023732; Catale C, 2009, J CLIN EXP NEUROPSYC, V31, P331, DOI 10.1080/13803390802134616; Catani M, 2005, ANN NEUROL, V57, P8, DOI 10.1002/ana.20319; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Catroppa C, 2008, J PEDIATR PSYCHOL, V33, P707, DOI 10.1093/jpepsy/jsn006; Catroppa C, 2012, J NEUROTRAUM, V29, P2539, DOI 10.1089/neu.2012.2403; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Conklin HM, 2008, BRAIN INJURY, V22, P847, DOI 10.1080/02699050802403565; De Smedt B, 2009, J EXP CHILD PSYCHOL, V103, P186, DOI 10.1016/j.jecp.2009.01.004; Dowker A, 2008, DEVELOPMENTAL SCI, V11, P650, DOI 10.1111/j.1467-7687.2008.00713.x; Dudal P., 2000, LEERLINGVOLGSYSTEEM; Ewing-Cobbs L, 1998, J CLIN EXP NEUROPSYC, V20, P769, DOI 10.1076/jcen.20.6.769.1109; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V26, P487, DOI 10.1207/s15326942dn2601_7; Ewing-Cobbs L, 2004, DEV NEUROPSYCHOL, V25, P107, DOI 10.1207/s15326942dn2501&2_7; Gathercole S.E., 2006, WORKING MEMORY ED, P33, DOI DOI 10.1016/B978-012554465-8/50010-7; Gathercole S. E., 2008, WORKING MEMORY LEARN; Gathercole SE, 2004, DEV PSYCHOL, V40, P177, DOI 10.1037/0012-1649.40.2.177; Gathercole SE, 2008, LEARN INDIVID DIFFER, V18, P214, DOI 10.1016/j.lindif.2007.10.003; Hausknecht JP, 2007, J APPL PSYCHOL, V92, P373, DOI 10.1037/0021-9010.92.2.373; Hawley CA, 2003, INJURY, V34, P256, DOI 10.1016/S0020-1383(02)00193-6; Holloway ID, 2009, J EXP CHILD PSYCHOL, V103, P17, DOI 10.1016/j.jecp.2008.04.001; Hubber PJ, 2014, Q J EXP PSYCHOL, V67, P936, DOI 10.1080/17470218.2013.838590; Kay T., 1993, J HEAD TRAUMA REHAB, V8, P86, DOI [10.1097/00001199-199309000-00010, DOI 10.1097/00001199-199309000-00009, DOI 10.1097/00001199-199309000-00010]; Koepsell TD, 2011, PEDIATRICS, V128, P946, DOI 10.1542/peds.2010-2259; Kort W., 2005, WISC 3 NL WECHSLER I; Lebel C, 2008, NEUROIMAGE, V40, P1044, DOI 10.1016/j.neuroimage.2007.12.053; Lebel C, 2011, J NEUROSCI, V31, P10937, DOI 10.1523/JNEUROSCI.5302-10.2011; Leemans A., 2009, P 17 SCI M INT SOC M, V17, P3537; LeFevre J, 1996, J EXP PSYCHOL LEARN, V22, P216, DOI 10.1037/0278-7393.22.1.216; Levin HS, 2004, NEUROPSYCHOLOGY, V18, P240, DOI 10.1037/0894-4105.18.2.240; Levin HS, 2002, ANN NEUROL, V52, P82, DOI 10.1002/ana.10252; Ling JM, 2012, BRAIN, V135, P1281, DOI 10.1093/brain/aws073; Loher S, 2014, APPL NEUROPSYCH-CHIL, V3, P103, DOI 10.1080/21622965.2012.716752; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Matejko AA, 2015, NEUROSCI BIOBEHAV R, V48, P35, DOI 10.1016/j.neubiorev.2014.11.006; Maugans TA, 2012, PEDIATRICS, V129, P28, DOI 10.1542/peds.2011-2083; Mayer AR, 2010, NEUROLOGY, V74, P643, DOI 10.1212/WNL.0b013e3181d0ccdd; Mayer AR, 2012, J NEUROSCI, V32, P17961, DOI 10.1523/JNEUROSCI.3379-12.2012; McCaffrey RJ, 1995, NEUROPSYCHOL REV, V5, P203, DOI 10.1007/BF02214762; Muscara F, 2008, DEV NEUROPSYCHOL, V33, P623, DOI 10.1080/87565640802171162; Nadebaum C, 2007, DEV NEUROPSYCHOL, V32, P703, DOI 10.1080/87565640701376086; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; OLDFIELD RC, 1971, NEUROPSYCHOLOGIA, V9, P97, DOI 10.1016/0028-3932(71)90067-4; Papoutsis J, 2014, DEV NEUROPSYCHOL, V39, P638, DOI 10.1080/87565641.2014.979926; Pickering S., 2001, WORKING MEMORY BATTE; Raghubar KP, 2010, LEARN INDIVID DIFFER, V20, P110, DOI 10.1016/j.lindif.2009.10.005; Rieger BP, 2013, BRAIN INJURY, V27, P169, DOI 10.3109/02699052.2012.729290; Rutland-Brown W, 2006, J HEAD TRAUMA REHAB, V21, P544, DOI 10.1097/00001199-200611000-00009; Sattler J.M., 2001, ASSESSMENT CHILDREN; Scherwath A, 2011, BRAIN INJURY, V25, P401, DOI 10.3109/02699052.2011.557351; Sesma HW, 2008, PEDIATRICS, V121, pE1686, DOI 10.1542/peds.2007-2461; Slater E.J., 1989, J ADOLESCENT RES, V4, P371; Stikov N, 2011, NEUROIMAGE, V54, P1112, DOI 10.1016/j.neuroimage.2010.08.068; Suskauer SJ, 2009, DEV DISABIL RES REV, V15, P117, DOI 10.1002/ddrr.62; Taylor HG, 2002, NEUROPSYCHOLOGY, V16, P15, DOI 10.1037//0894-4105.16.1.15; THOMPSON NM, 1994, NEUROPSYCHOLOGY, V8, P333, DOI DOI 10.1037/0894-4105.8.3.333; Todd JA, 1996, NEUROPSYCHOL REHABIL, V6, P81, DOI 10.1080/713755500; Treble A, 2013, J NEUROTRAUM, V30, P1609, DOI 10.1089/neu.2013.2934; Trick LM, 2008, PERCEPT PSYCHOPHYS, V70, P743, DOI 10.3758/PP.70.5.743; Van Beek L, 2015, J NEUROTRAUM, V32, P1567, DOI 10.1089/neu.2014.3809; Wakana S, 2007, NEUROIMAGE, V36, P630, DOI 10.1016/j.neuroimage.2007.02.049; Wang R., 2007, P INT SOC MAG RESON, V15, P3720; Wheeler-Kingshott CAM, 2009, MAGN RESON MED, V61, P1255, DOI 10.1002/mrm.21965; Whittall KP, 1997, MAGNET RESON MED, V37, P34, DOI 10.1002/mrm.1910370107; Wilde EA, 2008, NEUROLOGY, V70, P948, DOI 10.1212/01.wnl.0000305961.68029.54; Wu TC, 2010, DEV NEUROSCI-BASEL, V32, P361, DOI 10.1159/000317058; Wu TC, 2010, J NEUROTRAUM, V27, P303, DOI 10.1089/neu.2009.1110; Yeates KO, 2000, SCI PRACT NEUROPSYCH, P92; Yeates KO, 2003, HDB REY OSTERRIETH C, P83	78	15	15	1	15	TAYLOR & FRANCIS LTD	ABINGDON	2-4 PARK SQUARE, MILTON PARK, ABINGDON OR14 4RN, OXON, ENGLAND	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	DEC 6	2015	29	13-14					1701	1710		10.3109/02699052.2015.1075172			10	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CY8LL	WOS:000366659800023	26479021				2022-02-06	
J	Gavaskar, AS; Tummala, NC				Gavaskar, Ashok S.; Tummala, Naveen C.			Ganz Surgical Dislocation of the Hip Is a Safe Technique for Operative Treatment of Pipkin Fractures. Results of a Prospective Trial	JOURNAL OF ORTHOPAEDIC TRAUMA			English	Article						femoral head fracture; hip dislocation; pipkin; surgical dislocation; Ganz	FEMORAL-HEAD	Objectives:The primary objective was to study the incidence of femoral head osteonecrosis after Ganz approach for Pipkin fracture dislocations. Clinico-radiological and functional outcomes were also studied.Design:Prospective, nonrandomised.Setting:Tertiary care trauma center.Patients:Twenty-eight patients with type I/II Pipkin fracture dislocation reduced within 6 hours of injury.Intervention:The displaced head fracture was addressed through safe surgical dislocation after urgent closed reduction of the hip.Outcome Measurements:Incidence of osteonecrosis using radiographs and functional outcome using modified Merle d'Aubigne and Oxford scores were studied.Results:Twenty-six fractures were fixed, and 2 type I fractures were excised. Twenty-six of 28 patients were followed up for a mean of 36 months. There was no osteonecrosis. All fractures and osteotomies had united. The mean modified Merle d'Aubigne score was 16.5 (14-18), and the mean Oxford score was 42.65 (38-48).Conclusions:Safe surgical dislocation provides satisfactory results in Pipkin fracture dislocations. The incidence of osteonecrosis is not increased in patients undergoing early joint reduction.Level of Evidence:Therapeutic Level IV. See Instructions for Authors for a complete description of levels of evidence.	[Gavaskar, Ashok S.] Parvathy Hosp, Dept Orthoped & Trauma, Hip Unit, Madras 600094, Tamil Nadu, India; [Tummala, Naveen C.] Dhruv Clin, Madras, Tamil Nadu, India		Gavaskar, AS (corresponding author), Parvathy Hosp, Dept Orthoped & Trauma, Hip Unit, 63A-44 Gandhi Rd, Madras 600094, Tamil Nadu, India.	gavaskar.ortho@gmail.com					BUTLER JE, 1981, J BONE JOINT SURG AM, V63, P1292, DOI 10.2106/00004623-198163080-00011; Chen ZW, 2011, INT ORTHOP, V35, P1077, DOI 10.1007/s00264-010-1087-4; EPSTEIN HC, 1985, CLIN ORTHOP RELAT R, P9; Ganz R, 2001, J BONE JOINT SURG BR, V83B, P1119, DOI 10.1302/0301-620X.83B8.11964; Gardner MJ, 2005, J ORTHOP TRAUMA, V19, P334; Gautier E, 2000, J BONE JOINT SURG BR, V82B, P679, DOI 10.1302/0301-620X.82B5.10426; Henle P, 2007, INJURY, V38, P478, DOI 10.1016/j.injury.2007.01.023; HOUGAARD K, 1988, J BONE JOINT SURG AM, V70A, P233, DOI 10.2106/00004623-198870020-00011; Kloen P., 2002, EUR J TRAUMA EMERG S, V28, P221, DOI [10.1007/s00068-002-1173-4, DOI 10.1007/S00068-002-1173-4]; Konrath GA, 1999, J ORTHOP TRAUMA, V13, P407, DOI 10.1097/00005131-199908000-00003; McMurtry IA, 2001, INJURY, V32, P162, DOI 10.1016/S0020-1383(00)00152-2; ROEDER LF, 1980, CLIN ORTHOP RELAT R, P121; Ross JR, 2012, CURR REV MUSCULOSKE, V5, P199, DOI 10.1007/s12178-012-9129-8; Sahin V, 2003, J TRAUMA, V54, P520, DOI 10.1097/01.TA.0000020394.32496.52; Solberg BD, 2009, CLIN ORTHOP RELAT R, V467, P929, DOI 10.1007/s11999-008-0505-z; Stannard JP, 2000, CLIN ORTHOP RELAT R, P44; Swiontkowski M F, 1992, J Orthop Trauma, V6, P437, DOI 10.1097/00005131-199212000-00008	17	15	19	1	5	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0890-5339	1531-2291		J ORTHOP TRAUMA	J. Orthop. Trauma	DEC	2015	29	12					544	548		10.1097/BOT.0000000000000399			5	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	CX2FC	WOS:000365510200004	26595593				2022-02-06	
J	Lehre, MA; Eriksen, LM; Tirsit, A; Bekele, S; Petros, S; Park, KB; Bothun, ML; Wester, K				Lehre, Martin Andreas; Eriksen, Lars Magnus; Tirsit, Abenezer; Bekele, Segni; Petros, Saba; Park, Kee B.; Bothun, Marianne Lundervik; Wester, Knut			Outcome in patients undergoing surgery for spinal injury in an Ethiopian hospital	JOURNAL OF NEUROSURGERY-SPINE			English	Article						developing countries; Eastern Africa; neurotrauma; traumatic spinal cord injury; spinal instrumentation; surgery	CORD-INJURY; DEVELOPING-COUNTRIES; EPIDEMIOLOGY	OBJECT The objective of this study was to investigate epidemiology and outcome after surgical treatment for spinal injuries in Ethiopia. METHODS Medical records of patients who underwent surgery for spine injuries at Myungsung Christian Medical Center in Addis Ababa, Ethiopia, between January 2008 and September 2012 were reviewed retrospectively. Assessment of outcome and complications was determined froth patient consultations and phone interviews. RESULTS A total of 146 patients were included (129 males, 17 females). Their mean age was 31.7 years (range 15-81 years). The leading cause of injury was motor vehicle accidents (54.1%), and this was followed by falls (26.7%). The most common injury sites were lumbar (41.1%) and cervical (34.2%) regions of the spine. In 21.2% of patients, no.neurological deficit was present before surgery, 46.6% had incomplete spinal cord injury (American Spinal Injury Association [ASIA] Impairment Scale [AIS] Grade B D), and 32.2% had complete spinal cord injury (AIS Grade A). Follow-up was hampered by suboptimal infrastructure, but information regarding outcome was successfully obtained for 110 patients (75.3%). At follow-up (mean 22.9 months; range 2-57 months), 25 patients (17.1%) were confirmed dead and 85 patients (58.2%) were alive; 49 patients (33.6%) und'erwent physical examination. At least 8 of the 47 patients (17.0%) with a complete injury and 29 of the 68 patients (42.6%) with an incomplete injury showed neurological improvement. The reported incidences of pressure wounds, recurrent urinary tract infections, pneumonia, and thromboembolic events were 22.5%, 13.5%, 5.6%, and 1.1%, respectively. CONCLUSIONS Patients showed surprisingly good recovery considering the limited resources. Surgical treatment for spine injuries in Ethiopia is considered beneficial.	[Lehre, Martin Andreas; Eriksen, Lars Magnus; Bothun, Marianne Lundervik; Wester, Knut] Univ Bergen, Dept Clin Med K1, Bergen, Norway; [Bothun, Marianne Lundervik; Wester, Knut] Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway; [Tirsit, Abenezer] Univ Addis Ababa, Dept Surg, Neurosurg Unit, Addis Ababa, Ethiopia; [Bekele, Segni] Myungsung Christian Med Ctr, Addis Ababa, Ethiopia; [Petros, Saba] Yekatit 12 Hosp, Addis Ababa, Ethiopia; [Park, Kee B.] Preah Kossamak Hosp, Dept Neurosurg, Phnom Penh, Cambodia		Wester, K (corresponding author), Haukeland Hosp, Dept Neurosurg, N-5021 Bergen, Norway.	kgwe@helse-bergen.no					Abebe M, 2011, E CENTRAL AFR J SURG, V16, P2073; Ackery A, 2004, J NEUROTRAUM, V21, P1355, DOI 10.1089/neu.2004.21.1355; Aung TS, 1997, SPINAL CORD, V35, P147, DOI 10.1038/sj.sc.3100375; Brasil AVB, 1998, SPINAL CORD, V36, P353, DOI 10.1038/sj.sc.3100630; Burns AS, 2012, J SPINAL CORD MED, V35, P3, DOI 10.1179/2045772311Y.0000000043; Chiu WT, 2010, ASIA-PAC J PUBLIC HE, V22, P9, DOI 10.1177/1010539509355470; Cripps RA, 2011, SPINAL CORD, V49, P493, DOI 10.1038/sc.2010.146; Feng HY, 2011, J SPINAL CORD MED, V34, P388, DOI 10.1179/2045772311Y.0000000017; Gosselin RA, 2005, INT ORTHOP, V29, P330, DOI 10.1007/s00264-005-0665-3; Guserova J, 2013, COLLECTION SCI PAPER; Hagen EM, 2013, NEUROEPIDEMIOLOGY, V41, P86, DOI 10.1159/000351497; Haran MJ, 2005, ARCH PHYS MED REHAB, V86, P2290, DOI 10.1016/j.apmr.2005.07.293; Leduc BE, 2002, DISABIL REHABIL, V24, P196, DOI 10.1080/09638280110067603; Levy LF, 1998, SPINAL CORD, V36, P213, DOI 10.1038/sj.sc.3100574; Pagliacci MC, 2003, ARCH PHYS MED REHAB, V84, P1266, DOI 10.1016/S0003-9993(03)00234-X; Rahimi-Movaghar V, 2013, NEUROEPIDEMIOLOGY, V41, P65, DOI 10.1159/000350710; Roberts B, 2008, HEALTH QUAL LIFE OUT, V6, DOI 10.1186/1477-7525-6-108; Ware J., 2001, SCORE INTERPRET SING	18	15	15	0	4	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	1547-5654	1547-5646		J NEUROSURG-SPINE	J. Neurosurg.-Spine	DEC	2015	23	6					772	779		10.3171/2015.3.SPINE141282			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CX0FI	WOS:000365371900013	26340379	Bronze			2022-02-06	
J	Milleville-Pennel, I; Charron, C				Milleville-Pennel, Isabelle; Charron, Camilo			Driving for Real or on a Fixed-Base Simulator: Is It so Different? An Explorative Study	PRESENCE-VIRTUAL AND AUGMENTED REALITY			English	Article							TRAUMATIC BRAIN-INJURY; ON-ROAD; VIRTUAL ENVIRONMENTS; WORKLOAD; DRIVERS; PERFORMANCE; CONCURRENT; BEHAVIOR	The use of driving simulators to assess driving abilities is often controversial because of their artificiality. Our aim is thus to tackle this question by estimating and comparing new indicators such as the mental workload, the psychological feeling (e.g., stress, anxiety, pleasure, and mastery), and feeling of presence when driving a simulator and a real vehicle (either one's own or one that belongs to a driving school). We are most interested in a particular sort of real-world driving: the driving school. This situation has two advantages: It matches our own particular interest in the evaluation of driving abilities and, to some extent, it is as artificial as driving in a simulator. Fourteen expert drivers participated in this study. Each driver was invited to complete two questionnaires (i.e., the NASA-TLX and Questionnaire of Psychological Feeling) that relate to the various driving conditions (i.e., simulator, driving school vehicle, and personal vehicle). The heart rate of drivers was also recorded at rest and during some of the driving conditions. Our results indicate that the feeling of presence was, for some of its component parts, identical in both the simulator and in a real car. Moreover, in both the simulator and real car, none of the assessments of presence revealed values that were close to 100%; indeed, sometimes they were considerably lower. This result leads us to believe that presence may often be underestimated in virtual environments because of the lack of an objective value of reference in the real world. Moreover, results obtained for mental workload and affective feeling indicate that a simulator can be a useful tool for the initial resumption of driving after a period off the road. In particular, a simulator can help to avoid the sort of stress that can lead to task failure or a deterioration in performance.	[Milleville-Pennel, Isabelle; Charron, Camilo] CNRS, IRCCyN, F-44321 Nantes 03, France; [Charron, Camilo] Univ Rennes 2, F-35043 Rennes, France		Milleville-Pennel, I (corresponding author), CNRS, IRCCyN, BP 92101, F-44321 Nantes 03, France.	isabelle.milleville-pennel@irccyn.ec-nantes.fr					Abdi H., 2007, ENCY MEASUREMENT STA, P849; Abdi H, 2013, WIRES COMPUT STAT, V5, P149, DOI 10.1002/wics.1246; Anderson SW, 2005, P 3 INT DRIV S HUM F, P286; Bella F, 2008, ACCIDENT ANAL PREV, V40, P1078, DOI 10.1016/j.aap.2007.10.015; Bittner AC, 2002, TRANSPORT RES REC, P38; BLAAUW GJ, 1982, HUM FACTORS, V24, P473, DOI 10.1177/001872088202400408; Brookhuis KA, 2010, ACCIDENT ANAL PREV, V42, P898, DOI 10.1016/j.aap.2009.06.001; Cegarra J., 2009, COMM PRES CINQ ED C; Gerhard M., 2001, Intelligent Virtual Agents. Third International Workshop, IVA 2001. Proceedings (Lecture Notes in Artificial Intelligence Vol.2190), P137; Gopher D., 1986, HDB PERCEPTION HUMAN, V2, P1; HART S G, 1988, P139; Heuer H, 2013, FRONT HUM NEUROSCI, V7, DOI 10.3389/fnhum.2013.00032; Jahn G, 2005, TRANSPORT RES F-TRAF, V8, P255, DOI 10.1016/j.trf.2005.04.009; Johnson MJ, 2011, INT J PSYCHOPHYSIOL, V81, P203, DOI 10.1016/j.ijpsycho.2011.06.012; Lechner D., 1997, C SIA LYON AVR; Lecuyer A, 2009, PRESENCE-TELEOP VIRT, V18, P39, DOI 10.1162/pres.18.1.39; Lew HL, 2005, BRAIN INJURY, V19, P177, DOI 10.1080/02699050400017171; Matthews R, 2003, ACCIDENT ANAL PREV, V35, P451, DOI 10.1016/S0001-4575(02)00023-4; Mayhew DR, 2011, J SAFETY RES, V42, P267, DOI 10.1016/j.jsr.2011.06.004; Meehan M, 2005, APPL PSYCHOPHYS BIOF, V30, P239, DOI 10.1007/s10484-005-6381-3; Meehan M. J, 2001, THESIS U N CAROLINA; Mehler B., 2010, P 54 ANN M HUM FACT, V54, P2062; Mehler B, 2009, TRANSPORT RES REC, P6, DOI 10.3141/2138-02; Milleville-Pennel I, 2010, BRAIN INJURY, V24, P678, DOI 10.3109/02699051003692159; Otmani S, 2005, ACCIDENT ANAL PREV, V37, P930, DOI 10.1016/j.aap.2005.04.011; Patomella AH, 2006, J REHABIL MED, V38, P273, DOI 10.1080/16501970600632594; Pennel I, 2002, TRAV HUMAIN, V65, P29, DOI 10.3917/th.651.0029; Regenbrecht H, 2002, PRESENCE-TELEOP VIRT, V11, P425, DOI 10.1162/105474602760204318; Reimer B, 2011, ERGONOMICS, V54, P932, DOI 10.1080/00140139.2011.604431; ROBERT P, 1976, ROY STAT SOC C-APP, V25, P257; Robillard G, 2003, CYBERPSYCHOL BEHAV, V6, P467, DOI 10.1089/109493103769710497; Schubert T., 1999, VIS REPRESENT INTERP, P269, DOI DOI 10.1007/978-1-4471-0563-3_30; Slater M., 1995, ACM T COMPUT-HUM INT, V2, P201, DOI [10.1145/210079.210084, DOI 10.1145/210079.210084]; Slater M, 2010, ACM T GRAPHIC, V29, DOI 10.1145/1778765.1778829; Slater M, 2009, PHILOS T R SOC B, V364, P3549, DOI 10.1098/rstb.2009.0138; Stern E. B., 2004, 6 NAT WORKSH DRIV RE; Theeuwes J., 1996, TRANSPORT RES REC, V1550, P30, DOI DOI 10.1177/0361198196155000105; Tornros J, 1998, ACCIDENT ANAL PREV, V30, P497, DOI 10.1016/S0001-4575(97)00099-7; Villani D, 2012, INTERACT COMPUT, V24, P265, DOI 10.1016/j.intcom.2012.04.008; Vuadens P, 2001, Rev Med Suisse Romande, V121, P453; Walshe D, 2005, CYBERPSYCHOL BEHAV, V8, P532, DOI 10.1089/cpb.2005.8.532	41	15	15	0	107	MIT PRESS	CAMBRIDGE	ONE ROGERS ST, CAMBRIDGE, MA 02142-1209 USA		1531-3263		PRESENCE-VIRTUAL AUG	PRESENCE-Virtual Augmented Reality	WIN	2015	24	1					74	91		10.1162/PRES_a_00216			18	Computer Science, Cybernetics; Computer Science, Software Engineering	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Computer Science	CI1EN	WOS:000354485200005					2022-02-06	
J	Powell, DW; Williams, DSB				Powell, Douglas W.; Williams, D. S. Blaise, III			Athletes trained using stable compared to unstable surfaces exhibit distinct postural control profiles when assessed by traditional and nonlinear measures	HUMAN MOVEMENT SCIENCE			English	Article						Posture; Balance; Center of pressure; Training; Athletes; Sway	CEREBRAL CONCUSSION; APPROXIMATE ENTROPY; MULTIPLE-SCLEROSIS; GAIT VARIABILITY; HEALTHY CONTROLS; PARKINSONS-DISEASE; DOWNHILL WALKING; SWAY; YOUNG; DYNAMICS	Athletes are assumed to exhibit better balance than non-athletes; however, few studies have examined the role of different types of sports on balance measures. Two athlete groups that experience divergent sport-specific balance training are stable- (i.e. basketball) and unstable-surface athletes (i.e. surfers). The purpose of this study was to quantify the effect of stable- compared to unstable-surface sports on postural stability. Methods: Eight non-athletes (NON), eight stable-surface athletes (SSA) and eight unstable-surface athletes (USA) performed five 20-s quiet standing trials while ground reaction forces were recorded. Approximate entropy (ApEn), total excursion and root mean square distances (RMS) of the center of pressure position were calculated. Univariate ANOVAs with post hoc tests were conducted for each variable. Results: ApEn values were lower in SSA compared to NON in the ML direction (p = 0.012) and USA had lower ApEn values compared to SSA in the AP direction (p = 0.036). The USA had smaller AP RMS compared to SSA (p = 0.002) while the USA had greater ML RMS (p = 0.008) and resultant RMS values compared to SSA (p = 0.025). Discussion: These data suggest that USA and SSA may exhibit direction-specific differences in balance strategy due to feedback paradigm. (C) 2015 Elsevier B.V. All rights reserved.	[Powell, Douglas W.] Campbell Univ, Dept Phys Therapy, Buies Creek, NC 27506 USA; [Powell, Douglas W.] Campbell Univ, Sch Osteopath Med, Dept Physiol, Buies Creek, NC 27506 USA; [Williams, D. S. Blaise, III] Virginia Commonwealth Univ, Dept Phys Therapy, Richmond, VA USA; [Williams, D. S. Blaise, III] Virginia Commonwealth Univ, Dept Kinesiol & Hlth Sci, Richmond, VA USA		Powell, DW (corresponding author), Dept Phys Therapy, Buies Creek, NC 27506 USA.	dpowell@campbell.edu					Cavanaugh JT, 2007, J NEUROENG REHABIL, V4, DOI 10.1186/1743-0003-4-42; Cavanaugh JT, 2006, J ATHL TRAINING, V41, P305; Cavanaugh JT, 2005, SPORTS MED, V35, P935, DOI 10.2165/00007256-200535110-00002; Cavanaugh JT, 2005, BRIT J SPORT MED, V39, P805, DOI 10.1136/bjsm.2004.015909; Chen Wei-ting, 2006, J Zhejiang Univ Sci B, V7, P844, DOI 10.1631/jzus.2006.B0844; Fournier KA, 2014, GAIT POSTURE, V39, P420, DOI 10.1016/j.gaitpost.2013.08.016; Franz JR, 2013, GAIT POSTURE, V37, P378, DOI 10.1016/j.gaitpost.2012.08.004; Franz JR, 2013, J BIOMECH, V46, P535, DOI 10.1016/j.jbiomech.2012.09.032; Fujita T, 2005, J BONE MINER METAB, V23, P152, DOI 10.1007/s00774-004-0554-7; Gao JH, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0024446; Harringe ML, 2008, GAIT POSTURE, V28, P38, DOI 10.1016/j.gaitpost.2007.09.011; HOLM S, 1979, SCAND J STAT, V6, P65; Huisinga JM, 2013, ANN BIOMED ENG, V41, P1670, DOI 10.1007/s10439-012-0697-y; Jongman V, 2012, STUD HEALTH TECHNOL, V181, P93, DOI 10.3233/978-1-61499-121-2-93; Kaipust JP, 2012, MOTOR CONTROL, V16, P229, DOI 10.1123/mcj.16.2.229; Lamoth CJC, 2012, GAIT POSTURE, V35, P489, DOI 10.1016/j.gaitpost.2011.11.014; Lamoth CJC, 2009, GAIT POSTURE, V29, P546, DOI 10.1016/j.gaitpost.2008.12.006; McKeon PO, 2008, J ATHL TRAINING, V43, P293, DOI 10.4085/1062-6050-43.3.293; Myers SA, 2010, J SURG RES, V164, P6, DOI 10.1016/j.jss.2010.04.030; Myers SA, 2009, J VASC SURG, V49, P924, DOI 10.1016/j.jvs.2008.11.020; Negahban H, 2013, NEUROSCI LETT, V553, P126, DOI 10.1016/j.neulet.2013.08.024; O'Connell M, 1998, GAIT POSTURE, V8, P136, DOI 10.1016/S0966-6362(98)00023-X; PINCUS SM, 1991, P NATL ACAD SCI USA, V88, P2297, DOI 10.1073/pnas.88.6.2297; Powell DW, 2014, MOTOR CONTROL, V18, P263, DOI 10.1123/mc.2013-0025; Prieto TE, 1996, IEEE T BIO-MED ENG, V43, P956, DOI 10.1109/10.532130; Rocchi L, 2002, J NEUROL NEUROSUR PS, V73, P267, DOI 10.1136/jnnp.73.3.267; Smart LJ, 2001, J MANIP PHYSIOL THER, V24, P340, DOI 10.1067/mmt.2001.115262; Sosnoff JJ, 2011, J ATHL TRAINING, V46, P85, DOI 10.4085/1062-6050-46.1.85; Stergiou N, 2011, HUM MOVEMENT SCI, V30, P869, DOI 10.1016/j.humov.2011.06.002; Strang AJ, 2011, EUR J APPL PHYSIOL, V111, P1485, DOI 10.1007/s00421-010-1770-6; Thompson W R, 2010, ACSMS GUIDELINES EXE; Yamamoto R, 2001, DIABETES RES CLIN PR, V52, P213, DOI 10.1016/S0168-8227(01)00236-4	32	15	15	1	18	ELSEVIER SCIENCE BV	AMSTERDAM	PO BOX 211, 1000 AE AMSTERDAM, NETHERLANDS	0167-9457	1872-7646		HUM MOVEMENT SCI	Hum. Mov. Sci.	DEC	2015	44						73	80		10.1016/j.humov.2015.08.013			8	Neurosciences; Psychology; Psychology, Experimental; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychology; Sport Sciences	CX0BK	WOS:000365361700007	26319359				2022-02-06	
J	Bijttebier, S; Caeyenberghs, K; van den Ameele, H; Achten, E; Rujescu, D; Titeca, K; van Heeringen, C				Bijttebier, Stijn; Caeyenberghs, Karen; van den Ameele, Hans; Achten, Eric; Rujescu, Dan; Titeca, Koen; van Heeringen, Cornelis			The Vulnerability to Suicidal Behavior is Associated with Reduced Connectivity Strength	FRONTIERS IN HUMAN NEUROSCIENCE			English	Article						suicidal behavior; predisposition; connectivity strength; network based analysis; 5-HTTLPR; MAOA; whole brain tractography	TRAUMATIC BRAIN-INJURY; TENSOR IMAGING TRACTOGRAPHY; CORPUS-CALLOSUM; INTERHEMISPHERIC INTERACTION; VISUAL INFORMATION; FIBER TRACTOGRAPHY; COGNITIVE CONTROL; DIFFUSION MRI; RATING-SCALE; DEPRESSION	Suicidal behavior constitutes a major public health problem. Based on the stress diathesis model, biological correlates of a diathesis might help to predict risk after stressor-exposure. Structural changes in cortical and subcortical areas and their connections have increasingly been linked with the diathesis. The current study identified structural network changes associated with a diathesis using a whole-brain approach by examining the structural connectivity between regions in euthymic suicide attempters (SA). In addition, the association between connectivity measures, clinical and genetic characteristics was investigated. We hypothesized that SA showed lower connectivity strength, associated with an increased severity of general clinical characteristics and an elevated expression of short alleles in serotonin polymorphisms. Thirteen euthymic SA were compared with fifteen euthymic non-attempters and seventeen healthy controls (HC). Clinical characteristics and three serotonin-related genetic polymorphisms were assessed. Diffusion MRI together with anatomical scans were administered. Preprocessing was performed using Explore DTI. Whole brain tractography of the diffusion-weighted images was followed by a number of streamlines-weighted network analysis using NBS. The network analysis revealed decreased connectivity strength in SA in the connections between the left olfactory cortex and left anterior cingulate gyrus. Furthermore, SA had increased suicidal ideation, hopelessness and self-reported depression, but did not show any differences for the genetic polymorphisms. Finally, lower connectivity strength between the right calcarine fissure and the left middle occipital gyrus was associated with increased trait anxiety severity (r(s) = -0.78, p < 0.01) and hopelessness (r(s) = -0.76, p < 0.01). SA showed differences in white matter network connectivity strength associated with clinical characteristics. Together, these variables could play an important role in predicting suicidal behavior.	[Bijttebier, Stijn; van Heeringen, Cornelis] Univ Ghent, Dept Psychiat & Med Psychol, Unit Suicide Res, B-9000 Ghent, Belgium; [Caeyenberghs, Karen] Australian Catholic Univ, Fac Hlth Sci, Sch Psychol, Melbourne, Vic, Australia; [van den Ameele, Hans] AZ Sint Jan Brugge Oostende AV, Dept Psychiat, Brugge, Belgium; [Achten, Eric] Univ Ghent, Dept Radiol & Nucl Med, B-9000 Ghent, Belgium; [Achten, Eric] Univ Ghent, Ghent Inst Funct & Metab Imaging, B-9000 Ghent, Belgium; [Rujescu, Dan] Univ Halle Wittenberg, Univ Klin & Poliklin Psychiat Psychotherapie & Ps, D-06108 Halle, Germany; [Titeca, Koen] AZ Groeninge, Dept Psychiat, Kortrijk, Belgium		Bijttebier, S (corresponding author), Univ Ghent, Dept Psychiat & Med Psychol, Unit Suicide Res, B-9000 Ghent, Belgium.	stijn.bijttebier@ugent.be	van Heeringen, Kees/H-2384-2013	van Heeringen, Kees/0000-0001-5801-194X; Bijttebier, Stijn/0000-0001-7931-2901; Caeyenberghs, Karen/0000-0001-7009-6843			Antypa N, 2013, EUR NEUROPSYCHOPHARM, V23, P1125, DOI 10.1016/j.euroneuro.2013.03.013; Bai F, 2012, J NEUROSCI, V32, P4307, DOI 10.1523/JNEUROSCI.5061-11.2012; Banich MT, 1998, BRAIN COGNITION, V36, P128, DOI 10.1006/brcg.1997.0950; Basser PJ, 2000, MAGNET RESON MED, V44, P625, DOI 10.1002/1522-2594(200010)44:4<625::AID-MRM17>3.0.CO;2-O; Beck A.T., 1988, MANUAL BECK HOPELESS; BECK AT, 1979, J CONSULT CLIN PSYCH, V47, P343, DOI 10.1037/0022-006X.47.2.343; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; BECK AT, 1974, J CONSULT CLIN PSYCH, V42, P861, DOI 10.1037/h0037562; BERLUCCHI G, 1967, ARCH ITAL BIOL, V105, P583; Caeyenberghs K, 2015, NEUROIMAGE-CLIN, V7, P98, DOI 10.1016/j.nicl.2014.11.018; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2012, BRAIN, V135, P1293, DOI 10.1093/brain/aws048; Catani M, 2008, CORTEX, V44, P1105, DOI 10.1016/j.cortex.2008.05.004; Cyprien F, 2011, BIOL PSYCHIAT, V70, P320, DOI 10.1016/j.biopsych.2011.02.035; Desmyter S, 2013, CNS NEUROL DISORD-DR, V12, P921, DOI 10.2174/18715273113129990093; Dougherty RF, 2005, P NATL ACAD SCI USA, V102, P7350, DOI 10.1073/pnas.0500003102; Fan Q, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0035889; First M.B., 1994, STRUCTURED CLIN INTE; Fornito A, 2011, BIOL PSYCHIAT, V70, P64, DOI 10.1016/j.biopsych.2011.02.019; Franken IHA, 2005, J PSYCHOPATHOL BEHAV, V27, P25, DOI 10.1007/s10862-005-3262-2; Germana C, 2010, ACTA PSYCHIAT SCAND, V122, P481, DOI 10.1111/j.1600-0447.2010.01582.x; Gong GL, 2009, CEREB CORTEX, V19, P524, DOI 10.1093/cercor/bhn102; Hagmann P, 2008, PLOS BIOL, V6, P1479, DOI 10.1371/journal.pbio.0060159; HAMILTON M, 1960, J NEUROL NEUROSUR PS, V23, P56, DOI 10.1136/jnnp.23.1.56; Hawton K, 2009, LANCET, V373, P1372, DOI 10.1016/S0140-6736(09)60372-X; Hess CP, 2006, MAGN RESON MED, V56, P104, DOI 10.1002/mrm.20931; Jeurissen B, 2011, HUM BRAIN MAPP, V32, P461, DOI 10.1002/hbm.21032; Jia ZY, 2014, J PSYCHIATR NEUROSCI, V39, P170, DOI 10.1503/jpn.130023; Jia ZY, 2010, AM J PSYCHIAT, V167, P1381, DOI 10.1176/appi.ajp.2010.09101513; Jollant F, 2010, NEUROIMAGE, V51, P1275, DOI 10.1016/j.neuroimage.2010.03.027; Jones DK, 2013, NEUROIMAGE, V73, P239, DOI 10.1016/j.neuroimage.2012.06.081; Jones DK, 2011, METHODS MOL BIOL, V711, P127, DOI 10.1007/978-1-61737-992-5_6; Khalsa S, 2014, NEUROIMAGE, V102, P118, DOI 10.1016/j.neuroimage.2013.12.022; Kim B, 2015, J AFFECT DISORDERS, V175, P139, DOI 10.1016/j.jad.2015.01.001; Lebel C, 2012, MAGN RESON MED, V68, P474, DOI 10.1002/mrm.23254; Leemans A., 2009, P INT SOC MAG RESON; Leemans A, 2009, MAGN RESON MED, V61, P1336, DOI 10.1002/mrm.21890; Lo CP, 2007, EUR J NEUROL, V14, P777, DOI 10.1111/j.1468-1331.2007.01854.x; Lopez-Larson Melissa, 2013, Front Psychiatry, V4, P83, DOI 10.3389/fpsyt.2013.00083; Mahon K, 2012, BIPOLAR DISORD, V14, P80, DOI 10.1111/j.1399-5618.2012.00984.x; Mori S, 1999, ANN NEUROL, V45, P265, DOI 10.1002/1531-8249(199902)45:2<265::AID-ANA21>3.0.CO;2-3; Mori S, 2002, NMR BIOMED, V15, P468, DOI 10.1002/nbm.781; Olvet DM, 2014, J PSYCHIATR RES, V51, P60, DOI 10.1016/j.jpsychires.2014.01.002; Overbeek T., 1999, MINIINTERNATIONAL NE; Patton JH, 1995, J CLIN PSYCHOL, V51, P768, DOI 10.1002/1097-4679(199511)51:6<768::AID-JCLP2270510607>3.0.CO;2-1; Poudel GR, 2014, NEUROBIOL DIS, V65, P180, DOI 10.1016/j.nbd.2014.01.013; PTITO M, 1981, REV CAN BIOL EXPTL, V40, P61; Richard-Devantoy S, 2014, PSYCHOL MED, V44, P1663, DOI 10.1017/S0033291713002304; Rubinov M, 2011, J NEUROSCI, V31, P6263, DOI 10.1523/JNEUROSCI.0382-11.2011; Schmand B., 1992, NEUROPSYCHOLOGISCHE; Skudlarski P, 2008, NEUROIMAGE, V43, P554, DOI 10.1016/j.neuroimage.2008.07.063; Tournier JD, 2011, MAGN RESON MED, V65, P1532, DOI 10.1002/mrm.22924; Tzourio-Mazoyer N, 2002, NEUROIMAGE, V15, P273, DOI 10.1006/nimg.2001.0978; Van der Ploeg H.M., 2000, HANDLEIDING BIJ ZELF; van Heeringen C, 2011, NEUROSCI BIOBEHAV R, V35, P688, DOI 10.1016/j.neubiorev.2010.08.007; van Heeringen K, 2014, LANCET PSYCHIAT, V1, P63, DOI 10.1016/S2215-0366(14)70220-2; van Heeringen K, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00824; Vernon AC, 2012, BIOL PSYCHIAT, V71, P855, DOI 10.1016/j.biopsych.2011.12.004; Wedeen VJ, 2008, NEUROIMAGE, V41, P1267, DOI 10.1016/j.neuroimage.2008.03.036; Welcome SE, 2008, BRAIN COGNITION, V67, P69, DOI 10.1016/j.bandc.2007.11.005; Westlye LT, 2011, ARCH GEN PSYCHIAT, V68, P369, DOI 10.1001/archgenpsychiatry.2011.24; World Health Organization, 2014, PREVENTING SUICIDE G; Yamamoto A, 2007, AM J NEURORADIOL, V28, P92; Yeatman JD, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0049790; Yurgelun-Todd DA, 2011, J HEAD TRAUMA REHAB, V26, P276, DOI 10.1097/HTR.0b013e31822251dc; Zalesky A, 2011, BIOL PSYCHIAT, V69, P80, DOI 10.1016/j.biopsych.2010.08.022; Zalesky A, 2010, NEUROIMAGE, V53, P1197, DOI 10.1016/j.neuroimage.2010.06.041; Zimmerman M, 2013, J AFFECT DISORDERS, V150, P384, DOI 10.1016/j.jad.2013.04.028	68	15	17	1	19	FRONTIERS MEDIA SA	LAUSANNE	PO BOX 110, EPFL INNOVATION PARK, BUILDING I, LAUSANNE, 1015, SWITZERLAND	1662-5161			FRONT HUM NEUROSCI	Front. Hum. Neurosci.	NOV 30	2015	9								632	10.3389/fnhum.2015.00632			11	Neurosciences; Psychology	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Psychology	CY7DZ	WOS:000366569700001	26648857	Green Published, gold			2022-02-06	
J	Hilz, MJ; Aurnhammer, F; Flanagan, SR; Intravooth, T; Wang, RH; Hosl, KM; Pauli, E; Koehn, J				Hilz, Max J.; Aurnhammer, Felix; Flanagan, Steven R.; Intravooth, Tassanai; Wang, Ruihao; Hoesl, Katharina M.; Pauli, Elisabeth; Koehn, Julia			Eyeball Pressure Stimulation Unveils Subtle Autonomic Cardiovascular Dysfunction in Persons with a History of Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						autonomic dysfunction; eyeball pressure stimulation; mild traumatic brain injury; parasympathetic tone	GUILLAIN-BARRE-SYNDROME; HEART-RATE-VARIABILITY; CEREBROGENIC CARDIAC-ARRHYTHMIAS; BAROREFLEX SENSITIVITY; SUDDEN-DEATH; TRIGEMINOCARDIAC REFLEX; HYPERTENSIVE PATIENTS; MORTALITY; MODULATION; RESPONSES	After mild traumatic brain injury (mTBI), patients have increased long-term mortality rates, persisting even beyond 13 years. Pathophysiology is unclear. Yet, central autonomic network dysfunction may contribute to cardiovascular dysregulation and increased mortality. Purely parasympathetic cardiovascular challenge by eyeball pressure stimulation (EP), might unveil subtle autonomic dysfunction in post-mTBI patients. We investigated whether mild EP shows autonomic cardiovascular dysregulation in post-mTBI patients. In 24 patients (34 +/- 12 years; 5-86 months post-injury) and 27 controls (30 +/- 11 years), we monitored respiration, electrocardiographic RR intervals (RRI), systolic and diastolic blood pressure (BPsys, BPdia) before and during 2min of 30mm Hg EP, applied by an ophthalmologic ocular pressure device (Okulopressor((R))). We calculated spectral powers of RRI in the mainly sympathetic low frequency (LF; 0.04-0.15Hz) and parasympathetic high frequency (HF; 0.15-0.5Hz) ranges, and of BP in the sympathetic LF range, the RRI-LF/HF ratio as index of the sympathetic-parasympathetic balance, normalized (nu) RRI-LF- and HF-powers, and LF- and HF-powers after natural logarithmic transformation (ln). Parameters before and during EP in post-mTBI patients and controls were compared by repeated measurement analysis of variance with post hoc analysis (p<0.05). During EP, BPsys and BPdia increased in post-mTBI patients. Only in controls but not in post-mTBI patients, EP increased RRI-HFnu-powers and decreased RRI-LF-powers, RRI-LFnu-powers, BPsys-LF-powers, BPsys-lnLF-powers and BPdia-lnLF-powers. RRI-LF/HF ratios slightly increased in post-mTBI patients but slightly decreased in controls upon EP. Even with only mild EP, our controls showed normal EP responses and shifted sympathetic-parasympathetic balance towards parasympathetic predominance. In contrast, our post-mTBI patients could not increase parasympathetic heart rate modulation but increased BP upon EP, indicating a paradox sympathetic activation. The findings support the hypothesis that central autonomic dysfunction might contribute to an increased cardiovascular risk, even years after mTBI.	[Hilz, Max J.; Aurnhammer, Felix; Intravooth, Tassanai; Wang, Ruihao; Pauli, Elisabeth; Koehn, Julia] Univ Erlangen Nurnberg, Dept Neurol, D-91054 Erlangen, Germany; [Flanagan, Steven R.] NYU, Sch Med, Dept Rehabil Med, New York, NY USA; [Hoesl, Katharina M.] Klinikum Europakanal Erlangen, Dept Psychiat Addict Psychiat Psychotherapy & Psy, Erlangen, Germany		Hilz, MJ (corresponding author), Univ Erlangen Nurnberg, Dept Neurol, Schwabachanlage 6, D-91054 Erlangen, Germany.	max.hilz@uk-erlangen.de		Intravooth, Tassanai/0000-0002-6188-4503; Wang, Ruihao/0000-0003-4792-5572; Flanagan, Steven/0000-0001-9005-5897	International Brain Research Foundation (IBRF), Flanders, NJ	The study was partially funded by the International Brain Research Foundation (IBRF), Flanders, NJ.	Aminoff, 2002, NEUROMUSCULAR FUNCTI, P1899; ARNOLD RW, 1994, OPHTHALMOLOGY, V101, P1347; Arnold RW, 1999, YALE J BIOL MED, V72, P237; Ashman TA, 2006, MT SINAI J MED, V73, P999; Bazarian JJ, 2007, J NEUROTRAUM, V24, P1447, DOI 10.1089/neu.2007.0241; Benarroch EE, 1997, CENTRAL AUTONOMIC NE; BERNARDI L, 1995, CIRCULATION, V92, P2895, DOI 10.1161/01.CIR.92.10.2895; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Black M, 2002, J CLIN PATHOL, V55, P44, DOI 10.1136/jcp.55.1.44; Bowman R, 1996, BRIT J OPHTHALMOL, V80, P394, DOI 10.1136/bjo.80.5.394; Brown AW, 2004, NEUROREHABILITATION, V19, P37; Brown CM, 2008, DIABETOLOGIA, V51, P756, DOI 10.1007/s00125-008-0958-3; Brown CM, 2002, CLIN SCI, V102, P623, DOI 10.1042/CS20010242; Camm AJ, 1996, CIRCULATION, V93, P1043; Dutsch M, 2007, NEUROLOGY, V69, P2249, DOI 10.1212/01.wnl.0000286946.06639.a7; Flaada JT, 2007, J NEUROTRAUM, V24, P435, DOI 10.1089/neu.2006.0119; Flachenecker P, 1998, MUSCLE NERVE, V21, P680; Flachenecker P, 2001, NERVENARZT, V72, P610, DOI 10.1007/s001150170060; Flachenecker P, 1996, NEUROLOGY, V47, P102, DOI 10.1212/WNL.47.1.102; Flachenecker P, 2007, J NEUROL, V254, P96, DOI 10.1007/s00415-007-2024-3; GANDEVIA SC, 1978, J PHYSIOL-LONDON, V276, P383, DOI 10.1113/jphysiol.1978.sp012241; HACHINSKI VC, 1986, STROKE, V17, P387, DOI 10.1161/01.STR.17.3.387; Hemmer LB, 2010, J CLIN ANESTH, V22, P205, DOI 10.1016/j.jclinane.2009.03.017; Hilz MJ, 2008, STROKE, V39, P2421, DOI 10.1161/STROKEAHA.108.518613; Hilz MJ, 2006, BRAIN, V129, P3343, DOI 10.1093/brain/awl299; Hilz MJ, 2011, J HYPERTENS, V29, P2387, DOI 10.1097/HJH.0b013e32834c31db; Hilz MJ, 2011, J NEUROTRAUM, V28, P1727, DOI 10.1089/neu.2010.1497; Hilz MJ, 2006, MUSCLE NERVE, V33, P6, DOI 10.1002/mus.20365; Hilz MJ, 2001, ANN NEUROL, V49, P575, DOI 10.1002/ana.1006; Holm L, 2005, J REHABIL MED, V37, P137, DOI 10.1080/16501970510027321; Honzikova N, 2000, PHYSIOL RES, V49, P643; Huang MX, 2009, J NEUROTRAUM, V26, P1213, DOI 10.1089/neu.2008.0672; Johansson M, 2007, J HYPERTENS, V25, P163, DOI 10.1097/01.hjh.0000254377.18983.eb; Kallio H, 2011, ANAESTHESIA, V66, P278, DOI 10.1111/j.1365-2044.2011.06627.x; La Rovere MT, 2001, CIRCULATION, V103, P2072; La Rovere MT, 1998, LANCET, V351, P478; Lanfranchi PA, 2002, AM J PHYSIOL-REG I, V283, pR815, DOI 10.1152/ajpregu.00051.2002; LANG S, 1991, CAN J ANAESTH, V38, P757, DOI 10.1007/BF03008454; Langlois JA, 2005, J HEAD TRAUMA REHAB, V20, P229, DOI 10.1097/00001199-200505000-00006; Levine B, 2008, NEUROLOGY, V70, P771, DOI 10.1212/01.wnl.0000304108.32283.aa; LICHTENFELD P, 1971, AM J MED, V50, P772, DOI 10.1016/0002-9343(71)90185-9; LOKEN RG, 1994, CAN J ANAESTH, V41, P802, DOI 10.1007/BF03011587; Low PA, 1997, CLIN AUTONOMIC DISOR, V2, P287; Marr A, 2002, CENTRAL NERVOUS SYST; Marthol H, 2007, J NEUROL SCI, V252, P99, DOI 10.1016/j.jns.2006.10.003; McMillan TM, 2007, BRAIN, V130, P2520, DOI 10.1093/brain/awm185; McMillan TM, 2011, J NEUROL NEUROSUR PS, V82, P931, DOI 10.1136/jnnp.2010.222232; Minahan RE, 1996, NEUROLOGY, V47, P1239, DOI 10.1212/WNL.47.5.1239; NATELSON BH, 1993, NEUROL CLIN, V11, P293, DOI 10.1016/S0733-8619(18)30154-3; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Niogi SN, 2010, J HEAD TRAUMA REHAB, V25, P241, DOI 10.1097/HTR.0b013e3181e52c2a; Oppenheimer S, 2006, CLIN AUTON RES, V16, P6, DOI 10.1007/s10286-006-0276-0; OPPENHEIMER SM, 1991, BRAIN RES, V550, P115, DOI 10.1016/0006-8993(91)90412-O; OPPENHEIMER SM, 1990, ARCH NEUROL-CHICAGO, V47, P513, DOI 10.1001/archneur.1990.00530050029008; Orlandi G, 2000, ACTA NEUROL SCAND, V102, P317, DOI 10.1034/j.1600-0404.2000.102005317.x; Ormezzano O, 2008, J HYPERTENS, V26, P1373, DOI 10.1097/HJH.0b013e3283015e5a; PAGANI M, 1986, CIRC RES, V59, P178, DOI 10.1161/01.RES.59.2.178; Parati G, 2001, ANN NY ACAD SCI, V940, P469; Paton JFR, 2005, BRAIN RES REV, V49, P555, DOI 10.1016/j.brainresrev.2005.02.005; Ponikowski P, 1997, AM J CARDIOL, V79, P1645, DOI 10.1016/S0002-9149(97)00215-4; Rosengard-Barlund M, 2009, DIABETOLOGIA, V52, P1164, DOI 10.1007/s00125-009-1340-9; Rutgers DR, 2008, AM J NEURORADIOL, V29, P514, DOI 10.3174/ajnr.A0856; Schaller B, 2004, J NEUROL, V251, P658, DOI 10.1007/s00415-004-0458-4; Schini-Kerth VB, 1999, TRANSFUS CLIN BIOL, V6, P355, DOI 10.1016/S1246-7820(00)88980-6; Soros P, 2012, LANCET NEUROL, V11, P179, DOI 10.1016/S1474-4422(11)70291-5; Sykora M, 2008, CRIT CARE MED, V36, P3074, DOI 10.1097/CCM.0b013e31818b306d; Sykora M, 2009, STROKE, V40, P737, DOI 10.1161/STROKEAHA.108.519967; Tokgozoglu SL, 1999, STROKE, V30, P1307, DOI 10.1161/01.STR.30.7.1307; VANBROCKLIN MD, 1982, J AM OPTOM ASSOC, V53, P407; Xiong KL, 2014, BRAIN IMAGING BEHAV, V8, P487, DOI 10.1007/s11682-013-9288-2; ZOCHODNE DW, 1994, MUSCLE NERVE, V17, P1145, DOI 10.1002/mus.880171004	71	15	18	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	NOV 15	2015	32	22					1796	1804		10.1089/neu.2014.3842			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CV6ST	WOS:000364401500010	26192266				2022-02-06	
J	Bulloch, AGM; Fiest, KM; Williams, JVA; Lavorato, DH; Berzins, SA; Jette, N; Pringsheim, TM; Patten, SB				Bulloch, Andrew G. M.; Fiest, Kirsten M.; Williams, Jeanne V. A.; Lavorato, Dina H.; Berzins, Sandra A.; Jette, Nathalie; Pringsheim, Tamara M.; Patten, Scott B.			Depression - a common disorder across a broad spectrum of neurological conditions: a cross-sectional nationally representative survey	GENERAL HOSPITAL PSYCHIATRY			English	Article						Neurological conditions; Depressive disorder; Depression rating scales; Prevalence; Community-based study	QUALITY-OF-LIFE; HEALTH QUESTIONNAIRE PHQ-9; SELF-REPORTED EPILEPSY; MAJOR DEPRESSION; BRAIN-TUMOR; MULTIPLE-SCLEROSIS; SUICIDAL IDEATION; RISK-FACTORS; PREVALENCE; DISEASE	Objective: To estimate the prevalence of depression across a range of neurological conditions in a nationally representative sample. Methods: The data source was the Survey of Living with Neurological Conditions in Canada (SLNCC), which accrued its sample by selecting participants from the Canadian Community Health Survey. The point prevalence of depression was estimated by assessment of depressive symptoms with the Patient Health Questionnaire, Brief (Patient Health Questionnaire, 9-item). Results: A total of n=4408 participated in the SLNCC. The highest point prevalence of depression (>30%) was seen in those with traumatic brain injury and brain/spinal cord tumors. Depression was also highly prevalent (18-28%) in those with (listed from highest to lowest) Alzheimer's disease/dementia, dystonia, multiple sclerosis, Parkinson's disease, stroke, migraine, epilepsy and spina bifida. The odds ratios for depression, with the referent group being the general population, were significant (from highest to lowest) for migraine, traumatic brain injury, stroke, dystonia and epilepsy. Conclusions: All neurological conditions included in this study are associated with an elevated prevalence of depression in community populations. The conditions with the highest prevalence are traumatic brain injury and brain/spinal cord tumors. (c) 2015 Elsevier Inc. All rights reserved.	[Bulloch, Andrew G. M.; Fiest, Kirsten M.; Williams, Jeanne V. A.; Lavorato, Dina H.; Berzins, Sandra A.; Jette, Nathalie; Patten, Scott B.] Univ Calgary, Dept Community Hlth Sci, Calgary, AB T2N 1N4, Canada; [Bulloch, Andrew G. M.; Patten, Scott B.] Univ Calgary, Dept Psychiat, Calgary, AB T2N 1N4, Canada; [Jette, Nathalie; Pringsheim, Tamara M.] Univ Calgary, Hotchkiss Brain Inst, Dept Clin Neurosci, Calgary, AB T2N 1N4, Canada; [Jette, Nathalie; Pringsheim, Tamara M.] Univ Calgary, Inst Publ Hlth, Calgary, AB T2N 1N4, Canada; [Bulloch, Andrew G. M.; Fiest, Kirsten M.; Berzins, Sandra A.; Pringsheim, Tamara M.; Patten, Scott B.] Univ Calgary, Hotchkiss Brain Inst, Mathison Ctr Mental Hlth Res & Educ, Calgary, AB T2N 1N4, Canada		Bulloch, AGM (corresponding author), Dept Community Hlth Sci, TRW 4D67,3280 Hosp Dr NW, Calgary, AB T2N 4Z6, Canada.	bulloch@ucalgary.ca	Fiest, Kirsten/AAV-5052-2020; Patten, Scott/B-4434-2011; Pringsheim, Tamara/L-5955-2019	Fiest, Kirsten/0000-0002-7299-6594; Patten, Scott/0000-0001-9871-4041; Pringsheim, Tamara/0000-0002-8229-8431	Hotchkiss Brain Institute at the University of Calgary; Alberta Innovates - Health Solutions; Alberta Addiction and Mental Health Research Partnership Program; endMS Studentship	This project was supported by a grant from the Hotchkiss Brain Institute at the University of Calgary. This Institute had no role in study design, in the collection, analysis and interpretation of data, in the writing of the report or in the decision to submit the article for publication. Scott Patten, Nathalie Jette and Kirsten Fiest were supported by salary awards by Alberta Innovates - Health Solutions. Nathalie Jette also holds a Canada Research Chair Tier 2 in Neuroscience Health Services Research. Sandy Berzins was supported by an operating grant from the Alberta Addiction and Mental Health Research Partnership Program and by an endMS Studentship.	Ben-Shlomo Y, 2002, J NEUROL NEUROSUR PS, V72, P608, DOI 10.1136/jnnp.72.5.608; Boylan LS, 2004, NEUROLOGY, V62, P258, DOI 10.1212/01.WNL.0000103282.62353.85; Bronnum-Hansen H, 2005, J NEUROL NEUROSUR PS, V76, P1457, DOI 10.1136/jnnp.2004.056747; Brooks DR, 2012, EPILEPSY BEHAV, V23, P57, DOI 10.1016/j.yebeh.2011.11.002; Bruce Travis O, 2008, Curr Psychiatry Rep, V10, P258, DOI 10.1007/s11920-008-0042-1; DiMatteo MR, 2000, ARCH INTERN MED, V160, P2101, DOI 10.1001/archinte.160.14.2101; FARRER LA, 1986, AM J MED GENET, V24, P305, DOI 10.1002/ajmg.1320240211; Fenn AM, 2014, BIOL PSYCHIAT, V76, P575, DOI 10.1016/j.biopsych.2013.10.014; Fiest KM, 2014, EPILEPSIA, V55, P1642, DOI 10.1111/epi.12754; Fiest KM, 2013, NEUROLOGY, V80, P590, DOI 10.1212/WNL.0b013e31827b1ae0; Hart T, 2012, ARCH PHYS MED REHAB, V93, P1343, DOI 10.1016/j.apmr.2012.03.036; Hermida AP, 2012, EXPERT REV NEUROTHER, V12, P1339, DOI [10.1586/ern.12.127, 10.1586/ERN.12.127]; Jones JE, 2003, EPILEPSY BEHAV, V4, pS31, DOI 10.1016/j.yebeh.2003.08.019; Jorge RE, 2005, J HEAD TRAUMA REHAB, V20, P475, DOI 10.1097/00001199-200511000-00001; Kessler Ronald C., 1998, INT J METH PSYCH RES, V7, P171, DOI [DOI 10.1002/MPR.47, 10.1002/mpr.47]; Kroenke K, 2002, PSYCHIAT ANN, V32, P509, DOI 10.3928/0048-5713-20020901-06; Kroenke K, 2010, GEN HOSP PSYCHIAT, V32, P345, DOI 10.1016/j.genhosppsych.2010.03.006; Lewis L, 2008, J NEUROL, V255, P1750, DOI 10.1007/s00415-008-0020-x; Lou JS, 2003, NEUROLOGY, V60, P122, DOI 10.1212/01.WNL.0000042781.22278.0A; Mainio A, 2011, CLIN NEUROL NEUROSUR, V113, P649, DOI 10.1016/j.clineuro.2011.05.006; Manea L, 2012, CAN MED ASSOC J, V184, pE191, DOI 10.1503/cmaj.110829; Miller KM, 2007, MOVEMENT DISORD, V22, P666, DOI 10.1002/mds.21376; Moller-Leimkuhler AM, 2010, WORLD J BIOL PSYCHIA, V11, P922, DOI 10.3109/15622975.2010.523481; Mohr DC, 1997, ARCH NEUROL-CHICAGO, V54, P531, DOI 10.1001/archneur.1997.00550170015009; Noonan VK, 2012, NEUROEPIDEMIOLOGY, V38, P219, DOI 10.1159/000336014; Oladeji BD, 2013, CURR PSYCHIAT REP, V15, DOI 10.1007/s11920-013-0390-3; Paolucci Stefano, 2008, Neuropsychiatr Dis Treat, V4, P145; Pascoe MC, 2011, INT J STROKE, V6, P128, DOI 10.1111/j.1747-4949.2010.00565.x; Patten SB, 2015, MULT SCLER IN PRESS; Patten SB, 2008, GEN HOSP PSYCHIAT, V30, P407, DOI 10.1016/j.genhosppsych.2008.05.001; Payne JL, 2002, INT J GERIATR PSYCH, V17, P247, DOI 10.1002/gps.589; Pelletier G, 2002, J NEURO-ONCOL, V57, P41, DOI 10.1023/A:1015728825642; Poole L, 2011, J PSYCHOSOM RES, V71, P61, DOI 10.1016/j.jpsychores.2010.12.009; Reijnders JSAM, 2008, MOVEMENT DISORD, V23, P183, DOI 10.1002/mds.21803; Siegert RJ, 2005, J NEUROL NEUROSUR PS, V76, P469, DOI 10.1136/jnnp.2004.054635; Sjonnesen K, 2012, POSTGRAD MED, V124, P69, DOI 10.3810/pgm.2012.09.2595; Soh SE, 2011, PARKINSONISM RELAT D, V17, P1, DOI 10.1016/j.parkreldis.2010.08.012; STARKSTEIN SE, 2002, PSYCHIAT COGNITIVE D; Starkstein SE, 2008, MOVEMENT DISORD, V23, P546; Statistics Canada, SURV LIV NEUR COND C; Statistics Canada, TABL 105 1300 NEUR C; SULLIVAN M, 1993, ARCH INTERN MED, V153, P2251, DOI 10.1001/archinte.153.19.2251; Tellez-Zenteno JF, 2004, EPILEPSIA, V45, P1623, DOI 10.1111/j.0013-9580.2004.24904.x; Thompson AW, 2011, PARKINSONISM RELAT D, V17, P40, DOI 10.1016/j.parkreldis.2010.10.007; Vezzani A, 2014, EPILEPSY CURR, V14, P3, DOI 10.5698/1535-7511-14.s2.3; Viner R, 2014, J PSYCHOSOM RES, V76, P312, DOI 10.1016/j.jpsychores.2013.12.010; Walker AK, 2014, PHARMACOL REV, V66, P80, DOI 10.1124/pr.113.008144; Wang JL, 2000, INT J PSYCHIAT MED, V30, P309; Wellisch DK, 2002, PSYCHO-ONCOLOGY, V11, P230, DOI 10.1002/pon.562; Williams LS, 2005, SEMIN NEUROL, V25, P396, DOI 10.1055/s-2005-923534; Zunszain Patricia A, 2013, Curr Top Behav Neurosci, V14, P135, DOI 10.1007/7854_2012_211	51	15	15	0	19	ELSEVIER SCIENCE INC	NEW YORK	STE 800, 230 PARK AVE, NEW YORK, NY 10169 USA	0163-8343	1873-7714		GEN HOSP PSYCHIAT	Gen. Hosp. Psych.	NOV-DEC	2015	37	6					507	512		10.1016/j.genhosppsych.2015.06.007			6	Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Psychiatry	CV8AK	WOS:000364498700002	26153456				2022-02-06	
J	Colantonio, A; Hsueh, J; Petgrave, J; Hirdes, JP; Berg, K				Colantonio, Angela; Hsueh, Jayden; Petgrave, Josian; Hirdes, John P.; Berg, Katherine			A Profile of Patients With Traumatic Brain Injury Within Home Care, Long-Term Care, Complex Continuing Care, and Institutional Mental Health Settings in a Publicly Insured Population	JOURNAL OF HEAD TRAUMA REHABILITATION			English	Article						healthcare settings; patient profile; traumatic brain injury	RESIDENTS	Objective: To describe the sociodemographic and clinical profile of people with traumatic brain injury (TBI) in home care, nursing homes, and complex continuing care settings in a national sample. Methods: Cross-sectional study using available Resident Assessment Instrument (RAI 2.0 and RAI Home Care [HC]) national databases in Canada from 1996 to 2011. The profile of people with TBI was compared with patients with and without prespecified neurological conditions within each setting. Participants: Adults 18 years and older identified with TBI (n = 10 878) and adult patients with other neurological (n = 422 300) and nonneurological (n = 571 567) conditions. Main Measures: Demographic and clinical characteristics, functional characteristics, mood and behavior, and treatment and medication variables. Data from Canadian home care (RAI-HC), mental health (RAI-MH), nursing home, and complex continuing care facilities (RAI Minimum Data Set 2.0). Results: Patients with TBI were significantly different on almost all items. They were among the youngest in care settings, and psychotropic drug use by this population was among the highest in at least 2 settings. Conclusion: These data can inform the planning for appropriate care and resources for patients with TBI in a range of settings.	[Colantonio, Angela] Univ Hlth Network, Toronto Rehabil Inst, Toronto, ON, Canada; [Colantonio, Angela; Petgrave, Josian] Univ Waterloo, Dept Occupat Sci & Occupat Therapy, Waterloo, ON N2L 3G1, Canada; [Berg, Katherine] Univ Waterloo, Dept Phys Therapy, Waterloo, ON N2L 3G1, Canada; [Colantonio, Angela; Hsueh, Jayden; Berg, Katherine] Univ Waterloo, Grad Dept Rehabil Sci, Waterloo, ON N2L 3G1, Canada; [Hirdes, John P.] Univ Waterloo, Sch Publ Hlth & Hlth Syst, Waterloo, ON N2L 3G1, Canada		Colantonio, A (corresponding author), Univ Toronto, Occupat Sci & Occupat Therapy, Rehabil Sci Bldg,160-500 Univ Ave, Toronto, ON M5G 1V7, Canada.	angela.colantonio@utoronto.ca		Colantonio, Angela/0000-0003-2094-4765	Public Health Agency of Canada; Ontario Ministry of Health and Long Term CareMinistry of Health and Long-Term Care, Ontario; Saunderson Family Chair in Acquired Brain Injury Research at the Toronto Rehabilitation Institute; CIHR Research Chair in Gender Work and Health at the University of TorontoCanadian Institutes of Health Research (CIHR) [CGW-126580]; Ontario Home Care Research and Knowledge Exchange Chair by the Ontario Ministry of Health and Long Term Care	Funding for the study was provided by the Public Health Agency of Canada and funding from the Ontario Ministry of Health and Long Term Care to the Toronto Rehabilitation Institute. Dr Colantonio was supported by the Saunderson Family Chair in Acquired Brain Injury Research at the Toronto Rehabilitation Institute and a CIHR Research Chair in Gender Work and Health at the University of Toronto (CGW-126580). Dr Hirdes was supported by the Ontario Home Care Research and Knowledge Exchange Chair by the Ontario Ministry of Health and Long Term Care.	Arango-Lasprilla JC, 2010, ARCH PHYS MED REHAB, V91, P1495, DOI 10.1016/j.apmr.2010.07.010; Bronskill S, 2011, HLTH SYSTEM USE FRAI, P91; Buchanan RJ, 2003, BRAIN INJURY, V17, P507, DOI 10.1080/0269905031000070215; *CAN I HLTH INF, 2006, FAC BAS CONT CAR CAN; Canadian Cancer Care Society's Steering Committee on Cancer, 2011, CAN CANC STAT 2011; Canadian Institute for Health Information, 2007, BURD NEUR DIS DIS IN; Chen A, 2012, BMC NEUROL, V12, DOI 10.1186/1471-2377-12-76; Colantonio A, 2011, J REHABIL MED, V43, P311, DOI 10.2340/16501977-0783; Colantonio A, 2010, BRAIN IMPAIR, V11, P31, DOI 10.1375/brim.11.1.31; Cooper C, 2006, AM J GERIAT PSYCHIAT, V14, P489, DOI 10.1097/01.JGP.0000192498.18316.b6; Coronado VG, 2012, J SAFETY RES, V43, P299, DOI 10.1016/j.jsr.2012.08.011; Deb S, 1999, BRAIN INJURY, V13, P369, DOI 10.1080/026990599121557; Finkelstein E, 2003, INCIDENCE EC BURDEN; Frisina PG, 2010, REHABIL NURS, V35, P141, DOI 10.1002/j.2048-7940.2010.tb00039.x; Gabella BA, 2007, J HEAD TRAUMA REHAB, V22, P368, DOI 10.1097/01.HTR.0000300232.98242.ce; Henry-Sanchez JT, 2012, AM J PHYS MED REHAB, V91, P601, DOI 10.1097/PHM.0b013e31825596af; Hyder AA, 2007, NEUROREHABILITATION, V22, P341; Karon SL, 2007, J HEAD TRAUMA REHAB, V22, P350, DOI 10.1097/01.HTR.0000300230.13490.11; Kelly G, 2007, BRAIN IMPAIR, V8, P262, DOI DOI 10.1375/BRIM.8.3.262; Multiple Sclerosis International Federation, 2008, ATL MULT SCLER DAT; Murphy MP, 2012, NEUROREHABILITATION, V31, P85, DOI 10.3233/NRE-2012-0777; O'Reilly Kate, 2002, Aust Health Rev, V25, P46; Seeley H, 2012, BRIT J NEUROSURG, V26, P730, DOI 10.3109/02688697.2012.693647; Silver JM, 2001, BRAIN INJURY, V15, P935, DOI 10.1080/02699050110065295; Verhaeghe S, 2005, J CLIN NURS, V14, P1004, DOI 10.1111/j.1365-2702.2005.01126.x; Wodchis WP, 2008, MED CARE, V46, P882, DOI 10.1097/MLR.0b013e3181789471	26	15	15	0	7	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0885-9701	1550-509X		J HEAD TRAUMA REHAB	J. Head Trauma Rehabil.	NOV-DEC	2015	30	6					E18	E29		10.1097/HTR.0000000000000112			12	Clinical Neurology; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	DD0JN	WOS:000369606300003	25699620				2022-02-06	
J	Hughes, AJ; Hartoonian, N; Parmenter, B; Haselkorn, JK; Lovera, JF; Bourdette, D; Turner, AP				Hughes, Abbey J.; Hartoonian, Narineh; Parmenter, Brett; Haselkorn, Jodie K.; Lovera, Jesus F.; Bourdette, Dennis; Turner, Aaron P.			Cognitive Impairment and Community Integration Outcomes in Individuals Living With Multiple Sclerosis	ARCHIVES OF PHYSICAL MEDICINE AND REHABILITATION			English	Article						Community integration; Multiple sclerosis; Neurobehavioral manifestations; Rehabilitation	QUALITY-OF-LIFE; TRAUMATIC BRAIN-INJURY; INFORMATION-PROCESSING SPEED; BECK DEPRESSION INVENTORY; FATIGUE SEVERITY SCALE; MEMORY IMPAIRMENT; GINKGO-BILOBA; QUESTIONNAIRE; DISABILITY; VALIDITY	Objectives: To determine the association between unique domains of cognitive impairment and community integration in individuals with multiple sclerosis (MS), and to determine the contributions of cognitive impairment to community integration beyond the influence of demographic and clinical variables. Design: Cross-sectional analysis of objective neuropsychological assessment and self-report data. Data were collected during baseline assessment of a randomized, multisite controlled trial of ginkgo biloba for cognitive impairment in MS. Hierarchical regression analyses examined the association between subjective and objective measures of cognitive impairment and 3 domains of community integration, adjusting for relevant covariates. Setting: Two Veterans Affairs medical center MS clinics. Participants: Adults (N = 121; ages 24-65y) with a confirmed MS diagnosis. Interventions: Not applicable. Main Outcome Measures: Primary outcomes were scores on the Home Integration (CIQ-H), Social Integration (CIQ-S), and Productivity (CIQ-P) domains of the Community Integration Questionnaire (CIQ). Results: Cognitive impairment was associated with lower scores on the CIQ-H and CIQ-S, but not the CIQ-P. Greater levels of subjective cognitive impairment were associated with lower scores on the CIQ-H and CIQ-S. Greater levels of objective cognitive impairment, specifically slower processing speed and poorer inhibitory control, were related to lower CIQ-S scores. Subjective and objective measures of cognitive impairment were significantly and independently associated with CIQ-S. Conclusions: Objective cognitive impairment may interfere with participation in social activities. Subjective cognitive impairment is also important to assess, because individuals who perceive themselves to be cognitively impaired may be less likely to participate in both home and social activities. Clinical interventions to enhance community integration in individuals with MS may benefit from addressing objective and subjective cognitive impairment by integrating cognitive rehabilitation approaches with self-efficacy enhancing strategies. (C) 2015 by the American Congress of Rehabilitation Medicine	[Hughes, Abbey J.; Hartoonian, Narineh; Haselkorn, Jodie K.; Turner, Aaron P.] Vet Affairs Puget Sound Hlth Care Syst, Seattle Div, Multiple Sclerosis Ctr Excellence West, Seattle, WA USA; [Hughes, Abbey J.; Haselkorn, Jodie K.; Turner, Aaron P.] Univ Washington, Dept Rehabil Med, Seattle, WA 98104 USA; [Parmenter, Brett] Vet Affairs Puget Sound Hlth Care Syst, Amer Lake Div, Tacoma, WA USA; [Haselkorn, Jodie K.] Univ Washington, Dept Epidemiol, Seattle, WA 98104 USA; [Lovera, Jesus F.] Louisiana State Univ, Hlth Sci Ctr, Dept Neurol, New Orleans, LA USA; [Bourdette, Dennis] Vet Affairs Portland Hlth Care Syst, Multiple Sclerosis Ctr Excellence West, Portland, OR USA; [Bourdette, Dennis] Oregon Hlth & Sci Univ, Dept Neurol, Sch Med, Portland, OR 97201 USA		Hughes, AJ (corresponding author), Univ Washington, Dept Rehabil Med, 325 Ninth Ave,Box 359612, Seattle, WA 98104 USA.	ajhughes@uw.edu	Turner, Aaron/A-7902-2009	Turner, Aaron/0000-0001-6897-8003; Hughes, Abbey/0000-0002-7612-6887	Department of Veterans Affairs, Office of Research and Development, Rehabilitation Research and Development [B4368R]; National Multiple Sclerosis SocietyNational Multiple Sclerosis Society [MB 0026]	Supported by the Department of Veterans Affairs, Office of Research and Development, Rehabilitation Research and Development (grant no. B4368R), and by a mentor-based fellowship grant from the National Multiple Sclerosis Society (grant no. MB 0026). The contents of this paper do not represent the view of the Department of Veterans Affairs of the U.S. Government.	Archibald CJ, 2000, J CLIN EXP NEUROPSYC, V22, P686, DOI 10.1076/1380-3395(200010)22:5;1-9;FT686; Armutlu K, 2007, INT J REHABIL RES, V30, P81, DOI 10.1097/MRR.0b013e3280146ec4; Arnett PA, 1997, NEUROPSYCHOLOGY, V11, P535, DOI 10.1037/0894-4105.11.4.535; Beck A., 1996, MANUAL BDI 2; Beck AT, 1996, J PERS ASSESS, V67, P588, DOI 10.1207/s15327752jpa6703_13; Belsky DA, 2005, REGRESSION DIAGNOSTI, V571; Busche KD, 2003, CAN J NEUROL SCI, V30, P137, DOI 10.1017/S0317167100053403; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; CARROLL M, 1984, NEUROPSYCHOLOGIA, V22, P297, DOI 10.1016/0028-3932(84)90076-9; Chiaravalloti ND, 2008, LANCET NEUROL, V7, P1139, DOI 10.1016/S1474-4422(08)70259-X; Confavreux C, 2000, NEW ENGL J MED, V343, P1430, DOI 10.1056/NEJM200011163432001; Corrigan JD, 1998, ARCH PHYS MED REHAB, V79, P298, DOI 10.1016/S0003-9993(98)90010-7; CORRIGAN JD, 1995, J HEAD TRAUMA REHAB, V10, P41, DOI 10.1097/00001199-199508000-00005; Cutajar R, 2000, J NEUROVIROL, V6, pS186; Delis D.C., 2000, CALIFORNIA VERBAL LE; DELUCA J, 1994, J CLIN EXP NEUROPSYC, V16, P183, DOI 10.1080/01688639408402629; Demaree HA, 1999, J NEUROL NEUROSUR PS, V67, P661, DOI 10.1136/jnnp.67.5.661; Diamond BJ, 2000, ARCH PHYS MED REHAB, V81, P668, DOI 10.1053/mr.2000.3840; Dijkers MPJM, 2000, ARCH PHYS MED REHAB, V81, pS63, DOI 10.1053/apmr.2000.20627; Drew MA, 2009, ARCH CLIN NEUROPSYCH, V24, P47, DOI 10.1093/arclin/acp007; Ehde DM, 2006, MULT SCLER J, V12, P629, DOI 10.1177/1352458506071346; Fischer JS, 1999, MULT SCLER J, V5, P251, DOI 10.1177/135245859900500410; Gronwall D, 1974, PSYCHOL EFFECTS CONC; Hamster K., 1983, MULTILINGUAL APHASIA; Henry JD, 2006, NEUROPSYCHOLOGIA, V44, P1166, DOI 10.1016/j.neuropsychologia.2005.10.006; Hirsh AT, 2011, ARCH PHYS MED REHAB, V92, P1602, DOI 10.1016/j.apmr.2011.05.004; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hughes AJ, 2011, J INT NEUROPSYCH SOC, V17, P1113, DOI 10.1017/S1355617711001135; HUGHES C, 1995, AM J MENT RETARD, V99, P623; KRUPP LB, 1989, ARCH NEUROL-CHICAGO, V46, P1121, DOI 10.1001/archneur.1989.00520460115022; Kurtzke J, 1983, NEUROLOGY, V33, P1444; LAROCCA N, 1985, J CHRON DIS, V38, P203, DOI 10.1016/0021-9681(85)90093-1; Lovera J, 2006, J REHABIL RES DEV, V43, P73, DOI 10.1682/JRRD.2004.09.0118; Lovera JF, 2012, NEUROLOGY, V79, P1278, DOI 10.1212/WNL.0b013e31826aac60; Manic RA, 2003, MULT SCLER, V9, P621; Marini I, 2012, PSYCHOSOCIAL ASPECTS OF DISABILITY: INSIDER PERSPECTIVES AND COUNSELING STRATEGIES, P1; Minden SL, 2006, MULT SCLER J, V12, P24, DOI 10.1191/135248506ms1262oa; MINDEN SL, 1990, J CLIN EXP NEUROPSYC, V12, P566, DOI 10.1080/01688639008401002; O'Brien AR, 2008, ARCH PHYS MED REHAB, V89, P761, DOI 10.1016/j.apmr.2007.10.019; Parmenter BA, 2007, J CLIN EXP NEUROPSYC, V29, P215, DOI 10.1080/13803390600672163; Potter K, 2014, PHYS THER, V94, P593, DOI 10.2522/ptj.20130149; RAO SM, 1991, NEUROLOGY, V41, P685, DOI 10.1212/WNL.41.5.685; RAO SM, 1991, NEUROLOGY, V41, P692, DOI 10.1212/WNL.41.5.692; Rosti Otajiirvi EM, 2011, COCHRANE DB SYST REV; Schiavolin S, 2013, INT J REHABIL RES, V36, P105, DOI 10.1097/MRR.0b013e32835c79ea; Shukla D, 2011, CLIN NEUROL NEUROSUR, V113, P435, DOI 10.1016/j.clineuro.2011.02.013; Steyerberg, 2019, CLIN PREDICTION MODE; Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; van de Ven L, 2005, DISABIL SOC, V20, P311, DOI 10.1080/09687590500060778; WILLER B, 1993, J HEAD TRAUMA REHABI, V0003, P00075, DOI DOI 10.1097/00001199-199308020-00009; World Health Organization, 2007, INT CLASS FUNCT DIS; Yorkston KM, 2008, DISABIL REHABIL, V30, P88, DOI 10.1080/09638280701191891	52	15	15	0	10	W B SAUNDERS CO-ELSEVIER INC	PHILADELPHIA	1600 JOHN F KENNEDY BOULEVARD, STE 1800, PHILADELPHIA, PA 19103-2899 USA	0003-9993	1532-821X		ARCH PHYS MED REHAB	Arch. Phys. Med. Rehabil.	NOV	2015	96	11					1973	1979		10.1016/j.apmr.2015.07.003			7	Rehabilitation; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Rehabilitation; Sport Sciences	DB1YX	WOS:000368306600005	26189203				2022-02-06	
J	Kawasaki, T; Ota, C; Yoneda, T; Maki, N; Urayama, S; Nagao, M; Nagayama, M; Kaketa, T; Takazawa, Y; Kaneko, K				Kawasaki, Takayuki; Ota, Chihiro; Yoneda, Takeshi; Maki, Nobukazu; Urayama, Shingo; Nagao, Masashi; Nagayama, Masataka; Kaketa, Takefumi; Takazawa, Yuji; Kaneko, Kazuo			Incidence of Stingers in Young Rugby Players	AMERICAN JOURNAL OF SPORTS MEDICINE			English	Article						rugby; stinger; burner; epidemiology; young athlete	FOOTBALL PLAYERS; BURNER SYNDROME; UNION INJURIES; PART 2; EPIDEMIOLOGY; CONCUSSION; SCHOOL; NEURAPRAXIA; STENOSIS; NERVE	Background: A stinger is a type of neurapraxia of the cervical roots or brachial plexus and represents a reversible peripheral nerve injury. The incidence of and major risk factors for stingers among young rugby players remain uninvestigated. Purpose: To investigate the incidence, symptoms, and intrinsic risk factors for stingers in elite rugby union teams of young players. Study Design: Descriptive epidemiology study. Methods: A total of 569 male rugby players, including 358 players from 7 high school teams and 211 players from 2 university teams, were investigated using self-administered preseason and postseason questionnaires. Results: The prevalence of a history of stingers was 33.9% (95% CI, 30.3-37.9), and 20.9% (119/569) of players experienced at least 1 episode of a stinger during the season (34.2 [95% CI, 26.2-42.1] events per 1000 player-hours of match exposure). The reinjury rate for stingers per season was 37.3% (95% CI, 30.4-44.2). Using the multivariate Poisson regression method, a history of stingers in the previous season and the grade and position of the player were found to be risk factors for stingers during the current season. The mean severity of injury was 2.9 days, with 79.3% (191/241) of the players not losing any time from playing after sustaining a stinger injury and 5.8% (14/241) of the players recovering within more than 14 days. The most frequent symptom was numbness in the unilateral upper extremity, and the most severe symptom was weakness of grasping (mean severity, 6 days). A logistic regression analysis indicated that a history of stingers in the previous season and an injury with more than 3 symptoms, especially motor weakness, were correlated with the severity of injury. Conclusion: Young rugby players with a history of stingers have a significantly high rate of repeat injuries. Although nearly 80% of the players experienced only minimal (0-1 day) time loss injuries, neurological deficits sometimes last beyond 1 month. A history of stingers was identified to be the strongest risk factor for injuries and for lasting symptoms. This information may be useful for planning the proper treatment for stingers in young rugby players.	[Kawasaki, Takayuki] Juntendo Univ, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, Tokyo 1138421, Japan; [Kawasaki, Takayuki; Nagao, Masashi; Nagayama, Masataka; Kaketa, Takefumi; Takazawa, Yuji; Kaneko, Kazuo] Juntendo Univ, Fac Med, Dept Orthopaed Surg, Tokyo 1138421, Japan; [Ota, Chihiro; Yoneda, Takeshi] Keio Univ, Rugby Football Club, Yokohama, Kanagawa 223, Japan; [Maki, Nobukazu] Mejiro Orthopaed & Internal Med Clin, Tokyo, Japan; [Urayama, Shingo] Int Budo Univ, Dept Sports Med, Katsuura, Japan		Kawasaki, T (corresponding author), Juntendo Univ, Fac Med, Dept Orthopaed Surg, Bunkyo Ku, 2-1-1 Hongo, Tokyo 1138421, Japan.	k-saki@luck.ocn.ne.jp	t, Kawasaki/AAE-4548-2020				Baker JF, 2013, IRISH J MED SCI, V182, P121, DOI 10.1007/s11845-012-0846-1; Bleakley C, 2011, J ATHL TRAINING, V46, P555; Bottini E, 2000, BRIT J SPORT MED, V34, P94, DOI 10.1136/bjsm.34.2.94; Brooks JHM, 2005, BRIT J SPORT MED, V39, P757, DOI 10.1136/bjsm.2005.018135; Brooks JHM, 2005, BRIT J SPORT MED, V39, P767, DOI 10.1136/bjsm.2005.018408; Brooks JHM, 2008, CLIN SPORT MED, V27, P51, DOI 10.1016/j.csm.2007.09.001; Castro FP, 2003, CLIN SPORT MED, V22, P483, DOI 10.1016/S0278-5919(02)00094-7; Charbonneau RME, 2012, CLIN J SPORT MED, V22, P472, DOI 10.1097/JSM.0b013e3182699ed5; Collins CL, 2008, ARCH PEDIAT ADOL MED, V162, P49, DOI 10.1001/archpediatrics.2007.1; DAVIDSON RM, 1987, MED J AUSTRALIA, V147, P119, DOI 10.5694/j.1326-5377.1987.tb133299.x; Devereaux M D, 1983, Br J Sports Med, V17, P137; Feinberg Joseph H, 2008, HSS J, V4, P87, DOI 10.1007/s11420-007-9064-1; Fraas MR, 2014, PHYS THER SPORT, V15, P136, DOI 10.1016/j.ptsp.2013.08.002; Fuller CW, 2007, BRIT J SPORT MED, V41, P328, DOI 10.1136/bjsm.2006.033282; Fuller CW, 2015, BRIT J SPORT MED, V49, P478, DOI 10.1136/bjsports-2013-093381; Fuller CW, 2011, CLIN J SPORT MED, V21, P356, DOI 10.1097/JSM.0b013e31821f5085; Junge A, 2004, BRIT J SPORT MED, V38, P168, DOI 10.1136/bjsm.2002.003020; Kawasaki T, 2014, J SHOULDER ELB SURG, V23, pE293, DOI 10.1016/j.jse.2014.04.009; Lee AJ, 1996, BRIT J SPORT MED, V30, P213, DOI 10.1136/bjsm.30.3.213; Levitz CL, 1997, AM J SPORT MED, V25, P73, DOI 10.1177/036354659702500114; McIntosh AS, 2010, BRIT J SPORT MED, V44, P188, DOI 10.1136/bjsm.2007.041400; McIntosh Andrew S, 2005, Med Sport Sci, V49, P120, DOI 10.1159/000085394; McManus A, 2004, J SCI MED SPORT, V7, P438, DOI 10.1016/S1440-2440(04)80261-5; MEYER SA, 1994, AM J SPORT MED, V22, P158, DOI 10.1177/036354659402200202; NATHAN M, 1983, S AFR MED J, V64, P132; Nicol A, 2011, J PUBLIC HEALTH-UK, V33, P256, DOI 10.1093/pubmed/fdq047; Rihn JA, 2009, SPORTS MED, V39, P697, DOI 10.2165/11315190-000000000-00000; ROBERTSON WC, 1979, JAMA-J AM MED ASSOC, V241, P1480, DOI 10.1001/jama.241.14.1480; ROUX CE, 1987, S AFR MED J, V71, P307; Safran MR, 2004, AM J SPORT MED, V32, P1063, DOI 10.1177/0363546504265193; SALLIS RE, 1992, PHYSICIAN SPORTSMED, V20, P47, DOI 10.1080/00913847.1992.11947521; Shannon B, 2002, CLIN SPORT MED, V21, P29, DOI 10.1016/S0278-5919(03)00055-3; SPEER KP, 1990, AM J SPORT MED, V18, P591, DOI 10.1177/036354659001800606	33	15	15	0	8	SAGE PUBLICATIONS INC	THOUSAND OAKS	2455 TELLER RD, THOUSAND OAKS, CA 91320 USA	0363-5465	1552-3365		AM J SPORT MED	Am. J. Sports Med.	NOV	2015	43	11					2809	2815		10.1177/0363546515597678			7	Orthopedics; Sport Sciences	Science Citation Index Expanded (SCI-EXPANDED)	Orthopedics; Sport Sciences	CV3XF	WOS:000364199100023	26337244				2022-02-06	
J	Larrabee, GJ				Larrabee, Glenn J.			The Multiple Validities of Neuropsychological Assessment	AMERICAN PSYCHOLOGIST			English	Article						test and assessment validity; evidence-based; core battery	MILD COGNITIVE IMPAIRMENT; FALSE-POSITIVE ERROR; BIAS SCALE RBS; PERFORMANCE VALIDITY; RESPONSE BIAS; CONSTRUCT-VALIDITY; ALZHEIMERS-DISEASE; CROSS-VALIDATION; SYMPTOM VALIDITY; FINANCIAL CAPACITY	This article discusses construct and criterion validity of neuropsychological tests, as well as assessment validity, which allows determination of whether an individual examinee is producing valid test results. Factor analyses identify 6 domains of abilities. Tests of learning and memory and processing speed are most sensitive to presence of brain dysfunction in both traumatic brain injury (TBI) and Alzheimer's disease (AD). Tests of processing speed, working memory, verbal symbolic functions, and visuoperceptual and visuospatial judgment and problem solving are sensitive to the severity of TBI and AD, as well as to the functional consequences of these disorders, including ability to work, financial and medical decision-making capacities, and driving ability. Unilateral hemisphere stroke allows study of impairment in sensorimotor skills and lateralized neuropsychological abilities, as well as the moderating effects of aphasia and neglect on test performance. Assessment validity is determined by performance validity tests, measuring whether an examinee is providing an accurate measure of their actual level of ability, and symptom validity tests, measuring whether an examinee is providing an accurate report of their actual symptom experience. A core neuropsychological battery is described that includes tests with established construct and criterion validity, and assessment validity, for comprehensive evidence-based evaluation.			Larrabee, GJ (corresponding author), 2650 Bahia Vista St,Suite 308, Sarasota, FL 34239 USA.	glarrabee@aol.com					Axelrod BN, 2014, CLIN NEUROPSYCHOL, V28, P876, DOI 10.1080/13854046.2014.907583; Barrash J, 2004, J CLIN EXP NEUROPSYC, V26, P125, DOI 10.1076/jcen.26.1.125.23928; Bauer RM, 2000, CLIN GUIDE NEUROPSYC, P419; Ben-Porath Y., 2012, INTERPRETING MMPI 2; BENTON A, 1991, Neuropsychology Review, V2, P267, DOI 10.1007/BF01108848; Benton A., 1994, CONTRIBUTIONS NEUROP; Benton A. L., 1991, NEUROBEHAVIORAL ASPE, P3; Bianchini KJ, 2014, CLIN NEUROPSYCHOL, V28, P1376, DOI 10.1080/13854046.2014.986199; BLESSED G, 1968, BRIT J PSYCHIAT, V114, P797, DOI 10.1192/bjp.114.512.797; Boone KB, 2009, CLIN NEUROPSYCHOL, V23, P729, DOI 10.1080/13854040802427803; Borenstein M., 2009, INTRO META ANAL; Bush SS, 2005, ARCH CLIN NEUROPSYCH, V20, P419, DOI 10.1016/j.acn.2005.02.002; Carlozzi NE, 2015, CLIN NEUROPSYCHOL, V29, P21, DOI 10.1080/13854046.2015.1005677; Carroll J.B., 1993, HUMAN COGNITIVE ABIL, DOI DOI 10.1017/CBO9780511571312; Crook TH, 1988, NEUROPSYCHOLOGY, V2, P1, DOI 10.1037//0894-4105.2.1.1; Davis JJ, 2014, CLIN NEUROPSYCHOL, V28, P1224, DOI 10.1080/13854046.2014.987167; Davis JJ, 2012, CLIN NEUROPSYCHOL, V26, P1397, DOI 10.1080/13854046.2012.728627; DIKMEN SS, 1994, ARCH NEUROL-CHICAGO, V51, P177, DOI 10.1001/archneur.1994.00540140087018; DIKMEN SS, 1995, NEUROPSYCHOLOGY, V9, P80, DOI 10.1037/0894-4105.9.1.80; Earnst KS, 2001, AGING NEUROPSYCHOL C, V8, P109, DOI 10.1076/anec.8.2.109.839; Floyd FJ, 1995, PSYCHOL ASSESSMENT, V7, P286, DOI 10.1037/1040-3590.7.3.286; Frazier TW, 2004, J INT NEUROPSYCH SOC, V10, P578, DOI 10.1017/S1355617704104049; Gervais RO, 2007, ASSESSMENT, V14, P196, DOI 10.1177/1073191106295861; Gervais RO, 2008, CLIN NEUROPSYCHOL, V22, P1061, DOI 10.1080/13854040701756930; Green Paul, 2007, Phys Med Rehabil Clin N Am, V18, P43, DOI 10.1016/j.pmr.2006.11.002; Greenaway MC, 2009, CLIN NEUROPSYCHOL, V23, P7, DOI 10.1080/13854040801891686; Greiffenstein MF, 2003, CLIN NEUROPSYCHOL, V17, P561, DOI 10.1076/clin.17.4.561.27937; Griffith HR, 2006, J INT NEUROPSYCH SOC, V12, P166, DOI 10.1017/S1355617706060267; HANNAY HJ, 1979, CORTEX, V15, P269, DOI 10.1016/S0010-9452(79)80031-3; Heilbronner RL, 2009, CLIN NEUROPSYCHOL, V23, P1093, DOI 10.1080/13854040903155063; Heilman K.M., 2012, CLIN NEUROPSYCHOLOGY; Holdnack JA, 2011, ASSESSMENT, V18, P178, DOI 10.1177/1073191110393106; HUGHES CP, 1982, BRIT J PSYCHIAT, V140, P566, DOI 10.1192/bjp.140.6.566; KANE RL, 1985, J CLIN EXP NEUROPSYC, V7, P211, DOI 10.1080/01688638508401254; Keifer E, 2013, J CLIN EXP NEUROPSYC, V35, P1048, DOI 10.1080/13803395.2013.854319; Larrabee G. J., 1992, J CLIN EXPT NEUROPSY, V14, P65; LARRABEE GJ, 1985, J CLIN EXP NEUROPSYC, V7, P497, DOI 10.1080/01688638508401281; Larrabee GJ, 2003, ARCH CLIN NEUROPSYCH, V18, P673, DOI 10.1016/S0887-6177(02)00157-9; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P410, DOI 10.1076/clin.17.3.410.18089; Larrabee GJ, 2003, CLIN NEUROPSYCHOL, V17, P395, DOI 10.1076/clin.17.3.395.18087; LARRABEE GJ, 1983, J CLIN NEUROPSYCHOL, V5, P159, DOI 10.1080/01688638308401162; LARRABEE GJ, 1995, J CLIN EXP NEUROPSYC, V17, P536, DOI 10.1080/01688639508405144; LARRABEE GJ, 1992, ARCH CLIN NEUROPSYCH, V7, P395, DOI 10.1016/0887-6177(92)90152-D; LARRABEE GJ, 1986, INT J NEUROSCI, V29, P141, DOI 10.3109/00207458608985644; LARRABEE GJ, 1986, J CLIN EXP NEUROPSYC, V8, P275, DOI 10.1080/01688638608401318; Larrabee GJ, 2000, CLIN NEUROPSYCHOL, V14, P139, DOI 10.1076/1385-4046(200002)14:1;1-8;FT139; Larrabee GJ, 2014, CLIN NEUROPSYCHOL, V28, P1230, DOI 10.1080/13854046.2014.988754; Larrabee GJ, 2014, ARCH CLIN NEUROPSYCH, V29, P695, DOI 10.1093/arclin/acu049; Larrabee GJ, 2012, J INT NEUROPSYCH SOC, V18, P625, DOI 10.1017/S1355617712000240; Larrabee GJ, 2009, CLIN NEUROPSYCHOL, V23, P167, DOI 10.1080/13854040801968443; LEESHALEY PR, 1991, PSYCHOL REP, V68, P203, DOI 10.2466/PR0.68.1.203-210; Leonberger FT, 1992, NEUROPSYCHOLOGY, V6, P239, DOI DOI 10.1037/0894-4105.6.3.239; Lezak MD, 2012, NEUROPSYCHOLOGICAL A; Loring DW, 2008, CLIN NEUROPSYCHOL, V22, P524, DOI 10.1080/13854040701425445; Loring DW, 2006, CLIN NEUROPSYCHOL, V20, P221, DOI 10.1080/13854040590947443; MARSON DC, 1995, ARCH NEUROL-CHICAGO, V52, P949, DOI 10.1001/archneur.1995.00540340029010; Miller JB, 2010, CLIN NEUROPSYCHOL, V24, P678, DOI 10.1080/13854041003601493; Miller LS, 2001, NEUROPSYCHOL REV, V11, P143, DOI 10.1023/A:1016602708066; Novack TA, 2006, BRAIN INJURY, V20, P455, DOI 10.1080/02699050600664541; Powell J B, 1991, Arch Clin Neuropsychol, V6, P241, DOI 10.1016/0887-6177(91)90001-P; Reedy SD, 2013, ARCH CLIN NEUROPSYCH, V28, P30, DOI 10.1093/arclin/acs106; Rienstra A, 2013, J CLIN EXP NEUROPSYC, V35, P59, DOI 10.1080/13803395.2012.751361; Rohling ML, 2011, PSYCHOL BULL, V137, P708, DOI 10.1037/a0023327; Salthouse TA, 2005, NEUROPSYCHOLOGY, V19, P532, DOI 10.1037/0894-4105.19.4.532; Salthouse TA, 2010, PRACT RESOUR MENT, P217, DOI 10.1016/B978-0-12-375035-8.10008-4; SHERER M, 1994, ARCH CLIN NEUROPSYCH, V9, P427, DOI 10.1016/0887-6177(94)90005-1; Sherod MG, 2009, J INT NEUROPSYCH SOC, V15, P258, DOI 10.1017/S1355617709090365; Smith G. E., 1992, PSYCHOL ASSESSMENT, V4, P382, DOI DOI 10.1037/1040-3590.4.3.382; Sperling RA, 2011, ALZHEIMERS DEMENT, V7, P280, DOI 10.1016/j.jalz.2011.03.003; SPREEN O, 1965, J NERV MENT DIS, V140, P323, DOI 10.1097/00005053-196505000-00002; Sweet JJ, 2011, CLIN NEUROPSYCHOL, V25, P12, DOI 10.1080/13854046.2010.544165; Tenhula WN, 1996, CLIN NEUROPSYCHOL, V10, P104, DOI 10.1080/13854049608406669; Trahan DE, 1997, ARCH CLIN NEUROPSYCH, V12, P57, DOI 10.1016/S0887-6177(96)00025-X; TRAHAN DE, 1989, CLIN NEUROPSYCHOL, V3, P169, DOI DOI 10.1080/13854048908403290; VEGA A, 1967, J CONSULT PSYCHOL, V31, P619, DOI 10.1037/h0025112; Wechsler D., 2009, WMS 4 TECHNICAL INTE; Whelihan WM, 2005, ARCH CLIN NEUROPSYCH, V20, P217, DOI 10.1016/j.acn.2004.07.002; WILLIAMS JM, 1987, J CONSULT CLIN PSYCH, V55, P595, DOI 10.1037/0022-006X.55.4.595; Williams MW, 2013, CLIN NEUROPSYCHOL, V27, P356, DOI 10.1080/13854046.2013.765507; Wolfson, 1993, HALSTEAD REITAN NEUR; Zakzanis K. K., 1999, STUD NEUROPSYCHOL DE; [No title captured]	82	15	15	2	28	AMER PSYCHOLOGICAL ASSOC	WASHINGTON	750 FIRST ST NE, WASHINGTON, DC 20002-4242 USA	0003-066X	1935-990X		AM PSYCHOL	Am. Psychol.	NOV	2015	70	8					779	788		10.1037/a0039835			11	Psychology, Multidisciplinary	Social Science Citation Index (SSCI)	Psychology	CX4WM	WOS:000365701100023	26618971				2022-02-06	
J	Liu, ZH; Tu, PH; Chen, NY; Yip, PK; Bowes, AL; Lee, CC; Chan, SH; Kung, CC; Wang, AYC; Wu, CT; Lee, ST				Liu, Zhuo-Hao; Tu, Po-Hsun; Chen, Nan-Yu; Yip, Ping K.; Bowes, Amy L.; Lee, Cheng-Chi; Chan, She-Hung; Kung, Chua-Chi; Wang, Alvin Yi-Chou; Wu, Chieh-Tsai; Lee, Shih-Tseng			Raised Proinflammatory Cytokine Production Within Cerebrospinal Fluid Precedes Fever Onset in Patients With Neurosurgery-Associated Bacterial Meningitis	CRITICAL CARE MEDICINE			English	Article						cerebrospinal fluid; cytokines; fever; meningitis; neurosurgery; proinflammatory markers	NECROSIS-FACTOR-ALPHA; POSTOPERATIVE ASEPTIC-MENINGITIS; SERUM PROCALCITONIN LEVELS; TRAUMATIC BRAIN-INJURY; CENTRAL-NERVOUS-SYSTEM; GROWTH-FACTOR-BETA; SUBARACHNOID HEMORRHAGE; DIFFERENTIAL-DIAGNOSIS; MENINGEAL INFLAMMATION; INTERLEUKIN-6 LEVELS	Objective: The objective of the present study was to determine whether selective inflammatory cytokine concentrations within cerebrospinal fluid are useful markers for the differential diagnosis of aseptic and bacterial meningitis within neurosurgical patients. Design: Prospective, open-label, observational, cohort study. Setting: Neurosurgical ICU, Chang Gung Memorial Hospital. Patients: Thirty-two consecutive neurosurgical patients who had postoperative fever following external ventricular drain insertion for the treatment of brain injury underwent serial cerebrospinal fluid cytokine analysis pre and post fever to determine the value of such markers in ascertaining the differential diagnosis of meningitis. Intervention: Cerebrospinal fluid samples were collected on the day of fever onset, as well as on day 2 and 4 pre and post fever development. Tumor necrosis factor-, interleukin-1, interleukin-6, interleukin-8, transforming growth factor-, and procalcitonin were subsequently analyzed using enzyme-linked immunosorbent assay analysis techniques. Measurement and Main Results: Inflammatory marker levels were compared among febrile aseptic, bacterial, and nonmeningitis patients to determine cerebrospinal fluid inflammatory changes over time. Significant increases in cerebrospinal fluid tumor necrosis factor -, interleukin-1, interleukin-6, and interleukin-8 levels were observed within patients with bacterial meningitis at fever onset, which was not evident in aseptic or nonmeningitis patients. Furthermore, significant increases in cerebrospinal fluid tumor necrosis factor-, interleukin-1, interleukin-6, and interleukin-8 levels were detected as early as 4 days prior to fever onset within patients with bacterial meningitis when compared with both aseptic and nonmeningitis groups. Interestingly, procalcitonin was only significantly increased in patients with bacterial meningitis on the fourth day post fever. Conclusion: The present study suggests that raised cerebrospinal fluid tumor necrosis factor -, interleukin-1, and interleukin-8 in a temporal manner may indicate early bacterial meningitis development in neurosurgical patients, enabling earlier diagnostic certainty and improved patient outcomes.	[Liu, Zhuo-Hao; Tu, Po-Hsun; Lee, Cheng-Chi; Chan, She-Hung; Kung, Chua-Chi; Wang, Alvin Yi-Chou; Wu, Chieh-Tsai; Lee, Shih-Tseng] Chang Gung Med Coll & Univ, Chang Gung Mem Hosp, Dept Neurosurg, Linkou, Taiwan; [Liu, Zhuo-Hao; Yip, Ping K.; Bowes, Amy L.] Queen Mary Univ London, Blizard Inst, Barts & London Sch Med & Dent, Ctr Neurosci & Trauma, London, England; [Chen, Nan-Yu] Chang Gung Med Coll & Univ, Chang Gung Mem Hosp, Dept Internal Med, Linkou, Taiwan		Chen, NY (corresponding author), Chang Gung Med Coll & Univ, Chang Gung Mem Hosp, Dept Neurosurg, Linkou, Taiwan.	yun0710@cgmh.org.tw	Liu, Zhuo-Hao/C-6758-2011	Liu, Zhuo-Hao/0000-0003-4079-8697; Wu, Chieh-Tsai/0000-0002-8419-3764; Chen, Nan-Yu/0000-0001-8922-397X	Chang Gung Memorial Hospital, TaiwanChang Gung Memorial Hospital [CMRP982171B]; Barts and the London Charity	We acknowledge the generous support of Chang Gung Memorial Hospital, Taiwan (CMRP982171B) (Dr. Liu) and Barts and the London Charity (Dr. Yip).	Vazquez JA, 2012, J EMERG MED, V43, P322, DOI 10.1016/j.jemermed.2011.07.029; Alkholi UM, 2011, J GLOB INFECT DIS, V3, P14, DOI 10.4103/0974-777X.77290; ALOISI F, 1992, J IMMUNOL, V149, P2358; Arabi Y, 2005, AM J INFECT CONTROL, V33, P137, DOI 10.1016/j.ajic.2004.11.008; Aschner M, 1998, TOXICOL LETT, V103, P283, DOI 10.1016/S0378-4274(98)00324-5; Bhimraj A, 2012, CLEV CLIN J MED, V79, P393, DOI 10.3949/ccjm.79gr.12003; Bielekova B, 2012, PLOS ONE, V7, DOI 10.1371/journal.pone.0048370; BLOMSTEDT GC, 1985, ACTA NEUROCHIR, V78, P81, DOI 10.1007/BF01808684; BLOMSTEDT GC, 1987, ACTA NEUROCHIR, V89, P112, DOI 10.1007/BF01560375; Bociaga-Jasik M, 2012, ADV MED SCI-POLAND, V57, P142, DOI 10.2478/v10039-012-0013-y; BOHR V, 1984, ARCH NEUROL-CHICAGO, V41, P1045, DOI 10.1001/archneur.1984.04050210043012; Brouwer MC, 2012, LANCET, V380, P1684, DOI 10.1016/S0140-6736(12)61185-4; Brown EM, 2000, BRIT J NEUROSURG, V14, P7; Buttram SDW, 2007, J NEUROTRAUM, V24, P1707, DOI 10.1089/neu.2007.0349; CARMEL PW, 1993, PEDIATR NEUROSURG, V19, P276, DOI 10.1159/000120744; Chen C, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0101961; Choi SH, 2013, INFECT CHEMOTHER, V45, P308, DOI 10.3947/ic.2013.45.3.308; Coutinho LG, 2013, BMC INFECT DIS, V13, DOI 10.1186/1471-2334-13-326; Desai A, 2009, J NEUROS-PEDIATR, V4, P184, DOI 10.3171/2009.4.PEDS08279; Dubos F, 2006, J PEDIATR-US, V149, P72, DOI 10.1016/j.jpeds.2006.02.034; Fernandes D, 2014, J CRIT CARE, V29, P347, DOI 10.1016/j.jcrc.2013.12.001; Forgacs P, 2001, CLIN INFECT DIS, V32, P179, DOI 10.1086/318471; FREI K, 1989, EUR J IMMUNOL, V19, P689, DOI 10.1002/eji.1830190418; HAMA T, 1989, NEUROSCI LETT, V104, P340, DOI 10.1016/0304-3940(89)90600-9; HATTORI A, 1993, J BIOL CHEM, V268, P2577; Helmy A, 2011, J CEREBR BLOOD F MET, V31, P658, DOI 10.1038/jcbfm.2010.142; Hopkins SJ, 2012, J NEUROINFLAMM, V9, DOI 10.1186/1742-2094-9-255; Howitz MF, 2014, EPIDEMIOL INFECT, V142, P1300, DOI 10.1017/S0950268813001878; Huang CC, 1997, J NEUROL, V244, P634, DOI 10.1007/s004150050159; Imai K, 2000, INFECT IMMUN, V68, P2418, DOI 10.1128/IAI.68.5.2418-2423.2000; Jereb M, 2001, INFECTION, V29, P209, DOI 10.1007/s15010-001-1165-z; Junior P, 2011, BRAZ J INFECT DIS, V15, P156, DOI DOI 10.1016/S1413-8670(11)70162-3; Konstantinidis T, 2015, J CLIN LAB ANAL, V29, P169, DOI 10.1002/jcla.21746; Kulik DM, 2013, J EMERG MED, V45, P508, DOI 10.1016/j.jemermed.2013.03.042; Kwon KY, 2001, J KOREAN MED SCI, V16, P774, DOI 10.3346/jkms.2001.16.6.774; Laifer G, 2005, CLIN MICROBIOL INFEC, V11, P679, DOI 10.1111/j.1469-0691.2005.01205.x; LIU T, 1994, STROKE, V25, P1481, DOI 10.1161/01.STR.25.7.1481; Lopez-Cortes LF, 2000, CRIT CARE MED, V28, P215, DOI 10.1097/00003246-200001000-00035; LOPEZCORTES LF, 1995, J INFECT DIS, V172, P581, DOI 10.1093/infdis/172.2.581; Lozier AP, 2002, NEUROSURGERY, V51, P170, DOI 10.1097/00006123-200207000-00024; Lv S, 2014, EUR J NEUROL, V21, P1115, DOI 10.1111/ene.12441; Matera G, 2012, BMC MICROBIOL, V12, DOI 10.1186/1471-2180-12-68; MATHIESEN T, 1993, J NEUROSURG, V78, P562, DOI 10.3171/jns.1993.78.4.0562; Mukai AO, 2006, PEDIATR NEUROL, V34, P25, DOI 10.1016/j.pediatrneurol.2005.06.003; MUSTAFA MM, 1989, J PEDIATR-US, V115, P208, DOI 10.1016/S0022-3476(89)80067-8; Netea MG, 2010, PLOS PATHOG, V6, DOI 10.1371/journal.ppat.1000661; OHGA S, 1994, ARCH DIS CHILD, V70, P123, DOI 10.1136/adc.70.2.123; Ostergaard C, 1996, EUR J CLIN MICROBIOL, V15, P166, DOI 10.1007/BF01591492; Prasad R, 2014, PEDIATR NEUROL, V50, P60, DOI 10.1016/j.pediatrneurol.2013.08.016; QUAGLIARELLO V, 1992, NEW ENGL J MED, V327, P864, DOI 10.1056/NEJM199209173271208; RAMILO O, 1990, J EXP MED, V172, P497, DOI 10.1084/jem.172.2.497; REDDY ST, 1994, J LEUKOCYTE BIOL, V55, P192, DOI 10.1002/jlb.55.2.192; Richard GC, 2013, CLIN PEDIATR EMERG M, V14, P146; ROSS D, 1988, J NEUROSURG, V69, P669, DOI 10.3171/jns.1988.69.5.0669; SAUKKONEN K, 1990, J EXP MED, V171, P439, DOI 10.1084/jem.171.2.439; Schade RP, 2006, J NEUROSURG, V104, P101, DOI 10.3171/jns.2006.104.1.101; Schade RP, 2005, J NEUROSURG, V102, P229, DOI 10.3171/jns.2005.102.2.0229; Schoch B, 2008, ZBL NEUROCHIR, V69, P80, DOI 10.1055/s-2007-1022559; Schwarz S, 2000, CRIT CARE MED, V28, P1828, DOI 10.1097/00003246-200006000-00024; SEKI T, 1993, IMMUNOLOGY, V80, P333; Takahashi W, 2014, J CRIT CARE, V29, DOI 10.1016/j.jcrc.2014.02.020; Tang RB, 2001, CHILD NERV SYST, V17, P453, DOI 10.1007/s003810000422; Tauber MG, 1999, CLIN INFECT DIS, V28, P1, DOI 10.1086/515079; TAUPIN V, 1993, J NEUROIMMUNOL, V42, P177, DOI 10.1016/0165-5728(93)90008-M; TSUNAWAKI S, 1988, NATURE, V334, P260, DOI 10.1038/334260a0; Tunkel AR, 2004, CLIN INFECT DIS, V39, P1267, DOI 10.1086/425368; VAN MEIR E, 1992, CANCER RES, V52, P4297; Viallon A, 1999, CLIN INFECT DIS, V28, P1313, DOI 10.1086/514793; Viallon A, 2011, CRIT CARE, V15, DOI 10.1186/cc10254; Walti LN, 2013, J INFECTION, V66, P424, DOI 10.1016/j.jinf.2012.12.010; Wandschneider W, 2003, J THORAC CARDIOV SUR, V126, P872, DOI 10.1016/S0022-5223(03)00692-5; Yo CH, 2012, ANN EMERG MED, V60, P591, DOI 10.1016/j.annemergmed.2012.05.027; Zarrouk V, 2007, CLIN INFECT DIS, V44, P1555, DOI 10.1086/518169	73	15	17	0	3	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0090-3493	1530-0293		CRIT CARE MED	Crit. Care Med.	NOV	2015	43	11					2416	2428		10.1097/CCM.0000000000001188			13	Critical Care Medicine	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine	CT5CX	WOS:000362826200019	26196350				2022-02-06	
J	Wang, D; Zheng, SQ; Chen, XC; Jiang, SW; Chen, HB				Wang, Dong; Zheng, Shao-Qin; Chen, Xian-Cai; Jiang, Shi-Wen; Chen, Hai-Bin			Comparisons between small intestinal and gastric feeding in severe traumatic brain injury: a systematic review and meta-analysis of randomized controlled trials	JOURNAL OF NEUROSURGERY			English	Article						enteral nutrition; traumatic brain injury; small bowel feeding; gastric feeding; meta-analysis	IMMUNE-ENHANCING DIET; ENTERAL NUTRITION; VENTILATION; GUIDELINES; PNEUMONIA; SUPPORT; BLUNT; RISK; COMA	OBJECT Nutritional support is highly recommended for reducing the risk of nosocomial infections, such as pneumonitis, in patients with severe traumatic brain injury (TBI). Currently, there is no consensus for the preferred route of feeding. The authors compared the risks of pneumonitis and other important outcomes associated with small intestinal and gastric feeding in patients with severe TBI. METHODS This systematic review and meta-analysis was conducted according to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) guidelines. Relevant randomized controlled trials (up to December 16, 2013) that compared small bowel to gastric feeding in patients with severe TBI were identified from searches in the PubMed and Embase databases. The primary outcome was risk of pneumonia. Secondary outcomes included ventilator-associated pneumonia, mortality, length of intensive care unit stay, length of hospital stay, duration of mechanical ventilation, total number of complications, aspiration, diarrhea, distention, Glasgow Coma Scale score, Injury Severity Score, and Acute Physiology and Chronic Health Evaluation II score. RESULTS Five randomized controlled trials with 325 participants in total were included in the meta-analysis. Compared with gastric feeding, small bowel feeding was associated with a significant reduction in the incidence of pneumonitis (risk ratio [RR] 0.67; 95% CI 0.52-0.87; p = 0.002; I-2 = 0.0%) and ventilator-associated pneumonia (RR 0.52; 95% CI 0.34-0.81; p = 0.003; I-2 = 0.0%). Small intestinal feeding was also associated with a decrease in the total number of complications (RR 0.43; 95% CI 0.20-0.93; p = 0.03; I-2 = 68%). However, small intestinal feeding did not seem to significantly convert any of the other end points in the meta-analysis. CONCLUSIONS The limited evidence suggests that small bowel feeding in patients with severe TBI is associated with a risk of pneumonia that is lower than that with gastric feeding. From this result, the authors recommend the use of small intestinal feeding to reduce the incidence of pneumonitis in patients with severe TBI.	[Wang, Dong; Zheng, Shao-Qin; Chen, Hai-Bin] Shantou Univ, Affiliated Hosp 1, Coll Med, Dept Neurosurg, Shantou, Guangdong, Peoples R China; [Wang, Dong; Chen, Xian-Cai; Chen, Hai-Bin] Shantou Univ, Coll Med, Dept Histol & Embryol, Shantou 515041, Guangdong, Peoples R China; [Jiang, Shi-Wen] Mercer Univ, Sch Med, Dept Biomed Sci, Savannah, GA USA		Chen, HB (corresponding author), Shantou Univ, Coll Med, Dept Histol & Embryol, 22 Xinling Rd, Shantou 515041, Guangdong, Peoples R China.	chenhb@stu.edu.cn					Escribano JA, 2011, NUTR HOSP, V26, P72, DOI 10.1590/S0212-16112011000800016; Acosta-Escribano J, 2010, INTENS CARE MED, V36, P1532, DOI 10.1007/s00134-010-1908-3; Alhazzani W, 2013, CRIT CARE, V17, DOI 10.1186/cc12806; APELGREN KN, 1982, CRIT CARE MED, V10, P305, DOI 10.1097/00003246-198205000-00003; BAKER SP, 1974, J TRAUMA, V14, P187, DOI 10.1097/00005373-197403000-00001; Brain Trauma Foundation, 2007, J Neurotrauma, V24 Suppl 1, pS77; DEMPSEY DT, 1988, AM J CLIN NUTR, V47, P352, DOI 10.1093/ajcn/47.2.352; Faul M, 2010, TRAUMATIC BRAIN INJU; Fernandez-Vivas M, 2003, INTENS CARE MED, V29, P1126, DOI 10.1007/s00134-003-1768-1; Giacino JT, 2012, NEW ENGL J MED, V366, P819, DOI 10.1056/NEJMoa1102609; GRAHM TW, 1989, NEUROSURGERY, V25, P729, DOI 10.1227/00006123-198911000-00007; Higgins JPT, 2003, BRIT MED J, V327, P557, DOI 10.1136/bmj.327.7414.557; Higgins Julian P T, 2011, BMJ, V343, pd5928, DOI 10.1136/bmj.d5928; Jing JY, 2013, CLIN NUTR, V32, P8, DOI [10.1016/j.clnu.2012.07.002, 10.1016/j.clnu.2012.7.002]; KNAUS WA, 1985, CRIT CARE MED, V13, P818, DOI 10.1097/00003246-198510000-00009; Kortbeek JB, 1999, J TRAUMA, V46, P992, DOI 10.1097/00005373-199906000-00002; Kreymann KG, 2006, CLIN NUTR, V25, P210, DOI 10.1016/j.clnu.2006.01.021; KUDSK KA, 1992, ANN SURG, V215, P503, DOI 10.1097/00000658-199205000-00013; Kudsk KA, 1996, ANN SURG, V224, P531, DOI 10.1097/00000658-199610000-00011; Marino LV, 2005, J CLIN NEUROSCI, V12, P435, DOI 10.1016/j.jocn.2004.04.009; Minard G, 2000, JPEN-PARENTER ENTER, V24, P145, DOI 10.1177/0148607100024003145; Montejo JC, 2010, INTENS CARE MED, V36, P1386, DOI 10.1007/s00134-010-1856-y; Reignier J, 2013, JAMA-J AM MED ASSOC, V309, P249, DOI 10.1001/jama.2012.196377; Rosenfeld JV, 2012, LANCET, V380, P1088, DOI 10.1016/S0140-6736(12)60864-2; Taylor SJ, 1999, CRIT CARE MED, V27, P2525, DOI 10.1097/00003246-199911000-00033; TEASDALE G, 1976, ACTA NEUROCHIR, V34, P45, DOI 10.1007/BF01405862; TEASDALE G, 1974, LANCET, V2, P81; Wang X, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0058838	28	15	23	1	14	AMER ASSOC NEUROLOGICAL SURGEONS	ROLLING MEADOWS	5550 MEADOWBROOK DRIVE, ROLLING MEADOWS, IL 60008 USA	0022-3085	1933-0693		J NEUROSURG	J. Neurosurg.	NOV	2015	123	5					1194	1201		10.3171/2014.11.JNS141109			8	Clinical Neurology; Surgery	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Surgery	CU3QL	WOS:000363439800013	26024007	Bronze			2022-02-06	
J	Farrell-Carnahan, L; Barnett, S; Lamberty, G; Hammond, FM; Kretzmer, TS; Franke, LM; Geiss, M; Howe, L; Nakase-Richardson, R				Farrell-Carnahan, Leah; Barnett, Scott; Lamberty, Gregory; Hammond, Flora M.; Kretzmer, Tracy S.; Franke, Laura M.; Geiss, Meghan; Howe, Laura; Nakase-Richardson, Risa			Insomnia symptoms and behavioural health symptoms in veterans 1 year after traumatic brain injury	BRAIN INJURY			English	Article						Anxiety; depression; headache; insomnia; substance use; TBI; traumatic brain injury	DEPLOYED MILITARY PERSONNEL; POSTTRAUMATIC-STRESS-DISORDER; AFFAIRS POLYTRAUMA SYSTEM; SLEEP DISTURBANCE; HEAD-INJURY; ASSESSING DEPRESSION; SUICIDE RISK; REHABILITATION; SEVERITY; AMNESIA	Objective: Insomnia and behavioural health symptoms 1 year after traumatic brain injury (TBI) were examined in a clinical sample representative of veterans who received inpatient treatment for TBI-related issues within the Veterans Health Administration.Methods: This was a cross-sectional sub-study (n=112) of the Polytrauma Rehabilitation Centres' traumatic brain injury model system programme. Prevalence estimates of insomnia, depression, general anxiety, nightmares, headache and substance use, stratified by injury severity, were derived. Univariate logistic regression was used to examine unadjusted effects for each behavioural health problem and insomnia by injury severity.Results: Participants were primarily male, < 30 years old and high school educated. Twenty-nine per cent met study criteria for insomnia; those with mild TBI were significantly more likely to meet criteria (43%) than those with moderate/severe TBI (22%), (2)(1, n=112)=5.088, p0.05. Univariable logistic regression analyses revealeddepressive symptoms and general anxiety were significantly associated with insomnia symptoms after TBI of any severity. Headache and binge drinking were significantly inversely related to insomnia symptoms after moderate/severe TBI, but not MTBI.Conclusions: Veterans with history of TBI, of any severity, and current insomnia symptoms may be at increased risk for depression and anxiety 1 year after TBI.	[Farrell-Carnahan, Leah; Franke, Laura M.; Geiss, Meghan] Hunter Holmes McGuire Vet Affairs Med Ctr, Richmond, VA USA; [Farrell-Carnahan, Leah; Franke, Laura M.] Virginia Commonwealth Univ, Richmond, VA USA; [Barnett, Scott; Kretzmer, Tracy S.; Nakase-Richardson, Risa] James A Haley Vet Hosp, Tampa, FL 33612 USA; [Lamberty, Gregory] Minneapolis Vet Affairs Hlth Care Syst, Minneapolis, MN USA; [Lamberty, Gregory] Univ Minnesota, Sch Med, Minneapolis, MN 55455 USA; [Hammond, Flora M.] Indiana Univ Sch Med, Indianapolis, IN 46202 USA; [Franke, Laura M.] Def & Vet Brain Injury Ctr, Richmond, VA USA; [Howe, Laura] VA Palo Alto Hlth Care Syst, Palo Alto, CA USA		Farrell-Carnahan, L (corresponding author), 1201 Broad Rock Blvd Mailcode 116B, Richmond, VA 23249 USA.	leah.farrell-carnahan@va.gov		Howe, Laura/0000-0003-3357-2796	Department of Veterans AffairsUS Department of Veterans Affairs; Department of Education, National Institute on Disability and Rehabilitation Research	This study was carried out by researchers affiliated with the Polytrauma Rehabilitation Centre Traumatic Brain Injury Model System Collaboration, the National Institute for Disability and Rehabilitation Research Traumatic Brain Injury Model Systems (H133A120035) and the Federal Government Centre of Innovation on Disability and Rehabilitation VA Health Services Research and Development (HSRD) (1 I50 HX001233-01 & VA HSRD; SDR 13-228). The Polytrauma Rehabilitation Centre Traumatic Brain Injury Model System Collaboration is funded through an Interagency Agreement between the Department of Veterans Affairs and the Department of Education, National Institute on Disability and Rehabilitation Research. The contents do not necessarily represent the policy of the Department of Education or the Department of Veterans Affairs and endorsement by the USA federal government should not be assumed.	American Psychiatric Association, 2000, DSM 4 DIAGN STAT MAN, V4th; Baumann CR, 2007, BRAIN, V130, P1873, DOI 10.1093/brain/awm109; Beetar JT, 1996, ARCH PHYS MED REHAB, V77, P1298, DOI 10.1016/S0003-9993(96)90196-3; Bender R, 2001, J CLIN EPIDEMIOL, V54, P343, DOI 10.1016/S0895-4356(00)00314-0; Bogod NM, 2003, J INT NEUROPSYCH SOC, V9, P450, DOI 10.1017/S1355617703930104; Bradbury CL, 2008, ARCH PHYS MED REHAB, V89, pS61, DOI 10.1016/j.apmr.2008.08.210; Bryan CJ, 2013, JAMA PSYCHIAT, V70, P686, DOI 10.1001/jamapsychiatry.2013.1093; Bryan CJ, 2013, J HEAD TRAUMA REHAB, V28, P13, DOI 10.1097/HTR.0b013e31826c73cc; Bryan CJ, 2011, HEADACHE, V51, P945, DOI 10.1111/j.1526-4610.2011.01887.x; Cappelleri JC, 2009, HEALTH QUAL LIFE OUT, V7, DOI 10.1186/1477-7525-7-54; CICERONE KD, 1995, J HEAD TRAUMA REHAB, V10, P1, DOI 10.1097/00001199-199510030-00002; COUCH JR, 1995, J NEUROL REHABIL, V9, P83; Cox WM, 2003, J ADDICT DIS, V22, P93, DOI 10.1300/J069v22n01_07; de Man-van Ginkel JM, 2012, NURS RES, V61, P333, DOI 10.1097/NNR.0b013e31825d9e9e; Dobscha SK, 2009, PAIN MED, V10, P1200, DOI 10.1111/j.1526-4637.2009.00721.x; Fann JR, 2009, J NEUROTRAUM, V26, P2383, DOI 10.1089/neu.2009.1091; Fann JR, 2005, J HEAD TRAUMA REHAB, V20, P501, DOI 10.1097/00001199-200511000-00003; Farrell-Carnahan L, 2013, MIL MED, V178, P951, DOI 10.7205/MILMED-D-13-00037; Formisano R, 2009, J HEADACHE PAIN, V10, P145, DOI 10.1007/s10194-009-0108-4; Hanks RA, 2008, ARCH PHYS MED REHAB, V89, P950, DOI 10.1016/j.apmr.2008.01.011; Hatoum HT, 1998, PHARMACOECONOMICS, V14, P629, DOI 10.2165/00019053-199814060-00004; Hoffman JM, 2007, AM J PHYS MED REHAB, V86, P962, DOI 10.1097/PHM.0b013e31815b5ee5; Hoffman JM, 2011, J NEUROTRAUM, V28, P1719, DOI 10.1089/neu.2011.1914; Hoge CW, 2008, NEW ENGL J MED, V358, P2179; Jackson WT, 1998, ARCH PHYS MED REHAB, V79, P718, DOI 10.1016/S0003-9993(98)90051-X; Jorge RE, 2004, ARCH GEN PSYCHIAT, V61, P42, DOI 10.1001/archpsyc.61.1.42; Kalmar K, 2008, ARCH PHYS MED REHAB, V89, P942, DOI 10.1016/j.apmr.2008.01.008; Kreutzer JS, 2001, BRAIN INJURY, V15, P563, DOI 10.1080/02699050010009108; Kroenke K, 2001, J GEN INTERN MED, V16, P606, DOI 10.1046/j.1525-1497.2001.016009606.x; Lamberty GJ, 2014, J HEAD TRAUMA REHAB, V29, pE1, DOI 10.1097/HTR.0b013e31829a64d1; Leger D, 2006, SLEEP, V29, P171; LEVIN HS, 1979, J NERV MENT DIS, V167, P675, DOI 10.1097/00005053-197911000-00004; Lew HL, 2010, AM J PHYS MED REHAB, V89, P437, DOI 10.1097/PHM.0b013e3181ddd301; Lowe B, 2008, MED CARE, V46, P266, DOI 10.1097/MLR.0b013e318160d093; Macera CA, 2013, SLEEP, V36, P83, DOI 10.5665/sleep.2306; Mahmood O, 2004, J HEAD TRAUMA REHAB, V19, P378, DOI 10.1097/00001199-200409000-00003; Mathias JL, 2012, SLEEP MED, V13, P898, DOI 10.1016/j.sleep.2012.04.006; Naimi TS, 2003, JAMA-J AM MED ASSOC, V289, P70, DOI 10.1001/jama.289.1.70; Nakase-Richardson R, 2011, J NEUROL NEUROSUR PS, V82, P494, DOI 10.1136/jnnp.2010.222489; Nakase-Richardson R, 2007, J NEUROL NEUROSUR PS, V78, P872, DOI 10.1136/jnnp.2006.104190; Nakase-Richardson R, 2009, ARCH PHYS MED REHAB, V90, P17, DOI 10.1016/j.apmr.2008.06.030; Oluellet MC, 2007, ARCH PHYS MED REHAB, V88, P1581, DOI 10.1016/j.apmr.2007.09.006; Ouellet MC, 2006, J HEAD TRAUMA REHAB, V21, P199, DOI 10.1097/00001199-200605000-00001; Parsons E, 2013, THEM SESS MAY 20 8 1; Pinto-Meza A, 2005, J GEN INTERN MED, V20, P738, DOI 10.1111/j.1525-1497.2005.0144.x; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Rogers JM, 2007, BRAIN INJURY, V21, P1321, DOI 10.1080/02699050701765700; Ruff RL, 2009, J REHABIL RES DEV, V46, P1071, DOI 10.1682/JRRD.2009.05.0062; RUSSELL WR, 1946, BRAIN, V69, P280, DOI 10.1093/brain/69.4.280; RUSSELL WR, 1961, ARCH NEUROL-CHICAGO, V5, P4, DOI 10.1001/archneur.1961.00450130006002; Russell WR, 1932, BRAIN, V55, P549, DOI 10.1093/brain/55.4.549; Seel RT, 2003, ARCH PHYS MED REHAB, V84, P177, DOI 10.1053/apmr.2003.50106; SPIELMAN AJ, 1987, PSYCHIAT CLIN N AM, V10, P541; Spitzer RL, 2006, ARCH INTERN MED, V166, P1092, DOI 10.1001/archinte.166.10.1092; Tanielian T., 2008, INVISIBLE WOUNDS WAR; The Management of Major Depressive Disorder Working Group, 2010, VA DOD CLIN PRACT GU; The Management of Post-Traumatic Stress Working Group, 2009, MAN MAJ DEPR DIS; United States Department of Health and Human Services National Institutes of Health National Institute on Alcohol Abuse and Alcoholism, 2013, MOD BING DRINK; Wallace DM, 2011, SLEEP MED, V12, P850, DOI 10.1016/j.sleep.2011.06.004; WEATHERS FW, 1993, M INT SOC TRAUM STRE; Zeitzer JM, 2009, J REHABIL RES DEV, V46, P827, DOI 10.1682/JRRD.2008.08.0099	61	15	16	0	9	TAYLOR & FRANCIS INC	PHILADELPHIA	530 WALNUT STREET, STE 850, PHILADELPHIA, PA 19106 USA	0269-9052	1362-301X		BRAIN INJURY	Brain Inj.	OCT 15	2015	29	12					1400	1408		10.3109/02699052.2015.1063161			9	Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Rehabilitation	CV7CO	WOS:000364430200002	26287761				2022-02-06	
J	Hanell, A; Greer, JE; Jacobs, KM				Hanell, Anders; Greer, John E.; Jacobs, Kimberle M.			Increased Network Excitability Due to Altered Synaptic Inputs to Neocortical Layer V Intact and Axotomized Pyramidal Neurons after Mild Traumatic Brain Injury	JOURNAL OF NEUROTRAUMA			English	Article						axotomy; field potential; neocortex; patch clamp; synaptic excitation	CONTROLLED CORTICAL IMPACT; TENSOR IMAGING FINDINGS; POSTTRAUMATIC EPILEPSY; DENTATE GYRUS; UNITED-STATES; AXONAL INJURY; IN-VITRO; CONNECTIVITY; CORTEX; MODEL	Mild traumatic brain injury (mTBI) can produce long lasting cognitive dysfunction. There is typically no cell death and only diffuse structural injury after mTBI. Thus, functional changes in intact neurons may contribute to symptoms. We have previously shown altered intrinsic properties of axotomized and intact neurons within 2 d after a central fluid percussion injury in mice expressing yellow fluorescent protein (YFP) that allow identification of axonal state prior to recording. Here, whole-cell patch clamp recordings were used to examine synaptic properties of YFP+ layer V pyramidal neurons. An increased frequency of spontaneous and miniature excitatory postsynaptic currents (EPSCs) was recorded from axotomized neurons at 1 d and intact neurons at 2 d after injury, likely reflecting an increased number of afferents. This also was reflected in the increased amplitude of the EPSC evoked by local extracellular stimulation for all neurons from injured cortex and increased likelihood of producing an action potential for intact cells. Field potentials recorded in superficial layers after online deep layer stimulation contained a single negative peak in controls but multiple negative peaks in injured tissue. The amplitude of this evoked negativity was significantly larger than controls over a series of stimulus intensities at both the 1 d and 2 d survival times. Interictal-like spikes never occurred in the field potential recordings from controls but were observed in 20-80% of stimulus presentations in injured cortex. Together, these results suggest an overall increase in network excitability and the production of particularly powerful (intact) neurons that have both increased intrinsic and synaptic excitability.	[Hanell, Anders; Jacobs, Kimberle M.] Virginia Commonwealth Univ, Dept Anat & Neurobiol, Richmond, VA 23298 USA; [Greer, John E.] Virginia Commonwealth Univ, Dept Neurosurg, Richmond, VA 23298 USA		Jacobs, KM (corresponding author), Virginia Commonwealth Univ, Dept Anat & Neurobiol, POB 980709, Richmond, VA 23298 USA.	kmjacobs@vcu.edu	Jacobs, Kimberle/AAW-7526-2020; Hanell, Anders/E-4776-2011	Hanell, Anders/0000-0001-9369-3886	National Institutes of HealthUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USA [NS077675]; NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKEUnited States Department of Health & Human ServicesNational Institutes of Health (NIH) - USANIH National Institute of Neurological Disorders & Stroke (NINDS) [R01NS077675] Funding Source: NIH RePORTER	This work was supported by National Institutes of Health Grant NS077675.	[Anonymous], 2013, MMWR MORB MORTAL WKL, V62, P549; Asemota AO, 2013, J NEUROTRAUM, V30, P67, DOI 10.1089/neu.2012.2605; Bigler ED, 2012, BRAIN IMAGING BEHAV, V6, P108, DOI 10.1007/s11682-011-9145-0; Bigler ED, 2011, NEUROREHABILITATION, V28, P63, DOI 10.3233/NRE-2011-0633; Blizzard CA, 2007, EUR J NEUROSCI, V26, P1100, DOI 10.1111/j.1460-9568.2007.05750.x; Bolkvadze T, 2012, J NEUROTRAUM, V29, P789, DOI 10.1089/neu.2011.1954; Buki A, 2006, ACTA NEUROCHIR, V148, P181, DOI 10.1007/s00701-005-0674-4; Carlson KF, 2011, J HEAD TRAUMA REHAB, V26, P103, DOI 10.1097/HTR.0b013e3181e50ef1; Catroppa C, 2005, J INT NEUROPSYCH SOC, V11, P84, DOI 10.1017/S1355617705050101; Catroppa C, 2011, BRAIN INJURY, V25, P858, DOI 10.3109/02699052.2011.589794; Cohen AS, 2007, PROG BRAIN RES, V161, P143, DOI 10.1016/S0079-6123(06)61010-8; CONNORS BW, 1984, NATURE, V310, P685, DOI 10.1038/310685a0; Dickson TC, 2007, NEUROREPORT, V18, P283, DOI 10.1097/WNR.0b013e3280143cdb; Ding MC, 2011, J NEUROSCI, V31, P14085, DOI 10.1523/JNEUROSCI.3572-11.2011; DIXON C E, 1988, Journal of Neurotrauma, V5, P91, DOI 10.1089/neu.1988.5.91; DIXON CE, 1987, J NEUROSURG, V67, P110, DOI 10.3171/jns.1987.67.1.0110; Dodd AB, 2014, J NEUROTRAUM, V31, P1235, DOI 10.1089/neu.2014.3337; Falo MC, 2008, J NEUROTRAUM, V25, P769, DOI 10.1089/neu.2008.0511; Farkas O, 2007, PROG BRAIN RES, V161, P43, DOI 10.1016/S0079-6123(06)61004-2; Geary EK, 2010, J INT NEUROPSYCH SOC, V16, P506, DOI 10.1017/S135561771000010X; George AL, 2011, BRAIN RES, V1374, P116, DOI 10.1016/j.brainres.2010.12.020; Gerberding J, 2003, REPORT C MILD TRAUMA, P1; Goforth PB, 2011, J NEUROPHYSIOL, V105, P2350, DOI 10.1152/jn.00467.2010; Goforth PB, 1999, J NEUROSCI, V19, P7367, DOI 10.1523/JNEUROSCI.19-17-07367.1999; Greer JE, 2013, ACTA NEUROPATHOL, V126, P59, DOI 10.1007/s00401-013-1119-4; Greer JE, 2012, J NEUROSCI, V32, P6682, DOI 10.1523/JNEUROSCI.0881-12.2012; Greer JE, 2011, J NEUROSCI, V31, P5089, DOI 10.1523/JNEUROSCI.5103-10.2011; Hall EC, 2014, J TRAUMA ACUTE CARE, V76, P859, DOI 10.1097/TA.0000000000000148; HOFFMAN SN, 1994, J NEUROPHYSIOL, V71, P1762, DOI 10.1152/jn.1994.71.5.1762; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; Hunt RF, 2010, J NEUROPHYSIOL, V103, P1490, DOI 10.1152/jn.00957.2009; Hunt RF, 2009, EXP NEUROL, V215, P243, DOI 10.1016/j.expneurol.2008.10.005; Ilvesmaki T, 2014, BRAIN, V137, P1876, DOI 10.1093/brain/awu095; Jin XM, 2006, J NEUROSCI, V26, P4891, DOI 10.1523/JNEUROSCI.4361-05.2006; Johnstone VPA, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0063454; Kansagara D., 2013, COMPLICATIONS MILD T; Kerr Zachary Y, 2014, N C Med J, V75, P8; Kharatishvili I, 2006, NEUROSCIENCE, V140, P685, DOI 10.1016/j.neuroscience.2006.03.012; Li HF, 2002, J NEUROPHYSIOL, V88, P2, DOI 10.1152/jn.00507.2001; Luo Q, 2013, J NEUROTRAUM, V30, P1702, DOI 10.1089/neu.2012.2679; Makwana M, 2010, J COMP NEUROL, V518, P699, DOI 10.1002/cne.22240; Mangels JA, 2002, NEUROPSYCHOLOGIA, V40, P2369, DOI 10.1016/S0028-3932(02)00084-2; Mascaro ALA, 2013, P NATL ACAD SCI USA, V110, P10824, DOI 10.1073/pnas.1219256110; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; Mishra AK, 2014, PLOS ONE, V9, DOI [10.1371/journal.pone.0086852, 10.1371/journal.pone.0095280]; Morgan RJ, 2008, P NATL ACAD SCI USA, V105, P6179, DOI 10.1073/pnas.0801372105; Nakagawa H, 2013, CELL DEATH DIS, V4, DOI 10.1038/cddis.2013.62; Nakayama K, 2005, J NEUROSCI, V25, P4040, DOI 10.1523/JNEUROSCI.4115-04.2005; Niogi SN, 2008, AM J NEURORADIOL, V29, P967, DOI 10.3174/ajnr.A0970; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; PRINCE DA, 1993, J NEUROPHYSIOL, V69, P1276, DOI 10.1152/jn.1993.69.4.1276; Rabinowitz AR, 2014, PSYCHIAT CLIN N AM, V37, P1, DOI 10.1016/j.psc.2013.11.004; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Shenton ME, 2012, BRAIN IMAGING BEHAV, V6, P137, DOI 10.1007/s11682-012-9156-5; Tarapore PE, 2013, J NEUROSURG, V118, P1306, DOI 10.3171/2013.3.JNS12398; Toth A, 2013, J NEUROTRAUM, V30, P2, DOI 10.1089/neu.2012.2486; Turrigiano G, 2007, CURR OPIN NEUROBIOL, V17, P318, DOI 10.1016/j.conb.2007.04.004	57	15	15	0	5	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	0897-7151	1557-9042		J NEUROTRAUM	J. Neurotrauma	OCT 15	2015	32	20					1590	1598		10.1089/neu.2014.3592			9	Critical Care Medicine; Clinical Neurology; Neurosciences	Science Citation Index Expanded (SCI-EXPANDED)	General & Internal Medicine; Neurosciences & Neurology	CS6VH	WOS:000362220500007	25789412	Green Published			2022-02-06	
J	Neville, IS; Hayashi, CY; El Hajj, SA; Zaninotto, ALC; Sabino, JP; Sousa, LM; Nagumo, MM; Brunoni, AR; Shieh, BDS; Amorim, RLO; Teixeira, MJ; Paiva, WS				Neville, Iuri Santana; Hayashi, Cintya Yukie; El Hajj, Simone Alves; Costa Zaninotto, Ana Luiza; Sabino, Juliana Perez; Sousa, Leonardo Moura, Jr.; Nagumo, Marcia Mitie; Brunoni, Andre Russowsky; Silva Shieh, Barbara Dal Forno; Oliveira Amorim, Robson Luis; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva			Repetitive Transcranial Magnetic Stimulation (rTMS) for the cognitive rehabilitation of traumatic brain injury (TBI) victims: study protocol for a randomized controlled trial	TRIALS			English	Article						Brain Injury; Cognition; Cognitive; Diffuse Axonal Injury; Non-invasive brain stimulation; Psychology; Repetitive transcranial magnetic stimulation (TMS, rTMS)	DIFFUSE AXONAL INJURY; QUALITY-OF-LIFE; ANXIETY INVENTORY; HEAD-INJURY; IMPAIRMENT; DEPRESSION; INTEGRITY; MODERATE; DAMAGE	Background: Repetitive Transcranial Magnetic Stimulation (rTMS) has been proposed as a new tool in neurological rehabilitation of victims of traumatic brain injury (TBI). However, its usefulness to treat this condition has never been tested rigorously. The primary goal is to conduct a study protocol to determine whether rTMS used to cognitive rehabilitation of victims of TBI with diffuse axonal injury (DAI) is a safe instrument and if it enhances cognitive function recovery. Methods: Double-blind randomized controlled trial of patients with diffuse axonal injury. Thirty-six patients will be randomized to either an active coil group or sham group in a 1: 1 ratio. rTMS protocol: 10 sessions of high-frequency rTMS (10 Hz) over the left dorsolateral prefrontal cortex (DLPFC). Cortical Excitability measures will be obtained. Neuropsychological evaluations will be performed 1 week before, 1 week and 3 months after rTMS. There are 2 study hypotheses: (1) rTMS over the left DLPFC in patients with DAI will improve cognitive function and (2) whether rTMS is safe in TBI patients. Discussion: This study evaluates the immediate and delayed effects of rTMS over the DLPFC on the cognitive domain of patients with DAI following TBI. rTMS has shown good results in treating major depression and may be promising for patients with TBI. As such, the results of this study can greatly modify the cognitive rehabilitation strategies.	[Neville, Iuri Santana; Sousa, Leonardo Moura, Jr.; Oliveira Amorim, Robson Luis; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Hosp Clin, Div Neurosurg, BR-05403010 Sao Paulo, SP, Brazil; [Neville, Iuri Santana; Hayashi, Cintya Yukie; Costa Zaninotto, Ana Luiza; Sousa, Leonardo Moura, Jr.; Nagumo, Marcia Mitie; Brunoni, Andre Russowsky; Oliveira Amorim, Robson Luis; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Serv Interdisciplinary Neuromodulat, BR-05403010 Sao Paulo, SP, Brazil; [Hayashi, Cintya Yukie] Univ Sao Paulo, Sch Nursing, BR-05403010 Sao Paulo, SP, Brazil; [El Hajj, Simone Alves; Costa Zaninotto, Ana Luiza; Sabino, Juliana Perez; Silva Shieh, Barbara Dal Forno] Univ Sao Paulo, Hosp Clin, Div Neuropsychol, BR-05403010 Sao Paulo, SP, Brazil; [Neville, Iuri Santana; Sousa, Leonardo Moura, Jr.; Brunoni, Andre Russowsky; Oliveira Amorim, Robson Luis; Teixeira, Manoel Jacobsen; Paiva, Wellingson Silva] Univ Sao Paulo, Hosp Clin, Inst Psychiat, BR-05403010 Sao Paulo, SP, Brazil		Neville, IS (corresponding author), Univ Sao Paulo, Hosp Clin, Div Neurosurg, Rua Dr Eneas Aguiar 255-4079, BR-05403010 Sao Paulo, SP, Brazil.	iurineville@yahoo.com.br	Zaninotto, Ana Luiza C./I-4095-2016; Brunoni, Andre R./H-8394-2012; Paiva, Wellingson S/G-5517-2013; Amorim, Robson/AAK-1368-2021; Neville, Iuri S/P-5360-2014; Neville, Iuri/AAI-2852-2021	Zaninotto, Ana Luiza C./0000-0003-0639-0612; Brunoni, Andre R./0000-0002-6310-3571; Paiva, Wellingson S/0000-0002-5165-7040; Amorim, Robson/0000-0003-2391-7519; Neville, Iuri S/0000-0002-8561-9069; Neville, Iuri/0000-0002-8561-9069	Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazilian National Council for Scientific and Technological Development)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [459077/2014-7]; NARSAD Young Investigator from the Brain & Behavior Research FoundationNARSAD [13/20493]; FAPESP Young Researcher from the Sao Paulo State FoundationFundacao de Amparo a Pesquisa do Estado de Sao Paulo (FAPESP) [12/20911-5]; National Council for Scientific and Technological Development (CNPq)Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPQ) [13/470904]	The authors would like to acknowledge Ricardo Galhardoni (PhD) for the training provided and helpful discussions during the protocol design. We also acknowledge Vinicius Guirado (MD) for all his contribution during the recruitment. We acknowledge the Conselho Nacional de Desenvolvimento Cientifico e Tecnologico (CNPq, Brazilian National Council for Scientific and Technological Development) which awarded a grant (#459077/2014-7) to fund this study protocol. The principal investigator applied for the Chamada Universal (Universal Call, #14/2014), whose main goal is to select projects that could significantly contribute to the scientific and technologic development and innovation of the country (Brazil). ARB is supported by the following grants: 2013 NARSAD Young Investigator from the Brain & Behavior Research Foundation (Grant Number 13/20493), 2012 FAPESP Young Researcher from the Sao Paulo State Foundation (Grant Number 12/20911-5) and National Council for Scientific and Technological Development (CNPq, Grant Number 13/470904).	ADAMS JH, 1982, ANN NEUROL, V12, P557, DOI 10.1002/ana.410120610; Anderkova L, 2014, J NEUROL SCI, V339, P15, DOI 10.1016/j.jns.2014.01.037; Barr MS, 2013, BIOL PSYCHIAT, V73, P510, DOI 10.1016/j.biopsych.2012.08.020; Beam W, 2009, BRAIN STIMUL, V2, P50, DOI 10.1016/j.brs.2008.09.006; BECK AT, 1991, J ANXIETY DISORD, V5, P213, DOI 10.1016/0887-6185(91)90002-B; Benedict R., 1997, BRIEF VISUOSPATIAL M; Benedict RHB, 1998, CLIN NEUROPSYCHOL, V12, P43, DOI 10.1076/clin.12.1.43.1726; Bonni S, 2013, NEUROL SCI, V34, P2053, DOI 10.1007/s10072-013-1412-y; Lima DPD, 2008, INJURY, V39, P604, DOI 10.1016/j.injury.2007.11.008; Demirtas-Tatlidede A, 2013, NEUROPHARMACOLOGY, V64, P566, DOI 10.1016/j.neuropharm.2012.06.020; Demirtas-Tatlidede A, 2012, J HEAD TRAUMA REHAB, V27, P274, DOI 10.1097/HTR.0b013e318217df55; Esbjornsson E, 2013, J REHABIL MED, V45, P771, DOI 10.2340/16501977-1170; GENNARELLI TA, 1982, J NEUROSURG, V56, P26, DOI 10.3171/jns.1982.56.1.0026; Gorenstein C, 1996, BRAZ J MED BIOL RES, V29, P453; Jeurissen D, 2014, FRONT NEUROSCI-SWITZ, V8, DOI 10.3389/fnins.2014.00018; Kawai N, 2010, J NEUROTRAUM, V27, P2131, DOI 10.1089/neu.2010.1464; Kinnunen KM, 2011, BRAIN, V134, P449, DOI 10.1093/brain/awq347; Kraus MF, 2007, BRAIN, V130, P2508, DOI 10.1093/brain/awm216; Lezak MD., 1995, NEUROPSYCHOLOGICAL A, V3rd; Fernandez AL, 2009, CLIN NEUROPSYCHOL, V23, P501, DOI 10.1080/13854040802279675; Maset A, 1993, ARQ BRAS NEUROCIRURG, V12, P293; Mathias JL, 2005, BRAIN INJURY, V19, P271, DOI 10.1080/02699050400005028; MAXWELL WL, 1994, ACTA NEUROCHIR, P465; Meythaler JM, 2001, ARCH PHYS MED REHAB, V82, P1461, DOI 10.1053/apmr.2001.25137; Nadeau SE, 2014, COGN BEHAV NEUROL, V27, P77, DOI 10.1097/WNN.0000000000000031; Nielson DM, ARCH PHYS MED REHABI; Pape TLB, 2009, BRAIN STIMUL, V2, P22, DOI 10.1016/j.brs.2008.09.004; Rabey JM, 2013, J NEURAL TRANSM, V120, P813, DOI 10.1007/s00702-012-0902-z; Reilly PL, 2001, J CLIN NEUROSCI, V8, P398, DOI 10.1054/jocn.2001.0916; Rossi S, 2009, CLIN NEUROPHYSIOL, V120, P2008, DOI 10.1016/j.clinph.2009.08.016; Skandsen T, 2010, ARCH PHYS MED REHAB, V91, P1904, DOI 10.1016/j.apmr.2010.08.021; Skandsen T, 2010, J NEUROSURG, V113, P556, DOI 10.3171/2009.9.JNS09626; Spielberger CD., 1970, STATE TRAIT ANXIETY; Spreen O., 1998, COMPENDIUM NEUROPSYC, V2nd ed.); Strauss E., 2006, COMPENDIUM NEUROPSYC, V3rd; Styrke J, 2007, J NEUROTRAUM, V24, P1425, DOI 10.1089/neu.2007.0266; Thurman, 2001, HEAD TRAUMA BASIC PR, P1193; Tiffin, 1968, PURDUE PEGBOARD EXAM; Wang JY, 2008, ARCH NEUROL-CHICAGO, V65, P619, DOI 10.1001/archneur.65.5.619; Warner MA, 2010, J NEUROTRAUM, V27, P2121, DOI 10.1089/neu.2010.1429; Wechsler D., 1998, MANUAL WECHSLER ADUL	41	15	17	2	34	BMC	LONDON	CAMPUS, 4 CRINAN ST, LONDON N1 9XW, ENGLAND	1745-6215			TRIALS	Trials	OCT 5	2015	16								440	10.1186/s13063-015-0944-2			7	Medicine, Research & Experimental	Science Citation Index Expanded (SCI-EXPANDED)	Research & Experimental Medicine	CS6DI	WOS:000362167200002	26438108	Green Published, gold			2022-02-06	
J	Zhan, J; Gao, L; Zhou, FQ; Kuang, HM; Zhao, J; Wang, SY; He, LC; Zeng, XJ; Gong, HH				Zhan, Jie; Gao, Lei; Zhou, Fuqing; Kuang, Hongmei; Zhao, Jing; Wang, Siyong; He, Laichang; Zeng, Xianjun; Gong, Honghan			Decreased Regional Homogeneity in Patients With Acute Mild Traumatic Brain Injury A Resting-State fMRI Study	JOURNAL OF NERVOUS AND MENTAL DISEASE			English	Article						Acute brain injuries; mTBI; functional MRI; resting-state; regional homogeneity	DEFAULT-MODE NETWORK; MINI-MENTAL-STATE; WORKING-MEMORY; SALIENCE NETWORK; FUNCTIONAL CONNECTIVITY; MOTOR CORTEX; DISEASE; ABNORMALITIES; CONCUSSION; DISRUPTION	Mild traumatic brain injury (mTBI) is characterized by structural disconnection and large-scale neural network dysfunction in the resting state. However, little is known concerning the intrinsic changes in local spontaneous brain activity in patients with mTBI. The aim of the current study was to assess regional synchronization in acute mTBI patients. Fifteen acute mTBI patients and 15 sex-, age-, and education-matched healthy controls (HCs) were studied. We used the regional homogeneity (ReHo) method to map local connectivity across the whole brain and performed a two-sample t-test between the two groups. Compared with HCs, patients with acute mTBI showed significantly decreased ReHo in the left insula, left precentral/postcentral gyrus, and left supramarginal gyrus (p < 0.05, AlphaSim corrected). The ReHo index of the left insula showed a positive correlation with the Mini-Mental State Examination (MMSE) scores across all acute mTBI patients (p < 0.05, uncorrected). The ReHo method may provide an objective biomarker for evaluating the functional abnormity of mTBI in the acute setting.	[Zhan, Jie; Gao, Lei; Zhou, Fuqing; Kuang, Hongmei; Zhao, Jing; Wang, Siyong; He, Laichang; Zeng, Xianjun; Gong, Honghan] Nanchang Univ, Affiliated Hosp 1, Dept Radiol, Nanchang City 330006, Jiangxi, Peoples R China		Gong, HH (corresponding author), Nanchang Univ, Affiliated Hosp 1, Dept Radiol, 17 Yongwai Zheng St, Nanchang City 330006, Jiangxi, Peoples R China.	ncumd.cn@gmail.com		Gao, Lei/0000-0002-0081-0172	National Natural Science Foundations of ChinaNational Natural Science Foundation of China (NSFC) [81260217, 81460263]	This study was supported by grants from the National Natural Science Foundations of China (grant no. 81260217, 81460263).	Agcaoglu O, 2015, NEUROIMAGE, V104, P310, DOI 10.1016/j.neuroimage.2014.09.001; BECK AT, 1961, ARCH GEN PSYCHIAT, V4, P561, DOI 10.1001/archpsyc.1961.01710120031004; Binkofski F, 2002, J NEUROPHYSIOL, V88, P514, DOI 10.1152/jn.2002.88.1.514; BISWAL B, 1995, MAGNET RESON MED, V34, P537, DOI 10.1002/mrm.1910340409; Bonnelle V, 2012, P NATL ACAD SCI USA, V109, P4690, DOI 10.1073/pnas.1113455109; Byrnes Kimberly R, 2014, Front Neuroenergetics, V5, P13, DOI 10.3389/fnene.2013.00013; Capehart B, 2012, J REHABIL RES DEV, V49, P789, DOI 10.1682/JRRD.2011.10.0185; Chen CJ, 2012, RADIOLOGY, V264, P844, DOI 10.1148/radiol.12112154; Chiong W, 2013, BRAIN, V136, P1929, DOI 10.1093/brain/awt066; Chu Z, 2010, AM J NEURORADIOL, V31, P340, DOI 10.3174/ajnr.A1806; Crowe DA, 2004, EXP BRAIN RES, V158, P28, DOI 10.1007/s00221-004-1876-3; de Guise E, 2011, APPL NEUROPSYCHOL, V18, P179, DOI 10.1080/09084282.2011.595444; Deschamps I, 2014, NEUROPSYCHOLOGIA, V53, P39, DOI 10.1016/j.neuropsychologia.2013.10.015; Dettwiler A, 2014, J NEUROTRAUM, V31, P180, DOI 10.1089/neu.2013.2983; FOLSTEIN MF, 1975, J PSYCHIAT RES, V12, P189, DOI 10.1016/0022-3956(75)90026-6; Garcia-Panach J, 2011, J NEUROTRAUM, V28, P1707, DOI 10.1089/neu.2011.1851; Ghiso Jorge A, 2013, J Glaucoma, V22 Suppl 5, pS36, DOI 10.1097/IJG.0b013e3182934af6; Goldin PR, 2008, BIOL PSYCHIAT, V63, P577, DOI 10.1016/j.biopsych.2007.05.031; Graner J, 2013, FRONT NEUROL, V4, DOI 10.3389/fneur.2013.00016; HAMILTON M, 1959, BRIT J MED PSYCHOL, V32, P50, DOI 10.1111/j.2044-8341.1959.tb00467.x; Hartwigsen G, 2010, P NATL ACAD SCI USA, V107, P16494, DOI 10.1073/pnas.1008121107; Hummer TA, 2013, BIOL PSYCHIAT, V73, P136, DOI 10.1016/j.biopsych.2012.06.036; Iraji A, 2015, J NEUROTRAUM, V32, P1031, DOI 10.1089/neu.2014.3610; JacqminGadda H, 1997, AM J EPIDEMIOL, V145, P498; Jilka SR, 2014, J NEUROSCI, V34, P10798, DOI 10.1523/JNEUROSCI.0518-14.2014; Johnson B, 2012, NEUROIMAGE, V59, P511, DOI 10.1016/j.neuroimage.2011.07.081; Kiviniemi V, 2008, HUM BRAIN MAPP, V29, P810, DOI 10.1002/hbm.20582; Ma ZL, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0053148; Mac Donald CL, 2011, NEW ENGL J MED, V364, P2091, DOI 10.1056/NEJMoa1008069; Manoach DS, 1997, NEUROREPORT, V8, P545, DOI 10.1097/00001756-199701200-00033; Marin JR, 2014, JAMA-J AM MED ASSOC, V311, P1917, DOI 10.1001/jama.2014.3979; Mayer AR, 2011, HUM BRAIN MAPP, V32, P1825, DOI 10.1002/hbm.21151; McAllister TW, 2011, J NEUROPSYCH CLIN N, V23, P277, DOI 10.1176/appi.neuropsych.23.3.277; Messe A, 2011, HUM BRAIN MAPP, V32, P999, DOI 10.1002/hbm.21092; MUFSON EJ, 1982, J COMP NEUROL, V212, P23, DOI 10.1002/cne.902120103; Newsome MR, 2007, CORTEX, V43, P95, DOI 10.1016/S0010-9452(08)70448-9; Paakki JJ, 2010, BRAIN RES, V1321, P169, DOI 10.1016/j.brainres.2009.12.081; Rajab AS, 2014, FRONT HUM NEUROSCI, V8, DOI 10.3389/fnhum.2014.00625; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; Smits M, 2011, NEURORADIOLOGY, V53, P553, DOI 10.1007/s00234-010-0774-6; Sours C, 2013, BRAIN RES, V1537, P201, DOI 10.1016/j.brainres.2013.08.034; Sridharan D, 2008, P NATL ACAD SCI USA, V105, P12569, DOI 10.1073/pnas.0800005105; Stevens MC, 2012, BRAIN IMAGING BEHAV, V6, P293, DOI 10.1007/s11682-012-9157-4; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; TEASDALE G, 1974, LANCET, V2, P81; Vakhtin AA, 2013, BRAIN INJURY, V27, P1304, DOI 10.3109/02699052.2013.823561; Wang L, 2013, PLOS ONE, V8, DOI 10.1371/journal.pone.0060191; Witt ST, 2010, BRAIN IMAGING BEHAV, V4, P232, DOI 10.1007/s11682-010-9102-3; Wu T, 2009, HUM BRAIN MAPP, V30, P1502, DOI 10.1002/hbm.20622; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803; Yan CG, 2013, NEUROIMAGE, V80, P246, DOI 10.1016/j.neuroimage.2013.04.081; Yan CG, 2010, FRONT SYST NEUROSCI, V4, DOI 10.3389/fnsys.2010.00013; Zang YF, 2004, NEUROIMAGE, V22, P394, DOI 10.1016/j.neuroimage.2003.12.030; Zhang DY, 2010, NAT REV NEUROL, V6, P15, DOI 10.1038/nrneurol.2009.198; Zhang ZQ, 2012, NEUROIMAGE, V59, P1429, DOI 10.1016/j.neuroimage.2011.08.049; Zhou FQ, 2014, NEUROSCI LETT, V558, P192, DOI 10.1016/j.neulet.2013.11.022; Zhou YX, 2012, RADIOLOGY, V265, P882, DOI 10.1148/radiol.12120748; Zuo XN, 2013, NEUROIMAGE, V65, P374, DOI 10.1016/j.neuroimage.2012.10.017	58	15	17	0	9	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0022-3018	1539-736X		J NERV MENT DIS	J. Nerv. Ment. Dis.	OCT	2015	203	10					786	791		10.1097/NMD.0000000000000368			6	Clinical Neurology; Psychiatry	Science Citation Index Expanded (SCI-EXPANDED); Social Science Citation Index (SSCI)	Neurosciences & Neurology; Psychiatry	CT3LU	WOS:000362709000009	26348589				2022-02-06	
J	Zhang, J; Ge, W; Yuan, Z				Zhang, Jian; Ge, Wei; Yuan, Zhen			In vivo three-dimensional characterization of the adult zebrafish brain using a 1325 nm spectral-domain optical coherence tomography system with the 27 frame/s video rate	BIOMEDICAL OPTICS EXPRESS			English	Article							LIGHT-SHEET MICROSCOPY; RECONSTRUCTION; DYNAMICS; PROLIFERATION; NEUROGENESIS	In this study, a spectral-domain optical coherence tomography (SD-OCT) system was used for noninvasive imaging of the adult zebrafish brain. Based on a 1325 nm light source and two high-speed galvo mirrors, our SD-OCT system can offer a large field of view of brain morphology with high resolution (12 mu m axial and 13 mu m lateral) at video rate (27 frame/s). In vivo imaging of both the control and injured brain was performed using adult zebrafish model. The recovered results revealed that olfactory bulb, optic commissure, telencephalon, tectum opticum, cerebellum, medulla, preglomerular complex and posterior tuberculum could be clearly identified in the cross-sectional SD-OCT images of the adult zebrafish brain. The reconstructed results also suggested that SD-OCT can be used for diagnosis and monitoring of traumatic brain injury. In particular, we found the reconstructed volumetric SD-OCT images enable a comprehensive three-dimensional characterization of the control or injured brain in the intact zebrafish. (C)2015 Optical Society of America	[Zhang, Jian; Ge, Wei; Yuan, Zhen] Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China		Zhang, J (corresponding author), Univ Macau, Fac Hlth Sci, Taipa, Macau, Peoples R China.	zhenyuan@umac.mo	Yuan, zhen/ABG-3111-2020; , 镜海真人（袁振）/ABG-2380-2020	Yuan, Zhen/0000-0003-3061-6263	University of Macau in Macau; FDCT grant from Macao government [026/2014/A1];  [SRG2013-00035-FHS];  [MYRG2014-00093-FHS];  [MYRG2015-00036-FHS]	Authors would like to thank Dr. Weiting Chen and Yuqin Fan for their help of raising zebrafish. This study was supported from University of Macau in Macau, SRG2013-00035-FHS Grant, MYRG2014-00093-FHS Grant, MYRG2015-00036-FHS grant and FDCT grant 026/2014/A1 from Macao government.	Ahrens MB, 2013, NAT METHODS, V10, P413, DOI [10.1038/NMETH.2434, 10.1038/nmeth.2434]; Ahrens MB, 2012, NATURE, V485, P471, DOI 10.1038/nature11057; An L, 2011, BIOMED OPT EXPRESS, V2, P2770, DOI 10.1364/BOE.2.002770; Giraldez AJ, 2005, SCIENCE, V308, P833, DOI 10.1126/science.1109020; Grandel H, 2006, DEV BIOL, V295, P263, DOI 10.1016/j.ydbio.2006.03.040; Hariri S, 2014, J BIOMED OPT, V19, DOI 10.1117/1.JBO.19.10.106013; Hillman EMC, 2007, J BIOMED OPT, V12, DOI 10.1117/1.2789693; Kagemann L, 2008, MOL VIS, V14, P2157; Keller PJ, 2008, SCIENCE, V322, P1065, DOI 10.1126/science.1162493; Kyritsis N, 2012, SCIENCE, V338, P1353, DOI 10.1126/science.1228773; Lie DC, 2004, ANNU REV PHARMACOL, V44, P399, DOI 10.1146/annurev.pharmtox.44.101802.121631; Lin YS, 2013, J BIOPHOTONICS, V6, P668, DOI 10.1002/jbio.201200069; Ma ZH, 2010, BIOMED OPT EXPRESS, V1, P798, DOI 10.1364/BOE.1.000798; Mahmood F, 2013, BRAIN, V136, P1488, DOI 10.1093/brain/awt043; Mueller T, 2008, J COMP NEUROL, V507, P1245, DOI 10.1002/cne.21604; Mueller T, 2012, FRONT NEUROSCI-SWITZ, V6, DOI 10.3389/fnins.2012.00064; Rao KD, 2009, J BIOPHOTONICS, V2, P288, DOI 10.1002/jbio.200910032; Ronneberger O, 2012, NAT METHODS, V9, P735, DOI [10.1038/NMETH.2076, 10.1038/nmeth.2076]; Siebel AM, 2011, BRAIN RES BULL, V86, P385, DOI 10.1016/j.brainresbull.2011.08.017; Strangman G, 2002, BIOL PSYCHIAT, V52, P679, DOI 10.1016/S0006-3223(02)01550-0; Wullimann MF, 2004, J COMP NEUROL, V475, P143, DOI 10.1002/cne.20183; Yuan Z, 2014, BIOMED OPT EXPRESS, V5, P3011, DOI 10.1364/BOE.5.003011; Yuan Z, 2013, BIOMED OPT EXPRESS, V4, P2629, DOI 10.1364/BOE.4.002629; Yun SH, 2003, OPT EXPRESS, V11, P3598, DOI 10.1364/OE.11.003598; Zhang Q., 2014, J INNOV OPT HEAL SCI, V8; Zhang ZW, 2015, MOL ENDOCRINOL, V29, P76, DOI 10.1210/me.2014-1256	26	15	16	0	16	OPTICAL SOC AMER	WASHINGTON	2010 MASSACHUSETTS AVE NW, WASHINGTON, DC 20036 USA	2156-7085			BIOMED OPT EXPRESS	Biomed. Opt. Express	OCT 1	2015	6	10					3932	3940		10.1364/BOE.6.003932			9	Biochemical Research Methods; Optics; Radiology, Nuclear Medicine & Medical Imaging	Science Citation Index Expanded (SCI-EXPANDED)	Biochemistry & Molecular Biology; Optics; Radiology, Nuclear Medicine & Medical Imaging	CS7AT	WOS:000362236600025	26504643	Green Published, gold			2022-02-06	
J	Armstrong, E; Hersh, D; Katzenellenbogen, JM; Coffin, J; Thompson, SC; Ciccone, N; Hayward, C; Flicker, L; Woods, D; McAllister, M				Armstrong, Elizabeth; Hersh, Deborah; Katzenellenbogen, Judith M.; Coffin, Juli; Thompson, Sandra C.; Ciccone, Natalie; Hayward, Colleen; Flicker, Leon; Woods, Deborah; McAllister, Meaghan			Study Protocol: Missing Voices - Communication Difficulties after Stroke and Traumatic Brain Injury in Aboriginal Australians	BRAIN IMPAIRMENT			English	Article						Aboriginal; stroke; traumatic brain injury; acquired communication disorder; rehabilitation; speech pathology; health worker; Australia; aphasia; dysarthria	CHRONIC DISEASE; INDIGENOUS AUSTRALIANS; COGNITIVE ASSESSMENT; APHASIA; PEOPLE; CARE; EXPERIENCES; SERVICES; IMPACT	Background: Aboriginal and Torres Strait Islander Australians experience stroke and traumatic brain injury (TBI) with much greater frequency than non-Aboriginal Australians. Acquired communication disorders (ACD) can result from these conditions and can significantly impact everyday life. Yet few Aboriginal people access rehabilitation services and little is known about Aboriginal peoples' experiences of ACD. This paper describes the protocol surrounding a study that aims to explore the extent and impact of ACD in Western Australian Aboriginal populations following stroke or TBI and develop a culturally appropriate screening tool for ACD and accessible and culturally appropriate service delivery models. Method/Design: The 3-year, mixed methods study is being conducted in metropolitan Perth and five regional centres in Western Australia. Situated within an Aboriginal research framework, methods include an analysis of linked routine hospital admission data and retrospective file audits, development of a screening tool for ACD, interviews with people with ACD, their families, and health professionals, and drafting of alternative service delivery models. Discussion: This study will address the extent of ACD in Aboriginal populations and document challenges for Aboriginal people in accessing speech pathology services. Documenting the burden and impact of ACD within a culturally secure framework is a forerunner to developing better ways to address the problems faced by Aboriginal people with ACD and their families. This will in turn increase the likelihood that Aboriginal people with ACD will be diagnosed and referred to professional support to improve their communication, quality of life and functioning within the family and community context. Keywords: Aboriginal, stroke, traumatic brain injury, acquired	[Armstrong, Elizabeth; Hersh, Deborah; Ciccone, Natalie; McAllister, Meaghan] Edith Cowan Univ, Sch Psychol & Social Sci, Joondalup, WA 6025, Australia; [Katzenellenbogen, Judith M.; Thompson, Sandra C.] Univ Western Australia, Western Australian Ctr Rural Hlth, Geraldton, WA, Australia; [Coffin, Juli] Univ Western Australia, Telethon Inst Child Hlth Res, Perth, WA 6009, Australia; [Coffin, Juli; Woods, Deborah] Geraldton Reg Aboriginal Med Serv, Geraldton, WA, Australia; [Hayward, Colleen] Edith Cowan Univ, Ctr Indigenous Australian Educ & Res, Kurongkurl Katitjin, Perth, WA, Australia; [Flicker, Leon] Univ Western Australia, Med Res Ctr, Perth, WA 6009, Australia		Armstrong, E (corresponding author), Edith Cowan Univ, Sch Psychol & Social Sci, 270 Joondalup Dr, Joondalup, WA 6025, Australia.	b.armstrong@ecu.edu.au	Thompson, Sandra/H-5955-2014	Thompson, Sandra/0000-0003-0327-7155; Ciccone, Natalie/0000-0002-1822-7217; Armstrong, Elizabeth/0000-0003-4469-1117; Flicker, Leon/0000-0002-3650-0475; Hersh, Deborah/0000-0003-2466-0225; Katzenellenbogen, Judith/0000-0001-5287-5819	National Health and Medical Research Council ProjectNational Health and Medical Research Council of Australia [1046228]	The study is funded by National Health and Medical Research Council Project Grant #1046228.	Armstrong E, 2015, DISABIL REHABIL, V37, P1462, DOI 10.3109/09638288.2014.972581; Armstrong E, 2012, INT J SPEECH-LANG PA, V14, P271, DOI 10.3109/17549507.2011.663790; Australian Health Ministers' Advisory Council, 2011, AB TORR STRAIT ISL H; Australian Institute of Health and Welfare, 2004, HEART STROK VASC DIS; Australian Institute of Health and Welfare, 2008, IND TORR STRAIT ISL; Bessarab D., 2010, INT J CRIT INDIG STU, V3, P37; Brameld K, 1999, AM J KIDNEY DIS, V34, P1033, DOI 10.1016/S0272-6386(99)70008-9; Braun V., 2006, QUAL RES PSYCHOL, V3, P77, DOI [10.1191/1478088706qp063oa, DOI 10.1191/1478088706QP063OA]; Cass A, 2002, MED J AUSTRALIA, V176, P466, DOI 10.5694/j.1326-5377.2002.tb04517.x; Coffin Juli, 2007, ABORIGINAL ISLANDER, V31, P22; Cruice M, 2011, DISABIL REHABIL, V33, P219, DOI 10.3109/09638288.2010.503835; Dalemans R, 2009, CLIN REHABIL, V23, P948, DOI 10.1177/0269215509337197; Davidson P., 2010, RES METHODS HLTH FDN, P61; Dept. of Health of Western Australia, 2011, EP INJ W AUSTR 2000; Dingwall KM, 2010, AUST NZ J PSYCHIAT, V44, P20, DOI 10.3109/00048670903393670; Durey A, 2012, INTERN MED J, V42, P17, DOI 10.1111/j.1445-5994.2011.02628.x; Enderby P, 1996, DISABIL REHABIL, V18, P238, DOI 10.3109/09638289609166307; Engelter ST, 2006, STROKE, V37, P1379, DOI 10.1161/01.STR.0000221815.64093.8c; Faux S, 2009, TOP STROKE REHABIL, V16, P1, DOI [10.1310/tsr1601-01, 10.1310/tsr1601-1]; Gauld S, 2011, DISABIL REHABIL, V33, P1901, DOI 10.3109/09638288.2010.550382; Helander E. P., 2007, ASIA PACIFIC DISABIL, V18, P3; Hersh D, 2015, INT J SPEECH-LANG PA, V17, P74, DOI 10.3109/17549507.2014.923510; Hersh D, 2015, DISABIL REHABIL, V37, P33, DOI 10.3109/09638288.2014.890675; Hilari K, 2011, DISABIL REHABIL, V33, P211, DOI 10.3109/09638288.2010.508829; Hilari K, 2009, INT J LANG COMM DIS, V44, P193, DOI 10.1080/13682820802008820; Holman CDJ, 1999, AUST NZ J PUBL HEAL, V23, P453, DOI 10.1111/j.1467-842X.1999.tb01297.x; Jamieson LM, 2008, MED J AUSTRALIA, V188, P576, DOI 10.5694/j.1326-5377.2008.tb01793.x; Katzenellenbogen JM, 2011, STROKE, V42, P1515, DOI 10.1161/STROKEAHA.110.601799; Kauhanen ML, 2000, CEREBROVASC DIS, V10, P455, DOI 10.1159/000016107; Kilkenny MF, 2013, INT J STROKE, V8, P164, DOI 10.1111/j.1747-4949.2011.00717.x; Landau J., 2008, FAMILIES SYSTEMS HLT, V26, P69, DOI [10.1037/1091-7527.26.1.69, DOI 10.1037/1091-7527.26.1.69]; Laycock A., 2011, RES INDIGENOUS HLTH; Liamputtong P., 2009, QUALITATIVE RES METH; Liaw ST, 2011, AUST NZ J PUBL HEAL, V35, P238, DOI 10.1111/j.1753-6405.2011.00701.x; LoGiudice D, 2006, INT PSYCHOGERIATR, V18, P269, DOI 10.1017/S1041610205002681; LOMAS J, 1989, J SPEECH HEAR DISORD, V54, P113, DOI 10.1044/jshd.5401.113; Lowell A, 2012, INT J SPEECH-LANG PA, V14, P200, DOI 10.3109/17549507.2012.663791; Luck AM, 2007, APHASIOLOGY, V21, P208, DOI 10.1080/02687030601065470; MCLELLAN K, 2011, NZ MED J, V124, P1; McLellan KM, 2014, APHASIOLOGY, V28, P453, DOI 10.1080/02687038.2013.845740; National Health & Medical Research Council, 2003, NH MRC VAL ETH GUID; National Stroke Foundation, 2004, NAT STROK UN PROGR I; Purdy N, 2010, WORKING TOGETHER ABO; Quan HD, 2005, MED CARE, V43, P1130, DOI 10.1097/01.mlr.0000182534.19832.83; Queensland Health, 2010, JOURN AFT STROK; Shahid S, 2011, AUST HEALTH REV, V35, P235, DOI 10.1071/AH09835; Shahid S, 2009, BMC MED RES METHODOL, V9, DOI 10.1186/1471-2288-9-60; Shahid S, 2009, AUST NZ J PUBL HEAL, V33, P109, DOI 10.1111/j.1753-6405.2009.00355.x; Speech Pathology Australia, 2014, SUBM INQ PREV DIFF T; Tate R.L., 1998, J AUSTR NZ PUBLIC HL, V22, P11; Taylor KP, 2009, AUST HEALTH REV, V33, P549, DOI 10.1071/AH090549; Taylor S. J., 1994, CHALLENGES SERVICE S, P43; Temkin NR, 2009, J HEAD TRAUMA REHAB, V24, P460, DOI 10.1097/HTR.0b013e3181c13413; Thrift AG, 2011, STROKE, V42, P1501, DOI 10.1161/STROKEAHA.111.617746; Vos T, 2009, INT J EPIDEMIOL, V38, P470, DOI 10.1093/ije/dyn240; Zabiela C., 2007, ACQUIRING KNOWLEDGE, V9, P39	56	15	15	0	14	CAMBRIDGE UNIV PRESS	NEW YORK	32 AVENUE OF THE AMERICAS, NEW YORK, NY 10013-2473 USA	1443-9646	1839-5252		BRAIN IMPAIR	Brain Impair.	SEP	2015	16	2					145	156		10.1017/BrImp.2015.15			12	Clinical Neurology; Neurosciences; Rehabilitation	Science Citation Index Expanded (SCI-EXPANDED)	Neurosciences & Neurology; Rehabilitation	CV0MJ	WOS:000363944500007					2022-02-06	
J	Caeyenberghs, K; Siugzdaite, R; Drijkoningen, D; Marinazzo, D; Swinnen, SP				Caeyenberghs, Karen; Siugzdaite, Roma; Drijkoningen, David; Marinazzo, Daniele; Swinnen, Stephan P.			Functional Connectivity Density and Balance in Young Patients with Traumatic Axonal Injury	BRAIN CONNECTIVITY			English	Article						brain injury; functional connectivity density; fMRI; hubs; network; postural control; resting-state		Our previous study provided some evidence for the relationship between abnormal structural connectivity and poor balance performance in young traumatic axonal injury (TAI) patients. An enhanced understanding of the functional connectivity following TAI may allow targeted treatments geared toward improving brain function and postural control. Twelve patients with TAI and 28 normally developing children (aged 9-19 years) performed the sensory organization test (SOT) protocol of the EquiTest (Neurocom). All participants were scanned using resting-state functional magnetic resonance imaging series along with anatomical scans. We applied "functional connectivity density mapping'' (FCDM), a voxel-wise data-driven method that calculates individual functional connectivity maps to obtain both short-range and long-range FCD. Findings revealed that the TAI group scored generally lower than the control group on the SOT, especially when proprioceptive feedback was compromised. Between-group maps noted significantly decreased long-range FCD in the TAI group in frontal and subcortical regions and significantly increased short-range FCD in frontal regions, left inferior parietal, and cerebellar lobules. Moreover, lower balance levels in TAI patients were associated with a lower long-range FCD in left putamen and cerebellar vermis. These findings suggest that long-range connections may be more vulnerable to TAI than short-range connections. Moreover, higher values of short-range FCD may suggest adaptive mechanisms in the TAI group. Finally, this study supports the view that FCDM is a valuable tool for selectively predicting functional motor deficits in TAI patients.	[Caeyenberghs, Karen] Univ Ghent, Fac Med & Hlth Sci, Dept Phys Therapy & Motor Rehabil, Ghent, Belgium; [Caeyenberghs, Karen] Univ Ghent, Fac Med & Hlth Sci, Dept Movement & Sport Sci, Ghent, Belgium; [Siugzdaite, Roma; Marinazzo, Daniele] Univ Ghent, Fac Psychol & Pedag Sci, Dept Data Anal, Ghent, Belgium; [Drijkoningen, David; Swinnen, Stephan P.] Katholieke Univ Leuven, Grp Biomed Sci, Movement Control & Neuroplast Res Grp, Leuven, Belgium		Caeyenberghs, K (corresponding author), Dept Phys Therapy & Motor Rehabil, Campus Heymans UZ 2B3,Pintelaan 185, B-9000 Ghent, Belgium.	karen.caeyenberghs@ugent.be	Marinazzo, Daniele/H-4793-2019	Marinazzo, Daniele/0000-0002-9803-0122; Caeyenberghs, Karen/0000-0001-7009-6843	Research Programme of the Research Foundation-Flanders (FWO)FWO [G.0482.10, G.A114.11]	Support for this study was provided through a grant from the Research Programme of the Research Foundation-Flanders (FWO; Levenslijn G.0482.10 and G.A114.11).	Basford JR, 2003, ARCH PHYS MED REHAB, V84, P343, DOI 10.1053/apmr.2003.50034; Burgess PW, 2007, TRENDS COGN SCI, V11, P290, DOI 10.1016/j.tics.2007.05.004; Caeyenberghs K, 2014, BRAIN STRUCT FUNCT, V219, P193, DOI 10.1007/s00429-012-0494-2; Caeyenberghs K, 2012, NEUROIMAGE-CLIN, V1, P106, DOI 10.1016/j.nicl.2012.09.011; Caeyenberghs K, 2009, BRAIN, V132, P684, DOI 10.1093/brain/awn344; Caeyenberghs K, 2010, HUM BRAIN MAPP, V31, P992, DOI 10.1002/hbm.20911; Chan LL, 2014, PARKINSONISM RELAT D, V20, P53, DOI 10.1016/j.parkreldis.2013.09.017; Coffman KA, 2011, P NATL ACAD SCI USA, V108, P16068, DOI 10.1073/pnas.1107904108; Cordes D, 2001, AM J NEURORADIOL, V22, P1326; Duarte M, 2002, EXP BRAIN RES, V146, P60, DOI 10.1007/s00221-002-1154-1; Foerster BU, 2005, MAGNET RESON MED, V54, P1261, DOI 10.1002/mrm.20695; Gagnon I, 2004, ARCH PHYS MED REHAB, V85, P444, DOI 10.1016/j.apmr.2003.06.014; Gagnon I, 1998, BRAIN INJURY, V12, P843, DOI 10.1080/026990598122070; Gagnon I, 2001, J HEAD TRAUMA REHAB, V16, P595, DOI 10.1097/00001199-200112000-00007; GEORGE R, 1994, EXP NEUROL, V129, P225, DOI 10.1006/exnr.1994.1164; Geurts ACH, 1999, ARCH PHYS MED REHAB, V80, P144, DOI 10.1016/S0003-9993(99)90111-9; Geurts ACH, 1996, ARCH PHYS MED REHAB, V77, P639, DOI 10.1016/S0003-9993(96)90001-5; Goble DJ, 2012, HUM BRAIN MAPP, V33, P895, DOI 10.1002/hbm.21257; GRAYBIEL AM, 1990, REV NEUROL, V146, P570; Guskiewicz KM, 1997, MED SCI SPORT EXER, V29, pS213; Hulkower MB, 2013, AM J NEURORADIOL, V34, P2064, DOI 10.3174/ajnr.A3395; INGERSOLL CD, 1992, MED SCI SPORT EXER, V24, P739; Kaufman KR, 2006, MED ENG PHYS, V28, P234, DOI 10.1016/j.medengphy.2005.05.005; Keightley ML, 2014, J NEUROTRAUM, V31, P437, DOI [10.1089/NEU.2013.3052, 10.1089/neu.2013.3052]; LEHMANN JF, 1990, ARCH PHYS MED REHAB, V71, P955; Malec JF, 2007, J NEUROTRAUM, V24, P1417, DOI 10.1089/neu.2006.0245; NEISTADT ME, 1994, AM J OCCUP THER, V48, P225, DOI 10.5014/ajot.48.3.225; O'Reilly JX, 2010, CEREB CORTEX, V20, P953, DOI 10.1093/cercor/bhp157; Oliveira LF, 1996, PHYSIOL MEAS, V17, P305, DOI 10.1088/0967-3334/17/4/008; Palacios EM, 2013, JAMA NEUROL, V70, P845, DOI 10.1001/jamaneurol.2013.38; Pandit AS, 2013, NEUROLOGY, V80, P1826, DOI 10.1212/WNL.0b013e3182929f38; Picard N, 2001, CURR OPIN NEUROBIOL, V11, P663, DOI 10.1016/S0959-4388(01)00266-5; POVLISHOCK JT, 1992, BRAIN PATHOL, V2, P1; Povlishock JT, 2005, J HEAD TRAUMA REHAB, V20, P76, DOI 10.1097/00001199-200501000-00008; Power JD, 2012, NEUROIMAGE, V59, P2142, DOI 10.1016/j.neuroimage.2011.10.018; Prosperini L, 2013, RADIOLOGY, V268, P181, DOI 10.1148/radiol.13121695; Ralchle ME, 2007, NEUROIMAGE, V37, P1083, DOI 10.1016/j.neuroimage.2007.02.041; Ramnani N, 2012, CEREBELLUM, V11, P366, DOI 10.1007/s12311-011-0272-3; Riemann BL, 2000, J ATHL TRAINING, V35, P19; Rizzolatti G, 1998, ELECTROEN CLIN NEURO, V106, P283, DOI 10.1016/S0013-4694(98)00022-4; RUBIN AM, 1995, AM J OTOL, V16, P216; Sharp DJ, 2014, NAT REV NEUROL, V10, P156, DOI 10.1038/nrneurol.2014.15; Sharp DJ, 2011, BRAIN, V134, P2233, DOI 10.1093/brain/awr175; Shumskaya E, 2012, NEUROLOGY, V79, P175, DOI 10.1212/WNL.0b013e31825f04fb; SHUMWAYCOOK A, 1986, PHYS THER, V66, P1548, DOI 10.1093/ptj/66.10.1548; Song XW, 2011, PLOS ONE, V6, DOI 10.1371/journal.pone.0025031; Stoodley CJ, 2009, NEUROIMAGE, V44, P489, DOI 10.1016/j.neuroimage.2008.08.039; Tang L, 2011, RADIOLOGY, V260, P831, DOI 10.1148/radiol.11110014; Tomasi D, 2012, MOL PSYCHIATR, V17, P549, DOI 10.1038/mp.2011.81; Tomasi D, 2012, BIOL PSYCHIAT, V71, P443, DOI 10.1016/j.biopsych.2011.11.003; Tomasi D, 2012, HUM BRAIN MAPP, V33, P849, DOI 10.1002/hbm.21252; Tomasi D, 2011, NEUROIMAGE, V57, P908, DOI 10.1016/j.neuroimage.2011.05.024; Tomasi D, 2010, P NATL ACAD SCI USA, V107, P9885, DOI 10.1073/pnas.1001414107; Ungerleider LG, 1998, P NATL ACAD SCI USA, V95, P883, DOI 10.1073/pnas.95.3.883; Van Impe A, 2012, NEUROBIOL AGING, V33, P1900, DOI 10.1016/j.neurobiolaging.2011.06.013; Wang TY, 2014, BRAIN RES, V1563, P41, DOI 10.1016/j.brainres.2014.03.015; Ward B. D., 2000, SIMULTANEOUS INFEREN; WARREN M, 1993, AM J OCCUP THER, V47, P55, DOI 10.5014/ajot.47.1.55; Weiner KS, 2011, NEUROIMAGE, V56, P2183, DOI 10.1016/j.neuroimage.2011.03.041	59	15	15	0	9	MARY ANN LIEBERT, INC	NEW ROCHELLE	140 HUGUENOT STREET, 3RD FL, NEW ROCHELLE, NY 10801 USA	2158-0014	2158-0022		BRAIN CONNECT	Brain Connect.	SEP	2015	5	7			SI		423	432		10.1089/brain.2014.0293			10	Neurosciences	Emerging Sources Citation Index (ESCI)	Neurosciences & Neurology	VG7GK	WOS:000448203700003	25327385	Green Published			2022-02-06	
J	Joseph, B; Haider, AA; Pandit, V; Tang, A; Kulvatunyou, N; O'Keeffe, T; Rhee, P				Joseph, Bellal; Haider, Ansab A.; Pandit, Viraj; Tang, Andrew; Kulvatunyou, Narong; O'Keeffe, Terence; Rhee, Peter			Changing Paradigms in the Management of 2184 Patients With Traumatic Brain Injury	ANNALS OF SURGERY			English	Article; Proceedings Paper	135th Annual Meeting of the American-Surgical-Association (ASA)	APR 23-25, 2015	San Diego, CA	Amer Surg Assoc		acute care surgeons; brain injury guidelines; changing management; changing trends in traumatic brain injury; neurosurgical consultation; no repeat scans; repeat CT scans; traumatic brain injury	CRANIAL COMPUTED-TOMOGRAPHY; UNITED-STATES; HEAD TRAUMA; LOW-RISK; LEVEL I; MILD; CARE; HEMORRHAGE; COVERAGE; MODERATE	Objectives: The aim of this study was to assess the change in trends in the management of traumatic brain injury (TBI) at a level I trauma center and the utilization of resources as a result of this change in management. Background: The management of TBI has been evolving with trends toward management of minimally injured patients with intracranial hemorrhage exclusively by trauma surgeons. Methods: A 5-year (2009-2014) prospective database on all patients with TBI (skull fracture/intracranial hemorrhage on head computed tomography) presenting to a level I trauma center was analyzed for patient demographics, injuries, admission physiology, computed tomographic scan results, and hospital outcomes. These records were matched to the institutional registry and hospital financial database. Results: A total of 2184 patients were included with median (interquartile range) Glasgow Coma Scale score of 15 (12-15), and median (interquartile range) head-abbreviated injury scale score of 3 (2-4). The distribution of types and size of intracranial bleeds remained unchanged throughout the study period. The proportion of TBI managed exclusively by trauma surgeons increased significantly over the years from 6.8% to 40.1% (P < 0.001). Proportion of patients who received neurosurgical consultations (P < 0.001) and repeat head computed tomographic scans (P < 0.001), hospital length of stay (P = 0.028), and costs (P < 0.001) decreased significantly over time. The overall mortality rate (18.5%) and rate of intervention (14.1%) remained unchanged. Conclusions: TBI patients can be selectively managed without initially involving neurosurgeons safely in a cost-effective manner, resulting in more effective use of precious resources.	[Joseph, Bellal; Haider, Ansab A.; Pandit, Viraj; Tang, Andrew; Kulvatunyou, Narong; O'Keeffe, Terence; Rhee, Peter] Univ Arizona, Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, 1501 N Campbell Ave,Rm 5411,POB 245063, Tucson, AZ 85727 USA		Joseph, B (corresponding author), Univ Arizona, Med Ctr, Dept Surg, Div Trauma & Acute Care Surg, 1501 N Campbell Ave,Rm 5411,POB 245063, Tucson, AZ 85727 USA.	bjoseph@surgery.arizona.edu					Almenawer SA, 2013, NEUROSURGERY, V72, P56, DOI 10.1227/NEU.0b013e318276f899; [Anonymous], 2015, REP C MILD TRAUM BRA; Aziz H, 2013, J TRAUMA ACUTE CARE, V75, P550, DOI 10.1097/TA.0b013e3182a53a77; Barker DE, 2006, AM SURGEON, V72, P1166; Blackwell CD, 2007, ANN EMERG MED, V49, P320, DOI 10.1016/j.annemergmed.2006.09.025; Borczuk P, 2013, J TRAUMA ACUTE CARE, V74, P1504, DOI 10.1097/TA.0b013e31829215cf; Brown CVR, 2004, J TRAUMA, V57, P939, DOI 10.1097/01.TA.0000149492.92558.03; Connon FF, 2011, ANN SURG, V254, P1028, DOI 10.1097/SLA.0b013e318219727f; Ditty BJ, 2014, J NEUROSURG, V19, P1; Esposito TJ, 2005, ANN SURG, V242, P364, DOI 10.1097/01.sla.0000179624.50455.db; Homnick A, 2012, INJURY, V43, P2122, DOI 10.1016/j.injury.2012.04.013; Huynh T, 2006, AM SURGEON, V72, P1162; Il'Giovine Z, 2015, DO ALL PATIENTS MILD; JERET JS, 1993, NEUROSURGERY, V32, P9, DOI 10.1227/00006123-199301000-00002; Joseph B, 2014, J TRAUMA ACUTE CARE, V77, P984, DOI 10.1097/TA.0000000000000428; Joseph B, 2014, J AM COLL SURGEONS, V219, P45, DOI 10.1016/j.jamcollsurg.2013.12.062; Joseph B, 2014, J TRAUMA ACUTE CARE, V76, P965, DOI 10.1097/TA.0000000000000161; Joseph B, 2013, J TRAUMA ACUTE CARE, V75, P102, DOI 10.1097/TA.0b013e3182946667; Kaups KL, 2004, J TRAUMA, V56, P475, DOI 10.1097/01.TA.0000114304.56006.D4; Klein Y, 2010, J TRAUMA, V69, P544, DOI 10.1097/TA.0b013e3181c99936; Levy AS, 2014, WORLD NEUROSURG, V82, pE319, DOI 10.1016/j.wneu.2013.11.008; da Silva PSL, 2008, J TRAUMA, V65, P1293, DOI 10.1097/TA.0b013e318156866c; O'Keefe GE, 1999, ANN SURG, V229, P409, DOI 10.1097/00000658-199903000-00015; Overton TL, 2014, AM J SURG, V208, P806, DOI 10.1016/j.amjsurg.2014.02.012; Patel NY, 2000, J TRAUMA, V48, P367, DOI 10.1097/00005373-200003000-00001; Rao MB, 2010, ACAD EMERG MED, V17, P1374, DOI 10.1111/j.1553-2712.2010.00927.x; Shackford SR, 2004, J TRAUMA, V56, P480; Sifri ZC, 2006, J TRAUMA, V61, P862, DOI 10.1097/01.ta.0000224225.54982.90; Spain DA, 1998, J TRAUMA, V45, P101, DOI 10.1097/00005373-199807000-00022; STEIN SC, 1990, NEUROSURGERY, V26, P638, DOI 10.1227/00006123-199004000-00012; Stippler M, 2012, EMERG MED J, V29, P528, DOI 10.1136/emermed-2011-200162; Sugerman DE, 2012, J TRAUMA ACUTE CARE, V73, P1491, DOI 10.1097/TA.0b013e3182782675; Thompson HJ, 2006, J AM GERIATR SOC, V54, P1590, DOI 10.1111/j.1532-5415.2006.00894.x; Thurman D, 1999, JAMA-J AM MED ASSOC, V282, P954, DOI 10.1001/jama.282.10.954; van Essen TA, 2010, CLIN NEUROL NEUROSUR, V112, P775, DOI 10.1016/j.clineuro.2010.06.012	35	15	15	0	2	LIPPINCOTT WILLIAMS & WILKINS	PHILADELPHIA	TWO COMMERCE SQ, 2001 MARKET ST, PHILADELPHIA, PA 19103 USA	0003-4932	1528-1140		ANN SURG	Ann. Surg.	SEP	2015	262	3					440	448		10.1097/SLA.0000000000001418			9	Surgery	Science Citation Index Expanded (SCI-EXPANDED); Conference Proceedings Citation Index - Science (CPCI-S)	Surgery	DD0LZ	WOS:000369612800005	26258312				2022-02-06	
J	Kasmaei, VM; Asadi, P; Zohrevandi, B; Raouf, MT				Kasmaei, Vahid Monsef; Asadi, Payman; Zohrevandi, Behzad; Raouf, Mohammad Taghi			An Epidemiologic Study of Traumatic Brain Injuries in Emergency Department	EMERGENCY			English	Article						Brain injuries; head injuries; epidemiology; mortality; risk factors	IMPACT; LEGISLATION; OUTCOMES	Introduction: Traumatic brain injuries (TBI) are one of the most important causes of death in patients under the age of 25 years and is responsible for one third of total deaths caused by trauma. Therefore, knowing its epidemiologic pattern in different populations seems vital. Therefore, this study aims to examine the epidemiologic pattern of TBI in emergency department. Methods: In this cross-sectional study, the profiles of 1000 patients affected by TBI were selected using simple random sampling. The examined variables in this study included demographic, season, mechanism of injury, accompanying injuries, level of consciousness, hospitalization duration, computed tomography (CT) scan results, needing surgery, admission to intensive care unit, and outcome of the patient. In the end, independent risk factors for the death of patients were determined. Results: 1000 patients suffering from were studied (81.8% male; mean age 38.5 +/- 21.7 years). The frequency of their referral to hospital in spring (31.4%) was more (p<0.01). 45.9% of the patients had a level of consciousness less than 9 based on the Glasgow Coma Scale (GCS). Subdural (45.9%) and epidural bleeding (23.7%) were the most common findings in CT scans in this study (p<0.001). Finally, 233 (23.3%) of the patients were dead. Over 60 years of age, falling and motorcycle accidents, intracranial hemorrhage accompanied by brain contusion, subdural bleeding, a GCS of less than 9, and the need to be admitted to intensive care unit were independent risk factors of death in TBI. Conclusion: Age Over 60 years, falling and motorcycle accidents, intracranial hemorrhage accompanied by brain contusion, subdural bleeding, a GCS of less than 9, and need to be admitted to intensive care unit were independent risk factors for the death in TBI patients.	[Kasmaei, Vahid Monsef; Asadi, Payman; Zohrevandi, Behzad; Raouf, Mohammad Taghi] Guilan Univ Med Sci, Rd Trauma Res Ctr, Rasht, Iran		Asadi, P (corresponding author), Guilan Univ Med Sci, Rd Trauma Res Ctr, Rasht, Iran.	payman.asadi@yahoo.com	Raouf, Mohammad Taghi/AAH-7883-2021; Zohrevandi, Behzad/AAH-7283-2021	Raouf, Mohammad Taghi/0000-0001-8579-3115			Andelic N, 2008, NEUROEPIDEMIOLOGY, V30, P120, DOI 10.1159/000120025; Asadi P, 2014, IRAN J EMERG MED, V1, P28; Chlu WT, 2007, J CLIN NEUROSCI, V14, P930, DOI 10.1016/j.jocn.2006.08.004; Ducrocq SC, 2006, PEDIATR CRIT CARE ME, V7, P461, DOI 10.1097/01.PCC.0000235245.49129.27; Fakharian E, 2007, FEYZ J KASHAN UNI ME, V11, P21; Faul M, 2010, TRAUMATIC BRAIN INJU, P2; Greenwald BD, 2010, ARCH PHYS MED REHAB, V91, P3; Hijar M, 2012, REV PANAM SALUD PUBL, V32, P70, DOI 10.1590/S1020-49892012000700011; Hukkelhoven CWPM, 2003, J NEUROSURG, V99, P666, DOI 10.3171/jns.2003.99.4.0666; Kleiven Svein, 2003, Inj Control Saf Promot, V10, P173, DOI 10.1076/icsp.10.3.173.14552; Leitgeb J, 2013, ARCH ORTHOP TRAUM SU, V133, P659, DOI 10.1007/s00402-013-1710-0; Maas AIR, 2008, LANCET NEUROL, V7, P728, DOI 10.1016/S1474-4422(08)70164-9; Maegele M, 2007, EUR SURG RES, V39, P372, DOI 10.1159/000107097; Masson F, 2001, J TRAUMA, V51, P481, DOI 10.1097/00005373-200109000-00010; McGarry LJ, 2002, J TRAUMA, V53, P1152, DOI 10.1097/00005373-200212000-00020; Park E, 2010, CMAJ, V178, P1163; Roozenbeek B, 2013, NAT REV NEUROL, V9, P231, DOI 10.1038/nrneurol.2013.22; Saadat S, 2015, EMERGENCY, V3, P16; Steudel WI, 2005, ACTA NEUROCHIR, V147, P231, DOI 10.1007/s00701-004-0441-y; Tohme S, 2014, SCAND J TRAUMA RESUS, V22, DOI 10.1186/1757-7241-22-1; World Health Organization, 2008, VIOL INJ DIS BIENN 2; Wu X, 2008, J TRAUMA, V64, P1313, DOI 10.1097/TA.0b013e318165c803	22	15	15	2	2	SHAHID BEHESHTI UNIV MEDICAL SCIENCES, FAC MED	TEHRAN	SCH MEDICINE, KOODAK-YAR ST, PO BOX 19359, TEHRAN, 4618, IRAN	2345-4571			EMERGENCY	Emergency	FAL	2015	3	4					141	145					5	Emergency Medicine	Emerging Sources Citation Index (ESCI)	Emergency Medicine	V9Z6K	WOS:000409498900003	26495403				2022-02-06	
